id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
17114577|NCT00003702|38252438|FG000|Overall Study|Ineligible cell types|2|||
17114578|NCT00003702|38252439|FG001|Overall Study|Ineligible cell types|2|||
17114579|NCT00003702|38252438|FG000|Overall Study|Did not meet criteria for persistence|8|||
17114580|NCT00003702|38252439|FG001|Overall Study|Did not meet criteria for persistence|5|||
17114581|NCT00003702|38252438|FG000|Overall Study|WHO score > 6|2|||
17114582|NCT00003702|38252439|FG001|Overall Study|WHO score > 6|1|||
17114583|NCT00003702|38252438|FG000|Overall Study|Inadequate documentation of disease|1|||
17114584|NCT00003702|38252439|FG001|Overall Study|Inadequate documentation of disease|3|||
17114585|NCT00031590|38252446|FG000|Overall Study|Adverse Event|1|||
17114586|NCT00031590|38252446|FG000|Overall Study|Withdrawal by parents|2|||
17114587|NCT00239681|38252453|FG000|Overall Study|Adverse Event|100|||
17114588|NCT00239681|38252454|FG001|Overall Study|Adverse Event|99|||
17114589|NCT00239681|38252453|FG000|Overall Study|Withdrawal by Subject|458|||
17114590|NCT00239681|38252454|FG001|Overall Study|Withdrawal by Subject|489|||
17114591|NCT00239681|38252453|FG000|Overall Study|Lost to Follow-up|28|||
17114592|NCT00239681|38252454|FG001|Overall Study|Lost to Follow-up|22|||
17114593|NCT00239681|38252453|FG000|Overall Study|Protocol Violation|4|||
17114594|NCT00239681|38252454|FG001|Overall Study|Protocol Violation|4|||
17114595|NCT00239681|38252453|FG000|Overall Study|Physician Decision|13|||
17114596|NCT00239681|38252454|FG001|Overall Study|Physician Decision|17|||
17114597|NCT00239681|38252453|FG000|Overall Study|No information chacked on CaseReportForm|90|||
17114598|NCT00239681|38252454|FG001|Overall Study|No information chacked on CaseReportForm|84|||
17114599|NCT02878330|38252462|FG000|Overall Study|Death|3|||
17114600|NCT02878330|38252463|FG001|Overall Study|Death|2|||
17114601|NCT02878330|38252462|FG000|Overall Study|Lost to Follow-up|11|||
17114602|NCT02878330|38252463|FG001|Overall Study|Lost to Follow-up|26|||
17114603|NCT02878330|38252462|FG000|Overall Study|Withdrawal by Subject|11|||
17114604|NCT02878330|38252463|FG001|Overall Study|Withdrawal by Subject|21|||
17114605|NCT02878330|38252462|FG000|Overall Study|Other|4|||
17114606|NCT02878330|38252463|FG001|Overall Study|Other|7|||
17114607|NCT00238433|38252470|FG000|Overall Study|Screen failure|1|||
17114608|NCT00238433|38252470|FG000|Overall Study|Lost to Follow-up|1|||
17114609|NCT00238433|38252470|FG000|Overall Study|Death|1|||
17114610|NCT00045162|38252477|FG000|Overall Study|Ineligible|12|||
17201375|NCT00805129|38355643|FG000|Overall Study|Not treated|1|||
17201376|NCT02668185|38355647|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
17201377|NCT02668185|38355648|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
17201378|NCT02668185|38355647|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
17114611|NCT00045162|38252478|FG001|Overall Study|Ineligible|8|||
17114612|NCT00045162|38252477|FG000|Overall Study|Not treated|7|||
17114613|NCT00045162|38252478|FG001|Overall Study|Not treated|2|||
17114614|NCT00045162|38252477|FG000|Overall Study|Adverse Event|55|||
17114615|NCT00045162|38252478|FG001|Overall Study|Adverse Event|50|||
17114616|NCT00045162|38252477|FG000|Overall Study|Lack of Efficacy|32|||
17201379|NCT02668185|38355648|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
17201380|NCT02668185|38355647|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
17201381|NCT02668185|38355648|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
17201382|NCT02668185|38355647|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
17201383|NCT02668185|38355648|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
16941289|NCT01202773|38085853|FG000|Overall Study|Adverse Event|4|||
16941290|NCT01202773|38085854|FG001|Overall Study|Adverse Event|5|||
17027976|NCT00736476|38172318|FG000|Overall Study|Adverse Event|1|||
17027977|NCT00736476|38172319|FG001|Overall Study|Adverse Event|0|||
17027978|NCT00715299|38172331|FG000|Overall Study|Withdrawal by Subject|1|||
17027979|NCT00715299|38172331|FG000|Overall Study|Adverse Event|3|||
17027980|NCT00715299|38172331|FG000|Overall Study|failed the pre-screen exercise test|2|||
17027981|NCT00730236|38172335|FG000|Overall Study|Adverse Event|4|||
17027982|NCT00730236|38172335|FG000|Overall Study|Withdrawal by Subject|1|||
17027983|NCT00730236|38172335|FG000|Overall Study|Non-compliance|1|||
17027984|NCT00714285|38172343|FG000|Overall Study|Lost to Follow-up|0|||
17114617|NCT00045162|38252478|FG001|Overall Study|Lack of Efficacy|29|||
17114618|NCT00045162|38252477|FG000|Overall Study|Death|10|||
17114619|NCT00045162|38252478|FG001|Overall Study|Death|10|||
17114620|NCT00045162|38252477|FG000|Overall Study|Withdrawal by Subject|5|||
17114621|NCT00045162|38252478|FG001|Overall Study|Withdrawal by Subject|3|||
17114622|NCT00045162|38252477|FG000|Overall Study|Other|21|||
17114623|NCT00045162|38252478|FG001|Overall Study|Other|16|||
17114624|NCT02748616|38252484|FG000|Overall Study|Lost to Follow-up|1|||
17114625|NCT02748616|38252484|FG000|Overall Study|Withdrawal by Subject|2|||
17114626|NCT02748616|38252484|FG000|Overall Study|Physician Decision|2|||
17114627|NCT02748616|38252484|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
17201384|NCT02742181|38355659|FG000|Overall Study|Physician Decision|1|||
17027985|NCT00714285|38172344|FG001|Overall Study|Lost to Follow-up|2|||
17114628|NCT00238121|38252490|FG000|Overall Study|Withdrawal by Subject|1|||
17114629|NCT00238121|38252491|FG001|Overall Study|Withdrawal by Subject|1|||
17114630|NCT00238121|38252490|FG000|Overall Study|Adverse Event|2|||
17114631|NCT00238121|38252491|FG001|Overall Study|Adverse Event|1|||
17114632|NCT03139552|38252496|FG000|Overall Study|unable to attend tasting due to schedule|3|||
17114633|NCT03804918|38252507|FG000|Overall Study|Participant did not use the app|1|||
17114634|NCT03139240|38252515|FG000|Overall Study|Lost to Follow-up|0|||
17114635|NCT03139240|38252516|FG001|Overall Study|Lost to Follow-up|1|||
17114636|NCT03139240|38252517|FG002|Overall Study|Lost to Follow-up|1|||
17114637|NCT03139240|38252518|FG003|Overall Study|Lost to Follow-up|0|||
17114638|NCT00237809|38252530|FG000|Overall Study|Lost to Follow-up|11|||
17114639|NCT00237809|38252531|FG001|Overall Study|Lost to Follow-up|10|||
17114640|NCT00237809|38252532|FG002|Overall Study|Lost to Follow-up|9|||
17114641|NCT00237809|38252533|FG003|Overall Study|Lost to Follow-up|9|||
17114642|NCT00003498|38252543|FG000|Overall Study|Not evaluable.|4|||
17114643|NCT00003492|38252547|FG000|Overall Study|Not evaluable|6|||
17114644|NCT03136198|38252553|FG000|Overall Study|Withdrawal by Subject|0|||
17114645|NCT03136198|38252554|FG001|Overall Study|Withdrawal by Subject|1|||
17114646|NCT00042666|38252560|FG000|Overall Study|Adverse Event|2|||
17114647|NCT00042666|38252560|FG000|Overall Study|Death|4|||
17114648|NCT00042666|38252560|FG000|Overall Study|Protocol Violation|1|||
17114649|NCT00042666|38252560|FG000|Overall Study|Participant/Physician Perception|1|||
17114650|NCT00042666|38252560|FG000|Overall Study|Progressive Disease|41|||
17114651|NCT00042666|38252560|FG000|Overall Study|Other|1|||
17114652|NCT00042666|38252560|FG000|Overall Study|Other|4|||
17114653|NCT00042432|38252567|FG000|Overall Study|Adverse Event|4|||
17114654|NCT00042432|38252568|FG001|Overall Study|Adverse Event|1|||
17114655|NCT00042432|38252567|FG000|Overall Study|Withdrawal by Subject|1|||
17114656|NCT00042432|38252568|FG001|Overall Study|Withdrawal by Subject|3|||
17114657|NCT00042432|38252567|FG000|Overall Study|Death|0|||
17114658|NCT00042432|38252568|FG001|Overall Study|Death|2|||
17114659|NCT00042432|38252567|FG000|Overall Study|Ineligibility determined|1|||
17114660|NCT00042432|38252568|FG001|Overall Study|Ineligibility determined|0|||
17114661|NCT00042432|38252567|FG000|Overall Study|Initiation of maintenance dialysis|1|||
17114662|NCT00042432|38252568|FG001|Overall Study|Initiation of maintenance dialysis|1|||
17114663|NCT00042432|38252567|FG000|Overall Study|Other|2|||
17114664|NCT00042432|38252568|FG001|Overall Study|Other|0|||
17114665|NCT00003474|38252574|FG000|Overall Study|Not Evaluable|14|||
17114666|NCT01542736|38252578|FG000|Overall Study|Death|1|||
17114667|NCT01346410|38252582|FG000|Overall Study|Death|1|||
17114668|NCT00003456|38252586|FG000|Overall Study|Not evaluable|8|||
17114669|NCT02719522|38252590|FG000|Overall Study|Implant Failure|4|||
17114670|NCT02719522|38252590|FG000|Overall Study|Death|2|||
17114671|NCT02719522|38252590|FG000|Overall Study|Lost to Follow-up|5|||
17114672|NCT00237185|38252596|FG000|Core|Adverse Event|3|||
17114673|NCT00237185|38252597|FG001|Core|Adverse Event|4|||
17114674|NCT00237185|38252596|FG000|Core|Abnormal laboratory value|0|||
17114675|NCT00237185|38252597|FG001|Core|Abnormal laboratory value|4|||
17114676|NCT00237185|38252596|FG000|Core|Abnormal test procedure results|1|||
17114677|NCT00237185|38252597|FG001|Core|Abnormal test procedure results|0|||
17114678|NCT00237185|38252596|FG000|Core|Lack of Efficacy|30|||
17114679|NCT00237185|38252597|FG001|Core|Lack of Efficacy|23|||
17114680|NCT00237185|38252596|FG000|Core|Protocol Violation|1|||
17114681|NCT00237185|38252597|FG001|Core|Protocol Violation|1|||
17114682|NCT00237185|38252596|FG000|Core|Withdrawal by Subject|4|||
17114683|NCT00237185|38252597|FG001|Core|Withdrawal by Subject|4|||
17114684|NCT00237185|38252596|FG000|Core|Administrative problems|0|||
17114685|NCT00237185|38252597|FG001|Core|Administrative problems|1|||
17114686|NCT00237185|38252596|FG000|Core|Death|4|||
17114687|NCT00237185|38252597|FG001|Core|Death|0|||
17114688|NCT00237185|38252596|FG000|Core|Determined ineligible post randomization|1|||
17114689|NCT00237185|38252597|FG001|Core|Determined ineligible post randomization|0|||
17114690|NCT00237185|38252596|FG000|Extension|Adverse Event|1|||
17114691|NCT00237185|38252597|FG001|Extension|Adverse Event|0|||
17114692|NCT00237185|38252596|FG000|Extension|Abnormal laboratory value|0|||
17114693|NCT00237185|38252597|FG001|Extension|Abnormal laboratory value|1|||
17114694|NCT00237185|38252596|FG000|Extension|Lack of Efficacy|9|||
17114695|NCT00237185|38252597|FG001|Extension|Lack of Efficacy|14|||
17114696|NCT00237185|38252596|FG000|Extension|Condition no longer required study drug|0|||
17201385|NCT02742181|38355660|FG001|Overall Study|Physician Decision|0|||
17114697|NCT00237185|38252597|FG001|Extension|Condition no longer required study drug|1|||
17114698|NCT00237185|38252596|FG000|Extension|Withdrawal by Subject|3|||
17114699|NCT00237185|38252597|FG001|Extension|Withdrawal by Subject|2|||
17114700|NCT00237185|38252596|FG000|Extension|Lost to Follow-up|1|||
17114701|NCT00237185|38252597|FG001|Extension|Lost to Follow-up|0|||
17114702|NCT00237185|38252596|FG000|Extension|Administrative problems|1|||
17114703|NCT00237185|38252597|FG001|Extension|Administrative problems|0|||
17114704|NCT00237185|38252596|FG000|Extension|Death|1|||
17201386|NCT02742103|38355668|FG000|Overall Study|Protocol Violation|1|||
17114705|NCT00237185|38252597|FG001|Extension|Death|1|||
17114706|NCT00003222|38252605|FG000|Overall Study|Physician Decision|0|||
17114707|NCT00003222|38252606|FG001|Overall Study|Physician Decision|1|||
17114708|NCT02877082|38252612|FG000|Overall Study|Trial was closed early|5|||
17114709|NCT00003138|38252618|FG000|Step 1|Reasons off treatment not documented|60|||
17114710|NCT00003138|38252619|FG001|Step 1|Reasons off treatment not documented|57|||
17114711|NCT00003138|38252618|FG000|Step 1|Never started treatment|1|||
17114712|NCT00003138|38252619|FG001|Step 1|Never started treatment|0|||
17114713|NCT00003138|38252618|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
17114714|NCT00003138|38252619|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
17114715|NCT00003138|38252618|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
17114716|NCT00003138|38252619|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
17114717|NCT00003138|38252618|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
17114718|NCT00003138|38252619|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
17114719|NCT00003138|38252618|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
17114720|NCT00003138|38252619|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
17114721|NCT02875834|38252632|FG000|Open-label Phase|Withdrawal by Subject|3|||
17114722|NCT02875834|38252633|FG001|Open-label Phase|Withdrawal by Subject|0|||
17114723|NCT02875834|38252634|FG002|Open-label Phase|Withdrawal by Subject|0|||
17114724|NCT02875834|38252635|FG003|Open-label Phase|Withdrawal by Subject|0|||
17114725|NCT02875834|38252632|FG000|Open-label Phase|(Not collected)|4|||
17114726|NCT02875834|38252633|FG001|Open-label Phase|(Not collected)|0|||
17114727|NCT02875834|38252634|FG002|Open-label Phase|(Not collected)|0|||
17114728|NCT02875834|38252635|FG003|Open-label Phase|(Not collected)|0|||
17114729|NCT02875834|38252632|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
17114730|NCT02875834|38252633|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
17114731|NCT02875834|38252634|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
17114732|NCT02875834|38252635|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
17114733|NCT02875834|38252632|FG000|Randomized Treatment Phase|Protocol Violation|0|||
17114734|NCT02875834|38252633|FG001|Randomized Treatment Phase|Protocol Violation|2|||
17114735|NCT02875834|38252634|FG002|Randomized Treatment Phase|Protocol Violation|0|||
17114736|NCT02875834|38252635|FG003|Randomized Treatment Phase|Protocol Violation|0|||
17114737|NCT02875834|38252632|FG000|Randomized Treatment Phase|(Not collected)|0|||
17114738|NCT02875834|38252633|FG001|Randomized Treatment Phase|(Not collected)|9|||
17114739|NCT02875834|38252634|FG002|Randomized Treatment Phase|(Not collected)|10|||
17114740|NCT02875834|38252635|FG003|Randomized Treatment Phase|(Not collected)|9|||
17114741|NCT02875366|38252647|FG000|Overall Study|Adverse Event|0|||
17114742|NCT02875366|38252648|FG001|Overall Study|Adverse Event|2|||
17114743|NCT02875366|38252647|FG000|Overall Study|Noncompliance|0|||
17114744|NCT02875366|38252648|FG001|Overall Study|Noncompliance|1|||
17114745|NCT00003102|38252657|FG000|Overall Study|Physician Decision|1|||
17114746|NCT00003102|38252658|FG001|Overall Study|Physician Decision|1|||
17114747|NCT00003102|38252659|FG002|Overall Study|Physician Decision|0|||
17114748|NCT00003102|38252657|FG000|Overall Study|Progressive Disease|0|||
17114749|NCT00003102|38252658|FG001|Overall Study|Progressive Disease|1|||
17114750|NCT00003102|38252659|FG002|Overall Study|Progressive Disease|0|||
17114751|NCT00003102|38252657|FG000|Overall Study|Adverse Event|0|||
17114752|NCT00003102|38252658|FG001|Overall Study|Adverse Event|1|||
17114753|NCT00003102|38252659|FG002|Overall Study|Adverse Event|1|||
17114754|NCT00003102|38252657|FG000|Overall Study|Death|0|||
17114755|NCT00003102|38252658|FG001|Overall Study|Death|0|||
17114756|NCT00003102|38252659|FG002|Overall Study|Death|1|||
17114757|NCT00002850|38252670|FG000|Overall Study|Death|4|||
17114758|NCT00002850|38252671|FG001|Overall Study|Death|1|||
17114759|NCT00002850|38252672|FG002|Overall Study|Death|3|||
17114760|NCT00002850|38252670|FG000|Overall Study|Protocol Violation|1|||
17114761|NCT00002850|38252671|FG001|Overall Study|Protocol Violation|0|||
17114762|NCT00002850|38252672|FG002|Overall Study|Protocol Violation|1|||
17114763|NCT00002850|38252670|FG000|Overall Study|Withdrawal by Subject|0|||
17114764|NCT00002850|38252671|FG001|Overall Study|Withdrawal by Subject|1|||
17114765|NCT00002850|38252672|FG002|Overall Study|Withdrawal by Subject|0|||
17114766|NCT00002766|38252682|FG000|Overall Study|Withdrawal by Subject|0|||
17114767|NCT00002766|38252683|FG001|Overall Study|Withdrawal by Subject|1|||
17114768|NCT00002766|38252682|FG000|Overall Study|Patient Not Treated|1|||
17114769|NCT00002766|38252683|FG001|Overall Study|Patient Not Treated|2|||
17114770|NCT00002766|38252682|FG000|Overall Study|Adverse Event|1|||
17114771|NCT00002766|38252683|FG001|Overall Study|Adverse Event|1|||
17114772|NCT00002766|38252682|FG000|Overall Study|Protocol Violation|1|||
17114773|NCT00002766|38252683|FG001|Overall Study|Protocol Violation|0|||
17114774|NCT02306122|38252696|FG000|Initial Physician Randomization|Physician Decision|0|||
17114775|NCT02306122|38252697|FG001|Initial Physician Randomization|Physician Decision|0|||
17114776|NCT02306122|38252698|FG002|Initial Physician Randomization|Physician Decision|0|||
17114777|NCT02306122|38252699|FG003|Initial Physician Randomization|Physician Decision|0|||
17114778|NCT02306122|38252700|FG004|Initial Physician Randomization|Physician Decision|0|||
17114779|NCT02306122|38252701|FG005|Initial Physician Randomization|Physician Decision|0|||
17114780|NCT02306122|38252702|FG006|Initial Physician Randomization|Physician Decision|0|||
17114781|NCT02306122|38252703|FG007|Initial Physician Randomization|Physician Decision|0|||
17114782|NCT02306122|38252704|FG008|Initial Physician Randomization|Physician Decision|1|||
17114783|NCT02306122|38252705|FG009|Initial Physician Randomization|Physician Decision|0|||
17114784|NCT02306122|38252706|FG010|Initial Physician Randomization|Physician Decision|0|||
17114785|NCT00001962|38252724|FG000|Overall Study|Lack of Efficacy|18|||
17114786|NCT00001962|38252724|FG000|Overall Study|Lack of Accrual|6|||
17114787|NCT00001962|38252724|FG000|Overall Study|Death|1|||
17114788|NCT00001962|38252724|FG000|Overall Study|Lost to Follow-up|2|||
17114789|NCT00001962|38252724|FG000|Overall Study|Adverse Event|1|||
17114790|NCT00028002|38252728|FG000|Overall Study|Withdrawal by Subject|3|||
17114791|NCT00028002|38252728|FG000|Overall Study|Ineligible|8|||
17114792|NCT00256997|38252735|FG000|Overall Study|Protocol Violation|1|||
17114793|NCT00256997|38252736|FG001|Overall Study|Protocol Violation|4|||
17114794|NCT00256997|38252735|FG000|Overall Study|Lack of Efficacy|1|||
17114795|NCT00256997|38252736|FG001|Overall Study|Lack of Efficacy|4|||
17114796|NCT00256997|38252735|FG000|Overall Study|Death|2|||
17114797|NCT00256997|38252736|FG001|Overall Study|Death|0|||
17114798|NCT00256997|38252735|FG000|Overall Study|Adverse Event|4|||
17114799|NCT00256997|38252736|FG001|Overall Study|Adverse Event|0|||
17114800|NCT00256997|38252735|FG000|Overall Study|Lost to Follow-up|3|||
17114801|NCT00256997|38252736|FG001|Overall Study|Lost to Follow-up|5|||
17114802|NCT00256997|38252735|FG000|Overall Study|Withdrawal by Subject|13|||
17114803|NCT00256997|38252736|FG001|Overall Study|Withdrawal by Subject|3|||
17114804|NCT00256997|38252735|FG000|Overall Study|Started but not treated|2|||
17114805|NCT00256997|38252736|FG001|Overall Study|Started but not treated|0|||
17114806|NCT00256997|38252735|FG000|Overall Study|Other|5|||
17114807|NCT00256997|38252736|FG001|Overall Study|Other|8|||
17114808|NCT00256997|38252735|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
17114809|NCT00256997|38252736|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
17114810|NCT00256997|38252735|FG000|Overall Study|Participant Non-compliant|3|||
17114811|NCT00256997|38252736|FG001|Overall Study|Participant Non-compliant|6|||
17114812|NCT00256997|38252735|FG000|Overall Study|Investigator Withdrew Participant|2|||
17114813|NCT00256997|38252736|FG001|Overall Study|Investigator Withdrew Participant|1|||
17114814|NCT00027846|38252746|FG000|Overall Study|Lost to Follow-up|0|||
17114815|NCT00027846|38252747|FG001|Overall Study|Lost to Follow-up|41|||
17114816|NCT00027846|38252748|FG002|Overall Study|Lost to Follow-up|9|||
17114817|NCT00027846|38252746|FG000|Overall Study|Withdrawal by Subject|0|||
17114818|NCT00027846|38252747|FG001|Overall Study|Withdrawal by Subject|14|||
17114819|NCT00027846|38252748|FG002|Overall Study|Withdrawal by Subject|7|||
17114820|NCT00027846|38252746|FG000|Overall Study|Ineligible for study|2|||
17114821|NCT00027846|38252747|FG001|Overall Study|Ineligible for study|6|||
17027986|NCT00714285|38172345|FG002|Overall Study|Lost to Follow-up|0|||
17027987|NCT00714285|38172346|FG003|Overall Study|Lost to Follow-up|1|||
17027988|NCT00714285|38172343|FG000|Overall Study|Migrated/moved from study area|0|||
17027989|NCT00714285|38172344|FG001|Overall Study|Migrated/moved from study area|1|||
17027990|NCT00714285|38172345|FG002|Overall Study|Migrated/moved from study area|0|||
17114822|NCT00027846|38252748|FG002|Overall Study|Ineligible for study|14|||
17114823|NCT00027846|38252746|FG000|Overall Study|Entry into another COG therapeutic study|0|||
17114824|NCT00027846|38252747|FG001|Overall Study|Entry into another COG therapeutic study|5|||
17114825|NCT00027846|38252748|FG002|Overall Study|Entry into another COG therapeutic study|2|||
17114826|NCT00027846|38252746|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
17114827|NCT00027846|38252747|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
17114828|NCT00027846|38252748|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
17114829|NCT00027378|38252760|FG000|Overall Study|Physician Decision|0|||
17114830|NCT00027378|38252761|FG001|Overall Study|Physician Decision|3|||
17114831|NCT00235391|38252773|FG000|Overall Study|Adverse Event|4|||
17114832|NCT00235391|38252774|FG001|Overall Study|Adverse Event|5|||
17114833|NCT00235391|38252775|FG002|Overall Study|Adverse Event|10|||
17114834|NCT00235391|38252776|FG003|Overall Study|Adverse Event|72|||
17114835|NCT00235391|38252777|FG004|Overall Study|Adverse Event|5|||
17114836|NCT00235391|38252778|FG005|Overall Study|Adverse Event|2|||
17114837|NCT00235391|38252773|FG000|Overall Study|Abnormal laboratory value(s)|3|||
17027991|NCT00714285|38172346|FG003|Overall Study|Migrated/moved from study area|0|||
17114838|NCT00235391|38252774|FG001|Overall Study|Abnormal laboratory value(s)|5|||
17114839|NCT00235391|38252775|FG002|Overall Study|Abnormal laboratory value(s)|4|||
17114840|NCT00235391|38252776|FG003|Overall Study|Abnormal laboratory value(s)|27|||
17114841|NCT00235391|38252777|FG004|Overall Study|Abnormal laboratory value(s)|1|||
17114842|NCT00235391|38252778|FG005|Overall Study|Abnormal laboratory value(s)|2|||
17114843|NCT00235391|38252773|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
17114844|NCT00235391|38252774|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
17027992|NCT00776984|38172360|FG000|Overall Study|Adverse Event|8|||
17027993|NCT00776984|38172361|FG001|Overall Study|Adverse Event|2|||
17027994|NCT00776984|38172360|FG000|Overall Study|Protocol Violation|4|||
17114845|NCT00235391|38252775|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
17114846|NCT00235391|38252776|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
17114847|NCT00235391|38252777|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
17114848|NCT00235391|38252778|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
17114849|NCT00235391|38252773|FG000|Overall Study|Condition no longer requires treatment|3|||
17114850|NCT00235391|38252774|FG001|Overall Study|Condition no longer requires treatment|0|||
17114851|NCT00235391|38252775|FG002|Overall Study|Condition no longer requires treatment|0|||
17027995|NCT00776984|38172361|FG001|Overall Study|Protocol Violation|2|||
17027996|NCT00776984|38172360|FG000|Overall Study|Lost to Follow-up|2|||
17027997|NCT00776984|38172361|FG001|Overall Study|Lost to Follow-up|0|||
17027998|NCT00776984|38172360|FG000|Overall Study|Withdrawal by Subject|12|||
17027999|NCT00776984|38172361|FG001|Overall Study|Withdrawal by Subject|7|||
17028000|NCT00776984|38172360|FG000|Overall Study|Lack of Efficacy|0|||
16854676|NCT01984697|37807132|FG000|Overall Study|Adverse Event|0|||
16854677|NCT01984697|37807133|FG001|Overall Study|Adverse Event|0|||
16854678|NCT01984697|37807134|FG002|Overall Study|Adverse Event|2|||
16854679|NCT01984697|37807135|FG003|Overall Study|Adverse Event|0|||
16854680|NCT01984697|37807136|FG004|Overall Study|Adverse Event|0|||
16854681|NCT01984697|37807132|FG000|Overall Study|Lost to Follow-up|14|||
16854682|NCT01984697|37807133|FG001|Overall Study|Lost to Follow-up|5|||
16854683|NCT01984697|37807134|FG002|Overall Study|Lost to Follow-up|10|||
16854684|NCT01984697|37807135|FG003|Overall Study|Lost to Follow-up|6|||
16854685|NCT01984697|37807136|FG004|Overall Study|Lost to Follow-up|21|||
16854686|NCT01984697|37807132|FG000|Overall Study|Physician Decision|3|||
16854687|NCT01984697|37807133|FG001|Overall Study|Physician Decision|0|||
16854688|NCT01984697|37807134|FG002|Overall Study|Physician Decision|0|||
16854689|NCT01984697|37807135|FG003|Overall Study|Physician Decision|1|||
16854690|NCT01984697|37807136|FG004|Overall Study|Physician Decision|0|||
16854691|NCT01984697|37807132|FG000|Overall Study|Protocol Violation|8|||
17028001|NCT00776984|38172361|FG001|Overall Study|Lack of Efficacy|1|||
17028002|NCT00776984|38172360|FG000|Overall Study|Other|5|||
17028003|NCT00776984|38172361|FG001|Overall Study|Other|9|||
17028004|NCT00714051|38172369|FG000|Overall Study|Withdrawal by Subject|1|||
17028005|NCT00714051|38172370|FG001|Overall Study|Withdrawal by Subject|0|||
17028006|NCT00714051|38172369|FG000|Overall Study|Death|0|||
17028007|NCT00714051|38172370|FG001|Overall Study|Death|1|||
17028008|NCT00784784|38172378|FG000|Overall Study|Withdrawal by Subject|2|||
17028009|NCT00784784|38172379|FG001|Overall Study|Withdrawal by Subject|2|||
17028010|NCT00801983|38172387|FG000|Period 1|Lost to Follow-up|2|||
16854692|NCT01984697|37807133|FG001|Overall Study|Protocol Violation|5|||
16854693|NCT01984697|37807134|FG002|Overall Study|Protocol Violation|3|||
16854694|NCT01984697|37807135|FG003|Overall Study|Protocol Violation|2|||
16854695|NCT01984697|37807136|FG004|Overall Study|Protocol Violation|0|||
16854696|NCT01984697|37807132|FG000|Overall Study|Withdrawal by Subject|15|||
16854697|NCT01984697|37807133|FG001|Overall Study|Withdrawal by Subject|21|||
16854698|NCT01984697|37807134|FG002|Overall Study|Withdrawal by Subject|13|||
16854699|NCT01984697|37807135|FG003|Overall Study|Withdrawal by Subject|11|||
16854700|NCT01984697|37807136|FG004|Overall Study|Withdrawal by Subject|13|||
16854701|NCT01984697|37807132|FG000|Overall Study|Missed last follow-up visit|1|||
16854702|NCT01984697|37807133|FG001|Overall Study|Missed last follow-up visit|0|||
16854703|NCT01984697|37807134|FG002|Overall Study|Missed last follow-up visit|0|||
16854704|NCT01984697|37807135|FG003|Overall Study|Missed last follow-up visit|0|||
16854705|NCT01984697|37807136|FG004|Overall Study|Missed last follow-up visit|0|||
16854706|NCT01984697|37807132|FG000|Overall Study|Death|0|||
17028011|NCT00801983|38172388|FG001|Period 1|Lost to Follow-up|0|||
17114852|NCT00235391|38252776|FG003|Overall Study|Condition no longer requires treatment|11|||
17114853|NCT00235391|38252777|FG004|Overall Study|Condition no longer requires treatment|1|||
17114854|NCT00235391|38252778|FG005|Overall Study|Condition no longer requires treatment|0|||
17114855|NCT00235391|38252773|FG000|Overall Study|Protocol deviation|0|||
17114856|NCT00235391|38252774|FG001|Overall Study|Protocol deviation|0|||
17114857|NCT00235391|38252775|FG002|Overall Study|Protocol deviation|1|||
17114858|NCT00235391|38252776|FG003|Overall Study|Protocol deviation|11|||
17114859|NCT00235391|38252777|FG004|Overall Study|Protocol deviation|0|||
17114860|NCT00235391|38252778|FG005|Overall Study|Protocol deviation|0|||
17114861|NCT00235391|38252773|FG000|Overall Study|Withdrawal by Subject|2|||
17114862|NCT00235391|38252774|FG001|Overall Study|Withdrawal by Subject|3|||
17114863|NCT00235391|38252775|FG002|Overall Study|Withdrawal by Subject|3|||
17114864|NCT00235391|38252776|FG003|Overall Study|Withdrawal by Subject|61|||
17114865|NCT00235391|38252777|FG004|Overall Study|Withdrawal by Subject|5|||
17114866|NCT00235391|38252778|FG005|Overall Study|Withdrawal by Subject|0|||
17114867|NCT00235391|38252773|FG000|Overall Study|Lost to Follow-up|0|||
17114868|NCT00235391|38252774|FG001|Overall Study|Lost to Follow-up|3|||
17114869|NCT00235391|38252775|FG002|Overall Study|Lost to Follow-up|3|||
17114870|NCT00235391|38252776|FG003|Overall Study|Lost to Follow-up|16|||
17114871|NCT00235391|38252777|FG004|Overall Study|Lost to Follow-up|0|||
17114872|NCT00235391|38252778|FG005|Overall Study|Lost to Follow-up|0|||
17201387|NCT02742103|38355669|FG001|Overall Study|Protocol Violation|0|||
17201388|NCT02742103|38355668|FG000|Overall Study|Death|2|||
16854707|NCT01984697|37807133|FG001|Overall Study|Death|0|||
16854708|NCT01984697|37807134|FG002|Overall Study|Death|0|||
16854709|NCT01984697|37807135|FG003|Overall Study|Death|1|||
16854710|NCT01984697|37807136|FG004|Overall Study|Death|0|||
16854711|NCT01984697|37807132|FG000|Overall Study|Pregnancy|2|||
16854712|NCT01984697|37807133|FG001|Overall Study|Pregnancy|0|||
16854713|NCT01984697|37807134|FG002|Overall Study|Pregnancy|1|||
16854714|NCT01984697|37807135|FG003|Overall Study|Pregnancy|0|||
16854715|NCT01984697|37807136|FG004|Overall Study|Pregnancy|1|||
17201389|NCT02742103|38355669|FG001|Overall Study|Death|2|||
17201390|NCT02742103|38355668|FG000|Overall Study|Adverse Event|1|||
17201391|NCT02742103|38355669|FG001|Overall Study|Adverse Event|0|||
17201392|NCT02742103|38355668|FG000|Overall Study|Moved to another town|0|||
17201393|NCT02742103|38355669|FG001|Overall Study|Moved to another town|1|||
17201394|NCT02742103|38355668|FG000|Overall Study|Withdrawal by Subject|5|||
17201395|NCT02742103|38355669|FG001|Overall Study|Withdrawal by Subject|2|||
17201396|NCT02741713|38355677|FG000|Overall Study|Surgery type changed intra-operatively|2|||
17201397|NCT02741713|38355678|FG001|Overall Study|Surgery type changed intra-operatively|1|||
17201398|NCT02663271|38355685|FG000|Overall Study|Withdrawal by Subject|5|||
17201399|NCT02663271|38355685|FG000|Overall Study|Lack of Efficacy|1|||
17201400|NCT02742649|38355692|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
17201401|NCT02742649|38355693|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
17201402|NCT02742649|38355694|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
17201403|NCT02742649|38355695|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
17201404|NCT02742649|38355696|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
17201405|NCT02742649|38355692|FG000|Double-Blind Treatment Period|Adverse Event|0|||
17201406|NCT02742649|38355693|FG001|Double-Blind Treatment Period|Adverse Event|1|||
17201407|NCT02742649|38355694|FG002|Double-Blind Treatment Period|Adverse Event|0|||
17201408|NCT02742649|38355695|FG003|Double-Blind Treatment Period|Adverse Event|0|||
17201409|NCT02742649|38355696|FG004|Double-Blind Treatment Period|Adverse Event|0|||
17201410|NCT02742649|38355692|FG000|Open-Label Period|Lost to Follow-up|0|||
17201411|NCT02742649|38355693|FG001|Open-Label Period|Lost to Follow-up|0|||
17201412|NCT02742649|38355694|FG002|Open-Label Period|Lost to Follow-up|0|||
17201413|NCT02742649|38355695|FG003|Open-Label Period|Lost to Follow-up|0|||
17201414|NCT02742649|38355696|FG004|Open-Label Period|Lost to Follow-up|1|||
17201415|NCT02665689|38355709|FG000|Overall Study|Adverse Event|1|||
17201416|NCT02665689|38355710|FG001|Overall Study|Adverse Event|0|||
17201417|NCT02665689|38355709|FG000|Overall Study|Trial termination|1|||
17201418|NCT02665689|38355710|FG001|Overall Study|Trial termination|1|||
17201419|NCT02665689|38355709|FG000|Overall Study|Lost to Follow-up|0|||
17201420|NCT02665689|38355710|FG001|Overall Study|Lost to Follow-up|1|||
17201421|NCT02665455|38355716|FG000|Overall Study|Withdrawal by Subject|6|||
17201422|NCT02665455|38355716|FG000|Overall Study|Lost to Follow-up|1|||
17201423|NCT02665455|38355716|FG000|Overall Study|Adverse Event|1|||
17201424|NCT02665455|38355716|FG000|Overall Study|Protocol Violation|1|||
17201425|NCT02755805|38355722|FG000|Overall Study|Lost to Follow-up|1|||
17201426|NCT02755805|38355723|FG001|Overall Study|Lost to Follow-up|2|||
17201427|NCT02755805|38355722|FG000|Overall Study|Refused assessments|1|||
17201428|NCT02755805|38355723|FG001|Overall Study|Refused assessments|0|||
17201429|NCT02755805|38355722|FG000|Overall Study|Withdrawal by Subject|0|||
17201430|NCT02755805|38355723|FG001|Overall Study|Withdrawal by Subject|2|||
17201431|NCT02755649|38355732|FG000|Overall Study|Transitioned into OLE study|99|||
17201432|NCT02755649|38355733|FG001|Overall Study|Transitioned into OLE study|98|||
17201433|NCT02755649|38355734|FG002|Overall Study|Transitioned into OLE study|100|||
17201434|NCT02755649|38355732|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
17201435|NCT02755649|38355733|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
17201436|NCT02755649|38355734|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
17201437|NCT02755649|38355732|FG000|Overall Study|Physician Decision|0|||
17201438|NCT02755649|38355733|FG001|Overall Study|Physician Decision|0|||
17201439|NCT02755649|38355734|FG002|Overall Study|Physician Decision|2|||
17201440|NCT02755649|38355732|FG000|Overall Study|Withdrawal by Subject|0|||
17201441|NCT02755649|38355733|FG001|Overall Study|Withdrawal by Subject|1|||
17201442|NCT02755649|38355734|FG002|Overall Study|Withdrawal by Subject|0|||
17201443|NCT02755649|38355732|FG000|Overall Study|Undecided|1|||
17201444|NCT02755649|38355733|FG001|Overall Study|Undecided|0|||
17201445|NCT02755649|38355734|FG002|Overall Study|Undecided|0|||
17201446|NCT00151411|38355744|FG000|Overall Study|Lost to Follow-up|15|||
17201447|NCT00151411|38355745|FG001|Overall Study|Lost to Follow-up|19|||
17201448|NCT00151411|38355744|FG000|Overall Study|Withdrawal by Subject|12|||
17201449|NCT00151411|38355745|FG001|Overall Study|Withdrawal by Subject|20|||
17201450|NCT00151411|38355744|FG000|Overall Study|Adverse Event|6|||
17201451|NCT00151411|38355745|FG001|Overall Study|Adverse Event|0|||
17201452|NCT00151411|38355744|FG000|Overall Study|Pregnancy|0|||
17201453|NCT00151411|38355745|FG001|Overall Study|Pregnancy|4|||
17201454|NCT02662569|38355755|FG000|Overall Study|Withdrawal by Subject|6|||
17201455|NCT02662569|38355756|FG001|Overall Study|Withdrawal by Subject|1|||
17201456|NCT02662569|38355757|FG002|Overall Study|Withdrawal by Subject|6|||
17201457|NCT02662569|38355758|FG003|Overall Study|Withdrawal by Subject|4|||
17201458|NCT02662569|38355755|FG000|Overall Study|Lost to Follow-up|1|||
17201459|NCT02662569|38355756|FG001|Overall Study|Lost to Follow-up|0|||
17201460|NCT02662569|38355757|FG002|Overall Study|Lost to Follow-up|0|||
17201461|NCT02662569|38355758|FG003|Overall Study|Lost to Follow-up|0|||
17201462|NCT02741635|38355768|FG000|Overall Study|Withdrawal by Subject|1|||
17201463|NCT02753075|38355776|FG000|Overall Study|Adverse Event|2|||
16782473|NCT02701361|37722013|FG001|Overall Study|Lost to Follow-up|2|||
17201464|NCT02753075|38355777|FG001|Overall Study|Adverse Event|1|||
17201465|NCT02753075|38355778|FG002|Overall Study|Adverse Event|0|||
17201466|NCT02753075|38355776|FG000|Overall Study|Lost to Follow-up|2|||
17201467|NCT02753075|38355777|FG001|Overall Study|Lost to Follow-up|0|||
17201468|NCT02753075|38355778|FG002|Overall Study|Lost to Follow-up|0|||
17201469|NCT02753075|38355776|FG000|Overall Study|Withdrawal of Consent|1|||
17201470|NCT02753075|38355777|FG001|Overall Study|Withdrawal of Consent|1|||
17201471|NCT02753075|38355778|FG002|Overall Study|Withdrawal of Consent|3|||
17201472|NCT02753075|38355776|FG000|Overall Study|Physician Decision|3|||
17201473|NCT02753075|38355777|FG001|Overall Study|Physician Decision|1|||
17201474|NCT02753075|38355778|FG002|Overall Study|Physician Decision|0|||
17201475|NCT02332720|38355810|FG000|Part A and Part B|Lost to Follow-up|1|||
17201476|NCT02332720|38355811|FG001|Part A and Part B|Lost to Follow-up|0|||
17201477|NCT02332720|38355812|FG002|Part A and Part B|Lost to Follow-up|0|||
17201478|NCT02332720|38355813|FG003|Part A and Part B|Lost to Follow-up|0|||
17201479|NCT02332720|38355814|FG004|Part A and Part B|Lost to Follow-up|0|||
17201480|NCT02332720|38355815|FG005|Part A and Part B|Lost to Follow-up|2|||
17201481|NCT02332720|38355816|FG006|Part A and Part B|Lost to Follow-up|1|||
17201482|NCT02332720|38355817|FG007|Part A and Part B|Lost to Follow-up|1|||
17201483|NCT02332720|38355818|FG008|Part A and Part B|Lost to Follow-up|0|||
17201484|NCT02332720|38355819|FG009|Part A and Part B|Lost to Follow-up|0|||
17201485|NCT02332720|38355820|FG010|Part A and Part B|Lost to Follow-up|0|||
17201486|NCT02332720|38355821|FG011|Part A and Part B|Lost to Follow-up|0|||
17201487|NCT02332720|38355822|FG012|Part A and Part B|Lost to Follow-up|0|||
17201488|NCT02332720|38355823|FG013|Part A and Part B|Lost to Follow-up|0|||
17201489|NCT02332720|38355824|FG014|Part A and Part B|Lost to Follow-up|0|||
17201490|NCT02332720|38355825|FG015|Part A and Part B|Lost to Follow-up|1|||
17201491|NCT02332720|38355826|FG016|Part A and Part B|Lost to Follow-up|0|||
17201492|NCT02332720|38355827|FG017|Part A and Part B|Lost to Follow-up|0|||
17201493|NCT02332720|38355828|FG018|Part A and Part B|Lost to Follow-up|0|||
17201494|NCT02332720|38355829|FG019|Part A and Part B|Lost to Follow-up|0|||
17201495|NCT02332720|38355830|FG020|Part A and Part B|Lost to Follow-up|0|||
17201496|NCT02332720|38355831|FG021|Part A and Part B|Lost to Follow-up|0|||
17201497|NCT02332720|38355832|FG022|Part A and Part B|Lost to Follow-up|0|||
17201498|NCT02332720|38355810|FG000|Part A and Part B|Adverse Event|0|||
17201499|NCT02332720|38355811|FG001|Part A and Part B|Adverse Event|0|||
17201500|NCT02332720|38355812|FG002|Part A and Part B|Adverse Event|0|||
17201501|NCT02332720|38355813|FG003|Part A and Part B|Adverse Event|0|||
17201502|NCT02332720|38355814|FG004|Part A and Part B|Adverse Event|0|||
17201503|NCT02332720|38355815|FG005|Part A and Part B|Adverse Event|0|||
17201504|NCT02332720|38355816|FG006|Part A and Part B|Adverse Event|0|||
17201505|NCT02332720|38355817|FG007|Part A and Part B|Adverse Event|0|||
17201506|NCT02332720|38355818|FG008|Part A and Part B|Adverse Event|0|||
17201507|NCT02332720|38355819|FG009|Part A and Part B|Adverse Event|0|||
17201508|NCT02332720|38355820|FG010|Part A and Part B|Adverse Event|0|||
17201509|NCT02332720|38355821|FG011|Part A and Part B|Adverse Event|0|||
17201510|NCT02332720|38355822|FG012|Part A and Part B|Adverse Event|0|||
17201511|NCT02332720|38355823|FG013|Part A and Part B|Adverse Event|0|||
17201512|NCT02332720|38355824|FG014|Part A and Part B|Adverse Event|0|||
17201513|NCT02332720|38355825|FG015|Part A and Part B|Adverse Event|0|||
17201514|NCT02332720|38355826|FG016|Part A and Part B|Adverse Event|0|||
17201515|NCT02332720|38355827|FG017|Part A and Part B|Adverse Event|1|||
17201516|NCT02332720|38355828|FG018|Part A and Part B|Adverse Event|0|||
17201517|NCT02332720|38355829|FG019|Part A and Part B|Adverse Event|0|||
17201518|NCT02332720|38355830|FG020|Part A and Part B|Adverse Event|0|||
17201519|NCT02332720|38355831|FG021|Part A and Part B|Adverse Event|0|||
17201520|NCT02332720|38355832|FG022|Part A and Part B|Adverse Event|0|||
17201521|NCT02332720|38355810|FG000|Part A and Part B|Physician Decision|0|||
17201522|NCT02332720|38355811|FG001|Part A and Part B|Physician Decision|0|||
17201523|NCT02332720|38355812|FG002|Part A and Part B|Physician Decision|0|||
17201524|NCT02332720|38355813|FG003|Part A and Part B|Physician Decision|0|||
17201525|NCT02332720|38355814|FG004|Part A and Part B|Physician Decision|0|||
17201526|NCT02332720|38355815|FG005|Part A and Part B|Physician Decision|0|||
17201527|NCT02332720|38355816|FG006|Part A and Part B|Physician Decision|0|||
17201528|NCT02332720|38355817|FG007|Part A and Part B|Physician Decision|0|||
17201529|NCT02332720|38355818|FG008|Part A and Part B|Physician Decision|0|||
17201530|NCT02332720|38355819|FG009|Part A and Part B|Physician Decision|0|||
17201531|NCT02332720|38355820|FG010|Part A and Part B|Physician Decision|0|||
17201532|NCT02332720|38355821|FG011|Part A and Part B|Physician Decision|0|||
17201533|NCT02332720|38355822|FG012|Part A and Part B|Physician Decision|0|||
17201534|NCT02332720|38355823|FG013|Part A and Part B|Physician Decision|0|||
17201535|NCT02332720|38355824|FG014|Part A and Part B|Physician Decision|0|||
17201536|NCT02332720|38355825|FG015|Part A and Part B|Physician Decision|0|||
17201537|NCT02332720|38355826|FG016|Part A and Part B|Physician Decision|0|||
17201538|NCT02332720|38355827|FG017|Part A and Part B|Physician Decision|0|||
17201539|NCT02332720|38355828|FG018|Part A and Part B|Physician Decision|1|||
17201540|NCT02332720|38355829|FG019|Part A and Part B|Physician Decision|0|||
17201541|NCT02332720|38355830|FG020|Part A and Part B|Physician Decision|0|||
17201542|NCT02332720|38355831|FG021|Part A and Part B|Physician Decision|0|||
17201543|NCT02332720|38355832|FG022|Part A and Part B|Physician Decision|0|||
17201544|NCT02332720|38355810|FG000|Part A and Part B|Withdrawal by Subject|0|||
17201545|NCT02332720|38355811|FG001|Part A and Part B|Withdrawal by Subject|0|||
17201546|NCT02332720|38355812|FG002|Part A and Part B|Withdrawal by Subject|0|||
17201547|NCT02332720|38355813|FG003|Part A and Part B|Withdrawal by Subject|0|||
17201548|NCT02332720|38355814|FG004|Part A and Part B|Withdrawal by Subject|0|||
17201549|NCT02332720|38355815|FG005|Part A and Part B|Withdrawal by Subject|1|||
17201550|NCT02332720|38355816|FG006|Part A and Part B|Withdrawal by Subject|0|||
17201551|NCT02332720|38355817|FG007|Part A and Part B|Withdrawal by Subject|0|||
17201552|NCT02332720|38355818|FG008|Part A and Part B|Withdrawal by Subject|0|||
17201553|NCT02332720|38355819|FG009|Part A and Part B|Withdrawal by Subject|0|||
17201554|NCT02332720|38355820|FG010|Part A and Part B|Withdrawal by Subject|0|||
17201555|NCT02332720|38355821|FG011|Part A and Part B|Withdrawal by Subject|0|||
17201556|NCT02332720|38355822|FG012|Part A and Part B|Withdrawal by Subject|0|||
17201557|NCT02332720|38355823|FG013|Part A and Part B|Withdrawal by Subject|0|||
17201558|NCT02332720|38355824|FG014|Part A and Part B|Withdrawal by Subject|0|||
17201559|NCT02332720|38355825|FG015|Part A and Part B|Withdrawal by Subject|0|||
17201560|NCT02332720|38355826|FG016|Part A and Part B|Withdrawal by Subject|0|||
17201561|NCT02332720|38355827|FG017|Part A and Part B|Withdrawal by Subject|0|||
17201562|NCT02332720|38355828|FG018|Part A and Part B|Withdrawal by Subject|0|||
17201563|NCT02332720|38355829|FG019|Part A and Part B|Withdrawal by Subject|1|||
17201564|NCT02332720|38355830|FG020|Part A and Part B|Withdrawal by Subject|0|||
17201565|NCT02332720|38355831|FG021|Part A and Part B|Withdrawal by Subject|0|||
17201566|NCT02332720|38355832|FG022|Part A and Part B|Withdrawal by Subject|0|||
17201567|NCT02331394|38355904|FG000|Overall Study|Disease progression|1|||
17201568|NCT01645930|38355915|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
17201569|NCT01645930|38355915|FG000|Overall Study|Progressive Disease|12|||
17201570|NCT01645930|38355915|FG000|Overall Study|Adverse Event|4|||
17201571|NCT01645930|38355915|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
17201572|NCT01645930|38355915|FG000|Overall Study|Withdrawal by Participant|2|||
17201573|NCT01645930|38355915|FG000|Overall Study|Reason not Defined|1|||
17201574|NCT02299336|38355919|FG000|Overall Study|Withdrawal by Subject|11|||
17201575|NCT02299336|38355919|FG000|Overall Study|Adverse Event|1|||
17201576|NCT02299336|38355919|FG000|Overall Study|Death|1|||
17201577|NCT02299336|38355919|FG000|Overall Study|Lost to Follow-up|1|||
17201578|NCT02664441|38355925|FG000|Randomization|Withdrawal by Subject|0|||
17201579|NCT02664441|38355926|FG001|Randomization|Withdrawal by Subject|1|||
17201580|NCT02664441|38355925|FG000|36-week Randomized Trial|Adverse Event|2|||
17201581|NCT02664441|38355926|FG001|36-week Randomized Trial|Adverse Event|0|||
17201582|NCT02664441|38355925|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
17201583|NCT02664441|38355926|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
17201584|NCT02664441|38355925|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
17201585|NCT02664441|38355926|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
17201586|NCT02664441|38355925|FG000|18-week Open Label Extension|Adverse Event|1|||
17201587|NCT02664441|38355926|FG001|18-week Open Label Extension|Adverse Event|0|||
17201588|NCT02664441|38355925|FG000|18-week Open Label Extension|Physician Decision|1|||
17201589|NCT02664441|38355926|FG001|18-week Open Label Extension|Physician Decision|0|||
17201590|NCT02664441|38355925|FG000|18-week Open Label Extension|Death|1|||
17201591|NCT02664441|38355926|FG001|18-week Open Label Extension|Death|0|||
17201592|NCT02664441|38355925|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
17201593|NCT02664441|38355926|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
17201594|NCT02298946|38355935|FG000|Overall Study|Did not receive treatment|2|||
17201595|NCT02298946|38355936|FG001|Overall Study|Did not receive treatment|0|||
17201596|NCT02298946|38355935|FG000|Overall Study|Unevaluable|2|||
17201597|NCT02298946|38355936|FG001|Overall Study|Unevaluable|1|||
17201598|NCT02328040|38355943|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
17201599|NCT02328040|38355944|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
17201600|NCT01647958|38355952|FG000|Initial Study|Lost to Follow-up|2|||
17201601|NCT01647958|38355953|FG001|Initial Study|Lost to Follow-up|3|||
17201602|NCT01647958|38355952|FG000|Continuation Phase|treatment received during Overall Study|39|||
17201603|NCT01647958|38355953|FG001|Continuation Phase|treatment received during Overall Study|0|||
17201604|NCT01647958|38355952|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
17201605|NCT01647958|38355953|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
17201606|NCT02298868|38355968|FG000|Overall Study|Adverse Event|1|||
17201607|NCT02298868|38355968|FG000|Overall Study|Death|1|||
17201608|NCT02298868|38355968|FG000|Overall Study|Patient underwent transplant|1|||
17201609|NCT02327260|38355975|FG000|Overall Study|Lost to Follow-up|2|||
17201610|NCT02327260|38355976|FG001|Overall Study|Lost to Follow-up|3|||
17201611|NCT02327260|38355977|FG002|Overall Study|Lost to Follow-up|2|||
17201612|NCT02327260|38355975|FG000|Overall Study|invalid phone number|1|||
17201613|NCT02327260|38355976|FG001|Overall Study|invalid phone number|1|||
17201614|NCT02327260|38355977|FG002|Overall Study|invalid phone number|0|||
17201615|NCT02327260|38355975|FG000|Overall Study|non-adherence to protocol|2|||
17201616|NCT02327260|38355976|FG001|Overall Study|non-adherence to protocol|0|||
17201617|NCT02327260|38355977|FG002|Overall Study|non-adherence to protocol|0|||
17201618|NCT02327260|38355975|FG000|Overall Study|cognitive concerns|1|||
17201619|NCT02327260|38355976|FG001|Overall Study|cognitive concerns|0|||
17201620|NCT02327260|38355977|FG002|Overall Study|cognitive concerns|0|||
17201621|NCT02296840|38355988|FG000|Overall Study|Adverse Event|1|||
17201622|NCT02296840|38355989|FG001|Overall Study|Adverse Event|1|||
17201623|NCT02296840|38355988|FG000|Overall Study|Protocol Violation|2|||
17201624|NCT02296840|38355989|FG001|Overall Study|Protocol Violation|1|||
17201625|NCT02296840|38355988|FG000|Overall Study|Lost to Follow-up|6|||
17201626|NCT02296840|38355989|FG001|Overall Study|Lost to Follow-up|17|||
17201627|NCT02663895|38355998|FG000|Overall Study|Adverse Event|3|||
17201628|NCT02663895|38355998|FG000|Overall Study|Physician Decision|2|||
17201629|NCT02663895|38355998|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
17201630|NCT02663895|38355998|FG000|Overall Study|Withdrawal by Subject|1|||
17201631|NCT02663817|38356003|FG000|Overall Study|Screen failure|2|||
17201632|NCT01372605|38356011|FG000|Overall Study|Death|1|||
17201633|NCT01372605|38356012|FG001|Overall Study|Death|2|||
17201634|NCT01372605|38356011|FG000|Overall Study|Lost to Follow-up|2|||
17201635|NCT01372605|38356012|FG001|Overall Study|Lost to Follow-up|1|||
17201636|NCT01372605|38356011|FG000|Overall Study|Withdrawal by Subject|4|||
17201637|NCT01372605|38356012|FG001|Overall Study|Withdrawal by Subject|7|||
17201638|NCT01372605|38356011|FG000|Overall Study|Moved|3|||
17201639|NCT01372605|38356012|FG001|Overall Study|Moved|0|||
17201640|NCT01372605|38356011|FG000|Overall Study|Changed medical home|2|||
17201641|NCT01372605|38356012|FG001|Overall Study|Changed medical home|0|||
17201642|NCT02751983|38356020|FG000|Treatment|Stopped ACT, but Remained in study|2|||
17201643|NCT02751983|38356021|FG001|Treatment|Stopped ACT, but Remained in study|0|||
17201644|NCT02751983|38356020|FG000|Treatment|Discharged prior to beginning ACT|2|||
17201645|NCT02751983|38356021|FG001|Treatment|Discharged prior to beginning ACT|0|||
17201646|NCT02751983|38356020|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
17201647|NCT02751983|38356021|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
17201648|NCT02751983|38356020|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
17201649|NCT02751983|38356021|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
17201650|NCT02751983|38356020|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
17201651|NCT02751983|38356021|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
17201652|NCT00232141|38356041|FG000|Overall Study|Adverse Event|9|||
17201653|NCT00232141|38356042|FG001|Overall Study|Adverse Event|4|||
17201654|NCT00232141|38356041|FG000|Overall Study|Lack of Efficacy|0|||
17201655|NCT00232141|38356042|FG001|Overall Study|Lack of Efficacy|3|||
17201656|NCT00232141|38356041|FG000|Overall Study|Lost to Follow-up|9|||
17201657|NCT00232141|38356042|FG001|Overall Study|Lost to Follow-up|6|||
17201658|NCT00232141|38356041|FG000|Overall Study|Other|8|||
17201659|NCT00232141|38356042|FG001|Overall Study|Other|10|||
17201660|NCT00232141|38356041|FG000|Overall Study|Withdrawal by Subject|5|||
17201661|NCT00232141|38356042|FG001|Overall Study|Withdrawal by Subject|3|||
17201662|NCT02741245|38356071|FG000|Overall Study|Adverse Event|0|||
17201663|NCT02741245|38356072|FG001|Overall Study|Adverse Event|0|||
17201664|NCT02741245|38356073|FG002|Overall Study|Adverse Event|0|||
17201665|NCT02741245|38356074|FG003|Overall Study|Adverse Event|2|||
17201666|NCT02741245|38356075|FG004|Overall Study|Adverse Event|2|||
17201667|NCT02741245|38356071|FG000|Overall Study|Protocol Violation|0|||
17201668|NCT02741245|38356072|FG001|Overall Study|Protocol Violation|1|||
17201669|NCT02741245|38356073|FG002|Overall Study|Protocol Violation|0|||
17201670|NCT02741245|38356074|FG003|Overall Study|Protocol Violation|1|||
17201671|NCT02741245|38356075|FG004|Overall Study|Protocol Violation|0|||
17201672|NCT02741245|38356071|FG000|Overall Study|Withdrawal by Subject|0|||
17201673|NCT02741245|38356072|FG001|Overall Study|Withdrawal by Subject|0|||
17201674|NCT02741245|38356073|FG002|Overall Study|Withdrawal by Subject|0|||
17201675|NCT02741245|38356074|FG003|Overall Study|Withdrawal by Subject|1|||
17201676|NCT02741245|38356075|FG004|Overall Study|Withdrawal by Subject|0|||
17201677|NCT03227757|38356087|FG000|Overall Study|Death|7|||
17201678|NCT03227757|38356087|FG000|Overall Study|Withdrawal|5|||
17201679|NCT03227757|38356087|FG000|Overall Study|Missed visits|4|||
17201680|NCT02751827|38356098|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
17201681|NCT02751827|38356099|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
17201682|NCT02751827|38356100|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
17201683|NCT04896593|38356117|FG000|Overall Study|Withdrawal by Subject|2|||
17201684|NCT04896593|38356117|FG000|Overall Study|Lost to Follow-up|1|||
17201685|NCT04896593|38356117|FG000|Overall Study|Did not complete onboarding|2|||
17201686|NCT04601272|38356133|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
17201687|NCT04601272|38356134|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
17201688|NCT04601272|38356135|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
17201689|NCT04059484|38356154|FG000|Overall Study|Adverse Event|2|||
17201690|NCT04059484|38356155|FG001|Overall Study|Adverse Event|5|||
17201691|NCT04059484|38356154|FG000|Overall Study|Withdrawal by Subject|5|||
17201692|NCT04059484|38356155|FG001|Overall Study|Withdrawal by Subject|3|||
17201693|NCT04059484|38356154|FG000|Overall Study|Progressive disease|112|||
17201694|NCT04059484|38356155|FG001|Overall Study|Progressive disease|112|||
17201695|NCT04059484|38356154|FG000|Overall Study|Other|8|||
17201696|NCT04059484|38356155|FG001|Overall Study|Other|3|||
17201697|NCT04059484|38356154|FG000|Overall Study|Ongoing|20|||
17201698|NCT04059484|38356155|FG001|Overall Study|Ongoing|20|||
17201699|NCT03965091|38356167|FG000|Overall Study|Adverse Event|0|||
17201700|NCT03965091|38356168|FG001|Overall Study|Adverse Event|2|||
17201701|NCT03965091|38356169|FG002|Overall Study|Adverse Event|3|||
17201702|NCT03965091|38356167|FG000|Overall Study|Withdrawal by Subject|11|||
17201703|NCT03965091|38356168|FG001|Overall Study|Withdrawal by Subject|3|||
17201704|NCT03965091|38356169|FG002|Overall Study|Withdrawal by Subject|5|||
17201705|NCT03965091|38356167|FG000|Overall Study|Non-compliance with study drug|0|||
17201706|NCT03965091|38356168|FG001|Overall Study|Non-compliance with study drug|0|||
17201707|NCT03965091|38356169|FG002|Overall Study|Non-compliance with study drug|1|||
17201708|NCT03965091|38356167|FG000|Overall Study|Lost to Follow-up|1|||
17201709|NCT03965091|38356168|FG001|Overall Study|Lost to Follow-up|1|||
17201710|NCT03965091|38356169|FG002|Overall Study|Lost to Follow-up|1|||
17201711|NCT03965091|38356167|FG000|Overall Study|Lack of Efficacy|2|||
17201712|NCT03965091|38356168|FG001|Overall Study|Lack of Efficacy|0|||
17201713|NCT03965091|38356169|FG002|Overall Study|Lack of Efficacy|0|||
17201714|NCT03965091|38356167|FG000|Overall Study|Other than specified|9|||
17201715|NCT03965091|38356168|FG001|Overall Study|Other than specified|11|||
17201716|NCT03965091|38356169|FG002|Overall Study|Other than specified|8|||
17201717|NCT03359096|38356196|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
17201718|NCT03359096|38356197|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
17201719|NCT03359096|38356196|FG000|First Intervention (4 Weeks)|Death|1|||
17201720|NCT03359096|38356197|FG001|First Intervention (4 Weeks)|Death|0|||
17201721|NCT03359096|38356196|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
17201722|NCT03359096|38356197|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
17201723|NCT03261700|38356205|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
17201724|NCT03261700|38356206|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
17201725|NCT03019588|38356235|FG000|Overall Study|Death|44|||
17201726|NCT03019588|38356236|FG001|Overall Study|Death|46|||
17201727|NCT03019588|38356235|FG000|Overall Study|Study terminated by Sponsor|3|||
17201728|NCT03019588|38356236|FG001|Overall Study|Study terminated by Sponsor|1|||
17201729|NCT02975882|38356246|FG000|Overall Study|Adverse Event|1|||
17201730|NCT02975882|38356247|FG001|Overall Study|Adverse Event|2|||
17201731|NCT02975882|38356248|FG002|Overall Study|Adverse Event|1|||
17201732|NCT02975882|38356249|FG003|Overall Study|Adverse Event|1|||
17201733|NCT02975882|38356246|FG000|Overall Study|Death|0|||
17201734|NCT02975882|38356247|FG001|Overall Study|Death|1|||
17201735|NCT02975882|38356248|FG002|Overall Study|Death|0|||
17201736|NCT02975882|38356249|FG003|Overall Study|Death|0|||
17201737|NCT02975882|38356246|FG000|Overall Study|Lack of Efficacy|3|||
17201738|NCT02975882|38356247|FG001|Overall Study|Lack of Efficacy|7|||
17201739|NCT02975882|38356248|FG002|Overall Study|Lack of Efficacy|4|||
17201740|NCT02975882|38356249|FG003|Overall Study|Lack of Efficacy|3|||
17201741|NCT02975882|38356246|FG000|Overall Study|Physician Decision|0|||
17201742|NCT02975882|38356247|FG001|Overall Study|Physician Decision|2|||
17201743|NCT02975882|38356248|FG002|Overall Study|Physician Decision|4|||
17201744|NCT02975882|38356249|FG003|Overall Study|Physician Decision|2|||
17201745|NCT02975882|38356246|FG000|Overall Study|Ineligible|0|||
17201746|NCT02975882|38356247|FG001|Overall Study|Ineligible|1|||
17201747|NCT02975882|38356248|FG002|Overall Study|Ineligible|0|||
17201748|NCT02975882|38356249|FG003|Overall Study|Ineligible|0|||
17201749|NCT02890355|38356270|FG000|Overall Study|Adverse Event|5|||
17201750|NCT02890355|38356271|FG001|Overall Study|Adverse Event|5|||
17201751|NCT02890355|38356270|FG000|Overall Study|Refusal unrelated to adverse event|5|||
17201752|NCT02890355|38356271|FG001|Overall Study|Refusal unrelated to adverse event|10|||
17201753|NCT02890355|38356270|FG000|Overall Study|Progression/relapse|46|||
17201754|NCT02890355|38356271|FG001|Overall Study|Progression/relapse|39|||
17201755|NCT02890355|38356270|FG000|Overall Study|Not protocol specified|3|||
17201756|NCT02890355|38356271|FG001|Overall Study|Not protocol specified|4|||
17201757|NCT02872116|38356282|FG000|Pre-Treatment|Disease Progression|0|||
17201758|NCT02872116|38356283|FG001|Pre-Treatment|Disease Progression|1|||
17201759|NCT02872116|38356284|FG002|Pre-Treatment|Disease Progression|0|||
17201760|NCT02872116|38356282|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
17201761|NCT02872116|38356283|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
17201762|NCT02872116|38356284|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
17201763|NCT02872116|38356282|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
17201764|NCT02872116|38356283|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
17201765|NCT02872116|38356284|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
17201766|NCT02872116|38356282|FG000|Pre-Treatment|Participant withdrew consent|2|||
17201767|NCT02872116|38356283|FG001|Pre-Treatment|Participant withdrew consent|20|||
17201768|NCT02872116|38356284|FG002|Pre-Treatment|Participant withdrew consent|3|||
17201769|NCT02872116|38356282|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
17201770|NCT02872116|38356283|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
17201771|NCT02872116|38356284|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
17201772|NCT02872116|38356282|FG000|Pre-Treatment|Other reasons|1|||
17201773|NCT02872116|38356283|FG001|Pre-Treatment|Other reasons|2|||
17201774|NCT02872116|38356284|FG002|Pre-Treatment|Other reasons|2|||
17201775|NCT02872116|38356282|FG000|Treatment|Death|122|||
17201776|NCT02872116|38356283|FG001|Treatment|Death|94|||
17201777|NCT02872116|38356284|FG002|Treatment|Death|68|||
17201778|NCT02872116|38356282|FG000|Treatment|Lost to Follow-up|5|||
17201779|NCT02872116|38356283|FG001|Treatment|Lost to Follow-up|7|||
17201780|NCT02872116|38356284|FG002|Treatment|Lost to Follow-up|3|||
17201781|NCT02872116|38356282|FG000|Treatment|Participant withdrew consent|20|||
17201782|NCT02872116|38356283|FG001|Treatment|Participant withdrew consent|40|||
17201783|NCT02872116|38356284|FG002|Treatment|Participant withdrew consent|8|||
17201784|NCT02872116|38356282|FG000|Treatment|Other reasons|12|||
17201785|NCT02872116|38356283|FG001|Treatment|Other reasons|12|||
17201786|NCT02872116|38356284|FG002|Treatment|Other reasons|5|||
17201787|NCT02841280|38356298|FG000|Overall Study|Adverse Event|2|||
17201788|NCT02841280|38356299|FG001|Overall Study|Adverse Event|1|||
17201789|NCT02841280|38356298|FG000|Overall Study|Death|1|||
17201790|NCT02841280|38356299|FG001|Overall Study|Death|0|||
17201791|NCT02841280|38356298|FG000|Overall Study|Lost to Follow-up|2|||
17201792|NCT02841280|38356299|FG001|Overall Study|Lost to Follow-up|2|||
17201793|NCT02841280|38356298|FG000|Overall Study|Withdrawal by Subject|7|||
17201794|NCT02841280|38356299|FG001|Overall Study|Withdrawal by Subject|3|||
17201795|NCT02841280|38356298|FG000|Overall Study|Stop Point: BP above threshold|2|||
17201796|NCT02841280|38356299|FG001|Overall Study|Stop Point: BP above threshold|0|||
17201797|NCT02455557|38356322|FG000|Overall Study|Withdrawal by Subject|2|||
17201798|NCT02270450|38356330|FG000|Overall Study|Refusal unrelated to adverse event|3|||
17201799|NCT02270450|38356331|FG001|Overall Study|Refusal unrelated to adverse event|1|||
17201800|NCT02270450|38356332|FG002|Overall Study|Refusal unrelated to adverse event|5|||
17201801|NCT02270450|38356333|FG003|Overall Study|Refusal unrelated to adverse event|14|||
17201802|NCT02270450|38356330|FG000|Overall Study|Progression/relapse|1|||
17201803|NCT02270450|38356331|FG001|Overall Study|Progression/relapse|2|||
17201804|NCT02270450|38356332|FG002|Overall Study|Progression/relapse|4|||
17201805|NCT02270450|38356333|FG003|Overall Study|Progression/relapse|9|||
17201806|NCT02270450|38356330|FG000|Overall Study|Death|19|||
17201807|NCT02270450|38356331|FG001|Overall Study|Death|19|||
17201808|NCT02270450|38356332|FG002|Overall Study|Death|31|||
17201809|NCT02270450|38356333|FG003|Overall Study|Death|59|||
17201810|NCT01570868|38356356|FG000|Overall Study|Adverse Event|8|||
17201811|NCT01570868|38356357|FG001|Overall Study|Adverse Event|1|||
17201812|NCT01570868|38356356|FG000|Overall Study|FDA Recommendation|23|||
17201813|NCT01570868|38356357|FG001|Overall Study|FDA Recommendation|3|||
17201814|NCT01570868|38356356|FG000|Overall Study|Physician Decision|10|||
16941291|NCT01202773|38085855|FG002|Overall Study|Adverse Event|5|||
17201815|NCT01570868|38356357|FG001|Overall Study|Physician Decision|4|||
17201816|NCT01570868|38356356|FG000|Overall Study|Lost to Follow-up|1|||
17201817|NCT01570868|38356357|FG001|Overall Study|Lost to Follow-up|0|||
17201818|NCT01570868|38356356|FG000|Overall Study|Withdrawal by Subject|1|||
17201819|NCT01570868|38356357|FG001|Overall Study|Withdrawal by Subject|0|||
17201820|NCT01565499|38356367|FG000|Overall Study|Physician Decision|1|||
17201821|NCT01565499|38356367|FG000|Overall Study|Adverse Event|5|||
17201822|NCT01565499|38356367|FG000|Overall Study|Withdrawal by Subject|2|||
17201823|NCT01306942|38356374|FG000|Phase I|Adverse Event|2|||
17201824|NCT01306942|38356375|FG001|Phase I|Adverse Event|2|||
17201825|NCT01306942|38356376|FG002|Phase I|Adverse Event|0|||
17201826|NCT01306942|38356377|FG003|Phase I|Adverse Event|0|||
17201827|NCT01306942|38356374|FG000|Phase I|Physician Decision|3|||
17201828|NCT01306942|38356375|FG001|Phase I|Physician Decision|1|||
17201829|NCT01306942|38356376|FG002|Phase I|Physician Decision|0|||
17201830|NCT01306942|38356377|FG003|Phase I|Physician Decision|0|||
17201831|NCT01306942|38356374|FG000|Phase II|Adverse Event|0|||
17201832|NCT01306942|38356375|FG001|Phase II|Adverse Event|0|||
17201833|NCT01306942|38356376|FG002|Phase II|Adverse Event|0|||
17201834|NCT01306942|38356377|FG003|Phase II|Adverse Event|6|||
17201835|NCT01306942|38356374|FG000|Phase II|Physician Decision|2|||
17201836|NCT01306942|38356375|FG001|Phase II|Physician Decision|0|||
17201837|NCT01306942|38356376|FG002|Phase II|Physician Decision|0|||
17201838|NCT01306942|38356377|FG003|Phase II|Physician Decision|5|||
17201839|NCT01306942|38356374|FG000|Phase II|Withdrawal by Subject|0|||
17201840|NCT01306942|38356375|FG001|Phase II|Withdrawal by Subject|0|||
16782474|NCT02701361|37722014|FG002|Overall Study|Lost to Follow-up|1|||
17201841|NCT01306942|38356376|FG002|Phase II|Withdrawal by Subject|0|||
17201842|NCT01306942|38356377|FG003|Phase II|Withdrawal by Subject|2|||
17201843|NCT01306942|38356374|FG000|Phase II|Death|0|||
17201844|NCT01306942|38356375|FG001|Phase II|Death|0|||
17201845|NCT01306942|38356376|FG002|Phase II|Death|0|||
17201846|NCT01306942|38356377|FG003|Phase II|Death|1|||
17201847|NCT01306942|38356374|FG000|Phase II|Not finished treatment|0|||
17201848|NCT01306942|38356375|FG001|Phase II|Not finished treatment|0|||
17201849|NCT01306942|38356376|FG002|Phase II|Not finished treatment|0|||
17201850|NCT01306942|38356377|FG003|Phase II|Not finished treatment|1|||
17201851|NCT01306942|38356374|FG000|Phase II|Protocol Violation|0|||
17201852|NCT01306942|38356375|FG001|Phase II|Protocol Violation|0|||
17201853|NCT01306942|38356376|FG002|Phase II|Protocol Violation|0|||
17201854|NCT01306942|38356377|FG003|Phase II|Protocol Violation|1|||
17201855|NCT01036087|38356389|FG000|Overall Study|Adverse Event|2|||
17201856|NCT01036087|38356389|FG000|Overall Study|Lack of Efficacy|1|||
17201857|NCT00572156|38356406|FG000|Overall Study|Adverse Event|3|||
17201858|NCT00572156|38356407|FG001|Overall Study|Adverse Event|1|||
17201859|NCT00572156|38356408|FG002|Overall Study|Adverse Event|5|||
17201860|NCT00572156|38356409|FG003|Overall Study|Adverse Event|1|||
17201861|NCT00572156|38356406|FG000|Overall Study|Lost to Follow-up|1|||
17201862|NCT00572156|38356407|FG001|Overall Study|Lost to Follow-up|1|||
17201863|NCT00572156|38356408|FG002|Overall Study|Lost to Follow-up|1|||
17201864|NCT00572156|38356409|FG003|Overall Study|Lost to Follow-up|0|||
17201865|NCT00572156|38356406|FG000|Overall Study|Protocol Violation|1|||
17201866|NCT00572156|38356407|FG001|Overall Study|Protocol Violation|2|||
17201867|NCT00572156|38356408|FG002|Overall Study|Protocol Violation|0|||
17201868|NCT00572156|38356409|FG003|Overall Study|Protocol Violation|2|||
17201869|NCT00572156|38356406|FG000|Overall Study|Patient/Parent Decision|1|||
17201870|NCT00572156|38356407|FG001|Overall Study|Patient/Parent Decision|6|||
17201871|NCT00572156|38356408|FG002|Overall Study|Patient/Parent Decision|4|||
17201872|NCT00572156|38356409|FG003|Overall Study|Patient/Parent Decision|3|||
17201873|NCT00572156|38356406|FG000|Overall Study|Sponsor Decision|20|||
17201874|NCT00572156|38356407|FG001|Overall Study|Sponsor Decision|16|||
17201875|NCT00572156|38356408|FG002|Overall Study|Sponsor Decision|17|||
17201876|NCT00572156|38356409|FG003|Overall Study|Sponsor Decision|19|||
17201877|NCT00447772|38356419|FG000|Overall Study|Lack of Efficacy|3|||
17201878|NCT00447772|38356419|FG000|Overall Study|Insufficient compliance|6|||
17201879|NCT00447772|38356419|FG000|Overall Study|Discontinuation of drug therapy|1|||
17201880|NCT00447772|38356419|FG000|Overall Study|Lost to Follow-up|9|||
17201881|NCT00447772|38356419|FG000|Overall Study|Withdrawal by Subject|1|||
17201882|NCT00447772|38356419|FG000|Overall Study|Unable to attend all study visits|2|||
17201883|NCT00447772|38356419|FG000|Overall Study|Adverse Event|1|||
17201884|NCT00447772|38356419|FG000|Overall Study|Patient relocated|1|||
17201885|NCT00447772|38356419|FG000|Overall Study|Incomplete documentation at visit 1|1|||
17201886|NCT00447772|38356419|FG000|Overall Study|Chemotherapy for lung cancer|1|||
17201887|NCT00447772|38356419|FG000|Overall Study|Premature re-injection required|1|||
17028012|NCT00801983|38172387|FG000|Period 1|Withdrawal by Subject|2|||
17028013|NCT00801983|38172388|FG001|Period 1|Withdrawal by Subject|8|||
17028014|NCT00801983|38172387|FG000|Period 2|Withdrawal by Subject|2|||
16854716|NCT02000531|37807159|FG000|Overall Study|Lost to Follow-up|1|||
16854717|NCT02000531|37807160|FG001|Overall Study|Lost to Follow-up|0|||
16854718|NCT02000531|37807159|FG000|Overall Study|Discontinued due to data cut-off|3|||
16854719|NCT02000531|37807160|FG001|Overall Study|Discontinued due to data cut-off|8|||
16854720|NCT01609231|37807168|FG000|Overall Study|Adverse Event|1|||
16854721|NCT01609231|37807169|FG001|Overall Study|Adverse Event|3|||
16854722|NCT01609231|37807168|FG000|Overall Study|Physician Decision|1|||
16854723|NCT01609231|37807169|FG001|Overall Study|Physician Decision|0|||
16854724|NCT01609231|37807168|FG000|Overall Study|Withdrawal by Subject|1|||
16854725|NCT01609231|37807169|FG001|Overall Study|Withdrawal by Subject|0|||
16854726|NCT01793935|37807177|FG000|Overall Study|Pregnancy|1|||
16854727|NCT01793935|37807178|FG001|Overall Study|Pregnancy|0|||
16854728|NCT01793935|37807177|FG000|Overall Study|Protocol Violation|2|||
16854729|NCT01793935|37807178|FG001|Overall Study|Protocol Violation|1|||
16854730|NCT01793935|37807177|FG000|Overall Study|Adverse Event|2|||
16854731|NCT01793935|37807178|FG001|Overall Study|Adverse Event|0|||
16854732|NCT01793935|37807177|FG000|Overall Study|Patient did not take study medication|1|||
16854733|NCT01793935|37807178|FG001|Overall Study|Patient did not take study medication|1|||
16854734|NCT01793935|37807177|FG000|Overall Study|Lost to Follow-up|0|||
16854735|NCT01793935|37807178|FG001|Overall Study|Lost to Follow-up|1|||
16854736|NCT02092025|37807184|FG000|Overall Study|Case Report Forms Uncollected|44|||
16854737|NCT02092025|37807184|FG000|Overall Study|Protocol Deviation|24|||
16854738|NCT01769443|37807190|FG000|Overall Study|Study closure|1|||
16854739|NCT01769443|37807191|FG001|Overall Study|Study closure|0|||
16854740|NCT01768117|37807198|FG000|Overall Study|Lost to Follow-up|1|||
16854741|NCT01768117|37807198|FG000|Overall Study|Withdrawal by Subject|2|||
16854742|NCT01768117|37807198|FG000|Overall Study|Protocol Violation|3|||
16854743|NCT01767493|37807202|FG000|Overall Study|screen failures|3|||
16854744|NCT01274182|37807209|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
16854745|NCT01274182|37807210|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16854746|NCT01274182|37807211|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
16854747|NCT01274182|37807209|FG000|Overall Study|Adverse Event|4|||
16854748|NCT01274182|37807210|FG001|Overall Study|Adverse Event|5|||
16854749|NCT01274182|37807211|FG002|Overall Study|Adverse Event|3|||
16854750|NCT01274182|37807209|FG000|Overall Study|Withdrawal by Subject|5|||
16854751|NCT01274182|37807210|FG001|Overall Study|Withdrawal by Subject|5|||
16854752|NCT01274182|37807211|FG002|Overall Study|Withdrawal by Subject|3|||
16854753|NCT01274182|37807209|FG000|Overall Study|Lost to Follow-up|2|||
16854754|NCT01274182|37807210|FG001|Overall Study|Lost to Follow-up|3|||
16854755|NCT01274182|37807211|FG002|Overall Study|Lost to Follow-up|1|||
16854756|NCT01274182|37807209|FG000|Overall Study|Protocol Violation|3|||
16854757|NCT01274182|37807210|FG001|Overall Study|Protocol Violation|2|||
16854758|NCT01274182|37807211|FG002|Overall Study|Protocol Violation|0|||
16854759|NCT01274182|37807209|FG000|Overall Study|Death|1|||
16854760|NCT01274182|37807210|FG001|Overall Study|Death|0|||
16854761|NCT01274182|37807211|FG002|Overall Study|Death|1|||
16854762|NCT01984229|37807225|FG000|Safety Follow-up Period|Adverse Event|1|||
16854763|NCT01984229|37807226|FG001|Safety Follow-up Period|Adverse Event|1|||
16854764|NCT01984229|37807225|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
16854765|NCT01984229|37807226|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
16854766|NCT01835899|37807241|FG000|Overall Study|Adverse Event|0|||
16854767|NCT01835899|37807242|FG001|Overall Study|Adverse Event|0|||
16854768|NCT01835899|37807243|FG002|Overall Study|Adverse Event|1|||
16854769|NCT01835899|37807241|FG000|Overall Study|Other than stated above|0|||
16782475|NCT02701361|37722012|FG000|Overall Study|Withdrawal by Subject|4|||
16782476|NCT02701361|37722013|FG001|Overall Study|Withdrawal by Subject|0|||
16782477|NCT02701361|37722014|FG002|Overall Study|Withdrawal by Subject|0|||
16782478|NCT02701361|37722012|FG000|Overall Study|timed out in rehab center|0|||
16782479|NCT02701361|37722013|FG001|Overall Study|timed out in rehab center|1|||
16782480|NCT02701361|37722014|FG002|Overall Study|timed out in rehab center|0|||
16782481|NCT02701361|37722012|FG000|Overall Study|incarceration|0|||
16782482|NCT02701361|37722013|FG001|Overall Study|incarceration|0|||
16782483|NCT02701361|37722014|FG002|Overall Study|incarceration|1|||
16782484|NCT02566785|37722035|FG000|Overall Study|Lost to Follow-up|0|||
16782485|NCT02566785|37722036|FG001|Overall Study|Lost to Follow-up|2|||
16782486|NCT02566785|37722035|FG000|Overall Study|Worsening condition|1|||
16782487|NCT02566785|37722036|FG001|Overall Study|Worsening condition|1|||
16782488|NCT01662999|37722048|FG000|Period 3|Withdrawal by Subject|0|||
16782489|NCT01662999|37722049|FG001|Period 3|Withdrawal by Subject|1|||
16782490|NCT01662999|37722050|FG002|Period 3|Withdrawal by Subject|0|||
16782491|NCT01662999|37722051|FG003|Period 3|Withdrawal by Subject|0|||
16782492|NCT01662999|37722052|FG004|Period 3|Withdrawal by Subject|0|||
16782493|NCT01662999|37722053|FG005|Period 3|Withdrawal by Subject|0|||
16782494|NCT02565381|37722086|FG000|Overall Study|Lost to Follow-up|1|||
16782495|NCT02565381|37722087|FG001|Overall Study|Lost to Follow-up|0|||
16782496|NCT02565381|37722088|FG002|Overall Study|Lost to Follow-up|1|||
16782497|NCT02063854|37722103|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
16782498|NCT02063854|37722104|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
16782499|NCT02063854|37722105|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
16782500|NCT02063854|37722106|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
16782501|NCT02063854|37722107|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
16782502|NCT02063854|37722108|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
16782503|NCT02063854|37722109|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
16782504|NCT02063854|37722103|FG000|Overall Study|Major Protocol Deviation|0|||
16782505|NCT02063854|37722104|FG001|Overall Study|Major Protocol Deviation|0|||
16782506|NCT02063854|37722105|FG002|Overall Study|Major Protocol Deviation|3|||
16782507|NCT02063854|37722106|FG003|Overall Study|Major Protocol Deviation|0|||
16854770|NCT01835899|37807242|FG001|Overall Study|Other than stated above|1|||
16854771|NCT01835899|37807243|FG002|Overall Study|Other than stated above|0|||
16854772|NCT01766401|37807255|FG000|Overall Study|Adverse Event|7|||
16854773|NCT01766401|37807256|FG001|Overall Study|Adverse Event|22|||
16854774|NCT01766401|37807255|FG000|Overall Study|Lack of Efficacy|1|||
16854775|NCT01766401|37807256|FG001|Overall Study|Lack of Efficacy|2|||
16854776|NCT01766401|37807255|FG000|Overall Study|Protocol Violation|3|||
16854777|NCT01766401|37807256|FG001|Overall Study|Protocol Violation|8|||
16854778|NCT01766401|37807255|FG000|Overall Study|Withdrawal by Subject|15|||
16854779|NCT01766401|37807256|FG001|Overall Study|Withdrawal by Subject|12|||
16854780|NCT01766401|37807255|FG000|Overall Study|Lost to Follow-up|10|||
16854781|NCT01766401|37807256|FG001|Overall Study|Lost to Follow-up|11|||
16854782|NCT01766401|37807255|FG000|Overall Study|Pregnancy|1|||
16854783|NCT01766401|37807256|FG001|Overall Study|Pregnancy|1|||
16854784|NCT01272934|37807264|FG000|Overall Study|Adverse Event|0|||
16854785|NCT01272934|37807265|FG001|Overall Study|Adverse Event|1|||
16854786|NCT01272934|37807264|FG000|Overall Study|Abnormal Laboratory Value|0|||
16854787|NCT01272934|37807265|FG001|Overall Study|Abnormal Laboratory Value|1|||
16854788|NCT01983683|37807283|FG000|Overall Study|Withdrawal by Subject|14|||
16854789|NCT01983683|37807284|FG001|Overall Study|Withdrawal by Subject|18|||
16854790|NCT01983683|37807283|FG000|Overall Study|Death|11|||
16854791|NCT01983683|37807284|FG001|Overall Study|Death|15|||
16854792|NCT01983683|37807283|FG000|Overall Study|Physician Decision|8|||
16854793|NCT01983683|37807284|FG001|Overall Study|Physician Decision|9|||
16854794|NCT01983683|37807283|FG000|Overall Study|Lost to Follow-up|4|||
16854795|NCT01983683|37807284|FG001|Overall Study|Lost to Follow-up|8|||
16854796|NCT01983683|37807283|FG000|Overall Study|Sponsor Decision|1|||
16854797|NCT01983683|37807284|FG001|Overall Study|Sponsor Decision|1|||
16854798|NCT01998893|37807290|FG000|Overall Study|Adverse Event|2|||
16854799|NCT01998893|37807290|FG000|Overall Study|Death|1|||
16854800|NCT01998893|37807290|FG000|Overall Study|Lost to Follow-up|8|||
16854801|NCT01998893|37807290|FG000|Overall Study|Physician Decision|2|||
16854802|NCT01998893|37807290|FG000|Overall Study|Protocol Violation|2|||
16854803|NCT01998893|37807290|FG000|Overall Study|Withdrawal by Subject|1|||
16854804|NCT01998893|37807290|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
16854805|NCT01791985|37807294|FG000|Overall Study|Adverse Event|7|||
16854806|NCT01791985|37807294|FG000|Overall Study|Withdrawal by Subject|1|||
16854807|NCT01998737|37807301|FG000|Overall Study|Corrupted database|23|||
16854808|NCT01998737|37807302|FG001|Overall Study|Corrupted database|0|||
16854809|NCT01791517|37807311|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
16854810|NCT01791517|37807312|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
16854811|NCT01791517|37807313|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
16854812|NCT01791517|37807314|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
16854813|NCT01791517|37807315|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
16854814|NCT01791517|37807316|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
16854815|NCT01791517|37807317|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
16854816|NCT01791517|37807318|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
16854817|NCT01791517|37807319|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
16854818|NCT01791517|37807320|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
16854819|NCT01791517|37807321|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
16854820|NCT01791517|37807322|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
16854821|NCT01791517|37807311|FG000|Phase I: Period 1|Adverse Event|0|||
16854822|NCT01791517|37807312|FG001|Phase I: Period 1|Adverse Event|0|||
16854823|NCT01791517|37807313|FG002|Phase I: Period 1|Adverse Event|1|||
16854824|NCT01791517|37807314|FG003|Phase I: Period 1|Adverse Event|1|||
16854825|NCT01791517|37807315|FG004|Phase I: Period 1|Adverse Event|0|||
16854826|NCT01791517|37807316|FG005|Phase I: Period 1|Adverse Event|0|||
16854827|NCT01791517|37807317|FG006|Phase I: Period 1|Adverse Event|0|||
16854828|NCT01791517|37807318|FG007|Phase I: Period 1|Adverse Event|0|||
16854829|NCT01791517|37807319|FG008|Phase I: Period 1|Adverse Event|0|||
16854830|NCT01791517|37807320|FG009|Phase I: Period 1|Adverse Event|0|||
16854831|NCT01791517|37807321|FG010|Phase I: Period 1|Adverse Event|0|||
16854832|NCT01791517|37807322|FG011|Phase I: Period 1|Adverse Event|0|||
16854833|NCT01791517|37807311|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
16854834|NCT01791517|37807312|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854835|NCT01791517|37807313|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854836|NCT01791517|37807314|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854837|NCT01791517|37807315|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854838|NCT01791517|37807316|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854839|NCT01791517|37807317|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854840|NCT01791517|37807318|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854841|NCT01791517|37807319|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854842|NCT01791517|37807320|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854843|NCT01791517|37807321|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854844|NCT01791517|37807322|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16854845|NCT01791517|37807311|FG000|Phase I: Period 1|Protocol Violation|0|||
16854846|NCT01791517|37807312|FG001|Phase I: Period 1|Protocol Violation|1|||
16854847|NCT01791517|37807313|FG002|Phase I: Period 1|Protocol Violation|0|||
16854848|NCT01791517|37807314|FG003|Phase I: Period 1|Protocol Violation|0|||
16854849|NCT01791517|37807315|FG004|Phase I: Period 1|Protocol Violation|0|||
16854850|NCT01791517|37807316|FG005|Phase I: Period 1|Protocol Violation|0|||
16854851|NCT01791517|37807317|FG006|Phase I: Period 1|Protocol Violation|0|||
16854852|NCT01791517|37807318|FG007|Phase I: Period 1|Protocol Violation|0|||
16854853|NCT01791517|37807319|FG008|Phase I: Period 1|Protocol Violation|0|||
16854854|NCT01791517|37807320|FG009|Phase I: Period 1|Protocol Violation|0|||
16854855|NCT01791517|37807321|FG010|Phase I: Period 1|Protocol Violation|0|||
16854856|NCT01791517|37807322|FG011|Phase I: Period 1|Protocol Violation|0|||
16854857|NCT01791517|37807311|FG000|Phase I: Period 1|Lost to Follow-up|0|||
16854858|NCT01791517|37807312|FG001|Phase I: Period 1|Lost to Follow-up|0|||
16854859|NCT01791517|37807313|FG002|Phase I: Period 1|Lost to Follow-up|0|||
16854860|NCT01791517|37807314|FG003|Phase I: Period 1|Lost to Follow-up|1|||
16854861|NCT01791517|37807315|FG004|Phase I: Period 1|Lost to Follow-up|0|||
16854862|NCT01791517|37807316|FG005|Phase I: Period 1|Lost to Follow-up|0|||
16854863|NCT01791517|37807317|FG006|Phase I: Period 1|Lost to Follow-up|1|||
16854864|NCT01791517|37807318|FG007|Phase I: Period 1|Lost to Follow-up|0|||
16854865|NCT01791517|37807319|FG008|Phase I: Period 1|Lost to Follow-up|1|||
16854866|NCT01791517|37807320|FG009|Phase I: Period 1|Lost to Follow-up|1|||
16854867|NCT01791517|37807321|FG010|Phase I: Period 1|Lost to Follow-up|0|||
16854868|NCT01791517|37807322|FG011|Phase I: Period 1|Lost to Follow-up|0|||
16854869|NCT01791517|37807311|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854870|NCT01791517|37807312|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854871|NCT01791517|37807313|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854872|NCT01791517|37807314|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854873|NCT01791517|37807315|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854874|NCT01791517|37807316|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854875|NCT01791517|37807317|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854876|NCT01791517|37807318|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854877|NCT01791517|37807319|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854878|NCT01791517|37807320|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854879|NCT01791517|37807321|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
16854880|NCT01791517|37807322|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
16854881|NCT01791517|37807311|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
16854882|NCT01791517|37807312|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854883|NCT01791517|37807313|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854884|NCT01791517|37807314|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854885|NCT01791517|37807315|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854886|NCT01791517|37807316|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854887|NCT01791517|37807317|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854888|NCT01791517|37807318|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854889|NCT01791517|37807319|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854890|NCT01791517|37807320|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854891|NCT01791517|37807321|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854892|NCT01791517|37807322|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16854893|NCT01791517|37807311|FG000|Phase I: Period 2|Protocol Violation|0|||
16854894|NCT01791517|37807312|FG001|Phase I: Period 2|Protocol Violation|0|||
16854895|NCT01791517|37807313|FG002|Phase I: Period 2|Protocol Violation|0|||
16854896|NCT01791517|37807314|FG003|Phase I: Period 2|Protocol Violation|1|||
16854897|NCT01791517|37807315|FG004|Phase I: Period 2|Protocol Violation|0|||
16854898|NCT01791517|37807316|FG005|Phase I: Period 2|Protocol Violation|0|||
16854899|NCT01791517|37807317|FG006|Phase I: Period 2|Protocol Violation|0|||
16854900|NCT01791517|37807318|FG007|Phase I: Period 2|Protocol Violation|0|||
16854901|NCT01791517|37807319|FG008|Phase I: Period 2|Protocol Violation|0|||
16854902|NCT01791517|37807320|FG009|Phase I: Period 2|Protocol Violation|0|||
16854903|NCT01791517|37807321|FG010|Phase I: Period 2|Protocol Violation|0|||
16854904|NCT01791517|37807322|FG011|Phase I: Period 2|Protocol Violation|0|||
16854905|NCT01791517|37807311|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
16854906|NCT01791517|37807312|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
16854907|NCT01791517|37807313|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
16854908|NCT01791517|37807314|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
16854909|NCT01791517|37807315|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
16854910|NCT01791517|37807316|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
16854911|NCT01791517|37807317|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
16854912|NCT01791517|37807318|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
16854913|NCT01791517|37807319|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
16854914|NCT01791517|37807320|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
16854915|NCT01791517|37807321|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
16854916|NCT01791517|37807322|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
16854917|NCT01791517|37807311|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854918|NCT01791517|37807312|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854919|NCT01791517|37807313|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854920|NCT01791517|37807314|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854921|NCT01791517|37807315|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854922|NCT01791517|37807316|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854923|NCT01791517|37807317|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854924|NCT01791517|37807318|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854925|NCT01791517|37807319|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854926|NCT01791517|37807320|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854927|NCT01791517|37807321|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
16854928|NCT01791517|37807322|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16854929|NCT01791517|37807311|FG000|Phase I: Period 2|Lens Discomfort|0|||
16854930|NCT01791517|37807312|FG001|Phase I: Period 2|Lens Discomfort|0|||
16854931|NCT01791517|37807313|FG002|Phase I: Period 2|Lens Discomfort|0|||
16854932|NCT01791517|37807314|FG003|Phase I: Period 2|Lens Discomfort|0|||
16854933|NCT01791517|37807315|FG004|Phase I: Period 2|Lens Discomfort|0|||
16854934|NCT01791517|37807316|FG005|Phase I: Period 2|Lens Discomfort|1|||
16854935|NCT01791517|37807317|FG006|Phase I: Period 2|Lens Discomfort|0|||
16854936|NCT01791517|37807318|FG007|Phase I: Period 2|Lens Discomfort|0|||
16854937|NCT01791517|37807319|FG008|Phase I: Period 2|Lens Discomfort|0|||
16854938|NCT01791517|37807320|FG009|Phase I: Period 2|Lens Discomfort|0|||
16854939|NCT01791517|37807321|FG010|Phase I: Period 2|Lens Discomfort|0|||
16854940|NCT01791517|37807322|FG011|Phase I: Period 2|Lens Discomfort|0|||
16854941|NCT01791517|37807311|FG000|Phase I: Period 2|Lost to Follow-up|0|||
16854942|NCT01791517|37807312|FG001|Phase I: Period 2|Lost to Follow-up|3|||
16854943|NCT01791517|37807313|FG002|Phase I: Period 2|Lost to Follow-up|2|||
16854944|NCT01791517|37807314|FG003|Phase I: Period 2|Lost to Follow-up|0|||
16854945|NCT01791517|37807315|FG004|Phase I: Period 2|Lost to Follow-up|0|||
16854946|NCT01791517|37807316|FG005|Phase I: Period 2|Lost to Follow-up|0|||
16854947|NCT01791517|37807317|FG006|Phase I: Period 2|Lost to Follow-up|0|||
16854948|NCT01791517|37807318|FG007|Phase I: Period 2|Lost to Follow-up|0|||
16854949|NCT01791517|37807319|FG008|Phase I: Period 2|Lost to Follow-up|0|||
16854950|NCT01791517|37807320|FG009|Phase I: Period 2|Lost to Follow-up|0|||
16854951|NCT01791517|37807321|FG010|Phase I: Period 2|Lost to Follow-up|0|||
16854952|NCT01791517|37807322|FG011|Phase I: Period 2|Lost to Follow-up|0|||
16854953|NCT01791517|37807311|FG000|Phase I: Period 3|Lens Discomfort|0|||
16854954|NCT01791517|37807312|FG001|Phase I: Period 3|Lens Discomfort|0|||
16854955|NCT01791517|37807313|FG002|Phase I: Period 3|Lens Discomfort|0|||
16854956|NCT01791517|37807314|FG003|Phase I: Period 3|Lens Discomfort|0|||
16854957|NCT01791517|37807315|FG004|Phase I: Period 3|Lens Discomfort|0|||
16854958|NCT01791517|37807316|FG005|Phase I: Period 3|Lens Discomfort|0|||
16854959|NCT01791517|37807317|FG006|Phase I: Period 3|Lens Discomfort|0|||
16854960|NCT01791517|37807318|FG007|Phase I: Period 3|Lens Discomfort|0|||
16854961|NCT01791517|37807319|FG008|Phase I: Period 3|Lens Discomfort|0|||
16854962|NCT01791517|37807320|FG009|Phase I: Period 3|Lens Discomfort|0|||
16854963|NCT01791517|37807321|FG010|Phase I: Period 3|Lens Discomfort|0|||
16854964|NCT01791517|37807322|FG011|Phase I: Period 3|Lens Discomfort|1|||
16854965|NCT01791517|37807311|FG000|Phase I: Period 3|Lost to Follow-up|0|||
16854966|NCT01791517|37807312|FG001|Phase I: Period 3|Lost to Follow-up|1|||
16854967|NCT01791517|37807313|FG002|Phase I: Period 3|Lost to Follow-up|0|||
16854968|NCT01791517|37807314|FG003|Phase I: Period 3|Lost to Follow-up|0|||
16854969|NCT01791517|37807315|FG004|Phase I: Period 3|Lost to Follow-up|1|||
16854970|NCT01791517|37807316|FG005|Phase I: Period 3|Lost to Follow-up|0|||
16854971|NCT01791517|37807317|FG006|Phase I: Period 3|Lost to Follow-up|0|||
16854972|NCT01791517|37807318|FG007|Phase I: Period 3|Lost to Follow-up|0|||
16854973|NCT01791517|37807319|FG008|Phase I: Period 3|Lost to Follow-up|0|||
16854974|NCT01791517|37807320|FG009|Phase I: Period 3|Lost to Follow-up|0|||
16854975|NCT01791517|37807321|FG010|Phase I: Period 3|Lost to Follow-up|0|||
16854976|NCT01791517|37807322|FG011|Phase I: Period 3|Lost to Follow-up|0|||
16854977|NCT01791517|37807311|FG000|Phase I: Period 3|Adverse Event|0|||
16854978|NCT01791517|37807312|FG001|Phase I: Period 3|Adverse Event|0|||
16854979|NCT01791517|37807313|FG002|Phase I: Period 3|Adverse Event|0|||
16854980|NCT01791517|37807314|FG003|Phase I: Period 3|Adverse Event|1|||
16854981|NCT01791517|37807315|FG004|Phase I: Period 3|Adverse Event|0|||
16854982|NCT01791517|37807316|FG005|Phase I: Period 3|Adverse Event|0|||
16854983|NCT01791517|37807317|FG006|Phase I: Period 3|Adverse Event|0|||
16854984|NCT01791517|37807318|FG007|Phase I: Period 3|Adverse Event|0|||
16854985|NCT01791517|37807319|FG008|Phase I: Period 3|Adverse Event|0|||
16854986|NCT01791517|37807320|FG009|Phase I: Period 3|Adverse Event|0|||
16854987|NCT01791517|37807321|FG010|Phase I: Period 3|Adverse Event|0|||
16854988|NCT01791517|37807322|FG011|Phase I: Period 3|Adverse Event|0|||
16854989|NCT01791517|37807311|FG000|Phase II|Lost to Follow-up|1|||
16854990|NCT01791517|37807312|FG001|Phase II|Lost to Follow-up|0|||
16854991|NCT01791517|37807313|FG002|Phase II|Lost to Follow-up|1|||
16854992|NCT01791517|37807314|FG003|Phase II|Lost to Follow-up|0|||
16854993|NCT01791517|37807315|FG004|Phase II|Lost to Follow-up|1|||
16854994|NCT01791517|37807316|FG005|Phase II|Lost to Follow-up|2|||
16854995|NCT01791517|37807317|FG006|Phase II|Lost to Follow-up|0|||
16854996|NCT01791517|37807318|FG007|Phase II|Lost to Follow-up|1|||
16854997|NCT01791517|37807319|FG008|Phase II|Lost to Follow-up|1|||
16854998|NCT01791517|37807320|FG009|Phase II|Lost to Follow-up|1|||
16854999|NCT01791517|37807321|FG010|Phase II|Lost to Follow-up|0|||
16855000|NCT01791517|37807322|FG011|Phase II|Lost to Follow-up|0|||
16855001|NCT01791517|37807311|FG000|Phase II|Withdrawal by Subject|1|||
16855002|NCT01791517|37807312|FG001|Phase II|Withdrawal by Subject|0|||
16855003|NCT01791517|37807313|FG002|Phase II|Withdrawal by Subject|0|||
16855004|NCT01791517|37807314|FG003|Phase II|Withdrawal by Subject|0|||
16855005|NCT01791517|37807315|FG004|Phase II|Withdrawal by Subject|0|||
16855006|NCT01791517|37807316|FG005|Phase II|Withdrawal by Subject|2|||
16855007|NCT01791517|37807317|FG006|Phase II|Withdrawal by Subject|0|||
16855008|NCT01791517|37807318|FG007|Phase II|Withdrawal by Subject|1|||
16855009|NCT01791517|37807319|FG008|Phase II|Withdrawal by Subject|0|||
16855010|NCT01791517|37807320|FG009|Phase II|Withdrawal by Subject|0|||
16855011|NCT01791517|37807321|FG010|Phase II|Withdrawal by Subject|1|||
16855012|NCT01791517|37807322|FG011|Phase II|Withdrawal by Subject|0|||
16855013|NCT01791517|37807311|FG000|Phase II|Lack of Efficacy|0|||
16855014|NCT01791517|37807312|FG001|Phase II|Lack of Efficacy|0|||
16855015|NCT01791517|37807313|FG002|Phase II|Lack of Efficacy|0|||
16855016|NCT01791517|37807314|FG003|Phase II|Lack of Efficacy|0|||
16855017|NCT01791517|37807315|FG004|Phase II|Lack of Efficacy|1|||
16855018|NCT01791517|37807316|FG005|Phase II|Lack of Efficacy|0|||
16855019|NCT01791517|37807317|FG006|Phase II|Lack of Efficacy|0|||
16855020|NCT01791517|37807318|FG007|Phase II|Lack of Efficacy|0|||
16855021|NCT01791517|37807319|FG008|Phase II|Lack of Efficacy|0|||
16855022|NCT01791517|37807320|FG009|Phase II|Lack of Efficacy|0|||
16855023|NCT01791517|37807321|FG010|Phase II|Lack of Efficacy|0|||
16855024|NCT01791517|37807322|FG011|Phase II|Lack of Efficacy|0|||
16855025|NCT01791517|37807311|FG000|Phase II|Adverse Event|0|||
16855026|NCT01791517|37807312|FG001|Phase II|Adverse Event|0|||
16855027|NCT01791517|37807313|FG002|Phase II|Adverse Event|0|||
16855028|NCT01791517|37807314|FG003|Phase II|Adverse Event|0|||
16855029|NCT01791517|37807315|FG004|Phase II|Adverse Event|0|||
16855030|NCT01791517|37807316|FG005|Phase II|Adverse Event|0|||
16855031|NCT01791517|37807317|FG006|Phase II|Adverse Event|2|||
16855032|NCT01791517|37807318|FG007|Phase II|Adverse Event|1|||
17028015|NCT00801983|38172388|FG001|Period 2|Withdrawal by Subject|1|||
16855033|NCT01791517|37807319|FG008|Phase II|Adverse Event|0|||
16855034|NCT01791517|37807320|FG009|Phase II|Adverse Event|1|||
16855035|NCT01791517|37807321|FG010|Phase II|Adverse Event|0|||
16855036|NCT01791517|37807322|FG011|Phase II|Adverse Event|0|||
16855037|NCT01791517|37807311|FG000|Phase II|Lens Handling Difficulties|0|||
16855038|NCT01791517|37807312|FG001|Phase II|Lens Handling Difficulties|0|||
16855039|NCT01791517|37807313|FG002|Phase II|Lens Handling Difficulties|0|||
16855040|NCT01791517|37807314|FG003|Phase II|Lens Handling Difficulties|0|||
16855041|NCT01791517|37807315|FG004|Phase II|Lens Handling Difficulties|0|||
16855042|NCT01791517|37807316|FG005|Phase II|Lens Handling Difficulties|0|||
16855043|NCT01791517|37807317|FG006|Phase II|Lens Handling Difficulties|0|||
16855044|NCT01791517|37807318|FG007|Phase II|Lens Handling Difficulties|0|||
16855045|NCT01791517|37807319|FG008|Phase II|Lens Handling Difficulties|1|||
16855046|NCT01791517|37807320|FG009|Phase II|Lens Handling Difficulties|0|||
16855047|NCT01791517|37807321|FG010|Phase II|Lens Handling Difficulties|0|||
16855048|NCT01791517|37807322|FG011|Phase II|Lens Handling Difficulties|0|||
16855049|NCT01791517|37807311|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
16855050|NCT01791517|37807312|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
16855051|NCT01791517|37807313|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
16855052|NCT01791517|37807314|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
16855053|NCT01791517|37807315|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
16855054|NCT01791517|37807316|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
16855055|NCT01791517|37807317|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
16855056|NCT01791517|37807318|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
16855057|NCT01791517|37807319|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
16855058|NCT01791517|37807320|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
16855059|NCT01791517|37807321|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
16855060|NCT01791517|37807322|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
16855061|NCT01791517|37807311|FG000|Phase II|Pre-Existing Ocular Issue|0|||
16855062|NCT01791517|37807312|FG001|Phase II|Pre-Existing Ocular Issue|0|||
16855063|NCT01791517|37807313|FG002|Phase II|Pre-Existing Ocular Issue|0|||
16855064|NCT01791517|37807314|FG003|Phase II|Pre-Existing Ocular Issue|0|||
16855065|NCT01791517|37807315|FG004|Phase II|Pre-Existing Ocular Issue|0|||
16855066|NCT01791517|37807316|FG005|Phase II|Pre-Existing Ocular Issue|0|||
16855067|NCT01791517|37807317|FG006|Phase II|Pre-Existing Ocular Issue|0|||
16855068|NCT01791517|37807318|FG007|Phase II|Pre-Existing Ocular Issue|0|||
16855069|NCT01791517|37807319|FG008|Phase II|Pre-Existing Ocular Issue|0|||
16855070|NCT01791517|37807320|FG009|Phase II|Pre-Existing Ocular Issue|0|||
16855071|NCT01791517|37807321|FG010|Phase II|Pre-Existing Ocular Issue|0|||
16855072|NCT01791517|37807322|FG011|Phase II|Pre-Existing Ocular Issue|1|||
16855073|NCT01998581|37807342|FG000|Overall Study|Refused repeat treatment|20|||
16855074|NCT01998581|37807343|FG001|Overall Study|Refused repeat treatment|4|||
16855075|NCT01998581|37807342|FG000|Overall Study|Protocol Violation|1|||
16855076|NCT01998581|37807343|FG001|Overall Study|Protocol Violation|0|||
16855077|NCT01998581|37807342|FG000|Overall Study|Withdrawal by Subject|8|||
16855078|NCT01998581|37807343|FG001|Overall Study|Withdrawal by Subject|1|||
16855079|NCT01998581|37807342|FG000|Overall Study|Lost to Follow-up|12|||
16855080|NCT01998581|37807343|FG001|Overall Study|Lost to Follow-up|4|||
16855081|NCT01998581|37807342|FG000|Overall Study|Adverse Event|1|||
16855082|NCT01998581|37807343|FG001|Overall Study|Adverse Event|1|||
16855083|NCT01998581|37807342|FG000|Overall Study|Other reasons|3|||
16855084|NCT01998581|37807343|FG001|Overall Study|Other reasons|2|||
16855085|NCT01998581|37807342|FG000|Overall Study|Randomized but withdrew before treatment|1|||
16855086|NCT01998581|37807343|FG001|Overall Study|Randomized but withdrew before treatment|0|||
16855087|NCT01983293|37807352|FG000|Overall Study|Withdrawal by Subject|29|||
16855088|NCT01983293|37807353|FG001|Overall Study|Withdrawal by Subject|15|||
16855089|NCT01983293|37807352|FG000|Overall Study|Missing 12-month visit|3|||
16855090|NCT01983293|37807353|FG001|Overall Study|Missing 12-month visit|3|||
16855091|NCT01983293|37807352|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
16855092|NCT01983293|37807353|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
16855093|NCT01791205|37807361|FG000|Phase II|Lack of Efficacy|6|||
16855094|NCT01791205|37807362|FG001|Phase II|Lack of Efficacy|0|||
16855095|NCT01791205|37807361|FG000|Phase II|Adverse Event|2|||
16855096|NCT01791205|37807362|FG001|Phase II|Adverse Event|0|||
16855097|NCT01791205|37807361|FG000|Phase II|Safety|1|||
16855098|NCT01791205|37807362|FG001|Phase II|Safety|0|||
16855099|NCT01791205|37807361|FG000|Phase II|Lost to Follow-up|1|||
16855100|NCT01791205|37807362|FG001|Phase II|Lost to Follow-up|0|||
16855101|NCT01791205|37807361|FG000|Phase II|Remission of disease|1|||
16855102|NCT01791205|37807362|FG001|Phase II|Remission of disease|0|||
16855103|NCT01791205|37807361|FG000|Phase II|Physician's decision|1|||
16855104|NCT01791205|37807362|FG001|Phase II|Physician's decision|0|||
16855105|NCT01272232|37807371|FG000|Weeks 0-56|Adverse Event|39|||
16855106|NCT01272232|37807372|FG001|Weeks 0-56|Adverse Event|18|||
16855107|NCT01272232|37807373|FG002|Weeks 0-56|Adverse Event|7|||
16855108|NCT01272232|37807371|FG000|Weeks 0-56|Lack of Efficacy|0|||
16855109|NCT01272232|37807372|FG001|Weeks 0-56|Lack of Efficacy|0|||
16855110|NCT01272232|37807373|FG002|Weeks 0-56|Lack of Efficacy|3|||
16855111|NCT01272232|37807371|FG000|Weeks 0-56|Protocol Violation|12|||
16855112|NCT01272232|37807372|FG001|Weeks 0-56|Protocol Violation|8|||
16855113|NCT01272232|37807373|FG002|Weeks 0-56|Protocol Violation|13|||
16855114|NCT01272232|37807371|FG000|Weeks 0-56|Withdrawal criteria|32|||
16855115|NCT01272232|37807372|FG001|Weeks 0-56|Withdrawal criteria|14|||
16855116|NCT01272232|37807373|FG002|Weeks 0-56|Withdrawal criteria|37|||
16855117|NCT01272232|37807371|FG000|Weeks 0-56|Unclassified|16|||
16855118|NCT01272232|37807372|FG001|Weeks 0-56|Unclassified|7|||
16855119|NCT01272232|37807373|FG002|Weeks 0-56|Unclassified|12|||
16855120|NCT01272232|37807371|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
16855121|NCT01272232|37807372|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
16855122|NCT01272232|37807373|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
16855123|NCT01272232|37807371|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
16855124|NCT01272232|37807372|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
16855125|NCT01272232|37807373|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
16855126|NCT01272232|37807371|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
16855127|NCT01272232|37807372|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
16855128|NCT01272232|37807373|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
16855129|NCT01272232|37807371|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
16855130|NCT01272232|37807372|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
16855131|NCT01272232|37807373|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
16855132|NCT01272232|37807371|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
16855133|NCT01272232|37807372|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
16855134|NCT01272232|37807373|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
16855135|NCT01791127|37807381|FG000|Overall Study|Death|356|||
16855136|NCT01791127|37807381|FG000|Overall Study|Patient has withdrawn from study|293|||
16855137|NCT01791127|37807381|FG000|Overall Study|Lost to Follow-up|42|||
16855138|NCT01791127|37807381|FG000|Overall Study|All Siello leads are explanted|31|||
16855139|NCT01791127|37807381|FG000|Overall Study|Completion of 30 day safety registry|1|||
16855140|NCT01791127|37807381|FG000|Overall Study|Study terminated for EP Passion|749|||
16868089|NCT01580995|37841114|FG000|Overall Study|Lost to Follow-up|2|||
16868090|NCT01580995|37841115|FG001|Overall Study|Lost to Follow-up|2|||
16868091|NCT01535599|37841123|FG000|Overall Study|Adverse Event|6|||
16868092|NCT01535599|37841124|FG001|Overall Study|Adverse Event|15|||
16868093|NCT01535599|37841123|FG000|Overall Study|Lost to Follow-up|3|||
16868094|NCT01535599|37841124|FG001|Overall Study|Lost to Follow-up|4|||
16868095|NCT01535599|37841123|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
16868096|NCT01535599|37841124|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
16868097|NCT01535599|37841123|FG000|Overall Study|Treatment Failure|33|||
16868098|NCT01535599|37841124|FG001|Overall Study|Treatment Failure|66|||
16868099|NCT01535599|37841123|FG000|Overall Study|BL Culture + for Group A Strep|0|||
16868100|NCT01535599|37841124|FG001|Overall Study|BL Culture + for Group A Strep|1|||
16868101|NCT01535599|37841123|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
16868102|NCT01535599|37841124|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
16868103|NCT01535599|37841123|FG000|Overall Study|Randomized in Error|2|||
16868104|NCT01535599|37841124|FG001|Overall Study|Randomized in Error|4|||
16868105|NCT01535599|37841123|FG000|Overall Study|Did not use product|1|||
16868106|NCT01535599|37841124|FG001|Overall Study|Did not use product|0|||
16868107|NCT01535599|37841123|FG000|Overall Study|Other|1|||
16868108|NCT01535599|37841124|FG001|Overall Study|Other|0|||
16868109|NCT01535599|37841123|FG000|Overall Study|Stopped medication|0|||
16868110|NCT01535599|37841124|FG001|Overall Study|Stopped medication|1|||
16868111|NCT01535599|37841123|FG000|Overall Study|Noncompliance|0|||
16868112|NCT01535599|37841124|FG001|Overall Study|Noncompliance|1|||
16855141|NCT01997333|37807412|FG000|Randomization and Treatment|Disease Progression|70|||
16855142|NCT01997333|37807413|FG001|Randomization and Treatment|Disease Progression|159|||
16855143|NCT01997333|37807412|FG000|Randomization and Treatment|Adverse Event|10|||
16855144|NCT01997333|37807413|FG001|Randomization and Treatment|Adverse Event|32|||
16855145|NCT01997333|37807412|FG000|Randomization and Treatment|Physician Decision|0|||
16855146|NCT01997333|37807413|FG001|Randomization and Treatment|Physician Decision|4|||
16855147|NCT01997333|37807412|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
16855148|NCT01997333|37807413|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
16855149|NCT01997333|37807412|FG000|Randomization and Treatment|Did not receive treatment|17|||
16855150|NCT01997333|37807413|FG001|Randomization and Treatment|Did not receive treatment|5|||
16855151|NCT01997333|37807412|FG000|Survival Follow up|Withdrawal by Subject|15|||
16855152|NCT01997333|37807413|FG001|Survival Follow up|Withdrawal by Subject|6|||
16855153|NCT01997333|37807412|FG000|Survival Follow up|Lost to Follow-up|0|||
16855154|NCT01997333|37807413|FG001|Survival Follow up|Lost to Follow-up|6|||
16855155|NCT01997333|37807412|FG000|Survival Follow up|Various|1|||
16855156|NCT01997333|37807413|FG001|Survival Follow up|Various|2|||
16855157|NCT01982435|37807477|FG000|Overall Study|Adverse Event|1|||
16855158|NCT01982435|37807478|FG001|Overall Study|Adverse Event|0|||
16855159|NCT01620983|37807518|FG000|Overall Study|Lost to Follow-up|8|||
16855160|NCT01620983|37807519|FG001|Overall Study|Lost to Follow-up|4|||
16855161|NCT01620983|37807520|FG002|Overall Study|Lost to Follow-up|9|||
16855162|NCT01620983|37807518|FG000|Overall Study|Withdrawal by Subject|6|||
16855163|NCT01620983|37807519|FG001|Overall Study|Withdrawal by Subject|8|||
16855164|NCT01620983|37807520|FG002|Overall Study|Withdrawal by Subject|1|||
17114873|NCT00235391|38252773|FG000|Overall Study|Administrative problems|0|||
17114874|NCT00235391|38252774|FG001|Overall Study|Administrative problems|0|||
16855165|NCT01620983|37807518|FG000|Overall Study|Death|2|||
16855166|NCT01620983|37807519|FG001|Overall Study|Death|0|||
16855167|NCT01620983|37807520|FG002|Overall Study|Death|0|||
16855168|NCT01620983|37807518|FG000|Overall Study|Physician Decision|3|||
16855169|NCT01620983|37807519|FG001|Overall Study|Physician Decision|10|||
16855170|NCT01620983|37807520|FG002|Overall Study|Physician Decision|5|||
16855171|NCT01996709|37807530|FG000|Overall Study|Withdrawal by Subject|1|||
17114875|NCT00235391|38252775|FG002|Overall Study|Administrative problems|0|||
17114876|NCT00235391|38252776|FG003|Overall Study|Administrative problems|1|||
17114877|NCT00235391|38252777|FG004|Overall Study|Administrative problems|0|||
17114878|NCT00235391|38252778|FG005|Overall Study|Administrative problems|0|||
17114879|NCT00235391|38252773|FG000|Overall Study|Death|0|||
17114880|NCT00235391|38252774|FG001|Overall Study|Death|0|||
17114881|NCT00235391|38252775|FG002|Overall Study|Death|1|||
17114882|NCT00235391|38252776|FG003|Overall Study|Death|4|||
17114883|NCT00235391|38252777|FG004|Overall Study|Death|0|||
17114884|NCT00235391|38252778|FG005|Overall Study|Death|0|||
17114885|NCT00234533|38252822|FG000|Overall Study|Withdrawal by Subject|6|||
17114886|NCT00234533|38252822|FG000|Overall Study|Adverse Event|2|||
17114887|NCT00234533|38252822|FG000|Overall Study|Enrolled but not treated|3|||
17114888|NCT00026208|38252829|FG000|Overall Study|Complications of auto accident|1|||
17114889|NCT00026208|38252830|FG001|Overall Study|Complications of auto accident|0|||
17114890|NCT00025662|38252836|FG000|Overall Study|Withdrawal by Subject|2|||
17114891|NCT00025662|38252836|FG000|Overall Study|Technical failure of manipulation|1|||
17114892|NCT00025506|38252840|FG000|Overall Study|Ineligible: clerical error|1|||
17114893|NCT00025506|38252840|FG000|Overall Study|Ineligible: wrong cell type|5|||
17114894|NCT00025506|38252840|FG000|Overall Study|Ineligible: inadequate pathology|2|||
17114895|NCT00025506|38252840|FG000|Overall Study|Never Treated|2|||
17114896|NCT00024258|38252849|FG000|Overall Study|Withdrawal by Subject|1|||
17114897|NCT00024258|38252849|FG000|Overall Study|Disease Progression|8|||
17114898|NCT00023712|38252855|FG000|Overall Study|Not platinum sensitive|1|||
17114899|NCT00023712|38252856|FG001|Overall Study|Not platinum sensitive|0|||
17114900|NCT00023712|38252855|FG000|Overall Study|Never treated|1|||
17114901|NCT00023712|38252856|FG001|Overall Study|Never treated|1|||
17114902|NCT00023322|38252872|FG000|Overall Study|Lost to Follow-up|1|||
17114903|NCT04640168|38252878|FG000|Overall Study|Withdrawal by Subject|8|||
17114904|NCT04640168|38252879|FG001|Overall Study|Withdrawal by Subject|7|||
17114905|NCT04640168|38252878|FG000|Overall Study|Lost to Follow-up|1|||
17114906|NCT04640168|38252879|FG001|Overall Study|Lost to Follow-up|0|||
17114907|NCT04640168|38252878|FG000|Overall Study|Enrolled but not treated|12|||
17114908|NCT04640168|38252879|FG001|Overall Study|Enrolled but not treated|12|||
17114909|NCT00022698|38252887|FG000|Overall Study|Adverse Event|5|||
17114910|NCT00022698|38252888|FG001|Overall Study|Adverse Event|9|||
17114911|NCT00022698|38252887|FG000|Overall Study|Death|0|||
17114912|NCT00022698|38252888|FG001|Overall Study|Death|2|||
17114913|NCT00022698|38252887|FG000|Overall Study|Failure to return|0|||
16855172|NCT01996709|37807531|FG001|Overall Study|Withdrawal by Subject|0|||
16855173|NCT01996709|37807530|FG000|Overall Study|Lost to Follow-up|3|||
16855174|NCT01996709|37807531|FG001|Overall Study|Lost to Follow-up|0|||
16855175|NCT01996709|37807530|FG000|Overall Study|Subject Non-Compliant|1|||
16855176|NCT01996709|37807531|FG001|Overall Study|Subject Non-Compliant|0|||
17114914|NCT00022698|38252888|FG001|Overall Study|Failure to return|1|||
16855177|NCT01996709|37807530|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
16855178|NCT01996709|37807531|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
16855179|NCT01996319|37807556|FG000|Overall Study|Protocol Violation|1|||
16855180|NCT01996319|37807557|FG001|Overall Study|Protocol Violation|0|||
16855181|NCT01996319|37807556|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
16855182|NCT01996319|37807557|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
16855183|NCT01996319|37807556|FG000|Overall Study|Adverse Event|2|||
16855184|NCT01996319|37807557|FG001|Overall Study|Adverse Event|2|||
16855185|NCT01279486|37807563|FG000|Overall Study|Lost to Follow-up|1|||
16855186|NCT01279954|37807569|FG000|Overall Study|Lack of Efficacy|3|||
16855187|NCT01279954|37807570|FG001|Overall Study|Lack of Efficacy|4|||
16855188|NCT01278862|37807581|FG000|Overall Study|Lost to Follow-up|1|||
16855189|NCT01278862|37807582|FG001|Overall Study|Lost to Follow-up|1|||
16855190|NCT01278394|37807597|FG000|Overall Study|Lost to Follow-up|1|||
16855191|NCT01981187|37807601|FG000|Overall Study|Participant/guardian decision|2|||
16855192|NCT01981187|37807601|FG000|Overall Study|Physician Decision|1|||
16855193|NCT01981187|37807601|FG000|Overall Study|Disease progression|2|||
16855194|NCT01981187|37807601|FG000|Overall Study|Adverse Event|7|||
16855195|NCT01278160|37807607|FG000|Overall Study|Adverse Event|1|||
16855196|NCT01278160|37807608|FG001|Overall Study|Adverse Event|1|||
16855197|NCT01278160|37807607|FG000|Overall Study|Lost to Follow-up|0|||
16855198|NCT01278160|37807608|FG001|Overall Study|Lost to Follow-up|1|||
16855199|NCT01278160|37807607|FG000|Overall Study|Withdrawal by Subject|3|||
16855200|NCT01278160|37807608|FG001|Overall Study|Withdrawal by Subject|2|||
16855201|NCT01278160|37807607|FG000|Overall Study|Unclassified|1|||
16855202|NCT01278160|37807608|FG001|Overall Study|Unclassified|2|||
16855203|NCT01996241|37807616|FG000|Overall Study|Lost to Follow-up|252|||
16855204|NCT01996241|37807617|FG001|Overall Study|Lost to Follow-up|235|||
16855205|NCT02091869|37807627|FG000|Overall Study|Withdrawal by Subject|0|||
16855206|NCT02091869|37807628|FG001|Overall Study|Withdrawal by Subject|3|||
16855207|NCT01981109|37807643|FG000|Overall Study|Death|36|||
16855208|NCT01981109|37807643|FG000|Overall Study|Withdrawal by Subject|40|||
16855209|NCT01981109|37807643|FG000|Overall Study|Lost to Follow-up|9|||
16855210|NCT01981109|37807643|FG000|Overall Study|No Discontinuation Documentation|37|||
16855211|NCT01981109|37807643|FG000|Overall Study|Study Termination|100|||
16855212|NCT01981109|37807643|FG000|Overall Study|No data available|2|||
16855213|NCT00248794|37807651|FG000|Overall Study|Lost to Follow-up|6|||
16855214|NCT00248794|37807652|FG001|Overall Study|Lost to Follow-up|8|||
16855215|NCT00248794|37807653|FG002|Overall Study|Lost to Follow-up|3|||
16855216|NCT01995539|37807667|FG000|Overall Study|Screening Failure|1|||
16855217|NCT01995539|37807667|FG000|Overall Study|Withdrawal by Investigator|15|||
16855218|NCT01995539|37807667|FG000|Overall Study|Withdrawal by Subject|11|||
16855219|NCT01995539|37807667|FG000|Overall Study|Lost to Follow-up|5|||
16855220|NCT01995539|37807667|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
16855221|NCT01835587|37807675|FG000|Overall Study|Disease Recurrence or Relapse|0|||
16855222|NCT01835587|37807676|FG001|Overall Study|Disease Recurrence or Relapse|3|||
16855223|NCT01835587|37807677|FG002|Overall Study|Disease Recurrence or Relapse|0|||
16855224|NCT01835587|37807678|FG003|Overall Study|Disease Recurrence or Relapse|3|||
16855225|NCT01835587|37807675|FG000|Overall Study|Withdrawal by Subject|2|||
16855226|NCT01835587|37807676|FG001|Overall Study|Withdrawal by Subject|0|||
16855227|NCT01835587|37807677|FG002|Overall Study|Withdrawal by Subject|0|||
16855228|NCT01835587|37807678|FG003|Overall Study|Withdrawal by Subject|3|||
16855229|NCT01835587|37807675|FG000|Overall Study|Adverse Event|0|||
16855230|NCT01835587|37807676|FG001|Overall Study|Adverse Event|0|||
16855231|NCT01835587|37807677|FG002|Overall Study|Adverse Event|2|||
16855232|NCT01835587|37807678|FG003|Overall Study|Adverse Event|2|||
16855233|NCT01835587|37807675|FG000|Overall Study|Death|0|||
16855234|NCT01835587|37807676|FG001|Overall Study|Death|0|||
16855235|NCT01835587|37807677|FG002|Overall Study|Death|0|||
16855236|NCT01835587|37807678|FG003|Overall Study|Death|1|||
16855237|NCT01835587|37807675|FG000|Overall Study|Miscellaneous|0|||
16855238|NCT01835587|37807676|FG001|Overall Study|Miscellaneous|1|||
16855239|NCT01835587|37807677|FG002|Overall Study|Miscellaneous|0|||
16855240|NCT01835587|37807678|FG003|Overall Study|Miscellaneous|0|||
16855241|NCT01736917|37807695|FG000|Overall Study|Adverse Event|1|||
16855242|NCT01736917|37807695|FG000|Overall Study|Protocol Violation|10|||
16855243|NCT01277302|37807704|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
16855244|NCT01277302|37807705|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
16855245|NCT01277302|37807706|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
16855246|NCT01277302|37807704|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
16855247|NCT01277302|37807705|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
16855248|NCT01277302|37807706|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
16855249|NCT01277302|37807704|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
16855250|NCT01277302|37807705|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
16855251|NCT01277302|37807706|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
16855252|NCT01277302|37807704|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
16855253|NCT01277302|37807705|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
16855254|NCT01277302|37807706|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
16855255|NCT01277302|37807704|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
16855256|NCT01277302|37807705|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
16855257|NCT01277302|37807706|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
16855258|NCT01277302|37807704|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
16855259|NCT01277302|37807705|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
16855260|NCT01277302|37807706|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
16855261|NCT01277302|37807704|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
16855262|NCT01277302|37807705|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
16855263|NCT01277302|37807706|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
16855264|NCT01277302|37807704|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
16855265|NCT01277302|37807705|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
16855266|NCT01277302|37807706|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
16855267|NCT01277302|37807704|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
16855268|NCT01277302|37807705|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
16855269|NCT01277302|37807706|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
16855270|NCT01980875|37807717|FG000|Overall Study|Withdrew Consent|1|||
16855271|NCT01980875|37807718|FG001|Overall Study|Withdrew Consent|1|||
16855272|NCT01980875|37807719|FG002|Overall Study|Withdrew Consent|1|||
16855273|NCT01980875|37807717|FG000|Overall Study|Study Terminated by Sponsor|7|||
16855274|NCT01980875|37807718|FG001|Overall Study|Study Terminated by Sponsor|24|||
16855275|NCT01980875|37807719|FG002|Overall Study|Study Terminated by Sponsor|22|||
16855276|NCT01980875|37807717|FG000|Overall Study|Lost to Follow-up|0|||
16855277|NCT01980875|37807718|FG001|Overall Study|Lost to Follow-up|0|||
16855278|NCT01980875|37807719|FG002|Overall Study|Lost to Follow-up|1|||
16855279|NCT01995461|37807727|FG000|Overall Study|Death|1|||
16855280|NCT01995461|37807727|FG000|Overall Study|Lost to Follow-up|2|||
16855281|NCT01995461|37807727|FG000|Overall Study|Withdrawal by Subject|2|||
16855282|NCT01980095|37807733|FG000|Overall Study|Lost to Follow-up|6|||
16855283|NCT01980095|37807734|FG001|Overall Study|Lost to Follow-up|7|||
16855284|NCT01980095|37807733|FG000|Overall Study|Withdrawal by Subject|2|||
16855285|NCT01980095|37807734|FG001|Overall Study|Withdrawal by Subject|3|||
16855286|NCT01980095|37807733|FG000|Overall Study|Poor compliance|5|||
16855287|NCT01980095|37807734|FG001|Overall Study|Poor compliance|0|||
16855288|NCT01980095|37807733|FG000|Overall Study|Safety issue|0|||
16855289|NCT01980095|37807734|FG001|Overall Study|Safety issue|1|||
16855290|NCT01980095|37807733|FG000|Overall Study|Study drug discontinued|1|||
16855291|NCT01980095|37807734|FG001|Overall Study|Study drug discontinued|0|||
16855292|NCT01980095|37807733|FG000|Overall Study|Randomized by mistake|1|||
16855293|NCT01980095|37807734|FG001|Overall Study|Randomized by mistake|0|||
16855294|NCT01980017|37807744|FG000|Overall Study|Lost to Follow-up|30|||
16855295|NCT01980017|37807745|FG001|Overall Study|Lost to Follow-up|21|||
16855296|NCT01980017|37807744|FG000|Overall Study|Death|0|||
16855297|NCT01980017|37807745|FG001|Overall Study|Death|1|||
16855298|NCT01978145|37807754|FG000|Treatment Period 1|Adverse Event|1|||
16855299|NCT01978145|37807755|FG001|Treatment Period 1|Adverse Event|9|||
16855300|NCT01978145|37807754|FG000|Treatment Period 1|Physician Decision|1|||
16855301|NCT01978145|37807755|FG001|Treatment Period 1|Physician Decision|0|||
16855302|NCT01978145|37807754|FG000|Treatment Period 1|Withdrawal by Subject|5|||
16855303|NCT01978145|37807755|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16855304|NCT01978145|37807754|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
16855305|NCT01978145|37807755|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
16855306|NCT01978145|37807754|FG000|Washout Period 1|Adverse Event|0|||
16855307|NCT01978145|37807755|FG001|Washout Period 1|Adverse Event|1|||
16855308|NCT01978145|37807754|FG000|Washout Period 1|Withdrawal by Subject|1|||
16855309|NCT01978145|37807755|FG001|Washout Period 1|Withdrawal by Subject|1|||
16855310|NCT01978145|37807754|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
16855311|NCT01978145|37807755|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
16855312|NCT01978145|37807754|FG000|Treatment Period 2|Adverse Event|3|||
16855313|NCT01978145|37807755|FG001|Treatment Period 2|Adverse Event|3|||
16855314|NCT01978145|37807754|FG000|Treatment Period 2|Protocol Violation|0|||
16855315|NCT01978145|37807755|FG001|Treatment Period 2|Protocol Violation|1|||
16855316|NCT01978145|37807754|FG000|Treatment Period 2|Lost to Follow-up|1|||
16855317|NCT01978145|37807755|FG001|Treatment Period 2|Lost to Follow-up|1|||
16855318|NCT01978145|37807754|FG000|Treatment Period 2|Withdrawal by Subject|7|||
16855319|NCT01978145|37807755|FG001|Treatment Period 2|Withdrawal by Subject|4|||
16855320|NCT01978145|37807754|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
16855321|NCT01978145|37807755|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
16855322|NCT01967537|37807761|FG000|Overall Study|Withdrawal by Subject|52|||
16855323|NCT01967537|37807761|FG000|Overall Study|Refuse treatment|2|||
16855324|NCT01967537|37807761|FG000|Overall Study|Lost to Follow-up|6|||
16855325|NCT01967225|37807769|FG000|Overall Study|Adverse Event|3|||
16855326|NCT01967225|37807770|FG001|Overall Study|Adverse Event|1|||
16855327|NCT01967225|37807769|FG000|Overall Study|Withdrawal by Subject|2|||
16855328|NCT01967225|37807770|FG001|Overall Study|Withdrawal by Subject|1|||
16855329|NCT01967225|37807769|FG000|Overall Study|Lack of Efficacy|1|||
16855330|NCT01967225|37807770|FG001|Overall Study|Lack of Efficacy|1|||
16855331|NCT01967225|37807769|FG000|Overall Study|Switching to other therapy|2|||
16855332|NCT01967225|37807770|FG001|Overall Study|Switching to other therapy|0|||
16855333|NCT01967225|37807769|FG000|Overall Study|Protocol driven decision point|1|||
16855334|NCT01967225|37807770|FG001|Overall Study|Protocol driven decision point|0|||
16855335|NCT01967225|37807769|FG000|Overall Study|Logistical difficulties|1|||
16855336|NCT01967225|37807770|FG001|Overall Study|Logistical difficulties|0|||
16855337|NCT01967225|37807769|FG000|Overall Study|Protocol Violation|2|||
16855338|NCT01967225|37807770|FG001|Overall Study|Protocol Violation|0|||
16855339|NCT01967147|37807780|FG000|Overall Study|Adverse Event|5|||
16855340|NCT01967147|37807781|FG001|Overall Study|Adverse Event|2|||
16855341|NCT01967147|37807780|FG000|Overall Study|Lack of Efficacy|1|||
16855342|NCT01967147|37807781|FG001|Overall Study|Lack of Efficacy|4|||
16855343|NCT01967147|37807780|FG000|Overall Study|Lost to Follow-up|1|||
16855344|NCT01967147|37807781|FG001|Overall Study|Lost to Follow-up|2|||
16855345|NCT01967147|37807780|FG000|Overall Study|Withdrawal by Subject|2|||
16855346|NCT01967147|37807781|FG001|Overall Study|Withdrawal by Subject|4|||
16855347|NCT01967147|37807780|FG000|Overall Study|Non-compliance with Study Drug|0|||
16855348|NCT01967147|37807781|FG001|Overall Study|Non-compliance with Study Drug|3|||
16855349|NCT01967147|37807780|FG000|Overall Study|Other|4|||
16855350|NCT01967147|37807781|FG001|Overall Study|Other|5|||
16855351|NCT01967069|37807790|FG000|Overall Study|Adverse Event|2|||
16941292|NCT01202773|38085853|FG000|Overall Study|Lack of Efficacy|5|||
16941293|NCT01202773|38085854|FG001|Overall Study|Lack of Efficacy|4|||
16941294|NCT01202773|38085855|FG002|Overall Study|Lack of Efficacy|9|||
16941295|NCT01202773|38085853|FG000|Overall Study|Entry Criteria Not Met|2|||
16941296|NCT01202773|38085854|FG001|Overall Study|Entry Criteria Not Met|0|||
16941297|NCT01202773|38085855|FG002|Overall Study|Entry Criteria Not Met|1|||
16941298|NCT01202773|38085853|FG000|Overall Study|Lost to Follow-up|1|||
16941299|NCT01202773|38085854|FG001|Overall Study|Lost to Follow-up|2|||
16941300|NCT01202773|38085855|FG002|Overall Study|Lost to Follow-up|2|||
16941301|NCT01202773|38085853|FG000|Overall Study|Withdrawal by Subject|13|||
16941302|NCT01202773|38085854|FG001|Overall Study|Withdrawal by Subject|6|||
16941303|NCT01202773|38085855|FG002|Overall Study|Withdrawal by Subject|5|||
16941304|NCT01202773|38085853|FG000|Overall Study|Physician Decision|2|||
16941305|NCT01202773|38085854|FG001|Overall Study|Physician Decision|0|||
16941306|NCT01202773|38085855|FG002|Overall Study|Physician Decision|0|||
16941307|NCT01202773|38085853|FG000|Overall Study|Protocol Violation|11|||
16941308|NCT01202773|38085854|FG001|Overall Study|Protocol Violation|6|||
16941309|NCT01202773|38085855|FG002|Overall Study|Protocol Violation|10|||
16941310|NCT01202773|38085853|FG000|Overall Study|Sponsor Decision|19|||
16941311|NCT01202773|38085854|FG001|Overall Study|Sponsor Decision|20|||
16941312|NCT01202773|38085855|FG002|Overall Study|Sponsor Decision|23|||
16941313|NCT01180660|38085875|FG000|Overall Study|Changed to open surgery|1|||
16941314|NCT01180660|38085876|FG001|Overall Study|Changed to open surgery|0|||
16941315|NCT01202227|38085882|FG000|Overall Study|Adverse Event|16|||
16941316|NCT01202227|38085882|FG000|Overall Study|Withdrawal by Subject|2|||
16941317|NCT01202227|38085882|FG000|Overall Study|Lack of Efficacy|1|||
16941318|NCT01202188|38085891|FG000|Overall Study|Protocol deviation|14|||
16941319|NCT01202188|38085892|FG001|Overall Study|Protocol deviation|8|||
16941320|NCT01202188|38085893|FG002|Overall Study|Protocol deviation|12|||
16941321|NCT01202188|38085894|FG003|Overall Study|Protocol deviation|10|||
16941322|NCT01202188|38085895|FG004|Overall Study|Protocol deviation|11|||
16941323|NCT01202188|38085891|FG000|Overall Study|Subject withdrew consent|12|||
16941324|NCT01202188|38085892|FG001|Overall Study|Subject withdrew consent|13|||
16941325|NCT01202188|38085893|FG002|Overall Study|Subject withdrew consent|22|||
16941326|NCT01202188|38085894|FG003|Overall Study|Subject withdrew consent|11|||
16941327|NCT01202188|38085895|FG004|Overall Study|Subject withdrew consent|13|||
16941328|NCT01202188|38085891|FG000|Overall Study|Adverse Event|5|||
16941329|NCT01202188|38085892|FG001|Overall Study|Adverse Event|23|||
16941330|NCT01202188|38085893|FG002|Overall Study|Adverse Event|13|||
16941331|NCT01202188|38085894|FG003|Overall Study|Adverse Event|10|||
16941332|NCT01202188|38085895|FG004|Overall Study|Adverse Event|10|||
16941333|NCT01202188|38085891|FG000|Overall Study|Administrative problems|3|||
16941334|NCT01202188|38085892|FG001|Overall Study|Administrative problems|2|||
16941335|NCT01202188|38085893|FG002|Overall Study|Administrative problems|1|||
16941336|NCT01202188|38085894|FG003|Overall Study|Administrative problems|1|||
16941337|NCT01202188|38085895|FG004|Overall Study|Administrative problems|2|||
16855352|NCT01967069|37807791|FG001|Overall Study|Adverse Event|2|||
16855353|NCT01967069|37807790|FG000|Overall Study|Lost to Follow-up|5|||
16941338|NCT01202188|38085891|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16855354|NCT01967069|37807791|FG001|Overall Study|Lost to Follow-up|2|||
16941339|NCT01202188|38085892|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
16941340|NCT01202188|38085893|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
16941341|NCT01202188|38085894|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
16855355|NCT01967069|37807790|FG000|Overall Study|Withdrawal by Subject|1|||
16855356|NCT01967069|37807791|FG001|Overall Study|Withdrawal by Subject|3|||
16855357|NCT01967069|37807790|FG000|Overall Study|Lack of Efficacy|0|||
16855358|NCT01967069|37807791|FG001|Overall Study|Lack of Efficacy|1|||
16855359|NCT01790503|37807808|FG000|Overall Study|Adverse Event|1|||
16855360|NCT01790503|37807809|FG001|Overall Study|Adverse Event|0|||
16855361|NCT01790503|37807810|FG002|Overall Study|Adverse Event|0|||
16855362|NCT01790503|37807811|FG003|Overall Study|Adverse Event|0|||
16855363|NCT01790503|37807812|FG004|Overall Study|Adverse Event|0|||
16855364|NCT01790503|37807813|FG005|Overall Study|Adverse Event|2|||
16855365|NCT01790503|37807814|FG006|Overall Study|Adverse Event|0|||
16855366|NCT01790503|37807815|FG007|Overall Study|Adverse Event|0|||
16855367|NCT01790503|37807816|FG008|Overall Study|Adverse Event|2|||
16855368|NCT01790503|37807817|FG009|Overall Study|Adverse Event|4|||
16855369|NCT01790503|37807818|FG010|Overall Study|Adverse Event|7|||
16855370|NCT01790503|37807808|FG000|Overall Study|Withdrawal by Subject|0|||
16855371|NCT01790503|37807809|FG001|Overall Study|Withdrawal by Subject|0|||
16855372|NCT01790503|37807810|FG002|Overall Study|Withdrawal by Subject|1|||
16855373|NCT01790503|37807811|FG003|Overall Study|Withdrawal by Subject|1|||
16855374|NCT01790503|37807812|FG004|Overall Study|Withdrawal by Subject|1|||
16855375|NCT01790503|37807813|FG005|Overall Study|Withdrawal by Subject|2|||
16855376|NCT01790503|37807814|FG006|Overall Study|Withdrawal by Subject|1|||
16855377|NCT01790503|37807815|FG007|Overall Study|Withdrawal by Subject|0|||
16855378|NCT01790503|37807816|FG008|Overall Study|Withdrawal by Subject|0|||
16855379|NCT01790503|37807817|FG009|Overall Study|Withdrawal by Subject|0|||
16855380|NCT01790503|37807818|FG010|Overall Study|Withdrawal by Subject|1|||
16855381|NCT01790503|37807808|FG000|Overall Study|Disease progression|2|||
16855382|NCT01790503|37807809|FG001|Overall Study|Disease progression|1|||
16855383|NCT01790503|37807810|FG002|Overall Study|Disease progression|0|||
16855384|NCT01790503|37807811|FG003|Overall Study|Disease progression|1|||
16855385|NCT01790503|37807812|FG004|Overall Study|Disease progression|2|||
16855386|NCT01790503|37807813|FG005|Overall Study|Disease progression|1|||
16855387|NCT01790503|37807814|FG006|Overall Study|Disease progression|0|||
16855388|NCT01790503|37807815|FG007|Overall Study|Disease progression|1|||
16855389|NCT01790503|37807816|FG008|Overall Study|Disease progression|0|||
16855390|NCT01790503|37807817|FG009|Overall Study|Disease progression|17|||
16855391|NCT01790503|37807818|FG010|Overall Study|Disease progression|7|||
16855392|NCT01790503|37807808|FG000|Overall Study|Protocol Violation|0|||
16855393|NCT01790503|37807809|FG001|Overall Study|Protocol Violation|0|||
16855394|NCT01790503|37807810|FG002|Overall Study|Protocol Violation|0|||
16855395|NCT01790503|37807811|FG003|Overall Study|Protocol Violation|0|||
16855396|NCT01790503|37807812|FG004|Overall Study|Protocol Violation|0|||
16855397|NCT01790503|37807813|FG005|Overall Study|Protocol Violation|0|||
16855398|NCT01790503|37807814|FG006|Overall Study|Protocol Violation|0|||
16855399|NCT01790503|37807815|FG007|Overall Study|Protocol Violation|0|||
16855400|NCT01790503|37807816|FG008|Overall Study|Protocol Violation|0|||
16855401|NCT01790503|37807817|FG009|Overall Study|Protocol Violation|1|||
16855402|NCT01790503|37807818|FG010|Overall Study|Protocol Violation|0|||
16855403|NCT01790503|37807808|FG000|Overall Study|Physician Decision|0|||
16855404|NCT01790503|37807809|FG001|Overall Study|Physician Decision|0|||
16855405|NCT01790503|37807810|FG002|Overall Study|Physician Decision|0|||
16855406|NCT01790503|37807811|FG003|Overall Study|Physician Decision|0|||
16855407|NCT01790503|37807812|FG004|Overall Study|Physician Decision|0|||
16855408|NCT01790503|37807813|FG005|Overall Study|Physician Decision|0|||
16855409|NCT01790503|37807814|FG006|Overall Study|Physician Decision|0|||
16855410|NCT01790503|37807815|FG007|Overall Study|Physician Decision|0|||
16855411|NCT01790503|37807816|FG008|Overall Study|Physician Decision|0|||
16855412|NCT01790503|37807817|FG009|Overall Study|Physician Decision|1|||
16855413|NCT01790503|37807818|FG010|Overall Study|Physician Decision|1|||
16855414|NCT01790503|37807808|FG000|Overall Study|Death|0|||
16855415|NCT01790503|37807809|FG001|Overall Study|Death|0|||
16855416|NCT01790503|37807810|FG002|Overall Study|Death|0|||
16855417|NCT01790503|37807811|FG003|Overall Study|Death|0|||
16855418|NCT01790503|37807812|FG004|Overall Study|Death|0|||
16855419|NCT01790503|37807813|FG005|Overall Study|Death|0|||
16855420|NCT01790503|37807814|FG006|Overall Study|Death|0|||
16855421|NCT01790503|37807815|FG007|Overall Study|Death|0|||
16855422|NCT01790503|37807816|FG008|Overall Study|Death|0|||
16855423|NCT01790503|37807817|FG009|Overall Study|Death|1|||
16855424|NCT01790503|37807818|FG010|Overall Study|Death|0|||
16855425|NCT01790503|37807808|FG000|Overall Study|Non Compliance|0|||
16855426|NCT01790503|37807809|FG001|Overall Study|Non Compliance|0|||
16855427|NCT01790503|37807810|FG002|Overall Study|Non Compliance|0|||
16855428|NCT01790503|37807811|FG003|Overall Study|Non Compliance|0|||
16855429|NCT01790503|37807812|FG004|Overall Study|Non Compliance|1|||
16855430|NCT01790503|37807813|FG005|Overall Study|Non Compliance|0|||
16855431|NCT01790503|37807814|FG006|Overall Study|Non Compliance|0|||
16855432|NCT01790503|37807815|FG007|Overall Study|Non Compliance|0|||
16855433|NCT01790503|37807816|FG008|Overall Study|Non Compliance|0|||
16855434|NCT01790503|37807817|FG009|Overall Study|Non Compliance|0|||
16855435|NCT01790503|37807818|FG010|Overall Study|Non Compliance|0|||
16855436|NCT01790503|37807808|FG000|Overall Study|Other|0|||
16855437|NCT01790503|37807809|FG001|Overall Study|Other|0|||
16855438|NCT01790503|37807810|FG002|Overall Study|Other|0|||
16855439|NCT01790503|37807811|FG003|Overall Study|Other|0|||
16855440|NCT01790503|37807812|FG004|Overall Study|Other|1|||
16855441|NCT01790503|37807813|FG005|Overall Study|Other|0|||
16855442|NCT01790503|37807814|FG006|Overall Study|Other|0|||
16855443|NCT01790503|37807815|FG007|Overall Study|Other|0|||
16855444|NCT01790503|37807816|FG008|Overall Study|Other|1|||
16855445|NCT01790503|37807817|FG009|Overall Study|Other|2|||
16855446|NCT01790503|37807818|FG010|Overall Study|Other|0|||
16855447|NCT01790113|37807857|FG000|Overall Study|Adverse Event|2|||
16855448|NCT01790113|37807858|FG001|Overall Study|Adverse Event|7|||
16855449|NCT01790113|37807857|FG000|Overall Study|Study ended due to FDA clearance|1|||
16855450|NCT01790113|37807858|FG001|Overall Study|Study ended due to FDA clearance|68|||
16855451|NCT01789567|37807864|FG000|Overall Study|Death|6|||
16855452|NCT01765543|37807868|FG000|Overall Study|Death|1|||
16855453|NCT01765543|37807868|FG000|Overall Study|Withdrawal by Subject|2|||
16855454|NCT01765153|37807878|FG000|Training Phase 1|Format of intervention differed|1|||
16855455|NCT01765153|37807879|FG001|Training Phase 1|Format of intervention differed|0|||
16855456|NCT01765153|37807878|FG000|Training Phase 1|Poor participation in intervention|0|||
16855457|NCT01765153|37807879|FG001|Training Phase 1|Poor participation in intervention|1|||
16855458|NCT01765153|37807878|FG000|Rest Phase 1|Withdrawal by Subject|0|||
16855459|NCT01765153|37807879|FG001|Rest Phase 1|Withdrawal by Subject|1|||
16855460|NCT01765153|37807878|FG000|Training Phase 2|Withdrawal by Subject|0|||
16855461|NCT01765153|37807879|FG001|Training Phase 2|Withdrawal by Subject|1|||
16855462|NCT01765153|37807878|FG000|Rest Phase 2|Lost to Follow-up|2|||
16855463|NCT01765153|37807879|FG001|Rest Phase 2|Lost to Follow-up|1|||
16855464|NCT00248170|37807891|FG000|Overall Study|Withdrawal by Subject|71|||
16855465|NCT00248170|37807892|FG001|Overall Study|Withdrawal by Subject|79|||
16855466|NCT00248170|37807891|FG000|Overall Study|Protocol Violation|35|||
16855467|NCT00248170|37807892|FG001|Overall Study|Protocol Violation|30|||
16855468|NCT00248170|37807891|FG000|Overall Study|Lost to Follow-up|28|||
16855469|NCT00248170|37807892|FG001|Overall Study|Lost to Follow-up|35|||
16855470|NCT00248170|37807891|FG000|Overall Study|Disease progression|196|||
16855471|NCT00248170|37807892|FG001|Overall Study|Disease progression|216|||
16855472|NCT00248170|37807891|FG000|Overall Study|Death|28|||
16855473|NCT00248170|37807892|FG001|Overall Study|Death|47|||
16855474|NCT00248170|37807891|FG000|Overall Study|Adverse Event|311|||
16855475|NCT00248170|37807892|FG001|Overall Study|Adverse Event|296|||
16855476|NCT00248170|37807891|FG000|Overall Study|Administrative problems|22|||
16855477|NCT00248170|37807892|FG001|Overall Study|Administrative problems|25|||
16855478|NCT00248170|37807891|FG000|Overall Study|Abnormal test procedure(s) result|49|||
16855479|NCT00248170|37807892|FG001|Overall Study|Abnormal test procedure(s) result|61|||
16855480|NCT00248170|37807891|FG000|Overall Study|Abnormal laboratory values|4|||
16855481|NCT00248170|37807892|FG001|Overall Study|Abnormal laboratory values|0|||
16855482|NCT00248170|37807891|FG000|Overall Study|Protocol deviation|17|||
16855483|NCT00248170|37807892|FG001|Overall Study|Protocol deviation|19|||
16855484|NCT01764997|37807903|FG000|Run-in Period|Adverse Event|15|||
16855485|NCT01764997|37807904|FG001|Run-in Period|Adverse Event|0|||
16855486|NCT01764997|37807905|FG002|Run-in Period|Adverse Event|0|||
16855487|NCT01764997|37807906|FG003|Run-in Period|Adverse Event|0|||
16855488|NCT01764997|37807907|FG004|Run-in Period|Adverse Event|0|||
16855489|NCT01764997|37807903|FG000|Run-in Period|Lack of Efficacy|5|||
16855490|NCT01764997|37807904|FG001|Run-in Period|Lack of Efficacy|0|||
16855491|NCT01764997|37807905|FG002|Run-in Period|Lack of Efficacy|0|||
16855492|NCT01764997|37807906|FG003|Run-in Period|Lack of Efficacy|0|||
16855493|NCT01764997|37807907|FG004|Run-in Period|Lack of Efficacy|0|||
16855494|NCT01764997|37807903|FG000|Run-in Period|Poor compliance to protocol|1|||
16855495|NCT01764997|37807904|FG001|Run-in Period|Poor compliance to protocol|0|||
16855496|NCT01764997|37807905|FG002|Run-in Period|Poor compliance to protocol|0|||
16855497|NCT01764997|37807906|FG003|Run-in Period|Poor compliance to protocol|0|||
16855498|NCT01764997|37807907|FG004|Run-in Period|Poor compliance to protocol|0|||
16855499|NCT01764997|37807903|FG000|Run-in Period|Other than specified above|17|||
16855500|NCT01764997|37807904|FG001|Run-in Period|Other than specified above|0|||
16855501|NCT01764997|37807905|FG002|Run-in Period|Other than specified above|0|||
16855502|NCT01764997|37807906|FG003|Run-in Period|Other than specified above|0|||
16855503|NCT01764997|37807907|FG004|Run-in Period|Other than specified above|0|||
16855504|NCT01764997|37807903|FG000|Study Drug Treatment Period|Adverse Event|0|||
16855505|NCT01764997|37807904|FG001|Study Drug Treatment Period|Adverse Event|1|||
16855506|NCT01764997|37807905|FG002|Study Drug Treatment Period|Adverse Event|0|||
16855507|NCT01764997|37807906|FG003|Study Drug Treatment Period|Adverse Event|0|||
16855508|NCT01764997|37807907|FG004|Study Drug Treatment Period|Adverse Event|24|||
16855509|NCT01764997|37807903|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
16855510|NCT01764997|37807904|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
16855511|NCT01764997|37807905|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
16855512|NCT01764997|37807906|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
16855513|NCT01764997|37807907|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
16855514|NCT01764997|37807903|FG000|Study Drug Treatment Period|Other than specified above|0|||
16855515|NCT01764997|37807904|FG001|Study Drug Treatment Period|Other than specified above|0|||
16855516|NCT01764997|37807905|FG002|Study Drug Treatment Period|Other than specified above|0|||
16855517|NCT01764997|37807906|FG003|Study Drug Treatment Period|Other than specified above|0|||
16855518|NCT01764997|37807907|FG004|Study Drug Treatment Period|Other than specified above|10|||
16855519|NCT01276756|37807919|FG000|Overall Study|Lost to Follow-up|2|||
16855520|NCT01276756|37807920|FG001|Overall Study|Lost to Follow-up|0|||
16855521|NCT01276756|37807919|FG000|Overall Study|Adverse Event|3|||
16855522|NCT01276756|37807920|FG001|Overall Study|Adverse Event|2|||
16855523|NCT00246376|37807931|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
16855524|NCT00246376|37807932|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
16855525|NCT00246376|37807933|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
16855526|NCT00246376|37807934|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
16855527|NCT00246376|37807935|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
16855528|NCT00246376|37807931|FG000|Overall Study|Adverse Event|2|||
16855529|NCT00246376|37807932|FG001|Overall Study|Adverse Event|3|||
16855530|NCT00246376|37807933|FG002|Overall Study|Adverse Event|1|||
16855531|NCT00246376|37807934|FG003|Overall Study|Adverse Event|3|||
16855532|NCT00246376|37807935|FG004|Overall Study|Adverse Event|1|||
16855533|NCT00246376|37807931|FG000|Overall Study|Lost to Follow-up|2|||
16855534|NCT00246376|37807932|FG001|Overall Study|Lost to Follow-up|11|||
16855535|NCT00246376|37807933|FG002|Overall Study|Lost to Follow-up|11|||
16855536|NCT00246376|37807934|FG003|Overall Study|Lost to Follow-up|16|||
16855537|NCT00246376|37807935|FG004|Overall Study|Lost to Follow-up|13|||
16855538|NCT01764841|37807993|FG000|Overall Study|Logistical Difficulties|0|||
16855539|NCT01764841|37807994|FG001|Overall Study|Logistical Difficulties|1|||
16855540|NCT01764841|37807995|FG002|Overall Study|Logistical Difficulties|0|||
16855541|NCT01764841|37807996|FG003|Overall Study|Logistical Difficulties|0|||
16855542|NCT01764841|37807993|FG000|Overall Study|Death|3|||
16855543|NCT01764841|37807994|FG001|Overall Study|Death|0|||
16855544|NCT01764841|37807995|FG002|Overall Study|Death|1|||
16855545|NCT01764841|37807996|FG003|Overall Study|Death|4|||
16855546|NCT01764841|37807993|FG000|Overall Study|No Follow Up|1|||
16855547|NCT01764841|37807994|FG001|Overall Study|No Follow Up|0|||
16855548|NCT01764841|37807995|FG002|Overall Study|No Follow Up|1|||
16855549|NCT01764841|37807996|FG003|Overall Study|No Follow Up|0|||
16855550|NCT01764841|37807993|FG000|Overall Study|Protocol Violation|0|||
16855551|NCT01764841|37807994|FG001|Overall Study|Protocol Violation|1|||
16855552|NCT01764841|37807995|FG002|Overall Study|Protocol Violation|0|||
16855553|NCT01764841|37807996|FG003|Overall Study|Protocol Violation|0|||
16855554|NCT01764841|37807993|FG000|Overall Study|Withdrawal by Subject|16|||
16855555|NCT01764841|37807994|FG001|Overall Study|Withdrawal by Subject|24|||
16855556|NCT01764841|37807995|FG002|Overall Study|Withdrawal by Subject|11|||
16855557|NCT01764841|37807996|FG003|Overall Study|Withdrawal by Subject|15|||
16855558|NCT01764841|37807993|FG000|Overall Study|Lost to Follow-up|3|||
16855559|NCT01764841|37807994|FG001|Overall Study|Lost to Follow-up|0|||
17028016|NCT00587288|38172396|FG000|Overall Study|Adverse Event|0|||
17028017|NCT00587288|38172397|FG001|Overall Study|Adverse Event|1|||
16855560|NCT01764841|37807995|FG002|Overall Study|Lost to Follow-up|1|||
16855561|NCT01764841|37807996|FG003|Overall Study|Lost to Follow-up|0|||
16855562|NCT00245050|37808008|FG000|Overall Study|Adverse Event|3|||
16855563|NCT00245050|37808009|FG001|Overall Study|Adverse Event|2|||
16855564|NCT00243412|37808047|FG000|Overall Study|Death|0|||
16855565|NCT00243412|37808048|FG001|Overall Study|Death|1|||
16855566|NCT00243412|37808047|FG000|Overall Study|Adverse Event|4|||
16855567|NCT00243412|37808048|FG001|Overall Study|Adverse Event|2|||
16855568|NCT00243412|37808047|FG000|Overall Study|Lost to Follow-up|0|||
16855569|NCT00243412|37808048|FG001|Overall Study|Lost to Follow-up|1|||
16855570|NCT00243412|37808047|FG000|Overall Study|Physician Decision|1|||
16855571|NCT00243412|37808048|FG001|Overall Study|Physician Decision|1|||
16855572|NCT00243412|37808047|FG000|Overall Study|Withdrawal by Subject|4|||
16855573|NCT00243412|37808048|FG001|Overall Study|Withdrawal by Subject|5|||
16855574|NCT00243412|37808047|FG000|Overall Study|Other|1|||
16855575|NCT00243412|37808048|FG001|Overall Study|Other|1|||
16855576|NCT03805750|37808063|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
16855577|NCT03805750|37808064|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
16855578|NCT03804268|37808072|FG000|Overall Study|Adverse Event|2|||
16855579|NCT03804268|37808073|FG001|Overall Study|Adverse Event|2|||
16855580|NCT03804268|37808072|FG000|Overall Study|Withdrawal by Subject|2|||
16855581|NCT03804268|37808073|FG001|Overall Study|Withdrawal by Subject|0|||
16855582|NCT03804268|37808072|FG000|Overall Study|Lost to Follow-up|1|||
16855583|NCT03804268|37808073|FG001|Overall Study|Lost to Follow-up|0|||
16855584|NCT03804268|37808072|FG000|Overall Study|Physician Decision|2|||
16855585|NCT03804268|37808073|FG001|Overall Study|Physician Decision|0|||
16855586|NCT00243022|37808098|FG000|Overall Study|Withdrawal by Subject|1|||
16855587|NCT00243022|37808099|FG001|Overall Study|Withdrawal by Subject|0|||
16855588|NCT00243022|37808098|FG000|Overall Study|Death|1|||
16855589|NCT00243022|37808099|FG001|Overall Study|Death|0|||
16855590|NCT00243022|37808098|FG000|Overall Study|Difficult Travel Distance|0|||
16855591|NCT00243022|37808099|FG001|Overall Study|Difficult Travel Distance|1|||
16855592|NCT01736683|37808184|FG000|Overall Study|Disease Relapse|0|||
16855593|NCT01736683|37808185|FG001|Overall Study|Disease Relapse|0|||
16855594|NCT01736683|37808186|FG002|Overall Study|Disease Relapse|2|||
16855595|NCT01736683|37808187|FG003|Overall Study|Disease Relapse|1|||
16855596|NCT01736683|37808188|FG004|Overall Study|Disease Relapse|0|||
16855597|NCT01736683|37808184|FG000|Overall Study|Adverse Event|0|||
16855598|NCT01736683|37808185|FG001|Overall Study|Adverse Event|2|||
16855599|NCT01736683|37808186|FG002|Overall Study|Adverse Event|2|||
16855600|NCT01736683|37808187|FG003|Overall Study|Adverse Event|3|||
16855601|NCT01736683|37808188|FG004|Overall Study|Adverse Event|2|||
16855602|NCT01736683|37808184|FG000|Overall Study|Withdrawal by Subject|0|||
16855603|NCT01736683|37808185|FG001|Overall Study|Withdrawal by Subject|0|||
16855604|NCT01736683|37808186|FG002|Overall Study|Withdrawal by Subject|3|||
16855605|NCT01736683|37808187|FG003|Overall Study|Withdrawal by Subject|1|||
16855606|NCT01736683|37808188|FG004|Overall Study|Withdrawal by Subject|1|||
16855607|NCT01736683|37808184|FG000|Overall Study|Lack of Therapeutic Effect|7|||
16855608|NCT01736683|37808185|FG001|Overall Study|Lack of Therapeutic Effect|4|||
16855609|NCT01736683|37808186|FG002|Overall Study|Lack of Therapeutic Effect|13|||
16855610|NCT01736683|37808187|FG003|Overall Study|Lack of Therapeutic Effect|20|||
16855611|NCT01736683|37808188|FG004|Overall Study|Lack of Therapeutic Effect|1|||
16855612|NCT01736683|37808184|FG000|Overall Study|Progressive Disease|0|||
16855613|NCT01736683|37808185|FG001|Overall Study|Progressive Disease|0|||
16855614|NCT01736683|37808186|FG002|Overall Study|Progressive Disease|0|||
16855615|NCT01736683|37808187|FG003|Overall Study|Progressive Disease|1|||
16855616|NCT01736683|37808188|FG004|Overall Study|Progressive Disease|0|||
16855617|NCT01736683|37808184|FG000|Overall Study|Other|0|||
16855618|NCT01736683|37808185|FG001|Overall Study|Other|0|||
16855619|NCT01736683|37808186|FG002|Overall Study|Other|1|||
16855620|NCT01736683|37808187|FG003|Overall Study|Other|9|||
16855621|NCT01736683|37808188|FG004|Overall Study|Other|1|||
16855622|NCT01788943|37808204|FG000|Overall Study|Withdrawal by Subject|1|||
16855623|NCT01788943|37808205|FG001|Overall Study|Withdrawal by Subject|0|||
16855624|NCT01788163|37808232|FG000|Overall Study|Other|53|||
16855625|NCT01788163|37808233|FG001|Overall Study|Other|0|||
16855626|NCT01788163|37808234|FG002|Overall Study|Other|0|||
16855627|NCT01788163|37808235|FG003|Overall Study|Other|0|||
16855628|NCT01788163|37808236|FG004|Overall Study|Other|0|||
16855629|NCT01788163|37808237|FG005|Overall Study|Other|7|||
16855630|NCT01788163|37808238|FG006|Overall Study|Other|1|||
16855631|NCT01788163|37808239|FG007|Overall Study|Other|48|||
16855632|NCT01788163|37808240|FG008|Overall Study|Other|15|||
16855633|NCT01788163|37808232|FG000|Overall Study|Withdrawal by Subject|2|||
16855634|NCT01788163|37808233|FG001|Overall Study|Withdrawal by Subject|0|||
16855635|NCT01788163|37808234|FG002|Overall Study|Withdrawal by Subject|0|||
16855636|NCT01788163|37808235|FG003|Overall Study|Withdrawal by Subject|0|||
16855637|NCT01788163|37808236|FG004|Overall Study|Withdrawal by Subject|0|||
16855638|NCT01788163|37808237|FG005|Overall Study|Withdrawal by Subject|0|||
16855639|NCT01788163|37808238|FG006|Overall Study|Withdrawal by Subject|0|||
16855640|NCT01788163|37808239|FG007|Overall Study|Withdrawal by Subject|0|||
16855641|NCT01788163|37808240|FG008|Overall Study|Withdrawal by Subject|1|||
16855642|NCT01787461|37808376|FG000|Overall Study|Adverse Event|4|||
16855643|NCT01787461|37808377|FG001|Overall Study|Adverse Event|3|||
16855644|NCT01787461|37808376|FG000|Overall Study|Lost to Follow-up|3|||
16855645|NCT01787461|37808377|FG001|Overall Study|Lost to Follow-up|2|||
16855646|NCT01787461|37808376|FG000|Overall Study|No longer met eligibility criteria|1|||
16855647|NCT01787461|37808377|FG001|Overall Study|No longer met eligibility criteria|0|||
16855648|NCT01787461|37808376|FG000|Overall Study|Withdrawal by Subject|3|||
16855649|NCT01787461|37808377|FG001|Overall Study|Withdrawal by Subject|4|||
16855650|NCT01787461|37808376|FG000|Overall Study|Protocol Violation|3|||
16855651|NCT01787461|37808377|FG001|Overall Study|Protocol Violation|0|||
16855652|NCT01786993|37808402|FG000|Overall Study|Death|6|||
16855653|NCT01786993|37808403|FG001|Overall Study|Death|7|||
16855654|NCT01786993|37808402|FG000|Overall Study|Withdrawal by Subject|3|||
16855655|NCT01786993|37808403|FG001|Overall Study|Withdrawal by Subject|2|||
16855656|NCT01786993|37808402|FG000|Overall Study|Lost to Follow-up|0|||
16855657|NCT01786993|37808403|FG001|Overall Study|Lost to Follow-up|1|||
16855658|NCT01786993|37808402|FG000|Overall Study|Subject Non-Compliance|1|||
16855659|NCT01786993|37808403|FG001|Overall Study|Subject Non-Compliance|0|||
16855660|NCT01786993|37808402|FG000|Overall Study|System Explant|1|||
16855661|NCT01786993|37808403|FG001|Overall Study|System Explant|0|||
16855662|NCT01786993|37808402|FG000|Overall Study|Hospice Admission|1|||
16855663|NCT01786993|37808403|FG001|Overall Study|Hospice Admission|0|||
16855664|NCT01966445|37808428|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16855665|NCT01966445|37808429|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16855666|NCT01966445|37808430|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16855667|NCT01966445|37808431|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
16855668|NCT01966445|37808432|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16855669|NCT01966445|37808433|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
16855670|NCT01966445|37808434|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16855671|NCT01966445|37808428|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
16855672|NCT01966445|37808429|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
16855673|NCT01966445|37808430|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
16855674|NCT01966445|37808431|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
16855675|NCT01966445|37808432|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
16855676|NCT01966445|37808433|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
16855677|NCT01966445|37808434|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
16855678|NCT01966445|37808428|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
16855679|NCT01966445|37808429|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
16855680|NCT01966445|37808430|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
16855681|NCT01966445|37808431|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
16855682|NCT01966445|37808432|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
16855683|NCT01966445|37808433|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
16855684|NCT01966445|37808434|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
16855685|NCT01966445|37808428|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16855686|NCT01966445|37808429|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16855687|NCT01966445|37808430|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16855688|NCT01966445|37808431|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16855689|NCT01966445|37808432|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16855690|NCT01966445|37808433|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16855691|NCT01966445|37808434|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
16855692|NCT01966445|37808428|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16855693|NCT01966445|37808429|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16855694|NCT01966445|37808430|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16855695|NCT01966445|37808431|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16855696|NCT01966445|37808432|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16855697|NCT01966445|37808433|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16855698|NCT01966445|37808434|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
16855699|NCT01763905|37808454|FG000|Overall Study|Withdrawal by Subject|1|||
16855700|NCT01763905|37808455|FG001|Overall Study|Withdrawal by Subject|1|||
16855701|NCT01763905|37808456|FG002|Overall Study|Withdrawal by Subject|0|||
16855702|NCT01763905|37808457|FG003|Overall Study|Withdrawal by Subject|1|||
16855703|NCT01763905|37808454|FG000|Overall Study|Decision by sponsor|5|||
16855704|NCT01763905|37808455|FG001|Overall Study|Decision by sponsor|0|||
16855705|NCT01763905|37808456|FG002|Overall Study|Decision by sponsor|8|||
16855706|NCT01763905|37808457|FG003|Overall Study|Decision by sponsor|0|||
16855707|NCT01763905|37808454|FG000|Overall Study|Lost to Follow-up|0|||
16855708|NCT01763905|37808455|FG001|Overall Study|Lost to Follow-up|0|||
16855709|NCT01763905|37808456|FG002|Overall Study|Lost to Follow-up|1|||
16855710|NCT01763905|37808457|FG003|Overall Study|Lost to Follow-up|0|||
16855711|NCT02091167|37808469|FG000|Overall Study|Lost to Follow-up|0|||
16855712|NCT02091167|37808470|FG001|Overall Study|Lost to Follow-up|2|||
16855713|NCT02091089|37808476|FG000|Overall Study|Lost to Follow-up|2|||
16855714|NCT01763203|37808491|FG000|Overall Study|Death|4|||
16855715|NCT01763203|37808492|FG001|Overall Study|Death|7|||
16855716|NCT01763203|37808491|FG000|Overall Study|Lost to Follow-up|12|||
16855717|NCT01763203|37808492|FG001|Overall Study|Lost to Follow-up|12|||
16855718|NCT01763203|37808491|FG000|Overall Study|Withdrawal by Subject|8|||
16855719|NCT01763203|37808492|FG001|Overall Study|Withdrawal by Subject|12|||
16855720|NCT01763203|37808491|FG000|Overall Study|Moved out of study region|7|||
16855721|NCT01763203|37808492|FG001|Overall Study|Moved out of study region|10|||
16855722|NCT01763203|37808491|FG000|Overall Study|Physician Decision|2|||
16855723|NCT01763203|37808492|FG001|Overall Study|Physician Decision|1|||
16855724|NCT01763047|37808509|FG000|Period 1|Test Article Not Available|4|||
16855725|NCT01763047|37808510|FG001|Period 1|Test Article Not Available|1|||
16855726|NCT01763047|37808509|FG000|Period 1|Protocol Violation|4|||
16855727|NCT01763047|37808510|FG001|Period 1|Protocol Violation|4|||
16855728|NCT01763047|37808509|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
16855729|NCT01763047|37808510|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
16855730|NCT01763047|37808509|FG000|Period 1|Adverse Event|0|||
16855731|NCT01763047|37808510|FG001|Period 1|Adverse Event|1|||
16855732|NCT01763047|37808509|FG000|Period 1|Unsatisfactory Visual Response|0|||
16855733|NCT01763047|37808510|FG001|Period 1|Unsatisfactory Visual Response|3|||
16855734|NCT01763047|37808509|FG000|Period 1|Lens Power Not Available|0|||
16855735|NCT01763047|37808510|FG001|Period 1|Lens Power Not Available|1|||
16855736|NCT01763047|37808509|FG000|Period 1|Study Site office Closed|0|||
16855737|NCT01763047|37808510|FG001|Period 1|Study Site office Closed|1|||
16855738|NCT01763047|37808509|FG000|Period 2|Lens Discomfort|1|||
16855739|NCT01763047|37808510|FG001|Period 2|Lens Discomfort|0|||
16855740|NCT01763047|37808509|FG000|Period 2|No longer meets Eligibility Criteria|1|||
16855741|NCT01763047|37808510|FG001|Period 2|No longer meets Eligibility Criteria|0|||
16855742|NCT01763047|37808509|FG000|Period 2|Study Site office Closed|1|||
16855743|NCT01763047|37808510|FG001|Period 2|Study Site office Closed|1|||
16855744|NCT01763047|37808509|FG000|Period 2|Unsatisfactory Visual Response|1|||
16855745|NCT01763047|37808510|FG001|Period 2|Unsatisfactory Visual Response|1|||
16855746|NCT01763047|37808509|FG000|Period 2|Protocol Violation|0|||
16855747|NCT01763047|37808510|FG001|Period 2|Protocol Violation|2|||
16855748|NCT01763047|37808509|FG000|Period 2|Unsatisfactory lens Fitting|0|||
16855749|NCT01763047|37808510|FG001|Period 2|Unsatisfactory lens Fitting|1|||
16855750|NCT01977677|37808522|FG000|Overall Study|Unrelated Adverse Event|0|||
16855751|NCT01977677|37808523|FG001|Overall Study|Unrelated Adverse Event|0|||
16855752|NCT01977677|37808524|FG002|Overall Study|Unrelated Adverse Event|1|||
16855753|NCT01762345|37808532|FG000|Overall Study|Adverse Event|5|||
16855754|NCT01762345|37808532|FG000|Overall Study|Protocol Violation|2|||
16855755|NCT02090855|37808537|FG000|Overall Study|no evaluable Standard of Truth results|2|||
16855756|NCT01761565|37808544|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
16855757|NCT01619579|37808554|FG000|Overall Study|Withdrawal by Subject|0|||
16855758|NCT01619579|37808555|FG001|Overall Study|Withdrawal by Subject|3|||
16855759|NCT01736215|37808561|FG000|Overall Study|Early termination of erythropoietin use|1|||
16855760|NCT01736215|37808561|FG000|Overall Study|Adverse Event|4|||
16855761|NCT01736215|37808561|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
16855762|NCT01736215|37808561|FG000|Overall Study|Insufficient data to perform analysis|8|||
16855763|NCT01786603|37808567|FG000|Overall Study|Death|5|||
16855764|NCT01786603|37808568|FG001|Overall Study|Death|1|||
16855765|NCT01786603|37808567|FG000|Overall Study|Adverse Event|6|||
16855766|NCT01786603|37808568|FG001|Overall Study|Adverse Event|2|||
16855767|NCT01786603|37808567|FG000|Overall Study|Physician decision to withdraw|6|||
16855768|NCT01786603|37808568|FG001|Overall Study|Physician decision to withdraw|7|||
16855769|NCT01786603|37808567|FG000|Overall Study|Lost to Follow-up|1|||
16855770|NCT01786603|37808568|FG001|Overall Study|Lost to Follow-up|2|||
16855771|NCT01619423|37808591|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
16855772|NCT01619423|37808592|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
16855773|NCT01619423|37808593|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
16855774|NCT01619423|37808594|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
16855775|NCT01735279|37808607|FG000|Overall Study|Lost to Follow-up|11|||
16855776|NCT01735279|37808608|FG001|Overall Study|Lost to Follow-up|8|||
16855777|NCT01759381|37808616|FG000|Overall Study|Death|1|||
16855778|NCT01759381|37808617|FG001|Overall Study|Death|0|||
16855779|NCT01758523|37808636|FG000|Overall Study|Adverse Event|2|||
16855780|NCT01758523|37808637|FG001|Overall Study|Adverse Event|1|||
16855781|NCT01758523|37808636|FG000|Overall Study|Lack of Efficacy|4|||
16855782|NCT01758523|37808637|FG001|Overall Study|Lack of Efficacy|2|||
16855783|NCT01758523|37808636|FG000|Overall Study|Lost to Follow-up|3|||
16855784|NCT01758523|37808637|FG001|Overall Study|Lost to Follow-up|4|||
16855785|NCT01758523|37808636|FG000|Overall Study|Withdrawal by Subject|12|||
16855786|NCT01758523|37808637|FG001|Overall Study|Withdrawal by Subject|7|||
16855787|NCT01758289|37808660|FG000|Overall Study|Premature Study Termination|44|||
16855788|NCT01758289|37808660|FG000|Overall Study|Adverse Event|9|||
16855789|NCT01757821|37808684|FG000|Overall Study|Adverse Event|1|||
16855790|NCT01735201|37808713|FG000|Overall Study|Adverse Event|1|||
16855791|NCT01735201|37808714|FG001|Overall Study|Adverse Event|1|||
16855792|NCT01735201|37808715|FG002|Overall Study|Adverse Event|0|||
16855793|NCT01735201|37808716|FG003|Overall Study|Adverse Event|1|||
16855794|NCT01735201|37808717|FG004|Overall Study|Adverse Event|1|||
16855795|NCT01735201|37808718|FG005|Overall Study|Adverse Event|3|||
16855796|NCT01735201|37808719|FG006|Overall Study|Adverse Event|2|||
16855797|NCT01735201|37808720|FG007|Overall Study|Adverse Event|1|||
16855798|NCT01735201|37808713|FG000|Overall Study|Personal Reasons|1|||
16855799|NCT01735201|37808714|FG001|Overall Study|Personal Reasons|0|||
16855800|NCT01735201|37808715|FG002|Overall Study|Personal Reasons|0|||
16855801|NCT01735201|37808716|FG003|Overall Study|Personal Reasons|0|||
16855802|NCT01735201|37808717|FG004|Overall Study|Personal Reasons|0|||
16855803|NCT01735201|37808718|FG005|Overall Study|Personal Reasons|0|||
16855804|NCT01735201|37808719|FG006|Overall Study|Personal Reasons|0|||
16855805|NCT01735201|37808720|FG007|Overall Study|Personal Reasons|0|||
16855806|NCT01735201|37808713|FG000|Overall Study|Protocol Violation|1|||
16855807|NCT01735201|37808714|FG001|Overall Study|Protocol Violation|0|||
16855808|NCT01735201|37808715|FG002|Overall Study|Protocol Violation|0|||
16855809|NCT01735201|37808716|FG003|Overall Study|Protocol Violation|0|||
16855810|NCT01735201|37808717|FG004|Overall Study|Protocol Violation|0|||
16855811|NCT01735201|37808718|FG005|Overall Study|Protocol Violation|0|||
16855812|NCT01735201|37808719|FG006|Overall Study|Protocol Violation|0|||
16855813|NCT01735201|37808720|FG007|Overall Study|Protocol Violation|0|||
16855814|NCT01735201|37808713|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16855815|NCT01735201|37808714|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16855816|NCT01735201|37808715|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16855817|NCT01735201|37808716|FG003|Overall Study|Other Miscellaneous Reasons|1|||
16855818|NCT01735201|37808717|FG004|Overall Study|Other Miscellaneous Reasons|0|||
16855819|NCT01735201|37808718|FG005|Overall Study|Other Miscellaneous Reasons|2|||
16855820|NCT01735201|37808719|FG006|Overall Study|Other Miscellaneous Reasons|1|||
16855821|NCT01735201|37808720|FG007|Overall Study|Other Miscellaneous Reasons|1|||
16855822|NCT01734811|37808740|FG000|Overall Study|Lost to Follow-up|2|||
16855823|NCT01734811|37808741|FG001|Overall Study|Lost to Follow-up|3|||
16855824|NCT01734811|37808740|FG000|Overall Study|Withdrawal by Subject|2|||
16855825|NCT01734811|37808741|FG001|Overall Study|Withdrawal by Subject|0|||
16855826|NCT01757275|37808749|FG000|Overall Study|Lost to Follow-up|1|||
16855827|NCT01757275|37808750|FG001|Overall Study|Lost to Follow-up|2|||
16855828|NCT01757275|37808749|FG000|Overall Study|Adverse Event|3|||
16855829|NCT01757275|37808750|FG001|Overall Study|Adverse Event|3|||
16855830|NCT01757275|37808749|FG000|Overall Study|Withdrawal by Subject|2|||
16855831|NCT01757275|37808750|FG001|Overall Study|Withdrawal by Subject|4|||
16855832|NCT01757275|37808749|FG000|Overall Study|Not treated|3|||
16855833|NCT01757275|37808750|FG001|Overall Study|Not treated|4|||
16855834|NCT01757197|37808765|FG000|Overall Study|Death|2|||
16855835|NCT01784965|37808789|FG000|Overall Study|Withdrawal by Subject|6|||
16855836|NCT01784965|37808790|FG001|Overall Study|Withdrawal by Subject|3|||
16855837|NCT01784965|37808789|FG000|Overall Study|Adverse Event|0|||
16855838|NCT01784965|37808790|FG001|Overall Study|Adverse Event|8|||
16855839|NCT01784419|37808798|FG000|Overall Study|Adverse Event|3|||
16855840|NCT01784029|37808805|FG000|Overall Study|Lost to Follow-up|19|||
16855841|NCT01784029|37808806|FG001|Overall Study|Lost to Follow-up|20|||
16855842|NCT01784029|37808807|FG002|Overall Study|Lost to Follow-up|22|||
16855843|NCT01733329|37808829|FG000|Overall Study|Protocol Violation|1|||
16855844|NCT01733329|37808830|FG001|Overall Study|Protocol Violation|1|||
16855845|NCT01733329|37808829|FG000|Overall Study|Uterine artery injury|1|||
16855846|NCT01733329|37808830|FG001|Overall Study|Uterine artery injury|0|||
16855847|NCT01783483|37808838|FG000|Overall Study|Death|3|||
16855848|NCT01783483|37808839|FG001|Overall Study|Death|3|||
16855849|NCT01783483|37808838|FG000|Overall Study|Lost to Follow-up|14|||
16855850|NCT01783483|37808839|FG001|Overall Study|Lost to Follow-up|10|||
16855851|NCT01783483|37808838|FG000|Overall Study|Withdrawal by Subject|2|||
16855852|NCT01783483|37808839|FG001|Overall Study|Withdrawal by Subject|1|||
16855853|NCT01783483|37808838|FG000|Overall Study|Physician Decision|1|||
16855854|NCT01783483|37808839|FG001|Overall Study|Physician Decision|1|||
16855855|NCT01607593|37808858|FG000|Overall Study|Adverse Event|15|||
16855856|NCT01607593|37808858|FG000|Overall Study|Lack of Efficacy|16|||
16855857|NCT01607593|37808858|FG000|Overall Study|Lost to Follow-up|25|||
16855858|NCT01607593|37808858|FG000|Overall Study|Continuation|33|||
16855859|NCT01607593|37808858|FG000|Overall Study|Other|4|||
16855860|NCT01755637|37808871|FG000|Period 1|Adverse Event|0|||
16855861|NCT01755637|37808872|FG001|Period 1|Adverse Event|1|||
16855862|NCT01732549|37808890|FG000|Overall Study|Adverse Event|13|||
16855863|NCT01732549|37808891|FG001|Overall Study|Adverse Event|3|||
16855864|NCT01732549|37808890|FG000|Overall Study|Consent withdrawn|13|||
16855865|NCT01732549|37808891|FG001|Overall Study|Consent withdrawn|6|||
16855866|NCT01732549|37808890|FG000|Overall Study|Disease progression|37|||
16855867|NCT01732549|37808891|FG001|Overall Study|Disease progression|50|||
16855868|NCT01732549|37808890|FG000|Overall Study|Other|8|||
16855869|NCT01732549|37808891|FG001|Overall Study|Other|14|||
16855870|NCT01755091|37808910|FG000|Overall Study|Withdrawal by Subject|6|||
16855871|NCT01755091|37808911|FG001|Overall Study|Withdrawal by Subject|1|||
16855872|NCT01755091|37808912|FG002|Overall Study|Withdrawal by Subject|3|||
16855873|NCT01755091|37808910|FG000|Overall Study|Adverse Event|1|||
16855874|NCT01755091|37808911|FG001|Overall Study|Adverse Event|1|||
16855875|NCT01755091|37808912|FG002|Overall Study|Adverse Event|1|||
16855876|NCT01755091|37808910|FG000|Overall Study|Lost to Follow-up|1|||
16855877|NCT01755091|37808911|FG001|Overall Study|Lost to Follow-up|0|||
16855878|NCT01755091|37808912|FG002|Overall Study|Lost to Follow-up|1|||
16855879|NCT01755091|37808910|FG000|Overall Study|Physician Decision|1|||
16855880|NCT01755091|37808911|FG001|Overall Study|Physician Decision|1|||
16855881|NCT01755091|37808912|FG002|Overall Study|Physician Decision|2|||
16855882|NCT01754467|37808945|FG000|Overall Study|Lost to Follow-up|1|||
16855883|NCT01753999|37808949|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
16855884|NCT01753999|37808950|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
16855885|NCT01753999|37808949|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
16855886|NCT01753999|37808950|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
16855887|NCT01753999|37808949|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
16855888|NCT01753999|37808950|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
16855889|NCT01753999|37808949|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
16855890|NCT01753999|37808950|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
16855891|NCT01753999|37808949|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
16855892|NCT01753999|37808950|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
16855893|NCT01753999|37808949|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
16855894|NCT01753999|37808950|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
16855895|NCT01783015|37808970|FG000|Blinded Treatment|Adverse Event|0|||
16855896|NCT01783015|37808971|FG001|Blinded Treatment|Adverse Event|1|||
16855897|NCT01783015|37808972|FG002|Blinded Treatment|Adverse Event|0|||
16855898|NCT01783015|37808970|FG000|Blinded Treatment|Protocol Violation|0|||
16855899|NCT01783015|37808971|FG001|Blinded Treatment|Protocol Violation|1|||
16855900|NCT01783015|37808972|FG002|Blinded Treatment|Protocol Violation|0|||
16855901|NCT01783015|37808970|FG000|Blinded Treatment|Withdrawal by Subject|0|||
16855902|NCT01783015|37808971|FG001|Blinded Treatment|Withdrawal by Subject|1|||
16855903|NCT01783015|37808972|FG002|Blinded Treatment|Withdrawal by Subject|0|||
16855904|NCT01783015|37808970|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
16855905|NCT01783015|37808971|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
16855906|NCT01783015|37808972|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
16855907|NCT01783015|37808970|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
16855908|NCT01783015|37808971|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
16855909|NCT01783015|37808972|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
16855910|NCT01782859|37808982|FG000|Overall Study|Protocol Violation|6|||
16855911|NCT01782859|37808983|FG001|Overall Study|Protocol Violation|6|||
16855912|NCT01782859|37808982|FG000|Overall Study|Withdrawal by Subject|0|||
16855913|NCT01782859|37808983|FG001|Overall Study|Withdrawal by Subject|1|||
16855914|NCT01782469|37808990|FG000|Overall Study|Lost to Follow-up|1|||
16855915|NCT01782313|37808994|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
16855916|NCT01782313|37808994|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
16855917|NCT01782313|37808994|FG000|Treated Cycle 3|Progressive Disease|21|||
16855918|NCT01782313|37808994|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
16855919|NCT01782313|37808994|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
16855920|NCT01782313|37808994|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
16855921|NCT01782313|37808994|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
16855922|NCT01782313|37808994|FG000|Survival Follow up|Lost to Follow-up|1|||
16855923|NCT01781611|37809017|FG000|Overall Study|Adverse Event|4|||
16855924|NCT01781611|37809018|FG001|Overall Study|Adverse Event|0|||
16855925|NCT01781299|37809035|FG000|Overall Study|Withdrawal by Subject|0|||
16855926|NCT01781299|37809036|FG001|Overall Study|Withdrawal by Subject|1|||
16855927|NCT01732471|37809042|FG000|Overall Study|Withdrawal by Subject|1|||
16855928|NCT01780987|37809061|FG000|Overall Study|Adverse Event|0|||
16855929|NCT01780987|37809062|FG001|Overall Study|Adverse Event|4|||
16855930|NCT01780987|37809061|FG000|Overall Study|Withdrawal by Subject|2|||
16855931|NCT01780987|37809062|FG001|Overall Study|Withdrawal by Subject|0|||
16855932|NCT01780987|37809061|FG000|Overall Study|Request of Changing Hospital|0|||
16855933|NCT01780987|37809062|FG001|Overall Study|Request of Changing Hospital|1|||
16855934|NCT01780987|37809061|FG000|Overall Study|Changing Residence|1|||
16855935|NCT01780987|37809062|FG001|Overall Study|Changing Residence|0|||
16855936|NCT01780987|37809061|FG000|Overall Study|Not Receiving any Study Medication|0|||
16855937|NCT01780987|37809062|FG001|Overall Study|Not Receiving any Study Medication|1|||
16855938|NCT01753297|37809125|FG000|Overall Study|Lost to Follow-up|7|||
16855939|NCT01753297|37809126|FG001|Overall Study|Lost to Follow-up|2|||
16855940|NCT01753297|37809125|FG000|Overall Study|Withdrawal by Subject|26|||
16855941|NCT01753297|37809126|FG001|Overall Study|Withdrawal by Subject|23|||
16855942|NCT01753297|37809125|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
16855943|NCT01753297|37809126|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
16855944|NCT01753297|37809125|FG000|Overall Study|Death|0|||
16855945|NCT01753297|37809126|FG001|Overall Study|Death|2|||
16855946|NCT01753297|37809125|FG000|Overall Study|Did not attend end of study visit|7|||
16855947|NCT01753297|37809126|FG001|Overall Study|Did not attend end of study visit|8|||
16855948|NCT01730053|37809162|FG000|Overall Study|Participant moved|0|||
16855949|NCT01730053|37809163|FG001|Overall Study|Participant moved|0|||
16855950|NCT01730053|37809164|FG002|Overall Study|Participant moved|1|||
16855951|NCT01730053|37809165|FG003|Overall Study|Participant moved|0|||
16855952|NCT01730053|37809166|FG004|Overall Study|Participant moved|0|||
16855953|NCT01730053|37809167|FG005|Overall Study|Participant moved|0|||
16855954|NCT01730053|37809162|FG000|Overall Study|Physician Decision|0|||
16855955|NCT01730053|37809163|FG001|Overall Study|Physician Decision|0|||
16855956|NCT01730053|37809164|FG002|Overall Study|Physician Decision|0|||
16855957|NCT01730053|37809165|FG003|Overall Study|Physician Decision|1|||
16855958|NCT01730053|37809166|FG004|Overall Study|Physician Decision|0|||
16855959|NCT01730053|37809167|FG005|Overall Study|Physician Decision|0|||
16855960|NCT01730053|37809162|FG000|Overall Study|Adverse Event|2|||
16855961|NCT01730053|37809163|FG001|Overall Study|Adverse Event|6|||
16855962|NCT01730053|37809164|FG002|Overall Study|Adverse Event|3|||
16855963|NCT01730053|37809165|FG003|Overall Study|Adverse Event|3|||
16855964|NCT01730053|37809166|FG004|Overall Study|Adverse Event|2|||
16855965|NCT01730053|37809167|FG005|Overall Study|Adverse Event|2|||
16855966|NCT01730053|37809162|FG000|Overall Study|Poor compliance to protocol|1|||
16855967|NCT01730053|37809163|FG001|Overall Study|Poor compliance to protocol|2|||
16855968|NCT01730053|37809164|FG002|Overall Study|Poor compliance to protocol|2|||
16855969|NCT01730053|37809165|FG003|Overall Study|Poor compliance to protocol|0|||
16855970|NCT01730053|37809166|FG004|Overall Study|Poor compliance to protocol|0|||
16855971|NCT01730053|37809167|FG005|Overall Study|Poor compliance to protocol|2|||
16855972|NCT01730053|37809162|FG000|Overall Study|Other than specified|2|||
16855973|NCT01730053|37809163|FG001|Overall Study|Other than specified|6|||
16855974|NCT01730053|37809164|FG002|Overall Study|Other than specified|5|||
16855975|NCT01730053|37809165|FG003|Overall Study|Other than specified|4|||
16855976|NCT01730053|37809166|FG004|Overall Study|Other than specified|7|||
16855977|NCT01730053|37809167|FG005|Overall Study|Other than specified|9|||
16855978|NCT01752985|37809202|FG000|Treatment Period|Subject request to discontinue treatment|1|||
16855979|NCT01752985|37809203|FG001|Treatment Period|Subject request to discontinue treatment|0|||
16855980|NCT01752985|37809204|FG002|Treatment Period|Subject request to discontinue treatment|1|||
16855981|NCT01752985|37809202|FG000|Treatment Period|Subject no longer meets study criteria|0|||
16855982|NCT01752985|37809203|FG001|Treatment Period|Subject no longer meets study criteria|1|||
16855983|NCT01752985|37809204|FG002|Treatment Period|Subject no longer meets study criteria|1|||
16855984|NCT01752985|37809202|FG000|Treatment Period|Adverse Event|2|||
16855985|NCT01752985|37809203|FG001|Treatment Period|Adverse Event|1|||
16855986|NCT01752985|37809204|FG002|Treatment Period|Adverse Event|2|||
16855987|NCT01752985|37809202|FG000|Treatment Period|Withdrawal by Subject|1|||
16855988|NCT01752985|37809203|FG001|Treatment Period|Withdrawal by Subject|1|||
16855989|NCT01752985|37809204|FG002|Treatment Period|Withdrawal by Subject|0|||
16855990|NCT01752985|37809202|FG000|Treatment Period|Lost to Follow-up|0|||
16855991|NCT01752985|37809203|FG001|Treatment Period|Lost to Follow-up|0|||
16855992|NCT01752985|37809204|FG002|Treatment Period|Lost to Follow-up|1|||
16855993|NCT01751113|37809212|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16855994|NCT01751113|37809213|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16855995|NCT01751113|37809214|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16855996|NCT01751113|37809215|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
16855997|NCT01751113|37809216|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
16855998|NCT01751113|37809217|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16855999|NCT01751113|37809212|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16856000|NCT01751113|37809213|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16856001|NCT01751113|37809214|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16856002|NCT01751113|37809215|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16856003|NCT01751113|37809216|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16856004|NCT01751113|37809217|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
16856005|NCT01750879|37809237|FG000|Overall Study|Adverse Event|8|||
16856006|NCT01750879|37809238|FG001|Overall Study|Adverse Event|0|||
16856007|NCT01750879|37809237|FG000|Overall Study|Lack of Efficacy|1|||
16856008|NCT01750879|37809238|FG001|Overall Study|Lack of Efficacy|0|||
16856009|NCT01750879|37809237|FG000|Overall Study|Withdrawal by Subject|1|||
16856010|NCT01750879|37809238|FG001|Overall Study|Withdrawal by Subject|0|||
16856011|NCT01750879|37809237|FG000|Overall Study|Did not complete per protocol|0|||
16856012|NCT01750879|37809238|FG001|Overall Study|Did not complete per protocol|3|||
16856013|NCT01719380|37809264|FG000|Overall Study|Adverse Event|0|||
16856014|NCT01719380|37809265|FG001|Overall Study|Adverse Event|0|||
16856015|NCT01719380|37809266|FG002|Overall Study|Adverse Event|1|||
16856016|NCT01719380|37809267|FG003|Overall Study|Adverse Event|2|||
16856017|NCT01719380|37809268|FG004|Overall Study|Adverse Event|0|||
16856018|NCT01719380|37809269|FG005|Overall Study|Adverse Event|1|||
16856019|NCT01719380|37809270|FG006|Overall Study|Adverse Event|0|||
16856020|NCT01719380|37809271|FG007|Overall Study|Adverse Event|1|||
16856021|NCT01719380|37809272|FG008|Overall Study|Adverse Event|4|||
16856022|NCT01719380|37809273|FG009|Overall Study|Adverse Event|3|||
16856023|NCT01719380|37809264|FG000|Overall Study|Death|0|||
16856024|NCT01719380|37809265|FG001|Overall Study|Death|1|||
16856025|NCT01719380|37809266|FG002|Overall Study|Death|0|||
16856026|NCT01719380|37809267|FG003|Overall Study|Death|0|||
16856027|NCT01719380|37809268|FG004|Overall Study|Death|0|||
16856028|NCT01719380|37809269|FG005|Overall Study|Death|0|||
16856029|NCT01719380|37809270|FG006|Overall Study|Death|0|||
16856030|NCT01719380|37809271|FG007|Overall Study|Death|0|||
16856031|NCT01719380|37809272|FG008|Overall Study|Death|3|||
16856032|NCT01719380|37809273|FG009|Overall Study|Death|3|||
16856033|NCT01719380|37809264|FG000|Overall Study|Participant/Guardian Decision|0|||
16856034|NCT01719380|37809265|FG001|Overall Study|Participant/Guardian Decision|0|||
16856035|NCT01719380|37809266|FG002|Overall Study|Participant/Guardian Decision|1|||
16856036|NCT01719380|37809267|FG003|Overall Study|Participant/Guardian Decision|0|||
16856037|NCT01719380|37809268|FG004|Overall Study|Participant/Guardian Decision|0|||
16856038|NCT01719380|37809269|FG005|Overall Study|Participant/Guardian Decision|0|||
16856039|NCT01719380|37809270|FG006|Overall Study|Participant/Guardian Decision|0|||
16856040|NCT01719380|37809271|FG007|Overall Study|Participant/Guardian Decision|0|||
16856041|NCT01719380|37809272|FG008|Overall Study|Participant/Guardian Decision|2|||
16856042|NCT01719380|37809273|FG009|Overall Study|Participant/Guardian Decision|2|||
16856043|NCT01719380|37809264|FG000|Overall Study|Physician Decision|0|||
16856044|NCT01719380|37809265|FG001|Overall Study|Physician Decision|0|||
16856045|NCT01719380|37809266|FG002|Overall Study|Physician Decision|2|||
16856046|NCT01719380|37809267|FG003|Overall Study|Physician Decision|0|||
16856047|NCT01719380|37809268|FG004|Overall Study|Physician Decision|0|||
16856048|NCT01719380|37809269|FG005|Overall Study|Physician Decision|0|||
16856049|NCT01719380|37809270|FG006|Overall Study|Physician Decision|0|||
16856050|NCT01719380|37809271|FG007|Overall Study|Physician Decision|0|||
16856051|NCT01719380|37809272|FG008|Overall Study|Physician Decision|1|||
16856052|NCT01719380|37809273|FG009|Overall Study|Physician Decision|1|||
16856053|NCT01719380|37809264|FG000|Overall Study|Lack of Efficacy|2|||
16856054|NCT01719380|37809265|FG001|Overall Study|Lack of Efficacy|6|||
16856055|NCT01719380|37809266|FG002|Overall Study|Lack of Efficacy|5|||
16856056|NCT01719380|37809267|FG003|Overall Study|Lack of Efficacy|6|||
16856057|NCT01719380|37809268|FG004|Overall Study|Lack of Efficacy|3|||
16856058|NCT01719380|37809269|FG005|Overall Study|Lack of Efficacy|7|||
16856059|NCT01719380|37809270|FG006|Overall Study|Lack of Efficacy|10|||
16856060|NCT01719380|37809271|FG007|Overall Study|Lack of Efficacy|6|||
16856061|NCT01719380|37809272|FG008|Overall Study|Lack of Efficacy|39|||
16856062|NCT01719380|37809273|FG009|Overall Study|Lack of Efficacy|42|||
16856063|NCT01719380|37809264|FG000|Overall Study|Progressive Disease|0|||
16856064|NCT01719380|37809265|FG001|Overall Study|Progressive Disease|0|||
16856065|NCT01719380|37809266|FG002|Overall Study|Progressive Disease|0|||
16856066|NCT01719380|37809267|FG003|Overall Study|Progressive Disease|0|||
16856067|NCT01719380|37809268|FG004|Overall Study|Progressive Disease|0|||
16856068|NCT01719380|37809269|FG005|Overall Study|Progressive Disease|0|||
16856069|NCT01719380|37809270|FG006|Overall Study|Progressive Disease|0|||
16856070|NCT01719380|37809271|FG007|Overall Study|Progressive Disease|0|||
16856071|NCT01719380|37809272|FG008|Overall Study|Progressive Disease|1|||
16856072|NCT01719380|37809273|FG009|Overall Study|Progressive Disease|0|||
16856073|NCT01743560|37809323|FG000|Overall Study|Disease progression|26|||
16856074|NCT01743560|37809323|FG000|Overall Study|Adverse Event|8|||
16856075|NCT01743560|37809323|FG000|Overall Study|Death|3|||
16856076|NCT01743560|37809323|FG000|Overall Study|Withdrawal by Subject|2|||
16856077|NCT01743560|37809323|FG000|Overall Study|Protocol Violation|1|||
16856078|NCT01743560|37809323|FG000|Overall Study|>1 dose of study drug|3|||
16856079|NCT01743092|37809353|FG000|Overall Study|Lost to Follow-up|14|||
16856080|NCT01743092|37809354|FG001|Overall Study|Lost to Follow-up|15|||
16856081|NCT01780831|37809387|FG000|Overall Study|Withdrawal by Subject|0|||
16856082|NCT01780831|37809388|FG001|Overall Study|Withdrawal by Subject|0|||
16856083|NCT01780831|37809389|FG002|Overall Study|Withdrawal by Subject|4|||
16856084|NCT01780831|37809390|FG003|Overall Study|Withdrawal by Subject|0|||
16856085|NCT01780831|37809387|FG000|Overall Study|Lost to Follow-up|0|||
16856086|NCT01780831|37809388|FG001|Overall Study|Lost to Follow-up|0|||
16856087|NCT01780831|37809389|FG002|Overall Study|Lost to Follow-up|0|||
16856088|NCT01780831|37809390|FG003|Overall Study|Lost to Follow-up|1|||
16856089|NCT01778023|37809449|FG000|Overall Study|Withdrawal by Subject|0|||
16856090|NCT01778023|37809450|FG001|Overall Study|Withdrawal by Subject|3|||
16856091|NCT01777321|37809458|FG000|Overall Study|Withdrawal by Subject|0|||
16856092|NCT01777321|37809459|FG001|Overall Study|Withdrawal by Subject|1|||
16856093|NCT01729819|37809467|FG000|Overall Study|Adverse Event|2|||
16856094|NCT01729819|37809468|FG001|Overall Study|Adverse Event|4|||
16856095|NCT01729819|37809467|FG000|Overall Study|Lack of Efficacy|1|||
16856096|NCT01729819|37809468|FG001|Overall Study|Lack of Efficacy|0|||
16856097|NCT01729819|37809467|FG000|Overall Study|Lost to Follow-up|2|||
16856098|NCT01729819|37809468|FG001|Overall Study|Lost to Follow-up|0|||
16856099|NCT01729819|37809467|FG000|Overall Study|Other reason|1|||
16856100|NCT01729819|37809468|FG001|Overall Study|Other reason|0|||
16856101|NCT01729819|37809467|FG000|Overall Study|Protocol Violation|0|||
16856102|NCT01729819|37809468|FG001|Overall Study|Protocol Violation|1|||
16856103|NCT01729819|37809467|FG000|Overall Study|Withdrawal by Subject|0|||
16856104|NCT01729819|37809468|FG001|Overall Study|Withdrawal by Subject|2|||
16856105|NCT01776541|37809479|FG000|Overall Study|Administrative Reason|6|||
16856106|NCT01776541|37809480|FG001|Overall Study|Administrative Reason|2|||
16856107|NCT01776541|37809479|FG000|Overall Study|Death|4|||
16856108|NCT01776541|37809480|FG001|Overall Study|Death|0|||
16856109|NCT01776541|37809479|FG000|Overall Study|Lost to Follow-up|27|||
16856110|NCT01776541|37809480|FG001|Overall Study|Lost to Follow-up|48|||
16856111|NCT01776541|37809479|FG000|Overall Study|Unclassified|5|||
16856112|NCT01776541|37809480|FG001|Overall Study|Unclassified|4|||
16856113|NCT01776541|37809479|FG000|Overall Study|Protocol Violation|2|||
16856114|NCT01776541|37809480|FG001|Overall Study|Protocol Violation|1|||
16856115|NCT01776541|37809479|FG000|Overall Study|Withdrawal by Subject|12|||
16856116|NCT01776541|37809480|FG001|Overall Study|Withdrawal by Subject|20|||
16856117|NCT01742078|37809509|FG000|Overall Study|Withdrawal by Subject|0|||
16856118|NCT01742078|37809510|FG001|Overall Study|Withdrawal by Subject|0|||
16856119|NCT01742078|37809511|FG002|Overall Study|Withdrawal by Subject|0|||
16856120|NCT01742078|37809512|FG003|Overall Study|Withdrawal by Subject|1|||
16856121|NCT01742078|37809513|FG004|Overall Study|Withdrawal by Subject|0|||
16856122|NCT01742078|37809514|FG005|Overall Study|Withdrawal by Subject|0|||
16856123|NCT01742078|37809515|FG006|Overall Study|Withdrawal by Subject|0|||
16856124|NCT01742078|37809516|FG007|Overall Study|Withdrawal by Subject|0|||
16856125|NCT01742078|37809517|FG008|Overall Study|Withdrawal by Subject|0|||
17028018|NCT00587288|38172396|FG000|Overall Study|Lack of Efficacy|2|||
16856126|NCT01741688|37809539|FG000|Overall Study|Lack of insurance coverage|2|||
16856127|NCT01741688|37809539|FG000|Overall Study|Withdrawal by Subject|1|||
16856128|NCT01709084|37809546|FG000|Overall Study|Lost to Follow-up|4|||
16856129|NCT01709084|37809547|FG001|Overall Study|Lost to Follow-up|7|||
16856130|NCT01709084|37809546|FG000|Overall Study|Withdrawal by Subject|2|||
16856131|NCT01709084|37809547|FG001|Overall Study|Withdrawal by Subject|2|||
16856132|NCT01709084|37809546|FG000|Overall Study|Adverse Event|5|||
16856133|NCT01709084|37809547|FG001|Overall Study|Adverse Event|0|||
16856134|NCT01709084|37809546|FG000|Overall Study|Other|5|||
16856135|NCT01709084|37809547|FG001|Overall Study|Other|3|||
16856136|NCT01709084|37809546|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
16856137|NCT01709084|37809547|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
16856138|NCT01709084|37809546|FG000|Overall Study|Not Treated|0|||
16856139|NCT01709084|37809547|FG001|Overall Study|Not Treated|2|||
16856140|NCT01776307|37809556|FG000|Overall Study|Not dosed|0|||
16856141|NCT01776307|37809557|FG001|Overall Study|Not dosed|0|||
16856142|NCT01776307|37809558|FG002|Overall Study|Not dosed|1|||
16856143|NCT01729039|37809589|FG000|Overall Study|disqualified|2|||
16856144|NCT01729039|37809590|FG001|Overall Study|disqualified|5|||
16856145|NCT01729039|37809589|FG000|Overall Study|Withdrawal by Subject|8|||
16856146|NCT01729039|37809590|FG001|Overall Study|Withdrawal by Subject|7|||
16856147|NCT01775995|37809601|FG000|Overall Study|Lost to Follow-up|1|||
16856148|NCT01775995|37809602|FG001|Overall Study|Lost to Follow-up|1|||
16856149|NCT01741532|37809610|FG000|Overall Study|Adverse Event|4|||
16856150|NCT01741532|37809611|FG001|Overall Study|Adverse Event|0|||
16856151|NCT01741532|37809610|FG000|Overall Study|Withdrawal by Subject|1|||
16856152|NCT01741532|37809611|FG001|Overall Study|Withdrawal by Subject|1|||
16856153|NCT01741532|37809610|FG000|Overall Study|Protocol Violation|0|||
16856154|NCT01741532|37809611|FG001|Overall Study|Protocol Violation|1|||
16856155|NCT01741532|37809610|FG000|Overall Study|Worsening of the disease|3|||
16856156|NCT01741532|37809611|FG001|Overall Study|Worsening of the disease|1|||
16856157|NCT01741532|37809610|FG000|Overall Study|Sponsor decision|1|||
16856158|NCT01741532|37809611|FG001|Overall Study|Sponsor decision|0|||
16856159|NCT01741532|37809610|FG000|Overall Study|Medical event|1|||
16856160|NCT01741532|37809611|FG001|Overall Study|Medical event|0|||
16856161|NCT01719224|37809621|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
16856162|NCT01719224|37809622|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
16856163|NCT01717976|37809633|FG000|Overall Study|Protocol Violation|0|||
16856164|NCT01717976|37809634|FG001|Overall Study|Protocol Violation|1|||
16856165|NCT01740440|37809640|FG000|Overall Study|Lost to Follow-up|3|||
16856166|NCT01740128|37809647|FG000|Overall Study|Pregnancy|0|||
16856167|NCT01740128|37809648|FG001|Overall Study|Pregnancy|1|||
16856168|NCT01740128|37809647|FG000|Overall Study|Protocol Violation|1|||
16856169|NCT01740128|37809648|FG001|Overall Study|Protocol Violation|2|||
16856170|NCT01740128|37809647|FG000|Overall Study|Lost to Follow-up|2|||
16856171|NCT01740128|37809648|FG001|Overall Study|Lost to Follow-up|2|||
16856172|NCT01740128|37809647|FG000|Overall Study|Withdrawal by Subject|1|||
16856173|NCT01740128|37809648|FG001|Overall Study|Withdrawal by Subject|0|||
16856174|NCT01740128|37809647|FG000|Overall Study|Insufficient protocol compliance|2|||
16856175|NCT01740128|37809648|FG001|Overall Study|Insufficient protocol compliance|2|||
16856176|NCT01976741|37809664|FG000|Overall Study|Withdrawal by Subject|1|||
16856177|NCT01976741|37809665|FG001|Overall Study|Withdrawal by Subject|0|||
16856178|NCT01976741|37809666|FG002|Overall Study|Withdrawal by Subject|1|||
16856179|NCT01976741|37809667|FG003|Overall Study|Withdrawal by Subject|1|||
16856180|NCT01976741|37809668|FG004|Overall Study|Withdrawal by Subject|0|||
16941342|NCT01202188|38085895|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
16941343|NCT01202188|38085891|FG000|Overall Study|Lost to Follow-up|1|||
16941344|NCT01202188|38085892|FG001|Overall Study|Lost to Follow-up|1|||
16941345|NCT01202188|38085893|FG002|Overall Study|Lost to Follow-up|0|||
16941346|NCT01202188|38085894|FG003|Overall Study|Lost to Follow-up|4|||
16941347|NCT01202188|38085895|FG004|Overall Study|Lost to Follow-up|1|||
16941348|NCT01202188|38085891|FG000|Overall Study|Death|1|||
16941349|NCT01202188|38085892|FG001|Overall Study|Death|1|||
16941350|NCT01202188|38085893|FG002|Overall Study|Death|1|||
16856181|NCT01976741|37809669|FG005|Overall Study|Withdrawal by Subject|0|||
16856182|NCT01976741|37809670|FG006|Overall Study|Withdrawal by Subject|1|||
16856183|NCT01976741|37809671|FG007|Overall Study|Withdrawal by Subject|4|||
16856184|NCT01976741|37809672|FG008|Overall Study|Withdrawal by Subject|0|||
16856185|NCT01976741|37809673|FG009|Overall Study|Withdrawal by Subject|0|||
16856186|NCT01976741|37809664|FG000|Overall Study|Adverse Event|0|||
16856187|NCT01976741|37809665|FG001|Overall Study|Adverse Event|0|||
16856188|NCT01976741|37809666|FG002|Overall Study|Adverse Event|2|||
16856189|NCT01976741|37809667|FG003|Overall Study|Adverse Event|0|||
16941351|NCT01202188|38085894|FG003|Overall Study|Death|1|||
16941352|NCT01202188|38085895|FG004|Overall Study|Death|0|||
16856190|NCT01976741|37809668|FG004|Overall Study|Adverse Event|0|||
16856191|NCT01976741|37809669|FG005|Overall Study|Adverse Event|0|||
16856192|NCT01976741|37809670|FG006|Overall Study|Adverse Event|3|||
16856193|NCT01976741|37809671|FG007|Overall Study|Adverse Event|8|||
16941353|NCT01202188|38085891|FG000|Overall Study|Abnormal test procedure result (s)|0|||
16856194|NCT01976741|37809672|FG008|Overall Study|Adverse Event|1|||
16856195|NCT01976741|37809673|FG009|Overall Study|Adverse Event|4|||
16856196|NCT01727713|37809707|FG000|Overall Study|Lost to Follow-up|5|||
16856197|NCT01727713|37809707|FG000|Overall Study|Adverse Event|10|||
16856198|NCT01727713|37809707|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
16856199|NCT01727713|37809707|FG000|Overall Study|Withdrawal by Subject|13|||
16856200|NCT01727713|37809707|FG000|Overall Study|Protocol Deviation|2|||
16856201|NCT01965431|37809711|FG000|Overall Study|Adverse Event|0|||
16856202|NCT01965431|37809712|FG001|Overall Study|Adverse Event|1|||
16856203|NCT01965431|37809713|FG002|Overall Study|Adverse Event|0|||
16856204|NCT01965431|37809714|FG003|Overall Study|Adverse Event|0|||
16856205|NCT01965431|37809715|FG004|Overall Study|Adverse Event|0|||
16856206|NCT01965431|37809716|FG005|Overall Study|Adverse Event|0|||
16856207|NCT01965431|37809711|FG000|Overall Study|Other than stated above|6|||
16856208|NCT01965431|37809712|FG001|Overall Study|Other than stated above|5|||
16856209|NCT01965431|37809713|FG002|Overall Study|Other than stated above|6|||
16856210|NCT01965431|37809714|FG003|Overall Study|Other than stated above|6|||
16856211|NCT01965431|37809715|FG004|Overall Study|Other than stated above|6|||
16856212|NCT01965431|37809716|FG005|Overall Study|Other than stated above|6|||
16856213|NCT01976663|37809726|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
16856214|NCT01976663|37809726|FG000|Overall Study|Personal Reasons|6|||
16856215|NCT01976663|37809726|FG000|Overall Study|Withdrawal by Subject|4|||
16856216|NCT01976663|37809726|FG000|Overall Study|Screen Failure|3|||
16856217|NCT01976663|37809726|FG000|Overall Study|Adverse Event|2|||
16856218|NCT01976663|37809726|FG000|Overall Study|Lost to Follow-up|3|||
16856219|NCT01775137|37809734|FG000|Overall Study|Death|1|||
16856220|NCT01775137|37809734|FG000|Overall Study|Protocol deviation|2|||
16856221|NCT01775137|37809734|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16856222|NCT01775137|37809734|FG000|Overall Study|Adverse Event|1|||
16941354|NCT01202188|38085892|FG001|Overall Study|Abnormal test procedure result (s)|0|||
17028019|NCT00587288|38172397|FG001|Overall Study|Lack of Efficacy|8|||
17028020|NCT00587288|38172396|FG000|Overall Study|Protocol Violation|1|||
17028021|NCT00587288|38172397|FG001|Overall Study|Protocol Violation|0|||
17028022|NCT00800735|38172405|FG000|Overall Study|Administrative/Other|2|||
17028023|NCT00800735|38172405|FG000|Overall Study|Insufficient Therapeutic Response|2|||
17028024|NCT00800735|38172405|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
17028025|NCT00800735|38172405|FG000|Overall Study|Withdrew Consent|3|||
17028026|NCT00730158|38172411|FG000|Overall Study|Withdrawal by Subject|1|||
17028027|NCT00730158|38172412|FG001|Overall Study|Withdrawal by Subject|1|||
17028028|NCT00784550|38172424|FG000|Overall Study|Adverse Event|12|||
17028029|NCT00784550|38172425|FG001|Overall Study|Adverse Event|10|||
17028030|NCT00784550|38172424|FG000|Overall Study|Lack of Efficacy|0|||
17028031|NCT00784550|38172425|FG001|Overall Study|Lack of Efficacy|1|||
17028032|NCT00784550|38172424|FG000|Overall Study|Protocol Violation|10|||
17028033|NCT00784550|38172425|FG001|Overall Study|Protocol Violation|10|||
17028034|NCT00784550|38172424|FG000|Overall Study|Lost to Follow-up|8|||
17028035|NCT00784550|38172425|FG001|Overall Study|Lost to Follow-up|5|||
17028036|NCT00784550|38172424|FG000|Overall Study|Physician Decision|2|||
16941355|NCT01202188|38085893|FG002|Overall Study|Abnormal test procedure result (s)|2|||
16941356|NCT01202188|38085894|FG003|Overall Study|Abnormal test procedure result (s)|0|||
16941357|NCT01202188|38085895|FG004|Overall Study|Abnormal test procedure result (s)|0|||
17028037|NCT00784550|38172425|FG001|Overall Study|Physician Decision|3|||
17028038|NCT00784550|38172424|FG000|Overall Study|Withdrawal by Subject|4|||
17028039|NCT00784550|38172425|FG001|Overall Study|Withdrawal by Subject|13|||
17028040|NCT00729690|38172434|FG000|Overall Study|IT Catheter Malfunction|0|||
17028041|NCT00729690|38172435|FG001|Overall Study|IT Catheter Malfunction|2|||
17028042|NCT00729690|38172436|FG002|Overall Study|IT Catheter Malfunction|2|||
16856223|NCT01775137|37809734|FG000|Overall Study|Withdrawal by participants|5|||
16856224|NCT01976507|37809741|FG000|Overall Study|Adverse Event|6|||
16941358|NCT01201915|38085916|FG000|Overall Study|Adverse Event|2|||
16941359|NCT01201915|38085917|FG001|Overall Study|Adverse Event|1|||
16941360|NCT01201915|38085918|FG002|Overall Study|Adverse Event|1|||
16941361|NCT01201915|38085916|FG000|Overall Study|Lost to Follow-up|0|||
16941362|NCT01201915|38085917|FG001|Overall Study|Lost to Follow-up|4|||
16941363|NCT01201915|38085918|FG002|Overall Study|Lost to Follow-up|0|||
16941364|NCT01201915|38085916|FG000|Overall Study|Physician Decision|3|||
16941365|NCT01201915|38085917|FG001|Overall Study|Physician Decision|0|||
16941366|NCT01201915|38085918|FG002|Overall Study|Physician Decision|0|||
16941367|NCT01201915|38085916|FG000|Overall Study|Subject Decision|3|||
16941368|NCT01201915|38085917|FG001|Overall Study|Subject Decision|3|||
16941369|NCT01201915|38085918|FG002|Overall Study|Subject Decision|5|||
16941370|NCT01201915|38085916|FG000|Overall Study|Target Lesion Progression|0|||
16941371|NCT01201915|38085917|FG001|Overall Study|Target Lesion Progression|3|||
16941372|NCT01201915|38085918|FG002|Overall Study|Target Lesion Progression|0|||
16941373|NCT01179919|38085926|FG000|Overall Study|Protocol Violation|1|||
16941374|NCT01179919|38085926|FG000|Overall Study|Adverse Event|1|||
16941375|NCT01201798|38085932|FG000|Overall Study|Adverse Event|2|||
16941376|NCT01201798|38085933|FG001|Overall Study|Adverse Event|0|||
16856225|NCT01976507|37809741|FG000|Overall Study|ablation not done, drug not given|1|||
16856226|NCT01964963|37809745|FG000|Overall Study|Case Report Forms Uncollected|888|||
16856227|NCT01964963|37809745|FG000|Overall Study|Protocol Deviation|50|||
16856228|NCT01964963|37809745|FG000|Overall Study|Data Reliability was not Assured|5|||
16856229|NCT01964105|37809752|FG000|Overall Study|Lost to Follow-up|2|||
16856230|NCT01964105|37809753|FG001|Overall Study|Lost to Follow-up|13|||
16856231|NCT01964105|37809754|FG002|Overall Study|Lost to Follow-up|0|||
16856232|NCT01974323|37809764|FG000|Overall Study|Other Reasons|25|||
16856233|NCT01974323|37809765|FG001|Overall Study|Other Reasons|28|||
16856234|NCT01974323|37809764|FG000|Overall Study|Protocol Violation|2|||
16856235|NCT01974323|37809765|FG001|Overall Study|Protocol Violation|2|||
16856236|NCT01974323|37809764|FG000|Overall Study|Personal Reasons|15|||
16856237|NCT01974323|37809765|FG001|Overall Study|Personal Reasons|19|||
16856238|NCT01974323|37809764|FG000|Overall Study|Lost to Follow-up|45|||
16856239|NCT01974323|37809765|FG001|Overall Study|Lost to Follow-up|40|||
16856240|NCT01974323|37809764|FG000|Overall Study|Pregnancy|2|||
16856241|NCT01974323|37809765|FG001|Overall Study|Pregnancy|1|||
16856242|NCT01974323|37809764|FG000|Overall Study|Lack of Efficacy|1|||
16856243|NCT01974323|37809765|FG001|Overall Study|Lack of Efficacy|1|||
16856244|NCT01974323|37809764|FG000|Overall Study|Adverse Event|2|||
16856245|NCT01974323|37809765|FG001|Overall Study|Adverse Event|2|||
16856246|NCT01963403|37809773|FG000|Overall Study|Lost to Follow-up|2|||
16856247|NCT01963403|37809774|FG001|Overall Study|Lost to Follow-up|3|||
16856248|NCT01963403|37809773|FG000|Overall Study|Implant removal|0|||
16856249|NCT01963403|37809774|FG001|Overall Study|Implant removal|1|||
16856250|NCT01973387|37809784|FG000|Overall Study|Adverse Event|14|||
16856251|NCT01973387|37809785|FG001|Overall Study|Adverse Event|4|||
16856252|NCT01973387|37809784|FG000|Overall Study|Withdrawal by Subject|7|||
16941377|NCT01201798|38085932|FG000|Overall Study|Lost to Follow-up|3|||
16941378|NCT01201798|38085933|FG001|Overall Study|Lost to Follow-up|5|||
16941379|NCT01201798|38085932|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
16941380|NCT01201798|38085933|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
16941381|NCT01201798|38085932|FG000|Overall Study|Noncompliance|1|||
16941382|NCT01201798|38085933|FG001|Overall Study|Noncompliance|0|||
16941383|NCT01201798|38085932|FG000|Overall Study|Protocol Violation|1|||
16941384|NCT01201798|38085933|FG001|Overall Study|Protocol Violation|1|||
16941385|NCT01201798|38085932|FG000|Overall Study|Treatment Failure|1|||
16941386|NCT01201798|38085933|FG001|Overall Study|Treatment Failure|8|||
16941387|NCT01201759|38085941|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
16941388|NCT01201759|38085942|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
16941389|NCT01201759|38085941|FG000|Visit 3 - Washout|Adverse Event|0|||
16941390|NCT01201759|38085942|FG001|Visit 3 - Washout|Adverse Event|3|||
16941391|NCT01201759|38085941|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
16941392|NCT01201759|38085942|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
17028043|NCT00784238|38172444|FG000|Overall Study|Adverse Event|14|||
17028044|NCT00784238|38172444|FG000|Overall Study|Death|2|||
16941393|NCT01201759|38085941|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
16941394|NCT01201759|38085942|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
16941395|NCT01200589|38085952|FG000|Overall Study|Withdrawal by Subject|13|||
16941396|NCT01200589|38085953|FG001|Overall Study|Withdrawal by Subject|11|||
16941397|NCT01200589|38085952|FG000|Overall Study|Physician Decision|2|||
16856253|NCT01973387|37809785|FG001|Overall Study|Withdrawal by Subject|4|||
16856254|NCT01973387|37809784|FG000|Overall Study|Study terminated by sponsor|63|||
16856255|NCT01973387|37809785|FG001|Overall Study|Study terminated by sponsor|0|||
16856256|NCT01973387|37809784|FG000|Overall Study|Progressive disease or relapse|16|||
16856257|NCT01973387|37809785|FG001|Overall Study|Progressive disease or relapse|5|||
16856258|NCT01973387|37809784|FG000|Overall Study|Death|4|||
16856259|NCT01973387|37809785|FG001|Overall Study|Death|3|||
16856260|NCT01973387|37809784|FG000|Overall Study|Randomized, not treated|2|||
16856261|NCT01973387|37809785|FG001|Overall Study|Randomized, not treated|2|||
16856262|NCT01973231|37809793|FG000|Overall Study|Protocol Violation|1|||
16856263|NCT01973231|37809794|FG001|Overall Study|Protocol Violation|1|||
16856264|NCT01973231|37809793|FG000|Overall Study|Lost to Follow-up|1|||
16856265|NCT01973231|37809794|FG001|Overall Study|Lost to Follow-up|1|||
16856266|NCT01973231|37809793|FG000|Overall Study|unclassified|2|||
16856267|NCT01973231|37809794|FG001|Overall Study|unclassified|1|||
16856268|NCT01973231|37809793|FG000|Overall Study|Withdrawal by Subject|7|||
16856269|NCT01973231|37809794|FG001|Overall Study|Withdrawal by Subject|9|||
16856270|NCT01961687|37809800|FG000|Overall Study|Lost to Follow-up|19|||
16856271|NCT01961687|37809800|FG000|Overall Study|Re-operation|17|||
16941398|NCT01200589|38085953|FG001|Overall Study|Physician Decision|2|||
16941399|NCT01200589|38085952|FG000|Overall Study|Lost to Follow-up|5|||
16856272|NCT01961687|37809800|FG000|Overall Study|Death|7|||
16856273|NCT01961687|37809800|FG000|Overall Study|Withdrawal by Subject|6|||
16856274|NCT01961687|37809800|FG000|Overall Study|Adverse Event|6|||
16856275|NCT01961687|37809800|FG000|Overall Study|Moved to area without study site|2|||
16856276|NCT01961687|37809800|FG000|Overall Study|Sponsor decision|2|||
16856277|NCT01961687|37809800|FG000|Overall Study|Physician Decision|1|||
17028045|NCT00784238|38172444|FG000|Overall Study|Lack of Efficacy|33|||
16856278|NCT01961687|37809800|FG000|Overall Study|Unable to meet follow-up requirements|1|||
16856279|NCT01961609|37809862|FG000|Initiation|Missing|3|||
16856280|NCT01961609|37809863|FG001|Initiation|Missing|2|||
16856281|NCT01961609|37809864|FG002|Initiation|Missing|0|||
16856282|NCT01961609|37809865|FG003|Initiation|Missing|0|||
16856283|NCT01961609|37809862|FG000|Initiation|Protocol deviation|1|||
16856284|NCT01961609|37809863|FG001|Initiation|Protocol deviation|0|||
16856285|NCT01961609|37809864|FG002|Initiation|Protocol deviation|0|||
16856286|NCT01961609|37809865|FG003|Initiation|Protocol deviation|0|||
16856287|NCT01961609|37809862|FG000|Initiation|Death|0|||
16856288|NCT01961609|37809863|FG001|Initiation|Death|1|||
16856289|NCT01961609|37809864|FG002|Initiation|Death|0|||
16856290|NCT01961609|37809865|FG003|Initiation|Death|0|||
16856291|NCT01961609|37809862|FG000|Initiation|Administrative problems|1|||
16856292|NCT01961609|37809863|FG001|Initiation|Administrative problems|0|||
16856293|NCT01961609|37809864|FG002|Initiation|Administrative problems|0|||
16856294|NCT01961609|37809865|FG003|Initiation|Administrative problems|0|||
16856295|NCT01961609|37809862|FG000|Initiation|Withdrawal by Subject|1|||
16856296|NCT01961609|37809863|FG001|Initiation|Withdrawal by Subject|2|||
16856297|NCT01961609|37809864|FG002|Initiation|Withdrawal by Subject|0|||
16856298|NCT01961609|37809865|FG003|Initiation|Withdrawal by Subject|0|||
16856299|NCT01961609|37809862|FG000|Initiation|Lack of Efficacy|2|||
16856300|NCT01961609|37809863|FG001|Initiation|Lack of Efficacy|1|||
16856301|NCT01961609|37809864|FG002|Initiation|Lack of Efficacy|0|||
16856302|NCT01961609|37809865|FG003|Initiation|Lack of Efficacy|0|||
16856303|NCT01961609|37809862|FG000|Initiation|Abnormal lab values|0|||
16856304|NCT01961609|37809863|FG001|Initiation|Abnormal lab values|1|||
16856305|NCT01961609|37809864|FG002|Initiation|Abnormal lab values|0|||
16856306|NCT01961609|37809865|FG003|Initiation|Abnormal lab values|0|||
16856307|NCT01961609|37809862|FG000|Initiation|Adverse Event|3|||
16856308|NCT01961609|37809863|FG001|Initiation|Adverse Event|5|||
16856309|NCT01961609|37809864|FG002|Initiation|Adverse Event|0|||
16856310|NCT01961609|37809865|FG003|Initiation|Adverse Event|0|||
16856311|NCT01961609|37809862|FG000|Initiation|Randomized but not treated|1|||
16856312|NCT01961609|37809863|FG001|Initiation|Randomized but not treated|1|||
16856313|NCT01961609|37809864|FG002|Initiation|Randomized but not treated|0|||
16856314|NCT01961609|37809865|FG003|Initiation|Randomized but not treated|0|||
16856315|NCT01961609|37809862|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
16856316|NCT01961609|37809863|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
16856317|NCT01961609|37809864|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
16856318|NCT01961609|37809865|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
16856319|NCT01961609|37809862|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
16856320|NCT01961609|37809863|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
16856321|NCT01961609|37809864|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
16856322|NCT01961609|37809865|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
16941400|NCT01200589|38085953|FG001|Overall Study|Lost to Follow-up|4|||
16856323|NCT01961609|37809862|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
16856324|NCT01961609|37809863|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
16856325|NCT01961609|37809864|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
16941401|NCT01200589|38085952|FG000|Overall Study|Study terminated|170|||
16941402|NCT01200589|38085953|FG001|Overall Study|Study terminated|172|||
16941403|NCT01200511|38085959|FG000|Overall Study|Lost to Follow-up|3|||
16941404|NCT01200511|38085959|FG000|Overall Study|Withdrawal by Subject|1|||
16941405|NCT01200511|38085959|FG000|Overall Study|Adverse Event|1|||
16941406|NCT01179334|38085967|FG000|Treatment Period|Adverse Event|1|||
16941407|NCT01179334|38085968|FG001|Treatment Period|Adverse Event|0|||
16941408|NCT01179334|38085967|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
16941409|NCT01179334|38085968|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
16941410|NCT01179334|38085967|FG000|Long-term Extension (LTE) Period|Death|3|||
16941411|NCT01179334|38085968|FG001|Long-term Extension (LTE) Period|Death|0|||
16941412|NCT01179334|38085967|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
16941413|NCT01179334|38085968|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
16941414|NCT01178671|38085976|FG000|Overall Study|Adverse Event|4|||
16941415|NCT01178671|38085977|FG001|Overall Study|Adverse Event|6|||
16941416|NCT01178671|38085976|FG000|Overall Study|Protocol Violation|1|||
16941417|NCT01178671|38085977|FG001|Overall Study|Protocol Violation|1|||
16941418|NCT01178671|38085976|FG000|Overall Study|Lack of Efficacy|0|||
16941419|NCT01178671|38085977|FG001|Overall Study|Lack of Efficacy|1|||
16941420|NCT01178671|38085976|FG000|Overall Study|Lost to Follow-up|3|||
16941421|NCT01178671|38085977|FG001|Overall Study|Lost to Follow-up|1|||
16941422|NCT01178671|38085976|FG000|Overall Study|Physician Decision|4|||
16941423|NCT01178671|38085977|FG001|Overall Study|Physician Decision|6|||
16941424|NCT01178125|38085983|FG000|Overall Study|Lost to Follow-up|397|||
16941425|NCT01178125|38085983|FG000|Overall Study|Adverse Event|244|||
16941426|NCT01178125|38085983|FG000|Overall Study|Withdrawal by Subject|209|||
16941427|NCT01178125|38085983|FG000|Overall Study|Noncompliance|184|||
16856326|NCT01961609|37809865|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
16856327|NCT01961609|37809862|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
16856328|NCT01961609|37809863|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
16856329|NCT01961609|37809864|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
16856330|NCT01961609|37809865|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
16856331|NCT01961609|37809862|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
16856332|NCT01961609|37809863|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
16856333|NCT01961609|37809864|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
16856334|NCT01961609|37809865|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
16856335|NCT01961609|37809862|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
16856336|NCT01961609|37809863|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
16856337|NCT01961609|37809864|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
16856338|NCT01961609|37809865|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
16856339|NCT01961609|37809862|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
16856340|NCT01961609|37809863|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
16856341|NCT01961609|37809864|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
16856342|NCT01961609|37809865|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
16856343|NCT01961609|37809862|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
16856344|NCT01961609|37809863|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
16856345|NCT01961609|37809864|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
16856346|NCT01961609|37809865|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
16856347|NCT01961609|37809862|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
16856348|NCT01961609|37809863|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
16856349|NCT01961609|37809864|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
16856350|NCT01961609|37809865|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
16856351|NCT01961609|37809862|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
16856352|NCT01961609|37809863|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
16856353|NCT01961609|37809864|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
16856354|NCT01961609|37809865|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
16856355|NCT01961609|37809862|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
16856356|NCT01961609|37809863|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
16856357|NCT01961609|37809864|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
16856358|NCT01961609|37809865|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
16856359|NCT01961609|37809862|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
16856360|NCT01961609|37809863|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
16856361|NCT01961609|37809864|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
16856362|NCT01961609|37809865|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
16856363|NCT01774981|37809974|FG000|Overall Study|Adverse Event|0|||
16856364|NCT01774981|37809975|FG001|Overall Study|Adverse Event|0|||
16856365|NCT01774981|37809976|FG002|Overall Study|Adverse Event|0|||
16856366|NCT01774981|37809977|FG003|Overall Study|Adverse Event|0|||
16856367|NCT01774981|37809978|FG004|Overall Study|Adverse Event|0|||
16856368|NCT01774981|37809979|FG005|Overall Study|Adverse Event|1|||
16856369|NCT01774981|37809980|FG006|Overall Study|Adverse Event|0|||
16856370|NCT01774981|37809981|FG007|Overall Study|Adverse Event|0|||
16856371|NCT01774981|37809974|FG000|Overall Study|Withdrawal by Subject|0|||
16856372|NCT01774981|37809975|FG001|Overall Study|Withdrawal by Subject|0|||
16856373|NCT01774981|37809976|FG002|Overall Study|Withdrawal by Subject|0|||
16856374|NCT01774981|37809977|FG003|Overall Study|Withdrawal by Subject|0|||
16856375|NCT01774981|37809978|FG004|Overall Study|Withdrawal by Subject|0|||
16856376|NCT01774981|37809979|FG005|Overall Study|Withdrawal by Subject|0|||
16856377|NCT01774981|37809980|FG006|Overall Study|Withdrawal by Subject|0|||
16856378|NCT01774981|37809981|FG007|Overall Study|Withdrawal by Subject|1|||
16856379|NCT01774981|37809974|FG000|Overall Study|Death|0|||
16856380|NCT01774981|37809975|FG001|Overall Study|Death|0|||
16856381|NCT01774981|37809976|FG002|Overall Study|Death|0|||
16856382|NCT01774981|37809977|FG003|Overall Study|Death|0|||
16856383|NCT01774981|37809978|FG004|Overall Study|Death|1|||
16856384|NCT01774981|37809979|FG005|Overall Study|Death|0|||
16856385|NCT01774981|37809980|FG006|Overall Study|Death|0|||
16856386|NCT01774981|37809981|FG007|Overall Study|Death|0|||
16856387|NCT01972841|37810010|FG000|Overall Study|Randomized but Never Received Treatment|2|||
16856388|NCT01972841|37810011|FG001|Overall Study|Randomized but Never Received Treatment|5|||
16856389|NCT01972841|37810012|FG002|Overall Study|Randomized but Never Received Treatment|4|||
16856390|NCT01972841|37810013|FG003|Overall Study|Randomized but Never Received Treatment|2|||
16856391|NCT01972841|37810014|FG004|Overall Study|Randomized but Never Received Treatment|6|||
16856392|NCT01972841|37810015|FG005|Overall Study|Randomized but Never Received Treatment|13|||
16856393|NCT01972841|37810010|FG000|Overall Study|Adverse Event|13|||
16856394|NCT01972841|37810011|FG001|Overall Study|Adverse Event|8|||
16856395|NCT01972841|37810012|FG002|Overall Study|Adverse Event|12|||
16856396|NCT01972841|37810013|FG003|Overall Study|Adverse Event|9|||
16856397|NCT01972841|37810014|FG004|Overall Study|Adverse Event|21|||
16856398|NCT01972841|37810015|FG005|Overall Study|Adverse Event|26|||
16856399|NCT01972841|37810010|FG000|Overall Study|Lack of Efficacy|1|||
16856400|NCT01972841|37810011|FG001|Overall Study|Lack of Efficacy|0|||
16856401|NCT01972841|37810012|FG002|Overall Study|Lack of Efficacy|0|||
16856402|NCT01972841|37810013|FG003|Overall Study|Lack of Efficacy|2|||
16941428|NCT01178125|38085983|FG000|Overall Study|Pregnancy|55|||
16941429|NCT01178125|38085983|FG000|Overall Study|Other Reason|39|||
16941430|NCT01178125|38085983|FG000|Overall Study|Sponsor Decision|28|||
16941431|NCT01178125|38085983|FG000|Overall Study|Protocol Violation|17|||
16941432|NCT01178125|38085983|FG000|Overall Study|Investigator Decision|5|||
16941433|NCT01178086|38086005|FG000|Overall Study|Participant refusal|7|||
16941434|NCT01178086|38086005|FG000|Overall Study|Physician Decision|44|||
16941435|NCT01178086|38086005|FG000|Overall Study|Switch to other CLL therapy|113|||
16941436|NCT01178086|38086005|FG000|Overall Study|Death|59|||
16941437|NCT01178086|38086005|FG000|Overall Study|Other unspecified|89|||
16941438|NCT01178086|38086005|FG000|Overall Study|Excluded from EAS|20|||
16941439|NCT01177969|38086013|FG000|Overall Study|Protocol Violation|2|||
16941440|NCT01177969|38086014|FG001|Overall Study|Protocol Violation|1|||
16941441|NCT01177969|38086013|FG000|Overall Study|Withdrawal by Subject|1|||
16941442|NCT01177969|38086014|FG001|Overall Study|Withdrawal by Subject|2|||
16941443|NCT01177813|38086025|FG000|Overall Study|Adverse Event|8|||
16941444|NCT01177813|38086026|FG001|Overall Study|Adverse Event|2|||
17028046|NCT00784238|38172444|FG000|Overall Study|Lost to Follow-up|29|||
17028047|NCT00784238|38172444|FG000|Overall Study|Pregnancy|1|||
17028048|NCT00784238|38172444|FG000|Overall Study|Withdrawal by Subject|26|||
17028049|NCT00784238|38172444|FG000|Overall Study|Other|14|||
17028050|NCT00729612|38172451|FG000|Overall Study|Non evaluable for response|10|||
17028051|NCT00585546|38172455|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
17028052|NCT00585546|38172455|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
17028053|NCT00768248|38172461|FG000|Overall Study|Research coordinator didn't collect data|1|||
17028054|NCT00768248|38172462|FG001|Overall Study|Research coordinator didn't collect data|1|||
17028055|NCT00775268|38172470|FG000|Baseline|Drug not synthesize dose|1|||
17028056|NCT00775268|38172471|FG001|Baseline|Drug not synthesize dose|0|||
17028057|NCT00775268|38172470|FG000|Baseline|Not treated-ineligible per CT|0|||
17028058|NCT00775268|38172471|FG001|Baseline|Not treated-ineligible per CT|1|||
16941445|NCT01177813|38086027|FG002|Overall Study|Adverse Event|4|||
17028059|NCT00775268|38172470|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
17028060|NCT00775268|38172471|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
17028061|NCT00775268|38172470|FG000|After Completion|Participant missed scan appointment|1|||
17028062|NCT00775268|38172471|FG001|After Completion|Participant missed scan appointment|0|||
17028063|NCT00775190|38172490|FG000|Overall Study|Lost to Follow-up|2|||
17028064|NCT00775190|38172491|FG001|Overall Study|Lost to Follow-up|3|||
17028065|NCT00775190|38172490|FG000|Overall Study|Withdrawal by Subject|1|||
17028066|NCT00775190|38172491|FG001|Overall Study|Withdrawal by Subject|2|||
16941446|NCT01177813|38086028|FG003|Overall Study|Adverse Event|6|||
16941447|NCT01177813|38086029|FG004|Overall Study|Adverse Event|3|||
16941448|NCT01177813|38086025|FG000|Overall Study|Lack of Efficacy|1|||
16941449|NCT01177813|38086026|FG001|Overall Study|Lack of Efficacy|0|||
16941450|NCT01177813|38086027|FG002|Overall Study|Lack of Efficacy|0|||
16941451|NCT01177813|38086028|FG003|Overall Study|Lack of Efficacy|0|||
16941452|NCT01177813|38086029|FG004|Overall Study|Lack of Efficacy|0|||
16856403|NCT01972841|37810014|FG004|Overall Study|Lack of Efficacy|4|||
16856404|NCT01972841|37810015|FG005|Overall Study|Lack of Efficacy|1|||
16856405|NCT01972841|37810010|FG000|Overall Study|Lost to Follow-up|4|||
16856406|NCT01972841|37810011|FG001|Overall Study|Lost to Follow-up|2|||
16856407|NCT01972841|37810012|FG002|Overall Study|Lost to Follow-up|4|||
16856408|NCT01972841|37810013|FG003|Overall Study|Lost to Follow-up|2|||
16856409|NCT01972841|37810014|FG004|Overall Study|Lost to Follow-up|9|||
16856410|NCT01972841|37810015|FG005|Overall Study|Lost to Follow-up|3|||
16856411|NCT01972841|37810010|FG000|Overall Study|Protocol Violation|2|||
16856412|NCT01972841|37810011|FG001|Overall Study|Protocol Violation|2|||
16856413|NCT01972841|37810012|FG002|Overall Study|Protocol Violation|3|||
16856414|NCT01972841|37810013|FG003|Overall Study|Protocol Violation|5|||
16856415|NCT01972841|37810014|FG004|Overall Study|Protocol Violation|9|||
16856416|NCT01972841|37810015|FG005|Overall Study|Protocol Violation|4|||
16856417|NCT01972841|37810010|FG000|Overall Study|Withdrawal by participants|21|||
16856418|NCT01972841|37810011|FG001|Overall Study|Withdrawal by participants|27|||
16856419|NCT01972841|37810012|FG002|Overall Study|Withdrawal by participants|23|||
16856420|NCT01972841|37810013|FG003|Overall Study|Withdrawal by participants|16|||
16856421|NCT01972841|37810014|FG004|Overall Study|Withdrawal by participants|33|||
16856422|NCT01972841|37810015|FG005|Overall Study|Withdrawal by participants|34|||
16941453|NCT01177813|38086025|FG000|Overall Study|Protocol Violation|3|||
16941454|NCT01177813|38086026|FG001|Overall Study|Protocol Violation|2|||
16941455|NCT01177813|38086027|FG002|Overall Study|Protocol Violation|2|||
16941456|NCT01177813|38086028|FG003|Overall Study|Protocol Violation|0|||
16941457|NCT01177813|38086029|FG004|Overall Study|Protocol Violation|1|||
16856423|NCT01972841|37810010|FG000|Overall Study|Miscellaneous|0|||
16856424|NCT01972841|37810011|FG001|Overall Study|Miscellaneous|0|||
16941458|NCT01177813|38086025|FG000|Overall Study|Lost to Follow-up|12|||
16941459|NCT01177813|38086026|FG001|Overall Study|Lost to Follow-up|5|||
16941460|NCT01177813|38086027|FG002|Overall Study|Lost to Follow-up|6|||
16941461|NCT01177813|38086028|FG003|Overall Study|Lost to Follow-up|3|||
16941462|NCT01177813|38086029|FG004|Overall Study|Lost to Follow-up|0|||
16941463|NCT01177813|38086025|FG000|Overall Study|Withdrawal by Subject|12|||
16941464|NCT01177813|38086026|FG001|Overall Study|Withdrawal by Subject|7|||
16941465|NCT01177813|38086027|FG002|Overall Study|Withdrawal by Subject|6|||
16941466|NCT01177813|38086028|FG003|Overall Study|Withdrawal by Subject|5|||
16941467|NCT01177813|38086029|FG004|Overall Study|Withdrawal by Subject|3|||
16941468|NCT01177813|38086025|FG000|Overall Study|Other reason not defined above|5|||
16941469|NCT01177813|38086026|FG001|Overall Study|Other reason not defined above|2|||
16941470|NCT01177813|38086027|FG002|Overall Study|Other reason not defined above|2|||
16941471|NCT01177813|38086028|FG003|Overall Study|Other reason not defined above|3|||
16941472|NCT01177813|38086029|FG004|Overall Study|Other reason not defined above|2|||
16941473|NCT01200394|38086043|FG000|Overall Study|Adverse Event|0|||
16941474|NCT01200394|38086044|FG001|Overall Study|Adverse Event|14|||
16941475|NCT01200394|38086043|FG000|Overall Study|Death|1|||
16941476|NCT01200394|38086044|FG001|Overall Study|Death|0|||
16941477|NCT01200394|38086043|FG000|Overall Study|Lost to Follow-up|0|||
16941478|NCT01200394|38086044|FG001|Overall Study|Lost to Follow-up|1|||
16941479|NCT01200394|38086043|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16941480|NCT01200394|38086044|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
16941481|NCT01200394|38086043|FG000|Overall Study|Protocol Violation|0|||
16941482|NCT01200394|38086044|FG001|Overall Study|Protocol Violation|3|||
16941483|NCT01200394|38086043|FG000|Overall Study|Withdrawal by Subject|0|||
16941484|NCT01200394|38086044|FG001|Overall Study|Withdrawal by Subject|5|||
16941485|NCT01200394|38086043|FG000|Overall Study|Other|0|||
16941486|NCT01200394|38086044|FG001|Overall Study|Other|1|||
16941487|NCT01200355|38086053|FG000|Overall Study|Death|7|||
16941488|NCT01200355|38086054|FG001|Overall Study|Death|2|||
16941489|NCT01200238|38086062|FG000|Overall Study|Adverse Event|2|||
16941490|NCT01200238|38086063|FG001|Overall Study|Adverse Event|1|||
16941491|NCT01200238|38086062|FG000|Overall Study|Progressive Disease|5|||
16941492|NCT01200238|38086063|FG001|Overall Study|Progressive Disease|8|||
16941493|NCT01200238|38086062|FG000|Overall Study|Withdrawal by Subject|0|||
16941494|NCT01200238|38086063|FG001|Overall Study|Withdrawal by Subject|1|||
16941495|NCT01199731|38086072|FG000|Overall Study|Adverse Event|0|||
16941496|NCT01199731|38086073|FG001|Overall Study|Adverse Event|1|||
16941497|NCT01199731|38086074|FG002|Overall Study|Adverse Event|0|||
16941498|NCT01199731|38086072|FG000|Overall Study|Study closed/terminated|7|||
16941499|NCT01199731|38086073|FG001|Overall Study|Study closed/terminated|9|||
16941500|NCT01199731|38086074|FG002|Overall Study|Study closed/terminated|7|||
16941501|NCT01199731|38086072|FG000|Overall Study|Lost to Follow-up|0|||
16941502|NCT01199731|38086073|FG001|Overall Study|Lost to Follow-up|0|||
16941503|NCT01199731|38086074|FG002|Overall Study|Lost to Follow-up|2|||
16941504|NCT01199731|38086072|FG000|Overall Study|Physician Decision|0|||
16941505|NCT01199731|38086073|FG001|Overall Study|Physician Decision|1|||
16941506|NCT01199731|38086074|FG002|Overall Study|Physician Decision|1|||
16941507|NCT01199731|38086072|FG000|Overall Study|Withdrawal by Subject|2|||
16941508|NCT01199731|38086073|FG001|Overall Study|Withdrawal by Subject|0|||
16941509|NCT01199731|38086074|FG002|Overall Study|Withdrawal by Subject|0|||
16856425|NCT01972841|37810012|FG002|Overall Study|Miscellaneous|4|||
16856426|NCT01972841|37810013|FG003|Overall Study|Miscellaneous|1|||
16856427|NCT01972841|37810014|FG004|Overall Study|Miscellaneous|0|||
16856428|NCT01972841|37810015|FG005|Overall Study|Miscellaneous|4|||
16856429|NCT01972841|37810010|FG000|Overall Study|Did not have end of treatment page|0|||
16856430|NCT01972841|37810011|FG001|Overall Study|Did not have end of treatment page|0|||
16856431|NCT01972841|37810012|FG002|Overall Study|Did not have end of treatment page|0|||
16856432|NCT01972841|37810013|FG003|Overall Study|Did not have end of treatment page|0|||
16856433|NCT01972841|37810014|FG004|Overall Study|Did not have end of treatment page|1|||
16856434|NCT01972841|37810015|FG005|Overall Study|Did not have end of treatment page|0|||
16941511|NCT01199263|38086089|FG000|Overall Study|Ineligible|0|||
16941512|NCT01199263|38086090|FG001|Overall Study|Ineligible|2|||
16941513|NCT01199263|38086089|FG000|Overall Study|Never Treated|6|||
16941514|NCT01199263|38086090|FG001|Overall Study|Never Treated|0|||
16941515|NCT01199068|38086101|FG000|Overall Study|Unacceptable toxicity|0|||
16941516|NCT01199068|38086102|FG001|Overall Study|Unacceptable toxicity|0|||
16941517|NCT01199068|38086103|FG002|Overall Study|Unacceptable toxicity|2|||
16941518|NCT01199068|38086101|FG000|Overall Study|Progressive disease|3|||
16941519|NCT01199068|38086102|FG001|Overall Study|Progressive disease|3|||
16941520|NCT01199068|38086103|FG002|Overall Study|Progressive disease|6|||
16941521|NCT01199068|38086101|FG000|Overall Study|Withdrawal by Subject|0|||
16941522|NCT01199068|38086102|FG001|Overall Study|Withdrawal by Subject|0|||
16941523|NCT01199068|38086103|FG002|Overall Study|Withdrawal by Subject|1|||
16856435|NCT01774903|37810029|FG000|Overall Study|Adverse Event|7|||
16941524|NCT01198873|38086120|FG000|Overall Study|Adverse Event|4|||
16941525|NCT01198873|38086121|FG001|Overall Study|Adverse Event|7|||
16941526|NCT01198873|38086120|FG000|Overall Study|Study closure|29|||
16941527|NCT01198873|38086121|FG001|Overall Study|Study closure|23|||
16941528|NCT01198873|38086120|FG000|Overall Study|Other than above|4|||
16941529|NCT01198873|38086121|FG001|Overall Study|Other than above|2|||
16941530|NCT01198795|38086127|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
16941531|NCT01198795|38086127|FG000|Overall Study|Withdrawal by Subject|17|||
16941532|NCT01198795|38086127|FG000|Overall Study|Lost to Follow-up|15|||
16941533|NCT01198795|38086127|FG000|Overall Study|Adverse Event|9|||
16941534|NCT01198795|38086127|FG000|Overall Study|Lack of Efficacy|5|||
16941535|NCT01198795|38086127|FG000|Overall Study|Protocol Violation|2|||
16941536|NCT01198795|38086127|FG000|Overall Study|Other Reason|4|||
16941537|NCT01198756|38086135|FG000|Overall Study|Adverse Event|0|||
16941538|NCT01198756|38086136|FG001|Overall Study|Adverse Event|0|||
16941539|NCT01198756|38086137|FG002|Overall Study|Adverse Event|0|||
16941540|NCT01198756|38086138|FG003|Overall Study|Adverse Event|1|||
16941541|NCT01198756|38086135|FG000|Overall Study|Protocol Violation|0|||
16941542|NCT01198756|38086136|FG001|Overall Study|Protocol Violation|0|||
16941543|NCT01198756|38086137|FG002|Overall Study|Protocol Violation|0|||
16856436|NCT01774903|37810029|FG000|Overall Study|Withdrawal by Subject|2|||
16856437|NCT01774903|37810029|FG000|Overall Study|Lack of Efficacy|1|||
16856438|NCT01774903|37810029|FG000|Overall Study|Ineligible to continue the trial|1|||
16856439|NCT01774591|37810036|FG000|Overall Study|Physician Decision|1|||
16856440|NCT01774591|37810037|FG001|Overall Study|Physician Decision|1|||
16856441|NCT01774591|37810036|FG000|Overall Study|Withdrawal by Subject|0|||
16856442|NCT01774591|37810037|FG001|Overall Study|Withdrawal by Subject|1|||
16856443|NCT01774591|37810036|FG000|Overall Study|Adverse Event|0|||
16856444|NCT01774591|37810037|FG001|Overall Study|Adverse Event|2|||
16856445|NCT01708915|37810047|FG000|Overall Study|Adverse Event|1|||
16856446|NCT01708915|37810048|FG001|Overall Study|Adverse Event|0|||
16856447|NCT01708915|37810049|FG002|Overall Study|Adverse Event|9|||
16941544|NCT01198756|38086138|FG003|Overall Study|Protocol Violation|2|||
16941545|NCT01198756|38086135|FG000|Overall Study|Withdrawal by Subject|9|||
16941546|NCT01198756|38086136|FG001|Overall Study|Withdrawal by Subject|4|||
16941547|NCT01198756|38086137|FG002|Overall Study|Withdrawal by Subject|7|||
16941548|NCT01198756|38086138|FG003|Overall Study|Withdrawal by Subject|5|||
16941549|NCT01198756|38086135|FG000|Overall Study|Lost to Follow-up|29|||
16941550|NCT01198756|38086136|FG001|Overall Study|Lost to Follow-up|36|||
16941551|NCT01198756|38086137|FG002|Overall Study|Lost to Follow-up|23|||
16941552|NCT01198756|38086138|FG003|Overall Study|Lost to Follow-up|18|||
16941553|NCT01198600|38086155|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
16941554|NCT01198600|38086156|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
16941555|NCT01198600|38086157|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
16941556|NCT01198600|38086158|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
16941557|NCT01198600|38086155|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
16941558|NCT01198600|38086156|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
16941559|NCT01198600|38086157|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
16941560|NCT01198600|38086158|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
16941561|NCT01198600|38086155|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
16941562|NCT01198600|38086156|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
16941563|NCT01198600|38086157|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
16941564|NCT01198600|38086158|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
16941565|NCT01198600|38086155|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
16941566|NCT01198600|38086156|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
16941567|NCT01198600|38086157|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
16941568|NCT01198600|38086158|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
16941569|NCT01198600|38086155|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
16941570|NCT01198600|38086156|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
16941571|NCT01198600|38086157|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
16941572|NCT01198600|38086158|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
16941573|NCT01198600|38086155|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
16856448|NCT01708915|37810050|FG003|Overall Study|Adverse Event|13|||
16856449|NCT01708915|37810047|FG000|Overall Study|Lack of Efficacy|84|||
16856450|NCT01708915|37810048|FG001|Overall Study|Lack of Efficacy|60|||
16856451|NCT01708915|37810049|FG002|Overall Study|Lack of Efficacy|35|||
16856452|NCT01708915|37810050|FG003|Overall Study|Lack of Efficacy|15|||
16856453|NCT01708915|37810047|FG000|Overall Study|Protocol Violation|0|||
16856454|NCT01708915|37810048|FG001|Overall Study|Protocol Violation|0|||
16856455|NCT01708915|37810049|FG002|Overall Study|Protocol Violation|0|||
16856456|NCT01708915|37810050|FG003|Overall Study|Protocol Violation|1|||
16856457|NCT01708915|37810047|FG000|Overall Study|Withdrawal by Subject|0|||
16856458|NCT01708915|37810048|FG001|Overall Study|Withdrawal by Subject|1|||
16941574|NCT01198600|38086156|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
16997688|NCT00696787|38141676|FG000|Overall Study|Adverse Event|1|||
16856459|NCT01708915|37810049|FG002|Overall Study|Withdrawal by Subject|2|||
16856460|NCT01708915|37810050|FG003|Overall Study|Withdrawal by Subject|2|||
16856461|NCT01708915|37810047|FG000|Overall Study|Other reasons than stated above|1|||
16856462|NCT01708915|37810048|FG001|Overall Study|Other reasons than stated above|1|||
16856463|NCT01708915|37810049|FG002|Overall Study|Other reasons than stated above|0|||
16856464|NCT01708915|37810050|FG003|Overall Study|Other reasons than stated above|2|||
16856465|NCT01708291|37810062|FG000|Overall Study|fighting|2|||
16856466|NCT01708291|37810063|FG001|Overall Study|fighting|1|||
16856467|NCT01708057|37810069|FG000|Overall Study|Withdrawal due to study termination.|1|||
17028067|NCT00775190|38172490|FG000|Overall Study|Protocol Violation|1|||
17028068|NCT00775190|38172491|FG001|Overall Study|Protocol Violation|0|||
17028069|NCT00479557|38172504|FG000|Overall Study|Death|0|||
17028070|NCT00479557|38172505|FG001|Overall Study|Death|0|||
17028071|NCT00479557|38172506|FG002|Overall Study|Death|0|||
17028072|NCT00479557|38172507|FG003|Overall Study|Death|0|||
17028073|NCT00479557|38172508|FG004|Overall Study|Death|0|||
17028074|NCT00479557|38172509|FG005|Overall Study|Death|1|||
17028075|NCT00479557|38172510|FG006|Overall Study|Death|0|||
17028076|NCT00479557|38172504|FG000|Overall Study|Lack of Efficacy|1|||
17028077|NCT00479557|38172505|FG001|Overall Study|Lack of Efficacy|0|||
17028078|NCT00479557|38172506|FG002|Overall Study|Lack of Efficacy|0|||
17028079|NCT00479557|38172507|FG003|Overall Study|Lack of Efficacy|0|||
17028080|NCT00479557|38172508|FG004|Overall Study|Lack of Efficacy|0|||
17028081|NCT00479557|38172509|FG005|Overall Study|Lack of Efficacy|0|||
17028082|NCT00479557|38172510|FG006|Overall Study|Lack of Efficacy|0|||
17028083|NCT00479557|38172504|FG000|Overall Study|Lost to Follow-up|0|||
17028084|NCT00479557|38172505|FG001|Overall Study|Lost to Follow-up|2|||
17028085|NCT00479557|38172506|FG002|Overall Study|Lost to Follow-up|0|||
17028086|NCT00479557|38172507|FG003|Overall Study|Lost to Follow-up|2|||
17028087|NCT00479557|38172508|FG004|Overall Study|Lost to Follow-up|0|||
17028088|NCT00479557|38172509|FG005|Overall Study|Lost to Follow-up|0|||
17028089|NCT00479557|38172510|FG006|Overall Study|Lost to Follow-up|0|||
17028090|NCT00479557|38172504|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
17028091|NCT00479557|38172505|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
17028092|NCT00479557|38172506|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
17028093|NCT00479557|38172507|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
17028094|NCT00479557|38172508|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
17028095|NCT00479557|38172509|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
17028096|NCT00479557|38172510|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
17028097|NCT00479557|38172504|FG000|Overall Study|AE not related to Study Drug|1|||
17028098|NCT00479557|38172505|FG001|Overall Study|AE not related to Study Drug|3|||
17028099|NCT00479557|38172506|FG002|Overall Study|AE not related to Study Drug|0|||
17028100|NCT00479557|38172507|FG003|Overall Study|AE not related to Study Drug|0|||
17028101|NCT00479557|38172508|FG004|Overall Study|AE not related to Study Drug|2|||
17028102|NCT00479557|38172509|FG005|Overall Study|AE not related to Study Drug|2|||
17028103|NCT00479557|38172510|FG006|Overall Study|AE not related to Study Drug|1|||
17028104|NCT00479557|38172504|FG000|Overall Study|Caregiver Request|2|||
17028105|NCT00479557|38172505|FG001|Overall Study|Caregiver Request|2|||
17028106|NCT00479557|38172506|FG002|Overall Study|Caregiver Request|2|||
17028107|NCT00479557|38172507|FG003|Overall Study|Caregiver Request|0|||
17028108|NCT00479557|38172508|FG004|Overall Study|Caregiver Request|1|||
17028109|NCT00479557|38172509|FG005|Overall Study|Caregiver Request|2|||
17028110|NCT00479557|38172510|FG006|Overall Study|Caregiver Request|0|||
16941575|NCT01198600|38086157|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
16941576|NCT01198600|38086158|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
16941577|NCT01198600|38086155|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
16941578|NCT01198600|38086156|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
16941579|NCT01198600|38086157|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
16941580|NCT01198600|38086158|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
16941581|NCT01198132|38086168|FG000|Overall Study|Withdrawal by Subject|4|||
16941582|NCT01198132|38086169|FG001|Overall Study|Withdrawal by Subject|5|||
16941583|NCT01198132|38086168|FG000|Overall Study|Physician Decision|5|||
16941584|NCT01198132|38086169|FG001|Overall Study|Physician Decision|4|||
16941585|NCT01198132|38086168|FG000|Overall Study|Other Unspecified|3|||
16941586|NCT01198132|38086169|FG001|Overall Study|Other Unspecified|6|||
16941587|NCT01198132|38086168|FG000|Overall Study|Lack of Efficacy|2|||
16941588|NCT01198132|38086169|FG001|Overall Study|Lack of Efficacy|3|||
16941589|NCT01198132|38086168|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
16941590|NCT01198132|38086169|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
16941591|NCT01198132|38086168|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
16941592|NCT01198132|38086169|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
16941593|NCT01198132|38086168|FG000|Overall Study|Adverse Event|0|||
16941594|NCT01198132|38086169|FG001|Overall Study|Adverse Event|1|||
16941595|NCT01198132|38086168|FG000|Overall Study|Protocol Violation|1|||
16941596|NCT01198132|38086169|FG001|Overall Study|Protocol Violation|0|||
16941597|NCT01197508|38086181|FG000|Overall Study|Withdrawal by Subject|8|||
17028111|NCT00479557|38172504|FG000|Overall Study|Investigator Request|0|||
16941598|NCT01197508|38086182|FG001|Overall Study|Withdrawal by Subject|7|||
16941599|NCT01197508|38086183|FG002|Overall Study|Withdrawal by Subject|15|||
16941600|NCT01197508|38086184|FG003|Overall Study|Withdrawal by Subject|4|||
16941601|NCT01197508|38086181|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
16941602|NCT01197508|38086182|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
16941603|NCT01197508|38086183|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
16941604|NCT01197508|38086184|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
16941605|NCT01197508|38086181|FG000|Overall Study|Adverse Event|10|||
16941606|NCT01197508|38086182|FG001|Overall Study|Adverse Event|13|||
16941607|NCT01197508|38086183|FG002|Overall Study|Adverse Event|23|||
16941608|NCT01197508|38086184|FG003|Overall Study|Adverse Event|3|||
16941609|NCT01197508|38086181|FG000|Overall Study|Severe non-compliance to protocol|0|||
16941610|NCT01197508|38086182|FG001|Overall Study|Severe non-compliance to protocol|3|||
16941611|NCT01197508|38086183|FG002|Overall Study|Severe non-compliance to protocol|1|||
16941612|NCT01197508|38086184|FG003|Overall Study|Severe non-compliance to protocol|3|||
16941613|NCT01197508|38086181|FG000|Overall Study|Condition under investigation worsened|1|||
16941614|NCT01197508|38086182|FG001|Overall Study|Condition under investigation worsened|1|||
16941615|NCT01197508|38086183|FG002|Overall Study|Condition under investigation worsened|1|||
16941616|NCT01197508|38086184|FG003|Overall Study|Condition under investigation worsened|1|||
16941617|NCT01197508|38086181|FG000|Overall Study|Lack of Efficacy|1|||
16941618|NCT01197508|38086182|FG001|Overall Study|Lack of Efficacy|2|||
16941619|NCT01197508|38086183|FG002|Overall Study|Lack of Efficacy|2|||
16941620|NCT01197508|38086184|FG003|Overall Study|Lack of Efficacy|1|||
16941621|NCT01197508|38086181|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16941622|NCT01197508|38086182|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16941623|NCT01197508|38086183|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16941624|NCT01197508|38086184|FG003|Overall Study|Study-specific withdrawal criteria|2|||
16941625|NCT01197508|38086181|FG000|Overall Study|Lost to Follow-up|1|||
16856468|NCT01708057|37810070|FG001|Overall Study|Withdrawal due to study termination.|1|||
16856469|NCT01708057|37810071|FG002|Overall Study|Withdrawal due to study termination.|1|||
16856470|NCT01748071|37810088|FG000|Overall Study|Adverse Event|2|||
16856471|NCT01748071|37810089|FG001|Overall Study|Adverse Event|2|||
16856472|NCT01748071|37810090|FG002|Overall Study|Adverse Event|0|||
16856473|NCT01972529|37810102|FG000|Overall Study|Adverse Event|0|||
16941626|NCT01197508|38086182|FG001|Overall Study|Lost to Follow-up|1|||
16941627|NCT01197508|38086183|FG002|Overall Study|Lost to Follow-up|2|||
16941628|NCT01197508|38086184|FG003|Overall Study|Lost to Follow-up|0|||
16941629|NCT01197508|38086181|FG000|Overall Study|Other|2|||
16941630|NCT01197508|38086182|FG001|Overall Study|Other|3|||
16941631|NCT01197508|38086183|FG002|Overall Study|Other|2|||
16941632|NCT01197508|38086184|FG003|Overall Study|Other|2|||
16941633|NCT01196416|38086201|FG000|Overall Study|Withdrawal by Subject|2|||
16941634|NCT01196104|38086207|FG000|Overall Study|Lost to Follow-up|1|||
16941635|NCT01196104|38086208|FG001|Overall Study|Lost to Follow-up|0|||
16941636|NCT01196104|38086207|FG000|Overall Study|Physician Decision|0|||
16941637|NCT01196104|38086208|FG001|Overall Study|Physician Decision|1|||
16941638|NCT01196104|38086207|FG000|Overall Study|Withdrawal by Subject|3|||
16941639|NCT01196104|38086208|FG001|Overall Study|Withdrawal by Subject|3|||
16941640|NCT01196104|38086207|FG000|Overall Study|Various|0|||
16941641|NCT01196104|38086208|FG001|Overall Study|Various|1|||
16941642|NCT01196026|38086226|FG000|Overall Study|Withdrawal by Subject|1|||
16941643|NCT01196026|38086227|FG001|Overall Study|Withdrawal by Subject|4|||
16941644|NCT01196026|38086228|FG002|Overall Study|Withdrawal by Subject|0|||
16941645|NCT01196026|38086229|FG003|Overall Study|Withdrawal by Subject|0|||
16941646|NCT01196026|38086230|FG004|Overall Study|Withdrawal by Subject|0|||
16941647|NCT01196026|38086231|FG005|Overall Study|Withdrawal by Subject|0|||
16941648|NCT01196026|38086226|FG000|Overall Study|Lost to Follow-up|0|||
16941649|NCT01196026|38086227|FG001|Overall Study|Lost to Follow-up|3|||
16941650|NCT01196026|38086228|FG002|Overall Study|Lost to Follow-up|0|||
16941651|NCT01196026|38086229|FG003|Overall Study|Lost to Follow-up|0|||
16941652|NCT01196026|38086230|FG004|Overall Study|Lost to Follow-up|1|||
16856474|NCT01972529|37810103|FG001|Overall Study|Adverse Event|1|||
16856475|NCT01972529|37810104|FG002|Overall Study|Adverse Event|0|||
16856476|NCT01972529|37810105|FG003|Overall Study|Adverse Event|0|||
16856477|NCT01972529|37810102|FG000|Overall Study|Lost to Follow-up|1|||
16941653|NCT01196026|38086231|FG005|Overall Study|Lost to Follow-up|0|||
16941654|NCT01196026|38086226|FG000|Overall Study|Other|0|||
16941655|NCT01196026|38086227|FG001|Overall Study|Other|1|||
16941656|NCT01196026|38086228|FG002|Overall Study|Other|0|||
16941657|NCT01196026|38086229|FG003|Overall Study|Other|0|||
16941658|NCT01196026|38086230|FG004|Overall Study|Other|0|||
16941659|NCT01196026|38086231|FG005|Overall Study|Other|0|||
16941660|NCT01195948|38086254|FG000|Overall Study|Lost to Follow-up|0|||
16941661|NCT01195948|38086255|FG001|Overall Study|Lost to Follow-up|1|||
16941662|NCT01195948|38086256|FG002|Overall Study|Lost to Follow-up|2|||
16941663|NCT01195831|38086269|FG000|Overall Study|Lost to Follow-up|2|||
16941664|NCT01195831|38086270|FG001|Overall Study|Lost to Follow-up|4|||
16941665|NCT01195831|38086269|FG000|Overall Study|Withdrawal by Subject|2|||
16856478|NCT01972529|37810103|FG001|Overall Study|Lost to Follow-up|0|||
16941666|NCT01195831|38086270|FG001|Overall Study|Withdrawal by Subject|2|||
16941667|NCT01195831|38086269|FG000|Overall Study|Adverse Event|4|||
16941668|NCT01195831|38086270|FG001|Overall Study|Adverse Event|2|||
16941669|NCT01195831|38086269|FG000|Overall Study|Protocol Violation|0|||
16941670|NCT01195831|38086270|FG001|Overall Study|Protocol Violation|2|||
16941671|NCT01195675|38086276|FG000|Overall Study|Adverse Event|1|||
16941672|NCT01195675|38086276|FG000|Overall Study|Withdrawal by Subject|2|||
17028112|NCT00479557|38172505|FG001|Overall Study|Investigator Request|0|||
17028113|NCT00479557|38172506|FG002|Overall Study|Investigator Request|1|||
17028114|NCT00479557|38172507|FG003|Overall Study|Investigator Request|0|||
16941673|NCT01195636|38086293|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
16941674|NCT01195636|38086294|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
16941675|NCT01195636|38086293|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
16941676|NCT01195636|38086294|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
16941677|NCT01195636|38086293|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16941678|NCT01195636|38086294|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
16941679|NCT01195636|38086293|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
16941680|NCT01195636|38086294|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
16941681|NCT01195636|38086293|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
16941682|NCT01195636|38086294|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
16941683|NCT01195636|38086293|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
16941684|NCT01195636|38086294|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
16941685|NCT01195636|38086293|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
16941686|NCT01195636|38086294|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
16941687|NCT01195636|38086293|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
16941688|NCT01195636|38086294|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
16941689|NCT01195363|38086302|FG000|Overall Study|Lost to Follow-up|7|||
16941690|NCT01195363|38086303|FG001|Overall Study|Lost to Follow-up|4|||
16941691|NCT01195363|38086302|FG000|Overall Study|Adverse Event|3|||
16941692|NCT01195363|38086303|FG001|Overall Study|Adverse Event|1|||
16941693|NCT01195363|38086302|FG000|Overall Study|Lack of Efficacy|0|||
16941694|NCT01195363|38086303|FG001|Overall Study|Lack of Efficacy|4|||
16941695|NCT01195363|38086302|FG000|Overall Study|incarceration|1|||
16856479|NCT01972529|37810104|FG002|Overall Study|Lost to Follow-up|0|||
16856480|NCT01972529|37810105|FG003|Overall Study|Lost to Follow-up|0|||
16941696|NCT01195363|38086303|FG001|Overall Study|incarceration|0|||
16941697|NCT01195090|38086311|FG000|Overall Study|Adverse Event|1|||
16941698|NCT01195090|38086312|FG001|Overall Study|Adverse Event|2|||
16941699|NCT01195090|38086311|FG000|Overall Study|Lost to Follow-up|2|||
16941700|NCT01195090|38086312|FG001|Overall Study|Lost to Follow-up|2|||
16941701|NCT01195090|38086311|FG000|Overall Study|Protocol Violation|3|||
16941702|NCT01195090|38086312|FG001|Overall Study|Protocol Violation|4|||
16941703|NCT01194973|38086318|FG000|Screening Period|Screen Failure|3|||
16941704|NCT01194973|38086318|FG000|26 Week Treatment Period|Adverse Event|1|||
16941705|NCT01194973|38086318|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
17028115|NCT00479557|38172508|FG004|Overall Study|Investigator Request|0|||
17028116|NCT00479557|38172509|FG005|Overall Study|Investigator Request|0|||
17028117|NCT00479557|38172510|FG006|Overall Study|Investigator Request|0|||
16856481|NCT01972529|37810102|FG000|Overall Study|Participant Choice|0|||
16941706|NCT01194973|38086318|FG000|26 Week Treatment Period|Pregnancy|1|||
16941707|NCT02218697|38086324|FG000|Overall Study|Adverse Event|0|||
16941708|NCT02218697|38086325|FG001|Overall Study|Adverse Event|2|||
16941709|NCT02218697|38086324|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
16941710|NCT02218697|38086325|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
17028118|NCT00479557|38172504|FG000|Overall Study|Subject Request|3|||
17028119|NCT00479557|38172505|FG001|Overall Study|Subject Request|0|||
17028120|NCT00479557|38172506|FG002|Overall Study|Subject Request|1|||
17028121|NCT00479557|38172507|FG003|Overall Study|Subject Request|1|||
17028122|NCT00479557|38172508|FG004|Overall Study|Subject Request|1|||
17028123|NCT00479557|38172509|FG005|Overall Study|Subject Request|4|||
17028124|NCT00479557|38172510|FG006|Overall Study|Subject Request|1|||
17028125|NCT00479557|38172504|FG000|Overall Study|Other|2|||
17028126|NCT00479557|38172505|FG001|Overall Study|Other|3|||
17028127|NCT00479557|38172506|FG002|Overall Study|Other|1|||
17028128|NCT00479557|38172507|FG003|Overall Study|Other|0|||
17028129|NCT00479557|38172508|FG004|Overall Study|Other|0|||
17028130|NCT00479557|38172509|FG005|Overall Study|Other|3|||
17028131|NCT00479557|38172510|FG006|Overall Study|Other|0|||
17028132|NCT00774800|38172532|FG000|Intervention 4|Withdrawal by Subject|1|||
16856482|NCT01972529|37810103|FG001|Overall Study|Participant Choice|1|||
16856483|NCT01972529|37810104|FG002|Overall Study|Participant Choice|0|||
16856484|NCT01972529|37810105|FG003|Overall Study|Participant Choice|0|||
16856485|NCT01972529|37810102|FG000|Overall Study|Withdrawl of Consent|1|||
16856486|NCT01972529|37810103|FG001|Overall Study|Withdrawl of Consent|2|||
16856487|NCT01972529|37810104|FG002|Overall Study|Withdrawl of Consent|0|||
16856488|NCT01972529|37810105|FG003|Overall Study|Withdrawl of Consent|1|||
16941711|NCT02218697|38086324|FG000|Overall Study|Withdrawal by Subject|2|||
16856489|NCT01972529|37810102|FG000|Overall Study|Other|0|||
16856490|NCT01972529|37810103|FG001|Overall Study|Other|0|||
16856491|NCT01972529|37810104|FG002|Overall Study|Other|0|||
16856492|NCT01972529|37810105|FG003|Overall Study|Other|2|||
16856493|NCT01972529|37810102|FG000|Overall Study|Not treated|0|||
16856494|NCT01972529|37810103|FG001|Overall Study|Not treated|1|||
16856495|NCT01972529|37810104|FG002|Overall Study|Not treated|2|||
16941712|NCT02218697|38086325|FG001|Overall Study|Withdrawal by Subject|3|||
16941713|NCT01177540|38086333|FG000|Overall Study|Adverse Event|1|||
16941714|NCT01177540|38086334|FG001|Overall Study|Adverse Event|0|||
16941715|NCT02211131|38086342|FG000|Overall Study|Death|20|||
16941716|NCT02211131|38086343|FG001|Overall Study|Death|11|||
16941717|NCT02211131|38086342|FG000|Overall Study|Lost to Follow-up|1|||
16941718|NCT02211131|38086343|FG001|Overall Study|Lost to Follow-up|0|||
16941719|NCT02211131|38086342|FG000|Overall Study|Decision by Sponsor|1|||
17028133|NCT00439309|38172544|FG000|Follow-Up|Death|1|||
17028134|NCT00439309|38172545|FG001|Follow-Up|Death|0|||
17028135|NCT00439309|38172544|FG000|Follow-Up|Lost to Follow-up|2|||
17028136|NCT00439309|38172545|FG001|Follow-Up|Lost to Follow-up|0|||
17028137|NCT00439309|38172544|FG000|Follow-Up|Withdrawal by Subject|0|||
17028138|NCT00439309|38172545|FG001|Follow-Up|Withdrawal by Subject|1|||
16941720|NCT02211131|38086343|FG001|Overall Study|Decision by Sponsor|1|||
16941721|NCT02211131|38086342|FG000|Overall Study|Withdrawal by Subject|3|||
16941722|NCT02211131|38086343|FG001|Overall Study|Withdrawal by Subject|4|||
16941723|NCT02211131|38086342|FG000|Overall Study|Continuing on Study|49|||
16941724|NCT02211131|38086343|FG001|Overall Study|Continuing on Study|60|||
16941725|NCT01177384|38086358|FG000|Overall Study|Adverse Event|6|||
16941726|NCT01177384|38086359|FG001|Overall Study|Adverse Event|4|||
16941727|NCT01177384|38086358|FG000|Overall Study|Lack of Efficacy|0|||
16941728|NCT01177384|38086359|FG001|Overall Study|Lack of Efficacy|1|||
16941729|NCT01177384|38086358|FG000|Overall Study|Lost to Follow-up|3|||
16941730|NCT01177384|38086359|FG001|Overall Study|Lost to Follow-up|4|||
16941731|NCT01177384|38086358|FG000|Overall Study|Physician Decision|0|||
16856496|NCT01972529|37810105|FG003|Overall Study|Not treated|1|||
16941732|NCT01177384|38086359|FG001|Overall Study|Physician Decision|3|||
16941733|NCT01177384|38086358|FG000|Overall Study|Protocol Violation|0|||
16941734|NCT01177384|38086359|FG001|Overall Study|Protocol Violation|2|||
16941735|NCT01177384|38086358|FG000|Overall Study|Withdrawal by Subject|5|||
16941736|NCT01177384|38086359|FG001|Overall Study|Withdrawal by Subject|12|||
16941737|NCT01194154|38086367|FG000|Overall Study|Adverse Event|12|||
16941738|NCT01194154|38086368|FG001|Overall Study|Adverse Event|7|||
16941739|NCT01194154|38086367|FG000|Overall Study|Lost to Follow-up|2|||
16941740|NCT01194154|38086368|FG001|Overall Study|Lost to Follow-up|3|||
16941741|NCT01194154|38086367|FG000|Overall Study|Protocol Violation|0|||
16941742|NCT01194154|38086368|FG001|Overall Study|Protocol Violation|1|||
17028139|NCT00439309|38172544|FG000|Follow-Up|Late response by subject|0|||
17028140|NCT00439309|38172545|FG001|Follow-Up|Late response by subject|1|||
17028141|NCT00479167|38172551|FG000|Overall Study|Withdrawal by Subject|1|||
17028142|NCT00725712|38172558|FG000|Overall Study|Withdrawal by Subject|2|||
17028143|NCT00725712|38172559|FG001|Overall Study|Withdrawal by Subject|1|||
17028144|NCT00725712|38172558|FG000|Overall Study|Protocol Violation|1|||
17028145|NCT00725712|38172559|FG001|Overall Study|Protocol Violation|0|||
16941743|NCT01194154|38086367|FG000|Overall Study|Withdrawal by Subject|5|||
16941744|NCT01194154|38086368|FG001|Overall Study|Withdrawal by Subject|6|||
16941745|NCT01194154|38086367|FG000|Overall Study|Blood pressure increase|5|||
16941746|NCT01194154|38086368|FG001|Overall Study|Blood pressure increase|3|||
16941747|NCT01194154|38086367|FG000|Overall Study|Hemoglobin decrease|0|||
16941748|NCT01194154|38086368|FG001|Overall Study|Hemoglobin decrease|1|||
16941749|NCT01194154|38086367|FG000|Overall Study|Hemoglobin increase|12|||
16941750|NCT01194154|38086368|FG001|Overall Study|Hemoglobin increase|3|||
16941751|NCT01194154|38086367|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
16941752|NCT01194154|38086368|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
16941753|NCT01194154|38086367|FG000|Overall Study|Treatment with prohibited medication|4|||
16941754|NCT01194154|38086368|FG001|Overall Study|Treatment with prohibited medication|5|||
16941755|NCT01194154|38086367|FG000|Overall Study|Other|4|||
16941756|NCT01194154|38086368|FG001|Overall Study|Other|0|||
16941757|NCT01194154|38086367|FG000|Overall Study|Did not receive study medication|2|||
16941758|NCT01194154|38086368|FG001|Overall Study|Did not receive study medication|4|||
16941759|NCT01193920|38086395|FG000|Overall Study|Withdrawal by Subject|1|||
16941760|NCT01193920|38086396|FG001|Overall Study|Withdrawal by Subject|0|||
16941761|NCT01193920|38086397|FG002|Overall Study|Withdrawal by Subject|5|||
16941762|NCT01193920|38086398|FG003|Overall Study|Withdrawal by Subject|1|||
16941763|NCT01193920|38086399|FG004|Overall Study|Withdrawal by Subject|3|||
16941764|NCT01193920|38086400|FG005|Overall Study|Withdrawal by Subject|1|||
16941765|NCT01193920|38086401|FG006|Overall Study|Withdrawal by Subject|3|||
16941766|NCT01193920|38086402|FG007|Overall Study|Withdrawal by Subject|0|||
16856497|NCT01747915|37810119|FG000|Overall Study|Other|1|||
16856498|NCT01747915|37810120|FG001|Overall Study|Other|1|||
16941767|NCT01193920|38086403|FG008|Overall Study|Withdrawal by Subject|1|||
16941768|NCT01193920|38086404|FG009|Overall Study|Withdrawal by Subject|0|||
16941769|NCT01193920|38086395|FG000|Overall Study|Lost to Follow-up|1|||
16941770|NCT01193920|38086396|FG001|Overall Study|Lost to Follow-up|0|||
16941771|NCT01193920|38086397|FG002|Overall Study|Lost to Follow-up|1|||
16941772|NCT01193920|38086398|FG003|Overall Study|Lost to Follow-up|1|||
16941773|NCT01193920|38086399|FG004|Overall Study|Lost to Follow-up|3|||
16941774|NCT01193920|38086400|FG005|Overall Study|Lost to Follow-up|3|||
16941775|NCT01193920|38086401|FG006|Overall Study|Lost to Follow-up|1|||
16941776|NCT01193920|38086402|FG007|Overall Study|Lost to Follow-up|0|||
16941777|NCT01193920|38086403|FG008|Overall Study|Lost to Follow-up|2|||
17028146|NCT00725712|38172558|FG000|Overall Study|Progressive disease|37|||
17028147|NCT00725712|38172559|FG001|Overall Study|Progressive disease|16|||
16856499|NCT01747915|37810121|FG002|Overall Study|Other|1|||
16856500|NCT01747915|37810119|FG000|Overall Study|Adverse Event|8|||
16856501|NCT01747915|37810120|FG001|Overall Study|Adverse Event|5|||
16856502|NCT01747915|37810121|FG002|Overall Study|Adverse Event|2|||
16856503|NCT01747915|37810119|FG000|Overall Study|Death|0|||
16856504|NCT01747915|37810120|FG001|Overall Study|Death|0|||
16856505|NCT01747915|37810121|FG002|Overall Study|Death|1|||
16856506|NCT01747915|37810119|FG000|Overall Study|Lack of Efficacy|0|||
16856507|NCT01747915|37810120|FG001|Overall Study|Lack of Efficacy|1|||
16856508|NCT01747915|37810121|FG002|Overall Study|Lack of Efficacy|0|||
16856509|NCT01747915|37810119|FG000|Overall Study|Lost to Follow-up|1|||
16856510|NCT01747915|37810120|FG001|Overall Study|Lost to Follow-up|0|||
16941778|NCT01193920|38086404|FG009|Overall Study|Lost to Follow-up|3|||
16941779|NCT01193920|38086395|FG000|Overall Study|Protocol Violation|1|||
16941780|NCT01193920|38086396|FG001|Overall Study|Protocol Violation|0|||
16941781|NCT01193920|38086397|FG002|Overall Study|Protocol Violation|0|||
16941782|NCT01193920|38086398|FG003|Overall Study|Protocol Violation|0|||
16941783|NCT01193920|38086399|FG004|Overall Study|Protocol Violation|0|||
16941784|NCT01193920|38086400|FG005|Overall Study|Protocol Violation|0|||
16941785|NCT01193920|38086401|FG006|Overall Study|Protocol Violation|0|||
16941786|NCT01193920|38086402|FG007|Overall Study|Protocol Violation|0|||
16941787|NCT01193920|38086403|FG008|Overall Study|Protocol Violation|0|||
16941788|NCT01193920|38086404|FG009|Overall Study|Protocol Violation|0|||
16941789|NCT01193920|38086395|FG000|Overall Study|Death|0|||
16941790|NCT01193920|38086396|FG001|Overall Study|Death|0|||
16941791|NCT01193920|38086397|FG002|Overall Study|Death|0|||
17028148|NCT00725712|38172558|FG000|Overall Study|Clinical progression not based on RECIST|0|||
17028149|NCT00725712|38172559|FG001|Overall Study|Clinical progression not based on RECIST|3|||
16941792|NCT01193920|38086398|FG003|Overall Study|Death|1|||
16941793|NCT01193920|38086399|FG004|Overall Study|Death|0|||
16941794|NCT01193920|38086400|FG005|Overall Study|Death|0|||
16941795|NCT01193920|38086401|FG006|Overall Study|Death|2|||
16941796|NCT01193920|38086402|FG007|Overall Study|Death|3|||
16941797|NCT01193920|38086403|FG008|Overall Study|Death|2|||
16941798|NCT01193920|38086404|FG009|Overall Study|Death|4|||
16941799|NCT01193920|38086395|FG000|Overall Study|Unable to classify|0|||
16941800|NCT01193920|38086396|FG001|Overall Study|Unable to classify|0|||
16941801|NCT01193920|38086397|FG002|Overall Study|Unable to classify|0|||
16941802|NCT01193920|38086398|FG003|Overall Study|Unable to classify|1|||
16941803|NCT01193920|38086399|FG004|Overall Study|Unable to classify|0|||
16941804|NCT01193920|38086400|FG005|Overall Study|Unable to classify|0|||
16941805|NCT01193920|38086401|FG006|Overall Study|Unable to classify|0|||
16941806|NCT01193920|38086402|FG007|Overall Study|Unable to classify|1|||
16856511|NCT01747915|37810121|FG002|Overall Study|Lost to Follow-up|0|||
16941807|NCT01193920|38086403|FG008|Overall Study|Unable to classify|0|||
16941808|NCT01193920|38086404|FG009|Overall Study|Unable to classify|0|||
16941809|NCT01193686|38086429|FG000|Overall Study|Withdrawal by Subject|4|||
17028150|NCT00725712|38172558|FG000|Overall Study|Adverse Event|5|||
17028151|NCT00725712|38172559|FG001|Overall Study|Adverse Event|5|||
17028152|NCT00725712|38172558|FG000|Overall Study|Death|2|||
17028153|NCT00725712|38172559|FG001|Overall Study|Death|0|||
17028154|NCT00725712|38172558|FG000|Overall Study|Other: Death|1|||
17028155|NCT00725712|38172559|FG001|Overall Study|Other: Death|0|||
17028156|NCT00725712|38172558|FG000|Overall Study|Hospitalized, unable to continue|0|||
16941810|NCT01193686|38086430|FG001|Overall Study|Withdrawal by Subject|1|||
17028157|NCT00725712|38172559|FG001|Overall Study|Hospitalized, unable to continue|1|||
17028158|NCT00729378|38172571|FG000|Baseline|Did not complete study measurements|72|||
17028159|NCT00729378|38172572|FG001|Baseline|Did not complete study measurements|33|||
17028160|NCT00729378|38172571|FG000|Baseline|Withdrawal by Subject|66|||
17028161|NCT00729378|38172572|FG001|Baseline|Withdrawal by Subject|59|||
17028162|NCT00729378|38172571|FG000|12-months|Lost to Follow-up|100|||
17028163|NCT00729378|38172572|FG001|12-months|Lost to Follow-up|65|||
16856512|NCT01747915|37810119|FG000|Overall Study|Withdrawal by Subject|4|||
16941811|NCT01193686|38086429|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
16941812|NCT01193686|38086430|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
16941813|NCT01193608|38086443|FG000|Overall Study|Other|0|||
16941814|NCT01193608|38086444|FG001|Overall Study|Other|1|||
16941815|NCT01193608|38086445|FG002|Overall Study|Other|0|||
16941816|NCT01193608|38086446|FG003|Overall Study|Other|0|||
17028164|NCT00729378|38172571|FG000|24-months|Lost to Follow-up|72|||
17028165|NCT00729378|38172572|FG001|24-months|Lost to Follow-up|51|||
17028166|NCT00729378|38172571|FG000|36-months|Lost to Follow-up|15|||
17028167|NCT00729378|38172572|FG001|36-months|Lost to Follow-up|6|||
16941817|NCT01193608|38086447|FG004|Overall Study|Other|0|||
16941818|NCT01193608|38086448|FG005|Overall Study|Other|0|||
17028168|NCT00478933|38172581|FG000|Overall Study|Protocol Violation|22|||
16941819|NCT01193608|38086443|FG000|Overall Study|Withdrawal by Subject|0|||
16941820|NCT01193608|38086444|FG001|Overall Study|Withdrawal by Subject|1|||
16941821|NCT01193608|38086445|FG002|Overall Study|Withdrawal by Subject|2|||
16941822|NCT01193608|38086446|FG003|Overall Study|Withdrawal by Subject|3|||
16941823|NCT01193608|38086447|FG004|Overall Study|Withdrawal by Subject|3|||
16941824|NCT01193608|38086448|FG005|Overall Study|Withdrawal by Subject|0|||
16941825|NCT01193608|38086443|FG000|Overall Study|Lost to Follow-up|0|||
16941826|NCT01193608|38086444|FG001|Overall Study|Lost to Follow-up|0|||
16941827|NCT01193608|38086445|FG002|Overall Study|Lost to Follow-up|0|||
16941828|NCT01193608|38086446|FG003|Overall Study|Lost to Follow-up|0|||
16941829|NCT01193608|38086447|FG004|Overall Study|Lost to Follow-up|1|||
16941830|NCT01193608|38086448|FG005|Overall Study|Lost to Follow-up|2|||
16941831|NCT01193608|38086443|FG000|Overall Study|Adverse Event|0|||
16941832|NCT01193608|38086444|FG001|Overall Study|Adverse Event|0|||
16941833|NCT01193608|38086445|FG002|Overall Study|Adverse Event|0|||
16941834|NCT01193608|38086446|FG003|Overall Study|Adverse Event|0|||
16941835|NCT01193608|38086447|FG004|Overall Study|Adverse Event|1|||
16941836|NCT01193608|38086448|FG005|Overall Study|Adverse Event|0|||
16941837|NCT01177228|38086471|FG000|Overall Study|Positive tuberculosis test|0|||
16941838|NCT01177228|38086472|FG001|Overall Study|Positive tuberculosis test|1|||
16941839|NCT01177228|38086473|FG002|Overall Study|Positive tuberculosis test|0|||
16941840|NCT01177228|38086474|FG003|Overall Study|Positive tuberculosis test|0|||
16941841|NCT01177228|38086471|FG000|Overall Study|Worsening disease activity|1|||
16941842|NCT01177228|38086472|FG001|Overall Study|Worsening disease activity|0|||
16941843|NCT01177228|38086473|FG002|Overall Study|Worsening disease activity|0|||
16941844|NCT01177228|38086474|FG003|Overall Study|Worsening disease activity|0|||
16941845|NCT01177228|38086471|FG000|Overall Study|Withdrawal by Subject|0|||
16941846|NCT01177228|38086472|FG001|Overall Study|Withdrawal by Subject|1|||
16941847|NCT01177228|38086473|FG002|Overall Study|Withdrawal by Subject|0|||
16941848|NCT01177228|38086474|FG003|Overall Study|Withdrawal by Subject|0|||
17028169|NCT00478933|38172581|FG000|Overall Study|Informed consent not verified|3|||
17028170|NCT00478933|38172581|FG000|Overall Study|Inadequate data available|53|||
17028171|NCT00725322|38172607|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
17028172|NCT00725322|38172608|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
17028173|NCT00725322|38172607|FG000|Washout (28 Days)|Protocol Violation|0|||
17028174|NCT00725322|38172608|FG001|Washout (28 Days)|Protocol Violation|1|||
17028175|NCT00725010|38172614|FG000|Overall Study|Toxicity|9|||
17028176|NCT00725010|38172614|FG000|Overall Study|Tumor Progression|7|||
16941849|NCT01193530|38086491|FG000|Overall Study|Withdrawal by Subject|2|||
16941850|NCT01193530|38086492|FG001|Overall Study|Withdrawal by Subject|2|||
16941851|NCT01193530|38086491|FG000|Overall Study|Began Contraindicated Therapy|1|||
16941852|NCT01193530|38086492|FG001|Overall Study|Began Contraindicated Therapy|0|||
16941853|NCT01193530|38086491|FG000|Overall Study|Lost Light Box|0|||
16941854|NCT01193530|38086492|FG001|Overall Study|Lost Light Box|1|||
16941855|NCT01193530|38086491|FG000|Overall Study|Returned home - out of state|0|||
16941856|NCT01193530|38086492|FG001|Overall Study|Returned home - out of state|1|||
16941857|NCT01193530|38086491|FG000|Overall Study|Non-Compliance|0|||
17028177|NCT00725010|38172614|FG000|Overall Study|Withdrawal by Subject|2|||
17028178|NCT00725010|38172614|FG000|Overall Study|Death|1|||
17028179|NCT00725010|38172614|FG000|Overall Study|Lost to Follow-up|1|||
17028180|NCT00725010|38172614|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
17028181|NCT00725010|38172614|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
17028182|NCT00725010|38172614|FG000|Overall Study|No further documentation|1|||
17028183|NCT00725010|38172614|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
17028184|NCT00767000|38172625|FG000|54-week Study|Adverse Event|4|||
17028185|NCT00767000|38172626|FG001|54-week Study|Adverse Event|6|||
17028186|NCT00767000|38172627|FG002|54-week Study|Adverse Event|6|||
17028187|NCT00767000|38172628|FG003|54-week Study|Adverse Event|8|||
17028188|NCT00767000|38172629|FG004|54-week Study|Adverse Event|4|||
17028189|NCT00767000|38172625|FG000|54-week Study|Creaninine/creatinine clearance|2|||
17028190|NCT00767000|38172626|FG001|54-week Study|Creaninine/creatinine clearance|1|||
17028191|NCT00767000|38172627|FG002|54-week Study|Creaninine/creatinine clearance|2|||
17028192|NCT00767000|38172628|FG003|54-week Study|Creaninine/creatinine clearance|2|||
17028193|NCT00767000|38172629|FG004|54-week Study|Creaninine/creatinine clearance|4|||
17028194|NCT00767000|38172625|FG000|54-week Study|Hyperglycemia|0|||
17028195|NCT00767000|38172626|FG001|54-week Study|Hyperglycemia|0|||
17028196|NCT00767000|38172627|FG002|54-week Study|Hyperglycemia|1|||
17028197|NCT00767000|38172628|FG003|54-week Study|Hyperglycemia|0|||
17028198|NCT00767000|38172629|FG004|54-week Study|Hyperglycemia|1|||
17028199|NCT00767000|38172625|FG000|54-week Study|Hypoglycemia|0|||
16941858|NCT01193530|38086492|FG001|Overall Study|Non-Compliance|1|||
16997689|NCT00696787|38141677|FG001|Overall Study|Adverse Event|0|||
16997690|NCT00696787|38141678|FG002|Overall Study|Adverse Event|6|||
16997691|NCT00696787|38141676|FG000|Overall Study|Discontinuation by Sponsor|9|||
16997692|NCT00696787|38141677|FG001|Overall Study|Discontinuation by Sponsor|13|||
16997693|NCT00696787|38141678|FG002|Overall Study|Discontinuation by Sponsor|14|||
16997694|NCT00696787|38141676|FG000|Overall Study|Lack of Efficacy|0|||
16997695|NCT00696787|38141677|FG001|Overall Study|Lack of Efficacy|1|||
16997696|NCT00696787|38141678|FG002|Overall Study|Lack of Efficacy|0|||
16997697|NCT00696787|38141676|FG000|Overall Study|Lost to Follow-up|4|||
16997698|NCT00696787|38141677|FG001|Overall Study|Lost to Follow-up|0|||
16997699|NCT00696787|38141678|FG002|Overall Study|Lost to Follow-up|3|||
16997700|NCT00696787|38141676|FG000|Overall Study|Withdrawal by Subject|0|||
16997701|NCT00696787|38141677|FG001|Overall Study|Withdrawal by Subject|3|||
16997702|NCT00696787|38141678|FG002|Overall Study|Withdrawal by Subject|2|||
16997703|NCT00696787|38141676|FG000|Overall Study|Failed to return|1|||
16997704|NCT00696787|38141677|FG001|Overall Study|Failed to return|3|||
16997705|NCT00696787|38141678|FG002|Overall Study|Failed to return|1|||
16997706|NCT01012037|38141689|FG000|Overall Study|Adverse Event|0|||
16997707|NCT01012037|38141690|FG001|Overall Study|Adverse Event|8|||
16997708|NCT01012037|38141691|FG002|Overall Study|Adverse Event|3|||
16997709|NCT01012037|38141689|FG000|Overall Study|Protocol Violation|0|||
16997710|NCT01012037|38141690|FG001|Overall Study|Protocol Violation|3|||
16997711|NCT01012037|38141691|FG002|Overall Study|Protocol Violation|5|||
17114915|NCT00022698|38252887|FG000|Overall Study|Refused treatment|0|||
17114916|NCT00022698|38252888|FG001|Overall Study|Refused treatment|2|||
17114917|NCT00022698|38252887|FG000|Overall Study|Insufficient therapeutic response|2|||
17114918|NCT00022698|38252888|FG001|Overall Study|Insufficient therapeutic response|14|||
17114919|NCT00022698|38252887|FG000|Overall Study|Administrative /other|1|||
17114920|NCT00022698|38252888|FG001|Overall Study|Administrative /other|7|||
17114921|NCT04625972|38252898|FG000|Overall Study|Physician Decision|1|||
17114922|NCT04625972|38252899|FG001|Overall Study|Physician Decision|0|||
17114923|NCT04625972|38252898|FG000|Overall Study|Protocol Violation|0|||
17114924|NCT04625972|38252899|FG001|Overall Study|Protocol Violation|1|||
17114925|NCT04625972|38252898|FG000|Overall Study|Ongoing in Study|741|||
17114926|NCT04625972|38252899|FG001|Overall Study|Ongoing in Study|369|||
17114927|NCT04625972|38252898|FG000|Overall Study|Lost to Follow-up|2|||
17114928|NCT04625972|38252899|FG001|Overall Study|Lost to Follow-up|0|||
17114929|NCT04625972|38252898|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|5|||
17114930|NCT04625972|38252899|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|2|||
17114931|NCT04625972|38252898|FG000|Overall Study|Withdrawal by Subject|7|||
17114932|NCT04625972|38252899|FG001|Overall Study|Withdrawal by Subject|3|||
17114933|NCT00234065|38252907|FG000|Overall Study|Adverse Event|268|||
17114934|NCT00234065|38252908|FG001|Overall Study|Adverse Event|166|||
17114935|NCT00234065|38252907|FG000|Overall Study|Withdrawal by Subject|73|||
17114936|NCT00234065|38252908|FG001|Overall Study|Withdrawal by Subject|56|||
17114937|NCT00234065|38252907|FG000|Overall Study|Physician Decision|23|||
17114938|NCT00234065|38252908|FG001|Overall Study|Physician Decision|22|||
17114939|NCT00234065|38252907|FG000|Overall Study|Not Classified|111|||
17114940|NCT00234065|38252908|FG001|Overall Study|Not Classified|112|||
17114941|NCT00233987|38252914|FG000|Overall Study|Withdrawal by Subject|1|||
17114942|NCT00233987|38252914|FG000|Overall Study|Lack of Efficacy|2|||
17114943|NCT00233987|38252914|FG000|Overall Study|Reason Under Review|1|||
17114944|NCT00233987|38252914|FG000|Overall Study|Other - Not Protocol Specified|5|||
16997712|NCT01012037|38141689|FG000|Overall Study|Withdrawal by Subject|0|||
16997713|NCT01012037|38141690|FG001|Overall Study|Withdrawal by Subject|4|||
16997714|NCT01012037|38141691|FG002|Overall Study|Withdrawal by Subject|1|||
16997715|NCT01012037|38141689|FG000|Overall Study|Other reason (not specified)|1|||
16997716|NCT01012037|38141690|FG001|Overall Study|Other reason (not specified)|1|||
16997717|NCT01012037|38141691|FG002|Overall Study|Other reason (not specified)|1|||
16997718|NCT00734032|38141703|FG000|Overall Study|Adverse Event|0|||
16997719|NCT00734032|38141704|FG001|Overall Study|Adverse Event|1|||
16997720|NCT00734032|38141705|FG002|Overall Study|Adverse Event|0|||
16997721|NCT00734032|38141706|FG003|Overall Study|Adverse Event|0|||
16997722|NCT01010633|38141718|FG000|Overall Study|Adverse Event|1|||
16997723|NCT01010633|38141719|FG001|Overall Study|Adverse Event|1|||
16997724|NCT01010633|38141718|FG000|Overall Study|Protocol Violation|1|||
16997725|NCT01010633|38141719|FG001|Overall Study|Protocol Violation|2|||
16856513|NCT01747915|37810120|FG001|Overall Study|Withdrawal by Subject|4|||
16856514|NCT01747915|37810121|FG002|Overall Study|Withdrawal by Subject|1|||
16856515|NCT01747915|37810119|FG000|Overall Study|Protocol Violation|1|||
16856516|NCT01747915|37810120|FG001|Overall Study|Protocol Violation|0|||
16856517|NCT01747915|37810121|FG002|Overall Study|Protocol Violation|0|||
16856518|NCT01747915|37810119|FG000|Overall Study|Pregnancy|0|||
16856519|NCT01747915|37810120|FG001|Overall Study|Pregnancy|0|||
16856520|NCT01747915|37810121|FG002|Overall Study|Pregnancy|1|||
16856521|NCT01961297|37810131|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
16941859|NCT00107172|38086500|FG000|Overall Study|Withdrawal by Subject|1|||
16941860|NCT00107172|38086501|FG001|Overall Study|Withdrawal by Subject|0|||
16941861|NCT00107172|38086500|FG000|Overall Study|Death|0|||
16941862|NCT00107172|38086501|FG001|Overall Study|Death|2|||
16941863|NCT00107172|38086500|FG000|Overall Study|Other Reason|4|||
16941864|NCT00107172|38086501|FG001|Overall Study|Other Reason|3|||
16941865|NCT01680965|38086515|FG000|Overall Study|Death|0|||
16941866|NCT01680965|38086516|FG001|Overall Study|Death|0|||
16941867|NCT01680965|38086517|FG002|Overall Study|Death|0|||
16941868|NCT01680965|38086518|FG003|Overall Study|Death|6|||
16941869|NCT01339923|38086533|FG000|Overall Study|Adverse Event|1|||
16941870|NCT01339923|38086534|FG001|Overall Study|Adverse Event|1|||
16941871|NCT01339923|38086535|FG002|Overall Study|Adverse Event|1|||
16941872|NCT01339923|38086536|FG003|Overall Study|Adverse Event|0|||
16941873|NCT01339923|38086537|FG004|Overall Study|Adverse Event|0|||
16941874|NCT01339923|38086538|FG005|Overall Study|Adverse Event|0|||
16941875|NCT01339923|38086539|FG006|Overall Study|Adverse Event|1|||
17114945|NCT00233987|38252914|FG000|Overall Study|Eligible but No Treatment Received|2|||
17114946|NCT00233987|38252914|FG000|Overall Study|Ineligible|4|||
17114947|NCT04623242|38252923|FG000|Overall Study|Withdrawal by Subject|7|||
17114948|NCT04623242|38252924|FG001|Overall Study|Withdrawal by Subject|12|||
16856522|NCT01961297|37810132|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
16856523|NCT01960907|37810140|FG000|Overall Study|Death|4|||
16856524|NCT01960907|37810141|FG001|Overall Study|Death|3|||
16856525|NCT01960907|37810140|FG000|Overall Study|Withdrawal by Subject|32|||
16856526|NCT01960907|37810141|FG001|Overall Study|Withdrawal by Subject|42|||
16856527|NCT01747837|37810152|FG000|Overall Study|Lost to Follow-up|5|||
16856528|NCT01747837|37810153|FG001|Overall Study|Lost to Follow-up|2|||
16856529|NCT01747837|37810152|FG000|Overall Study|Death|4|||
16856530|NCT01747837|37810153|FG001|Overall Study|Death|4|||
16856531|NCT01971203|37810161|FG000|Overall Study|Protocol Violation|3|||
16856532|NCT01971203|37810162|FG001|Overall Study|Protocol Violation|2|||
16856533|NCT01971203|37810161|FG000|Overall Study|Withdrawal by Subject|5|||
16856534|NCT01971203|37810162|FG001|Overall Study|Withdrawal by Subject|6|||
16856535|NCT01971203|37810161|FG000|Overall Study|Adverse Event|1|||
16856536|NCT01971203|37810162|FG001|Overall Study|Adverse Event|0|||
16856537|NCT01605877|37810168|FG000|Overall Study|Withdrawal by Subject|1|||
16856538|NCT01970501|37810192|FG000|Overall Study|Discontinuation of study by sponsor|16|||
16941876|NCT01339923|38086533|FG000|Overall Study|Inappropriate Enrollment|1|||
16941877|NCT01339923|38086534|FG001|Overall Study|Inappropriate Enrollment|0|||
16941878|NCT01339923|38086535|FG002|Overall Study|Inappropriate Enrollment|0|||
16941879|NCT01339923|38086536|FG003|Overall Study|Inappropriate Enrollment|0|||
16941880|NCT01339923|38086537|FG004|Overall Study|Inappropriate Enrollment|0|||
16941881|NCT01339923|38086538|FG005|Overall Study|Inappropriate Enrollment|1|||
16941882|NCT01339923|38086539|FG006|Overall Study|Inappropriate Enrollment|0|||
16941883|NCT01339923|38086533|FG000|Overall Study|Lost to Follow-up|4|||
16941884|NCT01339923|38086534|FG001|Overall Study|Lost to Follow-up|4|||
16941885|NCT01339923|38086535|FG002|Overall Study|Lost to Follow-up|0|||
16941886|NCT01339923|38086536|FG003|Overall Study|Lost to Follow-up|3|||
16941887|NCT01339923|38086537|FG004|Overall Study|Lost to Follow-up|1|||
16941888|NCT01339923|38086538|FG005|Overall Study|Lost to Follow-up|1|||
16941889|NCT01339923|38086539|FG006|Overall Study|Lost to Follow-up|5|||
16941890|NCT01339923|38086533|FG000|Overall Study|Protocol Violation|0|||
16941891|NCT01339923|38086534|FG001|Overall Study|Protocol Violation|0|||
16941892|NCT01339923|38086535|FG002|Overall Study|Protocol Violation|0|||
16941893|NCT01339923|38086536|FG003|Overall Study|Protocol Violation|0|||
16941894|NCT01339923|38086537|FG004|Overall Study|Protocol Violation|0|||
16941895|NCT01339923|38086538|FG005|Overall Study|Protocol Violation|3|||
16941896|NCT01339923|38086539|FG006|Overall Study|Protocol Violation|1|||
16941897|NCT01339923|38086533|FG000|Overall Study|Unable to Classify|1|||
17114949|NCT04623242|38252925|FG002|Overall Study|Withdrawal by Subject|5|||
16856539|NCT01970501|37810193|FG001|Overall Study|Discontinuation of study by sponsor|14|||
16856540|NCT01970501|37810192|FG000|Overall Study|Withdrawal by Subject|6|||
16856541|NCT01970501|37810193|FG001|Overall Study|Withdrawal by Subject|7|||
16856542|NCT01970501|37810192|FG000|Overall Study|Adverse Event|2|||
16941898|NCT01339923|38086534|FG001|Overall Study|Unable to Classify|0|||
16941899|NCT01339923|38086535|FG002|Overall Study|Unable to Classify|1|||
16941900|NCT01339923|38086536|FG003|Overall Study|Unable to Classify|0|||
16941901|NCT01339923|38086537|FG004|Overall Study|Unable to Classify|0|||
16941902|NCT01339923|38086538|FG005|Overall Study|Unable to Classify|1|||
16856543|NCT01970501|37810193|FG001|Overall Study|Adverse Event|4|||
16856544|NCT01970501|37810192|FG000|Overall Study|Death|1|||
16941903|NCT01339923|38086539|FG006|Overall Study|Unable to Classify|5|||
16941904|NCT01339923|38086533|FG000|Overall Study|Withdrawal by Subject|7|||
16941905|NCT01339923|38086534|FG001|Overall Study|Withdrawal by Subject|11|||
16941906|NCT01339923|38086535|FG002|Overall Study|Withdrawal by Subject|6|||
16941907|NCT01339923|38086536|FG003|Overall Study|Withdrawal by Subject|1|||
16941908|NCT01339923|38086537|FG004|Overall Study|Withdrawal by Subject|4|||
16941909|NCT01339923|38086538|FG005|Overall Study|Withdrawal by Subject|3|||
17114950|NCT04623242|38252926|FG003|Overall Study|Withdrawal by Subject|7|||
17114951|NCT04623242|38252927|FG004|Overall Study|Withdrawal by Subject|0|||
17114952|NCT04623242|38252923|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
17114953|NCT04623242|38252924|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
17114954|NCT04623242|38252925|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
17114955|NCT04623242|38252926|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
17114956|NCT04623242|38252927|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
17114957|NCT04623242|38252923|FG000|Overall Study|Subject unblinded to mutation status|0|||
17114958|NCT04623242|38252924|FG001|Overall Study|Subject unblinded to mutation status|0|||
17114959|NCT04623242|38252925|FG002|Overall Study|Subject unblinded to mutation status|0|||
17114960|NCT04623242|38252926|FG003|Overall Study|Subject unblinded to mutation status|13|||
17114961|NCT04623242|38252927|FG004|Overall Study|Subject unblinded to mutation status|0|||
17114962|NCT00233363|38252944|FG000|Overall Study|Adverse Event|1|||
17114963|NCT00233363|38252945|FG001|Overall Study|Adverse Event|2|||
17114964|NCT00233363|38252944|FG000|Overall Study|Lack of Efficacy|0|||
17114965|NCT00233363|38252945|FG001|Overall Study|Lack of Efficacy|2|||
17114966|NCT00233363|38252944|FG000|Overall Study|Withdrawal by Subject|1|||
16941910|NCT01339923|38086539|FG006|Overall Study|Withdrawal by Subject|2|||
16941911|NCT01380093|38086572|FG000|Naloxone Challenge Phase|Screen failures|21|||
17114967|NCT00233363|38252945|FG001|Overall Study|Withdrawal by Subject|1|||
17114968|NCT00233363|38252944|FG000|Overall Study|Aggravation of complication|1|||
17114969|NCT00233363|38252945|FG001|Overall Study|Aggravation of complication|0|||
17114970|NCT01147666|38252966|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
17114971|NCT01147666|38252967|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
17114972|NCT01147666|38252968|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
17114973|NCT01147666|38252969|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114974|NCT01147666|38252970|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114975|NCT01147666|38252971|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114976|NCT01147666|38252972|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114977|NCT01147666|38252973|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114978|NCT01147666|38252974|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16941912|NCT01380093|38086573|FG001|Naloxone Challenge Phase|Screen failures|0|||
16941913|NCT01380093|38086574|FG002|Naloxone Challenge Phase|Screen failures|0|||
17114979|NCT01147666|38252975|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114980|NCT01147666|38252976|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114981|NCT01147666|38252977|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114982|NCT01147666|38252978|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
17114983|NCT01147666|38252979|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
17114984|NCT01147666|38252980|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16941914|NCT01380093|38086575|FG003|Naloxone Challenge Phase|Screen failures|0|||
16941915|NCT01380093|38086576|FG004|Naloxone Challenge Phase|Screen failures|0|||
16941916|NCT01380093|38086577|FG005|Naloxone Challenge Phase|Screen failures|0|||
16941917|NCT01380093|38086578|FG006|Naloxone Challenge Phase|Screen failures|0|||
16941918|NCT01380093|38086579|FG007|Naloxone Challenge Phase|Screen failures|0|||
16941919|NCT01380093|38086580|FG008|Naloxone Challenge Phase|Screen failures|0|||
16941920|NCT01380093|38086572|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16941921|NCT01380093|38086573|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
16941922|NCT01380093|38086574|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16941923|NCT01380093|38086575|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16941924|NCT01380093|38086576|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16941925|NCT01380093|38086577|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16941926|NCT01380093|38086578|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16941927|NCT01380093|38086579|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16941928|NCT01380093|38086580|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16941929|NCT01380093|38086572|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16941930|NCT01380093|38086573|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
16941931|NCT01380093|38086574|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
16941932|NCT01380093|38086575|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16941933|NCT01380093|38086576|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16941934|NCT01380093|38086577|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16941935|NCT01380093|38086578|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16941936|NCT01380093|38086579|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16941937|NCT01380093|38086580|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16941938|NCT01380093|38086572|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16941939|NCT01380093|38086573|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
16941940|NCT01380093|38086574|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16941941|NCT01380093|38086575|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16941942|NCT01380093|38086576|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16941943|NCT01380093|38086577|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16941944|NCT01380093|38086578|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16941945|NCT01380093|38086579|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16941946|NCT01380093|38086580|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16941947|NCT01380093|38086572|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16941948|NCT01380093|38086573|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
16941949|NCT01380093|38086574|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
16941950|NCT01380093|38086575|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16941951|NCT01380093|38086576|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16941952|NCT01380093|38086577|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
17114985|NCT01147666|38252966|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
17114986|NCT01147666|38252967|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
17114987|NCT01147666|38252968|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
17114988|NCT01147666|38252969|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
17114989|NCT01147666|38252970|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
17114990|NCT01147666|38252971|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
17114991|NCT01147666|38252972|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
17114992|NCT01147666|38252973|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
17114993|NCT01147666|38252974|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
17114994|NCT01147666|38252975|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
17114995|NCT01147666|38252976|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
17114996|NCT01147666|38252977|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
17114997|NCT01147666|38252978|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
17114998|NCT01147666|38252979|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
17114999|NCT01147666|38252980|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
17115000|NCT01147666|38252966|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
17115001|NCT01147666|38252967|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
17115002|NCT01147666|38252968|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
17115003|NCT01147666|38252969|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
17115004|NCT01147666|38252970|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
17115005|NCT01147666|38252971|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
17115006|NCT01147666|38252972|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
17115007|NCT01147666|38252973|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
17115008|NCT01147666|38252974|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
17115009|NCT01147666|38252975|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
17115010|NCT01147666|38252976|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
17115011|NCT01147666|38252977|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
17115012|NCT01147666|38252978|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
17115013|NCT01147666|38252979|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
17115014|NCT01147666|38252980|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
17115015|NCT01147666|38252966|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
17115016|NCT01147666|38252967|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115017|NCT01147666|38252968|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115018|NCT01147666|38252969|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
17115019|NCT01147666|38252970|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115020|NCT01147666|38252971|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115021|NCT01147666|38252972|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115022|NCT01147666|38252973|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115023|NCT01147666|38252974|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115024|NCT01147666|38252975|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115025|NCT01147666|38252976|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
17115026|NCT01147666|38252977|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115027|NCT01147666|38252978|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115028|NCT01147666|38252979|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115029|NCT01147666|38252980|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
17115030|NCT01147666|38252966|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115031|NCT01147666|38252967|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115032|NCT01147666|38252968|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115033|NCT01147666|38252969|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115034|NCT01147666|38252970|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
17115035|NCT01147666|38252971|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
17115036|NCT01147666|38252972|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115037|NCT01147666|38252973|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
17115038|NCT01147666|38252974|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115039|NCT01147666|38252975|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
17115040|NCT01147666|38252976|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115041|NCT01147666|38252977|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
17115042|NCT01147666|38252978|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115043|NCT01147666|38252979|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
17115044|NCT01147666|38252980|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
17115045|NCT01147666|38252966|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115046|NCT01147666|38252967|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115047|NCT01147666|38252968|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115048|NCT01147666|38252969|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
17115049|NCT01147666|38252970|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115050|NCT01147666|38252971|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115051|NCT01147666|38252972|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115052|NCT01147666|38252973|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115053|NCT01147666|38252974|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115054|NCT01147666|38252975|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115055|NCT01147666|38252976|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
17115056|NCT01147666|38252977|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115057|NCT01147666|38252978|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115058|NCT01147666|38252979|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115059|NCT01147666|38252980|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
17115060|NCT01147666|38252966|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16941953|NCT01380093|38086578|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16941954|NCT01380093|38086579|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16941955|NCT01380093|38086580|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16941956|NCT01380093|38086572|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16941957|NCT01380093|38086573|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
16941958|NCT01380093|38086574|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
16941959|NCT01380093|38086575|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16941960|NCT01380093|38086576|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16941961|NCT01380093|38086577|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16941962|NCT01380093|38086578|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16941963|NCT01380093|38086579|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16941964|NCT01380093|38086580|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16941965|NCT01380093|38086572|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
16941966|NCT01380093|38086573|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
16941967|NCT01380093|38086574|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
16941968|NCT01380093|38086575|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
16941969|NCT01380093|38086576|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
16941970|NCT01380093|38086577|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
16941971|NCT01380093|38086578|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
16941972|NCT01380093|38086579|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
16941973|NCT01380093|38086580|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
16941974|NCT01380093|38086572|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16941975|NCT01380093|38086573|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16941976|NCT01380093|38086574|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
16941977|NCT01380093|38086575|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16941978|NCT01380093|38086576|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16941979|NCT01380093|38086577|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16941980|NCT01380093|38086578|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16941981|NCT01380093|38086579|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16941982|NCT01380093|38086580|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16941983|NCT01380093|38086572|FG000|Treatment Phase: Second Intervention|Other|0|||
16941984|NCT01380093|38086573|FG001|Treatment Phase: Second Intervention|Other|0|||
16941985|NCT01380093|38086574|FG002|Treatment Phase: Second Intervention|Other|0|||
16941986|NCT01380093|38086575|FG003|Treatment Phase: Second Intervention|Other|1|||
16941987|NCT01380093|38086576|FG004|Treatment Phase: Second Intervention|Other|0|||
16941988|NCT01380093|38086577|FG005|Treatment Phase: Second Intervention|Other|0|||
16941989|NCT01380093|38086578|FG006|Treatment Phase: Second Intervention|Other|0|||
16941990|NCT01380093|38086579|FG007|Treatment Phase: Second Intervention|Other|0|||
16941991|NCT01380093|38086580|FG008|Treatment Phase: Second Intervention|Other|0|||
16941992|NCT01380093|38086572|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
16941993|NCT01380093|38086573|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
16941994|NCT01380093|38086574|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
16941995|NCT01380093|38086575|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
16941996|NCT01380093|38086576|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
16941997|NCT01380093|38086577|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
16941998|NCT01380093|38086578|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
16941999|NCT01380093|38086579|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
16942000|NCT01380093|38086580|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
16942001|NCT01380093|38086572|FG000|Treatment Phase: Third Intervention|Other|0|||
16942002|NCT01380093|38086573|FG001|Treatment Phase: Third Intervention|Other|0|||
16942003|NCT01380093|38086574|FG002|Treatment Phase: Third Intervention|Other|0|||
16942004|NCT01380093|38086575|FG003|Treatment Phase: Third Intervention|Other|0|||
16942005|NCT01380093|38086576|FG004|Treatment Phase: Third Intervention|Other|0|||
17115061|NCT01147666|38252967|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115062|NCT01147666|38252968|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115063|NCT01147666|38252969|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115064|NCT01147666|38252970|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115065|NCT01147666|38252971|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115066|NCT01147666|38252972|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115067|NCT01147666|38252973|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115068|NCT01147666|38252974|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115069|NCT01147666|38252975|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115070|NCT01147666|38252976|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115071|NCT01147666|38252977|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
17115072|NCT01147666|38252978|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
17115073|NCT01147666|38252979|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
17115074|NCT01147666|38252980|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
17115075|NCT01147666|38252966|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
17115076|NCT01147666|38252967|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
17115077|NCT01147666|38252968|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
17115078|NCT01147666|38252969|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
17115079|NCT01147666|38252970|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
17115080|NCT01147666|38252971|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
17115081|NCT01147666|38252972|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
17115082|NCT01147666|38252973|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
17115083|NCT01147666|38252974|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
17115084|NCT01147666|38252975|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
17115085|NCT01147666|38252976|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
17115086|NCT01147666|38252977|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
17115087|NCT01147666|38252978|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
17115088|NCT01147666|38252979|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
17115089|NCT01147666|38252980|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
17115090|NCT01147666|38252966|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
17115091|NCT01147666|38252967|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
17115092|NCT01147666|38252968|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
17115093|NCT01147666|38252969|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
17115094|NCT01147666|38252970|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
17115095|NCT01147666|38252971|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
17115096|NCT01147666|38252972|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
17115097|NCT01147666|38252973|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
17115098|NCT01147666|38252974|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
17115099|NCT01147666|38252975|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
17115100|NCT01147666|38252976|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
17115101|NCT01147666|38252977|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
17115102|NCT01147666|38252978|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
17115103|NCT01147666|38252979|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
17115104|NCT01147666|38252980|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
17115105|NCT01147666|38252966|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115106|NCT01147666|38252967|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115107|NCT01147666|38252968|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115108|NCT01147666|38252969|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
17115109|NCT01147666|38252970|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115110|NCT01147666|38252971|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115111|NCT01147666|38252972|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115112|NCT01147666|38252973|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115113|NCT01147666|38252974|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115114|NCT01147666|38252975|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115115|NCT01147666|38252976|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115116|NCT01147666|38252977|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115117|NCT01147666|38252978|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115118|NCT01147666|38252979|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
17115119|NCT01147666|38252980|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16942006|NCT01380093|38086577|FG005|Treatment Phase: Third Intervention|Other|0|||
17115120|NCT01147666|38252966|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115121|NCT01147666|38252967|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115122|NCT01147666|38252968|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115123|NCT01147666|38252969|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115124|NCT01147666|38252970|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
17115125|NCT01147666|38252971|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
17115126|NCT01147666|38252972|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115127|NCT01147666|38252973|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
17115128|NCT01147666|38252974|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115129|NCT01147666|38252975|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
17115130|NCT01147666|38252976|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115131|NCT01147666|38252977|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115132|NCT01147666|38252978|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115133|NCT01147666|38252979|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
17115134|NCT01147666|38252980|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
17115135|NCT01147666|38252966|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115136|NCT01147666|38252967|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115137|NCT01147666|38252968|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115138|NCT01147666|38252969|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
17115139|NCT01147666|38252970|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115140|NCT01147666|38252971|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115141|NCT01147666|38252972|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115142|NCT01147666|38252973|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115143|NCT01147666|38252974|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115144|NCT01147666|38252975|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115145|NCT01147666|38252976|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
17115146|NCT01147666|38252977|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115147|NCT01147666|38252978|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115148|NCT01147666|38252979|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115149|NCT01147666|38252980|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
17115150|NCT01147666|38252966|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115151|NCT01147666|38252967|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115152|NCT01147666|38252968|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115153|NCT01147666|38252969|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115154|NCT01147666|38252970|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115155|NCT01147666|38252971|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115156|NCT01147666|38252972|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115157|NCT01147666|38252973|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115158|NCT01147666|38252974|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115159|NCT01147666|38252975|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115160|NCT01147666|38252976|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115161|NCT01147666|38252977|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115162|NCT01147666|38252978|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
17115163|NCT01147666|38252979|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115164|NCT01147666|38252980|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
17115165|NCT01147666|38252966|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115166|NCT01147666|38252967|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115167|NCT01147666|38252968|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115168|NCT01147666|38252969|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115169|NCT01147666|38252970|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115170|NCT01147666|38252971|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115171|NCT01147666|38252972|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115172|NCT01147666|38252973|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115173|NCT01147666|38252974|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115174|NCT01147666|38252975|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115175|NCT01147666|38252976|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115176|NCT01147666|38252977|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115177|NCT01147666|38252978|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
17115178|NCT01147666|38252979|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
17115179|NCT01147666|38252980|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
17115180|NCT00256295|38253042|FG000|Overall Study|Withdrawal by Subject|3|||
17115181|NCT00256295|38253042|FG000|Overall Study|Death|1|||
17115182|NCT02877004|38253049|FG000|Overall Study|Pregnancy|0|||
17115183|NCT02877004|38253050|FG001|Overall Study|Pregnancy|0|||
17115184|NCT02877004|38253051|FG002|Overall Study|Pregnancy|1|||
17115185|NCT04617860|38253081|FG000|Overall Study|Adverse Event|0|||
17115186|NCT04617860|38253082|FG001|Overall Study|Adverse Event|2|||
17115187|NCT04617860|38253083|FG002|Overall Study|Adverse Event|2|||
17115188|NCT04617860|38253081|FG000|Overall Study|Withdrawal by Subject|0|||
16942007|NCT01380093|38086578|FG006|Treatment Phase: Third Intervention|Other|0|||
17115189|NCT04617860|38253082|FG001|Overall Study|Withdrawal by Subject|0|||
17115190|NCT04617860|38253083|FG002|Overall Study|Withdrawal by Subject|2|||
17115191|NCT04617860|38253081|FG000|Overall Study|Physician Decision|0|||
17115192|NCT04617860|38253082|FG001|Overall Study|Physician Decision|1|||
17115193|NCT04617860|38253083|FG002|Overall Study|Physician Decision|0|||
17115194|NCT04617860|38253081|FG000|Overall Study|Sponsor Decision|0|||
17115195|NCT04617860|38253082|FG001|Overall Study|Sponsor Decision|3|||
17115196|NCT04617860|38253083|FG002|Overall Study|Sponsor Decision|1|||
17115197|NCT04617860|38253081|FG000|Overall Study|Termination of Study by Sponsor|8|||
17115198|NCT04617860|38253082|FG001|Overall Study|Termination of Study by Sponsor|4|||
17115199|NCT04617860|38253083|FG002|Overall Study|Termination of Study by Sponsor|13|||
17115200|NCT04608500|38253095|FG000|Overall Study|Adverse Event|2|||
17115201|NCT04608500|38253096|FG001|Overall Study|Adverse Event|0|||
17115202|NCT04608500|38253095|FG000|Overall Study|Lost to Follow-up|15|||
17115203|NCT04608500|38253096|FG001|Overall Study|Lost to Follow-up|9|||
17115204|NCT04608500|38253095|FG000|Overall Study|Participant request|11|||
17115205|NCT04608500|38253096|FG001|Overall Study|Participant request|7|||
17115206|NCT04608500|38253095|FG000|Overall Study|Protocol Violation|1|||
17115207|NCT04608500|38253096|FG001|Overall Study|Protocol Violation|0|||
17115208|NCT04608500|38253095|FG000|Overall Study|Other|6|||
17115209|NCT04608500|38253096|FG001|Overall Study|Other|2|||
17115210|NCT04585646|38253102|FG000|First Intervention|Physician Decision|1|||
17115211|NCT04585646|38253103|FG001|First Intervention|Physician Decision|0|||
17115212|NCT04585646|38253102|FG000|First Intervention|Lost to Follow-up|0|||
17115213|NCT04585646|38253103|FG001|First Intervention|Lost to Follow-up|3|||
17115214|NCT04585646|38253102|FG000|First Intervention|Withdrawal by Subject|0|||
17115215|NCT04585646|38253103|FG001|First Intervention|Withdrawal by Subject|1|||
17115216|NCT04584788|38253119|FG000|Overall Study|Physician Decision|8|||
17115217|NCT04584788|38253119|FG000|Overall Study|Withdrawal by Subject|1|||
17115218|NCT04584788|38253119|FG000|Overall Study|Adverse Event|3|||
17115219|NCT04575038|38253125|FG000|Overall Study|Withdrawal by Subject|1|||
17115220|NCT04575038|38253126|FG001|Overall Study|Withdrawal by Subject|1|||
17115221|NCT03066622|38253134|FG000|Overall Study|Lost to Follow-up|24|||
17115222|NCT03066622|38253135|FG001|Overall Study|Lost to Follow-up|25|||
17115223|NCT03066622|38253134|FG000|Overall Study|Withdrawal by Subject|2|||
17115224|NCT03066622|38253135|FG001|Overall Study|Withdrawal by Subject|1|||
17115225|NCT04501952|38253167|FG000|Overall Study|Adverse Event|0|||
17115226|NCT04501952|38253168|FG001|Overall Study|Adverse Event|3|||
17115227|NCT04501952|38253167|FG000|Overall Study|Investigator's Discretion|0|||
17115228|NCT04501952|38253168|FG001|Overall Study|Investigator's Discretion|1|||
17115229|NCT04501952|38253167|FG000|Overall Study|Protocol Violation|1|||
17115230|NCT04501952|38253168|FG001|Overall Study|Protocol Violation|1|||
17115231|NCT04501952|38253167|FG000|Overall Study|Withdrew Consent|5|||
17115232|NCT04501952|38253168|FG001|Overall Study|Withdrew Consent|4|||
17115233|NCT04501952|38253167|FG000|Overall Study|Lost to Follow-up|7|||
17115234|NCT04501952|38253168|FG001|Overall Study|Lost to Follow-up|2|||
17115235|NCT04501952|38253167|FG000|Overall Study|Randomized and Never Treated|13|||
17115236|NCT04501952|38253168|FG001|Overall Study|Randomized and Never Treated|9|||
17115237|NCT02930122|38253186|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
17115238|NCT02930122|38253187|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
17115239|NCT04546724|38253196|FG000|Overall Study|Withdrawal by Subject|37|||
17115240|NCT04546724|38253197|FG001|Overall Study|Withdrawal by Subject|10|||
17115241|NCT04546724|38253196|FG000|Overall Study|Adverse Event|1|||
17115242|NCT04546724|38253197|FG001|Overall Study|Adverse Event|1|||
17115243|NCT04546724|38253196|FG000|Overall Study|Lost to Follow-up|30|||
17115244|NCT04546724|38253197|FG001|Overall Study|Lost to Follow-up|10|||
17115245|NCT04546724|38253196|FG000|Overall Study|Physician Decision|4|||
17115246|NCT04546724|38253197|FG001|Overall Study|Physician Decision|1|||
17115247|NCT04546724|38253196|FG000|Overall Study|Subject Moved|2|||
17115248|NCT04546724|38253197|FG001|Overall Study|Subject Moved|0|||
16942008|NCT01380093|38086579|FG007|Treatment Phase: Third Intervention|Other|0|||
16942009|NCT01380093|38086580|FG008|Treatment Phase: Third Intervention|Other|1|||
16942010|NCT01379937|38086598|FG000|Overall Study|Protocol Violation|0|||
16942011|NCT01379937|38086599|FG001|Overall Study|Protocol Violation|0|||
16942012|NCT01379937|38086600|FG002|Overall Study|Protocol Violation|0|||
16942013|NCT01379937|38086601|FG003|Overall Study|Protocol Violation|1|||
16942014|NCT01379937|38086598|FG000|Overall Study|Consent withdrawal|0|||
16942015|NCT01379937|38086599|FG001|Overall Study|Consent withdrawal|1|||
16942016|NCT01379937|38086600|FG002|Overall Study|Consent withdrawal|0|||
16942017|NCT01379937|38086601|FG003|Overall Study|Consent withdrawal|0|||
16942018|NCT01379937|38086598|FG000|Overall Study|Lost to Follow-up|1|||
16942019|NCT01379937|38086599|FG001|Overall Study|Lost to Follow-up|2|||
16942020|NCT01379937|38086600|FG002|Overall Study|Lost to Follow-up|2|||
17115249|NCT04546724|38253196|FG000|Overall Study|Subject Praticipating in another trial|0|||
17115250|NCT04546724|38253197|FG001|Overall Study|Subject Praticipating in another trial|1|||
17115251|NCT04546724|38253196|FG000|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|49|||
17115252|NCT04546724|38253197|FG001|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|12|||
17115253|NCT03697460|38253207|FG000|Overall Study|Withdrawal by Subject|3|||
17115254|NCT04498832|38253213|FG000|Overall Study|Adverse Event|1|||
17115255|NCT04498832|38253214|FG001|Overall Study|Adverse Event|3|||
17115256|NCT04498832|38253213|FG000|Overall Study|Withdrawal by Subject|0|||
17115257|NCT04498832|38253214|FG001|Overall Study|Withdrawal by Subject|1|||
17115258|NCT00070018|38253220|FG000|Overall Study|Adverse Event|2|||
16942021|NCT01379937|38086601|FG003|Overall Study|Lost to Follow-up|0|||
16942022|NCT01379781|38086627|FG000|Overall Study|Lost to Follow-up|11|||
16942023|NCT01379781|38086628|FG001|Overall Study|Lost to Follow-up|8|||
16942024|NCT01379703|38086634|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
16942025|NCT01379703|38086635|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
16942026|NCT01379703|38086636|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
16942027|NCT01379703|38086634|FG000|Study Start Through 9 Months|Adverse Event|0|||
16942028|NCT01379703|38086635|FG001|Study Start Through 9 Months|Adverse Event|14|||
16942029|NCT01379703|38086636|FG002|Study Start Through 9 Months|Adverse Event|10|||
16942030|NCT01379703|38086634|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
17115259|NCT00070018|38253220|FG000|Overall Study|Lack of Efficacy|1|||
17115260|NCT00070018|38253220|FG000|Overall Study|Withdrawal by Subject|1|||
17115261|NCT00231413|38253231|FG000|Overall Study|Non-serious AE|0|||
17115262|NCT00231413|38253232|FG001|Overall Study|Non-serious AE|0|||
17115263|NCT00231413|38253233|FG002|Overall Study|Non-serious AE|1|||
17115264|NCT00231413|38253234|FG003|Overall Study|Non-serious AE|0|||
17115265|NCT00231413|38253235|FG004|Overall Study|Non-serious AE|0|||
17115266|NCT00231413|38253236|FG005|Overall Study|Non-serious AE|0|||
17115267|NCT00231413|38253237|FG006|Overall Study|Non-serious AE|1|||
17115268|NCT00231413|38253231|FG000|Overall Study|Withdrawal by Subject|3|||
17115269|NCT00231413|38253232|FG001|Overall Study|Withdrawal by Subject|1|||
17115270|NCT00231413|38253233|FG002|Overall Study|Withdrawal by Subject|4|||
17115271|NCT00231413|38253234|FG003|Overall Study|Withdrawal by Subject|2|||
16942031|NCT01379703|38086635|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
16942032|NCT01379703|38086636|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
16942033|NCT01379703|38086634|FG000|Study Start Through 9 Months|Treatment Failure|0|||
16942034|NCT01379703|38086635|FG001|Study Start Through 9 Months|Treatment Failure|2|||
16942035|NCT01379703|38086636|FG002|Study Start Through 9 Months|Treatment Failure|2|||
16942036|NCT01379703|38086634|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
16942037|NCT01379703|38086635|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
17028200|NCT00767000|38172626|FG001|54-week Study|Hypoglycemia|1|||
17028201|NCT00767000|38172627|FG002|54-week Study|Hypoglycemia|0|||
17028202|NCT00767000|38172628|FG003|54-week Study|Hypoglycemia|0|||
17028203|NCT00767000|38172629|FG004|54-week Study|Hypoglycemia|0|||
17028204|NCT00767000|38172625|FG000|54-week Study|Interruption of study medication|0|||
17028205|NCT00767000|38172626|FG001|54-week Study|Interruption of study medication|0|||
17028206|NCT00767000|38172627|FG002|54-week Study|Interruption of study medication|1|||
17028207|NCT00767000|38172628|FG003|54-week Study|Interruption of study medication|0|||
17028208|NCT00767000|38172629|FG004|54-week Study|Interruption of study medication|0|||
17028209|NCT00767000|38172625|FG000|54-week Study|Lack of Efficacy|2|||
17028210|NCT00767000|38172626|FG001|54-week Study|Lack of Efficacy|0|||
17028211|NCT00767000|38172627|FG002|54-week Study|Lack of Efficacy|1|||
17028212|NCT00767000|38172628|FG003|54-week Study|Lack of Efficacy|0|||
17028213|NCT00767000|38172629|FG004|54-week Study|Lack of Efficacy|5|||
17028214|NCT00767000|38172625|FG000|54-week Study|Lost to Follow-up|4|||
17028215|NCT00767000|38172626|FG001|54-week Study|Lost to Follow-up|0|||
17028216|NCT00767000|38172627|FG002|54-week Study|Lost to Follow-up|1|||
17028217|NCT00767000|38172628|FG003|54-week Study|Lost to Follow-up|4|||
17028218|NCT00767000|38172629|FG004|54-week Study|Lost to Follow-up|2|||
17028219|NCT00767000|38172625|FG000|54-week Study|Physician Decision|4|||
17028220|NCT00767000|38172626|FG001|54-week Study|Physician Decision|0|||
17028221|NCT00767000|38172627|FG002|54-week Study|Physician Decision|1|||
17028222|NCT00767000|38172628|FG003|54-week Study|Physician Decision|1|||
17028223|NCT00767000|38172629|FG004|54-week Study|Physician Decision|1|||
17028224|NCT00767000|38172625|FG000|54-week Study|Progressive disease|0|||
17028225|NCT00767000|38172626|FG001|54-week Study|Progressive disease|0|||
17028226|NCT00767000|38172627|FG002|54-week Study|Progressive disease|1|||
17028227|NCT00767000|38172628|FG003|54-week Study|Progressive disease|0|||
17028228|NCT00767000|38172629|FG004|54-week Study|Progressive disease|0|||
17028229|NCT00767000|38172625|FG000|54-week Study|Protocol Violation|0|||
17028230|NCT00767000|38172626|FG001|54-week Study|Protocol Violation|0|||
17028231|NCT00767000|38172627|FG002|54-week Study|Protocol Violation|1|||
17028232|NCT00767000|38172628|FG003|54-week Study|Protocol Violation|2|||
17028233|NCT00767000|38172629|FG004|54-week Study|Protocol Violation|0|||
17028234|NCT00767000|38172625|FG000|54-week Study|Withdrawal by Subject|2|||
17028235|NCT00767000|38172626|FG001|54-week Study|Withdrawal by Subject|3|||
17028236|NCT00767000|38172627|FG002|54-week Study|Withdrawal by Subject|5|||
17028237|NCT00767000|38172628|FG003|54-week Study|Withdrawal by Subject|11|||
17028238|NCT00767000|38172629|FG004|54-week Study|Withdrawal by Subject|13|||
17028239|NCT00767000|38172625|FG000|54-week Study|Study terminated by sponsor|90|||
17028240|NCT00767000|38172626|FG001|54-week Study|Study terminated by sponsor|102|||
17028241|NCT00767000|38172627|FG002|54-week Study|Study terminated by sponsor|89|||
17028242|NCT00767000|38172628|FG003|54-week Study|Study terminated by sponsor|196|||
17028243|NCT00767000|38172629|FG004|54-week Study|Study terminated by sponsor|194|||
17028244|NCT00767000|38172625|FG000|54-week Study|Reason not reported|0|||
17028245|NCT00767000|38172626|FG001|54-week Study|Reason not reported|0|||
17028246|NCT00767000|38172627|FG002|54-week Study|Reason not reported|0|||
17028247|NCT00767000|38172628|FG003|54-week Study|Reason not reported|1|||
17028248|NCT00767000|38172629|FG004|54-week Study|Reason not reported|0|||
17028249|NCT00767000|38172625|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
17028250|NCT00767000|38172626|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
17028251|NCT00767000|38172627|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
17028252|NCT00767000|38172628|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
17028253|NCT00767000|38172629|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
17028254|NCT00724932|38172643|FG000|Overall Study|Lost to Follow-up|1|||
17028255|NCT00724932|38172644|FG001|Overall Study|Lost to Follow-up|0|||
17028256|NCT00724932|38172643|FG000|Overall Study|Not treated|4|||
17028257|NCT00724932|38172644|FG001|Overall Study|Not treated|3|||
17028258|NCT00766532|38172652|FG000|Overall Study|Protocol Violation|2|||
17028259|NCT00774566|38172658|FG000|Overall Study|Protocol Violation|18|||
17028260|NCT00774566|38172659|FG001|Overall Study|Protocol Violation|15|||
17028261|NCT00766376|38172665|FG000|Overall Study|Withdrawal by Subject|27|||
17028262|NCT00587054|38172669|FG000|Overall Study|Patient not treated|9|||
17028263|NCT00766142|38172673|FG000|Overall Study|Protocol Violation|4|||
17028264|NCT00724854|38172679|FG000|Overall Study|Lack of Efficacy|187|||
17028265|NCT00724854|38172680|FG001|Overall Study|Lack of Efficacy|13|||
17028266|NCT00724854|38172679|FG000|Overall Study|Lost to Follow-up|87|||
17028267|NCT00724854|38172680|FG001|Overall Study|Lost to Follow-up|10|||
17028268|NCT00724854|38172679|FG000|Overall Study|Adverse Event|62|||
17028269|NCT00724854|38172680|FG001|Overall Study|Adverse Event|4|||
17028270|NCT00724854|38172679|FG000|Overall Study|Other|42|||
17028271|NCT00724854|38172680|FG001|Overall Study|Other|3|||
17028272|NCT00724854|38172679|FG000|Overall Study|Death|11|||
17028273|NCT00724854|38172680|FG001|Overall Study|Death|0|||
17028274|NCT00724854|38172679|FG000|Overall Study|Change of treatment|7|||
17028275|NCT00724854|38172680|FG001|Overall Study|Change of treatment|0|||
17028276|NCT00724854|38172679|FG000|Overall Study|Withdrawal by Subject|5|||
17028277|NCT00724854|38172680|FG001|Overall Study|Withdrawal by Subject|0|||
17028278|NCT00724854|38172679|FG000|Overall Study|Adverse event + lack of efficacy|2|||
17028279|NCT00724854|38172680|FG001|Overall Study|Adverse event + lack of efficacy|1|||
17028280|NCT00728988|38172689|FG000|Overall Study|Not Treated|2|||
17028281|NCT00728988|38172690|FG001|Overall Study|Not Treated|2|||
17028282|NCT00728988|38172689|FG000|Overall Study|Death|1|||
17028283|NCT00728988|38172690|FG001|Overall Study|Death|1|||
17028284|NCT00728988|38172689|FG000|Overall Study|Adverse Event|3|||
17028285|NCT00728988|38172690|FG001|Overall Study|Adverse Event|2|||
17028286|NCT00728988|38172689|FG000|Overall Study|Other|85|||
17028287|NCT00728988|38172690|FG001|Overall Study|Other|77|||
17028288|NCT00728988|38172689|FG000|Overall Study|Withdrawal by Subject|2|||
17028289|NCT00728988|38172690|FG001|Overall Study|Withdrawal by Subject|6|||
17028290|NCT00728754|38172699|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
17028291|NCT00728754|38172700|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
17028292|NCT00728754|38172699|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
17028293|NCT00728754|38172700|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
17028294|NCT00728754|38172699|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
17028295|NCT00728754|38172700|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
17028296|NCT00728130|38172706|FG000|Overall Study|Withdrawal by Subject|1|||
17028297|NCT00728130|38172706|FG000|Overall Study|Paperwork not completed in time|1|||
17028298|NCT00728130|38172706|FG000|Overall Study|Physician Decision|1|||
17028299|NCT00735696|38172710|FG000|Overall Study|Withdrawal by Subject|1|||
17115272|NCT00231413|38253235|FG004|Overall Study|Withdrawal by Subject|2|||
17115273|NCT00231413|38253236|FG005|Overall Study|Withdrawal by Subject|0|||
17115274|NCT00231413|38253237|FG006|Overall Study|Withdrawal by Subject|3|||
17115275|NCT00231413|38253231|FG000|Overall Study|Migrated/moved from study area|0|||
17115276|NCT00231413|38253232|FG001|Overall Study|Migrated/moved from study area|0|||
17115277|NCT00231413|38253233|FG002|Overall Study|Migrated/moved from study area|1|||
17115278|NCT00231413|38253234|FG003|Overall Study|Migrated/moved from study area|0|||
17115279|NCT00231413|38253235|FG004|Overall Study|Migrated/moved from study area|0|||
17115280|NCT00231413|38253236|FG005|Overall Study|Migrated/moved from study area|1|||
17115281|NCT00231413|38253237|FG006|Overall Study|Migrated/moved from study area|0|||
17115282|NCT00231413|38253231|FG000|Overall Study|Lost to Follow-up|4|||
17115283|NCT00231413|38253232|FG001|Overall Study|Lost to Follow-up|4|||
17115284|NCT00231413|38253233|FG002|Overall Study|Lost to Follow-up|1|||
17115285|NCT00231413|38253234|FG003|Overall Study|Lost to Follow-up|1|||
17115286|NCT00231413|38253235|FG004|Overall Study|Lost to Follow-up|1|||
17115287|NCT00231413|38253236|FG005|Overall Study|Lost to Follow-up|4|||
17115288|NCT00231413|38253237|FG006|Overall Study|Lost to Follow-up|0|||
17115289|NCT00231413|38253231|FG000|Overall Study|Pregnancy|1|||
17115290|NCT00231413|38253232|FG001|Overall Study|Pregnancy|0|||
17115291|NCT00231413|38253233|FG002|Overall Study|Pregnancy|0|||
17115292|NCT00231413|38253234|FG003|Overall Study|Pregnancy|0|||
17115293|NCT00231413|38253235|FG004|Overall Study|Pregnancy|0|||
17115294|NCT00231413|38253236|FG005|Overall Study|Pregnancy|0|||
17115295|NCT00231413|38253237|FG006|Overall Study|Pregnancy|0|||
17115296|NCT04494646|38253255|FG000|Overall Study|Adverse Event|0|||
17115297|NCT04494646|38253256|FG001|Overall Study|Adverse Event|1|||
17115298|NCT04494646|38253255|FG000|Overall Study|Withdrawal by Subject|0|||
17115299|NCT04494646|38253256|FG001|Overall Study|Withdrawal by Subject|1|||
17115300|NCT04529096|38253264|FG000|Overall Study|Adverse Event|6|||
17115301|NCT04529096|38253265|FG001|Overall Study|Adverse Event|1|||
17115302|NCT04529096|38253264|FG000|Overall Study|Lack of Efficacy|1|||
17115303|NCT04529096|38253265|FG001|Overall Study|Lack of Efficacy|0|||
17115304|NCT04529096|38253264|FG000|Overall Study|Lost to Follow-up|1|||
17115305|NCT04529096|38253265|FG001|Overall Study|Lost to Follow-up|1|||
17115306|NCT04529096|38253264|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17115307|NCT04529096|38253265|FG001|Overall Study|Non-Compliance With Study Drug|1|||
17115308|NCT04529096|38253264|FG000|Overall Study|Physician Decision|1|||
17115309|NCT04529096|38253265|FG001|Overall Study|Physician Decision|3|||
17115310|NCT04529096|38253264|FG000|Overall Study|Withdrawal by Subject|5|||
17115311|NCT04529096|38253265|FG001|Overall Study|Withdrawal by Subject|0|||
17115312|NCT00231179|38253273|FG000|Overall Study|Lost to Follow-up|21|||
17115313|NCT00231179|38253274|FG001|Overall Study|Lost to Follow-up|21|||
17115314|NCT00231179|38253273|FG000|Overall Study|Withdrawal by Subject|3|||
17115315|NCT00231179|38253274|FG001|Overall Study|Withdrawal by Subject|3|||
17188948|NCT02508532|38341871|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
17188949|NCT02918071|38341900|FG000|Overall Study|Withdrawal by Subject|2|||
17188950|NCT02918071|38341900|FG000|Overall Study|Lost to Follow-up|1|||
17188951|NCT02507752|38341904|FG000|Overall Study|Adverse Event|1|||
17188952|NCT02507752|38341904|FG000|Overall Study|Protocol Violation|6|||
17188953|NCT02507752|38341904|FG000|Overall Study|Lost to Follow-up|7|||
17188954|NCT02507752|38341904|FG000|Overall Study|Infusion reaction at first infusion|1|||
17188955|NCT02507752|38341904|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
17188956|NCT02507752|38341904|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
17188957|NCT02506816|38341908|FG000|Overall Study|Adverse Event|3|||
17188958|NCT02506036|38341914|FG000|First Intervention (4-6 Weeks)|Death|1|||
17188959|NCT02506036|38341915|FG001|First Intervention (4-6 Weeks)|Death|0|||
17188960|NCT02506036|38341914|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
17188961|NCT02506036|38341915|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
17188962|NCT02506036|38341914|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
17188963|NCT02506036|38341915|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
17188964|NCT01063855|38341923|FG000|Overall Study|Adverse Event|4|||
17188965|NCT01063855|38341924|FG001|Overall Study|Adverse Event|4|||
17188966|NCT01063855|38341923|FG000|Overall Study|Death|0|||
16856545|NCT01970501|37810193|FG001|Overall Study|Death|3|||
16856546|NCT01970501|37810192|FG000|Overall Study|Physician Decision|2|||
16856547|NCT01970501|37810193|FG001|Overall Study|Physician Decision|0|||
16856548|NCT01969799|37810201|FG000|Overall Study|Adverse Event|0|||
16856549|NCT01969799|37810202|FG001|Overall Study|Adverse Event|1|||
16856550|NCT01969799|37810201|FG000|Overall Study|Death|16|||
16856551|NCT01969799|37810202|FG001|Overall Study|Death|11|||
16856552|NCT01969799|37810201|FG000|Overall Study|Lost to Follow-up|0|||
17188967|NCT01063855|38341924|FG001|Overall Study|Death|1|||
17188968|NCT01063855|38341923|FG000|Overall Study|Lost to Follow-up|8|||
17188969|NCT01063855|38341924|FG001|Overall Study|Lost to Follow-up|4|||
17115316|NCT00229931|38253282|FG000|Overall Study|Death|1|||
17115317|NCT00229931|38253283|FG001|Overall Study|Death|0|||
17115318|NCT00229931|38253282|FG000|Overall Study|Lost to Follow-up|3|||
17115319|NCT00229931|38253283|FG001|Overall Study|Lost to Follow-up|2|||
17115320|NCT03135028|38253289|FG000|Overall Study|Death|6|||
17115321|NCT03135028|38253289|FG000|Overall Study|Study Terminated by Sponsor|2|||
17115322|NCT03135028|38253289|FG000|Overall Study|Withdrew Consent|1|||
17115323|NCT00228917|38253301|FG000|Overall Study|Migrated/moved from study area|0|||
17115324|NCT00228917|38253302|FG001|Overall Study|Migrated/moved from study area|0|||
17115325|NCT00228917|38253303|FG002|Overall Study|Migrated/moved from study area|0|||
17115326|NCT00228917|38253304|FG003|Overall Study|Migrated/moved from study area|0|||
17115327|NCT00228917|38253305|FG004|Overall Study|Migrated/moved from study area|0|||
17115328|NCT00228917|38253306|FG005|Overall Study|Migrated/moved from study area|2|||
17115329|NCT00228917|38253307|FG006|Overall Study|Migrated/moved from study area|0|||
17115330|NCT00228917|38253308|FG007|Overall Study|Migrated/moved from study area|0|||
17115331|NCT00227903|38253324|FG000|Overall Study|Withdrawal by Subject|2|||
17115332|NCT00227903|38253325|FG001|Overall Study|Withdrawal by Subject|5|||
17115333|NCT00227903|38253324|FG000|Overall Study|Subject moved out of area|1|||
17115334|NCT00227903|38253325|FG001|Overall Study|Subject moved out of area|2|||
17115335|NCT00227903|38253324|FG000|Overall Study|Lost to Follow-up|1|||
16942038|NCT01379703|38086636|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
16942039|NCT01379703|38086634|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
16942040|NCT01379703|38086635|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
16942041|NCT01379703|38086636|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
16942042|NCT01379703|38086634|FG000|Study Start Through 9 Months|Medication not available|0|||
16942043|NCT01379703|38086635|FG001|Study Start Through 9 Months|Medication not available|2|||
16942044|NCT01379703|38086636|FG002|Study Start Through 9 Months|Medication not available|1|||
16942045|NCT01379703|38086634|FG000|Study Start Through 9 Months|Poor general condition|0|||
16942046|NCT01379703|38086635|FG001|Study Start Through 9 Months|Poor general condition|1|||
16942047|NCT01379703|38086636|FG002|Study Start Through 9 Months|Poor general condition|0|||
16942048|NCT01379703|38086634|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
16942049|NCT01379703|38086635|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
16942050|NCT01379703|38086636|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
16942051|NCT01379703|38086634|FG000|Study Start Through 9 Months|Reason unknown|2|||
16942052|NCT01379703|38086635|FG001|Study Start Through 9 Months|Reason unknown|31|||
16942053|NCT01379703|38086636|FG002|Study Start Through 9 Months|Reason unknown|24|||
16942054|NCT01379703|38086634|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
16942055|NCT01379703|38086635|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
16942056|NCT01379703|38086636|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
16942057|NCT01379703|38086634|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
16942058|NCT01379703|38086635|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
16942059|NCT01379703|38086636|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
16942060|NCT01379703|38086634|FG000|9 Months Through 18 Months|Adverse Event|0|||
16942061|NCT01379703|38086635|FG001|9 Months Through 18 Months|Adverse Event|6|||
16942062|NCT01379703|38086636|FG002|9 Months Through 18 Months|Adverse Event|0|||
16942063|NCT01379703|38086634|FG000|9 Months Through 18 Months|Treatment failure|0|||
16942064|NCT01379703|38086635|FG001|9 Months Through 18 Months|Treatment failure|5|||
17090018|NCT00271596|38230122|FG001|Overall Study|Protocol Violation|0|||
17090019|NCT00271596|38230121|FG000|Overall Study|Withdrawal by Subject|0|||
17090020|NCT00271596|38230122|FG001|Overall Study|Withdrawal by Subject|1|||
17115336|NCT00227903|38253325|FG001|Overall Study|Lost to Follow-up|3|||
17115337|NCT00227903|38253324|FG000|Overall Study|Miscarriage|1|||
17115338|NCT00227903|38253325|FG001|Overall Study|Miscarriage|0|||
17115339|NCT04411628|38253335|FG000|Overall Study|Withdrawal by Subject|1|||
17115340|NCT04411628|38253336|FG001|Overall Study|Withdrawal by Subject|1|||
17115341|NCT04411628|38253337|FG002|Overall Study|Withdrawal by Subject|2|||
17090021|NCT00291642|38230133|FG000|Overall Study|Adverse Event|1|||
17090022|NCT00291642|38230134|FG001|Overall Study|Adverse Event|0|||
17090023|NCT00291642|38230135|FG002|Overall Study|Adverse Event|1|||
17090024|NCT00291642|38230136|FG003|Overall Study|Adverse Event|0|||
17090025|NCT00291642|38230137|FG004|Overall Study|Adverse Event|1|||
17090026|NCT00291642|38230133|FG000|Overall Study|Patient missed visit|0|||
17090027|NCT00291642|38230134|FG001|Overall Study|Patient missed visit|0|||
17090028|NCT00291642|38230135|FG002|Overall Study|Patient missed visit|1|||
17090029|NCT00291642|38230136|FG003|Overall Study|Patient missed visit|0|||
17090030|NCT00291642|38230137|FG004|Overall Study|Patient missed visit|0|||
17090031|NCT00291642|38230133|FG000|Overall Study|Intake of prohibited medication|1|||
17090032|NCT00291642|38230134|FG001|Overall Study|Intake of prohibited medication|0|||
17090033|NCT00291642|38230135|FG002|Overall Study|Intake of prohibited medication|0|||
17090034|NCT00291642|38230136|FG003|Overall Study|Intake of prohibited medication|0|||
17090035|NCT00291642|38230137|FG004|Overall Study|Intake of prohibited medication|0|||
17090036|NCT00280566|38230151|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
17115342|NCT04411628|38253338|FG003|Overall Study|Withdrawal by Subject|0|||
17115343|NCT04411628|38253335|FG000|Overall Study|Lost to Follow-up|0|||
17115344|NCT04411628|38253336|FG001|Overall Study|Lost to Follow-up|1|||
17115345|NCT04411628|38253337|FG002|Overall Study|Lost to Follow-up|0|||
17115346|NCT04411628|38253338|FG003|Overall Study|Lost to Follow-up|0|||
17115347|NCT00227591|38253351|FG000|Overall Study|Withdrawal by Subject|1|||
17115348|NCT04512482|38253357|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
17115349|NCT04512482|38253358|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
17115350|NCT00226811|38253364|FG000|Overall Study|Death|8|||
17115351|NCT00226811|38253364|FG000|Overall Study|Adverse Event|11|||
17115352|NCT00226811|38253364|FG000|Overall Study|Lack of Efficacy|55|||
17115353|NCT00226811|38253364|FG000|Overall Study|Withdrawal by Subject|2|||
17115354|NCT02951052|38253370|FG000|Overall Study|Adverse Event|13|||
17115355|NCT02951052|38253371|FG001|Overall Study|Adverse Event|5|||
17115356|NCT02951052|38253370|FG000|Overall Study|Withdrawal by Subject|1|||
17115357|NCT02951052|38253371|FG001|Overall Study|Withdrawal by Subject|5|||
17115358|NCT02951052|38253370|FG000|Overall Study|Physician Decision|2|||
17115359|NCT02951052|38253371|FG001|Overall Study|Physician Decision|0|||
17115360|NCT02951052|38253370|FG000|Overall Study|Lost to Follow-up|1|||
17115361|NCT02951052|38253371|FG001|Overall Study|Lost to Follow-up|1|||
17115362|NCT02951052|38253370|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
17115363|NCT02951052|38253371|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
17115364|NCT02951052|38253370|FG000|Overall Study|Protocol Violation|5|||
17115365|NCT02951052|38253371|FG001|Overall Study|Protocol Violation|3|||
17115366|NCT02951052|38253370|FG000|Overall Study|Lack of Efficacy|3|||
17115367|NCT02951052|38253371|FG001|Overall Study|Lack of Efficacy|4|||
17115368|NCT02951052|38253370|FG000|Overall Study|Ongoing|1|||
17115369|NCT02951052|38253371|FG001|Overall Study|Ongoing|0|||
17115370|NCT00226655|38253381|FG000|Overall Study|Death|13|||
17115371|NCT00226655|38253381|FG000|Overall Study|Withdrawal by Subject|15|||
17115372|NCT00226655|38253381|FG000|Overall Study|Adverse Event|35|||
17115373|NCT00226655|38253381|FG000|Overall Study|Physician Decision|6|||
17115374|NCT00226655|38253381|FG000|Overall Study|Clinical deterioration|10|||
17115375|NCT03124108|38253397|FG000|Overall Study|Adverse Event|0|||
17115376|NCT03124108|38253398|FG001|Overall Study|Adverse Event|1|||
17115377|NCT03124108|38253399|FG002|Overall Study|Adverse Event|0|||
17115378|NCT04475588|38253411|FG000|Overall Study|Adverse Event|2|||
17115379|NCT04475588|38253412|FG001|Overall Study|Adverse Event|0|||
17115380|NCT04353596|38253421|FG000|Overall Study|Protocol Violation|4|||
17115381|NCT04353596|38253422|FG001|Overall Study|Protocol Violation|4|||
17115382|NCT04353596|38253421|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
17115383|NCT04353596|38253422|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
17115384|NCT04350788|38253430|FG000|Overall Study|Lost to Follow-up|6|||
17115385|NCT04350788|38253431|FG001|Overall Study|Lost to Follow-up|2|||
17115386|NCT04350788|38253430|FG000|Overall Study|Withdrawal by Subject|2|||
17115387|NCT04350788|38253431|FG001|Overall Study|Withdrawal by Subject|4|||
17115388|NCT04350788|38253430|FG000|Overall Study|Protocol Violation|4|||
17115389|NCT04350788|38253431|FG001|Overall Study|Protocol Violation|0|||
17115390|NCT03852316|38253442|FG000|Overall Study|Protocol Violation|1|||
17115391|NCT03852316|38253442|FG000|Overall Study|Withdrawal by Subject|2|||
17115392|NCT03852316|38253442|FG000|Overall Study|Enrolled but Device not Utilized|1|||
17115393|NCT04335812|38253448|FG000|Overall Study|Withdrawal by Subject|1|||
17115394|NCT04335812|38253449|FG001|Overall Study|Withdrawal by Subject|3|||
17115395|NCT04335812|38253448|FG000|Overall Study|Lost to Follow-up|12|||
17115396|NCT04335812|38253449|FG001|Overall Study|Lost to Follow-up|12|||
17115397|NCT04335812|38253448|FG000|Overall Study|Did not engage in the intervention|22|||
17115398|NCT04335812|38253449|FG001|Overall Study|Did not engage in the intervention|18|||
17115399|NCT03127384|38253455|FG000|Overall Study|Lost to Follow-up|4|||
17115400|NCT03127384|38253455|FG000|Overall Study|Subject request|2|||
17115401|NCT04398134|38253482|FG000|Overall Study|Adverse Event|0|||
17115402|NCT04398134|38253483|FG001|Overall Study|Adverse Event|0|||
17115403|NCT04398134|38253484|FG002|Overall Study|Adverse Event|1|||
17115404|NCT04398134|38253485|FG003|Overall Study|Adverse Event|0|||
17115405|NCT04398134|38253482|FG000|Overall Study|Withdrawal by Subject|2|||
17115406|NCT04398134|38253483|FG001|Overall Study|Withdrawal by Subject|0|||
17115407|NCT04398134|38253484|FG002|Overall Study|Withdrawal by Subject|0|||
17115408|NCT04398134|38253485|FG003|Overall Study|Withdrawal by Subject|1|||
17115409|NCT04398134|38253482|FG000|Overall Study|Study Terminated by Sponsor|30|||
17115410|NCT04398134|38253483|FG001|Overall Study|Study Terminated by Sponsor|11|||
17115411|NCT04398134|38253484|FG002|Overall Study|Study Terminated by Sponsor|32|||
17115412|NCT04398134|38253485|FG003|Overall Study|Study Terminated by Sponsor|11|||
17115413|NCT03122860|38253501|FG000|Overall Study|Discontinued Before Treatment|1|||
17115414|NCT03122860|38253502|FG001|Overall Study|Discontinued Before Treatment|1|||
17115415|NCT03122860|38253503|FG002|Overall Study|Discontinued Before Treatment|2|||
17115416|NCT03122860|38253504|FG003|Overall Study|Discontinued Before Treatment|0|||
17115417|NCT03122860|38253505|FG004|Overall Study|Discontinued Before Treatment|1|||
17115418|NCT03122860|38253506|FG005|Overall Study|Discontinued Before Treatment|0|||
17115419|NCT03122860|38253501|FG000|Overall Study|Adverse Event|1|||
17115420|NCT03122860|38253502|FG001|Overall Study|Adverse Event|0|||
17115421|NCT03122860|38253503|FG002|Overall Study|Adverse Event|1|||
17115422|NCT03122860|38253504|FG003|Overall Study|Adverse Event|1|||
17115423|NCT03122860|38253505|FG004|Overall Study|Adverse Event|0|||
17115424|NCT03122860|38253506|FG005|Overall Study|Adverse Event|0|||
17115425|NCT03122860|38253501|FG000|Overall Study|Lost to Follow-up|5|||
17115426|NCT03122860|38253502|FG001|Overall Study|Lost to Follow-up|2|||
17115427|NCT03122860|38253503|FG002|Overall Study|Lost to Follow-up|3|||
17115428|NCT03122860|38253504|FG003|Overall Study|Lost to Follow-up|3|||
17115429|NCT03122860|38253505|FG004|Overall Study|Lost to Follow-up|5|||
17115430|NCT03122860|38253506|FG005|Overall Study|Lost to Follow-up|4|||
17115431|NCT03122860|38253501|FG000|Overall Study|Subject Non-Compliance|0|||
17115432|NCT03122860|38253502|FG001|Overall Study|Subject Non-Compliance|0|||
17115433|NCT03122860|38253503|FG002|Overall Study|Subject Non-Compliance|1|||
17115434|NCT03122860|38253504|FG003|Overall Study|Subject Non-Compliance|0|||
17115435|NCT03122860|38253505|FG004|Overall Study|Subject Non-Compliance|0|||
17115436|NCT03122860|38253506|FG005|Overall Study|Subject Non-Compliance|0|||
17115437|NCT03122860|38253501|FG000|Overall Study|Withdrawal by Subject|3|||
17115438|NCT03122860|38253502|FG001|Overall Study|Withdrawal by Subject|2|||
17115439|NCT03122860|38253503|FG002|Overall Study|Withdrawal by Subject|5|||
17115440|NCT03122860|38253504|FG003|Overall Study|Withdrawal by Subject|7|||
17115441|NCT03122860|38253505|FG004|Overall Study|Withdrawal by Subject|9|||
17115442|NCT03122860|38253506|FG005|Overall Study|Withdrawal by Subject|8|||
17115443|NCT03798366|38253523|FG000|Overall Study|Lost to Follow-up|0|||
17115444|NCT03798366|38253524|FG001|Overall Study|Lost to Follow-up|1|||
17115445|NCT04327388|38253533|FG000|Overall Study|Adverse Event|17|||
17115446|NCT04327388|38253534|FG001|Overall Study|Adverse Event|18|||
17115447|NCT04327388|38253535|FG002|Overall Study|Adverse Event|9|||
17115448|NCT04327388|38253533|FG000|Overall Study|Other|1|||
17115449|NCT04327388|38253534|FG001|Overall Study|Other|2|||
17115450|NCT04327388|38253535|FG002|Overall Study|Other|0|||
17115451|NCT04327388|38253533|FG000|Overall Study|Randomized and not treated|2|||
17115452|NCT04327388|38253534|FG001|Overall Study|Randomized and not treated|0|||
17115453|NCT04327388|38253535|FG002|Overall Study|Randomized and not treated|2|||
17115454|NCT03796728|38253543|FG000|Overall Study|Lost to Follow-up|8|||
17115455|NCT03796728|38253543|FG000|Overall Study|Reason not Specified|16|||
17115456|NCT00352534|38253549|FG000|Initial Staging|Ineligible|8|||
17115457|NCT00352534|38253550|FG001|Initial Staging|Ineligible|9|||
17115458|NCT00352534|38253551|FG002|Initial Staging|Ineligible|0|||
17115459|NCT00352534|38253552|FG003|Initial Staging|Ineligible|0|||
17115460|NCT00352534|38253553|FG004|Initial Staging|Ineligible|0|||
17115461|NCT00352534|38253554|FG005|Initial Staging|Ineligible|0|||
17115462|NCT00352534|38253555|FG006|Initial Staging|Ineligible|0|||
17115463|NCT00352534|38253549|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
17115464|NCT00352534|38253550|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
17115465|NCT00352534|38253551|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
17115466|NCT00352534|38253552|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
17115467|NCT00352534|38253553|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
17115468|NCT00352534|38253554|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
17115469|NCT00352534|38253555|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
17115470|NCT00352534|38253549|FG000|Final Risk Group Assignment|Physician Decision|0|||
17115471|NCT00352534|38253550|FG001|Final Risk Group Assignment|Physician Decision|0|||
17115472|NCT00352534|38253551|FG002|Final Risk Group Assignment|Physician Decision|0|||
17115473|NCT00352534|38253552|FG003|Final Risk Group Assignment|Physician Decision|0|||
17115474|NCT00352534|38253553|FG004|Final Risk Group Assignment|Physician Decision|0|||
17115475|NCT00352534|38253554|FG005|Final Risk Group Assignment|Physician Decision|8|||
17115476|NCT00352534|38253555|FG006|Final Risk Group Assignment|Physician Decision|0|||
17115477|NCT00352534|38253549|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
17115478|NCT00352534|38253550|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
16856553|NCT01969799|37810202|FG001|Overall Study|Lost to Follow-up|2|||
16942065|NCT01379703|38086636|FG002|9 Months Through 18 Months|Treatment failure|0|||
16856554|NCT01969799|37810201|FG000|Overall Study|Physician Decision|1|||
16856555|NCT01969799|37810202|FG001|Overall Study|Physician Decision|0|||
16768811|NCT02296138|37706565|FG000|Overall Study|Adverse Event|348|||
16768812|NCT02296138|37706566|FG001|Overall Study|Adverse Event|259|||
16768813|NCT02296138|37706565|FG000|Overall Study|Lack of Efficacy|59|||
16768814|NCT02296138|37706566|FG001|Overall Study|Lack of Efficacy|37|||
16768815|NCT02296138|37706565|FG000|Overall Study|Protocol Violation|35|||
16768816|NCT02296138|37706566|FG001|Overall Study|Protocol Violation|36|||
16768817|NCT02296138|37706565|FG000|Overall Study|Lost to Follow-up|9|||
16768818|NCT02296138|37706566|FG001|Overall Study|Lost to Follow-up|12|||
16768819|NCT02296138|37706565|FG000|Overall Study|Withdrawal by Subject|184|||
16768820|NCT02296138|37706566|FG001|Overall Study|Withdrawal by Subject|131|||
16768821|NCT02296138|37706565|FG000|Overall Study|Not Treated|1|||
16768822|NCT02296138|37706566|FG001|Overall Study|Not Treated|1|||
16768823|NCT02296138|37706565|FG000|Overall Study|Patients with data irregularities|10|||
16768824|NCT02296138|37706566|FG001|Overall Study|Patients with data irregularities|11|||
16768825|NCT02296138|37706565|FG000|Overall Study|Other than specified|15|||
16768826|NCT02296138|37706566|FG001|Overall Study|Other than specified|13|||
16768827|NCT02324842|37706575|FG000|Overall Study|Lost to Follow-up|1|||
16768828|NCT02324842|37706576|FG001|Overall Study|Lost to Follow-up|1|||
16768829|NCT02324842|37706577|FG002|Overall Study|Lost to Follow-up|2|||
16768830|NCT02295280|37706587|FG000|Overall Study|Adverse Event|0|||
16768831|NCT02295280|37706588|FG001|Overall Study|Adverse Event|1|||
16768832|NCT02294734|37706596|FG000|Overall Study|Adverse Event|5|||
16768833|NCT02294734|37706597|FG001|Overall Study|Adverse Event|5|||
16768834|NCT02294734|37706596|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
16768835|NCT02294734|37706597|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
16768836|NCT02294734|37706596|FG000|Overall Study|Lost to Follow-up|2|||
16768837|NCT02294734|37706597|FG001|Overall Study|Lost to Follow-up|0|||
16768838|NCT02294734|37706596|FG000|Overall Study|Physician Decision|2|||
16768839|NCT02294734|37706597|FG001|Overall Study|Physician Decision|1|||
16768840|NCT02294734|37706596|FG000|Overall Study|Withdrawal by Subject|4|||
16768841|NCT02294734|37706597|FG001|Overall Study|Withdrawal by Subject|2|||
16768842|NCT02323204|37706618|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
16856556|NCT01969721|37810208|FG000|Overall Study|Adverse Event|3|||
16856557|NCT01969721|37810209|FG001|Overall Study|Adverse Event|8|||
16856558|NCT01969721|37810210|FG002|Overall Study|Adverse Event|3|||
17028300|NCT00735696|38172710|FG000|Overall Study|Enrolled but never Treated|1|||
17028301|NCT00478231|38172714|FG000|Overall Study|Death|7|||
17028302|NCT00478231|38172714|FG000|Overall Study|Lack of Efficacy|47|||
16856559|NCT01969721|37810211|FG003|Overall Study|Adverse Event|2|||
16942066|NCT01379703|38086634|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
16768843|NCT02323204|37706619|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
16768844|NCT02323204|37706620|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
16768845|NCT02323204|37706621|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
16768846|NCT02323204|37706618|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
16768847|NCT02323204|37706619|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
16768848|NCT02323204|37706620|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
16768849|NCT02323204|37706621|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
16768850|NCT02323204|37706618|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
16768851|NCT02323204|37706619|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
16768852|NCT02323204|37706620|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
16768853|NCT02323204|37706621|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
16768854|NCT02323204|37706618|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
16768855|NCT02323204|37706619|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
16768856|NCT02323204|37706620|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
16768857|NCT02323204|37706621|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
16768858|NCT02323204|37706618|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
16768859|NCT02323204|37706619|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
16768860|NCT02323204|37706620|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
16768861|NCT02323204|37706621|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
16768862|NCT02323204|37706618|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
16768863|NCT02323204|37706619|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
16768864|NCT02323204|37706620|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
16768865|NCT02323204|37706621|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
16768866|NCT02323204|37706618|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
16768867|NCT02323204|37706619|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
16768868|NCT02323204|37706620|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
16768869|NCT02323204|37706621|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
16768870|NCT02323204|37706618|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
16768871|NCT02323204|37706619|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
16768872|NCT02323204|37706620|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
16768873|NCT02323204|37706621|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
16768874|NCT02323204|37706618|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
16768875|NCT02323204|37706619|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
16768876|NCT02323204|37706620|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
16768877|NCT02323204|37706621|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
16768878|NCT02322892|37706633|FG000|Overall Study|Surgery cancelled|1|||
16768879|NCT02322892|37706634|FG001|Overall Study|Surgery cancelled|2|||
16768880|NCT02322892|37706633|FG000|Overall Study|Met exclusion criteria|0|||
16768881|NCT02322892|37706634|FG001|Overall Study|Met exclusion criteria|1|||
16768882|NCT02322892|37706633|FG000|Overall Study|Protocol Violation|1|||
16768883|NCT02322892|37706634|FG001|Overall Study|Protocol Violation|0|||
16768884|NCT03916081|37706643|FG000|Overall Study|Adverse Event|1|||
16768885|NCT03916081|37706644|FG001|Overall Study|Adverse Event|0|||
16768886|NCT03916081|37706645|FG002|Overall Study|Adverse Event|0|||
16768887|NCT03916081|37706643|FG000|Overall Study|Physician Decision|0|||
16768888|NCT03916081|37706644|FG001|Overall Study|Physician Decision|0|||
16768889|NCT03916081|37706645|FG002|Overall Study|Physician Decision|1|||
16768890|NCT03916081|37706643|FG000|Overall Study|Lost to Follow-up|0|||
16768891|NCT03916081|37706644|FG001|Overall Study|Lost to Follow-up|1|||
16768892|NCT03916081|37706645|FG002|Overall Study|Lost to Follow-up|0|||
16768893|NCT03916081|37706643|FG000|Overall Study|Withdrawal by Subject|3|||
16768894|NCT03916081|37706644|FG001|Overall Study|Withdrawal by Subject|0|||
16768895|NCT03916081|37706645|FG002|Overall Study|Withdrawal by Subject|1|||
16768896|NCT03916081|37706643|FG000|Overall Study|Worsening of AD|0|||
16768897|NCT03916081|37706644|FG001|Overall Study|Worsening of AD|0|||
16768898|NCT03916081|37706645|FG002|Overall Study|Worsening of AD|1|||
16768899|NCT02739997|37706653|FG000|Overall Study|Death|1|||
16768900|NCT02739997|37706653|FG000|Overall Study|Withdrawal by Subject|1|||
16768901|NCT02221037|37706670|FG000|Overall Study|Physician Decision|0|||
16768902|NCT02221037|37706671|FG001|Overall Study|Physician Decision|0|||
16768903|NCT02221037|37706672|FG002|Overall Study|Physician Decision|1|||
16768904|NCT02221037|37706673|FG003|Overall Study|Physician Decision|0|||
16768905|NCT02704429|37706689|FG000|Part A: 24 Weeks|Adverse Event|3|||
16768906|NCT02704429|37706690|FG001|Part A: 24 Weeks|Adverse Event|0|||
16768907|NCT02704429|37706689|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
16768908|NCT02704429|37706690|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
16768909|NCT02751359|37706697|FG000|Overall Study|Lost to Follow-up|1|||
16768910|NCT02750813|37706716|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
16768911|NCT02750813|37706717|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
16768912|NCT02750813|37706716|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
16768913|NCT02750813|37706717|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
16768914|NCT00503035|37706733|FG000|Overall Study|Lost to Follow-up|2|||
16768915|NCT00503035|37706733|FG000|Overall Study|Physician Decision|3|||
16768916|NCT00503035|37706733|FG000|Overall Study|Ineligible|15|||
16768917|NCT03137381|37706742|FG000|Overall Study|Adverse Event|3|||
16768918|NCT03137381|37706743|FG001|Overall Study|Adverse Event|0|||
16768919|NCT03137381|37706744|FG002|Overall Study|Adverse Event|2|||
16768920|NCT03137381|37706745|FG003|Overall Study|Adverse Event|0|||
16768921|NCT03137381|37706742|FG000|Overall Study|Lost to Follow-up|2|||
16768922|NCT03137381|37706743|FG001|Overall Study|Lost to Follow-up|1|||
16768923|NCT03137381|37706744|FG002|Overall Study|Lost to Follow-up|1|||
16768924|NCT03137381|37706745|FG003|Overall Study|Lost to Follow-up|0|||
16768925|NCT03137381|37706742|FG000|Overall Study|Protocol deviation|1|||
16768926|NCT03137381|37706743|FG001|Overall Study|Protocol deviation|1|||
16768927|NCT03137381|37706744|FG002|Overall Study|Protocol deviation|0|||
16768928|NCT03137381|37706745|FG003|Overall Study|Protocol deviation|1|||
16768929|NCT03137381|37706742|FG000|Overall Study|Withdrawal by Investigator|0|||
16768930|NCT03137381|37706743|FG001|Overall Study|Withdrawal by Investigator|1|||
16768931|NCT03137381|37706744|FG002|Overall Study|Withdrawal by Investigator|1|||
16768932|NCT03137381|37706745|FG003|Overall Study|Withdrawal by Investigator|0|||
16768933|NCT03137381|37706742|FG000|Overall Study|Withdrawal by Subject|3|||
16768934|NCT03137381|37706743|FG001|Overall Study|Withdrawal by Subject|4|||
16768935|NCT03137381|37706744|FG002|Overall Study|Withdrawal by Subject|3|||
16768936|NCT03137381|37706745|FG003|Overall Study|Withdrawal by Subject|0|||
16768937|NCT03137381|37706742|FG000|Overall Study|Pregnancy|0|||
16768938|NCT03137381|37706743|FG001|Overall Study|Pregnancy|0|||
16768939|NCT03137381|37706744|FG002|Overall Study|Pregnancy|1|||
16768940|NCT03137381|37706745|FG003|Overall Study|Pregnancy|0|||
16768941|NCT02750501|37706772|FG000|Overall Study|Adverse Event|4|||
16768942|NCT02750501|37706772|FG000|Overall Study|Physician Decision|1|||
16768943|NCT02750501|37706772|FG000|Overall Study|Protocol Violation|1|||
16768944|NCT02750501|37706772|FG000|Overall Study|G-tube came out|1|||
16768945|NCT02750501|37706772|FG000|Overall Study|Non-compliant use of PERT|1|||
16768946|NCT01337297|37706786|FG000|Overall Study|They entered to single anodal tDCS|4|||
16768947|NCT01337297|37706787|FG001|Overall Study|They entered to single anodal tDCS|3|||
16768948|NCT01337297|37706786|FG000|Overall Study|Lost to Follow-up|1|||
16768949|NCT01337297|37706787|FG001|Overall Study|Lost to Follow-up|3|||
16768950|NCT02302963|37706795|FG000|Overall Study|Withdrawal by Subject|2|||
16768951|NCT02302963|37706796|FG001|Overall Study|Withdrawal by Subject|1|||
16768952|NCT02302963|37706795|FG000|Overall Study|Steroid injection|0|||
16768953|NCT02302963|37706796|FG001|Overall Study|Steroid injection|1|||
16768954|NCT02302963|37706795|FG000|Overall Study|Physician Decision|1|||
16768955|NCT02302963|37706796|FG001|Overall Study|Physician Decision|0|||
16768956|NCT04702997|37706804|FG000|Overall Study|Withdrawal by Subject|1|||
16768957|NCT04702997|37706805|FG001|Overall Study|Withdrawal by Subject|1|||
16768958|NCT03507127|37706826|FG000|Overall Study|Withdrawal by Subject|1|||
16768959|NCT03507127|37706827|FG001|Overall Study|Withdrawal by Subject|0|||
16768960|NCT03507127|37706826|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
16768961|NCT03507127|37706827|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
16768962|NCT02322814|37706855|FG000|Overall Study|Ongoing Study|0|||
16768963|NCT02322814|37706856|FG001|Overall Study|Ongoing Study|13|||
16768964|NCT02322814|37706857|FG002|Overall Study|Ongoing Study|14|||
16768965|NCT02322814|37706858|FG003|Overall Study|Ongoing Study|20|||
16768966|NCT02322814|37706859|FG004|Overall Study|Ongoing Study|22|||
16768967|NCT02322814|37706855|FG000|Overall Study|Progressive Disease|0|||
16768968|NCT02322814|37706856|FG001|Overall Study|Progressive Disease|2|||
16768969|NCT02322814|37706857|FG002|Overall Study|Progressive Disease|0|||
16768970|NCT02322814|37706858|FG003|Overall Study|Progressive Disease|1|||
16768971|NCT02322814|37706859|FG004|Overall Study|Progressive Disease|0|||
16768972|NCT02322814|37706855|FG000|Overall Study|Lost to Follow-up|1|||
16768973|NCT02322814|37706856|FG001|Overall Study|Lost to Follow-up|2|||
16768974|NCT02322814|37706857|FG002|Overall Study|Lost to Follow-up|1|||
16768975|NCT02322814|37706858|FG003|Overall Study|Lost to Follow-up|0|||
16768976|NCT02322814|37706859|FG004|Overall Study|Lost to Follow-up|0|||
16768977|NCT02322814|37706855|FG000|Overall Study|Other|2|||
16768978|NCT02322814|37706856|FG001|Overall Study|Other|0|||
16768979|NCT02322814|37706857|FG002|Overall Study|Other|0|||
16768980|NCT02322814|37706858|FG003|Overall Study|Other|0|||
16768981|NCT02322814|37706859|FG004|Overall Study|Other|0|||
16768982|NCT02322814|37706855|FG000|Overall Study|Protocol Violation|1|||
16768983|NCT02322814|37706856|FG001|Overall Study|Protocol Violation|0|||
16768984|NCT02322814|37706857|FG002|Overall Study|Protocol Violation|0|||
16768985|NCT02322814|37706858|FG003|Overall Study|Protocol Violation|0|||
16768986|NCT02322814|37706859|FG004|Overall Study|Protocol Violation|0|||
16768987|NCT02322814|37706855|FG000|Overall Study|Death|7|||
16768988|NCT02322814|37706856|FG001|Overall Study|Death|22|||
16768989|NCT02322814|37706857|FG002|Overall Study|Death|30|||
16768990|NCT02322814|37706858|FG003|Overall Study|Death|10|||
16768991|NCT02322814|37706859|FG004|Overall Study|Death|6|||
16768992|NCT02322814|37706855|FG000|Overall Study|Withdrawal by Subject|5|||
16768993|NCT02322814|37706856|FG001|Overall Study|Withdrawal by Subject|4|||
16768994|NCT02322814|37706857|FG002|Overall Study|Withdrawal by Subject|2|||
16768995|NCT02322814|37706858|FG003|Overall Study|Withdrawal by Subject|1|||
16768996|NCT02322814|37706859|FG004|Overall Study|Withdrawal by Subject|3|||
16768997|NCT02322190|37706870|FG000|Overall Study|Death on study|1|||
16768998|NCT02322190|37706871|FG001|Overall Study|Death on study|0|||
16768999|NCT02321800|37706887|FG000|Overall Study|Withdrawal by Subject|3|||
16769000|NCT02321800|37706888|FG001|Overall Study|Withdrawal by Subject|3|||
16769001|NCT02321800|37706887|FG000|Overall Study|Death|1|||
16769002|NCT02321800|37706888|FG001|Overall Study|Death|0|||
16769003|NCT02321800|37706887|FG000|Overall Study|Protocol Violation|1|||
16769004|NCT02321800|37706888|FG001|Overall Study|Protocol Violation|0|||
16769005|NCT02321800|37706887|FG000|Overall Study|Lost to Follow-up|10|||
16769006|NCT02321800|37706888|FG001|Overall Study|Lost to Follow-up|4|||
16769007|NCT02321800|37706887|FG000|Overall Study|Adverse Event|2|||
16769008|NCT02321800|37706888|FG001|Overall Study|Adverse Event|3|||
16769009|NCT02321800|37706887|FG000|Overall Study|Other, Miscellaneous|3|||
16769010|NCT02321800|37706888|FG001|Overall Study|Other, Miscellaneous|1|||
16769011|NCT02292784|37706934|FG000|Overall Study|Lost to Follow-up|1|||
16769012|NCT02292784|37706935|FG001|Overall Study|Lost to Follow-up|17|||
16769013|NCT02292784|37706936|FG002|Overall Study|Lost to Follow-up|18|||
16769014|NCT02292784|37706934|FG000|Overall Study|Withdrawal by Subject|0|||
16769015|NCT02292784|37706935|FG001|Overall Study|Withdrawal by Subject|3|||
16769016|NCT02292784|37706936|FG002|Overall Study|Withdrawal by Subject|3|||
16769017|NCT02320396|37706946|FG000|Overall Study|Adverse Event|2|||
16769018|NCT02320396|37706947|FG001|Overall Study|Adverse Event|2|||
16769019|NCT02320396|37706946|FG000|Overall Study|Pregnancy|0|||
16769020|NCT02320396|37706947|FG001|Overall Study|Pregnancy|1|||
16769021|NCT02320396|37706946|FG000|Overall Study|Protocol Violation|0|||
16769022|NCT02320396|37706947|FG001|Overall Study|Protocol Violation|1|||
16769023|NCT02320396|37706946|FG000|Overall Study|Withdrawal by Subject|2|||
16769024|NCT02320396|37706947|FG001|Overall Study|Withdrawal by Subject|0|||
16769025|NCT02292238|37706955|FG000|Overall Study|Protocol Violation|1|||
16769026|NCT02292238|37706956|FG001|Overall Study|Protocol Violation|2|||
16769027|NCT02292238|37706955|FG000|Overall Study|Withdrawal by Subject|2|||
16769028|NCT02292238|37706956|FG001|Overall Study|Withdrawal by Subject|1|||
16769029|NCT02292238|37706955|FG000|Overall Study|Lost to Follow-up|1|||
16769030|NCT02292238|37706956|FG001|Overall Study|Lost to Follow-up|0|||
16769031|NCT02292238|37706955|FG000|Overall Study|Physician Decision|0|||
16769032|NCT02292238|37706956|FG001|Overall Study|Physician Decision|1|||
16769033|NCT02234843|37706993|FG000|Overall Study|Death|1|||
16769034|NCT02234843|37706994|FG001|Overall Study|Death|0|||
16769035|NCT02234843|37706995|FG002|Overall Study|Death|0|||
16769036|NCT02234843|37706996|FG003|Overall Study|Death|0|||
16769037|NCT02234843|37706997|FG004|Overall Study|Death|0|||
16769038|NCT02234843|37706998|FG005|Overall Study|Death|0|||
16769039|NCT02234843|37706999|FG006|Overall Study|Death|0|||
16769040|NCT02234843|37707000|FG007|Overall Study|Death|0|||
16769041|NCT02234843|37707001|FG008|Overall Study|Death|0|||
16769042|NCT02234843|37707002|FG009|Overall Study|Death|0|||
16769043|NCT02234843|37706993|FG000|Overall Study|Protocol Violation|1|||
16769044|NCT02234843|37706994|FG001|Overall Study|Protocol Violation|0|||
16769045|NCT02234843|37706995|FG002|Overall Study|Protocol Violation|1|||
16769046|NCT02234843|37706996|FG003|Overall Study|Protocol Violation|0|||
16769047|NCT02234843|37706997|FG004|Overall Study|Protocol Violation|0|||
16769048|NCT02234843|37706998|FG005|Overall Study|Protocol Violation|0|||
16769049|NCT02234843|37706999|FG006|Overall Study|Protocol Violation|0|||
16769050|NCT02234843|37707000|FG007|Overall Study|Protocol Violation|0|||
16769051|NCT02234843|37707001|FG008|Overall Study|Protocol Violation|0|||
16769052|NCT02234843|37707002|FG009|Overall Study|Protocol Violation|0|||
16769053|NCT02234843|37706993|FG000|Overall Study|Efficacy outcome reached|2|||
16769054|NCT02234843|37706994|FG001|Overall Study|Efficacy outcome reached|0|||
16769055|NCT02234843|37706995|FG002|Overall Study|Efficacy outcome reached|0|||
16769056|NCT02234843|37706996|FG003|Overall Study|Efficacy outcome reached|0|||
16769057|NCT02234843|37706997|FG004|Overall Study|Efficacy outcome reached|0|||
16769058|NCT02234843|37706998|FG005|Overall Study|Efficacy outcome reached|2|||
16769059|NCT02234843|37706999|FG006|Overall Study|Efficacy outcome reached|0|||
16769060|NCT02234843|37707000|FG007|Overall Study|Efficacy outcome reached|0|||
16769061|NCT02234843|37707001|FG008|Overall Study|Efficacy outcome reached|0|||
16769062|NCT02234843|37707002|FG009|Overall Study|Efficacy outcome reached|0|||
16769063|NCT02234843|37706993|FG000|Overall Study|Patient convenience|2|||
16769064|NCT02234843|37706994|FG001|Overall Study|Patient convenience|0|||
16769065|NCT02234843|37706995|FG002|Overall Study|Patient convenience|0|||
16769066|NCT02234843|37706996|FG003|Overall Study|Patient convenience|0|||
16769067|NCT02234843|37706997|FG004|Overall Study|Patient convenience|0|||
16769068|NCT02234843|37706998|FG005|Overall Study|Patient convenience|1|||
16769069|NCT02234843|37706999|FG006|Overall Study|Patient convenience|0|||
16769070|NCT02234843|37707000|FG007|Overall Study|Patient convenience|0|||
16769071|NCT02234843|37707001|FG008|Overall Study|Patient convenience|0|||
16769072|NCT02234843|37707002|FG009|Overall Study|Patient convenience|0|||
16769073|NCT02234843|37706993|FG000|Overall Study|Withdrawal by Subject|5|||
16856560|NCT01969721|37810208|FG000|Overall Study|Lack of Efficacy|0|||
16856561|NCT01969721|37810209|FG001|Overall Study|Lack of Efficacy|0|||
16769074|NCT02234843|37706994|FG001|Overall Study|Withdrawal by Subject|1|||
16769075|NCT02234843|37706995|FG002|Overall Study|Withdrawal by Subject|1|||
16769076|NCT02234843|37706996|FG003|Overall Study|Withdrawal by Subject|0|||
16769077|NCT02234843|37706997|FG004|Overall Study|Withdrawal by Subject|0|||
16769078|NCT02234843|37706998|FG005|Overall Study|Withdrawal by Subject|7|||
16769079|NCT02234843|37706999|FG006|Overall Study|Withdrawal by Subject|0|||
16769080|NCT02234843|37707000|FG007|Overall Study|Withdrawal by Subject|0|||
16769081|NCT02234843|37707001|FG008|Overall Study|Withdrawal by Subject|0|||
16769082|NCT02234843|37707002|FG009|Overall Study|Withdrawal by Subject|0|||
16769083|NCT02234843|37706993|FG000|Overall Study|Recovery|1|||
16769084|NCT02234843|37706994|FG001|Overall Study|Recovery|0|||
16769085|NCT02234843|37706995|FG002|Overall Study|Recovery|0|||
16769086|NCT02234843|37706996|FG003|Overall Study|Recovery|0|||
16769087|NCT02234843|37706997|FG004|Overall Study|Recovery|0|||
16769088|NCT02234843|37706998|FG005|Overall Study|Recovery|0|||
16769089|NCT02234843|37706999|FG006|Overall Study|Recovery|0|||
16769090|NCT02234843|37707000|FG007|Overall Study|Recovery|0|||
16769091|NCT02234843|37707001|FG008|Overall Study|Recovery|0|||
16769092|NCT02234843|37707002|FG009|Overall Study|Recovery|0|||
16769093|NCT02234843|37706993|FG000|Overall Study|Other|0|||
16769094|NCT02234843|37706994|FG001|Overall Study|Other|2|||
16769095|NCT02234843|37706995|FG002|Overall Study|Other|0|||
16769096|NCT02234843|37706996|FG003|Overall Study|Other|1|||
16769097|NCT02234843|37706997|FG004|Overall Study|Other|0|||
16769098|NCT02234843|37706998|FG005|Overall Study|Other|1|||
16769099|NCT02234843|37706999|FG006|Overall Study|Other|0|||
16769100|NCT02234843|37707000|FG007|Overall Study|Other|1|||
16769101|NCT02234843|37707001|FG008|Overall Study|Other|0|||
16769102|NCT02234843|37707002|FG009|Overall Study|Other|0|||
16769103|NCT02234843|37706993|FG000|Overall Study|Physician Decision|4|||
16769104|NCT02234843|37706994|FG001|Overall Study|Physician Decision|1|||
16769105|NCT02234843|37706995|FG002|Overall Study|Physician Decision|0|||
16769106|NCT02234843|37706996|FG003|Overall Study|Physician Decision|1|||
16769107|NCT02234843|37706997|FG004|Overall Study|Physician Decision|0|||
16769108|NCT02234843|37706998|FG005|Overall Study|Physician Decision|0|||
16769109|NCT02234843|37706999|FG006|Overall Study|Physician Decision|0|||
16769110|NCT02234843|37707000|FG007|Overall Study|Physician Decision|1|||
16769111|NCT02234843|37707001|FG008|Overall Study|Physician Decision|0|||
16769112|NCT02234843|37707002|FG009|Overall Study|Physician Decision|0|||
16769113|NCT02234843|37706993|FG000|Overall Study|Adverse Event|5|||
16769114|NCT02234843|37706994|FG001|Overall Study|Adverse Event|1|||
16769115|NCT02234843|37706995|FG002|Overall Study|Adverse Event|1|||
16769116|NCT02234843|37706996|FG003|Overall Study|Adverse Event|3|||
16769117|NCT02234843|37706997|FG004|Overall Study|Adverse Event|2|||
16769118|NCT02234843|37706998|FG005|Overall Study|Adverse Event|1|||
16769119|NCT02234843|37706999|FG006|Overall Study|Adverse Event|0|||
16769120|NCT02234843|37707000|FG007|Overall Study|Adverse Event|0|||
16769121|NCT02234843|37707001|FG008|Overall Study|Adverse Event|1|||
16769122|NCT02234843|37707002|FG009|Overall Study|Adverse Event|0|||
16769123|NCT02234843|37706993|FG000|Overall Study|Non-compliance with study drug|1|||
16769124|NCT02234843|37706994|FG001|Overall Study|Non-compliance with study drug|0|||
16769125|NCT02234843|37706995|FG002|Overall Study|Non-compliance with study drug|0|||
16769126|NCT02234843|37706996|FG003|Overall Study|Non-compliance with study drug|0|||
16769127|NCT02234843|37706997|FG004|Overall Study|Non-compliance with study drug|0|||
16769128|NCT02234843|37706998|FG005|Overall Study|Non-compliance with study drug|1|||
16769129|NCT02234843|37706999|FG006|Overall Study|Non-compliance with study drug|1|||
16769130|NCT02234843|37707000|FG007|Overall Study|Non-compliance with study drug|0|||
16769131|NCT02234843|37707001|FG008|Overall Study|Non-compliance with study drug|0|||
16769132|NCT02234843|37707002|FG009|Overall Study|Non-compliance with study drug|0|||
16769133|NCT02234843|37706993|FG000|Overall Study|Lost to Follow-up|0|||
16769134|NCT02234843|37706994|FG001|Overall Study|Lost to Follow-up|1|||
16769135|NCT02234843|37706995|FG002|Overall Study|Lost to Follow-up|0|||
16769136|NCT02234843|37706996|FG003|Overall Study|Lost to Follow-up|0|||
16769137|NCT02234843|37706997|FG004|Overall Study|Lost to Follow-up|0|||
16769138|NCT02234843|37706998|FG005|Overall Study|Lost to Follow-up|0|||
16769139|NCT02234843|37706999|FG006|Overall Study|Lost to Follow-up|1|||
16769140|NCT02234843|37707000|FG007|Overall Study|Lost to Follow-up|0|||
16769141|NCT02234843|37707001|FG008|Overall Study|Lost to Follow-up|0|||
16769142|NCT02234843|37707002|FG009|Overall Study|Lost to Follow-up|0|||
16769143|NCT02740231|37707039|FG000|Overall Study|Withdrawal by Subject|1|||
16769144|NCT02740231|37707040|FG001|Overall Study|Withdrawal by Subject|1|||
16769145|NCT02740231|37707041|FG002|Overall Study|Withdrawal by Subject|1|||
16769146|NCT02740231|37707042|FG003|Overall Study|Withdrawal by Subject|0|||
16769147|NCT02740231|37707039|FG000|Overall Study|Lack of Efficacy|0|||
16769148|NCT02740231|37707040|FG001|Overall Study|Lack of Efficacy|1|||
16769149|NCT02740231|37707041|FG002|Overall Study|Lack of Efficacy|0|||
16769150|NCT02740231|37707042|FG003|Overall Study|Lack of Efficacy|4|||
16769151|NCT02740231|37707039|FG000|Overall Study|Lost to Follow-up|1|||
16769152|NCT02740231|37707040|FG001|Overall Study|Lost to Follow-up|3|||
16769153|NCT02740231|37707041|FG002|Overall Study|Lost to Follow-up|0|||
16769154|NCT02740231|37707042|FG003|Overall Study|Lost to Follow-up|3|||
16769155|NCT02740231|37707039|FG000|Overall Study|Adverse Event|0|||
16769156|NCT02740231|37707040|FG001|Overall Study|Adverse Event|1|||
16769157|NCT02740231|37707041|FG002|Overall Study|Adverse Event|0|||
16769158|NCT02740231|37707042|FG003|Overall Study|Adverse Event|1|||
16769159|NCT02750345|37707052|FG000|Intervention 1|Adverse Event|0|||
16769160|NCT02750345|37707053|FG001|Intervention 1|Adverse Event|0|||
16769161|NCT02750345|37707054|FG002|Intervention 1|Adverse Event|0|||
16769162|NCT02750345|37707055|FG003|Intervention 1|Adverse Event|0|||
16769163|NCT02750345|37707056|FG004|Intervention 1|Adverse Event|1|||
16769164|NCT02750345|37707057|FG005|Intervention 1|Adverse Event|0|||
16769165|NCT02640625|37707067|FG000|Overall Study|Adverse Event|1|||
16769166|NCT01329263|37707074|FG000|Overall Study|Lost to Follow-up|4|||
16769167|NCT01329263|37707075|FG001|Overall Study|Lost to Follow-up|21|||
16769168|NCT01329263|37707074|FG000|Overall Study|Withdrawal by Subject|1|||
16769169|NCT01329263|37707075|FG001|Overall Study|Withdrawal by Subject|2|||
16769170|NCT02474329|37707083|FG000|Overall Study|Withdraw or did not contribute data.|13|||
16769171|NCT01388491|37707090|FG000|Overall Study|Adverse Event|10|||
16769172|NCT01388491|37707091|FG001|Overall Study|Adverse Event|9|||
16769173|NCT01388491|37707090|FG000|Overall Study|Sponsor Request|9|||
16769174|NCT01388491|37707091|FG001|Overall Study|Sponsor Request|7|||
16769175|NCT01388491|37707090|FG000|Overall Study|Withdrawal by Subject|6|||
16769176|NCT01388491|37707091|FG001|Overall Study|Withdrawal by Subject|10|||
16769177|NCT01388491|37707090|FG000|Overall Study|Lost to Follow-up|4|||
16769178|NCT01388491|37707091|FG001|Overall Study|Lost to Follow-up|3|||
16769179|NCT01388491|37707090|FG000|Overall Study|Protocol Violation|2|||
16769180|NCT01388491|37707091|FG001|Overall Study|Protocol Violation|0|||
16769181|NCT01388491|37707090|FG000|Overall Study|Noncompliance|2|||
16769182|NCT01388491|37707091|FG001|Overall Study|Noncompliance|0|||
16769183|NCT01388491|37707090|FG000|Overall Study|Pregnancy|1|||
16769184|NCT01388491|37707091|FG001|Overall Study|Pregnancy|0|||
16769185|NCT02749799|37707097|FG000|Overall Study|Adverse Event|2|||
16769186|NCT02749799|37707097|FG000|Overall Study|Lost to Follow-up|4|||
16769187|NCT02749799|37707097|FG000|Overall Study|Protocol Violation|1|||
16769188|NCT02749799|37707097|FG000|Overall Study|Withdrawal by Subject|1|||
16769189|NCT03253393|37707104|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
16769190|NCT03253393|37707105|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
16769191|NCT03253393|37707106|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
16769192|NCT03128671|37707122|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
16769193|NCT03128671|37707123|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
16769194|NCT03128671|37707122|FG000|Allocation|Death|1|||
16769195|NCT03128671|37707123|FG001|Allocation|Death|0|||
16769196|NCT03128671|37707122|FG000|Allocation|Withdrawal by Subject|4|||
16769197|NCT03128671|37707123|FG001|Allocation|Withdrawal by Subject|0|||
16769198|NCT03128671|37707122|FG000|Intervention|Withdrawal by Subject|11|||
16769199|NCT03128671|37707123|FG001|Intervention|Withdrawal by Subject|10|||
16769200|NCT03128671|37707122|FG000|Intervention|Palliative/hospice care initiated|9|||
16769201|NCT03128671|37707123|FG001|Intervention|Palliative/hospice care initiated|10|||
16769202|NCT03128671|37707122|FG000|Intervention|Death|13|||
16769203|NCT03128671|37707123|FG001|Intervention|Death|11|||
16769204|NCT03128671|37707122|FG000|Intervention|Interrupted by hurricane|1|||
16769205|NCT03128671|37707123|FG001|Intervention|Interrupted by hurricane|0|||
16769206|NCT03128671|37707122|FG000|Intervention|Physician Decision|2|||
16769207|NCT03128671|37707123|FG001|Intervention|Physician Decision|3|||
16769208|NCT02925338|37707134|FG000|Overall Study|Death|0|||
16769209|NCT02925338|37707135|FG001|Overall Study|Death|2|||
16769210|NCT02925338|37707136|FG002|Overall Study|Death|1|||
16769211|NCT02925338|37707137|FG003|Overall Study|Death|0|||
16769212|NCT02925338|37707138|FG004|Overall Study|Death|0|||
16769213|NCT02925338|37707134|FG000|Overall Study|Lost to Follow-up|30|||
16769214|NCT02925338|37707135|FG001|Overall Study|Lost to Follow-up|10|||
16769215|NCT02925338|37707136|FG002|Overall Study|Lost to Follow-up|1|||
16769216|NCT02925338|37707137|FG003|Overall Study|Lost to Follow-up|16|||
16769217|NCT02925338|37707138|FG004|Overall Study|Lost to Follow-up|3|||
16769218|NCT02925338|37707134|FG000|Overall Study|Withdrawal by Subject|3|||
16769219|NCT02925338|37707135|FG001|Overall Study|Withdrawal by Subject|0|||
16769220|NCT02925338|37707136|FG002|Overall Study|Withdrawal by Subject|3|||
16769221|NCT02925338|37707137|FG003|Overall Study|Withdrawal by Subject|2|||
16769222|NCT02925338|37707138|FG004|Overall Study|Withdrawal by Subject|2|||
16769223|NCT02925338|37707134|FG000|Overall Study|Missing|38|||
16769224|NCT02925338|37707135|FG001|Overall Study|Missing|27|||
16769225|NCT02925338|37707136|FG002|Overall Study|Missing|0|||
16769226|NCT02925338|37707137|FG003|Overall Study|Missing|3|||
16769227|NCT02925338|37707138|FG004|Overall Study|Missing|2|||
16769228|NCT02925338|37707134|FG000|Overall Study|Participant's Decision|11|||
16769229|NCT02925338|37707135|FG001|Overall Study|Participant's Decision|7|||
16769230|NCT02925338|37707136|FG002|Overall Study|Participant's Decision|3|||
16769231|NCT02925338|37707137|FG003|Overall Study|Participant's Decision|8|||
16769232|NCT02925338|37707138|FG004|Overall Study|Participant's Decision|1|||
16769233|NCT02925338|37707134|FG000|Overall Study|Treatment Discontinuation|144|||
16769234|NCT02925338|37707135|FG001|Overall Study|Treatment Discontinuation|65|||
16769235|NCT02925338|37707136|FG002|Overall Study|Treatment Discontinuation|56|||
16769236|NCT02925338|37707137|FG003|Overall Study|Treatment Discontinuation|131|||
16769237|NCT02925338|37707138|FG004|Overall Study|Treatment Discontinuation|22|||
16769238|NCT02543528|37707156|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
16769239|NCT02543528|37707157|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
16769240|NCT02543528|37707158|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
16769241|NCT02543528|37707159|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
16769242|NCT02543528|37707160|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
16769243|NCT02543528|37707156|FG000|Adaptation Period|Lens Handling Difficultes|0|||
16769244|NCT02543528|37707157|FG001|Adaptation Period|Lens Handling Difficultes|0|||
16769245|NCT02543528|37707158|FG002|Adaptation Period|Lens Handling Difficultes|0|||
16769246|NCT02543528|37707159|FG003|Adaptation Period|Lens Handling Difficultes|0|||
16769247|NCT02543528|37707160|FG004|Adaptation Period|Lens Handling Difficultes|8|||
16769248|NCT02543528|37707156|FG000|Adaptation Period|Lost to Follow-up|0|||
16769249|NCT02543528|37707157|FG001|Adaptation Period|Lost to Follow-up|0|||
16769250|NCT02543528|37707158|FG002|Adaptation Period|Lost to Follow-up|0|||
16769251|NCT02543528|37707159|FG003|Adaptation Period|Lost to Follow-up|0|||
16769252|NCT02543528|37707160|FG004|Adaptation Period|Lost to Follow-up|14|||
16769253|NCT02543528|37707156|FG000|Adaptation Period|Adverse Event|0|||
16769254|NCT02543528|37707157|FG001|Adaptation Period|Adverse Event|0|||
16769255|NCT02543528|37707158|FG002|Adaptation Period|Adverse Event|0|||
16769256|NCT02543528|37707159|FG003|Adaptation Period|Adverse Event|0|||
16769257|NCT02543528|37707160|FG004|Adaptation Period|Adverse Event|2|||
16769258|NCT02543528|37707156|FG000|Extended Wear Period|Adverse Event|17|||
16769259|NCT02543528|37707157|FG001|Extended Wear Period|Adverse Event|11|||
16769260|NCT02543528|37707158|FG002|Extended Wear Period|Adverse Event|16|||
16769261|NCT02543528|37707159|FG003|Extended Wear Period|Adverse Event|3|||
16769262|NCT02543528|37707160|FG004|Extended Wear Period|Adverse Event|0|||
16769263|NCT02543528|37707156|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
16769264|NCT02543528|37707157|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
16769265|NCT02543528|37707158|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
16769266|NCT02543528|37707159|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
16769267|NCT02543528|37707160|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
16769268|NCT02543528|37707156|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
16769269|NCT02543528|37707157|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
16769270|NCT02543528|37707158|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
16769271|NCT02543528|37707159|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
16769272|NCT02543528|37707160|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
16769273|NCT02543528|37707156|FG000|Extended Wear Period|Lost to Follow-up|0|||
16769274|NCT02543528|37707157|FG001|Extended Wear Period|Lost to Follow-up|1|||
16769275|NCT02543528|37707158|FG002|Extended Wear Period|Lost to Follow-up|2|||
16769276|NCT02543528|37707159|FG003|Extended Wear Period|Lost to Follow-up|1|||
16769277|NCT02543528|37707160|FG004|Extended Wear Period|Lost to Follow-up|0|||
16769278|NCT02543528|37707156|FG000|Extended Wear Period|Withdrawal by Subject|10|||
16769279|NCT02543528|37707157|FG001|Extended Wear Period|Withdrawal by Subject|9|||
16769280|NCT02543528|37707158|FG002|Extended Wear Period|Withdrawal by Subject|4|||
16769281|NCT02543528|37707159|FG003|Extended Wear Period|Withdrawal by Subject|5|||
16769282|NCT02543528|37707160|FG004|Extended Wear Period|Withdrawal by Subject|0|||
16769283|NCT00156533|37707178|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
16769284|NCT00156533|37707179|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
16769285|NCT00156533|37707180|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
16769286|NCT00156533|37707181|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
16769287|NCT00156533|37707178|FG000|Overall Study|Withdrawal by Subject|1|||
16769288|NCT00156533|37707179|FG001|Overall Study|Withdrawal by Subject|0|||
16769289|NCT00156533|37707180|FG002|Overall Study|Withdrawal by Subject|0|||
16769290|NCT00156533|37707181|FG003|Overall Study|Withdrawal by Subject|1|||
16769291|NCT00156533|37707178|FG000|Overall Study|Failed Screening|1|||
16769292|NCT00156533|37707179|FG001|Overall Study|Failed Screening|0|||
17115479|NCT00352534|38253551|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
16769293|NCT00156533|37707180|FG002|Overall Study|Failed Screening|1|||
16769294|NCT00156533|37707181|FG003|Overall Study|Failed Screening|1|||
16769295|NCT01660022|37707199|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
16769296|NCT01660022|37707200|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
16769297|NCT01660022|37707201|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
16769298|NCT01660022|37707202|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
16769299|NCT01660022|37707203|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
16769300|NCT01660022|37707204|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
16769301|NCT01660022|37707199|FG000|First Sequence (7 Days)|Adverse Event|0|||
16769302|NCT01660022|37707200|FG001|First Sequence (7 Days)|Adverse Event|0|||
16769303|NCT01660022|37707201|FG002|First Sequence (7 Days)|Adverse Event|0|||
16769304|NCT01660022|37707202|FG003|First Sequence (7 Days)|Adverse Event|0|||
16769305|NCT01660022|37707203|FG004|First Sequence (7 Days)|Adverse Event|1|||
16769306|NCT01660022|37707204|FG005|First Sequence (7 Days)|Adverse Event|3|||
16769307|NCT01660022|37707199|FG000|First Sequence (7 Days)|Protocol Violation|0|||
16769308|NCT01660022|37707200|FG001|First Sequence (7 Days)|Protocol Violation|0|||
16769309|NCT01660022|37707201|FG002|First Sequence (7 Days)|Protocol Violation|0|||
16769310|NCT01660022|37707202|FG003|First Sequence (7 Days)|Protocol Violation|0|||
16769311|NCT01660022|37707203|FG004|First Sequence (7 Days)|Protocol Violation|0|||
16769312|NCT01660022|37707204|FG005|First Sequence (7 Days)|Protocol Violation|1|||
16769313|NCT00156065|37707233|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
16769314|NCT00156065|37707234|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
16769315|NCT00156065|37707235|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
16769316|NCT00156065|37707233|FG000|Overall Study|Adverse Event|8|||
16769317|NCT00156065|37707234|FG001|Overall Study|Adverse Event|11|||
16769318|NCT00156065|37707235|FG002|Overall Study|Adverse Event|4|||
16769319|NCT00156065|37707233|FG000|Overall Study|Lack of Efficacy|2|||
16769320|NCT00156065|37707234|FG001|Overall Study|Lack of Efficacy|9|||
16769321|NCT00156065|37707235|FG002|Overall Study|Lack of Efficacy|3|||
16769322|NCT00156065|37707233|FG000|Overall Study|Withdrawal by Subject|13|||
16769323|NCT00156065|37707234|FG001|Overall Study|Withdrawal by Subject|26|||
16769324|NCT00156065|37707235|FG002|Overall Study|Withdrawal by Subject|16|||
16769325|NCT00156065|37707233|FG000|Overall Study|Lost to Follow-up|5|||
16769326|NCT00156065|37707234|FG001|Overall Study|Lost to Follow-up|7|||
16769327|NCT00156065|37707235|FG002|Overall Study|Lost to Follow-up|1|||
16769328|NCT00156065|37707233|FG000|Overall Study|Other|2|||
16769329|NCT00156065|37707234|FG001|Overall Study|Other|9|||
16769330|NCT00156065|37707235|FG002|Overall Study|Other|3|||
16769331|NCT01554956|37707246|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
16769332|NCT01554956|37707247|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
16769333|NCT01554956|37707248|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
16769334|NCT01554956|37707246|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
16769335|NCT01554956|37707247|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
16769336|NCT01554956|37707248|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
16769337|NCT01554956|37707246|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
16769338|NCT01554956|37707247|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
16769339|NCT01554956|37707248|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
16769340|NCT02138786|37707269|FG000|Overall Study|Adverse Event|0|||
16769341|NCT02138786|37707270|FG001|Overall Study|Adverse Event|2|||
16769342|NCT02138786|37707271|FG002|Overall Study|Adverse Event|1|||
16769343|NCT02138786|37707269|FG000|Overall Study|Death|1|||
16769344|NCT02138786|37707270|FG001|Overall Study|Death|7|||
16769345|NCT02138786|37707271|FG002|Overall Study|Death|2|||
16769346|NCT02138786|37707269|FG000|Overall Study|Disease Progression|1|||
16769347|NCT02138786|37707270|FG001|Overall Study|Disease Progression|1|||
16769348|NCT02138786|37707271|FG002|Overall Study|Disease Progression|3|||
16769349|NCT02138786|37707269|FG000|Overall Study|Withdrawal by Subject|1|||
16769350|NCT02138786|37707270|FG001|Overall Study|Withdrawal by Subject|2|||
16769351|NCT02138786|37707271|FG002|Overall Study|Withdrawal by Subject|0|||
16769352|NCT02138786|37707269|FG000|Overall Study|Patient's Wish|0|||
16769353|NCT02138786|37707270|FG001|Overall Study|Patient's Wish|2|||
16769354|NCT02138786|37707271|FG002|Overall Study|Patient's Wish|0|||
16769355|NCT02138786|37707269|FG000|Overall Study|Sponsor Terminated Study|0|||
16769356|NCT02138786|37707270|FG001|Overall Study|Sponsor Terminated Study|1|||
16769357|NCT02138786|37707271|FG002|Overall Study|Sponsor Terminated Study|1|||
16769358|NCT02138786|37707269|FG000|Overall Study|Non-Compliance|0|||
16942067|NCT01379703|38086635|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
16942068|NCT01379703|38086636|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
16942069|NCT01379703|38086634|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
16942070|NCT01379703|38086635|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
16942071|NCT01379703|38086636|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
16769359|NCT02138786|37707270|FG001|Overall Study|Non-Compliance|0|||
16769360|NCT02138786|37707271|FG002|Overall Study|Non-Compliance|1|||
16769361|NCT02529488|37707277|FG000|Overall Study|Adverse Event|1|||
16769362|NCT02529488|37707277|FG000|Overall Study|Death|3|||
16769363|NCT01329419|37707285|FG000|Overall Study|Protocol Violation|235|||
16769364|NCT01329341|37707290|FG000|Overall Study|Withdrawal by Subject|44|||
16769365|NCT02532764|37707304|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16769366|NCT02532764|37707305|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16769367|NCT02532764|37707306|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16769368|NCT02532764|37707307|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16769369|NCT02532764|37707308|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16769370|NCT02532764|37707309|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16769371|NCT02532764|37707310|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16769372|NCT02532764|37707311|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
16769373|NCT02532764|37707312|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
16769374|NCT02532764|37707313|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
16769375|NCT02528942|37707340|FG000|Overall Study|Did not meet imaging criteria|9|||
16769376|NCT02528942|37707340|FG000|Overall Study|Lost to Follow-up|25|||
16769377|NCT02527148|37707346|FG000|Overall Study|Did not receive study intervention|1|||
16769378|NCT02527148|37707347|FG001|Overall Study|Did not receive study intervention|0|||
16769379|NCT02291614|37707366|FG000|Overall Study|Lost to Follow-up|0|||
16769380|NCT02291614|37707367|FG001|Overall Study|Lost to Follow-up|0|||
16769381|NCT02291614|37707368|FG002|Overall Study|Lost to Follow-up|0|||
16769382|NCT02291614|37707369|FG003|Overall Study|Lost to Follow-up|0|||
16769383|NCT02291614|37707370|FG004|Overall Study|Lost to Follow-up|0|||
16769384|NCT02291614|37707371|FG005|Overall Study|Lost to Follow-up|0|||
16769385|NCT02291614|37707372|FG006|Overall Study|Lost to Follow-up|0|||
16769386|NCT02291614|37707373|FG007|Overall Study|Lost to Follow-up|1|||
16769387|NCT02291614|37707374|FG008|Overall Study|Lost to Follow-up|0|||
16769388|NCT02291614|37707375|FG009|Overall Study|Lost to Follow-up|0|||
16769389|NCT02291614|37707376|FG010|Overall Study|Lost to Follow-up|0|||
16769390|NCT02291614|37707366|FG000|Overall Study|Withdrawal by Subject|0|||
16769391|NCT02291614|37707367|FG001|Overall Study|Withdrawal by Subject|1|||
16769392|NCT02291614|37707368|FG002|Overall Study|Withdrawal by Subject|0|||
16769393|NCT02291614|37707369|FG003|Overall Study|Withdrawal by Subject|0|||
16769394|NCT02291614|37707370|FG004|Overall Study|Withdrawal by Subject|0|||
16769395|NCT02291614|37707371|FG005|Overall Study|Withdrawal by Subject|0|||
16769396|NCT02291614|37707372|FG006|Overall Study|Withdrawal by Subject|0|||
16769397|NCT02291614|37707373|FG007|Overall Study|Withdrawal by Subject|0|||
16769398|NCT02291614|37707374|FG008|Overall Study|Withdrawal by Subject|0|||
16769399|NCT02291614|37707375|FG009|Overall Study|Withdrawal by Subject|2|||
16769400|NCT02291614|37707376|FG010|Overall Study|Withdrawal by Subject|2|||
16769401|NCT02291614|37707366|FG000|Overall Study|Decision by sponsor|0|||
16769402|NCT02291614|37707367|FG001|Overall Study|Decision by sponsor|0|||
16769403|NCT02291614|37707368|FG002|Overall Study|Decision by sponsor|0|||
16769404|NCT02291614|37707369|FG003|Overall Study|Decision by sponsor|1|||
16769405|NCT02291614|37707370|FG004|Overall Study|Decision by sponsor|0|||
16769406|NCT02291614|37707371|FG005|Overall Study|Decision by sponsor|0|||
16769407|NCT02291614|37707372|FG006|Overall Study|Decision by sponsor|0|||
16769408|NCT02291614|37707373|FG007|Overall Study|Decision by sponsor|0|||
16769409|NCT02291614|37707374|FG008|Overall Study|Decision by sponsor|0|||
16769410|NCT02291614|37707375|FG009|Overall Study|Decision by sponsor|0|||
16769411|NCT02291614|37707376|FG010|Overall Study|Decision by sponsor|0|||
16769412|NCT02291614|37707366|FG000|Overall Study|Death|0|||
16769413|NCT02291614|37707367|FG001|Overall Study|Death|0|||
16769414|NCT02291614|37707368|FG002|Overall Study|Death|1|||
16769415|NCT02291614|37707369|FG003|Overall Study|Death|0|||
16769416|NCT02291614|37707370|FG004|Overall Study|Death|1|||
16769417|NCT02291614|37707371|FG005|Overall Study|Death|1|||
16769418|NCT02291614|37707372|FG006|Overall Study|Death|1|||
16769419|NCT02291614|37707373|FG007|Overall Study|Death|0|||
16769420|NCT02291614|37707374|FG008|Overall Study|Death|0|||
16769421|NCT02291614|37707375|FG009|Overall Study|Death|0|||
16769422|NCT02291614|37707376|FG010|Overall Study|Death|0|||
16769423|NCT02526524|37707412|FG000|Overall Study|Withdrawal by Subject|3|||
16769424|NCT02526524|37707413|FG001|Overall Study|Withdrawal by Subject|3|||
16769425|NCT02526524|37707414|FG002|Overall Study|Withdrawal by Subject|6|||
16769426|NCT02526524|37707415|FG003|Overall Study|Withdrawal by Subject|1|||
16769427|NCT02526524|37707416|FG004|Overall Study|Withdrawal by Subject|9|||
16769428|NCT02526524|37707417|FG005|Overall Study|Withdrawal by Subject|5|||
16769429|NCT02526524|37707412|FG000|Overall Study|Adverse Event|3|||
16769430|NCT02526524|37707413|FG001|Overall Study|Adverse Event|2|||
16769431|NCT02526524|37707414|FG002|Overall Study|Adverse Event|4|||
16769432|NCT02526524|37707415|FG003|Overall Study|Adverse Event|2|||
16769433|NCT02526524|37707416|FG004|Overall Study|Adverse Event|6|||
16769434|NCT02526524|37707417|FG005|Overall Study|Adverse Event|8|||
16769435|NCT02526524|37707412|FG000|Overall Study|Lost to Follow-up|2|||
16769436|NCT02526524|37707413|FG001|Overall Study|Lost to Follow-up|3|||
16769437|NCT02526524|37707414|FG002|Overall Study|Lost to Follow-up|8|||
16769438|NCT02526524|37707415|FG003|Overall Study|Lost to Follow-up|1|||
16769439|NCT02526524|37707416|FG004|Overall Study|Lost to Follow-up|2|||
16769440|NCT02526524|37707417|FG005|Overall Study|Lost to Follow-up|5|||
16769441|NCT02526524|37707412|FG000|Overall Study|Protocol Violation|3|||
16769442|NCT02526524|37707413|FG001|Overall Study|Protocol Violation|1|||
16769443|NCT02526524|37707414|FG002|Overall Study|Protocol Violation|5|||
16769444|NCT02526524|37707415|FG003|Overall Study|Protocol Violation|3|||
16769445|NCT02526524|37707416|FG004|Overall Study|Protocol Violation|4|||
16769446|NCT02526524|37707417|FG005|Overall Study|Protocol Violation|3|||
16769447|NCT02526524|37707412|FG000|Overall Study|Loss of Glucose Control|0|||
16769448|NCT02526524|37707413|FG001|Overall Study|Loss of Glucose Control|0|||
16769449|NCT02526524|37707414|FG002|Overall Study|Loss of Glucose Control|3|||
16769450|NCT02526524|37707415|FG003|Overall Study|Loss of Glucose Control|0|||
16769451|NCT02526524|37707416|FG004|Overall Study|Loss of Glucose Control|2|||
16769452|NCT02526524|37707417|FG005|Overall Study|Loss of Glucose Control|0|||
16769453|NCT02526524|37707412|FG000|Overall Study|Physician Decision|0|||
16769454|NCT02526524|37707413|FG001|Overall Study|Physician Decision|0|||
16769455|NCT02526524|37707414|FG002|Overall Study|Physician Decision|0|||
16769456|NCT02526524|37707415|FG003|Overall Study|Physician Decision|0|||
16769457|NCT02526524|37707416|FG004|Overall Study|Physician Decision|1|||
16769458|NCT02526524|37707417|FG005|Overall Study|Physician Decision|0|||
16769459|NCT02526524|37707412|FG000|Overall Study|Sponsor Decision|1|||
16769460|NCT02526524|37707413|FG001|Overall Study|Sponsor Decision|0|||
16769461|NCT02526524|37707414|FG002|Overall Study|Sponsor Decision|0|||
16769462|NCT02526524|37707415|FG003|Overall Study|Sponsor Decision|0|||
16769463|NCT02526524|37707416|FG004|Overall Study|Sponsor Decision|0|||
16769464|NCT02526524|37707417|FG005|Overall Study|Sponsor Decision|0|||
16769465|NCT02526290|37707431|FG000|Overall Study|Adverse Event|3|||
16769466|NCT02526290|37707431|FG000|Overall Study|Withdrawal by Subject|4|||
16769467|NCT02526290|37707431|FG000|Overall Study|Physician Decision|1|||
16769468|NCT02319148|37707438|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
16856562|NCT01969721|37810210|FG002|Overall Study|Lack of Efficacy|1|||
16769469|NCT02319148|37707439|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
16769470|NCT02319148|37707440|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
16769471|NCT02319148|37707441|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
16769472|NCT02319148|37707438|FG000|Second Intervention Period|No longer willing to participate|0|||
16769473|NCT02319148|37707439|FG001|Second Intervention Period|No longer willing to participate|1|||
16769474|NCT02319148|37707440|FG002|Second Intervention Period|No longer willing to participate|0|||
16769475|NCT02319148|37707441|FG003|Second Intervention Period|No longer willing to participate|0|||
16769476|NCT02319148|37707438|FG000|Second Intervention Period|Other|0|||
16769477|NCT02319148|37707439|FG001|Second Intervention Period|Other|0|||
16769478|NCT02319148|37707440|FG002|Second Intervention Period|Other|0|||
16769479|NCT02319148|37707441|FG003|Second Intervention Period|Other|1|||
16769480|NCT02526212|37707462|FG000|Overall Study|Incarceration|1|||
16769481|NCT02526212|37707463|FG001|Overall Study|Incarceration|0|||
16769482|NCT02526212|37707462|FG000|Overall Study|Lost to Follow-up|1|||
16769483|NCT02526212|37707463|FG001|Overall Study|Lost to Follow-up|0|||
16769484|NCT02526212|37707462|FG000|Overall Study|Death|0|||
16769485|NCT02526212|37707463|FG001|Overall Study|Death|1|||
16769486|NCT02532374|37707469|FG000|Overall Study|Withdrawal by Subject|1|||
16769487|NCT02532374|37707469|FG000|Overall Study|Physician Decision|1|||
16769488|NCT02525744|37707481|FG000|Period 1|Physician Decision|0|||
16769489|NCT02525744|37707482|FG001|Period 1|Physician Decision|0|||
16769490|NCT02525744|37707483|FG002|Period 1|Physician Decision|1|||
16769491|NCT02525744|37707484|FG003|Period 1|Physician Decision|0|||
16769492|NCT02525744|37707481|FG000|Period 3|Adverse Event|0|||
16769493|NCT02525744|37707482|FG001|Period 3|Adverse Event|1|||
16769494|NCT02525744|37707483|FG002|Period 3|Adverse Event|0|||
16769495|NCT02525744|37707484|FG003|Period 3|Adverse Event|0|||
16769496|NCT02525744|37707481|FG000|Period 4|Withdrawal by Subject|1|||
16769497|NCT02525744|37707482|FG001|Period 4|Withdrawal by Subject|0|||
16769498|NCT02525744|37707483|FG002|Period 4|Withdrawal by Subject|0|||
16769499|NCT02525744|37707484|FG003|Period 4|Withdrawal by Subject|0|||
16769500|NCT02525744|37707481|FG000|Period 5|Physician Decision|1|||
16769501|NCT02525744|37707482|FG001|Period 5|Physician Decision|0|||
16769502|NCT02525744|37707483|FG002|Period 5|Physician Decision|0|||
16769503|NCT02525744|37707484|FG003|Period 5|Physician Decision|0|||
16769504|NCT00152477|37707497|FG000|Chemotherapy Period|Adverse Event|9|||
16769505|NCT00152477|37707498|FG001|Chemotherapy Period|Adverse Event|4|||
16769506|NCT00152477|37707499|FG002|Chemotherapy Period|Adverse Event|5|||
16769507|NCT00152477|37707497|FG000|Chemotherapy Period|Death|1|||
16769508|NCT00152477|37707498|FG001|Chemotherapy Period|Death|3|||
16769509|NCT00152477|37707499|FG002|Chemotherapy Period|Death|3|||
16769510|NCT00152477|37707497|FG000|Chemotherapy Period|Lack of Efficacy|4|||
16769511|NCT00152477|37707498|FG001|Chemotherapy Period|Lack of Efficacy|5|||
16769512|NCT00152477|37707499|FG002|Chemotherapy Period|Lack of Efficacy|6|||
16769513|NCT00152477|37707497|FG000|Chemotherapy Period|Lost to Follow-up|1|||
16769514|NCT00152477|37707498|FG001|Chemotherapy Period|Lost to Follow-up|0|||
16769515|NCT00152477|37707499|FG002|Chemotherapy Period|Lost to Follow-up|1|||
16769516|NCT00152477|37707497|FG000|Chemotherapy Period|Protocol Violation|1|||
16769517|NCT00152477|37707498|FG001|Chemotherapy Period|Protocol Violation|1|||
16769518|NCT00152477|37707499|FG002|Chemotherapy Period|Protocol Violation|0|||
16769519|NCT00152477|37707497|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
16769520|NCT00152477|37707498|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
16769521|NCT00152477|37707499|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
16769522|NCT00152477|37707497|FG000|Chemotherapy Period|Progression of Disease|6|||
16769523|NCT00152477|37707498|FG001|Chemotherapy Period|Progression of Disease|8|||
16769524|NCT00152477|37707499|FG002|Chemotherapy Period|Progression of Disease|4|||
16769525|NCT00152477|37707497|FG000|Chemotherapy Period|Investigator decision|0|||
16769526|NCT00152477|37707498|FG001|Chemotherapy Period|Investigator decision|0|||
16769527|NCT00152477|37707499|FG002|Chemotherapy Period|Investigator decision|1|||
16769528|NCT00152477|37707497|FG000|Chemotherapy Period|Patient condition worsened|1|||
16769529|NCT00152477|37707498|FG001|Chemotherapy Period|Patient condition worsened|0|||
16769530|NCT00152477|37707499|FG002|Chemotherapy Period|Patient condition worsened|0|||
16769531|NCT00152477|37707497|FG000|Monotherapy Period|Adverse Event|1|||
16769532|NCT00152477|37707498|FG001|Monotherapy Period|Adverse Event|0|||
16769533|NCT00152477|37707499|FG002|Monotherapy Period|Adverse Event|5|||
16769534|NCT00152477|37707497|FG000|Monotherapy Period|Death|2|||
16769535|NCT00152477|37707498|FG001|Monotherapy Period|Death|0|||
16769536|NCT00152477|37707499|FG002|Monotherapy Period|Death|1|||
16769537|NCT00152477|37707497|FG000|Monotherapy Period|Lack of Efficacy|7|||
16769538|NCT00152477|37707498|FG001|Monotherapy Period|Lack of Efficacy|16|||
16769539|NCT00152477|37707499|FG002|Monotherapy Period|Lack of Efficacy|10|||
16769540|NCT00152477|37707497|FG000|Monotherapy Period|Protocol Violation|0|||
16769541|NCT00152477|37707498|FG001|Monotherapy Period|Protocol Violation|1|||
16769542|NCT00152477|37707499|FG002|Monotherapy Period|Protocol Violation|0|||
16769543|NCT00152477|37707497|FG000|Monotherapy Period|Withdrawal by Subject|0|||
16769544|NCT00152477|37707498|FG001|Monotherapy Period|Withdrawal by Subject|0|||
16769545|NCT00152477|37707499|FG002|Monotherapy Period|Withdrawal by Subject|4|||
16769546|NCT00152477|37707497|FG000|Monotherapy Period|Progression of Disease|5|||
16769547|NCT00152477|37707498|FG001|Monotherapy Period|Progression of Disease|11|||
16769548|NCT00152477|37707499|FG002|Monotherapy Period|Progression of Disease|12|||
16769549|NCT00152477|37707497|FG000|Monotherapy Period|Patient decision|0|||
16769550|NCT00152477|37707498|FG001|Monotherapy Period|Patient decision|1|||
16769551|NCT00152477|37707499|FG002|Monotherapy Period|Patient decision|1|||
16769552|NCT00152477|37707497|FG000|Monotherapy Period|Study personel decision|0|||
16769553|NCT00152477|37707498|FG001|Monotherapy Period|Study personel decision|0|||
16769554|NCT00152477|37707499|FG002|Monotherapy Period|Study personel decision|1|||
16769555|NCT02525588|37707512|FG000|Overall Study|Death|3|||
16769556|NCT02525588|37707513|FG001|Overall Study|Death|1|||
16769557|NCT02525588|37707512|FG000|Overall Study|Lost to Follow-up|2|||
16769558|NCT02525588|37707513|FG001|Overall Study|Lost to Follow-up|0|||
16769559|NCT02525588|37707512|FG000|Overall Study|Withdrawal by Subject|1|||
16769560|NCT02525588|37707513|FG001|Overall Study|Withdrawal by Subject|1|||
16769561|NCT02525588|37707512|FG000|Overall Study|Adverse Event|0|||
16769562|NCT02525588|37707513|FG001|Overall Study|Adverse Event|1|||
16769563|NCT00153179|37707521|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
16769564|NCT00153179|37707522|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
16769565|NCT00153179|37707523|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
16769566|NCT00153179|37707524|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
16769567|NCT02531594|37707534|FG000|Overall Study|Withdrawal by Subject|7|||
16769568|NCT02531594|37707535|FG001|Overall Study|Withdrawal by Subject|8|||
16769569|NCT02743949|37707544|FG000|Overall Study|Adverse Event|0|||
16769570|NCT02743949|37707545|FG001|Overall Study|Adverse Event|0|||
16769571|NCT02743949|37707546|FG002|Overall Study|Adverse Event|2|||
16769572|NCT02743949|37707544|FG000|Overall Study|Significant Protocol Deviation|2|||
16769573|NCT02743949|37707545|FG001|Overall Study|Significant Protocol Deviation|0|||
16769574|NCT02743949|37707546|FG002|Overall Study|Significant Protocol Deviation|1|||
16769575|NCT02743949|37707544|FG000|Overall Study|Voluntary Withdrawal|2|||
16769576|NCT02743949|37707545|FG001|Overall Study|Voluntary Withdrawal|1|||
16769577|NCT02743949|37707546|FG002|Overall Study|Voluntary Withdrawal|0|||
16769578|NCT02531438|37707556|FG000|Overall Study|Adverse Event|7|||
16769579|NCT02531438|37707557|FG001|Overall Study|Adverse Event|9|||
16769580|NCT02531438|37707556|FG000|Overall Study|Lost to Follow-up|0|||
16769581|NCT02531438|37707557|FG001|Overall Study|Lost to Follow-up|3|||
16769582|NCT02531438|37707556|FG000|Overall Study|Withdrawal by Subject|7|||
16769583|NCT02531438|37707557|FG001|Overall Study|Withdrawal by Subject|8|||
16769584|NCT02531438|37707556|FG000|Overall Study|Physician Decision|0|||
16769585|NCT02531438|37707557|FG001|Overall Study|Physician Decision|1|||
16769586|NCT02531438|37707556|FG000|Overall Study|Death|6|||
16769587|NCT02531438|37707557|FG001|Overall Study|Death|3|||
16769588|NCT02531438|37707556|FG000|Overall Study|Randomized, but Not Treated|4|||
16769589|NCT02531438|37707557|FG001|Overall Study|Randomized, but Not Treated|0|||
16769590|NCT02531438|37707556|FG000|Overall Study|Missed EOT/PTE Visit|5|||
16769591|NCT02531438|37707557|FG001|Overall Study|Missed EOT/PTE Visit|2|||
16769592|NCT02531438|37707556|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
16769593|NCT02531438|37707557|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
16769594|NCT02289898|37707566|FG000|Overall Study|Death|5|||
16769595|NCT02289898|37707567|FG001|Overall Study|Death|4|||
16769596|NCT02289898|37707568|FG002|Overall Study|Death|3|||
16769597|NCT02289898|37707566|FG000|Overall Study|Physician Decision|2|||
16769598|NCT02289898|37707567|FG001|Overall Study|Physician Decision|5|||
16769599|NCT02289898|37707568|FG002|Overall Study|Physician Decision|2|||
16769600|NCT02289898|37707566|FG000|Overall Study|Withdrawal by Subject|0|||
16769601|NCT02289898|37707567|FG001|Overall Study|Withdrawal by Subject|4|||
16769602|NCT02289898|37707568|FG002|Overall Study|Withdrawal by Subject|1|||
16769603|NCT02289898|37707566|FG000|Overall Study|Adverse Event|3|||
16769604|NCT02289898|37707567|FG001|Overall Study|Adverse Event|5|||
16769605|NCT02289898|37707568|FG002|Overall Study|Adverse Event|5|||
16769606|NCT02289898|37707566|FG000|Overall Study|Disease progression|34|||
16769607|NCT02289898|37707567|FG001|Overall Study|Disease progression|28|||
16769608|NCT02289898|37707568|FG002|Overall Study|Disease progression|34|||
16769609|NCT02289898|37707566|FG000|Overall Study|Use of another anticancer therapy|0|||
16769610|NCT02289898|37707567|FG001|Overall Study|Use of another anticancer therapy|0|||
16769611|NCT02289898|37707568|FG002|Overall Study|Use of another anticancer therapy|1|||
16769612|NCT02289898|37707566|FG000|Overall Study|Other|8|||
16769613|NCT02289898|37707567|FG001|Overall Study|Other|7|||
16769614|NCT02289898|37707568|FG002|Overall Study|Other|10|||
16769615|NCT01660412|37707575|FG000|Overall Study|Protocol Violation|0|||
16769616|NCT01660412|37707576|FG001|Overall Study|Protocol Violation|3|||
16769617|NCT01659554|37707582|FG000|Overall Study|Study Termination|4|||
16769618|NCT01659320|37707586|FG000|Overall Study|Withdrawal by Subject|2|||
16769619|NCT01659320|37707586|FG000|Overall Study|Physician Decision|1|||
16769620|NCT01660334|37707590|FG000|Overall Study|Lost to Follow-up|1|||
16769621|NCT01660256|37707597|FG000|Overall Study|Adverse Event|4|||
16769622|NCT01660256|37707598|FG001|Overall Study|Adverse Event|0|||
16769623|NCT01660256|37707599|FG002|Overall Study|Adverse Event|2|||
16769624|NCT01660256|37707597|FG000|Overall Study|Withdrawal by Subject|1|||
16769625|NCT01660256|37707598|FG001|Overall Study|Withdrawal by Subject|0|||
16769626|NCT01660256|37707599|FG002|Overall Study|Withdrawal by Subject|2|||
16769627|NCT02034123|37707625|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769628|NCT02034123|37707626|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769629|NCT02034123|37707627|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769630|NCT02034123|37707628|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769631|NCT02034123|37707629|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
16769632|NCT02034123|37707630|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769633|NCT02034123|37707631|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769634|NCT02034123|37707632|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
16769635|NCT02034123|37707633|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
16769636|NCT02034123|37707634|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769637|NCT02034123|37707635|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769638|NCT02034123|37707636|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769639|NCT02034123|37707637|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769640|NCT02034123|37707638|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769641|NCT02034123|37707639|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769642|NCT02034123|37707640|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769643|NCT02034123|37707641|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769644|NCT02034123|37707642|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16769645|NCT02034123|37707625|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769646|NCT02034123|37707626|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769647|NCT02034123|37707627|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769648|NCT02034123|37707628|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
16769649|NCT02034123|37707629|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769650|NCT02034123|37707630|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769651|NCT02034123|37707631|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769652|NCT02034123|37707632|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769653|NCT02034123|37707633|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769654|NCT02034123|37707634|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769655|NCT02034123|37707635|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769656|NCT02034123|37707636|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769657|NCT02034123|37707637|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769658|NCT02034123|37707638|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769659|NCT02034123|37707639|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769660|NCT02034123|37707640|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769661|NCT02034123|37707641|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769662|NCT02034123|37707642|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16769663|NCT02034123|37707625|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769664|NCT02034123|37707626|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769665|NCT02034123|37707627|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769666|NCT02034123|37707628|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769667|NCT02034123|37707629|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769668|NCT02034123|37707630|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769669|NCT02034123|37707631|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769670|NCT02034123|37707632|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769671|NCT02034123|37707633|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
16769672|NCT02034123|37707634|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769673|NCT02034123|37707635|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769674|NCT02034123|37707636|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769675|NCT02034123|37707637|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769676|NCT02034123|37707638|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769677|NCT02034123|37707639|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769678|NCT02034123|37707640|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769679|NCT02034123|37707641|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769680|NCT02034123|37707642|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16769681|NCT02034123|37707625|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769682|NCT02034123|37707626|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769683|NCT02034123|37707627|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769684|NCT02034123|37707628|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
16769685|NCT02034123|37707629|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
16769686|NCT02034123|37707630|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769687|NCT02034123|37707631|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769688|NCT02034123|37707632|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769689|NCT02034123|37707633|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769690|NCT02034123|37707634|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769691|NCT02034123|37707635|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769692|NCT02034123|37707636|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769693|NCT02034123|37707637|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769694|NCT02034123|37707638|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769695|NCT02034123|37707639|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769696|NCT02034123|37707640|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769697|NCT02034123|37707641|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16856563|NCT01969721|37810211|FG003|Overall Study|Lack of Efficacy|0|||
16769698|NCT02034123|37707642|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16769699|NCT02530970|37707685|FG000|Overall Study|Adverse Event|8|||
16769700|NCT02530970|37707685|FG000|Overall Study|Lost to Follow-up|88|||
16769701|NCT02530970|37707685|FG000|Overall Study|Physician Decision|5|||
16769702|NCT02530970|37707685|FG000|Overall Study|Withdrawal by Subject|14|||
16769703|NCT02530970|37707685|FG000|Overall Study|Death|6|||
16769704|NCT02530970|37707685|FG000|Overall Study|Hospitalization|1|||
16769705|NCT02530970|37707685|FG000|Overall Study|Insurance|2|||
16769706|NCT02530970|37707685|FG000|Overall Study|Explant|2|||
16769707|NCT02530970|37707685|FG000|Overall Study|Change in Provider|5|||
16769708|NCT02530970|37707685|FG000|Overall Study|Relocation|3|||
16769709|NCT02318602|37707692|FG000|Overall Study|Adverse Event|0|||
16769710|NCT02318602|37707693|FG001|Overall Study|Adverse Event|1|||
16769711|NCT02318602|37707694|FG002|Overall Study|Adverse Event|1|||
16769712|NCT02318602|37707692|FG000|Overall Study|Withdrawal by Subject|0|||
16769713|NCT02318602|37707693|FG001|Overall Study|Withdrawal by Subject|3|||
16769714|NCT02318602|37707694|FG002|Overall Study|Withdrawal by Subject|0|||
16769715|NCT02318602|37707692|FG000|Overall Study|Death|1|||
16769716|NCT02318602|37707693|FG001|Overall Study|Death|0|||
16769717|NCT02318602|37707694|FG002|Overall Study|Death|0|||
16769718|NCT02318602|37707692|FG000|Overall Study|Guardian decision to withdraw|0|||
16769719|NCT02318602|37707693|FG001|Overall Study|Guardian decision to withdraw|0|||
16769720|NCT02318602|37707694|FG002|Overall Study|Guardian decision to withdraw|1|||
16769721|NCT02318368|37707710|FG000|Overall Study|Withdrawal by Subject|2|||
16769722|NCT02318368|37707711|FG001|Overall Study|Withdrawal by Subject|0|||
16769723|NCT02318368|37707710|FG000|Overall Study|Study terminated by the sponsor|5|||
16769724|NCT02318368|37707711|FG001|Overall Study|Study terminated by the sponsor|2|||
16769725|NCT02318368|37707710|FG000|Overall Study|Death|0|||
16769726|NCT02318368|37707711|FG001|Overall Study|Death|1|||
16769727|NCT02318134|37707719|FG000|Overall Study|Withdrawal by Subject|2|||
16769728|NCT02318134|37707720|FG001|Overall Study|Withdrawal by Subject|1|||
16769729|NCT02317510|37707730|FG000|Overall Study|Adverse Event|0|||
16769730|NCT02317510|37707731|FG001|Overall Study|Adverse Event|1|||
16769731|NCT02317432|37707742|FG000|Overall Study|Death|4|||
16769732|NCT02317432|37707743|FG001|Overall Study|Death|1|||
16769733|NCT02317432|37707742|FG000|Overall Study|Lost to Follow-up|0|||
16769734|NCT02317432|37707743|FG001|Overall Study|Lost to Follow-up|5|||
16769735|NCT02317432|37707742|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
16769736|NCT02317432|37707743|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
16769737|NCT00494234|37707751|FG000|Overall Study|Lack of Efficacy|12|||
16769738|NCT00494234|37707752|FG001|Overall Study|Lack of Efficacy|9|||
16769739|NCT00494234|37707751|FG000|Overall Study|Withdrawal by Subject|1|||
16769740|NCT00494234|37707752|FG001|Overall Study|Withdrawal by Subject|0|||
16769741|NCT00494234|37707751|FG000|Overall Study|Death|2|||
16769742|NCT00494234|37707752|FG001|Overall Study|Death|1|||
16769743|NCT02289820|37707769|FG000|Overall Study|Withdrawal by Subject|2|||
16769744|NCT02289820|37707770|FG001|Overall Study|Withdrawal by Subject|1|||
16769745|NCT02289820|37707771|FG002|Overall Study|Withdrawal by Subject|2|||
16769746|NCT02289820|37707772|FG003|Overall Study|Withdrawal by Subject|1|||
16769747|NCT02289820|37707773|FG004|Overall Study|Withdrawal by Subject|0|||
16769748|NCT02289820|37707774|FG005|Overall Study|Withdrawal by Subject|0|||
16769749|NCT02289820|37707775|FG006|Overall Study|Withdrawal by Subject|1|||
16769750|NCT02289820|37707769|FG000|Overall Study|Death|0|||
16769751|NCT02289820|37707770|FG001|Overall Study|Death|0|||
16769752|NCT02289820|37707771|FG002|Overall Study|Death|1|||
16769753|NCT02289820|37707772|FG003|Overall Study|Death|0|||
16769754|NCT02289820|37707773|FG004|Overall Study|Death|0|||
16769755|NCT02289820|37707774|FG005|Overall Study|Death|0|||
16769756|NCT02289820|37707775|FG006|Overall Study|Death|0|||
16769757|NCT02289820|37707769|FG000|Overall Study|Lost to Follow-up|0|||
16769758|NCT02289820|37707770|FG001|Overall Study|Lost to Follow-up|0|||
16769759|NCT02289820|37707771|FG002|Overall Study|Lost to Follow-up|3|||
16769760|NCT02289820|37707772|FG003|Overall Study|Lost to Follow-up|1|||
16769761|NCT02289820|37707773|FG004|Overall Study|Lost to Follow-up|0|||
16769762|NCT02289820|37707774|FG005|Overall Study|Lost to Follow-up|1|||
16769763|NCT02289820|37707775|FG006|Overall Study|Lost to Follow-up|1|||
16769764|NCT02289820|37707769|FG000|Overall Study|withdrawal of consent|0|||
16769765|NCT02289820|37707770|FG001|Overall Study|withdrawal of consent|1|||
16769766|NCT02289820|37707771|FG002|Overall Study|withdrawal of consent|0|||
16769767|NCT02289820|37707772|FG003|Overall Study|withdrawal of consent|0|||
16769768|NCT02289820|37707773|FG004|Overall Study|withdrawal of consent|0|||
16769769|NCT02289820|37707774|FG005|Overall Study|withdrawal of consent|0|||
16769770|NCT02289820|37707775|FG006|Overall Study|withdrawal of consent|0|||
16769771|NCT02289742|37707797|FG000|First Wear Period|Adverse event prior to treatment|0|||
16769772|NCT02289742|37707798|FG001|First Wear Period|Adverse event prior to treatment|1|||
16769773|NCT02289742|37707799|FG002|First Wear Period|Adverse event prior to treatment|0|||
16769774|NCT02289742|37707800|FG003|First Wear Period|Adverse event prior to treatment|0|||
16769775|NCT02289742|37707797|FG000|First Wear Period|Adverse Event|0|||
16769776|NCT02289742|37707798|FG001|First Wear Period|Adverse Event|0|||
16769777|NCT02289742|37707799|FG002|First Wear Period|Adverse Event|1|||
16769778|NCT02289742|37707800|FG003|First Wear Period|Adverse Event|0|||
16769779|NCT02289742|37707797|FG000|First Wear Period|Other prior to treatment|0|||
16769780|NCT02289742|37707798|FG001|First Wear Period|Other prior to treatment|0|||
16769781|NCT02289742|37707799|FG002|First Wear Period|Other prior to treatment|0|||
16769782|NCT02289742|37707800|FG003|First Wear Period|Other prior to treatment|1|||
16769783|NCT02289742|37707797|FG000|Third Wear Period|Adverse Event|0|||
16769784|NCT02289742|37707798|FG001|Third Wear Period|Adverse Event|1|||
16769785|NCT02289742|37707799|FG002|Third Wear Period|Adverse Event|0|||
16769786|NCT02289742|37707800|FG003|Third Wear Period|Adverse Event|0|||
16769787|NCT02289742|37707797|FG000|Third Wear Period|Reason not given|0|||
16769788|NCT02289742|37707798|FG001|Third Wear Period|Reason not given|0|||
16769789|NCT02289742|37707799|FG002|Third Wear Period|Reason not given|0|||
16769790|NCT02289742|37707800|FG003|Third Wear Period|Reason not given|1|||
16769791|NCT02289352|37707817|FG000|Overall Study|Withdrawal by Subject|1|||
16769792|NCT02289352|37707818|FG001|Overall Study|Withdrawal by Subject|1|||
16769793|NCT02289352|37707819|FG002|Overall Study|Withdrawal by Subject|0|||
16769794|NCT02315560|37707828|FG000|Overall Study|noncompliance by subjects|3|||
16769795|NCT02288182|37707834|FG000|Overall Study|Adverse Event|0|||
16769796|NCT02288182|37707835|FG001|Overall Study|Adverse Event|1|||
16769797|NCT02288182|37707834|FG000|Overall Study|Lost to Follow-up|0|||
16769798|NCT02288182|37707835|FG001|Overall Study|Lost to Follow-up|1|||
16769799|NCT02522624|37707845|FG000|Overall Study|Technical failure|1|||
16769800|NCT02522624|37707846|FG001|Overall Study|Technical failure|0|||
16769801|NCT02287402|37707852|FG000|Treatment Period|Adverse Event|17|||
16769802|NCT02287402|37707852|FG000|Treatment Period|Voluntary Withdrawal|10|||
16769803|NCT02287402|37707852|FG000|Follow-up|Lost to Follow-up|1|||
16769804|NCT02287402|37707852|FG000|Follow-up|Voluntary Withdrawal|2|||
16769805|NCT02314780|37707859|FG000|Overall Study|organizational reasons|0|||
16769806|NCT02314780|37707860|FG001|Overall Study|organizational reasons|2|||
16769807|NCT02314780|37707861|FG002|Overall Study|organizational reasons|0|||
16769808|NCT02314780|37707859|FG000|Overall Study|Adverse Event|0|||
16769809|NCT02314780|37707860|FG001|Overall Study|Adverse Event|1|||
16769810|NCT02314780|37707861|FG002|Overall Study|Adverse Event|0|||
16769811|NCT02286466|37707871|FG000|Overall Study|Death|1|||
16769812|NCT02286466|37707872|FG001|Overall Study|Death|3|||
16769813|NCT02286466|37707871|FG000|Overall Study|Withdrawal by Subject|5|||
16769814|NCT02286466|37707872|FG001|Overall Study|Withdrawal by Subject|2|||
16769815|NCT02286466|37707871|FG000|Overall Study|Lost to Follow-up|1|||
16769816|NCT02286466|37707872|FG001|Overall Study|Lost to Follow-up|4|||
16769817|NCT02286466|37707871|FG000|Overall Study|Declined Clinician Assessment|0|||
16769818|NCT02286466|37707872|FG001|Overall Study|Declined Clinician Assessment|1|||
16769819|NCT02313766|37707881|FG000|Overall Study|surgery cancelled|1|||
16769820|NCT02313766|37707882|FG001|Overall Study|surgery cancelled|0|||
16769821|NCT02313766|37707883|FG002|Overall Study|surgery cancelled|0|||
16769822|NCT02313766|37707881|FG000|Overall Study|Lost to Follow-up|0|||
16769823|NCT02313766|37707882|FG001|Overall Study|Lost to Follow-up|2|||
16769824|NCT02313766|37707883|FG002|Overall Study|Lost to Follow-up|0|||
16769825|NCT02313766|37707881|FG000|Overall Study|Adverse Event|0|||
16769826|NCT02313766|37707882|FG001|Overall Study|Adverse Event|1|||
16769827|NCT02313766|37707883|FG002|Overall Study|Adverse Event|0|||
16769828|NCT01646398|37707893|FG000|Overall Study|Withdrawal by Subject|1|||
16769829|NCT01646398|37707894|FG001|Overall Study|Withdrawal by Subject|0|||
16769830|NCT01646320|37707902|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
16769831|NCT01646320|37707903|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
16769832|NCT01646320|37707902|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
16769833|NCT01646320|37707903|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
16769834|NCT01646320|37707902|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
16769835|NCT01646320|37707903|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
16769836|NCT01646320|37707902|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
16769837|NCT01646320|37707903|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
16769838|NCT01646320|37707902|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
16769839|NCT01646320|37707903|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
16769840|NCT01646320|37707902|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
16769841|NCT01646320|37707903|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
16769842|NCT01646320|37707902|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
16769843|NCT01646320|37707903|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
16769844|NCT01646320|37707902|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
16769845|NCT01646320|37707903|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
16769846|NCT01646320|37707902|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
16769847|NCT01646320|37707903|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
16769848|NCT01646320|37707902|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
16769849|NCT01646320|37707903|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
16769850|NCT01646320|37707902|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
16769851|NCT01646320|37707903|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
16769852|NCT02524730|37707909|FG000|Overall Study|Lost to Follow-up|5|||
16769853|NCT02524730|37707909|FG000|Overall Study|Withdrawal by Subject|18|||
16769854|NCT02524730|37707909|FG000|Overall Study|Death|10|||
16856564|NCT01969721|37810208|FG000|Overall Study|Non compliant with protocol|1|||
16856565|NCT01969721|37810209|FG001|Overall Study|Non compliant with protocol|1|||
16856566|NCT01969721|37810210|FG002|Overall Study|Non compliant with protocol|0|||
16856567|NCT01969721|37810211|FG003|Overall Study|Non compliant with protocol|2|||
16856568|NCT01969721|37810208|FG000|Overall Study|Other not defined above|0|||
16856569|NCT01969721|37810209|FG001|Overall Study|Other not defined above|2|||
16856570|NCT01969721|37810210|FG002|Overall Study|Other not defined above|0|||
16856571|NCT01969721|37810211|FG003|Overall Study|Other not defined above|0|||
16856572|NCT01969721|37810208|FG000|Overall Study|Discontinued during washout periods.|0|||
16856573|NCT01969721|37810209|FG001|Overall Study|Discontinued during washout periods.|1|||
16856574|NCT01969721|37810210|FG002|Overall Study|Discontinued during washout periods.|1|||
16856575|NCT01969721|37810211|FG003|Overall Study|Discontinued during washout periods.|2|||
16856576|NCT01969565|37810221|FG000|Overall Study|Withdrawal by Subject|1|||
16856577|NCT01968707|37810234|FG000|Overall Study|Did not meet treatment day baseline|49|||
16856578|NCT01968707|37810235|FG001|Overall Study|Did not meet treatment day baseline|12|||
16856579|NCT01968707|37810236|FG002|Overall Study|Did not meet treatment day baseline|41|||
16856580|NCT01968707|37810237|FG003|Overall Study|Did not meet treatment day baseline|44|||
16856581|NCT01968707|37810238|FG004|Overall Study|Did not meet treatment day baseline|36|||
16856582|NCT01968707|37810239|FG005|Overall Study|Did not meet treatment day baseline|11|||
16856583|NCT01968707|37810240|FG006|Overall Study|Did not meet treatment day baseline|34|||
16856584|NCT01968707|37810241|FG007|Overall Study|Did not meet treatment day baseline|35|||
16856585|NCT01959581|37810274|FG000|Overall Study|Lost to Follow-up|5|||
16856586|NCT01746901|37810278|FG000|Naloxone Challenge Phase|Adverse Event|2|||
16856587|NCT01746901|37810279|FG001|Naloxone Challenge Phase|Adverse Event|0|||
16856588|NCT01746901|37810280|FG002|Naloxone Challenge Phase|Adverse Event|0|||
16856589|NCT01746901|37810281|FG003|Naloxone Challenge Phase|Adverse Event|0|||
16856590|NCT01746901|37810282|FG004|Naloxone Challenge Phase|Adverse Event|0|||
16856591|NCT01746901|37810283|FG005|Naloxone Challenge Phase|Adverse Event|0|||
16856592|NCT01746901|37810284|FG006|Naloxone Challenge Phase|Adverse Event|0|||
16856593|NCT01746901|37810285|FG007|Naloxone Challenge Phase|Adverse Event|0|||
16856594|NCT01746901|37810286|FG008|Naloxone Challenge Phase|Adverse Event|0|||
16856595|NCT01746901|37810278|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
16856596|NCT01746901|37810279|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16856597|NCT01746901|37810280|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16769855|NCT02524730|37707909|FG000|Overall Study|Adverse Event|8|||
16769856|NCT02524730|37707909|FG000|Overall Study|Protocol Violation|1|||
16769857|NCT02524730|37707909|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
16769858|NCT01658150|37707913|FG000|Overall Study|Withdrawal by Subject|1|||
16769859|NCT02285998|37707920|FG000|Overall Study|Adverse Event|9|||
16769860|NCT02285998|37707921|FG001|Overall Study|Adverse Event|8|||
16769861|NCT02285998|37707920|FG000|Overall Study|Physician Decision|1|||
16769862|NCT02285998|37707921|FG001|Overall Study|Physician Decision|2|||
16769863|NCT02285998|37707920|FG000|Overall Study|Lost to Follow-up|176|||
16769864|NCT02285998|37707921|FG001|Overall Study|Lost to Follow-up|172|||
16769865|NCT02285998|37707920|FG000|Overall Study|Withdrawal by Subject|53|||
16769866|NCT02285998|37707921|FG001|Overall Study|Withdrawal by Subject|61|||
16769867|NCT02285998|37707920|FG000|Overall Study|Other Reasons|7|||
16769868|NCT02285998|37707921|FG001|Overall Study|Other Reasons|10|||
16769869|NCT01658072|37707929|FG000|Overall Study|Protocol Violation|4|||
16769870|NCT01658072|37707930|FG001|Overall Study|Protocol Violation|2|||
16769871|NCT02285920|37707940|FG000|Overall Study|Kidney transplantation|2|||
16769872|NCT02285920|37707941|FG001|Overall Study|Kidney transplantation|2|||
16769873|NCT02285920|37707942|FG002|Overall Study|Kidney transplantation|2|||
16769874|NCT02285920|37707943|FG003|Overall Study|Kidney transplantation|0|||
16769875|NCT02285920|37707940|FG000|Overall Study|Change to peritoneal dialysis|0|||
16769876|NCT02285920|37707941|FG001|Overall Study|Change to peritoneal dialysis|0|||
16769877|NCT02285920|37707942|FG002|Overall Study|Change to peritoneal dialysis|1|||
16769878|NCT02285920|37707943|FG003|Overall Study|Change to peritoneal dialysis|0|||
16769879|NCT02285920|37707940|FG000|Overall Study|Transfer to non-participating unit|0|||
16769880|NCT02285920|37707941|FG001|Overall Study|Transfer to non-participating unit|1|||
16769881|NCT02285920|37707942|FG002|Overall Study|Transfer to non-participating unit|0|||
16769882|NCT02285920|37707943|FG003|Overall Study|Transfer to non-participating unit|0|||
16769883|NCT02285920|37707940|FG000|Overall Study|Dialysis discontinuation|0|||
16769884|NCT02285920|37707941|FG001|Overall Study|Dialysis discontinuation|1|||
16769885|NCT02285920|37707942|FG002|Overall Study|Dialysis discontinuation|0|||
16769886|NCT02285920|37707943|FG003|Overall Study|Dialysis discontinuation|0|||
16769887|NCT02285920|37707940|FG000|Overall Study|Death|2|||
16769888|NCT02285920|37707941|FG001|Overall Study|Death|0|||
16769889|NCT02285920|37707942|FG002|Overall Study|Death|2|||
16769890|NCT02285920|37707943|FG003|Overall Study|Death|1|||
16769891|NCT02035137|37707956|FG000|Overall Study|Physician Decision|0|||
16769892|NCT02035137|37707957|FG001|Overall Study|Physician Decision|0|||
16769893|NCT02035137|37707958|FG002|Overall Study|Physician Decision|1|||
16769894|NCT02035137|37707956|FG000|Overall Study|Withdrawal by Subject|0|||
16769895|NCT02035137|37707957|FG001|Overall Study|Withdrawal by Subject|1|||
16769896|NCT02035137|37707958|FG002|Overall Study|Withdrawal by Subject|2|||
16769897|NCT02035137|37707956|FG000|Overall Study|Ineligible|0|||
16769898|NCT02035137|37707957|FG001|Overall Study|Ineligible|1|||
16769899|NCT02035137|37707958|FG002|Overall Study|Ineligible|2|||
16769900|NCT02035137|37707956|FG000|Overall Study|Disease progression prior to treatment start|2|||
16769901|NCT02035137|37707957|FG001|Overall Study|Disease progression prior to treatment start|0|||
16769902|NCT02035137|37707958|FG002|Overall Study|Disease progression prior to treatment start|0|||
16769903|NCT02522780|37707972|FG000|Overall Study|Consent withdrawn by subject|5|||
16769904|NCT02522780|37707973|FG001|Overall Study|Consent withdrawn by subject|7|||
16769905|NCT02522780|37707972|FG000|Overall Study|Protocol deviation|1|||
16769906|NCT02522780|37707973|FG001|Overall Study|Protocol deviation|3|||
16769907|NCT02522780|37707972|FG000|Overall Study|Subject refused endoscopic procedure|0|||
16769908|NCT02522780|37707973|FG001|Overall Study|Subject refused endoscopic procedure|1|||
16769909|NCT02522780|37707972|FG000|Overall Study|Adverse event, non-fatal|11|||
16769910|NCT02522780|37707973|FG001|Overall Study|Adverse event, non-fatal|16|||
16769911|NCT02285062|37707993|FG000|Overall Study|Withdrawal by Subject|12|||
16769912|NCT02285062|37707994|FG001|Overall Study|Withdrawal by Subject|17|||
16769913|NCT02285062|37707993|FG000|Overall Study|Death|58|||
16769914|NCT02285062|37707994|FG001|Overall Study|Death|62|||
16769915|NCT02285062|37707993|FG000|Overall Study|Lost to Follow-up|8|||
16769916|NCT02285062|37707994|FG001|Overall Study|Lost to Follow-up|5|||
16769917|NCT01352741|37708000|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
16769918|NCT01352741|37708001|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
16769919|NCT01352741|37708000|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
16769920|NCT01352741|37708001|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
16769921|NCT01352741|37708000|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
16769922|NCT01352741|37708001|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
16769923|NCT01352741|37708000|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
16769924|NCT01352741|37708001|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
16769925|NCT01352741|37708000|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
16769926|NCT01352741|37708001|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
16769927|NCT01352741|37708000|FG000|Open-label Tapentadol Titration Period|Other|4|||
16769928|NCT01352741|37708001|FG001|Open-label Tapentadol Titration Period|Other|0|||
16769929|NCT01352741|37708000|FG000|Double-blind Comparative Period|Protocol Violation|2|||
16769930|NCT01352741|37708001|FG001|Double-blind Comparative Period|Protocol Violation|0|||
16769931|NCT01352741|37708000|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
16769932|NCT01352741|37708001|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
16769933|NCT01352741|37708000|FG000|Double-blind Comparative Period|Adverse Event|16|||
16769934|NCT01352741|37708001|FG001|Double-blind Comparative Period|Adverse Event|17|||
16769935|NCT01352741|37708000|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
16769936|NCT01352741|37708001|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
16769937|NCT01352741|37708000|FG000|Double-blind Comparative Period|Death|0|||
16769938|NCT01352741|37708001|FG001|Double-blind Comparative Period|Death|1|||
16769939|NCT01352741|37708000|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
16769940|NCT01352741|37708001|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
16769941|NCT01352741|37708000|FG000|Double-blind Comparative Period|Other|1|||
16769942|NCT01352741|37708001|FG001|Double-blind Comparative Period|Other|2|||
16769943|NCT01352741|37708000|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
16769944|NCT01352741|37708001|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
16769945|NCT01352741|37708000|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
16769946|NCT01352741|37708001|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
16769947|NCT01352741|37708000|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
16769948|NCT01352741|37708001|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
16769949|NCT01352741|37708000|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
16769950|NCT01352741|37708001|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
16769951|NCT01657292|37708021|FG000|Overall Study|Adverse Event|6|||
16769952|NCT01657292|37708021|FG000|Overall Study|Withdrawal by Subject|2|||
16769953|NCT01657292|37708021|FG000|Overall Study|Violation of eligibility criteria|1|||
16769954|NCT01657292|37708021|FG000|Overall Study|Change of therapy|1|||
16769955|NCT00905567|37708037|FG000|Washout|Withdrawal by Subject|0|||
16769956|NCT00905567|37708038|FG001|Washout|Withdrawal by Subject|1|||
16769957|NCT02282020|37708044|FG000|Overall Study|Objective Disease Progression|128|||
16769958|NCT02282020|37708045|FG001|Overall Study|Objective Disease Progression|30|||
16769959|NCT02282020|37708044|FG000|Overall Study|Adverse Event|18|||
16769960|NCT02282020|37708045|FG001|Overall Study|Adverse Event|15|||
16769961|NCT02282020|37708044|FG000|Overall Study|Withdrawal by Subject|7|||
16769962|NCT02282020|37708045|FG001|Overall Study|Withdrawal by Subject|10|||
16769963|NCT02282020|37708044|FG000|Overall Study|Miscellaneous|5|||
16769964|NCT02282020|37708045|FG001|Overall Study|Miscellaneous|19|||
16769965|NCT02282020|37708044|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
16769966|NCT02282020|37708045|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
16769967|NCT02282020|37708044|FG000|Overall Study|Developed Discontinuation Criteria|0|||
16769968|NCT02282020|37708045|FG001|Overall Study|Developed Discontinuation Criteria|2|||
16769969|NCT02282020|37708044|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
16769970|NCT02282020|37708045|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
16769971|NCT02281552|37708061|FG000|Overall Study|Medication error|1|||
16769972|NCT02281552|37708062|FG001|Overall Study|Medication error|0|||
16769973|NCT02281552|37708061|FG000|Overall Study|Insufficient clinical response|0|||
16769974|NCT02281552|37708062|FG001|Overall Study|Insufficient clinical response|1|||
16769975|NCT02281552|37708061|FG000|Overall Study|Adverse Event|3|||
16769976|NCT02281552|37708062|FG001|Overall Study|Adverse Event|9|||
16769977|NCT00890591|37708068|FG000|Overall Study|Lack of Efficacy|20|||
16769978|NCT02284906|37708077|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16769979|NCT02284906|37708078|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16769980|NCT02284906|37708079|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16769981|NCT02284906|37708077|FG000|Overall Study|Major Protocol Deviation|0|||
16769982|NCT02284906|37708078|FG001|Overall Study|Major Protocol Deviation|1|||
16769983|NCT02284906|37708079|FG002|Overall Study|Major Protocol Deviation|0|||
16769984|NCT02284906|37708077|FG000|Overall Study|Voluntary Withdrawal|2|||
16769985|NCT02284906|37708078|FG001|Overall Study|Voluntary Withdrawal|4|||
16769986|NCT02284906|37708079|FG002|Overall Study|Voluntary Withdrawal|5|||
16769987|NCT02284906|37708077|FG000|Overall Study|Study Termination|0|||
16769988|NCT02284906|37708078|FG001|Overall Study|Study Termination|11|||
16769989|NCT02284906|37708079|FG002|Overall Study|Study Termination|14|||
16769990|NCT02284906|37708077|FG000|Overall Study|Reason not Specified|1|||
16769991|NCT02284906|37708078|FG001|Overall Study|Reason not Specified|1|||
16769992|NCT02284906|37708079|FG002|Overall Study|Reason not Specified|0|||
16769993|NCT02879305|37708089|FG000|Overall Study|Investigator Site Closed|55|||
16769994|NCT02879305|37708090|FG001|Overall Study|Investigator Site Closed|57|||
16769995|NCT02879305|37708089|FG000|Overall Study|Withdrawal by Subject|44|||
16769996|NCT02879305|37708090|FG001|Overall Study|Withdrawal by Subject|42|||
16769997|NCT02879305|37708089|FG000|Overall Study|Lost to Follow-up|17|||
16769998|NCT02879305|37708090|FG001|Overall Study|Lost to Follow-up|12|||
16769999|NCT02879305|37708089|FG000|Overall Study|Other|1|||
16770000|NCT02879305|37708090|FG001|Overall Study|Other|0|||
16770001|NCT02281318|37708098|FG000|Overall Study|Adverse Event|2|||
16770002|NCT02281318|37708099|FG001|Overall Study|Adverse Event|2|||
16770003|NCT02281318|37708098|FG000|Overall Study|Lack of Efficacy|2|||
16770004|NCT02281318|37708099|FG001|Overall Study|Lack of Efficacy|0|||
16770005|NCT02281318|37708098|FG000|Overall Study|Lost to Follow-up|2|||
16770006|NCT02281318|37708099|FG001|Overall Study|Lost to Follow-up|1|||
16770007|NCT02281318|37708098|FG000|Overall Study|Physician Decision|2|||
16770008|NCT02281318|37708099|FG001|Overall Study|Physician Decision|0|||
16770009|NCT02281318|37708098|FG000|Overall Study|Withdrawal by Subject|6|||
16770010|NCT02281318|37708099|FG001|Overall Study|Withdrawal by Subject|2|||
16770011|NCT01657760|37708107|FG000|Overall Study|Withdrawal by Subject|0|||
16770012|NCT01657760|37708108|FG001|Overall Study|Withdrawal by Subject|0|||
16770013|NCT01657760|37708109|FG002|Overall Study|Withdrawal by Subject|0|||
16770014|NCT01657760|37708110|FG003|Overall Study|Withdrawal by Subject|1|||
16770015|NCT01657760|37708107|FG000|Overall Study|Physician Decision|1|||
16770016|NCT01657760|37708108|FG001|Overall Study|Physician Decision|1|||
16770017|NCT01657760|37708109|FG002|Overall Study|Physician Decision|1|||
16770018|NCT01657760|37708110|FG003|Overall Study|Physician Decision|2|||
16770019|NCT02280304|37708137|FG000|Overall Study|Lost to Follow-up|7|||
16770020|NCT02280304|37708138|FG001|Overall Study|Lost to Follow-up|8|||
16770021|NCT02283658|37708158|FG000|Overall Study|Withdrawal by Subject|1|||
16770022|NCT02279524|37708185|FG000|Overall Study|Withdrawal by Subject|3|||
16770023|NCT02279524|37708186|FG001|Overall Study|Withdrawal by Subject|6|||
16770024|NCT02279524|37708187|FG002|Overall Study|Withdrawal by Subject|3|||
16770025|NCT02279524|37708185|FG000|Overall Study|Adverse Event|4|||
16770026|NCT02279524|37708186|FG001|Overall Study|Adverse Event|3|||
16770027|NCT02279524|37708187|FG002|Overall Study|Adverse Event|2|||
16770028|NCT02279524|37708185|FG000|Overall Study|Lost to Follow-up|1|||
16770029|NCT02279524|37708186|FG001|Overall Study|Lost to Follow-up|1|||
16770030|NCT02279524|37708187|FG002|Overall Study|Lost to Follow-up|0|||
16770031|NCT02279524|37708185|FG000|Overall Study|Disallowed medication|1|||
16770032|NCT02279524|37708186|FG001|Overall Study|Disallowed medication|1|||
16770033|NCT02279524|37708187|FG002|Overall Study|Disallowed medication|2|||
16770034|NCT02279524|37708185|FG000|Overall Study|Bariatric surgery|1|||
16770035|NCT02279524|37708186|FG001|Overall Study|Bariatric surgery|0|||
16770036|NCT02279524|37708187|FG002|Overall Study|Bariatric surgery|0|||
16770037|NCT02283268|37708195|FG000|Overall Study|Withdrawal by Subject|1|||
16770038|NCT00857285|37708209|FG000|Overall Study|Adverse Event|4|||
16770039|NCT00857285|37708210|FG001|Overall Study|Adverse Event|2|||
16770040|NCT00857285|37708209|FG000|Overall Study|Lack of Efficacy|0|||
16770041|NCT00857285|37708210|FG001|Overall Study|Lack of Efficacy|2|||
16770042|NCT00857285|37708209|FG000|Overall Study|Protocol Violation|3|||
16770043|NCT00857285|37708210|FG001|Overall Study|Protocol Violation|1|||
16770044|NCT00857285|37708209|FG000|Overall Study|Withdrawal by Subject|4|||
16770045|NCT00857285|37708210|FG001|Overall Study|Withdrawal by Subject|0|||
16770046|NCT00857285|37708209|FG000|Overall Study|Randomization criteria not met|1|||
16770047|NCT00857285|37708210|FG001|Overall Study|Randomization criteria not met|1|||
16770048|NCT02278354|37708216|FG000|Overall Study|Lost to Follow-up|2|||
16770049|NCT02278354|37708217|FG001|Overall Study|Lost to Follow-up|2|||
16770050|NCT02278354|37708216|FG000|Overall Study|Withdrawal by Subject|0|||
16770051|NCT02278354|37708217|FG001|Overall Study|Withdrawal by Subject|1|||
16770052|NCT02278354|37708216|FG000|Overall Study|<10 professional fights|2|||
16770053|NCT02278354|37708217|FG001|Overall Study|<10 professional fights|0|||
16770054|NCT01657370|37708236|FG000|Overall Study|Withdrawal by Subject|0|||
16770055|NCT01657370|37708237|FG001|Overall Study|Withdrawal by Subject|0|||
16770056|NCT01657370|37708238|FG002|Overall Study|Withdrawal by Subject|1|||
16770057|NCT01657370|37708239|FG003|Overall Study|Withdrawal by Subject|0|||
16770058|NCT01657370|37708240|FG004|Overall Study|Withdrawal by Subject|0|||
16770059|NCT01657370|37708241|FG005|Overall Study|Withdrawal by Subject|1|||
16770060|NCT01657370|37708236|FG000|Overall Study|Physician Decision|2|||
16770061|NCT01657370|37708237|FG001|Overall Study|Physician Decision|3|||
16770062|NCT01657370|37708238|FG002|Overall Study|Physician Decision|1|||
16770063|NCT01657370|37708239|FG003|Overall Study|Physician Decision|2|||
16770064|NCT01657370|37708240|FG004|Overall Study|Physician Decision|5|||
16770065|NCT01657370|37708241|FG005|Overall Study|Physician Decision|0|||
16770066|NCT01657370|37708236|FG000|Overall Study|Lack of Qualifying Event|1|||
16770067|NCT01657370|37708237|FG001|Overall Study|Lack of Qualifying Event|0|||
16770068|NCT01657370|37708238|FG002|Overall Study|Lack of Qualifying Event|3|||
16770069|NCT01657370|37708239|FG003|Overall Study|Lack of Qualifying Event|2|||
16770070|NCT01657370|37708240|FG004|Overall Study|Lack of Qualifying Event|1|||
16770071|NCT01657370|37708241|FG005|Overall Study|Lack of Qualifying Event|2|||
16770072|NCT01657370|37708236|FG000|Overall Study|Adverse Event|0|||
16770073|NCT01657370|37708237|FG001|Overall Study|Adverse Event|0|||
16770074|NCT01657370|37708238|FG002|Overall Study|Adverse Event|0|||
16770075|NCT01657370|37708239|FG003|Overall Study|Adverse Event|0|||
16770076|NCT01657370|37708240|FG004|Overall Study|Adverse Event|1|||
16770077|NCT01657370|37708241|FG005|Overall Study|Adverse Event|0|||
16770078|NCT01657370|37708236|FG000|Overall Study|Protocol Violation|1|||
16770079|NCT01657370|37708237|FG001|Overall Study|Protocol Violation|1|||
16770080|NCT01657370|37708238|FG002|Overall Study|Protocol Violation|1|||
16770081|NCT01657370|37708239|FG003|Overall Study|Protocol Violation|1|||
16770082|NCT01657370|37708240|FG004|Overall Study|Protocol Violation|0|||
16770083|NCT01657370|37708241|FG005|Overall Study|Protocol Violation|0|||
17028303|NCT00478231|38172714|FG000|Overall Study|Lost to Follow-up|7|||
16770084|NCT01657370|37708236|FG000|Overall Study|Lost to Follow-up|2|||
16770085|NCT01657370|37708237|FG001|Overall Study|Lost to Follow-up|0|||
16770086|NCT01657370|37708238|FG002|Overall Study|Lost to Follow-up|1|||
16770087|NCT01657370|37708239|FG003|Overall Study|Lost to Follow-up|0|||
16770088|NCT01657370|37708240|FG004|Overall Study|Lost to Follow-up|0|||
16770089|NCT01657370|37708241|FG005|Overall Study|Lost to Follow-up|1|||
16770090|NCT00849797|37708283|FG000|First Intervention|bad veins|1|||
16770091|NCT00849797|37708284|FG001|First Intervention|bad veins|0|||
16770092|NCT00849797|37708283|FG000|First Intervention|Adverse Event|0|||
16770093|NCT00849797|37708284|FG001|First Intervention|Adverse Event|1|||
16770094|NCT00849797|37708283|FG000|Washout: One Week|Withdrawal by Subject|0|||
16770095|NCT00849797|37708284|FG001|Washout: One Week|Withdrawal by Subject|2|||
16770096|NCT00840203|37708305|FG000|First Intervention|Protocol Violation|1|||
16770097|NCT00840203|37708306|FG001|First Intervention|Protocol Violation|1|||
16770098|NCT00840203|37708305|FG000|Washout|Protocol Violation|1|||
16770099|NCT00840203|37708306|FG001|Washout|Protocol Violation|0|||
16770100|NCT00835991|37708312|FG000|First Intervention|Adverse Event|0|||
16770101|NCT00835991|37708313|FG001|First Intervention|Adverse Event|1|||
16770102|NCT00835991|37708312|FG000|Washout|Protocol Violation|0|||
16942072|NCT01379703|38086634|FG000|9 Months Through 18 Months|Fatigue|0|||
16770103|NCT00835991|37708313|FG001|Washout|Protocol Violation|2|||
16770104|NCT00835991|37708312|FG000|Washout|Withdrawal by Subject|3|||
16770105|NCT00835991|37708313|FG001|Washout|Withdrawal by Subject|1|||
16770106|NCT02276872|37708320|FG000|Overall Study|Adverse Event|1|||
16770107|NCT02276872|37708321|FG001|Overall Study|Adverse Event|0|||
16770108|NCT02276872|37708322|FG002|Overall Study|Adverse Event|0|||
16770109|NCT00835367|37708337|FG000|Washout|Adverse Event|2|||
16770110|NCT00835367|37708338|FG001|Washout|Adverse Event|0|||
16770111|NCT00835367|37708337|FG000|Washout|Withdrawal by Subject|1|||
16770112|NCT00835367|37708338|FG001|Washout|Withdrawal by Subject|0|||
16770113|NCT00835367|37708337|FG000|Second Intervention|Adverse Event|1|||
16770114|NCT00835367|37708338|FG001|Second Intervention|Adverse Event|1|||
16770115|NCT02276560|37708345|FG000|Overall Study|Adverse Event|1|||
16770116|NCT02276560|37708346|FG001|Overall Study|Adverse Event|0|||
16770117|NCT02276560|37708347|FG002|Overall Study|Adverse Event|0|||
16770118|NCT02276482|37708357|FG000|Overall Study|Adverse Event|1|||
16770119|NCT02276482|37708358|FG001|Overall Study|Adverse Event|0|||
16770120|NCT02276482|37708357|FG000|Overall Study|Withdrawal by Subject|1|||
16770121|NCT02276482|37708358|FG001|Overall Study|Withdrawal by Subject|0|||
16770122|NCT02276482|37708357|FG000|Overall Study|Gram-negative infection|1|||
16770123|NCT02276482|37708358|FG001|Overall Study|Gram-negative infection|0|||
16770124|NCT02276482|37708357|FG000|Overall Study|Reason not specified|0|||
16770125|NCT02276482|37708358|FG001|Overall Study|Reason not specified|1|||
16770126|NCT00835211|37708376|FG000|First Intervention|Withdrawal by Subject|0|||
16770127|NCT00835211|37708377|FG001|First Intervention|Withdrawal by Subject|1|||
16770128|NCT00835211|37708376|FG000|Washout: 7 Days|Adverse Event|2|||
16770129|NCT00835211|37708377|FG001|Washout: 7 Days|Adverse Event|1|||
16770130|NCT00835211|37708376|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
16770131|NCT00835211|37708377|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
16770132|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Adverse Event|6|||
16770133|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Adverse Event|14|||
16770134|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Death|3|||
16770135|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Death|1|||
17188970|NCT01063855|38341923|FG000|Overall Study|Pregnancy|1|||
16770136|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
16770137|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
16770138|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
16770139|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
17188971|NCT01063855|38341924|FG001|Overall Study|Pregnancy|0|||
17188972|NCT01063855|38341923|FG000|Overall Study|Lack of Efficacy|0|||
17188973|NCT01063855|38341924|FG001|Overall Study|Lack of Efficacy|1|||
17188974|NCT01063855|38341923|FG000|Overall Study|Withdrawal by Subject|11|||
17188975|NCT01063855|38341924|FG001|Overall Study|Withdrawal by Subject|8|||
17188976|NCT01063855|38341923|FG000|Overall Study|Reason not specified|13|||
17188977|NCT01063855|38341924|FG001|Overall Study|Reason not specified|11|||
17188978|NCT01063153|38341936|FG000|Overall Study|Found Ineligible During Screening|2|||
17188979|NCT01063153|38341937|FG001|Overall Study|Found Ineligible During Screening|0|||
17188980|NCT01063153|38341936|FG000|Overall Study|Lost to Follow-up|0|||
17188981|NCT01063153|38341937|FG001|Overall Study|Lost to Follow-up|7|||
16770140|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
16770141|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
16770142|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
16770143|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
16770144|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
16770145|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
16770146|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Physician Decision|2|||
16770147|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Physician Decision|4|||
16770148|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Pregnancy|2|||
16770149|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Pregnancy|1|||
16770150|NCT02275780|37708390|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
16770151|NCT02275780|37708391|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
16770152|NCT02275780|37708390|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
16770153|NCT02275780|37708391|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
16770154|NCT00834743|37708399|FG000|Second Intervention|Withdrawal by Subject|1|||
16770155|NCT00834743|37708400|FG001|Second Intervention|Withdrawal by Subject|0|||
16770156|NCT00834587|37708406|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
16770157|NCT00834587|37708407|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
16770158|NCT00834431|37708413|FG000|First Intervention|Adverse Event|0|||
16770159|NCT00834431|37708414|FG001|First Intervention|Adverse Event|1|||
16770160|NCT00834431|37708413|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
16770161|NCT00834431|37708414|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
16770162|NCT00830219|37708434|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16770163|NCT00830219|37708435|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
16770164|NCT02274766|37708441|FG000|Overall Study|Withdrawal by Subject|3|||
16770165|NCT02274766|37708442|FG001|Overall Study|Withdrawal by Subject|6|||
16770166|NCT02274766|37708441|FG000|Overall Study|Did Not Receive Study Drug|1|||
16770167|NCT02274766|37708442|FG001|Overall Study|Did Not Receive Study Drug|1|||
16770168|NCT02274766|37708441|FG000|Overall Study|Subject Unwilling to Proceed|0|||
16770169|NCT02274766|37708442|FG001|Overall Study|Subject Unwilling to Proceed|1|||
16770170|NCT02274766|37708441|FG000|Overall Study|Adverse Event|0|||
16770171|NCT02274766|37708442|FG001|Overall Study|Adverse Event|1|||
16770172|NCT00829673|37708450|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16770173|NCT00829673|37708451|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16770174|NCT02370238|37708457|FG000|Overall Study|Death|42|||
16770175|NCT02370238|37708458|FG001|Overall Study|Death|35|||
16770176|NCT02370238|37708457|FG000|Overall Study|Lost to Follow-up|1|||
16770177|NCT02370238|37708458|FG001|Overall Study|Lost to Follow-up|3|||
16770178|NCT02370238|37708457|FG000|Overall Study|Withdrawal by Subject|2|||
16770179|NCT02370238|37708458|FG001|Overall Study|Withdrawal by Subject|6|||
16770180|NCT02370238|37708457|FG000|Overall Study|Other|2|||
16770181|NCT02370238|37708458|FG001|Overall Study|Other|1|||
16770182|NCT02370160|37708468|FG000|Overall Study|Death|3|||
16770183|NCT02370160|37708469|FG001|Overall Study|Death|4|||
16770184|NCT02370160|37708470|FG002|Overall Study|Death|1|||
16770185|NCT02273908|37708485|FG000|Overall Study|Adverse Event|16|||
16770186|NCT02273908|37708486|FG001|Overall Study|Adverse Event|0|||
16770187|NCT02273908|37708485|FG000|Overall Study|Lost to Follow-up|10|||
16770188|NCT02273908|37708486|FG001|Overall Study|Lost to Follow-up|1|||
16770189|NCT02273908|37708485|FG000|Overall Study|Did not meet entrance criteria|3|||
16770190|NCT02273908|37708486|FG001|Overall Study|Did not meet entrance criteria|2|||
16770191|NCT02273908|37708485|FG000|Overall Study|Withdrawal by Subject|4|||
16770192|NCT02273908|37708486|FG001|Overall Study|Withdrawal by Subject|2|||
16770193|NCT02273752|37708496|FG000|Overall Study|Trial was terminated early|2|||
16770194|NCT02273596|37708500|FG000|24-Week Treatment Period|Adverse Event|3|||
16770195|NCT02273596|37708500|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
16770196|NCT02273596|37708500|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
16770197|NCT02273596|37708500|FG000|24-Week Treatment Period|Physician Decision|1|||
16770198|NCT02273596|37708500|FG000|24-Week Treatment Period|Protocol Deviation|1|||
16770199|NCT02273596|37708500|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
16770200|NCT02273596|37708500|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
16770201|NCT02273596|37708500|FG000|Extension Period|Lost to Follow-up|1|||
16942073|NCT01379703|38086635|FG001|9 Months Through 18 Months|Fatigue|1|||
16770202|NCT02273596|37708500|FG000|Extension Period|Protocol Deviation|1|||
16770203|NCT01656200|37708510|FG000|Overall Study|Withdrawal by Subject|1|||
16770204|NCT02369848|37708514|FG000|Overall Study|Death|1|||
16770205|NCT02369848|37708514|FG000|Overall Study|Withdrawal by Subject|2|||
16770206|NCT02369848|37708514|FG000|Overall Study|Lost to Follow-up|1|||
16770207|NCT02368210|37708520|FG000|Overall Study|Withdrawal by Subject|1|||
16770208|NCT02368210|37708521|FG001|Overall Study|Withdrawal by Subject|0|||
16770209|NCT02368210|37708520|FG000|Overall Study|Adverse Event|0|||
16770210|NCT02368210|37708521|FG001|Overall Study|Adverse Event|1|||
16770211|NCT02273050|37708530|FG000|Overall Study|Adverse Event|4|||
16770212|NCT02273050|37708531|FG001|Overall Study|Adverse Event|3|||
16770213|NCT02273050|37708532|FG002|Overall Study|Adverse Event|3|||
16770214|NCT02273050|37708530|FG000|Overall Study|Death|0|||
16770215|NCT02273050|37708531|FG001|Overall Study|Death|0|||
16770216|NCT02273050|37708532|FG002|Overall Study|Death|1|||
16770217|NCT02273050|37708530|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
16770218|NCT02273050|37708531|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
16770219|NCT02273050|37708532|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
16770220|NCT02273050|37708530|FG000|Overall Study|Lack of Efficacy|0|||
16770221|NCT02273050|37708531|FG001|Overall Study|Lack of Efficacy|1|||
16770222|NCT02273050|37708532|FG002|Overall Study|Lack of Efficacy|1|||
16770223|NCT02273050|37708530|FG000|Overall Study|Withdrawal by Subject|17|||
16770224|NCT02273050|37708531|FG001|Overall Study|Withdrawal by Subject|14|||
16770225|NCT02273050|37708532|FG002|Overall Study|Withdrawal by Subject|16|||
16770226|NCT02273050|37708530|FG000|Overall Study|Lost to Follow-up|0|||
16770227|NCT02273050|37708531|FG001|Overall Study|Lost to Follow-up|2|||
16770228|NCT02273050|37708532|FG002|Overall Study|Lost to Follow-up|3|||
16770229|NCT02273050|37708530|FG000|Overall Study|Protocol Violation|3|||
16770230|NCT02273050|37708531|FG001|Overall Study|Protocol Violation|1|||
16770231|NCT02273050|37708532|FG002|Overall Study|Protocol Violation|4|||
16770232|NCT02272816|37708540|FG000|Overall Study|Adverse Event|1|||
16770233|NCT02271880|37708546|FG000|Overall Study|Premature discontinuation of study|3|||
16770234|NCT02271880|37708547|FG001|Overall Study|Premature discontinuation of study|4|||
16770235|NCT02367352|37708555|FG000|Overall Study|Progressive disease|7|||
16770236|NCT02367352|37708556|FG001|Overall Study|Progressive disease|0|||
16770237|NCT02367352|37708557|FG002|Overall Study|Progressive disease|0|||
16770238|NCT02367352|37708555|FG000|Overall Study|Participant Received Alternative Therapy|1|||
16770239|NCT02367352|37708556|FG001|Overall Study|Participant Received Alternative Therapy|0|||
16770240|NCT02367352|37708557|FG002|Overall Study|Participant Received Alternative Therapy|0|||
16770241|NCT02367352|37708555|FG000|Overall Study|Adverse Event|1|||
16770242|NCT02367352|37708556|FG001|Overall Study|Adverse Event|0|||
16770243|NCT02367352|37708557|FG002|Overall Study|Adverse Event|0|||
16770244|NCT02365636|37708566|FG000|Overall Study|Adverse Event|3|||
16770245|NCT02365636|37708567|FG001|Overall Study|Adverse Event|3|||
16770246|NCT02365636|37708568|FG002|Overall Study|Adverse Event|2|||
16770247|NCT02365636|37708566|FG000|Overall Study|Protocol Violation|1|||
16770248|NCT02365636|37708567|FG001|Overall Study|Protocol Violation|4|||
16770249|NCT02365636|37708568|FG002|Overall Study|Protocol Violation|0|||
16770250|NCT02365636|37708566|FG000|Overall Study|Lost to Follow-up|0|||
16770251|NCT02365636|37708567|FG001|Overall Study|Lost to Follow-up|0|||
16770252|NCT02365636|37708568|FG002|Overall Study|Lost to Follow-up|1|||
16770253|NCT02365636|37708566|FG000|Overall Study|Other|2|||
16770254|NCT02365636|37708567|FG001|Overall Study|Other|0|||
16770255|NCT02365636|37708568|FG002|Overall Study|Other|0|||
16770256|NCT01655498|37708576|FG000|Overall Study|Unrelated health issue|2|||
16770257|NCT01655498|37708576|FG000|Overall Study|Protocol Violation|2|||
16942074|NCT01379703|38086636|FG002|9 Months Through 18 Months|Fatigue|0|||
16942075|NCT01379703|38086634|FG000|9 Months Through 18 Months|Reason Unknown|0|||
16942076|NCT01379703|38086635|FG001|9 Months Through 18 Months|Reason Unknown|23|||
16770258|NCT01655498|37708576|FG000|Overall Study|Withdrawal by Subject|1|||
16770259|NCT02270944|37708585|FG000|Overall Study|Lost to Follow-up|9|||
16770260|NCT02270944|37708586|FG001|Overall Study|Lost to Follow-up|4|||
16770261|NCT02270944|37708585|FG000|Overall Study|Withdrawal by Subject|2|||
16770262|NCT02270944|37708586|FG001|Overall Study|Withdrawal by Subject|1|||
16770263|NCT02365558|37708593|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
16770264|NCT02365558|37708594|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
16770265|NCT02365558|37708593|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
16770266|NCT02365558|37708594|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
16770267|NCT02365480|37708605|FG000|Overall Study|Withdrawal by Subject|2|||
16770268|NCT02365480|37708606|FG001|Overall Study|Withdrawal by Subject|0|||
16770269|NCT02270242|37708614|FG000|Overall Study|Withdrawal by Subject|18|||
16770270|NCT02270242|37708615|FG001|Overall Study|Withdrawal by Subject|25|||
16770271|NCT02270242|37708614|FG000|Overall Study|Lost to Follow-up|41|||
16770272|NCT02270242|37708615|FG001|Overall Study|Lost to Follow-up|27|||
16770273|NCT02270242|37708614|FG000|Overall Study|Physician Decision|0|||
16770274|NCT02270242|37708615|FG001|Overall Study|Physician Decision|1|||
16770275|NCT02364388|37708621|FG000|Overall Study|Protocol Violation|1|||
16770276|NCT02364388|37708621|FG000|Overall Study|Technical Failure|3|||
16770277|NCT02364388|37708621|FG000|Overall Study|No OA/US data|2|||
16770278|NCT02364388|37708621|FG000|Overall Study|No Biopsy|2|||
16770279|NCT02363686|37708625|FG000|Overall Study|Withdrawal by Subject|22|||
16770280|NCT02363686|37708625|FG000|Overall Study|incomplete FEES examinations|13|||
16770281|NCT02268916|37708631|FG000|Overall Study|Lost to Follow-up|1|||
16770282|NCT02268916|37708632|FG001|Overall Study|Lost to Follow-up|1|||
16770283|NCT02268916|37708631|FG000|Overall Study|Withdrawal by Subject|6|||
16770284|NCT02268916|37708632|FG001|Overall Study|Withdrawal by Subject|5|||
16770285|NCT02268916|37708631|FG000|Overall Study|Participant did not have diabetes|1|||
16770286|NCT02268916|37708632|FG001|Overall Study|Participant did not have diabetes|0|||
16770287|NCT02268916|37708631|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
16770288|NCT02268916|37708632|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
16770289|NCT02518490|37708639|FG000|Overall Study|Withdrawal by Subject|1|||
16770290|NCT02518490|37708640|FG001|Overall Study|Withdrawal by Subject|1|||
16770291|NCT01364870|37708650|FG000|Overall Study|Withdrawal by Subject|13|||
16770292|NCT01364870|37708651|FG001|Overall Study|Withdrawal by Subject|24|||
16770293|NCT01364870|37708652|FG002|Overall Study|Withdrawal by Subject|10|||
16770294|NCT01364870|37708650|FG000|Overall Study|Adverse Event|8|||
16942077|NCT01379703|38086636|FG002|9 Months Through 18 Months|Reason Unknown|0|||
16942078|NCT01335477|38086647|FG000|Overall Study|Adverse Event|30|||
16770295|NCT01364870|37708651|FG001|Overall Study|Adverse Event|6|||
17115480|NCT00352534|38253552|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
16770296|NCT01364870|37708652|FG002|Overall Study|Adverse Event|4|||
16770297|NCT01364870|37708650|FG000|Overall Study|Protocol Violation|1|||
16770298|NCT01364870|37708651|FG001|Overall Study|Protocol Violation|0|||
16770299|NCT01364870|37708652|FG002|Overall Study|Protocol Violation|0|||
16770300|NCT02268526|37708663|FG000|Overall Study|Adverse Event|0|||
16770301|NCT02268526|37708664|FG001|Overall Study|Adverse Event|2|||
16770302|NCT02268526|37708665|FG002|Overall Study|Adverse Event|1|||
16770303|NCT02268526|37708663|FG000|Overall Study|Death|1|||
16770304|NCT02268526|37708664|FG001|Overall Study|Death|11|||
16770305|NCT02268526|37708665|FG002|Overall Study|Death|0|||
16770306|NCT02268526|37708663|FG000|Overall Study|protocol deviation|0|||
16770307|NCT02268526|37708664|FG001|Overall Study|protocol deviation|1|||
16770308|NCT02268526|37708665|FG002|Overall Study|protocol deviation|0|||
16770309|NCT02268526|37708663|FG000|Overall Study|Physician Decision|0|||
16770310|NCT02268526|37708664|FG001|Overall Study|Physician Decision|0|||
16770311|NCT02268526|37708665|FG002|Overall Study|Physician Decision|1|||
16770312|NCT02268526|37708663|FG000|Overall Study|Subject/guardian decision|0|||
16770313|NCT02268526|37708664|FG001|Overall Study|Subject/guardian decision|7|||
16770314|NCT02268526|37708665|FG002|Overall Study|Subject/guardian decision|3|||
16770315|NCT02268214|37708678|FG000|Overall Study|Subject no longer meets study criteria|0|||
16770316|NCT02268214|37708679|FG001|Overall Study|Subject no longer meets study criteria|2|||
16770317|NCT02268214|37708680|FG002|Overall Study|Subject no longer meets study criteria|0|||
16770318|NCT02268214|37708678|FG000|Overall Study|Pregnancy|2|||
16770319|NCT02268214|37708679|FG001|Overall Study|Pregnancy|2|||
16770320|NCT02268214|37708680|FG002|Overall Study|Pregnancy|1|||
16770321|NCT02268214|37708678|FG000|Overall Study|Lost to Follow-up|3|||
16770322|NCT02268214|37708679|FG001|Overall Study|Lost to Follow-up|3|||
16770323|NCT02268214|37708680|FG002|Overall Study|Lost to Follow-up|4|||
16770324|NCT02268214|37708678|FG000|Overall Study|Lack of Efficacy|1|||
16770325|NCT02268214|37708679|FG001|Overall Study|Lack of Efficacy|0|||
16770326|NCT02268214|37708680|FG002|Overall Study|Lack of Efficacy|2|||
16770327|NCT02268214|37708678|FG000|Overall Study|Adverse Event|11|||
16770328|NCT02268214|37708679|FG001|Overall Study|Adverse Event|14|||
16770329|NCT02268214|37708680|FG002|Overall Study|Adverse Event|9|||
16770330|NCT02268214|37708678|FG000|Overall Study|Withdrawal by Subject|4|||
16942079|NCT01335477|38086648|FG001|Overall Study|Adverse Event|42|||
16942080|NCT01335477|38086647|FG000|Overall Study|Non compliant with protocol|0|||
16770331|NCT02268214|37708679|FG001|Overall Study|Withdrawal by Subject|5|||
16770332|NCT02268214|37708680|FG002|Overall Study|Withdrawal by Subject|10|||
16770333|NCT02268214|37708678|FG000|Overall Study|Subject request to discontinue treatment|10|||
16770334|NCT02268214|37708679|FG001|Overall Study|Subject request to discontinue treatment|8|||
16770335|NCT02268214|37708680|FG002|Overall Study|Subject request to discontinue treatment|6|||
16770336|NCT02268214|37708678|FG000|Overall Study|Poor/non-compliance|2|||
16770337|NCT02268214|37708679|FG001|Overall Study|Poor/non-compliance|1|||
16770338|NCT02268214|37708680|FG002|Overall Study|Poor/non-compliance|2|||
16770339|NCT02268214|37708678|FG000|Overall Study|Other reasons|7|||
16770340|NCT02268214|37708679|FG001|Overall Study|Other reasons|3|||
16770341|NCT02268214|37708680|FG002|Overall Study|Other reasons|3|||
16770342|NCT02268214|37708678|FG000|Overall Study|Not entering long-term period|2|||
16770343|NCT02268214|37708679|FG001|Overall Study|Not entering long-term period|3|||
16770344|NCT02268214|37708680|FG002|Overall Study|Not entering long-term period|5|||
16770345|NCT02521376|37708692|FG000|Overall Study|Enrolled, But Not Treated|1|||
16770346|NCT02521376|37708693|FG001|Overall Study|Enrolled, But Not Treated|0|||
16770347|NCT02521376|37708694|FG002|Overall Study|Enrolled, But Not Treated|0|||
16770348|NCT02521376|37708695|FG003|Overall Study|Enrolled, But Not Treated|0|||
16770349|NCT02268058|37708717|FG000|Overall Study|Protocol Violation|1|||
16770350|NCT02268058|37708718|FG001|Overall Study|Protocol Violation|0|||
16770351|NCT02268058|37708719|FG002|Overall Study|Protocol Violation|0|||
16770352|NCT02268058|37708720|FG003|Overall Study|Protocol Violation|0|||
16770353|NCT02267824|37708732|FG000|Overall Study|Pregnancy|1|||
16770354|NCT02267824|37708733|FG001|Overall Study|Pregnancy|1|||
16770355|NCT02267824|37708732|FG000|Overall Study|Lost to Follow-up|4|||
16770356|NCT02267824|37708733|FG001|Overall Study|Lost to Follow-up|0|||
16770357|NCT02267824|37708732|FG000|Overall Study|Protocol Violation|3|||
16770358|NCT02267824|37708733|FG001|Overall Study|Protocol Violation|0|||
16770359|NCT02267824|37708732|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
16770360|NCT02267824|37708733|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
16770361|NCT02267746|37708742|FG000|Overall Study|Adverse Event|0|||
16770362|NCT02267746|37708743|FG001|Overall Study|Adverse Event|2|||
16770363|NCT02267746|37708744|FG002|Overall Study|Adverse Event|1|||
16770364|NCT02267746|37708742|FG000|Overall Study|Protocol Violation|8|||
16770365|NCT02267746|37708743|FG001|Overall Study|Protocol Violation|7|||
16770366|NCT02267746|37708744|FG002|Overall Study|Protocol Violation|3|||
16770367|NCT02267746|37708742|FG000|Overall Study|Lack of Efficacy|11|||
16770368|NCT02267746|37708743|FG001|Overall Study|Lack of Efficacy|11|||
16770369|NCT02267746|37708744|FG002|Overall Study|Lack of Efficacy|15|||
16770370|NCT02267746|37708742|FG000|Overall Study|Protocol Violation|1|||
16770371|NCT02267746|37708743|FG001|Overall Study|Protocol Violation|2|||
16770372|NCT02267746|37708744|FG002|Overall Study|Protocol Violation|1|||
16770373|NCT02267746|37708742|FG000|Overall Study|Miscellaneous|1|||
16770374|NCT02267746|37708743|FG001|Overall Study|Miscellaneous|0|||
16770375|NCT02267746|37708744|FG002|Overall Study|Miscellaneous|1|||
16770376|NCT02362360|37708754|FG000|Period 1|Lack of Efficacy|1|||
16770377|NCT02362360|37708755|FG001|Period 1|Lack of Efficacy|0|||
16770378|NCT02362360|37708754|FG000|Period 1|Withdrawal by Subject|2|||
16770379|NCT02362360|37708755|FG001|Period 1|Withdrawal by Subject|1|||
16770380|NCT02362282|37708763|FG000|Overall Study|Withdrawal by Subject|1|||
16770381|NCT02362282|37708764|FG001|Overall Study|Withdrawal by Subject|0|||
16770382|NCT02361580|37708772|FG000|Overall Study|Lost to Follow-up|6|||
16770383|NCT02361580|37708773|FG001|Overall Study|Lost to Follow-up|3|||
16770384|NCT02520284|37708782|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
16770385|NCT02520284|37708783|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
16770386|NCT02520284|37708784|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
16770387|NCT02520284|37708782|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
16770388|NCT02520284|37708783|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
16770389|NCT02520284|37708784|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
16770390|NCT02520284|37708782|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
16770391|NCT02520284|37708783|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
16770392|NCT02520284|37708784|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
16770393|NCT02520284|37708782|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
16770394|NCT02520284|37708783|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
16770395|NCT02520284|37708784|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
16770396|NCT02520284|37708782|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
16770397|NCT02520284|37708783|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
16770398|NCT02520284|37708784|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
16770399|NCT02520284|37708782|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
16770400|NCT02520284|37708783|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
16770401|NCT02520284|37708784|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
16770402|NCT02520284|37708782|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
16770403|NCT02520284|37708783|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
16770404|NCT02520284|37708784|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
16770405|NCT02520284|37708782|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
16770406|NCT02520284|37708783|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
16770407|NCT02520284|37708784|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
16770408|NCT02520284|37708782|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
16770409|NCT02520284|37708783|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
16770410|NCT02520284|37708784|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
16770411|NCT02520284|37708782|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
16770412|NCT02520284|37708783|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
16770413|NCT02520284|37708784|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
16770414|NCT02520284|37708782|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
16770415|NCT02520284|37708783|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
16770416|NCT02520284|37708784|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
16770417|NCT02517866|37708798|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16770418|NCT02517866|37708799|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
16770419|NCT02517866|37708800|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16770420|NCT02517866|37708798|FG000|Overall Study|Significant Protocol Deviation|4|||
16770421|NCT02517866|37708799|FG001|Overall Study|Significant Protocol Deviation|1|||
16770422|NCT02517866|37708800|FG002|Overall Study|Significant Protocol Deviation|0|||
16770423|NCT02517866|37708798|FG000|Overall Study|Lost to Follow-up|1|||
16770424|NCT02517866|37708799|FG001|Overall Study|Lost to Follow-up|0|||
16770425|NCT02517866|37708800|FG002|Overall Study|Lost to Follow-up|0|||
16770426|NCT02517866|37708798|FG000|Overall Study|Voluntary Withdrawal|2|||
16770427|NCT02517866|37708799|FG001|Overall Study|Voluntary Withdrawal|2|||
16770428|NCT02517866|37708800|FG002|Overall Study|Voluntary Withdrawal|0|||
16770429|NCT02517866|37708798|FG000|Overall Study|Investigator Decision|2|||
16770430|NCT02517866|37708799|FG001|Overall Study|Investigator Decision|1|||
16770431|NCT02517866|37708800|FG002|Overall Study|Investigator Decision|0|||
16770432|NCT02517866|37708798|FG000|Overall Study|Reason not specified|2|||
16770433|NCT02517866|37708799|FG001|Overall Study|Reason not specified|0|||
16770434|NCT02517866|37708800|FG002|Overall Study|Reason not specified|0|||
16770435|NCT02515994|37708812|FG000|Overall Study|Protocol Violation|3|||
16770436|NCT02515994|37708813|FG001|Overall Study|Protocol Violation|5|||
16770437|NCT02515994|37708812|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
16770438|NCT02515994|37708813|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
16770439|NCT02515994|37708812|FG000|Overall Study|Adverse Event|3|||
16770440|NCT02515994|37708813|FG001|Overall Study|Adverse Event|1|||
16770441|NCT02515994|37708812|FG000|Overall Study|Withdrawal by Subject|2|||
16770442|NCT02515994|37708813|FG001|Overall Study|Withdrawal by Subject|0|||
16770443|NCT02516306|37708821|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
16770444|NCT02516306|37708822|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
16770445|NCT02516228|37708828|FG000|Overall Study|Lost to Follow-up|1|||
16770446|NCT02516228|37708828|FG000|Overall Study|Withdrawal by Subject|1|||
16770447|NCT02516228|37708828|FG000|Overall Study|Physician Decision|1|||
16770448|NCT02519504|37708834|FG000|Overall Study|Protocol Violation|6|||
16770449|NCT02519504|37708835|FG001|Overall Study|Protocol Violation|5|||
16770450|NCT02519504|37708834|FG000|Overall Study|Ineligible for direct testing|12|||
16770451|NCT02519504|37708835|FG001|Overall Study|Ineligible for direct testing|12|||
16770452|NCT02519504|37708834|FG000|Overall Study|Did not participate in direct testing|95|||
16770453|NCT02519504|37708835|FG001|Overall Study|Did not participate in direct testing|86|||
16770454|NCT02514824|37708843|FG000|Overall Study|Withdrawal by Subject|1|||
16770455|NCT02514824|37708844|FG001|Overall Study|Withdrawal by Subject|0|||
16770456|NCT02514824|37708845|FG002|Overall Study|Withdrawal by Subject|0|||
16770457|NCT02514824|37708846|FG003|Overall Study|Withdrawal by Subject|0|||
16770458|NCT02514824|37708843|FG000|Overall Study|Dose-Limiting Toxicity|0|||
16770459|NCT02514824|37708844|FG001|Overall Study|Dose-Limiting Toxicity|1|||
16770460|NCT02514824|37708845|FG002|Overall Study|Dose-Limiting Toxicity|0|||
16770461|NCT02514824|37708846|FG003|Overall Study|Dose-Limiting Toxicity|0|||
16770462|NCT02514746|37708855|FG000|Overall Study|Chronically Ill|1|||
16770463|NCT02514746|37708856|FG001|Overall Study|Chronically Ill|2|||
16770464|NCT02514746|37708855|FG000|Overall Study|Physician Decision|4|||
16770465|NCT02514746|37708856|FG001|Overall Study|Physician Decision|2|||
16770466|NCT02514746|37708855|FG000|Overall Study|Withdrawal by Subject|12|||
16770467|NCT02514746|37708856|FG001|Overall Study|Withdrawal by Subject|10|||
16770468|NCT02514746|37708855|FG000|Overall Study|Other|5|||
16770469|NCT02514746|37708856|FG001|Overall Study|Other|1|||
16770470|NCT02483078|37708866|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
16770471|NCT02483078|37708867|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
16770472|NCT02483078|37708866|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
16770473|NCT02483078|37708867|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
16770474|NCT02483078|37708866|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
16770475|NCT02483078|37708867|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
16770476|NCT02483078|37708866|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
16770477|NCT02483078|37708867|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
16770478|NCT02483078|37708866|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
16770479|NCT02483078|37708867|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
16770480|NCT02483078|37708866|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
16770481|NCT02483078|37708867|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
16770482|NCT02452190|37708881|FG000|Overall Study|Withdrawal by Sponsor|1|||
16770483|NCT02452190|37708882|FG001|Overall Study|Withdrawal by Sponsor|3|||
16770484|NCT02452190|37708881|FG000|Overall Study|Pregnancy|1|||
16770485|NCT02452190|37708882|FG001|Overall Study|Pregnancy|0|||
16770486|NCT02452190|37708881|FG000|Overall Study|Investigator's Decision|2|||
16770487|NCT02452190|37708882|FG001|Overall Study|Investigator's Decision|0|||
16770488|NCT02452190|37708881|FG000|Overall Study|Lack of Efficacy|3|||
16770489|NCT02452190|37708882|FG001|Overall Study|Lack of Efficacy|1|||
16770490|NCT02452190|37708881|FG000|Overall Study|Lost to Follow-up|4|||
16770491|NCT02452190|37708882|FG001|Overall Study|Lost to Follow-up|3|||
16770492|NCT02452190|37708881|FG000|Overall Study|Adverse Event|2|||
16770493|NCT02452190|37708882|FG001|Overall Study|Adverse Event|5|||
16770494|NCT02452190|37708881|FG000|Overall Study|Withdrawal by Subject|20|||
16770495|NCT02452190|37708882|FG001|Overall Study|Withdrawal by Subject|11|||
16770496|NCT02452190|37708881|FG000|Overall Study|Noncompliance with study drug|1|||
16770497|NCT02452190|37708882|FG001|Overall Study|Noncompliance with study drug|0|||
16770498|NCT02452190|37708881|FG000|Overall Study|Participant traveled abroad|1|||
16770499|NCT02452190|37708882|FG001|Overall Study|Participant traveled abroad|0|||
16770500|NCT02452190|37708881|FG000|Overall Study|Death|0|||
16770501|NCT02452190|37708882|FG001|Overall Study|Death|1|||
16770502|NCT02514122|37708890|FG000|Overall Study|Withdrawal by Subject|2|||
16770503|NCT02514122|37708891|FG001|Overall Study|Withdrawal by Subject|0|||
16770504|NCT00730639|37708902|FG000|Overall Study|Adverse Event|3|||
16770505|NCT00730639|37708903|FG001|Overall Study|Adverse Event|0|||
16770506|NCT00730639|37708904|FG002|Overall Study|Adverse Event|9|||
16770507|NCT00730639|37708905|FG003|Overall Study|Adverse Event|8|||
16770508|NCT00730639|37708906|FG004|Overall Study|Adverse Event|23|||
16770509|NCT00730639|37708902|FG000|Overall Study|Complete Response|0|||
16770510|NCT00730639|37708903|FG001|Overall Study|Complete Response|0|||
16770511|NCT00730639|37708904|FG002|Overall Study|Complete Response|2|||
16770512|NCT00730639|37708905|FG003|Overall Study|Complete Response|2|||
16770513|NCT00730639|37708906|FG004|Overall Study|Complete Response|1|||
16770514|NCT00730639|37708902|FG000|Overall Study|Completed Maximum Cycles|0|||
16770515|NCT00730639|37708903|FG001|Overall Study|Completed Maximum Cycles|0|||
16770516|NCT00730639|37708904|FG002|Overall Study|Completed Maximum Cycles|11|||
16770517|NCT00730639|37708905|FG003|Overall Study|Completed Maximum Cycles|3|||
16770518|NCT00730639|37708906|FG004|Overall Study|Completed Maximum Cycles|6|||
16770519|NCT00730639|37708902|FG000|Overall Study|Death|0|||
16770520|NCT00730639|37708903|FG001|Overall Study|Death|0|||
16770521|NCT00730639|37708904|FG002|Overall Study|Death|0|||
16770522|NCT00730639|37708905|FG003|Overall Study|Death|0|||
16770523|NCT00730639|37708906|FG004|Overall Study|Death|2|||
16770524|NCT00730639|37708902|FG000|Overall Study|Disease Progression|12|||
16770525|NCT00730639|37708903|FG001|Overall Study|Disease Progression|13|||
16770526|NCT00730639|37708904|FG002|Overall Study|Disease Progression|48|||
16770527|NCT00730639|37708905|FG003|Overall Study|Disease Progression|32|||
16770528|NCT00730639|37708906|FG004|Overall Study|Disease Progression|88|||
16770529|NCT00730639|37708902|FG000|Overall Study|non-specified|0|||
16770530|NCT00730639|37708903|FG001|Overall Study|non-specified|0|||
16770531|NCT00730639|37708904|FG002|Overall Study|non-specified|4|||
16770532|NCT00730639|37708905|FG003|Overall Study|non-specified|2|||
16770533|NCT00730639|37708906|FG004|Overall Study|non-specified|3|||
16770534|NCT00730639|37708902|FG000|Overall Study|Protocol Violation|0|||
16770535|NCT00730639|37708903|FG001|Overall Study|Protocol Violation|0|||
16770536|NCT00730639|37708904|FG002|Overall Study|Protocol Violation|1|||
16770537|NCT00730639|37708905|FG003|Overall Study|Protocol Violation|0|||
16770538|NCT00730639|37708906|FG004|Overall Study|Protocol Violation|0|||
16770539|NCT00730639|37708902|FG000|Overall Study|Withdrawal by Subject|0|||
16770540|NCT00730639|37708903|FG001|Overall Study|Withdrawal by Subject|0|||
16770541|NCT00730639|37708904|FG002|Overall Study|Withdrawal by Subject|6|||
16770542|NCT00730639|37708905|FG003|Overall Study|Withdrawal by Subject|3|||
16770543|NCT00730639|37708906|FG004|Overall Study|Withdrawal by Subject|4|||
16770544|NCT00730639|37708902|FG000|Overall Study|Treatment on-going|2|||
16770545|NCT00730639|37708903|FG001|Overall Study|Treatment on-going|5|||
16770546|NCT00730639|37708904|FG002|Overall Study|Treatment on-going|5|||
16770547|NCT00730639|37708905|FG003|Overall Study|Treatment on-going|4|||
16770548|NCT00730639|37708906|FG004|Overall Study|Treatment on-going|4|||
16770549|NCT02536339|37708929|FG000|Overall Study|Death|20|||
16770550|NCT02536339|37708929|FG000|Overall Study|Withdrawal by Subject|3|||
16770551|NCT02536339|37708929|FG000|Overall Study|Lost to Follow-up|2|||
16770552|NCT02536339|37708929|FG000|Overall Study|Treatment discontinued|2|||
16770553|NCT02536339|37708929|FG000|Overall Study|Physician Decision|1|||
16770554|NCT02743871|37708963|FG000|Overall Study|Lost to Follow-up|0|||
16770555|NCT02743871|37708964|FG001|Overall Study|Lost to Follow-up|0|||
16770556|NCT02743871|37708965|FG002|Overall Study|Lost to Follow-up|0|||
16770557|NCT02743871|37708966|FG003|Overall Study|Lost to Follow-up|1|||
16770558|NCT02743871|37708967|FG004|Overall Study|Lost to Follow-up|0|||
16770559|NCT02743871|37708968|FG005|Overall Study|Lost to Follow-up|0|||
16770560|NCT02743871|37708969|FG006|Overall Study|Lost to Follow-up|1|||
16942081|NCT01335477|38086648|FG001|Overall Study|Non compliant with protocol|2|||
16770561|NCT02743871|37708970|FG007|Overall Study|Lost to Follow-up|0|||
16770562|NCT02743871|37708971|FG008|Overall Study|Lost to Follow-up|0|||
16770563|NCT02743871|37708972|FG009|Overall Study|Lost to Follow-up|0|||
16770564|NCT02743871|37708973|FG010|Overall Study|Lost to Follow-up|0|||
16770565|NCT02743871|37708974|FG011|Overall Study|Lost to Follow-up|2|||
16770566|NCT02743871|37708975|FG012|Overall Study|Lost to Follow-up|0|||
16770567|NCT02743871|37708976|FG013|Overall Study|Lost to Follow-up|0|||
16770568|NCT02743871|37708963|FG000|Overall Study|Withdrawal by Subject|0|||
16770569|NCT02743871|37708964|FG001|Overall Study|Withdrawal by Subject|0|||
16770570|NCT02743871|37708965|FG002|Overall Study|Withdrawal by Subject|0|||
16770571|NCT02743871|37708966|FG003|Overall Study|Withdrawal by Subject|0|||
16770572|NCT02743871|37708967|FG004|Overall Study|Withdrawal by Subject|0|||
16770573|NCT02743871|37708968|FG005|Overall Study|Withdrawal by Subject|0|||
16770574|NCT02743871|37708969|FG006|Overall Study|Withdrawal by Subject|0|||
16770575|NCT02743871|37708970|FG007|Overall Study|Withdrawal by Subject|0|||
16770576|NCT02743871|37708971|FG008|Overall Study|Withdrawal by Subject|0|||
16770577|NCT02743871|37708972|FG009|Overall Study|Withdrawal by Subject|0|||
16770578|NCT02743871|37708973|FG010|Overall Study|Withdrawal by Subject|1|||
16770579|NCT02743871|37708974|FG011|Overall Study|Withdrawal by Subject|0|||
16770580|NCT02743871|37708975|FG012|Overall Study|Withdrawal by Subject|12|||
16770581|NCT02743871|37708976|FG013|Overall Study|Withdrawal by Subject|6|||
16770582|NCT02743871|37708963|FG000|Overall Study|Adverse Event|1|||
16770583|NCT02743871|37708964|FG001|Overall Study|Adverse Event|0|||
16770584|NCT02743871|37708965|FG002|Overall Study|Adverse Event|0|||
16770585|NCT02743871|37708966|FG003|Overall Study|Adverse Event|0|||
16770586|NCT02743871|37708967|FG004|Overall Study|Adverse Event|0|||
16770587|NCT02743871|37708968|FG005|Overall Study|Adverse Event|0|||
16770588|NCT02743871|37708969|FG006|Overall Study|Adverse Event|0|||
16770589|NCT02743871|37708970|FG007|Overall Study|Adverse Event|0|||
16770590|NCT02743871|37708971|FG008|Overall Study|Adverse Event|0|||
16770591|NCT02743871|37708972|FG009|Overall Study|Adverse Event|0|||
16770592|NCT02743871|37708973|FG010|Overall Study|Adverse Event|0|||
16770593|NCT02743871|37708974|FG011|Overall Study|Adverse Event|0|||
16770594|NCT02743871|37708975|FG012|Overall Study|Adverse Event|0|||
16770595|NCT02743871|37708976|FG013|Overall Study|Adverse Event|0|||
16770596|NCT02743871|37708963|FG000|Overall Study|Other|0|||
16770597|NCT02743871|37708964|FG001|Overall Study|Other|0|||
16770598|NCT02743871|37708965|FG002|Overall Study|Other|0|||
16770599|NCT02743871|37708966|FG003|Overall Study|Other|0|||
16770600|NCT02743871|37708967|FG004|Overall Study|Other|0|||
16770601|NCT02743871|37708968|FG005|Overall Study|Other|0|||
16770602|NCT02743871|37708969|FG006|Overall Study|Other|0|||
16770603|NCT02743871|37708970|FG007|Overall Study|Other|0|||
16770604|NCT02743871|37708971|FG008|Overall Study|Other|0|||
16770605|NCT02743871|37708972|FG009|Overall Study|Other|0|||
16770606|NCT02743871|37708973|FG010|Overall Study|Other|0|||
16770607|NCT02743871|37708974|FG011|Overall Study|Other|1|||
16770608|NCT02743871|37708975|FG012|Overall Study|Other|1|||
16770609|NCT02743871|37708976|FG013|Overall Study|Other|1|||
16770610|NCT02743871|37708963|FG000|Overall Study|Protocol Violation|0|||
16770611|NCT02743871|37708964|FG001|Overall Study|Protocol Violation|0|||
16770612|NCT02743871|37708965|FG002|Overall Study|Protocol Violation|0|||
16770613|NCT02743871|37708966|FG003|Overall Study|Protocol Violation|0|||
16770614|NCT02743871|37708967|FG004|Overall Study|Protocol Violation|0|||
16770615|NCT02743871|37708968|FG005|Overall Study|Protocol Violation|0|||
16770616|NCT02743871|37708969|FG006|Overall Study|Protocol Violation|0|||
16770617|NCT02743871|37708970|FG007|Overall Study|Protocol Violation|0|||
16770618|NCT02743871|37708971|FG008|Overall Study|Protocol Violation|0|||
16770619|NCT02743871|37708972|FG009|Overall Study|Protocol Violation|0|||
16770620|NCT02743871|37708973|FG010|Overall Study|Protocol Violation|0|||
16770621|NCT02743871|37708974|FG011|Overall Study|Protocol Violation|0|||
16770622|NCT02743871|37708975|FG012|Overall Study|Protocol Violation|2|||
16770623|NCT02743871|37708976|FG013|Overall Study|Protocol Violation|0|||
16770624|NCT01704547|37709018|FG000|Overall Study|Physician Decision|4|||
16770625|NCT01704547|37709018|FG000|Overall Study|Withdrawal by Subject|1|||
16770626|NCT00796523|37709038|FG000|Overall Study|Lost to Follow-up|9|||
16770627|NCT00796523|37709039|FG001|Overall Study|Lost to Follow-up|7|||
16770628|NCT01352585|37709054|FG000|Overall Study|Adverse Event|2|||
16770629|NCT01352585|37709055|FG001|Overall Study|Adverse Event|1|||
16770630|NCT01352585|37709054|FG000|Overall Study|Lost to Follow-up|1|||
16770631|NCT01352585|37709055|FG001|Overall Study|Lost to Follow-up|0|||
16770632|NCT01352585|37709054|FG000|Overall Study|Other|5|||
16770633|NCT01352585|37709055|FG001|Overall Study|Other|2|||
16770634|NCT02032823|37709064|FG000|Overall Study|Death|59|||
16770635|NCT02032823|37709065|FG001|Overall Study|Death|86|||
16770636|NCT02032823|37709064|FG000|Overall Study|Lost to Follow-up|12|||
16770637|NCT02032823|37709065|FG001|Overall Study|Lost to Follow-up|15|||
16770638|NCT02032823|37709064|FG000|Overall Study|Withdrawal by Subject|65|||
16770639|NCT02032823|37709065|FG001|Overall Study|Withdrawal by Subject|49|||
16770640|NCT02032823|37709064|FG000|Overall Study|Ongoing study at data cut-off|782|||
16770641|NCT02032823|37709065|FG001|Overall Study|Ongoing study at data cut-off|760|||
16770642|NCT02032823|37709064|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
16770643|NCT02032823|37709065|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
16770644|NCT01352507|37709073|FG000|Treatment Period 1|Adverse Event|3|||
16770645|NCT01352507|37709074|FG001|Treatment Period 1|Adverse Event|0|||
16770646|NCT01352507|37709073|FG000|Treatment Period 1|Lost to Follow-up|3|||
16770647|NCT01352507|37709074|FG001|Treatment Period 1|Lost to Follow-up|4|||
16770648|NCT01352507|37709073|FG000|Treatment Period 1|Withdrawal by Subject|7|||
16770649|NCT01352507|37709074|FG001|Treatment Period 1|Withdrawal by Subject|5|||
16770650|NCT01352507|37709073|FG000|Treatment Period 1|Physician Decision|1|||
16770651|NCT01352507|37709074|FG001|Treatment Period 1|Physician Decision|0|||
16770652|NCT01352507|37709073|FG000|Washout Period|Withdrawal by Subject|0|||
16770653|NCT01352507|37709074|FG001|Washout Period|Withdrawal by Subject|1|||
16770654|NCT01352507|37709073|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
16770655|NCT01352507|37709074|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
16770656|NCT01352507|37709073|FG000|Treatment Period 2|Withdrawal by Subject|4|||
16770657|NCT01352507|37709074|FG001|Treatment Period 2|Withdrawal by Subject|3|||
16770658|NCT01352507|37709073|FG000|Treatment Period 2|Lack of Efficacy|1|||
16770659|NCT01352507|37709074|FG001|Treatment Period 2|Lack of Efficacy|0|||
16770660|NCT02361346|37709095|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
16770661|NCT02361346|37709096|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
16770662|NCT02361346|37709097|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
16770663|NCT02361346|37709098|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
16770664|NCT02361346|37709099|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
16770665|NCT02361346|37709100|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
16770666|NCT02361346|37709101|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
16770667|NCT02361346|37709102|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
16770668|NCT02361346|37709103|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
16770669|NCT02361346|37709095|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16770670|NCT02361346|37709096|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16770671|NCT02361346|37709097|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16770672|NCT02361346|37709098|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16770673|NCT02361346|37709099|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
16770674|NCT02361346|37709100|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16770675|NCT02361346|37709101|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16770676|NCT02361346|37709102|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16770677|NCT02361346|37709103|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16770678|NCT02361346|37709095|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
16770679|NCT02361346|37709096|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
16770680|NCT02361346|37709097|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
16770681|NCT02361346|37709098|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
16770682|NCT02361346|37709099|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
16770683|NCT02361346|37709100|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
16770684|NCT02361346|37709101|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
16770685|NCT02361346|37709102|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
16770686|NCT02361346|37709103|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
16770687|NCT02361346|37709095|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16770688|NCT02361346|37709096|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16770689|NCT02361346|37709097|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16770690|NCT02361346|37709098|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16770691|NCT02361346|37709099|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16770692|NCT02361346|37709100|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16770693|NCT02361346|37709101|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16770694|NCT02361346|37709102|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
16770695|NCT02361346|37709103|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16770696|NCT02361346|37709095|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16770697|NCT02361346|37709096|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16770698|NCT02361346|37709097|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16770699|NCT02361346|37709098|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16770700|NCT02361346|37709099|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16770701|NCT02361346|37709100|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16770702|NCT02361346|37709101|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16770703|NCT02361346|37709102|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
16770704|NCT02361346|37709103|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16770705|NCT02361346|37709095|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16770706|NCT02361346|37709096|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16770707|NCT02361346|37709097|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16770708|NCT02361346|37709098|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16770709|NCT02361346|37709099|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16770710|NCT02361346|37709100|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16770711|NCT02361346|37709101|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16770712|NCT02361346|37709102|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
16770713|NCT02361346|37709103|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16770714|NCT02267278|37709145|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
16770715|NCT02267278|37709145|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
16770716|NCT02267278|37709145|FG000|Overall Study|Developed new cancer diagnoses|2|||
16770717|NCT02267278|37709145|FG000|Overall Study|prescribed prohibited medication|1|||
16770718|NCT02360098|37709151|FG000|Overall Study|Physician Decision|7|||
16770719|NCT02266888|37709162|FG000|Overall Study|Death|2|||
16770720|NCT02266888|37709163|FG001|Overall Study|Death|2|||
16770721|NCT02266888|37709164|FG002|Overall Study|Death|4|||
16770722|NCT02266888|37709165|FG003|Overall Study|Death|2|||
16770723|NCT02266888|37709162|FG000|Overall Study|Physician Decision|0|||
16770724|NCT02266888|37709163|FG001|Overall Study|Physician Decision|1|||
16770725|NCT02266888|37709164|FG002|Overall Study|Physician Decision|2|||
16770726|NCT02266888|37709165|FG003|Overall Study|Physician Decision|2|||
16770727|NCT02266888|37709162|FG000|Overall Study|Study Terminated|5|||
16770728|NCT02266888|37709163|FG001|Overall Study|Study Terminated|1|||
16770729|NCT02266888|37709164|FG002|Overall Study|Study Terminated|0|||
16770730|NCT02266888|37709165|FG003|Overall Study|Study Terminated|0|||
16770731|NCT02266888|37709162|FG000|Overall Study|No Longer Eligible|0|||
16770732|NCT02266888|37709163|FG001|Overall Study|No Longer Eligible|0|||
16770733|NCT02266888|37709164|FG002|Overall Study|No Longer Eligible|0|||
16770734|NCT02266888|37709165|FG003|Overall Study|No Longer Eligible|2|||
16770735|NCT02266888|37709162|FG000|Overall Study|Randomization Closed|0|||
16770736|NCT02266888|37709163|FG001|Overall Study|Randomization Closed|0|||
16770737|NCT02266888|37709164|FG002|Overall Study|Randomization Closed|4|||
16770738|NCT02266888|37709165|FG003|Overall Study|Randomization Closed|0|||
16770739|NCT02266888|37709162|FG000|Overall Study|Personnel unavailable at transplant|0|||
16770740|NCT02266888|37709163|FG001|Overall Study|Personnel unavailable at transplant|0|||
16770741|NCT02266888|37709164|FG002|Overall Study|Personnel unavailable at transplant|0|||
16770742|NCT02266888|37709165|FG003|Overall Study|Personnel unavailable at transplant|1|||
16770743|NCT02266888|37709162|FG000|Overall Study|Transfer of care|0|||
16770744|NCT02266888|37709163|FG001|Overall Study|Transfer of care|0|||
16770745|NCT02266888|37709164|FG002|Overall Study|Transfer of care|1|||
16770746|NCT02266888|37709165|FG003|Overall Study|Transfer of care|0|||
16770747|NCT01641952|37709173|FG000|Overall Study|Lost to Follow-up|28|||
16770748|NCT01641952|37709173|FG000|Overall Study|Adverse Event|6|||
16770749|NCT02359552|37709179|FG000|Overall Study|Lost to Follow-up|3|||
16770750|NCT02359552|37709180|FG001|Overall Study|Lost to Follow-up|4|||
16770751|NCT02743793|37709188|FG000|Overall Study|Death|1|||
16770752|NCT02743793|37709189|FG001|Overall Study|Death|1|||
16770753|NCT02743793|37709188|FG000|Overall Study|Withdrawal by Subject|0|||
16770754|NCT02743793|37709189|FG001|Overall Study|Withdrawal by Subject|1|||
16770755|NCT02743793|37709188|FG000|Overall Study|Screen Failure|4|||
16770756|NCT02743793|37709189|FG001|Overall Study|Screen Failure|0|||
16770757|NCT02743793|37709188|FG000|Overall Study|No Primary Care Physician|0|||
16770758|NCT02743793|37709189|FG001|Overall Study|No Primary Care Physician|1|||
16770759|NCT02743793|37709188|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
16770760|NCT02743793|37709189|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
16770761|NCT02743793|37709188|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
16770762|NCT02743793|37709189|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
16770763|NCT00152009|37709198|FG000|Overall Study|Adverse Event|9|||
16770764|NCT00152009|37709199|FG001|Overall Study|Adverse Event|13|||
16770765|NCT00152009|37709200|FG002|Overall Study|Adverse Event|20|||
16770766|NCT00152009|37709201|FG003|Overall Study|Adverse Event|1|||
16770767|NCT00152009|37709198|FG000|Overall Study|Protocol Violation|3|||
16770768|NCT00152009|37709199|FG001|Overall Study|Protocol Violation|0|||
16770769|NCT00152009|37709200|FG002|Overall Study|Protocol Violation|0|||
16770770|NCT00152009|37709201|FG003|Overall Study|Protocol Violation|1|||
16770771|NCT00152009|37709198|FG000|Overall Study|Withdrawal by Subject|2|||
16770772|NCT00152009|37709199|FG001|Overall Study|Withdrawal by Subject|3|||
16770773|NCT00152009|37709200|FG002|Overall Study|Withdrawal by Subject|4|||
16770774|NCT00152009|37709201|FG003|Overall Study|Withdrawal by Subject|9|||
16770775|NCT00152009|37709198|FG000|Overall Study|Lost to Follow-up|2|||
16770776|NCT00152009|37709199|FG001|Overall Study|Lost to Follow-up|4|||
16770777|NCT00152009|37709200|FG002|Overall Study|Lost to Follow-up|3|||
16770778|NCT00152009|37709201|FG003|Overall Study|Lost to Follow-up|3|||
16770779|NCT00152009|37709198|FG000|Overall Study|Lack of Efficacy|8|||
16770780|NCT00152009|37709199|FG001|Overall Study|Lack of Efficacy|6|||
16770781|NCT00152009|37709200|FG002|Overall Study|Lack of Efficacy|7|||
16770782|NCT00152009|37709201|FG003|Overall Study|Lack of Efficacy|15|||
16770783|NCT00152009|37709198|FG000|Overall Study|ECG abnormalities|2|||
16770784|NCT00152009|37709199|FG001|Overall Study|ECG abnormalities|2|||
16770785|NCT00152009|37709200|FG002|Overall Study|ECG abnormalities|2|||
16770786|NCT00152009|37709201|FG003|Overall Study|ECG abnormalities|1|||
16770787|NCT00152009|37709198|FG000|Overall Study|Sponsor's decision|3|||
16770788|NCT00152009|37709199|FG001|Overall Study|Sponsor's decision|3|||
16770789|NCT00152009|37709200|FG002|Overall Study|Sponsor's decision|1|||
16770790|NCT00152009|37709201|FG003|Overall Study|Sponsor's decision|3|||
16770791|NCT02265952|37709211|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
16770792|NCT02265952|37709212|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
16770793|NCT02265952|37709211|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
16770794|NCT02265952|37709212|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
16770795|NCT02265796|37709220|FG000|Overall Study|Death|1|||
16770796|NCT02265796|37709221|FG001|Overall Study|Death|0|||
16770797|NCT02265796|37709220|FG000|Overall Study|started on excluded medication|1|||
16770798|NCT02265796|37709221|FG001|Overall Study|started on excluded medication|0|||
16770799|NCT02265796|37709220|FG000|Overall Study|Withdrawal by Subject|1|||
16770800|NCT02265796|37709221|FG001|Overall Study|Withdrawal by Subject|1|||
16770801|NCT02357368|37709231|FG000|Overall Study|Lost to Follow-up|0|||
16770802|NCT02357368|37709232|FG001|Overall Study|Lost to Follow-up|0|||
16770803|NCT02357368|37709233|FG002|Overall Study|Lost to Follow-up|0|||
16770804|NCT02357368|37709234|FG003|Overall Study|Lost to Follow-up|1|||
16770805|NCT02357368|37709231|FG000|Overall Study|Pregnancy|3|||
16770806|NCT02357368|37709232|FG001|Overall Study|Pregnancy|2|||
16770807|NCT02357368|37709233|FG002|Overall Study|Pregnancy|0|||
16770808|NCT02357368|37709234|FG003|Overall Study|Pregnancy|0|||
16770809|NCT02357368|37709231|FG000|Overall Study|Withdrawal by Subject|3|||
16770810|NCT02357368|37709232|FG001|Overall Study|Withdrawal by Subject|1|||
16770811|NCT02357368|37709233|FG002|Overall Study|Withdrawal by Subject|1|||
16770812|NCT02357368|37709234|FG003|Overall Study|Withdrawal by Subject|2|||
16770813|NCT03287245|37709248|FG000|Overall Study|Study terminated by sponsor|3|||
16770814|NCT03287245|37709249|FG001|Overall Study|Study terminated by sponsor|0|||
16770815|NCT03287245|37709250|FG002|Overall Study|Study terminated by sponsor|3|||
16770816|NCT03287245|37709251|FG003|Overall Study|Study terminated by sponsor|1|||
16770817|NCT03287245|37709248|FG000|Overall Study|Adverse Event|1|||
16770818|NCT03287245|37709249|FG001|Overall Study|Adverse Event|0|||
16770819|NCT03287245|37709250|FG002|Overall Study|Adverse Event|0|||
16770820|NCT03287245|37709251|FG003|Overall Study|Adverse Event|0|||
16770821|NCT03287245|37709248|FG000|Overall Study|Withdrawal by Subject|8|||
16770822|NCT03287245|37709249|FG001|Overall Study|Withdrawal by Subject|3|||
16770823|NCT03287245|37709250|FG002|Overall Study|Withdrawal by Subject|3|||
16770824|NCT03287245|37709251|FG003|Overall Study|Withdrawal by Subject|0|||
16770825|NCT03287245|37709248|FG000|Overall Study|Physician Decision|3|||
16770826|NCT03287245|37709249|FG001|Overall Study|Physician Decision|2|||
16770827|NCT03287245|37709250|FG002|Overall Study|Physician Decision|0|||
16770828|NCT03287245|37709251|FG003|Overall Study|Physician Decision|0|||
16770829|NCT02262754|37709284|FG000|Overall Study|Adverse Event|3|||
16770830|NCT02262754|37709285|FG001|Overall Study|Adverse Event|4|||
16770831|NCT02262754|37709286|FG002|Overall Study|Adverse Event|0|||
16770832|NCT02262754|37709284|FG000|Overall Study|Lack of Efficacy|2|||
16770833|NCT02262754|37709285|FG001|Overall Study|Lack of Efficacy|0|||
16770834|NCT02262754|37709286|FG002|Overall Study|Lack of Efficacy|1|||
16770835|NCT02262754|37709284|FG000|Overall Study|Lost to Follow-up|0|||
16770836|NCT02262754|37709285|FG001|Overall Study|Lost to Follow-up|0|||
16770837|NCT02262754|37709286|FG002|Overall Study|Lost to Follow-up|1|||
16770838|NCT02262754|37709284|FG000|Overall Study|No longer meets eligibility criteria|0|||
16770839|NCT02262754|37709285|FG001|Overall Study|No longer meets eligibility criteria|1|||
16770840|NCT02262754|37709286|FG002|Overall Study|No longer meets eligibility criteria|0|||
16770841|NCT02262754|37709284|FG000|Overall Study|Study terminated by sponsor|5|||
16770842|NCT02262754|37709285|FG001|Overall Study|Study terminated by sponsor|4|||
16770843|NCT02262754|37709286|FG002|Overall Study|Study terminated by sponsor|4|||
16770844|NCT02262754|37709284|FG000|Overall Study|Protocol Violation|1|||
16770845|NCT02262754|37709285|FG001|Overall Study|Protocol Violation|0|||
16770846|NCT02262754|37709286|FG002|Overall Study|Protocol Violation|0|||
16770847|NCT02262754|37709284|FG000|Overall Study|Withdrawal by Subject|1|||
16770848|NCT02262754|37709285|FG001|Overall Study|Withdrawal by Subject|0|||
16770849|NCT02262754|37709286|FG002|Overall Study|Withdrawal by Subject|1|||
16770850|NCT02262754|37709284|FG000|Overall Study|Other|4|||
16770851|NCT02262754|37709285|FG001|Overall Study|Other|0|||
16770852|NCT02262754|37709286|FG002|Overall Study|Other|2|||
16770853|NCT02262364|37709296|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
16770854|NCT00309985|37709302|FG000|Overall Study|Disease progression|12|||
16770855|NCT00309985|37709303|FG001|Overall Study|Disease progression|0|||
16770856|NCT00309985|37709302|FG000|Overall Study|Adverse Event|30|||
16770857|NCT00309985|37709303|FG001|Overall Study|Adverse Event|0|||
16770858|NCT00309985|37709302|FG000|Overall Study|Death|2|||
16770859|NCT00309985|37709303|FG001|Overall Study|Death|0|||
16770860|NCT00309985|37709302|FG000|Overall Study|Withdrawal by Subject|5|||
16770861|NCT00309985|37709303|FG001|Overall Study|Withdrawal by Subject|1|||
16770862|NCT00309985|37709302|FG000|Overall Study|Physician Decision|3|||
16770863|NCT00309985|37709303|FG001|Overall Study|Physician Decision|0|||
16770864|NCT00309985|37709302|FG000|Overall Study|Never started treatment|7|||
16770865|NCT00309985|37709303|FG001|Overall Study|Never started treatment|0|||
16770866|NCT00309985|37709302|FG000|Overall Study|Complicating disease|1|||
16770867|NCT00309985|37709303|FG001|Overall Study|Complicating disease|0|||
16770868|NCT00309985|37709302|FG000|Overall Study|Non-compliance|1|||
16770869|NCT00309985|37709303|FG001|Overall Study|Non-compliance|0|||
16770870|NCT00309985|37709302|FG000|Overall Study|Chemotherapy discontinued only|1|||
16770871|NCT00309985|37709303|FG001|Overall Study|Chemotherapy discontinued only|0|||
16770872|NCT02261974|37709311|FG000|Overall Study|Withdrawal by Subject|3|||
16770873|NCT02261974|37709312|FG001|Overall Study|Withdrawal by Subject|2|||
16770874|NCT02261974|37709311|FG000|Overall Study|Pregnancy|0|||
16770875|NCT02261974|37709312|FG001|Overall Study|Pregnancy|1|||
16770876|NCT02261974|37709311|FG000|Overall Study|Missed treatment cut-off date|6|||
16770877|NCT02261974|37709312|FG001|Overall Study|Missed treatment cut-off date|3|||
16770878|NCT02261974|37709311|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
16770879|NCT02261974|37709312|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
16770880|NCT02261974|37709311|FG000|Overall Study|Lost to Follow-up|2|||
16770881|NCT02261974|37709312|FG001|Overall Study|Lost to Follow-up|0|||
16770882|NCT02261974|37709311|FG000|Overall Study|Adverse Event|1|||
16770883|NCT02261974|37709312|FG001|Overall Study|Adverse Event|0|||
16770884|NCT02356588|37709320|FG000|Overall Study|Lack of Efficacy|4|||
16770885|NCT02356588|37709321|FG001|Overall Study|Lack of Efficacy|10|||
16770886|NCT02356588|37709320|FG000|Overall Study|Adverse Event|0|||
16770887|NCT02356588|37709321|FG001|Overall Study|Adverse Event|2|||
16770888|NCT02356588|37709320|FG000|Overall Study|Withdrawal by Subject|1|||
16770889|NCT02356588|37709321|FG001|Overall Study|Withdrawal by Subject|0|||
16770890|NCT02356588|37709320|FG000|Overall Study|Protocol Violation|0|||
16770891|NCT02356588|37709321|FG001|Overall Study|Protocol Violation|1|||
16770892|NCT02355028|37709329|FG000|Overall Study|Adverse Event|2|||
16770893|NCT02355028|37709330|FG001|Overall Study|Adverse Event|0|||
16770894|NCT02355028|37709329|FG000|Overall Study|Withdrawal by Subject|1|||
16770895|NCT02355028|37709330|FG001|Overall Study|Withdrawal by Subject|1|||
16770896|NCT02355028|37709329|FG000|Overall Study|Deemed ineligible after randomization|8|||
16770897|NCT02355028|37709330|FG001|Overall Study|Deemed ineligible after randomization|4|||
16770898|NCT01643668|37709345|FG000|Overall Study|Death|1|||
16770899|NCT02260882|37709351|FG000|Overall Study|Protocol Violation|0|||
16770900|NCT02260882|37709352|FG001|Overall Study|Protocol Violation|1|||
16770901|NCT02260804|37709361|FG000|Induction Study Period|Protocol Violation|2|||
16770902|NCT02260804|37709362|FG001|Induction Study Period|Protocol Violation|0|||
16770903|NCT02260804|37709361|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
16770904|NCT02260804|37709362|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
16770905|NCT02260804|37709361|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
16770906|NCT02260804|37709362|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
16770907|NCT02260804|37709361|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
16770908|NCT02260804|37709362|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
16770909|NCT02260804|37709361|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
16770910|NCT02260804|37709362|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
16770911|NCT02260804|37709361|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
16770912|NCT02260804|37709362|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
16770913|NCT02260804|37709361|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
16770914|NCT02260804|37709362|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
16770915|NCT02260804|37709361|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
16770916|NCT02260804|37709362|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
16770917|NCT02260804|37709361|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
16770918|NCT02260804|37709362|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
16770919|NCT02260804|37709361|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
16770920|NCT02260804|37709362|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
16770921|NCT02260804|37709361|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
16770922|NCT02260804|37709362|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
16770923|NCT02260648|37709371|FG000|Overall Study|Adverse Event|3|||
16770924|NCT02260648|37709372|FG001|Overall Study|Adverse Event|0|||
16770925|NCT02260648|37709373|FG002|Overall Study|Adverse Event|1|||
16770926|NCT02260648|37709371|FG000|Overall Study|Withdrawal by Subject|1|||
16770927|NCT02260648|37709372|FG001|Overall Study|Withdrawal by Subject|1|||
16770928|NCT02260648|37709373|FG002|Overall Study|Withdrawal by Subject|0|||
16770929|NCT02260648|37709371|FG000|Overall Study|Protocol Violation|1|||
16770930|NCT02260648|37709372|FG001|Overall Study|Protocol Violation|0|||
16770931|NCT02260648|37709373|FG002|Overall Study|Protocol Violation|0|||
16770932|NCT02260648|37709371|FG000|Overall Study|Discontinue Due to Study Termination|13|||
16770933|NCT02260648|37709372|FG001|Overall Study|Discontinue Due to Study Termination|12|||
16770934|NCT02260648|37709373|FG002|Overall Study|Discontinue Due to Study Termination|7|||
16770935|NCT02260492|37709384|FG000|Overall Study|Adverse Event|6|||
16770936|NCT02260492|37709385|FG001|Overall Study|Adverse Event|1|||
16770937|NCT02260492|37709386|FG002|Overall Study|Adverse Event|2|||
16770938|NCT02260492|37709384|FG000|Overall Study|Death|0|||
16770939|NCT02260492|37709385|FG001|Overall Study|Death|1|||
16770940|NCT02260492|37709386|FG002|Overall Study|Death|0|||
16770941|NCT02260492|37709384|FG000|Overall Study|Lost to Follow-up|12|||
16770942|NCT02260492|37709385|FG001|Overall Study|Lost to Follow-up|9|||
16770943|NCT02260492|37709386|FG002|Overall Study|Lost to Follow-up|0|||
16770944|NCT02260492|37709384|FG000|Overall Study|Physician Decision|2|||
16770945|NCT02260492|37709385|FG001|Overall Study|Physician Decision|0|||
16770946|NCT02260492|37709386|FG002|Overall Study|Physician Decision|1|||
16770947|NCT02260492|37709384|FG000|Overall Study|Withdrawal by Subject|3|||
16770948|NCT02260492|37709385|FG001|Overall Study|Withdrawal by Subject|2|||
16770949|NCT02260492|37709386|FG002|Overall Study|Withdrawal by Subject|2|||
16770950|NCT02260258|37709396|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
16770951|NCT02260258|37709397|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
16770952|NCT02260180|37709407|FG000|Overall Study|Adverse Event|2|||
16770953|NCT02260180|37709408|FG001|Overall Study|Adverse Event|0|||
16770954|NCT02260180|37709409|FG002|Overall Study|Adverse Event|1|||
16770955|NCT02353468|37709417|FG000|Overall Study|Study terminated|3|||
16770956|NCT02349412|37709423|FG000|Overall Study|Withdrawal by Subject|7|||
16770957|NCT02349412|37709424|FG001|Overall Study|Withdrawal by Subject|7|||
16770958|NCT02259400|37709432|FG000|Overall Study|Death|0|||
16770959|NCT02259400|37709433|FG001|Overall Study|Death|2|||
16770960|NCT01530997|37709439|FG000|Overall Study|Physician Decision|1|||
16770961|NCT01530997|37709439|FG000|Overall Study|Withdrawal by Subject|1|||
16770962|NCT02259088|37709452|FG000|Overall Study|Adverse Event|6|||
16770963|NCT02259088|37709453|FG001|Overall Study|Adverse Event|4|||
16770964|NCT02259088|37709452|FG000|Overall Study|Lost to Follow-up|2|||
16770965|NCT02259088|37709453|FG001|Overall Study|Lost to Follow-up|0|||
16770966|NCT02259088|37709452|FG000|Overall Study|Death|2|||
16770967|NCT02259088|37709453|FG001|Overall Study|Death|0|||
16770968|NCT02259088|37709452|FG000|Overall Study|Physician Decision|5|||
16770969|NCT02259088|37709453|FG001|Overall Study|Physician Decision|2|||
16770970|NCT02259088|37709452|FG000|Overall Study|Protocol deviation|5|||
16770971|NCT02259088|37709453|FG001|Overall Study|Protocol deviation|0|||
16770972|NCT02259088|37709452|FG000|Overall Study|Subject/guardian decision|8|||
16770973|NCT02259088|37709453|FG001|Overall Study|Subject/guardian decision|8|||
16770974|NCT02880241|37709465|FG000|Overall Study|Lack of Efficacy|1|||
16770975|NCT02880241|37709466|FG001|Overall Study|Lack of Efficacy|0|||
16770976|NCT02880241|37709467|FG002|Overall Study|Lack of Efficacy|0|||
16770977|NCT02880241|37709468|FG003|Overall Study|Lack of Efficacy|0|||
16770978|NCT02880241|37709469|FG004|Overall Study|Lack of Efficacy|0|||
16770979|NCT02880241|37709470|FG005|Overall Study|Lack of Efficacy|0|||
16770980|NCT02259010|37709486|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
16770981|NCT02021773|37709495|FG000|Overall Study|Adverse Event|1|||
16770982|NCT02021773|37709496|FG001|Overall Study|Adverse Event|4|||
16770983|NCT02021773|37709497|FG002|Overall Study|Adverse Event|3|||
16770984|NCT02021773|37709495|FG000|Overall Study|Lack of Efficacy|2|||
16770985|NCT02021773|37709496|FG001|Overall Study|Lack of Efficacy|2|||
16770986|NCT02021773|37709497|FG002|Overall Study|Lack of Efficacy|2|||
16770987|NCT02021773|37709495|FG000|Overall Study|Protocol Violation|2|||
16770988|NCT02021773|37709496|FG001|Overall Study|Protocol Violation|3|||
16770989|NCT02021773|37709497|FG002|Overall Study|Protocol Violation|1|||
16770990|NCT02021773|37709495|FG000|Overall Study|Withdrawal by Subject|3|||
16770991|NCT02021773|37709496|FG001|Overall Study|Withdrawal by Subject|4|||
16770992|NCT02021773|37709497|FG002|Overall Study|Withdrawal by Subject|5|||
16770993|NCT02021773|37709495|FG000|Overall Study|Lost to Follow-up|1|||
16770994|NCT02021773|37709496|FG001|Overall Study|Lost to Follow-up|3|||
16770995|NCT02021773|37709497|FG002|Overall Study|Lost to Follow-up|0|||
16770996|NCT02021773|37709495|FG000|Overall Study|Reason not specified|3|||
16770997|NCT02021773|37709496|FG001|Overall Study|Reason not specified|0|||
16770998|NCT02021773|37709497|FG002|Overall Study|Reason not specified|0|||
16770999|NCT00151775|37709510|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
16771000|NCT00151775|37709511|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
16771001|NCT00151775|37709512|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771002|NCT00151775|37709513|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771003|NCT00151775|37709514|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771004|NCT00151775|37709515|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771005|NCT00151775|37709516|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771006|NCT00151775|37709517|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16942082|NCT01335477|38086647|FG000|Overall Study|Lost to Follow-up|1|||
16771007|NCT00151775|37709518|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771008|NCT00151775|37709519|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771009|NCT00151775|37709520|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771010|NCT00151775|37709521|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16771011|NCT00151775|37709510|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
16771012|NCT00151775|37709511|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771013|NCT00151775|37709512|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771014|NCT00151775|37709513|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771015|NCT00151775|37709514|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771016|NCT00151775|37709515|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771017|NCT00151775|37709516|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
16771018|NCT00151775|37709517|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771019|NCT00151775|37709518|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771020|NCT00151775|37709519|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771021|NCT00151775|37709520|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
16771022|NCT00151775|37709521|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16771023|NCT00151775|37709510|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771024|NCT00151775|37709511|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
16771025|NCT00151775|37709512|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771026|NCT00151775|37709513|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771027|NCT00151775|37709514|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771028|NCT00151775|37709515|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771029|NCT00151775|37709516|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771030|NCT00151775|37709517|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771031|NCT00151775|37709518|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771032|NCT00151775|37709519|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771033|NCT00151775|37709520|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771034|NCT00151775|37709521|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16771035|NCT00151775|37709510|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
16771036|NCT00151775|37709511|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
16771037|NCT00151775|37709512|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
16771038|NCT00151775|37709513|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
16771039|NCT00151775|37709514|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
16771040|NCT00151775|37709515|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
16771041|NCT00151775|37709516|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
16771042|NCT00151775|37709517|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
16771043|NCT00151775|37709518|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
16771044|NCT00151775|37709519|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
16771045|NCT00151775|37709520|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
16771046|NCT00151775|37709521|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
16771047|NCT00151775|37709510|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771048|NCT00151775|37709511|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771049|NCT00151775|37709512|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771050|NCT00151775|37709513|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771051|NCT00151775|37709514|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771052|NCT00151775|37709515|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
16771053|NCT00151775|37709516|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771054|NCT00151775|37709517|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771055|NCT00151775|37709518|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771056|NCT00151775|37709519|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771057|NCT00151775|37709520|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771058|NCT00151775|37709521|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16771059|NCT00151775|37709510|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771060|NCT00151775|37709511|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771061|NCT00151775|37709512|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771062|NCT00151775|37709513|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771063|NCT00151775|37709514|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771064|NCT00151775|37709515|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
16771065|NCT00151775|37709516|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16856598|NCT01746901|37810281|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16856599|NCT01746901|37810282|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16856600|NCT01746901|37810283|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16771066|NCT00151775|37709517|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771067|NCT00151775|37709518|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771068|NCT00151775|37709519|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771069|NCT00151775|37709520|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771070|NCT00151775|37709521|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16771071|NCT00151775|37709510|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771072|NCT00151775|37709511|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771073|NCT00151775|37709512|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771074|NCT00151775|37709513|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771075|NCT00151775|37709514|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771076|NCT00151775|37709515|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771077|NCT00151775|37709516|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
16771078|NCT00151775|37709517|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771079|NCT00151775|37709518|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771080|NCT00151775|37709519|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771081|NCT00151775|37709520|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771082|NCT00151775|37709521|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16771083|NCT00151775|37709510|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771084|NCT00151775|37709511|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771085|NCT00151775|37709512|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771086|NCT00151775|37709513|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771087|NCT00151775|37709514|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771088|NCT00151775|37709515|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
16771089|NCT00151775|37709516|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771090|NCT00151775|37709517|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771091|NCT00151775|37709518|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771092|NCT00151775|37709519|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771093|NCT00151775|37709520|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771094|NCT00151775|37709521|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16771095|NCT00151775|37709510|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
16771096|NCT00151775|37709511|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
16771097|NCT00151775|37709512|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
16771098|NCT00151775|37709513|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
16771099|NCT00151775|37709514|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
16771100|NCT00151775|37709515|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
16771101|NCT00151775|37709516|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
16771102|NCT00151775|37709517|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
16771103|NCT00151775|37709518|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
16771104|NCT00151775|37709519|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
16771105|NCT00151775|37709520|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
16771106|NCT00151775|37709521|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
16771107|NCT00151775|37709510|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771108|NCT00151775|37709511|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771109|NCT00151775|37709512|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771110|NCT00151775|37709513|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771111|NCT00151775|37709514|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771112|NCT00151775|37709515|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771113|NCT00151775|37709516|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
16771114|NCT00151775|37709517|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771115|NCT00151775|37709518|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771116|NCT00151775|37709519|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771117|NCT00151775|37709520|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771118|NCT00151775|37709521|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16771119|NCT00151775|37709510|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771120|NCT00151775|37709511|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771121|NCT00151775|37709512|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
16771122|NCT00151775|37709513|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771123|NCT00151775|37709514|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771124|NCT00151775|37709515|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771125|NCT00151775|37709516|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771126|NCT00151775|37709517|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771127|NCT00151775|37709518|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771128|NCT00151775|37709519|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771129|NCT00151775|37709520|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771130|NCT00151775|37709521|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16771131|NCT00151775|37709510|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771132|NCT00151775|37709511|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771133|NCT00151775|37709512|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
16771134|NCT00151775|37709513|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771135|NCT00151775|37709514|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771136|NCT00151775|37709515|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771137|NCT00151775|37709516|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771138|NCT00151775|37709517|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771139|NCT00151775|37709518|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771140|NCT00151775|37709519|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771141|NCT00151775|37709520|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771142|NCT00151775|37709521|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16771143|NCT00151775|37709510|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771144|NCT00151775|37709511|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771145|NCT00151775|37709512|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771146|NCT00151775|37709513|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771147|NCT00151775|37709514|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771148|NCT00151775|37709515|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771149|NCT00151775|37709516|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771150|NCT00151775|37709517|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771151|NCT00151775|37709518|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771152|NCT00151775|37709519|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771153|NCT00151775|37709520|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16771154|NCT00151775|37709521|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
16771155|NCT00151775|37709510|FG000|Period 4: Open Label|Increased blood pressure|0|||
16771156|NCT00151775|37709511|FG001|Period 4: Open Label|Increased blood pressure|0|||
16771157|NCT00151775|37709512|FG002|Period 4: Open Label|Increased blood pressure|0|||
16771158|NCT00151775|37709513|FG003|Period 4: Open Label|Increased blood pressure|0|||
16771159|NCT00151775|37709514|FG004|Period 4: Open Label|Increased blood pressure|1|||
16771160|NCT00151775|37709515|FG005|Period 4: Open Label|Increased blood pressure|0|||
16771161|NCT00151775|37709516|FG006|Period 4: Open Label|Increased blood pressure|0|||
16771162|NCT00151775|37709517|FG007|Period 4: Open Label|Increased blood pressure|0|||
16771163|NCT00151775|37709518|FG008|Period 4: Open Label|Increased blood pressure|0|||
16771164|NCT00151775|37709519|FG009|Period 4: Open Label|Increased blood pressure|1|||
16771165|NCT00151775|37709520|FG010|Period 4: Open Label|Increased blood pressure|0|||
16771166|NCT00151775|37709521|FG011|Period 4: Open Label|Increased blood pressure|0|||
16771167|NCT00151775|37709510|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
16771168|NCT00151775|37709511|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
16771169|NCT00151775|37709512|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
16771170|NCT00151775|37709513|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
16771171|NCT00151775|37709514|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
16771172|NCT00151775|37709515|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
16771173|NCT00151775|37709516|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
16771174|NCT00151775|37709517|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
16771175|NCT00151775|37709518|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
16771176|NCT00151775|37709519|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
16771177|NCT00151775|37709520|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
16771178|NCT00151775|37709521|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
16771179|NCT00151775|37709510|FG000|Period 4: Open Label|Adverse Event|0|||
16771180|NCT00151775|37709511|FG001|Period 4: Open Label|Adverse Event|0|||
16771181|NCT00151775|37709512|FG002|Period 4: Open Label|Adverse Event|0|||
16771182|NCT00151775|37709513|FG003|Period 4: Open Label|Adverse Event|0|||
16771183|NCT00151775|37709514|FG004|Period 4: Open Label|Adverse Event|1|||
16771184|NCT00151775|37709515|FG005|Period 4: Open Label|Adverse Event|0|||
16771185|NCT00151775|37709516|FG006|Period 4: Open Label|Adverse Event|0|||
16771186|NCT00151775|37709517|FG007|Period 4: Open Label|Adverse Event|0|||
16771187|NCT00151775|37709518|FG008|Period 4: Open Label|Adverse Event|0|||
16771188|NCT00151775|37709519|FG009|Period 4: Open Label|Adverse Event|2|||
16771189|NCT00151775|37709520|FG010|Period 4: Open Label|Adverse Event|0|||
16771190|NCT00151775|37709521|FG011|Period 4: Open Label|Adverse Event|0|||
16771191|NCT00151775|37709510|FG000|Period 4: Open Label|Lost to Follow-up|0|||
16771192|NCT00151775|37709511|FG001|Period 4: Open Label|Lost to Follow-up|0|||
16771193|NCT00151775|37709512|FG002|Period 4: Open Label|Lost to Follow-up|0|||
16771194|NCT00151775|37709513|FG003|Period 4: Open Label|Lost to Follow-up|0|||
16856601|NCT01746901|37810284|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16856602|NCT01746901|37810285|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16856603|NCT01746901|37810286|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16856604|NCT01746901|37810278|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16856605|NCT01746901|37810279|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
16856606|NCT01746901|37810280|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16856607|NCT01746901|37810281|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16856608|NCT01746901|37810282|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16856609|NCT01746901|37810283|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16856610|NCT01746901|37810284|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16856611|NCT01746901|37810285|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16856612|NCT01746901|37810286|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16856613|NCT01746901|37810278|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16856614|NCT01746901|37810279|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
16856615|NCT01746901|37810280|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
16856616|NCT01746901|37810281|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16771195|NCT00151775|37709514|FG004|Period 4: Open Label|Lost to Follow-up|17|||
16771196|NCT00151775|37709515|FG005|Period 4: Open Label|Lost to Follow-up|0|||
16771197|NCT00151775|37709516|FG006|Period 4: Open Label|Lost to Follow-up|0|||
16771198|NCT00151775|37709517|FG007|Period 4: Open Label|Lost to Follow-up|0|||
16771199|NCT00151775|37709518|FG008|Period 4: Open Label|Lost to Follow-up|0|||
16771200|NCT00151775|37709519|FG009|Period 4: Open Label|Lost to Follow-up|7|||
16771201|NCT00151775|37709520|FG010|Period 4: Open Label|Lost to Follow-up|0|||
16771202|NCT00151775|37709521|FG011|Period 4: Open Label|Lost to Follow-up|0|||
16771203|NCT00151775|37709510|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
16771204|NCT00151775|37709511|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
16771205|NCT00151775|37709512|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
16771206|NCT00151775|37709513|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
16771207|NCT00151775|37709514|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
16771208|NCT00151775|37709515|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
16771209|NCT00151775|37709516|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
16771210|NCT00151775|37709517|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
16771211|NCT00151775|37709518|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
16771212|NCT00151775|37709519|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
16771213|NCT00151775|37709520|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
16771214|NCT00151775|37709521|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
16771215|NCT00151775|37709510|FG000|Period 4: Open Label|Other|0|||
16771216|NCT00151775|37709511|FG001|Period 4: Open Label|Other|0|||
16771217|NCT00151775|37709512|FG002|Period 4: Open Label|Other|0|||
16771218|NCT00151775|37709513|FG003|Period 4: Open Label|Other|0|||
16771219|NCT00151775|37709514|FG004|Period 4: Open Label|Other|1|||
16771220|NCT00151775|37709515|FG005|Period 4: Open Label|Other|0|||
16771221|NCT00151775|37709516|FG006|Period 4: Open Label|Other|0|||
16771222|NCT00151775|37709517|FG007|Period 4: Open Label|Other|0|||
16771223|NCT00151775|37709518|FG008|Period 4: Open Label|Other|0|||
16771224|NCT00151775|37709519|FG009|Period 4: Open Label|Other|3|||
16856617|NCT01746901|37810282|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16856618|NCT01746901|37810283|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16856619|NCT01746901|37810284|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16856620|NCT01746901|37810285|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16856621|NCT01746901|37810286|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16856622|NCT01746901|37810278|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16856623|NCT01746901|37810279|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
16856624|NCT01746901|37810280|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
16856625|NCT01746901|37810281|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16856626|NCT01746901|37810282|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16856627|NCT01746901|37810283|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16856628|NCT01746901|37810284|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16856629|NCT01746901|37810285|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16856630|NCT01746901|37810286|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16856631|NCT01746901|37810278|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16856632|NCT01746901|37810279|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
16856633|NCT01746901|37810280|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
16856634|NCT01746901|37810281|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16856635|NCT01746901|37810282|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16856636|NCT01746901|37810283|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16856637|NCT01746901|37810284|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16856638|NCT01746901|37810285|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16856639|NCT01746901|37810286|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16856640|NCT01746901|37810278|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
16856641|NCT01746901|37810279|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
16856642|NCT01746901|37810280|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
16856643|NCT01746901|37810281|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
16856644|NCT01746901|37810282|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
16856645|NCT01746901|37810283|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
16856646|NCT01746901|37810284|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
16856647|NCT01746901|37810285|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
16942083|NCT01335477|38086648|FG001|Overall Study|Lost to Follow-up|2|||
16771225|NCT00151775|37709520|FG010|Period 4: Open Label|Other|0|||
16771226|NCT00151775|37709521|FG011|Period 4: Open Label|Other|0|||
16771227|NCT00151775|37709510|FG000|Period 4: Open Label|Physician Decision|0|||
16771228|NCT00151775|37709511|FG001|Period 4: Open Label|Physician Decision|0|||
16771229|NCT00151775|37709512|FG002|Period 4: Open Label|Physician Decision|0|||
16771230|NCT00151775|37709513|FG003|Period 4: Open Label|Physician Decision|0|||
16771231|NCT00151775|37709514|FG004|Period 4: Open Label|Physician Decision|0|||
16771232|NCT00151775|37709515|FG005|Period 4: Open Label|Physician Decision|0|||
16771233|NCT00151775|37709516|FG006|Period 4: Open Label|Physician Decision|0|||
16771234|NCT00151775|37709517|FG007|Period 4: Open Label|Physician Decision|0|||
16771235|NCT00151775|37709518|FG008|Period 4: Open Label|Physician Decision|0|||
16771236|NCT00151775|37709519|FG009|Period 4: Open Label|Physician Decision|2|||
16771237|NCT00151775|37709520|FG010|Period 4: Open Label|Physician Decision|0|||
16771238|NCT00151775|37709521|FG011|Period 4: Open Label|Physician Decision|0|||
16771239|NCT00151775|37709510|FG000|Period 4: Open Label|Protocol Violation|0|||
16771240|NCT00151775|37709511|FG001|Period 4: Open Label|Protocol Violation|0|||
16771241|NCT00151775|37709512|FG002|Period 4: Open Label|Protocol Violation|0|||
16771242|NCT00151775|37709513|FG003|Period 4: Open Label|Protocol Violation|0|||
16771243|NCT00151775|37709514|FG004|Period 4: Open Label|Protocol Violation|1|||
16771244|NCT00151775|37709515|FG005|Period 4: Open Label|Protocol Violation|0|||
16771245|NCT00151775|37709516|FG006|Period 4: Open Label|Protocol Violation|0|||
16771246|NCT00151775|37709517|FG007|Period 4: Open Label|Protocol Violation|0|||
16771247|NCT00151775|37709518|FG008|Period 4: Open Label|Protocol Violation|0|||
16771248|NCT00151775|37709519|FG009|Period 4: Open Label|Protocol Violation|0|||
16771249|NCT00151775|37709520|FG010|Period 4: Open Label|Protocol Violation|0|||
16771250|NCT00151775|37709521|FG011|Period 4: Open Label|Protocol Violation|0|||
16771251|NCT02258464|37709564|FG000|Overall Study|Progressive disease (PD)|9|||
16771252|NCT02258464|37709565|FG001|Overall Study|Progressive disease (PD)|17|||
16771253|NCT02258464|37709564|FG000|Overall Study|Study drug never administered|1|||
16771254|NCT02258464|37709565|FG001|Overall Study|Study drug never administered|1|||
16771255|NCT02258464|37709564|FG000|Overall Study|AE not related to clinical PD|1|||
16771256|NCT02258464|37709565|FG001|Overall Study|AE not related to clinical PD|3|||
16771257|NCT02258464|37709564|FG000|Overall Study|Withdrawal by Subject|5|||
16771258|NCT02258464|37709565|FG001|Overall Study|Withdrawal by Subject|4|||
16771259|NCT02258464|37709564|FG000|Overall Study|AE related to clinical PD|1|||
16771260|NCT02258464|37709565|FG001|Overall Study|AE related to clinical PD|0|||
16771261|NCT02682901|37709573|FG000|Overall Study|Adverse Event|10|||
16771262|NCT02682901|37709574|FG001|Overall Study|Adverse Event|3|||
16771263|NCT02682901|37709573|FG000|Overall Study|Lack of Efficacy|0|||
16771264|NCT02682901|37709574|FG001|Overall Study|Lack of Efficacy|1|||
16771265|NCT02258074|37709584|FG000|Overall Study|Withdrawal by Subject|1|||
16771266|NCT02258074|37709585|FG001|Overall Study|Withdrawal by Subject|0|||
16771267|NCT02258074|37709586|FG002|Overall Study|Withdrawal by Subject|0|||
16771268|NCT02258074|37709587|FG003|Overall Study|Withdrawal by Subject|0|||
16771269|NCT02257684|37709597|FG000|Overall Study|Adverse Event|2|||
16771270|NCT02257684|37709597|FG000|Overall Study|Lack of Efficacy|1|||
16771271|NCT02257684|37709597|FG000|Overall Study|Sponsor's Decision|1|||
16771272|NCT01643044|37709603|FG000|Overall Study|Lost to Follow-up|1|||
16771273|NCT01643044|37709604|FG001|Overall Study|Lost to Follow-up|1|||
16771274|NCT01643044|37709603|FG000|Overall Study|Miscarried baby|2|||
16771275|NCT01643044|37709604|FG001|Overall Study|Miscarried baby|2|||
16771276|NCT01643044|37709603|FG000|Overall Study|Delivered outside of hospital|1|||
16771277|NCT01643044|37709604|FG001|Overall Study|Delivered outside of hospital|2|||
16771278|NCT01642732|37709610|FG000|Overall Study|Withdrawal by Subject|1|||
16771279|NCT02190721|37709617|FG000|Overall Study|Patient was out of the city|0|||
16771280|NCT02190721|37709618|FG001|Overall Study|Patient was out of the city|1|||
16771281|NCT02190721|37709619|FG002|Overall Study|Patient was out of the city|0|||
16771282|NCT00581477|37709627|FG000|Overall Study|Physician Decision|2|||
16771283|NCT02348008|37709643|FG000|Overall Study|Adverse Event|2|||
16771284|NCT02348008|37709644|FG001|Overall Study|Adverse Event|3|||
16771285|NCT02348008|37709645|FG002|Overall Study|Adverse Event|3|||
16771286|NCT02348008|37709643|FG000|Overall Study|Disease Progression|1|||
16771287|NCT02348008|37709644|FG001|Overall Study|Disease Progression|5|||
16771288|NCT02348008|37709645|FG002|Overall Study|Disease Progression|16|||
16771289|NCT02348008|37709643|FG000|Overall Study|Withdrawal by Subject|0|||
16771290|NCT02348008|37709644|FG001|Overall Study|Withdrawal by Subject|1|||
16771291|NCT02348008|37709645|FG002|Overall Study|Withdrawal by Subject|0|||
16771292|NCT02348008|37709643|FG000|Overall Study|Symptomatic Deterioration|0|||
16771293|NCT02348008|37709644|FG001|Overall Study|Symptomatic Deterioration|1|||
16771294|NCT02348008|37709645|FG002|Overall Study|Symptomatic Deterioration|0|||
16856648|NCT01746901|37810286|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
16771295|NCT00495131|37709653|FG000|Overall Study|Adverse Event|6|||
16771296|NCT00495131|37709654|FG001|Overall Study|Adverse Event|2|||
16771297|NCT00495131|37709653|FG000|Overall Study|Lack of Efficacy|0|||
16771298|NCT00495131|37709654|FG001|Overall Study|Lack of Efficacy|2|||
16771299|NCT00495131|37709653|FG000|Overall Study|Lost to Follow-up|0|||
16771300|NCT00495131|37709654|FG001|Overall Study|Lost to Follow-up|2|||
16771301|NCT00495131|37709653|FG000|Overall Study|Withdrawal by Subject|1|||
16771302|NCT00495131|37709654|FG001|Overall Study|Withdrawal by Subject|0|||
16771303|NCT02257372|37709660|FG000|Overall Study|Adverse Event|3|||
16771304|NCT02257372|37709661|FG001|Overall Study|Adverse Event|7|||
16771305|NCT02257372|37709660|FG000|Overall Study|Lack of Efficacy|2|||
16856649|NCT01746901|37810278|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16856650|NCT01746901|37810279|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16856651|NCT01746901|37810280|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16856652|NCT01746901|37810281|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16856653|NCT01746901|37810282|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16856654|NCT01746901|37810283|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16856655|NCT01746901|37810284|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16856656|NCT01746901|37810285|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
16856657|NCT01746901|37810286|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16856658|NCT01746901|37810278|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
16856659|NCT01746901|37810279|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
16856660|NCT01746901|37810280|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
16856661|NCT01746901|37810281|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
16856662|NCT01746901|37810282|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
16856663|NCT01746901|37810283|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
16856664|NCT01746901|37810284|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
16856665|NCT01746901|37810285|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
16856666|NCT01746901|37810286|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
16856667|NCT01746901|37810278|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16856668|NCT01746901|37810279|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16856669|NCT01746901|37810280|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16856670|NCT01746901|37810281|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
16856671|NCT01746901|37810282|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16856672|NCT01746901|37810283|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16856673|NCT01746901|37810284|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16856674|NCT01746901|37810285|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16856675|NCT01746901|37810286|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16856676|NCT01746901|37810278|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16856677|NCT01746901|37810279|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16856678|NCT01746901|37810280|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16856679|NCT01746901|37810281|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16856680|NCT01746901|37810282|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16856681|NCT01746901|37810283|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
16856682|NCT01746901|37810284|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16856683|NCT01746901|37810285|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16856684|NCT01746901|37810286|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
16856685|NCT01746901|37810278|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16856686|NCT01746901|37810279|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16856687|NCT01746901|37810280|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16856688|NCT01746901|37810281|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16856689|NCT01746901|37810282|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16856690|NCT01746901|37810283|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16856691|NCT01746901|37810284|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
16856692|NCT01746901|37810285|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16856693|NCT01746901|37810286|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
16856694|NCT01968551|37810325|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
16856695|NCT01968551|37810326|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
16856696|NCT01968551|37810327|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
16856697|NCT01968551|37810325|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
16856698|NCT01968551|37810326|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
16856699|NCT01968551|37810327|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
16856700|NCT01968551|37810325|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
16856701|NCT01968551|37810326|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
16856702|NCT01968551|37810327|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
16856703|NCT01968551|37810325|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
16771306|NCT02257372|37709661|FG001|Overall Study|Lack of Efficacy|1|||
16771307|NCT02257372|37709660|FG000|Overall Study|Protocol Violation|1|||
16771308|NCT02257372|37709661|FG001|Overall Study|Protocol Violation|1|||
16771309|NCT02257372|37709660|FG000|Overall Study|Lost to Follow-up|0|||
16771310|NCT02257372|37709661|FG001|Overall Study|Lost to Follow-up|1|||
16771311|NCT02257372|37709660|FG000|Overall Study|Withdrew consent|1|||
16771312|NCT02257372|37709661|FG001|Overall Study|Withdrew consent|0|||
16771313|NCT02256982|37709669|FG000|Overall Study|Disease Progression|0|||
16771314|NCT02256982|37709670|FG001|Overall Study|Disease Progression|1|||
16771315|NCT02736721|37709676|FG000|Overall Study|Adverse Event|8|||
16771316|NCT02736721|37709676|FG000|Overall Study|Lost to Follow-up|3|||
16771317|NCT02736721|37709676|FG000|Overall Study|Other|5|||
16771318|NCT04176445|37709680|FG000|Overall Study|Adverse Event|0|||
16771319|NCT04176445|37709681|FG001|Overall Study|Adverse Event|1|||
16771320|NCT04176445|37709680|FG000|Overall Study|change plans weaning after first intervention|0|||
16771321|NCT04176445|37709681|FG001|Overall Study|change plans weaning after first intervention|1|||
16771322|NCT02738203|37709689|FG000|Overall Study|Failed IUD Insertion|2|||
16771323|NCT02738203|37709690|FG001|Overall Study|Failed IUD Insertion|2|||
16771324|NCT02738203|37709689|FG000|Overall Study|Protocol Violation|0|||
16771325|NCT02738203|37709690|FG001|Overall Study|Protocol Violation|1|||
16771326|NCT02452034|37709702|FG000|Overall Study|Adverse Event|0|||
16771327|NCT02452034|37709703|FG001|Overall Study|Adverse Event|0|||
16771328|NCT02452034|37709704|FG002|Overall Study|Adverse Event|0|||
16771329|NCT02452034|37709705|FG003|Overall Study|Adverse Event|0|||
16771330|NCT02452034|37709706|FG004|Overall Study|Adverse Event|0|||
16771331|NCT02452034|37709707|FG005|Overall Study|Adverse Event|1|||
16771332|NCT02452034|37709702|FG000|Overall Study|Death|0|||
16771333|NCT02452034|37709703|FG001|Overall Study|Death|0|||
16771334|NCT02452034|37709704|FG002|Overall Study|Death|0|||
16771335|NCT02452034|37709705|FG003|Overall Study|Death|0|||
16771336|NCT02452034|37709706|FG004|Overall Study|Death|1|||
16771337|NCT02452034|37709707|FG005|Overall Study|Death|1|||
16771338|NCT02452034|37709702|FG000|Overall Study|Physician Decision|0|||
16771339|NCT02452034|37709703|FG001|Overall Study|Physician Decision|1|||
16771340|NCT02452034|37709704|FG002|Overall Study|Physician Decision|1|||
16771341|NCT02452034|37709705|FG003|Overall Study|Physician Decision|0|||
16771342|NCT02452034|37709706|FG004|Overall Study|Physician Decision|0|||
16771343|NCT02452034|37709707|FG005|Overall Study|Physician Decision|0|||
16771344|NCT02452034|37709702|FG000|Overall Study|Protocol Violation|0|||
16771345|NCT02452034|37709703|FG001|Overall Study|Protocol Violation|0|||
16771346|NCT02452034|37709704|FG002|Overall Study|Protocol Violation|0|||
16771347|NCT02452034|37709705|FG003|Overall Study|Protocol Violation|0|||
16771348|NCT02452034|37709706|FG004|Overall Study|Protocol Violation|0|||
16771349|NCT02452034|37709707|FG005|Overall Study|Protocol Violation|1|||
16771350|NCT02452034|37709702|FG000|Overall Study|Screen Failure|1|||
16771351|NCT02452034|37709703|FG001|Overall Study|Screen Failure|0|||
16771352|NCT02452034|37709704|FG002|Overall Study|Screen Failure|0|||
16771353|NCT02452034|37709705|FG003|Overall Study|Screen Failure|1|||
16771354|NCT02452034|37709706|FG004|Overall Study|Screen Failure|0|||
16771355|NCT02452034|37709707|FG005|Overall Study|Screen Failure|0|||
16771356|NCT02452034|37709702|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
16771357|NCT02452034|37709703|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
16771358|NCT02452034|37709704|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
16771359|NCT02452034|37709705|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
16771360|NCT02452034|37709706|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
16771361|NCT02452034|37709707|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
16771362|NCT02482298|37709734|FG000|Overall Study|Withdrawal by Subject|2|||
16771363|NCT02482298|37709735|FG001|Overall Study|Withdrawal by Subject|1|||
16771364|NCT02482298|37709736|FG002|Overall Study|Withdrawal by Subject|2|||
16771365|NCT02482298|37709734|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
16771366|NCT02482298|37709735|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
16771367|NCT02482298|37709736|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
16771368|NCT02482298|37709734|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
16771369|NCT02482298|37709735|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
16771370|NCT02482298|37709736|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
16771371|NCT02482298|37709734|FG000|Overall Study|Lost to Follow-up|0|||
16771372|NCT02482298|37709735|FG001|Overall Study|Lost to Follow-up|1|||
16771373|NCT02482298|37709736|FG002|Overall Study|Lost to Follow-up|0|||
16771374|NCT00440531|37709747|FG000|Overall Study|Adverse Event|1|||
16771375|NCT00440531|37709748|FG001|Overall Study|Adverse Event|0|||
16771376|NCT00440531|37709749|FG002|Overall Study|Adverse Event|2|||
16771377|NCT00440531|37709747|FG000|Overall Study|Withdrawal by Subject|2|||
16771378|NCT00440531|37709748|FG001|Overall Study|Withdrawal by Subject|0|||
16771379|NCT00440531|37709749|FG002|Overall Study|Withdrawal by Subject|0|||
16771380|NCT00440531|37709747|FG000|Overall Study|Protocol Violation|1|||
16771381|NCT00440531|37709748|FG001|Overall Study|Protocol Violation|2|||
16771382|NCT00440531|37709749|FG002|Overall Study|Protocol Violation|0|||
16771383|NCT00440531|37709747|FG000|Overall Study|Lost to Follow-up|4|||
16771384|NCT00440531|37709748|FG001|Overall Study|Lost to Follow-up|3|||
16771385|NCT00440531|37709749|FG002|Overall Study|Lost to Follow-up|5|||
16771386|NCT00440531|37709747|FG000|Overall Study|see pre-assignment details|2|||
16771387|NCT00440531|37709748|FG001|Overall Study|see pre-assignment details|0|||
16771388|NCT00440531|37709749|FG002|Overall Study|see pre-assignment details|0|||
16771389|NCT02513732|37709755|FG000|Overall Study|Lost to Follow-up|11|||
16771390|NCT02513732|37709755|FG000|Overall Study|Death|9|||
16771391|NCT02513732|37709755|FG000|Overall Study|Changing hospital|2|||
16771392|NCT00429923|37709762|FG000|Overall Study|Adverse Event|0|||
16771393|NCT00429923|37709763|FG001|Overall Study|Adverse Event|2|||
16771394|NCT00429923|37709764|FG002|Overall Study|Adverse Event|3|||
16771395|NCT00429923|37709762|FG000|Overall Study|Lack of Efficacy|4|||
16771396|NCT00429923|37709763|FG001|Overall Study|Lack of Efficacy|1|||
16771397|NCT00429923|37709764|FG002|Overall Study|Lack of Efficacy|33|||
16771398|NCT00429923|37709762|FG000|Overall Study|Lost to Follow-up|0|||
16771399|NCT00429923|37709763|FG001|Overall Study|Lost to Follow-up|0|||
16771400|NCT00429923|37709764|FG002|Overall Study|Lost to Follow-up|2|||
16771401|NCT00429923|37709762|FG000|Overall Study|Withdrew Consent|1|||
16771402|NCT00429923|37709763|FG001|Overall Study|Withdrew Consent|0|||
16771403|NCT00429923|37709764|FG002|Overall Study|Withdrew Consent|1|||
16771404|NCT00429923|37709762|FG000|Overall Study|Early Termination|0|||
16771405|NCT00429923|37709763|FG001|Overall Study|Early Termination|1|||
16771406|NCT00429923|37709764|FG002|Overall Study|Early Termination|0|||
16771407|NCT02256436|37709771|FG000|Overall Study|Adverse Event|9|||
16771408|NCT02256436|37709772|FG001|Overall Study|Adverse Event|14|||
16771409|NCT02256436|37709771|FG000|Overall Study|Death|216|||
16771410|NCT02256436|37709772|FG001|Overall Study|Death|208|||
16771411|NCT02256436|37709771|FG000|Overall Study|Lost to Follow-up|1|||
16771412|NCT02256436|37709772|FG001|Overall Study|Lost to Follow-up|2|||
16771413|NCT02256436|37709771|FG000|Overall Study|Physician Decision|1|||
16771414|NCT02256436|37709772|FG001|Overall Study|Physician Decision|0|||
16771415|NCT02256436|37709771|FG000|Overall Study|Protocol Violation|0|||
16771416|NCT02256436|37709772|FG001|Overall Study|Protocol Violation|1|||
16771417|NCT02256436|37709771|FG000|Overall Study|Withdrawal by Subject|26|||
16771418|NCT02256436|37709772|FG001|Overall Study|Withdrawal by Subject|10|||
16771419|NCT02256436|37709771|FG000|Overall Study|Transferred to Extension Study|11|||
16771420|NCT02256436|37709772|FG001|Overall Study|Transferred to Extension Study|23|||
16771421|NCT02256436|37709771|FG000|Overall Study|Did Not Continue on Extension Study|8|||
16771422|NCT02256436|37709772|FG001|Overall Study|Did Not Continue on Extension Study|12|||
16771423|NCT02481830|37709781|FG000|Overall Study|No longer meets Study Criteria|1|||
16771424|NCT02481830|37709782|FG001|Overall Study|No longer meets Study Criteria|4|||
16771425|NCT02481830|37709781|FG000|Overall Study|Withdrawal by Subject|0|||
16771426|NCT02481830|37709782|FG001|Overall Study|Withdrawal by Subject|14|||
16771427|NCT02481830|37709781|FG000|Overall Study|Disease Progression|1|||
16771428|NCT02481830|37709782|FG001|Overall Study|Disease Progression|1|||
16771429|NCT02481830|37709781|FG000|Overall Study|Participant not eligible for trial|0|||
16771430|NCT02481830|37709782|FG001|Overall Study|Participant not eligible for trial|1|||
16771431|NCT00326183|37709790|FG000|Overall Study|Lost to Follow-up|104|||
16771432|NCT00326183|37709791|FG001|Overall Study|Lost to Follow-up|56|||
16771433|NCT00326183|37709790|FG000|Overall Study|Protocol Violation|6|||
16771434|NCT00326183|37709791|FG001|Overall Study|Protocol Violation|3|||
16771435|NCT00326183|37709790|FG000|Overall Study|Withdrawal by Subject|35|||
16771436|NCT00326183|37709791|FG001|Overall Study|Withdrawal by Subject|7|||
16771437|NCT00326183|37709790|FG000|Overall Study|Subject Moved|7|||
16771438|NCT00326183|37709791|FG001|Overall Study|Subject Moved|4|||
16771439|NCT00326183|37709790|FG000|Overall Study|Other|47|||
16771440|NCT00326183|37709791|FG001|Overall Study|Other|13|||
16771441|NCT00326183|37709790|FG000|Overall Study|Adverse Event|1|||
16771442|NCT00326183|37709791|FG001|Overall Study|Adverse Event|0|||
16771443|NCT02481050|37709795|FG000|Overall Study|Adverse Event|1|||
16771444|NCT02481050|37709795|FG000|Overall Study|Disease Progression|47|||
16771445|NCT02481050|37709795|FG000|Overall Study|Withdrawal by Subject|7|||
16771446|NCT02481050|37709795|FG000|Overall Study|Other|3|||
16771447|NCT02511782|37709802|FG000|Overall Study|Withdrawal by Subject|1|||
16771448|NCT02511782|37709803|FG001|Overall Study|Withdrawal by Subject|0|||
16771449|NCT02511782|37709804|FG002|Overall Study|Withdrawal by Subject|0|||
16771450|NCT02480114|37709814|FG000|Overall Study|Not completing surveys|3|||
16856704|NCT01968551|37810326|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
16771451|NCT02480114|37709815|FG001|Overall Study|Not completing surveys|2|||
16771452|NCT02480114|37709814|FG000|Overall Study|Withdrawal by Subject|2|||
16771453|NCT02480114|37709815|FG001|Overall Study|Withdrawal by Subject|4|||
16771454|NCT02480114|37709814|FG000|Overall Study|Disease progression|3|||
16771455|NCT02480114|37709815|FG001|Overall Study|Disease progression|0|||
16771456|NCT02480114|37709814|FG000|Overall Study|Improper completion of survey|1|||
16771457|NCT02480114|37709815|FG001|Overall Study|Improper completion of survey|1|||
16771458|NCT02480114|37709814|FG000|Overall Study|Not eligible|0|||
16771459|NCT02480114|37709815|FG001|Overall Study|Not eligible|1|||
16771460|NCT02479880|37709823|FG000|Overall Study|Study Terminated by Sponsor|13|||
16771461|NCT02479880|37709824|FG001|Overall Study|Study Terminated by Sponsor|12|||
16771462|NCT02479880|37709823|FG000|Overall Study|Pregnancy|0|||
16771463|NCT02479880|37709824|FG001|Overall Study|Pregnancy|1|||
16771464|NCT02479802|37709830|FG000|Overall Study|Lost to Follow-up|1|||
16771465|NCT02479802|37709830|FG000|Overall Study|Adverse Event|1|||
16771466|NCT02479412|37709843|FG000|Overall Study|Adverse Event|0|||
16771467|NCT02479412|37709844|FG001|Overall Study|Adverse Event|0|||
16771468|NCT02479412|37709845|FG002|Overall Study|Adverse Event|1|||
16771469|NCT02479412|37709846|FG003|Overall Study|Adverse Event|0|||
16771470|NCT02479412|37709847|FG004|Overall Study|Adverse Event|0|||
16771471|NCT02479412|37709848|FG005|Overall Study|Adverse Event|0|||
16771472|NCT02479412|37709849|FG006|Overall Study|Adverse Event|0|||
16771473|NCT02479412|37709850|FG007|Overall Study|Adverse Event|0|||
16771474|NCT02479412|37709851|FG008|Overall Study|Adverse Event|0|||
16771475|NCT02479412|37709843|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16771476|NCT02479412|37709844|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16771477|NCT02479412|37709845|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16771478|NCT02479412|37709846|FG003|Overall Study|Study-specific withdrawal criteria|1|||
16771479|NCT02479412|37709847|FG004|Overall Study|Study-specific withdrawal criteria|0|||
16771480|NCT02479412|37709848|FG005|Overall Study|Study-specific withdrawal criteria|0|||
16771481|NCT02479412|37709849|FG006|Overall Study|Study-specific withdrawal criteria|0|||
16771482|NCT02479412|37709850|FG007|Overall Study|Study-specific withdrawal criteria|1|||
16771483|NCT02479412|37709851|FG008|Overall Study|Study-specific withdrawal criteria|1|||
16771484|NCT02479412|37709843|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
16771485|NCT02479412|37709844|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
16771486|NCT02479412|37709845|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
16771487|NCT02479412|37709846|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
16771488|NCT02479412|37709847|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
16771489|NCT02479412|37709848|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
16771490|NCT02479412|37709849|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
16771491|NCT02479412|37709850|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
16771492|NCT02479412|37709851|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
16771493|NCT00224003|37709867|FG000|Overall Study|Adverse Event|1|||
16771494|NCT00224003|37709867|FG000|Overall Study|Protocol Violation|2|||
16771495|NCT00224003|37709867|FG000|Overall Study|Withdrawal by Subject|1|||
16771496|NCT00224003|37709867|FG000|Overall Study|unk|3|||
16771497|NCT02450552|37709873|FG000|Overall Study|Withdrawal by Subject|4|||
16771498|NCT02450552|37709874|FG001|Overall Study|Withdrawal by Subject|0|||
16771499|NCT02450552|37709875|FG002|Overall Study|Withdrawal by Subject|4|||
16771500|NCT02450552|37709873|FG000|Overall Study|Physician Decision|1|||
16771501|NCT02450552|37709874|FG001|Overall Study|Physician Decision|0|||
16771502|NCT02450552|37709875|FG002|Overall Study|Physician Decision|1|||
16771503|NCT02508428|37709885|FG000|Overall Study|Death|32|||
16771504|NCT02508428|37709886|FG001|Overall Study|Death|33|||
16771505|NCT02508428|37709885|FG000|Overall Study|Liner revised|3|||
16771506|NCT02508428|37709886|FG001|Overall Study|Liner revised|19|||
16771507|NCT02508428|37709885|FG000|Overall Study|Incomplete follow-up|17|||
16771508|NCT02508428|37709886|FG001|Overall Study|Incomplete follow-up|15|||
16771509|NCT02448680|37709894|FG000|Overall Study|Physician Decision|1|||
16771510|NCT02448680|37709895|FG001|Overall Study|Physician Decision|1|||
16771511|NCT02448680|37709894|FG000|Overall Study|Withdrawal by Subject|0|||
16771512|NCT02448680|37709895|FG001|Overall Study|Withdrawal by Subject|2|||
16771513|NCT02448446|37709905|FG000|Overall Study|Withdrawal by Subject|1|||
16771514|NCT02448446|37709906|FG001|Overall Study|Withdrawal by Subject|0|||
16771515|NCT02447744|37709914|FG000|Overall Study|Withdrawal by Subject|3|||
16771516|NCT02447744|37709915|FG001|Overall Study|Withdrawal by Subject|1|||
16771517|NCT02447744|37709914|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
16856705|NCT01968551|37810327|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
16856706|NCT01968551|37810325|FG000|Extension Phase|Adverse Event|0|||
16771518|NCT02447744|37709915|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
16771519|NCT02478632|37709923|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
16771520|NCT02478632|37709924|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
16771521|NCT02478632|37709923|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
16771522|NCT02478632|37709924|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
16771523|NCT02478632|37709923|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
16771524|NCT02478632|37709924|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
16771525|NCT02478398|37709935|FG000|Overall Study|Adverse Event|20|||
16771526|NCT02478398|37709936|FG001|Overall Study|Adverse Event|5|||
16771527|NCT02478398|37709935|FG000|Overall Study|Lost to Follow-up|5|||
16771528|NCT02478398|37709936|FG001|Overall Study|Lost to Follow-up|4|||
16771529|NCT02478398|37709935|FG000|Overall Study|Non-Compliance With Study Drug|5|||
16771530|NCT02478398|37709936|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16771531|NCT02478398|37709935|FG000|Overall Study|Protocol Violation|3|||
16771532|NCT02478398|37709936|FG001|Overall Study|Protocol Violation|1|||
16771533|NCT02478398|37709935|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
16771534|NCT02478398|37709936|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
16771535|NCT02478398|37709935|FG000|Overall Study|Withdrawal By Participant|10|||
16771536|NCT02478398|37709936|FG001|Overall Study|Withdrawal By Participant|4|||
16771537|NCT02478164|37709943|FG000|Overall Study|Lack of Efficacy|13|||
16771538|NCT02478164|37709943|FG000|Overall Study|Adverse Event|1|||
16771539|NCT02478164|37709943|FG000|Overall Study|Withdrawal by Subject|1|||
16771540|NCT02476994|37709949|FG000|Overall Study|Based on feedback from FDA|1|||
16771541|NCT02476994|37709950|FG001|Overall Study|Based on feedback from FDA|0|||
17028304|NCT00478231|38172714|FG000|Overall Study|Withdrawal by Subject|6|||
17028305|NCT00478231|38172714|FG000|Overall Study|Other|9|||
16771542|NCT02508194|37709958|FG000|Overall Study|Death|5|||
16771543|NCT02508194|37709959|FG001|Overall Study|Death|3|||
16771544|NCT02508194|37709958|FG000|Overall Study|Lost to Follow-up|25|||
16771545|NCT02508194|37709959|FG001|Overall Study|Lost to Follow-up|18|||
16771546|NCT02508194|37709958|FG000|Overall Study|Withdrawal by Subject|20|||
16771547|NCT02508194|37709959|FG001|Overall Study|Withdrawal by Subject|18|||
16771548|NCT02508194|37709958|FG000|Overall Study|Error in Randomization|1|||
16771549|NCT02508194|37709959|FG001|Overall Study|Error in Randomization|3|||
16771550|NCT02508194|37709958|FG000|Overall Study|Principal Investigator Decision|1|||
16771551|NCT02508194|37709959|FG001|Overall Study|Principal Investigator Decision|2|||
16771552|NCT02476916|37709967|FG000|Core Period|Adverse Event|2|||
16771553|NCT02476916|37709968|FG001|Core Period|Adverse Event|2|||
16771554|NCT02476916|37709967|FG000|Core Period|Investigator decision|1|||
16771555|NCT02476916|37709968|FG001|Core Period|Investigator decision|1|||
16771556|NCT02476916|37709967|FG000|Core Period|Withdrawal by Subject|3|||
16771557|NCT02476916|37709968|FG001|Core Period|Withdrawal by Subject|0|||
16771558|NCT02476916|37709967|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
16771559|NCT02476916|37709968|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
16771560|NCT02476916|37709967|FG000|Extension Period|On Treatment|12|||
16771561|NCT02476916|37709968|FG001|Extension Period|On Treatment|17|||
16771562|NCT02508116|37709977|FG000|Overall Study|Lost to Follow-up|2|||
16771563|NCT02508116|37709978|FG001|Overall Study|Lost to Follow-up|3|||
16771564|NCT02508116|37709977|FG000|Overall Study|Withdrawal by Subject|3|||
16771565|NCT02508116|37709978|FG001|Overall Study|Withdrawal by Subject|2|||
16771566|NCT02508116|37709977|FG000|Overall Study|Protocol Violation|1|||
16771567|NCT02508116|37709978|FG001|Overall Study|Protocol Violation|2|||
16771568|NCT02508116|37709977|FG000|Overall Study|Physician Decision|2|||
16771569|NCT02508116|37709978|FG001|Overall Study|Physician Decision|0|||
16771570|NCT01653782|37709987|FG000|Overall Study|Withdrawal by Subject|9|||
16771571|NCT01653782|37709988|FG001|Overall Study|Withdrawal by Subject|15|||
16771572|NCT01653782|37709989|FG002|Overall Study|Withdrawal by Subject|4|||
16771573|NCT01653782|37709987|FG000|Overall Study|Lost to Follow-up|7|||
16771574|NCT01653782|37709988|FG001|Overall Study|Lost to Follow-up|3|||
16771575|NCT01653782|37709989|FG002|Overall Study|Lost to Follow-up|2|||
16771576|NCT02318329|37710007|FG000|Overall Study|Progressive Disease|2|||
16771577|NCT02318329|37710008|FG001|Overall Study|Progressive Disease|3|||
16771578|NCT02318329|37710009|FG002|Overall Study|Progressive Disease|2|||
16771579|NCT02318329|37710010|FG003|Overall Study|Progressive Disease|3|||
16771580|NCT02318329|37710011|FG004|Overall Study|Progressive Disease|3|||
16771581|NCT02318329|37710012|FG005|Overall Study|Progressive Disease|3|||
16771582|NCT02318329|37710013|FG006|Overall Study|Progressive Disease|1|||
16771583|NCT02318329|37710014|FG007|Overall Study|Progressive Disease|1|||
16771584|NCT02318329|37710015|FG008|Overall Study|Progressive Disease|5|||
16771585|NCT02318329|37710016|FG009|Overall Study|Progressive Disease|39|||
16771586|NCT02318329|37710007|FG000|Overall Study|Death|0|||
16771587|NCT02318329|37710008|FG001|Overall Study|Death|0|||
16771588|NCT02318329|37710009|FG002|Overall Study|Death|0|||
16771589|NCT02318329|37710010|FG003|Overall Study|Death|0|||
16771590|NCT02318329|37710011|FG004|Overall Study|Death|0|||
16771591|NCT02318329|37710012|FG005|Overall Study|Death|0|||
16771592|NCT02318329|37710013|FG006|Overall Study|Death|0|||
16771593|NCT02318329|37710014|FG007|Overall Study|Death|0|||
16771594|NCT02318329|37710015|FG008|Overall Study|Death|0|||
16771595|NCT02318329|37710016|FG009|Overall Study|Death|5|||
16771596|NCT02318329|37710007|FG000|Overall Study|Lost to Follow-up|0|||
16771597|NCT02318329|37710008|FG001|Overall Study|Lost to Follow-up|0|||
16771598|NCT02318329|37710009|FG002|Overall Study|Lost to Follow-up|0|||
16771599|NCT02318329|37710010|FG003|Overall Study|Lost to Follow-up|0|||
16771600|NCT02318329|37710011|FG004|Overall Study|Lost to Follow-up|0|||
16771601|NCT02318329|37710012|FG005|Overall Study|Lost to Follow-up|0|||
16771602|NCT02318329|37710013|FG006|Overall Study|Lost to Follow-up|0|||
16771603|NCT02318329|37710014|FG007|Overall Study|Lost to Follow-up|0|||
16771604|NCT02318329|37710015|FG008|Overall Study|Lost to Follow-up|0|||
16771605|NCT02318329|37710016|FG009|Overall Study|Lost to Follow-up|1|||
16771606|NCT02318329|37710007|FG000|Overall Study|Withdrawal by Subject|0|||
16771607|NCT02318329|37710008|FG001|Overall Study|Withdrawal by Subject|0|||
16771608|NCT02318329|37710009|FG002|Overall Study|Withdrawal by Subject|0|||
16771609|NCT02318329|37710010|FG003|Overall Study|Withdrawal by Subject|0|||
16771610|NCT02318329|37710011|FG004|Overall Study|Withdrawal by Subject|0|||
16771611|NCT02318329|37710012|FG005|Overall Study|Withdrawal by Subject|0|||
16771612|NCT02318329|37710013|FG006|Overall Study|Withdrawal by Subject|0|||
16771613|NCT02318329|37710014|FG007|Overall Study|Withdrawal by Subject|0|||
16771614|NCT02318329|37710015|FG008|Overall Study|Withdrawal by Subject|0|||
16771615|NCT02318329|37710016|FG009|Overall Study|Withdrawal by Subject|6|||
16771616|NCT02318329|37710007|FG000|Overall Study|Other|1|||
16771617|NCT02318329|37710008|FG001|Overall Study|Other|1|||
16771618|NCT02318329|37710009|FG002|Overall Study|Other|1|||
16771619|NCT02318329|37710010|FG003|Overall Study|Other|0|||
16771620|NCT02318329|37710011|FG004|Overall Study|Other|0|||
16771621|NCT02318329|37710012|FG005|Overall Study|Other|0|||
16771622|NCT02318329|37710013|FG006|Overall Study|Other|0|||
16771623|NCT02318329|37710014|FG007|Overall Study|Other|0|||
16771624|NCT02318329|37710015|FG008|Overall Study|Other|1|||
16771625|NCT02318329|37710016|FG009|Overall Study|Other|1|||
16771626|NCT02255656|37710057|FG000|Overall Study|Adverse Event|11|||
16771627|NCT02255656|37710057|FG000|Overall Study|Poor compliance to protocol|3|||
16771628|NCT02255656|37710057|FG000|Overall Study|Lost to Follow-up|30|||
16771629|NCT02255656|37710057|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
16771630|NCT02255656|37710057|FG000|Overall Study|Other|126|||
16771631|NCT02255500|37710070|FG000|Overall Study|Withdrawal by Subject|1|||
16771632|NCT02255500|37710071|FG001|Overall Study|Withdrawal by Subject|0|||
16771633|NCT02505542|37710077|FG000|Part A: Open-Label Period|Adverse Event|31|||
16771634|NCT02505542|37710078|FG001|Part A: Open-Label Period|Adverse Event|0|||
16771635|NCT02505542|37710079|FG002|Part A: Open-Label Period|Adverse Event|0|||
16771636|NCT02505542|37710080|FG003|Part A: Open-Label Period|Adverse Event|0|||
16771637|NCT02505542|37710077|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
16771638|NCT02505542|37710078|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
16771639|NCT02505542|37710079|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
16771640|NCT02505542|37710080|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
16771641|NCT02505542|37710077|FG000|Part A: Open-Label Period|Protocol Violation|1|||
16771642|NCT02505542|37710078|FG001|Part A: Open-Label Period|Protocol Violation|0|||
16771643|NCT02505542|37710079|FG002|Part A: Open-Label Period|Protocol Violation|0|||
16771644|NCT02505542|37710080|FG003|Part A: Open-Label Period|Protocol Violation|0|||
16771645|NCT02505542|37710077|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
16771646|NCT02505542|37710078|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
16771647|NCT02505542|37710079|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
16771648|NCT02505542|37710080|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
16771649|NCT02505542|37710077|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
16771650|NCT02505542|37710078|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
16771651|NCT02505542|37710079|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
16771652|NCT02505542|37710080|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
16771653|NCT02505542|37710077|FG000|Part A: Open-Label Period|New medical history available|1|||
16771654|NCT02505542|37710078|FG001|Part A: Open-Label Period|New medical history available|0|||
16771655|NCT02505542|37710079|FG002|Part A: Open-Label Period|New medical history available|0|||
16771656|NCT02505542|37710080|FG003|Part A: Open-Label Period|New medical history available|0|||
16771657|NCT02505542|37710077|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
16771658|NCT02505542|37710078|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
16771659|NCT02505542|37710079|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
16771660|NCT02505542|37710080|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
16771661|NCT02505542|37710077|FG000|Part A: Open-Label Period|Pregnancy|2|||
16771662|NCT02505542|37710078|FG001|Part A: Open-Label Period|Pregnancy|0|||
16771663|NCT02505542|37710079|FG002|Part A: Open-Label Period|Pregnancy|0|||
16771664|NCT02505542|37710080|FG003|Part A: Open-Label Period|Pregnancy|0|||
16771665|NCT02505542|37710077|FG000|Part A: Open-Label Period|Sponsor directive|1|||
16771666|NCT02505542|37710078|FG001|Part A: Open-Label Period|Sponsor directive|0|||
16771667|NCT02505542|37710079|FG002|Part A: Open-Label Period|Sponsor directive|0|||
16771668|NCT02505542|37710080|FG003|Part A: Open-Label Period|Sponsor directive|0|||
16771669|NCT02505542|37710077|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
16771670|NCT02505542|37710078|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
16771671|NCT02505542|37710079|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
16771672|NCT02505542|37710080|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
16771673|NCT02505542|37710077|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
16771674|NCT02505542|37710078|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
16771675|NCT02505542|37710079|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
16771676|NCT02505542|37710080|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
16771677|NCT02505542|37710077|FG000|Part A: Open-Label Period|Non-compliance|1|||
16771678|NCT02505542|37710078|FG001|Part A: Open-Label Period|Non-compliance|0|||
16771679|NCT02505542|37710079|FG002|Part A: Open-Label Period|Non-compliance|0|||
16771680|NCT02505542|37710080|FG003|Part A: Open-Label Period|Non-compliance|0|||
16771681|NCT02505542|37710077|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
16771682|NCT02505542|37710078|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
16771683|NCT02505542|37710079|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
16771684|NCT02505542|37710080|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
16771685|NCT02505542|37710077|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
16771686|NCT02505542|37710078|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
16771687|NCT02505542|37710079|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
16856707|NCT01968551|37810326|FG001|Extension Phase|Adverse Event|0|||
17028306|NCT00478231|38172714|FG000|Overall Study|Adverse Event|5|||
16771688|NCT02505542|37710080|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
16771689|NCT02505542|37710077|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
16771690|NCT02505542|37710078|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
16771691|NCT02505542|37710079|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
16771692|NCT02505542|37710080|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
16771693|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Adverse Event|0|||
16771694|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Adverse Event|0|||
16771695|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Adverse Event|1|||
16771696|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Adverse Event|3|||
16771697|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
16771698|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
16771699|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
16771700|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
16771701|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
16771702|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
16771703|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
16771704|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
16771705|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
16771706|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
16771707|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
16771708|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
16771709|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
16771710|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
16771711|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
16771712|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
16771713|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
16771714|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
16771715|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
16771716|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
16771717|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
16771718|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
16771719|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
16771720|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
16771721|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Miscalculation|0|||
16771722|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Miscalculation|1|||
16771723|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Miscalculation|0|||
16771724|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Miscalculation|0|||
16771725|NCT02505542|37710077|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
16771726|NCT02505542|37710078|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
16771727|NCT02505542|37710079|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
16771728|NCT02505542|37710080|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
16771729|NCT02475980|37710129|FG000|Overall Study|Lost to Follow-up|4|||
16771730|NCT02475980|37710129|FG000|Overall Study|Withdrawal by Subject|1|||
16771731|NCT02447432|37710135|FG000|Epoch 001|Adverse Event|1|||
16771732|NCT02447432|37710136|FG001|Epoch 001|Adverse Event|1|||
16771733|NCT02447432|37710135|FG000|Epoch 001|Withdrawal by Subject|0|||
16771734|NCT02447432|37710136|FG001|Epoch 001|Withdrawal by Subject|4|||
16771735|NCT02447432|37710135|FG000|Epoch 001|Migrated/moved from study area|3|||
16771736|NCT02447432|37710136|FG001|Epoch 001|Migrated/moved from study area|5|||
16771737|NCT02447432|37710135|FG000|Epoch 001|Lost to Follow-up|1|||
16771738|NCT02447432|37710136|FG001|Epoch 001|Lost to Follow-up|3|||
16771739|NCT02446886|37710144|FG000|Overall Study|Adverse Event|1|||
16771740|NCT02446886|37710145|FG001|Overall Study|Adverse Event|3|||
16771741|NCT02446886|37710144|FG000|Overall Study|Withdrawal by Subject|1|||
16771742|NCT02446886|37710145|FG001|Overall Study|Withdrawal by Subject|1|||
16771743|NCT03448939|37710163|FG000|Overall Study|Adverse Event|5|||
16771744|NCT03448939|37710164|FG001|Overall Study|Adverse Event|1|||
16771745|NCT03448939|37710163|FG000|Overall Study|Lost to Follow-up|6|||
16771746|NCT03448939|37710164|FG001|Overall Study|Lost to Follow-up|6|||
16771747|NCT03448939|37710163|FG000|Overall Study|Pregnancy|1|||
16771748|NCT03448939|37710164|FG001|Overall Study|Pregnancy|1|||
16771749|NCT03448939|37710163|FG000|Overall Study|Withdrawal by Subject|9|||
16771750|NCT03448939|37710164|FG001|Overall Study|Withdrawal by Subject|3|||
16771751|NCT02504294|37710182|FG000|Overall Study|Adverse Event|15|||
16771752|NCT02504294|37710183|FG001|Overall Study|Adverse Event|12|||
16771753|NCT02504294|37710182|FG000|Overall Study|Withdrawal by Subject|7|||
16771754|NCT02504294|37710183|FG001|Overall Study|Withdrawal by Subject|1|||
16771755|NCT02504294|37710182|FG000|Overall Study|Protocol Violation|27|||
16771756|NCT02504294|37710183|FG001|Overall Study|Protocol Violation|26|||
16771757|NCT02504294|37710182|FG000|Overall Study|Physician Decision|1|||
16771758|NCT02504294|37710183|FG001|Overall Study|Physician Decision|2|||
16771759|NCT02504294|37710182|FG000|Overall Study|Lost to Follow-up|6|||
16771760|NCT02504294|37710183|FG001|Overall Study|Lost to Follow-up|7|||
16771761|NCT02446418|37710191|FG000|Overall Study|Adverse Event|4|||
16771762|NCT02446418|37710192|FG001|Overall Study|Adverse Event|8|||
16771763|NCT02446418|37710191|FG000|Overall Study|Physician Decision|5|||
16771764|NCT02446418|37710192|FG001|Overall Study|Physician Decision|1|||
16771765|NCT02446418|37710191|FG000|Overall Study|Withdrawal by Subject|3|||
16771766|NCT02446418|37710192|FG001|Overall Study|Withdrawal by Subject|3|||
16771767|NCT02446418|37710191|FG000|Overall Study|Lost to Follow-up|2|||
16771768|NCT02446418|37710192|FG001|Overall Study|Lost to Follow-up|2|||
16771769|NCT02446418|37710191|FG000|Overall Study|Protocol Violation|1|||
16771770|NCT02446418|37710192|FG001|Overall Study|Protocol Violation|2|||
16771771|NCT02446418|37710191|FG000|Overall Study|Lack of Efficacy|2|||
16771772|NCT02446418|37710192|FG001|Overall Study|Lack of Efficacy|0|||
16771773|NCT02446418|37710191|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
16771774|NCT02446418|37710192|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
16771775|NCT02255422|37710205|FG000|Overall Study|Withdrawal by Subject|0|||
16771776|NCT02255422|37710206|FG001|Overall Study|Withdrawal by Subject|0|||
16771777|NCT02255422|37710207|FG002|Overall Study|Withdrawal by Subject|0|||
16771778|NCT02255422|37710208|FG003|Overall Study|Withdrawal by Subject|0|||
16771779|NCT02255422|37710209|FG004|Overall Study|Withdrawal by Subject|0|||
16771780|NCT02255422|37710210|FG005|Overall Study|Withdrawal by Subject|0|||
16771781|NCT02255422|37710211|FG006|Overall Study|Withdrawal by Subject|2|||
16771782|NCT02255422|37710205|FG000|Overall Study|Lost to Follow-up|0|||
16771783|NCT02255422|37710206|FG001|Overall Study|Lost to Follow-up|0|||
16771784|NCT02255422|37710207|FG002|Overall Study|Lost to Follow-up|1|||
16771785|NCT02255422|37710208|FG003|Overall Study|Lost to Follow-up|0|||
16771786|NCT02255422|37710209|FG004|Overall Study|Lost to Follow-up|0|||
16771787|NCT02255422|37710210|FG005|Overall Study|Lost to Follow-up|0|||
16771788|NCT02255422|37710211|FG006|Overall Study|Lost to Follow-up|0|||
16771789|NCT02445794|37710231|FG000|Overall Study|Adverse Event|0|||
16771790|NCT02445794|37710232|FG001|Overall Study|Adverse Event|0|||
16771791|NCT02445794|37710233|FG002|Overall Study|Adverse Event|2|||
16771792|NCT02445794|37710234|FG003|Overall Study|Adverse Event|0|||
16771793|NCT02475278|37710249|FG000|Overall Study|Lost to Follow-up|1|||
16771794|NCT02475278|37710249|FG000|Overall Study|Reason Not Specified|1|||
16771795|NCT02254486|37710255|FG000|Overall Study|Adverse Event|1|||
16771796|NCT02254486|37710256|FG001|Overall Study|Adverse Event|1|||
16771797|NCT02254486|37710255|FG000|Overall Study|Lack of Efficacy|1|||
16771798|NCT02254486|37710256|FG001|Overall Study|Lack of Efficacy|0|||
16771799|NCT02254486|37710255|FG000|Overall Study|Lost to Follow-up|2|||
16771800|NCT02254486|37710256|FG001|Overall Study|Lost to Follow-up|4|||
16771801|NCT02254486|37710255|FG000|Overall Study|Protocol Violation|1|||
16771802|NCT02254486|37710256|FG001|Overall Study|Protocol Violation|2|||
16771803|NCT02254486|37710255|FG000|Overall Study|Withdrawal by Subject|17|||
16771804|NCT02254486|37710256|FG001|Overall Study|Withdrawal by Subject|15|||
16771805|NCT02254486|37710255|FG000|Overall Study|GFR<60mL/min|16|||
16771806|NCT02254486|37710256|FG001|Overall Study|GFR<60mL/min|21|||
16771807|NCT02254486|37710255|FG000|Overall Study|Various|12|||
16771808|NCT02254486|37710256|FG001|Overall Study|Various|12|||
16771809|NCT01641640|37710262|FG000|Overall Study|Enrolled but not treated|1|||
16771810|NCT01641640|37710262|FG000|Overall Study|Efficacy failure|29|||
16771811|NCT01641640|37710262|FG000|Overall Study|Lost to Follow-up|3|||
16771812|NCT01641640|37710262|FG000|Overall Study|Withdrawal by Subject|2|||
16771813|NCT01641640|37710262|FG000|Overall Study|Adverse Event|1|||
16771814|NCT01639144|37710268|FG000|Overall Study|Withdrawal by Subject|4|||
16771815|NCT01639144|37710269|FG001|Overall Study|Withdrawal by Subject|2|||
16771816|NCT01639144|37710268|FG000|Overall Study|Physician Decision|2|||
16771817|NCT01639144|37710269|FG001|Overall Study|Physician Decision|0|||
16771818|NCT01639144|37710268|FG000|Overall Study|Met postoperative exclusion criteria|4|||
16771819|NCT01639144|37710269|FG001|Overall Study|Met postoperative exclusion criteria|3|||
16771820|NCT01601626|37710278|FG000|Overall Study|Death|1|||
16771821|NCT01601626|37710279|FG001|Overall Study|Death|1|||
16771822|NCT01601626|37710280|FG002|Overall Study|Death|1|||
16771823|NCT01601626|37710278|FG000|Overall Study|Lost to Follow-up|1|||
16771824|NCT01601626|37710279|FG001|Overall Study|Lost to Follow-up|2|||
16771825|NCT01601626|37710280|FG002|Overall Study|Lost to Follow-up|0|||
16771826|NCT01601626|37710278|FG000|Overall Study|Unable to Get to Clinic|0|||
16771827|NCT01601626|37710279|FG001|Overall Study|Unable to Get to Clinic|1|||
16771828|NCT01601626|37710280|FG002|Overall Study|Unable to Get to Clinic|0|||
16771829|NCT01601626|37710278|FG000|Overall Study|Withdrawal by Subject|0|||
16771830|NCT01601626|37710279|FG001|Overall Study|Withdrawal by Subject|1|||
16771831|NCT01601626|37710280|FG002|Overall Study|Withdrawal by Subject|1|||
16771832|NCT01601626|37710278|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
16771833|NCT01601626|37710279|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
16771834|NCT01601626|37710280|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
16771835|NCT02737501|37710290|FG000|Randomized Phase|Died|41|||
16771836|NCT02737501|37710291|FG001|Randomized Phase|Died|29|||
16771837|NCT02737501|37710292|FG002|Randomized Phase|Died|0|||
16771838|NCT02737501|37710290|FG000|Randomized Phase|Withdrawal by Subject|16|||
16771839|NCT02737501|37710291|FG001|Randomized Phase|Withdrawal by Subject|6|||
16771840|NCT02737501|37710292|FG002|Randomized Phase|Withdrawal by Subject|0|||
16771841|NCT02737501|37710290|FG000|Randomized Phase|Lost to Follow-up|0|||
16771842|NCT02737501|37710291|FG001|Randomized Phase|Lost to Follow-up|1|||
16771843|NCT02737501|37710292|FG002|Randomized Phase|Lost to Follow-up|0|||
16771844|NCT02737501|37710290|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
16771845|NCT02737501|37710291|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
16771846|NCT02737501|37710292|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
16771847|NCT02737501|37710290|FG000|Randomized Phase|Reason not Specified|1|||
16771848|NCT02737501|37710291|FG001|Randomized Phase|Reason not Specified|1|||
16771849|NCT02737501|37710292|FG002|Randomized Phase|Reason not Specified|0|||
16771850|NCT02737501|37710290|FG000|Randomized Phase|Never Treated|1|||
16771851|NCT02737501|37710291|FG001|Randomized Phase|Never Treated|1|||
16771852|NCT02737501|37710292|FG002|Randomized Phase|Never Treated|0|||
16771853|NCT02737501|37710290|FG000|Crossover Phase|Died|0|||
16771854|NCT02737501|37710291|FG001|Crossover Phase|Died|0|||
16771855|NCT02737501|37710292|FG002|Crossover Phase|Died|22|||
16771856|NCT02737501|37710290|FG000|Crossover Phase|Withdrew Consent|0|||
16771857|NCT02737501|37710291|FG001|Crossover Phase|Withdrew Consent|0|||
16771858|NCT02737501|37710292|FG002|Crossover Phase|Withdrew Consent|9|||
16771859|NCT02737501|37710290|FG000|Crossover Phase|Physician Decision|0|||
16771860|NCT02737501|37710291|FG001|Crossover Phase|Physician Decision|0|||
16771861|NCT02737501|37710292|FG002|Crossover Phase|Physician Decision|1|||
16771862|NCT02737501|37710290|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
16771863|NCT02737501|37710291|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
16771864|NCT02737501|37710292|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
16771865|NCT01640314|37710302|FG000|Overall Study|Protocol Violation|0|||
16771866|NCT01640314|37710303|FG001|Overall Study|Protocol Violation|1|||
16771867|NCT02740049|37710385|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
16771868|NCT01601704|37710391|FG000|Overall Study|Randomized but not dispensed study med|1|||
16771869|NCT01601704|37710392|FG001|Overall Study|Randomized but not dispensed study med|4|||
16771870|NCT04969276|37710401|FG000|Overall Study|Protocol Deviation|0|||
16771871|NCT04969276|37710402|FG001|Overall Study|Protocol Deviation|1|||
16771872|NCT04969276|37710403|FG002|Overall Study|Protocol Deviation|0|||
16771873|NCT04969276|37710401|FG000|Overall Study|Withdrawal by Subject|1|||
16771874|NCT04969276|37710402|FG001|Overall Study|Withdrawal by Subject|10|||
16771875|NCT04969276|37710403|FG002|Overall Study|Withdrawal by Subject|0|||
16771876|NCT04969276|37710401|FG000|Overall Study|Lost to Follow-up|0|||
16771877|NCT04969276|37710402|FG001|Overall Study|Lost to Follow-up|1|||
16771878|NCT04969276|37710403|FG002|Overall Study|Lost to Follow-up|0|||
16771879|NCT01601470|37710411|FG000|Period 2 - LCZ696|Physician Decision|1|||
16771880|NCT03275285|37710437|FG000|Overall Study|Ongoing|61|||
16771881|NCT03275285|37710438|FG001|Overall Study|Ongoing|105|||
16771882|NCT03248375|37710448|FG000|Overall Study|Lost to Follow-up|5|||
16771883|NCT01637272|37710452|FG000|Overall Study|Adverse Event|6|||
16771884|NCT01637272|37710452|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16771885|NCT01637272|37710452|FG000|Overall Study|Withdrawal by Subject|3|||
16771886|NCT01637272|37710452|FG000|Overall Study|Lost to Follow-up|2|||
16771887|NCT01637272|37710452|FG000|Overall Study|completed core, did not enter ext. phase|4|||
16771888|NCT01637272|37710452|FG000|Overall Study|Administrative problems|1|||
16771889|NCT01637272|37710452|FG000|Overall Study|Protocol Violation|2|||
16856708|NCT01968551|37810327|FG002|Extension Phase|Adverse Event|2|||
16856709|NCT01968551|37810325|FG000|Extension Phase|Death|0|||
16771890|NCT01636960|37710471|FG000|Induction Phase|Adverse Event|2|||
16771891|NCT01636960|37710471|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
16771892|NCT01636960|37710471|FG000|Maintenance Phase|Adverse Event|3|||
16771893|NCT01636960|37710471|FG000|Maintenance Phase|Progressive disease|1|||
16771894|NCT01636258|37710477|FG000|Overall Study|Lost to Follow-up|1|||
16771895|NCT01636258|37710478|FG001|Overall Study|Lost to Follow-up|0|||
16771896|NCT02504216|37710487|FG000|Overall Study|Lost to Follow-up|3|||
16771897|NCT02504216|37710488|FG001|Overall Study|Lost to Follow-up|3|||
16771898|NCT02504216|37710487|FG000|Overall Study|Withdrawal by Subject|8|||
16771899|NCT02504216|37710488|FG001|Overall Study|Withdrawal by Subject|12|||
16771900|NCT04354870|37710496|FG000|Overall Study|Lost to Follow-up|32|||
16771901|NCT04354870|37710497|FG001|Overall Study|Lost to Follow-up|12|||
16771902|NCT04354870|37710496|FG000|Overall Study|Withdrawal by Subject|10|||
16771903|NCT04354870|37710497|FG001|Overall Study|Withdrawal by Subject|16|||
16771904|NCT04354870|37710496|FG000|Overall Study|Did not complete all study visits|6|||
16771905|NCT04354870|37710497|FG001|Overall Study|Did not complete all study visits|5|||
16771906|NCT02473952|37710505|FG000|Overall Study|Adverse Event|2|||
16771907|NCT02473952|37710506|FG001|Overall Study|Adverse Event|2|||
16771908|NCT02473952|37710505|FG000|Overall Study|Withdrawal by Subject|0|||
16771909|NCT02473952|37710506|FG001|Overall Study|Withdrawal by Subject|6|||
16771910|NCT02473640|37710512|FG000|Treatment Period 1|Adverse Event|1|||
16771911|NCT01637584|37710521|FG000|Overall Study|Withdrawal by Subject|1|||
16771912|NCT01637584|37710522|FG001|Overall Study|Withdrawal by Subject|3|||
16771913|NCT03883906|37710529|FG000|Overall Study|Withdrawal by Subject|2|||
16771914|NCT03883906|37710529|FG000|Overall Study|Physician Decision|5|||
16771915|NCT03875092|37710535|FG000|Overall Study|Adverse Event|2|||
16771916|NCT03875092|37710536|FG001|Overall Study|Adverse Event|5|||
16771917|NCT03875092|37710535|FG000|Overall Study|Death|28|||
16771918|NCT03875092|37710536|FG001|Overall Study|Death|41|||
16771919|NCT03875092|37710535|FG000|Overall Study|Ongoing in Study|35|||
16771920|NCT03875092|37710536|FG001|Overall Study|Ongoing in Study|14|||
16771921|NCT02503202|37710547|FG000|Base Study: Up to Month 6|Death|1|||
16771922|NCT02503202|37710548|FG001|Base Study: Up to Month 6|Death|1|||
16771923|NCT02503202|37710549|FG002|Base Study: Up to Month 6|Death|0|||
16771924|NCT02503202|37710550|FG003|Base Study: Up to Month 6|Death|0|||
16771925|NCT02503202|37710551|FG004|Base Study: Up to Month 6|Death|0|||
16771926|NCT02503202|37710547|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
16771927|NCT02503202|37710548|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
16771928|NCT02503202|37710549|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
16771929|NCT02503202|37710550|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
16771930|NCT02503202|37710551|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
16771931|NCT02503202|37710547|FG000|Base Study: Up to Month 6|Physician Decision|0|||
16771932|NCT02503202|37710548|FG001|Base Study: Up to Month 6|Physician Decision|0|||
16771933|NCT02503202|37710549|FG002|Base Study: Up to Month 6|Physician Decision|0|||
16771934|NCT02503202|37710550|FG003|Base Study: Up to Month 6|Physician Decision|0|||
16771935|NCT02503202|37710551|FG004|Base Study: Up to Month 6|Physician Decision|1|||
16771936|NCT02503202|37710547|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
16771937|NCT02503202|37710548|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
16771938|NCT02503202|37710549|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
16771939|NCT02503202|37710550|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
16771940|NCT02503202|37710551|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
16771941|NCT02503202|37710547|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
16771942|NCT02503202|37710548|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
16771943|NCT02503202|37710549|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
16771944|NCT02503202|37710550|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
16771945|NCT02503202|37710551|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
16771946|NCT02503202|37710547|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
16771947|NCT02503202|37710548|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
16771948|NCT02503202|37710549|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
16771949|NCT02503202|37710550|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
16771950|NCT02503202|37710551|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
16771951|NCT02503202|37710547|FG000|Extension: Month 6 to 24|Death|1|||
16771952|NCT02503202|37710548|FG001|Extension: Month 6 to 24|Death|0|||
16771953|NCT02503202|37710549|FG002|Extension: Month 6 to 24|Death|0|||
16771954|NCT02503202|37710550|FG003|Extension: Month 6 to 24|Death|0|||
16771955|NCT02503202|37710551|FG004|Extension: Month 6 to 24|Death|0|||
16771956|NCT02503202|37710547|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
16771957|NCT02503202|37710548|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
16771958|NCT02503202|37710549|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
16771959|NCT02503202|37710550|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
16771960|NCT02503202|37710551|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
16771961|NCT02503202|37710547|FG000|Extension: Month 6 to 24|Physician Decision|1|||
16771962|NCT02503202|37710548|FG001|Extension: Month 6 to 24|Physician Decision|0|||
16771963|NCT02503202|37710549|FG002|Extension: Month 6 to 24|Physician Decision|1|||
16771964|NCT02503202|37710550|FG003|Extension: Month 6 to 24|Physician Decision|3|||
16771965|NCT02503202|37710551|FG004|Extension: Month 6 to 24|Physician Decision|0|||
16771966|NCT02503202|37710547|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
16771967|NCT02503202|37710548|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
16771968|NCT02503202|37710549|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
16771969|NCT02503202|37710550|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
16771970|NCT02503202|37710551|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
16771971|NCT02728102|37710566|FG000|Overall Study|Death|3|||
16771972|NCT02728102|37710567|FG001|Overall Study|Death|0|||
16771973|NCT02728102|37710568|FG002|Overall Study|Death|1|||
16771974|NCT02728102|37710566|FG000|Overall Study|Withdrawal by Subject|0|||
16771975|NCT02728102|37710567|FG001|Overall Study|Withdrawal by Subject|2|||
16771976|NCT02728102|37710568|FG002|Overall Study|Withdrawal by Subject|3|||
16771977|NCT02728102|37710566|FG000|Overall Study|Physician Decision|1|||
16771978|NCT02728102|37710567|FG001|Overall Study|Physician Decision|1|||
16771979|NCT02728102|37710568|FG002|Overall Study|Physician Decision|0|||
16771980|NCT02728102|37710566|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
16771981|NCT02728102|37710567|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
16771982|NCT02728102|37710568|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
16771983|NCT02728102|37710566|FG000|Overall Study|Covid|0|||
16771984|NCT02728102|37710567|FG001|Overall Study|Covid|0|||
16771985|NCT02728102|37710568|FG002|Overall Study|Covid|1|||
16771986|NCT02502734|37710577|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
16771987|NCT02502734|37710578|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
16771988|NCT02502734|37710577|FG000|Washout Period|Adverse Event|1|||
16771989|NCT02502734|37710578|FG001|Washout Period|Adverse Event|0|||
16771990|NCT02473250|37710586|FG000|Overall Study|Lost to Follow-up|10|||
16771991|NCT02473250|37710586|FG000|Overall Study|Physician Decision|5|||
16771992|NCT02473250|37710586|FG000|Overall Study|Did not tolerate medication washout|3|||
16771993|NCT02473250|37710586|FG000|Overall Study|Antidepressant effect of divalproex|2|||
16771994|NCT02501642|37710593|FG000|Overall Study|Lost to Follow-up|7|||
16771995|NCT02501642|37710594|FG001|Overall Study|Lost to Follow-up|11|||
16771996|NCT02706730|37710600|FG000|Overall Study|Adverse Event|3|||
16771997|NCT02706730|37710600|FG000|Overall Study|Lack of Efficacy|5|||
16771998|NCT02706730|37710600|FG000|Overall Study|Withdrawal by Subject|11|||
16771999|NCT02706730|37710600|FG000|Overall Study|Study Terminated by Sponsor|11|||
16772000|NCT02706730|37710600|FG000|Overall Study|Subject chose not to receive injection|3|||
16772001|NCT02443688|37710607|FG000|Overall Study|Adverse Event|2|||
16772002|NCT02443688|37710608|FG001|Overall Study|Adverse Event|3|||
16772003|NCT02443688|37710609|FG002|Overall Study|Adverse Event|2|||
16772004|NCT02443688|37710607|FG000|Overall Study|Lost to Follow-up|1|||
16772005|NCT02443688|37710608|FG001|Overall Study|Lost to Follow-up|0|||
16772006|NCT02443688|37710609|FG002|Overall Study|Lost to Follow-up|0|||
16772007|NCT02443688|37710607|FG000|Overall Study|Physician Decision|3|||
16772008|NCT02443688|37710608|FG001|Overall Study|Physician Decision|0|||
16772009|NCT02443688|37710609|FG002|Overall Study|Physician Decision|1|||
16772010|NCT02443688|37710607|FG000|Overall Study|Pregnancy|0|||
16772011|NCT02443688|37710608|FG001|Overall Study|Pregnancy|0|||
16772012|NCT02443688|37710609|FG002|Overall Study|Pregnancy|1|||
16772013|NCT02443688|37710607|FG000|Overall Study|Withdrawal by Subject|3|||
16772014|NCT02443688|37710608|FG001|Overall Study|Withdrawal by Subject|3|||
16772015|NCT02443688|37710609|FG002|Overall Study|Withdrawal by Subject|4|||
16772016|NCT02443688|37710607|FG000|Overall Study|Non-compliance with study drug|1|||
16772017|NCT02443688|37710608|FG001|Overall Study|Non-compliance with study drug|2|||
16772018|NCT02443688|37710609|FG002|Overall Study|Non-compliance with study drug|4|||
16772019|NCT02443688|37710607|FG000|Overall Study|Sponsor Request|2|||
16772020|NCT02443688|37710608|FG001|Overall Study|Sponsor Request|1|||
16772021|NCT02443688|37710609|FG002|Overall Study|Sponsor Request|0|||
16772022|NCT02443298|37710623|FG000|Overall Study|Adverse Event|3|||
16772023|NCT02443298|37710624|FG001|Overall Study|Adverse Event|3|||
16772024|NCT02443298|37710623|FG000|Overall Study|Withdrawal by Subject|1|||
16772025|NCT02443298|37710624|FG001|Overall Study|Withdrawal by Subject|2|||
16772026|NCT02500706|37710633|FG000|Overall Study|Adverse Event|0|||
16772027|NCT02500706|37710634|FG001|Overall Study|Adverse Event|0|||
16772028|NCT02500706|37710635|FG002|Overall Study|Adverse Event|1|||
16772029|NCT02500706|37710633|FG000|Overall Study|Lost to Follow-up|0|||
16772030|NCT02500706|37710634|FG001|Overall Study|Lost to Follow-up|1|||
16772031|NCT02500706|37710635|FG002|Overall Study|Lost to Follow-up|1|||
16772032|NCT02500706|37710633|FG000|Overall Study|Withdrawal by Subject|4|||
16772033|NCT02500706|37710634|FG001|Overall Study|Withdrawal by Subject|6|||
16772034|NCT02500706|37710635|FG002|Overall Study|Withdrawal by Subject|4|||
16772035|NCT02500706|37710633|FG000|Overall Study|Unclassified|0|||
16772036|NCT02500706|37710634|FG001|Overall Study|Unclassified|0|||
16772037|NCT02500706|37710635|FG002|Overall Study|Unclassified|1|||
16772038|NCT02442830|37710645|FG000|Overall Study|Technical Failure|0|||
16772039|NCT02442830|37710646|FG001|Overall Study|Technical Failure|1|||
16772040|NCT02471612|37710653|FG000|Overall Study|Lost to Follow-up|2|||
16772041|NCT02500550|37710670|FG000|Overall Study|Death|7|||
16772042|NCT03775486|37710676|FG000|Initial Therapy Phase|Other reason provided|0|||
16772043|NCT03775486|37710677|FG001|Initial Therapy Phase|Other reason provided|15|||
16772044|NCT03775486|37710676|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
16772045|NCT03775486|37710677|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
16772046|NCT03775486|37710676|FG000|Initial Therapy Phase|Protocol Violation|0|||
16772047|NCT03775486|37710677|FG001|Initial Therapy Phase|Protocol Violation|2|||
16772048|NCT03775486|37710676|FG000|Initial Therapy Phase|Adverse Event|0|||
16772049|NCT03775486|37710677|FG001|Initial Therapy Phase|Adverse Event|34|||
16772050|NCT03775486|37710676|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
16772051|NCT03775486|37710677|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
16772052|NCT03775486|37710676|FG000|Maintenance Phase|Withdrawal by Subject|13|||
16772053|NCT03775486|37710677|FG001|Maintenance Phase|Withdrawal by Subject|12|||
16772054|NCT03775486|37710676|FG000|Maintenance Phase|Death|44|||
16772055|NCT03775486|37710677|FG001|Maintenance Phase|Death|45|||
16772056|NCT02499770|37710686|FG000|Overall Study|Death|17|||
16772057|NCT02499770|37710687|FG001|Overall Study|Death|56|||
16772058|NCT02499770|37710686|FG000|Overall Study|Study completion|1|||
16772059|NCT02499770|37710687|FG001|Overall Study|Study completion|10|||
16772060|NCT02499770|37710686|FG000|Overall Study|Withdrawal by Subject|0|||
16772061|NCT02499770|37710687|FG001|Overall Study|Withdrawal by Subject|7|||
16772062|NCT02499770|37710686|FG000|Overall Study|Lost to Follow-up|0|||
16772063|NCT02499770|37710687|FG001|Overall Study|Lost to Follow-up|2|||
16772064|NCT02499770|37710686|FG000|Overall Study|Subject declined further treatment|1|||
16772065|NCT02499770|37710687|FG001|Overall Study|Subject declined further treatment|0|||
16772066|NCT02499770|37710686|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
16772067|NCT02499770|37710687|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
16772068|NCT02499770|37710686|FG000|Overall Study|Randomized but not enrolled|0|||
16772069|NCT02499770|37710687|FG001|Overall Study|Randomized but not enrolled|1|||
16772070|NCT02442284|37710699|FG000|Overall Study|Adverse Event|1|||
16772071|NCT02442284|37710699|FG000|Overall Study|Withdrew Consent|2|||
16772072|NCT02442284|37710699|FG000|Overall Study|Lost to Follow-up|3|||
16772073|NCT02442284|37710699|FG000|Overall Study|Other|1|||
16772074|NCT02442206|37710709|FG000|Period 1|Adverse Event|1|||
16772075|NCT02442206|37710710|FG001|Period 1|Adverse Event|1|||
16772076|NCT02442206|37710709|FG000|Period 1|withdrew consent|0|||
16772077|NCT02442206|37710710|FG001|Period 1|withdrew consent|1|||
16772078|NCT02442206|37710709|FG000|Period 1|COPD exacerbation|0|||
16772079|NCT02442206|37710710|FG001|Period 1|COPD exacerbation|1|||
16772080|NCT02442206|37710709|FG000|Period 2|Adverse Event|1|||
16772081|NCT02442206|37710710|FG001|Period 2|Adverse Event|0|||
16772082|NCT02499146|37710717|FG000|Overall Study|Lost to Follow-up|1|||
16772083|NCT02499146|37710717|FG000|Overall Study|Withdrawal by Subject|1|||
16772084|NCT02499146|37710717|FG000|Overall Study|Other|2|||
16772085|NCT02499146|37710717|FG000|Overall Study|Ongoing at date of cut-off|9|||
16772086|NCT02499146|37710717|FG000|Overall Study|Began other treatment/therapy|13|||
16772087|NCT03544138|37710721|FG000|Overall Study|Lost to Follow-up|29|||
16772088|NCT01634854|37710727|FG000|Overall Study|Cesarean delivery|2|||
16772089|NCT01634854|37710728|FG001|Overall Study|Cesarean delivery|7|||
16772090|NCT02469896|37710736|FG000|Overall Study|Withdrawal by Subject|2|||
16772091|NCT02469896|37710737|FG001|Overall Study|Withdrawal by Subject|0|||
16772092|NCT02441114|37710747|FG000|Washout2|Withdrawal by Subject|4|||
16772093|NCT02498678|37710753|FG000|Overall Study|interference from the surgical team|0|||
16772094|NCT02498678|37710754|FG001|Overall Study|interference from the surgical team|2|||
16772095|NCT02441036|37710765|FG000|Overall Study|No tissue resected|0|||
16772096|NCT02441036|37710766|FG001|Overall Study|No tissue resected|1|||
16772097|NCT02441036|37710767|FG002|Overall Study|No tissue resected|0|||
16772098|NCT02441036|37710768|FG003|Overall Study|No tissue resected|1|||
16772099|NCT02441036|37710769|FG004|Overall Study|No tissue resected|0|||
16772100|NCT02498444|37710784|FG000|Overall Study|Withdrawal by Subject|3|||
16772101|NCT02498444|37710785|FG001|Overall Study|Withdrawal by Subject|0|||
16772102|NCT02498444|37710784|FG000|Overall Study|Physician Decision|1|||
16772103|NCT02498444|37710785|FG001|Overall Study|Physician Decision|0|||
16772104|NCT02497976|37710793|FG000|Overall Study|Withdrawal by Subject|2|||
16772105|NCT02497976|37710794|FG001|Overall Study|Withdrawal by Subject|0|||
16772106|NCT02497976|37710793|FG000|Overall Study|Moved out of area|0|||
16772107|NCT02497976|37710794|FG001|Overall Study|Moved out of area|1|||
16772108|NCT03347188|37710802|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
16772109|NCT03347188|37710803|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
16772110|NCT03347188|37710802|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
16772111|NCT03347188|37710803|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
16772112|NCT03347188|37710802|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
16772113|NCT03347188|37710803|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
16772114|NCT03347188|37710802|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
16772115|NCT03347188|37710803|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
16772116|NCT03347188|37710802|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
16772117|NCT03347188|37710803|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
16772118|NCT03347188|37710802|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
16772119|NCT03347188|37710803|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
16772120|NCT03347188|37710802|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
16772121|NCT03347188|37710803|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
16772122|NCT03347188|37710802|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
16772123|NCT03347188|37710803|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
16772124|NCT02440568|37710813|FG000|Overall Study|Death|1|||
16772125|NCT02440568|37710814|FG001|Overall Study|Death|3|||
16772126|NCT02440568|37710815|FG002|Overall Study|Death|4|||
16772127|NCT02440568|37710816|FG003|Overall Study|Death|2|||
16772128|NCT02440568|37710813|FG000|Overall Study|Lack of Efficacy|2|||
16772129|NCT02440568|37710814|FG001|Overall Study|Lack of Efficacy|0|||
16772130|NCT02440568|37710815|FG002|Overall Study|Lack of Efficacy|1|||
16772131|NCT02440568|37710816|FG003|Overall Study|Lack of Efficacy|0|||
16772132|NCT02440568|37710813|FG000|Overall Study|Lost to Follow-up|1|||
16772133|NCT02440568|37710814|FG001|Overall Study|Lost to Follow-up|0|||
16772134|NCT02440568|37710815|FG002|Overall Study|Lost to Follow-up|0|||
16772135|NCT02440568|37710816|FG003|Overall Study|Lost to Follow-up|0|||
16772136|NCT01038778|37710829|FG000|Overall Study|Withdrawal by Subject|0|||
16772137|NCT01038778|37710830|FG001|Overall Study|Withdrawal by Subject|2|||
16772138|NCT01038778|37710831|FG002|Overall Study|Withdrawal by Subject|3|||
16772139|NCT03090191|37710840|FG000|Overall Study|Adverse Event|90|||
16772140|NCT03090191|37710841|FG001|Overall Study|Adverse Event|72|||
16772141|NCT03090191|37710840|FG000|Overall Study|Death|365|||
16772142|NCT03090191|37710841|FG001|Overall Study|Death|358|||
16772143|NCT03090191|37710840|FG000|Overall Study|Lost to Follow-up|382|||
16772144|NCT03090191|37710841|FG001|Overall Study|Lost to Follow-up|394|||
16772145|NCT03090191|37710840|FG000|Overall Study|Physician Decision|77|||
16772146|NCT03090191|37710841|FG001|Overall Study|Physician Decision|66|||
16772147|NCT03090191|37710840|FG000|Overall Study|Protocol Violation|43|||
16772148|NCT03090191|37710841|FG001|Overall Study|Protocol Violation|52|||
16772149|NCT03090191|37710840|FG000|Overall Study|Withdrawal by Subject|2160|||
16772150|NCT03090191|37710841|FG001|Overall Study|Withdrawal by Subject|2133|||
16772151|NCT03090191|37710840|FG000|Overall Study|Site terminated|7|||
16772152|NCT03090191|37710841|FG001|Overall Study|Site terminated|8|||
16772153|NCT03090191|37710840|FG000|Overall Study|Other|66|||
16772154|NCT03090191|37710841|FG001|Overall Study|Other|60|||
16772155|NCT03090191|37710840|FG000|Overall Study|Withdrawn before any study vaccination|43|||
16772156|NCT03090191|37710841|FG001|Overall Study|Withdrawn before any study vaccination|52|||
16772157|NCT00646204|37710849|FG000|Overall Study|Adverse Event|3|||
16772158|NCT00646204|37710850|FG001|Overall Study|Adverse Event|0|||
16772159|NCT00646204|37710849|FG000|Overall Study|Withdrawal by Subject|1|||
16772160|NCT00646204|37710850|FG001|Overall Study|Withdrawal by Subject|0|||
16772161|NCT02439320|37710873|FG000|Overall Study|Adverse Event|0|||
16772162|NCT02439320|37710874|FG001|Overall Study|Adverse Event|2|||
16772163|NCT02439320|37710875|FG002|Overall Study|Adverse Event|0|||
16772164|NCT02439320|37710873|FG000|Overall Study|Lost to Follow-up|37|||
16772165|NCT02439320|37710874|FG001|Overall Study|Lost to Follow-up|34|||
16772166|NCT02439320|37710875|FG002|Overall Study|Lost to Follow-up|42|||
16772167|NCT02439320|37710873|FG000|Overall Study|Death|0|||
16772168|NCT02439320|37710874|FG001|Overall Study|Death|1|||
16772169|NCT02439320|37710875|FG002|Overall Study|Death|0|||
16772170|NCT02439320|37710873|FG000|Overall Study|Noncompliance with Protocol|10|||
16772171|NCT02439320|37710874|FG001|Overall Study|Noncompliance with Protocol|11|||
16772172|NCT02439320|37710875|FG002|Overall Study|Noncompliance with Protocol|7|||
16772173|NCT02439320|37710873|FG000|Overall Study|Pregnancy|0|||
16772174|NCT02439320|37710874|FG001|Overall Study|Pregnancy|1|||
16772175|NCT02439320|37710875|FG002|Overall Study|Pregnancy|1|||
16772176|NCT02439320|37710873|FG000|Overall Study|Withdrawal by Subject|12|||
16772177|NCT02439320|37710874|FG001|Overall Study|Withdrawal by Subject|16|||
16772178|NCT02439320|37710875|FG002|Overall Study|Withdrawal by Subject|14|||
16772179|NCT02439320|37710873|FG000|Overall Study|Physician Decision|2|||
16772180|NCT02439320|37710874|FG001|Overall Study|Physician Decision|1|||
16772181|NCT02439320|37710875|FG002|Overall Study|Physician Decision|0|||
16772182|NCT02439320|37710873|FG000|Overall Study|Sponsor Request|0|||
16772183|NCT02439320|37710874|FG001|Overall Study|Sponsor Request|2|||
17115481|NCT00352534|38253553|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
17115482|NCT00352534|38253554|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
17115483|NCT00352534|38253555|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
17115484|NCT00352534|38253549|FG000|Final Risk Group Assignment|Ineligible|0|||
17115485|NCT00352534|38253550|FG001|Final Risk Group Assignment|Ineligible|0|||
17115486|NCT00352534|38253551|FG002|Final Risk Group Assignment|Ineligible|3|||
17115487|NCT00352534|38253552|FG003|Final Risk Group Assignment|Ineligible|1|||
17115488|NCT00352534|38253553|FG004|Final Risk Group Assignment|Ineligible|0|||
17115489|NCT00352534|38253554|FG005|Final Risk Group Assignment|Ineligible|13|||
17115490|NCT00352534|38253555|FG006|Final Risk Group Assignment|Ineligible|0|||
17115491|NCT00352534|38253549|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
17115492|NCT00352534|38253550|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
17115493|NCT00352534|38253551|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
17115494|NCT00352534|38253552|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
17115495|NCT00352534|38253553|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
17115496|NCT00352534|38253554|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
17115497|NCT00352534|38253555|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
17115498|NCT00352534|38253549|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
17115499|NCT00352534|38253550|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
17115500|NCT00352534|38253551|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
17115501|NCT00352534|38253552|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
17115502|NCT00352534|38253553|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
17115503|NCT00352534|38253554|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
17115504|NCT00352534|38253555|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
17115505|NCT00352534|38253549|FG000|Final Risk Group Assignment|Death|0|||
17115506|NCT00352534|38253550|FG001|Final Risk Group Assignment|Death|0|||
17115507|NCT00352534|38253551|FG002|Final Risk Group Assignment|Death|0|||
17115508|NCT00352534|38253552|FG003|Final Risk Group Assignment|Death|0|||
17115509|NCT00352534|38253553|FG004|Final Risk Group Assignment|Death|0|||
17115510|NCT00352534|38253554|FG005|Final Risk Group Assignment|Death|2|||
17115511|NCT00352534|38253555|FG006|Final Risk Group Assignment|Death|0|||
17115512|NCT04323800|38253567|FG000|Overall Study|Withdrawal by Subject|4|||
17115513|NCT04323800|38253568|FG001|Overall Study|Withdrawal by Subject|4|||
17115514|NCT04323800|38253567|FG000|Overall Study|Incomplete transfusion|1|||
17115515|NCT04323800|38253568|FG001|Overall Study|Incomplete transfusion|0|||
17115516|NCT04323800|38253567|FG000|Overall Study|Other|0|||
17115517|NCT04323800|38253568|FG001|Overall Study|Other|1|||
17115518|NCT04323800|38253567|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
17115519|NCT04323800|38253568|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
17115520|NCT04321460|38253576|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
17115521|NCT04321460|38253577|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
17115522|NCT03122548|38253583|FG000|Overall Study|Death|2|||
17115523|NCT03122548|38253583|FG000|Overall Study|Progression - subject went into hospice|1|||
16772184|NCT02439320|37710875|FG002|Overall Study|Sponsor Request|1|||
16772185|NCT02439320|37710873|FG000|Overall Study|Randomization Failure|35|||
16772186|NCT02439320|37710874|FG001|Overall Study|Randomization Failure|46|||
16772187|NCT02439320|37710875|FG002|Overall Study|Randomization Failure|34|||
17115524|NCT03122548|38253583|FG000|Overall Study|Study Terminated by Sponsor|2|||
17115525|NCT04459598|38253589|FG000|Overall Study|Adverse Event|1|||
17115526|NCT04459598|38253590|FG001|Overall Study|Adverse Event|1|||
16772188|NCT02469038|37710891|FG000|Overall Study|Physician Decision|4|||
16772189|NCT02469038|37710892|FG001|Overall Study|Physician Decision|5|||
16772190|NCT02468648|37710898|FG000|Overall Study|Death|1|||
16772191|NCT02468414|37710904|FG000|Overall Study|Early Study Termination by Sponsor|1|||
16772192|NCT02468414|37710905|FG001|Overall Study|Early Study Termination by Sponsor|0|||
16772193|NCT02468414|37710904|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
16772194|NCT02468414|37710905|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
16772195|NCT02468414|37710904|FG000|Overall Study|Screen Failure|1|||
16772196|NCT02468414|37710905|FG001|Overall Study|Screen Failure|0|||
16772197|NCT02466386|37710911|FG000|Overall Study|Adverse Event|5|||
16772198|NCT02466386|37710911|FG000|Overall Study|Protocol Violation|2|||
16772199|NCT02466386|37710911|FG000|Overall Study|Withdrawal by Subject|14|||
16772200|NCT02466386|37710911|FG000|Overall Study|Lost to Follow-up|5|||
16772201|NCT02466386|37710911|FG000|Overall Study|Lack of Efficacy|8|||
16772202|NCT02466386|37710911|FG000|Overall Study|Other|10|||
16772211|NCT01633060|37710928|FG000|Randomization Phase|Protocol deviation|1|||
16772212|NCT01633060|37710929|FG001|Randomization Phase|Protocol deviation|2|||
16772213|NCT01633060|37710928|FG000|Randomization Phase|Technical problem|0|||
16772214|NCT01633060|37710929|FG001|Randomization Phase|Technical problem|1|||
16772215|NCT01633060|37710928|FG000|Treatment Phase|Adverse Event|24|||
16772216|NCT01633060|37710929|FG001|Treatment Phase|Adverse Event|3|||
16772217|NCT01633060|37710928|FG000|Treatment Phase|Lost to Follow-up|1|||
16772218|NCT01633060|37710929|FG001|Treatment Phase|Lost to Follow-up|0|||
16772219|NCT01633060|37710928|FG000|Treatment Phase|Physician Decision|16|||
16772220|NCT01633060|37710929|FG001|Treatment Phase|Physician Decision|7|||
16772221|NCT01633060|37710928|FG000|Treatment Phase|Progressive Disease|210|||
16772222|NCT01633060|37710929|FG001|Treatment Phase|Progressive Disease|120|||
16772223|NCT01633060|37710928|FG000|Treatment Phase|Protocol Deviation|1|||
16772224|NCT01633060|37710929|FG001|Treatment Phase|Protocol Deviation|0|||
16772225|NCT01633060|37710928|FG000|Treatment Phase|Study Terminated by sponsor|7|||
16772226|NCT01633060|37710929|FG001|Treatment Phase|Study Terminated by sponsor|3|||
16772227|NCT01633060|37710928|FG000|Treatment Phase|Subject/guardian decision|25|||
16772228|NCT01633060|37710929|FG001|Treatment Phase|Subject/guardian decision|4|||
16772229|NCT01633060|37710928|FG000|Treatment Phase|Death|4|||
16772230|NCT01633060|37710929|FG001|Treatment Phase|Death|3|||
16772231|NCT01633060|37710928|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
16772232|NCT01633060|37710929|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16772233|NCT01633060|37710928|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
16772234|NCT01633060|37710929|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
16772235|NCT01633060|37710928|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
16772236|NCT01633060|37710929|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
16772237|NCT01633060|37710928|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
16772238|NCT01633060|37710929|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
16772239|NCT01633060|37710928|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
16772240|NCT01633060|37710929|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
16772241|NCT01633060|37710928|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
16772242|NCT01633060|37710929|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
16772243|NCT01632904|37710938|FG000|Overall Study|Adverse Event|4|||
16772244|NCT01632904|37710939|FG001|Overall Study|Adverse Event|1|||
16772245|NCT01632904|37710938|FG000|Overall Study|Physician Decision|0|||
16772246|NCT01632904|37710939|FG001|Overall Study|Physician Decision|1|||
16772247|NCT01632904|37710938|FG000|Overall Study|Subject decision|3|||
16772248|NCT01632904|37710939|FG001|Overall Study|Subject decision|2|||
16772249|NCT01632904|37710938|FG000|Overall Study|Disease Progression|0|||
16772250|NCT01632904|37710939|FG001|Overall Study|Disease Progression|1|||
16772251|NCT01632904|37710938|FG000|Overall Study|Reason for discontinuation not available|0|||
16772252|NCT01632904|37710939|FG001|Overall Study|Reason for discontinuation not available|1|||
16772253|NCT03834779|37710947|FG000|Overall Study|Death|1|||
16772254|NCT03834779|37710948|FG001|Overall Study|Death|2|||
16772255|NCT03834779|37710947|FG000|Overall Study|Lost to Follow-up|6|||
16772256|NCT03834779|37710948|FG001|Overall Study|Lost to Follow-up|4|||
16772257|NCT03726437|37710957|FG000|Overall Study|Lost to Follow-up|85|||
16772258|NCT03726437|37710958|FG001|Overall Study|Lost to Follow-up|76|||
16772259|NCT02465528|37710968|FG000|Overall Study|Progressive disease|0|||
16772260|NCT02465528|37710969|FG001|Overall Study|Progressive disease|2|||
16772261|NCT02465528|37710970|FG002|Overall Study|Progressive disease|9|||
16856710|NCT01968551|37810326|FG001|Extension Phase|Death|1|||
16856711|NCT01968551|37810327|FG002|Extension Phase|Death|0|||
16856712|NCT01968551|37810325|FG000|Extension Phase|Withdrew Consent|0|||
16856713|NCT01968551|37810326|FG001|Extension Phase|Withdrew Consent|0|||
16856714|NCT01968551|37810327|FG002|Extension Phase|Withdrew Consent|1|||
16856715|NCT01968551|37810325|FG000|Extension Phase|Lost to Follow-up|1|||
16856716|NCT01968551|37810326|FG001|Extension Phase|Lost to Follow-up|0|||
16856717|NCT01968551|37810327|FG002|Extension Phase|Lost to Follow-up|1|||
16856718|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
16856719|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
16856720|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
16856721|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
16856722|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
16856723|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
16856724|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
16856725|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
16856726|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
16856727|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
16856728|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
16856729|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
16772262|NCT02465528|37710971|FG003|Overall Study|Progressive disease|4|||
16772263|NCT02465528|37710968|FG000|Overall Study|Study terminated by sponsor|1|||
16772264|NCT02465528|37710969|FG001|Overall Study|Study terminated by sponsor|2|||
16772265|NCT02465528|37710970|FG002|Overall Study|Study terminated by sponsor|0|||
16772266|NCT02465528|37710971|FG003|Overall Study|Study terminated by sponsor|0|||
16772267|NCT02465528|37710968|FG000|Overall Study|Withdrawal by Subject|0|||
16772268|NCT02465528|37710969|FG001|Overall Study|Withdrawal by Subject|0|||
16772269|NCT02465528|37710970|FG002|Overall Study|Withdrawal by Subject|2|||
16772270|NCT02465528|37710971|FG003|Overall Study|Withdrawal by Subject|0|||
16772271|NCT02465528|37710968|FG000|Overall Study|Adverse Event|0|||
16772272|NCT02465528|37710969|FG001|Overall Study|Adverse Event|0|||
16772273|NCT02465528|37710970|FG002|Overall Study|Adverse Event|0|||
16772274|NCT02465528|37710971|FG003|Overall Study|Adverse Event|1|||
16772275|NCT02465528|37710968|FG000|Overall Study|Physician Decision|0|||
16772276|NCT02465528|37710969|FG001|Overall Study|Physician Decision|0|||
16772277|NCT02465528|37710970|FG002|Overall Study|Physician Decision|1|||
16772278|NCT02465528|37710971|FG003|Overall Study|Physician Decision|0|||
16772279|NCT02438384|37710986|FG000|Overall Study|Lost to Follow-up|8|||
16772280|NCT02438384|37710987|FG001|Overall Study|Lost to Follow-up|6|||
16772281|NCT02438384|37710988|FG002|Overall Study|Lost to Follow-up|4|||
16772282|NCT02463032|37710998|FG000|Overall Study|Lack of Efficacy|61|||
16856730|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
16856731|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
16856732|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
16856733|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
16772283|NCT02463032|37710999|FG001|Overall Study|Lack of Efficacy|50|||
16772284|NCT02463032|37710998|FG000|Overall Study|Death|8|||
16772285|NCT02463032|37710999|FG001|Overall Study|Death|8|||
16772286|NCT02463032|37710998|FG000|Overall Study|Adverse Event|2|||
16772287|NCT02463032|37710999|FG001|Overall Study|Adverse Event|6|||
16772288|NCT02496884|37711009|FG000|Overall Study|Counted twice as enrolled|2|||
16772289|NCT02496884|37711010|FG001|Overall Study|Counted twice as enrolled|0|||
16772290|NCT02496884|37711011|FG002|Overall Study|Counted twice as enrolled|0|||
16772291|NCT02496884|37711012|FG003|Overall Study|Counted twice as enrolled|0|||
16772292|NCT02496884|37711009|FG000|Overall Study|Withdrawal by Subject|0|||
16772293|NCT02496884|37711010|FG001|Overall Study|Withdrawal by Subject|3|||
16772294|NCT02496884|37711011|FG002|Overall Study|Withdrawal by Subject|0|||
16772295|NCT02496884|37711012|FG003|Overall Study|Withdrawal by Subject|0|||
16772296|NCT02462876|37711022|FG000|Overall Study|Death|3|||
16772297|NCT02462876|37711022|FG000|Overall Study|Lost to Follow-up|7|||
16772298|NCT02462876|37711022|FG000|Overall Study|Surgical Bypass|9|||
16772299|NCT02462876|37711022|FG000|Overall Study|Amputation Above the Metatarsals|1|||
16772300|NCT02462876|37711022|FG000|Overall Study|36 months follow-up visit missed|1|||
16772301|NCT02462876|37711022|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
16772302|NCT02462876|37711022|FG000|Overall Study|Patient did not come back to the vascular department|1|||
16772303|NCT02462876|37711022|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
16772304|NCT02462876|37711022|FG000|Overall Study|Patient refused to come back|1|||
16772305|NCT02462876|37711022|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
16772306|NCT02462876|37711022|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
16772307|NCT03386721|37711041|FG000|Overall Study|Death|12|||
16772308|NCT03386721|37711042|FG001|Overall Study|Death|21|||
16772309|NCT03386721|37711043|FG002|Overall Study|Death|2|||
16772310|NCT03386721|37711044|FG003|Overall Study|Death|5|||
16772311|NCT03386721|37711045|FG004|Overall Study|Death|1|||
16772312|NCT03386721|37711046|FG005|Overall Study|Death|12|||
16772313|NCT03386721|37711047|FG006|Overall Study|Death|1|||
16772314|NCT03386721|37711048|FG007|Overall Study|Death|1|||
16772315|NCT03386721|37711049|FG008|Overall Study|Death|12|||
16772316|NCT03386721|37711050|FG009|Overall Study|Death|20|||
16772317|NCT03386721|37711051|FG010|Overall Study|Death|21|||
16772318|NCT03386721|37711052|FG011|Overall Study|Death|21|||
16772319|NCT03386721|37711053|FG012|Overall Study|Death|14|||
16772320|NCT03386721|37711054|FG013|Overall Study|Death|2|||
16772321|NCT03386721|37711055|FG014|Overall Study|Death|1|||
16772322|NCT03386721|37711041|FG000|Overall Study|Lost to Follow-up|1|||
16772323|NCT03386721|37711042|FG001|Overall Study|Lost to Follow-up|3|||
16772324|NCT03386721|37711043|FG002|Overall Study|Lost to Follow-up|0|||
16772325|NCT03386721|37711044|FG003|Overall Study|Lost to Follow-up|0|||
16772326|NCT03386721|37711045|FG004|Overall Study|Lost to Follow-up|0|||
16772327|NCT03386721|37711046|FG005|Overall Study|Lost to Follow-up|2|||
16772328|NCT03386721|37711047|FG006|Overall Study|Lost to Follow-up|1|||
16772329|NCT03386721|37711048|FG007|Overall Study|Lost to Follow-up|0|||
16772330|NCT03386721|37711049|FG008|Overall Study|Lost to Follow-up|1|||
16772331|NCT03386721|37711050|FG009|Overall Study|Lost to Follow-up|2|||
16772332|NCT03386721|37711051|FG010|Overall Study|Lost to Follow-up|1|||
16772333|NCT03386721|37711052|FG011|Overall Study|Lost to Follow-up|0|||
16772334|NCT03386721|37711053|FG012|Overall Study|Lost to Follow-up|0|||
16772335|NCT03386721|37711054|FG013|Overall Study|Lost to Follow-up|0|||
16772336|NCT03386721|37711055|FG014|Overall Study|Lost to Follow-up|0|||
16772337|NCT03386721|37711041|FG000|Overall Study|Reason not specified|3|||
16772338|NCT03386721|37711042|FG001|Overall Study|Reason not specified|0|||
16772339|NCT03386721|37711043|FG002|Overall Study|Reason not specified|0|||
16772340|NCT03386721|37711044|FG003|Overall Study|Reason not specified|0|||
16772341|NCT03386721|37711045|FG004|Overall Study|Reason not specified|0|||
16772342|NCT03386721|37711046|FG005|Overall Study|Reason not specified|3|||
16772343|NCT03386721|37711047|FG006|Overall Study|Reason not specified|1|||
16772344|NCT03386721|37711048|FG007|Overall Study|Reason not specified|0|||
16772345|NCT03386721|37711049|FG008|Overall Study|Reason not specified|0|||
16772346|NCT03386721|37711050|FG009|Overall Study|Reason not specified|1|||
16772347|NCT03386721|37711051|FG010|Overall Study|Reason not specified|2|||
16772348|NCT03386721|37711052|FG011|Overall Study|Reason not specified|6|||
16772349|NCT03386721|37711053|FG012|Overall Study|Reason not specified|1|||
16772350|NCT03386721|37711054|FG013|Overall Study|Reason not specified|0|||
16772351|NCT03386721|37711055|FG014|Overall Study|Reason not specified|0|||
16772352|NCT03386721|37711041|FG000|Overall Study|Progressive Disease|0|||
16772353|NCT03386721|37711042|FG001|Overall Study|Progressive Disease|0|||
16772354|NCT03386721|37711043|FG002|Overall Study|Progressive Disease|1|||
16772355|NCT03386721|37711044|FG003|Overall Study|Progressive Disease|0|||
16772356|NCT03386721|37711045|FG004|Overall Study|Progressive Disease|0|||
16772357|NCT03386721|37711046|FG005|Overall Study|Progressive Disease|1|||
16772358|NCT03386721|37711047|FG006|Overall Study|Progressive Disease|0|||
16772359|NCT03386721|37711048|FG007|Overall Study|Progressive Disease|0|||
16772360|NCT03386721|37711049|FG008|Overall Study|Progressive Disease|2|||
16772361|NCT03386721|37711050|FG009|Overall Study|Progressive Disease|1|||
16772362|NCT03386721|37711051|FG010|Overall Study|Progressive Disease|1|||
16772363|NCT03386721|37711052|FG011|Overall Study|Progressive Disease|0|||
16772364|NCT03386721|37711053|FG012|Overall Study|Progressive Disease|1|||
16772365|NCT03386721|37711054|FG013|Overall Study|Progressive Disease|0|||
16772366|NCT03386721|37711055|FG014|Overall Study|Progressive Disease|0|||
16772367|NCT03386721|37711041|FG000|Overall Study|Site Terminated by Sponsor|5|||
16772368|NCT03386721|37711042|FG001|Overall Study|Site Terminated by Sponsor|5|||
16772369|NCT03386721|37711043|FG002|Overall Study|Site Terminated by Sponsor|0|||
16772370|NCT03386721|37711044|FG003|Overall Study|Site Terminated by Sponsor|0|||
16772371|NCT03386721|37711045|FG004|Overall Study|Site Terminated by Sponsor|1|||
16772372|NCT03386721|37711046|FG005|Overall Study|Site Terminated by Sponsor|3|||
16772373|NCT03386721|37711047|FG006|Overall Study|Site Terminated by Sponsor|0|||
16772374|NCT03386721|37711048|FG007|Overall Study|Site Terminated by Sponsor|1|||
16772375|NCT03386721|37711049|FG008|Overall Study|Site Terminated by Sponsor|4|||
16772376|NCT03386721|37711050|FG009|Overall Study|Site Terminated by Sponsor|5|||
16772377|NCT03386721|37711051|FG010|Overall Study|Site Terminated by Sponsor|3|||
16772378|NCT03386721|37711052|FG011|Overall Study|Site Terminated by Sponsor|11|||
16772379|NCT03386721|37711053|FG012|Overall Study|Site Terminated by Sponsor|6|||
16772380|NCT03386721|37711054|FG013|Overall Study|Site Terminated by Sponsor|0|||
16772381|NCT03386721|37711055|FG014|Overall Study|Site Terminated by Sponsor|0|||
16772382|NCT03386721|37711041|FG000|Overall Study|Symptomatic Deterioration|0|||
16772383|NCT03386721|37711042|FG001|Overall Study|Symptomatic Deterioration|0|||
16772384|NCT03386721|37711043|FG002|Overall Study|Symptomatic Deterioration|0|||
16772385|NCT03386721|37711044|FG003|Overall Study|Symptomatic Deterioration|0|||
16772386|NCT03386721|37711045|FG004|Overall Study|Symptomatic Deterioration|0|||
16772387|NCT03386721|37711046|FG005|Overall Study|Symptomatic Deterioration|0|||
16772388|NCT03386721|37711047|FG006|Overall Study|Symptomatic Deterioration|0|||
16772389|NCT03386721|37711048|FG007|Overall Study|Symptomatic Deterioration|0|||
16772390|NCT03386721|37711049|FG008|Overall Study|Symptomatic Deterioration|1|||
16772391|NCT03386721|37711050|FG009|Overall Study|Symptomatic Deterioration|0|||
16772392|NCT03386721|37711051|FG010|Overall Study|Symptomatic Deterioration|0|||
16772393|NCT03386721|37711052|FG011|Overall Study|Symptomatic Deterioration|1|||
16772394|NCT03386721|37711053|FG012|Overall Study|Symptomatic Deterioration|0|||
16772395|NCT03386721|37711054|FG013|Overall Study|Symptomatic Deterioration|0|||
16772396|NCT03386721|37711055|FG014|Overall Study|Symptomatic Deterioration|0|||
16772397|NCT03386721|37711041|FG000|Overall Study|Withdrawal by Subject|1|||
16772398|NCT03386721|37711042|FG001|Overall Study|Withdrawal by Subject|2|||
16772399|NCT03386721|37711043|FG002|Overall Study|Withdrawal by Subject|0|||
16772400|NCT03386721|37711044|FG003|Overall Study|Withdrawal by Subject|0|||
16772401|NCT03386721|37711045|FG004|Overall Study|Withdrawal by Subject|0|||
16772402|NCT03386721|37711046|FG005|Overall Study|Withdrawal by Subject|0|||
16772403|NCT03386721|37711047|FG006|Overall Study|Withdrawal by Subject|0|||
16772404|NCT03386721|37711048|FG007|Overall Study|Withdrawal by Subject|0|||
16772405|NCT03386721|37711049|FG008|Overall Study|Withdrawal by Subject|2|||
16772406|NCT03386721|37711050|FG009|Overall Study|Withdrawal by Subject|1|||
16772407|NCT03386721|37711051|FG010|Overall Study|Withdrawal by Subject|3|||
16772408|NCT03386721|37711052|FG011|Overall Study|Withdrawal by Subject|2|||
16772409|NCT03386721|37711053|FG012|Overall Study|Withdrawal by Subject|3|||
16772410|NCT03386721|37711054|FG013|Overall Study|Withdrawal by Subject|0|||
16772411|NCT03386721|37711055|FG014|Overall Study|Withdrawal by Subject|0|||
16772412|NCT02462720|37711087|FG000|Part 2|Withdrawal by Subject|1|||
16772413|NCT02462720|37711088|FG001|Part 2|Withdrawal by Subject|0|||
16772414|NCT02462720|37711087|FG000|Part 2|Protocol Violation|0|||
16772415|NCT02462720|37711088|FG001|Part 2|Protocol Violation|1|||
16772416|NCT02246218|37711098|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16772417|NCT02246218|37711099|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16772418|NCT02246218|37711098|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
16772419|NCT02246218|37711099|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
16772420|NCT02246218|37711098|FG000|Overall Study|Adverse Event|1|||
16772421|NCT02246218|37711099|FG001|Overall Study|Adverse Event|1|||
16772422|NCT02246218|37711098|FG000|Overall Study|Lost to Follow-up|1|||
16772423|NCT02246218|37711099|FG001|Overall Study|Lost to Follow-up|0|||
16772424|NCT02244580|37711105|FG000|Overall Study|No cancer tissues available|241|||
16772425|NCT02244424|37711115|FG000|Overall Study|Lost to Follow-up|20|||
16772426|NCT02244424|37711116|FG001|Overall Study|Lost to Follow-up|10|||
16772427|NCT00159783|37711125|FG000|Overall Study|Adverse Event|5|||
16772428|NCT00159783|37711126|FG001|Overall Study|Adverse Event|7|||
16772429|NCT00159783|37711127|FG002|Overall Study|Adverse Event|9|||
16772430|NCT00159783|37711125|FG000|Overall Study|Lack of Efficacy|1|||
16772431|NCT00159783|37711126|FG001|Overall Study|Lack of Efficacy|2|||
16772432|NCT00159783|37711127|FG002|Overall Study|Lack of Efficacy|3|||
16772433|NCT00159783|37711125|FG000|Overall Study|Withdrawal by Subject|7|||
16772434|NCT00159783|37711126|FG001|Overall Study|Withdrawal by Subject|11|||
16772435|NCT00159783|37711127|FG002|Overall Study|Withdrawal by Subject|12|||
16772436|NCT00159783|37711125|FG000|Overall Study|Lost to Follow-up|6|||
16772437|NCT00159783|37711126|FG001|Overall Study|Lost to Follow-up|5|||
16772438|NCT00159783|37711127|FG002|Overall Study|Lost to Follow-up|11|||
16772439|NCT00159783|37711125|FG000|Overall Study|Other|0|||
16772440|NCT00159783|37711126|FG001|Overall Study|Other|2|||
16772441|NCT00159783|37711127|FG002|Overall Study|Other|4|||
16772442|NCT02936323|37711146|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16772443|NCT02936323|37711147|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
16772444|NCT02936323|37711148|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16772445|NCT02936323|37711149|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
16772446|NCT02936323|37711150|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
16772447|NCT02936323|37711151|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
16772448|NCT02936323|37711152|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16772449|NCT02936323|37711153|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16772450|NCT02936323|37711154|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16772451|NCT02936323|37711155|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16772452|NCT02936323|37711146|FG000|Phase 1 Dose Escalation|Death|2|||
16772453|NCT02936323|37711147|FG001|Phase 1 Dose Escalation|Death|1|||
16772454|NCT02936323|37711148|FG002|Phase 1 Dose Escalation|Death|3|||
16772455|NCT02936323|37711149|FG003|Phase 1 Dose Escalation|Death|1|||
16772456|NCT02936323|37711150|FG004|Phase 1 Dose Escalation|Death|2|||
16772457|NCT02936323|37711151|FG005|Phase 1 Dose Escalation|Death|3|||
16772458|NCT02936323|37711152|FG006|Phase 1 Dose Escalation|Death|3|||
16772459|NCT02936323|37711153|FG007|Phase 1 Dose Escalation|Death|0|||
16772460|NCT02936323|37711154|FG008|Phase 1 Dose Escalation|Death|0|||
16772461|NCT02936323|37711155|FG009|Phase 1 Dose Escalation|Death|0|||
16772462|NCT02936323|37711146|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772463|NCT02936323|37711147|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772464|NCT02936323|37711148|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772465|NCT02936323|37711149|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772466|NCT02936323|37711150|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772467|NCT02936323|37711151|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
16772468|NCT02936323|37711152|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772469|NCT02936323|37711153|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772470|NCT02936323|37711154|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772471|NCT02936323|37711155|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16772472|NCT02936323|37711146|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16772473|NCT02936323|37711147|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16772474|NCT02936323|37711148|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16772475|NCT02936323|37711149|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16772476|NCT02936323|37711150|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16772477|NCT02936323|37711151|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16772478|NCT02936323|37711152|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16772479|NCT02936323|37711153|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
16772480|NCT02936323|37711154|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
16772481|NCT02936323|37711155|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
16772482|NCT02936323|37711146|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
16772483|NCT02936323|37711147|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
16772484|NCT02936323|37711148|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
16772485|NCT02936323|37711149|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
16772486|NCT02936323|37711150|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
16772487|NCT02936323|37711151|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
16772488|NCT02936323|37711152|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
16772489|NCT02936323|37711153|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
16772490|NCT02936323|37711154|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
16772491|NCT02936323|37711155|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
16772492|NCT02936323|37711146|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16772493|NCT02936323|37711147|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16772494|NCT02936323|37711148|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16772495|NCT02936323|37711149|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16772496|NCT02936323|37711150|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16772497|NCT02936323|37711151|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16772498|NCT02936323|37711152|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16772499|NCT02936323|37711153|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
16772500|NCT02936323|37711154|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
16772501|NCT02936323|37711155|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16772502|NCT02936323|37711146|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772503|NCT02936323|37711147|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772504|NCT02936323|37711148|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772505|NCT02936323|37711149|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772506|NCT02936323|37711150|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772507|NCT02936323|37711151|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772508|NCT02936323|37711152|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772509|NCT02936323|37711153|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772510|NCT02936323|37711154|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16772511|NCT02936323|37711155|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
16772512|NCT02936323|37711146|FG000|Phase 2a Dose Expansion|Death|0|||
16772513|NCT02936323|37711147|FG001|Phase 2a Dose Expansion|Death|0|||
16772514|NCT02936323|37711148|FG002|Phase 2a Dose Expansion|Death|0|||
16772515|NCT02936323|37711149|FG003|Phase 2a Dose Expansion|Death|0|||
16772516|NCT02936323|37711150|FG004|Phase 2a Dose Expansion|Death|0|||
16772517|NCT02936323|37711151|FG005|Phase 2a Dose Expansion|Death|0|||
16772518|NCT02936323|37711152|FG006|Phase 2a Dose Expansion|Death|0|||
16772519|NCT02936323|37711153|FG007|Phase 2a Dose Expansion|Death|4|||
16772520|NCT02936323|37711154|FG008|Phase 2a Dose Expansion|Death|8|||
16772521|NCT02936323|37711155|FG009|Phase 2a Dose Expansion|Death|10|||
16772522|NCT02243176|37711189|FG000|Overall Study|Other reason|1|||
16772523|NCT02243176|37711190|FG001|Overall Study|Other reason|2|||
16772524|NCT02243176|37711189|FG000|Overall Study|protocol specified withdrawal critera|1|||
16772525|NCT02243176|37711190|FG001|Overall Study|protocol specified withdrawal critera|3|||
16772526|NCT02243176|37711189|FG000|Overall Study|Protocol Violation|2|||
16772527|NCT02243176|37711190|FG001|Overall Study|Protocol Violation|1|||
17115527|NCT02929498|38253599|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
17115528|NCT02929498|38253600|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
17115529|NCT02929498|38253601|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
17115530|NCT02929498|38253599|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
17115531|NCT02929498|38253600|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
17115532|NCT02929498|38253601|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
17115533|NCT03792672|38253607|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
17115534|NCT03792672|38253608|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
17115535|NCT03792672|38253609|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
17115536|NCT03792672|38253610|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
17115537|NCT03792672|38253611|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
17115538|NCT03792672|38253612|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
17115539|NCT03792672|38253607|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
17115540|NCT03792672|38253608|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
17115541|NCT03792672|38253609|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
17115542|NCT03792672|38253610|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
17115543|NCT03792672|38253611|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
17115544|NCT03792672|38253612|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
17115545|NCT03792672|38253607|FG000|Treatment Period 4 (2 Days)|Other|1|||
17115546|NCT03792672|38253608|FG001|Treatment Period 4 (2 Days)|Other|0|||
17115547|NCT03792672|38253609|FG002|Treatment Period 4 (2 Days)|Other|0|||
17115548|NCT03792672|38253610|FG003|Treatment Period 4 (2 Days)|Other|0|||
17115549|NCT03792672|38253611|FG004|Treatment Period 4 (2 Days)|Other|0|||
17115550|NCT03792672|38253612|FG005|Treatment Period 4 (2 Days)|Other|0|||
17115551|NCT03120676|38253627|FG000|Overall Study|Not treated|1|||
17115552|NCT03120520|38253635|FG000|Overall Study|Lost to Follow-up|1|||
17115553|NCT03120520|38253636|FG001|Overall Study|Lost to Follow-up|1|||
17115554|NCT03120520|38253637|FG002|Overall Study|Lost to Follow-up|1|||
17115555|NCT03120520|38253638|FG003|Overall Study|Lost to Follow-up|1|||
17115556|NCT03120520|38253635|FG000|Overall Study|Withdrawal by Subject|3|||
17115557|NCT03120520|38253636|FG001|Overall Study|Withdrawal by Subject|2|||
17115558|NCT03120520|38253637|FG002|Overall Study|Withdrawal by Subject|3|||
17115559|NCT03120520|38253638|FG003|Overall Study|Withdrawal by Subject|2|||
17115560|NCT03120520|38253635|FG000|Overall Study|Other|0|||
17115561|NCT03120520|38253636|FG001|Overall Study|Other|1|||
17115562|NCT03120520|38253637|FG002|Overall Study|Other|0|||
16772528|NCT02243176|37711189|FG000|Overall Study|Withdrawal by Subject|8|||
16772529|NCT02243176|37711190|FG001|Overall Study|Withdrawal by Subject|7|||
16772530|NCT02243176|37711189|FG000|Overall Study|Adverse Event|2|||
16772531|NCT02243176|37711190|FG001|Overall Study|Adverse Event|2|||
16772532|NCT00002663|37711201|FG000|Overall Study|Death|4|||
16772533|NCT00002663|37711202|FG001|Overall Study|Death|1|||
16772534|NCT00002663|37711203|FG002|Overall Study|Death|1|||
16772535|NCT00002663|37711204|FG003|Overall Study|Death|0|||
16772536|NCT00002663|37711205|FG004|Overall Study|Death|0|||
16772537|NCT00002663|37711206|FG005|Overall Study|Death|13|||
16772538|NCT00002663|37711207|FG006|Overall Study|Death|0|||
16772539|NCT00002663|37711208|FG007|Overall Study|Death|1|||
16772540|NCT00002663|37711209|FG008|Overall Study|Death|1|||
16772541|NCT00002663|37711210|FG009|Overall Study|Death|1|||
16772542|NCT00002663|37711201|FG000|Overall Study|Lost to Follow-up|3|||
16772543|NCT00002663|37711202|FG001|Overall Study|Lost to Follow-up|0|||
16772544|NCT00002663|37711203|FG002|Overall Study|Lost to Follow-up|0|||
16772545|NCT00002663|37711204|FG003|Overall Study|Lost to Follow-up|1|||
16772546|NCT00002663|37711205|FG004|Overall Study|Lost to Follow-up|0|||
16772547|NCT00002663|37711206|FG005|Overall Study|Lost to Follow-up|1|||
16772548|NCT00002663|37711207|FG006|Overall Study|Lost to Follow-up|0|||
16772549|NCT00002663|37711208|FG007|Overall Study|Lost to Follow-up|0|||
16772550|NCT00002663|37711209|FG008|Overall Study|Lost to Follow-up|0|||
16772551|NCT00002663|37711210|FG009|Overall Study|Lost to Follow-up|0|||
16772552|NCT00002663|37711201|FG000|Overall Study|Other|0|||
16772553|NCT00002663|37711202|FG001|Overall Study|Other|1|||
16772554|NCT00002663|37711203|FG002|Overall Study|Other|0|||
16772555|NCT00002663|37711204|FG003|Overall Study|Other|0|||
16772556|NCT00002663|37711205|FG004|Overall Study|Other|0|||
16772557|NCT00002663|37711206|FG005|Overall Study|Other|1|||
16772558|NCT00002663|37711207|FG006|Overall Study|Other|1|||
16772559|NCT00002663|37711208|FG007|Overall Study|Other|0|||
16772560|NCT00002663|37711209|FG008|Overall Study|Other|0|||
16772561|NCT00002663|37711210|FG009|Overall Study|Other|0|||
16772562|NCT00002663|37711201|FG000|Overall Study|Physician Decision|0|||
16772563|NCT00002663|37711202|FG001|Overall Study|Physician Decision|0|||
16772564|NCT00002663|37711203|FG002|Overall Study|Physician Decision|0|||
16772565|NCT00002663|37711204|FG003|Overall Study|Physician Decision|0|||
16772566|NCT00002663|37711205|FG004|Overall Study|Physician Decision|1|||
16772567|NCT00002663|37711206|FG005|Overall Study|Physician Decision|0|||
16772568|NCT00002663|37711207|FG006|Overall Study|Physician Decision|0|||
16772569|NCT00002663|37711208|FG007|Overall Study|Physician Decision|0|||
16772570|NCT00002663|37711209|FG008|Overall Study|Physician Decision|1|||
16772571|NCT00002663|37711210|FG009|Overall Study|Physician Decision|1|||
16772572|NCT00002663|37711201|FG000|Overall Study|Adverse Event|0|||
16772573|NCT00002663|37711202|FG001|Overall Study|Adverse Event|0|||
16772574|NCT00002663|37711203|FG002|Overall Study|Adverse Event|0|||
16772575|NCT00002663|37711204|FG003|Overall Study|Adverse Event|1|||
16772576|NCT00002663|37711205|FG004|Overall Study|Adverse Event|0|||
16772577|NCT00002663|37711206|FG005|Overall Study|Adverse Event|0|||
16772578|NCT00002663|37711207|FG006|Overall Study|Adverse Event|0|||
16772579|NCT00002663|37711208|FG007|Overall Study|Adverse Event|1|||
16772580|NCT00002663|37711209|FG008|Overall Study|Adverse Event|0|||
16772581|NCT00002663|37711210|FG009|Overall Study|Adverse Event|0|||
16772582|NCT02240680|37711221|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
16772583|NCT02240680|37711222|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
16772584|NCT02240680|37711223|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
16772585|NCT02240680|37711224|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
16772586|NCT02240680|37711221|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
16772587|NCT02240680|37711222|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
16772588|NCT02240680|37711223|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
16772589|NCT02240680|37711224|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
16772590|NCT02240680|37711221|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
16772591|NCT02240680|37711222|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
16772592|NCT02240680|37711223|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
16772593|NCT02240680|37711224|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
16772594|NCT02240680|37711221|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
16772595|NCT02240680|37711222|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
16772596|NCT02240680|37711223|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
16772597|NCT02240680|37711224|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
16772598|NCT02240680|37711221|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
16772599|NCT02240680|37711222|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
16772600|NCT02240680|37711223|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
16772601|NCT02240680|37711224|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
16772602|NCT02240680|37711221|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
16772603|NCT02240680|37711222|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
16772604|NCT02240680|37711223|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
16772605|NCT02240680|37711224|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
16772606|NCT02240680|37711221|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
16772607|NCT02240680|37711222|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
16772608|NCT02240680|37711223|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
16772609|NCT02240680|37711224|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
16772610|NCT02240680|37711221|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
16772611|NCT02240680|37711222|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
16772612|NCT02240680|37711223|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
16772613|NCT02240680|37711224|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
16772614|NCT02240368|37711235|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
16772615|NCT02240368|37711236|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
16772616|NCT02240368|37711237|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
16772617|NCT02240368|37711235|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
16772618|NCT02240368|37711236|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
16772619|NCT02240368|37711237|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
16772620|NCT02239978|37711247|FG000|Overall Study|Withdrawal by Subject|2|||
16772621|NCT02239978|37711248|FG001|Overall Study|Withdrawal by Subject|0|||
16772622|NCT02239510|37711258|FG000|Overall Study|Lost to Follow-up|2|||
16772623|NCT02239510|37711259|FG001|Overall Study|Lost to Follow-up|1|||
17115563|NCT03120520|38253638|FG003|Overall Study|Other|0|||
16772624|NCT02462486|37711268|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
16772625|NCT02462486|37711269|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
16772626|NCT02462486|37711270|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
16772627|NCT02462486|37711268|FG000|Overall Study|Adverse Event|53|||
16772628|NCT02462486|37711269|FG001|Overall Study|Adverse Event|48|||
16772629|NCT02462486|37711270|FG002|Overall Study|Adverse Event|21|||
16772630|NCT02462486|37711268|FG000|Overall Study|Lack of Efficacy|6|||
16772631|NCT02462486|37711269|FG001|Overall Study|Lack of Efficacy|12|||
16772632|NCT02462486|37711270|FG002|Overall Study|Lack of Efficacy|3|||
16772633|NCT02462486|37711268|FG000|Overall Study|Lost to Follow-up|3|||
16772634|NCT02462486|37711269|FG001|Overall Study|Lost to Follow-up|4|||
16772635|NCT02462486|37711270|FG002|Overall Study|Lost to Follow-up|2|||
16772636|NCT02462486|37711268|FG000|Overall Study|Withdrawal by Subject|25|||
16772637|NCT02462486|37711269|FG001|Overall Study|Withdrawal by Subject|22|||
16772638|NCT02462486|37711270|FG002|Overall Study|Withdrawal by Subject|19|||
16772639|NCT02462486|37711268|FG000|Overall Study|Protocol Violation|3|||
16772640|NCT02462486|37711269|FG001|Overall Study|Protocol Violation|1|||
16772641|NCT02462486|37711270|FG002|Overall Study|Protocol Violation|1|||
16772642|NCT02462486|37711268|FG000|Overall Study|Reason not Specified|3|||
16772643|NCT02462486|37711269|FG001|Overall Study|Reason not Specified|4|||
16772644|NCT02462486|37711270|FG002|Overall Study|Reason not Specified|3|||
16772645|NCT02495948|37711278|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
16772646|NCT02495948|37711279|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
16772647|NCT02495948|37711278|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
16772648|NCT02495948|37711279|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
16772649|NCT02461628|37711288|FG000|Overall Study|Refused to complete survey|4|||
16772650|NCT02461628|37711289|FG001|Overall Study|Refused to complete survey|7|||
16772651|NCT02429791|37711297|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
16772652|NCT02429791|37711298|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
16772653|NCT02429791|37711297|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
16772654|NCT02429791|37711298|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
16772655|NCT02429791|37711297|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
16772656|NCT02429791|37711298|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
16772657|NCT02429791|37711297|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
16772658|NCT02429791|37711298|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
16772659|NCT02429791|37711297|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
16772660|NCT02429791|37711298|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
16772661|NCT02429791|37711297|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
16772662|NCT02429791|37711298|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
16772663|NCT02429791|37711297|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
16772664|NCT02429791|37711298|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
16772665|NCT02429791|37711297|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
16772666|NCT02429791|37711298|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
16772667|NCT02429791|37711297|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
16772668|NCT02429791|37711298|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
16772669|NCT02429791|37711297|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
16772670|NCT02429791|37711298|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
16772671|NCT02429791|37711297|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
16772672|NCT02429791|37711298|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
16772673|NCT02429791|37711297|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
16772674|NCT02429791|37711298|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
16772675|NCT02132611|37711311|FG000|Overall Study|Death|2|||
16772676|NCT02461160|37711328|FG000|Overall Study|Lost to Follow-up|0|||
16772677|NCT02461160|37711329|FG001|Overall Study|Lost to Follow-up|0|||
16772678|NCT02461160|37711330|FG002|Overall Study|Lost to Follow-up|0|||
16772679|NCT02461160|37711331|FG003|Overall Study|Lost to Follow-up|0|||
16772680|NCT02461160|37711332|FG004|Overall Study|Lost to Follow-up|0|||
16772681|NCT02461160|37711333|FG005|Overall Study|Lost to Follow-up|0|||
16772682|NCT02461160|37711334|FG006|Overall Study|Lost to Follow-up|0|||
16772683|NCT02461160|37711335|FG007|Overall Study|Lost to Follow-up|1|||
16772684|NCT02461160|37711336|FG008|Overall Study|Lost to Follow-up|0|||
16772685|NCT02461160|37711337|FG009|Overall Study|Lost to Follow-up|0|||
16772686|NCT02461160|37711338|FG010|Overall Study|Lost to Follow-up|0|||
16772687|NCT02461160|37711339|FG011|Overall Study|Lost to Follow-up|0|||
16772688|NCT02461160|37711340|FG012|Overall Study|Lost to Follow-up|0|||
16772689|NCT01653704|37711391|FG000|Overall Study|Technical failure during recording|1|||
16772690|NCT01653704|37711392|FG001|Overall Study|Technical failure during recording|1|||
16772691|NCT01653704|37711391|FG000|Overall Study|Performance not reflective of training|1|||
16772692|NCT01653704|37711392|FG001|Overall Study|Performance not reflective of training|0|||
16772693|NCT02495168|37711401|FG000|Overall Study|Other than Specified|18|||
16772694|NCT02495168|37711402|FG001|Overall Study|Other than Specified|22|||
16772695|NCT02495168|37711403|FG002|Overall Study|Other than Specified|5|||
16772696|NCT02495168|37711401|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
16772697|NCT02495168|37711402|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
16772698|NCT02495168|37711403|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
16772699|NCT02495168|37711401|FG000|Overall Study|Physician Decision|1|||
16772700|NCT02495168|37711402|FG001|Overall Study|Physician Decision|1|||
16772701|NCT02495168|37711403|FG002|Overall Study|Physician Decision|0|||
16772702|NCT02495168|37711401|FG000|Overall Study|Lost to Follow-up|10|||
16772703|NCT02495168|37711402|FG001|Overall Study|Lost to Follow-up|6|||
16772704|NCT02495168|37711403|FG002|Overall Study|Lost to Follow-up|1|||
16772705|NCT02495168|37711401|FG000|Overall Study|Withdrawal by Subject|1|||
16772706|NCT02495168|37711402|FG001|Overall Study|Withdrawal by Subject|4|||
16772707|NCT02495168|37711403|FG002|Overall Study|Withdrawal by Subject|2|||
16772708|NCT02495168|37711401|FG000|Overall Study|Protocol Violation|0|||
16772709|NCT02495168|37711402|FG001|Overall Study|Protocol Violation|10|||
16772710|NCT02495168|37711403|FG002|Overall Study|Protocol Violation|1|||
16772711|NCT02495168|37711401|FG000|Overall Study|Adverse Event|4|||
16772712|NCT02495168|37711402|FG001|Overall Study|Adverse Event|8|||
16772713|NCT02495168|37711403|FG002|Overall Study|Adverse Event|3|||
16772714|NCT02495168|37711401|FG000|Overall Study|Lack of Efficacy|0|||
16772715|NCT02495168|37711402|FG001|Overall Study|Lack of Efficacy|0|||
16772716|NCT02495168|37711403|FG002|Overall Study|Lack of Efficacy|3|||
16772717|NCT02494778|37711411|FG000|Overall Study|Death|3|||
16772718|NCT02494778|37711411|FG000|Overall Study|Other|173|||
16772719|NCT02494778|37711411|FG000|Overall Study|Lack of Efficacy|4|||
16772720|NCT02494778|37711411|FG000|Overall Study|Adverse Event|18|||
16772721|NCT02494778|37711411|FG000|Overall Study|Withdrawal by Subject|20|||
16772722|NCT02494778|37711411|FG000|Overall Study|Lost to Follow-up|2|||
16772723|NCT02494778|37711411|FG000|Overall Study|Noncompliant with study drug admin.|1|||
16772724|NCT02493764|37711417|FG000|Overall Study|Adverse Event|2|||
16772725|NCT02493764|37711418|FG001|Overall Study|Adverse Event|2|||
16772726|NCT02493764|37711417|FG000|Overall Study|Death|44|||
16772727|NCT02493764|37711418|FG001|Overall Study|Death|58|||
16772728|NCT02493764|37711417|FG000|Overall Study|Lost to Follow-up|2|||
16772729|NCT02493764|37711418|FG001|Overall Study|Lost to Follow-up|1|||
16772730|NCT02493764|37711417|FG000|Overall Study|Protocol Violation|6|||
16772731|NCT02493764|37711418|FG001|Overall Study|Protocol Violation|7|||
16772732|NCT02493764|37711417|FG000|Overall Study|Physician Decision|1|||
16772733|NCT02493764|37711418|FG001|Overall Study|Physician Decision|1|||
16772734|NCT02493764|37711417|FG000|Overall Study|Participant moved|17|||
16772735|NCT02493764|37711418|FG001|Overall Study|Participant moved|5|||
16772736|NCT02493764|37711417|FG000|Overall Study|Withdrawal parent/guardian|0|||
16772737|NCT02493764|37711418|FG001|Overall Study|Withdrawal parent/guardian|1|||
16772738|NCT02493764|37711417|FG000|Overall Study|Withdrawal by Subject|11|||
16772739|NCT02493764|37711418|FG001|Overall Study|Withdrawal by Subject|7|||
16772740|NCT02460380|37711426|FG000|Overall Study|Withdrawal by Subject|10|||
16772741|NCT02460380|37711427|FG001|Overall Study|Withdrawal by Subject|5|||
16772742|NCT02493062|37711434|FG000|Overall Study|Physician Decision|12|||
16772743|NCT02492984|37711440|FG000|Overall Study|Adverse Event|1|||
16772744|NCT02492984|37711441|FG001|Overall Study|Adverse Event|0|||
16772745|NCT02492984|37711440|FG000|Overall Study|Protocol Violation|1|||
16772746|NCT02492984|37711441|FG001|Overall Study|Protocol Violation|0|||
16772747|NCT02492984|37711440|FG000|Overall Study|Withdrawal by Subject|1|||
16772748|NCT02492984|37711441|FG001|Overall Study|Withdrawal by Subject|0|||
16772749|NCT01680159|37711454|FG000|Screening Period|Not meet criteria for dose-up period|7|||
16772750|NCT01680159|37711454|FG000|Increased Dose Period|Adverse Event|6|||
16772751|NCT01680159|37711454|FG000|Increased Dose Period|Withdrawal by Subject|2|||
16772752|NCT02491892|37711476|FG000|Overall Study|Adverse Event|1|||
16772753|NCT02491892|37711477|FG001|Overall Study|Adverse Event|1|||
16772754|NCT02491892|37711476|FG000|Overall Study|Death|1|||
16772755|NCT02491892|37711477|FG001|Overall Study|Death|1|||
16772756|NCT02491892|37711476|FG000|Overall Study|Lack of Efficacy|37|||
16772757|NCT02491892|37711477|FG001|Overall Study|Lack of Efficacy|36|||
16772758|NCT02491892|37711476|FG000|Overall Study|Refused Treatment|1|||
16772759|NCT02491892|37711477|FG001|Overall Study|Refused Treatment|0|||
16772760|NCT02491892|37711476|FG000|Overall Study|Lost to Follow-up|1|||
16772761|NCT02491892|37711477|FG001|Overall Study|Lost to Follow-up|0|||
16772762|NCT02436356|37711493|FG000|Overall Study|Excluded by MRI Screening|0|||
16772763|NCT02436356|37711494|FG001|Overall Study|Excluded by MRI Screening|0|||
16772764|NCT02436356|37711495|FG002|Overall Study|Excluded by MRI Screening|2|||
16772765|NCT02436356|37711493|FG000|Overall Study|Lost to Follow-up|0|||
16772766|NCT02436356|37711494|FG001|Overall Study|Lost to Follow-up|1|||
16772767|NCT02436356|37711495|FG002|Overall Study|Lost to Follow-up|0|||
16772768|NCT02436356|37711493|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
16772769|NCT02436356|37711494|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
16772770|NCT02436356|37711495|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
16772771|NCT02436356|37711493|FG000|Overall Study|Excluded due to other medical conditions|3|||
16772772|NCT02436356|37711494|FG001|Overall Study|Excluded due to other medical conditions|0|||
16772773|NCT02436356|37711495|FG002|Overall Study|Excluded due to other medical conditions|0|||
16772774|NCT02436356|37711493|FG000|Overall Study|Withdrawal by Subject|1|||
16772775|NCT02436356|37711494|FG001|Overall Study|Withdrawal by Subject|0|||
16772776|NCT02436356|37711495|FG002|Overall Study|Withdrawal by Subject|0|||
16772777|NCT02436200|37711508|FG000|Overall Study|Significant outlier|1|||
16772778|NCT01679613|37711512|FG000|Overall Study|other than stated above|0|||
16772779|NCT01679613|37711513|FG001|Overall Study|other than stated above|1|||
16772780|NCT01679613|37711514|FG002|Overall Study|other than stated above|2|||
16772781|NCT01679613|37711515|FG003|Overall Study|other than stated above|2|||
16772782|NCT02489630|37711524|FG000|Overall Study|Oversedation|1|||
16772783|NCT02489630|37711525|FG001|Overall Study|Oversedation|1|||
16772784|NCT02489630|37711524|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
16772785|NCT02489630|37711525|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
16772786|NCT02739347|37711533|FG000|Overall Study|Adverse Event|3|||
16772787|NCT02739347|37711534|FG001|Overall Study|Adverse Event|0|||
16772788|NCT02739347|37711533|FG000|Overall Study|Protocol Violation|0|||
16772789|NCT02739347|37711534|FG001|Overall Study|Protocol Violation|1|||
16772790|NCT02739347|37711533|FG000|Overall Study|Lost to Follow-up|0|||
16772791|NCT02739347|37711534|FG001|Overall Study|Lost to Follow-up|2|||
16772792|NCT02435966|37711543|FG000|Overall Study|Withdrawal by Subject|0|||
16772793|NCT02435966|37711544|FG001|Overall Study|Withdrawal by Subject|1|||
16772794|NCT02435966|37711545|FG002|Overall Study|Withdrawal by Subject|0|||
16772795|NCT01679301|37711553|FG000|Screening Period|screen failure|3|||
16772796|NCT01679301|37711554|FG001|Screening Period|screen failure|0|||
16772797|NCT01679301|37711555|FG002|Screening Period|screen failure|0|||
16772798|NCT01678911|37711561|FG000|Second Intervention|Lost to Follow-up|2|||
16772799|NCT01678911|37711562|FG001|Second Intervention|Lost to Follow-up|0|||
16772800|NCT02487446|37711568|FG000|Period 1|Physician Decision|0|||
16772801|NCT02487446|37711569|FG001|Period 1|Physician Decision|1|||
16772802|NCT02487446|37711568|FG000|Period 1|Lack of Efficacy|1|||
16772803|NCT02487446|37711569|FG001|Period 1|Lack of Efficacy|0|||
16772804|NCT02487446|37711568|FG000|Period 1|Protocol deviation|3|||
16772805|NCT02487446|37711569|FG001|Period 1|Protocol deviation|2|||
16772806|NCT02487446|37711568|FG000|Period 1|Lost to Follow-up|2|||
16772807|NCT02487446|37711569|FG001|Period 1|Lost to Follow-up|0|||
16772808|NCT02487446|37711568|FG000|Period 1|Withdrawal by Subject|2|||
16772809|NCT02487446|37711569|FG001|Period 1|Withdrawal by Subject|0|||
16772810|NCT02487446|37711568|FG000|Period 1|Adverse Event|5|||
16772811|NCT02487446|37711569|FG001|Period 1|Adverse Event|5|||
16772812|NCT02487446|37711568|FG000|Washout|Lost to Follow-up|0|||
16772813|NCT02487446|37711569|FG001|Washout|Lost to Follow-up|2|||
16772814|NCT02487446|37711568|FG000|Washout|Withdrawal by Subject|1|||
16772815|NCT02487446|37711569|FG001|Washout|Withdrawal by Subject|4|||
16772816|NCT02487446|37711568|FG000|Washout|Adverse Event|2|||
16772817|NCT02487446|37711569|FG001|Washout|Adverse Event|2|||
16772818|NCT02487446|37711568|FG000|Period 2|Protocol deviation|0|||
16772819|NCT02487446|37711569|FG001|Period 2|Protocol deviation|1|||
16772820|NCT02487446|37711568|FG000|Period 2|Lost to Follow-up|1|||
16772821|NCT02487446|37711569|FG001|Period 2|Lost to Follow-up|1|||
16772822|NCT02487446|37711568|FG000|Period 2|Withdrawal by Subject|1|||
16772823|NCT02487446|37711569|FG001|Period 2|Withdrawal by Subject|1|||
16772824|NCT02487446|37711568|FG000|Period 2|Adverse Event|6|||
16772825|NCT02487446|37711569|FG001|Period 2|Adverse Event|2|||
16772826|NCT02739269|37711578|FG000|Overall Study|Protocol Violation|5|||
17115564|NCT03787212|38253648|FG000|Period 1|Study Termination|2|||
16772827|NCT02739269|37711579|FG001|Overall Study|Protocol Violation|0|||
16772828|NCT02739269|37711578|FG000|Overall Study|Cycle cancellation|2|||
16772829|NCT02739269|37711579|FG001|Overall Study|Cycle cancellation|2|||
16772830|NCT02739269|37711578|FG000|Overall Study|Withdrawal by Subject|0|||
16772831|NCT02739269|37711579|FG001|Overall Study|Withdrawal by Subject|2|||
16772832|NCT03318523|37711589|FG000|PC Period: Up to Year 1|Adverse Event|1|||
16772833|NCT03318523|37711590|FG001|PC Period: Up to Year 1|Adverse Event|0|||
16772834|NCT03318523|37711591|FG002|PC Period: Up to Year 1|Adverse Event|2|||
16772835|NCT03318523|37711592|FG003|PC Period: Up to Year 1|Adverse Event|0|||
16772836|NCT03318523|37711593|FG004|PC Period: Up to Year 1|Adverse Event|0|||
16772837|NCT03318523|37711594|FG005|PC Period: Up to Year 1|Adverse Event|0|||
16772838|NCT03318523|37711595|FG006|PC Period: Up to Year 1|Adverse Event|0|||
16772839|NCT03318523|37711596|FG007|PC Period: Up to Year 1|Adverse Event|0|||
16772840|NCT03318523|37711597|FG008|PC Period: Up to Year 1|Adverse Event|0|||
16772841|NCT03318523|37711598|FG009|PC Period: Up to Year 1|Adverse Event|0|||
16772842|NCT03318523|37711589|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
16772843|NCT03318523|37711590|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
16772844|NCT03318523|37711591|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
16772845|NCT03318523|37711592|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
16772846|NCT03318523|37711593|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
16772847|NCT03318523|37711594|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
16772848|NCT03318523|37711595|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
16772849|NCT03318523|37711596|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
16772850|NCT03318523|37711597|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
16772851|NCT03318523|37711598|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
16772852|NCT03318523|37711589|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16772853|NCT03318523|37711590|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16772854|NCT03318523|37711591|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16772855|NCT03318523|37711592|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16772856|NCT03318523|37711593|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
16772857|NCT03318523|37711594|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16772858|NCT03318523|37711595|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16772859|NCT03318523|37711596|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
16772860|NCT03318523|37711597|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16772861|NCT03318523|37711598|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
16772862|NCT03318523|37711589|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16772863|NCT03318523|37711590|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16772864|NCT03318523|37711591|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16772865|NCT03318523|37711592|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16772866|NCT03318523|37711593|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
16772867|NCT03318523|37711594|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16772868|NCT03318523|37711595|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16772869|NCT03318523|37711596|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
16772870|NCT03318523|37711597|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
16772871|NCT03318523|37711598|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
16772872|NCT03318523|37711589|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772873|NCT03318523|37711590|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772874|NCT03318523|37711591|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772875|NCT03318523|37711592|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772876|NCT03318523|37711593|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772877|NCT03318523|37711594|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
16772878|NCT03318523|37711595|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772879|NCT03318523|37711596|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772880|NCT03318523|37711597|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772881|NCT03318523|37711598|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16772882|NCT03318523|37711589|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772883|NCT03318523|37711590|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772884|NCT03318523|37711591|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772885|NCT03318523|37711592|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772886|NCT03318523|37711593|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772887|NCT03318523|37711594|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772888|NCT03318523|37711595|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772889|NCT03318523|37711596|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772890|NCT03318523|37711597|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16772891|NCT03318523|37711598|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
16772892|NCT03318523|37711589|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
16772893|NCT03318523|37711590|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
16772894|NCT03318523|37711591|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
16772895|NCT03318523|37711592|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
16772896|NCT03318523|37711593|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
16772897|NCT03318523|37711594|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
16772898|NCT03318523|37711595|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
16772899|NCT03318523|37711596|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
16772900|NCT03318523|37711597|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
16772901|NCT03318523|37711598|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
16772902|NCT03318523|37711589|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16772903|NCT03318523|37711590|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16772904|NCT03318523|37711591|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16772905|NCT03318523|37711592|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16772906|NCT03318523|37711593|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
16772907|NCT03318523|37711594|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16772908|NCT03318523|37711595|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16772909|NCT03318523|37711596|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
16772910|NCT03318523|37711597|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
16772911|NCT03318523|37711598|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16772912|NCT01678209|37711625|FG000|Overall Study|could not scan twice|1|||
16772913|NCT01678209|37711626|FG001|Overall Study|could not scan twice|1|||
16772914|NCT01678209|37711627|FG002|Overall Study|could not scan twice|1|||
16772915|NCT01678209|37711625|FG000|Overall Study|scheduling conflicts|0|||
16772916|NCT01678209|37711626|FG001|Overall Study|scheduling conflicts|0|||
16772917|NCT01678209|37711627|FG002|Overall Study|scheduling conflicts|1|||
16772918|NCT01678209|37711625|FG000|Overall Study|screen fail|16|||
16772919|NCT01678209|37711626|FG001|Overall Study|screen fail|17|||
16772920|NCT01678209|37711627|FG002|Overall Study|screen fail|16|||
16772921|NCT02239120|37711637|FG000|Overall Study|Death|56|||
16772922|NCT02239120|37711638|FG001|Overall Study|Death|58|||
16772923|NCT02239120|37711637|FG000|Overall Study|Lost to Follow-up|19|||
16772924|NCT02239120|37711638|FG001|Overall Study|Lost to Follow-up|14|||
16772925|NCT01603407|37711647|FG000|Overall Study|Adverse Event|1|||
16772926|NCT01603407|37711648|FG001|Overall Study|Adverse Event|1|||
16772927|NCT01603407|37711649|FG002|Overall Study|Adverse Event|1|||
16772928|NCT01603407|37711647|FG000|Overall Study|Protocol Violation|2|||
16772929|NCT01603407|37711648|FG001|Overall Study|Protocol Violation|2|||
16772930|NCT01603407|37711649|FG002|Overall Study|Protocol Violation|0|||
16772931|NCT01603407|37711647|FG000|Overall Study|Withdrawal by Subject|8|||
16772932|NCT01603407|37711648|FG001|Overall Study|Withdrawal by Subject|5|||
16772933|NCT01603407|37711649|FG002|Overall Study|Withdrawal by Subject|7|||
16772934|NCT01603407|37711647|FG000|Overall Study|Lost to Follow-up|0|||
16772935|NCT01603407|37711648|FG001|Overall Study|Lost to Follow-up|3|||
16772936|NCT01603407|37711649|FG002|Overall Study|Lost to Follow-up|2|||
16772937|NCT03777436|37711659|FG000|Placebo-controlled Phase|Adverse Event|8|||
16772938|NCT03777436|37711660|FG001|Placebo-controlled Phase|Adverse Event|10|||
16772939|NCT03777436|37711661|FG002|Placebo-controlled Phase|Adverse Event|0|||
16772940|NCT03777436|37711659|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
16772941|NCT03777436|37711660|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
16772942|NCT03777436|37711661|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
16772943|NCT03777436|37711659|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
16772944|NCT03777436|37711660|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
16772945|NCT03777436|37711661|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
16772946|NCT03777436|37711659|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
16772947|NCT03777436|37711660|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
16772948|NCT03777436|37711661|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
16772949|NCT03777436|37711659|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
16772950|NCT03777436|37711660|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
16772951|NCT03777436|37711661|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
16772952|NCT03777436|37711659|FG000|Placebo-controlled Phase|Physician Decision|0|||
16772953|NCT03777436|37711660|FG001|Placebo-controlled Phase|Physician Decision|1|||
16772954|NCT03777436|37711661|FG002|Placebo-controlled Phase|Physician Decision|0|||
16772955|NCT03777436|37711659|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
16772956|NCT03777436|37711660|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
17115565|NCT03787212|38253649|FG001|Period 1|Study Termination|2|||
16772957|NCT03777436|37711661|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
16772958|NCT03777436|37711659|FG000|Apremilast Extension Phase|Adverse Event|0|||
16772959|NCT03777436|37711660|FG001|Apremilast Extension Phase|Adverse Event|0|||
16772960|NCT03777436|37711661|FG002|Apremilast Extension Phase|Adverse Event|6|||
16772961|NCT03777436|37711659|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
16772962|NCT03777436|37711660|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
16772963|NCT03777436|37711661|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
16772964|NCT03777436|37711659|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
16772965|NCT03777436|37711660|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
16772966|NCT03777436|37711661|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
16772967|NCT03777436|37711659|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
16772968|NCT03777436|37711660|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
16772969|NCT03777436|37711661|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
16772970|NCT03777436|37711659|FG000|Apremilast Extension Phase|Miscellaneous|0|||
16772971|NCT03777436|37711660|FG001|Apremilast Extension Phase|Miscellaneous|0|||
16772972|NCT03777436|37711661|FG002|Apremilast Extension Phase|Miscellaneous|1|||
16772973|NCT02235454|37711690|FG000|Overall Study|Withdrawal by Subject|2|||
17115566|NCT03125200|38253662|FG000|Overall Study|Study Termination|0|||
17115567|NCT03125200|38253663|FG001|Overall Study|Study Termination|0|||
17115568|NCT03125200|38253664|FG002|Overall Study|Study Termination|0|||
17115569|NCT03125200|38253665|FG003|Overall Study|Study Termination|1|||
17115570|NCT03125200|38253666|FG004|Overall Study|Study Termination|1|||
17115571|NCT03125200|38253667|FG005|Overall Study|Study Termination|2|||
17115572|NCT03125200|38253668|FG006|Overall Study|Study Termination|1|||
17115573|NCT03125200|38253662|FG000|Overall Study|Clinical Progression|0|||
17115574|NCT03125200|38253663|FG001|Overall Study|Clinical Progression|0|||
17115575|NCT03125200|38253664|FG002|Overall Study|Clinical Progression|0|||
17115576|NCT03125200|38253665|FG003|Overall Study|Clinical Progression|1|||
17115577|NCT03125200|38253666|FG004|Overall Study|Clinical Progression|0|||
17115578|NCT03125200|38253667|FG005|Overall Study|Clinical Progression|1|||
17115579|NCT03125200|38253668|FG006|Overall Study|Clinical Progression|0|||
17115580|NCT03125200|38253662|FG000|Overall Study|Progressive Disease|2|||
17115581|NCT03125200|38253663|FG001|Overall Study|Progressive Disease|1|||
17115582|NCT03125200|38253664|FG002|Overall Study|Progressive Disease|2|||
17115583|NCT03125200|38253665|FG003|Overall Study|Progressive Disease|1|||
17115584|NCT03125200|38253666|FG004|Overall Study|Progressive Disease|2|||
17115585|NCT03125200|38253667|FG005|Overall Study|Progressive Disease|0|||
17115586|NCT03125200|38253668|FG006|Overall Study|Progressive Disease|1|||
17115587|NCT03125200|38253662|FG000|Overall Study|Lack of Efficacy|0|||
17115588|NCT03125200|38253663|FG001|Overall Study|Lack of Efficacy|0|||
17115589|NCT03125200|38253664|FG002|Overall Study|Lack of Efficacy|0|||
17115590|NCT03125200|38253665|FG003|Overall Study|Lack of Efficacy|1|||
17115591|NCT03125200|38253666|FG004|Overall Study|Lack of Efficacy|0|||
17115592|NCT03125200|38253667|FG005|Overall Study|Lack of Efficacy|0|||
17115593|NCT03125200|38253668|FG006|Overall Study|Lack of Efficacy|0|||
17115594|NCT03125200|38253662|FG000|Overall Study|Toxicity|0|||
17115595|NCT03125200|38253663|FG001|Overall Study|Toxicity|0|||
17115596|NCT03125200|38253664|FG002|Overall Study|Toxicity|0|||
17115597|NCT03125200|38253665|FG003|Overall Study|Toxicity|1|||
17115598|NCT03125200|38253666|FG004|Overall Study|Toxicity|0|||
17115599|NCT03125200|38253667|FG005|Overall Study|Toxicity|0|||
17115600|NCT03125200|38253668|FG006|Overall Study|Toxicity|0|||
17115601|NCT03125200|38253662|FG000|Overall Study|Consent Withdrawn by Subject|0|||
17115602|NCT03125200|38253663|FG001|Overall Study|Consent Withdrawn by Subject|1|||
17115603|NCT03125200|38253664|FG002|Overall Study|Consent Withdrawn by Subject|0|||
17115604|NCT03125200|38253665|FG003|Overall Study|Consent Withdrawn by Subject|0|||
17115605|NCT03125200|38253666|FG004|Overall Study|Consent Withdrawn by Subject|1|||
17115606|NCT03125200|38253667|FG005|Overall Study|Consent Withdrawn by Subject|0|||
17115607|NCT03125200|38253668|FG006|Overall Study|Consent Withdrawn by Subject|1|||
17115608|NCT03132220|38253689|FG000|Overall Study|Lost to Follow-up|17|||
17115609|NCT03132220|38253690|FG001|Overall Study|Lost to Follow-up|8|||
17115610|NCT03132220|38253689|FG000|Overall Study|Withdrawal by Subject|1|||
17115611|NCT03132220|38253690|FG001|Overall Study|Withdrawal by Subject|4|||
17115612|NCT03119662|38253698|FG000|Overall Study|Withdrawal by Subject|0|||
17115613|NCT03119662|38253699|FG001|Overall Study|Withdrawal by Subject|1|||
17115614|NCT02728804|38253705|FG000|Overall Study|Ineligible|3|||
17115615|NCT02728804|38253705|FG000|Overall Study|Did not complete baseline questionnaire|9|||
17115616|NCT02728804|38253705|FG000|Overall Study|Death|99|||
17115617|NCT02699554|38253721|FG000|Overall Study|Lost to Follow-up|9|||
17115618|NCT03783780|38253746|FG000|Overall Study|Withdrawn prior to completion|1|||
17115619|NCT03783702|38253753|FG000|Overall Study|Lost to Follow-up|6|||
17115620|NCT03783702|38253754|FG001|Overall Study|Lost to Follow-up|8|||
17115621|NCT03783702|38253753|FG000|Overall Study|Protocol Violation|1|||
17115622|NCT03783702|38253754|FG001|Overall Study|Protocol Violation|3|||
17115623|NCT03575572|38253762|FG000|Overall Study|Withdrawal by Subject|2|||
16772974|NCT02235298|37711696|FG000|Overall Study|Lost to Follow-up|6|||
16772975|NCT02235298|37711697|FG001|Overall Study|Lost to Follow-up|5|||
17115624|NCT03575572|38253762|FG000|Overall Study|Physician Decision|2|||
17115625|NCT03116698|38253788|FG000|Overall Study|Adverse Event|1|||
17115626|NCT03116698|38253789|FG001|Overall Study|Adverse Event|1|||
17115627|NCT03116698|38253790|FG002|Overall Study|Adverse Event|1|||
17115628|NCT03116698|38253791|FG003|Overall Study|Adverse Event|0|||
17115629|NCT03116698|38253788|FG000|Overall Study|Withdrawal by Subject|1|||
17115630|NCT03116698|38253789|FG001|Overall Study|Withdrawal by Subject|4|||
17115631|NCT03116698|38253790|FG002|Overall Study|Withdrawal by Subject|5|||
17115632|NCT03116698|38253791|FG003|Overall Study|Withdrawal by Subject|2|||
17115633|NCT03116698|38253788|FG000|Overall Study|Lost to Follow-up|2|||
17115634|NCT03116698|38253789|FG001|Overall Study|Lost to Follow-up|0|||
17115635|NCT03116698|38253790|FG002|Overall Study|Lost to Follow-up|0|||
17115636|NCT03116698|38253791|FG003|Overall Study|Lost to Follow-up|0|||
17115637|NCT03116698|38253788|FG000|Overall Study|Physician Decision|1|||
17115638|NCT03116698|38253789|FG001|Overall Study|Physician Decision|1|||
17115639|NCT03116698|38253790|FG002|Overall Study|Physician Decision|0|||
17115640|NCT03116698|38253791|FG003|Overall Study|Physician Decision|0|||
17115641|NCT03116698|38253788|FG000|Overall Study|Protocol Violation|1|||
17115642|NCT03116698|38253789|FG001|Overall Study|Protocol Violation|0|||
17115643|NCT03116698|38253790|FG002|Overall Study|Protocol Violation|0|||
17115644|NCT03116698|38253791|FG003|Overall Study|Protocol Violation|0|||
17115645|NCT03116698|38253788|FG000|Overall Study|Death|0|||
17115646|NCT03116698|38253789|FG001|Overall Study|Death|0|||
17115647|NCT03116698|38253790|FG002|Overall Study|Death|2|||
17115648|NCT03116698|38253791|FG003|Overall Study|Death|0|||
17115649|NCT03116152|38253803|FG000|Overall Study|Disease Progression|49|||
17115650|NCT03116152|38253804|FG001|Overall Study|Disease Progression|47|||
17115651|NCT03116152|38253803|FG000|Overall Study|Death|5|||
17115652|NCT03116152|38253804|FG001|Overall Study|Death|2|||
17115653|NCT03116152|38253803|FG000|Overall Study|Adverse Event|21|||
17115654|NCT03116152|38253804|FG001|Overall Study|Adverse Event|7|||
17115655|NCT03116152|38253803|FG000|Overall Study|Protocol Violation|2|||
17115656|NCT03116152|38253804|FG001|Overall Study|Protocol Violation|2|||
17115657|NCT03116152|38253803|FG000|Overall Study|Withdrawal by Subject|0|||
17115658|NCT03116152|38253804|FG001|Overall Study|Withdrawal by Subject|1|||
17115659|NCT03116152|38253803|FG000|Overall Study|Physician Decision|3|||
17115660|NCT03116152|38253804|FG001|Overall Study|Physician Decision|2|||
17115661|NCT03116152|38253803|FG000|Overall Study|other|11|||
17115662|NCT03116152|38253804|FG001|Overall Study|other|34|||
17115663|NCT00226499|38253815|FG000|Overall Study|Adverse Event|10|||
17115664|NCT00226499|38253816|FG001|Overall Study|Adverse Event|6|||
17115665|NCT00226499|38253817|FG002|Overall Study|Adverse Event|3|||
17115666|NCT00226499|38253815|FG000|Overall Study|Others|1064|||
17115667|NCT00226499|38253816|FG001|Overall Study|Others|1066|||
17115668|NCT00226499|38253817|FG002|Overall Study|Others|356|||
17115669|NCT01400776|38253831|FG000|Overall Study|Adverse Event|7|||
17115670|NCT01400776|38253832|FG001|Overall Study|Adverse Event|2|||
17115671|NCT01400776|38253833|FG002|Overall Study|Adverse Event|9|||
17115672|NCT01400776|38253834|FG003|Overall Study|Adverse Event|2|||
17115673|NCT01400776|38253831|FG000|Overall Study|Lost to Follow-up|1|||
17115674|NCT01400776|38253832|FG001|Overall Study|Lost to Follow-up|0|||
17115675|NCT01400776|38253833|FG002|Overall Study|Lost to Follow-up|4|||
17115676|NCT01400776|38253834|FG003|Overall Study|Lost to Follow-up|1|||
17115677|NCT01400776|38253831|FG000|Overall Study|Withdrew Consent|4|||
17115678|NCT01400776|38253832|FG001|Overall Study|Withdrew Consent|2|||
17115679|NCT01400776|38253833|FG002|Overall Study|Withdrew Consent|6|||
17115680|NCT01400776|38253834|FG003|Overall Study|Withdrew Consent|1|||
17115681|NCT01400776|38253831|FG000|Overall Study|Protocol Deviation|6|||
17115682|NCT01400776|38253832|FG001|Overall Study|Protocol Deviation|1|||
17115683|NCT01400776|38253833|FG002|Overall Study|Protocol Deviation|5|||
17115684|NCT01400776|38253834|FG003|Overall Study|Protocol Deviation|2|||
17115685|NCT01400776|38253831|FG000|Overall Study|Reason not Specified|3|||
17115686|NCT01400776|38253832|FG001|Overall Study|Reason not Specified|0|||
17115687|NCT01400776|38253833|FG002|Overall Study|Reason not Specified|4|||
17115688|NCT01400776|38253834|FG003|Overall Study|Reason not Specified|3|||
17115689|NCT03131596|38253846|FG000|Overall Study|Protocol Violation|3|||
17115690|NCT03131596|38253847|FG001|Overall Study|Protocol Violation|3|||
17115691|NCT03131596|38253846|FG000|Overall Study|Lost to Follow-up|3|||
17115692|NCT03131596|38253847|FG001|Overall Study|Lost to Follow-up|0|||
17115693|NCT00255047|38253861|FG000|Overall Study|Serious Adverse Events|2|||
17115694|NCT00255047|38253862|FG001|Overall Study|Serious Adverse Events|1|||
17115695|NCT00255047|38253863|FG002|Overall Study|Serious Adverse Events|2|||
17115696|NCT00255047|38253864|FG003|Overall Study|Serious Adverse Events|1|||
17115697|NCT00255047|38253861|FG000|Overall Study|Adverse Event|0|||
17115698|NCT00255047|38253862|FG001|Overall Study|Adverse Event|3|||
17115699|NCT00255047|38253863|FG002|Overall Study|Adverse Event|2|||
17115700|NCT00255047|38253864|FG003|Overall Study|Adverse Event|1|||
17115701|NCT00255047|38253861|FG000|Overall Study|Protocol Violation|13|||
17115702|NCT00255047|38253862|FG001|Overall Study|Protocol Violation|13|||
17115703|NCT00255047|38253863|FG002|Overall Study|Protocol Violation|16|||
17115704|NCT00255047|38253864|FG003|Overall Study|Protocol Violation|20|||
17115705|NCT00255047|38253861|FG000|Overall Study|Lost to Follow-up|9|||
17115706|NCT00255047|38253862|FG001|Overall Study|Lost to Follow-up|8|||
17115707|NCT00255047|38253863|FG002|Overall Study|Lost to Follow-up|5|||
17115708|NCT00255047|38253864|FG003|Overall Study|Lost to Follow-up|6|||
17115709|NCT00255047|38253861|FG000|Overall Study|Withdrawal by Subject|24|||
17115710|NCT00255047|38253862|FG001|Overall Study|Withdrawal by Subject|23|||
17115711|NCT00255047|38253863|FG002|Overall Study|Withdrawal by Subject|25|||
17115712|NCT00255047|38253864|FG003|Overall Study|Withdrawal by Subject|18|||
17115713|NCT00225251|38253876|FG000|Overall Study|Withdrawal by Subject|1|||
17115714|NCT00225251|38253877|FG001|Overall Study|Withdrawal by Subject|1|||
17115715|NCT00254501|38253885|FG000|Overall Study|Lost to Follow-up|1|||
17115716|NCT00254501|38253886|FG001|Overall Study|Lost to Follow-up|1|||
17115717|NCT00253643|38253898|FG000|Overall Study|Withdrawal by Subject|0|||
17115718|NCT00253643|38253899|FG001|Overall Study|Withdrawal by Subject|0|||
17115719|NCT00253643|38253900|FG002|Overall Study|Withdrawal by Subject|1|||
17115720|NCT00253643|38253901|FG003|Overall Study|Withdrawal by Subject|1|||
17115721|NCT00253643|38253898|FG000|Overall Study|Non-Compliance|0|||
17115722|NCT00253643|38253899|FG001|Overall Study|Non-Compliance|0|||
17115723|NCT00253643|38253900|FG002|Overall Study|Non-Compliance|0|||
17115724|NCT00253643|38253901|FG003|Overall Study|Non-Compliance|2|||
17115725|NCT00221195|38253913|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
17115726|NCT00221195|38253914|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
17115727|NCT00221195|38253913|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
17115728|NCT00221195|38253914|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
17115729|NCT00221195|38253913|FG000|Washout Period (Months 7-9)|Death|0|||
17115730|NCT00221195|38253914|FG001|Washout Period (Months 7-9)|Death|1|||
17115731|NCT00221195|38253913|FG000|Therapy 2 (Months 10-15)|Death|1|||
17115732|NCT00221195|38253914|FG001|Therapy 2 (Months 10-15)|Death|0|||
17115733|NCT00221195|38253913|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
17115734|NCT00221195|38253914|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
17115735|NCT00220805|38253923|FG000|Overall Study|Adverse Event|1|||
17115736|NCT00220805|38253924|FG001|Overall Study|Adverse Event|3|||
17115737|NCT00220805|38253923|FG000|Overall Study|Withdrawal by Subject|3|||
17115738|NCT00220805|38253924|FG001|Overall Study|Withdrawal by Subject|0|||
17115739|NCT00220805|38253923|FG000|Overall Study|Lack of Efficacy|1|||
17115740|NCT00220805|38253924|FG001|Overall Study|Lack of Efficacy|0|||
17115741|NCT00220805|38253923|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
17115742|NCT00220805|38253924|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
17115743|NCT00220727|38253932|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
17115744|NCT00220727|38253933|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
17115745|NCT04495816|38253943|FG000|Overall Study|Lost to Follow-up|10|||
17115746|NCT04495816|38253944|FG001|Overall Study|Lost to Follow-up|4|||
17115747|NCT04495816|38253943|FG000|Overall Study|Withdrawal by Subject|3|||
17115748|NCT04495816|38253944|FG001|Overall Study|Withdrawal by Subject|5|||
17115749|NCT03971357|38253952|FG000|Overall Study|Lack of Efficacy|0|||
17115750|NCT03971357|38253953|FG001|Overall Study|Lack of Efficacy|1|||
17115751|NCT04310566|38253959|FG000|Period 1|Study Termination due to COVID-19|15|||
17115752|NCT04310566|38253960|FG001|Period 1|Study Termination due to COVID-19|17|||
17115753|NCT04310566|38253959|FG000|Period 1|Protocol Violation|0|||
17115754|NCT04310566|38253960|FG001|Period 1|Protocol Violation|1|||
17115755|NCT04310566|38253959|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
17115756|NCT04310566|38253960|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
17115757|NCT04310566|38253959|FG000|Period 1|Lost to Follow-up|1|||
17115758|NCT04310566|38253960|FG001|Period 1|Lost to Follow-up|0|||
17115759|NCT04310566|38253959|FG000|Period 1|Withdrawal by Subject|0|||
17115760|NCT04310566|38253960|FG001|Period 1|Withdrawal by Subject|1|||
17115761|NCT04310566|38253959|FG000|Period 2|Study Termination|7|||
17115762|NCT04310566|38253960|FG001|Period 2|Study Termination|5|||
17115763|NCT00252239|38253970|FG000|Overall Study|Withdrawal by Subject|1|||
17115764|NCT00252239|38253971|FG001|Overall Study|Withdrawal by Subject|0|||
17115765|NCT00252239|38253972|FG002|Overall Study|Withdrawal by Subject|0|||
17115766|NCT00252239|38253973|FG003|Overall Study|Withdrawal by Subject|1|||
17115767|NCT00252239|38253970|FG000|Overall Study|Lost to Follow-up|0|||
17115768|NCT00252239|38253971|FG001|Overall Study|Lost to Follow-up|0|||
17115769|NCT00252239|38253972|FG002|Overall Study|Lost to Follow-up|2|||
17115770|NCT00252239|38253973|FG003|Overall Study|Lost to Follow-up|0|||
17115771|NCT03103906|38253985|FG000|Overall Study|Adverse Event|2|||
17115772|NCT03103906|38253986|FG001|Overall Study|Adverse Event|3|||
17115773|NCT03103906|38253985|FG000|Overall Study|Other|2|||
17115774|NCT03103906|38253986|FG001|Overall Study|Other|0|||
17115775|NCT04799158|38253996|FG000|Run-In Period|Adverse Event|6|||
17115776|NCT04799158|38253997|FG001|Run-In Period|Adverse Event|0|||
17115777|NCT04799158|38253998|FG002|Run-In Period|Adverse Event|0|||
17115778|NCT04799158|38253999|FG003|Run-In Period|Adverse Event|0|||
17115779|NCT04799158|38254000|FG004|Run-In Period|Adverse Event|0|||
17115780|NCT04799158|38253996|FG000|Run-In Period|Lost to Follow-up|4|||
17115781|NCT04799158|38253997|FG001|Run-In Period|Lost to Follow-up|0|||
17115782|NCT04799158|38253998|FG002|Run-In Period|Lost to Follow-up|0|||
17115783|NCT04799158|38253999|FG003|Run-In Period|Lost to Follow-up|0|||
17115784|NCT04799158|38254000|FG004|Run-In Period|Lost to Follow-up|0|||
17115785|NCT04799158|38253996|FG000|Run-In Period|Significant Protocol Deviation|1|||
17115786|NCT04799158|38253997|FG001|Run-In Period|Significant Protocol Deviation|0|||
17115787|NCT04799158|38253998|FG002|Run-In Period|Significant Protocol Deviation|0|||
17115788|NCT04799158|38253999|FG003|Run-In Period|Significant Protocol Deviation|0|||
17115789|NCT04799158|38254000|FG004|Run-In Period|Significant Protocol Deviation|0|||
17115790|NCT04799158|38253996|FG000|Run-In Period|Withdrawal by Subject|11|||
17115791|NCT04799158|38253997|FG001|Run-In Period|Withdrawal by Subject|0|||
17115792|NCT04799158|38253998|FG002|Run-In Period|Withdrawal by Subject|0|||
17115793|NCT04799158|38253999|FG003|Run-In Period|Withdrawal by Subject|0|||
17115794|NCT04799158|38254000|FG004|Run-In Period|Withdrawal by Subject|0|||
17115795|NCT04799158|38253996|FG000|Run-In Period|Miscellaneous|3|||
17115796|NCT04799158|38253997|FG001|Run-In Period|Miscellaneous|0|||
17115797|NCT04799158|38253998|FG002|Run-In Period|Miscellaneous|0|||
17115798|NCT04799158|38253999|FG003|Run-In Period|Miscellaneous|0|||
17115799|NCT04799158|38254000|FG004|Run-In Period|Miscellaneous|0|||
17115800|NCT04799158|38253996|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
17115801|NCT04799158|38253997|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
17115802|NCT04799158|38253998|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
17115803|NCT04799158|38253999|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
17115804|NCT04799158|38254000|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
17115805|NCT04799158|38253996|FG000|On-Demand Treatment Period|Adverse Event|0|||
17115806|NCT04799158|38253997|FG001|On-Demand Treatment Period|Adverse Event|1|||
17115807|NCT04799158|38253998|FG002|On-Demand Treatment Period|Adverse Event|0|||
17115808|NCT04799158|38253999|FG003|On-Demand Treatment Period|Adverse Event|0|||
17115809|NCT04799158|38254000|FG004|On-Demand Treatment Period|Adverse Event|1|||
17115810|NCT04799158|38253996|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
17115811|NCT04799158|38253997|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
17115812|NCT04799158|38253998|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
17115813|NCT04799158|38253999|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
17115814|NCT04799158|38254000|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
17115815|NCT04799158|38253996|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
17115816|NCT04799158|38253997|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
17115817|NCT04799158|38253998|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
17115818|NCT04799158|38253999|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
17115819|NCT04799158|38254000|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
17115820|NCT04799158|38253996|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
17115821|NCT04799158|38253997|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
17115822|NCT04799158|38253998|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
17115823|NCT04799158|38253999|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
17115824|NCT04799158|38254000|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
17115825|NCT04799158|38253996|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
17115826|NCT04799158|38253997|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
17115827|NCT04799158|38253998|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
17115828|NCT04799158|38253999|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
17115829|NCT04799158|38254000|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
17115830|NCT04799158|38253996|FG000|On-Demand Treatment Period|Miscellaneous|0|||
17115831|NCT04799158|38253997|FG001|On-Demand Treatment Period|Miscellaneous|0|||
17115832|NCT04799158|38253998|FG002|On-Demand Treatment Period|Miscellaneous|0|||
17115833|NCT04799158|38253999|FG003|On-Demand Treatment Period|Miscellaneous|0|||
17115834|NCT04799158|38254000|FG004|On-Demand Treatment Period|Miscellaneous|1|||
17115835|NCT01319422|38254013|FG000|Overall Study|Withdrawal by Subject|1|||
17115836|NCT01319422|38254014|FG001|Overall Study|Withdrawal by Subject|0|||
17115837|NCT03102034|38254022|FG000|Overall Study|Withdrawal by Subject|1|||
17115838|NCT03102034|38254023|FG001|Overall Study|Withdrawal by Subject|0|||
17115839|NCT03774576|38254029|FG000|Period 2|Adverse Event|1|||
17115840|NCT02928952|38254040|FG000|Overall Study|Lost to Follow-up|5|||
17115841|NCT02928952|38254041|FG001|Overall Study|Lost to Follow-up|5|||
17115842|NCT02928952|38254040|FG000|Overall Study|Withdrawal by Subject|5|||
17115843|NCT02928952|38254041|FG001|Overall Study|Withdrawal by Subject|1|||
17115844|NCT02928952|38254040|FG000|Overall Study|Physician Decision|0|||
17115845|NCT02928952|38254041|FG001|Overall Study|Physician Decision|1|||
17115846|NCT03773796|38254047|FG000|Overall Study|Adverse Event|1|||
17115847|NCT03773796|38254047|FG000|Overall Study|Withdrawal by Subject|1|||
17115848|NCT03773796|38254047|FG000|Overall Study|Lack of Efficacy|1|||
17115849|NCT02927938|38254055|FG000|Overall Study|Death|0|||
17115850|NCT02927938|38254056|FG001|Overall Study|Death|1|||
17115851|NCT02927938|38254057|FG002|Overall Study|Death|0|||
17115852|NCT02927938|38254058|FG003|Overall Study|Death|4|||
17115853|NCT02927938|38254055|FG000|Overall Study|Early Study Termination|1|||
17115854|NCT02927938|38254056|FG001|Overall Study|Early Study Termination|5|||
17115855|NCT02927938|38254057|FG002|Overall Study|Early Study Termination|4|||
17115856|NCT02927938|38254058|FG003|Overall Study|Early Study Termination|3|||
17115857|NCT03765138|38254066|FG000|Overall Study|Lost to Follow-up|1|||
17115858|NCT03768726|38254073|FG000|Treatment Phase|Adverse Event|2|||
17115859|NCT03768726|38254074|FG001|Treatment Phase|Adverse Event|2|||
17115860|NCT03768726|38254073|FG000|Treatment Phase|Lost to Follow-up|1|||
17115861|NCT03768726|38254074|FG001|Treatment Phase|Lost to Follow-up|0|||
17115862|NCT03768726|38254073|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
17115863|NCT03768726|38254074|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
17115864|NCT03768726|38254073|FG000|Treatment Phase|Withdrawal by Subject|3|||
17115865|NCT03768726|38254074|FG001|Treatment Phase|Withdrawal by Subject|1|||
17115866|NCT03768726|38254073|FG000|Follow-Up|Adverse Event|2|||
17115867|NCT03768726|38254074|FG001|Follow-Up|Adverse Event|2|||
17115868|NCT03768726|38254073|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
17115869|NCT03768726|38254074|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
17115870|NCT03768726|38254073|FG000|Follow-Up|Withdrawal by Subject|2|||
17115871|NCT03768726|38254074|FG001|Follow-Up|Withdrawal by Subject|0|||
17115872|NCT03768726|38254073|FG000|Follow-Up|Other|1|||
17115873|NCT03768726|38254074|FG001|Follow-Up|Other|0|||
17115874|NCT03769896|38254082|FG000|Open-label Phase|Lack of Efficacy|5|||
17115875|NCT03769896|38254083|FG001|Open-label Phase|Lack of Efficacy|0|||
17115876|NCT03769896|38254082|FG000|Open-label Phase|Adverse Event|3|||
17115877|NCT03769896|38254083|FG001|Open-label Phase|Adverse Event|0|||
17115878|NCT03769896|38254082|FG000|Open-label Phase|Withdrawal by Subject|1|||
17115879|NCT03769896|38254083|FG001|Open-label Phase|Withdrawal by Subject|0|||
17115880|NCT00219557|38254093|FG000|Phase 1|Lack of Efficacy|3|||
17115881|NCT00219557|38254094|FG001|Phase 1|Lack of Efficacy|0|||
17115882|NCT00219557|38254095|FG002|Phase 1|Lack of Efficacy|0|||
17115883|NCT00219557|38254093|FG000|Phase 1|Adverse Event|2|||
17115884|NCT00219557|38254094|FG001|Phase 1|Adverse Event|0|||
17115885|NCT00219557|38254095|FG002|Phase 1|Adverse Event|0|||
17115886|NCT00219557|38254093|FG000|Phase 1|Withdrawal by Subject|1|||
17115887|NCT00219557|38254094|FG001|Phase 1|Withdrawal by Subject|0|||
17115888|NCT00219557|38254095|FG002|Phase 1|Withdrawal by Subject|0|||
17115889|NCT00219557|38254093|FG000|Phase 1|Started chemotherapy at other institute|1|||
17115890|NCT00219557|38254094|FG001|Phase 1|Started chemotherapy at other institute|0|||
17115891|NCT00219557|38254095|FG002|Phase 1|Started chemotherapy at other institute|0|||
17115892|NCT00219557|38254093|FG000|Phase 2|Lack of Efficacy|0|||
17115893|NCT00219557|38254094|FG001|Phase 2|Lack of Efficacy|21|||
17115894|NCT00219557|38254095|FG002|Phase 2|Lack of Efficacy|15|||
17115895|NCT00219557|38254093|FG000|Phase 2|Adverse Event|0|||
17115896|NCT00219557|38254094|FG001|Phase 2|Adverse Event|22|||
17115897|NCT00219557|38254095|FG002|Phase 2|Adverse Event|2|||
17115898|NCT00219557|38254093|FG000|Phase 2|Death|0|||
17115899|NCT00219557|38254094|FG001|Phase 2|Death|8|||
17115900|NCT00219557|38254095|FG002|Phase 2|Death|2|||
17115901|NCT00219557|38254093|FG000|Phase 2|Other|0|||
17115902|NCT00219557|38254094|FG001|Phase 2|Other|8|||
17115903|NCT00219557|38254095|FG002|Phase 2|Other|6|||
17115904|NCT00219557|38254093|FG000|Phase 2|Withdrawal by Subject|0|||
17115905|NCT00219557|38254094|FG001|Phase 2|Withdrawal by Subject|9|||
17115906|NCT00219557|38254095|FG002|Phase 2|Withdrawal by Subject|5|||
17115907|NCT00219557|38254093|FG000|Phase 2|Treatment not received|0|||
17115908|NCT00219557|38254094|FG001|Phase 2|Treatment not received|1|||
17115909|NCT00219557|38254095|FG002|Phase 2|Treatment not received|3|||
17115910|NCT00251927|38254110|FG000|Overall Study|Adverse Event|3|||
17115911|NCT00251927|38254111|FG001|Overall Study|Adverse Event|15|||
17115912|NCT00251927|38254110|FG000|Overall Study|Lack of Efficacy|22|||
17115913|NCT00251927|38254111|FG001|Overall Study|Lack of Efficacy|16|||
17115914|NCT00251927|38254110|FG000|Overall Study|Lost to Follow-up|22|||
17115915|NCT00251927|38254111|FG001|Overall Study|Lost to Follow-up|8|||
17115916|NCT00251927|38254110|FG000|Overall Study|Protocol Violation|1|||
17115917|NCT00251927|38254111|FG001|Overall Study|Protocol Violation|2|||
17115918|NCT00251927|38254110|FG000|Overall Study|Pregnancy|2|||
17115919|NCT00251927|38254111|FG001|Overall Study|Pregnancy|0|||
17115920|NCT00251927|38254110|FG000|Overall Study|Withdrawal by Subject|40|||
17115921|NCT00251927|38254111|FG001|Overall Study|Withdrawal by Subject|25|||
17115922|NCT00251927|38254110|FG000|Overall Study|Study-specific discont. achieved|13|||
17115923|NCT00251927|38254111|FG001|Overall Study|Study-specific discont. achieved|2|||
17115924|NCT00251927|38254110|FG000|Overall Study|Study procedure non-compliance|5|||
17115925|NCT00251927|38254111|FG001|Overall Study|Study procedure non-compliance|6|||
17115926|NCT00165503|38254118|FG000|Overall Study|Death|1|||
17115927|NCT00165503|38254118|FG000|Overall Study|Lost to Follow-up|12|||
17115928|NCT00165503|38254118|FG000|Overall Study|Unresectable|3|||
17115929|NCT00162773|38254122|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
17115930|NCT00209339|38254126|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
17115931|NCT00209339|38254126|FG000|At 12 Months Follow-up|Death|1|||
17115932|NCT00209339|38254126|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
17115933|NCT00209339|38254126|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
17115934|NCT00209339|38254126|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
17115935|NCT00209339|38254126|FG000|At 24 Months Follow-up|Death|1|||
17115936|NCT00209339|38254126|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
17115937|NCT00209339|38254126|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
17115938|NCT00209339|38254126|FG000|At 4 Years Follow-up|Death|1|||
17115939|NCT00209339|38254126|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
17115940|NCT00209339|38254126|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
17115941|NCT00209339|38254126|FG000|At 5 Years Follow-up|Death|1|||
17115942|NCT03823391|38254132|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
17115943|NCT03823391|38254133|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
17115944|NCT03823391|38254132|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
17115945|NCT03823391|38254133|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
17115946|NCT00161213|38254141|FG000|Overall Study|Withdrawal by Subject|1|||
17115947|NCT00161213|38254141|FG000|Overall Study|Evaluable for toxicity but not response|1|||
17115948|NCT00209027|38254147|FG000|Overall Study|study terminated|10|||
17115949|NCT00209027|38254148|FG001|Overall Study|study terminated|0|||
17115950|NCT00208325|38254158|FG000|Overall Study|Death|18|||
17115951|NCT00208325|38254159|FG001|Overall Study|Death|19|||
17115952|NCT00208325|38254160|FG002|Overall Study|Death|7|||
17115953|NCT00208325|38254161|FG003|Overall Study|Death|5|||
17115954|NCT00208325|38254158|FG000|Overall Study|Withdrawal by Subject|0|||
17115955|NCT00208325|38254159|FG001|Overall Study|Withdrawal by Subject|1|||
17115956|NCT00208325|38254160|FG002|Overall Study|Withdrawal by Subject|0|||
17115957|NCT00208325|38254161|FG003|Overall Study|Withdrawal by Subject|0|||
17115958|NCT00208325|38254158|FG000|Overall Study|Revision|4|||
17115959|NCT00208325|38254159|FG001|Overall Study|Revision|1|||
17115960|NCT00208325|38254160|FG002|Overall Study|Revision|0|||
17115961|NCT00208325|38254161|FG003|Overall Study|Revision|4|||
17115962|NCT00208325|38254158|FG000|Overall Study|Lost to Follow-up|1|||
17115963|NCT00208325|38254159|FG001|Overall Study|Lost to Follow-up|0|||
17115964|NCT00208325|38254160|FG002|Overall Study|Lost to Follow-up|2|||
17115965|NCT00208325|38254161|FG003|Overall Study|Lost to Follow-up|0|||
17115966|NCT00208325|38254158|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
17115967|NCT00208325|38254159|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
17115968|NCT00208325|38254160|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
17115969|NCT00208325|38254161|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
17115970|NCT00208325|38254158|FG000|Overall Study|Does not wish to Continue in Study|5|||
17115971|NCT00208325|38254159|FG001|Overall Study|Does not wish to Continue in Study|8|||
17115972|NCT00208325|38254160|FG002|Overall Study|Does not wish to Continue in Study|3|||
17115973|NCT00208325|38254161|FG003|Overall Study|Does not wish to Continue in Study|2|||
17115974|NCT00208325|38254158|FG000|Overall Study|Other|2|||
17115975|NCT00208325|38254159|FG001|Overall Study|Other|1|||
17115976|NCT00208325|38254160|FG002|Overall Study|Other|1|||
17115977|NCT00208325|38254161|FG003|Overall Study|Other|0|||
17115978|NCT00208325|38254158|FG000|Overall Study|Mis-Randomized|17|||
17115979|NCT00208325|38254159|FG001|Overall Study|Mis-Randomized|20|||
17115980|NCT00208325|38254160|FG002|Overall Study|Mis-Randomized|0|||
17115981|NCT00208325|38254161|FG003|Overall Study|Mis-Randomized|0|||
17115982|NCT00160667|38254174|FG000|Overall Study|Adverse Event|3|||
17115983|NCT00160667|38254175|FG001|Overall Study|Adverse Event|1|||
17115984|NCT00160667|38254176|FG002|Overall Study|Adverse Event|4|||
17115985|NCT00160667|38254174|FG000|Overall Study|Withdrawal by Subject|2|||
17115986|NCT00160667|38254175|FG001|Overall Study|Withdrawal by Subject|0|||
17115987|NCT00160667|38254176|FG002|Overall Study|Withdrawal by Subject|1|||
17115988|NCT00160667|38254174|FG000|Overall Study|Lack of Efficacy|0|||
17115989|NCT00160667|38254175|FG001|Overall Study|Lack of Efficacy|1|||
17115990|NCT00160667|38254176|FG002|Overall Study|Lack of Efficacy|0|||
17115991|NCT00160667|38254174|FG000|Overall Study|Protocol Violation|0|||
17115992|NCT00160667|38254175|FG001|Overall Study|Protocol Violation|1|||
17115993|NCT00160667|38254176|FG002|Overall Study|Protocol Violation|0|||
17115994|NCT00160667|38254174|FG000|Overall Study|Patient decision|0|||
17115995|NCT00160667|38254175|FG001|Overall Study|Patient decision|0|||
17115996|NCT00160667|38254176|FG002|Overall Study|Patient decision|1|||
17115997|NCT00206375|38254188|FG000|Overall Study|Lost to Follow-up|1|||
17115998|NCT00206375|38254189|FG001|Overall Study|Lost to Follow-up|0|||
17115999|NCT00206375|38254190|FG002|Overall Study|Lost to Follow-up|0|||
17116000|NCT00206375|38254188|FG000|Overall Study|Withdrawal by Subject|2|||
17116001|NCT00206375|38254189|FG001|Overall Study|Withdrawal by Subject|1|||
17116002|NCT00206375|38254190|FG002|Overall Study|Withdrawal by Subject|3|||
17116003|NCT00206375|38254188|FG000|Overall Study|Study terminated due to lack of funds|0|||
17116004|NCT00206375|38254189|FG001|Overall Study|Study terminated due to lack of funds|1|||
17116005|NCT00206375|38254190|FG002|Overall Study|Study terminated due to lack of funds|1|||
17116006|NCT00160199|38254200|FG000|Overall Study|Adverse Event|5|||
17116007|NCT00160199|38254201|FG001|Overall Study|Adverse Event|14|||
17116008|NCT00160199|38254200|FG000|Overall Study|Lack of Efficacy|0|||
17116009|NCT00160199|38254201|FG001|Overall Study|Lack of Efficacy|1|||
17116010|NCT00160199|38254200|FG000|Overall Study|Lost to Follow-up|7|||
17116011|NCT00160199|38254201|FG001|Overall Study|Lost to Follow-up|7|||
17116012|NCT00160199|38254200|FG000|Overall Study|Withdrawal by Subject|4|||
17116013|NCT00160199|38254201|FG001|Overall Study|Withdrawal by Subject|6|||
17116014|NCT00160199|38254200|FG000|Overall Study|Administrative|0|||
17116015|NCT00160199|38254201|FG001|Overall Study|Administrative|1|||
17116016|NCT00160199|38254200|FG000|Overall Study|Protocol Violation|8|||
17116017|NCT00160199|38254201|FG001|Overall Study|Protocol Violation|8|||
17116018|NCT00157157|38254207|FG000|Overall Study|Withdrawal by Subject|6|||
17116019|NCT00157157|38254207|FG000|Overall Study|Physician Decision|1|||
17116020|NCT00157157|38254207|FG000|Overall Study|Lost to Follow-up|1|||
17116021|NCT00157157|38254207|FG000|Overall Study|Enrolled in another study|1|||
17116022|NCT00157157|38254207|FG000|Overall Study|Met exclusion criteria|1|||
17116023|NCT00157157|38254207|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
17116024|NCT00203411|38254218|FG000|Follow-up|Progressive Disease|4|||
17116025|NCT00203021|38254225|FG000|Overall Study|Death|4|||
17116026|NCT00203021|38254226|FG001|Overall Study|Death|1|||
17116027|NCT00203021|38254225|FG000|Overall Study|Adverse Event|10|||
17116028|NCT00203021|38254226|FG001|Overall Study|Adverse Event|5|||
17116029|NCT00203021|38254225|FG000|Overall Study|Withdrawal by Subject|45|||
17116030|NCT00203021|38254226|FG001|Overall Study|Withdrawal by Subject|48|||
17116031|NCT00203021|38254225|FG000|Overall Study|Lost to Follow-up|9|||
17116032|NCT00203021|38254226|FG001|Overall Study|Lost to Follow-up|7|||
17116033|NCT00203021|38254225|FG000|Overall Study|Other than specified|11|||
17116034|NCT00203021|38254226|FG001|Overall Study|Other than specified|16|||
17116035|NCT00201851|38254235|FG000|Overall Study|Lost to Follow-up|2|||
17116036|NCT00201851|38254236|FG001|Overall Study|Lost to Follow-up|1|||
17116037|NCT00201851|38254237|FG002|Overall Study|Lost to Follow-up|0|||
17116038|NCT00201851|38254235|FG000|Overall Study|Ineligible post enrollment|6|||
17116039|NCT00201851|38254236|FG001|Overall Study|Ineligible post enrollment|1|||
17116040|NCT00201851|38254237|FG002|Overall Study|Ineligible post enrollment|1|||
17116041|NCT00200057|38254245|FG000|Overall Study|Lack of Efficacy|3|||
17116042|NCT00200057|38254245|FG000|Overall Study|Exited due to terminal illness of PI|2|||
17116043|NCT00200057|38254245|FG000|Overall Study|Withdrawal by Subject|1|||
17116044|NCT00200057|38254245|FG000|Overall Study|Change in medical condition|1|||
17116045|NCT00200057|38254245|FG000|Overall Study|Infection|1|||
17116046|NCT00200057|38254245|FG000|Overall Study|Death|1|||
17116047|NCT03129100|38254254|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
17116048|NCT03129100|38254255|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
17116049|NCT03129100|38254256|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
17116050|NCT03129100|38254257|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
17116051|NCT03129100|38254258|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
17116052|NCT03129100|38254259|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
17116053|NCT03129100|38254260|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
17116054|NCT03129100|38254261|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
17116055|NCT03129100|38254262|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
17116056|NCT03129100|38254263|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
17116057|NCT03129100|38254264|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
17116058|NCT03129100|38254265|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
17116059|NCT03129100|38254266|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
17116060|NCT03129100|38254267|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
17116061|NCT03129100|38254268|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
17116062|NCT03129100|38254269|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
17116063|NCT03129100|38254270|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
17116064|NCT03129100|38254271|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
17116065|NCT03129100|38254272|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
17116066|NCT03129100|38254273|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
17116067|NCT03129100|38254274|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
17116068|NCT03129100|38254275|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
17116069|NCT03129100|38254276|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
17116070|NCT03129100|38254277|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
17116071|NCT03129100|38254278|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
17116072|NCT03129100|38254279|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
17116073|NCT03129100|38254254|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
17116074|NCT03129100|38254255|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116075|NCT03129100|38254256|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116076|NCT03129100|38254257|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116077|NCT03129100|38254258|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116078|NCT03129100|38254259|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116079|NCT03129100|38254260|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116080|NCT03129100|38254261|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116081|NCT03129100|38254262|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116082|NCT03129100|38254263|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116083|NCT03129100|38254264|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116084|NCT03129100|38254265|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116085|NCT03129100|38254266|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116086|NCT03129100|38254267|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16772976|NCT02235298|37711696|FG000|Overall Study|Adverse Event|2|||
17116087|NCT03129100|38254268|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116088|NCT03129100|38254269|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116089|NCT03129100|38254270|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116090|NCT03129100|38254271|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116091|NCT03129100|38254272|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116092|NCT03129100|38254273|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116093|NCT03129100|38254274|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116094|NCT03129100|38254275|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116095|NCT03129100|38254276|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116096|NCT03129100|38254277|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116097|NCT03129100|38254278|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116098|NCT03129100|38254279|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
17116099|NCT03129100|38254254|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
17116100|NCT03129100|38254255|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
17116101|NCT03129100|38254256|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116102|NCT03129100|38254257|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116103|NCT03129100|38254258|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116104|NCT03129100|38254259|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116105|NCT03129100|38254260|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116106|NCT03129100|38254261|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116107|NCT03129100|38254262|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116108|NCT03129100|38254263|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116109|NCT03129100|38254264|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116110|NCT03129100|38254265|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116111|NCT03129100|38254266|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116112|NCT03129100|38254267|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116113|NCT03129100|38254268|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116114|NCT03129100|38254269|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116115|NCT03129100|38254270|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116116|NCT03129100|38254271|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116117|NCT03129100|38254272|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116118|NCT03129100|38254273|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116119|NCT03129100|38254274|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116120|NCT03129100|38254275|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116121|NCT03129100|38254276|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116122|NCT03129100|38254277|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116123|NCT03129100|38254278|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116124|NCT03129100|38254279|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
17116125|NCT03129100|38254254|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
17116126|NCT03129100|38254255|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
17116127|NCT03129100|38254256|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116128|NCT03129100|38254257|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116129|NCT03129100|38254258|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116130|NCT03129100|38254259|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116131|NCT03129100|38254260|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116132|NCT03129100|38254261|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116133|NCT03129100|38254262|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116134|NCT03129100|38254263|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116135|NCT03129100|38254264|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116136|NCT03129100|38254265|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116137|NCT03129100|38254266|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116138|NCT03129100|38254267|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116139|NCT03129100|38254268|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116140|NCT03129100|38254269|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116141|NCT03129100|38254270|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116142|NCT03129100|38254271|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116143|NCT03129100|38254272|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116144|NCT03129100|38254273|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116145|NCT03129100|38254274|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116146|NCT03129100|38254275|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116147|NCT03129100|38254276|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116148|NCT03129100|38254277|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116149|NCT03129100|38254278|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16772977|NCT02235298|37711697|FG001|Overall Study|Adverse Event|2|||
16772978|NCT02235298|37711696|FG000|Overall Study|Withdrawal by Subject|0|||
16772979|NCT02235298|37711697|FG001|Overall Study|Withdrawal by Subject|1|||
16772980|NCT02234596|37711703|FG000|Overall Study|Participant not treated|2|||
16772981|NCT02234362|37711707|FG000|Overall Study|Not eligible after first screening visit|17|||
16772982|NCT02234362|37711707|FG000|Overall Study|Lost to Follow-up|6|||
16772983|NCT02234362|37711707|FG000|Overall Study|Withdrawal by Subject|3|||
17116150|NCT03129100|38254279|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
17116151|NCT03129100|38254254|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116152|NCT03129100|38254255|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
17116153|NCT03129100|38254256|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116154|NCT03129100|38254257|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116155|NCT03129100|38254258|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116156|NCT03129100|38254259|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116157|NCT03129100|38254260|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116158|NCT03129100|38254261|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116159|NCT03129100|38254262|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116160|NCT03129100|38254263|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116161|NCT03129100|38254264|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116162|NCT03129100|38254265|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116163|NCT03129100|38254266|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116164|NCT03129100|38254267|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116165|NCT03129100|38254268|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116166|NCT03129100|38254269|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116167|NCT03129100|38254270|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116168|NCT03129100|38254271|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116169|NCT03129100|38254272|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116170|NCT03129100|38254273|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116171|NCT03129100|38254274|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116172|NCT03129100|38254275|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116173|NCT03129100|38254276|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116174|NCT03129100|38254277|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116175|NCT03129100|38254278|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116176|NCT03129100|38254279|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
17116177|NCT03129100|38254254|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116178|NCT03129100|38254255|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116179|NCT03129100|38254256|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
17116180|NCT03129100|38254257|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
17116181|NCT03129100|38254258|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116182|NCT03129100|38254259|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
17116183|NCT03129100|38254260|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116184|NCT03129100|38254261|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116185|NCT03129100|38254262|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116186|NCT03129100|38254263|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116187|NCT03129100|38254264|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116188|NCT03129100|38254265|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116189|NCT03129100|38254266|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116190|NCT03129100|38254267|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116191|NCT03129100|38254268|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116192|NCT03129100|38254269|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116193|NCT03129100|38254270|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116194|NCT03129100|38254271|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116195|NCT03129100|38254272|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116196|NCT03129100|38254273|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116197|NCT03129100|38254274|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116198|NCT03129100|38254275|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116199|NCT03129100|38254276|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116200|NCT03129100|38254277|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116201|NCT03129100|38254278|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116202|NCT03129100|38254279|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
17116203|NCT03129100|38254254|FG000|Period2 Extension Period (Group A and B)|Death|0|||
17116204|NCT03129100|38254255|FG001|Period2 Extension Period (Group A and B)|Death|0|||
17116205|NCT03129100|38254256|FG002|Period2 Extension Period (Group A and B)|Death|1|||
17116206|NCT03129100|38254257|FG003|Period2 Extension Period (Group A and B)|Death|0|||
17116207|NCT03129100|38254258|FG004|Period2 Extension Period (Group A and B)|Death|0|||
17116208|NCT03129100|38254259|FG005|Period2 Extension Period (Group A and B)|Death|0|||
17116209|NCT03129100|38254260|FG006|Period2 Extension Period (Group A and B)|Death|0|||
17116210|NCT03129100|38254261|FG007|Period2 Extension Period (Group A and B)|Death|0|||
17116211|NCT03129100|38254262|FG008|Period2 Extension Period (Group A and B)|Death|0|||
17116212|NCT03129100|38254263|FG009|Period2 Extension Period (Group A and B)|Death|0|||
17116213|NCT03129100|38254264|FG010|Period2 Extension Period (Group A and B)|Death|0|||
17116214|NCT03129100|38254265|FG011|Period2 Extension Period (Group A and B)|Death|0|||
17116215|NCT03129100|38254266|FG012|Period2 Extension Period (Group A and B)|Death|0|||
17116216|NCT03129100|38254267|FG013|Period2 Extension Period (Group A and B)|Death|0|||
16856734|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
17116217|NCT03129100|38254268|FG014|Period2 Extension Period (Group A and B)|Death|0|||
17116218|NCT03129100|38254269|FG015|Period2 Extension Period (Group A and B)|Death|0|||
17116219|NCT03129100|38254270|FG016|Period2 Extension Period (Group A and B)|Death|0|||
17116220|NCT03129100|38254271|FG017|Period2 Extension Period (Group A and B)|Death|0|||
16772984|NCT02234284|37711713|FG000|Overall Study|Death|4|||
17116221|NCT03129100|38254272|FG018|Period2 Extension Period (Group A and B)|Death|0|||
17116222|NCT03129100|38254273|FG019|Period2 Extension Period (Group A and B)|Death|0|||
17116223|NCT03129100|38254274|FG020|Period2 Extension Period (Group A and B)|Death|0|||
17116224|NCT03129100|38254275|FG021|Period2 Extension Period (Group A and B)|Death|0|||
17116225|NCT03129100|38254276|FG022|Period2 Extension Period (Group A and B)|Death|0|||
17116226|NCT03129100|38254277|FG023|Period2 Extension Period (Group A and B)|Death|0|||
17116227|NCT03129100|38254278|FG024|Period2 Extension Period (Group A and B)|Death|0|||
17116228|NCT03129100|38254279|FG025|Period2 Extension Period (Group A and B)|Death|0|||
16772985|NCT02234284|37711714|FG001|Overall Study|Death|2|||
16772986|NCT02234284|37711713|FG000|Overall Study|Withdrawal by Subject|1|||
16772987|NCT02234284|37711714|FG001|Overall Study|Withdrawal by Subject|0|||
16772988|NCT02234284|37711713|FG000|Overall Study|Lost to Follow-up|20|||
16772989|NCT02234284|37711714|FG001|Overall Study|Lost to Follow-up|7|||
16772990|NCT02233738|37711726|FG000|Overall Study|Lost to Follow-up|5|||
17116229|NCT03129100|38254254|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116230|NCT03129100|38254255|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116231|NCT03129100|38254256|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
17116232|NCT03129100|38254257|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
17116233|NCT03129100|38254258|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
17116234|NCT03129100|38254259|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
17116235|NCT03129100|38254260|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
17116236|NCT03129100|38254261|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116237|NCT03129100|38254262|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116238|NCT03129100|38254263|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116239|NCT03129100|38254264|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116240|NCT03129100|38254265|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116241|NCT03129100|38254266|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116242|NCT03129100|38254267|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116243|NCT03129100|38254268|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116244|NCT03129100|38254269|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116245|NCT03129100|38254270|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116246|NCT03129100|38254271|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116247|NCT03129100|38254272|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116248|NCT03129100|38254273|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116249|NCT03129100|38254274|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116250|NCT03129100|38254275|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116251|NCT03129100|38254276|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116252|NCT03129100|38254277|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116253|NCT03129100|38254278|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116254|NCT03129100|38254279|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
17116255|NCT03129100|38254254|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116256|NCT03129100|38254255|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116257|NCT03129100|38254256|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
17116258|NCT03129100|38254257|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116259|NCT03129100|38254258|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116260|NCT03129100|38254259|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116261|NCT03129100|38254260|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116262|NCT03129100|38254261|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116263|NCT03129100|38254262|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116264|NCT03129100|38254263|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116265|NCT03129100|38254264|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116266|NCT03129100|38254265|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116267|NCT03129100|38254266|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116268|NCT03129100|38254267|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116269|NCT03129100|38254268|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116270|NCT03129100|38254269|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16772991|NCT02233738|37711727|FG001|Overall Study|Lost to Follow-up|12|||
16772992|NCT02233738|37711726|FG000|Overall Study|Death|0|||
16856735|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
16772993|NCT02233738|37711727|FG001|Overall Study|Death|1|||
17116271|NCT03129100|38254270|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116272|NCT03129100|38254271|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116273|NCT03129100|38254272|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116274|NCT03129100|38254273|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116275|NCT03129100|38254274|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116276|NCT03129100|38254275|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116277|NCT03129100|38254276|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116278|NCT03129100|38254277|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116279|NCT03129100|38254278|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116280|NCT03129100|38254279|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
17116281|NCT03129100|38254254|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116282|NCT03129100|38254255|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116283|NCT03129100|38254256|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
17116284|NCT03129100|38254257|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116285|NCT03129100|38254258|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116286|NCT03129100|38254259|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116287|NCT03129100|38254260|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116288|NCT03129100|38254261|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116289|NCT03129100|38254262|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116290|NCT03129100|38254263|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116291|NCT03129100|38254264|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116292|NCT03129100|38254265|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116293|NCT03129100|38254266|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116294|NCT03129100|38254267|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116295|NCT03129100|38254268|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116296|NCT03129100|38254269|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116297|NCT03129100|38254270|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116298|NCT03129100|38254271|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116299|NCT03129100|38254272|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116300|NCT03129100|38254273|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116301|NCT03129100|38254274|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116302|NCT03129100|38254275|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116303|NCT03129100|38254276|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116304|NCT03129100|38254277|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116305|NCT03129100|38254278|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116306|NCT03129100|38254279|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
17116307|NCT03129100|38254254|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116308|NCT03129100|38254255|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116309|NCT03129100|38254256|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
17116310|NCT03129100|38254257|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116311|NCT03129100|38254258|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116312|NCT03129100|38254259|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116313|NCT03129100|38254260|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116314|NCT03129100|38254261|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116315|NCT03129100|38254262|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116316|NCT03129100|38254263|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116317|NCT03129100|38254264|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116318|NCT03129100|38254265|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116319|NCT03129100|38254266|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116320|NCT03129100|38254267|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116321|NCT03129100|38254268|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116322|NCT03129100|38254269|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116323|NCT03129100|38254270|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116324|NCT03129100|38254271|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116325|NCT03129100|38254272|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116326|NCT03129100|38254273|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116327|NCT03129100|38254274|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116328|NCT03129100|38254275|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116329|NCT03129100|38254276|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116330|NCT03129100|38254277|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116331|NCT03129100|38254278|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116332|NCT03129100|38254279|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
17116333|NCT03129100|38254254|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116334|NCT03129100|38254255|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116335|NCT03129100|38254256|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116336|NCT03129100|38254257|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116337|NCT03129100|38254258|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
17116338|NCT03129100|38254259|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
17116339|NCT03129100|38254260|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
17116340|NCT03129100|38254261|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116341|NCT03129100|38254262|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116342|NCT03129100|38254263|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116343|NCT03129100|38254264|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116344|NCT03129100|38254265|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116345|NCT03129100|38254266|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116346|NCT03129100|38254267|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116347|NCT03129100|38254268|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116348|NCT03129100|38254269|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116349|NCT03129100|38254270|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116350|NCT03129100|38254271|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116351|NCT03129100|38254272|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116352|NCT03129100|38254273|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116353|NCT03129100|38254274|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116354|NCT03129100|38254275|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16772994|NCT02233738|37711726|FG000|Overall Study|Withdrawal by Subject|0|||
16772995|NCT02233738|37711727|FG001|Overall Study|Withdrawal by Subject|1|||
16772996|NCT02233738|37711726|FG000|Overall Study|Did not return after Baseline|3|||
17028307|NCT00478231|38172714|FG000|Overall Study|Randomized, not treated|3|||
17028308|NCT00474175|38172721|FG000|Overall Study|Lack of Efficacy|0|||
17116355|NCT03129100|38254276|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16772997|NCT02233738|37711727|FG001|Overall Study|Did not return after Baseline|2|||
16772998|NCT02232880|37711895|FG000|Overall Study|study stopped prior to randomization|1|||
16772999|NCT02896855|37711901|FG000|Overall Study|Death|50|||
16773000|NCT02896855|37711902|FG001|Overall Study|Death|40|||
16773001|NCT02896855|37711901|FG000|Overall Study|Lost to Follow-up|15|||
16773002|NCT02896855|37711902|FG001|Overall Study|Lost to Follow-up|9|||
16773003|NCT02896855|37711901|FG000|Overall Study|Withdrawal by Subject|7|||
16773004|NCT02896855|37711902|FG001|Overall Study|Withdrawal by Subject|4|||
16773005|NCT02232802|37711913|FG000|Period 1|Sponsor request|1|||
16773006|NCT02232802|37711914|FG001|Period 1|Sponsor request|0|||
16773007|NCT02232802|37711913|FG000|Period 1|Adverse Event|1|||
16773008|NCT02232802|37711914|FG001|Period 1|Adverse Event|1|||
16773009|NCT00821587|37711922|FG000|Overall Study|Physician Decision|0|||
16773010|NCT00821587|37711923|FG001|Overall Study|Physician Decision|1|||
16773011|NCT02434328|37711931|FG000|Overall Study|Adverse Event|9|||
16773012|NCT02434328|37711932|FG001|Overall Study|Adverse Event|4|||
16773013|NCT02434328|37711931|FG000|Overall Study|Lack of Efficacy|0|||
16773014|NCT02434328|37711932|FG001|Overall Study|Lack of Efficacy|2|||
16773015|NCT02434328|37711931|FG000|Overall Study|Physician Decision|0|||
17116356|NCT03129100|38254277|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116357|NCT03129100|38254278|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116358|NCT03129100|38254279|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
17116359|NCT03129100|38254254|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116360|NCT03129100|38254255|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116361|NCT03129100|38254256|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116362|NCT03129100|38254257|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116363|NCT03129100|38254258|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116364|NCT03129100|38254259|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16773016|NCT02434328|37711932|FG001|Overall Study|Physician Decision|1|||
16773017|NCT02434328|37711931|FG000|Overall Study|Withdrawal by Subject|12|||
17028309|NCT00474175|38172722|FG001|Overall Study|Lack of Efficacy|0|||
17116365|NCT03129100|38254260|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116366|NCT03129100|38254261|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116367|NCT03129100|38254262|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116368|NCT03129100|38254263|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
17116369|NCT03129100|38254264|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116370|NCT03129100|38254265|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116371|NCT03129100|38254266|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116372|NCT03129100|38254267|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116373|NCT03129100|38254268|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116374|NCT03129100|38254269|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116375|NCT03129100|38254270|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116376|NCT03129100|38254271|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116377|NCT03129100|38254272|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116378|NCT03129100|38254273|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116379|NCT03129100|38254274|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116380|NCT03129100|38254275|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116381|NCT03129100|38254276|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116382|NCT03129100|38254277|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116383|NCT03129100|38254278|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116384|NCT03129100|38254279|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
17116385|NCT03129100|38254254|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116386|NCT03129100|38254255|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116387|NCT03129100|38254256|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116388|NCT03129100|38254257|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116389|NCT03129100|38254258|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116390|NCT03129100|38254259|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116391|NCT03129100|38254260|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116392|NCT03129100|38254261|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116393|NCT03129100|38254262|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116394|NCT03129100|38254263|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116395|NCT03129100|38254264|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116396|NCT03129100|38254265|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
17116397|NCT03129100|38254266|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116398|NCT03129100|38254267|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116399|NCT03129100|38254268|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116400|NCT03129100|38254269|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116401|NCT03129100|38254270|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116402|NCT03129100|38254271|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116403|NCT03129100|38254272|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116404|NCT03129100|38254273|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116405|NCT03129100|38254274|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116406|NCT03129100|38254275|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116407|NCT03129100|38254276|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116408|NCT03129100|38254277|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116409|NCT03129100|38254278|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116410|NCT03129100|38254279|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
17116411|NCT03129100|38254254|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116412|NCT03129100|38254255|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116413|NCT03129100|38254256|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116414|NCT03129100|38254257|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116415|NCT03129100|38254258|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116416|NCT03129100|38254259|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116417|NCT03129100|38254260|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116418|NCT03129100|38254261|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116419|NCT03129100|38254262|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116420|NCT03129100|38254263|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116421|NCT03129100|38254264|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116422|NCT03129100|38254265|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
17116423|NCT03129100|38254266|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
17116424|NCT03129100|38254267|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
17116425|NCT03129100|38254268|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
17116426|NCT03129100|38254269|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116427|NCT03129100|38254270|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16773018|NCT02434328|37711932|FG001|Overall Study|Withdrawal by Subject|21|||
16773019|NCT02434328|37711931|FG000|Overall Study|Death|4|||
16773020|NCT02434328|37711932|FG001|Overall Study|Death|7|||
16773021|NCT02434328|37711931|FG000|Overall Study|Lost to Follow-up|1|||
16773022|NCT02434328|37711932|FG001|Overall Study|Lost to Follow-up|6|||
16773023|NCT02434328|37711931|FG000|Overall Study|Other|4|||
16773024|NCT02434328|37711932|FG001|Overall Study|Other|1|||
16773025|NCT02660229|37711941|FG000|Overall Study|Adverse Event|2|||
16773026|NCT02660229|37711942|FG001|Overall Study|Adverse Event|0|||
16773027|NCT02660229|37711941|FG000|Overall Study|Withdrawal by Subject|0|||
16773028|NCT02660229|37711942|FG001|Overall Study|Withdrawal by Subject|1|||
16773029|NCT02232178|37711951|FG000|Overall Study|Lost to Follow-up|0|||
16773030|NCT02232178|37711952|FG001|Overall Study|Lost to Follow-up|1|||
16773031|NCT02232178|37711953|FG002|Overall Study|Lost to Follow-up|0|||
16773032|NCT02232178|37711951|FG000|Overall Study|ineligibility|0|||
16773033|NCT02232178|37711952|FG001|Overall Study|ineligibility|0|||
16773034|NCT02232178|37711953|FG002|Overall Study|ineligibility|1|||
16773035|NCT02232178|37711951|FG000|Overall Study|surgical complication|1|||
16773036|NCT02232178|37711952|FG001|Overall Study|surgical complication|0|||
16773037|NCT02232178|37711953|FG002|Overall Study|surgical complication|0|||
16773038|NCT01678131|37711964|FG000|Overall Study|Adverse Event|0|||
16773039|NCT01678131|37711965|FG001|Overall Study|Adverse Event|1|||
16773040|NCT01678131|37711966|FG002|Overall Study|Adverse Event|0|||
17116428|NCT03129100|38254271|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116429|NCT03129100|38254272|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116430|NCT03129100|38254273|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116431|NCT03129100|38254274|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116432|NCT03129100|38254275|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116433|NCT03129100|38254276|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116434|NCT03129100|38254277|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116435|NCT03129100|38254278|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116436|NCT03129100|38254279|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
17116437|NCT03129100|38254254|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116438|NCT03129100|38254255|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116439|NCT03129100|38254256|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116440|NCT03129100|38254257|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116441|NCT03129100|38254258|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116442|NCT03129100|38254259|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116443|NCT03129100|38254260|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116444|NCT03129100|38254261|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116445|NCT03129100|38254262|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116446|NCT03129100|38254263|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116447|NCT03129100|38254264|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116448|NCT03129100|38254265|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
17116449|NCT03129100|38254266|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116450|NCT03129100|38254267|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
16773041|NCT01678131|37711964|FG000|Overall Study|Withdrawal by Subject|0|||
16773042|NCT01678131|37711965|FG001|Overall Study|Withdrawal by Subject|0|||
16773043|NCT01678131|37711966|FG002|Overall Study|Withdrawal by Subject|2|||
16773044|NCT02231164|37711976|FG000|Overall Study|Adverse Event|1|||
16773045|NCT02231164|37711977|FG001|Overall Study|Adverse Event|1|||
16773046|NCT02231164|37711976|FG000|Overall Study|Lack of Efficacy|4|||
16773047|NCT02231164|37711977|FG001|Overall Study|Lack of Efficacy|3|||
16773048|NCT02231164|37711976|FG000|Overall Study|Withdrawal by Subject|1|||
16773049|NCT02231164|37711977|FG001|Overall Study|Withdrawal by Subject|2|||
16773050|NCT02457182|37711985|FG000|Overall Study|Lost to Follow-up|1|||
16773051|NCT02457182|37711986|FG001|Overall Study|Lost to Follow-up|0|||
16773052|NCT02230384|37711994|FG000|Phase 1|Lost to Follow-up|1|||
16773053|NCT02230384|37711995|FG001|Phase 1|Lost to Follow-up|0|||
16773054|NCT02230384|37711994|FG000|Phase 1|Physician Decision|0|||
16856736|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
16773055|NCT02230384|37711995|FG001|Phase 1|Physician Decision|1|||
16773056|NCT02230384|37711994|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
16773057|NCT02230384|37711995|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
16773058|NCT02230384|37711994|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
16773059|NCT02230384|37711995|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
16773060|NCT02230384|37711994|FG000|Phase 2 - Switch|Adverse Event|2|||
16773061|NCT02230384|37711995|FG001|Phase 2 - Switch|Adverse Event|0|||
16773062|NCT02738801|37712011|FG000|Overall Study|Adverse Event|1|||
16773063|NCT02738801|37712012|FG001|Overall Study|Adverse Event|1|||
16773064|NCT02738801|37712011|FG000|Overall Study|Withdrawal by Subject|0|||
16773065|NCT02738801|37712012|FG001|Overall Study|Withdrawal by Subject|1|||
16773066|NCT02230306|37712028|FG000|Overall Study|Did not receive study treatment|1|||
16773067|NCT01680861|37712034|FG000|Early Post-transplant Period|Protocol Violation|1|||
16773068|NCT01680861|37712035|FG001|Early Post-transplant Period|Protocol Violation|1|||
16773069|NCT02229214|37712045|FG000|Overall Study|Adverse Event|2|||
16773070|NCT02229214|37712046|FG001|Overall Study|Adverse Event|0|||
16773071|NCT02229214|37712045|FG000|Overall Study|Withdrawal by Subject|4|||
17116451|NCT03129100|38254268|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
17116452|NCT03129100|38254269|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116453|NCT03129100|38254270|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116454|NCT03129100|38254271|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116455|NCT03129100|38254272|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116456|NCT03129100|38254273|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116457|NCT03129100|38254274|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116458|NCT03129100|38254275|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116459|NCT03129100|38254276|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116460|NCT03129100|38254277|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116461|NCT03129100|38254278|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116462|NCT03129100|38254279|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
17116463|NCT03129100|38254254|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116464|NCT03129100|38254255|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116465|NCT03129100|38254256|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116466|NCT03129100|38254257|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116467|NCT03129100|38254258|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116468|NCT03129100|38254259|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116469|NCT03129100|38254260|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116470|NCT03129100|38254261|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116471|NCT03129100|38254262|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116472|NCT03129100|38254263|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116473|NCT03129100|38254264|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116474|NCT03129100|38254265|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116475|NCT03129100|38254266|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116476|NCT03129100|38254267|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116477|NCT03129100|38254268|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116478|NCT03129100|38254269|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
17116479|NCT03129100|38254270|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116480|NCT03129100|38254271|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116481|NCT03129100|38254272|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116482|NCT03129100|38254273|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116483|NCT03129100|38254274|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116484|NCT03129100|38254275|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116485|NCT03129100|38254276|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116486|NCT03129100|38254277|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16773072|NCT02229214|37712046|FG001|Overall Study|Withdrawal by Subject|0|||
16773073|NCT02228980|37712058|FG000|Overall Study|Adverse Event|14|||
16773074|NCT02228980|37712059|FG001|Overall Study|Adverse Event|0|||
17116487|NCT03129100|38254278|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116488|NCT03129100|38254279|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
17116489|NCT03129100|38254254|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116490|NCT03129100|38254255|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116491|NCT03129100|38254256|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116492|NCT03129100|38254257|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116493|NCT03129100|38254258|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116494|NCT03129100|38254259|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116495|NCT03129100|38254260|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116496|NCT03129100|38254261|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16942084|NCT01335477|38086647|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
17028310|NCT00474175|38172723|FG002|Overall Study|Lack of Efficacy|1|||
17116497|NCT03129100|38254262|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116498|NCT03129100|38254263|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116499|NCT03129100|38254264|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116500|NCT03129100|38254265|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116501|NCT03129100|38254266|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
17116502|NCT03129100|38254267|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116503|NCT03129100|38254268|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
17116504|NCT03129100|38254269|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
17116505|NCT03129100|38254270|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116506|NCT03129100|38254271|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116507|NCT03129100|38254272|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116508|NCT03129100|38254273|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116509|NCT03129100|38254274|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116510|NCT03129100|38254275|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116511|NCT03129100|38254276|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116512|NCT03129100|38254277|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116513|NCT03129100|38254278|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116514|NCT03129100|38254279|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
17116515|NCT03129100|38254254|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116516|NCT03129100|38254255|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116517|NCT03129100|38254256|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116518|NCT03129100|38254257|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116519|NCT03129100|38254258|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116520|NCT03129100|38254259|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116521|NCT03129100|38254260|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116522|NCT03129100|38254261|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116523|NCT03129100|38254262|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116524|NCT03129100|38254263|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116525|NCT03129100|38254264|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116526|NCT03129100|38254265|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116527|NCT03129100|38254266|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116528|NCT03129100|38254267|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116529|NCT03129100|38254268|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116530|NCT03129100|38254269|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116531|NCT03129100|38254270|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116532|NCT03129100|38254271|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
17116533|NCT03129100|38254272|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116534|NCT03129100|38254273|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
17116535|NCT03129100|38254274|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116536|NCT03129100|38254275|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116537|NCT03129100|38254276|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116538|NCT03129100|38254277|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116539|NCT03129100|38254278|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116540|NCT03129100|38254279|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
17116541|NCT03129100|38254254|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116542|NCT03129100|38254255|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116543|NCT03129100|38254256|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116544|NCT03129100|38254257|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116545|NCT03129100|38254258|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116546|NCT03129100|38254259|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116547|NCT03129100|38254260|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116548|NCT03129100|38254261|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116549|NCT03129100|38254262|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116550|NCT03129100|38254263|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116551|NCT03129100|38254264|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116552|NCT03129100|38254265|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116553|NCT03129100|38254266|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116554|NCT03129100|38254267|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116555|NCT03129100|38254268|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116556|NCT03129100|38254269|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116557|NCT03129100|38254270|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116558|NCT03129100|38254271|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116559|NCT03129100|38254272|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116560|NCT03129100|38254273|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116561|NCT03129100|38254274|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
17116562|NCT03129100|38254275|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116563|NCT03129100|38254276|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116564|NCT03129100|38254277|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116565|NCT03129100|38254278|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116566|NCT03129100|38254279|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
17116567|NCT03129100|38254254|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
17116568|NCT03129100|38254255|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
17116569|NCT03129100|38254256|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
17116570|NCT03129100|38254257|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
17116571|NCT03129100|38254258|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
17116572|NCT03129100|38254259|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
17116573|NCT03129100|38254260|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
17116574|NCT03129100|38254261|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
17116575|NCT03129100|38254262|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
17116576|NCT03129100|38254263|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
17116577|NCT03129100|38254264|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
17116578|NCT03129100|38254265|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
17116579|NCT03129100|38254266|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
17116580|NCT03129100|38254267|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
17116581|NCT03129100|38254268|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
17116582|NCT03129100|38254269|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
17116583|NCT03129100|38254270|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
17116584|NCT03129100|38254271|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
17116585|NCT03129100|38254272|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
17116586|NCT03129100|38254273|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
17116587|NCT03129100|38254274|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
17116588|NCT03129100|38254275|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
17116589|NCT03129100|38254276|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
17116590|NCT03129100|38254277|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
17116591|NCT03129100|38254278|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
17116592|NCT03129100|38254279|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
17116593|NCT03129100|38254254|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116594|NCT03129100|38254255|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116595|NCT03129100|38254256|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116596|NCT03129100|38254257|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116597|NCT03129100|38254258|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116598|NCT03129100|38254259|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116599|NCT03129100|38254260|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116600|NCT03129100|38254261|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116601|NCT03129100|38254262|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116602|NCT03129100|38254263|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116603|NCT03129100|38254264|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116604|NCT03129100|38254265|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116605|NCT03129100|38254266|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116606|NCT03129100|38254267|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116607|NCT03129100|38254268|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116608|NCT03129100|38254269|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116609|NCT03129100|38254270|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116610|NCT03129100|38254271|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116611|NCT03129100|38254272|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116612|NCT03129100|38254273|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116613|NCT03129100|38254274|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
17116614|NCT03129100|38254275|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116615|NCT03129100|38254276|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116616|NCT03129100|38254277|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116617|NCT03129100|38254278|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116618|NCT03129100|38254279|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
17116619|NCT03129100|38254254|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
17116620|NCT03129100|38254255|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
17116621|NCT03129100|38254256|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
17116622|NCT03129100|38254257|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
17116623|NCT03129100|38254258|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
17116624|NCT03129100|38254259|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
17116625|NCT03129100|38254260|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
17116626|NCT03129100|38254261|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
17116627|NCT03129100|38254262|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
17116628|NCT03129100|38254263|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
17116629|NCT03129100|38254264|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
17116630|NCT03129100|38254265|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
17116631|NCT03129100|38254266|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
17116632|NCT03129100|38254267|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
17116633|NCT03129100|38254268|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
17116634|NCT03129100|38254269|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
17116635|NCT03129100|38254270|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
17116636|NCT03129100|38254271|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
17116637|NCT03129100|38254272|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
17116638|NCT03129100|38254273|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
17116639|NCT03129100|38254274|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
17116640|NCT03129100|38254275|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
17116641|NCT03129100|38254276|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
17116642|NCT03129100|38254277|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
17116643|NCT03129100|38254278|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
17116644|NCT03129100|38254279|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
17116645|NCT03129100|38254254|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116646|NCT03129100|38254255|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116647|NCT03129100|38254256|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116648|NCT03129100|38254257|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116649|NCT03129100|38254258|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116650|NCT03129100|38254259|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116651|NCT03129100|38254260|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116652|NCT03129100|38254261|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116653|NCT03129100|38254262|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116654|NCT03129100|38254263|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116655|NCT03129100|38254264|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116656|NCT03129100|38254265|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116657|NCT03129100|38254266|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116658|NCT03129100|38254267|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116659|NCT03129100|38254268|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116660|NCT03129100|38254269|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116661|NCT03129100|38254270|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116662|NCT03129100|38254271|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116663|NCT03129100|38254272|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116664|NCT03129100|38254273|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116665|NCT03129100|38254274|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116666|NCT03129100|38254275|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116667|NCT03129100|38254276|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116668|NCT03129100|38254277|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
17116669|NCT03129100|38254278|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
17116670|NCT03129100|38254279|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
17116671|NCT03129100|38254254|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116672|NCT03129100|38254255|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116673|NCT03129100|38254256|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116674|NCT03129100|38254257|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116675|NCT03129100|38254258|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116676|NCT03129100|38254259|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116677|NCT03129100|38254260|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116678|NCT03129100|38254261|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116679|NCT03129100|38254262|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116680|NCT03129100|38254263|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116681|NCT03129100|38254264|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116682|NCT03129100|38254265|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116683|NCT03129100|38254266|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116684|NCT03129100|38254267|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116685|NCT03129100|38254268|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116686|NCT03129100|38254269|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116687|NCT03129100|38254270|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116688|NCT03129100|38254271|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116689|NCT03129100|38254272|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116690|NCT03129100|38254273|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116691|NCT03129100|38254274|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116692|NCT03129100|38254275|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116693|NCT03129100|38254276|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
17116694|NCT03129100|38254277|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
17116695|NCT03129100|38254278|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
17116696|NCT03129100|38254279|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
17116697|NCT03129100|38254254|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116698|NCT03129100|38254255|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116699|NCT03129100|38254256|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116700|NCT03129100|38254257|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116701|NCT03129100|38254258|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116702|NCT03129100|38254259|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116703|NCT03129100|38254260|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116704|NCT03129100|38254261|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116705|NCT03129100|38254262|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116706|NCT03129100|38254263|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116707|NCT03129100|38254264|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116708|NCT03129100|38254265|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116709|NCT03129100|38254266|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116710|NCT03129100|38254267|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116711|NCT03129100|38254268|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116712|NCT03129100|38254269|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116713|NCT03129100|38254270|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116714|NCT03129100|38254271|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116715|NCT03129100|38254272|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116716|NCT03129100|38254273|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116717|NCT03129100|38254274|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116718|NCT03129100|38254275|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116719|NCT03129100|38254276|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116720|NCT03129100|38254277|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116721|NCT03129100|38254278|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
17116722|NCT03129100|38254279|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
17116723|NCT03129100|38254254|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116724|NCT03129100|38254255|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116725|NCT03129100|38254256|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116726|NCT03129100|38254257|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116727|NCT03129100|38254258|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116728|NCT03129100|38254259|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116729|NCT03129100|38254260|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116730|NCT03129100|38254261|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116731|NCT03129100|38254262|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116732|NCT03129100|38254263|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116733|NCT03129100|38254264|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116734|NCT03129100|38254265|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116735|NCT03129100|38254266|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116736|NCT03129100|38254267|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116737|NCT03129100|38254268|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116738|NCT03129100|38254269|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116739|NCT03129100|38254270|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116740|NCT03129100|38254271|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116741|NCT03129100|38254272|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116742|NCT03129100|38254273|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116743|NCT03129100|38254274|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116744|NCT03129100|38254275|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116745|NCT03129100|38254276|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116746|NCT03129100|38254277|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116747|NCT03129100|38254278|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
17116748|NCT03129100|38254279|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
17116749|NCT03129100|38254254|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
17116750|NCT03129100|38254255|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
17116751|NCT03129100|38254256|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
17116752|NCT03129100|38254257|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
17116753|NCT03129100|38254258|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
17116754|NCT03129100|38254259|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
17116755|NCT03129100|38254260|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
17116756|NCT03129100|38254261|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
17116757|NCT03129100|38254262|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
17116758|NCT03129100|38254263|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
17116759|NCT03129100|38254264|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
17116760|NCT03129100|38254265|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
17116761|NCT03129100|38254266|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
17116762|NCT03129100|38254267|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
17116763|NCT03129100|38254268|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
17116764|NCT03129100|38254269|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
17116765|NCT03129100|38254270|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
17116766|NCT03129100|38254271|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
17116767|NCT03129100|38254272|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
17116768|NCT03129100|38254273|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
17116769|NCT03129100|38254274|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
17116770|NCT03129100|38254275|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
17116771|NCT03129100|38254276|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
17116772|NCT03129100|38254277|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
17116773|NCT03129100|38254278|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
17116774|NCT03129100|38254279|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
17116775|NCT03101020|38254318|FG000|Overall Study|Lack of time to participate|1|||
17116776|NCT03101020|38254319|FG001|Overall Study|Lack of time to participate|0|||
17116777|NCT03101020|38254318|FG000|Overall Study|Ran over by a car|0|||
17116778|NCT03101020|38254319|FG001|Overall Study|Ran over by a car|1|||
17116779|NCT03101020|38254318|FG000|Overall Study|Withdrawal by Subject|0|||
17116780|NCT03101020|38254319|FG001|Overall Study|Withdrawal by Subject|2|||
17116781|NCT03100942|38254329|FG000|Randomized Treatment Period|Withdrew Consent|4|||
17116782|NCT03100942|38254330|FG001|Randomized Treatment Period|Withdrew Consent|5|||
17116783|NCT03100942|38254331|FG002|Randomized Treatment Period|Withdrew Consent|3|||
17116784|NCT03100942|38254332|FG003|Randomized Treatment Period|Withdrew Consent|3|||
17116785|NCT03100942|38254333|FG004|Randomized Treatment Period|Withdrew Consent|0|||
17116786|NCT03100942|38254334|FG005|Randomized Treatment Period|Withdrew Consent|0|||
17116787|NCT03100942|38254335|FG006|Randomized Treatment Period|Withdrew Consent|0|||
17116788|NCT03100942|38254329|FG000|Randomized Treatment Period|Adverse Event|5|||
17116789|NCT03100942|38254330|FG001|Randomized Treatment Period|Adverse Event|2|||
17116790|NCT03100942|38254331|FG002|Randomized Treatment Period|Adverse Event|1|||
17116791|NCT03100942|38254332|FG003|Randomized Treatment Period|Adverse Event|0|||
17116792|NCT03100942|38254333|FG004|Randomized Treatment Period|Adverse Event|0|||
17116793|NCT03100942|38254334|FG005|Randomized Treatment Period|Adverse Event|0|||
17116794|NCT03100942|38254335|FG006|Randomized Treatment Period|Adverse Event|0|||
17116795|NCT03100942|38254329|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
17116796|NCT03100942|38254330|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
17116797|NCT03100942|38254331|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
17116798|NCT03100942|38254332|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
17116799|NCT03100942|38254333|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
17116800|NCT03100942|38254334|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
17116801|NCT03100942|38254335|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
17116802|NCT03100942|38254329|FG000|Randomized Treatment Period|Protocol Violation|0|||
17116803|NCT03100942|38254330|FG001|Randomized Treatment Period|Protocol Violation|1|||
17116804|NCT03100942|38254331|FG002|Randomized Treatment Period|Protocol Violation|1|||
17116805|NCT03100942|38254332|FG003|Randomized Treatment Period|Protocol Violation|1|||
17116806|NCT03100942|38254333|FG004|Randomized Treatment Period|Protocol Violation|0|||
17116807|NCT03100942|38254334|FG005|Randomized Treatment Period|Protocol Violation|0|||
17116808|NCT03100942|38254335|FG006|Randomized Treatment Period|Protocol Violation|0|||
17116809|NCT03100942|38254329|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
17116810|NCT03100942|38254330|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
17116811|NCT03100942|38254331|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
17116812|NCT03100942|38254332|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
17116813|NCT03100942|38254333|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
17116814|NCT03100942|38254334|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
17116815|NCT03100942|38254335|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
17116816|NCT03100942|38254329|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
17116817|NCT03100942|38254330|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
17116818|NCT03100942|38254331|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
17116819|NCT03100942|38254332|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
17116820|NCT03100942|38254333|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
17116821|NCT03100942|38254334|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
17116822|NCT03100942|38254335|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
17116823|NCT03100942|38254329|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
17116824|NCT03100942|38254330|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
17116825|NCT03100942|38254331|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
17116826|NCT03100942|38254332|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
17116827|NCT03100942|38254333|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
17116828|NCT03100942|38254334|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
17116829|NCT03100942|38254335|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
17116830|NCT03099694|38254350|FG000|Overall Study|Withdrawal by Subject|11|||
17116831|NCT03099694|38254351|FG001|Overall Study|Withdrawal by Subject|13|||
17116832|NCT03099694|38254350|FG000|Overall Study|Lost to Follow-up|9|||
17116833|NCT03099694|38254351|FG001|Overall Study|Lost to Follow-up|5|||
17116834|NCT03099538|38254358|FG000|Overall Study|Lack of Efficacy|3|||
17116835|NCT03099304|38254367|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
17116836|NCT03099304|38254368|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
17116837|NCT03099304|38254369|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
17116838|NCT03099304|38254370|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
17116839|NCT03099304|38254371|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
17116840|NCT03099304|38254372|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
17116841|NCT03099304|38254367|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
17116842|NCT03099304|38254368|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
17116843|NCT03099304|38254369|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
17116844|NCT03099304|38254370|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
17116845|NCT03099304|38254371|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
17116846|NCT03099304|38254372|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
17116847|NCT03099304|38254367|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
17116848|NCT03099304|38254368|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
17116849|NCT03099304|38254369|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
17116850|NCT03099304|38254370|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
17116851|NCT03099304|38254371|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
17116852|NCT03099304|38254372|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
17116853|NCT03099304|38254367|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
17116854|NCT03099304|38254368|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
17116855|NCT03099304|38254369|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
17116856|NCT03099304|38254370|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
17116857|NCT03099304|38254371|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
17116858|NCT03099304|38254372|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
17116859|NCT03099304|38254367|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
17116860|NCT03099304|38254368|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
17116861|NCT03099304|38254369|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
17116862|NCT03099304|38254370|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
17116863|NCT03099304|38254371|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
17116864|NCT03099304|38254372|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
17116865|NCT03099304|38254367|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
17116866|NCT03099304|38254368|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
17116867|NCT03099304|38254369|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
17116868|NCT03099304|38254370|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
17116869|NCT03099304|38254371|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
17116870|NCT03099304|38254372|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
17116871|NCT03099304|38254367|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
17116872|NCT03099304|38254368|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
17116873|NCT03099304|38254369|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
17116874|NCT03099304|38254370|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
17116875|NCT03099304|38254371|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
17116876|NCT03099304|38254372|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
17116877|NCT03099304|38254367|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
17116878|NCT03099304|38254368|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
17116879|NCT03099304|38254369|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
17116880|NCT03099304|38254370|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
17116881|NCT03099304|38254371|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
17116882|NCT03099304|38254372|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
17116883|NCT03099304|38254367|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
17116884|NCT03099304|38254368|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
17116885|NCT03099304|38254369|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
17116886|NCT03099304|38254370|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
17116887|NCT03099304|38254371|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
17116888|NCT03099304|38254372|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
17116889|NCT03099304|38254367|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
17116890|NCT03099304|38254368|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
17116891|NCT03099304|38254369|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
17116892|NCT03099304|38254370|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
17116893|NCT03099304|38254371|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
17116894|NCT03099304|38254372|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
17116895|NCT03099304|38254367|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
17116896|NCT03099304|38254368|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
17116897|NCT03099304|38254369|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
17116898|NCT03099304|38254370|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
17116899|NCT03099304|38254371|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
17116900|NCT03099304|38254372|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
17116901|NCT03099304|38254367|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
17116902|NCT03099304|38254368|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
17116903|NCT03099304|38254369|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
17116904|NCT03099304|38254370|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
17116905|NCT03099304|38254371|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
17116906|NCT03099304|38254372|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
17116907|NCT03099304|38254367|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
17116908|NCT03099304|38254368|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
17116909|NCT03099304|38254369|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
17116910|NCT03099304|38254370|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
17116911|NCT03099304|38254371|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
17116912|NCT03099304|38254372|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
17116913|NCT03099304|38254367|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
17116914|NCT03099304|38254368|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
17116915|NCT03099304|38254369|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
17116916|NCT03099304|38254370|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
17116917|NCT03099304|38254371|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
17116918|NCT03099304|38254372|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
17116919|NCT03099304|38254367|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
17116920|NCT03099304|38254368|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
17116921|NCT03099304|38254369|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
17116922|NCT03099304|38254370|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
17116923|NCT03099304|38254371|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
17116924|NCT03099304|38254372|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
17116925|NCT03099304|38254367|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
17116926|NCT03099304|38254368|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
17116927|NCT03099304|38254369|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
17116928|NCT03099304|38254370|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
17116929|NCT03099304|38254371|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
17116930|NCT03099304|38254372|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
17116931|NCT03099304|38254367|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
17116932|NCT03099304|38254368|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
17116933|NCT03099304|38254369|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
17116934|NCT03099304|38254370|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
17116935|NCT03099304|38254371|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
17116936|NCT03099304|38254372|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
17116937|NCT03097588|38254399|FG000|Overall Study|Adverse Event|1|||
17116938|NCT01631214|38254405|FG000|Overall Study|Withdrawal by Subject|276|||
17116939|NCT01631214|38254406|FG001|Overall Study|Withdrawal by Subject|290|||
17116940|NCT01631214|38254405|FG000|Overall Study|Death|113|||
17116941|NCT01631214|38254406|FG001|Overall Study|Death|106|||
17116942|NCT01631214|38254405|FG000|Overall Study|Lost to Follow-up|54|||
17116943|NCT01631214|38254406|FG001|Overall Study|Lost to Follow-up|40|||
17116944|NCT01631214|38254405|FG000|Overall Study|Adverse Event|45|||
17116945|NCT01631214|38254406|FG001|Overall Study|Adverse Event|45|||
17116946|NCT01631214|38254405|FG000|Overall Study|Other|22|||
17116947|NCT01631214|38254406|FG001|Overall Study|Other|19|||
17116948|NCT01631214|38254405|FG000|Overall Study|Noncompliance|16|||
17116949|NCT01631214|38254406|FG001|Overall Study|Noncompliance|15|||
17116950|NCT01631214|38254405|FG000|Overall Study|Requirement for Alternative Therapy|8|||
17116951|NCT01631214|38254406|FG001|Overall Study|Requirement for Alternative Therapy|3|||
17116952|NCT01631214|38254405|FG000|Overall Study|Protocol Deviation|4|||
17116953|NCT01631214|38254406|FG001|Overall Study|Protocol Deviation|3|||
17116954|NCT01631214|38254405|FG000|Overall Study|Ineligibility determined|5|||
17116955|NCT01631214|38254406|FG001|Overall Study|Ineligibility determined|2|||
17116956|NCT01631214|38254405|FG000|Overall Study|Administrative Decision|1|||
17116957|NCT01631214|38254406|FG001|Overall Study|Administrative Decision|0|||
17116958|NCT03093454|38254416|FG000|Overall Study|Withdrawal by Subject|1|||
17116959|NCT03093454|38254417|FG001|Overall Study|Withdrawal by Subject|1|||
17116960|NCT03093454|38254416|FG000|Overall Study|Scheduling conflict|3|||
17116961|NCT03093454|38254417|FG001|Overall Study|Scheduling conflict|1|||
17116962|NCT03093454|38254416|FG000|Overall Study|Physician Decision|2|||
17116963|NCT03093454|38254417|FG001|Overall Study|Physician Decision|1|||
17116964|NCT00468130|38254438|FG000|Overall Study|Adverse Event|2|||
17116965|NCT00468130|38254439|FG001|Overall Study|Adverse Event|1|||
17116966|NCT00468130|38254438|FG000|Overall Study|Withdrawal by Subject|0|||
17116967|NCT00468130|38254439|FG001|Overall Study|Withdrawal by Subject|1|||
17116968|NCT00911820|38254449|FG000|Overall Study|RECIST progression|12|||
17116969|NCT00911820|38254450|FG001|Overall Study|RECIST progression|8|||
17116970|NCT00911820|38254449|FG000|Overall Study|Adverse Event|8|||
17116971|NCT00911820|38254450|FG001|Overall Study|Adverse Event|8|||
17116972|NCT00911820|38254449|FG000|Overall Study|Clinical Progression|7|||
17116973|NCT00911820|38254450|FG001|Overall Study|Clinical Progression|5|||
17116974|NCT00911820|38254449|FG000|Overall Study|Physician Decision|5|||
17116975|NCT00911820|38254450|FG001|Overall Study|Physician Decision|9|||
17116976|NCT00911820|38254449|FG000|Overall Study|Decline in Performance Status|4|||
17116977|NCT00911820|38254450|FG001|Overall Study|Decline in Performance Status|2|||
17116978|NCT00911820|38254449|FG000|Overall Study|Withdrawal by Subject|3|||
17116979|NCT00911820|38254450|FG001|Overall Study|Withdrawal by Subject|4|||
17116980|NCT00911820|38254449|FG000|Overall Study|Death|1|||
17116981|NCT00911820|38254450|FG001|Overall Study|Death|2|||
17116982|NCT00911820|38254449|FG000|Overall Study|Pursue surgery|1|||
17116983|NCT00911820|38254450|FG001|Overall Study|Pursue surgery|1|||
17116984|NCT00911820|38254449|FG000|Overall Study|Pursue Radiation|1|||
17116985|NCT00911820|38254450|FG001|Overall Study|Pursue Radiation|0|||
17116986|NCT00911820|38254449|FG000|Overall Study|Still on Therapy|2|||
17116987|NCT00911820|38254450|FG001|Overall Study|Still on Therapy|2|||
17116988|NCT00911820|38254449|FG000|Overall Study|Pathology Not Confirmed|1|||
17116989|NCT00911820|38254450|FG001|Overall Study|Pathology Not Confirmed|0|||
17116990|NCT00911820|38254449|FG000|Overall Study|Withdraw before Receive Treatment|0|||
17116991|NCT00911820|38254450|FG001|Overall Study|Withdraw before Receive Treatment|2|||
17116992|NCT00246324|38254465|FG000|Overall Study|Withdrawal by Subject|1|||
17116993|NCT00999804|38254471|FG000|Overall Study|Lack of Efficacy|9|||
17116994|NCT00999804|38254472|FG001|Overall Study|Lack of Efficacy|2|||
17116995|NCT00999804|38254471|FG000|Overall Study|Adverse Event|4|||
17116996|NCT00999804|38254472|FG001|Overall Study|Adverse Event|3|||
17116997|NCT00999804|38254471|FG000|Overall Study|Withdrawal by Subject|4|||
17116998|NCT00999804|38254472|FG001|Overall Study|Withdrawal by Subject|0|||
17116999|NCT00999804|38254471|FG000|Overall Study|Death|1|||
17117000|NCT00999804|38254472|FG001|Overall Study|Death|0|||
17117001|NCT00999804|38254471|FG000|Overall Study|Ineligible|3|||
17117002|NCT00999804|38254472|FG001|Overall Study|Ineligible|0|||
17117003|NCT02874742|38254481|FG000|Overall Study|Death|3|||
17117004|NCT02874742|38254482|FG001|Overall Study|Death|1|||
17117005|NCT02874742|38254483|FG002|Overall Study|Death|1|||
17117006|NCT02874742|38254481|FG000|Overall Study|Lost to Follow-up|2|||
17117007|NCT02874742|38254482|FG001|Overall Study|Lost to Follow-up|0|||
17117008|NCT02874742|38254483|FG002|Overall Study|Lost to Follow-up|0|||
17117009|NCT02874742|38254481|FG000|Overall Study|Withdrawal by Subject|8|||
17117010|NCT02874742|38254482|FG001|Overall Study|Withdrawal by Subject|4|||
17117011|NCT02874742|38254483|FG002|Overall Study|Withdrawal by Subject|0|||
17117012|NCT02874742|38254481|FG000|Overall Study|Other|3|||
17117013|NCT02874742|38254482|FG001|Overall Study|Other|1|||
17117014|NCT02874742|38254483|FG002|Overall Study|Other|0|||
17117015|NCT02874742|38254481|FG000|Overall Study|Ongoing|87|||
17117016|NCT02874742|38254482|FG001|Overall Study|Ongoing|98|||
17117017|NCT02874742|38254483|FG002|Overall Study|Ongoing|15|||
17117018|NCT04234984|38254493|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
17117019|NCT04234984|38254493|FG000|Follow-up at the Second Time Point|Death|1|||
17117020|NCT04234984|38254493|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
17117021|NCT03922750|38254507|FG000|Overall Study|Unclassified|0|||
17117022|NCT03922750|38254508|FG001|Overall Study|Unclassified|0|||
17117023|NCT03922750|38254509|FG002|Overall Study|Unclassified|1|||
17117024|NCT03922750|38254507|FG000|Overall Study|Adverse Event|0|||
17117025|NCT03922750|38254508|FG001|Overall Study|Adverse Event|1|||
17117026|NCT03922750|38254509|FG002|Overall Study|Adverse Event|0|||
17117027|NCT03617172|38254519|FG000|Overall Study|Lost to Follow-up|1|||
17117028|NCT03617172|38254520|FG001|Overall Study|Lost to Follow-up|0|||
17117029|NCT03760146|38254532|FG000|Overall Study|Adverse Event|11|||
17117030|NCT03760146|38254533|FG001|Overall Study|Adverse Event|8|||
17117031|NCT03760146|38254534|FG002|Overall Study|Adverse Event|0|||
17117032|NCT03760146|38254535|FG003|Overall Study|Adverse Event|0|||
17117033|NCT03760146|38254536|FG004|Overall Study|Adverse Event|0|||
17117034|NCT03760146|38254537|FG005|Overall Study|Adverse Event|0|||
17117035|NCT03760146|38254532|FG000|Overall Study|Death|1|||
17117036|NCT03760146|38254533|FG001|Overall Study|Death|0|||
17117037|NCT03760146|38254534|FG002|Overall Study|Death|0|||
17117038|NCT03760146|38254535|FG003|Overall Study|Death|0|||
17117039|NCT03760146|38254536|FG004|Overall Study|Death|0|||
17117040|NCT03760146|38254537|FG005|Overall Study|Death|0|||
17117041|NCT03760146|38254532|FG000|Overall Study|Lost to Follow-up|41|||
17117042|NCT03760146|38254533|FG001|Overall Study|Lost to Follow-up|28|||
17117043|NCT03760146|38254534|FG002|Overall Study|Lost to Follow-up|9|||
17117044|NCT03760146|38254535|FG003|Overall Study|Lost to Follow-up|2|||
17117045|NCT03760146|38254536|FG004|Overall Study|Lost to Follow-up|14|||
17117046|NCT03760146|38254537|FG005|Overall Study|Lost to Follow-up|8|||
17117047|NCT03760146|38254532|FG000|Overall Study|No longer met eligibility criteria|3|||
17117048|NCT03760146|38254533|FG001|Overall Study|No longer met eligibility criteria|9|||
17117049|NCT03760146|38254534|FG002|Overall Study|No longer met eligibility criteria|0|||
17117050|NCT03760146|38254535|FG003|Overall Study|No longer met eligibility criteria|0|||
17117051|NCT03760146|38254536|FG004|Overall Study|No longer met eligibility criteria|1|||
17117052|NCT03760146|38254537|FG005|Overall Study|No longer met eligibility criteria|0|||
17117053|NCT03760146|38254532|FG000|Overall Study|Protocol Violation|21|||
17117054|NCT03760146|38254533|FG001|Overall Study|Protocol Violation|13|||
17117055|NCT03760146|38254534|FG002|Overall Study|Protocol Violation|1|||
17117056|NCT03760146|38254535|FG003|Overall Study|Protocol Violation|0|||
17117057|NCT03760146|38254536|FG004|Overall Study|Protocol Violation|1|||
17117058|NCT03760146|38254537|FG005|Overall Study|Protocol Violation|0|||
17117059|NCT03760146|38254532|FG000|Overall Study|Withdrawal by Subject|19|||
17117060|NCT03760146|38254533|FG001|Overall Study|Withdrawal by Subject|20|||
17117061|NCT03760146|38254534|FG002|Overall Study|Withdrawal by Subject|1|||
17117062|NCT03760146|38254535|FG003|Overall Study|Withdrawal by Subject|0|||
17117063|NCT03760146|38254536|FG004|Overall Study|Withdrawal by Subject|1|||
17117064|NCT03760146|38254537|FG005|Overall Study|Withdrawal by Subject|0|||
17117065|NCT03759366|38254555|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
17117066|NCT03759366|38254555|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
17117067|NCT03760068|38254561|FG000|Overall Study|Withdrawal by Subject|7|||
17117068|NCT03760068|38254562|FG001|Overall Study|Withdrawal by Subject|8|||
17117069|NCT03760068|38254561|FG000|Overall Study|Adverse Event|1|||
17117070|NCT03760068|38254562|FG001|Overall Study|Adverse Event|2|||
17117071|NCT03760068|38254561|FG000|Overall Study|Administrative Decision by Sponsor|0|||
17117072|NCT03760068|38254562|FG001|Overall Study|Administrative Decision by Sponsor|2|||
17117073|NCT03760068|38254561|FG000|Overall Study|Physician Decision|1|||
17117074|NCT03760068|38254562|FG001|Overall Study|Physician Decision|2|||
17117075|NCT03760068|38254561|FG000|Overall Study|Lost to Follow-up|4|||
17117076|NCT03760068|38254562|FG001|Overall Study|Lost to Follow-up|9|||
17117077|NCT03760068|38254561|FG000|Overall Study|Subject Moved Out of State|1|||
17117078|NCT03760068|38254562|FG001|Overall Study|Subject Moved Out of State|0|||
17117079|NCT03759600|38254569|FG000|Overall Study|Ongoing at Data Cut-off|16|||
17117080|NCT03759600|38254569|FG000|Overall Study|Adverse Event|1|||
17117081|NCT03759600|38254569|FG000|Overall Study|Progressive Disease|3|||
17117082|NCT03435640|38254584|FG000|Overall Study|Withdrawal by Subject|0|||
17117083|NCT03435640|38254585|FG001|Overall Study|Withdrawal by Subject|1|||
17117084|NCT03435640|38254586|FG002|Overall Study|Withdrawal by Subject|0|||
17117085|NCT03435640|38254587|FG003|Overall Study|Withdrawal by Subject|2|||
17117086|NCT03435640|38254588|FG004|Overall Study|Withdrawal by Subject|0|||
17117087|NCT03435640|38254589|FG005|Overall Study|Withdrawal by Subject|0|||
17117088|NCT03435640|38254590|FG006|Overall Study|Withdrawal by Subject|3|||
17117089|NCT03435640|38254591|FG007|Overall Study|Withdrawal by Subject|0|||
17117090|NCT03435640|38254592|FG008|Overall Study|Withdrawal by Subject|0|||
17117091|NCT03435640|38254593|FG009|Overall Study|Withdrawal by Subject|2|||
17117092|NCT03435640|38254594|FG010|Overall Study|Withdrawal by Subject|3|||
17117093|NCT03435640|38254584|FG000|Overall Study|Lost to Follow-up|0|||
17117094|NCT03435640|38254585|FG001|Overall Study|Lost to Follow-up|0|||
17117095|NCT03435640|38254586|FG002|Overall Study|Lost to Follow-up|1|||
17117096|NCT03435640|38254587|FG003|Overall Study|Lost to Follow-up|0|||
17117097|NCT03435640|38254588|FG004|Overall Study|Lost to Follow-up|0|||
17117098|NCT03435640|38254589|FG005|Overall Study|Lost to Follow-up|0|||
17117099|NCT03435640|38254590|FG006|Overall Study|Lost to Follow-up|0|||
17117100|NCT03435640|38254591|FG007|Overall Study|Lost to Follow-up|0|||
17117101|NCT03435640|38254592|FG008|Overall Study|Lost to Follow-up|0|||
17117102|NCT03435640|38254593|FG009|Overall Study|Lost to Follow-up|0|||
17117103|NCT03435640|38254594|FG010|Overall Study|Lost to Follow-up|0|||
17117104|NCT00655876|38254622|FG000|Overall Study|Protocol Violation|9|||
17117105|NCT00655876|38254623|FG001|Overall Study|Protocol Violation|7|||
17117106|NCT03092752|38254629|FG000|Overall Study|Aged <40 years|14209|||
17117107|NCT03092752|38254629|FG000|Overall Study|At least one claim with T2DM|61299|||
17117108|NCT03092752|38254629|FG000|Overall Study|Having no claim of study drugs|29282|||
17117109|NCT03092752|38254629|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
17117110|NCT03092752|38254629|FG000|Overall Study|<6 month history|245900|||
17117111|NCT03750552|38254652|FG000|Overall Study|Adverse Event|5|||
17117112|NCT03750552|38254653|FG001|Overall Study|Adverse Event|1|||
17117113|NCT03750552|38254652|FG000|Overall Study|Withdrawal by Subject|1|||
17117114|NCT03750552|38254653|FG001|Overall Study|Withdrawal by Subject|1|||
17117115|NCT03750552|38254652|FG000|Overall Study|Other|2|||
17117116|NCT03750552|38254653|FG001|Overall Study|Other|0|||
17117117|NCT03750240|38254660|FG000|Overall Study|Technical Difficulties|2|||
17117118|NCT00047008|38254666|FG000|Overall Study|Withdrawn consent|2|||
17117119|NCT00047008|38254667|FG001|Overall Study|Withdrawn consent|3|||
17117120|NCT00047008|38254666|FG000|Overall Study|Ineligible|9|||
17117121|NCT00047008|38254667|FG001|Overall Study|Ineligible|8|||
17117122|NCT03091738|38254673|FG000|Overall Study|Adverse Event|1|||
17117123|NCT03091738|38254673|FG000|Overall Study|Lost to Follow-up|1|||
17117124|NCT03193216|38254679|FG000|Overall Study|Lost to Follow-up|1|||
17117125|NCT03193216|38254680|FG001|Overall Study|Lost to Follow-up|0|||
17117126|NCT03193216|38254679|FG000|Overall Study|Withdrawal by Subject|5|||
17117127|NCT03193216|38254680|FG001|Overall Study|Withdrawal by Subject|0|||
17117128|NCT03193216|38254679|FG000|Overall Study|Physician Decision|4|||
17117129|NCT03193216|38254680|FG001|Overall Study|Physician Decision|0|||
17117130|NCT03091348|38254688|FG000|Overall Study|Lost to Follow-up|2|||
17117131|NCT03091348|38254689|FG001|Overall Study|Lost to Follow-up|1|||
17117132|NCT03751098|38254696|FG000|Overall Study|Withdrawal by Subject|0|||
17117133|NCT03751098|38254697|FG001|Overall Study|Withdrawal by Subject|1|||
17117134|NCT03751020|38254708|FG000|Overall Study|Withdrawal by Subject|2|||
17117135|NCT03751020|38254709|FG001|Overall Study|Withdrawal by Subject|0|||
17117136|NCT03751020|38254710|FG002|Overall Study|Withdrawal by Subject|0|||
17117137|NCT03751020|38254708|FG000|Overall Study|Lost to Follow-up|7|||
17117138|NCT03751020|38254709|FG001|Overall Study|Lost to Follow-up|4|||
17117139|NCT03751020|38254710|FG002|Overall Study|Lost to Follow-up|10|||
17117140|NCT03090100|38254720|FG000|Overall Study|Adverse Event|9|||
17117141|NCT03090100|38254721|FG001|Overall Study|Adverse Event|11|||
17117142|NCT03090100|38254720|FG000|Overall Study|Pregnancy|1|||
17117143|NCT03090100|38254721|FG001|Overall Study|Pregnancy|1|||
17117144|NCT03090100|38254720|FG000|Overall Study|Lack of Efficacy|2|||
17117145|NCT03090100|38254721|FG001|Overall Study|Lack of Efficacy|7|||
17117146|NCT03090100|38254720|FG000|Overall Study|Lost to Follow-up|2|||
17117147|NCT03090100|38254721|FG001|Overall Study|Lost to Follow-up|2|||
17117148|NCT03090100|38254720|FG000|Overall Study|Withdrawal by Subject|7|||
17117149|NCT03090100|38254721|FG001|Overall Study|Withdrawal by Subject|19|||
17117150|NCT03090100|38254720|FG000|Overall Study|Protocol Violation|2|||
17117151|NCT03090100|38254721|FG001|Overall Study|Protocol Violation|6|||
17117152|NCT03090100|38254720|FG000|Overall Study|Non-compliance|2|||
17117153|NCT03090100|38254721|FG001|Overall Study|Non-compliance|0|||
17117154|NCT03090100|38254720|FG000|Overall Study|Other|2|||
17117155|NCT03090100|38254721|FG001|Overall Study|Other|2|||
17117156|NCT03089944|38254727|FG000|Overall Study|Lost to Follow-up|8|||
17117157|NCT03089944|38254727|FG000|Overall Study|Withdrew Consent|2|||
17117158|NCT03089944|38254727|FG000|Overall Study|Adverse Event|1|||
17117159|NCT03089944|38254727|FG000|Overall Study|Other|1|||
17117160|NCT03739866|38254750|FG000|Overall Study|Lost to Follow-up|0|||
17117161|NCT03739866|38254751|FG001|Overall Study|Lost to Follow-up|0|||
17117162|NCT03739866|38254752|FG002|Overall Study|Lost to Follow-up|0|||
17117163|NCT03739866|38254753|FG003|Overall Study|Lost to Follow-up|1|||
17117164|NCT03739866|38254754|FG004|Overall Study|Lost to Follow-up|0|||
17117165|NCT03739866|38254755|FG005|Overall Study|Lost to Follow-up|0|||
17117166|NCT03739866|38254756|FG006|Overall Study|Lost to Follow-up|0|||
17117167|NCT03739866|38254757|FG007|Overall Study|Lost to Follow-up|0|||
17117168|NCT03739866|38254750|FG000|Overall Study|Enrolled but not treated|0|||
17117169|NCT03739866|38254751|FG001|Overall Study|Enrolled but not treated|0|||
17117170|NCT03739866|38254752|FG002|Overall Study|Enrolled but not treated|1|||
17117171|NCT03739866|38254753|FG003|Overall Study|Enrolled but not treated|0|||
17117172|NCT03739866|38254754|FG004|Overall Study|Enrolled but not treated|1|||
17117173|NCT03739866|38254755|FG005|Overall Study|Enrolled but not treated|0|||
17117174|NCT03739866|38254756|FG006|Overall Study|Enrolled but not treated|0|||
17117175|NCT03739866|38254757|FG007|Overall Study|Enrolled but not treated|0|||
17117176|NCT03739242|38254781|FG000|Overall Study|Withdrawal by Subject|1|||
17117177|NCT03739242|38254782|FG001|Overall Study|Withdrawal by Subject|1|||
17117178|NCT03739242|38254781|FG000|Overall Study|Protocol Violation|0|||
17117179|NCT03739242|38254782|FG001|Overall Study|Protocol Violation|1|||
17117180|NCT02849626|38254839|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
17117181|NCT02849626|38254840|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
17117182|NCT02849626|38254841|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
17117183|NCT02849626|38254842|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
17117184|NCT02849626|38254839|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
17117185|NCT02849626|38254840|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
17117186|NCT02849626|38254841|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
17117187|NCT02849626|38254842|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
17117188|NCT02849626|38254839|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
17117189|NCT02849626|38254840|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
17117190|NCT02849626|38254841|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
17117191|NCT02849626|38254842|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
17117192|NCT02849626|38254839|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
17117193|NCT02849626|38254840|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
17117194|NCT02849626|38254841|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
17117195|NCT02849626|38254842|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
17117196|NCT02849626|38254839|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
17117197|NCT02849626|38254840|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
17117198|NCT02849626|38254841|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
17117199|NCT02849626|38254842|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
17117200|NCT02849626|38254839|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
17117201|NCT02849626|38254840|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
17117202|NCT02849626|38254841|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
17117203|NCT02849626|38254842|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
17117204|NCT02849626|38254839|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
17117205|NCT02849626|38254840|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
17117206|NCT02849626|38254841|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
17117207|NCT02849626|38254842|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
17117208|NCT02849626|38254839|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
17117209|NCT02849626|38254840|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
17117210|NCT02849626|38254841|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
17117211|NCT02849626|38254842|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
17117212|NCT02849626|38254839|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
17117213|NCT02849626|38254840|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
17117214|NCT02849626|38254841|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
17117215|NCT02849626|38254842|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
17117216|NCT02849626|38254839|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
17117217|NCT02849626|38254840|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
17117218|NCT02849626|38254841|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
17117219|NCT02849626|38254842|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
17117220|NCT02849626|38254839|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
17117221|NCT02849626|38254840|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
17117222|NCT02849626|38254841|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
17117223|NCT02849626|38254842|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
17117224|NCT03735498|38254860|FG000|Overall Study|Withdrawal by Subject|5|||
17117225|NCT03735498|38254860|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
17117226|NCT02659540|38254866|FG000|Overall Study|Adverse Event|3|||
17117227|NCT02659540|38254867|FG001|Overall Study|Adverse Event|2|||
17117228|NCT02659540|38254866|FG000|Overall Study|Death|1|||
17117229|NCT02659540|38254867|FG001|Overall Study|Death|0|||
17117230|NCT02659540|38254866|FG000|Overall Study|Progressive disease|2|||
17117231|NCT02659540|38254867|FG001|Overall Study|Progressive disease|6|||
17117232|NCT01097746|38254873|FG000|Overall Study|Adverse Event|4|||
17117233|NCT01097746|38254873|FG000|Overall Study|taken off study before any treatment given|1|||
17117234|NCT03733470|38254903|FG000|Overall Study|PI Decision|1|||
17117235|NCT03733470|38254904|FG001|Overall Study|PI Decision|1|||
17117236|NCT03732534|38254910|FG000|Overall Study|Study terminated by Sponsor|6|||
17117237|NCT03087058|38254916|FG000|Overall Study|Withdrawal by Subject|2|||
17117238|NCT03087058|38254917|FG001|Overall Study|Withdrawal by Subject|0|||
17117239|NCT03087058|38254918|FG002|Overall Study|Withdrawal by Subject|0|||
17117240|NCT03726996|38254925|FG000|Overall Study|Parent's decision|2|||
17117241|NCT03726996|38254925|FG000|Overall Study|Study early termination|2|||
17117242|NCT03882970|38254933|FG000|Overall Study|Adverse Event|5|||
17117243|NCT03882970|38254934|FG001|Overall Study|Adverse Event|7|||
17117244|NCT03882970|38254935|FG002|Overall Study|Adverse Event|3|||
17117245|NCT03882970|38254936|FG003|Overall Study|Adverse Event|1|||
17117246|NCT03882970|38254933|FG000|Overall Study|Death|1|||
17117247|NCT03882970|38254934|FG001|Overall Study|Death|2|||
17117248|NCT03882970|38254935|FG002|Overall Study|Death|1|||
17117249|NCT03882970|38254936|FG003|Overall Study|Death|1|||
17117250|NCT03882970|38254933|FG000|Overall Study|Lost to Follow-up|8|||
17117251|NCT03882970|38254934|FG001|Overall Study|Lost to Follow-up|9|||
17117252|NCT03882970|38254935|FG002|Overall Study|Lost to Follow-up|5|||
17117253|NCT03882970|38254936|FG003|Overall Study|Lost to Follow-up|5|||
17117254|NCT03882970|38254933|FG000|Overall Study|Physician Decision|0|||
17117255|NCT03882970|38254934|FG001|Overall Study|Physician Decision|2|||
17117256|NCT03882970|38254935|FG002|Overall Study|Physician Decision|2|||
17117257|NCT03882970|38254936|FG003|Overall Study|Physician Decision|2|||
17117258|NCT03882970|38254933|FG000|Overall Study|Protocol Violation|2|||
17117259|NCT03882970|38254934|FG001|Overall Study|Protocol Violation|0|||
17117260|NCT03882970|38254935|FG002|Overall Study|Protocol Violation|0|||
17117261|NCT03882970|38254936|FG003|Overall Study|Protocol Violation|0|||
17117262|NCT03882970|38254933|FG000|Overall Study|Withdrawal by Subject|8|||
17117263|NCT03882970|38254934|FG001|Overall Study|Withdrawal by Subject|17|||
17117264|NCT03882970|38254935|FG002|Overall Study|Withdrawal by Subject|7|||
17117265|NCT03882970|38254936|FG003|Overall Study|Withdrawal by Subject|22|||
17117266|NCT03882970|38254933|FG000|Overall Study|Personal Reason|2|||
17117267|NCT03882970|38254934|FG001|Overall Study|Personal Reason|3|||
17117268|NCT03882970|38254935|FG002|Overall Study|Personal Reason|1|||
17117269|NCT03882970|38254936|FG003|Overall Study|Personal Reason|3|||
17117270|NCT03730480|38254950|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
17117271|NCT03674112|38254957|FG000|Overall Study|Adverse Event|1|||
17117272|NCT03674112|38254958|FG001|Overall Study|Adverse Event|0|||
17117273|NCT03674112|38254957|FG000|Overall Study|Ongoing in the Study|79|||
17117274|NCT03674112|38254958|FG001|Overall Study|Ongoing in the Study|80|||
17117275|NCT03668808|38254984|FG000|First Intervention|Withdrawal by Subject|2|||
17117276|NCT03668808|38254985|FG001|First Intervention|Withdrawal by Subject|2|||
17117277|NCT03725982|38254995|FG000|First Intervention|Withdrawal by Subject|0|||
17117278|NCT03725982|38254996|FG001|First Intervention|Withdrawal by Subject|1|||
17117279|NCT03725982|38254995|FG000|First Intervention|Physician Decision|1|||
17117280|NCT03725982|38254996|FG001|First Intervention|Physician Decision|1|||
17117281|NCT02982954|38255012|FG000|Overall Study|Death|55|||
17117282|NCT02982954|38255013|FG001|Overall Study|Death|29|||
17117283|NCT02982954|38255014|FG002|Overall Study|Death|15|||
17117284|NCT02982954|38255015|FG003|Overall Study|Death|20|||
17117285|NCT02982954|38255012|FG000|Overall Study|Lost to Follow-up|2|||
17117286|NCT02982954|38255013|FG001|Overall Study|Lost to Follow-up|1|||
17117287|NCT02982954|38255014|FG002|Overall Study|Lost to Follow-up|0|||
17117288|NCT02982954|38255015|FG003|Overall Study|Lost to Follow-up|0|||
17117289|NCT02982954|38255012|FG000|Overall Study|Participant withdrew consent|7|||
17117290|NCT02982954|38255013|FG001|Overall Study|Participant withdrew consent|5|||
17117291|NCT02982954|38255014|FG002|Overall Study|Participant withdrew consent|1|||
17117292|NCT02982954|38255015|FG003|Overall Study|Participant withdrew consent|1|||
17117293|NCT02982954|38255012|FG000|Overall Study|Other reasons|42|||
17117294|NCT02982954|38255013|FG001|Overall Study|Other reasons|17|||
17117295|NCT02982954|38255014|FG002|Overall Study|Other reasons|12|||
17117296|NCT02982954|38255015|FG003|Overall Study|Other reasons|3|||
17117297|NCT02982954|38255012|FG000|Overall Study|Premature site closure|0|||
17117298|NCT02982954|38255013|FG001|Overall Study|Premature site closure|0|||
17117299|NCT02982954|38255014|FG002|Overall Study|Premature site closure|0|||
17117300|NCT02982954|38255015|FG003|Overall Study|Premature site closure|1|||
17117301|NCT03724968|38255027|FG000|Overall Study|Insurance issues|0|||
17117302|NCT03724968|38255028|FG001|Overall Study|Insurance issues|1|||
17117303|NCT03724968|38255027|FG000|Overall Study|Study closed|0|||
17117304|NCT03724968|38255028|FG001|Overall Study|Study closed|1|||
17117305|NCT03724812|38255034|FG000|Overall Study|Missed Visit|1|||
17117306|NCT03724812|38255034|FG000|Overall Study|Death|2|||
17117307|NCT03724812|38255034|FG000|Overall Study|Withdrawal by Subject|1|||
17117308|NCT03722784|38255041|FG000|Overall Study|Withdrawal by Subject|1|||
17117309|NCT03722784|38255042|FG001|Overall Study|Withdrawal by Subject|0|||
17117310|NCT03722784|38255041|FG000|Overall Study|Physician Decision|1|||
17117311|NCT03722784|38255042|FG001|Overall Study|Physician Decision|1|||
17117312|NCT03722784|38255041|FG000|Overall Study|Protocol Violation|0|||
17117313|NCT03722784|38255042|FG001|Overall Study|Protocol Violation|1|||
17117314|NCT03722238|38255051|FG000|Overall Study|Protocol Violation|1|||
17117315|NCT03722238|38255052|FG001|Overall Study|Protocol Violation|0|||
17117316|NCT03722238|38255051|FG000|Overall Study|Physician Decision|1|||
17117317|NCT03722238|38255052|FG001|Overall Study|Physician Decision|0|||
17117318|NCT03722238|38255051|FG000|Overall Study|Death|1|||
17117319|NCT03722238|38255052|FG001|Overall Study|Death|0|||
17117320|NCT03722238|38255051|FG000|Overall Study|Lost to Follow-up|6|||
17117321|NCT03722238|38255052|FG001|Overall Study|Lost to Follow-up|0|||
17117322|NCT03722238|38255051|FG000|Overall Study|Partial missing data|44|||
17117323|NCT03722238|38255052|FG001|Overall Study|Partial missing data|1|||
17117324|NCT03722238|38255051|FG000|Overall Study|Withdrawal by Subject|2|||
17117325|NCT03722238|38255052|FG001|Overall Study|Withdrawal by Subject|0|||
17117326|NCT03722238|38255051|FG000|Overall Study|Other|4|||
17117327|NCT03722238|38255052|FG001|Overall Study|Other|0|||
17117328|NCT03722238|38255051|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
17117329|NCT03722238|38255052|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
17117330|NCT03722238|38255051|FG000|Overall Study|Did not meet risk classification group criteria|90|||
17117331|NCT03722238|38255052|FG001|Overall Study|Did not meet risk classification group criteria|0|||
17117332|NCT03722238|38255051|FG000|Overall Study|Did not sign consent|17|||
17117333|NCT03722238|38255052|FG001|Overall Study|Did not sign consent|0|||
17117334|NCT03722238|38255051|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
17117335|NCT03722238|38255052|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
17117336|NCT03722238|38255051|FG000|Overall Study|Not willing to purchase study medication|142|||
17117337|NCT03722238|38255052|FG001|Overall Study|Not willing to purchase study medication|0|||
17117338|NCT03722238|38255051|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
17117339|NCT03722238|38255052|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
17117340|NCT02927080|38255068|FG000|Overall Study|Withdrawal by Subject|0|||
17117341|NCT02927080|38255069|FG001|Overall Study|Withdrawal by Subject|0|||
17117342|NCT02927080|38255070|FG002|Overall Study|Withdrawal by Subject|0|||
17117343|NCT02927080|38255071|FG003|Overall Study|Withdrawal by Subject|0|||
17117344|NCT02927080|38255072|FG004|Overall Study|Withdrawal by Subject|1|||
17117345|NCT02927080|38255073|FG005|Overall Study|Withdrawal by Subject|0|||
17117346|NCT02927080|38255074|FG006|Overall Study|Withdrawal by Subject|1|||
17117347|NCT02927080|38255075|FG007|Overall Study|Withdrawal by Subject|1|||
17117348|NCT02927080|38255076|FG008|Overall Study|Withdrawal by Subject|0|||
17117349|NCT02927080|38255077|FG009|Overall Study|Withdrawal by Subject|2|||
17117350|NCT02927080|38255068|FG000|Overall Study|Willingness to comply with protocol|0|||
17117351|NCT02927080|38255069|FG001|Overall Study|Willingness to comply with protocol|0|||
17117352|NCT02927080|38255070|FG002|Overall Study|Willingness to comply with protocol|0|||
17117353|NCT02927080|38255071|FG003|Overall Study|Willingness to comply with protocol|0|||
17117354|NCT02927080|38255072|FG004|Overall Study|Willingness to comply with protocol|0|||
17117355|NCT02927080|38255073|FG005|Overall Study|Willingness to comply with protocol|0|||
17117356|NCT02927080|38255074|FG006|Overall Study|Willingness to comply with protocol|0|||
17117357|NCT02927080|38255075|FG007|Overall Study|Willingness to comply with protocol|0|||
17117358|NCT02927080|38255076|FG008|Overall Study|Willingness to comply with protocol|0|||
17117359|NCT02927080|38255077|FG009|Overall Study|Willingness to comply with protocol|1|||
17117360|NCT02927080|38255068|FG000|Overall Study|Study terminated by Sponsor|0|||
17117361|NCT02927080|38255069|FG001|Overall Study|Study terminated by Sponsor|0|||
17117362|NCT02927080|38255070|FG002|Overall Study|Study terminated by Sponsor|0|||
17117363|NCT02927080|38255071|FG003|Overall Study|Study terminated by Sponsor|0|||
17117364|NCT02927080|38255072|FG004|Overall Study|Study terminated by Sponsor|0|||
17117365|NCT02927080|38255073|FG005|Overall Study|Study terminated by Sponsor|0|||
17117366|NCT02927080|38255074|FG006|Overall Study|Study terminated by Sponsor|6|||
17117367|NCT02927080|38255075|FG007|Overall Study|Study terminated by Sponsor|7|||
17117368|NCT02927080|38255076|FG008|Overall Study|Study terminated by Sponsor|2|||
17117369|NCT02927080|38255077|FG009|Overall Study|Study terminated by Sponsor|3|||
17117370|NCT02927080|38255068|FG000|Overall Study|Adverse Event|0|||
17117371|NCT02927080|38255069|FG001|Overall Study|Adverse Event|1|||
17117372|NCT02927080|38255070|FG002|Overall Study|Adverse Event|0|||
17117373|NCT02927080|38255071|FG003|Overall Study|Adverse Event|0|||
17117374|NCT02927080|38255072|FG004|Overall Study|Adverse Event|0|||
17117375|NCT02927080|38255073|FG005|Overall Study|Adverse Event|0|||
17117376|NCT02927080|38255074|FG006|Overall Study|Adverse Event|0|||
17117377|NCT02927080|38255075|FG007|Overall Study|Adverse Event|1|||
17117378|NCT02927080|38255076|FG008|Overall Study|Adverse Event|0|||
17117379|NCT02927080|38255077|FG009|Overall Study|Adverse Event|1|||
17117380|NCT02927080|38255068|FG000|Overall Study|Other|0|||
17117381|NCT02927080|38255069|FG001|Overall Study|Other|0|||
17117382|NCT02927080|38255070|FG002|Overall Study|Other|0|||
17117383|NCT02927080|38255071|FG003|Overall Study|Other|0|||
17117384|NCT02927080|38255072|FG004|Overall Study|Other|0|||
17117385|NCT02927080|38255073|FG005|Overall Study|Other|0|||
17117386|NCT02927080|38255074|FG006|Overall Study|Other|1|||
17117387|NCT02927080|38255075|FG007|Overall Study|Other|0|||
17117388|NCT02927080|38255076|FG008|Overall Study|Other|1|||
16856737|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
17117389|NCT02927080|38255077|FG009|Overall Study|Other|0|||
17117390|NCT02563002|38255124|FG000|Overall Study|Death|62|||
17117391|NCT02563002|38255125|FG001|Overall Study|Death|75|||
17117392|NCT02563002|38255124|FG000|Overall Study|Lost to Follow-up|1|||
17117393|NCT02563002|38255125|FG001|Overall Study|Lost to Follow-up|0|||
17117394|NCT02563002|38255124|FG000|Overall Study|Withdrawal by Subject|0|||
17117395|NCT02563002|38255125|FG001|Overall Study|Withdrawal by Subject|9|||
17117396|NCT02563002|38255124|FG000|Overall Study|Ongoing|90|||
17117397|NCT02563002|38255125|FG001|Overall Study|Ongoing|70|||
17117398|NCT02374476|38255136|FG000|VT Induced Ablation|Screening Failures|36|||
17117399|NCT02374476|38255137|FG001|VT Induced Ablation|Screening Failures|0|||
17117400|NCT02374476|38255138|FG002|VT Induced Ablation|Screening Failures|0|||
17117401|NCT02374476|38255136|FG000|Arm Assignment|Withdrawal by Subject|0|||
17117402|NCT02374476|38255137|FG001|Arm Assignment|Withdrawal by Subject|0|||
17117403|NCT02374476|38255138|FG002|Arm Assignment|Withdrawal by Subject|1|||
17117404|NCT02918292|38255145|FG000|Study Enrollment Prior to Transplant|Death|1|||
17117405|NCT02918292|38255145|FG000|Study Follow up After Transplant|Death|6|||
17117406|NCT03720210|38255149|FG000|Overall Study|Lost to Follow-up|1|||
17117407|NCT03719586|38255157|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
17117408|NCT03719586|38255158|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
17117409|NCT03719586|38255159|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
17117410|NCT03719586|38255160|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
17117411|NCT00843882|38255173|FG000|Step 1|Lack of Efficacy|14|||
17117412|NCT00843882|38255174|FG001|Step 1|Lack of Efficacy|10|||
17117413|NCT00843882|38255175|FG002|Step 1|Lack of Efficacy|21|||
17117414|NCT00843882|38255173|FG000|Step 1|Adverse Event|8|||
17117415|NCT00843882|38255174|FG001|Step 1|Adverse Event|17|||
17117416|NCT00843882|38255175|FG002|Step 1|Adverse Event|20|||
17117417|NCT00843882|38255173|FG000|Step 1|Death|1|||
17117418|NCT00843882|38255174|FG001|Step 1|Death|2|||
17117419|NCT00843882|38255175|FG002|Step 1|Death|4|||
17117420|NCT00843882|38255173|FG000|Step 1|Withdrawal by Subject|6|||
17117421|NCT00843882|38255174|FG001|Step 1|Withdrawal by Subject|12|||
17117422|NCT00843882|38255175|FG002|Step 1|Withdrawal by Subject|9|||
17117423|NCT00843882|38255173|FG000|Step 1|Physician Decision|0|||
17117424|NCT00843882|38255174|FG001|Step 1|Physician Decision|5|||
17117425|NCT00843882|38255175|FG002|Step 1|Physician Decision|1|||
17117426|NCT00843882|38255173|FG000|Step 1|Patient and physician's decision|0|||
17117427|NCT00843882|38255174|FG001|Step 1|Patient and physician's decision|0|||
17117428|NCT00843882|38255175|FG002|Step 1|Patient and physician's decision|1|||
17117429|NCT00843882|38255173|FG000|Step 1|Other complicating disease|1|||
17117430|NCT00843882|38255174|FG001|Step 1|Other complicating disease|3|||
17117431|NCT00843882|38255175|FG002|Step 1|Other complicating disease|4|||
17117432|NCT00843882|38255173|FG000|Step 1|Alternative therapy|0|||
17117433|NCT00843882|38255174|FG001|Step 1|Alternative therapy|1|||
17117434|NCT00843882|38255175|FG002|Step 1|Alternative therapy|1|||
17117435|NCT00843882|38255173|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
17117436|NCT00843882|38255174|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
17117437|NCT00843882|38255175|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
17117438|NCT00843882|38255173|FG000|Step 1|Off treatment reason unknown|0|||
17117439|NCT00843882|38255174|FG001|Step 1|Off treatment reason unknown|1|||
17117440|NCT00843882|38255175|FG002|Step 1|Off treatment reason unknown|4|||
17117441|NCT00843882|38255173|FG000|Step 1|Never started treatment|2|||
17117442|NCT00843882|38255174|FG001|Step 1|Never started treatment|0|||
17117443|NCT00843882|38255175|FG002|Step 1|Never started treatment|0|||
17117444|NCT00843882|38255173|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
17117445|NCT00843882|38255174|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
17117446|NCT00843882|38255175|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
17117447|NCT00843882|38255173|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
17117448|NCT00843882|38255174|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
17117449|NCT00843882|38255175|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
17117450|NCT00843882|38255173|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
17117451|NCT00843882|38255174|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
17117452|NCT00843882|38255175|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
17117453|NCT00843882|38255173|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
17117454|NCT00843882|38255174|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
17117455|NCT00843882|38255175|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
17117456|NCT00843882|38255173|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
17117457|NCT00843882|38255174|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
17117458|NCT00843882|38255175|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
17117459|NCT00843882|38255173|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
17117460|NCT00843882|38255174|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
17117461|NCT00843882|38255175|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
17117462|NCT00843882|38255173|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
17117463|NCT00843882|38255174|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
17117464|NCT00843882|38255175|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
17117465|NCT03353350|38255204|FG000|30-week Core Treatment Period|Protocol Violation|1|||
17117466|NCT03353350|38255205|FG001|30-week Core Treatment Period|Protocol Violation|1|||
17117467|NCT03353350|38255206|FG002|30-week Core Treatment Period|Protocol Violation|1|||
17117468|NCT03353350|38255207|FG003|30-week Core Treatment Period|Protocol Violation|0|||
17117469|NCT03353350|38255204|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
17117470|NCT03353350|38255205|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
17117471|NCT03353350|38255206|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
17117472|NCT03353350|38255207|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
17117473|NCT03353350|38255204|FG000|30-week Core Treatment Period|Adverse Event|0|||
17117474|NCT03353350|38255205|FG001|30-week Core Treatment Period|Adverse Event|4|||
17117475|NCT03353350|38255206|FG002|30-week Core Treatment Period|Adverse Event|2|||
17117476|NCT03353350|38255207|FG003|30-week Core Treatment Period|Adverse Event|3|||
17117477|NCT03353350|38255204|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
17117478|NCT03353350|38255205|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
17117479|NCT03353350|38255206|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
17117480|NCT03353350|38255207|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
17117481|NCT03353350|38255204|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
17117482|NCT03353350|38255205|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
17117483|NCT03353350|38255206|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
17117484|NCT03353350|38255207|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
17117485|NCT03353350|38255204|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
17117486|NCT03353350|38255205|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
17117487|NCT03353350|38255206|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
17117488|NCT03353350|38255207|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
17117489|NCT03353350|38255204|FG000|26-week Treatment Extension Period|Adverse Event|1|||
17117490|NCT03353350|38255205|FG001|26-week Treatment Extension Period|Adverse Event|0|||
17117491|NCT03353350|38255206|FG002|26-week Treatment Extension Period|Adverse Event|0|||
17117492|NCT03353350|38255207|FG003|26-week Treatment Extension Period|Adverse Event|1|||
17117493|NCT03353350|38255204|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
17117494|NCT03353350|38255205|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
17117495|NCT03353350|38255206|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
17117496|NCT03353350|38255207|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
17117497|NCT03032068|38255221|FG000|Overall Study|Adverse Event|1|||
17117498|NCT02674516|38255241|FG000|Overall Study|Lost to Follow-up|3|||
17117499|NCT02674516|38255242|FG001|Overall Study|Lost to Follow-up|0|||
17117500|NCT02674516|38255241|FG000|Overall Study|Protocol Violation|0|||
17117501|NCT02674516|38255242|FG001|Overall Study|Protocol Violation|4|||
17117502|NCT02674516|38255241|FG000|Overall Study|Knowledge of study hypothesis|1|||
17117503|NCT02674516|38255242|FG001|Overall Study|Knowledge of study hypothesis|0|||
17117504|NCT02463448|38255248|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
17117505|NCT02463448|38255248|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
17117506|NCT02463448|38255248|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
17117507|NCT02463448|38255248|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
17117508|NCT03794544|38255256|FG000|Overall Study|Withdrawal by Subject|1|||
17117509|NCT03794544|38255257|FG001|Overall Study|Withdrawal by Subject|1|||
17117510|NCT03794544|38255258|FG002|Overall Study|Withdrawal by Subject|0|||
17117511|NCT03794544|38255259|FG003|Overall Study|Withdrawal by Subject|0|||
17117512|NCT03794544|38255256|FG000|Overall Study|Death|0|||
17117513|NCT03794544|38255257|FG001|Overall Study|Death|0|||
17117514|NCT03794544|38255258|FG002|Overall Study|Death|0|||
17117515|NCT03794544|38255259|FG003|Overall Study|Death|1|||
17117516|NCT03794544|38255256|FG000|Overall Study|Lost to Follow-up|0|||
17117517|NCT03794544|38255257|FG001|Overall Study|Lost to Follow-up|1|||
17117518|NCT03794544|38255258|FG002|Overall Study|Lost to Follow-up|1|||
17117519|NCT03794544|38255259|FG003|Overall Study|Lost to Follow-up|0|||
17117520|NCT03794544|38255256|FG000|Overall Study|Other|0|||
17117521|NCT03794544|38255257|FG001|Overall Study|Other|1|||
17117522|NCT03794544|38255258|FG002|Overall Study|Other|0|||
17117523|NCT03794544|38255259|FG003|Overall Study|Other|0|||
17117524|NCT01804270|38255271|FG000|Overall Study|Withdrawal by Subject|1|||
17117525|NCT01804270|38255272|FG001|Overall Study|Withdrawal by Subject|1|||
17117526|NCT03107026|38255281|FG000|Overall Study|Adverse Event|2|||
17117527|NCT03107026|38255282|FG001|Overall Study|Adverse Event|14|||
17117528|NCT03107026|38255283|FG002|Overall Study|Adverse Event|23|||
17117529|NCT03107026|38255281|FG000|Overall Study|Lost to Follow-up|12|||
17117530|NCT03107026|38255282|FG001|Overall Study|Lost to Follow-up|12|||
17117531|NCT03107026|38255283|FG002|Overall Study|Lost to Follow-up|13|||
17117532|NCT03107026|38255281|FG000|Overall Study|Protocol Violation|1|||
17117533|NCT03107026|38255282|FG001|Overall Study|Protocol Violation|2|||
17117534|NCT03107026|38255283|FG002|Overall Study|Protocol Violation|0|||
17117535|NCT03107026|38255281|FG000|Overall Study|Pregnancy|1|||
17117536|NCT03107026|38255282|FG001|Overall Study|Pregnancy|0|||
17117537|NCT03107026|38255283|FG002|Overall Study|Pregnancy|0|||
17117538|NCT03107026|38255281|FG000|Overall Study|Withdrawal by Subject|13|||
17117539|NCT03107026|38255282|FG001|Overall Study|Withdrawal by Subject|5|||
17117540|NCT03107026|38255283|FG002|Overall Study|Withdrawal by Subject|17|||
17117541|NCT03107026|38255281|FG000|Overall Study|non compliance with study visits|1|||
17117542|NCT03107026|38255282|FG001|Overall Study|non compliance with study visits|2|||
17117543|NCT03107026|38255283|FG002|Overall Study|non compliance with study visits|0|||
17117544|NCT03107026|38255281|FG000|Overall Study|non-compliance with study drug|2|||
17117545|NCT03107026|38255282|FG001|Overall Study|non-compliance with study drug|2|||
17117546|NCT03107026|38255283|FG002|Overall Study|non-compliance with study drug|3|||
17117547|NCT03107026|38255281|FG000|Overall Study|Physician Decision|0|||
17117548|NCT03107026|38255282|FG001|Overall Study|Physician Decision|1|||
17117549|NCT03107026|38255283|FG002|Overall Study|Physician Decision|0|||
17117550|NCT03717480|38255291|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
17117551|NCT00005044|38255297|FG000|Overall Study|Protocol Violation|37|||
17117552|NCT00005044|38255298|FG001|Overall Study|Protocol Violation|46|||
17117553|NCT00005044|38255297|FG000|Overall Study|Withdrawal by Subject|1|||
17117554|NCT00005044|38255298|FG001|Overall Study|Withdrawal by Subject|5|||
17117555|NCT00005044|38255297|FG000|Overall Study|No protocol treatment|0|||
17117556|NCT00005044|38255298|FG001|Overall Study|No protocol treatment|1|||
17117557|NCT03084796|38255310|FG000|Overall Study|Adverse Event|4|||
17117558|NCT03084796|38255311|FG001|Overall Study|Adverse Event|5|||
17117559|NCT03084796|38255312|FG002|Overall Study|Adverse Event|6|||
17117560|NCT03084796|38255313|FG003|Overall Study|Adverse Event|2|||
17117561|NCT03084796|38255314|FG004|Overall Study|Adverse Event|3|||
17117562|NCT03084796|38255315|FG005|Overall Study|Adverse Event|5|||
17117563|NCT03084796|38255310|FG000|Overall Study|Withdrawal by Subject|3|||
17117564|NCT03084796|38255311|FG001|Overall Study|Withdrawal by Subject|5|||
17117565|NCT03084796|38255312|FG002|Overall Study|Withdrawal by Subject|2|||
17117566|NCT03084796|38255313|FG003|Overall Study|Withdrawal by Subject|1|||
17117567|NCT03084796|38255314|FG004|Overall Study|Withdrawal by Subject|3|||
17117568|NCT03084796|38255315|FG005|Overall Study|Withdrawal by Subject|0|||
17117569|NCT03084796|38255310|FG000|Overall Study|Protocol Violation|0|||
17117570|NCT03084796|38255311|FG001|Overall Study|Protocol Violation|0|||
17117571|NCT03084796|38255312|FG002|Overall Study|Protocol Violation|1|||
17117572|NCT03084796|38255313|FG003|Overall Study|Protocol Violation|0|||
17117573|NCT03084796|38255314|FG004|Overall Study|Protocol Violation|1|||
17117574|NCT03084796|38255315|FG005|Overall Study|Protocol Violation|1|||
17117575|NCT03084796|38255310|FG000|Overall Study|Lack of Efficacy|0|||
17117576|NCT03084796|38255311|FG001|Overall Study|Lack of Efficacy|0|||
17117577|NCT03084796|38255312|FG002|Overall Study|Lack of Efficacy|1|||
17117578|NCT03084796|38255313|FG003|Overall Study|Lack of Efficacy|0|||
17117579|NCT03084796|38255314|FG004|Overall Study|Lack of Efficacy|1|||
17117580|NCT03084796|38255315|FG005|Overall Study|Lack of Efficacy|0|||
17117581|NCT03084796|38255310|FG000|Overall Study|Lost to Follow-up|0|||
17117582|NCT03084796|38255311|FG001|Overall Study|Lost to Follow-up|0|||
17117583|NCT03084796|38255312|FG002|Overall Study|Lost to Follow-up|1|||
17117584|NCT03084796|38255313|FG003|Overall Study|Lost to Follow-up|1|||
17117585|NCT03084796|38255314|FG004|Overall Study|Lost to Follow-up|3|||
17117586|NCT03084796|38255315|FG005|Overall Study|Lost to Follow-up|1|||
17117587|NCT03084796|38255310|FG000|Overall Study|Randomization error|0|||
17117588|NCT03084796|38255311|FG001|Overall Study|Randomization error|0|||
17117589|NCT03084796|38255312|FG002|Overall Study|Randomization error|1|||
17117590|NCT03084796|38255313|FG003|Overall Study|Randomization error|0|||
17117591|NCT03084796|38255314|FG004|Overall Study|Randomization error|0|||
17117592|NCT03084796|38255315|FG005|Overall Study|Randomization error|0|||
17117593|NCT03717012|38255331|FG000|Overall Study|Due to trial termination|1|||
17117594|NCT03717012|38255332|FG001|Overall Study|Due to trial termination|2|||
17117595|NCT03717012|38255331|FG000|Overall Study|Protocol Violation|0|||
17117596|NCT03717012|38255332|FG001|Overall Study|Protocol Violation|2|||
17117597|NCT03717012|38255331|FG000|Overall Study|Adverse Event|0|||
17117598|NCT03717012|38255332|FG001|Overall Study|Adverse Event|1|||
17117599|NCT03717012|38255331|FG000|Overall Study|Lung transplant|0|||
17117600|NCT03717012|38255332|FG001|Overall Study|Lung transplant|1|||
17117601|NCT00579826|38255345|FG000|Overall Study|Withdrawal by Subject|5|||
17117602|NCT00579826|38255346|FG001|Overall Study|Withdrawal by Subject|3|||
17117603|NCT03078556|38255354|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
17117604|NCT03078556|38255355|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
17117605|NCT03078556|38255356|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
17117606|NCT03078556|38255357|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
17117607|NCT03078556|38255354|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
17117608|NCT03078556|38255355|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
17117609|NCT03078556|38255356|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
17117610|NCT03078556|38255357|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
17117611|NCT03078556|38255354|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
17117612|NCT03078556|38255355|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
16942085|NCT01335477|38086648|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
17117613|NCT03078556|38255356|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
17117614|NCT03078556|38255357|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
17117615|NCT03078556|38255354|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
17117616|NCT03078556|38255355|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
17117617|NCT03078556|38255356|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
17117618|NCT03078556|38255357|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
17117619|NCT03714672|38255386|FG000|Overall Study|Adverse Event|0|||
17117620|NCT03714672|38255387|FG001|Overall Study|Adverse Event|0|||
17117621|NCT03714672|38255388|FG002|Overall Study|Adverse Event|3|||
17117622|NCT03714672|38255389|FG003|Overall Study|Adverse Event|0|||
17117623|NCT03714672|38255386|FG000|Overall Study|Physician Decision|0|||
17117624|NCT03714672|38255387|FG001|Overall Study|Physician Decision|1|||
17117625|NCT03714672|38255388|FG002|Overall Study|Physician Decision|0|||
17117626|NCT03714672|38255389|FG003|Overall Study|Physician Decision|0|||
17117627|NCT03714672|38255386|FG000|Overall Study|Other Reason|1|||
17117628|NCT03714672|38255387|FG001|Overall Study|Other Reason|2|||
17117629|NCT03714672|38255388|FG002|Overall Study|Other Reason|1|||
17117630|NCT03714672|38255389|FG003|Overall Study|Other Reason|1|||
17117631|NCT03714672|38255386|FG000|Overall Study|Lost to Follow-up|1|||
17117632|NCT03714672|38255387|FG001|Overall Study|Lost to Follow-up|1|||
17117633|NCT03714672|38255388|FG002|Overall Study|Lost to Follow-up|0|||
17117634|NCT03714672|38255389|FG003|Overall Study|Lost to Follow-up|0|||
17117635|NCT03083470|38255405|FG000|Overall Study|Lost to Follow-up|0|||
17117636|NCT03083470|38255406|FG001|Overall Study|Lost to Follow-up|0|||
17117637|NCT03083470|38255407|FG002|Overall Study|Lost to Follow-up|0|||
17117638|NCT03083470|38255408|FG003|Overall Study|Lost to Follow-up|0|||
17117639|NCT03083470|38255409|FG004|Overall Study|Lost to Follow-up|1|||
17117640|NCT03083470|38255405|FG000|Overall Study|Withdrawal by Subject|0|||
17117641|NCT03083470|38255406|FG001|Overall Study|Withdrawal by Subject|0|||
17117642|NCT03083470|38255407|FG002|Overall Study|Withdrawal by Subject|0|||
17117643|NCT03083470|38255408|FG003|Overall Study|Withdrawal by Subject|0|||
17117644|NCT03083470|38255409|FG004|Overall Study|Withdrawal by Subject|1|||
17117645|NCT05405244|38255421|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
17117646|NCT05405244|38255422|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
17117647|NCT05405244|38255421|FG000|Washout (2 Weeks)|Adverse Event|2|||
17117648|NCT05405244|38255422|FG001|Washout (2 Weeks)|Adverse Event|0|||
17117649|NCT05405244|38255421|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
17117650|NCT05405244|38255422|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
17117651|NCT03074500|38255435|FG000|Overall Study|Lost to Follow-up|1|||
17117652|NCT03074500|38255436|FG001|Overall Study|Lost to Follow-up|0|||
17117653|NCT03074500|38255437|FG002|Overall Study|Lost to Follow-up|0|||
17117654|NCT03074500|38255435|FG000|Overall Study|Lack of Efficacy|0|||
17117655|NCT03074500|38255436|FG001|Overall Study|Lack of Efficacy|1|||
17117656|NCT03074500|38255437|FG002|Overall Study|Lack of Efficacy|0|||
17117657|NCT03074500|38255435|FG000|Overall Study|Adverse Event|0|||
17117658|NCT03074500|38255436|FG001|Overall Study|Adverse Event|0|||
17117659|NCT03074500|38255437|FG002|Overall Study|Adverse Event|1|||
17117660|NCT03715530|38255450|FG000|Overall Study|Lost to Follow-up|3|||
17117661|NCT03715530|38255451|FG001|Overall Study|Lost to Follow-up|1|||
17117662|NCT03715530|38255452|FG002|Overall Study|Lost to Follow-up|2|||
17117663|NCT03077698|38255462|FG000|Progestin Monotherapy|Stable Disease|8|||
17117664|NCT03077698|38255463|FG001|Progestin Monotherapy|Stable Disease|0|||
17117665|NCT03077698|38255462|FG000|Progestin Monotherapy|Adverse Event|1|||
17117666|NCT03077698|38255463|FG001|Progestin Monotherapy|Adverse Event|0|||
17117667|NCT03077698|38255462|FG000|Progestin Monotherapy|Death|1|||
17117668|NCT03077698|38255463|FG001|Progestin Monotherapy|Death|0|||
17117669|NCT03077698|38255462|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
17117670|NCT03077698|38255463|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
17117671|NCT03077698|38255462|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
17117672|NCT03077698|38255463|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
17117673|NCT03077698|38255462|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
17117674|NCT03077698|38255463|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
17117675|NCT03077698|38255462|FG000|Safety Follow Up|Withdrawal by Subject|2|||
17117676|NCT03077698|38255463|FG001|Safety Follow Up|Withdrawal by Subject|1|||
17117677|NCT03077698|38255462|FG000|Safety Follow Up|Transfer of care to hospice|1|||
17117678|NCT03077698|38255463|FG001|Safety Follow Up|Transfer of care to hospice|0|||
17117679|NCT03079102|38255481|FG000|Overall Study|Physician Decision|0|||
17117680|NCT03079102|38255482|FG001|Overall Study|Physician Decision|1|||
17117681|NCT02434354|38255488|FG000|Overall Study|screen fail|3|||
17117682|NCT03076996|38255492|FG000|Overall Study|Withdrawal by Subject|2|||
17117683|NCT03076996|38255492|FG000|Overall Study|Lost to Follow-up|3|||
17117684|NCT03076996|38255492|FG000|Overall Study|Literacy precluded participation|1|||
17117685|NCT03078868|38255496|FG000|Overall Study|Physician Decision|3|||
17117686|NCT04524598|38255504|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
17117687|NCT04524598|38255505|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
17117688|NCT04524598|38255506|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
17117689|NCT04524598|38255507|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
17117690|NCT04524598|38255508|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
17117691|NCT04524598|38255504|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
17117692|NCT04524598|38255505|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
17117693|NCT04524598|38255506|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117694|NCT04524598|38255507|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117695|NCT04524598|38255508|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117696|NCT04524598|38255504|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
17117697|NCT04524598|38255505|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
17117698|NCT04524598|38255506|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
17117699|NCT04524598|38255507|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
17117700|NCT04524598|38255508|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
17117701|NCT04524598|38255504|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
17117702|NCT04524598|38255505|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
17117703|NCT04524598|38255506|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
17117704|NCT04524598|38255507|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
17117705|NCT04524598|38255508|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
17117706|NCT04524598|38255504|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117707|NCT04524598|38255505|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117708|NCT04524598|38255506|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
17117709|NCT04524598|38255507|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
17117710|NCT04524598|38255508|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117711|NCT04524598|38255504|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
17117712|NCT04524598|38255505|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
17117713|NCT04524598|38255506|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
17117714|NCT04524598|38255507|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
17117715|NCT04524598|38255508|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
17117716|NCT04524598|38255504|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117717|NCT04524598|38255505|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117718|NCT04524598|38255506|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117719|NCT04524598|38255507|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
17117720|NCT04524598|38255508|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
17117721|NCT03075904|38255522|FG000|Overall Study|Physician Decision|3|||
17117722|NCT03075904|38255522|FG000|Overall Study|Need for Medication not Permitted|1|||
17117723|NCT03073798|38255526|FG000|Overall Study|Adverse Event|1|||
17117724|NCT03073798|38255526|FG000|Overall Study|Withdrawal by Subject|1|||
17117725|NCT03075826|38255531|FG000|Overall Study|Withdrawal by Subject|1|||
17117726|NCT03075826|38255531|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
17117727|NCT02865850|38255546|FG000|Overall Study|Death|15|||
17117728|NCT02865850|38255547|FG001|Overall Study|Death|19|||
17117729|NCT02865850|38255546|FG000|Overall Study|Withdrawal by Subject|3|||
17117730|NCT02865850|38255547|FG001|Overall Study|Withdrawal by Subject|2|||
17117731|NCT02865850|38255546|FG000|Overall Study|Lost to Follow-up|3|||
17117732|NCT02865850|38255547|FG001|Overall Study|Lost to Follow-up|2|||
17117733|NCT03711162|38255556|FG000|Overall Study|Adverse Event|5|||
17117734|NCT03711162|38255557|FG001|Overall Study|Adverse Event|2|||
17117735|NCT03711162|38255558|FG002|Overall Study|Adverse Event|4|||
17117736|NCT03711162|38255556|FG000|Overall Study|Death|11|||
17117737|NCT03711162|38255557|FG001|Overall Study|Death|7|||
17117738|NCT03711162|38255558|FG002|Overall Study|Death|8|||
17117739|NCT03711162|38255556|FG000|Overall Study|Lost to Follow-up|1|||
17117740|NCT03711162|38255557|FG001|Overall Study|Lost to Follow-up|0|||
17117741|NCT03711162|38255558|FG002|Overall Study|Lost to Follow-up|1|||
17117742|NCT03711162|38255556|FG000|Overall Study|Study Terminated by Sponsor|139|||
17117743|NCT03711162|38255557|FG001|Overall Study|Study Terminated by Sponsor|152|||
17117744|NCT03711162|38255558|FG002|Overall Study|Study Terminated by Sponsor|146|||
17117745|NCT03711162|38255556|FG000|Overall Study|Withdrawal by Subject|17|||
17117746|NCT03711162|38255557|FG001|Overall Study|Withdrawal by Subject|10|||
17117747|NCT03711162|38255558|FG002|Overall Study|Withdrawal by Subject|10|||
17117748|NCT03711162|38255556|FG000|Overall Study|Miscellaneous|1|||
17117749|NCT03711162|38255557|FG001|Overall Study|Miscellaneous|2|||
17117750|NCT03711162|38255558|FG002|Overall Study|Miscellaneous|2|||
17117751|NCT03711162|38255556|FG000|Overall Study|Not Treated|1|||
17117752|NCT03711162|38255557|FG001|Overall Study|Not Treated|0|||
17117753|NCT03711162|38255558|FG002|Overall Study|Not Treated|1|||
17117754|NCT03711162|38255556|FG000|Overall Study|Physician Decision|0|||
17117755|NCT03711162|38255557|FG001|Overall Study|Physician Decision|2|||
17117756|NCT03711162|38255558|FG002|Overall Study|Physician Decision|0|||
17117757|NCT03711162|38255556|FG000|Overall Study|Lack of Efficacy|0|||
17117758|NCT03711162|38255557|FG001|Overall Study|Lack of Efficacy|0|||
17117759|NCT03711162|38255558|FG002|Overall Study|Lack of Efficacy|2|||
17117760|NCT03711162|38255556|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
17117761|NCT03711162|38255557|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
17117762|NCT03711162|38255558|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
17117763|NCT03072160|38255574|FG000|Overall Study|Adverse Event|3|||
17117764|NCT03072160|38255575|FG001|Overall Study|Adverse Event|1|||
17117765|NCT03072160|38255574|FG000|Overall Study|Refused further treatment|6|||
17117766|NCT03072160|38255575|FG001|Overall Study|Refused further treatment|1|||
17117767|NCT03072160|38255574|FG000|Overall Study|Physician Decision|1|||
17117768|NCT03072160|38255575|FG001|Overall Study|Physician Decision|0|||
17117769|NCT03072160|38255574|FG000|Overall Study|Disease progression on study|1|||
17117770|NCT03072160|38255575|FG001|Overall Study|Disease progression on study|1|||
17117771|NCT03072160|38255574|FG000|Overall Study|No contact|0|||
17117772|NCT03072160|38255575|FG001|Overall Study|No contact|1|||
17117773|NCT00407602|38255613|FG000|Overall Study|Death - unrelated to device|1|||
17117774|NCT00407602|38255613|FG000|Overall Study|Device explanted|5|||
17117775|NCT00407602|38255613|FG000|Overall Study|Withdrawal by Subject|1|||
17117776|NCT03057496|38255620|FG000|Overall Study|Withdrawal by Subject|8|||
17117777|NCT03057496|38255620|FG000|Overall Study|Lost to Follow-up|5|||
17117778|NCT03057496|38255620|FG000|Overall Study|Did not use device during home trial|3|||
17117779|NCT03057496|38255620|FG000|Overall Study|Device failure|2|||
17117780|NCT03708744|38255630|FG000|Overall Study|Withdrawal by Subject|0|||
17117781|NCT03708744|38255631|FG001|Overall Study|Withdrawal by Subject|0|||
17117782|NCT03708744|38255632|FG002|Overall Study|Withdrawal by Subject|1|||
17117783|NCT03708744|38255633|FG003|Overall Study|Withdrawal by Subject|0|||
17117784|NCT02574286|38255647|FG000|Overall Study|Adverse Event|3|||
17117785|NCT02574286|38255647|FG000|Overall Study|Withdrawal by Subject|2|||
17117786|NCT02366728|38255654|FG000|Overall Study|Death|0|||
17117787|NCT02366728|38255655|FG001|Overall Study|Death|0|||
17117788|NCT02366728|38255656|FG002|Overall Study|Death|1|||
17117789|NCT02366728|38255654|FG000|Overall Study|Adverse Event|1|||
17117790|NCT02366728|38255655|FG001|Overall Study|Adverse Event|0|||
17117791|NCT02366728|38255656|FG002|Overall Study|Adverse Event|0|||
17117792|NCT02366728|38255654|FG000|Overall Study|Screen Failure|2|||
17117793|NCT02366728|38255655|FG001|Overall Study|Screen Failure|1|||
17117794|NCT02366728|38255656|FG002|Overall Study|Screen Failure|0|||
16773075|NCT02228980|37712060|FG002|Overall Study|Adverse Event|0|||
16773076|NCT02228980|37712061|FG003|Overall Study|Adverse Event|0|||
16773077|NCT02228980|37712058|FG000|Overall Study|Protocol Violation|7|||
16773078|NCT02228980|37712059|FG001|Overall Study|Protocol Violation|0|||
16773079|NCT02228980|37712060|FG002|Overall Study|Protocol Violation|0|||
16773080|NCT02228980|37712061|FG003|Overall Study|Protocol Violation|0|||
16773081|NCT02228980|37712058|FG000|Overall Study|Withdrawal by Subject|3|||
16773082|NCT02228980|37712059|FG001|Overall Study|Withdrawal by Subject|3|||
17028311|NCT00474175|38172721|FG000|Overall Study|Withdrawal by Subject|0|||
17117795|NCT02366728|38255654|FG000|Overall Study|Only yielded 2 vaccines|1|||
17117796|NCT02366728|38255655|FG001|Overall Study|Only yielded 2 vaccines|0|||
17117797|NCT02366728|38255656|FG002|Overall Study|Only yielded 2 vaccines|0|||
17117798|NCT02083354|38255668|FG000|Overall Study|Withdrawal by Subject|9|||
17117799|NCT02083354|38255668|FG000|Overall Study|Lost to Follow-up|1|||
17117800|NCT02083354|38255668|FG000|Overall Study|Adverse Event|3|||
17117801|NCT02083354|38255668|FG000|Overall Study|Disease progression|46|||
17117802|NCT02083354|38255668|FG000|Overall Study|Study closed/terminated|5|||
17117803|NCT04230486|38255672|FG000|Overall Study|Screen Failure|1|||
17117804|NCT01399918|38255678|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
17117805|NCT03493854|38255684|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
17117806|NCT03493854|38255685|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
17117807|NCT03493854|38255684|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
17117808|NCT03493854|38255685|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
17117809|NCT03493854|38255684|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
17117810|NCT03493854|38255685|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
17117811|NCT03493854|38255684|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
17117812|NCT03493854|38255685|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
17117813|NCT03493854|38255684|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
17117814|NCT03493854|38255685|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
17117815|NCT03493854|38255684|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
17117816|NCT03493854|38255685|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
17117817|NCT03493854|38255684|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
17117818|NCT03493854|38255685|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
17117819|NCT03493854|38255684|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
17117820|NCT03493854|38255685|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
17117821|NCT03493854|38255684|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
17117822|NCT03493854|38255685|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
17117823|NCT03493854|38255684|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
17117824|NCT03493854|38255685|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
17117825|NCT03493854|38255684|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
17117826|NCT03493854|38255685|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
17117827|NCT03493854|38255684|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
17117828|NCT03493854|38255685|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
17117829|NCT03493854|38255684|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
17117830|NCT03493854|38255685|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
17117831|NCT03493854|38255684|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
17117832|NCT03493854|38255685|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
17117833|NCT03493854|38255684|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
17117834|NCT03493854|38255685|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
17117835|NCT03493854|38255684|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
17117836|NCT03493854|38255685|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
17117837|NCT00112840|38255694|FG000|Overall Study|Physician Decision|1|||
17117838|NCT00112840|38255695|FG001|Overall Study|Physician Decision|0|||
17117839|NCT00112840|38255696|FG002|Overall Study|Physician Decision|0|||
17117840|NCT00112840|38255694|FG000|Overall Study|Withdrawal by Subject|1|||
17117841|NCT00112840|38255695|FG001|Overall Study|Withdrawal by Subject|0|||
17117842|NCT00112840|38255696|FG002|Overall Study|Withdrawal by Subject|1|||
17117843|NCT00112840|38255694|FG000|Overall Study|Protocol Violation|0|||
17117844|NCT00112840|38255695|FG001|Overall Study|Protocol Violation|0|||
17117845|NCT00112840|38255696|FG002|Overall Study|Protocol Violation|5|||
17117846|NCT02197572|38255709|FG000|Overall Study|Progressive Disease|28|||
17117847|NCT02197572|38255709|FG000|Overall Study|Withdrawal by Subject|9|||
17117848|NCT02197572|38255709|FG000|Overall Study|Adverse Event|3|||
17117849|NCT02197572|38255709|FG000|Overall Study|Reason Not Specified|4|||
17117850|NCT03176784|38255717|FG000|Overall Study|Lost to Follow-up|77|||
17117851|NCT03176784|38255718|FG001|Overall Study|Lost to Follow-up|79|||
17117852|NCT03176784|38255719|FG002|Overall Study|Lost to Follow-up|79|||
17117853|NCT03176784|38255720|FG003|Overall Study|Lost to Follow-up|49|||
17117854|NCT03176784|38255717|FG000|Overall Study|Withdrawal by Subject|28|||
17117855|NCT03176784|38255718|FG001|Overall Study|Withdrawal by Subject|34|||
17117856|NCT03176784|38255719|FG002|Overall Study|Withdrawal by Subject|34|||
17117857|NCT03176784|38255720|FG003|Overall Study|Withdrawal by Subject|21|||
17117858|NCT03049852|38255733|FG000|Overall Study|Lost to Follow-up|0|||
17117859|NCT03049852|38255734|FG001|Overall Study|Lost to Follow-up|1|||
17117860|NCT03049852|38255735|FG002|Overall Study|Lost to Follow-up|0|||
17117861|NCT05091528|38255747|FG000|Overall Study|Study Termination by Sponsor|0|||
17117862|NCT05091528|38255748|FG001|Overall Study|Study Termination by Sponsor|1|||
17117863|NCT05091528|38255749|FG002|Overall Study|Study Termination by Sponsor|0|||
17117864|NCT05091528|38255750|FG003|Overall Study|Study Termination by Sponsor|1|||
17117865|NCT01317160|38255760|FG000|Overall Study|Incorrect inclusion|1|||
17117866|NCT01317160|38255761|FG001|Overall Study|Incorrect inclusion|1|||
17117867|NCT01317160|38255760|FG000|Overall Study|Lost to Follow-up|3|||
17117868|NCT01317160|38255761|FG001|Overall Study|Lost to Follow-up|3|||
17117869|NCT01317160|38255760|FG000|Overall Study|Withdrawal by Subject|0|||
17117870|NCT01317160|38255761|FG001|Overall Study|Withdrawal by Subject|2|||
17117871|NCT01317004|38255782|FG000|Overall Study|Withdrawal by Subject|1|||
17117872|NCT01317004|38255783|FG001|Overall Study|Withdrawal by Subject|4|||
17117873|NCT01317004|38255782|FG000|Overall Study|Protocol Violation|0|||
17117874|NCT01317004|38255783|FG001|Overall Study|Protocol Violation|2|||
17117875|NCT01317004|38255782|FG000|Overall Study|Adverse Event|3|||
17117876|NCT01317004|38255783|FG001|Overall Study|Adverse Event|3|||
17117877|NCT01343056|38255793|FG000|Overall Study|Lost to Follow-up|7|||
17117878|NCT01343056|38255794|FG001|Overall Study|Lost to Follow-up|5|||
17117879|NCT01343056|38255795|FG002|Overall Study|Lost to Follow-up|3|||
17117880|NCT01343056|38255796|FG003|Overall Study|Lost to Follow-up|9|||
17117881|NCT01316692|38255810|FG000|Overall Study|Adverse Event|5|||
17117882|NCT01316692|38255810|FG000|Overall Study|Disease Progression|7|||
17117883|NCT01316380|38255817|FG000|Overall Study|Adverse Event|0|||
17117884|NCT01316380|38255818|FG001|Overall Study|Adverse Event|2|||
17117885|NCT01316380|38255819|FG002|Overall Study|Adverse Event|1|||
17117886|NCT01316380|38255817|FG000|Overall Study|Protocol Violation|0|||
17117887|NCT01316380|38255818|FG001|Overall Study|Protocol Violation|0|||
17117888|NCT01316380|38255819|FG002|Overall Study|Protocol Violation|1|||
17117889|NCT01316380|38255817|FG000|Overall Study|Withdrawal by Subject|1|||
17117890|NCT01316380|38255818|FG001|Overall Study|Withdrawal by Subject|2|||
17117891|NCT01316380|38255819|FG002|Overall Study|Withdrawal by Subject|0|||
17117892|NCT01316380|38255817|FG000|Overall Study|Other|0|||
17117893|NCT01316380|38255818|FG001|Overall Study|Other|1|||
17117894|NCT01316380|38255819|FG002|Overall Study|Other|1|||
17117895|NCT01316380|38255817|FG000|Overall Study|Not treated|1|||
17117896|NCT01316380|38255818|FG001|Overall Study|Not treated|0|||
17117897|NCT01316380|38255819|FG002|Overall Study|Not treated|0|||
17117898|NCT01316224|38255827|FG000|Overall Study|Protocol Violation|3|||
17117899|NCT01316224|38255827|FG000|Overall Study|Adverse Event|3|||
17117900|NCT01316224|38255827|FG000|Overall Study|Lack of Efficacy|1|||
17117901|NCT01316224|38255827|FG000|Overall Study|Withdrawal by Subject|1|||
17117902|NCT01316224|38255827|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
17117903|NCT01316224|38255827|FG000|Overall Study|Other|1|||
17117904|NCT04315298|38255850|FG000|Overall Study|Withdrawal by Subject|0|||
17117905|NCT04315298|38255851|FG001|Overall Study|Withdrawal by Subject|0|||
17117906|NCT04315298|38255852|FG002|Overall Study|Withdrawal by Subject|0|||
17117907|NCT04315298|38255853|FG003|Overall Study|Withdrawal by Subject|2|||
17117908|NCT04315298|38255854|FG004|Overall Study|Withdrawal by Subject|2|||
17117909|NCT04315298|38255855|FG005|Overall Study|Withdrawal by Subject|2|||
17117910|NCT04315298|38255856|FG006|Overall Study|Withdrawal by Subject|0|||
17117911|NCT04315298|38255857|FG007|Overall Study|Withdrawal by Subject|1|||
17117912|NCT04315298|38255858|FG008|Overall Study|Withdrawal by Subject|1|||
17117913|NCT04315298|38255859|FG009|Overall Study|Withdrawal by Subject|1|||
17117914|NCT04315298|38255860|FG010|Overall Study|Withdrawal by Subject|0|||
17117915|NCT04315298|38255861|FG011|Overall Study|Withdrawal by Subject|0|||
17117916|NCT04315298|38255862|FG012|Overall Study|Withdrawal by Subject|0|||
17117917|NCT04315298|38255863|FG013|Overall Study|Withdrawal by Subject|0|||
17117918|NCT04315298|38255864|FG014|Overall Study|Withdrawal by Subject|0|||
17117919|NCT04315298|38255865|FG015|Overall Study|Withdrawal by Subject|0|||
17117920|NCT04315298|38255866|FG016|Overall Study|Withdrawal by Subject|0|||
17117921|NCT04315298|38255867|FG017|Overall Study|Withdrawal by Subject|0|||
17117922|NCT04315298|38255868|FG018|Overall Study|Withdrawal by Subject|0|||
17117923|NCT04315298|38255850|FG000|Overall Study|Physician Decision|0|||
17117924|NCT04315298|38255851|FG001|Overall Study|Physician Decision|0|||
17117925|NCT04315298|38255852|FG002|Overall Study|Physician Decision|0|||
17117926|NCT04315298|38255853|FG003|Overall Study|Physician Decision|0|||
17117927|NCT04315298|38255854|FG004|Overall Study|Physician Decision|1|||
17117928|NCT04315298|38255855|FG005|Overall Study|Physician Decision|0|||
17117929|NCT04315298|38255856|FG006|Overall Study|Physician Decision|0|||
17117930|NCT04315298|38255857|FG007|Overall Study|Physician Decision|0|||
17117931|NCT04315298|38255858|FG008|Overall Study|Physician Decision|0|||
17117932|NCT04315298|38255859|FG009|Overall Study|Physician Decision|0|||
17117933|NCT04315298|38255860|FG010|Overall Study|Physician Decision|0|||
17117934|NCT04315298|38255861|FG011|Overall Study|Physician Decision|0|||
17117935|NCT04315298|38255862|FG012|Overall Study|Physician Decision|0|||
17117936|NCT04315298|38255863|FG013|Overall Study|Physician Decision|0|||
17117937|NCT04315298|38255864|FG014|Overall Study|Physician Decision|0|||
17117938|NCT04315298|38255865|FG015|Overall Study|Physician Decision|0|||
17117939|NCT04315298|38255866|FG016|Overall Study|Physician Decision|0|||
17117940|NCT04315298|38255867|FG017|Overall Study|Physician Decision|0|||
17117941|NCT04315298|38255868|FG018|Overall Study|Physician Decision|0|||
17117942|NCT04315298|38255850|FG000|Overall Study|Lost to Follow-up|5|||
17117943|NCT04315298|38255851|FG001|Overall Study|Lost to Follow-up|10|||
17117944|NCT04315298|38255852|FG002|Overall Study|Lost to Follow-up|6|||
17117945|NCT04315298|38255853|FG003|Overall Study|Lost to Follow-up|8|||
17117946|NCT04315298|38255854|FG004|Overall Study|Lost to Follow-up|12|||
17117947|NCT04315298|38255855|FG005|Overall Study|Lost to Follow-up|13|||
17117948|NCT04315298|38255856|FG006|Overall Study|Lost to Follow-up|9|||
17117949|NCT04315298|38255857|FG007|Overall Study|Lost to Follow-up|16|||
17117950|NCT04315298|38255858|FG008|Overall Study|Lost to Follow-up|14|||
17117951|NCT04315298|38255859|FG009|Overall Study|Lost to Follow-up|0|||
17117952|NCT04315298|38255860|FG010|Overall Study|Lost to Follow-up|2|||
17117953|NCT04315298|38255861|FG011|Overall Study|Lost to Follow-up|1|||
17117954|NCT04315298|38255862|FG012|Overall Study|Lost to Follow-up|0|||
17117955|NCT04315298|38255863|FG013|Overall Study|Lost to Follow-up|0|||
17117956|NCT04315298|38255864|FG014|Overall Study|Lost to Follow-up|0|||
17117957|NCT04315298|38255865|FG015|Overall Study|Lost to Follow-up|2|||
17117958|NCT04315298|38255866|FG016|Overall Study|Lost to Follow-up|0|||
17117959|NCT04315298|38255867|FG017|Overall Study|Lost to Follow-up|0|||
17117960|NCT04315298|38255868|FG018|Overall Study|Lost to Follow-up|0|||
17117961|NCT04315298|38255850|FG000|Overall Study|Death|24|||
17117962|NCT04315298|38255851|FG001|Overall Study|Death|60|||
17117963|NCT04315298|38255852|FG002|Overall Study|Death|49|||
17117964|NCT04315298|38255853|FG003|Overall Study|Death|59|||
17117965|NCT04315298|38255854|FG004|Overall Study|Death|70|||
17117966|NCT04315298|38255855|FG005|Overall Study|Death|114|||
17117967|NCT04315298|38255856|FG006|Overall Study|Death|9|||
17117968|NCT04315298|38255857|FG007|Overall Study|Death|12|||
17117969|NCT04315298|38255858|FG008|Overall Study|Death|21|||
17117970|NCT04315298|38255859|FG009|Overall Study|Death|16|||
17117971|NCT04315298|38255860|FG010|Overall Study|Death|40|||
17117972|NCT04315298|38255861|FG011|Overall Study|Death|40|||
17117973|NCT04315298|38255862|FG012|Overall Study|Death|3|||
17117974|NCT04315298|38255863|FG013|Overall Study|Death|4|||
17117975|NCT04315298|38255864|FG014|Overall Study|Death|6|||
17117976|NCT04315298|38255865|FG015|Overall Study|Death|4|||
17117977|NCT04315298|38255866|FG016|Overall Study|Death|3|||
17117978|NCT04315298|38255867|FG017|Overall Study|Death|1|||
17117979|NCT04315298|38255868|FG018|Overall Study|Death|0|||
17117980|NCT04314284|38255937|FG000|Overall Study|Withdrawal by Subject|4|||
17117981|NCT04314284|38255938|FG001|Overall Study|Withdrawal by Subject|7|||
17117982|NCT04314284|38255937|FG000|Overall Study|Consented but did not complete survey|0|||
17117983|NCT04314284|38255938|FG001|Overall Study|Consented but did not complete survey|6|||
17117984|NCT04308668|38255946|FG000|Overall Study|Lost to Follow-up|32|||
17117985|NCT04308668|38255947|FG001|Overall Study|Lost to Follow-up|38|||
17117986|NCT04308668|38255946|FG000|Overall Study|Withdrawal by Subject|4|||
17117987|NCT04308668|38255947|FG001|Overall Study|Withdrawal by Subject|4|||
17117988|NCT02527434|38255956|FG000|Overall Study|Lost to Follow-up|2|||
17117989|NCT02527434|38255957|FG001|Overall Study|Lost to Follow-up|2|||
17117990|NCT02527434|38255958|FG002|Overall Study|Lost to Follow-up|0|||
17117991|NCT02527434|38255956|FG000|Overall Study|Death|19|||
17117992|NCT02527434|38255957|FG001|Overall Study|Death|6|||
17117993|NCT02527434|38255958|FG002|Overall Study|Death|17|||
17117994|NCT02527434|38255956|FG000|Overall Study|Withdrawal by Subject|5|||
17117995|NCT02527434|38255957|FG001|Overall Study|Withdrawal by Subject|3|||
17117996|NCT02527434|38255958|FG002|Overall Study|Withdrawal by Subject|3|||
17117997|NCT02527434|38255956|FG000|Overall Study|Reason Not Specified|1|||
17117998|NCT02527434|38255957|FG001|Overall Study|Reason Not Specified|0|||
17117999|NCT02527434|38255958|FG002|Overall Study|Reason Not Specified|0|||
17118000|NCT02527434|38255956|FG000|Overall Study|Site closure|1|||
17118001|NCT02527434|38255957|FG001|Overall Study|Site closure|0|||
17118002|NCT02527434|38255958|FG002|Overall Study|Site closure|0|||
17118003|NCT04451330|38255978|FG000|Overall Study|Adverse Event|1|||
17118004|NCT04451330|38255979|FG001|Overall Study|Adverse Event|2|||
17118005|NCT04451330|38255978|FG000|Overall Study|Lost to Follow-up|5|||
17118006|NCT04451330|38255979|FG001|Overall Study|Lost to Follow-up|0|||
17118007|NCT04451330|38255978|FG000|Overall Study|Withdrawal by Subject|3|||
17118008|NCT04451330|38255979|FG001|Overall Study|Withdrawal by Subject|1|||
17118009|NCT04451330|38255978|FG000|Overall Study|Withdrawal by parent/guardian|1|||
17118010|NCT04451330|38255979|FG001|Overall Study|Withdrawal by parent/guardian|0|||
17118011|NCT04451330|38255978|FG000|Overall Study|Other than specified|0|||
17118012|NCT04451330|38255979|FG001|Overall Study|Other than specified|1|||
17118013|NCT02493426|38255985|FG000|Overall Study|Withdrawal by Subject|0|||
17118014|NCT02493426|38255986|FG001|Overall Study|Withdrawal by Subject|1|||
17118015|NCT04664400|38255992|FG000|Overall Study|Withdrawal by Subject|2|||
17118016|NCT04448756|38256000|FG000|Overall Study|Adverse Event|0|||
17118017|NCT04448756|38256001|FG001|Overall Study|Adverse Event|1|||
17118018|NCT04448756|38256002|FG002|Overall Study|Adverse Event|0|||
17118019|NCT04448756|38256000|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
17118020|NCT04448756|38256001|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
17118021|NCT04448756|38256002|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
17118022|NCT04448756|38256000|FG000|Overall Study|Withdrawal by Subject|0|||
17118023|NCT04448756|38256001|FG001|Overall Study|Withdrawal by Subject|3|||
17118024|NCT04448756|38256002|FG002|Overall Study|Withdrawal by Subject|1|||
17118025|NCT04448756|38256000|FG000|Overall Study|Death|2|||
17118026|NCT04448756|38256001|FG001|Overall Study|Death|1|||
17118027|NCT04448756|38256002|FG002|Overall Study|Death|0|||
17118028|NCT04274192|38256012|FG000|Overall Study|Protocol Violation|1|||
17118029|NCT04274192|38256013|FG001|Overall Study|Protocol Violation|0|||
17118030|NCT04387136|38256023|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
17118031|NCT04387136|38256024|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
17118032|NCT04658784|38256032|FG000|6-month Follow-up|Lost to Follow-up|2|||
17118033|NCT04658784|38256033|FG001|6-month Follow-up|Lost to Follow-up|5|||
17118034|NCT04252586|38256039|FG000|Overall Study|Withdrawal by parent/guardian|3|||
17118035|NCT04252586|38256039|FG000|Overall Study|Adverse Event|1|||
17118036|NCT04252586|38256039|FG000|Overall Study|Death|2|||
17118037|NCT04252586|38256039|FG000|Overall Study|Study terminated by sponsor|4|||
17118038|NCT04252586|38256039|FG000|Overall Study|Sponsor request|10|||
17118039|NCT04252586|38256039|FG000|Overall Study|Did not complete treatment period|1|||
17118040|NCT04247828|38256044|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
17118041|NCT04507776|38256048|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
17118042|NCT04386902|38256057|FG000|Overall Study|Withdrawal by Subject|5|||
17118043|NCT04386902|38256057|FG000|Overall Study|Technical problems in the recording|5|||
17118044|NCT04232540|38256063|FG000|Overall Study|Lost to Follow-up|1|||
17118045|NCT04232540|38256064|FG001|Overall Study|Lost to Follow-up|0|||
17118046|NCT04504032|38256072|FG000|Overall Study|Adverse Event|1|||
17118047|NCT04504032|38256073|FG001|Overall Study|Adverse Event|2|||
17118048|NCT04504032|38256072|FG000|Overall Study|Lost to Follow-up|6|||
17118049|NCT04504032|38256073|FG001|Overall Study|Lost to Follow-up|9|||
17118050|NCT04504032|38256072|FG000|Overall Study|Protocol Violation|2|||
17118051|NCT04504032|38256073|FG001|Overall Study|Protocol Violation|0|||
17118052|NCT04504032|38256072|FG000|Overall Study|Study terminated by sponsor|1|||
17118053|NCT04504032|38256073|FG001|Overall Study|Study terminated by sponsor|2|||
17118054|NCT04504032|38256072|FG000|Overall Study|Withdrawal by Subject|9|||
17118055|NCT04504032|38256073|FG001|Overall Study|Withdrawal by Subject|11|||
17118056|NCT04504032|38256072|FG000|Overall Study|Disease progression prior to dosing|15|||
17118057|NCT04504032|38256073|FG001|Overall Study|Disease progression prior to dosing|3|||
17118058|NCT04504032|38256072|FG000|Overall Study|Drug supply issues|1|||
17118059|NCT04504032|38256073|FG001|Overall Study|Drug supply issues|1|||
17118060|NCT04504032|38256072|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
17118061|NCT04504032|38256073|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
17118062|NCT04439240|38256079|FG000|Overall Study|Ineligible|2|||
17118063|NCT04439240|38256079|FG000|Overall Study|Never started treatment|2|||
17118064|NCT04439240|38256079|FG000|Overall Study|Adverse Event|12|||
17118065|NCT04439240|38256079|FG000|Overall Study|Death|2|||
17118066|NCT04439240|38256079|FG000|Overall Study|Disease progression|25|||
17118067|NCT04439240|38256079|FG000|Overall Study|Other diseases|2|||
17118068|NCT04439240|38256079|FG000|Overall Study|Withdrawal by Subject|3|||
17118069|NCT04439240|38256079|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
17118070|NCT04439240|38256079|FG000|Overall Study|Symptomatic decline|1|||
17118071|NCT04439240|38256079|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
17118072|NCT04439240|38256079|FG000|Overall Study|Clinical progression|1|||
17118073|NCT04605588|38256085|FG000|Overall Study|Withdrawal by Subject|1|||
17118074|NCT04605588|38256086|FG001|Overall Study|Withdrawal by Subject|0|||
17118075|NCT04885296|38256092|FG000|Period 1|Covid-19 Related|1|||
17118076|NCT04885296|38256093|FG001|Period 1|Covid-19 Related|0|||
17118077|NCT04885296|38256092|FG000|Period 1|Adverse Event|0|||
17118078|NCT04885296|38256093|FG001|Period 1|Adverse Event|1|||
17118079|NCT04885296|38256092|FG000|Period 1|Withdrawal by Subject|1|||
17118080|NCT04885296|38256093|FG001|Period 1|Withdrawal by Subject|1|||
17118081|NCT04885296|38256092|FG000|Period 1|Test Article No Longer Available|1|||
17118082|NCT04885296|38256093|FG001|Period 1|Test Article No Longer Available|0|||
17118083|NCT04885296|38256092|FG000|Period 1|Dispensed Study lens in Error|1|||
17118084|NCT04885296|38256093|FG001|Period 1|Dispensed Study lens in Error|0|||
17118085|NCT04885296|38256092|FG000|Period 1|Lost to Follow-up|1|||
17118086|NCT04885296|38256093|FG001|Period 1|Lost to Follow-up|0|||
17118087|NCT04885296|38256092|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
17118088|NCT04885296|38256093|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
17118089|NCT04602000|38256104|FG000|Overall Study|Withdrawal by Subject|3|||
17118090|NCT04602000|38256105|FG001|Overall Study|Withdrawal by Subject|6|||
17118091|NCT04602000|38256106|FG002|Overall Study|Withdrawal by Subject|3|||
17118092|NCT04602000|38256107|FG003|Overall Study|Withdrawal by Subject|27|||
17118093|NCT04602000|38256108|FG004|Overall Study|Withdrawal by Subject|39|||
17118094|NCT04602000|38256104|FG000|Overall Study|Physician Decision|1|||
17118095|NCT04602000|38256105|FG001|Overall Study|Physician Decision|0|||
17118096|NCT04602000|38256106|FG002|Overall Study|Physician Decision|0|||
17118097|NCT04602000|38256107|FG003|Overall Study|Physician Decision|2|||
17118098|NCT04602000|38256108|FG004|Overall Study|Physician Decision|2|||
17118099|NCT04602000|38256104|FG000|Overall Study|Death|0|||
17118100|NCT04602000|38256105|FG001|Overall Study|Death|1|||
17118101|NCT04602000|38256106|FG002|Overall Study|Death|0|||
17118102|NCT04602000|38256107|FG003|Overall Study|Death|1|||
17118103|NCT04602000|38256108|FG004|Overall Study|Death|2|||
17118104|NCT04602000|38256104|FG000|Overall Study|Lost to Follow-up|0|||
17118105|NCT04602000|38256105|FG001|Overall Study|Lost to Follow-up|0|||
17118106|NCT04602000|38256106|FG002|Overall Study|Lost to Follow-up|0|||
17118107|NCT04602000|38256107|FG003|Overall Study|Lost to Follow-up|3|||
17118108|NCT04602000|38256108|FG004|Overall Study|Lost to Follow-up|4|||
17118109|NCT04602000|38256104|FG000|Overall Study|Other|4|||
17118110|NCT04602000|38256105|FG001|Overall Study|Other|1|||
17118111|NCT04602000|38256106|FG002|Overall Study|Other|2|||
17118112|NCT04602000|38256107|FG003|Overall Study|Other|5|||
17118113|NCT04602000|38256108|FG004|Overall Study|Other|4|||
17118114|NCT04602000|38256104|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
17118115|NCT04602000|38256105|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
17118116|NCT04602000|38256106|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
17118117|NCT04602000|38256107|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
17118118|NCT04602000|38256108|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
17118119|NCT03041116|38256124|FG000|Double-blind|Death|0|||
17118120|NCT03041116|38256125|FG001|Double-blind|Death|2|||
17118121|NCT03041116|38256124|FG000|Double-blind|Withdrawal by Subject|0|||
17118122|NCT03041116|38256125|FG001|Double-blind|Withdrawal by Subject|4|||
17118123|NCT03041116|38256124|FG000|Open-label|Death|1|||
17118124|NCT03041116|38256125|FG001|Open-label|Death|0|||
17118125|NCT03041116|38256124|FG000|Open-label|Termination of the study by Sponsor|39|||
17118126|NCT03041116|38256125|FG001|Open-label|Termination of the study by Sponsor|37|||
17118127|NCT03041116|38256124|FG000|Open-label|Withdrawal by Subject|1|||
17118128|NCT03041116|38256125|FG001|Open-label|Withdrawal by Subject|0|||
17118129|NCT04860258|38256142|FG000|Overall Study|Withdrawal by Subject|0|||
17118130|NCT04860258|38256143|FG001|Overall Study|Withdrawal by Subject|0|||
17118131|NCT04860258|38256144|FG002|Overall Study|Withdrawal by Subject|4|||
17118132|NCT04860258|38256145|FG003|Overall Study|Withdrawal by Subject|1|||
17118133|NCT04860258|38256146|FG004|Overall Study|Withdrawal by Subject|4|||
17118134|NCT04860258|38256147|FG005|Overall Study|Withdrawal by Subject|1|||
17118135|NCT04860258|38256148|FG006|Overall Study|Withdrawal by Subject|0|||
17118136|NCT03041038|38256166|FG000|Overall Study|Withdrawal by Subject|4|||
17118137|NCT03041038|38256167|FG001|Overall Study|Withdrawal by Subject|0|||
17118138|NCT03041038|38256166|FG000|Overall Study|Lost to Follow-up|1|||
17118139|NCT03041038|38256167|FG001|Overall Study|Lost to Follow-up|1|||
17118140|NCT03041038|38256166|FG000|Overall Study|Protocol Violation|1|||
17118141|NCT03041038|38256167|FG001|Overall Study|Protocol Violation|1|||
17118142|NCT04382066|38256178|FG000|Overall Study|Adverse Event|1|||
17118143|NCT04382066|38256179|FG001|Overall Study|Adverse Event|0|||
17118144|NCT04382066|38256180|FG002|Overall Study|Adverse Event|0|||
17118145|NCT04382066|38256178|FG000|Overall Study|Death|1|||
17118146|NCT04382066|38256179|FG001|Overall Study|Death|0|||
17118147|NCT04382066|38256180|FG002|Overall Study|Death|1|||
17118148|NCT04435184|38256196|FG000|Overall Study|follow-up blood draws missing|3|||
17118149|NCT04435184|38256197|FG001|Overall Study|follow-up blood draws missing|5|||
17118150|NCT04432376|38256206|FG000|Double-blind Treatment Period|Adverse Event|2|||
17118151|NCT04432376|38256207|FG001|Double-blind Treatment Period|Adverse Event|6|||
17118152|NCT04432376|38256208|FG002|Double-blind Treatment Period|Adverse Event|0|||
17118153|NCT04432376|38256206|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
17118154|NCT04432376|38256207|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
17118155|NCT04432376|38256208|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
17118156|NCT04432376|38256206|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
17118157|NCT04432376|38256207|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
17118158|NCT04432376|38256208|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
17118159|NCT04432376|38256206|FG000|Double-blind Treatment Period|Protocol Violation|0|||
17118160|NCT04432376|38256207|FG001|Double-blind Treatment Period|Protocol Violation|1|||
17118161|NCT04432376|38256208|FG002|Double-blind Treatment Period|Protocol Violation|0|||
17118162|NCT04432376|38256206|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
17118163|NCT04432376|38256207|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
17118164|NCT04432376|38256208|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
17118165|NCT03693404|38256217|FG000|Overall Study|Withdrawal by Subject|1|||
17118166|NCT03693404|38256218|FG001|Overall Study|Withdrawal by Subject|0|||
17118167|NCT03693404|38256217|FG000|Overall Study|Lost to Follow-up|0|||
17118168|NCT03693404|38256218|FG001|Overall Study|Lost to Follow-up|5|||
17118169|NCT03693404|38256217|FG000|Overall Study|Excluded from Analysis|0|||
17118170|NCT03693404|38256218|FG001|Overall Study|Excluded from Analysis|1|||
17118171|NCT03696108|38256226|FG000|Overall Study|Physician Decision|1|||
17118172|NCT03696108|38256227|FG001|Overall Study|Physician Decision|0|||
17118173|NCT03696108|38256226|FG000|Overall Study|Withdrawal by Subject|3|||
17118174|NCT03696108|38256227|FG001|Overall Study|Withdrawal by Subject|6|||
17118175|NCT04218110|38256237|FG000|Overall Study|Withdrawal by Subject|0|||
17118176|NCT04218110|38256238|FG001|Overall Study|Withdrawal by Subject|0|||
17118177|NCT04218110|38256239|FG002|Overall Study|Withdrawal by Subject|0|||
17118178|NCT04218110|38256240|FG003|Overall Study|Withdrawal by Subject|1|||
17118179|NCT04214600|38256252|FG000|Overall Study|Lost to Follow-up|9|||
17118180|NCT04214600|38256253|FG001|Overall Study|Lost to Follow-up|14|||
17118181|NCT04210310|38256262|FG000|Overall Study|Lost to Follow-up|32|||
17118182|NCT04210310|38256263|FG001|Overall Study|Lost to Follow-up|1|||
17118183|NCT04209530|38256271|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
17118184|NCT04209530|38256272|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
17118185|NCT04209530|38256271|FG000|Overall Study|Withdrawal by Subject|0|||
17118186|NCT04209530|38256272|FG001|Overall Study|Withdrawal by Subject|1|||
17118187|NCT04349098|38256280|FG000|Overall Study|Death|16|||
17118188|NCT04349098|38256281|FG001|Overall Study|Death|8|||
17118189|NCT04349098|38256280|FG000|Overall Study|Lost to Follow-up|11|||
17118190|NCT04349098|38256281|FG001|Overall Study|Lost to Follow-up|8|||
17118191|NCT04349098|38256280|FG000|Overall Study|Withdrawal by Subject|8|||
17118192|NCT04349098|38256281|FG001|Overall Study|Withdrawal by Subject|5|||
17118193|NCT04349098|38256280|FG000|Overall Study|Other|3|||
17118194|NCT04349098|38256281|FG001|Overall Study|Other|5|||
17118195|NCT04208750|38256289|FG000|Overall Study|Lost to Follow-up|16|||
17118196|NCT04208750|38256290|FG001|Overall Study|Lost to Follow-up|15|||
17118197|NCT04381988|38256298|FG000|Overall Study|The study was terminated|4|||
17118198|NCT04381988|38256299|FG001|Overall Study|The study was terminated|0|||
17118199|NCT04333498|38256307|FG000|Overall Study|Lost to Follow-up|1|||
17118200|NCT04333498|38256308|FG001|Overall Study|Lost to Follow-up|0|||
17118201|NCT04333498|38256307|FG000|Overall Study|Lost to Follow-up|0|||
17118202|NCT04333498|38256308|FG001|Overall Study|Lost to Follow-up|1|||
17118203|NCT03355664|38256316|FG000|Overall Study|Adverse Event|1|||
17118204|NCT03355664|38256317|FG001|Overall Study|Adverse Event|2|||
17118205|NCT03355664|38256316|FG000|Overall Study|Lost to Follow-up|11|||
17118206|NCT03355664|38256317|FG001|Overall Study|Lost to Follow-up|7|||
17118207|NCT03355664|38256316|FG000|Overall Study|Protocol Violation|1|||
17118208|NCT03355664|38256317|FG001|Overall Study|Protocol Violation|2|||
17118209|NCT03355664|38256316|FG000|Overall Study|Withdrawal by Subject|2|||
17118210|NCT03355664|38256317|FG001|Overall Study|Withdrawal by Subject|1|||
17118211|NCT04170686|38256325|FG000|Screening|Physician Decision|12|||
17118212|NCT04170686|38256326|FG001|Screening|Physician Decision|13|||
17118213|NCT04170686|38256325|FG000|Randomization and Treatment|Lost to Follow-up|26|||
17118214|NCT04170686|38256326|FG001|Randomization and Treatment|Lost to Follow-up|15|||
17118215|NCT03695094|38256334|FG000|Overall Study|Adverse Event|1|||
17118216|NCT03695094|38256335|FG001|Overall Study|Adverse Event|1|||
17118217|NCT03695094|38256334|FG000|Overall Study|Withdrawal by Subject|1|||
17118218|NCT03695094|38256335|FG001|Overall Study|Withdrawal by Subject|0|||
17118219|NCT04497948|38256343|FG000|Overall Study|Death|2|||
17118220|NCT04495374|38256353|FG000|Overall Study|Protocol Violation|2|||
17118221|NCT04495374|38256354|FG001|Overall Study|Protocol Violation|1|||
17118222|NCT04794270|38256360|FG000|Period 1|Non Compliance|1|||
17118223|NCT04794270|38256361|FG001|Period 1|Non Compliance|0|||
17118224|NCT04794270|38256360|FG000|Period 1|Adverse Event|1|||
17118225|NCT04794270|38256361|FG001|Period 1|Adverse Event|0|||
17118226|NCT04794270|38256360|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
17118227|NCT04794270|38256361|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
17118228|NCT04567186|38256367|FG000|Period 1|COVID-19 related|1|||
17118229|NCT04567186|38256368|FG001|Period 1|COVID-19 related|0|||
17118230|NCT04567186|38256367|FG000|Period 1|Protocol Violation|0|||
17118231|NCT04567186|38256368|FG001|Period 1|Protocol Violation|1|||
17118232|NCT04567186|38256367|FG000|Period 1|Adverse Event|0|||
17118233|NCT04567186|38256368|FG001|Period 1|Adverse Event|2|||
17118234|NCT04567186|38256367|FG000|Period 2|COVID-19 Related|0|||
17118235|NCT04567186|38256368|FG001|Period 2|COVID-19 Related|1|||
17118236|NCT04567186|38256367|FG000|Period 2|Protocol Violation|0|||
17118237|NCT04567186|38256368|FG001|Period 2|Protocol Violation|1|||
17118238|NCT04567186|38256367|FG000|Period 2|Lost to Follow-up|0|||
17118239|NCT04567186|38256368|FG001|Period 2|Lost to Follow-up|1|||
17118240|NCT04567186|38256367|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
17118241|NCT04567186|38256368|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
17118242|NCT04168190|38256379|FG000|Overall Study|Lost to Follow-up|0|||
17118243|NCT04168190|38256380|FG001|Overall Study|Lost to Follow-up|1|||
17118244|NCT04168190|38256381|FG002|Overall Study|Lost to Follow-up|0|||
17118245|NCT04168190|38256382|FG003|Overall Study|Lost to Follow-up|7|||
17118246|NCT04168190|38256383|FG004|Overall Study|Lost to Follow-up|5|||
17118247|NCT04168190|38256379|FG000|Overall Study|Withdrawal by Subject|1|||
17118248|NCT04168190|38256380|FG001|Overall Study|Withdrawal by Subject|0|||
17118249|NCT04168190|38256381|FG002|Overall Study|Withdrawal by Subject|0|||
17118250|NCT04168190|38256382|FG003|Overall Study|Withdrawal by Subject|2|||
17118251|NCT04168190|38256383|FG004|Overall Study|Withdrawal by Subject|4|||
17118252|NCT04168190|38256379|FG000|Overall Study|Death|0|||
17118253|NCT04168190|38256380|FG001|Overall Study|Death|0|||
17118254|NCT04168190|38256381|FG002|Overall Study|Death|0|||
17118255|NCT04168190|38256382|FG003|Overall Study|Death|1|||
17118256|NCT04168190|38256383|FG004|Overall Study|Death|0|||
17118257|NCT04476108|38256397|FG000|Overall Study|Adverse Event|4|||
17118258|NCT04476108|38256398|FG001|Overall Study|Adverse Event|1|||
17118259|NCT04476108|38256397|FG000|Overall Study|Lost to Follow-up|1|||
17118260|NCT04476108|38256398|FG001|Overall Study|Lost to Follow-up|0|||
17118261|NCT04476108|38256397|FG000|Overall Study|Inadvertent Enrollment|1|||
17118262|NCT04476108|38256398|FG001|Overall Study|Inadvertent Enrollment|0|||
17118263|NCT04476108|38256397|FG000|Overall Study|Protocol Violation|1|||
17118264|NCT04476108|38256398|FG001|Overall Study|Protocol Violation|1|||
17118265|NCT04476108|38256397|FG000|Overall Study|Withdrawal by Subject|1|||
17118266|NCT04476108|38256398|FG001|Overall Study|Withdrawal by Subject|1|||
17118267|NCT03529942|38256404|FG000|Overall Study|Withdrawal by Subject|13|||
17118268|NCT03529942|38256404|FG000|Overall Study|Physician Decision|1|||
17118269|NCT03529942|38256404|FG000|Overall Study|Lost to Follow-up|7|||
17118270|NCT03529942|38256404|FG000|Overall Study|Needle inserted but no drug administered|1|||
17118271|NCT03529942|38256404|FG000|Overall Study|Personal reasons|1|||
17118272|NCT04732338|38256413|FG000|Overall Study|Lost to Follow-up|3|||
17118273|NCT04732338|38256414|FG001|Overall Study|Lost to Follow-up|3|||
17118274|NCT04194008|38256420|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
17118275|NCT04194008|38256420|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
17118276|NCT04194008|38256420|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
17118277|NCT04194008|38256420|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
17118278|NCT04194008|38256420|FG000|Treatment Phase With Nerivio|Missing data|4|||
17118279|NCT04194008|38256420|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
17118280|NCT04189952|38256424|FG000|Follow-up Period|Death|1|||
17118281|NCT04189952|38256424|FG000|Follow-up Period|Withdrawal by Subject|1|||
17118282|NCT04716426|38256430|FG000|Overall Study|Vaccination|1|||
17118283|NCT04716426|38256431|FG001|Overall Study|Vaccination|1|||
17118284|NCT04716426|38256430|FG000|Overall Study|Contamination|1|||
17118285|NCT04716426|38256431|FG001|Overall Study|Contamination|0|||
17118286|NCT03694548|38256439|FG000|Part A Survey|Protocol Violation|3|||
17118287|NCT03694548|38256440|FG001|Part A Survey|Protocol Violation|3|||
17118288|NCT03694548|38256441|FG002|Part A Survey|Protocol Violation|0|||
17118289|NCT03694548|38256439|FG000|Part B Yoga Program|Protocol Violation|0|||
17118290|NCT03694548|38256440|FG001|Part B Yoga Program|Protocol Violation|0|||
17118291|NCT03694548|38256441|FG002|Part B Yoga Program|Protocol Violation|3|||
17118292|NCT03694548|38256439|FG000|Part B Yoga Program|Did not attend intervention|0|||
17118293|NCT03694548|38256440|FG001|Part B Yoga Program|Did not attend intervention|0|||
17118294|NCT03694548|38256441|FG002|Part B Yoga Program|Did not attend intervention|8|||
17118295|NCT04166630|38256453|FG000|Overall Study|Withdrawal by Subject|0|||
17118296|NCT04166630|38256454|FG001|Overall Study|Withdrawal by Subject|1|||
17118297|NCT04164758|38256463|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
17118298|NCT04164758|38256464|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
17118299|NCT04164758|38256465|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
17118300|NCT04164758|38256463|FG000|Overall Study|Adverse Event|0|||
17118301|NCT04164758|38256464|FG001|Overall Study|Adverse Event|1|||
17118302|NCT04164758|38256465|FG002|Overall Study|Adverse Event|0|||
17118303|NCT04178720|38256475|FG000|Overall Study|Withdrawal by Subject|2|||
17118304|NCT04178720|38256476|FG001|Overall Study|Withdrawal by Subject|0|||
17118305|NCT04178720|38256475|FG000|Overall Study|Relocation|0|||
17118306|NCT04178720|38256476|FG001|Overall Study|Relocation|1|||
17118307|NCT04177862|38256487|FG000|Overall Study|Protocol Violation|2|||
17118308|NCT04177862|38256488|FG001|Overall Study|Protocol Violation|7|||
17118309|NCT04173572|38256497|FG000|Overall Study|Withdrawal by Subject|1|||
17118310|NCT04173572|38256498|FG001|Overall Study|Withdrawal by Subject|5|||
17118311|NCT04173572|38256497|FG000|Overall Study|Lost to Follow-up|3|||
17118312|NCT04173572|38256498|FG001|Overall Study|Lost to Follow-up|1|||
17118313|NCT04157738|38256506|FG000|Overall Study|Moved out of state|0|||
17118314|NCT04157738|38256507|FG001|Overall Study|Moved out of state|2|||
17118315|NCT04157738|38256506|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
17118316|NCT04157738|38256507|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
17118317|NCT04156646|38256515|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
17118318|NCT04156646|38256516|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
17118319|NCT04676412|38256527|FG000|Overall Study|Death|17|||
17118320|NCT04676412|38256528|FG001|Overall Study|Death|23|||
17118321|NCT04676412|38256527|FG000|Overall Study|Withdrawal by Subject|0|||
17118322|NCT04676412|38256528|FG001|Overall Study|Withdrawal by Subject|2|||
17118323|NCT04676412|38256527|FG000|Overall Study|Participants ongoing|32|||
17118324|NCT04676412|38256528|FG001|Overall Study|Participants ongoing|33|||
17118325|NCT04150250|38256536|FG000|Overall Study|Lost to Follow-up|0|||
17118326|NCT04150250|38256537|FG001|Overall Study|Lost to Follow-up|2|||
17118327|NCT04537806|38256545|FG000|Overall Study|Randomized but not treated|1|||
17118328|NCT04537806|38256546|FG001|Overall Study|Randomized but not treated|0|||
17118329|NCT04537806|38256545|FG000|Overall Study|Adverse Event|1|||
17118330|NCT04537806|38256546|FG001|Overall Study|Adverse Event|1|||
17118331|NCT04015232|38256554|FG000|Overall Study|Withdrawal by Subject|7|||
17118332|NCT04015232|38256555|FG001|Overall Study|Withdrawal by Subject|4|||
17118333|NCT04015232|38256554|FG000|Overall Study|Protocol Violation|1|||
17118334|NCT04015232|38256555|FG001|Overall Study|Protocol Violation|0|||
17118335|NCT04015232|38256554|FG000|Overall Study|Medical Grounds|3|||
17118336|NCT04015232|38256555|FG001|Overall Study|Medical Grounds|3|||
17118337|NCT04533204|38256567|FG000|Overall Study|Unable to understand training instructions|1|||
17118338|NCT04533204|38256568|FG001|Overall Study|Unable to understand training instructions|1|||
17118339|NCT04465422|38256576|FG000|Overall Study|Lost to Follow-up|0|||
17118340|NCT04465422|38256577|FG001|Overall Study|Lost to Follow-up|2|||
17118341|NCT04014062|38256587|FG000|Period I: Dosing|Medical Grounds|4|||
17118342|NCT04014062|38256588|FG001|Period I: Dosing|Medical Grounds|5|||
17118343|NCT04014062|38256587|FG000|Period I: Dosing|Withdrawal by Subject|3|||
17118344|NCT04014062|38256588|FG001|Period I: Dosing|Withdrawal by Subject|1|||
17118345|NCT04531098|38256602|FG000|Stage I|Adverse Event|0|||
17118346|NCT04531098|38256603|FG001|Stage I|Adverse Event|0|||
17118347|NCT04531098|38256604|FG002|Stage I|Adverse Event|3|||
17118348|NCT04531098|38256602|FG000|Stage I|Protocol Violation|0|||
17118349|NCT04531098|38256603|FG001|Stage I|Protocol Violation|0|||
17118350|NCT04531098|38256604|FG002|Stage I|Protocol Violation|5|||
17118351|NCT04531098|38256602|FG000|Stage I|Withdrawal by Subject|0|||
17118352|NCT04531098|38256603|FG001|Stage I|Withdrawal by Subject|5|||
17118353|NCT04531098|38256604|FG002|Stage I|Withdrawal by Subject|10|||
17118354|NCT04531098|38256602|FG000|Stage II|Adverse Event|1|||
17118355|NCT04531098|38256603|FG001|Stage II|Adverse Event|2|||
17118356|NCT04531098|38256604|FG002|Stage II|Adverse Event|0|||
17118357|NCT04531098|38256602|FG000|Stage II|Protocol Violation|1|||
17118358|NCT04531098|38256603|FG001|Stage II|Protocol Violation|2|||
17118359|NCT04531098|38256604|FG002|Stage II|Protocol Violation|0|||
17118360|NCT04531098|38256602|FG000|Stage II|Withdrawal by Subject|3|||
17118361|NCT04531098|38256603|FG001|Stage II|Withdrawal by Subject|1|||
17118362|NCT04531098|38256604|FG002|Stage II|Withdrawal by Subject|0|||
17118363|NCT04531098|38256602|FG000|Stage II|Moved from study area|8|||
17118364|NCT04531098|38256603|FG001|Stage II|Moved from study area|5|||
17118365|NCT04531098|38256604|FG002|Stage II|Moved from study area|0|||
17118366|NCT04144166|38256612|FG000|Overall Study|Discharged before study start|1|||
17118367|NCT04144166|38256612|FG000|Overall Study|Pregnancy|1|||
17118368|NCT04144166|38256612|FG000|Overall Study|Nail polish could not be removed from finger|1|||
17118369|NCT04142450|38256621|FG000|Overall Study|Screen Failure|1|||
17118370|NCT04142450|38256621|FG000|Overall Study|Lost to Follow-up|1|||
17118371|NCT04529850|38256625|FG000|Overall Study|Death|2|||
17118372|NCT04529850|38256625|FG000|Overall Study|Physician Decision|1|||
17118373|NCT04529850|38256625|FG000|Overall Study|Withdrawal by Subject|2|||
17118374|NCT04225676|38256629|FG000|Overall Study|Physician Decision|1|||
17118375|NCT04225676|38256629|FG000|Overall Study|Lack of Efficacy|1|||
17118376|NCT04225676|38256629|FG000|Overall Study|Study terminated by sponsor|3|||
17118377|NCT00070564|38256641|FG000|Overall Study|Progression|2|||
17118378|NCT00070564|38256642|FG001|Overall Study|Progression|4|||
17118379|NCT00070564|38256643|FG002|Overall Study|Progression|7|||
17118380|NCT00070564|38256644|FG003|Overall Study|Progression|7|||
17118381|NCT00070564|38256645|FG004|Overall Study|Progression|1|||
17118382|NCT00070564|38256646|FG005|Overall Study|Progression|0|||
17118383|NCT00070564|38256641|FG000|Overall Study|Delinquent|1|||
17118384|NCT00070564|38256642|FG001|Overall Study|Delinquent|4|||
17118385|NCT00070564|38256643|FG002|Overall Study|Delinquent|2|||
17118386|NCT00070564|38256644|FG003|Overall Study|Delinquent|0|||
17118387|NCT00070564|38256645|FG004|Overall Study|Delinquent|0|||
17118388|NCT00070564|38256646|FG005|Overall Study|Delinquent|0|||
17118389|NCT00070564|38256641|FG000|Overall Study|Adverse Event|150|||
17118390|NCT00070564|38256642|FG001|Overall Study|Adverse Event|142|||
17118391|NCT00070564|38256643|FG002|Overall Study|Adverse Event|120|||
17118392|NCT00070564|38256644|FG003|Overall Study|Adverse Event|108|||
17118393|NCT00070564|38256645|FG004|Overall Study|Adverse Event|63|||
17118394|NCT00070564|38256646|FG005|Overall Study|Adverse Event|36|||
17118395|NCT00070564|38256641|FG000|Overall Study|Death|4|||
17118396|NCT00070564|38256642|FG001|Overall Study|Death|1|||
17118397|NCT00070564|38256643|FG002|Overall Study|Death|5|||
17118398|NCT00070564|38256644|FG003|Overall Study|Death|3|||
17118399|NCT00070564|38256645|FG004|Overall Study|Death|0|||
17118400|NCT00070564|38256646|FG005|Overall Study|Death|1|||
17118401|NCT00070564|38256641|FG000|Overall Study|Other, not protocol specified|17|||
17118402|NCT00070564|38256642|FG001|Overall Study|Other, not protocol specified|15|||
17118403|NCT00070564|38256643|FG002|Overall Study|Other, not protocol specified|14|||
17118404|NCT00070564|38256644|FG003|Overall Study|Other, not protocol specified|19|||
17118405|NCT00070564|38256645|FG004|Overall Study|Other, not protocol specified|6|||
17118406|NCT00070564|38256646|FG005|Overall Study|Other, not protocol specified|7|||
17118407|NCT00070564|38256641|FG000|Overall Study|Withdrawal by Subject|26|||
17118408|NCT00070564|38256642|FG001|Overall Study|Withdrawal by Subject|37|||
17118409|NCT00070564|38256643|FG002|Overall Study|Withdrawal by Subject|23|||
17118410|NCT00070564|38256644|FG003|Overall Study|Withdrawal by Subject|30|||
17118411|NCT00070564|38256645|FG004|Overall Study|Withdrawal by Subject|8|||
17118412|NCT00070564|38256646|FG005|Overall Study|Withdrawal by Subject|8|||
17118413|NCT00070564|38256641|FG000|Overall Study|Not reported|0|||
17118414|NCT00070564|38256642|FG001|Overall Study|Not reported|0|||
17118415|NCT00070564|38256643|FG002|Overall Study|Not reported|0|||
17118416|NCT00070564|38256644|FG003|Overall Study|Not reported|0|||
17118417|NCT00070564|38256645|FG004|Overall Study|Not reported|1|||
17118418|NCT00070564|38256646|FG005|Overall Study|Not reported|0|||
17118419|NCT04142216|38256668|FG000|Overall Study|Hospitalization|0|||
17118420|NCT04142216|38256669|FG001|Overall Study|Hospitalization|2|||
17118421|NCT04142216|38256668|FG000|Overall Study|Death|3|||
17118422|NCT04142216|38256669|FG001|Overall Study|Death|1|||
17118423|NCT04142216|38256668|FG000|Overall Study|Referral to another hemodialysis unit|3|||
17118424|NCT04142216|38256669|FG001|Overall Study|Referral to another hemodialysis unit|2|||
17118425|NCT04142216|38256668|FG000|Overall Study|Use of clove|0|||
17118426|NCT04142216|38256669|FG001|Overall Study|Use of clove|1|||
17118427|NCT04140890|38256677|FG000|Overall Study|Withdrawal by Subject|0|||
17118428|NCT04140890|38256678|FG001|Overall Study|Withdrawal by Subject|1|||
17118429|NCT03700320|38256689|FG000|Overall Study|Adverse Event|5|||
17118430|NCT03700320|38256690|FG001|Overall Study|Adverse Event|31|||
17118431|NCT03700320|38256689|FG000|Overall Study|Lack of Efficacy|2|||
17118432|NCT03700320|38256690|FG001|Overall Study|Lack of Efficacy|5|||
17118433|NCT03700320|38256689|FG000|Overall Study|Withdrawal by Subject|29|||
17118434|NCT03700320|38256690|FG001|Overall Study|Withdrawal by Subject|75|||
17118435|NCT03700320|38256689|FG000|Overall Study|Lost to Follow-up|16|||
17118436|NCT03700320|38256690|FG001|Overall Study|Lost to Follow-up|23|||
17118437|NCT03700320|38256689|FG000|Overall Study|Pregnancy|2|||
17118438|NCT03700320|38256690|FG001|Overall Study|Pregnancy|4|||
17118439|NCT03700320|38256689|FG000|Overall Study|Protocol Deviation|7|||
17118440|NCT03700320|38256690|FG001|Overall Study|Protocol Deviation|31|||
17118441|NCT03700320|38256689|FG000|Overall Study|Non-compliance with Study Drug|1|||
17118442|NCT03700320|38256690|FG001|Overall Study|Non-compliance with Study Drug|3|||
17118443|NCT03700320|38256689|FG000|Overall Study|Reason not Specified|0|||
17118444|NCT03700320|38256690|FG001|Overall Study|Reason not Specified|1|||
17118445|NCT04139018|38256698|FG000|Overall Study|Screen fail|1|||
17118446|NCT04139018|38256699|FG001|Overall Study|Screen fail|0|||
17118447|NCT04139018|38256698|FG000|Overall Study|Withdrawal by Subject|2|||
17118448|NCT04139018|38256699|FG001|Overall Study|Withdrawal by Subject|0|||
17118449|NCT04139018|38256698|FG000|Overall Study|Lost to Follow-up|0|||
17118450|NCT04139018|38256699|FG001|Overall Study|Lost to Follow-up|1|||
17118451|NCT04456686|38256707|FG000|Overall Study|Adverse Event|2|||
17118452|NCT04456686|38256708|FG001|Overall Study|Adverse Event|1|||
17118453|NCT04456686|38256707|FG000|Overall Study|Lack of Efficacy|3|||
17118454|NCT04456686|38256708|FG001|Overall Study|Lack of Efficacy|1|||
17118455|NCT04456686|38256707|FG000|Overall Study|Withdrew consent|3|||
17118456|NCT04456686|38256708|FG001|Overall Study|Withdrew consent|1|||
17118457|NCT04456686|38256707|FG000|Overall Study|Physician Decision|2|||
17118458|NCT04456686|38256708|FG001|Overall Study|Physician Decision|2|||
17118459|NCT04456686|38256707|FG000|Overall Study|Withdrawal by Subject|5|||
17118460|NCT04456686|38256708|FG001|Overall Study|Withdrawal by Subject|1|||
17118461|NCT04456686|38256707|FG000|Overall Study|Protocol Violation|0|||
17118462|NCT04456686|38256708|FG001|Overall Study|Protocol Violation|1|||
17118463|NCT04527978|38256716|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
17118464|NCT04527978|38256717|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
17118465|NCT04136444|38256728|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
17118466|NCT04136444|38256729|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
17118467|NCT04425252|38256743|FG000|Overall Study|Withdrawal by Subject|2|||
17118468|NCT04425252|38256744|FG001|Overall Study|Withdrawal by Subject|1|||
17118469|NCT04425252|38256743|FG000|Overall Study|Lost to Follow-up|1|||
17118470|NCT04425252|38256744|FG001|Overall Study|Lost to Follow-up|0|||
17118471|NCT04425252|38256743|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
17118472|NCT04425252|38256744|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
17118473|NCT03696576|38256755|FG000|Overall Study|Soreness of throat after therapy|1|||
17118474|NCT03696576|38256756|FG001|Overall Study|Soreness of throat after therapy|1|||
17118475|NCT03696576|38256755|FG000|Overall Study|Lost to Follow-up|2|||
17118476|NCT03696576|38256756|FG001|Overall Study|Lost to Follow-up|4|||
17118477|NCT04003610|38256765|FG000|Overall Study|Lost to Follow-up|0|||
17118478|NCT04003610|38256766|FG001|Overall Study|Lost to Follow-up|1|||
17118479|NCT04003610|38256767|FG002|Overall Study|Lost to Follow-up|0|||
17118480|NCT04003610|38256765|FG000|Overall Study|Death|0|||
17118481|NCT04003610|38256766|FG001|Overall Study|Death|0|||
17118482|NCT04003610|38256767|FG002|Overall Study|Death|3|||
17118483|NCT04003610|38256765|FG000|Overall Study|Study Terminated by Sponsor|0|||
17118484|NCT04003610|38256766|FG001|Overall Study|Study Terminated by Sponsor|0|||
17118485|NCT04003610|38256767|FG002|Overall Study|Study Terminated by Sponsor|3|||
17118486|NCT03999554|38256781|FG000|Overall Study|Lost to Follow-up|4|||
17118487|NCT03999554|38256782|FG001|Overall Study|Lost to Follow-up|5|||
17118488|NCT03999554|38256783|FG002|Overall Study|Lost to Follow-up|4|||
17118489|NCT03999554|38256784|FG003|Overall Study|Lost to Follow-up|5|||
17118490|NCT03999554|38256785|FG004|Overall Study|Lost to Follow-up|8|||
17118491|NCT03999554|38256781|FG000|Overall Study|Protocol Violation|0|||
17118492|NCT03999554|38256782|FG001|Overall Study|Protocol Violation|0|||
17118493|NCT03999554|38256783|FG002|Overall Study|Protocol Violation|5|||
17118494|NCT03999554|38256784|FG003|Overall Study|Protocol Violation|0|||
17118495|NCT03999554|38256785|FG004|Overall Study|Protocol Violation|0|||
17118496|NCT03999554|38256781|FG000|Overall Study|Pregnancy|0|||
17118497|NCT03999554|38256782|FG001|Overall Study|Pregnancy|0|||
17118498|NCT03999554|38256783|FG002|Overall Study|Pregnancy|1|||
17118499|NCT03999554|38256784|FG003|Overall Study|Pregnancy|0|||
17118500|NCT03999554|38256785|FG004|Overall Study|Pregnancy|0|||
17118501|NCT03999554|38256781|FG000|Overall Study|Withdrawal by Subject|2|||
17118502|NCT03999554|38256782|FG001|Overall Study|Withdrawal by Subject|2|||
17118503|NCT03999554|38256783|FG002|Overall Study|Withdrawal by Subject|2|||
17118504|NCT03999554|38256784|FG003|Overall Study|Withdrawal by Subject|1|||
17118505|NCT03999554|38256785|FG004|Overall Study|Withdrawal by Subject|1|||
17118506|NCT03999554|38256781|FG000|Overall Study|failure to comply with protocol requirements|0|||
17118507|NCT03999554|38256782|FG001|Overall Study|failure to comply with protocol requirements|0|||
17118508|NCT03999554|38256783|FG002|Overall Study|failure to comply with protocol requirements|0|||
17118509|NCT03999554|38256784|FG003|Overall Study|failure to comply with protocol requirements|1|||
17118510|NCT03999554|38256785|FG004|Overall Study|failure to comply with protocol requirements|0|||
17118511|NCT04129346|38256800|FG000|Overall Study|Death|1|||
17118512|NCT04129346|38256801|FG001|Overall Study|Death|0|||
17118513|NCT04526574|38256809|FG000|Overall Study|Protocol Violation|3|||
17118514|NCT04526574|38256810|FG001|Overall Study|Protocol Violation|1|||
17118515|NCT04526574|38256809|FG000|Overall Study|Withdrawal by Subject|12|||
17118516|NCT04526574|38256810|FG001|Overall Study|Withdrawal by Subject|9|||
17118517|NCT04526574|38256809|FG000|Overall Study|Other|1|||
17118518|NCT04526574|38256810|FG001|Overall Study|Other|2|||
17118519|NCT04526574|38256809|FG000|Overall Study|Adverse Event|1|||
17118520|NCT04526574|38256810|FG001|Overall Study|Adverse Event|1|||
17118521|NCT04526574|38256809|FG000|Overall Study|Death|2|||
17118522|NCT04526574|38256810|FG001|Overall Study|Death|3|||
17118523|NCT04526574|38256809|FG000|Overall Study|Lost to Follow-up|9|||
17118524|NCT04526574|38256810|FG001|Overall Study|Lost to Follow-up|9|||
17118525|NCT04526574|38256809|FG000|Overall Study|No longer meets eligibility criteria|8|||
17118526|NCT04526574|38256810|FG001|Overall Study|No longer meets eligibility criteria|8|||
17118527|NCT03993392|38256820|FG000|Overall Study|Withdrawal by Subject|3|||
17118528|NCT03993392|38256820|FG000|Overall Study|Lost to Follow-up|2|||
17118529|NCT03993392|38256820|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
17118530|NCT04422990|38256827|FG000|Overall Study|Withdrawal by Subject|0|||
17118531|NCT04422990|38256828|FG001|Overall Study|Withdrawal by Subject|1|||
17118532|NCT04422990|38256827|FG000|Overall Study|Travel|3|||
17118533|NCT04422990|38256828|FG001|Overall Study|Travel|0|||
17118534|NCT04377308|38256839|FG000|Overall Study|Withdrawal by Subject|0|||
17118535|NCT04377308|38256840|FG001|Overall Study|Withdrawal by Subject|1|||
17118536|NCT04447404|38256848|FG000|Overall Study|Death|2|||
17118537|NCT04447404|38256849|FG001|Overall Study|Death|0|||
17118538|NCT03988166|38256855|FG000|Overall Study|Lost to Follow-up|2|||
17118539|NCT03988166|38256855|FG000|Overall Study|Death|1|||
17118540|NCT03988088|38256864|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
17118541|NCT03988088|38256865|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
17118542|NCT03988088|38256866|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
17118543|NCT03988088|38256867|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
17118544|NCT03988088|38256864|FG000|Open-Label Addendum|Lost to Follow-up|0|||
17118545|NCT03988088|38256865|FG001|Open-Label Addendum|Lost to Follow-up|0|||
17118546|NCT03988088|38256866|FG002|Open-Label Addendum|Lost to Follow-up|1|||
17118547|NCT03988088|38256867|FG003|Open-Label Addendum|Lost to Follow-up|0|||
17118548|NCT03987932|38256878|FG000|Overall Study|Lost to Follow-up|2|||
17118549|NCT03987932|38256879|FG001|Overall Study|Lost to Follow-up|1|||
17118550|NCT03987932|38256880|FG002|Overall Study|Lost to Follow-up|1|||
17118551|NCT03987932|38256878|FG000|Overall Study|Non-study related elective surgery|0|||
17118552|NCT03987932|38256879|FG001|Overall Study|Non-study related elective surgery|0|||
17118553|NCT03987932|38256880|FG002|Overall Study|Non-study related elective surgery|1|||
17118554|NCT03987620|38256890|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
17118555|NCT03987620|38256891|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
17118556|NCT03987620|38256890|FG000|Overall Study|Adverse Event|3|||
17118557|NCT03987620|38256891|FG001|Overall Study|Adverse Event|0|||
17118558|NCT03987620|38256890|FG000|Overall Study|Lost to Follow-up|1|||
17118559|NCT03987620|38256891|FG001|Overall Study|Lost to Follow-up|2|||
17118560|NCT03987620|38256890|FG000|Overall Study|Physician Decision|0|||
17118561|NCT03987620|38256891|FG001|Overall Study|Physician Decision|1|||
17118562|NCT03987620|38256890|FG000|Overall Study|Pregnancy|1|||
17118563|NCT03987620|38256891|FG001|Overall Study|Pregnancy|0|||
17118564|NCT03987620|38256890|FG000|Overall Study|Withdrawal by Subject|7|||
17118565|NCT03987620|38256891|FG001|Overall Study|Withdrawal by Subject|1|||
17118566|NCT03987620|38256890|FG000|Overall Study|Other|2|||
17118567|NCT03987620|38256891|FG001|Overall Study|Other|5|||
17118568|NCT03069352|38256899|FG000|Overall Study|Ongoing|12|||
17118569|NCT03069352|38256900|FG001|Overall Study|Ongoing|40|||
17118570|NCT04376060|38256906|FG000|Overall Study|Physician Decision|1|||
17118571|NCT04413552|38256920|FG000|Overall Study|Adverse Event|0|||
17118572|NCT04413552|38256921|FG001|Overall Study|Adverse Event|0|||
17118573|NCT04413552|38256922|FG002|Overall Study|Adverse Event|0|||
17118574|NCT04413552|38256923|FG003|Overall Study|Adverse Event|0|||
17118575|NCT04413552|38256924|FG004|Overall Study|Adverse Event|0|||
17118576|NCT04413552|38256925|FG005|Overall Study|Adverse Event|0|||
17118577|NCT04413552|38256926|FG006|Overall Study|Adverse Event|1|||
17118578|NCT04413552|38256927|FG007|Overall Study|Adverse Event|0|||
17118579|NCT04413552|38256928|FG008|Overall Study|Adverse Event|0|||
17118580|NCT04413552|38256929|FG009|Overall Study|Adverse Event|0|||
17118581|NCT03987074|38256960|FG000|Overall Study|Withdrew Consent|1|||
17118582|NCT03987074|38256961|FG001|Overall Study|Withdrew Consent|1|||
17118583|NCT03987074|38256962|FG002|Overall Study|Withdrew Consent|0|||
17118584|NCT03987074|38256963|FG003|Overall Study|Withdrew Consent|2|||
17118585|NCT03987074|38256964|FG004|Overall Study|Withdrew Consent|1|||
17118586|NCT03987074|38256960|FG000|Overall Study|Adverse Event|2|||
17118587|NCT03987074|38256961|FG001|Overall Study|Adverse Event|1|||
17118588|NCT03987074|38256962|FG002|Overall Study|Adverse Event|0|||
17118589|NCT03987074|38256963|FG003|Overall Study|Adverse Event|0|||
17118590|NCT03987074|38256964|FG004|Overall Study|Adverse Event|1|||
17118591|NCT03987074|38256960|FG000|Overall Study|Lost to Follow-up|0|||
17118592|NCT03987074|38256961|FG001|Overall Study|Lost to Follow-up|0|||
17118593|NCT03987074|38256962|FG002|Overall Study|Lost to Follow-up|1|||
17118594|NCT03987074|38256963|FG003|Overall Study|Lost to Follow-up|1|||
17118595|NCT03987074|38256964|FG004|Overall Study|Lost to Follow-up|0|||
17118596|NCT03987074|38256960|FG000|Overall Study|Investigator's Discretion|0|||
17118597|NCT03987074|38256961|FG001|Overall Study|Investigator's Discretion|0|||
17118598|NCT03987074|38256962|FG002|Overall Study|Investigator's Discretion|0|||
17118599|NCT03987074|38256963|FG003|Overall Study|Investigator's Discretion|1|||
17118600|NCT03987074|38256964|FG004|Overall Study|Investigator's Discretion|0|||
17118601|NCT04439214|38256976|FG000|Overall Study|Adverse Event|13|||
17118602|NCT04439214|38256976|FG000|Overall Study|Disease progression|16|||
17118603|NCT04439214|38256976|FG000|Overall Study|Death|1|||
17118604|NCT04439214|38256976|FG000|Overall Study|Withdrawal by Subject|2|||
17118605|NCT04439214|38256976|FG000|Overall Study|Declining health|1|||
17118606|NCT04439214|38256976|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
17118607|NCT04439214|38256976|FG000|Overall Study|Ineligible|5|||
17118608|NCT03696342|38256982|FG000|Overall Study|Lost to Follow-up|1|||
17118609|NCT03696342|38256983|FG001|Overall Study|Lost to Follow-up|0|||
17118610|NCT04411680|38256991|FG000|Treatment Period|Adverse Event|3|||
17118611|NCT04411680|38256992|FG001|Treatment Period|Adverse Event|0|||
17118612|NCT04411680|38256991|FG000|Treatment Period|Discharged from hospital|18|||
17118613|NCT04411680|38256992|FG001|Treatment Period|Discharged from hospital|7|||
17118614|NCT04411680|38256991|FG000|Treatment Period|Missed 1 or more doses|8|||
17118615|NCT04411680|38256992|FG001|Treatment Period|Missed 1 or more doses|0|||
17118616|NCT04411680|38256991|FG000|Treatment Period|Transferred to another hospital|0|||
17118617|NCT04411680|38256992|FG001|Treatment Period|Transferred to another hospital|1|||
17118618|NCT04411680|38256991|FG000|Follow up Period|Withdrawal by Subject|2|||
17118619|NCT04411680|38256992|FG001|Follow up Period|Withdrawal by Subject|0|||
17118620|NCT04411680|38256991|FG000|Follow up Period|Lost to Follow-up|5|||
17118621|NCT04411680|38256992|FG001|Follow up Period|Lost to Follow-up|6|||
17118622|NCT04411680|38256991|FG000|Follow up Period|Death|11|||
17118623|NCT04411680|38256992|FG001|Follow up Period|Death|8|||
17118624|NCT04410198|38256998|FG000|Overall Study|Death|10|||
17118625|NCT04410198|38256998|FG000|Overall Study|Withdrawal by Subject|7|||
17118626|NCT04410198|38256998|FG000|Overall Study|Transferred/Relocation|4|||
17118627|NCT04410198|38256998|FG000|Overall Study|Kidney Transplant|9|||
17118628|NCT04410198|38256998|FG000|Overall Study|Adverse Event|4|||
17118629|NCT04410198|38256998|FG000|Overall Study|Physician Decision|2|||
17118630|NCT04410198|38256998|FG000|Overall Study|Other than specified|1|||
17118631|NCT04165824|38257002|FG000|Overall Study|Adverse Event|23|||
17118632|NCT04165824|38257002|FG000|Overall Study|Physician Decision|1|||
17118633|NCT04165824|38257002|FG000|Overall Study|Withdrawal by Subject|17|||
17118634|NCT04165824|38257002|FG000|Overall Study|Other|5|||
17118635|NCT04161144|38257008|FG000|Overall Study|Withdrawal by Subject|0|||
17118636|NCT04161144|38257009|FG001|Overall Study|Withdrawal by Subject|1|||
17118637|NCT04161144|38257008|FG000|Overall Study|Protocol Violation|1|||
17118638|NCT04161144|38257009|FG001|Overall Study|Protocol Violation|0|||
17118639|NCT03984812|38257026|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118640|NCT03984812|38257027|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118641|NCT03984812|38257028|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
17118642|NCT03984812|38257029|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118643|NCT03984812|38257030|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118644|NCT03984812|38257031|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118645|NCT03984812|38257032|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118646|NCT03984812|38257033|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118647|NCT03984812|38257034|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118648|NCT03984812|38257035|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118649|NCT03984812|38257036|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
17118650|NCT04160988|38257063|FG000|Overall Study|poor image quality|28|||
17118651|NCT04153188|38257084|FG000|Overall Study|Lost to Follow-up|1|||
17118652|NCT04153188|38257085|FG001|Overall Study|Lost to Follow-up|1|||
17118653|NCT04153188|38257084|FG000|Overall Study|Withdrawal by Subject|2|||
17118654|NCT04153188|38257085|FG001|Overall Study|Withdrawal by Subject|0|||
17118655|NCT04153188|38257084|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
17118656|NCT04153188|38257085|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
17118657|NCT04113746|38257093|FG000|Overall Study|Lost to Follow-up|4|||
17118658|NCT04113746|38257094|FG001|Overall Study|Lost to Follow-up|4|||
17118659|NCT03611010|38257104|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
17118660|NCT03611010|38257105|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
17118661|NCT03611010|38257106|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
17118662|NCT03611010|38257107|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
17118663|NCT04357782|38257122|FG000|Overall Study|Discharged from hospital|1|||
17118664|NCT04357782|38257123|FG001|Overall Study|Discharged from hospital|0|||
17118665|NCT04357782|38257122|FG000|Overall Study|Death|0|||
17118666|NCT04357782|38257123|FG001|Overall Study|Death|2|||
17118667|NCT03980522|38257134|FG000|Treatment Period|Adverse Event|1|||
17118668|NCT03980522|38257135|FG001|Treatment Period|Adverse Event|0|||
17118669|NCT03980522|38257136|FG002|Treatment Period|Adverse Event|0|||
17118670|NCT03980522|38257137|FG003|Treatment Period|Adverse Event|0|||
17118671|NCT03980522|38257138|FG004|Treatment Period|Adverse Event|0|||
17118672|NCT04402866|38257156|FG000|Overall Study|Discontinued Prior to Treatment|0|||
17118673|NCT04402866|38257157|FG001|Overall Study|Discontinued Prior to Treatment|0|||
17118674|NCT04402866|38257158|FG002|Overall Study|Discontinued Prior to Treatment|0|||
17118675|NCT04402866|38257159|FG003|Overall Study|Discontinued Prior to Treatment|0|||
17118676|NCT04402866|38257160|FG004|Overall Study|Discontinued Prior to Treatment|2|||
17118677|NCT04402866|38257161|FG005|Overall Study|Discontinued Prior to Treatment|3|||
17118678|NCT04402866|38257156|FG000|Overall Study|Adverse Event|2|||
17118679|NCT04402866|38257157|FG001|Overall Study|Adverse Event|1|||
17118680|NCT04402866|38257158|FG002|Overall Study|Adverse Event|0|||
17118681|NCT04402866|38257159|FG003|Overall Study|Adverse Event|0|||
17118682|NCT04402866|38257160|FG004|Overall Study|Adverse Event|13|||
17118683|NCT04402866|38257161|FG005|Overall Study|Adverse Event|8|||
17118684|NCT04402866|38257156|FG000|Overall Study|Miscellaneous|0|||
17118685|NCT04402866|38257157|FG001|Overall Study|Miscellaneous|0|||
17118686|NCT04402866|38257158|FG002|Overall Study|Miscellaneous|1|||
17118687|NCT04402866|38257159|FG003|Overall Study|Miscellaneous|0|||
17118688|NCT04402866|38257160|FG004|Overall Study|Miscellaneous|0|||
17118689|NCT04402866|38257161|FG005|Overall Study|Miscellaneous|0|||
17118690|NCT04402866|38257156|FG000|Overall Study|Lost to Follow-up|0|||
17118691|NCT04402866|38257157|FG001|Overall Study|Lost to Follow-up|0|||
17118692|NCT04402866|38257158|FG002|Overall Study|Lost to Follow-up|0|||
17118693|NCT04402866|38257159|FG003|Overall Study|Lost to Follow-up|0|||
17118694|NCT04402866|38257160|FG004|Overall Study|Lost to Follow-up|0|||
17118695|NCT04402866|38257161|FG005|Overall Study|Lost to Follow-up|1|||
17118696|NCT04402866|38257156|FG000|Overall Study|Withdrawal by Subject|0|||
17118697|NCT04402866|38257157|FG001|Overall Study|Withdrawal by Subject|0|||
17118698|NCT04402866|38257158|FG002|Overall Study|Withdrawal by Subject|0|||
17118699|NCT04402866|38257159|FG003|Overall Study|Withdrawal by Subject|0|||
17118700|NCT04402866|38257160|FG004|Overall Study|Withdrawal by Subject|0|||
17118701|NCT04402866|38257161|FG005|Overall Study|Withdrawal by Subject|2|||
17118702|NCT04400682|38257173|FG000|Period 1|Withdrawal by Subject|1|||
17118703|NCT04400682|38257174|FG001|Period 1|Withdrawal by Subject|4|||
17118704|NCT03066778|38257182|FG000|Overall Study|Death|195|||
17118705|NCT03066778|38257183|FG001|Overall Study|Death|205|||
17118706|NCT03066778|38257182|FG000|Overall Study|Withdrawal by Subject|5|||
17118707|NCT03066778|38257183|FG001|Overall Study|Withdrawal by Subject|7|||
17118708|NCT04348656|38257192|FG000|Overall Study|Withdrawal by Subject|2|||
17118709|NCT04348656|38257193|FG001|Overall Study|Withdrawal by Subject|0|||
17118710|NCT04348656|38257192|FG000|Overall Study|Lost to Follow-up|11|||
17118711|NCT04348656|38257193|FG001|Overall Study|Lost to Follow-up|6|||
17118712|NCT04348500|38257208|FG000|Overall Study|Death|2|||
17118713|NCT04348500|38257209|FG001|Overall Study|Death|2|||
17118714|NCT04348500|38257208|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
17118715|NCT04348500|38257209|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
17118716|NCT04347954|38257218|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
17118717|NCT04347954|38257219|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
17118718|NCT04347954|38257220|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
17118719|NCT04347954|38257218|FG000|Overall Study|Lost to Follow-up|0|||
17118720|NCT04347954|38257219|FG001|Overall Study|Lost to Follow-up|1|||
17118721|NCT04347954|38257220|FG002|Overall Study|Lost to Follow-up|0|||
17118722|NCT03065530|38257232|FG000|Overall Study|Lack of Efficacy|1|||
17118723|NCT03065530|38257233|FG001|Overall Study|Lack of Efficacy|1|||
17118724|NCT03065530|38257234|FG002|Overall Study|Lack of Efficacy|0|||
17118725|NCT03065530|38257235|FG003|Overall Study|Lack of Efficacy|1|||
17118726|NCT03065530|38257232|FG000|Overall Study|Protocol Violation|1|||
17118727|NCT03065530|38257233|FG001|Overall Study|Protocol Violation|0|||
17118728|NCT03065530|38257234|FG002|Overall Study|Protocol Violation|1|||
17118729|NCT03065530|38257235|FG003|Overall Study|Protocol Violation|1|||
17118730|NCT03979820|38257257|FG000|Overall Study|Protocol Violation|1|||
17118731|NCT03979820|38257258|FG001|Overall Study|Protocol Violation|0|||
17118732|NCT03979820|38257259|FG002|Overall Study|Protocol Violation|0|||
17118733|NCT03979820|38257260|FG003|Overall Study|Protocol Violation|0|||
17118734|NCT03979820|38257257|FG000|Overall Study|Withdrawal by Subject|0|||
17118735|NCT03979820|38257258|FG001|Overall Study|Withdrawal by Subject|0|||
17118736|NCT03979820|38257259|FG002|Overall Study|Withdrawal by Subject|1|||
17118737|NCT03979820|38257260|FG003|Overall Study|Withdrawal by Subject|0|||
17118738|NCT03979820|38257257|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
17118739|NCT03979820|38257258|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
17118740|NCT03979820|38257259|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
17118741|NCT03979820|38257260|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
17118742|NCT03647488|38257277|FG000|Overall Study|Progressive disease|10|||
17118743|NCT03647488|38257278|FG001|Overall Study|Progressive disease|0|||
17118744|NCT03647488|38257279|FG002|Overall Study|Progressive disease|0|||
17118745|NCT03647488|38257277|FG000|Overall Study|Adverse Event|5|||
17118746|NCT03647488|38257278|FG001|Overall Study|Adverse Event|0|||
17118747|NCT03647488|38257279|FG002|Overall Study|Adverse Event|0|||
17118748|NCT03647488|38257277|FG000|Overall Study|Clinical progression|2|||
17118749|NCT03647488|38257278|FG001|Overall Study|Clinical progression|0|||
17118750|NCT03647488|38257279|FG002|Overall Study|Clinical progression|0|||
17118751|NCT03647488|38257277|FG000|Overall Study|Participant refused to take investigational product|1|||
17118752|NCT03647488|38257278|FG001|Overall Study|Participant refused to take investigational product|0|||
17118753|NCT03647488|38257279|FG002|Overall Study|Participant refused to take investigational product|0|||
17118754|NCT03693950|38257287|FG000|Overall Study|Withdrawal by Subject|1|||
17118755|NCT03693950|38257288|FG001|Overall Study|Withdrawal by Subject|0|||
17118756|NCT04110314|38257300|FG000|Overall Study|Did not meet inclusion criteria|35255|||
17118757|NCT04110314|38257301|FG001|Overall Study|Did not meet inclusion criteria|35104|||
17118758|NCT04110314|38257302|FG002|Overall Study|Did not meet inclusion criteria|35636|||
17118759|NCT04110314|38257303|FG003|Overall Study|Did not meet inclusion criteria|35135|||
17118760|NCT04110314|38257304|FG004|Overall Study|Did not meet inclusion criteria|35247|||
17118761|NCT04110314|38257305|FG005|Overall Study|Did not meet inclusion criteria|35727|||
17118762|NCT04109222|38257320|FG000|Overall Study|Adverse Event|1|||
17118763|NCT04109222|38257321|FG001|Overall Study|Adverse Event|0|||
17118764|NCT04109222|38257322|FG002|Overall Study|Adverse Event|0|||
17118765|NCT04098458|38257330|FG000|Overall Study|Death|1|||
17118766|NCT04098458|38257330|FG000|Overall Study|did not meet study inclusion criteria|3|||
17118767|NCT04128696|38257337|FG000|Overall Study|Lost to Follow-up|0|||
17118768|NCT04128696|38257338|FG001|Overall Study|Lost to Follow-up|1|||
17118769|NCT04128696|38257337|FG000|Overall Study|Withdrawal by Subject|8|||
17118770|NCT04128696|38257338|FG001|Overall Study|Withdrawal by Subject|5|||
17118771|NCT04128696|38257337|FG000|Overall Study|In Follow-up|47|||
17118772|NCT04128696|38257338|FG001|Overall Study|In Follow-up|51|||
17118773|NCT04128696|38257337|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
17118774|NCT04128696|38257338|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
17118775|NCT03447262|38257344|FG000|Overall Study|Adverse Event|7|||
17118776|NCT03447262|38257344|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
17118777|NCT03447262|38257344|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
17118778|NCT03447262|38257344|FG000|Overall Study|Death|2|||
17118779|NCT03447262|38257344|FG000|Overall Study|Study Termination by Sponsor|455|||
17118780|NCT03447262|38257344|FG000|Overall Study|Other|4|||
17118781|NCT04094870|38257353|FG000|Overall Study|Lost to Follow-up|1|||
17118782|NCT04094870|38257354|FG001|Overall Study|Lost to Follow-up|1|||
17118783|NCT04399356|38257369|FG000|Overall Study|Lost to Follow-up|1|||
17118784|NCT04399356|38257370|FG001|Overall Study|Lost to Follow-up|1|||
17118785|NCT04399356|38257369|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
17118786|NCT04399356|38257370|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
17118787|NCT04399356|38257369|FG000|Overall Study|Withdrawal by Subject|1|||
17118788|NCT04399356|38257370|FG001|Overall Study|Withdrawal by Subject|0|||
17118789|NCT03692676|38257380|FG000|Overall Study|exclude patients with prior use|4424|||
17118790|NCT03692676|38257381|FG001|Overall Study|exclude patients with prior use|24726|||
17118791|NCT03692676|38257382|FG002|Overall Study|exclude patients with prior use|0|||
17118792|NCT03692676|38257383|FG003|Overall Study|exclude patients with prior use|0|||
17118793|NCT03692676|38257380|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
17118794|NCT03692676|38257381|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
17118795|NCT03692676|38257382|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
17118796|NCT03692676|38257383|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
17118797|NCT03692676|38257380|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
17118798|NCT03692676|38257381|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
17118799|NCT03692676|38257382|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
17118800|NCT03692676|38257383|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
17118801|NCT03692676|38257380|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
17118802|NCT03692676|38257381|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
17118803|NCT03692676|38257382|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
17118804|NCT03692676|38257383|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
17118805|NCT03692676|38257380|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
17118806|NCT03692676|38257381|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
17118807|NCT03692676|38257382|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
17118808|NCT03692676|38257383|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
17118809|NCT03692676|38257380|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
17118810|NCT03692676|38257381|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
17118811|NCT03692676|38257382|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
17118812|NCT03692676|38257383|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
17118813|NCT03692676|38257380|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
17118814|NCT03692676|38257381|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
17118815|NCT03692676|38257382|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
17118816|NCT03692676|38257383|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
17118817|NCT03692676|38257380|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
17118818|NCT03692676|38257381|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
17118819|NCT03692676|38257382|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
17118820|NCT03692676|38257383|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
17118821|NCT03692676|38257380|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
17118822|NCT03692676|38257381|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
17118823|NCT03692676|38257382|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
17118824|NCT03692676|38257383|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
17118825|NCT03692676|38257380|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
17118826|NCT03692676|38257381|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
17118827|NCT03692676|38257382|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
17118828|NCT03692676|38257383|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
17118829|NCT03692676|38257380|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
17118830|NCT03692676|38257381|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
17118831|NCT03692676|38257382|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
17118832|NCT03692676|38257383|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
17118833|NCT03692676|38257380|FG000|Overall Study|Other|0|||
17118834|NCT03692676|38257381|FG001|Overall Study|Other|805|||
17118835|NCT03692676|38257382|FG002|Overall Study|Other|758|||
17118836|NCT03692676|38257383|FG003|Overall Study|Other|277|||
17118837|NCT03692676|38257380|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
17118838|NCT03692676|38257381|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
17118839|NCT03692676|38257382|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
17118840|NCT03692676|38257383|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
17118841|NCT03691428|38257395|FG000|Overall Study|Withdrawal by Subject|6|||
17118842|NCT03691428|38257396|FG001|Overall Study|Withdrawal by Subject|8|||
17118843|NCT04124952|38257402|FG000|Overall Study|Lost to Follow-up|1|||
17118844|NCT04122534|38257406|FG000|Overall Study|Lost to Follow-up|4|||
17118845|NCT04091360|38257416|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
17118846|NCT04091360|38257417|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
17118847|NCT04091360|38257418|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
17118848|NCT04091360|38257419|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
17118849|NCT04091360|38257420|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
17118850|NCT04091360|38257421|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
17118851|NCT04091360|38257422|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
17118852|NCT04091360|38257423|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
17118853|NCT04091360|38257424|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
17118854|NCT04091360|38257425|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
17118855|NCT04091360|38257416|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
17118856|NCT04091360|38257417|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
17118857|NCT04091360|38257418|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
17118858|NCT04091360|38257419|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
17118859|NCT04091360|38257420|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
17118860|NCT04091360|38257421|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
17118861|NCT04091360|38257422|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
17118862|NCT04091360|38257423|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
17118863|NCT04091360|38257424|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
17118864|NCT04091360|38257425|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
17118865|NCT04091360|38257416|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
17118866|NCT04091360|38257417|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
17118867|NCT04091360|38257418|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
17118868|NCT04091360|38257419|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
17118869|NCT04091360|38257420|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
17118870|NCT04091360|38257421|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
17118871|NCT04091360|38257422|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
17118872|NCT04091360|38257423|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
17118873|NCT04091360|38257424|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
17118874|NCT04091360|38257425|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
17118875|NCT04118166|38257447|FG000|Overall Study|Adverse Event|1|||
17118876|NCT04346628|38257454|FG000|Overall Study|Lost to Follow-up|4|||
17118877|NCT04346628|38257455|FG001|Overall Study|Lost to Follow-up|4|||
17118878|NCT04346628|38257454|FG000|Overall Study|Withdrew (had personal reasons)|2|||
17118879|NCT04346628|38257455|FG001|Overall Study|Withdrew (had personal reasons)|5|||
17118880|NCT04346628|38257454|FG000|Overall Study|Withdrew (medication intolerant)|0|||
17118881|NCT04346628|38257455|FG001|Overall Study|Withdrew (medication intolerant)|3|||
17118882|NCT04346628|38257454|FG000|Overall Study|Withdrew (declined intervention)|0|||
17118883|NCT04346628|38257455|FG001|Overall Study|Withdrew (declined intervention)|1|||
17118884|NCT03681470|38257461|FG000|Overall Study|Lack of Efficacy|3|||
17118885|NCT03681470|38257461|FG000|Overall Study|Lost to Follow-up|1|||
17118886|NCT03681470|38257461|FG000|Overall Study|Protocol Violation|3|||
17118887|NCT03681470|38257461|FG000|Overall Study|Withdrawal by Subject|1|||
17118888|NCT04343976|38257467|FG000|Overall Study|Withdrawal by Subject|0|||
17118889|NCT04343976|38257468|FG001|Overall Study|Withdrawal by Subject|1|||
17118890|NCT03322540|38257476|FG000|Overall Study|Death|21|||
17118891|NCT03322540|38257477|FG001|Overall Study|Death|28|||
17118892|NCT03322540|38257476|FG000|Overall Study|Lost to Follow-up|0|||
17118893|NCT03322540|38257477|FG001|Overall Study|Lost to Follow-up|1|||
17118894|NCT03322540|38257476|FG000|Overall Study|Physician Decision|7|||
17118895|NCT03322540|38257477|FG001|Overall Study|Physician Decision|6|||
17118896|NCT03322540|38257476|FG000|Overall Study|Withdrawal by Subject|3|||
17118897|NCT03322540|38257477|FG001|Overall Study|Withdrawal by Subject|1|||
17118898|NCT03322540|38257476|FG000|Overall Study|Study terminated by sponsor|0|||
17118899|NCT03322540|38257477|FG001|Overall Study|Study terminated by sponsor|1|||
17118900|NCT04339296|38257487|FG000|Overall Study|Refuse to participate after allocation|1|||
17118901|NCT04339296|38257488|FG001|Overall Study|Refuse to participate after allocation|1|||
17118902|NCT04339296|38257487|FG000|Overall Study|Withdrew after completion of baseline|2|||
17118903|NCT04339296|38257488|FG001|Overall Study|Withdrew after completion of baseline|1|||
17118904|NCT04339296|38257487|FG000|Overall Study|Lost to Follow-up|0|||
17118905|NCT04339296|38257488|FG001|Overall Study|Lost to Follow-up|4|||
17118906|NCT04339296|38257487|FG000|Overall Study|Discontinued intervention|5|||
17118907|NCT04339296|38257488|FG001|Overall Study|Discontinued intervention|3|||
17118908|NCT02025556|38257497|FG000|Overall Study|Adverse Event|0|||
17118909|NCT02025556|38257498|FG001|Overall Study|Adverse Event|4|||
17118910|NCT02025556|38257499|FG002|Overall Study|Adverse Event|2|||
17118911|NCT02025556|38257497|FG000|Overall Study|Lack of Efficacy|2|||
17118912|NCT02025556|38257498|FG001|Overall Study|Lack of Efficacy|1|||
17118913|NCT02025556|38257499|FG002|Overall Study|Lack of Efficacy|0|||
17118914|NCT02025556|38257497|FG000|Overall Study|Protocol Violation|2|||
17118915|NCT02025556|38257498|FG001|Overall Study|Protocol Violation|1|||
17118916|NCT02025556|38257499|FG002|Overall Study|Protocol Violation|0|||
17118917|NCT02025556|38257497|FG000|Overall Study|Withdrawal by Subject|0|||
17118918|NCT02025556|38257498|FG001|Overall Study|Withdrawal by Subject|3|||
17118919|NCT02025556|38257499|FG002|Overall Study|Withdrawal by Subject|6|||
17118920|NCT02025556|38257497|FG000|Overall Study|Lost to Follow-up|2|||
17118921|NCT02025556|38257498|FG001|Overall Study|Lost to Follow-up|4|||
17118922|NCT02025556|38257499|FG002|Overall Study|Lost to Follow-up|0|||
17118923|NCT02025556|38257497|FG000|Overall Study|Reason not reported|0|||
17118924|NCT02025556|38257498|FG001|Overall Study|Reason not reported|0|||
17118925|NCT02025556|38257499|FG002|Overall Study|Reason not reported|1|||
17118926|NCT04334460|38257509|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
17118927|NCT04334460|38257510|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
17118928|NCT04334460|38257509|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
17118929|NCT04334460|38257510|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
17118930|NCT04334148|38257519|FG000|Overall Study|positive nasal swab at baseline|0|||
17118931|NCT04334148|38257520|FG001|Overall Study|positive nasal swab at baseline|1|||
17118932|NCT04399122|38257528|FG000|Overall Study|Lost to Follow-up|2|||
17118933|NCT04399122|38257529|FG001|Overall Study|Lost to Follow-up|0|||
17118934|NCT04399122|38257528|FG000|Overall Study|Withdrawal by Subject|1|||
17118935|NCT04399122|38257529|FG001|Overall Study|Withdrawal by Subject|0|||
17118936|NCT04398732|38257550|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
17118937|NCT04398030|38257556|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
17118938|NCT04398030|38257557|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
17118939|NCT04398030|38257556|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
17118940|NCT04398030|38257557|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
17118941|NCT03064438|38257565|FG000|Overall Study|Lost to Follow-up|1|||
17118942|NCT03064438|38257566|FG001|Overall Study|Lost to Follow-up|0|||
17118943|NCT03064438|38257565|FG000|Overall Study|Withdrawal by Subject|0|||
17118944|NCT03064438|38257566|FG001|Overall Study|Withdrawal by Subject|1|||
17118945|NCT04327986|38257572|FG000|Overall Study|Physician Decision|2|||
17118946|NCT04327986|38257573|FG001|Overall Study|Physician Decision|0|||
17118947|NCT04327986|38257574|FG002|Overall Study|Physician Decision|0|||
17118948|NCT04327986|38257572|FG000|Overall Study|Death|1|||
17118949|NCT04327986|38257573|FG001|Overall Study|Death|0|||
17118950|NCT04327986|38257574|FG002|Overall Study|Death|0|||
17118951|NCT04322682|38257580|FG000|Overall Study|Withdrawal by Subject|33|||
17118952|NCT04322682|38257581|FG001|Overall Study|Withdrawal by Subject|47|||
17118953|NCT04322682|38257580|FG000|Overall Study|Death|5|||
17118954|NCT04322682|38257581|FG001|Overall Study|Death|9|||
17118955|NCT04322682|38257580|FG000|Overall Study|Lost to Follow-up|4|||
17118956|NCT04322682|38257581|FG001|Overall Study|Lost to Follow-up|8|||
17118957|NCT04322682|38257580|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
17118958|NCT04322682|38257581|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
17118959|NCT04322526|38257589|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
17118960|NCT04322526|38257590|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
17118961|NCT04322526|38257589|FG000|Washout (1 Week)|Lost to Follow-up|1|||
17118962|NCT04322526|38257590|FG001|Washout (1 Week)|Lost to Follow-up|2|||
17118963|NCT04115358|38257599|FG000|Overall Study|exfoliation|0|||
17118964|NCT04115358|38257600|FG001|Overall Study|exfoliation|0|||
17118965|NCT04115358|38257601|FG002|Overall Study|exfoliation|1|||
17118966|NCT04109118|38257610|FG000|Overall Study|Lost to Follow-up|3|||
17118967|NCT04105998|38257617|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
17118968|NCT04105998|38257618|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
17118969|NCT04397718|38257626|FG000|Overall Study|Death|7|||
17118970|NCT04397718|38257627|FG001|Overall Study|Death|11|||
17118971|NCT04397718|38257626|FG000|Overall Study|Lost to Follow-up|0|||
17118972|NCT04397718|38257627|FG001|Overall Study|Lost to Follow-up|4|||
17118973|NCT04105218|38257635|FG000|Overall Study|Withdrawal by Subject|3|||
17118974|NCT04105218|38257636|FG001|Overall Study|Withdrawal by Subject|2|||
17118975|NCT04105218|38257635|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
17118976|NCT04105218|38257636|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
17118977|NCT04105218|38257635|FG000|Overall Study|Failed screening tests|2|||
17118978|NCT04105218|38257636|FG001|Overall Study|Failed screening tests|1|||
17118979|NCT04317690|38257647|FG000|Overall Study|did not have complete information for primary outcome|0|||
17118980|NCT04317690|38257648|FG001|Overall Study|did not have complete information for primary outcome|4|||
17118981|NCT04317690|38257649|FG002|Overall Study|did not have complete information for primary outcome|0|||
17118982|NCT04317690|38257650|FG003|Overall Study|did not have complete information for primary outcome|2|||
17118983|NCT04317690|38257651|FG004|Overall Study|did not have complete information for primary outcome|0|||
17118984|NCT03721276|38257678|FG000|Overall Study|Lost to Follow-up|5|||
17118985|NCT03721276|38257679|FG001|Overall Study|Lost to Follow-up|3|||
17118986|NCT03721276|38257678|FG000|Overall Study|Adverse Event|0|||
17118987|NCT03721276|38257679|FG001|Overall Study|Adverse Event|1|||
17118988|NCT03269344|38257694|FG000|Overall Study|Protocol Violation|4|||
17118989|NCT03269344|38257695|FG001|Overall Study|Protocol Violation|3|||
17118990|NCT04389840|38257707|FG000|Overall Study|Adverse Event|0|||
17118991|NCT04389840|38257708|FG001|Overall Study|Adverse Event|0|||
17118992|NCT04389840|38257709|FG002|Overall Study|Adverse Event|0|||
17118993|NCT04389840|38257710|FG003|Overall Study|Adverse Event|1|||
17118994|NCT04389840|38257711|FG004|Overall Study|Adverse Event|0|||
17118995|NCT04389840|38257712|FG005|Overall Study|Adverse Event|0|||
17118996|NCT04389840|38257707|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
17118997|NCT04389840|38257708|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
17118998|NCT04389840|38257709|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
17118999|NCT04389840|38257710|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
17119000|NCT04389840|38257711|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
17119001|NCT04389840|38257712|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
17119002|NCT04389840|38257707|FG000|Overall Study|Death|0|||
17119003|NCT04389840|38257708|FG001|Overall Study|Death|1|||
17119004|NCT04389840|38257709|FG002|Overall Study|Death|0|||
17119005|NCT04389840|38257710|FG003|Overall Study|Death|0|||
17119006|NCT04389840|38257711|FG004|Overall Study|Death|0|||
17119007|NCT04389840|38257712|FG005|Overall Study|Death|0|||
17119008|NCT04307940|38257735|FG000|Overall Study|Adverse Event|1|||
17119009|NCT04307940|38257736|FG001|Overall Study|Adverse Event|0|||
17119010|NCT04307940|38257737|FG002|Overall Study|Adverse Event|0|||
17119011|NCT04307940|38257735|FG000|Overall Study|Withdrawal by Subject|2|||
17119012|NCT04307940|38257736|FG001|Overall Study|Withdrawal by Subject|3|||
17119013|NCT04307940|38257737|FG002|Overall Study|Withdrawal by Subject|1|||
17119014|NCT04307940|38257735|FG000|Overall Study|Lost to Follow-up|2|||
17119015|NCT04307940|38257736|FG001|Overall Study|Lost to Follow-up|0|||
17119016|NCT04307940|38257737|FG002|Overall Study|Lost to Follow-up|1|||
17119017|NCT02054104|38257747|FG000|Overall Study|Did not want to continue due to college classes|1|||
17119018|NCT02054104|38257748|FG001|Overall Study|Did not want to continue due to college classes|0|||
17119019|NCT02054104|38257747|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
17119020|NCT02054104|38257748|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
17119021|NCT02054104|38257747|FG000|Overall Study|No evidence of immunologic response|2|||
17119022|NCT02054104|38257748|FG001|Overall Study|No evidence of immunologic response|2|||
17119023|NCT02054104|38257747|FG000|Overall Study|Disease Progression On Study|4|||
17119024|NCT02054104|38257748|FG001|Overall Study|Disease Progression On Study|5|||
17119025|NCT02054104|38257747|FG000|Overall Study|Diagnosis of lymphoma|0|||
17119026|NCT02054104|38257748|FG001|Overall Study|Diagnosis of lymphoma|1|||
17119027|NCT02054104|38257747|FG000|Overall Study|Inconclusive response|0|||
17119028|NCT02054104|38257748|FG001|Overall Study|Inconclusive response|1|||
17119029|NCT04480710|38257758|FG000|Overall Study|Adverse Event|0|||
17119030|NCT04480710|38257759|FG001|Overall Study|Adverse Event|2|||
17119031|NCT04480710|38257760|FG002|Overall Study|Adverse Event|0|||
17119032|NCT04480710|38257761|FG003|Overall Study|Adverse Event|0|||
17119033|NCT04480710|38257758|FG000|Overall Study|Withdrawal by Subject|0|||
17119034|NCT04480710|38257759|FG001|Overall Study|Withdrawal by Subject|1|||
17119035|NCT04480710|38257760|FG002|Overall Study|Withdrawal by Subject|0|||
17119036|NCT04480710|38257761|FG003|Overall Study|Withdrawal by Subject|0|||
17119037|NCT04480710|38257758|FG000|Overall Study|Physician Decision|0|||
17119038|NCT04480710|38257759|FG001|Overall Study|Physician Decision|0|||
17119039|NCT04480710|38257760|FG002|Overall Study|Physician Decision|1|||
17119040|NCT04480710|38257761|FG003|Overall Study|Physician Decision|0|||
17119041|NCT04090242|38257779|FG000|Overall Study|Withdrawal by Subject|1|||
17119042|NCT04090242|38257780|FG001|Overall Study|Withdrawal by Subject|0|||
17119043|NCT04090164|38257789|FG000|Overall Study|incomplete data on file|245|||
17119044|NCT04090164|38257790|FG001|Overall Study|incomplete data on file|0|||
17119045|NCT04292730|38257819|FG000|Overall Study|Lost to Follow-up|8|||
17119046|NCT04292730|38257820|FG001|Overall Study|Lost to Follow-up|12|||
17119047|NCT04292730|38257821|FG002|Overall Study|Lost to Follow-up|12|||
17119048|NCT04292730|38257822|FG003|Overall Study|Lost to Follow-up|48|||
17119049|NCT04292730|38257819|FG000|Overall Study|Death|2|||
17119050|NCT04292730|38257820|FG001|Overall Study|Death|2|||
17119051|NCT04292730|38257821|FG002|Overall Study|Death|4|||
17119052|NCT04292730|38257822|FG003|Overall Study|Death|12|||
17119053|NCT04292730|38257819|FG000|Overall Study|Withdrew Consent|2|||
17119054|NCT04292730|38257820|FG001|Overall Study|Withdrew Consent|2|||
17119055|NCT04292730|38257821|FG002|Overall Study|Withdrew Consent|5|||
17119056|NCT04292730|38257822|FG003|Overall Study|Withdrew Consent|6|||
17119057|NCT04292730|38257819|FG000|Overall Study|Non-Compliance with Study Drug|0|||
17119058|NCT04292730|38257820|FG001|Overall Study|Non-Compliance with Study Drug|1|||
17119059|NCT04292730|38257821|FG002|Overall Study|Non-Compliance with Study Drug|0|||
17119060|NCT04292730|38257822|FG003|Overall Study|Non-Compliance with Study Drug|0|||
17119061|NCT04292730|38257819|FG000|Overall Study|Protocol Violation|0|||
17119062|NCT04292730|38257820|FG001|Overall Study|Protocol Violation|0|||
17119063|NCT04292730|38257821|FG002|Overall Study|Protocol Violation|1|||
17119064|NCT04292730|38257822|FG003|Overall Study|Protocol Violation|0|||
17119065|NCT04292730|38257819|FG000|Overall Study|Randomized but not Treated|8|||
17119066|NCT04292730|38257820|FG001|Overall Study|Randomized but not Treated|4|||
17119067|NCT04292730|38257821|FG002|Overall Study|Randomized but not Treated|0|||
17119068|NCT04292730|38257822|FG003|Overall Study|Randomized but not Treated|14|||
17119069|NCT02861014|38257831|FG000|Primary Analysis|Adverse Event|7|||
17119070|NCT02861014|38257831|FG000|Primary Analysis|Death|1|||
17119071|NCT02861014|38257831|FG000|Primary Analysis|Lack of Efficacy|3|||
17119072|NCT02861014|38257831|FG000|Primary Analysis|Physician Decision|2|||
17119073|NCT02861014|38257831|FG000|Primary Analysis|Pregnancy|4|||
17119074|NCT02861014|38257831|FG000|Primary Analysis|Protocol Violation|2|||
17119075|NCT02861014|38257831|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
17119076|NCT02861014|38257831|FG000|Primary Analysis|Withdrawal by Subject|14|||
17119077|NCT02861014|38257831|FG000|Primary Analysis|Commercial ocrelizumab|3|||
17119078|NCT02861014|38257831|FG000|Safety Follow-up|Adverse Event|1|||
17119079|NCT02861014|38257831|FG000|Safety Follow-up|Pregnancy|1|||
17119080|NCT02861014|38257831|FG000|Safety Follow-up|Withdrawal by Subject|9|||
17119081|NCT02861014|38257831|FG000|Safety Follow-up|Study terminated by sponsor|1|||
17119082|NCT02861014|38257831|FG000|Safety Follow-up|Physician Decision|1|||
17119083|NCT02861014|38257831|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
17119084|NCT02861014|38257831|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
17119085|NCT04382586|38257839|FG000|Overall Study|Death|3|||
17119086|NCT04382586|38257840|FG001|Overall Study|Death|4|||
17119087|NCT04382586|38257839|FG000|Overall Study|Lost to Follow-up|11|||
17119088|NCT04382586|38257840|FG001|Overall Study|Lost to Follow-up|8|||
17119089|NCT04382586|38257839|FG000|Overall Study|Withdrawal by Subject|3|||
17119090|NCT04382586|38257840|FG001|Overall Study|Withdrawal by Subject|1|||
17119091|NCT04382586|38257839|FG000|Overall Study|Physician Decision|0|||
17119092|NCT04382586|38257840|FG001|Overall Study|Physician Decision|3|||
17119093|NCT04275336|38257849|FG000|Overall Study|First venipuncture failed|4|||
17119094|NCT04275336|38257850|FG001|Overall Study|First venipuncture failed|6|||
17119095|NCT04275336|38257851|FG002|Overall Study|First venipuncture failed|5|||
17119096|NCT04275336|38257849|FG000|Overall Study|Unscheduled venipuncture|9|||
17119097|NCT04275336|38257850|FG001|Overall Study|Unscheduled venipuncture|13|||
17119098|NCT04275336|38257851|FG002|Overall Study|Unscheduled venipuncture|7|||
17119099|NCT04275336|38257849|FG000|Overall Study|Failed specimen of saliva|4|||
17119100|NCT04275336|38257850|FG001|Overall Study|Failed specimen of saliva|3|||
17119101|NCT04275336|38257851|FG002|Overall Study|Failed specimen of saliva|4|||
17119102|NCT04268316|38257865|FG000|Overall Study|Withdrawal by Subject|2|||
17119103|NCT04268316|38257866|FG001|Overall Study|Withdrawal by Subject|1|||
17119104|NCT04268316|38257867|FG002|Overall Study|Withdrawal by Subject|0|||
17119105|NCT01971970|38257877|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
17119106|NCT01971970|38257878|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
17119107|NCT01971970|38257877|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
17119108|NCT01971970|38257878|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
17119109|NCT01971970|38257877|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
17119110|NCT01971970|38257878|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
17119111|NCT01971970|38257877|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
17119112|NCT01971970|38257878|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
17119113|NCT01971970|38257877|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
17119114|NCT01971970|38257878|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
17119115|NCT01971970|38257877|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
17119116|NCT01971970|38257878|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
17119117|NCT01971970|38257877|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
17119118|NCT01971970|38257878|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
17119119|NCT04079790|38257893|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
17119120|NCT04079790|38257894|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
17119121|NCT04079790|38257895|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
17119122|NCT04079790|38257896|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
17119123|NCT04079790|38257893|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
17119124|NCT04079790|38257894|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
17119125|NCT04079790|38257895|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
17119126|NCT04079790|38257896|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
17119127|NCT04079790|38257893|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
17119128|NCT04079790|38257894|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
17119129|NCT04079790|38257895|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
17119130|NCT04079790|38257896|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
17119131|NCT04259346|38257924|FG000|Overall Study|Lost to Follow-up|1|||
17119132|NCT04259346|38257925|FG001|Overall Study|Lost to Follow-up|3|||
17119133|NCT04259346|38257924|FG000|Overall Study|Protocol Violation|1|||
17119134|NCT04259346|38257925|FG001|Overall Study|Protocol Violation|0|||
17119135|NCT04259346|38257924|FG000|Overall Study|Withdrawal by Subject|1|||
17119136|NCT04259346|38257925|FG001|Overall Study|Withdrawal by Subject|0|||
17119137|NCT04259346|38257924|FG000|Overall Study|Adverse Event|1|||
17119138|NCT04259346|38257925|FG001|Overall Study|Adverse Event|1|||
17119139|NCT04230876|38257933|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
17119140|NCT04230876|38257934|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
17119141|NCT04228302|38257946|FG000|Overall Study|Adverse Event|0|||
17119142|NCT04228302|38257947|FG001|Overall Study|Adverse Event|0|||
17119143|NCT04228302|38257948|FG002|Overall Study|Adverse Event|0|||
17119144|NCT04228302|38257949|FG003|Overall Study|Adverse Event|0|||
17119145|NCT04228302|38257950|FG004|Overall Study|Adverse Event|1|||
17119146|NCT04228302|38257951|FG005|Overall Study|Adverse Event|0|||
17119147|NCT01348100|38257972|FG000|Overall Study|Subject Withdrew Consent|0|||
17119148|NCT01348100|38257973|FG001|Overall Study|Subject Withdrew Consent|0|||
17119149|NCT01348100|38257974|FG002|Overall Study|Subject Withdrew Consent|2|||
17119150|NCT01348100|38257975|FG003|Overall Study|Subject Withdrew Consent|0|||
17119151|NCT01348100|38257976|FG004|Overall Study|Subject Withdrew Consent|1|||
17119152|NCT01348100|38257977|FG005|Overall Study|Subject Withdrew Consent|0|||
17119153|NCT01348100|38257978|FG006|Overall Study|Subject Withdrew Consent|1|||
17119154|NCT01348100|38257972|FG000|Overall Study|Protocol Deviation|0|||
17119155|NCT01348100|38257973|FG001|Overall Study|Protocol Deviation|0|||
17119156|NCT01348100|38257974|FG002|Overall Study|Protocol Deviation|0|||
17119157|NCT01348100|38257975|FG003|Overall Study|Protocol Deviation|1|||
17119158|NCT01348100|38257976|FG004|Overall Study|Protocol Deviation|0|||
17119159|NCT01348100|38257977|FG005|Overall Study|Protocol Deviation|0|||
17119160|NCT01348100|38257978|FG006|Overall Study|Protocol Deviation|0|||
17119161|NCT01348100|38257972|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17119162|NCT01348100|38257973|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17119163|NCT01348100|38257974|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17119164|NCT01348100|38257975|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17119165|NCT01348100|38257976|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17119166|NCT01348100|38257977|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
17119167|NCT01348100|38257978|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17119168|NCT01348100|38257972|FG000|Overall Study|Lost to Follow-up|0|||
17119169|NCT01348100|38257973|FG001|Overall Study|Lost to Follow-up|0|||
17119170|NCT01348100|38257974|FG002|Overall Study|Lost to Follow-up|0|||
17119171|NCT01348100|38257975|FG003|Overall Study|Lost to Follow-up|0|||
17119172|NCT01348100|38257976|FG004|Overall Study|Lost to Follow-up|0|||
17119173|NCT01348100|38257977|FG005|Overall Study|Lost to Follow-up|0|||
17119174|NCT01348100|38257978|FG006|Overall Study|Lost to Follow-up|1|||
17119175|NCT01348100|38257972|FG000|Overall Study|Administrative Problems|0|||
17119176|NCT01348100|38257973|FG001|Overall Study|Administrative Problems|0|||
17119177|NCT01348100|38257974|FG002|Overall Study|Administrative Problems|0|||
17119178|NCT01348100|38257975|FG003|Overall Study|Administrative Problems|0|||
17119179|NCT01348100|38257976|FG004|Overall Study|Administrative Problems|0|||
17119180|NCT01348100|38257977|FG005|Overall Study|Administrative Problems|1|||
17119181|NCT01348100|38257978|FG006|Overall Study|Administrative Problems|1|||
17119182|NCT03676634|38257999|FG000|Overall Study|Red blood cell loss|1|||
17119183|NCT03676634|38257999|FG000|Overall Study|Out-of-limit pulse|2|||
17119184|NCT03675776|38258006|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
17119185|NCT03675776|38258007|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
17119186|NCT03675776|38258008|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
17119187|NCT03675776|38258006|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
17119188|NCT03675776|38258007|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
17119189|NCT03675776|38258008|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
17119190|NCT03673670|38258022|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
17119191|NCT03673670|38258023|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
17119192|NCT03673670|38258024|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
17119193|NCT03673670|38258025|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
17119194|NCT03673670|38258026|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
17119195|NCT03673670|38258027|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
17119196|NCT03673670|38258022|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
17119197|NCT03673670|38258023|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
17119198|NCT03673670|38258024|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
17119199|NCT03673670|38258025|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
17119200|NCT03673670|38258026|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
17119201|NCT03673670|38258027|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
17119202|NCT03673670|38258022|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
17119203|NCT03673670|38258023|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
17119204|NCT03673670|38258024|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
17119205|NCT03673670|38258025|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
17119206|NCT03673670|38258026|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
17119207|NCT03673670|38258027|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
17119208|NCT03673670|38258022|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
17119209|NCT03673670|38258023|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
17119210|NCT03673670|38258024|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
17119211|NCT03673670|38258025|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
17119212|NCT03673670|38258026|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
17119213|NCT03673670|38258027|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
17119214|NCT03673670|38258022|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
17119215|NCT03673670|38258023|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
17119216|NCT03673670|38258024|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
17119217|NCT03673670|38258025|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
17119218|NCT03673670|38258026|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
17119219|NCT03673670|38258027|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
17119220|NCT03673670|38258022|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
17119221|NCT03673670|38258023|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
17119222|NCT03673670|38258024|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
17119223|NCT03673670|38258025|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
17119224|NCT03673670|38258026|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
17119225|NCT03673670|38258027|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
17119226|NCT03673670|38258022|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
17119227|NCT03673670|38258023|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
17119228|NCT03673670|38258024|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
17119229|NCT03673670|38258025|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
17119230|NCT03673670|38258026|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
17119231|NCT03673670|38258027|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
17119232|NCT04369742|38258046|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
17119233|NCT04369742|38258047|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
17119234|NCT04369742|38258046|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
17119235|NCT04369742|38258047|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
17119236|NCT04369430|38258055|FG000|Overall Study|Adverse Event|2|||
17119237|NCT04369430|38258056|FG001|Overall Study|Adverse Event|3|||
17119238|NCT04369430|38258055|FG000|Overall Study|Death|1|||
17119239|NCT04369430|38258056|FG001|Overall Study|Death|0|||
17119240|NCT04369430|38258055|FG000|Overall Study|Withdrawal by Subject|4|||
17119241|NCT04369430|38258056|FG001|Overall Study|Withdrawal by Subject|3|||
17119242|NCT04369430|38258055|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
17119243|NCT04369430|38258056|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
17119244|NCT04369430|38258055|FG000|Overall Study|Lost to Follow-up|0|||
17119245|NCT04369430|38258056|FG001|Overall Study|Lost to Follow-up|1|||
17119246|NCT04363736|38258064|FG000|Overall Study|Withdrawal by Subject|1|||
17119247|NCT04363736|38258065|FG001|Overall Study|Withdrawal by Subject|0|||
17119248|NCT04363736|38258064|FG000|Overall Study|Lost to Follow-up|10|||
17119249|NCT04363736|38258065|FG001|Overall Study|Lost to Follow-up|7|||
17119250|NCT04363736|38258064|FG000|Overall Study|Death|8|||
17119251|NCT04363736|38258065|FG001|Overall Study|Death|6|||
17119252|NCT04362176|38258073|FG000|Overall Study|Lost to Follow-up|5|||
17119253|NCT04362176|38258074|FG001|Overall Study|Lost to Follow-up|8|||
17119254|NCT04362176|38258073|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
17119255|NCT04362176|38258074|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
17119256|NCT04080752|38258082|FG000|Overall Study|Adverse Event|2|||
17119257|NCT04080752|38258083|FG001|Overall Study|Adverse Event|3|||
17119258|NCT04080752|38258082|FG000|Overall Study|Lack of Efficacy|1|||
17119259|NCT04080752|38258083|FG001|Overall Study|Lack of Efficacy|0|||
17119260|NCT04080752|38258082|FG000|Overall Study|Lost to Follow-up|1|||
17119261|NCT04080752|38258083|FG001|Overall Study|Lost to Follow-up|0|||
17119262|NCT04080752|38258082|FG000|Overall Study|Pregnancy|0|||
17119263|NCT04080752|38258083|FG001|Overall Study|Pregnancy|1|||
17119264|NCT04080752|38258082|FG000|Overall Study|Withdrawal by Subject|7|||
17119265|NCT04080752|38258083|FG001|Overall Study|Withdrawal by Subject|0|||
17119266|NCT04080752|38258082|FG000|Overall Study|Non-Compliance with Study Drug|0|||
17119267|NCT04080752|38258083|FG001|Overall Study|Non-Compliance with Study Drug|1|||
17119268|NCT04080752|38258082|FG000|Overall Study|Other|2|||
17119269|NCT04080752|38258083|FG001|Overall Study|Other|1|||
17119270|NCT04079816|38258090|FG000|Overall Study|Request of Subject|2|||
17119271|NCT04079816|38258090|FG000|Overall Study|Unable to draw samples|1|||
17119272|NCT04079114|38258094|FG000|Overall Study|Study prematuely terminated.|166|||
17119273|NCT03055936|38258102|FG000|Overall Study|Adverse Event|0|||
17119274|NCT03055936|38258103|FG001|Overall Study|Adverse Event|1|||
17119275|NCT03055936|38258104|FG002|Overall Study|Adverse Event|1|||
17119276|NCT03055936|38258105|FG003|Overall Study|Adverse Event|1|||
17119277|NCT03055936|38258102|FG000|Overall Study|Personal reason|2|||
17119278|NCT03055936|38258103|FG001|Overall Study|Personal reason|0|||
17119279|NCT03055936|38258104|FG002|Overall Study|Personal reason|1|||
17119280|NCT03055936|38258105|FG003|Overall Study|Personal reason|0|||
17119281|NCT03891524|38258147|FG000|Overall Study|Death|0|||
17119282|NCT03891524|38258148|FG001|Overall Study|Death|0|||
17119283|NCT03891524|38258149|FG002|Overall Study|Death|0|||
17119284|NCT03891524|38258150|FG003|Overall Study|Death|0|||
17119285|NCT03891524|38258151|FG004|Overall Study|Death|0|||
17119286|NCT03891524|38258152|FG005|Overall Study|Death|0|||
17119287|NCT03891524|38258153|FG006|Overall Study|Death|0|||
17119288|NCT03891524|38258154|FG007|Overall Study|Death|1|||
17119289|NCT03891524|38258147|FG000|Overall Study|Withdrawal by Subject|0|||
17119290|NCT03891524|38258148|FG001|Overall Study|Withdrawal by Subject|1|||
17119291|NCT03891524|38258149|FG002|Overall Study|Withdrawal by Subject|2|||
17119292|NCT03891524|38258150|FG003|Overall Study|Withdrawal by Subject|1|||
17119293|NCT03891524|38258151|FG004|Overall Study|Withdrawal by Subject|2|||
17119294|NCT03891524|38258152|FG005|Overall Study|Withdrawal by Subject|2|||
17119295|NCT03891524|38258153|FG006|Overall Study|Withdrawal by Subject|2|||
17119296|NCT03891524|38258154|FG007|Overall Study|Withdrawal by Subject|1|||
17119297|NCT03055624|38258189|FG000|Overall Study|Study closed|9|||
17119298|NCT01346176|38258196|FG000|Recruited|Protocol Violation|1|||
17119299|NCT01346176|38258197|FG001|Recruited|Protocol Violation|0|||
17119300|NCT01346176|38258198|FG002|Recruited|Protocol Violation|0|||
17119301|NCT01346176|38258196|FG000|Completed Advance Directive|Death|3|||
17119302|NCT01346176|38258197|FG001|Completed Advance Directive|Death|2|||
17119303|NCT01346176|38258198|FG002|Completed Advance Directive|Death|2|||
17119304|NCT01346176|38258196|FG000|Completed Advance Directive|Became Ineligible|3|||
17119305|NCT01346176|38258197|FG001|Completed Advance Directive|Became Ineligible|0|||
17119306|NCT01346176|38258198|FG002|Completed Advance Directive|Became Ineligible|1|||
17119307|NCT01346176|38258196|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
17119308|NCT01346176|38258197|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
17119309|NCT01346176|38258198|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
17119310|NCT01346176|38258196|FG000|Completed Satisfaction Survey|Death|3|||
17119311|NCT01346176|38258197|FG001|Completed Satisfaction Survey|Death|0|||
17119312|NCT01346176|38258198|FG002|Completed Satisfaction Survey|Death|2|||
17119313|NCT01346176|38258196|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
17119314|NCT01346176|38258197|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
17119315|NCT01346176|38258198|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
17119316|NCT04075604|38258209|FG000|Overall Study|Adverse Event|0|||
17119317|NCT04075604|38258210|FG001|Overall Study|Adverse Event|0|||
17119318|NCT04075604|38258211|FG002|Overall Study|Adverse Event|3|||
17119319|NCT04075604|38258209|FG000|Overall Study|Participant request to discontinue study treatment|0|||
17119320|NCT04075604|38258210|FG001|Overall Study|Participant request to discontinue study treatment|0|||
17119321|NCT04075604|38258211|FG002|Overall Study|Participant request to discontinue study treatment|1|||
17119322|NCT04075604|38258209|FG000|Overall Study|Participant withdrew consent|0|||
17119323|NCT04075604|38258210|FG001|Overall Study|Participant withdrew consent|0|||
17119324|NCT04075604|38258211|FG002|Overall Study|Participant withdrew consent|1|||
17119325|NCT04075604|38258209|FG000|Overall Study|Other reasons|1|||
17119326|NCT04075604|38258210|FG001|Overall Study|Other reasons|0|||
17119327|NCT04075604|38258211|FG002|Overall Study|Other reasons|0|||
17119328|NCT04075604|38258209|FG000|Overall Study|Disease progression|0|||
17119329|NCT04075604|38258210|FG001|Overall Study|Disease progression|1|||
17119330|NCT04075604|38258211|FG002|Overall Study|Disease progression|0|||
17119331|NCT04075604|38258209|FG000|Overall Study|Study drug toxicity|0|||
17119332|NCT04075604|38258210|FG001|Overall Study|Study drug toxicity|5|||
17119333|NCT04075604|38258211|FG002|Overall Study|Study drug toxicity|1|||
17119334|NCT03796208|38258230|FG000|Overall Study|Withdrawal by Subject|3|||
17119335|NCT03796208|38258231|FG001|Overall Study|Withdrawal by Subject|0|||
17119336|NCT03796208|38258230|FG000|Overall Study|Loss of pregnancy|1|||
17119337|NCT03796208|38258231|FG001|Overall Study|Loss of pregnancy|1|||
17119338|NCT03796208|38258230|FG000|Overall Study|Changed prenatal clinics|0|||
17119339|NCT03796208|38258231|FG001|Overall Study|Changed prenatal clinics|5|||
17119340|NCT03796208|38258230|FG000|Overall Study|Lost to Follow-up|20|||
17119341|NCT03796208|38258231|FG001|Overall Study|Lost to Follow-up|16|||
17119342|NCT01318876|38258237|FG000|Day 8 Survey|email address invalid|96|||
17119343|NCT01318876|38258237|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
17119344|NCT01318876|38258237|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
17119345|NCT03668600|38258241|FG000|Overall Study|Study Terminated by the Sponsor|157|||
17119346|NCT03668600|38258241|FG000|Overall Study|Protocol Violation|1|||
17119347|NCT03668600|38258241|FG000|Overall Study|Pregnancy|1|||
17119348|NCT03668600|38258241|FG000|Overall Study|Lost to Follow-up|7|||
17119349|NCT03668600|38258241|FG000|Overall Study|Withdrawal by Subject|56|||
17119350|NCT03668600|38258241|FG000|Overall Study|Lack of Efficacy|7|||
17119351|NCT03668600|38258241|FG000|Overall Study|Adverse Event|1|||
17119352|NCT04073186|38258245|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
17119353|NCT04073186|38258245|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
17119354|NCT04073186|38258245|FG000|First Wearing Cycle|Protocol Violation|1|||
17119355|NCT04073186|38258245|FG000|First Wearing Cycle|Lens Discomfort|2|||
17188982|NCT01063153|38341936|FG000|Overall Study|Withdrawal by Subject|0|||
17119356|NCT04073186|38258245|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
17119357|NCT04073186|38258245|FG000|Second Wearing Cycle|Adverse Event|1|||
17119358|NCT03054064|38258250|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
17119359|NCT03054064|38258250|FG000|Overall Study|Investigator Decision|2|||
17119360|NCT03054064|38258250|FG000|Overall Study|Bladder Issue|1|||
17119361|NCT03054064|38258250|FG000|Overall Study|High Blood Pressure|1|||
17119362|NCT03054064|38258250|FG000|Overall Study|Change in Status|1|||
17119363|NCT03053518|38258254|FG000|Overall Study|Withdrawal by Subject|3|||
17119364|NCT03053518|38258254|FG000|Overall Study|Lost to Follow-up|2|||
17119365|NCT03053518|38258254|FG000|Overall Study|Ineligible|5|||
17119366|NCT04015336|38258258|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
17119367|NCT04071158|38258281|FG000|Overall Study|Lost to Follow-up|1|||
17119368|NCT04071158|38258282|FG001|Overall Study|Lost to Follow-up|2|||
17119369|NCT04071158|38258283|FG002|Overall Study|Lost to Follow-up|3|||
17119370|NCT04071158|38258284|FG003|Overall Study|Lost to Follow-up|3|||
17119371|NCT04071158|38258285|FG004|Overall Study|Lost to Follow-up|5|||
17119372|NCT04071158|38258281|FG000|Overall Study|Randomized but not treated|2|||
17119373|NCT04071158|38258282|FG001|Overall Study|Randomized but not treated|2|||
17119374|NCT04071158|38258283|FG002|Overall Study|Randomized but not treated|0|||
17119375|NCT04071158|38258284|FG003|Overall Study|Randomized but not treated|0|||
17119376|NCT04071158|38258285|FG004|Overall Study|Randomized but not treated|0|||
17119377|NCT01317940|38258309|FG000|Overall Study|Death|1|||
17119378|NCT01317940|38258310|FG001|Overall Study|Death|0|||
17119379|NCT01317940|38258311|FG002|Overall Study|Death|1|||
17119380|NCT01317940|38258312|FG003|Overall Study|Death|0|||
17119381|NCT01317940|38258313|FG004|Overall Study|Death|0|||
17119382|NCT01317940|38258314|FG005|Overall Study|Death|0|||
17119383|NCT01317940|38258309|FG000|Overall Study|Lost to Follow-up|0|||
17119384|NCT01317940|38258310|FG001|Overall Study|Lost to Follow-up|0|||
17119385|NCT01317940|38258311|FG002|Overall Study|Lost to Follow-up|1|||
17119386|NCT01317940|38258312|FG003|Overall Study|Lost to Follow-up|1|||
17119387|NCT01317940|38258313|FG004|Overall Study|Lost to Follow-up|1|||
17119388|NCT01317940|38258314|FG005|Overall Study|Lost to Follow-up|0|||
17119389|NCT01317940|38258309|FG000|Overall Study|Change in therapy plan|0|||
17119390|NCT01317940|38258310|FG001|Overall Study|Change in therapy plan|0|||
17119391|NCT01317940|38258311|FG002|Overall Study|Change in therapy plan|3|||
17119392|NCT01317940|38258312|FG003|Overall Study|Change in therapy plan|0|||
17119393|NCT01317940|38258313|FG004|Overall Study|Change in therapy plan|0|||
17119394|NCT01317940|38258314|FG005|Overall Study|Change in therapy plan|0|||
17119395|NCT01345786|38258333|FG000|Overall Study|Adverse Event|0|||
17119396|NCT01345786|38258334|FG001|Overall Study|Adverse Event|1|||
17119397|NCT01345786|38258335|FG002|Overall Study|Adverse Event|3|||
17119398|NCT01345786|38258336|FG003|Overall Study|Adverse Event|1|||
17119399|NCT01345786|38258333|FG000|Overall Study|Subject withdrew consent|2|||
17119400|NCT01345786|38258334|FG001|Overall Study|Subject withdrew consent|2|||
17119401|NCT01345786|38258335|FG002|Overall Study|Subject withdrew consent|1|||
17119402|NCT01345786|38258336|FG003|Overall Study|Subject withdrew consent|0|||
17119403|NCT01345786|38258333|FG000|Overall Study|Noncompliance with protocol|1|||
17119404|NCT01345786|38258334|FG001|Overall Study|Noncompliance with protocol|0|||
17119405|NCT01345786|38258335|FG002|Overall Study|Noncompliance with protocol|1|||
17119406|NCT01345786|38258336|FG003|Overall Study|Noncompliance with protocol|0|||
17119407|NCT01345786|38258333|FG000|Overall Study|Administrative|3|||
17119408|NCT01345786|38258334|FG001|Overall Study|Administrative|5|||
17119409|NCT01345786|38258335|FG002|Overall Study|Administrative|0|||
17119410|NCT01345786|38258336|FG003|Overall Study|Administrative|0|||
17119411|NCT01345786|38258333|FG000|Overall Study|Lost to Follow-up|0|||
17119412|NCT01345786|38258334|FG001|Overall Study|Lost to Follow-up|0|||
17119413|NCT01345786|38258335|FG002|Overall Study|Lost to Follow-up|0|||
17119414|NCT01345786|38258336|FG003|Overall Study|Lost to Follow-up|2|||
17119415|NCT01317550|38258350|FG000|Overall Study|Withdrawal by Subject|1|||
17119416|NCT01317550|38258351|FG001|Overall Study|Withdrawal by Subject|0|||
17119417|NCT01317550|38258352|FG002|Overall Study|Withdrawal by Subject|0|||
17119418|NCT01317550|38258353|FG003|Overall Study|Withdrawal by Subject|0|||
17119419|NCT01317550|38258350|FG000|Overall Study|Lack of compliance study med|1|||
17119420|NCT01317550|38258351|FG001|Overall Study|Lack of compliance study med|0|||
17119421|NCT01317550|38258352|FG002|Overall Study|Lack of compliance study med|0|||
17119422|NCT01317550|38258353|FG003|Overall Study|Lack of compliance study med|0|||
17119423|NCT01317472|38258365|FG000|Overall Study|Withdrawal by Subject|1|||
17119424|NCT01317472|38258366|FG001|Overall Study|Withdrawal by Subject|0|||
17119425|NCT01317472|38258365|FG000|Overall Study|Unrelated hospitalization|1|||
17119426|NCT01317472|38258366|FG001|Overall Study|Unrelated hospitalization|0|||
17119427|NCT01345630|38258374|FG000|Overall Study|Adverse Event|22|||
17119428|NCT01345630|38258375|FG001|Overall Study|Adverse Event|23|||
17119429|NCT01345630|38258374|FG000|Overall Study|Lost to Follow-up|17|||
17119430|NCT01345630|38258375|FG001|Overall Study|Lost to Follow-up|16|||
17119431|NCT01345630|38258374|FG000|Overall Study|Protocol Violation|4|||
17119432|NCT01345630|38258375|FG001|Overall Study|Protocol Violation|1|||
17119433|NCT01345630|38258374|FG000|Overall Study|Medication error without associated AE|0|||
17119434|NCT01345630|38258375|FG001|Overall Study|Medication error without associated AE|1|||
17119435|NCT01345630|38258374|FG000|Overall Study|Study terminated by sponsor|254|||
17119436|NCT01345630|38258375|FG001|Overall Study|Study terminated by sponsor|285|||
17119437|NCT01345630|38258374|FG000|Overall Study|Other reasons|6|||
17119438|NCT01345630|38258375|FG001|Overall Study|Other reasons|8|||
17119439|NCT01345630|38258374|FG000|Overall Study|Withdrawn due to pregnancy|1|||
17119440|NCT01345630|38258375|FG001|Overall Study|Withdrawn due to pregnancy|2|||
17119441|NCT01345630|38258374|FG000|Overall Study|No longer willing to participate|9|||
17119442|NCT01345630|38258375|FG001|Overall Study|No longer willing to participate|12|||
17119443|NCT01345630|38258374|FG000|Overall Study|Insufficient clinical response|48|||
17119444|NCT01345630|38258375|FG001|Overall Study|Insufficient clinical response|11|||
17119445|NCT03693612|38258392|FG000|Overall Study|Lost to Follow-up|0|||
17119446|NCT03693612|38258393|FG001|Overall Study|Lost to Follow-up|0|||
17119447|NCT03693612|38258394|FG002|Overall Study|Lost to Follow-up|0|||
17119448|NCT03693612|38258395|FG003|Overall Study|Lost to Follow-up|0|||
17119449|NCT03693612|38258396|FG004|Overall Study|Lost to Follow-up|1|||
17119450|NCT03693612|38258397|FG005|Overall Study|Lost to Follow-up|0|||
17119451|NCT03693612|38258398|FG006|Overall Study|Lost to Follow-up|0|||
17119452|NCT03693612|38258392|FG000|Overall Study|Withdrawal by Subject|0|||
17119453|NCT03693612|38258393|FG001|Overall Study|Withdrawal by Subject|0|||
17119454|NCT03693612|38258394|FG002|Overall Study|Withdrawal by Subject|1|||
17119455|NCT03693612|38258395|FG003|Overall Study|Withdrawal by Subject|0|||
17119456|NCT03693612|38258396|FG004|Overall Study|Withdrawal by Subject|2|||
17119457|NCT03693612|38258397|FG005|Overall Study|Withdrawal by Subject|0|||
17119458|NCT03693612|38258398|FG006|Overall Study|Withdrawal by Subject|0|||
17119459|NCT03693612|38258392|FG000|Overall Study|Study Terminated by Sponsor|0|||
17119460|NCT03693612|38258393|FG001|Overall Study|Study Terminated by Sponsor|1|||
17119461|NCT03693612|38258394|FG002|Overall Study|Study Terminated by Sponsor|0|||
17119462|NCT03693612|38258395|FG003|Overall Study|Study Terminated by Sponsor|0|||
17119463|NCT03693612|38258396|FG004|Overall Study|Study Terminated by Sponsor|3|||
17119464|NCT03693612|38258397|FG005|Overall Study|Study Terminated by Sponsor|0|||
17119465|NCT03693612|38258398|FG006|Overall Study|Study Terminated by Sponsor|0|||
17119466|NCT03692910|38258414|FG000|Overall Study|Lost to Follow-up|4|||
17119467|NCT03692910|38258415|FG001|Overall Study|Lost to Follow-up|0|||
17119468|NCT03692910|38258416|FG002|Overall Study|Lost to Follow-up|0|||
17119469|NCT03692910|38258414|FG000|Overall Study|Withdrawal by Subject|2|||
17119470|NCT03692910|38258415|FG001|Overall Study|Withdrawal by Subject|0|||
17119471|NCT03692910|38258416|FG002|Overall Study|Withdrawal by Subject|0|||
17119472|NCT04223232|38258422|FG000|Overall Study|Withdrawal by Subject|1|||
17119473|NCT04206384|38258426|FG000|Overall Study|Withdrawal by Subject|8|||
17119474|NCT04206384|38258426|FG000|Overall Study|Adverse Event|2|||
17119475|NCT04051944|38258432|FG000|Overall Study|Study ending|1|||
17119476|NCT04051944|38258433|FG001|Overall Study|Study ending|1|||
17119477|NCT04051944|38258432|FG000|Overall Study|Early study termination by participant|1|||
17119478|NCT04051944|38258433|FG001|Overall Study|Early study termination by participant|0|||
17119479|NCT04051944|38258432|FG000|Overall Study|Withdrawal by Subject|2|||
17119480|NCT04051944|38258433|FG001|Overall Study|Withdrawal by Subject|2|||
17119481|NCT04051944|38258432|FG000|Overall Study|Lack of Efficacy|3|||
17119482|NCT04051944|38258433|FG001|Overall Study|Lack of Efficacy|0|||
17119483|NCT04051944|38258432|FG000|Overall Study|Adverse event, non- fatal|1|||
17119484|NCT04051944|38258433|FG001|Overall Study|Adverse event, non- fatal|1|||
17119485|NCT04050618|38258441|FG000|First Intervention|Withdrawal by Subject|2|||
17119486|NCT04050618|38258442|FG001|First Intervention|Withdrawal by Subject|0|||
17119487|NCT04050618|38258441|FG000|Second Intervention|Withdrawal by Subject|1|||
17119488|NCT04050618|38258442|FG001|Second Intervention|Withdrawal by Subject|0|||
17119489|NCT04067492|38258459|FG000|Overall Study|Lost to Follow-up|0|||
17119490|NCT04067492|38258460|FG001|Overall Study|Lost to Follow-up|0|||
17119491|NCT04067492|38258461|FG002|Overall Study|Lost to Follow-up|0|||
17119492|NCT04067492|38258462|FG003|Overall Study|Lost to Follow-up|0|||
17119493|NCT04067492|38258463|FG004|Overall Study|Lost to Follow-up|0|||
17119494|NCT04067492|38258464|FG005|Overall Study|Lost to Follow-up|1|||
17119495|NCT04067492|38258459|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
17119496|NCT04067492|38258460|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
17119497|NCT04067492|38258461|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
17119498|NCT04067492|38258462|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
17119499|NCT04067492|38258463|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
17119500|NCT04067492|38258464|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
17119501|NCT04067492|38258459|FG000|Overall Study|COVID-19 epidemiological situation|0|||
17119502|NCT04067492|38258460|FG001|Overall Study|COVID-19 epidemiological situation|0|||
17119503|NCT04067492|38258461|FG002|Overall Study|COVID-19 epidemiological situation|0|||
17119504|NCT04067492|38258462|FG003|Overall Study|COVID-19 epidemiological situation|1|||
17119505|NCT04067492|38258463|FG004|Overall Study|COVID-19 epidemiological situation|0|||
17119506|NCT04067492|38258464|FG005|Overall Study|COVID-19 epidemiological situation|0|||
17119507|NCT04046250|38258480|FG000|Overall Study|Death|0|||
17119508|NCT04046250|38258481|FG001|Overall Study|Death|1|||
17119509|NCT04046250|38258480|FG000|Overall Study|Withdrawal by Subject|3|||
17119510|NCT04046250|38258481|FG001|Overall Study|Withdrawal by Subject|3|||
17119511|NCT04375878|38258491|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
17119512|NCT04375878|38258492|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
17119513|NCT04375878|38258493|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
17119514|NCT04375878|38258494|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
17119515|NCT04375878|38258495|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
17119516|NCT04375878|38258496|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
17119517|NCT04375878|38258491|FG000|Crossover First and Second Interventions|Adverse Event|0|||
17119518|NCT04375878|38258492|FG001|Crossover First and Second Interventions|Adverse Event|0|||
17119519|NCT04375878|38258493|FG002|Crossover First and Second Interventions|Adverse Event|1|||
17119520|NCT04375878|38258494|FG003|Crossover First and Second Interventions|Adverse Event|0|||
17119521|NCT04375878|38258495|FG004|Crossover First and Second Interventions|Adverse Event|0|||
17119522|NCT04375878|38258496|FG005|Crossover First and Second Interventions|Adverse Event|0|||
17119523|NCT04375878|38258491|FG000|Extension Phase|Withdrawal by Subject|0|||
17119524|NCT04375878|38258492|FG001|Extension Phase|Withdrawal by Subject|0|||
17119525|NCT04375878|38258493|FG002|Extension Phase|Withdrawal by Subject|0|||
17119526|NCT04375878|38258494|FG003|Extension Phase|Withdrawal by Subject|0|||
17119527|NCT04375878|38258495|FG004|Extension Phase|Withdrawal by Subject|1|||
17119528|NCT04375878|38258496|FG005|Extension Phase|Withdrawal by Subject|0|||
17119529|NCT04189224|38258516|FG000|Period 2|Adverse Event|0|||
17119530|NCT04189224|38258517|FG001|Period 2|Adverse Event|1|||
17119531|NCT04186806|38258525|FG000|Period 1: 7 Days|Adverse Event|1|||
17119532|NCT04186806|38258526|FG001|Period 1: 7 Days|Adverse Event|0|||
17119533|NCT04041414|38258535|FG000|Overall Study|Lost to Follow-up|1|||
17119534|NCT04041414|38258536|FG001|Overall Study|Lost to Follow-up|2|||
17119535|NCT04370028|38258545|FG000|Overall Study|Withdrawal by Subject|695|||
17119536|NCT04370028|38258545|FG000|Overall Study|Protocol Violation|9|||
17119537|NCT04370028|38258545|FG000|Overall Study|Adverse Event|3|||
17119538|NCT04037748|38258558|FG000|Treatment Period 1|Withdrawal by Subject|3|||
17119539|NCT04037748|38258559|FG001|Treatment Period 1|Withdrawal by Subject|0|||
17119540|NCT04037748|38258558|FG000|Treatment Period 1|Adverse Event|1|||
17119541|NCT04037748|38258559|FG001|Treatment Period 1|Adverse Event|1|||
17119542|NCT04037748|38258558|FG000|Treatment Period 1|Protocol Violation|4|||
17119543|NCT04037748|38258559|FG001|Treatment Period 1|Protocol Violation|5|||
17119544|NCT04037748|38258558|FG000|Treatment Period 2|Adverse Event|0|||
17119545|NCT04037748|38258559|FG001|Treatment Period 2|Adverse Event|1|||
17119546|NCT04037748|38258558|FG000|Treatment Period 2|Protocol Violation|2|||
17119547|NCT04037748|38258559|FG001|Treatment Period 2|Protocol Violation|0|||
17119548|NCT04036110|38258568|FG000|Overall Study|Lost to Follow-up|3|||
17119549|NCT04036110|38258569|FG001|Overall Study|Lost to Follow-up|2|||
17119550|NCT04036110|38258570|FG002|Overall Study|Lost to Follow-up|1|||
17119551|NCT04036110|38258568|FG000|Overall Study|Study Suspended|4|||
17119552|NCT04036110|38258569|FG001|Overall Study|Study Suspended|5|||
17119553|NCT04036110|38258570|FG002|Overall Study|Study Suspended|1|||
17119554|NCT03053050|38258581|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
17119555|NCT03053050|38258582|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
17119556|NCT03053050|38258583|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
17119557|NCT03053050|38258584|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
17119558|NCT03053050|38258581|FG000|Randomized Phase|Withdrew Consent|16|||
17119559|NCT03053050|38258582|FG001|Randomized Phase|Withdrew Consent|8|||
17119560|NCT03053050|38258583|FG002|Randomized Phase|Withdrew Consent|9|||
17119561|NCT03053050|38258584|FG003|Randomized Phase|Withdrew Consent|0|||
17119562|NCT03053050|38258581|FG000|Randomized Phase|Investigator's Discretion|6|||
17119563|NCT03053050|38258582|FG001|Randomized Phase|Investigator's Discretion|6|||
17119564|NCT03053050|38258583|FG002|Randomized Phase|Investigator's Discretion|3|||
17119565|NCT03053050|38258584|FG003|Randomized Phase|Investigator's Discretion|0|||
17119566|NCT03053050|38258581|FG000|Randomized Phase|Lost to Follow-up|5|||
17119567|NCT03053050|38258582|FG001|Randomized Phase|Lost to Follow-up|1|||
17119568|NCT03053050|38258583|FG002|Randomized Phase|Lost to Follow-up|1|||
17119569|NCT03053050|38258584|FG003|Randomized Phase|Lost to Follow-up|0|||
17119570|NCT03053050|38258581|FG000|Randomized Phase|Adverse Event|0|||
17119571|NCT03053050|38258582|FG001|Randomized Phase|Adverse Event|1|||
17119572|NCT03053050|38258583|FG002|Randomized Phase|Adverse Event|0|||
17119573|NCT03053050|38258584|FG003|Randomized Phase|Adverse Event|0|||
17119574|NCT03053050|38258581|FG000|Randomized Phase|Randomized but Never Treated|2|||
17119575|NCT03053050|38258582|FG001|Randomized Phase|Randomized but Never Treated|2|||
17119576|NCT03053050|38258583|FG002|Randomized Phase|Randomized but Never Treated|2|||
17119577|NCT03053050|38258584|FG003|Randomized Phase|Randomized but Never Treated|0|||
17119578|NCT03053050|38258581|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
17119579|NCT03053050|38258582|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
17119580|NCT03053050|38258583|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
17119581|NCT03053050|38258584|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
17119582|NCT03053050|38258581|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
17119583|NCT03053050|38258582|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
17119584|NCT03053050|38258583|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
17119585|NCT03053050|38258584|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
17119586|NCT03053050|38258581|FG000|Open-label Phase|Withdrew Consent|0|||
17119587|NCT03053050|38258582|FG001|Open-label Phase|Withdrew Consent|0|||
17119588|NCT03053050|38258583|FG002|Open-label Phase|Withdrew Consent|0|||
17119589|NCT03053050|38258584|FG003|Open-label Phase|Withdrew Consent|6|||
17119590|NCT03053050|38258581|FG000|Open-label Phase|Investigator's Discretion|0|||
17119591|NCT03053050|38258582|FG001|Open-label Phase|Investigator's Discretion|0|||
17119592|NCT03053050|38258583|FG002|Open-label Phase|Investigator's Discretion|0|||
17119593|NCT03053050|38258584|FG003|Open-label Phase|Investigator's Discretion|4|||
17119594|NCT04369950|38258595|FG000|Overall Study|Protocol Violation|2|||
17119595|NCT04369950|38258596|FG001|Overall Study|Protocol Violation|2|||
17119596|NCT04035564|38258604|FG000|Overall Study|Protocol Violation|1|||
17119597|NCT04035564|38258605|FG001|Overall Study|Protocol Violation|2|||
17119598|NCT04035564|38258604|FG000|Overall Study|No laboratory available|2|||
17119599|NCT04035564|38258605|FG001|Overall Study|No laboratory available|2|||
17119600|NCT04035564|38258604|FG000|Overall Study|Guardian declined consent|1|||
17119601|NCT04035564|38258605|FG001|Overall Study|Guardian declined consent|2|||
17119602|NCT02955602|38258614|FG000|Overall Study|Adverse Event|0|||
17119603|NCT02955602|38258615|FG001|Overall Study|Adverse Event|3|||
17119604|NCT02955602|38258616|FG002|Overall Study|Adverse Event|0|||
17119605|NCT02955602|38258614|FG000|Overall Study|Withdrawal of informed consent|1|||
17119606|NCT02955602|38258615|FG001|Overall Study|Withdrawal of informed consent|3|||
17119607|NCT02955602|38258616|FG002|Overall Study|Withdrawal of informed consent|2|||
17119608|NCT02955602|38258614|FG000|Overall Study|Lost to Follow-up|0|||
17119609|NCT02955602|38258615|FG001|Overall Study|Lost to Follow-up|0|||
17119610|NCT02955602|38258616|FG002|Overall Study|Lost to Follow-up|1|||
17119611|NCT02955602|38258614|FG000|Overall Study|Other|0|||
17119612|NCT02955602|38258615|FG001|Overall Study|Other|1|||
17119613|NCT02955602|38258616|FG002|Overall Study|Other|3|||
17119614|NCT04179786|38258624|FG000|Overall Study|Withdrawal by Subject|8|||
17119615|NCT03052816|38258630|FG000|Overall Study|Withdrawal by Subject|1|||
17119616|NCT03052816|38258631|FG001|Overall Study|Withdrawal by Subject|0|||
17119617|NCT03052816|38258630|FG000|Overall Study|Desired opioids|2|||
17119618|NCT03052816|38258631|FG001|Overall Study|Desired opioids|0|||
17119619|NCT04175808|38258639|FG000|Part A|Miscellaneous|2|||
17119620|NCT04175808|38258640|FG001|Part A|Miscellaneous|0|||
17119621|NCT04175808|38258641|FG002|Part A|Miscellaneous|0|||
17119622|NCT04175808|38258642|FG003|Part A|Miscellaneous|0|||
17119623|NCT04175808|38258643|FG004|Part A|Miscellaneous|0|||
17119624|NCT04175808|38258644|FG005|Part A|Miscellaneous|0|||
17119625|NCT04175808|38258645|FG006|Part A|Miscellaneous|0|||
17119626|NCT04057196|38258661|FG000|Overall Study|Withdrawal by Subject|3|||
17119627|NCT04057196|38258661|FG000|Overall Study|Death|3|||
17119628|NCT04027686|38258667|FG000|Overall Study|Lost to Follow-up|2|||
17119629|NCT04027686|38258668|FG001|Overall Study|Lost to Follow-up|0|||
17119630|NCT04027686|38258667|FG000|Overall Study|Withdrawal by Subject|0|||
17119631|NCT04027686|38258668|FG001|Overall Study|Withdrawal by Subject|1|||
17119632|NCT03052426|38258681|FG000|Overall Study|Withdrawal by Subject|0|||
17119633|NCT03052426|38258682|FG001|Overall Study|Withdrawal by Subject|1|||
17119634|NCT03052426|38258683|FG002|Overall Study|Withdrawal by Subject|0|||
17119635|NCT03052426|38258681|FG000|Overall Study|Lost to Follow-up|2|||
17119636|NCT03052426|38258682|FG001|Overall Study|Lost to Follow-up|0|||
16856738|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16856739|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16856740|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16856741|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16856742|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
16856743|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
16856744|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
16856745|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
16856746|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
16856747|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
16856748|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
16856749|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
16856750|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
16856751|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
16856752|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
16856753|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
16856754|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
17119637|NCT03052426|38258683|FG002|Overall Study|Lost to Follow-up|1|||
17119638|NCT03688880|38258698|FG000|Overall Study|Withdrawal by Subject|0|||
17119639|NCT03688880|38258699|FG001|Overall Study|Withdrawal by Subject|2|||
17119640|NCT03688880|38258698|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
17119641|NCT03688880|38258699|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
17119642|NCT03688880|38258698|FG000|Overall Study|Lost to Follow-up|4|||
17119643|NCT03688880|38258699|FG001|Overall Study|Lost to Follow-up|7|||
17119644|NCT03688880|38258698|FG000|Overall Study|Adverse Event|0|||
17119645|NCT03688880|38258699|FG001|Overall Study|Adverse Event|2|||
17119646|NCT03688880|38258698|FG000|Overall Study|Device deficiencies|0|||
17119647|NCT03688880|38258699|FG001|Overall Study|Device deficiencies|2|||
17119648|NCT03688880|38258698|FG000|Overall Study|Other|10|||
17119649|NCT03688880|38258699|FG001|Overall Study|Other|16|||
17119650|NCT03051178|38258705|FG000|Overall Study|Withdrawal by Subject|5|||
17119651|NCT03051100|38258711|FG000|Overall Study|Withdrawal by Subject|1|||
17119652|NCT03051100|38258712|FG001|Overall Study|Withdrawal by Subject|0|||
17119653|NCT01343368|38258720|FG000|Overall Study|Death|1|||
17119654|NCT01343368|38258721|FG001|Overall Study|Death|0|||
17119655|NCT01343368|38258720|FG000|Overall Study|Lost to Follow-up|1|||
17119656|NCT01343368|38258721|FG001|Overall Study|Lost to Follow-up|0|||
17119657|NCT02955212|38258729|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
17119658|NCT02955212|38258730|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
17119659|NCT02955212|38258729|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
17119660|NCT02955212|38258730|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
17119661|NCT02955212|38258729|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
17119662|NCT02955212|38258730|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
17119663|NCT02955212|38258729|FG000|Period 1: Double-blind Treatment Period|Other|3|||
17119664|NCT02955212|38258730|FG001|Period 1: Double-blind Treatment Period|Other|2|||
17119665|NCT02955212|38258729|FG000|Period 2: Open-label Extension|Adverse Event|11|||
17119666|NCT02955212|38258730|FG001|Period 2: Open-label Extension|Adverse Event|7|||
17119667|NCT02955212|38258729|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
17119668|NCT02955212|38258730|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
17119669|NCT02955212|38258729|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
17119670|NCT02955212|38258730|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
17119671|NCT02955212|38258729|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
17119672|NCT02955212|38258730|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
17119673|NCT02955212|38258729|FG000|Period 2: Open-label Extension|Other|2|||
17119674|NCT02955212|38258730|FG001|Period 2: Open-label Extension|Other|4|||
17119675|NCT03050398|38258737|FG000|Overall Study|Study terminated by sponsor|8|||
17119676|NCT03662750|38258741|FG000|Overall Study|Withdrawal by Subject|1|||
17119677|NCT04052204|38258745|FG000|Overall Study|Death|1|||
17119678|NCT04052204|38258746|FG001|Overall Study|Death|0|||
17119679|NCT04052204|38258747|FG002|Overall Study|Death|0|||
17119680|NCT04052204|38258745|FG000|Overall Study|Progressive disease|1|||
17119681|NCT04052204|38258746|FG001|Overall Study|Progressive disease|0|||
17119682|NCT04052204|38258747|FG002|Overall Study|Progressive disease|0|||
17119683|NCT04052204|38258745|FG000|Overall Study|Other|1|||
17119684|NCT04052204|38258746|FG001|Overall Study|Other|0|||
17119685|NCT04052204|38258747|FG002|Overall Study|Other|0|||
17119686|NCT04050722|38258753|FG000|Overall Study|Withdrawal by Subject|1|||
17119687|NCT04050722|38258754|FG001|Overall Study|Withdrawal by Subject|0|||
17119688|NCT04049552|38258760|FG000|Overall Study|Lost to Follow-up|1|||
17119689|NCT04093024|38258768|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
17119690|NCT04093024|38258769|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
17119691|NCT04093024|38258768|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
17119692|NCT04093024|38258769|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
17119693|NCT04093024|38258768|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
17119694|NCT04093024|38258769|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
17119695|NCT04093024|38258768|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
17119696|NCT04093024|38258769|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
17119697|NCT03048058|38258805|FG000|Overall Study|Lost to Follow-up|4|||
17119698|NCT03048058|38258806|FG001|Overall Study|Lost to Follow-up|0|||
17119699|NCT03048058|38258805|FG000|Overall Study|Withdrawal by Subject|0|||
17119700|NCT03048058|38258806|FG001|Overall Study|Withdrawal by Subject|4|||
17119701|NCT03047980|38258812|FG000|Overall Study|Adverse Event|1|||
17119702|NCT03631706|38258818|FG000|Overall Study|Randomized, not treated|1|||
17119703|NCT03631706|38258819|FG001|Overall Study|Randomized, not treated|0|||
17119704|NCT03631706|38258818|FG000|Overall Study|Treatment ongoing|26|||
17119705|NCT03631706|38258819|FG001|Overall Study|Treatment ongoing|57|||
17119706|NCT03631706|38258818|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
17119707|NCT03631706|38258819|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
17119708|NCT04048382|38258827|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
17119709|NCT04048382|38258828|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
17119710|NCT04048382|38258827|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
17119711|NCT04048382|38258828|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
17119712|NCT04048382|38258827|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
17119713|NCT04048382|38258828|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
17119714|NCT04047446|38258836|FG000|Overall Study|Physician Decision|1|||
17119715|NCT04047446|38258837|FG001|Overall Study|Physician Decision|0|||
17119716|NCT03655106|38258845|FG000|Overall Study|Withdrawal by Subject|3|||
17119717|NCT03655106|38258846|FG001|Overall Study|Withdrawal by Subject|2|||
17119718|NCT03655106|38258845|FG000|Overall Study|Lost to Follow-up|2|||
17119719|NCT03655106|38258846|FG001|Overall Study|Lost to Follow-up|1|||
17119720|NCT03655106|38258845|FG000|Overall Study|Duplicate Enrollment|1|||
17119721|NCT03655106|38258846|FG001|Overall Study|Duplicate Enrollment|1|||
17119722|NCT03655106|38258845|FG000|Overall Study|Protocol Violation|3|||
17119723|NCT03655106|38258846|FG001|Overall Study|Protocol Violation|0|||
17119724|NCT03630302|38258852|FG000|Surgery|hardware issue prevented LFP recordings|1|||
17119725|NCT03630302|38258852|FG000|3 Month Visit|Adverse Event|2|||
17119726|NCT03630302|38258852|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
17119727|NCT04041440|38258858|FG000|Overall Study|Withdrawal by Subject|0|||
17119728|NCT04041440|38258859|FG001|Overall Study|Withdrawal by Subject|1|||
17119729|NCT04041440|38258858|FG000|Overall Study|Lost to Follow-up|0|||
17119730|NCT04041440|38258859|FG001|Overall Study|Lost to Follow-up|1|||
17119731|NCT03654560|38258868|FG000|Overall Study|Death|3|||
17119732|NCT03654560|38258869|FG001|Overall Study|Death|1|||
17119733|NCT03654560|38258868|FG000|Overall Study|Lost to Follow-up|1|||
17119734|NCT03654560|38258869|FG001|Overall Study|Lost to Follow-up|0|||
17119735|NCT03629054|38258877|FG000|Period 2 (4 Days)|Not treated|0|||
17119736|NCT03629054|38258878|FG001|Period 2 (4 Days)|Not treated|1|||
17119737|NCT03628898|38258884|FG000|Overall Study|Device deficiency|1|||
17119738|NCT03628508|38258888|FG000|Overall Study|Lost to Follow-up|1|||
17119739|NCT03045328|38258892|FG000|Overall Study|Withdrawal by Subject|2|||
17119740|NCT02278120|38258898|FG000|Overall Study|Progressive disease|122|||
17119741|NCT02278120|38258899|FG001|Overall Study|Progressive disease|174|||
17119742|NCT02278120|38258898|FG000|Overall Study|Patient/guardian decision|14|||
17119743|NCT02278120|38258899|FG001|Overall Study|Patient/guardian decision|8|||
17119744|NCT02278120|38258898|FG000|Overall Study|Adverse Event|12|||
17119745|NCT02278120|38258899|FG001|Overall Study|Adverse Event|10|||
17119746|NCT02278120|38258898|FG000|Overall Study|Physician Decision|8|||
17119747|NCT02278120|38258899|FG001|Overall Study|Physician Decision|19|||
17119748|NCT02278120|38258898|FG000|Overall Study|Death|3|||
17119749|NCT02278120|38258899|FG001|Overall Study|Death|3|||
17119750|NCT02278120|38258898|FG000|Overall Study|Lost to Follow-up|2|||
17119751|NCT02278120|38258899|FG001|Overall Study|Lost to Follow-up|0|||
17119752|NCT02278120|38258898|FG000|Overall Study|Protocol Violation|0|||
17119753|NCT02278120|38258899|FG001|Overall Study|Protocol Violation|2|||
17119754|NCT02154490|38258907|FG000|Overall Study|No tissue submitted|23|||
17119755|NCT02154490|38258907|FG000|Overall Study|No biomarker results|167|||
17119756|NCT02154490|38258907|FG000|Overall Study|Not assigned to a sub-study|270|||
17119757|NCT02154490|38258907|FG000|Overall Study|Did not register to a sub-study|749|||
17119758|NCT01286272|38258913|FG000|Overall Study|Ineligible after beginning treatment|1|||
17119759|NCT01286272|38258914|FG001|Overall Study|Ineligible after beginning treatment|3|||
17119760|NCT03627494|38258932|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
17119761|NCT03627494|38258933|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119762|NCT03627494|38258934|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
17119763|NCT03627494|38258935|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119764|NCT03627494|38258936|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119765|NCT03627494|38258937|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119766|NCT03627494|38258938|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119767|NCT03627494|38258939|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119768|NCT03627494|38258940|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119769|NCT03627494|38258941|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119770|NCT03627494|38258942|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119771|NCT03627494|38258943|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
17119772|NCT03627494|38258932|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119773|NCT03627494|38258933|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119774|NCT03627494|38258934|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119775|NCT03627494|38258935|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119776|NCT03627494|38258936|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119777|NCT03627494|38258937|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119778|NCT03627494|38258938|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119779|NCT03627494|38258939|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119780|NCT03627494|38258940|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
17119781|NCT03627494|38258941|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119782|NCT03627494|38258942|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
16942086|NCT01335477|38086647|FG000|Overall Study|Not treated|1|||
17119783|NCT03627494|38258943|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
17119784|NCT03627494|38258932|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119785|NCT03627494|38258933|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119786|NCT03627494|38258934|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119787|NCT03627494|38258935|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119788|NCT03627494|38258936|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119789|NCT03627494|38258937|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119790|NCT03627494|38258938|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119791|NCT03627494|38258939|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119792|NCT03627494|38258940|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119793|NCT03627494|38258941|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
17119794|NCT03627494|38258942|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
17119795|NCT03627494|38258943|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
17119796|NCT03627416|38258984|FG000|Overall Study|Adverse Event|0|||
17119797|NCT03627416|38258985|FG001|Overall Study|Adverse Event|1|||
17119798|NCT00972478|38259002|FG000|Overall Study|Adverse Event|3|||
17119799|NCT00972478|38259003|FG001|Overall Study|Adverse Event|16|||
17119800|NCT00972478|38259002|FG000|Overall Study|Withdrawal by Subject|1|||
17119801|NCT00972478|38259003|FG001|Overall Study|Withdrawal by Subject|8|||
17119802|NCT00972478|38259002|FG000|Overall Study|Progression/Relapse|0|||
17119803|NCT00972478|38259003|FG001|Overall Study|Progression/Relapse|2|||
17119804|NCT00972478|38259002|FG000|Overall Study|Death|0|||
17119805|NCT00972478|38259003|FG001|Overall Study|Death|2|||
17119806|NCT00972478|38259002|FG000|Overall Study|Not protocol specified|1|||
17119807|NCT00972478|38259003|FG001|Overall Study|Not protocol specified|1|||
17119808|NCT00972478|38259002|FG000|Overall Study|Ineligible|1|||
17119809|NCT00972478|38259003|FG001|Overall Study|Ineligible|7|||
17119810|NCT00972478|38259002|FG000|Overall Study|Not start protocol treatment|1|||
17119811|NCT00972478|38259003|FG001|Overall Study|Not start protocol treatment|2|||
17119812|NCT00097539|38259034|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
17119813|NCT00097539|38259035|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
17119814|NCT00097539|38259036|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
17119815|NCT00097539|38259037|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
17119816|NCT00097539|38259038|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
17119817|NCT00097539|38259039|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
17119818|NCT00097539|38259040|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
17119819|NCT00097539|38259034|FG000|Overall Study|Withdrawal by Subject|925|||
17119820|NCT00097539|38259035|FG001|Overall Study|Withdrawal by Subject|323|||
17119821|NCT00097539|38259036|FG002|Overall Study|Withdrawal by Subject|346|||
17119822|NCT00097539|38259037|FG003|Overall Study|Withdrawal by Subject|217|||
17119823|NCT00097539|38259038|FG004|Overall Study|Withdrawal by Subject|68|||
17119824|NCT00097539|38259039|FG005|Overall Study|Withdrawal by Subject|229|||
17119825|NCT00097539|38259040|FG006|Overall Study|Withdrawal by Subject|3|||
17119826|NCT00097539|38259034|FG000|Overall Study|Participant Non-compliant|2140|||
17119827|NCT00097539|38259035|FG001|Overall Study|Participant Non-compliant|567|||
17119828|NCT00097539|38259036|FG002|Overall Study|Participant Non-compliant|1067|||
17119829|NCT00097539|38259037|FG003|Overall Study|Participant Non-compliant|353|||
17119830|NCT00097539|38259038|FG004|Overall Study|Participant Non-compliant|136|||
17119831|NCT00097539|38259039|FG005|Overall Study|Participant Non-compliant|543|||
17119832|NCT00097539|38259040|FG006|Overall Study|Participant Non-compliant|18|||
17119833|NCT00097539|38259034|FG000|Overall Study|Lack of Efficacy|249|||
17119834|NCT00097539|38259035|FG001|Overall Study|Lack of Efficacy|122|||
17119835|NCT00097539|38259036|FG002|Overall Study|Lack of Efficacy|202|||
17119836|NCT00097539|38259037|FG003|Overall Study|Lack of Efficacy|105|||
17119837|NCT00097539|38259038|FG004|Overall Study|Lack of Efficacy|45|||
17119838|NCT00097539|38259039|FG005|Overall Study|Lack of Efficacy|228|||
17119839|NCT00097539|38259040|FG006|Overall Study|Lack of Efficacy|5|||
17119840|NCT00097539|38259034|FG000|Overall Study|Adverse Event|78|||
17119841|NCT00097539|38259035|FG001|Overall Study|Adverse Event|133|||
17119842|NCT00097539|38259036|FG002|Overall Study|Adverse Event|37|||
17119843|NCT00097539|38259037|FG003|Overall Study|Adverse Event|27|||
17119844|NCT00097539|38259038|FG004|Overall Study|Adverse Event|30|||
17119845|NCT00097539|38259039|FG005|Overall Study|Adverse Event|59|||
17119846|NCT00097539|38259040|FG006|Overall Study|Adverse Event|1|||
17119847|NCT00097539|38259034|FG000|Overall Study|Death|2|||
17119848|NCT00097539|38259035|FG001|Overall Study|Death|7|||
17119849|NCT00097539|38259036|FG002|Overall Study|Death|0|||
17119850|NCT00097539|38259037|FG003|Overall Study|Death|0|||
17119851|NCT00097539|38259038|FG004|Overall Study|Death|1|||
17119852|NCT00097539|38259039|FG005|Overall Study|Death|3|||
17119853|NCT00097539|38259040|FG006|Overall Study|Death|0|||
17119854|NCT00097539|38259034|FG000|Overall Study|Reasons Other Than Above|3602|||
17119855|NCT00097539|38259035|FG001|Overall Study|Reasons Other Than Above|1382|||
17119856|NCT00097539|38259036|FG002|Overall Study|Reasons Other Than Above|1757|||
17119857|NCT00097539|38259037|FG003|Overall Study|Reasons Other Than Above|692|||
17119858|NCT00097539|38259038|FG004|Overall Study|Reasons Other Than Above|361|||
17119859|NCT00097539|38259039|FG005|Overall Study|Reasons Other Than Above|1244|||
17119860|NCT00097539|38259040|FG006|Overall Study|Reasons Other Than Above|34|||
17119861|NCT00097539|38259034|FG000|Overall Study|Reason not Specified|111|||
17119862|NCT00097539|38259035|FG001|Overall Study|Reason not Specified|49|||
17119863|NCT00097539|38259036|FG002|Overall Study|Reason not Specified|53|||
17119864|NCT00097539|38259037|FG003|Overall Study|Reason not Specified|21|||
17119865|NCT00097539|38259038|FG004|Overall Study|Reason not Specified|11|||
17119866|NCT00097539|38259039|FG005|Overall Study|Reason not Specified|40|||
17119867|NCT00097539|38259040|FG006|Overall Study|Reason not Specified|2|||
17119868|NCT03925324|38259058|FG000|Overall Study|Death|1|||
17119869|NCT03925324|38259059|FG001|Overall Study|Death|1|||
17119870|NCT03042910|38259065|FG000|Overall Study|Adverse Event|1|||
17119871|NCT03042910|38259065|FG000|Overall Study|Disease Progression|2|||
17119872|NCT03042910|38259065|FG000|Overall Study|Withdrawal by Subject|3|||
17119873|NCT03042910|38259065|FG000|Overall Study|Enrolled but not treated|1|||
17119874|NCT03059446|38259069|FG000|Overall Study|Adverse Event|11|||
17119875|NCT03059446|38259069|FG000|Overall Study|Withdrawal of Consent|16|||
17119876|NCT03059446|38259069|FG000|Overall Study|Lost to Follow-up|3|||
17119877|NCT03059446|38259069|FG000|Overall Study|Protocol Violation|1|||
17119878|NCT03059446|38259069|FG000|Overall Study|Study Terminated by Sponsor|131|||
17119879|NCT03059446|38259069|FG000|Overall Study|Reason not Specified|5|||
17119880|NCT00090519|38259075|FG000|Overall Study|Adverse Event|5|||
17119881|NCT00090519|38259076|FG001|Overall Study|Adverse Event|4|||
17119882|NCT00090519|38259075|FG000|Overall Study|Death|9|||
17119883|NCT00090519|38259076|FG001|Overall Study|Death|9|||
17119884|NCT00090519|38259075|FG000|Overall Study|Lost to Follow-up|26|||
17119885|NCT00090519|38259076|FG001|Overall Study|Lost to Follow-up|29|||
17119886|NCT00090519|38259075|FG000|Overall Study|Withdrawal by Subject|28|||
17119887|NCT00090519|38259076|FG001|Overall Study|Withdrawal by Subject|29|||
17119888|NCT00090519|38259075|FG000|Overall Study|Physician Decision|2|||
17119889|NCT00090519|38259076|FG001|Overall Study|Physician Decision|3|||
17119890|NCT00090519|38259075|FG000|Overall Study|Sponsor Decision|3|||
17119891|NCT00090519|38259076|FG001|Overall Study|Sponsor Decision|1|||
17119892|NCT00096993|38259106|FG000|Overall Study|Death|1|||
17119893|NCT00096993|38259107|FG001|Overall Study|Death|0|||
17119894|NCT00096993|38259106|FG000|Overall Study|Disease progression|56|||
17119895|NCT00096993|38259107|FG001|Overall Study|Disease progression|53|||
17119896|NCT00096993|38259106|FG000|Overall Study|Adverse Event|2|||
17119897|NCT00096993|38259107|FG001|Overall Study|Adverse Event|8|||
17119898|NCT00096993|38259106|FG000|Overall Study|Subject's decision|3|||
17119899|NCT00096993|38259107|FG001|Overall Study|Subject's decision|1|||
17119900|NCT00096993|38259106|FG000|Overall Study|Physician Decision|2|||
17119901|NCT00096993|38259107|FG001|Overall Study|Physician Decision|1|||
17119902|NCT00096993|38259106|FG000|Overall Study|Non-compliance|0|||
17119903|NCT00096993|38259107|FG001|Overall Study|Non-compliance|1|||
17119904|NCT00096993|38259106|FG000|Overall Study|Other unspecified|1|||
17119905|NCT00096993|38259107|FG001|Overall Study|Other unspecified|1|||
17119906|NCT03040336|38259115|FG000|Overall Study|Death|1|||
17119907|NCT03040336|38259116|FG001|Overall Study|Death|0|||
17119908|NCT03040336|38259115|FG000|Overall Study|Withdrawal by Subject|2|||
17119909|NCT03040336|38259116|FG001|Overall Study|Withdrawal by Subject|3|||
17119910|NCT00072189|38259123|FG000|Overall Study|Withdrawal by Subject|1|||
17119911|NCT03040024|38259130|FG000|Overall Study|Adverse Event|0|||
17119912|NCT03040024|38259131|FG001|Overall Study|Adverse Event|1|||
17119913|NCT03040024|38259132|FG002|Overall Study|Adverse Event|0|||
17119914|NCT03040024|38259130|FG000|Overall Study|Death|0|||
17119915|NCT03040024|38259131|FG001|Overall Study|Death|1|||
17119916|NCT03040024|38259132|FG002|Overall Study|Death|0|||
17119917|NCT03040024|38259130|FG000|Overall Study|Physician Decision|0|||
17119918|NCT03040024|38259131|FG001|Overall Study|Physician Decision|0|||
17119919|NCT03040024|38259132|FG002|Overall Study|Physician Decision|1|||
17119920|NCT03039790|38259160|FG000|Overall Study|Lost to Follow-up|2|||
17119921|NCT03039790|38259161|FG001|Overall Study|Lost to Follow-up|0|||
17119922|NCT03039790|38259162|FG002|Overall Study|Lost to Follow-up|1|||
17119923|NCT03039790|38259163|FG003|Overall Study|Lost to Follow-up|1|||
17119924|NCT03039790|38259164|FG004|Overall Study|Lost to Follow-up|0|||
17119925|NCT03039790|38259165|FG005|Overall Study|Lost to Follow-up|1|||
17119926|NCT03039790|38259166|FG006|Overall Study|Lost to Follow-up|1|||
17119927|NCT03039790|38259167|FG007|Overall Study|Lost to Follow-up|1|||
17119928|NCT03039790|38259168|FG008|Overall Study|Lost to Follow-up|0|||
17119929|NCT03039790|38259169|FG009|Overall Study|Lost to Follow-up|1|||
17119930|NCT03039790|38259170|FG010|Overall Study|Lost to Follow-up|1|||
17119931|NCT03039790|38259171|FG011|Overall Study|Lost to Follow-up|0|||
17119932|NCT03039790|38259172|FG012|Overall Study|Lost to Follow-up|1|||
17119933|NCT03039790|38259173|FG013|Overall Study|Lost to Follow-up|0|||
17119934|NCT03039790|38259174|FG014|Overall Study|Lost to Follow-up|3|||
17119935|NCT03039790|38259175|FG015|Overall Study|Lost to Follow-up|1|||
17119936|NCT03039790|38259176|FG016|Overall Study|Lost to Follow-up|2|||
17119937|NCT03039790|38259177|FG017|Overall Study|Lost to Follow-up|2|||
17119938|NCT03039790|38259178|FG018|Overall Study|Lost to Follow-up|1|||
17119939|NCT03039790|38259179|FG019|Overall Study|Lost to Follow-up|3|||
17119940|NCT03039790|38259160|FG000|Overall Study|Withdrawal of Consent|1|||
17119941|NCT03039790|38259161|FG001|Overall Study|Withdrawal of Consent|0|||
17119942|NCT03039790|38259162|FG002|Overall Study|Withdrawal of Consent|0|||
17119943|NCT03039790|38259163|FG003|Overall Study|Withdrawal of Consent|1|||
17119944|NCT03039790|38259164|FG004|Overall Study|Withdrawal of Consent|0|||
17119945|NCT03039790|38259165|FG005|Overall Study|Withdrawal of Consent|0|||
17119946|NCT03039790|38259166|FG006|Overall Study|Withdrawal of Consent|0|||
17119947|NCT03039790|38259167|FG007|Overall Study|Withdrawal of Consent|0|||
17119948|NCT03039790|38259168|FG008|Overall Study|Withdrawal of Consent|0|||
17119949|NCT03039790|38259169|FG009|Overall Study|Withdrawal of Consent|1|||
17119950|NCT03039790|38259170|FG010|Overall Study|Withdrawal of Consent|0|||
17119951|NCT03039790|38259171|FG011|Overall Study|Withdrawal of Consent|0|||
17119952|NCT03039790|38259172|FG012|Overall Study|Withdrawal of Consent|2|||
17119953|NCT03039790|38259173|FG013|Overall Study|Withdrawal of Consent|0|||
17119954|NCT03039790|38259174|FG014|Overall Study|Withdrawal of Consent|1|||
17119955|NCT03039790|38259175|FG015|Overall Study|Withdrawal of Consent|5|||
17119956|NCT03039790|38259176|FG016|Overall Study|Withdrawal of Consent|3|||
17119957|NCT03039790|38259177|FG017|Overall Study|Withdrawal of Consent|0|||
17119958|NCT03039790|38259178|FG018|Overall Study|Withdrawal of Consent|2|||
17119959|NCT03039790|38259179|FG019|Overall Study|Withdrawal of Consent|5|||
17119960|NCT03039790|38259160|FG000|Overall Study|Death|0|||
17119961|NCT03039790|38259161|FG001|Overall Study|Death|0|||
17119962|NCT03039790|38259162|FG002|Overall Study|Death|0|||
17119963|NCT03039790|38259163|FG003|Overall Study|Death|0|||
17119964|NCT03039790|38259164|FG004|Overall Study|Death|0|||
17119965|NCT03039790|38259165|FG005|Overall Study|Death|0|||
17119966|NCT03039790|38259166|FG006|Overall Study|Death|0|||
17119967|NCT03039790|38259167|FG007|Overall Study|Death|0|||
17119968|NCT03039790|38259168|FG008|Overall Study|Death|0|||
17119969|NCT03039790|38259169|FG009|Overall Study|Death|0|||
17119970|NCT03039790|38259170|FG010|Overall Study|Death|0|||
17119971|NCT03039790|38259171|FG011|Overall Study|Death|0|||
17119972|NCT03039790|38259172|FG012|Overall Study|Death|0|||
17119973|NCT03039790|38259173|FG013|Overall Study|Death|0|||
17119974|NCT03039790|38259174|FG014|Overall Study|Death|0|||
17119975|NCT03039790|38259175|FG015|Overall Study|Death|1|||
17119976|NCT03039790|38259176|FG016|Overall Study|Death|3|||
17119977|NCT03039790|38259177|FG017|Overall Study|Death|0|||
17119978|NCT03039790|38259178|FG018|Overall Study|Death|2|||
17119979|NCT03039790|38259179|FG019|Overall Study|Death|0|||
17119980|NCT03039790|38259160|FG000|Overall Study|Reason, not Specified|1|||
17119981|NCT03039790|38259161|FG001|Overall Study|Reason, not Specified|0|||
17119982|NCT03039790|38259162|FG002|Overall Study|Reason, not Specified|0|||
17119983|NCT03039790|38259163|FG003|Overall Study|Reason, not Specified|0|||
17119984|NCT03039790|38259164|FG004|Overall Study|Reason, not Specified|0|||
17119985|NCT03039790|38259165|FG005|Overall Study|Reason, not Specified|0|||
17119986|NCT03039790|38259166|FG006|Overall Study|Reason, not Specified|0|||
17119987|NCT03039790|38259167|FG007|Overall Study|Reason, not Specified|0|||
17119988|NCT03039790|38259168|FG008|Overall Study|Reason, not Specified|0|||
17119989|NCT03039790|38259169|FG009|Overall Study|Reason, not Specified|0|||
17119990|NCT03039790|38259170|FG010|Overall Study|Reason, not Specified|0|||
17119991|NCT03039790|38259171|FG011|Overall Study|Reason, not Specified|0|||
17119992|NCT03039790|38259172|FG012|Overall Study|Reason, not Specified|0|||
17119993|NCT03039790|38259173|FG013|Overall Study|Reason, not Specified|0|||
17119994|NCT03039790|38259174|FG014|Overall Study|Reason, not Specified|0|||
17119995|NCT03039790|38259175|FG015|Overall Study|Reason, not Specified|0|||
17119996|NCT03039790|38259176|FG016|Overall Study|Reason, not Specified|2|||
17119997|NCT03039790|38259177|FG017|Overall Study|Reason, not Specified|0|||
17119998|NCT03039790|38259178|FG018|Overall Study|Reason, not Specified|1|||
16942087|NCT01335477|38086648|FG001|Overall Study|Not treated|2|||
17119999|NCT03039790|38259179|FG019|Overall Study|Reason, not Specified|0|||
17120000|NCT03038620|38259252|FG000|Overall Study|Lost to Follow-up|18|||
17120001|NCT03038620|38259253|FG001|Overall Study|Lost to Follow-up|23|||
17120002|NCT03038620|38259252|FG000|Overall Study|Withdrawal by Subject|0|||
17120003|NCT03038620|38259253|FG001|Overall Study|Withdrawal by Subject|15|||
17120004|NCT03038620|38259252|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
17120005|NCT03038620|38259253|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
17120006|NCT01350934|38259274|FG000|Base Study|Adverse Event|6|||
17120007|NCT01350934|38259275|FG001|Base Study|Adverse Event|0|||
17120008|NCT01350934|38259274|FG000|Base Study|Lost to Follow-up|1|||
17120009|NCT01350934|38259275|FG001|Base Study|Lost to Follow-up|0|||
17120010|NCT01350934|38259274|FG000|Base Study|Protocol Violation|1|||
17120011|NCT01350934|38259275|FG001|Base Study|Protocol Violation|1|||
17120012|NCT01350934|38259274|FG000|Base Study|Withdrawal by Subject|1|||
17120013|NCT01350934|38259275|FG001|Base Study|Withdrawal by Subject|2|||
17120014|NCT01350934|38259274|FG000|Base Study|Non-Compliance With Study Drug|2|||
17120015|NCT01350934|38259275|FG001|Base Study|Non-Compliance With Study Drug|0|||
17120016|NCT01350934|38259274|FG000|Extension Study|Adverse Event|2|||
17120017|NCT01350934|38259275|FG001|Extension Study|Adverse Event|1|||
17120018|NCT01350934|38259274|FG000|Extension Study|Lost to Follow-up|2|||
17120019|NCT01350934|38259275|FG001|Extension Study|Lost to Follow-up|0|||
17120020|NCT01350934|38259274|FG000|Extension Study|Protocol Violation|1|||
17120021|NCT01350934|38259275|FG001|Extension Study|Protocol Violation|1|||
17120022|NCT01350934|38259274|FG000|Extension Study|Lack of Efficacy|0|||
17120023|NCT01350934|38259275|FG001|Extension Study|Lack of Efficacy|1|||
17120024|NCT01350934|38259274|FG000|Extension Study|Withdrawal by Subject|0|||
17120025|NCT01350934|38259275|FG001|Extension Study|Withdrawal by Subject|1|||
17120026|NCT03622580|38259299|FG000|Overall Study|Death|16|||
17120027|NCT03622580|38259300|FG001|Overall Study|Death|21|||
17120028|NCT03622580|38259301|FG002|Overall Study|Death|13|||
17120029|NCT03622580|38259299|FG000|Overall Study|Adverse Event|6|||
17120030|NCT03622580|38259300|FG001|Overall Study|Adverse Event|6|||
17120031|NCT03622580|38259301|FG002|Overall Study|Adverse Event|5|||
17120032|NCT03622580|38259299|FG000|Overall Study|Withdrawal by Subject|12|||
17120033|NCT03622580|38259300|FG001|Overall Study|Withdrawal by Subject|7|||
17120034|NCT03622580|38259301|FG002|Overall Study|Withdrawal by Subject|19|||
17120035|NCT03622580|38259299|FG000|Overall Study|Lost to Follow-up|12|||
17120036|NCT03622580|38259300|FG001|Overall Study|Lost to Follow-up|9|||
17120037|NCT03622580|38259301|FG002|Overall Study|Lost to Follow-up|9|||
17120038|NCT03622580|38259299|FG000|Overall Study|Protocol Violation|1|||
17120039|NCT03622580|38259300|FG001|Overall Study|Protocol Violation|0|||
17120040|NCT03622580|38259301|FG002|Overall Study|Protocol Violation|1|||
17120041|NCT03622580|38259299|FG000|Overall Study|Physician Decision|3|||
17120042|NCT03622580|38259300|FG001|Overall Study|Physician Decision|0|||
17120043|NCT03622580|38259301|FG002|Overall Study|Physician Decision|1|||
17120044|NCT03622580|38259299|FG000|Overall Study|Pregnancy|0|||
17120045|NCT03622580|38259300|FG001|Overall Study|Pregnancy|1|||
17120046|NCT03622580|38259301|FG002|Overall Study|Pregnancy|0|||
17120047|NCT03622580|38259299|FG000|Overall Study|Lack of Efficacy|0|||
17120048|NCT03622580|38259300|FG001|Overall Study|Lack of Efficacy|0|||
17120049|NCT03622580|38259301|FG002|Overall Study|Lack of Efficacy|1|||
17120050|NCT03622580|38259299|FG000|Overall Study|Other|2|||
17120051|NCT03622580|38259300|FG001|Overall Study|Other|0|||
17120052|NCT03622580|38259301|FG002|Overall Study|Other|3|||
17120053|NCT00461032|38259312|FG000|Overall Study|Adverse Event|5|||
17120054|NCT00461032|38259313|FG001|Overall Study|Adverse Event|6|||
17120055|NCT00461032|38259312|FG000|Overall Study|Lack of Efficacy|5|||
17120056|NCT00461032|38259313|FG001|Overall Study|Lack of Efficacy|1|||
17120057|NCT00461032|38259312|FG000|Overall Study|Lost to Follow-up|7|||
17120058|NCT00461032|38259313|FG001|Overall Study|Lost to Follow-up|12|||
17120059|NCT00461032|38259312|FG000|Overall Study|Protocol Violation|4|||
17120060|NCT00461032|38259313|FG001|Overall Study|Protocol Violation|4|||
17120061|NCT00461032|38259312|FG000|Overall Study|Withdrawal by Subject|7|||
17120062|NCT00461032|38259313|FG001|Overall Study|Withdrawal by Subject|15|||
17120063|NCT00461032|38259312|FG000|Overall Study|Patient Moved or Relocated|2|||
17120064|NCT00461032|38259313|FG001|Overall Study|Patient Moved or Relocated|1|||
17120065|NCT00461032|38259312|FG000|Overall Study|Other|7|||
17120066|NCT00461032|38259313|FG001|Overall Study|Other|5|||
17120067|NCT00090142|38259319|FG000|Treatment Period I|Lost to Follow-up|1|||
17120068|NCT00090142|38259320|FG001|Treatment Period I|Lost to Follow-up|2|||
17120069|NCT00090142|38259319|FG000|Treatment Period I|Protocol Violation|2|||
17120070|NCT00090142|38259320|FG001|Treatment Period I|Protocol Violation|0|||
17120071|NCT00090142|38259319|FG000|Treatment Period I|Withdrawal by Subject|2|||
17120072|NCT00090142|38259320|FG001|Treatment Period I|Withdrawal by Subject|0|||
17120073|NCT00090142|38259319|FG000|Treatment Period I|Other|0|||
17120074|NCT00090142|38259320|FG001|Treatment Period I|Other|1|||
17120075|NCT00090142|38259319|FG000|Treatment Period II|Other|1|||
17120076|NCT00090142|38259320|FG001|Treatment Period II|Other|0|||
17120077|NCT03622112|38259337|FG000|Overall Study|Withdrawal by Subject|6|||
16942088|NCT01335477|38086647|FG000|Overall Study|Reason other than those stated above|2|||
16942089|NCT01335477|38086648|FG001|Overall Study|Reason other than those stated above|2|||
17120078|NCT03622112|38259338|FG001|Overall Study|Withdrawal by Subject|2|||
17120079|NCT03622112|38259339|FG002|Overall Study|Withdrawal by Subject|4|||
17120080|NCT03622112|38259340|FG003|Overall Study|Withdrawal by Subject|2|||
17120081|NCT03622112|38259341|FG004|Overall Study|Withdrawal by Subject|1|||
17120082|NCT03622112|38259342|FG005|Overall Study|Withdrawal by Subject|2|||
17120083|NCT03622112|38259343|FG006|Overall Study|Withdrawal by Subject|2|||
17120084|NCT03622112|38259337|FG000|Overall Study|Death|0|||
17120085|NCT03622112|38259338|FG001|Overall Study|Death|0|||
17120086|NCT03622112|38259339|FG002|Overall Study|Death|0|||
17120087|NCT03622112|38259340|FG003|Overall Study|Death|1|||
17120088|NCT03622112|38259341|FG004|Overall Study|Death|0|||
17120089|NCT03622112|38259342|FG005|Overall Study|Death|0|||
17120090|NCT03622112|38259343|FG006|Overall Study|Death|0|||
17120091|NCT03622112|38259337|FG000|Overall Study|Lost to Follow-up|1|||
17120092|NCT03622112|38259338|FG001|Overall Study|Lost to Follow-up|1|||
17120093|NCT03622112|38259339|FG002|Overall Study|Lost to Follow-up|0|||
17120094|NCT03622112|38259340|FG003|Overall Study|Lost to Follow-up|0|||
17120095|NCT03622112|38259341|FG004|Overall Study|Lost to Follow-up|0|||
17120096|NCT03622112|38259342|FG005|Overall Study|Lost to Follow-up|0|||
17120097|NCT03622112|38259343|FG006|Overall Study|Lost to Follow-up|0|||
17120098|NCT03622112|38259337|FG000|Overall Study|Study-specific withdrawal criteria|10|||
17120099|NCT03622112|38259338|FG001|Overall Study|Study-specific withdrawal criteria|8|||
16773083|NCT02228980|37712060|FG002|Overall Study|Withdrawal by Subject|2|||
16773084|NCT02228980|37712061|FG003|Overall Study|Withdrawal by Subject|3|||
16773085|NCT02228590|37712075|FG000|Overall Study|Withdrawal by Subject|1|||
16773086|NCT02227108|37712080|FG000|Overall Study|Did not receive treatment|2|||
16773087|NCT02227108|37712080|FG000|Overall Study|Other|3|||
16773088|NCT02227108|37712080|FG000|Overall Study|Progressive disease|17|||
16773089|NCT02227108|37712080|FG000|Overall Study|Initiation of alternative therapy|2|||
16773090|NCT02227108|37712080|FG000|Overall Study|Investigator discretion|1|||
16773091|NCT02227108|37712080|FG000|Overall Study|Adverse Event|6|||
16773092|NCT03564145|37712084|FG000|Overall Study|Adverse Event|4|||
16773093|NCT03564145|37712084|FG000|Overall Study|Lost to Follow-up|21|||
16773094|NCT03564145|37712084|FG000|Overall Study|Protocol Violation|2|||
16773095|NCT03564145|37712084|FG000|Overall Study|Withdrawal by Subject|48|||
16773096|NCT03564145|37712084|FG000|Overall Study|Study Terminated by Sponsor|146|||
16773097|NCT03564145|37712084|FG000|Overall Study|Physician Decision|1|||
16773098|NCT03564145|37712084|FG000|Overall Study|Other Than Specified|1|||
16773099|NCT03564145|37712084|FG000|Overall Study|Pregnancy|1|||
16773100|NCT02226562|37712090|FG000|Overall Study|Lost to Follow-up|0|||
16773101|NCT02226562|37712091|FG001|Overall Study|Lost to Follow-up|1|||
16773102|NCT02456636|37712125|FG000|Overall Study|Death|0|||
16773103|NCT02456636|37712126|FG001|Overall Study|Death|3|||
16773104|NCT02456636|37712127|FG002|Overall Study|Death|0|||
16773105|NCT02456636|37712125|FG000|Overall Study|Pregnancy|1|||
16773106|NCT02456636|37712126|FG001|Overall Study|Pregnancy|3|||
16773107|NCT02456636|37712127|FG002|Overall Study|Pregnancy|5|||
16773108|NCT02456636|37712125|FG000|Overall Study|Physician Decision|4|||
16773109|NCT02456636|37712126|FG001|Overall Study|Physician Decision|5|||
16773110|NCT02456636|37712127|FG002|Overall Study|Physician Decision|4|||
16773111|NCT02456636|37712125|FG000|Overall Study|Withdrawal by Subject|13|||
16773112|NCT02456636|37712126|FG001|Overall Study|Withdrawal by Subject|14|||
16773113|NCT02456636|37712127|FG002|Overall Study|Withdrawal by Subject|16|||
16773114|NCT02456636|37712125|FG000|Overall Study|Lost to Follow-up|50|||
16773115|NCT02456636|37712126|FG001|Overall Study|Lost to Follow-up|44|||
17120100|NCT03622112|38259339|FG002|Overall Study|Study-specific withdrawal criteria|7|||
16773116|NCT02456636|37712127|FG002|Overall Study|Lost to Follow-up|50|||
16773117|NCT02226172|37712135|FG000|Overall Study|Participant refused further follow-up|4|||
17120101|NCT03622112|38259340|FG003|Overall Study|Study-specific withdrawal criteria|6|||
17120102|NCT03622112|38259341|FG004|Overall Study|Study-specific withdrawal criteria|4|||
17120103|NCT03622112|38259342|FG005|Overall Study|Study-specific withdrawal criteria|18|||
17120104|NCT03622112|38259343|FG006|Overall Study|Study-specific withdrawal criteria|4|||
17120105|NCT03622112|38259337|FG000|Overall Study|Protocol Violation|2|||
17120106|NCT03622112|38259338|FG001|Overall Study|Protocol Violation|0|||
17120107|NCT03622112|38259339|FG002|Overall Study|Protocol Violation|1|||
17120108|NCT03622112|38259340|FG003|Overall Study|Protocol Violation|1|||
17120109|NCT03622112|38259341|FG004|Overall Study|Protocol Violation|0|||
17120110|NCT03622112|38259342|FG005|Overall Study|Protocol Violation|0|||
17120111|NCT03622112|38259343|FG006|Overall Study|Protocol Violation|0|||
17120112|NCT03622112|38259337|FG000|Overall Study|Adverse Event|6|||
17120113|NCT03622112|38259338|FG001|Overall Study|Adverse Event|8|||
17120114|NCT03622112|38259339|FG002|Overall Study|Adverse Event|4|||
17120115|NCT03622112|38259340|FG003|Overall Study|Adverse Event|11|||
17120116|NCT03622112|38259341|FG004|Overall Study|Adverse Event|4|||
17120117|NCT03622112|38259342|FG005|Overall Study|Adverse Event|20|||
17120118|NCT03622112|38259343|FG006|Overall Study|Adverse Event|2|||
17120119|NCT03622112|38259337|FG000|Overall Study|Reason not specified|0|||
17120120|NCT03622112|38259338|FG001|Overall Study|Reason not specified|1|||
17120121|NCT03622112|38259339|FG002|Overall Study|Reason not specified|0|||
17120122|NCT03622112|38259340|FG003|Overall Study|Reason not specified|1|||
17120123|NCT03622112|38259341|FG004|Overall Study|Reason not specified|1|||
17120124|NCT03622112|38259342|FG005|Overall Study|Reason not specified|2|||
17120125|NCT03622112|38259343|FG006|Overall Study|Reason not specified|1|||
17120126|NCT04032158|38259361|FG000|Overall Study|Study Termination|2|||
17120127|NCT04032158|38259362|FG001|Overall Study|Study Termination|1|||
17120128|NCT04030598|38259371|FG000|Overall Study|Voluntary Withdrawal|0|||
17120129|NCT04030598|38259372|FG001|Overall Study|Voluntary Withdrawal|1|||
17120130|NCT04030598|38259373|FG002|Overall Study|Voluntary Withdrawal|0|||
17120131|NCT03654404|38259381|FG000|Overall Study|Death|1|||
17120132|NCT03654404|38259381|FG000|Overall Study|Lost to Follow-up|2|||
17120133|NCT03654404|38259381|FG000|Overall Study|Withdrawal by Subject|5|||
17120134|NCT03620708|38259388|FG000|Overall Study|Lost to Follow-up|1|||
17120135|NCT03620708|38259389|FG001|Overall Study|Lost to Follow-up|1|||
17120136|NCT03620708|38259390|FG002|Overall Study|Lost to Follow-up|2|||
17120137|NCT03620708|38259388|FG000|Overall Study|Withdrawal by Subject|0|||
17120138|NCT03620708|38259389|FG001|Overall Study|Withdrawal by Subject|0|||
17120139|NCT03620708|38259390|FG002|Overall Study|Withdrawal by Subject|1|||
17120140|NCT03654326|38259400|FG000|Overall Study|Withdrawal by Subject|5|||
17120141|NCT03654326|38259401|FG001|Overall Study|Withdrawal by Subject|3|||
17120142|NCT03654326|38259400|FG000|Overall Study|Physician Decision|0|||
17120143|NCT03654326|38259401|FG001|Overall Study|Physician Decision|1|||
17120144|NCT03654326|38259400|FG000|Overall Study|Unable to adhere to study schedule|0|||
17120145|NCT03654326|38259401|FG001|Overall Study|Unable to adhere to study schedule|1|||
17120146|NCT03654326|38259400|FG000|Overall Study|Lost to Follow-up|1|||
17120147|NCT03654326|38259401|FG001|Overall Study|Lost to Follow-up|1|||
17120148|NCT04025684|38259411|FG000|Overall Study|Withdrawal by Subject|1|||
17120149|NCT04025684|38259412|FG001|Overall Study|Withdrawal by Subject|1|||
17120150|NCT04025684|38259413|FG002|Overall Study|Withdrawal by Subject|0|||
17120151|NCT04025684|38259414|FG003|Overall Study|Withdrawal by Subject|0|||
17120152|NCT04025684|38259411|FG000|Overall Study|Multiple reasons|1|||
17120153|NCT04025684|38259412|FG001|Overall Study|Multiple reasons|3|||
17120154|NCT04025684|38259413|FG002|Overall Study|Multiple reasons|0|||
17120155|NCT04025684|38259414|FG003|Overall Study|Multiple reasons|1|||
17120156|NCT03617588|38259426|FG000|Overall Study|Withdrawal by Subject|1|||
17120157|NCT03617588|38259427|FG001|Overall Study|Withdrawal by Subject|0|||
17120158|NCT03616106|38259439|FG000|Overall Study|Removed by PI|6|||
17120159|NCT03616106|38259440|FG001|Overall Study|Removed by PI|0|||
17120160|NCT03616106|38259439|FG000|Overall Study|Withdrawal by Subject|1|||
17120161|NCT03616106|38259440|FG001|Overall Study|Withdrawal by Subject|1|||
17120162|NCT03616106|38259439|FG000|Overall Study|Lost to Follow-up|7|||
17120163|NCT03616106|38259440|FG001|Overall Study|Lost to Follow-up|0|||
17120164|NCT04019054|38259447|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
17120165|NCT04019054|38259448|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
17120166|NCT04019054|38259447|FG000|Overall Study|Withdrawal by Subject|3|||
17120167|NCT04019054|38259448|FG001|Overall Study|Withdrawal by Subject|1|||
17120168|NCT00071799|38259456|FG000|Overall Study|Adverse Event|19|||
17120169|NCT00071799|38259457|FG001|Overall Study|Adverse Event|10|||
17120170|NCT00071799|38259456|FG000|Overall Study|Protocol Violation|1|||
17120171|NCT00071799|38259457|FG001|Overall Study|Protocol Violation|7|||
17120172|NCT00071799|38259456|FG000|Overall Study|Lost to Follow-up|1|||
17120173|NCT00071799|38259457|FG001|Overall Study|Lost to Follow-up|1|||
17120174|NCT00071799|38259456|FG000|Overall Study|Withdrawal by Subject|15|||
17120175|NCT00071799|38259457|FG001|Overall Study|Withdrawal by Subject|37|||
17120176|NCT00071799|38259456|FG000|Overall Study|Physician Decision|0|||
17120177|NCT00071799|38259457|FG001|Overall Study|Physician Decision|2|||
17120178|NCT00071799|38259456|FG000|Overall Study|Lack of Efficacy|11|||
17120179|NCT00071799|38259457|FG001|Overall Study|Lack of Efficacy|18|||
17120180|NCT00071799|38259456|FG000|Overall Study|Disease Progression|23|||
17120181|NCT00071799|38259457|FG001|Overall Study|Disease Progression|20|||
17120182|NCT00071799|38259456|FG000|Overall Study|Different Central+Local Pathology Review|0|||
17120183|NCT00071799|38259457|FG001|Overall Study|Different Central+Local Pathology Review|1|||
17120184|NCT00071799|38259456|FG000|Overall Study|Not Documented|0|||
17120185|NCT00071799|38259457|FG001|Overall Study|Not Documented|2|||
17120186|NCT03615482|38259471|FG000|Overall Study|Death|1|||
17120187|NCT03615482|38259472|FG001|Overall Study|Death|0|||
17120188|NCT03615482|38259471|FG000|Overall Study|Lost to Follow-up|7|||
17120189|NCT03615482|38259472|FG001|Overall Study|Lost to Follow-up|7|||
17120190|NCT03615482|38259471|FG000|Overall Study|Physician Decision|2|||
17120191|NCT03615482|38259472|FG001|Overall Study|Physician Decision|3|||
17120192|NCT03615482|38259471|FG000|Overall Study|Withdrawal by Subject|7|||
17120193|NCT03615482|38259472|FG001|Overall Study|Withdrawal by Subject|7|||
17120194|NCT03688620|38259481|FG000|Overall Study|Other|0|||
17120195|NCT03688620|38259482|FG001|Overall Study|Other|0|||
17120196|NCT03688620|38259483|FG002|Overall Study|Other|1|||
17120197|NCT03688620|38259481|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
17120198|NCT03688620|38259482|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
17120199|NCT03688620|38259483|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
17120200|NCT03688620|38259481|FG000|Overall Study|Lost to Follow-up|16|||
17120201|NCT03688620|38259482|FG001|Overall Study|Lost to Follow-up|0|||
17120202|NCT03688620|38259483|FG002|Overall Study|Lost to Follow-up|1|||
17120203|NCT03688620|38259481|FG000|Overall Study|Withdrawal by Subject|0|||
17120204|NCT03688620|38259482|FG001|Overall Study|Withdrawal by Subject|0|||
17120205|NCT03688620|38259483|FG002|Overall Study|Withdrawal by Subject|6|||
17120206|NCT00090363|38259496|FG000|Overall Study|Lost to Follow-up|1|||
17120207|NCT00090363|38259497|FG001|Overall Study|Lost to Follow-up|2|||
17120208|NCT00090363|38259498|FG002|Overall Study|Lost to Follow-up|1|||
17120209|NCT00090363|38259496|FG000|Overall Study|Withdrawal by Subject|7|||
17120210|NCT00090363|38259497|FG001|Overall Study|Withdrawal by Subject|7|||
17120211|NCT00090363|38259498|FG002|Overall Study|Withdrawal by Subject|6|||
17120212|NCT00090363|38259496|FG000|Overall Study|Study-specific discontinuation criteria|75|||
17120213|NCT00090363|38259497|FG001|Overall Study|Study-specific discontinuation criteria|74|||
17120214|NCT00090363|38259498|FG002|Overall Study|Study-specific discontinuation criteria|62|||
17120215|NCT00090363|38259496|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
17120216|NCT00090363|38259497|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
17120217|NCT00090363|38259498|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
17120218|NCT00090363|38259496|FG000|Overall Study|Consent expired|7|||
17120219|NCT00090363|38259497|FG001|Overall Study|Consent expired|10|||
17120220|NCT00090363|38259498|FG002|Overall Study|Consent expired|9|||
17120221|NCT00090363|38259496|FG000|Overall Study|Reasons not specified|2|||
17120222|NCT00090363|38259497|FG001|Overall Study|Reasons not specified|1|||
17120223|NCT00090363|38259498|FG002|Overall Study|Reasons not specified|1|||
17120224|NCT00090363|38259496|FG000|Overall Study|Continuing on study off treatment|14|||
17120225|NCT00090363|38259497|FG001|Overall Study|Continuing on study off treatment|13|||
17120226|NCT00090363|38259498|FG002|Overall Study|Continuing on study off treatment|16|||
17120227|NCT03652610|38259508|FG000|Overall Study|Lost to Follow-up|1|||
17120228|NCT03652610|38259509|FG001|Overall Study|Lost to Follow-up|0|||
17120229|NCT03652610|38259508|FG000|Overall Study|Withdrawal by Subject|3|||
17120230|NCT03652610|38259509|FG001|Overall Study|Withdrawal by Subject|5|||
17120231|NCT03615404|38259515|FG000|Overall Study|Death|1|||
17120232|NCT03615404|38259515|FG000|Overall Study|vaccine did not pass quality assurance|1|||
17120233|NCT03614156|38259522|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
17120234|NCT03614156|38259523|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
17120235|NCT03614156|38259524|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
17120236|NCT03614156|38259525|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
17120237|NCT03614156|38259522|FG000|Open-Label Treatment Period|Adverse Event|7|||
17120238|NCT03614156|38259523|FG001|Open-Label Treatment Period|Adverse Event|0|||
17120239|NCT03614156|38259524|FG002|Open-Label Treatment Period|Adverse Event|0|||
17120240|NCT03614156|38259525|FG003|Open-Label Treatment Period|Adverse Event|0|||
17120241|NCT03614156|38259522|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
17120242|NCT03614156|38259523|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
17120243|NCT03614156|38259524|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
17120244|NCT03614156|38259525|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
17120245|NCT03614156|38259522|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
17120246|NCT03614156|38259523|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
17120247|NCT03614156|38259524|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
17120248|NCT03614156|38259525|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
17120249|NCT03614156|38259522|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
17120250|NCT03614156|38259523|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
17120251|NCT03614156|38259524|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
17120252|NCT03614156|38259525|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
17120253|NCT03614156|38259522|FG000|Open-Label Treatment Period|Protocol Violation|2|||
17120254|NCT03614156|38259523|FG001|Open-Label Treatment Period|Protocol Violation|0|||
17120255|NCT03614156|38259524|FG002|Open-Label Treatment Period|Protocol Violation|0|||
17120256|NCT03614156|38259525|FG003|Open-Label Treatment Period|Protocol Violation|0|||
17120257|NCT03614156|38259522|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
17120258|NCT03614156|38259523|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
17120259|NCT03614156|38259524|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
17120260|NCT03614156|38259525|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
17120261|NCT03614156|38259522|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
17120262|NCT03614156|38259523|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
17120263|NCT03614156|38259524|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
17120264|NCT03614156|38259525|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
17120265|NCT03614156|38259522|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
17120266|NCT03614156|38259523|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
17120267|NCT03614156|38259524|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
17120268|NCT03614156|38259525|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
17120269|NCT03614156|38259522|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
17120270|NCT03614156|38259523|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
17120271|NCT03614156|38259524|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
17120272|NCT03614156|38259525|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
17120273|NCT03614156|38259522|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
17120274|NCT03614156|38259523|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
17120275|NCT03614156|38259524|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
17120276|NCT03614156|38259525|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
17120277|NCT03614156|38259522|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
17120278|NCT03614156|38259523|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
17120279|NCT03614156|38259524|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
17120280|NCT03614156|38259525|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
17120281|NCT03614156|38259522|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
17120282|NCT03614156|38259523|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
17120283|NCT03614156|38259524|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
17120284|NCT03614156|38259525|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
17120285|NCT03614156|38259522|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
17120286|NCT03614156|38259523|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
17120287|NCT03614156|38259524|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
17120288|NCT03614156|38259525|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
17120289|NCT03614156|38259522|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
17120290|NCT03614156|38259523|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
17120291|NCT03614156|38259524|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
17120292|NCT03614156|38259525|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
17120293|NCT03614156|38259522|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
17120294|NCT03614156|38259523|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
17120295|NCT03614156|38259524|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
17120296|NCT03614156|38259525|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
17120297|NCT03614156|38259522|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
17120298|NCT03614156|38259523|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
17120299|NCT03614156|38259524|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
17120300|NCT03614156|38259525|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
17120301|NCT03614078|38259537|FG000|Overall Study|Withdrawal by Subject|2|||
17120302|NCT03614078|38259538|FG001|Overall Study|Withdrawal by Subject|2|||
17120303|NCT03614078|38259539|FG002|Overall Study|Withdrawal by Subject|3|||
17120304|NCT03614078|38259537|FG000|Overall Study|Participant Did Not Return for Visit|0|||
17120305|NCT03614078|38259538|FG001|Overall Study|Participant Did Not Return for Visit|1|||
17120306|NCT03614078|38259539|FG002|Overall Study|Participant Did Not Return for Visit|0|||
17120307|NCT03614078|38259537|FG000|Overall Study|High Neutrophils|0|||
17120308|NCT03614078|38259538|FG001|Overall Study|High Neutrophils|0|||
17120309|NCT03614078|38259539|FG002|Overall Study|High Neutrophils|2|||
17120310|NCT03614078|38259537|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
17120311|NCT03614078|38259538|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
17120312|NCT03614078|38259539|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
17120313|NCT03614078|38259537|FG000|Overall Study|Exacerbation of Psoriasis|0|||
17120314|NCT03614078|38259538|FG001|Overall Study|Exacerbation of Psoriasis|1|||
17120315|NCT03614078|38259539|FG002|Overall Study|Exacerbation of Psoriasis|0|||
17120316|NCT03614078|38259537|FG000|Overall Study|Adverse Event|0|||
17120317|NCT03614078|38259538|FG001|Overall Study|Adverse Event|2|||
17120318|NCT03614078|38259539|FG002|Overall Study|Adverse Event|0|||
17120319|NCT03614078|38259537|FG000|Overall Study|Dizziness and Rash|0|||
17120320|NCT03614078|38259538|FG001|Overall Study|Dizziness and Rash|1|||
17120321|NCT03614078|38259539|FG002|Overall Study|Dizziness and Rash|0|||
17120322|NCT03613454|38259549|FG000|Overall Study|Protocol Violation|1|||
17120323|NCT03613454|38259550|FG001|Overall Study|Protocol Violation|0|||
17120324|NCT03613454|38259549|FG000|Overall Study|Protocol Violation|0|||
17120325|NCT03613454|38259550|FG001|Overall Study|Protocol Violation|1|||
17120326|NCT03581786|38259558|FG000|Overall Study|Death|17|||
17120327|NCT03581786|38259559|FG001|Overall Study|Death|12|||
17120328|NCT03581786|38259558|FG000|Overall Study|Withdrawal by Subject|2|||
17120329|NCT03581786|38259559|FG001|Overall Study|Withdrawal by Subject|4|||
17120330|NCT03581786|38259558|FG000|Overall Study|Lost to Follow-up|1|||
17120331|NCT03581786|38259559|FG001|Overall Study|Lost to Follow-up|0|||
17120332|NCT03581786|38259558|FG000|Overall Study|reason other than specified above|0|||
17120333|NCT03581786|38259559|FG001|Overall Study|reason other than specified above|1|||
17120334|NCT03581786|38259558|FG000|Overall Study|Ongoing in the study|123|||
17120335|NCT03581786|38259559|FG001|Overall Study|Ongoing in the study|129|||
17120336|NCT03580382|38259567|FG000|Overall Study|Early Termination of Study|0|||
17120337|NCT03580382|38259568|FG001|Overall Study|Early Termination of Study|3|||
17120338|NCT03579290|38259573|FG000|Overall Study|Lost to Follow-up|9|||
17120339|NCT03611582|38259579|FG000|Overall Study|Adverse Event|26|||
17120340|NCT03611582|38259580|FG001|Overall Study|Adverse Event|6|||
17120341|NCT03611582|38259579|FG000|Overall Study|Protocol Violation|0|||
17120342|NCT03611582|38259580|FG001|Overall Study|Protocol Violation|1|||
17120343|NCT03611582|38259579|FG000|Overall Study|Pregnancy|1|||
17120344|NCT03611582|38259580|FG001|Overall Study|Pregnancy|2|||
17120345|NCT03611582|38259579|FG000|Overall Study|Lack of Efficacy|0|||
17120346|NCT03611582|38259580|FG001|Overall Study|Lack of Efficacy|1|||
17120347|NCT03611582|38259579|FG000|Overall Study|At the discretion of the investigator|1|||
17120348|NCT03611582|38259580|FG001|Overall Study|At the discretion of the investigator|0|||
17120349|NCT03611582|38259579|FG000|Overall Study|Safety concern as judged by the investigator|1|||
17120350|NCT03611582|38259580|FG001|Overall Study|Safety concern as judged by the investigator|2|||
17120351|NCT03611582|38259579|FG000|Overall Study|Withdrawal by Subject|4|||
17120352|NCT03611582|38259580|FG001|Overall Study|Withdrawal by Subject|3|||
17120353|NCT03611582|38259579|FG000|Overall Study|Lost to Follow-up|18|||
17120354|NCT03611582|38259580|FG001|Overall Study|Lost to Follow-up|7|||
17120355|NCT03611582|38259579|FG000|Overall Study|other|17|||
17120356|NCT03611582|38259580|FG001|Overall Study|other|16|||
17120357|NCT04015518|38259591|FG000|Overall Study|Adverse Event|6|||
17120358|NCT04015518|38259592|FG001|Overall Study|Adverse Event|1|||
17120359|NCT04015518|38259593|FG002|Overall Study|Adverse Event|1|||
17120360|NCT04015518|38259594|FG003|Overall Study|Adverse Event|3|||
17120361|NCT04015518|38259595|FG004|Overall Study|Adverse Event|3|||
17120362|NCT04015518|38259591|FG000|Overall Study|Lack of Efficacy|1|||
17120363|NCT04015518|38259592|FG001|Overall Study|Lack of Efficacy|0|||
17120364|NCT04015518|38259593|FG002|Overall Study|Lack of Efficacy|1|||
17120365|NCT04015518|38259594|FG003|Overall Study|Lack of Efficacy|0|||
17120366|NCT04015518|38259595|FG004|Overall Study|Lack of Efficacy|4|||
17120367|NCT04015518|38259591|FG000|Overall Study|Lost to Follow-up|0|||
17120368|NCT04015518|38259592|FG001|Overall Study|Lost to Follow-up|0|||
17120369|NCT04015518|38259593|FG002|Overall Study|Lost to Follow-up|0|||
17120370|NCT04015518|38259594|FG003|Overall Study|Lost to Follow-up|0|||
17120371|NCT04015518|38259595|FG004|Overall Study|Lost to Follow-up|1|||
17120372|NCT04015518|38259591|FG000|Overall Study|Withdrawal by Subject|0|||
17120373|NCT04015518|38259592|FG001|Overall Study|Withdrawal by Subject|1|||
17120374|NCT04015518|38259593|FG002|Overall Study|Withdrawal by Subject|0|||
17120375|NCT04015518|38259594|FG003|Overall Study|Withdrawal by Subject|1|||
17120376|NCT04015518|38259595|FG004|Overall Study|Withdrawal by Subject|1|||
17120377|NCT04015518|38259591|FG000|Overall Study|Patient did not come for consecutive visits|0|||
17120378|NCT04015518|38259592|FG001|Overall Study|Patient did not come for consecutive visits|1|||
17120379|NCT04015518|38259593|FG002|Overall Study|Patient did not come for consecutive visits|0|||
17120380|NCT04015518|38259594|FG003|Overall Study|Patient did not come for consecutive visits|0|||
17120381|NCT04015518|38259595|FG004|Overall Study|Patient did not come for consecutive visits|0|||
17120382|NCT04015518|38259591|FG000|Overall Study|not willing to travel due to Covid-19|0|||
17120383|NCT04015518|38259592|FG001|Overall Study|not willing to travel due to Covid-19|0|||
17120384|NCT04015518|38259593|FG002|Overall Study|not willing to travel due to Covid-19|1|||
17120385|NCT04015518|38259594|FG003|Overall Study|not willing to travel due to Covid-19|0|||
17120386|NCT04015518|38259595|FG004|Overall Study|not willing to travel due to Covid-19|0|||
17120387|NCT04015518|38259591|FG000|Overall Study|Patient wants to discontinue treatment|0|||
17120388|NCT04015518|38259592|FG001|Overall Study|Patient wants to discontinue treatment|0|||
17120389|NCT04015518|38259593|FG002|Overall Study|Patient wants to discontinue treatment|0|||
17120390|NCT04015518|38259594|FG003|Overall Study|Patient wants to discontinue treatment|1|||
17120391|NCT04015518|38259595|FG004|Overall Study|Patient wants to discontinue treatment|0|||
17120392|NCT04015518|38259591|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
17120393|NCT04015518|38259592|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
17120394|NCT04015518|38259593|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
17120395|NCT04015518|38259594|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
17120396|NCT04015518|38259595|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
17120397|NCT04015518|38259591|FG000|Overall Study|Pregnancy|0|||
17120398|NCT04015518|38259592|FG001|Overall Study|Pregnancy|0|||
17120399|NCT04015518|38259593|FG002|Overall Study|Pregnancy|0|||
17120400|NCT04015518|38259594|FG003|Overall Study|Pregnancy|0|||
17120401|NCT04015518|38259595|FG004|Overall Study|Pregnancy|1|||
17120402|NCT04015518|38259591|FG000|Overall Study|Personal reasons|1|||
17120403|NCT04015518|38259592|FG001|Overall Study|Personal reasons|0|||
17120404|NCT04015518|38259593|FG002|Overall Study|Personal reasons|0|||
17120405|NCT04015518|38259594|FG003|Overall Study|Personal reasons|0|||
17120406|NCT04015518|38259595|FG004|Overall Study|Personal reasons|1|||
17120407|NCT04015518|38259591|FG000|Overall Study|Withdrew consent|1|||
17120408|NCT04015518|38259592|FG001|Overall Study|Withdrew consent|0|||
17120409|NCT04015518|38259593|FG002|Overall Study|Withdrew consent|0|||
17120410|NCT04015518|38259594|FG003|Overall Study|Withdrew consent|0|||
17120411|NCT04015518|38259595|FG004|Overall Study|Withdrew consent|0|||
17120412|NCT04015518|38259591|FG000|Overall Study|Prostate carcinoma|1|||
17120413|NCT04015518|38259592|FG001|Overall Study|Prostate carcinoma|0|||
17120414|NCT04015518|38259593|FG002|Overall Study|Prostate carcinoma|0|||
17120415|NCT04015518|38259594|FG003|Overall Study|Prostate carcinoma|0|||
17120416|NCT04015518|38259595|FG004|Overall Study|Prostate carcinoma|0|||
17120417|NCT04015518|38259591|FG000|Overall Study|Could not keep appointments due to work|1|||
17120418|NCT04015518|38259592|FG001|Overall Study|Could not keep appointments due to work|0|||
17120419|NCT04015518|38259593|FG002|Overall Study|Could not keep appointments due to work|0|||
17120420|NCT04015518|38259594|FG003|Overall Study|Could not keep appointments due to work|0|||
17120421|NCT04015518|38259595|FG004|Overall Study|Could not keep appointments due to work|0|||
17120422|NCT03577730|38259612|FG000|Overall Study|Physician Decision|3|||
17120423|NCT03577730|38259613|FG001|Overall Study|Physician Decision|1|||
17120424|NCT03577730|38259612|FG000|Overall Study|Did not receive allocated intervention|1|||
17120425|NCT03577730|38259613|FG001|Overall Study|Did not receive allocated intervention|0|||
17120426|NCT03608774|38259621|FG000|Overall Study|Lost to Follow-up|5|||
17120427|NCT03608774|38259622|FG001|Overall Study|Lost to Follow-up|5|||
17120428|NCT03608774|38259621|FG000|Overall Study|Withdrawal by Subject|1|||
17120429|NCT03608774|38259622|FG001|Overall Study|Withdrawal by Subject|0|||
17120430|NCT03608774|38259621|FG000|Overall Study|Protocol Violation|1|||
17120431|NCT03608774|38259622|FG001|Overall Study|Protocol Violation|0|||
17120432|NCT03608774|38259621|FG000|Overall Study|Not eligible at enrollment|0|||
17120433|NCT03608774|38259622|FG001|Overall Study|Not eligible at enrollment|1|||
17120434|NCT03608774|38259621|FG000|Overall Study|Health related event|0|||
17120435|NCT03608774|38259622|FG001|Overall Study|Health related event|1|||
17120436|NCT04021524|38259630|FG000|Overall Study|Change in surgical intervention|0|||
17120437|NCT04021524|38259631|FG001|Overall Study|Change in surgical intervention|1|||
17120438|NCT03607682|38259637|FG000|Overall Study|Withdrawal by Subject|1|||
17120439|NCT03607682|38259637|FG000|Overall Study|Disease progression|1|||
17120440|NCT03606668|38259641|FG000|Overall Study|Screen Failure|1|||
17120441|NCT03606668|38259641|FG000|Overall Study|Lost to Follow-up|1|||
17120442|NCT03601052|38259645|FG000|Overall Study|Lost to Follow-up|2|||
17120443|NCT03600740|38259654|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
17120444|NCT03600428|38259660|FG000|Overall Study|Not eligible|0|||
17120445|NCT03600428|38259661|FG001|Overall Study|Not eligible|1|||
17120446|NCT03600428|38259660|FG000|Overall Study|Lost to Follow-up|5|||
17120447|NCT03600428|38259661|FG001|Overall Study|Lost to Follow-up|4|||
17120448|NCT03575702|38259669|FG000|Overall Study|Withdrawal by Subject|1|||
17120449|NCT03575702|38259670|FG001|Overall Study|Withdrawal by Subject|1|||
17120450|NCT03575702|38259669|FG000|Overall Study|Lost to Follow-up|1|||
17120451|NCT03575702|38259670|FG001|Overall Study|Lost to Follow-up|2|||
17120452|NCT03575702|38259669|FG000|Overall Study|Protocol Violation|0|||
17120453|NCT03575702|38259670|FG001|Overall Study|Protocol Violation|1|||
17120454|NCT03575702|38259669|FG000|Overall Study|Patient non compliance|4|||
17120455|NCT03575702|38259670|FG001|Overall Study|Patient non compliance|0|||
17120456|NCT03575468|38259678|FG000|Overall Study|Withdrawal by Subject|3|||
17120457|NCT03575468|38259679|FG001|Overall Study|Withdrawal by Subject|0|||
17120458|NCT03575468|38259678|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
17120459|NCT03575468|38259679|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
17120460|NCT03575468|38259678|FG000|Overall Study|Lost to Follow-up|13|||
17120461|NCT03575468|38259679|FG001|Overall Study|Lost to Follow-up|17|||
17120462|NCT03573908|38259687|FG000|Treatment Period|Adverse Event|4|||
17120463|NCT03573908|38259688|FG001|Treatment Period|Adverse Event|9|||
17120464|NCT03573908|38259689|FG002|Treatment Period|Adverse Event|0|||
17120465|NCT03573908|38259690|FG003|Treatment Period|Adverse Event|0|||
17120466|NCT03573908|38259691|FG004|Treatment Period|Adverse Event|0|||
17120467|NCT03573908|38259687|FG000|Treatment Period|Protocol Violation|1|||
17120468|NCT03573908|38259688|FG001|Treatment Period|Protocol Violation|0|||
17120469|NCT03573908|38259689|FG002|Treatment Period|Protocol Violation|0|||
17120470|NCT03573908|38259690|FG003|Treatment Period|Protocol Violation|0|||
17120471|NCT03573908|38259691|FG004|Treatment Period|Protocol Violation|0|||
17120472|NCT03573908|38259687|FG000|Treatment Period|Withdrawal by Subject|7|||
17120473|NCT03573908|38259688|FG001|Treatment Period|Withdrawal by Subject|5|||
17120474|NCT03573908|38259689|FG002|Treatment Period|Withdrawal by Subject|0|||
17120475|NCT03573908|38259690|FG003|Treatment Period|Withdrawal by Subject|0|||
17120476|NCT03573908|38259691|FG004|Treatment Period|Withdrawal by Subject|0|||
17120477|NCT03573908|38259687|FG000|Treatment Period|Lost to Follow-up|7|||
17120478|NCT03573908|38259688|FG001|Treatment Period|Lost to Follow-up|6|||
17120479|NCT03573908|38259689|FG002|Treatment Period|Lost to Follow-up|0|||
17120480|NCT03573908|38259690|FG003|Treatment Period|Lost to Follow-up|0|||
17120481|NCT03573908|38259691|FG004|Treatment Period|Lost to Follow-up|0|||
17120482|NCT03573908|38259687|FG000|Treatment Period|Pregnancy|1|||
17120483|NCT03573908|38259688|FG001|Treatment Period|Pregnancy|0|||
17120484|NCT03573908|38259689|FG002|Treatment Period|Pregnancy|0|||
17120485|NCT03573908|38259690|FG003|Treatment Period|Pregnancy|0|||
17120486|NCT03573908|38259691|FG004|Treatment Period|Pregnancy|0|||
17120487|NCT03573908|38259687|FG000|Treatment Period|Other, Not Specified|4|||
17120488|NCT03573908|38259688|FG001|Treatment Period|Other, Not Specified|6|||
17120489|NCT03573908|38259689|FG002|Treatment Period|Other, Not Specified|0|||
17120490|NCT03573908|38259690|FG003|Treatment Period|Other, Not Specified|0|||
17120491|NCT03573908|38259691|FG004|Treatment Period|Other, Not Specified|0|||
17120492|NCT03573908|38259687|FG000|Randomized Withdrawal Period|Adverse Event|0|||
17120493|NCT03573908|38259688|FG001|Randomized Withdrawal Period|Adverse Event|0|||
17120494|NCT03573908|38259689|FG002|Randomized Withdrawal Period|Adverse Event|3|||
17120495|NCT03573908|38259690|FG003|Randomized Withdrawal Period|Adverse Event|0|||
17120496|NCT03573908|38259691|FG004|Randomized Withdrawal Period|Adverse Event|0|||
17120497|NCT03573908|38259687|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17120498|NCT03573908|38259688|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17120499|NCT03573908|38259689|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17120500|NCT03573908|38259690|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17120501|NCT03573908|38259691|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
17120502|NCT03573908|38259687|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
17120503|NCT03573908|38259688|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
17120504|NCT03573908|38259689|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
17120505|NCT03573908|38259690|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
17120506|NCT03573908|38259691|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
17120507|NCT03573908|38259687|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
17120508|NCT03573908|38259688|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
17120509|NCT03573908|38259689|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
17120510|NCT03573908|38259690|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
17120511|NCT03573908|38259691|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
17120512|NCT03573830|38259702|FG000|Overall Study|Dropped without completing treatment|0|||
17120513|NCT03573830|38259703|FG001|Overall Study|Dropped without completing treatment|7|||
17120514|NCT03573830|38259702|FG000|Overall Study|Lost to Follow-up|4|||
17120515|NCT03573830|38259703|FG001|Overall Study|Lost to Follow-up|0|||
17120516|NCT03595904|38259710|FG000|Overall Study|Protocol Violation|3|||
17120517|NCT03595904|38259711|FG001|Overall Study|Protocol Violation|1|||
17120518|NCT03595904|38259710|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
17120519|NCT03595904|38259711|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
17120520|NCT03595904|38259710|FG000|Overall Study|Insurance complications|1|||
17120521|NCT03595904|38259711|FG001|Overall Study|Insurance complications|0|||
17120522|NCT03595904|38259710|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
17120523|NCT03595904|38259711|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
17120524|NCT03595280|38259720|FG000|Overall Study|Lost to Follow-up|6|||
17120525|NCT03595280|38259721|FG001|Overall Study|Lost to Follow-up|9|||
17120526|NCT03595280|38259722|FG002|Overall Study|Lost to Follow-up|15|||
17120527|NCT03593876|38259730|FG000|Overall Study|Withdrawal by Subject|1|||
17120528|NCT03593876|38259730|FG000|Overall Study|Discharged home before intervention completion|2|||
17120529|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Adverse Event|5|||
17120530|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Adverse Event|8|||
17120531|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Adverse Event|4|||
17120532|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Adverse Event|8|||
17120533|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
17120534|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
17120535|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
17120536|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
17120537|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
17120538|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
17120539|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
17120540|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
17120541|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Physician Decision|1|||
17120542|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Physician Decision|0|||
17120543|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Physician Decision|0|||
17120544|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Physician Decision|0|||
17120545|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
17120546|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
17120547|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
17120548|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
17120549|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Pregnancy|0|||
17120550|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Pregnancy|1|||
17120551|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Pregnancy|0|||
17120552|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Pregnancy|0|||
17120553|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
17120554|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
17120555|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
17120556|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
17120557|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Death|0|||
17120558|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Death|1|||
17120559|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Death|0|||
17120560|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Death|0|||
17120561|NCT00071487|38259738|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
17120562|NCT00071487|38259739|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
17120563|NCT00071487|38259740|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
17120564|NCT00071487|38259741|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
17120565|NCT00071487|38259738|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
17120566|NCT00071487|38259739|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
17120567|NCT00071487|38259740|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
17120568|NCT00071487|38259741|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
17120569|NCT00071487|38259738|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
17120570|NCT00071487|38259739|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
17120571|NCT00071487|38259740|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
17120572|NCT00071487|38259741|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
17120573|NCT00071487|38259738|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
17120574|NCT00071487|38259739|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
17120575|NCT00071487|38259740|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
17120576|NCT00071487|38259741|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
17120577|NCT00071487|38259738|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
17120578|NCT00071487|38259739|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
17120579|NCT00071487|38259740|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
17120580|NCT00071487|38259741|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
17120581|NCT00071487|38259738|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
17120582|NCT00071487|38259739|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
17120583|NCT00071487|38259740|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
17120584|NCT00071487|38259741|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
17120585|NCT00071487|38259738|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
17120586|NCT00071487|38259739|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
17120587|NCT00071487|38259740|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
17120588|NCT00071487|38259741|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
17120589|NCT03591146|38259758|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
17120590|NCT03591146|38259759|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
17120591|NCT03591146|38259760|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
17120592|NCT03591146|38259761|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
17120593|NCT03591146|38259762|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
17120594|NCT03591146|38259758|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
17120595|NCT03591146|38259759|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
17120596|NCT03591146|38259760|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
17120597|NCT03591146|38259761|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
17120598|NCT03591146|38259762|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
17120599|NCT03591146|38259758|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
17120600|NCT03591146|38259759|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
17120601|NCT03591146|38259760|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
17120602|NCT03591146|38259761|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
17120603|NCT03591146|38259762|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
17120604|NCT03591146|38259758|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
17120605|NCT03591146|38259759|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
17120606|NCT03591146|38259760|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
17120607|NCT03591146|38259761|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
17120608|NCT03591146|38259762|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
17120609|NCT00096447|38259774|FG000|Overall Study|Never treated|1|||
17120610|NCT03590366|38259785|FG000|Overall Study|Adverse Event|0|||
17120611|NCT03590366|38259786|FG001|Overall Study|Adverse Event|3|||
17120612|NCT03590366|38259785|FG000|Overall Study|Lost to Follow-up|3|||
17120613|NCT03590366|38259786|FG001|Overall Study|Lost to Follow-up|3|||
17120614|NCT03590366|38259785|FG000|Overall Study|Withdrawal by Subject|0|||
17120615|NCT03590366|38259786|FG001|Overall Study|Withdrawal by Subject|2|||
17120616|NCT03588572|38259794|FG000|Visitation 1|Lack of Efficacy|1|||
17120617|NCT03588572|38259795|FG001|Visitation 1|Lack of Efficacy|1|||
17120618|NCT03588572|38259794|FG000|Visitation 2|Lost to Follow-up|1|||
17120619|NCT03588572|38259795|FG001|Visitation 2|Lost to Follow-up|1|||
17120620|NCT03588572|38259794|FG000|Visitation 2|Lack of Efficacy|0|||
17120621|NCT03588572|38259795|FG001|Visitation 2|Lack of Efficacy|1|||
17120622|NCT03588572|38259794|FG000|Visitation 2|Withdrawal by Subject|1|||
17120623|NCT03588572|38259795|FG001|Visitation 2|Withdrawal by Subject|0|||
17120624|NCT03588572|38259794|FG000|Visitation 3|Lost to Follow-up|1|||
17120625|NCT03588572|38259795|FG001|Visitation 3|Lost to Follow-up|1|||
17120626|NCT03588572|38259794|FG000|Visitation 3|Physician Decision|1|||
17120627|NCT03588572|38259795|FG001|Visitation 3|Physician Decision|1|||
17120628|NCT03588572|38259794|FG000|Visitation 3|Withdrawal by Subject|1|||
17120629|NCT03588572|38259795|FG001|Visitation 3|Withdrawal by Subject|0|||
17120630|NCT00090285|38259803|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
17120631|NCT00090285|38259804|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
17120632|NCT00090285|38259805|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
17120633|NCT00090285|38259806|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
17120634|NCT00090285|38259807|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
17120635|NCT00090285|38259808|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
17120636|NCT00090285|38259803|FG000|Base Study Vaccination Period|Adverse Event|2|||
17120637|NCT00090285|38259804|FG001|Base Study Vaccination Period|Adverse Event|4|||
17120638|NCT00090285|38259805|FG002|Base Study Vaccination Period|Adverse Event|0|||
17120639|NCT00090285|38259806|FG003|Base Study Vaccination Period|Adverse Event|0|||
17120640|NCT00090285|38259807|FG004|Base Study Vaccination Period|Adverse Event|0|||
17120641|NCT00090285|38259808|FG005|Base Study Vaccination Period|Adverse Event|0|||
17120642|NCT00090285|38259803|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
17120643|NCT00090285|38259804|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
17120644|NCT00090285|38259805|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
17120645|NCT00090285|38259806|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
17120646|NCT00090285|38259807|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
17120647|NCT00090285|38259808|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
17120648|NCT00090285|38259803|FG000|Base Study Vaccination Period|Protocol Violation|2|||
17120649|NCT00090285|38259804|FG001|Base Study Vaccination Period|Protocol Violation|3|||
17120650|NCT00090285|38259805|FG002|Base Study Vaccination Period|Protocol Violation|0|||
17120651|NCT00090285|38259806|FG003|Base Study Vaccination Period|Protocol Violation|0|||
17120652|NCT00090285|38259807|FG004|Base Study Vaccination Period|Protocol Violation|0|||
17120653|NCT00090285|38259808|FG005|Base Study Vaccination Period|Protocol Violation|0|||
17120654|NCT00090285|38259803|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
17120655|NCT00090285|38259804|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
17120656|NCT00090285|38259805|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
17120657|NCT00090285|38259806|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
17120658|NCT00090285|38259807|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
17120659|NCT00090285|38259808|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
17120660|NCT00090285|38259803|FG000|Base Study Vaccination Period|Uncooperative|2|||
17120661|NCT00090285|38259804|FG001|Base Study Vaccination Period|Uncooperative|2|||
17120662|NCT00090285|38259805|FG002|Base Study Vaccination Period|Uncooperative|0|||
17120663|NCT00090285|38259806|FG003|Base Study Vaccination Period|Uncooperative|0|||
17120664|NCT00090285|38259807|FG004|Base Study Vaccination Period|Uncooperative|0|||
17120665|NCT00090285|38259808|FG005|Base Study Vaccination Period|Uncooperative|0|||
17120666|NCT00090285|38259803|FG000|Base Study Vaccination Period|Moved|20|||
17120667|NCT00090285|38259804|FG001|Base Study Vaccination Period|Moved|21|||
17120668|NCT00090285|38259805|FG002|Base Study Vaccination Period|Moved|0|||
17120669|NCT00090285|38259806|FG003|Base Study Vaccination Period|Moved|0|||
17120670|NCT00090285|38259807|FG004|Base Study Vaccination Period|Moved|0|||
17120671|NCT00090285|38259808|FG005|Base Study Vaccination Period|Moved|0|||
17120672|NCT00090285|38259803|FG000|Base Study Vaccination Period|Site Terminated|1|||
17120673|NCT00090285|38259804|FG001|Base Study Vaccination Period|Site Terminated|0|||
17120674|NCT00090285|38259805|FG002|Base Study Vaccination Period|Site Terminated|0|||
17120675|NCT00090285|38259806|FG003|Base Study Vaccination Period|Site Terminated|0|||
17120676|NCT00090285|38259807|FG004|Base Study Vaccination Period|Site Terminated|0|||
17120677|NCT00090285|38259808|FG005|Base Study Vaccination Period|Site Terminated|0|||
17120678|NCT00090285|38259803|FG000|Base Study Vaccination Period|Other|2|||
17120679|NCT00090285|38259804|FG001|Base Study Vaccination Period|Other|2|||
17120680|NCT00090285|38259805|FG002|Base Study Vaccination Period|Other|0|||
17120681|NCT00090285|38259806|FG003|Base Study Vaccination Period|Other|0|||
17120682|NCT00090285|38259807|FG004|Base Study Vaccination Period|Other|0|||
17120683|NCT00090285|38259808|FG005|Base Study Vaccination Period|Other|0|||
17120684|NCT00090285|38259803|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
17120685|NCT00090285|38259804|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
17120686|NCT00090285|38259805|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
17120687|NCT00090285|38259806|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
17120688|NCT00090285|38259807|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
17120689|NCT00090285|38259808|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
17120690|NCT00090285|38259803|FG000|Base Study Vaccination Period|HIV positive|1|||
17120691|NCT00090285|38259804|FG001|Base Study Vaccination Period|HIV positive|1|||
17120692|NCT00090285|38259805|FG002|Base Study Vaccination Period|HIV positive|0|||
17120693|NCT00090285|38259806|FG003|Base Study Vaccination Period|HIV positive|0|||
17120694|NCT00090285|38259807|FG004|Base Study Vaccination Period|HIV positive|0|||
17120695|NCT00090285|38259808|FG005|Base Study Vaccination Period|HIV positive|0|||
17120696|NCT00090285|38259803|FG000|Base Study Follow-up Period|Adverse Event|3|||
17120697|NCT00090285|38259804|FG001|Base Study Follow-up Period|Adverse Event|10|||
17120698|NCT00090285|38259805|FG002|Base Study Follow-up Period|Adverse Event|0|||
17120699|NCT00090285|38259806|FG003|Base Study Follow-up Period|Adverse Event|0|||
17120700|NCT00090285|38259807|FG004|Base Study Follow-up Period|Adverse Event|0|||
17120701|NCT00090285|38259808|FG005|Base Study Follow-up Period|Adverse Event|0|||
17120702|NCT00090285|38259803|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
17120703|NCT00090285|38259804|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
17120704|NCT00090285|38259805|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
17120705|NCT00090285|38259806|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
17120706|NCT00090285|38259807|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
17120707|NCT00090285|38259808|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
17120708|NCT00090285|38259803|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
17120709|NCT00090285|38259804|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
17120710|NCT00090285|38259805|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
17120711|NCT00090285|38259806|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
17120712|NCT00090285|38259807|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
17120713|NCT00090285|38259808|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
17120714|NCT00090285|38259803|FG000|Base Study Follow-up Period|Moved|41|||
17120715|NCT00090285|38259804|FG001|Base Study Follow-up Period|Moved|36|||
17120716|NCT00090285|38259805|FG002|Base Study Follow-up Period|Moved|0|||
17120717|NCT00090285|38259806|FG003|Base Study Follow-up Period|Moved|0|||
17120718|NCT00090285|38259807|FG004|Base Study Follow-up Period|Moved|0|||
16773118|NCT02226172|37712135|FG000|Overall Study|Other|5|||
16773119|NCT02226172|37712135|FG000|Overall Study|Death|1|||
17120719|NCT00090285|38259808|FG005|Base Study Follow-up Period|Moved|0|||
17120720|NCT00090285|38259803|FG000|Base Study Follow-up Period|Other|2|||
17120721|NCT00090285|38259804|FG001|Base Study Follow-up Period|Other|0|||
17120722|NCT00090285|38259805|FG002|Base Study Follow-up Period|Other|0|||
17120723|NCT00090285|38259806|FG003|Base Study Follow-up Period|Other|0|||
17120724|NCT00090285|38259807|FG004|Base Study Follow-up Period|Other|0|||
17120725|NCT00090285|38259808|FG005|Base Study Follow-up Period|Other|0|||
17120726|NCT00090285|38259803|FG000|Base Study Follow-up Period|Protocol Violation|1|||
17120727|NCT00090285|38259804|FG001|Base Study Follow-up Period|Protocol Violation|0|||
17120728|NCT00090285|38259805|FG002|Base Study Follow-up Period|Protocol Violation|0|||
17120729|NCT00090285|38259806|FG003|Base Study Follow-up Period|Protocol Violation|0|||
17120730|NCT00090285|38259807|FG004|Base Study Follow-up Period|Protocol Violation|0|||
17120731|NCT00090285|38259808|FG005|Base Study Follow-up Period|Protocol Violation|0|||
17120732|NCT00090285|38259803|FG000|Base Study Follow-up Period|Uncooperative|3|||
17120733|NCT00090285|38259804|FG001|Base Study Follow-up Period|Uncooperative|4|||
17120734|NCT00090285|38259805|FG002|Base Study Follow-up Period|Uncooperative|0|||
17120735|NCT00090285|38259806|FG003|Base Study Follow-up Period|Uncooperative|0|||
17120736|NCT00090285|38259807|FG004|Base Study Follow-up Period|Uncooperative|0|||
17120737|NCT00090285|38259808|FG005|Base Study Follow-up Period|Uncooperative|0|||
16773120|NCT02226172|37712135|FG000|Overall Study|Study terminated by sponsor|1|||
16773121|NCT02226172|37712135|FG000|Overall Study|Adverse Event|6|||
16773122|NCT01676961|37712139|FG000|Overall Study|Death|3|||
16773123|NCT01676961|37712139|FG000|Overall Study|Lost to Follow-up|1|||
16773124|NCT01676961|37712139|FG000|Overall Study|Withdrawal by Subject|1|||
16773125|NCT01676727|37712161|FG000|Overall Study|Death|18|||
17120738|NCT00090285|38259803|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
16773126|NCT01676727|37712161|FG000|Overall Study|Withdrawal by Subject|6|||
16773127|NCT01676727|37712161|FG000|Overall Study|Screening failure|5|||
16773128|NCT01676727|37712161|FG000|Overall Study|Not willing to attend 1-year visit|2|||
17120739|NCT00090285|38259804|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
17120740|NCT00090285|38259805|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
17120741|NCT00090285|38259806|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
16773129|NCT01676727|37712161|FG000|Overall Study|Valve explanted|1|||
17120742|NCT00090285|38259807|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
17120743|NCT00090285|38259808|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
17120744|NCT00090285|38259803|FG000|Extension 1|Adverse Event|0|||
17120745|NCT00090285|38259804|FG001|Extension 1|Adverse Event|0|||
17120746|NCT00090285|38259805|FG002|Extension 1|Adverse Event|2|||
17120747|NCT00090285|38259806|FG003|Extension 1|Adverse Event|0|||
17120748|NCT00090285|38259807|FG004|Extension 1|Adverse Event|0|||
17120749|NCT00090285|38259808|FG005|Extension 1|Adverse Event|0|||
17120750|NCT00090285|38259803|FG000|Extension 1|Lost to Follow-up|0|||
17120751|NCT00090285|38259804|FG001|Extension 1|Lost to Follow-up|0|||
17120752|NCT00090285|38259805|FG002|Extension 1|Lost to Follow-up|35|||
17120753|NCT00090285|38259806|FG003|Extension 1|Lost to Follow-up|0|||
17120754|NCT00090285|38259807|FG004|Extension 1|Lost to Follow-up|0|||
17120755|NCT00090285|38259808|FG005|Extension 1|Lost to Follow-up|0|||
17120756|NCT00090285|38259803|FG000|Extension 1|Withdrawal by Subject|0|||
17120757|NCT00090285|38259804|FG001|Extension 1|Withdrawal by Subject|0|||
17120758|NCT00090285|38259805|FG002|Extension 1|Withdrawal by Subject|13|||
17120759|NCT00090285|38259806|FG003|Extension 1|Withdrawal by Subject|1|||
17120760|NCT00090285|38259807|FG004|Extension 1|Withdrawal by Subject|0|||
17120761|NCT00090285|38259808|FG005|Extension 1|Withdrawal by Subject|0|||
17120762|NCT00090285|38259803|FG000|Extension 1|Other|0|||
17120763|NCT00090285|38259804|FG001|Extension 1|Other|0|||
17120764|NCT00090285|38259805|FG002|Extension 1|Other|4|||
17120765|NCT00090285|38259806|FG003|Extension 1|Other|0|||
17120766|NCT00090285|38259807|FG004|Extension 1|Other|0|||
17120767|NCT00090285|38259808|FG005|Extension 1|Other|0|||
16773130|NCT03745651|37712169|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
16773131|NCT03745651|37712170|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
16773132|NCT03745651|37712171|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16773133|NCT03745651|37712172|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16773134|NCT03745651|37712173|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16773135|NCT03745651|37712174|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16773136|NCT03745651|37712175|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16773137|NCT03745651|37712169|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
16773138|NCT03745651|37712170|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
16773139|NCT03745651|37712171|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
16773140|NCT03745651|37712172|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16773141|NCT03745651|37712173|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16773142|NCT03745651|37712174|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16773143|NCT03745651|37712175|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16773144|NCT03745651|37712169|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
16773145|NCT03745651|37712170|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16773146|NCT03745651|37712171|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
16773147|NCT03745651|37712172|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16773148|NCT03745651|37712173|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16773149|NCT03745651|37712174|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16773150|NCT03745651|37712175|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16773151|NCT03745651|37712169|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16773152|NCT03745651|37712170|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
16773153|NCT03745651|37712171|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16773154|NCT03745651|37712172|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16773155|NCT03745651|37712173|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16773156|NCT03745651|37712174|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16773157|NCT03745651|37712175|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16773158|NCT03745651|37712169|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
16773159|NCT03745651|37712170|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
16773160|NCT03745651|37712171|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
16773161|NCT03745651|37712172|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16773162|NCT03745651|37712173|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16773163|NCT03745651|37712174|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16773164|NCT03745651|37712175|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16773165|NCT03745651|37712169|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
16773166|NCT03745651|37712170|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
16856755|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
16942090|NCT01371825|38086654|FG000|Overall Study|Death|4|||
17120768|NCT00090285|38259803|FG000|Extension 1|Moved|0|||
17120769|NCT00090285|38259804|FG001|Extension 1|Moved|0|||
17120770|NCT00090285|38259805|FG002|Extension 1|Moved|3|||
17120771|NCT00090285|38259806|FG003|Extension 1|Moved|0|||
17120772|NCT00090285|38259807|FG004|Extension 1|Moved|0|||
17120773|NCT00090285|38259808|FG005|Extension 1|Moved|0|||
17120774|NCT00090285|38259803|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
17120775|NCT00090285|38259804|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
17120776|NCT00090285|38259805|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
17120777|NCT00090285|38259806|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
17120778|NCT00090285|38259807|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
17120779|NCT00090285|38259808|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
17120780|NCT00090285|38259803|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
17120781|NCT00090285|38259804|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
17120782|NCT00090285|38259805|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
17120783|NCT00090285|38259806|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
17120784|NCT00090285|38259807|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
17120785|NCT00090285|38259808|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
17120786|NCT00090285|38259803|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
17120787|NCT00090285|38259804|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
17120788|NCT00090285|38259805|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
17120789|NCT00090285|38259806|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
17120790|NCT00090285|38259807|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
17120791|NCT00090285|38259808|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
17120792|NCT00090285|38259803|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
17120793|NCT00090285|38259804|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
17120794|NCT00090285|38259805|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
17120795|NCT00090285|38259806|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
17120796|NCT00090285|38259807|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
17120797|NCT00090285|38259808|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
17120798|NCT00070941|38259826|FG000|Overall Study|Adverse Event|10|||
17120799|NCT00070941|38259827|FG001|Overall Study|Adverse Event|8|||
17120800|NCT00070941|38259828|FG002|Overall Study|Adverse Event|4|||
17120801|NCT00070707|38259838|FG000|Overall Study|Adverse Event|1|||
17120802|NCT00070707|38259839|FG001|Overall Study|Adverse Event|2|||
17120803|NCT00070707|38259838|FG000|Overall Study|Lack of Efficacy|4|||
17120804|NCT00070707|38259839|FG001|Overall Study|Lack of Efficacy|1|||
17120805|NCT00070707|38259838|FG000|Overall Study|Protocol Violation|8|||
17120806|NCT00070707|38259839|FG001|Overall Study|Protocol Violation|4|||
17120807|NCT00070707|38259838|FG000|Overall Study|Unrelated to Study Medication|1|||
17120808|NCT00070707|38259839|FG001|Overall Study|Unrelated to Study Medication|0|||
17120809|NCT03036124|38259847|FG000|Overall Study|Lost to Follow-up|0|||
17120810|NCT03036124|38259848|FG001|Overall Study|Lost to Follow-up|2|||
17120811|NCT03036124|38259847|FG000|Overall Study|Withdrawal by Subject|5|||
17120812|NCT03036124|38259848|FG001|Overall Study|Withdrawal by Subject|4|||
17120813|NCT00070317|38259854|FG000|Overall Study|Inevaluable (Never Treated)|1|||
17120814|NCT00070317|38259854|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
17120815|NCT00070317|38259854|FG000|Overall Study|Ineligible required test not done|1|||
17120816|NCT00070317|38259854|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
17120817|NCT00070317|38259854|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
17120818|NCT03649412|38259860|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
17120819|NCT03649412|38259861|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
17120820|NCT03649412|38259860|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
17120821|NCT03649412|38259861|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
17120822|NCT03649412|38259860|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
17120823|NCT03649412|38259861|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
17120824|NCT03649412|38259860|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
17120825|NCT03649412|38259861|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
17120826|NCT03649412|38259860|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
17120827|NCT03649412|38259861|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
17120828|NCT03649412|38259860|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
17120829|NCT03649412|38259861|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
17120830|NCT03587636|38259906|FG000|Overall Study|Lost to Follow-up|2|||
17120831|NCT03587636|38259907|FG001|Overall Study|Lost to Follow-up|5|||
17120832|NCT04021290|38259925|FG000|Overall Study|Adverse Event|4|||
17120833|NCT04021290|38259926|FG001|Overall Study|Adverse Event|3|||
17120834|NCT04021290|38259925|FG000|Overall Study|Lack of Efficacy|0|||
17120835|NCT04021290|38259926|FG001|Overall Study|Lack of Efficacy|3|||
17120836|NCT04021290|38259925|FG000|Overall Study|Lost to Follow-up|2|||
17120837|NCT04021290|38259926|FG001|Overall Study|Lost to Follow-up|1|||
17120838|NCT04021290|38259925|FG000|Overall Study|Death|1|||
17120839|NCT04021290|38259926|FG001|Overall Study|Death|0|||
17120840|NCT04021290|38259925|FG000|Overall Study|Physician Decision|1|||
17120841|NCT04021290|38259926|FG001|Overall Study|Physician Decision|2|||
17120842|NCT04021290|38259925|FG000|Overall Study|Withdrawal by Subject|1|||
17120843|NCT04021290|38259926|FG001|Overall Study|Withdrawal by Subject|5|||
17120844|NCT04021290|38259925|FG000|Overall Study|Ongoing|89|||
17120845|NCT04021290|38259926|FG001|Overall Study|Ongoing|0|||
17120846|NCT04021290|38259925|FG000|Overall Study|Protocol Deviation|5|||
17120847|NCT04021290|38259926|FG001|Overall Study|Protocol Deviation|4|||
17120848|NCT03586544|38259934|FG000|First Intervention|Adverse Event|0|||
17120849|NCT03586544|38259935|FG001|First Intervention|Adverse Event|1|||
17120850|NCT03586544|38259934|FG000|Second Intervention|Withdrawal by Subject|0|||
17120851|NCT03586544|38259935|FG001|Second Intervention|Withdrawal by Subject|1|||
17120852|NCT03585296|38259941|FG000|Overall Study|Adverse Event|1|||
17120853|NCT03585296|38259941|FG000|Overall Study|Lost to Follow-up|2|||
17120854|NCT03585296|38259941|FG000|Overall Study|Withdrawal by Subject|2|||
17120855|NCT03589768|38259949|FG000|Overall Study|Death|1|||
17120856|NCT03589768|38259950|FG001|Overall Study|Death|0|||
17120857|NCT03589768|38259951|FG002|Overall Study|Death|8|||
17120858|NCT03589768|38259952|FG003|Overall Study|Death|3|||
17120859|NCT03589768|38259949|FG000|Overall Study|Withdrawal by Subject|2|||
17120860|NCT03589768|38259950|FG001|Overall Study|Withdrawal by Subject|0|||
17120861|NCT03589768|38259951|FG002|Overall Study|Withdrawal by Subject|0|||
17120862|NCT03589768|38259952|FG003|Overall Study|Withdrawal by Subject|0|||
17120863|NCT03589768|38259949|FG000|Overall Study|Protocol Violation|1|||
17120864|NCT03589768|38259950|FG001|Overall Study|Protocol Violation|0|||
17120865|NCT03589768|38259951|FG002|Overall Study|Protocol Violation|0|||
17120866|NCT03589768|38259952|FG003|Overall Study|Protocol Violation|0|||
17120867|NCT02892422|38259962|FG000|Overall Study|Enrolled not treated|4|||
17120868|NCT02892422|38259962|FG000|Overall Study|Adverse Event|38|||
17120869|NCT02892422|38259962|FG000|Overall Study|Lack of Efficacy|32|||
17120870|NCT02892422|38259962|FG000|Overall Study|Non-compliance with study drug|11|||
17120871|NCT02892422|38259962|FG000|Overall Study|Protocol Violation|4|||
17120872|NCT02892422|38259962|FG000|Overall Study|Withdrawal by Subject|56|||
17120873|NCT02892422|38259962|FG000|Overall Study|Lost to Follow-up|5|||
17120874|NCT02892422|38259962|FG000|Overall Study|sponsor information 16159A results|21|||
17120875|NCT02892422|38259962|FG000|Overall Study|withdrawal of consent|13|||
17120876|NCT02892422|38259962|FG000|Overall Study|exclusion criteria met|3|||
17120877|NCT02892422|38259962|FG000|Overall Study|moving elsewhere|4|||
17120878|NCT02892422|38259962|FG000|Overall Study|non-compliance|10|||
17120879|NCT02892422|38259962|FG000|Overall Study|patient legally incapable|1|||
17120880|NCT02892422|38259962|FG000|Overall Study|patient decision|7|||
17120881|NCT02892422|38259962|FG000|Overall Study|Investigator decision|1|||
17120882|NCT03571646|38259968|FG000|Overall Study|Adverse Event|1|||
17120883|NCT03571646|38259969|FG001|Overall Study|Adverse Event|0|||
17120884|NCT03571646|38259968|FG000|Overall Study|Withdrawal by Subject|1|||
17120885|NCT03571646|38259969|FG001|Overall Study|Withdrawal by Subject|1|||
17120886|NCT03645434|38259975|FG000|Period 1|Adverse Event|0|||
17120887|NCT03645434|38259976|FG001|Period 1|Adverse Event|0|||
17120888|NCT03645434|38259977|FG002|Period 1|Adverse Event|0|||
17120889|NCT03645434|38259978|FG003|Period 1|Adverse Event|1|||
17120890|NCT03645434|38259979|FG004|Period 1|Adverse Event|0|||
17120891|NCT03645434|38259980|FG005|Period 1|Adverse Event|0|||
17120892|NCT03645434|38259975|FG000|Period 1|COPD exacerbation|0|||
17120893|NCT03645434|38259976|FG001|Period 1|COPD exacerbation|0|||
17120894|NCT03645434|38259977|FG002|Period 1|COPD exacerbation|0|||
17120895|NCT03645434|38259978|FG003|Period 1|COPD exacerbation|0|||
17120896|NCT03645434|38259979|FG004|Period 1|COPD exacerbation|1|||
17120897|NCT03645434|38259980|FG005|Period 1|COPD exacerbation|0|||
17120898|NCT00089505|38259992|FG000|Overall Study|Death|4|||
17120899|NCT00089505|38259993|FG001|Overall Study|Death|1|||
17120900|NCT00089505|38259994|FG002|Overall Study|Death|5|||
17120901|NCT00089505|38259995|FG003|Overall Study|Death|8|||
17120902|NCT00089505|38259992|FG000|Overall Study|Withdrawal by Subject|3|||
17120903|NCT00089505|38259993|FG001|Overall Study|Withdrawal by Subject|0|||
17120904|NCT00089505|38259994|FG002|Overall Study|Withdrawal by Subject|6|||
17120905|NCT00089505|38259995|FG003|Overall Study|Withdrawal by Subject|6|||
17120906|NCT00089505|38259992|FG000|Overall Study|Lost to Follow-up|1|||
17120907|NCT00089505|38259993|FG001|Overall Study|Lost to Follow-up|1|||
17120908|NCT00089505|38259994|FG002|Overall Study|Lost to Follow-up|9|||
17120909|NCT00089505|38259995|FG003|Overall Study|Lost to Follow-up|7|||
17120910|NCT00089505|38259992|FG000|Overall Study|Physician Decision|1|||
17120911|NCT00089505|38259993|FG001|Overall Study|Physician Decision|0|||
17120912|NCT00089505|38259994|FG002|Overall Study|Physician Decision|0|||
17120913|NCT00089505|38259995|FG003|Overall Study|Physician Decision|0|||
17120914|NCT00089505|38259992|FG000|Overall Study|Protocol Violation|0|||
17120915|NCT00089505|38259993|FG001|Overall Study|Protocol Violation|0|||
17120916|NCT00089505|38259994|FG002|Overall Study|Protocol Violation|1|||
17120917|NCT00089505|38259995|FG003|Overall Study|Protocol Violation|0|||
17120918|NCT04009824|38260010|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
17120919|NCT04009824|38260011|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
17120920|NCT04009824|38260012|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
17120921|NCT04009824|38260013|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
17120922|NCT04009824|38260014|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
17120923|NCT03555890|38260030|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17120924|NCT03555890|38260031|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17120925|NCT03555890|38260032|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17120926|NCT03555890|38260033|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
17120927|NCT03688074|38260045|FG000|Overall Study|Adverse Event|0|||
17120928|NCT03688074|38260046|FG001|Overall Study|Adverse Event|1|||
17120929|NCT03688074|38260045|FG000|Overall Study|Other|1|||
17120930|NCT03688074|38260046|FG001|Overall Study|Other|0|||
17120931|NCT03630120|38260056|FG000|Overall Study|Disease progression|0|||
17120932|NCT03630120|38260057|FG001|Overall Study|Disease progression|1|||
17120933|NCT03630120|38260058|FG002|Overall Study|Disease progression|1|||
17120934|NCT03630120|38260059|FG003|Overall Study|Disease progression|1|||
17120935|NCT03555266|38260071|FG000|Overall Study|Protocol Violation|6|||
17120936|NCT03555266|38260072|FG001|Overall Study|Protocol Violation|4|||
17120937|NCT03629886|38260080|FG000|Overall Study|Migrated / moved from the study area|0|||
17120938|NCT03629886|38260081|FG001|Overall Study|Migrated / moved from the study area|55|||
17120939|NCT03629886|38260080|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
17120940|NCT03629886|38260081|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
17120941|NCT03629886|38260080|FG000|Overall Study|Study vaccine not administrated|0|||
17120942|NCT03629886|38260081|FG001|Overall Study|Study vaccine not administrated|3|||
17120943|NCT03629886|38260080|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
17120944|NCT03629886|38260081|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
17120945|NCT03629886|38260080|FG000|Overall Study|Refused vaccination step of the study|0|||
17120946|NCT03629886|38260081|FG001|Overall Study|Refused vaccination step of the study|44|||
17120947|NCT03656874|38260090|FG000|Overall Study|Lost to Follow-up|3|||
17120948|NCT03656874|38260091|FG001|Overall Study|Lost to Follow-up|17|||
17120949|NCT03554486|38260099|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
17120950|NCT03554486|38260100|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
17120951|NCT03554486|38260101|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
17120952|NCT03554486|38260099|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
17120953|NCT03554486|38260100|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
17120954|NCT03554486|38260101|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
17120955|NCT03554486|38260099|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
17120956|NCT03554486|38260100|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
17120957|NCT03554486|38260101|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
17120958|NCT03520036|38260111|FG000|Overall Study|Adverse Event|1|||
17120959|NCT03520036|38260112|FG001|Overall Study|Adverse Event|2|||
17120960|NCT03520036|38260113|FG002|Overall Study|Adverse Event|0|||
17120961|NCT03520036|38260111|FG000|Overall Study|Protocol Violation|1|||
17120962|NCT03520036|38260112|FG001|Overall Study|Protocol Violation|0|||
17120963|NCT03520036|38260113|FG002|Overall Study|Protocol Violation|0|||
17120964|NCT03520036|38260111|FG000|Overall Study|Withdrawal by Subject|0|||
17120965|NCT03520036|38260112|FG001|Overall Study|Withdrawal by Subject|1|||
17120966|NCT03520036|38260113|FG002|Overall Study|Withdrawal by Subject|4|||
17120967|NCT03520036|38260111|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
17120968|NCT03520036|38260112|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
17120969|NCT03520036|38260113|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
17120970|NCT03554018|38260123|FG000|Overall Study|Lost to Follow-up|3|||
17120971|NCT03554018|38260124|FG001|Overall Study|Lost to Follow-up|7|||
17120972|NCT03571256|38260133|FG000|Overall Study|Adverse Event|3|||
17120973|NCT03571256|38260134|FG001|Overall Study|Adverse Event|0|||
17120974|NCT03571256|38260135|FG002|Overall Study|Adverse Event|1|||
17120975|NCT03571256|38260133|FG000|Overall Study|Withdrawal by Subject|3|||
17120976|NCT03571256|38260134|FG001|Overall Study|Withdrawal by Subject|1|||
17120977|NCT03571256|38260135|FG002|Overall Study|Withdrawal by Subject|1|||
17120978|NCT03571256|38260133|FG000|Overall Study|Other than specified|0|||
17120979|NCT03571256|38260134|FG001|Overall Study|Other than specified|1|||
17120980|NCT03571256|38260135|FG002|Overall Study|Other than specified|1|||
17120981|NCT03571256|38260133|FG000|Overall Study|Protocol Violation|0|||
17120982|NCT03571256|38260134|FG001|Overall Study|Protocol Violation|1|||
17120983|NCT03571256|38260135|FG002|Overall Study|Protocol Violation|1|||
17120984|NCT03570554|38260149|FG000|Overall Study|Non-compliance with study drug|0|||
17120985|NCT03570554|38260150|FG001|Overall Study|Non-compliance with study drug|0|||
17120986|NCT03570554|38260151|FG002|Overall Study|Non-compliance with study drug|1|||
17120987|NCT03570554|38260152|FG003|Overall Study|Non-compliance with study drug|0|||
17120988|NCT03570554|38260149|FG000|Overall Study|Adverse Event|0|||
17120989|NCT03570554|38260150|FG001|Overall Study|Adverse Event|0|||
17120990|NCT03570554|38260151|FG002|Overall Study|Adverse Event|0|||
17120991|NCT03570554|38260152|FG003|Overall Study|Adverse Event|1|||
17120992|NCT04004208|38260164|FG000|Overall Study|Withdrawal by parent/guardian|1|||
17120993|NCT04004208|38260165|FG001|Overall Study|Withdrawal by parent/guardian|1|||
17120994|NCT04004208|38260164|FG000|Overall Study|Death|3|||
17120995|NCT04004208|38260165|FG001|Overall Study|Death|0|||
17120996|NCT04004208|38260164|FG000|Overall Study|COVID-19 pandemic|1|||
17120997|NCT04004208|38260165|FG001|Overall Study|COVID-19 pandemic|0|||
17120998|NCT04004208|38260164|FG000|Overall Study|Physician Decision|1|||
17120999|NCT04004208|38260165|FG001|Overall Study|Physician Decision|0|||
17121000|NCT04004208|38260164|FG000|Overall Study|Adverse Event|1|||
17121001|NCT04004208|38260165|FG001|Overall Study|Adverse Event|1|||
17121002|NCT03643952|38260171|FG000|Overall Study|Lack of Efficacy|1|||
17121003|NCT03035032|38260183|FG000|Overall Study|Adverse Event|2|||
17121004|NCT03035032|38260183|FG000|Overall Study|Death|9|||
17121005|NCT03035032|38260183|FG000|Overall Study|Lost to Follow-up|1|||
17121006|NCT03035032|38260183|FG000|Overall Study|Progressive Disease|22|||
17121007|NCT03035032|38260183|FG000|Overall Study|Protocol Violation|2|||
17121008|NCT03035032|38260183|FG000|Overall Study|Withdrawal by Subject|2|||
17121009|NCT03035032|38260183|FG000|Overall Study|Physician Decision|5|||
17121010|NCT03629184|38260189|FG000|Overall Study|Withdrawal by Subject|2|||
17121011|NCT03629184|38260190|FG001|Overall Study|Withdrawal by Subject|1|||
17121012|NCT03629184|38260189|FG000|Overall Study|Physician Decision|1|||
17121013|NCT03629184|38260190|FG001|Overall Study|Physician Decision|0|||
17121014|NCT03549338|38260208|FG000|Overall Study|Progressive Disease|1|||
17121015|NCT03549338|38260209|FG001|Overall Study|Progressive Disease|0|||
17121016|NCT03549338|38260210|FG002|Overall Study|Progressive Disease|0|||
17121017|NCT03549338|38260208|FG000|Overall Study|Clinical Progression|0|||
17121018|NCT03549338|38260209|FG001|Overall Study|Clinical Progression|1|||
17121019|NCT03549338|38260210|FG002|Overall Study|Clinical Progression|0|||
17121020|NCT03629028|38260218|FG000|Overall Study|Lost to Follow-up|26|||
17121021|NCT03629028|38260219|FG001|Overall Study|Lost to Follow-up|23|||
17121022|NCT03629028|38260218|FG000|Overall Study|Pregnancy|4|||
17121023|NCT03629028|38260219|FG001|Overall Study|Pregnancy|2|||
17121024|NCT03629028|38260218|FG000|Overall Study|intolerance to examination|2|||
17121025|NCT03629028|38260219|FG001|Overall Study|intolerance to examination|0|||
17121026|NCT03549104|38260237|FG000|Overall Study|Physician Decision|2|||
17121027|NCT03549104|38260238|FG001|Overall Study|Physician Decision|0|||
17121028|NCT03549104|38260237|FG000|Overall Study|Withdrawal by Subject|5|||
17121029|NCT03549104|38260238|FG001|Overall Study|Withdrawal by Subject|2|||
17121030|NCT03549104|38260237|FG000|Overall Study|Covid shelter in place|1|||
17121031|NCT03549104|38260238|FG001|Overall Study|Covid shelter in place|2|||
17121032|NCT02892344|38260246|FG000|Overall Study|Protocol deviation|3|||
17121033|NCT02892344|38260247|FG001|Overall Study|Protocol deviation|4|||
17121034|NCT02892344|38260246|FG000|Overall Study|Adverse Event|1|||
17121035|NCT02892344|38260247|FG001|Overall Study|Adverse Event|8|||
17121036|NCT02892344|38260246|FG000|Overall Study|Lost to Follow-up|0|||
17121037|NCT02892344|38260247|FG001|Overall Study|Lost to Follow-up|1|||
17121038|NCT02892344|38260246|FG000|Overall Study|Non-compliance with study treatment|0|||
17121039|NCT02892344|38260247|FG001|Overall Study|Non-compliance with study treatment|1|||
17121040|NCT02892344|38260246|FG000|Overall Study|Physician Decision|0|||
17121041|NCT02892344|38260247|FG001|Overall Study|Physician Decision|2|||
17121042|NCT02892344|38260246|FG000|Overall Study|Subject/guardian decision|0|||
17121043|NCT02892344|38260247|FG001|Overall Study|Subject/guardian decision|4|||
17121044|NCT02892344|38260246|FG000|Overall Study|Technical problems|0|||
17121045|NCT02892344|38260247|FG001|Overall Study|Technical problems|1|||
17121046|NCT03567980|38260253|FG000|Overall Study|Adverse Event|1|||
17121047|NCT02894840|38260261|FG000|Overall Study|Lost to Follow-up|1|||
17121048|NCT02894840|38260262|FG001|Overall Study|Lost to Follow-up|0|||
17121049|NCT02894840|38260263|FG002|Overall Study|Lost to Follow-up|3|||
17121050|NCT02894840|38260264|FG003|Overall Study|Lost to Follow-up|0|||
17121051|NCT03358030|38260283|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
17121052|NCT03358030|38260284|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
17121053|NCT03358030|38260285|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
17121054|NCT03358030|38260286|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
17121055|NCT03358030|38260283|FG000|Overall Study|Ineligibility|0|||
17121056|NCT03358030|38260284|FG001|Overall Study|Ineligibility|0|||
17121057|NCT03358030|38260285|FG002|Overall Study|Ineligibility|0|||
17121058|NCT03358030|38260286|FG003|Overall Study|Ineligibility|2|||
17121059|NCT03358030|38260283|FG000|Overall Study|Voluntary Withdrawal|1|||
17121060|NCT03358030|38260284|FG001|Overall Study|Voluntary Withdrawal|1|||
17121061|NCT03358030|38260285|FG002|Overall Study|Voluntary Withdrawal|3|||
17121062|NCT03358030|38260286|FG003|Overall Study|Voluntary Withdrawal|1|||
17121063|NCT03358030|38260283|FG000|Overall Study|Other|0|||
17121064|NCT03358030|38260284|FG001|Overall Study|Other|0|||
17121065|NCT03358030|38260285|FG002|Overall Study|Other|1|||
17121066|NCT03358030|38260286|FG003|Overall Study|Other|0|||
17121067|NCT03566810|38260300|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
17121068|NCT03566810|38260301|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
17121069|NCT03566810|38260302|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
17121070|NCT03566810|38260303|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
17121071|NCT03628716|38260326|FG000|Overall Study|Adverse Event|1|||
17121072|NCT03628716|38260327|FG001|Overall Study|Adverse Event|1|||
17121073|NCT03628716|38260326|FG000|Overall Study|Death|1|||
17121074|NCT03628716|38260327|FG001|Overall Study|Death|0|||
17121075|NCT03628716|38260326|FG000|Overall Study|Lack of Efficacy|15|||
17121076|NCT03628716|38260327|FG001|Overall Study|Lack of Efficacy|20|||
17121077|NCT03628716|38260326|FG000|Overall Study|Withdrawal by Subject|1|||
17121078|NCT03628716|38260327|FG001|Overall Study|Withdrawal by Subject|2|||
17121079|NCT03628716|38260326|FG000|Overall Study|Study Terminated by Sponsor|1|||
17121080|NCT03628716|38260327|FG001|Overall Study|Study Terminated by Sponsor|0|||
17121081|NCT04002960|38260335|FG000|Overall Study|Withdrawn prior to Completion|2|||
17121082|NCT04002648|38260341|FG000|Overall Study|Lost to Follow-up|2|||
17121083|NCT04002648|38260342|FG001|Overall Study|Lost to Follow-up|0|||
17121084|NCT00088413|38260363|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
17121085|NCT00088413|38260364|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
17121086|NCT00088413|38260365|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
17121087|NCT00088413|38260366|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
17121088|NCT00088413|38260363|FG000|Overall Study|Adverse Events/Side Effects|0|||
17121089|NCT00088413|38260364|FG001|Overall Study|Adverse Events/Side Effects|1|||
17121090|NCT00088413|38260365|FG002|Overall Study|Adverse Events/Side Effects|1|||
17121091|NCT00088413|38260366|FG003|Overall Study|Adverse Events/Side Effects|0|||
17121092|NCT00088413|38260363|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
17121093|NCT00088413|38260364|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
17121094|NCT00088413|38260365|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
17121095|NCT00088413|38260366|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
17121096|NCT00088413|38260363|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
17121097|NCT00088413|38260364|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
17121098|NCT00088413|38260365|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
17121099|NCT00088413|38260366|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
17121100|NCT00088413|38260363|FG000|Overall Study|Death|0|||
17121101|NCT00088413|38260364|FG001|Overall Study|Death|1|||
17121102|NCT00088413|38260365|FG002|Overall Study|Death|0|||
17121103|NCT00088413|38260366|FG003|Overall Study|Death|0|||
17121104|NCT00088413|38260363|FG000|Overall Study|Progressive disease|9|||
17121105|NCT00088413|38260364|FG001|Overall Study|Progressive disease|11|||
17121106|NCT00088413|38260365|FG002|Overall Study|Progressive disease|8|||
17121107|NCT00088413|38260366|FG003|Overall Study|Progressive disease|14|||
17121108|NCT00088413|38260363|FG000|Overall Study|Other|0|||
17121109|NCT00088413|38260364|FG001|Overall Study|Other|1|||
17121110|NCT00088413|38260365|FG002|Overall Study|Other|0|||
17121111|NCT00088413|38260366|FG003|Overall Study|Other|0|||
17121112|NCT00088413|38260363|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
17121113|NCT00088413|38260364|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
17121114|NCT00088413|38260365|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
17121115|NCT00088413|38260366|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
17121116|NCT03995784|38260378|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
17121117|NCT00086385|38260393|FG000|Overall Study|Death|2|||
17121118|NCT00086385|38260394|FG001|Overall Study|Death|2|||
17121119|NCT00086385|38260395|FG002|Overall Study|Death|1|||
17121120|NCT00086385|38260396|FG003|Overall Study|Death|1|||
17121121|NCT03993288|38260408|FG000|Overall Study|Lost to Follow-up|2|||
17121122|NCT03993288|38260409|FG001|Overall Study|Lost to Follow-up|1|||
17121123|NCT03993288|38260408|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
17121124|NCT03993288|38260409|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
17121125|NCT03993288|38260408|FG000|Overall Study|wrong randomization|0|||
17121126|NCT03993288|38260409|FG001|Overall Study|wrong randomization|1|||
17121127|NCT03993288|38260408|FG000|Overall Study|improper enrollment|0|||
17121128|NCT03993288|38260409|FG001|Overall Study|improper enrollment|1|||
17121129|NCT03993288|38260408|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
17121130|NCT03993288|38260409|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
17121131|NCT03993288|38260408|FG000|Overall Study|developed SAE|2|||
17121132|NCT03993288|38260409|FG001|Overall Study|developed SAE|0|||
17121133|NCT03993288|38260408|FG000|Overall Study|consent withdrawal|1|||
17121134|NCT03993288|38260409|FG001|Overall Study|consent withdrawal|0|||
17121135|NCT03993288|38260408|FG000|Overall Study|did not follow the treatment schedule|1|||
17121136|NCT03993288|38260409|FG001|Overall Study|did not follow the treatment schedule|0|||
17121137|NCT03993288|38260408|FG000|Overall Study|did not follow the treatment regimen|1|||
17121138|NCT03993288|38260409|FG001|Overall Study|did not follow the treatment regimen|0|||
17121139|NCT03993288|38260408|FG000|Overall Study|Adverse Event|1|||
17121140|NCT03993288|38260409|FG001|Overall Study|Adverse Event|0|||
17121141|NCT03993288|38260408|FG000|Overall Study|Withdrawal by Subject|1|||
17121142|NCT03993288|38260409|FG001|Overall Study|Withdrawal by Subject|1|||
17121143|NCT03991494|38260415|FG000|Overall Study|Progressive Disease|4|||
17121144|NCT00086307|38260433|FG000|Overall Study|Lack of Efficacy|1|||
17121145|NCT00086307|38260434|FG001|Overall Study|Lack of Efficacy|1|||
17121146|NCT00086307|38260435|FG002|Overall Study|Lack of Efficacy|2|||
17121147|NCT00086307|38260433|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
17121148|NCT00086307|38260434|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
17121149|NCT00086307|38260435|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
17121150|NCT00086307|38260433|FG000|Overall Study|Nausea and headaches|0|||
17121151|NCT00086307|38260434|FG001|Overall Study|Nausea and headaches|0|||
17121152|NCT00086307|38260435|FG002|Overall Study|Nausea and headaches|1|||
17121153|NCT00086307|38260433|FG000|Overall Study|Constipation and sleepiness|0|||
17121154|NCT00086307|38260434|FG001|Overall Study|Constipation and sleepiness|0|||
17121155|NCT00086307|38260435|FG002|Overall Study|Constipation and sleepiness|1|||
17121156|NCT00086307|38260433|FG000|Overall Study|Suicidal ideation|0|||
17121157|NCT00086307|38260434|FG001|Overall Study|Suicidal ideation|0|||
17121158|NCT00086307|38260435|FG002|Overall Study|Suicidal ideation|1|||
17121159|NCT00086307|38260433|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
17121160|NCT00086307|38260434|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
17121161|NCT00086307|38260435|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
17121162|NCT00086307|38260433|FG000|Overall Study|Withdrawal by Subject|0|||
17121163|NCT00086307|38260434|FG001|Overall Study|Withdrawal by Subject|0|||
17121164|NCT00086307|38260435|FG002|Overall Study|Withdrawal by Subject|2|||
17121165|NCT03624972|38260446|FG000|Overall Study|Lost to Follow-up|2|||
17121166|NCT03624972|38260447|FG001|Overall Study|Lost to Follow-up|0|||
17121167|NCT03624972|38260448|FG002|Overall Study|Lost to Follow-up|0|||
17121168|NCT03624972|38260446|FG000|Overall Study|Withdrawal by Subject|0|||
17121169|NCT03624972|38260447|FG001|Overall Study|Withdrawal by Subject|2|||
17121170|NCT03624972|38260448|FG002|Overall Study|Withdrawal by Subject|0|||
17121171|NCT03988842|38260457|FG000|Overall Study|Death|1|||
17121172|NCT02668822|38260464|FG000|Overall Study|Protocol Violation|2|||
17121173|NCT02668822|38260465|FG001|Overall Study|Protocol Violation|0|||
17121174|NCT02668822|38260464|FG000|Overall Study|Study Terminated by Sponsor|7|||
17121175|NCT02668822|38260465|FG001|Overall Study|Study Terminated by Sponsor|9|||
17121176|NCT02524288|38260471|FG000|Overall Study|Adverse Event|115|||
17121177|NCT02524288|38260471|FG000|Overall Study|Lost to Follow-up|216|||
17121178|NCT02524288|38260471|FG000|Overall Study|Non-Compliance With Protocol|32|||
17121179|NCT02524288|38260471|FG000|Overall Study|Non-Compliance With Study Drug|14|||
17121180|NCT02524288|38260471|FG000|Overall Study|Pregnancy Wish|6|||
17121181|NCT02524288|38260471|FG000|Overall Study|Protocol Violation|6|||
17121182|NCT02524288|38260471|FG000|Overall Study|Screen Failure|2|||
17121183|NCT02524288|38260471|FG000|Overall Study|Site Discontinued Study Participation|1|||
17121184|NCT02524288|38260471|FG000|Overall Study|Study Terminated By Sponsor|1417|||
17121185|NCT02524288|38260471|FG000|Overall Study|Subject Moved|32|||
17121186|NCT02524288|38260471|FG000|Overall Study|Withdrawal by Subject|76|||
17121187|NCT02524288|38260471|FG000|Overall Study|Pregnancy|22|||
17121188|NCT02524288|38260471|FG000|Overall Study|Physician Decision|2|||
17121189|NCT03624504|38260475|FG000|Overall Study|Unsuccessful Implant|1|||
17121190|NCT02954952|38260482|FG000|Overall Study|Withdrawal by Subject|1|||
17121191|NCT02954952|38260483|FG001|Overall Study|Withdrawal by Subject|0|||
17121192|NCT02954952|38260484|FG002|Overall Study|Withdrawal by Subject|0|||
17121193|NCT02954952|38260482|FG000|Overall Study|No data collected|0|||
17121194|NCT02954952|38260483|FG001|Overall Study|No data collected|1|||
17121195|NCT02954952|38260484|FG002|Overall Study|No data collected|0|||
17121196|NCT03547154|38260494|FG000|Overall Study|Disease Progression/Recurrence|6|||
17121197|NCT03547154|38260495|FG001|Overall Study|Disease Progression/Recurrence|14|||
17121198|NCT03547154|38260494|FG000|Overall Study|Adverse Event|26|||
17121199|NCT03547154|38260495|FG001|Overall Study|Adverse Event|31|||
17121200|NCT03547154|38260494|FG000|Overall Study|Protocol Violation|6|||
17121201|NCT03547154|38260495|FG001|Overall Study|Protocol Violation|1|||
17121202|NCT03547154|38260494|FG000|Overall Study|Physician Decision|4|||
17121203|NCT03547154|38260495|FG001|Overall Study|Physician Decision|3|||
17121204|NCT03547154|38260494|FG000|Overall Study|Insufficient Therapeutic Response|13|||
17121205|NCT03547154|38260495|FG001|Overall Study|Insufficient Therapeutic Response|10|||
17121206|NCT03547154|38260494|FG000|Overall Study|Withdrawal by Subject|10|||
17121207|NCT03547154|38260495|FG001|Overall Study|Withdrawal by Subject|6|||
17121208|NCT03547154|38260494|FG000|Overall Study|Not Selected|0|||
17121209|NCT03547154|38260495|FG001|Overall Study|Not Selected|1|||
17121210|NCT03547154|38260494|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
17121211|NCT03547154|38260495|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
17121212|NCT02275546|38260501|FG000|Treatment Period 2|Withdrawal by Subject|2|||
17121213|NCT02275546|38260502|FG001|Treatment Period 2|Withdrawal by Subject|1|||
17121214|NCT02275546|38260501|FG000|Treatment Period 2|Protocol Violation|0|||
17121215|NCT02275546|38260502|FG001|Treatment Period 2|Protocol Violation|1|||
17121216|NCT03624192|38260508|FG000|Overall Study|Lost to Follow-up|1|||
17121217|NCT03624192|38260509|FG001|Overall Study|Lost to Follow-up|1|||
17121218|NCT03034954|38260519|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
17121219|NCT03034954|38260520|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
17121220|NCT00057837|38260528|FG000|Overall Study|Progression/relapse|12|||
17121221|NCT00057837|38260529|FG001|Overall Study|Progression/relapse|14|||
17121222|NCT00057837|38260528|FG000|Overall Study|Adverse Event|2|||
16942091|NCT01371747|38086664|FG000|Overall Study|Adverse Event|4|||
17121223|NCT00057837|38260529|FG001|Overall Study|Adverse Event|12|||
17121224|NCT00057837|38260528|FG000|Overall Study|Death|5|||
17121225|NCT00057837|38260529|FG001|Overall Study|Death|4|||
17121226|NCT00057837|38260528|FG000|Overall Study|Withdrawal by Subject|5|||
17121227|NCT00057837|38260529|FG001|Overall Study|Withdrawal by Subject|3|||
17121228|NCT00057837|38260528|FG000|Overall Study|Alternative therapy|0|||
17121229|NCT00057837|38260529|FG001|Overall Study|Alternative therapy|1|||
17121230|NCT00057837|38260528|FG000|Overall Study|Other complicating disease|2|||
17121231|NCT00057837|38260529|FG001|Overall Study|Other complicating disease|1|||
17121232|NCT00057837|38260528|FG000|Overall Study|Physician Decision|1|||
17121233|NCT00057837|38260529|FG001|Overall Study|Physician Decision|0|||
17121234|NCT00057837|38260528|FG000|Overall Study|Ineligible|3|||
17121235|NCT00057837|38260529|FG001|Overall Study|Ineligible|3|||
17121236|NCT00057837|38260528|FG000|Overall Study|Never started treatment|1|||
17121237|NCT00057837|38260529|FG001|Overall Study|Never started treatment|1|||
17121238|NCT03546842|38260535|FG000|Overall Study|Protocol Violation|1|||
17121239|NCT03546842|38260535|FG000|Overall Study|Withdrawal by Subject|2|||
17121240|NCT03640052|38260539|FG000|Overall Study|Lost to Follow-up|0|||
17121241|NCT03640052|38260540|FG001|Overall Study|Lost to Follow-up|1|||
17121242|NCT03640052|38260541|FG002|Overall Study|Lost to Follow-up|0|||
17121243|NCT03640052|38260542|FG003|Overall Study|Lost to Follow-up|0|||
17121244|NCT03640052|38260543|FG004|Overall Study|Lost to Follow-up|0|||
17121245|NCT00068601|38260557|FG000|Overall Study|Ineligible|11|||
17121246|NCT00068601|38260558|FG001|Overall Study|Ineligible|13|||
17121247|NCT00068601|38260557|FG000|Overall Study|Not evaluable: withdrew consent|5|||
17121248|NCT00068601|38260558|FG001|Overall Study|Not evaluable: withdrew consent|4|||
17121249|NCT00068601|38260557|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
17121250|NCT00068601|38260558|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
17121251|NCT00068601|38260557|FG000|Overall Study|Death|11|||
17121252|NCT00068601|38260558|FG001|Overall Study|Death|3|||
17121253|NCT00068601|38260557|FG000|Overall Study|Lost to Follow-up|3|||
17121254|NCT00068601|38260558|FG001|Overall Study|Lost to Follow-up|2|||
17121255|NCT00068601|38260557|FG000|Overall Study|Missing primary outcome data|30|||
17121256|NCT00068601|38260558|FG001|Overall Study|Missing primary outcome data|34|||
17121257|NCT03638258|38260567|FG000|Overall Study|Adverse Event|1|||
17121258|NCT03638258|38260568|FG001|Overall Study|Adverse Event|0|||
17121259|NCT03638258|38260569|FG002|Overall Study|Adverse Event|2|||
17121260|NCT03638258|38260567|FG000|Overall Study|Lost to Follow-up|2|||
17121261|NCT03638258|38260568|FG001|Overall Study|Lost to Follow-up|4|||
17121262|NCT03638258|38260569|FG002|Overall Study|Lost to Follow-up|5|||
17121263|NCT03638258|38260567|FG000|Overall Study|Pregnancy|0|||
17121264|NCT03638258|38260568|FG001|Overall Study|Pregnancy|0|||
17121265|NCT03638258|38260569|FG002|Overall Study|Pregnancy|1|||
17121266|NCT03638258|38260567|FG000|Overall Study|Protocol Violation|0|||
17121267|NCT03638258|38260568|FG001|Overall Study|Protocol Violation|0|||
17121268|NCT03638258|38260569|FG002|Overall Study|Protocol Violation|1|||
17121269|NCT03638258|38260567|FG000|Overall Study|Withdrawal by Subject|4|||
17121270|NCT03638258|38260568|FG001|Overall Study|Withdrawal by Subject|5|||
17121271|NCT03638258|38260569|FG002|Overall Study|Withdrawal by Subject|12|||
17121272|NCT03638258|38260567|FG000|Overall Study|Lack of Efficacy|0|||
17121273|NCT03638258|38260568|FG001|Overall Study|Lack of Efficacy|0|||
17121274|NCT03638258|38260569|FG002|Overall Study|Lack of Efficacy|2|||
17121275|NCT01670656|38260583|FG000|Overall Study|Non-compliance with study drug|0|||
17121276|NCT01670656|38260584|FG001|Overall Study|Non-compliance with study drug|0|||
17121277|NCT01670656|38260585|FG002|Overall Study|Non-compliance with study drug|3|||
17121278|NCT01670656|38260586|FG003|Overall Study|Non-compliance with study drug|0|||
17121279|NCT01670656|38260587|FG004|Overall Study|Non-compliance with study drug|1|||
17121280|NCT01670656|38260583|FG000|Overall Study|Pregnancy|0|||
17121281|NCT01670656|38260584|FG001|Overall Study|Pregnancy|0|||
17121282|NCT01670656|38260585|FG002|Overall Study|Pregnancy|0|||
17121283|NCT01670656|38260586|FG003|Overall Study|Pregnancy|0|||
17121284|NCT01670656|38260587|FG004|Overall Study|Pregnancy|1|||
17121285|NCT01670656|38260583|FG000|Overall Study|Withdrawal by Subject|1|||
16773167|NCT03745651|37712171|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
16773168|NCT03745651|37712172|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
16773169|NCT03745651|37712173|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
16773170|NCT03745651|37712174|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
16773171|NCT03745651|37712175|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
16773172|NCT03745651|37712169|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16773173|NCT03745651|37712170|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
17121286|NCT01670656|38260584|FG001|Overall Study|Withdrawal by Subject|1|||
17121287|NCT01670656|38260585|FG002|Overall Study|Withdrawal by Subject|0|||
17121288|NCT01670656|38260586|FG003|Overall Study|Withdrawal by Subject|0|||
17121289|NCT01670656|38260587|FG004|Overall Study|Withdrawal by Subject|0|||
17121290|NCT01670656|38260583|FG000|Overall Study|Non-compliance with protocol|0|||
17121291|NCT01670656|38260584|FG001|Overall Study|Non-compliance with protocol|3|||
17121292|NCT01670656|38260585|FG002|Overall Study|Non-compliance with protocol|1|||
17121293|NCT01670656|38260586|FG003|Overall Study|Non-compliance with protocol|1|||
17121294|NCT01670656|38260587|FG004|Overall Study|Non-compliance with protocol|2|||
17121295|NCT01670656|38260583|FG000|Overall Study|Adverse Event|2|||
17121296|NCT01670656|38260584|FG001|Overall Study|Adverse Event|2|||
17121297|NCT01670656|38260585|FG002|Overall Study|Adverse Event|2|||
17121298|NCT01670656|38260586|FG003|Overall Study|Adverse Event|3|||
17121299|NCT01670656|38260587|FG004|Overall Study|Adverse Event|3|||
17121300|NCT01670656|38260583|FG000|Overall Study|Subject withdrew consent|0|||
17121301|NCT01670656|38260584|FG001|Overall Study|Subject withdrew consent|1|||
17121302|NCT01670656|38260585|FG002|Overall Study|Subject withdrew consent|2|||
17121303|NCT01670656|38260586|FG003|Overall Study|Subject withdrew consent|1|||
17121304|NCT01670656|38260587|FG004|Overall Study|Subject withdrew consent|1|||
17121305|NCT01670656|38260583|FG000|Overall Study|Lost to Follow-up|0|||
17121306|NCT01670656|38260584|FG001|Overall Study|Lost to Follow-up|0|||
17121307|NCT01670656|38260585|FG002|Overall Study|Lost to Follow-up|0|||
17121308|NCT01670656|38260586|FG003|Overall Study|Lost to Follow-up|0|||
17121309|NCT01670656|38260587|FG004|Overall Study|Lost to Follow-up|3|||
17121310|NCT01670656|38260583|FG000|Overall Study|Subject moved|0|||
17121311|NCT01670656|38260584|FG001|Overall Study|Subject moved|0|||
17121312|NCT01670656|38260585|FG002|Overall Study|Subject moved|0|||
17121313|NCT01670656|38260586|FG003|Overall Study|Subject moved|1|||
17121314|NCT01670656|38260587|FG004|Overall Study|Subject moved|0|||
17121315|NCT03621696|38260603|FG000|Overall Study|Not eligible|0|||
17121316|NCT03621696|38260604|FG001|Overall Study|Not eligible|0|||
17121317|NCT03621696|38260605|FG002|Overall Study|Not eligible|0|||
17121318|NCT03621696|38260606|FG003|Overall Study|Not eligible|5|||
17121319|NCT03621696|38260603|FG000|Overall Study|Withdrawal by Subject|1|||
17121320|NCT03621696|38260604|FG001|Overall Study|Withdrawal by Subject|1|||
17121321|NCT03621696|38260605|FG002|Overall Study|Withdrawal by Subject|1|||
17121322|NCT03621696|38260606|FG003|Overall Study|Withdrawal by Subject|0|||
17121323|NCT03621696|38260603|FG000|Overall Study|Physician Decision|0|||
17121324|NCT03621696|38260604|FG001|Overall Study|Physician Decision|0|||
17121325|NCT03621696|38260605|FG002|Overall Study|Physician Decision|1|||
17121326|NCT03621696|38260606|FG003|Overall Study|Physician Decision|0|||
17121327|NCT00068445|38260616|FG000|Randomization|Cancel|1|||
17121328|NCT00068445|38260617|FG001|Randomization|Cancel|3|||
17121329|NCT00068445|38260616|FG000|Randomization|Ineligible|1|||
17121330|NCT00068445|38260617|FG001|Randomization|Ineligible|1|||
17121331|NCT00068445|38260616|FG000|Treatment|Refused Further Treatment|13|||
17121332|NCT00068445|38260617|FG001|Treatment|Refused Further Treatment|10|||
17121333|NCT00068445|38260616|FG000|Treatment|Adverse Event|7|||
17121334|NCT00068445|38260617|FG001|Treatment|Adverse Event|1|||
17121335|NCT00068445|38260616|FG000|Treatment|Other (Specifics not available)|9|||
17121336|NCT00068445|38260617|FG001|Treatment|Other (Specifics not available)|5|||
16773174|NCT03745651|37712171|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16773175|NCT03745651|37712172|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16773176|NCT03745651|37712173|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16773177|NCT03745651|37712174|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
16773178|NCT03745651|37712175|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16773179|NCT03745651|37712169|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16773180|NCT03745651|37712170|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16773181|NCT03745651|37712171|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16773182|NCT03745651|37712172|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
16773183|NCT03745651|37712173|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16773184|NCT03745651|37712174|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
16773185|NCT03745651|37712175|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
16773186|NCT03745651|37712169|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16773187|NCT03745651|37712170|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16773188|NCT03745651|37712171|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
17121337|NCT03653208|38260632|FG000|Overall Study|Withdrawal by Subject|0|||
17121338|NCT03653208|38260633|FG001|Overall Study|Withdrawal by Subject|0|||
17121339|NCT03653208|38260634|FG002|Overall Study|Withdrawal by Subject|0|||
17121340|NCT03653208|38260635|FG003|Overall Study|Withdrawal by Subject|0|||
17121341|NCT03653208|38260636|FG004|Overall Study|Withdrawal by Subject|1|||
17121342|NCT03653208|38260637|FG005|Overall Study|Withdrawal by Subject|0|||
17121343|NCT03653208|38260638|FG006|Overall Study|Withdrawal by Subject|0|||
17121344|NCT03653208|38260639|FG007|Overall Study|Withdrawal by Subject|1|||
17121345|NCT03653208|38260640|FG008|Overall Study|Withdrawal by Subject|1|||
17121346|NCT03545984|38260662|FG000|Overall Study|CSF cases not present during rotation|11|||
17121347|NCT03545984|38260663|FG001|Overall Study|CSF cases not present during rotation|9|||
17121348|NCT03033784|38260671|FG000|Overall Study|Anxiety related to MRI scanner|0|||
17121349|NCT03033784|38260672|FG001|Overall Study|Anxiety related to MRI scanner|1|||
17121350|NCT03033784|38260673|FG002|Overall Study|Anxiety related to MRI scanner|0|||
17121351|NCT03033784|38260674|FG003|Overall Study|Anxiety related to MRI scanner|0|||
17121352|NCT03033784|38260675|FG004|Overall Study|Anxiety related to MRI scanner|0|||
17121353|NCT03033784|38260676|FG005|Overall Study|Anxiety related to MRI scanner|0|||
17121354|NCT03033784|38260677|FG006|Overall Study|Anxiety related to MRI scanner|0|||
17121355|NCT03033784|38260678|FG007|Overall Study|Anxiety related to MRI scanner|0|||
17121356|NCT03033784|38260679|FG008|Overall Study|Anxiety related to MRI scanner|0|||
17121357|NCT03033784|38260680|FG009|Overall Study|Anxiety related to MRI scanner|0|||
17121358|NCT03033784|38260681|FG010|Overall Study|Anxiety related to MRI scanner|0|||
17121359|NCT03033784|38260682|FG011|Overall Study|Anxiety related to MRI scanner|0|||
17121360|NCT03033784|38260683|FG012|Overall Study|Anxiety related to MRI scanner|0|||
17121361|NCT03033784|38260671|FG000|Overall Study|Withdrawal by Subject|0|||
17121362|NCT03033784|38260672|FG001|Overall Study|Withdrawal by Subject|0|||
17121363|NCT03033784|38260673|FG002|Overall Study|Withdrawal by Subject|0|||
17121364|NCT03033784|38260674|FG003|Overall Study|Withdrawal by Subject|0|||
17121365|NCT03033784|38260675|FG004|Overall Study|Withdrawal by Subject|0|||
17121366|NCT03033784|38260676|FG005|Overall Study|Withdrawal by Subject|0|||
17121367|NCT03033784|38260677|FG006|Overall Study|Withdrawal by Subject|0|||
17121368|NCT03033784|38260678|FG007|Overall Study|Withdrawal by Subject|0|||
17121369|NCT03033784|38260679|FG008|Overall Study|Withdrawal by Subject|0|||
17121370|NCT03033784|38260680|FG009|Overall Study|Withdrawal by Subject|0|||
17121371|NCT03033784|38260681|FG010|Overall Study|Withdrawal by Subject|0|||
17121372|NCT03033784|38260682|FG011|Overall Study|Withdrawal by Subject|0|||
17121373|NCT03033784|38260683|FG012|Overall Study|Withdrawal by Subject|2|||
17121374|NCT00038649|38260694|FG000|Overall Study|Adverse Event|9|||
17121375|NCT03544268|38260700|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
17121376|NCT03544268|38260701|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
17121377|NCT03652818|38260712|FG000|Overall Study|Adverse Event|1|||
17121378|NCT03652818|38260713|FG001|Overall Study|Adverse Event|0|||
17121379|NCT03652818|38260714|FG002|Overall Study|Adverse Event|0|||
17121380|NCT03652818|38260715|FG003|Overall Study|Adverse Event|0|||
17121381|NCT03652818|38260716|FG004|Overall Study|Adverse Event|0|||
17121382|NCT03652818|38260712|FG000|Overall Study|Physician Decision|1|||
17121383|NCT03652818|38260713|FG001|Overall Study|Physician Decision|0|||
17121384|NCT03652818|38260714|FG002|Overall Study|Physician Decision|0|||
17121385|NCT03652818|38260715|FG003|Overall Study|Physician Decision|0|||
17121386|NCT03652818|38260716|FG004|Overall Study|Physician Decision|0|||
17121387|NCT03652818|38260712|FG000|Overall Study|Lost to Follow-up|0|||
17121388|NCT03652818|38260713|FG001|Overall Study|Lost to Follow-up|1|||
17121389|NCT03652818|38260714|FG002|Overall Study|Lost to Follow-up|2|||
17121390|NCT03652818|38260715|FG003|Overall Study|Lost to Follow-up|1|||
17121391|NCT03652818|38260716|FG004|Overall Study|Lost to Follow-up|1|||
17121392|NCT03619902|38260728|FG000|Overall Study|Termination of Study by Investigator|1|||
17121393|NCT03619902|38260728|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
17121394|NCT00620464|38260734|FG000|Overall Study|Adverse Event|15|||
17121395|NCT00620464|38260735|FG001|Overall Study|Adverse Event|17|||
17121396|NCT00620464|38260734|FG000|Overall Study|Lost to Follow-up|1|||
17121397|NCT00620464|38260735|FG001|Overall Study|Lost to Follow-up|1|||
17121398|NCT00620464|38260734|FG000|Overall Study|Planning Pregnancy|1|||
17121399|NCT00620464|38260735|FG001|Overall Study|Planning Pregnancy|4|||
17121400|NCT00620464|38260734|FG000|Overall Study|Personal|2|||
17121401|NCT00620464|38260735|FG001|Overall Study|Personal|2|||
17121402|NCT00620464|38260734|FG000|Overall Study|Used prohibited medication|1|||
17121403|NCT00620464|38260735|FG001|Overall Study|Used prohibited medication|0|||
17121404|NCT03652662|38260743|FG000|Overall Study|Withdrawal by Subject|2|||
17121405|NCT03652662|38260744|FG001|Overall Study|Withdrawal by Subject|1|||
17121406|NCT03652662|38260743|FG000|Overall Study|Lost to Follow-up|1|||
17121407|NCT03652662|38260744|FG001|Overall Study|Lost to Follow-up|0|||
17121408|NCT03560258|38260753|FG000|Overall Study|Lost to Follow-up|3|||
17121409|NCT03560258|38260754|FG001|Overall Study|Lost to Follow-up|0|||
17121410|NCT03560258|38260755|FG002|Overall Study|Lost to Follow-up|0|||
17121411|NCT03560258|38260753|FG000|Overall Study|Protocol Violation|0|||
17121412|NCT03560258|38260754|FG001|Overall Study|Protocol Violation|1|||
17121413|NCT03560258|38260755|FG002|Overall Study|Protocol Violation|0|||
17121414|NCT03560258|38260753|FG000|Overall Study|Withdrawal by Subject|0|||
16773189|NCT03745651|37712172|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
17121415|NCT03560258|38260754|FG001|Overall Study|Withdrawal by Subject|0|||
17121416|NCT03560258|38260755|FG002|Overall Study|Withdrawal by Subject|1|||
17121417|NCT02768662|38260763|FG000|Overall Study|Adverse Event|1|||
17121418|NCT02768662|38260763|FG000|Overall Study|Lost to Follow-up|4|||
17121419|NCT02768662|38260763|FG000|Overall Study|Withdrawal by Subject|3|||
17121420|NCT02768662|38260763|FG000|Overall Study|Study terminated by Sponsor|78|||
17121421|NCT03539432|38260769|FG000|Overall Study|Lost to Follow-up|0|||
17121422|NCT03539432|38260770|FG001|Overall Study|Lost to Follow-up|1|||
17121423|NCT03615924|38260778|FG000|Overall Study|Withdrawal by Subject|2|||
17121424|NCT03615924|38260779|FG001|Overall Study|Withdrawal by Subject|5|||
17121425|NCT03615924|38260778|FG000|Overall Study|Death|3|||
17121426|NCT03615924|38260779|FG001|Overall Study|Death|1|||
17121427|NCT03615924|38260778|FG000|Overall Study|Lost to Follow-up|1|||
17121428|NCT03615924|38260779|FG001|Overall Study|Lost to Follow-up|0|||
17121429|NCT03615924|38260778|FG000|Overall Study|Randomized in error|1|||
17121430|NCT03615924|38260779|FG001|Overall Study|Randomized in error|0|||
17121431|NCT03615924|38260778|FG000|Overall Study|Study termination by Sponsor|94|||
17121432|NCT03615924|38260779|FG001|Overall Study|Study termination by Sponsor|86|||
17121433|NCT03535844|38260787|FG000|Overall Study|Withdrawal by Subject|0|||
17121434|NCT03535844|38260788|FG001|Overall Study|Withdrawal by Subject|1|||
17121435|NCT03533114|38260805|FG000|Overall|Adverse Event|16|||
17121436|NCT03533114|38260806|FG001|Overall|Adverse Event|11|||
17121437|NCT03533114|38260805|FG000|Overall|Consent Withdrawal by Participant|7|||
17121438|NCT03533114|38260806|FG001|Overall|Consent Withdrawal by Participant|6|||
17121439|NCT03533114|38260805|FG000|Overall|Lack of Efficacy|5|||
17121440|NCT03533114|38260806|FG001|Overall|Lack of Efficacy|3|||
17121441|NCT03533114|38260805|FG000|Overall|Lost to Follow-up|1|||
17121442|NCT03533114|38260806|FG001|Overall|Lost to Follow-up|1|||
17121443|NCT03533114|38260805|FG000|Overall|Physician Decision|0|||
17121444|NCT03533114|38260806|FG001|Overall|Physician Decision|2|||
17121445|NCT03533114|38260805|FG000|Overall|Protocol deviation|1|||
17121446|NCT03533114|38260806|FG001|Overall|Protocol deviation|1|||
17121447|NCT03533114|38260805|FG000|Overall|Failure to meet randomization criteria|1|||
17121448|NCT03533114|38260806|FG001|Overall|Failure to meet randomization criteria|2|||
17121449|NCT03533114|38260805|FG000|Overall|Non-Compliance with study drug|0|||
17121450|NCT03533114|38260806|FG001|Overall|Non-Compliance with study drug|1|||
17121451|NCT03533114|38260805|FG000|Overall|Other|0|||
17121452|NCT03533114|38260806|FG001|Overall|Other|1|||
17121453|NCT03533114|38260805|FG000|Open Label Titration and Optimization|Adverse Event|11|||
17121454|NCT03533114|38260806|FG001|Open Label Titration and Optimization|Adverse Event|8|||
17121455|NCT03533114|38260805|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
17121456|NCT03533114|38260806|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
17121457|NCT03533114|38260805|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
17121458|NCT03533114|38260806|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
17121459|NCT03533114|38260805|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
17121460|NCT03533114|38260806|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
17121461|NCT03533114|38260805|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
17121462|NCT03533114|38260806|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
17121463|NCT03533114|38260805|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
17121464|NCT03533114|38260806|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
17121465|NCT03533114|38260805|FG000|Stable Dose|Adverse Event|0|||
17121466|NCT03533114|38260806|FG001|Stable Dose|Adverse Event|2|||
17121467|NCT03533114|38260805|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
17121468|NCT03533114|38260806|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
17121469|NCT03533114|38260805|FG000|Stable Dose|Lack of Efficacy|1|||
17121470|NCT03533114|38260806|FG001|Stable Dose|Lack of Efficacy|0|||
17121471|NCT03533114|38260805|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
17121472|NCT03533114|38260806|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
17121473|NCT03533114|38260805|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
17121474|NCT03533114|38260806|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
17121475|NCT03533114|38260805|FG000|Open-Label Safety Extension|Adverse Event|3|||
17121476|NCT03533114|38260806|FG001|Open-Label Safety Extension|Adverse Event|0|||
17121477|NCT03533114|38260805|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
17121478|NCT03533114|38260806|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
17121479|NCT03533114|38260805|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
17121480|NCT03533114|38260806|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
17121481|NCT03533114|38260805|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
17121482|NCT03533114|38260806|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
17121483|NCT03533114|38260805|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
17121484|NCT03533114|38260806|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
17121485|NCT03033394|38260814|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
17121486|NCT03033394|38260814|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
17121487|NCT03033394|38260814|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
17121488|NCT03033394|38260814|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
17121489|NCT03033394|38260814|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
17121490|NCT03981822|38260831|FG000|Overall Study|Lost to Follow-up|0|||
17121491|NCT03981822|38260832|FG001|Overall Study|Lost to Follow-up|1|||
17121492|NCT03981822|38260833|FG002|Overall Study|Lost to Follow-up|1|||
17121493|NCT03981822|38260834|FG003|Overall Study|Lost to Follow-up|0|||
17121494|NCT03981822|38260835|FG004|Overall Study|Lost to Follow-up|6|||
17121495|NCT03981822|38260836|FG005|Overall Study|Lost to Follow-up|4|||
17121496|NCT03981822|38260837|FG006|Overall Study|Lost to Follow-up|4|||
17121497|NCT03981822|38260838|FG007|Overall Study|Lost to Follow-up|2|||
17121498|NCT03981822|38260831|FG000|Overall Study|Withdrawal by Subject|0|||
17121499|NCT03981822|38260832|FG001|Overall Study|Withdrawal by Subject|1|||
17121500|NCT03981822|38260833|FG002|Overall Study|Withdrawal by Subject|0|||
17121501|NCT03981822|38260834|FG003|Overall Study|Withdrawal by Subject|0|||
17121502|NCT03981822|38260835|FG004|Overall Study|Withdrawal by Subject|0|||
17121503|NCT03981822|38260836|FG005|Overall Study|Withdrawal by Subject|1|||
17121504|NCT03981822|38260837|FG006|Overall Study|Withdrawal by Subject|0|||
17121505|NCT03981822|38260838|FG007|Overall Study|Withdrawal by Subject|2|||
17121506|NCT03981822|38260831|FG000|Overall Study|COVID-19 Related|0|||
17121507|NCT03981822|38260832|FG001|Overall Study|COVID-19 Related|0|||
17121508|NCT03981822|38260833|FG002|Overall Study|COVID-19 Related|0|||
17121509|NCT03981822|38260834|FG003|Overall Study|COVID-19 Related|0|||
17121510|NCT03981822|38260835|FG004|Overall Study|COVID-19 Related|2|||
17121511|NCT03981822|38260836|FG005|Overall Study|COVID-19 Related|1|||
17121512|NCT03981822|38260837|FG006|Overall Study|COVID-19 Related|2|||
17121513|NCT03981822|38260838|FG007|Overall Study|COVID-19 Related|1|||
17121514|NCT03980808|38260852|FG000|Overall Study|Lost to Follow-up|2|||
17121515|NCT03980808|38260853|FG001|Overall Study|Lost to Follow-up|2|||
17121516|NCT03650556|38260859|FG000|Overall Study|Death|2|||
17121517|NCT03650556|38260859|FG000|Overall Study|Withdrawal by Subject|20|||
17121518|NCT03650556|38260859|FG000|Overall Study|Physician Decision|2|||
17121519|NCT03650556|38260859|FG000|Overall Study|Lost to Follow-up|8|||
17121520|NCT03650556|38260859|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
17121521|NCT03650556|38260859|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
17121522|NCT03531632|38260867|FG000|Overall Study|Adverse Event|0|||
17121523|NCT03531632|38260868|FG001|Overall Study|Adverse Event|0|||
17121524|NCT03531632|38260869|FG002|Overall Study|Adverse Event|1|||
17121525|NCT03531632|38260867|FG000|Overall Study|Death|4|||
17121526|NCT03531632|38260868|FG001|Overall Study|Death|0|||
17121527|NCT03531632|38260869|FG002|Overall Study|Death|14|||
17121528|NCT03531632|38260867|FG000|Overall Study|Study Terminated|1|||
17121529|NCT03531632|38260868|FG001|Overall Study|Study Terminated|3|||
17121530|NCT03531632|38260869|FG002|Overall Study|Study Terminated|11|||
17121531|NCT03979638|38260880|FG000|Period 1|Physician Decision|1|||
17121532|NCT03979638|38260881|FG001|Period 1|Physician Decision|1|||
17121533|NCT03979638|38260880|FG000|Period 1|Withdrawal by Subject|4|||
17121534|NCT03979638|38260881|FG001|Period 1|Withdrawal by Subject|3|||
17121535|NCT03979638|38260880|FG000|Period 1|Study terminated by Sponsor|1|||
17121536|NCT03979638|38260881|FG001|Period 1|Study terminated by Sponsor|3|||
17121537|NCT03979638|38260880|FG000|Period 1|Protocol Violation|1|||
17121538|NCT03979638|38260881|FG001|Period 1|Protocol Violation|0|||
17121539|NCT03979638|38260880|FG000|Period 2|Study terminated by Sponsor|1|||
17121540|NCT03979638|38260881|FG001|Period 2|Study terminated by Sponsor|1|||
17121541|NCT03655054|38260896|FG000|Overall Study|Lost to Follow-up|1|||
17121542|NCT03615144|38260902|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
17121543|NCT03615144|38260903|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
17121544|NCT03682302|38260913|FG000|Overall Study|Lost to Follow-up|1|||
17121545|NCT03682302|38260914|FG001|Overall Study|Lost to Follow-up|2|||
17121546|NCT03682302|38260915|FG002|Overall Study|Lost to Follow-up|0|||
17121547|NCT03682302|38260916|FG003|Overall Study|Lost to Follow-up|1|||
17121548|NCT03682302|38260913|FG000|Overall Study|Study drug was not administered|0|||
17121549|NCT03682302|38260914|FG001|Overall Study|Study drug was not administered|0|||
17121550|NCT03682302|38260915|FG002|Overall Study|Study drug was not administered|1|||
17121551|NCT03682302|38260916|FG003|Overall Study|Study drug was not administered|1|||
17121552|NCT03522506|38260930|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
17121553|NCT03522506|38260931|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
17121554|NCT03522506|38260932|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
17121555|NCT03522506|38260933|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
17121556|NCT03522506|38260930|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
17121557|NCT03522506|38260931|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
17121558|NCT03522506|38260932|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
17121559|NCT03522506|38260933|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
17121560|NCT02892734|38260964|FG000|Treatment on Study|Progressive Disease|2|||
17121561|NCT02892734|38260964|FG000|Follow up for 2 Years|Death|2|||
17121562|NCT02892734|38260964|FG000|Follow up for 2 Years|Study closed early|1|||
17121563|NCT00055497|38260972|FG000|Overall Study|Adverse Event|1|||
17121564|NCT00055497|38260973|FG001|Overall Study|Adverse Event|1|||
17121565|NCT00055497|38260974|FG002|Overall Study|Adverse Event|1|||
17121566|NCT00055497|38260975|FG003|Overall Study|Adverse Event|28|||
17121567|NCT00055497|38260972|FG000|Overall Study|Withdrawal by Subject|3|||
17121568|NCT00055497|38260973|FG001|Overall Study|Withdrawal by Subject|1|||
17121569|NCT00055497|38260974|FG002|Overall Study|Withdrawal by Subject|1|||
17121570|NCT00055497|38260975|FG003|Overall Study|Withdrawal by Subject|15|||
17121571|NCT00055497|38260972|FG000|Overall Study|Lost to Follow-up|0|||
17121572|NCT00055497|38260973|FG001|Overall Study|Lost to Follow-up|1|||
17121573|NCT00055497|38260974|FG002|Overall Study|Lost to Follow-up|0|||
17121574|NCT00055497|38260975|FG003|Overall Study|Lost to Follow-up|5|||
17121575|NCT00055497|38260972|FG000|Overall Study|Protocol Violation|0|||
17121576|NCT00055497|38260973|FG001|Overall Study|Protocol Violation|0|||
17121577|NCT00055497|38260974|FG002|Overall Study|Protocol Violation|0|||
17121578|NCT00055497|38260975|FG003|Overall Study|Protocol Violation|3|||
17121579|NCT00055497|38260972|FG000|Overall Study|Lack of Efficacy|1|||
17121580|NCT00055497|38260973|FG001|Overall Study|Lack of Efficacy|0|||
17121581|NCT00055497|38260974|FG002|Overall Study|Lack of Efficacy|0|||
17121582|NCT00055497|38260975|FG003|Overall Study|Lack of Efficacy|27|||
17121583|NCT00055497|38260972|FG000|Overall Study|Administrative Reasons|0|||
17121584|NCT00055497|38260973|FG001|Overall Study|Administrative Reasons|0|||
17121585|NCT00055497|38260974|FG002|Overall Study|Administrative Reasons|0|||
17121586|NCT00055497|38260975|FG003|Overall Study|Administrative Reasons|1|||
17121587|NCT00055497|38260972|FG000|Overall Study|Other|0|||
17121588|NCT00055497|38260973|FG001|Overall Study|Other|0|||
17121589|NCT00055497|38260974|FG002|Overall Study|Other|0|||
17121590|NCT00055497|38260975|FG003|Overall Study|Other|11|||
17121591|NCT03520400|38260992|FG000|Overall Study|Physician Decision|15|||
17121592|NCT03520400|38260993|FG001|Overall Study|Physician Decision|7|||
17121593|NCT03615066|38261002|FG000|Main Study|Withdrew Consent|0|||
17121594|NCT03615066|38261003|FG001|Main Study|Withdrew Consent|1|||
17121595|NCT03615066|38261004|FG002|Main Study|Withdrew Consent|1|||
17121596|NCT03615066|38261002|FG000|Main Study|Lost to Follow-up|0|||
17121597|NCT03615066|38261003|FG001|Main Study|Lost to Follow-up|0|||
17121598|NCT03615066|38261004|FG002|Main Study|Lost to Follow-up|1|||
17121599|NCT03615066|38261002|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
17121600|NCT03615066|38261003|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
17121601|NCT03615066|38261004|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
17121602|NCT03615066|38261002|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
17121603|NCT03615066|38261003|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
17121604|NCT03615066|38261004|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
17121605|NCT03615066|38261002|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
17121606|NCT03615066|38261003|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
17121607|NCT03615066|38261004|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
17121608|NCT03527966|38261018|FG000|Overall Study|Lost to Follow-up|3|||
17121609|NCT03527966|38261019|FG001|Overall Study|Lost to Follow-up|0|||
17121610|NCT03808545|38261027|FG000|Overall Study|Withdrawal by Subject|1|||
17121611|NCT03808545|38261028|FG001|Overall Study|Withdrawal by Subject|1|||
17121612|NCT03807843|38261037|FG000|Overall Study|Lost to Follow-up|1|||
17121613|NCT03807843|38261038|FG001|Overall Study|Lost to Follow-up|0|||
17121614|NCT03519932|38261044|FG000|First Intervention|Adverse Event|1|||
17121615|NCT03519932|38261045|FG001|First Intervention|Adverse Event|3|||
17121616|NCT03806127|38261058|FG000|Overall Study|Withdrawal by Subject|4|||
17121617|NCT03806127|38261059|FG001|Overall Study|Withdrawal by Subject|5|||
17121618|NCT03806127|38261058|FG000|Overall Study|Protocol Violation|3|||
17121619|NCT03806127|38261059|FG001|Overall Study|Protocol Violation|1|||
17121620|NCT03806127|38261058|FG000|Overall Study|Adverse Event|3|||
17121621|NCT03806127|38261059|FG001|Overall Study|Adverse Event|0|||
17121622|NCT03806127|38261058|FG000|Overall Study|Unable to Complete Procedures|0|||
17121623|NCT03806127|38261059|FG001|Overall Study|Unable to Complete Procedures|1|||
17121624|NCT03806127|38261058|FG000|Overall Study|Pregnancy|0|||
17121625|NCT03806127|38261059|FG001|Overall Study|Pregnancy|1|||
17121626|NCT03806127|38261058|FG000|Overall Study|Lost to Follow-up|5|||
17121627|NCT03806127|38261059|FG001|Overall Study|Lost to Follow-up|1|||
17121628|NCT03806127|38261058|FG000|Overall Study|Physician Decision|1|||
17121629|NCT03806127|38261059|FG001|Overall Study|Physician Decision|1|||
17121630|NCT03806127|38261058|FG000|Overall Study|Could Not Come Due to Covid|1|||
17121631|NCT03806127|38261059|FG001|Overall Study|Could Not Come Due to Covid|0|||
17121632|NCT03806127|38261058|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
17121633|NCT03806127|38261059|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
17121634|NCT03806127|38261058|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
17121635|NCT03806127|38261059|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
17121636|NCT03806127|38261058|FG000|Overall Study|Covid 19 Restrictions|2|||
17121637|NCT03806127|38261059|FG001|Overall Study|Covid 19 Restrictions|0|||
17121638|NCT03806127|38261058|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
16942092|NCT01371747|38086665|FG001|Overall Study|Adverse Event|2|||
17121639|NCT03806127|38261059|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
17121640|NCT03806127|38261058|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
17121641|NCT03806127|38261059|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
17121642|NCT02843074|38261065|FG000|Overall Study|Withdrawal by Subject|5|||
17121643|NCT02843074|38261065|FG000|Overall Study|Progressive disease|1|||
17121644|NCT02843074|38261065|FG000|Overall Study|Physician Decision|1|||
17121645|NCT02843074|38261065|FG000|Overall Study|Lost to Follow-up|1|||
17121646|NCT02843074|38261065|FG000|Overall Study|Death|9|||
17121647|NCT03607422|38261075|FG000|Overall Study|Adverse Event|7|||
17121648|NCT03607422|38261076|FG001|Overall Study|Adverse Event|3|||
17121649|NCT03607422|38261077|FG002|Overall Study|Adverse Event|2|||
17121650|NCT03607422|38261078|FG003|Overall Study|Adverse Event|0|||
17121651|NCT03607422|38261079|FG004|Overall Study|Adverse Event|2|||
17121652|NCT03607422|38261080|FG005|Overall Study|Adverse Event|0|||
17121653|NCT03607422|38261075|FG000|Overall Study|Withdrawal by Subject|11|||
17121654|NCT03607422|38261076|FG001|Overall Study|Withdrawal by Subject|3|||
17121655|NCT03607422|38261077|FG002|Overall Study|Withdrawal by Subject|6|||
17121656|NCT03607422|38261078|FG003|Overall Study|Withdrawal by Subject|2|||
17121657|NCT03607422|38261079|FG004|Overall Study|Withdrawal by Subject|0|||
17121658|NCT03607422|38261080|FG005|Overall Study|Withdrawal by Subject|0|||
17121659|NCT03607422|38261075|FG000|Overall Study|Lost to Follow-up|0|||
17121660|NCT03607422|38261076|FG001|Overall Study|Lost to Follow-up|0|||
17121661|NCT03607422|38261077|FG002|Overall Study|Lost to Follow-up|1|||
17121662|NCT03607422|38261078|FG003|Overall Study|Lost to Follow-up|0|||
17121663|NCT03607422|38261079|FG004|Overall Study|Lost to Follow-up|0|||
17121664|NCT03607422|38261080|FG005|Overall Study|Lost to Follow-up|0|||
17121665|NCT03607422|38261075|FG000|Overall Study|Other|12|||
17121666|NCT03607422|38261076|FG001|Overall Study|Other|4|||
17121667|NCT03607422|38261077|FG002|Overall Study|Other|1|||
17121668|NCT03607422|38261078|FG003|Overall Study|Other|2|||
17121669|NCT03607422|38261079|FG004|Overall Study|Other|0|||
17121670|NCT03607422|38261080|FG005|Overall Study|Other|2|||
17121671|NCT03607422|38261075|FG000|Overall Study|Ongoing at Time of Analysis|8|||
17121672|NCT03607422|38261076|FG001|Overall Study|Ongoing at Time of Analysis|0|||
17121673|NCT03607422|38261077|FG002|Overall Study|Ongoing at Time of Analysis|2|||
17121674|NCT03607422|38261078|FG003|Overall Study|Ongoing at Time of Analysis|1|||
17121675|NCT03607422|38261079|FG004|Overall Study|Ongoing at Time of Analysis|1|||
17121676|NCT03607422|38261080|FG005|Overall Study|Ongoing at Time of Analysis|1|||
17121677|NCT03650400|38261096|FG000|Overall Study|Study terminated by sponsor|0|||
17121678|NCT03650400|38261097|FG001|Overall Study|Study terminated by sponsor|5|||
17121679|NCT00038103|38261105|FG000|Overall Study|Adverse Event|5|||
17121680|NCT00038103|38261106|FG001|Overall Study|Adverse Event|6|||
17121681|NCT00038103|38261105|FG000|Overall Study|Lack of Efficacy|48|||
17121682|NCT00038103|38261106|FG001|Overall Study|Lack of Efficacy|41|||
17121683|NCT00038103|38261105|FG000|Overall Study|Withdrawal by Subject|0|||
17121684|NCT00038103|38261106|FG001|Overall Study|Withdrawal by Subject|3|||
17121685|NCT00038103|38261105|FG000|Overall Study|Lost to Follow-up|0|||
17121686|NCT00038103|38261106|FG001|Overall Study|Lost to Follow-up|3|||
17121687|NCT00038103|38261105|FG000|Overall Study|Protocol Violation|0|||
17121688|NCT00038103|38261106|FG001|Overall Study|Protocol Violation|2|||
17121689|NCT00038103|38261105|FG000|Overall Study|Sponsor Decision|0|||
17121690|NCT00038103|38261106|FG001|Overall Study|Sponsor Decision|1|||
17121691|NCT00038103|38261105|FG000|Overall Study|Randomized/never treated|2|||
17121692|NCT00038103|38261106|FG001|Overall Study|Randomized/never treated|0|||
17121693|NCT03680742|38261112|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
17121694|NCT03678870|38261118|FG000|Overall Study|prescribed non- protocol medications|10|||
17121695|NCT03678870|38261119|FG001|Overall Study|prescribed non- protocol medications|6|||
17121696|NCT03678870|38261118|FG000|Overall Study|Lost to Follow-up|3|||
17121697|NCT03678870|38261119|FG001|Overall Study|Lost to Follow-up|2|||
17121698|NCT03805971|38261125|FG000|Overall Study|Withdrawal by Subject|1|||
17121699|NCT03805971|38261125|FG000|Overall Study|Protocol Violation|2|||
17121700|NCT03032380|38261132|FG000|Overall Study|Adverse Event|0|||
17121701|NCT03032380|38261133|FG001|Overall Study|Adverse Event|1|||
17121702|NCT03032380|38261132|FG000|Overall Study|Lack of Efficacy|1|||
17121703|NCT03032380|38261133|FG001|Overall Study|Lack of Efficacy|0|||
17121704|NCT03032380|38261132|FG000|Overall Study|Withdrawal by Subject|2|||
17121705|NCT03032380|38261133|FG001|Overall Study|Withdrawal by Subject|3|||
17121706|NCT03032380|38261132|FG000|Overall Study|Recovery|0|||
17121707|NCT03032380|38261133|FG001|Overall Study|Recovery|1|||
17121708|NCT03032380|38261132|FG000|Overall Study|Death|39|||
17121709|NCT03032380|38261133|FG001|Overall Study|Death|34|||
17121710|NCT03032380|38261132|FG000|Overall Study|Other - Miscellaneous|0|||
17121711|NCT03032380|38261133|FG001|Overall Study|Other - Miscellaneous|1|||
17121712|NCT03519854|38261157|FG000|Overall Study|Technical Error|0|||
17121713|NCT03519854|38261158|FG001|Overall Study|Technical Error|0|||
17121714|NCT03519854|38261159|FG002|Overall Study|Technical Error|1|||
17121715|NCT03519854|38261160|FG003|Overall Study|Technical Error|0|||
17121716|NCT03519854|38261161|FG004|Overall Study|Technical Error|0|||
17121717|NCT03519854|38261162|FG005|Overall Study|Technical Error|0|||
17121718|NCT03519854|38261163|FG006|Overall Study|Technical Error|0|||
17121719|NCT03519854|38261164|FG007|Overall Study|Technical Error|0|||
17121720|NCT03519854|38261165|FG008|Overall Study|Technical Error|0|||
17121721|NCT03519854|38261166|FG009|Overall Study|Technical Error|0|||
17121722|NCT03519854|38261167|FG010|Overall Study|Technical Error|0|||
17121723|NCT03519854|38261168|FG011|Overall Study|Technical Error|0|||
17121724|NCT03519854|38261169|FG012|Overall Study|Technical Error|0|||
17121725|NCT03519854|38261170|FG013|Overall Study|Technical Error|0|||
17121726|NCT03519854|38261171|FG014|Overall Study|Technical Error|0|||
17121727|NCT03519854|38261172|FG015|Overall Study|Technical Error|0|||
17121728|NCT03519854|38261173|FG016|Overall Study|Technical Error|0|||
17121729|NCT03519854|38261174|FG017|Overall Study|Technical Error|0|||
17121730|NCT03479216|38261214|FG000|Overall Study|Withdrawal by Subject|3|||
17121731|NCT03479216|38261215|FG001|Overall Study|Withdrawal by Subject|2|||
17121732|NCT03479216|38261214|FG000|Overall Study|Physician Decision|2|||
17121733|NCT03479216|38261215|FG001|Overall Study|Physician Decision|3|||
17121734|NCT03518840|38261221|FG000|Overall Study|Lost to Follow-up|6|||
17121735|NCT03436082|38261230|FG000|Overall Study|Did not undergo procedure|1|||
17121736|NCT03436082|38261231|FG001|Overall Study|Did not undergo procedure|0|||
17121737|NCT03677934|38261239|FG000|Overall Study|Adverse Event|1|||
17121738|NCT03677934|38261240|FG001|Overall Study|Adverse Event|1|||
17121739|NCT03677934|38261239|FG000|Overall Study|Death|8|||
17121740|NCT03677934|38261240|FG001|Overall Study|Death|4|||
17121741|NCT03677934|38261239|FG000|Overall Study|Lost to Follow-up|3|||
17121742|NCT03677934|38261240|FG001|Overall Study|Lost to Follow-up|0|||
17121743|NCT03677934|38261239|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17121744|NCT03677934|38261240|FG001|Overall Study|Non-Compliance With Study Drug|0|||
17121745|NCT03677934|38261239|FG000|Overall Study|Physician Decision|0|||
17121746|NCT03677934|38261240|FG001|Overall Study|Physician Decision|1|||
17121747|NCT03677934|38261239|FG000|Overall Study|Withdrawal by Subject|1|||
17121748|NCT03677934|38261240|FG001|Overall Study|Withdrawal by Subject|7|||
17121749|NCT03435692|38261252|FG000|Overall Study|Lack of Efficacy|2|||
17121750|NCT03435692|38261253|FG001|Overall Study|Lack of Efficacy|2|||
17121751|NCT03435692|38261254|FG002|Overall Study|Lack of Efficacy|0|||
17121752|NCT03475316|38261268|FG000|6 Month Intervention|Adverse Event|2|||
17121753|NCT03475316|38261269|FG001|6 Month Intervention|Adverse Event|1|||
17121754|NCT03475316|38261268|FG000|6 Month Intervention|Withdrawal by Subject|2|||
17121755|NCT03475316|38261269|FG001|6 Month Intervention|Withdrawal by Subject|0|||
17121756|NCT03475316|38261268|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
17121757|NCT03475316|38261269|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
17121758|NCT03475316|38261268|FG000|9 Months|Study stopped due to COVID pandemic|3|||
17121759|NCT03475316|38261269|FG001|9 Months|Study stopped due to COVID pandemic|4|||
17121760|NCT03673956|38261279|FG000|Overall Study|Lost to Follow-up|1|||
17121761|NCT03673956|38261280|FG001|Overall Study|Lost to Follow-up|0|||
17121762|NCT03673956|38261281|FG002|Overall Study|Lost to Follow-up|0|||
17121763|NCT03673956|38261282|FG003|Overall Study|Lost to Follow-up|0|||
17121764|NCT03673956|38261279|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
17121765|NCT03673956|38261280|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
17121766|NCT03673956|38261281|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
17121767|NCT03673956|38261282|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
17121768|NCT03517436|38261292|FG000|Overall Study|Death|3|||
17121769|NCT03517436|38261292|FG000|Overall Study|Withdrawal by Subject|4|||
17121770|NCT03517436|38261292|FG000|Overall Study|Did not receive study valve.|1|||
17121771|NCT03673098|38261298|FG000|Overall Study|Lost to Follow-up|2|||
17121772|NCT03673098|38261299|FG001|Overall Study|Lost to Follow-up|3|||
17121773|NCT03673098|38261298|FG000|Overall Study|Withdrawal by Subject|6|||
17121774|NCT03673098|38261299|FG001|Overall Study|Withdrawal by Subject|1|||
17121775|NCT03673098|38261298|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
17121776|NCT03673098|38261299|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
17121777|NCT03435224|38261312|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
17121778|NCT03672396|38261316|FG000|Overall Study|Withdrawal by Subject|4|||
17121779|NCT03672396|38261316|FG000|Overall Study|Physician Decision|1|||
17121780|NCT03672396|38261316|FG000|Overall Study|Adverse Event|1|||
17121781|NCT03516812|38261320|FG000|Overall Study|Adverse Event|4|||
17121782|NCT03516812|38261320|FG000|Overall Study|Lack of Efficacy|2|||
17121783|NCT03434834|38261324|FG000|Overall Study|unable to swallow OCT probe|16|||
17121784|NCT03605862|38261330|FG000|Overall Study|Withdrawal by Subject|12|||
17121785|NCT03605862|38261331|FG001|Overall Study|Withdrawal by Subject|9|||
17121786|NCT03605862|38261330|FG000|Overall Study|Adverse Event|2|||
17121787|NCT03605862|38261331|FG001|Overall Study|Adverse Event|1|||
17121788|NCT03605862|38261330|FG000|Overall Study|Physician Decision|3|||
17121789|NCT03605862|38261331|FG001|Overall Study|Physician Decision|1|||
17121790|NCT03605862|38261330|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
17121791|NCT03605862|38261331|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
17121792|NCT03672006|38261340|FG000|Overall Study|exclusion criteria met|0|||
17121793|NCT03672006|38261341|FG001|Overall Study|exclusion criteria met|1|||
17121794|NCT03512288|38261351|FG000|Overall Study|Adverse Event|1|||
16942093|NCT01371747|38086666|FG002|Overall Study|Adverse Event|7|||
17121795|NCT03512288|38261352|FG001|Overall Study|Adverse Event|0|||
17121796|NCT03512288|38261351|FG000|Overall Study|Lost to Follow-up|12|||
17121797|NCT03512288|38261352|FG001|Overall Study|Lost to Follow-up|15|||
17121798|NCT03512288|38261351|FG000|Overall Study|Physician Decision|0|||
17121799|NCT03512288|38261352|FG001|Overall Study|Physician Decision|2|||
17121800|NCT03512288|38261351|FG000|Overall Study|Protocol Violation|6|||
17121801|NCT03512288|38261352|FG001|Overall Study|Protocol Violation|4|||
17121802|NCT03512288|38261351|FG000|Overall Study|Medication error without associated adverse event|1|||
17121803|NCT03512288|38261352|FG001|Overall Study|Medication error without associated adverse event|0|||
17121804|NCT03512288|38261351|FG000|Overall Study|No longer met eligibility criteria|5|||
17121805|NCT03512288|38261352|FG001|Overall Study|No longer met eligibility criteria|2|||
17121806|NCT03512288|38261351|FG000|Overall Study|Withdrawal by parent/guardian|14|||
17121807|NCT03512288|38261352|FG001|Overall Study|Withdrawal by parent/guardian|18|||
17121808|NCT03512288|38261351|FG000|Overall Study|Other|1|||
17121809|NCT03512288|38261352|FG001|Overall Study|Other|1|||
17121810|NCT03512288|38261351|FG000|Overall Study|Randomized but not treated|1|||
17121811|NCT03512288|38261352|FG001|Overall Study|Randomized but not treated|1|||
17121812|NCT03031678|38261358|FG000|Overall Study|Study closed prior to completion|1|||
17121813|NCT03669588|38261368|FG000|Overall Study|Adverse Event|1|||
17121814|NCT03669588|38261369|FG001|Overall Study|Adverse Event|0|||
17121815|NCT03669588|38261368|FG000|Overall Study|Physician Decision|0|||
17121816|NCT03669588|38261369|FG001|Overall Study|Physician Decision|1|||
17121817|NCT03669588|38261368|FG000|Overall Study|Protocol Violation|1|||
17121818|NCT03669588|38261369|FG001|Overall Study|Protocol Violation|0|||
17121819|NCT03669588|38261368|FG000|Overall Study|Sponsor Decision|1|||
17121820|NCT03669588|38261369|FG001|Overall Study|Sponsor Decision|1|||
17121821|NCT03669588|38261368|FG000|Overall Study|Withdrawal by Subject|1|||
17121822|NCT03669588|38261369|FG001|Overall Study|Withdrawal by Subject|4|||
17121823|NCT03669588|38261368|FG000|Overall Study|Rescue Therapy Needed|0|||
17121824|NCT03669588|38261369|FG001|Overall Study|Rescue Therapy Needed|1|||
17121825|NCT03646656|38261395|FG000|Overall Study|Lost to Follow-up|1|||
17121826|NCT03646656|38261396|FG001|Overall Study|Lost to Follow-up|0|||
17121827|NCT03646656|38261395|FG000|Overall Study|Withdrawal by Subject|2|||
17121828|NCT03646656|38261396|FG001|Overall Study|Withdrawal by Subject|0|||
17121829|NCT03598140|38261408|FG000|Overall Study|enrolled but didn't start|1|||
17121830|NCT03598140|38261409|FG001|Overall Study|enrolled but didn't start|0|||
17121831|NCT03644550|38261415|FG000|Overall Study|Withdrawal by Subject|3|||
17121832|NCT03644550|38261415|FG000|Overall Study|Progressive disease|15|||
17121833|NCT03511664|38261422|FG000|Overall Study|Treatment ongoing|49|||
17121834|NCT03511664|38261423|FG001|Overall Study|Treatment ongoing|5|||
17121835|NCT03511664|38261422|FG000|Overall Study|Entered long-term follow-up|140|||
17121836|NCT03511664|38261423|FG001|Overall Study|Entered long-term follow-up|50|||
17121837|NCT03511664|38261422|FG000|Overall Study|Withdrawal by Subject|29|||
17121838|NCT03511664|38261423|FG001|Overall Study|Withdrawal by Subject|53|||
17121839|NCT03511664|38261422|FG000|Overall Study|Lost to Follow-up|4|||
17121840|NCT03511664|38261423|FG001|Overall Study|Lost to Follow-up|4|||
17121841|NCT03511664|38261422|FG000|Overall Study|Physician Decision|0|||
17121842|NCT03511664|38261423|FG001|Overall Study|Physician Decision|1|||
17121843|NCT00054717|38261431|FG000|Overall Study|Randomized but not treated|2|||
17121844|NCT00054717|38261432|FG001|Overall Study|Randomized but not treated|8|||
17121845|NCT00054717|38261431|FG000|Overall Study|Adverse Event|70|||
17121846|NCT00054717|38261432|FG001|Overall Study|Adverse Event|22|||
17121847|NCT00054717|38261431|FG000|Overall Study|Protocol Violation|18|||
17121848|NCT00054717|38261432|FG001|Overall Study|Protocol Violation|19|||
17121849|NCT00054717|38261431|FG000|Overall Study|Lost to Follow-up|23|||
17121850|NCT00054717|38261432|FG001|Overall Study|Lost to Follow-up|13|||
17121851|NCT00054717|38261431|FG000|Overall Study|Withdrawal by Subject|32|||
17121852|NCT00054717|38261432|FG001|Overall Study|Withdrawal by Subject|20|||
17121853|NCT00054717|38261431|FG000|Overall Study|Other reason not defined above|117|||
17121854|NCT00054717|38261432|FG001|Overall Study|Other reason not defined above|217|||
17121855|NCT03430856|38261441|FG000|Overall Study|Adverse Event|0|||
17121856|NCT03430856|38261442|FG001|Overall Study|Adverse Event|1|||
17121857|NCT03430856|38261443|FG002|Overall Study|Adverse Event|0|||
17121858|NCT03430856|38261441|FG000|Overall Study|Rescue criteria|1|||
17121859|NCT03430856|38261442|FG001|Overall Study|Rescue criteria|1|||
17121860|NCT03430856|38261443|FG002|Overall Study|Rescue criteria|0|||
16773190|NCT03745651|37712173|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
17121861|NCT03430856|38261441|FG000|Overall Study|Voluntary withdrawal of consent|1|||
17121862|NCT03430856|38261442|FG001|Overall Study|Voluntary withdrawal of consent|1|||
17121863|NCT03430856|38261443|FG002|Overall Study|Voluntary withdrawal of consent|1|||
17121864|NCT03731364|38261459|FG000|Overall Study|Adverse Event|0|||
17121865|NCT03731364|38261460|FG001|Overall Study|Adverse Event|0|||
17121866|NCT03731364|38261461|FG002|Overall Study|Adverse Event|1|||
17121867|NCT03731364|38261462|FG003|Overall Study|Adverse Event|2|||
17121868|NCT03731364|38261463|FG004|Overall Study|Adverse Event|1|||
17121869|NCT03510182|38261475|FG000|Overall Study|Withdrawal by Subject|2|||
17121870|NCT00066807|38261481|FG000|Overall Study|Study was terminated early|14|||
17121871|NCT00066807|38261482|FG001|Overall Study|Study was terminated early|15|||
17121872|NCT03428750|38261490|FG000|Overall Study|Withdrawal by Subject|11|||
17121873|NCT03428750|38261491|FG001|Overall Study|Withdrawal by Subject|10|||
17121874|NCT03428750|38261490|FG000|Overall Study|Lost to Follow-up|3|||
17121875|NCT03428750|38261491|FG001|Overall Study|Lost to Follow-up|9|||
17121876|NCT03428750|38261490|FG000|Overall Study|Adverse Event|9|||
17121877|NCT03428750|38261491|FG001|Overall Study|Adverse Event|1|||
17121878|NCT03428750|38261490|FG000|Overall Study|Protocol Violation|1|||
17121879|NCT03428750|38261491|FG001|Overall Study|Protocol Violation|0|||
17121880|NCT03428750|38261490|FG000|Overall Study|Administrative|0|||
17121881|NCT03428750|38261491|FG001|Overall Study|Administrative|1|||
17121882|NCT03666858|38261520|FG000|Cohort 1|Adverse Event|1|||
17121883|NCT03666858|38261521|FG001|Cohort 1|Adverse Event|0|||
17121884|NCT03666858|38261520|FG000|Cohort 2|Adverse Event|0|||
17121885|NCT03666858|38261521|FG001|Cohort 2|Adverse Event|1|||
17121886|NCT00054639|38261527|FG000|Overall Study|Lack of Efficacy|1|||
17121887|NCT00054639|38261527|FG000|Overall Study|Physician Decision|1|||
17121888|NCT03428360|38261531|FG000|Overall Study|Informed consent withdrawn|5|||
17121889|NCT03428360|38261531|FG000|Overall Study|Withdrawal by Subject|4|||
17121890|NCT03428360|38261531|FG000|Overall Study|Lost to Follow-up|5|||
17121891|NCT03428360|38261531|FG000|Overall Study|Physician Decision|2|||
17121892|NCT03428360|38261531|FG000|Overall Study|Informed consent withdrawn|5|||
17121893|NCT03428360|38261531|FG000|Overall Study|Study terminated by sponsor|10|||
17121894|NCT03428360|38261531|FG000|Overall Study|Non-compliant with study|1|||
17121895|NCT03428360|38261531|FG000|Overall Study|Non-compliant with study drug|3|||
17121896|NCT03428360|38261531|FG000|Overall Study|Death|3|||
17121897|NCT03428360|38261531|FG000|Overall Study|Adverse Event|1|||
17121898|NCT03428360|38261531|FG000|Overall Study|Not on antiepileptic drug|1|||
17121899|NCT03427892|38261539|FG000|Overall Study|Lost to Follow-up|2|||
17121900|NCT03595332|38261545|FG000|Overall Study|Lost to Follow-up|16|||
17121901|NCT03595332|38261546|FG001|Overall Study|Lost to Follow-up|22|||
17121902|NCT03595332|38261545|FG000|Overall Study|Unable to retrieve ID from school|0|||
17121903|NCT03595332|38261546|FG001|Overall Study|Unable to retrieve ID from school|2|||
17121904|NCT03427268|38261555|FG000|Overall Study|Progressive disease|25|||
17121905|NCT03427268|38261555|FG000|Overall Study|Never treated|2|||
17121906|NCT03427268|38261555|FG000|Overall Study|Compassionate use|1|||
17121907|NCT03427268|38261555|FG000|Overall Study|Withdrawal by Subject|1|||
17121908|NCT03427268|38261555|FG000|Overall Study|Adverse Event|3|||
17121909|NCT03509948|38261559|FG000|Overall Study|Protocol Violation|0|||
17121910|NCT03509948|38261560|FG001|Overall Study|Protocol Violation|1|||
17121911|NCT03466658|38261566|FG000|Overall Study|Withdrawal by Subject|3|||
17121912|NCT03425396|38261577|FG000|Overall Study|Lost to Follow-up|2|||
17121913|NCT03425396|38261578|FG001|Overall Study|Lost to Follow-up|5|||
17121914|NCT03425396|38261579|FG002|Overall Study|Lost to Follow-up|2|||
17121915|NCT03425396|38261580|FG003|Overall Study|Lost to Follow-up|0|||
17121916|NCT03425396|38261581|FG004|Overall Study|Lost to Follow-up|0|||
17121917|NCT03425396|38261577|FG000|Overall Study|Withdrawal by Subject|0|||
17121918|NCT03425396|38261578|FG001|Overall Study|Withdrawal by Subject|1|||
17121919|NCT03425396|38261579|FG002|Overall Study|Withdrawal by Subject|0|||
17121920|NCT03425396|38261580|FG003|Overall Study|Withdrawal by Subject|1|||
17121921|NCT03425396|38261581|FG004|Overall Study|Withdrawal by Subject|0|||
17121922|NCT03425396|38261577|FG000|Overall Study|Other|0|||
17121923|NCT03425396|38261578|FG001|Overall Study|Other|1|||
17121924|NCT03425396|38261579|FG002|Overall Study|Other|1|||
17121925|NCT03425396|38261580|FG003|Overall Study|Other|0|||
17121926|NCT03425396|38261581|FG004|Overall Study|Other|1|||
17121927|NCT00033657|38261595|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
17121928|NCT00033657|38261596|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
17121929|NCT00033657|38261595|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
17121930|NCT00033657|38261596|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
17121931|NCT00033657|38261595|FG000|Neoadjuvant Chemotherapy|Death|1|||
17121932|NCT00033657|38261596|FG001|Neoadjuvant Chemotherapy|Death|1|||
17121933|NCT00033657|38261595|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
17121934|NCT00033657|38261596|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
16856756|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
17121935|NCT00033657|38261595|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
17121936|NCT00033657|38261596|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
17121937|NCT00033657|38261595|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
17121938|NCT00033657|38261596|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
17121939|NCT00033657|38261595|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
17121940|NCT00033657|38261596|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
17121941|NCT00033657|38261595|FG000|Surgical Resection|not complete resection|0|||
17121942|NCT00033657|38261596|FG001|Surgical Resection|not complete resection|3|||
17121943|NCT00033657|38261595|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
17121944|NCT00033657|38261596|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
17121945|NCT00033657|38261595|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
17121946|NCT00033657|38261596|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
17121947|NCT00033657|38261595|FG000|Adjuvant Chemotherapy|Death|2|||
17121948|NCT00033657|38261596|FG001|Adjuvant Chemotherapy|Death|1|||
17121949|NCT00033657|38261595|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
17121950|NCT00033657|38261596|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
17121951|NCT00033657|38261595|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
17121952|NCT00033657|38261596|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
17121953|NCT00033657|38261595|FG000|Adjuvant Chemotherapy|Other|0|||
17121954|NCT00033657|38261596|FG001|Adjuvant Chemotherapy|Other|2|||
17121955|NCT00066729|38261604|FG000|Overall Study|Lost to Follow-up|1|||
17121956|NCT00066729|38261604|FG000|Overall Study|Disease progression|1|||
17121957|NCT00032487|38261610|FG000|Overall Study|Withdrawal by Subject|67|||
17121958|NCT00032487|38261611|FG001|Overall Study|Withdrawal by Subject|43|||
17121959|NCT00032487|38261610|FG000|Overall Study|Adverse Event|3|||
17121960|NCT00032487|38261611|FG001|Overall Study|Adverse Event|7|||
17121961|NCT00032487|38261610|FG000|Overall Study|Lost to Follow-up|57|||
17121962|NCT00032487|38261611|FG001|Overall Study|Lost to Follow-up|58|||
17121963|NCT00032487|38261610|FG000|Overall Study|Had other reason|12|||
17121964|NCT00032487|38261611|FG001|Overall Study|Had other reason|12|||
17121965|NCT03595176|38261619|FG000|Overall Study|Death|0|||
17121966|NCT03595176|38261620|FG001|Overall Study|Death|2|||
17121967|NCT03595176|38261619|FG000|Overall Study|Lost to Follow-up|0|||
17121968|NCT03595176|38261620|FG001|Overall Study|Lost to Follow-up|1|||
17121969|NCT03641508|38261628|FG000|First Injection|Lost to Follow-up|2|||
17121970|NCT03641508|38261629|FG001|First Injection|Lost to Follow-up|0|||
17121971|NCT00066573|38261637|FG000|Overall Study|Did not received protocol treatment|28|||
17121972|NCT00066573|38261638|FG001|Overall Study|Did not received protocol treatment|28|||
17121973|NCT03465878|38261646|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
17121974|NCT03465878|38261647|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
17121975|NCT03465878|38261648|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
17121976|NCT03465878|38261649|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
17121977|NCT03465878|38261646|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
17121978|NCT03465878|38261647|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
17121979|NCT03465878|38261648|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
17121980|NCT03465878|38261649|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
17121981|NCT03465878|38261646|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
17121982|NCT03465878|38261647|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
17121983|NCT03465878|38261648|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
17121984|NCT03465878|38261649|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
17121985|NCT03637374|38261677|FG000|Overall Study|Death|2|||
17121986|NCT03637374|38261678|FG001|Overall Study|Death|0|||
17121987|NCT03421730|38261684|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121988|NCT03421730|38261685|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
17121989|NCT03421730|38261686|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121990|NCT03421730|38261687|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121991|NCT03421730|38261688|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121992|NCT03421730|38261689|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121993|NCT03421730|38261690|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121994|NCT03421730|38261691|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121995|NCT03421730|38261692|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121996|NCT03421730|38261693|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121997|NCT03421730|38261694|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121998|NCT03421730|38261695|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
17121999|NCT03421730|38261684|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122000|NCT03421730|38261685|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122001|NCT03421730|38261686|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122002|NCT03421730|38261687|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122003|NCT03421730|38261688|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
17122004|NCT03421730|38261689|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122005|NCT03421730|38261690|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122006|NCT03421730|38261691|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122007|NCT03421730|38261692|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122008|NCT03421730|38261693|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122009|NCT03421730|38261694|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122010|NCT03421730|38261695|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
17122011|NCT00054327|38261715|FG000|Overall Study|Engraftment failure|1|||
17122012|NCT00054327|38261716|FG001|Overall Study|Engraftment failure|0|||
17122013|NCT00054327|38261717|FG002|Overall Study|Engraftment failure|0|||
17122014|NCT00054327|38261718|FG003|Overall Study|Engraftment failure|0|||
17122015|NCT00054327|38261719|FG004|Overall Study|Engraftment failure|0|||
17122016|NCT00054327|38261720|FG005|Overall Study|Engraftment failure|0|||
17122017|NCT03503162|38261734|FG000|Overall Study|did not meet eligibility|1|||
17122018|NCT03029650|38261738|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
17122019|NCT03029650|38261739|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
17122020|NCT03029650|38261738|FG000|Washout (1 Week)|Physician Decision|0|||
17122021|NCT03029650|38261739|FG001|Washout (1 Week)|Physician Decision|1|||
17122022|NCT03462680|38261751|FG000|Overall Study|Withdrawal by Subject|3|||
17122023|NCT03462680|38261752|FG001|Overall Study|Withdrawal by Subject|5|||
17122024|NCT03636906|38261761|FG000|Overall Study|Adverse Event|0|||
17122025|NCT03636906|38261762|FG001|Overall Study|Adverse Event|0|||
17122026|NCT03636906|38261763|FG002|Overall Study|Adverse Event|1|||
17122027|NCT03636906|38261761|FG000|Overall Study|Lost to Follow-up|1|||
17122028|NCT03636906|38261762|FG001|Overall Study|Lost to Follow-up|0|||
17122029|NCT03636906|38261763|FG002|Overall Study|Lost to Follow-up|0|||
17122030|NCT03636906|38261761|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
17122031|NCT03636906|38261762|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
17122032|NCT03636906|38261763|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
17122033|NCT03636906|38261761|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
17122034|NCT03636906|38261762|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17122035|NCT03636906|38261763|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
17122036|NCT03636906|38261761|FG000|Overall Study|Other|0|||
17122037|NCT03636906|38261762|FG001|Overall Study|Other|0|||
17122038|NCT03636906|38261763|FG002|Overall Study|Other|1|||
17122039|NCT03028870|38261781|FG000|Overall Study|Adverse Event|7|||
17122040|NCT03028870|38261782|FG001|Overall Study|Adverse Event|4|||
17122041|NCT03028870|38261783|FG002|Overall Study|Adverse Event|3|||
17122042|NCT03028870|38261784|FG003|Overall Study|Adverse Event|3|||
17122043|NCT03028870|38261781|FG000|Overall Study|Withdrawal by Subject|1|||
17122044|NCT03028870|38261782|FG001|Overall Study|Withdrawal by Subject|1|||
17122045|NCT03028870|38261783|FG002|Overall Study|Withdrawal by Subject|1|||
17122046|NCT03028870|38261784|FG003|Overall Study|Withdrawal by Subject|2|||
17122047|NCT03028870|38261781|FG000|Overall Study|Lost to Follow-up|1|||
17122048|NCT03028870|38261782|FG001|Overall Study|Lost to Follow-up|0|||
17122049|NCT03028870|38261783|FG002|Overall Study|Lost to Follow-up|0|||
17122050|NCT03028870|38261784|FG003|Overall Study|Lost to Follow-up|0|||
17122051|NCT03028870|38261781|FG000|Overall Study|Lack of Efficacy|3|||
17122052|NCT03028870|38261782|FG001|Overall Study|Lack of Efficacy|0|||
17122053|NCT03028870|38261783|FG002|Overall Study|Lack of Efficacy|0|||
17122054|NCT03028870|38261784|FG003|Overall Study|Lack of Efficacy|0|||
17122055|NCT03028870|38261781|FG000|Overall Study|Administrative|5|||
17122056|NCT03028870|38261782|FG001|Overall Study|Administrative|5|||
17122057|NCT03028870|38261783|FG002|Overall Study|Administrative|12|||
17122058|NCT03028870|38261784|FG003|Overall Study|Administrative|4|||
17122059|NCT03663582|38261794|FG000|Overall Study|Physician Decision|1|||
17122060|NCT03502616|38261800|FG000|Up to Week 16|Withdrawal by Subject|1|||
17122061|NCT03502616|38261801|FG001|Up to Week 16|Withdrawal by Subject|2|||
17122062|NCT03502616|38261800|FG000|Up to Week 16|Lost to Follow-up|0|||
17122063|NCT03502616|38261801|FG001|Up to Week 16|Lost to Follow-up|1|||
17122064|NCT03502616|38261800|FG000|Up to Week 16|Randomized, but not treated|1|||
17122065|NCT03502616|38261801|FG001|Up to Week 16|Randomized, but not treated|0|||
17122066|NCT03502616|38261800|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
17122067|NCT03502616|38261801|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
17122068|NCT03502616|38261800|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
17122069|NCT03502616|38261801|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
17122070|NCT03635424|38261819|FG000|Overall Study|Adverse Event|1|||
17122071|NCT03635424|38261819|FG000|Overall Study|Death|1|||
17122072|NCT03635424|38261819|FG000|Overall Study|Device not implanted|1|||
17122073|NCT03028012|38261826|FG000|Overall Study|Lost to Follow-up|2|||
17122074|NCT03028012|38261827|FG001|Overall Study|Lost to Follow-up|3|||
17122075|NCT03028012|38261828|FG002|Overall Study|Lost to Follow-up|3|||
17122076|NCT03635190|38261837|FG000|Overall Study|Lost to Follow-up|4|||
17122077|NCT03635190|38261837|FG000|Overall Study|Death|3|||
17122078|NCT03635190|38261837|FG000|Overall Study|Withdrawal by Subject|1|||
17122079|NCT03635190|38261837|FG000|Overall Study|Patient moved and did not return for follow up|1|||
17122080|NCT03634800|38261844|FG000|Overall Study|Adverse Event|1|||
17122081|NCT03634800|38261844|FG000|Overall Study|Disease Progression|4|||
16942094|NCT01371747|38086667|FG003|Overall Study|Adverse Event|2|||
17122082|NCT03634800|38261844|FG000|Overall Study|Withdrawal by Subject|1|||
17122083|NCT03027466|38261852|FG000|Overall Study|Opting out of the app|1869|||
17122084|NCT03027466|38261853|FG001|Overall Study|Opting out of the app|1819|||
17122085|NCT03027466|38261854|FG002|Overall Study|Opting out of the app|1743|||
17122086|NCT03027466|38261855|FG003|Overall Study|Opting out of the app|1821|||
17122087|NCT03662334|38261867|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
17122088|NCT03662334|38261868|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
17122089|NCT02955186|38261876|FG000|Overall Study|Withdrawal by Subject|6|||
17122090|NCT02955186|38261877|FG001|Overall Study|Withdrawal by Subject|2|||
17122091|NCT02955186|38261876|FG000|Overall Study|Protocol Violation|1|||
17122092|NCT02955186|38261877|FG001|Overall Study|Protocol Violation|0|||
17122093|NCT03502070|38261883|FG000|Overall Study|Withdrawal by Subject|1|||
17122094|NCT03502070|38261883|FG000|Overall Study|Screen Failure|1|||
17122095|NCT03586830|38261891|FG000|Overall Study|Site terminated by Sponsor|1|||
17122096|NCT03586830|38261892|FG001|Overall Study|Site terminated by Sponsor|4|||
17122097|NCT03586830|38261893|FG002|Overall Study|Site terminated by Sponsor|3|||
17122098|NCT03586830|38261894|FG003|Overall Study|Site terminated by Sponsor|3|||
17122099|NCT03586830|38261891|FG000|Overall Study|Lost to Follow-up|0|||
17122100|NCT03586830|38261892|FG001|Overall Study|Lost to Follow-up|2|||
17122101|NCT03586830|38261893|FG002|Overall Study|Lost to Follow-up|2|||
17122102|NCT03586830|38261894|FG003|Overall Study|Lost to Follow-up|1|||
17122103|NCT03586830|38261891|FG000|Overall Study|Withdrawal by Subject|1|||
17122104|NCT03586830|38261892|FG001|Overall Study|Withdrawal by Subject|0|||
17122105|NCT03586830|38261893|FG002|Overall Study|Withdrawal by Subject|3|||
17122106|NCT03586830|38261894|FG003|Overall Study|Withdrawal by Subject|1|||
17122107|NCT03026530|38261906|FG000|Overall Study|Lost to Follow-up|19|||
17122108|NCT03026530|38261907|FG001|Overall Study|Lost to Follow-up|24|||
17122109|NCT03026530|38261906|FG000|Overall Study|Protocol Violation|2|||
17122110|NCT03026530|38261907|FG001|Overall Study|Protocol Violation|5|||
17122111|NCT03418376|38261917|FG000|Overall Study|Musculoskeletal injury|1|||
17122112|NCT03418376|38261918|FG001|Overall Study|Musculoskeletal injury|2|||
17122113|NCT03418376|38261919|FG002|Overall Study|Musculoskeletal injury|1|||
17122114|NCT03418376|38261920|FG003|Overall Study|Musculoskeletal injury|0|||
17122115|NCT03418376|38261917|FG000|Overall Study|Personal reasons|0|||
17122116|NCT03418376|38261918|FG001|Overall Study|Personal reasons|2|||
17122117|NCT03418376|38261919|FG002|Overall Study|Personal reasons|2|||
17122118|NCT03418376|38261920|FG003|Overall Study|Personal reasons|1|||
17122119|NCT03418376|38261917|FG000|Overall Study|Exacerbation|0|||
17122120|NCT03418376|38261918|FG001|Overall Study|Exacerbation|1|||
17122121|NCT03418376|38261919|FG002|Overall Study|Exacerbation|0|||
17122122|NCT03418376|38261920|FG003|Overall Study|Exacerbation|0|||
17122123|NCT03585504|38261932|FG000|Overall Study|Lost to Follow-up|26|||
17122124|NCT03585504|38261933|FG001|Overall Study|Lost to Follow-up|29|||
17122125|NCT03417830|38261941|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
17122126|NCT03417830|38261942|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
17122127|NCT03576768|38261953|FG000|Overall Study|Lost to Follow-up|3|||
17122128|NCT03576768|38261954|FG001|Overall Study|Lost to Follow-up|3|||
17122129|NCT03576768|38261955|FG002|Overall Study|Lost to Follow-up|0|||
17122130|NCT03576768|38261956|FG003|Overall Study|Lost to Follow-up|0|||
17122131|NCT03576066|38261968|FG000|Overall Study|Noncompliance with study drug|0|||
17122132|NCT03576066|38261969|FG001|Overall Study|Noncompliance with study drug|1|||
17122133|NCT03557034|38261981|FG000|Overall Study|Withdrawal by Subject|1|||
17122134|NCT03557034|38261982|FG001|Overall Study|Withdrawal by Subject|0|||
17122135|NCT03583554|38261988|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
17122136|NCT03583554|38261989|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
17122137|NCT03583554|38261990|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
17122138|NCT03948178|38262001|FG000|Overall Study|Protocol Violation|1|||
17122139|NCT03948178|38262001|FG000|Overall Study|Lost to Follow-up|2|||
17122140|NCT03948178|38262001|FG000|Overall Study|Withdrawal by Subject|2|||
17122141|NCT03948178|38262001|FG000|Overall Study|Reason not known|2|||
17122142|NCT03948178|38262001|FG000|Overall Study|Personal reason|14|||
17122143|NCT03948178|38262001|FG000|Overall Study|Disease progression|30|||
17122144|NCT03948178|38262001|FG000|Overall Study|Adverse Event|12|||
17122145|NCT03948178|38262001|FG000|Overall Study|Sponsor terminated study|164|||
17122146|NCT03520920|38262008|FG000|Overall Study|Death|13|||
17122147|NCT03520920|38262009|FG001|Overall Study|Death|1|||
17122148|NCT03520920|38262010|FG002|Overall Study|Death|0|||
17122149|NCT03520920|38262008|FG000|Overall Study|Withdrawal by Subject|2|||
17122150|NCT03520920|38262009|FG001|Overall Study|Withdrawal by Subject|1|||
17122151|NCT03520920|38262010|FG002|Overall Study|Withdrawal by Subject|0|||
17122152|NCT03520920|38262008|FG000|Overall Study|Study Terminated by the Sponsor|5|||
17122153|NCT03520920|38262009|FG001|Overall Study|Study Terminated by the Sponsor|14|||
17122154|NCT03520920|38262010|FG002|Overall Study|Study Terminated by the Sponsor|5|||
17122155|NCT02953340|38262026|FG000|Overall Study|Death|0|||
16942095|NCT01371747|38086668|FG004|Overall Study|Adverse Event|2|||
16942096|NCT01371747|38086669|FG005|Overall Study|Adverse Event|2|||
16942097|NCT01371747|38086664|FG000|Overall Study|Death|1|||
17122156|NCT02953340|38262027|FG001|Overall Study|Death|1|||
17122157|NCT02953340|38262026|FG000|Overall Study|Investigator Decision|3|||
17122158|NCT02953340|38262027|FG001|Overall Study|Investigator Decision|3|||
17122159|NCT02953340|38262026|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
17122160|NCT02953340|38262027|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
17122161|NCT02953340|38262026|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
17122162|NCT02953340|38262027|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
17122163|NCT02953340|38262026|FG000|Overall Study|Withdrawal by Subject|9|||
17122164|NCT02953340|38262027|FG001|Overall Study|Withdrawal by Subject|9|||
17122165|NCT02953340|38262026|FG000|Overall Study|Sponsor decision|0|||
17122166|NCT02953340|38262027|FG001|Overall Study|Sponsor decision|2|||
17122167|NCT02953340|38262026|FG000|Overall Study|Lost to Follow-up|3|||
17122168|NCT02953340|38262027|FG001|Overall Study|Lost to Follow-up|2|||
17122169|NCT02953340|38262026|FG000|Overall Study|Reason not specified|2|||
17122170|NCT02953340|38262027|FG001|Overall Study|Reason not specified|2|||
17122171|NCT03554772|38262043|FG000|Overall Study|Lost to Follow-up|0|||
17122172|NCT03554772|38262044|FG001|Overall Study|Lost to Follow-up|0|||
17122173|NCT03554772|38262045|FG002|Overall Study|Lost to Follow-up|0|||
17122174|NCT03554772|38262046|FG003|Overall Study|Lost to Follow-up|2|||
17122175|NCT03573804|38262056|FG000|Overall Study|claustrophobia or MRI table problems|10|||
17122176|NCT03417440|38262074|FG000|Overall Study|Lost to Follow-up|0|||
17122177|NCT03417440|38262075|FG001|Overall Study|Lost to Follow-up|1|||
17122178|NCT03417440|38262076|FG002|Overall Study|Lost to Follow-up|0|||
17122179|NCT03417440|38262077|FG003|Overall Study|Lost to Follow-up|0|||
17122180|NCT03417440|38262078|FG004|Overall Study|Lost to Follow-up|1|||
17122181|NCT03417440|38262079|FG005|Overall Study|Lost to Follow-up|0|||
17122182|NCT03417440|38262080|FG006|Overall Study|Lost to Follow-up|0|||
17122183|NCT03417440|38262081|FG007|Overall Study|Lost to Follow-up|0|||
17122184|NCT03417440|38262074|FG000|Overall Study|Withdrawal by Subject|2|||
17122185|NCT03417440|38262075|FG001|Overall Study|Withdrawal by Subject|0|||
17122186|NCT03417440|38262076|FG002|Overall Study|Withdrawal by Subject|2|||
17122187|NCT03417440|38262077|FG003|Overall Study|Withdrawal by Subject|1|||
17122188|NCT03417440|38262078|FG004|Overall Study|Withdrawal by Subject|1|||
17122189|NCT03417440|38262079|FG005|Overall Study|Withdrawal by Subject|0|||
17122190|NCT03417440|38262080|FG006|Overall Study|Withdrawal by Subject|0|||
17122191|NCT03417440|38262081|FG007|Overall Study|Withdrawal by Subject|1|||
17122192|NCT03458702|38262104|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
17122193|NCT03458702|38262105|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
17122194|NCT03458702|38262104|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
17122195|NCT03458702|38262105|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
17122196|NCT03454412|38262111|FG000|Baseline Assesment|Physician Decision|12|||
17122197|NCT03452540|38262115|FG000|Overall Study|Adverse Event|1|||
17122198|NCT03452540|38262115|FG000|Overall Study|Withdrawal by Subject|1|||
17122199|NCT03452540|38262115|FG000|Overall Study|Other SAE and AE|2|||
17122200|NCT03573336|38262122|FG000|Overall Study|Study terminated|2|||
17122201|NCT03573336|38262123|FG001|Overall Study|Study terminated|4|||
17122202|NCT03573336|38262124|FG002|Overall Study|Study terminated|2|||
17122203|NCT03755518|38262132|FG000|Overall Study|Adverse Event|6|||
17122204|NCT03755518|38262132|FG000|Overall Study|Lack of Efficacy|6|||
17122205|NCT03755518|38262132|FG000|Overall Study|Bone Marrow Transplant|4|||
17122206|NCT03755518|38262132|FG000|Overall Study|Withdrawal by participant|4|||
17122207|NCT03755518|38262132|FG000|Overall Study|Progressive Disease|2|||
17122208|NCT03755518|38262132|FG000|Overall Study|Death|1|||
17122209|NCT03755518|38262132|FG000|Overall Study|Physician Decision|1|||
17122210|NCT03755518|38262132|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
17122211|NCT03500198|38262138|FG000|Overall Study|Lost to Follow-up|0|||
17122212|NCT03500198|38262139|FG001|Overall Study|Lost to Follow-up|1|||
17122213|NCT03553758|38262147|FG000|Overall Study|Lost to Follow-up|1|||
17122214|NCT03552198|38262157|FG000|Overall Study|Lost to Follow-up|42|||
17122215|NCT03552198|38262158|FG001|Overall Study|Lost to Follow-up|48|||
17122216|NCT03552198|38262159|FG002|Overall Study|Lost to Follow-up|15|||
17122217|NCT03552198|38262160|FG003|Overall Study|Lost to Follow-up|19|||
17122218|NCT03552198|38262157|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
17122219|NCT03552198|38262158|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
17122220|NCT03552198|38262159|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
17122221|NCT03552198|38262160|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
17122222|NCT03552198|38262157|FG000|Overall Study|Did not receive air alerts|1|||
17122223|NCT03552198|38262158|FG001|Overall Study|Did not receive air alerts|0|||
17122224|NCT03552198|38262159|FG002|Overall Study|Did not receive air alerts|0|||
17122225|NCT03552198|38262160|FG003|Overall Study|Did not receive air alerts|1|||
17122226|NCT02954354|38262173|FG000|Overall Study|Adverse Event|2|||
17122227|NCT02954354|38262174|FG001|Overall Study|Adverse Event|2|||
17122228|NCT02954354|38262175|FG002|Overall Study|Adverse Event|4|||
17122229|NCT02954354|38262173|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
17122230|NCT02954354|38262174|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
17122231|NCT02954354|38262175|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
17122232|NCT02954354|38262173|FG000|Overall Study|Lack of Efficacy|0|||
17122233|NCT02954354|38262174|FG001|Overall Study|Lack of Efficacy|2|||
17122234|NCT02954354|38262175|FG002|Overall Study|Lack of Efficacy|0|||
17122235|NCT02954354|38262173|FG000|Overall Study|Withdrawal by Subject|17|||
17122236|NCT02954354|38262174|FG001|Overall Study|Withdrawal by Subject|9|||
17122237|NCT02954354|38262175|FG002|Overall Study|Withdrawal by Subject|11|||
17122238|NCT02954354|38262173|FG000|Overall Study|Lost to Follow-up|12|||
17122239|NCT02954354|38262174|FG001|Overall Study|Lost to Follow-up|5|||
17122240|NCT02954354|38262175|FG002|Overall Study|Lost to Follow-up|0|||
17122241|NCT02954354|38262173|FG000|Overall Study|Miscellaneous|2|||
17122242|NCT02954354|38262174|FG001|Overall Study|Miscellaneous|2|||
17122243|NCT02954354|38262175|FG002|Overall Study|Miscellaneous|1|||
17122244|NCT03519516|38262187|FG000|Overall Study|Adverse Event|0|||
17122245|NCT03519516|38262188|FG001|Overall Study|Adverse Event|1|||
17122246|NCT03519204|38262196|FG000|Overall Study|Lost to Follow-up|3|||
17122247|NCT03519204|38262197|FG001|Overall Study|Lost to Follow-up|8|||
17122248|NCT03519204|38262196|FG000|Overall Study|Withdrawal by Subject|9|||
17122249|NCT03519204|38262197|FG001|Overall Study|Withdrawal by Subject|7|||
17122250|NCT03519204|38262196|FG000|Overall Study|Other Miscellaneous Reasons|1|||
17122251|NCT03519204|38262197|FG001|Overall Study|Other Miscellaneous Reasons|0|||
17122252|NCT03518658|38262209|FG000|Overall Study|Other|51|||
17122253|NCT03518658|38262210|FG001|Overall Study|Other|0|||
17122254|NCT03518112|38262218|FG000|Overall Study|Withdrawal by Subject|1|||
17122255|NCT03706456|38262222|FG000|Overall Study|Lack of Efficacy|1|||
17122256|NCT03706456|38262222|FG000|Overall Study|Ongoing|21|||
17122257|NCT03517566|38262231|FG000|Overall Study|Adverse Event|5|||
17122258|NCT03517566|38262232|FG001|Overall Study|Adverse Event|2|||
17122259|NCT03517566|38262233|FG002|Overall Study|Adverse Event|2|||
17122260|NCT03517566|38262234|FG003|Overall Study|Adverse Event|8|||
17122261|NCT03517566|38262235|FG004|Overall Study|Adverse Event|7|||
17122262|NCT03517566|38262231|FG000|Overall Study|Lack of Efficacy|3|||
17122263|NCT03517566|38262232|FG001|Overall Study|Lack of Efficacy|2|||
17122264|NCT03517566|38262233|FG002|Overall Study|Lack of Efficacy|1|||
17122265|NCT03517566|38262234|FG003|Overall Study|Lack of Efficacy|1|||
17122266|NCT03517566|38262235|FG004|Overall Study|Lack of Efficacy|4|||
17122267|NCT03517566|38262231|FG000|Overall Study|Lost to Follow-up|3|||
17122268|NCT03517566|38262232|FG001|Overall Study|Lost to Follow-up|1|||
17122269|NCT03517566|38262233|FG002|Overall Study|Lost to Follow-up|1|||
17122270|NCT03517566|38262234|FG003|Overall Study|Lost to Follow-up|1|||
17122271|NCT03517566|38262235|FG004|Overall Study|Lost to Follow-up|0|||
17122272|NCT03517566|38262231|FG000|Overall Study|Physician Decision|1|||
17122273|NCT03517566|38262232|FG001|Overall Study|Physician Decision|1|||
17122274|NCT03517566|38262233|FG002|Overall Study|Physician Decision|0|||
17122275|NCT03517566|38262234|FG003|Overall Study|Physician Decision|1|||
17122276|NCT03517566|38262235|FG004|Overall Study|Physician Decision|0|||
17122277|NCT03517566|38262231|FG000|Overall Study|Pregnancy|0|||
17122278|NCT03517566|38262232|FG001|Overall Study|Pregnancy|1|||
17122279|NCT03517566|38262233|FG002|Overall Study|Pregnancy|0|||
17122280|NCT03517566|38262234|FG003|Overall Study|Pregnancy|0|||
17122281|NCT03517566|38262235|FG004|Overall Study|Pregnancy|0|||
17122282|NCT03517566|38262231|FG000|Overall Study|Protocol Deviation|0|||
17122283|NCT03517566|38262232|FG001|Overall Study|Protocol Deviation|1|||
17122284|NCT03517566|38262233|FG002|Overall Study|Protocol Deviation|0|||
17122285|NCT03517566|38262234|FG003|Overall Study|Protocol Deviation|1|||
17122286|NCT03517566|38262235|FG004|Overall Study|Protocol Deviation|1|||
17122287|NCT03517566|38262231|FG000|Overall Study|Study terminated by Sponsor|11|||
17122288|NCT03517566|38262232|FG001|Overall Study|Study terminated by Sponsor|5|||
17122289|NCT03517566|38262233|FG002|Overall Study|Study terminated by Sponsor|6|||
17122290|NCT03517566|38262234|FG003|Overall Study|Study terminated by Sponsor|14|||
17122291|NCT03517566|38262235|FG004|Overall Study|Study terminated by Sponsor|12|||
17122292|NCT03517566|38262231|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
17122293|NCT03517566|38262232|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
17122294|NCT03517566|38262233|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
17122295|NCT03517566|38262234|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
17122296|NCT03517566|38262235|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
17122297|NCT03916744|38262251|FG000|Overall Study|Withdrawal by Subject|0|||
17122298|NCT03916744|38262252|FG001|Overall Study|Withdrawal by Subject|1|||
17122299|NCT03916744|38262253|FG002|Overall Study|Withdrawal by Subject|2|||
17122300|NCT03639610|38262268|FG000|Overall Study|Adverse Event|7|||
17122301|NCT03639610|38262269|FG001|Overall Study|Adverse Event|1|||
17122302|NCT03639610|38262270|FG002|Overall Study|Adverse Event|0|||
17122303|NCT03639610|38262268|FG000|Overall Study|Physician Decision|3|||
17122304|NCT03639610|38262269|FG001|Overall Study|Physician Decision|1|||
17122305|NCT03639610|38262270|FG002|Overall Study|Physician Decision|0|||
17122306|NCT03639610|38262268|FG000|Overall Study|Disease progression|8|||
17122307|NCT03639610|38262269|FG001|Overall Study|Disease progression|5|||
17122308|NCT03639610|38262270|FG002|Overall Study|Disease progression|3|||
17122309|NCT03639610|38262268|FG000|Overall Study|Study terminated by sponsor|2|||
17122310|NCT03639610|38262269|FG001|Overall Study|Study terminated by sponsor|1|||
17122311|NCT03639610|38262270|FG002|Overall Study|Study terminated by sponsor|1|||
17122312|NCT03639610|38262268|FG000|Overall Study|Patient request to stop treatment|1|||
17122313|NCT03639610|38262269|FG001|Overall Study|Patient request to stop treatment|2|||
17122314|NCT03639610|38262270|FG002|Overall Study|Patient request to stop treatment|0|||
17122315|NCT02954406|38262288|FG000|Overall Study|Adverse Event|0|||
17122316|NCT02954406|38262289|FG001|Overall Study|Adverse Event|1|||
17122317|NCT02954406|38262290|FG002|Overall Study|Adverse Event|0|||
17122318|NCT02954406|38262291|FG003|Overall Study|Adverse Event|0|||
17122319|NCT02954406|38262292|FG004|Overall Study|Adverse Event|1|||
17122320|NCT02954406|38262293|FG005|Overall Study|Adverse Event|0|||
17122321|NCT02954406|38262294|FG006|Overall Study|Adverse Event|0|||
17122322|NCT02954406|38262295|FG007|Overall Study|Adverse Event|0|||
17122323|NCT02954406|38262296|FG008|Overall Study|Adverse Event|1|||
17122324|NCT02954406|38262297|FG009|Overall Study|Adverse Event|1|||
17122325|NCT02954406|38262298|FG010|Overall Study|Adverse Event|0|||
17122326|NCT02954406|38262288|FG000|Overall Study|Progressive Disease|3|||
17122327|NCT02954406|38262289|FG001|Overall Study|Progressive Disease|4|||
17122328|NCT02954406|38262290|FG002|Overall Study|Progressive Disease|3|||
17122329|NCT02954406|38262291|FG003|Overall Study|Progressive Disease|4|||
17122330|NCT02954406|38262292|FG004|Overall Study|Progressive Disease|3|||
17122331|NCT02954406|38262293|FG005|Overall Study|Progressive Disease|3|||
17122332|NCT02954406|38262294|FG006|Overall Study|Progressive Disease|2|||
17122333|NCT02954406|38262295|FG007|Overall Study|Progressive Disease|2|||
17122334|NCT02954406|38262296|FG008|Overall Study|Progressive Disease|1|||
17122335|NCT02954406|38262297|FG009|Overall Study|Progressive Disease|1|||
17122336|NCT02954406|38262298|FG010|Overall Study|Progressive Disease|0|||
17122337|NCT02954406|38262288|FG000|Overall Study|Symptomatic Deterioration|0|||
17122338|NCT02954406|38262289|FG001|Overall Study|Symptomatic Deterioration|1|||
17122339|NCT02954406|38262290|FG002|Overall Study|Symptomatic Deterioration|0|||
17122340|NCT02954406|38262291|FG003|Overall Study|Symptomatic Deterioration|0|||
17122341|NCT02954406|38262292|FG004|Overall Study|Symptomatic Deterioration|0|||
17122342|NCT02954406|38262293|FG005|Overall Study|Symptomatic Deterioration|0|||
17122343|NCT02954406|38262294|FG006|Overall Study|Symptomatic Deterioration|0|||
17122344|NCT02954406|38262295|FG007|Overall Study|Symptomatic Deterioration|0|||
17122345|NCT02954406|38262296|FG008|Overall Study|Symptomatic Deterioration|0|||
17122346|NCT02954406|38262297|FG009|Overall Study|Symptomatic Deterioration|0|||
17122347|NCT02954406|38262298|FG010|Overall Study|Symptomatic Deterioration|0|||
17122348|NCT02954406|38262288|FG000|Overall Study|Death|0|||
17122349|NCT02954406|38262289|FG001|Overall Study|Death|0|||
17122350|NCT02954406|38262290|FG002|Overall Study|Death|0|||
17122351|NCT02954406|38262291|FG003|Overall Study|Death|0|||
17122352|NCT02954406|38262292|FG004|Overall Study|Death|1|||
17122353|NCT02954406|38262293|FG005|Overall Study|Death|0|||
17122354|NCT02954406|38262294|FG006|Overall Study|Death|0|||
17122355|NCT02954406|38262295|FG007|Overall Study|Death|0|||
17122356|NCT02954406|38262296|FG008|Overall Study|Death|1|||
17122357|NCT02954406|38262297|FG009|Overall Study|Death|1|||
17122358|NCT02954406|38262298|FG010|Overall Study|Death|0|||
17122359|NCT02954406|38262288|FG000|Overall Study|Reason Not Specified|0|||
17122360|NCT02954406|38262289|FG001|Overall Study|Reason Not Specified|0|||
17122361|NCT02954406|38262290|FG002|Overall Study|Reason Not Specified|3|||
17122362|NCT02954406|38262291|FG003|Overall Study|Reason Not Specified|2|||
17122363|NCT02954406|38262292|FG004|Overall Study|Reason Not Specified|2|||
17122364|NCT02954406|38262293|FG005|Overall Study|Reason Not Specified|0|||
17122365|NCT02954406|38262294|FG006|Overall Study|Reason Not Specified|1|||
17122366|NCT02954406|38262295|FG007|Overall Study|Reason Not Specified|0|||
17122367|NCT02954406|38262296|FG008|Overall Study|Reason Not Specified|1|||
17122368|NCT02954406|38262297|FG009|Overall Study|Reason Not Specified|0|||
17122369|NCT02954406|38262298|FG010|Overall Study|Reason Not Specified|0|||
17122370|NCT03514914|38262328|FG000|Overall Study|Death|3|||
17122371|NCT03514914|38262329|FG001|Overall Study|Death|3|||
17122372|NCT03514914|38262328|FG000|Overall Study|Lost to Follow-up|117|||
17122373|NCT03514914|38262329|FG001|Overall Study|Lost to Follow-up|89|||
17122374|NCT03513588|38262338|FG000|Overall Study|Lost to Follow-up|0|||
17122375|NCT03513588|38262339|FG001|Overall Study|Lost to Follow-up|1|||
17122376|NCT03513588|38262340|FG002|Overall Study|Lost to Follow-up|1|||
17122377|NCT03513588|38262338|FG000|Overall Study|Study dosing paused by sponsor|1|||
17122378|NCT03513588|38262339|FG001|Overall Study|Study dosing paused by sponsor|1|||
17122379|NCT03513588|38262340|FG002|Overall Study|Study dosing paused by sponsor|0|||
17122380|NCT03513588|38262338|FG000|Overall Study|Death|0|||
17122381|NCT03513588|38262339|FG001|Overall Study|Death|0|||
17122382|NCT03513588|38262340|FG002|Overall Study|Death|1|||
17122383|NCT03512028|38262352|FG000|Overall Study|Withdrawal by Subject|2|||
17122384|NCT03512028|38262353|FG001|Overall Study|Withdrawal by Subject|0|||
17122385|NCT03512028|38262352|FG000|Overall Study|Protocol Violation|2|||
17122386|NCT03512028|38262353|FG001|Overall Study|Protocol Violation|0|||
17122387|NCT03511326|38262359|FG000|Overall Study|Withdrawal by Subject|1|||
17122388|NCT03508830|38262365|FG000|Overall Study|Withdrawal by Subject|3|||
17122389|NCT03508830|38262366|FG001|Overall Study|Withdrawal by Subject|4|||
17122390|NCT03508830|38262365|FG000|Overall Study|Physician Decision|2|||
17122391|NCT03508830|38262366|FG001|Overall Study|Physician Decision|2|||
17122392|NCT03508050|38262374|FG000|Overall Study|Pleural adhesions|1|||
17122393|NCT03508050|38262375|FG001|Overall Study|Pleural adhesions|0|||
17122394|NCT03508050|38262374|FG000|Overall Study|Mucus plug|1|||
17122395|NCT03508050|38262375|FG001|Overall Study|Mucus plug|0|||
17122396|NCT03508050|38262374|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
17122397|NCT03508050|38262375|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
17122398|NCT03508050|38262374|FG000|Overall Study|Sustained desaturation|0|||
17122399|NCT03508050|38262375|FG001|Overall Study|Sustained desaturation|1|||
17122400|NCT03381274|38262387|FG000|Overall Study|Death|2|||
17122401|NCT03381274|38262388|FG001|Overall Study|Death|9|||
17122402|NCT03381274|38262389|FG002|Overall Study|Death|3|||
17122403|NCT03381274|38262390|FG003|Overall Study|Death|2|||
17122404|NCT03381274|38262391|FG004|Overall Study|Death|3|||
17122405|NCT03381274|38262387|FG000|Overall Study|Lost to Follow-up|0|||
17122406|NCT03381274|38262388|FG001|Overall Study|Lost to Follow-up|0|||
17122407|NCT03381274|38262389|FG002|Overall Study|Lost to Follow-up|0|||
17122408|NCT03381274|38262390|FG003|Overall Study|Lost to Follow-up|1|||
17122409|NCT03381274|38262391|FG004|Overall Study|Lost to Follow-up|0|||
17122410|NCT03381274|38262387|FG000|Overall Study|Withdrawal by Subject|2|||
17122411|NCT03381274|38262388|FG001|Overall Study|Withdrawal by Subject|1|||
17122412|NCT03381274|38262389|FG002|Overall Study|Withdrawal by Subject|3|||
17122413|NCT03381274|38262390|FG003|Overall Study|Withdrawal by Subject|1|||
17122414|NCT03381274|38262391|FG004|Overall Study|Withdrawal by Subject|0|||
17122415|NCT03381274|38262387|FG000|Overall Study|Other|1|||
17122416|NCT03381274|38262388|FG001|Overall Study|Other|11|||
17122417|NCT03381274|38262389|FG002|Overall Study|Other|0|||
17122418|NCT03381274|38262390|FG003|Overall Study|Other|2|||
17122419|NCT03381274|38262391|FG004|Overall Study|Other|2|||
17122420|NCT03569202|38262409|FG000|Part 3|Physician Decision|1|||
17122421|NCT03569202|38262410|FG001|Part 3|Physician Decision|0|||
17122422|NCT03569202|38262409|FG000|Part 3|Other|1|||
17122423|NCT03569202|38262410|FG001|Part 3|Other|1|||
17122424|NCT03568500|38262419|FG000|Overall Study|Lost to Follow-up|1|||
17122425|NCT03568500|38262420|FG001|Overall Study|Lost to Follow-up|1|||
17122426|NCT03568500|38262421|FG002|Overall Study|Lost to Follow-up|2|||
17122427|NCT03568500|38262419|FG000|Overall Study|Adverse Event|1|||
17122428|NCT03568500|38262420|FG001|Overall Study|Adverse Event|1|||
17122429|NCT03568500|38262421|FG002|Overall Study|Adverse Event|2|||
17122430|NCT03568500|38262419|FG000|Overall Study|Physician Decision|1|||
17122431|NCT03568500|38262420|FG001|Overall Study|Physician Decision|0|||
17122432|NCT03568500|38262421|FG002|Overall Study|Physician Decision|0|||
17122433|NCT03568500|38262419|FG000|Overall Study|Withdrawal by Subject|4|||
17122434|NCT03568500|38262420|FG001|Overall Study|Withdrawal by Subject|2|||
17122435|NCT03568500|38262421|FG002|Overall Study|Withdrawal by Subject|0|||
17122436|NCT03568500|38262419|FG000|Overall Study|Technical Problems|2|||
17122437|NCT03568500|38262420|FG001|Overall Study|Technical Problems|1|||
17122438|NCT03568500|38262421|FG002|Overall Study|Technical Problems|0|||
17122439|NCT03568500|38262419|FG000|Overall Study|Participant Noncompliance|1|||
17122440|NCT03568500|38262420|FG001|Overall Study|Participant Noncompliance|1|||
17122441|NCT03568500|38262421|FG002|Overall Study|Participant Noncompliance|0|||
17122442|NCT03504852|38262446|FG000|Overall Study|Withdrawal of informed consent|2|||
17122443|NCT03504852|38262447|FG001|Overall Study|Withdrawal of informed consent|1|||
17122444|NCT03504852|38262448|FG002|Overall Study|Withdrawal of informed consent|0|||
17122445|NCT03504852|38262446|FG000|Overall Study|Withdrawal by Subject|5|||
17122446|NCT03504852|38262447|FG001|Overall Study|Withdrawal by Subject|5|||
17122447|NCT03504852|38262448|FG002|Overall Study|Withdrawal by Subject|1|||
17122448|NCT03504852|38262446|FG000|Overall Study|Lost to Follow-up|4|||
17122449|NCT03504852|38262447|FG001|Overall Study|Lost to Follow-up|1|||
17122450|NCT03504852|38262448|FG002|Overall Study|Lost to Follow-up|0|||
17122451|NCT03504852|38262446|FG000|Overall Study|New therapy for study indication|1|||
17122452|NCT03504852|38262447|FG001|Overall Study|New therapy for study indication|0|||
17122453|NCT03504852|38262448|FG002|Overall Study|New therapy for study indication|0|||
17122454|NCT03504852|38262446|FG000|Overall Study|Lack of Efficacy|1|||
17122455|NCT03504852|38262447|FG001|Overall Study|Lack of Efficacy|2|||
17122456|NCT03504852|38262448|FG002|Overall Study|Lack of Efficacy|0|||
17122457|NCT03504852|38262446|FG000|Overall Study|Death|0|||
17122458|NCT03504852|38262447|FG001|Overall Study|Death|1|||
17122459|NCT03504852|38262448|FG002|Overall Study|Death|0|||
17122460|NCT03504852|38262446|FG000|Overall Study|Adverse Event|4|||
17122461|NCT03504852|38262447|FG001|Overall Study|Adverse Event|8|||
17122462|NCT03504852|38262448|FG002|Overall Study|Adverse Event|2|||
17122463|NCT03025828|38262458|FG000|Overall Study|Lost to Follow-up|1|||
17122464|NCT03546816|38262464|FG000|Overall Study|Adverse Event|5|||
17122465|NCT03546816|38262465|FG001|Overall Study|Adverse Event|3|||
17122466|NCT03546816|38262464|FG000|Overall Study|Lack of Efficacy|2|||
17122467|NCT03546816|38262465|FG001|Overall Study|Lack of Efficacy|4|||
17122468|NCT03546816|38262464|FG000|Overall Study|Pregnancy|1|||
17122469|NCT03546816|38262465|FG001|Overall Study|Pregnancy|0|||
17122470|NCT03546816|38262464|FG000|Overall Study|Physician Decision|2|||
17122471|NCT03546816|38262465|FG001|Overall Study|Physician Decision|0|||
17122472|NCT03546816|38262464|FG000|Overall Study|Withdrawal by Subject|8|||
17122473|NCT03546816|38262465|FG001|Overall Study|Withdrawal by Subject|10|||
17122474|NCT03546816|38262464|FG000|Overall Study|Lost to Follow-up|3|||
17122475|NCT03546816|38262465|FG001|Overall Study|Lost to Follow-up|2|||
17122476|NCT03024970|38262473|FG000|First Intervention|Adverse Event|1|||
17122477|NCT03024970|38262474|FG001|First Intervention|Adverse Event|0|||
17122478|NCT03024970|38262473|FG000|Second Intervention|Lost to Follow-up|1|||
17122479|NCT03024970|38262474|FG001|Second Intervention|Lost to Follow-up|0|||
17122480|NCT03500094|38262480|FG000|Overall Study|Withdrawal by Subject|1|||
17122481|NCT03500094|38262480|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
17122482|NCT03500094|38262480|FG000|Overall Study|Lost to Follow-up|1|||
17122483|NCT03566550|38262488|FG000|Overall Study|Withdrawal by Subject|0|||
17122484|NCT03566550|38262489|FG001|Overall Study|Withdrawal by Subject|1|||
17122485|NCT03563716|38262497|FG000|Overall Study|Death|20|||
17122486|NCT03563716|38262498|FG001|Overall Study|Death|14|||
17122487|NCT03563716|38262497|FG000|Overall Study|Withdrawal by Subject|3|||
17122488|NCT03563716|38262498|FG001|Overall Study|Withdrawal by Subject|3|||
17122489|NCT03563716|38262497|FG000|Overall Study|Still on Study|45|||
17122490|NCT03563716|38262498|FG001|Overall Study|Still on Study|50|||
17122491|NCT03566238|38262507|FG000|Overall Study|Adverse Event|0|||
17122492|NCT03566238|38262508|FG001|Overall Study|Adverse Event|1|||
17122493|NCT03566238|38262509|FG002|Overall Study|Adverse Event|0|||
17122494|NCT03566238|38262507|FG000|Overall Study|Lack of Efficacy|4|||
17122495|NCT03566238|38262508|FG001|Overall Study|Lack of Efficacy|2|||
17122496|NCT03566238|38262509|FG002|Overall Study|Lack of Efficacy|5|||
17122497|NCT03566238|38262507|FG000|Overall Study|Other|1|||
17122498|NCT03566238|38262508|FG001|Overall Study|Other|0|||
17122499|NCT03566238|38262509|FG002|Overall Study|Other|0|||
17122500|NCT02894502|38262520|FG000|Baseline|Withdrawal by Subject|24|||
17122501|NCT02894502|38262521|FG001|Baseline|Withdrawal by Subject|31|||
17122502|NCT02894502|38262522|FG002|Baseline|Withdrawal by Subject|36|||
17122503|NCT02894502|38262520|FG000|Baseline|Death|3|||
17122504|NCT02894502|38262521|FG001|Baseline|Death|1|||
17122505|NCT02894502|38262522|FG002|Baseline|Death|9|||
17122506|NCT02894502|38262520|FG000|First Follow up|Withdrawal by Subject|32|||
17122507|NCT02894502|38262521|FG001|First Follow up|Withdrawal by Subject|29|||
17122508|NCT02894502|38262522|FG002|First Follow up|Withdrawal by Subject|37|||
17122509|NCT02894502|38262520|FG000|First Follow up|Death|2|||
17122510|NCT02894502|38262521|FG001|First Follow up|Death|2|||
17122511|NCT02894502|38262522|FG002|First Follow up|Death|3|||
17122512|NCT02894502|38262520|FG000|Second Follow up|Withdrawal by Subject|13|||
17122513|NCT02894502|38262521|FG001|Second Follow up|Withdrawal by Subject|15|||
17122514|NCT02894502|38262522|FG002|Second Follow up|Withdrawal by Subject|13|||
17122515|NCT02894502|38262520|FG000|Second Follow up|Death|2|||
17122516|NCT02894502|38262521|FG001|Second Follow up|Death|3|||
17122517|NCT02894502|38262522|FG002|Second Follow up|Death|1|||
17122518|NCT02894502|38262520|FG000|Third Follow up|Withdrawal by Subject|5|||
17122519|NCT02894502|38262521|FG001|Third Follow up|Withdrawal by Subject|6|||
17122520|NCT02894502|38262522|FG002|Third Follow up|Withdrawal by Subject|3|||
17122521|NCT02894502|38262520|FG000|Third Follow up|Death|1|||
17122522|NCT02894502|38262521|FG001|Third Follow up|Death|1|||
17122523|NCT02894502|38262522|FG002|Third Follow up|Death|0|||
17122524|NCT03449030|38262543|FG000|Overall Study|Withdrawal by Subject|0|||
17122525|NCT03449030|38262544|FG001|Overall Study|Withdrawal by Subject|0|||
17122526|NCT03449030|38262545|FG002|Overall Study|Withdrawal by Subject|0|||
17122527|NCT03449030|38262546|FG003|Overall Study|Withdrawal by Subject|1|||
17122528|NCT03449030|38262547|FG004|Overall Study|Withdrawal by Subject|1|||
17122529|NCT03449030|38262548|FG005|Overall Study|Withdrawal by Subject|1|||
17122530|NCT03449030|38262549|FG006|Overall Study|Withdrawal by Subject|1|||
17122531|NCT03449030|38262550|FG007|Overall Study|Withdrawal by Subject|2|||
17122532|NCT03449030|38262551|FG008|Overall Study|Withdrawal by Subject|0|||
17122533|NCT03449030|38262552|FG009|Overall Study|Withdrawal by Subject|0|||
17122534|NCT03449030|38262543|FG000|Overall Study|Symptomatic Deterioration|0|||
17122535|NCT03449030|38262544|FG001|Overall Study|Symptomatic Deterioration|1|||
17122536|NCT03449030|38262545|FG002|Overall Study|Symptomatic Deterioration|0|||
17122537|NCT03449030|38262546|FG003|Overall Study|Symptomatic Deterioration|0|||
17122538|NCT03449030|38262547|FG004|Overall Study|Symptomatic Deterioration|0|||
17122539|NCT03449030|38262548|FG005|Overall Study|Symptomatic Deterioration|1|||
17122540|NCT03449030|38262549|FG006|Overall Study|Symptomatic Deterioration|1|||
17122541|NCT03449030|38262550|FG007|Overall Study|Symptomatic Deterioration|0|||
17122542|NCT03449030|38262551|FG008|Overall Study|Symptomatic Deterioration|2|||
17122543|NCT03449030|38262552|FG009|Overall Study|Symptomatic Deterioration|0|||
17122544|NCT03449030|38262543|FG000|Overall Study|Progressive Disease|1|||
17122545|NCT03449030|38262544|FG001|Overall Study|Progressive Disease|0|||
17122546|NCT03449030|38262545|FG002|Overall Study|Progressive Disease|1|||
17122547|NCT03449030|38262546|FG003|Overall Study|Progressive Disease|4|||
17122548|NCT03449030|38262547|FG004|Overall Study|Progressive Disease|5|||
17122549|NCT03449030|38262548|FG005|Overall Study|Progressive Disease|3|||
17122550|NCT03449030|38262549|FG006|Overall Study|Progressive Disease|0|||
17122551|NCT03449030|38262550|FG007|Overall Study|Progressive Disease|1|||
17122552|NCT03449030|38262551|FG008|Overall Study|Progressive Disease|1|||
17122553|NCT03449030|38262552|FG009|Overall Study|Progressive Disease|1|||
17122554|NCT03449030|38262543|FG000|Overall Study|Adverse Event|0|||
17122555|NCT03449030|38262544|FG001|Overall Study|Adverse Event|0|||
17122556|NCT03449030|38262545|FG002|Overall Study|Adverse Event|0|||
17122557|NCT03449030|38262546|FG003|Overall Study|Adverse Event|0|||
17122558|NCT03449030|38262547|FG004|Overall Study|Adverse Event|0|||
17122559|NCT03449030|38262548|FG005|Overall Study|Adverse Event|2|||
17122560|NCT03449030|38262549|FG006|Overall Study|Adverse Event|0|||
17122561|NCT03449030|38262550|FG007|Overall Study|Adverse Event|0|||
17122562|NCT03449030|38262551|FG008|Overall Study|Adverse Event|0|||
17122563|NCT03449030|38262552|FG009|Overall Study|Adverse Event|0|||
17122564|NCT03449030|38262543|FG000|Overall Study|Death|0|||
17122565|NCT03449030|38262544|FG001|Overall Study|Death|0|||
17122566|NCT03449030|38262545|FG002|Overall Study|Death|0|||
17122567|NCT03449030|38262546|FG003|Overall Study|Death|0|||
17122568|NCT03449030|38262547|FG004|Overall Study|Death|1|||
17122569|NCT03449030|38262548|FG005|Overall Study|Death|0|||
17122570|NCT03449030|38262549|FG006|Overall Study|Death|0|||
17122571|NCT03449030|38262550|FG007|Overall Study|Death|0|||
17122572|NCT03449030|38262551|FG008|Overall Study|Death|0|||
17122573|NCT03449030|38262552|FG009|Overall Study|Death|0|||
17122574|NCT03448406|38262577|FG000|Overall Study|Noncompliance of scheduled visits|1|||
17122575|NCT03448406|38262578|FG001|Overall Study|Noncompliance of scheduled visits|2|||
17122576|NCT03448406|38262577|FG000|Overall Study|Withdrawal by Subject|1|||
17122577|NCT03448406|38262578|FG001|Overall Study|Withdrawal by Subject|2|||
17122578|NCT03448406|38262577|FG000|Overall Study|Protocol Violation|1|||
17122579|NCT03448406|38262578|FG001|Overall Study|Protocol Violation|0|||
17122580|NCT03448406|38262577|FG000|Overall Study|Adverse Event|8|||
17122581|NCT03448406|38262578|FG001|Overall Study|Adverse Event|9|||
17122582|NCT03499028|38262586|FG000|Overall Study|Lost to Follow-up|12|||
17122583|NCT03499028|38262587|FG001|Overall Study|Lost to Follow-up|9|||
17122584|NCT03499028|38262586|FG000|Overall Study|Withdrawal by Subject|5|||
17122585|NCT03499028|38262587|FG001|Overall Study|Withdrawal by Subject|8|||
17122586|NCT03499028|38262586|FG000|Overall Study|Unplanned SNF discharge|5|||
17122587|NCT03499028|38262587|FG001|Overall Study|Unplanned SNF discharge|8|||
17122588|NCT03498560|38262595|FG000|Overall Study|Found Ineligible|2|||
17122589|NCT03498560|38262595|FG000|Overall Study|Withdrawal by Subject|14|||
17122590|NCT03498560|38262595|FG000|Overall Study|Lost to Follow-up|4|||
17122591|NCT03498560|38262595|FG000|Overall Study|Death|1|||
17122592|NCT00064701|38262603|FG000|One Year Post-transplant|Did not receive study drug|7|||
17122593|NCT00064701|38262604|FG001|One Year Post-transplant|Did not receive study drug|12|||
17122594|NCT00064701|38262605|FG002|One Year Post-transplant|Did not receive study drug|11|||
17122595|NCT00064701|38262603|FG000|One Year Post-transplant|Adverse Event|23|||
17122596|NCT00064701|38262604|FG001|One Year Post-transplant|Adverse Event|19|||
17122597|NCT00064701|38262605|FG002|One Year Post-transplant|Adverse Event|37|||
17122598|NCT00064701|38262603|FG000|One Year Post-transplant|Rejection|0|||
17122599|NCT00064701|38262604|FG001|One Year Post-transplant|Rejection|1|||
17122600|NCT00064701|38262605|FG002|One Year Post-transplant|Rejection|16|||
17122601|NCT00064701|38262603|FG000|One Year Post-transplant|Non-compliance|4|||
17122602|NCT00064701|38262604|FG001|One Year Post-transplant|Non-compliance|2|||
17122603|NCT00064701|38262605|FG002|One Year Post-transplant|Non-compliance|5|||
17122604|NCT00064701|38262603|FG000|One Year Post-transplant|Graft Failure|3|||
17122605|NCT00064701|38262604|FG001|One Year Post-transplant|Graft Failure|2|||
17122606|NCT00064701|38262605|FG002|One Year Post-transplant|Graft Failure|1|||
17122607|NCT00064701|38262603|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
17122608|NCT00064701|38262604|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
17122609|NCT00064701|38262605|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
17122610|NCT00064701|38262603|FG000|One Year Post-transplant|Lost to Follow-up|1|||
17122611|NCT00064701|38262604|FG001|One Year Post-transplant|Lost to Follow-up|0|||
17122612|NCT00064701|38262605|FG002|One Year Post-transplant|Lost to Follow-up|0|||
17122613|NCT00064701|38262603|FG000|One Year Post-transplant|Converted to rapamycin|1|||
17122614|NCT00064701|38262604|FG001|One Year Post-transplant|Converted to rapamycin|0|||
17122615|NCT00064701|38262605|FG002|One Year Post-transplant|Converted to rapamycin|0|||
17122616|NCT00064701|38262603|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
17122617|NCT00064701|38262604|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
17122618|NCT00064701|38262605|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
17122619|NCT00064701|38262603|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
17122620|NCT00064701|38262604|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
17122621|NCT00064701|38262605|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
17122622|NCT00064701|38262603|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
17122623|NCT00064701|38262604|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
17122624|NCT00064701|38262605|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
17122625|NCT00064701|38262603|FG000|One Year Post-transplant|Poor absorption|0|||
17122626|NCT00064701|38262604|FG001|One Year Post-transplant|Poor absorption|1|||
17122627|NCT00064701|38262605|FG002|One Year Post-transplant|Poor absorption|0|||
17122628|NCT00064701|38262603|FG000|One Year Post-transplant|Pancreas transplant|0|||
17122629|NCT00064701|38262604|FG001|One Year Post-transplant|Pancreas transplant|0|||
17122630|NCT00064701|38262605|FG002|One Year Post-transplant|Pancreas transplant|1|||
17122631|NCT00064701|38262603|FG000|Clinical Continuation Phase|Adverse Event|12|||
17122632|NCT00064701|38262604|FG001|Clinical Continuation Phase|Adverse Event|21|||
17122633|NCT00064701|38262605|FG002|Clinical Continuation Phase|Adverse Event|14|||
17122634|NCT00064701|38262603|FG000|Clinical Continuation Phase|Non-compliance|8|||
17122635|NCT00064701|38262604|FG001|Clinical Continuation Phase|Non-compliance|6|||
17122636|NCT00064701|38262605|FG002|Clinical Continuation Phase|Non-compliance|7|||
17122637|NCT00064701|38262603|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
17122638|NCT00064701|38262604|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
17122639|NCT00064701|38262605|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
17122640|NCT00064701|38262603|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
17122641|NCT00064701|38262604|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
17122642|NCT00064701|38262605|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
17122643|NCT00064701|38262603|FG000|Clinical Continuation Phase|Graft Failure|5|||
17122644|NCT00064701|38262604|FG001|Clinical Continuation Phase|Graft Failure|5|||
17122645|NCT00064701|38262605|FG002|Clinical Continuation Phase|Graft Failure|2|||
17122646|NCT00064701|38262603|FG000|Clinical Continuation Phase|Rejection|1|||
17122647|NCT00064701|38262604|FG001|Clinical Continuation Phase|Rejection|2|||
17122648|NCT00064701|38262605|FG002|Clinical Continuation Phase|Rejection|2|||
17122649|NCT00064701|38262603|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
17122650|NCT00064701|38262604|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
17122651|NCT00064701|38262605|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
17122652|NCT00064701|38262603|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
17122653|NCT00064701|38262604|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
17122654|NCT00064701|38262605|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
17122655|NCT00064701|38262603|FG000|Clinical Continuation Phase|Physician Decision|1|||
17122656|NCT00064701|38262604|FG001|Clinical Continuation Phase|Physician Decision|3|||
17122657|NCT00064701|38262605|FG002|Clinical Continuation Phase|Physician Decision|0|||
17122658|NCT00064701|38262603|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
17122659|NCT00064701|38262604|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
17122660|NCT00064701|38262605|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
17122661|NCT00064701|38262603|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
17122662|NCT00064701|38262604|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
17122663|NCT00064701|38262605|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
17122664|NCT00064701|38262603|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
17122665|NCT00064701|38262604|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
17122666|NCT00064701|38262605|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
17122667|NCT00064701|38262603|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
17122668|NCT00064701|38262604|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
17122669|NCT00064701|38262605|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
17122670|NCT00064701|38262603|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
17122671|NCT00064701|38262604|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
17122672|NCT00064701|38262605|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
17122673|NCT00064701|38262603|FG000|Clinical Continuation Phase|Patient opted out|0|||
17122674|NCT00064701|38262604|FG001|Clinical Continuation Phase|Patient opted out|0|||
17122675|NCT00064701|38262605|FG002|Clinical Continuation Phase|Patient opted out|1|||
17122676|NCT02990338|38262615|FG000|Overall Study|Ongoing|30|||
17122677|NCT02990338|38262616|FG001|Overall Study|Ongoing|36|||
17122678|NCT00064077|38262629|FG000|Overall Study|Improper prior treatment|1|||
17122679|NCT00064077|38262630|FG001|Overall Study|Improper prior treatment|0|||
17122680|NCT00064077|38262631|FG002|Overall Study|Improper prior treatment|0|||
17122681|NCT00064077|38262632|FG003|Overall Study|Improper prior treatment|0|||
17122682|NCT00064077|38262629|FG000|Overall Study|Poor risk|2|||
17122683|NCT00064077|38262630|FG001|Overall Study|Poor risk|0|||
17122684|NCT00064077|38262631|FG002|Overall Study|Poor risk|1|||
17122685|NCT00064077|38262632|FG003|Overall Study|Poor risk|1|||
17122686|NCT00064077|38262629|FG000|Overall Study|Pathology|10|||
17122687|NCT00064077|38262630|FG001|Overall Study|Pathology|7|||
17122688|NCT00064077|38262631|FG002|Overall Study|Pathology|3|||
17122689|NCT00064077|38262632|FG003|Overall Study|Pathology|4|||
17122690|NCT00064077|38262629|FG000|Overall Study|No surgery|0|||
17122691|NCT00064077|38262630|FG001|Overall Study|No surgery|0|||
17122692|NCT00064077|38262631|FG002|Overall Study|No surgery|1|||
17122693|NCT00064077|38262632|FG003|Overall Study|No surgery|0|||
17122694|NCT00064077|38262629|FG000|Overall Study|No tumor|0|||
17122695|NCT00064077|38262630|FG001|Overall Study|No tumor|0|||
17122696|NCT00064077|38262631|FG002|Overall Study|No tumor|1|||
17122697|NCT00064077|38262632|FG003|Overall Study|No tumor|0|||
17122698|NCT00064077|38262629|FG000|Overall Study|Other reasons|2|||
17122699|NCT00064077|38262630|FG001|Overall Study|Other reasons|2|||
17122700|NCT00064077|38262631|FG002|Overall Study|Other reasons|1|||
17122701|NCT00064077|38262632|FG003|Overall Study|Other reasons|2|||
17122702|NCT00063999|38262644|FG000|Overall Study|Withdrawal by Subject|1|||
17122703|NCT00063999|38262645|FG001|Overall Study|Withdrawal by Subject|0|||
17122704|NCT00063999|38262644|FG000|Overall Study|Ineligible|44|||
17122705|NCT00063999|38262645|FG001|Overall Study|Ineligible|24|||
17122706|NCT03131440|38262690|FG000|Overall Study|Withdrawal by Subject|1|||
17122707|NCT03131440|38262691|FG001|Overall Study|Withdrawal by Subject|3|||
17122708|NCT03131440|38262692|FG002|Overall Study|Withdrawal by Subject|0|||
17122709|NCT03131440|38262693|FG003|Overall Study|Withdrawal by Subject|0|||
17122710|NCT03131440|38262694|FG004|Overall Study|Withdrawal by Subject|1|||
17122711|NCT03131440|38262695|FG005|Overall Study|Withdrawal by Subject|0|||
17122712|NCT03131440|38262696|FG006|Overall Study|Withdrawal by Subject|0|||
17122713|NCT03131440|38262697|FG007|Overall Study|Withdrawal by Subject|1|||
17122714|NCT03131440|38262698|FG008|Overall Study|Withdrawal by Subject|1|||
17122715|NCT03131440|38262699|FG009|Overall Study|Withdrawal by Subject|1|||
17122716|NCT03131440|38262700|FG010|Overall Study|Withdrawal by Subject|0|||
17122717|NCT03131440|38262701|FG011|Overall Study|Withdrawal by Subject|1|||
17122718|NCT03131440|38262702|FG012|Overall Study|Withdrawal by Subject|1|||
17122719|NCT03131440|38262703|FG013|Overall Study|Withdrawal by Subject|0|||
17122720|NCT03131440|38262704|FG014|Overall Study|Withdrawal by Subject|1|||
17122721|NCT03131440|38262705|FG015|Overall Study|Withdrawal by Subject|0|||
17122722|NCT03131440|38262706|FG016|Overall Study|Withdrawal by Subject|0|||
17122723|NCT03131440|38262707|FG017|Overall Study|Withdrawal by Subject|0|||
17122724|NCT03131440|38262708|FG018|Overall Study|Withdrawal by Subject|1|||
17122725|NCT03131440|38262709|FG019|Overall Study|Withdrawal by Subject|0|||
17122726|NCT03131440|38262710|FG020|Overall Study|Withdrawal by Subject|1|||
17122727|NCT03131440|38262711|FG021|Overall Study|Withdrawal by Subject|1|||
17122728|NCT03131440|38262712|FG022|Overall Study|Withdrawal by Subject|1|||
17122729|NCT03131440|38262713|FG023|Overall Study|Withdrawal by Subject|0|||
17122730|NCT03131440|38262714|FG024|Overall Study|Withdrawal by Subject|0|||
17122731|NCT03131440|38262715|FG025|Overall Study|Withdrawal by Subject|0|||
17122732|NCT03131440|38262716|FG026|Overall Study|Withdrawal by Subject|0|||
17122733|NCT03131440|38262717|FG027|Overall Study|Withdrawal by Subject|0|||
17122734|NCT03131440|38262718|FG028|Overall Study|Withdrawal by Subject|0|||
17122735|NCT03131440|38262719|FG029|Overall Study|Withdrawal by Subject|0|||
17122736|NCT03131440|38262720|FG030|Overall Study|Withdrawal by Subject|1|||
17122737|NCT03131440|38262721|FG031|Overall Study|Withdrawal by Subject|0|||
17122738|NCT03131440|38262690|FG000|Overall Study|Lost to Follow-up|0|||
17122739|NCT03131440|38262691|FG001|Overall Study|Lost to Follow-up|0|||
17122740|NCT03131440|38262692|FG002|Overall Study|Lost to Follow-up|0|||
17122741|NCT03131440|38262693|FG003|Overall Study|Lost to Follow-up|0|||
17122742|NCT03131440|38262694|FG004|Overall Study|Lost to Follow-up|0|||
17122743|NCT03131440|38262695|FG005|Overall Study|Lost to Follow-up|1|||
17122744|NCT03131440|38262696|FG006|Overall Study|Lost to Follow-up|0|||
17122745|NCT03131440|38262697|FG007|Overall Study|Lost to Follow-up|0|||
17122746|NCT03131440|38262698|FG008|Overall Study|Lost to Follow-up|0|||
17122747|NCT03131440|38262699|FG009|Overall Study|Lost to Follow-up|0|||
17122748|NCT03131440|38262700|FG010|Overall Study|Lost to Follow-up|0|||
17122749|NCT03131440|38262701|FG011|Overall Study|Lost to Follow-up|0|||
17122750|NCT03131440|38262702|FG012|Overall Study|Lost to Follow-up|0|||
17122751|NCT03131440|38262703|FG013|Overall Study|Lost to Follow-up|0|||
17122752|NCT03131440|38262704|FG014|Overall Study|Lost to Follow-up|0|||
17122753|NCT03131440|38262705|FG015|Overall Study|Lost to Follow-up|0|||
17122754|NCT03131440|38262706|FG016|Overall Study|Lost to Follow-up|0|||
17122755|NCT03131440|38262707|FG017|Overall Study|Lost to Follow-up|0|||
17122756|NCT03131440|38262708|FG018|Overall Study|Lost to Follow-up|0|||
17122757|NCT03131440|38262709|FG019|Overall Study|Lost to Follow-up|2|||
17122758|NCT03131440|38262710|FG020|Overall Study|Lost to Follow-up|1|||
17122759|NCT03131440|38262711|FG021|Overall Study|Lost to Follow-up|0|||
17122760|NCT03131440|38262712|FG022|Overall Study|Lost to Follow-up|1|||
17122761|NCT03131440|38262713|FG023|Overall Study|Lost to Follow-up|0|||
17122762|NCT03131440|38262714|FG024|Overall Study|Lost to Follow-up|1|||
17122763|NCT03131440|38262715|FG025|Overall Study|Lost to Follow-up|0|||
17122764|NCT03131440|38262716|FG026|Overall Study|Lost to Follow-up|0|||
17122765|NCT03131440|38262717|FG027|Overall Study|Lost to Follow-up|2|||
17122766|NCT03131440|38262718|FG028|Overall Study|Lost to Follow-up|0|||
17122767|NCT03131440|38262719|FG029|Overall Study|Lost to Follow-up|2|||
17122768|NCT03131440|38262720|FG030|Overall Study|Lost to Follow-up|0|||
17122769|NCT03131440|38262721|FG031|Overall Study|Lost to Follow-up|0|||
17122770|NCT03131440|38262690|FG000|Overall Study|Death|0|||
17122771|NCT03131440|38262691|FG001|Overall Study|Death|0|||
17122772|NCT03131440|38262692|FG002|Overall Study|Death|0|||
17122773|NCT03131440|38262693|FG003|Overall Study|Death|0|||
17122774|NCT03131440|38262694|FG004|Overall Study|Death|0|||
17122775|NCT03131440|38262695|FG005|Overall Study|Death|0|||
17122776|NCT03131440|38262696|FG006|Overall Study|Death|0|||
17122777|NCT03131440|38262697|FG007|Overall Study|Death|0|||
17122778|NCT03131440|38262698|FG008|Overall Study|Death|0|||
17122779|NCT03131440|38262699|FG009|Overall Study|Death|0|||
17122780|NCT03131440|38262700|FG010|Overall Study|Death|0|||
17122781|NCT03131440|38262701|FG011|Overall Study|Death|0|||
17122782|NCT03131440|38262702|FG012|Overall Study|Death|0|||
17122783|NCT03131440|38262703|FG013|Overall Study|Death|0|||
17122784|NCT03131440|38262704|FG014|Overall Study|Death|0|||
17122785|NCT03131440|38262705|FG015|Overall Study|Death|0|||
17122786|NCT03131440|38262706|FG016|Overall Study|Death|0|||
17122787|NCT03131440|38262707|FG017|Overall Study|Death|0|||
17122788|NCT03131440|38262708|FG018|Overall Study|Death|0|||
17122789|NCT03131440|38262709|FG019|Overall Study|Death|0|||
17122790|NCT03131440|38262710|FG020|Overall Study|Death|0|||
17122791|NCT03131440|38262711|FG021|Overall Study|Death|0|||
17122792|NCT03131440|38262712|FG022|Overall Study|Death|0|||
17122793|NCT03131440|38262713|FG023|Overall Study|Death|0|||
17122794|NCT03131440|38262714|FG024|Overall Study|Death|0|||
17122795|NCT03131440|38262715|FG025|Overall Study|Death|1|||
17122796|NCT03131440|38262716|FG026|Overall Study|Death|0|||
17122797|NCT03131440|38262717|FG027|Overall Study|Death|0|||
17122798|NCT03131440|38262718|FG028|Overall Study|Death|0|||
17122799|NCT03131440|38262719|FG029|Overall Study|Death|0|||
17122800|NCT03131440|38262720|FG030|Overall Study|Death|0|||
17122801|NCT03131440|38262721|FG031|Overall Study|Death|0|||
17122802|NCT02915302|38262766|FG000|Overall Study|Adverse Event|3|||
17122803|NCT02915302|38262767|FG001|Overall Study|Adverse Event|0|||
17122804|NCT02915302|38262766|FG000|Overall Study|Protocol Violation|20|||
17122805|NCT02915302|38262767|FG001|Overall Study|Protocol Violation|27|||
17122806|NCT02915302|38262766|FG000|Overall Study|Lost to Follow-up|19|||
17122807|NCT02915302|38262767|FG001|Overall Study|Lost to Follow-up|22|||
17122808|NCT02915302|38262766|FG000|Overall Study|Withdrawal by Subject|22|||
17122809|NCT02915302|38262767|FG001|Overall Study|Withdrawal by Subject|29|||
17122810|NCT02915302|38262766|FG000|Overall Study|Other|1|||
17122811|NCT02915302|38262767|FG001|Overall Study|Other|0|||
17122812|NCT03023878|38262773|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
17122813|NCT03023878|38262773|FG000|Pre-Study Run-In Period|Death|1|||
17122814|NCT03023878|38262773|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
17122815|NCT03023878|38262773|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
17122816|NCT03023878|38262773|FG000|Treatment Period|Disease Progression|1|||
17122817|NCT03023878|38262773|FG000|Treatment Period|Withdrawal by Subject|1|||
17122818|NCT03023878|38262773|FG000|Treatment Period|Adverse Event|1|||
17122819|NCT03023878|38262773|FG000|Long Term Follow-Up Period|Death|2|||
17122820|NCT03022630|38262779|FG000|Overall Study|Death|9|||
17122821|NCT03022630|38262780|FG001|Overall Study|Death|7|||
17122822|NCT03022630|38262779|FG000|Overall Study|Withdrawal by Subject|0|||
17122823|NCT03022630|38262780|FG001|Overall Study|Withdrawal by Subject|5|||
17122824|NCT03023722|38262791|FG000|Overall Study|No follow-up assessment|4|||
17122825|NCT03022084|38262797|FG000|Overall Study|Lost to Follow-up|2|||
17122826|NCT03022084|38262798|FG001|Overall Study|Lost to Follow-up|3|||
17122827|NCT03021304|38262804|FG000|Overall Study|Lack of Efficacy|1|||
17122828|NCT01979536|38262810|FG000|Overall Study|Physician Decision|2|||
17122829|NCT01979536|38262811|FG001|Overall Study|Physician Decision|3|||
17122830|NCT01979536|38262810|FG000|Overall Study|Withdrawal by Subject|0|||
17122831|NCT01979536|38262811|FG001|Overall Study|Withdrawal by Subject|1|||
17122832|NCT01979536|38262810|FG000|Overall Study|Refusal|0|||
17122833|NCT01979536|38262811|FG001|Overall Study|Refusal|1|||
17122834|NCT01979536|38262810|FG000|Overall Study|Relapse|0|||
17122835|NCT01979536|38262811|FG001|Overall Study|Relapse|1|||
17122836|NCT01979536|38262810|FG000|Overall Study|Study terminated by Sponsor|0|||
17122837|NCT01979536|38262811|FG001|Overall Study|Study terminated by Sponsor|1|||
17122838|NCT01979536|38262810|FG000|Overall Study|Did not start treatment|0|||
17122839|NCT01979536|38262811|FG001|Overall Study|Did not start treatment|1|||
17122840|NCT03496298|38262833|FG000|Overall Study|Adverse Event|49|||
17122841|NCT03496298|38262834|FG001|Overall Study|Adverse Event|68|||
17122842|NCT03496298|38262835|FG002|Overall Study|Adverse Event|79|||
17122843|NCT03496298|38262833|FG000|Overall Study|Study terminated by Sponsor|1050|||
17122844|NCT03496298|38262834|FG001|Overall Study|Study terminated by Sponsor|1063|||
17122845|NCT03496298|38262835|FG002|Overall Study|Study terminated by Sponsor|1071|||
17122846|NCT03496298|38262833|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
17122847|NCT03496298|38262834|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
17122848|NCT03496298|38262835|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
17122849|NCT03496298|38262833|FG000|Overall Study|Withdrawal by Subject|176|||
17122850|NCT03496298|38262834|FG001|Overall Study|Withdrawal by Subject|154|||
17122851|NCT03496298|38262835|FG002|Overall Study|Withdrawal by Subject|151|||
17122852|NCT03496298|38262833|FG000|Overall Study|Other|29|||
17122853|NCT03496298|38262834|FG001|Overall Study|Other|20|||
17122854|NCT03496298|38262835|FG002|Overall Study|Other|23|||
17122855|NCT03496298|38262833|FG000|Overall Study|Randomized and not treated|1|||
17122856|NCT03496298|38262834|FG001|Overall Study|Randomized and not treated|1|||
17122857|NCT03496298|38262835|FG002|Overall Study|Randomized and not treated|1|||
17122858|NCT02914522|38262848|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
17122859|NCT02914522|38262849|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
17122860|NCT02914522|38262850|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
17122861|NCT02914522|38262851|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
17122862|NCT02914522|38262852|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
17122863|NCT02914522|38262853|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
17122864|NCT02914522|38262854|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
17122865|NCT02914522|38262855|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
17122866|NCT02914522|38262856|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
17122867|NCT02914522|38262857|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
17122868|NCT02914522|38262858|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
17122869|NCT02914522|38262848|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
17122870|NCT02914522|38262849|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
17122871|NCT02914522|38262850|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
17122872|NCT02914522|38262851|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
17122873|NCT02914522|38262852|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
17122874|NCT02914522|38262853|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
17122875|NCT02914522|38262854|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
17122876|NCT02914522|38262855|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
17122877|NCT02914522|38262856|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
17122878|NCT02914522|38262857|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
17122879|NCT02914522|38262858|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
17122880|NCT02914522|38262848|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
17122881|NCT02914522|38262849|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
17122882|NCT02914522|38262850|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
17122883|NCT02914522|38262851|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
17122884|NCT02914522|38262852|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
17122885|NCT02914522|38262853|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
17122886|NCT02914522|38262854|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
17122887|NCT02914522|38262855|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
17122888|NCT02914522|38262856|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
17122889|NCT02914522|38262857|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
17122890|NCT02914522|38262858|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
17122891|NCT02914522|38262848|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
17122892|NCT02914522|38262849|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
17122893|NCT02914522|38262850|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
17122894|NCT02914522|38262851|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
17122895|NCT02914522|38262852|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
17122896|NCT02914522|38262853|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
17122897|NCT02914522|38262854|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
17122898|NCT02914522|38262855|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
17122899|NCT02914522|38262856|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
17122900|NCT02914522|38262857|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
17122901|NCT02914522|38262858|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
17122902|NCT02914522|38262848|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122903|NCT02914522|38262849|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122904|NCT02914522|38262850|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122905|NCT02914522|38262851|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122906|NCT02914522|38262852|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
17122907|NCT02914522|38262853|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122908|NCT02914522|38262854|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122909|NCT02914522|38262855|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122910|NCT02914522|38262856|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122911|NCT02914522|38262857|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122912|NCT02914522|38262858|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
17122913|NCT02914522|38262848|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
17122914|NCT02914522|38262849|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
17122915|NCT02914522|38262850|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
17122916|NCT02914522|38262851|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16773191|NCT03745651|37712174|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
16856757|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
16856758|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
16856759|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
17122917|NCT02914522|38262852|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16773192|NCT03745651|37712175|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
16773193|NCT03745651|37712169|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16773194|NCT03745651|37712170|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16773195|NCT03745651|37712171|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16773196|NCT03745651|37712172|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
16773197|NCT03745651|37712173|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16773198|NCT03745651|37712174|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
16773199|NCT03745651|37712175|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
16773200|NCT03745651|37712169|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
17122918|NCT02914522|38262853|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
17122919|NCT02914522|38262854|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
17122920|NCT02914522|38262855|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
17122921|NCT02914522|38262856|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
17122922|NCT02914522|38262857|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
17122923|NCT02914522|38262858|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
17122924|NCT02914522|38262848|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
17122925|NCT02914522|38262849|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
17122926|NCT02914522|38262850|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
17122927|NCT02914522|38262851|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
17122928|NCT02914522|38262852|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
17122929|NCT02914522|38262853|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
17122930|NCT02914522|38262854|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
17122931|NCT02914522|38262855|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
17122932|NCT02914522|38262856|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
17122933|NCT02914522|38262857|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
17122934|NCT02914522|38262858|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
17122935|NCT02914522|38262848|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
17122936|NCT02914522|38262849|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
17122937|NCT02914522|38262850|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
17122938|NCT02914522|38262851|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
17122939|NCT02914522|38262852|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
17122940|NCT02914522|38262853|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
17122941|NCT02914522|38262854|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
17122942|NCT02914522|38262855|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
17122943|NCT02914522|38262856|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
17122944|NCT02914522|38262857|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
17122945|NCT02914522|38262858|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
17122946|NCT02914522|38262848|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
17122947|NCT02914522|38262849|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
17122948|NCT02914522|38262850|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
17122949|NCT02914522|38262851|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
17122950|NCT02914522|38262852|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
17122951|NCT02914522|38262853|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
17122952|NCT02914522|38262854|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
17122953|NCT02914522|38262855|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
17122954|NCT02914522|38262856|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
17122955|NCT02914522|38262857|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
17122956|NCT02914522|38262858|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
17122957|NCT02914522|38262848|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
17122958|NCT02914522|38262849|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
17122959|NCT02914522|38262850|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
17122960|NCT02914522|38262851|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
17122961|NCT02914522|38262852|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
17122962|NCT02914522|38262853|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
17122963|NCT02914522|38262854|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
17122964|NCT02914522|38262855|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
17122965|NCT02914522|38262856|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
17122966|NCT02914522|38262857|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
17122967|NCT02914522|38262858|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
17122968|NCT02914522|38262848|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
17122969|NCT02914522|38262849|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
17122970|NCT02914522|38262850|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
17122971|NCT02914522|38262851|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
17122972|NCT02914522|38262852|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
17122973|NCT02914522|38262853|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
17122974|NCT02914522|38262854|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
17122975|NCT02914522|38262855|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
17122976|NCT02914522|38262856|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
17122977|NCT02914522|38262857|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
17122978|NCT02914522|38262858|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
17122979|NCT02914522|38262848|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
17122980|NCT02914522|38262849|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
17122981|NCT02914522|38262850|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
17122982|NCT02914522|38262851|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
17122983|NCT02914522|38262852|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
17122984|NCT02914522|38262853|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
17122985|NCT02914522|38262854|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
17122986|NCT02914522|38262855|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
17122987|NCT02914522|38262856|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
17122988|NCT02914522|38262857|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
17122989|NCT02914522|38262858|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
17122990|NCT02914522|38262848|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
17122991|NCT02914522|38262849|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
17122992|NCT02914522|38262850|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
17122993|NCT02914522|38262851|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
17122994|NCT02914522|38262852|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
17122995|NCT02914522|38262853|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
17122996|NCT02914522|38262854|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
17122997|NCT02914522|38262855|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
17122998|NCT02914522|38262856|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
17122999|NCT02914522|38262857|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
17123000|NCT02914522|38262858|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
17123001|NCT02914522|38262848|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123002|NCT02914522|38262849|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123003|NCT02914522|38262850|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123004|NCT02914522|38262851|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123005|NCT02914522|38262852|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123006|NCT02914522|38262853|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123007|NCT02914522|38262854|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123008|NCT02914522|38262855|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
17123009|NCT02914522|38262856|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
17123010|NCT02914522|38262857|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123011|NCT02914522|38262858|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
17123012|NCT02914522|38262848|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123013|NCT02914522|38262849|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123014|NCT02914522|38262850|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123015|NCT02914522|38262851|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123016|NCT02914522|38262852|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123017|NCT02914522|38262853|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123018|NCT02914522|38262854|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123019|NCT02914522|38262855|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123020|NCT02914522|38262856|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
17123021|NCT02914522|38262857|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
17123022|NCT02914522|38262858|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
17123023|NCT02914522|38262848|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123024|NCT02914522|38262849|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123025|NCT02914522|38262850|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123026|NCT02914522|38262851|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123027|NCT02914522|38262852|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123028|NCT02914522|38262853|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123029|NCT02914522|38262854|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123030|NCT02914522|38262855|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123031|NCT02914522|38262856|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123032|NCT02914522|38262857|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
17123033|NCT02914522|38262858|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
17123034|NCT02924428|38262887|FG000|Overall Study|Adverse Event|1|||
17123035|NCT02924428|38262888|FG001|Overall Study|Adverse Event|0|||
17123036|NCT02924428|38262887|FG000|Overall Study|Physician Decision|1|||
17123037|NCT02924428|38262888|FG001|Overall Study|Physician Decision|0|||
17123038|NCT02924428|38262887|FG000|Overall Study|Lost to Follow-up|2|||
17123039|NCT02924428|38262888|FG001|Overall Study|Lost to Follow-up|4|||
17123040|NCT02924428|38262887|FG000|Overall Study|Pregnancy|0|||
17123041|NCT02924428|38262888|FG001|Overall Study|Pregnancy|1|||
17123042|NCT00062751|38262899|FG000|Overall Study|Disease progression|24|||
17123043|NCT00062751|38262900|FG001|Overall Study|Disease progression|17|||
17123044|NCT00062751|38262901|FG002|Overall Study|Disease progression|24|||
17123045|NCT00062751|38262902|FG003|Overall Study|Disease progression|2|||
17123046|NCT00062751|38262903|FG004|Overall Study|Disease progression|2|||
17123047|NCT00062751|38262899|FG000|Overall Study|Adverse Event|4|||
17123048|NCT00062751|38262900|FG001|Overall Study|Adverse Event|7|||
17123049|NCT00062751|38262901|FG002|Overall Study|Adverse Event|2|||
17123050|NCT00062751|38262902|FG003|Overall Study|Adverse Event|2|||
17123051|NCT00062751|38262903|FG004|Overall Study|Adverse Event|2|||
17123052|NCT00062751|38262899|FG000|Overall Study|Other|2|||
17123053|NCT00062751|38262900|FG001|Overall Study|Other|3|||
17123054|NCT00062751|38262901|FG002|Overall Study|Other|1|||
17123055|NCT00062751|38262902|FG003|Overall Study|Other|0|||
17123056|NCT00062751|38262903|FG004|Overall Study|Other|1|||
17123057|NCT00062751|38262899|FG000|Overall Study|Withdrawal by Subject|1|||
17123058|NCT00062751|38262900|FG001|Overall Study|Withdrawal by Subject|2|||
17123059|NCT00062751|38262901|FG002|Overall Study|Withdrawal by Subject|2|||
17123060|NCT00062751|38262902|FG003|Overall Study|Withdrawal by Subject|1|||
17123061|NCT00062751|38262903|FG004|Overall Study|Withdrawal by Subject|0|||
17123062|NCT00062751|38262899|FG000|Overall Study|Symptomatic deterioration|1|||
17123063|NCT00062751|38262900|FG001|Overall Study|Symptomatic deterioration|1|||
17123064|NCT00062751|38262901|FG002|Overall Study|Symptomatic deterioration|0|||
17123065|NCT00062751|38262902|FG003|Overall Study|Symptomatic deterioration|0|||
17123066|NCT00062751|38262903|FG004|Overall Study|Symptomatic deterioration|1|||
17123067|NCT00062751|38262899|FG000|Overall Study|Death|1|||
17123068|NCT00062751|38262900|FG001|Overall Study|Death|0|||
17123069|NCT00062751|38262901|FG002|Overall Study|Death|1|||
17123070|NCT00062751|38262902|FG003|Overall Study|Death|0|||
17123071|NCT00062751|38262903|FG004|Overall Study|Death|0|||
17123072|NCT00062439|38262920|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
17123073|NCT00062439|38262920|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
17123074|NCT00062439|38262920|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
17123075|NCT00062439|38262920|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
17123076|NCT00062439|38262920|FG000|Post Chemoradiation Assessment|Death|1|||
17123077|NCT00062439|38262920|FG000|Post Chemoradiation Assessment|Disease progression|2|||
17123078|NCT00062439|38262920|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
17123079|NCT00062439|38262920|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
17123080|NCT00062439|38262920|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
17123081|NCT00062439|38262920|FG000|Surgery|Physician Decision|4|||
17123082|NCT00062439|38262920|FG000|Surgery|Death|1|||
17123083|NCT00062439|38262920|FG000|Surgery|Adverse Event|2|||
17123084|NCT00062439|38262920|FG000|Consolidation Chemotherapy|Adverse Event|2|||
17123085|NCT00051363|38262931|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
17123086|NCT00051363|38262932|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
17123087|NCT00051363|38262931|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
17123088|NCT00051363|38262932|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
17123089|NCT00051363|38262931|FG000|Overall Study|Death|2|||
17123090|NCT00051363|38262932|FG001|Overall Study|Death|2|||
17123091|NCT00051363|38262931|FG000|Overall Study|Excluded Pre-Randomization|2|||
17123092|NCT00051363|38262932|FG001|Overall Study|Excluded Pre-Randomization|5|||
17123093|NCT00031551|38262940|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
17123094|NCT00031551|38262941|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
17123095|NCT00049257|38262951|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
17123096|NCT00049257|38262951|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
17123097|NCT00049257|38262951|FG000|Carboplatin, Paclitaxel|Death|2|||
17123098|NCT00049257|38262951|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
17123099|NCT00601900|38262957|FG000|Overall Study|Withdrawal by Subject|0|||
17123100|NCT00601900|38262958|FG001|Overall Study|Withdrawal by Subject|3|||
17123101|NCT03020992|38262964|FG000|Overall Study|Adverse Event|5|||
17123102|NCT03020992|38262964|FG000|Overall Study|Withdrawal by Subject|1|||
17123103|NCT03020914|38262971|FG000|Overall Study|Surgery Cancelled|1|||
17123104|NCT03020914|38262972|FG001|Overall Study|Surgery Cancelled|0|||
17123105|NCT03018340|38262980|FG000|Overall Study|Adverse Event|1|||
17123106|NCT03018340|38262981|FG001|Overall Study|Adverse Event|2|||
17123107|NCT03018340|38262980|FG000|Overall Study|Withdrawal by Subject|0|||
17123108|NCT03018340|38262981|FG001|Overall Study|Withdrawal by Subject|8|||
17123109|NCT03018340|38262980|FG000|Overall Study|Lack of Efficacy|0|||
17123110|NCT03018340|38262981|FG001|Overall Study|Lack of Efficacy|1|||
17123111|NCT03018340|38262980|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
17123112|NCT03018340|38262981|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
17123113|NCT03018340|38262980|FG000|Overall Study|Lost to Follow-up|1|||
17123114|NCT03018340|38262981|FG001|Overall Study|Lost to Follow-up|7|||
17123115|NCT03018340|38262980|FG000|Overall Study|Protocol Violation|3|||
17123116|NCT03018340|38262981|FG001|Overall Study|Protocol Violation|7|||
17123117|NCT03018340|38262980|FG000|Overall Study|Not further specified|0|||
17123118|NCT03018340|38262981|FG001|Overall Study|Not further specified|1|||
17123119|NCT03016078|38262991|FG000|Overall Study|Protocol Violation|1|||
17123120|NCT03016078|38262991|FG000|Overall Study|Protocol Violation|1|||
17123121|NCT00048165|38262997|FG000|Completed 6 Months Study|Administration/Other|8|||
17123122|NCT00048165|38262998|FG001|Completed 6 Months Study|Administration/Other|8|||
17123123|NCT00048165|38262997|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
17123124|NCT00048165|38262998|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
17123125|NCT00048165|38262997|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
17123126|NCT00048165|38262998|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
17123127|NCT00048165|38262997|FG000|Completed 6 Months Study|Death|12|||
17123128|NCT00048165|38262998|FG001|Completed 6 Months Study|Death|6|||
17123129|NCT00048165|38262997|FG000|Completed 6 Months Study|Insufficient therapy|1|||
17123130|NCT00048165|38262998|FG001|Completed 6 Months Study|Insufficient therapy|4|||
17123131|NCT00048165|38262997|FG000|Completed 6 Months Study|Other violation|4|||
17123132|NCT00048165|38262998|FG001|Completed 6 Months Study|Other violation|6|||
17123133|NCT00048165|38262997|FG000|Completed 6 Months Study|Refused treatment|5|||
17123134|NCT00048165|38262998|FG001|Completed 6 Months Study|Refused treatment|5|||
17123135|NCT00048165|38262997|FG000|Completed 6 Months Study|Violation criteria|0|||
17123136|NCT00048165|38262998|FG001|Completed 6 Months Study|Violation criteria|2|||
17123137|NCT00048165|38262997|FG000|Completed 6 Months Study|Did not receive study drug|6|||
17123138|NCT00048165|38262998|FG001|Completed 6 Months Study|Did not receive study drug|6|||
17123139|NCT00048165|38262997|FG000|Completed 12 Months Study|Administration/Other|0|||
17123140|NCT00048165|38262998|FG001|Completed 12 Months Study|Administration/Other|2|||
17123141|NCT00048165|38262997|FG000|Completed 12 Months Study|Death|2|||
17123142|NCT00048165|38262998|FG001|Completed 12 Months Study|Death|1|||
17123143|NCT00048165|38262997|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
17123144|NCT00048165|38262998|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
17123145|NCT00059787|38263006|FG000|Overall Study|Adverse Event|13|||
17123146|NCT00059787|38263006|FG000|Overall Study|disease progression|2|||
17123147|NCT00059787|38263006|FG000|Overall Study|ineligible|1|||
17123148|NCT00059787|38263006|FG000|Overall Study|Other|4|||
17123149|NCT00058539|38263011|FG000|Overall Study|Disease progression|24|||
17123150|NCT00058539|38263011|FG000|Overall Study|Adverse Event|3|||
17123151|NCT00058539|38263011|FG000|Overall Study|Withdrawal by Subject|5|||
17123152|NCT00058539|38263011|FG000|Overall Study|Physician Decision|9|||
17123153|NCT00058539|38263011|FG000|Overall Study|Death|1|||
17123154|NCT03015532|38263023|FG000|Overall Study|Adverse Event|0|||
17123155|NCT03015532|38263024|FG001|Overall Study|Adverse Event|0|||
17123156|NCT03015532|38263025|FG002|Overall Study|Adverse Event|0|||
17123157|NCT03015532|38263026|FG003|Overall Study|Adverse Event|0|||
17123158|NCT03015532|38263027|FG004|Overall Study|Adverse Event|0|||
17123159|NCT03015532|38263028|FG005|Overall Study|Adverse Event|2|||
17123160|NCT03015532|38263029|FG006|Overall Study|Adverse Event|1|||
17123161|NCT03015532|38263030|FG007|Overall Study|Adverse Event|0|||
17123162|NCT03015532|38263023|FG000|Overall Study|Withdrawal by Subject|0|||
17123163|NCT03015532|38263024|FG001|Overall Study|Withdrawal by Subject|0|||
17123164|NCT03015532|38263025|FG002|Overall Study|Withdrawal by Subject|0|||
17123165|NCT03015532|38263026|FG003|Overall Study|Withdrawal by Subject|0|||
17123166|NCT03015532|38263027|FG004|Overall Study|Withdrawal by Subject|0|||
17123167|NCT03015532|38263028|FG005|Overall Study|Withdrawal by Subject|0|||
17123168|NCT03015532|38263029|FG006|Overall Study|Withdrawal by Subject|1|||
17123169|NCT03015532|38263030|FG007|Overall Study|Withdrawal by Subject|0|||
17123170|NCT00047463|38263052|FG000|Overall Study|Withdrawal by Subject|0|||
17123171|NCT00047463|38263053|FG001|Overall Study|Withdrawal by Subject|3|||
17123172|NCT03015220|38263066|FG000|Overall Study|Withdrawal by Subject|3|||
17123173|NCT03015220|38263067|FG001|Overall Study|Withdrawal by Subject|2|||
17123174|NCT03015220|38263068|FG002|Overall Study|Withdrawal by Subject|2|||
17123175|NCT03015220|38263069|FG003|Overall Study|Withdrawal by Subject|2|||
17123176|NCT03015220|38263066|FG000|Overall Study|Lost to Follow-up|0|||
17123177|NCT03015220|38263067|FG001|Overall Study|Lost to Follow-up|0|||
17123178|NCT03015220|38263068|FG002|Overall Study|Lost to Follow-up|1|||
17123179|NCT03015220|38263069|FG003|Overall Study|Lost to Follow-up|0|||
17123180|NCT00022659|38263079|FG000|Overall Study|Ineligible: wrong primary|1|||
17123181|NCT00022659|38263079|FG000|Overall Study|Never treated|1|||
17123182|NCT03014674|38263090|FG000|Overall Study|Withdrawal by Subject|1|||
17123183|NCT03014674|38263091|FG001|Overall Study|Withdrawal by Subject|0|||
17123184|NCT03014674|38263092|FG002|Overall Study|Withdrawal by Subject|0|||
17123185|NCT03018106|38263102|FG000|Overall Study|Lost to Follow-up|0|||
17123186|NCT03018106|38263103|FG001|Overall Study|Lost to Follow-up|1|||
17123187|NCT03018028|38263112|FG000|Overall Study|Withdrawal by Subject|3|||
17123188|NCT03018028|38263113|FG001|Overall Study|Withdrawal by Subject|0|||
17123189|NCT03018028|38263114|FG002|Overall Study|Withdrawal by Subject|1|||
17123190|NCT03018028|38263115|FG003|Overall Study|Withdrawal by Subject|2|||
17123191|NCT03018028|38263116|FG004|Overall Study|Withdrawal by Subject|0|||
17123192|NCT03014206|38263128|FG000|Overall Study|Registration Violation|12|||
17123193|NCT03010462|38263134|FG000|Overall Study|Withdrawal by Subject|3|||
17123194|NCT03010462|38263135|FG001|Overall Study|Withdrawal by Subject|1|||
17123195|NCT00021255|38263144|FG000|Overall Study|Death|1|||
17123196|NCT00021255|38263145|FG001|Overall Study|Death|0|||
17123197|NCT00021255|38263146|FG002|Overall Study|Death|2|||
17123198|NCT00021255|38263144|FG000|Overall Study|Breast cancer relapse|5|||
17123199|NCT00021255|38263145|FG001|Overall Study|Breast cancer relapse|18|||
17123200|NCT00021255|38263146|FG002|Overall Study|Breast cancer relapse|11|||
17123201|NCT00021255|38263144|FG000|Overall Study|Second primary malignancy|0|||
17123202|NCT00021255|38263145|FG001|Overall Study|Second primary malignancy|4|||
17123203|NCT00021255|38263146|FG002|Overall Study|Second primary malignancy|1|||
17123204|NCT00021255|38263144|FG000|Overall Study|Withdrawal by Subject|41|||
17123205|NCT00021255|38263145|FG001|Overall Study|Withdrawal by Subject|64|||
17123206|NCT00021255|38263146|FG002|Overall Study|Withdrawal by Subject|26|||
17123207|NCT00021255|38263144|FG000|Overall Study|Lost to Follow-up|0|||
17123208|NCT00021255|38263145|FG001|Overall Study|Lost to Follow-up|2|||
17123209|NCT00021255|38263146|FG002|Overall Study|Lost to Follow-up|3|||
17123210|NCT00021255|38263144|FG000|Overall Study|Cardiac toxicity|0|||
17123211|NCT00021255|38263145|FG001|Overall Study|Cardiac toxicity|61|||
17123212|NCT00021255|38263146|FG002|Overall Study|Cardiac toxicity|32|||
17123213|NCT00021255|38263144|FG000|Overall Study|Herceptin toxicity|0|||
17123214|NCT00021255|38263145|FG001|Overall Study|Herceptin toxicity|22|||
17123215|NCT00021255|38263146|FG002|Overall Study|Herceptin toxicity|6|||
17123216|NCT00021255|38263144|FG000|Overall Study|Adverse Event|46|||
17123217|NCT00021255|38263145|FG001|Overall Study|Adverse Event|30|||
17123218|NCT00021255|38263146|FG002|Overall Study|Adverse Event|18|||
17123219|NCT00021255|38263144|FG000|Overall Study|Protocol Violation|0|||
17123220|NCT00021255|38263145|FG001|Overall Study|Protocol Violation|2|||
17123221|NCT00021255|38263146|FG002|Overall Study|Protocol Violation|0|||
17123222|NCT00021255|38263144|FG000|Overall Study|Other than specified above|0|||
17123223|NCT00021255|38263145|FG001|Overall Study|Other than specified above|38|||
17123224|NCT00021255|38263146|FG002|Overall Study|Other than specified above|19|||
17123225|NCT00021255|38263144|FG000|Overall Study|Missing|0|||
17123226|NCT00021255|38263145|FG001|Overall Study|Missing|27|||
17123227|NCT00021255|38263146|FG002|Overall Study|Missing|13|||
17123228|NCT00021255|38263144|FG000|Overall Study|Randomized but not treated|28|||
17123229|NCT00021255|38263145|FG001|Overall Study|Randomized but not treated|2|||
17123230|NCT00021255|38263146|FG002|Overall Study|Randomized but not treated|18|||
17123231|NCT03012334|38263164|FG000|Period 1|Withdrawal by Subject|0|||
17123232|NCT03012334|38263165|FG001|Period 1|Withdrawal by Subject|0|||
17123233|NCT03012334|38263166|FG002|Period 1|Withdrawal by Subject|0|||
17123234|NCT03012334|38263167|FG003|Period 1|Withdrawal by Subject|0|||
17123235|NCT03012334|38263168|FG004|Period 1|Withdrawal by Subject|0|||
17123236|NCT03012334|38263169|FG005|Period 1|Withdrawal by Subject|0|||
17123237|NCT03012334|38263170|FG006|Period 1|Withdrawal by Subject|0|||
17123238|NCT03012334|38263171|FG007|Period 1|Withdrawal by Subject|0|||
17123239|NCT03012334|38263172|FG008|Period 1|Withdrawal by Subject|0|||
17123240|NCT03012334|38263173|FG009|Period 1|Withdrawal by Subject|1|||
17123241|NCT03012334|38263164|FG000|Period 2|Withdrawal by Subject|0|||
17123242|NCT03012334|38263165|FG001|Period 2|Withdrawal by Subject|1|||
17123243|NCT03012334|38263166|FG002|Period 2|Withdrawal by Subject|0|||
17123244|NCT03012334|38263167|FG003|Period 2|Withdrawal by Subject|0|||
17123245|NCT03012334|38263168|FG004|Period 2|Withdrawal by Subject|0|||
17123246|NCT03012334|38263169|FG005|Period 2|Withdrawal by Subject|0|||
17123247|NCT03012334|38263170|FG006|Period 2|Withdrawal by Subject|0|||
17123248|NCT03012334|38263171|FG007|Period 2|Withdrawal by Subject|0|||
17123249|NCT03012334|38263172|FG008|Period 2|Withdrawal by Subject|0|||
17123250|NCT03012334|38263173|FG009|Period 2|Withdrawal by Subject|0|||
17123251|NCT03012334|38263164|FG000|Period 2|Protocol Violation|0|||
17123252|NCT03012334|38263165|FG001|Period 2|Protocol Violation|0|||
17123253|NCT03012334|38263166|FG002|Period 2|Protocol Violation|1|||
17123254|NCT03012334|38263167|FG003|Period 2|Protocol Violation|0|||
17123255|NCT03012334|38263168|FG004|Period 2|Protocol Violation|0|||
17123256|NCT03012334|38263169|FG005|Period 2|Protocol Violation|0|||
17123257|NCT03012334|38263170|FG006|Period 2|Protocol Violation|0|||
17123258|NCT03012334|38263171|FG007|Period 2|Protocol Violation|1|||
17123259|NCT03012334|38263172|FG008|Period 2|Protocol Violation|0|||
17123260|NCT03012334|38263173|FG009|Period 2|Protocol Violation|0|||
17123261|NCT03012334|38263164|FG000|Period 4|Non-Compliance|0|||
17123262|NCT03012334|38263165|FG001|Period 4|Non-Compliance|0|||
17123263|NCT03012334|38263166|FG002|Period 4|Non-Compliance|0|||
17123264|NCT03012334|38263167|FG003|Period 4|Non-Compliance|0|||
17123265|NCT03012334|38263168|FG004|Period 4|Non-Compliance|0|||
17123266|NCT03012334|38263169|FG005|Period 4|Non-Compliance|0|||
17123267|NCT03012334|38263170|FG006|Period 4|Non-Compliance|1|||
17123268|NCT03012334|38263171|FG007|Period 4|Non-Compliance|0|||
17123269|NCT03012334|38263172|FG008|Period 4|Non-Compliance|0|||
17123270|NCT03012334|38263173|FG009|Period 4|Non-Compliance|0|||
17123271|NCT03012334|38263164|FG000|Period 4|Adverse Event|0|||
16773201|NCT03745651|37712170|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
17123272|NCT03012334|38263165|FG001|Period 4|Adverse Event|0|||
17123273|NCT03012334|38263166|FG002|Period 4|Adverse Event|0|||
17123274|NCT03012334|38263167|FG003|Period 4|Adverse Event|0|||
17123275|NCT03012334|38263168|FG004|Period 4|Adverse Event|0|||
17123276|NCT03012334|38263169|FG005|Period 4|Adverse Event|0|||
17123277|NCT03012334|38263170|FG006|Period 4|Adverse Event|0|||
17123278|NCT03012334|38263171|FG007|Period 4|Adverse Event|0|||
17123279|NCT03012334|38263172|FG008|Period 4|Adverse Event|1|||
17123280|NCT03012334|38263173|FG009|Period 4|Adverse Event|0|||
17123281|NCT03565068|38263195|FG000|Overall Study|Protocol Violation|0|||
17123282|NCT03565068|38263196|FG001|Overall Study|Protocol Violation|0|||
17123283|NCT03565068|38263197|FG002|Overall Study|Protocol Violation|0|||
17123284|NCT03565068|38263198|FG003|Overall Study|Protocol Violation|0|||
17123285|NCT03565068|38263199|FG004|Overall Study|Protocol Violation|1|||
17123286|NCT03565068|38263200|FG005|Overall Study|Protocol Violation|0|||
17123287|NCT03565068|38263201|FG006|Overall Study|Protocol Violation|0|||
17123288|NCT03565068|38263202|FG007|Overall Study|Protocol Violation|1|||
17123289|NCT03565068|38263203|FG008|Overall Study|Protocol Violation|0|||
17123290|NCT03565068|38263195|FG000|Overall Study|Sponsor decision|0|||
17123291|NCT03565068|38263196|FG001|Overall Study|Sponsor decision|0|||
17123292|NCT03565068|38263197|FG002|Overall Study|Sponsor decision|0|||
17123293|NCT03565068|38263198|FG003|Overall Study|Sponsor decision|0|||
17123294|NCT03565068|38263199|FG004|Overall Study|Sponsor decision|1|||
17123295|NCT03565068|38263200|FG005|Overall Study|Sponsor decision|1|||
17123296|NCT03565068|38263201|FG006|Overall Study|Sponsor decision|0|||
17123297|NCT03565068|38263202|FG007|Overall Study|Sponsor decision|0|||
17123298|NCT03565068|38263203|FG008|Overall Study|Sponsor decision|0|||
17123299|NCT03565068|38263195|FG000|Overall Study|Withdrawal by Subject|0|||
17123300|NCT03565068|38263196|FG001|Overall Study|Withdrawal by Subject|0|||
17123301|NCT03565068|38263197|FG002|Overall Study|Withdrawal by Subject|1|||
17123302|NCT03565068|38263198|FG003|Overall Study|Withdrawal by Subject|0|||
17123303|NCT03565068|38263199|FG004|Overall Study|Withdrawal by Subject|2|||
17123304|NCT03565068|38263200|FG005|Overall Study|Withdrawal by Subject|0|||
17123305|NCT03565068|38263201|FG006|Overall Study|Withdrawal by Subject|1|||
17123306|NCT03565068|38263202|FG007|Overall Study|Withdrawal by Subject|5|||
17123307|NCT03565068|38263203|FG008|Overall Study|Withdrawal by Subject|1|||
17123308|NCT03565068|38263195|FG000|Overall Study|Physician Decision|0|||
17123309|NCT03565068|38263196|FG001|Overall Study|Physician Decision|0|||
17123310|NCT03565068|38263197|FG002|Overall Study|Physician Decision|0|||
17123311|NCT03565068|38263198|FG003|Overall Study|Physician Decision|0|||
17123312|NCT03565068|38263199|FG004|Overall Study|Physician Decision|0|||
17123313|NCT03565068|38263200|FG005|Overall Study|Physician Decision|0|||
17123314|NCT03565068|38263201|FG006|Overall Study|Physician Decision|0|||
17123315|NCT03565068|38263202|FG007|Overall Study|Physician Decision|1|||
17123316|NCT03565068|38263203|FG008|Overall Study|Physician Decision|0|||
17123317|NCT03565068|38263195|FG000|Overall Study|Lost to Follow-up|0|||
17123318|NCT03565068|38263196|FG001|Overall Study|Lost to Follow-up|0|||
17123319|NCT03565068|38263197|FG002|Overall Study|Lost to Follow-up|0|||
17123320|NCT03565068|38263198|FG003|Overall Study|Lost to Follow-up|0|||
17123321|NCT03565068|38263199|FG004|Overall Study|Lost to Follow-up|0|||
17123322|NCT03565068|38263200|FG005|Overall Study|Lost to Follow-up|0|||
17123323|NCT03565068|38263201|FG006|Overall Study|Lost to Follow-up|0|||
17123324|NCT03565068|38263202|FG007|Overall Study|Lost to Follow-up|1|||
17123325|NCT03565068|38263203|FG008|Overall Study|Lost to Follow-up|0|||
17123326|NCT00010803|38263262|FG000|Overall Study|Withdrawal by Subject|97|||
17123327|NCT00010803|38263263|FG001|Overall Study|Withdrawal by Subject|98|||
17123328|NCT02914834|38263271|FG000|Overall Study|Study halted due to COVID|1|||
17123329|NCT02914834|38263272|FG001|Overall Study|Study halted due to COVID|1|||
17123330|NCT02914834|38263271|FG000|Overall Study|1 subject withdrew|0|||
17123331|NCT02914834|38263272|FG001|Overall Study|1 subject withdrew|1|||
17123332|NCT03497130|38263280|FG000|Overall Study|Lost to Follow-up|1|||
17123333|NCT03497130|38263281|FG001|Overall Study|Lost to Follow-up|1|||
17123334|NCT03006562|38263289|FG000|Overall Study|Lost to Follow-up|0|||
17123335|NCT03006562|38263290|FG001|Overall Study|Lost to Follow-up|1|||
17123336|NCT03007966|38263298|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
17123337|NCT03007966|38263299|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
17123338|NCT03541200|38263306|FG000|Overall Study|Adverse Event|19|||
17123339|NCT03541200|38263306|FG000|Overall Study|Death|1|||
16773202|NCT03745651|37712171|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
16773203|NCT03745651|37712172|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
16773204|NCT03745651|37712173|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
16773205|NCT03745651|37712174|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
16773206|NCT03745651|37712175|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
16773207|NCT03745651|37712169|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16773208|NCT03745651|37712170|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16773209|NCT03745651|37712171|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16773210|NCT03745651|37712172|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17123340|NCT03541200|38263306|FG000|Overall Study|Lost to Follow-up|10|||
17123341|NCT03541200|38263306|FG000|Overall Study|Physician Decision|1|||
17123342|NCT03541200|38263306|FG000|Overall Study|Protocol Violation|51|||
17123343|NCT03541200|38263306|FG000|Overall Study|Withdrawal by Subject|23|||
16773211|NCT03745651|37712173|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17123344|NCT03541200|38263306|FG000|Overall Study|other|8|||
17123345|NCT03007888|38263310|FG000|First Intervention (14 Days)|Adverse Event|1|||
17123346|NCT03007888|38263311|FG001|First Intervention (14 Days)|Adverse Event|0|||
17123347|NCT03541044|38263320|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
17123348|NCT03541044|38263321|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
17123349|NCT03541044|38263320|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
17123350|NCT03541044|38263321|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
17123351|NCT00009945|38263331|FG000|Overall Study|no follow up data|7|||
17123352|NCT00009945|38263332|FG001|Overall Study|no follow up data|5|||
17123353|NCT03540030|38263340|FG000|Overall Study|Withdrawal by Subject|2|||
17123354|NCT03540030|38263341|FG001|Overall Study|Withdrawal by Subject|1|||
17123355|NCT03540030|38263340|FG000|Overall Study|screen fail|7|||
17123356|NCT03540030|38263341|FG001|Overall Study|screen fail|1|||
17123357|NCT03540030|38263340|FG000|Overall Study|never had surgery after signing consent|9|||
17123358|NCT03540030|38263341|FG001|Overall Study|never had surgery after signing consent|1|||
17123359|NCT00008385|38263349|FG000|Overall Study|Off treatment reasons not reported|79|||
17123360|NCT00008385|38263350|FG001|Overall Study|Off treatment reasons not reported|70|||
17123361|NCT00008385|38263349|FG000|Overall Study|Progressive disease|52|||
17123362|NCT00008385|38263350|FG001|Overall Study|Progressive disease|117|||
17123363|NCT00008385|38263349|FG000|Overall Study|Adverse Event|8|||
17123364|NCT00008385|38263350|FG001|Overall Study|Adverse Event|20|||
17123365|NCT00008385|38263349|FG000|Overall Study|Death|12|||
17123366|NCT00008385|38263350|FG001|Overall Study|Death|18|||
17123367|NCT00008385|38263349|FG000|Overall Study|Withdrawal by Subject|67|||
17123368|NCT00008385|38263350|FG001|Overall Study|Withdrawal by Subject|157|||
17123369|NCT00008385|38263349|FG000|Overall Study|Start non-protocol therapy|3|||
17123370|NCT00008385|38263350|FG001|Overall Study|Start non-protocol therapy|1|||
17123371|NCT00008385|38263349|FG000|Overall Study|Other complicating disease|17|||
17123372|NCT00008385|38263350|FG001|Overall Study|Other complicating disease|30|||
17123373|NCT00008385|38263349|FG000|Overall Study|Maximum dose reached|0|||
17123374|NCT00008385|38263350|FG001|Overall Study|Maximum dose reached|2|||
17123375|NCT00008385|38263349|FG000|Overall Study|Other|105|||
17123376|NCT00008385|38263350|FG001|Overall Study|Other|212|||
17123377|NCT00008385|38263349|FG000|Overall Study|Not start protocol therapy|44|||
17123378|NCT00008385|38263350|FG001|Overall Study|Not start protocol therapy|175|||
17123379|NCT03003676|38263358|FG000|Overall Study|Lack of Efficacy|5|||
17123380|NCT03003676|38263359|FG001|Overall Study|Lack of Efficacy|7|||
17123381|NCT03003676|38263358|FG000|Overall Study|Withdrawal by Subject|0|||
17123382|NCT03003676|38263359|FG001|Overall Study|Withdrawal by Subject|1|||
17123383|NCT03003676|38263358|FG000|Overall Study|Hepatitis B infection|1|||
17123384|NCT03003676|38263359|FG001|Overall Study|Hepatitis B infection|0|||
17123385|NCT00047385|38263369|FG000|Overall Study|Death before any screening|2|||
17123386|NCT00047385|38263370|FG001|Overall Study|Death before any screening|5|||
17123387|NCT00047385|38263369|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
17123388|NCT00047385|38263370|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
17123389|NCT00047385|38263369|FG000|Overall Study|Eligible for screening but had no screen|260|||
17123390|NCT00047385|38263370|FG001|Overall Study|Eligible for screening but had no screen|492|||
17123391|NCT03003520|38263378|FG000|Induction|Ongoing|1|||
17123392|NCT03003520|38263379|FG001|Induction|Ongoing|0|||
17123393|NCT03003520|38263378|FG000|Induction|Adverse Event|4|||
17123394|NCT03003520|38263379|FG001|Induction|Adverse Event|0|||
17123395|NCT03003520|38263378|FG000|Induction|Death|1|||
17123396|NCT03003520|38263379|FG001|Induction|Death|0|||
17123397|NCT03003520|38263378|FG000|Induction|Palliative care|1|||
17123398|NCT03003520|38263379|FG001|Induction|Palliative care|0|||
17123399|NCT03003520|38263378|FG000|Induction|Physician Decision|2|||
17123400|NCT03003520|38263379|FG001|Induction|Physician Decision|0|||
17123401|NCT03003520|38263378|FG000|Induction|Withdrawal by Subject|3|||
17123402|NCT03003520|38263379|FG001|Induction|Withdrawal by Subject|0|||
17123403|NCT03003520|38263378|FG000|Induction|Progressive disease|1|||
17123404|NCT03003520|38263379|FG001|Induction|Progressive disease|0|||
17123405|NCT03003520|38263378|FG000|Consolidation|Ongoing|18|||
17123406|NCT03003520|38263379|FG001|Consolidation|Ongoing|0|||
17123407|NCT03003520|38263378|FG000|Consolidation|Adverse Event|2|||
17123408|NCT03003520|38263379|FG001|Consolidation|Adverse Event|0|||
17123409|NCT03003520|38263378|FG000|Consolidation|Progressive disease|3|||
17123410|NCT03003520|38263379|FG001|Consolidation|Progressive disease|1|||
17123411|NCT03003520|38263378|FG000|Consolidation|Withdrawal by Subject|1|||
17123412|NCT03003520|38263379|FG001|Consolidation|Withdrawal by Subject|0|||
17123413|NCT03003520|38263378|FG000|Follow-up|Death|1|||
17123414|NCT03003520|38263379|FG001|Follow-up|Death|1|||
17123415|NCT03003520|38263378|FG000|Follow-up|Ongoing|12|||
17123416|NCT03003520|38263379|FG001|Follow-up|Ongoing|2|||
17123417|NCT03003520|38263378|FG000|Follow-up|Withdrawal by Subject|1|||
17123418|NCT03003520|38263379|FG001|Follow-up|Withdrawal by Subject|0|||
17123419|NCT03002818|38263393|FG000|Overall Study|Decision of the investigator|1|||
17123420|NCT03002194|38263397|FG000|Overall Study|Lost to Follow-up|6|||
17123421|NCT03002194|38263397|FG000|Overall Study|Adverse Event|1|||
17123422|NCT03002194|38263397|FG000|Overall Study|Lack of Efficacy|1|||
17123423|NCT03002194|38263397|FG000|Overall Study|Withdrawal by Subject|2|||
16942098|NCT01371747|38086665|FG001|Overall Study|Death|0|||
17123424|NCT02912650|38263405|FG000|Overall Study|Withdrawal by Subject|1|||
17123425|NCT02912650|38263406|FG001|Overall Study|Withdrawal by Subject|0|||
17123426|NCT02912650|38263407|FG002|Overall Study|Withdrawal by Subject|1|||
17123427|NCT02912650|38263408|FG003|Overall Study|Withdrawal by Subject|5|||
17123428|NCT02912650|38263405|FG000|Overall Study|Adverse Event|0|||
17123429|NCT02912650|38263406|FG001|Overall Study|Adverse Event|0|||
17123430|NCT02912650|38263407|FG002|Overall Study|Adverse Event|1|||
17123431|NCT02912650|38263408|FG003|Overall Study|Adverse Event|0|||
17123432|NCT03004924|38263421|FG000|Overall Study|Adverse Event|6|||
17123433|NCT03004924|38263422|FG001|Overall Study|Adverse Event|5|||
17123434|NCT03004924|38263423|FG002|Overall Study|Adverse Event|10|||
17123435|NCT03004924|38263421|FG000|Overall Study|Protocol Violation|4|||
17123436|NCT03004924|38263422|FG001|Overall Study|Protocol Violation|0|||
17123437|NCT03004924|38263423|FG002|Overall Study|Protocol Violation|1|||
17123438|NCT03004924|38263421|FG000|Overall Study|Withdrawal by Subject|5|||
17123439|NCT03004924|38263422|FG001|Overall Study|Withdrawal by Subject|3|||
17123440|NCT03004924|38263423|FG002|Overall Study|Withdrawal by Subject|5|||
17123441|NCT03004924|38263421|FG000|Overall Study|Lost to Follow-up|6|||
17123442|NCT03004924|38263422|FG001|Overall Study|Lost to Follow-up|1|||
17123443|NCT03004924|38263423|FG002|Overall Study|Lost to Follow-up|4|||
17123444|NCT03004924|38263421|FG000|Overall Study|Lack of Efficacy|2|||
17123445|NCT03004924|38263422|FG001|Overall Study|Lack of Efficacy|4|||
17123446|NCT03004924|38263423|FG002|Overall Study|Lack of Efficacy|2|||
17123447|NCT03004924|38263421|FG000|Overall Study|Physician Decision|1|||
17123448|NCT03004924|38263422|FG001|Overall Study|Physician Decision|0|||
17123449|NCT03004924|38263423|FG002|Overall Study|Physician Decision|1|||
17123450|NCT03004924|38263421|FG000|Overall Study|Withdrawal by parent/guardian|1|||
17123451|NCT03004924|38263422|FG001|Overall Study|Withdrawal by parent/guardian|0|||
17123452|NCT03004924|38263423|FG002|Overall Study|Withdrawal by parent/guardian|2|||
17123453|NCT03004924|38263421|FG000|Overall Study|Screen Failure|1|||
17123454|NCT03004924|38263422|FG001|Overall Study|Screen Failure|0|||
17123455|NCT03004924|38263423|FG002|Overall Study|Screen Failure|0|||
17123456|NCT03004924|38263421|FG000|Overall Study|Pregnancy|0|||
17123457|NCT03004924|38263422|FG001|Overall Study|Pregnancy|1|||
17123458|NCT03004924|38263423|FG002|Overall Study|Pregnancy|0|||
17123459|NCT03004924|38263421|FG000|Overall Study|Terminated by Sponsor|0|||
17123460|NCT03004924|38263422|FG001|Overall Study|Terminated by Sponsor|0|||
17123461|NCT03004924|38263423|FG002|Overall Study|Terminated by Sponsor|1|||
17123462|NCT03004924|38263421|FG000|Overall Study|Missed Study Visit|0|||
17123463|NCT03004924|38263422|FG001|Overall Study|Missed Study Visit|0|||
17123464|NCT03004924|38263423|FG002|Overall Study|Missed Study Visit|2|||
17123465|NCT03004924|38263421|FG000|Overall Study|HSV1 Positive|1|||
17123466|NCT03004924|38263422|FG001|Overall Study|HSV1 Positive|0|||
17123467|NCT03004924|38263423|FG002|Overall Study|HSV1 Positive|0|||
17123468|NCT03002038|38263434|FG000|Overall Study|Adverse Event|3|||
17123469|NCT03002038|38263435|FG001|Overall Study|Adverse Event|1|||
17123470|NCT03002038|38263434|FG000|Overall Study|Withdrawal by Subject|8|||
17123471|NCT03002038|38263435|FG001|Overall Study|Withdrawal by Subject|4|||
17123472|NCT03002038|38263434|FG000|Overall Study|Immigration to another region|0|||
17123473|NCT03002038|38263435|FG001|Overall Study|Immigration to another region|2|||
17123474|NCT02911948|38263443|FG000|Overall Study|Protocol Violation|0|||
17123475|NCT02911948|38263444|FG001|Overall Study|Protocol Violation|1|||
17123476|NCT02911948|38263443|FG000|Overall Study|Withdrawal by Subject|0|||
17123477|NCT02911948|38263444|FG001|Overall Study|Withdrawal by Subject|2|||
17123478|NCT02911948|38263443|FG000|Overall Study|Lack of Efficacy|0|||
17123479|NCT02911948|38263444|FG001|Overall Study|Lack of Efficacy|1|||
17123480|NCT02911948|38263443|FG000|Overall Study|Unclassified|0|||
17123481|NCT02911948|38263444|FG001|Overall Study|Unclassified|3|||
17123482|NCT02996968|38263452|FG000|Overall Study|Withdrawal by Subject|1|||
17123483|NCT02996968|38263453|FG001|Overall Study|Withdrawal by Subject|0|||
17123484|NCT00027027|38263464|FG000|Overall Study|Adverse Event|0|||
17123485|NCT00027027|38263465|FG001|Overall Study|Adverse Event|0|||
17123486|NCT00027027|38263466|FG002|Overall Study|Adverse Event|1|||
17123487|NCT00027027|38263467|FG003|Overall Study|Adverse Event|0|||
17123488|NCT00027027|38263468|FG004|Overall Study|Adverse Event|1|||
17123489|NCT00027027|38263464|FG000|Overall Study|Admitted for Signs of PD|0|||
17123490|NCT00027027|38263465|FG001|Overall Study|Admitted for Signs of PD|0|||
17123491|NCT00027027|38263466|FG002|Overall Study|Admitted for Signs of PD|0|||
17123492|NCT00027027|38263467|FG003|Overall Study|Admitted for Signs of PD|0|||
17123493|NCT00027027|38263468|FG004|Overall Study|Admitted for Signs of PD|1|||
17123494|NCT00027027|38263464|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
17123495|NCT00027027|38263465|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
17123496|NCT00027027|38263466|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
17123497|NCT00027027|38263467|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
17123498|NCT00027027|38263468|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
17123499|NCT00027027|38263464|FG000|Overall Study|PD Requiring Surgery|0|||
17123500|NCT00027027|38263465|FG001|Overall Study|PD Requiring Surgery|0|||
16773212|NCT03745651|37712174|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
17123501|NCT00027027|38263466|FG002|Overall Study|PD Requiring Surgery|1|||
17123502|NCT00027027|38263467|FG003|Overall Study|PD Requiring Surgery|0|||
17123503|NCT00027027|38263468|FG004|Overall Study|PD Requiring Surgery|0|||
17123504|NCT00027027|38263464|FG000|Overall Study|Physician Decision Due To PD|2|||
17123505|NCT00027027|38263465|FG001|Overall Study|Physician Decision Due To PD|3|||
17123506|NCT00027027|38263466|FG002|Overall Study|Physician Decision Due To PD|2|||
17123507|NCT00027027|38263467|FG003|Overall Study|Physician Decision Due To PD|3|||
17123508|NCT00027027|38263468|FG004|Overall Study|Physician Decision Due To PD|5|||
17123509|NCT00027027|38263464|FG000|Overall Study|Withdrawal by Subject|0|||
17123510|NCT00027027|38263465|FG001|Overall Study|Withdrawal by Subject|0|||
17123511|NCT00027027|38263466|FG002|Overall Study|Withdrawal by Subject|0|||
17123512|NCT00027027|38263467|FG003|Overall Study|Withdrawal by Subject|0|||
17123513|NCT00027027|38263468|FG004|Overall Study|Withdrawal by Subject|1|||
17123514|NCT00046839|38263486|FG000|Overall Study|Ineligible / No protocol treatment|0|||
17123515|NCT00046839|38263487|FG001|Overall Study|Ineligible / No protocol treatment|2|||
17123516|NCT00046839|38263486|FG000|Overall Study|Withdrawal of consent|1|||
17123517|NCT00046839|38263487|FG001|Overall Study|Withdrawal of consent|0|||
17123518|NCT00006903|38263496|FG000|Overall Study|Still receiving treatment|0|||
17123519|NCT00006903|38263497|FG001|Overall Study|Still receiving treatment|0|||
17123520|NCT00006903|38263498|FG002|Overall Study|Still receiving treatment|1|||
17123521|NCT00006903|38263496|FG000|Overall Study|Refused further treatment|0|||
17123522|NCT00006903|38263497|FG001|Overall Study|Refused further treatment|2|||
17123523|NCT00006903|38263498|FG002|Overall Study|Refused further treatment|1|||
17123524|NCT00006903|38263496|FG000|Overall Study|Adverse Event|0|||
17123525|NCT00006903|38263497|FG001|Overall Study|Adverse Event|0|||
17123526|NCT00006903|38263498|FG002|Overall Study|Adverse Event|1|||
17123527|NCT00006903|38263496|FG000|Overall Study|Death|0|||
17123528|NCT00006903|38263497|FG001|Overall Study|Death|1|||
17123529|NCT00006903|38263498|FG002|Overall Study|Death|0|||
17123530|NCT00006903|38263496|FG000|Overall Study|Patient never treated|0|||
17123531|NCT00006903|38263497|FG001|Overall Study|Patient never treated|0|||
17123532|NCT00006903|38263498|FG002|Overall Study|Patient never treated|1|||
17123533|NCT00006903|38263496|FG000|Overall Study|Ineligible|10|||
17123534|NCT00006903|38263497|FG001|Overall Study|Ineligible|1|||
17123535|NCT00006903|38263498|FG002|Overall Study|Ineligible|2|||
17123536|NCT00026793|38263506|FG000|Overall Study|Death on study due to underlying disease|4|||
17123537|NCT00026793|38263506|FG000|Overall Study|Physician Decision|2|||
17123538|NCT00026793|38263506|FG000|Overall Study|Off study|2|||
17123539|NCT03539484|38263517|FG000|Overall Study|Death|1|||
17123540|NCT03539484|38263518|FG001|Overall Study|Death|0|||
17123541|NCT03539484|38263519|FG002|Overall Study|Death|0|||
17123542|NCT03539484|38263520|FG003|Overall Study|Death|2|||
17123543|NCT03539484|38263521|FG004|Overall Study|Death|8|||
17123544|NCT03539484|38263522|FG005|Overall Study|Death|3|||
17123545|NCT03539484|38263523|FG006|Overall Study|Death|0|||
17123546|NCT03539484|38263517|FG000|Overall Study|Lost to Follow-up|0|||
17123547|NCT03539484|38263518|FG001|Overall Study|Lost to Follow-up|1|||
17123548|NCT03539484|38263519|FG002|Overall Study|Lost to Follow-up|0|||
17123549|NCT03539484|38263520|FG003|Overall Study|Lost to Follow-up|0|||
17123550|NCT03539484|38263521|FG004|Overall Study|Lost to Follow-up|1|||
17123551|NCT03539484|38263522|FG005|Overall Study|Lost to Follow-up|0|||
17123552|NCT03539484|38263523|FG006|Overall Study|Lost to Follow-up|0|||
17123553|NCT03539484|38263517|FG000|Overall Study|Withdrawal by Subject|0|||
17123554|NCT03539484|38263518|FG001|Overall Study|Withdrawal by Subject|0|||
17123555|NCT03539484|38263519|FG002|Overall Study|Withdrawal by Subject|0|||
17123556|NCT03539484|38263520|FG003|Overall Study|Withdrawal by Subject|0|||
17123557|NCT03539484|38263521|FG004|Overall Study|Withdrawal by Subject|2|||
17123558|NCT03539484|38263522|FG005|Overall Study|Withdrawal by Subject|0|||
17123559|NCT03539484|38263523|FG006|Overall Study|Withdrawal by Subject|1|||
17123560|NCT03539484|38263517|FG000|Overall Study|Study Terminated by Sponsor|0|||
17123561|NCT03539484|38263518|FG001|Overall Study|Study Terminated by Sponsor|0|||
17123562|NCT03539484|38263519|FG002|Overall Study|Study Terminated by Sponsor|1|||
17123563|NCT03539484|38263520|FG003|Overall Study|Study Terminated by Sponsor|1|||
17123564|NCT03539484|38263521|FG004|Overall Study|Study Terminated by Sponsor|2|||
17123565|NCT03539484|38263522|FG005|Overall Study|Study Terminated by Sponsor|2|||
17123566|NCT03539484|38263523|FG006|Overall Study|Study Terminated by Sponsor|1|||
17123567|NCT03561090|38263546|FG000|Overall Study|Adverse Event|11|||
17123568|NCT03561090|38263547|FG001|Overall Study|Adverse Event|7|||
17123569|NCT03561090|38263546|FG000|Overall Study|Non-Compliance With Study Drug|2|||
17123570|NCT03561090|38263547|FG001|Overall Study|Non-Compliance With Study Drug|0|||
17123571|NCT03561090|38263546|FG000|Overall Study|Protocol Violation|2|||
17123572|NCT03561090|38263547|FG001|Overall Study|Protocol Violation|2|||
17123573|NCT03561090|38263546|FG000|Overall Study|Withdrawal by Subject|7|||
17123574|NCT03561090|38263547|FG001|Overall Study|Withdrawal by Subject|7|||
17123575|NCT03561090|38263546|FG000|Overall Study|Lost to Follow-up|7|||
17123576|NCT03561090|38263547|FG001|Overall Study|Lost to Follow-up|2|||
17123577|NCT03561090|38263546|FG000|Overall Study|Study Terminated by Sponsor|10|||
17123578|NCT03561090|38263547|FG001|Overall Study|Study Terminated by Sponsor|15|||
17123579|NCT03561090|38263546|FG000|Overall Study|Randomized by Mistake|1|||
17123580|NCT03561090|38263547|FG001|Overall Study|Randomized by Mistake|1|||
17123581|NCT03561090|38263546|FG000|Overall Study|Other Not Specified|0|||
17123582|NCT03561090|38263547|FG001|Overall Study|Other Not Specified|2|||
17123583|NCT02996500|38263561|FG000|Overall Study|Adverse Event|1|||
17123584|NCT02996500|38263562|FG001|Overall Study|Adverse Event|1|||
17123585|NCT02996500|38263563|FG002|Overall Study|Adverse Event|4|||
17123586|NCT02996500|38263564|FG003|Overall Study|Adverse Event|3|||
17123587|NCT02996500|38263565|FG004|Overall Study|Adverse Event|1|||
17123588|NCT02996500|38263566|FG005|Overall Study|Adverse Event|2|||
17123589|NCT02996500|38263561|FG000|Overall Study|Lack of Efficacy|0|||
17123590|NCT02996500|38263562|FG001|Overall Study|Lack of Efficacy|0|||
17123591|NCT02996500|38263563|FG002|Overall Study|Lack of Efficacy|0|||
17123592|NCT02996500|38263564|FG003|Overall Study|Lack of Efficacy|0|||
17123593|NCT02996500|38263565|FG004|Overall Study|Lack of Efficacy|2|||
17123594|NCT02996500|38263566|FG005|Overall Study|Lack of Efficacy|0|||
17123595|NCT02996500|38263561|FG000|Overall Study|Lost to Follow-up|1|||
17123596|NCT02996500|38263562|FG001|Overall Study|Lost to Follow-up|0|||
17123597|NCT02996500|38263563|FG002|Overall Study|Lost to Follow-up|0|||
17123598|NCT02996500|38263564|FG003|Overall Study|Lost to Follow-up|0|||
17123599|NCT02996500|38263565|FG004|Overall Study|Lost to Follow-up|0|||
17123600|NCT02996500|38263566|FG005|Overall Study|Lost to Follow-up|1|||
17123601|NCT02996500|38263561|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
17123602|NCT02996500|38263562|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
17123603|NCT02996500|38263563|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
17123604|NCT02996500|38263564|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
17123605|NCT02996500|38263565|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
17123606|NCT02996500|38263566|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
17123607|NCT02996500|38263561|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17123608|NCT02996500|38263562|FG001|Overall Study|Non-Compliance With Study Drug|0|||
17123609|NCT02996500|38263563|FG002|Overall Study|Non-Compliance With Study Drug|0|||
17123610|NCT02996500|38263564|FG003|Overall Study|Non-Compliance With Study Drug|0|||
17123611|NCT02996500|38263565|FG004|Overall Study|Non-Compliance With Study Drug|0|||
17123612|NCT02996500|38263566|FG005|Overall Study|Non-Compliance With Study Drug|1|||
17123613|NCT02996500|38263561|FG000|Overall Study|Progressive Disease|1|||
17123614|NCT02996500|38263562|FG001|Overall Study|Progressive Disease|0|||
17123615|NCT02996500|38263563|FG002|Overall Study|Progressive Disease|0|||
17123616|NCT02996500|38263564|FG003|Overall Study|Progressive Disease|0|||
17123617|NCT02996500|38263565|FG004|Overall Study|Progressive Disease|0|||
17123618|NCT02996500|38263566|FG005|Overall Study|Progressive Disease|0|||
17123619|NCT02996500|38263561|FG000|Overall Study|Other|2|||
17123620|NCT02996500|38263562|FG001|Overall Study|Other|0|||
17123621|NCT02996500|38263563|FG002|Overall Study|Other|2|||
17123622|NCT02996500|38263564|FG003|Overall Study|Other|0|||
17123623|NCT02996500|38263565|FG004|Overall Study|Other|0|||
17123624|NCT02996500|38263566|FG005|Overall Study|Other|0|||
17123625|NCT02996500|38263561|FG000|Overall Study|Protocol Violation|0|||
17123626|NCT02996500|38263562|FG001|Overall Study|Protocol Violation|0|||
17123627|NCT02996500|38263563|FG002|Overall Study|Protocol Violation|0|||
17123628|NCT02996500|38263564|FG003|Overall Study|Protocol Violation|1|||
17123629|NCT02996500|38263565|FG004|Overall Study|Protocol Violation|0|||
17123630|NCT02996500|38263566|FG005|Overall Study|Protocol Violation|0|||
17123631|NCT02996500|38263561|FG000|Overall Study|Withdrawal by Subject|3|||
17123632|NCT02996500|38263562|FG001|Overall Study|Withdrawal by Subject|0|||
17123633|NCT02996500|38263563|FG002|Overall Study|Withdrawal by Subject|3|||
17123634|NCT02996500|38263564|FG003|Overall Study|Withdrawal by Subject|0|||
17123635|NCT02996500|38263565|FG004|Overall Study|Withdrawal by Subject|2|||
17123636|NCT02996500|38263566|FG005|Overall Study|Withdrawal by Subject|0|||
17123637|NCT00006489|38263588|FG000|Overall Study|Adverse Event|3|||
17123638|NCT00006489|38263589|FG001|Overall Study|Adverse Event|2|||
17123639|NCT00006489|38263590|FG002|Overall Study|Adverse Event|4|||
17123640|NCT00006489|38263591|FG003|Overall Study|Adverse Event|3|||
17123641|NCT00006489|38263588|FG000|Overall Study|Withdrawal by Subject|10|||
17123642|NCT00006489|38263589|FG001|Overall Study|Withdrawal by Subject|9|||
17123643|NCT00006489|38263590|FG002|Overall Study|Withdrawal by Subject|9|||
17123644|NCT00006489|38263591|FG003|Overall Study|Withdrawal by Subject|6|||
17123645|NCT00006489|38263588|FG000|Overall Study|Scheduling Conflict|0|||
17123646|NCT00006489|38263589|FG001|Overall Study|Scheduling Conflict|3|||
17123647|NCT00006489|38263590|FG002|Overall Study|Scheduling Conflict|2|||
17123648|NCT00006489|38263591|FG003|Overall Study|Scheduling Conflict|1|||
17123649|NCT00006489|38263588|FG000|Overall Study|Death|0|||
17123650|NCT00006489|38263589|FG001|Overall Study|Death|0|||
17123651|NCT00006489|38263590|FG002|Overall Study|Death|0|||
17123652|NCT00006489|38263591|FG003|Overall Study|Death|1|||
17123653|NCT03535974|38263604|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
17123654|NCT03535974|38263605|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
17123655|NCT03535974|38263606|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
17123656|NCT03535974|38263604|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
17123657|NCT03535974|38263605|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
17123658|NCT03535974|38263606|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
17123659|NCT00025233|38263614|FG000|Overall Study|Ineligible: wrong cell type|1|||
17123660|NCT00025233|38263614|FG000|Overall Study|Ineligible: wrong primary|1|||
17123661|NCT00025233|38263614|FG000|Overall Study|Ineligible: improper prior treatment|1|||
17123662|NCT00025233|38263614|FG000|Overall Study|Never treated|1|||
17123663|NCT03535740|38263624|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
17123664|NCT03535740|38263624|FG000|Overall Study|Death|34|||
17123665|NCT03535740|38263624|FG000|Overall Study|Lost to Follow-up|1|||
17123666|NCT03535740|38263624|FG000|Overall Study|Withdrawal by Subject|13|||
17123667|NCT00025155|38263629|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
17123668|NCT00025155|38263629|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
17123669|NCT02998996|38263644|FG000|Overall Study|Lost to Follow-up|0|||
17123670|NCT02998996|38263645|FG001|Overall Study|Lost to Follow-up|0|||
17123671|NCT02998996|38263646|FG002|Overall Study|Lost to Follow-up|1|||
17123672|NCT02998996|38263647|FG003|Overall Study|Lost to Follow-up|0|||
17123673|NCT02998996|38263648|FG004|Overall Study|Lost to Follow-up|0|||
17123674|NCT02998996|38263649|FG005|Overall Study|Lost to Follow-up|0|||
17123675|NCT02998996|38263644|FG000|Overall Study|Pregnancy|0|||
17123676|NCT02998996|38263645|FG001|Overall Study|Pregnancy|1|||
17123677|NCT02998996|38263646|FG002|Overall Study|Pregnancy|0|||
17123678|NCT02998996|38263647|FG003|Overall Study|Pregnancy|0|||
17123679|NCT02998996|38263648|FG004|Overall Study|Pregnancy|0|||
17123680|NCT02998996|38263649|FG005|Overall Study|Pregnancy|0|||
17123681|NCT02998996|38263644|FG000|Overall Study|Family reasons|0|||
17123682|NCT02998996|38263645|FG001|Overall Study|Family reasons|0|||
17123683|NCT02998996|38263646|FG002|Overall Study|Family reasons|0|||
17123684|NCT02998996|38263647|FG003|Overall Study|Family reasons|0|||
17123685|NCT02998996|38263648|FG004|Overall Study|Family reasons|1|||
17123686|NCT02998996|38263649|FG005|Overall Study|Family reasons|0|||
17123687|NCT02994940|38263665|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
17123688|NCT02994940|38263666|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
17123689|NCT02994940|38263665|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
17123690|NCT02994940|38263666|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
17123691|NCT02994940|38263665|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
17123692|NCT02994940|38263666|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
17123693|NCT02994394|38263674|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
17123694|NCT02994394|38263675|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
17123695|NCT02994394|38263676|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
17123696|NCT02994394|38263677|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
17123697|NCT02994394|38263678|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
17123698|NCT02994394|38263679|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
17123699|NCT02994394|38263674|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
17123700|NCT02994394|38263675|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
17123701|NCT02994394|38263676|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
17123702|NCT02994394|38263677|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
17123703|NCT02994394|38263678|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
17123704|NCT02994394|38263679|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
17123705|NCT02998840|38263697|FG000|Overall Study|Lost to Follow-up|1|||
17123706|NCT02998840|38263698|FG001|Overall Study|Lost to Follow-up|1|||
17123707|NCT02998840|38263699|FG002|Overall Study|Lost to Follow-up|2|||
17123708|NCT02998840|38263700|FG003|Overall Study|Lost to Follow-up|3|||
17123709|NCT02998840|38263697|FG000|Overall Study|Withdrawal by Subject|1|||
17123710|NCT02998840|38263698|FG001|Overall Study|Withdrawal by Subject|1|||
17123711|NCT02998840|38263699|FG002|Overall Study|Withdrawal by Subject|0|||
17123712|NCT02998840|38263700|FG003|Overall Study|Withdrawal by Subject|1|||
17123713|NCT02998840|38263697|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
17123714|NCT02998840|38263698|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
17123715|NCT02998840|38263699|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
17123716|NCT02998840|38263700|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
17123717|NCT00023673|38263711|FG000|Overall Study|Ineligible / no protocol treatment|0|||
17123718|NCT00023673|38263712|FG001|Overall Study|Ineligible / no protocol treatment|0|||
17123719|NCT00023673|38263713|FG002|Overall Study|Ineligible / no protocol treatment|0|||
17123720|NCT00023673|38263714|FG003|Overall Study|Ineligible / no protocol treatment|1|||
17123721|NCT00023673|38263711|FG000|Overall Study|Patient withdrew consent|0|||
17123722|NCT00023673|38263712|FG001|Overall Study|Patient withdrew consent|0|||
17123723|NCT00023673|38263713|FG002|Overall Study|Patient withdrew consent|0|||
17123724|NCT00023673|38263714|FG003|Overall Study|Patient withdrew consent|1|||
17123725|NCT01069900|38263726|FG000|Overall Study|Technical problems|0|||
17123726|NCT01069900|38263727|FG001|Overall Study|Technical problems|1|||
17123727|NCT01069900|38263726|FG000|Overall Study|Lost to Follow-up|7|||
17123728|NCT01069900|38263727|FG001|Overall Study|Lost to Follow-up|1|||
17123729|NCT01069900|38263726|FG000|Overall Study|Withdrawal by Subject|6|||
17123730|NCT01069900|38263727|FG001|Overall Study|Withdrawal by Subject|1|||
17123731|NCT01069900|38263726|FG000|Overall Study|Protocol Violation|4|||
17123732|NCT01069900|38263727|FG001|Overall Study|Protocol Violation|1|||
17123733|NCT01069900|38263726|FG000|Overall Study|Insufficient Therapeutic effect|1|||
17123734|NCT01069900|38263727|FG001|Overall Study|Insufficient Therapeutic effect|0|||
17123735|NCT01069120|38263735|FG000|Overall Study|Study prematurely terminated|27|||
17123736|NCT00006237|38263743|FG000|Overall Study|Adverse Event|39|||
17123737|NCT00006237|38263744|FG001|Overall Study|Adverse Event|29|||
17123738|NCT00006237|38263743|FG000|Overall Study|Death|1|||
17123739|NCT00006237|38263744|FG001|Overall Study|Death|0|||
17123740|NCT00006237|38263743|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
17123741|NCT00006237|38263744|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
17123742|NCT00006237|38263743|FG000|Overall Study|Progression/relapse|54|||
17123743|NCT00006237|38263744|FG001|Overall Study|Progression/relapse|2|||
17123744|NCT00006237|38263743|FG000|Overall Study|Not eligible|9|||
17123745|NCT00006237|38263744|FG001|Overall Study|Not eligible|20|||
17123746|NCT00006237|38263743|FG000|Overall Study|Withdrawal by Subject|0|||
17123747|NCT00006237|38263744|FG001|Overall Study|Withdrawal by Subject|1|||
17123748|NCT00006237|38263743|FG000|Overall Study|Not protocol specified|14|||
17123749|NCT00006237|38263744|FG001|Overall Study|Not protocol specified|5|||
17123750|NCT02993926|38263753|FG000|Enantone Treatment Phase|Adverse Event|1|||
17123751|NCT02993926|38263754|FG001|Enantone Treatment Phase|Adverse Event|0|||
17123752|NCT02993926|38263755|FG002|Enantone Treatment Phase|Adverse Event|0|||
17123753|NCT02993926|38263753|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
17123754|NCT02993926|38263754|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
17123755|NCT02993926|38263755|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
17123756|NCT02993926|38263753|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
17123757|NCT02993926|38263754|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
17123758|NCT02993926|38263755|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
17123759|NCT02993926|38263753|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
17123760|NCT02993926|38263754|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
17123761|NCT02993926|38263755|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
17123762|NCT02993224|38263765|FG000|Core Phase - Period 1|Adverse Event|4|||
17123763|NCT02993224|38263765|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
17123764|NCT02993224|38263765|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
17123765|NCT02993224|38263765|FG000|Core Phase- Period 2|Adverse Event|1|||
17123766|NCT02993224|38263765|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
17123767|NCT02993224|38263765|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
17123768|NCT02993224|38263765|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
17123769|NCT02993224|38263765|FG000|Extension Phase|Adverse Event|3|||
17123770|NCT02993224|38263765|FG000|Extension Phase|Withdrawal by Subject|3|||
17123771|NCT02993224|38263765|FG000|Extension Phase|Lost to Follow-up|2|||
17123772|NCT02993224|38263765|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
17123773|NCT03447314|38263789|FG000|Part 1 (Up to 27 Months)|Death|6|||
17123774|NCT03447314|38263790|FG001|Part 1 (Up to 27 Months)|Death|5|||
17123775|NCT03447314|38263791|FG002|Part 1 (Up to 27 Months)|Death|3|||
17123776|NCT03447314|38263792|FG003|Part 1 (Up to 27 Months)|Death|3|||
17123777|NCT03447314|38263793|FG004|Part 1 (Up to 27 Months)|Death|0|||
17123778|NCT03447314|38263794|FG005|Part 1 (Up to 27 Months)|Death|4|||
17123779|NCT03447314|38263795|FG006|Part 1 (Up to 27 Months)|Death|3|||
17123780|NCT03447314|38263796|FG007|Part 1 (Up to 27 Months)|Death|0|||
17123781|NCT03447314|38263797|FG008|Part 1 (Up to 27 Months)|Death|0|||
17123782|NCT03447314|38263798|FG009|Part 1 (Up to 27 Months)|Death|0|||
17123783|NCT03447314|38263799|FG010|Part 1 (Up to 27 Months)|Death|4|||
17123784|NCT03447314|38263800|FG011|Part 1 (Up to 27 Months)|Death|2|||
17123785|NCT03447314|38263801|FG012|Part 1 (Up to 27 Months)|Death|0|||
17123786|NCT03447314|38263802|FG013|Part 1 (Up to 27 Months)|Death|0|||
17123787|NCT03447314|38263803|FG014|Part 1 (Up to 27 Months)|Death|0|||
17123788|NCT03447314|38263804|FG015|Part 1 (Up to 27 Months)|Death|0|||
17123789|NCT03447314|38263805|FG016|Part 1 (Up to 27 Months)|Death|0|||
17123790|NCT03447314|38263806|FG017|Part 1 (Up to 27 Months)|Death|0|||
17123791|NCT03447314|38263789|FG000|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
17123792|NCT03447314|38263790|FG001|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
17123793|NCT03447314|38263791|FG002|Part 1 (Up to 27 Months)|Ongoing in the study|3|||
17123794|NCT03447314|38263792|FG003|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
17123795|NCT03447314|38263793|FG004|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
17123796|NCT03447314|38263794|FG005|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
17123797|NCT03447314|38263795|FG006|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
17123798|NCT03447314|38263796|FG007|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123799|NCT03447314|38263797|FG008|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123800|NCT03447314|38263798|FG009|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123801|NCT03447314|38263799|FG010|Part 1 (Up to 27 Months)|Ongoing in the study|3|||
17123802|NCT03447314|38263800|FG011|Part 1 (Up to 27 Months)|Ongoing in the study|4|||
17123803|NCT03447314|38263801|FG012|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123804|NCT03447314|38263802|FG013|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123805|NCT03447314|38263803|FG014|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123806|NCT03447314|38263804|FG015|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123807|NCT03447314|38263805|FG016|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123808|NCT03447314|38263806|FG017|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
17123809|NCT03447314|38263789|FG000|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
17123810|NCT03447314|38263790|FG001|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123811|NCT03447314|38263791|FG002|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
17123812|NCT03447314|38263792|FG003|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123813|NCT03447314|38263793|FG004|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123814|NCT03447314|38263794|FG005|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
17123815|NCT03447314|38263795|FG006|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123816|NCT03447314|38263796|FG007|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123817|NCT03447314|38263797|FG008|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123818|NCT03447314|38263798|FG009|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123819|NCT03447314|38263799|FG010|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123820|NCT03447314|38263800|FG011|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123821|NCT03447314|38263801|FG012|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123822|NCT03447314|38263802|FG013|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123823|NCT03447314|38263803|FG014|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123824|NCT03447314|38263804|FG015|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123825|NCT03447314|38263805|FG016|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123826|NCT03447314|38263806|FG017|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
17123827|NCT03447314|38263789|FG000|Part 1 (Up to 27 Months)|Disease progression|0|||
17123828|NCT03447314|38263790|FG001|Part 1 (Up to 27 Months)|Disease progression|0|||
17123829|NCT03447314|38263791|FG002|Part 1 (Up to 27 Months)|Disease progression|1|||
17123830|NCT03447314|38263792|FG003|Part 1 (Up to 27 Months)|Disease progression|0|||
17123831|NCT03447314|38263793|FG004|Part 1 (Up to 27 Months)|Disease progression|0|||
17123832|NCT03447314|38263794|FG005|Part 1 (Up to 27 Months)|Disease progression|0|||
17123833|NCT03447314|38263795|FG006|Part 1 (Up to 27 Months)|Disease progression|0|||
17123834|NCT03447314|38263796|FG007|Part 1 (Up to 27 Months)|Disease progression|0|||
17123835|NCT03447314|38263797|FG008|Part 1 (Up to 27 Months)|Disease progression|0|||
17123836|NCT03447314|38263798|FG009|Part 1 (Up to 27 Months)|Disease progression|0|||
17123837|NCT03447314|38263799|FG010|Part 1 (Up to 27 Months)|Disease progression|0|||
17123838|NCT03447314|38263800|FG011|Part 1 (Up to 27 Months)|Disease progression|0|||
17123839|NCT03447314|38263801|FG012|Part 1 (Up to 27 Months)|Disease progression|0|||
17123840|NCT03447314|38263802|FG013|Part 1 (Up to 27 Months)|Disease progression|0|||
17123841|NCT03447314|38263803|FG014|Part 1 (Up to 27 Months)|Disease progression|0|||
17123842|NCT03447314|38263804|FG015|Part 1 (Up to 27 Months)|Disease progression|0|||
17123843|NCT03447314|38263805|FG016|Part 1 (Up to 27 Months)|Disease progression|0|||
17123844|NCT03447314|38263806|FG017|Part 1 (Up to 27 Months)|Disease progression|0|||
17123845|NCT03447314|38263789|FG000|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123846|NCT03447314|38263790|FG001|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123847|NCT03447314|38263791|FG002|Part 1 (Up to 27 Months)|Lost to Follow-up|1|||
17123848|NCT03447314|38263792|FG003|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123849|NCT03447314|38263793|FG004|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123850|NCT03447314|38263794|FG005|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123851|NCT03447314|38263795|FG006|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123852|NCT03447314|38263796|FG007|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123853|NCT03447314|38263797|FG008|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123854|NCT03447314|38263798|FG009|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123855|NCT03447314|38263799|FG010|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123856|NCT03447314|38263800|FG011|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123857|NCT03447314|38263801|FG012|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123858|NCT03447314|38263802|FG013|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123859|NCT03447314|38263803|FG014|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123860|NCT03447314|38263804|FG015|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123861|NCT03447314|38263805|FG016|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123862|NCT03447314|38263806|FG017|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
17123863|NCT03495908|38263849|FG000|Overall Study|Withdrawal by Subject|3|||
17123864|NCT03495908|38263850|FG001|Overall Study|Withdrawal by Subject|1|||
17123865|NCT03495908|38263849|FG000|Overall Study|Lost to Follow-up|1|||
17123866|NCT03495908|38263850|FG001|Overall Study|Lost to Follow-up|4|||
17123867|NCT03495908|38263849|FG000|Overall Study|Adverse Event|0|||
17123868|NCT03495908|38263850|FG001|Overall Study|Adverse Event|2|||
17123869|NCT03495908|38263849|FG000|Overall Study|Death|1|||
17123870|NCT03495908|38263850|FG001|Overall Study|Death|0|||
17123871|NCT03495908|38263849|FG000|Overall Study|Physician Decision|5|||
17123872|NCT03495908|38263850|FG001|Overall Study|Physician Decision|4|||
17123873|NCT03495908|38263849|FG000|Overall Study|No documented reason|0|||
17123874|NCT03495908|38263850|FG001|Overall Study|No documented reason|2|||
17123875|NCT02992288|38263862|FG000|Overall Study|Adverse Event|8|||
17123876|NCT02992288|38263863|FG001|Overall Study|Adverse Event|2|||
17123877|NCT02992288|38263864|FG002|Overall Study|Adverse Event|2|||
17123878|NCT02992288|38263865|FG003|Overall Study|Adverse Event|2|||
17123879|NCT02992288|38263866|FG004|Overall Study|Adverse Event|2|||
17123880|NCT02992288|38263867|FG005|Overall Study|Adverse Event|7|||
17123881|NCT02992288|38263862|FG000|Overall Study|Non-compliance with study drug|0|||
17123882|NCT02992288|38263863|FG001|Overall Study|Non-compliance with study drug|1|||
17123883|NCT02992288|38263864|FG002|Overall Study|Non-compliance with study drug|1|||
17123884|NCT02992288|38263865|FG003|Overall Study|Non-compliance with study drug|0|||
17123885|NCT02992288|38263866|FG004|Overall Study|Non-compliance with study drug|1|||
17123886|NCT02992288|38263867|FG005|Overall Study|Non-compliance with study drug|0|||
17123887|NCT02992288|38263862|FG000|Overall Study|Physician Decision|3|||
17123888|NCT02992288|38263863|FG001|Overall Study|Physician Decision|0|||
17123889|NCT02992288|38263864|FG002|Overall Study|Physician Decision|1|||
17123890|NCT02992288|38263865|FG003|Overall Study|Physician Decision|0|||
17123891|NCT02992288|38263866|FG004|Overall Study|Physician Decision|0|||
17123892|NCT02992288|38263867|FG005|Overall Study|Physician Decision|1|||
17123893|NCT02992288|38263862|FG000|Overall Study|Death|2|||
17123894|NCT02992288|38263863|FG001|Overall Study|Death|0|||
17123895|NCT02992288|38263864|FG002|Overall Study|Death|2|||
17123896|NCT02992288|38263865|FG003|Overall Study|Death|1|||
17123897|NCT02992288|38263866|FG004|Overall Study|Death|2|||
17123898|NCT02992288|38263867|FG005|Overall Study|Death|0|||
17123899|NCT02992288|38263862|FG000|Overall Study|Lost to Follow-up|0|||
17123900|NCT02992288|38263863|FG001|Overall Study|Lost to Follow-up|0|||
17123901|NCT02992288|38263864|FG002|Overall Study|Lost to Follow-up|0|||
17123902|NCT02992288|38263865|FG003|Overall Study|Lost to Follow-up|1|||
17123903|NCT02992288|38263866|FG004|Overall Study|Lost to Follow-up|0|||
17123904|NCT02992288|38263867|FG005|Overall Study|Lost to Follow-up|0|||
17123905|NCT02992288|38263862|FG000|Overall Study|Protocol Violation|0|||
17123906|NCT02992288|38263863|FG001|Overall Study|Protocol Violation|0|||
17123907|NCT02992288|38263864|FG002|Overall Study|Protocol Violation|0|||
17123908|NCT02992288|38263865|FG003|Overall Study|Protocol Violation|0|||
17123909|NCT02992288|38263866|FG004|Overall Study|Protocol Violation|0|||
17123910|NCT02992288|38263867|FG005|Overall Study|Protocol Violation|1|||
17123911|NCT02992288|38263862|FG000|Overall Study|Withdrawal by Subject|4|||
17123912|NCT02992288|38263863|FG001|Overall Study|Withdrawal by Subject|2|||
17123913|NCT02992288|38263864|FG002|Overall Study|Withdrawal by Subject|1|||
17123914|NCT02992288|38263865|FG003|Overall Study|Withdrawal by Subject|5|||
17123915|NCT02992288|38263866|FG004|Overall Study|Withdrawal by Subject|3|||
17123916|NCT02992288|38263867|FG005|Overall Study|Withdrawal by Subject|4|||
17123917|NCT02953262|38263885|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
17123918|NCT02953262|38263886|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
17123919|NCT02953262|38263887|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
17123920|NCT02953262|38263888|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
17123921|NCT03415178|38263904|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
17123922|NCT03415178|38263905|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
17123923|NCT03415178|38263904|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
17123924|NCT03415178|38263905|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
17123925|NCT02992132|38263918|FG000|Overall Study|Adverse Event|4|||
17123926|NCT02992132|38263919|FG001|Overall Study|Adverse Event|1|||
17123927|NCT02992132|38263920|FG002|Overall Study|Adverse Event|3|||
17123928|NCT02992132|38263918|FG000|Overall Study|Lack of Efficacy|2|||
17123929|NCT02992132|38263919|FG001|Overall Study|Lack of Efficacy|0|||
17123930|NCT02992132|38263920|FG002|Overall Study|Lack of Efficacy|0|||
17123931|NCT02992132|38263918|FG000|Overall Study|Non-compliance with study drug|2|||
17123932|NCT02992132|38263919|FG001|Overall Study|Non-compliance with study drug|0|||
17123933|NCT02992132|38263920|FG002|Overall Study|Non-compliance with study drug|0|||
17123934|NCT02992132|38263918|FG000|Overall Study|Progressive disease|1|||
17123935|NCT02992132|38263919|FG001|Overall Study|Progressive disease|0|||
17123936|NCT02992132|38263920|FG002|Overall Study|Progressive disease|0|||
17123937|NCT02992132|38263918|FG000|Overall Study|Protocol Violation|2|||
17123938|NCT02992132|38263919|FG001|Overall Study|Protocol Violation|2|||
17123939|NCT02992132|38263920|FG002|Overall Study|Protocol Violation|0|||
17123940|NCT02992132|38263918|FG000|Overall Study|Caregiver withdrew consent|2|||
17123941|NCT02992132|38263919|FG001|Overall Study|Caregiver withdrew consent|3|||
17123942|NCT02992132|38263920|FG002|Overall Study|Caregiver withdrew consent|2|||
17123943|NCT02992132|38263918|FG000|Overall Study|Withdrawal by Subject|0|||
17123944|NCT02992132|38263919|FG001|Overall Study|Withdrawal by Subject|2|||
17123945|NCT02992132|38263920|FG002|Overall Study|Withdrawal by Subject|1|||
17123946|NCT02992132|38263918|FG000|Overall Study|Physician Decision|0|||
17123947|NCT02992132|38263919|FG001|Overall Study|Physician Decision|0|||
17123948|NCT02992132|38263920|FG002|Overall Study|Physician Decision|1|||
17123949|NCT03444584|38263930|FG000|Overall Study|Withdrawal by Subject|0|||
17123950|NCT03444584|38263931|FG001|Overall Study|Withdrawal by Subject|1|||
17123951|NCT03444584|38263930|FG000|Overall Study|Other|0|||
17123952|NCT03444584|38263931|FG001|Overall Study|Other|1|||
17123953|NCT02989168|38263940|FG000|Overall Study|Withdrawal by Subject|2|||
17123954|NCT02989168|38263941|FG001|Overall Study|Withdrawal by Subject|0|||
17123955|NCT02989168|38263940|FG000|Overall Study|Physician Decision|0|||
17123956|NCT02989168|38263941|FG001|Overall Study|Physician Decision|1|||
17123957|NCT02989168|38263940|FG000|Overall Study|Adverse Event|1|||
17123958|NCT02989168|38263941|FG001|Overall Study|Adverse Event|2|||
17123959|NCT02989168|38263940|FG000|Overall Study|Sponsor stopped study.|1|||
17123960|NCT02989168|38263941|FG001|Overall Study|Sponsor stopped study.|0|||
17123961|NCT02988622|38263949|FG000|Overall Study|Lost to Follow-up|17|||
17123962|NCT03412604|38263955|FG000|Overall Study|Withdrawal by Subject|1|||
17123963|NCT02991430|38263962|FG000|Treatment Period 1|Adverse Event|1|||
17123964|NCT02991430|38263963|FG001|Treatment Period 1|Adverse Event|0|||
17123965|NCT02991430|38263964|FG002|Treatment Period 1|Adverse Event|2|||
17123966|NCT02991430|38263962|FG000|Treatment Period 1|Withdrawal by Subject|0|||
17123967|NCT02991430|38263963|FG001|Treatment Period 1|Withdrawal by Subject|4|||
17123968|NCT02991430|38263964|FG002|Treatment Period 1|Withdrawal by Subject|0|||
17123969|NCT02991430|38263962|FG000|Treatment Period 2|Study Termination|6|||
17123970|NCT02991430|38263963|FG001|Treatment Period 2|Study Termination|3|||
17123971|NCT02991430|38263964|FG002|Treatment Period 2|Study Termination|3|||
17123972|NCT02991430|38263962|FG000|Treatment Period 2|Lost to Follow-up|0|||
17123973|NCT02991430|38263963|FG001|Treatment Period 2|Lost to Follow-up|0|||
17123974|NCT02991430|38263964|FG002|Treatment Period 2|Lost to Follow-up|1|||
17123975|NCT02991430|38263962|FG000|Post-treatment Observation Period|Study Termination|3|||
17123976|NCT02991430|38263963|FG001|Post-treatment Observation Period|Study Termination|6|||
17123977|NCT02991430|38263964|FG002|Post-treatment Observation Period|Study Termination|5|||
17123978|NCT03411902|38263974|FG000|Overall Study|Lost to Follow-up|3|||
17123979|NCT03411902|38263975|FG001|Overall Study|Lost to Follow-up|0|||
17123980|NCT03494816|38263981|FG000|Overall Study|Protocol Violation|2|||
17123981|NCT03494816|38263981|FG000|Overall Study|Physician Decision|2|||
17123982|NCT03494816|38263981|FG000|Overall Study|Did not start trial treatment|1|||
17123983|NCT03494816|38263981|FG000|Overall Study|Adverse Event|1|||
17123984|NCT03492554|38263991|FG000|Overall Study|Protocol Violation|0|||
17123985|NCT03492554|38263992|FG001|Overall Study|Protocol Violation|14|||
17123986|NCT03443414|38264004|FG000|Overall Study|Adverse Event|6|||
17123987|NCT03443414|38264005|FG001|Overall Study|Adverse Event|0|||
17123988|NCT03443414|38264006|FG002|Overall Study|Adverse Event|4|||
17123989|NCT03443414|38264007|FG003|Overall Study|Adverse Event|2|||
17123990|NCT03443414|38264008|FG004|Overall Study|Adverse Event|3|||
17123991|NCT03443414|38264004|FG000|Overall Study|Withdrawal by Subject|3|||
17123992|NCT03443414|38264005|FG001|Overall Study|Withdrawal by Subject|2|||
17123993|NCT03443414|38264006|FG002|Overall Study|Withdrawal by Subject|2|||
17123994|NCT03443414|38264007|FG003|Overall Study|Withdrawal by Subject|2|||
17123995|NCT03443414|38264008|FG004|Overall Study|Withdrawal by Subject|1|||
17123996|NCT03443414|38264004|FG000|Overall Study|Death|0|||
17123997|NCT03443414|38264005|FG001|Overall Study|Death|1|||
17123998|NCT03443414|38264006|FG002|Overall Study|Death|0|||
17123999|NCT03443414|38264007|FG003|Overall Study|Death|1|||
17124000|NCT03443414|38264008|FG004|Overall Study|Death|0|||
17124001|NCT03443414|38264004|FG000|Overall Study|Reason not specified|2|||
17124002|NCT03443414|38264005|FG001|Overall Study|Reason not specified|0|||
17124003|NCT03443414|38264006|FG002|Overall Study|Reason not specified|0|||
17124004|NCT03443414|38264007|FG003|Overall Study|Reason not specified|0|||
17124005|NCT03443414|38264008|FG004|Overall Study|Reason not specified|1|||
17124006|NCT02991118|38264022|FG000|Overall Study|Death|3|||
17124007|NCT02991118|38264023|FG001|Overall Study|Death|8|||
17124008|NCT02991118|38264022|FG000|Overall Study|Protocol Violation|0|||
17124009|NCT02991118|38264023|FG001|Overall Study|Protocol Violation|3|||
17124010|NCT02991118|38264022|FG000|Overall Study|Physician Decision|0|||
17124011|NCT02991118|38264023|FG001|Overall Study|Physician Decision|1|||
17124012|NCT02991118|38264022|FG000|Overall Study|Moved out of the country|0|||
17124013|NCT02991118|38264023|FG001|Overall Study|Moved out of the country|1|||
17124014|NCT02991118|38264022|FG000|Overall Study|Adverse Event|2|||
17124015|NCT02991118|38264023|FG001|Overall Study|Adverse Event|2|||
17124016|NCT02991118|38264022|FG000|Overall Study|Withdrawal by Subject|1|||
17124017|NCT02991118|38264023|FG001|Overall Study|Withdrawal by Subject|7|||
17124018|NCT02991118|38264022|FG000|Overall Study|Could not attend study visits|0|||
17124019|NCT02991118|38264023|FG001|Overall Study|Could not attend study visits|1|||
17124020|NCT02991118|38264022|FG000|Overall Study|Lost to Follow-up|1|||
17124021|NCT02991118|38264023|FG001|Overall Study|Lost to Follow-up|9|||
17124022|NCT03491150|38264031|FG000|Overall Study|Adverse Event|1|||
17124023|NCT03491150|38264032|FG001|Overall Study|Adverse Event|0|||
17124024|NCT03491150|38264031|FG000|Overall Study|Study Terminated by Sponsor|74|||
17124025|NCT03491150|38264032|FG001|Overall Study|Study Terminated by Sponsor|70|||
17124026|NCT03491150|38264031|FG000|Overall Study|Other|0|||
17124027|NCT03491150|38264032|FG001|Overall Study|Other|1|||
17124028|NCT03491150|38264031|FG000|Overall Study|Withdrawal by Subject|1|||
17124029|NCT03491150|38264032|FG001|Overall Study|Withdrawal by Subject|2|||
17124030|NCT02991040|38264038|FG000|Overall Study|Withdrawal by Subject|2|||
17124031|NCT02991040|38264038|FG000|Overall Study|Lost to Follow-up|2|||
17124032|NCT02910466|38264044|FG000|Overall Study|Adverse Event|1|||
17124033|NCT02910466|38264044|FG000|Overall Study|Withdrawal by Subject|3|||
17124034|NCT02910466|38264044|FG000|Overall Study|Lost to Follow-up|5|||
17124035|NCT02910466|38264044|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
17124036|NCT02910466|38264044|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
17124037|NCT01068730|38264048|FG000|Period 3|Personal reason|1|||
17124038|NCT01068730|38264049|FG001|Period 3|Personal reason|0|||
17124039|NCT01068730|38264050|FG002|Period 3|Personal reason|0|||
17124040|NCT01068730|38264051|FG003|Period 3|Personal reason|0|||
17124041|NCT01068730|38264048|FG000|Period 4|Family emergency|0|||
17124042|NCT01068730|38264049|FG001|Period 4|Family emergency|1|||
17124043|NCT01068730|38264050|FG002|Period 4|Family emergency|0|||
17124044|NCT01068730|38264051|FG003|Period 4|Family emergency|0|||
17124045|NCT01068652|38264070|FG000|Overall Study|Adverse Event|4|||
17124046|NCT01068652|38264071|FG001|Overall Study|Adverse Event|0|||
17124047|NCT01068652|38264070|FG000|Overall Study|Lack of Efficacy|0|||
17124048|NCT01068652|38264071|FG001|Overall Study|Lack of Efficacy|2|||
17124049|NCT01068652|38264070|FG000|Overall Study|Lost to Follow-up|2|||
17124050|NCT01068652|38264071|FG001|Overall Study|Lost to Follow-up|1|||
17124051|NCT01068652|38264070|FG000|Overall Study|Protocol Violation|3|||
17124052|NCT01068652|38264071|FG001|Overall Study|Protocol Violation|6|||
17124053|NCT01068652|38264070|FG000|Overall Study|Withdrawal criteria|1|||
17124054|NCT01068652|38264071|FG001|Overall Study|Withdrawal criteria|2|||
17124055|NCT01068652|38264070|FG000|Overall Study|Patient was not eligible|1|||
17124056|NCT01068652|38264071|FG001|Overall Study|Patient was not eligible|0|||
17124057|NCT01068652|38264070|FG000|Overall Study|Unclassified|7|||
17124058|NCT01068652|38264071|FG001|Overall Study|Unclassified|4|||
17124059|NCT02921776|38264083|FG000|Overall Study|patient deterioration, fatigue|2|||
17124060|NCT02921776|38264084|FG001|Overall Study|patient deterioration, fatigue|6|||
17124061|NCT02921776|38264085|FG002|Overall Study|patient deterioration, fatigue|0|||
17124062|NCT02921776|38264086|FG003|Overall Study|patient deterioration, fatigue|0|||
17124063|NCT02921776|38264087|FG004|Overall Study|patient deterioration, fatigue|0|||
17124064|NCT02921776|38264088|FG005|Overall Study|patient deterioration, fatigue|0|||
17124065|NCT02921776|38264089|FG006|Overall Study|patient deterioration, fatigue|0|||
17124066|NCT02921776|38264090|FG007|Overall Study|patient deterioration, fatigue|0|||
17124067|NCT02921776|38264083|FG000|Overall Study|Withdrawal by Subject|0|||
17124068|NCT02921776|38264084|FG001|Overall Study|Withdrawal by Subject|2|||
17124069|NCT02921776|38264085|FG002|Overall Study|Withdrawal by Subject|0|||
17124070|NCT02921776|38264086|FG003|Overall Study|Withdrawal by Subject|1|||
17124071|NCT02921776|38264087|FG004|Overall Study|Withdrawal by Subject|1|||
17124072|NCT02921776|38264088|FG005|Overall Study|Withdrawal by Subject|0|||
17124073|NCT02921776|38264089|FG006|Overall Study|Withdrawal by Subject|8|||
17124074|NCT02921776|38264090|FG007|Overall Study|Withdrawal by Subject|1|||
17124075|NCT02921776|38264083|FG000|Overall Study|Death|0|||
17124076|NCT02921776|38264084|FG001|Overall Study|Death|0|||
17124077|NCT02921776|38264085|FG002|Overall Study|Death|0|||
17124078|NCT02921776|38264086|FG003|Overall Study|Death|2|||
17124079|NCT02921776|38264087|FG004|Overall Study|Death|0|||
17124080|NCT02921776|38264088|FG005|Overall Study|Death|0|||
17124081|NCT02921776|38264089|FG006|Overall Study|Death|0|||
17124082|NCT02921776|38264090|FG007|Overall Study|Death|0|||
17124083|NCT02921776|38264083|FG000|Overall Study|extubation or early discharge|0|||
17124084|NCT02921776|38264084|FG001|Overall Study|extubation or early discharge|0|||
17124085|NCT02921776|38264085|FG002|Overall Study|extubation or early discharge|0|||
17124086|NCT02921776|38264086|FG003|Overall Study|extubation or early discharge|5|||
17124087|NCT02921776|38264087|FG004|Overall Study|extubation or early discharge|5|||
17124088|NCT02921776|38264088|FG005|Overall Study|extubation or early discharge|0|||
17124089|NCT02921776|38264089|FG006|Overall Study|extubation or early discharge|0|||
17124090|NCT02921776|38264090|FG007|Overall Study|extubation or early discharge|0|||
17124091|NCT02921776|38264083|FG000|Overall Study|Lost to Follow-up|0|||
17124092|NCT02921776|38264084|FG001|Overall Study|Lost to Follow-up|0|||
17124093|NCT02921776|38264085|FG002|Overall Study|Lost to Follow-up|0|||
17124094|NCT02921776|38264086|FG003|Overall Study|Lost to Follow-up|0|||
17124095|NCT02921776|38264087|FG004|Overall Study|Lost to Follow-up|0|||
17124096|NCT02921776|38264088|FG005|Overall Study|Lost to Follow-up|2|||
17124097|NCT02921776|38264089|FG006|Overall Study|Lost to Follow-up|3|||
17124098|NCT02921776|38264090|FG007|Overall Study|Lost to Follow-up|6|||
17124099|NCT02922634|38264114|FG000|Overall Study|Withdrawal by Subject|5|||
17124100|NCT02922634|38264114|FG000|Overall Study|Did not have their surgery|5|||
17124101|NCT00023595|38264130|FG000|5 Year Follow up|Lost to Follow-up|2|||
17124102|NCT00023595|38264131|FG001|5 Year Follow up|Lost to Follow-up|2|||
17124103|NCT00023595|38264132|FG002|5 Year Follow up|Lost to Follow-up|1|||
17124104|NCT00023595|38264133|FG003|5 Year Follow up|Lost to Follow-up|7|||
17124105|NCT00023595|38264134|FG004|5 Year Follow up|Lost to Follow-up|3|||
17124106|NCT00023595|38264130|FG000|10 Year Follow up|Lost to Follow-up|12|||
17124107|NCT00023595|38264131|FG001|10 Year Follow up|Lost to Follow-up|10|||
17124108|NCT00023595|38264132|FG002|10 Year Follow up|Lost to Follow-up|3|||
17124109|NCT00023595|38264133|FG003|10 Year Follow up|Lost to Follow-up|0|||
17124110|NCT00023595|38264134|FG004|10 Year Follow up|Lost to Follow-up|0|||
17124111|NCT02920528|38264160|FG000|Overall Study|Incomplete Data|1|||
17124112|NCT02920528|38264161|FG001|Overall Study|Incomplete Data|1|||
17124113|NCT02920528|38264162|FG002|Overall Study|Incomplete Data|1|||
17124114|NCT02920528|38264160|FG000|Overall Study|Adverse Event|0|||
17124115|NCT02920528|38264161|FG001|Overall Study|Adverse Event|0|||
17124116|NCT02920528|38264162|FG002|Overall Study|Adverse Event|3|||
17124117|NCT02920528|38264160|FG000|Overall Study|Did not meet inclusion criteria|2|||
17124118|NCT02920528|38264161|FG001|Overall Study|Did not meet inclusion criteria|0|||
17124119|NCT02920528|38264162|FG002|Overall Study|Did not meet inclusion criteria|1|||
17124120|NCT01068418|38264170|FG000|Overall Study|Physician Decision|12|||
17124121|NCT01068262|38264178|FG000|Overall Study|Adverse Event|2|||
17124122|NCT01068262|38264179|FG001|Overall Study|Adverse Event|0|||
17124123|NCT01068262|38264180|FG002|Overall Study|Adverse Event|1|||
17124124|NCT01068262|38264181|FG003|Overall Study|Adverse Event|0|||
17124125|NCT01068262|38264178|FG000|Overall Study|Protocol Violation|1|||
17124126|NCT01068262|38264179|FG001|Overall Study|Protocol Violation|0|||
17124127|NCT01068262|38264180|FG002|Overall Study|Protocol Violation|0|||
17124128|NCT01068262|38264181|FG003|Overall Study|Protocol Violation|0|||
17124129|NCT01068262|38264178|FG000|Overall Study|Withdrawal by Subject|0|||
17124130|NCT01068262|38264179|FG001|Overall Study|Withdrawal by Subject|1|||
17124131|NCT01068262|38264180|FG002|Overall Study|Withdrawal by Subject|0|||
17124132|NCT01068262|38264181|FG003|Overall Study|Withdrawal by Subject|0|||
17124133|NCT02920450|38264194|FG000|Overall Study|Death|1|||
17124134|NCT02920450|38264195|FG001|Overall Study|Death|0|||
17124135|NCT02920450|38264196|FG002|Overall Study|Death|0|||
17124136|NCT02920450|38264197|FG003|Overall Study|Death|0|||
17124137|NCT02920450|38264194|FG000|Overall Study|Withdrawal by Subject|1|||
17124138|NCT02920450|38264195|FG001|Overall Study|Withdrawal by Subject|0|||
17124139|NCT02920450|38264196|FG002|Overall Study|Withdrawal by Subject|0|||
17124140|NCT02920450|38264197|FG003|Overall Study|Withdrawal by Subject|0|||
17124141|NCT01066936|38264208|FG000|Overall Study|Death|2|||
17124142|NCT01066936|38264208|FG000|Overall Study|Device revised/removed|1|||
17124143|NCT01066936|38264208|FG000|Overall Study|Lost to Follow-up|3|||
17124144|NCT01066936|38264208|FG000|Overall Study|Withdrawal by Subject|4|||
17124145|NCT02919436|38264216|FG000|Overall Study|Did not undergo surgery|16|||
17124146|NCT02919436|38264217|FG001|Overall Study|Did not undergo surgery|20|||
17124147|NCT02919436|38264216|FG000|Overall Study|Enrolled before trial registration|44|||
17124148|NCT02919436|38264217|FG001|Overall Study|Enrolled before trial registration|33|||
17124149|NCT03804879|38264227|FG000|Overall Study|Adverse Event|3|||
17124150|NCT03804879|38264228|FG001|Overall Study|Adverse Event|0|||
17124151|NCT03804879|38264227|FG000|Overall Study|Study Terminated By Sponsor|10|||
17124152|NCT03804879|38264228|FG001|Overall Study|Study Terminated By Sponsor|12|||
17124153|NCT03804879|38264227|FG000|Overall Study|Withdrawal by Subject|3|||
17124154|NCT03804879|38264228|FG001|Overall Study|Withdrawal by Subject|1|||
17124155|NCT03803475|38264235|FG000|Overall Study|Physician Decision|1|||
17124156|NCT00005937|38264239|FG000|Overall Study|Lack of Efficacy|5|||
17124157|NCT03443024|38264247|FG000|Overall Study|Adverse Event|2|||
17124158|NCT03443024|38264248|FG001|Overall Study|Adverse Event|4|||
17124159|NCT03443024|38264249|FG002|Overall Study|Adverse Event|3|||
17124160|NCT03443024|38264250|FG003|Overall Study|Adverse Event|1|||
17124161|NCT03443024|38264247|FG000|Overall Study|Lost to Follow-up|9|||
17124162|NCT03443024|38264248|FG001|Overall Study|Lost to Follow-up|9|||
17124163|NCT03443024|38264249|FG002|Overall Study|Lost to Follow-up|7|||
17124164|NCT03443024|38264250|FG003|Overall Study|Lost to Follow-up|5|||
17124165|NCT03443024|38264247|FG000|Overall Study|Withdrawal by Subject|8|||
17124166|NCT03443024|38264248|FG001|Overall Study|Withdrawal by Subject|15|||
17124167|NCT03443024|38264249|FG002|Overall Study|Withdrawal by Subject|9|||
17124168|NCT03443024|38264250|FG003|Overall Study|Withdrawal by Subject|23|||
17124169|NCT03443024|38264247|FG000|Overall Study|Physician Decision|1|||
17124170|NCT03443024|38264248|FG001|Overall Study|Physician Decision|2|||
17124171|NCT03443024|38264249|FG002|Overall Study|Physician Decision|0|||
17124172|NCT03443024|38264250|FG003|Overall Study|Physician Decision|1|||
17124173|NCT03443024|38264247|FG000|Overall Study|Sponsor Decision|1|||
17124174|NCT03443024|38264248|FG001|Overall Study|Sponsor Decision|1|||
17124175|NCT03443024|38264249|FG002|Overall Study|Sponsor Decision|0|||
17124176|NCT03443024|38264250|FG003|Overall Study|Sponsor Decision|0|||
17124177|NCT03443024|38264247|FG000|Overall Study|Protocol Deviation|0|||
17124178|NCT03443024|38264248|FG001|Overall Study|Protocol Deviation|0|||
17124179|NCT03443024|38264249|FG002|Overall Study|Protocol Deviation|0|||
17124180|NCT03443024|38264250|FG003|Overall Study|Protocol Deviation|2|||
17124181|NCT02908516|38264262|FG000|Overall Study|Study Terminated|3|||
17124182|NCT02908516|38264263|FG001|Overall Study|Study Terminated|3|||
16868113|NCT01553279|37841132|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
17124183|NCT02907892|38264271|FG000|Overall Study|Lost to Follow-up|27|||
17124184|NCT02907892|38264272|FG001|Overall Study|Lost to Follow-up|40|||
17124185|NCT02906644|38264280|FG000|First 2 Weeks|Withdrawal by Subject|0|||
17124186|NCT02906644|38264281|FG001|First 2 Weeks|Withdrawal by Subject|2|||
17124187|NCT02906644|38264280|FG000|First 2 Weeks|Physician Decision|1|||
17124188|NCT02906644|38264281|FG001|First 2 Weeks|Physician Decision|1|||
17124189|NCT02906644|38264280|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
17124190|NCT02906644|38264281|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
17124191|NCT02906644|38264280|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
17124192|NCT02906644|38264281|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
17124193|NCT03410108|38264288|FG000|Overall Study|Ongoing|41|||
17124194|NCT03410108|38264288|FG000|Overall Study|Adverse Event|4|||
17124195|NCT03410108|38264288|FG000|Overall Study|Progressive Disease|58|||
17124196|NCT03410108|38264288|FG000|Overall Study|Withdrawal by Subject|1|||
17124197|NCT02982772|38264297|FG000|Intervention|Lost to Follow-up|19|||
17124198|NCT02982772|38264298|FG001|Intervention|Lost to Follow-up|13|||
17124199|NCT02982772|38264297|FG000|1M Follow-Up|Lost to Follow-up|21|||
17124200|NCT02982772|38264298|FG001|1M Follow-Up|Lost to Follow-up|18|||
17124201|NCT02982772|38264297|FG000|3M Follow-Up|Lost to Follow-up|17|||
17124202|NCT02982772|38264298|FG001|3M Follow-Up|Lost to Follow-up|11|||
17124203|NCT02982772|38264297|FG000|6M Follow-Up|Lost to Follow-up|11|||
17124204|NCT02982772|38264298|FG001|6M Follow-Up|Lost to Follow-up|9|||
17124205|NCT02982772|38264297|FG000|12M Follow-Up|Lost to Follow-up|11|||
17124206|NCT02982772|38264298|FG001|12M Follow-Up|Lost to Follow-up|5|||
17124207|NCT03488108|38264308|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
17124208|NCT03488108|38264309|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
17124209|NCT03488108|38264308|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
17124210|NCT03488108|38264309|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
17124211|NCT03440918|38264319|FG000|Overall Study|Protocol Violation|0|||
17124212|NCT03440918|38264320|FG001|Overall Study|Protocol Violation|16|||
17124213|NCT03486392|38264331|FG000|Overall Study|Lost to Follow-up|0|||
17124214|NCT03486392|38264332|FG001|Overall Study|Lost to Follow-up|0|||
17124215|NCT03486392|38264333|FG002|Overall Study|Lost to Follow-up|8|||
17124216|NCT03486392|38264334|FG003|Overall Study|Lost to Follow-up|5|||
17124217|NCT03486392|38264335|FG004|Overall Study|Lost to Follow-up|2|||
17124218|NCT03486392|38264331|FG000|Overall Study|Withdrawal by Subject|3|||
17124219|NCT03486392|38264332|FG001|Overall Study|Withdrawal by Subject|0|||
17124220|NCT03486392|38264333|FG002|Overall Study|Withdrawal by Subject|6|||
17124221|NCT03486392|38264334|FG003|Overall Study|Withdrawal by Subject|4|||
17124222|NCT03486392|38264335|FG004|Overall Study|Withdrawal by Subject|1|||
17124223|NCT03486392|38264331|FG000|Overall Study|Death|0|||
17124224|NCT03486392|38264332|FG001|Overall Study|Death|0|||
17124225|NCT03486392|38264333|FG002|Overall Study|Death|0|||
17124226|NCT03486392|38264334|FG003|Overall Study|Death|0|||
17124227|NCT03486392|38264335|FG004|Overall Study|Death|1|||
17124228|NCT02981602|38264352|FG000|Overall Study|Adverse Event|0|||
17124229|NCT02981602|38264353|FG001|Overall Study|Adverse Event|0|||
17124230|NCT02981602|38264354|FG002|Overall Study|Adverse Event|0|||
17124231|NCT02981602|38264355|FG003|Overall Study|Adverse Event|1|||
17124232|NCT02981602|38264356|FG004|Overall Study|Adverse Event|0|||
17124233|NCT02981524|38264369|FG000|Overall Study|Progressive Disease|14|||
17124234|NCT02981524|38264369|FG000|Overall Study|Death (unrelated)|1|||
17124235|NCT02981524|38264369|FG000|Overall Study|Treatment Related Toxicity|1|||
17124236|NCT02981524|38264369|FG000|Overall Study|Withdrawal by Subject|1|||
17124237|NCT03486314|38264373|FG000|Part A|Adverse Event|1|||
17124238|NCT03486314|38264374|FG001|Part A|Adverse Event|0|||
17124239|NCT03486314|38264375|FG002|Part A|Adverse Event|0|||
17124240|NCT03486314|38264373|FG000|Part A|Symptomatic Deterioration|2|||
17124241|NCT03486314|38264374|FG001|Part A|Symptomatic Deterioration|0|||
17124242|NCT03486314|38264375|FG002|Part A|Symptomatic Deterioration|0|||
17124243|NCT02905006|38264389|FG000|Overall Study|Adverse Event|1|||
17124244|NCT02905006|38264390|FG001|Overall Study|Adverse Event|1|||
17124245|NCT02905006|38264391|FG002|Overall Study|Adverse Event|1|||
17124246|NCT02905006|38264392|FG003|Overall Study|Adverse Event|1|||
17124247|NCT02905006|38264393|FG004|Overall Study|Adverse Event|0|||
17124248|NCT02905006|38264394|FG005|Overall Study|Adverse Event|1|||
17124249|NCT02905006|38264389|FG000|Overall Study|Lack of Efficacy|1|||
17124250|NCT02905006|38264390|FG001|Overall Study|Lack of Efficacy|0|||
17124251|NCT02905006|38264391|FG002|Overall Study|Lack of Efficacy|0|||
17124252|NCT02905006|38264392|FG003|Overall Study|Lack of Efficacy|0|||
17124253|NCT02905006|38264393|FG004|Overall Study|Lack of Efficacy|0|||
17124254|NCT02905006|38264394|FG005|Overall Study|Lack of Efficacy|0|||
17124255|NCT02905006|38264389|FG000|Overall Study|Protocol Violation|2|||
17124256|NCT02905006|38264390|FG001|Overall Study|Protocol Violation|0|||
17124257|NCT02905006|38264391|FG002|Overall Study|Protocol Violation|0|||
17124258|NCT02905006|38264392|FG003|Overall Study|Protocol Violation|0|||
17124259|NCT02905006|38264393|FG004|Overall Study|Protocol Violation|0|||
17124260|NCT02905006|38264394|FG005|Overall Study|Protocol Violation|0|||
17124261|NCT02905006|38264389|FG000|Overall Study|Lost to Follow-up|0|||
17124262|NCT02905006|38264390|FG001|Overall Study|Lost to Follow-up|0|||
17124263|NCT02905006|38264391|FG002|Overall Study|Lost to Follow-up|0|||
17124264|NCT02905006|38264392|FG003|Overall Study|Lost to Follow-up|1|||
17124265|NCT02905006|38264393|FG004|Overall Study|Lost to Follow-up|1|||
17124266|NCT02905006|38264394|FG005|Overall Study|Lost to Follow-up|0|||
17124267|NCT02905006|38264389|FG000|Overall Study|Withdrawal by Subject|0|||
17124268|NCT02905006|38264390|FG001|Overall Study|Withdrawal by Subject|0|||
17124269|NCT02905006|38264391|FG002|Overall Study|Withdrawal by Subject|1|||
17124270|NCT02905006|38264392|FG003|Overall Study|Withdrawal by Subject|1|||
17124271|NCT02905006|38264393|FG004|Overall Study|Withdrawal by Subject|0|||
17124272|NCT02905006|38264394|FG005|Overall Study|Withdrawal by Subject|1|||
17124273|NCT02905006|38264389|FG000|Overall Study|Screening exclusion criteria met|1|||
17124274|NCT02905006|38264390|FG001|Overall Study|Screening exclusion criteria met|0|||
17124275|NCT02905006|38264391|FG002|Overall Study|Screening exclusion criteria met|0|||
17124276|NCT02905006|38264392|FG003|Overall Study|Screening exclusion criteria met|0|||
17124277|NCT02905006|38264393|FG004|Overall Study|Screening exclusion criteria met|0|||
17124278|NCT02905006|38264394|FG005|Overall Study|Screening exclusion criteria met|0|||
17124279|NCT02905006|38264389|FG000|Overall Study|Lab withdrawal criterion met|0|||
17124280|NCT02905006|38264390|FG001|Overall Study|Lab withdrawal criterion met|1|||
17124281|NCT02905006|38264391|FG002|Overall Study|Lab withdrawal criterion met|2|||
17124282|NCT02905006|38264392|FG003|Overall Study|Lab withdrawal criterion met|2|||
17124283|NCT02905006|38264393|FG004|Overall Study|Lab withdrawal criterion met|2|||
17124284|NCT02905006|38264394|FG005|Overall Study|Lab withdrawal criterion met|1|||
17124285|NCT02905006|38264389|FG000|Overall Study|Positive for Tuberculosis|0|||
17124286|NCT02905006|38264390|FG001|Overall Study|Positive for Tuberculosis|1|||
17124287|NCT02905006|38264391|FG002|Overall Study|Positive for Tuberculosis|0|||
17124288|NCT02905006|38264392|FG003|Overall Study|Positive for Tuberculosis|0|||
17124289|NCT02905006|38264393|FG004|Overall Study|Positive for Tuberculosis|0|||
17124290|NCT02905006|38264394|FG005|Overall Study|Positive for Tuberculosis|0|||
17124291|NCT02905006|38264389|FG000|Overall Study|Subject positive for Hep B|0|||
17124292|NCT02905006|38264390|FG001|Overall Study|Subject positive for Hep B|0|||
17124293|NCT02905006|38264391|FG002|Overall Study|Subject positive for Hep B|1|||
17124294|NCT02905006|38264392|FG003|Overall Study|Subject positive for Hep B|0|||
17124295|NCT02905006|38264393|FG004|Overall Study|Subject positive for Hep B|0|||
17124296|NCT02905006|38264394|FG005|Overall Study|Subject positive for Hep B|0|||
17124297|NCT02905006|38264389|FG000|Overall Study|Patient moved abroad|0|||
17124298|NCT02905006|38264390|FG001|Overall Study|Patient moved abroad|0|||
17124299|NCT02905006|38264391|FG002|Overall Study|Patient moved abroad|0|||
17124300|NCT02905006|38264392|FG003|Overall Study|Patient moved abroad|1|||
17124301|NCT02905006|38264393|FG004|Overall Study|Patient moved abroad|0|||
17124302|NCT02905006|38264394|FG005|Overall Study|Patient moved abroad|0|||
17124303|NCT02905006|38264389|FG000|Overall Study|Patient randomized by mistake|0|||
17124304|NCT02905006|38264390|FG001|Overall Study|Patient randomized by mistake|0|||
17124305|NCT02905006|38264391|FG002|Overall Study|Patient randomized by mistake|0|||
17124306|NCT02905006|38264392|FG003|Overall Study|Patient randomized by mistake|0|||
17124307|NCT02905006|38264393|FG004|Overall Study|Patient randomized by mistake|0|||
17124308|NCT02905006|38264394|FG005|Overall Study|Patient randomized by mistake|1|||
17124309|NCT01066780|38264432|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
17124310|NCT01066780|38264433|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
17124311|NCT02975206|38264440|FG000|Overall Study|Withdrawal by Subject|14|||
17124312|NCT02975206|38264441|FG001|Overall Study|Withdrawal by Subject|11|||
17124313|NCT02975206|38264442|FG002|Overall Study|Withdrawal by Subject|11|||
17124314|NCT02975206|38264440|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
17124315|NCT02975206|38264441|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
17124316|NCT02975206|38264442|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
17124317|NCT01066156|38264450|FG000|Overall Study|ineligible|2|||
17124318|NCT01066156|38264450|FG000|Overall Study|Lost to Follow-up|7|||
17124319|NCT01066156|38264450|FG000|Overall Study|Withdrawal by Subject|1|||
17124320|NCT02980042|38264456|FG000|Overall Study|Lost to Follow-up|5|||
17124321|NCT02980042|38264457|FG001|Overall Study|Lost to Follow-up|0|||
17124322|NCT02980042|38264456|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
17124323|NCT02980042|38264457|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
17124324|NCT01066000|38264475|FG000|Overall Study|Protocol Violation|4|||
17124325|NCT01066000|38264475|FG000|Overall Study|Death|3|||
17124326|NCT01066000|38264475|FG000|Overall Study|Withdrawal by Subject|1|||
17124327|NCT01066000|38264475|FG000|Overall Study|Adverse Event|1|||
17124328|NCT01065844|38264479|FG000|Overall Study|Adverse Event|5|||
17124329|NCT00004635|38264485|FG000|Period One|refused|2|||
17124330|NCT00004635|38264486|FG001|Period One|refused|1|||
17124331|NCT00004635|38264485|FG000|Period One|Withdrawal by Subject|1|||
17124332|NCT00004635|38264486|FG001|Period One|Withdrawal by Subject|1|||
17124333|NCT00004635|38264485|FG000|Period One|Protocol Violation|1|||
17124334|NCT00004635|38264486|FG001|Period One|Protocol Violation|0|||
17124335|NCT00004635|38264485|FG000|Period One|PSA did not go <5 ng/mL|1|||
17124336|NCT00004635|38264486|FG001|Period One|PSA did not go <5 ng/mL|0|||
17124337|NCT00004635|38264485|FG000|Period One|second malignancy|1|||
17124338|NCT00004635|38264486|FG001|Period One|second malignancy|0|||
17124339|NCT00004635|38264485|FG000|Period One|progressed|0|||
17124340|NCT00004635|38264486|FG001|Period One|progressed|2|||
17124341|NCT00004635|38264485|FG000|Period One|health problem|0|||
17124342|NCT00004635|38264486|FG001|Period One|health problem|1|||
17124343|NCT00004635|38264485|FG000|Period One|discrepancy in data entry|0|||
17124344|NCT00004635|38264486|FG001|Period One|discrepancy in data entry|1|||
17124345|NCT00004635|38264485|FG000|Period Two|progression|2|||
17124346|NCT00004635|38264486|FG001|Period Two|progression|3|||
17124347|NCT00004635|38264485|FG000|Period Two|Adverse Event|1|||
17124348|NCT00004635|38264486|FG001|Period Two|Adverse Event|0|||
17124349|NCT00004635|38264485|FG000|Period Two|refused|0|||
17124350|NCT00004635|38264486|FG001|Period Two|refused|2|||
17124351|NCT00004635|38264485|FG000|Period Two|health problem|1|||
17124352|NCT00004635|38264486|FG001|Period Two|health problem|1|||
17124353|NCT00004635|38264485|FG000|Period Two|travel issues|0|||
17124354|NCT00004635|38264486|FG001|Period Two|travel issues|1|||
17124355|NCT00004635|38264485|FG000|Period Two|secondary malignancy|1|||
17124356|NCT00004635|38264486|FG001|Period Two|secondary malignancy|1|||
17124357|NCT00004635|38264485|FG000|Period Two|Lost to Follow-up|1|||
17124358|NCT00004635|38264486|FG001|Period Two|Lost to Follow-up|0|||
17124359|NCT00004635|38264485|FG000|Period Two|discrepancy in data entry|0|||
17124360|NCT00004635|38264486|FG001|Period Two|discrepancy in data entry|1|||
17124361|NCT00004563|38264497|FG000|Overall Study|Withdrawal by Subject|20|||
17124362|NCT00004563|38264498|FG001|Overall Study|Withdrawal by Subject|16|||
17124363|NCT00004563|38264497|FG000|Overall Study|Lack of Efficacy|3|||
17124364|NCT00004563|38264498|FG001|Overall Study|Lack of Efficacy|5|||
17124365|NCT00004563|38264497|FG000|Overall Study|Death|2|||
17124366|NCT00004563|38264498|FG001|Overall Study|Death|3|||
17124367|NCT00003645|38264506|FG000|Overall Study|Death|4|||
17124368|NCT00003645|38264507|FG001|Overall Study|Death|1|||
17124369|NCT00003645|38264506|FG000|Overall Study|Lost to Follow-up|7|||
17124370|NCT00003645|38264507|FG001|Overall Study|Lost to Follow-up|8|||
17124371|NCT00003645|38264506|FG000|Overall Study|Withdrawal by Subject|1|||
17124372|NCT00003645|38264507|FG001|Overall Study|Withdrawal by Subject|3|||
17124373|NCT00003537|38264515|FG000|Overall Study|Not evalauable|1|||
17124374|NCT00003531|38264519|FG000|Overall Study|Not evaluable|10|||
17124375|NCT02918968|38264525|FG000|1st Line AAT|Progressive disease|9|||
17124376|NCT02918968|38264526|FG001|1st Line AAT|Progressive disease|4|||
17124377|NCT02918968|38264525|FG000|1st Line AAT|Adverse Event|12|||
17124378|NCT02918968|38264526|FG001|1st Line AAT|Adverse Event|3|||
17124379|NCT02918968|38264525|FG000|1st Line AAT|Physician Decision|4|||
17124380|NCT02918968|38264526|FG001|1st Line AAT|Physician Decision|2|||
17124381|NCT02918968|38264525|FG000|1st Line AAT|Withdrawal by Subject|2|||
17124382|NCT02918968|38264526|FG001|1st Line AAT|Withdrawal by Subject|1|||
17124383|NCT02918968|38264525|FG000|1st Line AAT|Lost to Follow-up|0|||
17124384|NCT02918968|38264526|FG001|1st Line AAT|Lost to Follow-up|1|||
17124385|NCT02918968|38264525|FG000|1st Line AAT|Death|1|||
17124386|NCT02918968|38264526|FG001|1st Line AAT|Death|0|||
17124387|NCT02918968|38264525|FG000|1st Line AAT|Miscellaneous|1|||
17124388|NCT02918968|38264526|FG001|1st Line AAT|Miscellaneous|0|||
17124389|NCT02918968|38264525|FG000|2nd Line AAT|Progressive disease|21|||
17124390|NCT02918968|38264526|FG001|2nd Line AAT|Progressive disease|3|||
17124391|NCT02918968|38264525|FG000|2nd Line AAT|Adverse Event|2|||
17124392|NCT02918968|38264526|FG001|2nd Line AAT|Adverse Event|5|||
17124393|NCT02918968|38264525|FG000|2nd Line AAT|Physician Decision|0|||
17124394|NCT02918968|38264526|FG001|2nd Line AAT|Physician Decision|1|||
17124395|NCT02918968|38264525|FG000|2nd Line AAT|Withdrawal by Subject|2|||
17124396|NCT02918968|38264526|FG001|2nd Line AAT|Withdrawal by Subject|2|||
17124397|NCT02918968|38264525|FG000|2nd Line AAT|Death|0|||
17124398|NCT02918968|38264526|FG001|2nd Line AAT|Death|1|||
17124399|NCT01065766|38264534|FG000|Overall Study|Assessed before the contracted date|1|||
17124400|NCT01065766|38264534|FG000|Overall Study|Contraindication to administration|6|||
17124401|NCT01065766|38264534|FG000|Overall Study|Violated dosage/administration|25|||
17124402|NCT01063972|38264540|FG000|Overall Study|Death|12|||
17124403|NCT01063972|38264541|FG001|Overall Study|Death|11|||
17124404|NCT01063972|38264540|FG000|Overall Study|Incarcerated|2|||
17124405|NCT01063972|38264541|FG001|Overall Study|Incarcerated|1|||
17124406|NCT00042939|38264549|FG000|Overall Study|Adverse Event|6|||
17124407|NCT00042939|38264550|FG001|Overall Study|Adverse Event|7|||
17124408|NCT00042939|38264549|FG000|Overall Study|Death|3|||
17124409|NCT00042939|38264550|FG001|Overall Study|Death|2|||
17124410|NCT00042939|38264549|FG000|Overall Study|Withdrawal by Subject|3|||
17124411|NCT00042939|38264550|FG001|Overall Study|Withdrawal by Subject|4|||
17124412|NCT00042939|38264549|FG000|Overall Study|Other disease|1|||
17124413|NCT00042939|38264550|FG001|Overall Study|Other disease|0|||
17124414|NCT00042939|38264549|FG000|Overall Study|Ineligible|2|||
17124415|NCT00042939|38264550|FG001|Overall Study|Ineligible|2|||
17124416|NCT00042939|38264549|FG000|Overall Study|Deterioration of health|3|||
17124417|NCT00042939|38264550|FG001|Overall Study|Deterioration of health|4|||
17124418|NCT00042939|38264549|FG000|Overall Study|QOL diminished|1|||
17124419|NCT00042939|38264550|FG001|Overall Study|QOL diminished|0|||
17124420|NCT00042939|38264549|FG000|Overall Study|Rising ca 19-9|1|||
17124421|NCT00042939|38264550|FG001|Overall Study|Rising ca 19-9|0|||
17124422|NCT00042939|38264549|FG000|Overall Study|Patient non-compliance|1|||
17124423|NCT00042939|38264550|FG001|Overall Study|Patient non-compliance|0|||
17124424|NCT00042939|38264549|FG000|Overall Study|Still on treatment|1|||
17124425|NCT00042939|38264550|FG001|Overall Study|Still on treatment|0|||
17124426|NCT00042939|38264549|FG000|Overall Study|Treatment break > 4 weeks|0|||
17124427|NCT00042939|38264550|FG001|Overall Study|Treatment break > 4 weeks|1|||
17124428|NCT00042939|38264549|FG000|Overall Study|Did not start treatment|2|||
17124429|NCT00042939|38264550|FG001|Overall Study|Did not start treatment|1|||
17124430|NCT00003483|38264556|FG000|Overall Study|Not evaluable|1|||
17124431|NCT00003477|38264560|FG000|Overall Study|Not evalauable|4|||
17124432|NCT00003471|38264564|FG000|Overall Study|Not evaluable|4|||
17124433|NCT04185220|38264570|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
17124434|NCT04185220|38264571|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
17124435|NCT04185220|38264570|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
17124436|NCT04185220|38264571|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
17124437|NCT00002931|38264578|FG000|Overall Study|rapidly progressing disease during|2|||
17124438|NCT02918266|38264593|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
17124439|NCT02918266|38264594|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
17124440|NCT02918266|38264595|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
17124441|NCT02918266|38264596|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
17124442|NCT02918266|38264597|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
17124443|NCT02918266|38264598|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
17124444|NCT02918266|38264599|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
17124445|NCT02918266|38264600|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
17124446|NCT02918266|38264601|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
17124447|NCT02918266|38264602|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
17124448|NCT02918266|38264603|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
17124449|NCT00041067|38264623|FG000|Overall Study|Adverse Event|20|||
17124450|NCT00041067|38264623|FG000|Overall Study|Progression|19|||
17124451|NCT00041067|38264623|FG000|Overall Study|Patient refusal|12|||
17124452|NCT00041067|38264623|FG000|Overall Study|Other reasons|23|||
17124453|NCT00041067|38264623|FG000|Overall Study|Ineligible|2|||
17124454|NCT01063036|38264628|FG000|Participants Treated With Study Drug|Adverse Event|1|||
17124455|NCT01063036|38264628|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
17124456|NCT01063036|38264628|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
17124457|NCT01063036|38264628|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
17124458|NCT01063036|38264628|FG000|Participants Treated With Study Drug|Pregnancy|1|||
17124459|NCT01063036|38264628|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
17124460|NCT01063036|38264628|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
17124461|NCT01063036|38264628|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
17124462|NCT00040365|38264632|FG000|Overall Study|Death|1|||
17124463|NCT00040365|38264632|FG000|Overall Study|Progressive disease|7|||
17124464|NCT00040365|38264632|FG000|Overall Study|Lost to Follow-up|3|||
17124465|NCT02974114|38264639|FG000|Overall Study|Other (Not specified)|0|||
17124466|NCT02974114|38264640|FG001|Overall Study|Other (Not specified)|1|||
17124467|NCT02974114|38264641|FG002|Overall Study|Other (Not specified)|2|||
17124468|NCT00001959|38264651|FG000|Overall Study|newly diagnosed colon cancer|1|||
17124469|NCT00001959|38264651|FG000|Overall Study|disabling sedation|1|||
17124470|NCT00001959|38264651|FG000|Overall Study|non-compliance|1|||
17124471|NCT00001941|38264655|FG000|Overall Study|not treated- rapidly progressing disease|0|||
17124472|NCT00001941|38264656|FG001|Overall Study|not treated- rapidly progressing disease|0|||
17124473|NCT00001941|38264657|FG002|Overall Study|not treated- rapidly progressing disease|0|||
17124474|NCT00001941|38264658|FG003|Overall Study|not treated- rapidly progressing disease|0|||
17124475|NCT00001941|38264659|FG004|Overall Study|not treated- rapidly progressing disease|1|||
17124476|NCT02978326|38264667|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
17124477|NCT02978326|38264668|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
17124478|NCT02978326|38264669|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
17124479|NCT02978326|38264667|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
17124480|NCT02978326|38264668|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
17124481|NCT02978326|38264669|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
17124482|NCT02978326|38264667|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
17124483|NCT02978326|38264668|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
17124484|NCT02978326|38264669|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
17124485|NCT02978326|38264667|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
17124486|NCT02978326|38264668|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
17124487|NCT02978326|38264669|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
17124488|NCT01061866|38264679|FG000|Overall Study|Adverse Event|2|||
17124489|NCT01061008|38264685|FG000|Overall Study|Badiocephalic fistula failed|3|||
17124490|NCT01061008|38264686|FG001|Overall Study|Badiocephalic fistula failed|2|||
17124491|NCT01061008|38264685|FG000|Overall Study|Death|1|||
17124492|NCT01061008|38264686|FG001|Overall Study|Death|0|||
17124493|NCT01061008|38264685|FG000|Overall Study|Withdrawal by Subject|1|||
17124494|NCT01061008|38264686|FG001|Overall Study|Withdrawal by Subject|3|||
17124495|NCT01061008|38264685|FG000|Overall Study|Unable to exercise following surgery|1|||
17124496|NCT01061008|38264686|FG001|Overall Study|Unable to exercise following surgery|0|||
17124497|NCT01061008|38264685|FG000|Overall Study|Adverse Event|0|||
17124498|NCT01061008|38264686|FG001|Overall Study|Adverse Event|1|||
17124499|NCT00039741|38264696|FG000|Overall Study|Death|0|||
17124500|NCT00039741|38264697|FG001|Overall Study|Death|1|||
17124501|NCT00039741|38264698|FG002|Overall Study|Death|0|||
17124502|NCT00039741|38264699|FG003|Overall Study|Death|0|||
17124503|NCT00039741|38264696|FG000|Overall Study|Lost to Follow-up|3|||
17124504|NCT00039741|38264697|FG001|Overall Study|Lost to Follow-up|1|||
17124505|NCT00039741|38264698|FG002|Overall Study|Lost to Follow-up|5|||
17124506|NCT00039741|38264699|FG003|Overall Study|Lost to Follow-up|2|||
17124507|NCT00039741|38264696|FG000|Overall Study|Confounding medical condition|1|||
17124508|NCT00039741|38264697|FG001|Overall Study|Confounding medical condition|0|||
17124509|NCT00039741|38264698|FG002|Overall Study|Confounding medical condition|0|||
17124510|NCT00039741|38264699|FG003|Overall Study|Confounding medical condition|0|||
17124511|NCT00039741|38264696|FG000|Overall Study|Not able to get to clinic|5|||
17124512|NCT00039741|38264697|FG001|Overall Study|Not able to get to clinic|2|||
17124513|NCT00039741|38264698|FG002|Overall Study|Not able to get to clinic|0|||
17124514|NCT00039741|38264699|FG003|Overall Study|Not able to get to clinic|3|||
17124515|NCT00039741|38264696|FG000|Overall Study|Moved|3|||
17124516|NCT00039741|38264697|FG001|Overall Study|Moved|2|||
17124517|NCT00039741|38264698|FG002|Overall Study|Moved|3|||
17124518|NCT00039741|38264699|FG003|Overall Study|Moved|6|||
17124519|NCT00039741|38264696|FG000|Overall Study|Non-compliance with protocol|1|||
17124520|NCT00039741|38264697|FG001|Overall Study|Non-compliance with protocol|0|||
17124521|NCT00039741|38264698|FG002|Overall Study|Non-compliance with protocol|1|||
17124522|NCT00039741|38264699|FG003|Overall Study|Non-compliance with protocol|0|||
17124523|NCT00039741|38264696|FG000|Overall Study|Withdrew consent|0|||
17124524|NCT00039741|38264697|FG001|Overall Study|Withdrew consent|5|||
17124525|NCT00039741|38264698|FG002|Overall Study|Withdrew consent|0|||
17124526|NCT00039741|38264699|FG003|Overall Study|Withdrew consent|1|||
17124527|NCT00039741|38264696|FG000|Overall Study|Missed final visit|2|||
17124528|NCT00039741|38264697|FG001|Overall Study|Missed final visit|1|||
17124529|NCT00039741|38264698|FG002|Overall Study|Missed final visit|2|||
17124530|NCT00039741|38264699|FG003|Overall Study|Missed final visit|2|||
17124531|NCT02973802|38264709|FG000|Overall Study|Lost to Follow-up|1|||
17124532|NCT02973802|38264709|FG000|Overall Study|Withdrawal by Subject|1|||
17124533|NCT02973100|38264718|FG000|Overall Study|Adverse Event|1|||
17124534|NCT02973100|38264719|FG001|Overall Study|Adverse Event|2|||
17124535|NCT02973100|38264720|FG002|Overall Study|Adverse Event|1|||
17124536|NCT02973100|38264721|FG003|Overall Study|Adverse Event|2|||
17124537|NCT02973100|38264718|FG000|Overall Study|Lost to Follow-up|3|||
17124538|NCT02973100|38264719|FG001|Overall Study|Lost to Follow-up|1|||
17124539|NCT02973100|38264720|FG002|Overall Study|Lost to Follow-up|1|||
17124540|NCT02973100|38264721|FG003|Overall Study|Lost to Follow-up|0|||
17124541|NCT02973100|38264718|FG000|Overall Study|Withdrawal by Subject|3|||
17124542|NCT02973100|38264719|FG001|Overall Study|Withdrawal by Subject|5|||
17124543|NCT02973100|38264720|FG002|Overall Study|Withdrawal by Subject|1|||
17124544|NCT02973100|38264721|FG003|Overall Study|Withdrawal by Subject|4|||
17124545|NCT02973100|38264718|FG000|Overall Study|Notification of change in address|0|||
17124546|NCT02973100|38264719|FG001|Overall Study|Notification of change in address|0|||
17124547|NCT02973100|38264720|FG002|Overall Study|Notification of change in address|0|||
17124548|NCT02973100|38264721|FG003|Overall Study|Notification of change in address|1|||
17124549|NCT02973100|38264718|FG000|Overall Study|Failed to attend Safety followup period|0|||
17124550|NCT02973100|38264719|FG001|Overall Study|Failed to attend Safety followup period|0|||
17124551|NCT02973100|38264720|FG002|Overall Study|Failed to attend Safety followup period|1|||
17124552|NCT02973100|38264721|FG003|Overall Study|Failed to attend Safety followup period|0|||
17124553|NCT01060540|38264736|FG000|Overall Study|Withdrawal by Subject|10|||
17124554|NCT01060540|38264737|FG001|Overall Study|Withdrawal by Subject|20|||
17124555|NCT01060540|38264736|FG000|Overall Study|Lost to Follow-up|52|||
17124556|NCT01060540|38264737|FG001|Overall Study|Lost to Follow-up|43|||
17124557|NCT01060540|38264736|FG000|Overall Study|Death|2|||
17124558|NCT01060540|38264737|FG001|Overall Study|Death|1|||
17124559|NCT01060540|38264736|FG000|Overall Study|Physician Decision|0|||
17124560|NCT01060540|38264737|FG001|Overall Study|Physician Decision|1|||
17124561|NCT02972632|38264762|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
17124562|NCT02972632|38264762|FG000|Overall Study|Lost to Follow-up|4|||
17124563|NCT02972632|38264762|FG000|Overall Study|Voluntary Withdrawal|10|||
17124564|NCT01060384|38264766|FG000|Overall Study|Withdrawal by Subject|0|||
17124565|NCT01060384|38264767|FG001|Overall Study|Withdrawal by Subject|1|||
17124566|NCT01060384|38264768|FG002|Overall Study|Withdrawal by Subject|0|||
17124567|NCT01060384|38264769|FG003|Overall Study|Withdrawal by Subject|0|||
17124568|NCT01060384|38264770|FG004|Overall Study|Withdrawal by Subject|0|||
17124569|NCT01060384|38264766|FG000|Overall Study|Death|0|||
17124570|NCT01060384|38264767|FG001|Overall Study|Death|0|||
17124571|NCT01060384|38264768|FG002|Overall Study|Death|0|||
17124572|NCT01060384|38264769|FG003|Overall Study|Death|0|||
17124573|NCT01060384|38264770|FG004|Overall Study|Death|1|||
17124574|NCT01060384|38264766|FG000|Overall Study|Intercurrent illness|0|||
17124575|NCT01060384|38264767|FG001|Overall Study|Intercurrent illness|0|||
17124576|NCT01060384|38264768|FG002|Overall Study|Intercurrent illness|0|||
17124577|NCT01060384|38264769|FG003|Overall Study|Intercurrent illness|0|||
17124578|NCT01060384|38264770|FG004|Overall Study|Intercurrent illness|1|||
17124579|NCT01060150|38264779|FG000|Overall Study|Adverse Event|6|||
17124580|NCT01060150|38264779|FG000|Overall Study|Lost to Follow-up|1|||
17124581|NCT01060150|38264779|FG000|Overall Study|Protocol Violation|6|||
17124582|NCT01060150|38264779|FG000|Overall Study|Withdrawal by Subject|8|||
17124583|NCT01060150|38264779|FG000|Overall Study|Enrolled, but not treated|2|||
17124584|NCT02972242|38264785|FG000|Overall Study|Withdrawal by Subject|1|||
17124585|NCT02972242|38264786|FG001|Overall Study|Withdrawal by Subject|0|||
17124586|NCT02970292|38264794|FG000|Overall Study|Physician Decision|1|||
17124587|NCT02970292|38264795|FG001|Overall Study|Physician Decision|1|||
17124588|NCT02970292|38264794|FG000|Overall Study|Withdrawal by Subject|11|||
17124589|NCT02970292|38264795|FG001|Overall Study|Withdrawal by Subject|5|||
17124590|NCT02970292|38264794|FG000|Overall Study|Noncompliance with study drug|2|||
17124591|NCT02970292|38264795|FG001|Overall Study|Noncompliance with study drug|2|||
17124592|NCT02970292|38264794|FG000|Overall Study|Adverse Event|5|||
17124593|NCT02970292|38264795|FG001|Overall Study|Adverse Event|0|||
17124594|NCT02970292|38264794|FG000|Overall Study|Lack of Efficacy|1|||
17124595|NCT02970292|38264795|FG001|Overall Study|Lack of Efficacy|0|||
17124596|NCT02970292|38264794|FG000|Overall Study|Lost to Follow-up|1|||
17124597|NCT02970292|38264795|FG001|Overall Study|Lost to Follow-up|0|||
17124598|NCT02970292|38264794|FG000|Overall Study|Protocol Violation|2|||
17124599|NCT02970292|38264795|FG001|Overall Study|Protocol Violation|0|||
17124600|NCT02970292|38264794|FG000|Overall Study|Other|1|||
17124601|NCT02970292|38264795|FG001|Overall Study|Other|0|||
17124602|NCT02971228|38264801|FG000|Overall Study|Withdrawal by Subject|1|||
17124603|NCT02971228|38264802|FG001|Overall Study|Withdrawal by Subject|1|||
17124604|NCT02971228|38264803|FG002|Overall Study|Withdrawal by Subject|0|||
17124605|NCT02971228|38264804|FG003|Overall Study|Withdrawal by Subject|0|||
17124606|NCT02971228|38264805|FG004|Overall Study|Withdrawal by Subject|0|||
17124607|NCT02971228|38264801|FG000|Overall Study|Logistical challenges|0|||
17124608|NCT02971228|38264802|FG001|Overall Study|Logistical challenges|1|||
17124609|NCT02971228|38264803|FG002|Overall Study|Logistical challenges|0|||
17124610|NCT02971228|38264804|FG003|Overall Study|Logistical challenges|0|||
17124611|NCT02971228|38264805|FG004|Overall Study|Logistical challenges|0|||
17124612|NCT01060072|38264818|FG000|Overall Study|Adverse Event|1|||
17124613|NCT01060072|38264819|FG001|Overall Study|Adverse Event|1|||
17124614|NCT01060072|38264818|FG000|Overall Study|Physician Decision|0|||
17124615|NCT01060072|38264819|FG001|Overall Study|Physician Decision|2|||
17124616|NCT01060072|38264818|FG000|Overall Study|Protocol Violation|0|||
17124617|NCT01060072|38264819|FG001|Overall Study|Protocol Violation|1|||
17124618|NCT01060072|38264818|FG000|Overall Study|Acute cholecystitis|1|||
17124619|NCT01060072|38264819|FG001|Overall Study|Acute cholecystitis|0|||
17124620|NCT01060072|38264818|FG000|Overall Study|Excluded Medications|0|||
17124621|NCT01060072|38264819|FG001|Overall Study|Excluded Medications|1|||
17124622|NCT02969590|38264827|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
17124623|NCT02969590|38264828|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
17124624|NCT02969590|38264829|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
17124625|NCT03345849|38264841|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
17124626|NCT03345849|38264842|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
17124627|NCT03345849|38264843|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
17124628|NCT03345849|38264844|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
17124629|NCT03345849|38264841|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
17124630|NCT03345849|38264842|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
17124631|NCT03345849|38264843|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
17124632|NCT03345849|38264844|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
17124633|NCT03345849|38264841|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
17124634|NCT03345849|38264842|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
17124635|NCT03345849|38264843|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
17124636|NCT03345849|38264844|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
17124637|NCT03345849|38264841|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
17124638|NCT03345849|38264842|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
17124639|NCT03345849|38264843|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
17124640|NCT03345849|38264844|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
17124641|NCT03345849|38264841|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
17124642|NCT03345849|38264842|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
16942099|NCT01371747|38086666|FG002|Overall Study|Death|4|||
17124643|NCT03345849|38264843|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
17124644|NCT03345849|38264844|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
17124645|NCT03345849|38264841|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
17124646|NCT03345849|38264842|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
17124647|NCT03345849|38264843|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
17124648|NCT03345849|38264844|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
17124649|NCT03345849|38264841|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
17124650|NCT03345849|38264842|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
17124651|NCT03345849|38264843|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
17124652|NCT03345849|38264844|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
17124653|NCT03345849|38264841|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
17124654|NCT03345849|38264842|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
17124655|NCT03345849|38264843|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
17124656|NCT03345849|38264844|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
17124657|NCT03345849|38264841|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
17124658|NCT03345849|38264842|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
17124659|NCT03345849|38264843|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
17124660|NCT03345849|38264844|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
17124661|NCT03345849|38264841|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
17124662|NCT03345849|38264842|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
17124663|NCT03345849|38264843|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
17124664|NCT03345849|38264844|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
17124665|NCT03345849|38264841|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
17124666|NCT03345849|38264842|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
17124667|NCT03345849|38264843|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
17124668|NCT03345849|38264844|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
17124669|NCT03011307|38264854|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
17124670|NCT03011307|38264855|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
17124671|NCT03011307|38264854|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
17124672|NCT03011307|38264855|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
17124673|NCT03011307|38264854|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
17124674|NCT03011307|38264855|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
17124675|NCT03798717|38264867|FG000|Overall Study|Failed Screening|0|||
17124676|NCT03798717|38264868|FG001|Overall Study|Failed Screening|0|||
17124677|NCT03798717|38264869|FG002|Overall Study|Failed Screening|0|||
17124678|NCT03798717|38264870|FG003|Overall Study|Failed Screening|0|||
17124679|NCT03798717|38264871|FG004|Overall Study|Failed Screening|0|||
17124680|NCT03798717|38264872|FG005|Overall Study|Failed Screening|1|||
17124681|NCT03798717|38264867|FG000|Overall Study|Physician Decision|1|||
17124682|NCT03798717|38264868|FG001|Overall Study|Physician Decision|0|||
17124683|NCT03798717|38264869|FG002|Overall Study|Physician Decision|1|||
17124684|NCT03798717|38264870|FG003|Overall Study|Physician Decision|0|||
17124685|NCT03798717|38264871|FG004|Overall Study|Physician Decision|0|||
17124686|NCT03798717|38264872|FG005|Overall Study|Physician Decision|0|||
17124687|NCT03798717|38264867|FG000|Overall Study|Withdrawal by Subject|0|||
17124688|NCT03798717|38264868|FG001|Overall Study|Withdrawal by Subject|0|||
17124689|NCT03798717|38264869|FG002|Overall Study|Withdrawal by Subject|0|||
17124690|NCT03798717|38264870|FG003|Overall Study|Withdrawal by Subject|1|||
17124691|NCT03798717|38264871|FG004|Overall Study|Withdrawal by Subject|0|||
17124692|NCT03798717|38264872|FG005|Overall Study|Withdrawal by Subject|0|||
17124693|NCT03798717|38264867|FG000|Overall Study|Lost to Follow-up|1|||
17124694|NCT03798717|38264868|FG001|Overall Study|Lost to Follow-up|0|||
17124695|NCT03798717|38264869|FG002|Overall Study|Lost to Follow-up|0|||
17124696|NCT03798717|38264870|FG003|Overall Study|Lost to Follow-up|1|||
17124697|NCT03798717|38264871|FG004|Overall Study|Lost to Follow-up|0|||
17124698|NCT03798717|38264872|FG005|Overall Study|Lost to Follow-up|0|||
17124699|NCT03798717|38264867|FG000|Overall Study|Adverse Event|0|||
17124700|NCT03798717|38264868|FG001|Overall Study|Adverse Event|1|||
17124701|NCT03798717|38264869|FG002|Overall Study|Adverse Event|0|||
17124702|NCT03798717|38264870|FG003|Overall Study|Adverse Event|0|||
17124703|NCT03798717|38264871|FG004|Overall Study|Adverse Event|0|||
17124704|NCT03798717|38264872|FG005|Overall Study|Adverse Event|0|||
17124705|NCT03798717|38264867|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
17124706|NCT03798717|38264868|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
17124707|NCT03798717|38264869|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
17124708|NCT03798717|38264870|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
17124709|NCT03798717|38264871|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
17124710|NCT03798717|38264872|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
17124711|NCT03798483|38264881|FG000|Overall Study|Lost to Follow-up|2|||
17124712|NCT03792477|38264894|FG000|Overall Study|Adverse Event|0|||
17124713|NCT03792477|38264895|FG001|Overall Study|Adverse Event|0|||
17124714|NCT03792477|38264896|FG002|Overall Study|Adverse Event|0|||
17124715|NCT03792477|38264897|FG003|Overall Study|Adverse Event|1|||
17124716|NCT03792477|38264898|FG004|Overall Study|Adverse Event|0|||
17124717|NCT03792477|38264894|FG000|Overall Study|Lost to Follow-up|0|||
17124718|NCT03792477|38264895|FG001|Overall Study|Lost to Follow-up|0|||
17124719|NCT03792477|38264896|FG002|Overall Study|Lost to Follow-up|2|||
17124720|NCT03792477|38264897|FG003|Overall Study|Lost to Follow-up|0|||
17124721|NCT03792477|38264898|FG004|Overall Study|Lost to Follow-up|0|||
17124722|NCT03792477|38264894|FG000|Overall Study|Other|0|||
17124723|NCT03792477|38264895|FG001|Overall Study|Other|0|||
17124724|NCT03792477|38264896|FG002|Overall Study|Other|0|||
17124725|NCT03792477|38264897|FG003|Overall Study|Other|0|||
17124726|NCT03792477|38264898|FG004|Overall Study|Other|1|||
17124727|NCT03790917|38264904|FG000|Overall Study|Death|1|||
17124728|NCT03788967|38264911|FG000|Overall Study|Lost to Follow-up|14|||
17124729|NCT03788967|38264912|FG001|Overall Study|Lost to Follow-up|10|||
17124730|NCT03788967|38264911|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
17124731|NCT03788967|38264912|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
17124732|NCT03788967|38264911|FG000|Overall Study|Participant Withdrawal of Consent|13|||
17124733|NCT03788967|38264912|FG001|Overall Study|Participant Withdrawal of Consent|5|||
17124734|NCT03788967|38264911|FG000|Overall Study|Adverse Event|1|||
17124735|NCT03788967|38264912|FG001|Overall Study|Adverse Event|1|||
17124736|NCT03788967|38264911|FG000|Overall Study|COVID-19|1|||
17124737|NCT03788967|38264912|FG001|Overall Study|COVID-19|2|||
17124738|NCT03782571|38264920|FG000|Period 1|Withdrawal by Subject|1|||
17124739|NCT03782571|38264921|FG001|Period 1|Withdrawal by Subject|0|||
17124740|NCT03782571|38264922|FG002|Period 1|Withdrawal by Subject|0|||
17124741|NCT03782571|38264923|FG003|Period 1|Withdrawal by Subject|0|||
17124742|NCT03782571|38264920|FG000|Period 3|Subject Unable to Attend V5|1|||
17124743|NCT03782571|38264921|FG001|Period 3|Subject Unable to Attend V5|0|||
17124744|NCT03782571|38264922|FG002|Period 3|Subject Unable to Attend V5|0|||
17124745|NCT03782571|38264923|FG003|Period 3|Subject Unable to Attend V5|0|||
17124746|NCT03782571|38264920|FG000|Period 3|Adverse Event|1|||
17124747|NCT03782571|38264921|FG001|Period 3|Adverse Event|0|||
17124748|NCT03782571|38264922|FG002|Period 3|Adverse Event|0|||
17124749|NCT03782571|38264923|FG003|Period 3|Adverse Event|0|||
17124750|NCT03783039|38264937|FG000|Overall Study|Death|2|||
17124751|NCT03783039|38264938|FG001|Overall Study|Death|1|||
17124752|NCT03776175|38264948|FG000|Treatment Period (42 Days)|Adverse Event|0|||
17124753|NCT03776175|38264949|FG001|Treatment Period (42 Days)|Adverse Event|1|||
17124754|NCT03776175|38264950|FG002|Treatment Period (42 Days)|Adverse Event|1|||
17124755|NCT03776175|38264951|FG003|Treatment Period (42 Days)|Adverse Event|0|||
17124756|NCT03776175|38264948|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
17124757|NCT03776175|38264949|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
17124758|NCT03776175|38264950|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
17124759|NCT03776175|38264951|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
17124760|NCT03776175|38264948|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
17124761|NCT03776175|38264949|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
17124762|NCT03776175|38264950|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
17124763|NCT03776175|38264951|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
17124764|NCT03776175|38264948|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
17124765|NCT03776175|38264949|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
17124766|NCT03776175|38264950|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
17124767|NCT03776175|38264951|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
17124768|NCT03776175|38264948|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
17124769|NCT03776175|38264949|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
17124770|NCT03776175|38264950|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
16942100|NCT01371747|38086667|FG003|Overall Study|Death|1|||
17124771|NCT03776175|38264951|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
17124772|NCT03776175|38264948|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
17124773|NCT03776175|38264949|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
17124774|NCT03776175|38264950|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
17124775|NCT03776175|38264951|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
17124776|NCT02903914|38264969|FG000|Overall Study|Adverse Event|0|||
17124777|NCT02903914|38264970|FG001|Overall Study|Adverse Event|0|||
17124778|NCT02903914|38264971|FG002|Overall Study|Adverse Event|1|||
17124779|NCT02903914|38264972|FG003|Overall Study|Adverse Event|0|||
17124780|NCT02903914|38264973|FG004|Overall Study|Adverse Event|0|||
17124781|NCT02903914|38264974|FG005|Overall Study|Adverse Event|1|||
17124782|NCT02903914|38264975|FG006|Overall Study|Adverse Event|2|||
17124783|NCT02903914|38264976|FG007|Overall Study|Adverse Event|1|||
17124784|NCT02903914|38264969|FG000|Overall Study|Withdrawal by Subject|3|||
17124785|NCT02903914|38264970|FG001|Overall Study|Withdrawal by Subject|1|||
17124786|NCT02903914|38264971|FG002|Overall Study|Withdrawal by Subject|28|||
17124787|NCT02903914|38264972|FG003|Overall Study|Withdrawal by Subject|0|||
17124788|NCT02903914|38264973|FG004|Overall Study|Withdrawal by Subject|1|||
17124789|NCT02903914|38264974|FG005|Overall Study|Withdrawal by Subject|1|||
17124790|NCT02903914|38264975|FG006|Overall Study|Withdrawal by Subject|12|||
17124791|NCT02903914|38264976|FG007|Overall Study|Withdrawal by Subject|0|||
17124792|NCT02903914|38264969|FG000|Overall Study|Progressive Disease|1|||
17124793|NCT02903914|38264970|FG001|Overall Study|Progressive Disease|0|||
17124794|NCT02903914|38264971|FG002|Overall Study|Progressive Disease|4|||
17124795|NCT02903914|38264972|FG003|Overall Study|Progressive Disease|0|||
17124796|NCT02903914|38264973|FG004|Overall Study|Progressive Disease|0|||
17124797|NCT02903914|38264974|FG005|Overall Study|Progressive Disease|0|||
17124798|NCT02903914|38264975|FG006|Overall Study|Progressive Disease|2|||
17124799|NCT02903914|38264976|FG007|Overall Study|Progressive Disease|4|||
17124800|NCT02903914|38264969|FG000|Overall Study|Death|0|||
17124801|NCT02903914|38264970|FG001|Overall Study|Death|0|||
17124802|NCT02903914|38264971|FG002|Overall Study|Death|9|||
17124803|NCT02903914|38264972|FG003|Overall Study|Death|0|||
17124804|NCT02903914|38264973|FG004|Overall Study|Death|1|||
17124805|NCT02903914|38264974|FG005|Overall Study|Death|3|||
17124806|NCT02903914|38264975|FG006|Overall Study|Death|24|||
17124807|NCT02903914|38264976|FG007|Overall Study|Death|0|||
17124808|NCT02903914|38264969|FG000|Overall Study|Lost to Follow-up|0|||
17124809|NCT02903914|38264970|FG001|Overall Study|Lost to Follow-up|1|||
17124810|NCT02903914|38264971|FG002|Overall Study|Lost to Follow-up|0|||
17124811|NCT02903914|38264972|FG003|Overall Study|Lost to Follow-up|0|||
17124812|NCT02903914|38264973|FG004|Overall Study|Lost to Follow-up|2|||
17124813|NCT02903914|38264974|FG005|Overall Study|Lost to Follow-up|0|||
17124814|NCT02903914|38264975|FG006|Overall Study|Lost to Follow-up|1|||
17124815|NCT02903914|38264976|FG007|Overall Study|Lost to Follow-up|0|||
17124816|NCT02903914|38264969|FG000|Overall Study|Physician Decision|0|||
17124817|NCT02903914|38264970|FG001|Overall Study|Physician Decision|0|||
17124818|NCT02903914|38264971|FG002|Overall Study|Physician Decision|1|||
17124819|NCT02903914|38264972|FG003|Overall Study|Physician Decision|0|||
17124820|NCT02903914|38264973|FG004|Overall Study|Physician Decision|0|||
17124821|NCT02903914|38264974|FG005|Overall Study|Physician Decision|0|||
17124822|NCT02903914|38264975|FG006|Overall Study|Physician Decision|1|||
17124823|NCT02903914|38264976|FG007|Overall Study|Physician Decision|0|||
17124824|NCT02903914|38264969|FG000|Overall Study|Symptomatic Deterioration|0|||
17124825|NCT02903914|38264970|FG001|Overall Study|Symptomatic Deterioration|0|||
17124826|NCT02903914|38264971|FG002|Overall Study|Symptomatic Deterioration|1|||
17124827|NCT02903914|38264972|FG003|Overall Study|Symptomatic Deterioration|0|||
17124828|NCT02903914|38264973|FG004|Overall Study|Symptomatic Deterioration|0|||
17124829|NCT02903914|38264974|FG005|Overall Study|Symptomatic Deterioration|0|||
17124830|NCT02903914|38264975|FG006|Overall Study|Symptomatic Deterioration|0|||
17124831|NCT02903914|38264976|FG007|Overall Study|Symptomatic Deterioration|0|||
17124832|NCT02903914|38264969|FG000|Overall Study|New Cancer Therapy|2|||
17124833|NCT02903914|38264970|FG001|Overall Study|New Cancer Therapy|2|||
17124834|NCT02903914|38264971|FG002|Overall Study|New Cancer Therapy|21|||
17124835|NCT02903914|38264972|FG003|Overall Study|New Cancer Therapy|4|||
17124836|NCT02903914|38264973|FG004|Overall Study|New Cancer Therapy|3|||
17124837|NCT02903914|38264974|FG005|Overall Study|New Cancer Therapy|6|||
17124838|NCT02903914|38264975|FG006|Overall Study|New Cancer Therapy|55|||
17124839|NCT02903914|38264976|FG007|Overall Study|New Cancer Therapy|0|||
17124840|NCT02903914|38264969|FG000|Overall Study|Reasoning not specified|2|||
17124841|NCT02903914|38264970|FG001|Overall Study|Reasoning not specified|3|||
17124842|NCT02903914|38264971|FG002|Overall Study|Reasoning not specified|20|||
17124843|NCT02903914|38264972|FG003|Overall Study|Reasoning not specified|3|||
17124844|NCT02903914|38264973|FG004|Overall Study|Reasoning not specified|3|||
17124845|NCT02903914|38264974|FG005|Overall Study|Reasoning not specified|3|||
17124846|NCT02903914|38264975|FG006|Overall Study|Reasoning not specified|20|||
17124847|NCT02903914|38264976|FG007|Overall Study|Reasoning not specified|0|||
17124848|NCT02969044|38264998|FG000|Overall Study|Withdrawal by Subject|2|||
17124849|NCT02969044|38264999|FG001|Overall Study|Withdrawal by Subject|6|||
17124850|NCT02969044|38264998|FG000|Overall Study|Adverse Event|3|||
17124851|NCT02969044|38264999|FG001|Overall Study|Adverse Event|0|||
17124852|NCT02967562|38265007|FG000|Overall Study|Consent not obtained|1|||
17124853|NCT02967562|38265008|FG001|Overall Study|Consent not obtained|0|||
17124854|NCT02967562|38265007|FG000|Overall Study|High leak precluding analysis|1|||
17124855|NCT02967562|38265008|FG001|Overall Study|High leak precluding analysis|1|||
17124856|NCT02968576|38265014|FG000|Overall Study|Pregnancy|0|||
17124857|NCT02968576|38265015|FG001|Overall Study|Pregnancy|1|||
17124858|NCT02966002|38265019|FG000|Overall Study|Withdrawal by Subject|2|||
17124859|NCT02966002|38265019|FG000|Overall Study|Adverse Event|1|||
17124860|NCT02966002|38265019|FG000|Overall Study|Lost to Follow-up|1|||
17124861|NCT02965846|38265026|FG000|Overall Study|Lost to Follow-up|1|||
17124862|NCT02965846|38265027|FG001|Overall Study|Lost to Follow-up|0|||
17124863|NCT02965846|38265028|FG002|Overall Study|Lost to Follow-up|0|||
17124864|NCT02965846|38265026|FG000|Overall Study|Withdrawal by Subject|0|||
17124865|NCT02965846|38265027|FG001|Overall Study|Withdrawal by Subject|1|||
17124866|NCT02965846|38265028|FG002|Overall Study|Withdrawal by Subject|0|||
17124867|NCT02965846|38265026|FG000|Overall Study|Study Terminated By Sponsor|4|||
17124868|NCT02965846|38265027|FG001|Overall Study|Study Terminated By Sponsor|4|||
17124869|NCT02965846|38265028|FG002|Overall Study|Study Terminated By Sponsor|0|||
17124870|NCT02965846|38265026|FG000|Overall Study|Participants not randomized|0|||
17124871|NCT02965846|38265027|FG001|Overall Study|Participants not randomized|0|||
17124872|NCT02965846|38265028|FG002|Overall Study|Participants not randomized|33|||
17124873|NCT02900170|38265034|FG000|Overall Study|Lost to Follow-up|8|||
17124874|NCT02900092|38265038|FG000|Overall Study|Adverse Event|1|||
17124875|NCT02902120|38265046|FG000|Overall Study|Lack of Efficacy|1|||
17124876|NCT02965456|38265052|FG000|Overall Study|Lost to Follow-up|40|||
17124877|NCT02965456|38265053|FG001|Overall Study|Lost to Follow-up|18|||
17124878|NCT02965456|38265052|FG000|Overall Study|Subject Request|22|||
17124879|NCT02965456|38265053|FG001|Overall Study|Subject Request|13|||
17124880|NCT02965456|38265052|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
17124881|NCT02965456|38265053|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
17124882|NCT02965456|38265052|FG000|Overall Study|Adverse Event|3|||
17124883|NCT02965456|38265053|FG001|Overall Study|Adverse Event|0|||
17124884|NCT02965456|38265052|FG000|Overall Study|Noncompliance with Study Drug|1|||
17124885|NCT02965456|38265053|FG001|Overall Study|Noncompliance with Study Drug|1|||
17124886|NCT02965456|38265052|FG000|Overall Study|Worsening Condition|0|||
17124887|NCT02965456|38265053|FG001|Overall Study|Worsening Condition|2|||
17124888|NCT02965456|38265052|FG000|Overall Study|Lack of Efficacy|1|||
17124889|NCT02965456|38265053|FG001|Overall Study|Lack of Efficacy|0|||
17124890|NCT02965456|38265052|FG000|Overall Study|Physician Decision|0|||
17124891|NCT02965456|38265053|FG001|Overall Study|Physician Decision|1|||
17124892|NCT02965456|38265052|FG000|Overall Study|Pregnancy|1|||
17124893|NCT02965456|38265053|FG001|Overall Study|Pregnancy|0|||
17124894|NCT02965456|38265052|FG000|Overall Study|Protocol Violation|0|||
17124895|NCT02965456|38265053|FG001|Overall Study|Protocol Violation|1|||
17124896|NCT02965456|38265052|FG000|Overall Study|Participant ran out of study drug|0|||
17124897|NCT02965456|38265053|FG001|Overall Study|Participant ran out of study drug|1|||
17124898|NCT02965378|38265061|FG000|Overall Study|Progression|16|||
17124899|NCT02965378|38265062|FG001|Overall Study|Progression|4|||
17124900|NCT02965378|38265061|FG000|Overall Study|Adverse Event|5|||
17124901|NCT02965378|38265062|FG001|Overall Study|Adverse Event|2|||
17124902|NCT02965378|38265061|FG000|Overall Study|Death|2|||
17124903|NCT02965378|38265062|FG001|Overall Study|Death|0|||
17124904|NCT02965378|38265061|FG000|Overall Study|Refusal|2|||
17124905|NCT02965378|38265062|FG001|Overall Study|Refusal|1|||
17124906|NCT02965378|38265061|FG000|Overall Study|Not protocol specified|0|||
17124907|NCT02965378|38265062|FG001|Overall Study|Not protocol specified|2|||
17124908|NCT03772041|38265070|FG000|Overall Study|Adverse Event|8|||
17124909|NCT03772041|38265071|FG001|Overall Study|Adverse Event|3|||
17124910|NCT03772041|38265070|FG000|Overall Study|Withdrawal by Subject|0|||
17124911|NCT03772041|38265071|FG001|Overall Study|Withdrawal by Subject|2|||
17124912|NCT03772041|38265070|FG000|Overall Study|Protocol Violation|4|||
17124913|NCT03772041|38265071|FG001|Overall Study|Protocol Violation|2|||
17124914|NCT03772041|38265070|FG000|Overall Study|Physician Decision|2|||
17124915|NCT03772041|38265071|FG001|Overall Study|Physician Decision|3|||
17124916|NCT02899156|38265079|FG000|Overall Study|Death|1|||
17124917|NCT02899156|38265080|FG001|Overall Study|Death|0|||
17124918|NCT02899156|38265079|FG000|Overall Study|Physician Decision|0|||
17124919|NCT02899156|38265080|FG001|Overall Study|Physician Decision|1|||
17124920|NCT03773133|38265086|FG000|Overall Study|Screen Failure|8|||
17124921|NCT02969356|38265091|FG000|Overall Study|Adverse Event|7|||
17124922|NCT02969356|38265091|FG000|Overall Study|Consent withdrawn|2|||
17124923|NCT02969356|38265091|FG000|Overall Study|Lost to Follow-up|3|||
17124924|NCT02969356|38265091|FG000|Overall Study|Did not need to be reinjected|6|||
17124925|NCT02969356|38265091|FG000|Overall Study|Personal reasons|5|||
17124926|NCT02898454|38265098|FG000|Overall Study|Adverse Event|4|||
17124927|NCT02898454|38265099|FG001|Overall Study|Adverse Event|1|||
17124928|NCT02898454|38265100|FG002|Overall Study|Adverse Event|2|||
17124929|NCT02898454|38265098|FG000|Overall Study|Protocol Violation|1|||
17124930|NCT02898454|38265099|FG001|Overall Study|Protocol Violation|0|||
17124931|NCT02898454|38265100|FG002|Overall Study|Protocol Violation|1|||
17124932|NCT02898454|38265098|FG000|Overall Study|Lack of Efficacy|4|||
17124933|NCT02898454|38265099|FG001|Overall Study|Lack of Efficacy|1|||
17124934|NCT02898454|38265100|FG002|Overall Study|Lack of Efficacy|0|||
17124935|NCT02898454|38265098|FG000|Overall Study|Withdrawal by Subject|6|||
17124936|NCT02898454|38265099|FG001|Overall Study|Withdrawal by Subject|3|||
17124937|NCT02898454|38265100|FG002|Overall Study|Withdrawal by Subject|3|||
17124938|NCT02898454|38265098|FG000|Overall Study|Lost to Follow-up|1|||
17124939|NCT02898454|38265099|FG001|Overall Study|Lost to Follow-up|0|||
17124940|NCT02898454|38265100|FG002|Overall Study|Lost to Follow-up|0|||
16942101|NCT01371747|38086668|FG004|Overall Study|Death|2|||
17124941|NCT02898454|38265098|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
17124942|NCT02898454|38265099|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
17124943|NCT02898454|38265100|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
17124944|NCT03772587|38265118|FG000|Overall Study|COVID-19|0|||
17124945|NCT03772587|38265119|FG001|Overall Study|COVID-19|0|||
17124946|NCT03772587|38265120|FG002|Overall Study|COVID-19|1|||
17124947|NCT03772587|38265121|FG003|Overall Study|COVID-19|1|||
17124948|NCT03772587|38265122|FG004|Overall Study|COVID-19|0|||
17124949|NCT03772587|38265118|FG000|Overall Study|Withdrawal by Subject|1|||
17124950|NCT03772587|38265119|FG001|Overall Study|Withdrawal by Subject|0|||
17124951|NCT03772587|38265120|FG002|Overall Study|Withdrawal by Subject|0|||
17124952|NCT03772587|38265121|FG003|Overall Study|Withdrawal by Subject|0|||
17124953|NCT03772587|38265122|FG004|Overall Study|Withdrawal by Subject|0|||
17124954|NCT02963506|38265149|FG000|Double-Blind Period|Adverse Event|0|||
17124955|NCT02963506|38265150|FG001|Double-Blind Period|Adverse Event|0|||
17124956|NCT02963506|38265151|FG002|Double-Blind Period|Adverse Event|1|||
17124957|NCT02963506|38265152|FG003|Double-Blind Period|Adverse Event|0|||
17124958|NCT02963506|38265153|FG004|Double-Blind Period|Adverse Event|0|||
17124959|NCT02963506|38265154|FG005|Double-Blind Period|Adverse Event|0|||
17124960|NCT02963506|38265155|FG006|Double-Blind Period|Adverse Event|0|||
17124961|NCT02963506|38265156|FG007|Double-Blind Period|Adverse Event|0|||
17124962|NCT02963506|38265157|FG008|Double-Blind Period|Adverse Event|0|||
17124963|NCT02963506|38265158|FG009|Double-Blind Period|Adverse Event|0|||
17124964|NCT02963506|38265159|FG010|Double-Blind Period|Adverse Event|0|||
17124965|NCT02963506|38265160|FG011|Double-Blind Period|Adverse Event|0|||
17124966|NCT02963506|38265161|FG012|Double-Blind Period|Adverse Event|0|||
17124967|NCT02963506|38265149|FG000|Double-Blind Period|Death|0|||
17124968|NCT02963506|38265150|FG001|Double-Blind Period|Death|0|||
17124969|NCT02963506|38265151|FG002|Double-Blind Period|Death|0|||
17124970|NCT02963506|38265152|FG003|Double-Blind Period|Death|1|||
17124971|NCT02963506|38265153|FG004|Double-Blind Period|Death|0|||
17124972|NCT02963506|38265154|FG005|Double-Blind Period|Death|0|||
17124973|NCT02963506|38265155|FG006|Double-Blind Period|Death|0|||
17124974|NCT02963506|38265156|FG007|Double-Blind Period|Death|0|||
17124975|NCT02963506|38265157|FG008|Double-Blind Period|Death|0|||
17124976|NCT02963506|38265158|FG009|Double-Blind Period|Death|0|||
17124977|NCT02963506|38265159|FG010|Double-Blind Period|Death|0|||
17124978|NCT02963506|38265160|FG011|Double-Blind Period|Death|0|||
17124979|NCT02963506|38265161|FG012|Double-Blind Period|Death|0|||
17124980|NCT02963506|38265149|FG000|Double-Blind Period|Lost to Follow-up|0|||
17124981|NCT02963506|38265150|FG001|Double-Blind Period|Lost to Follow-up|1|||
17124982|NCT02963506|38265151|FG002|Double-Blind Period|Lost to Follow-up|0|||
17124983|NCT02963506|38265152|FG003|Double-Blind Period|Lost to Follow-up|0|||
17124984|NCT02963506|38265153|FG004|Double-Blind Period|Lost to Follow-up|0|||
17124985|NCT02963506|38265154|FG005|Double-Blind Period|Lost to Follow-up|0|||
17124986|NCT02963506|38265155|FG006|Double-Blind Period|Lost to Follow-up|0|||
17124987|NCT02963506|38265156|FG007|Double-Blind Period|Lost to Follow-up|0|||
17124988|NCT02963506|38265157|FG008|Double-Blind Period|Lost to Follow-up|0|||
17124989|NCT02963506|38265158|FG009|Double-Blind Period|Lost to Follow-up|0|||
17124990|NCT02963506|38265159|FG010|Double-Blind Period|Lost to Follow-up|0|||
17124991|NCT02963506|38265160|FG011|Double-Blind Period|Lost to Follow-up|0|||
17124992|NCT02963506|38265161|FG012|Double-Blind Period|Lost to Follow-up|0|||
17124993|NCT02963506|38265149|FG000|Double-Blind Period|Withdrawal by Subject|0|||
17124994|NCT02963506|38265150|FG001|Double-Blind Period|Withdrawal by Subject|0|||
17124995|NCT02963506|38265151|FG002|Double-Blind Period|Withdrawal by Subject|1|||
17124996|NCT02963506|38265152|FG003|Double-Blind Period|Withdrawal by Subject|1|||
17124997|NCT02963506|38265153|FG004|Double-Blind Period|Withdrawal by Subject|0|||
17124998|NCT02963506|38265154|FG005|Double-Blind Period|Withdrawal by Subject|0|||
17124999|NCT02963506|38265155|FG006|Double-Blind Period|Withdrawal by Subject|0|||
17125000|NCT02963506|38265156|FG007|Double-Blind Period|Withdrawal by Subject|0|||
17125001|NCT02963506|38265157|FG008|Double-Blind Period|Withdrawal by Subject|0|||
17125002|NCT02963506|38265158|FG009|Double-Blind Period|Withdrawal by Subject|0|||
17125003|NCT02963506|38265159|FG010|Double-Blind Period|Withdrawal by Subject|0|||
17028312|NCT00474175|38172722|FG001|Overall Study|Withdrawal by Subject|1|||
17028313|NCT00474175|38172723|FG002|Overall Study|Withdrawal by Subject|1|||
17028314|NCT00474175|38172721|FG000|Overall Study|Ineligible|1|||
17028315|NCT00474175|38172722|FG001|Overall Study|Ineligible|3|||
17028316|NCT00474175|38172723|FG002|Overall Study|Ineligible|1|||
17028317|NCT00474175|38172721|FG000|Overall Study|Protocol Violation|0|||
17028318|NCT00474175|38172722|FG001|Overall Study|Protocol Violation|2|||
17028319|NCT00474175|38172723|FG002|Overall Study|Protocol Violation|1|||
17028320|NCT00474175|38172721|FG000|Overall Study|Administrative|0|||
17028321|NCT00474175|38172722|FG001|Overall Study|Administrative|1|||
17125004|NCT02963506|38265160|FG011|Double-Blind Period|Withdrawal by Subject|0|||
17125005|NCT02963506|38265161|FG012|Double-Blind Period|Withdrawal by Subject|0|||
17125006|NCT02963506|38265149|FG000|Double-Blind Period|No compliance|0|||
17125007|NCT02963506|38265150|FG001|Double-Blind Period|No compliance|1|||
17125008|NCT02963506|38265151|FG002|Double-Blind Period|No compliance|0|||
17125009|NCT02963506|38265152|FG003|Double-Blind Period|No compliance|0|||
17125010|NCT02963506|38265153|FG004|Double-Blind Period|No compliance|0|||
17125011|NCT02963506|38265154|FG005|Double-Blind Period|No compliance|0|||
17125012|NCT02963506|38265155|FG006|Double-Blind Period|No compliance|0|||
17125013|NCT02963506|38265156|FG007|Double-Blind Period|No compliance|0|||
17125014|NCT02963506|38265157|FG008|Double-Blind Period|No compliance|0|||
17125015|NCT02963506|38265158|FG009|Double-Blind Period|No compliance|0|||
17125016|NCT02963506|38265159|FG010|Double-Blind Period|No compliance|0|||
17125017|NCT02963506|38265160|FG011|Double-Blind Period|No compliance|0|||
17125018|NCT02963506|38265161|FG012|Double-Blind Period|No compliance|0|||
17125019|NCT02963506|38265149|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125020|NCT02963506|38265150|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
17125021|NCT02963506|38265151|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125022|NCT02963506|38265152|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125023|NCT02963506|38265153|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125024|NCT02963506|38265154|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125025|NCT02963506|38265155|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125026|NCT02963506|38265156|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125027|NCT02963506|38265157|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125028|NCT02963506|38265158|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125029|NCT02963506|38265159|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125030|NCT02963506|38265160|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125031|NCT02963506|38265161|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
17125032|NCT02963506|38265149|FG000|Dose-Blind Period|Adverse Event|0|||
17125033|NCT02963506|38265150|FG001|Dose-Blind Period|Adverse Event|0|||
17125034|NCT02963506|38265151|FG002|Dose-Blind Period|Adverse Event|0|||
17125035|NCT02963506|38265152|FG003|Dose-Blind Period|Adverse Event|0|||
17125036|NCT02963506|38265153|FG004|Dose-Blind Period|Adverse Event|0|||
17125037|NCT02963506|38265154|FG005|Dose-Blind Period|Adverse Event|1|||
17125038|NCT02963506|38265155|FG006|Dose-Blind Period|Adverse Event|3|||
17125039|NCT02963506|38265156|FG007|Dose-Blind Period|Adverse Event|2|||
17125040|NCT02963506|38265157|FG008|Dose-Blind Period|Adverse Event|2|||
17125041|NCT02963506|38265158|FG009|Dose-Blind Period|Adverse Event|2|||
17125042|NCT02963506|38265159|FG010|Dose-Blind Period|Adverse Event|1|||
17125043|NCT02963506|38265160|FG011|Dose-Blind Period|Adverse Event|1|||
17125044|NCT02963506|38265161|FG012|Dose-Blind Period|Adverse Event|6|||
17125045|NCT02963506|38265149|FG000|Dose-Blind Period|Lack of Efficacy|0|||
17125046|NCT02963506|38265150|FG001|Dose-Blind Period|Lack of Efficacy|0|||
17125047|NCT02963506|38265151|FG002|Dose-Blind Period|Lack of Efficacy|0|||
17125048|NCT02963506|38265152|FG003|Dose-Blind Period|Lack of Efficacy|0|||
17125049|NCT02963506|38265153|FG004|Dose-Blind Period|Lack of Efficacy|0|||
17125050|NCT02963506|38265154|FG005|Dose-Blind Period|Lack of Efficacy|0|||
17125051|NCT02963506|38265155|FG006|Dose-Blind Period|Lack of Efficacy|0|||
17125052|NCT02963506|38265156|FG007|Dose-Blind Period|Lack of Efficacy|1|||
17125053|NCT02963506|38265157|FG008|Dose-Blind Period|Lack of Efficacy|0|||
17125054|NCT02963506|38265158|FG009|Dose-Blind Period|Lack of Efficacy|1|||
17125055|NCT02963506|38265159|FG010|Dose-Blind Period|Lack of Efficacy|0|||
17125056|NCT02963506|38265160|FG011|Dose-Blind Period|Lack of Efficacy|0|||
17125057|NCT02963506|38265161|FG012|Dose-Blind Period|Lack of Efficacy|0|||
17125058|NCT02963506|38265149|FG000|Dose-Blind Period|Lost to Follow-up|0|||
17125059|NCT02963506|38265150|FG001|Dose-Blind Period|Lost to Follow-up|0|||
17125060|NCT02963506|38265151|FG002|Dose-Blind Period|Lost to Follow-up|0|||
17125061|NCT02963506|38265152|FG003|Dose-Blind Period|Lost to Follow-up|0|||
17125062|NCT02963506|38265153|FG004|Dose-Blind Period|Lost to Follow-up|0|||
17125063|NCT02963506|38265154|FG005|Dose-Blind Period|Lost to Follow-up|1|||
17125064|NCT02963506|38265155|FG006|Dose-Blind Period|Lost to Follow-up|0|||
17125065|NCT02963506|38265156|FG007|Dose-Blind Period|Lost to Follow-up|0|||
17125066|NCT02963506|38265157|FG008|Dose-Blind Period|Lost to Follow-up|1|||
17125067|NCT02963506|38265158|FG009|Dose-Blind Period|Lost to Follow-up|0|||
17125068|NCT02963506|38265159|FG010|Dose-Blind Period|Lost to Follow-up|0|||
17125069|NCT02963506|38265160|FG011|Dose-Blind Period|Lost to Follow-up|1|||
17125070|NCT02963506|38265161|FG012|Dose-Blind Period|Lost to Follow-up|0|||
17125071|NCT02963506|38265149|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
17125072|NCT02963506|38265150|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
17125073|NCT02963506|38265151|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
17125074|NCT02963506|38265152|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
17125075|NCT02963506|38265153|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
17125076|NCT02963506|38265154|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
17125077|NCT02963506|38265155|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
17125078|NCT02963506|38265156|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
17125079|NCT02963506|38265157|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
17125080|NCT02963506|38265158|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
17125081|NCT02963506|38265159|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
17125082|NCT02963506|38265160|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
17125083|NCT02963506|38265161|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
17125084|NCT02963506|38265149|FG000|Dose-Blind Period|Sponsor decision|0|||
17125085|NCT02963506|38265150|FG001|Dose-Blind Period|Sponsor decision|0|||
17125086|NCT02963506|38265151|FG002|Dose-Blind Period|Sponsor decision|0|||
17125087|NCT02963506|38265152|FG003|Dose-Blind Period|Sponsor decision|0|||
17125088|NCT02963506|38265153|FG004|Dose-Blind Period|Sponsor decision|0|||
17125089|NCT02963506|38265154|FG005|Dose-Blind Period|Sponsor decision|1|||
17125090|NCT02963506|38265155|FG006|Dose-Blind Period|Sponsor decision|0|||
17125091|NCT02963506|38265156|FG007|Dose-Blind Period|Sponsor decision|0|||
17125092|NCT02963506|38265157|FG008|Dose-Blind Period|Sponsor decision|0|||
17125093|NCT02963506|38265158|FG009|Dose-Blind Period|Sponsor decision|0|||
17125094|NCT02963506|38265159|FG010|Dose-Blind Period|Sponsor decision|0|||
17125095|NCT02963506|38265160|FG011|Dose-Blind Period|Sponsor decision|0|||
17125096|NCT02963506|38265161|FG012|Dose-Blind Period|Sponsor decision|0|||
17125097|NCT02963506|38265149|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125098|NCT02963506|38265150|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125099|NCT02963506|38265151|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125100|NCT02963506|38265152|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125101|NCT02963506|38265153|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125102|NCT02963506|38265154|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125103|NCT02963506|38265155|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125104|NCT02963506|38265156|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125105|NCT02963506|38265157|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125106|NCT02963506|38265158|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125107|NCT02963506|38265159|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125108|NCT02963506|38265160|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
17125109|NCT02963506|38265161|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
17125110|NCT01345162|38265180|FG000|Overall Study|Protocol Violation|2|||
17125111|NCT01345162|38265181|FG001|Overall Study|Protocol Violation|4|||
17125112|NCT01345318|38265187|FG000|Overall Study|Adverse Event|16|||
17125113|NCT01345318|38265187|FG000|Overall Study|Lack of Efficacy|17|||
17125114|NCT01345318|38265187|FG000|Overall Study|Lost to Follow-up|2|||
17125115|NCT01345318|38265187|FG000|Overall Study|Protocol Violation|1|||
17125116|NCT01345318|38265187|FG000|Overall Study|Withdrawal by Subject|41|||
17125117|NCT01345318|38265187|FG000|Overall Study|Other|3|||
17125118|NCT02961244|38265194|FG000|Overall Study|Protocol Violation|0|||
17125119|NCT02961244|38265195|FG001|Overall Study|Protocol Violation|1|||
17125120|NCT02961244|38265194|FG000|Overall Study|Withdrawal by Subject|1|||
17125121|NCT02961244|38265195|FG001|Overall Study|Withdrawal by Subject|2|||
17125122|NCT02961244|38265194|FG000|Overall Study|Surgery plan change after study approval|0|||
17125123|NCT02961244|38265195|FG001|Overall Study|Surgery plan change after study approval|2|||
17125124|NCT02961244|38265194|FG000|Overall Study|Lost to Follow-up|0|||
17125125|NCT02961244|38265195|FG001|Overall Study|Lost to Follow-up|2|||
17125126|NCT02961244|38265194|FG000|Overall Study|İnadequate data|0|||
17125127|NCT02961244|38265195|FG001|Overall Study|İnadequate data|2|||
17125128|NCT03771963|38265201|FG000|Overall Study|Lost to Follow-up|22|||
17125129|NCT03771963|38265201|FG000|Overall Study|Withdrawal of Consent|10|||
17125130|NCT02962648|38265205|FG000|Overall Study|Withdrawal by Subject|3|||
17125131|NCT02962648|38265205|FG000|Overall Study|Lost to Follow-up|3|||
17125132|NCT02962648|38265205|FG000|Overall Study|Physician Decision|1|||
17125133|NCT02962648|38265205|FG000|Overall Study|Subject had problems with transportation|2|||
17125134|NCT02962882|38265209|FG000|Overall Study|Adverse Event|2|||
17125135|NCT02962882|38265209|FG000|Overall Study|Withdrawal by Subject|2|||
17125136|NCT02962882|38265209|FG000|Overall Study|Transfer from ICU|32|||
17125137|NCT02961790|38265218|FG000|Overall Study|Canceled|4|||
17125138|NCT02961790|38265219|FG001|Overall Study|Canceled|5|||
17125139|NCT02961790|38265220|FG002|Overall Study|Canceled|1|||
17125140|NCT02961790|38265221|FG003|Overall Study|Canceled|4|||
17125141|NCT02961790|38265218|FG000|Overall Study|without baseline data|4|||
17125142|NCT02961790|38265219|FG001|Overall Study|without baseline data|0|||
17125143|NCT02961790|38265220|FG002|Overall Study|without baseline data|1|||
17125144|NCT02961790|38265221|FG003|Overall Study|without baseline data|0|||
17125145|NCT02961790|38265218|FG000|Overall Study|without post baseline data|7|||
17125146|NCT02961790|38265219|FG001|Overall Study|without post baseline data|6|||
17125147|NCT02961790|38265220|FG002|Overall Study|without post baseline data|4|||
17125148|NCT02961790|38265221|FG003|Overall Study|without post baseline data|1|||
17125149|NCT02960854|38265243|FG000|Overall Study|Not Disclosed|2|||
17125150|NCT02960854|38265244|FG001|Overall Study|Not Disclosed|2|||
17125151|NCT02960854|38265243|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
17125152|NCT02960854|38265244|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
17125153|NCT02960854|38265243|FG000|Overall Study|Subject Withdrew Consent|0|||
17125154|NCT02960854|38265244|FG001|Overall Study|Subject Withdrew Consent|1|||
17125155|NCT02960854|38265243|FG000|Overall Study|Death|4|||
17125156|NCT02960854|38265244|FG001|Overall Study|Death|6|||
17125157|NCT01344538|38265252|FG000|Overall Study|Adverse Event|1|||
17125158|NCT01344538|38265253|FG001|Overall Study|Adverse Event|1|||
17125159|NCT01344538|38265252|FG000|Overall Study|Lost to Follow-up|1|||
17125160|NCT01344538|38265253|FG001|Overall Study|Lost to Follow-up|0|||
17125161|NCT01344460|38265259|FG000|Overall Study|Withdrawal by Subject|1|||
17125162|NCT01344460|38265259|FG000|Overall Study|Lost to Follow-up|2|||
17028322|NCT00474175|38172723|FG002|Overall Study|Administrative|0|||
17125163|NCT03764631|38265269|FG000|Overall Study|Personal Reasons|3|||
17125164|NCT03764631|38265270|FG001|Overall Study|Personal Reasons|2|||
17125165|NCT03764631|38265269|FG000|Overall Study|Switching Therapy|3|||
17125166|NCT03764631|38265270|FG001|Overall Study|Switching Therapy|3|||
17125167|NCT03764631|38265269|FG000|Overall Study|Adverse Event|0|||
17125168|NCT03764631|38265270|FG001|Overall Study|Adverse Event|1|||
17125169|NCT03764631|38265269|FG000|Overall Study|Lost to Follow-up|33|||
17125170|NCT03764631|38265270|FG001|Overall Study|Lost to Follow-up|41|||
17125171|NCT03764631|38265269|FG000|Overall Study|No data as study site was closed|2|||
17125172|NCT03764631|38265270|FG001|Overall Study|No data as study site was closed|6|||
17125173|NCT02956486|38265289|FG000|Core Phase|Adverse Event|51|||
17125174|NCT02956486|38265290|FG001|Core Phase|Adverse Event|88|||
17125175|NCT02956486|38265291|FG002|Core Phase|Adverse Event|0|||
17125176|NCT02956486|38265289|FG000|Core Phase|Lost to Follow-up|8|||
17125177|NCT02956486|38265290|FG001|Core Phase|Lost to Follow-up|6|||
17125178|NCT02956486|38265291|FG002|Core Phase|Lost to Follow-up|0|||
17125179|NCT02956486|38265289|FG000|Core Phase|Inadequate therapeutic effect|4|||
17125180|NCT02956486|38265290|FG001|Core Phase|Inadequate therapeutic effect|5|||
17125181|NCT02956486|38265291|FG002|Core Phase|Inadequate therapeutic effect|0|||
17125182|NCT02956486|38265289|FG000|Core Phase|Withdrawal by Subject|101|||
17125183|NCT02956486|38265290|FG001|Core Phase|Withdrawal by Subject|104|||
17125184|NCT02956486|38265291|FG002|Core Phase|Withdrawal by Subject|0|||
17125185|NCT02956486|38265289|FG000|Core Phase|Study terminated by sponsor|888|||
17125186|NCT02956486|38265290|FG001|Core Phase|Study terminated by sponsor|848|||
17125187|NCT02956486|38265291|FG002|Core Phase|Study terminated by sponsor|0|||
17125188|NCT02956486|38265289|FG000|Core Phase|Other|27|||
17125189|NCT02956486|38265290|FG001|Core Phase|Other|18|||
17125190|NCT02956486|38265291|FG002|Core Phase|Other|0|||
17125191|NCT02956486|38265289|FG000|Core Phase|Not treated|0|||
17125192|NCT02956486|38265290|FG001|Core Phase|Not treated|3|||
17125193|NCT02956486|38265291|FG002|Core Phase|Not treated|0|||
17125194|NCT02956486|38265289|FG000|Extension Phase|Adverse Event|0|||
17125195|NCT02956486|38265290|FG001|Extension Phase|Adverse Event|0|||
17125196|NCT02956486|38265291|FG002|Extension Phase|Adverse Event|2|||
17125197|NCT02956486|38265289|FG000|Extension Phase|Study terminated by sponsor|0|||
17125198|NCT02956486|38265290|FG001|Extension Phase|Study terminated by sponsor|0|||
17125199|NCT02956486|38265291|FG002|Extension Phase|Study terminated by sponsor|16|||
17125200|NCT02956486|38265289|FG000|Extension Phase|Not Treated|0|||
17125201|NCT02956486|38265290|FG001|Extension Phase|Not Treated|0|||
17125202|NCT02956486|38265291|FG002|Extension Phase|Not Treated|1|||
17125203|NCT03445533|38265306|FG000|Overall Study|Progressive Disease|48|||
17125204|NCT03445533|38265307|FG001|Overall Study|Progressive Disease|81|||
17125205|NCT03445533|38265306|FG000|Overall Study|Adverse Event|60|||
17125206|NCT03445533|38265307|FG001|Overall Study|Adverse Event|64|||
17125207|NCT03445533|38265306|FG000|Overall Study|Death|9|||
17125208|NCT03445533|38265307|FG001|Overall Study|Death|19|||
17125209|NCT03445533|38265306|FG000|Overall Study|Miscellaneous|0|||
17125210|NCT03445533|38265307|FG001|Overall Study|Miscellaneous|16|||
17125211|NCT03445533|38265306|FG000|Overall Study|Withdrawal by Subject|3|||
17125212|NCT03445533|38265307|FG001|Overall Study|Withdrawal by Subject|4|||
17125213|NCT03445533|38265306|FG000|Overall Study|Physician Decision|1|||
17125214|NCT03445533|38265307|FG001|Overall Study|Physician Decision|3|||
17125215|NCT03445533|38265306|FG000|Overall Study|Sponsor Decision|0|||
17125216|NCT03445533|38265307|FG001|Overall Study|Sponsor Decision|1|||
17125217|NCT03445533|38265306|FG000|Overall Study|Lost to Follow-up|0|||
17125218|NCT03445533|38265307|FG001|Overall Study|Lost to Follow-up|1|||
17125219|NCT03445533|38265306|FG000|Overall Study|Never Received any Study Treatment|7|||
17125220|NCT03445533|38265307|FG001|Overall Study|Never Received any Study Treatment|4|||
17125221|NCT01337050|38265316|FG000|Overall Study|Death|0|||
17125222|NCT01337050|38265317|FG001|Overall Study|Death|0|||
17125223|NCT01337050|38265318|FG002|Overall Study|Death|4|||
17125224|NCT01337050|38265316|FG000|Overall Study|Other|4|||
17125225|NCT01337050|38265317|FG001|Overall Study|Other|6|||
17125226|NCT01337050|38265318|FG002|Overall Study|Other|8|||
17125227|NCT01337050|38265316|FG000|Overall Study|Participants refused further follow-up|0|||
17125228|NCT01337050|38265317|FG001|Overall Study|Participants refused further follow-up|7|||
17125229|NCT01337050|38265318|FG002|Overall Study|Participants refused further follow-up|7|||
17125230|NCT01336972|38265330|FG000|Overall Study|Adverse Event|1|||
17125231|NCT01336972|38265331|FG001|Overall Study|Adverse Event|1|||
17125232|NCT01336972|38265332|FG002|Overall Study|Adverse Event|0|||
17125233|NCT03762681|38265349|FG000|Part 1|Withdrawal by Subject|0|||
17125234|NCT03762681|38265350|FG001|Part 1|Withdrawal by Subject|0|||
17125235|NCT03762681|38265351|FG002|Part 1|Withdrawal by Subject|0|||
17125236|NCT03762681|38265352|FG003|Part 1|Withdrawal by Subject|1|||
17125237|NCT03762681|38265353|FG004|Part 1|Withdrawal by Subject|0|||
17125238|NCT03762681|38265354|FG005|Part 1|Withdrawal by Subject|0|||
17125239|NCT03762681|38265355|FG006|Part 1|Withdrawal by Subject|0|||
17125240|NCT03762681|38265356|FG007|Part 1|Withdrawal by Subject|0|||
17125241|NCT03762681|38265349|FG000|Part 2a|Pandemic Travel Restrictions|0|||
17125242|NCT03762681|38265350|FG001|Part 2a|Pandemic Travel Restrictions|0|||
17125243|NCT03762681|38265351|FG002|Part 2a|Pandemic Travel Restrictions|0|||
17125244|NCT03762681|38265352|FG003|Part 2a|Pandemic Travel Restrictions|0|||
17125245|NCT03762681|38265353|FG004|Part 2a|Pandemic Travel Restrictions|0|||
17125246|NCT03762681|38265354|FG005|Part 2a|Pandemic Travel Restrictions|0|||
17125247|NCT03762681|38265355|FG006|Part 2a|Pandemic Travel Restrictions|0|||
17125248|NCT03762681|38265356|FG007|Part 2a|Pandemic Travel Restrictions|1|||
17125249|NCT03764475|38265385|FG000|Overall Study|Adverse Event|11|||
17125250|NCT03764475|38265386|FG001|Overall Study|Adverse Event|2|||
17125251|NCT03764475|38265385|FG000|Overall Study|Lost to Follow-up|24|||
17125252|NCT03764475|38265386|FG001|Overall Study|Lost to Follow-up|10|||
17125253|NCT03764475|38265385|FG000|Overall Study|Withdrawal by Subject|26|||
17125254|NCT03764475|38265386|FG001|Overall Study|Withdrawal by Subject|10|||
17125255|NCT03764475|38265385|FG000|Overall Study|Lack of Efficacy|3|||
17125256|NCT03764475|38265386|FG001|Overall Study|Lack of Efficacy|0|||
17125257|NCT03764475|38265385|FG000|Overall Study|COVID-19 Disruption|2|||
17125258|NCT03764475|38265386|FG001|Overall Study|COVID-19 Disruption|0|||
17125259|NCT03370276|38265399|FG000|Overall Study|Death|0|||
17125260|NCT03370276|38265400|FG001|Overall Study|Death|2|||
17125261|NCT03370276|38265401|FG002|Overall Study|Death|5|||
17125262|NCT02873338|38265412|FG000|Overall Study|Adverse Event|0|||
17125263|NCT02873338|38265413|FG001|Overall Study|Adverse Event|2|||
17125264|NCT02873338|38265414|FG002|Overall Study|Adverse Event|1|||
17125265|NCT02873338|38265412|FG000|Overall Study|Death|2|||
17125266|NCT02873338|38265413|FG001|Overall Study|Death|1|||
17125267|NCT02873338|38265414|FG002|Overall Study|Death|1|||
17125268|NCT02873338|38265412|FG000|Overall Study|Withdrawal by Subject|2|||
17125269|NCT02873338|38265413|FG001|Overall Study|Withdrawal by Subject|1|||
17125270|NCT02873338|38265414|FG002|Overall Study|Withdrawal by Subject|3|||
17125271|NCT02873338|38265412|FG000|Overall Study|Lack of Efficacy|0|||
17125272|NCT02873338|38265413|FG001|Overall Study|Lack of Efficacy|2|||
17125273|NCT02873338|38265414|FG002|Overall Study|Lack of Efficacy|0|||
17125274|NCT02873338|38265412|FG000|Overall Study|Other or Missing|14|||
17125275|NCT02873338|38265413|FG001|Overall Study|Other or Missing|15|||
17125276|NCT02873338|38265414|FG002|Overall Study|Other or Missing|13|||
17125277|NCT02872012|38265427|FG000|Overall Study|Withdrawal by Subject|1|||
17125278|NCT02872012|38265428|FG001|Overall Study|Withdrawal by Subject|0|||
17125279|NCT02872012|38265429|FG002|Overall Study|Withdrawal by Subject|0|||
17125280|NCT02872012|38265430|FG003|Overall Study|Withdrawal by Subject|0|||
17125281|NCT02872012|38265431|FG004|Overall Study|Withdrawal by Subject|0|||
17125282|NCT02959138|38265448|FG000|Overall Study|Enrolled but Never Treated|0|||
17125283|NCT02959138|38265449|FG001|Overall Study|Enrolled but Never Treated|1|||
17125284|NCT02959138|38265450|FG002|Overall Study|Enrolled but Never Treated|0|||
17125285|NCT01344226|38265462|FG000|Overall Study|Protocol Violation|2|||
17125286|NCT01344226|38265462|FG000|Overall Study|Withdrawal by Subject|3|||
17125287|NCT01344226|38265462|FG000|Overall Study|Lack of Efficacy|3|||
17125288|NCT02869438|38265468|FG000|Overall Study|Lost to Follow-up|1|||
17125289|NCT02869438|38265469|FG001|Overall Study|Lost to Follow-up|0|||
17125290|NCT02869438|38265468|FG000|Overall Study|Adverse Event|1|||
17125291|NCT02869438|38265469|FG001|Overall Study|Adverse Event|0|||
17125292|NCT02869438|38265468|FG000|Overall Study|Withdrawal by Subject|1|||
17125293|NCT02869438|38265469|FG001|Overall Study|Withdrawal by Subject|2|||
17125294|NCT02868892|38265475|FG000|Overall Study|Investigator left site and no follow-up|6|||
17125295|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Death|1|||
17125296|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Death|1|||
17125297|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Death|0|||
17125298|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Death|0|||
17125299|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Death|1|||
17125300|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Death|0|||
17125301|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Death|0|||
17125302|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Death|0|||
17125303|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Death|0|||
17125304|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Death|0|||
17125305|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
17125306|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
17125307|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
17125308|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
17125309|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
17125310|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
17125311|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
17125312|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
17125313|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
17125314|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
17125315|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125316|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125317|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125318|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125319|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
17125320|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125321|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125322|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125323|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125324|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
17125325|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
17125326|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125327|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125328|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125329|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125330|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125331|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125332|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125333|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125334|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
17125335|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
17125336|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
17125337|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
17125338|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
17125339|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
17125340|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
17125341|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
17125342|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
17125343|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
17125344|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
17125345|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
17125346|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
17125347|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
17125348|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
17125349|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
17125350|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
17125351|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
17125352|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
17125353|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
17125354|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
17125355|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
17125356|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
17125357|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
17125358|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
17125359|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
17125360|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
17125361|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
17125362|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
17125363|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
17125364|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
17125365|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
17125366|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
17125367|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
17125368|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125369|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
17125370|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125371|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125372|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125373|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125374|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125375|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
17125376|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
17125377|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
17125378|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
17125379|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
17125380|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
17125381|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
17125382|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
17125383|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
17125384|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
17125385|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
17125386|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
17125387|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125388|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
17125389|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
17125390|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125391|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125392|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125393|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125394|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125395|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125396|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125397|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
17125398|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125399|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
17125400|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125401|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125402|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125403|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125404|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125405|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
17125406|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
17125407|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
17125408|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
17125409|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
17125410|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
17125411|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
17125412|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
17125413|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
17125414|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
17125415|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125416|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125417|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125418|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
17125419|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
17125420|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125421|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125422|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125423|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125424|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125425|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
17125426|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125427|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
17125428|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
17125429|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
17125430|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125431|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125432|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125433|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125434|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125435|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
17125436|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125437|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125438|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125439|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
17125440|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125441|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125442|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125443|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125444|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
17125445|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125446|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125447|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125448|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125449|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
17125450|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125451|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125452|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125453|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125454|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125455|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
17125456|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
17125457|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
17125458|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
17125459|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
17125460|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
17125461|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
17125462|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
17125463|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
17125464|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
17125465|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
17125466|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
17125467|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
17125468|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
17125469|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
17125470|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
17125471|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
17125472|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
17125473|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
17125474|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
17125475|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
17125476|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
17125477|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
17125478|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
17125479|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
17125480|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
17125481|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
17125482|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
17125483|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
17125484|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
17125485|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Other|5|||
17125486|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Other|1|||
17125487|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Other|0|||
17125488|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Other|3|||
17125489|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Other|0|||
17125490|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Other|0|||
17125491|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Other|0|||
17125492|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Other|0|||
17125493|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Other|0|||
17125494|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Other|0|||
17125495|NCT03352557|38265484|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125496|NCT03352557|38265485|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125497|NCT03352557|38265486|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125498|NCT03352557|38265487|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125499|NCT03352557|38265488|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
17125500|NCT03352557|38265489|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125501|NCT03352557|38265490|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125502|NCT03352557|38265491|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125503|NCT03352557|38265492|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125504|NCT03352557|38265493|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
17125505|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Death|0|||
17125506|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Death|0|||
17125507|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Death|0|||
17125508|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Death|0|||
17125509|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Death|0|||
17125510|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Death|1|||
17125511|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Death|0|||
17125512|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Death|1|||
17125513|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Death|1|||
17125514|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Death|1|||
17125515|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125516|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125517|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125518|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125519|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125520|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
17125521|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125522|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125523|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125524|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
17125525|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125526|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125527|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125528|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125529|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125530|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125531|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125532|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125533|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
17125534|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
17125535|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
17125536|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
17125537|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
17125538|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
17125539|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
17125540|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
17125541|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
17125542|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
17125543|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
17125544|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
17125545|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125546|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125547|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125548|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125549|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125550|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
17125551|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
17125552|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
17125553|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
17125554|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
17125555|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125556|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125557|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125558|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125559|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125560|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
17125561|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125562|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
17125563|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
17125564|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
17125565|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
17125566|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
17125567|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
17125568|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
17125569|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
17125570|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
17125571|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
17125572|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
17125573|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
17125574|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
17125575|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125576|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125577|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125578|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125579|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125580|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125581|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125582|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
17125583|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
17125584|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
17125585|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125586|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125587|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125588|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125589|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125590|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125591|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125592|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
17125593|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125594|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
17125595|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125596|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125597|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125598|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125599|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125600|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125601|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125602|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
17125603|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125604|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
17125605|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125606|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125607|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125608|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125609|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125610|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125611|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125612|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
17125613|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
17125614|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
17125615|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
17125616|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
17125617|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
17125618|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
17125619|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
17125620|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
17125621|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
17125622|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
17125623|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
17125624|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
17125625|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125626|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125627|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125628|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125629|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125630|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125631|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125632|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125633|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
17125634|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
17125635|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
17125636|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
17125637|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
17125638|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
17125639|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
17125640|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
17125641|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
17125642|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
17125643|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
17125644|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
17125645|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
17125646|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
17125647|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
17125648|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
17125649|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
17125650|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
17125651|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
17125652|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
17125653|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
17125654|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
17125655|NCT03352557|38265484|FG000|LTE Period: Week 80 to Week 173|Other|0|||
17125656|NCT03352557|38265485|FG001|LTE Period: Week 80 to Week 173|Other|0|||
17125657|NCT03352557|38265486|FG002|LTE Period: Week 80 to Week 173|Other|0|||
17125658|NCT03352557|38265487|FG003|LTE Period: Week 80 to Week 173|Other|0|||
17125659|NCT03352557|38265488|FG004|LTE Period: Week 80 to Week 173|Other|0|||
17125660|NCT03352557|38265489|FG005|LTE Period: Week 80 to Week 173|Other|0|||
17125661|NCT03352557|38265490|FG006|LTE Period: Week 80 to Week 173|Other|0|||
17125662|NCT03352557|38265491|FG007|LTE Period: Week 80 to Week 173|Other|1|||
17125663|NCT03352557|38265492|FG008|LTE Period: Week 80 to Week 173|Other|0|||
17125664|NCT03352557|38265493|FG009|LTE Period: Week 80 to Week 173|Other|0|||
17125665|NCT02866942|38265518|FG000|Overall Study|Invalid consent|1|||
17125666|NCT02908672|38265572|FG000|Overall Study|Death|112|||
17125667|NCT02908672|38265573|FG001|Overall Study|Death|93|||
17125668|NCT02908672|38265572|FG000|Overall Study|Lost to Follow-up|3|||
17125669|NCT02908672|38265573|FG001|Overall Study|Lost to Follow-up|3|||
17125670|NCT02908672|38265572|FG000|Overall Study|Other|2|||
17125671|NCT02908672|38265573|FG001|Overall Study|Other|0|||
17125672|NCT02908672|38265572|FG000|Overall Study|Protocol Violation|1|||
17125673|NCT02908672|38265573|FG001|Overall Study|Protocol Violation|1|||
17125674|NCT02908672|38265572|FG000|Overall Study|Withdrawal by Subject|13|||
17125675|NCT02908672|38265573|FG001|Overall Study|Withdrawal by Subject|18|||
17125676|NCT02908672|38265572|FG000|Overall Study|Study is ongoing|124|||
17125677|NCT02908672|38265573|FG001|Overall Study|Study is ongoing|141|||
17125678|NCT02908672|38265572|FG000|Overall Study|Discontinued the study during run-in|3|||
17125679|NCT02908672|38265573|FG001|Overall Study|Discontinued the study during run-in|0|||
16773213|NCT03745651|37712175|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17125680|NCT01336894|38265581|FG000|Follow-up|Study terminated prematurely|2|||
17125681|NCT01336894|38265582|FG001|Follow-up|Study terminated prematurely|7|||
17125682|NCT02572167|38265591|FG000|Overall Study|Withdrawal by Subject|0|||
17125683|NCT02572167|38265592|FG001|Overall Study|Withdrawal by Subject|3|||
17125684|NCT02572167|38265593|FG002|Overall Study|Withdrawal by Subject|0|||
17125685|NCT02572167|38265591|FG000|Overall Study|Lost to Follow-up|2|||
17125686|NCT02572167|38265592|FG001|Overall Study|Lost to Follow-up|5|||
17125687|NCT02572167|38265593|FG002|Overall Study|Lost to Follow-up|3|||
17125688|NCT02572167|38265591|FG000|Overall Study|Death|0|||
17125689|NCT02572167|38265592|FG001|Overall Study|Death|8|||
17125690|NCT02572167|38265593|FG002|Overall Study|Death|3|||
17125691|NCT02572167|38265591|FG000|Overall Study|Did not meet inclusion criteria|0|||
17125692|NCT02572167|38265592|FG001|Overall Study|Did not meet inclusion criteria|0|||
17125693|NCT02572167|38265593|FG002|Overall Study|Did not meet inclusion criteria|1|||
17125694|NCT02572167|38265591|FG000|Overall Study|Study closure by Sponsor|4|||
17125695|NCT02572167|38265592|FG001|Overall Study|Study closure by Sponsor|40|||
17125696|NCT02572167|38265593|FG002|Overall Study|Study closure by Sponsor|24|||
17125697|NCT01336738|38265607|FG000|Overall Study|Adverse Event|0|||
17125698|NCT01336738|38265608|FG001|Overall Study|Adverse Event|3|||
17125699|NCT01336738|38265609|FG002|Overall Study|Adverse Event|2|||
17125700|NCT01336738|38265610|FG003|Overall Study|Adverse Event|1|||
17125701|NCT01336738|38265611|FG004|Overall Study|Adverse Event|3|||
17125702|NCT01336738|38265607|FG000|Overall Study|Lost to Follow-up|2|||
17125703|NCT01336738|38265608|FG001|Overall Study|Lost to Follow-up|1|||
17125704|NCT01336738|38265609|FG002|Overall Study|Lost to Follow-up|2|||
17125705|NCT01336738|38265610|FG003|Overall Study|Lost to Follow-up|2|||
17125706|NCT01336738|38265611|FG004|Overall Study|Lost to Follow-up|2|||
17125707|NCT01336738|38265607|FG000|Overall Study|Did not meet entrance criteria|0|||
17125708|NCT01336738|38265608|FG001|Overall Study|Did not meet entrance criteria|1|||
17125709|NCT01336738|38265609|FG002|Overall Study|Did not meet entrance criteria|0|||
17125710|NCT01336738|38265610|FG003|Overall Study|Did not meet entrance criteria|0|||
17125711|NCT01336738|38265611|FG004|Overall Study|Did not meet entrance criteria|0|||
17125712|NCT01336738|38265607|FG000|Overall Study|Protocol Violation|0|||
17125713|NCT01336738|38265608|FG001|Overall Study|Protocol Violation|1|||
17125714|NCT01336738|38265609|FG002|Overall Study|Protocol Violation|0|||
17125715|NCT01336738|38265610|FG003|Overall Study|Protocol Violation|0|||
17125716|NCT01336738|38265611|FG004|Overall Study|Protocol Violation|0|||
17125717|NCT01336738|38265607|FG000|Overall Study|Withdrawal by Subject|2|||
17125718|NCT01336738|38265608|FG001|Overall Study|Withdrawal by Subject|0|||
17125719|NCT01336738|38265609|FG002|Overall Study|Withdrawal by Subject|2|||
17125720|NCT01336738|38265610|FG003|Overall Study|Withdrawal by Subject|1|||
17125721|NCT01336738|38265611|FG004|Overall Study|Withdrawal by Subject|1|||
17125722|NCT01336738|38265607|FG000|Overall Study|Other|3|||
17125723|NCT01336738|38265608|FG001|Overall Study|Other|3|||
17125724|NCT01336738|38265609|FG002|Overall Study|Other|2|||
17125725|NCT01336738|38265610|FG003|Overall Study|Other|3|||
17125726|NCT01336738|38265611|FG004|Overall Study|Other|4|||
17125727|NCT02258451|38265625|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88|||
17125728|NCT02258451|38265626|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95|||
17125729|NCT02258451|38265625|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6|||
17125730|NCT02258451|38265626|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
17125731|NCT02258451|38265625|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
17125732|NCT02258451|38265626|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
17125733|NCT02258451|38265625|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
17125734|NCT02258451|38265626|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
17125735|NCT02258451|38265625|FG000|Overall Study|Death|4|||
17125736|NCT02258451|38265626|FG001|Overall Study|Death|3|||
17125737|NCT02258451|38265625|FG000|Overall Study|Withdrawal by Subject|21|||
17125738|NCT02258451|38265626|FG001|Overall Study|Withdrawal by Subject|12|||
17125739|NCT02258451|38265625|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1|||
17125740|NCT02258451|38265626|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0|||
17125741|NCT02258451|38265625|FG000|Overall Study|Discontinuation all treatment due to event point reached|1|||
17125742|NCT02258451|38265626|FG001|Overall Study|Discontinuation all treatment due to event point reached|1|||
17125743|NCT02258451|38265625|FG000|Overall Study|Physician Decision|0|||
17125744|NCT02258451|38265626|FG001|Overall Study|Physician Decision|2|||
17125745|NCT02258451|38265625|FG000|Overall Study|Never treated|2|||
17125746|NCT02258451|38265626|FG001|Overall Study|Never treated|3|||
17125747|NCT02258451|38265625|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3|||
17125748|NCT02258451|38265626|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11|||
17125749|NCT02865538|38265639|FG000|Overall Study|Withdrawal by Subject|0|||
17125750|NCT02865538|38265640|FG001|Overall Study|Withdrawal by Subject|0|||
17125751|NCT02865538|38265641|FG002|Overall Study|Withdrawal by Subject|1|||
17125752|NCT02865538|38265642|FG003|Overall Study|Withdrawal by Subject|0|||
17125753|NCT02865538|38265643|FG004|Overall Study|Withdrawal by Subject|0|||
17125754|NCT02865538|38265639|FG000|Overall Study|Lost to Follow-up|1|||
17125755|NCT02865538|38265640|FG001|Overall Study|Lost to Follow-up|0|||
17125756|NCT02865538|38265641|FG002|Overall Study|Lost to Follow-up|0|||
17125757|NCT02865538|38265642|FG003|Overall Study|Lost to Follow-up|0|||
17125758|NCT02865538|38265643|FG004|Overall Study|Lost to Follow-up|0|||
17125759|NCT02860546|38265655|FG000|Overall Study|Clinical Progression|6|||
17125760|NCT02860546|38265655|FG000|Overall Study|Radiological Progression|12|||
17125761|NCT01982955|38265664|FG000|Overall Study|Randomized but not treated|0|||
17125762|NCT01982955|38265665|FG001|Overall Study|Randomized but not treated|0|||
17125763|NCT01982955|38265666|FG002|Overall Study|Randomized but not treated|0|||
17125764|NCT01982955|38265667|FG003|Overall Study|Randomized but not treated|1|||
17125765|NCT01982955|38265668|FG004|Overall Study|Randomized but not treated|0|||
17125766|NCT00396279|38265681|FG000|Overall Study|Ongoing in study|26|||
17125767|NCT00396279|38265681|FG000|Overall Study|Disease progression|2|||
17125768|NCT00396279|38265681|FG000|Overall Study|Withdrawal by Subject|1|||
17125769|NCT00396279|38265681|FG000|Overall Study|Physician Decision|1|||
17125770|NCT01347866|38265702|FG000|Overall Study|Death|0|||
17125771|NCT01347866|38265703|FG001|Overall Study|Death|0|||
17125772|NCT01347866|38265704|FG002|Overall Study|Death|0|||
17125773|NCT01347866|38265705|FG003|Overall Study|Death|1|||
17125774|NCT01347866|38265706|FG004|Overall Study|Death|2|||
17125775|NCT01347866|38265707|FG005|Overall Study|Death|2|||
17125776|NCT01347866|38265708|FG006|Overall Study|Death|1|||
17125777|NCT01347866|38265709|FG007|Overall Study|Death|0|||
17125778|NCT01347866|38265710|FG008|Overall Study|Death|4|||
17125779|NCT01347866|38265711|FG009|Overall Study|Death|1|||
17125780|NCT01347866|38265712|FG010|Overall Study|Death|3|||
17125781|NCT01347866|38265713|FG011|Overall Study|Death|1|||
17125782|NCT01347866|38265714|FG012|Overall Study|Death|2|||
17125783|NCT01347866|38265715|FG013|Overall Study|Death|0|||
17125784|NCT01347866|38265716|FG014|Overall Study|Death|0|||
17125785|NCT01347866|38265717|FG015|Overall Study|Death|1|||
17125786|NCT01347866|38265718|FG016|Overall Study|Death|0|||
17125787|NCT01347866|38265702|FG000|Overall Study|Lost to Follow-up|0|||
17125788|NCT01347866|38265703|FG001|Overall Study|Lost to Follow-up|0|||
17125789|NCT01347866|38265704|FG002|Overall Study|Lost to Follow-up|0|||
17125790|NCT01347866|38265705|FG003|Overall Study|Lost to Follow-up|0|||
17125791|NCT01347866|38265706|FG004|Overall Study|Lost to Follow-up|0|||
17125792|NCT01347866|38265707|FG005|Overall Study|Lost to Follow-up|0|||
17125793|NCT01347866|38265708|FG006|Overall Study|Lost to Follow-up|0|||
17125794|NCT01347866|38265709|FG007|Overall Study|Lost to Follow-up|1|||
17125795|NCT01347866|38265710|FG008|Overall Study|Lost to Follow-up|1|||
17125796|NCT01347866|38265711|FG009|Overall Study|Lost to Follow-up|0|||
17125797|NCT01347866|38265712|FG010|Overall Study|Lost to Follow-up|0|||
17125798|NCT01347866|38265713|FG011|Overall Study|Lost to Follow-up|0|||
17125799|NCT01347866|38265714|FG012|Overall Study|Lost to Follow-up|0|||
17125800|NCT01347866|38265715|FG013|Overall Study|Lost to Follow-up|0|||
17125801|NCT01347866|38265716|FG014|Overall Study|Lost to Follow-up|0|||
17125802|NCT01347866|38265717|FG015|Overall Study|Lost to Follow-up|0|||
17125803|NCT01347866|38265718|FG016|Overall Study|Lost to Follow-up|0|||
17125804|NCT01347866|38265702|FG000|Overall Study|Other|3|||
17125805|NCT01347866|38265703|FG001|Overall Study|Other|1|||
17125806|NCT01347866|38265704|FG002|Overall Study|Other|1|||
17125807|NCT01347866|38265705|FG003|Overall Study|Other|4|||
17125808|NCT01347866|38265706|FG004|Overall Study|Other|5|||
17125809|NCT01347866|38265707|FG005|Overall Study|Other|0|||
17125810|NCT01347866|38265708|FG006|Overall Study|Other|5|||
17125811|NCT01347866|38265709|FG007|Overall Study|Other|3|||
17125812|NCT01347866|38265710|FG008|Overall Study|Other|22|||
17125813|NCT01347866|38265711|FG009|Overall Study|Other|5|||
17125814|NCT01347866|38265712|FG010|Overall Study|Other|0|||
17125815|NCT01347866|38265713|FG011|Overall Study|Other|3|||
17125816|NCT01347866|38265714|FG012|Overall Study|Other|4|||
17125817|NCT01347866|38265715|FG013|Overall Study|Other|4|||
17125818|NCT01347866|38265716|FG014|Overall Study|Other|2|||
17125819|NCT01347866|38265717|FG015|Overall Study|Other|3|||
17125820|NCT01347866|38265718|FG016|Overall Study|Other|0|||
17125821|NCT01347866|38265702|FG000|Overall Study|Subject refused further follow-up|2|||
17125822|NCT01347866|38265703|FG001|Overall Study|Subject refused further follow-up|0|||
17125823|NCT01347866|38265704|FG002|Overall Study|Subject refused further follow-up|0|||
17125824|NCT01347866|38265705|FG003|Overall Study|Subject refused further follow-up|2|||
17125825|NCT01347866|38265706|FG004|Overall Study|Subject refused further follow-up|0|||
17125826|NCT01347866|38265707|FG005|Overall Study|Subject refused further follow-up|1|||
17125827|NCT01347866|38265708|FG006|Overall Study|Subject refused further follow-up|0|||
17125828|NCT01347866|38265709|FG007|Overall Study|Subject refused further follow-up|0|||
17125829|NCT01347866|38265710|FG008|Overall Study|Subject refused further follow-up|4|||
17125830|NCT01347866|38265711|FG009|Overall Study|Subject refused further follow-up|1|||
17125831|NCT01347866|38265712|FG010|Overall Study|Subject refused further follow-up|0|||
17125832|NCT01347866|38265713|FG011|Overall Study|Subject refused further follow-up|0|||
17125833|NCT01347866|38265714|FG012|Overall Study|Subject refused further follow-up|1|||
17125834|NCT01347866|38265715|FG013|Overall Study|Subject refused further follow-up|3|||
17125835|NCT01347866|38265716|FG014|Overall Study|Subject refused further follow-up|1|||
17125836|NCT01347866|38265717|FG015|Overall Study|Subject refused further follow-up|0|||
17125837|NCT01347866|38265718|FG016|Overall Study|Subject refused further follow-up|2|||
17125838|NCT01347710|38265789|FG000|Overall Study|Withdrawal by Subject|2|||
17125839|NCT01347710|38265789|FG000|Overall Study|Adverse Event|4|||
17125840|NCT01347710|38265789|FG000|Overall Study|Angio or SPECT not completed|18|||
17125841|NCT01347710|38265789|FG000|Overall Study|issue with vitals prior to dosing|1|||
17125842|NCT01347710|38265789|FG000|Overall Study|Lost to Follow-up|1|||
17125843|NCT01347710|38265789|FG000|Overall Study|Physician Decision|2|||
17125844|NCT01347710|38265789|FG000|Overall Study|Other|3|||
17125845|NCT03485222|38265799|FG000|Overall Study|Death|0|||
17125846|NCT03485222|38265800|FG001|Overall Study|Death|1|||
17125847|NCT03485222|38265799|FG000|Overall Study|Lost to Follow-up|2|||
17125848|NCT03485222|38265800|FG001|Overall Study|Lost to Follow-up|1|||
17125849|NCT01347554|38265808|FG000|Overall Study|Lack of Efficacy|7|||
17125850|NCT01347554|38265809|FG001|Overall Study|Lack of Efficacy|11|||
17125851|NCT03482882|38265815|FG000|Overall Study|Adverse Event|3|||
17125852|NCT03482882|38265815|FG000|Overall Study|Lost to Follow-up|1|||
17125853|NCT03482882|38265815|FG000|Overall Study|Protocol Violation|2|||
17125854|NCT03482882|38265815|FG000|Overall Study|Not further specified|1|||
17125855|NCT03480932|38265822|FG000|Overall Study|Death|1|||
17125856|NCT03480932|38265823|FG001|Overall Study|Death|1|||
17125857|NCT03480932|38265824|FG002|Overall Study|Death|0|||
17125858|NCT03480932|38265822|FG000|Overall Study|Lost to Follow-up|0|||
17125859|NCT03480932|38265823|FG001|Overall Study|Lost to Follow-up|2|||
17125860|NCT03480932|38265824|FG002|Overall Study|Lost to Follow-up|3|||
17125861|NCT03480932|38265822|FG000|Overall Study|Incarcerated|2|||
17125862|NCT03480932|38265823|FG001|Overall Study|Incarcerated|2|||
17125863|NCT03480932|38265824|FG002|Overall Study|Incarcerated|2|||
17125864|NCT03387020|38265835|FG000|Overall Study|Adverse Event|0|||
17125865|NCT03387020|38265836|FG001|Overall Study|Adverse Event|2|||
17125866|NCT03387020|38265837|FG002|Overall Study|Adverse Event|0|||
17125867|NCT03387020|38265835|FG000|Overall Study|Withdrawal by Subject|2|||
17125868|NCT03387020|38265836|FG001|Overall Study|Withdrawal by Subject|0|||
17125869|NCT03387020|38265837|FG002|Overall Study|Withdrawal by Subject|0|||
17125870|NCT03386474|38265857|FG000|Overall Study|Death|1|||
17125871|NCT03386474|38265858|FG001|Overall Study|Death|0|||
17125872|NCT03386474|38265857|FG000|Overall Study|Adverse Event|0|||
17125873|NCT03386474|38265858|FG001|Overall Study|Adverse Event|1|||
17125874|NCT02446600|38265873|FG000|Overall Study|Never treated|20|||
17125875|NCT02446600|38265874|FG001|Overall Study|Never treated|2|||
17125876|NCT02446600|38265875|FG002|Overall Study|Never treated|6|||
17125877|NCT02446600|38265876|FG003|Overall Study|Never treated|0|||
17125878|NCT02446600|38265873|FG000|Overall Study|Withdrawal by Subject|19|||
17125879|NCT02446600|38265874|FG001|Overall Study|Withdrawal by Subject|5|||
17125880|NCT02446600|38265875|FG002|Overall Study|Withdrawal by Subject|17|||
17125881|NCT02446600|38265876|FG003|Overall Study|Withdrawal by Subject|0|||
17125882|NCT02446600|38265873|FG000|Overall Study|Ineligible|1|||
17125883|NCT02446600|38265874|FG001|Overall Study|Ineligible|4|||
17125884|NCT02446600|38265875|FG002|Overall Study|Ineligible|4|||
17125885|NCT02446600|38265876|FG003|Overall Study|Ineligible|1|||
17125886|NCT02446600|38265873|FG000|Overall Study|Duplicate Enrollment|0|||
17125887|NCT02446600|38265874|FG001|Overall Study|Duplicate Enrollment|1|||
17125888|NCT02446600|38265875|FG002|Overall Study|Duplicate Enrollment|0|||
17125889|NCT02446600|38265876|FG003|Overall Study|Duplicate Enrollment|0|||
17125890|NCT03405818|38265886|FG000|Overall Study|Withdrawal by Subject|4|||
17125891|NCT03405818|38265886|FG000|Overall Study|Lost to Follow-up|4|||
17125892|NCT03403634|38265890|FG000|Overall Study|Disease progression|3|||
17125893|NCT03403634|38265890|FG000|Overall Study|Did not meet eligibility criteria|4|||
17125894|NCT03403400|38265897|FG000|Overall Study|Lost to Follow-up|1|||
17125895|NCT03403400|38265898|FG001|Overall Study|Lost to Follow-up|0|||
17125896|NCT03403400|38265899|FG002|Overall Study|Lost to Follow-up|1|||
17125897|NCT03403400|38265897|FG000|Overall Study|Hospitalization|1|||
17125898|NCT03403400|38265898|FG001|Overall Study|Hospitalization|0|||
17125899|NCT03403400|38265899|FG002|Overall Study|Hospitalization|0|||
17125900|NCT03403400|38265897|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
17125901|NCT03403400|38265898|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
17125902|NCT03403400|38265899|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
17125903|NCT02863354|38265924|FG000|Year 1|Lost to Follow-up|1|||
17125904|NCT02863354|38265925|FG001|Year 1|Lost to Follow-up|1|||
17125905|NCT02863354|38265924|FG000|Year 1|Withdrawal by Subject|3|||
17125906|NCT02863354|38265925|FG001|Year 1|Withdrawal by Subject|0|||
17125907|NCT02863354|38265924|FG000|Year 1|Death|0|||
17125908|NCT02863354|38265925|FG001|Year 1|Death|1|||
17125909|NCT02863354|38265924|FG000|Year 2|Lost to Follow-up|2|||
17125910|NCT02863354|38265925|FG001|Year 2|Lost to Follow-up|2|||
17125911|NCT03480152|38265933|FG000|Phase I|Signed consent. Died before treatment.|1|||
17125912|NCT03480152|38265934|FG001|Phase I|Signed consent. Died before treatment.|0|||
17125913|NCT03480152|38265935|FG002|Phase I|Signed consent. Died before treatment.|0|||
17125914|NCT02859454|38265943|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
17125915|NCT02862730|38265950|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
17125916|NCT02862730|38265951|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
17125917|NCT02862730|38265952|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
17125918|NCT02862730|38265953|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
17125919|NCT02862730|38265954|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
17125920|NCT02862730|38265955|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
17125921|NCT02862730|38265956|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
17125922|NCT02862730|38265950|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
17125923|NCT02862730|38265951|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
17125924|NCT02862730|38265952|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
17125925|NCT02862730|38265953|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
17125926|NCT02862730|38265954|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
17125927|NCT02862730|38265955|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
17125928|NCT02862730|38265956|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
17125929|NCT02862730|38265950|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
17125930|NCT02862730|38265951|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
17125931|NCT02862730|38265952|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
17125932|NCT02862730|38265953|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
17125933|NCT02862730|38265954|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
17125934|NCT02862730|38265955|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
17125935|NCT02862730|38265956|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
17125936|NCT02862730|38265950|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
17125937|NCT02862730|38265951|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
17125938|NCT02862730|38265952|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
17125939|NCT02862730|38265953|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
17125940|NCT02862730|38265954|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
17125941|NCT02862730|38265955|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
17125942|NCT02862730|38265956|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
17125943|NCT03402386|38265971|FG000|Overall Study|Adverse Event|3|||
17125944|NCT03402386|38265971|FG000|Overall Study|Physician Decision|1|||
17125945|NCT03402386|38265971|FG000|Overall Study|Difficult to control Hb|2|||
17125946|NCT03401450|38265977|FG000|Overall Study|Lost to Follow-up|4|||
17125947|NCT03401450|38265978|FG001|Overall Study|Lost to Follow-up|6|||
17125948|NCT03401450|38265977|FG000|Overall Study|Anesthesia plan changed|2|||
17125949|NCT03401450|38265978|FG001|Overall Study|Anesthesia plan changed|2|||
17125950|NCT03401450|38265977|FG000|Overall Study|Did not complete medication diary|4|||
17125951|NCT03401450|38265978|FG001|Overall Study|Did not complete medication diary|2|||
17125952|NCT03401450|38265977|FG000|Overall Study|post surgery medication change|2|||
17125953|NCT03401450|38265978|FG001|Overall Study|post surgery medication change|1|||
17125954|NCT03401450|38265977|FG000|Overall Study|Cancelled surgery|0|||
17125955|NCT03401450|38265978|FG001|Overall Study|Cancelled surgery|2|||
17125956|NCT03353792|38265986|FG000|Overall Study|Lost to Follow-up|1|||
17125957|NCT03353792|38265987|FG001|Overall Study|Lost to Follow-up|0|||
17125958|NCT03353792|38265986|FG000|Overall Study|Participant Unable to Manage Device|1|||
17125959|NCT03353792|38265987|FG001|Overall Study|Participant Unable to Manage Device|0|||
17125960|NCT02862574|38265996|FG000|Double-Blind Treatment Period|Adverse Event|0|||
17125961|NCT02862574|38265997|FG001|Double-Blind Treatment Period|Adverse Event|1|||
17125962|NCT02862574|38265998|FG002|Double-Blind Treatment Period|Adverse Event|0|||
17125963|NCT02862574|38265996|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
17125964|NCT02862574|38265997|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
17125965|NCT02862574|38265998|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
17125966|NCT02862574|38265996|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
17125967|NCT02862574|38265997|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
17125968|NCT02862574|38265998|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
17125969|NCT02862106|38266013|FG000|Overall Study|Adverse Event|4|||
17125970|NCT02862106|38266014|FG001|Overall Study|Adverse Event|0|||
17125971|NCT02862106|38266013|FG000|Overall Study|Protocol Violation|16|||
17125972|NCT02862106|38266014|FG001|Overall Study|Protocol Violation|1|||
17125973|NCT02862106|38266013|FG000|Overall Study|Lost to Follow-up|15|||
17125974|NCT02862106|38266014|FG001|Overall Study|Lost to Follow-up|5|||
16942102|NCT01371747|38086669|FG005|Overall Study|Death|0|||
17125975|NCT02862106|38266013|FG000|Overall Study|Withdrawal by Subject|2|||
17125976|NCT02862106|38266014|FG001|Overall Study|Withdrawal by Subject|0|||
17125977|NCT02862106|38266013|FG000|Overall Study|Subjects moved to other city|1|||
17125978|NCT02862106|38266014|FG001|Overall Study|Subjects moved to other city|0|||
16942103|NCT01371747|38086664|FG000|Overall Study|Abnormal Renal Function|0|||
17125979|NCT04157296|38266029|FG000|Overall Study|Withdrawal by Subject|0|||
17125980|NCT04157296|38266030|FG001|Overall Study|Withdrawal by Subject|1|||
17125981|NCT04157296|38266029|FG000|Overall Study|Did not obtain second fMRI.|0|||
17125982|NCT04157296|38266030|FG001|Overall Study|Did not obtain second fMRI.|1|||
17125983|NCT04157296|38266029|FG000|Overall Study|MRI failed/no second fMRI|0|||
17125984|NCT04157296|38266030|FG001|Overall Study|MRI failed/no second fMRI|1|||
17125985|NCT02859142|38266038|FG000|Overall Study|Adverse Event|1|||
17125986|NCT02859142|38266039|FG001|Overall Study|Adverse Event|2|||
17125987|NCT02859142|38266038|FG000|Overall Study|Lost to Follow-up|1|||
17125988|NCT02859142|38266039|FG001|Overall Study|Lost to Follow-up|4|||
17125989|NCT02859142|38266038|FG000|Overall Study|Withdrawal by Subject|2|||
17125990|NCT02859142|38266039|FG001|Overall Study|Withdrawal by Subject|0|||
17125991|NCT02859142|38266038|FG000|Overall Study|Scheduling difficulties|0|||
17125992|NCT02859142|38266039|FG001|Overall Study|Scheduling difficulties|3|||
17125993|NCT03351608|38266050|FG000|Overall Study|Lost to Follow-up|0|||
17125994|NCT03351608|38266051|FG001|Overall Study|Lost to Follow-up|1|||
17125995|NCT03351608|38266052|FG002|Overall Study|Lost to Follow-up|1|||
17125996|NCT03351608|38266053|FG003|Overall Study|Lost to Follow-up|1|||
17125997|NCT03351608|38266054|FG004|Overall Study|Lost to Follow-up|1|||
17125998|NCT03351608|38266050|FG000|Overall Study|Physician Decision|1|||
17125999|NCT03351608|38266051|FG001|Overall Study|Physician Decision|0|||
17126000|NCT03351608|38266052|FG002|Overall Study|Physician Decision|0|||
17126001|NCT03351608|38266053|FG003|Overall Study|Physician Decision|2|||
17126002|NCT03351608|38266054|FG004|Overall Study|Physician Decision|1|||
17126003|NCT03351608|38266050|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
17126004|NCT03351608|38266051|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
17126005|NCT03351608|38266052|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
17126006|NCT03351608|38266053|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
17126007|NCT03351608|38266054|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
17126008|NCT03351608|38266050|FG000|Overall Study|Withdrawal by parent/guardian|0|||
17126009|NCT03351608|38266051|FG001|Overall Study|Withdrawal by parent/guardian|0|||
17126010|NCT03351608|38266052|FG002|Overall Study|Withdrawal by parent/guardian|1|||
17126011|NCT03351608|38266053|FG003|Overall Study|Withdrawal by parent/guardian|1|||
17126012|NCT03351608|38266054|FG004|Overall Study|Withdrawal by parent/guardian|0|||
17126013|NCT03351608|38266050|FG000|Overall Study|Other|0|||
17126014|NCT03351608|38266051|FG001|Overall Study|Other|1|||
17126015|NCT03351608|38266052|FG002|Overall Study|Other|1|||
17126016|NCT03351608|38266053|FG003|Overall Study|Other|3|||
17126017|NCT03351608|38266054|FG004|Overall Study|Other|0|||
17126018|NCT02857816|38266077|FG000|Overall Study|Screen Failure|33|||
17126019|NCT02857816|38266077|FG000|Overall Study|Withdrawal by Subject|4|||
17126020|NCT02857816|38266077|FG000|Overall Study|Lost to Follow-up|1|||
17126021|NCT02858440|38266082|FG000|Overall Study|Lost to Follow-up|3|||
17126022|NCT02858440|38266082|FG000|Overall Study|Protocol Violation|2|||
17126023|NCT02858440|38266082|FG000|Overall Study|Consent withdrawal|3|||
17126024|NCT02858440|38266082|FG000|Overall Study|Migrated/moved from study area|4|||
17126025|NCT03382418|38266089|FG000|Overall Study|Withdrawal by Subject|1|||
17126026|NCT03382418|38266090|FG001|Overall Study|Withdrawal by Subject|0|||
17126027|NCT03382418|38266091|FG002|Overall Study|Withdrawal by Subject|0|||
17126028|NCT03382418|38266089|FG000|Overall Study|Lost to Follow-up|2|||
17126029|NCT03382418|38266090|FG001|Overall Study|Lost to Follow-up|3|||
17126030|NCT03382418|38266091|FG002|Overall Study|Lost to Follow-up|0|||
17126031|NCT02858362|38266103|FG000|Overall Study|Protocol Violation|0|||
17126032|NCT02858362|38266104|FG001|Overall Study|Protocol Violation|1|||
17126033|NCT02858362|38266105|FG002|Overall Study|Protocol Violation|0|||
17126034|NCT02858362|38266103|FG000|Overall Study|Withdrawal by Subject|1|||
17126035|NCT02858362|38266104|FG001|Overall Study|Withdrawal by Subject|0|||
17126036|NCT02858362|38266105|FG002|Overall Study|Withdrawal by Subject|0|||
17126037|NCT02858362|38266103|FG000|Overall Study|Early Study Termination|0|||
17126038|NCT02858362|38266104|FG001|Overall Study|Early Study Termination|0|||
17126039|NCT02858362|38266105|FG002|Overall Study|Early Study Termination|3|||
17126040|NCT02858362|38266103|FG000|Overall Study|Lost to Follow-up|1|||
17126041|NCT02858362|38266104|FG001|Overall Study|Lost to Follow-up|0|||
17126042|NCT02858362|38266105|FG002|Overall Study|Lost to Follow-up|0|||
16942104|NCT01371747|38086665|FG001|Overall Study|Abnormal Renal Function|2|||
17126043|NCT03382262|38266122|FG000|Overall Study|Physician Decision|0|||
17126044|NCT03382262|38266123|FG001|Overall Study|Physician Decision|0|||
17126045|NCT03382262|38266124|FG002|Overall Study|Physician Decision|1|||
17126046|NCT03382262|38266125|FG003|Overall Study|Physician Decision|0|||
17126047|NCT03382262|38266122|FG000|Overall Study|Withdrawal by Subject|0|||
17126048|NCT03382262|38266123|FG001|Overall Study|Withdrawal by Subject|0|||
17126049|NCT03382262|38266124|FG002|Overall Study|Withdrawal by Subject|0|||
17126050|NCT03382262|38266125|FG003|Overall Study|Withdrawal by Subject|1|||
17126051|NCT03350750|38266137|FG000|Overall Study|Death|1|||
17126052|NCT03350750|38266138|FG001|Overall Study|Death|1|||
17126053|NCT03394508|38266148|FG000|Overall Study|Protocol Violation|0|||
17126054|NCT03394508|38266149|FG001|Overall Study|Protocol Violation|3|||
17126055|NCT03394508|38266148|FG000|Overall Study|Lost to Follow-up|1|||
17126056|NCT03394508|38266149|FG001|Overall Study|Lost to Follow-up|0|||
17126057|NCT02856880|38266159|FG000|Overall Study|Withdrawal of consent|1|||
17126058|NCT03393806|38266180|FG000|Overall Study|Physician Decision|1|||
17126059|NCT03393806|38266181|FG001|Overall Study|Physician Decision|0|||
17126060|NCT02856802|38266190|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
17126061|NCT02856802|38266191|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
17126062|NCT02856802|38266190|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
17126063|NCT02856802|38266191|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
17126064|NCT02856802|38266190|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
17126065|NCT02856802|38266191|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
17126066|NCT02856802|38266190|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
17126067|NCT02856802|38266191|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
17126068|NCT02856802|38266190|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
17126069|NCT02856802|38266191|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
17126070|NCT02856802|38266190|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
17126071|NCT02856802|38266191|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
17126072|NCT03381248|38266203|FG000|Overall Study|Withdrawal by Subject|5|||
17126073|NCT03381248|38266204|FG001|Overall Study|Withdrawal by Subject|3|||
17126074|NCT03381248|38266203|FG000|Overall Study|Lost to Follow-up|3|||
17126075|NCT03381248|38266204|FG001|Overall Study|Lost to Follow-up|2|||
17126076|NCT03381248|38266203|FG000|Overall Study|Lack of Efficacy|1|||
17126077|NCT03381248|38266204|FG001|Overall Study|Lack of Efficacy|0|||
17126078|NCT03381248|38266203|FG000|Overall Study|Adverse Event|2|||
17126079|NCT03381248|38266204|FG001|Overall Study|Adverse Event|0|||
17126080|NCT03381248|38266203|FG000|Overall Study|Protocol Violation|2|||
17126081|NCT03381248|38266204|FG001|Overall Study|Protocol Violation|1|||
17126082|NCT03380390|38266210|FG000|Overall Study|Adverse Event|3|||
17126083|NCT03350672|38266217|FG000|Overall Study|Withdrawal by Subject|7|||
17126084|NCT03350672|38266218|FG001|Overall Study|Withdrawal by Subject|0|||
17126085|NCT03350672|38266219|FG002|Overall Study|Withdrawal by Subject|0|||
17126086|NCT03392168|38266231|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
17126087|NCT03392168|38266232|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
17126088|NCT03392168|38266233|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
17126089|NCT03392168|38266234|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
17126090|NCT03392168|38266231|FG000|Period 2: Cohort 2|Other|0|||
17126091|NCT03392168|38266232|FG001|Period 2: Cohort 2|Other|1|||
17126092|NCT03392168|38266233|FG002|Period 2: Cohort 2|Other|0|||
17126093|NCT03392168|38266234|FG003|Period 2: Cohort 2|Other|0|||
17126094|NCT03391232|38266245|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
17126095|NCT03391232|38266246|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
17126096|NCT03391232|38266245|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
17126097|NCT03391232|38266246|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
17126098|NCT03379376|38266254|FG000|Overall Study|Lost to Follow-up|2|||
17126099|NCT03379376|38266254|FG000|Overall Study|Did not wish to complete follow up|1|||
17126100|NCT03379376|38266254|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
17126101|NCT03379376|38266254|FG000|Overall Study|Death|1|||
17126102|NCT03349034|38266260|FG000|Overall Study|catheters dislodged during transport|2|||
17126103|NCT03349034|38266261|FG001|Overall Study|catheters dislodged during transport|0|||
17126104|NCT03349034|38266260|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
17126105|NCT03349034|38266261|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
17126106|NCT03349034|38266260|FG000|Overall Study|soft tissue flap used|1|||
17126107|NCT03349034|38266261|FG001|Overall Study|soft tissue flap used|0|||
17126108|NCT03349034|38266260|FG000|Overall Study|Other|0|||
17126109|NCT03349034|38266261|FG001|Overall Study|Other|1|||
17126110|NCT00358215|38266271|FG000|Overall Study|Ineligibility determined|4|||
17126111|NCT00358215|38266272|FG001|Overall Study|Ineligibility determined|3|||
17126112|NCT00358215|38266271|FG000|Overall Study|Adverse Event|83|||
17126113|NCT00358215|38266272|FG001|Overall Study|Adverse Event|65|||
17126114|NCT00358215|38266271|FG000|Overall Study|Withdrawal by Subject|111|||
17126115|NCT00358215|38266272|FG001|Overall Study|Withdrawal by Subject|102|||
17126116|NCT00358215|38266271|FG000|Overall Study|Participant request|65|||
17126117|NCT00358215|38266272|FG001|Overall Study|Participant request|64|||
17126118|NCT00358215|38266271|FG000|Overall Study|Physician Decision|47|||
17126119|NCT00358215|38266272|FG001|Overall Study|Physician Decision|39|||
17126120|NCT00358215|38266271|FG000|Overall Study|Lost to Follow-up|16|||
17126121|NCT00358215|38266272|FG001|Overall Study|Lost to Follow-up|22|||
17126122|NCT00358215|38266271|FG000|Overall Study|Death|265|||
17126123|NCT00358215|38266272|FG001|Overall Study|Death|281|||
17126124|NCT00358215|38266271|FG000|Overall Study|Protocol Violation|64|||
17126125|NCT00358215|38266272|FG001|Overall Study|Protocol Violation|59|||
17126126|NCT00358215|38266271|FG000|Overall Study|Pregnancy|1|||
17126127|NCT00358215|38266272|FG001|Overall Study|Pregnancy|0|||
17126128|NCT00358215|38266271|FG000|Overall Study|Other|21|||
17126129|NCT00358215|38266272|FG001|Overall Study|Other|14|||
17126130|NCT00358215|38266271|FG000|Overall Study|Did not receive investigational product|2|||
17126131|NCT00358215|38266272|FG001|Overall Study|Did not receive investigational product|3|||
17126132|NCT02855164|38266286|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
17126133|NCT02855164|38266287|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
17126134|NCT02855164|38266288|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
17126135|NCT02855164|38266289|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
17126136|NCT02855164|38266290|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
17126137|NCT02855164|38266291|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
17126138|NCT02855164|38266292|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
17126139|NCT02855164|38266293|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
17126140|NCT02855164|38266286|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
17126141|NCT02855164|38266287|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
17126142|NCT02855164|38266288|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
17126143|NCT02855164|38266289|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
17126144|NCT02855164|38266290|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
17126145|NCT02855164|38266291|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
17126146|NCT02855164|38266292|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
17126147|NCT02855164|38266293|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
17126148|NCT02855164|38266286|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
17126149|NCT02855164|38266287|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
17126150|NCT02855164|38266288|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
17126151|NCT02855164|38266289|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
17126152|NCT02855164|38266290|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
17126153|NCT02855164|38266291|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
17126154|NCT02855164|38266292|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
17126155|NCT02855164|38266293|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
17126156|NCT02855164|38266286|FG000|Part C (Randomized Set)|Adverse Event|0|||
17126157|NCT02855164|38266287|FG001|Part C (Randomized Set)|Adverse Event|0|||
17126158|NCT02855164|38266288|FG002|Part C (Randomized Set)|Adverse Event|0|||
17126159|NCT02855164|38266289|FG003|Part C (Randomized Set)|Adverse Event|0|||
17126160|NCT02855164|38266290|FG004|Part C (Randomized Set)|Adverse Event|0|||
17126161|NCT02855164|38266291|FG005|Part C (Randomized Set)|Adverse Event|5|||
17126162|NCT02855164|38266292|FG006|Part C (Randomized Set)|Adverse Event|9|||
17126163|NCT02855164|38266293|FG007|Part C (Randomized Set)|Adverse Event|2|||
17126164|NCT02855164|38266286|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
17126165|NCT02855164|38266287|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
17126166|NCT02855164|38266288|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
17126167|NCT02855164|38266289|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
17126168|NCT02855164|38266290|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
17126169|NCT02855164|38266291|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
17126170|NCT02855164|38266292|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
17126171|NCT02855164|38266293|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
17126172|NCT02855164|38266286|FG000|Part C (Randomized Set)|Physician Decision|0|||
17126173|NCT02855164|38266287|FG001|Part C (Randomized Set)|Physician Decision|0|||
17126174|NCT02855164|38266288|FG002|Part C (Randomized Set)|Physician Decision|0|||
17126175|NCT02855164|38266289|FG003|Part C (Randomized Set)|Physician Decision|0|||
17126176|NCT02855164|38266290|FG004|Part C (Randomized Set)|Physician Decision|0|||
17126177|NCT02855164|38266291|FG005|Part C (Randomized Set)|Physician Decision|1|||
17126178|NCT02855164|38266292|FG006|Part C (Randomized Set)|Physician Decision|0|||
17126179|NCT02855164|38266293|FG007|Part C (Randomized Set)|Physician Decision|1|||
17126180|NCT02855164|38266286|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
17126181|NCT02855164|38266287|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
17126182|NCT02855164|38266288|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
17126183|NCT02855164|38266289|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
17126184|NCT02855164|38266290|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
17126185|NCT02855164|38266291|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
17126186|NCT02855164|38266292|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
17126187|NCT02855164|38266293|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
17126188|NCT01002742|38266333|FG000|Overall Study|Determined to be ineligible|0|||
17126189|NCT01002742|38266334|FG001|Overall Study|Determined to be ineligible|1|||
17126190|NCT02853760|38266340|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
17126191|NCT02853760|38266341|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
17126192|NCT02853760|38266342|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
17126193|NCT02853760|38266343|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
17126194|NCT02853760|38266344|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
17126195|NCT02853760|38266345|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
17126196|NCT02852434|38266355|FG000|Overall Study|Withdrawal by Subject|0|||
17126197|NCT02852434|38266356|FG001|Overall Study|Withdrawal by Subject|1|||
17126198|NCT02852434|38266355|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
17126199|NCT02852434|38266356|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
17126200|NCT02903368|38266364|FG000|Overall Study|Adverse Event|3|||
17126201|NCT02903368|38266365|FG001|Overall Study|Adverse Event|0|||
17126202|NCT02903368|38266364|FG000|Overall Study|Withdrawal by Subject|1|||
17126203|NCT02903368|38266365|FG001|Overall Study|Withdrawal by Subject|0|||
17126204|NCT02850016|38266373|FG000|Overall Study|Withdrawal by Subject|1|||
17126205|NCT02850016|38266374|FG001|Overall Study|Withdrawal by Subject|2|||
17126206|NCT02849704|38266382|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
17126207|NCT02849704|38266383|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
17126208|NCT02849704|38266382|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
17126209|NCT02849704|38266383|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
17126210|NCT02849704|38266382|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
17126211|NCT02849704|38266383|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
17126212|NCT03347396|38266404|FG000|Part A (26 Weeks)|Adverse Event|1|||
17126213|NCT03347396|38266405|FG001|Part A (26 Weeks)|Adverse Event|0|||
17126214|NCT03347396|38266404|FG000|Part A (26 Weeks)|Death|0|||
17126215|NCT03347396|38266405|FG001|Part A (26 Weeks)|Death|1|||
17126216|NCT03347396|38266404|FG000|Part B (149 Weeks)|Adverse Event|1|||
17126217|NCT03347396|38266405|FG001|Part B (149 Weeks)|Adverse Event|1|||
17126218|NCT03347396|38266404|FG000|Part B (149 Weeks)|Death|1|||
17126219|NCT03347396|38266405|FG001|Part B (149 Weeks)|Death|0|||
17126220|NCT03373760|38266416|FG000|Overall Study|Adverse Event|8|||
17126221|NCT03373760|38266416|FG000|Overall Study|Disease Progression|46|||
17126222|NCT03373760|38266416|FG000|Overall Study|Death|4|||
17126223|NCT03335150|38266425|FG000|Overall Study|Withdrawal by Subject|10|||
17126224|NCT03335150|38266426|FG001|Overall Study|Withdrawal by Subject|4|||
17126225|NCT03335150|38266425|FG000|Overall Study|Adverse Event|0|||
17126226|NCT03335150|38266426|FG001|Overall Study|Adverse Event|1|||
17126227|NCT02949128|38266432|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
17126228|NCT02949128|38266432|FG000|Initial Evaluation Period|Adverse Event|3|||
17126229|NCT02949128|38266432|FG000|Initial Evaluation Period|Death|2|||
17126230|NCT02949128|38266432|FG000|Initial Evaluation Period|Physician Decision|1|||
17126231|NCT02949128|38266432|FG000|Initial Evaluation Period|Protocol Violation|1|||
17126232|NCT02949128|38266432|FG000|Extension Period|Withdrawal by Subject|5|||
17126233|NCT02949128|38266432|FG000|Extension Period|Protocol Violation|1|||
17126234|NCT02949128|38266432|FG000|Extension Period|Physician Decision|2|||
17126235|NCT02949128|38266432|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
17126236|NCT03334448|38266436|FG000|Washout|Personal Reason|0|||
17126237|NCT03334448|38266437|FG001|Washout|Personal Reason|1|||
17126238|NCT03334448|38266438|FG002|Washout|Personal Reason|0|||
17126239|NCT03334448|38266439|FG003|Washout|Personal Reason|0|||
17126240|NCT03334448|38266436|FG000|Washout|Protocol Violation|0|||
17126241|NCT03334448|38266437|FG001|Washout|Protocol Violation|0|||
17126242|NCT03334448|38266438|FG002|Washout|Protocol Violation|0|||
17126243|NCT03334448|38266439|FG003|Washout|Protocol Violation|1|||
17126244|NCT02849080|38266447|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
17126245|NCT02849080|38266448|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
17126246|NCT02849080|38266449|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
17126247|NCT02849080|38266450|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
17126248|NCT02849080|38266447|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
17126249|NCT02849080|38266448|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
17126250|NCT02849080|38266449|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
17126251|NCT02849080|38266450|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
17126252|NCT02849080|38266447|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
17126253|NCT02849080|38266448|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
17126254|NCT02849080|38266449|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
17126255|NCT02849080|38266450|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
17126256|NCT02849080|38266447|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
17126257|NCT02849080|38266448|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
17126258|NCT02849080|38266449|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
17126259|NCT02849080|38266450|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
17126260|NCT02849080|38266447|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
17126261|NCT02849080|38266448|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
17126262|NCT02849080|38266449|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
17126263|NCT02849080|38266450|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
17126264|NCT02849080|38266447|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
17126265|NCT02849080|38266448|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
17126266|NCT02849080|38266449|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
17126267|NCT02849080|38266450|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
17126268|NCT03346070|38266467|FG000|Overall Study|Death|0|||
17126269|NCT03346070|38266468|FG001|Overall Study|Death|0|||
17126270|NCT03346070|38266469|FG002|Overall Study|Death|0|||
17126271|NCT03346070|38266470|FG003|Overall Study|Death|0|||
17126272|NCT03346070|38266471|FG004|Overall Study|Death|1|||
17126273|NCT03346070|38266467|FG000|Overall Study|Lost to Follow-up|0|||
17126274|NCT03346070|38266468|FG001|Overall Study|Lost to Follow-up|1|||
17126275|NCT03346070|38266469|FG002|Overall Study|Lost to Follow-up|2|||
17126276|NCT03346070|38266470|FG003|Overall Study|Lost to Follow-up|0|||
17126277|NCT03346070|38266471|FG004|Overall Study|Lost to Follow-up|0|||
17126278|NCT03346070|38266467|FG000|Overall Study|Physician Decision|0|||
17126279|NCT03346070|38266468|FG001|Overall Study|Physician Decision|0|||
17126280|NCT03346070|38266469|FG002|Overall Study|Physician Decision|0|||
17126281|NCT03346070|38266470|FG003|Overall Study|Physician Decision|1|||
17126282|NCT03346070|38266471|FG004|Overall Study|Physician Decision|1|||
17126283|NCT03346070|38266467|FG000|Overall Study|Withdrawal by Subject|1|||
17126284|NCT03346070|38266468|FG001|Overall Study|Withdrawal by Subject|0|||
17126285|NCT03346070|38266469|FG002|Overall Study|Withdrawal by Subject|0|||
17126286|NCT03346070|38266470|FG003|Overall Study|Withdrawal by Subject|1|||
17126287|NCT03346070|38266471|FG004|Overall Study|Withdrawal by Subject|0|||
17126288|NCT03346070|38266467|FG000|Overall Study|Study medication not received as planned|2|||
17126289|NCT03346070|38266468|FG001|Overall Study|Study medication not received as planned|3|||
17126290|NCT03346070|38266469|FG002|Overall Study|Study medication not received as planned|2|||
17126291|NCT03346070|38266470|FG003|Overall Study|Study medication not received as planned|3|||
17126292|NCT03346070|38266471|FG004|Overall Study|Study medication not received as planned|2|||
17126293|NCT03346070|38266467|FG000|Overall Study|Screen Failure|0|||
17126294|NCT03346070|38266468|FG001|Overall Study|Screen Failure|0|||
17126295|NCT03346070|38266469|FG002|Overall Study|Screen Failure|0|||
17126296|NCT03346070|38266470|FG003|Overall Study|Screen Failure|1|||
17126297|NCT03346070|38266471|FG004|Overall Study|Screen Failure|1|||
17126298|NCT02951780|38266494|FG000|Period 1|Adverse Event|0|||
17126299|NCT02951780|38266495|FG001|Period 1|Adverse Event|0|||
17126300|NCT02951780|38266496|FG002|Period 1|Adverse Event|0|||
17126301|NCT02951780|38266497|FG003|Period 1|Adverse Event|1|||
17126302|NCT02951780|38266498|FG004|Period 1|Adverse Event|0|||
17126303|NCT02951780|38266499|FG005|Period 1|Adverse Event|0|||
17126304|NCT02951780|38266500|FG006|Period 1|Adverse Event|0|||
17126305|NCT02951780|38266501|FG007|Period 1|Adverse Event|0|||
17126306|NCT02951780|38266502|FG008|Period 1|Adverse Event|0|||
17126307|NCT02951780|38266494|FG000|Period 1|Scheduling Conflicts|0|||
17126308|NCT02951780|38266495|FG001|Period 1|Scheduling Conflicts|0|||
17126309|NCT02951780|38266496|FG002|Period 1|Scheduling Conflicts|0|||
17126310|NCT02951780|38266497|FG003|Period 1|Scheduling Conflicts|0|||
17126311|NCT02951780|38266498|FG004|Period 1|Scheduling Conflicts|0|||
17126312|NCT02951780|38266499|FG005|Period 1|Scheduling Conflicts|0|||
17126313|NCT02951780|38266500|FG006|Period 1|Scheduling Conflicts|0|||
17126314|NCT02951780|38266501|FG007|Period 1|Scheduling Conflicts|1|||
17126315|NCT02951780|38266502|FG008|Period 1|Scheduling Conflicts|0|||
17126316|NCT02951780|38266494|FG000|Period 2|Scheduling Conflicts|0|||
17126317|NCT02951780|38266495|FG001|Period 2|Scheduling Conflicts|0|||
17126318|NCT02951780|38266496|FG002|Period 2|Scheduling Conflicts|0|||
17126319|NCT02951780|38266497|FG003|Period 2|Scheduling Conflicts|0|||
17126320|NCT02951780|38266498|FG004|Period 2|Scheduling Conflicts|0|||
17126321|NCT02951780|38266499|FG005|Period 2|Scheduling Conflicts|0|||
17126322|NCT02951780|38266500|FG006|Period 2|Scheduling Conflicts|0|||
17126323|NCT02951780|38266501|FG007|Period 2|Scheduling Conflicts|1|||
17126324|NCT02951780|38266502|FG008|Period 2|Scheduling Conflicts|0|||
17126325|NCT03334214|38266524|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
17126326|NCT03334214|38266525|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
17126327|NCT03334214|38266524|FG000|Overall Study|Withdrawal by Subject|0|||
17126328|NCT03334214|38266525|FG001|Overall Study|Withdrawal by Subject|1|||
17126329|NCT03334214|38266524|FG000|Overall Study|Other|1|||
17126330|NCT03334214|38266525|FG001|Overall Study|Other|0|||
17126331|NCT02250664|38266535|FG000|Overall Study|Lost to Follow-up|18|||
17126332|NCT02250664|38266536|FG001|Overall Study|Lost to Follow-up|28|||
17126333|NCT02250664|38266537|FG002|Overall Study|Lost to Follow-up|33|||
17126334|NCT02250664|38266535|FG000|Overall Study|Personal Reasons|7|||
17126335|NCT02250664|38266536|FG001|Overall Study|Personal Reasons|8|||
17126336|NCT02250664|38266537|FG002|Overall Study|Personal Reasons|14|||
17126337|NCT02250664|38266535|FG000|Overall Study|Adverse Event|6|||
17126338|NCT02250664|38266536|FG001|Overall Study|Adverse Event|3|||
17126339|NCT02250664|38266537|FG002|Overall Study|Adverse Event|8|||
17126340|NCT02250664|38266535|FG000|Overall Study|Incarcerated|2|||
17126341|NCT02250664|38266536|FG001|Overall Study|Incarcerated|1|||
17126342|NCT02250664|38266537|FG002|Overall Study|Incarcerated|2|||
17126343|NCT02250664|38266535|FG000|Overall Study|Withdrawal by Subject|0|||
17126344|NCT02250664|38266536|FG001|Overall Study|Withdrawal by Subject|1|||
17126345|NCT02250664|38266537|FG002|Overall Study|Withdrawal by Subject|2|||
17126346|NCT02250664|38266535|FG000|Overall Study|Death|0|||
17126347|NCT02250664|38266536|FG001|Overall Study|Death|1|||
17126348|NCT02250664|38266537|FG002|Overall Study|Death|1|||
17126349|NCT02250664|38266535|FG000|Overall Study|Physician Decision|1|||
17126350|NCT02250664|38266536|FG001|Overall Study|Physician Decision|3|||
17126351|NCT02250664|38266537|FG002|Overall Study|Physician Decision|1|||
17126352|NCT02250664|38266535|FG000|Overall Study|Protocol Violation|1|||
17126353|NCT02250664|38266536|FG001|Overall Study|Protocol Violation|0|||
17126354|NCT02250664|38266537|FG002|Overall Study|Protocol Violation|1|||
17126355|NCT02250664|38266535|FG000|Overall Study|Reason unknown|1|||
17126356|NCT02250664|38266536|FG001|Overall Study|Reason unknown|0|||
17126357|NCT02250664|38266537|FG002|Overall Study|Reason unknown|0|||
17126358|NCT02646982|38266547|FG000|Overall Study|Adverse Event|1|||
17126359|NCT02646982|38266548|FG001|Overall Study|Adverse Event|1|||
17126360|NCT02646982|38266547|FG000|Overall Study|Withdrawal by Subject|2|||
17126361|NCT02646982|38266548|FG001|Overall Study|Withdrawal by Subject|1|||
17126362|NCT02845336|38266556|FG000|Overall Study|Lost to Follow-up|3|||
17126363|NCT02845336|38266557|FG001|Overall Study|Lost to Follow-up|1|||
17126364|NCT02845336|38266556|FG000|Overall Study|Inability to get medication|2|||
17126365|NCT02845336|38266557|FG001|Overall Study|Inability to get medication|0|||
17126366|NCT02844946|38266565|FG000|Overall Study|Lost to Follow-up|7|||
17126367|NCT02844946|38266566|FG001|Overall Study|Lost to Follow-up|0|||
17126378|NCT02951156|38266584|FG000|Overall Study|Death|3|||
17126379|NCT02951156|38266585|FG001|Overall Study|Death|8|||
17126380|NCT02951156|38266586|FG002|Overall Study|Death|5|||
17126381|NCT02951156|38266584|FG000|Overall Study|Progressive disease|1|||
17126382|NCT02951156|38266585|FG001|Overall Study|Progressive disease|0|||
17126383|NCT02951156|38266586|FG002|Overall Study|Progressive disease|1|||
17126384|NCT02951156|38266584|FG000|Overall Study|Withdrawal by Subject|0|||
17126385|NCT02951156|38266585|FG001|Overall Study|Withdrawal by Subject|0|||
17126386|NCT02951156|38266586|FG002|Overall Study|Withdrawal by Subject|1|||
17126387|NCT02951156|38266584|FG000|Overall Study|Study terminated by sponsor|0|||
17126388|NCT02951156|38266585|FG001|Overall Study|Study terminated by sponsor|0|||
17126389|NCT02951156|38266586|FG002|Overall Study|Study terminated by sponsor|1|||
16868114|NCT01553279|37841133|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
17126390|NCT02951156|38266584|FG000|Overall Study|Other|5|||
17126391|NCT02951156|38266585|FG001|Overall Study|Other|1|||
17126392|NCT02951156|38266586|FG002|Overall Study|Other|2|||
17126393|NCT03345914|38266598|FG000|Overall Study|Transition to another study at week 16|80|||
17126394|NCT03345914|38266599|FG001|Overall Study|Transition to another study at week 16|86|||
17126395|NCT03345914|38266600|FG002|Overall Study|Transition to another study at week 16|78|||
17126396|NCT03345914|38266598|FG000|Overall Study|Transition to OLE during follow-up|37|||
17126397|NCT03345914|38266599|FG001|Overall Study|Transition to OLE during follow-up|33|||
17126398|NCT03345914|38266600|FG002|Overall Study|Transition to OLE during follow-up|39|||
17126399|NCT03345914|38266598|FG000|Overall Study|Physician Decision|0|||
17126400|NCT03345914|38266599|FG001|Overall Study|Physician Decision|1|||
17126401|NCT03345914|38266600|FG002|Overall Study|Physician Decision|1|||
17126402|NCT03345914|38266598|FG000|Overall Study|Withdrawal by Subject|5|||
17126403|NCT03345914|38266599|FG001|Overall Study|Withdrawal by Subject|1|||
17126404|NCT03345914|38266600|FG002|Overall Study|Withdrawal by Subject|2|||
17126405|NCT03345914|38266598|FG000|Overall Study|Other|1|||
17126406|NCT03345914|38266599|FG001|Overall Study|Other|1|||
17126407|NCT03345914|38266600|FG002|Overall Study|Other|1|||
17126408|NCT03345914|38266598|FG000|Overall Study|Ongoing|0|||
17126409|NCT03345914|38266599|FG001|Overall Study|Ongoing|0|||
17126410|NCT03345914|38266600|FG002|Overall Study|Ongoing|1|||
17126411|NCT03369704|38266610|FG000|Treatment Epoch|technical problems|1|||
17126412|NCT03369704|38266611|FG001|Treatment Epoch|technical problems|0|||
17126413|NCT03369704|38266610|FG000|Treatment Epoch|Protocol Violation|1|||
17126414|NCT03369704|38266611|FG001|Treatment Epoch|Protocol Violation|0|||
17126415|NCT03369704|38266610|FG000|Treatment Epoch|Lost to Follow-up|0|||
17126416|NCT03369704|38266611|FG001|Treatment Epoch|Lost to Follow-up|1|||
17126417|NCT03369704|38266610|FG000|Treatment Epoch|Lack of Efficacy|0|||
17126418|NCT03369704|38266611|FG001|Treatment Epoch|Lack of Efficacy|2|||
17126419|NCT03369704|38266610|FG000|Treatment Epoch|Adverse Event|2|||
17126420|NCT03369704|38266611|FG001|Treatment Epoch|Adverse Event|0|||
17126421|NCT03369704|38266610|FG000|Follow-up Epoch|Lost to Follow-up|1|||
17126422|NCT03369704|38266611|FG001|Follow-up Epoch|Lost to Follow-up|0|||
17126423|NCT03366428|38266617|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
17126424|NCT03366428|38266617|FG000|Overall Study|Adverse Event|12|||
17126425|NCT03366428|38266617|FG000|Overall Study|Clinical progression|2|||
17126426|NCT03366428|38266617|FG000|Overall Study|Withdrawal by Subject|4|||
17126427|NCT02839876|38266625|FG000|Overall Study|Protocol Violation|10|||
17126428|NCT02839876|38266626|FG001|Overall Study|Protocol Violation|11|||
17126429|NCT03366194|38266632|FG000|Overall Study|Lost to Follow-up|2|||
17126430|NCT02839798|38266637|FG000|Overall Study|Withdrawal by Subject|2|||
17126431|NCT03345836|38266644|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
17126432|NCT03345836|38266645|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
17126433|NCT03345836|38266646|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
17126434|NCT03345836|38266647|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
17126435|NCT03345836|38266648|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
17126436|NCT03345836|38266649|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
17126437|NCT03345836|38266644|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
17126438|NCT03345836|38266645|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
17126439|NCT03345836|38266646|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
17126440|NCT03345836|38266647|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
17126441|NCT03345836|38266648|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
17126442|NCT03345836|38266649|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
17126443|NCT03345836|38266644|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
17126444|NCT03345836|38266645|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
17126445|NCT03345836|38266646|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
17126446|NCT03345836|38266647|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
17126447|NCT03345836|38266648|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
17126448|NCT03345836|38266649|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
17126449|NCT03345836|38266644|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
17126450|NCT03345836|38266645|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
17126451|NCT03345836|38266646|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
17126452|NCT03345836|38266647|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
17126453|NCT03345836|38266648|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
17126454|NCT03345836|38266649|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
17126455|NCT03345836|38266644|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
17126456|NCT03345836|38266645|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
17126457|NCT03345836|38266646|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
17126458|NCT03345836|38266647|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
17126459|NCT03345836|38266648|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
17126460|NCT03345836|38266649|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
17126461|NCT03345836|38266644|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
17126462|NCT03345836|38266645|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
17126463|NCT03345836|38266646|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
17126464|NCT03345836|38266647|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
17126465|NCT03345836|38266648|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
17126466|NCT03345836|38266649|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
17126467|NCT03345836|38266644|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
17126468|NCT03345836|38266645|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
17126469|NCT03345836|38266646|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
17126470|NCT03345836|38266647|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
17126471|NCT03345836|38266648|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
16942105|NCT01371747|38086666|FG002|Overall Study|Abnormal Renal Function|0|||
17126472|NCT03345836|38266649|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
17126473|NCT03345836|38266644|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
17126474|NCT03345836|38266645|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
17126475|NCT03345836|38266646|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
17126476|NCT03345836|38266647|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
17126477|NCT03345836|38266648|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
17126478|NCT03345836|38266649|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
17126479|NCT03345836|38266644|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
17126480|NCT03345836|38266645|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
17126481|NCT03345836|38266646|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
17126482|NCT03345836|38266647|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
17126483|NCT03345836|38266648|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
17126484|NCT03345836|38266649|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
17126485|NCT03345836|38266644|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
17126486|NCT03345836|38266645|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
17126487|NCT03345836|38266646|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
17126488|NCT03345836|38266647|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
17126489|NCT03345836|38266648|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
17126490|NCT03345836|38266649|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
17126491|NCT03345836|38266644|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
17126492|NCT03345836|38266645|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
17126493|NCT03345836|38266646|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
17126494|NCT03345836|38266647|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
17126495|NCT03345836|38266648|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
17126496|NCT03345836|38266649|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
17126497|NCT02839330|38266669|FG000|Overall Study|Adverse Event|0|||
17126498|NCT02839330|38266670|FG001|Overall Study|Adverse Event|1|||
17126499|NCT02839330|38266671|FG002|Overall Study|Adverse Event|2|||
17126500|NCT02839330|38266672|FG003|Overall Study|Adverse Event|2|||
17126501|NCT02839330|38266669|FG000|Overall Study|Death|4|||
17126502|NCT02839330|38266670|FG001|Overall Study|Death|6|||
17126503|NCT02839330|38266671|FG002|Overall Study|Death|1|||
17126504|NCT02839330|38266672|FG003|Overall Study|Death|1|||
17126505|NCT02839330|38266669|FG000|Overall Study|Withdrawal by Subject|27|||
17126506|NCT02839330|38266670|FG001|Overall Study|Withdrawal by Subject|19|||
17126507|NCT02839330|38266671|FG002|Overall Study|Withdrawal by Subject|11|||
17126508|NCT02839330|38266672|FG003|Overall Study|Withdrawal by Subject|13|||
17126509|NCT02839330|38266669|FG000|Overall Study|Lost to Follow-up|22|||
17126510|NCT02839330|38266670|FG001|Overall Study|Lost to Follow-up|27|||
17126511|NCT02839330|38266671|FG002|Overall Study|Lost to Follow-up|29|||
17126512|NCT02839330|38266672|FG003|Overall Study|Lost to Follow-up|25|||
17126513|NCT02839330|38266669|FG000|Overall Study|Administrative Reason|0|||
17126514|NCT02839330|38266670|FG001|Overall Study|Administrative Reason|0|||
17126515|NCT02839330|38266671|FG002|Overall Study|Administrative Reason|0|||
17126516|NCT02839330|38266672|FG003|Overall Study|Administrative Reason|1|||
17126517|NCT02839330|38266669|FG000|Overall Study|Protocol Violation|1|||
17126518|NCT02839330|38266670|FG001|Overall Study|Protocol Violation|2|||
17126519|NCT02839330|38266671|FG002|Overall Study|Protocol Violation|2|||
17126520|NCT02839330|38266672|FG003|Overall Study|Protocol Violation|3|||
17126521|NCT02839330|38266669|FG000|Overall Study|Other reason, not specified|4|||
17126522|NCT02839330|38266670|FG001|Overall Study|Other reason, not specified|3|||
17126523|NCT02839330|38266671|FG002|Overall Study|Other reason, not specified|3|||
17126524|NCT02839330|38266672|FG003|Overall Study|Other reason, not specified|6|||
17126525|NCT03363776|38266686|FG000|Overall Study|Progressive disease|2|||
17126526|NCT03363776|38266687|FG001|Overall Study|Progressive disease|3|||
17126527|NCT03363776|38266688|FG002|Overall Study|Progressive disease|1|||
17126528|NCT03363776|38266686|FG000|Overall Study|Study drug toxicity|0|||
17126529|NCT03363776|38266687|FG001|Overall Study|Study drug toxicity|0|||
17126530|NCT03363776|38266688|FG002|Overall Study|Study drug toxicity|1|||
17126531|NCT03363776|38266686|FG000|Overall Study|Death|1|||
17126532|NCT03363776|38266687|FG001|Overall Study|Death|0|||
17126533|NCT03363776|38266688|FG002|Overall Study|Death|0|||
17126534|NCT03360344|38266699|FG000|Overall Study|Withdrawal by Subject|0|||
17126535|NCT03360344|38266700|FG001|Overall Study|Withdrawal by Subject|1|||
17126536|NCT03360344|38266701|FG002|Overall Study|Withdrawal by Subject|1|||
17126537|NCT02838628|38266711|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
17126538|NCT02838628|38266712|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
17126539|NCT02838628|38266711|FG000|Recurrence Follow-up Period|Adverse Event|1|||
17126540|NCT02838628|38266712|FG001|Recurrence Follow-up Period|Adverse Event|0|||
17126541|NCT02838628|38266711|FG000|Recurrence Follow-up Period|Non-compliance|0|||
17028323|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
17126542|NCT02838628|38266712|FG001|Recurrence Follow-up Period|Non-compliance|1|||
17126543|NCT02838628|38266711|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
17126544|NCT02838628|38266712|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
17126545|NCT02838628|38266711|FG000|Recurrence Follow-up Period|Other un-specified|1|||
17126546|NCT02838628|38266712|FG001|Recurrence Follow-up Period|Other un-specified|1|||
17126547|NCT02835820|38266721|FG000|Overall Study|Baseline Screen Failure|0|||
17126548|NCT02835820|38266722|FG001|Overall Study|Baseline Screen Failure|3|||
17126549|NCT03359174|38266728|FG000|Overall Study|Adverse Event|1|||
17126550|NCT02832622|38266732|FG000|Overall Study|MPP not programmed|1259|||
17126551|NCT02832622|38266732|FG000|Overall Study|Withdrawal by Subject|123|||
17126552|NCT02832622|38266732|FG000|Overall Study|Death|119|||
17126553|NCT02832622|38266732|FG000|Overall Study|Unsuccessful CRT implant|93|||
17126554|NCT02832622|38266732|FG000|Overall Study|Lost to Follow-up|45|||
17126555|NCT02832622|38266732|FG000|Overall Study|Patient non-compliance|42|||
17126556|NCT02832622|38266732|FG000|Overall Study|Withdrawal by other reasons|25|||
17126557|NCT02832622|38266732|FG000|Overall Study|System explant|24|||
17126558|NCT02832622|38266732|FG000|Overall Study|Physician Decision|6|||
17126559|NCT00093015|38266739|FG000|Overall Study|Withdrawal by Subject|194|||
17126560|NCT00093015|38266740|FG001|Overall Study|Withdrawal by Subject|171|||
17126561|NCT00093015|38266739|FG000|Overall Study|Lost to Follow-up|96|||
17126562|NCT00093015|38266740|FG001|Overall Study|Lost to Follow-up|108|||
17126563|NCT00093015|38266739|FG000|Overall Study|Death|375|||
17126564|NCT00093015|38266740|FG001|Overall Study|Death|385|||
17126565|NCT03358472|38266749|FG000|Overall Study|Death|6|||
17126566|NCT03358472|38266750|FG001|Overall Study|Death|3|||
17126567|NCT03358472|38266751|FG002|Overall Study|Death|10|||
17126568|NCT03358472|38266749|FG000|Overall Study|Physician Decision|0|||
17126569|NCT03358472|38266750|FG001|Overall Study|Physician Decision|1|||
17126570|NCT03358472|38266751|FG002|Overall Study|Physician Decision|0|||
17126571|NCT03358472|38266749|FG000|Overall Study|Withdrawal by Subject|0|||
17126572|NCT03358472|38266750|FG001|Overall Study|Withdrawal by Subject|0|||
17126573|NCT03358472|38266751|FG002|Overall Study|Withdrawal by Subject|1|||
17126574|NCT03358472|38266749|FG000|Overall Study|On-going at clinical cut off date|9|||
17126575|NCT03358472|38266750|FG001|Overall Study|On-going at clinical cut off date|6|||
17126576|NCT03358472|38266751|FG002|Overall Study|On-going at clinical cut off date|5|||
17126577|NCT03358238|38266761|FG000|Overall Study|Withdrawal by Subject|0|||
17126578|NCT03358238|38266762|FG001|Overall Study|Withdrawal by Subject|1|||
17126579|NCT03342638|38266774|FG000|Overall Study|Withdrawal by Subject|1|||
17126580|NCT03342638|38266775|FG001|Overall Study|Withdrawal by Subject|0|||
17126581|NCT03342638|38266774|FG000|Overall Study|Physician Decision|0|||
17126582|NCT03342638|38266775|FG001|Overall Study|Physician Decision|1|||
17126583|NCT03342560|38266781|FG000|Overall Study|Lost to Follow-up|2|||
17126584|NCT03355742|38266798|FG000|Overall Study|Lost to Follow-up|4|||
17126585|NCT03355742|38266798|FG000|Overall Study|Withdrawal by Subject|29|||
17126586|NCT03355742|38266798|FG000|Overall Study|Physician Decision|6|||
17126587|NCT03355742|38266798|FG000|Overall Study|Death|55|||
17126588|NCT03355742|38266798|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
17126589|NCT03341312|38266802|FG000|Period 1|Withdrawal by Subject|0|||
17126590|NCT03341312|38266803|FG001|Period 1|Withdrawal by Subject|1|||
17126591|NCT03341312|38266804|FG002|Period 1|Withdrawal by Subject|0|||
17126592|NCT03341312|38266805|FG003|Period 1|Withdrawal by Subject|0|||
17126593|NCT02949908|38266817|FG000|Overall Study|Study termination|2|||
17126594|NCT01358734|38266824|FG000|Overall Study|Adverse Event|4|||
17126595|NCT01358734|38266825|FG001|Overall Study|Adverse Event|7|||
17126596|NCT01358734|38266826|FG002|Overall Study|Adverse Event|3|||
17126597|NCT01358734|38266824|FG000|Overall Study|Lack of Efficacy|0|||
17126598|NCT01358734|38266825|FG001|Overall Study|Lack of Efficacy|1|||
17126599|NCT01358734|38266826|FG002|Overall Study|Lack of Efficacy|3|||
17126600|NCT01358734|38266824|FG000|Overall Study|Withdrawal by Subject|1|||
17126601|NCT01358734|38266825|FG001|Overall Study|Withdrawal by Subject|6|||
17126602|NCT01358734|38266826|FG002|Overall Study|Withdrawal by Subject|3|||
17126603|NCT01358734|38266824|FG000|Overall Study|Death|3|||
17126604|NCT01358734|38266825|FG001|Overall Study|Death|7|||
17126605|NCT01358734|38266826|FG002|Overall Study|Death|2|||
17126606|NCT01358734|38266824|FG000|Overall Study|Progressive Disease|5|||
17126607|NCT01358734|38266825|FG001|Overall Study|Progressive Disease|13|||
17126608|NCT01358734|38266826|FG002|Overall Study|Progressive Disease|16|||
17126609|NCT01358734|38266824|FG000|Overall Study|Non-compliance with study drug|0|||
17126610|NCT01358734|38266825|FG001|Overall Study|Non-compliance with study drug|0|||
17126611|NCT01358734|38266826|FG002|Overall Study|Non-compliance with study drug|1|||
17126612|NCT01358734|38266824|FG000|Overall Study|Other|2|||
17126613|NCT01358734|38266825|FG001|Overall Study|Other|5|||
17126614|NCT01358734|38266826|FG002|Overall Study|Other|4|||
17126615|NCT01358734|38266824|FG000|Overall Study|Protocol Violation|0|||
17126616|NCT01358734|38266825|FG001|Overall Study|Protocol Violation|0|||
17126617|NCT01358734|38266826|FG002|Overall Study|Protocol Violation|2|||
17126618|NCT01341652|38266836|FG000|Overall Study|Incorrect Random Assignment|0|||
17126619|NCT01341652|38266837|FG001|Overall Study|Incorrect Random Assignment|1|||
17126620|NCT01341652|38266836|FG000|Overall Study|ineligible; presence metastatic disease|0|||
17126621|NCT01341652|38266837|FG001|Overall Study|ineligible; presence metastatic disease|1|||
17126622|NCT02828644|38266845|FG000|Overall Study|Lost to Follow-up|23|||
17126623|NCT02828644|38266846|FG001|Overall Study|Lost to Follow-up|22|||
17126624|NCT02949362|38266855|FG000|Retrospective Period|Inform consent not signed by participant|4|||
17126625|NCT02949362|38266856|FG001|Retrospective Period|Inform consent not signed by participant|1|||
17126626|NCT02949362|38266857|FG002|Retrospective Period|Inform consent not signed by participant|0|||
17126627|NCT02949362|38266858|FG003|Retrospective Period|Inform consent not signed by participant|0|||
17126628|NCT02949362|38266855|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
17126629|NCT02949362|38266856|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
17126630|NCT02949362|38266857|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
17126631|NCT02949362|38266858|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
17126632|NCT02949362|38266855|FG000|Prospective Period|Other|0|||
17126633|NCT02949362|38266856|FG001|Prospective Period|Other|0|||
17126634|NCT02949362|38266857|FG002|Prospective Period|Other|0|||
17126635|NCT02949362|38266858|FG003|Prospective Period|Other|4|||
17126636|NCT02947022|38266870|FG000|Overall Study|Study Stopped|1|||
17126637|NCT03338972|38266881|FG000|Overall Study|Death|1|||
17126638|NCT03338972|38266882|FG001|Overall Study|Death|1|||
17126639|NCT03338972|38266883|FG002|Overall Study|Death|0|||
17126640|NCT03338972|38266884|FG003|Overall Study|Death|0|||
17126641|NCT03338972|38266881|FG000|Overall Study|Withdrawal by Subject|1|||
17126642|NCT03338972|38266882|FG001|Overall Study|Withdrawal by Subject|0|||
17126643|NCT03338972|38266883|FG002|Overall Study|Withdrawal by Subject|0|||
17126644|NCT03338972|38266884|FG003|Overall Study|Withdrawal by Subject|0|||
17126645|NCT03338894|38266894|FG000|Overall Study|not able able to attend 9 or more classes|10|||
17126646|NCT03338816|38266900|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
17126647|NCT03338816|38266901|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
17126648|NCT03338816|38266902|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
17126649|NCT03338816|38266903|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
17126650|NCT03338816|38266900|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
17126651|NCT03338816|38266901|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
17126652|NCT03338816|38266902|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
17126653|NCT03338816|38266903|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
17126654|NCT03338816|38266900|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
17126655|NCT03338816|38266901|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
17126656|NCT03338816|38266902|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
17126657|NCT03338816|38266903|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
17126658|NCT03338816|38266900|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
17126659|NCT03338816|38266901|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
17126660|NCT03338816|38266902|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
17126661|NCT03338816|38266903|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
17126662|NCT03338816|38266900|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
17126663|NCT03338816|38266901|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
17126664|NCT03338816|38266902|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
17126665|NCT03338816|38266903|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
17126666|NCT03338816|38266900|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
17126667|NCT03338816|38266901|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
17126668|NCT03338816|38266902|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
17126669|NCT03338816|38266903|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
17126670|NCT03338816|38266900|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
17126671|NCT03338816|38266901|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
17126672|NCT03338816|38266902|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
17126673|NCT03338816|38266903|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
17126674|NCT03337490|38266915|FG000|Overall Study|Withdrawal by Subject|1|||
17126675|NCT03337490|38266916|FG001|Overall Study|Withdrawal by Subject|0|||
17126676|NCT03337490|38266917|FG002|Overall Study|Withdrawal by Subject|0|||
17126677|NCT03337490|38266915|FG000|Overall Study|Lack of Efficacy|10|||
17126678|NCT03337490|38266916|FG001|Overall Study|Lack of Efficacy|12|||
17126679|NCT03337490|38266917|FG002|Overall Study|Lack of Efficacy|35|||
17126680|NCT03337490|38266915|FG000|Overall Study|Physician Decision|0|||
17126681|NCT03337490|38266916|FG001|Overall Study|Physician Decision|1|||
17126682|NCT03337490|38266917|FG002|Overall Study|Physician Decision|0|||
17126683|NCT03337490|38266915|FG000|Overall Study|Lost to Follow-up|0|||
17126684|NCT03337490|38266916|FG001|Overall Study|Lost to Follow-up|1|||
17126685|NCT03337490|38266917|FG002|Overall Study|Lost to Follow-up|0|||
17126686|NCT02944448|38266927|FG000|Overall Study|Adverse Event|37|||
17126687|NCT02944448|38266928|FG001|Overall Study|Adverse Event|6|||
17126688|NCT02944448|38266927|FG000|Overall Study|Lack of Efficacy|8|||
17126689|NCT02944448|38266928|FG001|Overall Study|Lack of Efficacy|5|||
17126690|NCT02944448|38266927|FG000|Overall Study|Lost to Follow-up|3|||
17126691|NCT02944448|38266928|FG001|Overall Study|Lost to Follow-up|1|||
17126692|NCT02944448|38266927|FG000|Overall Study|Protocol Violation|25|||
17126693|NCT02944448|38266928|FG001|Overall Study|Protocol Violation|7|||
17126694|NCT02944448|38266927|FG000|Overall Study|Withdrawal by Subject|14|||
17126695|NCT02944448|38266928|FG001|Overall Study|Withdrawal by Subject|4|||
17126696|NCT02944448|38266927|FG000|Overall Study|Sponsor did not supply drug in time|0|||
17126697|NCT02944448|38266928|FG001|Overall Study|Sponsor did not supply drug in time|1|||
17126698|NCT02944448|38266927|FG000|Overall Study|Noncompliant with dosing|1|||
17126699|NCT02944448|38266928|FG001|Overall Study|Noncompliant with dosing|0|||
17126700|NCT02944448|38266927|FG000|Overall Study|Abnormal laboratory values|1|||
17126701|NCT02944448|38266928|FG001|Overall Study|Abnormal laboratory values|0|||
17126702|NCT02943668|38266935|FG000|Overall Study|Disease Progression|1|||
17126703|NCT02891408|38266970|FG000|Overall Study|Lost to Follow-up|0|||
17126704|NCT02891408|38266971|FG001|Overall Study|Lost to Follow-up|0|||
17126705|NCT02891408|38266972|FG002|Overall Study|Lost to Follow-up|1|||
17126706|NCT02891408|38266973|FG003|Overall Study|Lost to Follow-up|0|||
17126707|NCT02891408|38266974|FG004|Overall Study|Lost to Follow-up|0|||
17126708|NCT02891408|38266975|FG005|Overall Study|Lost to Follow-up|0|||
17126709|NCT02891408|38266976|FG006|Overall Study|Lost to Follow-up|0|||
17126710|NCT03283670|38267002|FG000|Placebo Gas|Withdrawal by Subject|2|||
17126711|NCT03283670|38267002|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
17126712|NCT03283670|38267002|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
17126713|NCT01358578|38267023|FG000|Induction Period|Adverse Event|2|||
17126714|NCT01358578|38267024|FG001|Induction Period|Adverse Event|4|||
17126715|NCT01358578|38267025|FG002|Induction Period|Adverse Event|2|||
17126716|NCT01358578|38267026|FG003|Induction Period|Adverse Event|6|||
17126717|NCT01358578|38267027|FG004|Induction Period|Adverse Event|0|||
17126718|NCT01358578|38267028|FG005|Induction Period|Adverse Event|0|||
17126719|NCT01358578|38267023|FG000|Induction Period|Lack of Efficacy|0|||
17126720|NCT01358578|38267024|FG001|Induction Period|Lack of Efficacy|0|||
17126721|NCT01358578|38267025|FG002|Induction Period|Lack of Efficacy|9|||
17126722|NCT01358578|38267026|FG003|Induction Period|Lack of Efficacy|1|||
17126723|NCT01358578|38267027|FG004|Induction Period|Lack of Efficacy|0|||
17126724|NCT01358578|38267028|FG005|Induction Period|Lack of Efficacy|0|||
17126725|NCT01358578|38267023|FG000|Induction Period|Lost to Follow-up|0|||
17126726|NCT01358578|38267024|FG001|Induction Period|Lost to Follow-up|0|||
17126727|NCT01358578|38267025|FG002|Induction Period|Lost to Follow-up|1|||
17126728|NCT01358578|38267026|FG003|Induction Period|Lost to Follow-up|4|||
17126729|NCT01358578|38267027|FG004|Induction Period|Lost to Follow-up|0|||
17126730|NCT01358578|38267028|FG005|Induction Period|Lost to Follow-up|0|||
17126731|NCT01358578|38267023|FG000|Induction Period|Physician Decision|2|||
17126732|NCT01358578|38267024|FG001|Induction Period|Physician Decision|1|||
17126733|NCT01358578|38267025|FG002|Induction Period|Physician Decision|2|||
17126734|NCT01358578|38267026|FG003|Induction Period|Physician Decision|0|||
17126735|NCT01358578|38267027|FG004|Induction Period|Physician Decision|0|||
17126736|NCT01358578|38267028|FG005|Induction Period|Physician Decision|0|||
17126737|NCT01358578|38267023|FG000|Induction Period|Protocol Deviation|3|||
17126738|NCT01358578|38267024|FG001|Induction Period|Protocol Deviation|5|||
17126739|NCT01358578|38267025|FG002|Induction Period|Protocol Deviation|0|||
17126740|NCT01358578|38267026|FG003|Induction Period|Protocol Deviation|3|||
17126741|NCT01358578|38267027|FG004|Induction Period|Protocol Deviation|0|||
17126742|NCT01358578|38267028|FG005|Induction Period|Protocol Deviation|0|||
17126743|NCT01358578|38267023|FG000|Induction Period|technical problems|0|||
17126744|NCT01358578|38267024|FG001|Induction Period|technical problems|0|||
17126745|NCT01358578|38267025|FG002|Induction Period|technical problems|1|||
17126746|NCT01358578|38267026|FG003|Induction Period|technical problems|1|||
17126747|NCT01358578|38267027|FG004|Induction Period|technical problems|0|||
17126748|NCT01358578|38267028|FG005|Induction Period|technical problems|0|||
17126749|NCT01358578|38267023|FG000|Induction Period|Withdrawal by Subject|5|||
17126750|NCT01358578|38267024|FG001|Induction Period|Withdrawal by Subject|5|||
17126751|NCT01358578|38267025|FG002|Induction Period|Withdrawal by Subject|10|||
17126752|NCT01358578|38267026|FG003|Induction Period|Withdrawal by Subject|6|||
17126753|NCT01358578|38267027|FG004|Induction Period|Withdrawal by Subject|0|||
17126754|NCT01358578|38267028|FG005|Induction Period|Withdrawal by Subject|0|||
17126755|NCT01358578|38267023|FG000|Maintenance Period|Adverse Event|2|||
17126756|NCT01358578|38267024|FG001|Maintenance Period|Adverse Event|7|||
17126757|NCT01358578|38267025|FG002|Maintenance Period|Adverse Event|0|||
17126758|NCT01358578|38267026|FG003|Maintenance Period|Adverse Event|6|||
17126759|NCT01358578|38267027|FG004|Maintenance Period|Adverse Event|4|||
17126760|NCT01358578|38267028|FG005|Maintenance Period|Adverse Event|3|||
17126761|NCT01358578|38267023|FG000|Maintenance Period|Lack of Efficacy|10|||
17126762|NCT01358578|38267024|FG001|Maintenance Period|Lack of Efficacy|2|||
17126763|NCT01358578|38267025|FG002|Maintenance Period|Lack of Efficacy|0|||
17126764|NCT01358578|38267026|FG003|Maintenance Period|Lack of Efficacy|11|||
17126765|NCT01358578|38267027|FG004|Maintenance Period|Lack of Efficacy|3|||
17126766|NCT01358578|38267028|FG005|Maintenance Period|Lack of Efficacy|0|||
17126767|NCT01358578|38267023|FG000|Maintenance Period|Lost to Follow-up|4|||
17126768|NCT01358578|38267024|FG001|Maintenance Period|Lost to Follow-up|0|||
17126769|NCT01358578|38267025|FG002|Maintenance Period|Lost to Follow-up|0|||
17126770|NCT01358578|38267026|FG003|Maintenance Period|Lost to Follow-up|5|||
17126771|NCT01358578|38267027|FG004|Maintenance Period|Lost to Follow-up|1|||
17126772|NCT01358578|38267028|FG005|Maintenance Period|Lost to Follow-up|1|||
17126773|NCT01358578|38267023|FG000|Maintenance Period|Non-compliance with study treatment|3|||
17126774|NCT01358578|38267024|FG001|Maintenance Period|Non-compliance with study treatment|1|||
17126775|NCT01358578|38267025|FG002|Maintenance Period|Non-compliance with study treatment|0|||
17126776|NCT01358578|38267026|FG003|Maintenance Period|Non-compliance with study treatment|2|||
17126777|NCT01358578|38267027|FG004|Maintenance Period|Non-compliance with study treatment|1|||
17126778|NCT01358578|38267028|FG005|Maintenance Period|Non-compliance with study treatment|2|||
17126779|NCT01358578|38267023|FG000|Maintenance Period|Physician Decision|0|||
17126780|NCT01358578|38267024|FG001|Maintenance Period|Physician Decision|1|||
17126781|NCT01358578|38267025|FG002|Maintenance Period|Physician Decision|0|||
17126782|NCT01358578|38267026|FG003|Maintenance Period|Physician Decision|1|||
17126783|NCT01358578|38267027|FG004|Maintenance Period|Physician Decision|0|||
17126784|NCT01358578|38267028|FG005|Maintenance Period|Physician Decision|0|||
17126785|NCT01358578|38267023|FG000|Maintenance Period|Pregnancy|1|||
17126786|NCT01358578|38267024|FG001|Maintenance Period|Pregnancy|0|||
17126787|NCT01358578|38267025|FG002|Maintenance Period|Pregnancy|0|||
17126788|NCT01358578|38267026|FG003|Maintenance Period|Pregnancy|0|||
17126789|NCT01358578|38267027|FG004|Maintenance Period|Pregnancy|0|||
17126790|NCT01358578|38267028|FG005|Maintenance Period|Pregnancy|0|||
17126791|NCT01358578|38267023|FG000|Maintenance Period|Protocol deviation|7|||
17126792|NCT01358578|38267024|FG001|Maintenance Period|Protocol deviation|4|||
17126793|NCT01358578|38267025|FG002|Maintenance Period|Protocol deviation|0|||
17126794|NCT01358578|38267026|FG003|Maintenance Period|Protocol deviation|2|||
17126795|NCT01358578|38267027|FG004|Maintenance Period|Protocol deviation|2|||
17126796|NCT01358578|38267028|FG005|Maintenance Period|Protocol deviation|2|||
17126797|NCT01358578|38267023|FG000|Maintenance Period|Withdrawal by Subject|12|||
17126798|NCT01358578|38267024|FG001|Maintenance Period|Withdrawal by Subject|7|||
17126799|NCT01358578|38267025|FG002|Maintenance Period|Withdrawal by Subject|2|||
17126800|NCT01358578|38267026|FG003|Maintenance Period|Withdrawal by Subject|15|||
17126801|NCT01358578|38267027|FG004|Maintenance Period|Withdrawal by Subject|6|||
17126802|NCT01358578|38267028|FG005|Maintenance Period|Withdrawal by Subject|3|||
17126803|NCT01358578|38267023|FG000|Follow-up Period|Adverse Event|1|||
17126804|NCT01358578|38267024|FG001|Follow-up Period|Adverse Event|1|||
17126805|NCT01358578|38267025|FG002|Follow-up Period|Adverse Event|0|||
17126806|NCT01358578|38267026|FG003|Follow-up Period|Adverse Event|0|||
17126807|NCT01358578|38267027|FG004|Follow-up Period|Adverse Event|0|||
17126808|NCT01358578|38267028|FG005|Follow-up Period|Adverse Event|0|||
17126809|NCT01358578|38267023|FG000|Follow-up Period|Lack of Efficacy|3|||
17126810|NCT01358578|38267024|FG001|Follow-up Period|Lack of Efficacy|0|||
17126811|NCT01358578|38267025|FG002|Follow-up Period|Lack of Efficacy|4|||
17126812|NCT01358578|38267026|FG003|Follow-up Period|Lack of Efficacy|1|||
17126813|NCT01358578|38267027|FG004|Follow-up Period|Lack of Efficacy|0|||
17126814|NCT01358578|38267028|FG005|Follow-up Period|Lack of Efficacy|0|||
17126815|NCT01358578|38267023|FG000|Follow-up Period|Lost to Follow-up|0|||
17126816|NCT01358578|38267024|FG001|Follow-up Period|Lost to Follow-up|1|||
17126817|NCT01358578|38267025|FG002|Follow-up Period|Lost to Follow-up|0|||
17126818|NCT01358578|38267026|FG003|Follow-up Period|Lost to Follow-up|4|||
17126819|NCT01358578|38267027|FG004|Follow-up Period|Lost to Follow-up|0|||
17126820|NCT01358578|38267028|FG005|Follow-up Period|Lost to Follow-up|0|||
17126821|NCT01358578|38267023|FG000|Follow-up Period|non- compliance with study treatment|1|||
17126822|NCT01358578|38267024|FG001|Follow-up Period|non- compliance with study treatment|0|||
17126823|NCT01358578|38267025|FG002|Follow-up Period|non- compliance with study treatment|0|||
17126824|NCT01358578|38267026|FG003|Follow-up Period|non- compliance with study treatment|0|||
17126825|NCT01358578|38267027|FG004|Follow-up Period|non- compliance with study treatment|0|||
17126826|NCT01358578|38267028|FG005|Follow-up Period|non- compliance with study treatment|0|||
17126827|NCT01358578|38267023|FG000|Follow-up Period|Pregnancy|1|||
17126828|NCT01358578|38267024|FG001|Follow-up Period|Pregnancy|0|||
17126829|NCT01358578|38267025|FG002|Follow-up Period|Pregnancy|0|||
17126830|NCT01358578|38267026|FG003|Follow-up Period|Pregnancy|0|||
17126831|NCT01358578|38267027|FG004|Follow-up Period|Pregnancy|0|||
17126832|NCT01358578|38267028|FG005|Follow-up Period|Pregnancy|0|||
17126833|NCT01358578|38267023|FG000|Follow-up Period|Withdrawal by Subject|3|||
17126834|NCT01358578|38267024|FG001|Follow-up Period|Withdrawal by Subject|3|||
17126835|NCT01358578|38267025|FG002|Follow-up Period|Withdrawal by Subject|1|||
17126836|NCT01358578|38267026|FG003|Follow-up Period|Withdrawal by Subject|12|||
17126837|NCT01358578|38267027|FG004|Follow-up Period|Withdrawal by Subject|0|||
17126838|NCT01358578|38267028|FG005|Follow-up Period|Withdrawal by Subject|0|||
17126839|NCT01358578|38267023|FG000|Follow-up Period|Physician Decision|1|||
17126840|NCT01358578|38267024|FG001|Follow-up Period|Physician Decision|1|||
17126841|NCT01358578|38267025|FG002|Follow-up Period|Physician Decision|0|||
17126842|NCT01358578|38267026|FG003|Follow-up Period|Physician Decision|2|||
17126843|NCT01358578|38267027|FG004|Follow-up Period|Physician Decision|0|||
17126844|NCT01358578|38267028|FG005|Follow-up Period|Physician Decision|0|||
17126845|NCT02833948|38267058|FG000|Overall Study|Death|2|||
17126846|NCT02833948|38267059|FG001|Overall Study|Death|3|||
17126847|NCT02833948|38267058|FG000|Overall Study|were not scanned|8|||
17126848|NCT02833948|38267059|FG001|Overall Study|were not scanned|13|||
17126849|NCT02833948|38267058|FG000|Overall Study|scans could not be evaluated|5|||
17126850|NCT02833948|38267059|FG001|Overall Study|scans could not be evaluated|2|||
17126851|NCT02828020|38267072|FG000|Treatment Period|Adverse Event|3|||
17126852|NCT02828020|38267073|FG001|Treatment Period|Adverse Event|1|||
17126853|NCT02828020|38267074|FG002|Treatment Period|Adverse Event|1|||
17126854|NCT02828020|38267072|FG000|Treatment Period|Withdrawal of Consent|10|||
17126855|NCT02828020|38267073|FG001|Treatment Period|Withdrawal of Consent|14|||
17126856|NCT02828020|38267074|FG002|Treatment Period|Withdrawal of Consent|9|||
17126857|NCT02828020|38267072|FG000|Treatment Period|Lost to Follow-up|21|||
17126858|NCT02828020|38267073|FG001|Treatment Period|Lost to Follow-up|24|||
17126859|NCT02828020|38267074|FG002|Treatment Period|Lost to Follow-up|18|||
17126860|NCT02828020|38267072|FG000|Treatment Period|Lack of Qualifying Event|44|||
17126861|NCT02828020|38267073|FG001|Treatment Period|Lack of Qualifying Event|53|||
17126862|NCT02828020|38267074|FG002|Treatment Period|Lack of Qualifying Event|43|||
17126863|NCT02828020|38267072|FG000|Treatment Period|Pregnancy|0|||
17126864|NCT02828020|38267073|FG001|Treatment Period|Pregnancy|2|||
17126865|NCT02828020|38267074|FG002|Treatment Period|Pregnancy|0|||
17126866|NCT02828020|38267072|FG000|Treatment Period|Protocol Violation|2|||
17126867|NCT02828020|38267073|FG001|Treatment Period|Protocol Violation|4|||
16868115|NCT01553279|37841132|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
16942106|NCT01371747|38086667|FG003|Overall Study|Abnormal Renal Function|1|||
16942107|NCT01371747|38086668|FG004|Overall Study|Abnormal Renal Function|0|||
16856760|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
16856761|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
16856762|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
16856763|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
16856764|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
16856765|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
16856766|NCT01707992|37810342|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
16856767|NCT01707992|37810343|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
16856768|NCT01707992|37810344|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
16856769|NCT01707992|37810345|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
16856770|NCT01707992|37810346|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
16856771|NCT01707992|37810347|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
17028324|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
16856772|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
16773214|NCT03745651|37712169|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
17126868|NCT02828020|38267074|FG002|Treatment Period|Protocol Violation|7|||
17126869|NCT02828020|38267072|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
17126870|NCT02828020|38267073|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
17126871|NCT02828020|38267074|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
17126872|NCT02828020|38267072|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
17126873|NCT02828020|38267073|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
17126874|NCT02828020|38267074|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
17126875|NCT02828020|38267072|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
17126876|NCT02828020|38267073|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
17126877|NCT02828020|38267074|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
17126878|NCT02828020|38267072|FG000|Safety Follow-up Period|Protocol Violation|0|||
16773215|NCT03745651|37712170|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16773216|NCT03745651|37712171|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16773217|NCT03745651|37712172|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
16773218|NCT03745651|37712173|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
16773219|NCT03745651|37712174|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
16773220|NCT03745651|37712175|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
16773221|NCT03745651|37712169|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
16773222|NCT03745651|37712170|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
16773223|NCT03745651|37712171|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
16773224|NCT03745651|37712172|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
16773225|NCT03745651|37712173|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
16773226|NCT03745651|37712174|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
16773227|NCT03745651|37712175|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
16773228|NCT02738879|37712193|FG000|Overall Study|Adverse Event|1|||
16856773|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
16773229|NCT02738879|37712194|FG001|Overall Study|Adverse Event|1|||
16773230|NCT02738879|37712193|FG000|Overall Study|Death|0|||
16773231|NCT02738879|37712194|FG001|Overall Study|Death|2|||
16773232|NCT02738879|37712193|FG000|Overall Study|Lost to Follow-up|1|||
17126879|NCT02828020|38267073|FG001|Safety Follow-up Period|Protocol Violation|2|||
17126880|NCT02828020|38267074|FG002|Safety Follow-up Period|Protocol Violation|1|||
17126881|NCT02828020|38267072|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
17126882|NCT02828020|38267073|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
17126883|NCT02828020|38267074|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
17126884|NCT02827708|38267093|FG000|Overall Study|Lost to Follow-up|3|||
17126885|NCT02827708|38267094|FG001|Overall Study|Lost to Follow-up|1|||
17126886|NCT02827708|38267093|FG000|Overall Study|Withdrawal by Subject|1|||
17126887|NCT02827708|38267094|FG001|Overall Study|Withdrawal by Subject|2|||
17126888|NCT02827708|38267093|FG000|Overall Study|Death|1|||
17126889|NCT02827708|38267094|FG001|Overall Study|Death|2|||
17126890|NCT03760185|38267100|FG000|Overall Study|Lost to Follow-up|1|||
17126891|NCT03760185|38267101|FG001|Overall Study|Lost to Follow-up|1|||
17126892|NCT02891174|38267111|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
17126893|NCT02891174|38267112|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
17126894|NCT02891174|38267111|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
17126895|NCT02891174|38267112|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
17126896|NCT02891174|38267111|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
17126897|NCT02891174|38267112|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
17126898|NCT02891174|38267111|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
16856774|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
16773233|NCT02738879|37712194|FG001|Overall Study|Lost to Follow-up|5|||
16773234|NCT02738879|37712193|FG000|Overall Study|Protocol Violation|1|||
16773235|NCT02738879|37712194|FG001|Overall Study|Protocol Violation|3|||
16773236|NCT02738879|37712193|FG000|Overall Study|Physician Decision|3|||
16773237|NCT02738879|37712194|FG001|Overall Study|Physician Decision|4|||
16773238|NCT02738879|37712193|FG000|Overall Study|Pregnancy|0|||
16773239|NCT02738879|37712194|FG001|Overall Study|Pregnancy|1|||
16773240|NCT02738879|37712193|FG000|Overall Study|Screen Failure|1|||
16773241|NCT02738879|37712194|FG001|Overall Study|Screen Failure|2|||
16773242|NCT02738879|37712193|FG000|Overall Study|Site Discontinued Study Participation|1|||
17126899|NCT02891174|38267112|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
17126900|NCT02891174|38267111|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
17126901|NCT02891174|38267112|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
17126902|NCT02891174|38267111|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
17126903|NCT02891174|38267112|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
17126904|NCT02891174|38267111|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
17126905|NCT02891174|38267112|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
17126906|NCT01751984|38267133|FG000|Overall Study|Adverse Event|5|||
17126907|NCT01751984|38267134|FG001|Overall Study|Adverse Event|3|||
17126908|NCT01751984|38267133|FG000|Overall Study|Withdrawal by Subject|0|||
17126909|NCT01751984|38267134|FG001|Overall Study|Withdrawal by Subject|1|||
17126910|NCT01751984|38267133|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
17126911|NCT01751984|38267134|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
17126912|NCT03330236|38267142|FG000|Overall Study|Death|2|||
17126913|NCT03330236|38267143|FG001|Overall Study|Death|1|||
17126914|NCT03330236|38267142|FG000|Overall Study|Withdrawal by Subject|2|||
17126915|NCT03330236|38267143|FG001|Overall Study|Withdrawal by Subject|4|||
17126916|NCT03330236|38267142|FG000|Overall Study|Lost to Follow-up|0|||
17126917|NCT03330236|38267143|FG001|Overall Study|Lost to Follow-up|2|||
17126918|NCT03330236|38267142|FG000|Overall Study|Physician Decision|2|||
17126919|NCT03330236|38267143|FG001|Overall Study|Physician Decision|0|||
17126920|NCT03330236|38267142|FG000|Overall Study|Protocol Violation|4|||
17126921|NCT03330236|38267143|FG001|Overall Study|Protocol Violation|3|||
17126922|NCT03330236|38267142|FG000|Overall Study|SedLine malfunction/blinding|19|||
17126923|NCT03330236|38267143|FG001|Overall Study|SedLine malfunction/blinding|14|||
17126924|NCT03330236|38267142|FG000|Overall Study|Volatile anesthetics used|11|||
17126925|NCT03330236|38267143|FG001|Overall Study|Volatile anesthetics used|8|||
17126926|NCT03330236|38267142|FG000|Overall Study|Surgery aborted/converted to open|60|||
17126927|NCT03330236|38267143|FG001|Overall Study|Surgery aborted/converted to open|52|||
17126928|NCT02831764|38267151|FG000|Overall Study|Protocol specific withdrawal criteria|0|||
17126929|NCT02831764|38267152|FG001|Overall Study|Protocol specific withdrawal criteria|2|||
17126930|NCT02831764|38267151|FG000|Overall Study|Withdrawal by Subject|7|||
17126931|NCT02831764|38267152|FG001|Overall Study|Withdrawal by Subject|6|||
17126932|NCT02831764|38267151|FG000|Overall Study|Physician Decision|2|||
17126933|NCT02831764|38267152|FG001|Overall Study|Physician Decision|2|||
17126934|NCT02831764|38267151|FG000|Overall Study|Lost to Follow-up|6|||
17126935|NCT02831764|38267152|FG001|Overall Study|Lost to Follow-up|5|||
17126936|NCT02831764|38267151|FG000|Overall Study|Adverse Event|8|||
17126937|NCT02831764|38267152|FG001|Overall Study|Adverse Event|5|||
17126938|NCT02831764|38267151|FG000|Overall Study|Lack of Efficacy|2|||
17126939|NCT02831764|38267152|FG001|Overall Study|Lack of Efficacy|2|||
17126940|NCT02831764|38267151|FG000|Overall Study|Protocol Violation|5|||
17126941|NCT02831764|38267152|FG001|Overall Study|Protocol Violation|2|||
17126942|NCT02831764|38267151|FG000|Overall Study|Ongoing at the time of the analysis|330|||
17126943|NCT02831764|38267152|FG001|Overall Study|Ongoing at the time of the analysis|335|||
17126944|NCT03330002|38267158|FG000|Overall Study|Lost to Follow-up|15|||
17126945|NCT03330002|38267158|FG000|Overall Study|Death|7|||
17126946|NCT02948582|38267162|FG000|Washout Period 1|Adverse Event|0|||
17126947|NCT02948582|38267163|FG001|Washout Period 1|Adverse Event|2|||
17126948|NCT02948582|38267164|FG002|Washout Period 1|Adverse Event|0|||
17126949|NCT02948582|38267165|FG003|Washout Period 1|Adverse Event|0|||
17126950|NCT02948582|38267166|FG004|Washout Period 1|Adverse Event|0|||
17126951|NCT02948582|38267167|FG005|Washout Period 1|Adverse Event|0|||
17126952|NCT02948582|38267162|FG000|Washout Period 1|Protocol Violation|0|||
17126953|NCT02948582|38267163|FG001|Washout Period 1|Protocol Violation|0|||
17126954|NCT02948582|38267164|FG002|Washout Period 1|Protocol Violation|0|||
17126955|NCT02948582|38267165|FG003|Washout Period 1|Protocol Violation|0|||
17126956|NCT02948582|38267166|FG004|Washout Period 1|Protocol Violation|0|||
17126957|NCT02948582|38267167|FG005|Washout Period 1|Protocol Violation|1|||
17126958|NCT02948582|38267162|FG000|Washout Period 2|Adverse Event|0|||
17126959|NCT02948582|38267163|FG001|Washout Period 2|Adverse Event|1|||
17126960|NCT02948582|38267164|FG002|Washout Period 2|Adverse Event|0|||
17126961|NCT02948582|38267165|FG003|Washout Period 2|Adverse Event|0|||
17126962|NCT02948582|38267166|FG004|Washout Period 2|Adverse Event|0|||
17126963|NCT02948582|38267167|FG005|Washout Period 2|Adverse Event|0|||
17126964|NCT02948582|38267162|FG000|Washout Period 2|personal reasons|0|||
17126965|NCT02948582|38267163|FG001|Washout Period 2|personal reasons|0|||
16856775|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
17126966|NCT02948582|38267164|FG002|Washout Period 2|personal reasons|0|||
17126967|NCT02948582|38267165|FG003|Washout Period 2|personal reasons|1|||
17126968|NCT02948582|38267166|FG004|Washout Period 2|personal reasons|0|||
17126969|NCT02948582|38267167|FG005|Washout Period 2|personal reasons|0|||
17126970|NCT02948582|38267162|FG000|Washout Period 4|Adverse Event|1|||
17126971|NCT02948582|38267163|FG001|Washout Period 4|Adverse Event|0|||
17126972|NCT02948582|38267164|FG002|Washout Period 4|Adverse Event|1|||
17126973|NCT02948582|38267165|FG003|Washout Period 4|Adverse Event|0|||
17126974|NCT02948582|38267166|FG004|Washout Period 4|Adverse Event|0|||
17126975|NCT02948582|38267167|FG005|Washout Period 4|Adverse Event|0|||
17126976|NCT03756285|38267183|FG000|Overall Study|Lost to Follow-up|0|||
17126977|NCT03756285|38267184|FG001|Overall Study|Lost to Follow-up|1|||
17126978|NCT03756285|38267183|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
17126979|NCT03756285|38267184|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
17126980|NCT03756285|38267183|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
17126981|NCT03756285|38267184|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
17126982|NCT02825992|38267210|FG000|Overall Study|Withdrawal by Subject|4|||
17126983|NCT02825992|38267210|FG000|Overall Study|Lost to Follow-up|2|||
17126984|NCT02825992|38267210|FG000|Overall Study|Procedure terminated|2|||
17126985|NCT01339000|38267222|FG000|Overall Study|study closed due to lack of drug supply|1|||
17126986|NCT01339000|38267223|FG001|Overall Study|study closed due to lack of drug supply|0|||
17126987|NCT03755661|38267234|FG000|Overall Study|Lost to Follow-up|1|||
17126988|NCT03755661|38267235|FG001|Overall Study|Lost to Follow-up|0|||
17126989|NCT03752151|38267241|FG000|Overall Study|Withdrawal by Subject|1|||
17126990|NCT03752151|38267241|FG000|Overall Study|Protocol Violation|1|||
17126991|NCT01336634|38267249|FG000|Overall Study|Study closed/terminated|5|||
17126992|NCT01336634|38267250|FG001|Overall Study|Study closed/terminated|6|||
17126993|NCT01336634|38267251|FG002|Overall Study|Study closed/terminated|6|||
17126994|NCT01336634|38267249|FG000|Overall Study|Lost to Follow-up|2|||
17126995|NCT01336634|38267250|FG001|Overall Study|Lost to Follow-up|1|||
17126996|NCT01336634|38267251|FG002|Overall Study|Lost to Follow-up|1|||
17126997|NCT01336634|38267249|FG000|Overall Study|Physician Decision|1|||
17126998|NCT01336634|38267250|FG001|Overall Study|Physician Decision|1|||
17126999|NCT01336634|38267251|FG002|Overall Study|Physician Decision|0|||
17127000|NCT01336634|38267249|FG000|Overall Study|Withdrawal by Subject|6|||
17127001|NCT01336634|38267250|FG001|Overall Study|Withdrawal by Subject|0|||
17127002|NCT01336634|38267251|FG002|Overall Study|Withdrawal by Subject|2|||
17127003|NCT02947100|38267266|FG000|Overall Study|study terminated early|3|||
17127004|NCT02947100|38267266|FG000|Overall Study|did not meet inclusion criteria|1|||
17127005|NCT03329846|38267272|FG000|Overall Study|Disease progression|4|||
17127006|NCT03329846|38267273|FG001|Overall Study|Disease progression|6|||
17127007|NCT03329846|38267272|FG000|Overall Study|Study drug toxicity|1|||
17127008|NCT03329846|38267273|FG001|Overall Study|Study drug toxicity|0|||
17127009|NCT03329846|38267272|FG000|Overall Study|Participant request to discontinue treatment|0|||
17127010|NCT03329846|38267273|FG001|Overall Study|Participant request to discontinue treatment|1|||
17127011|NCT03329846|38267272|FG000|Overall Study|Participant withdrew consent|1|||
17127012|NCT03329846|38267273|FG001|Overall Study|Participant withdrew consent|0|||
17127013|NCT03329846|38267272|FG000|Overall Study|Other reasons|2|||
17127014|NCT03329846|38267273|FG001|Overall Study|Other reasons|2|||
17127015|NCT03325010|38267281|FG000|Overall Study|Adverse Event|3|||
17127016|NCT03325010|38267282|FG001|Overall Study|Adverse Event|8|||
17127017|NCT03325010|38267281|FG000|Overall Study|Protocol Violation|1|||
17127018|NCT03325010|38267282|FG001|Overall Study|Protocol Violation|8|||
17127019|NCT03325010|38267281|FG000|Overall Study|Withdrawal by Subject|1|||
17127020|NCT03325010|38267282|FG001|Overall Study|Withdrawal by Subject|3|||
17127021|NCT03325010|38267281|FG000|Overall Study|Lost to Follow-up|1|||
17127022|NCT03325010|38267282|FG001|Overall Study|Lost to Follow-up|0|||
17127023|NCT03325010|38267281|FG000|Overall Study|Physician Decision|1|||
17127024|NCT03325010|38267282|FG001|Overall Study|Physician Decision|1|||
17127025|NCT03325010|38267281|FG000|Overall Study|Lack of Efficacy|2|||
17127026|NCT03325010|38267282|FG001|Overall Study|Lack of Efficacy|0|||
17127027|NCT02823574|38267292|FG000|Pre-Treatment Period|Adverse Event Unrelated to Study drug|1|||
17127028|NCT02823574|38267293|FG001|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
17127029|NCT02823574|38267294|FG002|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
17127030|NCT02823574|38267295|FG003|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
17127031|NCT02823574|38267292|FG000|Pre-Treatment Period|Disease progression|0|||
17127032|NCT02823574|38267293|FG001|Pre-Treatment Period|Disease progression|0|||
17127033|NCT02823574|38267294|FG002|Pre-Treatment Period|Disease progression|1|||
17127034|NCT02823574|38267295|FG003|Pre-Treatment Period|Disease progression|0|||
17127035|NCT02823574|38267292|FG000|Treatment Period|Poor/Non Compliance|1|||
17127036|NCT02823574|38267293|FG001|Treatment Period|Poor/Non Compliance|0|||
17127037|NCT02823574|38267294|FG002|Treatment Period|Poor/Non Compliance|0|||
17127038|NCT02823574|38267295|FG003|Treatment Period|Poor/Non Compliance|1|||
17127039|NCT02823574|38267292|FG000|Treatment Period|Maximum Clinical Benefit|1|||
17127040|NCT02823574|38267293|FG001|Treatment Period|Maximum Clinical Benefit|0|||
17127041|NCT02823574|38267294|FG002|Treatment Period|Maximum Clinical Benefit|2|||
17127042|NCT02823574|38267295|FG003|Treatment Period|Maximum Clinical Benefit|0|||
17127043|NCT02823574|38267292|FG000|Treatment Period|Lost to Follow-up|1|||
17127044|NCT02823574|38267293|FG001|Treatment Period|Lost to Follow-up|0|||
17127045|NCT02823574|38267294|FG002|Treatment Period|Lost to Follow-up|0|||
17127046|NCT02823574|38267295|FG003|Treatment Period|Lost to Follow-up|0|||
17127047|NCT02823574|38267292|FG000|Treatment Period|Participant withdrew consent|2|||
17127048|NCT02823574|38267293|FG001|Treatment Period|Participant withdrew consent|0|||
17127049|NCT02823574|38267294|FG002|Treatment Period|Participant withdrew consent|0|||
17127050|NCT02823574|38267295|FG003|Treatment Period|Participant withdrew consent|0|||
17127051|NCT02823574|38267292|FG000|Treatment Period|Participant request to discontinue|4|||
17127052|NCT02823574|38267293|FG001|Treatment Period|Participant request to discontinue|0|||
17127053|NCT02823574|38267294|FG002|Treatment Period|Participant request to discontinue|2|||
17127054|NCT02823574|38267295|FG003|Treatment Period|Participant request to discontinue|3|||
17127055|NCT02823574|38267292|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
17127056|NCT02823574|38267293|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
17127057|NCT02823574|38267294|FG002|Treatment Period|Adverse Event unrelated to to study Drug|8|||
17127058|NCT02823574|38267295|FG003|Treatment Period|Adverse Event unrelated to to study Drug|1|||
17127059|NCT02823574|38267292|FG000|Treatment Period|Study Drug Toxicity|7|||
17127060|NCT02823574|38267293|FG001|Treatment Period|Study Drug Toxicity|2|||
17127061|NCT02823574|38267294|FG002|Treatment Period|Study Drug Toxicity|13|||
17127062|NCT02823574|38267295|FG003|Treatment Period|Study Drug Toxicity|3|||
17127063|NCT02823574|38267292|FG000|Treatment Period|Disease Progression|112|||
17127064|NCT02823574|38267293|FG001|Treatment Period|Disease Progression|60|||
17127065|NCT02823574|38267294|FG002|Treatment Period|Disease Progression|80|||
17127066|NCT02823574|38267295|FG003|Treatment Period|Disease Progression|41|||
17127067|NCT02823574|38267292|FG000|Treatment Period|participant no longer meets study criteria|0|||
16856776|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
16856777|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
16856778|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
17127068|NCT02823574|38267293|FG001|Treatment Period|participant no longer meets study criteria|0|||
16773243|NCT02738879|37712194|FG001|Overall Study|Site Discontinued Study Participation|0|||
17127069|NCT02823574|38267294|FG002|Treatment Period|participant no longer meets study criteria|1|||
17127070|NCT02823574|38267295|FG003|Treatment Period|participant no longer meets study criteria|0|||
17127071|NCT02823574|38267292|FG000|Treatment Period|Death|0|||
17127072|NCT02823574|38267293|FG001|Treatment Period|Death|0|||
17127073|NCT02823574|38267294|FG002|Treatment Period|Death|2|||
17127074|NCT02823574|38267295|FG003|Treatment Period|Death|1|||
17127075|NCT02823574|38267292|FG000|Treatment Period|Other reasons|1|||
17127076|NCT02823574|38267293|FG001|Treatment Period|Other reasons|2|||
17127077|NCT02823574|38267294|FG002|Treatment Period|Other reasons|0|||
17127078|NCT02823574|38267295|FG003|Treatment Period|Other reasons|1|||
17127079|NCT02824432|38267310|FG000|Overall Study|Major Protocol Deviation|1|||
17127080|NCT02824432|38267311|FG001|Overall Study|Major Protocol Deviation|0|||
17127081|NCT02823964|38267317|FG000|Overall Study|Adverse Event|2|||
17127082|NCT02823964|38267317|FG000|Overall Study|Physician Decision|1|||
17127083|NCT02823964|38267317|FG000|Overall Study|Lack of Efficacy|1|||
17127084|NCT02823964|38267317|FG000|Overall Study|Withdrawal by Subject|1|||
17127085|NCT01338610|38267324|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
17127086|NCT01338610|38267325|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
17127087|NCT01338610|38267326|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
17127088|NCT01338610|38267324|FG000|Overall Study|Protocol Violation|1|||
17127089|NCT01338610|38267325|FG001|Overall Study|Protocol Violation|0|||
17127090|NCT01338610|38267326|FG002|Overall Study|Protocol Violation|1|||
17127091|NCT01338610|38267324|FG000|Overall Study|Adverse Event|3|||
17127092|NCT01338610|38267325|FG001|Overall Study|Adverse Event|0|||
17127093|NCT01338610|38267326|FG002|Overall Study|Adverse Event|0|||
17127094|NCT01355302|38267333|FG000|Phase 1b|Death|4|||
17127095|NCT01355302|38267334|FG001|Phase 1b|Death|0|||
17127096|NCT01355302|38267335|FG002|Phase 1b|Death|0|||
17127097|NCT01355302|38267333|FG000|Phase 1b|Study terminated by sponsor|2|||
17127098|NCT01355302|38267334|FG001|Phase 1b|Study terminated by sponsor|0|||
17127099|NCT01355302|38267335|FG002|Phase 1b|Study terminated by sponsor|0|||
17127100|NCT01355068|38267343|FG000|First Intervention Period|Adverse Event|0|||
17127101|NCT01355068|38267344|FG001|First Intervention Period|Adverse Event|1|||
17127102|NCT01355068|38267343|FG000|First Intervention Period|Withdrawal by Subject|0|||
16856779|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
16856780|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
16856781|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
16856782|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
16856783|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
16856784|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
16856785|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
16856786|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
16856787|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
16856788|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
16856789|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
16856790|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
16856791|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
16856792|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
16856793|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
16856794|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
16856795|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
16856796|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
16856797|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
16942108|NCT01371747|38086669|FG005|Overall Study|Abnormal Renal Function|1|||
16942109|NCT01371747|38086664|FG000|Overall Study|High Serum Potassium Results|1|||
16942110|NCT01371747|38086665|FG001|Overall Study|High Serum Potassium Results|1|||
16942111|NCT01371747|38086666|FG002|Overall Study|High Serum Potassium Results|1|||
16942112|NCT01371747|38086667|FG003|Overall Study|High Serum Potassium Results|2|||
16942113|NCT01371747|38086668|FG004|Overall Study|High Serum Potassium Results|0|||
16942114|NCT01371747|38086669|FG005|Overall Study|High Serum Potassium Results|2|||
16856798|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
16856799|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
16856800|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
16856801|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
16856802|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Death|0|||
16856803|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Death|0|||
16856804|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Death|0|||
16856805|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Death|2|||
16856806|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Death|0|||
16856807|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Death|0|||
16856808|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
16856809|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
16856810|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
16856811|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
16856812|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
16856813|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
16856814|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
16856815|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
16856816|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
16773244|NCT02738879|37712193|FG000|Overall Study|Withdrawal by Subject|5|||
16773245|NCT02738879|37712194|FG001|Overall Study|Withdrawal by Subject|7|||
16773246|NCT03502811|37712200|FG000|Overall Study|Death|157|||
16942115|NCT01371747|38086664|FG000|Overall Study|Low Serum Potassium Results|1|||
16942116|NCT01371747|38086665|FG001|Overall Study|Low Serum Potassium Results|1|||
16773247|NCT03502811|37712200|FG000|Overall Study|Withdrawal by Subject|105|||
16773248|NCT03502811|37712200|FG000|Overall Study|Lost to Follow-up|26|||
16942117|NCT01371747|38086666|FG002|Overall Study|Low Serum Potassium Results|1|||
16942118|NCT01371747|38086667|FG003|Overall Study|Low Serum Potassium Results|1|||
16942119|NCT01371747|38086668|FG004|Overall Study|Low Serum Potassium Results|0|||
16942120|NCT01371747|38086669|FG005|Overall Study|Low Serum Potassium Results|3|||
16942121|NCT01371747|38086664|FG000|Overall Study|Protocol Violation|0|||
16942122|NCT01371747|38086665|FG001|Overall Study|Protocol Violation|0|||
16942123|NCT01371747|38086666|FG002|Overall Study|Protocol Violation|1|||
16942124|NCT01371747|38086667|FG003|Overall Study|Protocol Violation|0|||
16942125|NCT01371747|38086668|FG004|Overall Study|Protocol Violation|0|||
16942126|NCT01371747|38086669|FG005|Overall Study|Protocol Violation|0|||
16942127|NCT01371747|38086664|FG000|Overall Study|Non-Compliance|3|||
16942128|NCT01371747|38086665|FG001|Overall Study|Non-Compliance|4|||
16942129|NCT01371747|38086666|FG002|Overall Study|Non-Compliance|3|||
16942130|NCT01371747|38086667|FG003|Overall Study|Non-Compliance|0|||
16942131|NCT01371747|38086668|FG004|Overall Study|Non-Compliance|0|||
16942132|NCT01371747|38086669|FG005|Overall Study|Non-Compliance|1|||
16942133|NCT01371747|38086664|FG000|Overall Study|Physician Decision|0|||
16942134|NCT01371747|38086665|FG001|Overall Study|Physician Decision|0|||
16942135|NCT01371747|38086666|FG002|Overall Study|Physician Decision|0|||
16942136|NCT01371747|38086667|FG003|Overall Study|Physician Decision|0|||
16856817|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
16942137|NCT01371747|38086668|FG004|Overall Study|Physician Decision|1|||
16942138|NCT01371747|38086669|FG005|Overall Study|Physician Decision|0|||
16942139|NCT01371747|38086664|FG000|Overall Study|Withdrawal by Subject|6|||
16942140|NCT01371747|38086665|FG001|Overall Study|Withdrawal by Subject|12|||
16942141|NCT01371747|38086666|FG002|Overall Study|Withdrawal by Subject|5|||
16942142|NCT01371747|38086667|FG003|Overall Study|Withdrawal by Subject|2|||
16942143|NCT01371747|38086668|FG004|Overall Study|Withdrawal by Subject|2|||
17127103|NCT01355068|38267344|FG001|First Intervention Period|Withdrawal by Subject|1|||
17127104|NCT03756129|38267356|FG000|Overall Study|Adverse Event|1|||
17127105|NCT03756129|38267357|FG001|Overall Study|Adverse Event|1|||
17127106|NCT03756129|38267358|FG002|Overall Study|Adverse Event|0|||
17127107|NCT03756129|38267359|FG003|Overall Study|Adverse Event|2|||
17127108|NCT03756129|38267360|FG004|Overall Study|Adverse Event|0|||
17127109|NCT03756129|38267361|FG005|Overall Study|Adverse Event|0|||
17127110|NCT03756129|38267356|FG000|Overall Study|Withdrawal by Subject|2|||
17127111|NCT03756129|38267357|FG001|Overall Study|Withdrawal by Subject|1|||
17127112|NCT03756129|38267358|FG002|Overall Study|Withdrawal by Subject|3|||
17127113|NCT03756129|38267359|FG003|Overall Study|Withdrawal by Subject|1|||
17127114|NCT03756129|38267360|FG004|Overall Study|Withdrawal by Subject|1|||
17127115|NCT03756129|38267361|FG005|Overall Study|Withdrawal by Subject|3|||
17127116|NCT03756129|38267356|FG000|Overall Study|Lost to Follow-up|0|||
17127117|NCT03756129|38267357|FG001|Overall Study|Lost to Follow-up|0|||
17127118|NCT03756129|38267358|FG002|Overall Study|Lost to Follow-up|0|||
17127119|NCT03756129|38267359|FG003|Overall Study|Lost to Follow-up|0|||
17127120|NCT03756129|38267360|FG004|Overall Study|Lost to Follow-up|0|||
17127121|NCT03756129|38267361|FG005|Overall Study|Lost to Follow-up|1|||
17127122|NCT03756129|38267356|FG000|Overall Study|Physician Decision|0|||
17127123|NCT03756129|38267357|FG001|Overall Study|Physician Decision|0|||
17127124|NCT03756129|38267358|FG002|Overall Study|Physician Decision|0|||
17127125|NCT03756129|38267359|FG003|Overall Study|Physician Decision|0|||
17127126|NCT03756129|38267360|FG004|Overall Study|Physician Decision|0|||
17127127|NCT03756129|38267361|FG005|Overall Study|Physician Decision|1|||
17127128|NCT02822794|38267387|FG000|Overall Study|Withdrew Consent|1|||
17127129|NCT02822794|38267388|FG001|Overall Study|Withdrew Consent|0|||
17127130|NCT01338298|38267403|FG000|Overall Study|Withdrawal by Subject|1|||
17127131|NCT01338298|38267404|FG001|Overall Study|Withdrawal by Subject|1|||
17127132|NCT01338298|38267403|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
17127133|NCT01338298|38267404|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
17127134|NCT01338298|38267403|FG000|Overall Study|Administrative error|0|||
17127135|NCT01338298|38267404|FG001|Overall Study|Administrative error|1|||
17127136|NCT01338298|38267403|FG000|Overall Study|Positive symptom worsening|1|||
17127137|NCT01338298|38267404|FG001|Overall Study|Positive symptom worsening|0|||
17127138|NCT01338298|38267403|FG000|Overall Study|Depressive symptoms and nausea|1|||
17127139|NCT01338298|38267404|FG001|Overall Study|Depressive symptoms and nausea|0|||
17127140|NCT01338298|38267403|FG000|Overall Study|Non-adherence|1|||
17127141|NCT01338298|38267404|FG001|Overall Study|Non-adherence|0|||
17127142|NCT01354132|38267412|FG000|Randomization|Physician Decision|1|||
17127143|NCT01354132|38267413|FG001|Randomization|Physician Decision|0|||
17127144|NCT01354132|38267412|FG000|Randomization|Withdrawal by Subject|0|||
17127145|NCT01354132|38267413|FG001|Randomization|Withdrawal by Subject|1|||
17127146|NCT01354132|38267412|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
17127147|NCT01354132|38267413|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
17127148|NCT01354132|38267412|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
17127149|NCT01354132|38267413|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
17127150|NCT01354132|38267412|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
17127151|NCT01354132|38267413|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
17127152|NCT01353898|38267428|FG000|Overall Study|Study site terminated|0|||
17127153|NCT01353898|38267429|FG001|Overall Study|Study site terminated|0|||
16942144|NCT01371747|38086669|FG005|Overall Study|Withdrawal by Subject|4|||
16942145|NCT01371747|38086664|FG000|Overall Study|Other Reasons|2|||
16942146|NCT01371747|38086665|FG001|Overall Study|Other Reasons|1|||
16942147|NCT01371747|38086666|FG002|Overall Study|Other Reasons|2|||
16942148|NCT01371747|38086667|FG003|Overall Study|Other Reasons|0|||
16942149|NCT01371747|38086668|FG004|Overall Study|Other Reasons|0|||
16942150|NCT01371747|38086669|FG005|Overall Study|Other Reasons|1|||
16942151|NCT01371708|38086704|FG000|Overall Study|Insufficient clinical response|3|||
16942152|NCT01371708|38086705|FG001|Overall Study|Insufficient clinical response|2|||
16942153|NCT01371708|38086706|FG002|Overall Study|Insufficient clinical response|0|||
16942154|NCT01371708|38086704|FG000|Overall Study|Lost to Follow-up|5|||
16942155|NCT01371708|38086705|FG001|Overall Study|Lost to Follow-up|9|||
17127154|NCT01353898|38267430|FG002|Overall Study|Study site terminated|0|||
17127155|NCT01353898|38267431|FG003|Overall Study|Study site terminated|0|||
17127156|NCT01353898|38267432|FG004|Overall Study|Study site terminated|0|||
17127157|NCT01353898|38267433|FG005|Overall Study|Study site terminated|1|||
17127158|NCT01372150|38267450|FG000|Overall Study|Lack of Efficacy|3|||
17127159|NCT01372150|38267451|FG001|Overall Study|Lack of Efficacy|0|||
17127160|NCT01372150|38267452|FG002|Overall Study|Lack of Efficacy|1|||
17127161|NCT01372150|38267450|FG000|Overall Study|Lost to Follow-up|4|||
17127162|NCT01372150|38267451|FG001|Overall Study|Lost to Follow-up|5|||
17127163|NCT01372150|38267452|FG002|Overall Study|Lost to Follow-up|6|||
17127164|NCT01372150|38267450|FG000|Overall Study|Protocol Violation|1|||
17127165|NCT01372150|38267451|FG001|Overall Study|Protocol Violation|0|||
17127166|NCT01372150|38267452|FG002|Overall Study|Protocol Violation|3|||
17127167|NCT01372150|38267450|FG000|Overall Study|Withdrawal by Subject|2|||
17127168|NCT01372150|38267451|FG001|Overall Study|Withdrawal by Subject|7|||
17127169|NCT01372150|38267452|FG002|Overall Study|Withdrawal by Subject|2|||
17127170|NCT01372150|38267450|FG000|Overall Study|Other|1|||
17127171|NCT01372150|38267451|FG001|Overall Study|Other|0|||
17127172|NCT01372150|38267452|FG002|Overall Study|Other|2|||
17127173|NCT01372150|38267450|FG000|Overall Study|Adverse Event|2|||
17127174|NCT01372150|38267451|FG001|Overall Study|Adverse Event|1|||
17127175|NCT01372150|38267452|FG002|Overall Study|Adverse Event|2|||
17127176|NCT01372150|38267450|FG000|Overall Study|Randomized but not treated|0|||
17127177|NCT01372150|38267451|FG001|Overall Study|Randomized but not treated|1|||
17127178|NCT01372150|38267452|FG002|Overall Study|Randomized but not treated|0|||
17127179|NCT03749109|38267462|FG000|Overall Study|Adverse Event|2|||
17127180|NCT03749109|38267463|FG001|Overall Study|Adverse Event|0|||
17127181|NCT03329690|38267475|FG000|Overall Study|Progressive disease per RECIST|85|||
17127182|NCT03329690|38267476|FG001|Overall Study|Progressive disease per RECIST|44|||
17127183|NCT03329690|38267477|FG002|Overall Study|Progressive disease per RECIST|6|||
17127184|NCT03329690|38267478|FG003|Overall Study|Progressive disease per RECIST|16|||
17127185|NCT03329690|38267479|FG004|Overall Study|Progressive disease per RECIST|20|||
17127186|NCT03329690|38267475|FG000|Overall Study|Clinical progression|7|||
17127187|NCT03329690|38267476|FG001|Overall Study|Clinical progression|4|||
17127188|NCT03329690|38267477|FG002|Overall Study|Clinical progression|1|||
17127189|NCT03329690|38267478|FG003|Overall Study|Clinical progression|1|||
17127190|NCT03329690|38267479|FG004|Overall Study|Clinical progression|1|||
17127191|NCT03329690|38267475|FG000|Overall Study|Adverse Event|22|||
17127192|NCT03329690|38267476|FG001|Overall Study|Adverse Event|4|||
17127193|NCT03329690|38267477|FG002|Overall Study|Adverse Event|0|||
17127194|NCT03329690|38267478|FG003|Overall Study|Adverse Event|1|||
17127195|NCT03329690|38267479|FG004|Overall Study|Adverse Event|2|||
17127196|NCT03329690|38267475|FG000|Overall Study|Death|2|||
17127197|NCT03329690|38267476|FG001|Overall Study|Death|0|||
17127198|NCT03329690|38267477|FG002|Overall Study|Death|0|||
17127199|NCT03329690|38267478|FG003|Overall Study|Death|1|||
17127200|NCT03329690|38267479|FG004|Overall Study|Death|0|||
17127201|NCT03329690|38267475|FG000|Overall Study|Withdrawal by Subject|2|||
17127202|NCT03329690|38267476|FG001|Overall Study|Withdrawal by Subject|3|||
17127203|NCT03329690|38267477|FG002|Overall Study|Withdrawal by Subject|0|||
16942156|NCT01371708|38086706|FG002|Overall Study|Lost to Follow-up|7|||
17127204|NCT03329690|38267478|FG003|Overall Study|Withdrawal by Subject|1|||
16856818|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
16856819|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
16856820|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
16856821|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
16856822|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
16856823|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
16856824|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
16856825|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
16856826|NCT01707992|37810342|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16856827|NCT01707992|37810343|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16856828|NCT01707992|37810344|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16856829|NCT01707992|37810345|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16856830|NCT01707992|37810346|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
16856831|NCT01707992|37810347|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16856832|NCT01946165|37810364|FG000|Overall Study|Physician Decision|2|||
16856833|NCT01946165|37810365|FG001|Overall Study|Physician Decision|0|||
16856834|NCT01946165|37810364|FG000|Overall Study|Withdrawal by Subject|0|||
16856835|NCT01946165|37810365|FG001|Overall Study|Withdrawal by Subject|2|||
16856836|NCT01707667|37810374|FG000|Period 1|expulsion of colonic sensor catheter|1|||
16942157|NCT01371708|38086704|FG000|Overall Study|Protocol Violation|2|||
16942158|NCT01371708|38086705|FG001|Overall Study|Protocol Violation|1|||
16942159|NCT01371708|38086706|FG002|Overall Study|Protocol Violation|2|||
16942160|NCT01371708|38086704|FG000|Overall Study|No longer willing to participate|7|||
16942161|NCT01371708|38086705|FG001|Overall Study|No longer willing to participate|7|||
16942162|NCT01371708|38086706|FG002|Overall Study|No longer willing to participate|13|||
16942163|NCT01371708|38086704|FG000|Overall Study|Medication error/not related to AE|0|||
16942164|NCT01371708|38086705|FG001|Overall Study|Medication error/not related to AE|1|||
16856837|NCT01707667|37810375|FG001|Period 1|expulsion of colonic sensor catheter|0|||
16856838|NCT01959503|37810383|FG000|Overall Study|Death|2|||
16856839|NCT01959503|37810384|FG001|Overall Study|Death|1|||
16856840|NCT01959503|37810383|FG000|Overall Study|Randomized but not treated|1|||
16856841|NCT01959503|37810384|FG001|Overall Study|Randomized but not treated|1|||
16856842|NCT01605799|37810392|FG000|Overall Study|Withdrawal by Subject|2|||
16942165|NCT01371708|38086706|FG002|Overall Study|Medication error/not related to AE|0|||
16942166|NCT01371708|38086704|FG000|Overall Study|Other|3|||
16942167|NCT01371708|38086705|FG001|Overall Study|Other|2|||
16942168|NCT01371708|38086706|FG002|Overall Study|Other|4|||
16942169|NCT01371708|38086704|FG000|Overall Study|Adverse Event|5|||
16942170|NCT01371708|38086705|FG001|Overall Study|Adverse Event|8|||
16942171|NCT01371708|38086706|FG002|Overall Study|Adverse Event|12|||
16942172|NCT01371708|38086704|FG000|Overall Study|Started but did not receive treatment|1|||
16942173|NCT01371708|38086705|FG001|Overall Study|Started but did not receive treatment|0|||
16942174|NCT01371708|38086706|FG002|Overall Study|Started but did not receive treatment|1|||
16942175|NCT01335399|38086718|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
16942176|NCT01335399|38086719|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
16942177|NCT01335399|38086718|FG000|Pre-treatment Period|Participant request to discontinue|0|||
16942178|NCT01335399|38086719|FG001|Pre-treatment Period|Participant request to discontinue|1|||
16942179|NCT01335399|38086718|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
16942180|NCT01335399|38086719|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
16942181|NCT01335399|38086718|FG000|Pre-treatment Period|Consent withdrawal|3|||
16942182|NCT01335399|38086719|FG001|Pre-treatment Period|Consent withdrawal|0|||
17127205|NCT03329690|38267479|FG004|Overall Study|Withdrawal by Subject|0|||
16856843|NCT01605799|37810393|FG001|Overall Study|Withdrawal by Subject|1|||
16856844|NCT01706575|37810399|FG000|Overall Study|Participant Withdrew Consent|4|||
16856845|NCT01706575|37810399|FG000|Overall Study|Lost to Follow-up|2|||
16856846|NCT01706575|37810399|FG000|Overall Study|Started but not Treated|6|||
16856847|NCT01959425|37810405|FG000|Overall Study|Withdrawal by Subject|5|||
16856848|NCT01959425|37810406|FG001|Overall Study|Withdrawal by Subject|4|||
16856849|NCT01959425|37810405|FG000|Overall Study|Lost to Follow-up|1|||
16856850|NCT01959425|37810406|FG001|Overall Study|Lost to Follow-up|0|||
16856851|NCT01959425|37810405|FG000|Overall Study|Discontinued Subjects|6|||
16856852|NCT01959425|37810406|FG001|Overall Study|Discontinued Subjects|4|||
16856853|NCT01725529|37810415|FG000|Overall Study|Adverse Event|1|||
16856854|NCT01725529|37810416|FG001|Overall Study|Adverse Event|0|||
16856855|NCT01725529|37810417|FG002|Overall Study|Adverse Event|0|||
16856856|NCT01725529|37810415|FG000|Overall Study|Lost to Follow-up|2|||
16856857|NCT01725529|37810416|FG001|Overall Study|Lost to Follow-up|1|||
16856858|NCT01725529|37810417|FG002|Overall Study|Lost to Follow-up|1|||
16856859|NCT01725529|37810415|FG000|Overall Study|Protocol Violation|0|||
16856860|NCT01725529|37810416|FG001|Overall Study|Protocol Violation|1|||
17127206|NCT03329690|38267475|FG000|Overall Study|Physician Decision|1|||
17127207|NCT03329690|38267476|FG001|Overall Study|Physician Decision|0|||
17127208|NCT03329690|38267477|FG002|Overall Study|Physician Decision|0|||
17127209|NCT03329690|38267478|FG003|Overall Study|Physician Decision|0|||
17127210|NCT03329690|38267479|FG004|Overall Study|Physician Decision|1|||
17127211|NCT03329690|38267475|FG000|Overall Study|Miscellaneous|6|||
17127212|NCT03329690|38267476|FG001|Overall Study|Miscellaneous|0|||
17127213|NCT03329690|38267477|FG002|Overall Study|Miscellaneous|0|||
17127214|NCT03329690|38267478|FG003|Overall Study|Miscellaneous|0|||
17127215|NCT03329690|38267479|FG004|Overall Study|Miscellaneous|0|||
17127216|NCT03329690|38267475|FG000|Overall Study|Did not receive treatment|1|||
17127217|NCT03329690|38267476|FG001|Overall Study|Did not receive treatment|0|||
17127218|NCT03329690|38267477|FG002|Overall Study|Did not receive treatment|0|||
17127219|NCT03329690|38267478|FG003|Overall Study|Did not receive treatment|1|||
17127220|NCT03329690|38267479|FG004|Overall Study|Did not receive treatment|0|||
17127221|NCT03328832|38267499|FG000|Overall Study|Lost to Follow-up|0|||
17127222|NCT03328832|38267500|FG001|Overall Study|Lost to Follow-up|1|||
16856861|NCT01725529|37810417|FG002|Overall Study|Protocol Violation|1|||
16856862|NCT01725529|37810415|FG000|Overall Study|Withdrawal by Subject|12|||
16773249|NCT03502811|37712200|FG000|Overall Study|No Visits (Missed)|31|||
16856863|NCT01725529|37810416|FG001|Overall Study|Withdrawal by Subject|14|||
17127223|NCT02820844|38267508|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
17127224|NCT02820844|38267509|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
17028325|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
16773250|NCT00515671|37712212|FG000|Overall Study|Lost to Follow-up|13|||
16773251|NCT00515671|37712213|FG001|Overall Study|Lost to Follow-up|10|||
16942183|NCT01335399|38086718|FG000|Treatment Period|Disease progression|117|||
16942184|NCT01335399|38086719|FG001|Treatment Period|Disease progression|145|||
16942185|NCT01335399|38086718|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
16942186|NCT01335399|38086719|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
16773252|NCT00515671|37712212|FG000|Overall Study|Withdrawal by Subject|3|||
16773253|NCT00515671|37712213|FG001|Overall Study|Withdrawal by Subject|5|||
16773254|NCT00515671|37712212|FG000|Overall Study|incarcerated|1|||
16773255|NCT00515671|37712213|FG001|Overall Study|incarcerated|2|||
16773256|NCT01677195|37712222|FG000|Overall Study|Lost to Follow-up|14|||
16773257|NCT01677195|37712223|FG001|Overall Study|Lost to Follow-up|22|||
16773258|NCT01677195|37712224|FG002|Overall Study|Lost to Follow-up|22|||
16773259|NCT01677195|37712222|FG000|Overall Study|Withdrawal by Subject|1|||
16773260|NCT01677195|37712223|FG001|Overall Study|Withdrawal by Subject|0|||
16773261|NCT01677195|37712224|FG002|Overall Study|Withdrawal by Subject|1|||
16773262|NCT01677195|37712222|FG000|Overall Study|Adverse Event|6|||
16773263|NCT01677195|37712223|FG001|Overall Study|Adverse Event|4|||
16773264|NCT01677195|37712224|FG002|Overall Study|Adverse Event|1|||
16773265|NCT01677195|37712222|FG000|Overall Study|Physician Decision|1|||
16773266|NCT01677195|37712223|FG001|Overall Study|Physician Decision|2|||
16773267|NCT01677195|37712224|FG002|Overall Study|Physician Decision|2|||
16773268|NCT01677195|37712222|FG000|Overall Study|Pregnancy|0|||
16773269|NCT01677195|37712223|FG001|Overall Study|Pregnancy|1|||
16773270|NCT01677195|37712224|FG002|Overall Study|Pregnancy|0|||
16773271|NCT01677195|37712222|FG000|Overall Study|Protocol Violation|7|||
16773272|NCT01677195|37712223|FG001|Overall Study|Protocol Violation|3|||
16773273|NCT01677195|37712224|FG002|Overall Study|Protocol Violation|4|||
16773274|NCT00928447|37712236|FG000|Overall Study|Withdrawal by Subject|1|||
16773275|NCT00928447|37712236|FG000|Overall Study|Investigator's decision|1|||
16773276|NCT02224846|37712242|FG000|Period 1 (Month 3)|Adverse Event|2|||
16773277|NCT02224846|37712243|FG001|Period 1 (Month 3)|Adverse Event|1|||
16773278|NCT02224846|37712242|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
16773279|NCT02224846|37712243|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
16773280|NCT02224846|37712242|FG000|Period 1 (Month 3)|Protocol Violation|4|||
16773281|NCT02224846|37712243|FG001|Period 1 (Month 3)|Protocol Violation|8|||
16773282|NCT02224846|37712242|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
16773283|NCT02224846|37712243|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
16773284|NCT02224846|37712242|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
16773285|NCT02224846|37712243|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
16773286|NCT02224846|37712242|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
16773287|NCT02224846|37712243|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
16773288|NCT02224846|37712242|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
16773289|NCT02224846|37712243|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
16773290|NCT02224846|37712242|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
16773291|NCT02224846|37712243|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
16773292|NCT02224846|37712242|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
16773293|NCT02224846|37712243|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
16773294|NCT02224846|37712242|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
16773295|NCT02224846|37712243|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
16773296|NCT02224846|37712242|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
16773297|NCT02224846|37712243|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
16773298|NCT02224846|37712242|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
16773299|NCT02224846|37712243|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
16773300|NCT02224846|37712242|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
16773301|NCT02224846|37712243|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
16773302|NCT02224846|37712242|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
16773303|NCT02224846|37712243|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
16773304|NCT02224846|37712242|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
16773305|NCT02224846|37712243|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
16773306|NCT02224846|37712242|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
16773307|NCT02224846|37712243|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
16773308|NCT02224846|37712242|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
16773309|NCT02224846|37712243|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
16773310|NCT01632280|37712251|FG000|Overall Study|Withdrawal by Subject|1|||
16773311|NCT01632280|37712252|FG001|Overall Study|Withdrawal by Subject|0|||
16773312|NCT02224690|37712260|FG000|Overall Study|Adverse Event|8|||
16856864|NCT01725529|37810417|FG002|Overall Study|Withdrawal by Subject|8|||
17127225|NCT02820844|38267510|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
16773313|NCT02224690|37712261|FG001|Overall Study|Adverse Event|1|||
16942187|NCT01335399|38086718|FG000|Treatment Period|Study drug toxicity|52|||
16942188|NCT01335399|38086719|FG001|Treatment Period|Study drug toxicity|64|||
16856865|NCT01605097|37810425|FG000|Overall Study|Protocol Violation|1|||
16942189|NCT01335399|38086718|FG000|Treatment Period|Participant request to discontinue|30|||
16773314|NCT02224690|37712260|FG000|Overall Study|Met Withdrawal Criteria|4|||
16773315|NCT02224690|37712261|FG001|Overall Study|Met Withdrawal Criteria|0|||
16773316|NCT02224690|37712260|FG000|Overall Study|Use of G-tube|1|||
16773317|NCT02224690|37712261|FG001|Overall Study|Use of G-tube|0|||
16773318|NCT02224690|37712260|FG000|Overall Study|Did not meet eligibility criteria|1|||
16942190|NCT01335399|38086719|FG001|Treatment Period|Participant request to discontinue|22|||
17127226|NCT02820844|38267511|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
17127227|NCT02820844|38267512|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
17127228|NCT02820844|38267513|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
17127229|NCT02820844|38267508|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
17127230|NCT02820844|38267509|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
17127231|NCT02820844|38267510|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
17127232|NCT02820844|38267511|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
17127233|NCT02820844|38267512|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
16773319|NCT02224690|37712261|FG001|Overall Study|Did not meet eligibility criteria|0|||
16773320|NCT01634152|37712293|FG000|Overall Study|Adverse Event|2|||
16773321|NCT01634152|37712294|FG001|Overall Study|Adverse Event|0|||
17028326|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
16773322|NCT01634152|37712295|FG002|Overall Study|Adverse Event|2|||
16773323|NCT01634152|37712293|FG000|Overall Study|Consent withdrawn not due to AE|1|||
16942191|NCT01335399|38086718|FG000|Treatment Period|Other reasons|30|||
16773324|NCT01634152|37712294|FG001|Overall Study|Consent withdrawn not due to AE|0|||
16942192|NCT01335399|38086719|FG001|Treatment Period|Other reasons|30|||
16856866|NCT01605019|37810432|FG000|Overall Study|pt did not meet transplant endpoint|3|||
16856867|NCT01605019|37810433|FG001|Overall Study|pt did not meet transplant endpoint|0|||
16856868|NCT01705717|37810441|FG000|Overall Study|Adverse Event|2|||
16856869|NCT01705717|37810442|FG001|Overall Study|Adverse Event|2|||
16856870|NCT01705717|37810441|FG000|Overall Study|Lack of Efficacy|0|||
16856871|NCT01705717|37810442|FG001|Overall Study|Lack of Efficacy|1|||
16856872|NCT01705717|37810441|FG000|Overall Study|Other|0|||
16856873|NCT01705717|37810442|FG001|Overall Study|Other|2|||
16856874|NCT01744483|37810450|FG000|Overall Study|Death|9|||
16856875|NCT01744483|37810451|FG001|Overall Study|Death|4|||
16856876|NCT01744483|37810452|FG002|Overall Study|Death|11|||
16856877|NCT01744483|37810450|FG000|Overall Study|Lost to Follow-up|8|||
16856878|NCT01744483|37810451|FG001|Overall Study|Lost to Follow-up|9|||
16942193|NCT01335399|38086718|FG000|Treatment Period|Consent withdrawal|10|||
16942194|NCT01335399|38086719|FG001|Treatment Period|Consent withdrawal|7|||
16942195|NCT01335399|38086718|FG000|Treatment Period|Death|7|||
16942196|NCT01335399|38086719|FG001|Treatment Period|Death|6|||
16942197|NCT01335399|38086718|FG000|Treatment Period|Poor/Non-compliance|3|||
16942198|NCT01335399|38086719|FG001|Treatment Period|Poor/Non-compliance|4|||
16942199|NCT01335399|38086718|FG000|Treatment Period|Lost to Follow-up|2|||
16942200|NCT01335399|38086719|FG001|Treatment Period|Lost to Follow-up|2|||
16942201|NCT01335399|38086718|FG000|Treatment Period|Maximum clinical benefit|1|||
16942202|NCT01335399|38086719|FG001|Treatment Period|Maximum clinical benefit|1|||
16942203|NCT01335399|38086718|FG000|Treatment Period|No longer meet study criteria|1|||
16942204|NCT01335399|38086719|FG001|Treatment Period|No longer meet study criteria|1|||
16942205|NCT01335399|38086718|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
17127234|NCT02820844|38267513|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
17127235|NCT02820844|38267508|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
17127236|NCT02820844|38267509|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
17127237|NCT02820844|38267510|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
17127238|NCT02820844|38267511|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
17127239|NCT02820844|38267512|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
17127240|NCT02820844|38267513|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
17127241|NCT02820844|38267508|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
17127242|NCT02820844|38267509|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
17127243|NCT02820844|38267510|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
17127244|NCT02820844|38267511|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
17127245|NCT02820844|38267512|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
17127246|NCT02820844|38267513|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
17127247|NCT02820844|38267508|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
17127248|NCT02820844|38267509|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
17127249|NCT02820844|38267510|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16773325|NCT01634152|37712295|FG002|Overall Study|Consent withdrawn not due to AE|1|||
16942206|NCT01335399|38086719|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
16942207|NCT01366521|38086729|FG000|Overall Study|Adverse Event|1|||
16942208|NCT01366521|38086730|FG001|Overall Study|Adverse Event|0|||
16942209|NCT01366521|38086731|FG002|Overall Study|Adverse Event|0|||
16942210|NCT01366521|38086732|FG003|Overall Study|Adverse Event|0|||
16942211|NCT01366521|38086729|FG000|Overall Study|Protocol Violation|0|||
16942212|NCT01366521|38086730|FG001|Overall Study|Protocol Violation|0|||
16942213|NCT01366521|38086731|FG002|Overall Study|Protocol Violation|1|||
16856879|NCT01744483|37810452|FG002|Overall Study|Lost to Follow-up|11|||
16856880|NCT01744483|37810450|FG000|Overall Study|Protocol Violation|1|||
16856881|NCT01744483|37810451|FG001|Overall Study|Protocol Violation|2|||
16856882|NCT01744483|37810452|FG002|Overall Study|Protocol Violation|1|||
16856883|NCT01744483|37810450|FG000|Overall Study|Withdrawal by Subject|4|||
16942214|NCT01366521|38086732|FG003|Overall Study|Protocol Violation|0|||
16942215|NCT01366521|38086729|FG000|Overall Study|Physician Decision|0|||
16856884|NCT01744483|37810451|FG001|Overall Study|Withdrawal by Subject|6|||
16856885|NCT01744483|37810452|FG002|Overall Study|Withdrawal by Subject|2|||
16856886|NCT01744483|37810450|FG000|Overall Study|No ICU Admit|5|||
16856887|NCT01744483|37810451|FG001|Overall Study|No ICU Admit|1|||
16856888|NCT01744483|37810452|FG002|Overall Study|No ICU Admit|2|||
16856889|NCT01744483|37810450|FG000|Overall Study|Routed to OSH|2|||
16856890|NCT01744483|37810451|FG001|Overall Study|Routed to OSH|0|||
16856891|NCT01744483|37810452|FG002|Overall Study|Routed to OSH|1|||
17127250|NCT02820844|38267511|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16856892|NCT01744093|37810462|FG000|Overall Study|Withdrawal by Subject|6|||
16856893|NCT01744093|37810463|FG001|Overall Study|Withdrawal by Subject|1|||
16856894|NCT01725451|37810477|FG000|Period 1|Withdrawal by Subject|1|||
16856895|NCT01725451|37810478|FG001|Period 1|Withdrawal by Subject|0|||
16856896|NCT01725451|37810479|FG002|Period 1|Withdrawal by Subject|0|||
16942216|NCT01366521|38086730|FG001|Overall Study|Physician Decision|0|||
16773326|NCT01634152|37712293|FG000|Overall Study|Not treated|0|||
16856897|NCT01725451|37810480|FG003|Period 1|Withdrawal by Subject|0|||
16856898|NCT01725451|37810477|FG000|Washout From Period 3|Protocol Violation|0|||
17127251|NCT02820844|38267512|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16942217|NCT01366521|38086731|FG002|Overall Study|Physician Decision|1|||
16942218|NCT01366521|38086732|FG003|Overall Study|Physician Decision|0|||
16942219|NCT01366521|38086729|FG000|Overall Study|Withdrawal by Subject|0|||
16942220|NCT01366521|38086730|FG001|Overall Study|Withdrawal by Subject|1|||
16942221|NCT01366521|38086731|FG002|Overall Study|Withdrawal by Subject|0|||
16942222|NCT01366521|38086732|FG003|Overall Study|Withdrawal by Subject|0|||
16942223|NCT01335009|38086746|FG000|Overall Study|Too ill to travel to study sites|1|||
16773327|NCT01634152|37712294|FG001|Overall Study|Not treated|1|||
16773328|NCT01634152|37712295|FG002|Overall Study|Not treated|0|||
16773329|NCT01634152|37712293|FG000|Overall Study|Other reason not defined above|1|||
16773330|NCT01634152|37712294|FG001|Overall Study|Other reason not defined above|0|||
16773331|NCT01634152|37712295|FG002|Overall Study|Other reason not defined above|1|||
16773332|NCT03862807|37712303|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
16773333|NCT01378429|37712327|FG000|Overall Study|Noncompliance with study drug|1|||
16773334|NCT01378429|37712328|FG001|Overall Study|Noncompliance with study drug|0|||
16773335|NCT01599754|37712339|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
16773336|NCT01599754|37712340|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
16773337|NCT01599754|37712339|FG000|Overall Study|Participant noncompliance|4|||
16773338|NCT01599754|37712340|FG001|Overall Study|Participant noncompliance|4|||
16773339|NCT01599754|37712339|FG000|Overall Study|Lost to Follow-up|13|||
16773340|NCT01599754|37712340|FG001|Overall Study|Lost to Follow-up|6|||
16773341|NCT01599754|37712339|FG000|Overall Study|Death|31|||
16773342|NCT01599754|37712340|FG001|Overall Study|Death|33|||
16773343|NCT01599754|37712339|FG000|Overall Study|Adverse Event|3|||
16773344|NCT01599754|37712340|FG001|Overall Study|Adverse Event|2|||
16773345|NCT01599754|37712339|FG000|Overall Study|Investigator decision|1|||
16773346|NCT01599754|37712340|FG001|Overall Study|Investigator decision|3|||
16773347|NCT01599754|37712339|FG000|Overall Study|Withdrawal by Subject|24|||
16773348|NCT01599754|37712340|FG001|Overall Study|Withdrawal by Subject|25|||
16773349|NCT01599754|37712339|FG000|Overall Study|Study terminated by sponsor|282|||
16773350|NCT01599754|37712340|FG001|Overall Study|Study terminated by sponsor|285|||
16773351|NCT02138110|37712346|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
16773352|NCT02138110|37712346|FG000|Overall Scaffold Implantation|Death|3|||
16773353|NCT02223754|37712352|FG000|Period 1|Adverse Event|1|||
16773354|NCT02223754|37712353|FG001|Period 1|Adverse Event|0|||
16773355|NCT02223754|37712352|FG000|Period 1|Lost to Follow-up|0|||
16773356|NCT02223754|37712353|FG001|Period 1|Lost to Follow-up|1|||
16773357|NCT02223754|37712352|FG000|Period 1|Protocol Violation|2|||
16773358|NCT02223754|37712353|FG001|Period 1|Protocol Violation|4|||
16773359|NCT02223754|37712352|FG000|Period 1|Withdrawal by Subject|0|||
16773360|NCT02223754|37712353|FG001|Period 1|Withdrawal by Subject|4|||
16773361|NCT02223754|37712352|FG000|Period 1|Test Article No Longer Available|1|||
16773362|NCT02223754|37712353|FG001|Period 1|Test Article No Longer Available|5|||
16773363|NCT02223754|37712352|FG000|Period 1|Unsatisfactory Visual Response|0|||
16773364|NCT02223754|37712353|FG001|Period 1|Unsatisfactory Visual Response|1|||
16773365|NCT02223754|37712352|FG000|Period 2|Adverse Event|0|||
16773366|NCT02223754|37712353|FG001|Period 2|Adverse Event|1|||
16773367|NCT02223754|37712352|FG000|Period 2|Protocol Violation|1|||
16773368|NCT02223754|37712353|FG001|Period 2|Protocol Violation|0|||
16773369|NCT02223754|37712352|FG000|Period 2|Lens Discomfort|1|||
16773370|NCT02223754|37712353|FG001|Period 2|Lens Discomfort|1|||
16773371|NCT02223754|37712352|FG000|Period 2|Lost to Follow-up|1|||
16773372|NCT02223754|37712353|FG001|Period 2|Lost to Follow-up|0|||
16773373|NCT02223754|37712352|FG000|Period 2|Test Article No Longer Available|0|||
16773374|NCT02223754|37712353|FG001|Period 2|Test Article No Longer Available|1|||
16773375|NCT02223364|37712363|FG000|Overall Study|Protocol Violation|3|||
16773376|NCT02223364|37712364|FG001|Overall Study|Protocol Violation|0|||
16773377|NCT02223364|37712365|FG002|Overall Study|Protocol Violation|3|||
16773378|NCT02223364|37712363|FG000|Overall Study|subject expired before surgery|1|||
17127252|NCT02820844|38267513|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16856899|NCT01725451|37810478|FG001|Washout From Period 3|Protocol Violation|0|||
16856900|NCT01725451|37810479|FG002|Washout From Period 3|Protocol Violation|1|||
16942224|NCT01335009|38086747|FG001|Overall Study|Too ill to travel to study sites|0|||
16942225|NCT01335009|38086746|FG000|Overall Study|Death|28|||
16942226|NCT01335009|38086747|FG001|Overall Study|Death|32|||
16773379|NCT02223364|37712364|FG001|Overall Study|subject expired before surgery|0|||
16773380|NCT02223364|37712365|FG002|Overall Study|subject expired before surgery|0|||
16942227|NCT01335009|38086746|FG000|Overall Study|Withdrawal by Subject|1|||
16942228|NCT01335009|38086747|FG001|Overall Study|Withdrawal by Subject|1|||
16942229|NCT01335009|38086746|FG000|Overall Study|Lost to Follow-up|1|||
16942230|NCT01335009|38086747|FG001|Overall Study|Lost to Follow-up|0|||
16942231|NCT01366443|38086762|FG000|Overall Study|Lost to Follow-up|2|||
16942232|NCT01366443|38086762|FG000|Overall Study|Under 18 yo|1|||
16942233|NCT01332630|38086767|FG000|Overall Study|Withdrawal by Subject|3|||
16942234|NCT01366209|38086773|FG000|Overall Study|Adverse Event|6|||
16942235|NCT01366209|38086774|FG001|Overall Study|Adverse Event|7|||
16856901|NCT01725451|37810480|FG003|Washout From Period 3|Protocol Violation|0|||
16856902|NCT01725451|37810477|FG000|Washout From Period 3|Adverse Event|0|||
17127253|NCT02820844|38267508|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
16773381|NCT02223364|37712363|FG000|Overall Study|Physician Decision|1|||
16773382|NCT02223364|37712364|FG001|Overall Study|Physician Decision|0|||
16856903|NCT01725451|37810478|FG001|Washout From Period 3|Adverse Event|1|||
16942236|NCT01366209|38086773|FG000|Overall Study|Withdrawal by Subject|4|||
16856904|NCT01725451|37810479|FG002|Washout From Period 3|Adverse Event|0|||
16856905|NCT01725451|37810480|FG003|Washout From Period 3|Adverse Event|0|||
16856906|NCT01725451|37810477|FG000|Period 4|Adverse Event|0|||
16856907|NCT01725451|37810478|FG001|Period 4|Adverse Event|0|||
16856908|NCT01725451|37810479|FG002|Period 4|Adverse Event|1|||
16856909|NCT01725451|37810480|FG003|Period 4|Adverse Event|0|||
16856910|NCT01725217|37810498|FG000|Overall Study|Withdrawal by Subject|1|||
16856911|NCT01725217|37810499|FG001|Overall Study|Withdrawal by Subject|0|||
16856912|NCT01725217|37810500|FG002|Overall Study|Withdrawal by Subject|0|||
16856913|NCT01707290|37810519|FG000|Overall Study|Adverse event (AE)|1|||
16856914|NCT01707290|37810520|FG001|Overall Study|Adverse event (AE)|0|||
16856915|NCT01707290|37810519|FG000|Overall Study|Physician Decision|1|||
16856916|NCT01707290|37810520|FG001|Overall Study|Physician Decision|0|||
16856917|NCT01707290|37810519|FG000|Overall Study|Lost to Follow-up|3|||
16856918|NCT01707290|37810520|FG001|Overall Study|Lost to Follow-up|0|||
16856919|NCT01707290|37810519|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
16856920|NCT01707290|37810520|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
16856921|NCT01707290|37810519|FG000|Overall Study|Commercial drug available|60|||
16942237|NCT01366209|38086774|FG001|Overall Study|Withdrawal by Subject|4|||
16942238|NCT01366209|38086773|FG000|Overall Study|Death|12|||
16942239|NCT01366209|38086774|FG001|Overall Study|Death|19|||
16942240|NCT01366209|38086773|FG000|Overall Study|Lung transplantation|6|||
16942241|NCT01366209|38086774|FG001|Overall Study|Lung transplantation|1|||
16942242|NCT01366209|38086773|FG000|Overall Study|Lost to Follow-up|2|||
16942243|NCT01366209|38086774|FG001|Overall Study|Lost to Follow-up|1|||
16942244|NCT01366209|38086773|FG000|Overall Study|Physician Decision|1|||
16856922|NCT01707290|37810520|FG001|Overall Study|Commercial drug available|1|||
16856923|NCT01707290|37810519|FG000|Overall Study|Other unspecified|17|||
16942245|NCT01366209|38086774|FG001|Overall Study|Physician Decision|0|||
16856924|NCT01707290|37810520|FG001|Overall Study|Other unspecified|0|||
16856925|NCT01717040|37810531|FG000|Overall Study|Lost to Follow-up|2|||
17127254|NCT02820844|38267509|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
16773383|NCT02223364|37712365|FG002|Overall Study|Physician Decision|0|||
16942246|NCT01366209|38086773|FG000|Overall Study|Sponsors decision|0|||
16942247|NCT01366209|38086774|FG001|Overall Study|Sponsors decision|1|||
16773384|NCT01378975|37712375|FG000|Overall Study|Death|77|||
16856926|NCT01717040|37810532|FG001|Overall Study|Lost to Follow-up|3|||
16856927|NCT01717040|37810531|FG000|Overall Study|Lack of Efficacy|1|||
16856928|NCT01717040|37810532|FG001|Overall Study|Lack of Efficacy|1|||
16942248|NCT01366209|38086773|FG000|Overall Study|Withdrew consent|4|||
16942249|NCT01366209|38086774|FG001|Overall Study|Withdrew consent|3|||
16856929|NCT01717040|37810531|FG000|Overall Study|Adverse Event|1|||
16856930|NCT01717040|37810532|FG001|Overall Study|Adverse Event|0|||
16856931|NCT01717040|37810531|FG000|Overall Study|Required Medication Change|0|||
16856932|NCT01717040|37810532|FG001|Overall Study|Required Medication Change|1|||
16856933|NCT01717040|37810531|FG000|Overall Study|New Substance Use Disorder|1|||
16856934|NCT01717040|37810532|FG001|Overall Study|New Substance Use Disorder|0|||
16856935|NCT01743469|37810559|FG000|Active Treatment Phase|Adverse Event|10|||
16856936|NCT01743469|37810560|FG001|Active Treatment Phase|Adverse Event|5|||
16856937|NCT01743469|37810561|FG002|Active Treatment Phase|Adverse Event|8|||
16856938|NCT01743469|37810562|FG003|Active Treatment Phase|Adverse Event|1|||
16856939|NCT01743469|37810559|FG000|Active Treatment Phase|Disease Progression|40|||
17127255|NCT02820844|38267510|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
16856940|NCT01743469|37810560|FG001|Active Treatment Phase|Disease Progression|47|||
16856941|NCT01743469|37810561|FG002|Active Treatment Phase|Disease Progression|30|||
16856942|NCT01743469|37810562|FG003|Active Treatment Phase|Disease Progression|20|||
17127256|NCT02820844|38267511|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
16773385|NCT01378975|37712376|FG001|Overall Study|Death|46|||
16856943|NCT01743469|37810559|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
16773386|NCT01378975|37712375|FG000|Overall Study|Investigator Request|1|||
16773387|NCT01378975|37712376|FG001|Overall Study|Investigator Request|0|||
16773388|NCT01378975|37712375|FG000|Overall Study|Lost to Follow-up|4|||
16773389|NCT01378975|37712376|FG001|Overall Study|Lost to Follow-up|1|||
16856944|NCT01743469|37810560|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
16942250|NCT01365546|38086780|FG000|Overall Study|Withdrawal by Subject|1|||
16942251|NCT01365546|38086780|FG000|Overall Study|Screen failure|9|||
16942252|NCT01365546|38086780|FG000|Overall Study|Study termination|1|||
16942253|NCT01365507|38086790|FG000|Overall Study|Withdrawal Criteria|8|||
16942254|NCT01365507|38086791|FG001|Overall Study|Withdrawal Criteria|5|||
16942255|NCT01365507|38086790|FG000|Overall Study|Unclassified|1|||
16942256|NCT01365507|38086791|FG001|Overall Study|Unclassified|4|||
16942257|NCT01365468|38086815|FG000|Overall Study|Physician Decision|1|||
16942258|NCT01365468|38086816|FG001|Overall Study|Physician Decision|0|||
16942259|NCT01365468|38086815|FG000|Overall Study|Disease progression|1|||
16942260|NCT01365468|38086816|FG001|Overall Study|Disease progression|0|||
16942261|NCT01365468|38086815|FG000|Overall Study|Lost to Follow-up|2|||
16942262|NCT01365468|38086816|FG001|Overall Study|Lost to Follow-up|0|||
16942263|NCT01357980|38086827|FG000|Overall Study|Lack of Efficacy|0|||
16942264|NCT01357980|38086828|FG001|Overall Study|Lack of Efficacy|1|||
16942265|NCT01357980|38086829|FG002|Overall Study|Lack of Efficacy|0|||
16942266|NCT01357980|38086830|FG003|Overall Study|Lack of Efficacy|0|||
16942267|NCT01357980|38086827|FG000|Overall Study|Consent withdrawn|0|||
16942268|NCT01357980|38086828|FG001|Overall Study|Consent withdrawn|0|||
16942269|NCT01357980|38086829|FG002|Overall Study|Consent withdrawn|1|||
16942270|NCT01357980|38086830|FG003|Overall Study|Consent withdrawn|0|||
16942271|NCT01332318|38086844|FG000|Overall Study|Adverse Event|0|||
16942272|NCT01332318|38086845|FG001|Overall Study|Adverse Event|3|||
16942273|NCT01332318|38086846|FG002|Overall Study|Adverse Event|0|||
16942274|NCT01332318|38086847|FG003|Overall Study|Adverse Event|0|||
16942275|NCT01332318|38086844|FG000|Overall Study|Withdrawal by Subject|1|||
16942276|NCT01332318|38086845|FG001|Overall Study|Withdrawal by Subject|1|||
16942277|NCT01332318|38086846|FG002|Overall Study|Withdrawal by Subject|0|||
16942278|NCT01332318|38086847|FG003|Overall Study|Withdrawal by Subject|1|||
16942279|NCT01332318|38086844|FG000|Overall Study|Protocol Violation|1|||
16942280|NCT01332318|38086845|FG001|Overall Study|Protocol Violation|0|||
16942281|NCT01332318|38086846|FG002|Overall Study|Protocol Violation|1|||
16942282|NCT01332318|38086847|FG003|Overall Study|Protocol Violation|1|||
16942283|NCT01331109|38086862|FG000|Overall Study|Adverse Event|6|||
16942284|NCT01331109|38086862|FG000|Overall Study|Lack of Efficacy|2|||
16942285|NCT01331109|38086862|FG000|Overall Study|Protocol Violation|3|||
16942286|NCT01331109|38086862|FG000|Overall Study|Withdrawal by Subject|7|||
16942287|NCT01331109|38086862|FG000|Overall Study|Lost to Follow-up|1|||
16942288|NCT01331109|38086862|FG000|Overall Study|Study Terminated by Sponsor|38|||
16942289|NCT01357551|38086868|FG000|Overall Study|Withdrawal by Subject|6|||
16942290|NCT01357551|38086869|FG001|Overall Study|Withdrawal by Subject|4|||
16942291|NCT01357551|38086868|FG000|Overall Study|Death|0|||
16942292|NCT01357551|38086869|FG001|Overall Study|Death|1|||
16942293|NCT01357551|38086868|FG000|Overall Study|Lost to Follow-up|16|||
16942294|NCT01357551|38086869|FG001|Overall Study|Lost to Follow-up|6|||
16942295|NCT01357239|38086882|FG000|Stratum: All Patients|Adverse Event|0|||
16773390|NCT01378975|37712375|FG000|Overall Study|Withdrew Consent|4|||
16773391|NCT01378975|37712376|FG001|Overall Study|Withdrew Consent|3|||
16773392|NCT02222896|37712383|FG000|Abdomen|Did not qualify|34|||
16856945|NCT01743469|37810561|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
16856946|NCT01743469|37810562|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
16856947|NCT01743469|37810559|FG000|Active Treatment Phase|Missing|1|||
16856948|NCT01743469|37810560|FG001|Active Treatment Phase|Missing|0|||
16856949|NCT01743469|37810561|FG002|Active Treatment Phase|Missing|0|||
16856950|NCT01743469|37810562|FG003|Active Treatment Phase|Missing|0|||
16856951|NCT01743469|37810559|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
16856952|NCT01743469|37810560|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
16856953|NCT01743469|37810561|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
16856954|NCT01743469|37810562|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
16856955|NCT01743469|37810559|FG000|Follow-up Period - Post-Treatment|Death|43|||
16942296|NCT01357239|38086883|FG001|Stratum: All Patients|Adverse Event|0|||
16942297|NCT01357239|38086884|FG002|Stratum: All Patients|Adverse Event|1|||
16942298|NCT01357239|38086885|FG003|Stratum: All Patients|Adverse Event|1|||
16942299|NCT01357239|38086882|FG000|Stratum: All Patients|Subject withdrew consent|0|||
16942300|NCT01357239|38086883|FG001|Stratum: All Patients|Subject withdrew consent|0|||
16773393|NCT02222896|37712384|FG001|Abdomen|Did not qualify|10|||
16773394|NCT02222896|37712385|FG002|Abdomen|Did not qualify|32|||
16773395|NCT02222896|37712383|FG000|Groin|Did not qualify|43|||
16773396|NCT02222896|37712384|FG001|Groin|Did not qualify|9|||
16773397|NCT02222896|37712385|FG002|Groin|Did not qualify|40|||
16773398|NCT02222818|37712398|FG000|Period 1|Eligibility criteria not met|0|||
16773399|NCT02222818|37712399|FG001|Period 1|Eligibility criteria not met|3|||
16773400|NCT01378195|37712410|FG000|Overall Study|Lost to Follow-up|29|||
16856956|NCT01743469|37810560|FG001|Follow-up Period - Post-Treatment|Death|47|||
16856957|NCT01743469|37810561|FG002|Follow-up Period - Post-Treatment|Death|22|||
16856958|NCT01743469|37810562|FG003|Follow-up Period - Post-Treatment|Death|16|||
16856959|NCT01743469|37810559|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
16856960|NCT01743469|37810560|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
16856961|NCT01743469|37810561|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
16856962|NCT01743469|37810562|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
16856963|NCT01743001|37810574|FG000|Overall Study|Physician Decision|1|||
16856964|NCT01743001|37810575|FG001|Overall Study|Physician Decision|0|||
16856965|NCT01743001|37810574|FG000|Overall Study|Pregnancy|1|||
16856966|NCT01743001|37810575|FG001|Overall Study|Pregnancy|0|||
16856967|NCT01743001|37810574|FG000|Overall Study|Death|1|||
16856968|NCT01743001|37810575|FG001|Overall Study|Death|0|||
16856969|NCT01704079|37810594|FG000|Overall Study|Withdrawal by Subject|5|||
16856970|NCT01704079|37810595|FG001|Overall Study|Withdrawal by Subject|7|||
16856971|NCT01704079|37810594|FG000|Overall Study|Lost to Follow-up|2|||
16856972|NCT01704079|37810595|FG001|Overall Study|Lost to Follow-up|5|||
16856973|NCT01704079|37810594|FG000|Overall Study|Adverse Event|4|||
16856974|NCT01704079|37810595|FG001|Overall Study|Adverse Event|7|||
16856975|NCT01704079|37810594|FG000|Overall Study|Protocol Violation|1|||
16856976|NCT01704079|37810595|FG001|Overall Study|Protocol Violation|0|||
16856977|NCT01704079|37810594|FG000|Overall Study|Subject noncompliance|2|||
16856978|NCT01704079|37810595|FG001|Overall Study|Subject noncompliance|3|||
16856979|NCT01704079|37810594|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
16856980|NCT01704079|37810595|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
16856981|NCT01703845|37810603|FG000|Overall Study|Adverse Event|1|||
16856982|NCT01703845|37810604|FG001|Overall Study|Adverse Event|0|||
16856983|NCT01703845|37810603|FG000|Overall Study|Protocol Violation|1|||
16856984|NCT01703845|37810604|FG001|Overall Study|Protocol Violation|0|||
16856985|NCT01703845|37810603|FG000|Overall Study|other than stated above|1|||
16856986|NCT01703845|37810604|FG001|Overall Study|other than stated above|0|||
16856987|NCT01724359|37810612|FG000|Overall Study|Adverse Event|10|||
16856988|NCT01724359|37810612|FG000|Overall Study|Death|1|||
16856989|NCT01724359|37810612|FG000|Overall Study|Other|20|||
16856990|NCT01703221|37810621|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
16856991|NCT01703221|37810622|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
16856992|NCT01703221|37810623|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16856993|NCT01703221|37810621|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
16856994|NCT01703221|37810622|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
16773401|NCT01378195|37712411|FG001|Overall Study|Lost to Follow-up|18|||
16773402|NCT01378117|37712420|FG000|Overall Study|withdrawal|2|||
16773403|NCT01378117|37712421|FG001|Overall Study|withdrawal|1|||
16773404|NCT01378117|37712422|FG002|Overall Study|withdrawal|2|||
16773405|NCT01378117|37712420|FG000|Overall Study|discharged before med given|2|||
16856995|NCT01703221|37810623|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
16856996|NCT01703221|37810621|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
16856997|NCT01703221|37810622|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16856998|NCT01703221|37810623|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16856999|NCT01703221|37810621|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
16857000|NCT01703221|37810622|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16857001|NCT01703221|37810623|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16857002|NCT01703221|37810621|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16857003|NCT01703221|37810622|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16857004|NCT01703221|37810623|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
16857005|NCT01703221|37810621|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
16857006|NCT01703221|37810622|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
16857007|NCT01703221|37810623|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
16857008|NCT01703221|37810621|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
16857009|NCT01703221|37810622|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
16857010|NCT01703221|37810623|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
16857011|NCT01703221|37810621|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
16857012|NCT01703221|37810622|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
16857013|NCT01703221|37810623|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
16857014|NCT01722877|37810637|FG000|Overall Study|Death|1|||
16857015|NCT01722877|37810637|FG000|Overall Study|Lost to Follow-up|1|||
16857016|NCT01703065|37810682|FG000|Overall Study|Lack of Efficacy|1|||
16857017|NCT01703065|37810683|FG001|Overall Study|Lack of Efficacy|0|||
16857018|NCT01702987|37810696|FG000|Overall Study|Withdrawal by Subject|1|||
16857019|NCT01702987|37810697|FG001|Overall Study|Withdrawal by Subject|0|||
16857020|NCT01702519|37810718|FG000|Washout Period|Lost to Follow-up|1|||
16857021|NCT01702519|37810719|FG001|Washout Period|Lost to Follow-up|0|||
16857022|NCT01702519|37810718|FG000|Washout Period|Withdrawal by Subject|0|||
16857023|NCT01702519|37810719|FG001|Washout Period|Withdrawal by Subject|2|||
16857024|NCT01739803|37810731|FG000|Overall Study|Lost to Follow-up|9|||
16857025|NCT01739803|37810732|FG001|Overall Study|Lost to Follow-up|6|||
16857026|NCT01739335|37810744|FG000|Overall Study|Lost to Follow-up|7|||
16857027|NCT01739335|37810745|FG001|Overall Study|Lost to Follow-up|4|||
16857028|NCT01739335|37810744|FG000|Overall Study|Ineligible patient randomized|0|||
16857029|NCT01739335|37810745|FG001|Overall Study|Ineligible patient randomized|1|||
16857030|NCT01702363|37810770|FG000|Overall Study|Adverse Event|14|||
16857031|NCT01702363|37810770|FG000|Overall Study|Lack of Efficacy|4|||
16857032|NCT01702363|37810770|FG000|Overall Study|Withdrawal by Subject|2|||
16857033|NCT01722097|37810777|FG000|Overall Study|Patient sheets not returned|6|||
16857034|NCT01722097|37810778|FG001|Overall Study|Patient sheets not returned|5|||
16857035|NCT01701973|37810793|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16857036|NCT01701973|37810794|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
16857037|NCT01701973|37810795|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16857038|NCT01701973|37810796|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16857039|NCT01701973|37810797|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16857040|NCT01701973|37810798|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16942301|NCT01357239|38086884|FG002|Stratum: All Patients|Subject withdrew consent|1|||
16857041|NCT01701973|37810799|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16857042|NCT01701973|37810800|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16857043|NCT01721317|37810851|FG000|Overall Study|Study Closed / Terminated|2|||
16857044|NCT01721317|37810852|FG001|Overall Study|Study Closed / Terminated|2|||
16857045|NCT01721317|37810851|FG000|Overall Study|Physician Decision|0|||
16857046|NCT01721317|37810852|FG001|Overall Study|Physician Decision|1|||
16942302|NCT01357239|38086885|FG003|Stratum: All Patients|Subject withdrew consent|1|||
17127257|NCT02820844|38267512|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
17127258|NCT02820844|38267513|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
17127259|NCT02820844|38267508|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
17127260|NCT02820844|38267509|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
17127261|NCT02820844|38267510|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
17127262|NCT02820844|38267511|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
17127263|NCT02820844|38267512|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
17127264|NCT02820844|38267513|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
17127265|NCT02820844|38267508|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127266|NCT02820844|38267509|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127267|NCT02820844|38267510|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
17127268|NCT02820844|38267511|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
17127269|NCT02820844|38267512|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127270|NCT02820844|38267513|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127271|NCT02820844|38267508|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
17127272|NCT02820844|38267509|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
17127273|NCT02820844|38267510|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
17127274|NCT02820844|38267511|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
17127275|NCT02820844|38267512|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
17127276|NCT02820844|38267513|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
17127277|NCT02820844|38267508|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127278|NCT02820844|38267509|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127279|NCT02820844|38267510|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127280|NCT02820844|38267511|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127281|NCT02820844|38267512|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
17127282|NCT02820844|38267513|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
17127283|NCT02942576|38267532|FG000|Overall Study|Adverse Event|28|||
17127284|NCT02942576|38267533|FG001|Overall Study|Adverse Event|6|||
16857047|NCT01721317|37810851|FG000|Overall Study|Withdrawal by Subject|0|||
16857048|NCT01721317|37810852|FG001|Overall Study|Withdrawal by Subject|1|||
16857049|NCT01701193|37810862|FG000|Overall Study|Withdrawal by Subject|2|||
16857050|NCT01701193|37810863|FG001|Overall Study|Withdrawal by Subject|2|||
16857051|NCT01701193|37810864|FG002|Overall Study|Withdrawal by Subject|1|||
16857052|NCT01701193|37810865|FG003|Overall Study|Withdrawal by Subject|2|||
16857053|NCT01701193|37810862|FG000|Overall Study|Adverse Event|1|||
16857054|NCT01701193|37810863|FG001|Overall Study|Adverse Event|0|||
16857055|NCT01701193|37810864|FG002|Overall Study|Adverse Event|0|||
16857056|NCT01701193|37810865|FG003|Overall Study|Adverse Event|0|||
16857057|NCT01959347|37810913|FG000|Overall Study|Protocol Violation|9|||
16857058|NCT01959347|37810914|FG001|Overall Study|Protocol Violation|7|||
16857059|NCT01959035|37810940|FG000|Overall Study|Adverse Event|5|||
16857060|NCT01959035|37810940|FG000|Overall Study|Withdrawal by Subject|4|||
16857061|NCT01959035|37810940|FG000|Overall Study|Lost to Follow-up|1|||
16857062|NCT01959035|37810940|FG000|Overall Study|Other (no primary reason given)|1|||
16857063|NCT01700959|37810950|FG000|Overall Study|Adverse Event|0|||
16857064|NCT01700959|37810951|FG001|Overall Study|Adverse Event|1|||
16857065|NCT01700959|37810952|FG002|Overall Study|Adverse Event|1|||
16857066|NCT01700959|37810953|FG003|Overall Study|Adverse Event|2|||
16857067|NCT01700959|37810954|FG004|Overall Study|Adverse Event|0|||
16773406|NCT01378117|37712421|FG001|Overall Study|discharged before med given|0|||
16773407|NCT01378117|37712422|FG002|Overall Study|discharged before med given|1|||
17127285|NCT02942576|38267532|FG000|Overall Study|Withdrawal by Subject|7|||
17127286|NCT02942576|38267533|FG001|Overall Study|Withdrawal by Subject|5|||
16857068|NCT01700959|37810955|FG005|Overall Study|Adverse Event|2|||
16857069|NCT01700959|37810950|FG000|Overall Study|Withdrawal by Subject|15|||
16857070|NCT01700959|37810951|FG001|Overall Study|Withdrawal by Subject|9|||
16857071|NCT01700959|37810952|FG002|Overall Study|Withdrawal by Subject|12|||
16857072|NCT01700959|37810953|FG003|Overall Study|Withdrawal by Subject|11|||
16857073|NCT01700959|37810954|FG004|Overall Study|Withdrawal by Subject|8|||
16857074|NCT01700959|37810955|FG005|Overall Study|Withdrawal by Subject|12|||
16857075|NCT01700959|37810950|FG000|Overall Study|Ineligible|2|||
16857076|NCT01700959|37810951|FG001|Overall Study|Ineligible|1|||
16942303|NCT01357239|38086882|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
16857077|NCT01700959|37810952|FG002|Overall Study|Ineligible|2|||
16857078|NCT01700959|37810953|FG003|Overall Study|Ineligible|0|||
16857079|NCT01700959|37810954|FG004|Overall Study|Ineligible|0|||
16857080|NCT01700959|37810955|FG005|Overall Study|Ineligible|1|||
16857081|NCT01700959|37810950|FG000|Overall Study|Noncompliant|9|||
16857082|NCT01700959|37810951|FG001|Overall Study|Noncompliant|9|||
16857083|NCT01700959|37810952|FG002|Overall Study|Noncompliant|17|||
16857084|NCT01700959|37810953|FG003|Overall Study|Noncompliant|18|||
16857085|NCT01700959|37810954|FG004|Overall Study|Noncompliant|15|||
16857086|NCT01700959|37810955|FG005|Overall Study|Noncompliant|9|||
16857087|NCT01700959|37810950|FG000|Overall Study|Side effects|1|||
16857088|NCT01700959|37810951|FG001|Overall Study|Side effects|4|||
16857089|NCT01700959|37810952|FG002|Overall Study|Side effects|8|||
16857090|NCT01700959|37810953|FG003|Overall Study|Side effects|4|||
16857091|NCT01700959|37810954|FG004|Overall Study|Side effects|4|||
16857092|NCT01700959|37810955|FG005|Overall Study|Side effects|1|||
16857093|NCT01738477|37810977|FG000|Overall Study|Lost to Follow-up|1|||
16857094|NCT01738477|37810978|FG001|Overall Study|Lost to Follow-up|4|||
16857095|NCT01737931|37810994|FG000|Overall Study|Withdrawal by Subject|0|||
16857096|NCT01737931|37810995|FG001|Overall Study|Withdrawal by Subject|1|||
16857097|NCT01737931|37810996|FG002|Overall Study|Withdrawal by Subject|1|||
16857098|NCT01737931|37810994|FG000|Overall Study|Physician Decision|0|||
16857099|NCT01737931|37810995|FG001|Overall Study|Physician Decision|1|||
16857100|NCT01737931|37810996|FG002|Overall Study|Physician Decision|0|||
16857101|NCT01958489|37811002|FG000|Period 2|Adverse Event|0|||
16857102|NCT01958489|37811003|FG001|Period 2|Adverse Event|1|||
16857103|NCT01721161|37811016|FG000|Overall Study|Adverse Event|2|||
16857104|NCT01721161|37811017|FG001|Overall Study|Adverse Event|3|||
16857105|NCT01721161|37811016|FG000|Overall Study|Lost to Follow-up|1|||
16857106|NCT01721161|37811017|FG001|Overall Study|Lost to Follow-up|2|||
16857107|NCT01721161|37811016|FG000|Overall Study|Withdrawal by Subject|1|||
16857108|NCT01721161|37811017|FG001|Overall Study|Withdrawal by Subject|1|||
16857109|NCT01721161|37811016|FG000|Overall Study|Other|0|||
16857110|NCT01721161|37811017|FG001|Overall Study|Other|1|||
16857111|NCT01700179|37811024|FG000|Overall Study|Physician Decision|2|||
16857112|NCT01699867|37811028|FG000|Overall Study|Screening Failure|3|||
16857113|NCT01699789|37811047|FG000|Overall Study|Withdrawal by Subject|18|||
16857114|NCT01699789|37811048|FG001|Overall Study|Withdrawal by Subject|23|||
16857115|NCT01699789|37811047|FG000|Overall Study|Death|1|||
16857116|NCT01699789|37811048|FG001|Overall Study|Death|2|||
16857117|NCT01699789|37811047|FG000|Overall Study|Lost to Follow-up|83|||
16857118|NCT01699789|37811048|FG001|Overall Study|Lost to Follow-up|101|||
16857119|NCT01944839|37811071|FG000|Overall Study|Physician Decision|2|||
16857120|NCT01944839|37811072|FG001|Overall Study|Physician Decision|2|||
16857121|NCT01944839|37811071|FG000|Overall Study|Protocol Violation|0|||
16857122|NCT01944839|37811072|FG001|Overall Study|Protocol Violation|1|||
16857123|NCT01944839|37811071|FG000|Overall Study|Adverse Event|10|||
16857124|NCT01944839|37811072|FG001|Overall Study|Adverse Event|5|||
16857125|NCT01944839|37811071|FG000|Overall Study|Withdrawal by Subject|9|||
16857126|NCT01944839|37811072|FG001|Overall Study|Withdrawal by Subject|17|||
16857127|NCT01944839|37811071|FG000|Overall Study|Lost to Follow-up|1|||
16942304|NCT01357239|38086883|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
16857128|NCT01944839|37811072|FG001|Overall Study|Lost to Follow-up|0|||
16857129|NCT01944839|37811071|FG000|Overall Study|Subject non-compliance|0|||
16857130|NCT01944839|37811072|FG001|Overall Study|Subject non-compliance|3|||
16857131|NCT01944059|37811087|FG000|Overall Study|Lost to Follow-up|1|||
16857132|NCT01944059|37811087|FG000|Overall Study|Physician Decision|3|||
16857133|NCT01944059|37811087|FG000|Overall Study|Withdrawal by Subject|1|||
16857134|NCT01944059|37811087|FG000|Overall Study|Adverse Event|2|||
16857135|NCT01720225|37811094|FG000|Overall Study|Withdrawal by Subject|0|||
16857136|NCT01720225|37811095|FG001|Overall Study|Withdrawal by Subject|1|||
16773408|NCT04254809|37712457|FG000|Overall Study|Lost to Follow-up|5|||
16857137|NCT01720225|37811094|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
17127287|NCT02942576|38267532|FG000|Overall Study|Physician Decision|1|||
16857138|NCT01720225|37811095|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
16857139|NCT01943591|37811103|FG000|Overall Study|Lost to Follow-up|3|||
16857140|NCT01943591|37811104|FG001|Overall Study|Lost to Follow-up|4|||
16857141|NCT01943591|37811103|FG000|Overall Study|Death|2|||
16857142|NCT01943591|37811104|FG001|Overall Study|Death|7|||
16942305|NCT01357239|38086884|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
16942306|NCT01357239|38086885|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
16857143|NCT01699087|37811110|FG000|Overall Study|Lost to Follow-up|7|||
16857144|NCT01699087|37811110|FG000|Overall Study|Screen failure (prior to treatment)|15|||
16773409|NCT04254809|37712458|FG001|Overall Study|Lost to Follow-up|10|||
16773410|NCT02717611|37712464|FG000|Overall Study|Death|13|||
16773411|NCT02717611|37712464|FG000|Overall Study|Withdrawal by Subject|6|||
16773412|NCT02717611|37712464|FG000|Overall Study|Active, not recruiting|40|||
16773413|NCT02717611|37712464|FG000|Overall Study|Complicating disease|1|||
16773414|NCT02736409|37712472|FG000|Overall Study|Withdrawal by Subject|4|||
16773415|NCT02736409|37712473|FG001|Overall Study|Withdrawal by Subject|2|||
16773416|NCT02736409|37712474|FG002|Overall Study|Withdrawal by Subject|17|||
16942307|NCT01357239|38086882|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
16942308|NCT01357239|38086883|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
16942309|NCT01357239|38086884|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
16942310|NCT01357239|38086885|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
16942311|NCT01357239|38086882|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
16942312|NCT01357239|38086883|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
16942313|NCT01357239|38086884|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
16942314|NCT01357239|38086885|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
16942315|NCT01357161|38086901|FG000|Part 1 (Open Label Run-in)|Death|5|||
16942316|NCT01357161|38086902|FG001|Part 1 (Open Label Run-in)|Death|0|||
16942317|NCT01357161|38086903|FG002|Part 1 (Open Label Run-in)|Death|0|||
16857145|NCT01699087|37811110|FG000|Overall Study|Unable to make future visits|2|||
16857146|NCT01943435|37811118|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
16857147|NCT01943435|37811119|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
16942318|NCT01357161|38086901|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
16942319|NCT01357161|38086902|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
16942320|NCT01357161|38086903|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
16942321|NCT01357161|38086901|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
16942322|NCT01357161|38086902|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
16942323|NCT01357161|38086903|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
16942324|NCT01357161|38086901|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
16942325|NCT01357161|38086902|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
16942326|NCT01357161|38086903|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
16942327|NCT01357161|38086901|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
16942328|NCT01357161|38086902|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
16942329|NCT01357161|38086903|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
16942330|NCT01357161|38086901|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
16942331|NCT01357161|38086902|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
16857148|NCT01943435|37811120|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
16857149|NCT01943435|37811118|FG000|Intervention Period|Withdrawal by Subject|3|||
16857150|NCT01943435|37811119|FG001|Intervention Period|Withdrawal by Subject|3|||
16857151|NCT01943435|37811120|FG002|Intervention Period|Withdrawal by Subject|4|||
16857152|NCT01943435|37811118|FG000|2 Month Follow up|Lost to Follow-up|2|||
16857153|NCT01943435|37811119|FG001|2 Month Follow up|Lost to Follow-up|3|||
16857154|NCT01943435|37811120|FG002|2 Month Follow up|Lost to Follow-up|0|||
16857155|NCT01943435|37811118|FG000|6 Month Follow up|Lost to Follow-up|12|||
16857156|NCT01943435|37811119|FG001|6 Month Follow up|Lost to Follow-up|7|||
16857157|NCT01943435|37811120|FG002|6 Month Follow up|Lost to Follow-up|15|||
16857158|NCT01942733|37811138|FG000|Overall Study|Lost to Follow-up|1|||
16857159|NCT01942733|37811138|FG000|Overall Study|Non-compliance with IMP|1|||
16857160|NCT01942733|37811138|FG000|Overall Study|Administrative|1|||
16857161|NCT01957865|37811154|FG000|Overall Study|Found HIV negative|0|||
16857162|NCT01957865|37811155|FG001|Overall Study|Found HIV negative|0|||
16857163|NCT01957865|37811156|FG002|Overall Study|Found HIV negative|1|||
16857164|NCT01957865|37811154|FG000|Overall Study|Lost to Follow-up|0|||
16857165|NCT01957865|37811155|FG001|Overall Study|Lost to Follow-up|2|||
16857166|NCT01957865|37811156|FG002|Overall Study|Lost to Follow-up|2|||
16857167|NCT01957787|37811165|FG000|Overall Study|Death|18|||
16857168|NCT01957787|37811165|FG000|Overall Study|Lost to Follow-up|3|||
16857169|NCT01957787|37811165|FG000|Overall Study|Withdrawal by Subject|3|||
16857170|NCT01957787|37811165|FG000|Overall Study|Entered Hospice or Similar Program|2|||
16857171|NCT01957787|37811165|FG000|Overall Study|Index Tumor(s) Resected|2|||
16857172|NCT01957787|37811165|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
16857173|NCT01957787|37811165|FG000|Overall Study|Local therapy, not cryoablation|6|||
16857174|NCT01698775|37811171|FG000|Phase A|Adverse Event|2|||
16857175|NCT01698775|37811172|FG001|Phase A|Adverse Event|1|||
16857176|NCT01698775|37811171|FG000|Phase A|Death|1|||
16857177|NCT01698775|37811172|FG001|Phase A|Death|1|||
16857178|NCT01698775|37811171|FG000|Phase A|Lack of Efficacy|1|||
16857179|NCT01698775|37811172|FG001|Phase A|Lack of Efficacy|0|||
16857180|NCT01698775|37811171|FG000|Phase A|Lost to Follow-up|1|||
16857181|NCT01698775|37811172|FG001|Phase A|Lost to Follow-up|2|||
16857182|NCT01698775|37811171|FG000|Phase A|Protocol Violation|1|||
16942332|NCT01357161|38086903|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
16942333|NCT01357161|38086901|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
16942334|NCT01357161|38086902|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
16942335|NCT01357161|38086903|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
16942336|NCT01357161|38086901|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
16942337|NCT01357161|38086902|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
16942338|NCT01357161|38086903|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
16942339|NCT01357161|38086901|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
16942340|NCT01357161|38086902|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
16942341|NCT01357161|38086903|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
16942342|NCT01357161|38086901|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
16942343|NCT01357161|38086902|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
16942344|NCT01357161|38086903|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
16942345|NCT01357161|38086901|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
16857183|NCT01698775|37811172|FG001|Phase A|Protocol Violation|0|||
16857184|NCT01698775|37811171|FG000|Phase A|Withdrawal by Subject|3|||
16942346|NCT01357161|38086902|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
16942347|NCT01357161|38086903|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
16942348|NCT01351350|38086916|FG000|Overall Study|Disease Progression|5|||
16942349|NCT01351350|38086917|FG001|Overall Study|Disease Progression|13|||
16942350|NCT01351350|38086918|FG002|Overall Study|Disease Progression|6|||
16942351|NCT01351350|38086919|FG003|Overall Study|Disease Progression|8|||
16942352|NCT01351350|38086920|FG004|Overall Study|Disease Progression|5|||
16942353|NCT01351350|38086916|FG000|Overall Study|Adverse Event|1|||
16942354|NCT01351350|38086917|FG001|Overall Study|Adverse Event|10|||
16942355|NCT01351350|38086918|FG002|Overall Study|Adverse Event|1|||
16942356|NCT01351350|38086919|FG003|Overall Study|Adverse Event|2|||
16942357|NCT01351350|38086920|FG004|Overall Study|Adverse Event|0|||
16942358|NCT01351350|38086916|FG000|Overall Study|Participant Decision|2|||
16942359|NCT01351350|38086917|FG001|Overall Study|Participant Decision|6|||
16942360|NCT01351350|38086918|FG002|Overall Study|Participant Decision|3|||
16942361|NCT01351350|38086919|FG003|Overall Study|Participant Decision|3|||
16942362|NCT01351350|38086920|FG004|Overall Study|Participant Decision|2|||
16942363|NCT01351350|38086916|FG000|Overall Study|Enrolled but not Treated|0|||
16942364|NCT01351350|38086917|FG001|Overall Study|Enrolled but not Treated|0|||
16942365|NCT01351350|38086918|FG002|Overall Study|Enrolled but not Treated|1|||
16942366|NCT01351350|38086919|FG003|Overall Study|Enrolled but not Treated|0|||
16942367|NCT01351350|38086920|FG004|Overall Study|Enrolled but not Treated|0|||
16942368|NCT01350999|38086948|FG000|Overall Study|Adverse Event|4|||
16942369|NCT01350999|38086949|FG001|Overall Study|Adverse Event|9|||
16942370|NCT01350999|38086950|FG002|Overall Study|Adverse Event|10|||
16942371|NCT01350999|38086948|FG000|Overall Study|Voluntary withdrawal|3|||
16942372|NCT01350999|38086949|FG001|Overall Study|Voluntary withdrawal|4|||
16942373|NCT01350999|38086950|FG002|Overall Study|Voluntary withdrawal|6|||
16942374|NCT01350999|38086948|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
16942375|NCT01350999|38086949|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
16942376|NCT01350999|38086950|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
16942377|NCT01330914|38086969|FG000|Overall Study|Withdrawal by Subject|4|||
16942378|NCT01330914|38086969|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
16942379|NCT01350804|38086977|FG000|Core Study|Withdrawal by Subject|11|||
16942380|NCT01350804|38086978|FG001|Core Study|Withdrawal by Subject|17|||
16942381|NCT01350804|38086979|FG002|Core Study|Withdrawal by Subject|16|||
16942382|NCT01350804|38086980|FG003|Core Study|Withdrawal by Subject|7|||
16942383|NCT01350804|38086977|FG000|Core Study|Study terminated by Sponsor|0|||
16942384|NCT01350804|38086978|FG001|Core Study|Study terminated by Sponsor|0|||
16942385|NCT01350804|38086979|FG002|Core Study|Study terminated by Sponsor|0|||
16942386|NCT01350804|38086980|FG003|Core Study|Study terminated by Sponsor|2|||
16857185|NCT01698775|37811172|FG001|Phase A|Withdrawal by Subject|4|||
16857186|NCT01698775|37811171|FG000|Phase A|Kidney [transplant]|0|||
16942387|NCT01350804|38086977|FG000|Core Study|Protocol deviation|1|||
16773417|NCT02736409|37712475|FG003|Overall Study|Withdrawal by Subject|3|||
16857187|NCT01698775|37811172|FG001|Phase A|Kidney [transplant]|1|||
16857188|NCT01698775|37811171|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
16857189|NCT01698775|37811172|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
16857190|NCT01698775|37811171|FG000|Phase B|Adverse Event|6|||
16857191|NCT01698775|37811172|FG001|Phase B|Adverse Event|3|||
16857192|NCT01698775|37811171|FG000|Phase B|Death|0|||
16857193|NCT01698775|37811172|FG001|Phase B|Death|1|||
16857194|NCT01698775|37811171|FG000|Phase B|Lack of Efficacy|0|||
16857195|NCT01698775|37811172|FG001|Phase B|Lack of Efficacy|1|||
16857196|NCT01698775|37811171|FG000|Phase B|Lost to Follow-up|0|||
16857197|NCT01698775|37811172|FG001|Phase B|Lost to Follow-up|1|||
16857198|NCT01698775|37811171|FG000|Phase B|Physician Decision|1|||
16857199|NCT01698775|37811172|FG001|Phase B|Physician Decision|1|||
16857200|NCT01698775|37811171|FG000|Phase B|Protocol Violation|1|||
16857201|NCT01698775|37811172|FG001|Phase B|Protocol Violation|1|||
16857202|NCT01698775|37811171|FG000|Phase B|Withdrawal by Subject|6|||
16857203|NCT01698775|37811172|FG001|Phase B|Withdrawal by Subject|2|||
16857204|NCT01941095|37811182|FG000|Overall Study|Insufficient therapeutic response|13|||
16857205|NCT01941095|37811182|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
16857206|NCT01941095|37811182|FG000|Overall Study|Adverse Event|11|||
16857207|NCT01941095|37811182|FG000|Overall Study|Physician Decision|3|||
16857208|NCT01941095|37811182|FG000|Overall Study|Withdrawal by Subject|17|||
16857209|NCT01941095|37811182|FG000|Overall Study|Lost to Follow-up|10|||
16857210|NCT01957709|37811197|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
16857211|NCT01957553|37811214|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
16857212|NCT01957553|37811215|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
16857213|NCT01957553|37811214|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
16857214|NCT01957553|37811215|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
16857215|NCT01957553|37811214|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
16857216|NCT01957553|37811215|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
16857217|NCT01957553|37811214|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
16857218|NCT01957553|37811215|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
16857219|NCT01957553|37811214|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
16857220|NCT01957553|37811215|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
16857221|NCT01957553|37811214|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
16857222|NCT01957553|37811215|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
16857223|NCT01957553|37811214|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
16857224|NCT01957553|37811215|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
16857225|NCT01957553|37811214|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
16857226|NCT01957553|37811215|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
16857227|NCT01957553|37811214|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
16857228|NCT01957553|37811215|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
16857229|NCT01957475|37811240|FG000|Test Period 1|Withdrawal by Subject|1|||
16857230|NCT01957475|37811241|FG001|Test Period 1|Withdrawal by Subject|0|||
16857231|NCT01957475|37811240|FG000|Test Period 1|Other|1|||
16857232|NCT01957475|37811241|FG001|Test Period 1|Other|0|||
16857233|NCT01957475|37811240|FG000|Test Period 1|Lack of Efficacy|0|||
16857234|NCT01957475|37811241|FG001|Test Period 1|Lack of Efficacy|1|||
16857235|NCT01957475|37811240|FG000|Test Period 2|Adverse Event|1|||
16857236|NCT01957475|37811241|FG001|Test Period 2|Adverse Event|0|||
16857237|NCT01940939|37811249|FG000|Overall Study|Withdrawal by Subject|2|||
17127288|NCT02942576|38267533|FG001|Overall Study|Physician Decision|4|||
16942388|NCT01350804|38086978|FG001|Core Study|Protocol deviation|0|||
16942389|NCT01350804|38086979|FG002|Core Study|Protocol deviation|1|||
16942390|NCT01350804|38086980|FG003|Core Study|Protocol deviation|0|||
16942391|NCT01350804|38086977|FG000|Core Study|Physician Decision|1|||
16942392|NCT01350804|38086978|FG001|Core Study|Physician Decision|0|||
16942393|NCT01350804|38086979|FG002|Core Study|Physician Decision|1|||
16857238|NCT01940939|37811250|FG001|Overall Study|Withdrawal by Subject|8|||
16857239|NCT01957397|37811256|FG000|Test Period 1|sudden leakage/small bag|1|||
16857240|NCT01957397|37811257|FG001|Test Period 1|sudden leakage/small bag|1|||
16857241|NCT01957397|37811256|FG000|Test Period 1|Withdrawal by Subject|1|||
16857242|NCT01957397|37811257|FG001|Test Period 1|Withdrawal by Subject|0|||
16857243|NCT01957397|37811256|FG000|Test Period 2|Adverse Event|0|||
16857244|NCT01957397|37811257|FG001|Test Period 2|Adverse Event|1|||
16857245|NCT01957397|37811256|FG000|Test Period 3|Adverse Event|1|||
16857246|NCT01957397|37811257|FG001|Test Period 3|Adverse Event|2|||
16857247|NCT01957397|37811256|FG000|Test Period 3|the adhesive did not work|1|||
16857248|NCT01957397|37811257|FG001|Test Period 3|the adhesive did not work|0|||
16857249|NCT01940705|37811271|FG000|Overall Study|Lost to Follow-up|1|||
16857250|NCT01940705|37811272|FG001|Overall Study|Lost to Follow-up|3|||
16857251|NCT01940705|37811273|FG002|Overall Study|Lost to Follow-up|2|||
16857252|NCT01940705|37811274|FG003|Overall Study|Lost to Follow-up|2|||
16942394|NCT01350804|38086980|FG003|Core Study|Physician Decision|3|||
16857253|NCT01940705|37811271|FG000|Overall Study|Withdrawal by Subject|2|||
16857254|NCT01940705|37811272|FG001|Overall Study|Withdrawal by Subject|2|||
16857255|NCT01940705|37811273|FG002|Overall Study|Withdrawal by Subject|3|||
16857256|NCT01940705|37811274|FG003|Overall Study|Withdrawal by Subject|2|||
16857257|NCT01940705|37811271|FG000|Overall Study|Intervention not given|0|||
16857258|NCT01940705|37811272|FG001|Overall Study|Intervention not given|3|||
16857259|NCT01940705|37811273|FG002|Overall Study|Intervention not given|3|||
16857260|NCT01940705|37811274|FG003|Overall Study|Intervention not given|0|||
16857261|NCT01940705|37811271|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
16857262|NCT01940705|37811272|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
16857263|NCT01940705|37811273|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
16857264|NCT01940705|37811274|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
16857265|NCT01957163|37811299|FG000|Overall Study|Adverse Event|5|||
16857266|NCT01957163|37811300|FG001|Overall Study|Adverse Event|2|||
16857267|NCT01957163|37811301|FG002|Overall Study|Adverse Event|4|||
16857268|NCT01957163|37811299|FG000|Overall Study|Lack of Efficacy|5|||
16857269|NCT01957163|37811300|FG001|Overall Study|Lack of Efficacy|4|||
16857270|NCT01957163|37811301|FG002|Overall Study|Lack of Efficacy|9|||
16857271|NCT01957163|37811299|FG000|Overall Study|Protocol Violation|1|||
16857272|NCT01957163|37811300|FG001|Overall Study|Protocol Violation|2|||
16857273|NCT01957163|37811301|FG002|Overall Study|Protocol Violation|0|||
16857274|NCT01957163|37811299|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
16857275|NCT01957163|37811300|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
16857276|NCT01957163|37811301|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
16857277|NCT01957163|37811299|FG000|Overall Study|Lost to Follow-up|0|||
16857278|NCT01957163|37811300|FG001|Overall Study|Lost to Follow-up|1|||
16857279|NCT01957163|37811301|FG002|Overall Study|Lost to Follow-up|0|||
16857280|NCT01957163|37811299|FG000|Overall Study|Withdrawal by Subject|4|||
16857281|NCT01957163|37811300|FG001|Overall Study|Withdrawal by Subject|2|||
16857282|NCT01957163|37811301|FG002|Overall Study|Withdrawal by Subject|4|||
16857283|NCT01956773|37811324|FG000|Overall Study|Lost to Follow-up|628|||
16857284|NCT01956773|37811325|FG001|Overall Study|Lost to Follow-up|1|||
16857285|NCT01939223|37811364|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
16857286|NCT01939223|37811365|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
16857287|NCT01939223|37811364|FG000|Overall Study|Disease recurrence (radiological)|1|||
16857288|NCT01939223|37811365|FG001|Overall Study|Disease recurrence (radiological)|3|||
16857289|NCT01939223|37811364|FG000|Overall Study|Study stopped by Sponsor|5|||
16857290|NCT01939223|37811365|FG001|Overall Study|Study stopped by Sponsor|7|||
16857291|NCT01939223|37811364|FG000|Overall Study|Withdrawal by Subject|6|||
16857292|NCT01939223|37811365|FG001|Overall Study|Withdrawal by Subject|0|||
16857293|NCT01954745|37811410|FG000|Overall Study|Radiological Progression|11|||
16857294|NCT01954745|37811410|FG000|Overall Study|Clinical Progression|5|||
16857295|NCT01954745|37811410|FG000|Overall Study|Adverse Event|2|||
16857296|NCT01954745|37811410|FG000|Overall Study|Death|1|||
16857297|NCT01954121|37811425|FG000|Overall Study|Lack of Efficacy|94|||
16942395|NCT01350804|38086977|FG000|Core Study|Lost to Follow-up|3|||
16857298|NCT01954121|37811426|FG001|Overall Study|Lack of Efficacy|41|||
16857299|NCT01954121|37811425|FG000|Overall Study|Protocol Violation|0|||
16857300|NCT01954121|37811426|FG001|Overall Study|Protocol Violation|2|||
16857301|NCT01954121|37811425|FG000|Overall Study|Lost to Follow-up|5|||
16857302|NCT01954121|37811426|FG001|Overall Study|Lost to Follow-up|6|||
16857303|NCT01954121|37811425|FG000|Overall Study|Withdrawal by Subject|18|||
16857304|NCT01954121|37811426|FG001|Overall Study|Withdrawal by Subject|12|||
16857305|NCT01954121|37811425|FG000|Overall Study|Pregnancy|1|||
16942396|NCT01350804|38086978|FG001|Core Study|Lost to Follow-up|0|||
16857306|NCT01954121|37811426|FG001|Overall Study|Pregnancy|1|||
16857307|NCT01954121|37811425|FG000|Overall Study|AE, serious fatal|1|||
16857308|NCT01954121|37811426|FG001|Overall Study|AE, serious fatal|0|||
16857309|NCT01954121|37811425|FG000|Overall Study|AE, non-serious non-fatal|5|||
16857310|NCT01954121|37811426|FG001|Overall Study|AE, non-serious non-fatal|22|||
16857311|NCT01954121|37811425|FG000|Overall Study|SAE, non-fatal|1|||
16857312|NCT01954121|37811426|FG001|Overall Study|SAE, non-fatal|4|||
16857313|NCT01954121|37811425|FG000|Overall Study|Non-compliant with study procedures|1|||
16857314|NCT01954121|37811426|FG001|Overall Study|Non-compliant with study procedures|0|||
16857315|NCT01954121|37811425|FG000|Overall Study|Non-compliant patient|1|||
16857316|NCT01954121|37811426|FG001|Overall Study|Non-compliant patient|1|||
16857317|NCT01954121|37811425|FG000|Overall Study|Subject did not follow instructions|0|||
16857318|NCT01954121|37811426|FG001|Overall Study|Subject did not follow instructions|2|||
16857319|NCT01952015|37811461|FG000|Induction|Protocol Violation|1|||
16857320|NCT01952015|37811461|FG000|Maintenance|Adverse Event|2|||
16857321|NCT01952015|37811461|FG000|Treatment Period 3|Physician Decision|9|||
16857322|NCT01951703|37811494|FG000|First Intervention|Withdrawal by Subject|1|||
16857323|NCT01951703|37811495|FG001|First Intervention|Withdrawal by Subject|0|||
16942397|NCT01350804|38086979|FG002|Core Study|Lost to Follow-up|2|||
16942398|NCT01350804|38086980|FG003|Core Study|Lost to Follow-up|1|||
16942399|NCT01350804|38086977|FG000|Core Study|Lack of Efficacy|16|||
16942400|NCT01350804|38086978|FG001|Core Study|Lack of Efficacy|19|||
16942401|NCT01350804|38086979|FG002|Core Study|Lack of Efficacy|18|||
16942402|NCT01350804|38086980|FG003|Core Study|Lack of Efficacy|5|||
16942403|NCT01350804|38086977|FG000|Core Study|Death|1|||
16942404|NCT01350804|38086978|FG001|Core Study|Death|1|||
16942405|NCT01350804|38086979|FG002|Core Study|Death|1|||
16942406|NCT01350804|38086980|FG003|Core Study|Death|0|||
16942407|NCT01350804|38086977|FG000|Core Study|Adverse Event|8|||
16942408|NCT01350804|38086978|FG001|Core Study|Adverse Event|10|||
16942409|NCT01350804|38086979|FG002|Core Study|Adverse Event|8|||
16942410|NCT01350804|38086980|FG003|Core Study|Adverse Event|8|||
16942411|NCT01350804|38086977|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
16942412|NCT01350804|38086978|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
16942413|NCT01350804|38086979|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
16942414|NCT01350804|38086980|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
16942415|NCT01350804|38086977|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
16857324|NCT01951703|37811494|FG000|First Intervention|Subject was not compliant|1|||
16857325|NCT01951703|37811495|FG001|First Intervention|Subject was not compliant|1|||
16857326|NCT01951703|37811494|FG000|First Intervention|Physician Decision|1|||
16857327|NCT01951703|37811495|FG001|First Intervention|Physician Decision|0|||
16857328|NCT01951703|37811494|FG000|Second Intervention|Protocol Violation|0|||
16857329|NCT01951703|37811495|FG001|Second Intervention|Protocol Violation|1|||
16857330|NCT01951703|37811494|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
16857331|NCT01951703|37811495|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
16857332|NCT01937351|37811521|FG000|Overall Study|Withdrawal by Subject|4|||
16857333|NCT01937351|37811522|FG001|Overall Study|Withdrawal by Subject|2|||
16857334|NCT01937351|37811521|FG000|Overall Study|Death|1|||
16942416|NCT01350804|38086978|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
16942417|NCT01350804|38086979|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
16942418|NCT01350804|38086980|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
16942419|NCT01350804|38086977|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
16942420|NCT01350804|38086978|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
16942421|NCT01350804|38086979|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
16942422|NCT01350804|38086980|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
16942423|NCT01350804|38086977|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
16857335|NCT01937351|37811522|FG001|Overall Study|Death|0|||
16857336|NCT01937351|37811521|FG000|Overall Study|Not treated w device, per protocol fail|4|||
16857337|NCT01937351|37811522|FG001|Overall Study|Not treated w device, per protocol fail|0|||
16857338|NCT01737697|37811555|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857339|NCT01737697|37811556|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
16857340|NCT01737697|37811557|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857341|NCT01737697|37811558|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
16857342|NCT01737697|37811559|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
16857343|NCT01737697|37811560|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857344|NCT01737697|37811561|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857345|NCT01737697|37811562|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857346|NCT01737697|37811563|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857347|NCT01737697|37811564|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857348|NCT01737697|37811565|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857349|NCT01737697|37811566|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857350|NCT01737697|37811567|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857351|NCT01737697|37811568|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857352|NCT01737697|37811569|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16857353|NCT01737697|37811555|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
16857354|NCT01737697|37811556|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
16857355|NCT01737697|37811557|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
16857356|NCT01737697|37811558|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857357|NCT01737697|37811559|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857358|NCT01737697|37811560|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857359|NCT01737697|37811561|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857360|NCT01737697|37811562|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857361|NCT01737697|37811563|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857362|NCT01737697|37811564|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857363|NCT01737697|37811565|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857364|NCT01737697|37811566|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857365|NCT01737697|37811567|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857366|NCT01737697|37811568|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857367|NCT01737697|37811569|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16857368|NCT01737697|37811555|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857369|NCT01737697|37811556|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857370|NCT01737697|37811557|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857371|NCT01737697|37811558|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
16857372|NCT01737697|37811559|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857373|NCT01737697|37811560|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857374|NCT01737697|37811561|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857375|NCT01737697|37811562|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857376|NCT01737697|37811563|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857377|NCT01737697|37811564|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857378|NCT01737697|37811565|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857379|NCT01737697|37811566|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857380|NCT01737697|37811567|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857381|NCT01737697|37811568|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857382|NCT01737697|37811569|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
16857383|NCT01737697|37811555|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857384|NCT01737697|37811556|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
16857385|NCT01737697|37811557|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857386|NCT01737697|37811558|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857387|NCT01737697|37811559|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857388|NCT01737697|37811560|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857389|NCT01737697|37811561|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857390|NCT01737697|37811562|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857391|NCT01737697|37811563|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857392|NCT01737697|37811564|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857393|NCT01737697|37811565|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857394|NCT01737697|37811566|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857395|NCT01737697|37811567|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857396|NCT01737697|37811568|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857397|NCT01737697|37811569|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16857398|NCT01737697|37811555|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857399|NCT01737697|37811556|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857400|NCT01737697|37811557|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857401|NCT01737697|37811558|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857402|NCT01737697|37811559|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
16857403|NCT01737697|37811560|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857404|NCT01737697|37811561|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857405|NCT01737697|37811562|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857406|NCT01737697|37811563|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857407|NCT01737697|37811564|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857408|NCT01737697|37811565|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857409|NCT01737697|37811566|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857410|NCT01737697|37811567|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857411|NCT01737697|37811568|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857412|NCT01737697|37811569|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16857413|NCT01737697|37811555|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857414|NCT01737697|37811556|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
16857415|NCT01737697|37811557|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
16857416|NCT01737697|37811558|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
16857417|NCT01737697|37811559|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
16857418|NCT01737697|37811560|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857419|NCT01737697|37811561|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857420|NCT01737697|37811562|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857421|NCT01737697|37811563|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857422|NCT01737697|37811564|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857423|NCT01737697|37811565|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857424|NCT01737697|37811566|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857425|NCT01737697|37811567|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857426|NCT01737697|37811568|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857427|NCT01737697|37811569|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16857428|NCT01737697|37811555|FG000|Subacute Phase|Adverse Event|0|||
16857429|NCT01737697|37811556|FG001|Subacute Phase|Adverse Event|0|||
16857430|NCT01737697|37811557|FG002|Subacute Phase|Adverse Event|0|||
16857431|NCT01737697|37811558|FG003|Subacute Phase|Adverse Event|0|||
16857432|NCT01737697|37811559|FG004|Subacute Phase|Adverse Event|0|||
16857433|NCT01737697|37811560|FG005|Subacute Phase|Adverse Event|1|||
16857434|NCT01737697|37811561|FG006|Subacute Phase|Adverse Event|1|||
16857435|NCT01737697|37811562|FG007|Subacute Phase|Adverse Event|1|||
16857436|NCT01737697|37811563|FG008|Subacute Phase|Adverse Event|1|||
16857437|NCT01737697|37811564|FG009|Subacute Phase|Adverse Event|1|||
16857438|NCT01737697|37811565|FG010|Subacute Phase|Adverse Event|4|||
16857439|NCT01737697|37811566|FG011|Subacute Phase|Adverse Event|1|||
16857440|NCT01737697|37811567|FG012|Subacute Phase|Adverse Event|1|||
16857441|NCT01737697|37811568|FG013|Subacute Phase|Adverse Event|0|||
16857442|NCT01737697|37811569|FG014|Subacute Phase|Adverse Event|0|||
16857443|NCT01737697|37811555|FG000|Subacute Phase|Withdrawal by Subject|0|||
16857444|NCT01737697|37811556|FG001|Subacute Phase|Withdrawal by Subject|0|||
16857445|NCT01737697|37811557|FG002|Subacute Phase|Withdrawal by Subject|0|||
16857446|NCT01737697|37811558|FG003|Subacute Phase|Withdrawal by Subject|0|||
16857447|NCT01737697|37811559|FG004|Subacute Phase|Withdrawal by Subject|0|||
16857448|NCT01737697|37811560|FG005|Subacute Phase|Withdrawal by Subject|1|||
16857449|NCT01737697|37811561|FG006|Subacute Phase|Withdrawal by Subject|0|||
17127289|NCT02942576|38267532|FG000|Overall Study|Other|10|||
17127290|NCT02942576|38267533|FG001|Overall Study|Other|8|||
17127291|NCT02820298|38267541|FG000|Overall Study|Withdrawal by Subject|0|||
16857450|NCT01737697|37811562|FG007|Subacute Phase|Withdrawal by Subject|2|||
16857451|NCT01737697|37811563|FG008|Subacute Phase|Withdrawal by Subject|0|||
16857452|NCT01737697|37811564|FG009|Subacute Phase|Withdrawal by Subject|1|||
16857453|NCT01737697|37811565|FG010|Subacute Phase|Withdrawal by Subject|0|||
16857454|NCT01737697|37811566|FG011|Subacute Phase|Withdrawal by Subject|1|||
16857455|NCT01737697|37811567|FG012|Subacute Phase|Withdrawal by Subject|1|||
16857456|NCT01737697|37811568|FG013|Subacute Phase|Withdrawal by Subject|1|||
16857457|NCT01737697|37811569|FG014|Subacute Phase|Withdrawal by Subject|0|||
16857458|NCT01737697|37811555|FG000|Subacute Phase|Lost to Follow-up|0|||
16857459|NCT01737697|37811556|FG001|Subacute Phase|Lost to Follow-up|0|||
16857460|NCT01737697|37811557|FG002|Subacute Phase|Lost to Follow-up|0|||
16857461|NCT01737697|37811558|FG003|Subacute Phase|Lost to Follow-up|0|||
16857462|NCT01737697|37811559|FG004|Subacute Phase|Lost to Follow-up|0|||
16857463|NCT01737697|37811560|FG005|Subacute Phase|Lost to Follow-up|0|||
16857464|NCT01737697|37811561|FG006|Subacute Phase|Lost to Follow-up|0|||
16857465|NCT01737697|37811562|FG007|Subacute Phase|Lost to Follow-up|0|||
16857466|NCT01737697|37811563|FG008|Subacute Phase|Lost to Follow-up|0|||
16857467|NCT01737697|37811564|FG009|Subacute Phase|Lost to Follow-up|0|||
16857468|NCT01737697|37811565|FG010|Subacute Phase|Lost to Follow-up|0|||
16857469|NCT01737697|37811566|FG011|Subacute Phase|Lost to Follow-up|0|||
16857470|NCT01737697|37811567|FG012|Subacute Phase|Lost to Follow-up|0|||
16857471|NCT01737697|37811568|FG013|Subacute Phase|Lost to Follow-up|0|||
16857472|NCT01737697|37811569|FG014|Subacute Phase|Lost to Follow-up|1|||
16857473|NCT01737697|37811555|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
16857474|NCT01737697|37811556|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
16857475|NCT01737697|37811557|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
16857476|NCT01737697|37811558|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
16857477|NCT01737697|37811559|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
16857478|NCT01737697|37811560|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
16857479|NCT01737697|37811561|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
16857480|NCT01737697|37811562|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
16857481|NCT01737697|37811563|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
16857482|NCT01737697|37811564|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
16857483|NCT01737697|37811565|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
16857484|NCT01737697|37811566|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
16857485|NCT01737697|37811567|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
16857486|NCT01737697|37811568|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
16857487|NCT01737697|37811569|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
16857488|NCT01737697|37811555|FG000|Subacute Phase|Protocol Violation|0|||
16857489|NCT01737697|37811556|FG001|Subacute Phase|Protocol Violation|0|||
16857490|NCT01737697|37811557|FG002|Subacute Phase|Protocol Violation|0|||
16857491|NCT01737697|37811558|FG003|Subacute Phase|Protocol Violation|0|||
16857492|NCT01737697|37811559|FG004|Subacute Phase|Protocol Violation|0|||
16857493|NCT01737697|37811560|FG005|Subacute Phase|Protocol Violation|1|||
16857494|NCT01737697|37811561|FG006|Subacute Phase|Protocol Violation|0|||
16857495|NCT01737697|37811562|FG007|Subacute Phase|Protocol Violation|0|||
16857496|NCT01737697|37811563|FG008|Subacute Phase|Protocol Violation|0|||
16857497|NCT01737697|37811564|FG009|Subacute Phase|Protocol Violation|0|||
16857498|NCT01737697|37811565|FG010|Subacute Phase|Protocol Violation|1|||
16857499|NCT01737697|37811566|FG011|Subacute Phase|Protocol Violation|0|||
16857500|NCT01737697|37811567|FG012|Subacute Phase|Protocol Violation|0|||
16857501|NCT01737697|37811568|FG013|Subacute Phase|Protocol Violation|0|||
16857502|NCT01737697|37811569|FG014|Subacute Phase|Protocol Violation|0|||
16857503|NCT01737697|37811555|FG000|Subacute Phase|Physician Decision|0|||
16857504|NCT01737697|37811556|FG001|Subacute Phase|Physician Decision|0|||
16857505|NCT01737697|37811557|FG002|Subacute Phase|Physician Decision|0|||
16942424|NCT01350804|38086978|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
16942425|NCT01350804|38086979|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
16857506|NCT01737697|37811558|FG003|Subacute Phase|Physician Decision|0|||
16857507|NCT01737697|37811559|FG004|Subacute Phase|Physician Decision|0|||
16857508|NCT01737697|37811560|FG005|Subacute Phase|Physician Decision|0|||
16857509|NCT01737697|37811561|FG006|Subacute Phase|Physician Decision|0|||
16857510|NCT01737697|37811562|FG007|Subacute Phase|Physician Decision|0|||
16857511|NCT01737697|37811563|FG008|Subacute Phase|Physician Decision|1|||
16857512|NCT01737697|37811564|FG009|Subacute Phase|Physician Decision|0|||
16857513|NCT01737697|37811565|FG010|Subacute Phase|Physician Decision|0|||
16857514|NCT01737697|37811566|FG011|Subacute Phase|Physician Decision|0|||
16857515|NCT01737697|37811567|FG012|Subacute Phase|Physician Decision|0|||
16857516|NCT01737697|37811568|FG013|Subacute Phase|Physician Decision|0|||
16857517|NCT01737697|37811569|FG014|Subacute Phase|Physician Decision|0|||
16857518|NCT01737697|37811555|FG000|Subacute Phase|Death|0|||
16942426|NCT01350804|38086980|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
16942427|NCT01350804|38086977|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
16942428|NCT01350804|38086978|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
16942429|NCT01350804|38086979|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
16942430|NCT01350804|38086980|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
16942431|NCT01350804|38086977|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
16942432|NCT01350804|38086978|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
16942433|NCT01350804|38086979|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
16942434|NCT01350804|38086980|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
16942435|NCT01350492|38087002|FG000|Intervention|Lost to Follow-up|2|||
16942436|NCT01350492|38087003|FG001|Intervention|Lost to Follow-up|5|||
16942437|NCT01350492|38087002|FG000|Intervention|Withdrawal by Subject|3|||
16942438|NCT01350492|38087003|FG001|Intervention|Withdrawal by Subject|1|||
16942439|NCT01350492|38087002|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
16942440|NCT01350492|38087003|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
16942441|NCT01350492|38087002|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
16942442|NCT01350492|38087003|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
16942443|NCT02270957|38087011|FG000|Overall Study|Lack of Efficacy|2|||
16942444|NCT02270957|38087012|FG001|Overall Study|Lack of Efficacy|4|||
16942445|NCT02270957|38087011|FG000|Overall Study|Adverse Event|2|||
16942446|NCT02270957|38087012|FG001|Overall Study|Adverse Event|0|||
16942447|NCT01350414|38087019|FG000|Overall Study|Lost to Follow-up|13|||
16942448|NCT01350414|38087019|FG000|Overall Study|Withdrawal by Subject|4|||
16942449|NCT01350414|38087019|FG000|Overall Study|Physician Decision|2|||
16942450|NCT01350336|38087029|FG000|Overall Study|Lost to Follow-up|31|||
16942451|NCT01350336|38087029|FG000|Overall Study|Withdrawal by Subject|14|||
16942452|NCT01350336|38087029|FG000|Overall Study|Physician Decision|8|||
16942453|NCT01350336|38087029|FG000|Overall Study|Death|4|||
16942454|NCT01349049|38087087|FG000|Overall Study|Disease progression|3|||
16942455|NCT01349049|38087088|FG001|Overall Study|Disease progression|5|||
16942456|NCT01349049|38087089|FG002|Overall Study|Disease progression|3|||
16942457|NCT01349049|38087090|FG003|Overall Study|Disease progression|2|||
16942458|NCT01349049|38087091|FG004|Overall Study|Disease progression|2|||
16942459|NCT01349049|38087092|FG005|Overall Study|Disease progression|2|||
17028327|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
16857519|NCT01737697|37811556|FG001|Subacute Phase|Death|0|||
16857520|NCT01737697|37811557|FG002|Subacute Phase|Death|0|||
16857521|NCT01737697|37811558|FG003|Subacute Phase|Death|0|||
16857522|NCT01737697|37811559|FG004|Subacute Phase|Death|0|||
16857523|NCT01737697|37811560|FG005|Subacute Phase|Death|0|||
16857524|NCT01737697|37811561|FG006|Subacute Phase|Death|0|||
16857525|NCT01737697|37811562|FG007|Subacute Phase|Death|0|||
16942460|NCT01349049|38087093|FG006|Overall Study|Disease progression|3|||
16942461|NCT01349049|38087094|FG007|Overall Study|Disease progression|2|||
16942462|NCT01349049|38087095|FG008|Overall Study|Disease progression|33|||
16942463|NCT01349049|38087087|FG000|Overall Study|Adverse Event|0|||
16942464|NCT01349049|38087088|FG001|Overall Study|Adverse Event|1|||
16942465|NCT01349049|38087089|FG002|Overall Study|Adverse Event|0|||
16942466|NCT01349049|38087090|FG003|Overall Study|Adverse Event|0|||
16942467|NCT01349049|38087091|FG004|Overall Study|Adverse Event|0|||
16942468|NCT01349049|38087092|FG005|Overall Study|Adverse Event|3|||
16857526|NCT01737697|37811563|FG008|Subacute Phase|Death|0|||
16857527|NCT01737697|37811564|FG009|Subacute Phase|Death|0|||
16857528|NCT01737697|37811565|FG010|Subacute Phase|Death|1|||
16857529|NCT01737697|37811566|FG011|Subacute Phase|Death|0|||
16857530|NCT01737697|37811567|FG012|Subacute Phase|Death|0|||
16857531|NCT01737697|37811568|FG013|Subacute Phase|Death|0|||
16857532|NCT01737697|37811569|FG014|Subacute Phase|Death|0|||
16857533|NCT01682863|37811725|FG000|Overall Study|Subject/guardian decision|19|||
16857534|NCT01682863|37811726|FG001|Overall Study|Subject/guardian decision|12|||
16857535|NCT01682863|37811727|FG002|Overall Study|Subject/guardian decision|10|||
16857536|NCT01682863|37811725|FG000|Overall Study|Lost to Follow-up|5|||
16857537|NCT01682863|37811726|FG001|Overall Study|Lost to Follow-up|1|||
16857538|NCT01682863|37811727|FG002|Overall Study|Lost to Follow-up|6|||
16857539|NCT01682863|37811725|FG000|Overall Study|Death|1|||
16857540|NCT01682863|37811726|FG001|Overall Study|Death|3|||
16857541|NCT01682863|37811727|FG002|Overall Study|Death|4|||
16857542|NCT01682863|37811725|FG000|Overall Study|Protocol deviation|1|||
16857543|NCT01682863|37811726|FG001|Overall Study|Protocol deviation|0|||
16857544|NCT01682863|37811727|FG002|Overall Study|Protocol deviation|1|||
16857545|NCT01682863|37811725|FG000|Overall Study|Technical problems|1|||
16857546|NCT01682863|37811726|FG001|Overall Study|Technical problems|0|||
16857547|NCT01682863|37811727|FG002|Overall Study|Technical problems|0|||
16857548|NCT01682863|37811725|FG000|Overall Study|Adverse Event|0|||
16857549|NCT01682863|37811726|FG001|Overall Study|Adverse Event|1|||
16857550|NCT01682863|37811727|FG002|Overall Study|Adverse Event|2|||
16857551|NCT01682863|37811725|FG000|Overall Study|Physician Decision|0|||
16857552|NCT01682863|37811726|FG001|Overall Study|Physician Decision|0|||
16857553|NCT01682863|37811727|FG002|Overall Study|Physician Decision|1|||
16857554|NCT01951625|37811740|FG000|Treatment Period|Protocol Violation|2|||
16857555|NCT01951625|37811741|FG001|Treatment Period|Protocol Violation|0|||
16857556|NCT01951625|37811742|FG002|Treatment Period|Protocol Violation|1|||
16857557|NCT01951625|37811743|FG003|Treatment Period|Protocol Violation|3|||
16857558|NCT01951625|37811744|FG004|Treatment Period|Protocol Violation|2|||
16857559|NCT01951625|37811740|FG000|Treatment Period|Physician Decision|0|||
16857560|NCT01951625|37811741|FG001|Treatment Period|Physician Decision|0|||
16857561|NCT01951625|37811742|FG002|Treatment Period|Physician Decision|0|||
16857562|NCT01951625|37811743|FG003|Treatment Period|Physician Decision|0|||
16857563|NCT01951625|37811744|FG004|Treatment Period|Physician Decision|1|||
16857564|NCT01951625|37811740|FG000|Treatment Period|Protocol driven decision point|0|||
16857565|NCT01951625|37811741|FG001|Treatment Period|Protocol driven decision point|5|||
16857566|NCT01951625|37811742|FG002|Treatment Period|Protocol driven decision point|0|||
16857567|NCT01951625|37811743|FG003|Treatment Period|Protocol driven decision point|2|||
16857568|NCT01951625|37811744|FG004|Treatment Period|Protocol driven decision point|1|||
16857569|NCT01951625|37811740|FG000|Treatment Period|Non compliance with study drug|1|||
16857570|NCT01951625|37811741|FG001|Treatment Period|Non compliance with study drug|2|||
16857571|NCT01951625|37811742|FG002|Treatment Period|Non compliance with study drug|2|||
16857572|NCT01951625|37811743|FG003|Treatment Period|Non compliance with study drug|0|||
16857573|NCT01951625|37811744|FG004|Treatment Period|Non compliance with study drug|0|||
16857574|NCT01951625|37811740|FG000|Treatment Period|Death|3|||
16857575|NCT01951625|37811741|FG001|Treatment Period|Death|2|||
16857576|NCT01951625|37811742|FG002|Treatment Period|Death|2|||
16857577|NCT01951625|37811743|FG003|Treatment Period|Death|1|||
16857578|NCT01951625|37811744|FG004|Treatment Period|Death|2|||
16857579|NCT01951625|37811740|FG000|Treatment Period|Adverse Event|7|||
16857580|NCT01951625|37811741|FG001|Treatment Period|Adverse Event|10|||
16857581|NCT01951625|37811742|FG002|Treatment Period|Adverse Event|9|||
16857582|NCT01951625|37811743|FG003|Treatment Period|Adverse Event|8|||
16857583|NCT01951625|37811744|FG004|Treatment Period|Adverse Event|8|||
16857584|NCT01951625|37811740|FG000|Treatment Period|Withdrawal by Subject|5|||
16857585|NCT01951625|37811741|FG001|Treatment Period|Withdrawal by Subject|2|||
16857586|NCT01951625|37811742|FG002|Treatment Period|Withdrawal by Subject|1|||
16857587|NCT01951625|37811743|FG003|Treatment Period|Withdrawal by Subject|7|||
16857588|NCT01951625|37811744|FG004|Treatment Period|Withdrawal by Subject|3|||
16857589|NCT01951625|37811740|FG000|Treatment Period|Lost to Follow-up|1|||
16857590|NCT01951625|37811741|FG001|Treatment Period|Lost to Follow-up|0|||
16857591|NCT01951625|37811742|FG002|Treatment Period|Lost to Follow-up|0|||
16857592|NCT01951625|37811743|FG003|Treatment Period|Lost to Follow-up|1|||
16857593|NCT01951625|37811744|FG004|Treatment Period|Lost to Follow-up|0|||
16857594|NCT01951625|37811740|FG000|Follow Up Period|Non-compliance with study drug|1|||
16857595|NCT01951625|37811741|FG001|Follow Up Period|Non-compliance with study drug|0|||
16857596|NCT01951625|37811742|FG002|Follow Up Period|Non-compliance with study drug|0|||
16857597|NCT01951625|37811743|FG003|Follow Up Period|Non-compliance with study drug|0|||
16857598|NCT01951625|37811744|FG004|Follow Up Period|Non-compliance with study drug|0|||
16857599|NCT01951625|37811740|FG000|Follow Up Period|Death|1|||
16857600|NCT01951625|37811741|FG001|Follow Up Period|Death|3|||
16857601|NCT01951625|37811742|FG002|Follow Up Period|Death|2|||
16857602|NCT01951625|37811743|FG003|Follow Up Period|Death|2|||
16857603|NCT01951625|37811744|FG004|Follow Up Period|Death|1|||
16857604|NCT01951625|37811740|FG000|Follow Up Period|Logistical difficulties|1|||
16857605|NCT01951625|37811741|FG001|Follow Up Period|Logistical difficulties|2|||
16857606|NCT01951625|37811742|FG002|Follow Up Period|Logistical difficulties|0|||
16857607|NCT01951625|37811743|FG003|Follow Up Period|Logistical difficulties|0|||
16857608|NCT01951625|37811744|FG004|Follow Up Period|Logistical difficulties|0|||
16857609|NCT01951625|37811740|FG000|Follow Up Period|Adverse Event|0|||
16942469|NCT01349049|38087093|FG006|Overall Study|Adverse Event|1|||
16942470|NCT01349049|38087094|FG007|Overall Study|Adverse Event|0|||
16942471|NCT01349049|38087095|FG008|Overall Study|Adverse Event|4|||
16942472|NCT01349049|38087087|FG000|Overall Study|Physician Decision|0|||
16942473|NCT01349049|38087088|FG001|Overall Study|Physician Decision|1|||
16942474|NCT01349049|38087089|FG002|Overall Study|Physician Decision|0|||
16942475|NCT01349049|38087090|FG003|Overall Study|Physician Decision|0|||
16942476|NCT01349049|38087091|FG004|Overall Study|Physician Decision|0|||
17127292|NCT02820298|38267542|FG001|Overall Study|Withdrawal by Subject|1|||
16857610|NCT01951625|37811741|FG001|Follow Up Period|Adverse Event|3|||
16857611|NCT01951625|37811742|FG002|Follow Up Period|Adverse Event|2|||
16857612|NCT01951625|37811743|FG003|Follow Up Period|Adverse Event|3|||
16857613|NCT01951625|37811744|FG004|Follow Up Period|Adverse Event|5|||
16857614|NCT01951625|37811740|FG000|Follow Up Period|Withdrawal by Subject|4|||
16857615|NCT01951625|37811741|FG001|Follow Up Period|Withdrawal by Subject|1|||
16857616|NCT01951625|37811742|FG002|Follow Up Period|Withdrawal by Subject|0|||
16857617|NCT01951625|37811743|FG003|Follow Up Period|Withdrawal by Subject|5|||
16857618|NCT01951625|37811744|FG004|Follow Up Period|Withdrawal by Subject|3|||
16857619|NCT01951625|37811740|FG000|Follow Up Period|Lost to Follow-up|1|||
16857620|NCT01951625|37811741|FG001|Follow Up Period|Lost to Follow-up|0|||
16857621|NCT01951625|37811742|FG002|Follow Up Period|Lost to Follow-up|0|||
16857622|NCT01951625|37811743|FG003|Follow Up Period|Lost to Follow-up|1|||
16857623|NCT01951625|37811744|FG004|Follow Up Period|Lost to Follow-up|1|||
17028328|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
17028329|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
17028330|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
17028331|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
17028332|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
17127293|NCT02820298|38267541|FG000|Overall Study|Physician Decision|1|||
16857630|NCT04400890|37811772|FG000|Overall Study|Withdrawal by Subject|3|||
16857631|NCT04400890|37811773|FG001|Overall Study|Withdrawal by Subject|2|||
16857632|NCT01936649|37811779|FG000|Overall Study|Withdrawal by Subject|4|||
16857633|NCT01936649|37811779|FG000|Overall Study|Physician Decision|2|||
16857634|NCT01936649|37811779|FG000|Overall Study|Protocol Violation|2|||
16857635|NCT01936649|37811779|FG000|Overall Study|Other than specified above|5|||
16857636|NCT01720069|37811786|FG000|Overall Study|Could not use e-diary correctly|0|||
16857637|NCT01720069|37811787|FG001|Overall Study|Could not use e-diary correctly|1|||
16857638|NCT01720069|37811788|FG002|Overall Study|Could not use e-diary correctly|1|||
16857639|NCT01720069|37811786|FG000|Overall Study|Randomised without baseline values|0|||
16857640|NCT01720069|37811787|FG001|Overall Study|Randomised without baseline values|0|||
16857641|NCT01720069|37811788|FG002|Overall Study|Randomised without baseline values|1|||
16857642|NCT01720069|37811786|FG000|Overall Study|Adverse Event|0|||
16857643|NCT01720069|37811787|FG001|Overall Study|Adverse Event|0|||
16857644|NCT01720069|37811788|FG002|Overall Study|Adverse Event|1|||
16857645|NCT01720069|37811786|FG000|Overall Study|Lack of Efficacy|0|||
16857646|NCT01720069|37811787|FG001|Overall Study|Lack of Efficacy|4|||
16857647|NCT01720069|37811788|FG002|Overall Study|Lack of Efficacy|0|||
16857648|NCT01720069|37811786|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
16857649|NCT01720069|37811787|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
16857650|NCT01720069|37811788|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
16857651|NCT01720069|37811786|FG000|Overall Study|Withdrawal by Subject|0|||
16857652|NCT01720069|37811787|FG001|Overall Study|Withdrawal by Subject|2|||
16857653|NCT01720069|37811788|FG002|Overall Study|Withdrawal by Subject|1|||
16857654|NCT01720069|37811786|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
16857655|NCT01720069|37811787|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
16857656|NCT01720069|37811788|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
16857657|NCT01720069|37811786|FG000|Overall Study|Non-compliance on using e-diary|0|||
16857658|NCT01720069|37811787|FG001|Overall Study|Non-compliance on using e-diary|0|||
16857659|NCT01720069|37811788|FG002|Overall Study|Non-compliance on using e-diary|1|||
16857660|NCT01720069|37811786|FG000|Overall Study|Lost to Follow-up|0|||
16857661|NCT01720069|37811787|FG001|Overall Study|Lost to Follow-up|0|||
16942477|NCT01349049|38087092|FG005|Overall Study|Physician Decision|0|||
16942478|NCT01349049|38087093|FG006|Overall Study|Physician Decision|0|||
16942479|NCT01349049|38087094|FG007|Overall Study|Physician Decision|0|||
16942480|NCT01349049|38087095|FG008|Overall Study|Physician Decision|2|||
16942481|NCT01349049|38087087|FG000|Overall Study|Protocol Violation|0|||
16942482|NCT01349049|38087088|FG001|Overall Study|Protocol Violation|0|||
16942483|NCT01349049|38087089|FG002|Overall Study|Protocol Violation|0|||
16942484|NCT01349049|38087090|FG003|Overall Study|Protocol Violation|0|||
16942485|NCT01349049|38087091|FG004|Overall Study|Protocol Violation|0|||
16942486|NCT01349049|38087092|FG005|Overall Study|Protocol Violation|0|||
16942487|NCT01349049|38087093|FG006|Overall Study|Protocol Violation|0|||
16942488|NCT01349049|38087094|FG007|Overall Study|Protocol Violation|0|||
16942489|NCT01349049|38087095|FG008|Overall Study|Protocol Violation|1|||
16942490|NCT01349049|38087087|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
16942491|NCT01349049|38087088|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
16942492|NCT01349049|38087089|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
16942493|NCT01349049|38087090|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
16942494|NCT01349049|38087091|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
16942495|NCT01349049|38087092|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
16942496|NCT01349049|38087093|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
16942497|NCT01349049|38087094|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
16942498|NCT01349049|38087095|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
16942499|NCT01349049|38087087|FG000|Overall Study|Other|0|||
16942500|NCT01349049|38087088|FG001|Overall Study|Other|0|||
16942501|NCT01349049|38087089|FG002|Overall Study|Other|0|||
16942502|NCT01349049|38087090|FG003|Overall Study|Other|0|||
16942503|NCT01349049|38087091|FG004|Overall Study|Other|0|||
16942504|NCT01349049|38087092|FG005|Overall Study|Other|1|||
16942505|NCT01349049|38087093|FG006|Overall Study|Other|0|||
16942506|NCT01349049|38087094|FG007|Overall Study|Other|0|||
16942507|NCT01349049|38087095|FG008|Overall Study|Other|4|||
16942508|NCT01349049|38087087|FG000|Overall Study|Death|0|||
16942509|NCT01349049|38087088|FG001|Overall Study|Death|0|||
16942510|NCT01349049|38087089|FG002|Overall Study|Death|0|||
16942511|NCT01349049|38087090|FG003|Overall Study|Death|0|||
16942512|NCT01349049|38087091|FG004|Overall Study|Death|0|||
16942513|NCT01349049|38087092|FG005|Overall Study|Death|0|||
16942514|NCT01349049|38087093|FG006|Overall Study|Death|0|||
16942515|NCT01349049|38087094|FG007|Overall Study|Death|1|||
16942516|NCT01349049|38087095|FG008|Overall Study|Death|5|||
16942517|NCT01349049|38087087|FG000|Overall Study|Non-compliance|0|||
16942518|NCT01349049|38087088|FG001|Overall Study|Non-compliance|0|||
16942519|NCT01349049|38087089|FG002|Overall Study|Non-compliance|0|||
16942520|NCT01349049|38087090|FG003|Overall Study|Non-compliance|1|||
16942521|NCT01349049|38087091|FG004|Overall Study|Non-compliance|0|||
16942522|NCT01349049|38087092|FG005|Overall Study|Non-compliance|0|||
16942523|NCT01349049|38087093|FG006|Overall Study|Non-compliance|0|||
16942524|NCT01349049|38087094|FG007|Overall Study|Non-compliance|0|||
16942525|NCT01349049|38087095|FG008|Overall Study|Non-compliance|0|||
16942526|NCT01349049|38087087|FG000|Overall Study|Withdrawal by Subject|0|||
16942527|NCT01349049|38087088|FG001|Overall Study|Withdrawal by Subject|0|||
16942528|NCT01349049|38087089|FG002|Overall Study|Withdrawal by Subject|0|||
16942529|NCT01349049|38087090|FG003|Overall Study|Withdrawal by Subject|0|||
16942530|NCT01349049|38087091|FG004|Overall Study|Withdrawal by Subject|0|||
16942531|NCT01349049|38087092|FG005|Overall Study|Withdrawal by Subject|0|||
16942532|NCT01349049|38087093|FG006|Overall Study|Withdrawal by Subject|0|||
16942533|NCT01349049|38087094|FG007|Overall Study|Withdrawal by Subject|0|||
16942534|NCT01349049|38087095|FG008|Overall Study|Withdrawal by Subject|6|||
16942535|NCT01348854|38087129|FG000|Overall Study|Lost to Follow-up|2|||
16942536|NCT01348854|38087130|FG001|Overall Study|Lost to Follow-up|1|||
16942537|NCT01348854|38087129|FG000|Overall Study|Withdrawal by Subject|1|||
16942538|NCT01348854|38087130|FG001|Overall Study|Withdrawal by Subject|0|||
16942539|NCT01348776|38087136|FG000|Overall Study|Lost to Follow-up|3|||
16942540|NCT01348698|38087149|FG000|Overall Study|Does not meet lesion size criteria|1|||
16942541|NCT01348698|38087149|FG000|Overall Study|Death|3|||
16942542|NCT01348698|38087149|FG000|Overall Study|PI decision to close study|68|||
16942543|NCT01348542|38087155|FG000|Overall Study|Withdrawal by Subject|3|||
16773418|NCT02736409|37712472|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16942544|NCT01348542|38087156|FG001|Overall Study|Withdrawal by Subject|0|||
16942545|NCT01346709|38087162|FG000|Overall Study|Protocol Violation|35|||
16942546|NCT01346709|38087162|FG000|Overall Study|Lost to Follow-up|31|||
16942547|NCT01346709|38087162|FG000|Overall Study|Missing data in candidate risk factor|285|||
16942548|NCT01346592|38087169|FG000|Overall Study|Lost to Follow-up|62|||
16942549|NCT01346592|38087170|FG001|Overall Study|Lost to Follow-up|29|||
16942550|NCT01346592|38087171|FG002|Overall Study|Lost to Follow-up|29|||
16942551|NCT01346592|38087169|FG000|Overall Study|Protocol Violation|2|||
16942552|NCT01346592|38087170|FG001|Overall Study|Protocol Violation|1|||
16773419|NCT02736409|37712473|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16942553|NCT01346592|38087171|FG002|Overall Study|Protocol Violation|0|||
16942554|NCT01346592|38087169|FG000|Overall Study|Death|1|||
16942555|NCT01346592|38087170|FG001|Overall Study|Death|3|||
16942556|NCT01346592|38087171|FG002|Overall Study|Death|4|||
16942557|NCT01346592|38087169|FG000|Overall Study|Adverse Event|0|||
16942558|NCT01346592|38087170|FG001|Overall Study|Adverse Event|1|||
16942559|NCT01346592|38087171|FG002|Overall Study|Adverse Event|0|||
16942560|NCT01346592|38087169|FG000|Overall Study|Withdrawal by Subject|77|||
16942561|NCT01346592|38087170|FG001|Overall Study|Withdrawal by Subject|51|||
16942562|NCT01346592|38087171|FG002|Overall Study|Withdrawal by Subject|38|||
16942563|NCT01346592|38087169|FG000|Overall Study|Inappropriate enrollment|3|||
16942564|NCT01346592|38087170|FG001|Overall Study|Inappropriate enrollment|1|||
16942565|NCT01346592|38087171|FG002|Overall Study|Inappropriate enrollment|1|||
16942566|NCT01346592|38087169|FG000|Overall Study|Administrative reason|1|||
16942567|NCT01346592|38087170|FG001|Overall Study|Administrative reason|0|||
16942568|NCT01346592|38087171|FG002|Overall Study|Administrative reason|0|||
16942569|NCT01346592|38087169|FG000|Overall Study|Unable to Classify|7|||
16942570|NCT01346592|38087170|FG001|Overall Study|Unable to Classify|3|||
16942571|NCT01346592|38087171|FG002|Overall Study|Unable to Classify|6|||
16942572|NCT01346514|38087198|FG000|Overall Study|Lost to Follow-up|19|||
16942573|NCT01346514|38087199|FG001|Overall Study|Lost to Follow-up|30|||
16942574|NCT01346514|38087198|FG000|Overall Study|Withdrawal by Subject|7|||
16942575|NCT01346514|38087199|FG001|Overall Study|Withdrawal by Subject|3|||
16942576|NCT01346514|38087198|FG000|Overall Study|Death|3|||
16942577|NCT01346514|38087199|FG001|Overall Study|Death|4|||
16942578|NCT01193335|38087209|FG000|After Infant Series|Lost to Follow-up|1|||
16942579|NCT01193335|38087210|FG001|After Infant Series|Lost to Follow-up|2|||
16942580|NCT01193335|38087209|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
16942581|NCT01193335|38087210|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
16942582|NCT01193335|38087209|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
16942583|NCT01193335|38087210|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
16942584|NCT01193335|38087209|FG000|1-Year Follow-up|Lost to Follow-up|4|||
16942585|NCT01193335|38087210|FG001|1-Year Follow-up|Lost to Follow-up|0|||
16942586|NCT01193335|38087209|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
16942587|NCT01193335|38087210|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
16942588|NCT01193335|38087209|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
16942589|NCT01193335|38087210|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
16942590|NCT01342887|38087232|FG000|Overall Study|Death|2|||
16942591|NCT01342341|38087238|FG000|Overall Study|Lost to Follow-up|4|||
16942592|NCT01342341|38087239|FG001|Overall Study|Lost to Follow-up|4|||
16942593|NCT01340664|38087248|FG000|Overall Study|Adverse Event|0|||
16942594|NCT01340664|38087249|FG001|Overall Study|Adverse Event|1|||
16942595|NCT01340664|38087250|FG002|Overall Study|Adverse Event|7|||
16942596|NCT01340664|38087248|FG000|Overall Study|Lost to Follow-up|2|||
16942597|NCT01340664|38087249|FG001|Overall Study|Lost to Follow-up|0|||
16942598|NCT01340664|38087250|FG002|Overall Study|Lost to Follow-up|2|||
16942599|NCT01340664|38087248|FG000|Overall Study|Withdrawal by Subject|2|||
16942600|NCT01340664|38087249|FG001|Overall Study|Withdrawal by Subject|4|||
16942601|NCT01340664|38087250|FG002|Overall Study|Withdrawal by Subject|0|||
16942602|NCT01340664|38087248|FG000|Overall Study|Glycemic withdrawal criteria|2|||
16942603|NCT01340664|38087249|FG001|Overall Study|Glycemic withdrawal criteria|0|||
16942604|NCT01340664|38087250|FG002|Overall Study|Glycemic withdrawal criteria|0|||
16942605|NCT01340664|38087248|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
16942606|NCT01340664|38087249|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
16942607|NCT01340664|38087250|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
16942608|NCT01340664|38087248|FG000|Overall Study|Other|1|||
16942609|NCT01340664|38087249|FG001|Overall Study|Other|2|||
16942610|NCT01340664|38087250|FG002|Overall Study|Other|2|||
16942611|NCT01340625|38087260|FG000|First Intervention|Adverse Event|1|||
16942612|NCT01340625|38087261|FG001|First Intervention|Adverse Event|0|||
16942613|NCT01340625|38087260|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
16942614|NCT01340625|38087261|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
16942615|NCT01340196|38087267|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
16942616|NCT01327599|38087276|FG000|Overall Study|Adverse Event|1|||
16942617|NCT01327599|38087276|FG000|Overall Study|Could Not Attend Visit|1|||
16942618|NCT01327599|38087276|FG000|Overall Study|Withdrawal of Consent|1|||
16942619|NCT01193257|38087282|FG000|Overall Study|Death|202|||
16942620|NCT01193257|38087283|FG001|Overall Study|Death|391|||
16942621|NCT01193257|38087282|FG000|Overall Study|Study termination by sponsor|0|||
16942622|NCT01193257|38087283|FG001|Overall Study|Study termination by sponsor|3|||
16942623|NCT01193257|38087282|FG000|Overall Study|Withdrawal by Subject|26|||
16942624|NCT01193257|38087283|FG001|Overall Study|Withdrawal by Subject|86|||
16942625|NCT01193257|38087282|FG000|Overall Study|Lost to Follow-up|2|||
16857662|NCT01720069|37811788|FG002|Overall Study|Lost to Follow-up|1|||
16857663|NCT01719757|37811840|FG000|Overall Study|Adverse Event|38|||
16857664|NCT01719757|37811840|FG000|Overall Study|Withdrawal by Subject|15|||
16857665|NCT01719757|37811840|FG000|Overall Study|Lost to Follow-up|20|||
16857666|NCT01719757|37811840|FG000|Overall Study|Protocol Violation|1|||
16857667|NCT01719757|37811840|FG000|Overall Study|well controlled pain|27|||
16857668|NCT01718509|37811848|FG000|Overall Study|Lost to Follow-up|18|||
16857669|NCT01718509|37811849|FG001|Overall Study|Lost to Follow-up|15|||
16857670|NCT01718509|37811848|FG000|Overall Study|Withdrawal by Subject|7|||
16857671|NCT01718509|37811849|FG001|Overall Study|Withdrawal by Subject|13|||
16857672|NCT01718509|37811848|FG000|Overall Study|Adverse Event|5|||
16857673|NCT01718509|37811849|FG001|Overall Study|Adverse Event|7|||
16857674|NCT01718509|37811848|FG000|Overall Study|Other|13|||
16857675|NCT01718509|37811849|FG001|Overall Study|Other|11|||
16857676|NCT01718509|37811848|FG000|Overall Study|Protocol Violation|4|||
16857677|NCT01718509|37811849|FG001|Overall Study|Protocol Violation|2|||
16857678|NCT01718509|37811848|FG000|Overall Study|Lack of Efficacy|1|||
16857679|NCT01718509|37811849|FG001|Overall Study|Lack of Efficacy|0|||
16857680|NCT01857934|37811855|FG000|Overall Study|Relapse or progression|2|||
16857681|NCT01857934|37811855|FG000|Overall Study|Unacceptable toxicity|3|||
16857682|NCT01857934|37811855|FG000|Overall Study|Unwillingness or inability to comply|2|||
16857683|NCT01857934|37811855|FG000|Overall Study|Physician Decision|3|||
16857684|NCT01604941|37811896|FG000|Overall Study|Adverse Event|1|||
16857685|NCT01604941|37811897|FG001|Overall Study|Adverse Event|2|||
16857686|NCT01604941|37811898|FG002|Overall Study|Adverse Event|0|||
16857687|NCT01604941|37811899|FG003|Overall Study|Adverse Event|0|||
16857688|NCT01604941|37811900|FG004|Overall Study|Adverse Event|1|||
16857689|NCT01604941|37811901|FG005|Overall Study|Adverse Event|5|||
16857690|NCT01604941|37811896|FG000|Overall Study|Non-compliance|1|||
16857691|NCT01604941|37811897|FG001|Overall Study|Non-compliance|0|||
16857692|NCT01604941|37811898|FG002|Overall Study|Non-compliance|0|||
16857693|NCT01604941|37811899|FG003|Overall Study|Non-compliance|0|||
16857694|NCT01604941|37811900|FG004|Overall Study|Non-compliance|0|||
16857695|NCT01604941|37811901|FG005|Overall Study|Non-compliance|0|||
16857696|NCT01604941|37811896|FG000|Overall Study|Participant Decision|0|||
16857697|NCT01604941|37811897|FG001|Overall Study|Participant Decision|0|||
16857698|NCT01604941|37811898|FG002|Overall Study|Participant Decision|0|||
16857699|NCT01604941|37811899|FG003|Overall Study|Participant Decision|0|||
16857700|NCT01604941|37811900|FG004|Overall Study|Participant Decision|0|||
16857701|NCT01604941|37811901|FG005|Overall Study|Participant Decision|2|||
16857702|NCT01604941|37811896|FG000|Overall Study|Early Study Termination|9|||
16857703|NCT01604941|37811897|FG001|Overall Study|Early Study Termination|2|||
16857704|NCT01604941|37811898|FG002|Overall Study|Early Study Termination|3|||
16857705|NCT01604941|37811899|FG003|Overall Study|Early Study Termination|3|||
16857706|NCT01604941|37811900|FG004|Overall Study|Early Study Termination|0|||
16857707|NCT01604941|37811901|FG005|Overall Study|Early Study Termination|0|||
16857708|NCT01604785|37811909|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
16857709|NCT01604785|37811910|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
16857710|NCT01681849|37811919|FG000|Overall Study|Protocol Violation|2|||
16857711|NCT01681849|37811920|FG001|Overall Study|Protocol Violation|0|||
16857712|NCT01681849|37811921|FG002|Overall Study|Protocol Violation|0|||
16857713|NCT01681849|37811919|FG000|Overall Study|Withdrawal by Subject|3|||
16857714|NCT01681849|37811920|FG001|Overall Study|Withdrawal by Subject|5|||
16857715|NCT01681849|37811921|FG002|Overall Study|Withdrawal by Subject|33|||
16857716|NCT01681849|37811919|FG000|Overall Study|Lost to Follow-up|3|||
16857717|NCT01681849|37811920|FG001|Overall Study|Lost to Follow-up|2|||
16857718|NCT01681849|37811921|FG002|Overall Study|Lost to Follow-up|6|||
16857719|NCT01681771|37811930|FG000|Overall Study|Lost to Follow-up|4|||
16857720|NCT01681771|37811931|FG001|Overall Study|Lost to Follow-up|2|||
16857721|NCT04250350|37811937|FG000|Overall Study|Withdrawal by Subject|13|||
16857722|NCT04250350|37811937|FG000|Overall Study|Lost to Follow-up|8|||
16857723|NCT04250350|37811937|FG000|Overall Study|Adverse Event|5|||
16857724|NCT04250350|37811937|FG000|Overall Study|Lack of Efficacy|4|||
16857725|NCT04250350|37811937|FG000|Overall Study|Physician Decision|1|||
16857726|NCT04250350|37811937|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
16857727|NCT03536884|37811952|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
16857728|NCT03536884|37811953|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
16857729|NCT03536884|37811954|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
16857730|NCT03536884|37811955|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
16857731|NCT03536884|37811956|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
16857732|NCT03536884|37811952|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
16857733|NCT03536884|37811953|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
16857734|NCT03536884|37811954|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
16857735|NCT03536884|37811955|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
16857736|NCT03536884|37811956|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
16857737|NCT03536884|37811952|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
16857738|NCT03536884|37811953|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
16857739|NCT03536884|37811954|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
16857740|NCT03536884|37811955|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
16857741|NCT03536884|37811956|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
16857742|NCT03536884|37811952|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
16857743|NCT03536884|37811953|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
16942626|NCT01193257|38087283|FG001|Overall Study|Lost to Follow-up|3|||
16857744|NCT03536884|37811954|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
16857745|NCT03536884|37811955|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
16857746|NCT03536884|37811956|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
16857747|NCT03536884|37811952|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16857748|NCT03536884|37811953|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
16857749|NCT03536884|37811954|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16857750|NCT03536884|37811955|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16857751|NCT03536884|37811956|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16857752|NCT03536884|37811952|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
16857753|NCT03536884|37811953|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
16857754|NCT03536884|37811954|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
16857755|NCT03536884|37811955|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
16857756|NCT03536884|37811956|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
16857757|NCT03536884|37811952|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
16857758|NCT03536884|37811953|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
16857759|NCT03536884|37811954|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
16857760|NCT03536884|37811955|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
16857761|NCT03536884|37811956|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
16857762|NCT03536884|37811952|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
16857763|NCT03536884|37811953|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
16857764|NCT03536884|37811954|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
16857765|NCT03536884|37811955|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
16857766|NCT03536884|37811956|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
16857767|NCT03536884|37811952|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
16857768|NCT03536884|37811953|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
16857769|NCT03536884|37811954|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
16857770|NCT03536884|37811955|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
16857771|NCT03536884|37811956|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
16857772|NCT03536884|37811952|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
16857773|NCT03536884|37811953|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
16857774|NCT03536884|37811954|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
16857775|NCT03536884|37811955|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
16857776|NCT03536884|37811956|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
16857777|NCT03536884|37811952|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
16857778|NCT03536884|37811953|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
16857779|NCT03536884|37811954|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
16942627|NCT01193257|38087282|FG000|Overall Study|Unblinded due to futility|135|||
16942628|NCT01193257|38087283|FG001|Overall Study|Unblinded due to futility|251|||
16942629|NCT01193218|38087294|FG000|0-12 Weeks|Adverse Event|6|||
16942630|NCT01193218|38087295|FG001|0-12 Weeks|Adverse Event|0|||
16942631|NCT01193218|38087296|FG002|0-12 Weeks|Adverse Event|1|||
16942632|NCT01193218|38087297|FG003|0-12 Weeks|Adverse Event|0|||
16942633|NCT01193218|38087298|FG004|0-12 Weeks|Adverse Event|0|||
16942634|NCT01193218|38087299|FG005|0-12 Weeks|Adverse Event|2|||
16942635|NCT01193218|38087300|FG006|0-12 Weeks|Adverse Event|2|||
16942636|NCT01193218|38087301|FG007|0-12 Weeks|Adverse Event|0|||
16942637|NCT01193218|38087294|FG000|0-12 Weeks|Protocol Violation|0|||
16942638|NCT01193218|38087295|FG001|0-12 Weeks|Protocol Violation|0|||
16942639|NCT01193218|38087296|FG002|0-12 Weeks|Protocol Violation|0|||
16942640|NCT01193218|38087297|FG003|0-12 Weeks|Protocol Violation|0|||
16942641|NCT01193218|38087298|FG004|0-12 Weeks|Protocol Violation|1|||
16942642|NCT01193218|38087299|FG005|0-12 Weeks|Protocol Violation|1|||
16942643|NCT01193218|38087300|FG006|0-12 Weeks|Protocol Violation|0|||
16942644|NCT01193218|38087301|FG007|0-12 Weeks|Protocol Violation|0|||
16942645|NCT01193218|38087294|FG000|0-12 Weeks|Withdrawal by Subject|3|||
16942646|NCT01193218|38087295|FG001|0-12 Weeks|Withdrawal by Subject|0|||
16942647|NCT01193218|38087296|FG002|0-12 Weeks|Withdrawal by Subject|2|||
16942648|NCT01193218|38087297|FG003|0-12 Weeks|Withdrawal by Subject|0|||
16942649|NCT01193218|38087298|FG004|0-12 Weeks|Withdrawal by Subject|0|||
16942650|NCT01193218|38087299|FG005|0-12 Weeks|Withdrawal by Subject|0|||
16942651|NCT01193218|38087300|FG006|0-12 Weeks|Withdrawal by Subject|1|||
16942652|NCT01193218|38087301|FG007|0-12 Weeks|Withdrawal by Subject|0|||
16942653|NCT01193218|38087294|FG000|12-52 Weeks|Adverse Event|1|||
16942654|NCT01193218|38087295|FG001|12-52 Weeks|Adverse Event|0|||
16942655|NCT01193218|38087296|FG002|12-52 Weeks|Adverse Event|1|||
16942656|NCT01193218|38087297|FG003|12-52 Weeks|Adverse Event|2|||
16942657|NCT01193218|38087298|FG004|12-52 Weeks|Adverse Event|3|||
16942658|NCT01193218|38087299|FG005|12-52 Weeks|Adverse Event|3|||
16942659|NCT01193218|38087300|FG006|12-52 Weeks|Adverse Event|1|||
16942660|NCT01193218|38087301|FG007|12-52 Weeks|Adverse Event|2|||
16942661|NCT01193218|38087294|FG000|12-52 Weeks|Lack of Efficacy|0|||
16942662|NCT01193218|38087295|FG001|12-52 Weeks|Lack of Efficacy|0|||
16942663|NCT01193218|38087296|FG002|12-52 Weeks|Lack of Efficacy|0|||
16942664|NCT01193218|38087297|FG003|12-52 Weeks|Lack of Efficacy|0|||
16942665|NCT01193218|38087298|FG004|12-52 Weeks|Lack of Efficacy|0|||
16942666|NCT01193218|38087299|FG005|12-52 Weeks|Lack of Efficacy|0|||
16942667|NCT01193218|38087300|FG006|12-52 Weeks|Lack of Efficacy|1|||
16857780|NCT03536884|37811955|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
16857781|NCT03536884|37811956|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
16857782|NCT03536884|37811952|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
16857783|NCT03536884|37811953|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
16857784|NCT03536884|37811954|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
16857785|NCT03536884|37811955|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
16857786|NCT03536884|37811956|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
16857787|NCT01718353|37811989|FG000|Overall Study|Lost to Follow-up|0|||
16857788|NCT01718353|37811990|FG001|Overall Study|Lost to Follow-up|1|||
16857789|NCT01718353|37811989|FG000|Overall Study|Principal Investigator's Decision|10|||
16857790|NCT01718353|37811990|FG001|Overall Study|Principal Investigator's Decision|4|||
16857791|NCT01718353|37811989|FG000|Overall Study|Randomized but not treated|2|||
16857792|NCT01718353|37811990|FG001|Overall Study|Randomized but not treated|0|||
16857793|NCT01716715|37812000|FG000|Overall Study|Never Treated|2|||
16857794|NCT01716715|37812001|FG001|Overall Study|Never Treated|4|||
16857795|NCT01697449|37812009|FG000|Overall Study|Disease progression|47|||
16857796|NCT01697449|37812009|FG000|Overall Study|Adverse Event|7|||
16857797|NCT01697449|37812009|FG000|Overall Study|Lost to Follow-up|5|||
16857798|NCT01697449|37812009|FG000|Overall Study|Withdrawal by Subject|2|||
16857799|NCT01697449|37812009|FG000|Overall Study|Physician Decision|1|||
16857800|NCT01697449|37812009|FG000|Overall Study|Death|2|||
16857801|NCT01697449|37812009|FG000|Overall Study|Other|1|||
16857802|NCT01697449|37812009|FG000|Overall Study|Missing|25|||
16857803|NCT01696981|37812018|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
16857804|NCT01696981|37812019|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
16857805|NCT01696981|37812018|FG000|Overall Study|Died Before Randomization|3|||
16857806|NCT01696981|37812019|FG001|Overall Study|Died Before Randomization|8|||
16857807|NCT01696981|37812018|FG000|Overall Study|Died Before ASU (Control)|278|||
16857808|NCT01696981|37812019|FG001|Overall Study|Died Before ASU (Control)|0|||
16857809|NCT01696981|37812018|FG000|Overall Study|Refused ASU (Control)|920|||
16857810|NCT01696981|37812019|FG001|Overall Study|Refused ASU (Control)|0|||
16857811|NCT01696981|37812018|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
16857812|NCT01696981|37812019|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
16857813|NCT01696279|37812025|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
16857814|NCT01696279|37812026|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
16857815|NCT01696279|37812027|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
16857816|NCT01696279|37812028|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
16857817|NCT01696279|37812025|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
16857818|NCT01696279|37812026|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
16857819|NCT01696279|37812027|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
16857820|NCT01696279|37812028|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
16857821|NCT01696279|37812025|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
16857822|NCT01696279|37812026|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
16857823|NCT01696279|37812027|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
16857824|NCT01696279|37812028|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
16857825|NCT01696279|37812025|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
16857826|NCT01696279|37812026|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
16857827|NCT01696279|37812027|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
16857828|NCT01696279|37812028|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
16857829|NCT01696279|37812025|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
16857830|NCT01696279|37812026|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
16857831|NCT01696279|37812027|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
16857832|NCT01696279|37812028|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
16857833|NCT01696279|37812025|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
16857834|NCT01696279|37812026|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
16857835|NCT01696279|37812027|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
16857836|NCT01696279|37812028|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
16857837|NCT01696279|37812025|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
16857838|NCT01696279|37812026|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
16857839|NCT01696279|37812027|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
16857840|NCT01696279|37812028|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
16942668|NCT01193218|38087301|FG007|12-52 Weeks|Lack of Efficacy|0|||
16857841|NCT01696279|37812025|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
16857842|NCT01696279|37812026|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
16857843|NCT01696279|37812027|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
16857844|NCT01696279|37812028|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
16857845|NCT01696279|37812025|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
16857846|NCT01696279|37812026|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
16857847|NCT01696279|37812027|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
16857848|NCT01696279|37812028|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
16857849|NCT01696279|37812025|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
16857850|NCT01696279|37812026|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
16857851|NCT01696279|37812027|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
16857852|NCT01696279|37812028|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
16857853|NCT01696279|37812025|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
16857854|NCT01696279|37812026|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
16857855|NCT01696279|37812027|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
16857856|NCT01696279|37812028|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
16857857|NCT01681069|37812039|FG000|Overall Study|Withdrawal by Subject|4|||
16857858|NCT01681069|37812040|FG001|Overall Study|Withdrawal by Subject|5|||
16857859|NCT01681069|37812039|FG000|Overall Study|Protocol Violation|1|||
16857860|NCT01681069|37812040|FG001|Overall Study|Protocol Violation|1|||
16857861|NCT01681069|37812039|FG000|Overall Study|Adverse Event|0|||
16857862|NCT01681069|37812040|FG001|Overall Study|Adverse Event|1|||
16857863|NCT01716559|37812046|FG000|Overall Study|Adverse Event|11|||
16857864|NCT01716559|37812046|FG000|Overall Study|Death|21|||
16857865|NCT01716559|37812046|FG000|Overall Study|Withdrawal by Subject|4|||
16857866|NCT01716559|37812046|FG000|Overall Study|Other withdrawal reason|75|||
16857867|NCT01936181|37812052|FG000|Randomised, Double-blind|Adverse Event|27|||
16942669|NCT01193218|38087294|FG000|12-52 Weeks|Withdrawal by Subject|3|||
16942670|NCT01193218|38087295|FG001|12-52 Weeks|Withdrawal by Subject|0|||
16942671|NCT01193218|38087296|FG002|12-52 Weeks|Withdrawal by Subject|3|||
16942672|NCT01193218|38087297|FG003|12-52 Weeks|Withdrawal by Subject|0|||
16942673|NCT01193218|38087298|FG004|12-52 Weeks|Withdrawal by Subject|0|||
16942674|NCT01193218|38087299|FG005|12-52 Weeks|Withdrawal by Subject|2|||
16942675|NCT01193218|38087300|FG006|12-52 Weeks|Withdrawal by Subject|1|||
16942676|NCT01193218|38087301|FG007|12-52 Weeks|Withdrawal by Subject|2|||
16942677|NCT01193218|38087294|FG000|12-52 Weeks|Other reason than above|1|||
16942678|NCT01193218|38087295|FG001|12-52 Weeks|Other reason than above|0|||
16942679|NCT01193218|38087296|FG002|12-52 Weeks|Other reason than above|0|||
16942680|NCT01193218|38087297|FG003|12-52 Weeks|Other reason than above|1|||
16942681|NCT01193218|38087298|FG004|12-52 Weeks|Other reason than above|1|||
16942682|NCT01193218|38087299|FG005|12-52 Weeks|Other reason than above|0|||
16942683|NCT01193218|38087300|FG006|12-52 Weeks|Other reason than above|0|||
16942684|NCT01193218|38087301|FG007|12-52 Weeks|Other reason than above|0|||
16942685|NCT01193101|38087321|FG000|Overall Study|Adverse Event|0|||
16942686|NCT01193101|38087322|FG001|Overall Study|Adverse Event|1|||
16942687|NCT01193101|38087323|FG002|Overall Study|Adverse Event|1|||
16942688|NCT01193101|38087324|FG003|Overall Study|Adverse Event|3|||
16942689|NCT01193101|38087321|FG000|Overall Study|Lack of Efficacy|3|||
16942690|NCT01193101|38087322|FG001|Overall Study|Lack of Efficacy|1|||
16942691|NCT01193101|38087323|FG002|Overall Study|Lack of Efficacy|0|||
16942692|NCT01193101|38087324|FG003|Overall Study|Lack of Efficacy|8|||
16942693|NCT01193101|38087321|FG000|Overall Study|Withdrawal by Subject|2|||
16942694|NCT01193101|38087322|FG001|Overall Study|Withdrawal by Subject|4|||
16942695|NCT01193101|38087323|FG002|Overall Study|Withdrawal by Subject|1|||
16942696|NCT01193101|38087324|FG003|Overall Study|Withdrawal by Subject|1|||
16942697|NCT01193101|38087321|FG000|Overall Study|Administrative problems|0|||
16942698|NCT01193101|38087322|FG001|Overall Study|Administrative problems|0|||
16942699|NCT01193101|38087323|FG002|Overall Study|Administrative problems|1|||
16942700|NCT01193101|38087324|FG003|Overall Study|Administrative problems|0|||
16942701|NCT01193101|38087321|FG000|Overall Study|Abnormal test procedure results|0|||
16942702|NCT01193101|38087322|FG001|Overall Study|Abnormal test procedure results|1|||
16942703|NCT01193101|38087323|FG002|Overall Study|Abnormal test procedure results|0|||
16942704|NCT01193101|38087324|FG003|Overall Study|Abnormal test procedure results|0|||
16942705|NCT01192516|38087337|FG000|Overall Study|Lost to Follow-up|7|||
16942706|NCT01192516|38087338|FG001|Overall Study|Lost to Follow-up|10|||
16857868|NCT01936181|37812053|FG001|Randomised, Double-blind|Adverse Event|21|||
16857869|NCT01936181|37812054|FG002|Randomised, Double-blind|Adverse Event|0|||
16857870|NCT01936181|37812055|FG003|Randomised, Double-blind|Adverse Event|0|||
16942707|NCT01192516|38087339|FG002|Overall Study|Lost to Follow-up|7|||
16942708|NCT01192516|38087337|FG000|Overall Study|Withdrawal by Subject|4|||
16942709|NCT01192516|38087338|FG001|Overall Study|Withdrawal by Subject|4|||
16942710|NCT01192516|38087339|FG002|Overall Study|Withdrawal by Subject|1|||
16857871|NCT01936181|37812052|FG000|Randomised, Double-blind|Protocol Violation|1|||
16857872|NCT01936181|37812053|FG001|Randomised, Double-blind|Protocol Violation|5|||
16857873|NCT01936181|37812054|FG002|Randomised, Double-blind|Protocol Violation|0|||
16857874|NCT01936181|37812055|FG003|Randomised, Double-blind|Protocol Violation|0|||
16857875|NCT01936181|37812052|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
16857876|NCT01936181|37812053|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
16857877|NCT01936181|37812054|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
16942711|NCT01192516|38087337|FG000|Overall Study|started new treatment|5|||
16942712|NCT01192516|38087338|FG001|Overall Study|started new treatment|1|||
16942713|NCT01192516|38087339|FG002|Overall Study|started new treatment|0|||
16942714|NCT01192516|38087337|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
16942715|NCT01192516|38087338|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
16942716|NCT01192516|38087339|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
16942717|NCT01192399|38087351|FG000|Overall Study|Lack of Efficacy|2|||
16942718|NCT01176916|38087355|FG000|Overall Study|Adverse Event|61|||
16942719|NCT01176916|38087355|FG000|Overall Study|Death|1|||
16942720|NCT01176916|38087355|FG000|Overall Study|Lost to Follow-up|15|||
16942721|NCT01176916|38087355|FG000|Overall Study|Objective progression or relapse|17|||
16942722|NCT01176916|38087355|FG000|Overall Study|Protocol Violation|24|||
16857878|NCT01936181|37812055|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
16857879|NCT01936181|37812052|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
16857880|NCT01936181|37812053|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
16857881|NCT01936181|37812054|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
16857882|NCT01936181|37812055|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
16857883|NCT01936181|37812052|FG000|Randomised, Double-blind|Pregnancy|0|||
16857884|NCT01936181|37812053|FG001|Randomised, Double-blind|Pregnancy|1|||
16857885|NCT01936181|37812054|FG002|Randomised, Double-blind|Pregnancy|0|||
16857886|NCT01936181|37812055|FG003|Randomised, Double-blind|Pregnancy|0|||
16942723|NCT01176916|38087355|FG000|Overall Study|Withdrawal by Subject|37|||
16942724|NCT01176916|38087355|FG000|Overall Study|Other|6|||
16942725|NCT01176916|38087355|FG000|Overall Study|Withdrawal prior to Treatment|6|||
16942726|NCT01192204|38087361|FG000|Overall Study|could not keep recall appointments|1|||
16942727|NCT01192204|38087362|FG001|Overall Study|could not keep recall appointments|0|||
16942728|NCT01192126|38087369|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
16942729|NCT01192126|38087370|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
16942730|NCT01192126|38087369|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
16857887|NCT01936181|37812052|FG000|Randomised, Double-blind|Physician Decision|4|||
16857888|NCT01936181|37812053|FG001|Randomised, Double-blind|Physician Decision|4|||
16942731|NCT01192126|38087370|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
16942732|NCT01327482|38087376|FG000|Overall Study|Adverse Event|1|||
16942733|NCT01176565|38087382|FG000|Overall Study|Lost to Follow-up|12|||
16942734|NCT01176565|38087383|FG001|Overall Study|Lost to Follow-up|16|||
16942735|NCT01176565|38087382|FG000|Overall Study|Withdrawal by Subject|7|||
16942736|NCT01176565|38087383|FG001|Overall Study|Withdrawal by Subject|1|||
16942737|NCT01176565|38087382|FG000|Overall Study|Not Analyzed (any other reason)|1|||
16942738|NCT01176565|38087383|FG001|Overall Study|Not Analyzed (any other reason)|2|||
16942739|NCT01176292|38087391|FG000|Overall Study|Lost to Follow-up|2|||
16942740|NCT01176292|38087392|FG001|Overall Study|Lost to Follow-up|4|||
16942741|NCT01176292|38087391|FG000|Overall Study|Adverse Event|1|||
16942742|NCT01176292|38087392|FG001|Overall Study|Adverse Event|1|||
16942743|NCT01176292|38087391|FG000|Overall Study|Physician Decision|0|||
16942744|NCT01176292|38087392|FG001|Overall Study|Physician Decision|2|||
16942745|NCT01176292|38087391|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
16942746|NCT01176292|38087392|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
16857889|NCT01936181|37812054|FG002|Randomised, Double-blind|Physician Decision|0|||
16857890|NCT01936181|37812055|FG003|Randomised, Double-blind|Physician Decision|0|||
16857891|NCT01936181|37812052|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
16857892|NCT01936181|37812053|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
16857893|NCT01936181|37812054|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
16857894|NCT01936181|37812055|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
16857895|NCT01936181|37812052|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
16857896|NCT01936181|37812053|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
16857897|NCT01936181|37812054|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
16857898|NCT01936181|37812055|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
16857899|NCT01936181|37812052|FG000|Transition-extension|Adverse Event|3|||
16857900|NCT01936181|37812053|FG001|Transition-extension|Adverse Event|0|||
16857901|NCT01936181|37812054|FG002|Transition-extension|Adverse Event|3|||
16857902|NCT01936181|37812055|FG003|Transition-extension|Adverse Event|1|||
16857903|NCT01936181|37812052|FG000|Transition-extension|Lost to Follow-up|3|||
16857904|NCT01936181|37812053|FG001|Transition-extension|Lost to Follow-up|0|||
16857905|NCT01936181|37812054|FG002|Transition-extension|Lost to Follow-up|1|||
16857906|NCT01936181|37812055|FG003|Transition-extension|Lost to Follow-up|2|||
16857907|NCT01936181|37812052|FG000|Transition-extension|Physician Decision|2|||
16857908|NCT01936181|37812053|FG001|Transition-extension|Physician Decision|0|||
16857909|NCT01936181|37812054|FG002|Transition-extension|Physician Decision|0|||
16857910|NCT01936181|37812055|FG003|Transition-extension|Physician Decision|1|||
16857911|NCT01936181|37812052|FG000|Transition-extension|Withdrawal by Subject|7|||
16857912|NCT01936181|37812053|FG001|Transition-extension|Withdrawal by Subject|0|||
16857913|NCT01936181|37812054|FG002|Transition-extension|Withdrawal by Subject|2|||
17028333|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
17028334|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
17028335|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
17028336|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
17028337|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
17028338|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
17028339|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
17028340|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
17028341|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Missing|2|||
17028342|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Missing|1|||
17028343|NCT00443209|38172754|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
17028344|NCT00443209|38172755|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
17028345|NCT00443209|38172754|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
17028346|NCT00443209|38172755|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
17028347|NCT00443209|38172754|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
17028348|NCT00443209|38172755|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
17028349|NCT00443209|38172754|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
17028350|NCT00443209|38172755|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
17028351|NCT00443209|38172754|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
17028352|NCT00443209|38172755|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
17028353|NCT00443209|38172754|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
17127294|NCT02820298|38267542|FG001|Overall Study|Physician Decision|0|||
16857914|NCT01936181|37812055|FG003|Transition-extension|Withdrawal by Subject|1|||
16857915|NCT01696045|37812068|FG000|Overall Study|Study drug toxicity|1|||
16857916|NCT01696045|37812069|FG001|Overall Study|Study drug toxicity|5|||
16857917|NCT01696045|37812068|FG000|Overall Study|Disease progression|2|||
16857918|NCT01696045|37812069|FG001|Overall Study|Disease progression|2|||
16857919|NCT01716169|37812075|FG000|Overall Study|Adverse Event|1|||
16857920|NCT01716169|37812075|FG000|Overall Study|Lost to Follow-up|1|||
16857921|NCT01716169|37812075|FG000|Overall Study|Withdrawal by Subject|1|||
16857922|NCT01716169|37812075|FG000|Overall Study|inconsistent dressing application|1|||
16857923|NCT01935947|37812084|FG000|Overall Study|Adverse Event|0|||
16857924|NCT01935947|37812085|FG001|Overall Study|Adverse Event|2|||
16857925|NCT01935947|37812086|FG002|Overall Study|Adverse Event|0|||
16857926|NCT01935947|37812084|FG000|Overall Study|Diease Progression|2|||
16857927|NCT01935947|37812085|FG001|Overall Study|Diease Progression|2|||
16857928|NCT01935947|37812086|FG002|Overall Study|Diease Progression|2|||
16857929|NCT01935947|37812084|FG000|Overall Study|Death|1|||
16857930|NCT01935947|37812085|FG001|Overall Study|Death|0|||
16857931|NCT01935947|37812086|FG002|Overall Study|Death|0|||
16857932|NCT01618019|37812099|FG000|Overall Study|Withdrawal by Subject|14|||
16857933|NCT01618019|37812100|FG001|Overall Study|Withdrawal by Subject|14|||
16857934|NCT01593787|37812109|FG000|Overall Study|Adverse Event|1|||
16857935|NCT01593787|37812110|FG001|Overall Study|Adverse Event|0|||
16857936|NCT01593787|37812111|FG002|Overall Study|Adverse Event|0|||
16857937|NCT01951157|37812124|FG000|Overall Study|Progressive Disease|12|||
16857938|NCT01951157|37812125|FG001|Overall Study|Progressive Disease|13|||
16857939|NCT01951157|37812126|FG002|Overall Study|Progressive Disease|10|||
16857940|NCT01951157|37812124|FG000|Overall Study|Treatment-unrelated AE|1|||
16857941|NCT01951157|37812125|FG001|Overall Study|Treatment-unrelated AE|0|||
16857942|NCT01951157|37812126|FG002|Overall Study|Treatment-unrelated AE|3|||
16857943|NCT01951157|37812124|FG000|Overall Study|Study Termination|0|||
16857944|NCT01951157|37812125|FG001|Overall Study|Study Termination|0|||
16857945|NCT01951157|37812126|FG002|Overall Study|Study Termination|1|||
16857946|NCT01951157|37812124|FG000|Overall Study|Physician Decision|5|||
16857947|NCT01951157|37812125|FG001|Overall Study|Physician Decision|3|||
16857948|NCT01951157|37812126|FG002|Overall Study|Physician Decision|2|||
16857949|NCT01951157|37812124|FG000|Overall Study|Non-treatmentrelated death|2|||
16857950|NCT01951157|37812125|FG001|Overall Study|Non-treatmentrelated death|2|||
16857951|NCT01951157|37812126|FG002|Overall Study|Non-treatmentrelated death|2|||
16857952|NCT01951157|37812124|FG000|Overall Study|No treated|0|||
16857953|NCT01951157|37812125|FG001|Overall Study|No treated|1|||
16857954|NCT01951157|37812126|FG002|Overall Study|No treated|0|||
16857955|NCT01951157|37812124|FG000|Overall Study|Treatment-related AE|2|||
16857956|NCT01951157|37812125|FG001|Overall Study|Treatment-related AE|0|||
16857957|NCT01951157|37812126|FG002|Overall Study|Treatment-related AE|4|||
16857958|NCT01951157|37812124|FG000|Overall Study|Consent withdrawn by subject|0|||
16857959|NCT01951157|37812125|FG001|Overall Study|Consent withdrawn by subject|1|||
16857960|NCT01951157|37812126|FG002|Overall Study|Consent withdrawn by subject|3|||
16857961|NCT01951157|37812124|FG000|Overall Study|Treatment-related death|0|||
16857962|NCT01951157|37812125|FG001|Overall Study|Treatment-related death|2|||
16857963|NCT01951157|37812126|FG002|Overall Study|Treatment-related death|0|||
16857964|NCT01363349|37812137|FG000|Overall Study|Adverse Event|6|||
16857965|NCT01363349|37812138|FG001|Overall Study|Adverse Event|7|||
16857966|NCT01363349|37812137|FG000|Overall Study|Lack of Efficacy|3|||
16857967|NCT01363349|37812138|FG001|Overall Study|Lack of Efficacy|10|||
16857968|NCT01363349|37812137|FG000|Overall Study|Non compliance/Protocol deviations|2|||
16857969|NCT01363349|37812138|FG001|Overall Study|Non compliance/Protocol deviations|2|||
16857970|NCT01363349|37812137|FG000|Overall Study|Withdrawal by Subject|14|||
16857971|NCT01363349|37812138|FG001|Overall Study|Withdrawal by Subject|6|||
16857972|NCT01363349|37812137|FG000|Overall Study|Lost to Follow-up|5|||
16857973|NCT01363349|37812138|FG001|Overall Study|Lost to Follow-up|6|||
16857974|NCT01363349|37812137|FG000|Overall Study|Not reported|36|||
16857975|NCT01363349|37812138|FG001|Overall Study|Not reported|37|||
16857976|NCT01363349|37812137|FG000|Overall Study|missing|1|||
16857977|NCT01363349|37812138|FG001|Overall Study|missing|2|||
16857978|NCT01933919|37812229|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
16857979|NCT01933919|37812230|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
16857980|NCT01933919|37812229|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
16857981|NCT01933919|37812230|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
16857982|NCT01933919|37812229|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
16857983|NCT01933919|37812230|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
16857984|NCT01933919|37812229|FG000|Open-label Long-term Phase|Adverse Event|2|||
16857985|NCT01933919|37812230|FG001|Open-label Long-term Phase|Adverse Event|0|||
16857986|NCT01933919|37812229|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
16857987|NCT01933919|37812230|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
16857988|NCT01933919|37812229|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
16857989|NCT01933919|37812230|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
16857990|NCT01933919|37812229|FG000|Open-label Long-term Phase|Other|1|||
16857991|NCT01933919|37812230|FG001|Open-label Long-term Phase|Other|2|||
16857992|NCT01933217|37812259|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
16857993|NCT01933217|37812260|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
16857994|NCT01933217|37812259|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
16857995|NCT01933217|37812260|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
16857996|NCT01932437|37812270|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16857997|NCT01932437|37812271|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16857998|NCT01932437|37812272|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16857999|NCT01932437|37812273|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16858000|NCT01932437|37812274|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16942747|NCT01113541|38087398|FG000|Overall Study|Withdrawal by Subject|1|||
16942748|NCT01113541|38087398|FG000|Overall Study|Protocol Violation|1|||
16942749|NCT01113541|38087398|FG000|Overall Study|Study Terminated by Sponsor|7|||
16942750|NCT01113541|38087398|FG000|Overall Study|Adverse Event|4|||
16942751|NCT01113502|38087411|FG000|Overall Study|Withdrawal by Subject|1|||
16942752|NCT01113502|38087412|FG001|Overall Study|Withdrawal by Subject|0|||
16942753|NCT01113502|38087413|FG002|Overall Study|Withdrawal by Subject|1|||
16942754|NCT01113502|38087414|FG003|Overall Study|Withdrawal by Subject|1|||
16942755|NCT01113502|38087415|FG004|Overall Study|Withdrawal by Subject|0|||
16942756|NCT01113502|38087411|FG000|Overall Study|Adverse Event|0|||
16942757|NCT01113502|38087412|FG001|Overall Study|Adverse Event|0|||
16942758|NCT01113502|38087413|FG002|Overall Study|Adverse Event|3|||
16942759|NCT01113502|38087414|FG003|Overall Study|Adverse Event|2|||
16858001|NCT01932437|37812275|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
16858002|NCT01949051|37812296|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
16858003|NCT01949051|37812297|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
16858004|NCT01949051|37812298|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
16858005|NCT01949051|37812299|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
16858006|NCT01949051|37812300|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
16858007|NCT01949051|37812301|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
16858008|NCT01949051|37812296|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
16858009|NCT01949051|37812297|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16858010|NCT01949051|37812298|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16858011|NCT01949051|37812299|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16858012|NCT01949051|37812300|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16858013|NCT01949051|37812301|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16858014|NCT01949051|37812296|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16858015|NCT01949051|37812297|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16858016|NCT01949051|37812298|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16858017|NCT01949051|37812299|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16858018|NCT01949051|37812300|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16858019|NCT01949051|37812301|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
16858020|NCT01949051|37812296|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16858021|NCT01949051|37812297|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
16858022|NCT01949051|37812298|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16858023|NCT01949051|37812299|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16858024|NCT01949051|37812300|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16858025|NCT01949051|37812301|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16858026|NCT01949051|37812296|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16858027|NCT01949051|37812297|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16858028|NCT01949051|37812298|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
16858029|NCT01949051|37812299|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16858030|NCT01949051|37812300|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16858031|NCT01949051|37812301|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16858032|NCT01948427|37812314|FG000|Overall Study|Serious Adverse Event|3|||
16858033|NCT01948427|37812315|FG001|Overall Study|Serious Adverse Event|0|||
16858034|NCT01948427|37812316|FG002|Overall Study|Serious Adverse Event|0|||
16858035|NCT01948427|37812317|FG003|Overall Study|Serious Adverse Event|0|||
16858036|NCT01948427|37812318|FG004|Overall Study|Serious Adverse Event|1|||
16858037|NCT01948427|37812314|FG000|Overall Study|Investigator Request|0|||
16858038|NCT01948427|37812315|FG001|Overall Study|Investigator Request|8|||
16858039|NCT01948427|37812316|FG002|Overall Study|Investigator Request|0|||
16858040|NCT01948427|37812317|FG003|Overall Study|Investigator Request|0|||
16858041|NCT01948427|37812318|FG004|Overall Study|Investigator Request|6|||
16858042|NCT01948427|37812314|FG000|Overall Study|Lost to Follow-up|1|||
16858043|NCT01948427|37812315|FG001|Overall Study|Lost to Follow-up|0|||
16858044|NCT01948427|37812316|FG002|Overall Study|Lost to Follow-up|0|||
16858045|NCT01948427|37812317|FG003|Overall Study|Lost to Follow-up|0|||
16858046|NCT01948427|37812318|FG004|Overall Study|Lost to Follow-up|4|||
16858047|NCT01948427|37812314|FG000|Overall Study|Withdrawal by Subject|2|||
16858048|NCT01948427|37812315|FG001|Overall Study|Withdrawal by Subject|0|||
16858049|NCT01948427|37812316|FG002|Overall Study|Withdrawal by Subject|0|||
16858050|NCT01948427|37812317|FG003|Overall Study|Withdrawal by Subject|0|||
16858051|NCT01948427|37812318|FG004|Overall Study|Withdrawal by Subject|1|||
16858052|NCT01948427|37812314|FG000|Overall Study|Other, Not Specified|1|||
16942760|NCT01113502|38087415|FG004|Overall Study|Adverse Event|0|||
16942761|NCT01113463|38087428|FG000|Overall Study|Physician Decision|5|||
16942762|NCT01112917|38087432|FG000|Overall Study|Death|2|||
16942763|NCT01112917|38087433|FG001|Overall Study|Death|11|||
16942764|NCT01112917|38087432|FG000|Overall Study|Lost to Follow-up|1|||
16942765|NCT01112917|38087433|FG001|Overall Study|Lost to Follow-up|1|||
16942766|NCT01112917|38087432|FG000|Overall Study|Withdrawal by Subject|1|||
16858053|NCT01948427|37812315|FG001|Overall Study|Other, Not Specified|9|||
16858054|NCT01948427|37812316|FG002|Overall Study|Other, Not Specified|0|||
16858055|NCT01948427|37812317|FG003|Overall Study|Other, Not Specified|0|||
16858056|NCT01948427|37812318|FG004|Overall Study|Other, Not Specified|2|||
16858057|NCT01948193|37812335|FG000|Overall Study|Serious event|2|||
16858058|NCT01948193|37812335|FG000|Overall Study|Lost to Follow-up|7|||
16858059|NCT01694485|37812345|FG000|Overall Study|Withdrawal by Subject|20|||
16858060|NCT01694485|37812346|FG001|Overall Study|Withdrawal by Subject|6|||
16858061|NCT01694485|37812347|FG002|Overall Study|Withdrawal by Subject|7|||
16858062|NCT01694485|37812348|FG003|Overall Study|Withdrawal by Subject|25|||
16942767|NCT01112917|38087433|FG001|Overall Study|Withdrawal by Subject|3|||
16942768|NCT01112917|38087432|FG000|Overall Study|Unable to Convert Filter|3|||
16942769|NCT01112917|38087433|FG001|Overall Study|Unable to Convert Filter|0|||
16942770|NCT01176058|38087439|FG000|Overall Study|Adverse Event|1|||
16858063|NCT01694485|37812349|FG004|Overall Study|Withdrawal by Subject|18|||
16858064|NCT01694485|37812345|FG000|Overall Study|Sponsor Decision|3|||
16858065|NCT01694485|37812346|FG001|Overall Study|Sponsor Decision|0|||
16858066|NCT01694485|37812347|FG002|Overall Study|Sponsor Decision|0|||
16858067|NCT01694485|37812348|FG003|Overall Study|Sponsor Decision|2|||
16858068|NCT01694485|37812349|FG004|Overall Study|Sponsor Decision|0|||
16858069|NCT01694485|37812345|FG000|Overall Study|Lost to Follow-up|9|||
16858070|NCT01694485|37812346|FG001|Overall Study|Lost to Follow-up|1|||
16858071|NCT01694485|37812347|FG002|Overall Study|Lost to Follow-up|6|||
16858072|NCT01694485|37812348|FG003|Overall Study|Lost to Follow-up|10|||
16858073|NCT01694485|37812349|FG004|Overall Study|Lost to Follow-up|7|||
16858074|NCT01694485|37812345|FG000|Overall Study|Death|1|||
16858075|NCT01694485|37812346|FG001|Overall Study|Death|0|||
16858076|NCT01694485|37812347|FG002|Overall Study|Death|0|||
16858077|NCT01694485|37812348|FG003|Overall Study|Death|1|||
16858078|NCT01694485|37812349|FG004|Overall Study|Death|0|||
16858079|NCT01931735|37812370|FG000|Randomized Phase|Lost to Follow-up|2|||
16858080|NCT01931735|37812371|FG001|Randomized Phase|Lost to Follow-up|2|||
16858081|NCT01931735|37812372|FG002|Randomized Phase|Lost to Follow-up|5|||
16858082|NCT01931735|37812373|FG003|Randomized Phase|Lost to Follow-up|0|||
16858083|NCT01931735|37812370|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
16858084|NCT01931735|37812371|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
16858085|NCT01931735|37812372|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
16858086|NCT01931735|37812373|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
16858087|NCT01931735|37812370|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
16858088|NCT01931735|37812371|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
16858089|NCT01931735|37812372|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
16858090|NCT01931735|37812373|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
16858091|NCT01930799|37812383|FG000|Overall Study|Withdrawal by Subject|3|||
16858092|NCT01930799|37812383|FG000|Overall Study|Lost to Follow-up|5|||
16858093|NCT01947491|37812391|FG000|Overall Study|Lost to Follow-up|5|||
16858094|NCT01947491|37812392|FG001|Overall Study|Lost to Follow-up|3|||
16858095|NCT01947491|37812393|FG002|Overall Study|Lost to Follow-up|1|||
16858096|NCT01947491|37812394|FG003|Overall Study|Lost to Follow-up|2|||
16858097|NCT01947491|37812391|FG000|Overall Study|Lack of Efficacy|1|||
16858098|NCT01947491|37812392|FG001|Overall Study|Lack of Efficacy|0|||
16858099|NCT01947491|37812393|FG002|Overall Study|Lack of Efficacy|0|||
16858100|NCT01947491|37812394|FG003|Overall Study|Lack of Efficacy|1|||
16858101|NCT01947491|37812391|FG000|Overall Study|Protocol Violation|1|||
16858102|NCT01947491|37812392|FG001|Overall Study|Protocol Violation|0|||
16858103|NCT01947491|37812393|FG002|Overall Study|Protocol Violation|0|||
16858104|NCT01947491|37812394|FG003|Overall Study|Protocol Violation|0|||
16858105|NCT01947491|37812391|FG000|Overall Study|Withdrawal by Subject|1|||
16858106|NCT01947491|37812392|FG001|Overall Study|Withdrawal by Subject|1|||
16858107|NCT01947491|37812393|FG002|Overall Study|Withdrawal by Subject|1|||
16858108|NCT01947491|37812394|FG003|Overall Study|Withdrawal by Subject|0|||
16858109|NCT01947491|37812391|FG000|Overall Study|Worsening of condition|0|||
16858110|NCT01947491|37812392|FG001|Overall Study|Worsening of condition|1|||
16858111|NCT01947491|37812393|FG002|Overall Study|Worsening of condition|0|||
16858112|NCT01947491|37812394|FG003|Overall Study|Worsening of condition|0|||
16858113|NCT01947491|37812391|FG000|Overall Study|Adverse Event|0|||
16858114|NCT01947491|37812392|FG001|Overall Study|Adverse Event|1|||
16858115|NCT01947491|37812393|FG002|Overall Study|Adverse Event|0|||
16858116|NCT01947491|37812394|FG003|Overall Study|Adverse Event|2|||
16858117|NCT01715857|37812404|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
16858118|NCT01692301|37812410|FG000|Overall Study|Adverse Event|15|||
16858119|NCT01692301|37812411|FG001|Overall Study|Adverse Event|12|||
16858120|NCT01692301|37812410|FG000|Overall Study|Death|1|||
16858121|NCT01692301|37812411|FG001|Overall Study|Death|2|||
16858122|NCT01692301|37812410|FG000|Overall Study|Lack of Efficacy|0|||
16858123|NCT01692301|37812411|FG001|Overall Study|Lack of Efficacy|5|||
16858124|NCT01692301|37812410|FG000|Overall Study|Non-compliance with study treatment|1|||
16858125|NCT01692301|37812411|FG001|Overall Study|Non-compliance with study treatment|2|||
16858126|NCT01692301|37812410|FG000|Overall Study|Protocol deviation|9|||
16858127|NCT01692301|37812411|FG001|Overall Study|Protocol deviation|2|||
16858128|NCT01692301|37812410|FG000|Overall Study|Patient/guardian decision|16|||
16858129|NCT01692301|37812411|FG001|Overall Study|Patient/guardian decision|15|||
16858130|NCT01692301|37812410|FG000|Overall Study|Technical problems|0|||
16858131|NCT01692301|37812411|FG001|Overall Study|Technical problems|1|||
16858132|NCT01692301|37812410|FG000|Overall Study|Physician Decision|2|||
16858133|NCT01692301|37812411|FG001|Overall Study|Physician Decision|2|||
16858134|NCT01692301|37812410|FG000|Overall Study|Lost to Follow-up|1|||
16858135|NCT01692301|37812411|FG001|Overall Study|Lost to Follow-up|1|||
16858136|NCT01592773|37812417|FG000|Overall Study|Study Terminated by Sponsor|582|||
16858137|NCT01592773|37812417|FG000|Overall Study|Withdrawal by Subject|35|||
16858138|NCT01592773|37812417|FG000|Overall Study|Lost to Follow-up|19|||
16858139|NCT01592773|37812417|FG000|Overall Study|Adverse Event|17|||
16858140|NCT01592773|37812417|FG000|Overall Study|Lack of Efficacy|9|||
16858141|NCT01592773|37812417|FG000|Overall Study|Protocol Violation|2|||
16858142|NCT01592773|37812417|FG000|Overall Study|Inclusion/exclusion not meet|1|||
16858143|NCT01592773|37812417|FG000|Overall Study|Other Reason|1|||
16858144|NCT01930175|37812424|FG000|Core Study|Lost to Follow-up|0|||
16858145|NCT01930175|37812425|FG001|Core Study|Lost to Follow-up|1|||
16858146|NCT01930175|37812426|FG002|Core Study|Lost to Follow-up|0|||
16858147|NCT01930175|37812424|FG000|Core Study|Adverse Event|0|||
16858148|NCT01930175|37812425|FG001|Core Study|Adverse Event|0|||
16858149|NCT01930175|37812426|FG002|Core Study|Adverse Event|1|||
16858150|NCT01592695|37812437|FG000|Overall Study|Lost to Follow-up|8|||
16858151|NCT01592695|37812438|FG001|Overall Study|Lost to Follow-up|4|||
16858152|NCT01929863|37812444|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
16858153|NCT01929863|37812445|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
16858154|NCT01929863|37812444|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
16858155|NCT01929863|37812445|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
16858156|NCT01929863|37812444|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
16858157|NCT01929863|37812445|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
16858158|NCT01918085|37812458|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
16858159|NCT01918085|37812459|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
16858160|NCT01714687|37812469|FG000|Overall Study|Withdrawal by Subject|1|||
16858161|NCT01714687|37812470|FG001|Overall Study|Withdrawal by Subject|0|||
16942771|NCT01176058|38087440|FG001|Overall Study|Adverse Event|0|||
16942772|NCT01176058|38087439|FG000|Overall Study|Insufficient clinical response|2|||
16942773|NCT01176058|38087440|FG001|Overall Study|Insufficient clinical response|2|||
16942774|NCT01176058|38087439|FG000|Overall Study|Insufficient mycological response|0|||
16942775|NCT01176058|38087440|FG001|Overall Study|Insufficient mycological response|1|||
16942776|NCT01176058|38087439|FG000|Overall Study|Withdrawal by Subject|1|||
16942777|NCT01176058|38087440|FG001|Overall Study|Withdrawal by Subject|0|||
16942778|NCT01175824|38087448|FG000|Overall Study|Adverse Event|2|||
16942779|NCT01175824|38087449|FG001|Overall Study|Adverse Event|1|||
16942780|NCT01175824|38087448|FG000|Overall Study|Lack of Efficacy|2|||
16942781|NCT01175824|38087449|FG001|Overall Study|Lack of Efficacy|0|||
16942782|NCT01175824|38087448|FG000|Overall Study|Lost to Follow-up|0|||
16942783|NCT01175824|38087449|FG001|Overall Study|Lost to Follow-up|1|||
16942784|NCT01175824|38087448|FG000|Overall Study|Physician Decision|0|||
16942785|NCT01175824|38087449|FG001|Overall Study|Physician Decision|4|||
16942786|NCT01175824|38087448|FG000|Overall Study|Protocol Violation|2|||
16942787|NCT01175824|38087449|FG001|Overall Study|Protocol Violation|5|||
16942788|NCT01175824|38087448|FG000|Overall Study|Withdrawal by Subject|3|||
16858162|NCT01714687|37812469|FG000|Overall Study|Lost to Follow-up|2|||
16858163|NCT01714687|37812470|FG001|Overall Study|Lost to Follow-up|4|||
16858164|NCT01714609|37812480|FG000|Overall Study|Protocol Violation|1|||
16858165|NCT01714609|37812481|FG001|Overall Study|Protocol Violation|0|||
16858166|NCT01929707|37812487|FG000|Intervention Period 1|Lost to Follow-up|0|||
16858167|NCT01929707|37812488|FG001|Intervention Period 1|Lost to Follow-up|0|||
16858168|NCT01929707|37812489|FG002|Intervention Period 1|Lost to Follow-up|0|||
16858169|NCT01929707|37812490|FG003|Intervention Period 1|Lost to Follow-up|1|||
16858170|NCT01929707|37812491|FG004|Intervention Period 1|Lost to Follow-up|0|||
16858171|NCT01929707|37812492|FG005|Intervention Period 1|Lost to Follow-up|0|||
16858172|NCT01929707|37812493|FG006|Intervention Period 1|Lost to Follow-up|0|||
16858173|NCT01929707|37812494|FG007|Intervention Period 1|Lost to Follow-up|0|||
16858174|NCT01929707|37812487|FG000|Intervention Period 1|Withdrawal by Subject|0|||
16858175|NCT01929707|37812488|FG001|Intervention Period 1|Withdrawal by Subject|0|||
16858176|NCT01929707|37812489|FG002|Intervention Period 1|Withdrawal by Subject|0|||
16858177|NCT01929707|37812490|FG003|Intervention Period 1|Withdrawal by Subject|2|||
16858178|NCT01929707|37812491|FG004|Intervention Period 1|Withdrawal by Subject|0|||
16858179|NCT01929707|37812492|FG005|Intervention Period 1|Withdrawal by Subject|0|||
16858180|NCT01929707|37812493|FG006|Intervention Period 1|Withdrawal by Subject|0|||
16858181|NCT01929707|37812494|FG007|Intervention Period 1|Withdrawal by Subject|0|||
16858182|NCT01929707|37812487|FG000|Intervention Period 2|Withdrawal by Subject|0|||
16858183|NCT01929707|37812488|FG001|Intervention Period 2|Withdrawal by Subject|0|||
16858184|NCT01929707|37812489|FG002|Intervention Period 2|Withdrawal by Subject|0|||
16858185|NCT01929707|37812490|FG003|Intervention Period 2|Withdrawal by Subject|0|||
16858186|NCT01929707|37812491|FG004|Intervention Period 2|Withdrawal by Subject|0|||
16858187|NCT01929707|37812492|FG005|Intervention Period 2|Withdrawal by Subject|2|||
16858188|NCT01929707|37812493|FG006|Intervention Period 2|Withdrawal by Subject|0|||
16858189|NCT01929707|37812494|FG007|Intervention Period 2|Withdrawal by Subject|0|||
16858190|NCT01714063|37812515|FG000|Overall Study|Equipment malfunction|2|||
16858191|NCT01929395|37812526|FG000|Overall Study|Did not complete - non-related toxicity|1|||
16858192|NCT01929395|37812527|FG001|Overall Study|Did not complete - non-related toxicity|0|||
16858193|NCT01929395|37812528|FG002|Overall Study|Did not complete - non-related toxicity|0|||
16858194|NCT01929395|37812526|FG000|Overall Study|Withdrawal by Subject|0|||
16858195|NCT01929395|37812527|FG001|Overall Study|Withdrawal by Subject|1|||
16858196|NCT01929395|37812528|FG002|Overall Study|Withdrawal by Subject|0|||
16858197|NCT01929395|37812526|FG000|Overall Study|Screen Fail|0|||
16858198|NCT01929395|37812527|FG001|Overall Study|Screen Fail|0|||
16858199|NCT01929395|37812528|FG002|Overall Study|Screen Fail|1|||
16858200|NCT01713283|37812540|FG000|Overall Study|Lack of Efficacy|10|||
16858201|NCT01713283|37812541|FG001|Overall Study|Lack of Efficacy|2|||
16858202|NCT01713283|37812540|FG000|Overall Study|Lost to Follow-up|1|||
16858203|NCT01713283|37812541|FG001|Overall Study|Lost to Follow-up|1|||
16858204|NCT01592383|37812551|FG000|Overall Study|Adverse Event|1|||
16858205|NCT01691521|37812559|FG000|Overall Study|Adverse Event|4|||
16858206|NCT01691521|37812560|FG001|Overall Study|Adverse Event|0|||
16858207|NCT01691521|37812561|FG002|Overall Study|Adverse Event|1|||
16942789|NCT01175824|38087449|FG001|Overall Study|Withdrawal by Subject|7|||
16942790|NCT01175824|38087448|FG000|Overall Study|Sponsor Decision|1|||
16858208|NCT01691521|37812559|FG000|Overall Study|Lack of Efficacy|1|||
16858209|NCT01691521|37812560|FG001|Overall Study|Lack of Efficacy|1|||
16858210|NCT01691521|37812561|FG002|Overall Study|Lack of Efficacy|2|||
16858211|NCT01691521|37812559|FG000|Overall Study|Protocol Violation|0|||
16858212|NCT01691521|37812560|FG001|Overall Study|Protocol Violation|3|||
16858213|NCT01691521|37812561|FG002|Overall Study|Protocol Violation|0|||
16858214|NCT01691521|37812559|FG000|Overall Study|Lost to Follow-up|0|||
16858215|NCT01691521|37812560|FG001|Overall Study|Lost to Follow-up|2|||
16858216|NCT01691521|37812561|FG002|Overall Study|Lost to Follow-up|2|||
16858217|NCT01691521|37812559|FG000|Overall Study|Physician Decision|2|||
16858218|NCT01691521|37812560|FG001|Overall Study|Physician Decision|1|||
16858219|NCT01691521|37812561|FG002|Overall Study|Physician Decision|0|||
16858220|NCT01691521|37812559|FG000|Overall Study|Withdrawal by Subject|5|||
16858221|NCT01691521|37812560|FG001|Overall Study|Withdrawal by Subject|9|||
16858222|NCT01691521|37812561|FG002|Overall Study|Withdrawal by Subject|4|||
16858223|NCT01929317|37812572|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
16858224|NCT01929317|37812573|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
16858225|NCT01929317|37812572|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
16858226|NCT01929317|37812573|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
16858227|NCT01929317|37812572|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
16858228|NCT01929317|37812573|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
16858229|NCT01929317|37812572|FG000|Long-term Phase|Adverse Event|5|||
16858230|NCT01929317|37812573|FG001|Long-term Phase|Adverse Event|1|||
16858231|NCT01929317|37812572|FG000|Long-term Phase|Physician Decision|3|||
16942791|NCT01175824|38087449|FG001|Overall Study|Sponsor Decision|0|||
16942792|NCT01175824|38087448|FG000|Overall Study|Entry Criteria Not Met|6|||
16942793|NCT01175824|38087449|FG001|Overall Study|Entry Criteria Not Met|4|||
16942794|NCT01175707|38087457|FG000|Overall Study|Adverse Event|4|||
16942795|NCT01175707|38087458|FG001|Overall Study|Adverse Event|6|||
16942796|NCT01112059|38087467|FG000|Overall Study|Withdrawal by Subject|1|||
16942797|NCT01112059|38087468|FG001|Overall Study|Withdrawal by Subject|0|||
16942798|NCT01175668|38087479|FG000|Overall Study|Withdrawal by Subject|2|||
16942799|NCT01175668|38087480|FG001|Overall Study|Withdrawal by Subject|0|||
16942800|NCT01111825|38087490|FG000|Overall Study|Withdrawal by Subject|0|||
16942801|NCT01111825|38087491|FG001|Overall Study|Withdrawal by Subject|0|||
16942802|NCT01111825|38087492|FG002|Overall Study|Withdrawal by Subject|1|||
16942803|NCT01111825|38087493|FG003|Overall Study|Withdrawal by Subject|0|||
16942804|NCT01111825|38087490|FG000|Overall Study|Lost to Follow-up|0|||
16942805|NCT01111825|38087491|FG001|Overall Study|Lost to Follow-up|0|||
16942806|NCT01111825|38087492|FG002|Overall Study|Lost to Follow-up|3|||
16942807|NCT01111825|38087493|FG003|Overall Study|Lost to Follow-up|1|||
16942808|NCT01111825|38087490|FG000|Overall Study|Adverse Event|2|||
16858232|NCT01929317|37812573|FG001|Long-term Phase|Physician Decision|0|||
16858233|NCT01929317|37812572|FG000|Long-term Phase|Withdrawal by Subject|4|||
16858234|NCT01929317|37812573|FG001|Long-term Phase|Withdrawal by Subject|0|||
16942809|NCT01111825|38087491|FG001|Overall Study|Adverse Event|1|||
16942810|NCT01111825|38087492|FG002|Overall Study|Adverse Event|4|||
16942811|NCT01111825|38087493|FG003|Overall Study|Adverse Event|0|||
16942812|NCT01111825|38087490|FG000|Overall Study|Disease Progression|1|||
16942813|NCT01111825|38087491|FG001|Overall Study|Disease Progression|0|||
16942814|NCT01111825|38087492|FG002|Overall Study|Disease Progression|0|||
16942815|NCT01111825|38087493|FG003|Overall Study|Disease Progression|0|||
16942816|NCT01111825|38087490|FG000|Overall Study|Discontinuation by Sponsor|0|||
16942817|NCT01111825|38087491|FG001|Overall Study|Discontinuation by Sponsor|0|||
16942818|NCT01111825|38087492|FG002|Overall Study|Discontinuation by Sponsor|0|||
16942819|NCT01111825|38087493|FG003|Overall Study|Discontinuation by Sponsor|20|||
16942820|NCT01175590|38087505|FG000|Overall Study|Lost to Follow-up|1|||
16942821|NCT01175590|38087506|FG001|Overall Study|Lost to Follow-up|0|||
16942822|NCT01175590|38087505|FG000|Overall Study|Withdrawal by Subject|0|||
16942823|NCT01175590|38087506|FG001|Overall Study|Withdrawal by Subject|2|||
16942824|NCT01175590|38087505|FG000|Overall Study|Adverse Event|4|||
16942825|NCT01175590|38087506|FG001|Overall Study|Adverse Event|0|||
16942826|NCT01175590|38087505|FG000|Overall Study|Physician Decision|1|||
16942827|NCT01175590|38087506|FG001|Overall Study|Physician Decision|4|||
16942828|NCT01175590|38087505|FG000|Overall Study|Lack of Efficacy|1|||
16942829|NCT01175590|38087506|FG001|Overall Study|Lack of Efficacy|1|||
16942830|NCT01175590|38087505|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
16942831|NCT01175590|38087506|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
16942832|NCT01175590|38087505|FG000|Overall Study|Treated not as randomized|3|||
16942833|NCT01175590|38087506|FG001|Overall Study|Treated not as randomized|2|||
16942834|NCT01175590|38087505|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
16942835|NCT01175590|38087506|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
16942836|NCT01175590|38087505|FG000|Overall Study|Protocol Violation|0|||
16942837|NCT01175590|38087506|FG001|Overall Study|Protocol Violation|1|||
16942838|NCT01175473|38087515|FG000|Overall Study|Adverse Event|2|||
16942839|NCT01175473|38087516|FG001|Overall Study|Adverse Event|2|||
16942840|NCT01111552|38087522|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
16942841|NCT01111552|38087523|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16942842|NCT01111552|38087524|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16942843|NCT01111552|38087525|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16942844|NCT01111552|38087526|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16942845|NCT01111552|38087522|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
16942846|NCT01111552|38087523|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16942847|NCT01111552|38087524|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16942848|NCT01111552|38087525|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16942849|NCT01111552|38087526|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16942850|NCT01111552|38087522|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
16942851|NCT01111552|38087523|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16942852|NCT01111552|38087524|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16942853|NCT01111552|38087525|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16942854|NCT01111552|38087526|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16942855|NCT01111552|38087522|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
16942856|NCT01111552|38087523|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
16942857|NCT01111552|38087524|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
16942858|NCT01111552|38087525|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
16942859|NCT01111552|38087526|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
16942860|NCT01111552|38087522|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
16942861|NCT01111552|38087523|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
16942862|NCT01111552|38087524|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
16942863|NCT01111552|38087525|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
16942864|NCT01111552|38087526|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
16942865|NCT01111552|38087522|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
16942866|NCT01111552|38087523|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
16942867|NCT01111552|38087524|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
16942868|NCT01111552|38087525|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
16942869|NCT01111552|38087526|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
16942870|NCT01111552|38087522|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
16942871|NCT01111552|38087523|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16942872|NCT01111552|38087524|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16942873|NCT01111552|38087525|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16942874|NCT01111552|38087526|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16942875|NCT01111552|38087522|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
16942876|NCT01111552|38087523|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
16942877|NCT01111552|38087524|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
16942878|NCT01111552|38087525|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
16942879|NCT01111552|38087526|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
16942880|NCT01111552|38087522|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16942881|NCT01111552|38087523|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16942882|NCT01111552|38087524|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16942883|NCT01111552|38087525|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
16942884|NCT01111552|38087526|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16942885|NCT01111552|38087522|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
16942886|NCT01111552|38087523|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
16942887|NCT01111552|38087524|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
16942888|NCT01111552|38087525|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
16942889|NCT01111552|38087526|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
16858235|NCT01929317|37812572|FG000|Long-term Phase|Protocol Violation|1|||
16858236|NCT01929317|37812573|FG001|Long-term Phase|Protocol Violation|0|||
16858237|NCT01929317|37812572|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
16858238|NCT01929317|37812573|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
16858239|NCT01929317|37812572|FG000|Long-term Phase|Study Closed/Terminated|5|||
16858240|NCT01929317|37812573|FG001|Long-term Phase|Study Closed/Terminated|3|||
16858241|NCT01711879|37812587|FG000|Overall Study|Death|1|||
16858242|NCT01711879|37812588|FG001|Overall Study|Death|0|||
16858243|NCT01689649|37812611|FG000|Overall Study|Lack of Efficacy|3|||
16858244|NCT01689649|37812611|FG000|Overall Study|Non-compliance|11|||
16858245|NCT01689649|37812611|FG000|Overall Study|Protocol Violation|3|||
16858246|NCT01689649|37812611|FG000|Overall Study|Lost to Follow-up|5|||
16858247|NCT01929083|37812615|FG000|Intervention 1|Lost to Follow-up|2|||
16858248|NCT01929083|37812616|FG001|Intervention 1|Lost to Follow-up|0|||
16858249|NCT01929083|37812615|FG000|Intervention 1|Nonadherent to study medications|1|||
16858250|NCT01929083|37812616|FG001|Intervention 1|Nonadherent to study medications|0|||
16858251|NCT01929083|37812615|FG000|Intervention 2|Adverse Event|0|||
16858252|NCT01929083|37812616|FG001|Intervention 2|Adverse Event|1|||
16858253|NCT01689337|37812622|FG000|Overall Study|Study Discontinuation|1|||
17127295|NCT02820298|38267541|FG000|Overall Study|Protocol Violation|0|||
16858254|NCT01688635|37812628|FG000|Washout 1|Withdrawal by Subject|1|||
16858255|NCT01688635|37812629|FG001|Washout 1|Withdrawal by Subject|0|||
16858256|NCT01688635|37812628|FG000|Washout 1|Adverse Event|0|||
16858257|NCT01688635|37812629|FG001|Washout 1|Adverse Event|1|||
16858258|NCT01688635|37812628|FG000|Washout 1|Physician Decision|0|||
16858259|NCT01688635|37812629|FG001|Washout 1|Physician Decision|1|||
16858260|NCT01688635|37812628|FG000|Washout 2|Physician Decision|1|||
16858261|NCT01688635|37812629|FG001|Washout 2|Physician Decision|0|||
16858262|NCT01688635|37812628|FG000|Washout 2|Withdrawal by Subject|1|||
16858263|NCT01688635|37812629|FG001|Washout 2|Withdrawal by Subject|0|||
16858264|NCT01688635|37812628|FG000|Washout 2|Sponsor Decision|1|||
16858265|NCT01688635|37812629|FG001|Washout 2|Sponsor Decision|2|||
16858266|NCT01688635|37812628|FG000|Washout 3|Withdrawal by Subject|1|||
16858267|NCT01688635|37812629|FG001|Washout 3|Withdrawal by Subject|0|||
16858268|NCT01591681|37812636|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
16858269|NCT01591681|37812636|FG000|Overall Study|Failed to use system during run-in|1|||
16858270|NCT01711645|37812651|FG000|Overall Study|Withdrawal by Subject|8|||
16858271|NCT01711645|37812651|FG000|Overall Study|Lost to Follow-up|6|||
16858272|NCT01711645|37812651|FG000|Overall Study|Physician Decision|5|||
16858273|NCT01590433|37812666|FG000|Overall Study|Lost to Follow-up|20|||
16858274|NCT01590433|37812667|FG001|Overall Study|Lost to Follow-up|8|||
16858275|NCT01590433|37812666|FG000|Overall Study|Withdrawal by Subject|21|||
16858276|NCT01590433|37812667|FG001|Overall Study|Withdrawal by Subject|11|||
16858277|NCT01590433|37812666|FG000|Overall Study|Adverse Event|11|||
16858278|NCT01590433|37812667|FG001|Overall Study|Adverse Event|3|||
16858279|NCT01928927|37812684|FG000|Overall Study|Lost to Follow-up|1|||
16858280|NCT01928927|37812685|FG001|Overall Study|Lost to Follow-up|0|||
16858281|NCT01928927|37812684|FG000|Overall Study|Withdrawal by Subject|1|||
16858282|NCT01928927|37812685|FG001|Overall Study|Withdrawal by Subject|1|||
16858283|NCT01710709|37812706|FG000|Overall Study|Lost to Follow-up|29|||
16858284|NCT01710709|37812706|FG000|Overall Study|Adverse Event|48|||
16858285|NCT01710709|37812706|FG000|Overall Study|Participant met withdrawal criteria|33|||
16858286|NCT01710709|37812706|FG000|Overall Study|Participant withdrawn by investigator|2|||
16858287|NCT01710709|37812706|FG000|Overall Study|Withdrawal by Subject|53|||
16858288|NCT01710709|37812706|FG000|Overall Study|Protocol Violation|5|||
16858289|NCT01710709|37812706|FG000|Overall Study|Lack of Efficacy|3|||
16858290|NCT01617629|37812711|FG000|Overall Study|Death|2|||
16858291|NCT01617629|37812711|FG000|Overall Study|Investigator's Clinical Judgement|1|||
16858292|NCT01617629|37812711|FG000|Overall Study|Reason Not Specified|1|||
16858293|NCT01617629|37812711|FG000|Overall Study|Participant Withdrew Consent|2|||
16858294|NCT01686373|37812726|FG000|Overall Study|Lost to Follow-up|3|||
16858295|NCT01686373|37812727|FG001|Overall Study|Lost to Follow-up|0|||
16858296|NCT01686373|37812726|FG000|Overall Study|Withdrawal by Subject|0|||
16858297|NCT01686373|37812727|FG001|Overall Study|Withdrawal by Subject|1|||
16858298|NCT01686373|37812726|FG000|Overall Study|Adverse Event|0|||
16858299|NCT01686373|37812727|FG001|Overall Study|Adverse Event|1|||
16858300|NCT01709695|37812735|FG000|Overall Study|Withdrawal by Subject|1|||
16858301|NCT01709695|37812736|FG001|Overall Study|Withdrawal by Subject|1|||
16858302|NCT01685983|37812746|FG000|Overall Study|Adverse Event|7|||
16858303|NCT01685983|37812746|FG000|Overall Study|Death|1|||
16858304|NCT01685983|37812746|FG000|Overall Study|Withdrawal by Subject|19|||
16858305|NCT01685983|37812746|FG000|Overall Study|Protocol Violation|2|||
16858306|NCT01685983|37812746|FG000|Overall Study|Physician Decision|13|||
16858307|NCT01685983|37812746|FG000|Overall Study|Other|7|||
16858308|NCT01685983|37812746|FG000|Overall Study|Progressive Disease|32|||
16858309|NCT01685983|37812746|FG000|Overall Study|Noncompliance with Study Drug|1|||
16858310|NCT01685437|37812758|FG000|Overall Study|Withdrawal by Subject|22|||
16858311|NCT01685437|37812758|FG000|Overall Study|Lost to Follow-up|3|||
16858312|NCT01685437|37812758|FG000|Overall Study|Adverse Event|1|||
16858313|NCT01685437|37812758|FG000|Overall Study|Protocol Violation|4|||
16858314|NCT01685437|37812758|FG000|Overall Study|Unable to make visits due to work|1|||
16858315|NCT01685203|37812798|FG000|Overall Study|Lost to Follow-up|3|||
16858316|NCT01685203|37812799|FG001|Overall Study|Lost to Follow-up|3|||
16858317|NCT01685203|37812800|FG002|Overall Study|Lost to Follow-up|0|||
16858318|NCT01685203|37812801|FG003|Overall Study|Lost to Follow-up|1|||
16858319|NCT01685203|37812802|FG004|Overall Study|Lost to Follow-up|0|||
16858320|NCT01685203|37812803|FG005|Overall Study|Lost to Follow-up|0|||
16942890|NCT01111552|38087522|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
16858321|NCT01685203|37812804|FG006|Overall Study|Lost to Follow-up|0|||
16858322|NCT01685203|37812798|FG000|Overall Study|Adverse Event|0|||
16858323|NCT01685203|37812799|FG001|Overall Study|Adverse Event|0|||
16858324|NCT01685203|37812800|FG002|Overall Study|Adverse Event|0|||
16858325|NCT01685203|37812801|FG003|Overall Study|Adverse Event|0|||
16858326|NCT01685203|37812802|FG004|Overall Study|Adverse Event|0|||
16858327|NCT01685203|37812803|FG005|Overall Study|Adverse Event|2|||
16858328|NCT01685203|37812804|FG006|Overall Study|Adverse Event|0|||
16858329|NCT01685203|37812798|FG000|Overall Study|Adverse event and withdrew consent|1|||
16858330|NCT01685203|37812799|FG001|Overall Study|Adverse event and withdrew consent|0|||
16858331|NCT01685203|37812800|FG002|Overall Study|Adverse event and withdrew consent|0|||
16858332|NCT01685203|37812801|FG003|Overall Study|Adverse event and withdrew consent|0|||
16858333|NCT01685203|37812802|FG004|Overall Study|Adverse event and withdrew consent|0|||
16858334|NCT01685203|37812803|FG005|Overall Study|Adverse event and withdrew consent|0|||
16858335|NCT01685203|37812804|FG006|Overall Study|Adverse event and withdrew consent|0|||
16858336|NCT01685203|37812798|FG000|Overall Study|Patient's decision|0|||
16858337|NCT01685203|37812799|FG001|Overall Study|Patient's decision|0|||
16858338|NCT01685203|37812800|FG002|Overall Study|Patient's decision|0|||
16858339|NCT01685203|37812801|FG003|Overall Study|Patient's decision|0|||
16858340|NCT01685203|37812802|FG004|Overall Study|Patient's decision|0|||
16858341|NCT01685203|37812803|FG005|Overall Study|Patient's decision|1|||
16858342|NCT01685203|37812804|FG006|Overall Study|Patient's decision|0|||
16858343|NCT01928771|37812823|FG000|Overall Study|Adverse Event|6|||
16858344|NCT01928771|37812824|FG001|Overall Study|Adverse Event|5|||
16858345|NCT01928771|37812825|FG002|Overall Study|Adverse Event|1|||
16858346|NCT01928771|37812823|FG000|Overall Study|Death|2|||
16858347|NCT01928771|37812824|FG001|Overall Study|Death|2|||
16858348|NCT01928771|37812825|FG002|Overall Study|Death|2|||
16858349|NCT01928771|37812823|FG000|Overall Study|Lost to Follow-up|5|||
16858350|NCT01928771|37812824|FG001|Overall Study|Lost to Follow-up|6|||
16858351|NCT01928771|37812825|FG002|Overall Study|Lost to Follow-up|3|||
16858352|NCT01928771|37812823|FG000|Overall Study|Withdrawal by Subject|20|||
16858353|NCT01928771|37812824|FG001|Overall Study|Withdrawal by Subject|15|||
16858354|NCT01928771|37812825|FG002|Overall Study|Withdrawal by Subject|17|||
16858355|NCT01928771|37812823|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
16858356|NCT01928771|37812824|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
16858357|NCT01928771|37812825|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
16942891|NCT01111552|38087523|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
16942892|NCT01111552|38087524|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
16942893|NCT01111552|38087525|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
16942894|NCT01111552|38087526|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
16942895|NCT01111552|38087522|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
16942896|NCT01111552|38087523|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
16942897|NCT01111552|38087524|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
16942898|NCT01111552|38087525|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
16942899|NCT01111552|38087526|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
16942900|NCT01111552|38087522|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
16942901|NCT01111552|38087523|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
16942902|NCT01111552|38087524|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
16942903|NCT01111552|38087525|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
16942904|NCT01111552|38087526|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
16942905|NCT01111552|38087522|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16942906|NCT01111552|38087523|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16942907|NCT01111552|38087524|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
16942908|NCT01111552|38087525|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16942909|NCT01111552|38087526|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16942910|NCT01175083|38087542|FG000|Primary Epoch|Withdrawal by Subject|0|||
16942911|NCT01175083|38087543|FG001|Primary Epoch|Withdrawal by Subject|0|||
16942912|NCT01175083|38087544|FG002|Primary Epoch|Withdrawal by Subject|0|||
16942913|NCT01175083|38087545|FG003|Primary Epoch|Withdrawal by Subject|0|||
16942914|NCT01175083|38087546|FG004|Primary Epoch|Withdrawal by Subject|0|||
16942915|NCT01175083|38087547|FG005|Primary Epoch|Withdrawal by Subject|2|||
16942916|NCT01175083|38087542|FG000|Primary Epoch|Lost to Follow-up|0|||
16942917|NCT01175083|38087543|FG001|Primary Epoch|Lost to Follow-up|0|||
16942918|NCT01175083|38087544|FG002|Primary Epoch|Lost to Follow-up|0|||
16942919|NCT01175083|38087545|FG003|Primary Epoch|Lost to Follow-up|0|||
16942920|NCT01175083|38087546|FG004|Primary Epoch|Lost to Follow-up|0|||
16942921|NCT01175083|38087547|FG005|Primary Epoch|Lost to Follow-up|1|||
16942922|NCT01175083|38087542|FG000|Booster Epoch|Death|0|||
16942923|NCT01175083|38087543|FG001|Booster Epoch|Death|0|||
16942924|NCT01175083|38087544|FG002|Booster Epoch|Death|1|||
16942925|NCT01175083|38087545|FG003|Booster Epoch|Death|0|||
16942926|NCT01175083|38087546|FG004|Booster Epoch|Death|0|||
16942927|NCT01175083|38087547|FG005|Booster Epoch|Death|0|||
16942928|NCT01175083|38087542|FG000|Booster Epoch|Withdrawal by Subject|0|||
16942929|NCT01175083|38087543|FG001|Booster Epoch|Withdrawal by Subject|0|||
16942930|NCT01175083|38087544|FG002|Booster Epoch|Withdrawal by Subject|0|||
16942931|NCT01175083|38087545|FG003|Booster Epoch|Withdrawal by Subject|1|||
16942932|NCT01175083|38087546|FG004|Booster Epoch|Withdrawal by Subject|0|||
16942933|NCT01175083|38087547|FG005|Booster Epoch|Withdrawal by Subject|0|||
16942934|NCT01174459|38087565|FG000|Overall Study|case report form (CRF) not collected|5|||
16858358|NCT01928771|37812823|FG000|Overall Study|Other Reasons|9|||
16858359|NCT01928771|37812824|FG001|Overall Study|Other Reasons|9|||
16858360|NCT01928771|37812825|FG002|Overall Study|Other Reasons|14|||
16858361|NCT01928771|37812823|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
16858362|NCT01928771|37812824|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
16858363|NCT01928771|37812825|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
16858364|NCT01589653|37812835|FG000|Overall Study|Protocol Violation|3|||
16858365|NCT01589653|37812836|FG001|Overall Study|Protocol Violation|1|||
16858366|NCT01589653|37812835|FG000|Overall Study|Withdrawal criteria|4|||
16858367|NCT01589653|37812836|FG001|Overall Study|Withdrawal criteria|7|||
16858368|NCT01589653|37812835|FG000|Overall Study|Unclassified|0|||
16858369|NCT01589653|37812836|FG001|Overall Study|Unclassified|3|||
16858370|NCT01928615|37812842|FG000|Overall Study|Study Terminated by Sponsor|2|||
16858371|NCT01589497|37812851|FG000|Overall Study|Withdrawal by Subject|0|||
16858372|NCT01589497|37812852|FG001|Overall Study|Withdrawal by Subject|1|||
16858373|NCT01589497|37812853|FG002|Overall Study|Withdrawal by Subject|0|||
16858374|NCT01589497|37812854|FG003|Overall Study|Withdrawal by Subject|1|||
16858375|NCT01589497|37812851|FG000|Overall Study|Death|1|||
16858376|NCT01589497|37812852|FG001|Overall Study|Death|0|||
16858377|NCT01589497|37812853|FG002|Overall Study|Death|0|||
16858378|NCT01589497|37812854|FG003|Overall Study|Death|0|||
16858379|NCT01589497|37812851|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
16858380|NCT01589497|37812852|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
16858381|NCT01589497|37812853|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
16858382|NCT01589497|37812854|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
16858383|NCT01928381|37812869|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
16858384|NCT01928381|37812870|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16858385|NCT01928381|37812871|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16858386|NCT01928381|37812872|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16858387|NCT01928381|37812873|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16858388|NCT01928381|37812874|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16858389|NCT01928381|37812875|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16858390|NCT01928381|37812869|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
16858391|NCT01928381|37812870|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
16858392|NCT01928381|37812871|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
16858393|NCT01928381|37812872|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
16858394|NCT01928381|37812873|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
16858395|NCT01928381|37812874|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
16858396|NCT01928381|37812875|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
16858397|NCT01928381|37812869|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
16858398|NCT01928381|37812870|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
16858399|NCT01928381|37812871|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
16942935|NCT01174342|38087569|FG000|Overall Study|Conversion to cesarean section|4|||
16942936|NCT01111474|38087573|FG000|Overall Study|Lost to Follow-up|12|||
16942937|NCT01174264|38087582|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
16942938|NCT01174264|38087583|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
16942939|NCT01174264|38087584|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
16942940|NCT01174264|38087582|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
16942941|NCT01174264|38087583|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
16942942|NCT01174264|38087584|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
16942943|NCT01174264|38087582|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
16942944|NCT01174264|38087583|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
16942945|NCT01174264|38087584|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
16942946|NCT01174186|38087594|FG000|Overall Study|Lost to Follow-up|0|||
16942947|NCT01174186|38087595|FG001|Overall Study|Lost to Follow-up|1|||
16942948|NCT01174186|38087594|FG000|Overall Study|Withdrawal by Subject|0|||
16942949|NCT01174186|38087595|FG001|Overall Study|Withdrawal by Subject|2|||
16942950|NCT01173718|38087601|FG000|Overall Study|Death|17|||
17127296|NCT02820298|38267542|FG001|Overall Study|Protocol Violation|1|||
16942951|NCT01173718|38087601|FG000|Overall Study|Abandonment of study graft|27|||
16942952|NCT01111240|38087605|FG000|Overall Study|Adverse Event|190|||
16942953|NCT01111240|38087605|FG000|Overall Study|Lack of Efficacy|545|||
16942954|NCT01111240|38087605|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
16942955|NCT01111240|38087605|FG000|Overall Study|Other|312|||
16942956|NCT01111123|38087611|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
16942957|NCT01111123|38087612|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
16942958|NCT01111123|38087611|FG000|Maintenance Phase|Lost to Follow-up|0|||
16942959|NCT01111123|38087612|FG001|Maintenance Phase|Lost to Follow-up|2|||
16942960|NCT01173679|38087620|FG000|Overall Study|Death|1|||
16942961|NCT01110382|38087627|FG000|Overall Study|Withdrawal by Subject|0|||
16942962|NCT01110382|38087628|FG001|Overall Study|Withdrawal by Subject|1|||
16942963|NCT01110382|38087627|FG000|Overall Study|Protocol Violation|0|||
16942964|NCT01110382|38087628|FG001|Overall Study|Protocol Violation|1|||
16942965|NCT01173601|38087638|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
16942966|NCT01173601|38087639|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16942967|NCT01173601|38087640|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16858400|NCT01928381|37812872|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
16858401|NCT01928381|37812873|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
16942968|NCT01173601|38087641|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16942969|NCT01173601|38087642|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16942970|NCT01173601|38087638|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
16942971|NCT01173601|38087639|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16942972|NCT01173601|38087640|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16942973|NCT01173601|38087641|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16942974|NCT01173601|38087642|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16942975|NCT01173601|38087638|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
16942976|NCT01173601|38087639|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16942977|NCT01173601|38087640|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16942978|NCT01173601|38087641|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16942979|NCT01173601|38087642|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16942980|NCT01173601|38087638|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
16942981|NCT01173601|38087639|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16942982|NCT01173601|38087640|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16858402|NCT01928381|37812874|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
16858403|NCT01928381|37812875|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
16858404|NCT01928381|37812869|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
16858405|NCT01928381|37812870|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
16858406|NCT01928381|37812871|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
16858407|NCT01928381|37812872|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
16858408|NCT01928381|37812873|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
16858409|NCT01928381|37812874|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
16858410|NCT01928381|37812875|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
16858411|NCT01928381|37812869|FG000|Part 1 - Pain Training|Protocol Violation|1|||
16858412|NCT01928381|37812870|FG001|Part 1 - Pain Training|Protocol Violation|0|||
16858413|NCT01928381|37812871|FG002|Part 1 - Pain Training|Protocol Violation|0|||
16858414|NCT01928381|37812872|FG003|Part 1 - Pain Training|Protocol Violation|0|||
16858415|NCT01928381|37812873|FG004|Part 1 - Pain Training|Protocol Violation|0|||
16858416|NCT01928381|37812874|FG005|Part 1 - Pain Training|Protocol Violation|0|||
16858417|NCT01928381|37812875|FG006|Part 1 - Pain Training|Protocol Violation|0|||
16858418|NCT01928381|37812869|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
16858419|NCT01928381|37812870|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16858420|NCT01928381|37812871|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16942983|NCT01173601|38087641|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16942984|NCT01173601|38087642|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16858421|NCT01928381|37812872|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16858422|NCT01928381|37812873|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16858423|NCT01928381|37812874|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16858424|NCT01928381|37812875|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16858425|NCT01928381|37812869|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
16858426|NCT01928381|37812870|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16858427|NCT01928381|37812871|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16858428|NCT01928381|37812872|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16858429|NCT01928381|37812873|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16858430|NCT01928381|37812874|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16858431|NCT01928381|37812875|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16858432|NCT01928381|37812869|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
16858433|NCT01928381|37812870|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16858434|NCT01928381|37812871|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16858435|NCT01928381|37812872|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16858436|NCT01928381|37812873|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16858437|NCT01928381|37812874|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16858438|NCT01928381|37812875|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16858439|NCT01928381|37812869|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
16858440|NCT01928381|37812870|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16858441|NCT01928381|37812871|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16858442|NCT01928381|37812872|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16858443|NCT01928381|37812873|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16858444|NCT01928381|37812874|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16858445|NCT01928381|37812875|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16858446|NCT01928381|37812869|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
16858447|NCT01928381|37812870|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
16858448|NCT01928381|37812871|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
16858449|NCT01928381|37812872|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
16858450|NCT01928381|37812873|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
16858451|NCT01928381|37812874|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
16858452|NCT01928381|37812875|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
16858453|NCT01928381|37812869|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16858454|NCT01928381|37812870|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16858455|NCT01928381|37812871|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
16858456|NCT01928381|37812872|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16858457|NCT01928381|37812873|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16858458|NCT01928381|37812874|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16858459|NCT01928381|37812875|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16858460|NCT01928381|37812869|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
16858461|NCT01928381|37812870|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
16858462|NCT01928381|37812871|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
16858463|NCT01928381|37812872|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
16858464|NCT01928381|37812873|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
16858465|NCT01928381|37812874|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
16858466|NCT01928381|37812875|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
16858467|NCT01928381|37812869|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
16858468|NCT01928381|37812870|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
16858469|NCT01928381|37812871|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
16858470|NCT01928381|37812872|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
16858471|NCT01928381|37812873|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
16858472|NCT01928381|37812874|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
16858473|NCT01928381|37812875|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
16942985|NCT01173601|38087638|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
16942986|NCT01173601|38087639|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16942987|NCT01173601|38087640|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16942988|NCT01173601|38087641|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16858474|NCT01928381|37812869|FG000|Washout First Intervention|Protocol Violation|0|||
16858475|NCT01928381|37812870|FG001|Washout First Intervention|Protocol Violation|0|||
16858476|NCT01928381|37812871|FG002|Washout First Intervention|Protocol Violation|0|||
16858477|NCT01928381|37812872|FG003|Washout First Intervention|Protocol Violation|0|||
16858478|NCT01928381|37812873|FG004|Washout First Intervention|Protocol Violation|1|||
16858479|NCT01928381|37812874|FG005|Washout First Intervention|Protocol Violation|0|||
16858480|NCT01928381|37812875|FG006|Washout First Intervention|Protocol Violation|0|||
16858481|NCT01928381|37812869|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
16858482|NCT01928381|37812870|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
16858483|NCT01928381|37812871|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
16858484|NCT01928381|37812872|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
16858485|NCT01928381|37812873|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
16858486|NCT01928381|37812874|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
16858487|NCT01928381|37812875|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
16858488|NCT01928381|37812869|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
16858489|NCT01928381|37812870|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
16858490|NCT01928381|37812871|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
16858491|NCT01928381|37812872|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
16858492|NCT01928381|37812873|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
16858493|NCT01928381|37812874|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
16942989|NCT01173601|38087642|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16942990|NCT01173601|38087638|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
16942991|NCT01173601|38087639|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16942992|NCT01173601|38087640|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16942993|NCT01173601|38087641|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16942994|NCT01173601|38087642|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16942995|NCT01173601|38087638|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
16942996|NCT01173601|38087639|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16942997|NCT01173601|38087640|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16942998|NCT01173601|38087641|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16942999|NCT01173601|38087642|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16943000|NCT01173601|38087638|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
16943001|NCT01173601|38087639|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
16943002|NCT01173601|38087640|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
16943003|NCT01173601|38087641|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
16943004|NCT01173601|38087642|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
16943005|NCT01173601|38087638|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
16943006|NCT01173601|38087639|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
16943007|NCT01173601|38087640|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
16943008|NCT01173601|38087641|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
16943009|NCT01173601|38087642|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
16943010|NCT01173601|38087638|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
16943011|NCT01173601|38087639|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
16943012|NCT01173601|38087640|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
16943013|NCT01173601|38087641|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
16943014|NCT01173601|38087642|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
16943015|NCT01173601|38087638|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16943016|NCT01173601|38087639|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
16943017|NCT01173601|38087640|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16943018|NCT01173601|38087641|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
16943019|NCT01173601|38087642|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
16943020|NCT01173601|38087638|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
16943021|NCT01173601|38087639|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
16943022|NCT01173601|38087640|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16943023|NCT01173601|38087641|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
16943024|NCT01173601|38087642|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16943025|NCT01173601|38087638|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
16943026|NCT01173601|38087639|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
17127297|NCT02819440|38267556|FG000|Overall Study|Adverse Event|3|||
16858494|NCT01928381|37812875|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
16858495|NCT01928225|37812887|FG000|Overall Study|Pregnancy|1|||
16858496|NCT01928225|37812888|FG001|Overall Study|Pregnancy|0|||
16858497|NCT01928225|37812887|FG000|Overall Study|basaloid cervical cancer|1|||
16858498|NCT01928225|37812888|FG001|Overall Study|basaloid cervical cancer|0|||
16858499|NCT01928225|37812887|FG000|Overall Study|Lost to Follow-up|1|||
16858500|NCT01928225|37812888|FG001|Overall Study|Lost to Follow-up|3|||
16858501|NCT01927757|37812895|FG000|Overall Study|Withdrawal by Subject|14|||
16858502|NCT01927757|37812895|FG000|Overall Study|Lost to Follow-up|2|||
16858503|NCT01927757|37812895|FG000|Overall Study|Decision by Sponsor|2|||
16858504|NCT01927757|37812895|FG000|Overall Study|Other|1|||
16858505|NCT01927757|37812895|FG000|Overall Study|Ethical Reasons|4|||
16858506|NCT01927367|37812905|FG000|Overall Study|Withdrawal by Subject|7|||
16858507|NCT01927367|37812906|FG001|Overall Study|Withdrawal by Subject|4|||
16858508|NCT01927367|37812905|FG000|Overall Study|No baseline data|0|||
16858509|NCT01927367|37812906|FG001|Overall Study|No baseline data|1|||
16858510|NCT01913639|37812912|FG000|Overall Study|Not Eligible|3|||
16858511|NCT01913483|37812918|FG000|Overall Study|Withdrawal by Subject|1|||
16858512|NCT01913483|37812919|FG001|Overall Study|Withdrawal by Subject|2|||
16858513|NCT01913483|37812918|FG000|Overall Study|Lost to Follow-up|6|||
16858514|NCT01913483|37812919|FG001|Overall Study|Lost to Follow-up|3|||
16858515|NCT01913483|37812918|FG000|Overall Study|Death|14|||
16858516|NCT01913483|37812919|FG001|Overall Study|Death|17|||
16858517|NCT01913405|37812925|FG000|Overall Study|Withdrawal by Subject|1|||
16858518|NCT01913405|37812925|FG000|Overall Study|Adverse Event|1|||
16858519|NCT01927055|37812945|FG000|Open-label|Adverse Event|6|||
16858520|NCT01927055|37812946|FG001|Open-label|Adverse Event|0|||
16858521|NCT01927055|37812947|FG002|Open-label|Adverse Event|0|||
16858522|NCT01927055|37812945|FG000|Open-label|Withdrawal by Subject|1|||
16858523|NCT01927055|37812946|FG001|Open-label|Withdrawal by Subject|0|||
16858524|NCT01927055|37812947|FG002|Open-label|Withdrawal by Subject|0|||
16858525|NCT01927055|37812945|FG000|Open-label|Study Stopped|4|||
16858526|NCT01927055|37812946|FG001|Open-label|Study Stopped|0|||
16858527|NCT01927055|37812947|FG002|Open-label|Study Stopped|0|||
16858528|NCT01927055|37812945|FG000|Open-label|Supine Hypertension|4|||
16858529|NCT01927055|37812946|FG001|Open-label|Supine Hypertension|0|||
16858530|NCT01927055|37812947|FG002|Open-label|Supine Hypertension|0|||
16858531|NCT01927055|37812945|FG000|Open-label|Difficulty attending study visits|1|||
16858532|NCT01927055|37812946|FG001|Open-label|Difficulty attending study visits|0|||
16858533|NCT01927055|37812947|FG002|Open-label|Difficulty attending study visits|0|||
16858534|NCT01927055|37812945|FG000|Double-Blind|Adverse Event|0|||
16858535|NCT01927055|37812946|FG001|Double-Blind|Adverse Event|1|||
16858536|NCT01927055|37812947|FG002|Double-Blind|Adverse Event|1|||
16858537|NCT01927055|37812945|FG000|Double-Blind|Protocol Violation|0|||
16858538|NCT01927055|37812946|FG001|Double-Blind|Protocol Violation|0|||
16858539|NCT01927055|37812947|FG002|Double-Blind|Protocol Violation|1|||
16858540|NCT01927055|37812945|FG000|Double-Blind|Withdrawal by Subject|0|||
16858541|NCT01927055|37812946|FG001|Double-Blind|Withdrawal by Subject|2|||
16858542|NCT01927055|37812947|FG002|Double-Blind|Withdrawal by Subject|3|||
16858543|NCT01927055|37812945|FG000|Double-Blind|Study Stopped|0|||
16858544|NCT01927055|37812946|FG001|Double-Blind|Study Stopped|7|||
16858545|NCT01927055|37812947|FG002|Double-Blind|Study Stopped|7|||
16858546|NCT01927055|37812945|FG000|Double-Blind|Supine Hypertension|0|||
16858547|NCT01927055|37812946|FG001|Double-Blind|Supine Hypertension|0|||
16858548|NCT01927055|37812947|FG002|Double-Blind|Supine Hypertension|1|||
16858549|NCT01927055|37812945|FG000|Double-Blind|Extended Vacation|0|||
16858550|NCT01927055|37812946|FG001|Double-Blind|Extended Vacation|1|||
16858551|NCT01927055|37812947|FG002|Double-Blind|Extended Vacation|0|||
16858552|NCT01913327|37812956|FG000|Overall Study|Withdrawal by Subject|0|||
16858553|NCT01913327|37812957|FG001|Overall Study|Withdrawal by Subject|1|||
16858554|NCT01926509|37812967|FG000|Overall Study|vital sign met discontinuation criteria|1|||
16858555|NCT01926509|37812968|FG001|Overall Study|vital sign met discontinuation criteria|0|||
16858556|NCT01926509|37812969|FG002|Overall Study|vital sign met discontinuation criteria|0|||
16858557|NCT01926509|37812970|FG003|Overall Study|vital sign met discontinuation criteria|0|||
16858558|NCT01926119|37812980|FG000|Overall Study|Withdrawal by Subject|1|||
16858559|NCT01912781|37812986|FG000|Overall Study|Withdrawal by Subject|2|||
16858560|NCT01912781|37812987|FG001|Overall Study|Withdrawal by Subject|0|||
16858561|NCT01925417|37812994|FG000|Overall Study|Withdrawal by Subject|2|||
16858562|NCT01925417|37812994|FG000|Overall Study|Death|1|||
16858563|NCT01911845|37812999|FG000|Overall Study|Adverse Event|2|||
16858564|NCT01911845|37812999|FG000|Overall Study|Lost to Follow-up|1|||
16858565|NCT01911845|37812999|FG000|Overall Study|Other (not specified)|3|||
16858566|NCT01925339|37813007|FG000|Overall Study|Adverse Event|2|||
16858567|NCT01925339|37813008|FG001|Overall Study|Adverse Event|0|||
16858568|NCT01925183|37813016|FG000|Overall Study|Adverse Event|1|||
16858569|NCT01925183|37813017|FG001|Overall Study|Adverse Event|0|||
16858570|NCT01910519|37813025|FG000|Overall Study|Withdrawal by Subject|2|||
16858571|NCT01910519|37813026|FG001|Overall Study|Withdrawal by Subject|0|||
16858572|NCT01910519|37813025|FG000|Overall Study|Adverse Event|2|||
16858573|NCT01910519|37813026|FG001|Overall Study|Adverse Event|0|||
16858574|NCT01910441|37813034|FG000|Overall Study|Sponsor decision|0|||
16858575|NCT01910441|37813035|FG001|Overall Study|Sponsor decision|2|||
16858576|NCT01910441|37813034|FG000|Overall Study|Lost to Follow-up|6|||
16858577|NCT01910441|37813035|FG001|Overall Study|Lost to Follow-up|5|||
16858578|NCT01910441|37813034|FG000|Overall Study|Withdrawal by Subject|0|||
16858579|NCT01910441|37813035|FG001|Overall Study|Withdrawal by Subject|1|||
16858580|NCT01910441|37813034|FG000|Overall Study|Non-compliance|0|||
16858581|NCT01910441|37813035|FG001|Overall Study|Non-compliance|1|||
16858582|NCT01910441|37813034|FG000|Overall Study|Adverse Event|1|||
16858583|NCT01910441|37813035|FG001|Overall Study|Adverse Event|0|||
16858584|NCT01910441|37813034|FG000|Overall Study|Physician Decision|0|||
16858585|NCT01910441|37813035|FG001|Overall Study|Physician Decision|1|||
16858586|NCT01923467|37813041|FG000|Overall Study|Lost to Follow-up|62|||
16858587|NCT01923467|37813041|FG000|Overall Study|Subject non-interest|479|||
16858588|NCT01910129|37813047|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
16858589|NCT01910129|37813048|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
16858590|NCT01910129|37813049|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
16858591|NCT01910129|37813047|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
16858592|NCT01910129|37813048|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
16858593|NCT01910129|37813049|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
16858594|NCT01909973|37813069|FG000|Overall Study|Lost to Follow-up|1|||
16858595|NCT01909973|37813070|FG001|Overall Study|Lost to Follow-up|0|||
16858596|NCT01617005|37813076|FG000|Overall Study|Pregnancy|1|||
16858597|NCT01617005|37813076|FG000|Overall Study|Lack of motivation for treatment|1|||
16858598|NCT01908803|37813082|FG000|Overall Study|Adverse Event|1|||
16858599|NCT01908803|37813083|FG001|Overall Study|Adverse Event|0|||
16858600|NCT01908803|37813082|FG000|Overall Study|Physician Decision|0|||
16858601|NCT01908803|37813083|FG001|Overall Study|Physician Decision|1|||
16858602|NCT01908803|37813082|FG000|Overall Study|Withdrawal by Subject|1|||
16858603|NCT01908803|37813083|FG001|Overall Study|Withdrawal by Subject|0|||
16858604|NCT01908803|37813082|FG000|Overall Study|Randomization Error|1|||
16858605|NCT01908803|37813083|FG001|Overall Study|Randomization Error|0|||
16858606|NCT01908803|37813082|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
16858607|NCT01908803|37813083|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
16858608|NCT01908101|37813090|FG000|Overall Study|Physician Decision|1|||
16858609|NCT01908101|37813090|FG000|Overall Study|Withdrawal by Subject|1|||
16943027|NCT01173601|38087640|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
16943028|NCT01173601|38087641|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
16943029|NCT01173601|38087642|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
16943030|NCT01173601|38087638|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16943031|NCT01173601|38087639|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16943032|NCT01173601|38087640|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16943033|NCT01173601|38087641|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
16943034|NCT01173601|38087642|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
16943035|NCT01173523|38087662|FG000|Overall Study|Clinical Progression|1|||
16943036|NCT01173523|38087663|FG001|Overall Study|Clinical Progression|1|||
16943037|NCT01173523|38087662|FG000|Overall Study|Progressive Disease|10|||
16943038|NCT01173523|38087663|FG001|Overall Study|Progressive Disease|8|||
16858610|NCT01908101|37813090|FG000|Overall Study|Incorrect Diagnosis|2|||
16943039|NCT01173523|38087662|FG000|Overall Study|Other|2|||
16943040|NCT01173523|38087663|FG001|Overall Study|Other|3|||
16943041|NCT01173055|38087671|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
16943042|NCT01173055|38087672|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
16943043|NCT01173055|38087671|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
16943044|NCT01173055|38087672|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
16943045|NCT01172938|38087681|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
16943046|NCT01172938|38087682|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
16943047|NCT01172938|38087683|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
16943048|NCT01172938|38087684|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16943049|NCT01172938|38087685|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16943050|NCT01172938|38087686|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16943051|NCT01172938|38087687|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16943052|NCT01172938|38087688|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16943053|NCT01172938|38087689|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16858611|NCT01908101|37813090|FG000|Overall Study|Incorrect Starting Dose|1|||
16858612|NCT01908101|37813090|FG000|Overall Study|Did not complete the first cycle|4|||
16858613|NCT01923389|37813096|FG000|Overall Study|Protocol Violation|1|||
16858614|NCT01923389|37813097|FG001|Overall Study|Protocol Violation|0|||
16858615|NCT01907087|37813104|FG000|Overall Study|Withdrawal by Subject|1|||
16858616|NCT01616771|37813108|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
16858617|NCT01589185|37813122|FG000|Overall Study|Death|1|||
16858618|NCT01589185|37813123|FG001|Overall Study|Death|2|||
16858619|NCT01589185|37813124|FG002|Overall Study|Death|2|||
16858620|NCT01589185|37813125|FG003|Overall Study|Death|0|||
16858621|NCT01589185|37813126|FG004|Overall Study|Death|1|||
16858622|NCT01589185|37813122|FG000|Overall Study|Lost to Follow-up|1|||
16858623|NCT01589185|37813123|FG001|Overall Study|Lost to Follow-up|0|||
16858624|NCT01589185|37813124|FG002|Overall Study|Lost to Follow-up|2|||
16858625|NCT01589185|37813125|FG003|Overall Study|Lost to Follow-up|3|||
16858626|NCT01589185|37813126|FG004|Overall Study|Lost to Follow-up|0|||
16858627|NCT01588951|37813142|FG000|Overall Study|Ineligible in retrospect|0|||
16858628|NCT01588951|37813143|FG001|Overall Study|Ineligible in retrospect|0|||
16858629|NCT01588951|37813144|FG002|Overall Study|Ineligible in retrospect|1|||
16858630|NCT01709383|37813154|FG000|Overall Study|Lost to Follow-up|1|||
16858631|NCT01709383|37813155|FG001|Overall Study|Lost to Follow-up|0|||
16858632|NCT01588405|37813163|FG000|Overall Study|Adverse Event|1|||
16858633|NCT01588405|37813163|FG000|Overall Study|Clinical Worsening|1|||
16858634|NCT01923311|37813172|FG000|Overall Study|Pregnancy|1|||
16858635|NCT01923311|37813173|FG001|Overall Study|Pregnancy|0|||
16858636|NCT01923311|37813172|FG000|Overall Study|Investigator's Discretion|1|||
16858637|NCT01923311|37813173|FG001|Overall Study|Investigator's Discretion|0|||
16858638|NCT01923311|37813172|FG000|Overall Study|Non-Compliance with Study Drug|2|||
16858639|NCT01923311|37813173|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16858640|NCT01923311|37813172|FG000|Overall Study|Withdrew Consent|1|||
16858641|NCT01923311|37813173|FG001|Overall Study|Withdrew Consent|0|||
16858642|NCT01923311|37813172|FG000|Overall Study|Study Terminated by Sponsor|12|||
16858643|NCT01923311|37813173|FG001|Overall Study|Study Terminated by Sponsor|0|||
16858644|NCT01603615|37813180|FG000|Overall Study|Did not Receive Treatment|7|||
16858645|NCT01603615|37813180|FG000|Overall Study|Lost to Follow-up|9|||
16858646|NCT01603615|37813180|FG000|Overall Study|Personal Reasons|17|||
16858647|NCT01603615|37813180|FG000|Overall Study|Other Miscellaneous|1|||
16858648|NCT01685047|37813184|FG000|Overall Study|Withdrawal by Subject|20|||
16858649|NCT01685047|37813184|FG000|Overall Study|Death|26|||
16858650|NCT01685047|37813184|FG000|Overall Study|Lost to Follow-up|8|||
16858651|NCT01685047|37813184|FG000|Overall Study|Physician Decision|25|||
16858652|NCT01685047|37813184|FG000|Overall Study|Adverse Event|5|||
16858653|NCT01685047|37813184|FG000|Overall Study|patient withdrawn by sponsor|1|||
16858654|NCT01905683|37813188|FG000|Overall Study|Protocol Violation|1|||
16858655|NCT01905683|37813188|FG000|Overall Study|Re-injection criteria not met; others|13|||
16858656|NCT01905683|37813188|FG000|Overall Study|Physician Decision|1|||
16858657|NCT01905683|37813188|FG000|Overall Study|Lack of Efficacy|8|||
16858658|NCT01905683|37813188|FG000|Overall Study|Withdrawal by Subject|20|||
16858659|NCT01905683|37813188|FG000|Overall Study|Adverse Event|4|||
16858660|NCT01905683|37813188|FG000|Overall Study|Lost to Follow-up|4|||
16858661|NCT01921829|37813194|FG000|Overall Study|Withdrawal by Subject|0|||
16858662|NCT01921829|37813195|FG001|Overall Study|Withdrawal by Subject|1|||
16858663|NCT01904903|37813201|FG000|Overall Study|Withdrawal by Subject|1|||
16858664|NCT01921517|37813207|FG000|Overall Study|Lost to Follow-up|5|||
16858665|NCT01921517|37813208|FG001|Overall Study|Lost to Follow-up|0|||
16858666|NCT01921517|37813207|FG000|Overall Study|Newly diagnosed health concern|2|||
16858667|NCT01921517|37813208|FG001|Overall Study|Newly diagnosed health concern|0|||
16858668|NCT01921517|37813207|FG000|Overall Study|Physician Decision|0|||
16858669|NCT01921517|37813208|FG001|Overall Study|Physician Decision|2|||
16858670|NCT01921517|37813207|FG000|Overall Study|Withdrawal by Subject|7|||
16858671|NCT01921517|37813208|FG001|Overall Study|Withdrawal by Subject|3|||
16858672|NCT01921517|37813207|FG000|Overall Study|Subject missed final imaging|1|||
16858673|NCT01921517|37813208|FG001|Overall Study|Subject missed final imaging|4|||
16858674|NCT01921205|37813216|FG000|Overall Study|Adverse Event|12|||
16858675|NCT01921205|37813217|FG001|Overall Study|Adverse Event|7|||
16858676|NCT01921205|37813216|FG000|Overall Study|Lack of Efficacy|1|||
16858677|NCT01921205|37813217|FG001|Overall Study|Lack of Efficacy|0|||
16858678|NCT01921205|37813216|FG000|Overall Study|Protocol Violation|1|||
16858679|NCT01921205|37813217|FG001|Overall Study|Protocol Violation|3|||
16858680|NCT01921205|37813216|FG000|Overall Study|Lost to Follow-up|1|||
16858681|NCT01921205|37813217|FG001|Overall Study|Lost to Follow-up|1|||
16858682|NCT01921205|37813216|FG000|Overall Study|Withdrawal by Subject|6|||
16858683|NCT01921205|37813217|FG001|Overall Study|Withdrawal by Subject|5|||
16858684|NCT01921205|37813216|FG000|Overall Study|Use Of Prohibited Medication|0|||
16858685|NCT01921205|37813217|FG001|Overall Study|Use Of Prohibited Medication|1|||
16943054|NCT01172938|38087681|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
16943055|NCT01172938|38087682|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
16943056|NCT01172938|38087683|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
16943057|NCT01172938|38087684|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16943058|NCT01172938|38087685|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16943059|NCT01172938|38087686|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16943060|NCT01172938|38087687|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16943061|NCT01172938|38087688|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16943062|NCT01172938|38087689|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16943063|NCT01172938|38087681|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16943064|NCT01172938|38087682|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
16943065|NCT01172938|38087683|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
16943066|NCT01172938|38087684|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16943067|NCT01172938|38087685|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16943068|NCT01172938|38087686|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16943069|NCT01172938|38087687|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16943070|NCT01172938|38087688|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16943071|NCT01172938|38087689|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16943072|NCT01172938|38087681|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
16943073|NCT01172938|38087682|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
16943074|NCT01172938|38087683|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
16943075|NCT01172938|38087684|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16943076|NCT01172938|38087685|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16943077|NCT01172938|38087686|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16943078|NCT01172938|38087687|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16943079|NCT01172938|38087688|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16943080|NCT01172938|38087689|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16943081|NCT01172938|38087681|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
16943082|NCT01172938|38087682|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
16943083|NCT01172938|38087683|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
16943084|NCT01172938|38087684|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
16943085|NCT01172938|38087685|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
16943086|NCT01172938|38087686|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
16943087|NCT01172938|38087687|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
16943088|NCT01172938|38087688|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
16943089|NCT01172938|38087689|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
16943090|NCT01172938|38087681|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
16943091|NCT01172938|38087682|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16858686|NCT01921205|37813216|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
16858687|NCT01921205|37813217|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
16943092|NCT01172938|38087683|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16943093|NCT01172938|38087684|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16943094|NCT01172938|38087685|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16943095|NCT01172938|38087686|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16943096|NCT01172938|38087687|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16943097|NCT01172938|38087688|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16943098|NCT01172938|38087689|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16943099|NCT01172938|38087681|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
16943100|NCT01172938|38087682|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
16943101|NCT01172938|38087683|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
16943102|NCT01172938|38087684|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
16943103|NCT01172938|38087685|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
16943104|NCT01172938|38087686|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
16943105|NCT01172938|38087687|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
16943106|NCT01172938|38087688|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
16943107|NCT01172938|38087689|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
16943108|NCT01172938|38087681|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
16943109|NCT01172938|38087682|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
16943110|NCT01172938|38087683|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
16943111|NCT01172938|38087684|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
16943112|NCT01172938|38087685|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
16943113|NCT01172938|38087686|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
16943114|NCT01172938|38087687|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
16943115|NCT01172938|38087688|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
16943116|NCT01172938|38087689|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
16943117|NCT01172938|38087681|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
16943118|NCT01172938|38087682|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
16943119|NCT01172938|38087683|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
16943120|NCT01172938|38087684|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
16943121|NCT01172938|38087685|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
16943122|NCT01172938|38087686|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
16943123|NCT01172938|38087687|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
16943124|NCT01172938|38087688|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
16943125|NCT01172938|38087689|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
16943126|NCT01172938|38087681|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16943127|NCT01172938|38087682|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16943128|NCT01172938|38087683|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
16943129|NCT01172938|38087684|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16943130|NCT01172938|38087685|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16943131|NCT01172938|38087686|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16943132|NCT01172938|38087687|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16943133|NCT01172938|38087688|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16943134|NCT01172938|38087689|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16943135|NCT01172938|38087681|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
16943136|NCT01172938|38087682|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
16943137|NCT01172938|38087683|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
16943138|NCT01172938|38087684|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
16943139|NCT01172938|38087685|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
16943140|NCT01172938|38087686|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
16943141|NCT01172938|38087687|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
16943142|NCT01172938|38087688|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
16943143|NCT01172938|38087689|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
16943144|NCT01172938|38087681|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16943145|NCT01172938|38087682|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
16943146|NCT01172938|38087683|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
16943147|NCT01172938|38087684|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
16943148|NCT01172938|38087685|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16858688|NCT01921205|37813216|FG000|Overall Study|Non Compliance Of The Parent|0|||
16858689|NCT01921205|37813217|FG001|Overall Study|Non Compliance Of The Parent|1|||
16858690|NCT01921205|37813216|FG000|Overall Study|Non Compliance Of Child|0|||
16858691|NCT01921205|37813217|FG001|Overall Study|Non Compliance Of Child|1|||
16858692|NCT01920893|37813225|FG000|Overall Study|Adverse Event|5|||
16858693|NCT01920893|37813226|FG001|Overall Study|Adverse Event|2|||
16858694|NCT01920893|37813225|FG000|Overall Study|Lack of Efficacy|2|||
16858695|NCT01920893|37813226|FG001|Overall Study|Lack of Efficacy|0|||
16858696|NCT01709305|37813233|FG000|Phase 1|Clinical Adverse Event|80|||
16858697|NCT01709305|37813234|FG001|Phase 1|Clinical Adverse Event|0|||
16858698|NCT01709305|37813235|FG002|Phase 1|Clinical Adverse Event|0|||
16858699|NCT01709305|37813236|FG003|Phase 1|Clinical Adverse Event|0|||
16858700|NCT01709305|37813237|FG004|Phase 1|Clinical Adverse Event|0|||
16858701|NCT01709305|37813233|FG000|Phase 1|Death|2|||
16858702|NCT01709305|37813234|FG001|Phase 1|Death|0|||
16858703|NCT01709305|37813235|FG002|Phase 1|Death|0|||
16858704|NCT01709305|37813236|FG003|Phase 1|Death|0|||
16858705|NCT01709305|37813237|FG004|Phase 1|Death|0|||
16858706|NCT01709305|37813233|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
16858707|NCT01709305|37813234|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
16858708|NCT01709305|37813235|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
16858709|NCT01709305|37813236|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
16858710|NCT01709305|37813237|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
16858711|NCT01709305|37813233|FG000|Phase 1|Laboratory Adverse Event|16|||
16858712|NCT01709305|37813234|FG001|Phase 1|Laboratory Adverse Event|0|||
16858713|NCT01709305|37813235|FG002|Phase 1|Laboratory Adverse Event|0|||
16858714|NCT01709305|37813236|FG003|Phase 1|Laboratory Adverse Event|0|||
16858715|NCT01709305|37813237|FG004|Phase 1|Laboratory Adverse Event|0|||
16858716|NCT01709305|37813233|FG000|Phase 1|Lost to Follow-up|147|||
16858717|NCT01709305|37813234|FG001|Phase 1|Lost to Follow-up|0|||
17127298|NCT02819440|38267557|FG001|Overall Study|Adverse Event|1|||
16858718|NCT01709305|37813235|FG002|Phase 1|Lost to Follow-up|0|||
16858719|NCT01709305|37813236|FG003|Phase 1|Lost to Follow-up|0|||
16858720|NCT01709305|37813237|FG004|Phase 1|Lost to Follow-up|0|||
16858721|NCT01709305|37813233|FG000|Phase 1|Travel, moving, etc.|30|||
16858722|NCT01709305|37813234|FG001|Phase 1|Travel, moving, etc.|0|||
16858723|NCT01709305|37813235|FG002|Phase 1|Travel, moving, etc.|0|||
16858724|NCT01709305|37813236|FG003|Phase 1|Travel, moving, etc.|0|||
16858725|NCT01709305|37813237|FG004|Phase 1|Travel, moving, etc.|0|||
16858726|NCT01709305|37813233|FG000|Phase 1|Physician Decision|13|||
16858727|NCT01709305|37813234|FG001|Phase 1|Physician Decision|0|||
16858728|NCT01709305|37813235|FG002|Phase 1|Physician Decision|0|||
16858729|NCT01709305|37813236|FG003|Phase 1|Physician Decision|0|||
16858730|NCT01709305|37813237|FG004|Phase 1|Physician Decision|0|||
16858731|NCT01709305|37813233|FG000|Phase 1|Protocol Violation|118|||
16858732|NCT01709305|37813234|FG001|Phase 1|Protocol Violation|0|||
16858733|NCT01709305|37813235|FG002|Phase 1|Protocol Violation|0|||
16858734|NCT01709305|37813236|FG003|Phase 1|Protocol Violation|0|||
16858735|NCT01709305|37813237|FG004|Phase 1|Protocol Violation|0|||
16858736|NCT01709305|37813233|FG000|Phase 1|Withdrawal by Subject|218|||
16858737|NCT01709305|37813234|FG001|Phase 1|Withdrawal by Subject|0|||
16858738|NCT01709305|37813235|FG002|Phase 1|Withdrawal by Subject|0|||
16858739|NCT01709305|37813236|FG003|Phase 1|Withdrawal by Subject|0|||
16858740|NCT01709305|37813237|FG004|Phase 1|Withdrawal by Subject|0|||
16858741|NCT01709305|37813233|FG000|Phase 2|Clinical Adverse Event|0|||
16858742|NCT01709305|37813234|FG001|Phase 2|Clinical Adverse Event|10|||
16858743|NCT01709305|37813235|FG002|Phase 2|Clinical Adverse Event|10|||
16858744|NCT01709305|37813236|FG003|Phase 2|Clinical Adverse Event|6|||
16858745|NCT01709305|37813237|FG004|Phase 2|Clinical Adverse Event|11|||
16858746|NCT01709305|37813233|FG000|Phase 2|Death|0|||
16858747|NCT01709305|37813234|FG001|Phase 2|Death|0|||
16858748|NCT01709305|37813235|FG002|Phase 2|Death|1|||
16858749|NCT01709305|37813236|FG003|Phase 2|Death|0|||
16858750|NCT01709305|37813237|FG004|Phase 2|Death|0|||
16858751|NCT01709305|37813233|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
16858752|NCT01709305|37813234|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
16858753|NCT01709305|37813235|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
16858754|NCT01709305|37813236|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
16858755|NCT01709305|37813237|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
16858756|NCT01709305|37813233|FG000|Phase 2|Laboratory Adverse Event|0|||
16858757|NCT01709305|37813234|FG001|Phase 2|Laboratory Adverse Event|1|||
16858758|NCT01709305|37813235|FG002|Phase 2|Laboratory Adverse Event|0|||
16858759|NCT01709305|37813236|FG003|Phase 2|Laboratory Adverse Event|1|||
16858760|NCT01709305|37813237|FG004|Phase 2|Laboratory Adverse Event|1|||
16858761|NCT01709305|37813233|FG000|Phase 2|Lost to Follow-up|0|||
16858762|NCT01709305|37813234|FG001|Phase 2|Lost to Follow-up|10|||
16858763|NCT01709305|37813235|FG002|Phase 2|Lost to Follow-up|6|||
16858764|NCT01709305|37813236|FG003|Phase 2|Lost to Follow-up|9|||
16858765|NCT01709305|37813237|FG004|Phase 2|Lost to Follow-up|5|||
16858766|NCT01709305|37813233|FG000|Phase 2|Travel, moving, etc.|0|||
16858767|NCT01709305|37813234|FG001|Phase 2|Travel, moving, etc.|2|||
16858768|NCT01709305|37813235|FG002|Phase 2|Travel, moving, etc.|3|||
16858769|NCT01709305|37813236|FG003|Phase 2|Travel, moving, etc.|3|||
16858770|NCT01709305|37813237|FG004|Phase 2|Travel, moving, etc.|5|||
16858771|NCT01709305|37813233|FG000|Phase 2|Physician Decision|0|||
16858772|NCT01709305|37813234|FG001|Phase 2|Physician Decision|2|||
16858773|NCT01709305|37813235|FG002|Phase 2|Physician Decision|0|||
16858774|NCT01709305|37813236|FG003|Phase 2|Physician Decision|1|||
16858775|NCT01709305|37813237|FG004|Phase 2|Physician Decision|2|||
16858776|NCT01709305|37813233|FG000|Phase 2|Protocol Violation|0|||
16858777|NCT01709305|37813234|FG001|Phase 2|Protocol Violation|19|||
16943149|NCT01172938|38087686|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16858778|NCT01709305|37813235|FG002|Phase 2|Protocol Violation|19|||
16858779|NCT01709305|37813236|FG003|Phase 2|Protocol Violation|13|||
16858780|NCT01709305|37813237|FG004|Phase 2|Protocol Violation|9|||
16858781|NCT01709305|37813233|FG000|Phase 2|Withdrawal by Subject|0|||
16943150|NCT01172938|38087687|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16943151|NCT01172938|38087688|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16943152|NCT01172938|38087689|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16943153|NCT01172938|38087681|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
16943154|NCT01172938|38087682|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
16943155|NCT01172938|38087683|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
16858782|NCT01709305|37813234|FG001|Phase 2|Withdrawal by Subject|8|||
16858783|NCT01709305|37813235|FG002|Phase 2|Withdrawal by Subject|6|||
16858784|NCT01709305|37813236|FG003|Phase 2|Withdrawal by Subject|15|||
16858785|NCT01709305|37813237|FG004|Phase 2|Withdrawal by Subject|12|||
16858786|NCT01684423|37813257|FG000|Overall Study|Withdrawal by Subject|0|||
16858787|NCT01684423|37813258|FG001|Overall Study|Withdrawal by Subject|0|||
16858788|NCT01684423|37813259|FG002|Overall Study|Withdrawal by Subject|1|||
16858789|NCT01684423|37813260|FG003|Overall Study|Withdrawal by Subject|0|||
16858790|NCT01684423|37813261|FG004|Overall Study|Withdrawal by Subject|0|||
16858791|NCT01709227|37813277|FG000|Overall Study|Physician Decision|1|||
16858792|NCT01709227|37813278|FG001|Overall Study|Physician Decision|0|||
16858793|NCT01709227|37813277|FG000|Overall Study|Pleural Peritoneal communication|0|||
16858794|NCT01709227|37813278|FG001|Overall Study|Pleural Peritoneal communication|9|||
16858795|NCT01684033|37813285|FG000|Period 1, First 30 Days|Adverse Event|1|||
16858796|NCT01684033|37813286|FG001|Period 1, First 30 Days|Adverse Event|1|||
16858797|NCT01684033|37813285|FG000|Period 1, First 30 Days|Noncompliance|1|||
16858798|NCT01684033|37813286|FG001|Period 1, First 30 Days|Noncompliance|0|||
16858799|NCT01684033|37813285|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
16858800|NCT01684033|37813286|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
16858801|NCT01684033|37813285|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
16858802|NCT01684033|37813286|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
16858803|NCT01684033|37813285|FG000|Period 2, Second 30 Days|Adverse Event|1|||
16858804|NCT01684033|37813286|FG001|Period 2, Second 30 Days|Adverse Event|0|||
16858805|NCT01903811|37813327|FG000|Overall Study|No measurable disease|1|||
16858806|NCT01903811|37813328|FG001|Overall Study|No measurable disease|1|||
16858807|NCT01903811|37813327|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
16858808|NCT01903811|37813328|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
16858809|NCT01903811|37813327|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
16858810|NCT01903811|37813328|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
16858811|NCT01903811|37813327|FG000|Overall Study|Withdrawal by Subject|0|||
16858812|NCT01903811|37813328|FG001|Overall Study|Withdrawal by Subject|1|||
16858813|NCT01709149|37813345|FG000|Open-label Lead-in Phase|Adverse Event|109|||
16858814|NCT01709149|37813346|FG001|Open-label Lead-in Phase|Adverse Event|0|||
16858815|NCT01709149|37813347|FG002|Open-label Lead-in Phase|Adverse Event|0|||
16858816|NCT01709149|37813345|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
16943156|NCT01172938|38087684|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
16943157|NCT01172938|38087685|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
16943158|NCT01172938|38087686|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
16943159|NCT01172938|38087687|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
16943160|NCT01172938|38087688|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
16943161|NCT01172938|38087689|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
16943162|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16943163|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
16943164|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
16943165|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16943166|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16943167|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16943168|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16943169|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
16943170|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
16943171|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16943172|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
16943173|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
16943174|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16943175|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
17127299|NCT02819440|38267556|FG000|Overall Study|Lost to Follow-up|1|||
16858817|NCT01709149|37813346|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
16858818|NCT01709149|37813347|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
16858819|NCT01709149|37813345|FG000|Open-label Lead-in Phase|Death|1|||
16858820|NCT01709149|37813346|FG001|Open-label Lead-in Phase|Death|0|||
16858821|NCT01709149|37813347|FG002|Open-label Lead-in Phase|Death|0|||
16858822|NCT01709149|37813345|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
16858823|NCT01709149|37813346|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
16858824|NCT01709149|37813347|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
16858825|NCT01709149|37813345|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16858826|NCT01709149|37813346|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
16943176|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16858827|NCT01709149|37813347|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
16858828|NCT01709149|37813345|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16858829|NCT01709149|37813346|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
16858830|NCT01709149|37813347|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
16858831|NCT01709149|37813345|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16858832|NCT01709149|37813346|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
16858833|NCT01709149|37813347|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
16858834|NCT01709149|37813345|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
16858835|NCT01709149|37813346|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
16858836|NCT01709149|37813347|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
16858837|NCT01709149|37813345|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
16858838|NCT01709149|37813346|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
16858839|NCT01709149|37813347|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
16858840|NCT01709149|37813345|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16858841|NCT01709149|37813346|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
16858842|NCT01709149|37813347|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16858843|NCT01568593|37813356|FG000|Overall Study|Lack of Efficacy|4|||
16858844|NCT01568593|37813357|FG001|Overall Study|Lack of Efficacy|1|||
16858845|NCT01568593|37813356|FG000|Overall Study|Adverse Event|3|||
16858846|NCT01568593|37813357|FG001|Overall Study|Adverse Event|2|||
16858847|NCT01683565|37813365|FG000|Overall Study|Lost to Follow-up|2|||
16943177|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16943178|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
16943179|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16943180|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16943181|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16943182|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
16943183|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16943184|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16858848|NCT01683565|37813366|FG001|Overall Study|Lost to Follow-up|0|||
16858849|NCT01683565|37813365|FG000|Overall Study|Discontinued Intervention|1|||
16858850|NCT01683565|37813366|FG001|Overall Study|Discontinued Intervention|1|||
16858851|NCT01903031|37813390|FG000|Overall Study|Not Able to Attend Clinic|1|||
16858852|NCT01903031|37813391|FG001|Overall Study|Not Able to Attend Clinic|1|||
16858853|NCT01903031|37813392|FG002|Overall Study|Not Able to Attend Clinic|0|||
16858854|NCT01903031|37813390|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
16858855|NCT01903031|37813391|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
16858856|NCT01903031|37813392|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
16858857|NCT01903031|37813390|FG000|Overall Study|Adverse Event|0|||
16858858|NCT01903031|37813391|FG001|Overall Study|Adverse Event|1|||
16858859|NCT01903031|37813392|FG002|Overall Study|Adverse Event|0|||
16858860|NCT01903031|37813390|FG000|Overall Study|Withdrawal by Subject|0|||
16858861|NCT01903031|37813391|FG001|Overall Study|Withdrawal by Subject|1|||
16858862|NCT01903031|37813392|FG002|Overall Study|Withdrawal by Subject|1|||
16858863|NCT01903031|37813390|FG000|Overall Study|Protocol Violation|0|||
16858864|NCT01903031|37813391|FG001|Overall Study|Protocol Violation|0|||
16858865|NCT01903031|37813392|FG002|Overall Study|Protocol Violation|2|||
16858866|NCT01903031|37813390|FG000|Overall Study|Lost to Follow-up|0|||
16858867|NCT01903031|37813391|FG001|Overall Study|Lost to Follow-up|0|||
16858868|NCT01903031|37813392|FG002|Overall Study|Lost to Follow-up|1|||
16858869|NCT01903031|37813390|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
16858870|NCT01903031|37813391|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
16858871|NCT01903031|37813392|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
16858872|NCT01616693|37813424|FG000|Evaluated for Safety|Physician Decision|1|||
16858873|NCT01616693|37813425|FG001|Evaluated for Safety|Physician Decision|0|||
16858874|NCT01616693|37813426|FG002|Evaluated for Safety|Physician Decision|1|||
16858875|NCT01616693|37813427|FG003|Evaluated for Safety|Physician Decision|0|||
16858876|NCT01616693|37813424|FG000|Received Both Vaccines|Adverse Event|2|||
16858877|NCT01616693|37813425|FG001|Received Both Vaccines|Adverse Event|0|||
16858878|NCT01616693|37813426|FG002|Received Both Vaccines|Adverse Event|0|||
16858879|NCT01616693|37813427|FG003|Received Both Vaccines|Adverse Event|0|||
16858880|NCT01616693|37813424|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
16858881|NCT01616693|37813425|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
16858882|NCT01616693|37813426|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
16858883|NCT01616693|37813427|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
16943185|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16943186|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16943187|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16943188|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16943189|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16943190|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
16858884|NCT01616693|37813424|FG000|Received Both Vaccines|Lost to Follow-up|4|||
16858885|NCT01616693|37813425|FG001|Received Both Vaccines|Lost to Follow-up|3|||
16943191|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
16943192|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
17127300|NCT02819440|38267557|FG001|Overall Study|Lost to Follow-up|3|||
16858886|NCT01616693|37813426|FG002|Received Both Vaccines|Lost to Follow-up|4|||
16858887|NCT01616693|37813427|FG003|Received Both Vaccines|Lost to Follow-up|4|||
16858888|NCT01616693|37813424|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
16858889|NCT01616693|37813425|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
16858890|NCT01616693|37813426|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
16858891|NCT01616693|37813427|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
16858892|NCT04062448|37813494|FG000|Overall Study|Lost to Follow-up|1|||
16858893|NCT04062448|37813494|FG000|Overall Study|Withdrawal by Subject|1|||
16858894|NCT04062448|37813494|FG000|Overall Study|Ongoing|14|||
16858895|NCT01616459|37813538|FG000|Overall Study|Adverse Event|1|||
16858896|NCT01616459|37813539|FG001|Overall Study|Adverse Event|1|||
16858897|NCT01616459|37813540|FG002|Overall Study|Adverse Event|2|||
16858898|NCT01616459|37813541|FG003|Overall Study|Adverse Event|0|||
16858899|NCT01616459|37813538|FG000|Overall Study|Lost to Follow-up|1|||
16858900|NCT01616459|37813539|FG001|Overall Study|Lost to Follow-up|11|||
16858901|NCT01616459|37813540|FG002|Overall Study|Lost to Follow-up|3|||
16858902|NCT01616459|37813541|FG003|Overall Study|Lost to Follow-up|2|||
16858903|NCT01616459|37813538|FG000|Overall Study|Protocol Violation|0|||
16858904|NCT01616459|37813539|FG001|Overall Study|Protocol Violation|0|||
16858905|NCT01616459|37813540|FG002|Overall Study|Protocol Violation|0|||
16858906|NCT01616459|37813541|FG003|Overall Study|Protocol Violation|2|||
16858907|NCT01616459|37813538|FG000|Overall Study|Withdrawal by Subject|2|||
16858908|NCT01616459|37813539|FG001|Overall Study|Withdrawal by Subject|4|||
16858909|NCT01616459|37813540|FG002|Overall Study|Withdrawal by Subject|4|||
16858910|NCT01616459|37813541|FG003|Overall Study|Withdrawal by Subject|4|||
16858911|NCT01616459|37813538|FG000|Overall Study|Other reason|0|||
16858912|NCT01616459|37813539|FG001|Overall Study|Other reason|1|||
16858913|NCT01616459|37813540|FG002|Overall Study|Other reason|1|||
16858914|NCT01616459|37813541|FG003|Overall Study|Other reason|0|||
16858915|NCT01919801|37813558|FG000|Overall Study|Withdrawal by Subject|1|||
16858916|NCT01919801|37813559|FG001|Overall Study|Withdrawal by Subject|0|||
16858917|NCT01919801|37813558|FG000|Overall Study|Physician Decision|0|||
16858918|NCT01919801|37813559|FG001|Overall Study|Physician Decision|1|||
16858919|NCT01919801|37813558|FG000|Overall Study|Lost to Follow-up|0|||
16858920|NCT01919801|37813559|FG001|Overall Study|Lost to Follow-up|1|||
16858921|NCT01919801|37813558|FG000|Overall Study|Other|0|||
16858922|NCT01919801|37813559|FG001|Overall Study|Other|1|||
16858923|NCT01919723|37813567|FG000|Overall Study|Blood Samples Hemolyzed|2|||
16858924|NCT01919723|37813568|FG001|Overall Study|Blood Samples Hemolyzed|2|||
16858925|NCT01919489|37813576|FG000|Overall Study|Rejected the need of injections|4|||
16858926|NCT01919489|37813577|FG001|Overall Study|Rejected the need of injections|7|||
16858927|NCT01919489|37813576|FG000|Overall Study|Adverse Event|10|||
16858928|NCT01919489|37813577|FG001|Overall Study|Adverse Event|0|||
16858929|NCT01919489|37813576|FG000|Overall Study|Hospital readmission|2|||
16858930|NCT01919489|37813577|FG001|Overall Study|Hospital readmission|9|||
16858931|NCT01919489|37813576|FG000|Overall Study|Death|2|||
16858932|NCT01919489|37813577|FG001|Overall Study|Death|1|||
16858933|NCT01919489|37813576|FG000|Overall Study|Lost to Follow-up|38|||
16858934|NCT01919489|37813577|FG001|Overall Study|Lost to Follow-up|27|||
16858935|NCT01919411|37813585|FG000|Overall Study|Lost to Follow-up|2|||
16858936|NCT01919411|37813586|FG001|Overall Study|Lost to Follow-up|4|||
16858937|NCT01919411|37813585|FG000|Overall Study|Physician Decision|1|||
16858938|NCT01919411|37813586|FG001|Overall Study|Physician Decision|0|||
16858939|NCT01919411|37813585|FG000|Overall Study|Protocol Violation|2|||
16858940|NCT01919411|37813586|FG001|Overall Study|Protocol Violation|1|||
16858941|NCT01901393|37813594|FG000|Overall Study|Adverse Event|1|||
16858942|NCT01901393|37813595|FG001|Overall Study|Adverse Event|0|||
16858943|NCT01890707|37813603|FG000|Overall Study|Lost to Follow-up|1|||
16858944|NCT01890707|37813604|FG001|Overall Study|Lost to Follow-up|1|||
16858945|NCT01900691|37813610|FG000|Overall Study|Death|7|||
16858946|NCT01900691|37813610|FG000|Overall Study|Lost to Follow-up|4|||
16858947|NCT01900691|37813610|FG000|Overall Study|Study Device Not Placed|3|||
16858948|NCT01900691|37813610|FG000|Overall Study|Non study stent placed|2|||
16858949|NCT01900691|37813610|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
16858950|NCT01900691|37813610|FG000|Overall Study|Complete stent migration through digestive tract|1|||
16858951|NCT01890473|37813617|FG000|Overall Study|Lost to Follow-up|1|||
16858952|NCT01890473|37813618|FG001|Overall Study|Lost to Follow-up|0|||
16858953|NCT01890473|37813617|FG000|Overall Study|Poor/non-compliance|1|||
16858954|NCT01890473|37813618|FG001|Overall Study|Poor/non-compliance|0|||
16858955|NCT01889069|37813628|FG000|Overall Study|Death|18|||
16858956|NCT01889069|37813628|FG000|Overall Study|Progression of Disease|14|||
16858957|NCT01889069|37813628|FG000|Overall Study|Lost to Follow-up|6|||
16858958|NCT01889069|37813628|FG000|Overall Study|Other|4|||
16858959|NCT01889069|37813628|FG000|Overall Study|Consent Withdrawal|3|||
16858960|NCT02533180|37813640|FG000|Overall Study|Death|0|||
16858961|NCT02533180|37813641|FG001|Overall Study|Death|1|||
16943193|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16943194|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16943195|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16943196|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
16943197|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
16943198|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16943199|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16943200|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
16943201|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16943202|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16943203|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16943204|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16943205|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16943206|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16943207|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16943208|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
16943209|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
16943210|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16943211|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16943212|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16943213|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16943214|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
16943215|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16943216|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16858962|NCT02533180|37813640|FG000|Overall Study|Lost to Follow-up|0|||
16858963|NCT02533180|37813641|FG001|Overall Study|Lost to Follow-up|1|||
16858964|NCT02533180|37813640|FG000|Overall Study|Physician Decision|0|||
16858965|NCT02533180|37813641|FG001|Overall Study|Physician Decision|1|||
16858966|NCT02533180|37813640|FG000|Overall Study|Withdrawal by Subject|2|||
16858967|NCT02533180|37813641|FG001|Overall Study|Withdrawal by Subject|4|||
16858968|NCT02533180|37813640|FG000|Overall Study|Screen Failure|37|||
16943217|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
16943218|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16943219|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16943220|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16943221|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16943222|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16943223|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16943224|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
16943225|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16943226|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
16943227|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16943228|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16943229|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16943230|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16943231|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16943232|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16943233|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16943234|NCT01172938|38087681|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16943235|NCT01172938|38087682|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16943236|NCT01172938|38087683|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16943237|NCT01172938|38087684|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16943238|NCT01172938|38087685|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16943239|NCT01172938|38087686|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16943240|NCT01172938|38087687|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16943241|NCT01172938|38087688|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16943242|NCT01172938|38087689|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
16943243|NCT01172938|38087681|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16943244|NCT01172938|38087682|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
16943245|NCT01172938|38087683|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
16943246|NCT01172938|38087684|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16943247|NCT01172938|38087685|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16943248|NCT01172938|38087686|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16943249|NCT01172938|38087687|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16943250|NCT01172938|38087688|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
16943251|NCT01172938|38087689|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
16943252|NCT01172938|38087681|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16943253|NCT01172938|38087682|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
16943254|NCT01172938|38087683|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
16943255|NCT01172938|38087684|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16943256|NCT01172938|38087685|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16943257|NCT01172938|38087686|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16943258|NCT01172938|38087687|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
17127301|NCT02819440|38267556|FG000|Overall Study|Withdrawal by Subject|9|||
16858969|NCT02533180|37813641|FG001|Overall Study|Screen Failure|0|||
16858970|NCT02533180|37813640|FG000|Overall Study|Protocol Deviation|0|||
16858971|NCT02533180|37813641|FG001|Overall Study|Protocol Deviation|1|||
16858972|NCT02533180|37813640|FG000|Overall Study|On Study|0|||
16858973|NCT02533180|37813641|FG001|Overall Study|On Study|39|||
16858974|NCT01739348|37813672|FG000|Part I (Base Study)|Adverse Event|41|||
16858975|NCT01739348|37813673|FG001|Part I (Base Study)|Adverse Event|52|||
16858976|NCT01739348|37813674|FG002|Part I (Base Study)|Adverse Event|8|||
16858977|NCT01739348|37813675|FG003|Part I (Base Study)|Adverse Event|33|||
17127302|NCT02819440|38267557|FG001|Overall Study|Withdrawal by Subject|8|||
16858978|NCT01739348|37813672|FG000|Part I (Base Study)|Death|10|||
16858979|NCT01739348|37813673|FG001|Part I (Base Study)|Death|7|||
16858980|NCT01739348|37813674|FG002|Part I (Base Study)|Death|2|||
16858981|NCT01739348|37813675|FG003|Part I (Base Study)|Death|8|||
16858982|NCT01739348|37813672|FG000|Part I (Base Study)|Lack of Efficacy|3|||
16858983|NCT01739348|37813673|FG001|Part I (Base Study)|Lack of Efficacy|8|||
16858984|NCT01739348|37813674|FG002|Part I (Base Study)|Lack of Efficacy|0|||
16858985|NCT01739348|37813675|FG003|Part I (Base Study)|Lack of Efficacy|7|||
16858986|NCT01739348|37813672|FG000|Part I (Base Study)|Lost to Follow-up|4|||
16858987|NCT01739348|37813673|FG001|Part I (Base Study)|Lost to Follow-up|2|||
16858988|NCT01739348|37813674|FG002|Part I (Base Study)|Lost to Follow-up|4|||
16858989|NCT01739348|37813675|FG003|Part I (Base Study)|Lost to Follow-up|4|||
16858990|NCT01739348|37813672|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
16858991|NCT01739348|37813673|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
16858992|NCT01739348|37813674|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
16858993|NCT01739348|37813675|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
16858994|NCT01739348|37813672|FG000|Part I (Base Study)|Physician Decision|10|||
16858995|NCT01739348|37813673|FG001|Part I (Base Study)|Physician Decision|7|||
16858996|NCT01739348|37813674|FG002|Part I (Base Study)|Physician Decision|1|||
16858997|NCT01739348|37813675|FG003|Part I (Base Study)|Physician Decision|4|||
16858998|NCT01739348|37813672|FG000|Part I (Base Study)|Protocol Violation|2|||
16858999|NCT01739348|37813673|FG001|Part I (Base Study)|Protocol Violation|0|||
16859000|NCT01739348|37813674|FG002|Part I (Base Study)|Protocol Violation|1|||
16859001|NCT01739348|37813675|FG003|Part I (Base Study)|Protocol Violation|2|||
16859002|NCT01739348|37813672|FG000|Part I (Base Study)|Screen Failure|2|||
16859003|NCT01739348|37813673|FG001|Part I (Base Study)|Screen Failure|0|||
16859004|NCT01739348|37813674|FG002|Part I (Base Study)|Screen Failure|0|||
16859005|NCT01739348|37813675|FG003|Part I (Base Study)|Screen Failure|0|||
16859006|NCT01739348|37813672|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
16859007|NCT01739348|37813673|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
16859008|NCT01739348|37813674|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
16859009|NCT01739348|37813675|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
16859010|NCT01739348|37813672|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
16859011|NCT01739348|37813673|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
16859012|NCT01739348|37813674|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
16859013|NCT01739348|37813675|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
16859014|NCT01739348|37813672|FG000|Part I (Base Study)|Participant Moved|4|||
16859015|NCT01739348|37813673|FG001|Part I (Base Study)|Participant Moved|3|||
16859016|NCT01739348|37813674|FG002|Part I (Base Study)|Participant Moved|1|||
16859017|NCT01739348|37813675|FG003|Part I (Base Study)|Participant Moved|7|||
16859018|NCT01739348|37813672|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
16859019|NCT01739348|37813673|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
16859020|NCT01739348|37813674|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
16859021|NCT01739348|37813675|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
16859022|NCT01739348|37813672|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
16859023|NCT01739348|37813673|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
16859024|NCT01739348|37813674|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
16859025|NCT01739348|37813675|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
16859026|NCT01739348|37813672|FG000|Part II (Extension Study)|Adverse Event|10|||
16859027|NCT01739348|37813673|FG001|Part II (Extension Study)|Adverse Event|11|||
16859028|NCT01739348|37813674|FG002|Part II (Extension Study)|Adverse Event|7|||
16859029|NCT01739348|37813675|FG003|Part II (Extension Study)|Adverse Event|26|||
16859030|NCT01739348|37813672|FG000|Part II (Extension Study)|Death|3|||
16859031|NCT01739348|37813673|FG001|Part II (Extension Study)|Death|3|||
16859032|NCT01739348|37813674|FG002|Part II (Extension Study)|Death|2|||
16859033|NCT01739348|37813675|FG003|Part II (Extension Study)|Death|6|||
17127303|NCT03814720|38267568|FG000|Overall Study|Lost to Follow-up|0|||
16943259|NCT01172938|38087688|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
16943260|NCT01172938|38087689|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
16943261|NCT01172938|38087681|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
16943262|NCT01172938|38087682|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
16943263|NCT01172938|38087683|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
16943264|NCT01172938|38087684|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
16943265|NCT01172938|38087685|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
16943266|NCT01172938|38087686|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
16943267|NCT01172938|38087687|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
16943268|NCT01172938|38087688|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
16943269|NCT01172938|38087689|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
16943270|NCT01172938|38087681|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16943271|NCT01172938|38087682|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
16943272|NCT01172938|38087683|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16943273|NCT01172938|38087684|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16943274|NCT01172938|38087685|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16943275|NCT01172938|38087686|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16943276|NCT01172938|38087687|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16943277|NCT01172938|38087688|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16943278|NCT01172938|38087689|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16943279|NCT01172938|38087681|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16943280|NCT01172938|38087682|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16943281|NCT01172938|38087683|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
16943282|NCT01172938|38087684|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16943283|NCT01172938|38087685|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16943284|NCT01172938|38087686|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16943285|NCT01172938|38087687|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16943286|NCT01172938|38087688|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16943287|NCT01172938|38087689|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16943288|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16943289|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
16943290|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
16943291|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16943292|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16943293|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16943294|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16943295|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
16943296|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16943297|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16943298|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
16943299|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
16943300|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16943301|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16943302|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16943303|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16943304|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
16943305|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
16943306|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16943307|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
16943308|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
16943309|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16943310|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16943311|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16943312|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16943313|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
16943314|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
16943315|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16943316|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16943317|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
16943318|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16943319|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16943320|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16943321|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16943322|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16943323|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
16943324|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16943325|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16943326|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16943327|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16943328|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16943329|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16943330|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16943331|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
16943332|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16943333|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16943334|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16943335|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
16943336|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16943337|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16943338|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16943339|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16943340|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
16943341|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
16943342|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16943343|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16943344|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
16943345|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16943346|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16943347|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16943348|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16943349|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16943350|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16943351|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16943352|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
16943353|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16943354|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16943355|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16943356|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16943357|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16943358|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
17127304|NCT03814720|38267569|FG001|Overall Study|Lost to Follow-up|1|||
17127305|NCT03814720|38267570|FG002|Overall Study|Lost to Follow-up|0|||
16943359|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16859034|NCT01739348|37813672|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
16859035|NCT01739348|37813673|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
16859036|NCT01739348|37813674|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
16859037|NCT01739348|37813675|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
16859038|NCT01739348|37813672|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
16859039|NCT01739348|37813673|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
16859040|NCT01739348|37813674|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
16859041|NCT01739348|37813675|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
16859042|NCT01739348|37813672|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
16859043|NCT01739348|37813673|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
16859044|NCT01739348|37813674|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
16859045|NCT01739348|37813675|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
16859046|NCT01739348|37813672|FG000|Part II (Extension Study)|Physician Decision|7|||
16859047|NCT01739348|37813673|FG001|Part II (Extension Study)|Physician Decision|11|||
16859048|NCT01739348|37813674|FG002|Part II (Extension Study)|Physician Decision|6|||
16859049|NCT01739348|37813675|FG003|Part II (Extension Study)|Physician Decision|12|||
16859050|NCT01739348|37813672|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
17127306|NCT03814720|38267571|FG003|Overall Study|Lost to Follow-up|0|||
16859051|NCT01739348|37813673|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
16859052|NCT01739348|37813674|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
16859053|NCT01739348|37813675|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
16859054|NCT01739348|37813672|FG000|Part II (Extension Study)|Participant Moved|3|||
16859055|NCT01739348|37813673|FG001|Part II (Extension Study)|Participant Moved|3|||
16859056|NCT01739348|37813674|FG002|Part II (Extension Study)|Participant Moved|0|||
16859057|NCT01739348|37813675|FG003|Part II (Extension Study)|Participant Moved|3|||
16859058|NCT01739348|37813672|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
16859059|NCT01739348|37813673|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
16859060|NCT01739348|37813674|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
16859061|NCT01739348|37813675|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
16859062|NCT01739348|37813672|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
16859063|NCT01739348|37813673|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
16859064|NCT01739348|37813674|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
16859065|NCT01739348|37813675|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
16859066|NCT01738646|37813707|FG000|Overall Study|Still Receiving Treatment|2|||
16859067|NCT01716104|37813714|FG000|Overall Study|Do not meet inclusion criteria|6|||
16859068|NCT01716104|37813715|FG001|Overall Study|Do not meet inclusion criteria|7|||
16859069|NCT04426695|37813795|FG000|Overall Study|Death|2|||
16859070|NCT04426695|37813796|FG001|Overall Study|Death|0|||
16859071|NCT04426695|37813797|FG002|Overall Study|Death|1|||
16859072|NCT04426695|37813798|FG003|Overall Study|Death|27|||
16859073|NCT04426695|37813799|FG004|Overall Study|Death|25|||
16859074|NCT04426695|37813800|FG005|Overall Study|Death|21|||
16859075|NCT04426695|37813801|FG006|Overall Study|Death|42|||
16859076|NCT04426695|37813802|FG007|Overall Study|Death|23|||
16859077|NCT04426695|37813803|FG008|Overall Study|Death|37|||
16859078|NCT04426695|37813804|FG009|Overall Study|Death|14|||
16859079|NCT04426695|37813805|FG010|Overall Study|Death|8|||
16859080|NCT04426695|37813806|FG011|Overall Study|Death|7|||
16859081|NCT04426695|37813807|FG012|Overall Study|Death|13|||
16859082|NCT04426695|37813808|FG013|Overall Study|Death|25|||
16859083|NCT04426695|37813809|FG014|Overall Study|Death|19|||
16859084|NCT04426695|37813810|FG015|Overall Study|Death|7|||
16859085|NCT04426695|37813811|FG016|Overall Study|Death|8|||
16859086|NCT04426695|37813812|FG017|Overall Study|Death|4|||
16859087|NCT04426695|37813795|FG000|Overall Study|Lost to Follow-up|2|||
16859088|NCT04426695|37813796|FG001|Overall Study|Lost to Follow-up|4|||
16859089|NCT04426695|37813797|FG002|Overall Study|Lost to Follow-up|1|||
16859090|NCT04426695|37813798|FG003|Overall Study|Lost to Follow-up|19|||
16859091|NCT04426695|37813799|FG004|Overall Study|Lost to Follow-up|10|||
16859092|NCT04426695|37813800|FG005|Overall Study|Lost to Follow-up|14|||
16859093|NCT04426695|37813801|FG006|Overall Study|Lost to Follow-up|5|||
16859094|NCT04426695|37813802|FG007|Overall Study|Lost to Follow-up|14|||
16859095|NCT04426695|37813803|FG008|Overall Study|Lost to Follow-up|10|||
16859096|NCT04426695|37813804|FG009|Overall Study|Lost to Follow-up|11|||
16859097|NCT04426695|37813805|FG010|Overall Study|Lost to Follow-up|12|||
16859098|NCT04426695|37813806|FG011|Overall Study|Lost to Follow-up|6|||
16859099|NCT04426695|37813807|FG012|Overall Study|Lost to Follow-up|2|||
16859100|NCT04426695|37813808|FG013|Overall Study|Lost to Follow-up|2|||
16859101|NCT04426695|37813809|FG014|Overall Study|Lost to Follow-up|2|||
16859102|NCT04426695|37813810|FG015|Overall Study|Lost to Follow-up|0|||
16859103|NCT04426695|37813811|FG016|Overall Study|Lost to Follow-up|0|||
16859104|NCT04426695|37813812|FG017|Overall Study|Lost to Follow-up|0|||
16859105|NCT04426695|37813795|FG000|Overall Study|Participant Decision|1|||
16859106|NCT04426695|37813796|FG001|Overall Study|Participant Decision|2|||
16859107|NCT04426695|37813797|FG002|Overall Study|Participant Decision|2|||
16859108|NCT04426695|37813798|FG003|Overall Study|Participant Decision|12|||
16859109|NCT04426695|37813799|FG004|Overall Study|Participant Decision|18|||
16859110|NCT04426695|37813800|FG005|Overall Study|Participant Decision|22|||
16859111|NCT04426695|37813801|FG006|Overall Study|Participant Decision|13|||
16859112|NCT04426695|37813802|FG007|Overall Study|Participant Decision|13|||
16859113|NCT04426695|37813803|FG008|Overall Study|Participant Decision|10|||
16859114|NCT04426695|37813804|FG009|Overall Study|Participant Decision|15|||
16859115|NCT04426695|37813805|FG010|Overall Study|Participant Decision|16|||
16859116|NCT04426695|37813806|FG011|Overall Study|Participant Decision|17|||
16859117|NCT04426695|37813807|FG012|Overall Study|Participant Decision|2|||
16859118|NCT04426695|37813808|FG013|Overall Study|Participant Decision|1|||
16859119|NCT04426695|37813809|FG014|Overall Study|Participant Decision|2|||
16859120|NCT04426695|37813810|FG015|Overall Study|Participant Decision|0|||
16859121|NCT04426695|37813811|FG016|Overall Study|Participant Decision|0|||
16859122|NCT04426695|37813812|FG017|Overall Study|Participant Decision|0|||
16859123|NCT04426695|37813795|FG000|Overall Study|Adverse Event|0|||
16859124|NCT04426695|37813796|FG001|Overall Study|Adverse Event|0|||
16859125|NCT04426695|37813797|FG002|Overall Study|Adverse Event|0|||
16859126|NCT04426695|37813798|FG003|Overall Study|Adverse Event|0|||
16859127|NCT04426695|37813799|FG004|Overall Study|Adverse Event|0|||
16859128|NCT04426695|37813800|FG005|Overall Study|Adverse Event|0|||
16859129|NCT04426695|37813801|FG006|Overall Study|Adverse Event|0|||
16859130|NCT04426695|37813802|FG007|Overall Study|Adverse Event|1|||
16859131|NCT04426695|37813803|FG008|Overall Study|Adverse Event|0|||
16859132|NCT04426695|37813804|FG009|Overall Study|Adverse Event|0|||
16859133|NCT04426695|37813805|FG010|Overall Study|Adverse Event|1|||
16859134|NCT04426695|37813806|FG011|Overall Study|Adverse Event|1|||
16859135|NCT04426695|37813807|FG012|Overall Study|Adverse Event|0|||
16859136|NCT04426695|37813808|FG013|Overall Study|Adverse Event|0|||
16859137|NCT04426695|37813809|FG014|Overall Study|Adverse Event|0|||
16859138|NCT04426695|37813810|FG015|Overall Study|Adverse Event|0|||
16859139|NCT04426695|37813811|FG016|Overall Study|Adverse Event|0|||
16859140|NCT04426695|37813812|FG017|Overall Study|Adverse Event|0|||
16859141|NCT04426695|37813795|FG000|Overall Study|Sponsor Request|0|||
16859142|NCT04426695|37813796|FG001|Overall Study|Sponsor Request|0|||
16859143|NCT04426695|37813797|FG002|Overall Study|Sponsor Request|0|||
16859144|NCT04426695|37813798|FG003|Overall Study|Sponsor Request|0|||
16859145|NCT04426695|37813799|FG004|Overall Study|Sponsor Request|0|||
16859146|NCT04426695|37813800|FG005|Overall Study|Sponsor Request|0|||
16859147|NCT04426695|37813801|FG006|Overall Study|Sponsor Request|1|||
16859148|NCT04426695|37813802|FG007|Overall Study|Sponsor Request|0|||
16859149|NCT04426695|37813803|FG008|Overall Study|Sponsor Request|0|||
16859150|NCT04426695|37813804|FG009|Overall Study|Sponsor Request|0|||
16859151|NCT04426695|37813805|FG010|Overall Study|Sponsor Request|0|||
16859152|NCT04426695|37813806|FG011|Overall Study|Sponsor Request|0|||
16859153|NCT04426695|37813807|FG012|Overall Study|Sponsor Request|0|||
16859154|NCT04426695|37813808|FG013|Overall Study|Sponsor Request|0|||
16859155|NCT04426695|37813809|FG014|Overall Study|Sponsor Request|0|||
16859156|NCT04426695|37813810|FG015|Overall Study|Sponsor Request|0|||
16859157|NCT04426695|37813811|FG016|Overall Study|Sponsor Request|0|||
16859158|NCT04426695|37813812|FG017|Overall Study|Sponsor Request|0|||
16859159|NCT04426695|37813795|FG000|Overall Study|Physician Decision|0|||
16859160|NCT04426695|37813796|FG001|Overall Study|Physician Decision|0|||
16859161|NCT04426695|37813797|FG002|Overall Study|Physician Decision|0|||
16859162|NCT04426695|37813798|FG003|Overall Study|Physician Decision|0|||
16859163|NCT04426695|37813799|FG004|Overall Study|Physician Decision|0|||
16859164|NCT04426695|37813800|FG005|Overall Study|Physician Decision|0|||
16859165|NCT04426695|37813801|FG006|Overall Study|Physician Decision|0|||
16859166|NCT04426695|37813802|FG007|Overall Study|Physician Decision|0|||
16859167|NCT04426695|37813803|FG008|Overall Study|Physician Decision|0|||
16859168|NCT04426695|37813804|FG009|Overall Study|Physician Decision|1|||
16859169|NCT04426695|37813805|FG010|Overall Study|Physician Decision|0|||
16859170|NCT04426695|37813806|FG011|Overall Study|Physician Decision|0|||
16859171|NCT04426695|37813807|FG012|Overall Study|Physician Decision|1|||
16859172|NCT04426695|37813808|FG013|Overall Study|Physician Decision|0|||
16859173|NCT04426695|37813809|FG014|Overall Study|Physician Decision|0|||
16943360|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16943361|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
16943362|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
16943363|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16943364|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16943365|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16943366|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16943367|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
16943368|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16943369|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16943370|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16943371|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
16943372|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16943373|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16943374|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16943375|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16943376|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16943377|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16943378|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16859174|NCT04426695|37813810|FG015|Overall Study|Physician Decision|0|||
16859175|NCT04426695|37813811|FG016|Overall Study|Physician Decision|0|||
16859176|NCT04426695|37813812|FG017|Overall Study|Physician Decision|0|||
16859177|NCT04426695|37813795|FG000|Overall Study|Randomized but Never Treated|3|||
16859178|NCT04426695|37813796|FG001|Overall Study|Randomized but Never Treated|1|||
16859179|NCT04426695|37813797|FG002|Overall Study|Randomized but Never Treated|0|||
16859180|NCT04426695|37813798|FG003|Overall Study|Randomized but Never Treated|4|||
16859181|NCT04426695|37813799|FG004|Overall Study|Randomized but Never Treated|5|||
16859182|NCT04426695|37813800|FG005|Overall Study|Randomized but Never Treated|5|||
16859183|NCT04426695|37813801|FG006|Overall Study|Randomized but Never Treated|4|||
16943379|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16943380|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
16943381|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16943382|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16943383|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16859184|NCT04426695|37813802|FG007|Overall Study|Randomized but Never Treated|6|||
16859185|NCT04426695|37813803|FG008|Overall Study|Randomized but Never Treated|6|||
16859186|NCT04426695|37813804|FG009|Overall Study|Randomized but Never Treated|3|||
16859187|NCT04426695|37813805|FG010|Overall Study|Randomized but Never Treated|3|||
16859188|NCT04426695|37813806|FG011|Overall Study|Randomized but Never Treated|6|||
16859189|NCT04426695|37813807|FG012|Overall Study|Randomized but Never Treated|1|||
16859190|NCT04426695|37813808|FG013|Overall Study|Randomized but Never Treated|2|||
16859191|NCT04426695|37813809|FG014|Overall Study|Randomized but Never Treated|0|||
16859192|NCT04426695|37813810|FG015|Overall Study|Randomized but Never Treated|0|||
16859193|NCT04426695|37813811|FG016|Overall Study|Randomized but Never Treated|0|||
16859194|NCT04426695|37813812|FG017|Overall Study|Randomized but Never Treated|0|||
16859195|NCT01838200|37813889|FG000|Overall Study|Adverse Event|0|||
16859196|NCT01838200|37813890|FG001|Overall Study|Adverse Event|2|||
16859197|NCT01838200|37813889|FG000|Overall Study|Progressive disease|3|||
16859198|NCT01838200|37813890|FG001|Overall Study|Progressive disease|0|||
16859199|NCT03219034|37813933|FG000|Overall Study|Lost to Follow-up|9|||
16859200|NCT03219034|37813934|FG001|Overall Study|Lost to Follow-up|13|||
16859201|NCT03219034|37813933|FG000|Overall Study|Additional dental work needed|1|||
16859202|NCT03219034|37813934|FG001|Overall Study|Additional dental work needed|0|||
16859203|NCT03219034|37813933|FG000|Overall Study|UPPP Surgery|1|||
16859204|NCT03219034|37813934|FG001|Overall Study|UPPP Surgery|0|||
16859205|NCT03219034|37813933|FG000|Overall Study|Dental sensitivity|0|||
16859206|NCT03219034|37813934|FG001|Overall Study|Dental sensitivity|1|||
16859207|NCT03219034|37813933|FG000|Overall Study|Death in family|0|||
16859208|NCT03219034|37813934|FG001|Overall Study|Death in family|1|||
16859209|NCT01706198|37813958|FG000|Overall Study|Adverse Event|12|||
16859210|NCT01706198|37813959|FG001|Overall Study|Adverse Event|15|||
16859211|NCT01706198|37813958|FG000|Overall Study|Protocol Violation|7|||
16859212|NCT01706198|37813959|FG001|Overall Study|Protocol Violation|5|||
16859213|NCT01706198|37813958|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
16859214|NCT01706198|37813959|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
16859215|NCT01706198|37813958|FG000|Overall Study|Lost to Follow-up|97|||
16859216|NCT01706198|37813959|FG001|Overall Study|Lost to Follow-up|93|||
16859217|NCT01706198|37813958|FG000|Overall Study|Physician Decision|23|||
16859218|NCT01706198|37813959|FG001|Overall Study|Physician Decision|37|||
16859219|NCT01706198|37813958|FG000|Overall Study|Withdrawal by Subject|23|||
16859220|NCT01706198|37813959|FG001|Overall Study|Withdrawal by Subject|31|||
16859221|NCT01705730|37813965|FG000|Overall Study|Lack of Efficacy|1|||
16859222|NCT01705730|37813965|FG000|Overall Study|Adverse Event|3|||
16859223|NCT01705730|37813965|FG000|Overall Study|Lost to Follow-up|1|||
16859224|NCT01705730|37813965|FG000|Overall Study|Reason not Specified|4|||
16859225|NCT01705652|37813971|FG000|Overall Study|Adverse Event|1|||
16943384|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16943385|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16943386|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16943387|NCT01172938|38087681|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16943388|NCT01172938|38087682|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16943389|NCT01172938|38087683|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16943390|NCT01172938|38087684|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16943391|NCT01172938|38087685|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16943392|NCT01172938|38087686|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16943393|NCT01172938|38087687|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16943394|NCT01172938|38087688|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16943395|NCT01172938|38087689|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
16943396|NCT01109992|38087709|FG000|Overall Study|Withdrawal by Subject|0|||
16943397|NCT01109992|38087710|FG001|Overall Study|Withdrawal by Subject|1|||
16943398|NCT01109992|38087709|FG000|Overall Study|Movement during rest scan.|0|||
16943399|NCT01109992|38087710|FG001|Overall Study|Movement during rest scan.|1|||
16943400|NCT01109524|38087719|FG000|Overall Study|Disease Progression|29|||
16943401|NCT01109524|38087719|FG000|Overall Study|Study Drug toxicity|6|||
16943402|NCT01109524|38087719|FG000|Overall Study|Adverse Event|4|||
16943403|NCT01109524|38087719|FG000|Overall Study|Withdrawal by Subject|2|||
16943404|NCT01109524|38087719|FG000|Overall Study|Maximum clinical benefit|3|||
16943405|NCT01109524|38087719|FG000|Overall Study|Death|2|||
16943406|NCT01109524|38087719|FG000|Overall Study|No longer meets criteria|2|||
16943407|NCT01109524|38087719|FG000|Overall Study|Participant requested to end treatment|4|||
16943408|NCT01109524|38087719|FG000|Overall Study|Other|5|||
16943409|NCT01109173|38087734|FG000|Overall Study|Adverse Event|15|||
16943410|NCT01109173|38087735|FG001|Overall Study|Adverse Event|17|||
16943411|NCT01109173|38087736|FG002|Overall Study|Adverse Event|9|||
16943412|NCT01109173|38087737|FG003|Overall Study|Adverse Event|6|||
16943413|NCT01109173|38087734|FG000|Overall Study|Lost to Follow-up|0|||
16943414|NCT01109173|38087735|FG001|Overall Study|Lost to Follow-up|1|||
16943415|NCT01109173|38087736|FG002|Overall Study|Lost to Follow-up|0|||
16943416|NCT01109173|38087737|FG003|Overall Study|Lost to Follow-up|0|||
16943417|NCT01109173|38087734|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
16943418|NCT01109173|38087735|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
16943419|NCT01109173|38087736|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
16943420|NCT01109173|38087737|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
16943421|NCT01109173|38087734|FG000|Overall Study|Noncompliance|0|||
16943422|NCT01109173|38087735|FG001|Overall Study|Noncompliance|1|||
16943423|NCT01109173|38087736|FG002|Overall Study|Noncompliance|0|||
16943424|NCT01109173|38087737|FG003|Overall Study|Noncompliance|0|||
16943425|NCT01109173|38087734|FG000|Overall Study|Treatment Failure|25|||
16943426|NCT01109173|38087735|FG001|Overall Study|Treatment Failure|32|||
16943427|NCT01109173|38087736|FG002|Overall Study|Treatment Failure|69|||
16943428|NCT01109173|38087737|FG003|Overall Study|Treatment Failure|64|||
16943429|NCT01109173|38087734|FG000|Overall Study|Protocol Violation|4|||
16943430|NCT01109173|38087735|FG001|Overall Study|Protocol Violation|5|||
16943431|NCT01109173|38087736|FG002|Overall Study|Protocol Violation|1|||
16943432|NCT01109173|38087737|FG003|Overall Study|Protocol Violation|2|||
16943433|NCT01109173|38087734|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
16943434|NCT01109173|38087735|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
16943435|NCT01109173|38087736|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
16943436|NCT01109173|38087737|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
16943437|NCT01109173|38087734|FG000|Overall Study|Not Specifiied|5|||
16943438|NCT01109173|38087735|FG001|Overall Study|Not Specifiied|4|||
16943439|NCT01109173|38087736|FG002|Overall Study|Not Specifiied|9|||
16943440|NCT01109173|38087737|FG003|Overall Study|Not Specifiied|14|||
16943441|NCT01172821|38087751|FG000|Overall Study|Adverse Event|5|||
16943442|NCT01172821|38087752|FG001|Overall Study|Adverse Event|2|||
16943443|NCT01172821|38087753|FG002|Overall Study|Adverse Event|2|||
16943444|NCT01172821|38087754|FG003|Overall Study|Adverse Event|7|||
16943445|NCT01172821|38087751|FG000|Overall Study|Protocol Violation|0|||
16943446|NCT01172821|38087752|FG001|Overall Study|Protocol Violation|2|||
16943447|NCT01172821|38087753|FG002|Overall Study|Protocol Violation|1|||
16943448|NCT01172821|38087754|FG003|Overall Study|Protocol Violation|2|||
16943449|NCT01172821|38087751|FG000|Overall Study|Lost to Follow-up|4|||
16943450|NCT01172821|38087752|FG001|Overall Study|Lost to Follow-up|1|||
16943451|NCT01172821|38087753|FG002|Overall Study|Lost to Follow-up|2|||
16943452|NCT01172821|38087754|FG003|Overall Study|Lost to Follow-up|2|||
16943453|NCT01172821|38087751|FG000|Overall Study|Withdrawal by Subject|2|||
16943454|NCT01172821|38087752|FG001|Overall Study|Withdrawal by Subject|3|||
16943455|NCT01172821|38087753|FG002|Overall Study|Withdrawal by Subject|3|||
16943456|NCT01172821|38087754|FG003|Overall Study|Withdrawal by Subject|3|||
16943457|NCT01172821|38087751|FG000|Overall Study|Other|3|||
16943458|NCT01172821|38087752|FG001|Overall Study|Other|4|||
16943459|NCT01172821|38087753|FG002|Overall Study|Other|5|||
16943460|NCT01172821|38087754|FG003|Overall Study|Other|3|||
16943461|NCT01172275|38087766|FG000|Overall Study|Lost to Follow-up|1|||
16943462|NCT01172275|38087767|FG001|Overall Study|Lost to Follow-up|0|||
16943463|NCT01172275|38087766|FG000|Overall Study|Protocol Violation|1|||
16943464|NCT01172275|38087767|FG001|Overall Study|Protocol Violation|0|||
16943465|NCT01108510|38087775|FG000|Overall Study|Randomized but Not Treated|5|||
16943466|NCT01108510|38087776|FG001|Overall Study|Randomized but Not Treated|1|||
16943467|NCT01108510|38087775|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
16943468|NCT01108510|38087776|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
16943469|NCT01108510|38087775|FG000|Overall Study|Adverse Event|26|||
16943470|NCT01108510|38087776|FG001|Overall Study|Adverse Event|19|||
16943471|NCT01108510|38087775|FG000|Overall Study|Lost to Follow-up|20|||
16943472|NCT01108510|38087776|FG001|Overall Study|Lost to Follow-up|17|||
16943473|NCT01108510|38087775|FG000|Overall Study|Withdrew Consent|21|||
16943474|NCT01108510|38087776|FG001|Overall Study|Withdrew Consent|15|||
16943475|NCT01108510|38087775|FG000|Overall Study|Investigator's Discretion|12|||
16943476|NCT01108510|38087776|FG001|Overall Study|Investigator's Discretion|10|||
16943477|NCT01108510|38087775|FG000|Overall Study|Participant Noncompliance|5|||
16943478|NCT01108510|38087776|FG001|Overall Study|Participant Noncompliance|7|||
16859226|NCT01705652|37813972|FG001|Overall Study|Adverse Event|0|||
16859227|NCT01705652|37813971|FG000|Overall Study|Withdrawal by Subject|1|||
16859228|NCT01705652|37813972|FG001|Overall Study|Withdrawal by Subject|2|||
16859229|NCT01705652|37813971|FG000|Overall Study|non-compliance|1|||
16943479|NCT01108510|38087775|FG000|Overall Study|Lack of Efficacy|3|||
16943480|NCT01108510|38087776|FG001|Overall Study|Lack of Efficacy|0|||
16859230|NCT01705652|37813972|FG001|Overall Study|non-compliance|1|||
16859231|NCT01705574|37814000|FG000|Double-Blind Phase|Lost to Follow-up|12|||
16859232|NCT01705574|37814001|FG001|Double-Blind Phase|Lost to Follow-up|16|||
16859233|NCT01705574|37814002|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16859234|NCT01705574|37814003|FG003|Double-Blind Phase|Lost to Follow-up|0|||
16859235|NCT01705574|37814000|FG000|Double-Blind Phase|Adverse Event|3|||
16859236|NCT01705574|37814001|FG001|Double-Blind Phase|Adverse Event|10|||
16859237|NCT01705574|37814002|FG002|Double-Blind Phase|Adverse Event|0|||
16943481|NCT01108510|38087775|FG000|Overall Study|Pregnancy|0|||
16943482|NCT01108510|38087776|FG001|Overall Study|Pregnancy|3|||
16943483|NCT01108510|38087775|FG000|Overall Study|Death|1|||
16943484|NCT01108510|38087776|FG001|Overall Study|Death|1|||
16859238|NCT01705574|37814003|FG003|Double-Blind Phase|Adverse Event|0|||
16859239|NCT01705574|37814000|FG000|Double-Blind Phase|Withdrew Consent|8|||
16859240|NCT01705574|37814001|FG001|Double-Blind Phase|Withdrew Consent|5|||
16859241|NCT01705574|37814002|FG002|Double-Blind Phase|Withdrew Consent|0|||
16859242|NCT01705574|37814003|FG003|Double-Blind Phase|Withdrew Consent|0|||
16859243|NCT01705574|37814000|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
16859244|NCT01705574|37814001|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
16859245|NCT01705574|37814002|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
16859246|NCT01705574|37814003|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
16859247|NCT01705574|37814000|FG000|Double-Blind Phase|Pregnancy|1|||
16859248|NCT01705574|37814001|FG001|Double-Blind Phase|Pregnancy|1|||
16859249|NCT01705574|37814002|FG002|Double-Blind Phase|Pregnancy|0|||
16859250|NCT01705574|37814003|FG003|Double-Blind Phase|Pregnancy|0|||
16859251|NCT01705574|37814000|FG000|Double-Blind Phase|Protocol Violation|1|||
16859252|NCT01705574|37814001|FG001|Double-Blind Phase|Protocol Violation|0|||
16859253|NCT01705574|37814002|FG002|Double-Blind Phase|Protocol Violation|0|||
16859254|NCT01705574|37814003|FG003|Double-Blind Phase|Protocol Violation|0|||
16859255|NCT01705574|37814000|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
16859256|NCT01705574|37814001|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
16859257|NCT01705574|37814002|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
16943485|NCT01108237|38087784|FG000|Overall Study|No alignment data|2|||
16943486|NCT01108237|38087785|FG001|Overall Study|No alignment data|17|||
16943487|NCT01108237|38087784|FG000|Overall Study|Did not meet criteria for analysis|7|||
16943488|NCT01108237|38087785|FG001|Overall Study|Did not meet criteria for analysis|0|||
16943489|NCT01340027|38087803|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
16943490|NCT01340027|38087804|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
16943491|NCT01340027|38087805|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
16943492|NCT01340027|38087806|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
16943493|NCT01340027|38087807|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
16943494|NCT01340027|38087808|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
16943495|NCT01340027|38087809|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
16943496|NCT01340027|38087810|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
16943497|NCT01340027|38087811|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
16943498|NCT01340027|38087812|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
16943499|NCT01340027|38087813|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
16943500|NCT01340027|38087814|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
16943501|NCT01340027|38087803|FG000|Overall Study|Adverse Event|0|||
16943502|NCT01340027|38087804|FG001|Overall Study|Adverse Event|1|||
16943503|NCT01340027|38087805|FG002|Overall Study|Adverse Event|2|||
16943504|NCT01340027|38087806|FG003|Overall Study|Adverse Event|0|||
16859258|NCT01705574|37814003|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
16859259|NCT01705574|37814000|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
16859260|NCT01705574|37814001|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
16859261|NCT01705574|37814002|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
16859262|NCT01705574|37814003|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
16859263|NCT01705574|37814000|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
16859264|NCT01705574|37814001|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
16859265|NCT01705574|37814002|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
16859266|NCT01705574|37814003|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
16859267|NCT01705574|37814000|FG000|Open-Label Extension Phase|Adverse Event|3|||
16859268|NCT01705574|37814001|FG001|Open-Label Extension Phase|Adverse Event|0|||
16859269|NCT01705574|37814002|FG002|Open-Label Extension Phase|Adverse Event|0|||
16859270|NCT01705574|37814003|FG003|Open-Label Extension Phase|Adverse Event|1|||
16859271|NCT01705574|37814000|FG000|Open-Label Extension Phase|Death|2|||
16859272|NCT01705574|37814001|FG001|Open-Label Extension Phase|Death|0|||
16859273|NCT01705574|37814002|FG002|Open-Label Extension Phase|Death|1|||
16859274|NCT01705574|37814003|FG003|Open-Label Extension Phase|Death|0|||
16859275|NCT01705574|37814000|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
16859276|NCT01705574|37814001|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
16859277|NCT01705574|37814002|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
16859278|NCT01705574|37814003|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
16859279|NCT01705574|37814000|FG000|Open-Label Extension Phase|Physician Decision|0|||
16859280|NCT01705574|37814001|FG001|Open-Label Extension Phase|Physician Decision|0|||
16859281|NCT01705574|37814002|FG002|Open-Label Extension Phase|Physician Decision|2|||
16859282|NCT01705574|37814003|FG003|Open-Label Extension Phase|Physician Decision|0|||
16943505|NCT01340027|38087807|FG004|Overall Study|Adverse Event|1|||
16943506|NCT01340027|38087808|FG005|Overall Study|Adverse Event|2|||
16943507|NCT01340027|38087809|FG006|Overall Study|Adverse Event|2|||
16943508|NCT01340027|38087810|FG007|Overall Study|Adverse Event|1|||
16943509|NCT01340027|38087811|FG008|Overall Study|Adverse Event|4|||
16943510|NCT01340027|38087812|FG009|Overall Study|Adverse Event|1|||
16943511|NCT01340027|38087813|FG010|Overall Study|Adverse Event|1|||
16943512|NCT01340027|38087814|FG011|Overall Study|Adverse Event|3|||
16943513|NCT01340027|38087803|FG000|Overall Study|Lack of Efficacy|0|||
16859283|NCT01705574|37814000|FG000|Open-Label Extension Phase|Pregnancy|0|||
16859284|NCT01705574|37814001|FG001|Open-Label Extension Phase|Pregnancy|0|||
16859285|NCT01705574|37814002|FG002|Open-Label Extension Phase|Pregnancy|1|||
16859286|NCT01705574|37814003|FG003|Open-Label Extension Phase|Pregnancy|1|||
16859287|NCT01737710|37814024|FG000|Overall Study|Lost to Follow-up|0|||
16859288|NCT01737710|37814025|FG001|Overall Study|Lost to Follow-up|2|||
16859289|NCT01737710|37814026|FG002|Overall Study|Lost to Follow-up|2|||
16859290|NCT01737710|37814027|FG003|Overall Study|Lost to Follow-up|0|||
16859291|NCT01737710|37814028|FG004|Overall Study|Lost to Follow-up|0|||
16859292|NCT01737710|37814024|FG000|Overall Study|Withdrawal by Subject|1|||
16859293|NCT01737710|37814025|FG001|Overall Study|Withdrawal by Subject|1|||
16859294|NCT01737710|37814026|FG002|Overall Study|Withdrawal by Subject|1|||
16859295|NCT01737710|37814027|FG003|Overall Study|Withdrawal by Subject|0|||
16859296|NCT01737710|37814028|FG004|Overall Study|Withdrawal by Subject|0|||
16859297|NCT01737710|37814024|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
16859298|NCT01737710|37814025|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
16859299|NCT01737710|37814026|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
16859300|NCT01737710|37814027|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
16859301|NCT01737710|37814028|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
16859302|NCT01682876|37814043|FG000|Overall Study|Administrative reason|4|||
16859303|NCT01682876|37814044|FG001|Overall Study|Administrative reason|4|||
16859304|NCT01682876|37814045|FG002|Overall Study|Administrative reason|0|||
16859305|NCT01682876|37814046|FG003|Overall Study|Administrative reason|3|||
16859306|NCT01682876|37814043|FG000|Overall Study|Adverse Event|0|||
16859307|NCT01682876|37814044|FG001|Overall Study|Adverse Event|0|||
16859308|NCT01682876|37814045|FG002|Overall Study|Adverse Event|0|||
16859309|NCT01682876|37814046|FG003|Overall Study|Adverse Event|1|||
16859310|NCT01682876|37814043|FG000|Overall Study|Lost to Follow-up|11|||
16859311|NCT01682876|37814044|FG001|Overall Study|Lost to Follow-up|15|||
16859312|NCT01682876|37814045|FG002|Overall Study|Lost to Follow-up|9|||
16859313|NCT01682876|37814046|FG003|Overall Study|Lost to Follow-up|11|||
16859314|NCT01682876|37814043|FG000|Overall Study|Protocol Violation|1|||
16859315|NCT01682876|37814044|FG001|Overall Study|Protocol Violation|1|||
16859316|NCT01682876|37814045|FG002|Overall Study|Protocol Violation|1|||
16859317|NCT01682876|37814046|FG003|Overall Study|Protocol Violation|1|||
16859318|NCT01682876|37814043|FG000|Overall Study|Withdrawal by Subject|4|||
16859319|NCT01682876|37814044|FG001|Overall Study|Withdrawal by Subject|0|||
16859320|NCT01682876|37814045|FG002|Overall Study|Withdrawal by Subject|0|||
16859321|NCT01682876|37814046|FG003|Overall Study|Withdrawal by Subject|2|||
16859322|NCT01682876|37814043|FG000|Overall Study|Other|1|||
16859323|NCT01682876|37814044|FG001|Overall Study|Other|0|||
16859324|NCT01682876|37814045|FG002|Overall Study|Other|1|||
16859325|NCT01682876|37814046|FG003|Overall Study|Other|1|||
16859326|NCT01682720|37814063|FG000|Overall Study|Randomized but Not Treated|0|||
16859327|NCT01682720|37814064|FG001|Overall Study|Randomized but Not Treated|1|||
16859328|NCT01682720|37814065|FG002|Overall Study|Randomized but Not Treated|1|||
16859329|NCT01682720|37814066|FG003|Overall Study|Randomized but Not Treated|0|||
16859330|NCT01682720|37814063|FG000|Overall Study|Terminated by Sponsor|83|||
16859331|NCT01682720|37814064|FG001|Overall Study|Terminated by Sponsor|0|||
16859332|NCT01682720|37814065|FG002|Overall Study|Terminated by Sponsor|0|||
16859333|NCT01682720|37814066|FG003|Overall Study|Terminated by Sponsor|0|||
16859334|NCT01682720|37814063|FG000|Overall Study|Efficacy Failure|0|||
16859335|NCT01682720|37814064|FG001|Overall Study|Efficacy Failure|3|||
16859336|NCT01682720|37814065|FG002|Overall Study|Efficacy Failure|3|||
16859337|NCT01682720|37814066|FG003|Overall Study|Efficacy Failure|30|||
16859338|NCT01682720|37814063|FG000|Overall Study|Lost to Follow-up|1|||
16859339|NCT01682720|37814064|FG001|Overall Study|Lost to Follow-up|1|||
16859340|NCT01682720|37814065|FG002|Overall Study|Lost to Follow-up|0|||
16859341|NCT01682720|37814066|FG003|Overall Study|Lost to Follow-up|6|||
16859342|NCT01682720|37814063|FG000|Overall Study|Subject Withdrew Consent|0|||
16943514|NCT01340027|38087804|FG001|Overall Study|Lack of Efficacy|0|||
17127307|NCT03814720|38267572|FG004|Overall Study|Lost to Follow-up|0|||
17127308|NCT02818036|38267588|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
17127309|NCT02818036|38267589|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
17127310|NCT02818036|38267588|FG000|Overall Study|Withdrawal by Subject|1|||
17127311|NCT02818036|38267589|FG001|Overall Study|Withdrawal by Subject|0|||
17127312|NCT01287741|38267597|FG000|Overall Study|Withdrawal by Subject|35|||
17127313|NCT01287741|38267598|FG001|Overall Study|Withdrawal by Subject|38|||
17127314|NCT01287741|38267597|FG000|Overall Study|Protocol Violation|2|||
17127315|NCT01287741|38267598|FG001|Overall Study|Protocol Violation|0|||
17127316|NCT01287741|38267597|FG000|Overall Study|Physician Decision|15|||
17127317|NCT01287741|38267598|FG001|Overall Study|Physician Decision|23|||
17127318|NCT01287741|38267597|FG000|Overall Study|Non-compliance|8|||
17127319|NCT01287741|38267598|FG001|Overall Study|Non-compliance|6|||
17127320|NCT01287741|38267597|FG000|Overall Study|Lost to Follow-up|10|||
17127321|NCT01287741|38267598|FG001|Overall Study|Lost to Follow-up|8|||
17127322|NCT01287741|38267597|FG000|Overall Study|Death|32|||
17127323|NCT01287741|38267598|FG001|Overall Study|Death|44|||
17127324|NCT01287741|38267597|FG000|Overall Study|Adverse Event|4|||
17127325|NCT01287741|38267598|FG001|Overall Study|Adverse Event|6|||
17127326|NCT01287741|38267597|FG000|Overall Study|Study terminated by Sponsor|307|||
17127327|NCT01287741|38267598|FG001|Overall Study|Study terminated by Sponsor|315|||
17127328|NCT01287741|38267597|FG000|Overall Study|Progressive disease|190|||
17127329|NCT01287741|38267598|FG001|Overall Study|Progressive disease|166|||
16859343|NCT01682720|37814064|FG001|Overall Study|Subject Withdrew Consent|0|||
16859344|NCT01682720|37814065|FG002|Overall Study|Subject Withdrew Consent|2|||
16859345|NCT01682720|37814066|FG003|Overall Study|Subject Withdrew Consent|2|||
16859346|NCT01682720|37814063|FG000|Overall Study|Adverse Event|1|||
16859347|NCT01682720|37814064|FG001|Overall Study|Adverse Event|0|||
16943515|NCT01340027|38087805|FG002|Overall Study|Lack of Efficacy|0|||
16943516|NCT01340027|38087806|FG003|Overall Study|Lack of Efficacy|0|||
16943517|NCT01340027|38087807|FG004|Overall Study|Lack of Efficacy|0|||
16943518|NCT01340027|38087808|FG005|Overall Study|Lack of Efficacy|0|||
16943519|NCT01340027|38087809|FG006|Overall Study|Lack of Efficacy|1|||
16943520|NCT01340027|38087810|FG007|Overall Study|Lack of Efficacy|1|||
16943521|NCT01340027|38087811|FG008|Overall Study|Lack of Efficacy|1|||
16943522|NCT01340027|38087812|FG009|Overall Study|Lack of Efficacy|0|||
16943523|NCT01340027|38087813|FG010|Overall Study|Lack of Efficacy|0|||
16943524|NCT01340027|38087814|FG011|Overall Study|Lack of Efficacy|0|||
16943525|NCT01340027|38087803|FG000|Overall Study|Lost to Follow-up|0|||
16943526|NCT01340027|38087804|FG001|Overall Study|Lost to Follow-up|1|||
16943527|NCT01340027|38087805|FG002|Overall Study|Lost to Follow-up|0|||
16943528|NCT01340027|38087806|FG003|Overall Study|Lost to Follow-up|0|||
16943529|NCT01340027|38087807|FG004|Overall Study|Lost to Follow-up|0|||
16943530|NCT01340027|38087808|FG005|Overall Study|Lost to Follow-up|0|||
16943531|NCT01340027|38087809|FG006|Overall Study|Lost to Follow-up|1|||
16943532|NCT01340027|38087810|FG007|Overall Study|Lost to Follow-up|0|||
16943533|NCT01340027|38087811|FG008|Overall Study|Lost to Follow-up|0|||
16943534|NCT01340027|38087812|FG009|Overall Study|Lost to Follow-up|1|||
16943535|NCT01340027|38087813|FG010|Overall Study|Lost to Follow-up|0|||
16943536|NCT01340027|38087814|FG011|Overall Study|Lost to Follow-up|0|||
16943537|NCT01340027|38087803|FG000|Overall Study|Protocol Violation|1|||
16859348|NCT01682720|37814065|FG002|Overall Study|Adverse Event|1|||
16859349|NCT01682720|37814066|FG003|Overall Study|Adverse Event|1|||
16943538|NCT01340027|38087804|FG001|Overall Study|Protocol Violation|2|||
16943539|NCT01340027|38087805|FG002|Overall Study|Protocol Violation|0|||
16943540|NCT01340027|38087806|FG003|Overall Study|Protocol Violation|0|||
16943541|NCT01340027|38087807|FG004|Overall Study|Protocol Violation|6|||
16943542|NCT01340027|38087808|FG005|Overall Study|Protocol Violation|0|||
16943543|NCT01340027|38087809|FG006|Overall Study|Protocol Violation|0|||
16943544|NCT01340027|38087810|FG007|Overall Study|Protocol Violation|1|||
16943545|NCT01340027|38087811|FG008|Overall Study|Protocol Violation|2|||
16943546|NCT01340027|38087812|FG009|Overall Study|Protocol Violation|2|||
16943547|NCT01340027|38087813|FG010|Overall Study|Protocol Violation|0|||
16943548|NCT01340027|38087814|FG011|Overall Study|Protocol Violation|0|||
16943549|NCT01340027|38087803|FG000|Overall Study|Withdrawal by Subject|4|||
16943550|NCT01340027|38087804|FG001|Overall Study|Withdrawal by Subject|3|||
17127330|NCT01287741|38267597|FG000|Overall Study|Reason not specified|23|||
17127331|NCT01287741|38267598|FG001|Overall Study|Reason not specified|9|||
17127332|NCT03739203|38267612|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
16859350|NCT01714544|37814085|FG000|Overall Study|Lost to Follow-up|1|||
16859351|NCT01714544|37814085|FG000|Overall Study|Physician Decision|1|||
16859352|NCT01714544|37814085|FG000|Overall Study|Withdrawal by Subject|1|||
16859353|NCT01703858|37814092|FG000|Overall Study|Withdrawal by Subject|0|||
16859354|NCT01703858|37814093|FG001|Overall Study|Withdrawal by Subject|1|||
16859355|NCT01703858|37814094|FG002|Overall Study|Withdrawal by Subject|0|||
16859356|NCT01714310|37814110|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
16859357|NCT01714310|37814111|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
16859358|NCT01714310|37814112|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
16943551|NCT01340027|38087805|FG002|Overall Study|Withdrawal by Subject|1|||
16943552|NCT01340027|38087806|FG003|Overall Study|Withdrawal by Subject|3|||
16943553|NCT01340027|38087807|FG004|Overall Study|Withdrawal by Subject|3|||
16943554|NCT01340027|38087808|FG005|Overall Study|Withdrawal by Subject|2|||
16943555|NCT01340027|38087809|FG006|Overall Study|Withdrawal by Subject|3|||
16943556|NCT01340027|38087810|FG007|Overall Study|Withdrawal by Subject|4|||
16943557|NCT01340027|38087811|FG008|Overall Study|Withdrawal by Subject|1|||
16943558|NCT01340027|38087812|FG009|Overall Study|Withdrawal by Subject|2|||
16943559|NCT01340027|38087813|FG010|Overall Study|Withdrawal by Subject|0|||
16943560|NCT01340027|38087814|FG011|Overall Study|Withdrawal by Subject|1|||
16943561|NCT01340027|38087803|FG000|Overall Study|Miscellaneous|0|||
16943562|NCT01340027|38087804|FG001|Overall Study|Miscellaneous|0|||
16943563|NCT01340027|38087805|FG002|Overall Study|Miscellaneous|0|||
16943564|NCT01340027|38087806|FG003|Overall Study|Miscellaneous|1|||
16943565|NCT01340027|38087807|FG004|Overall Study|Miscellaneous|0|||
16943566|NCT01340027|38087808|FG005|Overall Study|Miscellaneous|0|||
16943567|NCT01340027|38087809|FG006|Overall Study|Miscellaneous|0|||
16943568|NCT01340027|38087810|FG007|Overall Study|Miscellaneous|0|||
16943569|NCT01340027|38087811|FG008|Overall Study|Miscellaneous|0|||
16859359|NCT01714310|37814110|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
16859360|NCT01714310|37814111|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
16859361|NCT01714310|37814112|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
16859362|NCT01714310|37814110|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
16859363|NCT01714310|37814111|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
16859364|NCT01714310|37814112|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
16859365|NCT01714310|37814110|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
16859366|NCT01714310|37814111|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
16859367|NCT01714310|37814112|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
16859368|NCT01713998|37814133|FG000|Overall Study|Lost to Follow-up|2|||
16859369|NCT01713998|37814134|FG001|Overall Study|Lost to Follow-up|0|||
16859370|NCT01713998|37814135|FG002|Overall Study|Lost to Follow-up|2|||
16859371|NCT01713998|37814133|FG000|Overall Study|Withdrawal by Subject|1|||
16859372|NCT01713998|37814134|FG001|Overall Study|Withdrawal by Subject|0|||
16859373|NCT01713998|37814135|FG002|Overall Study|Withdrawal by Subject|0|||
16859374|NCT01681628|37814145|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
16859375|NCT01681628|37814146|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
16859376|NCT01681628|37814145|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
16859377|NCT01681628|37814146|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
16859378|NCT01681628|37814145|FG000|19 Months Follow-up|Death|1|||
16859379|NCT01681628|37814146|FG001|19 Months Follow-up|Death|0|||
16859380|NCT01681628|37814145|FG000|19 Months Follow-up|Lost to Follow-up|61|||
16859381|NCT01681628|37814146|FG001|19 Months Follow-up|Lost to Follow-up|43|||
16859382|NCT00016354|37814168|FG000|Overall Study|Lack of Efficacy|0|||
16859383|NCT00016354|37814169|FG001|Overall Study|Lack of Efficacy|0|||
16859384|NCT00016354|37814170|FG002|Overall Study|Lack of Efficacy|0|||
16859385|NCT00016354|37814171|FG003|Overall Study|Lack of Efficacy|0|||
16859386|NCT00016354|37814172|FG004|Overall Study|Lack of Efficacy|0|||
16859387|NCT00016354|37814173|FG005|Overall Study|Lack of Efficacy|0|||
16859388|NCT00016354|37814174|FG006|Overall Study|Lack of Efficacy|0|||
16859389|NCT00016354|37814175|FG007|Overall Study|Lack of Efficacy|1|||
16943570|NCT01340027|38087812|FG009|Overall Study|Miscellaneous|0|||
16943571|NCT01340027|38087813|FG010|Overall Study|Miscellaneous|1|||
16943572|NCT01340027|38087814|FG011|Overall Study|Miscellaneous|0|||
16859390|NCT01681472|37814183|FG000|Overall Study|Adverse Event|0|||
16859391|NCT01681472|37814184|FG001|Overall Study|Adverse Event|1|||
16943573|NCT01327053|38087842|FG000|Overall Study|Adverse Event|23|||
16943574|NCT01327053|38087843|FG001|Overall Study|Adverse Event|57|||
16943575|NCT01327053|38087842|FG000|Overall Study|Patient/guardian decision|11|||
16943576|NCT01327053|38087843|FG001|Overall Study|Patient/guardian decision|35|||
16943577|NCT01327053|38087842|FG000|Overall Study|Physician Decision|10|||
16943578|NCT01327053|38087843|FG001|Overall Study|Physician Decision|14|||
16943579|NCT01327053|38087842|FG000|Overall Study|Death|1|||
16943580|NCT01327053|38087843|FG001|Overall Study|Death|5|||
16943581|NCT01327053|38087842|FG000|Overall Study|Lost to Follow-up|2|||
16943582|NCT01327053|38087843|FG001|Overall Study|Lost to Follow-up|4|||
16943583|NCT01327053|38087842|FG000|Overall Study|Non-compliance with study treatment|0|||
16943584|NCT01327053|38087843|FG001|Overall Study|Non-compliance with study treatment|5|||
16943585|NCT01327053|38087842|FG000|Overall Study|Study terminated by Sponsor|1|||
16943586|NCT01327053|38087843|FG001|Overall Study|Study terminated by Sponsor|3|||
16943587|NCT01327053|38087842|FG000|Overall Study|Progressive disease|31|||
16943588|NCT01327053|38087843|FG001|Overall Study|Progressive disease|26|||
16943589|NCT01327053|38087842|FG000|Overall Study|Protocol Violation|0|||
16943590|NCT01327053|38087843|FG001|Overall Study|Protocol Violation|1|||
16943591|NCT01327053|38087842|FG000|Overall Study|Untreated|0|||
16943592|NCT01327053|38087843|FG001|Overall Study|Untreated|1|||
16943593|NCT01107925|38087857|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
16943594|NCT01107925|38087858|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
16943595|NCT01107925|38087859|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
16943596|NCT01107925|38087860|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
16943597|NCT01107925|38087861|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
16943598|NCT01107925|38087862|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
16943599|NCT01107925|38087857|FG000|Period 2|Withdrawal by Subject|0|||
16943600|NCT01107925|38087858|FG001|Period 2|Withdrawal by Subject|1|||
16943601|NCT01107925|38087859|FG002|Period 2|Withdrawal by Subject|0|||
16943602|NCT01107925|38087860|FG003|Period 2|Withdrawal by Subject|0|||
16943603|NCT01107925|38087861|FG004|Period 2|Withdrawal by Subject|0|||
17127333|NCT03739203|38267613|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
17127334|NCT03739203|38267614|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
16859392|NCT01681472|37814185|FG002|Overall Study|Adverse Event|0|||
16859393|NCT01681472|37814186|FG003|Overall Study|Adverse Event|0|||
16859394|NCT01049308|37814215|FG000|Pill Counts|Withdrawal by Subject|83|||
16859395|NCT01713686|37814222|FG000|Overall Study|Lost to Follow-up|9|||
16859396|NCT01713686|37814222|FG000|Overall Study|Withdrawal by Subject|6|||
16859397|NCT01047436|37814228|FG000|Overall Study|Protocol Violation|1|||
16859398|NCT01047436|37814229|FG001|Overall Study|Protocol Violation|0|||
16943604|NCT01107925|38087862|FG005|Period 2|Withdrawal by Subject|1|||
16943605|NCT01339832|38087890|FG000|Overall Study|Lost to Follow-up|3|||
16943606|NCT01339832|38087890|FG000|Overall Study|Death|11|||
16943607|NCT01339559|38087894|FG000|Overall Study|Adverse Event|92|||
16943608|NCT01339559|38087894|FG000|Overall Study|Death|5|||
16943609|NCT01339559|38087894|FG000|Overall Study|Lack of Efficacy|164|||
16943610|NCT01339559|38087894|FG000|Overall Study|Lost to Follow-up|22|||
16943611|NCT01339559|38087894|FG000|Overall Study|Subject choice|89|||
16943612|NCT01339559|38087894|FG000|Overall Study|Protocol Violation|15|||
16943613|NCT01339559|38087894|FG000|Overall Study|Study closure at site|1|||
16943614|NCT01339559|38087894|FG000|Overall Study|Incarcerated|2|||
16943615|NCT01339559|38087894|FG000|Overall Study|Epilepsy surgery|1|||
16943616|NCT01339559|38087894|FG000|Overall Study|Pregnancy planned|2|||
16943617|NCT01339559|38087894|FG000|Overall Study|Left the country|1|||
16943618|NCT01339559|38087894|FG000|Overall Study|Investigator decision|2|||
16943619|NCT01339559|38087894|FG000|Overall Study|Patient didn't wish to continue|1|||
16943620|NCT01339559|38087894|FG000|Overall Study|PI decision|1|||
16943621|NCT00107900|38087905|FG000|Overall Study|Adverse Event|3|||
16943622|NCT00107900|38087906|FG001|Overall Study|Adverse Event|2|||
16943623|NCT00107900|38087907|FG002|Overall Study|Adverse Event|10|||
16943624|NCT00107900|38087908|FG003|Overall Study|Adverse Event|3|||
16943625|NCT00107900|38087909|FG004|Overall Study|Adverse Event|5|||
16943626|NCT00107900|38087910|FG005|Overall Study|Adverse Event|3|||
16943627|NCT00107900|38087905|FG000|Overall Study|Death|0|||
16943628|NCT00107900|38087906|FG001|Overall Study|Death|0|||
16943629|NCT00107900|38087907|FG002|Overall Study|Death|0|||
16943630|NCT00107900|38087908|FG003|Overall Study|Death|0|||
16943631|NCT00107900|38087909|FG004|Overall Study|Death|1|||
16943632|NCT00107900|38087910|FG005|Overall Study|Death|0|||
16943633|NCT00107900|38087905|FG000|Overall Study|Lost to Follow-up|4|||
16943634|NCT00107900|38087906|FG001|Overall Study|Lost to Follow-up|1|||
16943635|NCT00107900|38087907|FG002|Overall Study|Lost to Follow-up|3|||
16943636|NCT00107900|38087908|FG003|Overall Study|Lost to Follow-up|2|||
16943637|NCT00107900|38087909|FG004|Overall Study|Lost to Follow-up|5|||
16943638|NCT00107900|38087910|FG005|Overall Study|Lost to Follow-up|5|||
16943639|NCT00107900|38087905|FG000|Overall Study|Protocol Violation|1|||
16943640|NCT00107900|38087906|FG001|Overall Study|Protocol Violation|0|||
16943641|NCT00107900|38087907|FG002|Overall Study|Protocol Violation|5|||
16943642|NCT00107900|38087908|FG003|Overall Study|Protocol Violation|5|||
16943643|NCT00107900|38087909|FG004|Overall Study|Protocol Violation|7|||
16943644|NCT00107900|38087910|FG005|Overall Study|Protocol Violation|0|||
16943645|NCT00107900|38087905|FG000|Overall Study|Withdrawal by Subject|1|||
16943646|NCT00107900|38087906|FG001|Overall Study|Withdrawal by Subject|0|||
16943647|NCT00107900|38087907|FG002|Overall Study|Withdrawal by Subject|5|||
16943648|NCT00107900|38087908|FG003|Overall Study|Withdrawal by Subject|0|||
16943649|NCT00107900|38087909|FG004|Overall Study|Withdrawal by Subject|1|||
16943650|NCT00107900|38087910|FG005|Overall Study|Withdrawal by Subject|1|||
16943651|NCT00107900|38087905|FG000|Overall Study|Administrative Reasons|1|||
16943652|NCT00107900|38087906|FG001|Overall Study|Administrative Reasons|0|||
16943653|NCT00107900|38087907|FG002|Overall Study|Administrative Reasons|2|||
16943654|NCT00107900|38087908|FG003|Overall Study|Administrative Reasons|2|||
16943655|NCT00107900|38087909|FG004|Overall Study|Administrative Reasons|2|||
16943656|NCT00107900|38087910|FG005|Overall Study|Administrative Reasons|0|||
16943657|NCT01339052|38087926|FG000|Overall Study|Disease progression|13|||
16943658|NCT01339052|38087927|FG001|Overall Study|Disease progression|46|||
16943659|NCT01339052|38087926|FG000|Overall Study|Adverse Event|1|||
16943660|NCT01339052|38087927|FG001|Overall Study|Adverse Event|1|||
16943661|NCT01339052|38087926|FG000|Overall Study|Withdrawal by Subject|0|||
16943662|NCT01339052|38087927|FG001|Overall Study|Withdrawal by Subject|3|||
16943663|NCT01339052|38087926|FG000|Overall Study|Physician Decision|1|||
16943664|NCT01339052|38087927|FG001|Overall Study|Physician Decision|0|||
16943665|NCT00107315|38087936|FG000|Overall Study|Disease Progression|9|||
16943666|NCT00107315|38087936|FG000|Overall Study|Adverse Event|4|||
16943667|NCT00107315|38087936|FG000|Overall Study|Withdrawal by Subject|2|||
16943668|NCT01335971|38087943|FG000|Overall Study|Withdrawal by Subject|1|||
16943669|NCT01335971|38087944|FG001|Overall Study|Withdrawal by Subject|0|||
16943670|NCT01335971|38087945|FG002|Overall Study|Withdrawal by Subject|0|||
16943671|NCT01335971|38087943|FG000|Overall Study|Did not complete bronchoscopy|1|||
16943672|NCT01335971|38087944|FG001|Overall Study|Did not complete bronchoscopy|1|||
16943673|NCT01335971|38087945|FG002|Overall Study|Did not complete bronchoscopy|1|||
16943674|NCT00107276|38087953|FG000|Overall Study|Progression|46|||
16943675|NCT00107276|38087953|FG000|Overall Study|Adverse Event|6|||
16943676|NCT00107276|38087953|FG000|Overall Study|M.D. decision|2|||
16943677|NCT00107276|38087953|FG000|Overall Study|Patient refusal|1|||
16943678|NCT00107276|38087953|FG000|Overall Study|Death|1|||
16943679|NCT00107276|38087953|FG000|Overall Study|Ineligible|16|||
16943680|NCT01335698|38087963|FG000|Treatment Stage 1|Lack of Efficacy|3|||
16943681|NCT01335698|38087964|FG001|Treatment Stage 1|Lack of Efficacy|1|||
16943682|NCT01335698|38087965|FG002|Treatment Stage 1|Lack of Efficacy|3|||
16943683|NCT01335698|38087966|FG003|Treatment Stage 1|Lack of Efficacy|3|||
16943684|NCT01335698|38087967|FG004|Treatment Stage 1|Lack of Efficacy|1|||
16943685|NCT01335698|38087963|FG000|Treatment Stage 1|Adverse Event|1|||
16943686|NCT01335698|38087964|FG001|Treatment Stage 1|Adverse Event|2|||
16943687|NCT01335698|38087965|FG002|Treatment Stage 1|Adverse Event|2|||
16943688|NCT01335698|38087966|FG003|Treatment Stage 1|Adverse Event|1|||
16943689|NCT01335698|38087967|FG004|Treatment Stage 1|Adverse Event|1|||
16943690|NCT01335698|38087963|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
16943691|NCT01335698|38087964|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
16943692|NCT01335698|38087965|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
16943693|NCT01335698|38087966|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
16943694|NCT01335698|38087967|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
16943695|NCT01335698|38087963|FG000|Treatment Stage 1|Lost to Follow-up|1|||
16943696|NCT01335698|38087964|FG001|Treatment Stage 1|Lost to Follow-up|1|||
16943697|NCT01335698|38087965|FG002|Treatment Stage 1|Lost to Follow-up|0|||
16943698|NCT01335698|38087966|FG003|Treatment Stage 1|Lost to Follow-up|0|||
16943699|NCT01335698|38087967|FG004|Treatment Stage 1|Lost to Follow-up|0|||
16943700|NCT01335698|38087963|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
16943701|NCT01335698|38087964|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
16943702|NCT01335698|38087965|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
16943703|NCT01335698|38087966|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
16943704|NCT01335698|38087967|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
16943705|NCT01335698|38087963|FG000|Treatment Stage 1|No longer meets study criteria|1|||
16943706|NCT01335698|38087964|FG001|Treatment Stage 1|No longer meets study criteria|1|||
16943707|NCT01335698|38087965|FG002|Treatment Stage 1|No longer meets study criteria|0|||
16943708|NCT01335698|38087966|FG003|Treatment Stage 1|No longer meets study criteria|1|||
16943709|NCT01335698|38087967|FG004|Treatment Stage 1|No longer meets study criteria|0|||
16943710|NCT01335698|38087963|FG000|Treatment Stage 1|Other|1|||
16943711|NCT01335698|38087964|FG001|Treatment Stage 1|Other|0|||
16943712|NCT01335698|38087965|FG002|Treatment Stage 1|Other|0|||
16943713|NCT01335698|38087966|FG003|Treatment Stage 1|Other|1|||
16943714|NCT01335698|38087967|FG004|Treatment Stage 1|Other|0|||
16943715|NCT01335698|38087963|FG000|Treatment Stage 2|Lack of Efficacy|2|||
16943716|NCT01335698|38087964|FG001|Treatment Stage 2|Lack of Efficacy|1|||
16943717|NCT01335698|38087965|FG002|Treatment Stage 2|Lack of Efficacy|3|||
16943718|NCT01335698|38087966|FG003|Treatment Stage 2|Lack of Efficacy|1|||
16943719|NCT01335698|38087967|FG004|Treatment Stage 2|Lack of Efficacy|0|||
16943720|NCT01335698|38087963|FG000|Treatment Stage 2|Adverse Event|2|||
16943721|NCT01335698|38087964|FG001|Treatment Stage 2|Adverse Event|0|||
16943722|NCT01335698|38087965|FG002|Treatment Stage 2|Adverse Event|0|||
16943723|NCT01335698|38087966|FG003|Treatment Stage 2|Adverse Event|3|||
16943724|NCT01335698|38087967|FG004|Treatment Stage 2|Adverse Event|0|||
16943725|NCT01335698|38087963|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
16943726|NCT01335698|38087964|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
16943727|NCT01335698|38087965|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
16943728|NCT01335698|38087966|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
16943729|NCT01335698|38087967|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
16943730|NCT01335698|38087963|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
16943731|NCT01335698|38087964|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
16943732|NCT01335698|38087965|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
16943733|NCT01335698|38087966|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
16943734|NCT01335698|38087967|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
16943735|NCT01335698|38087963|FG000|Treatment Stage 2|Lost to Follow-up|1|||
16943736|NCT01335698|38087964|FG001|Treatment Stage 2|Lost to Follow-up|0|||
16943737|NCT01335698|38087965|FG002|Treatment Stage 2|Lost to Follow-up|0|||
16943738|NCT01335698|38087966|FG003|Treatment Stage 2|Lost to Follow-up|0|||
16943739|NCT01335698|38087967|FG004|Treatment Stage 2|Lost to Follow-up|0|||
16943740|NCT01335698|38087963|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
16943741|NCT01335698|38087964|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
17127335|NCT03739203|38267612|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
17127336|NCT03739203|38267613|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16943742|NCT01335698|38087965|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
16943743|NCT01335698|38087966|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
16943744|NCT01335698|38087967|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
16943745|NCT01335698|38087963|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
16943746|NCT01335698|38087964|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
16943747|NCT01335698|38087965|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
16943748|NCT01335698|38087966|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
16943749|NCT01335698|38087967|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
16943750|NCT01335698|38087963|FG000|Treatment Stage 2|Switched to another formulation|1|||
16943751|NCT01335698|38087964|FG001|Treatment Stage 2|Switched to another formulation|1|||
16943752|NCT01335698|38087965|FG002|Treatment Stage 2|Switched to another formulation|0|||
16943753|NCT01335698|38087966|FG003|Treatment Stage 2|Switched to another formulation|0|||
16943754|NCT01335698|38087967|FG004|Treatment Stage 2|Switched to another formulation|0|||
16943755|NCT00107198|38087981|FG000|Overall Study|Lack of Efficacy|28|||
16859399|NCT01681004|37814237|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
16859400|NCT01681004|37814238|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
16859401|NCT01681004|37814237|FG000|Study Completion|Lost to Follow-up|8|||
16859402|NCT01681004|37814238|FG001|Study Completion|Lost to Follow-up|3|||
16859403|NCT01681004|37814237|FG000|Study Completion|Physician Decision|1|||
16859404|NCT01681004|37814238|FG001|Study Completion|Physician Decision|3|||
16859405|NCT01681004|37814237|FG000|Study Completion|Site Termination|2|||
16859406|NCT01681004|37814238|FG001|Study Completion|Site Termination|1|||
16943756|NCT00107198|38087981|FG000|Overall Study|Lost to Follow-up|12|||
16943757|NCT00107198|38087981|FG000|Overall Study|Protocol Violation|1|||
16943758|NCT00107198|38087981|FG000|Overall Study|Withdrawal by Subject|6|||
16943759|NCT00107198|38087981|FG000|Overall Study|Ineligible|5|||
16943760|NCT00107120|38087987|FG000|Overall Study|Adverse Event|4|||
16943761|NCT00107120|38087988|FG001|Overall Study|Adverse Event|1|||
16943762|NCT00107120|38087987|FG000|Overall Study|Lack of Efficacy|5|||
16943763|NCT00107120|38087988|FG001|Overall Study|Lack of Efficacy|5|||
16943764|NCT00107120|38087987|FG000|Overall Study|Protocol Violation|3|||
16943765|NCT00107120|38087988|FG001|Overall Study|Protocol Violation|0|||
16943766|NCT00107120|38087987|FG000|Overall Study|Withdrawal by Subject|8|||
16943767|NCT00107120|38087988|FG001|Overall Study|Withdrawal by Subject|9|||
16943768|NCT00107120|38087987|FG000|Overall Study|Lost to Follow-up|8|||
16943769|NCT00107120|38087988|FG001|Overall Study|Lost to Follow-up|6|||
16943770|NCT00107120|38087987|FG000|Overall Study|Pregnancy|0|||
16859407|NCT01681004|37814237|FG000|Study Completion|Death|1|||
16859408|NCT01681004|37814238|FG001|Study Completion|Death|1|||
16859409|NCT01046110|37814250|FG000|Overall Study|Adverse Event|9|||
16859410|NCT01046110|37814251|FG001|Overall Study|Adverse Event|2|||
16859411|NCT01046110|37814250|FG000|Overall Study|Lack of Efficacy|0|||
16859412|NCT01046110|37814251|FG001|Overall Study|Lack of Efficacy|1|||
16859413|NCT01046110|37814250|FG000|Overall Study|Protocol Violation|7|||
16859414|NCT01046110|37814251|FG001|Overall Study|Protocol Violation|12|||
16859415|NCT01046110|37814250|FG000|Overall Study|Withdrawal Criteria|3|||
16859416|NCT01046110|37814251|FG001|Overall Study|Withdrawal Criteria|5|||
16859417|NCT01046110|37814250|FG000|Overall Study|Unclassified|36|||
16859418|NCT01046110|37814251|FG001|Overall Study|Unclassified|35|||
16943771|NCT00107120|38087988|FG001|Overall Study|Pregnancy|1|||
16943772|NCT00107120|38087987|FG000|Overall Study|moving away from site|1|||
16943773|NCT00107120|38087988|FG001|Overall Study|moving away from site|1|||
16943774|NCT00107120|38087987|FG000|Overall Study|death of parent|0|||
16943775|NCT00107120|38087988|FG001|Overall Study|death of parent|1|||
16943776|NCT01335464|38087996|FG000|Overall Study|Adverse Event|15|||
16943777|NCT01335464|38087997|FG001|Overall Study|Adverse Event|25|||
16943778|NCT01335464|38087996|FG000|Overall Study|Non compliant with protocol|2|||
16943779|NCT01335464|38087997|FG001|Overall Study|Non compliant with protocol|0|||
16943780|NCT01335464|38087996|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
16859419|NCT01713530|37814259|FG000|Overall Study|Adverse Event|0|||
16859420|NCT01713530|37814260|FG001|Overall Study|Adverse Event|5|||
16859421|NCT01713530|37814259|FG000|Overall Study|Withdrawal criteria|21|||
16943781|NCT01335464|38087997|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
16943782|NCT01335464|38087996|FG000|Overall Study|Not treated|2|||
16943783|NCT01335464|38087997|FG001|Overall Study|Not treated|0|||
16943784|NCT01335464|38087996|FG000|Overall Study|Reason other than those stated above|1|||
16943785|NCT01335464|38087997|FG001|Overall Study|Reason other than those stated above|1|||
16943786|NCT00107042|38088005|FG000|Overall Study|Lost to Follow-up|9|||
16943787|NCT00107042|38088006|FG001|Overall Study|Lost to Follow-up|7|||
16943788|NCT00107042|38088005|FG000|Overall Study|Withdrawal by Subject|6|||
16943789|NCT00107042|38088006|FG001|Overall Study|Withdrawal by Subject|1|||
16943790|NCT00107042|38088005|FG000|Overall Study|Moved out of area|5|||
16943791|NCT00107042|38088006|FG001|Overall Study|Moved out of area|3|||
16859422|NCT01713530|37814260|FG001|Overall Study|Withdrawal criteria|12|||
16859423|NCT01713530|37814259|FG000|Overall Study|Unclassified|4|||
16859424|NCT01713530|37814260|FG001|Overall Study|Unclassified|2|||
16859425|NCT01045798|37814268|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
16859426|NCT01045798|37814269|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
16859427|NCT01045798|37814268|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
16859428|NCT01045798|37814269|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
16859429|NCT01045798|37814268|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
16859430|NCT01045798|37814269|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
16859431|NCT01045798|37814268|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
16859432|NCT01045798|37814269|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
16859433|NCT01712984|37814282|FG000|Overall Study|Adverse Event|0|||
16859434|NCT01712984|37814283|FG001|Overall Study|Adverse Event|0|||
16859435|NCT01712984|37814284|FG002|Overall Study|Adverse Event|1|||
16859436|NCT01712984|37814282|FG000|Overall Study|Protocol Violation|2|||
16859437|NCT01712984|37814283|FG001|Overall Study|Protocol Violation|0|||
16859438|NCT01712984|37814284|FG002|Overall Study|Protocol Violation|1|||
16859439|NCT01712984|37814282|FG000|Overall Study|Lost to Follow-up|8|||
16859440|NCT01712984|37814283|FG001|Overall Study|Lost to Follow-up|10|||
16859441|NCT01712984|37814284|FG002|Overall Study|Lost to Follow-up|1|||
16943792|NCT00107042|38088005|FG000|Overall Study|Pregnancy|1|||
16943793|NCT00107042|38088006|FG001|Overall Study|Pregnancy|1|||
16943794|NCT00107042|38088005|FG000|Overall Study|Inadvertent enrollment|0|||
16943795|NCT00107042|38088006|FG001|Overall Study|Inadvertent enrollment|1|||
16943796|NCT00107042|38088005|FG000|Overall Study|vaccinated outside window|1|||
16943797|NCT00107042|38088006|FG001|Overall Study|vaccinated outside window|1|||
16859442|NCT01712984|37814282|FG000|Overall Study|Withdrawal by Subject|6|||
16943798|NCT00107042|38088005|FG000|Overall Study|Disallowed medications|0|||
16943799|NCT00107042|38088006|FG001|Overall Study|Disallowed medications|2|||
16943800|NCT00106964|38088057|FG000|Overall Study|Lost to Follow-up|8|||
16943801|NCT00106964|38088058|FG001|Overall Study|Lost to Follow-up|6|||
16943802|NCT00106964|38088059|FG002|Overall Study|Lost to Follow-up|2|||
16943803|NCT00106964|38088057|FG000|Overall Study|Pregnancy|2|||
16943804|NCT00106964|38088058|FG001|Overall Study|Pregnancy|3|||
16943805|NCT00106964|38088059|FG002|Overall Study|Pregnancy|2|||
17127337|NCT03739203|38267614|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
17127338|NCT03739203|38267612|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
17127339|NCT03739203|38267613|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
17127340|NCT03739203|38267614|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
17127341|NCT03739203|38267612|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
17127342|NCT03739203|38267613|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
16859443|NCT01712984|37814283|FG001|Overall Study|Withdrawal by Subject|6|||
16859444|NCT01712984|37814284|FG002|Overall Study|Withdrawal by Subject|7|||
16859445|NCT01042678|37814295|FG000|Overall Study|Physician Decision|1|||
16859446|NCT01042678|37814296|FG001|Overall Study|Physician Decision|0|||
16859447|NCT01042678|37814297|FG002|Overall Study|Physician Decision|0|||
16859448|NCT01042678|37814298|FG003|Overall Study|Physician Decision|0|||
16859449|NCT01042678|37814299|FG004|Overall Study|Physician Decision|0|||
16859450|NCT01042678|37814300|FG005|Overall Study|Physician Decision|0|||
16943806|NCT00106964|38088057|FG000|Overall Study|Death|1|||
16943807|NCT00106964|38088058|FG001|Overall Study|Death|1|||
16943808|NCT00106964|38088059|FG002|Overall Study|Death|0|||
16943809|NCT00106964|38088057|FG000|Overall Study|Incarceration|0|||
16943810|NCT00106964|38088058|FG001|Overall Study|Incarceration|1|||
16943811|NCT00106964|38088059|FG002|Overall Study|Incarceration|0|||
16859451|NCT01042600|37814310|FG000|Overall Study|Ineligible|1|||
16859452|NCT01042600|37814311|FG001|Overall Study|Ineligible|0|||
16859453|NCT01041976|37814320|FG000|Overall Study|Withdrawal by Subject|3|||
16859454|NCT01041976|37814321|FG001|Overall Study|Withdrawal by Subject|0|||
16943812|NCT00106964|38088057|FG000|Overall Study|Site Funding Terminated|0|||
16943813|NCT00106964|38088058|FG001|Overall Study|Site Funding Terminated|1|||
17127343|NCT03739203|38267614|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
17127344|NCT03739203|38267612|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
17127345|NCT03739203|38267613|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
17127346|NCT03739203|38267614|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
17127347|NCT03739203|38267612|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
16859455|NCT01041976|37814320|FG000|Overall Study|Incarceration|2|||
16859456|NCT01041976|37814321|FG001|Overall Study|Incarceration|0|||
16859457|NCT01041976|37814320|FG000|Overall Study|Death|0|||
16859458|NCT01041976|37814321|FG001|Overall Study|Death|4|||
16943814|NCT00106964|38088059|FG002|Overall Study|Site Funding Terminated|1|||
16943815|NCT00106964|38088057|FG000|Overall Study|Failure to adhere|2|||
16943816|NCT00106964|38088058|FG001|Overall Study|Failure to adhere|0|||
16943817|NCT00106964|38088059|FG002|Overall Study|Failure to adhere|0|||
16943818|NCT00106964|38088057|FG000|Overall Study|Did not meet eligibility criteria|0|||
16859459|NCT01712516|37814347|FG000|Overall Study|Technical problems|0|||
16859460|NCT01712516|37814348|FG001|Overall Study|Technical problems|0|||
16943819|NCT00106964|38088058|FG001|Overall Study|Did not meet eligibility criteria|2|||
16943820|NCT00106964|38088059|FG002|Overall Study|Did not meet eligibility criteria|2|||
16943821|NCT00106964|38088057|FG000|Overall Study|Required disallowed medication|0|||
16943822|NCT00106964|38088058|FG001|Overall Study|Required disallowed medication|1|||
16943823|NCT00106964|38088059|FG002|Overall Study|Required disallowed medication|0|||
16943824|NCT00106184|38088078|FG000|Overall Study|Withdrawal by Subject|3|||
16943825|NCT00106184|38088079|FG001|Overall Study|Withdrawal by Subject|2|||
16943826|NCT01334918|38088089|FG000|Overall Study|Did not receive study drug|6|||
16943827|NCT01334918|38088090|FG001|Overall Study|Did not receive study drug|0|||
16943828|NCT01334918|38088089|FG000|Overall Study|Adverse Event|2|||
16943829|NCT01334918|38088090|FG001|Overall Study|Adverse Event|0|||
16943830|NCT01334918|38088089|FG000|Overall Study|Withdrawal by Subject|0|||
16943831|NCT01334918|38088090|FG001|Overall Study|Withdrawal by Subject|1|||
16943832|NCT01332968|38088109|FG000|Induction Period|Adverse Event|23|||
16943833|NCT01332968|38088110|FG001|Induction Period|Adverse Event|26|||
16943834|NCT01332968|38088111|FG002|Induction Period|Adverse Event|0|||
16943835|NCT01332968|38088112|FG003|Induction Period|Adverse Event|0|||
16943836|NCT01332968|38088113|FG004|Induction Period|Adverse Event|0|||
16943837|NCT01332968|38088114|FG005|Induction Period|Adverse Event|0|||
16943838|NCT01332968|38088115|FG006|Induction Period|Adverse Event|0|||
16943839|NCT01332968|38088116|FG007|Induction Period|Adverse Event|0|||
17028354|NCT00443209|38172755|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
17028355|NCT00443209|38172754|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
17028356|NCT00443209|38172755|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
17028357|NCT00439231|38172761|FG000|Overall Study|Lack of Efficacy|28|||
17028358|NCT00437983|38172767|FG000|Overall Study|Adverse Event|6|||
17028359|NCT00437983|38172768|FG001|Overall Study|Adverse Event|6|||
17028360|NCT00437983|38172767|FG000|Overall Study|Protocol Violation|2|||
17028361|NCT00437983|38172768|FG001|Overall Study|Protocol Violation|1|||
17028362|NCT00437983|38172767|FG000|Overall Study|Withdrawal by Subject|5|||
16943840|NCT01332968|38088109|FG000|Induction Period|Death|1|||
16943841|NCT01332968|38088110|FG001|Induction Period|Death|4|||
16943842|NCT01332968|38088111|FG002|Induction Period|Death|0|||
16943843|NCT01332968|38088112|FG003|Induction Period|Death|0|||
16943844|NCT01332968|38088113|FG004|Induction Period|Death|0|||
17127348|NCT03739203|38267613|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
17127349|NCT03739203|38267614|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
17127350|NCT03739203|38267612|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
17127351|NCT03739203|38267613|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
17127352|NCT03739203|38267614|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
17127353|NCT03739203|38267612|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
17127354|NCT03739203|38267613|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
17127355|NCT03739203|38267614|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
17127356|NCT03739203|38267612|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
17127357|NCT03739203|38267613|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
17127358|NCT03739203|38267614|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
17127359|NCT03739203|38267612|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
17127360|NCT03739203|38267613|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
17127361|NCT03739203|38267614|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
17127362|NCT03739203|38267612|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
17127363|NCT03739203|38267613|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
17127364|NCT03739203|38267614|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
17127365|NCT02942264|38267631|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
17127366|NCT02942264|38267632|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
17127367|NCT02942264|38267633|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
17127368|NCT02942264|38267634|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
16943845|NCT01332968|38088114|FG005|Induction Period|Death|0|||
16943846|NCT01332968|38088115|FG006|Induction Period|Death|0|||
16943847|NCT01332968|38088116|FG007|Induction Period|Death|0|||
16859461|NCT01712516|37814349|FG002|Overall Study|Technical problems|0|||
16943848|NCT01332968|38088109|FG000|Induction Period|Non-compliance|1|||
16943849|NCT01332968|38088110|FG001|Induction Period|Non-compliance|0|||
16943850|NCT01332968|38088111|FG002|Induction Period|Non-compliance|0|||
16943851|NCT01332968|38088112|FG003|Induction Period|Non-compliance|0|||
16859462|NCT01712516|37814350|FG003|Overall Study|Technical problems|2|||
16859463|NCT01712516|37814347|FG000|Overall Study|Lost to Follow-up|0|||
16859464|NCT01712516|37814348|FG001|Overall Study|Lost to Follow-up|0|||
16859465|NCT01712516|37814349|FG002|Overall Study|Lost to Follow-up|2|||
16859466|NCT01712516|37814350|FG003|Overall Study|Lost to Follow-up|1|||
16859467|NCT01712516|37814347|FG000|Overall Study|Death|0|||
16859468|NCT01712516|37814348|FG001|Overall Study|Death|1|||
16859469|NCT01712516|37814349|FG002|Overall Study|Death|0|||
16859470|NCT01712516|37814350|FG003|Overall Study|Death|0|||
16859471|NCT01712516|37814347|FG000|Overall Study|Protocol deviation|1|||
16859472|NCT01712516|37814348|FG001|Overall Study|Protocol deviation|0|||
16859473|NCT01712516|37814349|FG002|Overall Study|Protocol deviation|1|||
16859474|NCT01712516|37814350|FG003|Overall Study|Protocol deviation|0|||
16859475|NCT01712516|37814347|FG000|Overall Study|Physician Decision|2|||
16859476|NCT01712516|37814348|FG001|Overall Study|Physician Decision|0|||
16859477|NCT01712516|37814349|FG002|Overall Study|Physician Decision|0|||
16859478|NCT01712516|37814350|FG003|Overall Study|Physician Decision|1|||
16859479|NCT01712516|37814347|FG000|Overall Study|Withdrawal by Subject|3|||
16859480|NCT01712516|37814348|FG001|Overall Study|Withdrawal by Subject|9|||
16859481|NCT01712516|37814349|FG002|Overall Study|Withdrawal by Subject|3|||
16859482|NCT01712516|37814350|FG003|Overall Study|Withdrawal by Subject|9|||
16859483|NCT01703000|37814360|FG000|Overall Study|Death|1|||
16859484|NCT01040728|37814364|FG000|Overall Study|Adverse Event|4|||
16859485|NCT01040728|37814365|FG001|Overall Study|Adverse Event|8|||
16859486|NCT01040728|37814366|FG002|Overall Study|Adverse Event|0|||
16859487|NCT01040728|37814367|FG003|Overall Study|Adverse Event|4|||
16859488|NCT01040728|37814364|FG000|Overall Study|Withdrawal by Subject|0|||
16859489|NCT01040728|37814365|FG001|Overall Study|Withdrawal by Subject|1|||
16859490|NCT01040728|37814366|FG002|Overall Study|Withdrawal by Subject|1|||
16859491|NCT01040728|37814367|FG003|Overall Study|Withdrawal by Subject|0|||
16859492|NCT01040728|37814364|FG000|Overall Study|Protocol Violation|0|||
16859493|NCT01040728|37814365|FG001|Overall Study|Protocol Violation|0|||
16859494|NCT01040728|37814366|FG002|Overall Study|Protocol Violation|0|||
16859495|NCT01040728|37814367|FG003|Overall Study|Protocol Violation|1|||
16859496|NCT01040728|37814364|FG000|Overall Study|Lack of Efficacy|0|||
16859497|NCT01040728|37814365|FG001|Overall Study|Lack of Efficacy|1|||
16859498|NCT01040728|37814366|FG002|Overall Study|Lack of Efficacy|0|||
16859499|NCT01040728|37814367|FG003|Overall Study|Lack of Efficacy|1|||
16859500|NCT01040728|37814364|FG000|Overall Study|Other reasons not listed above|0|||
16859501|NCT01040728|37814365|FG001|Overall Study|Other reasons not listed above|1|||
16859502|NCT01040728|37814366|FG002|Overall Study|Other reasons not listed above|0|||
16943852|NCT01332968|38088113|FG004|Induction Period|Non-compliance|0|||
16859503|NCT01040728|37814367|FG003|Overall Study|Other reasons not listed above|0|||
16859504|NCT01593020|37814385|FG000|Overall Study|Adverse Event|1|||
16859505|NCT01593020|37814386|FG001|Overall Study|Adverse Event|1|||
16859506|NCT01593020|37814385|FG000|Overall Study|Death|0|||
16859507|NCT01593020|37814386|FG001|Overall Study|Death|1|||
16859508|NCT01593020|37814385|FG000|Overall Study|Ineligible|1|||
16859509|NCT01593020|37814386|FG001|Overall Study|Ineligible|0|||
16859510|NCT01040260|37814394|FG000|Overall Study|Withdrawal by Subject|12|||
16859511|NCT01040260|37814395|FG001|Overall Study|Withdrawal by Subject|6|||
16859512|NCT01040260|37814394|FG000|Overall Study|Lost to Follow-up|3|||
16859513|NCT01040260|37814395|FG001|Overall Study|Lost to Follow-up|5|||
16859514|NCT01712438|37814401|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
16859515|NCT01712438|37814401|FG000|Overall Study|Ongoing ITI treatment|6|||
16859516|NCT01712438|37814401|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
16859517|NCT01712438|37814401|FG000|Overall Study|Prematurely Discontinued|25|||
16859518|NCT01712204|37814412|FG000|Overall Study|Adverse Event|3|||
16859519|NCT01712204|37814413|FG001|Overall Study|Adverse Event|1|||
16859520|NCT01712204|37814412|FG000|Overall Study|Withdrawal by Subject|3|||
16943853|NCT01332968|38088114|FG005|Induction Period|Non-compliance|0|||
16943854|NCT01332968|38088115|FG006|Induction Period|Non-compliance|0|||
16943855|NCT01332968|38088116|FG007|Induction Period|Non-compliance|0|||
16943856|NCT01332968|38088109|FG000|Induction Period|Other|2|||
16943857|NCT01332968|38088110|FG001|Induction Period|Other|2|||
16943858|NCT01332968|38088111|FG002|Induction Period|Other|0|||
16943859|NCT01332968|38088112|FG003|Induction Period|Other|0|||
16943860|NCT01332968|38088113|FG004|Induction Period|Other|0|||
16943861|NCT01332968|38088114|FG005|Induction Period|Other|0|||
16943862|NCT01332968|38088115|FG006|Induction Period|Other|0|||
16943863|NCT01332968|38088116|FG007|Induction Period|Other|0|||
16943864|NCT01332968|38088109|FG000|Induction Period|Physician Decision|6|||
16943865|NCT01332968|38088110|FG001|Induction Period|Physician Decision|1|||
16943866|NCT01332968|38088111|FG002|Induction Period|Physician Decision|0|||
16943867|NCT01332968|38088112|FG003|Induction Period|Physician Decision|0|||
16943868|NCT01332968|38088113|FG004|Induction Period|Physician Decision|0|||
17127369|NCT02942264|38267635|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
17127370|NCT02942264|38267636|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
17127371|NCT02942264|38267637|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
17127372|NCT02942264|38267638|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
17127373|NCT02942264|38267639|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
17127374|NCT02942264|38267631|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
17127375|NCT02942264|38267632|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
17127376|NCT02942264|38267633|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
17127377|NCT02942264|38267634|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
17127378|NCT02942264|38267635|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
17127379|NCT02942264|38267636|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16859521|NCT01712204|37814413|FG001|Overall Study|Withdrawal by Subject|3|||
16943869|NCT01332968|38088114|FG005|Induction Period|Physician Decision|0|||
16943870|NCT01332968|38088115|FG006|Induction Period|Physician Decision|0|||
16943871|NCT01332968|38088116|FG007|Induction Period|Physician Decision|0|||
16943872|NCT01332968|38088109|FG000|Induction Period|Progressive Disease|15|||
16943873|NCT01332968|38088110|FG001|Induction Period|Progressive Disease|7|||
16943874|NCT01332968|38088111|FG002|Induction Period|Progressive Disease|0|||
16943875|NCT01332968|38088112|FG003|Induction Period|Progressive Disease|0|||
16943876|NCT01332968|38088113|FG004|Induction Period|Progressive Disease|0|||
16943877|NCT01332968|38088114|FG005|Induction Period|Progressive Disease|0|||
16943878|NCT01332968|38088115|FG006|Induction Period|Progressive Disease|0|||
16943879|NCT01332968|38088116|FG007|Induction Period|Progressive Disease|0|||
16943880|NCT01332968|38088109|FG000|Induction Period|Protocol Violation|3|||
16943881|NCT01332968|38088110|FG001|Induction Period|Protocol Violation|4|||
16943882|NCT01332968|38088111|FG002|Induction Period|Protocol Violation|0|||
16943883|NCT01332968|38088112|FG003|Induction Period|Protocol Violation|0|||
16943884|NCT01332968|38088113|FG004|Induction Period|Protocol Violation|0|||
16943885|NCT01332968|38088114|FG005|Induction Period|Protocol Violation|0|||
16943886|NCT01332968|38088115|FG006|Induction Period|Protocol Violation|0|||
16943887|NCT01332968|38088116|FG007|Induction Period|Protocol Violation|0|||
16943888|NCT01332968|38088109|FG000|Induction Period|Withdrawal by Subject|3|||
16943889|NCT01332968|38088110|FG001|Induction Period|Withdrawal by Subject|5|||
16943890|NCT01332968|38088111|FG002|Induction Period|Withdrawal by Subject|0|||
16943891|NCT01332968|38088112|FG003|Induction Period|Withdrawal by Subject|0|||
16943892|NCT01332968|38088113|FG004|Induction Period|Withdrawal by Subject|0|||
16859522|NCT01712204|37814412|FG000|Overall Study|Lost to Follow-up|1|||
16859523|NCT01712204|37814413|FG001|Overall Study|Lost to Follow-up|0|||
16859524|NCT01712204|37814412|FG000|Overall Study|Protocol Violation|1|||
16943893|NCT01332968|38088114|FG005|Induction Period|Withdrawal by Subject|0|||
16943894|NCT01332968|38088115|FG006|Induction Period|Withdrawal by Subject|0|||
16943895|NCT01332968|38088116|FG007|Induction Period|Withdrawal by Subject|0|||
16943896|NCT01332968|38088109|FG000|Induction Period|Randomised but not treated|4|||
16943897|NCT01332968|38088110|FG001|Induction Period|Randomised but not treated|7|||
16943898|NCT01332968|38088111|FG002|Induction Period|Randomised but not treated|0|||
16943899|NCT01332968|38088112|FG003|Induction Period|Randomised but not treated|0|||
16943900|NCT01332968|38088113|FG004|Induction Period|Randomised but not treated|0|||
16943901|NCT01332968|38088114|FG005|Induction Period|Randomised but not treated|0|||
16943902|NCT01332968|38088115|FG006|Induction Period|Randomised but not treated|0|||
16943903|NCT01332968|38088116|FG007|Induction Period|Randomised but not treated|0|||
16943904|NCT01332968|38088109|FG000|Maintenance/Observation Period|Adverse Event|0|||
16943905|NCT01332968|38088110|FG001|Maintenance/Observation Period|Adverse Event|0|||
16943906|NCT01332968|38088111|FG002|Maintenance/Observation Period|Adverse Event|53|||
16943907|NCT01332968|38088112|FG003|Maintenance/Observation Period|Adverse Event|66|||
16943908|NCT01332968|38088113|FG004|Maintenance/Observation Period|Adverse Event|0|||
16943909|NCT01332968|38088114|FG005|Maintenance/Observation Period|Adverse Event|0|||
16943910|NCT01332968|38088115|FG006|Maintenance/Observation Period|Adverse Event|0|||
16943911|NCT01332968|38088116|FG007|Maintenance/Observation Period|Adverse Event|0|||
16943912|NCT01332968|38088109|FG000|Maintenance/Observation Period|Death|0|||
16943913|NCT01332968|38088110|FG001|Maintenance/Observation Period|Death|0|||
16943914|NCT01332968|38088111|FG002|Maintenance/Observation Period|Death|5|||
16859525|NCT01712204|37814413|FG001|Overall Study|Protocol Violation|1|||
16859526|NCT01592864|37814421|FG000|Overall Study|Withdrawal by Subject|0|||
16859527|NCT01592864|37814422|FG001|Overall Study|Withdrawal by Subject|1|||
16859528|NCT01592786|37814428|FG000|Overall Study|Adverse Event|60|||
16859529|NCT01592786|37814428|FG000|Overall Study|Lack of Efficacy|19|||
16859530|NCT01592786|37814428|FG000|Overall Study|Protocol Violation|14|||
16859531|NCT01592786|37814428|FG000|Overall Study|Withdrawal by Subject|23|||
16859532|NCT01592786|37814428|FG000|Overall Study|Lost to Follow-up|19|||
16859533|NCT01592786|37814428|FG000|Overall Study|Other|3|||
16859534|NCT01711736|37814434|FG000|Overall Study|Lost to Follow-up|4|||
16859535|NCT01711736|37814435|FG001|Overall Study|Lost to Follow-up|1|||
16859536|NCT01711736|37814434|FG000|Overall Study|Withdrawal by Subject|6|||
16859537|NCT01711736|37814435|FG001|Overall Study|Withdrawal by Subject|6|||
16859538|NCT01711736|37814434|FG000|Overall Study|Migrated/moved from study area|2|||
16859539|NCT01711736|37814435|FG001|Overall Study|Migrated/moved from study area|1|||
16859540|NCT01592708|37814444|FG000|Overall Study|Protocol Violation|3|||
16859541|NCT01592708|37814445|FG001|Overall Study|Protocol Violation|0|||
16859542|NCT01042522|37814456|FG000|Overall Study|Adverse Event|1|||
16859543|NCT01042522|37814457|FG001|Overall Study|Adverse Event|2|||
16859544|NCT01042522|37814456|FG000|Overall Study|Disease Progression|5|||
16859545|NCT01042522|37814457|FG001|Overall Study|Disease Progression|0|||
16859546|NCT01042522|37814456|FG000|Overall Study|Death|1|||
16859547|NCT01042522|37814457|FG001|Overall Study|Death|0|||
16859548|NCT01042522|37814456|FG000|Overall Study|Patient Refused|0|||
16859549|NCT01042522|37814457|FG001|Overall Study|Patient Refused|3|||
16859550|NCT01042522|37814456|FG000|Overall Study|Withdrawal by Subject|1|||
16859551|NCT01042522|37814457|FG001|Overall Study|Withdrawal by Subject|1|||
16859552|NCT01702844|37814463|FG000|Overall Study|Adverse Event|9|||
16859553|NCT01702844|37814463|FG000|Overall Study|Death|1|||
16859554|NCT01702844|37814463|FG000|Overall Study|Withdrawal by Subject|3|||
16859555|NCT01702844|37814463|FG000|Overall Study|Physician Decision|6|||
16859556|NCT01702532|37814469|FG000|Overall Study|Adverse Event|0|||
16859557|NCT01702532|37814470|FG001|Overall Study|Adverse Event|1|||
16859558|NCT01702454|37814479|FG000|Overall Study|Consent withdrawal|0|||
16859559|NCT01702454|37814480|FG001|Overall Study|Consent withdrawal|1|||
16859560|NCT01702454|37814479|FG000|Overall Study|Migrated/moved from study area|0|||
16859561|NCT01702454|37814480|FG001|Overall Study|Migrated/moved from study area|1|||
16859562|NCT01702454|37814479|FG000|Overall Study|Lost to Follow-up|3|||
16859563|NCT01702454|37814480|FG001|Overall Study|Lost to Follow-up|6|||
16859564|NCT01702298|37814493|FG000|Overall Study|Withdrawal by Subject|1|||
16859565|NCT01701674|37814497|FG000|Overall Study|Unable to safely complete treatment|1|||
16859566|NCT02993523|37814506|FG000|Overall Study|Withdrew Consent|0|||
16859567|NCT02993523|37814507|FG001|Overall Study|Withdrew Consent|0|||
16859568|NCT02993523|37814508|FG002|Overall Study|Withdrew Consent|2|||
16859569|NCT02993523|37814509|FG003|Overall Study|Withdrew Consent|9|||
16859570|NCT02993523|37814510|FG004|Overall Study|Withdrew Consent|0|||
16859571|NCT02993523|37814506|FG000|Overall Study|Lost to Follow-up|0|||
16859572|NCT02993523|37814507|FG001|Overall Study|Lost to Follow-up|0|||
16859573|NCT02993523|37814508|FG002|Overall Study|Lost to Follow-up|3|||
16859574|NCT02993523|37814509|FG003|Overall Study|Lost to Follow-up|6|||
16859575|NCT02993523|37814510|FG004|Overall Study|Lost to Follow-up|0|||
16859576|NCT02993523|37814506|FG000|Overall Study|Death|1|||
16859577|NCT02993523|37814507|FG001|Overall Study|Death|1|||
16859578|NCT02993523|37814508|FG002|Overall Study|Death|138|||
16859579|NCT02993523|37814509|FG003|Overall Study|Death|222|||
16859580|NCT02993523|37814510|FG004|Overall Study|Death|6|||
16859581|NCT02993523|37814506|FG000|Overall Study|Reason not Specified|0|||
16859582|NCT02993523|37814507|FG001|Overall Study|Reason not Specified|0|||
16859583|NCT02993523|37814508|FG002|Overall Study|Reason not Specified|1|||
16859584|NCT02993523|37814509|FG003|Overall Study|Reason not Specified|1|||
16859585|NCT02993523|37814510|FG004|Overall Study|Reason not Specified|0|||
16859586|NCT01701362|37814520|FG000|Overall Study|Adverse events not related to study drug|1|||
16859587|NCT01701362|37814521|FG001|Overall Study|Adverse events not related to study drug|6|||
16859588|NCT01701362|37814520|FG000|Overall Study|Adverse events related to study drug|12|||
16859589|NCT01701362|37814521|FG001|Overall Study|Adverse events related to study drug|10|||
16859590|NCT01701362|37814520|FG000|Overall Study|Protocol Violation|5|||
16859591|NCT01701362|37814521|FG001|Overall Study|Protocol Violation|3|||
16859592|NCT01701362|37814520|FG000|Overall Study|No longer willing to participate|8|||
16943915|NCT01332968|38088112|FG003|Maintenance/Observation Period|Death|6|||
16943916|NCT01332968|38088113|FG004|Maintenance/Observation Period|Death|0|||
16943917|NCT01332968|38088114|FG005|Maintenance/Observation Period|Death|0|||
16943918|NCT01332968|38088115|FG006|Maintenance/Observation Period|Death|0|||
16943919|NCT01332968|38088116|FG007|Maintenance/Observation Period|Death|0|||
16943920|NCT01332968|38088109|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
16943921|NCT01332968|38088110|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
16943922|NCT01332968|38088111|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
16943923|NCT01332968|38088112|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
16943924|NCT01332968|38088113|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
16943925|NCT01332968|38088114|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
16943926|NCT01332968|38088115|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
16943927|NCT01332968|38088116|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
16943928|NCT01332968|38088109|FG000|Maintenance/Observation Period|Non-compliance|0|||
16943929|NCT01332968|38088110|FG001|Maintenance/Observation Period|Non-compliance|0|||
16943930|NCT01332968|38088111|FG002|Maintenance/Observation Period|Non-compliance|4|||
16943931|NCT01332968|38088112|FG003|Maintenance/Observation Period|Non-compliance|3|||
16943932|NCT01332968|38088113|FG004|Maintenance/Observation Period|Non-compliance|0|||
16943933|NCT01332968|38088114|FG005|Maintenance/Observation Period|Non-compliance|0|||
16943934|NCT01332968|38088115|FG006|Maintenance/Observation Period|Non-compliance|0|||
16943935|NCT01332968|38088116|FG007|Maintenance/Observation Period|Non-compliance|0|||
16943936|NCT01332968|38088109|FG000|Maintenance/Observation Period|Other|0|||
16943937|NCT01332968|38088110|FG001|Maintenance/Observation Period|Other|0|||
16943938|NCT01332968|38088111|FG002|Maintenance/Observation Period|Other|4|||
16943939|NCT01332968|38088112|FG003|Maintenance/Observation Period|Other|7|||
16943940|NCT01332968|38088113|FG004|Maintenance/Observation Period|Other|0|||
16943941|NCT01332968|38088114|FG005|Maintenance/Observation Period|Other|0|||
16943942|NCT01332968|38088115|FG006|Maintenance/Observation Period|Other|0|||
16943943|NCT01332968|38088116|FG007|Maintenance/Observation Period|Other|0|||
17028363|NCT00437983|38172768|FG001|Overall Study|Withdrawal by Subject|6|||
17028364|NCT00783692|38172777|FG000|Induction Phase|Adverse Event|7|||
17028365|NCT00783692|38172778|FG001|Induction Phase|Adverse Event|9|||
17028366|NCT00783692|38172779|FG002|Induction Phase|Adverse Event|24|||
17028367|NCT00783692|38172780|FG003|Induction Phase|Adverse Event|0|||
17028368|NCT00783692|38172781|FG004|Induction Phase|Adverse Event|0|||
17028369|NCT00783692|38172782|FG005|Induction Phase|Adverse Event|0|||
17028370|NCT00783692|38172783|FG006|Induction Phase|Adverse Event|0|||
17028371|NCT00783692|38172777|FG000|Induction Phase|Protocol Violation|0|||
17028372|NCT00783692|38172778|FG001|Induction Phase|Protocol Violation|0|||
17028373|NCT00783692|38172779|FG002|Induction Phase|Protocol Violation|1|||
17028374|NCT00783692|38172780|FG003|Induction Phase|Protocol Violation|0|||
17028375|NCT00783692|38172781|FG004|Induction Phase|Protocol Violation|0|||
17028376|NCT00783692|38172782|FG005|Induction Phase|Protocol Violation|0|||
16859593|NCT01701362|37814521|FG001|Overall Study|No longer willing to participate|14|||
16859594|NCT01701362|37814520|FG000|Overall Study|Lost to Follow-up|6|||
16943944|NCT01332968|38088109|FG000|Maintenance/Observation Period|Physician Decision|0|||
16943945|NCT01332968|38088110|FG001|Maintenance/Observation Period|Physician Decision|0|||
16943946|NCT01332968|38088111|FG002|Maintenance/Observation Period|Physician Decision|14|||
16943947|NCT01332968|38088112|FG003|Maintenance/Observation Period|Physician Decision|19|||
16943948|NCT01332968|38088113|FG004|Maintenance/Observation Period|Physician Decision|0|||
16943949|NCT01332968|38088114|FG005|Maintenance/Observation Period|Physician Decision|1|||
16943950|NCT01332968|38088115|FG006|Maintenance/Observation Period|Physician Decision|0|||
16943951|NCT01332968|38088116|FG007|Maintenance/Observation Period|Physician Decision|0|||
16943952|NCT01332968|38088109|FG000|Maintenance/Observation Period|Progressive Disease|0|||
16943953|NCT01332968|38088110|FG001|Maintenance/Observation Period|Progressive Disease|0|||
16943954|NCT01332968|38088111|FG002|Maintenance/Observation Period|Progressive Disease|72|||
16943955|NCT01332968|38088112|FG003|Maintenance/Observation Period|Progressive Disease|40|||
16943956|NCT01332968|38088113|FG004|Maintenance/Observation Period|Progressive Disease|0|||
16943957|NCT01332968|38088114|FG005|Maintenance/Observation Period|Progressive Disease|0|||
16943958|NCT01332968|38088115|FG006|Maintenance/Observation Period|Progressive Disease|0|||
16943959|NCT01332968|38088116|FG007|Maintenance/Observation Period|Progressive Disease|0|||
17028377|NCT00783692|38172783|FG006|Induction Phase|Protocol Violation|0|||
16943960|NCT01332968|38088109|FG000|Maintenance/Observation Period|Protocol Violation|0|||
16943961|NCT01332968|38088110|FG001|Maintenance/Observation Period|Protocol Violation|0|||
16943962|NCT01332968|38088111|FG002|Maintenance/Observation Period|Protocol Violation|1|||
16943963|NCT01332968|38088112|FG003|Maintenance/Observation Period|Protocol Violation|1|||
16943964|NCT01332968|38088113|FG004|Maintenance/Observation Period|Protocol Violation|0|||
16943965|NCT01332968|38088114|FG005|Maintenance/Observation Period|Protocol Violation|0|||
16943966|NCT01332968|38088115|FG006|Maintenance/Observation Period|Protocol Violation|0|||
16943967|NCT01332968|38088116|FG007|Maintenance/Observation Period|Protocol Violation|0|||
16943968|NCT01332968|38088109|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
16943969|NCT01332968|38088110|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
16859595|NCT01701362|37814521|FG001|Overall Study|Lost to Follow-up|9|||
16859596|NCT01701362|37814520|FG000|Overall Study|Insufficient clinical response|6|||
16859597|NCT01701362|37814521|FG001|Overall Study|Insufficient clinical response|6|||
16859598|NCT01701362|37814520|FG000|Overall Study|Death|0|||
16859599|NCT01701362|37814521|FG001|Overall Study|Death|1|||
16859600|NCT01701362|37814520|FG000|Overall Study|Randomized but not treated|1|||
16859601|NCT01701362|37814521|FG001|Overall Study|Randomized but not treated|2|||
16859602|NCT01701362|37814520|FG000|Overall Study|Reasons other than those mentioned above|3|||
16859603|NCT01701362|37814521|FG001|Overall Study|Reasons other than those mentioned above|5|||
16859604|NCT01710800|37814550|FG000|Overall Study|Withdrawal by Subject|21|||
16859605|NCT01710800|37814550|FG000|Overall Study|Protocol Violation|1|||
16943970|NCT01332968|38088111|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
16943971|NCT01332968|38088112|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
16943972|NCT01332968|38088113|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
16943973|NCT01332968|38088114|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
16943974|NCT01332968|38088115|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
16943975|NCT01332968|38088116|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
16943976|NCT01332968|38088109|FG000|Follow-Up Period|Adverse Event|0|||
16943977|NCT01332968|38088110|FG001|Follow-Up Period|Adverse Event|0|||
16943978|NCT01332968|38088111|FG002|Follow-Up Period|Adverse Event|0|||
16943979|NCT01332968|38088112|FG003|Follow-Up Period|Adverse Event|0|||
16943980|NCT01332968|38088113|FG004|Follow-Up Period|Adverse Event|0|||
16943981|NCT01332968|38088114|FG005|Follow-Up Period|Adverse Event|0|||
16943982|NCT01332968|38088115|FG006|Follow-Up Period|Adverse Event|0|||
16943983|NCT01332968|38088116|FG007|Follow-Up Period|Adverse Event|4|||
16943984|NCT01332968|38088109|FG000|Follow-Up Period|Death|0|||
16943985|NCT01332968|38088110|FG001|Follow-Up Period|Death|0|||
16943986|NCT01332968|38088111|FG002|Follow-Up Period|Death|0|||
16943987|NCT01332968|38088112|FG003|Follow-Up Period|Death|0|||
16943988|NCT01332968|38088113|FG004|Follow-Up Period|Death|0|||
16943989|NCT01332968|38088114|FG005|Follow-Up Period|Death|0|||
16943990|NCT01332968|38088115|FG006|Follow-Up Period|Death|27|||
16943991|NCT01332968|38088116|FG007|Follow-Up Period|Death|30|||
16943992|NCT01332968|38088109|FG000|Follow-Up Period|Lost to Follow-up|0|||
16943993|NCT01332968|38088110|FG001|Follow-Up Period|Lost to Follow-up|0|||
16943994|NCT01332968|38088111|FG002|Follow-Up Period|Lost to Follow-up|0|||
16943995|NCT01332968|38088112|FG003|Follow-Up Period|Lost to Follow-up|0|||
16943996|NCT01332968|38088113|FG004|Follow-Up Period|Lost to Follow-up|0|||
16943997|NCT01332968|38088114|FG005|Follow-Up Period|Lost to Follow-up|0|||
16943998|NCT01332968|38088115|FG006|Follow-Up Period|Lost to Follow-up|11|||
16943999|NCT01332968|38088116|FG007|Follow-Up Period|Lost to Follow-up|15|||
16944000|NCT01332968|38088109|FG000|Follow-Up Period|Non-compliance|0|||
16944001|NCT01332968|38088110|FG001|Follow-Up Period|Non-compliance|0|||
16944002|NCT01332968|38088111|FG002|Follow-Up Period|Non-compliance|0|||
16944003|NCT01332968|38088112|FG003|Follow-Up Period|Non-compliance|0|||
16944004|NCT01332968|38088113|FG004|Follow-Up Period|Non-compliance|0|||
16944005|NCT01332968|38088114|FG005|Follow-Up Period|Non-compliance|0|||
16944006|NCT01332968|38088115|FG006|Follow-Up Period|Non-compliance|4|||
16944007|NCT01332968|38088116|FG007|Follow-Up Period|Non-compliance|9|||
16944008|NCT01332968|38088109|FG000|Follow-Up Period|Other|0|||
16944009|NCT01332968|38088110|FG001|Follow-Up Period|Other|0|||
16944010|NCT01332968|38088111|FG002|Follow-Up Period|Other|0|||
16944011|NCT01332968|38088112|FG003|Follow-Up Period|Other|0|||
16944012|NCT01332968|38088113|FG004|Follow-Up Period|Other|0|||
16944013|NCT01332968|38088114|FG005|Follow-Up Period|Other|0|||
16944014|NCT01332968|38088115|FG006|Follow-Up Period|Other|18|||
16944015|NCT01332968|38088116|FG007|Follow-Up Period|Other|21|||
16944016|NCT01332968|38088109|FG000|Follow-Up Period|Physician Decision|0|||
16944017|NCT01332968|38088110|FG001|Follow-Up Period|Physician Decision|0|||
16944018|NCT01332968|38088111|FG002|Follow-Up Period|Physician Decision|0|||
16944019|NCT01332968|38088112|FG003|Follow-Up Period|Physician Decision|0|||
16944020|NCT01332968|38088113|FG004|Follow-Up Period|Physician Decision|0|||
16944021|NCT01332968|38088114|FG005|Follow-Up Period|Physician Decision|0|||
16944022|NCT01332968|38088115|FG006|Follow-Up Period|Physician Decision|12|||
16944023|NCT01332968|38088116|FG007|Follow-Up Period|Physician Decision|15|||
16944024|NCT01332968|38088109|FG000|Follow-Up Period|Progressive Disease|0|||
16944025|NCT01332968|38088110|FG001|Follow-Up Period|Progressive Disease|0|||
16859606|NCT01710020|37814556|FG000|Period 1|Protocol Violation|1|||
16859607|NCT01700348|37814562|FG000|Overall Study|Withdrawal by Subject|22|||
16859608|NCT01700348|37814562|FG000|Overall Study|Lost to Follow-up|1|||
16859609|NCT01700192|37814570|FG000|Overall Study|Adverse Event|73|||
16859610|NCT01700192|37814571|FG001|Overall Study|Adverse Event|18|||
16859611|NCT01700192|37814570|FG000|Overall Study|Lack of Efficacy|1|||
16859612|NCT01700192|37814571|FG001|Overall Study|Lack of Efficacy|0|||
16859613|NCT01700192|37814570|FG000|Overall Study|Lost to Follow-up|42|||
16859614|NCT01700192|37814571|FG001|Overall Study|Lost to Follow-up|29|||
16859615|NCT01700192|37814570|FG000|Overall Study|Noncompliance with study drug|0|||
16859616|NCT01700192|37814571|FG001|Overall Study|Noncompliance with study drug|5|||
16859617|NCT01700192|37814570|FG000|Overall Study|Physician Decision|2|||
16944026|NCT01332968|38088111|FG002|Follow-Up Period|Progressive Disease|0|||
16944027|NCT01332968|38088112|FG003|Follow-Up Period|Progressive Disease|0|||
16944028|NCT01332968|38088113|FG004|Follow-Up Period|Progressive Disease|0|||
16944029|NCT01332968|38088114|FG005|Follow-Up Period|Progressive Disease|0|||
16944030|NCT01332968|38088115|FG006|Follow-Up Period|Progressive Disease|126|||
16944031|NCT01332968|38088116|FG007|Follow-Up Period|Progressive Disease|106|||
16944032|NCT01332968|38088109|FG000|Follow-Up Period|Protocol Violation|0|||
16944033|NCT01332968|38088110|FG001|Follow-Up Period|Protocol Violation|0|||
16944034|NCT01332968|38088111|FG002|Follow-Up Period|Protocol Violation|0|||
16859618|NCT01700192|37814571|FG001|Overall Study|Physician Decision|3|||
16859619|NCT01700192|37814570|FG000|Overall Study|Pregnancy|1|||
16859620|NCT01700192|37814571|FG001|Overall Study|Pregnancy|4|||
16859621|NCT01700192|37814570|FG000|Overall Study|Progressive disease|1|||
16859622|NCT01700192|37814571|FG001|Overall Study|Progressive disease|0|||
16859623|NCT01700192|37814570|FG000|Overall Study|Protocol Violation|3|||
16859624|NCT01700192|37814571|FG001|Overall Study|Protocol Violation|4|||
16859625|NCT01700192|37814570|FG000|Overall Study|Technical problems|0|||
16859626|NCT01700192|37814571|FG001|Overall Study|Technical problems|1|||
16859627|NCT01700192|37814570|FG000|Overall Study|Withdrawal by Subject|56|||
16859628|NCT01700192|37814571|FG001|Overall Study|Withdrawal by Subject|64|||
16859629|NCT01700192|37814570|FG000|Overall Study|Never received study drug|1|||
16859630|NCT01700192|37814571|FG001|Overall Study|Never received study drug|0|||
16859631|NCT03153111|37814588|FG000|Overall Study|Death|2|||
16944035|NCT01332968|38088112|FG003|Follow-Up Period|Protocol Violation|0|||
16944036|NCT01332968|38088113|FG004|Follow-Up Period|Protocol Violation|0|||
16944037|NCT01332968|38088114|FG005|Follow-Up Period|Protocol Violation|0|||
16944038|NCT01332968|38088115|FG006|Follow-Up Period|Protocol Violation|1|||
16859632|NCT03153111|37814589|FG001|Overall Study|Death|5|||
16944039|NCT01332968|38088116|FG007|Follow-Up Period|Protocol Violation|0|||
16944040|NCT01332968|38088109|FG000|Follow-Up Period|Withdrawal by Subject|0|||
16944041|NCT01332968|38088110|FG001|Follow-Up Period|Withdrawal by Subject|0|||
16944042|NCT01332968|38088111|FG002|Follow-Up Period|Withdrawal by Subject|0|||
16944043|NCT01332968|38088112|FG003|Follow-Up Period|Withdrawal by Subject|0|||
16944044|NCT01332968|38088113|FG004|Follow-Up Period|Withdrawal by Subject|0|||
16944045|NCT01332968|38088114|FG005|Follow-Up Period|Withdrawal by Subject|0|||
16944046|NCT01332968|38088115|FG006|Follow-Up Period|Withdrawal by Subject|29|||
16944047|NCT01332968|38088116|FG007|Follow-Up Period|Withdrawal by Subject|32|||
16944048|NCT01332968|38088109|FG000|Follow-Up Period|No reason provided|0|||
16944049|NCT01332968|38088110|FG001|Follow-Up Period|No reason provided|0|||
16944050|NCT01332968|38088111|FG002|Follow-Up Period|No reason provided|0|||
16944051|NCT01332968|38088112|FG003|Follow-Up Period|No reason provided|0|||
16944052|NCT01332968|38088113|FG004|Follow-Up Period|No reason provided|0|||
16944053|NCT01332968|38088114|FG005|Follow-Up Period|No reason provided|0|||
16944054|NCT01332968|38088115|FG006|Follow-Up Period|No reason provided|2|||
16944055|NCT01332968|38088116|FG007|Follow-Up Period|No reason provided|3|||
16944056|NCT01332851|38088126|FG000|Overall Study|Withdrawal by Subject|4|||
16944057|NCT01332851|38088127|FG001|Overall Study|Withdrawal by Subject|2|||
16944058|NCT01332851|38088126|FG000|Overall Study|Lost to Follow-up|7|||
16944059|NCT01332851|38088127|FG001|Overall Study|Lost to Follow-up|11|||
16944060|NCT01332305|38088142|FG000|Overall Study|Adverse Event|1|||
16944061|NCT01332305|38088143|FG001|Overall Study|Adverse Event|4|||
16944062|NCT01332305|38088144|FG002|Overall Study|Adverse Event|6|||
16944063|NCT01332305|38088145|FG003|Overall Study|Adverse Event|3|||
16944064|NCT01332305|38088146|FG004|Overall Study|Adverse Event|5|||
16944065|NCT01332305|38088142|FG000|Overall Study|Withdrawal by Subject|6|||
16944066|NCT01332305|38088143|FG001|Overall Study|Withdrawal by Subject|5|||
16944067|NCT01332305|38088144|FG002|Overall Study|Withdrawal by Subject|4|||
16944068|NCT01332305|38088145|FG003|Overall Study|Withdrawal by Subject|1|||
16944069|NCT01332305|38088146|FG004|Overall Study|Withdrawal by Subject|0|||
16944070|NCT01332305|38088142|FG000|Overall Study|Lost to Follow-up|0|||
16944071|NCT01332305|38088143|FG001|Overall Study|Lost to Follow-up|2|||
16944072|NCT01332305|38088144|FG002|Overall Study|Lost to Follow-up|3|||
16944073|NCT01332305|38088145|FG003|Overall Study|Lost to Follow-up|2|||
16944074|NCT01332305|38088146|FG004|Overall Study|Lost to Follow-up|3|||
16944075|NCT01332305|38088142|FG000|Overall Study|Protocol Violation|1|||
16944076|NCT01332305|38088143|FG001|Overall Study|Protocol Violation|2|||
16944077|NCT01332305|38088144|FG002|Overall Study|Protocol Violation|1|||
16944078|NCT01332305|38088145|FG003|Overall Study|Protocol Violation|0|||
16944079|NCT01332305|38088146|FG004|Overall Study|Protocol Violation|3|||
16944080|NCT01332305|38088142|FG000|Overall Study|Withdrawal by Sponsor|1|||
16944081|NCT01332305|38088143|FG001|Overall Study|Withdrawal by Sponsor|0|||
16944082|NCT01332305|38088144|FG002|Overall Study|Withdrawal by Sponsor|0|||
16944083|NCT01332305|38088145|FG003|Overall Study|Withdrawal by Sponsor|1|||
16944084|NCT01332305|38088146|FG004|Overall Study|Withdrawal by Sponsor|1|||
16944085|NCT01332305|38088142|FG000|Overall Study|Treatment Failure|1|||
16944086|NCT01332305|38088143|FG001|Overall Study|Treatment Failure|1|||
16944087|NCT01332305|38088144|FG002|Overall Study|Treatment Failure|0|||
16944088|NCT01332305|38088145|FG003|Overall Study|Treatment Failure|0|||
17028378|NCT00783692|38172777|FG000|Induction Phase|Lack of Efficacy|1|||
17028379|NCT00783692|38172778|FG001|Induction Phase|Lack of Efficacy|3|||
17028380|NCT00783692|38172779|FG002|Induction Phase|Lack of Efficacy|28|||
17028381|NCT00783692|38172780|FG003|Induction Phase|Lack of Efficacy|0|||
17028382|NCT00783692|38172781|FG004|Induction Phase|Lack of Efficacy|0|||
17028383|NCT00783692|38172782|FG005|Induction Phase|Lack of Efficacy|0|||
17028384|NCT00783692|38172783|FG006|Induction Phase|Lack of Efficacy|0|||
17028385|NCT00783692|38172777|FG000|Induction Phase|Withdrawal by Subject|3|||
17028386|NCT00783692|38172778|FG001|Induction Phase|Withdrawal by Subject|9|||
17028387|NCT00783692|38172779|FG002|Induction Phase|Withdrawal by Subject|16|||
17028388|NCT00783692|38172780|FG003|Induction Phase|Withdrawal by Subject|0|||
17028389|NCT00783692|38172781|FG004|Induction Phase|Withdrawal by Subject|0|||
17028390|NCT00783692|38172782|FG005|Induction Phase|Withdrawal by Subject|0|||
17028391|NCT00783692|38172783|FG006|Induction Phase|Withdrawal by Subject|0|||
17028392|NCT00783692|38172777|FG000|Induction Phase|Lost to Follow-up|0|||
17028393|NCT00783692|38172778|FG001|Induction Phase|Lost to Follow-up|0|||
17028394|NCT00783692|38172779|FG002|Induction Phase|Lost to Follow-up|3|||
17028395|NCT00783692|38172780|FG003|Induction Phase|Lost to Follow-up|0|||
17028396|NCT00783692|38172781|FG004|Induction Phase|Lost to Follow-up|0|||
17028397|NCT00783692|38172782|FG005|Induction Phase|Lost to Follow-up|0|||
17028398|NCT00783692|38172783|FG006|Induction Phase|Lost to Follow-up|0|||
17028399|NCT00783692|38172777|FG000|Induction Phase|Other|0|||
17028400|NCT00783692|38172778|FG001|Induction Phase|Other|0|||
17028401|NCT00783692|38172779|FG002|Induction Phase|Other|2|||
16944089|NCT01332305|38088146|FG004|Overall Study|Treatment Failure|0|||
16944090|NCT01332305|38088142|FG000|Overall Study|Physician Decision|0|||
17028402|NCT00783692|38172780|FG003|Induction Phase|Other|0|||
17028403|NCT00783692|38172781|FG004|Induction Phase|Other|0|||
16944091|NCT01332305|38088143|FG001|Overall Study|Physician Decision|0|||
16944092|NCT01332305|38088144|FG002|Overall Study|Physician Decision|0|||
16944093|NCT01332305|38088145|FG003|Overall Study|Physician Decision|1|||
16944094|NCT01332305|38088146|FG004|Overall Study|Physician Decision|0|||
16944095|NCT01332227|38088160|FG000|Overall Study|Adverse Event|4|||
16944096|NCT01332227|38088161|FG001|Overall Study|Adverse Event|1|||
16944097|NCT01332227|38088160|FG000|Overall Study|Withdrawal by Subject|5|||
16944098|NCT01332227|38088161|FG001|Overall Study|Withdrawal by Subject|1|||
16944099|NCT01332227|38088160|FG000|Overall Study|Lost to Follow-up|2|||
16944100|NCT01332227|38088161|FG001|Overall Study|Lost to Follow-up|0|||
16944101|NCT01332227|38088160|FG000|Overall Study|Lack of Efficacy|3|||
16944102|NCT01332227|38088161|FG001|Overall Study|Lack of Efficacy|1|||
16944103|NCT01332227|38088160|FG000|Overall Study|Poor compliance/noncompliance|1|||
16944104|NCT01332227|38088161|FG001|Overall Study|Poor compliance/noncompliance|1|||
16944105|NCT01332227|38088160|FG000|Overall Study|Patient moved from area|1|||
16944106|NCT01332227|38088161|FG001|Overall Study|Patient moved from area|0|||
16944107|NCT01332227|38088160|FG000|Overall Study|Patient began prohibited medication|0|||
16944108|NCT01332227|38088161|FG001|Overall Study|Patient began prohibited medication|1|||
16944109|NCT01332149|38088169|FG000|Overall Study|Adverse Event|11|||
16944110|NCT01332149|38088170|FG001|Overall Study|Adverse Event|9|||
16944111|NCT01332149|38088169|FG000|Overall Study|Other unspecified|5|||
16944112|NCT01332149|38088170|FG001|Overall Study|Other unspecified|7|||
16944113|NCT01332149|38088169|FG000|Overall Study|Protocol Violation|1|||
16859633|NCT03153111|37814588|FG000|Overall Study|Lost to Follow-up|1|||
16859634|NCT03153111|37814589|FG001|Overall Study|Lost to Follow-up|0|||
16859635|NCT03153111|37814588|FG000|Overall Study|Physician Decision|5|||
16859636|NCT03153111|37814589|FG001|Overall Study|Physician Decision|1|||
16859637|NCT03153111|37814588|FG000|Overall Study|Withdrawal by Subject|3|||
16859638|NCT03153111|37814589|FG001|Overall Study|Withdrawal by Subject|3|||
16859639|NCT01709864|37814597|FG000|Overall Study|Physician Decision|0|||
16859640|NCT01709864|37814598|FG001|Overall Study|Physician Decision|1|||
16859641|NCT01709864|37814597|FG000|Overall Study|subject/guardian decision|5|||
16859642|NCT01709864|37814598|FG001|Overall Study|subject/guardian decision|6|||
16859643|NCT01709864|37814597|FG000|Overall Study|Lost to Follow-up|1|||
16859644|NCT01709864|37814598|FG001|Overall Study|Lost to Follow-up|0|||
16859645|NCT01709864|37814597|FG000|Overall Study|non-compliance with study treatment|1|||
16859646|NCT01709864|37814598|FG001|Overall Study|non-compliance with study treatment|1|||
16859647|NCT01709864|37814597|FG000|Overall Study|Adverse Event|0|||
16859648|NCT01709864|37814598|FG001|Overall Study|Adverse Event|2|||
16859649|NCT01709864|37814597|FG000|Overall Study|Death|0|||
16859650|NCT01709864|37814598|FG001|Overall Study|Death|1|||
16859651|NCT01709708|37814606|FG000|Overall Study|Protocol Violation|1|||
16859652|NCT01709708|37814607|FG001|Overall Study|Protocol Violation|2|||
16859653|NCT01709318|37814630|FG000|Overall Study|Adverse Event|3|||
16859654|NCT01709318|37814631|FG001|Overall Study|Adverse Event|4|||
16859655|NCT01709318|37814632|FG002|Overall Study|Adverse Event|2|||
16859656|NCT01709318|37814633|FG003|Overall Study|Adverse Event|2|||
16859657|NCT01709318|37814634|FG004|Overall Study|Adverse Event|0|||
16859658|NCT01709318|37814635|FG005|Overall Study|Adverse Event|1|||
16859659|NCT01709318|37814636|FG006|Overall Study|Adverse Event|2|||
16859660|NCT01709318|37814630|FG000|Overall Study|Lost to Follow-up|2|||
16859661|NCT01709318|37814631|FG001|Overall Study|Lost to Follow-up|0|||
16859662|NCT01709318|37814632|FG002|Overall Study|Lost to Follow-up|0|||
16859663|NCT01709318|37814633|FG003|Overall Study|Lost to Follow-up|0|||
16859664|NCT01709318|37814634|FG004|Overall Study|Lost to Follow-up|1|||
16859665|NCT01709318|37814635|FG005|Overall Study|Lost to Follow-up|1|||
16859666|NCT01709318|37814636|FG006|Overall Study|Lost to Follow-up|1|||
16859667|NCT01709318|37814630|FG000|Overall Study|Non-compliance with Study Drug|0|||
16859668|NCT01709318|37814631|FG001|Overall Study|Non-compliance with Study Drug|2|||
16859669|NCT01709318|37814632|FG002|Overall Study|Non-compliance with Study Drug|1|||
16859670|NCT01709318|37814633|FG003|Overall Study|Non-compliance with Study Drug|1|||
16859671|NCT01709318|37814634|FG004|Overall Study|Non-compliance with Study Drug|0|||
16859672|NCT01709318|37814635|FG005|Overall Study|Non-compliance with Study Drug|0|||
16859673|NCT01709318|37814636|FG006|Overall Study|Non-compliance with Study Drug|2|||
16859674|NCT01709318|37814630|FG000|Overall Study|Physician Decision|0|||
16859675|NCT01709318|37814631|FG001|Overall Study|Physician Decision|0|||
16859676|NCT01709318|37814632|FG002|Overall Study|Physician Decision|0|||
16859677|NCT01709318|37814633|FG003|Overall Study|Physician Decision|0|||
16859678|NCT01709318|37814634|FG004|Overall Study|Physician Decision|0|||
16859679|NCT01709318|37814635|FG005|Overall Study|Physician Decision|0|||
16859680|NCT01709318|37814636|FG006|Overall Study|Physician Decision|1|||
16859681|NCT01709318|37814630|FG000|Overall Study|Pregnancy|0|||
16859682|NCT01709318|37814631|FG001|Overall Study|Pregnancy|0|||
16859683|NCT01709318|37814632|FG002|Overall Study|Pregnancy|0|||
16859684|NCT01709318|37814633|FG003|Overall Study|Pregnancy|0|||
16859685|NCT01709318|37814634|FG004|Overall Study|Pregnancy|1|||
16859686|NCT01709318|37814635|FG005|Overall Study|Pregnancy|0|||
16859687|NCT01709318|37814636|FG006|Overall Study|Pregnancy|0|||
16944114|NCT01332149|38088170|FG001|Overall Study|Protocol Violation|3|||
16944115|NCT01332149|38088169|FG000|Overall Study|Withdrawal by Subject|4|||
16944116|NCT01332149|38088170|FG001|Overall Study|Withdrawal by Subject|5|||
16944117|NCT01332149|38088169|FG000|Overall Study|Lost to Follow-up|1|||
16944118|NCT01332149|38088170|FG001|Overall Study|Lost to Follow-up|1|||
16944119|NCT01332149|38088169|FG000|Overall Study|Insufficient clinical response|4|||
16944120|NCT01332149|38088170|FG001|Overall Study|Insufficient clinical response|7|||
16944121|NCT01332149|38088169|FG000|Overall Study|Did not meet entrance criteria|3|||
16944122|NCT01332149|38088170|FG001|Overall Study|Did not meet entrance criteria|4|||
16944123|NCT01332149|38088169|FG000|Overall Study|Randomized but not treated|1|||
16944124|NCT01332149|38088170|FG001|Overall Study|Randomized but not treated|2|||
16944125|NCT01330628|38088178|FG000|Overall Study|Death|2|||
16944126|NCT01330628|38088179|FG001|Overall Study|Death|3|||
16944127|NCT01330628|38088178|FG000|Overall Study|Lost to Follow-up|5|||
16944128|NCT01330628|38088179|FG001|Overall Study|Lost to Follow-up|6|||
16944129|NCT01330628|38088178|FG000|Overall Study|Adverse Event|44|||
16944130|NCT01330628|38088179|FG001|Overall Study|Adverse Event|25|||
16944131|NCT01330628|38088178|FG000|Overall Study|Withdrawn|18|||
16944132|NCT01330628|38088179|FG001|Overall Study|Withdrawn|6|||
16944133|NCT01330628|38088178|FG000|Overall Study|Didn't receive study treatment|1|||
16944134|NCT01330628|38088179|FG001|Overall Study|Didn't receive study treatment|0|||
16944135|NCT01330433|38088187|FG000|Overall Study|Death|1|||
16944136|NCT01330433|38088188|FG001|Overall Study|Death|3|||
16944137|NCT01330433|38088187|FG000|Overall Study|Lost to Follow-up|1|||
16944138|NCT01330433|38088188|FG001|Overall Study|Lost to Follow-up|0|||
16944139|NCT01330316|38088196|FG000|Overall Study|Adverse Event|2|||
16944140|NCT01330316|38088197|FG001|Overall Study|Adverse Event|2|||
16944141|NCT01330316|38088196|FG000|Overall Study|Lack of Efficacy|0|||
16944142|NCT01330316|38088197|FG001|Overall Study|Lack of Efficacy|10|||
16944143|NCT01330316|38088196|FG000|Overall Study|Lost to Follow-up|0|||
16944144|NCT01330316|38088197|FG001|Overall Study|Lost to Follow-up|1|||
16944145|NCT01330316|38088196|FG000|Overall Study|Withdrawal by Subject|0|||
16944146|NCT01330316|38088197|FG001|Overall Study|Withdrawal by Subject|1|||
16859688|NCT01709318|37814630|FG000|Overall Study|Protocol Violation|0|||
16859689|NCT01709318|37814631|FG001|Overall Study|Protocol Violation|0|||
16859690|NCT01709318|37814632|FG002|Overall Study|Protocol Violation|0|||
16944147|NCT01330316|38088196|FG000|Overall Study|other than above|0|||
16944148|NCT01330316|38088197|FG001|Overall Study|other than above|1|||
16944149|NCT01326702|38088210|FG000|Overall Study|Other|1|||
16944150|NCT01326702|38088211|FG001|Overall Study|Other|0|||
16944151|NCT01326702|38088212|FG002|Overall Study|Other|0|||
16944152|NCT01326702|38088213|FG003|Overall Study|Other|0|||
16859691|NCT01709318|37814633|FG003|Overall Study|Protocol Violation|0|||
16859692|NCT01709318|37814634|FG004|Overall Study|Protocol Violation|2|||
16944153|NCT01326702|38088214|FG004|Overall Study|Other|0|||
16944154|NCT01326702|38088215|FG005|Overall Study|Other|1|||
16944155|NCT01326702|38088216|FG006|Overall Study|Other|0|||
16944156|NCT01326702|38088210|FG000|Overall Study|progressive disease|1|||
16859693|NCT01709318|37814635|FG005|Overall Study|Protocol Violation|0|||
16859694|NCT01709318|37814636|FG006|Overall Study|Protocol Violation|1|||
16859695|NCT01709318|37814630|FG000|Overall Study|Technical Problems|1|||
16859696|NCT01709318|37814631|FG001|Overall Study|Technical Problems|0|||
16859697|NCT01709318|37814632|FG002|Overall Study|Technical Problems|0|||
16859698|NCT01709318|37814633|FG003|Overall Study|Technical Problems|0|||
16859699|NCT01709318|37814634|FG004|Overall Study|Technical Problems|0|||
16859700|NCT01709318|37814635|FG005|Overall Study|Technical Problems|0|||
17127380|NCT02942264|38267637|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
17127381|NCT02942264|38267638|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
17127382|NCT02942264|38267639|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
17127383|NCT03322514|38267666|FG000|Overall Study|Withdrawal by Subject|1|||
17127384|NCT03322514|38267667|FG001|Overall Study|Withdrawal by Subject|1|||
17127385|NCT03325712|38267681|FG000|Overall Study|Protocol Violation|0|||
17127386|NCT03325712|38267682|FG001|Overall Study|Protocol Violation|0|||
17127387|NCT03325712|38267683|FG002|Overall Study|Protocol Violation|0|||
16859701|NCT01709318|37814636|FG006|Overall Study|Technical Problems|0|||
16944157|NCT01326702|38088211|FG001|Overall Study|progressive disease|1|||
17127388|NCT03325712|38267684|FG003|Overall Study|Protocol Violation|0|||
17127389|NCT03325712|38267685|FG004|Overall Study|Protocol Violation|1|||
17127390|NCT03325712|38267686|FG005|Overall Study|Protocol Violation|0|||
17127391|NCT03325712|38267687|FG006|Overall Study|Protocol Violation|0|||
17127392|NCT03325712|38267688|FG007|Overall Study|Protocol Violation|0|||
17127393|NCT03325712|38267681|FG000|Overall Study|Adverse Event|0|||
17127394|NCT03325712|38267682|FG001|Overall Study|Adverse Event|0|||
17127395|NCT03325712|38267683|FG002|Overall Study|Adverse Event|0|||
17127396|NCT03325712|38267684|FG003|Overall Study|Adverse Event|0|||
16859702|NCT01709318|37814630|FG000|Overall Study|Withdrawal by Subject|3|||
16944158|NCT01326702|38088212|FG002|Overall Study|progressive disease|3|||
16944159|NCT01326702|38088213|FG003|Overall Study|progressive disease|1|||
16859703|NCT01709318|37814631|FG001|Overall Study|Withdrawal by Subject|0|||
16944160|NCT01326702|38088214|FG004|Overall Study|progressive disease|3|||
16944161|NCT01326702|38088215|FG005|Overall Study|progressive disease|2|||
17127397|NCT03325712|38267685|FG004|Overall Study|Adverse Event|1|||
17127398|NCT03325712|38267686|FG005|Overall Study|Adverse Event|0|||
17127399|NCT03325712|38267687|FG006|Overall Study|Adverse Event|0|||
17127400|NCT03325712|38267688|FG007|Overall Study|Adverse Event|0|||
17127401|NCT03734679|38267716|FG000|Overall Study|Missed Visit|1|||
17127402|NCT03325556|38267720|FG000|Open-label Period|Lack of Response in OL period|70|||
17127403|NCT03325556|38267721|FG001|Open-label Period|Lack of Response in OL period|0|||
17127404|NCT03325556|38267722|FG002|Open-label Period|Lack of Response in OL period|0|||
16944162|NCT01326702|38088216|FG006|Overall Study|progressive disease|3|||
16944163|NCT01326702|38088210|FG000|Overall Study|Death|0|||
16944164|NCT01326702|38088211|FG001|Overall Study|Death|1|||
16944165|NCT01326702|38088212|FG002|Overall Study|Death|0|||
16944166|NCT01326702|38088213|FG003|Overall Study|Death|0|||
16944167|NCT01326702|38088214|FG004|Overall Study|Death|0|||
16944168|NCT01326702|38088215|FG005|Overall Study|Death|0|||
16944169|NCT01326702|38088216|FG006|Overall Study|Death|0|||
16944170|NCT01326702|38088210|FG000|Overall Study|Adverse Event|0|||
16944171|NCT01326702|38088211|FG001|Overall Study|Adverse Event|0|||
16944172|NCT01326702|38088212|FG002|Overall Study|Adverse Event|1|||
16944173|NCT01326702|38088213|FG003|Overall Study|Adverse Event|1|||
16944174|NCT01326702|38088214|FG004|Overall Study|Adverse Event|0|||
16944175|NCT01326702|38088215|FG005|Overall Study|Adverse Event|3|||
16944176|NCT01326702|38088216|FG006|Overall Study|Adverse Event|1|||
16944177|NCT01326702|38088210|FG000|Overall Study|Withdrawal by Subject|0|||
16944178|NCT01326702|38088211|FG001|Overall Study|Withdrawal by Subject|0|||
16944179|NCT01326702|38088212|FG002|Overall Study|Withdrawal by Subject|1|||
16944180|NCT01326702|38088213|FG003|Overall Study|Withdrawal by Subject|0|||
16944181|NCT01326702|38088214|FG004|Overall Study|Withdrawal by Subject|1|||
16944182|NCT01326702|38088215|FG005|Overall Study|Withdrawal by Subject|1|||
16944183|NCT01326702|38088216|FG006|Overall Study|Withdrawal by Subject|3|||
16944184|NCT01326702|38088210|FG000|Overall Study|Not Treated|0|||
16944185|NCT01326702|38088211|FG001|Overall Study|Not Treated|0|||
16944186|NCT01326702|38088212|FG002|Overall Study|Not Treated|0|||
16944187|NCT01326702|38088213|FG003|Overall Study|Not Treated|1|||
16944188|NCT01326702|38088214|FG004|Overall Study|Not Treated|0|||
16944189|NCT01326702|38088215|FG005|Overall Study|Not Treated|1|||
16944190|NCT01326702|38088216|FG006|Overall Study|Not Treated|0|||
16944191|NCT01327703|38088235|FG000|Second Treatment Period|Adverse Event|1|||
16944192|NCT01327703|38088236|FG001|Second Treatment Period|Adverse Event|1|||
16944193|NCT01327703|38088235|FG000|Second Treatment Period|Protocol Violation|0|||
16944194|NCT01327703|38088236|FG001|Second Treatment Period|Protocol Violation|1|||
16944195|NCT01380080|38088247|FG000|Overall Study|Death|36|||
16944196|NCT01380080|38088248|FG001|Overall Study|Death|44|||
16944197|NCT01380080|38088247|FG000|Overall Study|Site is closing|28|||
16944198|NCT01380080|38088248|FG001|Overall Study|Site is closing|31|||
16944199|NCT01380080|38088247|FG000|Overall Study|Not able to get to clinic|7|||
16944200|NCT01380080|38088248|FG001|Overall Study|Not able to get to clinic|1|||
17127405|NCT03325556|38267720|FG000|Open-label Period|Adverse Event|27|||
17127406|NCT03325556|38267721|FG001|Open-label Period|Adverse Event|0|||
17127407|NCT03325556|38267722|FG002|Open-label Period|Adverse Event|0|||
17127408|NCT03325556|38267720|FG000|Open-label Period|Death|1|||
17127409|NCT03325556|38267721|FG001|Open-label Period|Death|0|||
17127410|NCT03325556|38267722|FG002|Open-label Period|Death|0|||
17127411|NCT03325556|38267720|FG000|Open-label Period|Lost to Follow-up|1|||
17127412|NCT03325556|38267721|FG001|Open-label Period|Lost to Follow-up|0|||
17127413|NCT03325556|38267722|FG002|Open-label Period|Lost to Follow-up|0|||
17127414|NCT03325556|38267720|FG000|Open-label Period|Non-compliance with study drug|5|||
17127415|NCT03325556|38267721|FG001|Open-label Period|Non-compliance with study drug|0|||
17127416|NCT03325556|38267722|FG002|Open-label Period|Non-compliance with study drug|0|||
17127417|NCT03325556|38267720|FG000|Open-label Period|Use of prohibited medication|1|||
17127418|NCT03325556|38267721|FG001|Open-label Period|Use of prohibited medication|0|||
17127419|NCT03325556|38267722|FG002|Open-label Period|Use of prohibited medication|0|||
17127420|NCT03325556|38267720|FG000|Open-label Period|Protocol Violation|4|||
17127421|NCT03325556|38267721|FG001|Open-label Period|Protocol Violation|0|||
17127422|NCT03325556|38267722|FG002|Open-label Period|Protocol Violation|0|||
17127423|NCT03325556|38267720|FG000|Open-label Period|Withdrawal by Subject|17|||
17127424|NCT03325556|38267721|FG001|Open-label Period|Withdrawal by Subject|0|||
17127425|NCT03325556|38267722|FG002|Open-label Period|Withdrawal by Subject|0|||
17127426|NCT03325556|38267720|FG000|Open-label Period|Not otherwise specified|8|||
17127427|NCT03325556|38267721|FG001|Open-label Period|Not otherwise specified|0|||
17127428|NCT03325556|38267722|FG002|Open-label Period|Not otherwise specified|0|||
17127429|NCT03325556|38267720|FG000|Open-label Period|Administrative discont. at study termination|41|||
17127430|NCT03325556|38267721|FG001|Open-label Period|Administrative discont. at study termination|0|||
17127431|NCT03325556|38267722|FG002|Open-label Period|Administrative discont. at study termination|0|||
16944201|NCT01380080|38088247|FG000|Overall Study|Not willing to adhere to requirements|6|||
16944202|NCT01380080|38088248|FG001|Overall Study|Not willing to adhere to requirements|2|||
16944203|NCT01380080|38088247|FG000|Overall Study|Withdrawal by Subject|5|||
17127432|NCT03325556|38267720|FG000|Double-blind Period|Relapse|0|||
17127433|NCT03325556|38267721|FG001|Double-blind Period|Relapse|15|||
17127434|NCT03325556|38267722|FG002|Double-blind Period|Relapse|34|||
17127435|NCT03325556|38267720|FG000|Double-blind Period|Adverse Event|0|||
17127436|NCT03325556|38267721|FG001|Double-blind Period|Adverse Event|3|||
17127437|NCT03325556|38267722|FG002|Double-blind Period|Adverse Event|1|||
17127438|NCT03325556|38267720|FG000|Double-blind Period|Noncompliance with study drug|0|||
17127439|NCT03325556|38267721|FG001|Double-blind Period|Noncompliance with study drug|0|||
17127440|NCT03325556|38267722|FG002|Double-blind Period|Noncompliance with study drug|1|||
17127441|NCT03325556|38267720|FG000|Double-blind Period|Use of prohibited medication|0|||
17127442|NCT03325556|38267721|FG001|Double-blind Period|Use of prohibited medication|1|||
17127443|NCT03325556|38267722|FG002|Double-blind Period|Use of prohibited medication|0|||
17127444|NCT03325556|38267720|FG000|Double-blind Period|Physician Decision|0|||
17127445|NCT03325556|38267721|FG001|Double-blind Period|Physician Decision|0|||
17127446|NCT03325556|38267722|FG002|Double-blind Period|Physician Decision|1|||
17127447|NCT03325556|38267720|FG000|Double-blind Period|Withdrawal by Subject|0|||
17127448|NCT03325556|38267721|FG001|Double-blind Period|Withdrawal by Subject|6|||
17127449|NCT03325556|38267722|FG002|Double-blind Period|Withdrawal by Subject|4|||
17127450|NCT03325556|38267720|FG000|Double-blind Period|Not otherwise specified|0|||
17127451|NCT03325556|38267721|FG001|Double-blind Period|Not otherwise specified|1|||
17127452|NCT03325556|38267722|FG002|Double-blind Period|Not otherwise specified|5|||
17127453|NCT03325556|38267720|FG000|Double-blind Period|Administrative discont. at study termination|0|||
17127454|NCT03325556|38267721|FG001|Double-blind Period|Administrative discont. at study termination|35|||
17127455|NCT03325556|38267722|FG002|Double-blind Period|Administrative discont. at study termination|31|||
17127456|NCT03320564|38267729|FG000|Overall Study|Protocol Violation|1|||
17127457|NCT03325166|38267733|FG000|Overall Study|Adverse Event|1|||
17127458|NCT02888756|38267740|FG000|Analytical Treatment Interruption|Physician Decision|10|||
17127459|NCT02888756|38267741|FG001|Analytical Treatment Interruption|Physician Decision|6|||
17127460|NCT02888756|38267742|FG002|Analytical Treatment Interruption|Physician Decision|5|||
17127461|NCT03305666|38267752|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
17127462|NCT03305666|38267753|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
17127463|NCT03304184|38267761|FG000|Overall Study|Withdrawal by Subject|1|||
17127464|NCT03304184|38267762|FG001|Overall Study|Withdrawal by Subject|2|||
17127465|NCT03736785|38267772|FG000|Overall Study|Adverse Event|1|||
16859704|NCT01709318|37814632|FG002|Overall Study|Withdrawal by Subject|3|||
16859705|NCT01709318|37814633|FG003|Overall Study|Withdrawal by Subject|3|||
16944204|NCT01380080|38088248|FG001|Overall Study|Withdrawal by Subject|2|||
16944205|NCT01380080|38088247|FG000|Overall Study|Lost to Follow-up|3|||
16944206|NCT01380080|38088248|FG001|Overall Study|Lost to Follow-up|3|||
16944207|NCT01379768|38088257|FG000|Overall Study|Adverse Event|1|||
16944208|NCT01379768|38088258|FG001|Overall Study|Adverse Event|1|||
16944209|NCT01379768|38088259|FG002|Overall Study|Adverse Event|0|||
16944210|NCT01379768|38088257|FG000|Overall Study|Lost to Follow-up|2|||
17127466|NCT03736785|38267773|FG001|Overall Study|Adverse Event|1|||
17127467|NCT03736785|38267774|FG002|Overall Study|Adverse Event|1|||
17127468|NCT03736785|38267772|FG000|Overall Study|Death|1|||
17127469|NCT03736785|38267773|FG001|Overall Study|Death|0|||
17127470|NCT03736785|38267774|FG002|Overall Study|Death|1|||
17127471|NCT03736785|38267772|FG000|Overall Study|Lost to Follow-up|0|||
17127472|NCT03736785|38267773|FG001|Overall Study|Lost to Follow-up|2|||
17127473|NCT03736785|38267774|FG002|Overall Study|Lost to Follow-up|3|||
16859706|NCT01709318|37814634|FG004|Overall Study|Withdrawal by Subject|0|||
16859707|NCT01709318|37814635|FG005|Overall Study|Withdrawal by Subject|2|||
16859708|NCT01709318|37814636|FG006|Overall Study|Withdrawal by Subject|4|||
16859709|NCT01709318|37814630|FG000|Overall Study|Other Protocol Specified Criteria|0|||
16859710|NCT01709318|37814631|FG001|Overall Study|Other Protocol Specified Criteria|1|||
16859711|NCT01709318|37814632|FG002|Overall Study|Other Protocol Specified Criteria|0|||
16859712|NCT01709318|37814633|FG003|Overall Study|Other Protocol Specified Criteria|0|||
16859713|NCT01709318|37814634|FG004|Overall Study|Other Protocol Specified Criteria|0|||
16859714|NCT01709318|37814635|FG005|Overall Study|Other Protocol Specified Criteria|0|||
16859715|NCT01709318|37814636|FG006|Overall Study|Other Protocol Specified Criteria|0|||
16859716|NCT01699178|37814654|FG000|Overall Study|Adverse Event|1|||
16859717|NCT01699178|37814655|FG001|Overall Study|Adverse Event|5|||
16859718|NCT01699178|37814654|FG000|Overall Study|Lost to Follow-up|1|||
16859719|NCT01699178|37814655|FG001|Overall Study|Lost to Follow-up|6|||
16859720|NCT01699178|37814654|FG000|Overall Study|Non-compliance with Study Drug|3|||
16859721|NCT01699178|37814655|FG001|Overall Study|Non-compliance with Study Drug|1|||
16859722|NCT01699178|37814654|FG000|Overall Study|Physician Decision|1|||
16859723|NCT01699178|37814655|FG001|Overall Study|Physician Decision|0|||
16859724|NCT01699178|37814654|FG000|Overall Study|Withdrawal by Subject|4|||
16859725|NCT01699178|37814655|FG001|Overall Study|Withdrawal by Subject|12|||
16859726|NCT01699178|37814654|FG000|Overall Study|Hematocrit >54%|1|||
16859727|NCT01699178|37814655|FG001|Overall Study|Hematocrit >54%|1|||
16944211|NCT01379768|38088258|FG001|Overall Study|Lost to Follow-up|0|||
16859728|NCT01699178|37814654|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
16859729|NCT01699178|37814655|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
16859730|NCT01699178|37814654|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
16859731|NCT01699178|37814655|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
16859732|NCT01683409|37814666|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
16859733|NCT01683409|37814667|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
16859734|NCT01683409|37814668|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
16859735|NCT01683409|37814669|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
16859736|NCT01683409|37814670|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
16859737|NCT01683409|37814666|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
16859738|NCT01683409|37814667|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
16859739|NCT01683409|37814668|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
16859740|NCT01683409|37814669|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
16859741|NCT01683409|37814670|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
16859742|NCT01683409|37814666|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
16859743|NCT01683409|37814667|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
16859744|NCT01683409|37814668|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
16859745|NCT01683409|37814669|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
16859746|NCT01683409|37814670|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
16859747|NCT01683409|37814666|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
16859748|NCT01683409|37814667|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
16859749|NCT01683409|37814668|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
16859750|NCT01683409|37814669|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
16859751|NCT01683409|37814670|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
16859752|NCT01683409|37814666|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
16859753|NCT01683409|37814667|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
17127474|NCT03736785|38267772|FG000|Overall Study|Non compliance with study drug|1|||
16859754|NCT01683409|37814668|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
16859755|NCT01683409|37814669|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
16859756|NCT01683409|37814670|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
16859757|NCT01683409|37814666|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
16859758|NCT01683409|37814667|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
16859759|NCT01683409|37814668|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
16859760|NCT01683409|37814669|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
16859761|NCT01683409|37814670|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
16859762|NCT01683409|37814666|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
16859763|NCT01683409|37814667|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
16859764|NCT01683409|37814668|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
16859765|NCT01683409|37814669|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
16859766|NCT01683409|37814670|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
16859767|NCT01683409|37814666|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
16859768|NCT01683409|37814667|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
16859769|NCT01683409|37814668|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
16859770|NCT01683409|37814669|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
16859771|NCT01683409|37814670|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
16859772|NCT01683409|37814666|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
16859773|NCT01683409|37814667|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
16859774|NCT01683409|37814668|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
16859775|NCT01683409|37814669|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
16859776|NCT01683409|37814670|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
16859777|NCT01683409|37814666|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
16859778|NCT01683409|37814667|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
16859779|NCT01683409|37814668|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
16859780|NCT01683409|37814669|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
16859781|NCT01683409|37814670|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
16859782|NCT01683409|37814666|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
16859783|NCT01683409|37814667|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
16859784|NCT01683409|37814668|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
16859785|NCT01683409|37814669|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
16859786|NCT01683409|37814670|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
16859787|NCT01699022|37814696|FG000|Overall Study|Early discontinuation from the study|3|||
16859788|NCT01683019|37814704|FG000|Overall Study|Withdrawal by Subject|2|||
16859789|NCT01683019|37814705|FG001|Overall Study|Withdrawal by Subject|1|||
16859790|NCT01683019|37814706|FG002|Overall Study|Withdrawal by Subject|4|||
16859791|NCT01709162|37814716|FG000|Overall Study|Disease progression|3|||
16859792|NCT01709162|37814717|FG001|Overall Study|Disease progression|3|||
16859793|NCT01709162|37814716|FG000|Overall Study|Study drug toxicity|2|||
16859794|NCT01709162|37814717|FG001|Overall Study|Study drug toxicity|0|||
16859795|NCT01709162|37814716|FG000|Overall Study|Administrative reason by sponsor|0|||
16859796|NCT01709162|37814717|FG001|Overall Study|Administrative reason by sponsor|1|||
16859797|NCT01709162|37814716|FG000|Overall Study|Other|1|||
16859798|NCT01709162|37814717|FG001|Overall Study|Other|0|||
16859799|NCT01709162|37814716|FG000|Overall Study|Withdrawal by Subject|0|||
16859800|NCT01709162|37814717|FG001|Overall Study|Withdrawal by Subject|1|||
16859801|NCT01698554|37814727|FG000|Overall Study|Adverse Event|2|||
16859802|NCT01698554|37814728|FG001|Overall Study|Adverse Event|5|||
16859803|NCT01698554|37814729|FG002|Overall Study|Adverse Event|0|||
16859804|NCT01698554|37814730|FG003|Overall Study|Adverse Event|1|||
16859805|NCT01698554|37814727|FG000|Overall Study|Lost to Follow-up|1|||
16859806|NCT01698554|37814728|FG001|Overall Study|Lost to Follow-up|0|||
16859807|NCT01698554|37814729|FG002|Overall Study|Lost to Follow-up|0|||
16859808|NCT01698554|37814730|FG003|Overall Study|Lost to Follow-up|0|||
16859809|NCT01698554|37814727|FG000|Overall Study|Personal Reasons|0|||
16859810|NCT01698554|37814728|FG001|Overall Study|Personal Reasons|5|||
16859811|NCT01698554|37814729|FG002|Overall Study|Personal Reasons|1|||
16859812|NCT01698554|37814730|FG003|Overall Study|Personal Reasons|1|||
16859813|NCT01698554|37814727|FG000|Overall Study|Protocol Violation|2|||
16859814|NCT01698554|37814728|FG001|Overall Study|Protocol Violation|0|||
16859815|NCT01698554|37814729|FG002|Overall Study|Protocol Violation|1|||
16859816|NCT01698554|37814730|FG003|Overall Study|Protocol Violation|0|||
16859817|NCT01698554|37814727|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16859818|NCT01698554|37814728|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16859819|NCT01698554|37814729|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16859820|NCT01698554|37814730|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16859821|NCT01698320|37814742|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
16859822|NCT01698320|37814743|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
16859823|NCT01698320|37814744|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
16859824|NCT01698320|37814742|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
16859825|NCT01698320|37814743|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
16859826|NCT01698320|37814744|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
16859827|NCT01698320|37814742|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
16859828|NCT01698320|37814743|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
16859829|NCT01698320|37814744|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
16859830|NCT01698320|37814742|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
16859831|NCT01698320|37814743|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
16859832|NCT01698320|37814744|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
16859833|NCT01698320|37814742|FG000|12-Week Double-Blind Period|Adverse Event|0|||
16859834|NCT01698320|37814743|FG001|12-Week Double-Blind Period|Adverse Event|1|||
16859835|NCT01698320|37814744|FG002|12-Week Double-Blind Period|Adverse Event|1|||
16859836|NCT01698320|37814742|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
16859837|NCT01698320|37814743|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
16859838|NCT01698320|37814744|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
16859839|NCT01698320|37814742|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
16859840|NCT01698320|37814743|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
16859841|NCT01698320|37814744|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
16859842|NCT01698320|37814742|FG000|12-Week Double-Blind Period|Pregnancy|0|||
16859843|NCT01698320|37814743|FG001|12-Week Double-Blind Period|Pregnancy|1|||
16859844|NCT01698320|37814744|FG002|12-Week Double-Blind Period|Pregnancy|1|||
16859845|NCT01698320|37814742|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
16859846|NCT01698320|37814743|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
16859847|NCT01698320|37814744|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
16859848|NCT01698320|37814742|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
16859849|NCT01698320|37814743|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
16859850|NCT01698320|37814744|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
16859851|NCT01698320|37814742|FG000|40-Week Open-Label Period|Adverse Event|0|||
16859852|NCT01698320|37814743|FG001|40-Week Open-Label Period|Adverse Event|3|||
16859853|NCT01698320|37814744|FG002|40-Week Open-Label Period|Adverse Event|2|||
16859854|NCT01698320|37814742|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
16859855|NCT01698320|37814743|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
16859856|NCT01698320|37814744|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
16859857|NCT01698320|37814742|FG000|40-Week Open-Label Period|Pregnancy|0|||
16859858|NCT01698320|37814743|FG001|40-Week Open-Label Period|Pregnancy|2|||
16859859|NCT01698320|37814744|FG002|40-Week Open-Label Period|Pregnancy|1|||
16859860|NCT01698320|37814742|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
16859861|NCT01698320|37814743|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
16859862|NCT01698320|37814744|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
16944212|NCT01379768|38088259|FG002|Overall Study|Lost to Follow-up|0|||
16859863|NCT01698320|37814742|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
16859864|NCT01698320|37814743|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
16859865|NCT01698320|37814744|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
16859866|NCT01698008|37814754|FG000|Overall Study|Withdrawal by Subject|1|||
16859867|NCT01698008|37814755|FG001|Overall Study|Withdrawal by Subject|2|||
16859868|NCT01697696|37814771|FG000|Overall Study|Study terminated by sponsor|0|||
16859869|NCT01697696|37814772|FG001|Overall Study|Study terminated by sponsor|3|||
16859870|NCT01697696|37814771|FG000|Overall Study|Protocol deviation|1|||
16859871|NCT01697696|37814772|FG001|Overall Study|Protocol deviation|0|||
16859872|NCT01697696|37814771|FG000|Overall Study|Physician Decision|1|||
16859873|NCT01697696|37814772|FG001|Overall Study|Physician Decision|0|||
16859874|NCT01697696|37814771|FG000|Overall Study|Death|4|||
16859875|NCT01697696|37814772|FG001|Overall Study|Death|2|||
16859876|NCT01697696|37814771|FG000|Overall Study|Lost to Follow-up|10|||
16859877|NCT01697696|37814772|FG001|Overall Study|Lost to Follow-up|7|||
16859878|NCT01697696|37814771|FG000|Overall Study|Subject/guardian decision|31|||
16859879|NCT01697696|37814772|FG001|Overall Study|Subject/guardian decision|35|||
16859880|NCT01569152|37814780|FG000|Phase IIa, Period 1|Early Escape|5|||
16859881|NCT01569152|37814781|FG001|Phase IIa, Period 1|Early Escape|22|||
16859882|NCT01569152|37814782|FG002|Phase IIa, Period 1|Early Escape|0|||
16859883|NCT01569152|37814780|FG000|Phase IIa, Period 1|Adverse Event|4|||
16859884|NCT01569152|37814781|FG001|Phase IIa, Period 1|Adverse Event|0|||
16859885|NCT01569152|37814782|FG002|Phase IIa, Period 1|Adverse Event|0|||
16859886|NCT01569152|37814780|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
16859887|NCT01569152|37814781|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
16859888|NCT01569152|37814782|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
16859889|NCT01569152|37814780|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
16859890|NCT01569152|37814781|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
16859891|NCT01569152|37814782|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
16859892|NCT01569152|37814780|FG000|Phase IIa, Period 1|Protocol Violation|0|||
16859893|NCT01569152|37814781|FG001|Phase IIa, Period 1|Protocol Violation|1|||
16859894|NCT01569152|37814782|FG002|Phase IIa, Period 1|Protocol Violation|0|||
16859895|NCT01569152|37814780|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
16859896|NCT01569152|37814781|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
16859897|NCT01569152|37814782|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
16859898|NCT01569152|37814780|FG000|Safety Extension, Period 3|Adverse Event|0|||
16859899|NCT01569152|37814781|FG001|Safety Extension, Period 3|Adverse Event|0|||
16859900|NCT01569152|37814782|FG002|Safety Extension, Period 3|Adverse Event|4|||
16859901|NCT01569152|37814780|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
16859902|NCT01569152|37814781|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
16859903|NCT01569152|37814782|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
16859904|NCT01569152|37814780|FG000|Safety Extension, Period 3|Physician Decision|0|||
16859905|NCT01569152|37814781|FG001|Safety Extension, Period 3|Physician Decision|0|||
16859906|NCT01569152|37814782|FG002|Safety Extension, Period 3|Physician Decision|2|||
16859907|NCT01569152|37814780|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
16859908|NCT01569152|37814781|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
16859909|NCT01569152|37814782|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
16859910|NCT01569074|37814807|FG000|Overall Study|Study stopped|6|||
16859911|NCT01569074|37814808|FG001|Overall Study|Study stopped|6|||
16859912|NCT01569074|37814809|FG002|Overall Study|Study stopped|8|||
16859913|NCT01569074|37814810|FG003|Overall Study|Study stopped|7|||
16859914|NCT01569074|37814811|FG004|Overall Study|Study stopped|7|||
16859915|NCT01569074|37814807|FG000|Overall Study|Study-specific discontinuation criteria|0|||
16859916|NCT01569074|37814808|FG001|Overall Study|Study-specific discontinuation criteria|1|||
16944213|NCT01379573|38088267|FG000|Overall Study|Lost to Follow-up|1|||
16944214|NCT01379573|38088267|FG000|Overall Study|Screen Failure|10|||
16944215|NCT01379534|38088273|FG000|Treatment Phase|Withdrawal by Subject|2|||
16944216|NCT01379534|38088274|FG001|Treatment Phase|Withdrawal by Subject|2|||
16944217|NCT01379534|38088273|FG000|Treatment Phase|Progressive disease|13|||
16944218|NCT01379534|38088274|FG001|Treatment Phase|Progressive disease|22|||
16944219|NCT01379534|38088273|FG000|Treatment Phase|Adverse Event|7|||
16944220|NCT01379534|38088274|FG001|Treatment Phase|Adverse Event|7|||
16944221|NCT01379534|38088273|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
16944222|NCT01379534|38088274|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
16944223|NCT01379534|38088273|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
16944224|NCT01379534|38088274|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
16944225|NCT01379534|38088273|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
16944226|NCT01379534|38088274|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
16944227|NCT01379534|38088273|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
16944228|NCT01379534|38088274|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
16944229|NCT01371851|38088282|FG000|Overall Study|Lost to Follow-up|5|||
16944230|NCT01371851|38088283|FG001|Overall Study|Lost to Follow-up|8|||
16859917|NCT01569074|37814809|FG002|Overall Study|Study-specific discontinuation criteria|0|||
16859918|NCT01569074|37814810|FG003|Overall Study|Study-specific discontinuation criteria|0|||
16859919|NCT01569074|37814811|FG004|Overall Study|Study-specific discontinuation criteria|0|||
16944231|NCT01371851|38088282|FG000|Overall Study|was arrested and put in jail|0|||
16944232|NCT01371851|38088283|FG001|Overall Study|was arrested and put in jail|1|||
16944233|NCT01371851|38088282|FG000|Overall Study|non study related adverse event|1|||
16944234|NCT01371851|38088283|FG001|Overall Study|non study related adverse event|0|||
16944235|NCT01371851|38088282|FG000|Overall Study|Blood Pressure outside study parameters|2|||
16944236|NCT01371851|38088283|FG001|Overall Study|Blood Pressure outside study parameters|0|||
16944237|NCT01371734|38088292|FG000|Overall Study|Other|2|||
16944238|NCT01371734|38088293|FG001|Overall Study|Other|1|||
16944239|NCT01371734|38088294|FG002|Overall Study|Other|2|||
16944240|NCT01371734|38088292|FG000|Overall Study|Withdrawal by Subject|3|||
16944241|NCT01371734|38088293|FG001|Overall Study|Withdrawal by Subject|4|||
16944242|NCT01371734|38088294|FG002|Overall Study|Withdrawal by Subject|9|||
16944243|NCT01371734|38088292|FG000|Overall Study|Lost to Follow-up|5|||
16944244|NCT01371734|38088293|FG001|Overall Study|Lost to Follow-up|3|||
16944245|NCT01371734|38088294|FG002|Overall Study|Lost to Follow-up|1|||
16944246|NCT01371734|38088292|FG000|Overall Study|Protocol Violation|3|||
16944247|NCT01371734|38088293|FG001|Overall Study|Protocol Violation|1|||
16944248|NCT01371734|38088294|FG002|Overall Study|Protocol Violation|2|||
16944249|NCT01371734|38088292|FG000|Overall Study|Adverse Event|8|||
16944250|NCT01371734|38088293|FG001|Overall Study|Adverse Event|8|||
16944251|NCT01371734|38088294|FG002|Overall Study|Adverse Event|3|||
16944252|NCT01371734|38088292|FG000|Overall Study|Lack of Efficacy|2|||
16944253|NCT01371734|38088293|FG001|Overall Study|Lack of Efficacy|2|||
16944254|NCT01371734|38088294|FG002|Overall Study|Lack of Efficacy|0|||
16944255|NCT01365494|38088304|FG000|Overall Study|Adverse Event|1|||
17127475|NCT03736785|38267773|FG001|Overall Study|Non compliance with study drug|1|||
17127476|NCT03736785|38267774|FG002|Overall Study|Non compliance with study drug|0|||
17127477|NCT03736785|38267772|FG000|Overall Study|Physician Decision|0|||
17127478|NCT03736785|38267773|FG001|Overall Study|Physician Decision|1|||
17127479|NCT03736785|38267774|FG002|Overall Study|Physician Decision|1|||
16944256|NCT01365494|38088305|FG001|Overall Study|Adverse Event|0|||
16944257|NCT01365494|38088304|FG000|Overall Study|Withdrawal by Subject|0|||
16944258|NCT01365494|38088305|FG001|Overall Study|Withdrawal by Subject|1|||
16944259|NCT01365494|38088304|FG000|Overall Study|Lost to Follow-up|1|||
16944260|NCT01365494|38088305|FG001|Overall Study|Lost to Follow-up|2|||
16944261|NCT01357889|38088314|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
16944262|NCT01357889|38088315|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
16944263|NCT01357889|38088314|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
16944264|NCT01357889|38088315|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
16944265|NCT01357889|38088314|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
16944266|NCT01357889|38088315|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
16944267|NCT01357889|38088314|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
16944268|NCT01357889|38088315|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
16944269|NCT01357889|38088314|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
16944270|NCT01357889|38088315|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
16944271|NCT01357889|38088314|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
16944272|NCT01357889|38088315|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
16944273|NCT01357889|38088314|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
16944274|NCT01357889|38088315|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
16944275|NCT01357889|38088314|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
16944276|NCT01357889|38088315|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
16944277|NCT01357889|38088314|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
16944278|NCT01357889|38088315|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
16859920|NCT01569074|37814807|FG000|Overall Study|Severe non-compliance to protocol|0|||
16859921|NCT01569074|37814808|FG001|Overall Study|Severe non-compliance to protocol|0|||
16859922|NCT01569074|37814809|FG002|Overall Study|Severe non-compliance to protocol|1|||
16859923|NCT01569074|37814810|FG003|Overall Study|Severe non-compliance to protocol|0|||
16859924|NCT01569074|37814811|FG004|Overall Study|Severe non-compliance to protocol|0|||
16859925|NCT01569074|37814807|FG000|Overall Study|eg change in circumstances|0|||
16859926|NCT01569074|37814808|FG001|Overall Study|eg change in circumstances|2|||
16859927|NCT01569074|37814809|FG002|Overall Study|eg change in circumstances|0|||
16859928|NCT01569074|37814810|FG003|Overall Study|eg change in circumstances|1|||
16859929|NCT01569074|37814811|FG004|Overall Study|eg change in circumstances|1|||
16859930|NCT01569074|37814807|FG000|Overall Study|Adverse Event|1|||
16859931|NCT01569074|37814808|FG001|Overall Study|Adverse Event|0|||
16859932|NCT01569074|37814809|FG002|Overall Study|Adverse Event|3|||
16859933|NCT01569074|37814810|FG003|Overall Study|Adverse Event|0|||
16859934|NCT01569074|37814811|FG004|Overall Study|Adverse Event|0|||
16859935|NCT01604408|37814829|FG000|Treatment Period 1|Protocol Violation|0|||
16859936|NCT01604408|37814830|FG001|Treatment Period 1|Protocol Violation|1|||
16859937|NCT01604408|37814829|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16859938|NCT01604408|37814830|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16859939|NCT01604408|37814829|FG000|Treatment Period 2|Protocol Violation|1|||
16859940|NCT01604408|37814830|FG001|Treatment Period 2|Protocol Violation|0|||
16859941|NCT01604408|37814829|FG000|Treatment Period 2|Adverse Event|0|||
16859942|NCT01604408|37814830|FG001|Treatment Period 2|Adverse Event|1|||
16859943|NCT01604408|37814829|FG000|Treatment Period 3|Protocol Violation|1|||
16859944|NCT01604408|37814830|FG001|Treatment Period 3|Protocol Violation|1|||
16944279|NCT01357889|38088314|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
16944280|NCT01357889|38088315|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
16944281|NCT01357889|38088314|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
16944282|NCT01357889|38088315|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
16944283|NCT01357889|38088314|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
16944284|NCT01357889|38088315|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
16944285|NCT01357889|38088314|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
16944286|NCT01357889|38088315|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
16944287|NCT01357850|38088327|FG000|Overall Study|Lost to Follow-up|1|||
16944288|NCT01357850|38088328|FG001|Overall Study|Lost to Follow-up|0|||
16944289|NCT01357850|38088329|FG002|Overall Study|Lost to Follow-up|0|||
16944290|NCT01357850|38088330|FG003|Overall Study|Lost to Follow-up|0|||
16944291|NCT01357655|38088343|FG000|Overall Study|Administrative Reason by Sponsor|45|||
16944292|NCT01357655|38088344|FG001|Overall Study|Administrative Reason by Sponsor|0|||
16944293|NCT01357655|38088343|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
16944294|NCT01357655|38088344|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16944295|NCT01357655|38088343|FG000|Overall Study|Disease Progression|1|||
16944296|NCT01357655|38088344|FG001|Overall Study|Disease Progression|0|||
16944297|NCT01357655|38088343|FG000|Overall Study|Lost to Follow-up|2|||
16944298|NCT01357655|38088344|FG001|Overall Study|Lost to Follow-up|0|||
16944299|NCT01357655|38088343|FG000|Overall Study|Maximum Clinical Benefit|2|||
16944300|NCT01357655|38088344|FG001|Overall Study|Maximum Clinical Benefit|0|||
16944301|NCT01357655|38088343|FG000|Overall Study|Reason Unspecified|1|||
16944302|NCT01357655|38088344|FG001|Overall Study|Reason Unspecified|0|||
16944303|NCT01357655|38088343|FG000|Overall Study|Study Drug Toxicity|11|||
16944304|NCT01357655|38088344|FG001|Overall Study|Study Drug Toxicity|0|||
16944305|NCT01357655|38088343|FG000|Overall Study|Subject Withdrew Consent|1|||
16944306|NCT01357655|38088344|FG001|Overall Study|Subject Withdrew Consent|0|||
16944307|NCT01357616|38088351|FG000|Overall Study|Adverse Event|1|||
16944308|NCT01357616|38088352|FG001|Overall Study|Adverse Event|1|||
16944309|NCT01357616|38088351|FG000|Overall Study|Lost to Follow-up|4|||
16944310|NCT01357616|38088352|FG001|Overall Study|Lost to Follow-up|3|||
16944311|NCT01357616|38088351|FG000|Overall Study|Protocol Violation|0|||
16944312|NCT01357616|38088352|FG001|Overall Study|Protocol Violation|2|||
16944313|NCT01357616|38088351|FG000|Overall Study|Inadequate Control of IOP|1|||
17028404|NCT00783692|38172782|FG005|Induction Phase|Other|0|||
16944314|NCT01357616|38088352|FG001|Overall Study|Inadequate Control of IOP|2|||
16944315|NCT01357616|38088351|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
16944316|NCT01357616|38088352|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
16944317|NCT01357616|38088351|FG000|Overall Study|Withdrawal by Subject|1|||
16944318|NCT01357616|38088352|FG001|Overall Study|Withdrawal by Subject|0|||
16944319|NCT01357577|38088360|FG000|Overall Study|Lost to Follow-up|20|||
16944320|NCT01357577|38088361|FG001|Overall Study|Lost to Follow-up|16|||
17028405|NCT00783692|38172783|FG006|Induction Phase|Other|0|||
16944321|NCT01357577|38088360|FG000|Overall Study|Withdrawal by Subject|16|||
16944322|NCT01357577|38088361|FG001|Overall Study|Withdrawal by Subject|8|||
16944323|NCT01357577|38088360|FG000|Overall Study|look at data in database?|1|||
16944324|NCT01357577|38088361|FG001|Overall Study|look at data in database?|2|||
16944325|NCT01351025|38088370|FG000|Week 0 - 20|Lost to Follow-up|2|||
16944326|NCT01351025|38088371|FG001|Week 0 - 20|Lost to Follow-up|1|||
16944327|NCT01351025|38088370|FG000|Week 0 - 20|Withdrawal by Subject|1|||
16944328|NCT01351025|38088371|FG001|Week 0 - 20|Withdrawal by Subject|0|||
16944329|NCT01351025|38088370|FG000|Week 24 - 44|Lost to Follow-up|0|||
16944330|NCT01351025|38088371|FG001|Week 24 - 44|Lost to Follow-up|2|||
16944331|NCT01351025|38088370|FG000|Week 24 - 44|Site closed|0|||
16944332|NCT01351025|38088371|FG001|Week 24 - 44|Site closed|1|||
16944333|NCT01351025|38088370|FG000|Week 24 - 44|unable to get to clinic|1|||
16944334|NCT01351025|38088371|FG001|Week 24 - 44|unable to get to clinic|1|||
16944335|NCT01349036|38088385|FG000|Overall Study|Disease progression|13|||
16944336|NCT01349036|38088386|FG001|Overall Study|Disease progression|22|||
16944337|NCT01349036|38088385|FG000|Overall Study|Other|1|||
16944338|NCT01349036|38088386|FG001|Overall Study|Other|0|||
16944339|NCT01349036|38088385|FG000|Overall Study|Withdrawal by Subject|0|||
16944340|NCT01349036|38088386|FG001|Overall Study|Withdrawal by Subject|2|||
16944341|NCT01348763|38088396|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
16944342|NCT01348763|38088396|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
16944343|NCT01346969|38088404|FG000|Overall Study|Withdrawal by Subject|0|||
16944344|NCT01346969|38088405|FG001|Overall Study|Withdrawal by Subject|0|||
16944345|NCT01346969|38088406|FG002|Overall Study|Withdrawal by Subject|1|||
16944346|NCT01346969|38088407|FG003|Overall Study|Withdrawal by Subject|0|||
16944347|NCT01346969|38088404|FG000|Overall Study|Lost to Follow-up|1|||
16944348|NCT01346969|38088405|FG001|Overall Study|Lost to Follow-up|0|||
16944349|NCT01346969|38088406|FG002|Overall Study|Lost to Follow-up|2|||
16944350|NCT01346969|38088407|FG003|Overall Study|Lost to Follow-up|0|||
16944351|NCT01346969|38088404|FG000|Overall Study|Physician Decision|0|||
16944352|NCT01346969|38088405|FG001|Overall Study|Physician Decision|0|||
16944353|NCT01346969|38088406|FG002|Overall Study|Physician Decision|0|||
16944354|NCT01346969|38088407|FG003|Overall Study|Physician Decision|1|||
16944355|NCT01346969|38088404|FG000|Overall Study|Randomized but not treated|1|||
16944356|NCT01346969|38088405|FG001|Overall Study|Randomized but not treated|0|||
16944357|NCT01346969|38088406|FG002|Overall Study|Randomized but not treated|0|||
16944358|NCT01346969|38088407|FG003|Overall Study|Randomized but not treated|0|||
16944359|NCT01346774|38088419|FG000|Overall Study|Did not take a single dose|6|||
16944360|NCT01346774|38088420|FG001|Overall Study|Did not take a single dose|4|||
16944361|NCT01346774|38088419|FG000|Overall Study|Lost to Follow-up|3|||
16944362|NCT01346774|38088420|FG001|Overall Study|Lost to Follow-up|4|||
16944363|NCT01346774|38088419|FG000|Overall Study|Withdrawal by Subject|1|||
16944364|NCT01346774|38088420|FG001|Overall Study|Withdrawal by Subject|4|||
16944365|NCT01346774|38088419|FG000|Overall Study|Protocol Violation|2|||
16944366|NCT01346774|38088420|FG001|Overall Study|Protocol Violation|3|||
16944367|NCT01346774|38088419|FG000|Overall Study|Adverse Event|1|||
16944368|NCT01346774|38088420|FG001|Overall Study|Adverse Event|2|||
16944369|NCT01346696|38088426|FG000|Overall Study|Death|1|||
16944370|NCT01346540|38088432|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
16944371|NCT01346540|38088433|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
16944372|NCT01346540|38088432|FG000|Overall Study|Adverse Event|0|||
16944373|NCT01346540|38088433|FG001|Overall Study|Adverse Event|4|||
16944374|NCT01342913|38088442|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
16944375|NCT01342913|38088443|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16944376|NCT01342913|38088444|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16944377|NCT01342913|38088442|FG000|2-week Run-in Period|Physician Decision|6|||
16944378|NCT01342913|38088443|FG001|2-week Run-in Period|Physician Decision|0|||
16944379|NCT01342913|38088444|FG002|2-week Run-in Period|Physician Decision|0|||
16944380|NCT01342913|38088442|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
16944381|NCT01342913|38088443|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16944382|NCT01342913|38088444|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16944383|NCT01342913|38088442|FG000|2-week Run-in Period|Adverse Event|2|||
16944384|NCT01342913|38088443|FG001|2-week Run-in Period|Adverse Event|0|||
16944385|NCT01342913|38088444|FG002|2-week Run-in Period|Adverse Event|0|||
16944386|NCT01342913|38088442|FG000|2-week Run-in Period|Protocol Violation|5|||
16944387|NCT01342913|38088443|FG001|2-week Run-in Period|Protocol Violation|0|||
16944388|NCT01342913|38088444|FG002|2-week Run-in Period|Protocol Violation|0|||
16944389|NCT01342913|38088442|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
16944390|NCT01342913|38088443|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
16944391|NCT01342913|38088444|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
16944392|NCT01342913|38088442|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16944393|NCT01342913|38088443|FG001|Double-Blind Treatment Period|Adverse Event|3|||
16944394|NCT01342913|38088444|FG002|Double-Blind Treatment Period|Adverse Event|6|||
16944395|NCT01342913|38088442|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
16944396|NCT01342913|38088443|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
16944397|NCT01342913|38088444|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
16944398|NCT01342913|38088442|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16944399|NCT01342913|38088443|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
16944400|NCT01342913|38088444|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
16944401|NCT01342913|38088442|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16944402|NCT01342913|38088443|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
16944403|NCT01342913|38088444|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
16944404|NCT01342913|38088442|FG000|Double-Blind Treatment Period|Physician Decision|0|||
16944405|NCT01342913|38088443|FG001|Double-Blind Treatment Period|Physician Decision|2|||
16944406|NCT01342913|38088444|FG002|Double-Blind Treatment Period|Physician Decision|0|||
16944407|NCT01342913|38088442|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16944408|NCT01342913|38088443|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16859945|NCT01604408|37814829|FG000|Treatment Period 3|Adverse Event|0|||
16859946|NCT01604408|37814830|FG001|Treatment Period 3|Adverse Event|3|||
16859947|NCT01604408|37814829|FG000|Treatment Period 3|Withdrawal by Subject|3|||
16859948|NCT01604408|37814830|FG001|Treatment Period 3|Withdrawal by Subject|1|||
16859949|NCT01604408|37814829|FG000|Treatment Period 3|Sponsor Decision|1|||
16859950|NCT01604408|37814830|FG001|Treatment Period 3|Sponsor Decision|0|||
16944409|NCT01342913|38088444|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16944410|NCT01342796|38088452|FG000|Overall Study|Withdrawal by Subject|2|||
16944411|NCT01342796|38088453|FG001|Overall Study|Withdrawal by Subject|0|||
16944412|NCT01342796|38088452|FG000|Overall Study|Lost to Follow-up|0|||
16944413|NCT01342796|38088453|FG001|Overall Study|Lost to Follow-up|3|||
16944414|NCT01342796|38088452|FG000|Overall Study|Inappropriate enrollment|1|||
16944415|NCT01342796|38088453|FG001|Overall Study|Inappropriate enrollment|0|||
16944416|NCT01342640|38088459|FG000|Overall Study|Adverse Event|3|||
16859951|NCT01604408|37814829|FG000|Treatment Period 4|Death|1|||
16859952|NCT01604408|37814830|FG001|Treatment Period 4|Death|0|||
16859953|NCT01604408|37814829|FG000|Treatment Period 4|Withdrawal by Subject|2|||
16859954|NCT01604408|37814830|FG001|Treatment Period 4|Withdrawal by Subject|1|||
16859955|NCT01604408|37814829|FG000|Treatment Period 4|Adverse Event|0|||
16859956|NCT01604408|37814830|FG001|Treatment Period 4|Adverse Event|1|||
16859957|NCT01604408|37814829|FG000|Treatment Period 5|Adverse Event|4|||
16859958|NCT01604408|37814830|FG001|Treatment Period 5|Adverse Event|0|||
16859959|NCT01604408|37814829|FG000|Treatment Period 6|Lost to Follow-up|0|||
16859960|NCT01604408|37814830|FG001|Treatment Period 6|Lost to Follow-up|1|||
16859961|NCT01604408|37814829|FG000|Treatment Period 6|Adverse Event|2|||
16859962|NCT01604408|37814830|FG001|Treatment Period 6|Adverse Event|0|||
16859963|NCT01604408|37814829|FG000|Treatment Period 6|Sponsor decision|0|||
16859964|NCT01604408|37814830|FG001|Treatment Period 6|Sponsor decision|1|||
16859965|NCT01604408|37814829|FG000|Observation Period|Adverse Event|1|||
16859966|NCT01604408|37814830|FG001|Observation Period|Adverse Event|1|||
16859967|NCT01604408|37814829|FG000|Observation Period|Withdrawal by Subject|0|||
16859968|NCT01604408|37814830|FG001|Observation Period|Withdrawal by Subject|2|||
16859969|NCT01567826|37814838|FG000|Overall Study|Lost to Follow-up|3|||
16859970|NCT01567826|37814839|FG001|Overall Study|Lost to Follow-up|2|||
16859971|NCT01697462|37814847|FG000|Overall Study|Disease Progression|1|||
16859972|NCT01697462|37814847|FG000|Overall Study|Adverse Event|6|||
16859973|NCT01697462|37814847|FG000|Overall Study|Lost to Follow-up|21|||
16859974|NCT01697462|37814847|FG000|Overall Study|Withdrawal by Subject|12|||
16859975|NCT01697462|37814847|FG000|Overall Study|Investigator Decision|21|||
16859976|NCT01697462|37814847|FG000|Overall Study|Death|1|||
16859977|NCT01697462|37814847|FG000|Overall Study|Other|10|||
16859978|NCT01697462|37814847|FG000|Overall Study|Missing|5|||
16859979|NCT01696994|37814853|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
16859980|NCT01696994|37814854|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
16859981|NCT01696994|37814853|FG000|Overall Study|Died Before Randomization|1|||
16859982|NCT01696994|37814854|FG001|Overall Study|Died Before Randomization|2|||
16859983|NCT01696994|37814853|FG000|Overall Study|Died Before ASU (Control)|73|||
16859984|NCT01696994|37814854|FG001|Overall Study|Died Before ASU (Control)|0|||
16859985|NCT01696994|37814853|FG000|Overall Study|No Ovaries at Baseline|4807|||
16859986|NCT01696994|37814854|FG001|Overall Study|No Ovaries at Baseline|4851|||
16859987|NCT01696994|37814853|FG000|Overall Study|Refused ASU (Control)|311|||
16859988|NCT01696994|37814854|FG001|Overall Study|Refused ASU (Control)|0|||
16859989|NCT01696994|37814853|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
16859990|NCT01696994|37814854|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
16859991|NCT01592240|37815033|FG000|Overall Study|Adverse Event|1|||
16944417|NCT01342640|38088459|FG000|Overall Study|Protocol Violation|16|||
16944418|NCT01342640|38088459|FG000|Overall Study|Lost to Follow-up|21|||
16944419|NCT01342640|38088459|FG000|Overall Study|Other|1|||
16859992|NCT01592240|37815034|FG001|Overall Study|Adverse Event|0|||
16859993|NCT01592240|37815035|FG002|Overall Study|Adverse Event|0|||
16859994|NCT01592240|37815036|FG003|Overall Study|Adverse Event|1|||
16859995|NCT01592240|37815037|FG004|Overall Study|Adverse Event|1|||
16859996|NCT01592240|37815038|FG005|Overall Study|Adverse Event|0|||
16859997|NCT01592240|37815039|FG006|Overall Study|Adverse Event|0|||
16859998|NCT01592240|37815033|FG000|Overall Study|Death|0|||
16859999|NCT01592240|37815034|FG001|Overall Study|Death|1|||
16860000|NCT01592240|37815035|FG002|Overall Study|Death|0|||
16860001|NCT01592240|37815036|FG003|Overall Study|Death|0|||
16860002|NCT01592240|37815037|FG004|Overall Study|Death|0|||
16860003|NCT01592240|37815038|FG005|Overall Study|Death|0|||
16860004|NCT01592240|37815039|FG006|Overall Study|Death|0|||
16860005|NCT01592240|37815033|FG000|Overall Study|Lost to Follow-up|1|||
16944420|NCT01342484|38088466|FG000|Overall Study|Other Reasons|1|||
16944421|NCT01342484|38088467|FG001|Overall Study|Other Reasons|0|||
16944422|NCT01342484|38088468|FG002|Overall Study|Other Reasons|0|||
16944423|NCT01342484|38088466|FG000|Overall Study|Protocol Violation|0|||
16944424|NCT01342484|38088467|FG001|Overall Study|Protocol Violation|0|||
16944425|NCT01342484|38088468|FG002|Overall Study|Protocol Violation|1|||
16944426|NCT01342484|38088466|FG000|Overall Study|Withdrawal by Subject|1|||
16944427|NCT01342484|38088467|FG001|Overall Study|Withdrawal by Subject|0|||
16944428|NCT01342484|38088468|FG002|Overall Study|Withdrawal by Subject|0|||
16944429|NCT01342445|38088478|FG000|Overall Study|Experienced side effects|0|||
16944430|NCT01342445|38088479|FG001|Overall Study|Experienced side effects|2|||
16944431|NCT01342367|38088491|FG000|Overall Study|Death|1|||
16944432|NCT01342367|38088492|FG001|Overall Study|Death|0|||
16944433|NCT01342367|38088491|FG000|Overall Study|Withdrawal by Subject|1|||
16860006|NCT01592240|37815034|FG001|Overall Study|Lost to Follow-up|3|||
16860007|NCT01592240|37815035|FG002|Overall Study|Lost to Follow-up|1|||
16860008|NCT01592240|37815036|FG003|Overall Study|Lost to Follow-up|0|||
16860009|NCT01592240|37815037|FG004|Overall Study|Lost to Follow-up|3|||
16860010|NCT01592240|37815038|FG005|Overall Study|Lost to Follow-up|2|||
16860011|NCT01592240|37815039|FG006|Overall Study|Lost to Follow-up|0|||
16860012|NCT01592240|37815033|FG000|Overall Study|Protocol Violation|0|||
16860013|NCT01592240|37815034|FG001|Overall Study|Protocol Violation|0|||
16860014|NCT01592240|37815035|FG002|Overall Study|Protocol Violation|0|||
16860015|NCT01592240|37815036|FG003|Overall Study|Protocol Violation|0|||
16860016|NCT01592240|37815037|FG004|Overall Study|Protocol Violation|0|||
16860017|NCT01592240|37815038|FG005|Overall Study|Protocol Violation|1|||
16860018|NCT01592240|37815039|FG006|Overall Study|Protocol Violation|0|||
16860019|NCT01592240|37815033|FG000|Overall Study|Withdrawal by Subject|0|||
16860020|NCT01592240|37815034|FG001|Overall Study|Withdrawal by Subject|4|||
16860021|NCT01592240|37815035|FG002|Overall Study|Withdrawal by Subject|4|||
16860022|NCT01592240|37815036|FG003|Overall Study|Withdrawal by Subject|1|||
16860023|NCT01592240|37815037|FG004|Overall Study|Withdrawal by Subject|3|||
16860024|NCT01592240|37815038|FG005|Overall Study|Withdrawal by Subject|0|||
16860025|NCT01592240|37815039|FG006|Overall Study|Withdrawal by Subject|2|||
16860026|NCT01592240|37815033|FG000|Overall Study|Other|0|||
16860027|NCT01592240|37815034|FG001|Overall Study|Other|3|||
16860028|NCT01592240|37815035|FG002|Overall Study|Other|1|||
16860029|NCT01592240|37815036|FG003|Overall Study|Other|1|||
16860030|NCT01592240|37815037|FG004|Overall Study|Other|0|||
16860031|NCT01592240|37815038|FG005|Overall Study|Other|0|||
16860032|NCT01592240|37815039|FG006|Overall Study|Other|1|||
16860033|NCT01592240|37815033|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16860034|NCT01592240|37815034|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
16860035|NCT01592240|37815035|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
16944434|NCT01342367|38088492|FG001|Overall Study|Withdrawal by Subject|2|||
16944435|NCT01342211|38088503|FG000|Overall Study|Lost to Follow-up|0|||
16944436|NCT01342211|38088504|FG001|Overall Study|Lost to Follow-up|0|||
16944437|NCT01342211|38088505|FG002|Overall Study|Lost to Follow-up|0|||
16944438|NCT01342211|38088506|FG003|Overall Study|Lost to Follow-up|1|||
16944439|NCT01342211|38088507|FG004|Overall Study|Lost to Follow-up|0|||
16944440|NCT01342211|38088503|FG000|Overall Study|Adverse Event|0|||
16944441|NCT01342211|38088504|FG001|Overall Study|Adverse Event|0|||
16944442|NCT01342211|38088505|FG002|Overall Study|Adverse Event|0|||
16944443|NCT01342211|38088506|FG003|Overall Study|Adverse Event|0|||
16944444|NCT01342211|38088507|FG004|Overall Study|Adverse Event|1|||
16944445|NCT01342211|38088503|FG000|Overall Study|Withdrawal by Subject|0|||
16860036|NCT01592240|37815036|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
16860037|NCT01592240|37815037|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
16860038|NCT01592240|37815038|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
16860039|NCT01592240|37815039|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
16860040|NCT01591616|37815082|FG000|Overall Study|Withdrawal by Subject|1|||
16944446|NCT01342211|38088504|FG001|Overall Study|Withdrawal by Subject|0|||
16860041|NCT01591460|37815238|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
16860042|NCT01591460|37815238|FG000|Overall Study|Futility Rule (Week 12)|7|||
16944447|NCT01342211|38088505|FG002|Overall Study|Withdrawal by Subject|0|||
16944448|NCT01342211|38088506|FG003|Overall Study|Withdrawal by Subject|1|||
16860043|NCT01591460|37815238|FG000|Overall Study|Futility Rule (Week 24)|3|||
16860044|NCT01591460|37815238|FG000|Overall Study|Rebound or Breakthrough|3|||
16860045|NCT01591460|37815238|FG000|Overall Study|Treatment Discontinued by Error|1|||
16860046|NCT01591460|37815238|FG000|Overall Study|Lost to Follow-up|1|||
16860047|NCT01591460|37815238|FG000|Overall Study|Noncompliance|1|||
16860048|NCT01591460|37815238|FG000|Overall Study|Participant Refusal|3|||
16860049|NCT01591460|37815238|FG000|Overall Study|Withdrawal by Subject|1|||
16860050|NCT01591460|37815238|FG000|Overall Study|Protocol Violation|1|||
16860051|NCT01591382|37815261|FG000|Overall Study|Discharged Prior to Study Completion|2|||
16860052|NCT01591382|37815262|FG001|Overall Study|Discharged Prior to Study Completion|1|||
16860053|NCT01591382|37815261|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
16860054|NCT01591382|37815262|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
16860055|NCT01696214|37815280|FG000|Overall Study|Lost to Follow-up|1|||
16860056|NCT01696214|37815281|FG001|Overall Study|Lost to Follow-up|0|||
16860057|NCT01696214|37815282|FG002|Overall Study|Lost to Follow-up|0|||
16860058|NCT01696214|37815283|FG003|Overall Study|Lost to Follow-up|0|||
16860059|NCT01543087|37815316|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
16860060|NCT01543087|37815317|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
16860061|NCT01543087|37815318|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
16860062|NCT01543087|37815319|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
16860063|NCT01543087|37815320|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
16860064|NCT01543087|37815321|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
16860065|NCT01543087|37815316|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
16944449|NCT01342211|38088507|FG004|Overall Study|Withdrawal by Subject|0|||
16944450|NCT01342211|38088503|FG000|Overall Study|Randomized, but not Treated|0|||
16944451|NCT01342211|38088504|FG001|Overall Study|Randomized, but not Treated|2|||
16944452|NCT01342211|38088505|FG002|Overall Study|Randomized, but not Treated|0|||
16944453|NCT01342211|38088506|FG003|Overall Study|Randomized, but not Treated|0|||
16944454|NCT01342211|38088507|FG004|Overall Study|Randomized, but not Treated|1|||
16944455|NCT01342094|38088525|FG000|Overall Study|Adverse Event|5|||
16944456|NCT01342094|38088526|FG001|Overall Study|Adverse Event|0|||
16944457|NCT01342094|38088525|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16944458|NCT01342094|38088526|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
16944459|NCT01342094|38088525|FG000|Overall Study|Withdrawal by Subject|0|||
16944460|NCT01342094|38088526|FG001|Overall Study|Withdrawal by Subject|2|||
16944461|NCT01340768|38088534|FG000|Overall Study|Lost to Follow-up|10|||
16944462|NCT01340768|38088535|FG001|Overall Study|Lost to Follow-up|4|||
16944463|NCT01340768|38088534|FG000|Overall Study|Withdrawal by Subject|5|||
16944464|NCT01340768|38088535|FG001|Overall Study|Withdrawal by Subject|1|||
16944465|NCT01340768|38088534|FG000|Overall Study|Other|2|||
16944466|NCT01340768|38088535|FG001|Overall Study|Other|0|||
16944467|NCT01340651|38088541|FG000|Overall Study|Adverse Event|3|||
16944468|NCT01340651|38088541|FG000|Overall Study|Consent Withdrawn|2|||
16944469|NCT01340651|38088541|FG000|Overall Study|Commercial Supply per Sponsor|12|||
16944470|NCT01340495|38088547|FG000|Overall Study|Withdrawal by Subject|1|||
16944471|NCT01340300|38088555|FG000|Overall Study|Lost to Follow-up|3|||
16944472|NCT01340300|38088556|FG001|Overall Study|Lost to Follow-up|0|||
16944473|NCT01340300|38088557|FG002|Overall Study|Lost to Follow-up|5|||
16944474|NCT01340300|38088558|FG003|Overall Study|Lost to Follow-up|10|||
16944475|NCT01340300|38088555|FG000|Overall Study|Withdrawal by Subject|5|||
16944476|NCT01340300|38088556|FG001|Overall Study|Withdrawal by Subject|6|||
16944477|NCT01340300|38088557|FG002|Overall Study|Withdrawal by Subject|6|||
16944478|NCT01340300|38088558|FG003|Overall Study|Withdrawal by Subject|3|||
16944479|NCT01340300|38088555|FG000|Overall Study|Adverse Event|1|||
16944480|NCT01340300|38088556|FG001|Overall Study|Adverse Event|0|||
16944481|NCT01340300|38088557|FG002|Overall Study|Adverse Event|4|||
16944482|NCT01340300|38088558|FG003|Overall Study|Adverse Event|0|||
16944483|NCT01340300|38088555|FG000|Overall Study|Physician Decision|0|||
16944484|NCT01340300|38088556|FG001|Overall Study|Physician Decision|1|||
16944485|NCT01340300|38088557|FG002|Overall Study|Physician Decision|0|||
16944486|NCT01340300|38088558|FG003|Overall Study|Physician Decision|0|||
16944487|NCT01340300|38088555|FG000|Overall Study|Unrelated sickness|0|||
16944488|NCT01340300|38088556|FG001|Overall Study|Unrelated sickness|2|||
16944489|NCT01340300|38088557|FG002|Overall Study|Unrelated sickness|0|||
16944490|NCT01340300|38088558|FG003|Overall Study|Unrelated sickness|1|||
16944491|NCT01340066|38088570|FG000|Placebo Run in Period|Screen Failures|27|||
16944492|NCT01340066|38088571|FG001|Placebo Run in Period|Screen Failures|0|||
16944493|NCT01340066|38088572|FG002|Placebo Run in Period|Screen Failures|0|||
16944494|NCT01340066|38088570|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
16944495|NCT01340066|38088571|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
16944496|NCT01340066|38088572|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
16944497|NCT01340066|38088570|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
16944498|NCT01340066|38088571|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
16944499|NCT01340066|38088572|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
16944500|NCT01340066|38088570|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
16944501|NCT01340066|38088571|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
16944502|NCT01340066|38088572|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
16944503|NCT01107535|38088579|FG000|Overall Study|Death|5|||
16944504|NCT01326546|38088585|FG000|Overall Study|Lost to Follow-up|8|||
16944505|NCT01326546|38088586|FG001|Overall Study|Lost to Follow-up|7|||
16944506|NCT01326546|38088585|FG000|Overall Study|Protocol Violation|3|||
16944507|NCT01326546|38088586|FG001|Overall Study|Protocol Violation|4|||
16944508|NCT01326546|38088585|FG000|Overall Study|Pregnancy|0|||
16944509|NCT01326546|38088586|FG001|Overall Study|Pregnancy|1|||
16944510|NCT01326546|38088585|FG000|Overall Study|Adverse Event|1|||
16944511|NCT01326546|38088586|FG001|Overall Study|Adverse Event|0|||
16944512|NCT01326546|38088585|FG000|Overall Study|Withdrawal by Subject|5|||
16944513|NCT01326546|38088586|FG001|Overall Study|Withdrawal by Subject|1|||
16944514|NCT01325532|38088594|FG000|Overall Study|Withdrawal by Subject|2|||
16944515|NCT01325532|38088595|FG001|Overall Study|Withdrawal by Subject|0|||
16860066|NCT01543087|37815317|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
16860067|NCT01543087|37815318|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
16860068|NCT01543087|37815319|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
16860069|NCT01543087|37815320|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
16860070|NCT01543087|37815321|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
16860071|NCT01543087|37815316|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
16860072|NCT01543087|37815317|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
16860073|NCT01543087|37815318|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
16860074|NCT01543087|37815319|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
16860075|NCT01543087|37815320|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
16860076|NCT01543087|37815321|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
16860077|NCT01543087|37815316|FG000|Stage 1 (48 Months)|Other than specified|5|||
16860078|NCT01543087|37815317|FG001|Stage 1 (48 Months)|Other than specified|0|||
16860079|NCT01543087|37815318|FG002|Stage 1 (48 Months)|Other than specified|9|||
16860080|NCT01543087|37815319|FG003|Stage 1 (48 Months)|Other than specified|0|||
16860081|NCT01543087|37815320|FG004|Stage 1 (48 Months)|Other than specified|0|||
16860082|NCT01543087|37815321|FG005|Stage 1 (48 Months)|Other than specified|0|||
16860083|NCT01543087|37815316|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
16860084|NCT01543087|37815317|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
16860085|NCT01543087|37815318|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
16860086|NCT01543087|37815319|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
16860087|NCT01543087|37815320|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
16860088|NCT01543087|37815321|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
16860089|NCT01543087|37815316|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
16860090|NCT01543087|37815317|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
16860091|NCT01543087|37815318|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
16860092|NCT01543087|37815319|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
16860093|NCT01543087|37815320|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
16860094|NCT01543087|37815321|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
16860095|NCT01543087|37815316|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
16860096|NCT01543087|37815317|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
16860097|NCT01543087|37815318|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
16860098|NCT01543087|37815319|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
16860099|NCT01543087|37815320|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
16860100|NCT01543087|37815321|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
16860101|NCT01696058|37815359|FG000|Overall Study|Adverse Event|21|||
16860102|NCT01696058|37815360|FG001|Overall Study|Adverse Event|11|||
16860103|NCT01696058|37815359|FG000|Overall Study|Lack of Efficacy|2|||
16860104|NCT01696058|37815360|FG001|Overall Study|Lack of Efficacy|3|||
16860105|NCT01696058|37815359|FG000|Overall Study|Protocol Violation|9|||
16860106|NCT01696058|37815360|FG001|Overall Study|Protocol Violation|3|||
16860107|NCT01696058|37815359|FG000|Overall Study|Lost to Follow-up|2|||
16860108|NCT01696058|37815360|FG001|Overall Study|Lost to Follow-up|5|||
16860109|NCT01696058|37815359|FG000|Overall Study|Withdrawal by Subject|4|||
16860110|NCT01696058|37815360|FG001|Overall Study|Withdrawal by Subject|6|||
16860111|NCT01696058|37815359|FG000|Overall Study|Other reason prematurely discontinued|5|||
16860112|NCT01696058|37815360|FG001|Overall Study|Other reason prematurely discontinued|3|||
16860113|NCT01695746|37815366|FG000|Overall Study|Adverse Event|1|||
16860114|NCT01695746|37815366|FG000|Overall Study|Non-compliance by the participant|3|||
16860115|NCT01695746|37815366|FG000|Overall Study|Protocol Violation|5|||
16860116|NCT01695746|37815366|FG000|Overall Study|Participant not willing to participate|3|||
16860117|NCT01694420|37815377|FG000|Overall Study|Lost to Follow-up|3|||
16860118|NCT01675479|37815548|FG000|Overall Study|Lost to Follow-up|11|||
16860119|NCT02406027|37815673|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16860120|NCT02406027|37815674|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
16860121|NCT02406027|37815675|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
16860122|NCT02406027|37815676|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16860123|NCT02406027|37815677|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16860124|NCT02406027|37815678|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16860125|NCT02406027|37815679|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16860126|NCT02406027|37815673|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
17127480|NCT03736785|38267772|FG000|Overall Study|Protocol Violation|1|||
17127481|NCT03736785|38267773|FG001|Overall Study|Protocol Violation|4|||
17127482|NCT03736785|38267774|FG002|Overall Study|Protocol Violation|3|||
17127483|NCT03736785|38267772|FG000|Overall Study|Sponsor Decision|1|||
17127484|NCT03736785|38267773|FG001|Overall Study|Sponsor Decision|0|||
17127485|NCT03736785|38267774|FG002|Overall Study|Sponsor Decision|0|||
17127486|NCT03736785|38267772|FG000|Overall Study|Unknown/Missing data|3|||
17127487|NCT03736785|38267773|FG001|Overall Study|Unknown/Missing data|2|||
17127488|NCT03736785|38267774|FG002|Overall Study|Unknown/Missing data|1|||
17127489|NCT03736785|38267772|FG000|Overall Study|Withdrawal by Subject|9|||
17127490|NCT03736785|38267773|FG001|Overall Study|Withdrawal by Subject|6|||
17127491|NCT03736785|38267774|FG002|Overall Study|Withdrawal by Subject|4|||
17127492|NCT03734991|38267785|FG000|Overall Study|Adverse Event|4|||
17127493|NCT03734991|38267786|FG001|Overall Study|Adverse Event|0|||
17127494|NCT03734991|38267785|FG000|Overall Study|Lost to Follow-up|4|||
16860127|NCT02406027|37815674|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16860128|NCT02406027|37815675|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
16860129|NCT02406027|37815676|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16860130|NCT02406027|37815677|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16860131|NCT02406027|37815678|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16860132|NCT02406027|37815679|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16860133|NCT02406027|37815673|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
16860134|NCT02406027|37815674|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
16860135|NCT02406027|37815675|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
16860136|NCT02406027|37815676|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
16860137|NCT02406027|37815677|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
16860138|NCT02406027|37815678|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
16860139|NCT02406027|37815679|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
16860140|NCT02406027|37815673|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
16860141|NCT02406027|37815674|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16860142|NCT02406027|37815675|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
16860143|NCT02406027|37815676|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16860144|NCT02406027|37815677|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16860145|NCT02406027|37815678|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16860146|NCT02406027|37815679|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16860147|NCT02406027|37815673|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
16860148|NCT02406027|37815674|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
16860149|NCT02406027|37815675|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
16860150|NCT02406027|37815676|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
16860151|NCT02406027|37815677|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
16860152|NCT02406027|37815678|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
16860153|NCT02406027|37815679|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
16860154|NCT02406027|37815673|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
16860155|NCT02406027|37815674|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
16860156|NCT02406027|37815675|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
16860157|NCT02406027|37815676|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
16860158|NCT02406027|37815677|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
16860159|NCT02406027|37815678|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
16860160|NCT02406027|37815679|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
16860161|NCT02406027|37815673|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
16860162|NCT02406027|37815674|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
16860163|NCT02406027|37815675|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
16860164|NCT02406027|37815676|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
16860165|NCT02406027|37815677|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
16860166|NCT02406027|37815678|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
16860167|NCT02406027|37815679|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
16860168|NCT02406027|37815673|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
16860169|NCT02406027|37815674|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
16860170|NCT02406027|37815675|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
16860171|NCT02406027|37815676|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
16860172|NCT02406027|37815677|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
16860173|NCT02406027|37815678|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
16860174|NCT02406027|37815679|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
16860175|NCT02406027|37815673|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16860176|NCT02406027|37815674|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16860177|NCT02406027|37815675|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16860178|NCT02406027|37815676|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16860179|NCT02406027|37815677|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16860180|NCT02406027|37815678|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
16860181|NCT02406027|37815679|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16860182|NCT02406027|37815673|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16860183|NCT02406027|37815674|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16860184|NCT02406027|37815675|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16860185|NCT02406027|37815676|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16860186|NCT02406027|37815677|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
16860187|NCT02406027|37815678|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16860188|NCT02406027|37815679|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16860189|NCT00089973|37815695|FG000|Overall Study|Adverse Event|3|||
16860190|NCT00089973|37815695|FG000|Overall Study|Withdrawal by Subject|1|||
16860191|NCT00089973|37815695|FG000|Overall Study|Disease progression|45|||
16860192|NCT00089973|37815695|FG000|Overall Study|Death|1|||
16860193|NCT00089661|37815713|FG000|Overall Study|Adverse Event|0|||
16860194|NCT00089661|37815714|FG001|Overall Study|Adverse Event|2|||
16860195|NCT00089661|37815713|FG000|Overall Study|Death|1|||
16944516|NCT01171963|38088603|FG000|Overall Study|Adverse Event|10|||
16944517|NCT01171963|38088604|FG001|Overall Study|Adverse Event|15|||
16944518|NCT01171963|38088603|FG000|Overall Study|Lost to Follow-up|23|||
16944519|NCT01171963|38088604|FG001|Overall Study|Lost to Follow-up|24|||
16944520|NCT01171963|38088603|FG000|Overall Study|Other - diarrhoea|1|||
16944521|NCT01171963|38088604|FG001|Overall Study|Other - diarrhoea|0|||
16944522|NCT01171963|38088603|FG000|Overall Study|Withdrawal by Subject|114|||
16944523|NCT01171963|38088604|FG001|Overall Study|Withdrawal by Subject|129|||
16944524|NCT01171183|38088615|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
16944525|NCT01171183|38088616|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
17127495|NCT03734991|38267786|FG001|Overall Study|Lost to Follow-up|0|||
16944526|NCT01171183|38088615|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
16944527|NCT01171183|38088616|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
16944528|NCT01171183|38088615|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
16944529|NCT01171183|38088616|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
16944530|NCT01171183|38088615|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
16944531|NCT01171183|38088616|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
16944532|NCT01171183|38088615|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
16944533|NCT01171183|38088616|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
16944534|NCT01171183|38088615|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
16944535|NCT01171183|38088616|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
16944536|NCT01170091|38088622|FG000|Overall Study|Missing efficacy evaluation|3|||
16944537|NCT01170091|38088622|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
16944538|NCT01169779|38088628|FG000|Overall Study|Adverse Event|3|||
16944539|NCT01169779|38088629|FG001|Overall Study|Adverse Event|11|||
16944540|NCT01169779|38088628|FG000|Overall Study|Lack of Efficacy|1|||
16944541|NCT01169779|38088629|FG001|Overall Study|Lack of Efficacy|0|||
16944542|NCT01169779|38088628|FG000|Overall Study|Protocol Violation|1|||
16944543|NCT01169779|38088629|FG001|Overall Study|Protocol Violation|1|||
17127496|NCT03734991|38267785|FG000|Overall Study|Physician Decision|0|||
17127497|NCT03734991|38267786|FG001|Overall Study|Physician Decision|1|||
17127498|NCT03734991|38267785|FG000|Overall Study|Pregnancy|1|||
17127499|NCT03734991|38267786|FG001|Overall Study|Pregnancy|0|||
17127500|NCT03734991|38267785|FG000|Overall Study|Withdrawal by Subject|6|||
17127501|NCT03734991|38267786|FG001|Overall Study|Withdrawal by Subject|3|||
17127502|NCT03734991|38267785|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
17127503|NCT03734991|38267786|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
17127504|NCT03734991|38267785|FG000|Overall Study|Other|2|||
17127505|NCT03734991|38267786|FG001|Overall Study|Other|2|||
17127506|NCT03303092|38267795|FG000|Overall Study|Adverse Event|1|||
17127507|NCT03303092|38267796|FG001|Overall Study|Adverse Event|0|||
17127508|NCT03303092|38267797|FG002|Overall Study|Adverse Event|1|||
17127509|NCT03303092|38267795|FG000|Overall Study|Protocol Violation|1|||
17127510|NCT03303092|38267796|FG001|Overall Study|Protocol Violation|5|||
17127511|NCT03303092|38267797|FG002|Overall Study|Protocol Violation|1|||
17127512|NCT03303092|38267795|FG000|Overall Study|Withdrawal by Subject|1|||
17127513|NCT03303092|38267796|FG001|Overall Study|Withdrawal by Subject|1|||
17127514|NCT03303092|38267797|FG002|Overall Study|Withdrawal by Subject|3|||
17127515|NCT04517864|38267807|FG000|Placebo-Controlled Phase|Adverse Event|1|||
17127516|NCT04517864|38267808|FG001|Placebo-Controlled Phase|Adverse Event|0|||
17127517|NCT04517864|38267807|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
17127518|NCT04517864|38267808|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
16944544|NCT01169779|38088628|FG000|Overall Study|Withdrawal by Subject|3|||
17127519|NCT04517864|38267807|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
17127520|NCT04517864|38267808|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
17127521|NCT04517864|38267807|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
17127522|NCT04517864|38267808|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
17127523|NCT04517864|38267807|FG000|Active Therapy Extension Phase|Adverse Event|1|||
17127524|NCT04517864|38267808|FG001|Active Therapy Extension Phase|Adverse Event|0|||
17127525|NCT03302936|38267829|FG000|Overall Study|Protocol Violation|3|||
17127526|NCT03302936|38267830|FG001|Overall Study|Protocol Violation|4|||
17127527|NCT03733899|38267840|FG000|Period 1|Protocol Violation|0|||
16944545|NCT01169779|38088629|FG001|Overall Study|Withdrawal by Subject|2|||
16944546|NCT01169779|38088628|FG000|Overall Study|Familial and personal reasons|3|||
16944547|NCT01169779|38088629|FG001|Overall Study|Familial and personal reasons|3|||
16944548|NCT01169701|38088637|FG000|Overall Study|Lost to Follow-up|1|||
16944549|NCT01169701|38088638|FG001|Overall Study|Lost to Follow-up|1|||
16944550|NCT01169701|38088637|FG000|Overall Study|Withdrawal by Subject|1|||
16944551|NCT01169701|38088638|FG001|Overall Study|Withdrawal by Subject|3|||
16944552|NCT01169701|38088637|FG000|Overall Study|Adverse Event|1|||
16944553|NCT01169701|38088638|FG001|Overall Study|Adverse Event|2|||
16944554|NCT01169701|38088637|FG000|Overall Study|Exclusion criteria|2|||
16944555|NCT01169701|38088638|FG001|Overall Study|Exclusion criteria|0|||
16944556|NCT01169701|38088637|FG000|Overall Study|Death|0|||
16944557|NCT01169701|38088638|FG001|Overall Study|Death|1|||
16944558|NCT01169701|38088637|FG000|Overall Study|Administrative problems|0|||
16944559|NCT01169701|38088638|FG001|Overall Study|Administrative problems|1|||
16944560|NCT01169701|38088637|FG000|Overall Study|Serious adverse event|0|||
16944561|NCT01169701|38088638|FG001|Overall Study|Serious adverse event|1|||
16944562|NCT01169701|38088637|FG000|Overall Study|Sponsor decision|0|||
16944563|NCT01169701|38088638|FG001|Overall Study|Sponsor decision|1|||
16944564|NCT01168999|38088648|FG000|Overall Study|Lost to Follow-up|2|||
16944565|NCT01168999|38088649|FG001|Overall Study|Lost to Follow-up|1|||
16944566|NCT01168999|38088650|FG002|Overall Study|Lost to Follow-up|0|||
16944567|NCT01168999|38088651|FG003|Overall Study|Lost to Follow-up|0|||
16944568|NCT01167907|38088663|FG000|Overall Study|Protocol Violation|1|||
16944569|NCT01167907|38088664|FG001|Overall Study|Protocol Violation|0|||
16944570|NCT01167907|38088663|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
16944571|NCT01167907|38088664|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
16944572|NCT01166659|38088670|FG000|Overall Study|Subject Decision|8|||
16944573|NCT01166659|38088670|FG000|Overall Study|Investigator Decision|2|||
16944574|NCT01166659|38088670|FG000|Overall Study|Death|1|||
16944575|NCT01166659|38088670|FG000|Overall Study|Lost to Follow-up|1|||
16944576|NCT01166659|38088670|FG000|Overall Study|Study Closed at Site|1|||
16944577|NCT01115491|38088675|FG000|Overall Study|Death|22|||
16944578|NCT01115491|38088675|FG000|Overall Study|Adverse Event|3|||
16944579|NCT01115491|38088675|FG000|Overall Study|Lost to Follow-up|3|||
16944580|NCT01115491|38088675|FG000|Overall Study|Withdrawal by Subject|1|||
16944581|NCT01115491|38088675|FG000|Overall Study|Physician Decision|1|||
16944582|NCT01113931|38088681|FG000|Overall Study|Adverse Event|2|||
16944583|NCT01113931|38088682|FG001|Overall Study|Adverse Event|2|||
16944584|NCT01113931|38088681|FG000|Overall Study|Physician Decision|0|||
16944585|NCT01113931|38088682|FG001|Overall Study|Physician Decision|2|||
16944586|NCT01113931|38088681|FG000|Overall Study|Lost to Follow-up|12|||
16944587|NCT01113931|38088682|FG001|Overall Study|Lost to Follow-up|9|||
16944588|NCT01113931|38088681|FG000|Overall Study|Various|2|||
16944589|NCT01113931|38088682|FG001|Overall Study|Various|4|||
16944590|NCT01113931|38088681|FG000|Overall Study|Withdrawal by Subject|3|||
16944591|NCT01113931|38088682|FG001|Overall Study|Withdrawal by Subject|0|||
16944592|NCT01107379|38088688|FG000|Overall Study|Withdrawal by Subject|18|||
16944593|NCT01107379|38088688|FG000|Overall Study|Lost to Follow-up|3|||
16944594|NCT01106911|38088692|FG000|Overall Study|Physician Decision|2|||
16944595|NCT01106911|38088692|FG000|Overall Study|deemed ineligible after screening|3|||
16944596|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
16944597|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
16944598|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
16944599|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
16944600|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Death|0|||
16944601|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Death|0|||
16944602|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Death|1|||
16944603|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Death|0|||
16944604|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
16944605|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
16944606|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
16944607|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
16944608|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
16944609|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
16944610|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
16944611|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
16944612|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
16944613|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
16944614|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
16944615|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
16944616|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
16944617|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
16944618|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
16944619|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
16944620|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
16944621|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
16944622|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
16944623|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
17028406|NCT00783692|38172777|FG000|Maintenance Phase|Adverse Event|7|||
17028407|NCT00783692|38172778|FG001|Maintenance Phase|Adverse Event|0|||
16860196|NCT00089661|37815714|FG001|Overall Study|Death|0|||
16860197|NCT00089661|37815713|FG000|Overall Study|Lost to Follow-up|0|||
16860198|NCT00089661|37815714|FG001|Overall Study|Lost to Follow-up|3|||
16860199|NCT00089661|37815713|FG000|Overall Study|Withdrawal by Subject|11|||
16860200|NCT00089661|37815714|FG001|Overall Study|Withdrawal by Subject|9|||
16860201|NCT00089661|37815713|FG000|Overall Study|Disease progression|1|||
16860202|NCT00089661|37815714|FG001|Overall Study|Disease progression|3|||
16860203|NCT00089661|37815713|FG000|Overall Study|Ineligibility determined|4|||
16860204|NCT00089661|37815714|FG001|Overall Study|Ineligibility determined|4|||
16860205|NCT00089661|37815713|FG000|Overall Study|Noncompliance|2|||
16860206|NCT00089661|37815714|FG001|Overall Study|Noncompliance|4|||
16860207|NCT00089661|37815713|FG000|Overall Study|Other|2|||
16860208|NCT00089661|37815714|FG001|Overall Study|Other|1|||
16860209|NCT00089583|37815735|FG000|Overall Study|Adverse Event|0|||
16860210|NCT00089583|37815736|FG001|Overall Study|Adverse Event|3|||
16860211|NCT00089583|37815735|FG000|Overall Study|Insufficient Viral Load Response|5|||
16860212|NCT00089583|37815736|FG001|Overall Study|Insufficient Viral Load Response|5|||
16860213|NCT00089583|37815735|FG000|Overall Study|Withdrawal by Subject|0|||
16860214|NCT00089583|37815736|FG001|Overall Study|Withdrawal by Subject|4|||
16860215|NCT00089583|37815735|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
16860216|NCT00089583|37815736|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
16860217|NCT00089583|37815735|FG000|Overall Study|Participant Refused Study Medication|0|||
16944624|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
16944625|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
16944626|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
16944627|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
16944628|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16944629|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
16944630|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16944631|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16944632|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
16944633|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
16944634|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
16944635|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
16944636|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
16944637|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
16944638|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
16944639|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
16944640|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Other|8|||
16944641|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Other|14|||
16944642|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Other|8|||
16944643|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Other|23|||
16944644|NCT01106677|38088700|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
16944645|NCT01106677|38088701|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
16944646|NCT01106677|38088702|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
16944647|NCT01106677|38088703|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
16944648|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
17127528|NCT03733899|38267841|FG001|Period 1|Protocol Violation|0|||
17127529|NCT03733899|38267842|FG002|Period 1|Protocol Violation|0|||
16860218|NCT00089583|37815736|FG001|Overall Study|Participant Refused Study Medication|2|||
16860219|NCT00089583|37815735|FG000|Overall Study|Non-Compliance|0|||
16860220|NCT00089583|37815736|FG001|Overall Study|Non-Compliance|4|||
16860221|NCT00089583|37815735|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
16860222|NCT00089583|37815736|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
16860223|NCT00089583|37815735|FG000|Overall Study|Participant Management Criteria Met|0|||
16860224|NCT00089583|37815736|FG001|Overall Study|Participant Management Criteria Met|1|||
16860225|NCT00089583|37815735|FG000|Overall Study|Reason Not Provided|0|||
16860226|NCT00089583|37815736|FG001|Overall Study|Reason Not Provided|1|||
16860227|NCT00089583|37815735|FG000|Overall Study|Protocol Violation|0|||
16860228|NCT00089583|37815736|FG001|Overall Study|Protocol Violation|3|||
16860229|NCT00089583|37815735|FG000|Overall Study|Principal Investigator Decision|0|||
16860230|NCT00089583|37815736|FG001|Overall Study|Principal Investigator Decision|10|||
16860231|NCT00089583|37815735|FG000|Overall Study|Start of Disallowed Medication|0|||
16860232|NCT00089583|37815736|FG001|Overall Study|Start of Disallowed Medication|1|||
16860233|NCT00089583|37815735|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
16860234|NCT00089583|37815736|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
16860235|NCT00089583|37815735|FG000|Overall Study|Participant Incarcerated|0|||
16860236|NCT00089583|37815736|FG001|Overall Study|Participant Incarcerated|1|||
16860237|NCT00088881|37815748|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
16860238|NCT00088881|37815748|FG000|Step 1 - R-CHOP|Adverse Event|1|||
16860239|NCT00088881|37815748|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
16860240|NCT00088881|37815748|FG000|Step 1 - R-CHOP|Physician Decision|1|||
16860241|NCT00088881|37815748|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
16860242|NCT00088881|37815748|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
16860243|NCT00088881|37815748|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
16860244|NCT00087555|37815796|FG000|Overall Study|Adverse Event|3|||
16860245|NCT00087555|37815797|FG001|Overall Study|Adverse Event|6|||
16860246|NCT00087555|37815798|FG002|Overall Study|Adverse Event|14|||
16860247|NCT00087555|37815796|FG000|Overall Study|Lost to Follow-up|0|||
16860248|NCT00087555|37815797|FG001|Overall Study|Lost to Follow-up|1|||
16860249|NCT00087555|37815798|FG002|Overall Study|Lost to Follow-up|1|||
16860250|NCT00087555|37815796|FG000|Overall Study|Non - Compliance|1|||
16860251|NCT00087555|37815797|FG001|Overall Study|Non - Compliance|0|||
16860252|NCT00087555|37815798|FG002|Overall Study|Non - Compliance|0|||
16860253|NCT00087555|37815796|FG000|Overall Study|Protocol Violation|0|||
16860254|NCT00087555|37815797|FG001|Overall Study|Protocol Violation|0|||
16860255|NCT00087555|37815798|FG002|Overall Study|Protocol Violation|2|||
16860256|NCT00087555|37815796|FG000|Overall Study|Screen Failure|1|||
16860257|NCT00087555|37815797|FG001|Overall Study|Screen Failure|1|||
16860258|NCT00087555|37815798|FG002|Overall Study|Screen Failure|0|||
16860259|NCT00087555|37815796|FG000|Overall Study|Pregnancy|0|||
16860260|NCT00087555|37815797|FG001|Overall Study|Pregnancy|1|||
16860261|NCT00087555|37815798|FG002|Overall Study|Pregnancy|1|||
16860262|NCT00087555|37815796|FG000|Overall Study|Withdrawal by Subject|3|||
16860263|NCT00087555|37815797|FG001|Overall Study|Withdrawal by Subject|2|||
16860264|NCT00087555|37815798|FG002|Overall Study|Withdrawal by Subject|1|||
16944649|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16944650|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
16944651|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
16944652|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Death|0|||
16944653|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Death|0|||
16944654|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Death|0|||
16944655|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Death|1|||
16944656|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
16944657|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
16944658|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
16944659|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
16944660|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16944661|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
16944662|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
16944663|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
16944664|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16944665|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
16944666|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16944667|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
16944668|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16944669|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16944670|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16944671|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16944672|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16944673|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
16944674|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
16944675|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16944676|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
16944677|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
16944678|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
16944679|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
16944680|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16944681|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16944682|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16944683|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16860265|NCT00087555|37815796|FG000|Overall Study|Lack of Efficacy|2|||
16860266|NCT00087555|37815797|FG001|Overall Study|Lack of Efficacy|0|||
16860267|NCT00087555|37815798|FG002|Overall Study|Lack of Efficacy|1|||
16860268|NCT00087555|37815796|FG000|Overall Study|Non Compliance|0|||
16860269|NCT00087555|37815797|FG001|Overall Study|Non Compliance|0|||
16860270|NCT00087555|37815798|FG002|Overall Study|Non Compliance|1|||
17127530|NCT03733899|38267843|FG003|Period 1|Protocol Violation|0|||
17127531|NCT03733899|38267844|FG004|Period 1|Protocol Violation|0|||
17127532|NCT03733899|38267845|FG005|Period 1|Protocol Violation|1|||
17127533|NCT03733899|38267840|FG000|Period 2|Unscuccessful Treatment|0|||
16944684|NCT01106677|38088700|FG000|Extension Period: Week 26 to Week 52|Other|6|||
16944685|NCT01106677|38088701|FG001|Extension Period: Week 26 to Week 52|Other|5|||
16944686|NCT01106677|38088702|FG002|Extension Period: Week 26 to Week 52|Other|8|||
16944687|NCT01106677|38088703|FG003|Extension Period: Week 26 to Week 52|Other|5|||
16944688|NCT01106287|38088724|FG000|Overall Study|Adverse Event|1|||
16944689|NCT01106287|38088725|FG001|Overall Study|Adverse Event|0|||
16944690|NCT01106287|38088726|FG002|Overall Study|Adverse Event|0|||
16944691|NCT01106287|38088727|FG003|Overall Study|Adverse Event|0|||
16944692|NCT01104493|38088743|FG000|Overall Study|Lost to Follow-up|0|||
16944693|NCT01104493|38088744|FG001|Overall Study|Lost to Follow-up|2|||
16944694|NCT01104415|38088750|FG000|Core Phase|Consent withdrawn by subjects|1|||
16944695|NCT01104415|38088751|FG001|Core Phase|Consent withdrawn by subjects|0|||
16944696|NCT01104415|38088750|FG000|Extension Period|Progressive disease|0|||
16944697|NCT01104415|38088751|FG001|Extension Period|Progressive disease|4|||
16944698|NCT01104415|38088750|FG000|Extension Period|Death|0|||
16944699|NCT01104415|38088751|FG001|Extension Period|Death|1|||
16944700|NCT01104415|38088750|FG000|Extension Period|Physician Decision|0|||
16944701|NCT01104415|38088751|FG001|Extension Period|Physician Decision|1|||
16944702|NCT01104415|38088750|FG000|Extension Period|Transition to Study LX1606.302|0|||
16944703|NCT01104415|38088751|FG001|Extension Period|Transition to Study LX1606.302|4|||
16944704|NCT01104415|38088750|FG000|Extension Period|Heart surgery/feeling miserable|0|||
16860271|NCT00087555|37815796|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
16944705|NCT01104415|38088751|FG001|Extension Period|Heart surgery/feeling miserable|1|||
17127534|NCT03733899|38267841|FG001|Period 2|Unscuccessful Treatment|1|||
17127535|NCT03733899|38267842|FG002|Period 2|Unscuccessful Treatment|0|||
17127536|NCT03733899|38267843|FG003|Period 2|Unscuccessful Treatment|0|||
17127537|NCT03733899|38267844|FG004|Period 2|Unscuccessful Treatment|0|||
16944706|NCT01099579|38088761|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
16944707|NCT01099579|38088762|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
16944708|NCT01099579|38088763|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
16944709|NCT01099579|38088761|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
16944710|NCT01099579|38088762|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
16944711|NCT01099579|38088763|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
16944712|NCT01099579|38088761|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
16944713|NCT01099579|38088762|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
16944714|NCT01099579|38088763|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
16944715|NCT01099579|38088761|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
16944716|NCT01099579|38088762|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
16944717|NCT01099579|38088763|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
16944718|NCT01099579|38088761|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
16944719|NCT01099579|38088762|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
16944720|NCT01099579|38088763|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
16944721|NCT01099579|38088761|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
16944722|NCT01099579|38088762|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
16944723|NCT01099579|38088763|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
16944724|NCT01099579|38088761|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
16944725|NCT01099579|38088762|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
16944726|NCT01099579|38088763|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
16944727|NCT01099579|38088761|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
16944728|NCT01099579|38088762|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
16944729|NCT01099579|38088763|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
16944730|NCT01099579|38088761|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
16944731|NCT01099579|38088762|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
16944732|NCT01099579|38088763|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
16944733|NCT01099579|38088761|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
16944734|NCT01099579|38088762|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
16944735|NCT01099579|38088763|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
16944736|NCT01103713|38088773|FG000|Overall Study|Lost to Follow-up|2|||
16944737|NCT01103713|38088773|FG000|Overall Study|Withdrawal by Subject|8|||
16944738|NCT01103713|38088773|FG000|Overall Study|Study terminated by sponsor|2|||
16944739|NCT01103713|38088773|FG000|Overall Study|Other|1|||
16944740|NCT01103479|38088783|FG000|Overall Study|Up to date with CRC screening|1|||
16944741|NCT01103479|38088784|FG001|Overall Study|Up to date with CRC screening|9|||
16944742|NCT01103479|38088785|FG002|Overall Study|Up to date with CRC screening|12|||
16944743|NCT01103479|38088783|FG000|Overall Study|Family history of CRC|1|||
16944744|NCT01103479|38088784|FG001|Overall Study|Family history of CRC|0|||
16944745|NCT01103479|38088785|FG002|Overall Study|Family history of CRC|2|||
16944746|NCT01103479|38088783|FG000|Overall Study|Active cancer|1|||
16944747|NCT01103479|38088784|FG001|Overall Study|Active cancer|0|||
16944748|NCT01103479|38088785|FG002|Overall Study|Active cancer|0|||
16944749|NCT01103479|38088783|FG000|Overall Study|Saw non-study physician|2|||
16944750|NCT01103479|38088784|FG001|Overall Study|Saw non-study physician|0|||
16944751|NCT01103479|38088785|FG002|Overall Study|Saw non-study physician|0|||
16944752|NCT01103323|38088796|FG000|Without/Before Drug Switch|Adverse Event|50|||
16944753|NCT01103323|38088797|FG001|Without/Before Drug Switch|Adverse Event|7|||
16944754|NCT01103323|38088796|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
16944755|NCT01103323|38088797|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
16944756|NCT01103323|38088796|FG000|Without/Before Drug Switch|Protocol Violation|2|||
16944757|NCT01103323|38088797|FG001|Without/Before Drug Switch|Protocol Violation|0|||
16944758|NCT01103323|38088796|FG000|Without/Before Drug Switch|Physician Decision|2|||
16944759|NCT01103323|38088797|FG001|Without/Before Drug Switch|Physician Decision|0|||
16944760|NCT01103323|38088796|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
16944761|NCT01103323|38088797|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
16944762|NCT01103323|38088796|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
16944763|NCT01103323|38088797|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
16944764|NCT01103323|38088796|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
16944765|NCT01103323|38088797|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
16944766|NCT01103245|38088808|FG000|Overall Study|Withdrawal by Subject|1|||
16944767|NCT01103245|38088809|FG001|Overall Study|Withdrawal by Subject|0|||
16944768|NCT01103245|38088810|FG002|Overall Study|Withdrawal by Subject|3|||
16944769|NCT01103245|38088811|FG003|Overall Study|Withdrawal by Subject|0|||
16944770|NCT01103245|38088808|FG000|Overall Study|Inadequate IV access|1|||
16944771|NCT01103245|38088809|FG001|Overall Study|Inadequate IV access|0|||
17028408|NCT00783692|38172779|FG002|Maintenance Phase|Adverse Event|0|||
16944772|NCT01103245|38088810|FG002|Overall Study|Inadequate IV access|0|||
16944773|NCT01103245|38088811|FG003|Overall Study|Inadequate IV access|0|||
16944774|NCT01103245|38088808|FG000|Overall Study|Adverse Event|0|||
16944775|NCT01103245|38088809|FG001|Overall Study|Adverse Event|2|||
16944776|NCT01103245|38088810|FG002|Overall Study|Adverse Event|1|||
16944777|NCT01103245|38088811|FG003|Overall Study|Adverse Event|0|||
16944778|NCT01103245|38088808|FG000|Overall Study|Physician Decision|1|||
16944779|NCT01103245|38088809|FG001|Overall Study|Physician Decision|0|||
16944780|NCT01103245|38088810|FG002|Overall Study|Physician Decision|0|||
16944781|NCT01103245|38088811|FG003|Overall Study|Physician Decision|0|||
16860272|NCT00087555|37815797|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
16860273|NCT00087555|37815798|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
16860274|NCT00087555|37815796|FG000|Overall Study|Patient wanted to go back on Med|1|||
16860275|NCT00087555|37815797|FG001|Overall Study|Patient wanted to go back on Med|0|||
16860276|NCT00087555|37815798|FG002|Overall Study|Patient wanted to go back on Med|0|||
16860277|NCT00086619|37815821|FG000|Overall Study|Withdrawal by Subject|6|||
16860278|NCT00086619|37815822|FG001|Overall Study|Withdrawal by Subject|6|||
16860279|NCT00086619|37815821|FG000|Overall Study|Adverse Event|8|||
16860280|NCT00086619|37815822|FG001|Overall Study|Adverse Event|10|||
16860281|NCT00086619|37815821|FG000|Overall Study|Protocol Violation|1|||
16860282|NCT00086619|37815822|FG001|Overall Study|Protocol Violation|1|||
16860283|NCT00085917|37815835|FG000|Overall Study|Adverse Event|4|||
16860284|NCT00085917|37815836|FG001|Overall Study|Adverse Event|3|||
16860285|NCT00084747|37815842|FG000|Overall Study|Relapsed|8|||
16860286|NCT00084747|37815842|FG000|Overall Study|Death|3|||
16860287|NCT00084747|37815842|FG000|Overall Study|Withdrawal by Subject|2|||
16860288|NCT00081159|37815877|FG000|Overall Study|Withdrawal by Subject|0|||
16860289|NCT00081159|37815878|FG001|Overall Study|Withdrawal by Subject|3|||
16860290|NCT00081159|37815877|FG000|Overall Study|Myelosuppression prior to treatment|0|||
16860291|NCT00081159|37815878|FG001|Overall Study|Myelosuppression prior to treatment|1|||
16860292|NCT00081159|37815877|FG000|Overall Study|Lost to Follow-up|2|||
16860293|NCT00081159|37815878|FG001|Overall Study|Lost to Follow-up|1|||
16860294|NCT00080223|37815893|FG000|Overall Study|Adverse Event|23|||
16860295|NCT00080223|37815893|FG000|Overall Study|Death|21|||
16860296|NCT00080223|37815893|FG000|Overall Study|Withdrawal by Subject|13|||
16860297|NCT00080223|37815893|FG000|Overall Study|Lung Transplantation|9|||
16860298|NCT00080223|37815893|FG000|Overall Study|Non-compliance With Study Treatment|7|||
16860299|NCT00080223|37815893|FG000|Overall Study|Participant unwilling to continue|2|||
16860300|NCT00080223|37815893|FG000|Overall Study|Physician Decision|1|||
16868116|NCT01553279|37841133|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
16868117|NCT01553279|37841132|FG000|Interim Period|Withdrawal by Subject|2|||
16868118|NCT01553279|37841133|FG001|Interim Period|Withdrawal by Subject|2|||
16868119|NCT01553279|37841132|FG000|Interim Period|Lost to Follow-up|1|||
16868120|NCT01553279|37841133|FG001|Interim Period|Lost to Follow-up|0|||
16868121|NCT01553279|37841132|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
16868122|NCT01553279|37841133|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
16868123|NCT01553279|37841132|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
16868124|NCT01553279|37841133|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
16868125|NCT01562743|37841140|FG000|Overall Study|Adverse Event|29|||
16868126|NCT01562743|37841140|FG000|Overall Study|Lack of Efficacy|3|||
16868127|NCT01562743|37841140|FG000|Overall Study|Withdrawal by Subject|13|||
16868128|NCT01562743|37841140|FG000|Overall Study|Protocol Violation|1|||
16868129|NCT01562743|37841140|FG000|Overall Study|Discontinuation criteria|2|||
16868130|NCT01562743|37841140|FG000|Overall Study|Lost to Follow-up|2|||
16868131|NCT01562743|37841140|FG000|Overall Study|Physician Decision|2|||
16868132|NCT01535443|37841144|FG000|Overall Study|Physician Decision|3|||
16868133|NCT01535287|37841151|FG000|Overall Study|drug not prepared in time|5|||
16868134|NCT01535287|37841152|FG001|Overall Study|drug not prepared in time|6|||
16868135|NCT01551173|37841160|FG000|Overall Study|Withdrawal by Subject|11|||
16868136|NCT01551173|37841161|FG001|Overall Study|Withdrawal by Subject|16|||
16868137|NCT01551173|37841160|FG000|Overall Study|Adverse Event|7|||
16868138|NCT01551173|37841161|FG001|Overall Study|Adverse Event|6|||
16868139|NCT01551173|37841160|FG000|Overall Study|Lost to Follow-up|5|||
16868140|NCT01551173|37841161|FG001|Overall Study|Lost to Follow-up|7|||
16868141|NCT01551173|37841160|FG000|Overall Study|Other|5|||
16868142|NCT01551173|37841161|FG001|Overall Study|Other|3|||
16868143|NCT01549613|37841170|FG000|Overall Study|Lost to Follow-up|11|||
16868144|NCT01549613|37841171|FG001|Overall Study|Lost to Follow-up|11|||
16868145|NCT01548599|37841179|FG000|Overall Study|Lost to Follow-up|0|||
16868146|NCT01548599|37841180|FG001|Overall Study|Lost to Follow-up|1|||
16868147|NCT01548599|37841179|FG000|Overall Study|Withdrawal by Subject|4|||
16868148|NCT01548599|37841180|FG001|Overall Study|Withdrawal by Subject|0|||
16868149|NCT01548599|37841179|FG000|Overall Study|Death|2|||
16868150|NCT01548599|37841180|FG001|Overall Study|Death|1|||
16868151|NCT01548287|37841193|FG000|Screening|No reason provided|0|||
16868152|NCT01548287|37841194|FG001|Screening|No reason provided|0|||
16944782|NCT01099267|38088821|FG000|MDS-003 Study|Adverse Event|37|||
16944783|NCT01099267|38088821|FG000|MDS-003 Study|Lack of Efficacy|52|||
17127538|NCT03733899|38267845|FG005|Period 2|Unscuccessful Treatment|0|||
17127539|NCT03733899|38267840|FG000|Period 3|Withdrawal by Subject|1|||
17127540|NCT03733899|38267841|FG001|Period 3|Withdrawal by Subject|0|||
17127541|NCT03733899|38267842|FG002|Period 3|Withdrawal by Subject|0|||
16860301|NCT01899053|37816531|FG000|Overall Study|Progressive Disease|4|||
16860302|NCT01899053|37816532|FG001|Overall Study|Progressive Disease|0|||
16860303|NCT01899053|37816533|FG002|Overall Study|Progressive Disease|3|||
16860304|NCT01899053|37816534|FG003|Overall Study|Progressive Disease|0|||
16860305|NCT01899053|37816535|FG004|Overall Study|Progressive Disease|3|||
16860306|NCT01899053|37816536|FG005|Overall Study|Progressive Disease|1|||
16860307|NCT01899053|37816537|FG006|Overall Study|Progressive Disease|1|||
16860308|NCT01899053|37816538|FG007|Overall Study|Progressive Disease|1|||
16860309|NCT01899053|37816539|FG008|Overall Study|Progressive Disease|4|||
16860310|NCT01899053|37816540|FG009|Overall Study|Progressive Disease|3|||
16860311|NCT01899053|37816541|FG010|Overall Study|Progressive Disease|12|||
16860312|NCT01899053|37816542|FG011|Overall Study|Progressive Disease|5|||
16860313|NCT01899053|37816543|FG012|Overall Study|Progressive Disease|8|||
16860314|NCT01899053|37816544|FG013|Overall Study|Progressive Disease|17|||
16860315|NCT01899053|37816531|FG000|Overall Study|Adverse Event|1|||
16860316|NCT01899053|37816532|FG001|Overall Study|Adverse Event|1|||
16860317|NCT01899053|37816533|FG002|Overall Study|Adverse Event|1|||
16860318|NCT01899053|37816534|FG003|Overall Study|Adverse Event|3|||
16860319|NCT01899053|37816535|FG004|Overall Study|Adverse Event|1|||
16860320|NCT01899053|37816536|FG005|Overall Study|Adverse Event|1|||
16860321|NCT01899053|37816537|FG006|Overall Study|Adverse Event|1|||
16860322|NCT01899053|37816538|FG007|Overall Study|Adverse Event|0|||
16860323|NCT01899053|37816539|FG008|Overall Study|Adverse Event|2|||
16860324|NCT01899053|37816540|FG009|Overall Study|Adverse Event|0|||
16860325|NCT01899053|37816541|FG010|Overall Study|Adverse Event|3|||
16860326|NCT01899053|37816542|FG011|Overall Study|Adverse Event|1|||
16860327|NCT01899053|37816543|FG012|Overall Study|Adverse Event|2|||
16860328|NCT01899053|37816544|FG013|Overall Study|Adverse Event|2|||
16860329|NCT01899053|37816531|FG000|Overall Study|Reason Not Specified|0|||
16860330|NCT01899053|37816532|FG001|Overall Study|Reason Not Specified|0|||
16860331|NCT01899053|37816533|FG002|Overall Study|Reason Not Specified|0|||
16860332|NCT01899053|37816534|FG003|Overall Study|Reason Not Specified|0|||
16860333|NCT01899053|37816535|FG004|Overall Study|Reason Not Specified|0|||
16860334|NCT01899053|37816536|FG005|Overall Study|Reason Not Specified|0|||
16860335|NCT01899053|37816537|FG006|Overall Study|Reason Not Specified|1|||
16860336|NCT01899053|37816538|FG007|Overall Study|Reason Not Specified|0|||
16860337|NCT01899053|37816539|FG008|Overall Study|Reason Not Specified|0|||
16860338|NCT01899053|37816540|FG009|Overall Study|Reason Not Specified|0|||
16860339|NCT01899053|37816541|FG010|Overall Study|Reason Not Specified|0|||
16860340|NCT01899053|37816542|FG011|Overall Study|Reason Not Specified|0|||
16860341|NCT01899053|37816543|FG012|Overall Study|Reason Not Specified|1|||
16860342|NCT01899053|37816544|FG013|Overall Study|Reason Not Specified|0|||
16860343|NCT01899053|37816531|FG000|Overall Study|Withdrawal by Subject|1|||
16860344|NCT01899053|37816532|FG001|Overall Study|Withdrawal by Subject|1|||
16860345|NCT01899053|37816533|FG002|Overall Study|Withdrawal by Subject|2|||
16860346|NCT01899053|37816534|FG003|Overall Study|Withdrawal by Subject|0|||
16860347|NCT01899053|37816535|FG004|Overall Study|Withdrawal by Subject|2|||
16860348|NCT01899053|37816536|FG005|Overall Study|Withdrawal by Subject|0|||
16860349|NCT01899053|37816537|FG006|Overall Study|Withdrawal by Subject|0|||
16860350|NCT01899053|37816538|FG007|Overall Study|Withdrawal by Subject|1|||
16860351|NCT01899053|37816539|FG008|Overall Study|Withdrawal by Subject|0|||
16860352|NCT01899053|37816540|FG009|Overall Study|Withdrawal by Subject|0|||
16860353|NCT01899053|37816541|FG010|Overall Study|Withdrawal by Subject|0|||
16944784|NCT01099267|38088821|FG000|MDS-003 Study|Withdrawal by Subject|8|||
16860354|NCT01899053|37816542|FG011|Overall Study|Withdrawal by Subject|0|||
16860355|NCT01899053|37816543|FG012|Overall Study|Withdrawal by Subject|1|||
16860356|NCT01899053|37816544|FG013|Overall Study|Withdrawal by Subject|1|||
16860357|NCT01899053|37816531|FG000|Overall Study|Protocol Violation|0|||
16860358|NCT01899053|37816532|FG001|Overall Study|Protocol Violation|0|||
16860359|NCT01899053|37816533|FG002|Overall Study|Protocol Violation|1|||
16860360|NCT01899053|37816534|FG003|Overall Study|Protocol Violation|0|||
16860361|NCT01899053|37816535|FG004|Overall Study|Protocol Violation|0|||
16860362|NCT01899053|37816536|FG005|Overall Study|Protocol Violation|0|||
16860363|NCT01899053|37816537|FG006|Overall Study|Protocol Violation|0|||
16860364|NCT01899053|37816538|FG007|Overall Study|Protocol Violation|0|||
16860365|NCT01899053|37816539|FG008|Overall Study|Protocol Violation|0|||
16860366|NCT01899053|37816540|FG009|Overall Study|Protocol Violation|0|||
16860367|NCT01899053|37816541|FG010|Overall Study|Protocol Violation|0|||
16860368|NCT01899053|37816542|FG011|Overall Study|Protocol Violation|0|||
16860369|NCT01899053|37816543|FG012|Overall Study|Protocol Violation|0|||
16860370|NCT01899053|37816544|FG013|Overall Study|Protocol Violation|0|||
16944785|NCT01099267|38088821|FG000|MDS-003 Study|Lost to Follow-up|1|||
16860371|NCT01899053|37816531|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
16860372|NCT01899053|37816532|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
16860373|NCT01899053|37816533|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
16860374|NCT01899053|37816534|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
16860375|NCT01899053|37816535|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
16944786|NCT01099267|38088821|FG000|MDS-003 Study|Death|11|||
16944787|NCT01099267|38088821|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
16944788|NCT01099267|38088821|FG000|MDS-003 Study|Disease Progression|7|||
16944789|NCT01099267|38088821|FG000|MDS-003 Study|Investigator Decision|2|||
16944790|NCT01099267|38088821|FG000|MDS-003 Study|Non-Compliance|2|||
16944791|NCT01099267|38088821|FG000|MDS-003 Study|Loss of Response|1|||
16944792|NCT01099267|38088821|FG000|MDS-003 Study|Secondary Malign Disease|1|||
16944793|NCT01098487|38088825|FG000|Overall Study|Adverse Event|22|||
16944794|NCT01098487|38088825|FG000|Overall Study|Lack of Efficacy|11|||
16944795|NCT01098487|38088825|FG000|Overall Study|Withdrawal by Subject|7|||
16944796|NCT01098487|38088825|FG000|Overall Study|Lost to Follow-up|3|||
16860376|NCT01899053|37816536|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
16860377|NCT01899053|37816537|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
16860378|NCT01899053|37816538|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
16860379|NCT01899053|37816539|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
16860380|NCT01899053|37816540|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
16860381|NCT01899053|37816541|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
16860382|NCT01899053|37816542|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
16860383|NCT01899053|37816543|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
17127542|NCT03733899|38267843|FG003|Period 3|Withdrawal by Subject|0|||
16860384|NCT01899053|37816544|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
16773420|NCT02736409|37712474|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16773421|NCT02736409|37712475|FG003|Overall Study|Non-Compliance with Study Drug|1|||
16773422|NCT02736409|37712472|FG000|Overall Study|Adverse Event|0|||
16773423|NCT02736409|37712473|FG001|Overall Study|Adverse Event|1|||
16773424|NCT02736409|37712474|FG002|Overall Study|Adverse Event|5|||
16773425|NCT02736409|37712475|FG003|Overall Study|Adverse Event|4|||
16773426|NCT02736409|37712472|FG000|Overall Study|Other|0|||
16773427|NCT02736409|37712473|FG001|Overall Study|Other|0|||
16773428|NCT02736409|37712474|FG002|Overall Study|Other|1|||
16773429|NCT02736409|37712475|FG003|Overall Study|Other|1|||
16773430|NCT02736409|37712472|FG000|Overall Study|Pregnancy|0|||
16773431|NCT02736409|37712473|FG001|Overall Study|Pregnancy|0|||
16773432|NCT02736409|37712474|FG002|Overall Study|Pregnancy|1|||
16773433|NCT02736409|37712475|FG003|Overall Study|Pregnancy|0|||
16773434|NCT02736409|37712472|FG000|Overall Study|Lost to Follow-up|0|||
16773435|NCT02736409|37712473|FG001|Overall Study|Lost to Follow-up|0|||
16773436|NCT02736409|37712474|FG002|Overall Study|Lost to Follow-up|2|||
16773437|NCT02736409|37712475|FG003|Overall Study|Lost to Follow-up|1|||
16773438|NCT02736409|37712472|FG000|Overall Study|Physician Decision|0|||
16773439|NCT02736409|37712473|FG001|Overall Study|Physician Decision|0|||
16773440|NCT02736409|37712474|FG002|Overall Study|Physician Decision|0|||
16860385|NCT01899053|37816531|FG000|Overall Study|Symptomatic Deterioration|0|||
16860386|NCT01899053|37816532|FG001|Overall Study|Symptomatic Deterioration|0|||
16860387|NCT01899053|37816533|FG002|Overall Study|Symptomatic Deterioration|0|||
16860388|NCT01899053|37816534|FG003|Overall Study|Symptomatic Deterioration|0|||
16860389|NCT01899053|37816535|FG004|Overall Study|Symptomatic Deterioration|0|||
16860390|NCT01899053|37816536|FG005|Overall Study|Symptomatic Deterioration|1|||
16860391|NCT01899053|37816537|FG006|Overall Study|Symptomatic Deterioration|0|||
16860392|NCT01899053|37816538|FG007|Overall Study|Symptomatic Deterioration|1|||
16860393|NCT01899053|37816539|FG008|Overall Study|Symptomatic Deterioration|0|||
16860394|NCT01899053|37816540|FG009|Overall Study|Symptomatic Deterioration|0|||
16860395|NCT01899053|37816541|FG010|Overall Study|Symptomatic Deterioration|0|||
16860396|NCT01899053|37816542|FG011|Overall Study|Symptomatic Deterioration|1|||
16860397|NCT01899053|37816543|FG012|Overall Study|Symptomatic Deterioration|2|||
16860398|NCT01899053|37816544|FG013|Overall Study|Symptomatic Deterioration|0|||
16860399|NCT01888367|37816649|FG000|Overall Study|Physician Decision|3|||
16860400|NCT01888367|37816650|FG001|Overall Study|Physician Decision|4|||
16860401|NCT01888367|37816651|FG002|Overall Study|Physician Decision|2|||
16860402|NCT01888367|37816649|FG000|Overall Study|Death|2|||
16860403|NCT01888367|37816650|FG001|Overall Study|Death|0|||
16860404|NCT01888367|37816651|FG002|Overall Study|Death|1|||
16860405|NCT01888367|37816649|FG000|Overall Study|Withdrawal by Subject|1|||
16860406|NCT01888367|37816650|FG001|Overall Study|Withdrawal by Subject|0|||
16860407|NCT01888367|37816651|FG002|Overall Study|Withdrawal by Subject|1|||
16860408|NCT01888367|37816649|FG000|Overall Study|Lost to Follow-up|1|||
16860409|NCT01888367|37816650|FG001|Overall Study|Lost to Follow-up|1|||
16860410|NCT01888367|37816651|FG002|Overall Study|Lost to Follow-up|0|||
16860411|NCT01888367|37816649|FG000|Overall Study|Protocol Violation|0|||
16860412|NCT01888367|37816650|FG001|Overall Study|Protocol Violation|0|||
16944797|NCT01098487|38088825|FG000|Overall Study|Physician Decision|1|||
16773441|NCT02736409|37712475|FG003|Overall Study|Physician Decision|2|||
16773442|NCT03099707|37712488|FG000|Overall Study|Withdrawal by Subject|0|||
16860413|NCT01888367|37816651|FG002|Overall Study|Protocol Violation|1|||
16860414|NCT01888367|37816649|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
16860415|NCT01888367|37816650|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
16860416|NCT01888367|37816651|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
16860417|NCT01898195|37816677|FG000|Smoking Abstinence|Did not have good measurements|35|||
16773443|NCT03099707|37712489|FG001|Overall Study|Withdrawal by Subject|3|||
16773444|NCT03099707|37712488|FG000|Overall Study|Lost to Follow-up|0|||
16773445|NCT03099707|37712489|FG001|Overall Study|Lost to Follow-up|1|||
16773446|NCT02906033|37712497|FG000|Baseline|Protocol Violation|37|||
16773447|NCT02906033|37712498|FG001|Baseline|Protocol Violation|33|||
16773448|NCT02906033|37712497|FG000|Follow-up|Lost to Follow-up|46|||
16773449|NCT02906033|37712498|FG001|Follow-up|Lost to Follow-up|62|||
16773450|NCT02221882|37712510|FG000|Overall Study|Withdrawal by Subject|0|||
16773451|NCT02221882|37712511|FG001|Overall Study|Withdrawal by Subject|0|||
16773452|NCT02221882|37712512|FG002|Overall Study|Withdrawal by Subject|4|||
16773453|NCT02221882|37712513|FG003|Overall Study|Withdrawal by Subject|2|||
16773454|NCT02221882|37712514|FG004|Overall Study|Withdrawal by Subject|2|||
16773455|NCT02221882|37712515|FG005|Overall Study|Withdrawal by Subject|2|||
16773456|NCT02221882|37712510|FG000|Overall Study|Death|0|||
16773457|NCT02221882|37712511|FG001|Overall Study|Death|1|||
16773458|NCT02221882|37712512|FG002|Overall Study|Death|0|||
16773459|NCT02221882|37712513|FG003|Overall Study|Death|0|||
16773460|NCT02221882|37712514|FG004|Overall Study|Death|0|||
16773461|NCT02221882|37712515|FG005|Overall Study|Death|0|||
16773462|NCT02837783|37712536|FG000|Overall Study|Adverse Event|1|||
16773463|NCT02837783|37712537|FG001|Overall Study|Adverse Event|0|||
16773464|NCT02837783|37712536|FG000|Overall Study|Other, Not Specified|1|||
16773465|NCT02837783|37712537|FG001|Overall Study|Other, Not Specified|2|||
16773466|NCT02221648|37712545|FG000|Overall Study|Withdrawal by Subject|3|||
16773467|NCT02221648|37712546|FG001|Overall Study|Withdrawal by Subject|3|||
16773468|NCT02220712|37712556|FG000|Overall Study|Adverse Event|1|||
16773469|NCT02220712|37712556|FG000|Overall Study|Withdrawal by Subject|2|||
16773470|NCT02220712|37712556|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
16860418|NCT01898195|37816678|FG001|Smoking Abstinence|Did not have good measurements|38|||
16860419|NCT01898195|37816679|FG002|Smoking Abstinence|Did not have good measurements|36|||
16860420|NCT01897727|37816693|FG000|Overall Study|Exclusion: central sleep apnea|0|||
16860421|NCT01897727|37816694|FG001|Overall Study|Exclusion: central sleep apnea|1|||
16860422|NCT01897493|37816700|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
16860423|NCT01887353|37816709|FG000|Overall Study|Study stopped early|4|||
16860424|NCT01887353|37816710|FG001|Overall Study|Study stopped early|3|||
16860425|NCT01896869|37816732|FG000|Overall Study|Withdrawal by Subject|0|||
16860426|NCT01896869|37816733|FG001|Overall Study|Withdrawal by Subject|6|||
16860427|NCT01896869|37816732|FG000|Overall Study|Lost to Follow-up|1|||
16860428|NCT01896869|37816733|FG001|Overall Study|Lost to Follow-up|0|||
16860429|NCT01896557|37816743|FG000|Clopidogrel Alone|Adverse Event|1|||
16860430|NCT01896557|37816744|FG001|Clopidogrel Alone|Adverse Event|0|||
16860431|NCT01896557|37816743|FG000|Clopidogrel + GI Protector|low adherence|1|||
16860432|NCT01896557|37816744|FG001|Clopidogrel + GI Protector|low adherence|1|||
16860433|NCT01896557|37816743|FG000|Clopidogrel + GI Protector|Reading error|1|||
16773471|NCT02219932|37712566|FG000|Overall Study|Other|5|||
16773472|NCT02219932|37712567|FG001|Overall Study|Other|11|||
16773473|NCT02219932|37712566|FG000|Overall Study|Death|1|||
16773474|NCT02219932|37712567|FG001|Overall Study|Death|1|||
16860434|NCT01896557|37816744|FG001|Clopidogrel + GI Protector|Reading error|3|||
16860435|NCT01886105|37816759|FG000|Overall Study|Lack of Efficacy|3|||
16860436|NCT01895777|37816788|FG000|Overall Study|Adverse Event|1|||
16773475|NCT02219932|37712566|FG000|Overall Study|Investigator Decision|0|||
16773476|NCT02219932|37712567|FG001|Overall Study|Investigator Decision|1|||
16773477|NCT02219932|37712566|FG000|Overall Study|Consent Withdrawn|11|||
16773478|NCT02219932|37712567|FG001|Overall Study|Consent Withdrawn|7|||
16773479|NCT02219932|37712566|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
16773480|NCT02219932|37712567|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
16773481|NCT02219932|37712566|FG000|Overall Study|Protocol Violation|10|||
16773482|NCT02219932|37712567|FG001|Overall Study|Protocol Violation|6|||
16773483|NCT02219932|37712566|FG000|Overall Study|Pregnancy|1|||
16773484|NCT02219932|37712567|FG001|Overall Study|Pregnancy|0|||
16773485|NCT02219932|37712566|FG000|Overall Study|Lost to Follow-up|4|||
16773486|NCT02219932|37712567|FG001|Overall Study|Lost to Follow-up|2|||
16773487|NCT02219932|37712566|FG000|Overall Study|Adverse Event|23|||
16773488|NCT02219932|37712567|FG001|Overall Study|Adverse Event|21|||
16773489|NCT02219464|37712575|FG000|Overall Study|Withdrawal by Subject|1|||
16773490|NCT02219464|37712576|FG001|Overall Study|Withdrawal by Subject|0|||
16773491|NCT02219464|37712575|FG000|Overall Study|case cancelled|1|||
16773492|NCT02219464|37712576|FG001|Overall Study|case cancelled|0|||
16773493|NCT02219464|37712575|FG000|Overall Study|catheter malfunction|1|||
16773494|NCT02219464|37712576|FG001|Overall Study|catheter malfunction|0|||
16773495|NCT02219308|37712584|FG000|Overall Study|Withdrawal by Subject|1|||
16773496|NCT02219308|37712585|FG001|Overall Study|Withdrawal by Subject|2|||
16773497|NCT02218372|37712593|FG000|Overall Study|Adverse Event|1|||
16773498|NCT02218372|37712594|FG001|Overall Study|Adverse Event|1|||
16773499|NCT02218372|37712593|FG000|Overall Study|Miscellaneous|2|||
16773500|NCT02218372|37712594|FG001|Overall Study|Miscellaneous|1|||
16773501|NCT02218372|37712593|FG000|Overall Study|Randomized but did not receive treatment|2|||
16773502|NCT02218372|37712594|FG001|Overall Study|Randomized but did not receive treatment|3|||
16773503|NCT02218372|37712593|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16773504|NCT02218372|37712594|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16773505|NCT02218216|37712607|FG000|Overall Study|Study terminated before completed|6|||
16773506|NCT02218216|37712608|FG001|Overall Study|Study terminated before completed|0|||
16773507|NCT02218216|37712609|FG002|Overall Study|Study terminated before completed|0|||
16773508|NCT02217982|37712619|FG000|Overall Study|Trial discontinued|1|||
16773509|NCT02217982|37712620|FG001|Overall Study|Trial discontinued|0|||
16773510|NCT02217982|37712619|FG000|Overall Study|Adverse Event|0|||
16773511|NCT02217982|37712620|FG001|Overall Study|Adverse Event|1|||
16773512|NCT02254408|37712628|FG000|Overall Study|Randomized But Not Treated|1|||
16773513|NCT02254408|37712629|FG001|Overall Study|Randomized But Not Treated|3|||
16773514|NCT02254408|37712628|FG000|Overall Study|Adverse Event|1|||
16773515|NCT02254408|37712629|FG001|Overall Study|Adverse Event|0|||
16773516|NCT02254408|37712628|FG000|Overall Study|Death|2|||
16773517|NCT02254408|37712629|FG001|Overall Study|Death|3|||
16773518|NCT02254408|37712628|FG000|Overall Study|Investigator's Discretion|0|||
16773519|NCT02254408|37712629|FG001|Overall Study|Investigator's Discretion|1|||
16773520|NCT02254408|37712628|FG000|Overall Study|Withdrawal by Subject|3|||
16773521|NCT02254408|37712629|FG001|Overall Study|Withdrawal by Subject|3|||
16773522|NCT02254408|37712628|FG000|Overall Study|Lost to Follow-up|1|||
16773523|NCT02254408|37712629|FG001|Overall Study|Lost to Follow-up|0|||
16773524|NCT02207608|37712637|FG000|Overall Study|Adverse Event|1|||
16773525|NCT02207608|37712638|FG001|Overall Study|Adverse Event|0|||
16773526|NCT03530995|37712646|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
16773527|NCT03530995|37712647|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
16773528|NCT03530995|37712646|FG000|Part 1 Period 3|Protocol Violation|1|||
16773529|NCT03530995|37712647|FG001|Part 1 Period 3|Protocol Violation|0|||
16773530|NCT03530995|37712646|FG000|Part 1 Period 4|Physician Decision|1|||
16773531|NCT03530995|37712647|FG001|Part 1 Period 4|Physician Decision|0|||
16773532|NCT03530995|37712646|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
16773533|NCT03530995|37712647|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
16773534|NCT02217436|37712671|FG000|Overall Study|Protocol Violation|1|||
16773535|NCT02217436|37712672|FG001|Overall Study|Protocol Violation|1|||
16773536|NCT02217436|37712671|FG000|Overall Study|Incomplete data|0|||
16773537|NCT02217436|37712672|FG001|Overall Study|Incomplete data|1|||
16773538|NCT02207530|37712678|FG000|Overall Study|Worsening condition under investigation|78|||
16773539|NCT02207530|37712678|FG000|Overall Study|Patient decision to stop study treatment|5|||
16773540|NCT02207530|37712678|FG000|Overall Study|Adverse Event|8|||
16773541|NCT02207374|37712685|FG000|Overall Study|Withdrawal by Subject|5|||
16773542|NCT02207374|37712686|FG001|Overall Study|Withdrawal by Subject|9|||
16773543|NCT02207374|37712687|FG002|Overall Study|Withdrawal by Subject|4|||
16773544|NCT02207374|37712685|FG000|Overall Study|Death|1|||
16773545|NCT02207374|37712686|FG001|Overall Study|Death|0|||
16773546|NCT02207374|37712687|FG002|Overall Study|Death|1|||
16773547|NCT02207374|37712685|FG000|Overall Study|Missing follow-up information|0|||
16773548|NCT02207374|37712686|FG001|Overall Study|Missing follow-up information|1|||
16773549|NCT02207374|37712687|FG002|Overall Study|Missing follow-up information|1|||
16773550|NCT02217280|37712695|FG000|Overall Study|Withdrawal by Subject|2|||
16773551|NCT02217280|37712695|FG000|Overall Study|Post-consent sceen fail|2|||
16773552|NCT02786537|37712706|FG000|As Randomized|Adverse Event|0|||
16773553|NCT02786537|37712707|FG001|As Randomized|Adverse Event|11|||
16773554|NCT02786537|37712708|FG002|As Randomized|Adverse Event|0|||
16773555|NCT02786537|37712709|FG003|As Randomized|Adverse Event|4|||
16773556|NCT02786537|37712710|FG004|As Randomized|Adverse Event|6|||
16773557|NCT02786537|37712711|FG005|As Randomized|Adverse Event|2|||
16773558|NCT02786537|37712706|FG000|As Randomized|Lack of Efficacy|0|||
16773559|NCT02786537|37712707|FG001|As Randomized|Lack of Efficacy|0|||
16773560|NCT02786537|37712708|FG002|As Randomized|Lack of Efficacy|0|||
16773561|NCT02786537|37712709|FG003|As Randomized|Lack of Efficacy|1|||
16773562|NCT02786537|37712710|FG004|As Randomized|Lack of Efficacy|0|||
16773563|NCT02786537|37712711|FG005|As Randomized|Lack of Efficacy|0|||
16773564|NCT02786537|37712706|FG000|As Randomized|Withdrawal by Subject|1|||
16773565|NCT02786537|37712707|FG001|As Randomized|Withdrawal by Subject|2|||
16773566|NCT02786537|37712708|FG002|As Randomized|Withdrawal by Subject|0|||
16773567|NCT02786537|37712709|FG003|As Randomized|Withdrawal by Subject|1|||
16773568|NCT02786537|37712710|FG004|As Randomized|Withdrawal by Subject|1|||
16773569|NCT02786537|37712711|FG005|As Randomized|Withdrawal by Subject|0|||
16773570|NCT02786537|37712706|FG000|As Randomized|Death|0|||
16773571|NCT02786537|37712707|FG001|As Randomized|Death|2|||
16773572|NCT02786537|37712708|FG002|As Randomized|Death|0|||
16773573|NCT02786537|37712709|FG003|As Randomized|Death|3|||
16773574|NCT02786537|37712710|FG004|As Randomized|Death|1|||
16773575|NCT02786537|37712711|FG005|As Randomized|Death|0|||
16773576|NCT02786537|37712706|FG000|As Randomized|Non-compliance with study drug|1|||
16773577|NCT02786537|37712707|FG001|As Randomized|Non-compliance with study drug|11|||
16773578|NCT02786537|37712708|FG002|As Randomized|Non-compliance with study drug|0|||
16773579|NCT02786537|37712709|FG003|As Randomized|Non-compliance with study drug|1|||
16773580|NCT02786537|37712710|FG004|As Randomized|Non-compliance with study drug|0|||
16773581|NCT02786537|37712711|FG005|As Randomized|Non-compliance with study drug|1|||
16773582|NCT02786537|37712706|FG000|As Randomized|Lost to treatment follow-up|4|||
16773583|NCT02786537|37712707|FG001|As Randomized|Lost to treatment follow-up|32|||
16773584|NCT02786537|37712708|FG002|As Randomized|Lost to treatment follow-up|0|||
16773585|NCT02786537|37712709|FG003|As Randomized|Lost to treatment follow-up|24|||
16773586|NCT02786537|37712710|FG004|As Randomized|Lost to treatment follow-up|4|||
16773587|NCT02786537|37712711|FG005|As Randomized|Lost to treatment follow-up|4|||
16773588|NCT02786537|37712706|FG000|As Randomized|Incarceration|0|||
16773589|NCT02786537|37712707|FG001|As Randomized|Incarceration|1|||
16773590|NCT02786537|37712708|FG002|As Randomized|Incarceration|0|||
16773591|NCT02786537|37712709|FG003|As Randomized|Incarceration|0|||
16773592|NCT02786537|37712710|FG004|As Randomized|Incarceration|0|||
16773593|NCT02786537|37712711|FG005|As Randomized|Incarceration|0|||
16773594|NCT02786537|37712706|FG000|As Randomized|Opiate Dependency Relapse|0|||
16773595|NCT02786537|37712707|FG001|As Randomized|Opiate Dependency Relapse|1|||
16773596|NCT02786537|37712708|FG002|As Randomized|Opiate Dependency Relapse|0|||
16773597|NCT02786537|37712709|FG003|As Randomized|Opiate Dependency Relapse|0|||
16773598|NCT02786537|37712710|FG004|As Randomized|Opiate Dependency Relapse|0|||
16773599|NCT02786537|37712711|FG005|As Randomized|Opiate Dependency Relapse|0|||
16773600|NCT02786537|37712706|FG000|As Randomized|HCV drugs stolen from pt|0|||
16773601|NCT02786537|37712707|FG001|As Randomized|HCV drugs stolen from pt|1|||
16773602|NCT02786537|37712708|FG002|As Randomized|HCV drugs stolen from pt|0|||
16773603|NCT02786537|37712709|FG003|As Randomized|HCV drugs stolen from pt|0|||
16773604|NCT02786537|37712710|FG004|As Randomized|HCV drugs stolen from pt|0|||
16773605|NCT02786537|37712711|FG005|As Randomized|HCV drugs stolen from pt|0|||
16773606|NCT02786537|37712706|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
16773607|NCT02786537|37712707|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
16773608|NCT02786537|37712708|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
16773609|NCT02786537|37712709|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
16773610|NCT02786537|37712710|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
16773611|NCT02786537|37712711|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
16773612|NCT02786537|37712706|FG000|As Randomized|Subject lost insurance|0|||
16773613|NCT02786537|37712707|FG001|As Randomized|Subject lost insurance|0|||
16773614|NCT02786537|37712708|FG002|As Randomized|Subject lost insurance|0|||
16773615|NCT02786537|37712709|FG003|As Randomized|Subject lost insurance|1|||
16773616|NCT02786537|37712710|FG004|As Randomized|Subject lost insurance|0|||
16773617|NCT02786537|37712711|FG005|As Randomized|Subject lost insurance|0|||
16773618|NCT02786537|37712706|FG000|As Treated|Adverse Event|0|||
16773619|NCT02786537|37712707|FG001|As Treated|Adverse Event|11|||
16773620|NCT02786537|37712708|FG002|As Treated|Adverse Event|0|||
16773621|NCT02786537|37712709|FG003|As Treated|Adverse Event|4|||
16773622|NCT02786537|37712710|FG004|As Treated|Adverse Event|6|||
16773623|NCT02786537|37712711|FG005|As Treated|Adverse Event|2|||
16773624|NCT02786537|37712706|FG000|As Treated|Death|0|||
16773625|NCT02786537|37712707|FG001|As Treated|Death|2|||
16773626|NCT02786537|37712708|FG002|As Treated|Death|0|||
16773627|NCT02786537|37712709|FG003|As Treated|Death|3|||
16773628|NCT02786537|37712710|FG004|As Treated|Death|1|||
16773629|NCT02786537|37712711|FG005|As Treated|Death|0|||
16773630|NCT02786537|37712706|FG000|As Treated|Lack of Efficacy|0|||
16773631|NCT02786537|37712707|FG001|As Treated|Lack of Efficacy|0|||
16773632|NCT02786537|37712708|FG002|As Treated|Lack of Efficacy|0|||
16773633|NCT02786537|37712709|FG003|As Treated|Lack of Efficacy|1|||
16773634|NCT02786537|37712710|FG004|As Treated|Lack of Efficacy|0|||
16773635|NCT02786537|37712711|FG005|As Treated|Lack of Efficacy|0|||
16773636|NCT02786537|37712706|FG000|As Treated|Lost to Follow-up|4|||
16773637|NCT02786537|37712707|FG001|As Treated|Lost to Follow-up|32|||
16773638|NCT02786537|37712708|FG002|As Treated|Lost to Follow-up|0|||
16773639|NCT02786537|37712709|FG003|As Treated|Lost to Follow-up|25|||
16773640|NCT02786537|37712710|FG004|As Treated|Lost to Follow-up|4|||
16773641|NCT02786537|37712711|FG005|As Treated|Lost to Follow-up|4|||
16773642|NCT02786537|37712706|FG000|As Treated|Non-compliance with study drug|1|||
16773643|NCT02786537|37712707|FG001|As Treated|Non-compliance with study drug|11|||
16773644|NCT02786537|37712708|FG002|As Treated|Non-compliance with study drug|0|||
16773645|NCT02786537|37712709|FG003|As Treated|Non-compliance with study drug|1|||
16773646|NCT02786537|37712710|FG004|As Treated|Non-compliance with study drug|0|||
16773647|NCT02786537|37712711|FG005|As Treated|Non-compliance with study drug|1|||
16773648|NCT02786537|37712706|FG000|As Treated|Lost insurance|0|||
16773649|NCT02786537|37712707|FG001|As Treated|Lost insurance|0|||
16773650|NCT02786537|37712708|FG002|As Treated|Lost insurance|0|||
16773651|NCT02786537|37712709|FG003|As Treated|Lost insurance|1|||
16773652|NCT02786537|37712710|FG004|As Treated|Lost insurance|0|||
16773653|NCT02786537|37712711|FG005|As Treated|Lost insurance|0|||
16773654|NCT02786537|37712706|FG000|As Treated|Withdrawal by Subject|1|||
16773655|NCT02786537|37712707|FG001|As Treated|Withdrawal by Subject|2|||
16773656|NCT02786537|37712708|FG002|As Treated|Withdrawal by Subject|0|||
16773657|NCT02786537|37712709|FG003|As Treated|Withdrawal by Subject|0|||
16773658|NCT02786537|37712710|FG004|As Treated|Withdrawal by Subject|1|||
16773659|NCT02786537|37712711|FG005|As Treated|Withdrawal by Subject|0|||
16773660|NCT02786537|37712706|FG000|As Treated|Incarceration|0|||
16773661|NCT02786537|37712707|FG001|As Treated|Incarceration|1|||
16773662|NCT02786537|37712708|FG002|As Treated|Incarceration|0|||
16773663|NCT02786537|37712709|FG003|As Treated|Incarceration|0|||
16773664|NCT02786537|37712710|FG004|As Treated|Incarceration|0|||
16773665|NCT02786537|37712711|FG005|As Treated|Incarceration|0|||
16773666|NCT02786537|37712706|FG000|As Treated|Opiate dependency relapse|0|||
16773667|NCT02786537|37712707|FG001|As Treated|Opiate dependency relapse|1|||
16773668|NCT02786537|37712708|FG002|As Treated|Opiate dependency relapse|0|||
16773669|NCT02786537|37712709|FG003|As Treated|Opiate dependency relapse|0|||
16773670|NCT02786537|37712710|FG004|As Treated|Opiate dependency relapse|0|||
16773671|NCT02786537|37712711|FG005|As Treated|Opiate dependency relapse|0|||
16773672|NCT02786537|37712706|FG000|As Treated|Drugs stolen from patient|0|||
16773673|NCT02786537|37712707|FG001|As Treated|Drugs stolen from patient|1|||
16773674|NCT02786537|37712708|FG002|As Treated|Drugs stolen from patient|0|||
16773675|NCT02786537|37712709|FG003|As Treated|Drugs stolen from patient|0|||
16773676|NCT02786537|37712710|FG004|As Treated|Drugs stolen from patient|0|||
16773677|NCT02786537|37712711|FG005|As Treated|Drugs stolen from patient|0|||
16773678|NCT02786537|37712706|FG000|As Treated|Advised to stop tx after loss of meds|0|||
16773679|NCT02786537|37712707|FG001|As Treated|Advised to stop tx after loss of meds|1|||
16773680|NCT02786537|37712708|FG002|As Treated|Advised to stop tx after loss of meds|0|||
16773681|NCT02786537|37712709|FG003|As Treated|Advised to stop tx after loss of meds|0|||
16773682|NCT02786537|37712710|FG004|As Treated|Advised to stop tx after loss of meds|0|||
16773683|NCT02786537|37712711|FG005|As Treated|Advised to stop tx after loss of meds|0|||
16773684|NCT02216812|37712819|FG000|Overall Study|Lost to Follow-up|10|||
16773685|NCT02216812|37712820|FG001|Overall Study|Lost to Follow-up|5|||
16773686|NCT02252536|37712828|FG000|Overall Study|Lost to Follow-up|5|||
16773687|NCT02252536|37712829|FG001|Overall Study|Lost to Follow-up|3|||
16773688|NCT02206828|37712835|FG000|Overall Study|Lost to Follow-up|7|||
16773689|NCT01209767|37712862|FG000|Overall Study|Withdrawal by Subject|1|||
16773690|NCT01209767|37712862|FG000|Overall Study|Lost to Follow-up|3|||
16773691|NCT02252146|37712870|FG000|Overall Study|Lack of Efficacy|4|||
16773692|NCT02252146|37712870|FG000|Overall Study|Entered hospice care|1|||
16773693|NCT02252146|37712870|FG000|Overall Study|Inability to travel to study site|1|||
16773694|NCT02500589|37712876|FG000|Overall Study|Withdrawal by Subject|11|||
16773695|NCT02500589|37712877|FG001|Overall Study|Withdrawal by Subject|14|||
16773696|NCT02500589|37712876|FG000|Overall Study|Lost to Follow-up|10|||
16773697|NCT02500589|37712877|FG001|Overall Study|Lost to Follow-up|12|||
16773698|NCT02500589|37712876|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
16773699|NCT02500589|37712877|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
16773700|NCT02500589|37712876|FG000|Overall Study|Death|7|||
16773701|NCT02500589|37712877|FG001|Overall Study|Death|5|||
16773702|NCT02251990|37712889|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
16773703|NCT02251990|37712890|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
16773704|NCT02251990|37712889|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
16773705|NCT02251990|37712890|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
16773706|NCT02251990|37712889|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
16773707|NCT02251990|37712890|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
16773708|NCT02251990|37712889|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
16773709|NCT02251990|37712890|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
16773710|NCT02251990|37712889|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
16773711|NCT02251990|37712890|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
16773712|NCT02251990|37712889|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
16773713|NCT02251990|37712890|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
16773714|NCT02251912|37712899|FG000|Overall Study|Withdrawal by Subject|2|||
16773715|NCT02251912|37712900|FG001|Overall Study|Withdrawal by Subject|3|||
16773716|NCT02251912|37712899|FG000|Overall Study|Adverse Event|0|||
16773717|NCT02251912|37712900|FG001|Overall Study|Adverse Event|2|||
16773718|NCT02206048|37712915|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
16773719|NCT02205814|37712927|FG000|Overall Study|Lost to Follow-up|0|||
16773720|NCT02205814|37712928|FG001|Overall Study|Lost to Follow-up|0|||
16773721|NCT02205814|37712929|FG002|Overall Study|Lost to Follow-up|0|||
16773722|NCT02205814|37712930|FG003|Overall Study|Lost to Follow-up|1|||
16773723|NCT02205814|37712927|FG000|Overall Study|Lack of Efficacy|1|||
16773724|NCT02205814|37712928|FG001|Overall Study|Lack of Efficacy|0|||
16773725|NCT02205814|37712929|FG002|Overall Study|Lack of Efficacy|1|||
16773726|NCT02205814|37712930|FG003|Overall Study|Lack of Efficacy|1|||
16773727|NCT02205814|37712927|FG000|Overall Study|Physician Decision|0|||
16773728|NCT02205814|37712928|FG001|Overall Study|Physician Decision|0|||
16773729|NCT02205814|37712929|FG002|Overall Study|Physician Decision|1|||
16773730|NCT02205814|37712930|FG003|Overall Study|Physician Decision|0|||
16773731|NCT02205814|37712927|FG000|Overall Study|Protocol Violation|1|||
16773732|NCT02205814|37712928|FG001|Overall Study|Protocol Violation|0|||
16773733|NCT02205814|37712929|FG002|Overall Study|Protocol Violation|0|||
16773734|NCT02205814|37712930|FG003|Overall Study|Protocol Violation|1|||
16773735|NCT02205814|37712927|FG000|Overall Study|Withdrawal by Subject|0|||
16773736|NCT02205814|37712928|FG001|Overall Study|Withdrawal by Subject|1|||
16773737|NCT02205814|37712929|FG002|Overall Study|Withdrawal by Subject|2|||
16773738|NCT02205814|37712930|FG003|Overall Study|Withdrawal by Subject|1|||
16773739|NCT02205814|37712927|FG000|Overall Study|not compliant with study procedures|0|||
16773740|NCT02205814|37712928|FG001|Overall Study|not compliant with study procedures|0|||
16773741|NCT02205814|37712929|FG002|Overall Study|not compliant with study procedures|1|||
16860437|NCT01895777|37816789|FG001|Overall Study|Adverse Event|2|||
16860438|NCT01895777|37816788|FG000|Overall Study|Lost to Follow-up|2|||
16860439|NCT01895777|37816789|FG001|Overall Study|Lost to Follow-up|0|||
16860440|NCT01895777|37816788|FG000|Overall Study|Not treated|1|||
16860441|NCT01895777|37816789|FG001|Overall Study|Not treated|0|||
16860442|NCT01895777|37816788|FG000|Overall Study|Other reasons|3|||
16860443|NCT01895777|37816789|FG001|Overall Study|Other reasons|2|||
16860444|NCT01895777|37816788|FG000|Overall Study|Non-compliance with the CTP|2|||
16860445|NCT01895777|37816789|FG001|Overall Study|Non-compliance with the CTP|1|||
16860446|NCT01885559|37816817|FG000|Overall Study|Lost to Follow-up|15|||
16860447|NCT01885559|37816818|FG001|Overall Study|Lost to Follow-up|16|||
16860448|NCT01885559|37816817|FG000|Overall Study|Less than full participation|9|||
16860449|NCT01885559|37816818|FG001|Overall Study|Less than full participation|19|||
16860450|NCT01885559|37816817|FG000|Overall Study|Protocol Violation|0|||
16860451|NCT01885559|37816818|FG001|Overall Study|Protocol Violation|1|||
16860452|NCT01884545|37816828|FG000|Overall Study|Lost to Follow-up|6|||
16860453|NCT01884545|37816829|FG001|Overall Study|Lost to Follow-up|4|||
16860454|NCT01884545|37816830|FG002|Overall Study|Lost to Follow-up|9|||
16860455|NCT01884545|37816831|FG003|Overall Study|Lost to Follow-up|4|||
16860456|NCT01884545|37816828|FG000|Overall Study|Patient withdrawn|7|||
16860457|NCT01884545|37816829|FG001|Overall Study|Patient withdrawn|12|||
16860458|NCT01884545|37816830|FG002|Overall Study|Patient withdrawn|5|||
16860459|NCT01884545|37816831|FG003|Overall Study|Patient withdrawn|5|||
16860460|NCT01884545|37816828|FG000|Overall Study|Non-adherence|0|||
16860461|NCT01884545|37816829|FG001|Overall Study|Non-adherence|2|||
16860462|NCT01884545|37816830|FG002|Overall Study|Non-adherence|0|||
16860463|NCT01884545|37816831|FG003|Overall Study|Non-adherence|0|||
16860464|NCT01895543|37816841|FG000|Overall Study|Withdrawal by Subject|43|||
16860465|NCT01895543|37816841|FG000|Overall Study|Lost to Follow-up|25|||
16860466|NCT01895543|37816841|FG000|Overall Study|Adverse Event|28|||
16860467|NCT01895543|37816841|FG000|Overall Study|Subject's substantial non-compliance|6|||
16860468|NCT01895543|37816841|FG000|Overall Study|Protocol Violation|1|||
16860469|NCT01895543|37816841|FG000|Overall Study|Physician Decision|2|||
16860470|NCT01895543|37816841|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
16860471|NCT04828161|37816938|FG000|Overall Study|Withdrawal by Subject|0|||
16860472|NCT04828161|37816939|FG001|Overall Study|Withdrawal by Subject|3|||
16860473|NCT04828161|37816940|FG002|Overall Study|Withdrawal by Subject|3|||
16860474|NCT04828161|37816941|FG003|Overall Study|Withdrawal by Subject|4|||
16860475|NCT04828161|37816938|FG000|Overall Study|Lost to Follow-up|1|||
16860476|NCT04828161|37816939|FG001|Overall Study|Lost to Follow-up|4|||
16860477|NCT04828161|37816940|FG002|Overall Study|Lost to Follow-up|2|||
16860478|NCT04828161|37816941|FG003|Overall Study|Lost to Follow-up|2|||
16860479|NCT04828161|37816938|FG000|Overall Study|Other|2|||
16860480|NCT04828161|37816939|FG001|Overall Study|Other|0|||
16860481|NCT04828161|37816940|FG002|Overall Study|Other|2|||
16860482|NCT04828161|37816941|FG003|Overall Study|Other|0|||
16860483|NCT04828161|37816938|FG000|Overall Study|Death|0|||
16860484|NCT04828161|37816939|FG001|Overall Study|Death|0|||
16860485|NCT04828161|37816940|FG002|Overall Study|Death|0|||
16860486|NCT04828161|37816941|FG003|Overall Study|Death|2|||
16860487|NCT01895309|37817039|FG000|Overall Study|Adverse Event|13|||
16860488|NCT01895309|37817040|FG001|Overall Study|Adverse Event|17|||
16860489|NCT01895309|37817039|FG000|Overall Study|Protocol Violation|1|||
16773742|NCT02205814|37712930|FG003|Overall Study|not compliant with study procedures|0|||
16773743|NCT02662985|37712942|FG000|Treatment Period 1|Adverse Event|0|||
16773744|NCT02662985|37712943|FG001|Treatment Period 1|Adverse Event|2|||
16773745|NCT02662985|37712942|FG000|Treatment Period 1|Protocol Violation|0|||
16773746|NCT02662985|37712943|FG001|Treatment Period 1|Protocol Violation|1|||
16773747|NCT02662985|37712942|FG000|Treatment Period 1|Physician Decision|1|||
16773748|NCT02662985|37712943|FG001|Treatment Period 1|Physician Decision|0|||
16773749|NCT02662985|37712942|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16773750|NCT02662985|37712943|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16773751|NCT02662985|37712942|FG000|Treatment Period 2|Lack of Efficacy|0|||
16773752|NCT02662985|37712943|FG001|Treatment Period 2|Lack of Efficacy|1|||
16773753|NCT02662985|37712942|FG000|Treatment Period 2|Lost to Follow-up|1|||
16773754|NCT02662985|37712943|FG001|Treatment Period 2|Lost to Follow-up|0|||
16773755|NCT02662985|37712942|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
16773756|NCT02662985|37712943|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
16773757|NCT02662985|37712942|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
16773758|NCT02662985|37712943|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
16773759|NCT02662985|37712942|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
16860490|NCT01895309|37817040|FG001|Overall Study|Protocol Violation|0|||
16860491|NCT01895309|37817039|FG000|Overall Study|Lack of Efficacy|1|||
16860492|NCT01895309|37817040|FG001|Overall Study|Lack of Efficacy|3|||
16860493|NCT01895309|37817039|FG000|Overall Study|Lost to Follow-up|1|||
16860494|NCT01895309|37817040|FG001|Overall Study|Lost to Follow-up|3|||
16860495|NCT01895309|37817039|FG000|Overall Study|Physician Decision|15|||
16860496|NCT01895309|37817040|FG001|Overall Study|Physician Decision|10|||
16860497|NCT01895309|37817039|FG000|Overall Study|Withdrawal by Subject|9|||
16860498|NCT01895309|37817040|FG001|Overall Study|Withdrawal by Subject|18|||
16860499|NCT01884311|37817050|FG000|Overall Study|Withdrawal by Subject|3|||
16860500|NCT01884311|37817050|FG000|Overall Study|withdrew consent due to AEs|1|||
16860501|NCT01884311|37817050|FG000|Overall Study|Precautionary measure|1|||
16860502|NCT01884077|37817090|FG000|Overall Study|screen fail|0|||
16860503|NCT01884077|37817091|FG001|Overall Study|screen fail|2|||
16860504|NCT01884077|37817090|FG000|Overall Study|canceled surgery|2|||
16860505|NCT01884077|37817091|FG001|Overall Study|canceled surgery|0|||
16860506|NCT01884077|37817090|FG000|Overall Study|Lost to Follow-up|0|||
16860507|NCT01884077|37817091|FG001|Overall Study|Lost to Follow-up|4|||
16860508|NCT01884077|37817090|FG000|Overall Study|study closed|6|||
16860509|NCT01884077|37817091|FG001|Overall Study|study closed|4|||
16773760|NCT02662985|37712943|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
16773761|NCT02662985|37712942|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
16773762|NCT02662985|37712943|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
16773763|NCT02662985|37712942|FG000|Treatment Period 3 (Extension Period)|Death|0|||
16773764|NCT02662985|37712943|FG001|Treatment Period 3 (Extension Period)|Death|1|||
16773765|NCT01631812|37712949|FG000|Overall Study|Adverse Event|25|||
16773766|NCT01631812|37712949|FG000|Overall Study|Lack of Efficacy|5|||
16773767|NCT01631812|37712949|FG000|Overall Study|Withdrawal by Subject|4|||
16773768|NCT01631812|37712949|FG000|Overall Study|Physician Decision|3|||
16773769|NCT02323295|37712955|FG000|Overall Study|Adverse Event|0|||
16773770|NCT02323295|37712956|FG001|Overall Study|Adverse Event|1|||
16773771|NCT02323295|37712955|FG000|Overall Study|Withdrawal by Subject|0|||
16773772|NCT02323295|37712956|FG001|Overall Study|Withdrawal by Subject|1|||
16773773|NCT02323295|37712955|FG000|Overall Study|Patient did not have surgery as planned.|0|||
16773774|NCT02323295|37712956|FG001|Overall Study|Patient did not have surgery as planned.|1|||
16773775|NCT02215954|37712965|FG000|Overall Study|Adverse Event|0|||
16773776|NCT02215954|37712966|FG001|Overall Study|Adverse Event|0|||
16773777|NCT02215954|37712967|FG002|Overall Study|Adverse Event|1|||
16773778|NCT02215954|37712965|FG000|Overall Study|Withdrawal by Subject|0|||
16773779|NCT02215954|37712966|FG001|Overall Study|Withdrawal by Subject|0|||
16773780|NCT02215954|37712967|FG002|Overall Study|Withdrawal by Subject|2|||
16773781|NCT02215954|37712965|FG000|Overall Study|Not exposed|1|||
16773782|NCT02215954|37712966|FG001|Overall Study|Not exposed|1|||
16773783|NCT02215954|37712967|FG002|Overall Study|Not exposed|3|||
16773784|NCT01941719|37712978|FG000|Overall Study|Lost to Follow-up|20|||
16773785|NCT01941719|37712979|FG001|Overall Study|Lost to Follow-up|19|||
16773786|NCT02215252|37712989|FG000|Overall Study|Adverse Event|1|||
16773787|NCT02215252|37712990|FG001|Overall Study|Adverse Event|5|||
16773788|NCT02215252|37712991|FG002|Overall Study|Adverse Event|2|||
16773789|NCT02215252|37712989|FG000|Overall Study|Lost to Follow-up|0|||
16773790|NCT02215252|37712990|FG001|Overall Study|Lost to Follow-up|0|||
16773791|NCT02215252|37712991|FG002|Overall Study|Lost to Follow-up|1|||
16773792|NCT02215252|37712989|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
16773793|NCT02215252|37712990|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
16773794|NCT02215252|37712991|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
16773795|NCT02215252|37712989|FG000|Overall Study|Protocol Violation|0|||
16773796|NCT02215252|37712990|FG001|Overall Study|Protocol Violation|1|||
16773797|NCT02215252|37712991|FG002|Overall Study|Protocol Violation|0|||
16773798|NCT02215252|37712989|FG000|Overall Study|Withdrawal by Subject|1|||
16773799|NCT02215252|37712990|FG001|Overall Study|Withdrawal by Subject|0|||
16773800|NCT02215252|37712991|FG002|Overall Study|Withdrawal by Subject|0|||
16773801|NCT02215252|37712989|FG000|Overall Study|Other|0|||
16773802|NCT02215252|37712990|FG001|Overall Study|Other|1|||
16773803|NCT02215252|37712991|FG002|Overall Study|Other|1|||
16860510|NCT01894919|37817110|FG000|Overall Study|Withdrawal by Subject|1|||
16860511|NCT01894919|37817111|FG001|Overall Study|Withdrawal by Subject|0|||
16860512|NCT01894919|37817112|FG002|Overall Study|Withdrawal by Subject|0|||
16860513|NCT01894919|37817113|FG003|Overall Study|Withdrawal by Subject|0|||
16860514|NCT01894919|37817114|FG004|Overall Study|Withdrawal by Subject|1|||
16860515|NCT01894919|37817115|FG005|Overall Study|Withdrawal by Subject|0|||
16860516|NCT01894919|37817116|FG006|Overall Study|Withdrawal by Subject|0|||
16773804|NCT02204410|37712999|FG000|Overall Study|Lost to Follow-up|5|||
16773805|NCT02204410|37712999|FG000|Overall Study|Physician Decision|2|||
16860517|NCT01894919|37817117|FG007|Overall Study|Withdrawal by Subject|0|||
16860518|NCT01894919|37817118|FG008|Overall Study|Withdrawal by Subject|0|||
16860519|NCT01894919|37817119|FG009|Overall Study|Withdrawal by Subject|1|||
16868153|NCT01548287|37841195|FG002|Screening|No reason provided|0|||
16860520|NCT01894919|37817120|FG010|Overall Study|Withdrawal by Subject|1|||
16860521|NCT01894919|37817121|FG011|Overall Study|Withdrawal by Subject|0|||
16860522|NCT01894919|37817122|FG012|Overall Study|Withdrawal by Subject|0|||
16860523|NCT01894919|37817110|FG000|Overall Study|Adverse Event|0|||
16860524|NCT01894919|37817111|FG001|Overall Study|Adverse Event|0|||
16860525|NCT01894919|37817112|FG002|Overall Study|Adverse Event|0|||
16860526|NCT01894919|37817113|FG003|Overall Study|Adverse Event|0|||
16860527|NCT01894919|37817114|FG004|Overall Study|Adverse Event|0|||
16860528|NCT01894919|37817115|FG005|Overall Study|Adverse Event|0|||
16860529|NCT01894919|37817116|FG006|Overall Study|Adverse Event|0|||
16860530|NCT01894919|37817117|FG007|Overall Study|Adverse Event|0|||
16860531|NCT01894919|37817118|FG008|Overall Study|Adverse Event|0|||
16860532|NCT01894919|37817119|FG009|Overall Study|Adverse Event|0|||
16860533|NCT01894919|37817120|FG010|Overall Study|Adverse Event|1|||
16860534|NCT01894919|37817121|FG011|Overall Study|Adverse Event|0|||
16860535|NCT01894919|37817122|FG012|Overall Study|Adverse Event|0|||
16860536|NCT01894919|37817110|FG000|Overall Study|Other-Unspecified|1|||
16860537|NCT01894919|37817111|FG001|Overall Study|Other-Unspecified|0|||
16860538|NCT01894919|37817112|FG002|Overall Study|Other-Unspecified|0|||
16860539|NCT01894919|37817113|FG003|Overall Study|Other-Unspecified|0|||
16860540|NCT01894919|37817114|FG004|Overall Study|Other-Unspecified|0|||
16860541|NCT01894919|37817115|FG005|Overall Study|Other-Unspecified|0|||
16860542|NCT01894919|37817116|FG006|Overall Study|Other-Unspecified|0|||
16860543|NCT01894919|37817117|FG007|Overall Study|Other-Unspecified|0|||
16860544|NCT01894919|37817118|FG008|Overall Study|Other-Unspecified|0|||
16860545|NCT01894919|37817119|FG009|Overall Study|Other-Unspecified|0|||
16860546|NCT01894919|37817120|FG010|Overall Study|Other-Unspecified|0|||
16860547|NCT01894919|37817121|FG011|Overall Study|Other-Unspecified|0|||
16860548|NCT01894919|37817122|FG012|Overall Study|Other-Unspecified|0|||
16860549|NCT01894919|37817110|FG000|Overall Study|Lost to Follow-up|0|||
16860550|NCT01894919|37817111|FG001|Overall Study|Lost to Follow-up|0|||
16860551|NCT01894919|37817112|FG002|Overall Study|Lost to Follow-up|0|||
16860552|NCT01894919|37817113|FG003|Overall Study|Lost to Follow-up|0|||
16860553|NCT01894919|37817114|FG004|Overall Study|Lost to Follow-up|2|||
16860554|NCT01894919|37817115|FG005|Overall Study|Lost to Follow-up|0|||
16860555|NCT01894919|37817116|FG006|Overall Study|Lost to Follow-up|0|||
16860556|NCT01894919|37817117|FG007|Overall Study|Lost to Follow-up|0|||
16860557|NCT01894919|37817118|FG008|Overall Study|Lost to Follow-up|0|||
16860558|NCT01894919|37817119|FG009|Overall Study|Lost to Follow-up|0|||
16860559|NCT01894919|37817120|FG010|Overall Study|Lost to Follow-up|0|||
16860560|NCT01894919|37817121|FG011|Overall Study|Lost to Follow-up|0|||
16860561|NCT01894919|37817122|FG012|Overall Study|Lost to Follow-up|0|||
16860562|NCT01894841|37817166|FG000|Overall Study|Withdrawal by Subject|9|||
16860563|NCT01894841|37817167|FG001|Overall Study|Withdrawal by Subject|4|||
16860564|NCT01894841|37817166|FG000|Overall Study|Withdrawn by investigator|2|||
16860565|NCT01894841|37817167|FG001|Overall Study|Withdrawn by investigator|2|||
16860566|NCT01894841|37817166|FG000|Overall Study|Lost to Follow-up|7|||
16860567|NCT01894841|37817167|FG001|Overall Study|Lost to Follow-up|3|||
16860568|NCT01894607|37817177|FG000|Overall Study|Ineligible|1|||
16860569|NCT01883453|37817183|FG000|Overall Study|No episode of common cold|25|||
16860570|NCT01883453|37817184|FG001|Overall Study|No episode of common cold|23|||
16860571|NCT01882985|37817218|FG000|Overall Study|Lost to Follow-up|1|||
16860572|NCT01882985|37817218|FG000|Overall Study|Withdrawal by Subject|1|||
16860573|NCT01893905|37817231|FG000|Overall Study|Withdrawal by Subject|1|||
16860574|NCT01893905|37817232|FG001|Overall Study|Withdrawal by Subject|0|||
16860575|NCT01893905|37817231|FG000|Overall Study|Adverse Event|9|||
16860576|NCT01893905|37817232|FG001|Overall Study|Adverse Event|3|||
16860577|NCT01893905|37817231|FG000|Overall Study|Lack of Efficacy|5|||
16860578|NCT01893905|37817232|FG001|Overall Study|Lack of Efficacy|7|||
16860579|NCT01893905|37817231|FG000|Overall Study|Lost to Follow-up|1|||
16860580|NCT01893905|37817232|FG001|Overall Study|Lost to Follow-up|0|||
16860581|NCT01893905|37817231|FG000|Overall Study|Protocol Violation|6|||
16860582|NCT01893905|37817232|FG001|Overall Study|Protocol Violation|1|||
16860583|NCT01893905|37817231|FG000|Overall Study|Lack of adherence to treatment|2|||
16860584|NCT01893905|37817232|FG001|Overall Study|Lack of adherence to treatment|0|||
16860585|NCT01893905|37817231|FG000|Overall Study|Other reason|1|||
16860586|NCT01893905|37817232|FG001|Overall Study|Other reason|3|||
16860587|NCT01893827|37817245|FG000|Overall Study|Lost to Follow-up|19|||
16860588|NCT01893827|37817246|FG001|Overall Study|Lost to Follow-up|26|||
16860589|NCT01882907|37817254|FG000|Overall Study|Adverse Event|3|||
16860590|NCT01882907|37817255|FG001|Overall Study|Adverse Event|1|||
16860591|NCT01882907|37817254|FG000|Overall Study|Lack of Efficacy|0|||
16860592|NCT01882907|37817255|FG001|Overall Study|Lack of Efficacy|3|||
16860593|NCT01882907|37817254|FG000|Overall Study|Lost to Follow-up|1|||
16860594|NCT01882907|37817255|FG001|Overall Study|Lost to Follow-up|4|||
16860595|NCT01882907|37817254|FG000|Overall Study|Protocol Violation|10|||
16860596|NCT01882907|37817255|FG001|Overall Study|Protocol Violation|14|||
16860597|NCT01882907|37817254|FG000|Overall Study|Withdrawal by Subject|0|||
16860598|NCT01882907|37817255|FG001|Overall Study|Withdrawal by Subject|6|||
16860599|NCT01893281|37817277|FG000|Overall Study|Adverse Event|1|||
16860600|NCT01893281|37817277|FG000|Overall Study|Protocol Violation|1|||
16860601|NCT01893281|37817277|FG000|Overall Study|Withdrawal by Subject|1|||
16860602|NCT01893203|37817281|FG000|Overall Study|Withdrawal by Subject|1|||
16860603|NCT01882829|37817285|FG000|Overall Study|Adverse Event|4|||
16860604|NCT01882829|37817285|FG000|Overall Study|Protocol Violation|1|||
16860605|NCT01882829|37817285|FG000|Overall Study|Withdrawal by Subject|1|||
16860606|NCT01882439|37817369|FG000|Overall Study|Adverse event related to study drug|3|||
16860607|NCT01882439|37817370|FG001|Overall Study|Adverse event related to study drug|8|||
16860608|NCT01882439|37817371|FG002|Overall Study|Adverse event related to study drug|1|||
16860609|NCT01882439|37817372|FG003|Overall Study|Adverse event related to study drug|2|||
16860610|NCT01882439|37817369|FG000|Overall Study|Pregnancy|0|||
16860611|NCT01882439|37817370|FG001|Overall Study|Pregnancy|1|||
16860612|NCT01882439|37817371|FG002|Overall Study|Pregnancy|0|||
16860613|NCT01882439|37817372|FG003|Overall Study|Pregnancy|0|||
16860614|NCT01882439|37817369|FG000|Overall Study|Protocol Violation|2|||
16860615|NCT01882439|37817370|FG001|Overall Study|Protocol Violation|2|||
16860616|NCT01882439|37817371|FG002|Overall Study|Protocol Violation|0|||
16860617|NCT01882439|37817372|FG003|Overall Study|Protocol Violation|1|||
16860618|NCT01882439|37817369|FG000|Overall Study|No longer willing to participate|1|||
16860619|NCT01882439|37817370|FG001|Overall Study|No longer willing to participate|4|||
16860620|NCT01882439|37817371|FG002|Overall Study|No longer willing to participate|2|||
16860621|NCT01882439|37817372|FG003|Overall Study|No longer willing to participate|3|||
16860622|NCT01882439|37817369|FG000|Overall Study|Medication error with no associated AE|0|||
16860623|NCT01882439|37817370|FG001|Overall Study|Medication error with no associated AE|0|||
16860624|NCT01882439|37817371|FG002|Overall Study|Medication error with no associated AE|2|||
16860625|NCT01882439|37817372|FG003|Overall Study|Medication error with no associated AE|0|||
16860626|NCT01882439|37817369|FG000|Overall Study|Insufficient clinical response|1|||
16860627|NCT01882439|37817370|FG001|Overall Study|Insufficient clinical response|4|||
16860628|NCT01882439|37817371|FG002|Overall Study|Insufficient clinical response|4|||
16860629|NCT01882439|37817372|FG003|Overall Study|Insufficient clinical response|2|||
16860630|NCT01882439|37817369|FG000|Overall Study|Adverse event unrelated to study drug|2|||
16860631|NCT01882439|37817370|FG001|Overall Study|Adverse event unrelated to study drug|2|||
16860632|NCT01882439|37817371|FG002|Overall Study|Adverse event unrelated to study drug|1|||
16860633|NCT01882439|37817372|FG003|Overall Study|Adverse event unrelated to study drug|1|||
16860634|NCT01892657|37817419|FG000|Overall Study|Withdrawal by Subject|6|||
16860635|NCT01892657|37817419|FG000|Overall Study|Protocol Violation|12|||
16860636|NCT01881737|37817446|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
16860637|NCT01881737|37817446|FG000|Overall Study|Withdrawal by Subject|1|||
16860638|NCT01881737|37817446|FG000|Overall Study|Worsening of baseline behavior|1|||
16860639|NCT01892501|37817482|FG000|Overall Study|Protocol Violation|2|||
16860640|NCT01892501|37817482|FG000|Overall Study|Puncture not carried out|9|||
16860641|NCT01892501|37817482|FG000|Overall Study|Radiological monitoring not carried out|5|||
16860642|NCT01892501|37817482|FG000|Overall Study|Non-contributory histological result|12|||
16860643|NCT01892345|37817497|FG000|Overall Study|Adverse Event|0|||
16860644|NCT01892345|37817498|FG001|Overall Study|Adverse Event|2|||
16860645|NCT01892345|37817497|FG000|Overall Study|Death|1|||
16860646|NCT01892345|37817498|FG001|Overall Study|Death|0|||
16860647|NCT01892345|37817497|FG000|Overall Study|Lost to Follow-up|3|||
16860648|NCT01892345|37817498|FG001|Overall Study|Lost to Follow-up|0|||
16860649|NCT01892345|37817497|FG000|Overall Study|Withdrawal by Subject|12|||
16860650|NCT01892345|37817498|FG001|Overall Study|Withdrawal by Subject|1|||
16860651|NCT01892189|37817575|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
16860652|NCT01892189|37817576|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
16860653|NCT01892189|37817577|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
16860654|NCT01892189|37817578|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
16860655|NCT01892189|37817579|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
16860656|NCT01892189|37817580|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
16860657|NCT01892189|37817581|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
16860658|NCT01892189|37817582|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
16860659|NCT01892189|37817583|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
16860660|NCT01892189|37817575|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16860661|NCT01892189|37817576|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16860662|NCT01892189|37817577|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
16860663|NCT01892189|37817578|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16860664|NCT01892189|37817579|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16860665|NCT01892189|37817580|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16860666|NCT01892189|37817581|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16860667|NCT01892189|37817582|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16860668|NCT01892189|37817583|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16860669|NCT01892189|37817575|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16860670|NCT01892189|37817576|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16860671|NCT01892189|37817577|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16860672|NCT01892189|37817578|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16860673|NCT01892189|37817579|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16860674|NCT01892189|37817580|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
16860675|NCT01892189|37817581|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16860676|NCT01892189|37817582|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16860677|NCT01892189|37817583|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16860678|NCT01881425|37817614|FG000|Overall Study|Death|5|||
16860679|NCT01881425|37817615|FG001|Overall Study|Death|1|||
16860680|NCT01881425|37817614|FG000|Overall Study|Withdrawal by Subject|8|||
16860681|NCT01881425|37817615|FG001|Overall Study|Withdrawal by Subject|3|||
16860682|NCT01881425|37817614|FG000|Overall Study|Physician Decision|2|||
16860683|NCT01881425|37817615|FG001|Overall Study|Physician Decision|1|||
16860684|NCT01881425|37817614|FG000|Overall Study|Adverse Event|3|||
16860685|NCT01881425|37817615|FG001|Overall Study|Adverse Event|0|||
16860686|NCT01881425|37817614|FG000|Overall Study|General Anesthesia panic attack|0|||
16860687|NCT01881425|37817615|FG001|Overall Study|General Anesthesia panic attack|1|||
16860688|NCT01881425|37817614|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
16860689|NCT01881425|37817615|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
16860690|NCT01881425|37817614|FG000|Overall Study|Lost to Follow-up|7|||
16860691|NCT01881425|37817615|FG001|Overall Study|Lost to Follow-up|2|||
16860692|NCT01891721|37817634|FG000|Overall Study|Lost to Follow-up|10|||
16860693|NCT01891721|37817635|FG001|Overall Study|Lost to Follow-up|5|||
16860694|NCT01891721|37817636|FG002|Overall Study|Lost to Follow-up|1|||
16860695|NCT01880957|37817655|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
16860696|NCT01880957|37817656|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
16860697|NCT01880957|37817655|FG000|Overall Study|Lost to Follow-up|11|||
16860698|NCT01880957|37817656|FG001|Overall Study|Lost to Follow-up|0|||
16860699|NCT01880957|37817655|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
16860700|NCT01880957|37817656|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
16860701|NCT01879553|37817684|FG000|Overall Study|Withdrawal by Subject|1|||
16860702|NCT01879553|37817685|FG001|Overall Study|Withdrawal by Subject|0|||
16860703|NCT01890785|37817706|FG000|Third Intervention|Withdrawal by Subject|0|||
16860704|NCT01890785|37817707|FG001|Third Intervention|Withdrawal by Subject|1|||
16860705|NCT01890785|37817708|FG002|Third Intervention|Withdrawal by Subject|0|||
16860706|NCT01890785|37817709|FG003|Third Intervention|Withdrawal by Subject|0|||
16860707|NCT01890785|37817710|FG004|Third Intervention|Withdrawal by Subject|0|||
16860708|NCT01890785|37817711|FG005|Third Intervention|Withdrawal by Subject|0|||
16860709|NCT01878383|37817735|FG000|Overall Study|Lost to Follow-up|0|||
16860710|NCT01878383|37817736|FG001|Overall Study|Lost to Follow-up|1499|||
16860711|NCT01878149|37817744|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
16860712|NCT01878149|37817745|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
16860713|NCT01863953|37817767|FG000|Overall Study|Adverse Event|0|||
16860714|NCT01863953|37817768|FG001|Overall Study|Adverse Event|0|||
16860715|NCT01863953|37817769|FG002|Overall Study|Adverse Event|1|||
16860716|NCT03049449|37818045|FG000|Overall Study|Did not receive treatment.|0|||
16773806|NCT02204410|37712999|FG000|Overall Study|Protocol Violation|1|||
16773807|NCT02204410|37712999|FG000|Overall Study|Withdrawal by Subject|3|||
16773808|NCT02250274|37713005|FG000|Overall Study|Insufficient blood draw amount|7|||
16773809|NCT02250274|37713006|FG001|Overall Study|Insufficient blood draw amount|6|||
16773810|NCT02213458|37713020|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
16860717|NCT03049449|37818046|FG001|Overall Study|Did not receive treatment.|0|||
16860718|NCT03049449|37818047|FG002|Overall Study|Did not receive treatment.|0|||
16860719|NCT03049449|37818048|FG003|Overall Study|Did not receive treatment.|0|||
16860720|NCT03049449|37818049|FG004|Overall Study|Did not receive treatment.|0|||
16860721|NCT03049449|37818050|FG005|Overall Study|Did not receive treatment.|0|||
16860722|NCT03049449|37818051|FG006|Overall Study|Did not receive treatment.|0|||
16860723|NCT03049449|37818052|FG007|Overall Study|Did not receive treatment.|0|||
16860724|NCT03049449|37818053|FG008|Overall Study|Did not receive treatment.|1|||
16860725|NCT03049449|37818054|FG009|Overall Study|Did not receive treatment.|0|||
16860726|NCT03049449|37818045|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
16860727|NCT03049449|37818046|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
16868154|NCT01548287|37841196|FG003|Screening|No reason provided|0|||
16773811|NCT02213458|37713021|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
16773812|NCT02213458|37713020|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
16773813|NCT02213458|37713021|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
16773814|NCT02213458|37713020|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
16773815|NCT02213458|37713021|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
16860728|NCT03049449|37818047|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
16860729|NCT03049449|37818048|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
16860730|NCT03049449|37818049|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
16860731|NCT03049449|37818050|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
16860732|NCT03049449|37818051|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
16860733|NCT03049449|37818052|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
16860734|NCT03049449|37818053|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
16860735|NCT03049449|37818054|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
16860736|NCT03049449|37818045|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16860737|NCT03049449|37818046|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16773816|NCT02213458|37713020|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
16773817|NCT02213458|37713021|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
16773818|NCT02213458|37713020|FG000|Overall Study|Refused re-consent|6|||
16773819|NCT02213458|37713021|FG001|Overall Study|Refused re-consent|0|||
16773820|NCT02213458|37713020|FG000|Overall Study|Lost to Follow-up|2|||
16860738|NCT03049449|37818047|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16860739|NCT03049449|37818048|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16860740|NCT03049449|37818049|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16860741|NCT03049449|37818050|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16860742|NCT03049449|37818051|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16860743|NCT03049449|37818052|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
16860744|NCT03049449|37818053|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16860745|NCT03049449|37818054|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
16860746|NCT02989857|37818187|FG000|Randomization Phase|Not Treated|3|||
16860747|NCT02989857|37818188|FG001|Randomization Phase|Not Treated|2|||
16860748|NCT02989857|37818189|FG002|Randomization Phase|Not Treated|0|||
16860749|NCT01877915|37818200|FG000|Overall Study|Lost to Follow-up|10|||
16860750|NCT01877915|37818201|FG001|Overall Study|Lost to Follow-up|9|||
16860751|NCT01877915|37818200|FG000|Overall Study|Withdrawal by Subject|42|||
16860752|NCT01877915|37818201|FG001|Overall Study|Withdrawal by Subject|55|||
16860753|NCT01877915|37818200|FG000|Overall Study|Other|2|||
16860754|NCT01877915|37818201|FG001|Overall Study|Other|4|||
16860755|NCT01876979|37818209|FG000|Overall Study|Physician Decision|2|||
16860756|NCT01876979|37818210|FG001|Overall Study|Physician Decision|3|||
16860757|NCT01860989|37818216|FG000|Overall Study|Unsatisfactory therapeutic|5|||
16860758|NCT01860677|37818232|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
16860759|NCT01860677|37818233|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
16860760|NCT01876901|37818251|FG000|Overall Study|Protocol Violation|10|||
16773821|NCT02213458|37713021|FG001|Overall Study|Lost to Follow-up|2|||
16773822|NCT02213458|37713020|FG000|Overall Study|Withdrawal by Subject|26|||
16773823|NCT02213458|37713021|FG001|Overall Study|Withdrawal by Subject|8|||
16773824|NCT02213380|37713029|FG000|Underwent Randomization|Withdrawal by Subject|2|||
16773825|NCT02213380|37713030|FG001|Underwent Randomization|Withdrawal by Subject|0|||
16773826|NCT02213380|37713029|FG000|Underwent Randomization|Not treated|3|||
16773827|NCT02213380|37713030|FG001|Underwent Randomization|Not treated|3|||
16773828|NCT02213380|37713029|FG000|Per-protocol Analysis|Protocol Violation|32|||
16773829|NCT02213380|37713030|FG001|Per-protocol Analysis|Protocol Violation|36|||
16773830|NCT02202850|37713038|FG000|Overall Study|Other|2|||
16773831|NCT02202850|37713039|FG001|Overall Study|Other|2|||
16773832|NCT02202850|37713038|FG000|Overall Study|Enbrel treatment discontinued|15|||
16773833|NCT02202850|37713039|FG001|Overall Study|Enbrel treatment discontinued|3|||
16860761|NCT01876901|37818252|FG001|Overall Study|Protocol Violation|2|||
16773834|NCT02202850|37713038|FG000|Overall Study|Lost to Follow-up|7|||
16860762|NCT01876901|37818251|FG000|Overall Study|No or other surgical intervention|7|||
16860763|NCT01876901|37818252|FG001|Overall Study|No or other surgical intervention|5|||
16860764|NCT01876823|37818259|FG000|Overall Study|Withdrawal by Subject|5|||
16860765|NCT01876823|37818259|FG000|Overall Study|Physician Decision|2|||
16860766|NCT01876823|37818259|FG000|Overall Study|Patients moved|2|||
16860767|NCT01876511|37818266|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
16860768|NCT01876511|37818267|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
16860769|NCT01876511|37818268|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
16860770|NCT01876511|37818266|FG000|Overall Study|Death (unrelated)|3|||
16860771|NCT01876511|37818267|FG001|Overall Study|Death (unrelated)|0|||
16860772|NCT01876511|37818268|FG002|Overall Study|Death (unrelated)|2|||
16860773|NCT01876511|37818266|FG000|Overall Study|Drug-related Toxicity|5|||
16860774|NCT01876511|37818267|FG001|Overall Study|Drug-related Toxicity|1|||
16860775|NCT01876511|37818268|FG002|Overall Study|Drug-related Toxicity|6|||
16860776|NCT01876511|37818266|FG000|Overall Study|Patient Decision|3|||
16860777|NCT01876511|37818267|FG001|Overall Study|Patient Decision|0|||
16860778|NCT01876511|37818268|FG002|Overall Study|Patient Decision|6|||
16860779|NCT01876511|37818266|FG000|Overall Study|Physician Decision|1|||
16860780|NCT01876511|37818267|FG001|Overall Study|Physician Decision|0|||
16860781|NCT01876511|37818268|FG002|Overall Study|Physician Decision|1|||
16860782|NCT01993719|37818283|FG000|First Drug Administration|Not treated|1|||
16860783|NCT01993719|37818284|FG001|First Drug Administration|Not treated|0|||
16860784|NCT01993719|37818285|FG002|First Drug Administration|Not treated|0|||
16860785|NCT01993719|37818286|FG003|First Drug Administration|Not treated|0|||
16860786|NCT01993719|37818287|FG004|First Drug Administration|Not treated|0|||
16860787|NCT00638235|37818329|FG000|Overall Study|Lost to Follow-up|31|||
16860788|NCT00638235|37818330|FG001|Overall Study|Lost to Follow-up|3|||
16860789|NCT00638235|37818331|FG002|Overall Study|Lost to Follow-up|18|||
16860790|NCT00638235|37818332|FG003|Overall Study|Lost to Follow-up|10|||
16860791|NCT00638235|37818333|FG004|Overall Study|Lost to Follow-up|13|||
16860792|NCT00638235|37818334|FG005|Overall Study|Lost to Follow-up|26|||
16860793|NCT00638235|37818335|FG006|Overall Study|Lost to Follow-up|0|||
16860794|NCT00638235|37818336|FG007|Overall Study|Lost to Follow-up|1|||
16860795|NCT00638235|37818337|FG008|Overall Study|Lost to Follow-up|18|||
16860796|NCT00638157|37818375|FG000|Overall Study|Adverse Event|0|||
16860797|NCT00638157|37818376|FG001|Overall Study|Adverse Event|1|||
16860798|NCT00638157|37818375|FG000|Overall Study|Clinical (symptomatic) failure|1|||
16860799|NCT00638157|37818376|FG001|Overall Study|Clinical (symptomatic) failure|1|||
16860800|NCT00638157|37818375|FG000|Overall Study|Microbiological failure|1|||
16860801|NCT00638157|37818376|FG001|Overall Study|Microbiological failure|0|||
16860802|NCT00638157|37818375|FG000|Overall Study|Lost to Follow-up|1|||
16860803|NCT00638157|37818376|FG001|Overall Study|Lost to Follow-up|0|||
16860804|NCT00638157|37818375|FG000|Overall Study|Physician Decision|1|||
16860805|NCT00638157|37818376|FG001|Overall Study|Physician Decision|0|||
16860806|NCT00638157|37818375|FG000|Overall Study|Other|1|||
16860807|NCT00638157|37818376|FG001|Overall Study|Other|2|||
16860808|NCT00638157|37818375|FG000|Overall Study|Randomized, not treated|2|||
16860809|NCT00638157|37818376|FG001|Overall Study|Randomized, not treated|0|||
16860810|NCT00637377|37818387|FG000|Overall Study|Adverse Event|2|||
16860811|NCT00637377|37818388|FG001|Overall Study|Adverse Event|6|||
16860812|NCT00637377|37818389|FG002|Overall Study|Adverse Event|8|||
16860813|NCT00637377|37818390|FG003|Overall Study|Adverse Event|9|||
16860814|NCT00637377|37818387|FG000|Overall Study|Death|1|||
16860815|NCT00637377|37818388|FG001|Overall Study|Death|3|||
16860816|NCT00637377|37818389|FG002|Overall Study|Death|2|||
16860817|NCT00637377|37818390|FG003|Overall Study|Death|1|||
16860818|NCT00637377|37818387|FG000|Overall Study|Lack of Efficacy|0|||
16860819|NCT00637377|37818388|FG001|Overall Study|Lack of Efficacy|0|||
16860820|NCT00637377|37818389|FG002|Overall Study|Lack of Efficacy|1|||
16860821|NCT00637377|37818390|FG003|Overall Study|Lack of Efficacy|1|||
16860822|NCT00637377|37818387|FG000|Overall Study|Lost to Follow-up|4|||
16860823|NCT00637377|37818388|FG001|Overall Study|Lost to Follow-up|1|||
16860824|NCT00637377|37818389|FG002|Overall Study|Lost to Follow-up|2|||
16860825|NCT00637377|37818390|FG003|Overall Study|Lost to Follow-up|2|||
16860826|NCT00637377|37818387|FG000|Overall Study|Protocol Violation|2|||
16860827|NCT00637377|37818388|FG001|Overall Study|Protocol Violation|1|||
16860828|NCT00637377|37818389|FG002|Overall Study|Protocol Violation|1|||
16860829|NCT00637377|37818390|FG003|Overall Study|Protocol Violation|0|||
16860830|NCT00637377|37818387|FG000|Overall Study|Withdrawal by Subject|11|||
16860831|NCT00637377|37818388|FG001|Overall Study|Withdrawal by Subject|15|||
16860832|NCT00637377|37818389|FG002|Overall Study|Withdrawal by Subject|13|||
16860833|NCT00637377|37818390|FG003|Overall Study|Withdrawal by Subject|11|||
16860834|NCT00637377|37818387|FG000|Overall Study|Other (no further information available)|7|||
16860835|NCT00637377|37818388|FG001|Overall Study|Other (no further information available)|6|||
16860836|NCT00637377|37818389|FG002|Overall Study|Other (no further information available)|10|||
16860837|NCT00637377|37818390|FG003|Overall Study|Other (no further information available)|5|||
16860838|NCT00636987|37818400|FG000|Overall Study|Death|44|||
16860839|NCT00636987|37818400|FG000|Overall Study|Explanted|13|||
16860840|NCT00636987|37818400|FG000|Overall Study|Lost to Follow-up|63|||
16860841|NCT00636987|37818400|FG000|Overall Study|5 year visit window not complete|69|||
16860842|NCT00636441|37818555|FG000|Overall Study|Adverse Event|0|||
16860843|NCT00636441|37818556|FG001|Overall Study|Adverse Event|1|||
16860844|NCT00636441|37818557|FG002|Overall Study|Adverse Event|1|||
16860845|NCT00636441|37818558|FG003|Overall Study|Adverse Event|0|||
16860846|NCT00636441|37818559|FG004|Overall Study|Adverse Event|0|||
16860847|NCT00636441|37818560|FG005|Overall Study|Adverse Event|1|||
16860848|NCT00636441|37818561|FG006|Overall Study|Adverse Event|0|||
16860849|NCT00636441|37818555|FG000|Overall Study|Late, ineligible|0|||
16860850|NCT00636441|37818556|FG001|Overall Study|Late, ineligible|0|||
16860851|NCT00636441|37818557|FG002|Overall Study|Late, ineligible|0|||
16860852|NCT00636441|37818558|FG003|Overall Study|Late, ineligible|0|||
16860853|NCT00636441|37818559|FG004|Overall Study|Late, ineligible|0|||
16860854|NCT00636441|37818560|FG005|Overall Study|Late, ineligible|0|||
16860855|NCT00636441|37818561|FG006|Overall Study|Late, ineligible|1|||
16860856|NCT00636441|37818555|FG000|Overall Study|Screen Failure|0|||
16860857|NCT00636441|37818556|FG001|Overall Study|Screen Failure|0|||
16860858|NCT00636441|37818557|FG002|Overall Study|Screen Failure|0|||
16860859|NCT00636441|37818558|FG003|Overall Study|Screen Failure|0|||
16860860|NCT00636441|37818559|FG004|Overall Study|Screen Failure|0|||
16860861|NCT00636441|37818560|FG005|Overall Study|Screen Failure|0|||
16860862|NCT00636441|37818561|FG006|Overall Study|Screen Failure|17|||
16860863|NCT00636363|37818584|FG000|Overall Study|Conjunctivitis|0|||
16860864|NCT00636363|37818585|FG001|Overall Study|Conjunctivitis|0|||
16860865|NCT00636363|37818586|FG002|Overall Study|Conjunctivitis|1|||
16860866|NCT00636363|37818584|FG000|Overall Study|Adverse Event|0|||
16860867|NCT00636363|37818585|FG001|Overall Study|Adverse Event|0|||
16860868|NCT00636363|37818586|FG002|Overall Study|Adverse Event|1|||
16860869|NCT00636363|37818584|FG000|Overall Study|Positive slit lamp finding|0|||
16860870|NCT00636363|37818585|FG001|Overall Study|Positive slit lamp finding|2|||
16860871|NCT00636363|37818586|FG002|Overall Study|Positive slit lamp finding|1|||
16860872|NCT00636363|37818584|FG000|Overall Study|Study related symptoms/complaints|8|||
16860873|NCT00636363|37818585|FG001|Overall Study|Study related symptoms/complaints|7|||
16860874|NCT00636363|37818586|FG002|Overall Study|Study related symptoms/complaints|4|||
16860875|NCT00636363|37818584|FG000|Overall Study|Met ineligibility criteria|0|||
16860876|NCT00636363|37818585|FG001|Overall Study|Met ineligibility criteria|0|||
16860877|NCT00636363|37818586|FG002|Overall Study|Met ineligibility criteria|3|||
16860878|NCT00636363|37818584|FG000|Overall Study|Missed > 1 visit|0|||
16860879|NCT00636363|37818585|FG001|Overall Study|Missed > 1 visit|1|||
16860880|NCT00636363|37818586|FG002|Overall Study|Missed > 1 visit|3|||
16860881|NCT00636363|37818584|FG000|Overall Study|Lack of motivation|1|||
16860882|NCT00636363|37818585|FG001|Overall Study|Lack of motivation|0|||
16860883|NCT00636363|37818586|FG002|Overall Study|Lack of motivation|1|||
16860884|NCT00636363|37818584|FG000|Overall Study|Protocol Violation|0|||
16860885|NCT00636363|37818585|FG001|Overall Study|Protocol Violation|3|||
16860886|NCT00636363|37818586|FG002|Overall Study|Protocol Violation|0|||
16860887|NCT00636363|37818584|FG000|Overall Study|Lost to Follow-up|3|||
16860888|NCT00636363|37818585|FG001|Overall Study|Lost to Follow-up|4|||
16860889|NCT00636363|37818586|FG002|Overall Study|Lost to Follow-up|2|||
16860890|NCT00636363|37818584|FG000|Overall Study|Withdrawal by Subject|1|||
16860891|NCT00636363|37818585|FG001|Overall Study|Withdrawal by Subject|3|||
16860892|NCT00636363|37818586|FG002|Overall Study|Withdrawal by Subject|2|||
16860893|NCT00636207|37818628|FG000|Overall Study|Adverse Event|1|||
16860894|NCT00636207|37818629|FG001|Overall Study|Adverse Event|0|||
16860895|NCT00636207|37818630|FG002|Overall Study|Adverse Event|0|||
16860896|NCT00636207|37818631|FG003|Overall Study|Adverse Event|0|||
16860897|NCT00636207|37818632|FG004|Overall Study|Adverse Event|0|||
16860898|NCT00636207|37818633|FG005|Overall Study|Adverse Event|0|||
16860899|NCT00636207|37818634|FG006|Overall Study|Adverse Event|0|||
16860900|NCT00636207|37818628|FG000|Overall Study|Withdrawal by Subject|0|||
16944798|NCT01098097|38088829|FG000|Overall Study|Adverse Event|17|||
16860901|NCT00636207|37818629|FG001|Overall Study|Withdrawal by Subject|1|||
16860902|NCT00636207|37818630|FG002|Overall Study|Withdrawal by Subject|0|||
16860903|NCT00636207|37818631|FG003|Overall Study|Withdrawal by Subject|0|||
16860904|NCT00636207|37818632|FG004|Overall Study|Withdrawal by Subject|1|||
16860905|NCT00636207|37818633|FG005|Overall Study|Withdrawal by Subject|0|||
16860906|NCT00636207|37818634|FG006|Overall Study|Withdrawal by Subject|0|||
16860907|NCT00635661|37818655|FG000|Overall Study|Withdrawal by Subject|4|||
16860908|NCT00635427|37818744|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
16860909|NCT00635427|37818745|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
16860910|NCT00635427|37818746|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
16860911|NCT00635427|37818747|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
16860912|NCT00635427|37818748|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
16860913|NCT00635427|37818744|FG000|Overall Study|Death|0|||
16860914|NCT00635427|37818745|FG001|Overall Study|Death|0|||
16860915|NCT00635427|37818746|FG002|Overall Study|Death|0|||
16860916|NCT00635427|37818747|FG003|Overall Study|Death|1|||
16860917|NCT00635427|37818748|FG004|Overall Study|Death|0|||
16860918|NCT00635427|37818744|FG000|Overall Study|Termination Of Study By Sponsor|12|||
16860919|NCT00635427|37818745|FG001|Overall Study|Termination Of Study By Sponsor|6|||
16860920|NCT00635427|37818746|FG002|Overall Study|Termination Of Study By Sponsor|10|||
16860921|NCT00635427|37818747|FG003|Overall Study|Termination Of Study By Sponsor|6|||
16860922|NCT00635427|37818748|FG004|Overall Study|Termination Of Study By Sponsor|6|||
16860923|NCT00635427|37818744|FG000|Overall Study|Withdrawal Of Consent|0|||
16860924|NCT00635427|37818745|FG001|Overall Study|Withdrawal Of Consent|0|||
16860925|NCT00635427|37818746|FG002|Overall Study|Withdrawal Of Consent|0|||
16860926|NCT00635427|37818747|FG003|Overall Study|Withdrawal Of Consent|2|||
16860927|NCT00635427|37818748|FG004|Overall Study|Withdrawal Of Consent|2|||
16860928|NCT00635349|37818760|FG000|Overall Study|Other|8|||
16860929|NCT00635349|37818761|FG001|Overall Study|Other|6|||
16860930|NCT00635349|37818760|FG000|Overall Study|Protocol Violation|18|||
16860931|NCT00635349|37818761|FG001|Overall Study|Protocol Violation|22|||
16860932|NCT00635349|37818760|FG000|Overall Study|Withdrawal by Subject|3|||
16860933|NCT00635349|37818761|FG001|Overall Study|Withdrawal by Subject|8|||
16860934|NCT00635349|37818760|FG000|Overall Study|Lost to Follow-up|4|||
16860935|NCT00635349|37818761|FG001|Overall Study|Lost to Follow-up|3|||
16860936|NCT00635349|37818760|FG000|Overall Study|Adverse Event|11|||
16860937|NCT00635349|37818761|FG001|Overall Study|Adverse Event|9|||
16860938|NCT00634803|37818770|FG000|Overall Study|Lost to Follow-up|6|||
16860939|NCT00634803|37818771|FG001|Overall Study|Lost to Follow-up|7|||
16860940|NCT00634803|37818772|FG002|Overall Study|Lost to Follow-up|7|||
16860941|NCT01217385|37818788|FG000|Overall Study|Withdrawal by Subject|3|||
16860942|NCT01217385|37818788|FG000|Overall Study|DOSI not performed/not eval|12|||
16860943|NCT01217385|37818788|FG000|Overall Study|Central Path not Available|1|||
16860944|NCT01217385|37818788|FG000|Overall Study|Normal Breast TOI not available|10|||
16860945|NCT01378104|37819140|FG000|Overall Study|Adverse Event|8|||
16860946|NCT01378104|37819141|FG001|Overall Study|Adverse Event|8|||
16860947|NCT01378104|37819140|FG000|Overall Study|Lack of Efficacy|7|||
16860948|NCT01378104|37819141|FG001|Overall Study|Lack of Efficacy|5|||
16860949|NCT01378104|37819140|FG000|Overall Study|Withdrawal by Subject|12|||
16860950|NCT01378104|37819141|FG001|Overall Study|Withdrawal by Subject|13|||
16860951|NCT01379274|37819182|FG000|Overall Study|funding withdrawn|1|||
16860952|NCT01216683|37819384|FG000|Induction|Never started treatment|0|||
16860953|NCT01216683|37819385|FG001|Induction|Never started treatment|6|||
16860954|NCT01216683|37819386|FG002|Induction|Never started treatment|3|||
16860955|NCT01216683|37819384|FG000|Induction|Lack of Efficacy|4|||
16860956|NCT01216683|37819385|FG001|Induction|Lack of Efficacy|3|||
16860957|NCT01216683|37819386|FG002|Induction|Lack of Efficacy|7|||
16860958|NCT01216683|37819384|FG000|Induction|Adverse Event|0|||
16860959|NCT01216683|37819385|FG001|Induction|Adverse Event|5|||
16860960|NCT01216683|37819386|FG002|Induction|Adverse Event|5|||
16860961|NCT01216683|37819384|FG000|Induction|Death|0|||
16860962|NCT01216683|37819385|FG001|Induction|Death|0|||
16860963|NCT01216683|37819386|FG002|Induction|Death|2|||
16860964|NCT01216683|37819384|FG000|Induction|Withdrawal by Subject|0|||
16860965|NCT01216683|37819385|FG001|Induction|Withdrawal by Subject|4|||
16860966|NCT01216683|37819386|FG002|Induction|Withdrawal by Subject|2|||
16860967|NCT01216683|37819384|FG000|Induction|Other disease|0|||
16860968|NCT01216683|37819385|FG001|Induction|Other disease|1|||
16860969|NCT01216683|37819386|FG002|Induction|Other disease|2|||
16860970|NCT01216683|37819384|FG000|Continuation|Lack of Efficacy|3|||
16860971|NCT01216683|37819385|FG001|Continuation|Lack of Efficacy|2|||
16860972|NCT01216683|37819386|FG002|Continuation|Lack of Efficacy|7|||
16860973|NCT01216683|37819384|FG000|Continuation|Adverse Event|5|||
16860974|NCT01216683|37819385|FG001|Continuation|Adverse Event|3|||
16860975|NCT01216683|37819386|FG002|Continuation|Adverse Event|16|||
16860976|NCT01216683|37819384|FG000|Continuation|Death|1|||
16860977|NCT01216683|37819385|FG001|Continuation|Death|0|||
16860978|NCT01216683|37819386|FG002|Continuation|Death|2|||
16860979|NCT01216683|37819384|FG000|Continuation|Withdrawal by Subject|4|||
16860980|NCT01216683|37819385|FG001|Continuation|Withdrawal by Subject|5|||
16860981|NCT01216683|37819386|FG002|Continuation|Withdrawal by Subject|9|||
16860982|NCT01216683|37819384|FG000|Continuation|Other diseases|0|||
16860983|NCT01216683|37819385|FG001|Continuation|Other diseases|2|||
16860984|NCT01216683|37819386|FG002|Continuation|Other diseases|1|||
16860985|NCT01216683|37819384|FG000|Continuation|Physician Decision|1|||
16860986|NCT01216683|37819385|FG001|Continuation|Physician Decision|0|||
16860987|NCT01216683|37819386|FG002|Continuation|Physician Decision|1|||
16860988|NCT01216683|37819384|FG000|Continuation|Non-compliance|1|||
16860989|NCT01216683|37819385|FG001|Continuation|Non-compliance|0|||
16860990|NCT01216683|37819386|FG002|Continuation|Non-compliance|1|||
16860991|NCT01216683|37819384|FG000|Continuation|Insurance change|0|||
16860992|NCT01216683|37819385|FG001|Continuation|Insurance change|1|||
16860993|NCT01216683|37819386|FG002|Continuation|Insurance change|0|||
16860994|NCT01216683|37819384|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
16860995|NCT01216683|37819385|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
16860996|NCT01216683|37819386|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
16860997|NCT01216683|37819384|FG000|Continuation|Not reported|0|||
16860998|NCT01216683|37819385|FG001|Continuation|Not reported|0|||
16860999|NCT01216683|37819386|FG002|Continuation|Not reported|1|||
16861000|NCT01216683|37819384|FG000|Continuation|Never started treatment|0|||
16861001|NCT01216683|37819385|FG001|Continuation|Never started treatment|1|||
16861002|NCT01216683|37819386|FG002|Continuation|Never started treatment|5|||
16861003|NCT00634569|37819409|FG000|Overall Study|Withdrawal by Subject|0|||
16861004|NCT00634569|37819410|FG001|Overall Study|Withdrawal by Subject|4|||
16861005|NCT00634569|37819409|FG000|Overall Study|Physician Decision|0|||
16861006|NCT00634569|37819410|FG001|Overall Study|Physician Decision|1|||
16861007|NCT00634179|37819455|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
16861008|NCT03877926|37819530|FG000|Overall Study|Adverse Event|1|||
16861009|NCT03877926|37819531|FG001|Overall Study|Adverse Event|0|||
16861010|NCT03877926|37819532|FG002|Overall Study|Adverse Event|0|||
16861011|NCT03877926|37819533|FG003|Overall Study|Adverse Event|0|||
16861012|NCT03877926|37819530|FG000|Overall Study|Death|2|||
16861013|NCT03877926|37819531|FG001|Overall Study|Death|2|||
16861014|NCT03877926|37819532|FG002|Overall Study|Death|2|||
16861015|NCT03877926|37819533|FG003|Overall Study|Death|0|||
16861016|NCT03877926|37819530|FG000|Overall Study|Lost to Follow-up|41|||
16861017|NCT03877926|37819531|FG001|Overall Study|Lost to Follow-up|52|||
16861018|NCT03877926|37819532|FG002|Overall Study|Lost to Follow-up|45|||
16861019|NCT03877926|37819533|FG003|Overall Study|Lost to Follow-up|17|||
16861020|NCT03877926|37819530|FG000|Overall Study|Physician Decision|2|||
16861021|NCT03877926|37819531|FG001|Overall Study|Physician Decision|0|||
16861022|NCT03877926|37819532|FG002|Overall Study|Physician Decision|2|||
16861023|NCT03877926|37819533|FG003|Overall Study|Physician Decision|0|||
16861024|NCT03877926|37819530|FG000|Overall Study|Withdrawal by Subject|18|||
16861025|NCT03877926|37819531|FG001|Overall Study|Withdrawal by Subject|21|||
16861026|NCT03877926|37819532|FG002|Overall Study|Withdrawal by Subject|12|||
16861027|NCT03877926|37819533|FG003|Overall Study|Withdrawal by Subject|4|||
16861028|NCT03877926|37819530|FG000|Overall Study|Other - Various|4|||
16861029|NCT03877926|37819531|FG001|Overall Study|Other - Various|1|||
16861030|NCT03877926|37819532|FG002|Overall Study|Other - Various|1|||
16861031|NCT03877926|37819533|FG003|Overall Study|Other - Various|0|||
16861032|NCT03877926|37819530|FG000|Overall Study|Not Treated|3|||
16861033|NCT03877926|37819531|FG001|Overall Study|Not Treated|1|||
16773835|NCT02202850|37713039|FG001|Overall Study|Lost to Follow-up|1|||
16773836|NCT02212678|37713045|FG000|Overall Study|Adverse Event|1|||
16773837|NCT03104075|37713051|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
16773838|NCT03104075|37713052|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
16773839|NCT03038087|37713059|FG000|Overall Study|lost data|1|||
16773840|NCT02249182|37713070|FG000|Treatment Phase|Lost to Follow-up|4|||
16773841|NCT02249182|37713071|FG001|Treatment Phase|Lost to Follow-up|0|||
16773842|NCT02249182|37713072|FG002|Treatment Phase|Lost to Follow-up|0|||
16773843|NCT02249182|37713073|FG003|Treatment Phase|Lost to Follow-up|0|||
16773844|NCT02249182|37713074|FG004|Treatment Phase|Lost to Follow-up|0|||
16773845|NCT03641339|37713114|FG000|Overall Study|Physician Decision|1|||
16861034|NCT03877926|37819532|FG002|Overall Study|Not Treated|1|||
16861035|NCT03877926|37819533|FG003|Overall Study|Not Treated|0|||
16861036|NCT02874144|37819756|FG000|Overall Study|Lost to Follow-up|3|||
16861037|NCT02874144|37819757|FG001|Overall Study|Lost to Follow-up|5|||
16861038|NCT02611830|37819787|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
16861039|NCT02611830|37819788|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
16861040|NCT02611830|37819789|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
16861041|NCT02611830|37819790|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
16861042|NCT02611830|37819787|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
16861043|NCT02611830|37819788|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
16861044|NCT02611830|37819789|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
16868155|NCT01548287|37841197|FG004|Screening|No reason provided|9|||
16773846|NCT03641339|37713115|FG001|Overall Study|Physician Decision|0|||
16773847|NCT03641339|37713116|FG002|Overall Study|Physician Decision|0|||
16773848|NCT03641339|37713117|FG003|Overall Study|Physician Decision|0|||
16773849|NCT03641339|37713118|FG004|Overall Study|Physician Decision|0|||
16773850|NCT03641339|37713119|FG005|Overall Study|Physician Decision|0|||
16773851|NCT03641339|37713114|FG000|Overall Study|Withdrawal by Subject|0|||
16773852|NCT03641339|37713115|FG001|Overall Study|Withdrawal by Subject|2|||
16773853|NCT03641339|37713116|FG002|Overall Study|Withdrawal by Subject|0|||
16773854|NCT03641339|37713117|FG003|Overall Study|Withdrawal by Subject|2|||
16773855|NCT03641339|37713118|FG004|Overall Study|Withdrawal by Subject|0|||
16773856|NCT03641339|37713119|FG005|Overall Study|Withdrawal by Subject|1|||
16773857|NCT02248480|37713135|FG000|Overall Study|Lack of Efficacy|4|||
16773858|NCT02248480|37713136|FG001|Overall Study|Lack of Efficacy|6|||
16773859|NCT02248480|37713135|FG000|Overall Study|Adverse Event|11|||
16773860|NCT02248480|37713136|FG001|Overall Study|Adverse Event|2|||
16773861|NCT02248480|37713135|FG000|Overall Study|Withdrawal by Subject|2|||
16773862|NCT02248480|37713136|FG001|Overall Study|Withdrawal by Subject|4|||
16773863|NCT02248480|37713135|FG000|Overall Study|Entry Criteria Not Met|0|||
16773864|NCT02248480|37713136|FG001|Overall Study|Entry Criteria Not Met|1|||
16773865|NCT02248480|37713135|FG000|Overall Study|Other:Physician Decision|0|||
16773866|NCT02248480|37713136|FG001|Overall Study|Other:Physician Decision|1|||
16773867|NCT01653158|37713143|FG000|Overall Study|Death|0|||
16773868|NCT01653158|37713144|FG001|Overall Study|Death|0|||
16773869|NCT01653158|37713145|FG002|Overall Study|Death|0|||
16773870|NCT01653158|37713146|FG003|Overall Study|Death|1|||
16773871|NCT01653158|37713147|FG004|Overall Study|Death|0|||
16773872|NCT01653158|37713148|FG005|Overall Study|Death|0|||
16773873|NCT01653158|37713149|FG006|Overall Study|Death|0|||
16773874|NCT01653158|37713150|FG007|Overall Study|Death|2|||
16773875|NCT01653158|37713143|FG000|Overall Study|Adverse Event|0|||
16773876|NCT01653158|37713144|FG001|Overall Study|Adverse Event|0|||
16773877|NCT01653158|37713145|FG002|Overall Study|Adverse Event|0|||
16773878|NCT01653158|37713146|FG003|Overall Study|Adverse Event|1|||
16773879|NCT01653158|37713147|FG004|Overall Study|Adverse Event|0|||
16773880|NCT01653158|37713148|FG005|Overall Study|Adverse Event|0|||
16861045|NCT02611830|37819790|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
16861046|NCT02611830|37819787|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
16861047|NCT02611830|37819788|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
16861048|NCT02611830|37819789|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
16861049|NCT02611830|37819790|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
16861050|NCT02611830|37819787|FG000|OL Induction Phase|Lack of Efficacy|9|||
16861051|NCT02611830|37819788|FG001|OL Induction Phase|Lack of Efficacy|0|||
16861052|NCT02611830|37819789|FG002|OL Induction Phase|Lack of Efficacy|0|||
16861053|NCT02611830|37819790|FG003|OL Induction Phase|Lack of Efficacy|0|||
16861054|NCT02611830|37819787|FG000|OL Induction Phase|Reason not specified|3|||
16861055|NCT02611830|37819788|FG001|OL Induction Phase|Reason not specified|0|||
16861056|NCT02611830|37819789|FG002|OL Induction Phase|Reason not specified|0|||
16861057|NCT02611830|37819790|FG003|OL Induction Phase|Reason not specified|0|||
16861058|NCT02611830|37819787|FG000|Maintenance Phase|Lack of Efficacy|0|||
16861059|NCT02611830|37819788|FG001|Maintenance Phase|Lack of Efficacy|29|||
16861060|NCT02611830|37819789|FG002|Maintenance Phase|Lack of Efficacy|18|||
16861061|NCT02611830|37819790|FG003|Maintenance Phase|Lack of Efficacy|6|||
16861062|NCT02611830|37819787|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16861063|NCT02611830|37819788|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
16861064|NCT02611830|37819789|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
16861065|NCT02611830|37819790|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
16861066|NCT02611830|37819787|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
16861067|NCT02611830|37819788|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
16861068|NCT02611830|37819789|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
16861069|NCT02611830|37819790|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
16861070|NCT02611830|37819787|FG000|Maintenance Phase|Lost to Follow-up|0|||
16861071|NCT02611830|37819788|FG001|Maintenance Phase|Lost to Follow-up|0|||
16861072|NCT02611830|37819789|FG002|Maintenance Phase|Lost to Follow-up|0|||
16861073|NCT02611830|37819790|FG003|Maintenance Phase|Lost to Follow-up|1|||
16861074|NCT02611830|37819787|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
16861075|NCT02611830|37819788|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
16861076|NCT02611830|37819789|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
16861077|NCT02611830|37819790|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
16861078|NCT02611830|37819787|FG000|Maintenance Phase|Pregnancy|0|||
16861079|NCT02611830|37819788|FG001|Maintenance Phase|Pregnancy|0|||
16861080|NCT02611830|37819789|FG002|Maintenance Phase|Pregnancy|1|||
16861081|NCT02611830|37819790|FG003|Maintenance Phase|Pregnancy|0|||
16861082|NCT02611830|37819787|FG000|Maintenance Phase|Reason not specified|0|||
16861083|NCT02611830|37819788|FG001|Maintenance Phase|Reason not specified|1|||
16861084|NCT02611830|37819789|FG002|Maintenance Phase|Reason not specified|4|||
16861085|NCT02611830|37819790|FG003|Maintenance Phase|Reason not specified|0|||
16861086|NCT01328574|37819976|FG000|Overall Study|Refused further treatment|1|||
16861087|NCT01328496|37820098|FG000|Overall Study|Significant Change in Health Status|1|||
16861088|NCT01328496|37820099|FG001|Overall Study|Significant Change in Health Status|0|||
16861089|NCT02734212|37820219|FG000|Overall Study|Lost to Follow-up|5|||
16861090|NCT02734212|37820220|FG001|Overall Study|Lost to Follow-up|10|||
16861091|NCT04604184|37820297|FG000|Overall Study|Adverse Event|5|||
16861092|NCT04604184|37820298|FG001|Overall Study|Adverse Event|5|||
16861093|NCT04604184|37820297|FG000|Overall Study|Death|2|||
16861094|NCT04604184|37820298|FG001|Overall Study|Death|1|||
16861095|NCT04604184|37820297|FG000|Overall Study|Withdrawal by Subject|1|||
16861096|NCT04604184|37820298|FG001|Overall Study|Withdrawal by Subject|3|||
16861097|NCT04604184|37820297|FG000|Overall Study|Not treated|2|||
16861098|NCT04604184|37820298|FG001|Overall Study|Not treated|2|||
16861099|NCT04604184|37820297|FG000|Overall Study|Due to sponsor decision|9|||
16861100|NCT04604184|37820298|FG001|Overall Study|Due to sponsor decision|7|||
16861101|NCT04604184|37820297|FG000|Overall Study|Physician Decision|0|||
16861102|NCT04604184|37820298|FG001|Overall Study|Physician Decision|1|||
16861103|NCT04604184|37820297|FG000|Overall Study|Transfer to healthcare|1|||
16861104|NCT04604184|37820298|FG001|Overall Study|Transfer to healthcare|0|||
16861105|NCT01192776|37820469|FG000|Overall Study|Death|8|||
16861106|NCT01192776|37820470|FG001|Overall Study|Death|15|||
16773881|NCT01653158|37713149|FG006|Overall Study|Adverse Event|0|||
16773882|NCT01653158|37713150|FG007|Overall Study|Adverse Event|3|||
16773883|NCT01653158|37713143|FG000|Overall Study|Other|0|||
16773884|NCT01653158|37713144|FG001|Overall Study|Other|0|||
16773885|NCT01653158|37713145|FG002|Overall Study|Other|0|||
16773886|NCT01653158|37713146|FG003|Overall Study|Other|0|||
16773887|NCT01653158|37713147|FG004|Overall Study|Other|0|||
16773888|NCT01653158|37713148|FG005|Overall Study|Other|0|||
16773889|NCT01653158|37713149|FG006|Overall Study|Other|0|||
16773890|NCT01653158|37713150|FG007|Overall Study|Other|1|||
16773891|NCT01653158|37713143|FG000|Overall Study|Progressive disease|0|||
16773892|NCT01653158|37713144|FG001|Overall Study|Progressive disease|0|||
16773893|NCT01653158|37713145|FG002|Overall Study|Progressive disease|0|||
16773894|NCT01653158|37713146|FG003|Overall Study|Progressive disease|0|||
16773895|NCT01653158|37713147|FG004|Overall Study|Progressive disease|1|||
16773896|NCT01653158|37713148|FG005|Overall Study|Progressive disease|1|||
16773897|NCT01653158|37713149|FG006|Overall Study|Progressive disease|2|||
16773898|NCT01653158|37713150|FG007|Overall Study|Progressive disease|9|||
16773899|NCT01653158|37713143|FG000|Overall Study|Withdrawal by Subject|1|||
16773900|NCT01653158|37713144|FG001|Overall Study|Withdrawal by Subject|0|||
16773901|NCT01653158|37713145|FG002|Overall Study|Withdrawal by Subject|0|||
16773902|NCT01653158|37713146|FG003|Overall Study|Withdrawal by Subject|0|||
16773903|NCT01653158|37713147|FG004|Overall Study|Withdrawal by Subject|0|||
16773904|NCT01653158|37713148|FG005|Overall Study|Withdrawal by Subject|0|||
16773905|NCT01653158|37713149|FG006|Overall Study|Withdrawal by Subject|0|||
16773906|NCT01653158|37713150|FG007|Overall Study|Withdrawal by Subject|0|||
16773907|NCT02247466|37713175|FG000|Overall Study|Procedure changed to open surgery|0|||
16773908|NCT02247466|37713176|FG001|Overall Study|Procedure changed to open surgery|3|||
16773909|NCT03317795|37713184|FG000|Overall Study|IUD Expulsion|1|||
16773910|NCT03317795|37713185|FG001|Overall Study|IUD Expulsion|0|||
16773911|NCT03317795|37713184|FG000|Overall Study|Lost to Follow-up|1|||
16773912|NCT03317795|37713185|FG001|Overall Study|Lost to Follow-up|3|||
16773913|NCT03317795|37713184|FG000|Overall Study|Treatment change|0|||
16773914|NCT03317795|37713185|FG001|Overall Study|Treatment change|3|||
16773915|NCT03317795|37713184|FG000|Overall Study|Intolerance of medication|0|||
16773916|NCT03317795|37713185|FG001|Overall Study|Intolerance of medication|1|||
16773917|NCT02202616|37713191|FG000|Overall Study|Screen failed|24|||
16773918|NCT02202616|37713191|FG000|Overall Study|Adverse Event|32|||
16773919|NCT02202616|37713191|FG000|Overall Study|Protocol deviation|18|||
16773920|NCT02202616|37713191|FG000|Overall Study|Patient withdrew consent|12|||
16773921|NCT02202616|37713191|FG000|Overall Study|Lost to Follow-up|6|||
16773922|NCT02202616|37713191|FG000|Overall Study|Administrative problems|6|||
16773923|NCT02202616|37713191|FG000|Overall Study|Abnormal test procedure result|1|||
16773924|NCT02202616|37713191|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16773925|NCT02455388|37713198|FG000|Overall Study|Protocol Violation|1|||
16773926|NCT02455388|37713199|FG001|Overall Study|Protocol Violation|0|||
16773927|NCT02455388|37713200|FG002|Overall Study|Protocol Violation|4|||
16773928|NCT02455388|37713198|FG000|Overall Study|Withdrawal by Subject|0|||
16773929|NCT02455388|37713199|FG001|Overall Study|Withdrawal by Subject|0|||
16773930|NCT02455388|37713200|FG002|Overall Study|Withdrawal by Subject|7|||
16773931|NCT02455076|37713213|FG000|Inpatient|Withdrawal by Subject|1|||
16773932|NCT02455076|37713214|FG001|Inpatient|Withdrawal by Subject|0|||
16773933|NCT02455076|37713215|FG002|Inpatient|Withdrawal by Subject|0|||
16773934|NCT02455076|37713216|FG003|Inpatient|Withdrawal by Subject|0|||
16773935|NCT02455076|37713217|FG004|Inpatient|Withdrawal by Subject|0|||
16773936|NCT02455076|37713213|FG000|Inpatient|Discharged <24 h after admission|0|||
16773937|NCT02455076|37713214|FG001|Inpatient|Discharged <24 h after admission|1|||
16773938|NCT02455076|37713215|FG002|Inpatient|Discharged <24 h after admission|0|||
16773939|NCT02455076|37713216|FG003|Inpatient|Discharged <24 h after admission|0|||
16773940|NCT02455076|37713217|FG004|Inpatient|Discharged <24 h after admission|0|||
16773941|NCT02455076|37713213|FG000|Inpatient|Adverse Event|3|||
16773942|NCT02455076|37713214|FG001|Inpatient|Adverse Event|0|||
16773943|NCT02455076|37713215|FG002|Inpatient|Adverse Event|0|||
16773944|NCT02455076|37713216|FG003|Inpatient|Adverse Event|0|||
16773945|NCT02455076|37713217|FG004|Inpatient|Adverse Event|0|||
16773946|NCT02455076|37713213|FG000|Outpatient|Adverse Event|0|||
16773947|NCT02455076|37713214|FG001|Outpatient|Adverse Event|0|||
16773948|NCT02455076|37713215|FG002|Outpatient|Adverse Event|0|||
16773949|NCT02455076|37713216|FG003|Outpatient|Adverse Event|5|||
16773950|NCT02455076|37713217|FG004|Outpatient|Adverse Event|0|||
16773951|NCT02455076|37713213|FG000|Outpatient|Lost to Follow-up|0|||
16773952|NCT02455076|37713214|FG001|Outpatient|Lost to Follow-up|0|||
16773953|NCT02455076|37713215|FG002|Outpatient|Lost to Follow-up|0|||
16773954|NCT02455076|37713216|FG003|Outpatient|Lost to Follow-up|1|||
16773955|NCT02455076|37713217|FG004|Outpatient|Lost to Follow-up|12|||
16773956|NCT02433080|37713231|FG000|Overall Study|Lost to Follow-up|1|||
16773957|NCT02433080|37713232|FG001|Overall Study|Lost to Follow-up|2|||
16773958|NCT02433080|37713231|FG000|Overall Study|Withdrawal by Subject|0|||
16773959|NCT02433080|37713232|FG001|Overall Study|Withdrawal by Subject|2|||
16773960|NCT03092219|37713241|FG000|Overall Study|Protocol Violation|7|||
16773961|NCT03092219|37713242|FG001|Overall Study|Protocol Violation|4|||
16773962|NCT02432846|37713257|FG000|Overall Study (4 Arms/Strata)|Death|3|||
16773963|NCT02432846|37713258|FG001|Overall Study (4 Arms/Strata)|Death|2|||
16773964|NCT02432846|37713259|FG002|Overall Study (4 Arms/Strata)|Death|4|||
16773965|NCT02432846|37713260|FG003|Overall Study (4 Arms/Strata)|Death|3|||
16773966|NCT02432846|37713261|FG004|Overall Study (4 Arms/Strata)|Death|0|||
16773967|NCT02432846|37713262|FG005|Overall Study (4 Arms/Strata)|Death|0|||
16773968|NCT02432846|37713257|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
16773969|NCT02432846|37713258|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
16861107|NCT01192776|37820471|FG002|Overall Study|Death|18|||
16861108|NCT01192776|37820472|FG003|Overall Study|Death|15|||
16861109|NCT01192776|37820469|FG000|Overall Study|Lost to Follow-up|3|||
16861110|NCT01192776|37820470|FG001|Overall Study|Lost to Follow-up|6|||
16861111|NCT01192776|37820471|FG002|Overall Study|Lost to Follow-up|3|||
16861112|NCT01192776|37820472|FG003|Overall Study|Lost to Follow-up|5|||
16861113|NCT01859741|37820492|FG000|Overall Study|Death|3|||
16861114|NCT01859741|37820493|FG001|Overall Study|Death|2|||
16861115|NCT01859741|37820494|FG002|Overall Study|Death|4|||
16861116|NCT01859741|37820495|FG003|Overall Study|Death|3|||
16861117|NCT01859741|37820496|FG004|Overall Study|Death|5|||
16861118|NCT01859741|37820497|FG005|Overall Study|Death|4|||
16861119|NCT01859741|37820498|FG006|Overall Study|Death|51|||
16861120|NCT01859741|37820499|FG007|Overall Study|Death|51|||
16861121|NCT01859741|37820492|FG000|Overall Study|Lost to Follow-up|0|||
16861122|NCT01859741|37820493|FG001|Overall Study|Lost to Follow-up|0|||
16861123|NCT01859741|37820494|FG002|Overall Study|Lost to Follow-up|0|||
16861124|NCT01859741|37820495|FG003|Overall Study|Lost to Follow-up|0|||
16861125|NCT01859741|37820496|FG004|Overall Study|Lost to Follow-up|0|||
16861126|NCT01859741|37820497|FG005|Overall Study|Lost to Follow-up|1|||
16861127|NCT01859741|37820498|FG006|Overall Study|Lost to Follow-up|0|||
16861128|NCT01859741|37820499|FG007|Overall Study|Lost to Follow-up|4|||
16861129|NCT01859741|37820492|FG000|Overall Study|Withdrawal by Subject|0|||
16861130|NCT01859741|37820493|FG001|Overall Study|Withdrawal by Subject|1|||
16861131|NCT01859741|37820494|FG002|Overall Study|Withdrawal by Subject|2|||
16861132|NCT01859741|37820495|FG003|Overall Study|Withdrawal by Subject|0|||
16861133|NCT01859741|37820496|FG004|Overall Study|Withdrawal by Subject|0|||
16861134|NCT01859741|37820497|FG005|Overall Study|Withdrawal by Subject|1|||
16861135|NCT01859741|37820498|FG006|Overall Study|Withdrawal by Subject|1|||
16861136|NCT01859741|37820499|FG007|Overall Study|Withdrawal by Subject|1|||
16861137|NCT01859741|37820492|FG000|Overall Study|Study Terminated by Sponsor|0|||
16861138|NCT01859741|37820493|FG001|Overall Study|Study Terminated by Sponsor|0|||
16861139|NCT01859741|37820494|FG002|Overall Study|Study Terminated by Sponsor|0|||
16861140|NCT01859741|37820495|FG003|Overall Study|Study Terminated by Sponsor|0|||
16861141|NCT01859741|37820496|FG004|Overall Study|Study Terminated by Sponsor|1|||
16861142|NCT01859741|37820497|FG005|Overall Study|Study Terminated by Sponsor|0|||
16861143|NCT01859741|37820498|FG006|Overall Study|Study Terminated by Sponsor|16|||
16861144|NCT01859741|37820499|FG007|Overall Study|Study Terminated by Sponsor|14|||
16861145|NCT01859741|37820492|FG000|Overall Study|Other|0|||
16861146|NCT01859741|37820493|FG001|Overall Study|Other|0|||
16861147|NCT01859741|37820494|FG002|Overall Study|Other|0|||
16861148|NCT01859741|37820495|FG003|Overall Study|Other|0|||
16861149|NCT01859741|37820496|FG004|Overall Study|Other|0|||
16861150|NCT01859741|37820497|FG005|Overall Study|Other|0|||
16861151|NCT01859741|37820498|FG006|Overall Study|Other|2|||
16861152|NCT01859741|37820499|FG007|Overall Study|Other|0|||
16773970|NCT02432846|37713259|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
16773971|NCT02432846|37713260|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
16861153|NCT01859507|37820545|FG000|Overall Study|left the country|4|||
16861154|NCT01876043|37820550|FG000|Overall Study|Death|1|||
16861155|NCT01876043|37820550|FG000|Overall Study|Withdrawal by Subject|1|||
16861156|NCT01875731|37820556|FG000|Overall Study|Fail to obtain lab sample|1|||
16861157|NCT01875731|37820557|FG001|Overall Study|Fail to obtain lab sample|0|||
16861158|NCT01873859|37820565|FG000|Overall Study|Withdrawal by Subject|0|||
16861159|NCT01873859|37820566|FG001|Overall Study|Withdrawal by Subject|4|||
16861160|NCT01857869|37820583|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
16861161|NCT01857869|37820584|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
16861162|NCT01857869|37820585|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
16861163|NCT01857869|37820586|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
16861164|NCT01857869|37820587|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
16861165|NCT01857869|37820588|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
16861166|NCT01857869|37820589|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
16861167|NCT01857869|37820590|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
16861168|NCT01857869|37820591|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
16861169|NCT01857869|37820592|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
16861170|NCT01857869|37820583|FG000|Primary/Challenge Phase|Pregnancy|1|||
16861171|NCT01857869|37820584|FG001|Primary/Challenge Phase|Pregnancy|0|||
16861172|NCT01857869|37820585|FG002|Primary/Challenge Phase|Pregnancy|0|||
16861173|NCT01857869|37820586|FG003|Primary/Challenge Phase|Pregnancy|0|||
16861174|NCT01857869|37820587|FG004|Primary/Challenge Phase|Pregnancy|0|||
16861175|NCT01857869|37820588|FG005|Primary/Challenge Phase|Pregnancy|0|||
16861176|NCT01857869|37820589|FG006|Primary/Challenge Phase|Pregnancy|0|||
16861177|NCT01857869|37820590|FG007|Primary/Challenge Phase|Pregnancy|0|||
16861178|NCT01857869|37820591|FG008|Primary/Challenge Phase|Pregnancy|0|||
16861179|NCT01857869|37820592|FG009|Primary/Challenge Phase|Pregnancy|0|||
16861180|NCT01857869|37820583|FG000|Primary/Challenge Phase|Protocol Violation|1|||
16861181|NCT01857869|37820584|FG001|Primary/Challenge Phase|Protocol Violation|0|||
16861182|NCT01857869|37820585|FG002|Primary/Challenge Phase|Protocol Violation|0|||
16861183|NCT01857869|37820586|FG003|Primary/Challenge Phase|Protocol Violation|0|||
16861184|NCT01857869|37820587|FG004|Primary/Challenge Phase|Protocol Violation|0|||
16861185|NCT01857869|37820588|FG005|Primary/Challenge Phase|Protocol Violation|0|||
16861186|NCT01857869|37820589|FG006|Primary/Challenge Phase|Protocol Violation|0|||
16861187|NCT01857869|37820590|FG007|Primary/Challenge Phase|Protocol Violation|0|||
16861188|NCT01857869|37820591|FG008|Primary/Challenge Phase|Protocol Violation|0|||
16861189|NCT01857869|37820592|FG009|Primary/Challenge Phase|Protocol Violation|0|||
16861190|NCT01857869|37820583|FG000|Primary/Challenge Phase|Other|1|||
16861191|NCT01857869|37820584|FG001|Primary/Challenge Phase|Other|1|||
16861192|NCT01857869|37820585|FG002|Primary/Challenge Phase|Other|0|||
16861193|NCT01857869|37820586|FG003|Primary/Challenge Phase|Other|0|||
16861194|NCT01857869|37820587|FG004|Primary/Challenge Phase|Other|0|||
16861195|NCT01857869|37820588|FG005|Primary/Challenge Phase|Other|0|||
16861196|NCT01857869|37820589|FG006|Primary/Challenge Phase|Other|0|||
16861197|NCT01857869|37820590|FG007|Primary/Challenge Phase|Other|0|||
16861198|NCT01857869|37820591|FG008|Primary/Challenge Phase|Other|0|||
16861199|NCT01857869|37820592|FG009|Primary/Challenge Phase|Other|0|||
16861200|NCT01857869|37820583|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861201|NCT01857869|37820584|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861202|NCT01857869|37820585|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861203|NCT01857869|37820586|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
16861204|NCT01857869|37820587|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861205|NCT01857869|37820588|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861206|NCT01857869|37820589|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861207|NCT01857869|37820590|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861208|NCT01857869|37820591|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861209|NCT01857869|37820592|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16861210|NCT01857869|37820583|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861211|NCT01857869|37820584|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861212|NCT01857869|37820585|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861213|NCT01857869|37820586|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
16861214|NCT01857869|37820587|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861215|NCT01857869|37820588|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861216|NCT01857869|37820589|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861217|NCT01857869|37820590|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861218|NCT01857869|37820591|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861219|NCT01857869|37820592|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16861220|NCT00861705|37820751|FG000|Overall Study|Never Began Treatment|7|||
16861221|NCT00861705|37820752|FG001|Overall Study|Never Began Treatment|3|||
16861222|NCT00861705|37820753|FG002|Overall Study|Never Began Treatment|0|||
16861223|NCT00861705|37820754|FG003|Overall Study|Never Began Treatment|1|||
16861224|NCT00634101|37820854|FG000|Overall Study|Study Terminated|3|||
16861225|NCT00634101|37820855|FG001|Overall Study|Study Terminated|3|||
16861226|NCT00634101|37820854|FG000|Overall Study|Lost to Follow-up|2|||
16861227|NCT00634101|37820855|FG001|Overall Study|Lost to Follow-up|0|||
16861228|NCT00633477|37820872|FG000|Overall Study|Death|1|||
16861229|NCT00633477|37820873|FG001|Overall Study|Death|0|||
16861230|NCT00633477|37820872|FG000|Overall Study|Randomized but not treated|1|||
16861231|NCT00633477|37820873|FG001|Overall Study|Randomized but not treated|0|||
16861232|NCT00331773|37820898|FG000|Overall Study|Withdrawal by Subject|6|||
16861233|NCT00331773|37820899|FG001|Overall Study|Withdrawal by Subject|4|||
16861234|NCT00331773|37820898|FG000|Overall Study|Protocol Violation|10|||
16861235|NCT00331773|37820899|FG001|Overall Study|Protocol Violation|3|||
16861236|NCT00633243|37820932|FG000|Overall Study|Withdrawal by Subject|0|||
16861237|NCT00633243|37820933|FG001|Overall Study|Withdrawal by Subject|1|||
16861238|NCT00633243|37820932|FG000|Overall Study|incarceration|0|||
16861239|NCT00633243|37820933|FG001|Overall Study|incarceration|2|||
16861240|NCT00633243|37820932|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
16861241|NCT00633243|37820933|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
16861242|NCT00633243|37820932|FG000|Overall Study|Not comfortable with self-injecting|0|||
16861243|NCT00633243|37820933|FG001|Overall Study|Not comfortable with self-injecting|1|||
16861244|NCT00633243|37820932|FG000|Overall Study|Mental Health--Depression|0|||
16861245|NCT00633243|37820933|FG001|Overall Study|Mental Health--Depression|1|||
16861246|NCT00633243|37820932|FG000|Overall Study|Couldn't tolerate side-effects|1|||
16861247|NCT00633243|37820933|FG001|Overall Study|Couldn't tolerate side-effects|1|||
16861248|NCT01872689|37820943|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
16861249|NCT01872689|37820944|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
16861250|NCT01872689|37820945|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
16861251|NCT01872689|37820946|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
16861252|NCT01872689|37820943|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
16861253|NCT01872689|37820944|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
16861254|NCT01872689|37820945|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
16861255|NCT01872689|37820946|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
16861256|NCT01872689|37820943|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
16773972|NCT02432846|37713261|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
16773973|NCT02432846|37713262|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
16773974|NCT02432846|37713257|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
16773975|NCT02432846|37713258|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16773976|NCT02432846|37713259|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16773977|NCT02432846|37713260|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16773978|NCT02432846|37713261|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16773979|NCT02432846|37713262|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16773980|NCT02432846|37713257|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
16773981|NCT02432846|37713258|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
16773982|NCT02432846|37713259|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
16773983|NCT02432846|37713260|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
16773984|NCT02432846|37713261|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
16773985|NCT02432846|37713262|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
16773986|NCT02432846|37713257|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
16773987|NCT02432846|37713258|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
16773988|NCT02432846|37713259|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
16773989|NCT02432846|37713260|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
16773990|NCT02432846|37713261|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
16773991|NCT02432846|37713262|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
16773992|NCT02432846|37713257|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
16773993|NCT02432846|37713258|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
16773994|NCT02432846|37713259|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
16773995|NCT02432846|37713260|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
16773996|NCT02432846|37713261|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
16773997|NCT02432846|37713262|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
16773998|NCT02432846|37713257|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16773999|NCT02432846|37713258|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16774000|NCT02432846|37713259|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
16774001|NCT02432846|37713260|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16861257|NCT01872689|37820944|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
16861258|NCT01872689|37820945|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
16861259|NCT01872689|37820946|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
16861260|NCT01872689|37820943|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
16861261|NCT01872689|37820944|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
16861262|NCT01872689|37820945|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
16861263|NCT01872689|37820946|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
16861264|NCT01872689|37820943|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
16861265|NCT01872689|37820944|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
16861266|NCT01872689|37820945|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
16861267|NCT01872689|37820946|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
16861268|NCT01872689|37820943|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
16861269|NCT01872689|37820944|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
16861270|NCT01872689|37820945|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
16774002|NCT02432846|37713261|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16861271|NCT01872689|37820946|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
16861272|NCT01872689|37820943|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
16861273|NCT01872689|37820944|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
16861274|NCT01872689|37820945|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
16861275|NCT01872689|37820946|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
16861276|NCT01872689|37820943|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
16861277|NCT01872689|37820944|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
16861278|NCT01872689|37820945|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
16861279|NCT01872689|37820946|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
16861280|NCT01872689|37820943|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
16861281|NCT01872689|37820944|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
16861282|NCT01872689|37820945|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
16861283|NCT01872689|37820946|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
16861284|NCT01872689|37820943|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
16861285|NCT01872689|37820944|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
16861286|NCT01872689|37820945|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
16861287|NCT01872689|37820946|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
16861288|NCT01872689|37820943|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
16861289|NCT01872689|37820944|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
16861290|NCT01872689|37820945|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
16861291|NCT01872689|37820946|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
16861292|NCT01872689|37820943|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
16861293|NCT01872689|37820944|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
16861294|NCT01872689|37820945|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
16861295|NCT01872689|37820946|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
16861296|NCT01872689|37820943|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
16861297|NCT01872689|37820944|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
16861298|NCT01872689|37820945|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
16861299|NCT01872689|37820946|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
16861300|NCT01872689|37820943|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
16861301|NCT01872689|37820944|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
16861302|NCT01872689|37820945|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
16861303|NCT01872689|37820946|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
16861304|NCT00632931|37820959|FG000|Part 1, Period 1|Protocol Violation|1|||
16861305|NCT00632931|37820960|FG001|Part 1, Period 1|Protocol Violation|0|||
16861306|NCT00632931|37820961|FG002|Part 1, Period 1|Protocol Violation|0|||
16861307|NCT00632931|37820959|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
16861308|NCT00632931|37820960|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
16861309|NCT00632931|37820961|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
16861310|NCT00632931|37820959|FG000|Part 2|Adverse Event|0|||
16861311|NCT00632931|37820960|FG001|Part 2|Adverse Event|0|||
16861312|NCT00632931|37820961|FG002|Part 2|Adverse Event|3|||
16861313|NCT00632931|37820959|FG000|Part 2|Death|0|||
16861314|NCT00632931|37820960|FG001|Part 2|Death|0|||
16861315|NCT00632931|37820961|FG002|Part 2|Death|1|||
16861316|NCT00632931|37820959|FG000|Part 2|Lack of Efficacy|0|||
16861317|NCT00632931|37820960|FG001|Part 2|Lack of Efficacy|0|||
16861318|NCT00632931|37820961|FG002|Part 2|Lack of Efficacy|17|||
16861319|NCT00632931|37820959|FG000|Part 2|Withdrawal by Subject|0|||
16861320|NCT00632931|37820960|FG001|Part 2|Withdrawal by Subject|0|||
16861321|NCT00632931|37820961|FG002|Part 2|Withdrawal by Subject|3|||
16861322|NCT01857323|37820966|FG000|Overall Study|Adverse Event|1|||
16861323|NCT01857323|37820966|FG000|Overall Study|Withdrawal by Subject|3|||
16861324|NCT01857323|37820966|FG000|Overall Study|Non-compliance|1|||
16861325|NCT01857323|37820966|FG000|Overall Study|Protocol Violation|6|||
16861326|NCT01857323|37820966|FG000|Overall Study|Lost to Follow-up|1|||
16861327|NCT01857323|37820966|FG000|Overall Study|Other|4|||
16861328|NCT01857323|37820966|FG000|Overall Study|Did not complete 180 doses|48|||
16861329|NCT00632541|37820970|FG000|Overall Study|Adverse Event|7|||
16861330|NCT01872611|37820976|FG000|Overall Study|Adverse Event|3|||
16861331|NCT01872611|37820977|FG001|Overall Study|Adverse Event|1|||
16861332|NCT01872611|37820976|FG000|Overall Study|Adverse Event, prior to treatment|0|||
16861333|NCT01872611|37820977|FG001|Overall Study|Adverse Event, prior to treatment|1|||
16861334|NCT01872611|37820976|FG000|Overall Study|Death|0|||
16861335|NCT01872611|37820977|FG001|Overall Study|Death|1|||
16861336|NCT01872611|37820976|FG000|Overall Study|Death, prior to treatment|0|||
16861337|NCT01872611|37820977|FG001|Overall Study|Death, prior to treatment|1|||
16861338|NCT01872611|37820976|FG000|Overall Study|Lost to Follow-up|8|||
16861339|NCT01872611|37820977|FG001|Overall Study|Lost to Follow-up|1|||
16861340|NCT01872611|37820976|FG000|Overall Study|Physician Decision|1|||
16861341|NCT01872611|37820977|FG001|Overall Study|Physician Decision|0|||
16861342|NCT01872611|37820976|FG000|Overall Study|Withdrawal by Subject|6|||
16861343|NCT01872611|37820977|FG001|Overall Study|Withdrawal by Subject|1|||
16861344|NCT01872611|37820976|FG000|Overall Study|Reason not provided|6|||
16861345|NCT01872611|37820977|FG001|Overall Study|Reason not provided|6|||
16861346|NCT03089853|37820987|FG000|Overall Study|Lost to Follow-up|2|||
16861347|NCT03089853|37820988|FG001|Overall Study|Lost to Follow-up|1|||
16861348|NCT03086967|37820996|FG000|Overall Study|Screen Failure|2|||
16861349|NCT03086967|37820997|FG001|Overall Study|Screen Failure|2|||
16861350|NCT01856543|37821005|FG000|Overall Study|Treatment discontinued|6|||
16861351|NCT01856543|37821006|FG001|Overall Study|Treatment discontinued|3|||
16861352|NCT01856543|37821005|FG000|Overall Study|Withdrawn before start|7|||
16861353|NCT01856543|37821006|FG001|Overall Study|Withdrawn before start|3|||
16774003|NCT02432846|37713262|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16774004|NCT02432846|37713257|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
16774005|NCT02432846|37713258|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
16774006|NCT02432846|37713259|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
16774007|NCT02432846|37713260|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
16774008|NCT02432846|37713261|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
16774009|NCT02432846|37713262|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
16774010|NCT02432846|37713257|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
16861354|NCT00632463|37821016|FG000|Overall Study|Adverse Event|0|||
16861355|NCT00632463|37821017|FG001|Overall Study|Adverse Event|1|||
16861356|NCT00632463|37821018|FG002|Overall Study|Adverse Event|0|||
16861357|NCT00632229|37821028|FG000|Overall Study|Adverse Event|6|||
16861358|NCT00632229|37821029|FG001|Overall Study|Adverse Event|0|||
16861359|NCT00632229|37821028|FG000|Overall Study|Lost to Follow-up|0|||
16861360|NCT00632229|37821029|FG001|Overall Study|Lost to Follow-up|3|||
16861361|NCT00632229|37821028|FG000|Overall Study|Lack of Efficacy|0|||
16861362|NCT00632229|37821029|FG001|Overall Study|Lack of Efficacy|2|||
16774011|NCT02432846|37713258|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
16774012|NCT02432846|37713259|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
16774013|NCT02432846|37713260|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
16774014|NCT02432846|37713261|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
16774015|NCT02432846|37713262|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
16861363|NCT00632229|37821028|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
16861364|NCT00632229|37821029|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
16861365|NCT00631137|37821037|FG000|Overall Study|Withdrawal by Subject|1|||
16861366|NCT00631137|37821038|FG001|Overall Study|Withdrawal by Subject|0|||
16861367|NCT03086343|37821046|FG000|Overall Study|Adverse Event|7|||
16861368|NCT03086343|37821047|FG001|Overall Study|Adverse Event|7|||
16861369|NCT03086343|37821046|FG000|Overall Study|Withdrawal by Subject|10|||
16861370|NCT03086343|37821047|FG001|Overall Study|Withdrawal by Subject|6|||
16861371|NCT03086343|37821046|FG000|Overall Study|Lost to Follow-up|3|||
16861372|NCT03086343|37821047|FG001|Overall Study|Lost to Follow-up|1|||
16861373|NCT03086343|37821046|FG000|Overall Study|Lack of Efficacy|4|||
16861374|NCT03086343|37821047|FG001|Overall Study|Lack of Efficacy|6|||
16861375|NCT03086343|37821046|FG000|Overall Study|Other, not specified|8|||
16861376|NCT03086343|37821047|FG001|Overall Study|Other, not specified|4|||
16861377|NCT03086343|37821046|FG000|Overall Study|Missing|0|||
16861378|NCT03086343|37821047|FG001|Overall Study|Missing|1|||
16861379|NCT00630825|37821066|FG000|Overall Study|Adverse Event|4|||
16861380|NCT00630825|37821067|FG001|Overall Study|Adverse Event|4|||
16861381|NCT00630825|37821068|FG002|Overall Study|Adverse Event|3|||
16861382|NCT00630825|37821069|FG003|Overall Study|Adverse Event|1|||
16861383|NCT00630825|37821066|FG000|Overall Study|Entry Criteria Not Met|1|||
16861384|NCT00630825|37821067|FG001|Overall Study|Entry Criteria Not Met|0|||
16861385|NCT00630825|37821068|FG002|Overall Study|Entry Criteria Not Met|2|||
16861386|NCT00630825|37821069|FG003|Overall Study|Entry Criteria Not Met|1|||
16861387|NCT00630825|37821066|FG000|Overall Study|Lost to Follow-up|1|||
16861388|NCT00630825|37821067|FG001|Overall Study|Lost to Follow-up|1|||
16861389|NCT00630825|37821068|FG002|Overall Study|Lost to Follow-up|1|||
16861390|NCT00630825|37821069|FG003|Overall Study|Lost to Follow-up|1|||
16861391|NCT00630825|37821066|FG000|Overall Study|Physician Decision|1|||
16861392|NCT00630825|37821067|FG001|Overall Study|Physician Decision|0|||
16861393|NCT00630825|37821068|FG002|Overall Study|Physician Decision|0|||
16861394|NCT00630825|37821069|FG003|Overall Study|Physician Decision|0|||
16861395|NCT00630825|37821066|FG000|Overall Study|Withdrawal by Subject|2|||
16861396|NCT00630825|37821067|FG001|Overall Study|Withdrawal by Subject|2|||
16861397|NCT00630825|37821068|FG002|Overall Study|Withdrawal by Subject|2|||
16861398|NCT00630825|37821069|FG003|Overall Study|Withdrawal by Subject|3|||
16861399|NCT03052608|37821361|FG000|Treatment Phase|Adverse Event|10|||
16861400|NCT03052608|37821362|FG001|Treatment Phase|Adverse Event|12|||
16861401|NCT03052608|37821361|FG000|Treatment Phase|Death|6|||
16861402|NCT03052608|37821362|FG001|Treatment Phase|Death|4|||
16861403|NCT03052608|37821361|FG000|Treatment Phase|Withdrawal by Subject|4|||
16861404|NCT03052608|37821362|FG001|Treatment Phase|Withdrawal by Subject|12|||
16861405|NCT03052608|37821361|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
16861406|NCT03052608|37821362|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
16861407|NCT03052608|37821361|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
16861408|NCT03052608|37821362|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
16861409|NCT03052608|37821361|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
16861410|NCT03052608|37821362|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
16861411|NCT03052608|37821361|FG000|Treatment Phase|Ongoing|103|||
16861412|NCT03052608|37821362|FG001|Treatment Phase|Ongoing|31|||
16861413|NCT03052608|37821361|FG000|Long-Term Follow-up Phase|Death|23|||
16861414|NCT03052608|37821362|FG001|Long-Term Follow-up Phase|Death|28|||
16861415|NCT03052608|37821361|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
16861416|NCT03052608|37821362|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
16861417|NCT03052608|37821361|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
16861418|NCT03052608|37821362|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
16861419|NCT03052608|37821361|FG000|Long-Term Follow-up Phase|Ongoing|122|||
16861420|NCT03052608|37821362|FG001|Long-Term Follow-up Phase|Ongoing|99|||
16861421|NCT04075734|37821401|FG000|Overall Study|Lost to Follow-up|1|||
16861422|NCT04075734|37821402|FG001|Overall Study|Lost to Follow-up|1|||
16861423|NCT04075734|37821403|FG002|Overall Study|Lost to Follow-up|0|||
16861424|NCT04075734|37821401|FG000|Overall Study|Withdrawal by Subject|3|||
16861425|NCT04075734|37821402|FG001|Overall Study|Withdrawal by Subject|0|||
16861426|NCT04075734|37821403|FG002|Overall Study|Withdrawal by Subject|0|||
16861427|NCT00989781|37821448|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
16944799|NCT01098097|38088829|FG000|Overall Study|Lost to Follow-up|18|||
16861428|NCT00989781|37821449|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
16861429|NCT00989235|37821490|FG000|Overall Study|Death|0|||
16861430|NCT00989235|37821491|FG001|Overall Study|Death|1|||
16861431|NCT00989235|37821490|FG000|Overall Study|Adverse Event|0|||
16861432|NCT00989235|37821491|FG001|Overall Study|Adverse Event|1|||
16861433|NCT00989235|37821490|FG000|Overall Study|Lack of Efficacy|1|||
16861434|NCT00989235|37821491|FG001|Overall Study|Lack of Efficacy|0|||
16861435|NCT00989235|37821490|FG000|Overall Study|Withdrawal of Consent|1|||
16861436|NCT00989235|37821491|FG001|Overall Study|Withdrawal of Consent|1|||
16861437|NCT00989235|37821490|FG000|Overall Study|Desire to Become Pregnant|1|||
16861438|NCT00989235|37821491|FG001|Overall Study|Desire to Become Pregnant|0|||
16861439|NCT00989235|37821490|FG000|Overall Study|Randomized by Mistake|0|||
16861440|NCT00989235|37821491|FG001|Overall Study|Randomized by Mistake|2|||
17028409|NCT00783692|38172780|FG003|Maintenance Phase|Adverse Event|15|||
17028410|NCT00783692|38172781|FG004|Maintenance Phase|Adverse Event|12|||
17028411|NCT00783692|38172782|FG005|Maintenance Phase|Adverse Event|9|||
17028412|NCT00783692|38172783|FG006|Maintenance Phase|Adverse Event|38|||
17028413|NCT00783692|38172777|FG000|Maintenance Phase|Protocol Violation|0|||
17028414|NCT00783692|38172778|FG001|Maintenance Phase|Protocol Violation|0|||
17028415|NCT00783692|38172779|FG002|Maintenance Phase|Protocol Violation|0|||
16861441|NCT00989235|37821490|FG000|Overall Study|Lost to Follow-up|0|||
16861442|NCT00989235|37821491|FG001|Overall Study|Lost to Follow-up|1|||
16861443|NCT00988533|37821531|FG000|Overall Study|Lost to Follow-up|3|||
16861444|NCT03633396|37821563|FG000|Overall Study|Withdrawal by Subject|4|||
16861445|NCT03633396|37821564|FG001|Overall Study|Withdrawal by Subject|4|||
16861446|NCT03633396|37821563|FG000|Overall Study|Adverse Event|1|||
16861447|NCT03633396|37821564|FG001|Overall Study|Adverse Event|1|||
16861448|NCT03633396|37821563|FG000|Overall Study|Lack of Efficacy|1|||
16861449|NCT03633396|37821564|FG001|Overall Study|Lack of Efficacy|0|||
16861450|NCT03633396|37821563|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
16861451|NCT03633396|37821564|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
16861452|NCT00988065|37821577|FG000|Overall Study|Adverse Event|4|||
16861453|NCT00988065|37821578|FG001|Overall Study|Adverse Event|10|||
16861454|NCT00988065|37821579|FG002|Overall Study|Adverse Event|2|||
16861455|NCT00988065|37821577|FG000|Overall Study|Lost to Follow-up|1|||
16861456|NCT00988065|37821578|FG001|Overall Study|Lost to Follow-up|2|||
16861457|NCT00988065|37821579|FG002|Overall Study|Lost to Follow-up|2|||
16861458|NCT00988065|37821577|FG000|Overall Study|Subject withdrew consent|3|||
16861459|NCT00988065|37821578|FG001|Overall Study|Subject withdrew consent|5|||
16861460|NCT00988065|37821579|FG002|Overall Study|Subject withdrew consent|2|||
16861461|NCT00988065|37821577|FG000|Overall Study|Noncompliance with protocol|5|||
16861462|NCT00988065|37821578|FG001|Overall Study|Noncompliance with protocol|6|||
16861463|NCT00988065|37821579|FG002|Overall Study|Noncompliance with protocol|9|||
16861464|NCT00987831|37821603|FG000|Overall Study|Never flared in 12 months|1|||
16861465|NCT00987831|37821604|FG001|Overall Study|Never flared in 12 months|0|||
16861466|NCT00987831|37821605|FG002|Overall Study|Never flared in 12 months|0|||
16861467|NCT00987831|37821603|FG000|Overall Study|Lost to Follow-up|0|||
16861468|NCT00987831|37821604|FG001|Overall Study|Lost to Follow-up|3|||
16861469|NCT00987831|37821605|FG002|Overall Study|Lost to Follow-up|0|||
16861470|NCT00986973|37821636|FG000|Overall Study|Withdrawn by study team|1|||
16861471|NCT00986427|37821643|FG000|Overall Study|Lost to Follow-up|2|||
16861472|NCT00986427|37821644|FG001|Overall Study|Lost to Follow-up|0|||
16861473|NCT00986427|37821643|FG000|Overall Study|Lack of Efficacy|1|||
16861474|NCT00986427|37821644|FG001|Overall Study|Lack of Efficacy|0|||
16861475|NCT00986427|37821643|FG000|Overall Study|Withdrawal by Subject|1|||
16861476|NCT00986427|37821644|FG001|Overall Study|Withdrawal by Subject|0|||
16861477|NCT00986349|37821654|FG000|Overall Study|Unsuccessful implant procedure|3|||
16861478|NCT00986349|37821654|FG000|Overall Study|Adverse Event|2|||
16861479|NCT00986349|37821654|FG000|Overall Study|Physician Decision|1|||
16861480|NCT00986349|37821654|FG000|Overall Study|device migration|1|||
16861481|NCT00985959|37821677|FG000|Overall Study|Adverse Event|0|||
16861482|NCT00985959|37821678|FG001|Overall Study|Adverse Event|0|||
16861483|NCT00985959|37821679|FG002|Overall Study|Adverse Event|19|||
16861484|NCT00985959|37821677|FG000|Overall Study|Withdrawal by Subject|0|||
16861485|NCT00985959|37821678|FG001|Overall Study|Withdrawal by Subject|0|||
16861486|NCT00985959|37821679|FG002|Overall Study|Withdrawal by Subject|8|||
16861487|NCT00985959|37821677|FG000|Overall Study|Progressive disease|1|||
16861488|NCT00985959|37821678|FG001|Overall Study|Progressive disease|2|||
16861489|NCT00985959|37821679|FG002|Overall Study|Progressive disease|8|||
16861490|NCT00985959|37821677|FG000|Overall Study|Unrecovered toxicity|0|||
16861491|NCT00985959|37821678|FG001|Overall Study|Unrecovered toxicity|0|||
16861492|NCT00985959|37821679|FG002|Overall Study|Unrecovered toxicity|7|||
16861493|NCT00985959|37821677|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
16861494|NCT00985959|37821678|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
16861495|NCT00985959|37821679|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
16861496|NCT00985959|37821677|FG000|Overall Study|Complete response observed over 2 cycles|0|||
16861497|NCT00985959|37821678|FG001|Overall Study|Complete response observed over 2 cycles|1|||
16861498|NCT00985959|37821679|FG002|Overall Study|Complete response observed over 2 cycles|4|||
16861499|NCT00985959|37821677|FG000|Overall Study|Other|0|||
16944800|NCT01098097|38088829|FG000|Overall Study|Status unknown|16|||
17028416|NCT00783692|38172780|FG003|Maintenance Phase|Protocol Violation|1|||
16861500|NCT00985959|37821678|FG001|Overall Study|Other|0|||
16861501|NCT00985959|37821679|FG002|Overall Study|Other|11|||
16861502|NCT00985725|37821695|FG000|Overall Study|Adverse Event|4|||
16861503|NCT00985725|37821696|FG001|Overall Study|Adverse Event|1|||
16861504|NCT00985725|37821695|FG000|Overall Study|Protocol Violation|1|||
16861505|NCT00985725|37821696|FG001|Overall Study|Protocol Violation|3|||
16861506|NCT00985725|37821695|FG000|Overall Study|Withdrawal by Subject|4|||
16861507|NCT00985725|37821696|FG001|Overall Study|Withdrawal by Subject|4|||
16861508|NCT00985725|37821695|FG000|Overall Study|Lost to Follow-up|1|||
16861509|NCT00985725|37821696|FG001|Overall Study|Lost to Follow-up|1|||
16861510|NCT00985725|37821695|FG000|Overall Study|Lack of Efficacy|0|||
16861511|NCT00985725|37821696|FG001|Overall Study|Lack of Efficacy|1|||
16861512|NCT00985725|37821695|FG000|Overall Study|Non-compliance|1|||
16861513|NCT00985725|37821696|FG001|Overall Study|Non-compliance|2|||
16861514|NCT00985725|37821695|FG000|Overall Study|Out-of-window visits|0|||
16861515|NCT00985725|37821696|FG001|Overall Study|Out-of-window visits|1|||
16861516|NCT00985491|37821711|FG000|Overall Study|Adverse Event|8|||
16861517|NCT00985491|37821711|FG000|Overall Study|device migration|7|||
16861518|NCT00985491|37821711|FG000|Overall Study|Withdrawal by Subject|1|||
16861519|NCT00985491|37821711|FG000|Overall Study|implant failure|3|||
16861520|NCT00984867|37821746|FG000|Overall Study|Adverse Event|3|||
16861521|NCT00984867|37821747|FG001|Overall Study|Adverse Event|7|||
16861522|NCT00984867|37821746|FG000|Overall Study|Death|1|||
16861523|NCT00984867|37821747|FG001|Overall Study|Death|0|||
16861524|NCT00984867|37821746|FG000|Overall Study|Withdrawal by Subject|13|||
16861525|NCT00984867|37821747|FG001|Overall Study|Withdrawal by Subject|4|||
16861526|NCT00984867|37821746|FG000|Overall Study|Lost to Follow-up|3|||
16861527|NCT00984867|37821747|FG001|Overall Study|Lost to Follow-up|4|||
16861528|NCT00984867|37821746|FG000|Overall Study|Poor/non-compliance|0|||
16861529|NCT00984867|37821747|FG001|Overall Study|Poor/non-compliance|1|||
16861530|NCT00984867|37821746|FG000|Overall Study|Subject no longer meets study criteria|1|||
16861531|NCT00984867|37821747|FG001|Overall Study|Subject no longer meets study criteria|1|||
16861532|NCT00984867|37821746|FG000|Overall Study|site closing|1|||
16861533|NCT00984867|37821747|FG001|Overall Study|site closing|0|||
16861534|NCT00984867|37821746|FG000|Overall Study|lack of efficacy and subject compliance|1|||
16861535|NCT00984867|37821747|FG001|Overall Study|lack of efficacy and subject compliance|0|||
16861536|NCT00984009|37821787|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
16861537|NCT00983931|37821794|FG000|14 Day Washout Period|Physician Decision|1|||
16861538|NCT00983853|37821806|FG000|Overall Study|Lost to Follow-up|1|||
16861539|NCT00983853|37821807|FG001|Overall Study|Lost to Follow-up|1|||
16861540|NCT00983853|37821808|FG002|Overall Study|Lost to Follow-up|2|||
16861541|NCT00983853|37821809|FG003|Overall Study|Lost to Follow-up|2|||
16861542|NCT00983853|37821810|FG004|Overall Study|Lost to Follow-up|2|||
16861543|NCT00983853|37821811|FG005|Overall Study|Lost to Follow-up|1|||
16861544|NCT00983853|37821806|FG000|Overall Study|Withdrawal by Subject|0|||
16861545|NCT00983853|37821807|FG001|Overall Study|Withdrawal by Subject|0|||
16861546|NCT00983853|37821808|FG002|Overall Study|Withdrawal by Subject|1|||
16861547|NCT00983853|37821809|FG003|Overall Study|Withdrawal by Subject|0|||
16861548|NCT00983853|37821810|FG004|Overall Study|Withdrawal by Subject|1|||
16861549|NCT00983853|37821811|FG005|Overall Study|Withdrawal by Subject|0|||
16861550|NCT00983853|37821806|FG000|Overall Study|Unable to come to study follow-up visits|0|||
16861551|NCT00983853|37821807|FG001|Overall Study|Unable to come to study follow-up visits|1|||
16861552|NCT00983853|37821808|FG002|Overall Study|Unable to come to study follow-up visits|0|||
16861553|NCT00983853|37821809|FG003|Overall Study|Unable to come to study follow-up visits|0|||
16861554|NCT00983853|37821810|FG004|Overall Study|Unable to come to study follow-up visits|0|||
16861555|NCT00983853|37821811|FG005|Overall Study|Unable to come to study follow-up visits|0|||
16861556|NCT00983073|37821827|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
16861557|NCT00983073|37821827|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
16861558|NCT00983073|37821827|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
16861559|NCT00983073|37821827|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
16861560|NCT00983073|37821827|FG000|Titration and Optimal Dose Period|Other reason|4|||
16861561|NCT00983073|37821827|FG000|Maintenance Period|Adverse Event|5|||
16861562|NCT00983073|37821827|FG000|Maintenance Period|Withdrawal by Subject|2|||
16861563|NCT00983073|37821827|FG000|Maintenance Period|Lack of Efficacy|2|||
16861564|NCT00983073|37821827|FG000|Maintenance Period|Other Reason|7|||
16861565|NCT00982137|37821836|FG000|Overall Study|Lost to Follow-up|0|||
16861566|NCT00982137|37821837|FG001|Overall Study|Lost to Follow-up|0|||
16861567|NCT00982137|37821838|FG002|Overall Study|Lost to Follow-up|0|||
16861568|NCT00982137|37821839|FG003|Overall Study|Lost to Follow-up|1|||
16861569|NCT00982137|37821836|FG000|Overall Study|Withdrawal by Subject|0|||
16861570|NCT00982137|37821837|FG001|Overall Study|Withdrawal by Subject|1|||
16861571|NCT00982137|37821838|FG002|Overall Study|Withdrawal by Subject|0|||
16861572|NCT00982137|37821839|FG003|Overall Study|Withdrawal by Subject|0|||
16861573|NCT00981747|37821856|FG000|Losartan|Withdrawal by Subject|1|||
16861574|NCT00981747|37821856|FG000|Losartan|Death|1|||
16861575|NCT00981747|37821856|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
16861576|NCT01856309|37822011|FG000|Overall Study|Death|4|||
16861577|NCT01856309|37822012|FG001|Overall Study|Death|6|||
16861578|NCT01856309|37822013|FG002|Overall Study|Death|11|||
16861579|NCT01856309|37822014|FG003|Overall Study|Death|6|||
16861580|NCT01856309|37822011|FG000|Overall Study|Lost to Follow-up|6|||
16861581|NCT01856309|37822012|FG001|Overall Study|Lost to Follow-up|2|||
16861582|NCT01856309|37822013|FG002|Overall Study|Lost to Follow-up|4|||
16861583|NCT01856309|37822014|FG003|Overall Study|Lost to Follow-up|8|||
16861584|NCT01856309|37822011|FG000|Overall Study|Withdrawal by Subject|11|||
16861585|NCT01856309|37822012|FG001|Overall Study|Withdrawal by Subject|13|||
16861586|NCT01856309|37822013|FG002|Overall Study|Withdrawal by Subject|28|||
16861587|NCT01856309|37822014|FG003|Overall Study|Withdrawal by Subject|26|||
16861588|NCT01856309|37822011|FG000|Overall Study|Other|227|||
16861589|NCT01856309|37822012|FG001|Overall Study|Other|225|||
16861590|NCT01856309|37822013|FG002|Overall Study|Other|447|||
16861591|NCT01856309|37822014|FG003|Overall Study|Other|469|||
16861592|NCT01856309|37822011|FG000|Overall Study|Lack of Efficacy|14|||
16861593|NCT01856309|37822012|FG001|Overall Study|Lack of Efficacy|9|||
16861594|NCT01856309|37822013|FG002|Overall Study|Lack of Efficacy|40|||
16861595|NCT01856309|37822014|FG003|Overall Study|Lack of Efficacy|25|||
16861596|NCT01856309|37822011|FG000|Overall Study|Adverse Event|31|||
16861597|NCT01856309|37822012|FG001|Overall Study|Adverse Event|31|||
16861598|NCT01856309|37822013|FG002|Overall Study|Adverse Event|55|||
16861599|NCT01856309|37822014|FG003|Overall Study|Adverse Event|65|||
16861600|NCT01856309|37822011|FG000|Overall Study|Pregnancy|0|||
16861601|NCT01856309|37822012|FG001|Overall Study|Pregnancy|0|||
16861602|NCT01856309|37822013|FG002|Overall Study|Pregnancy|0|||
16861603|NCT01856309|37822014|FG003|Overall Study|Pregnancy|1|||
16861604|NCT01856309|37822011|FG000|Overall Study|Physician Decision|6|||
16861605|NCT01856309|37822012|FG001|Overall Study|Physician Decision|1|||
16861606|NCT01856309|37822013|FG002|Overall Study|Physician Decision|6|||
16861607|NCT01856309|37822014|FG003|Overall Study|Physician Decision|8|||
16861608|NCT01856309|37822011|FG000|Overall Study|Noncompliance With Study Drug|0|||
16861609|NCT01856309|37822012|FG001|Overall Study|Noncompliance With Study Drug|1|||
16861610|NCT01856309|37822013|FG002|Overall Study|Noncompliance With Study Drug|4|||
16861611|NCT01856309|37822014|FG003|Overall Study|Noncompliance With Study Drug|1|||
16861612|NCT01855919|37822212|FG000|Overall Study|Adverse Event|16|||
16861613|NCT01855919|37822213|FG001|Overall Study|Adverse Event|8|||
16861614|NCT01855919|37822212|FG000|Overall Study|Lack of Efficacy|1|||
16861615|NCT01855919|37822213|FG001|Overall Study|Lack of Efficacy|3|||
16861616|NCT01855919|37822212|FG000|Overall Study|Withdrawal by Subject|4|||
16861617|NCT01855919|37822213|FG001|Overall Study|Withdrawal by Subject|10|||
16861618|NCT01855919|37822212|FG000|Overall Study|Entry Criteria Not Met|1|||
16861619|NCT01855919|37822213|FG001|Overall Study|Entry Criteria Not Met|1|||
16861620|NCT01855919|37822212|FG000|Overall Study|Protocol Violation|1|||
16861621|NCT01855919|37822213|FG001|Overall Study|Protocol Violation|4|||
16861622|NCT01871519|37822229|FG000|Overall Study|Death|26|||
16861623|NCT01871519|37822229|FG000|Overall Study|Lost to Follow-up|15|||
16861624|NCT01871519|37822229|FG000|Overall Study|Withdrawal by Subject|49|||
16861625|NCT01871285|37822236|FG000|First Intervention (1 Day)|Adverse Event|1|||
16861626|NCT01871285|37822237|FG001|First Intervention (1 Day)|Adverse Event|0|||
16861627|NCT01871285|37822238|FG002|First Intervention (1 Day)|Adverse Event|0|||
16861628|NCT01871285|37822239|FG003|First Intervention (1 Day)|Adverse Event|0|||
16861629|NCT01871285|37822236|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
16861630|NCT01871285|37822237|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
16861631|NCT01871285|37822238|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
16861632|NCT01871285|37822239|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
16861633|NCT01870973|37822265|FG000|Overall Study|Lost to Follow-up|10|||
16861634|NCT01870973|37822266|FG001|Overall Study|Lost to Follow-up|3|||
16861635|NCT01854827|37822285|FG000|Overall Study|Death|1|||
16861636|NCT01854047|37822428|FG000|Overall Study|Lack of Efficacy|1|||
16861637|NCT01854047|37822429|FG001|Overall Study|Lack of Efficacy|0|||
16861638|NCT01854047|37822430|FG002|Overall Study|Lack of Efficacy|0|||
16861639|NCT01854047|37822431|FG003|Overall Study|Lack of Efficacy|0|||
16861640|NCT01854047|37822432|FG004|Overall Study|Lack of Efficacy|0|||
16861641|NCT01854047|37822428|FG000|Overall Study|Poor compliance to protocol|3|||
16861642|NCT01854047|37822429|FG001|Overall Study|Poor compliance to protocol|0|||
16861643|NCT01854047|37822430|FG002|Overall Study|Poor compliance to protocol|2|||
16861644|NCT01854047|37822431|FG003|Overall Study|Poor compliance to protocol|0|||
16861645|NCT01854047|37822432|FG004|Overall Study|Poor compliance to protocol|0|||
16861646|NCT01854047|37822428|FG000|Overall Study|Adverse Event|5|||
16861647|NCT01854047|37822429|FG001|Overall Study|Adverse Event|4|||
16861648|NCT01854047|37822430|FG002|Overall Study|Adverse Event|6|||
16861649|NCT01854047|37822431|FG003|Overall Study|Adverse Event|10|||
16861650|NCT01854047|37822432|FG004|Overall Study|Adverse Event|7|||
16861651|NCT01854047|37822428|FG000|Overall Study|Randomized but not treated|0|||
16861652|NCT01854047|37822429|FG001|Overall Study|Randomized but not treated|1|||
16861653|NCT01854047|37822430|FG002|Overall Study|Randomized but not treated|2|||
16861654|NCT01854047|37822431|FG003|Overall Study|Randomized but not treated|0|||
16861655|NCT01854047|37822432|FG004|Overall Study|Randomized but not treated|4|||
16861656|NCT01854047|37822428|FG000|Overall Study|Other than specified above|3|||
16861657|NCT01854047|37822429|FG001|Overall Study|Other than specified above|3|||
16861658|NCT01854047|37822430|FG002|Overall Study|Other than specified above|3|||
16861659|NCT01854047|37822431|FG003|Overall Study|Other than specified above|5|||
16861660|NCT01854047|37822432|FG004|Overall Study|Other than specified above|8|||
16861661|NCT01870739|37822482|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
16861662|NCT01870739|37822483|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
16861663|NCT01870739|37822482|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
16861664|NCT01870739|37822483|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
16861665|NCT01870739|37822482|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
16861666|NCT01870739|37822483|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
16861667|NCT01870739|37822482|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
16861668|NCT01870739|37822483|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
16861669|NCT01870739|37822482|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
16861670|NCT01870739|37822483|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
16861671|NCT01870739|37822482|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
16861672|NCT01870739|37822483|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
16861673|NCT01870739|37822482|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
16861674|NCT01870739|37822483|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
16861675|NCT01613417|37822521|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
16861676|NCT01613417|37822522|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
16861677|NCT01870583|37822550|FG000|Overall Study|Protocol Violation|0|||
16861678|NCT01870583|37822551|FG001|Overall Study|Protocol Violation|5|||
16861679|NCT01870583|37822552|FG002|Overall Study|Protocol Violation|3|||
16861680|NCT01870583|37822550|FG000|Overall Study|Lost to Follow-up|11|||
16861681|NCT01870583|37822551|FG001|Overall Study|Lost to Follow-up|13|||
16861682|NCT01870583|37822552|FG002|Overall Study|Lost to Follow-up|5|||
16861683|NCT01869959|37822610|FG000|Randomization Period|Physician Decision|0|||
16861684|NCT01869959|37822611|FG001|Randomization Period|Physician Decision|0|||
16861685|NCT01869959|37822612|FG002|Randomization Period|Physician Decision|0|||
16861686|NCT01869959|37822613|FG003|Randomization Period|Physician Decision|0|||
16861687|NCT01869959|37822614|FG004|Randomization Period|Physician Decision|1|||
16861688|NCT01869959|37822610|FG000|Treatment Period|Adverse Event|1|||
16861689|NCT01869959|37822611|FG001|Treatment Period|Adverse Event|0|||
16861690|NCT01869959|37822612|FG002|Treatment Period|Adverse Event|3|||
16861691|NCT01869959|37822613|FG003|Treatment Period|Adverse Event|1|||
16861692|NCT01869959|37822614|FG004|Treatment Period|Adverse Event|0|||
16861693|NCT01869959|37822610|FG000|Treatment Period|Sponsor decision|0|||
16861694|NCT01869959|37822611|FG001|Treatment Period|Sponsor decision|1|||
16861695|NCT01869959|37822612|FG002|Treatment Period|Sponsor decision|0|||
16861696|NCT01869959|37822613|FG003|Treatment Period|Sponsor decision|1|||
16861697|NCT01869959|37822614|FG004|Treatment Period|Sponsor decision|0|||
16861698|NCT01869959|37822610|FG000|Treatment Period|Withdrawal by Subject|0|||
16861699|NCT01869959|37822611|FG001|Treatment Period|Withdrawal by Subject|1|||
16861700|NCT01869959|37822612|FG002|Treatment Period|Withdrawal by Subject|0|||
16861701|NCT01869959|37822613|FG003|Treatment Period|Withdrawal by Subject|0|||
16861702|NCT01869959|37822614|FG004|Treatment Period|Withdrawal by Subject|0|||
16861703|NCT01613027|37822675|FG000|Overall Study|Lost to Follow-up|5|||
16861704|NCT01613027|37822675|FG000|Overall Study|Switched Physician|1|||
16861705|NCT01613027|37822675|FG000|Overall Study|Lack of Efficacy|1|||
16861706|NCT01613027|37822675|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
16861707|NCT01869725|37822693|FG000|Overall Study|ineligible after registration|1|||
16861708|NCT01869725|37822693|FG000|Overall Study|Death|1|||
16861709|NCT01869725|37822693|FG000|Overall Study|Lost to Follow-up|2|||
16861710|NCT01851863|37822714|FG000|Overall Study|Did not receive study medication|2|||
16861711|NCT01851863|37822715|FG001|Overall Study|Did not receive study medication|5|||
16861712|NCT01851863|37822716|FG002|Overall Study|Did not receive study medication|3|||
16861713|NCT01851863|37822717|FG003|Overall Study|Did not receive study medication|0|||
16861714|NCT01851863|37822714|FG000|Overall Study|Lost to Follow-up|3|||
16861715|NCT01851863|37822715|FG001|Overall Study|Lost to Follow-up|4|||
16861716|NCT01851863|37822716|FG002|Overall Study|Lost to Follow-up|2|||
16861717|NCT01851863|37822717|FG003|Overall Study|Lost to Follow-up|3|||
16861718|NCT01850615|37822745|FG000|Overall Study|Protocol Violation|4|||
16861719|NCT01850615|37822746|FG001|Overall Study|Protocol Violation|1|||
16861720|NCT01850615|37822745|FG000|Overall Study|Adverse Event|2|||
16861721|NCT01850615|37822746|FG001|Overall Study|Adverse Event|1|||
16861722|NCT01850615|37822745|FG000|Overall Study|Withdrawal by Subject|3|||
16861723|NCT01850615|37822746|FG001|Overall Study|Withdrawal by Subject|1|||
16861724|NCT01850615|37822745|FG000|Overall Study|Lost to Follow-up|0|||
16861725|NCT01850615|37822746|FG001|Overall Study|Lost to Follow-up|1|||
16861726|NCT01850615|37822745|FG000|Overall Study|Unclassified|0|||
16861727|NCT01850615|37822746|FG001|Overall Study|Unclassified|1|||
16861728|NCT01868477|37822831|FG000|Overall Study|Adverse Event|2|||
16861729|NCT01868477|37822832|FG001|Overall Study|Adverse Event|4|||
16861730|NCT01868477|37822831|FG000|Overall Study|Disease progression|1|||
16861731|NCT01868477|37822832|FG001|Overall Study|Disease progression|1|||
16861732|NCT01868477|37822831|FG000|Overall Study|Withdrawal by Subject|1|||
16861733|NCT01868477|37822832|FG001|Overall Study|Withdrawal by Subject|0|||
16861734|NCT01849289|37822847|FG000|Overall Study|Adverse Event|3|||
16861735|NCT01849289|37822848|FG001|Overall Study|Adverse Event|3|||
16861736|NCT01849289|37822847|FG000|Overall Study|Protocol Violation|3|||
16861737|NCT01849289|37822848|FG001|Overall Study|Protocol Violation|3|||
16861738|NCT01849289|37822847|FG000|Overall Study|Withdrawal criteria|1|||
16861739|NCT01849289|37822848|FG001|Overall Study|Withdrawal criteria|0|||
16861740|NCT01849289|37822847|FG000|Overall Study|Unclassified|25|||
16861741|NCT01849289|37822848|FG001|Overall Study|Unclassified|18|||
16861742|NCT01868243|37822856|FG000|Overall Study|Death|0|||
16861743|NCT01868243|37822857|FG001|Overall Study|Death|1|||
16861744|NCT01611935|37822865|FG000|Overall Study|Family Declined Participation|1|||
16861745|NCT01611935|37822866|FG001|Overall Study|Family Declined Participation|0|||
16861746|NCT01868165|37822872|FG000|Overall Study|Withdrawal by Subject|36|||
16861747|NCT01868165|37822872|FG000|Overall Study|Physician Decision|2|||
16861748|NCT01868165|37822872|FG000|Overall Study|Lost to Follow-up|3|||
16861749|NCT01868165|37822872|FG000|Overall Study|Death|4|||
16861750|NCT01868009|37822911|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
16861751|NCT01868009|37822912|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
16861752|NCT01868009|37822911|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
16861753|NCT01868009|37822912|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
16861754|NCT01868009|37822911|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
16861755|NCT01868009|37822912|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
16861756|NCT01849055|37822966|FG000|Overall Study|Withdrawal by Subject|0|||
16861757|NCT01849055|37822967|FG001|Overall Study|Withdrawal by Subject|0|||
16861758|NCT01849055|37822968|FG002|Overall Study|Withdrawal by Subject|1|||
16861759|NCT01849055|37822969|FG003|Overall Study|Withdrawal by Subject|0|||
16861760|NCT01849055|37822970|FG004|Overall Study|Withdrawal by Subject|0|||
16861761|NCT01849055|37822971|FG005|Overall Study|Withdrawal by Subject|0|||
16861762|NCT01848353|37822997|FG000|Phase 1|Withdrawal by Subject|3|||
16861763|NCT01848353|37822998|FG001|Phase 1|Withdrawal by Subject|1|||
16861764|NCT01848353|37822999|FG002|Phase 1|Withdrawal by Subject|0|||
16861765|NCT01848353|37823000|FG003|Phase 1|Withdrawal by Subject|0|||
16861766|NCT01848353|37822997|FG000|Phase 2|Withdrawal by Subject|3|||
16861767|NCT01848353|37822998|FG001|Phase 2|Withdrawal by Subject|2|||
16861768|NCT01848353|37822999|FG002|Phase 2|Withdrawal by Subject|0|||
16861769|NCT01848353|37823000|FG003|Phase 2|Withdrawal by Subject|0|||
16861770|NCT01848353|37822997|FG000|Phase 3|Withdrawal by Subject|1|||
16861771|NCT01848353|37822998|FG001|Phase 3|Withdrawal by Subject|1|||
16861772|NCT01848353|37822999|FG002|Phase 3|Withdrawal by Subject|0|||
16861773|NCT01848353|37823000|FG003|Phase 3|Withdrawal by Subject|0|||
16861774|NCT02372136|37823029|FG000|Overall Study|Death|3|||
16861775|NCT02372136|37823030|FG001|Overall Study|Death|1|||
16861776|NCT01847885|37823040|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
16861777|NCT01847885|37823041|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
16861778|NCT01847885|37823042|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
16861779|NCT01847885|37823040|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
16861780|NCT01847885|37823041|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
16861781|NCT01847885|37823042|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
16861782|NCT01847885|37823040|FG000|Initial Enrollment (Consented)|Screen failure|39|||
16861783|NCT01847885|37823041|FG001|Initial Enrollment (Consented)|Screen failure|0|||
16861784|NCT01847885|37823042|FG002|Initial Enrollment (Consented)|Screen failure|0|||
16861785|NCT01847885|37823040|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
16861786|NCT01847885|37823041|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
16861787|NCT01847885|37823042|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
16861788|NCT01847885|37823040|FG000|Randomization|Protocol Violation|0|||
16861789|NCT01847885|37823041|FG001|Randomization|Protocol Violation|1|||
16861790|NCT01847885|37823042|FG002|Randomization|Protocol Violation|0|||
16861791|NCT01847885|37823040|FG000|Randomization|Withdrawal by Subject|0|||
16861792|NCT01847885|37823041|FG001|Randomization|Withdrawal by Subject|0|||
16861793|NCT01847885|37823042|FG002|Randomization|Withdrawal by Subject|2|||
16861794|NCT01847885|37823040|FG000|Randomization|Screen Failure|0|||
16861795|NCT01847885|37823041|FG001|Randomization|Screen Failure|3|||
16861796|NCT01847885|37823042|FG002|Randomization|Screen Failure|0|||
16861797|NCT01867307|37823080|FG000|Overall Study|Protocol Violation|2|||
16861798|NCT01867307|37823081|FG001|Overall Study|Protocol Violation|0|||
16861799|NCT01867307|37823080|FG000|Overall Study|Other Adverse Event|1|||
16861800|NCT01867307|37823081|FG001|Overall Study|Other Adverse Event|3|||
16861801|NCT01845077|37823090|FG000|Washout Period|Lost to Follow-up|0|||
16861802|NCT01845077|37823091|FG001|Washout Period|Lost to Follow-up|1|||
16861803|NCT01845077|37823092|FG002|Washout Period|Lost to Follow-up|0|||
16861804|NCT01845077|37823093|FG003|Washout Period|Lost to Follow-up|1|||
16861805|NCT01845077|37823094|FG004|Washout Period|Lost to Follow-up|0|||
16861806|NCT01845077|37823095|FG005|Washout Period|Lost to Follow-up|1|||
16861807|NCT01845077|37823090|FG000|Washout Period|Adverse Event|1|||
16861808|NCT01845077|37823091|FG001|Washout Period|Adverse Event|0|||
16861809|NCT01845077|37823092|FG002|Washout Period|Adverse Event|0|||
16861810|NCT01845077|37823093|FG003|Washout Period|Adverse Event|0|||
16861811|NCT01845077|37823094|FG004|Washout Period|Adverse Event|0|||
16861812|NCT01845077|37823095|FG005|Washout Period|Adverse Event|0|||
16861813|NCT01845077|37823090|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
16861814|NCT01845077|37823091|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
16861815|NCT01845077|37823092|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
16861816|NCT01845077|37823093|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
16861817|NCT01845077|37823094|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
16861818|NCT01845077|37823095|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
16861819|NCT01845077|37823090|FG000|Washout Period|Protocol Violation|0|||
16861820|NCT01845077|37823091|FG001|Washout Period|Protocol Violation|0|||
16861821|NCT01845077|37823092|FG002|Washout Period|Protocol Violation|0|||
16861822|NCT01845077|37823093|FG003|Washout Period|Protocol Violation|1|||
16861823|NCT01845077|37823094|FG004|Washout Period|Protocol Violation|1|||
16861824|NCT01845077|37823095|FG005|Washout Period|Protocol Violation|0|||
16861825|NCT01866917|37823112|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
16861826|NCT01866917|37823113|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
16861827|NCT01844765|37823248|FG000|Overall Study|Adverse Event|6|||
16861828|NCT01844765|37823249|FG001|Overall Study|Adverse Event|8|||
16861829|NCT01844765|37823248|FG000|Overall Study|Withdrawal by Subject|2|||
16861830|NCT01844765|37823249|FG001|Overall Study|Withdrawal by Subject|3|||
16861831|NCT01844765|37823248|FG000|Overall Study|Disease progression|1|||
16861832|NCT01844765|37823249|FG001|Overall Study|Disease progression|0|||
16861833|NCT01844765|37823248|FG000|Overall Study|Administrative problems|3|||
16861834|NCT01844765|37823249|FG001|Overall Study|Administrative problems|4|||
16861835|NCT01844765|37823248|FG000|Overall Study|Protocol deviation|2|||
16861836|NCT01844765|37823249|FG001|Overall Study|Protocol deviation|0|||
16861837|NCT01844765|37823248|FG000|Overall Study|Untreated|1|||
16861838|NCT01844765|37823249|FG001|Overall Study|Untreated|0|||
16861839|NCT01866293|37823264|FG000|Overall Study|Adverse Event|2|||
16861840|NCT01844687|37823268|FG000|Visit 1|Protocol Violation|3|||
16861841|NCT01844687|37823268|FG000|Visit 1|Lost to Follow-up|5|||
16861842|NCT01844687|37823268|FG000|Visit 2|Withdrawal by Subject|1|||
16861843|NCT01844687|37823268|FG000|Visit 2|Protocol Violation|1|||
16861844|NCT01844687|37823268|FG000|Visit 3|Lost to Follow-up|1|||
16861845|NCT01844687|37823268|FG000|Visit 3|Withdrawal by Subject|3|||
16861846|NCT01844687|37823268|FG000|Visit 3|child care problems|1|||
16861847|NCT01844687|37823268|FG000|Visit 4|Pregnancy|1|||
16861848|NCT01844687|37823268|FG000|Visit 4|Lost to Follow-up|1|||
16861849|NCT01844687|37823268|FG000|Visit 4|Withdrawal by Subject|2|||
16861850|NCT01844531|37823294|FG000|Overall Study|Withdrawal by Subject|0|||
16861851|NCT01844531|37823295|FG001|Overall Study|Withdrawal by Subject|1|||
16861852|NCT01844531|37823296|FG002|Overall Study|Withdrawal by Subject|0|||
16861853|NCT01844531|37823297|FG003|Overall Study|Withdrawal by Subject|0|||
16861854|NCT01844375|37823309|FG000|Overall Study|Protocol Violation|1|||
16861855|NCT01844375|37823310|FG001|Overall Study|Protocol Violation|1|||
16861856|NCT02367456|37823319|FG000|Overall Study|Death|8|||
16861857|NCT02367456|37823320|FG001|Overall Study|Death|21|||
16861858|NCT02367456|37823321|FG002|Overall Study|Death|14|||
16861859|NCT02367456|37823319|FG000|Overall Study|Lost to Follow-up|1|||
16861860|NCT02367456|37823320|FG001|Overall Study|Lost to Follow-up|3|||
16861861|NCT02367456|37823321|FG002|Overall Study|Lost to Follow-up|1|||
16861862|NCT02367456|37823319|FG000|Overall Study|Ongoing|0|||
16861863|NCT02367456|37823320|FG001|Overall Study|Ongoing|6|||
16861864|NCT02367456|37823321|FG002|Overall Study|Ongoing|15|||
16861865|NCT02367456|37823319|FG000|Overall Study|Other reason|3|||
16861866|NCT02367456|37823320|FG001|Overall Study|Other reason|0|||
16861867|NCT02367456|37823321|FG002|Overall Study|Other reason|0|||
16861868|NCT01865747|37823352|FG000|Overall Study (ITT)|Adverse Event|32|||
16861869|NCT01865747|37823353|FG001|Overall Study (ITT)|Adverse Event|31|||
16861870|NCT01865747|37823352|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
16861871|NCT01865747|37823353|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
16861872|NCT01865747|37823352|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
16861873|NCT01865747|37823353|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
17028417|NCT00783692|38172781|FG004|Maintenance Phase|Protocol Violation|2|||
17028418|NCT00783692|38172782|FG005|Maintenance Phase|Protocol Violation|3|||
17028419|NCT00783692|38172783|FG006|Maintenance Phase|Protocol Violation|4|||
17028420|NCT00783692|38172777|FG000|Maintenance Phase|Lack of Efficacy|79|||
16861874|NCT01865747|37823352|FG000|Overall Study (ITT)|Protocol Violation|1|||
16861875|NCT01865747|37823353|FG001|Overall Study (ITT)|Protocol Violation|1|||
16861876|NCT01865747|37823352|FG000|Overall Study (ITT)|Physician Decision|5|||
16861877|NCT01865747|37823353|FG001|Overall Study (ITT)|Physician Decision|2|||
16861878|NCT01865747|37823352|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
16861879|NCT01865747|37823353|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
16861880|NCT01865747|37823352|FG000|Overall Study (ITT)|Sponsor Decision|0|||
16861881|NCT01865747|37823353|FG001|Overall Study (ITT)|Sponsor Decision|1|||
16861882|NCT01865747|37823352|FG000|Overall Study (ITT)|Progressive Disease|122|||
16861883|NCT01865747|37823353|FG001|Overall Study (ITT)|Progressive Disease|158|||
16861884|NCT01865747|37823352|FG000|Overall Study (ITT)|Reason Not Provided|0|||
16861885|NCT01865747|37823353|FG001|Overall Study (ITT)|Reason Not Provided|1|||
16861886|NCT01865747|37823352|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
16861887|NCT01865747|37823353|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
16861888|NCT01865747|37823352|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
16861889|NCT01865747|37823353|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
16861890|NCT01865747|37823352|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
16861891|NCT01865747|37823353|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
16861892|NCT01865747|37823352|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
16861893|NCT01865747|37823353|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
16861894|NCT01865747|37823352|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
16861895|NCT01865747|37823353|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
16861896|NCT01865747|37823352|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
16861897|NCT01865747|37823353|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
16861898|NCT01865747|37823352|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
16944801|NCT01098097|38088829|FG000|Overall Study|No reason reported|31|||
16944802|NCT01097863|38088836|FG000|Overall Study|Discomfort|1|||
16861899|NCT01865747|37823353|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
16861900|NCT01865747|37823352|FG000|Primary Intent to Treat (PITT)|Other|0|||
16861901|NCT01865747|37823353|FG001|Primary Intent to Treat (PITT)|Other|1|||
16861902|NCT01843673|37823394|FG000|Overall Study|Lack of Efficacy|2|||
16861903|NCT01843673|37823394|FG000|Overall Study|Withdrawal by Subject|4|||
16861904|NCT01843205|37823413|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
16861905|NCT01843205|37823414|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
16861906|NCT01835015|37823501|FG000|Overall Study|Adverse Event|0|||
16861907|NCT01835015|37823502|FG001|Overall Study|Adverse Event|0|||
16861908|NCT01835015|37823503|FG002|Overall Study|Adverse Event|1|||
16861909|NCT01835015|37823504|FG003|Overall Study|Adverse Event|0|||
16861910|NCT01835015|37823505|FG004|Overall Study|Adverse Event|0|||
16861911|NCT01842581|37823533|FG000|Overall Study|Adverse Event|6|||
16861912|NCT01842581|37823534|FG001|Overall Study|Adverse Event|4|||
16861913|NCT01842581|37823533|FG000|Overall Study|HE breakthrough|26|||
16861914|NCT01842581|37823534|FG001|Overall Study|HE breakthrough|13|||
16861915|NCT01842581|37823533|FG000|Overall Study|Liver transplant|2|||
16861916|NCT01842581|37823534|FG001|Overall Study|Liver transplant|0|||
16861917|NCT01842581|37823533|FG000|Overall Study|Lost to Follow-up|2|||
16861918|NCT01842581|37823534|FG001|Overall Study|Lost to Follow-up|5|||
16861919|NCT01842581|37823533|FG000|Overall Study|Withdrawal by Subject|5|||
16861920|NCT01842581|37823534|FG001|Overall Study|Withdrawal by Subject|7|||
16861921|NCT01842581|37823533|FG000|Overall Study|Other than specified|3|||
16944803|NCT01097863|38088837|FG001|Overall Study|Discomfort|0|||
16944804|NCT01097863|38088838|FG002|Overall Study|Discomfort|1|||
16944805|NCT01097863|38088836|FG000|Overall Study|Did not return for final visit|0|||
16944806|NCT01097863|38088837|FG001|Overall Study|Did not return for final visit|0|||
16944807|NCT01097863|38088838|FG002|Overall Study|Did not return for final visit|1|||
16944808|NCT01326962|38088846|FG000|Overall Study|Adverse Event|1|||
16861922|NCT01842581|37823534|FG001|Overall Study|Other than specified|1|||
16944809|NCT01326962|38088846|FG000|Overall Study|Withdrawal by Subject|1|||
16944810|NCT01326962|38088846|FG000|Overall Study|Lost to Follow-up|3|||
16944811|NCT01326962|38088846|FG000|Overall Study|Other|2|||
16944812|NCT01326728|38088852|FG000|Overall Study|Death|13|||
16944813|NCT01326728|38088853|FG001|Overall Study|Death|0|||
16944814|NCT01326728|38088852|FG000|Overall Study|Early closure of study|34|||
16944815|NCT01326728|38088853|FG001|Overall Study|Early closure of study|9|||
16944816|NCT01097707|38088863|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16861923|NCT01833533|37823542|FG000|Overall Study|Adverse Event|0|||
16861924|NCT01833533|37823543|FG001|Overall Study|Adverse Event|1|||
16861925|NCT01833533|37823542|FG000|Overall Study|Lost to Follow-up|4|||
16861926|NCT01833533|37823543|FG001|Overall Study|Lost to Follow-up|9|||
16861927|NCT01833533|37823542|FG000|Overall Study|To Enter an Extension Study|0|||
16944817|NCT01097707|38088864|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16944818|NCT01097707|38088865|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16944819|NCT01097707|38088866|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16944820|NCT01097707|38088867|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16861928|NCT01833533|37823543|FG001|Overall Study|To Enter an Extension Study|4|||
16861929|NCT01833533|37823542|FG000|Overall Study|Other|2|||
16861930|NCT01833533|37823543|FG001|Overall Study|Other|7|||
16861931|NCT01833455|37823551|FG000|Overall Study|Withdrawal by Subject|1|||
16861932|NCT01833455|37823552|FG001|Overall Study|Withdrawal by Subject|0|||
16861933|NCT01833143|37823570|FG000|Overall Study|Not Treated|1|||
16861934|NCT01841567|37823574|FG000|Overall Study|Adverse Event|3|||
16861935|NCT01833065|37823581|FG000|Overall Study|Adverse Event|6|||
16861936|NCT01833065|37823582|FG001|Overall Study|Adverse Event|1|||
16861937|NCT01833065|37823583|FG002|Overall Study|Adverse Event|0|||
16861938|NCT01833065|37823584|FG003|Overall Study|Adverse Event|2|||
16861939|NCT01833065|37823585|FG004|Overall Study|Adverse Event|3|||
16861940|NCT01833065|37823581|FG000|Overall Study|Protocol Violation|1|||
16861941|NCT01833065|37823582|FG001|Overall Study|Protocol Violation|0|||
16861942|NCT01833065|37823583|FG002|Overall Study|Protocol Violation|0|||
16861943|NCT01833065|37823584|FG003|Overall Study|Protocol Violation|0|||
16861944|NCT01833065|37823585|FG004|Overall Study|Protocol Violation|2|||
16861945|NCT01833065|37823581|FG000|Overall Study|Lost to Follow-up|1|||
16861946|NCT01833065|37823582|FG001|Overall Study|Lost to Follow-up|0|||
16861947|NCT01833065|37823583|FG002|Overall Study|Lost to Follow-up|0|||
16861948|NCT01833065|37823584|FG003|Overall Study|Lost to Follow-up|0|||
16861949|NCT01833065|37823585|FG004|Overall Study|Lost to Follow-up|3|||
16861950|NCT01833065|37823581|FG000|Overall Study|Withdrawal by Subject|6|||
16861951|NCT01833065|37823582|FG001|Overall Study|Withdrawal by Subject|2|||
16861952|NCT01833065|37823583|FG002|Overall Study|Withdrawal by Subject|4|||
16861953|NCT01833065|37823584|FG003|Overall Study|Withdrawal by Subject|3|||
16861954|NCT01833065|37823585|FG004|Overall Study|Withdrawal by Subject|11|||
16861955|NCT01833065|37823581|FG000|Overall Study|Subject's substantial non-compliance|0|||
16861956|NCT01833065|37823582|FG001|Overall Study|Subject's substantial non-compliance|1|||
16861957|NCT01833065|37823583|FG002|Overall Study|Subject's substantial non-compliance|0|||
16861958|NCT01833065|37823584|FG003|Overall Study|Subject's substantial non-compliance|0|||
16861959|NCT01833065|37823585|FG004|Overall Study|Subject's substantial non-compliance|0|||
16861960|NCT01833065|37823581|FG000|Overall Study|Trial terminated by sponsor|8|||
16861961|NCT01833065|37823582|FG001|Overall Study|Trial terminated by sponsor|8|||
16861962|NCT01833065|37823583|FG002|Overall Study|Trial terminated by sponsor|7|||
16861963|NCT01833065|37823584|FG003|Overall Study|Trial terminated by sponsor|3|||
16861964|NCT01833065|37823585|FG004|Overall Study|Trial terminated by sponsor|13|||
16861965|NCT01833065|37823581|FG000|Overall Study|Others|2|||
16861966|NCT01833065|37823582|FG001|Overall Study|Others|1|||
16861967|NCT01833065|37823583|FG002|Overall Study|Others|1|||
16861968|NCT01833065|37823584|FG003|Overall Study|Others|1|||
16861969|NCT01833065|37823585|FG004|Overall Study|Others|4|||
16861970|NCT01831817|37823599|FG000|Overall Study|Lost to Follow-up|1|||
16861971|NCT01831817|37823600|FG001|Overall Study|Lost to Follow-up|0|||
16861972|NCT01831817|37823601|FG002|Overall Study|Lost to Follow-up|0|||
16861973|NCT01831817|37823602|FG003|Overall Study|Lost to Follow-up|0|||
16861974|NCT01831817|37823599|FG000|Overall Study|Withdrawl of Consent|3|||
16861975|NCT01831817|37823600|FG001|Overall Study|Withdrawl of Consent|0|||
16861976|NCT01831817|37823601|FG002|Overall Study|Withdrawl of Consent|0|||
16861977|NCT01831817|37823602|FG003|Overall Study|Withdrawl of Consent|0|||
16861978|NCT01840943|37823627|FG000|Overall Study|Withdrawal by Subject|5|||
16861979|NCT01840943|37823628|FG001|Overall Study|Withdrawal by Subject|6|||
16861980|NCT01840943|37823627|FG000|Overall Study|Physician Decision|4|||
16861981|NCT01840943|37823628|FG001|Overall Study|Physician Decision|2|||
16861982|NCT01840943|37823627|FG000|Overall Study|Lost to Follow-up|4|||
16861983|NCT01840943|37823628|FG001|Overall Study|Lost to Follow-up|4|||
16861984|NCT01840163|37823636|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
16861985|NCT01840163|37823637|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
16861986|NCT01840163|37823636|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
16861987|NCT01840163|37823637|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
16861988|NCT01840163|37823636|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
16861989|NCT01840163|37823637|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
16861990|NCT01831427|37823800|FG000|Overall Study|Adverse Event|0|||
16861991|NCT01831427|37823801|FG001|Overall Study|Adverse Event|1|||
16861992|NCT01831427|37823802|FG002|Overall Study|Adverse Event|0|||
16861993|NCT01831427|37823803|FG003|Overall Study|Adverse Event|0|||
16861994|NCT01831427|37823804|FG004|Overall Study|Adverse Event|0|||
16861995|NCT01831427|37823805|FG005|Overall Study|Adverse Event|1|||
16861996|NCT01831427|37823806|FG006|Overall Study|Adverse Event|0|||
16861997|NCT01831427|37823807|FG007|Overall Study|Adverse Event|1|||
16861998|NCT01831427|37823808|FG008|Overall Study|Adverse Event|0|||
16861999|NCT01831427|37823809|FG009|Overall Study|Adverse Event|0|||
16862000|NCT01831427|37823810|FG010|Overall Study|Adverse Event|2|||
16862001|NCT01831427|37823800|FG000|Overall Study|Investigator's Discretion|0|||
16862002|NCT01831427|37823801|FG001|Overall Study|Investigator's Discretion|0|||
16862003|NCT01831427|37823802|FG002|Overall Study|Investigator's Discretion|0|||
16862004|NCT01831427|37823803|FG003|Overall Study|Investigator's Discretion|1|||
16862005|NCT01831427|37823804|FG004|Overall Study|Investigator's Discretion|0|||
16862006|NCT01831427|37823805|FG005|Overall Study|Investigator's Discretion|0|||
16862007|NCT01831427|37823806|FG006|Overall Study|Investigator's Discretion|0|||
16862008|NCT01831427|37823807|FG007|Overall Study|Investigator's Discretion|0|||
16862009|NCT01831427|37823808|FG008|Overall Study|Investigator's Discretion|0|||
16862010|NCT01831427|37823809|FG009|Overall Study|Investigator's Discretion|0|||
16862011|NCT01831427|37823810|FG010|Overall Study|Investigator's Discretion|0|||
16862012|NCT01831427|37823800|FG000|Overall Study|Withdrew Consent|0|||
16862013|NCT01831427|37823801|FG001|Overall Study|Withdrew Consent|0|||
16862014|NCT01831427|37823802|FG002|Overall Study|Withdrew Consent|0|||
16862015|NCT01831427|37823803|FG003|Overall Study|Withdrew Consent|0|||
16862016|NCT01831427|37823804|FG004|Overall Study|Withdrew Consent|0|||
16862017|NCT01831427|37823805|FG005|Overall Study|Withdrew Consent|0|||
16862018|NCT01831427|37823806|FG006|Overall Study|Withdrew Consent|2|||
16862019|NCT01831427|37823807|FG007|Overall Study|Withdrew Consent|0|||
16862020|NCT01831427|37823808|FG008|Overall Study|Withdrew Consent|0|||
16862021|NCT01831427|37823809|FG009|Overall Study|Withdrew Consent|1|||
16862022|NCT01831427|37823810|FG010|Overall Study|Withdrew Consent|1|||
16862023|NCT01830881|37823856|FG000|Overall Study|Changed decision to have an abortion|0|||
16862024|NCT01830881|37823857|FG001|Overall Study|Changed decision to have an abortion|1|||
16862025|NCT01838681|37823893|FG000|Period A|Adverse Event|39|||
16862026|NCT01838681|37823894|FG001|Period A|Adverse Event|0|||
16862027|NCT01838681|37823895|FG002|Period A|Adverse Event|0|||
16862028|NCT01838681|37823896|FG003|Period A|Adverse Event|0|||
16862029|NCT01838681|37823893|FG000|Period A|Lack of Efficacy|21|||
16862030|NCT01838681|37823894|FG001|Period A|Lack of Efficacy|0|||
16862031|NCT01838681|37823895|FG002|Period A|Lack of Efficacy|0|||
16862032|NCT01838681|37823896|FG003|Period A|Lack of Efficacy|0|||
16862033|NCT01838681|37823893|FG000|Period A|Early response|148|||
16862034|NCT01838681|37823894|FG001|Period A|Early response|0|||
16862035|NCT01838681|37823895|FG002|Period A|Early response|0|||
16862036|NCT01838681|37823896|FG003|Period A|Early response|0|||
16862037|NCT01838681|37823893|FG000|Period A|Withdrawal by Subject|70|||
16862038|NCT01838681|37823894|FG001|Period A|Withdrawal by Subject|0|||
16862039|NCT01838681|37823895|FG002|Period A|Withdrawal by Subject|0|||
16862040|NCT01838681|37823896|FG003|Period A|Withdrawal by Subject|0|||
16862041|NCT01838681|37823893|FG000|Period A|Protocol Violation|16|||
16862042|NCT01838681|37823894|FG001|Period A|Protocol Violation|0|||
16862043|NCT01838681|37823895|FG002|Period A|Protocol Violation|0|||
16862044|NCT01838681|37823896|FG003|Period A|Protocol Violation|0|||
16862045|NCT01838681|37823893|FG000|Period A|Non-compliance with IMP|6|||
16862046|NCT01838681|37823894|FG001|Period A|Non-compliance with IMP|0|||
16862047|NCT01838681|37823895|FG002|Period A|Non-compliance with IMP|0|||
16862048|NCT01838681|37823896|FG003|Period A|Non-compliance with IMP|0|||
16862049|NCT01838681|37823893|FG000|Period A|Lost to Follow-up|4|||
16862050|NCT01838681|37823894|FG001|Period A|Lost to Follow-up|0|||
16862051|NCT01838681|37823895|FG002|Period A|Lost to Follow-up|0|||
16862052|NCT01838681|37823896|FG003|Period A|Lost to Follow-up|0|||
16862053|NCT01838681|37823893|FG000|Period A|Withdrawal before treatment|4|||
16862054|NCT01838681|37823894|FG001|Period A|Withdrawal before treatment|0|||
16862055|NCT01838681|37823895|FG002|Period A|Withdrawal before treatment|0|||
16862056|NCT01838681|37823896|FG003|Period A|Withdrawal before treatment|0|||
16862057|NCT01838681|37823893|FG000|Period A|Administrative or other reasons|17|||
16862058|NCT01838681|37823894|FG001|Period A|Administrative or other reasons|0|||
16862059|NCT01838681|37823895|FG002|Period A|Administrative or other reasons|0|||
16862060|NCT01838681|37823896|FG003|Period A|Administrative or other reasons|0|||
16862061|NCT01838681|37823893|FG000|Period B/A+|Adverse Event|0|||
16862062|NCT01838681|37823894|FG001|Period B/A+|Adverse Event|13|||
16862063|NCT01838681|37823895|FG002|Period B/A+|Adverse Event|27|||
16862064|NCT01838681|37823896|FG003|Period B/A+|Adverse Event|16|||
16862065|NCT01838681|37823893|FG000|Period B/A+|Lack of Efficacy|0|||
16862066|NCT01838681|37823894|FG001|Period B/A+|Lack of Efficacy|9|||
16862067|NCT01838681|37823895|FG002|Period B/A+|Lack of Efficacy|11|||
16862068|NCT01838681|37823896|FG003|Period B/A+|Lack of Efficacy|6|||
16862069|NCT01838681|37823893|FG000|Period B/A+|Withdrawal by Subject|0|||
16862070|NCT01838681|37823894|FG001|Period B/A+|Withdrawal by Subject|28|||
16862071|NCT01838681|37823895|FG002|Period B/A+|Withdrawal by Subject|35|||
16862072|NCT01838681|37823896|FG003|Period B/A+|Withdrawal by Subject|47|||
16862073|NCT01838681|37823893|FG000|Period B/A+|Protocol Violation|0|||
16862074|NCT01838681|37823894|FG001|Period B/A+|Protocol Violation|1|||
16862075|NCT01838681|37823895|FG002|Period B/A+|Protocol Violation|4|||
16862076|NCT01838681|37823896|FG003|Period B/A+|Protocol Violation|6|||
16862077|NCT01838681|37823893|FG000|Period B/A+|Non-compliance with IMP|0|||
16862078|NCT01838681|37823894|FG001|Period B/A+|Non-compliance with IMP|2|||
16862079|NCT01838681|37823895|FG002|Period B/A+|Non-compliance with IMP|3|||
16862080|NCT01838681|37823896|FG003|Period B/A+|Non-compliance with IMP|3|||
16862081|NCT01838681|37823893|FG000|Period B/A+|Lost to Follow-up|0|||
16862082|NCT01838681|37823894|FG001|Period B/A+|Lost to Follow-up|2|||
16862083|NCT01838681|37823895|FG002|Period B/A+|Lost to Follow-up|5|||
16862084|NCT01838681|37823896|FG003|Period B/A+|Lost to Follow-up|11|||
16862085|NCT01838681|37823893|FG000|Period B/A+|Withdrawal before treatment|0|||
16862086|NCT01838681|37823894|FG001|Period B/A+|Withdrawal before treatment|1|||
16862087|NCT01838681|37823895|FG002|Period B/A+|Withdrawal before treatment|0|||
16944821|NCT01097707|38088863|FG000|Overall Study|Adverse Event|4|||
16862088|NCT01838681|37823896|FG003|Period B/A+|Withdrawal before treatment|0|||
16862089|NCT01838681|37823893|FG000|Period B/A+|Administrative or other reasons|0|||
16862090|NCT01838681|37823894|FG001|Period B/A+|Administrative or other reasons|6|||
16862091|NCT01838681|37823895|FG002|Period B/A+|Administrative or other reasons|10|||
16862092|NCT01838681|37823896|FG003|Period B/A+|Administrative or other reasons|28|||
16862093|NCT01611857|37823954|FG000|Overall Study|Withdrawal by Subject|0|||
16862094|NCT01611857|37823955|FG001|Overall Study|Withdrawal by Subject|2|||
16862095|NCT01829477|37823978|FG000|Overall Study|Study Terminated by Sponsor|15|||
16862096|NCT01829477|37823979|FG001|Overall Study|Study Terminated by Sponsor|15|||
16862097|NCT01829477|37823978|FG000|Overall Study|Withdrawal by Subject|1|||
16862098|NCT01829477|37823979|FG001|Overall Study|Withdrawal by Subject|0|||
16862099|NCT01611155|37823995|FG000|Overall Study|Adverse Event|1|||
16862100|NCT01611155|37823996|FG001|Overall Study|Adverse Event|1|||
16862101|NCT01611155|37823995|FG000|Overall Study|Refused further treatment|6|||
16862102|NCT01611155|37823996|FG001|Overall Study|Refused further treatment|4|||
16862103|NCT01611155|37823995|FG000|Overall Study|Disease progression|1|||
16862104|NCT01611155|37823996|FG001|Overall Study|Disease progression|0|||
16862105|NCT01611155|37823995|FG000|Overall Study|Withdrawal by Subject|1|||
16862106|NCT01611155|37823996|FG001|Overall Study|Withdrawal by Subject|0|||
16862107|NCT01611155|37823995|FG000|Overall Study|Alternative treatment|0|||
16862108|NCT01611155|37823996|FG001|Overall Study|Alternative treatment|1|||
16862109|NCT01611155|37823995|FG000|Overall Study|Ineligible patient|0|||
16862110|NCT01611155|37823996|FG001|Overall Study|Ineligible patient|1|||
16862111|NCT01829243|37824011|FG000|First Intervention|Screen Failure|4|||
16862112|NCT01829243|37824012|FG001|First Intervention|Screen Failure|2|||
16862113|NCT01838447|37824022|FG000|Overall Study|Change in surgical plan|1|||
16862114|NCT01838447|37824023|FG001|Overall Study|Change in surgical plan|2|||
16862115|NCT01838447|37824022|FG000|Overall Study|Withdrawal by Subject|1|||
16862116|NCT01838447|37824023|FG001|Overall Study|Withdrawal by Subject|1|||
16862117|NCT01829165|37824031|FG000|Overall Study|Did not complete intervention|2|||
16862118|NCT01829165|37824032|FG001|Overall Study|Did not complete intervention|0|||
16862119|NCT01838213|37824040|FG000|Overall Study|Ineligible|166|||
16862120|NCT01838213|37824041|FG001|Overall Study|Ineligible|191|||
16862121|NCT01837823|37824047|FG000|Overall Study|Lost to Follow-up|6|||
16862122|NCT01828073|37824057|FG000|Overall Study|Lost to Follow-up|1|||
16862123|NCT01828073|37824058|FG001|Overall Study|Lost to Follow-up|2|||
16862124|NCT03819114|37824078|FG000|Overall Study|Protocol Violation|0|||
16862125|NCT03819114|37824079|FG001|Overall Study|Protocol Violation|1|||
16862126|NCT03819114|37824080|FG002|Overall Study|Protocol Violation|1|||
16862127|NCT03819114|37824081|FG003|Overall Study|Protocol Violation|0|||
16862128|NCT03819114|37824078|FG000|Overall Study|Lost to Follow-up|0|||
16862129|NCT03819114|37824079|FG001|Overall Study|Lost to Follow-up|0|||
16862130|NCT03819114|37824080|FG002|Overall Study|Lost to Follow-up|1|||
16862131|NCT03819114|37824081|FG003|Overall Study|Lost to Follow-up|0|||
16862132|NCT01827839|37824093|FG000|Overall Study|Adverse Event|1|||
16862133|NCT01827839|37824093|FG000|Overall Study|Consent Withdrawal|2|||
16862134|NCT01827371|37824108|FG000|Overall Study|Adverse Event|0|||
16862135|NCT01827371|37824109|FG001|Overall Study|Adverse Event|0|||
16862136|NCT01827371|37824110|FG002|Overall Study|Adverse Event|4|||
16862137|NCT01827371|37824111|FG003|Overall Study|Adverse Event|2|||
16862138|NCT01827371|37824108|FG000|Overall Study|Lost to Follow-up|0|||
16862139|NCT01827371|37824109|FG001|Overall Study|Lost to Follow-up|2|||
16862140|NCT01827371|37824110|FG002|Overall Study|Lost to Follow-up|0|||
16862141|NCT01827371|37824111|FG003|Overall Study|Lost to Follow-up|4|||
16862142|NCT01827371|37824108|FG000|Overall Study|Protocol Violation|1|||
16862143|NCT01827371|37824109|FG001|Overall Study|Protocol Violation|0|||
16862144|NCT01827371|37824110|FG002|Overall Study|Protocol Violation|0|||
16862145|NCT01827371|37824111|FG003|Overall Study|Protocol Violation|0|||
16774016|NCT02432846|37713257|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16862146|NCT01827371|37824108|FG000|Overall Study|Withdrawal by Subject|1|||
16862147|NCT01827371|37824109|FG001|Overall Study|Withdrawal by Subject|2|||
16862148|NCT01827371|37824110|FG002|Overall Study|Withdrawal by Subject|2|||
16862149|NCT01827371|37824111|FG003|Overall Study|Withdrawal by Subject|3|||
16862150|NCT01827371|37824108|FG000|Overall Study|Physician Decision|0|||
16862151|NCT01827371|37824109|FG001|Overall Study|Physician Decision|1|||
16862152|NCT01827371|37824110|FG002|Overall Study|Physician Decision|0|||
16862153|NCT01827371|37824111|FG003|Overall Study|Physician Decision|1|||
16862154|NCT01827371|37824108|FG000|Overall Study|Temporary study halt to vaccinations|11|||
16862155|NCT01827371|37824109|FG001|Overall Study|Temporary study halt to vaccinations|2|||
16862156|NCT01827371|37824110|FG002|Overall Study|Temporary study halt to vaccinations|5|||
16862157|NCT01827371|37824111|FG003|Overall Study|Temporary study halt to vaccinations|13|||
16862158|NCT04409262|37824300|FG000|Overall Study|Adverse Event|0|||
16862159|NCT04409262|37824301|FG001|Overall Study|Adverse Event|2|||
16862160|NCT04409262|37824300|FG000|Overall Study|Death|55|||
16862161|NCT04409262|37824301|FG001|Overall Study|Death|97|||
16862162|NCT04409262|37824300|FG000|Overall Study|Lost to Follow-up|12|||
16862163|NCT04409262|37824301|FG001|Overall Study|Lost to Follow-up|23|||
16862164|NCT04409262|37824300|FG000|Overall Study|Lack of Staff|0|||
16862165|NCT04409262|37824301|FG001|Overall Study|Lack of Staff|1|||
16862166|NCT04409262|37824300|FG000|Overall Study|Protocol Violation|3|||
16862167|NCT04409262|37824301|FG001|Overall Study|Protocol Violation|1|||
16862168|NCT04409262|37824300|FG000|Overall Study|Withdrawal by Subject|5|||
16862169|NCT04409262|37824301|FG001|Overall Study|Withdrawal by Subject|10|||
16862170|NCT04305912|37824345|FG000|First Intervention|COVID-19 Suspension|2|||
16862171|NCT04305912|37824346|FG001|First Intervention|COVID-19 Suspension|0|||
16862172|NCT04305912|37824345|FG000|First Intervention|Withdrawal by Subject|0|||
16862173|NCT04305912|37824346|FG001|First Intervention|Withdrawal by Subject|1|||
16862174|NCT04305912|37824345|FG000|Second Intervention|Adverse Event|0|||
16862175|NCT04305912|37824346|FG001|Second Intervention|Adverse Event|1|||
16862176|NCT00782184|37824575|FG000|Overall Study|Adverse Event|1|||
16862177|NCT00782184|37824576|FG001|Overall Study|Adverse Event|2|||
16862178|NCT00782184|37824575|FG000|Overall Study|Protocol Violation|0|||
16862179|NCT00782184|37824576|FG001|Overall Study|Protocol Violation|1|||
16862180|NCT00782184|37824575|FG000|Overall Study|Withdrawal by Subject|3|||
16862181|NCT00782184|37824576|FG001|Overall Study|Withdrawal by Subject|2|||
16862182|NCT02731638|37824612|FG000|Overall Study|Lost to Follow-up|6|||
16862183|NCT02731638|37824613|FG001|Overall Study|Lost to Follow-up|9|||
16862184|NCT03730662|37825060|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
16862185|NCT03730662|37825061|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
16862186|NCT03730662|37825062|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
16862187|NCT03730662|37825063|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
16862188|NCT03730662|37825060|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
16862189|NCT03730662|37825061|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
16862190|NCT03730662|37825062|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
16862191|NCT03730662|37825063|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
16862192|NCT03730662|37825060|FG000|Treatment Period (52 Weeks)|Death|6|||
16862193|NCT03730662|37825061|FG001|Treatment Period (52 Weeks)|Death|2|||
16862194|NCT03730662|37825062|FG002|Treatment Period (52 Weeks)|Death|2|||
16862195|NCT03730662|37825063|FG003|Treatment Period (52 Weeks)|Death|9|||
16862196|NCT03730662|37825060|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
16862197|NCT03730662|37825061|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
16862198|NCT03730662|37825062|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
16862199|NCT03730662|37825063|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
16862200|NCT03730662|37825060|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
16862201|NCT03730662|37825061|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
16862202|NCT03730662|37825062|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
16862203|NCT03730662|37825063|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
16862204|NCT03730662|37825060|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
16862205|NCT03730662|37825061|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
16862206|NCT03730662|37825062|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
16862207|NCT03730662|37825063|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
16862208|NCT03730662|37825060|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
16862209|NCT03730662|37825061|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
16862210|NCT03730662|37825062|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
16862211|NCT03730662|37825063|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
16862212|NCT03730662|37825060|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
16862213|NCT03730662|37825061|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
16862214|NCT03730662|37825062|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
16862215|NCT03730662|37825063|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
16862216|NCT03730662|37825060|FG000|Variable Treatment Period|Adverse Event|1|||
16862217|NCT03730662|37825061|FG001|Variable Treatment Period|Adverse Event|2|||
16862218|NCT03730662|37825062|FG002|Variable Treatment Period|Adverse Event|0|||
16862219|NCT03730662|37825063|FG003|Variable Treatment Period|Adverse Event|7|||
16862220|NCT03730662|37825060|FG000|Variable Treatment Period|Death|9|||
16862221|NCT03730662|37825061|FG001|Variable Treatment Period|Death|0|||
16862222|NCT03730662|37825062|FG002|Variable Treatment Period|Death|6|||
16862223|NCT03730662|37825063|FG003|Variable Treatment Period|Death|26|||
16862224|NCT03730662|37825060|FG000|Variable Treatment Period|Lost to Follow-up|2|||
16862225|NCT03730662|37825061|FG001|Variable Treatment Period|Lost to Follow-up|1|||
16862226|NCT03730662|37825062|FG002|Variable Treatment Period|Lost to Follow-up|4|||
16862227|NCT03730662|37825063|FG003|Variable Treatment Period|Lost to Follow-up|11|||
16862228|NCT03730662|37825060|FG000|Variable Treatment Period|Personal Reason|0|||
16862229|NCT03730662|37825061|FG001|Variable Treatment Period|Personal Reason|2|||
16862230|NCT03730662|37825062|FG002|Variable Treatment Period|Personal Reason|1|||
16862231|NCT03730662|37825063|FG003|Variable Treatment Period|Personal Reason|6|||
16862232|NCT03730662|37825060|FG000|Variable Treatment Period|Physician Decision|0|||
16862233|NCT03730662|37825061|FG001|Variable Treatment Period|Physician Decision|0|||
16862234|NCT03730662|37825062|FG002|Variable Treatment Period|Physician Decision|0|||
16862235|NCT03730662|37825063|FG003|Variable Treatment Period|Physician Decision|3|||
16862236|NCT03730662|37825060|FG000|Variable Treatment Period|Protocol Violation|0|||
16862237|NCT03730662|37825061|FG001|Variable Treatment Period|Protocol Violation|1|||
16862238|NCT03730662|37825062|FG002|Variable Treatment Period|Protocol Violation|1|||
16862239|NCT03730662|37825063|FG003|Variable Treatment Period|Protocol Violation|1|||
16862240|NCT03730662|37825060|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
16862241|NCT03730662|37825061|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
16862242|NCT03730662|37825062|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
16862243|NCT03730662|37825063|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
16862244|NCT03185832|37825178|FG000|Overall Study|Death|9|||
16862245|NCT03185832|37825179|FG001|Overall Study|Death|14|||
16862246|NCT03185832|37825180|FG002|Overall Study|Death|9|||
16862247|NCT03185832|37825181|FG003|Overall Study|Death|7|||
16862248|NCT03185832|37825178|FG000|Overall Study|Withdrawn - vital status available|0|||
16862249|NCT03185832|37825179|FG001|Overall Study|Withdrawn - vital status available|1|||
16862250|NCT03185832|37825180|FG002|Overall Study|Withdrawn - vital status available|1|||
16862251|NCT03185832|37825181|FG003|Overall Study|Withdrawn - vital status available|4|||
16862252|NCT04569786|37825233|FG000|Overall Study|Lost to Follow-up|1|||
16862253|NCT04569786|37825234|FG001|Overall Study|Lost to Follow-up|0|||
16862254|NCT04569786|37825235|FG002|Overall Study|Lost to Follow-up|4|||
16862255|NCT04569786|37825236|FG003|Overall Study|Lost to Follow-up|1|||
16862256|NCT04569786|37825237|FG004|Overall Study|Lost to Follow-up|0|||
16862257|NCT04569786|37825233|FG000|Overall Study|Withdrawal by Subject|0|||
16862258|NCT04569786|37825234|FG001|Overall Study|Withdrawal by Subject|0|||
16862259|NCT04569786|37825235|FG002|Overall Study|Withdrawal by Subject|0|||
16862260|NCT04569786|37825236|FG003|Overall Study|Withdrawal by Subject|5|||
16862261|NCT04569786|37825237|FG004|Overall Study|Withdrawal by Subject|1|||
16862262|NCT04569786|37825233|FG000|Overall Study|Physician Decision|0|||
16862263|NCT04569786|37825234|FG001|Overall Study|Physician Decision|0|||
16862264|NCT04569786|37825235|FG002|Overall Study|Physician Decision|0|||
16862265|NCT04569786|37825236|FG003|Overall Study|Physician Decision|1|||
16862266|NCT04569786|37825237|FG004|Overall Study|Physician Decision|0|||
16862267|NCT01826981|37825413|FG000|Overall Study|Lack of Efficacy|0|||
16862268|NCT01826981|37825414|FG001|Overall Study|Lack of Efficacy|1|||
16862269|NCT01826981|37825415|FG002|Overall Study|Lack of Efficacy|0|||
16862270|NCT01826981|37825416|FG003|Overall Study|Lack of Efficacy|0|||
16862271|NCT01826981|37825417|FG004|Overall Study|Lack of Efficacy|5|||
16862272|NCT01826981|37825418|FG005|Overall Study|Lack of Efficacy|0|||
16862273|NCT01826981|37825419|FG006|Overall Study|Lack of Efficacy|0|||
16862274|NCT01826981|37825420|FG007|Overall Study|Lack of Efficacy|8|||
16862275|NCT01826981|37825421|FG008|Overall Study|Lack of Efficacy|7|||
16862276|NCT01826981|37825422|FG009|Overall Study|Lack of Efficacy|0|||
16862277|NCT01826981|37825423|FG010|Overall Study|Lack of Efficacy|1|||
16862278|NCT01826981|37825424|FG011|Overall Study|Lack of Efficacy|0|||
16862279|NCT01826981|37825425|FG012|Overall Study|Lack of Efficacy|0|||
16862280|NCT01826981|37825426|FG013|Overall Study|Lack of Efficacy|3|||
16862281|NCT01826981|37825427|FG014|Overall Study|Lack of Efficacy|0|||
16862282|NCT01826981|37825413|FG000|Overall Study|Lost to Follow-up|0|||
16862283|NCT01826981|37825414|FG001|Overall Study|Lost to Follow-up|0|||
16862284|NCT01826981|37825415|FG002|Overall Study|Lost to Follow-up|0|||
16862285|NCT01826981|37825416|FG003|Overall Study|Lost to Follow-up|0|||
16862286|NCT01826981|37825417|FG004|Overall Study|Lost to Follow-up|1|||
16862287|NCT01826981|37825418|FG005|Overall Study|Lost to Follow-up|1|||
16862288|NCT01826981|37825419|FG006|Overall Study|Lost to Follow-up|0|||
16862289|NCT01826981|37825420|FG007|Overall Study|Lost to Follow-up|1|||
16862290|NCT01826981|37825421|FG008|Overall Study|Lost to Follow-up|0|||
16862291|NCT01826981|37825422|FG009|Overall Study|Lost to Follow-up|1|||
16862292|NCT01826981|37825423|FG010|Overall Study|Lost to Follow-up|1|||
16862293|NCT01826981|37825424|FG011|Overall Study|Lost to Follow-up|1|||
16862294|NCT01826981|37825425|FG012|Overall Study|Lost to Follow-up|1|||
16862295|NCT01826981|37825426|FG013|Overall Study|Lost to Follow-up|0|||
16862296|NCT01826981|37825427|FG014|Overall Study|Lost to Follow-up|0|||
16862297|NCT01826981|37825413|FG000|Overall Study|Withdrew Consent|0|||
16862298|NCT01826981|37825414|FG001|Overall Study|Withdrew Consent|0|||
16862299|NCT01826981|37825415|FG002|Overall Study|Withdrew Consent|0|||
16862300|NCT01826981|37825416|FG003|Overall Study|Withdrew Consent|0|||
16862301|NCT01826981|37825417|FG004|Overall Study|Withdrew Consent|0|||
16862302|NCT01826981|37825418|FG005|Overall Study|Withdrew Consent|0|||
16862303|NCT01826981|37825419|FG006|Overall Study|Withdrew Consent|1|||
16862304|NCT01826981|37825420|FG007|Overall Study|Withdrew Consent|1|||
16862305|NCT01826981|37825421|FG008|Overall Study|Withdrew Consent|0|||
16862306|NCT01826981|37825422|FG009|Overall Study|Withdrew Consent|0|||
16862307|NCT01826981|37825423|FG010|Overall Study|Withdrew Consent|0|||
16862308|NCT01826981|37825424|FG011|Overall Study|Withdrew Consent|1|||
16862309|NCT01826981|37825425|FG012|Overall Study|Withdrew Consent|0|||
16862310|NCT01826981|37825426|FG013|Overall Study|Withdrew Consent|1|||
16862311|NCT01826981|37825427|FG014|Overall Study|Withdrew Consent|0|||
16862312|NCT01826981|37825413|FG000|Overall Study|Adverse Event|0|||
16862313|NCT01826981|37825414|FG001|Overall Study|Adverse Event|0|||
16862314|NCT01826981|37825415|FG002|Overall Study|Adverse Event|0|||
16862315|NCT01826981|37825416|FG003|Overall Study|Adverse Event|0|||
16862316|NCT01826981|37825417|FG004|Overall Study|Adverse Event|1|||
16862317|NCT01826981|37825418|FG005|Overall Study|Adverse Event|0|||
16862318|NCT01826981|37825419|FG006|Overall Study|Adverse Event|0|||
16862319|NCT01826981|37825420|FG007|Overall Study|Adverse Event|0|||
16862320|NCT01826981|37825421|FG008|Overall Study|Adverse Event|0|||
16862321|NCT01826981|37825422|FG009|Overall Study|Adverse Event|0|||
16862322|NCT01826981|37825423|FG010|Overall Study|Adverse Event|0|||
16862323|NCT01826981|37825424|FG011|Overall Study|Adverse Event|0|||
16862324|NCT01826981|37825425|FG012|Overall Study|Adverse Event|0|||
16862325|NCT01826981|37825426|FG013|Overall Study|Adverse Event|0|||
16862326|NCT01826981|37825427|FG014|Overall Study|Adverse Event|0|||
16862327|NCT01826981|37825413|FG000|Overall Study|Upper G-I Haemorrhage|0|||
16862328|NCT01826981|37825414|FG001|Overall Study|Upper G-I Haemorrhage|0|||
16862329|NCT01826981|37825415|FG002|Overall Study|Upper G-I Haemorrhage|0|||
16862330|NCT01826981|37825416|FG003|Overall Study|Upper G-I Haemorrhage|0|||
16862331|NCT01826981|37825417|FG004|Overall Study|Upper G-I Haemorrhage|0|||
16862332|NCT01826981|37825418|FG005|Overall Study|Upper G-I Haemorrhage|0|||
16862333|NCT01826981|37825419|FG006|Overall Study|Upper G-I Haemorrhage|0|||
16862334|NCT01826981|37825420|FG007|Overall Study|Upper G-I Haemorrhage|0|||
16862335|NCT01826981|37825421|FG008|Overall Study|Upper G-I Haemorrhage|0|||
16862336|NCT01826981|37825422|FG009|Overall Study|Upper G-I Haemorrhage|0|||
16862337|NCT01826981|37825423|FG010|Overall Study|Upper G-I Haemorrhage|0|||
16862338|NCT01826981|37825424|FG011|Overall Study|Upper G-I Haemorrhage|0|||
16862339|NCT01826981|37825425|FG012|Overall Study|Upper G-I Haemorrhage|0|||
16862340|NCT01826981|37825426|FG013|Overall Study|Upper G-I Haemorrhage|1|||
16862341|NCT01826981|37825427|FG014|Overall Study|Upper G-I Haemorrhage|0|||
16862342|NCT01826981|37825413|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862343|NCT01826981|37825414|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862344|NCT01826981|37825415|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862345|NCT01826981|37825416|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862346|NCT01826981|37825417|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862347|NCT01826981|37825418|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862348|NCT01826981|37825419|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862349|NCT01826981|37825420|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
16862350|NCT01826981|37825421|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862351|NCT01826981|37825422|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862352|NCT01826981|37825423|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862353|NCT01826981|37825424|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862354|NCT01826981|37825425|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862355|NCT01826981|37825426|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862356|NCT01826981|37825427|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
16862357|NCT01804049|37825499|FG000|Overall Study|Adverse Event|2|||
16862358|NCT01804049|37825500|FG001|Overall Study|Adverse Event|10|||
16862359|NCT01804049|37825499|FG000|Overall Study|Lost to Follow-up|2|||
16862360|NCT01804049|37825500|FG001|Overall Study|Lost to Follow-up|1|||
16862361|NCT01804049|37825499|FG000|Overall Study|Decreased interest/personal|4|||
16862362|NCT01804049|37825500|FG001|Overall Study|Decreased interest/personal|5|||
16862363|NCT01804049|37825499|FG000|Overall Study|Other health concerns|2|||
16862364|NCT01804049|37825500|FG001|Overall Study|Other health concerns|7|||
16862365|NCT01804049|37825499|FG000|Overall Study|Moved out of area|0|||
16862366|NCT01804049|37825500|FG001|Overall Study|Moved out of area|7|||
16862367|NCT01804049|37825499|FG000|Overall Study|other MD recommended|1|||
16862368|NCT01804049|37825500|FG001|Overall Study|other MD recommended|1|||
16862369|NCT01804049|37825499|FG000|Overall Study|Enrollment in dual studies|0|||
16862370|NCT01804049|37825500|FG001|Overall Study|Enrollment in dual studies|1|||
16862371|NCT01826825|37825510|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
16862372|NCT01826825|37825511|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
16862373|NCT01803737|37825521|FG000|Overall Study|Lack of Time|1|||
16862374|NCT01803737|37825522|FG001|Overall Study|Lack of Time|0|||
16862375|NCT01803737|37825521|FG000|Overall Study|Medical Reason|0|||
16862376|NCT01803737|37825522|FG001|Overall Study|Medical Reason|1|||
16862377|NCT01803737|37825521|FG000|Overall Study|Lost to Follow-up|0|||
16862378|NCT01803737|37825522|FG001|Overall Study|Lost to Follow-up|2|||
16862379|NCT01826201|37825528|FG000|Overall Study|Non compliance with protocol|4|||
16862380|NCT01803269|37825559|FG000|Overall Study|Withdrawal by Subject|3|||
16862381|NCT01803269|37825560|FG001|Overall Study|Withdrawal by Subject|0|||
16862382|NCT01803269|37825561|FG002|Overall Study|Withdrawal by Subject|0|||
16862383|NCT01802879|37825569|FG000|Overall Study|Administrative problems|2|||
16862384|NCT01802879|37825569|FG000|Overall Study|Disease progression|6|||
16862385|NCT01825577|37825573|FG000|Overall Study|Physician Decision|2|||
16862386|NCT01825577|37825573|FG000|Overall Study|Withdrawal by Subject|1|||
16862387|NCT01825577|37825573|FG000|Overall Study|Withdrawn by family members|2|||
16862388|NCT01825577|37825573|FG000|Overall Study|Lack of Efficacy|3|||
16862389|NCT01802411|37825579|FG000|Overall Study|Death|2|||
16862390|NCT01802411|37825580|FG001|Overall Study|Death|1|||
16862391|NCT01802411|37825579|FG000|Overall Study|Adverse Event|2|||
16862392|NCT01802411|37825580|FG001|Overall Study|Adverse Event|7|||
16862393|NCT01802411|37825579|FG000|Overall Study|Lack of Efficacy|8|||
16862394|NCT01802411|37825580|FG001|Overall Study|Lack of Efficacy|10|||
16862395|NCT01802411|37825579|FG000|Overall Study|Withdrawal by Subject|0|||
16862396|NCT01802411|37825580|FG001|Overall Study|Withdrawal by Subject|2|||
16862397|NCT01802411|37825579|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
16862398|NCT01802411|37825580|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
16862399|NCT01802411|37825579|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
16862400|NCT01802411|37825580|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
16862401|NCT01802411|37825579|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
16862402|NCT01802411|37825580|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
16862403|NCT02963610|37825621|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
16862404|NCT02606136|37825703|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
16862405|NCT02606136|37825703|FG000|Overall Study|Withdrawal by Subject|1|||
16862406|NCT01802333|37825846|FG000|Overall Study|Ineligible|2|||
16862407|NCT01802333|37825847|FG001|Overall Study|Ineligible|6|||
16862408|NCT01802333|37825848|FG002|Overall Study|Ineligible|8|||
16862409|NCT01802333|37825846|FG000|Overall Study|Adverse Event|1|||
16862410|NCT01802333|37825847|FG001|Overall Study|Adverse Event|8|||
16862411|NCT01802333|37825848|FG002|Overall Study|Adverse Event|8|||
16862412|NCT01802333|37825846|FG000|Overall Study|Withdrawal by Subject|6|||
16862413|NCT01802333|37825847|FG001|Overall Study|Withdrawal by Subject|6|||
16862414|NCT01802333|37825848|FG002|Overall Study|Withdrawal by Subject|5|||
16862415|NCT01802333|37825846|FG000|Overall Study|Progression/relapse|1|||
16862416|NCT01802333|37825847|FG001|Overall Study|Progression/relapse|3|||
16862417|NCT01802333|37825848|FG002|Overall Study|Progression/relapse|0|||
16862418|NCT01802333|37825846|FG000|Overall Study|Death|7|||
16862419|NCT01802333|37825847|FG001|Overall Study|Death|14|||
16862420|NCT01802333|37825848|FG002|Overall Study|Death|13|||
16862421|NCT01802333|37825846|FG000|Overall Study|Other - not protocol specified|32|||
16862422|NCT01802333|37825847|FG001|Overall Study|Other - not protocol specified|22|||
16862423|NCT01802333|37825848|FG002|Overall Study|Other - not protocol specified|24|||
16862424|NCT01802333|37825846|FG000|Overall Study|Did not start treatment|0|||
16862425|NCT01802333|37825847|FG001|Overall Study|Did not start treatment|2|||
16862426|NCT01802333|37825848|FG002|Overall Study|Did not start treatment|5|||
16862427|NCT00980655|37825893|FG000|Overall Study|Adverse Event|13|||
16862428|NCT00980655|37825894|FG001|Overall Study|Adverse Event|31|||
16862429|NCT00980655|37825893|FG000|Overall Study|Death|0|||
16862430|NCT00980655|37825894|FG001|Overall Study|Death|7|||
16862431|NCT00980655|37825893|FG000|Overall Study|Protocol Violation|2|||
16862432|NCT00980655|37825894|FG001|Overall Study|Protocol Violation|7|||
16862433|NCT00980655|37825893|FG000|Overall Study|Withdrawal by Subject|0|||
16862434|NCT00980655|37825894|FG001|Overall Study|Withdrawal by Subject|4|||
16862435|NCT00980655|37825893|FG000|Overall Study|Lost to Follow-up|0|||
16862436|NCT00980655|37825894|FG001|Overall Study|Lost to Follow-up|1|||
16862437|NCT00980655|37825893|FG000|Overall Study|Parent/legal guardian request|1|||
16862438|NCT00980655|37825894|FG001|Overall Study|Parent/legal guardian request|0|||
16862439|NCT00980655|37825893|FG000|Overall Study|Other|0|||
16862440|NCT00980655|37825894|FG001|Overall Study|Other|1|||
16862441|NCT01824875|37825907|FG000|Overall Study|Disease progression|22|||
16862442|NCT01824875|37825908|FG001|Overall Study|Disease progression|15|||
16862443|NCT01824875|37825907|FG000|Overall Study|Withdrawal by Subject|5|||
16862444|NCT01824875|37825908|FG001|Overall Study|Withdrawal by Subject|4|||
16862445|NCT01824875|37825907|FG000|Overall Study|Adverse Event|4|||
16862446|NCT01824875|37825908|FG001|Overall Study|Adverse Event|10|||
16862447|NCT01824875|37825907|FG000|Overall Study|Alternative therapy|3|||
16862448|NCT01824875|37825908|FG001|Overall Study|Alternative therapy|0|||
16862449|NCT01824875|37825907|FG000|Overall Study|Complicating disease|1|||
16862450|NCT01824875|37825908|FG001|Overall Study|Complicating disease|0|||
16862451|NCT01824875|37825907|FG000|Overall Study|Physician Decision|0|||
16862452|NCT01824875|37825908|FG001|Overall Study|Physician Decision|1|||
16862453|NCT01824875|37825907|FG000|Overall Study|Non-compliance|1|||
16862454|NCT01824875|37825908|FG001|Overall Study|Non-compliance|1|||
16862455|NCT01824875|37825907|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
16862456|NCT01824875|37825908|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
16862457|NCT01824875|37825907|FG000|Overall Study|Administrative issues|0|||
16862458|NCT01824875|37825908|FG001|Overall Study|Administrative issues|2|||
16862459|NCT01824875|37825907|FG000|Overall Study|Ineligible or never started treatment|9|||
16862460|NCT01824875|37825908|FG001|Overall Study|Ineligible or never started treatment|5|||
16862461|NCT01824875|37825907|FG000|Overall Study|Other|0|||
16862462|NCT01824875|37825908|FG001|Overall Study|Other|2|||
16862463|NCT01801865|37825949|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
16862464|NCT01801865|37825949|FG000|Overall Study|Physician Decision|7|||
16862465|NCT00980343|37825959|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
16862466|NCT00980343|37825960|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
16862467|NCT01801475|37825970|FG000|Overall Study|Withdrawal by Subject|0|||
16862468|NCT01801475|37825971|FG001|Overall Study|Withdrawal by Subject|0|||
16862469|NCT01801475|37825972|FG002|Overall Study|Withdrawal by Subject|0|||
16862470|NCT01801475|37825973|FG003|Overall Study|Withdrawal by Subject|0|||
16862471|NCT01801475|37825974|FG004|Overall Study|Withdrawal by Subject|1|||
16862472|NCT01822925|37826033|FG000|Overall Study|Adverse Event|1|||
16862473|NCT01822925|37826034|FG001|Overall Study|Adverse Event|1|||
16862474|NCT01822925|37826035|FG002|Overall Study|Adverse Event|1|||
16862475|NCT01822925|37826036|FG003|Overall Study|Adverse Event|1|||
16862476|NCT01822925|37826033|FG000|Overall Study|Lost to Follow-up|0|||
16862477|NCT01822925|37826034|FG001|Overall Study|Lost to Follow-up|1|||
16862478|NCT01822925|37826035|FG002|Overall Study|Lost to Follow-up|0|||
16862479|NCT01822925|37826036|FG003|Overall Study|Lost to Follow-up|0|||
16862480|NCT01822925|37826033|FG000|Overall Study|Protocol Violation|1|||
16862481|NCT01822925|37826034|FG001|Overall Study|Protocol Violation|0|||
16862482|NCT01822925|37826035|FG002|Overall Study|Protocol Violation|0|||
16862483|NCT01822925|37826036|FG003|Overall Study|Protocol Violation|1|||
16862484|NCT01822925|37826033|FG000|Overall Study|Withdrawal by Subject|2|||
16862485|NCT01822925|37826034|FG001|Overall Study|Withdrawal by Subject|0|||
16862486|NCT01822925|37826035|FG002|Overall Study|Withdrawal by Subject|2|||
16862487|NCT01822925|37826036|FG003|Overall Study|Withdrawal by Subject|2|||
16862488|NCT01822925|37826033|FG000|Overall Study|Taking prohibited medication|2|||
16862489|NCT01822925|37826034|FG001|Overall Study|Taking prohibited medication|0|||
16862490|NCT01822925|37826035|FG002|Overall Study|Taking prohibited medication|0|||
16862491|NCT01822925|37826036|FG003|Overall Study|Taking prohibited medication|1|||
16862492|NCT01801007|37826069|FG000|Overall Study|Adverse Event|2|||
16862493|NCT01801007|37826069|FG000|Overall Study|Lost to Follow-up|4|||
16862494|NCT01801007|37826069|FG000|Overall Study|Withdrawal by Subject|5|||
16862495|NCT01822691|37826073|FG000|Overall Study|Withdrawal by Subject|2|||
16862496|NCT01822535|37826079|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
16862497|NCT01822535|37826080|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
16862498|NCT01822535|37826079|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
16862499|NCT01822535|37826080|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
16862500|NCT01822535|37826079|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
16862501|NCT01822535|37826080|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
16862502|NCT01799993|37826166|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
16862503|NCT01799993|37826167|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
16862504|NCT01799993|37826166|FG000|Overall Study|Death|61|||
16862505|NCT01799993|37826167|FG001|Overall Study|Death|45|||
16862506|NCT01799993|37826166|FG000|Overall Study|Withdrawal by Subject|23|||
16862507|NCT01799993|37826167|FG001|Overall Study|Withdrawal by Subject|24|||
16862508|NCT01799993|37826166|FG000|Overall Study|Lost to Follow-up|5|||
16862509|NCT01799993|37826167|FG001|Overall Study|Lost to Follow-up|8|||
16862510|NCT01799993|37826166|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
16862511|NCT01799993|37826167|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
16862512|NCT01799993|37826166|FG000|Overall Study|Protocol driven decision point|0|||
16862513|NCT01799993|37826167|FG001|Overall Study|Protocol driven decision point|3|||
16862514|NCT01799993|37826166|FG000|Overall Study|Protocol Violation|1|||
16862515|NCT01799993|37826167|FG001|Overall Study|Protocol Violation|1|||
16862516|NCT01799993|37826166|FG000|Overall Study|Deterioration of general conditions|2|||
16862517|NCT01799993|37826167|FG001|Overall Study|Deterioration of general conditions|0|||
16862518|NCT01799993|37826166|FG000|Overall Study|Screen failure|0|||
16862519|NCT01799993|37826167|FG001|Overall Study|Screen failure|1|||
16862520|NCT01799993|37826166|FG000|Overall Study|Adverse Event|1|||
16862521|NCT01799993|37826167|FG001|Overall Study|Adverse Event|0|||
16862522|NCT01799993|37826166|FG000|Overall Study|Lack of Efficacy|1|||
16862523|NCT01799993|37826167|FG001|Overall Study|Lack of Efficacy|0|||
16862524|NCT01799993|37826166|FG000|Overall Study|Recovery|0|||
16862525|NCT01799993|37826167|FG001|Overall Study|Recovery|1|||
16862526|NCT01799993|37826166|FG000|Overall Study|Logistical difficulties|1|||
16862527|NCT01799993|37826167|FG001|Overall Study|Logistical difficulties|0|||
16862528|NCT01799993|37826166|FG000|Overall Study|Protocol deviation|1|||
16862529|NCT01799993|37826167|FG001|Overall Study|Protocol deviation|0|||
16862530|NCT01799993|37826166|FG000|Overall Study|Non-compliance with medical device|1|||
16862531|NCT01799993|37826167|FG001|Overall Study|Non-compliance with medical device|0|||
16862532|NCT01799993|37826166|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16862533|NCT01799993|37826167|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16862534|NCT01799993|37826166|FG000|Overall Study|Other|1|||
16862535|NCT01799993|37826167|FG001|Overall Study|Other|0|||
16862536|NCT01799993|37826166|FG000|Overall Study|Subject didn't return for follow-up|0|||
16862537|NCT01799993|37826167|FG001|Overall Study|Subject didn't return for follow-up|1|||
16862538|NCT01822223|37826184|FG000|Overall Study|Death|0|||
16862539|NCT01822223|37826185|FG001|Overall Study|Death|1|||
16862540|NCT02228382|37826271|FG000|Overall Study|Death|5|||
16862541|NCT02228382|37826272|FG001|Overall Study|Death|7|||
16862542|NCT02228382|37826273|FG002|Overall Study|Death|5|||
16862543|NCT02228382|37826274|FG003|Overall Study|Death|0|||
16862544|NCT02228382|37826275|FG004|Overall Study|Death|2|||
16862545|NCT02228382|37826271|FG000|Overall Study|Participant refused further follow-up|0|||
16862546|NCT02228382|37826272|FG001|Overall Study|Participant refused further follow-up|0|||
16862547|NCT02228382|37826273|FG002|Overall Study|Participant refused further follow-up|1|||
16862548|NCT02228382|37826274|FG003|Overall Study|Participant refused further follow-up|0|||
16862549|NCT02228382|37826275|FG004|Overall Study|Participant refused further follow-up|0|||
16862550|NCT02228382|37826271|FG000|Overall Study|Study terminated by sponsor|3|||
16862551|NCT02228382|37826272|FG001|Overall Study|Study terminated by sponsor|5|||
16862552|NCT02228382|37826273|FG002|Overall Study|Study terminated by sponsor|7|||
16862553|NCT02228382|37826274|FG003|Overall Study|Study terminated by sponsor|0|||
16862554|NCT02228382|37826275|FG004|Overall Study|Study terminated by sponsor|0|||
16862555|NCT02228382|37826271|FG000|Overall Study|Lost to Follow-up|0|||
16862556|NCT02228382|37826272|FG001|Overall Study|Lost to Follow-up|0|||
16862557|NCT02228382|37826273|FG002|Overall Study|Lost to Follow-up|3|||
16862558|NCT02228382|37826274|FG003|Overall Study|Lost to Follow-up|1|||
16862559|NCT02228382|37826275|FG004|Overall Study|Lost to Follow-up|0|||
16862560|NCT02228382|37826271|FG000|Overall Study|Withdrawal by Subject|0|||
16862561|NCT02228382|37826272|FG001|Overall Study|Withdrawal by Subject|3|||
16862562|NCT02228382|37826273|FG002|Overall Study|Withdrawal by Subject|2|||
16862563|NCT02228382|37826274|FG003|Overall Study|Withdrawal by Subject|1|||
16862564|NCT02228382|37826275|FG004|Overall Study|Withdrawal by Subject|0|||
16862565|NCT02228382|37826271|FG000|Overall Study|Other|2|||
16862566|NCT02228382|37826272|FG001|Overall Study|Other|3|||
16862567|NCT02228382|37826273|FG002|Overall Study|Other|3|||
16862568|NCT02228382|37826274|FG003|Overall Study|Other|0|||
16862569|NCT02228382|37826275|FG004|Overall Study|Other|0|||
16862570|NCT01900002|37826319|FG000|Overall Study|Withdrawal by Subject|2|||
16862571|NCT01900002|37826319|FG000|Overall Study|ineligible for Y-90|4|||
16862572|NCT01377012|37826349|FG000|Core Study|Study terminated by Sponsor|47|||
16862573|NCT01377012|37826350|FG001|Core Study|Study terminated by Sponsor|54|||
16862574|NCT01377012|37826351|FG002|Core Study|Study terminated by Sponsor|46|||
16862575|NCT01377012|37826349|FG000|Core Study|Technical problems|1|||
16862576|NCT01377012|37826350|FG001|Core Study|Technical problems|0|||
16862577|NCT01377012|37826351|FG002|Core Study|Technical problems|0|||
16862578|NCT01377012|37826349|FG000|Core Study|Withdrawal by Subject|15|||
16862579|NCT01377012|37826350|FG001|Core Study|Withdrawal by Subject|23|||
16862580|NCT01377012|37826351|FG002|Core Study|Withdrawal by Subject|18|||
16862581|NCT01377012|37826349|FG000|Core Study|Protocol Violation|7|||
16862582|NCT01377012|37826350|FG001|Core Study|Protocol Violation|3|||
16862583|NCT01377012|37826351|FG002|Core Study|Protocol Violation|2|||
16862584|NCT01377012|37826349|FG000|Core Study|Pregnancy|0|||
16862585|NCT01377012|37826350|FG001|Core Study|Pregnancy|0|||
16862586|NCT01377012|37826351|FG002|Core Study|Pregnancy|1|||
16862587|NCT01377012|37826349|FG000|Core Study|Physician Decision|5|||
16862588|NCT01377012|37826350|FG001|Core Study|Physician Decision|4|||
16862589|NCT01377012|37826351|FG002|Core Study|Physician Decision|10|||
16862590|NCT01377012|37826349|FG000|Core Study|Non-Compliant with study treatment|0|||
16862591|NCT01377012|37826350|FG001|Core Study|Non-Compliant with study treatment|0|||
16862592|NCT01377012|37826351|FG002|Core Study|Non-Compliant with study treatment|1|||
16862593|NCT01377012|37826349|FG000|Core Study|No Longer require treatment|0|||
16862594|NCT01377012|37826350|FG001|Core Study|No Longer require treatment|0|||
16862595|NCT01377012|37826351|FG002|Core Study|No Longer require treatment|1|||
16862596|NCT01377012|37826349|FG000|Core Study|Lost to Follow-up|7|||
16862597|NCT01377012|37826350|FG001|Core Study|Lost to Follow-up|5|||
16862598|NCT01377012|37826351|FG002|Core Study|Lost to Follow-up|4|||
16862599|NCT01377012|37826349|FG000|Core Study|Lack of Efficacy|41|||
16862600|NCT01377012|37826350|FG001|Core Study|Lack of Efficacy|28|||
16862601|NCT01377012|37826351|FG002|Core Study|Lack of Efficacy|37|||
16862602|NCT01377012|37826349|FG000|Core Study|Death|1|||
16862603|NCT01377012|37826350|FG001|Core Study|Death|1|||
16862604|NCT01377012|37826351|FG002|Core Study|Death|1|||
16862605|NCT01377012|37826349|FG000|Core Study|Adverse Event|10|||
16862606|NCT01377012|37826350|FG001|Core Study|Adverse Event|14|||
16862607|NCT01377012|37826351|FG002|Core Study|Adverse Event|13|||
16862608|NCT01377012|37826349|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
16862609|NCT01377012|37826350|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
16862610|NCT01377012|37826351|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
16862611|NCT01377012|37826349|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
16862612|NCT01377012|37826350|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
16862613|NCT01377012|37826351|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
16862614|NCT01377012|37826349|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
16862615|NCT01377012|37826350|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
16862616|NCT01377012|37826351|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
16862617|NCT01377012|37826349|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
16862618|NCT01377012|37826350|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
16862619|NCT01377012|37826351|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
16862620|NCT01377012|37826349|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
16862621|NCT01377012|37826350|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
16862622|NCT01377012|37826351|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
16862623|NCT01377012|37826349|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
16862624|NCT01377012|37826350|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
16862625|NCT01377012|37826351|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
16862626|NCT01376310|37826600|FG000|Overall Study|Study closed/terminated|1|||
16862627|NCT01376310|37826601|FG001|Overall Study|Study closed/terminated|2|||
16862628|NCT01376310|37826600|FG000|Overall Study|Withdrawal by Subject|8|||
16862629|NCT01376310|37826601|FG001|Overall Study|Withdrawal by Subject|2|||
16862630|NCT01376310|37826600|FG000|Overall Study|Physician Decision|26|||
16862631|NCT01376310|37826601|FG001|Overall Study|Physician Decision|7|||
16862632|NCT01376310|37826600|FG000|Overall Study|Lost to Follow-up|1|||
16862633|NCT01376310|37826601|FG001|Overall Study|Lost to Follow-up|0|||
16862634|NCT01949506|37826607|FG000|Overall Study|Physician Decision|1|||
16862635|NCT00709098|37826704|FG000|Double-blind Period|Withdrawal of consent|3|||
16862636|NCT00709098|37826705|FG001|Double-blind Period|Withdrawal of consent|3|||
16862637|NCT00709098|37826706|FG002|Double-blind Period|Withdrawal of consent|0|||
16862638|NCT00709098|37826704|FG000|Double-blind Period|Administrative reason|1|||
16862639|NCT00709098|37826705|FG001|Double-blind Period|Administrative reason|3|||
16862640|NCT00709098|37826706|FG002|Double-blind Period|Administrative reason|0|||
16862641|NCT00709098|37826704|FG000|Double-blind Period|Death|1|||
16862642|NCT00709098|37826705|FG001|Double-blind Period|Death|1|||
16862643|NCT00709098|37826706|FG002|Double-blind Period|Death|0|||
16862644|NCT00709098|37826704|FG000|Double-blind Period|Lost to Follow-up|1|||
16862645|NCT00709098|37826705|FG001|Double-blind Period|Lost to Follow-up|1|||
16862646|NCT00709098|37826706|FG002|Double-blind Period|Lost to Follow-up|0|||
16862647|NCT00709098|37826704|FG000|Open-label Period|Withdrawal of consent|0|||
16862648|NCT00709098|37826705|FG001|Open-label Period|Withdrawal of consent|0|||
16862649|NCT00709098|37826706|FG002|Open-label Period|Withdrawal of consent|7|||
16862650|NCT00709098|37826704|FG000|Open-label Period|Administrative reason|0|||
16862651|NCT00709098|37826705|FG001|Open-label Period|Administrative reason|0|||
16862652|NCT00709098|37826706|FG002|Open-label Period|Administrative reason|5|||
16862653|NCT00709098|37826704|FG000|Open-label Period|Death|0|||
16862654|NCT00709098|37826705|FG001|Open-label Period|Death|0|||
16862655|NCT00709098|37826706|FG002|Open-label Period|Death|1|||
16862656|NCT00709098|37826704|FG000|Open-label Period|Lost to Follow-up|0|||
16862657|NCT00709098|37826705|FG001|Open-label Period|Lost to Follow-up|0|||
16862658|NCT00709098|37826706|FG002|Open-label Period|Lost to Follow-up|1|||
16862659|NCT01376700|37826715|FG000|Overall Study|Sponsor terminated study early|8|||
16862660|NCT01376700|37826715|FG000|Overall Study|Low or high titer inhibitor|8|||
16862661|NCT01797965|37826726|FG000|Overall Study|Adverse Event|104|||
16774017|NCT02432846|37713258|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16862662|NCT01797965|37826727|FG001|Overall Study|Adverse Event|129|||
16862663|NCT01797965|37826728|FG002|Overall Study|Adverse Event|4|||
16862664|NCT01797965|37826729|FG003|Overall Study|Adverse Event|21|||
16862665|NCT01797965|37826726|FG000|Overall Study|Lost to Follow-up|9|||
16862666|NCT01797965|37826727|FG001|Overall Study|Lost to Follow-up|8|||
16862667|NCT01797965|37826728|FG002|Overall Study|Lost to Follow-up|1|||
16862668|NCT01797965|37826729|FG003|Overall Study|Lost to Follow-up|2|||
16862669|NCT01797965|37826726|FG000|Overall Study|Consent withdrawn|130|||
16862670|NCT01797965|37826727|FG001|Overall Study|Consent withdrawn|117|||
16862671|NCT01797965|37826728|FG002|Overall Study|Consent withdrawn|3|||
16862672|NCT01797965|37826729|FG003|Overall Study|Consent withdrawn|35|||
16862673|NCT01797965|37826726|FG000|Overall Study|Investigator decision|21|||
16862674|NCT01797965|37826727|FG001|Overall Study|Investigator decision|15|||
16862675|NCT01797965|37826728|FG002|Overall Study|Investigator decision|0|||
16862676|NCT01797965|37826729|FG003|Overall Study|Investigator decision|0|||
16862677|NCT01797965|37826726|FG000|Overall Study|Death|2|||
16862678|NCT01797965|37826727|FG001|Overall Study|Death|4|||
16862679|NCT01797965|37826728|FG002|Overall Study|Death|0|||
16862680|NCT01797965|37826729|FG003|Overall Study|Death|0|||
16862681|NCT01797965|37826726|FG000|Overall Study|Disease progression, defined by protocol|3|||
16862682|NCT01797965|37826727|FG001|Overall Study|Disease progression, defined by protocol|1|||
16862683|NCT01797965|37826728|FG002|Overall Study|Disease progression, defined by protocol|0|||
16862684|NCT01797965|37826729|FG003|Overall Study|Disease progression, defined by protocol|0|||
16862685|NCT01797965|37826726|FG000|Overall Study|Reason Not Specified|280|||
16862686|NCT01797965|37826727|FG001|Overall Study|Reason Not Specified|295|||
16862687|NCT01797965|37826728|FG002|Overall Study|Reason Not Specified|0|||
16862688|NCT01797965|37826729|FG003|Overall Study|Reason Not Specified|15|||
16862689|NCT01376388|37826774|FG000|Overall Study|Adverse Event|13|||
16862690|NCT01376388|37826774|FG000|Overall Study|Lack of Efficacy|2|||
16862691|NCT01376388|37826774|FG000|Overall Study|Withdrawal by Subject|3|||
16862692|NCT01821677|37826795|FG000|Overall Study|Adverse Event|4|||
16862693|NCT01821677|37826796|FG001|Overall Study|Adverse Event|6|||
16862694|NCT01821677|37826797|FG002|Overall Study|Adverse Event|5|||
16862695|NCT01821677|37826795|FG000|Overall Study|Physician Decision|1|||
16862696|NCT01821677|37826796|FG001|Overall Study|Physician Decision|4|||
16862697|NCT01821677|37826797|FG002|Overall Study|Physician Decision|1|||
16862698|NCT01821677|37826795|FG000|Overall Study|Non-compliance|0|||
16862699|NCT01821677|37826796|FG001|Overall Study|Non-compliance|1|||
16862700|NCT01821677|37826797|FG002|Overall Study|Non-compliance|2|||
16862701|NCT01821677|37826795|FG000|Overall Study|Lost to Follow-up|2|||
16862702|NCT01821677|37826796|FG001|Overall Study|Lost to Follow-up|1|||
16862703|NCT01821677|37826797|FG002|Overall Study|Lost to Follow-up|3|||
16862704|NCT01821677|37826795|FG000|Overall Study|Protocol Violation|0|||
16862705|NCT01821677|37826796|FG001|Overall Study|Protocol Violation|0|||
16862706|NCT01821677|37826797|FG002|Overall Study|Protocol Violation|2|||
16862707|NCT01821677|37826795|FG000|Overall Study|Withdrawal by Subject|7|||
16862708|NCT01821677|37826796|FG001|Overall Study|Withdrawal by Subject|3|||
16862709|NCT01821677|37826797|FG002|Overall Study|Withdrawal by Subject|2|||
16862710|NCT01821677|37826795|FG000|Overall Study|Other|9|||
16862711|NCT01821677|37826796|FG001|Overall Study|Other|0|||
16862712|NCT01821677|37826797|FG002|Overall Study|Other|0|||
16862713|NCT01797731|37826808|FG000|Overall Study|Didn't have proper radiographs required|3|||
16862714|NCT01797731|37826809|FG001|Overall Study|Didn't have proper radiographs required|3|||
16862715|NCT00709722|37826815|FG000|Overall Study|Adverse Event|1|||
16862716|NCT01820585|37826836|FG000|Overall Study|Adverse Event|9|||
16862717|NCT01820585|37826837|FG001|Overall Study|Adverse Event|13|||
16862718|NCT01820585|37826838|FG002|Overall Study|Adverse Event|23|||
16862719|NCT01820585|37826839|FG003|Overall Study|Adverse Event|34|||
16862720|NCT01820585|37826836|FG000|Overall Study|Lack of Efficacy|9|||
16862721|NCT01820585|37826837|FG001|Overall Study|Lack of Efficacy|7|||
16862722|NCT01820585|37826838|FG002|Overall Study|Lack of Efficacy|5|||
16862723|NCT01820585|37826839|FG003|Overall Study|Lack of Efficacy|1|||
16862724|NCT01820585|37826836|FG000|Overall Study|Withdrawal by Subject|3|||
16862725|NCT01820585|37826837|FG001|Overall Study|Withdrawal by Subject|7|||
16862726|NCT01820585|37826838|FG002|Overall Study|Withdrawal by Subject|3|||
16862727|NCT01820585|37826839|FG003|Overall Study|Withdrawal by Subject|8|||
16862728|NCT01820585|37826836|FG000|Overall Study|Lost to Follow-up|3|||
16862729|NCT01820585|37826837|FG001|Overall Study|Lost to Follow-up|3|||
16862730|NCT01820585|37826838|FG002|Overall Study|Lost to Follow-up|0|||
16862731|NCT01820585|37826839|FG003|Overall Study|Lost to Follow-up|3|||
16862732|NCT01820585|37826836|FG000|Overall Study|Protocol Violation|3|||
16862733|NCT01820585|37826837|FG001|Overall Study|Protocol Violation|1|||
16862734|NCT01820585|37826838|FG002|Overall Study|Protocol Violation|1|||
16862735|NCT01820585|37826839|FG003|Overall Study|Protocol Violation|1|||
16862736|NCT01820585|37826836|FG000|Overall Study|Subject non-compliance|0|||
16862737|NCT01820585|37826837|FG001|Overall Study|Subject non-compliance|0|||
16862738|NCT01820585|37826838|FG002|Overall Study|Subject non-compliance|1|||
16862739|NCT01820585|37826839|FG003|Overall Study|Subject non-compliance|2|||
16862740|NCT01820585|37826836|FG000|Overall Study|at sponsor request|0|||
16862741|NCT01820585|37826837|FG001|Overall Study|at sponsor request|0|||
16862742|NCT01820585|37826838|FG002|Overall Study|at sponsor request|1|||
16862743|NCT01820585|37826839|FG003|Overall Study|at sponsor request|0|||
16862744|NCT01820585|37826836|FG000|Overall Study|Pregnancy|0|||
16862745|NCT01820585|37826837|FG001|Overall Study|Pregnancy|1|||
16862746|NCT01820585|37826838|FG002|Overall Study|Pregnancy|0|||
16862747|NCT01820585|37826839|FG003|Overall Study|Pregnancy|0|||
16862748|NCT01797263|37826851|FG000|Overall Study|Withdrawal by Subject|21|||
16862749|NCT01797263|37826852|FG001|Overall Study|Withdrawal by Subject|25|||
16862750|NCT01797263|37826851|FG000|Overall Study|Death|1|||
16862751|NCT01797263|37826852|FG001|Overall Study|Death|0|||
16862752|NCT01797263|37826851|FG000|Overall Study|Lost to Follow-up|15|||
16862753|NCT01797263|37826852|FG001|Overall Study|Lost to Follow-up|15|||
16862754|NCT01797185|37826917|FG000|Overall Study|Adverse Event|5|||
16862755|NCT01797185|37826918|FG001|Overall Study|Adverse Event|15|||
16862756|NCT01797185|37826919|FG002|Overall Study|Adverse Event|6|||
16862757|NCT01797185|37826917|FG000|Overall Study|Withdrawal by Subject|6|||
16862758|NCT01797185|37826918|FG001|Overall Study|Withdrawal by Subject|9|||
16862759|NCT01797185|37826919|FG002|Overall Study|Withdrawal by Subject|5|||
16862760|NCT01797185|37826917|FG000|Overall Study|Site terminated|8|||
16862761|NCT01797185|37826918|FG001|Overall Study|Site terminated|4|||
16862762|NCT01797185|37826919|FG002|Overall Study|Site terminated|0|||
16862763|NCT01797185|37826917|FG000|Overall Study|Lost to Follow-up|2|||
16862764|NCT01797185|37826918|FG001|Overall Study|Lost to Follow-up|6|||
16862765|NCT01797185|37826919|FG002|Overall Study|Lost to Follow-up|1|||
16862766|NCT01797185|37826917|FG000|Overall Study|Withdrawn per sponsor|5|||
16862767|NCT01797185|37826918|FG001|Overall Study|Withdrawn per sponsor|0|||
16862768|NCT01797185|37826919|FG002|Overall Study|Withdrawn per sponsor|0|||
16862769|NCT01797185|37826917|FG000|Overall Study|Physician Decision|1|||
16862770|NCT01797185|37826918|FG001|Overall Study|Physician Decision|3|||
16862771|NCT01797185|37826919|FG002|Overall Study|Physician Decision|0|||
16862772|NCT01797185|37826917|FG000|Overall Study|Protocol Violation|1|||
16862773|NCT01797185|37826918|FG001|Overall Study|Protocol Violation|1|||
16862774|NCT01797185|37826919|FG002|Overall Study|Protocol Violation|0|||
16862775|NCT01819727|37826975|FG000|Overall Study|Adverse Event|8|||
16862776|NCT01819727|37826976|FG001|Overall Study|Adverse Event|9|||
16862777|NCT01819727|37826975|FG000|Overall Study|Death|1|||
16862778|NCT01819727|37826976|FG001|Overall Study|Death|0|||
16862779|NCT01819727|37826975|FG000|Overall Study|Lost to Follow-up|1|||
16862780|NCT01819727|37826976|FG001|Overall Study|Lost to Follow-up|1|||
16862781|NCT01819727|37826975|FG000|Overall Study|Physician Decision|3|||
16862782|NCT01819727|37826976|FG001|Overall Study|Physician Decision|2|||
16862783|NCT01819727|37826975|FG000|Overall Study|Pregnancy|1|||
16862784|NCT01819727|37826976|FG001|Overall Study|Pregnancy|0|||
16862785|NCT01819727|37826975|FG000|Overall Study|Protocol Violation|0|||
16862786|NCT01819727|37826976|FG001|Overall Study|Protocol Violation|2|||
16862787|NCT01819727|37826975|FG000|Overall Study|Study Terminated by Sponsor|0|||
16862788|NCT01819727|37826976|FG001|Overall Study|Study Terminated by Sponsor|1|||
16862789|NCT01819727|37826975|FG000|Overall Study|Withdrawal by Subject|6|||
16862790|NCT01819727|37826976|FG001|Overall Study|Withdrawal by Subject|11|||
16862791|NCT01819727|37826975|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
16862792|NCT01819727|37826976|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
16862793|NCT01819727|37826975|FG000|Overall Study|Quit due to lack of health benifits|0|||
16862794|NCT01819727|37826976|FG001|Overall Study|Quit due to lack of health benifits|1|||
16862795|NCT01795937|37827035|FG000|Overall Study|Withdrawal by Subject|1|||
16862796|NCT01795937|37827036|FG001|Overall Study|Withdrawal by Subject|0|||
16862797|NCT01795937|37827037|FG002|Overall Study|Withdrawal by Subject|0|||
16862798|NCT01795937|37827035|FG000|Overall Study|Physician Decision|0|||
17127543|NCT03733899|38267844|FG004|Period 3|Withdrawal by Subject|0|||
17127544|NCT03733899|38267845|FG005|Period 3|Withdrawal by Subject|0|||
17127545|NCT03727347|38267858|FG000|Overall Study|Withdrawal by Subject|2|||
17127546|NCT03727347|38267858|FG000|Overall Study|Lost to Follow-up|1|||
17127547|NCT03302234|38267873|FG000|Overall Study|Death|137|||
17127548|NCT03302234|38267874|FG001|Overall Study|Death|135|||
17127549|NCT03302234|38267873|FG000|Overall Study|Withdrawal by Subject|1|||
17127550|NCT03302234|38267874|FG001|Overall Study|Withdrawal by Subject|1|||
17127551|NCT03302234|38267873|FG000|Overall Study|Laryngeal carcinoma|0|||
17127552|NCT03302234|38267874|FG001|Overall Study|Laryngeal carcinoma|1|||
17127553|NCT03915626|38267881|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
17127554|NCT03301844|38267893|FG000|Overall Study|suspected colon cancer|1|||
17127555|NCT03301844|38267894|FG001|Overall Study|suspected colon cancer|1|||
17127556|NCT03313310|38267902|FG000|Phase 2|Lost to Follow-up|4|||
17127557|NCT03313310|38267903|FG001|Phase 2|Lost to Follow-up|0|||
17127558|NCT03313310|38267902|FG000|Phase 3|Lost to Follow-up|0|||
16862799|NCT01795937|37827036|FG001|Overall Study|Physician Decision|1|||
16862800|NCT01795937|37827037|FG002|Overall Study|Physician Decision|0|||
16862801|NCT01817777|37827079|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
16862802|NCT01817777|37827080|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
16862803|NCT01817777|37827081|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
16862804|NCT01817777|37827079|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
17127559|NCT03313310|38267903|FG001|Phase 3|Lost to Follow-up|1|||
16862805|NCT01817777|37827080|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
16862806|NCT01817777|37827081|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
16862807|NCT01817777|37827079|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
16862808|NCT01817777|37827080|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
16862809|NCT01817777|37827081|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
16862810|NCT01817777|37827079|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
16862811|NCT01817777|37827080|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
16862812|NCT01817777|37827081|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
16862813|NCT01817777|37827079|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
16862814|NCT01817777|37827080|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
16862815|NCT01817777|37827081|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
16862816|NCT01795547|37827107|FG000|Overall Study|Adverse Event|16|||
16862817|NCT01795547|37827108|FG001|Overall Study|Adverse Event|27|||
16862818|NCT01795547|37827107|FG000|Overall Study|Lack of Efficacy|8|||
16862819|NCT01795547|37827108|FG001|Overall Study|Lack of Efficacy|3|||
16862820|NCT01795547|37827107|FG000|Overall Study|Protocol Violation|6|||
16862821|NCT01795547|37827108|FG001|Overall Study|Protocol Violation|4|||
16862822|NCT01795547|37827107|FG000|Overall Study|Lost to Follow-up|2|||
16862823|NCT01795547|37827108|FG001|Overall Study|Lost to Follow-up|5|||
16862824|NCT01795547|37827107|FG000|Overall Study|Withdrawal of consent|7|||
16862825|NCT01795547|37827108|FG001|Overall Study|Withdrawal of consent|12|||
16862826|NCT01795547|37827107|FG000|Overall Study|Not Treated|4|||
16862827|NCT01795547|37827108|FG001|Overall Study|Not Treated|10|||
16862828|NCT01795547|37827107|FG000|Overall Study|Non-compliance with IMP|1|||
16862829|NCT01795547|37827108|FG001|Overall Study|Non-compliance with IMP|1|||
16862830|NCT01795547|37827107|FG000|Overall Study|Others|4|||
16862831|NCT01795547|37827108|FG001|Overall Study|Others|1|||
16862832|NCT01795547|37827107|FG000|Overall Study|Not stated|0|||
16862833|NCT01795547|37827108|FG001|Overall Study|Not stated|1|||
16862834|NCT01794923|37827134|FG000|Overall Study|Adverse Event|0|||
16862835|NCT01794923|37827135|FG001|Overall Study|Adverse Event|0|||
16862836|NCT01794923|37827136|FG002|Overall Study|Adverse Event|1|||
16862837|NCT01794845|37827144|FG000|Overall Study|Withdrawal by Subject|1|||
16862838|NCT01794689|37827152|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
16862839|NCT01794689|37827153|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
16862840|NCT01794689|37827154|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
16862841|NCT01794689|37827155|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
16862842|NCT01794689|37827152|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
16862843|NCT01794689|37827153|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
16862844|NCT01794689|37827154|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
16862845|NCT01794689|37827155|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
16862846|NCT01794689|37827152|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
16862847|NCT01794689|37827153|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
16862848|NCT01794689|37827154|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
16862849|NCT01794689|37827155|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
16862850|NCT01794689|37827152|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
16862851|NCT01794689|37827153|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
16862852|NCT01794689|37827154|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
16862853|NCT01794689|37827155|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
16862854|NCT01794299|37827171|FG000|Overall Study|ATIR manufacturing not possible|1|||
16862855|NCT01794299|37827171|FG000|Overall Study|Death|14|||
16862856|NCT01794299|37827171|FG000|Overall Study|Graft failure|1|||
16862857|NCT01794299|37827171|FG000|Overall Study|ATIR batch rejected|2|||
16862858|NCT01794299|37827171|FG000|Overall Study|Relapse|2|||
16862859|NCT01794299|37827171|FG000|Overall Study|Discontinued from active follow-up|1|||
16862860|NCT01794299|37827171|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
16862861|NCT01817075|37827177|FG000|Overall Study|Adverse Event|7|||
16862862|NCT01817075|37827178|FG001|Overall Study|Adverse Event|5|||
16862863|NCT01817075|37827177|FG000|Overall Study|Physician Decision|9|||
16862864|NCT01817075|37827178|FG001|Overall Study|Physician Decision|12|||
16862865|NCT01817075|37827177|FG000|Overall Study|Withdrawal by Subject|31|||
16862866|NCT01817075|37827178|FG001|Overall Study|Withdrawal by Subject|15|||
16862867|NCT01817075|37827177|FG000|Overall Study|Received Sorafenib after enrollment|0|||
16862868|NCT01817075|37827178|FG001|Overall Study|Received Sorafenib after enrollment|1|||
16862869|NCT01817075|37827177|FG000|Overall Study|Ineligible|0|||
16862870|NCT01817075|37827178|FG001|Overall Study|Ineligible|2|||
16862871|NCT01816763|37827187|FG000|Overall Study|The main reason for an incomplete survey|4|||
16862872|NCT01816763|37827188|FG001|Overall Study|The main reason for an incomplete survey|15|||
16862873|NCT01816763|37827189|FG002|Overall Study|The main reason for an incomplete survey|11|||
16862874|NCT01816685|37827202|FG000|Overall Study|Lost to Follow-up|7|||
16862875|NCT01816685|37827203|FG001|Overall Study|Lost to Follow-up|9|||
16862876|NCT01816685|37827202|FG000|Overall Study|Surgery Cancelled|3|||
16862877|NCT01816685|37827203|FG001|Overall Study|Surgery Cancelled|2|||
16862878|NCT00708552|37827234|FG000|Overall Study|Adverse Event|10|||
16862879|NCT00708552|37827235|FG001|Overall Study|Adverse Event|3|||
16862880|NCT00708552|37827236|FG002|Overall Study|Adverse Event|4|||
16862881|NCT00708552|37827237|FG003|Overall Study|Adverse Event|6|||
16862882|NCT00708552|37827234|FG000|Overall Study|Lack of Efficacy|0|||
16862883|NCT00708552|37827235|FG001|Overall Study|Lack of Efficacy|4|||
16862884|NCT00708552|37827236|FG002|Overall Study|Lack of Efficacy|1|||
16862885|NCT00708552|37827237|FG003|Overall Study|Lack of Efficacy|0|||
16862886|NCT00708552|37827234|FG000|Overall Study|Protocol Violation|0|||
16862887|NCT00708552|37827235|FG001|Overall Study|Protocol Violation|0|||
16862888|NCT00708552|37827236|FG002|Overall Study|Protocol Violation|2|||
16862889|NCT00708552|37827237|FG003|Overall Study|Protocol Violation|4|||
16862890|NCT00708552|37827234|FG000|Overall Study|Lost to Follow-up|4|||
16862891|NCT00708552|37827235|FG001|Overall Study|Lost to Follow-up|2|||
16862892|NCT00708552|37827236|FG002|Overall Study|Lost to Follow-up|0|||
16862893|NCT00708552|37827237|FG003|Overall Study|Lost to Follow-up|1|||
16862894|NCT00708552|37827234|FG000|Overall Study|Physician Decision|1|||
16862895|NCT00708552|37827235|FG001|Overall Study|Physician Decision|2|||
16862896|NCT00708552|37827236|FG002|Overall Study|Physician Decision|0|||
16862897|NCT00708552|37827237|FG003|Overall Study|Physician Decision|0|||
16862898|NCT00708552|37827234|FG000|Overall Study|Withdrawal by Subject|12|||
16862899|NCT00708552|37827235|FG001|Overall Study|Withdrawal by Subject|7|||
16862900|NCT00708552|37827236|FG002|Overall Study|Withdrawal by Subject|8|||
16862901|NCT00708552|37827237|FG003|Overall Study|Withdrawal by Subject|10|||
16862902|NCT01816295|37827367|FG000|Double Blind Phase|Adverse Event|11|||
16862903|NCT01816295|37827368|FG001|Double Blind Phase|Adverse Event|8|||
16862904|NCT01816295|37827367|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
16862905|NCT01816295|37827368|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
16862906|NCT01816295|37827367|FG000|Double Blind Phase|Lost to Follow-up|3|||
16862907|NCT01816295|37827368|FG001|Double Blind Phase|Lost to Follow-up|5|||
16862908|NCT01816295|37827367|FG000|Double Blind Phase|Physician Decision|2|||
16862909|NCT01816295|37827368|FG001|Double Blind Phase|Physician Decision|2|||
16862910|NCT01816295|37827367|FG000|Double Blind Phase|Protocol Violation|17|||
16862911|NCT01816295|37827368|FG001|Double Blind Phase|Protocol Violation|11|||
16862912|NCT01816295|37827367|FG000|Double Blind Phase|Sponsor Decision|8|||
16862913|NCT01816295|37827368|FG001|Double Blind Phase|Sponsor Decision|8|||
16862914|NCT01816295|37827367|FG000|Double Blind Phase|Withdrawal by Subject|22|||
16862915|NCT01816295|37827368|FG001|Double Blind Phase|Withdrawal by Subject|20|||
16862916|NCT01816295|37827367|FG000|OLE Phase|Adverse Event|17|||
16862917|NCT01816295|37827368|FG001|OLE Phase|Adverse Event|15|||
16862918|NCT01816295|37827367|FG000|OLE Phase|Death|1|||
16862919|NCT01816295|37827368|FG001|OLE Phase|Death|0|||
16862920|NCT01816295|37827367|FG000|OLE Phase|Entry Criteria Not Met|3|||
16862921|NCT01816295|37827368|FG001|OLE Phase|Entry Criteria Not Met|5|||
16862922|NCT01816295|37827367|FG000|OLE Phase|Lost to Follow-up|5|||
16862923|NCT01816295|37827368|FG001|OLE Phase|Lost to Follow-up|5|||
16862924|NCT01816295|37827367|FG000|OLE Phase|Physician Decision|3|||
16862925|NCT01816295|37827368|FG001|OLE Phase|Physician Decision|1|||
16862926|NCT01816295|37827367|FG000|OLE Phase|Protocol Violation|4|||
16862927|NCT01816295|37827368|FG001|OLE Phase|Protocol Violation|4|||
16862928|NCT01816295|37827367|FG000|OLE Phase|Sponsor Decision|7|||
16862929|NCT01816295|37827368|FG001|OLE Phase|Sponsor Decision|9|||
16862930|NCT01816295|37827367|FG000|OLE Phase|Withdrawal by Subject|10|||
16862931|NCT01816295|37827368|FG001|OLE Phase|Withdrawal by Subject|10|||
16862932|NCT01816295|37827367|FG000|OLE Phase|Lack of Efficacy|3|||
16862933|NCT01816295|37827368|FG001|OLE Phase|Lack of Efficacy|7|||
16862934|NCT01610297|37827393|FG000|Overall Study|Lost to Follow-up|1|||
16862935|NCT01793051|37827404|FG000|Overall Study|Withdrawal by Subject|6|||
16862936|NCT01793051|37827405|FG001|Overall Study|Withdrawal by Subject|4|||
16862937|NCT01793051|37827404|FG000|Overall Study|Adverse Event|0|||
16862938|NCT01793051|37827405|FG001|Overall Study|Adverse Event|2|||
16862939|NCT01793051|37827404|FG000|Overall Study|Too ill to continue|1|||
16862940|NCT01793051|37827405|FG001|Overall Study|Too ill to continue|0|||
16862941|NCT01793051|37827404|FG000|Overall Study|Switched chemo|1|||
16862942|NCT01793051|37827405|FG001|Overall Study|Switched chemo|1|||
16862943|NCT01793051|37827404|FG000|Overall Study|Lack of compliance|1|||
16862944|NCT01793051|37827405|FG001|Overall Study|Lack of compliance|0|||
16862945|NCT01793051|37827404|FG000|Overall Study|Requested to be removed from the study|1|||
16862946|NCT01793051|37827405|FG001|Overall Study|Requested to be removed from the study|1|||
16862947|NCT01816061|37827438|FG000|Overall Study|Lost to Follow-up|13|||
16862948|NCT01816061|37827439|FG001|Overall Study|Lost to Follow-up|24|||
16862949|NCT01792115|37827465|FG000|Overall Study|Lost to Follow-up|0|||
16862950|NCT01792115|37827466|FG001|Overall Study|Lost to Follow-up|1|||
16862951|NCT01792115|37827467|FG002|Overall Study|Lost to Follow-up|0|||
16862952|NCT01791803|37827479|FG000|Overall Study|Withdrawal by Subject|0|||
16862953|NCT01791803|37827480|FG001|Overall Study|Withdrawal by Subject|0|||
16862954|NCT01791803|37827481|FG002|Overall Study|Withdrawal by Subject|0|||
16862955|NCT01791803|37827482|FG003|Overall Study|Withdrawal by Subject|2|||
16862956|NCT01791803|37827479|FG000|Overall Study|Physician Decision|0|||
16862957|NCT01791803|37827480|FG001|Overall Study|Physician Decision|2|||
16862958|NCT01791803|37827481|FG002|Overall Study|Physician Decision|0|||
16862959|NCT01791803|37827482|FG003|Overall Study|Physician Decision|1|||
16862960|NCT01791803|37827479|FG000|Overall Study|Death|0|||
16862961|NCT01791803|37827480|FG001|Overall Study|Death|0|||
16862962|NCT01791803|37827481|FG002|Overall Study|Death|2|||
16862963|NCT01791803|37827482|FG003|Overall Study|Death|2|||
16862964|NCT01791725|37827507|FG000|Overall Study|Withdrawal by Subject|0|||
16862965|NCT01791725|37827508|FG001|Overall Study|Withdrawal by Subject|1|||
16862966|NCT01791725|37827509|FG002|Overall Study|Withdrawal by Subject|0|||
16862967|NCT01791413|37827519|FG000|Overall Study|Lost to Follow-up|5|||
16862968|NCT01791413|37827520|FG001|Overall Study|Lost to Follow-up|1|||
16862969|NCT01610063|37827533|FG000|Overall Study|Lost to Follow-up|42|||
16862970|NCT01610063|37827534|FG001|Overall Study|Lost to Follow-up|20|||
16862971|NCT01813721|37827540|FG000|Overall Study|Ineligibility determined|63|||
16862972|NCT01813721|37827540|FG000|Overall Study|Withdrawal by Subject|1|||
16862973|NCT01790633|37827564|FG000|Overall Study|Protocol Violation|1|||
16862974|NCT01790633|37827565|FG001|Overall Study|Protocol Violation|2|||
16862975|NCT01790633|37827564|FG000|Overall Study|Did not have serology performed|47|||
16862976|NCT01790633|37827565|FG001|Overall Study|Did not have serology performed|0|||
16862977|NCT01790633|37827564|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
16862978|NCT01790633|37827565|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
16862979|NCT01788215|37827574|FG000|Overall Study|Withdrawal by Subject|0|||
16862980|NCT01788215|37827575|FG001|Overall Study|Withdrawal by Subject|1|||
16862981|NCT01788215|37827574|FG000|Overall Study|Lost to Follow-up|2|||
16862982|NCT01788215|37827575|FG001|Overall Study|Lost to Follow-up|0|||
16862983|NCT01787825|37827581|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
16862984|NCT01787825|37827582|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
16862985|NCT01787825|37827581|FG000|Overall Study|Data Not Analyzable|5|||
16862986|NCT01787825|37827582|FG001|Overall Study|Data Not Analyzable|1|||
16862987|NCT01813019|37827591|FG000|Overall Study|Adverse Event|0|||
16862988|NCT01813019|37827592|FG001|Overall Study|Adverse Event|3|||
16862989|NCT01813019|37827591|FG000|Overall Study|Withdrawal by Subject|3|||
16862990|NCT01813019|37827592|FG001|Overall Study|Withdrawal by Subject|2|||
16862991|NCT01813019|37827591|FG000|Overall Study|administrative problems|2|||
16862992|NCT01813019|37827592|FG001|Overall Study|administrative problems|0|||
16862993|NCT01813019|37827591|FG000|Overall Study|Protocol Deviation|2|||
16862994|NCT01813019|37827592|FG001|Overall Study|Protocol Deviation|1|||
16862995|NCT01787591|37827600|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
16862996|NCT01787591|37827601|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
16862997|NCT01787591|37827602|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
16862998|NCT01787591|37827603|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
16862999|NCT01812707|37827618|FG000|Overall Study|Adverse Event|0|||
16863000|NCT01812707|37827619|FG001|Overall Study|Adverse Event|0|||
16863001|NCT01812707|37827620|FG002|Overall Study|Adverse Event|0|||
16863002|NCT01812707|37827621|FG003|Overall Study|Adverse Event|2|||
16863003|NCT01812707|37827618|FG000|Overall Study|Poor compliance to protocol|1|||
16863004|NCT01812707|37827619|FG001|Overall Study|Poor compliance to protocol|0|||
16863005|NCT01812707|37827620|FG002|Overall Study|Poor compliance to protocol|0|||
16863006|NCT01812707|37827621|FG003|Overall Study|Poor compliance to protocol|0|||
16863007|NCT01812707|37827618|FG000|Overall Study|Consent withdrawn by participant|1|||
16863008|NCT01812707|37827619|FG001|Overall Study|Consent withdrawn by participant|0|||
16863009|NCT01812707|37827620|FG002|Overall Study|Consent withdrawn by participant|0|||
16863010|NCT01812707|37827621|FG003|Overall Study|Consent withdrawn by participant|0|||
16863011|NCT01787279|37827632|FG000|Overall Study|Lost to Follow-up|2|||
16863012|NCT01787279|37827632|FG000|Overall Study|Lack of Efficacy|1|||
16863013|NCT02728206|37827636|FG000|Overall Study|Death|1|||
16863014|NCT01811225|37827640|FG000|Treatment Period 1|Adverse Event|2|||
16863015|NCT01811225|37827641|FG001|Treatment Period 1|Adverse Event|3|||
16863016|NCT01811225|37827640|FG000|Treatment Period 1|Lost to Follow-up|12|||
16863017|NCT01811225|37827641|FG001|Treatment Period 1|Lost to Follow-up|8|||
16863018|NCT01811225|37827640|FG000|Treatment Period 1|transporation|1|||
16863019|NCT01811225|37827641|FG001|Treatment Period 1|transporation|0|||
16863020|NCT01811225|37827640|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
16863021|NCT01811225|37827641|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
16863022|NCT01811225|37827640|FG000|Treatment Period 2|Lost to Follow-up|1|||
16863023|NCT01811225|37827641|FG001|Treatment Period 2|Lost to Follow-up|2|||
16863024|NCT01811225|37827640|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
16863025|NCT01811225|37827641|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
16863026|NCT01809197|37827649|FG000|Overall Study|Lost to Follow-up|4|||
16863027|NCT01809197|37827650|FG001|Overall Study|Lost to Follow-up|2|||
16863028|NCT01809197|37827649|FG000|Overall Study|Adverse Event|2|||
16863029|NCT01809197|37827650|FG001|Overall Study|Adverse Event|3|||
16863030|NCT01809197|37827649|FG000|Overall Study|Failed slit lamp exam|1|||
16863031|NCT01809197|37827650|FG001|Overall Study|Failed slit lamp exam|0|||
16863032|NCT01809197|37827649|FG000|Overall Study|Non-Compliance|1|||
16863033|NCT01809197|37827650|FG001|Overall Study|Non-Compliance|1|||
16863034|NCT01809197|37827649|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
16863035|NCT01809197|37827650|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
16863036|NCT01809197|37827649|FG000|Overall Study|Withdrawal by Subject|1|||
16863037|NCT01809197|37827650|FG001|Overall Study|Withdrawal by Subject|1|||
16863038|NCT01809197|37827649|FG000|Overall Study|Product not available|0|||
16863039|NCT01809197|37827650|FG001|Overall Study|Product not available|1|||
16863040|NCT01786109|37827659|FG000|Overall Study|fail manometry barostat tube placement|1|||
16863041|NCT01786109|37827660|FG001|Overall Study|fail manometry barostat tube placement|0|||
16863042|NCT01786109|37827661|FG002|Overall Study|fail manometry barostat tube placement|0|||
16863043|NCT01786109|37827659|FG000|Overall Study|unrelated illness|0|||
16863044|NCT01786109|37827660|FG001|Overall Study|unrelated illness|0|||
16863045|NCT01786109|37827661|FG002|Overall Study|unrelated illness|1|||
16863046|NCT01786109|37827659|FG000|Overall Study|adverse effects colon preparation|0|||
16863047|NCT01786109|37827660|FG001|Overall Study|adverse effects colon preparation|0|||
16863048|NCT01786109|37827661|FG002|Overall Study|adverse effects colon preparation|1|||
17127560|NCT03313076|38267913|FG000|Overall Study|Withdrawal by Subject|2|||
16863049|NCT02728830|37827745|FG000|Overall Study|Exclusionary Surgery|9|||
16863050|NCT02728830|37827745|FG000|Overall Study|Exclusionary Pathology|6|||
16863051|NCT02728830|37827745|FG000|Overall Study|Physician Decision|3|||
16863052|NCT02728830|37827745|FG000|Overall Study|Withdrawal by Subject|2|||
16863053|NCT02728830|37827745|FG000|Overall Study|Lost to Follow-up|1|||
16863054|NCT02728830|37827745|FG000|Overall Study|Exclusionary Lab Values|1|||
16863055|NCT02728830|37827745|FG000|Overall Study|Contraindicated Illness|1|||
16863056|NCT02728830|37827745|FG000|Overall Study|Language Barrier|1|||
16863057|NCT02728596|37827799|FG000|Overall Study|Refusal unrelated to adverse event|3|||
16863058|NCT02728596|37827800|FG001|Overall Study|Refusal unrelated to adverse event|6|||
16863059|NCT02728596|37827801|FG002|Overall Study|Refusal unrelated to adverse event|7|||
16863060|NCT02728596|37827802|FG003|Overall Study|Refusal unrelated to adverse event|7|||
16863061|NCT02728596|37827799|FG000|Overall Study|Death|44|||
16863062|NCT02728596|37827800|FG001|Overall Study|Death|42|||
16863063|NCT02728596|37827801|FG002|Overall Study|Death|123|||
16863064|NCT02728596|37827802|FG003|Overall Study|Death|68|||
16863065|NCT00708162|37828185|FG000|Randomized Phase|Randomized but Not Treated|7|||
16863066|NCT00708162|37828186|FG001|Randomized Phase|Randomized but Not Treated|5|||
16863067|NCT00708162|37828185|FG000|Randomized Phase|Participant Noncompliance|40|||
16863068|NCT00708162|37828186|FG001|Randomized Phase|Participant Noncompliance|32|||
16863069|NCT00708162|37828185|FG000|Randomized Phase|Lost to Follow-up|34|||
16863070|NCT00708162|37828186|FG001|Randomized Phase|Lost to Follow-up|34|||
16863071|NCT00708162|37828185|FG000|Randomized Phase|Withdrew Consent|31|||
16863072|NCT00708162|37828186|FG001|Randomized Phase|Withdrew Consent|22|||
16863073|NCT00708162|37828185|FG000|Randomized Phase|Lack of Efficacy|14|||
16863074|NCT00708162|37828186|FG001|Randomized Phase|Lack of Efficacy|19|||
16863075|NCT00708162|37828185|FG000|Randomized Phase|Protocol Violation|10|||
16863076|NCT00708162|37828186|FG001|Randomized Phase|Protocol Violation|11|||
16863077|NCT00708162|37828185|FG000|Randomized Phase|Adverse Event|8|||
16863078|NCT00708162|37828186|FG001|Randomized Phase|Adverse Event|12|||
16863079|NCT00708162|37828185|FG000|Randomized Phase|Investigator's Discretion|7|||
16863080|NCT00708162|37828186|FG001|Randomized Phase|Investigator's Discretion|10|||
16863081|NCT00708162|37828185|FG000|Randomized Phase|Death|2|||
16863082|NCT00708162|37828186|FG001|Randomized Phase|Death|9|||
16863083|NCT00708162|37828185|FG000|Randomized Phase|Pregnancy|3|||
16863084|NCT00708162|37828186|FG001|Randomized Phase|Pregnancy|0|||
16863085|NCT00708162|37828185|FG000|Open-Label Phase|Lost to Follow-up|10|||
16863086|NCT00708162|37828186|FG001|Open-Label Phase|Lost to Follow-up|8|||
16863087|NCT00708162|37828185|FG000|Open-Label Phase|Withdrew Consent|12|||
16863088|NCT00708162|37828186|FG001|Open-Label Phase|Withdrew Consent|6|||
16863089|NCT00708162|37828185|FG000|Open-Label Phase|Participant Noncompliance|7|||
16863090|NCT00708162|37828186|FG001|Open-Label Phase|Participant Noncompliance|7|||
16863091|NCT00708162|37828185|FG000|Open-Label Phase|Lack of Efficacy|7|||
16863092|NCT00708162|37828186|FG001|Open-Label Phase|Lack of Efficacy|4|||
16863093|NCT00708162|37828185|FG000|Open-Label Phase|Investigator's Discretion|3|||
16863094|NCT00708162|37828186|FG001|Open-Label Phase|Investigator's Discretion|2|||
16863095|NCT00708162|37828185|FG000|Open-Label Phase|Death|3|||
16863096|NCT00708162|37828186|FG001|Open-Label Phase|Death|1|||
16863097|NCT00708162|37828185|FG000|Open-Label Phase|Adverse Event|1|||
16863098|NCT00708162|37828186|FG001|Open-Label Phase|Adverse Event|2|||
16863099|NCT00708162|37828185|FG000|Open-Label Phase|Other|1|||
16863100|NCT00708162|37828186|FG001|Open-Label Phase|Other|0|||
16863101|NCT02245672|37828262|FG000|Overall Study|Adverse Event|4|||
16863102|NCT02245672|37828263|FG001|Overall Study|Adverse Event|4|||
16863103|NCT02245672|37828264|FG002|Overall Study|Adverse Event|4|||
16863104|NCT02245672|37828262|FG000|Overall Study|Lost to Follow-up|3|||
16863105|NCT02245672|37828263|FG001|Overall Study|Lost to Follow-up|5|||
16863106|NCT02245672|37828264|FG002|Overall Study|Lost to Follow-up|1|||
16863107|NCT02245672|37828262|FG000|Overall Study|Withdrawal by Subject|6|||
16863108|NCT02245672|37828263|FG001|Overall Study|Withdrawal by Subject|3|||
16863109|NCT02245672|37828264|FG002|Overall Study|Withdrawal by Subject|0|||
16863110|NCT02245672|37828262|FG000|Overall Study|Randomized in error (not treated)|0|||
16863111|NCT02245672|37828263|FG001|Overall Study|Randomized in error (not treated)|1|||
16863112|NCT02245672|37828264|FG002|Overall Study|Randomized in error (not treated)|0|||
16863113|NCT00706992|37828409|FG000|Overall Study|Study termination|5|||
16863114|NCT00706992|37828410|FG001|Overall Study|Study termination|5|||
16863115|NCT00706992|37828411|FG002|Overall Study|Study termination|6|||
16863116|NCT00706992|37828412|FG003|Overall Study|Study termination|2|||
16863117|NCT00706992|37828413|FG004|Overall Study|Study termination|3|||
16863118|NCT00706992|37828414|FG005|Overall Study|Study termination|2|||
16863119|NCT00706992|37828415|FG006|Overall Study|Study termination|3|||
16863120|NCT00706992|37828409|FG000|Overall Study|Disease progression before treatment|0|||
16863121|NCT00706992|37828410|FG001|Overall Study|Disease progression before treatment|0|||
16863122|NCT00706992|37828411|FG002|Overall Study|Disease progression before treatment|0|||
16863123|NCT00706992|37828412|FG003|Overall Study|Disease progression before treatment|0|||
16863124|NCT00706992|37828413|FG004|Overall Study|Disease progression before treatment|1|||
16863125|NCT00706992|37828414|FG005|Overall Study|Disease progression before treatment|0|||
16863126|NCT00706992|37828415|FG006|Overall Study|Disease progression before treatment|0|||
16863127|NCT01785875|37828468|FG000|Overall Study|Withdrawal by Subject|41|||
16863128|NCT01785875|37828469|FG001|Overall Study|Withdrawal by Subject|34|||
16863129|NCT01785875|37828470|FG002|Overall Study|Withdrawal by Subject|36|||
16863130|NCT01785875|37828468|FG000|Overall Study|Lost to Follow-up|19|||
16863131|NCT01785875|37828469|FG001|Overall Study|Lost to Follow-up|22|||
16863132|NCT01785875|37828470|FG002|Overall Study|Lost to Follow-up|6|||
16863133|NCT01785875|37828468|FG000|Overall Study|Death|27|||
16863134|NCT01785875|37828469|FG001|Overall Study|Death|16|||
16863135|NCT01785875|37828470|FG002|Overall Study|Death|7|||
16863136|NCT01785875|37828468|FG000|Overall Study|Sponsor Decision|0|||
16863137|NCT01785875|37828469|FG001|Overall Study|Sponsor Decision|2|||
16863138|NCT01785875|37828470|FG002|Overall Study|Sponsor Decision|0|||
16863139|NCT01785875|37828468|FG000|Overall Study|Protocol Specified Criteria|207|||
16863140|NCT01785875|37828469|FG001|Overall Study|Protocol Specified Criteria|214|||
16863141|NCT01785875|37828470|FG002|Overall Study|Protocol Specified Criteria|55|||
16863142|NCT01785875|37828468|FG000|Overall Study|Missing|0|||
16863143|NCT01785875|37828469|FG001|Overall Study|Missing|1|||
16863144|NCT01785875|37828470|FG002|Overall Study|Missing|3|||
16863145|NCT00706914|37828532|FG000|Overall Study|Lack of Efficacy|0|||
16863146|NCT00706914|37828533|FG001|Overall Study|Lack of Efficacy|1|||
16863147|NCT00706914|37828534|FG002|Overall Study|Lack of Efficacy|0|||
16863148|NCT00706914|37828532|FG000|Overall Study|Lost to Follow-up|1|||
16863149|NCT00706914|37828533|FG001|Overall Study|Lost to Follow-up|0|||
16863150|NCT00706914|37828534|FG002|Overall Study|Lost to Follow-up|0|||
16863151|NCT00706914|37828532|FG000|Overall Study|Adverse Event|2|||
16863152|NCT00706914|37828533|FG001|Overall Study|Adverse Event|2|||
16863153|NCT00706914|37828534|FG002|Overall Study|Adverse Event|0|||
16863154|NCT00706914|37828532|FG000|Overall Study|Protocol Violation|3|||
16863155|NCT00706914|37828533|FG001|Overall Study|Protocol Violation|1|||
16863156|NCT00706914|37828534|FG002|Overall Study|Protocol Violation|1|||
16863157|NCT01808651|37828641|FG000|Study Period 1|Lost to Follow-up|1|||
16863158|NCT01808651|37828642|FG001|Study Period 1|Lost to Follow-up|3|||
16863159|NCT01808651|37828643|FG002|Study Period 1|Lost to Follow-up|0|||
16863160|NCT01808651|37828641|FG000|Study Period 1|Protocol Violation|1|||
16863161|NCT01808651|37828642|FG001|Study Period 1|Protocol Violation|0|||
16863162|NCT01808651|37828643|FG002|Study Period 1|Protocol Violation|1|||
16863163|NCT01808651|37828641|FG000|Study Period 1|Physician Decision|3|||
16863164|NCT01808651|37828642|FG001|Study Period 1|Physician Decision|2|||
16863165|NCT01808651|37828643|FG002|Study Period 1|Physician Decision|0|||
16863166|NCT01808651|37828641|FG000|Study Period 1|Lack of Efficacy|2|||
16863167|NCT01808651|37828642|FG001|Study Period 1|Lack of Efficacy|1|||
16863168|NCT01808651|37828643|FG002|Study Period 1|Lack of Efficacy|0|||
16863169|NCT01808651|37828641|FG000|Study Period 1|Adverse Event|10|||
16863170|NCT01808651|37828642|FG001|Study Period 1|Adverse Event|4|||
16863171|NCT01808651|37828643|FG002|Study Period 1|Adverse Event|1|||
16863172|NCT01808651|37828641|FG000|Study Period 1|Participant Decision|9|||
16863173|NCT01808651|37828642|FG001|Study Period 1|Participant Decision|7|||
16863174|NCT01808651|37828643|FG002|Study Period 1|Participant Decision|3|||
16863175|NCT00706134|37828708|FG000|Overall Study|Adverse Event|8|||
16863176|NCT00706134|37828709|FG001|Overall Study|Adverse Event|7|||
16863177|NCT00706134|37828710|FG002|Overall Study|Adverse Event|2|||
16863178|NCT00706134|37828711|FG003|Overall Study|Adverse Event|3|||
16863179|NCT00706134|37828708|FG000|Overall Study|Lost to Follow-up|0|||
16863180|NCT00706134|37828709|FG001|Overall Study|Lost to Follow-up|1|||
16863181|NCT00706134|37828710|FG002|Overall Study|Lost to Follow-up|0|||
16863182|NCT00706134|37828711|FG003|Overall Study|Lost to Follow-up|0|||
16863183|NCT00706134|37828708|FG000|Overall Study|Protocol Violation|0|||
16863184|NCT00706134|37828709|FG001|Overall Study|Protocol Violation|6|||
16863185|NCT00706134|37828710|FG002|Overall Study|Protocol Violation|0|||
16863186|NCT00706134|37828711|FG003|Overall Study|Protocol Violation|3|||
16863187|NCT00706134|37828708|FG000|Overall Study|Withdrawal by Subject|1|||
16863188|NCT00706134|37828709|FG001|Overall Study|Withdrawal by Subject|2|||
16863189|NCT00706134|37828710|FG002|Overall Study|Withdrawal by Subject|1|||
16863190|NCT00706134|37828711|FG003|Overall Study|Withdrawal by Subject|0|||
16863191|NCT00706134|37828708|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
16863192|NCT00706134|37828709|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16863193|NCT00706134|37828710|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
16863194|NCT00706134|37828711|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
16863195|NCT00706134|37828708|FG000|Overall Study|Did not meet study criteria|2|||
16863196|NCT00706134|37828709|FG001|Overall Study|Did not meet study criteria|0|||
16863197|NCT00706134|37828710|FG002|Overall Study|Did not meet study criteria|0|||
16863198|NCT00706134|37828711|FG003|Overall Study|Did not meet study criteria|0|||
16863199|NCT01808573|37828723|FG000|Overall Study|Death|212|||
16863200|NCT01808573|37828724|FG001|Overall Study|Death|240|||
16863201|NCT01808573|37828723|FG000|Overall Study|Withdrawal by Subject|12|||
16863202|NCT01808573|37828724|FG001|Overall Study|Withdrawal by Subject|10|||
16863203|NCT01808573|37828723|FG000|Overall Study|Lost to Follow-up|3|||
16863204|NCT01808573|37828724|FG001|Overall Study|Lost to Follow-up|0|||
16863205|NCT01808573|37828723|FG000|Overall Study|Discontinuation of study by sponsor|79|||
16944822|NCT01097707|38088864|FG001|Overall Study|Adverse Event|2|||
16863206|NCT01808573|37828724|FG001|Overall Study|Discontinuation of study by sponsor|64|||
16863207|NCT01808573|37828723|FG000|Overall Study|Randomized in Error|1|||
16863208|NCT01808573|37828724|FG001|Overall Study|Randomized in Error|0|||
16863209|NCT02246530|37828751|FG000|Overall Study|Lost to Follow-up|4|||
16863210|NCT02246530|37828752|FG001|Overall Study|Lost to Follow-up|0|||
16863211|NCT01808339|37828758|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16863212|NCT01808339|37828759|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16863213|NCT01808339|37828760|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16863214|NCT01808339|37828761|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
16863215|NCT01808339|37828762|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
16863216|NCT01808339|37828763|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
16863217|NCT01808339|37828758|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16863218|NCT01808339|37828759|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16863219|NCT01808339|37828760|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16863220|NCT01808339|37828761|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16863221|NCT01808339|37828762|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16863222|NCT01808339|37828763|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16863223|NCT01808339|37828758|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16863224|NCT01808339|37828759|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16863225|NCT01808339|37828760|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
16863226|NCT01808339|37828761|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16863227|NCT01808339|37828762|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16863228|NCT01808339|37828763|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16863229|NCT02727660|37828813|FG000|Overall Study|Lack of Efficacy|40|||
16863230|NCT02727660|37828814|FG001|Overall Study|Lack of Efficacy|40|||
16863231|NCT02727660|37828815|FG002|Overall Study|Lack of Efficacy|70|||
16863232|NCT02727660|37828813|FG000|Overall Study|Adverse Event|28|||
16863233|NCT02727660|37828814|FG001|Overall Study|Adverse Event|21|||
16863234|NCT02727660|37828815|FG002|Overall Study|Adverse Event|32|||
16863235|NCT02727660|37828813|FG000|Overall Study|Withdrawal by Subject|26|||
16863236|NCT02727660|37828814|FG001|Overall Study|Withdrawal by Subject|25|||
16863237|NCT02727660|37828815|FG002|Overall Study|Withdrawal by Subject|30|||
16863238|NCT02727660|37828813|FG000|Overall Study|Physician Decision|3|||
16863239|NCT02727660|37828814|FG001|Overall Study|Physician Decision|8|||
16863240|NCT02727660|37828815|FG002|Overall Study|Physician Decision|14|||
16863241|NCT02727660|37828813|FG000|Overall Study|Lost to Follow-up|5|||
16863242|NCT02727660|37828814|FG001|Overall Study|Lost to Follow-up|9|||
16863243|NCT02727660|37828815|FG002|Overall Study|Lost to Follow-up|8|||
16863244|NCT02727660|37828813|FG000|Overall Study|Protocol Violation|7|||
16863245|NCT02727660|37828814|FG001|Overall Study|Protocol Violation|5|||
16863246|NCT02727660|37828815|FG002|Overall Study|Protocol Violation|5|||
16863247|NCT02727660|37828813|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
16863248|NCT02727660|37828814|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
16863249|NCT02727660|37828815|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
16863250|NCT02727660|37828813|FG000|Overall Study|Administrative Reasons|2|||
16863251|NCT02727660|37828814|FG001|Overall Study|Administrative Reasons|3|||
16863252|NCT02727660|37828815|FG002|Overall Study|Administrative Reasons|4|||
16863253|NCT01784861|37828829|FG000|Overall Study|Adverse Event|0|||
16863254|NCT01784861|37828830|FG001|Overall Study|Adverse Event|0|||
16863255|NCT01784861|37828831|FG002|Overall Study|Adverse Event|1|||
16863256|NCT01784861|37828832|FG003|Overall Study|Adverse Event|2|||
16863257|NCT01784861|37828833|FG004|Overall Study|Adverse Event|1|||
16863258|NCT01784861|37828834|FG005|Overall Study|Adverse Event|0|||
16863259|NCT01784861|37828829|FG000|Overall Study|Withdrawal by Subject|0|||
16863260|NCT01784861|37828830|FG001|Overall Study|Withdrawal by Subject|0|||
16863261|NCT01784861|37828831|FG002|Overall Study|Withdrawal by Subject|0|||
16863262|NCT01784861|37828832|FG003|Overall Study|Withdrawal by Subject|1|||
16863263|NCT01784861|37828833|FG004|Overall Study|Withdrawal by Subject|0|||
16863264|NCT01784861|37828834|FG005|Overall Study|Withdrawal by Subject|0|||
16863265|NCT01784861|37828829|FG000|Overall Study|Physician Decision|0|||
16863266|NCT01784861|37828830|FG001|Overall Study|Physician Decision|0|||
16863267|NCT01784861|37828831|FG002|Overall Study|Physician Decision|0|||
16863268|NCT01784861|37828832|FG003|Overall Study|Physician Decision|2|||
16863269|NCT01784861|37828833|FG004|Overall Study|Physician Decision|0|||
16863270|NCT01784861|37828834|FG005|Overall Study|Physician Decision|1|||
16863271|NCT02727192|37828908|FG000|Overall Study|Lost to Follow-up|1|||
16863272|NCT02727192|37828909|FG001|Overall Study|Lost to Follow-up|0|||
16863273|NCT02727192|37828910|FG002|Overall Study|Lost to Follow-up|0|||
16863274|NCT00705666|37828930|FG000|Overall Study|No post-treatment questionnaire|279|||
16863275|NCT00705666|37828930|FG000|Overall Study|Withdrawal by Subject|21|||
17127561|NCT03313076|38267914|FG001|Overall Study|Withdrawal by Subject|0|||
16863276|NCT00705666|37828930|FG000|Overall Study|Physician Decision|7|||
16863277|NCT00705666|37828930|FG000|Overall Study|Lost to Follow-up|5|||
16863278|NCT00705666|37828930|FG000|Overall Study|Death|1|||
16863279|NCT00705666|37828930|FG000|Overall Study|Adverse Event|4|||
16863280|NCT00705666|37828930|FG000|Overall Study|Other|12|||
16863281|NCT00705666|37828930|FG000|Overall Study|Other|2|||
16863282|NCT00705666|37828930|FG000|Overall Study|Lack of data|3|||
16863283|NCT00705666|37828930|FG000|Overall Study|Untreated|5|||
16863284|NCT02725866|37829089|FG000|Overall Study|Failure to return|6|||
16863285|NCT02725866|37829089|FG000|Overall Study|Withdrew consent|3|||
16863286|NCT02725866|37829089|FG000|Overall Study|Insufficient virological response|1|||
16863287|NCT02725866|37829089|FG000|Overall Study|Other, not specified|4|||
16863288|NCT02726022|37829125|FG000|Overall Study|Adverse Event|14|||
16863289|NCT02726022|37829125|FG000|Overall Study|Treatment Failure|8|||
16863290|NCT02726022|37829125|FG000|Overall Study|Poor Compliance|13|||
16863291|NCT02726022|37829125|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
16863292|NCT02725788|37829140|FG000|Overall Study|Lost to Follow-up|1|||
16863293|NCT02725788|37829141|FG001|Overall Study|Lost to Follow-up|1|||
16863294|NCT02725788|37829140|FG000|Overall Study|Protocol Violation|0|||
16863295|NCT02725788|37829141|FG001|Overall Study|Protocol Violation|1|||
16863296|NCT02725710|37829280|FG000|Overall Study|Lost to Follow-up|1|||
16863297|NCT02725710|37829281|FG001|Overall Study|Lost to Follow-up|0|||
16863298|NCT02724462|37829312|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
16863299|NCT02724462|37829313|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
16863300|NCT02724462|37829312|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
16863301|NCT02724462|37829313|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
16863302|NCT02724462|37829312|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
16863303|NCT02724462|37829313|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
16863304|NCT02724462|37829312|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
16863305|NCT02724462|37829313|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
16863306|NCT02724462|37829312|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
16863307|NCT02724462|37829313|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
16863308|NCT02724462|37829312|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
16863309|NCT02724462|37829313|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
16863310|NCT02725476|37829370|FG000|Overall Study|Physician Decision|2|||
16863311|NCT02725476|37829371|FG001|Overall Study|Physician Decision|0|||
16863312|NCT02725476|37829370|FG000|Overall Study|Adverse Event|1|||
16863313|NCT02725476|37829371|FG001|Overall Study|Adverse Event|1|||
16863314|NCT02725008|37829476|FG000|Overall Study|Lost to Follow-up|7|||
16863315|NCT02725008|37829477|FG001|Overall Study|Lost to Follow-up|9|||
16863316|NCT02725008|37829476|FG000|Overall Study|Withdrawal by Subject|2|||
16863317|NCT02725008|37829477|FG001|Overall Study|Withdrawal by Subject|2|||
16863318|NCT02725008|37829476|FG000|Overall Study|Admitted to hospital|0|||
16863319|NCT02725008|37829477|FG001|Overall Study|Admitted to hospital|1|||
16863320|NCT01807949|37829749|FG000|Overall Study|Adverse Event|1|||
16863321|NCT01807949|37829750|FG001|Overall Study|Adverse Event|2|||
16863322|NCT01807949|37829751|FG002|Overall Study|Adverse Event|2|||
16863323|NCT01807949|37829749|FG000|Overall Study|Withdrawal by Subject|1|||
16863324|NCT01807949|37829750|FG001|Overall Study|Withdrawal by Subject|2|||
16863325|NCT01807949|37829751|FG002|Overall Study|Withdrawal by Subject|2|||
16863326|NCT01807949|37829749|FG000|Overall Study|Non-Compliance|0|||
16863327|NCT01807949|37829750|FG001|Overall Study|Non-Compliance|0|||
16863328|NCT01807949|37829751|FG002|Overall Study|Non-Compliance|1|||
16863329|NCT01807949|37829749|FG000|Overall Study|Undefined|0|||
16863330|NCT01807949|37829750|FG001|Overall Study|Undefined|1|||
16863331|NCT01807949|37829751|FG002|Overall Study|Undefined|2|||
16863332|NCT01807949|37829749|FG000|Overall Study|Randomized But Not Treated|0|||
16863333|NCT01807949|37829750|FG001|Overall Study|Randomized But Not Treated|2|||
16863334|NCT01807949|37829751|FG002|Overall Study|Randomized But Not Treated|2|||
16863335|NCT01806779|37829763|FG000|Overall Study|Physician Decision|2|||
16863336|NCT01806779|37829764|FG001|Overall Study|Physician Decision|0|||
16863337|NCT01806779|37829765|FG002|Overall Study|Physician Decision|1|||
16863338|NCT01806779|37829763|FG000|Overall Study|Lack of Efficacy|1|||
16863339|NCT01806779|37829764|FG001|Overall Study|Lack of Efficacy|1|||
16863340|NCT01806779|37829765|FG002|Overall Study|Lack of Efficacy|0|||
16863341|NCT01806779|37829763|FG000|Overall Study|Lost to Follow-up|19|||
16863342|NCT01806779|37829764|FG001|Overall Study|Lost to Follow-up|20|||
16863343|NCT01806779|37829765|FG002|Overall Study|Lost to Follow-up|0|||
16863344|NCT01806779|37829763|FG000|Overall Study|Withdrawal by Subject|20|||
16863345|NCT01806779|37829764|FG001|Overall Study|Withdrawal by Subject|23|||
16863346|NCT01806779|37829765|FG002|Overall Study|Withdrawal by Subject|22|||
16863347|NCT01607957|37829839|FG000|Overall Study|Not treated|1|||
16863348|NCT01607957|37829840|FG001|Overall Study|Not treated|1|||
16863349|NCT01607957|37829839|FG000|Overall Study|Death|367|||
16863350|NCT01607957|37829840|FG001|Overall Study|Death|211|||
16863351|NCT01607957|37829839|FG000|Overall Study|Lost to Follow-up|3|||
16863352|NCT01607957|37829840|FG001|Overall Study|Lost to Follow-up|3|||
16863353|NCT01607957|37829839|FG000|Overall Study|Participant refusal|1|||
16863354|NCT01607957|37829840|FG001|Overall Study|Participant refusal|0|||
16863355|NCT01806623|37829860|FG000|Overall Study|Withdrawal by Subject|1|||
16863356|NCT01806623|37829860|FG000|Overall Study|Adverse Event|1|||
16863357|NCT01806623|37829860|FG000|Overall Study|Did not meet the inclusion criteria|56|||
16863358|NCT01806545|37829866|FG000|Overall Study|Adverse Event|2|||
16863359|NCT01806545|37829867|FG001|Overall Study|Adverse Event|3|||
16863360|NCT01806545|37829866|FG000|Overall Study|Lost to Follow-up|1|||
16863361|NCT01806545|37829867|FG001|Overall Study|Lost to Follow-up|0|||
16863362|NCT01806545|37829866|FG000|Overall Study|Withdrawal by Subject|3|||
16863363|NCT01806545|37829867|FG001|Overall Study|Withdrawal by Subject|2|||
16863364|NCT01806389|37829873|FG000|Overall Study|Withdrawal by Subject|4|||
16863365|NCT01782131|37830129|FG000|Overall Study|Death|93|||
16863366|NCT01782131|37830130|FG001|Overall Study|Death|96|||
16863367|NCT01782131|37830129|FG000|Overall Study|Lost to Follow-up|1|||
16863368|NCT01782131|37830130|FG001|Overall Study|Lost to Follow-up|3|||
16863369|NCT01782131|37830129|FG000|Overall Study|Withdrawal by Subject|10|||
16863370|NCT01782131|37830130|FG001|Overall Study|Withdrawal by Subject|10|||
16863371|NCT01782131|37830129|FG000|Overall Study|Randomized but not treated|5|||
16863372|NCT01782131|37830130|FG001|Overall Study|Randomized but not treated|5|||
16863373|NCT01782131|37830129|FG000|Overall Study|Reason not provided|0|||
16863374|NCT01782131|37830130|FG001|Overall Study|Reason not provided|1|||
16863375|NCT01781975|37830151|FG000|Overall Study|Death|1|||
16863376|NCT01781975|37830152|FG001|Overall Study|Death|0|||
16863377|NCT01781975|37830151|FG000|Overall Study|Withdrawal by Subject|1|||
16863378|NCT01781975|37830152|FG001|Overall Study|Withdrawal by Subject|1|||
16863379|NCT01804673|37830173|FG000|Overall Study|Adverse Event|4|||
16863380|NCT01804673|37830173|FG000|Overall Study|Withdrawal by Subject|1|||
16863381|NCT01804673|37830173|FG000|Overall Study|Lack of Efficacy|9|||
16863382|NCT01804673|37830173|FG000|Overall Study|Change to Oral Therapy|37|||
16863383|NCT01804673|37830173|FG000|Overall Study|No Further Therapy Required|84|||
16863384|NCT01804673|37830173|FG000|Overall Study|Use of Prohibited Medication|1|||
16863385|NCT01804673|37830173|FG000|Overall Study|Other|4|||
16863386|NCT01774097|37830183|FG000|Overall Study|Withdrawal by Subject|1|||
16863387|NCT01774097|37830184|FG001|Overall Study|Withdrawal by Subject|1|||
16863388|NCT01774097|37830183|FG000|Overall Study|Adverse Event|1|||
16863389|NCT01774097|37830184|FG001|Overall Study|Adverse Event|1|||
16863390|NCT02859558|37830258|FG000|Step 1|Not Eligible|0|||
16863391|NCT02859558|37830259|FG001|Step 1|Not Eligible|0|||
16863392|NCT02859558|37830260|FG002|Step 1|Not Eligible|0|||
16863393|NCT02859558|37830261|FG003|Step 1|Not Eligible|0|||
16863394|NCT02859558|37830262|FG004|Step 1|Not Eligible|3|||
16863395|NCT02859558|37830258|FG000|Step 1|Lost to Follow-up|1|||
16863396|NCT02859558|37830259|FG001|Step 1|Lost to Follow-up|3|||
16863397|NCT02859558|37830260|FG002|Step 1|Lost to Follow-up|3|||
16863398|NCT02859558|37830261|FG003|Step 1|Lost to Follow-up|0|||
16944823|NCT01097707|38088865|FG002|Overall Study|Adverse Event|3|||
16944824|NCT01097707|38088866|FG003|Overall Study|Adverse Event|1|||
16944825|NCT01097707|38088867|FG004|Overall Study|Adverse Event|3|||
16944826|NCT01097707|38088863|FG000|Overall Study|Entry Criteria Not Met|2|||
16944827|NCT01097707|38088864|FG001|Overall Study|Entry Criteria Not Met|1|||
16863399|NCT02859558|37830262|FG004|Step 1|Lost to Follow-up|0|||
16863400|NCT02859558|37830258|FG000|Step 1|Did Not Return to Clinic|2|||
16863401|NCT02859558|37830259|FG001|Step 1|Did Not Return to Clinic|3|||
16863402|NCT02859558|37830260|FG002|Step 1|Did Not Return to Clinic|4|||
16863403|NCT02859558|37830261|FG003|Step 1|Did Not Return to Clinic|0|||
16863404|NCT02859558|37830262|FG004|Step 1|Did Not Return to Clinic|0|||
16863405|NCT02859558|37830258|FG000|Step 1|Moved|0|||
16863406|NCT02859558|37830259|FG001|Step 1|Moved|1|||
16863407|NCT02859558|37830260|FG002|Step 1|Moved|1|||
16863408|NCT02859558|37830261|FG003|Step 1|Moved|0|||
16863409|NCT02859558|37830262|FG004|Step 1|Moved|0|||
16863410|NCT02859558|37830258|FG000|Step 1|Withdrawal By Participant|1|||
16863411|NCT02859558|37830259|FG001|Step 1|Withdrawal By Participant|2|||
16863412|NCT02859558|37830260|FG002|Step 1|Withdrawal By Participant|1|||
16863413|NCT02859558|37830261|FG003|Step 1|Withdrawal By Participant|0|||
16863414|NCT02859558|37830262|FG004|Step 1|Withdrawal By Participant|0|||
16863415|NCT02859558|37830258|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
16863416|NCT02859558|37830259|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
16863417|NCT02859558|37830260|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
16863418|NCT02859558|37830261|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
16863419|NCT02859558|37830262|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
16863420|NCT02859558|37830258|FG000|Step 1|Incarceration|0|||
16863421|NCT02859558|37830259|FG001|Step 1|Incarceration|1|||
16863422|NCT02859558|37830260|FG002|Step 1|Incarceration|0|||
16863423|NCT02859558|37830261|FG003|Step 1|Incarceration|0|||
16863424|NCT02859558|37830262|FG004|Step 1|Incarceration|0|||
16863425|NCT02859558|37830258|FG000|Step 1|Non-Adherence to Study Drug|2|||
16863426|NCT02859558|37830259|FG001|Step 1|Non-Adherence to Study Drug|0|||
16863427|NCT02859558|37830260|FG002|Step 1|Non-Adherence to Study Drug|1|||
16863428|NCT02859558|37830261|FG003|Step 1|Non-Adherence to Study Drug|0|||
16863429|NCT02859558|37830262|FG004|Step 1|Non-Adherence to Study Drug|0|||
16863430|NCT02859558|37830258|FG000|Step 1|Non-Adherence to Study Requirements|3|||
16863431|NCT02859558|37830259|FG001|Step 1|Non-Adherence to Study Requirements|1|||
16863432|NCT02859558|37830260|FG002|Step 1|Non-Adherence to Study Requirements|0|||
16863433|NCT02859558|37830261|FG003|Step 1|Non-Adherence to Study Requirements|0|||
16863434|NCT02859558|37830262|FG004|Step 1|Non-Adherence to Study Requirements|0|||
16863435|NCT02859558|37830258|FG000|Step 1|Virologic Failure|2|||
16863436|NCT02859558|37830259|FG001|Step 1|Virologic Failure|1|||
16863437|NCT02859558|37830260|FG002|Step 1|Virologic Failure|1|||
16863438|NCT02859558|37830261|FG003|Step 1|Virologic Failure|0|||
16863439|NCT02859558|37830262|FG004|Step 1|Virologic Failure|0|||
16863440|NCT02859558|37830258|FG000|Step 2|Active On Study|23|||
16863441|NCT02859558|37830259|FG001|Step 2|Active On Study|38|||
16863442|NCT02859558|37830260|FG002|Step 2|Active On Study|20|||
16863443|NCT02859558|37830261|FG003|Step 2|Active On Study|0|||
16863444|NCT02859558|37830262|FG004|Step 2|Active On Study|0|||
16863445|NCT02859558|37830258|FG000|Step 2|Did Not Return to Clinic|2|||
16863446|NCT02859558|37830259|FG001|Step 2|Did Not Return to Clinic|0|||
16863447|NCT02859558|37830260|FG002|Step 2|Did Not Return to Clinic|0|||
16863448|NCT02859558|37830261|FG003|Step 2|Did Not Return to Clinic|0|||
16863449|NCT02859558|37830262|FG004|Step 2|Did Not Return to Clinic|0|||
16863450|NCT02859558|37830258|FG000|Step 2|Unexpected Closure of Site|0|||
16863451|NCT02859558|37830259|FG001|Step 2|Unexpected Closure of Site|1|||
16863452|NCT02859558|37830260|FG002|Step 2|Unexpected Closure of Site|1|||
16863453|NCT02859558|37830261|FG003|Step 2|Unexpected Closure of Site|0|||
16863454|NCT02859558|37830262|FG004|Step 2|Unexpected Closure of Site|0|||
16863455|NCT00705432|37830313|FG000|Treatment Period|Adverse Event|45|||
16863456|NCT00705432|37830314|FG001|Treatment Period|Adverse Event|37|||
16944828|NCT01097707|38088865|FG002|Overall Study|Entry Criteria Not Met|1|||
16863457|NCT00705432|37830315|FG002|Treatment Period|Adverse Event|51|||
16863458|NCT00705432|37830316|FG003|Treatment Period|Adverse Event|12|||
16863459|NCT00705432|37830317|FG004|Treatment Period|Adverse Event|8|||
16863460|NCT00705432|37830318|FG005|Treatment Period|Adverse Event|9|||
16863461|NCT00705432|37830313|FG000|Treatment Period|Treatment failure|92|||
16944829|NCT01097707|38088866|FG003|Overall Study|Entry Criteria Not Met|0|||
17127562|NCT03313076|38267915|FG002|Overall Study|Withdrawal by Subject|0|||
17127563|NCT03313076|38267916|FG003|Overall Study|Withdrawal by Subject|0|||
17127564|NCT03313076|38267913|FG000|Overall Study|Lost to Follow-up|0|||
17127565|NCT03313076|38267914|FG001|Overall Study|Lost to Follow-up|2|||
17127566|NCT03313076|38267915|FG002|Overall Study|Lost to Follow-up|2|||
17127567|NCT03313076|38267916|FG003|Overall Study|Lost to Follow-up|2|||
17127568|NCT02940626|38267934|FG000|Overall Study|Death|40|||
17127569|NCT02940626|38267935|FG001|Overall Study|Death|32|||
17127570|NCT02940626|38267934|FG000|Overall Study|Lost to Follow-up|5|||
17127571|NCT02940626|38267935|FG001|Overall Study|Lost to Follow-up|2|||
17127572|NCT02940626|38267934|FG000|Overall Study|Withdrawal by Subject|1|||
17127573|NCT02940626|38267935|FG001|Overall Study|Withdrawal by Subject|0|||
17127574|NCT02940626|38267934|FG000|Overall Study|Transfer to Hospice Care|1|||
17127575|NCT02940626|38267935|FG001|Overall Study|Transfer to Hospice Care|0|||
17127576|NCT02940626|38267934|FG000|Overall Study|Prohibited Concomitant Medication|0|||
17127577|NCT02940626|38267935|FG001|Overall Study|Prohibited Concomitant Medication|1|||
17127578|NCT03300050|38267948|FG000|Overall Study|Lost to Follow-up|2|||
17127579|NCT03300050|38267949|FG001|Overall Study|Lost to Follow-up|1|||
17127580|NCT03300050|38267950|FG002|Overall Study|Lost to Follow-up|0|||
17127581|NCT03300050|38267951|FG003|Overall Study|Lost to Follow-up|0|||
17127582|NCT03300050|38267952|FG004|Overall Study|Lost to Follow-up|1|||
17127583|NCT03300050|38267948|FG000|Overall Study|Withdrawal by Subject|1|||
17127584|NCT03300050|38267949|FG001|Overall Study|Withdrawal by Subject|1|||
17127585|NCT03300050|38267950|FG002|Overall Study|Withdrawal by Subject|1|||
17127586|NCT03300050|38267951|FG003|Overall Study|Withdrawal by Subject|0|||
17127587|NCT03300050|38267952|FG004|Overall Study|Withdrawal by Subject|0|||
17127588|NCT03300050|38267948|FG000|Overall Study|Death|0|||
17127589|NCT03300050|38267949|FG001|Overall Study|Death|0|||
17127590|NCT03300050|38267950|FG002|Overall Study|Death|1|||
17127591|NCT03300050|38267951|FG003|Overall Study|Death|0|||
16863462|NCT00705432|37830314|FG001|Treatment Period|Treatment failure|42|||
16863463|NCT00705432|37830315|FG002|Treatment Period|Treatment failure|33|||
16863464|NCT00705432|37830316|FG003|Treatment Period|Treatment failure|25|||
16863465|NCT00705432|37830317|FG004|Treatment Period|Treatment failure|13|||
16863466|NCT00705432|37830318|FG005|Treatment Period|Treatment failure|14|||
16863467|NCT00705432|37830313|FG000|Treatment Period|Non medical reason|26|||
16863468|NCT00705432|37830314|FG001|Treatment Period|Non medical reason|32|||
16863469|NCT00705432|37830315|FG002|Treatment Period|Non medical reason|37|||
16863470|NCT00705432|37830316|FG003|Treatment Period|Non medical reason|4|||
16863471|NCT00705432|37830317|FG004|Treatment Period|Non medical reason|7|||
16863472|NCT00705432|37830318|FG005|Treatment Period|Non medical reason|7|||
16863473|NCT00705432|37830313|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
16863474|NCT00705432|37830314|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
16863475|NCT00705432|37830315|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
16863476|NCT00705432|37830316|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
16863477|NCT00705432|37830317|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
16863478|NCT00705432|37830318|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
16863479|NCT00705432|37830313|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
16863480|NCT00705432|37830314|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
16863481|NCT00705432|37830315|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
16863482|NCT00705432|37830316|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
16863483|NCT00705432|37830317|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
16863484|NCT00705432|37830318|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
16863485|NCT00704964|37830329|FG000|Overall Study|Not completed on time|328|||
16863486|NCT00704808|37830345|FG000|Overall Study|Discontinued prior to starting treatment|14|||
16863487|NCT00704808|37830345|FG000|Overall Study|Death|7|||
16863488|NCT00704808|37830345|FG000|Overall Study|Tumor progression|80|||
16863489|NCT00704808|37830345|FG000|Overall Study|Patient's decision|11|||
16863490|NCT00704808|37830345|FG000|Overall Study|Early therapy discontinuation|16|||
16863491|NCT00704808|37830345|FG000|Overall Study|Adverse Event|1|||
16863492|NCT00704808|37830345|FG000|Overall Study|Lost to Follow-up|1|||
16863493|NCT00704808|37830345|FG000|Overall Study|Treatment change|1|||
16863494|NCT05166876|37830379|FG000|Overall Study|Withdrawal by Subject|1|||
16863495|NCT05166876|37830380|FG001|Overall Study|Withdrawal by Subject|0|||
17127592|NCT03300050|38267952|FG004|Overall Study|Death|0|||
17127593|NCT03300050|38267948|FG000|Overall Study|Not Eligible at Randomization|0|||
16863496|NCT05166876|37830381|FG002|Overall Study|Withdrawal by Subject|0|||
16863497|NCT01375608|37830393|FG000|Overall Study|Withdrawal by Subject|2|||
16863498|NCT00704418|37830408|FG000|Overall Study|Withdrawal by Subject|2|||
16863499|NCT00704418|37830409|FG001|Overall Study|Withdrawal by Subject|0|||
16863500|NCT00704418|37830408|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
16863501|NCT00704418|37830409|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
16863502|NCT00704340|37830478|FG000|Overall Study|Lost to Follow-up|2|||
16863503|NCT00704340|37830479|FG001|Overall Study|Lost to Follow-up|1|||
16863504|NCT00704340|37830478|FG000|Overall Study|Death|0|||
16863505|NCT00704340|37830479|FG001|Overall Study|Death|1|||
16863506|NCT00552058|37830487|FG000|Overall Study|Adverse Event|8|||
16863507|NCT00552058|37830488|FG001|Overall Study|Adverse Event|7|||
16863508|NCT00552058|37830487|FG000|Overall Study|Lack of Efficacy|1|||
16863509|NCT00552058|37830488|FG001|Overall Study|Lack of Efficacy|5|||
16863510|NCT00552058|37830487|FG000|Overall Study|Lost to Follow-up|1|||
16863511|NCT00552058|37830488|FG001|Overall Study|Lost to Follow-up|0|||
16863512|NCT00552058|37830487|FG000|Overall Study|Withdrawal by Subject|4|||
16863513|NCT00552058|37830488|FG001|Overall Study|Withdrawal by Subject|4|||
16863514|NCT00552058|37830487|FG000|Overall Study|Other: Protocol Violation|0|||
16863515|NCT00552058|37830488|FG001|Overall Study|Other: Protocol Violation|1|||
16863516|NCT00552058|37830487|FG000|Overall Study|Other: Non Compliance|1|||
16863517|NCT00552058|37830488|FG001|Overall Study|Other: Non Compliance|2|||
16863518|NCT00552058|37830487|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
16863519|NCT00552058|37830488|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
16863520|NCT00552058|37830487|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
16863521|NCT00552058|37830488|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
16863522|NCT00552058|37830487|FG000|Overall Study|Other: Positive Stool Result|0|||
16863523|NCT00552058|37830488|FG001|Overall Study|Other: Positive Stool Result|1|||
16863524|NCT00552058|37830487|FG000|Overall Study|Other: Randomized in error|0|||
16863525|NCT00552058|37830488|FG001|Overall Study|Other: Randomized in error|1|||
16863526|NCT00552058|37830487|FG000|Overall Study|Other: Sponsors Decision|0|||
16863527|NCT00552058|37830488|FG001|Overall Study|Other: Sponsors Decision|1|||
16863528|NCT00552058|37830487|FG000|Overall Study|Other: Early Roll Over|1|||
16863529|NCT00552058|37830488|FG001|Overall Study|Other: Early Roll Over|0|||
16863530|NCT00550732|37830517|FG000|Overall Study|Death|4|||
16863531|NCT00550732|37830517|FG000|Overall Study|Withdrawal by Subject|2|||
16863532|NCT00550732|37830517|FG000|Overall Study|Physician Decision|2|||
16863533|NCT00550732|37830517|FG000|Overall Study|Lost to Follow-up|1|||
16863534|NCT00550732|37830517|FG000|Overall Study|Palliative care|1|||
16863535|NCT00550732|37830517|FG000|Overall Study|Adverse Event|1|||
16863536|NCT00550420|37830531|FG000|Overall Study|Adverse Event|28|||
16863537|NCT00550420|37830531|FG000|Overall Study|Lost to Follow-up|8|||
16863538|NCT00550420|37830531|FG000|Overall Study|Protocol Violation|11|||
16863539|NCT00550420|37830531|FG000|Overall Study|Withdrawal by Subject|30|||
16863540|NCT00550420|37830531|FG000|Overall Study|Still in study at termination|206|||
16863541|NCT00550420|37830531|FG000|Overall Study|Missing|2|||
16863542|NCT00550420|37830531|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
16863543|NCT00550420|37830531|FG000|Overall Study|Investigators opinion|1|||
16863544|NCT00550420|37830531|FG000|Overall Study|Lack of curative effect|1|||
16863545|NCT00550420|37830531|FG000|Overall Study|Unethical stop of enrollment|2|||
16863546|NCT00550420|37830531|FG000|Overall Study|Caregiver's decision to withdraw|1|||
16863547|NCT00550420|37830531|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
16863548|NCT00550420|37830531|FG000|Overall Study|Exclusion criteria|1|||
16863549|NCT00550420|37830531|FG000|Overall Study|Prohibited medicine|1|||
16863550|NCT00558064|37830543|FG000|Overall Study|Adverse Event|3|||
16863551|NCT00558064|37830544|FG001|Overall Study|Adverse Event|2|||
16863552|NCT00558064|37830543|FG000|Overall Study|Lack of Efficacy|0|||
16863553|NCT00558064|37830544|FG001|Overall Study|Lack of Efficacy|1|||
16863554|NCT00558064|37830543|FG000|Overall Study|Protocol Violation|1|||
16863555|NCT00558064|37830544|FG001|Overall Study|Protocol Violation|0|||
16863556|NCT00558064|37830543|FG000|Overall Study|Lost to Follow-up|0|||
16863557|NCT00558064|37830544|FG001|Overall Study|Lost to Follow-up|1|||
16863558|NCT00558064|37830543|FG000|Overall Study|Withdrawal by Subject|0|||
16863559|NCT00558064|37830544|FG001|Overall Study|Withdrawal by Subject|1|||
16863560|NCT00558064|37830543|FG000|Overall Study|No visit within allowance period|1|||
16863561|NCT00558064|37830544|FG001|Overall Study|No visit within allowance period|0|||
16863562|NCT00557830|37830553|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
16863563|NCT00557830|37830554|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
16863564|NCT00557830|37830555|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
16863565|NCT00557830|37830553|FG000|Screening Treatment Phase|Adverse Event|2|||
16863566|NCT00557830|37830554|FG001|Screening Treatment Phase|Adverse Event|0|||
16863567|NCT00557830|37830555|FG002|Screening Treatment Phase|Adverse Event|0|||
16863568|NCT00557830|37830553|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
16863569|NCT00557830|37830554|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
16863570|NCT00557830|37830555|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
16863571|NCT00557440|37830566|FG000|Treatment Period 1|Adverse Event|0|||
16863572|NCT00557440|37830567|FG001|Treatment Period 1|Adverse Event|0|||
16863573|NCT00557440|37830568|FG002|Treatment Period 1|Adverse Event|1|||
16863574|NCT00556894|37830579|FG000|Overall Study|Adverse Event|2|||
16863575|NCT00556894|37830580|FG001|Overall Study|Adverse Event|3|||
16863576|NCT00556894|37830581|FG002|Overall Study|Adverse Event|3|||
16863577|NCT00556894|37830579|FG000|Overall Study|Death|1|||
16863578|NCT00556894|37830580|FG001|Overall Study|Death|0|||
16863579|NCT00556894|37830581|FG002|Overall Study|Death|0|||
16863580|NCT00556894|37830579|FG000|Overall Study|regulatory decision in Bulgaria|10|||
16863581|NCT00556894|37830580|FG001|Overall Study|regulatory decision in Bulgaria|14|||
16863582|NCT00556894|37830581|FG002|Overall Study|regulatory decision in Bulgaria|13|||
16863583|NCT00556894|37830579|FG000|Overall Study|Change in therapy|2|||
16863584|NCT00556894|37830580|FG001|Overall Study|Change in therapy|1|||
16863585|NCT00556894|37830581|FG002|Overall Study|Change in therapy|2|||
16863586|NCT00556894|37830579|FG000|Overall Study|Withdrawal by Subject|1|||
16863587|NCT00556894|37830580|FG001|Overall Study|Withdrawal by Subject|1|||
16863588|NCT00556894|37830581|FG002|Overall Study|Withdrawal by Subject|1|||
17127594|NCT03300050|38267949|FG001|Overall Study|Not Eligible at Randomization|0|||
17127595|NCT03300050|38267950|FG002|Overall Study|Not Eligible at Randomization|1|||
17127596|NCT03300050|38267951|FG003|Overall Study|Not Eligible at Randomization|1|||
17127597|NCT03300050|38267952|FG004|Overall Study|Not Eligible at Randomization|0|||
17127598|NCT03725085|38267964|FG000|Overall Study|Lost to Follow-up|2|||
17127599|NCT02940392|38267969|FG000|Overall Study|Lost to Follow-up|3|||
17127600|NCT02940392|38267969|FG000|Overall Study|Retreatment|3|||
17127601|NCT02940392|38267969|FG000|Overall Study|Death|2|||
17127602|NCT03298412|38267982|FG000|Run-in Period|Other, Not Specified|1|||
17127603|NCT03298412|38267982|FG000|Run-in Period|Disease Progression|1|||
17127604|NCT03298412|38267982|FG000|Run-in Period|Ineligibility Determined|1|||
17127605|NCT03298412|38267982|FG000|Run-in Period|Decision by Sponsor|6|||
17127606|NCT03297398|38267989|FG000|Overall Study|Sponsor's decision|6|||
17127607|NCT03297398|38267990|FG001|Overall Study|Sponsor's decision|9|||
17127608|NCT03297398|38267991|FG002|Overall Study|Sponsor's decision|7|||
17127609|NCT03297398|38267989|FG000|Overall Study|Adverse Event|1|||
17127610|NCT03297398|38267990|FG001|Overall Study|Adverse Event|4|||
17127611|NCT03297398|38267991|FG002|Overall Study|Adverse Event|4|||
17127612|NCT03297398|38267989|FG000|Overall Study|Withdrawal by Subject|1|||
17127613|NCT03297398|38267990|FG001|Overall Study|Withdrawal by Subject|2|||
17127614|NCT03297398|38267991|FG002|Overall Study|Withdrawal by Subject|2|||
17127615|NCT03297398|38267989|FG000|Overall Study|Protocol Violation|0|||
17127616|NCT03297398|38267990|FG001|Overall Study|Protocol Violation|2|||
17127617|NCT03297398|38267991|FG002|Overall Study|Protocol Violation|0|||
17127618|NCT03297398|38267989|FG000|Overall Study|Physician Decision|0|||
17127619|NCT03297398|38267990|FG001|Overall Study|Physician Decision|0|||
17127620|NCT03297398|38267991|FG002|Overall Study|Physician Decision|1|||
17127621|NCT03297398|38267989|FG000|Overall Study|Lost to Follow-up|0|||
16863589|NCT02722044|37830589|FG000|Overall Study|Adverse Event|2|||
16863590|NCT02722044|37830589|FG000|Overall Study|Physician Decision|1|||
16863591|NCT02722044|37830589|FG000|Overall Study|Withdrawal by Subject|1|||
16863592|NCT02722044|37830589|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
16863593|NCT00556426|37830594|FG000|Overall Study|Withdrawal by Subject|3|||
16863594|NCT00556426|37830594|FG000|Overall Study|Death|6|||
16863595|NCT00555568|37830602|FG000|Overall Study|Lost to Follow-up|26|||
16863596|NCT00555568|37830603|FG001|Overall Study|Lost to Follow-up|16|||
16863597|NCT00555568|37830604|FG002|Overall Study|Lost to Follow-up|16|||
16863598|NCT00702702|37830615|FG000|Overall Study|Study prematurely terminated|56|||
16863599|NCT02721966|37830626|FG000|Overall Study|Protocol Violation|1|||
16863600|NCT02721966|37830627|FG001|Overall Study|Protocol Violation|0|||
16863601|NCT02721966|37830628|FG002|Overall Study|Protocol Violation|0|||
16863602|NCT02721966|37830629|FG003|Overall Study|Protocol Violation|0|||
16863603|NCT02721966|37830630|FG004|Overall Study|Protocol Violation|0|||
16863604|NCT02721966|37830626|FG000|Overall Study|Withdrawal by Subject|9|||
16863605|NCT02721966|37830627|FG001|Overall Study|Withdrawal by Subject|2|||
16863606|NCT02721966|37830628|FG002|Overall Study|Withdrawal by Subject|3|||
16863607|NCT02721966|37830629|FG003|Overall Study|Withdrawal by Subject|7|||
16863608|NCT02721966|37830630|FG004|Overall Study|Withdrawal by Subject|0|||
16863609|NCT02721966|37830626|FG000|Overall Study|Adverse Event|4|||
16863610|NCT02721966|37830627|FG001|Overall Study|Adverse Event|4|||
16863611|NCT02721966|37830628|FG002|Overall Study|Adverse Event|3|||
16863612|NCT02721966|37830629|FG003|Overall Study|Adverse Event|0|||
16863613|NCT02721966|37830630|FG004|Overall Study|Adverse Event|0|||
16863614|NCT02721966|37830626|FG000|Overall Study|Death|1|||
16863615|NCT02721966|37830627|FG001|Overall Study|Death|0|||
16863616|NCT02721966|37830628|FG002|Overall Study|Death|0|||
16863617|NCT02721966|37830629|FG003|Overall Study|Death|0|||
16863618|NCT02721966|37830630|FG004|Overall Study|Death|0|||
17127622|NCT03297398|38267990|FG001|Overall Study|Lost to Follow-up|0|||
16863619|NCT02721966|37830626|FG000|Overall Study|Lack of Efficacy|7|||
16863620|NCT02721966|37830627|FG001|Overall Study|Lack of Efficacy|4|||
16863621|NCT02721966|37830628|FG002|Overall Study|Lack of Efficacy|0|||
16863622|NCT02721966|37830629|FG003|Overall Study|Lack of Efficacy|0|||
16863623|NCT02721966|37830630|FG004|Overall Study|Lack of Efficacy|0|||
17127623|NCT03297398|38267991|FG002|Overall Study|Lost to Follow-up|1|||
17127624|NCT03293654|38268002|FG000|Overall Study|Lost to Follow-up|0|||
17127625|NCT03293654|38268003|FG001|Overall Study|Lost to Follow-up|1|||
16863624|NCT02721966|37830626|FG000|Overall Study|Lost to Follow-up|0|||
16863625|NCT02721966|37830627|FG001|Overall Study|Lost to Follow-up|0|||
16863626|NCT02721966|37830628|FG002|Overall Study|Lost to Follow-up|3|||
16863627|NCT02721966|37830629|FG003|Overall Study|Lost to Follow-up|0|||
16863628|NCT02721966|37830630|FG004|Overall Study|Lost to Follow-up|0|||
16863629|NCT02721966|37830626|FG000|Overall Study|Physician Decision|1|||
16863630|NCT02721966|37830627|FG001|Overall Study|Physician Decision|1|||
16863631|NCT02721966|37830628|FG002|Overall Study|Physician Decision|0|||
16863632|NCT02721966|37830629|FG003|Overall Study|Physician Decision|0|||
16863633|NCT02721966|37830630|FG004|Overall Study|Physician Decision|0|||
16863634|NCT02721966|37830626|FG000|Overall Study|Pregnancy|1|||
16863635|NCT02721966|37830627|FG001|Overall Study|Pregnancy|0|||
16863636|NCT02721966|37830628|FG002|Overall Study|Pregnancy|0|||
16863637|NCT02721966|37830629|FG003|Overall Study|Pregnancy|0|||
16863638|NCT02721966|37830630|FG004|Overall Study|Pregnancy|0|||
16863639|NCT02721966|37830626|FG000|Overall Study|Did not continue to period 2|5|||
16863640|NCT02721966|37830627|FG001|Overall Study|Did not continue to period 2|12|||
16863641|NCT02721966|37830628|FG002|Overall Study|Did not continue to period 2|0|||
16863642|NCT02721966|37830629|FG003|Overall Study|Did not continue to period 2|0|||
16863643|NCT02721966|37830630|FG004|Overall Study|Did not continue to period 2|5|||
16863644|NCT00553462|37830638|FG000|Overall Study|Adverse Event|4|||
16863645|NCT00553462|37830638|FG000|Overall Study|Progression|4|||
16863646|NCT00553462|37830638|FG000|Overall Study|Withdrawal by Subject|5|||
16863647|NCT00553462|37830638|FG000|Overall Study|Physician Decision|1|||
16863648|NCT00553150|37830644|FG000|Overall Study|Withdrawal by Subject|0|||
16863649|NCT00553150|37830645|FG001|Overall Study|Withdrawal by Subject|0|||
16863650|NCT00553150|37830646|FG002|Overall Study|Withdrawal by Subject|0|||
16863651|NCT00553150|37830647|FG003|Overall Study|Withdrawal by Subject|2|||
16863652|NCT00553150|37830644|FG000|Overall Study|Protocol Violation|0|||
16863653|NCT00553150|37830645|FG001|Overall Study|Protocol Violation|0|||
16863654|NCT00553150|37830646|FG002|Overall Study|Protocol Violation|0|||
16863655|NCT00553150|37830647|FG003|Overall Study|Protocol Violation|1|||
16863656|NCT00553150|37830644|FG000|Overall Study|Ineligible|0|||
16863657|NCT00553150|37830645|FG001|Overall Study|Ineligible|0|||
16863658|NCT00553150|37830646|FG002|Overall Study|Ineligible|0|||
16863659|NCT00553150|37830647|FG003|Overall Study|Ineligible|1|||
16863660|NCT03301350|37830655|FG000|Overall Study|Withdrawal by Subject|4|||
16863661|NCT03301350|37830655|FG000|Overall Study|Adverse Event|1|||
16863662|NCT03301350|37830655|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
16863663|NCT03301350|37830655|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
16863664|NCT03301350|37830655|FG000|Overall Study|no detail provided|1|||
16863665|NCT04735432|37830662|FG000|Overall Study|Other - due to personal reason|1|||
16863666|NCT04735432|37830663|FG001|Overall Study|Other - due to personal reason|0|||
16863667|NCT04735432|37830662|FG000|Overall Study|Adverse Event|2|||
16863668|NCT04735432|37830663|FG001|Overall Study|Adverse Event|0|||
16863669|NCT02722278|37830672|FG000|Overall Study|Withdrawal by Subject|5|||
16863670|NCT02722278|37830673|FG001|Overall Study|Withdrawal by Subject|3|||
16863671|NCT02722278|37830672|FG000|Overall Study|Adverse Event|4|||
16863672|NCT02722278|37830673|FG001|Overall Study|Adverse Event|1|||
16863673|NCT02722278|37830672|FG000|Overall Study|Lost to Follow-up|2|||
16863674|NCT02722278|37830673|FG001|Overall Study|Lost to Follow-up|0|||
16863675|NCT02722278|37830672|FG000|Overall Study|Protocol Violation|1|||
16863676|NCT02722278|37830673|FG001|Overall Study|Protocol Violation|0|||
16863677|NCT02722278|37830672|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
16863678|NCT02722278|37830673|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
16863679|NCT02722278|37830672|FG000|Overall Study|Subject declined after tx assignment|0|||
16863680|NCT02722278|37830673|FG001|Overall Study|Subject declined after tx assignment|1|||
16863681|NCT02722278|37830672|FG000|Overall Study|Site closure not study related|0|||
16863682|NCT02722278|37830673|FG001|Overall Study|Site closure not study related|1|||
16863683|NCT00703092|37830681|FG000|Overall Study|Withdrawal by Subject|2|||
16863684|NCT02720484|37830685|FG000|Treatment on Study|Adverse Event|1|||
16863685|NCT02720484|37830685|FG000|Treatment on Study|Withdrawal by Subject|1|||
16863686|NCT02720484|37830685|FG000|Treatment on Study|Progressive Disease|4|||
16863687|NCT02720484|37830685|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
16863688|NCT02720484|37830685|FG000|Follow Up for 2 Years|Death|3|||
16863689|NCT02720484|37830685|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
16863690|NCT02715804|37830691|FG000|Overall Study|Death|222|||
16863691|NCT02715804|37830692|FG001|Overall Study|Death|106|||
16863692|NCT02715804|37830691|FG000|Overall Study|Withdrawal by Subject|5|||
16863693|NCT02715804|37830692|FG001|Overall Study|Withdrawal by Subject|4|||
16863694|NCT02715804|37830691|FG000|Overall Study|Other than specified|2|||
16863695|NCT02715804|37830692|FG001|Overall Study|Other than specified|3|||
16863696|NCT02717832|37830698|FG000|Overall Study|Inability to place IV|3|||
16863697|NCT02717754|37830709|FG000|Overall Study|Incorrect Infusion Duration|0|||
16863698|NCT02717754|37830710|FG001|Overall Study|Incorrect Infusion Duration|0|||
16863699|NCT02717754|37830711|FG002|Overall Study|Incorrect Infusion Duration|0|||
16863700|NCT02717754|37830712|FG003|Overall Study|Incorrect Infusion Duration|10|||
16863701|NCT02717754|37830713|FG004|Overall Study|Incorrect Infusion Duration|20|||
16863702|NCT02717754|37830714|FG005|Overall Study|Incorrect Infusion Duration|20|||
16863703|NCT02927262|37830726|FG000|Overall Study|Adverse Event|7|||
16863704|NCT02927262|37830727|FG001|Overall Study|Adverse Event|1|||
16863705|NCT02927262|37830726|FG000|Overall Study|Death|1|||
16863706|NCT02927262|37830727|FG001|Overall Study|Death|0|||
16863707|NCT02927262|37830726|FG000|Overall Study|Withdrawal by Subject|3|||
16863708|NCT02927262|37830727|FG001|Overall Study|Withdrawal by Subject|0|||
16863709|NCT02927262|37830726|FG000|Overall Study|Disease Relapse|23|||
16863710|NCT02927262|37830727|FG001|Overall Study|Disease Relapse|18|||
16863711|NCT02927262|37830726|FG000|Overall Study|Miscellaneous|5|||
16863712|NCT02927262|37830727|FG001|Overall Study|Miscellaneous|4|||
16863713|NCT02927262|37830726|FG000|Overall Study|Ongoing|4|||
16863714|NCT02927262|37830727|FG001|Overall Study|Ongoing|0|||
16863715|NCT02717130|37830733|FG000|Overall Study|Withdrawal by Subject|1|||
16863716|NCT02717130|37830733|FG000|Overall Study|Adverse Event|1|||
16863717|NCT02717130|37830733|FG000|Overall Study|Physician Decision|1|||
16863718|NCT02717130|37830733|FG000|Overall Study|Study Closure|4|||
16863719|NCT02192502|37830739|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
16863720|NCT02192502|37830740|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
16863721|NCT02192502|37830739|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
16863722|NCT02192502|37830740|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
16863723|NCT02192502|37830739|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
16863724|NCT02192502|37830740|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
16863725|NCT01781429|37830761|FG000|Overall Study|Death|0|||
16863726|NCT01781429|37830762|FG001|Overall Study|Death|0|||
16863727|NCT01781429|37830763|FG002|Overall Study|Death|0|||
16863728|NCT01781429|37830764|FG003|Overall Study|Death|0|||
16863729|NCT01781429|37830765|FG004|Overall Study|Death|0|||
16863730|NCT01781429|37830766|FG005|Overall Study|Death|0|||
16863731|NCT01781429|37830767|FG006|Overall Study|Death|0|||
16863732|NCT01781429|37830768|FG007|Overall Study|Death|0|||
16863733|NCT01781429|37830769|FG008|Overall Study|Death|0|||
16863734|NCT01781429|37830770|FG009|Overall Study|Death|1|||
16863735|NCT01781429|37830771|FG010|Overall Study|Death|0|||
16863736|NCT01781429|37830772|FG011|Overall Study|Death|0|||
16863737|NCT01781429|37830773|FG012|Overall Study|Death|1|||
16863738|NCT01781429|37830774|FG013|Overall Study|Death|0|||
16863739|NCT01781429|37830775|FG014|Overall Study|Death|1|||
16863740|NCT01781429|37830776|FG015|Overall Study|Death|0|||
16863741|NCT01781429|37830761|FG000|Overall Study|Withdrawal by Subject|0|||
16863742|NCT01781429|37830762|FG001|Overall Study|Withdrawal by Subject|0|||
16863743|NCT01781429|37830763|FG002|Overall Study|Withdrawal by Subject|0|||
16863744|NCT01781429|37830764|FG003|Overall Study|Withdrawal by Subject|0|||
16863745|NCT01781429|37830765|FG004|Overall Study|Withdrawal by Subject|0|||
16863746|NCT01781429|37830766|FG005|Overall Study|Withdrawal by Subject|0|||
16863747|NCT01781429|37830767|FG006|Overall Study|Withdrawal by Subject|0|||
16863748|NCT01781429|37830768|FG007|Overall Study|Withdrawal by Subject|0|||
16863749|NCT01781429|37830769|FG008|Overall Study|Withdrawal by Subject|1|||
16863750|NCT01781429|37830770|FG009|Overall Study|Withdrawal by Subject|3|||
16863751|NCT01781429|37830771|FG010|Overall Study|Withdrawal by Subject|1|||
16863752|NCT01781429|37830772|FG011|Overall Study|Withdrawal by Subject|1|||
16863753|NCT01781429|37830773|FG012|Overall Study|Withdrawal by Subject|5|||
16863754|NCT01781429|37830774|FG013|Overall Study|Withdrawal by Subject|2|||
16863755|NCT01781429|37830775|FG014|Overall Study|Withdrawal by Subject|3|||
16863756|NCT01781429|37830776|FG015|Overall Study|Withdrawal by Subject|0|||
16863757|NCT01781429|37830761|FG000|Overall Study|Disease Progression|1|||
16863758|NCT01781429|37830762|FG001|Overall Study|Disease Progression|0|||
16863759|NCT01781429|37830763|FG002|Overall Study|Disease Progression|1|||
16863760|NCT01781429|37830764|FG003|Overall Study|Disease Progression|1|||
16863761|NCT01781429|37830765|FG004|Overall Study|Disease Progression|1|||
16863762|NCT01781429|37830766|FG005|Overall Study|Disease Progression|4|||
16863763|NCT01781429|37830767|FG006|Overall Study|Disease Progression|7|||
16863764|NCT01781429|37830768|FG007|Overall Study|Disease Progression|4|||
16863765|NCT01781429|37830769|FG008|Overall Study|Disease Progression|6|||
16863766|NCT01781429|37830770|FG009|Overall Study|Disease Progression|15|||
16863767|NCT01781429|37830771|FG010|Overall Study|Disease Progression|15|||
16863768|NCT01781429|37830772|FG011|Overall Study|Disease Progression|15|||
16863769|NCT01781429|37830773|FG012|Overall Study|Disease Progression|15|||
16863770|NCT01781429|37830774|FG013|Overall Study|Disease Progression|4|||
16863771|NCT01781429|37830775|FG014|Overall Study|Disease Progression|11|||
16863772|NCT01781429|37830776|FG015|Overall Study|Disease Progression|0|||
16863773|NCT01781429|37830761|FG000|Overall Study|Unacceptable Toxicity|0|||
16863774|NCT01781429|37830762|FG001|Overall Study|Unacceptable Toxicity|0|||
16863775|NCT01781429|37830763|FG002|Overall Study|Unacceptable Toxicity|0|||
16863776|NCT01781429|37830764|FG003|Overall Study|Unacceptable Toxicity|0|||
16863777|NCT01781429|37830765|FG004|Overall Study|Unacceptable Toxicity|0|||
16863778|NCT01781429|37830766|FG005|Overall Study|Unacceptable Toxicity|0|||
16863779|NCT01781429|37830767|FG006|Overall Study|Unacceptable Toxicity|0|||
16863780|NCT01781429|37830768|FG007|Overall Study|Unacceptable Toxicity|0|||
16863781|NCT01781429|37830769|FG008|Overall Study|Unacceptable Toxicity|0|||
16863782|NCT01781429|37830770|FG009|Overall Study|Unacceptable Toxicity|0|||
16863783|NCT01781429|37830771|FG010|Overall Study|Unacceptable Toxicity|0|||
16863784|NCT01781429|37830772|FG011|Overall Study|Unacceptable Toxicity|2|||
16863785|NCT01781429|37830773|FG012|Overall Study|Unacceptable Toxicity|0|||
16863786|NCT01781429|37830774|FG013|Overall Study|Unacceptable Toxicity|0|||
16863787|NCT01781429|37830775|FG014|Overall Study|Unacceptable Toxicity|0|||
16863788|NCT01781429|37830776|FG015|Overall Study|Unacceptable Toxicity|0|||
16863789|NCT01781429|37830761|FG000|Overall Study|Patient Condition Changed|0|||
16863790|NCT01781429|37830762|FG001|Overall Study|Patient Condition Changed|0|||
16863791|NCT01781429|37830763|FG002|Overall Study|Patient Condition Changed|0|||
16863792|NCT01781429|37830764|FG003|Overall Study|Patient Condition Changed|0|||
16863793|NCT01781429|37830765|FG004|Overall Study|Patient Condition Changed|0|||
16863794|NCT01781429|37830766|FG005|Overall Study|Patient Condition Changed|0|||
16863795|NCT01781429|37830767|FG006|Overall Study|Patient Condition Changed|0|||
16863796|NCT01781429|37830768|FG007|Overall Study|Patient Condition Changed|0|||
16863797|NCT01781429|37830769|FG008|Overall Study|Patient Condition Changed|0|||
16863798|NCT01781429|37830770|FG009|Overall Study|Patient Condition Changed|4|||
16863799|NCT01781429|37830771|FG010|Overall Study|Patient Condition Changed|0|||
16863800|NCT01781429|37830772|FG011|Overall Study|Patient Condition Changed|1|||
16863801|NCT01781429|37830773|FG012|Overall Study|Patient Condition Changed|0|||
16863802|NCT01781429|37830774|FG013|Overall Study|Patient Condition Changed|1|||
16863803|NCT01781429|37830775|FG014|Overall Study|Patient Condition Changed|0|||
16863804|NCT01781429|37830776|FG015|Overall Study|Patient Condition Changed|0|||
16863805|NCT01781429|37830761|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
16863806|NCT01781429|37830762|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
16863807|NCT01781429|37830763|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
16863808|NCT01781429|37830764|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
16863809|NCT01781429|37830765|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
16863810|NCT01781429|37830766|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
16863811|NCT01781429|37830767|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
16944830|NCT01097707|38088867|FG004|Overall Study|Entry Criteria Not Met|1|||
16944831|NCT01097707|38088863|FG000|Overall Study|Lack of Efficacy|1|||
16944832|NCT01097707|38088864|FG001|Overall Study|Lack of Efficacy|0|||
16863812|NCT01781429|37830768|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
16863813|NCT01781429|37830769|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
16863814|NCT01781429|37830770|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
16863815|NCT01781429|37830771|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
16863816|NCT01781429|37830772|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
16863817|NCT01781429|37830773|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
16863818|NCT01781429|37830774|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
16863819|NCT01781429|37830775|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
16863820|NCT01781429|37830776|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
16863821|NCT01781429|37830761|FG000|Overall Study|Enrolled, but not treated|0|||
16863822|NCT01781429|37830762|FG001|Overall Study|Enrolled, but not treated|0|||
16944833|NCT01097707|38088865|FG002|Overall Study|Lack of Efficacy|0|||
16863823|NCT01781429|37830763|FG002|Overall Study|Enrolled, but not treated|0|||
16863824|NCT01781429|37830764|FG003|Overall Study|Enrolled, but not treated|0|||
16863825|NCT01781429|37830765|FG004|Overall Study|Enrolled, but not treated|0|||
16863826|NCT01781429|37830766|FG005|Overall Study|Enrolled, but not treated|0|||
16863827|NCT01781429|37830767|FG006|Overall Study|Enrolled, but not treated|0|||
16863828|NCT01781429|37830768|FG007|Overall Study|Enrolled, but not treated|0|||
16863829|NCT01781429|37830769|FG008|Overall Study|Enrolled, but not treated|0|||
16863830|NCT01781429|37830770|FG009|Overall Study|Enrolled, but not treated|0|||
16863831|NCT01781429|37830771|FG010|Overall Study|Enrolled, but not treated|1|||
16863832|NCT01781429|37830772|FG011|Overall Study|Enrolled, but not treated|0|||
16863833|NCT01781429|37830773|FG012|Overall Study|Enrolled, but not treated|0|||
16863834|NCT01781429|37830774|FG013|Overall Study|Enrolled, but not treated|0|||
16863835|NCT01781429|37830775|FG014|Overall Study|Enrolled, but not treated|0|||
16863836|NCT01781429|37830776|FG015|Overall Study|Enrolled, but not treated|0|||
16863837|NCT01773473|37830811|FG000|Overall Study|Adverse Event|3|||
16863838|NCT01773473|37830812|FG001|Overall Study|Adverse Event|2|||
16863839|NCT01773473|37830811|FG000|Overall Study|Protocol Violation|0|||
16863840|NCT01773473|37830812|FG001|Overall Study|Protocol Violation|4|||
16863841|NCT01773473|37830811|FG000|Overall Study|Physician Decision|3|||
16863842|NCT01773473|37830812|FG001|Overall Study|Physician Decision|5|||
16863843|NCT01773473|37830811|FG000|Overall Study|Sponsor Decision|2|||
16863844|NCT01773473|37830812|FG001|Overall Study|Sponsor Decision|0|||
16863845|NCT01773473|37830811|FG000|Overall Study|Lack of Efficacy|0|||
16863846|NCT01773473|37830812|FG001|Overall Study|Lack of Efficacy|1|||
16863847|NCT01773473|37830811|FG000|Overall Study|Non-Compliance with study drug|1|||
16863848|NCT01773473|37830812|FG001|Overall Study|Non-Compliance with study drug|4|||
16863849|NCT01773473|37830811|FG000|Overall Study|Withdrawal by Subject|5|||
16863850|NCT01773473|37830812|FG001|Overall Study|Withdrawal by Subject|3|||
16863851|NCT01773473|37830811|FG000|Overall Study|Lost to Follow-up|2|||
16863852|NCT01773473|37830812|FG001|Overall Study|Lost to Follow-up|0|||
16863853|NCT01772693|37830820|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
16863854|NCT01772693|37830821|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
16863855|NCT01772693|37830820|FG000|Overall Study|Withdrawal by Subject|2|||
16863856|NCT01772693|37830821|FG001|Overall Study|Withdrawal by Subject|0|||
16863857|NCT01772693|37830820|FG000|Overall Study|Alternative Treatment|2|||
16863858|NCT01772693|37830821|FG001|Overall Study|Alternative Treatment|0|||
16863859|NCT01779869|37830827|FG000|Overall Study|Physician Decision|2|||
16863860|NCT01772537|37830834|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
16863861|NCT01772537|37830835|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
16863862|NCT01772537|37830836|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
17028421|NCT00783692|38172778|FG001|Maintenance Phase|Lack of Efficacy|0|||
17028422|NCT00783692|38172779|FG002|Maintenance Phase|Lack of Efficacy|0|||
17028423|NCT00783692|38172780|FG003|Maintenance Phase|Lack of Efficacy|64|||
17028424|NCT00783692|38172781|FG004|Maintenance Phase|Lack of Efficacy|58|||
16863863|NCT01772147|37830849|FG000|Overall Study|Adverse Event|13|||
16863864|NCT01772147|37830850|FG001|Overall Study|Adverse Event|10|||
16863865|NCT01772147|37830851|FG002|Overall Study|Adverse Event|6|||
16863866|NCT01772147|37830849|FG000|Overall Study|Withdrew Consent|7|||
16863867|NCT01772147|37830850|FG001|Overall Study|Withdrew Consent|8|||
17028425|NCT00783692|38172782|FG005|Maintenance Phase|Lack of Efficacy|48|||
16863868|NCT01772147|37830851|FG002|Overall Study|Withdrew Consent|4|||
16944834|NCT01097707|38088866|FG003|Overall Study|Lack of Efficacy|1|||
16863869|NCT01772147|37830849|FG000|Overall Study|Lost to Follow-up|1|||
16863870|NCT01772147|37830850|FG001|Overall Study|Lost to Follow-up|0|||
16863871|NCT01772147|37830851|FG002|Overall Study|Lost to Follow-up|1|||
16863872|NCT01772147|37830849|FG000|Overall Study|Protocol Deviation|2|||
16863873|NCT01772147|37830850|FG001|Overall Study|Protocol Deviation|1|||
16863874|NCT01772147|37830851|FG002|Overall Study|Protocol Deviation|1|||
16863875|NCT01772147|37830849|FG000|Overall Study|Lack of Efficacy|8|||
16863876|NCT01772147|37830850|FG001|Overall Study|Lack of Efficacy|6|||
16863877|NCT01772147|37830851|FG002|Overall Study|Lack of Efficacy|6|||
16863878|NCT01771913|37830861|FG000|Overall Study|Withdrawal by Subject|1|||
16863879|NCT01771913|37830862|FG001|Overall Study|Withdrawal by Subject|0|||
16863880|NCT01606787|37830870|FG000|Overall Study|Withdrawal by Subject|4|||
16863881|NCT01606787|37830871|FG001|Overall Study|Withdrawal by Subject|5|||
16863882|NCT01606787|37830870|FG000|Overall Study|Surgery canceled|0|||
16863883|NCT01606787|37830871|FG001|Overall Study|Surgery canceled|2|||
16863884|NCT01778855|37830879|FG000|Overall Study|Death|0|||
16863885|NCT01778855|37830880|FG001|Overall Study|Death|1|||
16863886|NCT01770743|37830891|FG000|Overall Study|Adverse Event|1|||
16863887|NCT01770743|37830892|FG001|Overall Study|Adverse Event|0|||
16863888|NCT01770743|37830893|FG002|Overall Study|Adverse Event|0|||
16863889|NCT01770743|37830894|FG003|Overall Study|Adverse Event|0|||
16863890|NCT01770743|37830895|FG004|Overall Study|Adverse Event|0|||
16863891|NCT01770743|37830891|FG000|Overall Study|Withdrawal by Subject|0|||
16863892|NCT01770743|37830892|FG001|Overall Study|Withdrawal by Subject|0|||
16863893|NCT01770743|37830893|FG002|Overall Study|Withdrawal by Subject|1|||
16863894|NCT01770743|37830894|FG003|Overall Study|Withdrawal by Subject|1|||
16863895|NCT01770743|37830895|FG004|Overall Study|Withdrawal by Subject|1|||
16863896|NCT01770743|37830891|FG000|Overall Study|Lost to Follow-up|0|||
16863897|NCT01770743|37830892|FG001|Overall Study|Lost to Follow-up|2|||
16863898|NCT01770743|37830893|FG002|Overall Study|Lost to Follow-up|0|||
16863899|NCT01770743|37830894|FG003|Overall Study|Lost to Follow-up|0|||
16863900|NCT01770743|37830895|FG004|Overall Study|Lost to Follow-up|1|||
16863901|NCT01770743|37830891|FG000|Overall Study|Sponsor Terminated Subject|1|||
16863902|NCT01770743|37830892|FG001|Overall Study|Sponsor Terminated Subject|0|||
16863903|NCT01770743|37830893|FG002|Overall Study|Sponsor Terminated Subject|0|||
16863904|NCT01770743|37830894|FG003|Overall Study|Sponsor Terminated Subject|1|||
16863905|NCT01770743|37830895|FG004|Overall Study|Sponsor Terminated Subject|0|||
16863906|NCT01770743|37830891|FG000|Overall Study|Moving Out of State|0|||
16863907|NCT01770743|37830892|FG001|Overall Study|Moving Out of State|1|||
16863908|NCT01770743|37830893|FG002|Overall Study|Moving Out of State|0|||
16863909|NCT01770743|37830894|FG003|Overall Study|Moving Out of State|0|||
16863910|NCT01770743|37830895|FG004|Overall Study|Moving Out of State|0|||
16863911|NCT01777997|37830907|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
16863912|NCT01777997|37830907|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
16863913|NCT01777997|37830907|FG000|Weeks 48 to 72/96 on ART|Death|1|||
16863914|NCT01777997|37830907|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
16863915|NCT01770509|37830913|FG000|Overall Study|Injury|0|||
16863916|NCT01770509|37830914|FG001|Overall Study|Injury|1|||
16863917|NCT01770509|37830913|FG000|Overall Study|Lost to Follow-up|1|||
16863918|NCT01770509|37830914|FG001|Overall Study|Lost to Follow-up|2|||
16863919|NCT01770353|37830922|FG000|Overall Study|Progressive disease|2|||
16863920|NCT01770353|37830923|FG001|Overall Study|Progressive disease|1|||
16863921|NCT01770353|37830922|FG000|Overall Study|Adverse Event|0|||
16863922|NCT01770353|37830923|FG001|Overall Study|Adverse Event|1|||
16863923|NCT01770353|37830922|FG000|Overall Study|Protocol Violation|1|||
16863924|NCT01770353|37830923|FG001|Overall Study|Protocol Violation|0|||
16863925|NCT01770353|37830922|FG000|Overall Study|Physician Decision|0|||
16863926|NCT01770353|37830923|FG001|Overall Study|Physician Decision|3|||
16863927|NCT01770353|37830922|FG000|Overall Study|Clinical deterioration|3|||
16863928|NCT01770353|37830923|FG001|Overall Study|Clinical deterioration|6|||
16863929|NCT01770353|37830922|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
16863930|NCT01770353|37830923|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
16863931|NCT01777763|37830939|FG000|Overall Study|Adverse Event|2|||
16863932|NCT01777763|37830940|FG001|Overall Study|Adverse Event|32|||
16863933|NCT01777763|37830939|FG000|Overall Study|Protocol Violation|1|||
16863934|NCT01777763|37830940|FG001|Overall Study|Protocol Violation|7|||
16863935|NCT01777763|37830939|FG000|Overall Study|Withdrawal by Subject|0|||
16863936|NCT01777763|37830940|FG001|Overall Study|Withdrawal by Subject|2|||
16944835|NCT01097707|38088867|FG004|Overall Study|Lack of Efficacy|0|||
16863937|NCT01777763|37830939|FG000|Overall Study|Treatment Failure|1|||
16863938|NCT01777763|37830940|FG001|Overall Study|Treatment Failure|6|||
16863939|NCT01769339|37830946|FG000|Overall Study|Lost to Follow-up|42|||
16863940|NCT01769339|37830946|FG000|Overall Study|Adverse Event|1|||
16863941|NCT01769105|37830952|FG000|First Intervention|Protocol Violation|2|||
16863942|NCT01769105|37830953|FG001|First Intervention|Protocol Violation|2|||
16863943|NCT01769105|37830952|FG000|Cross-over|Lost to Follow-up|5|||
16863944|NCT01769105|37830953|FG001|Cross-over|Lost to Follow-up|0|||
16863945|NCT01777139|37830961|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
16863946|NCT01777139|37830962|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
16863947|NCT01777139|37830961|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
16863948|NCT01777139|37830962|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
16863949|NCT01777139|37830961|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
16863950|NCT01777139|37830962|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
16863951|NCT01777139|37830961|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
16863952|NCT01777139|37830962|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
16863953|NCT01777139|37830961|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
16863954|NCT01777139|37830962|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
16863955|NCT01777139|37830961|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
16863956|NCT01777139|37830962|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
16863957|NCT01777139|37830961|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
16863958|NCT01777139|37830962|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
16863959|NCT01777139|37830961|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
16863960|NCT01777139|37830962|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
16863961|NCT01768637|37830971|FG000|Overall Study|Lost to Follow-up|2|||
16863962|NCT01768637|37830972|FG001|Overall Study|Lost to Follow-up|7|||
16863963|NCT01768637|37830971|FG000|Overall Study|Difficult blood draw|1|||
16863964|NCT01768637|37830972|FG001|Overall Study|Difficult blood draw|0|||
16863965|NCT01886872|37830981|FG000|Overall Study|Ineligible|7|||
16863966|NCT01886872|37830982|FG001|Overall Study|Ineligible|4|||
16863967|NCT01886872|37830983|FG002|Overall Study|Ineligible|12|||
16863968|NCT01768559|37830995|FG000|Overall Study|Randomized but not treated|0|||
16863969|NCT01768559|37830996|FG001|Overall Study|Randomized but not treated|0|||
16863970|NCT01768559|37830997|FG002|Overall Study|Randomized but not treated|1|||
16863971|NCT01768559|37830995|FG000|Overall Study|Adverse Event|15|||
16863972|NCT01768559|37830996|FG001|Overall Study|Adverse Event|2|||
16863973|NCT01768559|37830997|FG002|Overall Study|Adverse Event|5|||
16863974|NCT01768559|37830995|FG000|Overall Study|Lack of Efficacy|6|||
16863975|NCT01768559|37830996|FG001|Overall Study|Lack of Efficacy|4|||
16863976|NCT01768559|37830997|FG002|Overall Study|Lack of Efficacy|0|||
16863977|NCT01768559|37830995|FG000|Overall Study|Poor compliance to protocol|0|||
16863978|NCT01768559|37830996|FG001|Overall Study|Poor compliance to protocol|3|||
16863979|NCT01768559|37830997|FG002|Overall Study|Poor compliance to protocol|2|||
16863980|NCT01768559|37830995|FG000|Overall Study|Other than specified|9|||
16863981|NCT01768559|37830996|FG001|Overall Study|Other than specified|8|||
16863982|NCT01768559|37830997|FG002|Overall Study|Other than specified|5|||
16863983|NCT00983619|37831021|FG000|Overall Study|Lost to Follow-up|0|||
16863984|NCT00983619|37831022|FG001|Overall Study|Lost to Follow-up|1|||
16863985|NCT00983619|37831023|FG002|Overall Study|Lost to Follow-up|0|||
16863986|NCT00983619|37831024|FG003|Overall Study|Lost to Follow-up|0|||
16863987|NCT00983619|37831025|FG004|Overall Study|Lost to Follow-up|0|||
16863988|NCT00983619|37831026|FG005|Overall Study|Lost to Follow-up|2|||
16863989|NCT00983619|37831027|FG006|Overall Study|Lost to Follow-up|0|||
16863990|NCT00983619|37831028|FG007|Overall Study|Lost to Follow-up|0|||
16863991|NCT00983619|37831029|FG008|Overall Study|Lost to Follow-up|0|||
16863992|NCT00983619|37831030|FG009|Overall Study|Lost to Follow-up|0|||
16863993|NCT00983619|37831031|FG010|Overall Study|Lost to Follow-up|0|||
16863994|NCT00983619|37831032|FG011|Overall Study|Lost to Follow-up|2|||
16863995|NCT00983619|37831021|FG000|Overall Study|Withdrawal by Subject|2|||
16863996|NCT00983619|37831022|FG001|Overall Study|Withdrawal by Subject|1|||
16863997|NCT00983619|37831023|FG002|Overall Study|Withdrawal by Subject|1|||
16863998|NCT00983619|37831024|FG003|Overall Study|Withdrawal by Subject|3|||
16863999|NCT00983619|37831025|FG004|Overall Study|Withdrawal by Subject|1|||
16864000|NCT00983619|37831026|FG005|Overall Study|Withdrawal by Subject|23|||
16864001|NCT00983619|37831027|FG006|Overall Study|Withdrawal by Subject|0|||
16864002|NCT00983619|37831028|FG007|Overall Study|Withdrawal by Subject|0|||
16864003|NCT00983619|37831029|FG008|Overall Study|Withdrawal by Subject|0|||
16864004|NCT00983619|37831030|FG009|Overall Study|Withdrawal by Subject|0|||
16864005|NCT00983619|37831031|FG010|Overall Study|Withdrawal by Subject|1|||
16864006|NCT00983619|37831032|FG011|Overall Study|Withdrawal by Subject|1|||
16864007|NCT00983619|37831021|FG000|Overall Study|Death|0|||
16864008|NCT00983619|37831022|FG001|Overall Study|Death|2|||
16864009|NCT00983619|37831023|FG002|Overall Study|Death|2|||
16864010|NCT00983619|37831024|FG003|Overall Study|Death|1|||
16864011|NCT00983619|37831025|FG004|Overall Study|Death|2|||
16864012|NCT00983619|37831026|FG005|Overall Study|Death|30|||
16864013|NCT00983619|37831027|FG006|Overall Study|Death|1|||
16864014|NCT00983619|37831028|FG007|Overall Study|Death|0|||
16864015|NCT00983619|37831029|FG008|Overall Study|Death|1|||
16864016|NCT00983619|37831030|FG009|Overall Study|Death|2|||
16864017|NCT00983619|37831031|FG010|Overall Study|Death|9|||
16864018|NCT00983619|37831032|FG011|Overall Study|Death|8|||
16864019|NCT00983619|37831021|FG000|Overall Study|Other|1|||
16864020|NCT00983619|37831022|FG001|Overall Study|Other|0|||
16864021|NCT00983619|37831023|FG002|Overall Study|Other|0|||
16864022|NCT00983619|37831024|FG003|Overall Study|Other|1|||
16864023|NCT00983619|37831025|FG004|Overall Study|Other|0|||
16864024|NCT00983619|37831026|FG005|Overall Study|Other|12|||
16864025|NCT00983619|37831027|FG006|Overall Study|Other|2|||
16864026|NCT00983619|37831028|FG007|Overall Study|Other|2|||
16864027|NCT00983619|37831029|FG008|Overall Study|Other|0|||
16864028|NCT00983619|37831030|FG009|Overall Study|Other|1|||
16864029|NCT00983619|37831031|FG010|Overall Study|Other|1|||
16864030|NCT00983619|37831032|FG011|Overall Study|Other|0|||
16864031|NCT00653068|37831082|FG000|Overall Study|Death|9|||
16864032|NCT00653068|37831082|FG000|Overall Study|Lack of Efficacy|34|||
16864033|NCT00653068|37831082|FG000|Overall Study|Physician Decision|4|||
16864034|NCT00653068|37831082|FG000|Overall Study|Withdrawal by Subject|1|||
16864035|NCT00653068|37831082|FG000|Overall Study|Ineligible|2|||
16864036|NCT01767857|37831091|FG000|Overall Study|Adverse Event|27|||
16864037|NCT01767857|37831092|FG001|Overall Study|Adverse Event|7|||
16864038|NCT01767857|37831091|FG000|Overall Study|Death|28|||
16864039|NCT01767857|37831092|FG001|Overall Study|Death|13|||
16864040|NCT01767857|37831091|FG000|Overall Study|Lack of Efficacy|299|||
16864041|NCT01767857|37831092|FG001|Overall Study|Lack of Efficacy|151|||
16864042|NCT01767857|37831091|FG000|Overall Study|Lost to Follow-up|1|||
16864043|NCT01767857|37831092|FG001|Overall Study|Lost to Follow-up|1|||
16864044|NCT01767857|37831091|FG000|Overall Study|Withdrawal by Subject|38|||
16864045|NCT01767857|37831092|FG001|Overall Study|Withdrawal by Subject|18|||
16864046|NCT01767857|37831091|FG000|Overall Study|Physician Decision|17|||
16864047|NCT01767857|37831092|FG001|Overall Study|Physician Decision|10|||
16864048|NCT01767857|37831091|FG000|Overall Study|Protocol Terminated|1|||
16864049|NCT01767857|37831092|FG001|Overall Study|Protocol Terminated|0|||
16864050|NCT01767857|37831091|FG000|Overall Study|Randomized But Never Treated|19|||
16864051|NCT01767857|37831092|FG001|Overall Study|Randomized But Never Treated|13|||
16864052|NCT01775501|37831099|FG000|Overall Study|Discontinued prior to treatment|1|||
16864053|NCT01775189|37831128|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16864054|NCT01775189|37831129|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
16864055|NCT01775189|37831130|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16864056|NCT01775189|37831131|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16864057|NCT01775189|37831132|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16864058|NCT01775189|37831133|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16864059|NCT01775189|37831134|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16864060|NCT01775189|37831128|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16864061|NCT01775189|37831129|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
16864062|NCT01775189|37831130|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16864063|NCT01775189|37831131|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16864064|NCT01775189|37831132|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16864065|NCT01775189|37831133|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16864066|NCT01775189|37831134|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16864067|NCT01775189|37831128|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16864068|NCT01775189|37831129|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
16864069|NCT01775189|37831130|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
16864070|NCT01775189|37831131|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16864071|NCT01775189|37831132|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16864072|NCT01775189|37831133|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16864073|NCT01775189|37831134|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16864074|NCT01775189|37831128|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16864075|NCT01775189|37831129|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16864076|NCT01775189|37831130|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16864077|NCT01775189|37831131|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16864078|NCT01775189|37831132|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16864079|NCT01775189|37831133|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
16864080|NCT01775189|37831134|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16864081|NCT01775189|37831128|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16864082|NCT01775189|37831129|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16864083|NCT01775189|37831130|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16864084|NCT01775189|37831131|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
16864085|NCT01775189|37831132|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16864086|NCT01775189|37831133|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16864087|NCT01775189|37831134|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16864088|NCT01775189|37831128|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16864089|NCT01775189|37831129|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16864090|NCT01775189|37831130|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16864091|NCT01775189|37831131|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
16864092|NCT01775189|37831132|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16864093|NCT01775189|37831133|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16864094|NCT01775189|37831134|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
16864095|NCT01767467|37831284|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
16864096|NCT01767467|37831285|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
16864097|NCT01767467|37831284|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
16864098|NCT01767467|37831285|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
16864099|NCT01767467|37831284|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
16864100|NCT01767467|37831285|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
16864101|NCT01767467|37831284|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
16864102|NCT01767467|37831285|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
16864103|NCT01767467|37831284|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
16864104|NCT01767467|37831285|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
16864105|NCT01767467|37831284|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
16864106|NCT01767467|37831285|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
16864107|NCT01767467|37831284|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
16864108|NCT01767467|37831285|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
16864109|NCT01767467|37831284|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
16864110|NCT01767467|37831285|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
16864111|NCT01767467|37831284|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
16864112|NCT01767467|37831285|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
16864113|NCT01767467|37831284|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
16864114|NCT01767467|37831285|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
16864115|NCT01767467|37831284|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
16864116|NCT01767467|37831285|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
16864117|NCT01767467|37831284|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
16864118|NCT01767467|37831285|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
16864119|NCT01767467|37831284|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
16864120|NCT01767467|37831285|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
16864121|NCT01767467|37831284|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
16864122|NCT01767467|37831285|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
16864123|NCT04126083|37831358|FG000|Overall Study|Withdrawal by Subject|1|||
16864124|NCT01766921|37831398|FG000|Overall Study|Administrative Reason|5|||
16864125|NCT01766921|37831399|FG001|Overall Study|Administrative Reason|5|||
16864126|NCT01766921|37831398|FG000|Overall Study|Death|1|||
16864127|NCT01766921|37831399|FG001|Overall Study|Death|1|||
16864128|NCT01766921|37831398|FG000|Overall Study|Lost to Follow-up|1|||
16864129|NCT01766921|37831399|FG001|Overall Study|Lost to Follow-up|3|||
16864130|NCT01766921|37831398|FG000|Overall Study|Unclassified|2|||
16864131|NCT01766921|37831399|FG001|Overall Study|Unclassified|2|||
16864132|NCT01766921|37831398|FG000|Overall Study|Protocol Violation|1|||
16864133|NCT01766921|37831399|FG001|Overall Study|Protocol Violation|1|||
16864134|NCT01766921|37831398|FG000|Overall Study|Withdrawal by Subject|14|||
16864135|NCT01766921|37831399|FG001|Overall Study|Withdrawal by Subject|5|||
16864136|NCT01774799|37831417|FG000|Overall Study|Lost to Follow-up|1|||
16864137|NCT01774799|37831418|FG001|Overall Study|Lost to Follow-up|1|||
16864138|NCT01774799|37831419|FG002|Overall Study|Lost to Follow-up|0|||
16864139|NCT01774799|37831420|FG003|Overall Study|Lost to Follow-up|0|||
16864140|NCT01774253|37831426|FG000|Overall Study|Lack of Efficacy|4|||
16864141|NCT01774253|37831426|FG000|Overall Study|Physician Decision|2|||
16864142|NCT01774253|37831426|FG000|Overall Study|Withdrawal by Subject|2|||
16864143|NCT01774253|37831426|FG000|Overall Study|Death|1|||
16864144|NCT01765751|37831466|FG000|Overall Study|Lost to Follow-up|0|||
16864145|NCT01765751|37831467|FG001|Overall Study|Lost to Follow-up|2|||
16864146|NCT01765751|37831468|FG002|Overall Study|Lost to Follow-up|1|||
16864147|NCT01736657|37831488|FG000|Overall Study|insufficient vascular access|1|||
16864148|NCT01736579|37831503|FG000|Overall Study|Termination of Study by Sponsor|2|||
16864149|NCT01736579|37831504|FG001|Overall Study|Termination of Study by Sponsor|2|||
16864150|NCT01765673|37831535|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
16864151|NCT01764659|37831542|FG000|Overall Study|Death|1|||
16864152|NCT01764659|37831542|FG000|Overall Study|Physician Decision|1|||
16864153|NCT01736189|37831548|FG000|Overall Study|Violation of registration criteria|41|||
16864154|NCT01736189|37831548|FG000|Overall Study|Protocol Violation|4|||
16864155|NCT01736189|37831548|FG000|Overall Study|Criteria and protocol violations|1|||
16864156|NCT01735175|37831580|FG000|Overall Study|Withdrawal by Subject|9|||
16864157|NCT01735175|37831581|FG001|Overall Study|Withdrawal by Subject|2|||
16864158|NCT01735175|37831580|FG000|Overall Study|Lost to Follow-up|4|||
16864159|NCT01735175|37831581|FG001|Overall Study|Lost to Follow-up|2|||
16864160|NCT01735175|37831580|FG000|Overall Study|Death|3|||
16864161|NCT01735175|37831581|FG001|Overall Study|Death|2|||
16864162|NCT01735175|37831580|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
16864163|NCT01735175|37831581|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
16864164|NCT01762943|37831593|FG000|Overall Study|Physician Decision|1|||
16864165|NCT01762943|37831594|FG001|Overall Study|Physician Decision|1|||
16864166|NCT01762943|37831593|FG000|Overall Study|Protocol Violation|1|||
16864167|NCT01762943|37831594|FG001|Overall Study|Protocol Violation|0|||
16864168|NCT01762943|37831593|FG000|Overall Study|Withdrawal by Subject|2|||
16864169|NCT01762943|37831594|FG001|Overall Study|Withdrawal by Subject|1|||
16864170|NCT01734785|37831657|FG000|Open-Label Period|Adverse Event|0|||
16864171|NCT01734785|37831658|FG001|Open-Label Period|Adverse Event|0|||
16864172|NCT01734785|37831659|FG002|Open-Label Period|Adverse Event|0|||
16864173|NCT01734785|37831660|FG003|Open-Label Period|Adverse Event|9|||
16864174|NCT01734785|37831657|FG000|Open-Label Period|Lack of Efficacy|0|||
16864175|NCT01734785|37831658|FG001|Open-Label Period|Lack of Efficacy|0|||
16864176|NCT01734785|37831659|FG002|Open-Label Period|Lack of Efficacy|0|||
16864177|NCT01734785|37831660|FG003|Open-Label Period|Lack of Efficacy|1|||
16864178|NCT01734785|37831657|FG000|Open-Label Period|Protocol Violation|0|||
16864179|NCT01734785|37831658|FG001|Open-Label Period|Protocol Violation|0|||
16864180|NCT01734785|37831659|FG002|Open-Label Period|Protocol Violation|0|||
16864181|NCT01734785|37831660|FG003|Open-Label Period|Protocol Violation|13|||
16944836|NCT01097707|38088863|FG000|Overall Study|Lost to Follow-up|1|||
16864182|NCT01734785|37831657|FG000|Open-Label Period|Lost to Follow-up|0|||
16864183|NCT01734785|37831658|FG001|Open-Label Period|Lost to Follow-up|0|||
16864184|NCT01734785|37831659|FG002|Open-Label Period|Lost to Follow-up|0|||
16864185|NCT01734785|37831660|FG003|Open-Label Period|Lost to Follow-up|14|||
16864186|NCT01734785|37831657|FG000|Open-Label Period|Withdrawal by Subject|0|||
16864187|NCT01734785|37831658|FG001|Open-Label Period|Withdrawal by Subject|0|||
16864188|NCT01734785|37831659|FG002|Open-Label Period|Withdrawal by Subject|0|||
16864189|NCT01734785|37831660|FG003|Open-Label Period|Withdrawal by Subject|12|||
16864190|NCT01734785|37831657|FG000|Open-Label Period|Other Reasons|0|||
16864191|NCT01734785|37831658|FG001|Open-Label Period|Other Reasons|0|||
16864192|NCT01734785|37831659|FG002|Open-Label Period|Other Reasons|0|||
16864193|NCT01734785|37831660|FG003|Open-Label Period|Other Reasons|224|||
16864194|NCT01734785|37831657|FG000|Double-Blind Period|Adverse Event|0|||
16864195|NCT01734785|37831658|FG001|Double-Blind Period|Adverse Event|3|||
16864196|NCT01734785|37831659|FG002|Double-Blind Period|Adverse Event|2|||
16864197|NCT01734785|37831660|FG003|Double-Blind Period|Adverse Event|0|||
16864198|NCT01734785|37831657|FG000|Double-Blind Period|Lack of Efficacy|0|||
16864199|NCT01734785|37831658|FG001|Double-Blind Period|Lack of Efficacy|1|||
16864200|NCT01734785|37831659|FG002|Double-Blind Period|Lack of Efficacy|0|||
16864201|NCT01734785|37831660|FG003|Double-Blind Period|Lack of Efficacy|0|||
16864202|NCT01734785|37831657|FG000|Double-Blind Period|Protocol Violation|0|||
16864203|NCT01734785|37831658|FG001|Double-Blind Period|Protocol Violation|1|||
16864204|NCT01734785|37831659|FG002|Double-Blind Period|Protocol Violation|1|||
16864205|NCT01734785|37831660|FG003|Double-Blind Period|Protocol Violation|0|||
16864206|NCT01734785|37831657|FG000|Double-Blind Period|Lost to Follow-up|2|||
16864207|NCT01734785|37831658|FG001|Double-Blind Period|Lost to Follow-up|4|||
16864208|NCT01734785|37831659|FG002|Double-Blind Period|Lost to Follow-up|2|||
16864209|NCT01734785|37831660|FG003|Double-Blind Period|Lost to Follow-up|0|||
16864210|NCT01734785|37831657|FG000|Double-Blind Period|Withdrawal by Subject|2|||
16864211|NCT01734785|37831658|FG001|Double-Blind Period|Withdrawal by Subject|0|||
16864212|NCT01734785|37831659|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16864213|NCT01734785|37831660|FG003|Double-Blind Period|Withdrawal by Subject|0|||
16864214|NCT01734785|37831657|FG000|Double-Blind Period|Not treated|1|||
16864215|NCT01734785|37831658|FG001|Double-Blind Period|Not treated|0|||
16864216|NCT01734785|37831659|FG002|Double-Blind Period|Not treated|0|||
16864217|NCT01734785|37831660|FG003|Double-Blind Period|Not treated|0|||
16864218|NCT01734395|37831669|FG000|Overall Study|Other|65|||
16864219|NCT01734395|37831669|FG000|Overall Study|Lost to Follow-up|287|||
16864220|NCT01734395|37831669|FG000|Overall Study|Lack of Efficacy|5|||
16864221|NCT01734395|37831669|FG000|Overall Study|Adverse Event|40|||
16864222|NCT01734395|37831669|FG000|Overall Study|Withdrawal by Subject|10|||
16864223|NCT01734395|37831669|FG000|Overall Study|Missing the reasons for not completed|3|||
16864224|NCT01597505|37831708|FG000|Overall Study|Physician Decision|5|||
16864225|NCT01597505|37831709|FG001|Overall Study|Physician Decision|0|||
16774018|NCT02432846|37713259|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16774019|NCT02432846|37713260|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16774020|NCT02432846|37713261|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
16774021|NCT02432846|37713262|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16774022|NCT02432846|37713257|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
16774023|NCT02432846|37713258|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
16774024|NCT02432846|37713259|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
16774025|NCT02432846|37713260|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
16774026|NCT02432846|37713261|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
16864226|NCT01597505|37831708|FG000|Overall Study|Adverse Event|19|||
16864227|NCT01597505|37831709|FG001|Overall Study|Adverse Event|7|||
16864228|NCT01597505|37831708|FG000|Overall Study|Lost to Follow-up|4|||
16864229|NCT01597505|37831709|FG001|Overall Study|Lost to Follow-up|2|||
16864230|NCT01597505|37831708|FG000|Overall Study|Withdrawal by Subject|10|||
16864231|NCT01597505|37831709|FG001|Overall Study|Withdrawal by Subject|18|||
16864232|NCT01597505|37831708|FG000|Overall Study|Other|5|||
16864233|NCT01597505|37831709|FG001|Overall Study|Other|6|||
16864234|NCT01597505|37831708|FG000|Overall Study|Missing|1|||
16864235|NCT01597505|37831709|FG001|Overall Study|Missing|0|||
16864236|NCT01760447|37831748|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
16864237|NCT01760447|37831749|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
16864238|NCT01760447|37831750|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
16864239|NCT01760447|37831751|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
16864240|NCT01760447|37831748|FG000|Weeks 0-20|Withdrawal by Subject|2|||
16864241|NCT01760447|37831749|FG001|Weeks 0-20|Withdrawal by Subject|0|||
16864242|NCT01760447|37831750|FG002|Weeks 0-20|Withdrawal by Subject|1|||
16864243|NCT01760447|37831751|FG003|Weeks 0-20|Withdrawal by Subject|0|||
16864244|NCT01760447|37831748|FG000|Weeks 0-20|Lost to Follow-up|1|||
16864245|NCT01760447|37831749|FG001|Weeks 0-20|Lost to Follow-up|0|||
16864246|NCT01760447|37831750|FG002|Weeks 0-20|Lost to Follow-up|1|||
16864247|NCT01760447|37831751|FG003|Weeks 0-20|Lost to Follow-up|1|||
16864248|NCT01760447|37831748|FG000|Weeks 0-20|Randomized but not treated|0|||
16864249|NCT01760447|37831749|FG001|Weeks 0-20|Randomized but not treated|0|||
16864250|NCT01760447|37831750|FG002|Weeks 0-20|Randomized but not treated|2|||
16864251|NCT01760447|37831751|FG003|Weeks 0-20|Randomized but not treated|0|||
16864252|NCT01760447|37831748|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
16864253|NCT01760447|37831749|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
16864254|NCT01760447|37831750|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
16864255|NCT01760447|37831751|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
16864256|NCT01760447|37831748|FG000|Weeks 20-54|Withdrawal by Subject|2|||
16864257|NCT01760447|37831749|FG001|Weeks 20-54|Withdrawal by Subject|1|||
16864258|NCT01760447|37831750|FG002|Weeks 20-54|Withdrawal by Subject|1|||
16864259|NCT01760447|37831751|FG003|Weeks 20-54|Withdrawal by Subject|2|||
16864260|NCT01760447|37831748|FG000|Weeks 20-54|Lost to Follow-up|0|||
16864261|NCT01760447|37831749|FG001|Weeks 20-54|Lost to Follow-up|0|||
16864262|NCT01760447|37831750|FG002|Weeks 20-54|Lost to Follow-up|1|||
16864263|NCT01760447|37831751|FG003|Weeks 20-54|Lost to Follow-up|2|||
16864264|NCT01732913|37831840|FG000|Overall Study|Study Terminated by Sponsor|105|||
16864265|NCT01732913|37831841|FG001|Overall Study|Study Terminated by Sponsor|55|||
16864266|NCT01732913|37831840|FG000|Overall Study|Withdrawal by Subject|27|||
16864267|NCT01732913|37831841|FG001|Overall Study|Withdrawal by Subject|4|||
16864268|NCT01732913|37831840|FG000|Overall Study|Physician Decision|14|||
16864269|NCT01732913|37831841|FG001|Overall Study|Physician Decision|7|||
16864270|NCT01732913|37831840|FG000|Overall Study|Other|7|||
16864271|NCT01732913|37831841|FG001|Overall Study|Other|1|||
16864272|NCT01732913|37831840|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
16864273|NCT01732913|37831841|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
16864274|NCT01732835|37831872|FG000|6-month Primary Endpoint|Did not receive device|19|||
16864275|NCT01732835|37831872|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
16864276|NCT01732835|37831872|FG000|6-month Primary Endpoint|Adverse Event|3|||
16864277|NCT01732835|37831872|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
16864278|NCT01732835|37831872|FG000|2-year Extended Follow-up|Adverse Event|3|||
16864279|NCT01732835|37831872|FG000|2-year Extended Follow-up|Death|1|||
16864280|NCT01759511|37831926|FG000|Overall Study|Adverse Event|4|||
16864281|NCT01759511|37831926|FG000|Overall Study|Death|2|||
16864282|NCT01759511|37831926|FG000|Overall Study|Lack of Efficacy|2|||
16864283|NCT01759511|37831926|FG000|Overall Study|Physician Decision|1|||
16864284|NCT01759511|37831926|FG000|Overall Study|Progressive Disease|5|||
16864285|NCT01759511|37831926|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
16864286|NCT01759511|37831926|FG000|Overall Study|Study Terminated by Sponsor|13|||
16864287|NCT01759511|37831926|FG000|Overall Study|Withdrawal by Subject|3|||
16864288|NCT01732757|37831944|FG000|Overall Study|Lost to Follow-up|1|||
16864289|NCT01732757|37831945|FG001|Overall Study|Lost to Follow-up|0|||
16864290|NCT01732757|37831946|FG002|Overall Study|Lost to Follow-up|0|||
16864291|NCT01758731|37831954|FG000|Overall Study|Physician Decision|1|||
16864292|NCT01606319|37831964|FG000|Overall Study|Lost to Follow-up|17|||
16864293|NCT01606319|37831965|FG001|Overall Study|Lost to Follow-up|14|||
16864294|NCT01606319|37831964|FG000|Overall Study|Withdrawal by Subject|9|||
16944837|NCT01097707|38088864|FG001|Overall Study|Lost to Follow-up|1|||
16864295|NCT01606319|37831965|FG001|Overall Study|Withdrawal by Subject|12|||
16864296|NCT01606319|37831964|FG000|Overall Study|Physician Decision|1|||
16864297|NCT01606319|37831965|FG001|Overall Study|Physician Decision|2|||
16864298|NCT01606319|37831964|FG000|Overall Study|Lack of Efficacy|6|||
16864299|NCT01606319|37831965|FG001|Overall Study|Lack of Efficacy|8|||
16864300|NCT01606319|37831964|FG000|Overall Study|Adverse Event|1|||
16864301|NCT01606319|37831965|FG001|Overall Study|Adverse Event|4|||
16864302|NCT01757405|37831973|FG000|Overall Study|Lost to Follow-up|1|||
16864303|NCT01757405|37831974|FG001|Overall Study|Lost to Follow-up|1|||
16864304|NCT01757405|37831973|FG000|Overall Study|Withdrawal by Subject|0|||
16864305|NCT01757405|37831974|FG001|Overall Study|Withdrawal by Subject|1|||
16864306|NCT01455597|37831980|FG000|Overall Study|Adverse Event|7|||
16864307|NCT01455597|37831981|FG001|Overall Study|Adverse Event|0|||
16864308|NCT01455597|37831982|FG002|Overall Study|Adverse Event|5|||
16864309|NCT01455597|37831983|FG003|Overall Study|Adverse Event|1|||
16864310|NCT01455597|37831980|FG000|Overall Study|Lack of Efficacy|0|||
16864311|NCT01455597|37831981|FG001|Overall Study|Lack of Efficacy|1|||
16864312|NCT01455597|37831982|FG002|Overall Study|Lack of Efficacy|2|||
16864313|NCT01455597|37831983|FG003|Overall Study|Lack of Efficacy|0|||
16864314|NCT01455597|37831980|FG000|Overall Study|Lost to Follow-up|3|||
16864315|NCT01455597|37831981|FG001|Overall Study|Lost to Follow-up|0|||
16864316|NCT01455597|37831982|FG002|Overall Study|Lost to Follow-up|2|||
16864317|NCT01455597|37831983|FG003|Overall Study|Lost to Follow-up|1|||
16864318|NCT01455597|37831980|FG000|Overall Study|Withdrew Consent|6|||
16864319|NCT01455597|37831981|FG001|Overall Study|Withdrew Consent|5|||
16864320|NCT01455597|37831982|FG002|Overall Study|Withdrew Consent|8|||
16864321|NCT01455597|37831983|FG003|Overall Study|Withdrew Consent|5|||
16864322|NCT01455597|37831980|FG000|Overall Study|Reason not Specified|1|||
16864323|NCT01455597|37831981|FG001|Overall Study|Reason not Specified|2|||
16864324|NCT01455597|37831982|FG002|Overall Study|Reason not Specified|3|||
16864325|NCT01455597|37831983|FG003|Overall Study|Reason not Specified|3|||
16864326|NCT01757171|37832006|FG000|Overall Study|Adverse Event|5|||
16864327|NCT01757171|37832007|FG001|Overall Study|Adverse Event|1|||
16864328|NCT01757171|37832006|FG000|Overall Study|Disease Progression|1|||
16864329|NCT01757171|37832007|FG001|Overall Study|Disease Progression|0|||
16864330|NCT01757171|37832006|FG000|Overall Study|Hospitalization|1|||
16864331|NCT01757171|37832007|FG001|Overall Study|Hospitalization|0|||
16864332|NCT01757171|37832006|FG000|Overall Study|ECOG decline|1|||
16864333|NCT01757171|37832007|FG001|Overall Study|ECOG decline|0|||
16864334|NCT01756235|37832013|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
16864335|NCT01730729|37832017|FG000|Overall Study|Adverse Event|1|||
16864336|NCT01730729|37832017|FG000|Overall Study|Death|1|||
16864337|NCT01730729|37832017|FG000|Overall Study|Progressive Disease|12|||
16864338|NCT01756157|37832021|FG000|First Intervention Period|Withdrawal by Subject|1|||
16864339|NCT01756157|37832022|FG001|First Intervention Period|Withdrawal by Subject|0|||
16864340|NCT01756157|37832021|FG000|First Intervention Period|Lost to Follow-up|0|||
16864341|NCT01756157|37832022|FG001|First Intervention Period|Lost to Follow-up|2|||
16864342|NCT01756079|37832028|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
16864343|NCT01756079|37832028|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
16864344|NCT01756079|37832028|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
16864345|NCT01756079|37832028|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
16864346|NCT01756079|37832028|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
16864347|NCT01755767|37832046|FG000|Overall Study|Progressive Disease|8|||
16864348|NCT01755767|37832047|FG001|Overall Study|Progressive Disease|7|||
16864349|NCT01755767|37832048|FG002|Overall Study|Progressive Disease|91|||
16864350|NCT01755767|37832049|FG003|Overall Study|Progressive Disease|43|||
16864351|NCT01755767|37832046|FG000|Overall Study|Clinical Disease Progression|4|||
16864352|NCT01755767|37832047|FG001|Overall Study|Clinical Disease Progression|2|||
16864353|NCT01755767|37832048|FG002|Overall Study|Clinical Disease Progression|29|||
16864354|NCT01755767|37832049|FG003|Overall Study|Clinical Disease Progression|20|||
16864355|NCT01755767|37832046|FG000|Overall Study|Radiographic Disease Progression|9|||
16864356|NCT01755767|37832047|FG001|Overall Study|Radiographic Disease Progression|4|||
16864357|NCT01755767|37832048|FG002|Overall Study|Radiographic Disease Progression|44|||
16864358|NCT01755767|37832049|FG003|Overall Study|Radiographic Disease Progression|27|||
16864359|NCT01755767|37832046|FG000|Overall Study|Adverse Event|6|||
16864360|NCT01755767|37832047|FG001|Overall Study|Adverse Event|0|||
16864361|NCT01755767|37832048|FG002|Overall Study|Adverse Event|28|||
16864362|NCT01755767|37832049|FG003|Overall Study|Adverse Event|11|||
16864363|NCT01755767|37832046|FG000|Overall Study|Death|1|||
16864364|NCT01755767|37832047|FG001|Overall Study|Death|2|||
16864365|NCT01755767|37832048|FG002|Overall Study|Death|15|||
16864366|NCT01755767|37832049|FG003|Overall Study|Death|4|||
16864367|NCT01755767|37832046|FG000|Overall Study|Subject Decision|0|||
16864368|NCT01755767|37832047|FG001|Overall Study|Subject Decision|0|||
16864369|NCT01755767|37832048|FG002|Overall Study|Subject Decision|10|||
16864370|NCT01755767|37832049|FG003|Overall Study|Subject Decision|3|||
16864371|NCT01755767|37832046|FG000|Overall Study|Withdrawal by Subject|0|||
16864372|NCT01755767|37832047|FG001|Overall Study|Withdrawal by Subject|0|||
16864373|NCT01755767|37832048|FG002|Overall Study|Withdrawal by Subject|2|||
16864374|NCT01755767|37832049|FG003|Overall Study|Withdrawal by Subject|1|||
16864375|NCT01755767|37832046|FG000|Overall Study|Other|0|||
16864376|NCT01755767|37832047|FG001|Overall Study|Other|0|||
16864377|NCT01755767|37832048|FG002|Overall Study|Other|2|||
16864378|NCT01755767|37832049|FG003|Overall Study|Other|3|||
16864379|NCT01755767|37832046|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
16864380|NCT01755767|37832047|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
16864381|NCT01755767|37832048|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
16864382|NCT01755767|37832049|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
16864383|NCT01730339|37832145|FG000|Overall Study|Withdrawal by Subject|3|||
16864384|NCT01730339|37832146|FG001|Overall Study|Withdrawal by Subject|2|||
16864385|NCT01730339|37832145|FG000|Overall Study|Lost to Follow-up|1|||
16864386|NCT01730339|37832146|FG001|Overall Study|Lost to Follow-up|1|||
16864387|NCT01730339|37832145|FG000|Overall Study|Un-specified|1|||
16864388|NCT01730339|37832146|FG001|Overall Study|Un-specified|0|||
16864389|NCT01754753|37832203|FG000|Overall Study|Study close|43|||
16864390|NCT01754753|37832204|FG001|Overall Study|Study close|44|||
16864391|NCT01754753|37832203|FG000|Overall Study|Lost to Follow-up|9|||
16864392|NCT01754753|37832204|FG001|Overall Study|Lost to Follow-up|5|||
16864393|NCT01729871|37832212|FG000|Overall Study|Adverse Event|7|||
16864394|NCT01729871|37832213|FG001|Overall Study|Adverse Event|7|||
16864395|NCT01729871|37832212|FG000|Overall Study|Death|0|||
16864396|NCT01729871|37832213|FG001|Overall Study|Death|1|||
16864397|NCT01729871|37832212|FG000|Overall Study|Lack of Efficacy|0|||
16864398|NCT01729871|37832213|FG001|Overall Study|Lack of Efficacy|1|||
16864399|NCT01729871|37832212|FG000|Overall Study|Physician Decision|0|||
16864400|NCT01729871|37832213|FG001|Overall Study|Physician Decision|2|||
16864401|NCT01729871|37832212|FG000|Overall Study|Protocol Violation|1|||
16864402|NCT01729871|37832213|FG001|Overall Study|Protocol Violation|0|||
16864403|NCT01729871|37832212|FG000|Overall Study|Withdrawal by Subject|0|||
16864404|NCT01729871|37832213|FG001|Overall Study|Withdrawal by Subject|3|||
16864405|NCT01729871|37832212|FG000|Overall Study|Other|4|||
16864406|NCT01729871|37832213|FG001|Overall Study|Other|9|||
16864407|NCT01729559|37832221|FG000|Overall Study|Protocol Violation|31|||
16864408|NCT01729559|37832222|FG001|Overall Study|Protocol Violation|28|||
16864409|NCT01728779|37832241|FG000|Overall Study|Withdrawal by Subject|1|||
16864410|NCT01728623|37832252|FG000|Overall Study|Disease progression|26|||
16864411|NCT01728623|37832252|FG000|Overall Study|Adverse Event|1|||
16864412|NCT01728623|37832252|FG000|Overall Study|Withdrawal by Subject|1|||
16864413|NCT01754129|37832263|FG000|Overall Study|Death|13|||
16864414|NCT01754129|37832263|FG000|Overall Study|Duodopa discontinuation|9|||
16864415|NCT01754129|37832263|FG000|Overall Study|Lost to Follow-up|7|||
16864416|NCT01754129|37832263|FG000|Overall Study|Withdrew consent|1|||
16864417|NCT01754129|37832263|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
16864418|NCT01728077|37832276|FG000|Overall Study|Lack of Efficacy|3|||
16864419|NCT01728077|37832277|FG001|Overall Study|Lack of Efficacy|1|||
16864420|NCT01728077|37832276|FG000|Overall Study|Lost to Follow-up|1|||
16864421|NCT01728077|37832277|FG001|Overall Study|Lost to Follow-up|0|||
16864422|NCT01728077|37832276|FG000|Overall Study|Subject choice|2|||
16864423|NCT01728077|37832277|FG001|Overall Study|Subject choice|3|||
16864424|NCT01728077|37832276|FG000|Overall Study|Death|0|||
16864425|NCT01728077|37832277|FG001|Overall Study|Death|1|||
16864426|NCT01728077|37832276|FG000|Overall Study|Patient moving|1|||
16864427|NCT01728077|37832277|FG001|Overall Study|Patient moving|0|||
16864428|NCT01728077|37832276|FG000|Overall Study|Non compliance|1|||
16864429|NCT01728077|37832277|FG001|Overall Study|Non compliance|0|||
16864430|NCT01606007|37832296|FG000|Overall Study|Reason 'Other' in the protocol|0|||
16864431|NCT01606007|37832297|FG001|Overall Study|Reason 'Other' in the protocol|1|||
16864432|NCT01606007|37832298|FG002|Overall Study|Reason 'Other' in the protocol|1|||
16864433|NCT01606007|37832296|FG000|Overall Study|Pregnancy|0|||
16864434|NCT01606007|37832297|FG001|Overall Study|Pregnancy|1|||
16864435|NCT01606007|37832298|FG002|Overall Study|Pregnancy|1|||
16864436|NCT01606007|37832296|FG000|Overall Study|Withdrawal by Subject|8|||
16864437|NCT01606007|37832297|FG001|Overall Study|Withdrawal by Subject|6|||
16864438|NCT01606007|37832298|FG002|Overall Study|Withdrawal by Subject|1|||
16864439|NCT01606007|37832296|FG000|Overall Study|Adverse Event|0|||
16864440|NCT01606007|37832297|FG001|Overall Study|Adverse Event|1|||
16864441|NCT01606007|37832298|FG002|Overall Study|Adverse Event|1|||
16864442|NCT01606007|37832296|FG000|Overall Study|discontinue study treatment|0|||
16864443|NCT01606007|37832297|FG001|Overall Study|discontinue study treatment|2|||
16864444|NCT01606007|37832298|FG002|Overall Study|discontinue study treatment|1|||
16864445|NCT01606007|37832296|FG000|Overall Study|Lost to Follow-up|6|||
16864446|NCT01606007|37832297|FG001|Overall Study|Lost to Follow-up|8|||
16864447|NCT01606007|37832298|FG002|Overall Study|Lost to Follow-up|5|||
16864448|NCT01606007|37832296|FG000|Overall Study|Poor/Non-compliance|1|||
16864449|NCT01606007|37832297|FG001|Overall Study|Poor/Non-compliance|0|||
16864450|NCT01606007|37832298|FG002|Overall Study|Poor/Non-compliance|0|||
16864451|NCT01753193|37832377|FG000|Overall Study|Withdrawal by Subject|23|||
16864452|NCT01753193|37832377|FG000|Overall Study|Lost to Follow-up|6|||
16864453|NCT01753193|37832377|FG000|Overall Study|Death|1|||
16864454|NCT01753193|37832377|FG000|Overall Study|Other|16|||
16864455|NCT01727297|37832424|FG000|Overall Study|Death|13|||
16864456|NCT01727297|37832425|FG001|Overall Study|Death|0|||
16864457|NCT01727297|37832424|FG000|Overall Study|Protocol Violation|1|||
16864458|NCT01727297|37832425|FG001|Overall Study|Protocol Violation|10|||
16864459|NCT01727297|37832424|FG000|Overall Study|Adverse Event|3|||
16864460|NCT01727297|37832425|FG001|Overall Study|Adverse Event|1|||
16864461|NCT01727297|37832424|FG000|Overall Study|Lost to Follow-up|11|||
16864462|NCT01727297|37832425|FG001|Overall Study|Lost to Follow-up|0|||
16864463|NCT01727297|37832424|FG000|Overall Study|Withdrawal by Subject|26|||
16864464|NCT01727297|37832425|FG001|Overall Study|Withdrawal by Subject|27|||
16864465|NCT01727297|37832424|FG000|Overall Study|Physician Decision|19|||
16864466|NCT01727297|37832425|FG001|Overall Study|Physician Decision|5|||
16864467|NCT01727297|37832424|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
16864468|NCT01727297|37832425|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
16864469|NCT01753115|37832441|FG000|Overall Study|Lost to Follow-up|3|||
16864470|NCT01753115|37832442|FG001|Overall Study|Lost to Follow-up|6|||
16864471|NCT01753115|37832443|FG002|Overall Study|Lost to Follow-up|8|||
16864472|NCT01753115|37832441|FG000|Overall Study|Withdrawal by Subject|6|||
16864473|NCT01753115|37832442|FG001|Overall Study|Withdrawal by Subject|5|||
16864474|NCT01753115|37832443|FG002|Overall Study|Withdrawal by Subject|6|||
16864475|NCT01753115|37832441|FG000|Overall Study|Subject non-compliant|3|||
16864476|NCT01753115|37832442|FG001|Overall Study|Subject non-compliant|3|||
16864477|NCT01753115|37832443|FG002|Overall Study|Subject non-compliant|0|||
16864478|NCT01753115|37832441|FG000|Overall Study|Used excluded drug|0|||
16864479|NCT01753115|37832442|FG001|Overall Study|Used excluded drug|1|||
16864480|NCT01753115|37832443|FG002|Overall Study|Used excluded drug|0|||
16864481|NCT01727141|37832464|FG000|Overall Study|Physician Decision|0|||
16864482|NCT01727141|37832465|FG001|Overall Study|Physician Decision|1|||
16864483|NCT01727141|37832466|FG002|Overall Study|Physician Decision|0|||
16864484|NCT01727141|37832467|FG003|Overall Study|Physician Decision|2|||
16864485|NCT01727141|37832464|FG000|Overall Study|Lost to Follow-up|0|||
16864486|NCT01727141|37832465|FG001|Overall Study|Lost to Follow-up|2|||
16864487|NCT01727141|37832466|FG002|Overall Study|Lost to Follow-up|0|||
16864488|NCT01727141|37832467|FG003|Overall Study|Lost to Follow-up|0|||
16864489|NCT01727141|37832464|FG000|Overall Study|Death|0|||
16864490|NCT01727141|37832465|FG001|Overall Study|Death|1|||
16864491|NCT01727141|37832466|FG002|Overall Study|Death|1|||
16864492|NCT01727141|37832467|FG003|Overall Study|Death|1|||
16864493|NCT01727141|37832464|FG000|Overall Study|Protocol deviation|1|||
16864494|NCT01727141|37832465|FG001|Overall Study|Protocol deviation|1|||
16864495|NCT01727141|37832466|FG002|Overall Study|Protocol deviation|0|||
16864496|NCT01727141|37832467|FG003|Overall Study|Protocol deviation|1|||
16864497|NCT01727141|37832464|FG000|Overall Study|Withdrawal by Subject|4|||
16864498|NCT01727141|37832465|FG001|Overall Study|Withdrawal by Subject|4|||
16864499|NCT01727141|37832466|FG002|Overall Study|Withdrawal by Subject|2|||
16864500|NCT01727141|37832467|FG003|Overall Study|Withdrawal by Subject|11|||
16864501|NCT01726517|37832491|FG000|Overall Study|Withdrawal by Subject|0|||
16864502|NCT01726517|37832492|FG001|Overall Study|Withdrawal by Subject|0|||
16864503|NCT01726517|37832493|FG002|Overall Study|Withdrawal by Subject|1|||
16864504|NCT01726517|37832494|FG003|Overall Study|Withdrawal by Subject|0|||
16864505|NCT01726517|37832495|FG004|Overall Study|Withdrawal by Subject|0|||
16864506|NCT01752023|37832509|FG000|Overall Study|Physician Decision|2|||
16864507|NCT01752023|37832510|FG001|Overall Study|Physician Decision|1|||
16864508|NCT01726049|37832522|FG000|Overall Study|Death|1|||
16864509|NCT01726049|37832523|FG001|Overall Study|Death|1|||
16864510|NCT01726049|37832522|FG000|Overall Study|Adverse Event|4|||
16864511|NCT01726049|37832523|FG001|Overall Study|Adverse Event|1|||
16864512|NCT01726049|37832522|FG000|Overall Study|refused second HC|0|||
16864513|NCT01726049|37832523|FG001|Overall Study|refused second HC|2|||
16864514|NCT01605617|37832544|FG000|First Intervention|Adverse Event|0|||
16864515|NCT01605617|37832545|FG001|First Intervention|Adverse Event|1|||
16864516|NCT01605617|37832544|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
16864517|NCT01605617|37832545|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
16864518|NCT01751867|37832562|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
16864519|NCT01751867|37832563|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
16864520|NCT01751867|37832562|FG000|Overall Study|Diease Progression|4|||
16864521|NCT01751867|37832563|FG001|Overall Study|Diease Progression|18|||
16864522|NCT01751867|37832562|FG000|Overall Study|Adverse Event|8|||
16864523|NCT01751867|37832563|FG001|Overall Study|Adverse Event|15|||
16864524|NCT01751867|37832562|FG000|Overall Study|Poor Compliance|0|||
16864525|NCT01751867|37832563|FG001|Overall Study|Poor Compliance|5|||
16864526|NCT01751867|37832562|FG000|Overall Study|Withdrawal by Subject|3|||
16864527|NCT01751867|37832563|FG001|Overall Study|Withdrawal by Subject|1|||
16864528|NCT01751867|37832562|FG000|Overall Study|Physician Decision|4|||
16864529|NCT01751867|37832563|FG001|Overall Study|Physician Decision|7|||
16864530|NCT01751867|37832562|FG000|Overall Study|Protocol Violation|0|||
16864531|NCT01751867|37832563|FG001|Overall Study|Protocol Violation|2|||
16864532|NCT01751867|37832562|FG000|Overall Study|Death|0|||
16864533|NCT01751867|37832563|FG001|Overall Study|Death|5|||
16864534|NCT01751867|37832562|FG000|Overall Study|Other|11|||
16864535|NCT01751867|37832563|FG001|Overall Study|Other|37|||
16864536|NCT01751867|37832562|FG000|Overall Study|Randomized but not treated.|2|||
16864537|NCT01751867|37832563|FG001|Overall Study|Randomized but not treated.|1|||
16864538|NCT01751165|37832589|FG000|Overall Study|Adverse event, serious fatal|1|||
16864539|NCT01751165|37832590|FG001|Overall Study|Adverse event, serious fatal|0|||
16864540|NCT01751165|37832591|FG002|Overall Study|Adverse event, serious fatal|1|||
16864541|NCT01751165|37832589|FG000|Overall Study|Withdrawal by Subject|0|||
16864542|NCT01751165|37832590|FG001|Overall Study|Withdrawal by Subject|0|||
16864543|NCT01751165|37832591|FG002|Overall Study|Withdrawal by Subject|1|||
16864544|NCT01751165|37832589|FG000|Overall Study|Serious adverse event|0|||
16864545|NCT01751165|37832590|FG001|Overall Study|Serious adverse event|2|||
16864546|NCT01751165|37832591|FG002|Overall Study|Serious adverse event|0|||
16864547|NCT01751165|37832589|FG000|Overall Study|Lost to Follow-up|1|||
16864548|NCT01751165|37832590|FG001|Overall Study|Lost to Follow-up|1|||
16864549|NCT01751165|37832591|FG002|Overall Study|Lost to Follow-up|1|||
16864550|NCT01751087|37832604|FG000|Overall Study|Withdrawal by Subject|1|||
16864551|NCT01751087|37832605|FG001|Overall Study|Withdrawal by Subject|0|||
16864552|NCT01751087|37832606|FG002|Overall Study|Withdrawal by Subject|0|||
16864553|NCT01751087|37832604|FG000|Overall Study|Physician Decision|0|||
16864554|NCT01751087|37832605|FG001|Overall Study|Physician Decision|0|||
16864555|NCT01751087|37832606|FG002|Overall Study|Physician Decision|1|||
16864556|NCT01750697|37832614|FG000|Overall Study|Transferred Back to Local Hospital|1|||
16864557|NCT01750697|37832614|FG000|Overall Study|Physician and Family Decision|1|||
16864558|NCT01750697|37832614|FG000|Overall Study|Transferred to Adult Services|5|||
16864559|NCT01750697|37832614|FG000|Overall Study|Physician Decision|1|||
16864560|NCT01750697|37832614|FG000|Overall Study|Withdrawal by Subject|1|||
16864561|NCT01750229|37832625|FG000|Randomized Crossover Phase|Adverse Event|1|||
16864562|NCT01750229|37832625|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
16864563|NCT01750229|37832625|FG000|Long-term Follow-up Phase|Adverse Event|2|||
16864564|NCT01750229|37832625|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
16864565|NCT01724489|37832637|FG000|Overall Study|Adverse Event|8|||
16864566|NCT01724489|37832638|FG001|Overall Study|Adverse Event|3|||
16864567|NCT01724489|37832637|FG000|Overall Study|Surgery, medication|1|||
16864568|NCT01724489|37832638|FG001|Overall Study|Surgery, medication|1|||
16864569|NCT01724489|37832637|FG000|Overall Study|Lost to Follow-up|1|||
16864570|NCT01724489|37832638|FG001|Overall Study|Lost to Follow-up|2|||
16864571|NCT01724489|37832637|FG000|Overall Study|Withdrawal by Subject|6|||
16864572|NCT01724489|37832638|FG001|Overall Study|Withdrawal by Subject|6|||
16864573|NCT01724177|37832653|FG000|Overall Study|Adverse Event|8|||
16864574|NCT01724177|37832653|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
16864575|NCT01724177|37832653|FG000|Overall Study|Nervous participant|1|||
16864576|NCT01724177|37832653|FG000|Overall Study|Serious Adverse Event Related|1|||
16864577|NCT04378270|37832685|FG000|Overall Study|Lack of Efficacy|1|||
16864578|NCT04378270|37832685|FG000|Overall Study|Withdrawal by Subject|1|||
16864579|NCT04378270|37832685|FG000|Overall Study|Screen Failure|1|||
16864580|NCT04378270|37832685|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
16864581|NCT01724021|37832691|FG000|Overall Study|Adverse Event|11|||
16864582|NCT01724021|37832692|FG001|Overall Study|Adverse Event|6|||
16864583|NCT01724021|37832691|FG000|Overall Study|Death|46|||
16864584|NCT01724021|37832692|FG001|Overall Study|Death|58|||
16864585|NCT01724021|37832691|FG000|Overall Study|Participant request/ Withdrew consent|18|||
17127626|NCT03293654|38268004|FG002|Overall Study|Lost to Follow-up|0|||
17127627|NCT03312218|38268014|FG000|Overall Study|Never signed in to access the app|54|||
17127628|NCT03312218|38268015|FG001|Overall Study|Never signed in to access the app|58|||
17127629|NCT03930615|38268023|FG000|Overall Study|Death|9|||
17127630|NCT03930615|38268024|FG001|Overall Study|Death|3|||
17127631|NCT03930615|38268023|FG000|Overall Study|Lost to Follow-up|1|||
17127632|NCT03930615|38268024|FG001|Overall Study|Lost to Follow-up|2|||
17127633|NCT03930615|38268023|FG000|Overall Study|Physician Decision|3|||
17127634|NCT03930615|38268024|FG001|Overall Study|Physician Decision|4|||
17127635|NCT03930615|38268023|FG000|Overall Study|Withdrawal by Subject|13|||
17127636|NCT03930615|38268024|FG001|Overall Study|Withdrawal by Subject|2|||
17127637|NCT03930615|38268023|FG000|Overall Study|Not treated|1|||
17127638|NCT03930615|38268024|FG001|Overall Study|Not treated|1|||
17127639|NCT03292640|38268032|FG000|Overall Study|Withdrawal by Subject|17|||
17127640|NCT03292640|38268033|FG001|Overall Study|Withdrawal by Subject|16|||
17127641|NCT03292640|38268032|FG000|Overall Study|Adverse Event|20|||
17127642|NCT03292640|38268033|FG001|Overall Study|Adverse Event|2|||
17127643|NCT03292640|38268032|FG000|Overall Study|Lost to Follow-up|24|||
17127644|NCT03292640|38268033|FG001|Overall Study|Lost to Follow-up|24|||
16864586|NCT01724021|37832692|FG001|Overall Study|Participant request/ Withdrew consent|14|||
16864587|NCT01724021|37832691|FG000|Overall Study|Lost to Follow-up|15|||
16864588|NCT01724021|37832692|FG001|Overall Study|Lost to Follow-up|15|||
16864589|NCT01724021|37832691|FG000|Overall Study|Reason Not Specified|36|||
16864590|NCT01724021|37832692|FG001|Overall Study|Reason Not Specified|39|||
16864591|NCT01724021|37832691|FG000|Overall Study|Missing|1|||
16864592|NCT01724021|37832692|FG001|Overall Study|Missing|1|||
16864593|NCT01723397|37832706|FG000|Study Period 1|Protocol Violation|0|||
16864594|NCT01723397|37832707|FG001|Study Period 1|Protocol Violation|1|||
16864595|NCT01723397|37832706|FG000|Study Period 2|Protocol Violation|0|||
16864596|NCT01723397|37832707|FG001|Study Period 2|Protocol Violation|1|||
16864597|NCT01723163|37832715|FG000|Treatment Phase|Withdrawal by Subject|14|||
16864598|NCT01723163|37832716|FG001|Treatment Phase|Withdrawal by Subject|6|||
16864599|NCT01723163|37832715|FG000|Treatment Phase|Withdrawal by PI|5|||
16864600|NCT01723163|37832716|FG001|Treatment Phase|Withdrawal by PI|1|||
16864601|NCT01723163|37832715|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
16864602|NCT01723163|37832716|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
16864603|NCT01723163|37832715|FG000|3-Month Follow-up|Unable to Contact|12|||
16864604|NCT01723163|37832716|FG001|3-Month Follow-up|Unable to Contact|19|||
16864605|NCT01723163|37832715|FG000|6-Month Follow-up|Death|1|||
16864606|NCT01723163|37832716|FG001|6-Month Follow-up|Death|0|||
16864607|NCT01723163|37832715|FG000|6-Month Follow-up|Unable to Contact|17|||
16864608|NCT01723163|37832716|FG001|6-Month Follow-up|Unable to Contact|15|||
16864609|NCT01723163|37832715|FG000|12-Month Follow-up|Death|1|||
16864610|NCT01723163|37832716|FG001|12-Month Follow-up|Death|0|||
16864611|NCT01723163|37832715|FG000|12-Month Follow-up|Unable to Contact|23|||
16864612|NCT01723163|37832716|FG001|12-Month Follow-up|Unable to Contact|28|||
16864613|NCT01722071|37832726|FG000|Overall Study|Protocol Violation|1|||
16864614|NCT01722071|37832727|FG001|Overall Study|Protocol Violation|0|||
16864615|NCT01721759|37832733|FG000|Treatment Period|Disease Progression|85|||
16864616|NCT01721759|37832733|FG000|Treatment Period|Study drug toxicity|14|||
16864617|NCT01721759|37832733|FG000|Treatment Period|Death|1|||
16864618|NCT01721759|37832733|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
16864619|NCT01721759|37832733|FG000|Treatment Period|Participant request to withdraw|3|||
16864620|NCT01721759|37832733|FG000|Treatment Period|Other Reasons|3|||
16864621|NCT01721759|37832733|FG000|End of Study Period|Participant Withdrew Consent|5|||
16864622|NCT01721759|37832733|FG000|End of Study Period|Death|101|||
16864623|NCT01721759|37832733|FG000|End of Study Period|Lost to Follow-up|1|||
16864624|NCT01721759|37832733|FG000|End of Study Period|Other Reasons|10|||
16864625|NCT01721369|37832742|FG000|Overall Study|Not initial etiological diagnosis|12|||
16864626|NCT01721057|37832804|FG000|Treatment Period|Withdrawal by Subject|11|||
16864627|NCT01721057|37832805|FG001|Treatment Period|Withdrawal by Subject|5|||
16864628|NCT01721057|37832806|FG002|Treatment Period|Withdrawal by Subject|8|||
16864629|NCT01721057|37832807|FG003|Treatment Period|Withdrawal by Subject|0|||
16864630|NCT01721057|37832808|FG004|Treatment Period|Withdrawal by Subject|0|||
16864631|NCT01721057|37832809|FG005|Treatment Period|Withdrawal by Subject|0|||
16864632|NCT01721057|37832810|FG006|Treatment Period|Withdrawal by Subject|0|||
16864633|NCT01721057|37832804|FG000|Treatment Period|Adverse Event|7|||
16864634|NCT01721057|37832805|FG001|Treatment Period|Adverse Event|10|||
16864635|NCT01721057|37832806|FG002|Treatment Period|Adverse Event|12|||
16864636|NCT01721057|37832807|FG003|Treatment Period|Adverse Event|0|||
16864637|NCT01721057|37832808|FG004|Treatment Period|Adverse Event|0|||
16864638|NCT01721057|37832809|FG005|Treatment Period|Adverse Event|0|||
16864639|NCT01721057|37832810|FG006|Treatment Period|Adverse Event|0|||
16864640|NCT01721057|37832804|FG000|Treatment Period|Lack of Efficacy|7|||
16864641|NCT01721057|37832805|FG001|Treatment Period|Lack of Efficacy|3|||
16864642|NCT01721057|37832806|FG002|Treatment Period|Lack of Efficacy|0|||
16864643|NCT01721057|37832807|FG003|Treatment Period|Lack of Efficacy|0|||
16864644|NCT01721057|37832808|FG004|Treatment Period|Lack of Efficacy|0|||
16864645|NCT01721057|37832809|FG005|Treatment Period|Lack of Efficacy|0|||
16864646|NCT01721057|37832810|FG006|Treatment Period|Lack of Efficacy|0|||
16864647|NCT01721057|37832804|FG000|Treatment Period|Lost to Follow-up|1|||
16864648|NCT01721057|37832805|FG001|Treatment Period|Lost to Follow-up|0|||
16864649|NCT01721057|37832806|FG002|Treatment Period|Lost to Follow-up|0|||
16864650|NCT01721057|37832807|FG003|Treatment Period|Lost to Follow-up|0|||
16864651|NCT01721057|37832808|FG004|Treatment Period|Lost to Follow-up|0|||
16864652|NCT01721057|37832809|FG005|Treatment Period|Lost to Follow-up|0|||
16864653|NCT01721057|37832810|FG006|Treatment Period|Lost to Follow-up|0|||
16864654|NCT01721057|37832804|FG000|Treatment Period|Physician Decision|0|||
16864655|NCT01721057|37832805|FG001|Treatment Period|Physician Decision|1|||
16864656|NCT01721057|37832806|FG002|Treatment Period|Physician Decision|3|||
16864657|NCT01721057|37832807|FG003|Treatment Period|Physician Decision|0|||
16864658|NCT01721057|37832808|FG004|Treatment Period|Physician Decision|0|||
16864659|NCT01721057|37832809|FG005|Treatment Period|Physician Decision|0|||
16864660|NCT01721057|37832810|FG006|Treatment Period|Physician Decision|0|||
16864661|NCT01721057|37832804|FG000|Treatment Period|Death|2|||
16864662|NCT01721057|37832805|FG001|Treatment Period|Death|0|||
16864663|NCT01721057|37832806|FG002|Treatment Period|Death|0|||
16864664|NCT01721057|37832807|FG003|Treatment Period|Death|0|||
16864665|NCT01721057|37832808|FG004|Treatment Period|Death|0|||
16864666|NCT01721057|37832809|FG005|Treatment Period|Death|0|||
16864667|NCT01721057|37832810|FG006|Treatment Period|Death|0|||
16864668|NCT01721057|37832804|FG000|Rescue Period|Adverse Event|0|||
16864669|NCT01721057|37832805|FG001|Rescue Period|Adverse Event|0|||
16864670|NCT01721057|37832806|FG002|Rescue Period|Adverse Event|0|||
16864671|NCT01721057|37832807|FG003|Rescue Period|Adverse Event|1|||
16864672|NCT01721057|37832808|FG004|Rescue Period|Adverse Event|0|||
16864673|NCT01721057|37832809|FG005|Rescue Period|Adverse Event|0|||
16864674|NCT01721057|37832810|FG006|Rescue Period|Adverse Event|0|||
16864675|NCT01721057|37832804|FG000|Rescue Period|Lack of Efficacy|0|||
16864676|NCT01721057|37832805|FG001|Rescue Period|Lack of Efficacy|0|||
16864677|NCT01721057|37832806|FG002|Rescue Period|Lack of Efficacy|0|||
16864678|NCT01721057|37832807|FG003|Rescue Period|Lack of Efficacy|2|||
16864679|NCT01721057|37832808|FG004|Rescue Period|Lack of Efficacy|0|||
16864680|NCT01721057|37832809|FG005|Rescue Period|Lack of Efficacy|0|||
16864681|NCT01721057|37832810|FG006|Rescue Period|Lack of Efficacy|0|||
16864682|NCT04570384|37832839|FG000|Overall Study|Adverse Event|2|||
16864683|NCT04570384|37832840|FG001|Overall Study|Adverse Event|1|||
16864684|NCT04570384|37832839|FG000|Overall Study|Death|2|||
16864685|NCT04570384|37832840|FG001|Overall Study|Death|5|||
16864686|NCT04570384|37832839|FG000|Overall Study|Lost to Follow-up|1|||
16864687|NCT04570384|37832840|FG001|Overall Study|Lost to Follow-up|0|||
16864688|NCT04570384|37832839|FG000|Overall Study|Other|1|||
16864689|NCT04570384|37832840|FG001|Overall Study|Other|0|||
16864690|NCT04570384|37832839|FG000|Overall Study|Protocol Violation|0|||
16864691|NCT04570384|37832840|FG001|Overall Study|Protocol Violation|1|||
16864692|NCT04570384|37832839|FG000|Overall Study|Sponsor Decision|1|||
16864693|NCT04570384|37832840|FG001|Overall Study|Sponsor Decision|0|||
16864694|NCT04570384|37832839|FG000|Overall Study|Withdrawal by Subject|4|||
16864695|NCT04570384|37832840|FG001|Overall Study|Withdrawal by Subject|2|||
16864696|NCT02563522|37832893|FG000|Overall Study|Adverse Event|2|||
16864697|NCT02563522|37832894|FG001|Overall Study|Adverse Event|3|||
16864698|NCT02563522|37832893|FG000|Overall Study|Lost to Follow-up|1|||
16864699|NCT02563522|37832894|FG001|Overall Study|Lost to Follow-up|0|||
16864700|NCT02563522|37832893|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
16864701|NCT02563522|37832894|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
16864702|NCT02180724|37832902|FG000|Overall Study|Death|26|||
16864703|NCT02180724|37832903|FG001|Overall Study|Death|1|||
16864704|NCT02180724|37832902|FG000|Overall Study|Lost to Follow-up|3|||
16864705|NCT02180724|37832903|FG001|Overall Study|Lost to Follow-up|1|||
16864706|NCT02180724|37832902|FG000|Overall Study|Withdrawal by Subject|4|||
16864707|NCT02180724|37832903|FG001|Overall Study|Withdrawal by Subject|2|||
16864708|NCT02180724|37832902|FG000|Overall Study|PI Decision|5|||
16864709|NCT02180724|37832903|FG001|Overall Study|PI Decision|2|||
16864710|NCT02180724|37832902|FG000|Overall Study|Study terminated by sponsor|54|||
16864711|NCT02180724|37832903|FG001|Overall Study|Study terminated by sponsor|8|||
16864712|NCT03578146|37832930|FG000|Overall Study|Did Not Receive Treatment|1|||
16864713|NCT03578146|37832931|FG001|Overall Study|Did Not Receive Treatment|0|||
16864714|NCT03578146|37832932|FG002|Overall Study|Did Not Receive Treatment|0|||
16864715|NCT03578146|37832933|FG003|Overall Study|Did Not Receive Treatment|0|||
16864716|NCT03578146|37832934|FG004|Overall Study|Did Not Receive Treatment|0|||
16864717|NCT03578146|37832935|FG005|Overall Study|Did Not Receive Treatment|2|||
16864718|NCT03578146|37832930|FG000|Overall Study|Lost to Follow-up|0|||
16864719|NCT03578146|37832931|FG001|Overall Study|Lost to Follow-up|1|||
16864720|NCT03578146|37832932|FG002|Overall Study|Lost to Follow-up|1|||
16864721|NCT03578146|37832933|FG003|Overall Study|Lost to Follow-up|0|||
16864722|NCT03578146|37832934|FG004|Overall Study|Lost to Follow-up|0|||
16864723|NCT03578146|37832935|FG005|Overall Study|Lost to Follow-up|1|||
16864724|NCT02716896|37832951|FG000|Overall Study|Physician Decision|0|||
16864725|NCT02716896|37832952|FG001|Overall Study|Physician Decision|1|||
16864726|NCT02715726|37833020|FG000|Overall Study|Adverse Event|2|||
16864727|NCT02715726|37833021|FG001|Overall Study|Adverse Event|6|||
16864728|NCT02715726|37833020|FG000|Overall Study|Protocol Violation|1|||
16864729|NCT02715726|37833021|FG001|Overall Study|Protocol Violation|0|||
16864730|NCT02715726|37833020|FG000|Overall Study|Death|2|||
16864731|NCT02715726|37833021|FG001|Overall Study|Death|1|||
16864732|NCT02715726|37833020|FG000|Overall Study|Participant moved|1|||
16864733|NCT02715726|37833021|FG001|Overall Study|Participant moved|3|||
16864734|NCT02715726|37833020|FG000|Overall Study|Other than specified above|11|||
16864735|NCT02715726|37833021|FG001|Overall Study|Other than specified above|15|||
16864736|NCT02715726|37833020|FG000|Overall Study|Randomized but not treated|1|||
16864737|NCT02715726|37833021|FG001|Overall Study|Randomized but not treated|2|||
16864738|NCT04248816|37833034|FG000|Overall Study|Ineligible post-randomization|7|||
16864739|NCT04248816|37833035|FG001|Overall Study|Ineligible post-randomization|21|||
16864740|NCT04248816|37833036|FG002|Overall Study|Ineligible post-randomization|25|||
16864741|NCT02314156|37833073|FG000|Overall Study|Adverse Event|1|||
16864742|NCT02314156|37833074|FG001|Overall Study|Adverse Event|0|||
16864743|NCT02314156|37833073|FG000|Overall Study|Withdrawal by Subject|1|||
16864744|NCT02314156|37833074|FG001|Overall Study|Withdrawal by Subject|0|||
16864745|NCT02716584|37833156|FG000|Overall Study|Lost to Follow-up|8|||
16864746|NCT02716584|37833157|FG001|Overall Study|Lost to Follow-up|5|||
16864747|NCT04034238|37833276|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
16864748|NCT04034238|37833277|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16864749|NCT04034238|37833278|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16864750|NCT04034238|37833279|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16864751|NCT04034238|37833276|FG000|Dose Escalation Phase|Screen failures|0|||
16864752|NCT04034238|37833277|FG001|Dose Escalation Phase|Screen failures|0|||
16864753|NCT04034238|37833278|FG002|Dose Escalation Phase|Screen failures|0|||
16864754|NCT04034238|37833279|FG003|Dose Escalation Phase|Screen failures|2|||
16864755|NCT04034238|37833276|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
16864756|NCT04034238|37833277|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
16864757|NCT04034238|37833278|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
16864758|NCT04034238|37833279|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
16864759|NCT04034238|37833276|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
16864760|NCT04034238|37833277|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
16864761|NCT04034238|37833278|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
16864762|NCT04034238|37833279|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
16864763|NCT02716194|37833391|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
16864764|NCT02716194|37833392|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
16864765|NCT02716194|37833393|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
16868156|NCT01548287|37841193|FG000|Screening|Did not meet eligibility criteria|0|||
16864766|NCT03773484|37833463|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
16864767|NCT02715258|37833656|FG000|Overall Study|Withdrawal by Subject|6|||
16864768|NCT02715258|37833657|FG001|Overall Study|Withdrawal by Subject|1|||
16864769|NCT02715258|37833656|FG000|Overall Study|Lost to Follow-up|7|||
16864770|NCT02715258|37833657|FG001|Overall Study|Lost to Follow-up|1|||
16864771|NCT02715258|37833656|FG000|Overall Study|Terminated by Sponsor|0|||
16864772|NCT02715258|37833657|FG001|Overall Study|Terminated by Sponsor|1|||
16864773|NCT02715258|37833656|FG000|Overall Study|Death|0|||
16864774|NCT02715258|37833657|FG001|Overall Study|Death|1|||
16864775|NCT02715258|37833656|FG000|Overall Study|Subject non-compliant|1|||
16864776|NCT02715258|37833657|FG001|Overall Study|Subject non-compliant|1|||
16864777|NCT02715258|37833656|FG000|Overall Study|GCP violation|2|||
16864778|NCT02715258|37833657|FG001|Overall Study|GCP violation|1|||
16864779|NCT02714868|37833682|FG000|Overall Study|Withdrawal by Subject|3|||
16864780|NCT02714868|37833683|FG001|Overall Study|Withdrawal by Subject|0|||
16864781|NCT02714868|37833682|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
16864782|NCT02714868|37833683|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
16864783|NCT02714868|37833682|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
16864784|NCT02714868|37833683|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
16864785|NCT02713542|37834007|FG000|Overall Study|Use of prohibited medication|14|||
16944838|NCT01097707|38088865|FG002|Overall Study|Lost to Follow-up|2|||
16864786|NCT02713542|37834008|FG001|Overall Study|Use of prohibited medication|5|||
16864787|NCT02713542|37834007|FG000|Overall Study|Withdrawal by Subject|4|||
16864788|NCT02713542|37834008|FG001|Overall Study|Withdrawal by Subject|1|||
16864789|NCT03548220|37834092|FG000|Overall Study|Lost to Follow-up|1|||
16864790|NCT03548220|37834093|FG001|Overall Study|Lost to Follow-up|0|||
16864791|NCT03548220|37834094|FG002|Overall Study|Lost to Follow-up|0|||
16864792|NCT03548220|37834095|FG003|Overall Study|Lost to Follow-up|0|||
16864793|NCT02712996|37834130|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
16864794|NCT02712996|37834131|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
16864795|NCT00701064|37834238|FG000|Overall Study|Protocol Violation|1|||
16864796|NCT00701064|37834239|FG001|Overall Study|Protocol Violation|1|||
16864797|NCT00701064|37834238|FG000|Overall Study|Withdrawal by Subject|1|||
16864798|NCT00701064|37834239|FG001|Overall Study|Withdrawal by Subject|1|||
16864799|NCT00701064|37834238|FG000|Overall Study|initiated other PTSD treatment|2|||
16864800|NCT00701064|37834239|FG001|Overall Study|initiated other PTSD treatment|2|||
16864801|NCT01748825|37834378|FG000|Dose Escalation|Refused further treatment|2|||
16864802|NCT01748825|37834379|FG001|Dose Escalation|Refused further treatment|2|||
16864803|NCT01748825|37834380|FG002|Dose Escalation|Refused further treatment|0|||
16864804|NCT01748825|37834381|FG003|Dose Escalation|Refused further treatment|0|||
16864805|NCT01748825|37834382|FG004|Dose Escalation|Refused further treatment|1|||
16864806|NCT01748825|37834383|FG005|Dose Escalation|Refused further treatment|2|||
16864807|NCT01748825|37834384|FG006|Dose Escalation|Refused further treatment|0|||
16864808|NCT01748825|37834385|FG007|Dose Escalation|Refused further treatment|0|||
16864809|NCT01748825|37834386|FG008|Dose Escalation|Refused further treatment|0|||
16864810|NCT01748825|37834387|FG009|Dose Escalation|Refused further treatment|0|||
16864811|NCT01748825|37834378|FG000|Dose Escalation|Switched to alternative treatment|0|||
16864812|NCT01748825|37834379|FG001|Dose Escalation|Switched to alternative treatment|0|||
16864813|NCT01748825|37834380|FG002|Dose Escalation|Switched to alternative treatment|0|||
16864814|NCT01748825|37834381|FG003|Dose Escalation|Switched to alternative treatment|1|||
16864815|NCT01748825|37834382|FG004|Dose Escalation|Switched to alternative treatment|0|||
16864816|NCT01748825|37834383|FG005|Dose Escalation|Switched to alternative treatment|0|||
16864817|NCT01748825|37834384|FG006|Dose Escalation|Switched to alternative treatment|0|||
16944839|NCT01097707|38088866|FG003|Overall Study|Lost to Follow-up|0|||
16864818|NCT01748825|37834385|FG007|Dose Escalation|Switched to alternative treatment|0|||
16864819|NCT01748825|37834386|FG008|Dose Escalation|Switched to alternative treatment|0|||
16864820|NCT01748825|37834387|FG009|Dose Escalation|Switched to alternative treatment|0|||
16864821|NCT01748825|37834378|FG000|Dose Escalation|Adverse Event|0|||
16864822|NCT01748825|37834379|FG001|Dose Escalation|Adverse Event|0|||
16864823|NCT01748825|37834380|FG002|Dose Escalation|Adverse Event|0|||
16864824|NCT01748825|37834381|FG003|Dose Escalation|Adverse Event|0|||
16864825|NCT01748825|37834382|FG004|Dose Escalation|Adverse Event|0|||
16864826|NCT01748825|37834383|FG005|Dose Escalation|Adverse Event|0|||
16864827|NCT01748825|37834384|FG006|Dose Escalation|Adverse Event|1|||
16864828|NCT01748825|37834385|FG007|Dose Escalation|Adverse Event|0|||
16864829|NCT01748825|37834386|FG008|Dose Escalation|Adverse Event|0|||
16864830|NCT01748825|37834387|FG009|Dose Escalation|Adverse Event|0|||
16864831|NCT01748825|37834378|FG000|Dose Expansion|Refused further treatment|0|||
16864832|NCT01748825|37834379|FG001|Dose Expansion|Refused further treatment|0|||
16864833|NCT01748825|37834380|FG002|Dose Expansion|Refused further treatment|0|||
16864834|NCT01748825|37834381|FG003|Dose Expansion|Refused further treatment|0|||
16864835|NCT01748825|37834382|FG004|Dose Expansion|Refused further treatment|0|||
16864836|NCT01748825|37834383|FG005|Dose Expansion|Refused further treatment|0|||
16864837|NCT01748825|37834384|FG006|Dose Expansion|Refused further treatment|0|||
16864838|NCT01748825|37834385|FG007|Dose Expansion|Refused further treatment|0|||
16864839|NCT01748825|37834386|FG008|Dose Expansion|Refused further treatment|1|||
16864840|NCT01748825|37834387|FG009|Dose Expansion|Refused further treatment|1|||
16864841|NCT01748825|37834378|FG000|Dose Expansion|Switched to alternative treatment|0|||
16864842|NCT01748825|37834379|FG001|Dose Expansion|Switched to alternative treatment|0|||
16864843|NCT01748825|37834380|FG002|Dose Expansion|Switched to alternative treatment|0|||
16864844|NCT01748825|37834381|FG003|Dose Expansion|Switched to alternative treatment|0|||
16864845|NCT01748825|37834382|FG004|Dose Expansion|Switched to alternative treatment|0|||
16944840|NCT01097707|38088867|FG004|Overall Study|Lost to Follow-up|3|||
16864846|NCT01748825|37834383|FG005|Dose Expansion|Switched to alternative treatment|0|||
16864847|NCT01748825|37834384|FG006|Dose Expansion|Switched to alternative treatment|0|||
16864848|NCT01748825|37834385|FG007|Dose Expansion|Switched to alternative treatment|0|||
16864849|NCT01748825|37834386|FG008|Dose Expansion|Switched to alternative treatment|0|||
16864850|NCT01748825|37834387|FG009|Dose Expansion|Switched to alternative treatment|1|||
16864851|NCT01748825|37834378|FG000|Dose Expansion|Adverse Event|0|||
16864852|NCT01748825|37834379|FG001|Dose Expansion|Adverse Event|0|||
16864853|NCT01748825|37834380|FG002|Dose Expansion|Adverse Event|0|||
16864854|NCT01748825|37834381|FG003|Dose Expansion|Adverse Event|0|||
16864855|NCT01748825|37834382|FG004|Dose Expansion|Adverse Event|0|||
16864856|NCT01748825|37834383|FG005|Dose Expansion|Adverse Event|0|||
16864857|NCT01748825|37834384|FG006|Dose Expansion|Adverse Event|0|||
16864858|NCT01748825|37834385|FG007|Dose Expansion|Adverse Event|0|||
16864859|NCT01748825|37834386|FG008|Dose Expansion|Adverse Event|0|||
16864860|NCT01748825|37834387|FG009|Dose Expansion|Adverse Event|3|||
16864861|NCT01748825|37834378|FG000|Dose Expansion|Physician Decision|0|||
16864862|NCT01748825|37834379|FG001|Dose Expansion|Physician Decision|0|||
16864863|NCT01748825|37834380|FG002|Dose Expansion|Physician Decision|0|||
16864864|NCT01748825|37834381|FG003|Dose Expansion|Physician Decision|0|||
16864865|NCT01748825|37834382|FG004|Dose Expansion|Physician Decision|0|||
16864866|NCT01748825|37834383|FG005|Dose Expansion|Physician Decision|0|||
16864867|NCT01748825|37834384|FG006|Dose Expansion|Physician Decision|0|||
16864868|NCT01748825|37834385|FG007|Dose Expansion|Physician Decision|0|||
16864869|NCT01748825|37834386|FG008|Dose Expansion|Physician Decision|1|||
16864870|NCT01748825|37834387|FG009|Dose Expansion|Physician Decision|0|||
16864871|NCT01720667|37834449|FG000|Overall Study|Adverse Event|1|||
16864872|NCT01720667|37834450|FG001|Overall Study|Adverse Event|1|||
16864873|NCT01720667|37834449|FG000|Overall Study|Withdrawal by Subject|3|||
16864874|NCT01720667|37834450|FG001|Overall Study|Withdrawal by Subject|0|||
16864875|NCT01720043|37834458|FG000|Overall Study|Withdrawal by Subject|1|||
16864876|NCT00700752|37834462|FG000|First Intervention|Withdrawal by Subject|0|||
16864877|NCT00700752|37834463|FG001|First Intervention|Withdrawal by Subject|2|||
16864878|NCT01747811|37834480|FG000|Overall Study|Lack of Efficacy|2|||
16864879|NCT01747811|37834481|FG001|Overall Study|Lack of Efficacy|4|||
16864880|NCT01747655|37834489|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
16864881|NCT01747655|37834490|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
16864882|NCT01747655|37834489|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
16864883|NCT01747655|37834490|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
16864884|NCT01747655|37834489|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
16864885|NCT01747655|37834490|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
16864886|NCT01718483|37834498|FG000|Overall Study|Withdrawal by Subject|14|||
16864887|NCT01718483|37834499|FG001|Overall Study|Withdrawal by Subject|12|||
16864888|NCT01718483|37834498|FG000|Overall Study|Adverse Event|5|||
16864889|NCT01718483|37834499|FG001|Overall Study|Adverse Event|12|||
16864890|NCT01718483|37834498|FG000|Overall Study|Lost to Follow-up|8|||
16864891|NCT01718483|37834499|FG001|Overall Study|Lost to Follow-up|3|||
16864892|NCT01718483|37834498|FG000|Overall Study|Protocol Violation|4|||
16864893|NCT01718483|37834499|FG001|Overall Study|Protocol Violation|2|||
16864894|NCT01718483|37834498|FG000|Overall Study|Other|1|||
16864895|NCT01718483|37834499|FG001|Overall Study|Other|4|||
16864896|NCT01718483|37834498|FG000|Overall Study|Pregnancy|1|||
16864897|NCT01718483|37834499|FG001|Overall Study|Pregnancy|1|||
16864898|NCT01718483|37834498|FG000|Overall Study|Lack of Efficacy|1|||
16864899|NCT01718483|37834499|FG001|Overall Study|Lack of Efficacy|0|||
16864900|NCT01717859|37834505|FG000|Overall Study|Adverse Event|5|||
16864901|NCT01717859|37834505|FG000|Overall Study|Moved out of state|1|||
16864902|NCT01717859|37834505|FG000|Overall Study|Patient concerned about mental health|1|||
16864903|NCT01717859|37834505|FG000|Overall Study|Lost to Follow-up|1|||
16864904|NCT01717859|37834505|FG000|Overall Study|Withdrawal by Subject|2|||
16864905|NCT01747499|37834798|FG000|Overall Study|Steroid refractory aGvHD|1|||
16864906|NCT01747499|37834799|FG001|Overall Study|Steroid refractory aGvHD|0|||
16864907|NCT01747499|37834800|FG002|Overall Study|Steroid refractory aGvHD|0|||
16864908|NCT01747499|37834801|FG003|Overall Study|Steroid refractory aGvHD|1|||
16864909|NCT01747499|37834802|FG004|Overall Study|Steroid refractory aGvHD|4|||
16864910|NCT01747499|37834798|FG000|Overall Study|Physician Decision|0|||
16864911|NCT01747499|37834799|FG001|Overall Study|Physician Decision|1|||
16864912|NCT01747499|37834800|FG002|Overall Study|Physician Decision|0|||
16864913|NCT01747499|37834801|FG003|Overall Study|Physician Decision|0|||
16864914|NCT01747499|37834802|FG004|Overall Study|Physician Decision|2|||
16864915|NCT01747499|37834798|FG000|Overall Study|Death|0|||
16864916|NCT01747499|37834799|FG001|Overall Study|Death|0|||
16864917|NCT01747499|37834800|FG002|Overall Study|Death|0|||
16864918|NCT01747499|37834801|FG003|Overall Study|Death|1|||
16864919|NCT01747499|37834802|FG004|Overall Study|Death|1|||
16864920|NCT01747499|37834798|FG000|Overall Study|Withdrawal by Subject|0|||
16864921|NCT01747499|37834799|FG001|Overall Study|Withdrawal by Subject|0|||
16864922|NCT01747499|37834800|FG002|Overall Study|Withdrawal by Subject|0|||
16864923|NCT01747499|37834801|FG003|Overall Study|Withdrawal by Subject|0|||
16864924|NCT01747499|37834802|FG004|Overall Study|Withdrawal by Subject|6|||
16864925|NCT01747499|37834798|FG000|Overall Study|Developed AML and death|0|||
16864926|NCT01747499|37834799|FG001|Overall Study|Developed AML and death|0|||
16864927|NCT01747499|37834800|FG002|Overall Study|Developed AML and death|0|||
16864928|NCT01747499|37834801|FG003|Overall Study|Developed AML and death|0|||
16864929|NCT01747499|37834802|FG004|Overall Study|Developed AML and death|1|||
16864930|NCT01747499|37834798|FG000|Overall Study|Determined not to be eligible|0|||
16864931|NCT01747499|37834799|FG001|Overall Study|Determined not to be eligible|0|||
16864932|NCT01747499|37834800|FG002|Overall Study|Determined not to be eligible|0|||
16864933|NCT01747499|37834801|FG003|Overall Study|Determined not to be eligible|0|||
16864934|NCT01747499|37834802|FG004|Overall Study|Determined not to be eligible|1|||
16864935|NCT01717391|37834834|FG000|Overall Study|Withdrawal by Subject|5|||
16864936|NCT01717391|37834834|FG000|Overall Study|Physician Decision|1|||
16864937|NCT01717391|37834834|FG000|Overall Study|FLT technical failure|3|||
16864938|NCT01746017|37834977|FG000|Period 1|Withdrawal by Subject|0|||
16864939|NCT01746017|37834978|FG001|Period 1|Withdrawal by Subject|0|||
16864940|NCT01746017|37834979|FG002|Period 1|Withdrawal by Subject|0|||
16864941|NCT01746017|37834980|FG003|Period 1|Withdrawal by Subject|0|||
16864942|NCT01746017|37834981|FG004|Period 1|Withdrawal by Subject|0|||
16864943|NCT01746017|37834982|FG005|Period 1|Withdrawal by Subject|0|||
16864944|NCT01746017|37834983|FG006|Period 1|Withdrawal by Subject|1|||
16864945|NCT01746017|37834984|FG007|Period 1|Withdrawal by Subject|0|||
16864946|NCT01746017|37834985|FG008|Period 1|Withdrawal by Subject|0|||
16864947|NCT01746017|37834986|FG009|Period 1|Withdrawal by Subject|0|||
16864948|NCT01746017|37834987|FG010|Period 1|Withdrawal by Subject|0|||
16864949|NCT01746017|37834977|FG000|Period 3|Withdrawal by Subject|0|||
16864950|NCT01746017|37834978|FG001|Period 3|Withdrawal by Subject|0|||
16864951|NCT01746017|37834979|FG002|Period 3|Withdrawal by Subject|0|||
16864952|NCT01746017|37834980|FG003|Period 3|Withdrawal by Subject|0|||
16864953|NCT01746017|37834981|FG004|Period 3|Withdrawal by Subject|0|||
16864954|NCT01746017|37834982|FG005|Period 3|Withdrawal by Subject|1|||
16864955|NCT01746017|37834983|FG006|Period 3|Withdrawal by Subject|0|||
16864956|NCT01746017|37834984|FG007|Period 3|Withdrawal by Subject|0|||
16864957|NCT01746017|37834985|FG008|Period 3|Withdrawal by Subject|0|||
16864958|NCT01746017|37834986|FG009|Period 3|Withdrawal by Subject|0|||
16864959|NCT01746017|37834987|FG010|Period 3|Withdrawal by Subject|0|||
16864960|NCT01717313|37835049|FG000|Phase A (Weeks 0 to 24)|Death|0|||
16864961|NCT01717313|37835050|FG001|Phase A (Weeks 0 to 24)|Death|1|||
16864962|NCT01717313|37835049|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
16864963|NCT01717313|37835050|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
16864964|NCT01717313|37835049|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
16864965|NCT01717313|37835050|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
16864966|NCT01717313|37835049|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
16864967|NCT01717313|37835050|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
16864968|NCT01717313|37835049|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
16864969|NCT01717313|37835050|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
16864970|NCT01717313|37835049|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
16864971|NCT01717313|37835050|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
16864972|NCT01717313|37835049|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
16864973|NCT01717313|37835050|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
16864974|NCT01717313|37835049|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
16864975|NCT01717313|37835050|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
16864976|NCT01717313|37835049|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
16864977|NCT01717313|37835050|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
16864978|NCT01745393|37835062|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
16864979|NCT01745393|37835063|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
16864980|NCT01745393|37835062|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
16864981|NCT01745393|37835063|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
16864982|NCT01745393|37835062|FG000|12-month Follow-up|Lost to Follow-up|6|||
16864983|NCT01745393|37835063|FG001|12-month Follow-up|Lost to Follow-up|5|||
16864984|NCT01744691|37835094|FG000|Overall Study|Progressive Disease|18|||
16864985|NCT01744691|37835094|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
16864986|NCT01744691|37835094|FG000|Overall Study|Withdrawal of consent for treatment|3|||
16864987|NCT01744691|37835094|FG000|Overall Study|Physician Decision|4|||
16864988|NCT01716533|37835129|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
16864989|NCT01716533|37835130|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
16864990|NCT01716533|37835131|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
16864991|NCT01716533|37835132|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
16864992|NCT01716533|37835129|FG000|Overall Study|Withdrawal by Subject|0|||
16864993|NCT01716533|37835130|FG001|Overall Study|Withdrawal by Subject|0|||
16864994|NCT01716533|37835131|FG002|Overall Study|Withdrawal by Subject|0|||
16864995|NCT01716533|37835132|FG003|Overall Study|Withdrawal by Subject|5|||
16864996|NCT01716533|37835129|FG000|Overall Study|Death|0|||
16864997|NCT01716533|37835130|FG001|Overall Study|Death|0|||
16864998|NCT01716533|37835131|FG002|Overall Study|Death|0|||
16864999|NCT01716533|37835132|FG003|Overall Study|Death|2|||
16865000|NCT01716533|37835129|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
16865001|NCT01716533|37835130|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
16865002|NCT01716533|37835131|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
16865003|NCT01716533|37835132|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
16865004|NCT01375374|37835146|FG000|Overall Study|Adverse Event|1|||
16865005|NCT01743989|37835758|FG000|Treatment Phase|Unstable MR4.0|0|||
16865006|NCT01743989|37835759|FG001|Treatment Phase|Unstable MR4.0|6|||
16865007|NCT01743989|37835760|FG002|Treatment Phase|Unstable MR4.0|263|||
16865008|NCT01743989|37835758|FG000|Treatment Phase|Adverse Event|0|||
16865009|NCT01743989|37835759|FG001|Treatment Phase|Adverse Event|4|||
16865010|NCT01743989|37835760|FG002|Treatment Phase|Adverse Event|67|||
16865011|NCT01743989|37835758|FG000|Treatment Phase|Withdrawal by Subject|1|||
16865012|NCT01743989|37835759|FG001|Treatment Phase|Withdrawal by Subject|3|||
16865013|NCT01743989|37835760|FG002|Treatment Phase|Withdrawal by Subject|28|||
16865014|NCT01743989|37835758|FG000|Treatment Phase|Death|0|||
16865015|NCT01743989|37835759|FG001|Treatment Phase|Death|1|||
16865016|NCT01743989|37835760|FG002|Treatment Phase|Death|3|||
16865017|NCT01743989|37835758|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
16865018|NCT01743989|37835759|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
16865019|NCT01743989|37835760|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
16865020|NCT01743989|37835758|FG000|Treatment Phase|Protocol deviation|0|||
16865021|NCT01743989|37835759|FG001|Treatment Phase|Protocol deviation|0|||
16865022|NCT01743989|37835760|FG002|Treatment Phase|Protocol deviation|3|||
16865023|NCT01743989|37835758|FG000|Treatment Phase|Pregnancy|0|||
16865024|NCT01743989|37835759|FG001|Treatment Phase|Pregnancy|0|||
16865025|NCT01743989|37835760|FG002|Treatment Phase|Pregnancy|2|||
16865026|NCT01743989|37835758|FG000|Treatment Phase|Lost to Follow-up|0|||
16865027|NCT01743989|37835759|FG001|Treatment Phase|Lost to Follow-up|0|||
16865028|NCT01743989|37835760|FG002|Treatment Phase|Lost to Follow-up|2|||
16865029|NCT01743989|37835758|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
16865030|NCT01743989|37835759|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
16865031|NCT01743989|37835760|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
16865032|NCT01743989|37835758|FG000|Treatment Phase|Administrative problems|0|||
16865033|NCT01743989|37835759|FG001|Treatment Phase|Administrative problems|0|||
16865034|NCT01743989|37835760|FG002|Treatment Phase|Administrative problems|1|||
16865035|NCT01743989|37835758|FG000|Treatment Phase|New cancer (CML) therapy|0|||
16865036|NCT01743989|37835759|FG001|Treatment Phase|New cancer (CML) therapy|1|||
16865037|NCT01743989|37835760|FG002|Treatment Phase|New cancer (CML) therapy|0|||
16865038|NCT01743989|37835758|FG000|Treatment Phase|Physician Decision|0|||
16865039|NCT01743989|37835759|FG001|Treatment Phase|Physician Decision|0|||
16865040|NCT01743989|37835760|FG002|Treatment Phase|Physician Decision|3|||
16865041|NCT01743989|37835758|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
16865042|NCT01743989|37835759|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
16865043|NCT01743989|37835760|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
16865044|NCT01743989|37835758|FG000|Treatment Phase|Not randomized by mistake|0|||
16865045|NCT01743989|37835759|FG001|Treatment Phase|Not randomized by mistake|0|||
16865046|NCT01743989|37835760|FG002|Treatment Phase|Not randomized by mistake|1|||
16865047|NCT01743989|37835758|FG000|Treatment Phase|Included by mistake|0|||
16865048|NCT01743989|37835759|FG001|Treatment Phase|Included by mistake|0|||
16865049|NCT01743989|37835760|FG002|Treatment Phase|Included by mistake|1|||
16865050|NCT01743989|37835758|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
16865051|NCT01743989|37835759|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
16865052|NCT01743989|37835760|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
16865053|NCT01743989|37835758|FG000|TFR Phase|Adverse Event|0|||
16865054|NCT01743989|37835759|FG001|TFR Phase|Adverse Event|1|||
16865055|NCT01743989|37835760|FG002|TFR Phase|Adverse Event|0|||
16865056|NCT01743989|37835758|FG000|TFR Phase|Lost to Follow-up|0|||
16865057|NCT01743989|37835759|FG001|TFR Phase|Lost to Follow-up|2|||
16865058|NCT01743989|37835760|FG002|TFR Phase|Lost to Follow-up|0|||
16865059|NCT01743989|37835758|FG000|TFR Phase|Physician Decision|0|||
16865060|NCT01743989|37835759|FG001|TFR Phase|Physician Decision|1|||
16865061|NCT01743989|37835760|FG002|TFR Phase|Physician Decision|0|||
16865062|NCT01743989|37835758|FG000|TFR Phase|Logistical problems|0|||
16865063|NCT01743989|37835759|FG001|TFR Phase|Logistical problems|2|||
16865064|NCT01743989|37835760|FG002|TFR Phase|Logistical problems|0|||
16865065|NCT01743989|37835758|FG000|TFR Phase|Protocol deviation|0|||
16865066|NCT01743989|37835759|FG001|TFR Phase|Protocol deviation|1|||
16865067|NCT01743989|37835760|FG002|TFR Phase|Protocol deviation|0|||
16865068|NCT01743989|37835758|FG000|TFR Phase|Withdrawal by Subject|0|||
16865069|NCT01743989|37835759|FG001|TFR Phase|Withdrawal by Subject|2|||
16865070|NCT01743989|37835760|FG002|TFR Phase|Withdrawal by Subject|0|||
16865071|NCT01743989|37835758|FG000|Re-treatment Phase|Adverse Event|8|||
16865072|NCT01743989|37835759|FG001|Re-treatment Phase|Adverse Event|4|||
16865073|NCT01743989|37835760|FG002|Re-treatment Phase|Adverse Event|0|||
16865074|NCT01743989|37835758|FG000|Re-treatment Phase|Death|1|||
16865075|NCT01743989|37835759|FG001|Re-treatment Phase|Death|1|||
16865076|NCT01743989|37835760|FG002|Re-treatment Phase|Death|0|||
16865077|NCT01743989|37835758|FG000|Re-treatment Phase|Administrative problems|1|||
16865078|NCT01743989|37835759|FG001|Re-treatment Phase|Administrative problems|1|||
16865079|NCT01743989|37835760|FG002|Re-treatment Phase|Administrative problems|0|||
16865080|NCT01743989|37835758|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
16865081|NCT01743989|37835759|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
16865082|NCT01743989|37835760|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
16865083|NCT01743989|37835758|FG000|Re-treatment Phase|Unstable MR|1|||
16865084|NCT01743989|37835759|FG001|Re-treatment Phase|Unstable MR|0|||
16865085|NCT01743989|37835760|FG002|Re-treatment Phase|Unstable MR|0|||
16865086|NCT01743989|37835758|FG000|Re-treatment Phase|Physician Decision|0|||
16865087|NCT01743989|37835759|FG001|Re-treatment Phase|Physician Decision|1|||
16865088|NCT01743989|37835760|FG002|Re-treatment Phase|Physician Decision|0|||
16865089|NCT01743989|37835758|FG000|Re-treatment Phase|Lost to Follow-up|0|||
16865090|NCT01743989|37835759|FG001|Re-treatment Phase|Lost to Follow-up|1|||
16865091|NCT01743989|37835760|FG002|Re-treatment Phase|Lost to Follow-up|0|||
16865092|NCT01605461|37835793|FG000|Overall Study|Lost to Follow-up|3|||
16865093|NCT01605461|37835793|FG000|Overall Study|Withdrawal by Subject|1|||
16865094|NCT01742897|37835797|FG000|Overall Study|Adverse Event|3|||
16865095|NCT01742897|37835797|FG000|Overall Study|Withdrawal by Subject|1|||
16865096|NCT01742897|37835797|FG000|Overall Study|Other|1|||
16865097|NCT01715831|37835801|FG000|Overall Study|Adverse Event|1|||
16865098|NCT01741259|37835807|FG000|Overall Study|Protocol Violation|6|||
16865099|NCT01741259|37835808|FG001|Overall Study|Protocol Violation|4|||
16865100|NCT01741259|37835807|FG000|Overall Study|Withdrawal by Subject|0|||
16865101|NCT01741259|37835808|FG001|Overall Study|Withdrawal by Subject|2|||
16865102|NCT01715129|37835814|FG000|Overall Study|Adverse Event, fatal|1|||
16865103|NCT01715129|37835814|FG000|Overall Study|Lack of Efficacy|3|||
16865104|NCT01715129|37835814|FG000|Overall Study|Protocol Violation|1|||
16865105|NCT01715129|37835814|FG000|Overall Study|Consent Withdrawn|2|||
16865106|NCT01715129|37835814|FG000|Overall Study|Lost to Follow-up|1|||
16865107|NCT01715129|37835814|FG000|Overall Study|Other|1|||
16865108|NCT01740791|37835907|FG000|Overall Study|Randomized but never treated|5|||
16865109|NCT01740791|37835908|FG001|Overall Study|Randomized but never treated|3|||
16865110|NCT01740791|37835909|FG002|Overall Study|Randomized but never treated|2|||
16865111|NCT01740791|37835910|FG003|Overall Study|Randomized but never treated|2|||
16865112|NCT01740791|37835911|FG004|Overall Study|Randomized but never treated|1|||
16865113|NCT01740791|37835912|FG005|Overall Study|Randomized but never treated|3|||
16865114|NCT01740791|37835907|FG000|Overall Study|Lost to Follow-up|2|||
16865115|NCT01740791|37835908|FG001|Overall Study|Lost to Follow-up|0|||
16865116|NCT01740791|37835909|FG002|Overall Study|Lost to Follow-up|2|||
16865117|NCT01740791|37835910|FG003|Overall Study|Lost to Follow-up|3|||
16865118|NCT01740791|37835911|FG004|Overall Study|Lost to Follow-up|2|||
16865119|NCT01740791|37835912|FG005|Overall Study|Lost to Follow-up|3|||
16865120|NCT01740791|37835907|FG000|Overall Study|Withdrew Consent|4|||
16865121|NCT01740791|37835908|FG001|Overall Study|Withdrew Consent|0|||
16865122|NCT01740791|37835909|FG002|Overall Study|Withdrew Consent|1|||
16865123|NCT01740791|37835910|FG003|Overall Study|Withdrew Consent|2|||
16865124|NCT01740791|37835911|FG004|Overall Study|Withdrew Consent|0|||
16865125|NCT01740791|37835912|FG005|Overall Study|Withdrew Consent|3|||
16865126|NCT01740791|37835907|FG000|Overall Study|Investigator's discretion|1|||
16865127|NCT01740791|37835908|FG001|Overall Study|Investigator's discretion|0|||
16865128|NCT01740791|37835909|FG002|Overall Study|Investigator's discretion|1|||
16865129|NCT01740791|37835910|FG003|Overall Study|Investigator's discretion|0|||
16865130|NCT01740791|37835911|FG004|Overall Study|Investigator's discretion|0|||
16865131|NCT01740791|37835912|FG005|Overall Study|Investigator's discretion|1|||
16865132|NCT01740791|37835907|FG000|Overall Study|Adverse Event|0|||
16865133|NCT01740791|37835908|FG001|Overall Study|Adverse Event|0|||
16865134|NCT01740791|37835909|FG002|Overall Study|Adverse Event|0|||
16865135|NCT01740791|37835910|FG003|Overall Study|Adverse Event|0|||
16865136|NCT01740791|37835911|FG004|Overall Study|Adverse Event|0|||
16865137|NCT01740791|37835912|FG005|Overall Study|Adverse Event|1|||
16865138|NCT01740401|37835967|FG000|Overall Study|Progression of disease|6|||
16865139|NCT01740401|37835967|FG000|Overall Study|Adverse Event|2|||
16865140|NCT01740401|37835967|FG000|Overall Study|Did not reach primary endpoint|2|||
16865141|NCT01740323|37835973|FG000|Overall Study|Adverse Event|1|||
16865142|NCT01740323|37835974|FG001|Overall Study|Adverse Event|0|||
16865143|NCT01740323|37835973|FG000|Overall Study|Randomized but did not take study drug|1|||
16865144|NCT01740323|37835974|FG001|Overall Study|Randomized but did not take study drug|0|||
16865145|NCT01740089|37835992|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
16865146|NCT01740089|37835993|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
16865147|NCT01740089|37835994|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
16865148|NCT01740089|37835992|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
16865149|NCT01740089|37835993|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
16865150|NCT01740089|37835994|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
16865151|NCT01740089|37835992|FG000|After 12 Weeks|Lack of Efficacy|3|||
16865152|NCT01740089|37835993|FG001|After 12 Weeks|Lack of Efficacy|1|||
16865153|NCT01740089|37835994|FG002|After 12 Weeks|Lack of Efficacy|4|||
16865154|NCT01740089|37835992|FG000|After 12 Weeks|Adverse Event|2|||
16865155|NCT01740089|37835993|FG001|After 12 Weeks|Adverse Event|0|||
16865156|NCT01740089|37835994|FG002|After 12 Weeks|Adverse Event|5|||
16865157|NCT01740089|37835992|FG000|After 12 Weeks|Protocol Violation|1|||
16865158|NCT01740089|37835993|FG001|After 12 Weeks|Protocol Violation|1|||
16865159|NCT01740089|37835994|FG002|After 12 Weeks|Protocol Violation|1|||
16865160|NCT01740089|37835992|FG000|After 12 Weeks|Withdrawal by Subject|1|||
16865161|NCT01740089|37835993|FG001|After 12 Weeks|Withdrawal by Subject|1|||
16774027|NCT02432846|37713262|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
16865162|NCT01740089|37835994|FG002|After 12 Weeks|Withdrawal by Subject|1|||
16865163|NCT01739933|37836005|FG000|Overall Study|Death|89|||
16865164|NCT01739933|37836006|FG001|Overall Study|Death|86|||
16865165|NCT01739933|37836005|FG000|Overall Study|Withdrawal by Subject|10|||
16865166|NCT01739933|37836006|FG001|Overall Study|Withdrawal by Subject|8|||
16865167|NCT01739933|37836005|FG000|Overall Study|Lost to Follow-up|3|||
16865168|NCT01739933|37836006|FG001|Overall Study|Lost to Follow-up|10|||
16865169|NCT01739933|37836005|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
16865170|NCT01739933|37836006|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
16865171|NCT01738919|37836023|FG000|Overall Study|Lost to Follow-up|1|||
16865172|NCT01738919|37836024|FG001|Overall Study|Lost to Follow-up|0|||
16865173|NCT01738919|37836023|FG000|Overall Study|Immigrated|0|||
16865174|NCT01738919|37836024|FG001|Overall Study|Immigrated|1|||
16865175|NCT01738919|37836023|FG000|Overall Study|Withdrawal by Subject|0|||
16865176|NCT01738919|37836024|FG001|Overall Study|Withdrawal by Subject|1|||
16865177|NCT01738919|37836023|FG000|Overall Study|Not treated in accordance to guidelines|0|||
16865178|NCT01738919|37836024|FG001|Overall Study|Not treated in accordance to guidelines|1|||
16865179|NCT01712399|37836045|FG000|Overall Study|Lost to Follow-up|1|||
16865180|NCT01712399|37836045|FG000|Overall Study|Withdrawal by Subject|39|||
16865181|NCT01712399|37836045|FG000|Overall Study|Death|1|||
16865182|NCT01712399|37836045|FG000|Overall Study|Adverse Event|11|||
16865183|NCT01712399|37836045|FG000|Overall Study|Study closure|345|||
16865184|NCT03225846|37836156|FG000|Overall Study|Adverse Event|0|||
16865185|NCT03225846|37836157|FG001|Overall Study|Adverse Event|0|||
16865186|NCT03225846|37836158|FG002|Overall Study|Adverse Event|0|||
16865187|NCT03225846|37836159|FG003|Overall Study|Adverse Event|0|||
16865188|NCT03225846|37836160|FG004|Overall Study|Adverse Event|0|||
16865189|NCT03225846|37836161|FG005|Overall Study|Adverse Event|0|||
16865190|NCT03225846|37836162|FG006|Overall Study|Adverse Event|6|||
16865191|NCT03225846|37836156|FG000|Overall Study|Withdrawal by Subject|0|||
16865192|NCT03225846|37836157|FG001|Overall Study|Withdrawal by Subject|1|||
16865193|NCT03225846|37836158|FG002|Overall Study|Withdrawal by Subject|0|||
16865194|NCT03225846|37836159|FG003|Overall Study|Withdrawal by Subject|0|||
16865195|NCT03225846|37836160|FG004|Overall Study|Withdrawal by Subject|0|||
16865196|NCT03225846|37836161|FG005|Overall Study|Withdrawal by Subject|0|||
16865197|NCT03225846|37836162|FG006|Overall Study|Withdrawal by Subject|0|||
16865198|NCT03225846|37836156|FG000|Overall Study|Death|0|||
16865199|NCT03225846|37836157|FG001|Overall Study|Death|1|||
16865200|NCT03225846|37836158|FG002|Overall Study|Death|0|||
16865201|NCT03225846|37836159|FG003|Overall Study|Death|0|||
17127645|NCT03292406|38268055|FG000|Overall Study|Progressive Disease|6|||
16865202|NCT03225846|37836160|FG004|Overall Study|Death|0|||
16865203|NCT03225846|37836161|FG005|Overall Study|Death|0|||
16865204|NCT03225846|37836162|FG006|Overall Study|Death|0|||
16865205|NCT03225846|37836156|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
16865206|NCT03225846|37836157|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
16865207|NCT03225846|37836158|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
16865208|NCT03225846|37836159|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
16865209|NCT03225846|37836160|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
16865210|NCT03225846|37836161|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
16865211|NCT03225846|37836162|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
16865212|NCT03225846|37836156|FG000|Overall Study|Patient decision|0|||
16865213|NCT03225846|37836157|FG001|Overall Study|Patient decision|0|||
16865214|NCT03225846|37836158|FG002|Overall Study|Patient decision|0|||
16865215|NCT03225846|37836159|FG003|Overall Study|Patient decision|0|||
16865216|NCT03225846|37836160|FG004|Overall Study|Patient decision|0|||
16865217|NCT03225846|37836161|FG005|Overall Study|Patient decision|0|||
16865218|NCT03225846|37836162|FG006|Overall Study|Patient decision|1|||
16865219|NCT01712009|37836227|FG000|Overall Study|Withdrawal by Subject|24|||
16865220|NCT01712009|37836228|FG001|Overall Study|Withdrawal by Subject|15|||
16865221|NCT01712009|37836229|FG002|Overall Study|Withdrawal by Subject|8|||
16865222|NCT01712009|37836227|FG000|Overall Study|Lost to Follow-up|2|||
16865223|NCT01712009|37836228|FG001|Overall Study|Lost to Follow-up|0|||
16865224|NCT01712009|37836229|FG002|Overall Study|Lost to Follow-up|1|||
16865225|NCT01712009|37836227|FG000|Overall Study|Decision by Sponsor|12|||
16865226|NCT01712009|37836228|FG001|Overall Study|Decision by Sponsor|14|||
16865227|NCT01712009|37836229|FG002|Overall Study|Decision by Sponsor|12|||
16865228|NCT01711853|37836258|FG000|Overall Study|Not treated|3|||
16865229|NCT01708187|37836264|FG000|Overall Study|Lost to Follow-up|0|||
16865230|NCT01708187|37836265|FG001|Overall Study|Lost to Follow-up|1|||
16865231|NCT01711619|37836354|FG000|Overall Study|Early study termination|10|||
16865232|NCT01711619|37836355|FG001|Overall Study|Early study termination|14|||
16865233|NCT01711619|37836354|FG000|Overall Study|Withdrawal by Subject|3|||
16865234|NCT01711619|37836355|FG001|Overall Study|Withdrawal by Subject|7|||
16865235|NCT01711619|37836354|FG000|Overall Study|Protocol Violation|2|||
16865236|NCT01711619|37836355|FG001|Overall Study|Protocol Violation|3|||
16865237|NCT01711619|37836354|FG000|Overall Study|Adverse Event|2|||
16865238|NCT01711619|37836355|FG001|Overall Study|Adverse Event|0|||
16865239|NCT01711619|37836354|FG000|Overall Study|Lost to Follow-up|1|||
16865240|NCT01711619|37836355|FG001|Overall Study|Lost to Follow-up|0|||
16865241|NCT01710527|37836370|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
16865242|NCT01710527|37836371|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
16865243|NCT01706939|37836379|FG000|Pre Randomization|Screen Failure|1|||
16865244|NCT01706939|37836380|FG001|Pre Randomization|Screen Failure|0|||
16865245|NCT01706939|37836381|FG002|Pre Randomization|Screen Failure|0|||
16865246|NCT01706939|37836379|FG000|Pre Randomization|Ineligible for Randomization|1|||
16865247|NCT01706939|37836380|FG001|Pre Randomization|Ineligible for Randomization|0|||
16865248|NCT01706939|37836381|FG002|Pre Randomization|Ineligible for Randomization|0|||
16865249|NCT01706939|37836379|FG000|Pre Randomization|Withdrawal by Subject|1|||
16865250|NCT01706939|37836380|FG001|Pre Randomization|Withdrawal by Subject|0|||
16865251|NCT01706939|37836381|FG002|Pre Randomization|Withdrawal by Subject|0|||
16865252|NCT01706939|37836379|FG000|Randomization|Insufficient QoL survey compliance|0|||
16865253|NCT01706939|37836380|FG001|Randomization|Insufficient QoL survey compliance|1|||
16865254|NCT01706939|37836381|FG002|Randomization|Insufficient QoL survey compliance|1|||
16865255|NCT01706939|37836379|FG000|Randomization|Progression of disease|0|||
16865256|NCT01706939|37836380|FG001|Randomization|Progression of disease|2|||
16865257|NCT01706939|37836381|FG002|Randomization|Progression of disease|1|||
16865258|NCT01709903|37836390|FG000|Overall Study|administrative problems|2|||
16865259|NCT01709903|37836391|FG001|Overall Study|administrative problems|6|||
16865260|NCT01709903|37836390|FG000|Overall Study|Abnormal test procedure results|1|||
16865261|NCT01709903|37836391|FG001|Overall Study|Abnormal test procedure results|0|||
16865262|NCT01709903|37836390|FG000|Overall Study|In ability to use device|1|||
16865263|NCT01709903|37836391|FG001|Overall Study|In ability to use device|1|||
16865264|NCT01709903|37836390|FG000|Overall Study|no longer needed study drug|0|||
16865265|NCT01709903|37836391|FG001|Overall Study|no longer needed study drug|1|||
16865266|NCT01709903|37836390|FG000|Overall Study|Lost to Follow-up|0|||
16865267|NCT01709903|37836391|FG001|Overall Study|Lost to Follow-up|2|||
16865268|NCT01709903|37836390|FG000|Overall Study|Death|2|||
16865269|NCT01709903|37836391|FG001|Overall Study|Death|0|||
16865270|NCT01709903|37836390|FG000|Overall Study|Protocol Violation|3|||
16865271|NCT01709903|37836391|FG001|Overall Study|Protocol Violation|2|||
16865272|NCT01709903|37836390|FG000|Overall Study|Lack of Efficacy|3|||
16865273|NCT01709903|37836391|FG001|Overall Study|Lack of Efficacy|3|||
16865274|NCT01709903|37836390|FG000|Overall Study|Withdrawal by Subject|6|||
16865275|NCT01709903|37836391|FG001|Overall Study|Withdrawal by Subject|6|||
16865276|NCT01709903|37836390|FG000|Overall Study|Adverse Event|11|||
16865277|NCT01709903|37836391|FG001|Overall Study|Adverse Event|18|||
16865278|NCT04492618|37836397|FG000|Overall Study|Withdrawal by Subject|1|||
16865279|NCT01605227|37836403|FG000|Overall Study|Did not receive study treatment|2|||
16865280|NCT01605227|37836404|FG001|Overall Study|Did not receive study treatment|3|||
16865281|NCT01605227|37836403|FG000|Overall Study|Adverse Event|228|||
16865282|NCT01605227|37836404|FG001|Overall Study|Adverse Event|42|||
16865283|NCT01605227|37836403|FG000|Overall Study|Progressive Disease|132|||
16865284|NCT01605227|37836404|FG001|Overall Study|Progressive Disease|128|||
16865285|NCT01605227|37836403|FG000|Overall Study|Clinical Deterioration|227|||
16944841|NCT01097707|38088863|FG000|Overall Study|Protocol Violation|2|||
17127646|NCT03292406|38268056|FG001|Overall Study|Progressive Disease|3|||
17127647|NCT03292406|38268057|FG002|Overall Study|Progressive Disease|4|||
17127648|NCT03292406|38268055|FG000|Overall Study|Adverse Event|7|||
17127649|NCT03292406|38268056|FG001|Overall Study|Adverse Event|1|||
17127650|NCT03292406|38268057|FG002|Overall Study|Adverse Event|4|||
16944842|NCT01097707|38088864|FG001|Overall Study|Protocol Violation|2|||
16944843|NCT01097707|38088865|FG002|Overall Study|Protocol Violation|3|||
16944844|NCT01097707|38088866|FG003|Overall Study|Protocol Violation|2|||
16944845|NCT01097707|38088867|FG004|Overall Study|Protocol Violation|2|||
16944846|NCT01097707|38088863|FG000|Overall Study|Sponsor Decision|31|||
16944847|NCT01097707|38088864|FG001|Overall Study|Sponsor Decision|31|||
16944848|NCT01097707|38088865|FG002|Overall Study|Sponsor Decision|34|||
16944849|NCT01097707|38088866|FG003|Overall Study|Sponsor Decision|35|||
16944850|NCT01097707|38088867|FG004|Overall Study|Sponsor Decision|36|||
16865286|NCT01605227|37836404|FG001|Overall Study|Clinical Deterioration|133|||
16865287|NCT01605227|37836403|FG000|Overall Study|Lost to Follow-up|1|||
16865288|NCT01605227|37836404|FG001|Overall Study|Lost to Follow-up|0|||
16865289|NCT01605227|37836403|FG000|Overall Study|Protocol Violation|1|||
16865290|NCT01605227|37836404|FG001|Overall Study|Protocol Violation|0|||
16865291|NCT01605227|37836403|FG000|Overall Study|Physician Decision|9|||
16865292|NCT01605227|37836404|FG001|Overall Study|Physician Decision|7|||
16865293|NCT01605227|37836403|FG000|Overall Study|Withdrawal by Subject|18|||
16865294|NCT01605227|37836404|FG001|Overall Study|Withdrawal by Subject|14|||
16865295|NCT01605227|37836403|FG000|Overall Study|Sponsor Decision|2|||
16865296|NCT01605227|37836404|FG001|Overall Study|Sponsor Decision|0|||
16865297|NCT01605227|37836403|FG000|Overall Study|Started New Therapy|1|||
16865298|NCT01605227|37836404|FG001|Overall Study|Started New Therapy|0|||
16944851|NCT01097707|38088863|FG000|Overall Study|Withdrawal by Subject|3|||
16944852|NCT01097707|38088864|FG001|Overall Study|Withdrawal by Subject|6|||
16944853|NCT01097707|38088865|FG002|Overall Study|Withdrawal by Subject|1|||
16944854|NCT01097707|38088866|FG003|Overall Study|Withdrawal by Subject|4|||
16944855|NCT01097707|38088867|FG004|Overall Study|Withdrawal by Subject|3|||
16944856|NCT01097707|38088863|FG000|Overall Study|Reason unknown|0|||
16865299|NCT01605227|37836403|FG000|Overall Study|Subject Decision|0|||
16865300|NCT01605227|37836404|FG001|Overall Study|Subject Decision|1|||
16865301|NCT01605227|37836403|FG000|Overall Study|Dose Held >6 weeks|0|||
16865302|NCT01605227|37836404|FG001|Overall Study|Dose Held >6 weeks|1|||
16944857|NCT01097707|38088864|FG001|Overall Study|Reason unknown|0|||
17127651|NCT03292406|38268055|FG000|Overall Study|Withdrawal by Subject|0|||
16865303|NCT01709513|37836413|FG000|Overall Study|Randomized but not treated|0|||
16865304|NCT01709513|37836414|FG001|Overall Study|Randomized but not treated|1|||
16865305|NCT01709513|37836415|FG002|Overall Study|Randomized but not treated|0|||
16865306|NCT01709513|37836413|FG000|Overall Study|Adverse Event|16|||
16865307|NCT01709513|37836414|FG001|Overall Study|Adverse Event|31|||
16865308|NCT01709513|37836415|FG002|Overall Study|Adverse Event|23|||
16865309|NCT01709513|37836413|FG000|Overall Study|Poor compliance to protocol|2|||
16865310|NCT01709513|37836414|FG001|Overall Study|Poor compliance to protocol|0|||
16865311|NCT01709513|37836415|FG002|Overall Study|Poor compliance to protocol|0|||
16865312|NCT01709513|37836413|FG000|Overall Study|Other|3|||
16865313|NCT01709513|37836414|FG001|Overall Study|Other|11|||
16865314|NCT01709513|37836415|FG002|Overall Study|Other|7|||
16865315|NCT01605071|37836428|FG000|Overall Study|Withdrawal by Subject|3|||
16865316|NCT01605071|37836429|FG001|Overall Study|Withdrawal by Subject|2|||
16865317|NCT02710422|37836439|FG000|Overall Study|Termination of study|9|||
16865318|NCT02710422|37836440|FG001|Overall Study|Termination of study|9|||
16865319|NCT01706159|37836450|FG000|Overall Study|Withdrawal Criteria|2|||
16865320|NCT01706159|37836451|FG001|Overall Study|Withdrawal Criteria|1|||
16865321|NCT01706159|37836450|FG000|Overall Study|Unclassified|6|||
16865322|NCT01706159|37836451|FG001|Overall Study|Unclassified|1|||
16865323|NCT01706003|37836459|FG000|Overall Study|Withdrawal by Subject|2|||
16865324|NCT01706003|37836460|FG001|Overall Study|Withdrawal by Subject|0|||
16865325|NCT01706003|37836459|FG000|Overall Study|Not scheduled|3|||
16865326|NCT01706003|37836460|FG001|Overall Study|Not scheduled|0|||
16865327|NCT01706003|37836459|FG000|Overall Study|Lost to Follow-up|6|||
16865328|NCT01706003|37836460|FG001|Overall Study|Lost to Follow-up|4|||
16865329|NCT01705691|37836468|FG000|Overall Study|Death|1|||
16865330|NCT01705691|37836469|FG001|Overall Study|Death|2|||
16944858|NCT01097707|38088865|FG002|Overall Study|Reason unknown|0|||
16865331|NCT01705691|37836468|FG000|Overall Study|Withdrawal by Subject|1|||
16865332|NCT01705691|37836469|FG001|Overall Study|Withdrawal by Subject|2|||
16865333|NCT01705691|37836468|FG000|Overall Study|Lost to Follow-up|1|||
16865334|NCT01705691|37836469|FG001|Overall Study|Lost to Follow-up|1|||
16865335|NCT01705691|37836468|FG000|Overall Study|Other|0|||
16865336|NCT01705691|37836469|FG001|Overall Study|Other|1|||
16865337|NCT03766906|37836475|FG000|Overall Study|Withdrawal by Subject|6|||
16865338|NCT01705145|37836479|FG000|Part B|Adverse Event|1|||
16865339|NCT01704755|37836497|FG000|Overall Study|Adverse Event|4|||
16865340|NCT01704755|37836498|FG001|Overall Study|Adverse Event|1|||
16865341|NCT01704755|37836497|FG000|Overall Study|Lost to Follow-up|3|||
16865342|NCT01704755|37836498|FG001|Overall Study|Lost to Follow-up|4|||
16865343|NCT01704755|37836497|FG000|Overall Study|Withdrew consent|1|||
16865344|NCT01704755|37836498|FG001|Overall Study|Withdrew consent|1|||
16865345|NCT01704755|37836497|FG000|Overall Study|Other (not specified)|3|||
16865346|NCT01704755|37836498|FG001|Overall Study|Other (not specified)|1|||
16865347|NCT01704755|37836497|FG000|Overall Study|Withdrew consent and personal issues|1|||
16865348|NCT01704755|37836498|FG001|Overall Study|Withdrew consent and personal issues|0|||
16865349|NCT01704599|37836504|FG000|Overall Study|Adverse Event|1|||
16865350|NCT03599518|37836536|FG000|Overall Study|Clinical progression|0|||
16865351|NCT03599518|37836537|FG001|Overall Study|Clinical progression|0|||
16865352|NCT03599518|37836538|FG002|Overall Study|Clinical progression|0|||
16865353|NCT03599518|37836539|FG003|Overall Study|Clinical progression|0|||
16865354|NCT03599518|37836540|FG004|Overall Study|Clinical progression|1|||
16865355|NCT03599518|37836536|FG000|Overall Study|Adverse Event|0|||
16865356|NCT03599518|37836537|FG001|Overall Study|Adverse Event|0|||
16865357|NCT03599518|37836538|FG002|Overall Study|Adverse Event|0|||
16944859|NCT01097707|38088866|FG003|Overall Study|Reason unknown|0|||
16944860|NCT01097707|38088867|FG004|Overall Study|Reason unknown|1|||
16944861|NCT01326104|38088881|FG000|Overall Study|progressed prior to vaccine|0|||
16944862|NCT01326104|38088882|FG001|Overall Study|progressed prior to vaccine|2|||
16944863|NCT01326104|38088881|FG000|Overall Study|unable to make vaccine|0|||
16944864|NCT01326104|38088882|FG001|Overall Study|unable to make vaccine|2|||
16865358|NCT03599518|37836539|FG003|Overall Study|Adverse Event|0|||
16865359|NCT03599518|37836540|FG004|Overall Study|Adverse Event|1|||
16865360|NCT03599518|37836536|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
16865361|NCT03599518|37836537|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
16865362|NCT03599518|37836538|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
16865363|NCT03599518|37836539|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
16865364|NCT03599518|37836540|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
16865365|NCT03599518|37836536|FG000|Overall Study|Participant withdrawal from study treatment|0|||
16865366|NCT03599518|37836537|FG001|Overall Study|Participant withdrawal from study treatment|0|||
16865367|NCT03599518|37836538|FG002|Overall Study|Participant withdrawal from study treatment|1|||
16865368|NCT03599518|37836539|FG003|Overall Study|Participant withdrawal from study treatment|0|||
16865369|NCT03599518|37836540|FG004|Overall Study|Participant withdrawal from study treatment|0|||
16865370|NCT02709486|37836617|FG000|Overall Study|Adverse Event|2|||
16865371|NCT02709486|37836618|FG001|Overall Study|Adverse Event|5|||
16865372|NCT02709486|37836619|FG002|Overall Study|Adverse Event|3|||
16865373|NCT02709486|37836617|FG000|Overall Study|Death|0|||
16865374|NCT02709486|37836618|FG001|Overall Study|Death|0|||
16865375|NCT02709486|37836619|FG002|Overall Study|Death|2|||
16865376|NCT02709486|37836617|FG000|Overall Study|Insufficient clinical response|7|||
16865377|NCT02709486|37836618|FG001|Overall Study|Insufficient clinical response|3|||
16865378|NCT02709486|37836619|FG002|Overall Study|Insufficient clinical response|3|||
16865379|NCT02709486|37836617|FG000|Overall Study|Lost to Follow-up|3|||
16865380|NCT02709486|37836618|FG001|Overall Study|Lost to Follow-up|2|||
16865381|NCT02709486|37836619|FG002|Overall Study|Lost to Follow-up|2|||
16865382|NCT02709486|37836617|FG000|Overall Study|Other|0|||
16865383|NCT02709486|37836618|FG001|Overall Study|Other|2|||
16865384|NCT02709486|37836619|FG002|Overall Study|Other|3|||
16865385|NCT02709486|37836617|FG000|Overall Study|Withdrawal by Subject|32|||
16865386|NCT02709486|37836618|FG001|Overall Study|Withdrawal by Subject|22|||
16865387|NCT02709486|37836619|FG002|Overall Study|Withdrawal by Subject|32|||
16865388|NCT03110770|37836636|FG000|Overall Study|Death|1|||
16865389|NCT03110770|37836637|FG001|Overall Study|Death|0|||
16865390|NCT03110770|37836638|FG002|Overall Study|Death|0|||
16865391|NCT03110770|37836639|FG003|Overall Study|Death|1|||
16865392|NCT03110770|37836640|FG004|Overall Study|Death|0|||
16865393|NCT03110770|37836636|FG000|Overall Study|Enrolled but did not receive product|0|||
16865394|NCT03110770|37836637|FG001|Overall Study|Enrolled but did not receive product|0|||
16865395|NCT03110770|37836638|FG002|Overall Study|Enrolled but did not receive product|0|||
16865396|NCT03110770|37836639|FG003|Overall Study|Enrolled but did not receive product|8|||
16865397|NCT03110770|37836640|FG004|Overall Study|Enrolled but did not receive product|7|||
16865398|NCT03110770|37836636|FG000|Overall Study|Lost to Follow-up|0|||
16865399|NCT03110770|37836637|FG001|Overall Study|Lost to Follow-up|0|||
16865400|NCT03110770|37836638|FG002|Overall Study|Lost to Follow-up|0|||
16865401|NCT03110770|37836639|FG003|Overall Study|Lost to Follow-up|53|||
16865402|NCT03110770|37836640|FG004|Overall Study|Lost to Follow-up|45|||
16865403|NCT03110770|37836636|FG000|Overall Study|Investigator Decision|0|||
16865404|NCT03110770|37836637|FG001|Overall Study|Investigator Decision|0|||
16865405|NCT03110770|37836638|FG002|Overall Study|Investigator Decision|0|||
16865406|NCT03110770|37836639|FG003|Overall Study|Investigator Decision|5|||
16865407|NCT03110770|37836640|FG004|Overall Study|Investigator Decision|3|||
16865408|NCT03110770|37836636|FG000|Overall Study|Withdrawal by Subject|0|||
16865409|NCT03110770|37836637|FG001|Overall Study|Withdrawal by Subject|0|||
16865410|NCT03110770|37836638|FG002|Overall Study|Withdrawal by Subject|0|||
16865411|NCT03110770|37836639|FG003|Overall Study|Withdrawal by Subject|24|||
16865412|NCT03110770|37836640|FG004|Overall Study|Withdrawal by Subject|24|||
16865413|NCT03110770|37836636|FG000|Overall Study|Moved from area|5|||
16865414|NCT03110770|37836637|FG001|Overall Study|Moved from area|0|||
16865415|NCT03110770|37836638|FG002|Overall Study|Moved from area|2|||
16865416|NCT03110770|37836639|FG003|Overall Study|Moved from area|42|||
16865417|NCT03110770|37836640|FG004|Overall Study|Moved from area|43|||
16865418|NCT03110770|37836636|FG000|Overall Study|Illness/Injury unrelated to product|0|||
16865419|NCT03110770|37836637|FG001|Overall Study|Illness/Injury unrelated to product|0|||
16865420|NCT03110770|37836638|FG002|Overall Study|Illness/Injury unrelated to product|0|||
16865421|NCT03110770|37836639|FG003|Overall Study|Illness/Injury unrelated to product|0|||
16865422|NCT03110770|37836640|FG004|Overall Study|Illness/Injury unrelated to product|1|||
16865423|NCT00703326|37836846|FG000|Overall Study|Lost to Follow-up|47|||
16865424|NCT00703326|37836847|FG001|Overall Study|Lost to Follow-up|18|||
16865425|NCT00703326|37836846|FG000|Overall Study|Withdrawal by Subject|54|||
16865426|NCT00703326|37836847|FG001|Overall Study|Withdrawal by Subject|20|||
16865427|NCT00703326|37836846|FG000|Overall Study|Adverse Event|1|||
16865428|NCT00703326|37836847|FG001|Overall Study|Adverse Event|0|||
16865429|NCT04868500|37836900|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
16865430|NCT04868500|37836901|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
16865431|NCT04868500|37836900|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
16865432|NCT04868500|37836901|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
16865433|NCT04372186|37836909|FG000|Overall Study|Death|24|||
16865434|NCT04372186|37836910|FG001|Overall Study|Death|11|||
16865435|NCT04372186|37836909|FG000|Overall Study|Transferred to a different facility for care|0|||
16865436|NCT04372186|37836910|FG001|Overall Study|Transferred to a different facility for care|2|||
16865437|NCT04317040|37836940|FG000|Overall Study|Lost to Follow-up|2|||
16865438|NCT04317040|37836941|FG001|Overall Study|Lost to Follow-up|0|||
16865439|NCT04317040|37836940|FG000|Overall Study|Death|16|||
16865440|NCT04317040|37836941|FG001|Overall Study|Death|18|||
16865441|NCT04317040|37836940|FG000|Overall Study|Withdrawal by Subject|0|||
16865442|NCT04317040|37836941|FG001|Overall Study|Withdrawal by Subject|1|||
16865443|NCT04317040|37836940|FG000|Overall Study|Incomplete assessments|0|||
16865444|NCT04317040|37836941|FG001|Overall Study|Incomplete assessments|1|||
16865445|NCT00703014|37837021|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
16865446|NCT00703014|37837022|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
16865447|NCT00703014|37837023|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
16865448|NCT00703014|37837024|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
16865449|NCT00703014|37837021|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
16865450|NCT00703014|37837022|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
16865451|NCT00703014|37837023|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
16865452|NCT00703014|37837024|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
16865453|NCT03915496|37837076|FG000|Overall Study|Adverse Event|2|||
16865454|NCT03915496|37837077|FG001|Overall Study|Adverse Event|1|||
16865455|NCT03915496|37837078|FG002|Overall Study|Adverse Event|2|||
16865456|NCT02709330|37837095|FG000|Overall Study|Death|5|||
16865457|NCT02709330|37837096|FG001|Overall Study|Death|0|||
16865458|NCT02709330|37837095|FG000|Overall Study|Lost to Follow-up|2|||
16865459|NCT02709330|37837096|FG001|Overall Study|Lost to Follow-up|0|||
16865460|NCT02709330|37837095|FG000|Overall Study|Physician Decision|2|||
16865461|NCT02709330|37837096|FG001|Overall Study|Physician Decision|0|||
16865462|NCT02709330|37837095|FG000|Overall Study|Withdrawal by Subject|4|||
16865463|NCT02709330|37837096|FG001|Overall Study|Withdrawal by Subject|0|||
16865464|NCT02709096|37837104|FG000|Overall Study|non-compliance|1|||
16865465|NCT02709096|37837105|FG001|Overall Study|non-compliance|1|||
16865466|NCT01372410|37837111|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
16865467|NCT01372410|37837112|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
16865468|NCT01372410|37837113|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16865469|NCT01372410|37837114|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16865470|NCT01372410|37837115|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
16865471|NCT01372410|37837116|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16865472|NCT01372410|37837117|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16865473|NCT01372410|37837118|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16865474|NCT01372410|37837111|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
16865475|NCT01372410|37837112|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
16865476|NCT01372410|37837113|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
16865477|NCT01372410|37837114|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
16865478|NCT01372410|37837115|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
16865479|NCT01372410|37837116|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
16865480|NCT01372410|37837117|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
16865481|NCT01372410|37837118|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
16865482|NCT01372410|37837111|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16865483|NCT01372410|37837112|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16865484|NCT01372410|37837113|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16865485|NCT01372410|37837114|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16865486|NCT01372410|37837115|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
16865487|NCT01372410|37837116|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16865488|NCT01372410|37837117|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16865489|NCT01372410|37837118|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16865490|NCT01372410|37837111|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16865491|NCT01372410|37837112|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16865492|NCT01372410|37837113|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16865493|NCT01372410|37837114|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16865494|NCT01372410|37837115|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16865495|NCT01372410|37837116|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16865496|NCT01372410|37837117|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
16865497|NCT01372410|37837118|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16865498|NCT01372410|37837111|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
16865499|NCT01372410|37837112|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16865500|NCT01372410|37837113|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16865501|NCT01372410|37837114|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16865502|NCT01372410|37837115|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16944865|NCT01326026|38088890|FG000|Overall Study|Adverse Event|4|||
16944866|NCT01326026|38088891|FG001|Overall Study|Adverse Event|3|||
16944867|NCT01326026|38088890|FG000|Overall Study|Withdrawal Criteria|5|||
16944868|NCT01326026|38088891|FG001|Overall Study|Withdrawal Criteria|7|||
16944869|NCT01326026|38088890|FG000|Overall Study|Other|3|||
16944870|NCT01326026|38088891|FG001|Overall Study|Other|3|||
16944871|NCT01097629|38088900|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
16865503|NCT01372410|37837116|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16944872|NCT01097629|38088901|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
16944873|NCT01097629|38088902|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
16865504|NCT01372410|37837117|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16865505|NCT01372410|37837118|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
16865506|NCT01372410|37837111|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16865507|NCT01372410|37837112|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16865508|NCT01372410|37837113|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16865509|NCT01372410|37837114|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16865510|NCT01372410|37837115|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
16865511|NCT01372410|37837116|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16865512|NCT01372410|37837117|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16865513|NCT01372410|37837118|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16865514|NCT01372410|37837111|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16865515|NCT01372410|37837112|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16865516|NCT01372410|37837113|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16865517|NCT01372410|37837114|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16865518|NCT01372410|37837115|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
16865519|NCT01372410|37837116|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16865520|NCT01372410|37837117|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
16865521|NCT01372410|37837118|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
16865522|NCT01372410|37837111|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16865523|NCT01372410|37837112|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16865524|NCT01372410|37837113|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16865525|NCT01372410|37837114|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16865526|NCT01372410|37837115|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16865527|NCT01372410|37837116|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16865528|NCT01372410|37837117|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16865529|NCT01372410|37837118|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
16865530|NCT01372410|37837111|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
16865531|NCT01372410|37837112|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
16865532|NCT01372410|37837113|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
16865533|NCT01372410|37837114|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
16865534|NCT01372410|37837115|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
16865535|NCT01372410|37837116|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
16865536|NCT01372410|37837117|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
16865537|NCT01372410|37837118|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
16865538|NCT01372410|37837111|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16865539|NCT01372410|37837112|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16865540|NCT01372410|37837113|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16865541|NCT01372410|37837114|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16865542|NCT01372410|37837115|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16865543|NCT01372410|37837116|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
16865544|NCT01372410|37837117|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16865545|NCT01372410|37837118|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16865546|NCT04624672|37837139|FG000|Overall Study|Early Study Closure|2|||
16865547|NCT04624672|37837140|FG001|Overall Study|Early Study Closure|1|||
16865548|NCT01704287|37837165|FG000|Initial Treatment Period|Death|139|||
16865549|NCT01704287|37837166|FG001|Initial Treatment Period|Death|129|||
16865550|NCT01704287|37837167|FG002|Initial Treatment Period|Death|71|||
16865551|NCT01704287|37837168|FG003|Initial Treatment Period|Death|0|||
16865552|NCT01704287|37837169|FG004|Initial Treatment Period|Death|0|||
16865553|NCT01704287|37837165|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
16865554|NCT01704287|37837166|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
16865555|NCT01704287|37837167|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
16865556|NCT01704287|37837168|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
16865557|NCT01704287|37837169|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
16865558|NCT01704287|37837165|FG000|Initial Treatment Period|Lost to Follow-up|5|||
16865559|NCT01704287|37837166|FG001|Initial Treatment Period|Lost to Follow-up|3|||
16865560|NCT01704287|37837167|FG002|Initial Treatment Period|Lost to Follow-up|0|||
16865561|NCT01704287|37837168|FG003|Initial Treatment Period|Lost to Follow-up|0|||
16865562|NCT01704287|37837169|FG004|Initial Treatment Period|Lost to Follow-up|0|||
16865563|NCT01704287|37837165|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
16865564|NCT01704287|37837166|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
16865565|NCT01704287|37837167|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
16865566|NCT01704287|37837168|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
16865567|NCT01704287|37837169|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
16865568|NCT01704287|37837165|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
16865569|NCT01704287|37837166|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
16865570|NCT01704287|37837167|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
16865571|NCT01704287|37837168|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
16865572|NCT01704287|37837169|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
16865573|NCT01704287|37837165|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
16865574|NCT01704287|37837166|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
16865575|NCT01704287|37837167|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
16865576|NCT01704287|37837168|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
16865577|NCT01704287|37837169|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
16865578|NCT01704287|37837165|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
16865579|NCT01704287|37837166|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
16865580|NCT01704287|37837167|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
16865581|NCT01704287|37837168|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
16865582|NCT01704287|37837169|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
16865583|NCT01682837|37837197|FG000|Baseline|Withdrawal by Subject|5|||
16865584|NCT01703819|37837234|FG000|Overall Study|Adverse Event|0|||
16865585|NCT01703819|37837235|FG001|Overall Study|Adverse Event|1|||
16865586|NCT01703819|37837234|FG000|Overall Study|Withdrawal by Subject|0|||
16865587|NCT01703819|37837235|FG001|Overall Study|Withdrawal by Subject|1|||
16865588|NCT01682759|37837247|FG000|Overall Study|Death|2|||
16865589|NCT01682759|37837248|FG001|Overall Study|Death|1|||
16865590|NCT01682759|37837247|FG000|Overall Study|Lost to Follow-up|10|||
16865591|NCT01682759|37837248|FG001|Overall Study|Lost to Follow-up|13|||
16865592|NCT01682759|37837247|FG000|Overall Study|Physician Decision|1|||
16865593|NCT01682759|37837248|FG001|Overall Study|Physician Decision|1|||
16865594|NCT01682759|37837247|FG000|Overall Study|Withdrawal by Subject|56|||
16865595|NCT01682759|37837248|FG001|Overall Study|Withdrawal by Subject|55|||
16865596|NCT01682681|37837258|FG000|Overall Study|Lack of Efficacy|62|||
16865597|NCT01682681|37837258|FG000|Overall Study|Withdrawal by Subject|1|||
16865598|NCT01682681|37837258|FG000|Overall Study|Moved to other hospital|10|||
16865599|NCT01682681|37837258|FG000|Overall Study|Lost to Follow-up|174|||
16865600|NCT01682681|37837258|FG000|Overall Study|Adverse Event|46|||
16865601|NCT01682681|37837258|FG000|Overall Study|tapering of topiramate|5|||
16865602|NCT01682681|37837258|FG000|Overall Study|Other|21|||
16865603|NCT01682681|37837258|FG000|Overall Study|Low compliance|13|||
16865604|NCT01682603|37837262|FG000|Overall Study|Lost to Follow-up|3|||
16865605|NCT01682213|37837278|FG000|Overall Study|Withdrawal by Subject|2|||
16865606|NCT01703741|37837287|FG000|Overall Study|Withdrawal by Subject|6|||
16865607|NCT01703741|37837287|FG000|Overall Study|Adverse Event|2|||
16865608|NCT01703741|37837287|FG000|Overall Study|Physician Decision|2|||
16865609|NCT01703741|37837287|FG000|Overall Study|Protocol Violation|1|||
16865610|NCT01703741|37837287|FG000|Overall Study|Lost to Follow-up|3|||
16865611|NCT01703741|37837287|FG000|Overall Study|Subject did not want to continue|2|||
16865612|NCT01703741|37837287|FG000|Overall Study|Subject cannot comply with study visits|1|||
16865613|NCT01703741|37837287|FG000|Overall Study|Subject started testosterone injections|1|||
16865614|NCT01681511|37837293|FG000|Overall Study|No Treatment Received|1|||
16865615|NCT01681511|37837294|FG001|Overall Study|No Treatment Received|3|||
16865616|NCT01681511|37837293|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
16865617|NCT01681511|37837294|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
16865618|NCT01681511|37837293|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
16865619|NCT01681511|37837294|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
16865620|NCT01681511|37837293|FG000|Overall Study|No Daily Urine Sample Collected|0|||
16865621|NCT01681511|37837294|FG001|Overall Study|No Daily Urine Sample Collected|1|||
16865622|NCT01681511|37837293|FG000|Overall Study|No post-catheter sample collected|11|||
16865623|NCT01681511|37837294|FG001|Overall Study|No post-catheter sample collected|4|||
16865624|NCT02175004|37837302|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
16865625|NCT02175004|37837303|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
16865626|NCT02175004|37837302|FG000|Overall Study|Investigator Judgment|1|||
16865627|NCT02175004|37837303|FG001|Overall Study|Investigator Judgment|4|||
16865628|NCT02175004|37837302|FG000|Overall Study|Voluntary Withdrawal|6|||
16865629|NCT02175004|37837303|FG001|Overall Study|Voluntary Withdrawal|19|||
16865630|NCT02175004|37837302|FG000|Overall Study|Liver Transplant|1|||
16865631|NCT02175004|37837303|FG001|Overall Study|Liver Transplant|0|||
16865632|NCT02175004|37837302|FG000|Overall Study|Disease Progression|1|||
16865633|NCT02175004|37837303|FG001|Overall Study|Disease Progression|0|||
16865634|NCT02175004|37837302|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
16865635|NCT02175004|37837303|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
16865636|NCT01681433|37837311|FG000|Overall Study|Lack of Efficacy|23|||
16865637|NCT01681433|37837312|FG001|Overall Study|Lack of Efficacy|23|||
16865638|NCT01681433|37837311|FG000|Overall Study|Withdrawal by Subject|5|||
16865639|NCT01681433|37837312|FG001|Overall Study|Withdrawal by Subject|5|||
16865640|NCT01681433|37837311|FG000|Overall Study|Protocol Violation|2|||
16865641|NCT01681433|37837312|FG001|Overall Study|Protocol Violation|0|||
16865642|NCT01681433|37837311|FG000|Overall Study|Adverse Event|2|||
16865643|NCT01681433|37837312|FG001|Overall Study|Adverse Event|4|||
16865644|NCT01681433|37837311|FG000|Overall Study|Lost to Follow-up|0|||
16865645|NCT01681433|37837312|FG001|Overall Study|Lost to Follow-up|1|||
16865646|NCT01681277|37837323|FG000|Overall Study|Adverse Event|1|||
16865647|NCT01681277|37837324|FG001|Overall Study|Adverse Event|0|||
16865648|NCT01681277|37837325|FG002|Overall Study|Adverse Event|0|||
16865649|NCT01681277|37837326|FG003|Overall Study|Adverse Event|0|||
16865650|NCT01681277|37837327|FG004|Overall Study|Adverse Event|0|||
16865651|NCT01703117|37837345|FG000|Overall Study|Adverse Event|4|||
16865652|NCT01703117|37837346|FG001|Overall Study|Adverse Event|3|||
16865653|NCT01703117|37837345|FG000|Overall Study|Withdrawal by Subject|0|||
16865654|NCT01703117|37837346|FG001|Overall Study|Withdrawal by Subject|1|||
16865655|NCT01702961|37837354|FG000|Overall Study|Additional treatment|3|||
16865656|NCT01702961|37837354|FG000|Overall Study|Progressive disease|5|||
16865657|NCT01702961|37837354|FG000|Overall Study|Relapse|20|||
16865658|NCT01702961|37837354|FG000|Overall Study|Death|6|||
16865659|NCT01702961|37837354|FG000|Overall Study|Lost to Follow-up|2|||
16865660|NCT01702961|37837354|FG000|Overall Study|Ongoing|11|||
16865661|NCT01593917|37837358|FG000|Overall Study|Death|67|||
16865662|NCT01593917|37837358|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
16865663|NCT01593917|37837358|FG000|Overall Study|Withdrawal by Subject|23|||
16865664|NCT01593917|37837358|FG000|Overall Study|Lost to Follow-up|12|||
16865665|NCT01593917|37837358|FG000|Overall Study|Protocol Violation|5|||
16865666|NCT01593917|37837358|FG000|Overall Study|Physician Decision|3|||
16865667|NCT01593761|37837362|FG000|Overall Study|Lost to Follow-up|1|||
16865668|NCT01593761|37837362|FG000|Overall Study|culture negative for MRSA at baseline|5|||
16865669|NCT01593761|37837362|FG000|Overall Study|positive for hepatitis C virus|1|||
16865670|NCT01593761|37837362|FG000|Overall Study|secondary cellulitis|1|||
16865671|NCT02706834|37837383|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16865672|NCT02706834|37837384|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16865673|NCT02706834|37837385|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16865674|NCT02706834|37837386|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
16865675|NCT02706834|37837387|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
16865676|NCT02706834|37837388|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
16865677|NCT02706834|37837389|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
16865678|NCT02706834|37837390|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
16865679|NCT02706834|37837391|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
16865680|NCT02706834|37837392|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
16865681|NCT02706834|37837393|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
16865682|NCT02706834|37837383|FG000|Overall Study|Lost to Follow-up|0|||
16865683|NCT02706834|37837384|FG001|Overall Study|Lost to Follow-up|0|||
16865684|NCT02706834|37837385|FG002|Overall Study|Lost to Follow-up|1|||
16865685|NCT02706834|37837386|FG003|Overall Study|Lost to Follow-up|0|||
16865686|NCT02706834|37837387|FG004|Overall Study|Lost to Follow-up|0|||
16865687|NCT02706834|37837388|FG005|Overall Study|Lost to Follow-up|0|||
16865688|NCT02706834|37837389|FG006|Overall Study|Lost to Follow-up|0|||
16865689|NCT02706834|37837390|FG007|Overall Study|Lost to Follow-up|0|||
16865690|NCT02706834|37837391|FG008|Overall Study|Lost to Follow-up|0|||
16865691|NCT02706834|37837392|FG009|Overall Study|Lost to Follow-up|0|||
16865692|NCT02706834|37837393|FG010|Overall Study|Lost to Follow-up|0|||
16865693|NCT02706834|37837383|FG000|Overall Study|Voluntary Withdrawal|1|||
16865694|NCT02706834|37837384|FG001|Overall Study|Voluntary Withdrawal|0|||
16865695|NCT02706834|37837385|FG002|Overall Study|Voluntary Withdrawal|0|||
16865696|NCT02706834|37837386|FG003|Overall Study|Voluntary Withdrawal|0|||
16865697|NCT02706834|37837387|FG004|Overall Study|Voluntary Withdrawal|0|||
16865698|NCT02706834|37837388|FG005|Overall Study|Voluntary Withdrawal|0|||
16865699|NCT02706834|37837389|FG006|Overall Study|Voluntary Withdrawal|0|||
16865700|NCT02706834|37837390|FG007|Overall Study|Voluntary Withdrawal|0|||
16865701|NCT02706834|37837391|FG008|Overall Study|Voluntary Withdrawal|0|||
16865702|NCT02706834|37837392|FG009|Overall Study|Voluntary Withdrawal|1|||
16865703|NCT02706834|37837393|FG010|Overall Study|Voluntary Withdrawal|0|||
16865704|NCT02706834|37837383|FG000|Overall Study|Other Reason Not Specified|1|||
16865705|NCT02706834|37837384|FG001|Overall Study|Other Reason Not Specified|0|||
16865706|NCT02706834|37837385|FG002|Overall Study|Other Reason Not Specified|0|||
16865707|NCT02706834|37837386|FG003|Overall Study|Other Reason Not Specified|0|||
16865708|NCT02706834|37837387|FG004|Overall Study|Other Reason Not Specified|1|||
16865709|NCT02706834|37837388|FG005|Overall Study|Other Reason Not Specified|0|||
16865710|NCT02706834|37837389|FG006|Overall Study|Other Reason Not Specified|0|||
16865711|NCT02706834|37837390|FG007|Overall Study|Other Reason Not Specified|0|||
16865712|NCT02706834|37837391|FG008|Overall Study|Other Reason Not Specified|0|||
16865713|NCT02706834|37837392|FG009|Overall Study|Other Reason Not Specified|0|||
16865714|NCT02706834|37837393|FG010|Overall Study|Other Reason Not Specified|0|||
16865715|NCT01702025|37837442|FG000|Overall Study|Equipment failure|1|||
16865716|NCT01702025|37837443|FG001|Overall Study|Equipment failure|0|||
16865717|NCT01702025|37837444|FG002|Overall Study|Equipment failure|0|||
16865718|NCT01702025|37837445|FG003|Overall Study|Equipment failure|0|||
16865719|NCT01702025|37837442|FG000|Overall Study|Adverse Event|1|||
16865720|NCT01702025|37837443|FG001|Overall Study|Adverse Event|1|||
16865721|NCT01702025|37837444|FG002|Overall Study|Adverse Event|1|||
16865722|NCT01702025|37837445|FG003|Overall Study|Adverse Event|0|||
16865723|NCT01592747|37837462|FG000|Overall Study|Loss of Therapeutic Response|107|||
16865724|NCT01592747|37837463|FG001|Overall Study|Loss of Therapeutic Response|108|||
16865725|NCT01592747|37837464|FG002|Overall Study|Loss of Therapeutic Response|100|||
16865726|NCT01592747|37837462|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
16865727|NCT01592747|37837463|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
16865728|NCT01592747|37837464|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
16865729|NCT01592747|37837462|FG000|Overall Study|Adverse Event|1|||
16865730|NCT01592747|37837463|FG001|Overall Study|Adverse Event|0|||
16865731|NCT01592747|37837464|FG002|Overall Study|Adverse Event|0|||
16865732|NCT01592747|37837462|FG000|Overall Study|Protocol Violation|4|||
16865733|NCT01592747|37837463|FG001|Overall Study|Protocol Violation|0|||
16865734|NCT01592747|37837464|FG002|Overall Study|Protocol Violation|4|||
16865735|NCT01592747|37837462|FG000|Overall Study|Lack of Efficacy|0|||
16865736|NCT01592747|37837463|FG001|Overall Study|Lack of Efficacy|1|||
16865737|NCT01592747|37837464|FG002|Overall Study|Lack of Efficacy|0|||
16865738|NCT01592747|37837462|FG000|Overall Study|Withdrawal by Subject|2|||
16865739|NCT01592747|37837463|FG001|Overall Study|Withdrawal by Subject|0|||
16865740|NCT01592747|37837464|FG002|Overall Study|Withdrawal by Subject|2|||
16865741|NCT01592747|37837462|FG000|Overall Study|Lost to Follow-up|1|||
16865742|NCT01592747|37837463|FG001|Overall Study|Lost to Follow-up|0|||
16865743|NCT01592747|37837464|FG002|Overall Study|Lost to Follow-up|1|||
16865744|NCT01592747|37837462|FG000|Overall Study|Other Reasons|1|||
16865745|NCT01592747|37837463|FG001|Overall Study|Other Reasons|1|||
16865746|NCT01592747|37837464|FG002|Overall Study|Other Reasons|0|||
16865747|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Death|3|||
16944874|NCT01097629|38088903|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16865748|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Death|3|||
16865749|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Death|0|||
16865750|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Death|0|||
16865751|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
16865752|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
16865753|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
16865754|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
16865755|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
16865756|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
16865757|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
16865758|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
16865759|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
16865760|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
16865761|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
16865762|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
16865763|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
16865764|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
16865765|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
16865766|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
16865767|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
16865768|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
16865769|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
16865770|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
16865771|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
16865772|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
16865773|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
16865774|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
16865775|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Other|6|||
16865776|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Other|3|||
16865777|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Other|0|||
16865778|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Other|0|||
16865779|NCT02051608|37837477|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
16865780|NCT02051608|37837478|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
16865781|NCT02051608|37837479|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
16865782|NCT02051608|37837480|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
16865783|NCT02051608|37837477|FG000|Part 2: Open-label Extension|Adverse Event|0|||
16865784|NCT02051608|37837478|FG001|Part 2: Open-label Extension|Adverse Event|0|||
16865785|NCT02051608|37837479|FG002|Part 2: Open-label Extension|Adverse Event|6|||
16865786|NCT02051608|37837480|FG003|Part 2: Open-label Extension|Adverse Event|8|||
16865787|NCT02051608|37837477|FG000|Part 2: Open-label Extension|Death|0|||
16865788|NCT02051608|37837478|FG001|Part 2: Open-label Extension|Death|0|||
16865789|NCT02051608|37837479|FG002|Part 2: Open-label Extension|Death|7|||
16865790|NCT02051608|37837480|FG003|Part 2: Open-label Extension|Death|4|||
16865791|NCT02051608|37837477|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
16865792|NCT02051608|37837478|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
16865793|NCT02051608|37837479|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
16865794|NCT02051608|37837480|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
16865795|NCT02051608|37837477|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
16865796|NCT02051608|37837478|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
16865797|NCT02051608|37837479|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
16865798|NCT02051608|37837480|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
16865799|NCT02051608|37837477|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
16865800|NCT02051608|37837478|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
16865801|NCT02051608|37837479|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
16865802|NCT02051608|37837480|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
16865803|NCT02051608|37837477|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
16865804|NCT02051608|37837478|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
16865805|NCT02051608|37837479|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
16865806|NCT02051608|37837480|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
16865807|NCT02051608|37837477|FG000|Part 2: Open-label Extension|Physician Decision|0|||
16865808|NCT02051608|37837478|FG001|Part 2: Open-label Extension|Physician Decision|0|||
16865809|NCT02051608|37837479|FG002|Part 2: Open-label Extension|Physician Decision|8|||
16865810|NCT02051608|37837480|FG003|Part 2: Open-label Extension|Physician Decision|5|||
16865811|NCT02051608|37837477|FG000|Part 2: Open-label Extension|Other|0|||
16865812|NCT02051608|37837478|FG001|Part 2: Open-label Extension|Other|0|||
16865813|NCT02051608|37837479|FG002|Part 2: Open-label Extension|Other|9|||
16865814|NCT02051608|37837480|FG003|Part 2: Open-label Extension|Other|9|||
16865815|NCT02705586|37837493|FG000|Overall Study|Health Issues|2|||
16865816|NCT02705586|37837493|FG000|Overall Study|Transportation Difficulties|5|||
16865817|NCT02705586|37837493|FG000|Overall Study|Vacation/Planned Absence|1|||
16865818|NCT01592045|37837499|FG000|Overall Study|Disease Progression|1|||
16865819|NCT01592045|37837500|FG001|Overall Study|Disease Progression|1|||
16865820|NCT01592045|37837499|FG000|Overall Study|Adverse Event|1|||
16865821|NCT01592045|37837500|FG001|Overall Study|Adverse Event|1|||
16865822|NCT01592045|37837499|FG000|Overall Study|Withdrawal by Subject|1|||
16865823|NCT01592045|37837500|FG001|Overall Study|Withdrawal by Subject|0|||
16865824|NCT01592045|37837499|FG000|Overall Study|Moved out of country|2|||
16865825|NCT01592045|37837500|FG001|Overall Study|Moved out of country|0|||
16865826|NCT01591499|37837508|FG000|Baseline Visit|Withdrawal by Subject|0|||
16865827|NCT01591499|37837509|FG001|Baseline Visit|Withdrawal by Subject|2|||
16865828|NCT01591499|37837510|FG002|Baseline Visit|Withdrawal by Subject|0|||
16865829|NCT01591499|37837511|FG003|Baseline Visit|Withdrawal by Subject|2|||
16865830|NCT01591499|37837508|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
16865831|NCT01591499|37837509|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
16865832|NCT01591499|37837510|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
16865833|NCT01591499|37837511|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
16865834|NCT01591499|37837508|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
16865835|NCT01591499|37837509|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
16865836|NCT01591499|37837510|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
16865837|NCT01591499|37837511|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
16865838|NCT01981720|37837535|FG000|Overall Study|Adverse Event|1|||
16865839|NCT01981720|37837535|FG000|Overall Study|Withdrawal by Subject|3|||
16865840|NCT01981720|37837535|FG000|Overall Study|Pregnancy|1|||
16865841|NCT01590797|37837545|FG000|Overall Study|Adverse Event|4|||
16865842|NCT01590797|37837546|FG001|Overall Study|Adverse Event|3|||
16865843|NCT01590797|37837545|FG000|Overall Study|Lack of Efficacy|0|||
16865844|NCT01590797|37837546|FG001|Overall Study|Lack of Efficacy|2|||
16865845|NCT01590797|37837545|FG000|Overall Study|Lost to Follow-up|0|||
16865846|NCT01590797|37837546|FG001|Overall Study|Lost to Follow-up|1|||
16865847|NCT01590797|37837545|FG000|Overall Study|Protocol Violation|4|||
16865848|NCT01590797|37837546|FG001|Overall Study|Protocol Violation|1|||
16865849|NCT01590797|37837545|FG000|Overall Study|Withdrawal by Subject|7|||
16865850|NCT01590797|37837546|FG001|Overall Study|Withdrawal by Subject|5|||
16865851|NCT01590797|37837545|FG000|Overall Study|Other Protocol Specified Criteria|2|||
16865852|NCT01590797|37837546|FG001|Overall Study|Other Protocol Specified Criteria|4|||
16865853|NCT01590563|37837552|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
16865854|NCT01867606|37837559|FG000|Overall Study|Withdrawal by Subject|10|||
16865855|NCT01867606|37837560|FG001|Overall Study|Withdrawal by Subject|14|||
16865856|NCT01867606|37837559|FG000|Overall Study|Protocol Violation|0|||
16865857|NCT01867606|37837560|FG001|Overall Study|Protocol Violation|1|||
16865858|NCT01701401|37837576|FG000|Overall Study|Randomized But Not Treated|3|||
16865859|NCT01701401|37837577|FG001|Overall Study|Randomized But Not Treated|1|||
16865860|NCT01701401|37837578|FG002|Overall Study|Randomized But Not Treated|0|||
16865861|NCT01701401|37837579|FG003|Overall Study|Randomized But Not Treated|1|||
16865862|NCT01701401|37837576|FG000|Overall Study|Lost to Follow-up|5|||
16865863|NCT01701401|37837577|FG001|Overall Study|Lost to Follow-up|5|||
16865864|NCT01701401|37837578|FG002|Overall Study|Lost to Follow-up|1|||
16865865|NCT01701401|37837579|FG003|Overall Study|Lost to Follow-up|3|||
16865866|NCT01701401|37837576|FG000|Overall Study|Withdrew Consent|0|||
16865867|NCT01701401|37837577|FG001|Overall Study|Withdrew Consent|3|||
16865868|NCT01701401|37837578|FG002|Overall Study|Withdrew Consent|1|||
16865869|NCT01701401|37837579|FG003|Overall Study|Withdrew Consent|2|||
16865870|NCT01701401|37837576|FG000|Overall Study|Lack of Efficacy|1|||
16865871|NCT01701401|37837577|FG001|Overall Study|Lack of Efficacy|0|||
16865872|NCT01701401|37837578|FG002|Overall Study|Lack of Efficacy|2|||
16865873|NCT01701401|37837579|FG003|Overall Study|Lack of Efficacy|0|||
16865874|NCT01701401|37837576|FG000|Overall Study|Adverse Event|1|||
16865875|NCT01701401|37837577|FG001|Overall Study|Adverse Event|0|||
16865876|NCT01701401|37837578|FG002|Overall Study|Adverse Event|0|||
16865877|NCT01701401|37837579|FG003|Overall Study|Adverse Event|0|||
16865878|NCT01701401|37837576|FG000|Overall Study|Protocol Violation|0|||
16865879|NCT01701401|37837577|FG001|Overall Study|Protocol Violation|0|||
16865880|NCT01701401|37837578|FG002|Overall Study|Protocol Violation|1|||
16865881|NCT01701401|37837579|FG003|Overall Study|Protocol Violation|0|||
16865882|NCT01701245|37837591|FG000|Overall Study|Protocol Violation|1|||
16865883|NCT01701245|37837592|FG001|Overall Study|Protocol Violation|3|||
16865884|NCT01701245|37837591|FG000|Overall Study|Did not complete the open label period|11|||
16865885|NCT01701245|37837592|FG001|Overall Study|Did not complete the open label period|12|||
16865886|NCT01590017|37837598|FG000|Overall Study|Adverse Event|1|||
16865887|NCT01590017|37837598|FG000|Overall Study|Withdrawal by Subject|1|||
16865888|NCT01590017|37837598|FG000|Overall Study|Lack of Efficacy|1|||
16865889|NCT01590017|37837598|FG000|Overall Study|Physician Decision|1|||
16865890|NCT01700621|37837604|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
16865891|NCT01700621|37837605|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
16865892|NCT01700621|37837604|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
16865893|NCT01700621|37837605|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
16865894|NCT01700621|37837604|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
16865895|NCT01700621|37837605|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
16865896|NCT01589237|37837616|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
16865897|NCT01589237|37837617|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
16865898|NCT01589237|37837618|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
16865899|NCT01589237|37837619|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
16865900|NCT01589237|37837616|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
16865901|NCT01589237|37837617|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
16865902|NCT01589237|37837618|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
16865903|NCT01589237|37837619|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
16865904|NCT01589237|37837616|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
16865905|NCT01589237|37837617|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
16865906|NCT01589237|37837618|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
16865907|NCT01589237|37837619|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
16865908|NCT01589237|37837616|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
16865909|NCT01589237|37837617|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
16865910|NCT01589237|37837618|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
16944875|NCT01097629|38088904|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16865911|NCT01589237|37837619|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
16865912|NCT01700387|37837635|FG000|Overall Study|Withdrawal by Subject|1|||
16865913|NCT01700387|37837636|FG001|Overall Study|Withdrawal by Subject|2|||
16865914|NCT01700387|37837635|FG000|Overall Study|Adverse Event|1|||
16865915|NCT01700387|37837636|FG001|Overall Study|Adverse Event|1|||
16865916|NCT01700387|37837635|FG000|Overall Study|Lost to Follow-up|2|||
16865917|NCT01700387|37837636|FG001|Overall Study|Lost to Follow-up|1|||
16865918|NCT01699685|37837648|FG000|Period 1|Adverse Event|1|||
16865919|NCT01699685|37837649|FG001|Period 1|Adverse Event|1|||
16865920|NCT01699685|37837648|FG000|Period 1|Medical or ethical, noncompliance|2|||
16865921|NCT01699685|37837649|FG001|Period 1|Medical or ethical, noncompliance|0|||
16865922|NCT01699685|37837648|FG000|Period 1|Other|0|||
16865923|NCT01699685|37837649|FG001|Period 1|Other|1|||
16865924|NCT01699685|37837648|FG000|Period 1|Patient request|0|||
16865925|NCT01699685|37837649|FG001|Period 1|Patient request|1|||
16865926|NCT01699685|37837648|FG000|Period 2|Lost to Follow-up|1|||
16865927|NCT01699685|37837649|FG001|Period 2|Lost to Follow-up|0|||
16865928|NCT01587989|37837657|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
16865929|NCT01587989|37837658|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
16865930|NCT01587989|37837659|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
16865931|NCT01587989|37837657|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
16865932|NCT01587989|37837658|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
16865933|NCT01587989|37837659|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
16865934|NCT01587989|37837657|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
16865935|NCT01587989|37837658|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
16865936|NCT01587989|37837659|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
16865937|NCT01587989|37837657|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
16944876|NCT01097629|38088905|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16774028|NCT02432846|37713257|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
16865938|NCT01587989|37837658|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
16865939|NCT01587989|37837659|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
16865940|NCT01587989|37837657|FG000|Randomized Study Treatment|Screening failure|0|||
16865941|NCT01587989|37837658|FG001|Randomized Study Treatment|Screening failure|1|||
16865942|NCT01587989|37837659|FG002|Randomized Study Treatment|Screening failure|0|||
16865943|NCT01587989|37837657|FG000|Randomized Study Treatment|Physician Decision|0|||
16865944|NCT01587989|37837658|FG001|Randomized Study Treatment|Physician Decision|0|||
16865945|NCT01587989|37837659|FG002|Randomized Study Treatment|Physician Decision|1|||
16865946|NCT01697969|37837665|FG000|Overall Study|Did not meet inc/exc criteria|3|||
16865947|NCT01586819|37837672|FG000|Overall Study|Withdrawal by Subject|1|||
16865948|NCT01586819|37837673|FG001|Overall Study|Withdrawal by Subject|0|||
16865949|NCT01697579|37837684|FG000|Base Study-Cycle 1|Adverse Event|1|||
16865950|NCT01697579|37837685|FG001|Base Study-Cycle 1|Adverse Event|0|||
16865951|NCT01697579|37837686|FG002|Base Study-Cycle 1|Adverse Event|0|||
16865952|NCT01697579|37837687|FG003|Base Study-Cycle 1|Adverse Event|0|||
16865953|NCT01697579|37837688|FG004|Base Study-Cycle 1|Adverse Event|0|||
16865954|NCT01697579|37837689|FG005|Base Study-Cycle 1|Adverse Event|0|||
16865955|NCT01697579|37837690|FG006|Base Study-Cycle 1|Adverse Event|0|||
16865956|NCT01697579|37837684|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
16865957|NCT01697579|37837685|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16865958|NCT01697579|37837686|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16865959|NCT01697579|37837687|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16865960|NCT01697579|37837688|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16865961|NCT01697579|37837689|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16865962|NCT01697579|37837690|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16865963|NCT01697579|37837684|FG000|Base Study-Cycle 1|Protocol Violation|0|||
16865964|NCT01697579|37837685|FG001|Base Study-Cycle 1|Protocol Violation|0|||
16865965|NCT01697579|37837686|FG002|Base Study-Cycle 1|Protocol Violation|0|||
16865966|NCT01697579|37837687|FG003|Base Study-Cycle 1|Protocol Violation|0|||
16865967|NCT01697579|37837688|FG004|Base Study-Cycle 1|Protocol Violation|3|||
16865968|NCT01697579|37837689|FG005|Base Study-Cycle 1|Protocol Violation|0|||
16865969|NCT01697579|37837690|FG006|Base Study-Cycle 1|Protocol Violation|0|||
16865970|NCT01697579|37837684|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16865971|NCT01697579|37837685|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
16865972|NCT01697579|37837686|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16865973|NCT01697579|37837687|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16865974|NCT01697579|37837688|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16944877|NCT01097629|38088906|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16865975|NCT01697579|37837689|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16865976|NCT01697579|37837690|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16865977|NCT01697579|37837684|FG000|Base Study-Cycle 1|Technical Problems|0|||
16865978|NCT01697579|37837685|FG001|Base Study-Cycle 1|Technical Problems|0|||
16865979|NCT01697579|37837686|FG002|Base Study-Cycle 1|Technical Problems|1|||
16865980|NCT01697579|37837687|FG003|Base Study-Cycle 1|Technical Problems|1|||
16865981|NCT01697579|37837688|FG004|Base Study-Cycle 1|Technical Problems|0|||
16865982|NCT01697579|37837689|FG005|Base Study-Cycle 1|Technical Problems|0|||
16865983|NCT01697579|37837690|FG006|Base Study-Cycle 1|Technical Problems|0|||
16865984|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Death|0|||
16865985|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Death|0|||
16865986|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Death|0|||
16865987|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Death|0|||
16865988|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Death|0|||
16865989|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Death|0|||
16865990|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Death|2|||
16865991|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16865992|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16865993|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16865994|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16865995|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16865996|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
16865997|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
16865998|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
16865999|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
16866000|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
16866001|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
16866002|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
16866003|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
16866004|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
16866005|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16866006|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16866007|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16866008|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16944878|NCT01097629|38088907|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16866009|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16866010|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16866011|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
16866012|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16866013|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16866014|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16866015|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16866016|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16866017|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
16866018|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
16866019|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16866020|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16866021|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16866022|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16866023|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16866024|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
16866025|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16866026|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16866027|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16866028|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16866029|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16866030|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16866031|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
16866032|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
16866033|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16866034|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16866035|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16866036|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16866037|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16866038|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
16866039|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
16866040|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16866041|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16866042|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16866043|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16866044|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16866045|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16866046|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
16866047|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
16866048|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
16866049|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
16866050|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
16866051|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
16866052|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
16866053|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
16866054|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
16866055|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
16866056|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
16866057|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
16866058|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
16866059|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
16866060|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
16866061|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16866062|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16866063|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16866064|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16866065|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16866066|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
16866067|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
16866068|NCT01697579|37837684|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16866069|NCT01697579|37837685|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16866070|NCT01697579|37837686|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16866071|NCT01697579|37837687|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16866072|NCT01697579|37837688|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16866073|NCT01697579|37837689|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16866074|NCT01697579|37837690|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
16866075|NCT01586195|37837718|FG000|Overall Study|Death|11|||
16866076|NCT01586195|37837718|FG000|Overall Study|Withdrawal of Consent|5|||
16866077|NCT01586195|37837718|FG000|Overall Study|Started new anti-melanoma therapy|1|||
16866078|NCT01586195|37837718|FG000|Overall Study|Reason not specified|9|||
16866079|NCT01585961|37837722|FG000|Overall Study|Death|6|||
16866080|NCT01585961|37837722|FG000|Overall Study|Physician Decision|1|||
16866081|NCT01585961|37837722|FG000|Overall Study|Decision to use non-study catheter|1|||
16866082|NCT01585961|37837722|FG000|Overall Study|Withdrawal by Subject|1|||
16866083|NCT01585961|37837722|FG000|Overall Study|Lost to Follow-up|23|||
16866084|NCT01585961|37837722|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
16866085|NCT01697501|37837726|FG000|Overall Study|Protocol Violation|2|||
16866086|NCT01697345|37837739|FG000|Overall Study|Withdrawal by Subject|1|||
16866087|NCT01802632|37837764|FG000|Overall Study|Death|28|||
16866088|NCT01802632|37837765|FG001|Overall Study|Death|1|||
16866089|NCT01802632|37837766|FG002|Overall Study|Death|38|||
16866090|NCT01802632|37837767|FG003|Overall Study|Death|0|||
16866091|NCT01802632|37837768|FG004|Overall Study|Death|2|||
16866092|NCT01802632|37837769|FG005|Overall Study|Death|0|||
16866093|NCT01802632|37837764|FG000|Overall Study|Withdrawal by Subject|4|||
16866094|NCT01802632|37837765|FG001|Overall Study|Withdrawal by Subject|2|||
16866095|NCT01802632|37837766|FG002|Overall Study|Withdrawal by Subject|7|||
16866096|NCT01802632|37837767|FG003|Overall Study|Withdrawal by Subject|3|||
16866097|NCT01802632|37837768|FG004|Overall Study|Withdrawal by Subject|0|||
16866098|NCT01802632|37837769|FG005|Overall Study|Withdrawal by Subject|1|||
16866099|NCT01802632|37837764|FG000|Overall Study|Objective Disease Progression|1|||
16866100|NCT01802632|37837765|FG001|Overall Study|Objective Disease Progression|12|||
16866101|NCT01802632|37837766|FG002|Overall Study|Objective Disease Progression|104|||
16866102|NCT01802632|37837767|FG003|Overall Study|Objective Disease Progression|6|||
16866103|NCT01802632|37837768|FG004|Overall Study|Objective Disease Progression|4|||
16866104|NCT01802632|37837769|FG005|Overall Study|Objective Disease Progression|4|||
16866105|NCT01802632|37837764|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
16866106|NCT01802632|37837765|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
16866107|NCT01802632|37837766|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
16866108|NCT01802632|37837767|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
16866109|NCT01802632|37837768|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
16866110|NCT01802632|37837769|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
16866111|NCT01802632|37837764|FG000|Overall Study|Other (not specified)|0|||
16866112|NCT01802632|37837765|FG001|Overall Study|Other (not specified)|0|||
16866113|NCT01802632|37837766|FG002|Overall Study|Other (not specified)|7|||
16866114|NCT01802632|37837767|FG003|Overall Study|Other (not specified)|1|||
16866115|NCT01802632|37837768|FG004|Overall Study|Other (not specified)|0|||
16866116|NCT01802632|37837769|FG005|Overall Study|Other (not specified)|1|||
16866117|NCT01697267|37837831|FG000|Overall Study|Death|3|||
16866118|NCT01697267|37837832|FG001|Overall Study|Death|1|||
16866119|NCT01697267|37837831|FG000|Overall Study|Withdrawal by Subject|5|||
16866120|NCT01697267|37837832|FG001|Overall Study|Withdrawal by Subject|5|||
16866121|NCT01697267|37837831|FG000|Overall Study|Adverse Event|2|||
16866122|NCT01697267|37837832|FG001|Overall Study|Adverse Event|1|||
16866123|NCT01697267|37837831|FG000|Overall Study|Lost to Follow-up|2|||
16866124|NCT01697267|37837832|FG001|Overall Study|Lost to Follow-up|4|||
16866125|NCT01697267|37837831|FG000|Overall Study|Physician Decision|2|||
16866126|NCT01697267|37837832|FG001|Overall Study|Physician Decision|4|||
16866127|NCT01696955|37837894|FG000|Main Study|Protocol Violation|1|||
16866128|NCT01696955|37837895|FG001|Main Study|Protocol Violation|0|||
16866129|NCT01696955|37837894|FG000|Main Study|Withdrawal by Subject|1|||
16866130|NCT01696955|37837895|FG001|Main Study|Withdrawal by Subject|1|||
16866131|NCT02702388|37837919|FG000|Overall Study|Disease Progression|18|||
16866132|NCT02702388|37837920|FG001|Overall Study|Disease Progression|25|||
16866133|NCT02702388|37837919|FG000|Overall Study|Withdrawal by Subject|9|||
16866134|NCT02702388|37837920|FG001|Overall Study|Withdrawal by Subject|7|||
16866135|NCT02702388|37837919|FG000|Overall Study|Adverse Event|11|||
16866136|NCT02702388|37837920|FG001|Overall Study|Adverse Event|15|||
16866137|NCT02702388|37837919|FG000|Overall Study|Other|2|||
16866138|NCT02702388|37837920|FG001|Overall Study|Other|4|||
16866139|NCT01696877|37837946|FG000|Overall Study|Adverse Event|0|||
16866140|NCT01696877|37837947|FG001|Overall Study|Adverse Event|1|||
16866141|NCT02703636|37838143|FG000|Overall Study|Adverse Event|14|||
16866142|NCT02703636|37838143|FG000|Overall Study|Study stopped by sponsor|1|||
16866143|NCT02703636|37838143|FG000|Overall Study|Withdrawal by Subject|1|||
16866144|NCT02703324|37838371|FG000|Period Two|Withdrawal by Subject|0|||
16866145|NCT02703324|37838372|FG001|Period Two|Withdrawal by Subject|0|||
16866146|NCT02703324|37838373|FG002|Period Two|Withdrawal by Subject|1|||
16866147|NCT02703324|37838374|FG003|Period Two|Withdrawal by Subject|0|||
16866148|NCT02703324|37838375|FG004|Period Two|Withdrawal by Subject|0|||
16866149|NCT02703324|37838376|FG005|Period Two|Withdrawal by Subject|0|||
16866150|NCT02701764|37838387|FG000|Overall Study|Lost to Follow-up|0|||
16866151|NCT02701764|37838388|FG001|Overall Study|Lost to Follow-up|1|||
16866152|NCT01696643|37838569|FG000|Overall Study|Adverse Event|15|||
16866153|NCT01696643|37838570|FG001|Overall Study|Adverse Event|7|||
16866154|NCT01696643|37838569|FG000|Overall Study|Death|1|||
16866155|NCT01696643|37838570|FG001|Overall Study|Death|2|||
16866156|NCT01696643|37838569|FG000|Overall Study|Lack of Efficacy|3|||
16866157|NCT01696643|37838570|FG001|Overall Study|Lack of Efficacy|0|||
16866158|NCT01696643|37838569|FG000|Overall Study|Lost to Follow-up|67|||
16866159|NCT01696643|37838570|FG001|Overall Study|Lost to Follow-up|67|||
16866160|NCT01696643|37838569|FG000|Overall Study|Physician Decision|3|||
16866161|NCT01696643|37838570|FG001|Overall Study|Physician Decision|2|||
16866162|NCT01696643|37838569|FG000|Overall Study|Pregnancy|0|||
16866163|NCT01696643|37838570|FG001|Overall Study|Pregnancy|1|||
16866164|NCT01696643|37838569|FG000|Overall Study|Protocol Violation|7|||
16866165|NCT01696643|37838570|FG001|Overall Study|Protocol Violation|7|||
16866166|NCT01696643|37838569|FG000|Overall Study|Study Terminated by Sponsor|286|||
16866167|NCT01696643|37838570|FG001|Overall Study|Study Terminated by Sponsor|294|||
16866168|NCT01696643|37838569|FG000|Overall Study|Withdrawal by Subject|142|||
16866169|NCT01696643|37838570|FG001|Overall Study|Withdrawal by Subject|149|||
16866170|NCT01696643|37838569|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
16866171|NCT01696643|37838570|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
16866172|NCT01696643|37838569|FG000|Overall Study|Site Error|2|||
16866173|NCT01696643|37838570|FG001|Overall Study|Site Error|1|||
16866174|NCT01696643|37838569|FG000|Overall Study|Participant Incarcerated|0|||
16866175|NCT01696643|37838570|FG001|Overall Study|Participant Incarcerated|1|||
16866176|NCT01696643|37838569|FG000|Overall Study|Medical Monitor Decision|0|||
16866177|NCT01696643|37838570|FG001|Overall Study|Medical Monitor Decision|2|||
16866178|NCT01696643|37838569|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
16866179|NCT01696643|37838570|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
16866180|NCT01695317|37838582|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
16866181|NCT01695317|37838583|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
16866182|NCT01695317|37838582|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
16866183|NCT01695317|37838583|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
16866184|NCT02701296|37838639|FG000|Overall Study|Incomplete Data|0|||
16866185|NCT02701296|37838640|FG001|Overall Study|Incomplete Data|2|||
16866186|NCT01582451|37838657|FG000|Overall Study|Adverse Event|1|||
16866187|NCT01582451|37838658|FG001|Overall Study|Adverse Event|3|||
16866188|NCT01582451|37838657|FG000|Overall Study|Death|3|||
16866189|NCT01582451|37838658|FG001|Overall Study|Death|3|||
16866190|NCT01582451|37838657|FG000|Overall Study|Lost to Follow-up|0|||
16866191|NCT01582451|37838658|FG001|Overall Study|Lost to Follow-up|2|||
16866192|NCT01582451|37838657|FG000|Overall Study|Protocol Violation|11|||
16866193|NCT01582451|37838658|FG001|Overall Study|Protocol Violation|3|||
16866194|NCT01582451|37838657|FG000|Overall Study|Withdrawal by Subject|13|||
16866195|NCT01582451|37838658|FG001|Overall Study|Withdrawal by Subject|9|||
16866196|NCT01582451|37838657|FG000|Overall Study|Physician Decision|3|||
16866197|NCT01582451|37838658|FG001|Overall Study|Physician Decision|0|||
16866198|NCT01582451|37838657|FG000|Overall Study|Sponsor Decision|1|||
16866199|NCT01582451|37838658|FG001|Overall Study|Sponsor Decision|0|||
16866200|NCT02700984|37838751|FG000|Overall Study|Death|2|||
16866201|NCT02700984|37838752|FG001|Overall Study|Death|1|||
16866202|NCT02700984|37838751|FG000|Overall Study|Lost to Follow-up|2|||
16866203|NCT02700984|37838752|FG001|Overall Study|Lost to Follow-up|1|||
16866204|NCT02700984|37838751|FG000|Overall Study|Physician Decision|0|||
16866205|NCT02700984|37838752|FG001|Overall Study|Physician Decision|1|||
16866206|NCT02700984|37838751|FG000|Overall Study|Withdrawal by Subject|8|||
16866207|NCT02700984|37838752|FG001|Overall Study|Withdrawal by Subject|9|||
16866208|NCT02700984|37838751|FG000|Overall Study|Reason not specified|3|||
16866209|NCT02700984|37838752|FG001|Overall Study|Reason not specified|2|||
16866210|NCT02696850|37838826|FG000|Overall Study|Withdrawal by Subject|3|||
16866211|NCT02696850|37838827|FG001|Overall Study|Withdrawal by Subject|3|||
16866212|NCT02696850|37838826|FG000|Overall Study|Lost to Follow-up|8|||
16866213|NCT02696850|37838827|FG001|Overall Study|Lost to Follow-up|5|||
16866214|NCT02698410|37838990|FG000|Overall Study|Adverse Event|2|||
16866215|NCT02698410|37838990|FG000|Overall Study|Withdrawal by Subject|1|||
16866216|NCT02698410|37838990|FG000|Overall Study|Other|1|||
16866217|NCT02699892|37838994|FG000|Overall Study|Other|36|||
16866218|NCT02698176|37839001|FG000|Overall Study|Progressive disease|4|||
16866219|NCT02698176|37839002|FG001|Overall Study|Progressive disease|3|||
16866220|NCT02698176|37839003|FG002|Overall Study|Progressive disease|1|||
16866221|NCT02698176|37839004|FG003|Overall Study|Progressive disease|0|||
16866222|NCT02698176|37839001|FG000|Overall Study|Adverse Event|2|||
16866223|NCT02698176|37839002|FG001|Overall Study|Adverse Event|0|||
16866224|NCT02698176|37839003|FG002|Overall Study|Adverse Event|0|||
16866225|NCT02698176|37839004|FG003|Overall Study|Adverse Event|0|||
16866226|NCT02698176|37839001|FG000|Overall Study|Clinical progression|3|||
16866227|NCT02698176|37839002|FG001|Overall Study|Clinical progression|0|||
16866228|NCT02698176|37839003|FG002|Overall Study|Clinical progression|0|||
16866229|NCT02698176|37839004|FG003|Overall Study|Clinical progression|0|||
16866230|NCT04024462|37839017|FG000|Overall Study|Withdrawal by Subject|6|||
16866231|NCT04024462|37839018|FG001|Overall Study|Withdrawal by Subject|7|||
16866232|NCT04024462|37839017|FG000|Overall Study|Progressive Disease|0|||
16866233|NCT04024462|37839018|FG001|Overall Study|Progressive Disease|1|||
16866234|NCT04024462|37839017|FG000|Overall Study|Adverse Event|0|||
16866235|NCT04024462|37839018|FG001|Overall Study|Adverse Event|1|||
16866236|NCT04024462|37839017|FG000|Overall Study|Death|0|||
16866237|NCT04024462|37839018|FG001|Overall Study|Death|1|||
16866238|NCT04024462|37839017|FG000|Overall Study|Lost to Follow-up|1|||
16866239|NCT04024462|37839018|FG001|Overall Study|Lost to Follow-up|0|||
16866240|NCT04024462|37839017|FG000|Overall Study|Ongoing in the Study|94|||
16866241|NCT04024462|37839018|FG001|Overall Study|Ongoing in the Study|89|||
16866242|NCT02693418|37839029|FG000|Overall Study|Lost to Follow-up|1|||
16866243|NCT02693418|37839030|FG001|Overall Study|Lost to Follow-up|2|||
16866244|NCT02693418|37839031|FG002|Overall Study|Lost to Follow-up|0|||
16866245|NCT02693418|37839032|FG003|Overall Study|Lost to Follow-up|0|||
16866246|NCT02693418|37839033|FG004|Overall Study|Lost to Follow-up|0|||
16866247|NCT02693418|37839029|FG000|Overall Study|Menses during study period|0|||
16866248|NCT02693418|37839030|FG001|Overall Study|Menses during study period|0|||
16866249|NCT02693418|37839031|FG002|Overall Study|Menses during study period|2|||
16866250|NCT02693418|37839032|FG003|Overall Study|Menses during study period|0|||
16866251|NCT02693418|37839033|FG004|Overall Study|Menses during study period|0|||
16866252|NCT02693106|37839066|FG000|Overall Study|No time|3|||
16866253|NCT02546986|37839078|FG000|Treatment Period|Progressive Disease|20|||
16866254|NCT02546986|37839079|FG001|Treatment Period|Progressive Disease|22|||
16866255|NCT02546986|37839078|FG000|Treatment Period|Adverse Event|14|||
16866256|NCT02546986|37839079|FG001|Treatment Period|Adverse Event|6|||
16866257|NCT02546986|37839078|FG000|Treatment Period|Symptomatic Deterioration|4|||
16866258|NCT02546986|37839079|FG001|Treatment Period|Symptomatic Deterioration|3|||
16866259|NCT02546986|37839078|FG000|Treatment Period|Death|3|||
16866260|NCT02546986|37839079|FG001|Treatment Period|Death|4|||
16866261|NCT02546986|37839078|FG000|Treatment Period|Physician Decision|1|||
16866262|NCT02546986|37839079|FG001|Treatment Period|Physician Decision|2|||
16866263|NCT02546986|37839078|FG000|Treatment Period|Protocol Violation|1|||
16866264|NCT02546986|37839079|FG001|Treatment Period|Protocol Violation|0|||
16866265|NCT02546986|37839078|FG000|Treatment Period|Withdrawal by Subject|1|||
16866266|NCT02546986|37839079|FG001|Treatment Period|Withdrawal by Subject|1|||
16866267|NCT02546986|37839078|FG000|Treatment Period|Non-compliance with Study Drug|0|||
16866268|NCT02546986|37839079|FG001|Treatment Period|Non-compliance with Study Drug|1|||
16866269|NCT02546986|37839078|FG000|Treatment Period|Study Terminated by Sponsor|0|||
16866270|NCT02546986|37839079|FG001|Treatment Period|Study Terminated by Sponsor|1|||
16866271|NCT02546986|37839078|FG000|Treatment Period|Miscellaneous|7|||
16866272|NCT02546986|37839079|FG001|Treatment Period|Miscellaneous|9|||
16866273|NCT02546986|37839078|FG000|Survival Follow-Up Phase|Missing Status|3|||
16866274|NCT02546986|37839079|FG001|Survival Follow-Up Phase|Missing Status|5|||
16866275|NCT02546986|37839078|FG000|Survival Follow-Up Phase|Death|18|||
16866276|NCT02546986|37839079|FG001|Survival Follow-Up Phase|Death|12|||
16866277|NCT02546986|37839078|FG000|Survival Follow-Up Phase|Alive|13|||
16866278|NCT02546986|37839079|FG001|Survival Follow-Up Phase|Alive|16|||
16866279|NCT02546986|37839078|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
16866280|NCT02546986|37839079|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
16866281|NCT02689206|37839090|FG000|Overall Study|Adverse Event|0|||
16866282|NCT02689206|37839091|FG001|Overall Study|Adverse Event|0|||
16866283|NCT02689206|37839092|FG002|Overall Study|Adverse Event|1|||
16866284|NCT02689206|37839093|FG003|Overall Study|Adverse Event|0|||
16866285|NCT02689206|37839094|FG004|Overall Study|Adverse Event|2|||
16866286|NCT02689206|37839090|FG000|Overall Study|Protocol Violation|1|||
16866287|NCT02689206|37839091|FG001|Overall Study|Protocol Violation|0|||
16866288|NCT02689206|37839092|FG002|Overall Study|Protocol Violation|0|||
16866289|NCT02689206|37839093|FG003|Overall Study|Protocol Violation|1|||
16866290|NCT02689206|37839094|FG004|Overall Study|Protocol Violation|2|||
16866291|NCT02689206|37839090|FG000|Overall Study|Other: Reached stopping criteria|0|||
16866292|NCT02689206|37839091|FG001|Overall Study|Other: Reached stopping criteria|1|||
16866293|NCT02689206|37839092|FG002|Overall Study|Other: Reached stopping criteria|2|||
16866294|NCT02689206|37839093|FG003|Overall Study|Other: Reached stopping criteria|3|||
16866295|NCT02689206|37839094|FG004|Overall Study|Other: Reached stopping criteria|4|||
16866296|NCT02689206|37839090|FG000|Overall Study|Physician Decision|1|||
16866297|NCT02689206|37839091|FG001|Overall Study|Physician Decision|0|||
16866298|NCT02689206|37839092|FG002|Overall Study|Physician Decision|0|||
16866299|NCT02689206|37839093|FG003|Overall Study|Physician Decision|0|||
16866300|NCT02689206|37839094|FG004|Overall Study|Physician Decision|0|||
16866301|NCT02689206|37839090|FG000|Overall Study|Withdrawal by Subject|1|||
16866302|NCT02689206|37839091|FG001|Overall Study|Withdrawal by Subject|0|||
16866303|NCT02689206|37839092|FG002|Overall Study|Withdrawal by Subject|1|||
16866304|NCT02689206|37839093|FG003|Overall Study|Withdrawal by Subject|0|||
16866305|NCT02689206|37839094|FG004|Overall Study|Withdrawal by Subject|0|||
16866306|NCT01695239|37839114|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
16866307|NCT01695239|37839115|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
16866308|NCT01695239|37839116|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
16866309|NCT01695239|37839117|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
16866310|NCT01695239|37839118|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866311|NCT01695239|37839119|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866312|NCT01695239|37839120|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866313|NCT01695239|37839121|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866314|NCT01695239|37839122|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866315|NCT01695239|37839123|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866316|NCT01695239|37839124|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866317|NCT01695239|37839125|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866318|NCT01695239|37839126|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866319|NCT01695239|37839127|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16866320|NCT01695239|37839114|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
16866321|NCT01695239|37839115|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
16866322|NCT01695239|37839116|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
16866323|NCT01695239|37839117|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
16866324|NCT01695239|37839118|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866325|NCT01695239|37839119|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866326|NCT01695239|37839120|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866327|NCT01695239|37839121|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866328|NCT01695239|37839122|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866329|NCT01695239|37839123|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866330|NCT01695239|37839124|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866331|NCT01695239|37839125|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866332|NCT01695239|37839126|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866333|NCT01695239|37839127|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16866334|NCT01695239|37839114|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
16866335|NCT01695239|37839115|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866336|NCT01695239|37839116|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
16866337|NCT01695239|37839117|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866338|NCT01695239|37839118|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866339|NCT01695239|37839119|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866340|NCT01695239|37839120|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866341|NCT01695239|37839121|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866342|NCT01695239|37839122|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16944879|NCT01097629|38088900|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
16944880|NCT01097629|38088901|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
16944881|NCT01097629|38088902|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
16944882|NCT01097629|38088903|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16944883|NCT01097629|38088904|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16944884|NCT01097629|38088905|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16866343|NCT01695239|37839123|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866344|NCT01695239|37839124|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866345|NCT01695239|37839125|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866346|NCT01695239|37839126|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866347|NCT01695239|37839127|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16866348|NCT01695239|37839114|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
16866349|NCT01695239|37839115|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
16866350|NCT01695239|37839116|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
16866351|NCT01695239|37839117|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866352|NCT01695239|37839118|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866353|NCT01695239|37839119|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866354|NCT01695239|37839120|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866355|NCT01695239|37839121|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866356|NCT01695239|37839122|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866357|NCT01695239|37839123|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866358|NCT01695239|37839124|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16944885|NCT01097629|38088906|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16944886|NCT01097629|38088907|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16866359|NCT01695239|37839125|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866360|NCT01695239|37839126|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866361|NCT01695239|37839127|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16866362|NCT01695239|37839114|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
16866363|NCT01695239|37839115|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866364|NCT01695239|37839116|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
16866365|NCT01695239|37839117|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866366|NCT01695239|37839118|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866367|NCT01695239|37839119|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866368|NCT01695239|37839120|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866369|NCT01695239|37839121|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866370|NCT01695239|37839122|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866371|NCT01695239|37839123|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866372|NCT01695239|37839124|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866373|NCT01695239|37839125|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866374|NCT01695239|37839126|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866375|NCT01695239|37839127|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16866376|NCT01695239|37839114|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
16866377|NCT01695239|37839115|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866378|NCT01695239|37839116|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
16866379|NCT01695239|37839117|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866380|NCT01695239|37839118|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866381|NCT01695239|37839119|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866382|NCT01695239|37839120|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866383|NCT01695239|37839121|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866384|NCT01695239|37839122|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866385|NCT01695239|37839123|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866386|NCT01695239|37839124|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866387|NCT01695239|37839125|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866388|NCT01695239|37839126|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866389|NCT01695239|37839127|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16866390|NCT01695239|37839114|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
16866391|NCT01695239|37839115|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866392|NCT01695239|37839116|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866393|NCT01695239|37839117|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866394|NCT01695239|37839118|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866395|NCT01695239|37839119|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866396|NCT01695239|37839120|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866397|NCT01695239|37839121|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866398|NCT01695239|37839122|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866399|NCT01695239|37839123|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866400|NCT01695239|37839124|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866401|NCT01695239|37839125|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866402|NCT01695239|37839126|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866403|NCT01695239|37839127|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16866404|NCT01695239|37839114|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866405|NCT01695239|37839115|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866406|NCT01695239|37839116|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866407|NCT01695239|37839117|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866408|NCT01695239|37839118|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866409|NCT01695239|37839119|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866410|NCT01695239|37839120|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866411|NCT01695239|37839121|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
16866412|NCT01695239|37839122|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866413|NCT01695239|37839123|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866414|NCT01695239|37839124|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866415|NCT01695239|37839125|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866416|NCT01695239|37839126|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866417|NCT01695239|37839127|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16866418|NCT01695239|37839114|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866419|NCT01695239|37839115|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866420|NCT01695239|37839116|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866421|NCT01695239|37839117|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866422|NCT01695239|37839118|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866423|NCT01695239|37839119|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866424|NCT01695239|37839120|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866425|NCT01695239|37839121|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
16866426|NCT01695239|37839122|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866427|NCT01695239|37839123|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866428|NCT01695239|37839124|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866429|NCT01695239|37839125|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866430|NCT01695239|37839126|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866431|NCT01695239|37839127|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16866432|NCT01695239|37839114|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866433|NCT01695239|37839115|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866434|NCT01695239|37839116|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866435|NCT01695239|37839117|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866436|NCT01695239|37839118|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866437|NCT01695239|37839119|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866438|NCT01695239|37839120|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866439|NCT01695239|37839121|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
16866440|NCT01695239|37839122|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866441|NCT01695239|37839123|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866442|NCT01695239|37839124|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866443|NCT01695239|37839125|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866444|NCT01695239|37839126|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866445|NCT01695239|37839127|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16866446|NCT01695239|37839114|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866447|NCT01695239|37839115|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866448|NCT01695239|37839116|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866449|NCT01695239|37839117|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866450|NCT01695239|37839118|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866451|NCT01695239|37839119|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866452|NCT01695239|37839120|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866453|NCT01695239|37839121|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866454|NCT01695239|37839122|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
16866455|NCT01695239|37839123|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
16866456|NCT01695239|37839124|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866457|NCT01695239|37839125|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866458|NCT01695239|37839126|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866459|NCT01695239|37839127|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16866460|NCT01695239|37839114|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
16866461|NCT01695239|37839115|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
16866462|NCT01695239|37839116|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
16866463|NCT01695239|37839117|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
16866464|NCT01695239|37839118|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
16866465|NCT01695239|37839119|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
16866466|NCT01695239|37839120|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
16866467|NCT01695239|37839121|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
16866468|NCT01695239|37839122|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
16866469|NCT01695239|37839123|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
16866470|NCT01695239|37839124|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
16866471|NCT01695239|37839125|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
16866472|NCT01695239|37839126|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
16866473|NCT01695239|37839127|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
16866474|NCT01695239|37839114|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866475|NCT01695239|37839115|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866476|NCT01695239|37839116|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866477|NCT01695239|37839117|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866478|NCT01695239|37839118|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866479|NCT01695239|37839119|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866480|NCT01695239|37839120|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866481|NCT01695239|37839121|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866482|NCT01695239|37839122|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
16866483|NCT01695239|37839123|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
16866484|NCT01695239|37839124|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866485|NCT01695239|37839125|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866486|NCT01695239|37839126|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866487|NCT01695239|37839127|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16866488|NCT01695239|37839114|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
16866489|NCT01695239|37839115|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
16866490|NCT01695239|37839116|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
16866491|NCT01695239|37839117|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
16866492|NCT01695239|37839118|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
16866493|NCT01695239|37839119|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
16866494|NCT01695239|37839120|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
16866495|NCT01695239|37839121|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
16866496|NCT01695239|37839122|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
16866497|NCT01695239|37839123|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
16866498|NCT01695239|37839124|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
16866499|NCT01695239|37839125|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
16866500|NCT01695239|37839126|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
16866501|NCT01695239|37839127|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
16866502|NCT01695239|37839114|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866503|NCT01695239|37839115|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866504|NCT01695239|37839116|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866505|NCT01695239|37839117|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866506|NCT01695239|37839118|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866507|NCT01695239|37839119|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866508|NCT01695239|37839120|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866509|NCT01695239|37839121|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866510|NCT01695239|37839122|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
16866511|NCT01695239|37839123|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
16866512|NCT01695239|37839124|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866513|NCT01695239|37839125|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866514|NCT01695239|37839126|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866515|NCT01695239|37839127|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16866516|NCT01695239|37839114|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866517|NCT01695239|37839115|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866518|NCT01695239|37839116|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866519|NCT01695239|37839117|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866520|NCT01695239|37839118|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866521|NCT01695239|37839119|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866522|NCT01695239|37839120|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866523|NCT01695239|37839121|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866524|NCT01695239|37839122|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
16866525|NCT01695239|37839123|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
16866526|NCT01695239|37839124|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866527|NCT01695239|37839125|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866528|NCT01695239|37839126|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866529|NCT01695239|37839127|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16866530|NCT01695239|37839114|FG000|Extension Long-Term Extension Periods|Death|0|||
16866531|NCT01695239|37839115|FG001|Extension Long-Term Extension Periods|Death|0|||
16866532|NCT01695239|37839116|FG002|Extension Long-Term Extension Periods|Death|0|||
16866533|NCT01695239|37839117|FG003|Extension Long-Term Extension Periods|Death|0|||
16866534|NCT01695239|37839118|FG004|Extension Long-Term Extension Periods|Death|0|||
16866535|NCT01695239|37839119|FG005|Extension Long-Term Extension Periods|Death|0|||
16866536|NCT01695239|37839120|FG006|Extension Long-Term Extension Periods|Death|0|||
16866537|NCT01695239|37839121|FG007|Extension Long-Term Extension Periods|Death|0|||
16866538|NCT01695239|37839122|FG008|Extension Long-Term Extension Periods|Death|1|||
16866539|NCT01695239|37839123|FG009|Extension Long-Term Extension Periods|Death|0|||
16866540|NCT01695239|37839124|FG010|Extension Long-Term Extension Periods|Death|0|||
16866541|NCT01695239|37839125|FG011|Extension Long-Term Extension Periods|Death|0|||
16866542|NCT01695239|37839126|FG012|Extension Long-Term Extension Periods|Death|0|||
16866543|NCT01695239|37839127|FG013|Extension Long-Term Extension Periods|Death|0|||
16866544|NCT01695239|37839114|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866545|NCT01695239|37839115|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866546|NCT01695239|37839116|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866547|NCT01695239|37839117|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866548|NCT01695239|37839118|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866549|NCT01695239|37839119|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866550|NCT01695239|37839120|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866551|NCT01695239|37839121|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866552|NCT01695239|37839122|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866553|NCT01695239|37839123|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866554|NCT01695239|37839124|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16866555|NCT01695239|37839125|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
16866556|NCT01695239|37839126|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
16866557|NCT01695239|37839127|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
16866558|NCT01695239|37839114|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866559|NCT01695239|37839115|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866560|NCT01695239|37839116|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866561|NCT01695239|37839117|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866562|NCT01695239|37839118|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866563|NCT01695239|37839119|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866564|NCT01695239|37839120|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866565|NCT01695239|37839121|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866566|NCT01695239|37839122|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866567|NCT01695239|37839123|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866568|NCT01695239|37839124|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866569|NCT01695239|37839125|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16866570|NCT01695239|37839126|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
16866571|NCT01695239|37839127|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
16866572|NCT01695239|37839114|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866573|NCT01695239|37839115|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866574|NCT01695239|37839116|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866575|NCT01695239|37839117|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866576|NCT01695239|37839118|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866577|NCT01695239|37839119|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866578|NCT01695239|37839120|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866579|NCT01695239|37839121|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866580|NCT01695239|37839122|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866581|NCT01695239|37839123|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866582|NCT01695239|37839124|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866583|NCT01695239|37839125|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866584|NCT01695239|37839126|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
16866585|NCT01695239|37839127|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
16866586|NCT01695239|37839114|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866587|NCT01695239|37839115|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866588|NCT01695239|37839116|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866589|NCT01695239|37839117|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866590|NCT01695239|37839118|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866591|NCT01695239|37839119|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866592|NCT01695239|37839120|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866593|NCT01695239|37839121|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866594|NCT01695239|37839122|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866595|NCT01695239|37839123|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866596|NCT01695239|37839124|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16782508|NCT02063854|37722107|FG004|Overall Study|Major Protocol Deviation|0|||
16782509|NCT02063854|37722108|FG005|Overall Study|Major Protocol Deviation|0|||
16782510|NCT02063854|37722109|FG006|Overall Study|Major Protocol Deviation|0|||
16782511|NCT02063854|37722103|FG000|Overall Study|Voluntary Withdrawal|2|||
16782512|NCT02063854|37722104|FG001|Overall Study|Voluntary Withdrawal|0|||
16782513|NCT02063854|37722105|FG002|Overall Study|Voluntary Withdrawal|8|||
16782514|NCT02063854|37722106|FG003|Overall Study|Voluntary Withdrawal|1|||
16782515|NCT02063854|37722107|FG004|Overall Study|Voluntary Withdrawal|3|||
16782516|NCT02063854|37722108|FG005|Overall Study|Voluntary Withdrawal|6|||
16782517|NCT02063854|37722109|FG006|Overall Study|Voluntary Withdrawal|1|||
16782518|NCT02063854|37722103|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
16782519|NCT02063854|37722104|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
16782520|NCT02063854|37722105|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
16782521|NCT02063854|37722106|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
16782522|NCT02063854|37722107|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
16782523|NCT02063854|37722108|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
16782524|NCT02063854|37722109|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
16782525|NCT02063854|37722103|FG000|Overall Study|Reason Not Specified|1|||
16782526|NCT02063854|37722104|FG001|Overall Study|Reason Not Specified|0|||
16782527|NCT02063854|37722105|FG002|Overall Study|Reason Not Specified|0|||
16782528|NCT02063854|37722106|FG003|Overall Study|Reason Not Specified|0|||
16782529|NCT02063854|37722107|FG004|Overall Study|Reason Not Specified|0|||
16782530|NCT02063854|37722108|FG005|Overall Study|Reason Not Specified|0|||
16782531|NCT02063854|37722109|FG006|Overall Study|Reason Not Specified|0|||
16782532|NCT02063854|37722103|FG000|Overall Study|Did Not Receive Study Drug|0|||
16782533|NCT02063854|37722104|FG001|Overall Study|Did Not Receive Study Drug|0|||
16782534|NCT02063854|37722105|FG002|Overall Study|Did Not Receive Study Drug|0|||
16782535|NCT02063854|37722106|FG003|Overall Study|Did Not Receive Study Drug|0|||
16782536|NCT02063854|37722107|FG004|Overall Study|Did Not Receive Study Drug|0|||
16782537|NCT02063854|37722108|FG005|Overall Study|Did Not Receive Study Drug|1|||
16782538|NCT02063854|37722109|FG006|Overall Study|Did Not Receive Study Drug|0|||
16782539|NCT02063698|37722129|FG000|Overall Study|did not complete booklet for days 2-8|1|||
16782540|NCT02063698|37722130|FG001|Overall Study|did not complete booklet for days 2-8|2|||
16782541|NCT02062450|37722138|FG000|Overall Study|No follow-up visit|124|||
16782542|NCT02561247|37722146|FG000|Overall Study|Protocol Violation|1|||
16782543|NCT02561247|37722146|FG000|Overall Study|Withdrawal by Subject|1|||
16866597|NCT01695239|37839125|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866598|NCT01695239|37839126|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16866599|NCT01695239|37839127|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
16866600|NCT02163694|37839151|FG000|Overall Study|Adverse event- related to progression|3|||
16866601|NCT02163694|37839152|FG001|Overall Study|Adverse event- related to progression|8|||
16866602|NCT02163694|37839151|FG000|Overall Study|Adverse event- not related to progression|7|||
16866603|NCT02163694|37839152|FG001|Overall Study|Adverse event- not related to progression|17|||
16866604|NCT02163694|37839151|FG000|Overall Study|Withdrew consent|8|||
16866605|NCT02163694|37839152|FG001|Overall Study|Withdrew consent|21|||
16866606|NCT02163694|37839151|FG000|Overall Study|Lost to Follow-up|1|||
16866607|NCT02163694|37839152|FG001|Overall Study|Lost to Follow-up|2|||
16866608|NCT02163694|37839151|FG000|Overall Study|Progressive disease per protocol|122|||
16866609|NCT02163694|37839152|FG001|Overall Study|Progressive disease per protocol|197|||
16866610|NCT02163694|37839151|FG000|Overall Study|Other, not specified|13|||
16866611|NCT02163694|37839152|FG001|Overall Study|Other, not specified|22|||
16866612|NCT01694849|37839186|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
16866613|NCT01694849|37839187|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
16866614|NCT01694849|37839188|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
16866615|NCT01694849|37839186|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
16866616|NCT01694849|37839187|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
16866617|NCT01694849|37839188|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
16866618|NCT01694849|37839186|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
16866619|NCT01694849|37839187|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
16866620|NCT01694849|37839188|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
16866621|NCT01694849|37839186|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
16866622|NCT01694849|37839187|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
16866623|NCT01694849|37839188|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
16866624|NCT01694849|37839186|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
16866625|NCT01694849|37839187|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
16866626|NCT01694849|37839188|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
16866627|NCT01694849|37839186|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
16866628|NCT01694849|37839187|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
16866629|NCT01694849|37839188|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
16866630|NCT01694849|37839186|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
16866631|NCT01694849|37839187|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
16866632|NCT01694849|37839188|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
16866633|NCT01694849|37839186|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
16866634|NCT01694849|37839187|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
16866635|NCT01694849|37839188|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
16866636|NCT01694771|37839237|FG000|Overall Study|Adverse Event|18|||
16866637|NCT01694771|37839238|FG001|Overall Study|Adverse Event|16|||
16866638|NCT01694771|37839237|FG000|Overall Study|Lack of Efficacy|1|||
16866639|NCT01694771|37839238|FG001|Overall Study|Lack of Efficacy|0|||
16866640|NCT01694771|37839237|FG000|Overall Study|Non compliance protocol|7|||
16866641|NCT01694771|37839238|FG001|Overall Study|Non compliance protocol|6|||
16866642|NCT01694771|37839237|FG000|Overall Study|Lost to Follow-up|2|||
16866643|NCT01694771|37839238|FG001|Overall Study|Lost to Follow-up|3|||
16866644|NCT01694771|37839237|FG000|Overall Study|Consent withdrawn|7|||
16866645|NCT01694771|37839238|FG001|Overall Study|Consent withdrawn|9|||
16866646|NCT01694771|37839237|FG000|Overall Study|Other reasons|5|||
16866647|NCT01694771|37839238|FG001|Overall Study|Other reasons|6|||
16866648|NCT01582061|37839267|FG000|Overall Study|Lack of Efficacy|3|||
16866649|NCT01582061|37839268|FG001|Overall Study|Lack of Efficacy|23|||
16866650|NCT01582061|37839267|FG000|Overall Study|Adverse Event|12|||
16866651|NCT01582061|37839268|FG001|Overall Study|Adverse Event|8|||
16866652|NCT01582061|37839267|FG000|Overall Study|Withdrawal by Subject|10|||
16774029|NCT02432846|37713258|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
16774030|NCT02432846|37713259|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
16774031|NCT02432846|37713260|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
16774032|NCT02432846|37713261|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
16774033|NCT02432846|37713262|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
16774034|NCT02432846|37713257|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
16774035|NCT02432846|37713258|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
16774036|NCT02432846|37713259|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
16866653|NCT01582061|37839268|FG001|Overall Study|Withdrawal by Subject|4|||
16866654|NCT01582061|37839267|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16866655|NCT01582061|37839268|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16866656|NCT01582061|37839267|FG000|Overall Study|Death|0|||
16866657|NCT01582061|37839268|FG001|Overall Study|Death|1|||
16866658|NCT01582061|37839267|FG000|Overall Study|condition no longer requires study drug|1|||
16866659|NCT01582061|37839268|FG001|Overall Study|condition no longer requires study drug|0|||
16866660|NCT01582061|37839267|FG000|Overall Study|Lost to Follow-up|1|||
16866661|NCT01582061|37839268|FG001|Overall Study|Lost to Follow-up|0|||
16866662|NCT01693523|37839287|FG000|Overall Study|Adverse Event|2|||
16866663|NCT01693523|37839288|FG001|Overall Study|Adverse Event|1|||
16866664|NCT01693523|37839289|FG002|Overall Study|Adverse Event|0|||
16866665|NCT01693523|37839287|FG000|Overall Study|Death|0|||
16866666|NCT01693523|37839288|FG001|Overall Study|Death|1|||
16866667|NCT01693523|37839289|FG002|Overall Study|Death|1|||
16866668|NCT01693523|37839287|FG000|Overall Study|Lost to Follow-up|0|||
16866669|NCT01693523|37839288|FG001|Overall Study|Lost to Follow-up|0|||
16866670|NCT01693523|37839289|FG002|Overall Study|Lost to Follow-up|4|||
16866671|NCT01693523|37839287|FG000|Overall Study|Physician Decision|0|||
16866672|NCT01693523|37839288|FG001|Overall Study|Physician Decision|0|||
16866673|NCT01693523|37839289|FG002|Overall Study|Physician Decision|1|||
16866674|NCT01693523|37839287|FG000|Overall Study|Withdrawal by Subject|1|||
16866675|NCT01693523|37839288|FG001|Overall Study|Withdrawal by Subject|2|||
16866676|NCT01693523|37839289|FG002|Overall Study|Withdrawal by Subject|2|||
16866677|NCT01693523|37839287|FG000|Overall Study|Lack of compliance study medication|1|||
16866678|NCT01693523|37839288|FG001|Overall Study|Lack of compliance study medication|2|||
16866679|NCT01693523|37839289|FG002|Overall Study|Lack of compliance study medication|0|||
16866680|NCT01693523|37839287|FG000|Overall Study|Chemotherapy was held|1|||
16866681|NCT01693523|37839288|FG001|Overall Study|Chemotherapy was held|2|||
16866682|NCT01693523|37839289|FG002|Overall Study|Chemotherapy was held|0|||
16866683|NCT01581593|37839305|FG000|Overall Study|Withdrawal by Subject|1|||
16866684|NCT01581281|37839316|FG000|Overall Study|Early Study Closure|15|||
16866685|NCT01581281|37839317|FG001|Overall Study|Early Study Closure|6|||
16866686|NCT01581281|37839318|FG002|Overall Study|Early Study Closure|12|||
16866687|NCT02692716|37839329|FG000|Overall Study|Lost to Follow-up|2|||
16866688|NCT02692716|37839330|FG001|Overall Study|Lost to Follow-up|5|||
16866689|NCT02692716|37839329|FG000|Overall Study|Withdrawal by Subject|3|||
16866690|NCT02692716|37839330|FG001|Overall Study|Withdrawal by Subject|1|||
16866691|NCT01580969|37839339|FG000|Overall Study|Physician Decision|3|||
16866692|NCT01580969|37839340|FG001|Overall Study|Physician Decision|0|||
16866693|NCT01580969|37839341|FG002|Overall Study|Physician Decision|0|||
16866694|NCT01693367|37839351|FG000|Overall Study|Withdrawal by Subject|1|||
16866695|NCT01693367|37839352|FG001|Overall Study|Withdrawal by Subject|1|||
16866696|NCT01693367|37839351|FG000|Overall Study|Physician Decision|0|||
16866697|NCT01693367|37839352|FG001|Overall Study|Physician Decision|1|||
16866698|NCT02696226|37839362|FG000|Overall Study|Study terminated - lack of enrollment|1|||
16866699|NCT02696226|37839363|FG001|Overall Study|Study terminated - lack of enrollment|0|||
16866700|NCT02696226|37839364|FG002|Overall Study|Study terminated - lack of enrollment|2|||
16866701|NCT02696226|37839365|FG003|Overall Study|Study terminated - lack of enrollment|0|||
16866702|NCT01692275|37839381|FG000|Overall Study|Lost to Follow-up|57|||
16866703|NCT01692275|37839382|FG001|Overall Study|Lost to Follow-up|48|||
16866704|NCT01692275|37839381|FG000|Overall Study|Withdrawal by Subject|9|||
16866705|NCT01692275|37839382|FG001|Overall Study|Withdrawal by Subject|11|||
16866706|NCT02692560|37839402|FG000|Overall Study|Withdrawal by Subject|0|||
16866707|NCT02692560|37839403|FG001|Overall Study|Withdrawal by Subject|6|||
16866708|NCT02688192|37839411|FG000|Overall Study|Lost to Follow-up|11|||
16866709|NCT02688192|37839412|FG001|Overall Study|Lost to Follow-up|5|||
16866710|NCT02688192|37839411|FG000|Overall Study|Physician Decision|1|||
16866711|NCT02688192|37839412|FG001|Overall Study|Physician Decision|0|||
16866712|NCT01579565|37839421|FG000|Randomized|Adverse Event|1|||
16866713|NCT01579565|37839422|FG001|Randomized|Adverse Event|3|||
16866714|NCT01579565|37839421|FG000|Randomized|Withdrawal by Subject|3|||
16866715|NCT01579565|37839422|FG001|Randomized|Withdrawal by Subject|0|||
16866716|NCT01579565|37839421|FG000|Randomized|inadequate preoperative pupil dilation|0|||
16866717|NCT01579565|37839422|FG001|Randomized|inadequate preoperative pupil dilation|1|||
16866718|NCT01579565|37839421|FG000|Randomized|prohibited preoperative eating|1|||
16866719|NCT01579565|37839422|FG001|Randomized|prohibited preoperative eating|0|||
16866720|NCT01579565|37839421|FG000|Randomized|prohibited preoperative medication|0|||
16866721|NCT01579565|37839422|FG001|Randomized|prohibited preoperative medication|1|||
16866722|NCT01579565|37839421|FG000|Treated|Physician Decision|0|||
16866723|NCT01579565|37839422|FG001|Treated|Physician Decision|1|||
16866724|NCT01579565|37839421|FG000|Treated|Lost to Follow-up|2|||
16866725|NCT01579565|37839422|FG001|Treated|Lost to Follow-up|1|||
16866726|NCT01579565|37839421|FG000|Treated|declined to return for final visit|0|||
16866727|NCT01579565|37839422|FG001|Treated|declined to return for final visit|1|||
16866728|NCT01578785|37839432|FG000|Overall Study|Withdrawal by Subject|0|||
16866729|NCT01578785|37839433|FG001|Overall Study|Withdrawal by Subject|1|||
16866730|NCT01578785|37839432|FG000|Overall Study|Study terminated by sponsor|59|||
16866731|NCT01578785|37839433|FG001|Overall Study|Study terminated by sponsor|118|||
16866732|NCT02692482|37839441|FG000|Overall Study|Death|2|||
16866733|NCT02692482|37839442|FG001|Overall Study|Death|2|||
16866734|NCT02692482|37839441|FG000|Overall Study|Withdrawal by Subject|1|||
16866735|NCT02692482|37839442|FG001|Overall Study|Withdrawal by Subject|2|||
16866736|NCT01578551|37839451|FG000|Overall Study|Adverse Event|1|||
16866737|NCT01578551|37839452|FG001|Overall Study|Adverse Event|0|||
16866738|NCT01692197|37839459|FG000|Overall Study|Failed Screening|3|||
16866739|NCT01692119|37839466|FG000|Overall Study|Protocol Violation|3|||
16866740|NCT01692119|37839467|FG001|Overall Study|Protocol Violation|1|||
16866741|NCT01692119|37839466|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
16866742|NCT01692119|37839467|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
16866743|NCT01691885|37839473|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
16866744|NCT01691885|37839474|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
16866745|NCT01691885|37839473|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
16866746|NCT01691885|37839474|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
16866747|NCT01587703|37839507|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
16866748|NCT01587703|37839508|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866749|NCT01587703|37839509|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866750|NCT01587703|37839510|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866751|NCT01587703|37839511|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866752|NCT01587703|37839512|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866753|NCT01587703|37839513|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866754|NCT01587703|37839514|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866755|NCT01587703|37839515|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866756|NCT01587703|37839516|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866757|NCT01587703|37839517|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866758|NCT01587703|37839518|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866759|NCT01587703|37839519|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866760|NCT01587703|37839520|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866761|NCT01587703|37839521|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866762|NCT01587703|37839522|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866763|NCT01587703|37839523|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866764|NCT01587703|37839524|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866765|NCT01587703|37839525|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16866766|NCT01587703|37839507|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866767|NCT01587703|37839508|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866768|NCT01587703|37839509|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866769|NCT01587703|37839510|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866770|NCT01587703|37839511|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866771|NCT01587703|37839512|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
16866772|NCT01587703|37839513|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866773|NCT01587703|37839514|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
16866774|NCT01587703|37839515|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866775|NCT01587703|37839516|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866776|NCT01587703|37839517|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866777|NCT01587703|37839518|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866778|NCT01587703|37839519|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866779|NCT01587703|37839520|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866780|NCT01587703|37839521|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866781|NCT01587703|37839522|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866782|NCT01587703|37839523|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866783|NCT01587703|37839524|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866784|NCT01587703|37839525|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16866785|NCT01587703|37839507|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866786|NCT01587703|37839508|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866787|NCT01587703|37839509|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866788|NCT01587703|37839510|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866789|NCT01587703|37839511|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866790|NCT01587703|37839512|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866791|NCT01587703|37839513|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
16866792|NCT01587703|37839514|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866793|NCT01587703|37839515|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866794|NCT01587703|37839516|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866795|NCT01587703|37839517|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866796|NCT01587703|37839518|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866797|NCT01587703|37839519|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866798|NCT01587703|37839520|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866799|NCT01587703|37839521|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866800|NCT01587703|37839522|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866801|NCT01587703|37839523|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866802|NCT01587703|37839524|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866803|NCT01587703|37839525|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16866804|NCT01587703|37839507|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
16866805|NCT01587703|37839508|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
16866806|NCT01587703|37839509|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
16866807|NCT01587703|37839510|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
16866808|NCT01587703|37839511|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
16866809|NCT01587703|37839512|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
16866810|NCT01587703|37839513|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
16866811|NCT01587703|37839514|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
16866812|NCT01587703|37839515|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866813|NCT01587703|37839516|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866814|NCT01587703|37839517|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866815|NCT01587703|37839518|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866816|NCT01587703|37839519|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866817|NCT01587703|37839520|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866818|NCT01587703|37839521|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866819|NCT01587703|37839522|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866820|NCT01587703|37839523|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866821|NCT01587703|37839524|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866822|NCT01587703|37839525|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16866823|NCT01587703|37839507|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866824|NCT01587703|37839508|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866825|NCT01587703|37839509|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866826|NCT01587703|37839510|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866827|NCT01587703|37839511|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866828|NCT01587703|37839512|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866829|NCT01587703|37839513|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866830|NCT01587703|37839514|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866831|NCT01587703|37839515|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
16866832|NCT01587703|37839516|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
16866833|NCT01587703|37839517|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
16866834|NCT01587703|37839518|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866835|NCT01587703|37839519|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866836|NCT01587703|37839520|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866837|NCT01587703|37839521|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866838|NCT01587703|37839522|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866839|NCT01587703|37839523|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866840|NCT01587703|37839524|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866841|NCT01587703|37839525|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16866842|NCT01587703|37839507|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866843|NCT01587703|37839508|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866844|NCT01587703|37839509|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866845|NCT01587703|37839510|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866846|NCT01587703|37839511|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866847|NCT01587703|37839512|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866848|NCT01587703|37839513|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16944887|NCT01097629|38088900|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
16866849|NCT01587703|37839514|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866850|NCT01587703|37839515|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
16866851|NCT01587703|37839516|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866852|NCT01587703|37839517|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
16866853|NCT01587703|37839518|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866854|NCT01587703|37839519|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866855|NCT01587703|37839520|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866856|NCT01587703|37839521|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866857|NCT01587703|37839522|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866858|NCT01587703|37839523|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866859|NCT01587703|37839524|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866860|NCT01587703|37839525|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16866861|NCT01587703|37839507|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866862|NCT01587703|37839508|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866863|NCT01587703|37839509|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866864|NCT01587703|37839510|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866865|NCT01587703|37839511|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866866|NCT01587703|37839512|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866867|NCT01587703|37839513|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16944888|NCT01097629|38088901|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
16944889|NCT01097629|38088902|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
16866868|NCT01587703|37839514|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866869|NCT01587703|37839515|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866870|NCT01587703|37839516|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
16866871|NCT01587703|37839517|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
16866872|NCT01587703|37839518|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866873|NCT01587703|37839519|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866874|NCT01587703|37839520|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866875|NCT01587703|37839521|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866876|NCT01587703|37839522|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866877|NCT01587703|37839523|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866878|NCT01587703|37839524|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866879|NCT01587703|37839525|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16866880|NCT01587703|37839507|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866881|NCT01587703|37839508|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866882|NCT01587703|37839509|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866883|NCT01587703|37839510|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866884|NCT01587703|37839511|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866885|NCT01587703|37839512|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866886|NCT01587703|37839513|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866887|NCT01587703|37839514|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866888|NCT01587703|37839515|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
16866889|NCT01587703|37839516|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866890|NCT01587703|37839517|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866891|NCT01587703|37839518|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866892|NCT01587703|37839519|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866893|NCT01587703|37839520|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866894|NCT01587703|37839521|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866895|NCT01587703|37839522|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866896|NCT01587703|37839523|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866897|NCT01587703|37839524|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866898|NCT01587703|37839525|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16866899|NCT01587703|37839507|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866900|NCT01587703|37839508|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866901|NCT01587703|37839509|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866902|NCT01587703|37839510|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866903|NCT01587703|37839511|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866904|NCT01587703|37839512|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866905|NCT01587703|37839513|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866906|NCT01587703|37839514|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866907|NCT01587703|37839515|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866908|NCT01587703|37839516|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866909|NCT01587703|37839517|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866910|NCT01587703|37839518|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866911|NCT01587703|37839519|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866912|NCT01587703|37839520|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866913|NCT01587703|37839521|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866914|NCT01587703|37839522|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866915|NCT01587703|37839523|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866916|NCT01587703|37839524|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16866917|NCT01587703|37839525|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
16866918|NCT01587703|37839507|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866919|NCT01587703|37839508|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866920|NCT01587703|37839509|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866921|NCT01587703|37839510|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866922|NCT01587703|37839511|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866923|NCT01587703|37839512|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866924|NCT01587703|37839513|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866925|NCT01587703|37839514|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866926|NCT01587703|37839515|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866927|NCT01587703|37839516|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866928|NCT01587703|37839517|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866929|NCT01587703|37839518|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866930|NCT01587703|37839519|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866931|NCT01587703|37839520|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866932|NCT01587703|37839521|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866933|NCT01587703|37839522|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866934|NCT01587703|37839523|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16866935|NCT01587703|37839524|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
16866936|NCT01587703|37839525|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
16866937|NCT01587703|37839507|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866938|NCT01587703|37839508|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866939|NCT01587703|37839509|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866940|NCT01587703|37839510|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866941|NCT01587703|37839511|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866942|NCT01587703|37839512|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866943|NCT01587703|37839513|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866944|NCT01587703|37839514|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866945|NCT01587703|37839515|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866946|NCT01587703|37839516|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866947|NCT01587703|37839517|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866948|NCT01587703|37839518|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866949|NCT01587703|37839519|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866950|NCT01587703|37839520|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866951|NCT01587703|37839521|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866952|NCT01587703|37839522|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
16866953|NCT01587703|37839523|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866954|NCT01587703|37839524|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866955|NCT01587703|37839525|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16866956|NCT01587703|37839507|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866957|NCT01587703|37839508|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866958|NCT01587703|37839509|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866959|NCT01587703|37839510|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866960|NCT01587703|37839511|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866961|NCT01587703|37839512|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866962|NCT01587703|37839513|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866963|NCT01587703|37839514|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866964|NCT01587703|37839515|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866965|NCT01587703|37839516|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866966|NCT01587703|37839517|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866967|NCT01587703|37839518|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
16866968|NCT01587703|37839519|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866969|NCT01587703|37839520|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866970|NCT01587703|37839521|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
16866971|NCT01587703|37839522|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866972|NCT01587703|37839523|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866973|NCT01587703|37839524|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866974|NCT01587703|37839525|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16866975|NCT01587703|37839507|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866976|NCT01587703|37839508|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866977|NCT01587703|37839509|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866978|NCT01587703|37839510|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866979|NCT01587703|37839511|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866980|NCT01587703|37839512|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866981|NCT01587703|37839513|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866982|NCT01587703|37839514|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866983|NCT01587703|37839515|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866984|NCT01587703|37839516|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866985|NCT01587703|37839517|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866986|NCT01587703|37839518|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
16866987|NCT01587703|37839519|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
16866988|NCT01587703|37839520|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
16866989|NCT01587703|37839521|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
16866990|NCT01587703|37839522|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
16866991|NCT01587703|37839523|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
16866992|NCT01587703|37839524|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866993|NCT01587703|37839525|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16866994|NCT01587703|37839507|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
16866995|NCT01587703|37839508|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
16866996|NCT01587703|37839509|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
16866997|NCT01587703|37839510|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
16866998|NCT01587703|37839511|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
16866999|NCT01587703|37839512|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
16867000|NCT01587703|37839513|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
16867001|NCT01587703|37839514|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
16867002|NCT01587703|37839515|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
16867003|NCT01587703|37839516|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
16867004|NCT01587703|37839517|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
16867005|NCT01587703|37839518|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
16867006|NCT01587703|37839519|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
16867007|NCT01587703|37839520|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
16867008|NCT01587703|37839521|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
16867009|NCT01587703|37839522|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
16867010|NCT01587703|37839523|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
16867011|NCT01587703|37839524|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
16867012|NCT01587703|37839525|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
16867013|NCT01587703|37839507|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867014|NCT01587703|37839508|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867015|NCT01587703|37839509|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867016|NCT01587703|37839510|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867017|NCT01587703|37839511|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867018|NCT01587703|37839512|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867019|NCT01587703|37839513|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867020|NCT01587703|37839514|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16774037|NCT02432846|37713260|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
16774038|NCT02432846|37713261|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
16774039|NCT02432846|37713262|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
16774040|NCT02432846|37713257|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16774041|NCT02432846|37713258|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16774042|NCT02432846|37713259|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16774043|NCT02432846|37713260|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16774044|NCT02432846|37713261|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
16774045|NCT02432846|37713262|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16774046|NCT02432144|37713275|FG000|Overall Study|Participant Non-Compliance|1|||
16774047|NCT02246998|37713283|FG000|Overall Study|Adverse Event|0|||
16867021|NCT01587703|37839515|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867022|NCT01587703|37839516|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867023|NCT01587703|37839517|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867024|NCT01587703|37839518|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
16867025|NCT01587703|37839519|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867026|NCT01587703|37839520|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867027|NCT01587703|37839521|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867028|NCT01587703|37839522|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867029|NCT01587703|37839523|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867030|NCT01587703|37839524|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867031|NCT01587703|37839525|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16867032|NCT01577381|37839588|FG000|Overall Study|Discontinued|2|||
16867033|NCT01577381|37839589|FG001|Overall Study|Discontinued|1|||
16867034|NCT01577381|37839590|FG002|Overall Study|Discontinued|2|||
16867035|NCT01577381|37839591|FG003|Overall Study|Discontinued|2|||
16867036|NCT01577381|37839588|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
16867037|NCT01577381|37839589|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
16867038|NCT01577381|37839590|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
16867039|NCT01577381|37839591|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
16867040|NCT02686164|37839601|FG000|Overall Study|Adverse Event|1|||
16867041|NCT02686164|37839601|FG000|Overall Study|Withdrawal of consent|1|||
16867042|NCT02686164|37839601|FG000|Overall Study|Clinical progression|1|||
16867043|NCT01691105|37839622|FG000|1 Month Follow-up|Lost to Follow-up|41|||
16867044|NCT01691105|37839623|FG001|1 Month Follow-up|Lost to Follow-up|38|||
16867045|NCT01691105|37839622|FG000|1 Month Follow-up|Death|2|||
16867046|NCT01691105|37839623|FG001|1 Month Follow-up|Death|3|||
16867047|NCT01691105|37839622|FG000|6 Month Follow-up|Lost to Follow-up|39|||
16867048|NCT01691105|37839623|FG001|6 Month Follow-up|Lost to Follow-up|58|||
16867049|NCT01691105|37839622|FG000|6 Month Follow-up|Death|13|||
16867050|NCT01691105|37839623|FG001|6 Month Follow-up|Death|13|||
16867051|NCT01691105|37839622|FG000|12 Month Follow-up|Lost to Follow-up|50|||
16867052|NCT01691105|37839623|FG001|12 Month Follow-up|Lost to Follow-up|71|||
16867053|NCT01691105|37839622|FG000|12 Month Follow-up|Death|22|||
16867054|NCT01691105|37839623|FG001|12 Month Follow-up|Death|30|||
16867055|NCT01691105|37839622|FG000|12 Month Biochemical Verification|Death|22|||
16867056|NCT01691105|37839623|FG001|12 Month Biochemical Verification|Death|30|||
16867057|NCT01691105|37839622|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
16867058|NCT01691105|37839623|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
16867059|NCT01691105|37839622|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
16867060|NCT01691105|37839623|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
16867061|NCT02685072|37839631|FG000|Treatment Period|Lost to Follow-up|12|||
16867062|NCT02685072|37839632|FG001|Treatment Period|Lost to Follow-up|6|||
16867063|NCT02685072|37839631|FG000|Treatment Period|Withdrawal by Subject|1|||
16867064|NCT02685072|37839632|FG001|Treatment Period|Withdrawal by Subject|3|||
16867065|NCT02685072|37839631|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
16867066|NCT02685072|37839632|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
16867067|NCT02695524|37839702|FG000|Overall Study|Lost to Follow-up|3|||
16867068|NCT02695524|37839703|FG001|Overall Study|Lost to Follow-up|2|||
16867069|NCT02695524|37839702|FG000|Overall Study|Death|0|||
16867070|NCT02695524|37839703|FG001|Overall Study|Death|1|||
16867071|NCT01576367|37839709|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16867072|NCT01576367|37839709|FG000|Overall Study|Moved to commercial use after 6 months|1|||
16867073|NCT01689857|37839720|FG000|Overall Study|Lost to Follow-up|5|||
16867074|NCT01689857|37839721|FG001|Overall Study|Lost to Follow-up|2|||
16867075|NCT01587079|37839736|FG000|Overall Study|Protocol-specified criteria|9|||
16867076|NCT01587079|37839736|FG000|Overall Study|Protocol Violation|5|||
16867077|NCT01587079|37839736|FG000|Overall Study|Lost to Follow-up|2|||
16867078|NCT01587079|37839736|FG000|Overall Study|Physician Decision|2|||
16867079|NCT01587079|37839736|FG000|Overall Study|Withdrawal by Subject|7|||
16867080|NCT01587079|37839736|FG000|Overall Study|Adverse Event|14|||
16867081|NCT01587001|37839789|FG000|Overall Study|Lost to Follow-up|2|||
16867082|NCT01587001|37839790|FG001|Overall Study|Lost to Follow-up|0|||
16867083|NCT01587001|37839789|FG000|Overall Study|Insufficient samples to complete testing|4|||
16867084|NCT01587001|37839790|FG001|Overall Study|Insufficient samples to complete testing|1|||
16867085|NCT01568047|37839820|FG000|Overall Study|Ineligibility|1|||
16867086|NCT01568047|37839821|FG001|Overall Study|Ineligibility|0|||
16867087|NCT01568047|37839822|FG002|Overall Study|Ineligibility|0|||
16867088|NCT01568047|37839823|FG003|Overall Study|Ineligibility|0|||
16867089|NCT01568047|37839820|FG000|Overall Study|Withdrawal by Subject|0|||
16867090|NCT01568047|37839821|FG001|Overall Study|Withdrawal by Subject|1|||
16867091|NCT01568047|37839822|FG002|Overall Study|Withdrawal by Subject|0|||
16867092|NCT01568047|37839823|FG003|Overall Study|Withdrawal by Subject|0|||
16867093|NCT01568047|37839820|FG000|Overall Study|Adverse Event|0|||
16867094|NCT01568047|37839821|FG001|Overall Study|Adverse Event|0|||
16867095|NCT01568047|37839822|FG002|Overall Study|Adverse Event|1|||
16867096|NCT01568047|37839823|FG003|Overall Study|Adverse Event|1|||
16867097|NCT02694978|37839835|FG000|Overall Study|Adverse Event|10|||
16867098|NCT02694978|37839836|FG001|Overall Study|Adverse Event|9|||
16867099|NCT02694978|37839835|FG000|Overall Study|Withdrawal by Subject|22|||
16867100|NCT02694978|37839836|FG001|Overall Study|Withdrawal by Subject|19|||
16867101|NCT02694978|37839835|FG000|Overall Study|Lost to Follow-up|14|||
16867102|NCT02694978|37839836|FG001|Overall Study|Lost to Follow-up|17|||
16867103|NCT02694978|37839835|FG000|Overall Study|Death|4|||
16867104|NCT02694978|37839836|FG001|Overall Study|Death|1|||
16867105|NCT02694978|37839835|FG000|Overall Study|Other-Decision of Participant|6|||
16867106|NCT02694978|37839836|FG001|Overall Study|Other-Decision of Participant|1|||
16867107|NCT02694978|37839835|FG000|Overall Study|Other-Investigator's decision|1|||
16867108|NCT02694978|37839836|FG001|Overall Study|Other-Investigator's decision|0|||
16867109|NCT02694978|37839835|FG000|Overall Study|Other-Unable to be reached|0|||
16867110|NCT02694978|37839836|FG001|Overall Study|Other-Unable to be reached|1|||
16867111|NCT02694978|37839835|FG000|Overall Study|Other-Protocol noncompliant|2|||
16867112|NCT02694978|37839836|FG001|Overall Study|Other-Protocol noncompliant|1|||
16867113|NCT02694978|37839835|FG000|Overall Study|Other-Personal reasons|3|||
16867114|NCT02694978|37839836|FG001|Overall Study|Other-Personal reasons|3|||
16867115|NCT02694978|37839835|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
16867116|NCT02694978|37839836|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
16867117|NCT01688999|37839845|FG000|Overall Study|Withdrawal by Subject|5|||
16867118|NCT01688999|37839846|FG001|Overall Study|Withdrawal by Subject|1|||
16867119|NCT01688999|37839847|FG002|Overall Study|Withdrawal by Subject|1|||
16867120|NCT01688999|37839845|FG000|Overall Study|Adverse Event|2|||
16867121|NCT01688999|37839846|FG001|Overall Study|Adverse Event|0|||
16867122|NCT01688999|37839847|FG002|Overall Study|Adverse Event|2|||
16867123|NCT01688999|37839845|FG000|Overall Study|Ineligible/Not treated|1|||
16867124|NCT01688999|37839846|FG001|Overall Study|Ineligible/Not treated|0|||
16867125|NCT01688999|37839847|FG002|Overall Study|Ineligible/Not treated|0|||
16867126|NCT01541917|37839871|FG000|Overall Study|Lost to Follow-up|2|||
16867127|NCT01541917|37839872|FG001|Overall Study|Lost to Follow-up|2|||
16867128|NCT01541917|37839871|FG000|Overall Study|Withdrawal by Subject|13|||
16867129|NCT01541917|37839872|FG001|Overall Study|Withdrawal by Subject|7|||
16867130|NCT01688921|37839892|FG000|Overall Study|Lost to Follow-up|7|||
16867131|NCT01688921|37839893|FG001|Overall Study|Lost to Follow-up|13|||
16867132|NCT01688921|37839892|FG000|Overall Study|Physician Decision|6|||
16867133|NCT01688921|37839893|FG001|Overall Study|Physician Decision|1|||
16867134|NCT01688921|37839892|FG000|Overall Study|Protocol Violation|0|||
16867135|NCT01688921|37839893|FG001|Overall Study|Protocol Violation|1|||
16867136|NCT01688921|37839892|FG000|Overall Study|informed consent|3|||
16867137|NCT01688921|37839893|FG001|Overall Study|informed consent|0|||
16867138|NCT01541371|37839915|FG000|Overall Study|Withdrawal by Subject|14|||
16867139|NCT01541371|37839915|FG000|Overall Study|Lost to Follow-up|21|||
16867140|NCT01541371|37839915|FG000|Overall Study|Adverse Event|15|||
16867141|NCT01541371|37839915|FG000|Overall Study|Lack of Efficacy|12|||
16867142|NCT01541371|37839915|FG000|Overall Study|Protocol Violation|6|||
16867143|NCT01541371|37839915|FG000|Overall Study|Study medication non-compliance|3|||
16867144|NCT01541371|37839915|FG000|Overall Study|Other|6|||
16867145|NCT01687673|37839948|FG000|Overall Study|Physician Decision|1|||
16867146|NCT01687595|37840037|FG000|Overall Study|Withdrawal by Subject|8|||
16867147|NCT01687595|37840038|FG001|Overall Study|Withdrawal by Subject|0|||
16867148|NCT01687595|37840037|FG000|Overall Study|Lost to Follow-up|3|||
16867149|NCT01687595|37840038|FG001|Overall Study|Lost to Follow-up|1|||
16867150|NCT01687595|37840037|FG000|Overall Study|Investigator's decision|1|||
16867151|NCT01687595|37840038|FG001|Overall Study|Investigator's decision|0|||
16867152|NCT01687595|37840037|FG000|Overall Study|Sponsor's decision|1|||
16867153|NCT01687595|37840038|FG001|Overall Study|Sponsor's decision|0|||
16867154|NCT01687595|37840037|FG000|Overall Study|Noncompliance|1|||
16867155|NCT01687595|37840038|FG001|Overall Study|Noncompliance|2|||
16867156|NCT01687595|37840037|FG000|Overall Study|Other than specified|56|||
16867157|NCT01687595|37840038|FG001|Overall Study|Other than specified|7|||
16867158|NCT01687283|37840046|FG000|Overall Study|Adverse Event|11|||
16867159|NCT01687283|37840047|FG001|Overall Study|Adverse Event|4|||
16867160|NCT01687283|37840046|FG000|Overall Study|Lack of Efficacy|3|||
16867161|NCT01687283|37840047|FG001|Overall Study|Lack of Efficacy|1|||
16867162|NCT01687283|37840046|FG000|Overall Study|Protocol Violation|1|||
16867163|NCT01687283|37840047|FG001|Overall Study|Protocol Violation|3|||
16867164|NCT01687283|37840046|FG000|Overall Study|protocol defined stopping criteria|8|||
16867165|NCT01687283|37840047|FG001|Overall Study|protocol defined stopping criteria|10|||
16867166|NCT01687283|37840046|FG000|Overall Study|Lost to Follow-up|1|||
16867167|NCT01687283|37840047|FG001|Overall Study|Lost to Follow-up|1|||
16867168|NCT01687283|37840046|FG000|Overall Study|Investigator discretion|2|||
16867169|NCT01687283|37840047|FG001|Overall Study|Investigator discretion|0|||
16867170|NCT01687283|37840046|FG000|Overall Study|Withdrawal by Subject|9|||
16867171|NCT01687283|37840047|FG001|Overall Study|Withdrawal by Subject|8|||
16867172|NCT02684370|37840056|FG000|Part A|Adverse Event|2|||
16867173|NCT02684370|37840057|FG001|Part A|Adverse Event|0|||
16867174|NCT02684370|37840058|FG002|Part A|Adverse Event|1|||
16867175|NCT02684370|37840059|FG003|Part A|Adverse Event|0|||
16867176|NCT02684370|37840060|FG004|Part A|Adverse Event|0|||
16867177|NCT02684370|37840061|FG005|Part A|Adverse Event|0|||
16867178|NCT02684370|37840056|FG000|Part A|Lost to Follow-up|1|||
16867179|NCT02684370|37840057|FG001|Part A|Lost to Follow-up|1|||
16867180|NCT02684370|37840058|FG002|Part A|Lost to Follow-up|0|||
16867181|NCT02684370|37840059|FG003|Part A|Lost to Follow-up|0|||
16867182|NCT02684370|37840060|FG004|Part A|Lost to Follow-up|0|||
16867183|NCT02684370|37840061|FG005|Part A|Lost to Follow-up|0|||
16867184|NCT02684370|37840056|FG000|Part A|Subject Withdrawal|1|||
16867185|NCT02684370|37840057|FG001|Part A|Subject Withdrawal|0|||
16867186|NCT02684370|37840058|FG002|Part A|Subject Withdrawal|3|||
16867187|NCT02684370|37840059|FG003|Part A|Subject Withdrawal|0|||
16867188|NCT02684370|37840060|FG004|Part A|Subject Withdrawal|0|||
16867189|NCT02684370|37840061|FG005|Part A|Subject Withdrawal|0|||
16867190|NCT02684370|37840056|FG000|Part A|Other|0|||
16867191|NCT02684370|37840057|FG001|Part A|Other|0|||
16867192|NCT02684370|37840058|FG002|Part A|Other|1|||
16867193|NCT02684370|37840059|FG003|Part A|Other|0|||
16867194|NCT02684370|37840060|FG004|Part A|Other|0|||
16867195|NCT02684370|37840061|FG005|Part A|Other|0|||
16867196|NCT02684370|37840056|FG000|Part B|Adverse Event|0|||
16867197|NCT02684370|37840057|FG001|Part B|Adverse Event|0|||
16867198|NCT02684370|37840058|FG002|Part B|Adverse Event|0|||
16867199|NCT02684370|37840059|FG003|Part B|Adverse Event|0|||
16867200|NCT02684370|37840060|FG004|Part B|Adverse Event|2|||
16867201|NCT02684370|37840061|FG005|Part B|Adverse Event|1|||
16867202|NCT02684370|37840056|FG000|Part B|Lost to Follow-up|0|||
16867203|NCT02684370|37840057|FG001|Part B|Lost to Follow-up|0|||
16867204|NCT02684370|37840058|FG002|Part B|Lost to Follow-up|0|||
16867205|NCT02684370|37840059|FG003|Part B|Lost to Follow-up|1|||
16867206|NCT02684370|37840060|FG004|Part B|Lost to Follow-up|2|||
16867207|NCT02684370|37840061|FG005|Part B|Lost to Follow-up|5|||
16867208|NCT02684370|37840056|FG000|Part B|Subject Withdrawal|0|||
16867209|NCT02684370|37840057|FG001|Part B|Subject Withdrawal|0|||
16867210|NCT02684370|37840058|FG002|Part B|Subject Withdrawal|0|||
16867211|NCT02684370|37840059|FG003|Part B|Subject Withdrawal|1|||
16867212|NCT02684370|37840060|FG004|Part B|Subject Withdrawal|1|||
16867213|NCT02684370|37840061|FG005|Part B|Subject Withdrawal|2|||
16867214|NCT01686581|37840088|FG000|Overall Study|Side-effects or Health Problems|15|||
16867215|NCT01686581|37840088|FG000|Overall Study|Lack of Efficacy|90|||
16867216|NCT01686581|37840088|FG000|Overall Study|Participant Concerned about Risks|6|||
16867217|NCT01686581|37840088|FG000|Overall Study|Thinks Injections Too Painful|8|||
16867218|NCT01686581|37840088|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
16867219|NCT01686581|37840088|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
16867220|NCT01686581|37840088|FG000|Overall Study|Thinks it is Inconvenient|17|||
16867221|NCT01686581|37840088|FG000|Overall Study|Other Miscellaneous Reasons|36|||
16867222|NCT01686581|37840088|FG000|Overall Study|Reason Missing|1|||
16867223|NCT02691936|37840106|FG000|Overall Study|Withdrawal by Subject|2|||
16867224|NCT02691936|37840107|FG001|Overall Study|Withdrawal by Subject|5|||
16867225|NCT01685801|37840154|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
16867226|NCT01685801|37840155|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
16867227|NCT01685801|37840156|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
16867228|NCT01685801|37840157|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
16867229|NCT01685801|37840154|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
16867230|NCT01685801|37840155|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
16867231|NCT01685801|37840156|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
16867232|NCT01685801|37840157|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
16867233|NCT01353222|37840176|FG000|Overall Study|Death|30|||
16867234|NCT01353222|37840177|FG001|Overall Study|Death|30|||
16867235|NCT01353222|37840176|FG000|Overall Study|Withdrawal by Subject|8|||
16867236|NCT01353222|37840177|FG001|Overall Study|Withdrawal by Subject|5|||
16867237|NCT01353222|37840176|FG000|Overall Study|Study Terminated|31|||
16867238|NCT01353222|37840177|FG001|Overall Study|Study Terminated|37|||
16867239|NCT01353222|37840176|FG000|Overall Study|Site closed research department|1|||
16867240|NCT01353222|37840177|FG001|Overall Study|Site closed research department|0|||
16867241|NCT01684943|37840207|FG000|Overall Study|Inadequate Venous Access|3|||
16867242|NCT01684943|37840208|FG001|Overall Study|Inadequate Venous Access|0|||
16867243|NCT01684943|37840209|FG002|Overall Study|Inadequate Venous Access|0|||
16867244|NCT01684943|37840207|FG000|Overall Study|Principal Investigator Determination|1|||
16867245|NCT01684943|37840208|FG001|Overall Study|Principal Investigator Determination|0|||
16867246|NCT01684943|37840209|FG002|Overall Study|Principal Investigator Determination|0|||
16867247|NCT01684943|37840207|FG000|Overall Study|Excluded from Analysis|1|||
16867248|NCT01684943|37840208|FG001|Overall Study|Excluded from Analysis|1|||
16867249|NCT01684943|37840209|FG002|Overall Study|Excluded from Analysis|1|||
16867250|NCT01684943|37840207|FG000|Overall Study|Lost to Follow-up|3|||
16867251|NCT01684943|37840208|FG001|Overall Study|Lost to Follow-up|0|||
16867252|NCT01684943|37840209|FG002|Overall Study|Lost to Follow-up|0|||
16867253|NCT01684943|37840207|FG000|Overall Study|Planning Pregnancy|1|||
16867254|NCT01684943|37840208|FG001|Overall Study|Planning Pregnancy|0|||
16867255|NCT01684943|37840209|FG002|Overall Study|Planning Pregnancy|0|||
16867256|NCT01683383|37840224|FG000|Overall Study|Infant was not transported|1|||
16867257|NCT01683383|37840225|FG001|Overall Study|Infant was not transported|0|||
16867258|NCT02694744|37840233|FG000|Overall Study|Adverse Event|2|||
16867259|NCT02694744|37840234|FG001|Overall Study|Adverse Event|1|||
16867260|NCT02694744|37840233|FG000|Overall Study|Withdrawal by Subject|2|||
16867261|NCT02694744|37840234|FG001|Overall Study|Withdrawal by Subject|1|||
16867262|NCT02694744|37840233|FG000|Overall Study|Physician Decision|1|||
16867263|NCT02694744|37840234|FG001|Overall Study|Physician Decision|2|||
16867264|NCT02694744|37840233|FG000|Overall Study|Lost to Follow-up|1|||
16867265|NCT02694744|37840234|FG001|Overall Study|Lost to Follow-up|0|||
16867266|NCT02694744|37840233|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
16867267|NCT02694744|37840234|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
16867268|NCT01683071|37840248|FG000|Part 1|Lack of Efficacy|1|||
16867269|NCT01683071|37840249|FG001|Part 1|Lack of Efficacy|0|||
16867270|NCT01683071|37840250|FG002|Part 1|Lack of Efficacy|0|||
16867271|NCT01683071|37840251|FG003|Part 1|Lack of Efficacy|3|||
16867272|NCT01683071|37840252|FG004|Part 1|Lack of Efficacy|0|||
16867273|NCT01683071|37840253|FG005|Part 1|Lack of Efficacy|0|||
16867274|NCT01683071|37840248|FG000|Part 1|Withdrawal by Subject|1|||
16867275|NCT01683071|37840249|FG001|Part 1|Withdrawal by Subject|2|||
16867276|NCT01683071|37840250|FG002|Part 1|Withdrawal by Subject|2|||
16867277|NCT01683071|37840251|FG003|Part 1|Withdrawal by Subject|1|||
16867278|NCT01683071|37840252|FG004|Part 1|Withdrawal by Subject|0|||
16867279|NCT01683071|37840253|FG005|Part 1|Withdrawal by Subject|0|||
16867280|NCT01683071|37840248|FG000|Part 1|Surgery Cancelled|1|||
16867281|NCT01683071|37840249|FG001|Part 1|Surgery Cancelled|0|||
16867282|NCT01683071|37840250|FG002|Part 1|Surgery Cancelled|0|||
16867283|NCT01683071|37840251|FG003|Part 1|Surgery Cancelled|0|||
16867284|NCT01683071|37840252|FG004|Part 1|Surgery Cancelled|0|||
16867285|NCT01683071|37840253|FG005|Part 1|Surgery Cancelled|0|||
16867286|NCT01683071|37840248|FG000|Part 1|Did not receive study drug|1|||
16867287|NCT01683071|37840249|FG001|Part 1|Did not receive study drug|0|||
16867288|NCT01683071|37840250|FG002|Part 1|Did not receive study drug|0|||
16867289|NCT01683071|37840251|FG003|Part 1|Did not receive study drug|1|||
16867290|NCT01683071|37840252|FG004|Part 1|Did not receive study drug|0|||
16867291|NCT01683071|37840253|FG005|Part 1|Did not receive study drug|0|||
16867292|NCT01683071|37840248|FG000|Part 1|Early termination; met exclusion criteria|0|||
16867293|NCT01683071|37840249|FG001|Part 1|Early termination; met exclusion criteria|2|||
16867294|NCT01683071|37840250|FG002|Part 1|Early termination; met exclusion criteria|1|||
16867295|NCT01683071|37840251|FG003|Part 1|Early termination; met exclusion criteria|0|||
16867296|NCT01683071|37840252|FG004|Part 1|Early termination; met exclusion criteria|0|||
16867297|NCT01683071|37840253|FG005|Part 1|Early termination; met exclusion criteria|0|||
16867298|NCT01683071|37840248|FG000|Part 2|Lack of Efficacy|0|||
16867299|NCT01683071|37840249|FG001|Part 2|Lack of Efficacy|0|||
16867300|NCT01683071|37840250|FG002|Part 2|Lack of Efficacy|0|||
16867301|NCT01683071|37840251|FG003|Part 2|Lack of Efficacy|0|||
16867302|NCT01683071|37840252|FG004|Part 2|Lack of Efficacy|3|||
16867303|NCT01683071|37840253|FG005|Part 2|Lack of Efficacy|4|||
16867304|NCT01683071|37840248|FG000|Part 2|Lost to Follow-up|0|||
16867305|NCT01683071|37840249|FG001|Part 2|Lost to Follow-up|0|||
16867306|NCT01683071|37840250|FG002|Part 2|Lost to Follow-up|0|||
16867307|NCT01683071|37840251|FG003|Part 2|Lost to Follow-up|0|||
16867308|NCT01683071|37840252|FG004|Part 2|Lost to Follow-up|2|||
16867309|NCT01683071|37840253|FG005|Part 2|Lost to Follow-up|0|||
16867310|NCT01683071|37840248|FG000|Part 2|Withdrawal by Subject|0|||
16867311|NCT01683071|37840249|FG001|Part 2|Withdrawal by Subject|0|||
16867312|NCT01683071|37840250|FG002|Part 2|Withdrawal by Subject|0|||
16867313|NCT01683071|37840251|FG003|Part 2|Withdrawal by Subject|0|||
16867314|NCT01683071|37840252|FG004|Part 2|Withdrawal by Subject|3|||
16867315|NCT01683071|37840253|FG005|Part 2|Withdrawal by Subject|3|||
16867316|NCT01683071|37840248|FG000|Part 2|Surgery cancelled|0|||
16867317|NCT01683071|37840249|FG001|Part 2|Surgery cancelled|0|||
16867318|NCT01683071|37840250|FG002|Part 2|Surgery cancelled|0|||
16867319|NCT01683071|37840251|FG003|Part 2|Surgery cancelled|0|||
16867320|NCT01683071|37840252|FG004|Part 2|Surgery cancelled|4|||
16867321|NCT01683071|37840253|FG005|Part 2|Surgery cancelled|2|||
16867322|NCT01683071|37840248|FG000|Part 2|Did not receive study drug|0|||
16867323|NCT01683071|37840249|FG001|Part 2|Did not receive study drug|0|||
16867324|NCT01683071|37840250|FG002|Part 2|Did not receive study drug|0|||
16867325|NCT01683071|37840251|FG003|Part 2|Did not receive study drug|0|||
16867326|NCT01683071|37840252|FG004|Part 2|Did not receive study drug|2|||
16867327|NCT01683071|37840253|FG005|Part 2|Did not receive study drug|1|||
16867328|NCT01683071|37840248|FG000|Part 2|Met exclusion criterion|0|||
16867329|NCT01683071|37840249|FG001|Part 2|Met exclusion criterion|0|||
16867330|NCT01683071|37840250|FG002|Part 2|Met exclusion criterion|0|||
16867331|NCT01683071|37840251|FG003|Part 2|Met exclusion criterion|0|||
16867332|NCT01683071|37840252|FG004|Part 2|Met exclusion criterion|1|||
16867333|NCT01683071|37840253|FG005|Part 2|Met exclusion criterion|1|||
16867334|NCT01683071|37840248|FG000|Part 2|Protocol deviation|0|||
16867335|NCT01683071|37840249|FG001|Part 2|Protocol deviation|0|||
16867336|NCT01683071|37840250|FG002|Part 2|Protocol deviation|0|||
16867337|NCT01683071|37840251|FG003|Part 2|Protocol deviation|0|||
16867338|NCT01683071|37840252|FG004|Part 2|Protocol deviation|1|||
16867339|NCT01683071|37840253|FG005|Part 2|Protocol deviation|2|||
16867340|NCT01683071|37840248|FG000|Part 2|Withdrawal by investigator decision|0|||
16867341|NCT01683071|37840249|FG001|Part 2|Withdrawal by investigator decision|0|||
16867342|NCT01683071|37840250|FG002|Part 2|Withdrawal by investigator decision|0|||
16867343|NCT01683071|37840251|FG003|Part 2|Withdrawal by investigator decision|0|||
16867344|NCT01683071|37840252|FG004|Part 2|Withdrawal by investigator decision|1|||
16867345|NCT01683071|37840253|FG005|Part 2|Withdrawal by investigator decision|2|||
16867346|NCT01567865|37840277|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
16867347|NCT01567865|37840278|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
16867348|NCT01567865|37840279|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
16867349|NCT01567865|37840280|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
16867350|NCT01567865|37840277|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
16867351|NCT01567865|37840278|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
16867352|NCT01567865|37840279|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
16867353|NCT01567865|37840280|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
16867354|NCT01567163|37840291|FG000|Overall Study|Progressive Disease|2|||
16867355|NCT01567163|37840291|FG000|Overall Study|Lost to Follow-up|2|||
16867356|NCT01567085|37840300|FG000|Overall Study|Death|6|||
16867357|NCT01567085|37840300|FG000|Overall Study|Adverse Event|6|||
16867358|NCT01567085|37840300|FG000|Overall Study|Lost to Follow-up|3|||
16867359|NCT01567085|37840300|FG000|Overall Study|Graft loss|2|||
16867360|NCT01567085|37840300|FG000|Overall Study|Renal transplantectomy|1|||
16867361|NCT01567085|37840300|FG000|Overall Study|Returned to chronic dialysis|1|||
16867362|NCT01567085|37840300|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
16867363|NCT01566773|37840304|FG000|Overall Study|Protocol specified criteria|4|||
16867364|NCT01566773|37840304|FG000|Overall Study|Protocol Violation|4|||
16867365|NCT01566773|37840304|FG000|Overall Study|Withdrawal by Subject|9|||
16867366|NCT01566773|37840304|FG000|Overall Study|Administrative reason|1|||
16867367|NCT01566773|37840304|FG000|Overall Study|Adverse Event|10|||
16867368|NCT01566773|37840304|FG000|Overall Study|Physician Decision|2|||
16867369|NCT01566149|37840326|FG000|Overall Study|Adverse Event|0|||
16867370|NCT01566149|37840327|FG001|Overall Study|Adverse Event|1|||
16867371|NCT01566149|37840326|FG000|Overall Study|Non-compliance with study medication|2|||
16867372|NCT01566149|37840327|FG001|Overall Study|Non-compliance with study medication|0|||
16867373|NCT01566149|37840326|FG000|Overall Study|Protocol Violation|0|||
16867374|NCT01566149|37840327|FG001|Overall Study|Protocol Violation|1|||
16867375|NCT01566149|37840326|FG000|Overall Study|Withdrawal by Subject|1|||
16867376|NCT01566149|37840327|FG001|Overall Study|Withdrawal by Subject|0|||
16867377|NCT01565993|37840335|FG000|Overall Study|Physician Decision|0|||
16867378|NCT01565993|37840336|FG001|Overall Study|Physician Decision|3|||
16867379|NCT01565291|37840344|FG000|Overall Study|Withdrawal by Subject|1|||
16867380|NCT01565291|37840345|FG001|Overall Study|Withdrawal by Subject|0|||
16867381|NCT03382834|37840353|FG000|Overall Study|Lost to Follow-up|1|||
16867382|NCT03382834|37840354|FG001|Overall Study|Lost to Follow-up|0|||
16867383|NCT03382834|37840353|FG000|Overall Study|Withdrawal by Subject|0|||
16867384|NCT03382834|37840354|FG001|Overall Study|Withdrawal by Subject|1|||
16774048|NCT02246998|37713284|FG001|Overall Study|Adverse Event|1|||
16774049|NCT02246998|37713285|FG002|Overall Study|Adverse Event|1|||
16774050|NCT02246998|37713286|FG003|Overall Study|Adverse Event|0|||
16774051|NCT02246998|37713283|FG000|Overall Study|Lost to Follow-up|1|||
16774052|NCT02246998|37713284|FG001|Overall Study|Lost to Follow-up|0|||
16774053|NCT02246998|37713285|FG002|Overall Study|Lost to Follow-up|0|||
16774054|NCT02246998|37713286|FG003|Overall Study|Lost to Follow-up|1|||
16774055|NCT02246998|37713283|FG000|Overall Study|Randomized but Never Dosed|1|||
16774056|NCT02246998|37713284|FG001|Overall Study|Randomized but Never Dosed|2|||
16774057|NCT02246998|37713285|FG002|Overall Study|Randomized but Never Dosed|2|||
16774058|NCT02246998|37713286|FG003|Overall Study|Randomized but Never Dosed|1|||
16774059|NCT02486588|37713305|FG000|Overall Study|Randomized in error- ineligible|738|||
16774060|NCT02486588|37713306|FG001|Overall Study|Randomized in error- ineligible|750|||
16774061|NCT02486588|37713307|FG002|Overall Study|Randomized in error- ineligible|755|||
16774062|NCT02486588|37713308|FG003|Overall Study|Randomized in error- ineligible|738|||
16774063|NCT02486588|37713309|FG004|Overall Study|Randomized in error- ineligible|746|||
16867385|NCT02691702|37840371|FG000|Overall Study|Adverse Event|1|||
16867386|NCT02691702|37840372|FG001|Overall Study|Adverse Event|0|||
16774064|NCT02486588|37713310|FG005|Overall Study|Randomized in error- ineligible|746|||
16774065|NCT00805961|37713329|FG000|Modality Therapy|Withdrawal by Subject|1|||
16774066|NCT00805961|37713329|FG000|Modality Therapy|Adverse Event|1|||
16867387|NCT02691702|37840373|FG002|Overall Study|Adverse Event|0|||
16867388|NCT02691702|37840374|FG003|Overall Study|Adverse Event|0|||
16774067|NCT00805961|37713329|FG000|Modality Therapy|Disease Progression|2|||
16774068|NCT00805961|37713329|FG000|Treatment-Free Interval|Adverse Event|3|||
16774069|NCT00805961|37713329|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
16774070|NCT00805961|37713329|FG000|Treatment-Free Interval|Physician Decision|1|||
16774071|NCT00805961|37713329|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
16774072|NCT00805961|37713329|FG000|Maintenance Treatment|Lack of Efficacy|13|||
16774073|NCT00805961|37713329|FG000|Maintenance Treatment|Intercurrent Illness|7|||
16774074|NCT00805961|37713329|FG000|Maintenance Treatment|Adverse Event|6|||
16774075|NCT00805961|37713329|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
16774076|NCT00805961|37713329|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
16867389|NCT02691702|37840375|FG004|Overall Study|Adverse Event|0|||
16867390|NCT02691702|37840376|FG005|Overall Study|Adverse Event|0|||
16867391|NCT02691702|37840377|FG006|Overall Study|Adverse Event|0|||
16867392|NCT02691702|37840378|FG007|Overall Study|Adverse Event|0|||
16867393|NCT02691702|37840379|FG008|Overall Study|Adverse Event|1|||
16867394|NCT02691702|37840380|FG009|Overall Study|Adverse Event|0|||
16867395|NCT02691702|37840381|FG010|Overall Study|Adverse Event|1|||
16867396|NCT02691702|37840371|FG000|Overall Study|Lost to Follow-up|0|||
16867397|NCT02691702|37840372|FG001|Overall Study|Lost to Follow-up|0|||
16867398|NCT02691702|37840373|FG002|Overall Study|Lost to Follow-up|1|||
16867399|NCT02691702|37840374|FG003|Overall Study|Lost to Follow-up|0|||
16867400|NCT02691702|37840375|FG004|Overall Study|Lost to Follow-up|0|||
16867401|NCT02691702|37840376|FG005|Overall Study|Lost to Follow-up|2|||
16867402|NCT02691702|37840377|FG006|Overall Study|Lost to Follow-up|0|||
16867403|NCT02691702|37840378|FG007|Overall Study|Lost to Follow-up|0|||
16867404|NCT02691702|37840379|FG008|Overall Study|Lost to Follow-up|0|||
16867405|NCT02691702|37840380|FG009|Overall Study|Lost to Follow-up|0|||
16867406|NCT02691702|37840381|FG010|Overall Study|Lost to Follow-up|1|||
16867407|NCT02691702|37840371|FG000|Overall Study|Withdrawal by Subject|1|||
16867408|NCT02691702|37840372|FG001|Overall Study|Withdrawal by Subject|1|||
16867409|NCT02691702|37840373|FG002|Overall Study|Withdrawal by Subject|0|||
16867410|NCT02691702|37840374|FG003|Overall Study|Withdrawal by Subject|0|||
16867411|NCT02691702|37840375|FG004|Overall Study|Withdrawal by Subject|0|||
16867412|NCT02691702|37840376|FG005|Overall Study|Withdrawal by Subject|1|||
16867413|NCT02691702|37840377|FG006|Overall Study|Withdrawal by Subject|2|||
16867414|NCT02691702|37840378|FG007|Overall Study|Withdrawal by Subject|0|||
16867415|NCT02691702|37840379|FG008|Overall Study|Withdrawal by Subject|0|||
16867416|NCT02691702|37840380|FG009|Overall Study|Withdrawal by Subject|0|||
16867417|NCT02691702|37840381|FG010|Overall Study|Withdrawal by Subject|0|||
16867418|NCT02691702|37840371|FG000|Overall Study|Other|0|||
16867419|NCT02691702|37840372|FG001|Overall Study|Other|0|||
16867420|NCT02691702|37840373|FG002|Overall Study|Other|0|||
16867421|NCT02691702|37840374|FG003|Overall Study|Other|0|||
16867422|NCT02691702|37840375|FG004|Overall Study|Other|0|||
16867423|NCT02691702|37840376|FG005|Overall Study|Other|0|||
16867424|NCT02691702|37840377|FG006|Overall Study|Other|1|||
16867425|NCT02691702|37840378|FG007|Overall Study|Other|0|||
16867426|NCT02691702|37840379|FG008|Overall Study|Other|1|||
16867427|NCT02691702|37840380|FG009|Overall Study|Other|0|||
16867428|NCT02691702|37840381|FG010|Overall Study|Other|0|||
16867429|NCT02691702|37840371|FG000|Overall Study|Protocol Violation|0|||
16867430|NCT02691702|37840372|FG001|Overall Study|Protocol Violation|0|||
16867431|NCT02691702|37840373|FG002|Overall Study|Protocol Violation|0|||
16867432|NCT02691702|37840374|FG003|Overall Study|Protocol Violation|0|||
16867433|NCT02691702|37840375|FG004|Overall Study|Protocol Violation|0|||
16867434|NCT02691702|37840376|FG005|Overall Study|Protocol Violation|0|||
16867435|NCT02691702|37840377|FG006|Overall Study|Protocol Violation|0|||
16867436|NCT02691702|37840378|FG007|Overall Study|Protocol Violation|0|||
16867437|NCT02691702|37840379|FG008|Overall Study|Protocol Violation|0|||
16867438|NCT02691702|37840380|FG009|Overall Study|Protocol Violation|2|||
16867439|NCT02691702|37840381|FG010|Overall Study|Protocol Violation|0|||
16867440|NCT01564277|37840415|FG000|Overall Study|Protocol Violation|0|||
16774077|NCT00805961|37713329|FG000|Maintenance Treatment|Withdrawn Consent|1|||
16774078|NCT02202538|37713333|FG000|Overall Study|Withdrawal by Subject|5|||
16774079|NCT02202538|37713333|FG000|Overall Study|Did not meet all inclusion criteria|2|||
16774080|NCT02202538|37713333|FG000|Overall Study|Investigator Decision|1|||
16774081|NCT02454608|37713340|FG000|Double-Blind Period|Lack of Efficacy|0|||
16774082|NCT02454608|37713341|FG001|Double-Blind Period|Lack of Efficacy|2|||
16774083|NCT02454608|37713342|FG002|Double-Blind Period|Lack of Efficacy|0|||
16774084|NCT02454608|37713340|FG000|Open Label Period|Lost to Follow-up|0|||
16774085|NCT02454608|37713341|FG001|Open Label Period|Lost to Follow-up|0|||
16774086|NCT02454608|37713342|FG002|Open Label Period|Lost to Follow-up|11|||
16774087|NCT02454608|37713340|FG000|Open Label Period|Withdrawal by Subject|0|||
16774088|NCT02454608|37713341|FG001|Open Label Period|Withdrawal by Subject|0|||
16774089|NCT02454608|37713342|FG002|Open Label Period|Withdrawal by Subject|8|||
16774090|NCT02246764|37713353|FG000|Overall Study|Adverse Event|15|||
16774091|NCT02246764|37713354|FG001|Overall Study|Adverse Event|29|||
16774092|NCT02246764|37713355|FG002|Overall Study|Adverse Event|1|||
16774093|NCT02246764|37713353|FG000|Overall Study|Withdrawal by Subject|0|||
16774094|NCT02246764|37713354|FG001|Overall Study|Withdrawal by Subject|0|||
16774095|NCT02246764|37713355|FG002|Overall Study|Withdrawal by Subject|1|||
16774096|NCT02246764|37713353|FG000|Overall Study|Disallowed Concomitant Medication|1|||
16774097|NCT02246764|37713354|FG001|Overall Study|Disallowed Concomitant Medication|0|||
16774098|NCT02246764|37713355|FG002|Overall Study|Disallowed Concomitant Medication|0|||
16774099|NCT02246764|37713353|FG000|Overall Study|Physician Decision|0|||
16774100|NCT02246764|37713354|FG001|Overall Study|Physician Decision|2|||
16774101|NCT02246764|37713355|FG002|Overall Study|Physician Decision|1|||
16774102|NCT02246764|37713353|FG000|Overall Study|Protocol Violation|2|||
16774103|NCT02246764|37713354|FG001|Overall Study|Protocol Violation|1|||
16774104|NCT02246764|37713355|FG002|Overall Study|Protocol Violation|1|||
16774105|NCT02454530|37713365|FG000|Overall Study|Other|8|||
16774106|NCT02454530|37713366|FG001|Overall Study|Other|13|||
16774107|NCT02454530|37713365|FG000|Overall Study|Missing information|56|||
16774108|NCT02454530|37713366|FG001|Overall Study|Missing information|69|||
16867441|NCT01564277|37840416|FG001|Overall Study|Protocol Violation|1|||
16774109|NCT02454530|37713365|FG000|Overall Study|Death|2|||
16774110|NCT02454530|37713366|FG001|Overall Study|Death|41|||
16774111|NCT02454530|37713365|FG000|Overall Study|Lost to Follow-up|4|||
16867442|NCT01564277|37840415|FG000|Overall Study|Physician Decision|1|||
16867443|NCT01564277|37840416|FG001|Overall Study|Physician Decision|0|||
16867444|NCT03361306|37840422|FG000|Overall Study|Death|5|||
16867445|NCT03361306|37840422|FG000|Overall Study|Still On Study (on study treatment)|3|||
16867446|NCT03361306|37840422|FG000|Overall Study|Still On Study (in follow up)|7|||
16867447|NCT02679222|37840426|FG000|Overall Study|No time for project|1|||
16867448|NCT01563185|37840438|FG000|Overall Study|Withdrawal by Subject|1|||
16867449|NCT01563185|37840438|FG000|Overall Study|Non-Compliance with study drug|1|||
16867450|NCT03305848|37840442|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
16867451|NCT03305848|37840442|FG000|Overall Study|Physician Decision|2|||
16867452|NCT01563029|37840451|FG000|Overall Study|Adverse Event|1|||
16867453|NCT01563029|37840452|FG001|Overall Study|Adverse Event|0|||
16867454|NCT01563029|37840453|FG002|Overall Study|Adverse Event|1|||
16867455|NCT01563029|37840454|FG003|Overall Study|Adverse Event|2|||
16867456|NCT01563029|37840455|FG004|Overall Study|Adverse Event|1|||
16867457|NCT01563029|37840451|FG000|Overall Study|Lack of Efficacy|42|||
16867458|NCT01563029|37840452|FG001|Overall Study|Lack of Efficacy|16|||
16867459|NCT01563029|37840453|FG002|Overall Study|Lack of Efficacy|23|||
16867460|NCT01563029|37840454|FG003|Overall Study|Lack of Efficacy|21|||
16867461|NCT01563029|37840455|FG004|Overall Study|Lack of Efficacy|19|||
16867462|NCT01563029|37840451|FG000|Overall Study|Protocol Violation|1|||
16867463|NCT01563029|37840452|FG001|Overall Study|Protocol Violation|2|||
16867464|NCT01563029|37840453|FG002|Overall Study|Protocol Violation|3|||
16867465|NCT01563029|37840454|FG003|Overall Study|Protocol Violation|1|||
16867466|NCT01563029|37840455|FG004|Overall Study|Protocol Violation|3|||
16867467|NCT01563029|37840451|FG000|Overall Study|Protocol defined stopping criteria|1|||
16867468|NCT01563029|37840452|FG001|Overall Study|Protocol defined stopping criteria|0|||
16867469|NCT01563029|37840453|FG002|Overall Study|Protocol defined stopping criteria|0|||
16867470|NCT01563029|37840454|FG003|Overall Study|Protocol defined stopping criteria|0|||
16867471|NCT01563029|37840455|FG004|Overall Study|Protocol defined stopping criteria|0|||
16867472|NCT01563029|37840451|FG000|Overall Study|Lost to Follow-up|1|||
16867473|NCT01563029|37840452|FG001|Overall Study|Lost to Follow-up|0|||
16867474|NCT01563029|37840453|FG002|Overall Study|Lost to Follow-up|1|||
16867475|NCT01563029|37840454|FG003|Overall Study|Lost to Follow-up|1|||
16867476|NCT01563029|37840455|FG004|Overall Study|Lost to Follow-up|1|||
16867477|NCT01563029|37840451|FG000|Overall Study|Physician Decision|3|||
16867478|NCT01563029|37840452|FG001|Overall Study|Physician Decision|5|||
16867479|NCT01563029|37840453|FG002|Overall Study|Physician Decision|2|||
16867480|NCT01563029|37840454|FG003|Overall Study|Physician Decision|4|||
16867481|NCT01563029|37840455|FG004|Overall Study|Physician Decision|2|||
16867482|NCT01563029|37840451|FG000|Overall Study|Withdrawal by Subject|4|||
16867483|NCT01563029|37840452|FG001|Overall Study|Withdrawal by Subject|1|||
16867484|NCT01563029|37840453|FG002|Overall Study|Withdrawal by Subject|3|||
16867485|NCT01563029|37840454|FG003|Overall Study|Withdrawal by Subject|4|||
16867486|NCT01563029|37840455|FG004|Overall Study|Withdrawal by Subject|3|||
16867487|NCT01562873|37840468|FG000|Overall Study|Disease Progression per RECIST|10|||
16867488|NCT01562873|37840469|FG001|Overall Study|Disease Progression per RECIST|0|||
16867489|NCT01562873|37840468|FG000|Overall Study|Adverse Event|1|||
16867490|NCT01562873|37840469|FG001|Overall Study|Adverse Event|0|||
16867491|NCT01562873|37840468|FG000|Overall Study|Clinical Disease Progression|9|||
16867492|NCT01562873|37840469|FG001|Overall Study|Clinical Disease Progression|0|||
16867493|NCT01562873|37840468|FG000|Overall Study|Clinical PD and adverse event|1|||
16867494|NCT01562873|37840469|FG001|Overall Study|Clinical PD and adverse event|0|||
16867495|NCT03273712|37840473|FG000|Overall Study|Death|5|||
16867496|NCT03273712|37840473|FG000|Overall Study|Adverse Event|1|||
16867497|NCT03273712|37840473|FG000|Overall Study|Disease Progression|1|||
16867498|NCT01562327|37840478|FG000|Overall Study|Adverse Event|2|||
16867499|NCT01562327|37840478|FG000|Overall Study|Lack of Efficacy|1|||
16867500|NCT01562327|37840478|FG000|Overall Study|Participant drop-out|1|||
16867501|NCT01562327|37840478|FG000|Overall Study|Infusion not received at 6 month window|4|||
16867502|NCT01561313|37840485|FG000|Overall Study|Withdrawal by Subject|1|||
16867503|NCT01561313|37840486|FG001|Overall Study|Withdrawal by Subject|0|||
16867504|NCT01561313|37840485|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
16867505|NCT01561313|37840486|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
16867506|NCT01561079|37840492|FG000|Overall Study|Physician Decision|17|||
16867507|NCT01561079|37840492|FG000|Overall Study|Withdrawal by Subject|59|||
16867508|NCT01561079|37840492|FG000|Overall Study|Protocol Violation|2|||
16867509|NCT01559675|37840537|FG000|Overall Study|Protocol Violation|1|||
16867510|NCT01559675|37840538|FG001|Overall Study|Protocol Violation|2|||
16867511|NCT01559675|37840537|FG000|Overall Study|2nd operation on same patient excluded|14|||
16867512|NCT01559675|37840538|FG001|Overall Study|2nd operation on same patient excluded|12|||
16867513|NCT01374906|37840546|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16867514|NCT01374906|37840547|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16867515|NCT01374906|37840546|FG000|Overall Study|Administrative problems|2|||
16774112|NCT02454530|37713366|FG001|Overall Study|Lost to Follow-up|4|||
16867516|NCT01374906|37840547|FG001|Overall Study|Administrative problems|2|||
16867517|NCT01374906|37840546|FG000|Overall Study|Adverse Event|10|||
16867518|NCT01374906|37840547|FG001|Overall Study|Adverse Event|11|||
16867519|NCT01374906|37840546|FG000|Overall Study|Death|0|||
16867520|NCT01374906|37840547|FG001|Overall Study|Death|2|||
16867521|NCT01374906|37840546|FG000|Overall Study|Protocol Violation|2|||
16867522|NCT01374906|37840547|FG001|Overall Study|Protocol Violation|2|||
16867523|NCT01374906|37840546|FG000|Overall Study|Withdrawal by Subject|15|||
16867524|NCT01374906|37840547|FG001|Overall Study|Withdrawal by Subject|9|||
16867525|NCT01374906|37840546|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
16867526|NCT01374906|37840547|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
16867527|NCT03228394|37840565|FG000|Overall Study|Lost to Follow-up|0|||
16867528|NCT03228394|37840566|FG001|Overall Study|Lost to Follow-up|0|||
16867529|NCT03228394|37840567|FG002|Overall Study|Lost to Follow-up|1|||
16867530|NCT03228394|37840568|FG003|Overall Study|Lost to Follow-up|1|||
16867531|NCT03228394|37840569|FG004|Overall Study|Lost to Follow-up|0|||
16867532|NCT03228394|37840570|FG005|Overall Study|Lost to Follow-up|0|||
16867533|NCT03228394|37840571|FG006|Overall Study|Lost to Follow-up|2|||
16867534|NCT03228394|37840572|FG007|Overall Study|Lost to Follow-up|0|||
16867535|NCT03228394|37840565|FG000|Overall Study|Withdrawal by Subject|0|||
16867536|NCT03228394|37840566|FG001|Overall Study|Withdrawal by Subject|0|||
16867537|NCT03228394|37840567|FG002|Overall Study|Withdrawal by Subject|1|||
16867538|NCT03228394|37840568|FG003|Overall Study|Withdrawal by Subject|0|||
16867539|NCT03228394|37840569|FG004|Overall Study|Withdrawal by Subject|0|||
16867540|NCT03228394|37840570|FG005|Overall Study|Withdrawal by Subject|0|||
16867541|NCT03228394|37840571|FG006|Overall Study|Withdrawal by Subject|1|||
16774113|NCT02431676|37713376|FG000|Overall Study|no lab obtained|0|||
16774114|NCT02431676|37713377|FG001|Overall Study|no lab obtained|1|||
16774115|NCT02431676|37713378|FG002|Overall Study|no lab obtained|2|||
16774116|NCT01654250|37713388|FG000|Overall Study|Lost to Follow-up|1|||
16774117|NCT01654250|37713389|FG001|Overall Study|Lost to Follow-up|0|||
16774118|NCT01652690|37713398|FG000|Overall Study|Withdrawal by Subject|16|||
16774119|NCT01652690|37713399|FG001|Overall Study|Withdrawal by Subject|4|||
16774120|NCT01652690|37713398|FG000|Overall Study|Other|8|||
16774121|NCT01652690|37713399|FG001|Overall Study|Other|9|||
16774122|NCT01652690|37713398|FG000|Overall Study|Lost to Follow-up|6|||
16867542|NCT03228394|37840572|FG007|Overall Study|Withdrawal by Subject|3|||
16774123|NCT01652690|37713399|FG001|Overall Study|Lost to Follow-up|6|||
16774124|NCT01652690|37713398|FG000|Overall Study|Death|5|||
16774125|NCT01652690|37713399|FG001|Overall Study|Death|2|||
17127652|NCT03292406|38268056|FG001|Overall Study|Withdrawal by Subject|7|||
17127653|NCT03292406|38268057|FG002|Overall Study|Withdrawal by Subject|2|||
16774126|NCT02429414|37713407|FG000|Overall Study|Physician Decision|0|||
16867543|NCT03228394|37840565|FG000|Overall Study|Protocol Violation|0|||
16867544|NCT03228394|37840566|FG001|Overall Study|Protocol Violation|0|||
16867545|NCT03228394|37840567|FG002|Overall Study|Protocol Violation|0|||
16867546|NCT03228394|37840568|FG003|Overall Study|Protocol Violation|1|||
16867547|NCT03228394|37840569|FG004|Overall Study|Protocol Violation|0|||
16867548|NCT03228394|37840570|FG005|Overall Study|Protocol Violation|0|||
16867549|NCT03228394|37840571|FG006|Overall Study|Protocol Violation|0|||
16867550|NCT03228394|37840572|FG007|Overall Study|Protocol Violation|0|||
16867551|NCT03228394|37840565|FG000|Overall Study|Physician Decision|0|||
16867552|NCT03228394|37840566|FG001|Overall Study|Physician Decision|0|||
16867553|NCT03228394|37840567|FG002|Overall Study|Physician Decision|0|||
16867554|NCT03228394|37840568|FG003|Overall Study|Physician Decision|0|||
16867555|NCT03228394|37840569|FG004|Overall Study|Physician Decision|0|||
16867556|NCT03228394|37840570|FG005|Overall Study|Physician Decision|0|||
16867557|NCT03228394|37840571|FG006|Overall Study|Physician Decision|1|||
16867558|NCT03228394|37840572|FG007|Overall Study|Physician Decision|0|||
16867559|NCT03228394|37840565|FG000|Overall Study|Noncompliance|0|||
16867560|NCT03228394|37840566|FG001|Overall Study|Noncompliance|0|||
16867561|NCT03228394|37840567|FG002|Overall Study|Noncompliance|0|||
16867562|NCT03228394|37840568|FG003|Overall Study|Noncompliance|0|||
16867563|NCT03228394|37840569|FG004|Overall Study|Noncompliance|0|||
16867564|NCT03228394|37840570|FG005|Overall Study|Noncompliance|0|||
16867565|NCT03228394|37840571|FG006|Overall Study|Noncompliance|1|||
16867566|NCT03228394|37840572|FG007|Overall Study|Noncompliance|0|||
16867567|NCT02683746|37840611|FG000|Overall Study|Adverse Event|3|||
16867568|NCT02683746|37840612|FG001|Overall Study|Adverse Event|2|||
16867569|NCT02683746|37840611|FG000|Overall Study|Lost to Follow-up|5|||
16867570|NCT02683746|37840612|FG001|Overall Study|Lost to Follow-up|6|||
16774127|NCT02429414|37713408|FG001|Overall Study|Physician Decision|1|||
16774128|NCT02429258|37713416|FG000|Overall Study|Withdrawal by Subject|2|||
16774129|NCT02429258|37713417|FG001|Overall Study|Withdrawal by Subject|0|||
16774130|NCT02429258|37713416|FG000|Overall Study|Protocol Violation|0|||
16774131|NCT02429258|37713417|FG001|Overall Study|Protocol Violation|1|||
16774132|NCT02201524|37713427|FG000|Overall Study|Adverse Event|0|||
16774133|NCT02201524|37713428|FG001|Overall Study|Adverse Event|2|||
16774134|NCT02201524|37713429|FG002|Overall Study|Adverse Event|1|||
16867571|NCT02683746|37840611|FG000|Overall Study|Withdrawal by Subject|6|||
16867572|NCT02683746|37840612|FG001|Overall Study|Withdrawal by Subject|5|||
16867573|NCT02683746|37840611|FG000|Overall Study|Physician Decision|2|||
16867574|NCT02683746|37840612|FG001|Overall Study|Physician Decision|1|||
16774135|NCT02201524|37713430|FG003|Overall Study|Adverse Event|0|||
16774136|NCT02201524|37713427|FG000|Overall Study|Insufficient clinical response|1|||
16774137|NCT02201524|37713428|FG001|Overall Study|Insufficient clinical response|0|||
16774138|NCT02201524|37713429|FG002|Overall Study|Insufficient clinical response|0|||
16774139|NCT02201524|37713430|FG003|Overall Study|Insufficient clinical response|0|||
16774140|NCT02201524|37713427|FG000|Overall Study|Lost to Follow-up|0|||
16774141|NCT02201524|37713428|FG001|Overall Study|Lost to Follow-up|0|||
16867575|NCT01559129|37840620|FG000|Treatment Phase|Adverse Event|0|||
17127654|NCT03292406|38268055|FG000|Overall Study|Protocol Violation|0|||
16867576|NCT01559129|37840621|FG001|Treatment Phase|Adverse Event|2|||
16867577|NCT01559129|37840620|FG000|Treatment Phase|Progressive Disease|1|||
16867578|NCT01559129|37840621|FG001|Treatment Phase|Progressive Disease|1|||
16867579|NCT01559129|37840620|FG000|Treatment Phase|Lack of Efficacy|0|||
16867580|NCT01559129|37840621|FG001|Treatment Phase|Lack of Efficacy|1|||
16867581|NCT01559129|37840620|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
16867582|NCT01559129|37840621|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
16867583|NCT01559129|37840620|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
16867584|NCT01559129|37840621|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
16867585|NCT01559129|37840620|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
16867586|NCT01559129|37840621|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
16867587|NCT01559129|37840620|FG000|Open-label Extension Period|Adverse Event|1|||
16867588|NCT01559129|37840621|FG001|Open-label Extension Period|Adverse Event|0|||
16867589|NCT01559129|37840620|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
16867590|NCT01559129|37840621|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
16867591|NCT02691468|37840635|FG000|Overall Study|Bronchial blocker use|2|||
16867592|NCT02691468|37840636|FG001|Overall Study|Bronchial blocker use|1|||
16867593|NCT02691468|37840635|FG000|Overall Study|Lost to Follow-up|2|||
16867594|NCT02691468|37840636|FG001|Overall Study|Lost to Follow-up|1|||
16867595|NCT02691468|37840635|FG000|Overall Study|Failure to advance FOB|2|||
16867596|NCT02691468|37840636|FG001|Overall Study|Failure to advance FOB|0|||
16867597|NCT02678676|37840644|FG000|Overall Study|Death|619|||
16867598|NCT02678676|37840645|FG001|Overall Study|Death|649|||
16867599|NCT02678676|37840644|FG000|Overall Study|Withdrawal by Subject|13|||
16867600|NCT02678676|37840645|FG001|Overall Study|Withdrawal by Subject|5|||
16867601|NCT02678676|37840644|FG000|Overall Study|Lost to Follow-up|171|||
16867602|NCT02678676|37840645|FG001|Overall Study|Lost to Follow-up|151|||
16867603|NCT02678676|37840644|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
16867604|NCT02678676|37840645|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
16867605|NCT01558739|37840651|FG000|Overall Study|Adverse Event|7|||
16867606|NCT01558739|37840651|FG000|Overall Study|Withdrawal by Subject|2|||
16867607|NCT01558739|37840651|FG000|Overall Study|Death|3|||
16867608|NCT01558739|37840651|FG000|Overall Study|Disease Progression|4|||
16867609|NCT01558739|37840651|FG000|Overall Study|Protocol Violation|1|||
16867610|NCT02683668|37840655|FG000|Period 2|Withdrawal by Subject|0|||
16867611|NCT02683668|37840656|FG001|Period 2|Withdrawal by Subject|1|||
16867612|NCT02683668|37840657|FG002|Period 2|Withdrawal by Subject|0|||
16867613|NCT02678286|37840665|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
16867614|NCT02678286|37840666|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
16867615|NCT02678286|37840665|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
16867616|NCT02678286|37840666|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
16867617|NCT02678286|37840665|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
16867618|NCT02678286|37840666|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
16867619|NCT02678286|37840665|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
16867620|NCT02678286|37840666|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
16867621|NCT02678286|37840665|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
16867622|NCT02678286|37840666|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
16867623|NCT02682264|37840674|FG000|Overall Study|Withdrawal by Subject|56|||
16867624|NCT02682264|37840675|FG001|Overall Study|Withdrawal by Subject|45|||
16867625|NCT02682264|37840674|FG000|Overall Study|Lost to Follow-up|49|||
16867626|NCT02682264|37840675|FG001|Overall Study|Lost to Follow-up|41|||
16867627|NCT02682264|37840674|FG000|Overall Study|Lack of Efficacy|14|||
16867628|NCT02682264|37840675|FG001|Overall Study|Lack of Efficacy|16|||
16867629|NCT02682264|37840674|FG000|Overall Study|Withdrawal by Parent|6|||
16867630|NCT02682264|37840675|FG001|Overall Study|Withdrawal by Parent|7|||
16867631|NCT02682264|37840674|FG000|Overall Study|Adverse Event|9|||
16867632|NCT02682264|37840675|FG001|Overall Study|Adverse Event|0|||
16867633|NCT02682264|37840674|FG000|Overall Study|Noncompliance with study drug|1|||
16867634|NCT02682264|37840675|FG001|Overall Study|Noncompliance with study drug|4|||
16867635|NCT02682264|37840674|FG000|Overall Study|Pregnancy|1|||
16867636|NCT02682264|37840675|FG001|Overall Study|Pregnancy|2|||
16867637|NCT02682264|37840674|FG000|Overall Study|Recovery|1|||
16867638|NCT02682264|37840675|FG001|Overall Study|Recovery|2|||
16867639|NCT02682264|37840674|FG000|Overall Study|Progressive Disease|1|||
16867640|NCT02682264|37840675|FG001|Overall Study|Progressive Disease|0|||
16867641|NCT02682264|37840674|FG000|Overall Study|Technical Problems|0|||
16867642|NCT02682264|37840675|FG001|Overall Study|Technical Problems|1|||
16867643|NCT02682264|37840674|FG000|Overall Study|Moved abroad and unable to continue|0|||
16867644|NCT02682264|37840675|FG001|Overall Study|Moved abroad and unable to continue|3|||
16867645|NCT02682264|37840674|FG000|Overall Study|Stopped test article application|0|||
16867646|NCT02682264|37840675|FG001|Overall Study|Stopped test article application|1|||
16867647|NCT02998528|37840684|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
16867648|NCT02998528|37840685|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
16867649|NCT02998528|37840686|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
16867650|NCT02998528|37840684|FG000|Randomization Period|Participant withdrew consent|0|||
16867651|NCT02998528|37840685|FG001|Randomization Period|Participant withdrew consent|3|||
16867652|NCT02998528|37840686|FG002|Randomization Period|Participant withdrew consent|0|||
16867653|NCT02998528|37840684|FG000|Randomization Period|Participant no longer meets study criteria|1|||
16867654|NCT02998528|37840685|FG001|Randomization Period|Participant no longer meets study criteria|3|||
16867655|NCT02998528|37840686|FG002|Randomization Period|Participant no longer meets study criteria|2|||
16867656|NCT02998528|37840684|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
16867657|NCT02998528|37840685|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
16867658|NCT02998528|37840686|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
16867659|NCT02998528|37840684|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
16867660|NCT02998528|37840685|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
16867661|NCT02998528|37840686|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
16867662|NCT02998528|37840684|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
16867663|NCT02998528|37840685|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
16867664|NCT02998528|37840686|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
16867665|NCT02998528|37840684|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
16867666|NCT02998528|37840685|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
16867667|NCT02998528|37840686|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
16867668|NCT02998528|37840684|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
16867669|NCT02998528|37840685|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
16867670|NCT02998528|37840686|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
16867671|NCT02998528|37840684|FG000|Neoadjuvant Treatment Period|Death|1|||
16867672|NCT02998528|37840685|FG001|Neoadjuvant Treatment Period|Death|0|||
16867673|NCT02998528|37840686|FG002|Neoadjuvant Treatment Period|Death|0|||
16867674|NCT02998528|37840684|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
16867675|NCT02998528|37840685|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
16867676|NCT02998528|37840686|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
16867677|NCT02998528|37840684|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
16867678|NCT02998528|37840685|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
16867679|NCT02998528|37840686|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
16867680|NCT02998528|37840684|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
16867681|NCT02998528|37840685|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
16867682|NCT02998528|37840686|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
16867683|NCT02998528|37840684|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
16867684|NCT02998528|37840685|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
16867685|NCT02998528|37840686|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
16867686|NCT02998528|37840684|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
16867687|NCT02998528|37840685|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
16867688|NCT02998528|37840686|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
16867689|NCT02998528|37840684|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
16774142|NCT02201524|37713429|FG002|Overall Study|Lost to Follow-up|2|||
16867690|NCT02998528|37840685|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
16867691|NCT02998528|37840686|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
16867692|NCT01566721|37840695|FG000|Treatment Period|Withdrawal by Subject|35|||
16867693|NCT01566721|37840696|FG001|Treatment Period|Withdrawal by Subject|9|||
16867694|NCT01566721|37840695|FG000|Treatment Period|Disease Progression/Recurrence|37|||
16867695|NCT01566721|37840696|FG001|Treatment Period|Disease Progression/Recurrence|13|||
16867696|NCT01566721|37840695|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
16867697|NCT01566721|37840696|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
16867698|NCT01566721|37840695|FG000|Treatment Period|Other|13|||
16867699|NCT01566721|37840696|FG001|Treatment Period|Other|2|||
16867700|NCT01566721|37840695|FG000|Treatment Period|Lack of Compliance|5|||
16867701|NCT01566721|37840696|FG001|Treatment Period|Lack of Compliance|1|||
16867702|NCT01566721|37840695|FG000|Treatment Period|Adverse Event|100|||
16867703|NCT01566721|37840696|FG001|Treatment Period|Adverse Event|30|||
16867704|NCT01566721|37840695|FG000|Treatment Period|Pregnancy|1|||
16867705|NCT01566721|37840696|FG001|Treatment Period|Pregnancy|0|||
16867706|NCT01566721|37840695|FG000|Safety Follow-up|Physician Decision|6|||
16867707|NCT01566721|37840696|FG001|Safety Follow-up|Physician Decision|4|||
16867708|NCT01566721|37840695|FG000|Safety Follow-up|Lost to Follow-up|101|||
16867709|NCT01566721|37840696|FG001|Safety Follow-up|Lost to Follow-up|48|||
16867710|NCT01566721|37840695|FG000|Safety Follow-up|Withdrawal by Subject|155|||
16867711|NCT01566721|37840696|FG001|Safety Follow-up|Withdrawal by Subject|49|||
16867712|NCT01566721|37840695|FG000|Safety Follow-up|Death|28|||
16867713|NCT01566721|37840696|FG001|Safety Follow-up|Death|4|||
16867714|NCT01566721|37840695|FG000|Safety Follow-up|Non-compliance|7|||
16867715|NCT01566721|37840696|FG001|Safety Follow-up|Non-compliance|3|||
16867716|NCT01566721|37840695|FG000|Safety Follow-up|Protocol Violation|7|||
16867717|NCT01566721|37840696|FG001|Safety Follow-up|Protocol Violation|0|||
16867718|NCT01566721|37840695|FG000|Safety Follow-up|Site closure|2|||
16867719|NCT01566721|37840696|FG001|Safety Follow-up|Site closure|3|||
16867720|NCT01566721|37840695|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
16867721|NCT01566721|37840696|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
16867722|NCT01566721|37840695|FG000|Safety Follow-up|Missing|7|||
16867723|NCT01566721|37840696|FG001|Safety Follow-up|Missing|2|||
16867724|NCT01566721|37840695|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
16867725|NCT01566721|37840696|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
16867726|NCT01566721|37840695|FG000|Safety Follow-up|Sponsor decision|1|||
16867727|NCT01566721|37840696|FG001|Safety Follow-up|Sponsor decision|0|||
16867728|NCT01566721|37840695|FG000|Safety Follow-up|Adverse Event|8|||
16867729|NCT01566721|37840696|FG001|Safety Follow-up|Adverse Event|4|||
16867730|NCT01541215|37840711|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
16867731|NCT01541215|37840712|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
16867732|NCT01541215|37840711|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
16867733|NCT01541215|37840712|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
16867734|NCT01541215|37840711|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
16867735|NCT01541215|37840712|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
16867736|NCT01541215|37840711|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
16867737|NCT01541215|37840712|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
16867738|NCT01541215|37840711|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
16867739|NCT01541215|37840712|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
16867740|NCT01541215|37840711|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
16867741|NCT01541215|37840712|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
16867742|NCT01540981|37840724|FG000|Overall Study|Withdrawal by Subject|1|||
16867743|NCT01540981|37840725|FG001|Overall Study|Withdrawal by Subject|0|||
16944890|NCT01097629|38088903|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16944891|NCT01097629|38088904|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16944892|NCT01097629|38088905|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16944893|NCT01097629|38088906|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16944894|NCT01097629|38088907|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16944895|NCT01097629|38088900|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
16944896|NCT01097629|38088901|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
16944897|NCT01097629|38088902|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
16944898|NCT01097629|38088903|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16944899|NCT01097629|38088904|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16944900|NCT01097629|38088905|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16944901|NCT01097629|38088906|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16944902|NCT01097629|38088907|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16944903|NCT01097629|38088900|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
16867744|NCT01585987|37840733|FG000|Randomized|Withdrawal by Subject|0|||
16867745|NCT01585987|37840734|FG001|Randomized|Withdrawal by Subject|4|||
16867746|NCT01585987|37840733|FG000|Randomized|No longer met criteria|0|||
16867747|NCT01585987|37840734|FG001|Randomized|No longer met criteria|2|||
16867748|NCT01585987|37840733|FG000|Treated|Disease Progression|39|||
16867749|NCT01585987|37840734|FG001|Treated|Disease Progression|36|||
16867750|NCT01585987|37840733|FG000|Treated|Study Drug Toxicity|9|||
16867751|NCT01585987|37840734|FG001|Treated|Study Drug Toxicity|5|||
16867752|NCT01585987|37840733|FG000|Treated|Adverse Event|3|||
16867753|NCT01585987|37840734|FG001|Treated|Adverse Event|0|||
16867754|NCT01585987|37840733|FG000|Treated|Withdrawal by Subject|1|||
16867755|NCT01585987|37840734|FG001|Treated|Withdrawal by Subject|2|||
16867756|NCT01585987|37840733|FG000|Treated|Death|1|||
16867757|NCT01585987|37840734|FG001|Treated|Death|0|||
16867758|NCT01585987|37840733|FG000|Treated|Lost to Follow-up|0|||
16867759|NCT01585987|37840734|FG001|Treated|Lost to Follow-up|1|||
16867760|NCT01585987|37840733|FG000|Treated|Maximum Clinical Benefit|0|||
16867761|NCT01585987|37840734|FG001|Treated|Maximum Clinical Benefit|1|||
16867762|NCT01585987|37840733|FG000|Treated|Non-Specified|1|||
16867763|NCT01585987|37840734|FG001|Treated|Non-Specified|2|||
16867764|NCT01585987|37840733|FG000|Treated|Subject Request|0|||
16867765|NCT01585987|37840734|FG001|Treated|Subject Request|1|||
16867766|NCT01585987|37840733|FG000|Treated|Poor/Non-Compliance|0|||
16867767|NCT01585987|37840734|FG001|Treated|Poor/Non-Compliance|1|||
16867768|NCT01585831|37840743|FG000|Overall Study|Physician Decision|0|||
16867769|NCT01585831|37840744|FG001|Overall Study|Physician Decision|1|||
16867770|NCT01585831|37840743|FG000|Overall Study|Withdrawal by Subject|2|||
16867771|NCT01585831|37840744|FG001|Overall Study|Withdrawal by Subject|1|||
16867772|NCT01565941|37840752|FG000|Overall Study|Withdrawn by parent/guardian|3|||
16867773|NCT01565941|37840753|FG001|Overall Study|Withdrawn by parent/guardian|2|||
16867774|NCT01565941|37840752|FG000|Overall Study|Randomized; did not receive intevention|8|||
16867775|NCT01565941|37840753|FG001|Overall Study|Randomized; did not receive intevention|2|||
16867776|NCT01558271|37840768|FG000|Overall Study|Adverse Event|6|||
16867777|NCT01558271|37840769|FG001|Overall Study|Adverse Event|3|||
16867778|NCT01558271|37840770|FG002|Overall Study|Adverse Event|4|||
16867779|NCT01558271|37840768|FG000|Overall Study|Lost to Follow-up|1|||
16867780|NCT01558271|37840769|FG001|Overall Study|Lost to Follow-up|0|||
16867781|NCT01558271|37840770|FG002|Overall Study|Lost to Follow-up|0|||
16867782|NCT01558271|37840768|FG000|Overall Study|Protocol Violation|1|||
16867783|NCT01558271|37840769|FG001|Overall Study|Protocol Violation|0|||
16867784|NCT01558271|37840770|FG002|Overall Study|Protocol Violation|0|||
16867785|NCT01558271|37840768|FG000|Overall Study|Withdrawal by Subject|10|||
16867786|NCT01558271|37840769|FG001|Overall Study|Withdrawal by Subject|6|||
16867787|NCT01558271|37840770|FG002|Overall Study|Withdrawal by Subject|12|||
16867788|NCT01558271|37840768|FG000|Overall Study|Physician Decision|0|||
16867789|NCT01558271|37840769|FG001|Overall Study|Physician Decision|2|||
16867790|NCT01558271|37840770|FG002|Overall Study|Physician Decision|1|||
16867791|NCT01565707|37840786|FG000|Overall Study|Adverse Event|1|||
16867792|NCT01565707|37840787|FG001|Overall Study|Adverse Event|6|||
16867793|NCT01565707|37840788|FG002|Overall Study|Adverse Event|2|||
16867794|NCT01565707|37840789|FG003|Overall Study|Adverse Event|1|||
16867795|NCT01565707|37840786|FG000|Overall Study|Lost to Follow-up|1|||
16867796|NCT01565707|37840787|FG001|Overall Study|Lost to Follow-up|0|||
16867797|NCT01565707|37840788|FG002|Overall Study|Lost to Follow-up|0|||
16867798|NCT01565707|37840789|FG003|Overall Study|Lost to Follow-up|0|||
16867799|NCT01565707|37840786|FG000|Overall Study|Protocol Violation|1|||
16867800|NCT01565707|37840787|FG001|Overall Study|Protocol Violation|0|||
16867801|NCT01565707|37840788|FG002|Overall Study|Protocol Violation|0|||
16867802|NCT01565707|37840789|FG003|Overall Study|Protocol Violation|1|||
16867803|NCT01565707|37840786|FG000|Overall Study|Withdrawal by Subject|3|||
16867804|NCT01565707|37840787|FG001|Overall Study|Withdrawal by Subject|1|||
16867805|NCT01565707|37840788|FG002|Overall Study|Withdrawal by Subject|1|||
16867806|NCT01565707|37840789|FG003|Overall Study|Withdrawal by Subject|1|||
16867807|NCT01565707|37840786|FG000|Overall Study|Randomized but not evaluable|2|||
16867808|NCT01565707|37840787|FG001|Overall Study|Randomized but not evaluable|0|||
16867809|NCT01565707|37840788|FG002|Overall Study|Randomized but not evaluable|0|||
16867810|NCT01565707|37840789|FG003|Overall Study|Randomized but not evaluable|0|||
16867811|NCT01565707|37840786|FG000|Overall Study|Miscellaneous|1|||
16867812|NCT01565707|37840787|FG001|Overall Study|Miscellaneous|1|||
16867813|NCT01565707|37840788|FG002|Overall Study|Miscellaneous|0|||
16867814|NCT01565707|37840789|FG003|Overall Study|Miscellaneous|2|||
16867815|NCT01557569|37840808|FG000|Overall Study|Adverse Event|2|||
16867816|NCT01557569|37840809|FG001|Overall Study|Adverse Event|0|||
16867817|NCT01557569|37840808|FG000|Overall Study|high blood pressure|0|||
16867818|NCT01557569|37840809|FG001|Overall Study|high blood pressure|1|||
16867819|NCT01557569|37840808|FG000|Overall Study|Withdrawal by Subject|3|||
16867820|NCT01557569|37840809|FG001|Overall Study|Withdrawal by Subject|5|||
16867821|NCT01557569|37840808|FG000|Overall Study|noncompliance with rules of residential|0|||
16867822|NCT01557569|37840809|FG001|Overall Study|noncompliance with rules of residential|1|||
16867823|NCT01538719|37840817|FG000|Overall Study|Lost to Follow-up|2|||
16867824|NCT01538719|37840818|FG001|Overall Study|Lost to Follow-up|0|||
16867825|NCT01537783|37840826|FG000|Overall Study|Lost to Follow-up|11|||
16867826|NCT01537783|37840827|FG001|Overall Study|Lost to Follow-up|2|||
16867827|NCT01556165|37840835|FG000|Overall Study|Adverse Event|5|||
16867828|NCT01556165|37840836|FG001|Overall Study|Adverse Event|3|||
16867829|NCT01556165|37840835|FG000|Overall Study|Protocol Violation|0|||
16867830|NCT01556165|37840836|FG001|Overall Study|Protocol Violation|3|||
16867831|NCT01556165|37840835|FG000|Overall Study|Withdrawal of Consent|7|||
16867832|NCT01556165|37840836|FG001|Overall Study|Withdrawal of Consent|1|||
16867833|NCT01537549|37840842|FG000|Overall Study|Lost to Follow-up|1|||
16867834|NCT01537549|37840842|FG000|Overall Study|Withdrawal by Subject|2|||
16867835|NCT01555931|37840850|FG000|Overall Study|Lost to Follow-up|2|||
16867836|NCT01555931|37840851|FG001|Overall Study|Lost to Follow-up|5|||
16867837|NCT01583179|37840859|FG000|Overall Study|Screen failure|1|||
16867838|NCT01583179|37840860|FG001|Overall Study|Screen failure|2|||
16867839|NCT01582945|37840866|FG000|Overall Study|Intolerable side-effects|1|||
16867840|NCT01582945|37840866|FG000|Overall Study|Scheduling conflicts|1|||
16867841|NCT01565083|37840872|FG000|Overall Study|Withdrawal by Subject|6|||
16867842|NCT01565083|37840873|FG001|Overall Study|Withdrawal by Subject|4|||
16867843|NCT01565083|37840872|FG000|Overall Study|Lost to Follow-up|2|||
16867844|NCT01565083|37840873|FG001|Overall Study|Lost to Follow-up|7|||
16867845|NCT01565083|37840872|FG000|Overall Study|Death|22|||
16867846|NCT01565083|37840873|FG001|Overall Study|Death|23|||
16867847|NCT01565083|37840872|FG000|Overall Study|Other|3|||
16867848|NCT01565083|37840873|FG001|Overall Study|Other|5|||
17127655|NCT03292406|38268056|FG001|Overall Study|Protocol Violation|1|||
16867849|NCT01555463|37840881|FG000|Treatment|Adverse Event|6|||
16867850|NCT01555463|37840882|FG001|Treatment|Adverse Event|12|||
16867851|NCT01555463|37840881|FG000|Treatment|Withdrawal by Subject|24|||
16867852|NCT01555463|37840882|FG001|Treatment|Withdrawal by Subject|36|||
16867853|NCT01555463|37840881|FG000|Treatment|Lost to Follow-up|28|||
16867854|NCT01555463|37840882|FG001|Treatment|Lost to Follow-up|23|||
16867855|NCT01555463|37840881|FG000|Treatment|Protocol Violation|4|||
16867856|NCT01555463|37840882|FG001|Treatment|Protocol Violation|5|||
16867857|NCT01555463|37840881|FG000|Treatment|Other reason|2|||
16867858|NCT01555463|37840882|FG001|Treatment|Other reason|3|||
16867859|NCT01555463|37840881|FG000|Follow up|Adverse Event|2|||
16867860|NCT01555463|37840882|FG001|Follow up|Adverse Event|5|||
16867861|NCT01555463|37840881|FG000|Follow up|Death|0|||
16867862|NCT01555463|37840882|FG001|Follow up|Death|1|||
16867863|NCT01555463|37840881|FG000|Follow up|Withdrawal by Subject|22|||
16867864|NCT01555463|37840882|FG001|Follow up|Withdrawal by Subject|22|||
16867865|NCT01555463|37840881|FG000|Follow up|Lost to Follow-up|9|||
16867866|NCT01555463|37840882|FG001|Follow up|Lost to Follow-up|10|||
16944904|NCT01097629|38088901|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
16944905|NCT01097629|38088902|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
16944906|NCT01097629|38088903|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16944907|NCT01097629|38088904|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16944908|NCT01097629|38088905|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16944909|NCT01097629|38088906|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16944910|NCT01097629|38088907|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16944911|NCT01097629|38088900|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
16944912|NCT01097629|38088901|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
16944913|NCT01097629|38088902|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
17127656|NCT03292406|38268057|FG002|Overall Study|Protocol Violation|1|||
16867867|NCT01555463|37840881|FG000|Follow up|Protocol Violation|2|||
16867868|NCT01555463|37840882|FG001|Follow up|Protocol Violation|4|||
16867869|NCT01555463|37840881|FG000|Follow up|Other reason|3|||
16867870|NCT01555463|37840882|FG001|Follow up|Other reason|3|||
16867871|NCT01582789|37840888|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
16867872|NCT01582789|37840889|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
16867873|NCT01537393|37840899|FG000|Overall Study|Exclude prior to study|32|||
16867874|NCT01537393|37840900|FG001|Overall Study|Exclude prior to study|44|||
16867875|NCT01537393|37840899|FG000|Overall Study|Death|20|||
16867876|NCT01537393|37840900|FG001|Overall Study|Death|32|||
16867877|NCT01537393|37840899|FG000|Overall Study|Withdrawal by Subject|18|||
16867878|NCT01537393|37840900|FG001|Overall Study|Withdrawal by Subject|17|||
16867879|NCT01537393|37840899|FG000|Overall Study|Lost to Follow-up|53|||
16867880|NCT01537393|37840900|FG001|Overall Study|Lost to Follow-up|48|||
16867881|NCT01537393|37840899|FG000|Overall Study|Failure - Regrafted|28|||
16867882|NCT01537393|37840900|FG001|Overall Study|Failure - Regrafted|43|||
16867883|NCT01537393|37840899|FG000|Overall Study|Failure - Not regrafted|2|||
16867884|NCT01537393|37840900|FG001|Overall Study|Failure - Not regrafted|6|||
16867885|NCT01537393|37840899|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
16867886|NCT01537393|37840900|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
16867887|NCT01555151|37840910|FG000|Overall Study|Withdrawal by Subject|6|||
16867888|NCT01555151|37840911|FG001|Overall Study|Withdrawal by Subject|2|||
16867889|NCT01555151|37840912|FG002|Overall Study|Withdrawal by Subject|0|||
16867890|NCT01555151|37840913|FG003|Overall Study|Withdrawal by Subject|2|||
16867891|NCT01555151|37840910|FG000|Overall Study|Administrative|3|||
16867892|NCT01555151|37840911|FG001|Overall Study|Administrative|1|||
16867893|NCT01555151|37840912|FG002|Overall Study|Administrative|2|||
16867894|NCT01555151|37840913|FG003|Overall Study|Administrative|0|||
16867895|NCT01555151|37840910|FG000|Overall Study|Protocol Violation|3|||
16867896|NCT01555151|37840911|FG001|Overall Study|Protocol Violation|3|||
16867897|NCT01555151|37840912|FG002|Overall Study|Protocol Violation|3|||
16867898|NCT01555151|37840913|FG003|Overall Study|Protocol Violation|5|||
16867899|NCT01555151|37840910|FG000|Overall Study|Adverse Event|1|||
16867900|NCT01555151|37840911|FG001|Overall Study|Adverse Event|2|||
16867901|NCT01555151|37840912|FG002|Overall Study|Adverse Event|1|||
16867902|NCT01555151|37840913|FG003|Overall Study|Adverse Event|2|||
16944914|NCT01097629|38088903|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16867903|NCT01555151|37840910|FG000|Overall Study|Lost to Follow-up|0|||
16867904|NCT01555151|37840911|FG001|Overall Study|Lost to Follow-up|0|||
16867905|NCT01555151|37840912|FG002|Overall Study|Lost to Follow-up|0|||
16867906|NCT01555151|37840913|FG003|Overall Study|Lost to Follow-up|1|||
16867907|NCT01537081|37840927|FG000|Overall Study|Adverse Event|5|||
16867908|NCT01537081|37840928|FG001|Overall Study|Adverse Event|2|||
16867909|NCT01537081|37840929|FG002|Overall Study|Adverse Event|2|||
16944915|NCT01097629|38088904|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16944916|NCT01097629|38088905|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16944917|NCT01097629|38088906|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16944918|NCT01097629|38088907|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16944919|NCT01097629|38088900|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
16944920|NCT01097629|38088901|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
16944921|NCT01097629|38088902|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
16944922|NCT01097629|38088903|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16944923|NCT01097629|38088904|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16944924|NCT01097629|38088905|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16944925|NCT01097629|38088906|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16944926|NCT01097629|38088907|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16944927|NCT01097629|38088900|FG000|DB RO Phase|Withdrawal by Subject|0|||
16944928|NCT01097629|38088901|FG001|DB RO Phase|Withdrawal by Subject|0|||
16944929|NCT01097629|38088902|FG002|DB RO Phase|Withdrawal by Subject|0|||
16944930|NCT01097629|38088903|FG003|DB RO Phase|Withdrawal by Subject|0|||
16944931|NCT01097629|38088904|FG004|DB RO Phase|Withdrawal by Subject|0|||
16944932|NCT01097629|38088905|FG005|DB RO Phase|Withdrawal by Subject|0|||
16944933|NCT01097629|38088906|FG006|DB RO Phase|Withdrawal by Subject|0|||
16944934|NCT01097629|38088907|FG007|DB RO Phase|Withdrawal by Subject|1|||
16944935|NCT01097629|38088900|FG000|DB RO Phase|Protocol Violation|0|||
16944936|NCT01097629|38088901|FG001|DB RO Phase|Protocol Violation|0|||
16944937|NCT01097629|38088902|FG002|DB RO Phase|Protocol Violation|0|||
16944938|NCT01097629|38088903|FG003|DB RO Phase|Protocol Violation|1|||
16944939|NCT01097629|38088904|FG004|DB RO Phase|Protocol Violation|0|||
16867910|NCT01537081|37840927|FG000|Overall Study|Lack of Efficacy|2|||
16867911|NCT01537081|37840928|FG001|Overall Study|Lack of Efficacy|1|||
16867912|NCT01537081|37840929|FG002|Overall Study|Lack of Efficacy|0|||
16867913|NCT01537081|37840927|FG000|Overall Study|Lost to Follow-up|17|||
16867914|NCT01537081|37840928|FG001|Overall Study|Lost to Follow-up|15|||
16867915|NCT01537081|37840929|FG002|Overall Study|Lost to Follow-up|9|||
16867916|NCT01537081|37840927|FG000|Overall Study|Protocol Violation|3|||
16867917|NCT01537081|37840928|FG001|Overall Study|Protocol Violation|2|||
16867918|NCT01537081|37840929|FG002|Overall Study|Protocol Violation|2|||
16944940|NCT01097629|38088905|FG005|DB RO Phase|Protocol Violation|1|||
16944941|NCT01097629|38088906|FG006|DB RO Phase|Protocol Violation|1|||
16944942|NCT01097629|38088907|FG007|DB RO Phase|Protocol Violation|0|||
16944943|NCT01097629|38088900|FG000|DB RO Phase|Lost to Follow-up|0|||
16944944|NCT01097629|38088901|FG001|DB RO Phase|Lost to Follow-up|0|||
16944945|NCT01097629|38088902|FG002|DB RO Phase|Lost to Follow-up|0|||
16944946|NCT01097629|38088903|FG003|DB RO Phase|Lost to Follow-up|0|||
16944947|NCT01097629|38088904|FG004|DB RO Phase|Lost to Follow-up|0|||
16944948|NCT01097629|38088905|FG005|DB RO Phase|Lost to Follow-up|0|||
16944949|NCT01097629|38088906|FG006|DB RO Phase|Lost to Follow-up|2|||
16944950|NCT01097629|38088907|FG007|DB RO Phase|Lost to Follow-up|0|||
16944951|NCT01324622|38088932|FG000|Overall Study|Lost to Follow-up|7|||
16944952|NCT01324622|38088933|FG001|Overall Study|Lost to Follow-up|7|||
16944953|NCT01324622|38088932|FG000|Overall Study|Death|1|||
16944954|NCT01324622|38088933|FG001|Overall Study|Death|0|||
16944955|NCT01324622|38088932|FG000|Overall Study|Lack of Efficacy|1|||
16944956|NCT01324622|38088933|FG001|Overall Study|Lack of Efficacy|0|||
16944957|NCT01097005|38088940|FG000|Overall Study|Case Report Form not collected|18|||
16944958|NCT01097005|38088940|FG000|Overall Study|Subjects cannot visit the hospital|1|||
16944959|NCT01097005|38088940|FG000|Overall Study|Poor medication compliance|1|||
16944960|NCT01097005|38088940|FG000|Overall Study|No examination data available|244|||
16944961|NCT01097005|38088940|FG000|Overall Study|Deviation from exclusion criteria|37|||
16944962|NCT01097005|38088940|FG000|Overall Study|Adverse Event|14|||
16944963|NCT01097005|38088940|FG000|Overall Study|Discontinuance by complication|50|||
16944964|NCT01096849|38088949|FG000|Overall Study|Consent Withdrawn|1|||
16944965|NCT01096849|38088950|FG001|Overall Study|Consent Withdrawn|4|||
16944966|NCT01096849|38088951|FG002|Overall Study|Consent Withdrawn|2|||
16944967|NCT01096849|38088949|FG000|Overall Study|Lack of Efficacy|0|||
16944968|NCT01096849|38088950|FG001|Overall Study|Lack of Efficacy|2|||
16944969|NCT01096849|38088951|FG002|Overall Study|Lack of Efficacy|0|||
16944970|NCT01096849|38088949|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
16944971|NCT01096849|38088950|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
16944972|NCT01096849|38088951|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
16944973|NCT01096849|38088949|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
16944974|NCT01096849|38088950|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
16944975|NCT01096849|38088951|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
16944976|NCT01096849|38088949|FG000|Overall Study|Administrative Reasons|0|||
16944977|NCT01096849|38088950|FG001|Overall Study|Administrative Reasons|1|||
16944978|NCT01096849|38088951|FG002|Overall Study|Administrative Reasons|2|||
16944979|NCT01096849|38088949|FG000|Overall Study|Lost to Follow-up|1|||
16944980|NCT01096849|38088950|FG001|Overall Study|Lost to Follow-up|3|||
16944981|NCT01096849|38088951|FG002|Overall Study|Lost to Follow-up|1|||
16944982|NCT01324388|38088962|FG000|Part 1 of Study|Adverse Event|2|||
16944983|NCT01324388|38088963|FG001|Part 1 of Study|Adverse Event|0|||
16944984|NCT01324388|38088964|FG002|Part 1 of Study|Adverse Event|0|||
16944985|NCT01324388|38088965|FG003|Part 1 of Study|Adverse Event|0|||
16944986|NCT01324388|38088962|FG000|Part 1 of Study|Protocol Violation|1|||
16944987|NCT01324388|38088963|FG001|Part 1 of Study|Protocol Violation|2|||
16944988|NCT01324388|38088964|FG002|Part 1 of Study|Protocol Violation|0|||
16944989|NCT01324388|38088965|FG003|Part 1 of Study|Protocol Violation|0|||
16944990|NCT01324388|38088962|FG000|Part 1 of Study|Physician Decision|1|||
16944991|NCT01324388|38088963|FG001|Part 1 of Study|Physician Decision|0|||
16944992|NCT01324388|38088964|FG002|Part 1 of Study|Physician Decision|0|||
16944993|NCT01324388|38088965|FG003|Part 1 of Study|Physician Decision|0|||
16944994|NCT01324388|38088962|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
16944995|NCT01324388|38088963|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
16944996|NCT01324388|38088964|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
17127657|NCT03292406|38268055|FG000|Overall Study|Other|0|||
16944997|NCT01324388|38088965|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
16944998|NCT01324388|38088962|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
16944999|NCT01324388|38088963|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
16945000|NCT01324388|38088964|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
16945001|NCT01324388|38088965|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
16945002|NCT01102777|38088979|FG000|Overall Study|Death|2|||
16945003|NCT01102777|38088980|FG001|Overall Study|Death|6|||
16945004|NCT01102777|38088979|FG000|Overall Study|Lost to Follow-up|7|||
16945005|NCT01102777|38088980|FG001|Overall Study|Lost to Follow-up|10|||
16945006|NCT01324310|38088987|FG000|Overall Study|Adverse Event|1|||
16945007|NCT01324310|38088987|FG000|Overall Study|Disease Progression|1|||
16945008|NCT01102231|38088993|FG000|Overall Study|Protocol Violation|3|||
16945009|NCT01102231|38088993|FG000|Overall Study|Lack of Efficacy|2|||
16945010|NCT01102231|38088993|FG000|Overall Study|Death|2|||
16945011|NCT01102231|38088993|FG000|Overall Study|Adverse Event|3|||
16945012|NCT01102231|38088993|FG000|Overall Study|Withdrawal by Subject|1|||
16945013|NCT01102231|38088993|FG000|Overall Study|Did not received the treatment|4|||
16945014|NCT01094743|38088998|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
16945015|NCT01095835|38089006|FG000|Overall Study|Adverse Event|8|||
16945016|NCT01095835|38089007|FG001|Overall Study|Adverse Event|6|||
16945017|NCT01095835|38089008|FG002|Overall Study|Adverse Event|6|||
16945018|NCT01095835|38089006|FG000|Overall Study|Lack of Efficacy|0|||
16945019|NCT01095835|38089007|FG001|Overall Study|Lack of Efficacy|1|||
16945020|NCT01095835|38089008|FG002|Overall Study|Lack of Efficacy|0|||
16945021|NCT01095835|38089006|FG000|Overall Study|Physician Decision|0|||
16945022|NCT01095835|38089007|FG001|Overall Study|Physician Decision|0|||
16945023|NCT01095835|38089008|FG002|Overall Study|Physician Decision|1|||
16945024|NCT01095835|38089006|FG000|Overall Study|Withdrawal by Subject|1|||
16945025|NCT01095835|38089007|FG001|Overall Study|Withdrawal by Subject|3|||
16945026|NCT01095835|38089008|FG002|Overall Study|Withdrawal by Subject|0|||
16945027|NCT01095835|38089006|FG000|Overall Study|Non study compliance|0|||
16945028|NCT01095835|38089007|FG001|Overall Study|Non study compliance|0|||
16945029|NCT01095835|38089008|FG002|Overall Study|Non study compliance|1|||
16774143|NCT02201524|37713430|FG003|Overall Study|Lost to Follow-up|0|||
16945030|NCT01095835|38089006|FG000|Overall Study|Protocol Violation|1|||
16945031|NCT01095835|38089007|FG001|Overall Study|Protocol Violation|2|||
16945032|NCT01095835|38089008|FG002|Overall Study|Protocol Violation|0|||
16945033|NCT01324232|38089021|FG000|Overall Study|Protocol Violation|0|||
16945034|NCT01324232|38089022|FG001|Overall Study|Protocol Violation|0|||
16945035|NCT01324232|38089023|FG002|Overall Study|Protocol Violation|0|||
16945036|NCT01324232|38089024|FG003|Overall Study|Protocol Violation|2|||
16945037|NCT01324232|38089021|FG000|Overall Study|Missing|0|||
16945038|NCT01324232|38089022|FG001|Overall Study|Missing|0|||
16945039|NCT01324232|38089023|FG002|Overall Study|Missing|1|||
16945040|NCT01324232|38089024|FG003|Overall Study|Missing|0|||
16945041|NCT01324232|38089021|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
16945042|NCT01324232|38089022|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
16945043|NCT01324232|38089023|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
16945044|NCT01324232|38089024|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
16945045|NCT01324232|38089021|FG000|Overall Study|Lack of Efficacy|2|||
16945046|NCT01324232|38089022|FG001|Overall Study|Lack of Efficacy|1|||
16945047|NCT01324232|38089023|FG002|Overall Study|Lack of Efficacy|2|||
16945048|NCT01324232|38089024|FG003|Overall Study|Lack of Efficacy|2|||
16945049|NCT01324232|38089021|FG000|Overall Study|Participant Refused Medication|0|||
16945050|NCT01324232|38089022|FG001|Overall Study|Participant Refused Medication|1|||
16945051|NCT01324232|38089023|FG002|Overall Study|Participant Refused Medication|0|||
16945052|NCT01324232|38089024|FG003|Overall Study|Participant Refused Medication|0|||
16945053|NCT01324232|38089021|FG000|Overall Study|Intercurrent illness|0|||
16945054|NCT01324232|38089022|FG001|Overall Study|Intercurrent illness|0|||
16945055|NCT01324232|38089023|FG002|Overall Study|Intercurrent illness|0|||
16945056|NCT01324232|38089024|FG003|Overall Study|Intercurrent illness|1|||
16945057|NCT01324232|38089021|FG000|Overall Study|Adverse Event|2|||
16945058|NCT01324232|38089022|FG001|Overall Study|Adverse Event|5|||
16945059|NCT01324232|38089023|FG002|Overall Study|Adverse Event|6|||
16945060|NCT01324232|38089024|FG003|Overall Study|Adverse Event|6|||
16945061|NCT01324232|38089021|FG000|Overall Study|Withdrawal by Subject|0|||
16945062|NCT01324232|38089022|FG001|Overall Study|Withdrawal by Subject|3|||
16945063|NCT01324232|38089023|FG002|Overall Study|Withdrawal by Subject|4|||
16945064|NCT01324232|38089024|FG003|Overall Study|Withdrawal by Subject|0|||
16945065|NCT01324232|38089021|FG000|Overall Study|Lost to Follow-up|1|||
16945066|NCT01324232|38089022|FG001|Overall Study|Lost to Follow-up|0|||
16945067|NCT01324232|38089023|FG002|Overall Study|Lost to Follow-up|0|||
16945068|NCT01324232|38089024|FG003|Overall Study|Lost to Follow-up|0|||
16945069|NCT01094119|38089041|FG000|Overall Study|Lack of Efficacy|2|||
16945070|NCT01094119|38089042|FG001|Overall Study|Lack of Efficacy|4|||
16945071|NCT01323920|38089048|FG000|Overall Study|Death|5|||
16945072|NCT01323920|38089048|FG000|Overall Study|Withdrawal by Subject|1|||
16945073|NCT01093885|38089052|FG000|Overall Study|Adverse Event|4|||
16945074|NCT01093885|38089052|FG000|Overall Study|Lost to Follow-up|1|||
16945075|NCT01101997|38089057|FG000|Overall Study|Withdrawal by Subject|2|||
16945076|NCT01324830|38089082|FG000|Overall Study|Progressive Disease|3|||
16945077|NCT01324830|38089083|FG001|Overall Study|Progressive Disease|2|||
16945078|NCT01324830|38089084|FG002|Overall Study|Progressive Disease|3|||
16945079|NCT01324830|38089085|FG003|Overall Study|Progressive Disease|3|||
16945080|NCT01324830|38089086|FG004|Overall Study|Progressive Disease|6|||
16945081|NCT01324830|38089087|FG005|Overall Study|Progressive Disease|6|||
16945082|NCT01324830|38089088|FG006|Overall Study|Progressive Disease|3|||
16945083|NCT01324830|38089089|FG007|Overall Study|Progressive Disease|3|||
16945084|NCT01324830|38089090|FG008|Overall Study|Progressive Disease|3|||
16945085|NCT01324830|38089091|FG009|Overall Study|Progressive Disease|6|||
16945086|NCT01324830|38089092|FG010|Overall Study|Progressive Disease|2|||
16945087|NCT01324830|38089093|FG011|Overall Study|Progressive Disease|1|||
16945088|NCT01324830|38089094|FG012|Overall Study|Progressive Disease|1|||
16945089|NCT01324830|38089095|FG013|Overall Study|Progressive Disease|1|||
16945090|NCT01324830|38089096|FG014|Overall Study|Progressive Disease|1|||
16945091|NCT01324830|38089097|FG015|Overall Study|Progressive Disease|3|||
16945092|NCT01324830|38089098|FG016|Overall Study|Progressive Disease|2|||
16945093|NCT01324830|38089099|FG017|Overall Study|Progressive Disease|3|||
16945094|NCT01324830|38089100|FG018|Overall Study|Progressive Disease|4|||
16945095|NCT01324830|38089082|FG000|Overall Study|Dose limiting toxicity|0|||
16945096|NCT01324830|38089083|FG001|Overall Study|Dose limiting toxicity|0|||
16945097|NCT01324830|38089084|FG002|Overall Study|Dose limiting toxicity|0|||
16945098|NCT01324830|38089085|FG003|Overall Study|Dose limiting toxicity|0|||
16945099|NCT01324830|38089086|FG004|Overall Study|Dose limiting toxicity|1|||
16945100|NCT01324830|38089087|FG005|Overall Study|Dose limiting toxicity|0|||
16945101|NCT01324830|38089088|FG006|Overall Study|Dose limiting toxicity|0|||
16945102|NCT01324830|38089089|FG007|Overall Study|Dose limiting toxicity|0|||
16945103|NCT01324830|38089090|FG008|Overall Study|Dose limiting toxicity|0|||
16945104|NCT01324830|38089091|FG009|Overall Study|Dose limiting toxicity|0|||
16945105|NCT01324830|38089092|FG010|Overall Study|Dose limiting toxicity|0|||
16945106|NCT01324830|38089093|FG011|Overall Study|Dose limiting toxicity|0|||
16945107|NCT01324830|38089094|FG012|Overall Study|Dose limiting toxicity|0|||
16945108|NCT01324830|38089095|FG013|Overall Study|Dose limiting toxicity|0|||
16945109|NCT01324830|38089096|FG014|Overall Study|Dose limiting toxicity|0|||
16945110|NCT01324830|38089097|FG015|Overall Study|Dose limiting toxicity|0|||
16945111|NCT01324830|38089098|FG016|Overall Study|Dose limiting toxicity|1|||
16945112|NCT01324830|38089099|FG017|Overall Study|Dose limiting toxicity|1|||
16945113|NCT01324830|38089100|FG018|Overall Study|Dose limiting toxicity|1|||
16945114|NCT01324830|38089082|FG000|Overall Study|Reason not mentioned above|0|||
16945115|NCT01324830|38089083|FG001|Overall Study|Reason not mentioned above|0|||
16945116|NCT01324830|38089084|FG002|Overall Study|Reason not mentioned above|0|||
16945117|NCT01324830|38089085|FG003|Overall Study|Reason not mentioned above|0|||
16945118|NCT01324830|38089086|FG004|Overall Study|Reason not mentioned above|0|||
16945119|NCT01324830|38089087|FG005|Overall Study|Reason not mentioned above|0|||
16945120|NCT01324830|38089088|FG006|Overall Study|Reason not mentioned above|0|||
16945121|NCT01324830|38089089|FG007|Overall Study|Reason not mentioned above|0|||
16945122|NCT01324830|38089090|FG008|Overall Study|Reason not mentioned above|0|||
16945123|NCT01324830|38089091|FG009|Overall Study|Reason not mentioned above|0|||
16945124|NCT01324830|38089092|FG010|Overall Study|Reason not mentioned above|0|||
16945125|NCT01324830|38089093|FG011|Overall Study|Reason not mentioned above|0|||
16945126|NCT01324830|38089094|FG012|Overall Study|Reason not mentioned above|0|||
16945127|NCT01324830|38089095|FG013|Overall Study|Reason not mentioned above|0|||
16945128|NCT01324830|38089096|FG014|Overall Study|Reason not mentioned above|0|||
16945129|NCT01324830|38089097|FG015|Overall Study|Reason not mentioned above|0|||
16945130|NCT01324830|38089098|FG016|Overall Study|Reason not mentioned above|0|||
16945131|NCT01324830|38089099|FG017|Overall Study|Reason not mentioned above|1|||
16945132|NCT01324830|38089100|FG018|Overall Study|Reason not mentioned above|0|||
16945133|NCT01324830|38089082|FG000|Overall Study|Adverse Event, serious fatal|0|||
16945134|NCT01324830|38089083|FG001|Overall Study|Adverse Event, serious fatal|1|||
16945135|NCT01324830|38089084|FG002|Overall Study|Adverse Event, serious fatal|0|||
16945136|NCT01324830|38089085|FG003|Overall Study|Adverse Event, serious fatal|0|||
16945137|NCT01324830|38089086|FG004|Overall Study|Adverse Event, serious fatal|0|||
16945138|NCT01324830|38089087|FG005|Overall Study|Adverse Event, serious fatal|0|||
16945139|NCT01324830|38089088|FG006|Overall Study|Adverse Event, serious fatal|0|||
16945140|NCT01324830|38089089|FG007|Overall Study|Adverse Event, serious fatal|0|||
16945141|NCT01324830|38089090|FG008|Overall Study|Adverse Event, serious fatal|0|||
16945142|NCT01324830|38089091|FG009|Overall Study|Adverse Event, serious fatal|0|||
16945143|NCT01324830|38089092|FG010|Overall Study|Adverse Event, serious fatal|0|||
16945144|NCT01324830|38089093|FG011|Overall Study|Adverse Event, serious fatal|0|||
16945145|NCT01324830|38089094|FG012|Overall Study|Adverse Event, serious fatal|0|||
16945146|NCT01324830|38089095|FG013|Overall Study|Adverse Event, serious fatal|0|||
16945147|NCT01324830|38089096|FG014|Overall Study|Adverse Event, serious fatal|0|||
16945148|NCT01324830|38089097|FG015|Overall Study|Adverse Event, serious fatal|0|||
16945149|NCT01324830|38089098|FG016|Overall Study|Adverse Event, serious fatal|0|||
16945150|NCT01324830|38089099|FG017|Overall Study|Adverse Event, serious fatal|0|||
16945151|NCT01324830|38089100|FG018|Overall Study|Adverse Event, serious fatal|0|||
16945152|NCT01324830|38089082|FG000|Overall Study|Adverse Event, non-fatal|0|||
16945153|NCT01324830|38089083|FG001|Overall Study|Adverse Event, non-fatal|0|||
16945154|NCT01324830|38089084|FG002|Overall Study|Adverse Event, non-fatal|0|||
16945155|NCT01324830|38089085|FG003|Overall Study|Adverse Event, non-fatal|0|||
16945156|NCT01324830|38089086|FG004|Overall Study|Adverse Event, non-fatal|0|||
16945157|NCT01324830|38089087|FG005|Overall Study|Adverse Event, non-fatal|0|||
16945158|NCT01324830|38089088|FG006|Overall Study|Adverse Event, non-fatal|0|||
16945159|NCT01324830|38089089|FG007|Overall Study|Adverse Event, non-fatal|0|||
16945160|NCT01324830|38089090|FG008|Overall Study|Adverse Event, non-fatal|2|||
16945161|NCT01324830|38089091|FG009|Overall Study|Adverse Event, non-fatal|0|||
16945162|NCT01324830|38089092|FG010|Overall Study|Adverse Event, non-fatal|1|||
16945163|NCT01324830|38089093|FG011|Overall Study|Adverse Event, non-fatal|0|||
16945164|NCT01324830|38089094|FG012|Overall Study|Adverse Event, non-fatal|0|||
16945165|NCT01324830|38089095|FG013|Overall Study|Adverse Event, non-fatal|0|||
16945166|NCT01324830|38089096|FG014|Overall Study|Adverse Event, non-fatal|0|||
16945167|NCT01324830|38089097|FG015|Overall Study|Adverse Event, non-fatal|0|||
16945168|NCT01324830|38089098|FG016|Overall Study|Adverse Event, non-fatal|0|||
16945169|NCT01324830|38089099|FG017|Overall Study|Adverse Event, non-fatal|1|||
16945170|NCT01324830|38089100|FG018|Overall Study|Adverse Event, non-fatal|0|||
16945171|NCT01324830|38089082|FG000|Overall Study|Withdrawal by Subject|0|||
16945172|NCT01324830|38089083|FG001|Overall Study|Withdrawal by Subject|0|||
16945173|NCT01324830|38089084|FG002|Overall Study|Withdrawal by Subject|0|||
16945174|NCT01324830|38089085|FG003|Overall Study|Withdrawal by Subject|0|||
16945175|NCT01324830|38089086|FG004|Overall Study|Withdrawal by Subject|0|||
16945176|NCT01324830|38089087|FG005|Overall Study|Withdrawal by Subject|1|||
16945177|NCT01324830|38089088|FG006|Overall Study|Withdrawal by Subject|0|||
16945178|NCT01324830|38089089|FG007|Overall Study|Withdrawal by Subject|0|||
16945179|NCT01324830|38089090|FG008|Overall Study|Withdrawal by Subject|0|||
16945180|NCT01324830|38089091|FG009|Overall Study|Withdrawal by Subject|0|||
16945181|NCT01324830|38089092|FG010|Overall Study|Withdrawal by Subject|1|||
16945182|NCT01324830|38089093|FG011|Overall Study|Withdrawal by Subject|0|||
16945183|NCT01324830|38089094|FG012|Overall Study|Withdrawal by Subject|0|||
16945184|NCT01324830|38089095|FG013|Overall Study|Withdrawal by Subject|0|||
16945185|NCT01324830|38089096|FG014|Overall Study|Withdrawal by Subject|0|||
16945186|NCT01324830|38089097|FG015|Overall Study|Withdrawal by Subject|0|||
16945187|NCT01324830|38089098|FG016|Overall Study|Withdrawal by Subject|0|||
16945188|NCT01324830|38089099|FG017|Overall Study|Withdrawal by Subject|0|||
16945189|NCT01324830|38089100|FG018|Overall Study|Withdrawal by Subject|1|||
16945190|NCT01324440|38089148|FG000|Overall Study|Subject moved|0|||
16945191|NCT01324440|38089149|FG001|Overall Study|Subject moved|1|||
16945192|NCT01325493|38089157|FG000|Overall Study|Protocol Violation|0|||
16945193|NCT01325493|38089158|FG001|Overall Study|Protocol Violation|1|||
16945194|NCT01325493|38089157|FG000|Overall Study|loss of neuromonitoring signals|0|||
16945195|NCT01325493|38089158|FG001|Overall Study|loss of neuromonitoring signals|2|||
16945196|NCT01325493|38089157|FG000|Overall Study|Allergy|1|||
16945197|NCT01325493|38089158|FG001|Overall Study|Allergy|0|||
16945198|NCT01323972|38089168|FG000|Overall Study|Withdrawal by Subject|1|||
16945199|NCT01323972|38089169|FG001|Overall Study|Withdrawal by Subject|0|||
16945200|NCT01323972|38089170|FG002|Overall Study|Withdrawal by Subject|1|||
16945201|NCT01323972|38089171|FG003|Overall Study|Withdrawal by Subject|0|||
16945202|NCT01323972|38089168|FG000|Overall Study|Migrated/moved from study area|1|||
16945203|NCT01323972|38089169|FG001|Overall Study|Migrated/moved from study area|2|||
16945204|NCT01323972|38089170|FG002|Overall Study|Migrated/moved from study area|0|||
16945205|NCT01323972|38089171|FG003|Overall Study|Migrated/moved from study area|0|||
16945206|NCT01323972|38089168|FG000|Overall Study|Lost to Follow-up|0|||
16945207|NCT01323972|38089169|FG001|Overall Study|Lost to Follow-up|1|||
16945208|NCT01323972|38089170|FG002|Overall Study|Lost to Follow-up|1|||
16945209|NCT01323972|38089171|FG003|Overall Study|Lost to Follow-up|1|||
16945210|NCT01325337|38089188|FG000|Overall Study|Adverse Event|0|||
16945211|NCT01325337|38089189|FG001|Overall Study|Adverse Event|2|||
16945212|NCT01325337|38089190|FG002|Overall Study|Adverse Event|2|||
16945213|NCT01325337|38089191|FG003|Overall Study|Adverse Event|1|||
16945214|NCT01325337|38089192|FG004|Overall Study|Adverse Event|2|||
16945215|NCT01325337|38089188|FG000|Overall Study|Lost to Follow-up|2|||
16945216|NCT01325337|38089189|FG001|Overall Study|Lost to Follow-up|2|||
16945217|NCT01325337|38089190|FG002|Overall Study|Lost to Follow-up|2|||
16945218|NCT01325337|38089191|FG003|Overall Study|Lost to Follow-up|1|||
16945219|NCT01325337|38089192|FG004|Overall Study|Lost to Follow-up|2|||
16945220|NCT01325337|38089188|FG000|Overall Study|Personal Reasons|2|||
16945221|NCT01325337|38089189|FG001|Overall Study|Personal Reasons|5|||
16945222|NCT01325337|38089190|FG002|Overall Study|Personal Reasons|4|||
16945223|NCT01325337|38089191|FG003|Overall Study|Personal Reasons|8|||
16945224|NCT01325337|38089192|FG004|Overall Study|Personal Reasons|3|||
16945225|NCT01325337|38089188|FG000|Overall Study|Withdrawal by Subject|1|||
16945226|NCT01325337|38089189|FG001|Overall Study|Withdrawal by Subject|0|||
16945227|NCT01325337|38089190|FG002|Overall Study|Withdrawal by Subject|1|||
16945228|NCT01325337|38089191|FG003|Overall Study|Withdrawal by Subject|0|||
16945229|NCT01325337|38089192|FG004|Overall Study|Withdrawal by Subject|1|||
16945230|NCT01324947|38089204|FG000|Overall Study|Adverse Event|7|||
16945231|NCT01324947|38089204|FG000|Overall Study|Death|10|||
16945232|NCT01324947|38089204|FG000|Overall Study|Other|3|||
16945233|NCT01324947|38089204|FG000|Overall Study|Progressive Disease|50|||
16945234|NCT01324947|38089204|FG000|Overall Study|Withdrawal by Subject|3|||
16945235|NCT01324947|38089204|FG000|Overall Study|1 discontinued before starting drug|1|||
16945236|NCT01101841|38089212|FG000|Overall Study|Adverse Event|15|||
16945237|NCT01101841|38089213|FG001|Overall Study|Adverse Event|15|||
16945238|NCT01101841|38089212|FG000|Overall Study|Lost to Follow-up|9|||
16945239|NCT01101841|38089213|FG001|Overall Study|Lost to Follow-up|3|||
16945240|NCT01101841|38089212|FG000|Overall Study|Withdrawal by Subject|21|||
16945241|NCT01101841|38089213|FG001|Overall Study|Withdrawal by Subject|40|||
16945242|NCT01101841|38089212|FG000|Overall Study|Protocol Violation|1|||
16945243|NCT01101841|38089213|FG001|Overall Study|Protocol Violation|1|||
16945244|NCT01101841|38089212|FG000|Overall Study|Physician Decision|0|||
16945245|NCT01101841|38089213|FG001|Overall Study|Physician Decision|2|||
16945246|NCT01101841|38089212|FG000|Overall Study|Lack of Efficacy|0|||
16945247|NCT01101841|38089213|FG001|Overall Study|Lack of Efficacy|2|||
16945248|NCT01101841|38089212|FG000|Overall Study|Other|0|||
16945249|NCT01101841|38089213|FG001|Overall Study|Other|1|||
16945250|NCT01101841|38089212|FG000|Overall Study|Suicidality Tracking Scale|3|||
16945251|NCT01101841|38089213|FG001|Overall Study|Suicidality Tracking Scale|1|||
16945252|NCT01101841|38089212|FG000|Overall Study|Eligibility Criteria|1|||
16945253|NCT01101841|38089213|FG001|Overall Study|Eligibility Criteria|2|||
16945254|NCT01324401|38089222|FG000|Overall Study|Withdrawn before any treatment|0|||
16945255|NCT01324401|38089223|FG001|Overall Study|Withdrawn before any treatment|3|||
16945256|NCT01324401|38089222|FG000|Overall Study|Adverse Event|1|||
16945257|NCT01324401|38089223|FG001|Overall Study|Adverse Event|3|||
16945258|NCT01323660|38089229|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
16945259|NCT01323660|38089230|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
16945260|NCT01323660|38089231|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
16945261|NCT01323660|38089232|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
16945262|NCT01323660|38089233|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
16945263|NCT01323660|38089234|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
16945264|NCT01323660|38089229|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
16945265|NCT01323660|38089230|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
16945266|NCT01323660|38089231|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
16945267|NCT01323660|38089232|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
16945268|NCT01323660|38089233|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
16945269|NCT01323660|38089234|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
16945270|NCT01323660|38089229|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
16945271|NCT01323660|38089230|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
16945272|NCT01323660|38089231|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
16945273|NCT01323660|38089232|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
16945274|NCT01323660|38089233|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
16945275|NCT01323660|38089234|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
16945276|NCT01323660|38089229|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16945277|NCT01323660|38089230|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16945278|NCT01323660|38089231|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16945279|NCT01323660|38089232|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16945280|NCT01323660|38089233|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
16945281|NCT01323660|38089234|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16945282|NCT01323660|38089229|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16945283|NCT01323660|38089230|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16945284|NCT01323660|38089231|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16945285|NCT01323660|38089232|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16945286|NCT01323660|38089233|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16945287|NCT01323660|38089234|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16945288|NCT01323660|38089229|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
16945289|NCT01323660|38089230|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16945290|NCT01323660|38089231|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
16945291|NCT01323660|38089232|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
16945292|NCT01323660|38089233|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
16945293|NCT01323660|38089234|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16945294|NCT01323660|38089229|FG000|Washout Period (14 Days)|Adverse Event|0|||
16945295|NCT01323660|38089230|FG001|Washout Period (14 Days)|Adverse Event|0|||
16945296|NCT01323660|38089231|FG002|Washout Period (14 Days)|Adverse Event|0|||
16945297|NCT01323660|38089232|FG003|Washout Period (14 Days)|Adverse Event|0|||
16945298|NCT01323660|38089233|FG004|Washout Period (14 Days)|Adverse Event|1|||
16945299|NCT01323660|38089234|FG005|Washout Period (14 Days)|Adverse Event|0|||
16945300|NCT01323660|38089229|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
16945301|NCT01323660|38089230|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
16945302|NCT01323660|38089231|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
16945303|NCT01323660|38089232|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
16945304|NCT01323660|38089233|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
16945305|NCT01323660|38089234|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
16945306|NCT01323660|38089229|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16945307|NCT01323660|38089230|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16945308|NCT01323660|38089231|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16945309|NCT01323660|38089232|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16945310|NCT01323660|38089233|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16945311|NCT01323660|38089234|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
16945312|NCT01323660|38089229|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
16945313|NCT01323660|38089230|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
16945314|NCT01323660|38089231|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
16945315|NCT01323660|38089232|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
16945316|NCT01323660|38089233|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
16945317|NCT01323660|38089234|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
16945318|NCT01323660|38089229|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16945319|NCT01323660|38089230|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16945320|NCT01323660|38089231|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16945321|NCT01323660|38089232|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16945322|NCT01323660|38089233|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16945323|NCT01323660|38089234|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
16945324|NCT01323660|38089229|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
16945325|NCT01323660|38089230|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16945326|NCT01323660|38089231|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16945327|NCT01323660|38089232|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16945328|NCT01323660|38089233|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16945329|NCT01323660|38089234|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
16945330|NCT01323660|38089229|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16945331|NCT01323660|38089230|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16945332|NCT01323660|38089231|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16945333|NCT01323660|38089232|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16945334|NCT01323660|38089233|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
16945335|NCT01323660|38089234|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16945336|NCT01092637|38089250|FG000|Overall Study|Death|47|||
16945337|NCT01092637|38089251|FG001|Overall Study|Death|49|||
16945338|NCT01324323|38089258|FG000|Overall Study|Withdrawal by Subject|1|||
16945339|NCT01323582|38089272|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
16945340|NCT01323582|38089273|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
16945341|NCT01323582|38089272|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
16945342|NCT01323582|38089273|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
16945343|NCT01323582|38089272|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
16945344|NCT01323582|38089273|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
16945345|NCT01323621|38089283|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
16945346|NCT01323621|38089284|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
16945347|NCT01323621|38089285|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
16945348|NCT01323621|38089283|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
16945349|NCT01323621|38089284|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
16945350|NCT01323621|38089285|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
16945351|NCT01323621|38089283|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
16945352|NCT01323621|38089284|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
16945353|NCT01323621|38089285|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
16945354|NCT01323621|38089283|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
16945355|NCT01323621|38089284|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
16945356|NCT01323621|38089285|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
16945357|NCT01323621|38089283|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
16945358|NCT01323621|38089284|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
16945359|NCT01323621|38089285|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
16945360|NCT01323621|38089283|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
16945361|NCT01323621|38089284|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
16945362|NCT01323621|38089285|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
16945363|NCT01323621|38089283|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
16945364|NCT01323621|38089284|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
16945365|NCT01323621|38089285|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
16945366|NCT01323621|38089283|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
16945367|NCT01323621|38089284|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
16945368|NCT01323621|38089285|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
16945369|NCT01323621|38089283|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
16945370|NCT01323621|38089284|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
16945371|NCT01323621|38089285|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
16945372|NCT01323621|38089283|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16945373|NCT01323621|38089284|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16945374|NCT01323621|38089285|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16945375|NCT01323621|38089283|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
16945376|NCT01323621|38089284|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
16945377|NCT01323621|38089285|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
16945378|NCT01323621|38089283|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16945379|NCT01323621|38089284|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
16945380|NCT01323621|38089285|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
16945381|NCT01323192|38089293|FG000|Overall Study|Adverse Event|6|||
16945382|NCT01323192|38089294|FG001|Overall Study|Adverse Event|1|||
16945383|NCT01323192|38089293|FG000|Overall Study|Withdrawal by Subject|3|||
16945384|NCT01323192|38089294|FG001|Overall Study|Withdrawal by Subject|1|||
16945385|NCT01323192|38089293|FG000|Overall Study|Noncompliance with study medication|0|||
16945386|NCT01323192|38089294|FG001|Overall Study|Noncompliance with study medication|3|||
16945387|NCT01323192|38089293|FG000|Overall Study|Nonmedical reasons|0|||
16945388|NCT01323192|38089294|FG001|Overall Study|Nonmedical reasons|1|||
16945389|NCT01323387|38089300|FG000|Overall Study|Withdrawal by Subject|41|||
16945390|NCT01323387|38089300|FG000|Overall Study|Radiographic Data Unavailable|1|||
16945391|NCT01323387|38089300|FG000|Overall Study|Revision|14|||
16945392|NCT01323387|38089300|FG000|Overall Study|Protocol Violation|12|||
16945393|NCT01323387|38089300|FG000|Overall Study|Randomized but Never Treated|16|||
16945394|NCT01321749|38089308|FG000|Overall Study|Lost to Follow-up|4|||
16945395|NCT01321749|38089309|FG001|Overall Study|Lost to Follow-up|11|||
16945396|NCT01321749|38089308|FG000|Overall Study|Protocol Violation|4|||
16945397|NCT01321749|38089309|FG001|Overall Study|Protocol Violation|7|||
16945398|NCT01321749|38089308|FG000|Overall Study|Withdrawal by Subject|5|||
16945399|NCT01321749|38089309|FG001|Overall Study|Withdrawal by Subject|4|||
16945400|NCT01320735|38089315|FG000|Overall Study|Adverse Event|3|||
16945401|NCT01320735|38089315|FG000|Overall Study|Withdrawal by Subject|3|||
16945402|NCT01320735|38089315|FG000|Overall Study|Lost to Follow-up|13|||
16945403|NCT01320735|38089315|FG000|Overall Study|Administrative Reason|6|||
16945404|NCT01320735|38089315|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
16945405|NCT01320735|38089315|FG000|Overall Study|Protocol Violation|1|||
16945406|NCT01320735|38089315|FG000|Overall Study|Other|1|||
16945407|NCT01320735|38089315|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
16945408|NCT01320735|38089315|FG000|Overall Study|Investigator Unable to be Contacted|17|||
16945409|NCT01320033|38089322|FG000|Overall Study|Lack of Efficacy|0|||
16945410|NCT01320033|38089323|FG001|Overall Study|Lack of Efficacy|0|||
16945411|NCT01320033|38089324|FG002|Overall Study|Lack of Efficacy|1|||
16945412|NCT01320033|38089322|FG000|Overall Study|Adverse Event|9|||
16945413|NCT01320033|38089323|FG001|Overall Study|Adverse Event|7|||
16945414|NCT01320033|38089324|FG002|Overall Study|Adverse Event|8|||
16945415|NCT01320033|38089322|FG000|Overall Study|Withdrawal by Subject|22|||
16945416|NCT01320033|38089323|FG001|Overall Study|Withdrawal by Subject|23|||
16945417|NCT01320033|38089324|FG002|Overall Study|Withdrawal by Subject|23|||
16945418|NCT01320033|38089322|FG000|Overall Study|Protocol Violation|3|||
16945419|NCT01320033|38089323|FG001|Overall Study|Protocol Violation|5|||
16945420|NCT01320033|38089324|FG002|Overall Study|Protocol Violation|3|||
16945421|NCT01320033|38089322|FG000|Overall Study|Lost to Follow-up|22|||
16945422|NCT01320033|38089323|FG001|Overall Study|Lost to Follow-up|26|||
16945423|NCT01320033|38089324|FG002|Overall Study|Lost to Follow-up|17|||
16945424|NCT01320033|38089322|FG000|Overall Study|Other|2|||
16945425|NCT01320033|38089323|FG001|Overall Study|Other|3|||
16945426|NCT01320033|38089324|FG002|Overall Study|Other|1|||
16945427|NCT01101061|38089338|FG000|Overall Study|Adverse Event|0|||
16945428|NCT01101061|38089339|FG001|Overall Study|Adverse Event|0|||
16945429|NCT01101061|38089340|FG002|Overall Study|Adverse Event|1|||
16945430|NCT01101061|38089341|FG003|Overall Study|Adverse Event|0|||
16945431|NCT01101061|38089342|FG004|Overall Study|Adverse Event|0|||
16945432|NCT01101061|38089343|FG005|Overall Study|Adverse Event|0|||
16945433|NCT01317615|38089361|FG000|Overall Study|Disease progression|25|||
16945434|NCT01317615|38089361|FG000|Overall Study|New cancer therapy|5|||
16945435|NCT01317615|38089361|FG000|Overall Study|Death|6|||
16945436|NCT01317615|38089361|FG000|Overall Study|Withdrawal by Subject|5|||
16945437|NCT01317615|38089361|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16945438|NCT01317615|38089361|FG000|Overall Study|Adverse Event|7|||
16945439|NCT01078675|38089367|FG000|Overall Study|Withdrawal by Subject|7|||
16945440|NCT01078675|38089368|FG001|Overall Study|Withdrawal by Subject|3|||
16945441|NCT01078675|38089367|FG000|Overall Study|Protocol Violation|56|||
16945442|NCT01078675|38089368|FG001|Overall Study|Protocol Violation|0|||
16945443|NCT01078675|38089367|FG000|Overall Study|Provided in CRF for specific reasons|2|||
16945444|NCT01078675|38089368|FG001|Overall Study|Provided in CRF for specific reasons|3|||
16945445|NCT01078675|38089367|FG000|Overall Study|Adverse Event|3|||
16945446|NCT01078675|38089368|FG001|Overall Study|Adverse Event|0|||
16945447|NCT01100437|38089374|FG000|Titration/Stabilization|Adverse Event|0|||
16945448|NCT01100437|38089375|FG001|Titration/Stabilization|Adverse Event|0|||
16945449|NCT01100437|38089376|FG002|Titration/Stabilization|Adverse Event|4|||
16945450|NCT01100437|38089374|FG000|Titration/Stabilization|Non-compliance|0|||
16945451|NCT01100437|38089375|FG001|Titration/Stabilization|Non-compliance|0|||
16945452|NCT01100437|38089376|FG002|Titration/Stabilization|Non-compliance|1|||
16945453|NCT01100437|38089374|FG000|Titration/Stabilization|Sponsor canceled study|0|||
16945454|NCT01100437|38089375|FG001|Titration/Stabilization|Sponsor canceled study|0|||
16945455|NCT01100437|38089376|FG002|Titration/Stabilization|Sponsor canceled study|1|||
16945456|NCT01100437|38089374|FG000|Maintenance|Withdrawal by Subject|0|||
16945457|NCT01100437|38089375|FG001|Maintenance|Withdrawal by Subject|0|||
16945458|NCT01100437|38089376|FG002|Maintenance|Withdrawal by Subject|1|||
16945459|NCT01100437|38089374|FG000|Maintenance|Sponsor termination of study|0|||
16945460|NCT01100437|38089375|FG001|Maintenance|Sponsor termination of study|0|||
16945461|NCT01100437|38089376|FG002|Maintenance|Sponsor termination of study|1|||
16945462|NCT01322490|38089388|FG000|Treatment Period|Adverse Event|12|||
16945463|NCT01322490|38089389|FG001|Treatment Period|Adverse Event|18|||
16945464|NCT01322490|38089390|FG002|Treatment Period|Adverse Event|15|||
16945465|NCT01322490|38089388|FG000|Treatment Period|Death|5|||
16945466|NCT01322490|38089389|FG001|Treatment Period|Death|7|||
16945467|NCT01322490|38089390|FG002|Treatment Period|Death|3|||
16945468|NCT01322490|38089388|FG000|Treatment Period|Lack of Efficacy|89|||
16945469|NCT01322490|38089389|FG001|Treatment Period|Lack of Efficacy|100|||
16945470|NCT01322490|38089390|FG002|Treatment Period|Lack of Efficacy|112|||
16945471|NCT01322490|38089388|FG000|Treatment Period|Physician Decision|0|||
16945472|NCT01322490|38089389|FG001|Treatment Period|Physician Decision|2|||
16945473|NCT01322490|38089390|FG002|Treatment Period|Physician Decision|1|||
16945474|NCT01322490|38089388|FG000|Treatment Period|Protocol Violation|7|||
16945475|NCT01322490|38089389|FG001|Treatment Period|Protocol Violation|5|||
16945476|NCT01322490|38089390|FG002|Treatment Period|Protocol Violation|4|||
16945477|NCT01322490|38089388|FG000|Treatment Period|Withdrawal by Subject|14|||
16945478|NCT01322490|38089389|FG001|Treatment Period|Withdrawal by Subject|16|||
16945479|NCT01322490|38089390|FG002|Treatment Period|Withdrawal by Subject|11|||
16945480|NCT01322490|38089388|FG000|Treatment Period|Non-compliance with study drug|0|||
16945481|NCT01322490|38089389|FG001|Treatment Period|Non-compliance with study drug|0|||
16945482|NCT01322490|38089390|FG002|Treatment Period|Non-compliance with study drug|1|||
16945483|NCT01322490|38089388|FG000|Treatment Period|Other per report|2|||
16945484|NCT01322490|38089389|FG001|Treatment Period|Other per report|2|||
16945485|NCT01322490|38089390|FG002|Treatment Period|Other per report|1|||
16945486|NCT01322490|38089388|FG000|Treatment Period|Randomized but Not Treated|3|||
16945487|NCT01322490|38089389|FG001|Treatment Period|Randomized but Not Treated|3|||
16945488|NCT01322490|38089390|FG002|Treatment Period|Randomized but Not Treated|5|||
16945489|NCT01322490|38089388|FG000|Long Term Follow-up Period|Death|235|||
16945490|NCT01322490|38089389|FG001|Long Term Follow-up Period|Death|239|||
16945491|NCT01322490|38089390|FG002|Long Term Follow-up Period|Death|236|||
16945492|NCT01322490|38089388|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
16945493|NCT01322490|38089389|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
16945494|NCT01322490|38089390|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
16945495|NCT01322490|38089388|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
16945496|NCT01322490|38089389|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
16945497|NCT01322490|38089390|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
16945498|NCT01322490|38089388|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
16945499|NCT01322490|38089389|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
16945500|NCT01322490|38089390|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
16945501|NCT01322490|38089388|FG000|Long Term Follow-up Period|Other per report|3|||
16945502|NCT01322490|38089389|FG001|Long Term Follow-up Period|Other per report|2|||
16945503|NCT01322490|38089390|FG002|Long Term Follow-up Period|Other per report|2|||
16945504|NCT01322490|38089388|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
16945505|NCT01322490|38089389|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
16945506|NCT01322490|38089390|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
16945507|NCT01314261|38089402|FG000|Overall Study|Adverse Event|1|||
16945508|NCT01314261|38089403|FG001|Overall Study|Adverse Event|0|||
16945509|NCT01314261|38089404|FG002|Overall Study|Adverse Event|0|||
16945510|NCT01314261|38089405|FG003|Overall Study|Adverse Event|0|||
16945511|NCT01314261|38089402|FG000|Overall Study|Withdrawal by Subject|0|||
16945512|NCT01314261|38089403|FG001|Overall Study|Withdrawal by Subject|3|||
16945513|NCT01314261|38089404|FG002|Overall Study|Withdrawal by Subject|1|||
16945514|NCT01314261|38089405|FG003|Overall Study|Withdrawal by Subject|0|||
16945515|NCT01314261|38089402|FG000|Overall Study|Lost to Follow-up|1|||
16945516|NCT01314261|38089403|FG001|Overall Study|Lost to Follow-up|0|||
16945517|NCT01314261|38089404|FG002|Overall Study|Lost to Follow-up|2|||
16945518|NCT01314261|38089405|FG003|Overall Study|Lost to Follow-up|2|||
16945519|NCT01314261|38089402|FG000|Overall Study|Virologic Failure|0|||
16945520|NCT01314261|38089403|FG001|Overall Study|Virologic Failure|1|||
16945521|NCT01314261|38089404|FG002|Overall Study|Virologic Failure|0|||
16945522|NCT01314261|38089405|FG003|Overall Study|Virologic Failure|1|||
16945523|NCT01321710|38089418|FG000|Overall Study|Lost to Follow-up|4|||
16945524|NCT01321710|38089419|FG001|Overall Study|Lost to Follow-up|5|||
16945525|NCT01321710|38089420|FG002|Overall Study|Lost to Follow-up|0|||
16945526|NCT01321008|38089430|FG000|Overall Study|Early Study Termination|1|||
16945527|NCT01320150|38089436|FG000|Overall Study|Protocol Violation|15|||
16945528|NCT01320150|38089436|FG000|Overall Study|Withdrawal by Subject|5|||
16945529|NCT01320150|38089436|FG000|Overall Study|Death|2|||
16945530|NCT01320150|38089436|FG000|Overall Study|Lost to Follow-up|44|||
16945531|NCT01323530|38089447|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
16945532|NCT01323530|38089448|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16945533|NCT01323530|38089449|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16945534|NCT01323530|38089450|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16945535|NCT01323530|38089451|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16945536|NCT01323530|38089452|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
16945537|NCT01323530|38089453|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16945538|NCT01323530|38089447|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
16945539|NCT01323530|38089448|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
16945540|NCT01323530|38089449|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
16945541|NCT01323530|38089450|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16945542|NCT01323530|38089451|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
16945543|NCT01323530|38089452|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16945544|NCT01323530|38089453|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16945545|NCT01323530|38089447|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
16945546|NCT01323530|38089448|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
16945547|NCT01323530|38089449|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
16945548|NCT01323530|38089450|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
16945549|NCT01323530|38089451|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
16945550|NCT01323530|38089452|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
16945551|NCT01323530|38089453|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
16945552|NCT01323530|38089447|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16945553|NCT01323530|38089448|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16945554|NCT01323530|38089449|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16945555|NCT01323530|38089450|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16945556|NCT01323530|38089451|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16945557|NCT01323530|38089452|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16945558|NCT01323530|38089453|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
17127658|NCT03292406|38268056|FG001|Overall Study|Other|1|||
16945559|NCT01323530|38089447|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16945560|NCT01323530|38089448|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16945561|NCT01323530|38089449|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16945562|NCT01323530|38089450|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16945563|NCT01323530|38089451|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16945564|NCT01323530|38089452|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16945565|NCT01323530|38089453|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
16945566|NCT01323530|38089447|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16945567|NCT01323530|38089448|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16945568|NCT01323530|38089449|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16945569|NCT01323530|38089450|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16945570|NCT01323530|38089451|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16945571|NCT01323530|38089452|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16945572|NCT01323530|38089453|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
16945573|NCT01323530|38089447|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16945574|NCT01323530|38089448|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16945575|NCT01323530|38089449|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16945576|NCT01323530|38089450|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16945577|NCT01323530|38089451|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16945578|NCT01323530|38089452|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16945579|NCT01323530|38089453|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
16945580|NCT01323530|38089447|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16945581|NCT01323530|38089448|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16945582|NCT01323530|38089449|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16945583|NCT01323530|38089450|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16945584|NCT01323530|38089451|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16945585|NCT01323530|38089452|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16945586|NCT01323530|38089453|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
16945587|NCT01313637|38089474|FG000|Overall Study|Adverse Event|17|||
16945588|NCT01313637|38089475|FG001|Overall Study|Adverse Event|24|||
16945589|NCT01313637|38089476|FG002|Overall Study|Adverse Event|25|||
16945590|NCT01313637|38089477|FG003|Overall Study|Adverse Event|18|||
16945591|NCT01313637|38089474|FG000|Overall Study|Lack of Efficacy|44|||
16945592|NCT01313637|38089475|FG001|Overall Study|Lack of Efficacy|38|||
16945593|NCT01313637|38089476|FG002|Overall Study|Lack of Efficacy|37|||
16945594|NCT01313637|38089477|FG003|Overall Study|Lack of Efficacy|24|||
16945595|NCT01313637|38089474|FG000|Overall Study|Protocol Violation|4|||
16945596|NCT01313637|38089475|FG001|Overall Study|Protocol Violation|3|||
16945597|NCT01313637|38089476|FG002|Overall Study|Protocol Violation|11|||
16945598|NCT01313637|38089477|FG003|Overall Study|Protocol Violation|5|||
16945599|NCT01313637|38089474|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
16945600|NCT01313637|38089475|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
16945601|NCT01313637|38089476|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
16945602|NCT01313637|38089477|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
16945603|NCT01313637|38089474|FG000|Overall Study|Lost to Follow-up|0|||
16945604|NCT01313637|38089475|FG001|Overall Study|Lost to Follow-up|2|||
16945605|NCT01313637|38089476|FG002|Overall Study|Lost to Follow-up|1|||
16945606|NCT01313637|38089477|FG003|Overall Study|Lost to Follow-up|3|||
16945607|NCT01313637|38089474|FG000|Overall Study|Withdrawal by Subject|11|||
16945608|NCT01313637|38089475|FG001|Overall Study|Withdrawal by Subject|13|||
16945609|NCT01313637|38089476|FG002|Overall Study|Withdrawal by Subject|18|||
16945610|NCT01313637|38089477|FG003|Overall Study|Withdrawal by Subject|15|||
16945611|NCT01320722|38089492|FG000|Overall Study|Did not Receive Intervention|3|||
16945612|NCT01320722|38089493|FG001|Overall Study|Did not Receive Intervention|2|||
16945613|NCT01320722|38089494|FG002|Overall Study|Did not Receive Intervention|1|||
16945614|NCT01320722|38089495|FG003|Overall Study|Did not Receive Intervention|1|||
16945615|NCT01320722|38089496|FG004|Overall Study|Did not Receive Intervention|2|||
16945616|NCT01320722|38089492|FG000|Overall Study|Lost to Follow-up|0|||
16945617|NCT01320722|38089493|FG001|Overall Study|Lost to Follow-up|1|||
16945618|NCT01320722|38089494|FG002|Overall Study|Lost to Follow-up|0|||
16945619|NCT01320722|38089495|FG003|Overall Study|Lost to Follow-up|1|||
16945620|NCT01320722|38089496|FG004|Overall Study|Lost to Follow-up|3|||
16945621|NCT01320722|38089492|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
16945622|NCT01320722|38089493|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
17127659|NCT03292406|38268057|FG002|Overall Study|Other|2|||
17127660|NCT03292016|38268077|FG000|Second Washout|Adverse Event|0|||
17127661|NCT03292016|38268078|FG001|Second Washout|Adverse Event|1|||
17127662|NCT03292016|38268079|FG002|Second Washout|Adverse Event|0|||
17127663|NCT03292016|38268080|FG003|Second Washout|Adverse Event|0|||
17127664|NCT03292016|38268081|FG004|Second Washout|Adverse Event|0|||
17127665|NCT03292016|38268082|FG005|Second Washout|Adverse Event|0|||
16945623|NCT01320722|38089494|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
16945624|NCT01320722|38089495|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
16945625|NCT01320722|38089496|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
16945626|NCT01320722|38089492|FG000|Overall Study|Participant Developed a Rash|0|||
16945627|NCT01320722|38089493|FG001|Overall Study|Participant Developed a Rash|0|||
16945628|NCT01320722|38089494|FG002|Overall Study|Participant Developed a Rash|2|||
16945629|NCT01320722|38089495|FG003|Overall Study|Participant Developed a Rash|1|||
16945630|NCT01320722|38089496|FG004|Overall Study|Participant Developed a Rash|1|||
16945631|NCT01320722|38089492|FG000|Overall Study|Non-compliant with Medication|0|||
16945632|NCT01320722|38089493|FG001|Overall Study|Non-compliant with Medication|0|||
16945633|NCT01320722|38089494|FG002|Overall Study|Non-compliant with Medication|1|||
16945634|NCT01320722|38089495|FG003|Overall Study|Non-compliant with Medication|0|||
16945635|NCT01320722|38089496|FG004|Overall Study|Non-compliant with Medication|0|||
16945636|NCT01320722|38089492|FG000|Overall Study|Adverse Event|0|||
16945637|NCT01320722|38089493|FG001|Overall Study|Adverse Event|0|||
16945638|NCT01320722|38089494|FG002|Overall Study|Adverse Event|3|||
16945639|NCT01320722|38089495|FG003|Overall Study|Adverse Event|6|||
16945640|NCT01320722|38089496|FG004|Overall Study|Adverse Event|0|||
16945641|NCT01320722|38089492|FG000|Overall Study|Not Compliant with Study Procedures|0|||
16945642|NCT01320722|38089493|FG001|Overall Study|Not Compliant with Study Procedures|0|||
16945643|NCT01320722|38089494|FG002|Overall Study|Not Compliant with Study Procedures|0|||
16945644|NCT01320722|38089495|FG003|Overall Study|Not Compliant with Study Procedures|4|||
16945645|NCT01320722|38089496|FG004|Overall Study|Not Compliant with Study Procedures|0|||
16945646|NCT01320722|38089492|FG000|Overall Study|Pregnancy|0|||
16945647|NCT01320722|38089493|FG001|Overall Study|Pregnancy|0|||
16945648|NCT01320722|38089494|FG002|Overall Study|Pregnancy|0|||
16945649|NCT01320722|38089495|FG003|Overall Study|Pregnancy|1|||
16945650|NCT01320722|38089496|FG004|Overall Study|Pregnancy|0|||
16945651|NCT01320722|38089492|FG000|Overall Study|Started an Exclusionary Medication|0|||
16945652|NCT01320722|38089493|FG001|Overall Study|Started an Exclusionary Medication|0|||
16945653|NCT01320722|38089494|FG002|Overall Study|Started an Exclusionary Medication|0|||
17127666|NCT03290300|38268090|FG000|Overall Study|Lost to Follow-up|3|||
16945654|NCT01320722|38089495|FG003|Overall Study|Started an Exclusionary Medication|0|||
16945655|NCT01320722|38089496|FG004|Overall Study|Started an Exclusionary Medication|1|||
16945656|NCT01320722|38089492|FG000|Overall Study|Withdrew due to Health Condition|0|||
16945657|NCT01320722|38089493|FG001|Overall Study|Withdrew due to Health Condition|0|||
16945658|NCT01320722|38089494|FG002|Overall Study|Withdrew due to Health Condition|0|||
16945659|NCT01320722|38089495|FG003|Overall Study|Withdrew due to Health Condition|0|||
16945660|NCT01320722|38089496|FG004|Overall Study|Withdrew due to Health Condition|1|||
16945661|NCT01313559|38089513|FG000|Overall Study|Withdrawal by Subject|1|||
16945662|NCT01313559|38089514|FG001|Overall Study|Withdrawal by Subject|2|||
16945663|NCT01313559|38089513|FG000|Overall Study|Disease progression|1|||
16945664|NCT01313559|38089514|FG001|Overall Study|Disease progression|0|||
16945665|NCT01313559|38089513|FG000|Overall Study|Rising PSA|2|||
16945666|NCT01313559|38089514|FG001|Overall Study|Rising PSA|0|||
16945667|NCT01312779|38089520|FG000|Overall Study|Withdrawal by Subject|2|||
16945668|NCT01312779|38089520|FG000|Overall Study|Death|3|||
16945669|NCT01312779|38089520|FG000|Overall Study|Not Implanted with Device|27|||
16945670|NCT01312467|38089533|FG000|Overall Study|Adverse Event|4|||
16945671|NCT01312467|38089533|FG000|Overall Study|Lost to Follow-up|1|||
16945672|NCT01312467|38089533|FG000|Overall Study|Withdrawal by Subject|2|||
16945673|NCT01312467|38089533|FG000|Overall Study|Deported to country of origin|1|||
16945674|NCT01312467|38089533|FG000|Overall Study|Another medical condition|1|||
16945675|NCT01312467|38089533|FG000|Overall Study|Ineligible|4|||
16945676|NCT01310127|38089540|FG000|Overall Study|Protocol Violation|1|||
16945677|NCT01310127|38089541|FG001|Overall Study|Protocol Violation|1|||
16945678|NCT01310127|38089540|FG000|Overall Study|advanced psc cataract outlier|1|||
16945679|NCT01310127|38089541|FG001|Overall Study|advanced psc cataract outlier|0|||
16945680|NCT01309893|38089547|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
16945681|NCT01309893|38089548|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
16945682|NCT01309893|38089547|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
16945683|NCT01309893|38089548|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
16945684|NCT01318902|38089558|FG000|Overall Study|Symptomatic Deterioration|0|||
16945685|NCT01318902|38089559|FG001|Overall Study|Symptomatic Deterioration|1|||
16945686|NCT01318902|38089560|FG002|Overall Study|Symptomatic Deterioration|1|||
16945687|NCT01318902|38089561|FG003|Overall Study|Symptomatic Deterioration|2|||
16945688|NCT01318902|38089558|FG000|Overall Study|Withdrawal by Patient|0|||
16945689|NCT01318902|38089559|FG001|Overall Study|Withdrawal by Patient|1|||
16945690|NCT01318902|38089560|FG002|Overall Study|Withdrawal by Patient|0|||
16945691|NCT01318902|38089561|FG003|Overall Study|Withdrawal by Patient|3|||
16945692|NCT01318902|38089558|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
16945693|NCT01318902|38089559|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
16945694|NCT01318902|38089560|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
16945695|NCT01318902|38089561|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
16945696|NCT01318902|38089558|FG000|Overall Study|Adverse Event|0|||
16945697|NCT01318902|38089559|FG001|Overall Study|Adverse Event|1|||
16945698|NCT01318902|38089560|FG002|Overall Study|Adverse Event|0|||
16945699|NCT01318902|38089561|FG003|Overall Study|Adverse Event|0|||
16945700|NCT01318902|38089558|FG000|Overall Study|Terminated by Sponsor|0|||
16945701|NCT01318902|38089559|FG001|Overall Study|Terminated by Sponsor|0|||
16945702|NCT01318902|38089560|FG002|Overall Study|Terminated by Sponsor|1|||
16945703|NCT01318902|38089561|FG003|Overall Study|Terminated by Sponsor|0|||
16945704|NCT01313858|38089576|FG000|Overall Study|Premature Treatment Termination|251|||
16945705|NCT01313858|38089577|FG001|Overall Study|Premature Treatment Termination|219|||
16945706|NCT01313858|38089578|FG002|Overall Study|Premature Treatment Termination|191|||
16945707|NCT01313858|38089576|FG000|Overall Study|Lost to Follow-up|35|||
16945708|NCT01313858|38089577|FG001|Overall Study|Lost to Follow-up|51|||
16945709|NCT01313858|38089578|FG002|Overall Study|Lost to Follow-up|47|||
16945710|NCT01090765|38089590|FG000|Overall Study|Patient withdrew consent|0|||
16945711|NCT01090765|38089591|FG001|Overall Study|Patient withdrew consent|0|||
16945712|NCT01090765|38089592|FG002|Overall Study|Patient withdrew consent|0|||
16945713|NCT01090765|38089593|FG003|Overall Study|Patient withdrew consent|0|||
16945714|NCT01090765|38089594|FG004|Overall Study|Patient withdrew consent|1|||
16945715|NCT01090765|38089595|FG005|Overall Study|Patient withdrew consent|1|||
16945716|NCT01090765|38089590|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
16945717|NCT01090765|38089591|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
16945718|NCT01090765|38089592|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
16945719|NCT01090765|38089593|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
16945720|NCT01090765|38089594|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
16945721|NCT01090765|38089595|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
16945722|NCT01090765|38089590|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
16945723|NCT01090765|38089591|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
16945724|NCT01090765|38089592|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
16945725|NCT01090765|38089593|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
16945726|NCT01090765|38089594|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
16945727|NCT01090765|38089595|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
16945728|NCT01313780|38089612|FG000|Overall Study|Lack of Efficacy|4|||
16945729|NCT01313780|38089613|FG001|Overall Study|Lack of Efficacy|2|||
16774144|NCT02201524|37713427|FG000|Overall Study|No longer meets eligibility criteria|0|||
16774145|NCT02201524|37713428|FG001|Overall Study|No longer meets eligibility criteria|0|||
16945730|NCT01313780|38089612|FG000|Overall Study|Adverse Event|6|||
16945731|NCT01313780|38089613|FG001|Overall Study|Adverse Event|11|||
16945732|NCT01313780|38089612|FG000|Overall Study|Withdrawal by Subject|2|||
16945733|NCT01313780|38089613|FG001|Overall Study|Withdrawal by Subject|8|||
16945734|NCT01313780|38089612|FG000|Overall Study|Protocol Violation|10|||
16945735|NCT01313780|38089613|FG001|Overall Study|Protocol Violation|4|||
16945736|NCT01313780|38089612|FG000|Overall Study|missing data|3|||
16945737|NCT01313780|38089613|FG001|Overall Study|missing data|3|||
16945738|NCT01090453|38089621|FG000|Overall Study|Withdrawal by Subject|1|||
16945739|NCT01090453|38089622|FG001|Overall Study|Withdrawal by Subject|2|||
16945740|NCT01090453|38089621|FG000|Overall Study|Lost to Follow-up|7|||
16945741|NCT01090453|38089622|FG001|Overall Study|Lost to Follow-up|7|||
16945742|NCT01090453|38089621|FG000|Overall Study|Non serious AEs|1|||
16945743|NCT01090453|38089622|FG001|Overall Study|Non serious AEs|0|||
16945744|NCT01090453|38089621|FG000|Overall Study|Protocol Violation|2|||
16945745|NCT01090453|38089622|FG001|Overall Study|Protocol Violation|0|||
16945746|NCT01090453|38089621|FG000|Overall Study|Other|2|||
16945747|NCT01090453|38089622|FG001|Overall Study|Other|4|||
16945748|NCT01090453|38089621|FG000|Overall Study|Eligibility Criteria|0|||
16945749|NCT01090453|38089622|FG001|Overall Study|Eligibility Criteria|1|||
16945750|NCT01171612|38089628|FG000|Overall Study|Lost to Follow-up|51|||
16945751|NCT01171534|38089637|FG000|Overall Study|Lost to Follow-up|0|||
16945752|NCT01171534|38089638|FG001|Overall Study|Lost to Follow-up|2|||
16945753|NCT01171534|38089637|FG000|Overall Study|screen failure|0|||
16945754|NCT01171534|38089638|FG001|Overall Study|screen failure|1|||
16945755|NCT01170598|38089644|FG000|Overall Study|Withdrawal by Subject|1|||
16945756|NCT01170598|38089644|FG000|Overall Study|Death|3|||
16945757|NCT01170598|38089644|FG000|Overall Study|Lost to Follow-up|1|||
16945758|NCT01170598|38089644|FG000|Overall Study|Refused|1|||
16945759|NCT01170364|38089650|FG000|Overall Study|Protocol Violation|4|||
16945760|NCT01170364|38089651|FG001|Overall Study|Protocol Violation|1|||
16945761|NCT01076179|38089657|FG000|Overall Study|Withdrawal by Subject|1|||
16945762|NCT01170208|38089665|FG000|Overall Study|Withdrawal by Subject|5|||
16945763|NCT01170208|38089666|FG001|Overall Study|Withdrawal by Subject|0|||
17028426|NCT00783692|38172783|FG006|Maintenance Phase|Lack of Efficacy|177|||
17028427|NCT00783692|38172777|FG000|Maintenance Phase|Withdrawal by Subject|7|||
17028428|NCT00783692|38172778|FG001|Maintenance Phase|Withdrawal by Subject|0|||
17028429|NCT00783692|38172779|FG002|Maintenance Phase|Withdrawal by Subject|0|||
17028430|NCT00783692|38172780|FG003|Maintenance Phase|Withdrawal by Subject|7|||
17028431|NCT00783692|38172781|FG004|Maintenance Phase|Withdrawal by Subject|6|||
17028432|NCT00783692|38172782|FG005|Maintenance Phase|Withdrawal by Subject|9|||
17028433|NCT00783692|38172783|FG006|Maintenance Phase|Withdrawal by Subject|24|||
17028434|NCT00783692|38172777|FG000|Maintenance Phase|Lost to Follow-up|2|||
17028435|NCT00783692|38172778|FG001|Maintenance Phase|Lost to Follow-up|0|||
17028436|NCT00783692|38172779|FG002|Maintenance Phase|Lost to Follow-up|0|||
17028437|NCT00783692|38172780|FG003|Maintenance Phase|Lost to Follow-up|1|||
17028438|NCT00783692|38172781|FG004|Maintenance Phase|Lost to Follow-up|3|||
17028439|NCT00783692|38172782|FG005|Maintenance Phase|Lost to Follow-up|2|||
17028440|NCT00783692|38172783|FG006|Maintenance Phase|Lost to Follow-up|5|||
17028441|NCT00783692|38172777|FG000|Maintenance Phase|Other|0|||
17028442|NCT00783692|38172778|FG001|Maintenance Phase|Other|0|||
17028443|NCT00783692|38172779|FG002|Maintenance Phase|Other|0|||
17028444|NCT00783692|38172780|FG003|Maintenance Phase|Other|1|||
17028445|NCT00783692|38172781|FG004|Maintenance Phase|Other|0|||
17028446|NCT00783692|38172782|FG005|Maintenance Phase|Other|1|||
17028447|NCT00783692|38172783|FG006|Maintenance Phase|Other|1|||
17028448|NCT04992273|38172798|FG000|Overall Study|Lost to Follow-up|0|||
17028449|NCT04992273|38172799|FG001|Overall Study|Lost to Follow-up|1|||
17028450|NCT00783302|38172806|FG000|Overall Study|Lost to Follow-up|17|||
17028451|NCT00783302|38172806|FG000|Overall Study|Technical Problems|11|||
16774146|NCT02201524|37713429|FG002|Overall Study|No longer meets eligibility criteria|0|||
16945764|NCT01170208|38089667|FG002|Overall Study|Withdrawal by Subject|1|||
16945765|NCT01170208|38089665|FG000|Overall Study|Protocol Violation|1|||
16945766|NCT01170208|38089666|FG001|Overall Study|Protocol Violation|0|||
16945767|NCT01170208|38089667|FG002|Overall Study|Protocol Violation|1|||
16945768|NCT01313624|38089680|FG000|Double-Blind Phase|Adverse Event|27|||
16945769|NCT01313624|38089681|FG001|Double-Blind Phase|Adverse Event|4|||
16945770|NCT01313624|38089680|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
16945771|NCT01313624|38089681|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
16945772|NCT01313624|38089680|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16945773|NCT01313624|38089681|FG001|Double-Blind Phase|Lost to Follow-up|2|||
16945774|NCT01313624|38089680|FG000|Double-Blind Phase|Physician Decision|1|||
16945775|NCT01313624|38089681|FG001|Double-Blind Phase|Physician Decision|0|||
16945776|NCT01313624|38089680|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16945777|NCT01313624|38089681|FG001|Double-Blind Phase|Lack of Efficacy|0|||
16945778|NCT01313624|38089680|FG000|Open-Label Phase|Adverse Event|1|||
16945779|NCT01313624|38089681|FG001|Open-Label Phase|Adverse Event|10|||
16945780|NCT01313624|38089680|FG000|Open-Label Phase|Withdrawal by Subject|2|||
16945781|NCT01313624|38089681|FG001|Open-Label Phase|Withdrawal by Subject|2|||
16945782|NCT01313624|38089680|FG000|Open-Label Phase|Lost to Follow-up|1|||
16945783|NCT01313624|38089681|FG001|Open-Label Phase|Lost to Follow-up|1|||
16945784|NCT01169350|38089689|FG000|Overall Study|Physician Decision|3|||
16945785|NCT01169350|38089689|FG000|Overall Study|Lost to Follow-up|2|||
16945786|NCT01169038|38089693|FG000|Overall Study|Death|1|||
16945787|NCT01169038|38089693|FG000|Overall Study|Adverse Event|5|||
16945788|NCT01169038|38089693|FG000|Overall Study|Required antibiotic administration|1|||
16945789|NCT01167634|38089701|FG000|Overall Study|Lost to Follow-up|1|||
16945790|NCT01167634|38089702|FG001|Overall Study|Lost to Follow-up|3|||
16945791|NCT01167634|38089703|FG002|Overall Study|Lost to Follow-up|3|||
16945792|NCT01167634|38089704|FG003|Overall Study|Lost to Follow-up|4|||
16945793|NCT01167634|38089701|FG000|Overall Study|Withdrawal by Subject|1|||
16945794|NCT01167634|38089702|FG001|Overall Study|Withdrawal by Subject|1|||
16945795|NCT01167634|38089703|FG002|Overall Study|Withdrawal by Subject|0|||
16945796|NCT01167634|38089704|FG003|Overall Study|Withdrawal by Subject|0|||
16945797|NCT01166386|38089716|FG000|Overall Study|Withdrawal by Subject|3|||
16945798|NCT01166386|38089717|FG001|Overall Study|Withdrawal by Subject|5|||
16945799|NCT01114828|38089725|FG000|Overall Study|Adverse Event|1|||
16945800|NCT01114828|38089726|FG001|Overall Study|Adverse Event|1|||
16945801|NCT01114828|38089725|FG000|Overall Study|Lack of Efficacy|0|||
16945802|NCT01114828|38089726|FG001|Overall Study|Lack of Efficacy|2|||
16945803|NCT01114828|38089725|FG000|Overall Study|Protocol Violation|2|||
16945804|NCT01114828|38089726|FG001|Overall Study|Protocol Violation|0|||
16945805|NCT01114828|38089725|FG000|Overall Study|Withdrawal by Subject|0|||
16945806|NCT01114828|38089726|FG001|Overall Study|Withdrawal by Subject|1|||
16945807|NCT01313312|38089732|FG000|Overall Study|Adverse Event|5|||
16945808|NCT01313312|38089732|FG000|Overall Study|Withdrawal by Subject|18|||
16945809|NCT01313312|38089732|FG000|Overall Study|Lack of Efficacy|3|||
16945810|NCT01313312|38089732|FG000|Overall Study|Investigator Decision|1|||
16945811|NCT01313312|38089732|FG000|Overall Study|Observational Phase|1|||
17127667|NCT03289676|38268103|FG000|Overall Study|Withdrawal by Subject|2|||
17127668|NCT03289676|38268104|FG001|Overall Study|Withdrawal by Subject|0|||
17127669|NCT03289676|38268103|FG000|Overall Study|Protocol Violation|2|||
17127670|NCT03289676|38268104|FG001|Overall Study|Protocol Violation|0|||
17127671|NCT03289676|38268103|FG000|Overall Study|Lost to Follow-up|0|||
17127672|NCT03289676|38268104|FG001|Overall Study|Lost to Follow-up|1|||
17127673|NCT03289208|38268113|FG000|Overall Study|Adverse Event|1|||
17127674|NCT03289208|38268114|FG001|Overall Study|Adverse Event|0|||
17127675|NCT03289208|38268115|FG002|Overall Study|Adverse Event|0|||
17127676|NCT03287804|38268133|FG000|Overall Study|Death|1|||
17127677|NCT03287804|38268133|FG000|Overall Study|Physician Decision|2|||
17127678|NCT03287804|38268133|FG000|Overall Study|Progressive disease|8|||
17127679|NCT03286400|38268138|FG000|Overall Study|Death|10|||
16945812|NCT01313312|38089732|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
16945813|NCT01313312|38089732|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
16945814|NCT01114672|38089738|FG000|Overall Study|Death|0|||
16945815|NCT01114672|38089739|FG001|Overall Study|Death|1|||
16945816|NCT01114672|38089738|FG000|Overall Study|Withdrawal by Subject|2|||
16945817|NCT01114672|38089739|FG001|Overall Study|Withdrawal by Subject|1|||
16945818|NCT01114672|38089738|FG000|Overall Study|Lost to Follow-up|1|||
16945819|NCT01114672|38089739|FG001|Overall Study|Lost to Follow-up|0|||
16945820|NCT01114672|38089738|FG000|Overall Study|transplanted|1|||
16945821|NCT01114672|38089739|FG001|Overall Study|transplanted|0|||
16945822|NCT01114516|38089747|FG000|Overall Study|Lost to Follow-up|2|||
16945823|NCT01114516|38089748|FG001|Overall Study|Lost to Follow-up|1|||
17127680|NCT03286400|38268138|FG000|Overall Study|Lost to Follow-up|10|||
17127681|NCT03286400|38268138|FG000|Overall Study|Physician Decision|1|||
17127682|NCT03286400|38268138|FG000|Overall Study|Scheduling difficulty|4|||
17127683|NCT03310970|38268142|FG000|Overall Study|Withdrawal by Subject|0|||
17127684|NCT03310970|38268143|FG001|Overall Study|Withdrawal by Subject|1|||
17127685|NCT03285308|38268152|FG000|Overall Study|Adverse Event|3|||
17127686|NCT03285308|38268153|FG001|Overall Study|Adverse Event|7|||
17127687|NCT03285308|38268152|FG000|Overall Study|Withdrawal by Subject|8|||
17127688|NCT03285308|38268153|FG001|Overall Study|Withdrawal by Subject|9|||
17127689|NCT03285308|38268152|FG000|Overall Study|Lost to Follow-up|3|||
17127690|NCT03285308|38268153|FG001|Overall Study|Lost to Follow-up|1|||
17127691|NCT03285308|38268152|FG000|Overall Study|Protocol Deviation|6|||
17127692|NCT03285308|38268153|FG001|Overall Study|Protocol Deviation|5|||
17127693|NCT03285308|38268152|FG000|Overall Study|Reason not Specified|0|||
17127694|NCT03285308|38268153|FG001|Overall Study|Reason not Specified|1|||
17127695|NCT03537651|38268160|FG000|Overall Study|Adverse Event|2|||
16945824|NCT01114438|38089754|FG000|Overall Study|Adverse Event|10|||
16945825|NCT01114438|38089754|FG000|Overall Study|concomitant medication|1|||
16945826|NCT01114438|38089754|FG000|Overall Study|Physician Decision|1|||
16945827|NCT01114438|38089754|FG000|Overall Study|Withdrawal by Subject|2|||
16945828|NCT01313078|38089763|FG000|Overall Study|Death|1|||
16945829|NCT01313078|38089763|FG000|Overall Study|Discontinued study drug|1|||
16945830|NCT01313078|38089763|FG000|Overall Study|Withdrawal by Subject|1|||
16945831|NCT01114360|38089767|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
16945832|NCT01114360|38089768|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
16945833|NCT01310036|38089788|FG000|Overall Study|Administrative/other|10|||
16945834|NCT01310036|38089788|FG000|Overall Study|Withdrew Consent|11|||
16945835|NCT01310036|38089788|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
16945836|NCT01310036|38089788|FG000|Overall Study|Progression of Disease|164|||
16945837|NCT01310036|38089788|FG000|Overall Study|Death|1|||
16945838|NCT01310036|38089788|FG000|Overall Study|Adverse event or intercurrent illness|12|||
16945839|NCT01309100|38089792|FG000|Overall Study|Protocol Violation|1|||
16945840|NCT01309100|38089792|FG000|Overall Study|Positive Slit lamp finding|1|||
16945841|NCT01308788|38089801|FG000|2-year Treatment|medication change by treating physician|4|||
16945842|NCT01308788|38089802|FG001|2-year Treatment|medication change by treating physician|11|||
16945843|NCT01075321|38089808|FG000|Overall Study|Withdrawal by Subject|0|||
16945844|NCT01075321|38089809|FG001|Overall Study|Withdrawal by Subject|0|||
16945845|NCT01075321|38089810|FG002|Overall Study|Withdrawal by Subject|1|||
16945846|NCT01075321|38089811|FG003|Overall Study|Withdrawal by Subject|1|||
16945847|NCT01075321|38089808|FG000|Overall Study|Protocol Violation|0|||
16945848|NCT01075321|38089809|FG001|Overall Study|Protocol Violation|0|||
16945849|NCT01075321|38089810|FG002|Overall Study|Protocol Violation|1|||
16945850|NCT01075321|38089811|FG003|Overall Study|Protocol Violation|0|||
16945851|NCT01075321|38089808|FG000|Overall Study|Treatment Incomplete due to progression|1|||
16945852|NCT01075321|38089809|FG001|Overall Study|Treatment Incomplete due to progression|0|||
16945853|NCT01075321|38089810|FG002|Overall Study|Treatment Incomplete due to progression|0|||
16945854|NCT01075321|38089811|FG003|Overall Study|Treatment Incomplete due to progression|0|||
16945855|NCT01075321|38089808|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
16945856|NCT01075321|38089809|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
16945857|NCT01075321|38089810|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
16945858|NCT01075321|38089811|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
16945859|NCT01114204|38089825|FG000|Overall Study|Adverse Event|3|||
16945860|NCT01114204|38089826|FG001|Overall Study|Adverse Event|2|||
16945861|NCT01114204|38089825|FG000|Overall Study|Lost to Follow-up|1|||
16945862|NCT01114204|38089826|FG001|Overall Study|Lost to Follow-up|0|||
16945863|NCT01114204|38089825|FG000|Overall Study|Withdrawal by Subject|10|||
16945864|NCT01114204|38089826|FG001|Overall Study|Withdrawal by Subject|6|||
16945865|NCT01114204|38089825|FG000|Overall Study|Death|1|||
16945866|NCT01114204|38089826|FG001|Overall Study|Death|0|||
16945867|NCT01114204|38089825|FG000|Overall Study|Other-Personal reasons|2|||
16945868|NCT01114204|38089826|FG001|Overall Study|Other-Personal reasons|0|||
16945869|NCT01114204|38089825|FG000|Overall Study|Other-Medical monitor request|1|||
16945870|NCT01114204|38089826|FG001|Overall Study|Other-Medical monitor request|0|||
16945871|NCT01114204|38089825|FG000|Overall Study|Other-Participant request|2|||
16945872|NCT01114204|38089826|FG001|Overall Study|Other-Participant request|0|||
16945873|NCT01114204|38089825|FG000|Overall Study|Other-Protocol Violation|1|||
16945874|NCT01114204|38089826|FG001|Overall Study|Other-Protocol Violation|0|||
16945875|NCT01075243|38089835|FG000|Overall Study|Lost to Follow-up|5|||
16945876|NCT01075243|38089836|FG001|Overall Study|Lost to Follow-up|2|||
16945877|NCT01075243|38089837|FG002|Overall Study|Lost to Follow-up|0|||
16945878|NCT01075243|38089835|FG000|Overall Study|Withdrawal by Subject|1|||
16945879|NCT01075243|38089836|FG001|Overall Study|Withdrawal by Subject|1|||
16945880|NCT01075243|38089837|FG002|Overall Study|Withdrawal by Subject|0|||
16945881|NCT01308476|38089849|FG000|Overall Study|Lost to Follow-up|2|||
16945882|NCT01308476|38089850|FG001|Overall Study|Lost to Follow-up|2|||
16945883|NCT01308476|38089849|FG000|Overall Study|Other|1|||
16945884|NCT01308476|38089850|FG001|Overall Study|Other|0|||
16945885|NCT01078441|38089856|FG000|Overall Study|Withdrawal by Subject|1|||
16945886|NCT01308008|38089862|FG000|4 Weeks|Illness, disinterest, time|9|||
16945887|NCT01308008|38089863|FG001|4 Weeks|Illness, disinterest, time|2|||
16945888|NCT01113892|38089871|FG000|Overall Study|Lost to Follow-up|2|||
16945889|NCT01113892|38089872|FG001|Overall Study|Lost to Follow-up|2|||
16945890|NCT01113892|38089871|FG000|Overall Study|Withdrawal by Subject|1|||
16945891|NCT01113892|38089872|FG001|Overall Study|Withdrawal by Subject|1|||
16945892|NCT01113892|38089871|FG000|Overall Study|Death|2|||
16945893|NCT01113892|38089872|FG001|Overall Study|Death|4|||
16945894|NCT01113892|38089871|FG000|Overall Study|Graft no longer evaluable|9|||
16945895|NCT01113892|38089872|FG001|Overall Study|Graft no longer evaluable|9|||
16945896|NCT01090063|38089878|FG000|Screen|Screen Failed|4|||
16945897|NCT01090063|38089878|FG000|Treatment|Withdrawal by Subject|4|||
16945898|NCT01113580|38089894|FG000|Overall Study|Protocol Violation|1|||
16945899|NCT01113580|38089895|FG001|Overall Study|Protocol Violation|0|||
16945900|NCT01306214|38089904|FG000|Overall Study|Death|0|||
16945901|NCT01306214|38089905|FG001|Overall Study|Death|0|||
16945902|NCT01306214|38089906|FG002|Overall Study|Death|1|||
16945903|NCT01306214|38089904|FG000|Overall Study|Lost to Follow-up|3|||
16945904|NCT01306214|38089905|FG001|Overall Study|Lost to Follow-up|5|||
16945905|NCT01306214|38089906|FG002|Overall Study|Lost to Follow-up|4|||
16945906|NCT01306214|38089904|FG000|Overall Study|Withdrawal by Subject|24|||
16945907|NCT01306214|38089905|FG001|Overall Study|Withdrawal by Subject|22|||
16945908|NCT01306214|38089906|FG002|Overall Study|Withdrawal by Subject|16|||
16945909|NCT01306214|38089904|FG000|Overall Study|Not treated|1|||
16945910|NCT01306214|38089905|FG001|Overall Study|Not treated|1|||
16945911|NCT01306214|38089906|FG002|Overall Study|Not treated|1|||
16945912|NCT01077739|38089916|FG000|Overall Study|Premature withdrawal|1|||
16945913|NCT01077739|38089917|FG001|Overall Study|Premature withdrawal|3|||
16945914|NCT01077739|38089916|FG000|Overall Study|Withdrawal by Subject|1|||
16945915|NCT01077739|38089917|FG001|Overall Study|Withdrawal by Subject|0|||
16945916|NCT01077739|38089916|FG000|Overall Study|Death|0|||
16945917|NCT01077739|38089917|FG001|Overall Study|Death|3|||
16945918|NCT01077739|38089916|FG000|Overall Study|Unacceptable toxicity|1|||
16945919|NCT01077739|38089917|FG001|Overall Study|Unacceptable toxicity|2|||
16945920|NCT01077739|38089916|FG000|Overall Study|Other|2|||
16945921|NCT01077739|38089917|FG001|Overall Study|Other|2|||
16945922|NCT01306058|38089923|FG000|Overall Study|Death|1|||
16945923|NCT01306058|38089923|FG000|Overall Study|Enrolled but did not get treatment|1|||
16945924|NCT01305200|38089930|FG000|Overall Study|Physician Decision|4|||
16945925|NCT01305200|38089931|FG001|Overall Study|Physician Decision|6|||
16945926|NCT01305200|38089932|FG002|Overall Study|Physician Decision|1|||
16945927|NCT01305200|38089930|FG000|Overall Study|Withdrawal by Subject|24|||
16945928|NCT01305200|38089931|FG001|Overall Study|Withdrawal by Subject|21|||
16945929|NCT01305200|38089932|FG002|Overall Study|Withdrawal by Subject|1|||
16945930|NCT01305200|38089930|FG000|Overall Study|Ineligible|1|||
16945931|NCT01305200|38089931|FG001|Overall Study|Ineligible|2|||
16945932|NCT01305200|38089932|FG002|Overall Study|Ineligible|1|||
16945933|NCT01305200|38089930|FG000|Overall Study|Death|0|||
16945934|NCT01305200|38089931|FG001|Overall Study|Death|2|||
16945935|NCT01305200|38089932|FG002|Overall Study|Death|0|||
16945936|NCT01077271|38089942|FG000|Overall Study|Parental desire|8|||
16945937|NCT01077271|38089942|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
16945938|NCT01077271|38089942|FG000|Overall Study|Noncompliance|2|||
16945939|NCT01077271|38089942|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
16945940|NCT01077271|38089942|FG000|Overall Study|Changed doctors|2|||
16945941|NCT01077271|38089942|FG000|Overall Study|Parents thought too many injections|2|||
16945942|NCT01077271|38089942|FG000|Overall Study|End of RSV season nearly reached|1|||
16945943|NCT01077271|38089942|FG000|Overall Study|Mother unconvinced of the necessity|1|||
16945944|NCT01305044|38089956|FG000|Overall Study|Withdrawal by Subject|3|||
16945945|NCT01305044|38089957|FG001|Overall Study|Withdrawal by Subject|6|||
16945946|NCT01304498|38089965|FG000|Overall Study|Adverse Event|1|||
16945947|NCT01304498|38089966|FG001|Overall Study|Adverse Event|1|||
16945948|NCT01304498|38089965|FG000|Overall Study|Withdrawal by Subject|2|||
16945949|NCT01304498|38089966|FG001|Overall Study|Withdrawal by Subject|3|||
16945950|NCT01304498|38089965|FG000|Overall Study|Protocol Violation|1|||
16945951|NCT01304498|38089966|FG001|Overall Study|Protocol Violation|0|||
16945952|NCT01304498|38089965|FG000|Overall Study|Lost to Follow-up|2|||
16945953|NCT01304498|38089966|FG001|Overall Study|Lost to Follow-up|1|||
16945954|NCT01077193|38089972|FG000|Overall Study|Lost to Follow-up|1|||
16945955|NCT01077193|38089972|FG000|Overall Study|Withdrawal by Subject|2|||
16945956|NCT01077193|38089972|FG000|Overall Study|Lack of Efficacy|1|||
16945957|NCT01077193|38089972|FG000|Overall Study|Study Terminated by Sponsor|40|||
16945958|NCT01074931|38089976|FG000|Overall Study|Economic reasons|1|||
16945959|NCT01074931|38089976|FG000|Overall Study|Death|5|||
16945960|NCT01303172|38089986|FG000|Overall Study|Physician Decision|9|||
16945961|NCT01303172|38089987|FG001|Overall Study|Physician Decision|6|||
16945962|NCT01303172|38089986|FG000|Overall Study|Adverse Event|5|||
16945963|NCT01303172|38089987|FG001|Overall Study|Adverse Event|2|||
16945964|NCT01303172|38089986|FG000|Overall Study|Withdrawal by Subject|4|||
16945965|NCT01303172|38089987|FG001|Overall Study|Withdrawal by Subject|2|||
16945966|NCT01303172|38089986|FG000|Overall Study|Death|20|||
16945967|NCT01303172|38089987|FG001|Overall Study|Death|7|||
16945968|NCT01303172|38089986|FG000|Overall Study|Lack of Efficacy|25|||
16945969|NCT01303172|38089987|FG001|Overall Study|Lack of Efficacy|17|||
16945970|NCT01302938|38089996|FG000|Overall Study|Withdrawal by Subject|1|||
16945971|NCT01302938|38089997|FG001|Overall Study|Withdrawal by Subject|0|||
16945972|NCT01302938|38089996|FG000|Overall Study|Adverse Event|1|||
16945973|NCT01302938|38089997|FG001|Overall Study|Adverse Event|0|||
16945974|NCT01302548|38090006|FG000|Overall Study|Lost to Follow-up|2|||
16945975|NCT01302548|38090007|FG001|Overall Study|Lost to Follow-up|1|||
16945976|NCT01076959|38090013|FG000|Overall Study|Adverse Event|767|||
16945977|NCT01076959|38090013|FG000|Overall Study|Lack of Efficacy|849|||
16945978|NCT01076959|38090013|FG000|Overall Study|Non-compliance|274|||
16945979|NCT01076959|38090013|FG000|Overall Study|Lost to Follow-up|241|||
16945980|NCT01076959|38090013|FG000|Overall Study|Other|119|||
16945981|NCT01302392|38090032|FG000|Overall Study|Lost to Follow-up|1|||
16945982|NCT01302392|38090033|FG001|Overall Study|Lost to Follow-up|0|||
16945983|NCT01302392|38090032|FG000|Overall Study|Withdrawal by Subject|6|||
16945984|NCT01302392|38090033|FG001|Overall Study|Withdrawal by Subject|1|||
16945985|NCT01076647|38090041|FG000|Overall Study|Adverse Event|4|||
16945986|NCT01076647|38090042|FG001|Overall Study|Adverse Event|1|||
16945987|NCT01076647|38090041|FG000|Overall Study|Lack of Efficacy|0|||
16945988|NCT01076647|38090042|FG001|Overall Study|Lack of Efficacy|1|||
16945989|NCT01076647|38090041|FG000|Overall Study|Protocol Violation|7|||
16945990|NCT01076647|38090042|FG001|Overall Study|Protocol Violation|9|||
16945991|NCT01076647|38090041|FG000|Overall Study|Withdrawal criteria|2|||
16945992|NCT01076647|38090042|FG001|Overall Study|Withdrawal criteria|2|||
16945993|NCT01076647|38090041|FG000|Overall Study|Unclassified|12|||
16945994|NCT01076647|38090042|FG001|Overall Study|Unclassified|12|||
17028452|NCT00783302|38172806|FG000|Overall Study|Protocol Violation|3|||
16945995|NCT01074307|38090050|FG000|Overall Study|No primary endpoint evaluation|14|||
16945996|NCT01074307|38090051|FG001|Overall Study|No primary endpoint evaluation|6|||
16945997|NCT01074307|38090050|FG000|Overall Study|Exclusion criterion|0|||
16945998|NCT01074307|38090051|FG001|Overall Study|Exclusion criterion|1|||
16945999|NCT01074307|38090050|FG000|Overall Study|Protocol Violation|8|||
16946000|NCT01074307|38090051|FG001|Overall Study|Protocol Violation|5|||
16946001|NCT01076335|38090057|FG000|Overall Study|Withdrawal by Subject|3|||
16946002|NCT01076335|38090057|FG000|Overall Study|Withdrawal without treatment|1|||
16946003|NCT01309737|38090064|FG000|Week 0 to 16|Death|1|||
16946004|NCT01309737|38090065|FG001|Week 0 to 16|Death|0|||
16946005|NCT01309737|38090066|FG002|Week 0 to 16|Death|1|||
16946006|NCT01309737|38090067|FG003|Week 0 to 16|Death|0|||
16946007|NCT01309737|38090068|FG004|Week 0 to 16|Death|0|||
16946008|NCT01309737|38090064|FG000|Week 0 to 16|Adverse Event|11|||
16946009|NCT01309737|38090065|FG001|Week 0 to 16|Adverse Event|10|||
16946010|NCT01309737|38090066|FG002|Week 0 to 16|Adverse Event|5|||
16946011|NCT01309737|38090067|FG003|Week 0 to 16|Adverse Event|0|||
16946012|NCT01309737|38090068|FG004|Week 0 to 16|Adverse Event|0|||
16946013|NCT01309737|38090064|FG000|Week 0 to 16|Lack of Efficacy|15|||
16946014|NCT01309737|38090065|FG001|Week 0 to 16|Lack of Efficacy|2|||
16946015|NCT01309737|38090066|FG002|Week 0 to 16|Lack of Efficacy|24|||
16946016|NCT01309737|38090067|FG003|Week 0 to 16|Lack of Efficacy|0|||
16946017|NCT01309737|38090068|FG004|Week 0 to 16|Lack of Efficacy|0|||
16946018|NCT01309737|38090064|FG000|Week 0 to 16|Lost to Follow-up|7|||
16946019|NCT01309737|38090065|FG001|Week 0 to 16|Lost to Follow-up|8|||
16946020|NCT01309737|38090066|FG002|Week 0 to 16|Lost to Follow-up|3|||
16946021|NCT01309737|38090067|FG003|Week 0 to 16|Lost to Follow-up|0|||
16946022|NCT01309737|38090068|FG004|Week 0 to 16|Lost to Follow-up|0|||
16946023|NCT01309737|38090064|FG000|Week 0 to 16|Withdrawal by Subject|7|||
16946024|NCT01309737|38090065|FG001|Week 0 to 16|Withdrawal by Subject|6|||
16946025|NCT01309737|38090066|FG002|Week 0 to 16|Withdrawal by Subject|7|||
16946026|NCT01309737|38090067|FG003|Week 0 to 16|Withdrawal by Subject|0|||
16946027|NCT01309737|38090068|FG004|Week 0 to 16|Withdrawal by Subject|0|||
16946028|NCT01309737|38090064|FG000|Week 0 to 16|Other|10|||
16946029|NCT01309737|38090065|FG001|Week 0 to 16|Other|14|||
16946030|NCT01309737|38090066|FG002|Week 0 to 16|Other|4|||
16946031|NCT01309737|38090067|FG003|Week 0 to 16|Other|0|||
16946032|NCT01309737|38090068|FG004|Week 0 to 16|Other|0|||
16946033|NCT01309737|38090064|FG000|Week 0 to 16|Randomized, but not treated|1|||
16946034|NCT01309737|38090065|FG001|Week 0 to 16|Randomized, but not treated|0|||
16946035|NCT01309737|38090066|FG002|Week 0 to 16|Randomized, but not treated|0|||
16946036|NCT01309737|38090067|FG003|Week 0 to 16|Randomized, but not treated|0|||
16946037|NCT01309737|38090068|FG004|Week 0 to 16|Randomized, but not treated|0|||
16946038|NCT01309737|38090064|FG000|Week 16 to 52|Death|0|||
16946039|NCT01309737|38090065|FG001|Week 16 to 52|Death|0|||
16946040|NCT01309737|38090066|FG002|Week 16 to 52|Death|0|||
16946041|NCT01309737|38090067|FG003|Week 16 to 52|Death|0|||
16946042|NCT01309737|38090068|FG004|Week 16 to 52|Death|1|||
16946043|NCT01309737|38090064|FG000|Week 16 to 52|Adverse Event|7|||
16946044|NCT01309737|38090065|FG001|Week 16 to 52|Adverse Event|7|||
16946045|NCT01309737|38090066|FG002|Week 16 to 52|Adverse Event|0|||
16946046|NCT01309737|38090067|FG003|Week 16 to 52|Adverse Event|6|||
16946047|NCT01309737|38090068|FG004|Week 16 to 52|Adverse Event|5|||
16946048|NCT01309737|38090064|FG000|Week 16 to 52|Lack of Efficacy|107|||
16946049|NCT01309737|38090065|FG001|Week 16 to 52|Lack of Efficacy|76|||
16946050|NCT01309737|38090066|FG002|Week 16 to 52|Lack of Efficacy|0|||
16946051|NCT01309737|38090067|FG003|Week 16 to 52|Lack of Efficacy|25|||
16946052|NCT01309737|38090068|FG004|Week 16 to 52|Lack of Efficacy|21|||
16946053|NCT01309737|38090064|FG000|Week 16 to 52|Lost to Follow-up|4|||
16946054|NCT01309737|38090065|FG001|Week 16 to 52|Lost to Follow-up|2|||
16946055|NCT01309737|38090066|FG002|Week 16 to 52|Lost to Follow-up|0|||
16946056|NCT01309737|38090067|FG003|Week 16 to 52|Lost to Follow-up|1|||
16946057|NCT01309737|38090068|FG004|Week 16 to 52|Lost to Follow-up|4|||
16946058|NCT01309737|38090064|FG000|Week 16 to 52|Withdrawal by Subject|5|||
16946059|NCT01309737|38090065|FG001|Week 16 to 52|Withdrawal by Subject|6|||
16946060|NCT01309737|38090066|FG002|Week 16 to 52|Withdrawal by Subject|0|||
16946061|NCT01309737|38090067|FG003|Week 16 to 52|Withdrawal by Subject|0|||
16946062|NCT01309737|38090068|FG004|Week 16 to 52|Withdrawal by Subject|2|||
16946063|NCT01309737|38090064|FG000|Week 16 to 52|Other|10|||
16946064|NCT01309737|38090065|FG001|Week 16 to 52|Other|12|||
16946065|NCT01309737|38090066|FG002|Week 16 to 52|Other|0|||
16946066|NCT01309737|38090067|FG003|Week 16 to 52|Other|2|||
16946067|NCT01309737|38090068|FG004|Week 16 to 52|Other|0|||
16946068|NCT01074229|38090094|FG000|Overall Study|Lost to Follow-up|1|||
16946069|NCT01074229|38090095|FG001|Overall Study|Lost to Follow-up|0|||
16946070|NCT01074229|38090096|FG002|Overall Study|Lost to Follow-up|0|||
16946071|NCT01074229|38090094|FG000|Overall Study|Change to open surgical procedure|1|||
16946072|NCT01074229|38090095|FG001|Overall Study|Change to open surgical procedure|3|||
16946073|NCT01074229|38090096|FG002|Overall Study|Change to open surgical procedure|4|||
16946074|NCT01106014|38090108|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
16946075|NCT01106014|38090109|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
16946076|NCT01106014|38090108|FG000|Overall Study|Adverse Event|78|||
16946077|NCT01106014|38090109|FG001|Overall Study|Adverse Event|42|||
16946078|NCT01106014|38090108|FG000|Overall Study|Withdrawal by Subject|43|||
16946079|NCT01106014|38090109|FG001|Overall Study|Withdrawal by Subject|37|||
16946080|NCT01106014|38090108|FG000|Overall Study|Administrative reason|7|||
16946081|NCT01106014|38090109|FG001|Overall Study|Administrative reason|6|||
16946082|NCT01106014|38090108|FG000|Overall Study|Lost to Follow-up|2|||
16946083|NCT01106014|38090109|FG001|Overall Study|Lost to Follow-up|3|||
16946084|NCT01073605|38090118|FG000|Overall Study|Ongoing at Cutoff Date|1|||
16946085|NCT01073605|38090119|FG001|Overall Study|Ongoing at Cutoff Date|1|||
16946086|NCT01073605|38090120|FG002|Overall Study|Ongoing at Cutoff Date|0|||
16946087|NCT01073605|38090118|FG000|Overall Study|Adverse Event|2|||
16946088|NCT01073605|38090119|FG001|Overall Study|Adverse Event|1|||
16946089|NCT01073605|38090120|FG002|Overall Study|Adverse Event|0|||
16946090|NCT01073605|38090118|FG000|Overall Study|Lost to Follow-up|3|||
16946091|NCT01073605|38090119|FG001|Overall Study|Lost to Follow-up|4|||
16946092|NCT01073605|38090120|FG002|Overall Study|Lost to Follow-up|9|||
16946093|NCT01073605|38090118|FG000|Overall Study|Other|25|||
16946094|NCT01073605|38090119|FG001|Overall Study|Other|21|||
16946095|NCT01073605|38090120|FG002|Overall Study|Other|29|||
16946096|NCT01073605|38090118|FG000|Overall Study|Withdrawal by Subject|31|||
16946097|NCT01073605|38090119|FG001|Overall Study|Withdrawal by Subject|39|||
16946098|NCT01073605|38090120|FG002|Overall Study|Withdrawal by Subject|22|||
16946099|NCT01073605|38090118|FG000|Overall Study|Randomized But Not Treated|0|||
16946100|NCT01073605|38090119|FG001|Overall Study|Randomized But Not Treated|1|||
16946101|NCT01073605|38090120|FG002|Overall Study|Randomized But Not Treated|1|||
16946102|NCT01073293|38090130|FG000|Overall Study|Lost to Follow-up|0|||
16946103|NCT01073293|38090131|FG001|Overall Study|Lost to Follow-up|1|||
16946104|NCT01073293|38090130|FG000|Overall Study|Withdrawal by Subject|5|||
16946105|NCT01073293|38090131|FG001|Overall Study|Withdrawal by Subject|10|||
16946106|NCT01105936|38090137|FG000|Period 1|Adverse Event|0|||
16946107|NCT01105936|38090138|FG001|Period 1|Adverse Event|0|||
16946108|NCT01105936|38090139|FG002|Period 1|Adverse Event|0|||
16946109|NCT01105936|38090140|FG003|Period 1|Adverse Event|1|||
16946110|NCT01105936|38090137|FG000|Period 2|Adverse Event|1|||
16946111|NCT01105936|38090138|FG001|Period 2|Adverse Event|0|||
16946112|NCT01105936|38090139|FG002|Period 2|Adverse Event|0|||
16946113|NCT01105936|38090140|FG003|Period 2|Adverse Event|0|||
16946114|NCT01105936|38090137|FG000|Period 3|Protocol Violation|0|||
16946115|NCT01105936|38090138|FG001|Period 3|Protocol Violation|2|||
16946116|NCT01105936|38090139|FG002|Period 3|Protocol Violation|0|||
16946117|NCT01105936|38090140|FG003|Period 3|Protocol Violation|0|||
16946118|NCT01309659|38090151|FG000|Overall Study|Protocol Violation|0|||
16946119|NCT01309659|38090152|FG001|Overall Study|Protocol Violation|1|||
16946120|NCT01104766|38090162|FG000|Overall Study|Did not meet inc/exc criteria|1|||
16946121|NCT01104766|38090163|FG001|Overall Study|Did not meet inc/exc criteria|0|||
16946122|NCT01104766|38090164|FG002|Overall Study|Did not meet inc/exc criteria|0|||
16946123|NCT01104766|38090165|FG003|Overall Study|Did not meet inc/exc criteria|0|||
16946124|NCT01104766|38090162|FG000|Overall Study|Adverse Event|17|||
16946125|NCT01104766|38090163|FG001|Overall Study|Adverse Event|15|||
16946126|NCT01104766|38090164|FG002|Overall Study|Adverse Event|20|||
16946127|NCT01104766|38090165|FG003|Overall Study|Adverse Event|14|||
16946128|NCT01104766|38090162|FG000|Overall Study|Lack of Efficacy|20|||
16946129|NCT01104766|38090163|FG001|Overall Study|Lack of Efficacy|15|||
16946130|NCT01104766|38090164|FG002|Overall Study|Lack of Efficacy|14|||
16946131|NCT01104766|38090165|FG003|Overall Study|Lack of Efficacy|8|||
16946132|NCT01104766|38090162|FG000|Overall Study|Protocol Violation|2|||
16946133|NCT01104766|38090163|FG001|Overall Study|Protocol Violation|0|||
16946134|NCT01104766|38090164|FG002|Overall Study|Protocol Violation|0|||
16946135|NCT01104766|38090165|FG003|Overall Study|Protocol Violation|0|||
16946136|NCT01104766|38090162|FG000|Overall Study|Withdrawal by Subject|17|||
16946137|NCT01104766|38090163|FG001|Overall Study|Withdrawal by Subject|19|||
16946138|NCT01104766|38090164|FG002|Overall Study|Withdrawal by Subject|25|||
16946139|NCT01104766|38090165|FG003|Overall Study|Withdrawal by Subject|15|||
16946140|NCT01104766|38090162|FG000|Overall Study|Lost to Follow-up|1|||
16946141|NCT01104766|38090163|FG001|Overall Study|Lost to Follow-up|2|||
16946142|NCT01104766|38090164|FG002|Overall Study|Lost to Follow-up|1|||
16946143|NCT01104766|38090165|FG003|Overall Study|Lost to Follow-up|1|||
16946144|NCT01104376|38090175|FG000|Overall Study|Withdrawal by Subject|15|||
16946145|NCT01104376|38090175|FG000|Overall Study|Consented but excluded after labs|13|||
16946146|NCT01072357|38090181|FG000|Overall Study|Lost to Follow-up|0|||
16946147|NCT01072357|38090182|FG001|Overall Study|Lost to Follow-up|1|||
16946148|NCT01072201|38090190|FG000|Overall Study|Lost to Follow-up|0|||
16946149|NCT01072201|38090191|FG001|Overall Study|Lost to Follow-up|1|||
16946150|NCT01103362|38090197|FG000|Overall Study|study terminated|596|||
16946151|NCT01103284|38090203|FG000|Overall Study|Death|2|||
16946152|NCT01103284|38090204|FG001|Overall Study|Death|0|||
16946153|NCT01103284|38090203|FG000|Overall Study|Lost to Follow-up|9|||
16946154|NCT01103284|38090204|FG001|Overall Study|Lost to Follow-up|10|||
16946155|NCT01103284|38090203|FG000|Overall Study|Pregnancy|3|||
16946156|NCT01103284|38090204|FG001|Overall Study|Pregnancy|1|||
16946157|NCT01103284|38090203|FG000|Overall Study|Protocol Violation|12|||
16946158|NCT01103284|38090204|FG001|Overall Study|Protocol Violation|5|||
16946159|NCT01103284|38090203|FG000|Overall Study|Adverse Event|0|||
16946160|NCT01103284|38090204|FG001|Overall Study|Adverse Event|5|||
16946161|NCT01103284|38090203|FG000|Overall Study|Withdrawal by Subject|14|||
16946162|NCT01103284|38090204|FG001|Overall Study|Withdrawal by Subject|18|||
16946163|NCT01103284|38090203|FG000|Overall Study|Dermal Hypersensitivity|0|||
16946164|NCT01103284|38090204|FG001|Overall Study|Dermal Hypersensitivity|1|||
16946165|NCT01103284|38090203|FG000|Overall Study|Termination by the Sponsor|0|||
16946166|NCT01103284|38090204|FG001|Overall Study|Termination by the Sponsor|1|||
16946167|NCT01103284|38090203|FG000|Overall Study|Not described|2|||
16946168|NCT01103284|38090204|FG001|Overall Study|Not described|1|||
16946169|NCT01103284|38090203|FG000|Overall Study|Missing CRF entries for study completion|0|||
16946170|NCT01103284|38090204|FG001|Overall Study|Missing CRF entries for study completion|2|||
16946171|NCT01070953|38090210|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
16946172|NCT01070953|38090210|FG000|Participants for Safety Evaluation|Off-label use|283|||
16946173|NCT01070953|38090210|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
16946174|NCT01070953|38090210|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
16946175|NCT01070953|38090210|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
16946176|NCT01070953|38090210|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
16946177|NCT01070953|38090210|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
16946178|NCT01070953|38090210|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
16946179|NCT01070953|38090210|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
16946180|NCT01070953|38090210|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
16946181|NCT01089361|38090222|FG000|Overall Study|Death|1|||
16946182|NCT01089361|38090223|FG001|Overall Study|Death|0|||
16946183|NCT01102972|38090233|FG000|Overall Study|Adverse Event|8|||
16946184|NCT01102972|38090234|FG001|Overall Study|Adverse Event|2|||
16946185|NCT01102972|38090233|FG000|Overall Study|Lack of Efficacy|2|||
16946186|NCT01102972|38090234|FG001|Overall Study|Lack of Efficacy|1|||
16946187|NCT01102972|38090233|FG000|Overall Study|Protocol Violation|1|||
16946188|NCT01102972|38090234|FG001|Overall Study|Protocol Violation|0|||
16946189|NCT01102972|38090233|FG000|Overall Study|Lost to Follow-up|10|||
16946190|NCT01102972|38090234|FG001|Overall Study|Lost to Follow-up|5|||
16946191|NCT01102972|38090233|FG000|Overall Study|Investigator Discretion|2|||
16946192|NCT01102972|38090234|FG001|Overall Study|Investigator Discretion|0|||
16946193|NCT01102972|38090233|FG000|Overall Study|Withdrawal by Subject|6|||
16946194|NCT01102972|38090234|FG001|Overall Study|Withdrawal by Subject|6|||
16946195|NCT01309269|38090240|FG000|Overall Study|Adverse Event|56|||
16946196|NCT01309269|38090240|FG000|Overall Study|Withdrawal by Subject|25|||
16946197|NCT01309269|38090240|FG000|Overall Study|Lack of Acceptance|15|||
16946198|NCT01309269|38090240|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
16946199|NCT01309269|38090240|FG000|Overall Study|Kidney Transplant|25|||
16946200|NCT01309269|38090240|FG000|Overall Study|Administrative Problems|141|||
16946201|NCT01309269|38090240|FG000|Overall Study|Other|256|||
16946202|NCT01309269|38090240|FG000|Overall Study|Other|1|||
16946203|NCT01309269|38090240|FG000|Overall Study|Study Completion Data Not Recorded|95|||
16946204|NCT01309269|38090240|FG000|Overall Study|Enrolled but not Treated|107|||
16946205|NCT01088503|38090247|FG000|Overall Study|Withdrawal by Subject|118|||
16946206|NCT01088503|38090248|FG001|Overall Study|Withdrawal by Subject|327|||
16946207|NCT01088503|38090249|FG002|Overall Study|Withdrawal by Subject|10|||
16946208|NCT01088503|38090247|FG000|Overall Study|Death|64|||
16946209|NCT01088503|38090248|FG001|Overall Study|Death|358|||
16946210|NCT01088503|38090249|FG002|Overall Study|Death|7|||
16946211|NCT01087489|38090255|FG000|Overall Study|enrolled in another VA study|0|||
16946212|NCT01087489|38090256|FG001|Overall Study|enrolled in another VA study|1|||
16946213|NCT01087489|38090255|FG000|Overall Study|Death|0|||
16946214|NCT01087489|38090256|FG001|Overall Study|Death|1|||
16946215|NCT01087489|38090255|FG000|Overall Study|unable to survey by telephone|0|||
16946216|NCT01087489|38090256|FG001|Overall Study|unable to survey by telephone|1|||
16946217|NCT01082965|38090264|FG000|Overall Study|Protocol Violation|0|||
16946218|NCT01082965|38090265|FG001|Overall Study|Protocol Violation|1|||
16946219|NCT01082965|38090264|FG000|Overall Study|Other|1|||
16946220|NCT01082965|38090265|FG001|Overall Study|Other|1|||
16946221|NCT01102426|38090273|FG000|Overall Study|Randomized but not treated|4|||
16946222|NCT01102426|38090274|FG001|Overall Study|Randomized but not treated|1|||
16946223|NCT01102426|38090273|FG000|Overall Study|Adverse Events (treatment-related)|15|||
16946224|NCT01102426|38090274|FG001|Overall Study|Adverse Events (treatment-related)|8|||
16946225|NCT01102426|38090273|FG000|Overall Study|Physician Decision|9|||
16946226|NCT01102426|38090274|FG001|Overall Study|Physician Decision|6|||
16946227|NCT01102426|38090273|FG000|Overall Study|Progressive Disease|85|||
16946228|NCT01102426|38090274|FG001|Overall Study|Progressive Disease|44|||
16946229|NCT01102426|38090273|FG000|Overall Study|Adverse Events (unrelated to|9|||
16946230|NCT01102426|38090274|FG001|Overall Study|Adverse Events (unrelated to|1|||
16946231|NCT01102426|38090273|FG000|Overall Study|Patient Refusal|24|||
16946232|NCT01102426|38090274|FG001|Overall Study|Patient Refusal|12|||
16946233|NCT01102426|38090273|FG000|Overall Study|Death (due to adverse events|0|||
16946234|NCT01102426|38090274|FG001|Overall Study|Death (due to adverse events|1|||
16946235|NCT01102426|38090273|FG000|Overall Study|Death (non-related to the study|19|||
16946236|NCT01102426|38090274|FG001|Overall Study|Death (non-related to the study|8|||
16946237|NCT01101334|38090282|FG000|Overall Study|Adverse Event|9|||
16946238|NCT01101334|38090283|FG001|Overall Study|Adverse Event|4|||
16946239|NCT01101334|38090282|FG000|Overall Study|Death|7|||
16946240|NCT01101334|38090283|FG001|Overall Study|Death|1|||
16946241|NCT01101334|38090282|FG000|Overall Study|Withdrawal by Subject|4|||
16946242|NCT01101334|38090283|FG001|Overall Study|Withdrawal by Subject|3|||
16946243|NCT01101334|38090282|FG000|Overall Study|Withdrawal by Sponsor|1|||
16946244|NCT01101334|38090283|FG001|Overall Study|Withdrawal by Sponsor|1|||
16946245|NCT01101334|38090282|FG000|Overall Study|Progressive Disease|22|||
16946246|NCT01101334|38090283|FG001|Overall Study|Progressive Disease|35|||
16946247|NCT01101334|38090282|FG000|Overall Study|Other|2|||
16946248|NCT01101334|38090283|FG001|Overall Study|Other|1|||
16946249|NCT01327547|38090291|FG000|Overall Study|Adverse Event|4|||
16946250|NCT01327547|38090292|FG001|Overall Study|Adverse Event|1|||
16946251|NCT01327547|38090291|FG000|Overall Study|Death|1|||
16946252|NCT01327547|38090292|FG001|Overall Study|Death|2|||
16946253|NCT01327547|38090291|FG000|Overall Study|Lost to Follow-up|6|||
16946254|NCT01327547|38090292|FG001|Overall Study|Lost to Follow-up|6|||
16946255|NCT01327547|38090291|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
16946256|NCT01327547|38090292|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
16946257|NCT01327547|38090291|FG000|Overall Study|Withdrawal by Subject|3|||
16946258|NCT01327547|38090292|FG001|Overall Study|Withdrawal by Subject|7|||
16946259|NCT01327547|38090291|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
16946260|NCT01327547|38090292|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
16946261|NCT01327547|38090291|FG000|Overall Study|Protocol Violation|1|||
16946262|NCT01327547|38090292|FG001|Overall Study|Protocol Violation|0|||
16946263|NCT01327547|38090291|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
16946264|NCT01327547|38090292|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
16946265|NCT01327547|38090291|FG000|Overall Study|Required prohibited medication|2|||
16946266|NCT01327547|38090292|FG001|Overall Study|Required prohibited medication|0|||
16946267|NCT01327547|38090291|FG000|Overall Study|Non-compliance with study procedures|1|||
16946268|NCT01327547|38090292|FG001|Overall Study|Non-compliance with study procedures|0|||
16946269|NCT01327547|38090291|FG000|Overall Study|By investigator in subject's interest|0|||
16946270|NCT01327547|38090292|FG001|Overall Study|By investigator in subject's interest|1|||
16946271|NCT01308567|38090314|FG000|Overall Study|Lost to Follow-up|2|||
16946272|NCT01308567|38090315|FG001|Overall Study|Lost to Follow-up|4|||
16946273|NCT01308567|38090316|FG002|Overall Study|Lost to Follow-up|4|||
16946274|NCT01307319|38090327|FG000|Overall Study|Adverse Event|2|||
16946275|NCT01307319|38090328|FG001|Overall Study|Adverse Event|2|||
16946276|NCT01307319|38090329|FG002|Overall Study|Adverse Event|1|||
16946277|NCT01307319|38090327|FG000|Overall Study|Lost to Follow-up|1|||
16946278|NCT01307319|38090328|FG001|Overall Study|Lost to Follow-up|0|||
16946279|NCT01307319|38090329|FG002|Overall Study|Lost to Follow-up|1|||
16946280|NCT01307319|38090327|FG000|Overall Study|Protocol Violation|1|||
16946281|NCT01307319|38090328|FG001|Overall Study|Protocol Violation|1|||
16946282|NCT01307319|38090329|FG002|Overall Study|Protocol Violation|0|||
17028453|NCT00783302|38172806|FG000|Overall Study|Physician Decision|1|||
16946283|NCT01307319|38090327|FG000|Overall Study|Withdrawal by Subject|0|||
16946284|NCT01307319|38090328|FG001|Overall Study|Withdrawal by Subject|1|||
16946285|NCT01307319|38090329|FG002|Overall Study|Withdrawal by Subject|2|||
16946286|NCT01307319|38090327|FG000|Overall Study|Other|0|||
16946287|NCT01307319|38090328|FG001|Overall Study|Other|4|||
16946288|NCT01307319|38090329|FG002|Overall Study|Other|3|||
16946289|NCT01080391|38090339|FG000|Overall Study|Randomized but not treated|7|||
16946290|NCT01080391|38090340|FG001|Overall Study|Randomized but not treated|4|||
16946291|NCT01070329|38090348|FG000|Overall Study|Adverse Event|13|||
16946292|NCT01070329|38090349|FG001|Overall Study|Adverse Event|10|||
16946293|NCT01070329|38090348|FG000|Overall Study|Lost to Follow-up|22|||
16946294|NCT01070329|38090349|FG001|Overall Study|Lost to Follow-up|12|||
16946295|NCT01070329|38090348|FG000|Overall Study|Withdrawal by Subject|9|||
16946296|NCT01070329|38090349|FG001|Overall Study|Withdrawal by Subject|11|||
16946297|NCT01070329|38090348|FG000|Overall Study|Protocol Violation|3|||
16946298|NCT01070329|38090349|FG001|Overall Study|Protocol Violation|8|||
16946299|NCT01070329|38090348|FG000|Overall Study|Lack of Efficacy|2|||
16946300|NCT01070329|38090349|FG001|Overall Study|Lack of Efficacy|6|||
16946301|NCT01070329|38090348|FG000|Overall Study|Physician Decision|2|||
16946302|NCT01070329|38090349|FG001|Overall Study|Physician Decision|1|||
16946303|NCT01070329|38090348|FG000|Overall Study|Entry Criteria Not Met|1|||
16946304|NCT01070329|38090349|FG001|Overall Study|Entry Criteria Not Met|0|||
16946305|NCT01070329|38090348|FG000|Overall Study|Sponsor Decision|0|||
16946306|NCT01070329|38090349|FG001|Overall Study|Sponsor Decision|1|||
16946307|NCT01069861|38090355|FG000|Overall Study|Death|1|||
16946308|NCT01069861|38090355|FG000|Overall Study|Adverse Event|1|||
16946309|NCT01069861|38090355|FG000|Overall Study|Did not meet entrance criteria|1|||
16946310|NCT01306929|38090359|FG000|Overall Study|Withdrawal by Subject|23|||
16946311|NCT01306929|38090359|FG000|Overall Study|Adverse Event|21|||
16946312|NCT01306929|38090359|FG000|Overall Study|Physician Decision|13|||
16946313|NCT01306929|38090359|FG000|Overall Study|Death|8|||
16946314|NCT01306929|38090359|FG000|Overall Study|Withdrawal by parent/guardian|5|||
16946315|NCT01306929|38090359|FG000|Overall Study|Protocol Violation|3|||
16946316|NCT01306929|38090359|FG000|Overall Study|Non-compliance with study drug|2|||
16946317|NCT01306929|38090359|FG000|Overall Study|Lost to Follow-up|2|||
16946318|NCT01306929|38090359|FG000|Overall Study|Various|17|||
16946319|NCT01064401|38090365|FG000|Overall Study|Adverse Event|47|||
16946320|NCT01064401|38090366|FG001|Overall Study|Adverse Event|56|||
16946321|NCT01064401|38090365|FG000|Overall Study|Lack of Efficacy|46|||
16946322|NCT01064401|38090366|FG001|Overall Study|Lack of Efficacy|23|||
16946323|NCT01064401|38090365|FG000|Overall Study|Lost to Follow-up|12|||
16946324|NCT01064401|38090366|FG001|Overall Study|Lost to Follow-up|9|||
16946325|NCT01064401|38090365|FG000|Overall Study|Consent Withdrawn|98|||
16946326|NCT01064401|38090366|FG001|Overall Study|Consent Withdrawn|80|||
16946327|NCT01064401|38090365|FG000|Overall Study|Investigator Decision|4|||
16946328|NCT01064401|38090366|FG001|Overall Study|Investigator Decision|6|||
16946329|NCT01064401|38090365|FG000|Overall Study|Death|4|||
16946330|NCT01064401|38090366|FG001|Overall Study|Death|0|||
16946331|NCT01064401|38090365|FG000|Overall Study|Pregnancy|4|||
16946332|NCT01064401|38090366|FG001|Overall Study|Pregnancy|7|||
16946333|NCT01064401|38090365|FG000|Overall Study|Noncompliance|7|||
16946334|NCT01064401|38090366|FG001|Overall Study|Noncompliance|8|||
16946335|NCT01064401|38090365|FG000|Overall Study|Site Closure|4|||
16946336|NCT01064401|38090366|FG001|Overall Study|Site Closure|5|||
16946337|NCT01064401|38090365|FG000|Overall Study|Other|2|||
16946338|NCT01064401|38090366|FG001|Overall Study|Other|1|||
16946339|NCT01306617|38090376|FG000|Overall Study|Adverse Event|1|||
16946340|NCT01306617|38090377|FG001|Overall Study|Adverse Event|0|||
16946341|NCT01306617|38090378|FG002|Overall Study|Adverse Event|0|||
16946342|NCT01306617|38090376|FG000|Overall Study|Virologic Failure|0|||
16946343|NCT01306617|38090377|FG001|Overall Study|Virologic Failure|0|||
16946344|NCT01306617|38090378|FG002|Overall Study|Virologic Failure|5|||
16946345|NCT01306617|38090376|FG000|Overall Study|Non-compliance|0|||
16946346|NCT01306617|38090377|FG001|Overall Study|Non-compliance|1|||
16946347|NCT01306617|38090378|FG002|Overall Study|Non-compliance|0|||
16946348|NCT01306305|38090388|FG000|Overall Study|Lost to Follow-up|1|||
16946349|NCT01306305|38090389|FG001|Overall Study|Lost to Follow-up|0|||
16946350|NCT01306305|38090388|FG000|Overall Study|Withdrew consent|1|||
16946351|NCT01306305|38090389|FG001|Overall Study|Withdrew consent|0|||
16946352|NCT01038427|38090398|FG000|Overall Study|Lost to follow up|1|||
16946353|NCT01038427|38090399|FG001|Overall Study|Lost to follow up|1|||
16946354|NCT01038427|38090400|FG002|Overall Study|Lost to follow up|0|||
16946355|NCT01038427|38090398|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
16946356|NCT01038427|38090399|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
16946357|NCT01038427|38090400|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
16946358|NCT01038427|38090398|FG000|Overall Study|Withdrew consent|0|||
16946359|NCT01038427|38090399|FG001|Overall Study|Withdrew consent|0|||
16946360|NCT01038427|38090400|FG002|Overall Study|Withdrew consent|1|||
16946361|NCT01038427|38090398|FG000|Overall Study|Adverse Event|2|||
16946362|NCT01038427|38090399|FG001|Overall Study|Adverse Event|2|||
16946363|NCT01038427|38090400|FG002|Overall Study|Adverse Event|1|||
16946364|NCT01038427|38090398|FG000|Overall Study|Enrolled in error|0|||
16946365|NCT01038427|38090399|FG001|Overall Study|Enrolled in error|1|||
16946366|NCT01038427|38090400|FG002|Overall Study|Enrolled in error|1|||
16946367|NCT01038427|38090398|FG000|Overall Study|Other|0|||
16946368|NCT01038427|38090399|FG001|Overall Study|Other|2|||
16946369|NCT01038427|38090400|FG002|Overall Study|Other|0|||
16946370|NCT01037413|38090408|FG000|Part A: Skin Testing|Adverse Event|1|||
16946371|NCT01037413|38090409|FG001|Part A: Skin Testing|Adverse Event|0|||
16946372|NCT01037413|38090408|FG000|Part A: Skin Testing|Protocol Violation|1|||
16946373|NCT01037413|38090409|FG001|Part A: Skin Testing|Protocol Violation|0|||
16946374|NCT01037413|38090408|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
16946375|NCT01037413|38090409|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
16946376|NCT01037413|38090408|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
16946377|NCT01037413|38090409|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
17028454|NCT00783302|38172806|FG000|Overall Study|Withdrawal by Subject|3|||
17028455|NCT00783224|38172828|FG000|Overall Study|Adverse Event|0|||
17028456|NCT00783224|38172829|FG001|Overall Study|Adverse Event|0|||
17028457|NCT00783224|38172830|FG002|Overall Study|Adverse Event|1|||
17028458|NCT00783224|38172831|FG003|Overall Study|Adverse Event|0|||
16946378|NCT01326845|38090424|FG000|Overall Study|Administrative Problems|5|||
16946379|NCT01326845|38090425|FG001|Overall Study|Administrative Problems|2|||
16946380|NCT01326845|38090424|FG000|Overall Study|Adverse Event|1|||
16946381|NCT01326845|38090425|FG001|Overall Study|Adverse Event|0|||
16946382|NCT01326845|38090424|FG000|Overall Study|Misisng|1|||
16946383|NCT01326845|38090425|FG001|Overall Study|Misisng|3|||
16946384|NCT01062763|38090433|FG000|Overall Study|Adverse Event|3|||
16946385|NCT01062763|38090434|FG001|Overall Study|Adverse Event|4|||
16946386|NCT01048099|38090440|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
16946387|NCT01048099|38090440|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
16946388|NCT01303965|38090448|FG000|Overall Study|Adverse Event|1|||
16946389|NCT01303965|38090449|FG001|Overall Study|Adverse Event|1|||
16946390|NCT01303965|38090448|FG000|Overall Study|Death|0|||
16946391|NCT01303965|38090449|FG001|Overall Study|Death|3|||
16946392|NCT01303965|38090448|FG000|Overall Study|Withdrawal by Subject|1|||
16946393|NCT01303965|38090449|FG001|Overall Study|Withdrawal by Subject|0|||
16946394|NCT01303965|38090448|FG000|Overall Study|Disease Progression|1|||
16946395|NCT01303965|38090449|FG001|Overall Study|Disease Progression|6|||
16946396|NCT01045993|38090459|FG000|Overall Study|Treated-later found eligibility not met|0|||
16946397|NCT01045993|38090460|FG001|Overall Study|Treated-later found eligibility not met|1|||
16946398|NCT01045993|38090461|FG002|Overall Study|Treated-later found eligibility not met|0|||
16946399|NCT01045993|38090462|FG003|Overall Study|Treated-later found eligibility not met|0|||
16946400|NCT01303419|38090472|FG000|Overall Study|Discontinuation of study|60|||
16946401|NCT01303419|38090472|FG000|Overall Study|Did not complete both imaging methods|5|||
16946402|NCT01303419|38090472|FG000|Overall Study|Did not meet all I/E after screening|31|||
16946403|NCT01326533|38090478|FG000|Overall Study|Lost to Follow-up|2|||
16946404|NCT01326533|38090479|FG001|Overall Study|Lost to Follow-up|0|||
16946405|NCT01326533|38090478|FG000|Overall Study|Withdrawal by Subject|1|||
16946406|NCT01326533|38090479|FG001|Overall Study|Withdrawal by Subject|0|||
16946407|NCT01326533|38090478|FG000|Overall Study|Adverse Event|1|||
16946408|NCT01326533|38090479|FG001|Overall Study|Adverse Event|0|||
16946409|NCT01045447|38090487|FG000|Overall Study|Adverse Event|0|||
16946410|NCT01045447|38090488|FG001|Overall Study|Adverse Event|1|||
16946411|NCT01045447|38090487|FG000|Overall Study|Lack of Efficacy|3|||
16946412|NCT01045447|38090488|FG001|Overall Study|Lack of Efficacy|1|||
16946413|NCT01045447|38090487|FG000|Overall Study|Protocol Violation|6|||
16946414|NCT01045447|38090488|FG001|Overall Study|Protocol Violation|3|||
16946415|NCT01045447|38090487|FG000|Overall Study|Withdrawal Criteria|10|||
16946416|NCT01045447|38090488|FG001|Overall Study|Withdrawal Criteria|10|||
16946417|NCT01045447|38090487|FG000|Overall Study|Unclassified|17|||
16946418|NCT01045447|38090488|FG001|Overall Study|Unclassified|13|||
16946419|NCT01301625|38090494|FG000|Overall Study|Death|5|||
16946420|NCT01301625|38090494|FG000|Overall Study|Not Due|21|||
16946421|NCT01301625|38090494|FG000|Overall Study|Expected|8|||
16946422|NCT01301625|38090494|FG000|Overall Study|Lost to Follow-up|1|||
16946423|NCT01301391|38090498|FG000|Overall Study|Death|13|||
16946424|NCT01301391|38090498|FG000|Overall Study|Lost to Follow-up|3|||
16946425|NCT01301391|38090498|FG000|Overall Study|Physician Decision|2|||
16946426|NCT01301391|38090498|FG000|Overall Study|Sponsor's decision|8|||
16946427|NCT01036321|38090504|FG000|Overall Study|Ineligible after randomization|0|||
16946428|NCT01036321|38090505|FG001|Overall Study|Ineligible after randomization|1|||
16946429|NCT01036321|38090504|FG000|Overall Study|Withdrawal by Subject|3|||
16946430|NCT01036321|38090505|FG001|Overall Study|Withdrawal by Subject|2|||
16946431|NCT01036321|38090504|FG000|Overall Study|Adverse Event|2|||
16946432|NCT01036321|38090505|FG001|Overall Study|Adverse Event|1|||
16946433|NCT01061359|38090511|FG000|Overall Study|Death|32|||
16946434|NCT01061359|38090511|FG000|Overall Study|Lost to Follow-up|1072|||
16946435|NCT01061359|38090511|FG000|Overall Study|Relapse|187|||
16946436|NCT01061359|38090511|FG000|Overall Study|Secondary neoplasm|11|||
16946437|NCT01301079|38090517|FG000|Overall Study|Lost to Follow-up|2|||
16946438|NCT01301079|38090518|FG001|Overall Study|Lost to Follow-up|2|||
16946439|NCT01036165|38090528|FG000|Overall Study|Adverse Event|6|||
16946440|NCT01036165|38090528|FG000|Overall Study|Lost to Follow-up|2|||
16946441|NCT01036165|38090528|FG000|Overall Study|Withdrawal by Subject|3|||
16946442|NCT01036165|38090528|FG000|Overall Study|Device Related Issues|3|||
16946443|NCT01036165|38090528|FG000|Overall Study|Problems finding proper area to inject|1|||
16946446|NCT01301001|38090536|FG000|First Intervention|Lost to Follow-up|4|||
16946447|NCT01301001|38090537|FG001|First Intervention|Lost to Follow-up|4|||
16946448|NCT01301001|38090536|FG000|First Intervention|Withdrawal by Subject|1|||
16946449|NCT01301001|38090537|FG001|First Intervention|Withdrawal by Subject|4|||
16946450|NCT01301001|38090536|FG000|First Intervention|Adverse Event|5|||
16946451|NCT01301001|38090537|FG001|First Intervention|Adverse Event|0|||
16946452|NCT01301001|38090536|FG000|First Intervention|Protocol Violation|0|||
16946453|NCT01301001|38090537|FG001|First Intervention|Protocol Violation|1|||
16946454|NCT01301001|38090536|FG000|Second Intervention|Adverse Event|2|||
16946455|NCT01301001|38090537|FG001|Second Intervention|Adverse Event|0|||
16946456|NCT01301001|38090536|FG000|Second Intervention|Withdrawal by Subject|2|||
16946457|NCT01301001|38090537|FG001|Second Intervention|Withdrawal by Subject|0|||
16946458|NCT01035463|38090546|FG000|Overall Study|Adverse Event|0|||
16946459|NCT01035463|38090547|FG001|Overall Study|Adverse Event|0|||
16946460|NCT01035463|38090548|FG002|Overall Study|Adverse Event|4|||
16946461|NCT01035463|38090549|FG003|Overall Study|Adverse Event|1|||
16946462|NCT01035463|38090550|FG004|Overall Study|Adverse Event|5|||
16946463|NCT01035463|38090551|FG005|Overall Study|Adverse Event|7|||
16946464|NCT01035463|38090546|FG000|Overall Study|Withdrawal by Subject|0|||
16946465|NCT01035463|38090547|FG001|Overall Study|Withdrawal by Subject|2|||
16946466|NCT01035463|38090548|FG002|Overall Study|Withdrawal by Subject|1|||
16946467|NCT01035463|38090549|FG003|Overall Study|Withdrawal by Subject|0|||
16946468|NCT01035463|38090550|FG004|Overall Study|Withdrawal by Subject|1|||
16946469|NCT01035463|38090551|FG005|Overall Study|Withdrawal by Subject|4|||
16946470|NCT01035463|38090546|FG000|Overall Study|Disease progression|0|||
16946471|NCT01035463|38090547|FG001|Overall Study|Disease progression|0|||
16946472|NCT01035463|38090548|FG002|Overall Study|Disease progression|0|||
16946473|NCT01035463|38090549|FG003|Overall Study|Disease progression|0|||
16946474|NCT01035463|38090550|FG004|Overall Study|Disease progression|0|||
16946475|NCT01035463|38090551|FG005|Overall Study|Disease progression|3|||
16946476|NCT01035463|38090546|FG000|Overall Study|Other Malignancy|0|||
16946477|NCT01035463|38090547|FG001|Overall Study|Other Malignancy|0|||
16946478|NCT01035463|38090548|FG002|Overall Study|Other Malignancy|0|||
16946479|NCT01035463|38090549|FG003|Overall Study|Other Malignancy|0|||
16946480|NCT01035463|38090550|FG004|Overall Study|Other Malignancy|0|||
16946481|NCT01035463|38090551|FG005|Overall Study|Other Malignancy|2|||
16946482|NCT01035463|38090546|FG000|Overall Study|Other|0|||
16946483|NCT01035463|38090547|FG001|Overall Study|Other|0|||
16946484|NCT01035463|38090548|FG002|Overall Study|Other|0|||
16946485|NCT01035463|38090549|FG003|Overall Study|Other|1|||
16946486|NCT01035463|38090550|FG004|Overall Study|Other|0|||
16946487|NCT01035463|38090551|FG005|Overall Study|Other|2|||
16946488|NCT01300923|38090558|FG000|Overall Study|Physician Decision|0|||
16946489|NCT01300923|38090559|FG001|Overall Study|Physician Decision|2|||
16946490|NCT01300767|38090564|FG000|Overall Study|Discomfort|2|||
16946491|NCT01300767|38090564|FG000|Overall Study|Biomicroscopy|1|||
16946492|NCT01300767|38090564|FG000|Overall Study|Unacceptable fit|1|||
16946493|NCT01300455|38090572|FG000|Washout|Withdrawal by Subject|1|||
16946494|NCT01300455|38090573|FG001|Washout|Withdrawal by Subject|0|||
16946495|NCT01107418|38090583|FG000|Overall Study|Disease Progression|45|||
16946496|NCT01107418|38090583|FG000|Overall Study|Adverse Event|3|||
16946497|NCT01107418|38090583|FG000|Overall Study|Withdrawal by Subject|1|||
16946498|NCT01107418|38090583|FG000|Overall Study|Study Closing|1|||
16946499|NCT01107418|38090583|FG000|Overall Study|Started Other Therapy|1|||
16946500|NCT01107418|38090583|FG000|Overall Study|Entered Extension Study|1|||
16946501|NCT01101178|38090598|FG000|Period 1|Withdrawal by Subject|1|||
16946502|NCT01101178|38090599|FG001|Period 1|Withdrawal by Subject|2|||
16946503|NCT01101178|38090598|FG000|Period 1|Positive drug screen|1|||
16946504|NCT01101178|38090599|FG001|Period 1|Positive drug screen|1|||
16946505|NCT01101178|38090598|FG000|Period 1|Adverse Event|2|||
16946506|NCT01101178|38090599|FG001|Period 1|Adverse Event|1|||
16946507|NCT01101178|38090598|FG000|Period 2|Withdrawal by Subject|0|||
16946508|NCT01101178|38090599|FG001|Period 2|Withdrawal by Subject|1|||
16946509|NCT01101022|38090608|FG000|Overall Study|Adverse Event|6|||
16946510|NCT01101022|38090609|FG001|Overall Study|Adverse Event|2|||
16946511|NCT01101022|38090608|FG000|Overall Study|Protocol Violation|4|||
16946512|NCT01101022|38090609|FG001|Overall Study|Protocol Violation|3|||
16946513|NCT01101022|38090608|FG000|Overall Study|Withdrawal by Subject|3|||
16946514|NCT01101022|38090609|FG001|Overall Study|Withdrawal by Subject|8|||
16946515|NCT01101022|38090608|FG000|Overall Study|Lost to Follow-up|1|||
16946516|NCT01101022|38090609|FG001|Overall Study|Lost to Follow-up|4|||
16946517|NCT01101022|38090608|FG000|Overall Study|Lack of Efficacy|0|||
16946518|NCT01101022|38090609|FG001|Overall Study|Lack of Efficacy|7|||
16946519|NCT01101022|38090608|FG000|Overall Study|Sponsor decision|1|||
16946520|NCT01101022|38090609|FG001|Overall Study|Sponsor decision|1|||
16946521|NCT01101022|38090608|FG000|Overall Study|Non-compliance|1|||
16946522|NCT01101022|38090609|FG001|Overall Study|Non-compliance|0|||
16946523|NCT01101022|38090608|FG000|Overall Study|Work schedule|1|||
16946524|NCT01101022|38090609|FG001|Overall Study|Work schedule|1|||
16946525|NCT01101022|38090608|FG000|Overall Study|Vacation|0|||
16946526|NCT01101022|38090609|FG001|Overall Study|Vacation|1|||
16946527|NCT01299909|38090618|FG000|Overall Study|Lost to Follow-up|22|||
16946528|NCT01299909|38090619|FG001|Overall Study|Lost to Follow-up|18|||
16946529|NCT01299909|38090620|FG002|Overall Study|Lost to Follow-up|17|||
16946530|NCT01298661|38090630|FG000|Overall Study|Withdrawal by Subject|2|||
16946531|NCT01298661|38090631|FG001|Overall Study|Withdrawal by Subject|0|||
16946532|NCT01298661|38090632|FG002|Overall Study|Withdrawal by Subject|2|||
16946533|NCT01100944|38090641|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
16946534|NCT01100944|38090642|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
16946535|NCT01100944|38090643|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
16946536|NCT01100944|38090641|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
16946537|NCT01100944|38090642|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
16946538|NCT01100944|38090643|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
16946539|NCT01100944|38090641|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
16946540|NCT01100944|38090642|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
16946541|NCT01100944|38090643|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
16946542|NCT01100944|38090641|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
16946543|NCT01100944|38090642|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
16946544|NCT01100944|38090643|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
16946545|NCT01100320|38090664|FG000|Period 1|Withdrawal by Subject|2|||
16946546|NCT01100320|38090665|FG001|Period 1|Withdrawal by Subject|4|||
16946547|NCT01100320|38090664|FG000|Period 1|Positive Drug Screen|1|||
16946548|NCT01100320|38090665|FG001|Period 1|Positive Drug Screen|1|||
16946549|NCT01100320|38090664|FG000|Period 1|Adverse Event|2|||
16946550|NCT01100320|38090665|FG001|Period 1|Adverse Event|2|||
16946551|NCT01100320|38090664|FG000|Period 2|Withdrawal by Subject|1|||
16946552|NCT01100320|38090665|FG001|Period 2|Withdrawal by Subject|1|||
16946553|NCT01100086|38090671|FG000|Period 1|Withdrawal by Subject|1|||
16946554|NCT01100086|38090672|FG001|Period 1|Withdrawal by Subject|0|||
16946555|NCT01297959|38090680|FG000|Overall Study|Adverse Event|0|||
16946556|NCT01297959|38090681|FG001|Overall Study|Adverse Event|1|||
16946557|NCT01297959|38090680|FG000|Overall Study|Protocol Violation|2|||
16946558|NCT01297959|38090681|FG001|Overall Study|Protocol Violation|1|||
16946559|NCT01297959|38090680|FG000|Overall Study|Withdrawal by Subject|5|||
16946560|NCT01297959|38090681|FG001|Overall Study|Withdrawal by Subject|4|||
16946561|NCT01297959|38090680|FG000|Overall Study|Physician Decision|0|||
16946562|NCT01297959|38090681|FG001|Overall Study|Physician Decision|1|||
16946563|NCT01297959|38090680|FG000|Overall Study|Unrelated medical illness / complication|0|||
16946564|NCT01297959|38090681|FG001|Overall Study|Unrelated medical illness / complication|2|||
16946565|NCT01297959|38090680|FG000|Overall Study|Other|13|||
16946566|NCT01297959|38090681|FG001|Overall Study|Other|7|||
16946567|NCT01035229|38090689|FG000|Overall Study|Adverse Event|61|||
16946568|NCT01035229|38090690|FG001|Overall Study|Adverse Event|14|||
16946569|NCT01035229|38090689|FG000|Overall Study|Withdrawal by Subject|20|||
16946570|NCT01035229|38090690|FG001|Overall Study|Withdrawal by Subject|7|||
16946571|NCT01035229|38090689|FG000|Overall Study|Lost to Follow-up|1|||
16946572|NCT01035229|38090690|FG001|Overall Study|Lost to Follow-up|0|||
16946573|NCT01035229|38090689|FG000|Overall Study|Administrative problems|1|||
16946574|NCT01035229|38090690|FG001|Overall Study|Administrative problems|1|||
16946575|NCT01035229|38090689|FG000|Overall Study|Death|13|||
16946576|NCT01035229|38090690|FG001|Overall Study|Death|5|||
16946577|NCT01035229|38090689|FG000|Overall Study|New cancer therapy|2|||
16946578|NCT01035229|38090690|FG001|Overall Study|New cancer therapy|0|||
16946579|NCT01035229|38090689|FG000|Overall Study|Protocol Violation|0|||
16946580|NCT01035229|38090690|FG001|Overall Study|Protocol Violation|2|||
16946581|NCT01035229|38090689|FG000|Overall Study|Sponsor's decision to end study|3|||
16946582|NCT01035229|38090690|FG001|Overall Study|Sponsor's decision to end study|3|||
16946583|NCT01035229|38090689|FG000|Overall Study|Disease Progression|261|||
16946584|NCT01035229|38090690|FG001|Overall Study|Disease Progression|152|||
16946585|NCT01106404|38090700|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
16946586|NCT01106404|38090701|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
16946587|NCT01106404|38090700|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
16946588|NCT01106404|38090701|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
16946589|NCT01106404|38090700|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
16946590|NCT01106404|38090701|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
16946591|NCT01106404|38090700|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
16946592|NCT01106404|38090701|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
16946593|NCT01059799|38090715|FG000|Overall Study|Adverse Event|2|||
16946594|NCT01059799|38090716|FG001|Overall Study|Adverse Event|3|||
16946595|NCT01059799|38090715|FG000|Overall Study|Lack of Efficacy|1|||
16946596|NCT01059799|38090716|FG001|Overall Study|Lack of Efficacy|0|||
16946597|NCT01059799|38090715|FG000|Overall Study|Protocol Violation|3|||
16946598|NCT01059799|38090716|FG001|Overall Study|Protocol Violation|2|||
16946599|NCT01059799|38090715|FG000|Overall Study|Withdrawal criteria|13|||
16946600|NCT01059799|38090716|FG001|Overall Study|Withdrawal criteria|2|||
16946601|NCT01059799|38090715|FG000|Overall Study|Other|12|||
16946602|NCT01059799|38090716|FG001|Overall Study|Other|3|||
16946603|NCT01106248|38090722|FG000|Overall Study|Adverse Event|1|||
16946604|NCT01106248|38090722|FG000|Overall Study|Administrative|2|||
16946605|NCT01059175|38090728|FG000|Overall Study|Death|17|||
16946606|NCT01059175|38090729|FG001|Overall Study|Death|17|||
16946607|NCT01059175|38090728|FG000|Overall Study|Adverse Event|4|||
16946608|NCT01059175|38090729|FG001|Overall Study|Adverse Event|2|||
16946609|NCT01059175|38090728|FG000|Overall Study|Lost to Follow-up|0|||
16946610|NCT01059175|38090729|FG001|Overall Study|Lost to Follow-up|1|||
16946611|NCT01297491|38090737|FG000|Overall Study|Adverse Event|11|||
16946612|NCT01297491|38090738|FG001|Overall Study|Adverse Event|6|||
16946613|NCT01297491|38090737|FG000|Overall Study|Physician Decision|3|||
16946614|NCT01297491|38090738|FG001|Overall Study|Physician Decision|2|||
16946615|NCT01297491|38090737|FG000|Overall Study|Progressive disease|11|||
16946616|NCT01297491|38090738|FG001|Overall Study|Progressive disease|20|||
16946617|NCT01297491|38090737|FG000|Overall Study|Patient/Guardian decision|3|||
16946618|NCT01297491|38090738|FG001|Overall Study|Patient/Guardian decision|4|||
16946619|NCT01297491|38090737|FG000|Overall Study|Death|2|||
16946620|NCT01297491|38090738|FG001|Overall Study|Death|1|||
16946621|NCT01106092|38090748|FG000|Overall Study|Withdrawal by Subject|0|||
16946622|NCT01106092|38090749|FG001|Overall Study|Withdrawal by Subject|0|||
16946623|NCT01106092|38090750|FG002|Overall Study|Withdrawal by Subject|0|||
16946624|NCT01106092|38090751|FG003|Overall Study|Withdrawal by Subject|1|||
16946625|NCT01097668|38090763|FG000|Overall Study|Withdrawal by Subject|1|||
16946626|NCT01097668|38090764|FG001|Overall Study|Withdrawal by Subject|2|||
16946627|NCT01097668|38090763|FG000|Overall Study|Lost to Follow-up|1|||
16946628|NCT01097668|38090764|FG001|Overall Study|Lost to Follow-up|0|||
16946629|NCT01325207|38090780|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16946630|NCT01325207|38090781|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16946631|NCT01325207|38090782|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16946632|NCT01325207|38090783|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16946633|NCT01325207|38090784|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
16946634|NCT01325207|38090785|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16946635|NCT01325207|38090780|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
16946636|NCT01325207|38090781|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
16946637|NCT01325207|38090782|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
16946638|NCT01325207|38090783|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
16946639|NCT01325207|38090784|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
16946640|NCT01325207|38090785|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
16946641|NCT01325207|38090780|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
16946642|NCT01325207|38090781|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
16946643|NCT01325207|38090782|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
16946644|NCT01325207|38090783|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
16946645|NCT01325207|38090784|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
16946646|NCT01325207|38090785|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
16946647|NCT01325207|38090780|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16946648|NCT01325207|38090781|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
16946649|NCT01325207|38090782|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16946650|NCT01325207|38090783|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16946651|NCT01325207|38090784|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16946652|NCT01325207|38090785|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16946653|NCT01325207|38090780|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16946654|NCT01325207|38090781|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16946655|NCT01325207|38090782|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16946656|NCT01325207|38090783|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16946657|NCT01325207|38090784|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16946658|NCT01325207|38090785|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
16946659|NCT01325207|38090780|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16946660|NCT01325207|38090781|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16946661|NCT01325207|38090782|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16946662|NCT01325207|38090783|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16946663|NCT01325207|38090784|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16946664|NCT01325207|38090785|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
16946665|NCT01325207|38090780|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16946666|NCT01325207|38090781|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16946667|NCT01325207|38090782|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16946668|NCT01325207|38090783|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16774147|NCT02201524|37713430|FG003|Overall Study|No longer meets eligibility criteria|2|||
16946669|NCT01325207|38090784|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
16946670|NCT01325207|38090785|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16946671|NCT01324349|38090802|FG000|Overall Study|Death|1|||
16946672|NCT01324349|38090803|FG001|Overall Study|Death|1|||
16946673|NCT01324349|38090802|FG000|Overall Study|Withdrawal by Subject|0|||
16946674|NCT01324349|38090803|FG001|Overall Study|Withdrawal by Subject|1|||
16946675|NCT01095250|38090813|FG000|Overall Study|administrative reasons|8|||
16946676|NCT01095250|38090814|FG001|Overall Study|administrative reasons|10|||
16946677|NCT01095250|38090815|FG002|Overall Study|administrative reasons|7|||
16946678|NCT01095250|38090816|FG003|Overall Study|administrative reasons|5|||
16946679|NCT01095250|38090813|FG000|Overall Study|Withdrawal by Subject|0|||
16946680|NCT01095250|38090814|FG001|Overall Study|Withdrawal by Subject|0|||
16946681|NCT01095250|38090815|FG002|Overall Study|Withdrawal by Subject|1|||
16946682|NCT01095250|38090816|FG003|Overall Study|Withdrawal by Subject|0|||
16946683|NCT01324271|38090826|FG000|Overall Study|Lost to Follow-up|3|||
16946684|NCT01324271|38090827|FG001|Overall Study|Lost to Follow-up|0|||
16946685|NCT01324271|38090826|FG000|Overall Study|Physician Decision|1|||
16946686|NCT01324271|38090827|FG001|Overall Study|Physician Decision|0|||
16946687|NCT01095094|38090833|FG000|Overall Study|Withdrawal by Subject|1|||
16946688|NCT01095094|38090833|FG000|Overall Study|Death|1|||
16946689|NCT01095094|38090833|FG000|Overall Study|Physician Decision|1|||
16946690|NCT01323647|38090839|FG000|Overall Study|Migrated/moved from study area|2|||
16946691|NCT01323647|38090840|FG001|Overall Study|Migrated/moved from study area|0|||
16946692|NCT01323647|38090839|FG000|Overall Study|Withdrawal by Subject|5|||
16946693|NCT01323647|38090840|FG001|Overall Study|Withdrawal by Subject|0|||
16946694|NCT01323647|38090839|FG000|Overall Study|Lost to Follow-up|2|||
16946695|NCT01323647|38090840|FG001|Overall Study|Lost to Follow-up|0|||
16946696|NCT01094782|38090852|FG000|Overall Study|Withdrawal by Subject|5|||
16946697|NCT01094782|38090853|FG001|Overall Study|Withdrawal by Subject|5|||
16946698|NCT01094782|38090854|FG002|Overall Study|Withdrawal by Subject|1|||
16946699|NCT01094782|38090855|FG003|Overall Study|Withdrawal by Subject|5|||
16946700|NCT01094782|38090856|FG004|Overall Study|Withdrawal by Subject|5|||
16946701|NCT01094782|38090857|FG005|Overall Study|Withdrawal by Subject|0|||
16946702|NCT01094782|38090852|FG000|Overall Study|Lost to Follow-up|1|||
16946703|NCT01094782|38090853|FG001|Overall Study|Lost to Follow-up|0|||
16946704|NCT01094782|38090854|FG002|Overall Study|Lost to Follow-up|0|||
16946705|NCT01094782|38090855|FG003|Overall Study|Lost to Follow-up|2|||
16946706|NCT01094782|38090856|FG004|Overall Study|Lost to Follow-up|1|||
16946707|NCT01094782|38090857|FG005|Overall Study|Lost to Follow-up|4|||
16946708|NCT01094782|38090852|FG000|Overall Study|Positive Drug Screen|2|||
16946709|NCT01094782|38090853|FG001|Overall Study|Positive Drug Screen|2|||
16946710|NCT01094782|38090854|FG002|Overall Study|Positive Drug Screen|1|||
16946711|NCT01094782|38090855|FG003|Overall Study|Positive Drug Screen|1|||
16946712|NCT01094782|38090856|FG004|Overall Study|Positive Drug Screen|3|||
16946713|NCT01094782|38090857|FG005|Overall Study|Positive Drug Screen|2|||
16946714|NCT01094782|38090852|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
16946715|NCT01094782|38090853|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
16946716|NCT01094782|38090854|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
16946717|NCT01094782|38090855|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
16946718|NCT01094782|38090856|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
16946719|NCT01094782|38090857|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
16946720|NCT01094782|38090852|FG000|Overall Study|Unable to Complete Questionnaires|0|||
16946721|NCT01094782|38090853|FG001|Overall Study|Unable to Complete Questionnaires|1|||
16946722|NCT01094782|38090854|FG002|Overall Study|Unable to Complete Questionnaires|0|||
16946723|NCT01094782|38090855|FG003|Overall Study|Unable to Complete Questionnaires|0|||
16946724|NCT01094782|38090856|FG004|Overall Study|Unable to Complete Questionnaires|0|||
16946725|NCT01094782|38090857|FG005|Overall Study|Unable to Complete Questionnaires|0|||
16946726|NCT01094782|38090852|FG000|Overall Study|Healthy Subject Had Pain|0|||
16946727|NCT01094782|38090853|FG001|Overall Study|Healthy Subject Had Pain|1|||
16946728|NCT01094782|38090854|FG002|Overall Study|Healthy Subject Had Pain|0|||
16946729|NCT01094782|38090855|FG003|Overall Study|Healthy Subject Had Pain|0|||
16946730|NCT01094782|38090856|FG004|Overall Study|Healthy Subject Had Pain|0|||
16946731|NCT01094782|38090857|FG005|Overall Study|Healthy Subject Had Pain|0|||
16946732|NCT01094782|38090852|FG000|Overall Study|Hypertension|0|||
16946733|NCT01094782|38090853|FG001|Overall Study|Hypertension|0|||
16946734|NCT01094782|38090854|FG002|Overall Study|Hypertension|1|||
16946735|NCT01094782|38090855|FG003|Overall Study|Hypertension|0|||
16946736|NCT01094782|38090856|FG004|Overall Study|Hypertension|0|||
16946737|NCT01094782|38090857|FG005|Overall Study|Hypertension|0|||
16946738|NCT01094782|38090852|FG000|Overall Study|Wrong Pain Condition|0|||
16946739|NCT01094782|38090853|FG001|Overall Study|Wrong Pain Condition|0|||
16946740|NCT01094782|38090854|FG002|Overall Study|Wrong Pain Condition|0|||
16946741|NCT01094782|38090855|FG003|Overall Study|Wrong Pain Condition|2|||
16946742|NCT01094782|38090856|FG004|Overall Study|Wrong Pain Condition|1|||
16946743|NCT01094782|38090857|FG005|Overall Study|Wrong Pain Condition|1|||
16946744|NCT01094782|38090852|FG000|Overall Study|Recent Interventional Injection|0|||
16946745|NCT01094782|38090853|FG001|Overall Study|Recent Interventional Injection|0|||
16946746|NCT01094782|38090854|FG002|Overall Study|Recent Interventional Injection|0|||
16946747|NCT01094782|38090855|FG003|Overall Study|Recent Interventional Injection|0|||
16946748|NCT01094782|38090856|FG004|Overall Study|Recent Interventional Injection|0|||
16946749|NCT01094782|38090857|FG005|Overall Study|Recent Interventional Injection|1|||
16946750|NCT01094782|38090852|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16946751|NCT01094782|38090853|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16946752|NCT01094782|38090854|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16946753|NCT01094782|38090855|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16946754|NCT01094782|38090856|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
16946755|NCT01094782|38090857|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16946756|NCT01094782|38090852|FG000|Overall Study|Noncompliance With Study Schedule|0|||
16946757|NCT01094782|38090853|FG001|Overall Study|Noncompliance With Study Schedule|0|||
16946758|NCT01094782|38090854|FG002|Overall Study|Noncompliance With Study Schedule|0|||
16946759|NCT01094782|38090855|FG003|Overall Study|Noncompliance With Study Schedule|1|||
16946760|NCT01094782|38090856|FG004|Overall Study|Noncompliance With Study Schedule|0|||
16946761|NCT01094782|38090857|FG005|Overall Study|Noncompliance With Study Schedule|0|||
16946762|NCT01097044|38090873|FG000|Overall Study|Withdrawal by Subject|4|||
16946763|NCT01097044|38090874|FG001|Overall Study|Withdrawal by Subject|4|||
16946764|NCT01097044|38090873|FG000|Overall Study|Lost to Follow-up|1|||
16946765|NCT01097044|38090874|FG001|Overall Study|Lost to Follow-up|0|||
16946766|NCT01097044|38090873|FG000|Overall Study|Withdrawal by Sponsor|0|||
16946767|NCT01097044|38090874|FG001|Overall Study|Withdrawal by Sponsor|1|||
16946768|NCT01322009|38090884|FG000|Overall Study|Death|0|||
16946769|NCT01322009|38090885|FG001|Overall Study|Death|1|||
16946770|NCT01322009|38090884|FG000|Overall Study|Adverse Event|0|||
16946771|NCT01322009|38090885|FG001|Overall Study|Adverse Event|1|||
16946772|NCT01322009|38090884|FG000|Overall Study|ng tube discontinued|0|||
16946773|NCT01322009|38090885|FG001|Overall Study|ng tube discontinued|1|||
16946774|NCT01321697|38090891|FG000|Overall Study|Study Terminated|7|||
16946775|NCT01320683|38090895|FG000|Overall Study|Positive antibody response|1|||
16946776|NCT01320293|38090899|FG000|Overall Study|Lack of Efficacy|1|||
16946777|NCT01320293|38090899|FG000|Overall Study|Adverse Event|1|||
16946778|NCT01318811|38090905|FG000|Overall Study|Physician Decision|1|||
16946779|NCT01318811|38090906|FG001|Overall Study|Physician Decision|1|||
16946780|NCT01318811|38090905|FG000|Overall Study|CRRT stopped for head CT|0|||
16946781|NCT01318811|38090906|FG001|Overall Study|CRRT stopped for head CT|1|||
16946782|NCT01318811|38090905|FG000|Overall Study|Death|0|||
16946783|NCT01318811|38090906|FG001|Overall Study|Death|1|||
16946784|NCT01318811|38090905|FG000|Overall Study|CRRT stopped for head MRI|0|||
16946785|NCT01318811|38090906|FG001|Overall Study|CRRT stopped for head MRI|1|||
16946786|NCT01093846|38090915|FG000|Overall Study|Adverse Event|0|||
16946787|NCT01093846|38090916|FG001|Overall Study|Adverse Event|0|||
16946788|NCT01093846|38090917|FG002|Overall Study|Adverse Event|1|||
16946789|NCT01093846|38090915|FG000|Overall Study|Lack of Efficacy|0|||
16946790|NCT01093846|38090916|FG001|Overall Study|Lack of Efficacy|0|||
16946791|NCT01093846|38090917|FG002|Overall Study|Lack of Efficacy|4|||
16946792|NCT01093846|38090915|FG000|Overall Study|Condition no longer required study drug|1|||
16946793|NCT01093846|38090916|FG001|Overall Study|Condition no longer required study drug|1|||
16946794|NCT01093846|38090917|FG002|Overall Study|Condition no longer required study drug|1|||
16946795|NCT01093846|38090915|FG000|Overall Study|Administrative Problems|18|||
16946796|NCT01093846|38090916|FG001|Overall Study|Administrative Problems|17|||
16946797|NCT01093846|38090917|FG002|Overall Study|Administrative Problems|15|||
16946798|NCT01315847|38090925|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
16946799|NCT01315847|38090926|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
16946800|NCT01315847|38090925|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
16946801|NCT01315847|38090926|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
16946802|NCT01093534|38090935|FG000|Overall Study|Adverse Event|2|||
16946803|NCT01093534|38090936|FG001|Overall Study|Adverse Event|5|||
16946804|NCT01093534|38090937|FG002|Overall Study|Adverse Event|2|||
16946805|NCT01093534|38090935|FG000|Overall Study|Lack of Efficacy|2|||
16946806|NCT01093534|38090936|FG001|Overall Study|Lack of Efficacy|1|||
16946807|NCT01093534|38090937|FG002|Overall Study|Lack of Efficacy|1|||
16946808|NCT01093534|38090935|FG000|Overall Study|Withdrawal by Subject|5|||
16946809|NCT01093534|38090936|FG001|Overall Study|Withdrawal by Subject|7|||
16946810|NCT01093534|38090937|FG002|Overall Study|Withdrawal by Subject|2|||
16946811|NCT01093534|38090935|FG000|Overall Study|Other|1|||
16946812|NCT01093534|38090936|FG001|Overall Study|Other|3|||
16946813|NCT01093534|38090937|FG002|Overall Study|Other|4|||
16946814|NCT01314911|38090948|FG000|Overall Study|Lost to Follow-up|3|||
16946815|NCT01314911|38090949|FG001|Overall Study|Lost to Follow-up|2|||
16946816|NCT01314911|38090948|FG000|Overall Study|Withdrawal by Subject|1|||
16946817|NCT01314911|38090949|FG001|Overall Study|Withdrawal by Subject|3|||
16946818|NCT01314911|38090948|FG000|Overall Study|Received Non-randomized Study Drug|0|||
16946819|NCT01314911|38090949|FG001|Overall Study|Received Non-randomized Study Drug|1|||
16946820|NCT01314911|38090948|FG000|Overall Study|Never Started Treatment|1|||
16946821|NCT01314911|38090949|FG001|Overall Study|Never Started Treatment|0|||
16946822|NCT01093222|38090955|FG000|Overall Study|Ineligible|6|||
16946823|NCT01093222|38090955|FG000|Overall Study|Adverse Event|7|||
16946824|NCT01093222|38090955|FG000|Overall Study|Progression/relapse|24|||
16946825|NCT01093222|38090955|FG000|Overall Study|Death|2|||
16946826|NCT01093222|38090955|FG000|Overall Study|Not protocol specified|1|||
16946827|NCT01313663|38090961|FG000|Overall Study|Study Closed/Terminated|2|||
16946828|NCT01313663|38090962|FG001|Overall Study|Study Closed/Terminated|4|||
16946829|NCT01313663|38090961|FG000|Overall Study|Lost to Follow-up|0|||
16946830|NCT01313663|38090962|FG001|Overall Study|Lost to Follow-up|1|||
16946831|NCT01313663|38090961|FG000|Overall Study|Physician Decision|0|||
16946832|NCT01313663|38090962|FG001|Overall Study|Physician Decision|2|||
16946833|NCT01313663|38090961|FG000|Overall Study|Withdrawal by Subject|2|||
16946834|NCT01313663|38090962|FG001|Overall Study|Withdrawal by Subject|1|||
16946835|NCT01092832|38090970|FG000|Overall Study|Other|1|||
16946836|NCT01092832|38090971|FG001|Overall Study|Other|0|||
16946837|NCT01313273|38090979|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
16946838|NCT01313273|38090980|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
16946839|NCT01313273|38090979|FG000|Overall Study|Withdrawal by Subject|1|||
16946840|NCT01313273|38090980|FG001|Overall Study|Withdrawal by Subject|0|||
16946841|NCT01313273|38090979|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
16946842|NCT01313273|38090980|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
16946843|NCT01091974|38090990|FG000|Overall Study|Did not start intervention|3|||
16946844|NCT01091974|38090991|FG001|Overall Study|Did not start intervention|1|||
16946845|NCT01091974|38090992|FG002|Overall Study|Did not start intervention|3|||
16946846|NCT01091974|38090993|FG003|Overall Study|Did not start intervention|1|||
16946847|NCT01091974|38090990|FG000|Overall Study|resumed sleep medication|0|||
16946848|NCT01091974|38090991|FG001|Overall Study|resumed sleep medication|0|||
16946849|NCT01091974|38090992|FG002|Overall Study|resumed sleep medication|1|||
16946850|NCT01091974|38090993|FG003|Overall Study|resumed sleep medication|2|||
16946851|NCT01091974|38090990|FG000|Overall Study|Withdrawal by Subject|1|||
16946852|NCT01091974|38090991|FG001|Overall Study|Withdrawal by Subject|3|||
16946853|NCT01091974|38090992|FG002|Overall Study|Withdrawal by Subject|2|||
16946854|NCT01091974|38090993|FG003|Overall Study|Withdrawal by Subject|2|||
16946855|NCT01091974|38090990|FG000|Overall Study|side-effects|1|||
16946856|NCT01091974|38090991|FG001|Overall Study|side-effects|1|||
16946857|NCT01091974|38090992|FG002|Overall Study|side-effects|0|||
16946858|NCT01091974|38090993|FG003|Overall Study|side-effects|2|||
16946859|NCT01313117|38091003|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
16946860|NCT01313117|38091003|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
16946861|NCT01313039|38091008|FG000|Overall Study|Physician Decision|1|||
16946862|NCT01313039|38091008|FG000|Overall Study|Adverse Event|1|||
16946863|NCT01091662|38091014|FG000|Overall Study|Adverse Event|1|||
16946864|NCT01091662|38091015|FG001|Overall Study|Adverse Event|9|||
16946865|NCT01091662|38091014|FG000|Overall Study|Physician Decision|1|||
16946866|NCT01091662|38091015|FG001|Overall Study|Physician Decision|1|||
16946867|NCT01091662|38091014|FG000|Overall Study|Withdrawal by Subject|7|||
16946868|NCT01091662|38091015|FG001|Overall Study|Withdrawal by Subject|6|||
16946869|NCT01091662|38091014|FG000|Overall Study|met exit criteria|7|||
16946870|NCT01091662|38091015|FG001|Overall Study|met exit criteria|13|||
16946871|NCT01091662|38091014|FG000|Overall Study|met exclusion criteria|1|||
16946872|NCT01091662|38091015|FG001|Overall Study|met exclusion criteria|0|||
16946873|NCT01091662|38091014|FG000|Overall Study|Lost to Follow-up|0|||
16946874|NCT01091662|38091015|FG001|Overall Study|Lost to Follow-up|1|||
16946875|NCT01091662|38091014|FG000|Overall Study|Pregnancy|0|||
16946876|NCT01091662|38091015|FG001|Overall Study|Pregnancy|1|||
16946877|NCT01091662|38091014|FG000|Overall Study|Protocol Violation|0|||
16946878|NCT01091662|38091015|FG001|Overall Study|Protocol Violation|2|||
16946879|NCT01091662|38091014|FG000|Overall Study|unable to swallow capsule|0|||
16946880|NCT01091662|38091015|FG001|Overall Study|unable to swallow capsule|1|||
16946881|NCT01312961|38091028|FG000|Overall Study|Adverse Event|3|||
16946882|NCT01312961|38091029|FG001|Overall Study|Adverse Event|3|||
16946883|NCT01312961|38091028|FG000|Overall Study|Lack of Efficacy|11|||
16946884|NCT01312961|38091029|FG001|Overall Study|Lack of Efficacy|1|||
16946885|NCT01312961|38091028|FG000|Overall Study|Poor compliance to protocol|1|||
16946886|NCT01312961|38091029|FG001|Overall Study|Poor compliance to protocol|0|||
16946887|NCT01312961|38091028|FG000|Overall Study|Other than specified above|2|||
16946888|NCT01312961|38091029|FG001|Overall Study|Other than specified above|3|||
16946889|NCT01311557|38091038|FG000|Overall Study|Serious adverse event|0|||
16946890|NCT01311557|38091039|FG001|Overall Study|Serious adverse event|1|||
16946891|NCT01311557|38091038|FG000|Overall Study|Protocol Violation|4|||
16946892|NCT01311557|38091039|FG001|Overall Study|Protocol Violation|2|||
16946893|NCT01311557|38091038|FG000|Overall Study|Lost to Follow-up|0|||
16946894|NCT01311557|38091039|FG001|Overall Study|Lost to Follow-up|1|||
16946895|NCT01311557|38091038|FG000|Overall Study|Withdrawal by Subject|1|||
16946896|NCT01311557|38091039|FG001|Overall Study|Withdrawal by Subject|2|||
16946897|NCT01310777|38091048|FG000|Overall Study|Adverse Event|23|||
16946898|NCT01310777|38091049|FG001|Overall Study|Adverse Event|1|||
16946899|NCT01310777|38091050|FG002|Overall Study|Adverse Event|15|||
16946900|NCT01310777|38091048|FG000|Overall Study|Lost to Follow-up|0|||
16946901|NCT01310777|38091049|FG001|Overall Study|Lost to Follow-up|4|||
16946902|NCT01310777|38091050|FG002|Overall Study|Lost to Follow-up|1|||
16946903|NCT01310777|38091048|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
16946904|NCT01310777|38091049|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
16946905|NCT01310777|38091050|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
16946906|NCT01310777|38091048|FG000|Overall Study|Inadequate Control of IOP|5|||
16946907|NCT01310777|38091049|FG001|Overall Study|Inadequate Control of IOP|7|||
16946908|NCT01310777|38091050|FG002|Overall Study|Inadequate Control of IOP|10|||
16946909|NCT01310777|38091048|FG000|Overall Study|Other|4|||
16946910|NCT01310777|38091049|FG001|Overall Study|Other|1|||
16946911|NCT01310777|38091050|FG002|Overall Study|Other|2|||
16946912|NCT01310699|38091060|FG000|Overall Study|Patients did not complete tandem.|4|||
16946913|NCT01310699|38091061|FG001|Overall Study|Patients did not complete tandem.|6|||
16946914|NCT01310075|38091071|FG000|Overall Study|Lost to Follow-up|1|||
16946915|NCT01310075|38091072|FG001|Overall Study|Lost to Follow-up|0|||
16946916|NCT01310075|38091071|FG000|Overall Study|Physician Decision|10|||
16946917|NCT01310075|38091072|FG001|Overall Study|Physician Decision|7|||
16946918|NCT01310075|38091071|FG000|Overall Study|Protocol Violation|2|||
16946919|NCT01310075|38091072|FG001|Overall Study|Protocol Violation|2|||
16946920|NCT01310075|38091071|FG000|Overall Study|Withdrawal by Subject|1|||
16946921|NCT01310075|38091072|FG001|Overall Study|Withdrawal by Subject|1|||
16946922|NCT01309997|38091080|FG000|Overall Study|Adverse Event|1|||
16946923|NCT01309997|38091081|FG001|Overall Study|Adverse Event|0|||
16946924|NCT01309997|38091080|FG000|Overall Study|Death|1|||
16946925|NCT01309997|38091081|FG001|Overall Study|Death|3|||
16946926|NCT01309997|38091080|FG000|Overall Study|Lack of Efficacy|2|||
16946927|NCT01309997|38091081|FG001|Overall Study|Lack of Efficacy|2|||
16946928|NCT01309997|38091080|FG000|Overall Study|Withdrawal by Subject|1|||
16946929|NCT01309997|38091081|FG001|Overall Study|Withdrawal by Subject|1|||
16946930|NCT01309919|38091100|FG000|Overall Study|Did not receive a postpartum IUD|17|||
16946931|NCT01309919|38091101|FG001|Overall Study|Did not receive a postpartum IUD|48|||
16946932|NCT01309841|38091110|FG000|Overall Study|Other|0|||
16946933|NCT01309841|38091111|FG001|Overall Study|Other|1|||
16946934|NCT01309841|38091112|FG002|Overall Study|Other|1|||
16946935|NCT01309841|38091110|FG000|Overall Study|Lost to Follow-up|7|||
16946936|NCT01309841|38091111|FG001|Overall Study|Lost to Follow-up|6|||
16946937|NCT01309841|38091112|FG002|Overall Study|Lost to Follow-up|4|||
16946938|NCT01309841|38091110|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
16946939|NCT01309841|38091111|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
16946940|NCT01309841|38091112|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
16946941|NCT01309841|38091110|FG000|Overall Study|Lack of Efficacy|0|||
16946942|NCT01309841|38091111|FG001|Overall Study|Lack of Efficacy|0|||
16946943|NCT01309841|38091112|FG002|Overall Study|Lack of Efficacy|2|||
16946944|NCT01309841|38091110|FG000|Overall Study|Adverse Event|9|||
16946945|NCT01309841|38091111|FG001|Overall Study|Adverse Event|22|||
16946946|NCT01309841|38091112|FG002|Overall Study|Adverse Event|11|||
16946947|NCT01309841|38091110|FG000|Overall Study|Death|1|||
16946948|NCT01309841|38091111|FG001|Overall Study|Death|0|||
16946949|NCT01309841|38091112|FG002|Overall Study|Death|0|||
16946950|NCT01309841|38091110|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16946951|NCT01309841|38091111|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16946952|NCT01309841|38091112|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
16946953|NCT01309841|38091110|FG000|Overall Study|Withdrawal by Subject|17|||
16946954|NCT01309841|38091111|FG001|Overall Study|Withdrawal by Subject|6|||
16946955|NCT01309841|38091112|FG002|Overall Study|Withdrawal by Subject|13|||
16946956|NCT01309841|38091110|FG000|Overall Study|Did Not Receive Treatment|2|||
16946957|NCT01309841|38091111|FG001|Overall Study|Did Not Receive Treatment|0|||
16946958|NCT01309841|38091112|FG002|Overall Study|Did Not Receive Treatment|1|||
16946959|NCT01309841|38091110|FG000|Overall Study|Severe non-compliance with protocol|0|||
16946960|NCT01309841|38091111|FG001|Overall Study|Severe non-compliance with protocol|5|||
16946961|NCT01309841|38091112|FG002|Overall Study|Severe non-compliance with protocol|2|||
16946962|NCT01308749|38091122|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
16946963|NCT01308749|38091123|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
16946964|NCT01308749|38091122|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
16946965|NCT01308749|38091123|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
16946966|NCT01308749|38091122|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
16946967|NCT01308749|38091123|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
16946968|NCT01307891|38091145|FG000|Overall Study|Progressive Disease|3|||
16946969|NCT01307891|38091146|FG001|Overall Study|Progressive Disease|1|||
16946970|NCT01307579|38091154|FG000|Overall Study|Death|3|||
16946971|NCT01307579|38091155|FG001|Overall Study|Death|6|||
16946972|NCT01307579|38091154|FG000|Overall Study|Physician Decision|26|||
16946973|NCT01307579|38091155|FG001|Overall Study|Physician Decision|29|||
16946974|NCT01307579|38091154|FG000|Overall Study|Withdrawal by Subject|7|||
16946975|NCT01307579|38091155|FG001|Overall Study|Withdrawal by Subject|3|||
16946976|NCT01307579|38091154|FG000|Overall Study|Institutional diagnosis of IFD|21|||
16946977|NCT01307579|38091155|FG001|Overall Study|Institutional diagnosis of IFD|36|||
16946978|NCT01307579|38091154|FG000|Overall Study|Begin conditioning for HSCT|42|||
16946979|NCT01307579|38091155|FG001|Overall Study|Begin conditioning for HSCT|44|||
16946980|NCT01307579|38091154|FG000|Overall Study|Refractory or relapsed AML|38|||
16946981|NCT01307579|38091155|FG001|Overall Study|Refractory or relapsed AML|23|||
16946982|NCT01307579|38091154|FG000|Overall Study|Ineligible|3|||
16946983|NCT01307579|38091155|FG001|Overall Study|Ineligible|4|||
16946984|NCT01057693|38091161|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
16946985|NCT01057693|38091162|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
16946986|NCT01057693|38091163|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
16946987|NCT01057693|38091161|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
16946988|NCT01057693|38091162|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
16946989|NCT01057693|38091163|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
16946990|NCT01057693|38091161|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
16946991|NCT01057693|38091162|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
16946992|NCT01057693|38091163|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
16946993|NCT01057693|38091161|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
16946994|NCT01057693|38091162|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
16946995|NCT01057693|38091163|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
16946996|NCT01057693|38091161|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
16946997|NCT01057693|38091162|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
16946998|NCT01057693|38091163|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
16946999|NCT01057693|38091161|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
16947000|NCT01057693|38091162|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
16947001|NCT01057693|38091163|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
16947002|NCT01057693|38091161|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
16947003|NCT01057693|38091162|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
16947004|NCT01057693|38091163|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
16947005|NCT01057693|38091161|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
16947006|NCT01057693|38091162|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
16947007|NCT01057693|38091163|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
16947008|NCT01057693|38091161|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
16947009|NCT01057693|38091162|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
16947010|NCT01057693|38091163|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
16947011|NCT01057693|38091161|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
16947012|NCT01057693|38091162|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
16947013|NCT01057693|38091163|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
16947014|NCT01057693|38091161|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
16947015|NCT01057693|38091162|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
16947016|NCT01057693|38091163|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
16947017|NCT01057693|38091161|FG000|Between Single-Blind and Double-Blind|Other|6|||
16947018|NCT01057693|38091162|FG001|Between Single-Blind and Double-Blind|Other|0|||
16947019|NCT01057693|38091163|FG002|Between Single-Blind and Double-Blind|Other|0|||
16947020|NCT01057693|38091161|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
16947021|NCT01057693|38091162|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
16947022|NCT01057693|38091163|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
16947023|NCT01057693|38091161|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
16947024|NCT01057693|38091162|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
16947025|NCT01057693|38091163|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
16947026|NCT01057693|38091161|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
16947027|NCT01057693|38091162|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
16947028|NCT01057693|38091163|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
16947029|NCT01057693|38091161|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
16947030|NCT01057693|38091162|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
16947031|NCT01057693|38091163|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
16947032|NCT01057693|38091161|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
16947033|NCT01057693|38091162|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
16947034|NCT01057693|38091163|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
16947035|NCT01057693|38091161|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
16947036|NCT01057693|38091162|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
16947037|NCT01057693|38091163|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
16947038|NCT01057693|38091161|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
16947039|NCT01057693|38091162|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
16947040|NCT01057693|38091163|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
16947041|NCT01307501|38091171|FG000|Overall Study|Treatment Failure|1|||
16947042|NCT01307501|38091171|FG000|Overall Study|Death|20|||
16947043|NCT01307501|38091171|FG000|Overall Study|Lost to Follow-up|1|||
16947044|NCT01307501|38091171|FG000|Overall Study|Starting Hospice|1|||
16947045|NCT01034137|38091178|FG000|Overall Study|Adverse Event|9|||
16947046|NCT01034137|38091179|FG001|Overall Study|Adverse Event|10|||
16947047|NCT01034137|38091180|FG002|Overall Study|Adverse Event|8|||
16947048|NCT01034137|38091178|FG000|Overall Study|Withdrawal by Subject|4|||
16947049|NCT01034137|38091179|FG001|Overall Study|Withdrawal by Subject|3|||
16947050|NCT01034137|38091180|FG002|Overall Study|Withdrawal by Subject|3|||
16947051|NCT01034137|38091178|FG000|Overall Study|Lack of Efficacy|9|||
16947052|NCT01034137|38091179|FG001|Overall Study|Lack of Efficacy|4|||
16947053|NCT01034137|38091180|FG002|Overall Study|Lack of Efficacy|13|||
16947054|NCT01034137|38091178|FG000|Overall Study|Protocol Violation|2|||
16947055|NCT01034137|38091179|FG001|Overall Study|Protocol Violation|2|||
16947056|NCT01034137|38091180|FG002|Overall Study|Protocol Violation|1|||
16947057|NCT01034137|38091178|FG000|Overall Study|Refused treatment or did not cooperate|2|||
16947058|NCT01034137|38091179|FG001|Overall Study|Refused treatment or did not cooperate|0|||
16947059|NCT01034137|38091180|FG002|Overall Study|Refused treatment or did not cooperate|1|||
16947060|NCT01034137|38091178|FG000|Overall Study|Administrative or other|2|||
16947061|NCT01034137|38091179|FG001|Overall Study|Administrative or other|3|||
16947062|NCT01034137|38091180|FG002|Overall Study|Administrative or other|4|||
16947063|NCT01056289|38091189|FG000|Open-label Phase|Adverse Event|29|||
16947064|NCT01056289|38091190|FG001|Open-label Phase|Adverse Event|0|||
16774148|NCT02201524|37713427|FG000|Overall Study|Protocol Violation|0|||
16947065|NCT01056289|38091191|FG002|Open-label Phase|Adverse Event|0|||
16947066|NCT01056289|38091192|FG003|Open-label Phase|Adverse Event|0|||
16947067|NCT01056289|38091189|FG000|Open-label Phase|Lost to Follow-up|30|||
16947068|NCT01056289|38091190|FG001|Open-label Phase|Lost to Follow-up|0|||
16947069|NCT01056289|38091191|FG002|Open-label Phase|Lost to Follow-up|0|||
16947070|NCT01056289|38091192|FG003|Open-label Phase|Lost to Follow-up|0|||
16947071|NCT01056289|38091189|FG000|Open-label Phase|Other|9|||
16947072|NCT01056289|38091190|FG001|Open-label Phase|Other|0|||
16947073|NCT01056289|38091191|FG002|Open-label Phase|Other|0|||
16947074|NCT01056289|38091192|FG003|Open-label Phase|Other|0|||
16947075|NCT01056289|38091189|FG000|Open-label Phase|Protocol Violation|6|||
16947076|NCT01056289|38091190|FG001|Open-label Phase|Protocol Violation|0|||
16947077|NCT01056289|38091191|FG002|Open-label Phase|Protocol Violation|0|||
16947078|NCT01056289|38091192|FG003|Open-label Phase|Protocol Violation|0|||
16947079|NCT01056289|38091189|FG000|Open-label Phase|Withdrawal by Subject|26|||
16947080|NCT01056289|38091190|FG001|Open-label Phase|Withdrawal by Subject|0|||
16774149|NCT02201524|37713428|FG001|Overall Study|Protocol Violation|0|||
16947081|NCT01056289|38091191|FG002|Open-label Phase|Withdrawal by Subject|0|||
16947082|NCT01056289|38091192|FG003|Open-label Phase|Withdrawal by Subject|0|||
16947083|NCT01056289|38091189|FG000|Open-label Phase|Lack of Efficacy|18|||
16947084|NCT01056289|38091190|FG001|Open-label Phase|Lack of Efficacy|0|||
16947085|NCT01056289|38091191|FG002|Open-label Phase|Lack of Efficacy|0|||
16947086|NCT01056289|38091192|FG003|Open-label Phase|Lack of Efficacy|0|||
16947087|NCT01056289|38091189|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
16947088|NCT01056289|38091190|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
16947089|NCT01056289|38091191|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
16947090|NCT01056289|38091192|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
16947091|NCT01056289|38091189|FG000|Double-blind Phase|Adverse Event|0|||
16947092|NCT01056289|38091190|FG001|Double-blind Phase|Adverse Event|1|||
16947093|NCT01056289|38091191|FG002|Double-blind Phase|Adverse Event|2|||
16947094|NCT01056289|38091192|FG003|Double-blind Phase|Adverse Event|1|||
16947095|NCT01056289|38091189|FG000|Double-blind Phase|Lost to Follow-up|0|||
16947096|NCT01056289|38091190|FG001|Double-blind Phase|Lost to Follow-up|2|||
16947097|NCT01056289|38091191|FG002|Double-blind Phase|Lost to Follow-up|2|||
16947098|NCT01056289|38091192|FG003|Double-blind Phase|Lost to Follow-up|2|||
16947099|NCT01056289|38091189|FG000|Double-blind Phase|Other|0|||
16947100|NCT01056289|38091190|FG001|Double-blind Phase|Other|0|||
16947101|NCT01056289|38091191|FG002|Double-blind Phase|Other|1|||
16947102|NCT01056289|38091192|FG003|Double-blind Phase|Other|2|||
16947103|NCT01056289|38091189|FG000|Double-blind Phase|Protocol Violation|0|||
16947104|NCT01056289|38091190|FG001|Double-blind Phase|Protocol Violation|0|||
16947105|NCT01056289|38091191|FG002|Double-blind Phase|Protocol Violation|1|||
16947106|NCT01056289|38091192|FG003|Double-blind Phase|Protocol Violation|1|||
16947107|NCT01056289|38091189|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16947108|NCT01056289|38091190|FG001|Double-blind Phase|Withdrawal by Subject|0|||
16947109|NCT01056289|38091191|FG002|Double-blind Phase|Withdrawal by Subject|4|||
16947110|NCT01056289|38091192|FG003|Double-blind Phase|Withdrawal by Subject|2|||
16947111|NCT01056289|38091189|FG000|Double-blind Phase|Discontinuation symptom|0|||
16947112|NCT01056289|38091190|FG001|Double-blind Phase|Discontinuation symptom|1|||
16947113|NCT01056289|38091191|FG002|Double-blind Phase|Discontinuation symptom|2|||
16947114|NCT01056289|38091192|FG003|Double-blind Phase|Discontinuation symptom|2|||
16947115|NCT01056289|38091189|FG000|Double-blind Phase|Physician Decision|0|||
16947116|NCT01056289|38091190|FG001|Double-blind Phase|Physician Decision|0|||
16947117|NCT01056289|38091191|FG002|Double-blind Phase|Physician Decision|1|||
16947118|NCT01056289|38091192|FG003|Double-blind Phase|Physician Decision|0|||
16947119|NCT01039675|38091204|FG000|Overall Study|Adverse Event|0|||
16947120|NCT01039675|38091205|FG001|Overall Study|Adverse Event|2|||
16947121|NCT01039675|38091204|FG000|Overall Study|Lack of Efficacy|0|||
16947122|NCT01039675|38091205|FG001|Overall Study|Lack of Efficacy|2|||
16947123|NCT01039675|38091204|FG000|Overall Study|Withdrawal by Subject|0|||
16947124|NCT01039675|38091205|FG001|Overall Study|Withdrawal by Subject|1|||
16947125|NCT01039675|38091204|FG000|Overall Study|Lost to Follow-up|0|||
16947126|NCT01039675|38091205|FG001|Overall Study|Lost to Follow-up|1|||
16947127|NCT01039675|38091204|FG000|Overall Study|Physician Decision|0|||
16947128|NCT01039675|38091205|FG001|Overall Study|Physician Decision|1|||
16947129|NCT01033825|38091218|FG000|Overall Study|Withdrawal by Subject|2|||
16947130|NCT01033825|38091219|FG001|Overall Study|Withdrawal by Subject|3|||
16947131|NCT01033825|38091220|FG002|Overall Study|Withdrawal by Subject|2|||
16947132|NCT01033825|38091221|FG003|Overall Study|Withdrawal by Subject|1|||
16947133|NCT01033825|38091222|FG004|Overall Study|Withdrawal by Subject|1|||
16947134|NCT01033825|38091223|FG005|Overall Study|Withdrawal by Subject|0|||
16947135|NCT01033825|38091224|FG006|Overall Study|Withdrawal by Subject|0|||
16947136|NCT01033825|38091218|FG000|Overall Study|Adverse Event|0|||
16947137|NCT01033825|38091219|FG001|Overall Study|Adverse Event|0|||
16947138|NCT01033825|38091220|FG002|Overall Study|Adverse Event|0|||
16947139|NCT01033825|38091221|FG003|Overall Study|Adverse Event|1|||
16947140|NCT01033825|38091222|FG004|Overall Study|Adverse Event|0|||
16947141|NCT01033825|38091223|FG005|Overall Study|Adverse Event|0|||
16947142|NCT01033825|38091224|FG006|Overall Study|Adverse Event|0|||
16947143|NCT01033825|38091218|FG000|Overall Study|Protocol Violation|1|||
16947144|NCT01033825|38091219|FG001|Overall Study|Protocol Violation|0|||
16947145|NCT01033825|38091220|FG002|Overall Study|Protocol Violation|0|||
16947146|NCT01033825|38091221|FG003|Overall Study|Protocol Violation|0|||
16947147|NCT01033825|38091222|FG004|Overall Study|Protocol Violation|0|||
16947148|NCT01033825|38091223|FG005|Overall Study|Protocol Violation|0|||
16947149|NCT01033825|38091224|FG006|Overall Study|Protocol Violation|0|||
16947150|NCT01033825|38091218|FG000|Overall Study|Other|0|||
16947151|NCT01033825|38091219|FG001|Overall Study|Other|0|||
16947152|NCT01033825|38091220|FG002|Overall Study|Other|0|||
16947153|NCT01033825|38091221|FG003|Overall Study|Other|0|||
16947154|NCT01033825|38091222|FG004|Overall Study|Other|1|||
16947155|NCT01033825|38091223|FG005|Overall Study|Other|0|||
16947156|NCT01033825|38091224|FG006|Overall Study|Other|0|||
16947157|NCT01033747|38091244|FG000|Overall Study|Adverse Event|9|||
16947158|NCT01033747|38091245|FG001|Overall Study|Adverse Event|4|||
16947159|NCT01033747|38091244|FG000|Overall Study|Abnormal Laboratory Value|1|||
16947160|NCT01033747|38091245|FG001|Overall Study|Abnormal Laboratory Value|0|||
16947161|NCT01033747|38091244|FG000|Overall Study|Abnormal test procedure|0|||
16947162|NCT01033747|38091245|FG001|Overall Study|Abnormal test procedure|1|||
16774150|NCT02201524|37713429|FG002|Overall Study|Protocol Violation|0|||
16774151|NCT02201524|37713430|FG003|Overall Study|Protocol Violation|1|||
16947163|NCT01033747|38091244|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
16947164|NCT01033747|38091245|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
16947165|NCT01033747|38091244|FG000|Overall Study|Protocol Violation|1|||
16947166|NCT01033747|38091245|FG001|Overall Study|Protocol Violation|0|||
16947167|NCT01033747|38091244|FG000|Overall Study|Withdrawal by Subject|9|||
16947168|NCT01033747|38091245|FG001|Overall Study|Withdrawal by Subject|6|||
16947169|NCT01033747|38091244|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
16947170|NCT01033747|38091245|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
16947171|NCT01033747|38091244|FG000|Overall Study|Stopped at end of Extension 1|2|||
16947172|NCT01033747|38091245|FG001|Overall Study|Stopped at end of Extension 1|0|||
16947173|NCT01091428|38091255|FG000|Phase 1|Progressive Disease|24|||
16947174|NCT01091428|38091256|FG001|Phase 1|Progressive Disease|8|||
16947175|NCT01091428|38091257|FG002|Phase 1|Progressive Disease|0|||
16947176|NCT01091428|38091258|FG003|Phase 1|Progressive Disease|0|||
16947177|NCT01091428|38091255|FG000|Phase 1|Symptomatic Deterioration|3|||
16947178|NCT01091428|38091256|FG001|Phase 1|Symptomatic Deterioration|2|||
16947179|NCT01091428|38091257|FG002|Phase 1|Symptomatic Deterioration|0|||
16947180|NCT01091428|38091258|FG003|Phase 1|Symptomatic Deterioration|0|||
16947181|NCT01091428|38091255|FG000|Phase 1|Adverse Event|2|||
16947182|NCT01091428|38091256|FG001|Phase 1|Adverse Event|0|||
16947183|NCT01091428|38091257|FG002|Phase 1|Adverse Event|0|||
16947184|NCT01091428|38091258|FG003|Phase 1|Adverse Event|0|||
16947185|NCT01091428|38091255|FG000|Phase 1|Withdrawal by Subject|7|||
16947186|NCT01091428|38091256|FG001|Phase 1|Withdrawal by Subject|0|||
16947187|NCT01091428|38091257|FG002|Phase 1|Withdrawal by Subject|0|||
16947188|NCT01091428|38091258|FG003|Phase 1|Withdrawal by Subject|0|||
16947189|NCT01091428|38091255|FG000|Phase 1|Reason not specified|0|||
16947190|NCT01091428|38091256|FG001|Phase 1|Reason not specified|1|||
16947191|NCT01091428|38091257|FG002|Phase 1|Reason not specified|0|||
16947192|NCT01091428|38091258|FG003|Phase 1|Reason not specified|0|||
16947193|NCT01091428|38091255|FG000|Phase 1|Single-Patient IND|2|||
16947194|NCT01091428|38091256|FG001|Phase 1|Single-Patient IND|0|||
16947195|NCT01091428|38091257|FG002|Phase 1|Single-Patient IND|0|||
16947196|NCT01091428|38091258|FG003|Phase 1|Single-Patient IND|0|||
16947197|NCT01091428|38091255|FG000|Phase 2|Progressive Disease|0|||
16947198|NCT01091428|38091256|FG001|Phase 2|Progressive Disease|0|||
16947199|NCT01091428|38091257|FG002|Phase 2|Progressive Disease|44|||
16947200|NCT01091428|38091258|FG003|Phase 2|Progressive Disease|46|||
16947201|NCT01091428|38091255|FG000|Phase 2|Symptomatic Deterioration|0|||
16947202|NCT01091428|38091256|FG001|Phase 2|Symptomatic Deterioration|0|||
16947203|NCT01091428|38091257|FG002|Phase 2|Symptomatic Deterioration|1|||
16947204|NCT01091428|38091258|FG003|Phase 2|Symptomatic Deterioration|6|||
16947205|NCT01091428|38091255|FG000|Phase 2|Adverse Event|0|||
16947206|NCT01091428|38091256|FG001|Phase 2|Adverse Event|0|||
16947207|NCT01091428|38091257|FG002|Phase 2|Adverse Event|12|||
16947208|NCT01091428|38091258|FG003|Phase 2|Adverse Event|5|||
16947209|NCT01091428|38091255|FG000|Phase 2|Withdrawal by Subject|0|||
16947210|NCT01091428|38091256|FG001|Phase 2|Withdrawal by Subject|0|||
16947211|NCT01091428|38091257|FG002|Phase 2|Withdrawal by Subject|9|||
16947212|NCT01091428|38091258|FG003|Phase 2|Withdrawal by Subject|8|||
16947213|NCT01091428|38091255|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
16947214|NCT01091428|38091256|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
16947215|NCT01091428|38091257|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
16947216|NCT01091428|38091258|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
16947217|NCT01091428|38091255|FG000|Phase 2|Reason not specified|0|||
16947218|NCT01091428|38091256|FG001|Phase 2|Reason not specified|0|||
16947219|NCT01091428|38091257|FG002|Phase 2|Reason not specified|4|||
16947220|NCT01091428|38091258|FG003|Phase 2|Reason not specified|3|||
16947221|NCT01091428|38091255|FG000|Phase 2|Physician Decision|0|||
16947222|NCT01091428|38091256|FG001|Phase 2|Physician Decision|0|||
16947223|NCT01091428|38091257|FG002|Phase 2|Physician Decision|2|||
16947224|NCT01091428|38091258|FG003|Phase 2|Physician Decision|0|||
16947225|NCT01096342|38091277|FG000|Overall Study|Protocol Violation|1|||
16947226|NCT01039519|38091281|FG000|Treatment|Progressive disease|20|||
16947227|NCT01039519|38091281|FG000|Treatment|Treatment failure|2|||
16947228|NCT01039519|38091281|FG000|Treatment|Adverse Event|3|||
16947229|NCT01039519|38091281|FG000|Treatment|Physician Decision|2|||
16947230|NCT01039519|38091281|FG000|Survival Follow-up|Death|23|||
16947231|NCT01039519|38091281|FG000|Survival Follow-up|Sponsor decision|4|||
16947232|NCT01096186|38091285|FG000|Overall Study|Adverse Event|16|||
16947233|NCT01096186|38091285|FG000|Overall Study|Death|4|||
16947234|NCT01096186|38091285|FG000|Overall Study|Lack of Efficacy|4|||
16947235|NCT01096186|38091285|FG000|Overall Study|Lost to Follow-up|2|||
16947236|NCT01096186|38091285|FG000|Overall Study|Withdrawal by Subject|22|||
16947237|NCT01096186|38091285|FG000|Overall Study|Physician Decision|1|||
16947238|NCT01096186|38091285|FG000|Overall Study|Noncompliance with study drug|1|||
16947239|NCT01032889|38091292|FG000|Overall Study|Adverse Event|2|||
16947240|NCT01032889|38091293|FG001|Overall Study|Adverse Event|2|||
16947241|NCT01032889|38091294|FG002|Overall Study|Adverse Event|0|||
16947242|NCT01032889|38091292|FG000|Overall Study|Withdrawal of Consent|1|||
16947243|NCT01032889|38091293|FG001|Overall Study|Withdrawal of Consent|2|||
16947244|NCT01032889|38091294|FG002|Overall Study|Withdrawal of Consent|1|||
16947245|NCT01032889|38091292|FG000|Overall Study|Patient Request|0|||
16947246|NCT01032889|38091293|FG001|Overall Study|Patient Request|1|||
16947247|NCT01032889|38091294|FG002|Overall Study|Patient Request|0|||
16947248|NCT01032889|38091292|FG000|Overall Study|Lost to Follow-up|1|||
16947249|NCT01032889|38091293|FG001|Overall Study|Lost to Follow-up|1|||
16947250|NCT01032889|38091294|FG002|Overall Study|Lost to Follow-up|0|||
16947251|NCT01032889|38091292|FG000|Overall Study|Lack of Submental Fat|2|||
16947252|NCT01032889|38091293|FG001|Overall Study|Lack of Submental Fat|8|||
16947253|NCT01032889|38091294|FG002|Overall Study|Lack of Submental Fat|1|||
16947254|NCT01032889|38091292|FG000|Overall Study|Miscellaneous Reasons|2|||
16947255|NCT01032889|38091293|FG001|Overall Study|Miscellaneous Reasons|1|||
16947256|NCT01032889|38091294|FG002|Overall Study|Miscellaneous Reasons|1|||
16947257|NCT01049503|38091308|FG000|Overall Study|Lost to Follow-up|11|||
16947258|NCT01049503|38091309|FG001|Overall Study|Lost to Follow-up|12|||
16947259|NCT01049503|38091310|FG002|Overall Study|Lost to Follow-up|24|||
16947260|NCT01049503|38091311|FG003|Overall Study|Lost to Follow-up|26|||
16947261|NCT01049503|38091312|FG004|Overall Study|Lost to Follow-up|27|||
16947262|NCT01049503|38091313|FG005|Overall Study|Lost to Follow-up|8|||
16947263|NCT01029925|38091336|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
16947264|NCT01029925|38091336|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
16947265|NCT01029925|38091336|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
16947266|NCT01029691|38091343|FG000|Continued APAP to Delivery|Death|0|||
16947267|NCT01029691|38091344|FG001|Continued APAP to Delivery|Death|0|||
16947268|NCT01029691|38091345|FG002|Continued APAP to Delivery|Death|1|||
16947269|NCT01029535|38091354|FG000|Overall Study|Lost to Follow-up|24|||
16947270|NCT01029535|38091354|FG000|Overall Study|Protocol Violation|2|||
16947271|NCT01029535|38091354|FG000|Overall Study|Participant Withdrew Consent|2|||
16947272|NCT01029535|38091354|FG000|Overall Study|Adverse Event|1|||
16947273|NCT01029535|38091354|FG000|Overall Study|Use of Another Treatment|1|||
16947274|NCT01029535|38091354|FG000|Overall Study|Death|1|||
16947275|NCT01028053|38091359|FG000|Overall Study|Screen Failure|113|||
16947276|NCT01028053|38091359|FG000|Overall Study|Patient Request|11|||
16947277|NCT01028053|38091359|FG000|Overall Study|Protocol Violation|1|||
16947278|NCT01028053|38091359|FG000|Overall Study|Physician Decision|2|||
16947279|NCT01028053|38091359|FG000|Overall Study|Technical Problem|1|||
16947280|NCT01028053|38091359|FG000|Overall Study|Terminated by Sponsor|1|||
16947281|NCT01028053|38091359|FG000|Overall Study|Various reasons|4|||
16947282|NCT01023217|38091367|FG000|Overall Study|Withdrawal by Subject|1|||
16947283|NCT01023217|38091368|FG001|Overall Study|Withdrawal by Subject|0|||
16947284|NCT01095796|38091376|FG000|Overall Study|Randomized but Not Treated|5|||
16947285|NCT01095796|38091377|FG001|Overall Study|Randomized but Not Treated|2|||
16947286|NCT01095796|38091376|FG000|Overall Study|Adverse Event|9|||
16947287|NCT01095796|38091377|FG001|Overall Study|Adverse Event|19|||
16947288|NCT01095796|38091376|FG000|Overall Study|Death|3|||
16947289|NCT01095796|38091377|FG001|Overall Study|Death|2|||
16947290|NCT01095796|38091376|FG000|Overall Study|Pregnancy|2|||
16947291|NCT01095796|38091377|FG001|Overall Study|Pregnancy|0|||
16947292|NCT01095796|38091376|FG000|Overall Study|Lack of Efficacy|5|||
16947293|NCT01095796|38091377|FG001|Overall Study|Lack of Efficacy|3|||
16947294|NCT01095796|38091376|FG000|Overall Study|Investigator's Discretion|7|||
16947295|NCT01095796|38091377|FG001|Overall Study|Investigator's Discretion|2|||
16947296|NCT01095796|38091376|FG000|Overall Study|Withdrew Consent|16|||
16947297|NCT01095796|38091377|FG001|Overall Study|Withdrew Consent|22|||
16947298|NCT01095796|38091376|FG000|Overall Study|Lost to Follow-up|27|||
16947299|NCT01095796|38091377|FG001|Overall Study|Lost to Follow-up|29|||
16947300|NCT01095796|38091376|FG000|Overall Study|Participant Noncompliance|5|||
16947301|NCT01095796|38091377|FG001|Overall Study|Participant Noncompliance|10|||
16947302|NCT01095796|38091376|FG000|Overall Study|Protocol Violation|1|||
16947303|NCT01095796|38091377|FG001|Overall Study|Protocol Violation|0|||
16947304|NCT01095796|38091376|FG000|Overall Study|Participant Transferred to Another Study|215|||
16947305|NCT01095796|38091377|FG001|Overall Study|Participant Transferred to Another Study|200|||
16947306|NCT01023061|38091383|FG000|Overall Study|Withdrawal prior to treatment|2|||
16947307|NCT01027897|38091387|FG000|Overall Study|Protocol Violation|1|||
16947308|NCT01027897|38091387|FG000|Overall Study|Withdrawal by Subject|1|||
16947309|NCT01027351|38091397|FG000|Overall Study|Withdrawal by Subject|1|||
16947310|NCT01027351|38091398|FG001|Overall Study|Withdrawal by Subject|0|||
16947311|NCT01027351|38091399|FG002|Overall Study|Withdrawal by Subject|1|||
16947312|NCT01027351|38091400|FG003|Overall Study|Withdrawal by Subject|0|||
16947313|NCT01027351|38091401|FG004|Overall Study|Withdrawal by Subject|3|||
16947314|NCT01027351|38091402|FG005|Overall Study|Withdrawal by Subject|5|||
16947315|NCT01027351|38091397|FG000|Overall Study|Lost to Follow-up|1|||
16947316|NCT01027351|38091398|FG001|Overall Study|Lost to Follow-up|1|||
16947317|NCT01027351|38091399|FG002|Overall Study|Lost to Follow-up|0|||
16947318|NCT01027351|38091400|FG003|Overall Study|Lost to Follow-up|1|||
16947319|NCT01027351|38091401|FG004|Overall Study|Lost to Follow-up|6|||
16947320|NCT01027351|38091402|FG005|Overall Study|Lost to Follow-up|0|||
16947321|NCT01027351|38091397|FG000|Overall Study|Inappropriate enrollment|0|||
16947322|NCT01027351|38091398|FG001|Overall Study|Inappropriate enrollment|0|||
16947323|NCT01027351|38091399|FG002|Overall Study|Inappropriate enrollment|0|||
16947324|NCT01027351|38091400|FG003|Overall Study|Inappropriate enrollment|0|||
16947325|NCT01027351|38091401|FG004|Overall Study|Inappropriate enrollment|1|||
16947326|NCT01027351|38091402|FG005|Overall Study|Inappropriate enrollment|0|||
16947327|NCT01027351|38091397|FG000|Overall Study|Protocol Violation|1|||
16947328|NCT01027351|38091398|FG001|Overall Study|Protocol Violation|0|||
16947329|NCT01027351|38091399|FG002|Overall Study|Protocol Violation|0|||
16947330|NCT01027351|38091400|FG003|Overall Study|Protocol Violation|1|||
16947331|NCT01027351|38091401|FG004|Overall Study|Protocol Violation|1|||
16947332|NCT01027351|38091402|FG005|Overall Study|Protocol Violation|0|||
16947333|NCT01027273|38091425|FG000|Overall Study|Lost to Follow-up|57|||
16947334|NCT01027273|38091426|FG001|Overall Study|Lost to Follow-up|31|||
16947335|NCT01027273|38091425|FG000|Overall Study|Death|2|||
16947336|NCT01027273|38091426|FG001|Overall Study|Death|2|||
16947337|NCT01022203|38091434|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
16947338|NCT01022203|38091435|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
16947339|NCT01022203|38091434|FG000|Post Treatment Assessment|Physician Decision|2|||
16947340|NCT01022203|38091435|FG001|Post Treatment Assessment|Physician Decision|0|||
16947341|NCT01022203|38091434|FG000|Post Treatment Assessment|Adverse Event|0|||
16947342|NCT01022203|38091435|FG001|Post Treatment Assessment|Adverse Event|2|||
16947343|NCT01022203|38091434|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
16947344|NCT01022203|38091435|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
16947345|NCT01296711|38091452|FG000|Overall Study|Adverse Event|3|||
16947346|NCT01296711|38091453|FG001|Overall Study|Adverse Event|1|||
16947347|NCT01296711|38091454|FG002|Overall Study|Adverse Event|4|||
16947348|NCT01296711|38091455|FG003|Overall Study|Adverse Event|3|||
16947349|NCT01296711|38091456|FG004|Overall Study|Adverse Event|1|||
16947350|NCT01296711|38091457|FG005|Overall Study|Adverse Event|6|||
16947351|NCT01296711|38091458|FG006|Overall Study|Adverse Event|11|||
16947352|NCT01296711|38091459|FG007|Overall Study|Adverse Event|3|||
16947353|NCT01296711|38091452|FG000|Overall Study|Lack of Efficacy|1|||
16947354|NCT01296711|38091453|FG001|Overall Study|Lack of Efficacy|4|||
16947355|NCT01296711|38091454|FG002|Overall Study|Lack of Efficacy|1|||
16947356|NCT01296711|38091455|FG003|Overall Study|Lack of Efficacy|1|||
16947357|NCT01296711|38091456|FG004|Overall Study|Lack of Efficacy|1|||
16947358|NCT01296711|38091457|FG005|Overall Study|Lack of Efficacy|0|||
16947359|NCT01296711|38091458|FG006|Overall Study|Lack of Efficacy|2|||
16947360|NCT01296711|38091459|FG007|Overall Study|Lack of Efficacy|3|||
16947361|NCT01296711|38091452|FG000|Overall Study|Lost to Follow-up|0|||
16947362|NCT01296711|38091453|FG001|Overall Study|Lost to Follow-up|0|||
16947363|NCT01296711|38091454|FG002|Overall Study|Lost to Follow-up|1|||
16947364|NCT01296711|38091455|FG003|Overall Study|Lost to Follow-up|1|||
16947365|NCT01296711|38091456|FG004|Overall Study|Lost to Follow-up|2|||
16947366|NCT01296711|38091457|FG005|Overall Study|Lost to Follow-up|0|||
16947367|NCT01296711|38091458|FG006|Overall Study|Lost to Follow-up|4|||
16947368|NCT01296711|38091459|FG007|Overall Study|Lost to Follow-up|2|||
16947369|NCT01296711|38091452|FG000|Overall Study|Protocol Violation|0|||
16947370|NCT01296711|38091453|FG001|Overall Study|Protocol Violation|0|||
16947371|NCT01296711|38091454|FG002|Overall Study|Protocol Violation|0|||
16947372|NCT01296711|38091455|FG003|Overall Study|Protocol Violation|1|||
16947373|NCT01296711|38091456|FG004|Overall Study|Protocol Violation|1|||
16947374|NCT01296711|38091457|FG005|Overall Study|Protocol Violation|0|||
16947375|NCT01296711|38091458|FG006|Overall Study|Protocol Violation|0|||
16947376|NCT01296711|38091459|FG007|Overall Study|Protocol Violation|0|||
16947377|NCT01296711|38091452|FG000|Overall Study|Withdrawal by Subject|4|||
16947378|NCT01296711|38091453|FG001|Overall Study|Withdrawal by Subject|2|||
16947379|NCT01296711|38091454|FG002|Overall Study|Withdrawal by Subject|2|||
16947380|NCT01296711|38091455|FG003|Overall Study|Withdrawal by Subject|1|||
16947381|NCT01296711|38091456|FG004|Overall Study|Withdrawal by Subject|1|||
16947382|NCT01296711|38091457|FG005|Overall Study|Withdrawal by Subject|1|||
16947383|NCT01296711|38091458|FG006|Overall Study|Withdrawal by Subject|2|||
16947384|NCT01296711|38091459|FG007|Overall Study|Withdrawal by Subject|1|||
16947385|NCT01296711|38091452|FG000|Overall Study|Study termination|8|||
16947386|NCT01296711|38091453|FG001|Overall Study|Study termination|1|||
16947387|NCT01296711|38091454|FG002|Overall Study|Study termination|5|||
16947388|NCT01296711|38091455|FG003|Overall Study|Study termination|4|||
16947389|NCT01296711|38091456|FG004|Overall Study|Study termination|4|||
16947390|NCT01296711|38091457|FG005|Overall Study|Study termination|4|||
16947391|NCT01296711|38091458|FG006|Overall Study|Study termination|8|||
16947392|NCT01296711|38091459|FG007|Overall Study|Study termination|10|||
16947393|NCT01296711|38091452|FG000|Overall Study|Continued elevated liver enzymes|0|||
16947394|NCT01296711|38091453|FG001|Overall Study|Continued elevated liver enzymes|0|||
16947395|NCT01296711|38091454|FG002|Overall Study|Continued elevated liver enzymes|0|||
16947396|NCT01296711|38091455|FG003|Overall Study|Continued elevated liver enzymes|1|||
16947397|NCT01296711|38091456|FG004|Overall Study|Continued elevated liver enzymes|0|||
16947398|NCT01296711|38091457|FG005|Overall Study|Continued elevated liver enzymes|0|||
16947399|NCT01296711|38091458|FG006|Overall Study|Continued elevated liver enzymes|0|||
16947400|NCT01296711|38091459|FG007|Overall Study|Continued elevated liver enzymes|0|||
16947401|NCT01296711|38091452|FG000|Overall Study|Methotrexate discontinued|0|||
16947402|NCT01296711|38091453|FG001|Overall Study|Methotrexate discontinued|0|||
16947403|NCT01296711|38091454|FG002|Overall Study|Methotrexate discontinued|0|||
16947404|NCT01296711|38091455|FG003|Overall Study|Methotrexate discontinued|1|||
16947405|NCT01296711|38091456|FG004|Overall Study|Methotrexate discontinued|0|||
16947406|NCT01296711|38091457|FG005|Overall Study|Methotrexate discontinued|0|||
16947407|NCT01296711|38091458|FG006|Overall Study|Methotrexate discontinued|0|||
16947408|NCT01296711|38091459|FG007|Overall Study|Methotrexate discontinued|0|||
16947409|NCT01296711|38091452|FG000|Overall Study|Investigator discretion|0|||
16947410|NCT01296711|38091453|FG001|Overall Study|Investigator discretion|0|||
16947411|NCT01296711|38091454|FG002|Overall Study|Investigator discretion|0|||
16947412|NCT01296711|38091455|FG003|Overall Study|Investigator discretion|0|||
16947413|NCT01296711|38091456|FG004|Overall Study|Investigator discretion|0|||
16947414|NCT01296711|38091457|FG005|Overall Study|Investigator discretion|0|||
16947415|NCT01296711|38091458|FG006|Overall Study|Investigator discretion|1|||
16947416|NCT01296711|38091459|FG007|Overall Study|Investigator discretion|0|||
16947417|NCT01296711|38091452|FG000|Overall Study|Other|0|||
16947418|NCT01296711|38091453|FG001|Overall Study|Other|0|||
16947419|NCT01296711|38091454|FG002|Overall Study|Other|0|||
16947420|NCT01296711|38091455|FG003|Overall Study|Other|0|||
16947421|NCT01296711|38091456|FG004|Overall Study|Other|0|||
16947422|NCT01296711|38091457|FG005|Overall Study|Other|0|||
16947423|NCT01296711|38091458|FG006|Overall Study|Other|1|||
16947424|NCT01296711|38091459|FG007|Overall Study|Other|0|||
16947425|NCT01296711|38091452|FG000|Overall Study|Required restricted steroid injections|0|||
16947426|NCT01296711|38091453|FG001|Overall Study|Required restricted steroid injections|0|||
16947427|NCT01296711|38091454|FG002|Overall Study|Required restricted steroid injections|0|||
16947428|NCT01296711|38091455|FG003|Overall Study|Required restricted steroid injections|0|||
16947429|NCT01296711|38091456|FG004|Overall Study|Required restricted steroid injections|0|||
16947430|NCT01296711|38091457|FG005|Overall Study|Required restricted steroid injections|0|||
16947431|NCT01296711|38091458|FG006|Overall Study|Required restricted steroid injections|1|||
16947432|NCT01296711|38091459|FG007|Overall Study|Required restricted steroid injections|0|||
16947433|NCT01296711|38091452|FG000|Overall Study|Ongoing missed appointments|0|||
16947434|NCT01296711|38091453|FG001|Overall Study|Ongoing missed appointments|0|||
16947435|NCT01296711|38091454|FG002|Overall Study|Ongoing missed appointments|0|||
16947436|NCT01296711|38091455|FG003|Overall Study|Ongoing missed appointments|0|||
16947437|NCT01296711|38091456|FG004|Overall Study|Ongoing missed appointments|0|||
16947438|NCT01296711|38091457|FG005|Overall Study|Ongoing missed appointments|0|||
16947439|NCT01296711|38091458|FG006|Overall Study|Ongoing missed appointments|1|||
16947440|NCT01296711|38091459|FG007|Overall Study|Ongoing missed appointments|0|||
16947441|NCT01296711|38091452|FG000|Overall Study|Failure to comply with visits|0|||
16947442|NCT01296711|38091453|FG001|Overall Study|Failure to comply with visits|0|||
16947443|NCT01296711|38091454|FG002|Overall Study|Failure to comply with visits|0|||
16947444|NCT01296711|38091455|FG003|Overall Study|Failure to comply with visits|0|||
16947445|NCT01296711|38091456|FG004|Overall Study|Failure to comply with visits|0|||
16947446|NCT01296711|38091457|FG005|Overall Study|Failure to comply with visits|0|||
16947447|NCT01296711|38091458|FG006|Overall Study|Failure to comply with visits|0|||
16947448|NCT01296711|38091459|FG007|Overall Study|Failure to comply with visits|1|||
16947449|NCT01296711|38091452|FG000|Overall Study|Patient decision due to transport|0|||
16947450|NCT01296711|38091453|FG001|Overall Study|Patient decision due to transport|0|||
16947451|NCT01296711|38091454|FG002|Overall Study|Patient decision due to transport|0|||
16947452|NCT01296711|38091455|FG003|Overall Study|Patient decision due to transport|0|||
16947453|NCT01296711|38091456|FG004|Overall Study|Patient decision due to transport|0|||
16947454|NCT01296711|38091457|FG005|Overall Study|Patient decision due to transport|0|||
16947455|NCT01296711|38091458|FG006|Overall Study|Patient decision due to transport|0|||
16947456|NCT01296711|38091459|FG007|Overall Study|Patient decision due to transport|1|||
16947457|NCT01294917|38091477|FG000|Overall Study|Relocation|5|||
16947458|NCT01294917|38091477|FG000|Overall Study|Inconvenience|1|||
16947459|NCT01294683|38091485|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
16947460|NCT01294683|38091486|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
16947461|NCT01294683|38091485|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
16947462|NCT01294683|38091486|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
16947463|NCT01294683|38091485|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
16947464|NCT01294683|38091486|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
16947465|NCT01294683|38091485|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
16947466|NCT01294683|38091486|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
16947467|NCT01294683|38091485|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
16947468|NCT01294683|38091486|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
16947469|NCT01294683|38091485|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
16947470|NCT01294683|38091486|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
16947471|NCT01294683|38091485|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
16947472|NCT01294683|38091486|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
16947473|NCT01294683|38091485|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
16947474|NCT01294683|38091486|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
16947475|NCT01294683|38091485|FG000|Post Crossover (Period III)|Adverse Event|6|||
16947476|NCT01294683|38091486|FG001|Post Crossover (Period III)|Adverse Event|6|||
16947477|NCT01294683|38091485|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
16947478|NCT01294683|38091486|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
16947479|NCT01294683|38091485|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
16947480|NCT01294683|38091486|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
16947481|NCT01294683|38091485|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
16947482|NCT01294683|38091486|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
16947483|NCT01294449|38091500|FG000|Overall Study|Death|11|||
16947484|NCT01294449|38091501|FG001|Overall Study|Death|12|||
16947485|NCT01294449|38091500|FG000|Overall Study|Withdrawal by Subject|1|||
16947486|NCT01294449|38091501|FG001|Overall Study|Withdrawal by Subject|3|||
16947487|NCT01294371|38091507|FG000|Overall Study|Adverse Event|1|||
16947488|NCT01294371|38091507|FG000|Overall Study|Withdrawal by Subject|12|||
16947489|NCT01294371|38091507|FG000|Overall Study|Lost to Follow-up|6|||
16947490|NCT01294371|38091507|FG000|Overall Study|Administrative Reason|1|||
16947491|NCT01294371|38091507|FG000|Overall Study|Other|14|||
16947492|NCT01293123|38091516|FG000|Overall Study|Lost to Follow-up|0|||
16947493|NCT01293123|38091517|FG001|Overall Study|Lost to Follow-up|1|||
16947494|NCT01292187|38091525|FG000|Overall Study|Adverse Event|10|||
16947495|NCT01292187|38091526|FG001|Overall Study|Adverse Event|5|||
16947496|NCT01292187|38091525|FG000|Overall Study|Withdrawal by Subject|6|||
16947497|NCT01292187|38091526|FG001|Overall Study|Withdrawal by Subject|5|||
16947498|NCT01292187|38091525|FG000|Overall Study|All other reasons|1|||
16947499|NCT01292187|38091526|FG001|Overall Study|All other reasons|3|||
16947500|NCT01026493|38091541|FG000|Overall Study|Protocol Violation|0|||
16947501|NCT01026493|38091542|FG001|Overall Study|Protocol Violation|1|||
16947502|NCT01026493|38091543|FG002|Overall Study|Protocol Violation|0|||
16947503|NCT01026493|38091544|FG003|Overall Study|Protocol Violation|0|||
16947504|NCT01026493|38091545|FG004|Overall Study|Protocol Violation|2|||
16947505|NCT01026493|38091546|FG005|Overall Study|Protocol Violation|3|||
16947506|NCT01026493|38091547|FG006|Overall Study|Protocol Violation|4|||
16947507|NCT01026493|38091548|FG007|Overall Study|Protocol Violation|1|||
16947508|NCT01026103|38091566|FG000|Overall Study|Physician Decision|1|||
16947509|NCT01026103|38091566|FG000|Overall Study|did not receive study device bc of error|1|||
16947510|NCT01291173|38091574|FG000|Overall Study|Adverse Event|0|||
16947511|NCT01291173|38091575|FG001|Overall Study|Adverse Event|3|||
16947512|NCT01291173|38091576|FG002|Overall Study|Adverse Event|1|||
16947513|NCT01291173|38091577|FG003|Overall Study|Adverse Event|3|||
16947514|NCT01291173|38091574|FG000|Overall Study|Protocol Violation|7|||
16947515|NCT01291173|38091575|FG001|Overall Study|Protocol Violation|2|||
16947516|NCT01291173|38091576|FG002|Overall Study|Protocol Violation|2|||
16947517|NCT01291173|38091577|FG003|Overall Study|Protocol Violation|5|||
16947518|NCT01291173|38091574|FG000|Overall Study|Withdrawal by Subject|6|||
16947519|NCT01291173|38091575|FG001|Overall Study|Withdrawal by Subject|4|||
16947520|NCT01291173|38091576|FG002|Overall Study|Withdrawal by Subject|4|||
16947521|NCT01291173|38091577|FG003|Overall Study|Withdrawal by Subject|2|||
16947522|NCT01291173|38091574|FG000|Overall Study|Lost to Follow-up|4|||
16947523|NCT01291173|38091575|FG001|Overall Study|Lost to Follow-up|6|||
16947524|NCT01291173|38091576|FG002|Overall Study|Lost to Follow-up|3|||
16947525|NCT01291173|38091577|FG003|Overall Study|Lost to Follow-up|2|||
16947526|NCT01291173|38091574|FG000|Overall Study|Unable to meet visit schedule|0|||
16947527|NCT01291173|38091575|FG001|Overall Study|Unable to meet visit schedule|0|||
16947528|NCT01291173|38091576|FG002|Overall Study|Unable to meet visit schedule|1|||
16947529|NCT01291173|38091577|FG003|Overall Study|Unable to meet visit schedule|0|||
16947530|NCT01291173|38091574|FG000|Overall Study|Lack of compliance|0|||
16947531|NCT01291173|38091575|FG001|Overall Study|Lack of compliance|0|||
16947532|NCT01291173|38091576|FG002|Overall Study|Lack of compliance|0|||
16947533|NCT01291173|38091577|FG003|Overall Study|Lack of compliance|1|||
16947534|NCT01291173|38091574|FG000|Overall Study|Subject was unblinded|0|||
16947535|NCT01291173|38091575|FG001|Overall Study|Subject was unblinded|0|||
16947536|NCT01291173|38091576|FG002|Overall Study|Subject was unblinded|1|||
16947537|NCT01291173|38091577|FG003|Overall Study|Subject was unblinded|0|||
16947538|NCT01291173|38091574|FG000|Overall Study|Excluded therapy|0|||
16947539|NCT01291173|38091575|FG001|Overall Study|Excluded therapy|0|||
16947540|NCT01291173|38091576|FG002|Overall Study|Excluded therapy|1|||
16947541|NCT01291173|38091577|FG003|Overall Study|Excluded therapy|0|||
16947542|NCT01291017|38091587|FG000|Overall Study|Lost to Follow-up|2|||
16947543|NCT01291017|38091587|FG000|Overall Study|Withdrawal by Subject|3|||
16947544|NCT01290315|38091595|FG000|Overall Study|Adverse Event|0|||
16947545|NCT01290315|38091596|FG001|Overall Study|Adverse Event|0|||
16947546|NCT01290315|38091597|FG002|Overall Study|Adverse Event|0|||
16947547|NCT01290315|38091598|FG003|Overall Study|Adverse Event|3|||
16947548|NCT01290315|38091595|FG000|Overall Study|Selection criteria/compliance|2|||
16947549|NCT01290315|38091596|FG001|Overall Study|Selection criteria/compliance|1|||
16947550|NCT01290315|38091597|FG002|Overall Study|Selection criteria/compliance|0|||
16947551|NCT01290315|38091598|FG003|Overall Study|Selection criteria/compliance|2|||
16947552|NCT01290315|38091595|FG000|Overall Study|Lost to Follow-up|0|||
16947553|NCT01290315|38091596|FG001|Overall Study|Lost to Follow-up|1|||
16947554|NCT01290315|38091597|FG002|Overall Study|Lost to Follow-up|0|||
16947555|NCT01290315|38091598|FG003|Overall Study|Lost to Follow-up|0|||
16947556|NCT01290315|38091595|FG000|Overall Study|Withdrawal by Subject|1|||
16947557|NCT01290315|38091596|FG001|Overall Study|Withdrawal by Subject|1|||
16947558|NCT01290315|38091597|FG002|Overall Study|Withdrawal by Subject|0|||
16947559|NCT01290315|38091598|FG003|Overall Study|Withdrawal by Subject|0|||
16947560|NCT01289847|38091607|FG000|Overall Study|Patient could not comply with visits|1|||
16947561|NCT01079182|38091611|FG000|Overall Study|Lost to Follow-up|1634|||
16947562|NCT01079182|38091611|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
16947563|NCT01079182|38091611|FG000|Overall Study|Lack of Efficacy|514|||
16947564|NCT01079182|38091611|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
16947565|NCT01079182|38091611|FG000|Overall Study|Reasons not Evaluated|271|||
16947566|NCT01021813|38091617|FG000|DB Treatment Phase|Adverse Event|60|||
16947567|NCT01021813|38091618|FG001|DB Treatment Phase|Adverse Event|22|||
16947568|NCT01021813|38091619|FG002|DB Treatment Phase|Adverse Event|0|||
16947569|NCT01021813|38091620|FG003|DB Treatment Phase|Adverse Event|0|||
16947570|NCT01021813|38091621|FG004|DB Treatment Phase|Adverse Event|0|||
16947571|NCT01021813|38091617|FG000|DB Treatment Phase|Lack of Efficacy|44|||
16947572|NCT01021813|38091618|FG001|DB Treatment Phase|Lack of Efficacy|28|||
16947573|NCT01021813|38091619|FG002|DB Treatment Phase|Lack of Efficacy|0|||
16947574|NCT01021813|38091620|FG003|DB Treatment Phase|Lack of Efficacy|0|||
16947575|NCT01021813|38091621|FG004|DB Treatment Phase|Lack of Efficacy|0|||
16947576|NCT01021813|38091617|FG000|DB Treatment Phase|Lost to Follow-up|14|||
16947577|NCT01021813|38091618|FG001|DB Treatment Phase|Lost to Follow-up|12|||
16947578|NCT01021813|38091619|FG002|DB Treatment Phase|Lost to Follow-up|0|||
16947579|NCT01021813|38091620|FG003|DB Treatment Phase|Lost to Follow-up|0|||
16947580|NCT01021813|38091621|FG004|DB Treatment Phase|Lost to Follow-up|0|||
16947581|NCT01021813|38091617|FG000|DB Treatment Phase|Physician Decision|17|||
16947582|NCT01021813|38091618|FG001|DB Treatment Phase|Physician Decision|8|||
16947583|NCT01021813|38091619|FG002|DB Treatment Phase|Physician Decision|0|||
16947584|NCT01021813|38091620|FG003|DB Treatment Phase|Physician Decision|0|||
16947585|NCT01021813|38091621|FG004|DB Treatment Phase|Physician Decision|0|||
16947586|NCT01021813|38091617|FG000|DB Treatment Phase|Pregnancy|1|||
16947587|NCT01021813|38091618|FG001|DB Treatment Phase|Pregnancy|0|||
16947588|NCT01021813|38091619|FG002|DB Treatment Phase|Pregnancy|0|||
16947589|NCT01021813|38091620|FG003|DB Treatment Phase|Pregnancy|0|||
16947590|NCT01021813|38091621|FG004|DB Treatment Phase|Pregnancy|0|||
16947591|NCT01021813|38091617|FG000|DB Treatment Phase|Protocol Violation|4|||
16947592|NCT01021813|38091618|FG001|DB Treatment Phase|Protocol Violation|3|||
16947593|NCT01021813|38091619|FG002|DB Treatment Phase|Protocol Violation|0|||
16947594|NCT01021813|38091620|FG003|DB Treatment Phase|Protocol Violation|0|||
16947595|NCT01021813|38091621|FG004|DB Treatment Phase|Protocol Violation|0|||
16947596|NCT01021813|38091617|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
16947597|NCT01021813|38091618|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
16947598|NCT01021813|38091619|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
16947599|NCT01021813|38091620|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
16947600|NCT01021813|38091621|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
16947601|NCT01021813|38091617|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
16947602|NCT01021813|38091618|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
16947603|NCT01021813|38091619|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
16947604|NCT01021813|38091620|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
16947605|NCT01021813|38091621|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
16947606|NCT01021813|38091617|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
16947607|NCT01021813|38091618|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
16947608|NCT01021813|38091619|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
16947609|NCT01021813|38091620|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
16947610|NCT01021813|38091621|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
16947611|NCT01021813|38091617|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
16947612|NCT01021813|38091618|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
16947613|NCT01021813|38091619|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
16947614|NCT01021813|38091620|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
16947615|NCT01021813|38091621|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
16947616|NCT01021813|38091617|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
16947617|NCT01021813|38091618|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
16947618|NCT01021813|38091619|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
16947619|NCT01021813|38091620|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
16947620|NCT01021813|38091621|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
16947621|NCT01021813|38091617|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
16947622|NCT01021813|38091618|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
16947623|NCT01021813|38091619|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
16947624|NCT01021813|38091620|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
16947625|NCT01021813|38091621|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
16947626|NCT01025635|38091640|FG000|Overall Study|Withdrawal by Subject|6|||
16947627|NCT01025635|38091641|FG001|Overall Study|Withdrawal by Subject|7|||
16947628|NCT01025635|38091640|FG000|Overall Study|Protocol Violation|4|||
16947629|NCT01025635|38091641|FG001|Overall Study|Protocol Violation|2|||
16947630|NCT01025635|38091640|FG000|Overall Study|Lack of Efficacy|0|||
16947631|NCT01025635|38091641|FG001|Overall Study|Lack of Efficacy|1|||
16947632|NCT01025635|38091640|FG000|Overall Study|Lost to Follow-up|9|||
16947633|NCT01025635|38091641|FG001|Overall Study|Lost to Follow-up|13|||
16947634|NCT01025635|38091640|FG000|Overall Study|Reason not known|4|||
16947635|NCT01025635|38091641|FG001|Overall Study|Reason not known|2|||
16947636|NCT01021423|38091649|FG000|Overall Study|Study terminated|4|||
16947637|NCT01021423|38091650|FG001|Overall Study|Study terminated|5|||
16947638|NCT01020877|38091658|FG000|Second Intervention|Withdrawal by Subject|1|||
16947639|NCT01020877|38091659|FG001|Second Intervention|Withdrawal by Subject|0|||
16947640|NCT01020799|38091668|FG000|Overall Study|Adverse Event|4|||
16947641|NCT01020799|38091669|FG001|Overall Study|Adverse Event|3|||
16947642|NCT01020799|38091670|FG002|Overall Study|Adverse Event|2|||
16947643|NCT01020799|38091668|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
16947644|NCT01020799|38091669|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
16947645|NCT01020799|38091670|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
16947646|NCT01020799|38091668|FG000|Overall Study|Protocol Violation|3|||
16947647|NCT01020799|38091669|FG001|Overall Study|Protocol Violation|2|||
16947648|NCT01020799|38091670|FG002|Overall Study|Protocol Violation|0|||
16947649|NCT01020799|38091668|FG000|Overall Study|Withdrawal by Subject|2|||
16947650|NCT01020799|38091669|FG001|Overall Study|Withdrawal by Subject|2|||
16947651|NCT01020799|38091670|FG002|Overall Study|Withdrawal by Subject|3|||
16947652|NCT01020799|38091668|FG000|Overall Study|Lost to Follow-up|6|||
16947653|NCT01020799|38091669|FG001|Overall Study|Lost to Follow-up|4|||
16947654|NCT01020799|38091670|FG002|Overall Study|Lost to Follow-up|2|||
16947655|NCT01288989|38091683|FG000|Overall Study|Death|0|||
16947656|NCT01288989|38091684|FG001|Overall Study|Death|0|||
16947657|NCT01288989|38091685|FG002|Overall Study|Death|0|||
16947658|NCT01288989|38091686|FG003|Overall Study|Death|1|||
16947659|NCT01288989|38091687|FG004|Overall Study|Death|0|||
16947660|NCT01288989|38091683|FG000|Overall Study|Dose limiting toxicity|1|||
16774152|NCT02201524|37713427|FG000|Overall Study|Withdrawal by Subject|0|||
16947661|NCT01288989|38091684|FG001|Overall Study|Dose limiting toxicity|0|||
16947662|NCT01288989|38091685|FG002|Overall Study|Dose limiting toxicity|0|||
16947663|NCT01288989|38091686|FG003|Overall Study|Dose limiting toxicity|0|||
16947664|NCT01288989|38091687|FG004|Overall Study|Dose limiting toxicity|0|||
16947665|NCT01288989|38091683|FG000|Overall Study|Adverse Event|0|||
16947666|NCT01288989|38091684|FG001|Overall Study|Adverse Event|0|||
16947667|NCT01288989|38091685|FG002|Overall Study|Adverse Event|0|||
16947668|NCT01288989|38091686|FG003|Overall Study|Adverse Event|0|||
16947669|NCT01288989|38091687|FG004|Overall Study|Adverse Event|2|||
16947670|NCT01288989|38091683|FG000|Overall Study|Physician Decision|0|||
16947671|NCT01288989|38091684|FG001|Overall Study|Physician Decision|0|||
16947672|NCT01288989|38091685|FG002|Overall Study|Physician Decision|0|||
16947673|NCT01288989|38091686|FG003|Overall Study|Physician Decision|0|||
16947674|NCT01288989|38091687|FG004|Overall Study|Physician Decision|1|||
16947675|NCT01288989|38091683|FG000|Overall Study|Withdrawal by Subject|0|||
16947676|NCT01288989|38091684|FG001|Overall Study|Withdrawal by Subject|0|||
16947677|NCT01288989|38091685|FG002|Overall Study|Withdrawal by Subject|0|||
16947678|NCT01288989|38091686|FG003|Overall Study|Withdrawal by Subject|0|||
16947679|NCT01288989|38091687|FG004|Overall Study|Withdrawal by Subject|3|||
16947680|NCT01020487|38091708|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
16947681|NCT01020487|38091709|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
16947682|NCT01020487|38091710|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
16947683|NCT01020487|38091708|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
16947684|NCT01020487|38091709|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
16947685|NCT01020487|38091710|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
16947686|NCT01020487|38091708|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
16947687|NCT01020487|38091709|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
16947688|NCT01020487|38091710|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
16947689|NCT01020487|38091708|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
16947690|NCT01020487|38091709|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
16947691|NCT01020487|38091710|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
16947692|NCT01020487|38091708|FG000|Part 2 Open-label Period|Adverse Event|0|||
16947693|NCT01020487|38091709|FG001|Part 2 Open-label Period|Adverse Event|4|||
16947694|NCT01020487|38091710|FG002|Part 2 Open-label Period|Adverse Event|1|||
16947695|NCT01024855|38091720|FG000|Overall Study|Inclusion/exclusion criteria|1|||
16947696|NCT01014013|38091727|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
16947697|NCT01014013|38091728|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
16947698|NCT01014013|38091727|FG000|Overall Study|Clinical adverse experience|4|||
16947699|NCT01014013|38091728|FG001|Overall Study|Clinical adverse experience|2|||
16947700|NCT01014013|38091727|FG000|Overall Study|Laboratory adverse experience|1|||
16947701|NCT01014013|38091728|FG001|Overall Study|Laboratory adverse experience|1|||
16947702|NCT01014013|38091727|FG000|Overall Study|Protocol Violation|1|||
16947703|NCT01014013|38091728|FG001|Overall Study|Protocol Violation|3|||
16947704|NCT01014013|38091727|FG000|Overall Study|Withdrawal by Subject|7|||
16947705|NCT01014013|38091728|FG001|Overall Study|Withdrawal by Subject|4|||
16947706|NCT01014013|38091727|FG000|Overall Study|Clinical/microbiologic failure|1|||
16947707|NCT01014013|38091728|FG001|Overall Study|Clinical/microbiologic failure|2|||
16947708|NCT01014013|38091727|FG000|Overall Study|Pathogen culture = no growth|26|||
16947709|NCT01014013|38091728|FG001|Overall Study|Pathogen culture = no growth|34|||
16947710|NCT01014013|38091727|FG000|Overall Study|Negative urine culture|2|||
16947711|NCT01014013|38091728|FG001|Overall Study|Negative urine culture|0|||
16947712|NCT01014013|38091727|FG000|Overall Study|Pathogen resistant|7|||
16947713|NCT01014013|38091728|FG001|Overall Study|Pathogen resistant|4|||
16947714|NCT01014013|38091727|FG000|Overall Study|Physician Decision|0|||
16947715|NCT01014013|38091728|FG001|Overall Study|Physician Decision|1|||
16947716|NCT01014013|38091727|FG000|Overall Study|Another antibiotic therapy required|0|||
16947717|NCT01014013|38091728|FG001|Overall Study|Another antibiotic therapy required|1|||
16947718|NCT01014013|38091727|FG000|Overall Study|Appendectomy|1|||
16947719|NCT01014013|38091728|FG001|Overall Study|Appendectomy|0|||
16947720|NCT01014013|38091727|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
16947721|NCT01014013|38091728|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
16947722|NCT01013701|38091736|FG000|Overall Study|study prematurely terminated|7|||
16947723|NCT01020019|38091743|FG000|Overall Study|Lost to Follow-up|21|||
16947724|NCT01020019|38091744|FG001|Overall Study|Lost to Follow-up|18|||
16947725|NCT01020019|38091743|FG000|Overall Study|Adverse Event|1|||
16947726|NCT01020019|38091744|FG001|Overall Study|Adverse Event|5|||
16947727|NCT01020019|38091743|FG000|Overall Study|not interested in treatment|4|||
16947728|NCT01020019|38091744|FG001|Overall Study|not interested in treatment|4|||
16947729|NCT01020019|38091743|FG000|Overall Study|moving|0|||
16947730|NCT01020019|38091744|FG001|Overall Study|moving|2|||
16947731|NCT01024465|38091750|FG000|Overall Study|Adverse Event|2|||
16947732|NCT01024465|38091750|FG000|Overall Study|Physician Decision|1|||
16947733|NCT01024387|38091754|FG000|Overall Study|Radiographic Progression|29|||
16947734|NCT01024387|38091754|FG000|Overall Study|Symptomatic Progression|10|||
16947735|NCT01024387|38091754|FG000|Overall Study|Physician Decision|5|||
16947736|NCT01024387|38091754|FG000|Overall Study|Withdrawal by Subject|5|||
16947737|NCT01024387|38091754|FG000|Overall Study|Death|2|||
16947738|NCT01024387|38091754|FG000|Overall Study|Prolonged Treatment Delay|1|||
16947739|NCT01024387|38091754|FG000|Overall Study|Adverse Event|3|||
16947740|NCT01024387|38091754|FG000|Overall Study|Other|5|||
16947741|NCT01019317|38091758|FG000|Overall Study|Not Eligible|4|||
16947742|NCT01024309|38091764|FG000|Overall Study|Physician Decision|4|||
16947743|NCT01024309|38091765|FG001|Overall Study|Physician Decision|0|||
16947744|NCT01024309|38091764|FG000|Overall Study|Withdrawal by Subject|4|||
16947745|NCT01024309|38091765|FG001|Overall Study|Withdrawal by Subject|4|||
16947746|NCT01090492|38091779|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
16947747|NCT01090492|38091780|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
16947748|NCT01090492|38091781|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
16947749|NCT01090492|38091782|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
16947750|NCT01090492|38091783|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
16947751|NCT01090492|38091784|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
16947752|NCT01090492|38091785|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
16947753|NCT01090492|38091786|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
16947754|NCT01090492|38091779|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16947755|NCT01090492|38091780|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
16947756|NCT01090492|38091781|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16947757|NCT01090492|38091782|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16774153|NCT02201524|37713428|FG001|Overall Study|Withdrawal by Subject|0|||
16947758|NCT01090492|38091783|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16947759|NCT01090492|38091784|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16947760|NCT01090492|38091785|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16947761|NCT01090492|38091786|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
16947762|NCT01090492|38091779|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947763|NCT01090492|38091780|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947764|NCT01090492|38091781|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
16947765|NCT01090492|38091782|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947766|NCT01090492|38091783|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947767|NCT01090492|38091784|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947768|NCT01090492|38091785|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947769|NCT01090492|38091786|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947770|NCT01090492|38091779|FG000|First Intervention Period (4 Weeks)|Other|0|||
16947771|NCT01090492|38091780|FG001|First Intervention Period (4 Weeks)|Other|0|||
16947772|NCT01090492|38091781|FG002|First Intervention Period (4 Weeks)|Other|1|||
16947773|NCT01090492|38091782|FG003|First Intervention Period (4 Weeks)|Other|1|||
16947774|NCT01090492|38091783|FG004|First Intervention Period (4 Weeks)|Other|2|||
16947775|NCT01090492|38091784|FG005|First Intervention Period (4 Weeks)|Other|0|||
16947776|NCT01090492|38091785|FG006|First Intervention Period (4 Weeks)|Other|0|||
16947777|NCT01090492|38091786|FG007|First Intervention Period (4 Weeks)|Other|0|||
16947778|NCT01090492|38091779|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
16947779|NCT01090492|38091780|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
16947780|NCT01090492|38091781|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
16947781|NCT01090492|38091782|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
16947782|NCT01090492|38091783|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
16947783|NCT01090492|38091784|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
16947784|NCT01090492|38091785|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
16947785|NCT01090492|38091786|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
16947786|NCT01090492|38091779|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
16947787|NCT01090492|38091780|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
16947788|NCT01090492|38091781|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
16947789|NCT01090492|38091782|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
16947790|NCT01090492|38091783|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
16947791|NCT01090492|38091784|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
16947792|NCT01090492|38091785|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
16947793|NCT01090492|38091786|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
16947794|NCT01090492|38091779|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
16947795|NCT01090492|38091780|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
16947796|NCT01090492|38091781|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
16947797|NCT01090492|38091782|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
16947798|NCT01090492|38091783|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
16947799|NCT01090492|38091784|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
16947800|NCT01090492|38091785|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
16947801|NCT01090492|38091786|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
16947802|NCT01090492|38091779|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16947803|NCT01090492|38091780|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
16947804|NCT01090492|38091781|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16947805|NCT01090492|38091782|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16947806|NCT01090492|38091783|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16947807|NCT01090492|38091784|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16947808|NCT01090492|38091785|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16947809|NCT01090492|38091786|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16947810|NCT01090492|38091779|FG000|Second Intervention Period (4 Weeks)|Other|0|||
16947811|NCT01090492|38091780|FG001|Second Intervention Period (4 Weeks)|Other|1|||
16947812|NCT01090492|38091781|FG002|Second Intervention Period (4 Weeks)|Other|1|||
16947813|NCT01090492|38091782|FG003|Second Intervention Period (4 Weeks)|Other|0|||
16947814|NCT01090492|38091783|FG004|Second Intervention Period (4 Weeks)|Other|0|||
16947815|NCT01090492|38091784|FG005|Second Intervention Period (4 Weeks)|Other|0|||
16947816|NCT01090492|38091785|FG006|Second Intervention Period (4 Weeks)|Other|0|||
16947817|NCT01090492|38091786|FG007|Second Intervention Period (4 Weeks)|Other|0|||
16947818|NCT01090492|38091779|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
16947819|NCT01090492|38091780|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
16947820|NCT01090492|38091781|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
16947821|NCT01090492|38091782|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
16947822|NCT01090492|38091783|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
16947823|NCT01090492|38091784|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
16947824|NCT01090492|38091785|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
16947825|NCT01090492|38091786|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
16947826|NCT01090492|38091779|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947827|NCT01090492|38091780|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947828|NCT01090492|38091781|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947829|NCT01090492|38091782|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947830|NCT01090492|38091783|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947831|NCT01090492|38091784|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947832|NCT01090492|38091785|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
16947833|NCT01090492|38091786|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16947834|NCT01288911|38091807|FG000|Double-blind Period|Death|11|||
16947835|NCT01288911|38091808|FG001|Double-blind Period|Death|7|||
16947836|NCT01288911|38091807|FG000|Double-blind Period|Lost to Follow-up|0|||
16947837|NCT01288911|38091808|FG001|Double-blind Period|Lost to Follow-up|2|||
16947838|NCT01288911|38091807|FG000|Double-blind Period|Progressive Disease|75|||
16947839|NCT01288911|38091808|FG001|Double-blind Period|Progressive Disease|103|||
16947840|NCT01288911|38091807|FG000|Double-blind Period|Protocol Violation|1|||
16947841|NCT01288911|38091808|FG001|Double-blind Period|Protocol Violation|0|||
16947842|NCT01288911|38091807|FG000|Double-blind Period|Withdrawal by Subject|25|||
16947843|NCT01288911|38091808|FG001|Double-blind Period|Withdrawal by Subject|26|||
16947844|NCT01288911|38091807|FG000|Double-blind Period|Miscellaneous Reason|29|||
16947845|NCT01288911|38091808|FG001|Double-blind Period|Miscellaneous Reason|42|||
16947846|NCT01288911|38091807|FG000|Double-blind Period|Randomized but never received study drug|1|||
16947847|NCT01288911|38091808|FG001|Double-blind Period|Randomized but never received study drug|2|||
16947848|NCT01288911|38091807|FG000|Open-label Period (All Enzalutamide)|Death|0|||
16947849|NCT01288911|38091808|FG001|Open-label Period (All Enzalutamide)|Death|1|||
16947850|NCT01288911|38091807|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
16947851|NCT01288911|38091808|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
16947852|NCT01288911|38091807|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
16947853|NCT01288911|38091808|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
16947854|NCT01288911|38091807|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
16947855|NCT01288911|38091808|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
16947856|NCT01288911|38091807|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
16947857|NCT01288911|38091808|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
16947858|NCT01288911|38091807|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
16947859|NCT01288911|38091808|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
16947860|NCT01288443|38091823|FG000|Overall Study|Adverse Event|0|||
16947861|NCT01288443|38091824|FG001|Overall Study|Adverse Event|0|||
16947862|NCT01288443|38091825|FG002|Overall Study|Adverse Event|1|||
16947863|NCT01288443|38091826|FG003|Overall Study|Adverse Event|1|||
16947864|NCT01288443|38091827|FG004|Overall Study|Adverse Event|3|||
16947865|NCT01288443|38091828|FG005|Overall Study|Adverse Event|1|||
16947866|NCT01288443|38091823|FG000|Overall Study|Poor compliance to protocol|0|||
16947867|NCT01288443|38091824|FG001|Overall Study|Poor compliance to protocol|0|||
16947868|NCT01288443|38091825|FG002|Overall Study|Poor compliance to protocol|0|||
16947869|NCT01288443|38091826|FG003|Overall Study|Poor compliance to protocol|0|||
16947870|NCT01288443|38091827|FG004|Overall Study|Poor compliance to protocol|0|||
16947871|NCT01288443|38091828|FG005|Overall Study|Poor compliance to protocol|1|||
16947872|NCT01288443|38091823|FG000|Overall Study|Participant Moved|0|||
16947873|NCT01288443|38091824|FG001|Overall Study|Participant Moved|0|||
16947874|NCT01288443|38091825|FG002|Overall Study|Participant Moved|0|||
16947875|NCT01288443|38091826|FG003|Overall Study|Participant Moved|1|||
16947876|NCT01288443|38091827|FG004|Overall Study|Participant Moved|2|||
16947877|NCT01288443|38091828|FG005|Overall Study|Participant Moved|1|||
16947878|NCT01288443|38091823|FG000|Overall Study|Consent withdrawn by Participant|0|||
16947879|NCT01288443|38091824|FG001|Overall Study|Consent withdrawn by Participant|0|||
16947880|NCT01288443|38091825|FG002|Overall Study|Consent withdrawn by Participant|0|||
16947881|NCT01288443|38091826|FG003|Overall Study|Consent withdrawn by Participant|0|||
16947882|NCT01288443|38091827|FG004|Overall Study|Consent withdrawn by Participant|0|||
16947883|NCT01288443|38091828|FG005|Overall Study|Consent withdrawn by Participant|1|||
16947884|NCT01288443|38091823|FG000|Overall Study|Lost to Follow-up|0|||
16947885|NCT01288443|38091824|FG001|Overall Study|Lost to Follow-up|1|||
16947886|NCT01288443|38091825|FG002|Overall Study|Lost to Follow-up|0|||
16947887|NCT01288443|38091826|FG003|Overall Study|Lost to Follow-up|0|||
16947888|NCT01288443|38091827|FG004|Overall Study|Lost to Follow-up|0|||
16947889|NCT01288443|38091828|FG005|Overall Study|Lost to Follow-up|0|||
16947890|NCT01288443|38091823|FG000|Overall Study|Study drug auto-injector administration|0|||
16947891|NCT01288443|38091824|FG001|Overall Study|Study drug auto-injector administration|0|||
16947892|NCT01288443|38091825|FG002|Overall Study|Study drug auto-injector administration|0|||
16947893|NCT01288443|38091826|FG003|Overall Study|Study drug auto-injector administration|0|||
16947894|NCT01288443|38091827|FG004|Overall Study|Study drug auto-injector administration|1|||
16947895|NCT01288443|38091828|FG005|Overall Study|Study drug auto-injector administration|1|||
16947896|NCT01288443|38091823|FG000|Overall Study|Other than above|0|||
16947897|NCT01288443|38091824|FG001|Overall Study|Other than above|0|||
16947898|NCT01288443|38091825|FG002|Overall Study|Other than above|0|||
16947899|NCT01288443|38091826|FG003|Overall Study|Other than above|2|||
16947900|NCT01288443|38091827|FG004|Overall Study|Other than above|1|||
16947901|NCT01288443|38091828|FG005|Overall Study|Other than above|0|||
16947902|NCT01288287|38091842|FG000|Overall Study|Lost to Follow-up|8|||
16947903|NCT01288287|38091842|FG000|Overall Study|Withdrawal by Subject|4|||
16947904|NCT01288287|38091842|FG000|Overall Study|Lack of Efficacy|13|||
16947905|NCT01288287|38091842|FG000|Overall Study|Other Reason|13|||
16947906|NCT01288287|38091842|FG000|Overall Study|Unknown Reason|1|||
16947907|NCT01288287|38091842|FG000|Overall Study|Unknown Status|7|||
16947908|NCT01288209|38091849|FG000|Overall Study|Withdrawal by Subject|1|||
16947909|NCT01288209|38091850|FG001|Overall Study|Withdrawal by Subject|3|||
16947910|NCT01288209|38091849|FG000|Overall Study|Other|1|||
16947911|NCT01288209|38091850|FG001|Overall Study|Other|0|||
16947912|NCT01288053|38091856|FG000|Overall Study|Death|1|||
16947913|NCT01287897|38091864|FG000|Overall Study|Adverse Event|5|||
16947914|NCT01287897|38091865|FG001|Overall Study|Adverse Event|3|||
16947915|NCT01287897|38091866|FG002|Overall Study|Adverse Event|6|||
16947916|NCT01287897|38091867|FG003|Overall Study|Adverse Event|4|||
16947917|NCT01287897|38091864|FG000|Overall Study|Lack of Efficacy|2|||
16947918|NCT01287897|38091865|FG001|Overall Study|Lack of Efficacy|0|||
16947919|NCT01287897|38091866|FG002|Overall Study|Lack of Efficacy|0|||
16947920|NCT01287897|38091867|FG003|Overall Study|Lack of Efficacy|0|||
16947921|NCT01287897|38091864|FG000|Overall Study|Protocol Violation|1|||
16947922|NCT01287897|38091865|FG001|Overall Study|Protocol Violation|1|||
16947923|NCT01287897|38091866|FG002|Overall Study|Protocol Violation|0|||
16947924|NCT01287897|38091867|FG003|Overall Study|Protocol Violation|1|||
16947925|NCT01287897|38091864|FG000|Overall Study|Lost to Follow-up|0|||
16947926|NCT01287897|38091865|FG001|Overall Study|Lost to Follow-up|0|||
16947927|NCT01287897|38091866|FG002|Overall Study|Lost to Follow-up|2|||
16947928|NCT01287897|38091867|FG003|Overall Study|Lost to Follow-up|0|||
16947929|NCT01287897|38091864|FG000|Overall Study|Withdrawal by Subject|1|||
16947930|NCT01287897|38091865|FG001|Overall Study|Withdrawal by Subject|5|||
16947931|NCT01287897|38091866|FG002|Overall Study|Withdrawal by Subject|3|||
16947932|NCT01287897|38091867|FG003|Overall Study|Withdrawal by Subject|2|||
16947933|NCT01287897|38091864|FG000|Overall Study|Not consented properly|0|||
16947934|NCT01287897|38091865|FG001|Overall Study|Not consented properly|1|||
16947935|NCT01287897|38091866|FG002|Overall Study|Not consented properly|0|||
16947936|NCT01287897|38091867|FG003|Overall Study|Not consented properly|0|||
16947937|NCT01287897|38091864|FG000|Overall Study|Not meeting entrance criteria|1|||
16947938|NCT01287897|38091865|FG001|Overall Study|Not meeting entrance criteria|1|||
16947939|NCT01287897|38091866|FG002|Overall Study|Not meeting entrance criteria|0|||
16947940|NCT01287897|38091867|FG003|Overall Study|Not meeting entrance criteria|0|||
16947941|NCT01287897|38091864|FG000|Overall Study|Other|1|||
16947942|NCT01287897|38091865|FG001|Overall Study|Other|0|||
16947943|NCT01287897|38091866|FG002|Overall Study|Other|1|||
16947944|NCT01287897|38091867|FG003|Overall Study|Other|0|||
16947945|NCT01287195|38091881|FG000|Overall Study|Withdrawal by Subject|2|||
16947946|NCT01287117|38091889|FG000|Overall Study|Adverse Event|2|||
16947947|NCT01287117|38091890|FG001|Overall Study|Adverse Event|1|||
16947948|NCT01287117|38091891|FG002|Overall Study|Adverse Event|1|||
16947949|NCT01287117|38091892|FG003|Overall Study|Adverse Event|1|||
16947950|NCT01287117|38091889|FG000|Overall Study|Lost to Follow-up|1|||
16947951|NCT01287117|38091890|FG001|Overall Study|Lost to Follow-up|1|||
16947952|NCT01287117|38091891|FG002|Overall Study|Lost to Follow-up|0|||
16947953|NCT01287117|38091892|FG003|Overall Study|Lost to Follow-up|0|||
16947954|NCT01287117|38091889|FG000|Overall Study|Physician Decision|0|||
16947955|NCT01287117|38091890|FG001|Overall Study|Physician Decision|1|||
16947956|NCT01287117|38091891|FG002|Overall Study|Physician Decision|1|||
16947957|NCT01287117|38091892|FG003|Overall Study|Physician Decision|1|||
16947958|NCT01287117|38091889|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
16947959|NCT01287117|38091890|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
16947960|NCT01287117|38091891|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
16947961|NCT01287117|38091892|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
16947962|NCT01287117|38091889|FG000|Overall Study|Disease Progression|10|||
16947963|NCT01287117|38091890|FG001|Overall Study|Disease Progression|5|||
16947964|NCT01287117|38091891|FG002|Overall Study|Disease Progression|6|||
16947965|NCT01287117|38091892|FG003|Overall Study|Disease Progression|5|||
16947966|NCT01287039|38091904|FG000|Overall Study|Noncompliance with study procedures|0|||
16947967|NCT01287039|38091905|FG001|Overall Study|Noncompliance with study procedures|1|||
16947968|NCT01287039|38091904|FG000|Overall Study|Change of location/residence|0|||
16947969|NCT01287039|38091905|FG001|Overall Study|Change of location/residence|3|||
16947970|NCT01287039|38091904|FG000|Overall Study|Elective surgery|0|||
16947971|NCT01287039|38091905|FG001|Overall Study|Elective surgery|1|||
16947972|NCT01287039|38091904|FG000|Overall Study|Protocol Violation|2|||
16947973|NCT01287039|38091905|FG001|Overall Study|Protocol Violation|3|||
16947974|NCT01287039|38091904|FG000|Overall Study|Excluded medication taken|1|||
16947975|NCT01287039|38091905|FG001|Overall Study|Excluded medication taken|0|||
16947976|NCT01287039|38091904|FG000|Overall Study|Noncompliance with study medication|0|||
16947977|NCT01287039|38091905|FG001|Overall Study|Noncompliance with study medication|1|||
16947978|NCT01287039|38091904|FG000|Overall Study|Problem with travel|0|||
16947979|NCT01287039|38091905|FG001|Overall Study|Problem with travel|1|||
16947980|NCT01287039|38091904|FG000|Overall Study|Death|1|||
16947981|NCT01287039|38091905|FG001|Overall Study|Death|0|||
16947982|NCT01287039|38091904|FG000|Overall Study|Change of residence|1|||
16947983|NCT01287039|38091905|FG001|Overall Study|Change of residence|0|||
16947984|NCT01287039|38091904|FG000|Overall Study|Adverse Event|7|||
16947985|NCT01287039|38091905|FG001|Overall Study|Adverse Event|4|||
16947986|NCT01287039|38091904|FG000|Overall Study|Withdrawal by Subject|14|||
16947987|NCT01287039|38091905|FG001|Overall Study|Withdrawal by Subject|11|||
16947988|NCT01287039|38091904|FG000|Overall Study|Lost to Follow-up|3|||
16947989|NCT01287039|38091905|FG001|Overall Study|Lost to Follow-up|2|||
16947990|NCT01285401|38091913|FG000|Overall Study|Prematurely withdrawn from the study|17|||
16947991|NCT01285401|38091914|FG001|Overall Study|Prematurely withdrawn from the study|29|||
16947992|NCT01285323|38091922|FG000|Overall Study|Adverse Event|9|||
16947993|NCT01285323|38091923|FG001|Overall Study|Adverse Event|8|||
16947994|NCT01285323|38091922|FG000|Overall Study|Lack of Efficacy|4|||
16947995|NCT01285323|38091923|FG001|Overall Study|Lack of Efficacy|2|||
16947996|NCT01285323|38091922|FG000|Overall Study|Withdrawal by Subject|15|||
16947997|NCT01285323|38091923|FG001|Overall Study|Withdrawal by Subject|11|||
16947998|NCT01285323|38091922|FG000|Overall Study|Protocol Violation|1|||
16947999|NCT01285323|38091923|FG001|Overall Study|Protocol Violation|2|||
16948000|NCT01285323|38091922|FG000|Overall Study|Non-compliance with study procedures|2|||
16948001|NCT01285323|38091923|FG001|Overall Study|Non-compliance with study procedures|3|||
16948002|NCT01285323|38091922|FG000|Overall Study|Lost to Follow-up|1|||
16948003|NCT01285323|38091923|FG001|Overall Study|Lost to Follow-up|1|||
16948004|NCT01285323|38091922|FG000|Overall Study|Other|1|||
16948005|NCT01285323|38091923|FG001|Overall Study|Other|3|||
16948006|NCT01284621|38091929|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16948007|NCT01284621|38091930|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16948008|NCT01284621|38091931|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16948009|NCT01284621|38091932|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16948010|NCT01284621|38091933|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
16948011|NCT01284621|38091934|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16948012|NCT01283139|38091948|FG000|Overall Study|Lost to Follow-up|5|||
16948013|NCT01283139|38091949|FG001|Overall Study|Lost to Follow-up|2|||
16948014|NCT01283139|38091950|FG002|Overall Study|Lost to Follow-up|3|||
16948015|NCT01283139|38091951|FG003|Overall Study|Lost to Follow-up|1|||
16948016|NCT01283139|38091948|FG000|Overall Study|Withdrawal by Subject|8|||
16948017|NCT01283139|38091949|FG001|Overall Study|Withdrawal by Subject|8|||
16948018|NCT01283139|38091950|FG002|Overall Study|Withdrawal by Subject|6|||
16948019|NCT01283139|38091951|FG003|Overall Study|Withdrawal by Subject|8|||
16948020|NCT01283139|38091948|FG000|Overall Study|Death|2|||
16948021|NCT01283139|38091949|FG001|Overall Study|Death|0|||
16948022|NCT01283139|38091950|FG002|Overall Study|Death|2|||
16948023|NCT01283139|38091951|FG003|Overall Study|Death|2|||
16948024|NCT01283139|38091948|FG000|Overall Study|Lack of Efficacy|1|||
16948025|NCT01283139|38091949|FG001|Overall Study|Lack of Efficacy|2|||
16948026|NCT01283139|38091950|FG002|Overall Study|Lack of Efficacy|2|||
16948027|NCT01283139|38091951|FG003|Overall Study|Lack of Efficacy|1|||
16948028|NCT01283139|38091948|FG000|Overall Study|Early termination due to AE/SAE|1|||
16948029|NCT01283139|38091949|FG001|Overall Study|Early termination due to AE/SAE|1|||
16948030|NCT01283139|38091950|FG002|Overall Study|Early termination due to AE/SAE|0|||
16948031|NCT01283139|38091951|FG003|Overall Study|Early termination due to AE/SAE|0|||
16948032|NCT01283139|38091948|FG000|Overall Study|Participant's refusal to continue|0|||
16948033|NCT01283139|38091949|FG001|Overall Study|Participant's refusal to continue|3|||
16948034|NCT01283139|38091950|FG002|Overall Study|Participant's refusal to continue|1|||
16948035|NCT01283139|38091951|FG003|Overall Study|Participant's refusal to continue|1|||
16948036|NCT01283139|38091948|FG000|Overall Study|Pregnancy|0|||
16948037|NCT01283139|38091949|FG001|Overall Study|Pregnancy|1|||
16948038|NCT01283139|38091950|FG002|Overall Study|Pregnancy|1|||
16948039|NCT01283139|38091951|FG003|Overall Study|Pregnancy|0|||
16948040|NCT01283139|38091948|FG000|Overall Study|Missed follow-up visit|0|||
16948041|NCT01283139|38091949|FG001|Overall Study|Missed follow-up visit|1|||
16948042|NCT01283139|38091950|FG002|Overall Study|Missed follow-up visit|2|||
16948043|NCT01283139|38091951|FG003|Overall Study|Missed follow-up visit|2|||
16948044|NCT01283139|38091948|FG000|Overall Study|Participant randomized in error|0|||
16948045|NCT01283139|38091949|FG001|Overall Study|Participant randomized in error|0|||
16948046|NCT01283139|38091950|FG002|Overall Study|Participant randomized in error|1|||
16948047|NCT01283139|38091951|FG003|Overall Study|Participant randomized in error|0|||
16948048|NCT01282203|38091961|FG000|Overall Study|Adverse Event|1|||
16948049|NCT01281969|38091970|FG000|Overall Study|not randomized didn't meet criteria|0|||
16948050|NCT01281969|38091971|FG001|Overall Study|not randomized didn't meet criteria|0|||
16948051|NCT01281969|38091972|FG002|Overall Study|not randomized didn't meet criteria|7|||
16948052|NCT01281969|38091970|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
16948053|NCT01281969|38091971|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
16948054|NCT01281969|38091972|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
16948055|NCT01281969|38091970|FG000|Overall Study|not randomized, child consent not given|0|||
16948056|NCT01281969|38091971|FG001|Overall Study|not randomized, child consent not given|0|||
16948057|NCT01281969|38091972|FG002|Overall Study|not randomized, child consent not given|2|||
16948058|NCT01281813|38091983|FG000|Overall Study|Adverse Event|0|||
16948059|NCT01281813|38091984|FG001|Overall Study|Adverse Event|0|||
16948060|NCT01281813|38091985|FG002|Overall Study|Adverse Event|10|||
16948061|NCT01281813|38091983|FG000|Overall Study|Lost to Follow-up|0|||
16774154|NCT02201524|37713429|FG002|Overall Study|Withdrawal by Subject|1|||
16774155|NCT02201524|37713430|FG003|Overall Study|Withdrawal by Subject|1|||
16774156|NCT02201524|37713427|FG000|Overall Study|Other|1|||
16774157|NCT02201524|37713428|FG001|Overall Study|Other|1|||
16774158|NCT02201524|37713429|FG002|Overall Study|Other|0|||
16774159|NCT02201524|37713430|FG003|Overall Study|Other|0|||
16774160|NCT02453048|37713445|FG000|Overall Study|Only part of initial 6 mo. study|0|||
16774161|NCT02453048|37713446|FG001|Overall Study|Only part of initial 6 mo. study|0|||
16774162|NCT02453048|37713447|FG002|Overall Study|Only part of initial 6 mo. study|0|||
16774163|NCT02453048|37713448|FG003|Overall Study|Only part of initial 6 mo. study|0|||
16774164|NCT02453048|37713449|FG004|Overall Study|Only part of initial 6 mo. study|6|||
16774165|NCT02453048|37713445|FG000|Overall Study|Lost to Follow-up|0|||
16948062|NCT01281813|38091984|FG001|Overall Study|Lost to Follow-up|0|||
16948063|NCT01281813|38091985|FG002|Overall Study|Lost to Follow-up|31|||
16948064|NCT01281813|38091983|FG000|Overall Study|Withdrawal by Subject|0|||
16948065|NCT01281813|38091984|FG001|Overall Study|Withdrawal by Subject|0|||
16948066|NCT01281813|38091985|FG002|Overall Study|Withdrawal by Subject|13|||
16948067|NCT01281813|38091983|FG000|Overall Study|Subject Non-Compliant|0|||
16948068|NCT01281813|38091984|FG001|Overall Study|Subject Non-Compliant|0|||
16948069|NCT01281813|38091985|FG002|Overall Study|Subject Non-Compliant|6|||
16948070|NCT01281813|38091983|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
16948071|NCT01281813|38091984|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
16948072|NCT01281813|38091985|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
16774166|NCT02453048|37713446|FG001|Overall Study|Lost to Follow-up|1|||
16948073|NCT01281813|38091983|FG000|Overall Study|Sponsor's Decision|4|||
16948074|NCT01281813|38091984|FG001|Overall Study|Sponsor's Decision|3|||
16948075|NCT01281813|38091985|FG002|Overall Study|Sponsor's Decision|7|||
16948076|NCT01281813|38091983|FG000|Overall Study|Switched to Commercially Available Medication|0|||
16774167|NCT02453048|37713447|FG002|Overall Study|Lost to Follow-up|2|||
16948077|NCT01281813|38091984|FG001|Overall Study|Switched to Commercially Available Medication|0|||
16774168|NCT02453048|37713448|FG003|Overall Study|Lost to Follow-up|0|||
16948078|NCT01281813|38091985|FG002|Overall Study|Switched to Commercially Available Medication|26|||
16948079|NCT01281813|38091983|FG000|Overall Study|Other|0|||
16948080|NCT01281813|38091984|FG001|Overall Study|Other|1|||
16948081|NCT01281813|38091985|FG002|Overall Study|Other|39|||
16948082|NCT01090414|38091997|FG000|Study 101-99|Progressive Disease|28|||
16948083|NCT01090414|38091998|FG001|Study 101-99|Progressive Disease|48|||
16948084|NCT01090414|38091999|FG002|Study 101-99|Progressive Disease|10|||
16948085|NCT01090414|38092000|FG003|Study 101-99|Progressive Disease|4|||
16948086|NCT01090414|38091997|FG000|Study 101-99|Adverse Event|10|||
16948087|NCT01090414|38091998|FG001|Study 101-99|Adverse Event|28|||
16948088|NCT01090414|38091999|FG002|Study 101-99|Adverse Event|18|||
16948089|NCT01090414|38092000|FG003|Study 101-99|Adverse Event|0|||
16948090|NCT01090414|38091997|FG000|Study 101-99|Investigator Request|1|||
16948091|NCT01090414|38091998|FG001|Study 101-99|Investigator Request|11|||
16948092|NCT01090414|38091999|FG002|Study 101-99|Investigator Request|4|||
16948093|NCT01090414|38092000|FG003|Study 101-99|Investigator Request|0|||
16948094|NCT01090414|38091997|FG000|Study 101-99|Death|3|||
16948095|NCT01090414|38091998|FG001|Study 101-99|Death|8|||
16948096|NCT01090414|38091999|FG002|Study 101-99|Death|1|||
16948097|NCT01090414|38092000|FG003|Study 101-99|Death|0|||
16948098|NCT01090414|38091997|FG000|Study 101-99|Sponsor Discontinued Study|0|||
16948099|NCT01090414|38091998|FG001|Study 101-99|Sponsor Discontinued Study|7|||
16948100|NCT01090414|38091999|FG002|Study 101-99|Sponsor Discontinued Study|5|||
16948101|NCT01090414|38092000|FG003|Study 101-99|Sponsor Discontinued Study|0|||
16948102|NCT01090414|38091997|FG000|Study 101-99|Other (Unknown Reasons)|3|||
16948103|NCT01090414|38091998|FG001|Study 101-99|Other (Unknown Reasons)|3|||
16948104|NCT01090414|38091999|FG002|Study 101-99|Other (Unknown Reasons)|0|||
16948105|NCT01090414|38092000|FG003|Study 101-99|Other (Unknown Reasons)|0|||
16948106|NCT01090414|38091997|FG000|Study 101-99|Withdrew Consent|0|||
16948107|NCT01090414|38091998|FG001|Study 101-99|Withdrew Consent|2|||
16948108|NCT01090414|38091999|FG002|Study 101-99|Withdrew Consent|3|||
16948109|NCT01090414|38092000|FG003|Study 101-99|Withdrew Consent|1|||
16948110|NCT01090414|38091997|FG000|Study 101-99|Participant Request|3|||
16948111|NCT01090414|38091998|FG001|Study 101-99|Participant Request|1|||
16948112|NCT01090414|38091999|FG002|Study 101-99|Participant Request|0|||
16948113|NCT01090414|38092000|FG003|Study 101-99|Participant Request|0|||
16948114|NCT01090102|38092024|FG000|First 12 Weeks|Withdrawal by Subject|1|||
16948115|NCT01090102|38092025|FG001|First 12 Weeks|Withdrawal by Subject|1|||
16948116|NCT01090102|38092024|FG000|First 12 Weeks|Adverse Event|2|||
16774169|NCT02453048|37713449|FG004|Overall Study|Lost to Follow-up|0|||
16774170|NCT02137252|37713463|FG000|Overall Study|trial terminated early|2|||
16774171|NCT02137252|37713464|FG001|Overall Study|trial terminated early|1|||
16774172|NCT02201290|37713470|FG000|Overall Study|Withdrawal by Subject|2|||
16774173|NCT02201290|37713470|FG000|Overall Study|Lack of Efficacy|2|||
16948117|NCT01090102|38092025|FG001|First 12 Weeks|Adverse Event|0|||
16948118|NCT01090102|38092024|FG000|First 12 Weeks|Death|1|||
16948119|NCT01090102|38092025|FG001|First 12 Weeks|Death|1|||
16948120|NCT01090102|38092024|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
16948121|NCT01090102|38092025|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
16948122|NCT01090024|38092031|FG000|Period 1|Met exclusion criteria|0|||
16948123|NCT01090024|38092032|FG001|Period 1|Met exclusion criteria|0|||
16948124|NCT01090024|38092033|FG002|Period 1|Met exclusion criteria|0|||
16948125|NCT01090024|38092034|FG003|Period 1|Met exclusion criteria|0|||
16948126|NCT01090024|38092035|FG004|Period 1|Met exclusion criteria|0|||
16948127|NCT01090024|38092036|FG005|Period 1|Met exclusion criteria|0|||
16948128|NCT01090024|38092037|FG006|Period 1|Met exclusion criteria|0|||
16948129|NCT01090024|38092038|FG007|Period 1|Met exclusion criteria|0|||
16948130|NCT01090024|38092039|FG008|Period 1|Met exclusion criteria|0|||
16948131|NCT01090024|38092040|FG009|Period 1|Met exclusion criteria|0|||
16948132|NCT01090024|38092041|FG010|Period 1|Met exclusion criteria|0|||
16948133|NCT01090024|38092042|FG011|Period 1|Met exclusion criteria|0|||
16948134|NCT01090024|38092043|FG012|Period 1|Met exclusion criteria|0|||
16948135|NCT01090024|38092044|FG013|Period 1|Met exclusion criteria|0|||
16948136|NCT01090024|38092045|FG014|Period 1|Met exclusion criteria|1|||
16948137|NCT01090024|38092046|FG015|Period 1|Met exclusion criteria|0|||
16948138|NCT01090024|38092047|FG016|Period 1|Met exclusion criteria|0|||
16948139|NCT01090024|38092048|FG017|Period 1|Met exclusion criteria|0|||
16948140|NCT01090024|38092031|FG000|Period 1|Adverse Event|0|||
16948141|NCT01090024|38092032|FG001|Period 1|Adverse Event|0|||
16948142|NCT01090024|38092033|FG002|Period 1|Adverse Event|0|||
16948143|NCT01090024|38092034|FG003|Period 1|Adverse Event|0|||
16948144|NCT01090024|38092035|FG004|Period 1|Adverse Event|0|||
16948145|NCT01090024|38092036|FG005|Period 1|Adverse Event|0|||
16948146|NCT01090024|38092037|FG006|Period 1|Adverse Event|0|||
16948147|NCT01090024|38092038|FG007|Period 1|Adverse Event|0|||
16948148|NCT01090024|38092039|FG008|Period 1|Adverse Event|0|||
16948149|NCT01090024|38092040|FG009|Period 1|Adverse Event|1|||
16948150|NCT01090024|38092041|FG010|Period 1|Adverse Event|0|||
16948151|NCT01090024|38092042|FG011|Period 1|Adverse Event|1|||
16948152|NCT01090024|38092043|FG012|Period 1|Adverse Event|0|||
16948153|NCT01090024|38092044|FG013|Period 1|Adverse Event|0|||
16948154|NCT01090024|38092045|FG014|Period 1|Adverse Event|0|||
16948155|NCT01090024|38092046|FG015|Period 1|Adverse Event|0|||
16774174|NCT02201290|37713470|FG000|Overall Study|Adverse Event|1|||
16774175|NCT02200510|37713476|FG000|Overall Study|Death|1|||
16774176|NCT02200510|37713477|FG001|Overall Study|Death|1|||
16774177|NCT02200510|37713476|FG000|Overall Study|Protocol Violation|0|||
16774178|NCT02200510|37713477|FG001|Overall Study|Protocol Violation|1|||
16774179|NCT02200510|37713476|FG000|Overall Study|Lost to Follow-up|7|||
16774180|NCT02200510|37713477|FG001|Overall Study|Lost to Follow-up|1|||
16774181|NCT02200510|37713476|FG000|Overall Study|potential COI - joined study team|1|||
16774182|NCT02200510|37713477|FG001|Overall Study|potential COI - joined study team|0|||
16774183|NCT02452892|37713487|FG000|Week 1 Initial Randommization|Adverse Event|1|||
16774184|NCT02452892|37713488|FG001|Week 1 Initial Randommization|Adverse Event|0|||
16774185|NCT02452892|37713489|FG002|Week 1 Initial Randommization|Adverse Event|0|||
16774186|NCT02452892|37713490|FG003|Week 1 Initial Randommization|Adverse Event|0|||
16774187|NCT02452892|37713487|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
16774188|NCT02452892|37713488|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
16774189|NCT02452892|37713489|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
16774190|NCT02452892|37713490|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
16774191|NCT02452892|37713487|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
16774192|NCT02452892|37713488|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
16774193|NCT02452892|37713489|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
16948156|NCT01090024|38092047|FG016|Period 1|Adverse Event|0|||
16948157|NCT01090024|38092048|FG017|Period 1|Adverse Event|1|||
16948158|NCT01090024|38092031|FG000|Period 1|Withdrawal by Subject|0|||
16948159|NCT01090024|38092032|FG001|Period 1|Withdrawal by Subject|0|||
16948160|NCT01090024|38092033|FG002|Period 1|Withdrawal by Subject|0|||
16948161|NCT01090024|38092034|FG003|Period 1|Withdrawal by Subject|1|||
16948162|NCT01090024|38092035|FG004|Period 1|Withdrawal by Subject|0|||
16948163|NCT01090024|38092036|FG005|Period 1|Withdrawal by Subject|0|||
16948164|NCT01090024|38092037|FG006|Period 1|Withdrawal by Subject|0|||
16948165|NCT01090024|38092038|FG007|Period 1|Withdrawal by Subject|0|||
16948166|NCT01090024|38092039|FG008|Period 1|Withdrawal by Subject|0|||
16948167|NCT01090024|38092040|FG009|Period 1|Withdrawal by Subject|0|||
16948168|NCT01090024|38092041|FG010|Period 1|Withdrawal by Subject|0|||
16948169|NCT01090024|38092042|FG011|Period 1|Withdrawal by Subject|0|||
16948170|NCT01090024|38092043|FG012|Period 1|Withdrawal by Subject|0|||
16948171|NCT01090024|38092044|FG013|Period 1|Withdrawal by Subject|0|||
16948172|NCT01090024|38092045|FG014|Period 1|Withdrawal by Subject|0|||
16948173|NCT01090024|38092046|FG015|Period 1|Withdrawal by Subject|0|||
16948174|NCT01090024|38092047|FG016|Period 1|Withdrawal by Subject|0|||
16948175|NCT01090024|38092048|FG017|Period 1|Withdrawal by Subject|0|||
16948176|NCT01090024|38092031|FG000|Period 1|Lost to Follow-up|0|||
16948177|NCT01090024|38092032|FG001|Period 1|Lost to Follow-up|1|||
16948178|NCT01090024|38092033|FG002|Period 1|Lost to Follow-up|0|||
16948179|NCT01090024|38092034|FG003|Period 1|Lost to Follow-up|0|||
16948180|NCT01090024|38092035|FG004|Period 1|Lost to Follow-up|0|||
16948181|NCT01090024|38092036|FG005|Period 1|Lost to Follow-up|0|||
16948182|NCT01090024|38092037|FG006|Period 1|Lost to Follow-up|0|||
16948183|NCT01090024|38092038|FG007|Period 1|Lost to Follow-up|0|||
16948184|NCT01090024|38092039|FG008|Period 1|Lost to Follow-up|0|||
16948185|NCT01090024|38092040|FG009|Period 1|Lost to Follow-up|0|||
16948186|NCT01090024|38092041|FG010|Period 1|Lost to Follow-up|0|||
16948187|NCT01090024|38092042|FG011|Period 1|Lost to Follow-up|0|||
16948188|NCT01090024|38092043|FG012|Period 1|Lost to Follow-up|0|||
16948189|NCT01090024|38092044|FG013|Period 1|Lost to Follow-up|0|||
16948190|NCT01090024|38092045|FG014|Period 1|Lost to Follow-up|0|||
16948191|NCT01090024|38092046|FG015|Period 1|Lost to Follow-up|0|||
16948192|NCT01090024|38092047|FG016|Period 1|Lost to Follow-up|0|||
16948193|NCT01090024|38092048|FG017|Period 1|Lost to Follow-up|0|||
16948194|NCT01090024|38092031|FG000|Period 2|Lost to Follow-up|0|||
16948195|NCT01090024|38092032|FG001|Period 2|Lost to Follow-up|0|||
16948196|NCT01090024|38092033|FG002|Period 2|Lost to Follow-up|0|||
16948197|NCT01090024|38092034|FG003|Period 2|Lost to Follow-up|1|||
16948198|NCT01090024|38092035|FG004|Period 2|Lost to Follow-up|0|||
16948199|NCT01090024|38092036|FG005|Period 2|Lost to Follow-up|0|||
16948200|NCT01090024|38092037|FG006|Period 2|Lost to Follow-up|0|||
16948201|NCT01090024|38092038|FG007|Period 2|Lost to Follow-up|0|||
16948202|NCT01090024|38092039|FG008|Period 2|Lost to Follow-up|0|||
16948203|NCT01090024|38092040|FG009|Period 2|Lost to Follow-up|0|||
16948204|NCT01090024|38092041|FG010|Period 2|Lost to Follow-up|0|||
16948205|NCT01090024|38092042|FG011|Period 2|Lost to Follow-up|0|||
16948206|NCT01090024|38092043|FG012|Period 2|Lost to Follow-up|0|||
16948207|NCT01090024|38092044|FG013|Period 2|Lost to Follow-up|0|||
16948208|NCT01090024|38092045|FG014|Period 2|Lost to Follow-up|0|||
16948209|NCT01090024|38092046|FG015|Period 2|Lost to Follow-up|0|||
16948210|NCT01090024|38092047|FG016|Period 2|Lost to Follow-up|0|||
16948211|NCT01090024|38092048|FG017|Period 2|Lost to Follow-up|0|||
16948212|NCT01090024|38092031|FG000|Period 2|Adverse Event|1|||
16948213|NCT01090024|38092032|FG001|Period 2|Adverse Event|0|||
16948214|NCT01090024|38092033|FG002|Period 2|Adverse Event|0|||
16948215|NCT01090024|38092034|FG003|Period 2|Adverse Event|0|||
16948216|NCT01090024|38092035|FG004|Period 2|Adverse Event|0|||
16948217|NCT01090024|38092036|FG005|Period 2|Adverse Event|0|||
16948218|NCT01090024|38092037|FG006|Period 2|Adverse Event|0|||
16948219|NCT01090024|38092038|FG007|Period 2|Adverse Event|0|||
16948220|NCT01090024|38092039|FG008|Period 2|Adverse Event|0|||
16948221|NCT01090024|38092040|FG009|Period 2|Adverse Event|0|||
16948222|NCT01090024|38092041|FG010|Period 2|Adverse Event|0|||
16948223|NCT01090024|38092042|FG011|Period 2|Adverse Event|0|||
16948224|NCT01090024|38092043|FG012|Period 2|Adverse Event|0|||
16948225|NCT01090024|38092044|FG013|Period 2|Adverse Event|0|||
16948226|NCT01090024|38092045|FG014|Period 2|Adverse Event|0|||
16948227|NCT01090024|38092046|FG015|Period 2|Adverse Event|0|||
16948228|NCT01090024|38092047|FG016|Period 2|Adverse Event|0|||
16948229|NCT01090024|38092048|FG017|Period 2|Adverse Event|0|||
16948230|NCT01090024|38092031|FG000|Period 3|Withdrawal by Subject|0|||
16948231|NCT01090024|38092032|FG001|Period 3|Withdrawal by Subject|0|||
16948232|NCT01090024|38092033|FG002|Period 3|Withdrawal by Subject|0|||
16948233|NCT01090024|38092034|FG003|Period 3|Withdrawal by Subject|0|||
16948234|NCT01090024|38092035|FG004|Period 3|Withdrawal by Subject|0|||
16948235|NCT01090024|38092036|FG005|Period 3|Withdrawal by Subject|0|||
16948236|NCT01090024|38092037|FG006|Period 3|Withdrawal by Subject|0|||
16948237|NCT01090024|38092038|FG007|Period 3|Withdrawal by Subject|0|||
16948238|NCT01090024|38092039|FG008|Period 3|Withdrawal by Subject|0|||
16948239|NCT01090024|38092040|FG009|Period 3|Withdrawal by Subject|0|||
16948240|NCT01090024|38092041|FG010|Period 3|Withdrawal by Subject|0|||
16948241|NCT01090024|38092042|FG011|Period 3|Withdrawal by Subject|0|||
16948242|NCT01090024|38092043|FG012|Period 3|Withdrawal by Subject|0|||
16948243|NCT01090024|38092044|FG013|Period 3|Withdrawal by Subject|0|||
16948244|NCT01090024|38092045|FG014|Period 3|Withdrawal by Subject|0|||
16948245|NCT01090024|38092046|FG015|Period 3|Withdrawal by Subject|1|||
16948246|NCT01090024|38092047|FG016|Period 3|Withdrawal by Subject|0|||
16948247|NCT01090024|38092048|FG017|Period 3|Withdrawal by Subject|0|||
16948248|NCT01090024|38092031|FG000|Period 3|Protocol Violation|0|||
16948249|NCT01090024|38092032|FG001|Period 3|Protocol Violation|0|||
16948250|NCT01090024|38092033|FG002|Period 3|Protocol Violation|0|||
16948251|NCT01090024|38092034|FG003|Period 3|Protocol Violation|0|||
16948252|NCT01090024|38092035|FG004|Period 3|Protocol Violation|0|||
16948253|NCT01090024|38092036|FG005|Period 3|Protocol Violation|0|||
16948254|NCT01090024|38092037|FG006|Period 3|Protocol Violation|0|||
16948255|NCT01090024|38092038|FG007|Period 3|Protocol Violation|0|||
16948256|NCT01090024|38092039|FG008|Period 3|Protocol Violation|1|||
16948257|NCT01090024|38092040|FG009|Period 3|Protocol Violation|0|||
16948258|NCT01090024|38092041|FG010|Period 3|Protocol Violation|0|||
16948259|NCT01090024|38092042|FG011|Period 3|Protocol Violation|0|||
16948260|NCT01090024|38092043|FG012|Period 3|Protocol Violation|0|||
16948261|NCT01090024|38092044|FG013|Period 3|Protocol Violation|0|||
16948262|NCT01090024|38092045|FG014|Period 3|Protocol Violation|0|||
16948263|NCT01090024|38092046|FG015|Period 3|Protocol Violation|0|||
16948264|NCT01090024|38092047|FG016|Period 3|Protocol Violation|0|||
16948265|NCT01090024|38092048|FG017|Period 3|Protocol Violation|0|||
16948266|NCT01090024|38092031|FG000|Period 3|Adverse Event|0|||
16948267|NCT01090024|38092032|FG001|Period 3|Adverse Event|0|||
16948268|NCT01090024|38092033|FG002|Period 3|Adverse Event|0|||
16948269|NCT01090024|38092034|FG003|Period 3|Adverse Event|0|||
16948270|NCT01090024|38092035|FG004|Period 3|Adverse Event|0|||
16948271|NCT01090024|38092036|FG005|Period 3|Adverse Event|1|||
16948272|NCT01090024|38092037|FG006|Period 3|Adverse Event|0|||
16948273|NCT01090024|38092038|FG007|Period 3|Adverse Event|0|||
16948274|NCT01090024|38092039|FG008|Period 3|Adverse Event|0|||
16948275|NCT01090024|38092040|FG009|Period 3|Adverse Event|0|||
16948276|NCT01090024|38092041|FG010|Period 3|Adverse Event|0|||
16948277|NCT01090024|38092042|FG011|Period 3|Adverse Event|0|||
16948278|NCT01090024|38092043|FG012|Period 3|Adverse Event|0|||
16948279|NCT01090024|38092044|FG013|Period 3|Adverse Event|0|||
16948280|NCT01090024|38092045|FG014|Period 3|Adverse Event|0|||
16948281|NCT01090024|38092046|FG015|Period 3|Adverse Event|0|||
16948282|NCT01090024|38092047|FG016|Period 3|Adverse Event|0|||
16948283|NCT01090024|38092048|FG017|Period 3|Adverse Event|0|||
16948284|NCT04868890|38092060|FG000|Overall Study|Death|2|||
16948285|NCT04868890|38092061|FG001|Overall Study|Death|1|||
16948286|NCT04868890|38092060|FG000|Overall Study|Withdrawal by Subject|1|||
16948287|NCT04868890|38092061|FG001|Overall Study|Withdrawal by Subject|5|||
16948288|NCT01281189|38092069|FG000|Overall Study|Adverse Event|7|||
16948289|NCT01281189|38092070|FG001|Overall Study|Adverse Event|9|||
16948290|NCT01281189|38092069|FG000|Overall Study|Lost to Follow-up|6|||
16948291|NCT01281189|38092070|FG001|Overall Study|Lost to Follow-up|4|||
16948292|NCT01281189|38092069|FG000|Overall Study|Withdrawal by Subject|21|||
16948293|NCT01281189|38092070|FG001|Overall Study|Withdrawal by Subject|24|||
16948294|NCT01281189|38092069|FG000|Overall Study|Physician Decision|2|||
16948295|NCT01281189|38092070|FG001|Overall Study|Physician Decision|3|||
16948296|NCT01281189|38092069|FG000|Overall Study|Death|103|||
16948297|NCT01281189|38092070|FG001|Overall Study|Death|91|||
16948298|NCT01281189|38092069|FG000|Overall Study|Other|8|||
16948299|NCT01281189|38092070|FG001|Overall Study|Other|12|||
16948300|NCT01280955|38092076|FG000|Overall Study|Death|2|||
16948301|NCT01280955|38092076|FG000|Overall Study|Withdrawal by Subject|1|||
16948302|NCT01280721|38092082|FG000|Overall Study|Adverse Event|4|||
16948303|NCT01280721|38092082|FG000|Overall Study|Physician Decision|3|||
16948304|NCT01280721|38092082|FG000|Overall Study|Withdrawal by Subject|6|||
16948305|NCT01280721|38092082|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
16948306|NCT01280721|38092082|FG000|Overall Study|No tolerability for the lowest dose|2|||
16948307|NCT01087762|38092100|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
16948308|NCT01087762|38092101|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
16948309|NCT01087762|38092102|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
16948310|NCT01087762|38092103|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
16948311|NCT01087762|38092104|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
16948312|NCT01087762|38092100|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
16948313|NCT01087762|38092101|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
16948314|NCT01087762|38092102|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
16948315|NCT01087762|38092103|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
16948316|NCT01087762|38092104|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
16948317|NCT01087762|38092100|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
16948318|NCT01087762|38092101|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
16948319|NCT01087762|38092102|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
16948320|NCT01087762|38092103|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
16948321|NCT01087762|38092104|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
16948322|NCT01087762|38092100|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
16948323|NCT01087762|38092101|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
16948324|NCT01087762|38092102|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
16948325|NCT01087762|38092103|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
16948326|NCT01087762|38092104|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
16948327|NCT01087762|38092100|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
16948328|NCT01087762|38092101|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
16948329|NCT01087762|38092102|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
16948330|NCT01087762|38092103|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
16948331|NCT01087762|38092104|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
16948332|NCT01087762|38092100|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
16948333|NCT01087762|38092101|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
16948334|NCT01087762|38092102|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
16948335|NCT01087762|38092103|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
16948336|NCT01087762|38092104|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
16948337|NCT01087762|38092100|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
16948338|NCT01087762|38092101|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
16948339|NCT01087762|38092102|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
16948340|NCT01087762|38092103|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
16948341|NCT01087762|38092104|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
16948342|NCT01087762|38092100|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
16948343|NCT01087762|38092101|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
16948344|NCT01087762|38092102|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
16948345|NCT01087762|38092103|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
16948346|NCT01087762|38092104|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
16948347|NCT01087762|38092100|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
16948348|NCT01087762|38092101|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
16948349|NCT01087762|38092102|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
16948350|NCT01087762|38092103|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
16948351|NCT01087762|38092104|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
16948352|NCT01087762|38092100|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
16948353|NCT01087762|38092101|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
16948354|NCT01087762|38092102|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
16948355|NCT01087762|38092103|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
16948356|NCT01087762|38092104|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
16948357|NCT01087762|38092100|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
16948358|NCT01087762|38092101|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
16948359|NCT01087762|38092102|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
16948360|NCT01087762|38092103|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
16948361|NCT01087762|38092104|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
16948362|NCT01087762|38092100|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
16948363|NCT01087762|38092101|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
16948364|NCT01087762|38092102|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
16948365|NCT01087762|38092103|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
16948366|NCT01087762|38092104|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
16948367|NCT01087762|38092100|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
16948368|NCT01087762|38092101|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
16948369|NCT01087762|38092102|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
16948370|NCT01087762|38092103|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
16948371|NCT01087762|38092104|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
16948372|NCT01078168|38092116|FG000|Overall Study|Physician Decision|0|||
16948373|NCT01078168|38092117|FG001|Overall Study|Physician Decision|1|||
16948374|NCT01086358|38092123|FG000|First Intervention|Lost to Follow-up|9|||
16948375|NCT01086358|38092124|FG001|First Intervention|Lost to Follow-up|4|||
16948376|NCT01086358|38092123|FG000|First Intervention|Withdrawal by Subject|0|||
16948377|NCT01086358|38092124|FG001|First Intervention|Withdrawal by Subject|1|||
16948378|NCT01086358|38092123|FG000|Second Intervention|Lost to Follow-up|4|||
16948379|NCT01086358|38092124|FG001|Second Intervention|Lost to Follow-up|4|||
16948380|NCT01277601|38092134|FG000|Overall Study|Adverse Event|5|||
16948381|NCT01277601|38092135|FG001|Overall Study|Adverse Event|3|||
16948382|NCT01277601|38092136|FG002|Overall Study|Adverse Event|0|||
16948383|NCT01277601|38092137|FG003|Overall Study|Adverse Event|7|||
16948384|NCT01277601|38092134|FG000|Overall Study|Withdrawal by Subject|18|||
16948385|NCT01277601|38092135|FG001|Overall Study|Withdrawal by Subject|21|||
16948386|NCT01277601|38092136|FG002|Overall Study|Withdrawal by Subject|8|||
16948387|NCT01277601|38092137|FG003|Overall Study|Withdrawal by Subject|17|||
16948388|NCT01277601|38092134|FG000|Overall Study|Lost to Follow-up|7|||
16948389|NCT01277601|38092135|FG001|Overall Study|Lost to Follow-up|9|||
16948390|NCT01277601|38092136|FG002|Overall Study|Lost to Follow-up|4|||
16948391|NCT01277601|38092137|FG003|Overall Study|Lost to Follow-up|2|||
16948392|NCT01277601|38092134|FG000|Overall Study|Physician Decision|3|||
16948393|NCT01277601|38092135|FG001|Overall Study|Physician Decision|5|||
16948394|NCT01277601|38092136|FG002|Overall Study|Physician Decision|1|||
16948395|NCT01277601|38092137|FG003|Overall Study|Physician Decision|6|||
16948396|NCT01277601|38092134|FG000|Overall Study|Pregnancy|2|||
16948397|NCT01277601|38092135|FG001|Overall Study|Pregnancy|2|||
16948398|NCT01277601|38092136|FG002|Overall Study|Pregnancy|4|||
16948399|NCT01277601|38092137|FG003|Overall Study|Pregnancy|1|||
16948400|NCT01277601|38092134|FG000|Overall Study|Noncompliance with Study Drug|1|||
16948401|NCT01277601|38092135|FG001|Overall Study|Noncompliance with Study Drug|3|||
16948402|NCT01277601|38092136|FG002|Overall Study|Noncompliance with Study Drug|2|||
16948403|NCT01277601|38092137|FG003|Overall Study|Noncompliance with Study Drug|0|||
16948404|NCT01277601|38092134|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
16948405|NCT01277601|38092135|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
16948406|NCT01277601|38092136|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
16948407|NCT01277601|38092137|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
16948408|NCT01277601|38092134|FG000|Overall Study|Protocol Violation|0|||
16948409|NCT01277601|38092135|FG001|Overall Study|Protocol Violation|2|||
16948410|NCT01277601|38092136|FG002|Overall Study|Protocol Violation|5|||
16948411|NCT01277601|38092137|FG003|Overall Study|Protocol Violation|0|||
16948412|NCT01277601|38092134|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
16948413|NCT01277601|38092135|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
16948414|NCT01277601|38092136|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
16948415|NCT01277601|38092137|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
16948416|NCT01277523|38092167|FG000|Overall Study|Adverse Event|1|||
16948417|NCT01277523|38092168|FG001|Overall Study|Adverse Event|0|||
16948418|NCT01277523|38092169|FG002|Overall Study|Adverse Event|0|||
16948419|NCT01277523|38092167|FG000|Overall Study|Protocol Violation|2|||
16948420|NCT01277523|38092168|FG001|Overall Study|Protocol Violation|0|||
16948421|NCT01277523|38092169|FG002|Overall Study|Protocol Violation|0|||
16948422|NCT01277523|38092167|FG000|Overall Study|Other Reason not Defined|0|||
16948423|NCT01277523|38092168|FG001|Overall Study|Other Reason not Defined|1|||
16948424|NCT01277523|38092169|FG002|Overall Study|Other Reason not Defined|0|||
16948425|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
16948426|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
16948427|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
16948428|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
16948429|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
16948430|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
16948431|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
16948432|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
16948433|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
16948434|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
16948435|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Death|1|||
16948436|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Death|0|||
16948437|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Death|0|||
16948438|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Death|0|||
16948439|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Death|0|||
16948440|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
16948441|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
16948442|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
16948443|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
16948444|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
16948445|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
16948446|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
16948447|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
16948448|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
16948449|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
16948450|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
16948451|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
16948452|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
16948453|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
16948454|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
16948455|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
16948456|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
16948457|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
16948458|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
16948459|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16948460|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
16948461|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16948462|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16948463|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16948464|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16948465|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Other|4|||
16948466|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Other|4|||
16948467|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Other|3|||
16948468|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Other|1|||
16948469|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Other|0|||
16948470|NCT01081834|38092182|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
16948471|NCT01081834|38092183|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
16948472|NCT01081834|38092184|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16948473|NCT01081834|38092185|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16948474|NCT01081834|38092186|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16948475|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16948476|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16948477|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16948478|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16948479|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16948480|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Death|1|||
16948481|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Death|0|||
16948482|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Death|0|||
16948483|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Death|0|||
16948484|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Death|0|||
16948485|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
16948486|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
16948487|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16948488|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16948489|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16948490|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16948491|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16948492|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16948493|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16948494|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16948495|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16948496|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
16948497|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16948498|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16948499|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16948500|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16948501|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16948502|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16948503|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16948504|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16948505|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
16948506|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
16948507|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
16948508|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
16948509|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
16948510|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Other|4|||
16948511|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Other|5|||
16948512|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Other|4|||
16948513|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Other|0|||
16948514|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Other|0|||
16948515|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
16948516|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
16948517|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
16948518|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
16948519|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
16948520|NCT01081834|38092182|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16948521|NCT01081834|38092183|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
16948522|NCT01081834|38092184|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16948523|NCT01081834|38092185|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16948524|NCT01081834|38092186|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16948525|NCT01276509|38092209|FG000|Overall Study|Adverse Event|9|||
16948526|NCT01276509|38092210|FG001|Overall Study|Adverse Event|8|||
16948527|NCT01276509|38092211|FG002|Overall Study|Adverse Event|4|||
16948528|NCT01276509|38092212|FG003|Overall Study|Adverse Event|3|||
16948529|NCT01276509|38092209|FG000|Overall Study|Lack of Efficacy|2|||
16948530|NCT01276509|38092210|FG001|Overall Study|Lack of Efficacy|1|||
16948531|NCT01276509|38092211|FG002|Overall Study|Lack of Efficacy|1|||
16948532|NCT01276509|38092212|FG003|Overall Study|Lack of Efficacy|2|||
16948533|NCT01276509|38092209|FG000|Overall Study|Pregnancy|1|||
16948534|NCT01276509|38092210|FG001|Overall Study|Pregnancy|0|||
16948535|NCT01276509|38092211|FG002|Overall Study|Pregnancy|0|||
16948536|NCT01276509|38092212|FG003|Overall Study|Pregnancy|0|||
16948537|NCT01276509|38092209|FG000|Overall Study|Withdrawal by Subject|1|||
16948538|NCT01276509|38092210|FG001|Overall Study|Withdrawal by Subject|2|||
16948539|NCT01276509|38092211|FG002|Overall Study|Withdrawal by Subject|0|||
16948540|NCT01276509|38092212|FG003|Overall Study|Withdrawal by Subject|0|||
16948541|NCT01276509|38092209|FG000|Overall Study|Other|0|||
16948542|NCT01276509|38092210|FG001|Overall Study|Other|1|||
16948543|NCT01276509|38092211|FG002|Overall Study|Other|0|||
16948544|NCT01276509|38092212|FG003|Overall Study|Other|0|||
16948545|NCT01079962|38092224|FG000|Overall Study|Adverse Event|2|||
16948546|NCT01079962|38092225|FG001|Overall Study|Adverse Event|2|||
16948547|NCT01079962|38092224|FG000|Overall Study|Withdrawal by Subject|5|||
16948548|NCT01079962|38092225|FG001|Overall Study|Withdrawal by Subject|7|||
16948549|NCT01079962|38092224|FG000|Overall Study|Protocol Violation|2|||
16948550|NCT01079962|38092225|FG001|Overall Study|Protocol Violation|2|||
16948551|NCT01079962|38092224|FG000|Overall Study|No blood pressure (BP) control|3|||
16948552|NCT01079962|38092225|FG001|Overall Study|No blood pressure (BP) control|0|||
16948553|NCT01079962|38092224|FG000|Overall Study|Inclusion/exclusion criteria|1|||
16948554|NCT01079962|38092225|FG001|Overall Study|Inclusion/exclusion criteria|3|||
16948555|NCT01079962|38092224|FG000|Overall Study|Participant not returning for next visit|1|||
16948556|NCT01079962|38092225|FG001|Overall Study|Participant not returning for next visit|0|||
16948557|NCT01079962|38092224|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
16948558|NCT01079962|38092225|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
16948559|NCT01274637|38092233|FG000|Overall Study|Withdrawal by Subject|0|||
16948560|NCT01274637|38092234|FG001|Overall Study|Withdrawal by Subject|1|||
16948561|NCT01274637|38092233|FG000|Overall Study|Lost to Follow-up|0|||
16948562|NCT01274637|38092234|FG001|Overall Study|Lost to Follow-up|1|||
16948563|NCT01079806|38092242|FG000|Day 1 to Week 96|Adverse Event|0|||
16948564|NCT01079806|38092243|FG001|Day 1 to Week 96|Adverse Event|3|||
16948565|NCT01079806|38092242|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
16948566|NCT01079806|38092243|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
16948567|NCT01079806|38092242|FG000|Day 1 to Week 96|Pregnancy|0|||
16948568|NCT01079806|38092243|FG001|Day 1 to Week 96|Pregnancy|1|||
16948569|NCT01079806|38092242|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
16948570|NCT01079806|38092243|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
16948571|NCT01079806|38092242|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
16948572|NCT01079806|38092243|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
16948573|NCT01079806|38092242|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
16948574|NCT01079806|38092243|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
16948575|NCT01079806|38092242|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
16948576|NCT01079806|38092243|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
16948577|NCT01079806|38092242|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
16948578|NCT01079806|38092243|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
16948579|NCT01079806|38092242|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
16948580|NCT01079806|38092243|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
16948581|NCT01079806|38092242|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
16948582|NCT01079806|38092243|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
16948583|NCT01078090|38092251|FG000|Overall Study|Lost to Follow-up|2363|||
16948584|NCT01078090|38092251|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
16948585|NCT01078090|38092251|FG000|Overall Study|Lack of Efficacy|1193|||
16948586|NCT01078090|38092251|FG000|Overall Study|ADR and lack of efficacy|61|||
16948587|NCT01078090|38092251|FG000|Overall Study|Other|523|||
16948588|NCT01077622|38092269|FG000|Overall Study|Physician Decision|2|||
16948589|NCT01077622|38092269|FG000|Overall Study|Withdrawal by Subject|1|||
16948590|NCT01313676|38092277|FG000|Overall Study|Adverse Event|395|||
16948591|NCT01313676|38092278|FG001|Overall Study|Adverse Event|365|||
16948592|NCT01313676|38092279|FG002|Overall Study|Adverse Event|372|||
16948593|NCT01313676|38092280|FG003|Overall Study|Adverse Event|333|||
16948594|NCT01313676|38092277|FG000|Overall Study|Lack of Efficacy|98|||
16948595|NCT01313676|38092278|FG001|Overall Study|Lack of Efficacy|90|||
16948596|NCT01313676|38092279|FG002|Overall Study|Lack of Efficacy|65|||
16948597|NCT01313676|38092280|FG003|Overall Study|Lack of Efficacy|46|||
16948598|NCT01313676|38092277|FG000|Overall Study|Protocol Violation|37|||
16948599|NCT01313676|38092278|FG001|Overall Study|Protocol Violation|44|||
16948600|NCT01313676|38092279|FG002|Overall Study|Protocol Violation|46|||
16948601|NCT01313676|38092280|FG003|Overall Study|Protocol Violation|44|||
16948602|NCT01313676|38092277|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
16948603|NCT01313676|38092278|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
16948604|NCT01313676|38092279|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
16948605|NCT01313676|38092280|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
16948606|NCT01313676|38092277|FG000|Overall Study|Study Closed/terminated|7|||
16948607|NCT01313676|38092278|FG001|Overall Study|Study Closed/terminated|6|||
16948608|NCT01313676|38092279|FG002|Overall Study|Study Closed/terminated|9|||
16948609|NCT01313676|38092280|FG003|Overall Study|Study Closed/terminated|9|||
16948610|NCT01313676|38092277|FG000|Overall Study|Lost to Follow-up|0|||
16948611|NCT01313676|38092278|FG001|Overall Study|Lost to Follow-up|0|||
16948612|NCT01313676|38092279|FG002|Overall Study|Lost to Follow-up|1|||
16948613|NCT01313676|38092280|FG003|Overall Study|Lost to Follow-up|0|||
16948614|NCT01313676|38092277|FG000|Overall Study|Physician Decision|53|||
16948615|NCT01313676|38092278|FG001|Overall Study|Physician Decision|64|||
16948616|NCT01313676|38092279|FG002|Overall Study|Physician Decision|62|||
16948617|NCT01313676|38092280|FG003|Overall Study|Physician Decision|48|||
16948618|NCT01313676|38092277|FG000|Overall Study|Decision by Participant or Proxy|643|||
16948619|NCT01313676|38092278|FG001|Overall Study|Decision by Participant or Proxy|527|||
16948620|NCT01313676|38092279|FG002|Overall Study|Decision by Participant or Proxy|515|||
16948621|NCT01313676|38092280|FG003|Overall Study|Decision by Participant or Proxy|492|||
16948622|NCT01313676|38092277|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
16948623|NCT01313676|38092278|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
16948624|NCT01313676|38092279|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
16948625|NCT01313676|38092280|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
16948626|NCT01313676|38092277|FG000|Overall Study|Investigator Site Closed|12|||
16948627|NCT01313676|38092278|FG001|Overall Study|Investigator Site Closed|11|||
16948628|NCT01313676|38092279|FG002|Overall Study|Investigator Site Closed|15|||
16948629|NCT01313676|38092280|FG003|Overall Study|Investigator Site Closed|10|||
16948630|NCT01313676|38092277|FG000|Overall Study|Missing|1|||
16948631|NCT01313676|38092278|FG001|Overall Study|Missing|1|||
16948632|NCT01313676|38092279|FG002|Overall Study|Missing|1|||
16948633|NCT01313676|38092280|FG003|Overall Study|Missing|0|||
16948634|NCT01313286|38092291|FG000|Period 1|Withdrawal by Subject|2|||
16948635|NCT01313286|38092292|FG001|Period 1|Withdrawal by Subject|0|||
16948636|NCT01313208|38092300|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
16948637|NCT01313208|38092301|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
16948638|NCT01313208|38092300|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
16948639|NCT01313208|38092301|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
16948640|NCT01313208|38092300|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
16948641|NCT01313208|38092301|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
16948642|NCT01313208|38092300|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
16948643|NCT01313208|38092301|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
16948644|NCT01313208|38092300|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
16948645|NCT01313208|38092301|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
16948646|NCT01313208|38092300|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
16948647|NCT01313208|38092301|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
16948648|NCT01313208|38092300|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
16948649|NCT01313208|38092301|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
16948650|NCT01313208|38092300|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
16948651|NCT01313208|38092301|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
16948652|NCT01313208|38092300|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
16948653|NCT01313208|38092301|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
16948654|NCT01312428|38092311|FG000|Overall Study|Study Termination|3|||
16948655|NCT01312428|38092312|FG001|Overall Study|Study Termination|4|||
16948656|NCT01075984|38092325|FG000|Treatment Phase|Adverse Event|0|||
16948657|NCT01075984|38092326|FG001|Treatment Phase|Adverse Event|1|||
16948658|NCT01075984|38092327|FG002|Treatment Phase|Adverse Event|3|||
16948659|NCT01075984|38092328|FG003|Treatment Phase|Adverse Event|7|||
16948660|NCT01075984|38092329|FG004|Treatment Phase|Adverse Event|35|||
16948661|NCT01075984|38092325|FG000|Treatment Phase|Protocol Violation|0|||
16948662|NCT01075984|38092326|FG001|Treatment Phase|Protocol Violation|0|||
16948663|NCT01075984|38092327|FG002|Treatment Phase|Protocol Violation|1|||
16948664|NCT01075984|38092328|FG003|Treatment Phase|Protocol Violation|0|||
16948665|NCT01075984|38092329|FG004|Treatment Phase|Protocol Violation|3|||
16948666|NCT01075984|38092325|FG000|Treatment Phase|Withdrawal by Subject|0|||
16948667|NCT01075984|38092326|FG001|Treatment Phase|Withdrawal by Subject|0|||
16948668|NCT01075984|38092327|FG002|Treatment Phase|Withdrawal by Subject|2|||
16948669|NCT01075984|38092328|FG003|Treatment Phase|Withdrawal by Subject|0|||
16948670|NCT01075984|38092329|FG004|Treatment Phase|Withdrawal by Subject|15|||
16948671|NCT01075984|38092325|FG000|Treatment Phase|Treatment Failure|0|||
16948672|NCT01075984|38092326|FG001|Treatment Phase|Treatment Failure|0|||
16948673|NCT01075984|38092327|FG002|Treatment Phase|Treatment Failure|1|||
16948674|NCT01075984|38092328|FG003|Treatment Phase|Treatment Failure|0|||
16948675|NCT01075984|38092329|FG004|Treatment Phase|Treatment Failure|5|||
16948676|NCT01075984|38092325|FG000|Treatment Phase|Progression of disease|0|||
16948677|NCT01075984|38092326|FG001|Treatment Phase|Progression of disease|0|||
16948678|NCT01075984|38092327|FG002|Treatment Phase|Progression of disease|0|||
16948679|NCT01075984|38092328|FG003|Treatment Phase|Progression of disease|0|||
16948680|NCT01075984|38092329|FG004|Treatment Phase|Progression of disease|2|||
16948681|NCT01075984|38092325|FG000|Follow-up Phase|Protocol Violation|0|||
16948682|NCT01075984|38092326|FG001|Follow-up Phase|Protocol Violation|0|||
16948683|NCT01075984|38092327|FG002|Follow-up Phase|Protocol Violation|1|||
16948684|NCT01075984|38092328|FG003|Follow-up Phase|Protocol Violation|0|||
16948685|NCT01075984|38092329|FG004|Follow-up Phase|Protocol Violation|3|||
16948686|NCT01075984|38092325|FG000|Follow-up Phase|Adverse Event|0|||
16948687|NCT01075984|38092326|FG001|Follow-up Phase|Adverse Event|0|||
16948688|NCT01075984|38092327|FG002|Follow-up Phase|Adverse Event|0|||
16948689|NCT01075984|38092328|FG003|Follow-up Phase|Adverse Event|2|||
16948690|NCT01075984|38092329|FG004|Follow-up Phase|Adverse Event|27|||
16948691|NCT01075984|38092325|FG000|Follow-up Phase|Administrative|0|||
16948692|NCT01075984|38092326|FG001|Follow-up Phase|Administrative|0|||
16948693|NCT01075984|38092327|FG002|Follow-up Phase|Administrative|0|||
16948694|NCT01075984|38092328|FG003|Follow-up Phase|Administrative|0|||
16948695|NCT01075984|38092329|FG004|Follow-up Phase|Administrative|1|||
16948696|NCT01075984|38092325|FG000|Follow-up Phase|Withdrawal by Subject|0|||
16948697|NCT01075984|38092326|FG001|Follow-up Phase|Withdrawal by Subject|0|||
16948698|NCT01075984|38092327|FG002|Follow-up Phase|Withdrawal by Subject|0|||
16948699|NCT01075984|38092328|FG003|Follow-up Phase|Withdrawal by Subject|0|||
16948700|NCT01075984|38092329|FG004|Follow-up Phase|Withdrawal by Subject|10|||
16948701|NCT01075984|38092325|FG000|Follow-up Phase|Progression of disease|0|||
16948702|NCT01075984|38092326|FG001|Follow-up Phase|Progression of disease|0|||
16948703|NCT01075984|38092327|FG002|Follow-up Phase|Progression of disease|0|||
16948704|NCT01075984|38092328|FG003|Follow-up Phase|Progression of disease|0|||
16948705|NCT01075984|38092329|FG004|Follow-up Phase|Progression of disease|2|||
16948706|NCT01075984|38092325|FG000|Follow-up Phase|Treatment failure|0|||
16948707|NCT01075984|38092326|FG001|Follow-up Phase|Treatment failure|0|||
16948708|NCT01075984|38092327|FG002|Follow-up Phase|Treatment failure|0|||
16948709|NCT01075984|38092328|FG003|Follow-up Phase|Treatment failure|0|||
16948710|NCT01075984|38092329|FG004|Follow-up Phase|Treatment failure|4|||
16948711|NCT01024231|38092348|FG000|Overall Study|Other Reasons|1|||
16948712|NCT01024231|38092349|FG001|Overall Study|Other Reasons|2|||
16948713|NCT01024231|38092350|FG002|Overall Study|Other Reasons|0|||
16948714|NCT01024231|38092351|FG003|Overall Study|Other Reasons|0|||
16948715|NCT01024231|38092352|FG004|Overall Study|Other Reasons|2|||
16948716|NCT01024231|38092353|FG005|Overall Study|Other Reasons|0|||
16948717|NCT01024231|38092354|FG006|Overall Study|Other Reasons|1|||
16948718|NCT01024231|38092348|FG000|Overall Study|Maximum Clinical Benefit|1|||
16948719|NCT01024231|38092349|FG001|Overall Study|Maximum Clinical Benefit|2|||
16948720|NCT01024231|38092350|FG002|Overall Study|Maximum Clinical Benefit|0|||
16948721|NCT01024231|38092351|FG003|Overall Study|Maximum Clinical Benefit|1|||
16948722|NCT01024231|38092352|FG004|Overall Study|Maximum Clinical Benefit|1|||
16948723|NCT01024231|38092353|FG005|Overall Study|Maximum Clinical Benefit|0|||
16948724|NCT01024231|38092354|FG006|Overall Study|Maximum Clinical Benefit|0|||
16948725|NCT01024231|38092348|FG000|Overall Study|Disease Progression|3|||
16948726|NCT01024231|38092349|FG001|Overall Study|Disease Progression|1|||
16948727|NCT01024231|38092350|FG002|Overall Study|Disease Progression|3|||
16948728|NCT01024231|38092351|FG003|Overall Study|Disease Progression|0|||
16948729|NCT01024231|38092352|FG004|Overall Study|Disease Progression|4|||
16948730|NCT01024231|38092353|FG005|Overall Study|Disease Progression|11|||
16948731|NCT01024231|38092354|FG006|Overall Study|Disease Progression|6|||
16948732|NCT01024231|38092348|FG000|Overall Study|AE unrelated to Study Drug|0|||
16948733|NCT01024231|38092349|FG001|Overall Study|AE unrelated to Study Drug|1|||
16948734|NCT01024231|38092350|FG002|Overall Study|AE unrelated to Study Drug|0|||
16948735|NCT01024231|38092351|FG003|Overall Study|AE unrelated to Study Drug|0|||
16948736|NCT01024231|38092352|FG004|Overall Study|AE unrelated to Study Drug|0|||
16948737|NCT01024231|38092353|FG005|Overall Study|AE unrelated to Study Drug|0|||
16948738|NCT01024231|38092354|FG006|Overall Study|AE unrelated to Study Drug|0|||
16948739|NCT01024231|38092348|FG000|Overall Study|No longer meets criteria|0|||
16948740|NCT01024231|38092349|FG001|Overall Study|No longer meets criteria|0|||
16948741|NCT01024231|38092350|FG002|Overall Study|No longer meets criteria|0|||
16948742|NCT01024231|38092351|FG003|Overall Study|No longer meets criteria|0|||
16948743|NCT01024231|38092352|FG004|Overall Study|No longer meets criteria|1|||
16948744|NCT01024231|38092353|FG005|Overall Study|No longer meets criteria|0|||
16948745|NCT01024231|38092354|FG006|Overall Study|No longer meets criteria|1|||
16948746|NCT01024231|38092348|FG000|Overall Study|Study Drug Toxicity|1|||
16948747|NCT01024231|38092349|FG001|Overall Study|Study Drug Toxicity|6|||
16948748|NCT01024231|38092350|FG002|Overall Study|Study Drug Toxicity|6|||
16948749|NCT01024231|38092351|FG003|Overall Study|Study Drug Toxicity|4|||
16948750|NCT01024231|38092352|FG004|Overall Study|Study Drug Toxicity|2|||
16948751|NCT01024231|38092353|FG005|Overall Study|Study Drug Toxicity|0|||
16948752|NCT01024231|38092354|FG006|Overall Study|Study Drug Toxicity|7|||
16948753|NCT01024231|38092348|FG000|Overall Study|Death|6|||
16948754|NCT01024231|38092349|FG001|Overall Study|Death|2|||
16948755|NCT01024231|38092350|FG002|Overall Study|Death|1|||
16948756|NCT01024231|38092351|FG003|Overall Study|Death|0|||
16948757|NCT01024231|38092352|FG004|Overall Study|Death|4|||
16948758|NCT01024231|38092353|FG005|Overall Study|Death|3|||
16948759|NCT01024231|38092354|FG006|Overall Study|Death|5|||
16948760|NCT01024231|38092348|FG000|Overall Study|Lost to Follow-up|0|||
16948761|NCT01024231|38092349|FG001|Overall Study|Lost to Follow-up|0|||
16948762|NCT01024231|38092350|FG002|Overall Study|Lost to Follow-up|0|||
16948763|NCT01024231|38092351|FG003|Overall Study|Lost to Follow-up|0|||
16948764|NCT01024231|38092352|FG004|Overall Study|Lost to Follow-up|0|||
16948765|NCT01024231|38092353|FG005|Overall Study|Lost to Follow-up|0|||
16948766|NCT01024231|38092354|FG006|Overall Study|Lost to Follow-up|1|||
16948767|NCT01024231|38092348|FG000|Overall Study|Withdrew Consent|0|||
16948768|NCT01024231|38092349|FG001|Overall Study|Withdrew Consent|1|||
16948769|NCT01024231|38092350|FG002|Overall Study|Withdrew Consent|0|||
16948770|NCT01024231|38092351|FG003|Overall Study|Withdrew Consent|0|||
16948771|NCT01024231|38092352|FG004|Overall Study|Withdrew Consent|0|||
16948772|NCT01024231|38092353|FG005|Overall Study|Withdrew Consent|0|||
16948773|NCT01024231|38092354|FG006|Overall Study|Withdrew Consent|0|||
16948774|NCT01024231|38092348|FG000|Overall Study|Continuing on Treatment|0|||
16948775|NCT01024231|38092349|FG001|Overall Study|Continuing on Treatment|0|||
16948776|NCT01024231|38092350|FG002|Overall Study|Continuing on Treatment|0|||
16948777|NCT01024231|38092351|FG003|Overall Study|Continuing on Treatment|0|||
16948778|NCT01024231|38092352|FG004|Overall Study|Continuing on Treatment|3|||
16948779|NCT01024231|38092353|FG005|Overall Study|Continuing on Treatment|2|||
16948780|NCT01024231|38092354|FG006|Overall Study|Continuing on Treatment|0|||
16948781|NCT01077544|38092377|FG000|Overall Study|New Cancer Therapy|3|||
16948782|NCT01077544|38092378|FG001|Overall Study|New Cancer Therapy|3|||
16948783|NCT01077544|38092377|FG000|Overall Study|Adverse Event|0|||
16948784|NCT01077544|38092378|FG001|Overall Study|Adverse Event|1|||
16948785|NCT01077544|38092377|FG000|Overall Study|Disease Progression|0|||
16948786|NCT01077544|38092378|FG001|Overall Study|Disease Progression|1|||
16948787|NCT01075516|38092386|FG000|Overall Study|Death|5|||
16948788|NCT01075516|38092387|FG001|Overall Study|Death|9|||
16948789|NCT01075516|38092386|FG000|Overall Study|Lost to Follow-up|10|||
16948790|NCT01075516|38092387|FG001|Overall Study|Lost to Follow-up|2|||
16948791|NCT01075516|38092386|FG000|Overall Study|Withdrawal by Subject|3|||
16948792|NCT01075516|38092387|FG001|Overall Study|Withdrawal by Subject|5|||
16948793|NCT01012999|38092393|FG000|Overall Study|Protocol Violation|1|||
16948794|NCT01017601|38092399|FG000|Overall Study|Disease Progression|12|||
16948795|NCT01017601|38092400|FG001|Overall Study|Disease Progression|12|||
16948796|NCT01017601|38092399|FG000|Overall Study|Withdrawal by Subject|0|||
16948797|NCT01017601|38092400|FG001|Overall Study|Withdrawal by Subject|1|||
16948798|NCT01016977|38092408|FG000|Overall Study|Lost to Follow-up|1|||
16948799|NCT01016977|38092409|FG001|Overall Study|Lost to Follow-up|0|||
16948800|NCT01016977|38092408|FG000|Overall Study|Withdrawal by Subject|2|||
16948801|NCT01016977|38092409|FG001|Overall Study|Withdrawal by Subject|2|||
16948802|NCT01012765|38092418|FG000|Treatment Period 1|Adverse Event|1|||
16948803|NCT01012765|38092419|FG001|Treatment Period 1|Adverse Event|0|||
16948804|NCT01012765|38092420|FG002|Treatment Period 1|Adverse Event|1|||
16948805|NCT01012765|38092421|FG003|Treatment Period 1|Adverse Event|0|||
16948806|NCT01012765|38092422|FG004|Treatment Period 1|Adverse Event|0|||
16948807|NCT01012765|38092423|FG005|Treatment Period 1|Adverse Event|0|||
16948808|NCT01012765|38092418|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16948809|NCT01012765|38092419|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16948810|NCT01012765|38092420|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16948811|NCT01012765|38092421|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16948812|NCT01012765|38092422|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16948813|NCT01012765|38092423|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16948814|NCT01012765|38092418|FG000|Treatment Period 1|Administrative problems|0|||
16948815|NCT01012765|38092419|FG001|Treatment Period 1|Administrative problems|0|||
16948816|NCT01012765|38092420|FG002|Treatment Period 1|Administrative problems|1|||
16948817|NCT01012765|38092421|FG003|Treatment Period 1|Administrative problems|1|||
16948818|NCT01012765|38092422|FG004|Treatment Period 1|Administrative problems|1|||
16948819|NCT01012765|38092423|FG005|Treatment Period 1|Administrative problems|0|||
16948820|NCT01012765|38092418|FG000|Treatment Period 1|Protocol Violation|0|||
16948821|NCT01012765|38092419|FG001|Treatment Period 1|Protocol Violation|0|||
16948822|NCT01012765|38092420|FG002|Treatment Period 1|Protocol Violation|0|||
16948823|NCT01012765|38092421|FG003|Treatment Period 1|Protocol Violation|2|||
16948824|NCT01012765|38092422|FG004|Treatment Period 1|Protocol Violation|1|||
16948825|NCT01012765|38092423|FG005|Treatment Period 1|Protocol Violation|0|||
16948826|NCT01012765|38092418|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16948827|NCT01012765|38092419|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16948828|NCT01012765|38092420|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16948829|NCT01012765|38092421|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16948830|NCT01012765|38092422|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
16948831|NCT01012765|38092423|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16948832|NCT01012765|38092418|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16948833|NCT01012765|38092419|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16948834|NCT01012765|38092420|FG002|Treatment Period 2|Withdrawal by Subject|1|||
16948835|NCT01012765|38092421|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16948836|NCT01012765|38092422|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16948837|NCT01012765|38092423|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16948838|NCT01012765|38092418|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
16948839|NCT01012765|38092419|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
16948840|NCT01012765|38092420|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
16948841|NCT01012765|38092421|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
16948842|NCT01012765|38092422|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
16948843|NCT01012765|38092423|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
16948844|NCT01012765|38092418|FG000|Treatment Period 2|Adverse Event|0|||
16948845|NCT01012765|38092419|FG001|Treatment Period 2|Adverse Event|1|||
16948846|NCT01012765|38092420|FG002|Treatment Period 2|Adverse Event|1|||
16948847|NCT01012765|38092421|FG003|Treatment Period 2|Adverse Event|0|||
16948848|NCT01012765|38092422|FG004|Treatment Period 2|Adverse Event|0|||
16948849|NCT01012765|38092423|FG005|Treatment Period 2|Adverse Event|0|||
16948850|NCT01012765|38092418|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
16948851|NCT01012765|38092419|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
16948852|NCT01012765|38092420|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
16948853|NCT01012765|38092421|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
16948854|NCT01012765|38092422|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
16948855|NCT01012765|38092423|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
16948856|NCT01010503|38092431|FG000|Overall Study|Adverse Event|1|||
16948857|NCT01010503|38092431|FG000|Overall Study|Death|1|||
16948858|NCT01009645|38092439|FG000|Overall Study|Lost to Follow-up|2|||
16948859|NCT01009645|38092440|FG001|Overall Study|Lost to Follow-up|8|||
16948860|NCT01009645|38092441|FG002|Overall Study|Lost to Follow-up|4|||
16948861|NCT01009645|38092442|FG003|Overall Study|Lost to Follow-up|5|||
16948862|NCT01006291|38092455|FG000|Overall Study|Adverse Event|2|||
16948863|NCT01006291|38092456|FG001|Overall Study|Adverse Event|1|||
16948864|NCT01006291|38092457|FG002|Overall Study|Adverse Event|2|||
16948865|NCT01006291|38092455|FG000|Overall Study|Lack of Efficacy|2|||
16948866|NCT01006291|38092456|FG001|Overall Study|Lack of Efficacy|2|||
16948867|NCT01006291|38092457|FG002|Overall Study|Lack of Efficacy|1|||
16948868|NCT01006291|38092455|FG000|Overall Study|Protocol Violation|3|||
16948869|NCT01006291|38092456|FG001|Overall Study|Protocol Violation|3|||
16948870|NCT01006291|38092457|FG002|Overall Study|Protocol Violation|3|||
16948871|NCT01006291|38092455|FG000|Overall Study|Withdrawal criteria|5|||
16948872|NCT01006291|38092456|FG001|Overall Study|Withdrawal criteria|4|||
16948873|NCT01006291|38092457|FG002|Overall Study|Withdrawal criteria|4|||
16948874|NCT01006291|38092455|FG000|Overall Study|Other|14|||
16948875|NCT01006291|38092456|FG001|Overall Study|Other|14|||
16948876|NCT01006291|38092457|FG002|Overall Study|Other|17|||
16948877|NCT01006135|38092465|FG000|Overall Study|Adverse Event|22|||
16948878|NCT01006135|38092465|FG000|Overall Study|Protocol Violation|14|||
16948879|NCT01006135|38092465|FG000|Overall Study|Lost to Follow-up|32|||
16948880|NCT01006135|38092465|FG000|Overall Study|Other|72|||
16948881|NCT01012609|38092471|FG000|Overall Study|Withdrawal by Subject|1|||
16948882|NCT01012609|38092472|FG001|Overall Study|Withdrawal by Subject|1|||
16948883|NCT01012219|38092479|FG000|Period 1|Withdrawal by Subject|1|||
16948884|NCT01012219|38092479|FG000|Period 2|Withdrawal by Subject|1|||
16948885|NCT01011907|38092488|FG000|Overall Study|Withdrawal by Subject|13|||
16948886|NCT01011907|38092489|FG001|Overall Study|Withdrawal by Subject|11|||
16948887|NCT01011907|38092488|FG000|Overall Study|Adverse Event|1|||
16948888|NCT01011907|38092489|FG001|Overall Study|Adverse Event|4|||
16948889|NCT01011673|38092497|FG000|Randomized|Secondary headache|2|||
16948890|NCT01011673|38092498|FG001|Randomized|Secondary headache|1|||
16948891|NCT01011673|38092497|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
16948892|NCT01011673|38092498|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
16948893|NCT01311648|38092507|FG000|Main Study|Protocol Violation|0|||
16948894|NCT01311648|38092508|FG001|Main Study|Protocol Violation|1|||
16948895|NCT01311648|38092507|FG000|Main Study|Adverse Event|0|||
16948896|NCT01311648|38092508|FG001|Main Study|Adverse Event|1|||
16948897|NCT01311648|38092507|FG000|Main Study|Inhibitor management|0|||
16948898|NCT01311648|38092508|FG001|Main Study|Inhibitor management|17|||
16948899|NCT01311648|38092507|FG000|Main Study|Withdrawal by Subject|0|||
16948900|NCT01311648|38092508|FG001|Main Study|Withdrawal by Subject|2|||
16948901|NCT01311648|38092507|FG000|Extension Study|Physician Decision|0|||
16948902|NCT01311648|38092508|FG001|Extension Study|Physician Decision|1|||
16948903|NCT01311648|38092507|FG000|Extension Study|ITI therapy with marketed product|0|||
16948904|NCT01311648|38092508|FG001|Extension Study|ITI therapy with marketed product|1|||
16948905|NCT01311648|38092507|FG000|Extension Study|Incorrect visit planning|0|||
16948906|NCT01311648|38092508|FG001|Extension Study|Incorrect visit planning|1|||
16948907|NCT01311648|38092507|FG000|Extension Study|Family's decision|0|||
16948908|NCT01311648|38092508|FG001|Extension Study|Family's decision|1|||
16948909|NCT01311648|38092507|FG000|Extension Study|Failure of ITI therapy|0|||
16948910|NCT01311648|38092508|FG001|Extension Study|Failure of ITI therapy|3|||
16948911|NCT01311648|38092507|FG000|Extension Study|Long travel|0|||
16948912|NCT01311648|38092508|FG001|Extension Study|Long travel|1|||
16948913|NCT01311648|38092507|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
16948914|NCT01311648|38092508|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
16948915|NCT01311648|38092507|FG000|Extension Study|Withdrawal by Subject|0|||
16948916|NCT01311648|38092508|FG001|Extension Study|Withdrawal by Subject|1|||
16948917|NCT01311648|38092507|FG000|Extension Study|Inhibitor management|0|||
16948918|NCT01311648|38092508|FG001|Extension Study|Inhibitor management|2|||
16948919|NCT01011439|38092521|FG000|Overall Study|Death|37|||
16948920|NCT01011439|38092521|FG000|Overall Study|Lost to Follow-up|4|||
16948921|NCT01011439|38092521|FG000|Overall Study|Withdrawal by Subject|1|||
16948922|NCT01011439|38092521|FG000|Overall Study|Sponsor's decision|15|||
16948923|NCT01311024|38092528|FG000|Overall Study|Protocol Violation|35|||
16948924|NCT01311024|38092529|FG001|Overall Study|Protocol Violation|22|||
16948925|NCT01310868|38092535|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
16948926|NCT01273155|38092543|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
16948927|NCT01273155|38092544|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
16948928|NCT01273155|38092545|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
16948929|NCT01273155|38092546|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
16948930|NCT01273155|38092547|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
16948931|NCT01273155|38092548|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
16948932|NCT01273155|38092549|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
16948933|NCT01273155|38092543|FG000|Overall Study|Change in liver function/no longer eval.|0|||
16948934|NCT01273155|38092544|FG001|Overall Study|Change in liver function/no longer eval.|1|||
16948935|NCT01273155|38092545|FG002|Overall Study|Change in liver function/no longer eval.|0|||
16948936|NCT01273155|38092546|FG003|Overall Study|Change in liver function/no longer eval.|0|||
16948937|NCT01273155|38092547|FG004|Overall Study|Change in liver function/no longer eval.|1|||
16948938|NCT01273155|38092548|FG005|Overall Study|Change in liver function/no longer eval.|0|||
16948939|NCT01273155|38092549|FG006|Overall Study|Change in liver function/no longer eval.|0|||
16948940|NCT01273155|38092543|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
16948941|NCT01273155|38092544|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
16948942|NCT01273155|38092545|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
16948943|NCT01273155|38092546|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
16948944|NCT01273155|38092547|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
16948945|NCT01273155|38092548|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
16948946|NCT01273155|38092549|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
16948947|NCT01273155|38092543|FG000|Overall Study|Died during Cycle 1|0|||
16948948|NCT01273155|38092544|FG001|Overall Study|Died during Cycle 1|0|||
16948949|NCT01273155|38092545|FG002|Overall Study|Died during Cycle 1|1|||
16948950|NCT01273155|38092546|FG003|Overall Study|Died during Cycle 1|1|||
16948951|NCT01273155|38092547|FG004|Overall Study|Died during Cycle 1|0|||
16948952|NCT01273155|38092548|FG005|Overall Study|Died during Cycle 1|2|||
16948953|NCT01273155|38092549|FG006|Overall Study|Died during Cycle 1|2|||
16948954|NCT01273155|38092543|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
16948955|NCT01273155|38092544|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
16948956|NCT01273155|38092545|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
16948957|NCT01273155|38092546|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
16948958|NCT01273155|38092547|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
16948959|NCT01273155|38092548|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
16948960|NCT01273155|38092549|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
16948961|NCT01005901|38092574|FG000|Overall Study|Withdrawal by Subject|38|||
16948962|NCT01005901|38092575|FG001|Overall Study|Withdrawal by Subject|14|||
16948963|NCT01005901|38092574|FG000|Overall Study|Adverse Event|30|||
16948964|NCT01005901|38092575|FG001|Overall Study|Adverse Event|16|||
16948965|NCT01005901|38092574|FG000|Overall Study|Administrative problems|21|||
16948966|NCT01005901|38092575|FG001|Overall Study|Administrative problems|13|||
16948967|NCT01005901|38092574|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
16948968|NCT01005901|38092575|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
16948969|NCT01005901|38092574|FG000|Overall Study|Protocol Violation|4|||
16948970|NCT01005901|38092575|FG001|Overall Study|Protocol Violation|3|||
16948971|NCT01005901|38092574|FG000|Overall Study|Death|2|||
16948972|NCT01005901|38092575|FG001|Overall Study|Death|3|||
16948973|NCT01005901|38092574|FG000|Overall Study|Lost to Follow-up|1|||
16948974|NCT01005901|38092575|FG001|Overall Study|Lost to Follow-up|2|||
16948975|NCT01005901|38092574|FG000|Overall Study|Patient's inability to use the device|1|||
16948976|NCT01005901|38092575|FG001|Overall Study|Patient's inability to use the device|1|||
16948977|NCT01005901|38092574|FG000|Overall Study|No longer requires study drug|0|||
16948978|NCT01005901|38092575|FG001|Overall Study|No longer requires study drug|1|||
16948979|NCT04968925|38092583|FG000|Phase I- Period 1|COVID-19 related|0|||
16948980|NCT04968925|38092584|FG001|Phase I- Period 1|COVID-19 related|1|||
16948981|NCT04968925|38092585|FG002|Phase I- Period 1|COVID-19 related|0|||
16948982|NCT04968925|38092586|FG003|Phase I- Period 1|COVID-19 related|0|||
16948983|NCT04968925|38092583|FG000|Phase I- Period 1|Subject enrolled in error|1|||
16948984|NCT04968925|38092584|FG001|Phase I- Period 1|Subject enrolled in error|1|||
16948985|NCT04968925|38092585|FG002|Phase I- Period 1|Subject enrolled in error|0|||
16948986|NCT04968925|38092586|FG003|Phase I- Period 1|Subject enrolled in error|0|||
16948987|NCT04968925|38092583|FG000|Phase II- Period 1|COVID-19 Related|0|||
16948988|NCT04968925|38092584|FG001|Phase II- Period 1|COVID-19 Related|0|||
16948989|NCT04968925|38092585|FG002|Phase II- Period 1|COVID-19 Related|6|||
16948990|NCT04968925|38092586|FG003|Phase II- Period 1|COVID-19 Related|6|||
16948991|NCT04968925|38092583|FG000|Phase II- Period 1|Subject enrolled in error|0|||
16948992|NCT04968925|38092584|FG001|Phase II- Period 1|Subject enrolled in error|0|||
16948993|NCT04968925|38092585|FG002|Phase II- Period 1|Subject enrolled in error|1|||
16948994|NCT04968925|38092586|FG003|Phase II- Period 1|Subject enrolled in error|0|||
16948995|NCT04968925|38092583|FG000|Phase II -Period 2|COVID-19 related|0|||
16948996|NCT04968925|38092584|FG001|Phase II -Period 2|COVID-19 related|0|||
16948997|NCT04968925|38092585|FG002|Phase II -Period 2|COVID-19 related|4|||
16948998|NCT04968925|38092586|FG003|Phase II -Period 2|COVID-19 related|3|||
16948999|NCT04968925|38092583|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
16949000|NCT04968925|38092584|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
16949001|NCT04968925|38092585|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
16949002|NCT04968925|38092586|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
16949003|NCT01266993|38092598|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
16949004|NCT01266993|38092599|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
16949005|NCT01266993|38092598|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
16949006|NCT01266993|38092599|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
16949007|NCT01309386|38092607|FG000|Overall Study|Other|2|||
16949008|NCT01309386|38092608|FG001|Overall Study|Other|0|||
16949009|NCT01309386|38092607|FG000|Overall Study|Withdrawal by Subject|2|||
16949010|NCT01309386|38092608|FG001|Overall Study|Withdrawal by Subject|0|||
16949011|NCT01309386|38092607|FG000|Overall Study|Progressive disease|9|||
16949012|NCT01309386|38092608|FG001|Overall Study|Progressive disease|11|||
16949013|NCT01309386|38092607|FG000|Overall Study|Physician Decision|1|||
16949014|NCT01309386|38092608|FG001|Overall Study|Physician Decision|1|||
16949015|NCT01309386|38092607|FG000|Overall Study|Lack of Efficacy|3|||
16949016|NCT01309386|38092608|FG001|Overall Study|Lack of Efficacy|1|||
16949017|NCT01309386|38092607|FG000|Overall Study|Adverse Event|5|||
16949018|NCT01309386|38092608|FG001|Overall Study|Adverse Event|8|||
16949019|NCT01266603|38092614|FG000|Overall Study|Adverse Event|1|||
16949020|NCT01266603|38092614|FG000|Overall Study|Lack of Efficacy|14|||
16949021|NCT01266603|38092614|FG000|Overall Study|Withdrawal by Subject|1|||
16949022|NCT01266603|38092614|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
16949023|NCT01309308|38092620|FG000|Overall Study|Lost to Follow-up|6|||
16949024|NCT01309308|38092621|FG001|Overall Study|Lost to Follow-up|4|||
16949025|NCT01266291|38092627|FG000|Overall Study|Adverse Event|1|||
16949026|NCT01004263|38092631|FG000|Overall Study|Adverse Event|15|||
16949027|NCT01004263|38092631|FG000|Overall Study|Withdrawal by Subject|58|||
16949028|NCT01004263|38092631|FG000|Overall Study|Protocol Violation|10|||
16949029|NCT01004263|38092631|FG000|Overall Study|Lost to Follow-up|64|||
16949030|NCT01004263|38092631|FG000|Overall Study|Lack of Efficacy|13|||
16949031|NCT01004263|38092631|FG000|Overall Study|Pregnancy|2|||
16949032|NCT01004263|38092631|FG000|Overall Study|Physician Decision|15|||
16949033|NCT01004263|38092631|FG000|Overall Study|Lack of Qualifying Event|2|||
16949034|NCT01308762|38092638|FG000|Overall Study|Protocol Violation|0|||
16949035|NCT01308762|38092639|FG001|Overall Study|Protocol Violation|1|||
16949036|NCT01308762|38092640|FG002|Overall Study|Protocol Violation|0|||
16949037|NCT01265823|38092651|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
16949038|NCT01265823|38092651|FG000|Overall Study|Failure to Return|4|||
16949039|NCT01265823|38092651|FG000|Overall Study|Protocol Violation|1|||
16949040|NCT01265823|38092651|FG000|Overall Study|Participant Request|1|||
16949041|NCT01004185|38092661|FG000|Overall Study|Adverse Event|1|||
16949042|NCT01004185|38092662|FG001|Overall Study|Adverse Event|1|||
16949043|NCT01004185|38092661|FG000|Overall Study|Lost to Follow-up|0|||
16949044|NCT01004185|38092662|FG001|Overall Study|Lost to Follow-up|1|||
16949045|NCT01004185|38092661|FG000|Overall Study|Lack of Efficacy|2|||
16949046|NCT01004185|38092662|FG001|Overall Study|Lack of Efficacy|1|||
16949047|NCT01004185|38092661|FG000|Overall Study|Sponsor Terminated Study|4|||
16949048|NCT01004185|38092662|FG001|Overall Study|Sponsor Terminated Study|5|||
16949049|NCT01004185|38092661|FG000|Overall Study|Withdrawal by Subject|2|||
16949050|NCT01004185|38092662|FG001|Overall Study|Withdrawal by Subject|1|||
16949051|NCT01265511|38092670|FG000|Overall Study|Lack of Efficacy|2|||
16949052|NCT01265511|38092671|FG001|Overall Study|Lack of Efficacy|1|||
16949053|NCT01265511|38092670|FG000|Overall Study|Met stopping rules|0|||
16949054|NCT01265511|38092671|FG001|Overall Study|Met stopping rules|2|||
16949055|NCT01264965|38092677|FG000|Overall Study|Withdrawal by Subject|10|||
16949056|NCT01264887|38092681|FG000|Overall Study|Adverse Event|5|||
16949057|NCT01264887|38092681|FG000|Overall Study|Death|7|||
16949058|NCT01264887|38092681|FG000|Overall Study|Lack of Efficacy|5|||
16949059|NCT01264887|38092681|FG000|Overall Study|Physician Decision|4|||
16949060|NCT01264887|38092681|FG000|Overall Study|Withdrawal by Subject|6|||
16949061|NCT01264887|38092681|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
16949062|NCT01264887|38092681|FG000|Overall Study|Other|2|||
16949063|NCT01306968|38092691|FG000|Overall Study|Lost to Follow-up|1|||
16949064|NCT01306968|38092692|FG001|Overall Study|Lost to Follow-up|1|||
16949065|NCT01306968|38092693|FG002|Overall Study|Lost to Follow-up|0|||
16949066|NCT01306968|38092694|FG003|Overall Study|Lost to Follow-up|0|||
16949067|NCT01306968|38092691|FG000|Overall Study|Physician Decision|0|||
16949068|NCT01306968|38092692|FG001|Overall Study|Physician Decision|1|||
16949069|NCT01306968|38092693|FG002|Overall Study|Physician Decision|0|||
16949070|NCT01306968|38092694|FG003|Overall Study|Physician Decision|0|||
16949071|NCT01306968|38092691|FG000|Overall Study|Relocated and left active duty|0|||
16949072|NCT01306968|38092692|FG001|Overall Study|Relocated and left active duty|1|||
16949073|NCT01306968|38092693|FG002|Overall Study|Relocated and left active duty|1|||
16949074|NCT01306968|38092694|FG003|Overall Study|Relocated and left active duty|1|||
16949075|NCT01306968|38092691|FG000|Overall Study|Withdrew - time commitment|0|||
16949076|NCT01306968|38092692|FG001|Overall Study|Withdrew - time commitment|0|||
16949077|NCT01306968|38092693|FG002|Overall Study|Withdrew - time commitment|0|||
16949078|NCT01306968|38092694|FG003|Overall Study|Withdrew - time commitment|2|||
16949079|NCT01306968|38092691|FG000|Overall Study|Withdrew over privacy concerns|0|||
16949080|NCT01306968|38092692|FG001|Overall Study|Withdrew over privacy concerns|0|||
16949081|NCT01306968|38092693|FG002|Overall Study|Withdrew over privacy concerns|0|||
16949082|NCT01306968|38092694|FG003|Overall Study|Withdrew over privacy concerns|1|||
16949083|NCT01264419|38092706|FG000|Overall Study|Lost to Follow-up|3|||
16949084|NCT01263873|38092712|FG000|Overall Study|One provider unable to complete numbers|1|||
16949085|NCT01263873|38092713|FG001|Overall Study|One provider unable to complete numbers|1|||
16949086|NCT01263639|38092721|FG000|Overall Study|Lost to Follow-up|66|||
16949087|NCT01263639|38092722|FG001|Overall Study|Lost to Follow-up|70|||
16949088|NCT01263639|38092721|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
16949089|NCT01263639|38092722|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
16949090|NCT01011283|38092730|FG000|Overall Study|Adverse Event|4|||
16949091|NCT01011283|38092731|FG001|Overall Study|Adverse Event|2|||
16949092|NCT01011283|38092730|FG000|Overall Study|Progressive Disease|0|||
16949093|NCT01011283|38092731|FG001|Overall Study|Progressive Disease|2|||
16949094|NCT01011283|38092730|FG000|Overall Study|Terminated by Sponsor|5|||
16949095|NCT01011283|38092731|FG001|Overall Study|Terminated by Sponsor|5|||
16949096|NCT01011283|38092730|FG000|Overall Study|Other|2|||
16949097|NCT01011283|38092731|FG001|Overall Study|Other|2|||
16949098|NCT01263561|38092739|FG000|Overall Study|Death|1|||
16949099|NCT01263561|38092740|FG001|Overall Study|Death|2|||
16949100|NCT01009099|38092748|FG000|Overall Study|Lost to Follow-up|1|||
16949101|NCT01009099|38092749|FG001|Overall Study|Lost to Follow-up|0|||
16949102|NCT01009099|38092748|FG000|Overall Study|Physician Decision|3|||
16949103|NCT01009099|38092749|FG001|Overall Study|Physician Decision|2|||
16949104|NCT01009099|38092748|FG000|Overall Study|Withdrawal by Subject|1|||
16949105|NCT01009099|38092749|FG001|Overall Study|Withdrawal by Subject|1|||
16949106|NCT01009099|38092748|FG000|Overall Study|Death|0|||
16949107|NCT01009099|38092749|FG001|Overall Study|Death|1|||
16949108|NCT01263483|38092758|FG000|Overall Study|Adverse Event|4|||
16949109|NCT01263483|38092759|FG001|Overall Study|Adverse Event|0|||
16949110|NCT01263483|38092760|FG002|Overall Study|Adverse Event|3|||
16949111|NCT01263483|38092758|FG000|Overall Study|Withdrawal by Subject|1|||
16949112|NCT01263483|38092759|FG001|Overall Study|Withdrawal by Subject|0|||
16949113|NCT01263483|38092760|FG002|Overall Study|Withdrawal by Subject|0|||
16949114|NCT01263483|38092758|FG000|Overall Study|Lack of Efficacy|2|||
16949115|NCT01263483|38092759|FG001|Overall Study|Lack of Efficacy|0|||
16949116|NCT01263483|38092760|FG002|Overall Study|Lack of Efficacy|0|||
16949117|NCT01263483|38092758|FG000|Overall Study|Protocol Violation|0|||
16949118|NCT01263483|38092759|FG001|Overall Study|Protocol Violation|1|||
16949119|NCT01263483|38092760|FG002|Overall Study|Protocol Violation|1|||
16949120|NCT01263483|38092758|FG000|Overall Study|Participant Unavailability|0|||
16949121|NCT01263483|38092759|FG001|Overall Study|Participant Unavailability|1|||
16949122|NCT01263483|38092760|FG002|Overall Study|Participant Unavailability|1|||
16949123|NCT01306890|38092768|FG000|Overall Study|Adverse Event|2|||
16949124|NCT01306890|38092768|FG000|Overall Study|Death|1223|||
16949125|NCT01306890|38092768|FG000|Overall Study|Lost to Follow-up|58|||
16949126|NCT01306890|38092768|FG000|Overall Study|Withdrawal by Subject|88|||
16949127|NCT01306890|38092768|FG000|Overall Study|Unspecified reasons|104|||
16949128|NCT01306890|38092768|FG000|Overall Study|Study Termination|3|||
16949129|NCT01306890|38092768|FG000|Overall Study|No discontinuation documentation|41|||
16949130|NCT01011049|38092776|FG000|Overall Study|Protocol Violation|0|||
16949131|NCT01011049|38092777|FG001|Overall Study|Protocol Violation|0|||
16949132|NCT01011049|38092778|FG002|Overall Study|Protocol Violation|2|||
16949133|NCT01011049|38092779|FG003|Overall Study|Protocol Violation|0|||
16949134|NCT01011049|38092776|FG000|Overall Study|Lost to Follow-up|1|||
16949135|NCT01011049|38092777|FG001|Overall Study|Lost to Follow-up|2|||
16949136|NCT01011049|38092778|FG002|Overall Study|Lost to Follow-up|1|||
16949137|NCT01011049|38092779|FG003|Overall Study|Lost to Follow-up|0|||
16949138|NCT01011049|38092776|FG000|Overall Study|Withdrawal by Subject|0|||
16949139|NCT01011049|38092777|FG001|Overall Study|Withdrawal by Subject|0|||
16949140|NCT01011049|38092778|FG002|Overall Study|Withdrawal by Subject|1|||
16949141|NCT01011049|38092779|FG003|Overall Study|Withdrawal by Subject|0|||
16949142|NCT01263093|38092791|FG000|Washout|Physician Decision|1|||
16949143|NCT01263093|38092792|FG001|Washout|Physician Decision|0|||
16949144|NCT01263093|38092791|FG000|Period 2|Adverse Event|1|||
16949145|NCT01263093|38092792|FG001|Period 2|Adverse Event|0|||
16949146|NCT01010971|38092802|FG000|Overall Study|Adverse Event|2|||
16949147|NCT01010971|38092803|FG001|Overall Study|Adverse Event|4|||
16949148|NCT01010971|38092804|FG002|Overall Study|Adverse Event|3|||
16949149|NCT01010971|38092802|FG000|Overall Study|Withdrawal by Subject|0|||
16949150|NCT01010971|38092803|FG001|Overall Study|Withdrawal by Subject|2|||
16949151|NCT01010971|38092804|FG002|Overall Study|Withdrawal by Subject|5|||
16949152|NCT01010971|38092802|FG000|Overall Study|Lost to Follow-up|0|||
16949153|NCT01010971|38092803|FG001|Overall Study|Lost to Follow-up|2|||
16949154|NCT01010971|38092804|FG002|Overall Study|Lost to Follow-up|3|||
16949155|NCT01010971|38092802|FG000|Overall Study|Other|1|||
16949156|NCT01010971|38092803|FG001|Overall Study|Other|0|||
16949157|NCT01010971|38092804|FG002|Overall Study|Other|2|||
16949158|NCT01306656|38092814|FG000|Overall Study|Lost to Follow-up|1|||
16949159|NCT01306656|38092815|FG001|Overall Study|Lost to Follow-up|0|||
16949160|NCT01008943|38092823|FG000|Overall Study|Withdrawal by Subject|1|||
16949161|NCT01003639|38092829|FG000|Overall Study|Lost to Follow-up|6|||
16949162|NCT01003639|38092830|FG001|Overall Study|Lost to Follow-up|9|||
16949163|NCT01003639|38092829|FG000|Overall Study|Withdrawal by Subject|9|||
16949164|NCT01003639|38092830|FG001|Overall Study|Withdrawal by Subject|5|||
16949165|NCT01003639|38092829|FG000|Overall Study|Lack of Efficacy|1|||
16949166|NCT01003639|38092830|FG001|Overall Study|Lack of Efficacy|6|||
16949167|NCT01003639|38092829|FG000|Overall Study|Adverse Event|0|||
16949168|NCT01003639|38092830|FG001|Overall Study|Adverse Event|1|||
16949169|NCT01003639|38092829|FG000|Overall Study|Protocol Violation|0|||
16949170|NCT01003639|38092830|FG001|Overall Study|Protocol Violation|1|||
16949171|NCT01003639|38092829|FG000|Overall Study|Physician Decision|1|||
16949172|NCT01003639|38092830|FG001|Overall Study|Physician Decision|0|||
16949173|NCT01003249|38092836|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16949174|NCT01003249|38092837|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16949175|NCT01003249|38092836|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
16949176|NCT01003249|38092837|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
16949177|NCT01003249|38092836|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16949178|NCT01003249|38092837|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16949179|NCT01003249|38092836|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
16949180|NCT01003249|38092837|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
16949181|NCT01001767|38092849|FG000|Overall Study|no baseline study performed|1|||
16949182|NCT01001767|38092850|FG001|Overall Study|no baseline study performed|0|||
16949183|NCT01001767|38092849|FG000|Overall Study|Protocol Violation|1|||
16949184|NCT01001767|38092850|FG001|Overall Study|Protocol Violation|0|||
16949185|NCT01001767|38092849|FG000|Overall Study|Lost to Follow-up|1|||
16949186|NCT01001767|38092850|FG001|Overall Study|Lost to Follow-up|0|||
16949187|NCT01001767|38092849|FG000|Overall Study|Physician Decision|1|||
16949188|NCT01001767|38092850|FG001|Overall Study|Physician Decision|0|||
16949189|NCT01306032|38092862|FG000|First Intervention|Adverse Event|1|||
16949190|NCT01306032|38092863|FG001|First Intervention|Adverse Event|0|||
16949191|NCT01306032|38092864|FG002|First Intervention|Adverse Event|1|||
16949192|NCT01306032|38092865|FG003|First Intervention|Adverse Event|0|||
16949193|NCT01306032|38092866|FG004|First Intervention|Adverse Event|0|||
16949194|NCT01306032|38092867|FG005|First Intervention|Adverse Event|1|||
16949195|NCT01306032|38092862|FG000|First Intervention|Withdrawal by Subject|0|||
16949196|NCT01306032|38092863|FG001|First Intervention|Withdrawal by Subject|2|||
16949197|NCT01306032|38092864|FG002|First Intervention|Withdrawal by Subject|0|||
16949198|NCT01306032|38092865|FG003|First Intervention|Withdrawal by Subject|1|||
16949199|NCT01306032|38092866|FG004|First Intervention|Withdrawal by Subject|0|||
16949200|NCT01306032|38092867|FG005|First Intervention|Withdrawal by Subject|0|||
16949201|NCT01306032|38092862|FG000|First Intervention|Death|0|||
16949202|NCT01306032|38092863|FG001|First Intervention|Death|0|||
16949203|NCT01306032|38092864|FG002|First Intervention|Death|1|||
16949204|NCT01306032|38092865|FG003|First Intervention|Death|0|||
16949205|NCT01306032|38092866|FG004|First Intervention|Death|0|||
16949206|NCT01306032|38092867|FG005|First Intervention|Death|0|||
16949207|NCT01306032|38092862|FG000|First Intervention|Ineligible|0|||
16949208|NCT01306032|38092863|FG001|First Intervention|Ineligible|0|||
16949209|NCT01306032|38092864|FG002|First Intervention|Ineligible|0|||
16949210|NCT01306032|38092865|FG003|First Intervention|Ineligible|0|||
16949211|NCT01306032|38092866|FG004|First Intervention|Ineligible|0|||
16949212|NCT01306032|38092867|FG005|First Intervention|Ineligible|1|||
16949213|NCT01306032|38092862|FG000|First Intervention|Progressive disease|0|||
16949214|NCT01306032|38092863|FG001|First Intervention|Progressive disease|0|||
16949215|NCT01306032|38092864|FG002|First Intervention|Progressive disease|0|||
16949216|NCT01306032|38092865|FG003|First Intervention|Progressive disease|0|||
16949217|NCT01306032|38092866|FG004|First Intervention|Progressive disease|2|||
16949218|NCT01306032|38092867|FG005|First Intervention|Progressive disease|0|||
16949219|NCT01306032|38092862|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
16949220|NCT01306032|38092863|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
16949221|NCT01306032|38092864|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
16949222|NCT01306032|38092865|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
16949223|NCT01306032|38092866|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
16949224|NCT01306032|38092867|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
16949225|NCT01306032|38092862|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
16949226|NCT01306032|38092863|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
16949227|NCT01306032|38092864|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
16949228|NCT01306032|38092865|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
16949229|NCT01306032|38092866|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
16949230|NCT01306032|38092867|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
16949231|NCT01263015|38092895|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
16949232|NCT01263015|38092896|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
16949233|NCT01263015|38092895|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
16949234|NCT01263015|38092896|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
16949235|NCT01263015|38092895|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
16949236|NCT01263015|38092896|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
16949237|NCT01263015|38092895|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
16949238|NCT01263015|38092896|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
16949239|NCT01263015|38092895|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
16949240|NCT01263015|38092896|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
16949241|NCT01263015|38092895|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
16949242|NCT01263015|38092896|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
16949243|NCT01263015|38092895|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
16949244|NCT01263015|38092896|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
16949245|NCT01263015|38092895|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
16949246|NCT01263015|38092896|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
16949247|NCT01263015|38092895|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
16949248|NCT01263015|38092896|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
16949249|NCT01263015|38092895|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
16949250|NCT01263015|38092896|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
16949251|NCT01263015|38092895|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
16949252|NCT01263015|38092896|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
16949253|NCT01263015|38092895|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
16949254|NCT01263015|38092896|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
16949255|NCT01305564|38092902|FG000|Overall Study|Death|21|||
16949256|NCT01305564|38092902|FG000|Overall Study|Lost to Follow-up|12|||
16949257|NCT01305564|38092902|FG000|Overall Study|Withdrawal by Subject|1|||
16949258|NCT01305564|38092902|FG000|Overall Study|Physician Decision|3|||
16949259|NCT01305408|38092919|FG000|Overall Study|Adverse Event|10|||
16949260|NCT01305408|38092920|FG001|Overall Study|Adverse Event|7|||
16949261|NCT01305408|38092919|FG000|Overall Study|Lack of Efficacy|3|||
16949262|NCT01305408|38092920|FG001|Overall Study|Lack of Efficacy|4|||
16949263|NCT01305408|38092919|FG000|Overall Study|Withdrawal by Subject|9|||
16949264|NCT01305408|38092920|FG001|Overall Study|Withdrawal by Subject|9|||
16949265|NCT01305408|38092919|FG000|Overall Study|Protocol Violation|4|||
16949266|NCT01305408|38092920|FG001|Overall Study|Protocol Violation|6|||
16949267|NCT01305408|38092919|FG000|Overall Study|Lost to Follow-up|5|||
16949268|NCT01305408|38092920|FG001|Overall Study|Lost to Follow-up|3|||
16949269|NCT01305408|38092919|FG000|Overall Study|Noncompliance with study medication|0|||
16949270|NCT01305408|38092920|FG001|Overall Study|Noncompliance with study medication|1|||
16949271|NCT01305408|38092919|FG000|Overall Study|Noncompliance with study procedures|0|||
16949272|NCT01305408|38092920|FG001|Overall Study|Noncompliance with study procedures|1|||
16949273|NCT01305408|38092919|FG000|Overall Study|Other|1|||
16949274|NCT01305408|38092920|FG001|Overall Study|Other|0|||
16949275|NCT01304940|38092928|FG000|Overall Study|not meet symptom severity requirement|3|||
16949276|NCT01304940|38092929|FG001|Overall Study|not meet symptom severity requirement|0|||
16949277|NCT01261611|38092938|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
16949278|NCT01261611|38092939|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
16949279|NCT01261611|38092940|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
16949280|NCT01261611|38092938|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
16949281|NCT01261611|38092939|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
16949282|NCT01261611|38092940|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
16949283|NCT01261611|38092938|FG000|Treatment Cycle 1|Adverse Event|0|||
16949284|NCT01261611|38092939|FG001|Treatment Cycle 1|Adverse Event|1|||
16949285|NCT01261611|38092940|FG002|Treatment Cycle 1|Adverse Event|0|||
16949286|NCT01261611|38092938|FG000|Treatment Cycle 1|Protocol Violation|0|||
16949287|NCT01261611|38092939|FG001|Treatment Cycle 1|Protocol Violation|0|||
16949288|NCT01261611|38092940|FG002|Treatment Cycle 1|Protocol Violation|2|||
16949289|NCT01261611|38092938|FG000|Treatment Cycle 2|Completed study|4|||
16949290|NCT01261611|38092939|FG001|Treatment Cycle 2|Completed study|0|||
16949291|NCT01261611|38092940|FG002|Treatment Cycle 2|Completed study|0|||
16949292|NCT01261611|38092938|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
16949293|NCT01261611|38092939|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
16949294|NCT01261611|38092940|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
16949295|NCT01261611|38092938|FG000|Treatment Cycle 2|Adverse Event|1|||
16949296|NCT01261611|38092939|FG001|Treatment Cycle 2|Adverse Event|0|||
16949297|NCT01261611|38092940|FG002|Treatment Cycle 2|Adverse Event|0|||
16949298|NCT01261611|38092938|FG000|Treatment Cycle 2|Protocol Violation|2|||
16949299|NCT01261611|38092939|FG001|Treatment Cycle 2|Protocol Violation|0|||
16949300|NCT01261611|38092940|FG002|Treatment Cycle 2|Protocol Violation|0|||
16949301|NCT01261611|38092938|FG000|Treatment Cycle 2|Not otherwise specified|2|||
16949302|NCT01261611|38092939|FG001|Treatment Cycle 2|Not otherwise specified|0|||
16949303|NCT01261611|38092940|FG002|Treatment Cycle 2|Not otherwise specified|0|||
16949304|NCT01261611|38092938|FG000|Treatment Cycle 3|Completed study|24|||
16949305|NCT01261611|38092939|FG001|Treatment Cycle 3|Completed study|0|||
16949306|NCT01261611|38092940|FG002|Treatment Cycle 3|Completed study|0|||
16949307|NCT01261611|38092938|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
16949308|NCT01261611|38092939|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
16949309|NCT01261611|38092940|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
16949310|NCT01261611|38092938|FG000|Treatment Cycle 3|Adverse Event|1|||
16949311|NCT01261611|38092939|FG001|Treatment Cycle 3|Adverse Event|0|||
16949312|NCT01261611|38092940|FG002|Treatment Cycle 3|Adverse Event|0|||
16949313|NCT01261611|38092938|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
16949314|NCT01261611|38092939|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
16949315|NCT01261611|38092940|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
16949316|NCT01261611|38092938|FG000|Treatment Cycle 4|Completed study|87|||
16949317|NCT01261611|38092939|FG001|Treatment Cycle 4|Completed study|0|||
16949318|NCT01261611|38092940|FG002|Treatment Cycle 4|Completed study|0|||
16949319|NCT01261611|38092938|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
16949320|NCT01261611|38092939|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
16949321|NCT01261611|38092940|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
16949322|NCT01261611|38092938|FG000|Treatment Cycle 4|Adverse Event|1|||
16949323|NCT01261611|38092939|FG001|Treatment Cycle 4|Adverse Event|0|||
16949324|NCT01261611|38092940|FG002|Treatment Cycle 4|Adverse Event|0|||
16949325|NCT01261611|38092938|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
16949326|NCT01261611|38092939|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
16949327|NCT01261611|38092940|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
16949328|NCT01261611|38092938|FG000|Treatment Cycle 4|Not otherwise specified|3|||
16949329|NCT01261611|38092939|FG001|Treatment Cycle 4|Not otherwise specified|0|||
16949330|NCT01261611|38092940|FG002|Treatment Cycle 4|Not otherwise specified|0|||
16949331|NCT01261611|38092938|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
16949332|NCT01261611|38092939|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
16949333|NCT01261611|38092940|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
16949334|NCT01261611|38092938|FG000|Treatment Cycle 5|Adverse Event|1|||
16949335|NCT01261611|38092939|FG001|Treatment Cycle 5|Adverse Event|0|||
16949336|NCT01261611|38092940|FG002|Treatment Cycle 5|Adverse Event|0|||
16949337|NCT01261611|38092938|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
16949338|NCT01261611|38092939|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
16949339|NCT01261611|38092940|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
16949340|NCT01304706|38092952|FG000|Overall Study|Adverse Event|2|||
16949341|NCT01304706|38092952|FG000|Overall Study|Lack of Efficacy|1|||
16949342|NCT01304706|38092952|FG000|Overall Study|Death|3|||
16949343|NCT01304706|38092952|FG000|Overall Study|Withdrawal by Subject|3|||
16949344|NCT01304706|38092952|FG000|Overall Study|Lost to Follow-up|7|||
16949345|NCT01304706|38092952|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
16949346|NCT01303380|38092956|FG000|Overall Study|Lack of compliance to study procedures|1|||
16949347|NCT01008553|38092960|FG000|Period 1 (Titration Period)|Physician Decision|2|||
16949348|NCT01008553|38092961|FG001|Period 1 (Titration Period)|Physician Decision|0|||
16949349|NCT01008553|38092962|FG002|Period 1 (Titration Period)|Physician Decision|0|||
16949350|NCT01008553|38092960|FG000|Period 1 (Titration Period)|Adverse Event|33|||
16949351|NCT01008553|38092961|FG001|Period 1 (Titration Period)|Adverse Event|0|||
16949352|NCT01008553|38092962|FG002|Period 1 (Titration Period)|Adverse Event|0|||
16949353|NCT01008553|38092960|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
16949354|NCT01008553|38092961|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
16949355|NCT01008553|38092962|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
16949356|NCT01008553|38092960|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
16949357|NCT01008553|38092961|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
16949358|NCT01008553|38092962|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
16949359|NCT01008553|38092960|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
16949360|NCT01008553|38092961|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
16949361|NCT01008553|38092962|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
16949362|NCT01008553|38092960|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
16949363|NCT01008553|38092961|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
16949364|NCT01008553|38092962|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
16949365|NCT01008553|38092960|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
16949366|NCT01008553|38092961|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
16949367|NCT01008553|38092962|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
16949368|NCT01008553|38092960|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
16949369|NCT01008553|38092961|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
16949370|NCT01008553|38092962|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
16949371|NCT01008553|38092960|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
16949372|NCT01008553|38092961|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
16949373|NCT01008553|38092962|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
16949374|NCT01008553|38092960|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
16949375|NCT01008553|38092961|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
16949376|NCT01008553|38092962|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
16949377|NCT01008553|38092960|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
16949378|NCT01008553|38092961|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
16949379|NCT01008553|38092962|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
16949380|NCT01008553|38092960|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
16949381|NCT01008553|38092961|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
16949382|NCT01008553|38092962|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
16949383|NCT01008553|38092960|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
16949384|NCT01008553|38092961|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
16949385|NCT01008553|38092962|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
16949386|NCT01008553|38092960|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
16949387|NCT01008553|38092961|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
16949388|NCT01008553|38092962|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
16949389|NCT01302834|38092973|FG000|Overall Study|Protocol Violation|17|||
16949390|NCT01302834|38092974|FG001|Overall Study|Protocol Violation|23|||
16949391|NCT01302834|38092973|FG000|Overall Study|HIV positive|1|||
16949392|NCT01302834|38092974|FG001|Overall Study|HIV positive|3|||
16949393|NCT01259115|38092980|FG000|Period 1|Adverse Event|1|||
16949394|NCT01259115|38092981|FG001|Period 1|Adverse Event|0|||
16949395|NCT01259115|38092980|FG000|Period 1|Protocol Violation|2|||
16949396|NCT01259115|38092981|FG001|Period 1|Protocol Violation|0|||
16949397|NCT01259115|38092980|FG000|Period 1|Lost to Follow-up|0|||
16949398|NCT01259115|38092981|FG001|Period 1|Lost to Follow-up|1|||
16949399|NCT01259115|38092980|FG000|Period 2|Adverse Event|1|||
16949400|NCT01259115|38092981|FG001|Period 2|Adverse Event|0|||
16949401|NCT01302366|38092992|FG000|Overall Study|patient choice or noncompliance|5|||
16949402|NCT01302054|38092996|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
16949403|NCT01302054|38092997|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
16949404|NCT01302054|38092998|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
16949405|NCT01302054|38092996|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
16949406|NCT01302054|38092997|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
16949407|NCT01302054|38092998|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
16949408|NCT01302054|38092996|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
16949409|NCT01302054|38092997|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
16949410|NCT01302054|38092998|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
16949411|NCT01302054|38092996|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
16949412|NCT01302054|38092997|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
16949413|NCT01302054|38092998|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
16949414|NCT01302054|38092996|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
16949415|NCT01302054|38092997|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
16949416|NCT01302054|38092998|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
16774194|NCT02452892|37713490|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
16949417|NCT01302054|38092996|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
16949418|NCT01302054|38092997|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
16949419|NCT01302054|38092998|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
16949420|NCT01302054|38092996|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
16949421|NCT01302054|38092997|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
16949422|NCT01302054|38092998|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
16949423|NCT01302054|38092996|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
16949424|NCT01302054|38092997|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
16949425|NCT01302054|38092998|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
16949426|NCT01302054|38092996|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16949427|NCT01302054|38092997|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
16949428|NCT01302054|38092998|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
16949429|NCT01302054|38092996|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16949430|NCT01302054|38092997|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
16949431|NCT01302054|38092998|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16949432|NCT01302054|38092996|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16949433|NCT01302054|38092997|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
16949434|NCT01302054|38092998|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
16949435|NCT01302054|38092996|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
16949436|NCT01302054|38092997|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
16949437|NCT01302054|38092998|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
16949438|NCT01302054|38092996|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
16949439|NCT01302054|38092997|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
16949440|NCT01302054|38092998|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
16949441|NCT01302054|38092996|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
16949442|NCT01302054|38092997|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
16949443|NCT01302054|38092998|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
16949444|NCT01302054|38092996|FG000|Double-Blind Treatment Phase|Other|0|||
16949445|NCT01302054|38092997|FG001|Double-Blind Treatment Phase|Other|4|||
16949446|NCT01302054|38092998|FG002|Double-Blind Treatment Phase|Other|9|||
16949447|NCT01301508|38093009|FG000|Overall Study|Withdrawal by Subject|1|||
16949448|NCT01301508|38093010|FG001|Overall Study|Withdrawal by Subject|2|||
16949449|NCT01301508|38093009|FG000|Overall Study|Lost to Follow-up|0|||
16949450|NCT01301508|38093010|FG001|Overall Study|Lost to Follow-up|1|||
16949451|NCT01301274|38093018|FG000|Overall Study|Physician Decision|2|||
16949452|NCT01301274|38093019|FG001|Overall Study|Physician Decision|1|||
16949453|NCT01300650|38093030|FG000|Overall Study|Adverse Event|1|||
16949454|NCT01300572|38093035|FG000|Overall Study|HAMA + post dosimetry|1|||
16949455|NCT01077154|38093042|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
16949456|NCT01077154|38093043|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
16949457|NCT01077154|38093042|FG000|Overall Study|Withdrawal by Subject|369|||
16949458|NCT01077154|38093043|FG001|Overall Study|Withdrawal by Subject|385|||
16949459|NCT01077154|38093042|FG000|Overall Study|Death|215|||
16949460|NCT01077154|38093043|FG001|Overall Study|Death|214|||
16949461|NCT01077154|38093042|FG000|Overall Study|Lost to Follow-up|43|||
16949462|NCT01077154|38093043|FG001|Overall Study|Lost to Follow-up|35|||
16949463|NCT01077154|38093042|FG000|Overall Study|Noncompliance|22|||
16949464|NCT01077154|38093043|FG001|Overall Study|Noncompliance|20|||
16949465|NCT01077154|38093042|FG000|Overall Study|Disease Progression|18|||
16949466|NCT01077154|38093043|FG001|Overall Study|Disease Progression|20|||
16949467|NCT01077154|38093042|FG000|Overall Study|Ineligibility Determined|10|||
16949468|NCT01077154|38093043|FG001|Overall Study|Ineligibility Determined|14|||
16949469|NCT01077154|38093042|FG000|Overall Study|Other|14|||
16949470|NCT01077154|38093043|FG001|Overall Study|Other|11|||
16949471|NCT01077154|38093042|FG000|Overall Study|Adverse Event|9|||
16949472|NCT01077154|38093043|FG001|Overall Study|Adverse Event|9|||
16949473|NCT01077154|38093042|FG000|Overall Study|Administrative Decision|1|||
16949474|NCT01077154|38093043|FG001|Overall Study|Administrative Decision|6|||
16949475|NCT01077154|38093042|FG000|Overall Study|Protocol Deviation|1|||
16949476|NCT01077154|38093043|FG001|Overall Study|Protocol Deviation|0|||
16949477|NCT01258101|38093053|FG000|Overall Study|Adverse Event|5|||
16949478|NCT01258101|38093054|FG001|Overall Study|Adverse Event|6|||
16949479|NCT01258101|38093055|FG002|Overall Study|Adverse Event|0|||
16949480|NCT01258101|38093056|FG003|Overall Study|Adverse Event|0|||
16949481|NCT01258101|38093053|FG000|Overall Study|Extra exclusion criterion amended|2|||
16949482|NCT01258101|38093054|FG001|Overall Study|Extra exclusion criterion amended|1|||
16949483|NCT01258101|38093055|FG002|Overall Study|Extra exclusion criterion amended|1|||
16949484|NCT01258101|38093056|FG003|Overall Study|Extra exclusion criterion amended|1|||
16949485|NCT01258101|38093053|FG000|Overall Study|Informed consent has been withdrawn|2|||
16949486|NCT01258101|38093054|FG001|Overall Study|Informed consent has been withdrawn|2|||
16949487|NCT01258101|38093055|FG002|Overall Study|Informed consent has been withdrawn|1|||
16949488|NCT01258101|38093056|FG003|Overall Study|Informed consent has been withdrawn|1|||
16949489|NCT01258101|38093053|FG000|Overall Study|Patient is not able to attend visits|8|||
16949490|NCT01258101|38093054|FG001|Overall Study|Patient is not able to attend visits|9|||
16949491|NCT01258101|38093055|FG002|Overall Study|Patient is not able to attend visits|7|||
16949492|NCT01258101|38093056|FG003|Overall Study|Patient is not able to attend visits|6|||
16949493|NCT01258101|38093053|FG000|Overall Study|Patient´s compliance|4|||
16949494|NCT01258101|38093054|FG001|Overall Study|Patient´s compliance|3|||
16949495|NCT01258101|38093055|FG002|Overall Study|Patient´s compliance|1|||
16949496|NCT01258101|38093056|FG003|Overall Study|Patient´s compliance|2|||
16949497|NCT01258101|38093053|FG000|Overall Study|Lost to Follow-up|5|||
16949498|NCT01258101|38093054|FG001|Overall Study|Lost to Follow-up|5|||
16949499|NCT01258101|38093055|FG002|Overall Study|Lost to Follow-up|0|||
16949500|NCT01258101|38093056|FG003|Overall Study|Lost to Follow-up|6|||
16949501|NCT01258101|38093053|FG000|Overall Study|PCR positive at week 24|0|||
16949502|NCT01258101|38093054|FG001|Overall Study|PCR positive at week 24|0|||
16949503|NCT01258101|38093055|FG002|Overall Study|PCR positive at week 24|0|||
16949504|NCT01258101|38093056|FG003|Overall Study|PCR positive at week 24|1|||
16949505|NCT01258101|38093053|FG000|Overall Study|Other reason|7|||
16949506|NCT01258101|38093054|FG001|Overall Study|Other reason|8|||
16949507|NCT01258101|38093055|FG002|Overall Study|Other reason|1|||
16949508|NCT01258101|38093056|FG003|Overall Study|Other reason|8|||
16949509|NCT01300338|38093068|FG000|Overall Study|Lost to Follow-up|5|||
16949510|NCT01300338|38093069|FG001|Overall Study|Lost to Follow-up|0|||
16949511|NCT01300260|38093077|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
16949512|NCT01300260|38093078|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
16949513|NCT01300260|38093077|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
16949514|NCT01300260|38093078|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
16949515|NCT01300260|38093077|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
16949516|NCT01300260|38093078|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
16949517|NCT01256385|38093097|FG000|Overall Study|Physician Decision|1|||
16949518|NCT01256385|38093098|FG001|Overall Study|Physician Decision|1|||
16949519|NCT01256385|38093097|FG000|Overall Study|Withdrawal by Subject|2|||
16949520|NCT01256385|38093098|FG001|Overall Study|Withdrawal by Subject|2|||
16949521|NCT01298778|38093106|FG000|Overall Study|Lost to Follow-up|2|||
16949522|NCT01298778|38093107|FG001|Overall Study|Lost to Follow-up|3|||
16949523|NCT01298778|38093106|FG000|Overall Study|Incorrect use of VAS|1|||
16949524|NCT01298778|38093107|FG001|Overall Study|Incorrect use of VAS|0|||
16949525|NCT01298778|38093106|FG000|Overall Study|Withdrawal by Subject|0|||
16949526|NCT01298778|38093107|FG001|Overall Study|Withdrawal by Subject|1|||
16949527|NCT01298778|38093106|FG000|Overall Study|Protocol Violation|0|||
16949528|NCT01298778|38093107|FG001|Overall Study|Protocol Violation|1|||
16949529|NCT01298778|38093106|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
16949530|NCT01298778|38093107|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
16949531|NCT01298700|38093117|FG000|Overall Study|Adverse Event|50|||
16949532|NCT01298700|38093118|FG001|Overall Study|Adverse Event|51|||
16949533|NCT01298700|38093117|FG000|Overall Study|Lack of Efficacy|9|||
16774195|NCT02452892|37713487|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
16774196|NCT02452892|37713488|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
16949534|NCT01298700|38093118|FG001|Overall Study|Lack of Efficacy|14|||
16949535|NCT01298700|38093117|FG000|Overall Study|Lost to Follow-up|5|||
16949536|NCT01298700|38093118|FG001|Overall Study|Lost to Follow-up|2|||
16949537|NCT01298700|38093117|FG000|Overall Study|Withdrawal by Subject|12|||
16949538|NCT01298700|38093118|FG001|Overall Study|Withdrawal by Subject|9|||
16949539|NCT01298700|38093117|FG000|Overall Study|Protocol Violation|6|||
16949540|NCT01298700|38093118|FG001|Overall Study|Protocol Violation|4|||
16949541|NCT01298700|38093117|FG000|Overall Study|Other Miscellaneous Reasons|16|||
16949542|NCT01298700|38093118|FG001|Overall Study|Other Miscellaneous Reasons|15|||
16949543|NCT01298700|38093117|FG000|Overall Study|Did not Receive Study Drug|3|||
16949544|NCT01298700|38093118|FG001|Overall Study|Did not Receive Study Drug|5|||
16949545|NCT01297920|38093127|FG000|Overall Study|Adverse Event|42|||
16949546|NCT01297920|38093128|FG001|Overall Study|Adverse Event|10|||
16949547|NCT01297920|38093129|FG002|Overall Study|Adverse Event|38|||
16949548|NCT01297920|38093127|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
16949549|NCT01297920|38093128|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
16949550|NCT01297920|38093129|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
16949551|NCT01297920|38093127|FG000|Overall Study|Noncompliance|1|||
16949552|NCT01297920|38093128|FG001|Overall Study|Noncompliance|0|||
16949553|NCT01297920|38093129|FG002|Overall Study|Noncompliance|0|||
16949554|NCT01297920|38093127|FG000|Overall Study|Protocol Violation|1|||
16949555|NCT01297920|38093128|FG001|Overall Study|Protocol Violation|3|||
16949556|NCT01297920|38093129|FG002|Overall Study|Protocol Violation|0|||
16949557|NCT01297920|38093127|FG000|Overall Study|Inadequate Control of IOP|7|||
16949558|NCT01297920|38093128|FG001|Overall Study|Inadequate Control of IOP|9|||
16949559|NCT01297920|38093129|FG002|Overall Study|Inadequate Control of IOP|17|||
16949560|NCT01297920|38093127|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
16949561|NCT01297920|38093128|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
16949562|NCT01297920|38093129|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
16949563|NCT01255761|38093139|FG000|Overall Study|Adverse Event|29|||
16949564|NCT01255761|38093140|FG001|Overall Study|Adverse Event|43|||
16949565|NCT01255761|38093139|FG000|Overall Study|Lack of Efficacy|86|||
16949566|NCT01255761|38093140|FG001|Overall Study|Lack of Efficacy|74|||
16949567|NCT01255761|38093139|FG000|Overall Study|Protocol Violation|9|||
16949568|NCT01255761|38093140|FG001|Overall Study|Protocol Violation|5|||
16949569|NCT01255761|38093139|FG000|Overall Study|Lost to Follow-up|10|||
16949570|NCT01255761|38093140|FG001|Overall Study|Lost to Follow-up|8|||
16949571|NCT01255761|38093139|FG000|Overall Study|Withdrawal by Subject|11|||
16949572|NCT01255761|38093140|FG001|Overall Study|Withdrawal by Subject|27|||
16949573|NCT01255761|38093139|FG000|Overall Study|Other Reasons|37|||
16949574|NCT01255761|38093140|FG001|Overall Study|Other Reasons|18|||
16949575|NCT01297062|38093152|FG000|Overall Study|Adverse Event|2|||
16949576|NCT01297062|38093153|FG001|Overall Study|Adverse Event|0|||
16949577|NCT01297062|38093154|FG002|Overall Study|Adverse Event|1|||
16949578|NCT01297062|38093155|FG003|Overall Study|Adverse Event|0|||
16949579|NCT01297062|38093156|FG004|Overall Study|Adverse Event|0|||
16949580|NCT01297062|38093157|FG005|Overall Study|Adverse Event|0|||
16949581|NCT01297062|38093158|FG006|Overall Study|Adverse Event|0|||
16949582|NCT01297062|38093152|FG000|Overall Study|Physician Decision|1|||
16949583|NCT01297062|38093153|FG001|Overall Study|Physician Decision|0|||
16949584|NCT01297062|38093154|FG002|Overall Study|Physician Decision|1|||
16949585|NCT01297062|38093155|FG003|Overall Study|Physician Decision|0|||
16949586|NCT01297062|38093156|FG004|Overall Study|Physician Decision|0|||
16949587|NCT01297062|38093157|FG005|Overall Study|Physician Decision|0|||
16949588|NCT01297062|38093158|FG006|Overall Study|Physician Decision|6|||
16949589|NCT01297062|38093152|FG000|Overall Study|Protocol Violation|0|||
16949590|NCT01297062|38093153|FG001|Overall Study|Protocol Violation|0|||
16949591|NCT01297062|38093154|FG002|Overall Study|Protocol Violation|0|||
16949592|NCT01297062|38093155|FG003|Overall Study|Protocol Violation|0|||
16949593|NCT01297062|38093156|FG004|Overall Study|Protocol Violation|1|||
16949594|NCT01297062|38093157|FG005|Overall Study|Protocol Violation|0|||
16949595|NCT01297062|38093158|FG006|Overall Study|Protocol Violation|0|||
16949596|NCT01297062|38093152|FG000|Overall Study|Subject Decision|1|||
16949597|NCT01297062|38093153|FG001|Overall Study|Subject Decision|1|||
16949598|NCT01297062|38093154|FG002|Overall Study|Subject Decision|0|||
16949599|NCT01297062|38093155|FG003|Overall Study|Subject Decision|1|||
16949600|NCT01297062|38093156|FG004|Overall Study|Subject Decision|1|||
16949601|NCT01297062|38093157|FG005|Overall Study|Subject Decision|1|||
16949602|NCT01297062|38093158|FG006|Overall Study|Subject Decision|2|||
16949603|NCT01254747|38093170|FG000|Overall Study|Unacceptable subjective vision|0|||
16949604|NCT01254747|38093171|FG001|Overall Study|Unacceptable subjective vision|0|||
16949605|NCT01254747|38093172|FG002|Overall Study|Unacceptable subjective vision|0|||
16949606|NCT01254747|38093173|FG003|Overall Study|Unacceptable subjective vision|2|||
16949607|NCT01254747|38093170|FG000|Overall Study|Difficult removal handling|0|||
16774197|NCT02452892|37713489|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
16949608|NCT01254747|38093171|FG001|Overall Study|Difficult removal handling|0|||
16949609|NCT01254747|38093172|FG002|Overall Study|Difficult removal handling|1|||
16949610|NCT01254747|38093173|FG003|Overall Study|Difficult removal handling|0|||
16949611|NCT01254747|38093170|FG000|Overall Study|Symptoms and problems|0|||
16949612|NCT01254747|38093171|FG001|Overall Study|Symptoms and problems|2|||
16949613|NCT01254747|38093172|FG002|Overall Study|Symptoms and problems|1|||
16949614|NCT01254747|38093173|FG003|Overall Study|Symptoms and problems|0|||
16949615|NCT01254747|38093170|FG000|Overall Study|Lost to Follow-up|0|||
16949616|NCT01254747|38093171|FG001|Overall Study|Lost to Follow-up|0|||
16949617|NCT01254747|38093172|FG002|Overall Study|Lost to Follow-up|1|||
16949618|NCT01254747|38093173|FG003|Overall Study|Lost to Follow-up|0|||
16949619|NCT01254747|38093170|FG000|Overall Study|Biomicroscopy|0|||
16949620|NCT01254747|38093171|FG001|Overall Study|Biomicroscopy|0|||
16949621|NCT01254747|38093172|FG002|Overall Study|Biomicroscopy|1|||
16949622|NCT01254747|38093173|FG003|Overall Study|Biomicroscopy|0|||
16949623|NCT01254747|38093170|FG000|Overall Study|Discomfort|0|||
16949624|NCT01254747|38093171|FG001|Overall Study|Discomfort|4|||
16949625|NCT01254747|38093172|FG002|Overall Study|Discomfort|0|||
16949626|NCT01254747|38093173|FG003|Overall Study|Discomfort|0|||
16949627|NCT01296672|38093185|FG000|Overall Study|Lost to Follow-up|73|||
16949628|NCT01296672|38093186|FG001|Overall Study|Lost to Follow-up|18|||
16949629|NCT01254669|38093196|FG000|Overall Study|Withdrawal by Subject|0|||
16949630|NCT01254669|38093197|FG001|Overall Study|Withdrawal by Subject|1|||
16949631|NCT01254669|38093196|FG000|Overall Study|time constraint|2|||
16949632|NCT01254669|38093197|FG001|Overall Study|time constraint|2|||
16949633|NCT01254669|38093196|FG000|Overall Study|called to clinic during intervention|1|||
16949634|NCT01254669|38093197|FG001|Overall Study|called to clinic during intervention|1|||
16949635|NCT01295814|38093207|FG000|Overall Study|Lack of Efficacy|0|||
16949636|NCT01295814|38093208|FG001|Overall Study|Lack of Efficacy|2|||
16949637|NCT01295814|38093207|FG000|Overall Study|Withdrawal by Subject|2|||
16949638|NCT01295814|38093208|FG001|Overall Study|Withdrawal by Subject|0|||
16949639|NCT01254045|38093214|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
16949640|NCT01254045|38093215|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16949641|NCT01254045|38093216|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16949642|NCT01254045|38093217|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16949643|NCT01254045|38093218|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16949644|NCT01254045|38093219|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16949645|NCT01075282|38093232|FG000|Overall Study|Withdrawal by Subject|11|||
16949646|NCT01075282|38093233|FG001|Overall Study|Withdrawal by Subject|7|||
16949647|NCT01075282|38093234|FG002|Overall Study|Withdrawal by Subject|11|||
16949648|NCT01075282|38093232|FG000|Overall Study|Adverse Event|9|||
16949649|NCT01075282|38093233|FG001|Overall Study|Adverse Event|8|||
16949650|NCT01075282|38093234|FG002|Overall Study|Adverse Event|5|||
16949651|NCT01075282|38093232|FG000|Overall Study|Entry Criteria Not Met|3|||
16949652|NCT01075282|38093233|FG001|Overall Study|Entry Criteria Not Met|2|||
16949653|NCT01075282|38093234|FG002|Overall Study|Entry Criteria Not Met|0|||
16949654|NCT01075282|38093232|FG000|Overall Study|Lost to Follow-up|3|||
16949655|NCT01075282|38093233|FG001|Overall Study|Lost to Follow-up|3|||
16949656|NCT01075282|38093234|FG002|Overall Study|Lost to Follow-up|3|||
16949657|NCT01075282|38093232|FG000|Overall Study|Physician Decision|3|||
16949658|NCT01075282|38093233|FG001|Overall Study|Physician Decision|3|||
16949659|NCT01075282|38093234|FG002|Overall Study|Physician Decision|3|||
16949660|NCT01075282|38093232|FG000|Overall Study|Lack of Efficacy|1|||
16949661|NCT01075282|38093233|FG001|Overall Study|Lack of Efficacy|1|||
16949662|NCT01075282|38093234|FG002|Overall Study|Lack of Efficacy|0|||
16949663|NCT01075282|38093232|FG000|Overall Study|Treatment Non-compliance|1|||
16949664|NCT01075282|38093233|FG001|Overall Study|Treatment Non-compliance|2|||
16949665|NCT01075282|38093234|FG002|Overall Study|Treatment Non-compliance|2|||
16949666|NCT01075282|38093232|FG000|Overall Study|Protocol Violation|0|||
16949667|NCT01075282|38093233|FG001|Overall Study|Protocol Violation|2|||
16949668|NCT01075282|38093234|FG002|Overall Study|Protocol Violation|1|||
16949669|NCT01075282|38093232|FG000|Overall Study|Death|0|||
16949670|NCT01075282|38093233|FG001|Overall Study|Death|1|||
16949671|NCT01075282|38093234|FG002|Overall Study|Death|2|||
16949672|NCT01253811|38093243|FG000|Overall Study|Withdrawal criteria|1|||
16949673|NCT01295580|38093249|FG000|Overall Study|Protocol Violation|4|||
16949674|NCT01295580|38093250|FG001|Overall Study|Protocol Violation|2|||
16949675|NCT01295580|38093249|FG000|Overall Study|Withdrawal by Subject|1|||
16949676|NCT01295580|38093250|FG001|Overall Study|Withdrawal by Subject|4|||
16949677|NCT01295580|38093249|FG000|Overall Study|Adverse Event|2|||
16949678|NCT01295580|38093250|FG001|Overall Study|Adverse Event|1|||
16949679|NCT01295580|38093249|FG000|Overall Study|Lost to Follow-up|1|||
16949680|NCT01295580|38093250|FG001|Overall Study|Lost to Follow-up|0|||
16949681|NCT01295580|38093249|FG000|Overall Study|Lack of Efficacy|1|||
16949682|NCT01295580|38093250|FG001|Overall Study|Lack of Efficacy|0|||
16949683|NCT01295580|38093249|FG000|Overall Study|Other: inconvenience|1|||
16949684|NCT01295580|38093250|FG001|Overall Study|Other: inconvenience|0|||
16949685|NCT01295580|38093249|FG000|Overall Study|Other: family objection|0|||
16949686|NCT01295580|38093250|FG001|Overall Study|Other: family objection|1|||
16949687|NCT01253577|38093256|FG000|Overall Study|Lost to Follow-up|3|||
16949688|NCT01295034|38093264|FG000|Overall Study|Lost to Follow-up|5|||
16949689|NCT01295034|38093265|FG001|Overall Study|Lost to Follow-up|5|||
16949690|NCT01253421|38093276|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
16949691|NCT01253421|38093277|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
16949692|NCT01253421|38093278|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
16949693|NCT01253421|38093279|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
16949694|NCT01253421|38093280|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
16949695|NCT01253421|38093276|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
16949696|NCT01253421|38093277|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
16949697|NCT01253421|38093278|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
16949698|NCT01253421|38093279|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
16949699|NCT01253421|38093280|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
16949700|NCT01253421|38093276|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
16949701|NCT01253421|38093277|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
16949702|NCT01253421|38093278|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
16949703|NCT01253421|38093279|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
16949704|NCT01253421|38093280|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
16949705|NCT01253421|38093276|FG000|Assessment and Scheduling|Physician Decision|1|||
16949706|NCT01253421|38093277|FG001|Assessment and Scheduling|Physician Decision|0|||
16949707|NCT01253421|38093278|FG002|Assessment and Scheduling|Physician Decision|0|||
16949708|NCT01253421|38093279|FG003|Assessment and Scheduling|Physician Decision|0|||
16949709|NCT01253421|38093280|FG004|Assessment and Scheduling|Physician Decision|0|||
16949710|NCT01253421|38093276|FG000|Drug+Scanning Visit|Physician Decision|0|||
16949711|NCT01253421|38093277|FG001|Drug+Scanning Visit|Physician Decision|0|||
16949712|NCT01253421|38093278|FG002|Drug+Scanning Visit|Physician Decision|0|||
16949713|NCT01253421|38093279|FG003|Drug+Scanning Visit|Physician Decision|0|||
16949714|NCT01253421|38093280|FG004|Drug+Scanning Visit|Physician Decision|1|||
16949715|NCT01077076|38093290|FG000|First Intervention|Withdrawal by Subject|1|||
16949716|NCT01077076|38093291|FG001|First Intervention|Withdrawal by Subject|0|||
16949717|NCT01077076|38093292|FG002|First Intervention|Withdrawal by Subject|0|||
16949718|NCT01077076|38093293|FG003|First Intervention|Withdrawal by Subject|0|||
16949719|NCT01077076|38093294|FG004|First Intervention|Withdrawal by Subject|0|||
16949720|NCT01077076|38093295|FG005|First Intervention|Withdrawal by Subject|0|||
16949721|NCT01077076|38093290|FG000|Third Intervention|Death in the participant's family|0|||
16949722|NCT01077076|38093291|FG001|Third Intervention|Death in the participant's family|0|||
16949723|NCT01077076|38093292|FG002|Third Intervention|Death in the participant's family|0|||
16949724|NCT01077076|38093293|FG003|Third Intervention|Death in the participant's family|0|||
16949725|NCT01077076|38093294|FG004|Third Intervention|Death in the participant's family|0|||
16949726|NCT01077076|38093295|FG005|Third Intervention|Death in the participant's family|1|||
16949727|NCT01294800|38093307|FG000|Overall Study|Adverse Event|7|||
16949728|NCT01294800|38093308|FG001|Overall Study|Adverse Event|6|||
16949729|NCT01294800|38093309|FG002|Overall Study|Adverse Event|12|||
16949730|NCT01294800|38093310|FG003|Overall Study|Adverse Event|5|||
16949731|NCT01294800|38093307|FG000|Overall Study|Subject Withdrew Consent|2|||
16949732|NCT01294800|38093308|FG001|Overall Study|Subject Withdrew Consent|2|||
16949733|NCT01294800|38093309|FG002|Overall Study|Subject Withdrew Consent|2|||
16949734|NCT01294800|38093310|FG003|Overall Study|Subject Withdrew Consent|11|||
16949735|NCT01294800|38093307|FG000|Overall Study|Lost to Follow-up|0|||
16949736|NCT01294800|38093308|FG001|Overall Study|Lost to Follow-up|0|||
16949737|NCT01294800|38093309|FG002|Overall Study|Lost to Follow-up|1|||
16949738|NCT01294800|38093310|FG003|Overall Study|Lost to Follow-up|0|||
16949739|NCT01294800|38093307|FG000|Overall Study|Non-compliance With Protocol|0|||
16949740|NCT01294800|38093308|FG001|Overall Study|Non-compliance With Protocol|1|||
16949741|NCT01294800|38093309|FG002|Overall Study|Non-compliance With Protocol|1|||
16949742|NCT01294800|38093310|FG003|Overall Study|Non-compliance With Protocol|0|||
16949743|NCT01294800|38093307|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
16949744|NCT01294800|38093308|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
16949745|NCT01294800|38093309|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
16949746|NCT01294800|38093310|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
16949747|NCT01294644|38093323|FG000|Overall Study|Adverse Event|2|||
16949748|NCT01294644|38093324|FG001|Overall Study|Adverse Event|0|||
16949749|NCT01294644|38093325|FG002|Overall Study|Adverse Event|1|||
16949750|NCT01294644|38093323|FG000|Overall Study|Withdrawal by Subject|3|||
16949751|NCT01294644|38093324|FG001|Overall Study|Withdrawal by Subject|7|||
16949752|NCT01294644|38093325|FG002|Overall Study|Withdrawal by Subject|4|||
16949753|NCT01294644|38093323|FG000|Overall Study|Lost to Follow-up|3|||
16949754|NCT01294644|38093324|FG001|Overall Study|Lost to Follow-up|2|||
16949755|NCT01294644|38093325|FG002|Overall Study|Lost to Follow-up|5|||
16949756|NCT01294644|38093323|FG000|Overall Study|Miscellaneous Reason|2|||
16949757|NCT01294644|38093324|FG001|Overall Study|Miscellaneous Reason|1|||
16949758|NCT01294644|38093325|FG002|Overall Study|Miscellaneous Reason|4|||
16949759|NCT01293240|38093333|FG000|Overall Study|Noncompliance|2|||
16949760|NCT01253265|38093342|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
16949761|NCT01253265|38093343|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
16949762|NCT01253265|38093344|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
16949763|NCT01253265|38093345|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
16949764|NCT01253265|38093346|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
16949765|NCT01253265|38093342|FG000|Overall Study|Withdrawal by Subject|0|||
16949766|NCT01253265|38093343|FG001|Overall Study|Withdrawal by Subject|0|||
16949767|NCT01253265|38093344|FG002|Overall Study|Withdrawal by Subject|0|||
16949768|NCT01253265|38093345|FG003|Overall Study|Withdrawal by Subject|0|||
16949769|NCT01253265|38093346|FG004|Overall Study|Withdrawal by Subject|1|||
16949770|NCT01293084|38093358|FG000|Overall Study|Physician Decision|3|||
16949771|NCT01293084|38093358|FG000|Overall Study|Withdrawal by Subject|2|||
16949772|NCT01293006|38093368|FG000|Period 2|Lost to Follow-up|1|||
16949773|NCT01293006|38093369|FG001|Period 2|Lost to Follow-up|0|||
16949774|NCT01293006|38093370|FG002|Period 2|Lost to Follow-up|0|||
16949775|NCT01293006|38093371|FG003|Period 2|Lost to Follow-up|0|||
16949776|NCT01292928|38093386|FG000|Overall Study|Death|8|||
16949777|NCT01292928|38093386|FG000|Overall Study|Withdrawal by Subject|8|||
16949778|NCT01292928|38093386|FG000|Overall Study|Lost to Follow-up|6|||
16949779|NCT01292928|38093386|FG000|Overall Study|Physician Decision|2|||
16949780|NCT01253187|38093392|FG000|Period 2|Withdrawal by Subject|0|||
16949781|NCT01253187|38093393|FG001|Period 2|Withdrawal by Subject|0|||
16949782|NCT01253187|38093394|FG002|Period 2|Withdrawal by Subject|0|||
16949783|NCT01253187|38093395|FG003|Period 2|Withdrawal by Subject|0|||
16949784|NCT01253187|38093396|FG004|Period 2|Withdrawal by Subject|1|||
16949785|NCT01253187|38093397|FG005|Period 2|Withdrawal by Subject|0|||
16949786|NCT01253187|38093392|FG000|Period 3|Pregnancy|1|||
16949787|NCT01253187|38093393|FG001|Period 3|Pregnancy|0|||
16949788|NCT01253187|38093394|FG002|Period 3|Pregnancy|0|||
16949789|NCT01253187|38093395|FG003|Period 3|Pregnancy|0|||
16949790|NCT01253187|38093396|FG004|Period 3|Pregnancy|0|||
16949791|NCT01253187|38093397|FG005|Period 3|Pregnancy|0|||
16949792|NCT01253187|38093392|FG000|Period 3|difficulty with blood sampling|0|||
16949793|NCT01253187|38093393|FG001|Period 3|difficulty with blood sampling|1|||
16949794|NCT01253187|38093394|FG002|Period 3|difficulty with blood sampling|0|||
16949795|NCT01253187|38093395|FG003|Period 3|difficulty with blood sampling|0|||
16949796|NCT01253187|38093396|FG004|Period 3|difficulty with blood sampling|0|||
16949797|NCT01253187|38093397|FG005|Period 3|difficulty with blood sampling|0|||
16949798|NCT01253187|38093392|FG000|Period 3|non-compliance|0|||
16949799|NCT01253187|38093393|FG001|Period 3|non-compliance|0|||
16949800|NCT01253187|38093394|FG002|Period 3|non-compliance|0|||
16949801|NCT01253187|38093395|FG003|Period 3|non-compliance|0|||
16949802|NCT01253187|38093396|FG004|Period 3|non-compliance|1|||
16949803|NCT01253187|38093397|FG005|Period 3|non-compliance|0|||
16949804|NCT01252953|38093410|FG000|Overall Study|Withdrawal by Subject|16|||
16949805|NCT01252953|38093411|FG001|Overall Study|Withdrawal by Subject|17|||
16949806|NCT01252953|38093410|FG000|Overall Study|Lost to Follow-up|22|||
16949807|NCT01252953|38093411|FG001|Overall Study|Lost to Follow-up|21|||
16949808|NCT01252563|38093418|FG000|Overall Study|Contract Deviation|41|||
16949809|NCT01252563|38093418|FG000|Overall Study|Centralized Registration Deviation|30|||
16949810|NCT01252563|38093418|FG000|Overall Study|Lost to Follow-up|161|||
16949811|NCT01252563|38093418|FG000|Overall Study|No visit after first day of treatment|194|||
16949812|NCT01252563|38093418|FG000|Overall Study|No drug administration|6|||
16949813|NCT01292226|38093453|FG000|Overall Study|Adverse Event|5|||
16949814|NCT01292226|38093453|FG000|Overall Study|Death|1|||
16949815|NCT01292226|38093453|FG000|Overall Study|Graft loss|1|||
16949816|NCT01292226|38093453|FG000|Overall Study|Protocol Violation|3|||
16949817|NCT01292226|38093453|FG000|Overall Study|Withdrawal by Subject|1|||
16949818|NCT01292226|38093453|FG000|Overall Study|Other|2|||
16949819|NCT01290822|38093457|FG000|Overall Study|Withdrawal by Subject|1|||
16949820|NCT01290822|38093457|FG000|Overall Study|Physician Decision|10|||
16949821|NCT01075048|38093464|FG000|Overall Study|Death|4|||
16949822|NCT01075048|38093465|FG001|Overall Study|Death|17|||
16949823|NCT01075048|38093466|FG002|Overall Study|Death|12|||
16949824|NCT01075048|38093464|FG000|Overall Study|Start of other or new therapy|4|||
16949825|NCT01075048|38093465|FG001|Overall Study|Start of other or new therapy|36|||
16949826|NCT01075048|38093466|FG002|Overall Study|Start of other or new therapy|46|||
16949827|NCT01075048|38093464|FG000|Overall Study|Withdrawal by Subject|1|||
16949828|NCT01075048|38093465|FG001|Overall Study|Withdrawal by Subject|6|||
16949829|NCT01075048|38093466|FG002|Overall Study|Withdrawal by Subject|3|||
16949830|NCT01075048|38093464|FG000|Overall Study|Lost to Follow-up|0|||
16949831|NCT01075048|38093465|FG001|Overall Study|Lost to Follow-up|1|||
16949832|NCT01075048|38093466|FG002|Overall Study|Lost to Follow-up|1|||
16949833|NCT01290666|38093477|FG000|Overall Study|Lost to Follow-up|11|||
16949834|NCT01290666|38093477|FG000|Overall Study|Withdrawal by Subject|23|||
16949835|NCT01290666|38093477|FG000|Overall Study|Early Termination of Study|4|||
16949836|NCT01252251|38093481|FG000|Overall Study|Withdrawal by Subject|1|||
16949837|NCT01289574|38093488|FG000|Overall Study|Lack of Efficacy|4|||
16949838|NCT01289574|38093489|FG001|Overall Study|Lack of Efficacy|0|||
16949839|NCT01289574|38093490|FG002|Overall Study|Lack of Efficacy|1|||
16949840|NCT01289574|38093488|FG000|Overall Study|Lost to Follow-up|2|||
16949841|NCT01289574|38093489|FG001|Overall Study|Lost to Follow-up|0|||
16949842|NCT01289574|38093490|FG002|Overall Study|Lost to Follow-up|1|||
16949843|NCT01289574|38093488|FG000|Overall Study|Withdrawal by Subject|1|||
16949844|NCT01289574|38093489|FG001|Overall Study|Withdrawal by Subject|1|||
16949845|NCT01289574|38093490|FG002|Overall Study|Withdrawal by Subject|1|||
16949846|NCT01289574|38093488|FG000|Overall Study|Adverse Event|0|||
16949847|NCT01289574|38093489|FG001|Overall Study|Adverse Event|1|||
16949848|NCT01289574|38093490|FG002|Overall Study|Adverse Event|0|||
16949849|NCT01289574|38093488|FG000|Overall Study|Subject wanted alternate treatment|0|||
16949850|NCT01289574|38093489|FG001|Overall Study|Subject wanted alternate treatment|1|||
16949851|NCT01289574|38093490|FG002|Overall Study|Subject wanted alternate treatment|0|||
16949852|NCT01252095|38093501|FG000|Overall Study|Disease progression|1|||
16949853|NCT01252095|38093502|FG001|Overall Study|Disease progression|0|||
16949854|NCT01289418|38093511|FG000|Day 8 Survey|email address invalid|283|||
16949855|NCT01289418|38093511|FG000|Day 8 Survey|participants did not complete the survey|1935|||
16949856|NCT01289418|38093511|FG000|Day 29 Survey|email address invalid|283|||
16949857|NCT01289418|38093511|FG000|Day 29 Survey|participants did not complete the survey|2185|||
16949858|NCT01074658|38093517|FG000|Overall Study|No implant attempted|19|||
16949859|NCT01074502|38093521|FG000|Overall Study|Withdrawal by Subject|1|||
16949860|NCT01289028|38093525|FG000|Overall Study|Progressive Disease|49|||
16949861|NCT01289028|38093525|FG000|Overall Study|Adverse Event|14|||
16949862|NCT01289028|38093525|FG000|Overall Study|Withdrawal by Subject|6|||
16949863|NCT01289028|38093525|FG000|Overall Study|Death|4|||
16949864|NCT01289028|38093525|FG000|Overall Study|Lack of Efficacy|2|||
16949865|NCT01289028|38093525|FG000|Overall Study|No longer required|2|||
16949866|NCT01289028|38093525|FG000|Overall Study|Lost to Follow-up|2|||
16949867|NCT01289028|38093525|FG000|Overall Study|New Cancer Therapy|2|||
16949868|NCT01289028|38093525|FG000|Overall Study|Abnormal Lab Value|1|||
16949869|NCT01289028|38093525|FG000|Overall Study|Missing reason for discon|1|||
16949870|NCT01251861|38093533|FG000|Overall Study|Disease progression|6|||
16949871|NCT01251861|38093534|FG001|Overall Study|Disease progression|6|||
16949872|NCT01251861|38093533|FG000|Overall Study|Adverse Event|2|||
16949873|NCT01251861|38093534|FG001|Overall Study|Adverse Event|17|||
16949874|NCT01251861|38093533|FG000|Overall Study|Withdrawal by Subject|2|||
16949875|NCT01251861|38093534|FG001|Overall Study|Withdrawal by Subject|2|||
16949876|NCT01251861|38093533|FG000|Overall Study|Alternative therapy|1|||
16949877|NCT01251861|38093534|FG001|Overall Study|Alternative therapy|0|||
16949878|NCT01251861|38093533|FG000|Overall Study|Other complicating disease|0|||
16949879|NCT01251861|38093534|FG001|Overall Study|Other complicating disease|1|||
16949880|NCT01251861|38093533|FG000|Overall Study|Physician Decision|1|||
16949881|NCT01251861|38093534|FG001|Overall Study|Physician Decision|0|||
16949882|NCT01251861|38093533|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
16949883|NCT01251861|38093534|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
16949884|NCT01251861|38093533|FG000|Overall Study|Other|1|||
16949885|NCT01251861|38093534|FG001|Overall Study|Other|0|||
16949886|NCT01251861|38093533|FG000|Overall Study|Never started therapy|4|||
16949887|NCT01251861|38093534|FG001|Overall Study|Never started therapy|1|||
16949888|NCT01251861|38093533|FG000|Overall Study|Potential interaction of drugs|0|||
16949889|NCT01251861|38093534|FG001|Overall Study|Potential interaction of drugs|1|||
16949890|NCT01250925|38093543|FG000|Overall Study|Lost to Follow-up|1|||
16949891|NCT01250925|38093544|FG001|Overall Study|Lost to Follow-up|1|||
16949892|NCT01250925|38093545|FG002|Overall Study|Lost to Follow-up|0|||
16949893|NCT01250925|38093543|FG000|Overall Study|Withdrawal by Subject|2|||
16949894|NCT01250925|38093544|FG001|Overall Study|Withdrawal by Subject|0|||
16949895|NCT01250925|38093545|FG002|Overall Study|Withdrawal by Subject|0|||
16949896|NCT01250925|38093543|FG000|Overall Study|Protocol Violation|2|||
16949897|NCT01250925|38093544|FG001|Overall Study|Protocol Violation|0|||
16949898|NCT01250925|38093545|FG002|Overall Study|Protocol Violation|0|||
16949899|NCT01250925|38093543|FG000|Overall Study|Physician Decision|0|||
16949900|NCT01250925|38093544|FG001|Overall Study|Physician Decision|2|||
16949901|NCT01250925|38093545|FG002|Overall Study|Physician Decision|1|||
16949902|NCT01250925|38093543|FG000|Overall Study|Adverse Event|0|||
16949903|NCT01250925|38093544|FG001|Overall Study|Adverse Event|0|||
16949904|NCT01250925|38093545|FG002|Overall Study|Adverse Event|1|||
16949905|NCT01285908|38093553|FG000|Baseline Measurement|unable to insert catheter|1|||
16949906|NCT01285908|38093554|FG001|Baseline Measurement|unable to insert catheter|0|||
16949907|NCT01285908|38093555|FG002|Baseline Measurement|unable to insert catheter|0|||
16949908|NCT01285908|38093553|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
16949909|NCT01285908|38093554|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
16949910|NCT01285908|38093555|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
16949911|NCT01285908|38093553|FG000|Baseline Measurement|unable to tolerate procedure|1|||
16949912|NCT01285908|38093554|FG001|Baseline Measurement|unable to tolerate procedure|0|||
16949913|NCT01285908|38093555|FG002|Baseline Measurement|unable to tolerate procedure|0|||
16949914|NCT01250769|38093589|FG000|Overall Study|Withdrawal by Subject|0|||
16949915|NCT01250769|38093590|FG001|Overall Study|Withdrawal by Subject|1|||
16949916|NCT01250769|38093591|FG002|Overall Study|Withdrawal by Subject|1|||
16949917|NCT01250769|38093592|FG003|Overall Study|Withdrawal by Subject|0|||
16949918|NCT01250769|38093589|FG000|Overall Study|Adverse Event|0|||
16949919|NCT01250769|38093590|FG001|Overall Study|Adverse Event|0|||
16949920|NCT01250769|38093591|FG002|Overall Study|Adverse Event|1|||
16949921|NCT01250769|38093592|FG003|Overall Study|Adverse Event|0|||
16949922|NCT01074268|38093604|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
16949923|NCT01074268|38093605|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
16949924|NCT01074268|38093604|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
16949925|NCT01074268|38093605|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
16949926|NCT01074268|38093604|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
16949927|NCT01074268|38093605|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
16949928|NCT01074268|38093604|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
16949929|NCT01074268|38093605|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
16949930|NCT01074268|38093604|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
16949931|NCT01074268|38093605|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
16949932|NCT01074268|38093604|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
16949933|NCT01074268|38093605|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
16949934|NCT01074268|38093604|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
16949935|NCT01074268|38093605|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
16949936|NCT01074268|38093604|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
16949937|NCT01074268|38093605|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
16949938|NCT01074268|38093604|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
16949939|NCT01074268|38093605|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
16949940|NCT01074190|38093614|FG000|Overall Study|Emergency Cesarean Delivery|1|||
16949941|NCT01074190|38093615|FG001|Overall Study|Emergency Cesarean Delivery|2|||
16949942|NCT01074190|38093616|FG002|Overall Study|Emergency Cesarean Delivery|1|||
16949943|NCT01074190|38093614|FG000|Overall Study|Protocol Violation|2|||
16949944|NCT01074190|38093615|FG001|Overall Study|Protocol Violation|1|||
16949945|NCT01074190|38093616|FG002|Overall Study|Protocol Violation|0|||
16949946|NCT01074190|38093614|FG000|Overall Study|Delivered in under 90 minutes|0|||
16949947|NCT01074190|38093615|FG001|Overall Study|Delivered in under 90 minutes|2|||
16949948|NCT01074190|38093616|FG002|Overall Study|Delivered in under 90 minutes|1|||
16949949|NCT01074190|38093614|FG000|Overall Study|Subject withdrew consent|1|||
16949950|NCT01074190|38093615|FG001|Overall Study|Subject withdrew consent|1|||
16949951|NCT01074190|38093616|FG002|Overall Study|Subject withdrew consent|1|||
16949952|NCT01073566|38093629|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
16949953|NCT01073566|38093630|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
16949954|NCT01072396|38093638|FG000|Period One|Adverse Event|1|||
16949955|NCT01072396|38093639|FG001|Period One|Adverse Event|1|||
16949956|NCT01072396|38093638|FG000|Period One|Protocol Violation|2|||
16949957|NCT01072396|38093639|FG001|Period One|Protocol Violation|1|||
16949958|NCT01072396|38093638|FG000|Period One|Withdrawal by Subject|2|||
16949959|NCT01072396|38093639|FG001|Period One|Withdrawal by Subject|0|||
16949960|NCT01072396|38093638|FG000|Washout Period|Missing termination information|0|||
16949961|NCT01072396|38093639|FG001|Washout Period|Missing termination information|1|||
16949962|NCT01072396|38093638|FG000|Period Two|Adverse Event|0|||
16949963|NCT01072396|38093639|FG001|Period Two|Adverse Event|3|||
16949964|NCT01072396|38093638|FG000|Period Two|Lost to Follow-up|1|||
16949965|NCT01072396|38093639|FG001|Period Two|Lost to Follow-up|0|||
16949966|NCT01045096|38093648|FG000|Overall Study|Withdrawal by Subject|2|||
16949967|NCT01045096|38093649|FG001|Overall Study|Withdrawal by Subject|0|||
16949968|NCT01045096|38093650|FG002|Overall Study|Withdrawal by Subject|0|||
16949969|NCT01045096|38093648|FG000|Overall Study|Other|1|||
16949970|NCT01045096|38093649|FG001|Overall Study|Other|0|||
16949971|NCT01045096|38093650|FG002|Overall Study|Other|0|||
16949972|NCT01285518|38093666|FG000|Overall Study|Lost to Follow-up|0|||
16949973|NCT01285518|38093667|FG001|Overall Study|Lost to Follow-up|0|||
16949974|NCT01285518|38093668|FG002|Overall Study|Lost to Follow-up|0|||
16949975|NCT01285518|38093669|FG003|Overall Study|Lost to Follow-up|0|||
16949976|NCT01285518|38093670|FG004|Overall Study|Lost to Follow-up|0|||
16949977|NCT01285518|38093671|FG005|Overall Study|Lost to Follow-up|1|||
16949978|NCT01285518|38093672|FG006|Overall Study|Lost to Follow-up|0|||
16949979|NCT01285518|38093673|FG007|Overall Study|Lost to Follow-up|0|||
16949980|NCT01073020|38093696|FG000|Overall Study|Withdrawal by Subject|6|||
16949981|NCT01073020|38093697|FG001|Overall Study|Withdrawal by Subject|4|||
16949982|NCT01073020|38093698|FG002|Overall Study|Withdrawal by Subject|1|||
16949983|NCT01073020|38093699|FG003|Overall Study|Withdrawal by Subject|2|||
16949984|NCT01073020|38093696|FG000|Overall Study|Physician Decision|1|||
16949985|NCT01073020|38093697|FG001|Overall Study|Physician Decision|0|||
16949986|NCT01073020|38093698|FG002|Overall Study|Physician Decision|2|||
16949987|NCT01073020|38093699|FG003|Overall Study|Physician Decision|0|||
16949988|NCT01073020|38093696|FG000|Overall Study|Death|0|||
16949989|NCT01073020|38093697|FG001|Overall Study|Death|1|||
16949990|NCT01073020|38093698|FG002|Overall Study|Death|0|||
16949991|NCT01073020|38093699|FG003|Overall Study|Death|0|||
16949992|NCT01284114|38093709|FG000|Overall Study|viral infection|1|||
16949993|NCT01284114|38093709|FG000|Overall Study|From the results of ALLTITUDE study|1|||
16949994|NCT01284114|38093709|FG000|Overall Study|Symptomatic hypotension|1|||
16949995|NCT01284114|38093709|FG000|Overall Study|dizziness|1|||
16949996|NCT01283334|38093714|FG000|Overall Study|Withdrawal by Subject|1|||
16949997|NCT01283334|38093714|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
16949998|NCT01283334|38093714|FG000|Overall Study|Adverse Event|4|||
16949999|NCT01283334|38093714|FG000|Overall Study|Physician Decision|1|||
16950000|NCT01282866|38093720|FG000|Overall Study|Adverse Event|1|||
16950001|NCT01071070|38093726|FG000|Overall Study|Adverse Event|0|||
16950002|NCT01071070|38093727|FG001|Overall Study|Adverse Event|3|||
16950003|NCT01071070|38093726|FG000|Overall Study|Withdrawal by Subject|1|||
16950004|NCT01071070|38093727|FG001|Overall Study|Withdrawal by Subject|0|||
16950005|NCT01071070|38093726|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
16950006|NCT01071070|38093727|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
16950007|NCT01071070|38093726|FG000|Overall Study|Hypercalcemia|1|||
16950008|NCT01071070|38093727|FG001|Overall Study|Hypercalcemia|0|||
16950009|NCT01282476|38093733|FG000|Overall Study|Death|11|||
16950010|NCT01282164|38093739|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
16950011|NCT01282164|38093740|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
16950012|NCT01250379|38093756|FG000|Overall Study|Death|141|||
16950013|NCT01250379|38093757|FG001|Overall Study|Death|148|||
16950014|NCT01250379|38093756|FG000|Overall Study|Withdrawal by Subject|32|||
16950015|NCT01250379|38093757|FG001|Overall Study|Withdrawal by Subject|20|||
16950016|NCT01250379|38093756|FG000|Overall Study|Physician Decision|11|||
16950017|NCT01250379|38093757|FG001|Overall Study|Physician Decision|3|||
16950018|NCT01250379|38093756|FG000|Overall Study|Protocol Violation|2|||
16950019|NCT01250379|38093757|FG001|Overall Study|Protocol Violation|8|||
16950020|NCT01250379|38093756|FG000|Overall Study|Lost to Follow-up|9|||
16950021|NCT01250379|38093757|FG001|Overall Study|Lost to Follow-up|6|||
16950022|NCT01250379|38093756|FG000|Overall Study|Adverse Event|5|||
16950023|NCT01250379|38093757|FG001|Overall Study|Adverse Event|4|||
16950024|NCT01250379|38093756|FG000|Overall Study|Other|0|||
16950025|NCT01250379|38093757|FG001|Overall Study|Other|4|||
16950026|NCT01250379|38093756|FG000|Overall Study|Participant noncompliance|2|||
16950027|NCT01250379|38093757|FG001|Overall Study|Participant noncompliance|0|||
16950028|NCT01072630|38093766|FG000|Overall Study|Adverse Event|11|||
16950029|NCT01072630|38093767|FG001|Overall Study|Adverse Event|19|||
16950030|NCT01072630|38093768|FG002|Overall Study|Adverse Event|2|||
16950031|NCT01072630|38093766|FG000|Overall Study|Lack of Efficacy|10|||
16950032|NCT01072630|38093767|FG001|Overall Study|Lack of Efficacy|10|||
16950033|NCT01072630|38093768|FG002|Overall Study|Lack of Efficacy|1|||
16950034|NCT01072630|38093766|FG000|Overall Study|Withdrawal by Subject|8|||
16950035|NCT01072630|38093767|FG001|Overall Study|Withdrawal by Subject|7|||
16950036|NCT01072630|38093768|FG002|Overall Study|Withdrawal by Subject|2|||
16950037|NCT01072630|38093766|FG000|Overall Study|Protocol Violation|10|||
16950038|NCT01072630|38093767|FG001|Overall Study|Protocol Violation|8|||
16950039|NCT01072630|38093768|FG002|Overall Study|Protocol Violation|4|||
16950040|NCT01072630|38093766|FG000|Overall Study|Lost to Follow-up|11|||
16950041|NCT01072630|38093767|FG001|Overall Study|Lost to Follow-up|11|||
16950042|NCT01072630|38093768|FG002|Overall Study|Lost to Follow-up|1|||
16950043|NCT01072630|38093766|FG000|Overall Study|Noncompliance with study medication|1|||
16950044|NCT01072630|38093767|FG001|Overall Study|Noncompliance with study medication|1|||
16950045|NCT01072630|38093768|FG002|Overall Study|Noncompliance with study medication|1|||
16950046|NCT01072630|38093766|FG000|Overall Study|Noncompliance with study procedures|1|||
16950047|NCT01072630|38093767|FG001|Overall Study|Noncompliance with study procedures|2|||
16950048|NCT01072630|38093768|FG002|Overall Study|Noncompliance with study procedures|1|||
16950049|NCT01072630|38093766|FG000|Overall Study|Other|3|||
16950050|NCT01072630|38093767|FG001|Overall Study|Other|2|||
16950051|NCT01072630|38093768|FG002|Overall Study|Other|1|||
16950052|NCT01281306|38093784|FG000|Overall Study|Lack of Efficacy|0|||
16950053|NCT01281306|38093785|FG001|Overall Study|Lack of Efficacy|1|||
16950054|NCT01281306|38093786|FG002|Overall Study|Lack of Efficacy|3|||
16950055|NCT01281306|38093787|FG003|Overall Study|Lack of Efficacy|0|||
16950056|NCT01281306|38093788|FG004|Overall Study|Lack of Efficacy|2|||
16950057|NCT01281306|38093789|FG005|Overall Study|Lack of Efficacy|0|||
16950058|NCT01281306|38093790|FG006|Overall Study|Lack of Efficacy|1|||
16950059|NCT01281306|38093784|FG000|Overall Study|Withdrawal by Subject|1|||
16950060|NCT01281306|38093785|FG001|Overall Study|Withdrawal by Subject|0|||
16950061|NCT01281306|38093786|FG002|Overall Study|Withdrawal by Subject|2|||
16950062|NCT01281306|38093787|FG003|Overall Study|Withdrawal by Subject|4|||
16950063|NCT01281306|38093788|FG004|Overall Study|Withdrawal by Subject|1|||
16950064|NCT01281306|38093789|FG005|Overall Study|Withdrawal by Subject|3|||
16950065|NCT01281306|38093790|FG006|Overall Study|Withdrawal by Subject|1|||
16950066|NCT01281306|38093784|FG000|Overall Study|Protocol deviation|0|||
16950067|NCT01281306|38093785|FG001|Overall Study|Protocol deviation|1|||
16950068|NCT01281306|38093786|FG002|Overall Study|Protocol deviation|1|||
16950069|NCT01281306|38093787|FG003|Overall Study|Protocol deviation|1|||
16950070|NCT01281306|38093788|FG004|Overall Study|Protocol deviation|1|||
16950071|NCT01281306|38093789|FG005|Overall Study|Protocol deviation|0|||
16950072|NCT01281306|38093790|FG006|Overall Study|Protocol deviation|0|||
16950073|NCT01281306|38093784|FG000|Overall Study|Condition no longer requires study drug|1|||
16950074|NCT01281306|38093785|FG001|Overall Study|Condition no longer requires study drug|0|||
16950075|NCT01281306|38093786|FG002|Overall Study|Condition no longer requires study drug|0|||
16950076|NCT01281306|38093787|FG003|Overall Study|Condition no longer requires study drug|0|||
16950077|NCT01281306|38093788|FG004|Overall Study|Condition no longer requires study drug|0|||
16950078|NCT01281306|38093789|FG005|Overall Study|Condition no longer requires study drug|1|||
16774198|NCT02452892|37713490|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
16950079|NCT01281306|38093790|FG006|Overall Study|Condition no longer requires study drug|1|||
16950080|NCT01281306|38093784|FG000|Overall Study|Lost to Follow-up|1|||
16950081|NCT01281306|38093785|FG001|Overall Study|Lost to Follow-up|0|||
16950082|NCT01281306|38093786|FG002|Overall Study|Lost to Follow-up|0|||
16950083|NCT01281306|38093787|FG003|Overall Study|Lost to Follow-up|2|||
16950084|NCT01281306|38093788|FG004|Overall Study|Lost to Follow-up|0|||
16950085|NCT01281306|38093789|FG005|Overall Study|Lost to Follow-up|0|||
16950086|NCT01281306|38093790|FG006|Overall Study|Lost to Follow-up|1|||
16950087|NCT01281306|38093784|FG000|Overall Study|Death|1|||
16950088|NCT01281306|38093785|FG001|Overall Study|Death|0|||
16950089|NCT01281306|38093786|FG002|Overall Study|Death|0|||
16950090|NCT01281306|38093787|FG003|Overall Study|Death|0|||
16950091|NCT01281306|38093788|FG004|Overall Study|Death|0|||
16950092|NCT01281306|38093789|FG005|Overall Study|Death|0|||
16950093|NCT01281306|38093790|FG006|Overall Study|Death|0|||
16950094|NCT01281306|38093784|FG000|Overall Study|Adverse Event|3|||
16950095|NCT01281306|38093785|FG001|Overall Study|Adverse Event|2|||
16950096|NCT01281306|38093786|FG002|Overall Study|Adverse Event|2|||
16950097|NCT01281306|38093787|FG003|Overall Study|Adverse Event|3|||
16950098|NCT01281306|38093788|FG004|Overall Study|Adverse Event|5|||
16950099|NCT01281306|38093789|FG005|Overall Study|Adverse Event|3|||
16950100|NCT01281306|38093790|FG006|Overall Study|Adverse Event|3|||
16950101|NCT01281306|38093784|FG000|Overall Study|Randomized in error|1|||
16950102|NCT01281306|38093785|FG001|Overall Study|Randomized in error|0|||
16950103|NCT01281306|38093786|FG002|Overall Study|Randomized in error|0|||
16950104|NCT01281306|38093787|FG003|Overall Study|Randomized in error|1|||
16950105|NCT01281306|38093788|FG004|Overall Study|Randomized in error|0|||
16950106|NCT01281306|38093789|FG005|Overall Study|Randomized in error|0|||
16950107|NCT01281306|38093790|FG006|Overall Study|Randomized in error|0|||
16950108|NCT01250145|38093808|FG000|Overall Study|Adverse Event|2|||
16950109|NCT01250145|38093809|FG001|Overall Study|Adverse Event|1|||
16950110|NCT01250145|38093808|FG000|Overall Study|Withdrawal by Subject|0|||
16950111|NCT01250145|38093809|FG001|Overall Study|Withdrawal by Subject|4|||
16950112|NCT01067326|38093831|FG000|Overall Study|Adverse Event|0|||
16950113|NCT01067326|38093832|FG001|Overall Study|Adverse Event|2|||
16950114|NCT01067326|38093831|FG000|Overall Study|Withdrawal by Subject|1|||
16950115|NCT01067326|38093832|FG001|Overall Study|Withdrawal by Subject|0|||
16950116|NCT01067326|38093831|FG000|Overall Study|Early Study Termination|1|||
16950117|NCT01067326|38093832|FG001|Overall Study|Early Study Termination|1|||
16950118|NCT01279200|38093840|FG000|Overall Study|Withdrawal by Subject|1|||
16950119|NCT01279200|38093841|FG001|Overall Study|Withdrawal by Subject|3|||
16950120|NCT01279200|38093840|FG000|Overall Study|Patient withdrawal due to high cost|0|||
16950121|NCT01279200|38093841|FG001|Overall Study|Patient withdrawal due to high cost|1|||
16950122|NCT01279200|38093840|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
16950123|NCT01279200|38093841|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
16950124|NCT01279200|38093840|FG000|Overall Study|ultrasound screening failure|0|||
16950125|NCT01279200|38093841|FG001|Overall Study|ultrasound screening failure|1|||
16950126|NCT01279200|38093840|FG000|Overall Study|Lost to Follow-up|0|||
16950127|NCT01279200|38093841|FG001|Overall Study|Lost to Follow-up|1|||
16950128|NCT01279200|38093840|FG000|Overall Study|Adverse Event|1|||
16950129|NCT01279200|38093841|FG001|Overall Study|Adverse Event|0|||
16950130|NCT01273818|38093850|FG000|Overall Study|Physician Decision|13|||
16950131|NCT01273818|38093851|FG001|Overall Study|Physician Decision|2|||
16950132|NCT01273818|38093852|FG002|Overall Study|Physician Decision|9|||
16950133|NCT01245387|38093860|FG000|Overall Study|Lost to Follow-up|106|||
16950134|NCT01245387|38093860|FG000|Overall Study|Lack of Efficacy|195|||
16950135|NCT01245387|38093860|FG000|Overall Study|Adverse Event|9|||
16950136|NCT01245387|38093860|FG000|Overall Study|Death|3|||
16950137|NCT01245387|38093860|FG000|Overall Study|Other|131|||
16950138|NCT01245387|38093860|FG000|Overall Study|Missing discontinuation status|369|||
16950139|NCT01037218|38093868|FG000|Overall Study|Adverse Event|4|||
16950140|NCT01037218|38093869|FG001|Overall Study|Adverse Event|2|||
16950141|NCT01037218|38093870|FG002|Overall Study|Adverse Event|2|||
16950142|NCT01037218|38093871|FG003|Overall Study|Adverse Event|1|||
16950143|NCT01037218|38093868|FG000|Overall Study|Lack of Efficacy|0|||
16950144|NCT01037218|38093869|FG001|Overall Study|Lack of Efficacy|2|||
16950145|NCT01037218|38093870|FG002|Overall Study|Lack of Efficacy|1|||
16950146|NCT01037218|38093871|FG003|Overall Study|Lack of Efficacy|5|||
16950147|NCT01037218|38093868|FG000|Overall Study|Lost to Follow-up|3|||
16950148|NCT01037218|38093869|FG001|Overall Study|Lost to Follow-up|5|||
16950149|NCT01037218|38093870|FG002|Overall Study|Lost to Follow-up|4|||
16950150|NCT01037218|38093871|FG003|Overall Study|Lost to Follow-up|2|||
16950151|NCT01037218|38093868|FG000|Overall Study|Withdrawal by Subject|6|||
16950152|NCT01037218|38093869|FG001|Overall Study|Withdrawal by Subject|7|||
16950153|NCT01037218|38093870|FG002|Overall Study|Withdrawal by Subject|7|||
16950154|NCT01037218|38093871|FG003|Overall Study|Withdrawal by Subject|4|||
16950155|NCT01037218|38093868|FG000|Overall Study|Partner Withdrew Consent|0|||
16950156|NCT01037218|38093869|FG001|Overall Study|Partner Withdrew Consent|3|||
16950157|NCT01037218|38093870|FG002|Overall Study|Partner Withdrew Consent|2|||
16950158|NCT01037218|38093871|FG003|Overall Study|Partner Withdrew Consent|1|||
16950159|NCT01037218|38093868|FG000|Overall Study|Protocol Violation|0|||
16950160|NCT01037218|38093869|FG001|Overall Study|Protocol Violation|0|||
16950161|NCT01037218|38093870|FG002|Overall Study|Protocol Violation|2|||
16950162|NCT01037218|38093871|FG003|Overall Study|Protocol Violation|2|||
16950163|NCT01037218|38093868|FG000|Overall Study|Various|3|||
16950164|NCT01037218|38093869|FG001|Overall Study|Various|2|||
16950165|NCT01037218|38093870|FG002|Overall Study|Various|3|||
16950166|NCT01037218|38093871|FG003|Overall Study|Various|1|||
16950167|NCT01038856|38093881|FG000|Overall Study|Adverse Event|2|||
16950168|NCT01066546|38093887|FG000|Overall Study|Study terminated by sponsor|5|||
16950169|NCT01272804|38093897|FG000|Overall Study|Adverse Event|1|||
16950170|NCT01272804|38093898|FG001|Overall Study|Adverse Event|0|||
16950171|NCT01272804|38093899|FG002|Overall Study|Adverse Event|0|||
16950172|NCT01272804|38093900|FG003|Overall Study|Adverse Event|0|||
16950173|NCT01272804|38093901|FG004|Overall Study|Adverse Event|2|||
16950174|NCT01272804|38093902|FG005|Overall Study|Adverse Event|1|||
16950175|NCT01269918|38093918|FG000|Overall Study|Did not receive study drug|0|||
16950176|NCT01269918|38093919|FG001|Overall Study|Did not receive study drug|3|||
16950177|NCT01036594|38093925|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
16950178|NCT01036594|38093926|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
16950179|NCT01036594|38093925|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
16950180|NCT01036594|38093926|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
16950181|NCT01036594|38093925|FG000|Week 12 Evaluation|Adverse Event|5|||
16950182|NCT01036594|38093926|FG001|Week 12 Evaluation|Adverse Event|0|||
16950183|NCT01036594|38093925|FG000|Week 12 Evaluation|Physician Decision|1|||
16950184|NCT01036594|38093926|FG001|Week 12 Evaluation|Physician Decision|0|||
16950185|NCT01036594|38093925|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
16950186|NCT01036594|38093926|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
16950187|NCT01036594|38093925|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
16950188|NCT01036594|38093926|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
16950189|NCT01036594|38093925|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
16950190|NCT01036594|38093926|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
16950191|NCT01036594|38093925|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
16950192|NCT01036594|38093926|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
16950193|NCT01036594|38093925|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
16950194|NCT01036594|38093926|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
16950195|NCT01036438|38093934|FG000|Overall Study|Adverse Event|7|||
16950196|NCT01036438|38093935|FG001|Overall Study|Adverse Event|8|||
16950197|NCT01036438|38093934|FG000|Overall Study|Death|0|||
16950198|NCT01036438|38093935|FG001|Overall Study|Death|1|||
16950199|NCT01036438|38093934|FG000|Overall Study|No effect of study treatment|3|||
16950200|NCT01036438|38093935|FG001|Overall Study|No effect of study treatment|1|||
16950201|NCT01268514|38093941|FG000|Overall Study|Adverse Event|20|||
16950202|NCT01268514|38093941|FG000|Overall Study|Death|8|||
16950203|NCT01268514|38093941|FG000|Overall Study|Lost to Follow-up|5|||
16950204|NCT01268514|38093941|FG000|Overall Study|Withdrawal by Subject|3|||
16950205|NCT01268514|38093941|FG000|Overall Study|Withdrawal by Surgeon|5|||
16950206|NCT01268046|38093951|FG000|Overall Study|Withdrawal by Subject|1|||
16950207|NCT01268046|38093952|FG001|Overall Study|Withdrawal by Subject|0|||
16950208|NCT01268046|38093953|FG002|Overall Study|Withdrawal by Subject|0|||
16950209|NCT01268046|38093954|FG003|Overall Study|Withdrawal by Subject|1|||
16950210|NCT01268046|38093951|FG000|Overall Study|Lost to Follow-up|0|||
16950211|NCT01268046|38093952|FG001|Overall Study|Lost to Follow-up|0|||
16950212|NCT01268046|38093953|FG002|Overall Study|Lost to Follow-up|1|||
16950213|NCT01268046|38093954|FG003|Overall Study|Lost to Follow-up|0|||
16950214|NCT01267266|38093964|FG000|Enrollment Phase|Withdrawal by Subject|2|||
16950215|NCT01267266|38093965|FG001|Enrollment Phase|Withdrawal by Subject|0|||
16950216|NCT01267266|38093964|FG000|Lead-in Phase|Lack of Efficacy|20|||
16950217|NCT01267266|38093965|FG001|Lead-in Phase|Lack of Efficacy|0|||
16950218|NCT01267266|38093964|FG000|Lead-in Phase|Adverse Event|2|||
16950219|NCT01267266|38093965|FG001|Lead-in Phase|Adverse Event|0|||
16950220|NCT01267266|38093964|FG000|Lead-in Phase|Withdrawal by Subject|1|||
16950221|NCT01267266|38093965|FG001|Lead-in Phase|Withdrawal by Subject|0|||
16950222|NCT01034176|38093976|FG000|Overall Study|Physician Decision|2|||
16950223|NCT01034176|38093977|FG001|Overall Study|Physician Decision|0|||
16950224|NCT01034176|38093976|FG000|Overall Study|Withdrawal by Subject|0|||
16950225|NCT01034176|38093977|FG001|Overall Study|Withdrawal by Subject|1|||
16950226|NCT01034176|38093976|FG000|Overall Study|Lost to Follow-up|0|||
16950227|NCT01034176|38093977|FG001|Overall Study|Lost to Follow-up|1|||
16950228|NCT01033942|38093986|FG000|Overall Study|Withdrawal by Subject|1|||
16950229|NCT01033942|38093987|FG001|Overall Study|Withdrawal by Subject|1|||
16774199|NCT02452892|37713487|FG000|Follow-up|Withdrawal by Subject|0|||
16950230|NCT01033942|38093988|FG002|Overall Study|Withdrawal by Subject|1|||
16950231|NCT01033942|38093986|FG000|Overall Study|Lost to Follow-up|1|||
16950232|NCT01033942|38093987|FG001|Overall Study|Lost to Follow-up|0|||
16950233|NCT01033942|38093988|FG002|Overall Study|Lost to Follow-up|0|||
16950234|NCT01033942|38093986|FG000|Overall Study|Enrolled in Extension Study|0|||
16950235|NCT01033942|38093987|FG001|Overall Study|Enrolled in Extension Study|3|||
16950236|NCT01033942|38093988|FG002|Overall Study|Enrolled in Extension Study|0|||
16950237|NCT01062256|38094001|FG000|Overall Study|Adverse Event|1|||
16950238|NCT01062256|38094002|FG001|Overall Study|Adverse Event|0|||
16950239|NCT01062256|38094003|FG002|Overall Study|Adverse Event|0|||
16950240|NCT01062256|38094001|FG000|Overall Study|Withdrawal by Subject|1|||
16950241|NCT01062256|38094002|FG001|Overall Study|Withdrawal by Subject|1|||
16950242|NCT01062256|38094003|FG002|Overall Study|Withdrawal by Subject|1|||
16950243|NCT01062256|38094001|FG000|Overall Study|Ineligible|1|||
16950244|NCT01062256|38094002|FG001|Overall Study|Ineligible|4|||
16950245|NCT01062256|38094003|FG002|Overall Study|Ineligible|3|||
16950246|NCT01062256|38094001|FG000|Overall Study|Administrative|0|||
16950247|NCT01062256|38094002|FG001|Overall Study|Administrative|2|||
16950248|NCT01062256|38094003|FG002|Overall Study|Administrative|0|||
16950249|NCT01029886|38094013|FG000|Overall Study|Adverse Event|12|||
16950250|NCT01029886|38094014|FG001|Overall Study|Adverse Event|25|||
16950251|NCT01029886|38094013|FG000|Overall Study|Lost to Follow-up|1|||
16950252|NCT01029886|38094014|FG001|Overall Study|Lost to Follow-up|0|||
16950253|NCT01029886|38094013|FG000|Overall Study|Physician Decision|2|||
16950254|NCT01029886|38094014|FG001|Overall Study|Physician Decision|6|||
16950255|NCT01029886|38094013|FG000|Overall Study|Protocol Violation|17|||
16950256|NCT01029886|38094014|FG001|Overall Study|Protocol Violation|5|||
16950257|NCT01029886|38094013|FG000|Overall Study|Withdrawal by Subject|8|||
16950258|NCT01029886|38094014|FG001|Overall Study|Withdrawal by Subject|18|||
16950259|NCT01029886|38094013|FG000|Overall Study|Entry Criteria Not Met|13|||
16950260|NCT01029886|38094014|FG001|Overall Study|Entry Criteria Not Met|5|||
16950261|NCT01029886|38094013|FG000|Overall Study|Sponsor Decision|1|||
16950262|NCT01029886|38094014|FG001|Overall Study|Sponsor Decision|0|||
16950263|NCT01029886|38094013|FG000|Overall Study|Loss Glucose Control|7|||
16950264|NCT01029886|38094014|FG001|Overall Study|Loss Glucose Control|1|||
16950265|NCT01244763|38094030|FG000|Overall Study|Adverse Event|1|||
16950266|NCT01244763|38094031|FG001|Overall Study|Adverse Event|0|||
16950267|NCT01244763|38094032|FG002|Overall Study|Adverse Event|0|||
16950268|NCT01244763|38094033|FG003|Overall Study|Adverse Event|0|||
16950269|NCT01244763|38094034|FG004|Overall Study|Adverse Event|0|||
16950270|NCT01244763|38094035|FG005|Overall Study|Adverse Event|1|||
16950271|NCT01244763|38094030|FG000|Overall Study|Death|1|||
16950272|NCT01244763|38094031|FG001|Overall Study|Death|0|||
16950273|NCT01244763|38094032|FG002|Overall Study|Death|1|||
16950274|NCT01244763|38094033|FG003|Overall Study|Death|0|||
16950275|NCT01244763|38094034|FG004|Overall Study|Death|2|||
16950276|NCT01244763|38094035|FG005|Overall Study|Death|0|||
16950277|NCT01244763|38094030|FG000|Overall Study|Physician Decision|0|||
16950278|NCT01244763|38094031|FG001|Overall Study|Physician Decision|0|||
16950279|NCT01244763|38094032|FG002|Overall Study|Physician Decision|1|||
16950280|NCT01244763|38094033|FG003|Overall Study|Physician Decision|0|||
16950281|NCT01244763|38094034|FG004|Overall Study|Physician Decision|0|||
16950282|NCT01244763|38094035|FG005|Overall Study|Physician Decision|0|||
16950283|NCT01244763|38094030|FG000|Overall Study|Withdrawal by Subject|1|||
16950284|NCT01244763|38094031|FG001|Overall Study|Withdrawal by Subject|2|||
16950285|NCT01244763|38094032|FG002|Overall Study|Withdrawal by Subject|0|||
16950286|NCT01244763|38094033|FG003|Overall Study|Withdrawal by Subject|1|||
16950287|NCT01244763|38094034|FG004|Overall Study|Withdrawal by Subject|1|||
16950288|NCT01244763|38094035|FG005|Overall Study|Withdrawal by Subject|2|||
16950289|NCT01244763|38094030|FG000|Overall Study|Lost to Follow-up|0|||
16950290|NCT01244763|38094031|FG001|Overall Study|Lost to Follow-up|1|||
16950291|NCT01244763|38094032|FG002|Overall Study|Lost to Follow-up|0|||
16950292|NCT01244763|38094033|FG003|Overall Study|Lost to Follow-up|0|||
16950293|NCT01244763|38094034|FG004|Overall Study|Lost to Follow-up|0|||
16950294|NCT01244763|38094035|FG005|Overall Study|Lost to Follow-up|0|||
16950295|NCT01244763|38094030|FG000|Overall Study|Enrolled into the Extension Study|0|||
16950296|NCT01244763|38094031|FG001|Overall Study|Enrolled into the Extension Study|0|||
16950297|NCT01244763|38094032|FG002|Overall Study|Enrolled into the Extension Study|0|||
16950298|NCT01244763|38094033|FG003|Overall Study|Enrolled into the Extension Study|0|||
16950299|NCT01244763|38094034|FG004|Overall Study|Enrolled into the Extension Study|0|||
16950300|NCT01244763|38094035|FG005|Overall Study|Enrolled into the Extension Study|1|||
16950301|NCT01244061|38094051|FG000|Overall Study|Death|1|||
16950302|NCT01244061|38094052|FG001|Overall Study|Death|0|||
16950303|NCT01244061|38094051|FG000|Overall Study|Did not meet entrance criteria|1|||
16950304|NCT01244061|38094052|FG001|Overall Study|Did not meet entrance criteria|0|||
16950305|NCT01244061|38094051|FG000|Overall Study|Lack of Efficacy|1|||
16950306|NCT01244061|38094052|FG001|Overall Study|Lack of Efficacy|3|||
16950307|NCT01244061|38094051|FG000|Overall Study|Lost to Follow-up|34|||
16950308|NCT01244061|38094052|FG001|Overall Study|Lost to Follow-up|30|||
16950309|NCT01244061|38094051|FG000|Overall Study|Withdrawal by Subject|29|||
16950310|NCT01244061|38094052|FG001|Overall Study|Withdrawal by Subject|46|||
16950311|NCT01244061|38094051|FG000|Overall Study|Other|8|||
16950312|NCT01244061|38094052|FG001|Overall Study|Other|19|||
16950313|NCT01244061|38094051|FG000|Overall Study|Protocol Violation|1|||
16950314|NCT01244061|38094052|FG001|Overall Study|Protocol Violation|1|||
16950315|NCT01244061|38094051|FG000|Overall Study|Adverse Event|5|||
16950316|NCT01244061|38094052|FG001|Overall Study|Adverse Event|2|||
16950317|NCT01244061|38094051|FG000|Overall Study|Randomized but not treated|2|||
16950318|NCT01244061|38094052|FG001|Overall Study|Randomized but not treated|2|||
16950319|NCT01243671|38094058|FG000|Overall Study|Adverse Event|3|||
16950320|NCT01243671|38094058|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
16950321|NCT01243671|38094058|FG000|Overall Study|Other|1|||
16950322|NCT01240785|38094064|FG000|Overall Study|Lost to Follow-up|1|||
16950323|NCT01240785|38094065|FG001|Overall Study|Lost to Follow-up|0|||
16950324|NCT01240785|38094064|FG000|Overall Study|Protocol Violation|0|||
16950325|NCT01240785|38094065|FG001|Overall Study|Protocol Violation|3|||
16950326|NCT01240551|38094073|FG000|Overall Study|Refused further treatment|3|||
16950327|NCT01240551|38094074|FG001|Overall Study|Refused further treatment|2|||
16950328|NCT01240551|38094073|FG000|Overall Study|Lost to Follow-up|1|||
16950329|NCT01240551|38094074|FG001|Overall Study|Lost to Follow-up|1|||
16950330|NCT01239381|38094080|FG000|Overall Study|Protocol Violation|1|||
16950331|NCT01239381|38094080|FG000|Overall Study|Withdrawal by Subject|1|||
16950332|NCT01266876|38094090|FG000|Overall Study|Adverse Event|0|||
16950333|NCT01266876|38094091|FG001|Overall Study|Adverse Event|0|||
16950334|NCT01266876|38094092|FG002|Overall Study|Adverse Event|0|||
16950335|NCT01266876|38094093|FG003|Overall Study|Adverse Event|1|||
16950336|NCT01266876|38094094|FG004|Overall Study|Adverse Event|0|||
16950337|NCT01266642|38094108|FG000|Overall Study|Protocol Violation|0|||
16950338|NCT01266642|38094109|FG001|Overall Study|Protocol Violation|1|||
16950339|NCT01033240|38094118|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
16950340|NCT01033240|38094119|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
16950341|NCT01033240|38094120|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
16950342|NCT01033240|38094118|FG000|Overall Study|Death|2|||
16950343|NCT01033240|38094119|FG001|Overall Study|Death|0|||
16950344|NCT01033240|38094120|FG002|Overall Study|Death|0|||
16950345|NCT01033240|38094118|FG000|Overall Study|Withdrew Consent|2|||
16950346|NCT01033240|38094119|FG001|Overall Study|Withdrew Consent|9|||
16950347|NCT01033240|38094120|FG002|Overall Study|Withdrew Consent|2|||
16950348|NCT01033240|38094118|FG000|Overall Study|Disease Progression|35|||
16950349|NCT01033240|38094119|FG001|Overall Study|Disease Progression|32|||
16950350|NCT01033240|38094120|FG002|Overall Study|Disease Progression|41|||
16950351|NCT01033240|38094118|FG000|Overall Study|Investigator Discretion|0|||
16950352|NCT01033240|38094119|FG001|Overall Study|Investigator Discretion|0|||
16950353|NCT01033240|38094120|FG002|Overall Study|Investigator Discretion|2|||
16950354|NCT01033240|38094118|FG000|Overall Study|Other|0|||
16950355|NCT01033240|38094119|FG001|Overall Study|Other|1|||
16950356|NCT01033240|38094120|FG002|Overall Study|Other|2|||
16950357|NCT01266018|38094128|FG000|Overall Study|Physician Decision|1|||
16950358|NCT01266018|38094129|FG001|Overall Study|Physician Decision|0|||
16950359|NCT01266018|38094128|FG000|Overall Study|Progressive disease|0|||
16950360|NCT01266018|38094129|FG001|Overall Study|Progressive disease|1|||
16950361|NCT01032382|38094137|FG000|Overall Study|Disease dissemination|1|||
16950362|NCT01032382|38094138|FG001|Overall Study|Disease dissemination|1|||
16950363|NCT01032382|38094137|FG000|Overall Study|Treatment failure|3|||
16950364|NCT01032382|38094138|FG001|Overall Study|Treatment failure|1|||
16950365|NCT01032382|38094137|FG000|Overall Study|Index lesion relapse|1|||
16950366|NCT01032382|38094138|FG001|Overall Study|Index lesion relapse|3|||
16950367|NCT01029652|38094146|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
16950368|NCT01029652|38094147|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
16950369|NCT01029652|38094146|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
16950370|NCT01029652|38094147|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
16950371|NCT01029652|38094146|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
16950372|NCT01029652|38094147|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
16950373|NCT01029652|38094146|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
16950374|NCT01029652|38094147|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
16950375|NCT01029652|38094146|FG000|Core Study (0-12 Weeks)|Death|0|||
16950376|NCT01029652|38094147|FG001|Core Study (0-12 Weeks)|Death|1|||
16950377|NCT01029652|38094146|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
16950378|NCT01029652|38094147|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
16950379|NCT01029652|38094146|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
16950380|NCT01029652|38094147|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
16950381|NCT01029652|38094146|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
16950382|NCT01029652|38094147|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
16950383|NCT01029652|38094146|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
16950384|NCT01029652|38094147|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
16950385|NCT01029652|38094146|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
16950386|NCT01029652|38094147|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
16950387|NCT01029652|38094146|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
16950388|NCT01029652|38094147|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
16950389|NCT01029652|38094146|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
16950390|NCT01029652|38094147|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
16950391|NCT01029340|38094176|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
16950392|NCT01029340|38094177|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
16950393|NCT01029340|38094178|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
16950394|NCT01029340|38094179|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
16950395|NCT01029340|38094180|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
16950396|NCT01029340|38094181|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
16950397|NCT01029340|38094176|FG000|Part B Treatment Period|Protocol Violation|0|||
16950398|NCT01029340|38094177|FG001|Part B Treatment Period|Protocol Violation|0|||
16950399|NCT01029340|38094178|FG002|Part B Treatment Period|Protocol Violation|1|||
16950400|NCT01029340|38094179|FG003|Part B Treatment Period|Protocol Violation|0|||
16950401|NCT01029340|38094180|FG004|Part B Treatment Period|Protocol Violation|0|||
16950402|NCT01029340|38094181|FG005|Part B Treatment Period|Protocol Violation|0|||
16950403|NCT01029340|38094176|FG000|Extension Period|Adverse Event|0|||
16950404|NCT01029340|38094177|FG001|Extension Period|Adverse Event|0|||
16950405|NCT01029340|38094178|FG002|Extension Period|Adverse Event|0|||
16950406|NCT01029340|38094179|FG003|Extension Period|Adverse Event|0|||
16950407|NCT01029340|38094180|FG004|Extension Period|Adverse Event|0|||
16950408|NCT01029340|38094181|FG005|Extension Period|Adverse Event|1|||
16950409|NCT01029340|38094176|FG000|Extension Period|starting another study|0|||
16950410|NCT01029340|38094177|FG001|Extension Period|starting another study|0|||
16950411|NCT01029340|38094178|FG002|Extension Period|starting another study|0|||
16950412|NCT01029340|38094179|FG003|Extension Period|starting another study|0|||
16950413|NCT01029340|38094180|FG004|Extension Period|starting another study|0|||
16950414|NCT01029340|38094181|FG005|Extension Period|starting another study|8|||
16950415|NCT01029340|38094176|FG000|Extension Period|non-compliance|0|||
16950416|NCT01029340|38094177|FG001|Extension Period|non-compliance|0|||
16950417|NCT01029340|38094178|FG002|Extension Period|non-compliance|0|||
16950418|NCT01029340|38094179|FG003|Extension Period|non-compliance|0|||
16950419|NCT01029340|38094180|FG004|Extension Period|non-compliance|0|||
16950420|NCT01029340|38094181|FG005|Extension Period|non-compliance|1|||
16950421|NCT01029340|38094176|FG000|Extension Period|Withdrawal by Subject|0|||
16950422|NCT01029340|38094177|FG001|Extension Period|Withdrawal by Subject|0|||
16950423|NCT01029340|38094178|FG002|Extension Period|Withdrawal by Subject|0|||
16950424|NCT01029340|38094179|FG003|Extension Period|Withdrawal by Subject|0|||
16950425|NCT01029340|38094180|FG004|Extension Period|Withdrawal by Subject|0|||
16950426|NCT01029340|38094181|FG005|Extension Period|Withdrawal by Subject|1|||
16950427|NCT01029340|38094176|FG000|Extension Period|Physician Decision|0|||
16950428|NCT01029340|38094177|FG001|Extension Period|Physician Decision|0|||
16950429|NCT01029340|38094178|FG002|Extension Period|Physician Decision|0|||
16950430|NCT01029340|38094179|FG003|Extension Period|Physician Decision|0|||
16950431|NCT01029340|38094180|FG004|Extension Period|Physician Decision|0|||
16950432|NCT01029340|38094181|FG005|Extension Period|Physician Decision|1|||
16950433|NCT01265550|38094198|FG000|Pre Randomization|Withdrawal by Subject|0|||
16950434|NCT01265550|38094199|FG001|Pre Randomization|Withdrawal by Subject|0|||
16950435|NCT01265550|38094200|FG002|Pre Randomization|Withdrawal by Subject|0|||
16950436|NCT01265550|38094201|FG003|Pre Randomization|Withdrawal by Subject|70|||
16950437|NCT01265550|38094198|FG000|Pre Randomization|Technical Exclusions|0|||
16950438|NCT01265550|38094199|FG001|Pre Randomization|Technical Exclusions|0|||
16950439|NCT01265550|38094200|FG002|Pre Randomization|Technical Exclusions|0|||
16950440|NCT01265550|38094201|FG003|Pre Randomization|Technical Exclusions|54|||
16950441|NCT01265550|38094198|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
16950442|NCT01265550|38094199|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
16950443|NCT01265550|38094200|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
16950444|NCT01265550|38094201|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
16950445|NCT01265550|38094198|FG000|Pre Randomization|Non-GERD organic disorders|0|||
16950446|NCT01265550|38094199|FG001|Pre Randomization|Non-GERD organic disorders|0|||
16950447|NCT01265550|38094200|FG002|Pre Randomization|Non-GERD organic disorders|0|||
16950448|NCT01265550|38094201|FG003|Pre Randomization|Non-GERD organic disorders|23|||
16950449|NCT01265550|38094198|FG000|Pre Randomization|Functional heartburn|0|||
16950450|NCT01265550|38094199|FG001|Pre Randomization|Functional heartburn|0|||
16950451|NCT01265550|38094200|FG002|Pre Randomization|Functional heartburn|0|||
16950452|NCT01265550|38094201|FG003|Pre Randomization|Functional heartburn|99|||
16950453|NCT01265394|38094215|FG000|Overall Study|Subjects withdrawn|37|||
16950454|NCT01029262|38094222|FG000|Overall Study|Adverse Event|9|||
16950455|NCT01029262|38094223|FG001|Overall Study|Adverse Event|52|||
16950456|NCT01029262|38094222|FG000|Overall Study|Lack of therapeutic effect|57|||
16950457|NCT01029262|38094223|FG001|Overall Study|Lack of therapeutic effect|76|||
16950458|NCT01029262|38094222|FG000|Overall Study|Withdrawal by Subject|10|||
16950459|NCT01029262|38094223|FG001|Overall Study|Withdrawal by Subject|17|||
16774200|NCT02452892|37713488|FG001|Follow-up|Withdrawal by Subject|0|||
16950460|NCT01029262|38094222|FG000|Overall Study|Protocol Violation|2|||
16950461|NCT01029262|38094223|FG001|Overall Study|Protocol Violation|3|||
16950462|NCT01029262|38094222|FG000|Overall Study|Miscellaneous|1|||
16950463|NCT01029262|38094223|FG001|Overall Study|Miscellaneous|9|||
16950464|NCT01029262|38094222|FG000|Overall Study|Death|0|||
16950465|NCT01029262|38094223|FG001|Overall Study|Death|3|||
16950466|NCT01028560|38094236|FG000|Overall Study|Lack of Efficacy|3|||
16950467|NCT01028560|38094237|FG001|Overall Study|Lack of Efficacy|6|||
16950468|NCT01028560|38094236|FG000|Overall Study|Withdrawal by Subject|7|||
16950469|NCT01028560|38094237|FG001|Overall Study|Withdrawal by Subject|12|||
16950470|NCT01061710|38094244|FG000|Overall Study|Protocol Violation|14|||
16950471|NCT01028014|38094254|FG000|Overall Study|Lost to Follow-up|1|||
16950472|NCT01028014|38094255|FG001|Overall Study|Lost to Follow-up|2|||
16950473|NCT01028014|38094256|FG002|Overall Study|Lost to Follow-up|0|||
16950474|NCT01028014|38094257|FG003|Overall Study|Lost to Follow-up|1|||
16950475|NCT01028014|38094258|FG004|Overall Study|Lost to Follow-up|1|||
16950476|NCT01028014|38094259|FG005|Overall Study|Lost to Follow-up|2|||
16950477|NCT01264770|38094279|FG000|Overall Study|Not reported|0|||
16950478|NCT01264770|38094280|FG001|Overall Study|Not reported|0|||
16950479|NCT01264770|38094281|FG002|Overall Study|Not reported|1|||
16950480|NCT01264770|38094282|FG003|Overall Study|Not reported|0|||
16950481|NCT01264770|38094283|FG004|Overall Study|Not reported|0|||
16950482|NCT01264770|38094284|FG005|Overall Study|Not reported|0|||
16950483|NCT01264770|38094279|FG000|Overall Study|e.g., change in circumstances|8|||
16950484|NCT01264770|38094280|FG001|Overall Study|e.g., change in circumstances|3|||
16950485|NCT01264770|38094281|FG002|Overall Study|e.g., change in circumstances|3|||
16950486|NCT01264770|38094282|FG003|Overall Study|e.g., change in circumstances|3|||
16950487|NCT01264770|38094283|FG004|Overall Study|e.g., change in circumstances|4|||
16950488|NCT01264770|38094284|FG005|Overall Study|e.g., change in circumstances|4|||
16950489|NCT01264770|38094279|FG000|Overall Study|Severe non-compliance to protocol|0|||
16950490|NCT01264770|38094280|FG001|Overall Study|Severe non-compliance to protocol|0|||
16950491|NCT01264770|38094281|FG002|Overall Study|Severe non-compliance to protocol|1|||
16950492|NCT01264770|38094282|FG003|Overall Study|Severe non-compliance to protocol|1|||
16950493|NCT01264770|38094283|FG004|Overall Study|Severe non-compliance to protocol|0|||
16950494|NCT01264770|38094284|FG005|Overall Study|Severe non-compliance to protocol|0|||
16950495|NCT01264770|38094279|FG000|Overall Study|Lack of therapeutic response|1|||
16950496|NCT01264770|38094280|FG001|Overall Study|Lack of therapeutic response|0|||
16950497|NCT01264770|38094281|FG002|Overall Study|Lack of therapeutic response|2|||
16950498|NCT01264770|38094282|FG003|Overall Study|Lack of therapeutic response|1|||
16950499|NCT01264770|38094283|FG004|Overall Study|Lack of therapeutic response|1|||
16950500|NCT01264770|38094284|FG005|Overall Study|Lack of therapeutic response|0|||
16950501|NCT01264770|38094279|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
16950502|NCT01264770|38094280|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
16950503|NCT01264770|38094281|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
16950504|NCT01264770|38094282|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
16950505|NCT01264770|38094283|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
16950506|NCT01264770|38094284|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
16950507|NCT01264770|38094279|FG000|Overall Study|Lost to Follow-up|0|||
16950508|NCT01264770|38094280|FG001|Overall Study|Lost to Follow-up|0|||
16950509|NCT01264770|38094281|FG002|Overall Study|Lost to Follow-up|1|||
16950510|NCT01264770|38094282|FG003|Overall Study|Lost to Follow-up|1|||
16950511|NCT01264770|38094283|FG004|Overall Study|Lost to Follow-up|0|||
16950512|NCT01264770|38094284|FG005|Overall Study|Lost to Follow-up|0|||
16950513|NCT01264770|38094279|FG000|Overall Study|Adverse Event|7|||
16950514|NCT01264770|38094280|FG001|Overall Study|Adverse Event|7|||
16950515|NCT01264770|38094281|FG002|Overall Study|Adverse Event|8|||
16950516|NCT01264770|38094282|FG003|Overall Study|Adverse Event|0|||
16950517|NCT01264770|38094283|FG004|Overall Study|Adverse Event|2|||
16950518|NCT01264770|38094284|FG005|Overall Study|Adverse Event|1|||
16950519|NCT01027702|38094304|FG000|Overall Study|Received subsequent therapy|1|||
16950520|NCT01027702|38094305|FG001|Overall Study|Received subsequent therapy|2|||
16950521|NCT01027702|38094306|FG002|Overall Study|Received subsequent therapy|0|||
16950522|NCT01027702|38094307|FG003|Overall Study|Received subsequent therapy|4|||
16950523|NCT01027702|38094308|FG004|Overall Study|Received subsequent therapy|1|||
16950524|NCT01027702|38094309|FG005|Overall Study|Received subsequent therapy|0|||
16950525|NCT01027702|38094310|FG006|Overall Study|Received subsequent therapy|1|||
16950526|NCT01027702|38094304|FG000|Overall Study|Death|0|||
16950527|NCT01027702|38094305|FG001|Overall Study|Death|0|||
16950528|NCT01027702|38094306|FG002|Overall Study|Death|1|||
16950529|NCT01027702|38094307|FG003|Overall Study|Death|0|||
16950530|NCT01027702|38094308|FG004|Overall Study|Death|0|||
16950531|NCT01027702|38094309|FG005|Overall Study|Death|0|||
16950532|NCT01027702|38094310|FG006|Overall Study|Death|0|||
16950533|NCT01302080|38094324|FG000|Overall Study|Withdrew Consent|92|||
16950534|NCT01302080|38094325|FG001|Overall Study|Withdrew Consent|39|||
16950535|NCT01302080|38094324|FG000|Overall Study|Patient/Family Moved|28|||
16950536|NCT01302080|38094325|FG001|Overall Study|Patient/Family Moved|3|||
16950537|NCT01302080|38094324|FG000|Overall Study|Lost to Follow-up|192|||
16950538|NCT01302080|38094325|FG001|Overall Study|Lost to Follow-up|93|||
16950539|NCT01302080|38094324|FG000|Overall Study|Death|1|||
16950540|NCT01302080|38094325|FG001|Overall Study|Death|0|||
16950541|NCT01302080|38094324|FG000|Overall Study|Other|52|||
16950542|NCT01302080|38094325|FG001|Overall Study|Other|8|||
16950543|NCT01302080|38094324|FG000|Overall Study|Reason Missing For Discontinuation|1|||
16950544|NCT01302080|38094325|FG001|Overall Study|Reason Missing For Discontinuation|0|||
16950545|NCT01238991|38094365|FG000|Overall Study|Adverse Event|1|||
16950546|NCT01238991|38094366|FG001|Overall Study|Adverse Event|0|||
16950547|NCT01238991|38094367|FG002|Overall Study|Adverse Event|3|||
16950548|NCT01238991|38094368|FG003|Overall Study|Adverse Event|1|||
16950549|NCT01238991|38094369|FG004|Overall Study|Adverse Event|1|||
16950550|NCT01238991|38094370|FG005|Overall Study|Adverse Event|0|||
16950551|NCT01238991|38094371|FG006|Overall Study|Adverse Event|1|||
16950552|NCT01238991|38094372|FG007|Overall Study|Adverse Event|1|||
16950553|NCT01238991|38094373|FG008|Overall Study|Adverse Event|0|||
16950554|NCT01238991|38094374|FG009|Overall Study|Adverse Event|0|||
16950555|NCT01238991|38094365|FG000|Overall Study|Death|0|||
16950556|NCT01238991|38094366|FG001|Overall Study|Death|0|||
16950557|NCT01238991|38094367|FG002|Overall Study|Death|0|||
16950558|NCT01238991|38094368|FG003|Overall Study|Death|1|||
16950559|NCT01238991|38094369|FG004|Overall Study|Death|0|||
16950560|NCT01238991|38094370|FG005|Overall Study|Death|0|||
16950561|NCT01238991|38094371|FG006|Overall Study|Death|0|||
16950562|NCT01238991|38094372|FG007|Overall Study|Death|0|||
16950563|NCT01238991|38094373|FG008|Overall Study|Death|0|||
16950564|NCT01238991|38094374|FG009|Overall Study|Death|0|||
16950565|NCT01238991|38094365|FG000|Overall Study|Lack of Efficacy|0|||
16950566|NCT01238991|38094366|FG001|Overall Study|Lack of Efficacy|0|||
16950567|NCT01238991|38094367|FG002|Overall Study|Lack of Efficacy|1|||
16950568|NCT01238991|38094368|FG003|Overall Study|Lack of Efficacy|0|||
16950569|NCT01238991|38094369|FG004|Overall Study|Lack of Efficacy|0|||
16950570|NCT01238991|38094370|FG005|Overall Study|Lack of Efficacy|0|||
16950571|NCT01238991|38094371|FG006|Overall Study|Lack of Efficacy|0|||
16950572|NCT01238991|38094372|FG007|Overall Study|Lack of Efficacy|0|||
16774201|NCT02452892|37713489|FG002|Follow-up|Withdrawal by Subject|0|||
16774202|NCT02452892|37713490|FG003|Follow-up|Withdrawal by Subject|1|||
16774203|NCT02452892|37713487|FG000|Follow-up|Subject left town on Day 42|1|||
16774204|NCT02452892|37713488|FG001|Follow-up|Subject left town on Day 42|0|||
16774205|NCT02452892|37713489|FG002|Follow-up|Subject left town on Day 42|0|||
16774206|NCT02452892|37713490|FG003|Follow-up|Subject left town on Day 42|0|||
16774207|NCT02135848|37713505|FG000|Overall Study|Adverse Event|2|||
16950573|NCT01238991|38094373|FG008|Overall Study|Lack of Efficacy|1|||
16950574|NCT01238991|38094374|FG009|Overall Study|Lack of Efficacy|0|||
16950575|NCT01238991|38094365|FG000|Overall Study|Withdrawal by Subject|0|||
16950576|NCT01238991|38094366|FG001|Overall Study|Withdrawal by Subject|0|||
16950577|NCT01238991|38094367|FG002|Overall Study|Withdrawal by Subject|1|||
16950578|NCT01238991|38094368|FG003|Overall Study|Withdrawal by Subject|0|||
16950579|NCT01238991|38094369|FG004|Overall Study|Withdrawal by Subject|0|||
16950580|NCT01238991|38094370|FG005|Overall Study|Withdrawal by Subject|0|||
16950581|NCT01238991|38094371|FG006|Overall Study|Withdrawal by Subject|0|||
16950582|NCT01238991|38094372|FG007|Overall Study|Withdrawal by Subject|0|||
16950583|NCT01238991|38094373|FG008|Overall Study|Withdrawal by Subject|0|||
16950584|NCT01238991|38094374|FG009|Overall Study|Withdrawal by Subject|0|||
16774208|NCT02135848|37713506|FG001|Overall Study|Adverse Event|0|||
16774209|NCT02135848|37713505|FG000|Overall Study|Withdrawal by Subject|1|||
16774210|NCT02135848|37713506|FG001|Overall Study|Withdrawal by Subject|1|||
16774211|NCT02738333|37713526|FG000|Overall Study|Death|1|||
16774212|NCT02738333|37713527|FG001|Overall Study|Death|0|||
16774213|NCT02738333|37713528|FG002|Overall Study|Death|0|||
16774214|NCT02738333|37713526|FG000|Overall Study|Lost to Follow-up|1|||
16774215|NCT02738333|37713527|FG001|Overall Study|Lost to Follow-up|0|||
16774216|NCT02738333|37713528|FG002|Overall Study|Lost to Follow-up|0|||
16774217|NCT02135692|37713536|FG000|Overall Study|Adverse Event|3|||
16774218|NCT02135692|37713536|FG000|Overall Study|Lack of Efficacy|2|||
16774219|NCT02135692|37713536|FG000|Overall Study|Protocol Violation|2|||
16774220|NCT02135692|37713536|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
16774221|NCT02135692|37713536|FG000|Overall Study|Product commercially available|159|||
16774222|NCT02135692|37713536|FG000|Overall Study|Study closed/terminated|153|||
16774223|NCT02135692|37713536|FG000|Overall Study|Lost to Follow-up|4|||
16774224|NCT02135692|37713536|FG000|Overall Study|Withdrawal by Subject|15|||
16774225|NCT02135614|37713542|FG000|Overall Study|Randomized but Not Treated|2|||
16774226|NCT02135614|37713543|FG001|Overall Study|Randomized but Not Treated|1|||
16950585|NCT01238991|38094365|FG000|Overall Study|Study Terminated by Sponsor|0|||
16950586|NCT01238991|38094366|FG001|Overall Study|Study Terminated by Sponsor|0|||
16950587|NCT01238991|38094367|FG002|Overall Study|Study Terminated by Sponsor|0|||
16950588|NCT01238991|38094368|FG003|Overall Study|Study Terminated by Sponsor|0|||
16774227|NCT02135614|37713542|FG000|Overall Study|Adverse Event|0|||
16774228|NCT02135614|37713543|FG001|Overall Study|Adverse Event|1|||
16774229|NCT02135614|37713542|FG000|Overall Study|Death|1|||
16774230|NCT02135614|37713543|FG001|Overall Study|Death|0|||
16774231|NCT02135614|37713542|FG000|Overall Study|Investigator's Discretion|0|||
16950589|NCT01238991|38094369|FG004|Overall Study|Study Terminated by Sponsor|1|||
16774232|NCT02135614|37713543|FG001|Overall Study|Investigator's Discretion|1|||
16950590|NCT01238991|38094370|FG005|Overall Study|Study Terminated by Sponsor|0|||
16950591|NCT01238991|38094371|FG006|Overall Study|Study Terminated by Sponsor|7|||
16950592|NCT01238991|38094372|FG007|Overall Study|Study Terminated by Sponsor|4|||
16950593|NCT01238991|38094373|FG008|Overall Study|Study Terminated by Sponsor|2|||
16950594|NCT01238991|38094374|FG009|Overall Study|Study Terminated by Sponsor|2|||
16950595|NCT01238991|38094365|FG000|Overall Study|Caregiver's request|0|||
16950596|NCT01238991|38094366|FG001|Overall Study|Caregiver's request|0|||
16950597|NCT01238991|38094367|FG002|Overall Study|Caregiver's request|0|||
16950598|NCT01238991|38094368|FG003|Overall Study|Caregiver's request|0|||
16950599|NCT01238991|38094369|FG004|Overall Study|Caregiver's request|0|||
16950600|NCT01238991|38094370|FG005|Overall Study|Caregiver's request|0|||
16950601|NCT01238991|38094371|FG006|Overall Study|Caregiver's request|0|||
16950602|NCT01238991|38094372|FG007|Overall Study|Caregiver's request|0|||
16950603|NCT01238991|38094373|FG008|Overall Study|Caregiver's request|1|||
16950604|NCT01238991|38094374|FG009|Overall Study|Caregiver's request|0|||
16950605|NCT01238991|38094365|FG000|Overall Study|Admission to a nursing home|1|||
16950606|NCT01238991|38094366|FG001|Overall Study|Admission to a nursing home|0|||
16950607|NCT01238991|38094367|FG002|Overall Study|Admission to a nursing home|1|||
16950608|NCT01238991|38094368|FG003|Overall Study|Admission to a nursing home|0|||
16950609|NCT01238991|38094369|FG004|Overall Study|Admission to a nursing home|0|||
16950610|NCT01238991|38094370|FG005|Overall Study|Admission to a nursing home|0|||
16950611|NCT01238991|38094371|FG006|Overall Study|Admission to a nursing home|0|||
16950612|NCT01238991|38094372|FG007|Overall Study|Admission to a nursing home|0|||
16950613|NCT01238991|38094373|FG008|Overall Study|Admission to a nursing home|0|||
16950614|NCT01238991|38094374|FG009|Overall Study|Admission to a nursing home|0|||
16950615|NCT01238835|38094399|FG000|Overall Study|Death|124|||
16950616|NCT01238835|38094399|FG000|Overall Study|Withdrawal by Subject|9|||
16950617|NCT01238835|38094399|FG000|Overall Study|Lost to Follow-up|1|||
16950618|NCT01238835|38094399|FG000|Overall Study|Site early discontinuation|2|||
16950619|NCT01032070|38094405|FG000|Overall Study|Disease progression|13|||
16950620|NCT01032070|38094406|FG001|Overall Study|Disease progression|8|||
16950621|NCT01032070|38094405|FG000|Overall Study|Medical or ethical reasons|0|||
16950622|NCT01032070|38094406|FG001|Overall Study|Medical or ethical reasons|2|||
16950623|NCT01032070|38094405|FG000|Overall Study|Withdrawal by Subject|0|||
16950624|NCT01032070|38094406|FG001|Overall Study|Withdrawal by Subject|2|||
16950625|NCT01237899|38094423|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
16950626|NCT01237899|38094424|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
16950627|NCT01237899|38094425|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
16950628|NCT01237899|38094426|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
16950629|NCT01237899|38094427|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
16950630|NCT01237899|38094428|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
16950631|NCT01237899|38094429|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
16950632|NCT01237899|38094430|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
16950633|NCT01237899|38094431|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
16950634|NCT01237899|38094432|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
16950635|NCT01237899|38094433|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
16950636|NCT01264380|38094451|FG000|Period C|Disease Progression|0|||
16950637|NCT01264380|38094452|FG001|Period C|Disease Progression|0|||
16950638|NCT01264380|38094453|FG002|Period C|Disease Progression|4|||
16950639|NCT01264380|38094451|FG000|Period C|Death|0|||
16950640|NCT01264380|38094452|FG001|Period C|Death|0|||
16950641|NCT01264380|38094453|FG002|Period C|Death|2|||
16950642|NCT01264380|38094451|FG000|Period C|Follow-up for survival status|0|||
16950643|NCT01264380|38094452|FG001|Period C|Follow-up for survival status|0|||
16950644|NCT01264380|38094453|FG002|Period C|Follow-up for survival status|6|||
16950645|NCT01264380|38094451|FG000|Period C|Withdrawal by Subject|0|||
16950646|NCT01264380|38094452|FG001|Period C|Withdrawal by Subject|0|||
16950647|NCT01264380|38094453|FG002|Period C|Withdrawal by Subject|1|||
17127696|NCT03537651|38268160|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
17127697|NCT03537651|38268160|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
17127698|NCT03537651|38268160|FG000|Overall Study|Other|1|||
17127699|NCT03723915|38268167|FG000|Screening|Failed to meet screening requirements.|2|||
17127700|NCT03723915|38268167|FG000|On Treatment|Failed to meet treatment requirements|2|||
17127701|NCT03281876|38268173|FG000|Overall Study|Adverse Event|4|||
17127702|NCT03281876|38268174|FG001|Overall Study|Adverse Event|15|||
17127703|NCT03281876|38268173|FG000|Overall Study|Lost to Follow-up|1|||
17127704|NCT03281876|38268174|FG001|Overall Study|Lost to Follow-up|4|||
17127705|NCT03281876|38268173|FG000|Overall Study|Withdrawal by Subject|11|||
17127706|NCT03281876|38268174|FG001|Overall Study|Withdrawal by Subject|15|||
17127707|NCT03281876|38268173|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
17127708|NCT03281876|38268174|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17127709|NCT03281876|38268173|FG000|Overall Study|OTHER|5|||
17127710|NCT03281876|38268174|FG001|Overall Study|OTHER|5|||
17127711|NCT02819518|38268185|FG000|Overall Study|Death|9|||
17127712|NCT02819518|38268186|FG001|Overall Study|Death|11|||
17127713|NCT02819518|38268187|FG002|Overall Study|Death|9|||
17127714|NCT02819518|38268188|FG003|Overall Study|Death|447|||
17127715|NCT02819518|38268189|FG004|Overall Study|Death|233|||
17127716|NCT02819518|38268185|FG000|Overall Study|Withdrawal by Subject|0|||
17127717|NCT02819518|38268186|FG001|Overall Study|Withdrawal by Subject|0|||
17127718|NCT02819518|38268187|FG002|Overall Study|Withdrawal by Subject|0|||
17127719|NCT02819518|38268188|FG003|Overall Study|Withdrawal by Subject|21|||
17127720|NCT02819518|38268189|FG004|Overall Study|Withdrawal by Subject|6|||
17127721|NCT02819518|38268185|FG000|Overall Study|Ongoing in Study|2|||
17127722|NCT02819518|38268186|FG001|Overall Study|Ongoing in Study|3|||
17127723|NCT02819518|38268187|FG002|Overall Study|Ongoing in Study|1|||
17127724|NCT02819518|38268188|FG003|Overall Study|Ongoing in Study|98|||
17127725|NCT02819518|38268189|FG004|Overall Study|Ongoing in Study|42|||
17127726|NCT03310580|38268206|FG000|Overall Study|Adverse Event|0|||
17127727|NCT03310580|38268207|FG001|Overall Study|Adverse Event|1|||
17127728|NCT03310580|38268208|FG002|Overall Study|Adverse Event|0|||
17127729|NCT03415022|38268231|FG000|Overall Study|Withdrawal by Subject|1|||
17127730|NCT03415022|38268232|FG001|Overall Study|Withdrawal by Subject|2|||
17127731|NCT03415022|38268231|FG000|Overall Study|COVID-19 Suspension|2|||
17127732|NCT03415022|38268232|FG001|Overall Study|COVID-19 Suspension|3|||
17127733|NCT03415022|38268231|FG000|Overall Study|Lost to Follow-up|2|||
17127734|NCT03415022|38268232|FG001|Overall Study|Lost to Follow-up|0|||
16774233|NCT02135614|37713542|FG000|Overall Study|Withdrew Consent|2|||
16950648|NCT01264380|38094451|FG000|Period C|Adverse Event|0|||
17127735|NCT02816398|38268238|FG000|Overall Study|Death|5|||
17127736|NCT02816398|38268238|FG000|Overall Study|Lack of Efficacy|8|||
17127737|NCT02816398|38268238|FG000|Overall Study|Lost to Follow-up|1|||
17127738|NCT02812186|38268244|FG000|Period 1|Post randomization screen failure|5|||
17127739|NCT02812186|38268245|FG001|Period 1|Post randomization screen failure|9|||
17127740|NCT02812186|38268244|FG000|Period 1|nonevaluable data sets|6|||
17127741|NCT02812186|38268245|FG001|Period 1|nonevaluable data sets|6|||
17127742|NCT02811640|38268254|FG000|Overall Study|Technology malfunction|2|||
17127743|NCT03310268|38268261|FG000|Overall Study|(Not specified)|1|||
17127744|NCT03310268|38268262|FG001|Overall Study|(Not specified)|5|||
17127745|NCT03310268|38268263|FG002|Overall Study|(Not specified)|0|||
17127746|NCT02810392|38268273|FG000|Overall Study|Subject too ill to continue|1|||
16950649|NCT01264380|38094452|FG001|Period C|Adverse Event|0|||
16950650|NCT01264380|38094453|FG002|Period C|Adverse Event|1|||
16950651|NCT01263444|38094461|FG000|Overall Study|Adverse Event|8|||
16950652|NCT01263444|38094461|FG000|Overall Study|Withdrawal by Subject|1|||
16950653|NCT01263444|38094461|FG000|Overall Study|Protocol Violation|1|||
16950654|NCT01263054|38094467|FG000|Overall Study|Death|1|||
16950655|NCT01263054|38094468|FG001|Overall Study|Death|0|||
16950656|NCT01263054|38094467|FG000|Overall Study|Lost to Follow-up|2|||
16950657|NCT01263054|38094468|FG001|Overall Study|Lost to Follow-up|2|||
16950658|NCT01263054|38094467|FG000|Overall Study|Withdrawal by Subject|1|||
16950659|NCT01263054|38094468|FG001|Overall Study|Withdrawal by Subject|3|||
16950660|NCT01263054|38094467|FG000|Overall Study|Qualification Violation|1|||
16950661|NCT01263054|38094468|FG001|Overall Study|Qualification Violation|0|||
16950662|NCT01263054|38094467|FG000|Overall Study|Other|0|||
16950663|NCT01263054|38094468|FG001|Overall Study|Other|1|||
16950664|NCT01031836|38094480|FG000|Stage I|Adverse Event|1|||
16950665|NCT01031836|38094481|FG001|Stage I|Adverse Event|1|||
16950666|NCT01031836|38094482|FG002|Stage I|Adverse Event|0|||
16950667|NCT01031836|38094483|FG003|Stage I|Adverse Event|0|||
16950668|NCT01031836|38094484|FG004|Stage I|Adverse Event|0|||
16950669|NCT01031836|38094485|FG005|Stage I|Adverse Event|0|||
16950670|NCT01031836|38094480|FG000|Stage I|Other|0|||
16950671|NCT01031836|38094481|FG001|Stage I|Other|1|||
16950672|NCT01031836|38094482|FG002|Stage I|Other|0|||
16950673|NCT01031836|38094483|FG003|Stage I|Other|0|||
16950674|NCT01031836|38094484|FG004|Stage I|Other|0|||
16950675|NCT01031836|38094485|FG005|Stage I|Other|1|||
16950676|NCT01031836|38094480|FG000|Stage II|Adverse Event|0|||
16950677|NCT01031836|38094481|FG001|Stage II|Adverse Event|0|||
16950678|NCT01031836|38094482|FG002|Stage II|Adverse Event|2|||
16950679|NCT01031836|38094483|FG003|Stage II|Adverse Event|2|||
16950680|NCT01031836|38094484|FG004|Stage II|Adverse Event|1|||
16950681|NCT01031836|38094485|FG005|Stage II|Adverse Event|1|||
16950682|NCT01031836|38094480|FG000|Stage II|Other|2|||
16950683|NCT01031836|38094481|FG001|Stage II|Other|0|||
16950684|NCT01031836|38094482|FG002|Stage II|Other|0|||
16950685|NCT01031836|38094483|FG003|Stage II|Other|1|||
16950686|NCT01031836|38094484|FG004|Stage II|Other|1|||
16950687|NCT01031836|38094485|FG005|Stage II|Other|0|||
16950688|NCT01237587|38094501|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
16950689|NCT01237587|38094502|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
16950690|NCT01237587|38094501|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
16950691|NCT01237587|38094502|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
16950692|NCT01237587|38094501|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
16950693|NCT01237587|38094502|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
16950694|NCT01237587|38094501|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
16950695|NCT01237587|38094502|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
16950696|NCT01237587|38094501|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
16950697|NCT01237587|38094502|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
16950698|NCT01237587|38094501|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
16950699|NCT01237587|38094502|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
16950700|NCT01237587|38094501|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
16950701|NCT01237587|38094502|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
16950702|NCT01237587|38094501|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
16950703|NCT01237587|38094502|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
16950704|NCT01237587|38094501|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
16950705|NCT01237587|38094502|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
16950706|NCT01237587|38094501|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
16950707|NCT01237587|38094502|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
16950708|NCT01237587|38094501|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
16950709|NCT01237587|38094502|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
16950710|NCT01237587|38094501|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
16950711|NCT01237587|38094502|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
16950712|NCT01237587|38094501|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
16950713|NCT01237587|38094502|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
16950714|NCT01237587|38094501|FG000|Taper Phase|Adverse Event|0|||
16950715|NCT01237587|38094502|FG001|Taper Phase|Adverse Event|2|||
16950716|NCT01237587|38094501|FG000|Taper Phase|Protocol Violation|2|||
16950717|NCT01237587|38094502|FG001|Taper Phase|Protocol Violation|0|||
16950718|NCT01237587|38094501|FG000|Taper Phase|Lack of Efficacy|2|||
16950719|NCT01237587|38094502|FG001|Taper Phase|Lack of Efficacy|5|||
16950720|NCT01237587|38094501|FG000|Taper Phase|Parent/Guardian Decision|0|||
16950721|NCT01237587|38094502|FG001|Taper Phase|Parent/Guardian Decision|2|||
16950722|NCT01237587|38094501|FG000|Taper Phase|Sponsor Decision|1|||
17127747|NCT02810392|38268274|FG001|Overall Study|Subject too ill to continue|0|||
16950723|NCT01237587|38094502|FG001|Taper Phase|Sponsor Decision|0|||
16950724|NCT01237587|38094501|FG000|Taper Phase|Withdrawal by Subject|0|||
16950725|NCT01237587|38094502|FG001|Taper Phase|Withdrawal by Subject|1|||
16950726|NCT01031680|38094517|FG000|Overall Study|Adverse Event|8|||
16950727|NCT01031680|38094518|FG001|Overall Study|Adverse Event|3|||
16950728|NCT01031680|38094517|FG000|Overall Study|Lost to Follow-up|2|||
16950729|NCT01031680|38094518|FG001|Overall Study|Lost to Follow-up|10|||
16950730|NCT01031680|38094517|FG000|Overall Study|Withdrawal by Subject|12|||
16950731|NCT01031680|38094518|FG001|Overall Study|Withdrawal by Subject|16|||
16950732|NCT01031680|38094517|FG000|Overall Study|Death|2|||
16950733|NCT01031680|38094518|FG001|Overall Study|Death|1|||
16950734|NCT01031680|38094517|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
16950735|NCT01031680|38094518|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
16950736|NCT01031680|38094517|FG000|Overall Study|Poor/Non-compliance|5|||
16950737|NCT01031680|38094518|FG001|Overall Study|Poor/Non-compliance|6|||
16950738|NCT01031680|38094517|FG000|Overall Study|Safety|1|||
16950739|NCT01031680|38094518|FG001|Overall Study|Safety|0|||
16950740|NCT01031680|38094517|FG000|Overall Study|Incorrect Enrolment|1|||
16950741|NCT01031680|38094518|FG001|Overall Study|Incorrect Enrolment|2|||
16950742|NCT01031680|38094517|FG000|Overall Study|Administrative Reason by Sponsor|0|||
16950743|NCT01031680|38094518|FG001|Overall Study|Administrative Reason by Sponsor|1|||
16950744|NCT01031680|38094517|FG000|Overall Study|Various|0|||
16950745|NCT01031680|38094518|FG001|Overall Study|Various|2|||
16950746|NCT01031446|38094524|FG000|Overall Study|Disease Progression|38|||
16950747|NCT01031446|38094524|FG000|Overall Study|Adverse Event|9|||
16950748|NCT01031446|38094524|FG000|Overall Study|Physician Decision|4|||
16950749|NCT01031446|38094524|FG000|Overall Study|Withdrawal by Subject|3|||
16950750|NCT01031446|38094524|FG000|Overall Study|Still on treatment|1|||
16950751|NCT01030900|38094530|FG000|Overall Study|Not treated due to congestive heart failure|1|||
16950752|NCT01030900|38094530|FG000|Overall Study|Not treated due to rapid disease|1|||
16950753|NCT01030822|38094537|FG000|Overall Study|Moved/migrated from study area|6|||
16950754|NCT01030822|38094538|FG001|Overall Study|Moved/migrated from study area|7|||
16950755|NCT01030822|38094539|FG002|Overall Study|Moved/migrated from study area|3|||
16950756|NCT01030822|38094537|FG000|Overall Study|Withdrawal by Subject|16|||
16950757|NCT01030822|38094538|FG001|Overall Study|Withdrawal by Subject|13|||
16950758|NCT01030822|38094539|FG002|Overall Study|Withdrawal by Subject|16|||
16950759|NCT01030822|38094537|FG000|Overall Study|Lost to Follow-up|9|||
16950760|NCT01030822|38094538|FG001|Overall Study|Lost to Follow-up|4|||
16950761|NCT01030822|38094539|FG002|Overall Study|Lost to Follow-up|7|||
16950762|NCT01026454|38094550|FG000|Second Intervention|Pregnancy|1|||
16950763|NCT01026454|38094551|FG001|Second Intervention|Pregnancy|1|||
16950764|NCT01026220|38094557|FG000|Induction|Death|1|||
16950765|NCT01026220|38094558|FG001|Induction|Death|0|||
16950766|NCT01026220|38094559|FG002|Induction|Death|0|||
16950767|NCT01026220|38094557|FG000|Induction|Lack of Efficacy|2|||
16950768|NCT01026220|38094558|FG001|Induction|Lack of Efficacy|0|||
16950769|NCT01026220|38094559|FG002|Induction|Lack of Efficacy|0|||
16950770|NCT01026220|38094557|FG000|Induction|Physician Decision|12|||
16950771|NCT01026220|38094558|FG001|Induction|Physician Decision|0|||
16950772|NCT01026220|38094559|FG002|Induction|Physician Decision|0|||
16950773|NCT01026220|38094557|FG000|Induction|Withdrawal by Subject|9|||
16950774|NCT01026220|38094558|FG001|Induction|Withdrawal by Subject|0|||
16950775|NCT01026220|38094559|FG002|Induction|Withdrawal by Subject|0|||
16950776|NCT01026220|38094557|FG000|Induction|Ineligible|1|||
16950777|NCT01026220|38094558|FG001|Induction|Ineligible|0|||
16950778|NCT01026220|38094559|FG002|Induction|Ineligible|0|||
16950779|NCT01026220|38094557|FG000|Consolidation Maintenance|Death|0|||
16950780|NCT01026220|38094558|FG001|Consolidation Maintenance|Death|1|||
16950781|NCT01026220|38094559|FG002|Consolidation Maintenance|Death|0|||
16950782|NCT01026220|38094557|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
16950783|NCT01026220|38094558|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
16950784|NCT01026220|38094559|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
16950785|NCT01026220|38094557|FG000|Consolidation Maintenance|Physician Decision|0|||
16950786|NCT01026220|38094558|FG001|Consolidation Maintenance|Physician Decision|2|||
16950787|NCT01026220|38094559|FG002|Consolidation Maintenance|Physician Decision|7|||
16950788|NCT01026220|38094557|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
16950789|NCT01026220|38094558|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
16950790|NCT01026220|38094559|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
16950791|NCT01026142|38094576|FG000|Overall Study|Death|136|||
16950792|NCT01026142|38094577|FG001|Overall Study|Death|134|||
16950793|NCT01026142|38094576|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
16950794|NCT01026142|38094577|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
16950795|NCT01030666|38094585|FG000|Overall Study|Lost to Follow-up|3|||
16950796|NCT01030666|38094586|FG001|Overall Study|Lost to Follow-up|2|||
16950797|NCT01025752|38094595|FG000|Overall Study|Lost to Follow-up|7|||
16950798|NCT01025752|38094596|FG001|Overall Study|Lost to Follow-up|10|||
16950799|NCT01025752|38094595|FG000|Overall Study|Physician Decision|1|||
16950800|NCT01025752|38094596|FG001|Overall Study|Physician Decision|3|||
17127748|NCT02810392|38268273|FG000|Overall Study|COVID 19 research restrictions|0|||
17127749|NCT02810392|38268274|FG001|Overall Study|COVID 19 research restrictions|1|||
17127750|NCT02815540|38268280|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
17127751|NCT03280550|38268286|FG000|Overall Study|Withdrawal by Subject|2|||
17127752|NCT03280550|38268287|FG001|Overall Study|Withdrawal by Subject|2|||
17127753|NCT03280550|38268286|FG000|Overall Study|Physician Decision|0|||
17127754|NCT03280550|38268287|FG001|Overall Study|Physician Decision|1|||
17127755|NCT03276026|38268295|FG000|Overall Study|Protocol Violation|1|||
17127756|NCT03276026|38268296|FG001|Overall Study|Protocol Violation|0|||
17127757|NCT01589523|38268302|FG000|Overall Study|Withdrawal by Subject|1|||
17127758|NCT03277352|38268308|FG000|Overall Study|Study Terminated By Sponsor|2|||
17127759|NCT03277352|38268308|FG000|Overall Study|Withdrawal by Subject|4|||
17127760|NCT03277352|38268308|FG000|Overall Study|Death|4|||
16950801|NCT01030198|38094604|FG000|Overall Study|Could not measure efficacy accurately|0|||
16950802|NCT01030198|38094605|FG001|Overall Study|Could not measure efficacy accurately|7|||
16950803|NCT01301456|38094623|FG000|Stage 1|Withdrawal by Subject|0|||
16950804|NCT01301456|38094624|FG001|Stage 1|Withdrawal by Subject|0|||
16950805|NCT01301456|38094625|FG002|Stage 1|Withdrawal by Subject|1|||
16950806|NCT01301456|38094626|FG003|Stage 1|Withdrawal by Subject|0|||
16950807|NCT01301456|38094627|FG004|Stage 1|Withdrawal by Subject|1|||
16950808|NCT01301456|38094628|FG005|Stage 1|Withdrawal by Subject|0|||
16950809|NCT01301456|38094629|FG006|Stage 1|Withdrawal by Subject|0|||
16950810|NCT01301456|38094630|FG007|Stage 1|Withdrawal by Subject|0|||
16950811|NCT01301456|38094631|FG008|Stage 1|Withdrawal by Subject|0|||
16950812|NCT01301456|38094632|FG009|Stage 1|Withdrawal by Subject|0|||
16950813|NCT01301456|38094633|FG010|Stage 1|Withdrawal by Subject|0|||
16950814|NCT01301456|38094634|FG011|Stage 1|Withdrawal by Subject|0|||
16950815|NCT01301456|38094623|FG000|Stage 1|Randomized but not treated|0|||
16950816|NCT01301456|38094624|FG001|Stage 1|Randomized but not treated|0|||
16950817|NCT01301456|38094625|FG002|Stage 1|Randomized but not treated|0|||
16950818|NCT01301456|38094626|FG003|Stage 1|Randomized but not treated|0|||
16950819|NCT01301456|38094627|FG004|Stage 1|Randomized but not treated|0|||
16950820|NCT01301456|38094628|FG005|Stage 1|Randomized but not treated|0|||
16950821|NCT01301456|38094629|FG006|Stage 1|Randomized but not treated|1|||
16950822|NCT01301456|38094630|FG007|Stage 1|Randomized but not treated|0|||
16950823|NCT01301456|38094631|FG008|Stage 1|Randomized but not treated|0|||
16950824|NCT01301456|38094632|FG009|Stage 1|Randomized but not treated|0|||
16950825|NCT01301456|38094633|FG010|Stage 1|Randomized but not treated|0|||
16950826|NCT01301456|38094634|FG011|Stage 1|Randomized but not treated|0|||
16950827|NCT01301456|38094623|FG000|Stage 2|Adverse Event|0|||
16950828|NCT01301456|38094624|FG001|Stage 2|Adverse Event|0|||
16950829|NCT01301456|38094625|FG002|Stage 2|Adverse Event|0|||
16950830|NCT01301456|38094626|FG003|Stage 2|Adverse Event|0|||
16950831|NCT01301456|38094627|FG004|Stage 2|Adverse Event|0|||
16950832|NCT01301456|38094628|FG005|Stage 2|Adverse Event|0|||
16950833|NCT01301456|38094629|FG006|Stage 2|Adverse Event|0|||
16950834|NCT01301456|38094630|FG007|Stage 2|Adverse Event|0|||
16950835|NCT01301456|38094631|FG008|Stage 2|Adverse Event|0|||
16950836|NCT01301456|38094632|FG009|Stage 2|Adverse Event|0|||
16950837|NCT01301456|38094633|FG010|Stage 2|Adverse Event|1|||
16950838|NCT01301456|38094634|FG011|Stage 2|Adverse Event|0|||
16950839|NCT01023256|38094682|FG000|Overall Study|Protocol Violation|2|||
16950840|NCT01023256|38094683|FG001|Overall Study|Protocol Violation|3|||
16950841|NCT01023256|38094684|FG002|Overall Study|Protocol Violation|0|||
16950842|NCT01023256|38094685|FG003|Overall Study|Protocol Violation|0|||
16950843|NCT01023256|38094682|FG000|Overall Study|Randomized but not treated|1|||
16950844|NCT01023256|38094683|FG001|Overall Study|Randomized but not treated|0|||
16950845|NCT01023256|38094684|FG002|Overall Study|Randomized but not treated|1|||
16950846|NCT01023256|38094685|FG003|Overall Study|Randomized but not treated|0|||
16950847|NCT01023256|38094682|FG000|Overall Study|Other|1|||
16950848|NCT01023256|38094683|FG001|Overall Study|Other|0|||
16950849|NCT01023256|38094684|FG002|Overall Study|Other|0|||
16950850|NCT01023256|38094685|FG003|Overall Study|Other|2|||
16950851|NCT01023256|38094682|FG000|Overall Study|Adverse Event|0|||
16950852|NCT01023256|38094683|FG001|Overall Study|Adverse Event|0|||
16950853|NCT01023256|38094684|FG002|Overall Study|Adverse Event|0|||
16950854|NCT01023256|38094685|FG003|Overall Study|Adverse Event|1|||
16950855|NCT01023256|38094682|FG000|Overall Study|Withdrawal by Subject|0|||
16950856|NCT01023256|38094683|FG001|Overall Study|Withdrawal by Subject|0|||
16950857|NCT01023256|38094684|FG002|Overall Study|Withdrawal by Subject|0|||
16950858|NCT01023256|38094685|FG003|Overall Study|Withdrawal by Subject|2|||
16950859|NCT01023022|38094698|FG000|Overall Study|Death|5|||
16950860|NCT01023022|38094698|FG000|Overall Study|Lost to Follow-up|7|||
16950861|NCT01023022|38094698|FG000|Overall Study|due to technical issues|2|||
16950862|NCT01058668|38094705|FG000|Double-blind Treatment Phase|Adverse Event|8|||
16950863|NCT01058668|38094706|FG001|Double-blind Treatment Phase|Adverse Event|15|||
16950864|NCT01058668|38094707|FG002|Double-blind Treatment Phase|Adverse Event|25|||
16950865|NCT01058668|38094705|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
16950866|NCT01058668|38094706|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
16950867|NCT01058668|38094707|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
16950868|NCT01058668|38094705|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
16950869|NCT01058668|38094706|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
16950870|NCT01058668|38094707|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
16950871|NCT01058668|38094705|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
16950872|NCT01058668|38094706|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
16950873|NCT01058668|38094707|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
16950874|NCT01058668|38094705|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16950875|NCT01058668|38094706|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
16950876|NCT01058668|38094707|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
16950877|NCT01058668|38094705|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
16950878|NCT01058668|38094706|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
16950879|NCT01058668|38094707|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
16950880|NCT01301066|38094717|FG000|Overall Study|Lost to Follow-up|5|||
16950881|NCT01301066|38094718|FG001|Overall Study|Lost to Follow-up|11|||
16950882|NCT01301066|38094717|FG000|Overall Study|Protocol Violation|8|||
16950883|NCT01301066|38094718|FG001|Overall Study|Protocol Violation|7|||
16950884|NCT01301066|38094717|FG000|Overall Study|Withdrawal by Subject|4|||
16950885|NCT01301066|38094718|FG001|Overall Study|Withdrawal by Subject|9|||
16950886|NCT01301066|38094717|FG000|Overall Study|Adverse Event|6|||
16950887|NCT01301066|38094718|FG001|Overall Study|Adverse Event|6|||
16950888|NCT01301066|38094717|FG000|Overall Study|Sponsor Decision|2|||
16950889|NCT01301066|38094718|FG001|Overall Study|Sponsor Decision|1|||
16950890|NCT01301066|38094717|FG000|Overall Study|Physician Decision|0|||
16950891|NCT01301066|38094718|FG001|Overall Study|Physician Decision|1|||
16950892|NCT01301066|38094717|FG000|Overall Study|Other|2|||
16950893|NCT01301066|38094718|FG001|Overall Study|Other|0|||
16950894|NCT01022398|38094726|FG000|Overall Study|Study terminated|2|||
16950895|NCT01022398|38094727|FG001|Overall Study|Study terminated|2|||
16950896|NCT01262976|38094738|FG000|Up to Month 2|Serious Adverse Event|0|||
16950897|NCT01262976|38094739|FG001|Up to Month 2|Serious Adverse Event|0|||
16950898|NCT01262976|38094740|FG002|Up to Month 2|Serious Adverse Event|1|||
16950899|NCT01262976|38094741|FG003|Up to Month 2|Serious Adverse Event|0|||
16950900|NCT01262976|38094742|FG004|Up to Month 2|Serious Adverse Event|0|||
16950901|NCT01262976|38094743|FG005|Up to Month 2|Serious Adverse Event|0|||
16950902|NCT01262976|38094738|FG000|Up to Month 2|Withdrawal by Subject|1|||
16950903|NCT01262976|38094739|FG001|Up to Month 2|Withdrawal by Subject|0|||
16950904|NCT01262976|38094740|FG002|Up to Month 2|Withdrawal by Subject|0|||
16950905|NCT01262976|38094741|FG003|Up to Month 2|Withdrawal by Subject|0|||
16950906|NCT01262976|38094742|FG004|Up to Month 2|Withdrawal by Subject|0|||
16950907|NCT01262976|38094743|FG005|Up to Month 2|Withdrawal by Subject|0|||
16950908|NCT01262976|38094738|FG000|Up to Month 2|Migrated/moved from study area|0|||
16950909|NCT01262976|38094739|FG001|Up to Month 2|Migrated/moved from study area|1|||
16950910|NCT01262976|38094740|FG002|Up to Month 2|Migrated/moved from study area|0|||
16950911|NCT01262976|38094741|FG003|Up to Month 2|Migrated/moved from study area|0|||
16950912|NCT01262976|38094742|FG004|Up to Month 2|Migrated/moved from study area|1|||
16950913|NCT01262976|38094743|FG005|Up to Month 2|Migrated/moved from study area|1|||
16950914|NCT01262976|38094738|FG000|Up to Month 2|Lost to Follow-up|1|||
16950915|NCT01262976|38094739|FG001|Up to Month 2|Lost to Follow-up|0|||
16950916|NCT01262976|38094740|FG002|Up to Month 2|Lost to Follow-up|0|||
16950917|NCT01262976|38094741|FG003|Up to Month 2|Lost to Follow-up|1|||
16950918|NCT01262976|38094742|FG004|Up to Month 2|Lost to Follow-up|1|||
16950919|NCT01262976|38094743|FG005|Up to Month 2|Lost to Follow-up|1|||
16950920|NCT01262976|38094738|FG000|Up to Month 2|Other|1|||
16950921|NCT01262976|38094739|FG001|Up to Month 2|Other|0|||
16950922|NCT01262976|38094740|FG002|Up to Month 2|Other|0|||
16950923|NCT01262976|38094741|FG003|Up to Month 2|Other|1|||
16950924|NCT01262976|38094742|FG004|Up to Month 2|Other|0|||
16950925|NCT01262976|38094743|FG005|Up to Month 2|Other|2|||
16950926|NCT01262976|38094738|FG000|Up to Month 7|Serious Adverse Event|0|||
16950927|NCT01262976|38094739|FG001|Up to Month 7|Serious Adverse Event|0|||
16950928|NCT01262976|38094740|FG002|Up to Month 7|Serious Adverse Event|2|||
16950929|NCT01262976|38094741|FG003|Up to Month 7|Serious Adverse Event|0|||
16950930|NCT01262976|38094742|FG004|Up to Month 7|Serious Adverse Event|0|||
16950931|NCT01262976|38094743|FG005|Up to Month 7|Serious Adverse Event|0|||
16950932|NCT01262976|38094738|FG000|Up to Month 7|Withdrawal by Subject|1|||
16950933|NCT01262976|38094739|FG001|Up to Month 7|Withdrawal by Subject|0|||
16950934|NCT01262976|38094740|FG002|Up to Month 7|Withdrawal by Subject|0|||
16950935|NCT01262976|38094741|FG003|Up to Month 7|Withdrawal by Subject|0|||
16950936|NCT01262976|38094742|FG004|Up to Month 7|Withdrawal by Subject|0|||
16774234|NCT02135614|37713543|FG001|Overall Study|Withdrew Consent|2|||
16774235|NCT02135614|37713542|FG000|Overall Study|Lost to Follow-up|3|||
16774236|NCT02135614|37713543|FG001|Overall Study|Lost to Follow-up|0|||
16774237|NCT02168842|37713551|FG000|Overall Study|Withdrawal by Subject|5|||
16950937|NCT01262976|38094743|FG005|Up to Month 7|Withdrawal by Subject|0|||
16950938|NCT01262976|38094738|FG000|Up to Month 7|Migrated/moved from study area|0|||
16950939|NCT01262976|38094739|FG001|Up to Month 7|Migrated/moved from study area|0|||
16950940|NCT01262976|38094740|FG002|Up to Month 7|Migrated/moved from study area|1|||
16774238|NCT02168842|37713552|FG001|Overall Study|Withdrawal by Subject|3|||
16774239|NCT02168842|37713551|FG000|Overall Study|Lost to Follow-up|0|||
16774240|NCT02168842|37713552|FG001|Overall Study|Lost to Follow-up|2|||
16774241|NCT02168842|37713551|FG000|Overall Study|Death|2|||
16774242|NCT02168842|37713552|FG001|Overall Study|Death|1|||
16774243|NCT02168842|37713551|FG000|Overall Study|Physician Decision|1|||
16774244|NCT02168842|37713552|FG001|Overall Study|Physician Decision|2|||
16774245|NCT02200042|37713562|FG000|Overall Study|Withdrawal by Subject|0|||
16774246|NCT02200042|37713563|FG001|Overall Study|Withdrawal by Subject|1|||
16774247|NCT02199028|37713571|FG000|Week 1|Adverse Event|1|||
16774248|NCT02199028|37713572|FG001|Week 1|Adverse Event|0|||
16774249|NCT02199028|37713571|FG000|Week 3|Adverse Event|1|||
16774250|NCT02199028|37713572|FG001|Week 3|Adverse Event|0|||
16774251|NCT03347123|37713581|FG000|Overall Study|Death|1|||
16774252|NCT03347123|37713582|FG001|Overall Study|Death|2|||
16774253|NCT03347123|37713583|FG002|Overall Study|Death|0|||
16950941|NCT01262976|38094741|FG003|Up to Month 7|Migrated/moved from study area|3|||
16950942|NCT01262976|38094742|FG004|Up to Month 7|Migrated/moved from study area|1|||
16950943|NCT01262976|38094743|FG005|Up to Month 7|Migrated/moved from study area|1|||
16950944|NCT01262976|38094738|FG000|Up to Month 7|Lost to Follow-up|1|||
16950945|NCT01262976|38094739|FG001|Up to Month 7|Lost to Follow-up|0|||
16950946|NCT01262976|38094740|FG002|Up to Month 7|Lost to Follow-up|1|||
16950947|NCT01262976|38094741|FG003|Up to Month 7|Lost to Follow-up|3|||
16774254|NCT03347123|37713584|FG003|Overall Study|Death|0|||
16774255|NCT03347123|37713585|FG004|Overall Study|Death|0|||
16774256|NCT03347123|37713586|FG005|Overall Study|Death|0|||
16950948|NCT01262976|38094742|FG004|Up to Month 7|Lost to Follow-up|1|||
16774257|NCT03347123|37713587|FG006|Overall Study|Death|0|||
16774258|NCT03347123|37713581|FG000|Overall Study|Withdrawal by Subject|1|||
16774259|NCT03347123|37713582|FG001|Overall Study|Withdrawal by Subject|0|||
16950949|NCT01262976|38094743|FG005|Up to Month 7|Lost to Follow-up|3|||
16950950|NCT01262976|38094738|FG000|Up to Month 7|Other|3|||
16950951|NCT01262976|38094739|FG001|Up to Month 7|Other|0|||
16950952|NCT01262976|38094740|FG002|Up to Month 7|Other|2|||
16950953|NCT01262976|38094741|FG003|Up to Month 7|Other|0|||
16950954|NCT01262976|38094742|FG004|Up to Month 7|Other|0|||
16950955|NCT01262976|38094743|FG005|Up to Month 7|Other|0|||
16950956|NCT01262976|38094738|FG000|Up to Year 1|Serious Adverse Event|0|||
16950957|NCT01262976|38094739|FG001|Up to Year 1|Serious Adverse Event|0|||
16950958|NCT01262976|38094740|FG002|Up to Year 1|Serious Adverse Event|2|||
16950959|NCT01262976|38094741|FG003|Up to Year 1|Serious Adverse Event|0|||
16950960|NCT01262976|38094742|FG004|Up to Year 1|Serious Adverse Event|0|||
16950961|NCT01262976|38094743|FG005|Up to Year 1|Serious Adverse Event|0|||
16950962|NCT01262976|38094738|FG000|Up to Year 1|Withdrawal by Subject|1|||
16950963|NCT01262976|38094739|FG001|Up to Year 1|Withdrawal by Subject|0|||
16950964|NCT01262976|38094740|FG002|Up to Year 1|Withdrawal by Subject|0|||
16950965|NCT01262976|38094741|FG003|Up to Year 1|Withdrawal by Subject|0|||
16950966|NCT01262976|38094742|FG004|Up to Year 1|Withdrawal by Subject|0|||
16950967|NCT01262976|38094743|FG005|Up to Year 1|Withdrawal by Subject|0|||
16950968|NCT01262976|38094738|FG000|Up to Year 1|Migrated/moved from study area|1|||
16950969|NCT01262976|38094739|FG001|Up to Year 1|Migrated/moved from study area|0|||
16950970|NCT01262976|38094740|FG002|Up to Year 1|Migrated/moved from study area|0|||
16950971|NCT01262976|38094741|FG003|Up to Year 1|Migrated/moved from study area|3|||
16950972|NCT01262976|38094742|FG004|Up to Year 1|Migrated/moved from study area|3|||
16950973|NCT01262976|38094743|FG005|Up to Year 1|Migrated/moved from study area|2|||
16950974|NCT01262976|38094738|FG000|Up to Year 1|Lost to Follow-up|4|||
16950975|NCT01262976|38094739|FG001|Up to Year 1|Lost to Follow-up|0|||
16950976|NCT01262976|38094740|FG002|Up to Year 1|Lost to Follow-up|0|||
16950977|NCT01262976|38094741|FG003|Up to Year 1|Lost to Follow-up|1|||
17127761|NCT02814838|38268315|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
17127762|NCT02814838|38268316|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
17127763|NCT02814838|38268315|FG000|Overall Study|Consent withdrawal|1|||
17127764|NCT02814838|38268316|FG001|Overall Study|Consent withdrawal|1|||
17127765|NCT03276728|38268330|FG000|Overall Study|Lost to Follow-up|0|||
17127766|NCT03276728|38268331|FG001|Overall Study|Lost to Follow-up|0|||
17127767|NCT03276728|38268332|FG002|Overall Study|Lost to Follow-up|2|||
16950978|NCT01262976|38094742|FG004|Up to Year 1|Lost to Follow-up|6|||
16950979|NCT01262976|38094743|FG005|Up to Year 1|Lost to Follow-up|5|||
16950980|NCT01262976|38094738|FG000|Up to Year 1|Other|3|||
16950981|NCT01262976|38094739|FG001|Up to Year 1|Other|1|||
16950982|NCT01262976|38094740|FG002|Up to Year 1|Other|0|||
16950983|NCT01262976|38094741|FG003|Up to Year 1|Other|0|||
16950984|NCT01262976|38094742|FG004|Up to Year 1|Other|2|||
16950985|NCT01262976|38094743|FG005|Up to Year 1|Other|1|||
16950986|NCT01262976|38094738|FG000|Up to Year 1|Subjects with unknown completion status|0|||
16950987|NCT01262976|38094739|FG001|Up to Year 1|Subjects with unknown completion status|0|||
16950988|NCT01262976|38094740|FG002|Up to Year 1|Subjects with unknown completion status|1|||
16950989|NCT01262976|38094741|FG003|Up to Year 1|Subjects with unknown completion status|0|||
16950990|NCT01262976|38094742|FG004|Up to Year 1|Subjects with unknown completion status|0|||
16950991|NCT01262976|38094743|FG005|Up to Year 1|Subjects with unknown completion status|1|||
16950992|NCT01262976|38094738|FG000|Up to Year 2|Serious Adverse Event|0|||
16950993|NCT01262976|38094739|FG001|Up to Year 2|Serious Adverse Event|0|||
16950994|NCT01262976|38094740|FG002|Up to Year 2|Serious Adverse Event|2|||
16950995|NCT01262976|38094741|FG003|Up to Year 2|Serious Adverse Event|0|||
16950996|NCT01262976|38094742|FG004|Up to Year 2|Serious Adverse Event|0|||
16950997|NCT01262976|38094743|FG005|Up to Year 2|Serious Adverse Event|0|||
16950998|NCT01262976|38094738|FG000|Up to Year 2|Withdrawal by Subject|1|||
16950999|NCT01262976|38094739|FG001|Up to Year 2|Withdrawal by Subject|0|||
16951000|NCT01262976|38094740|FG002|Up to Year 2|Withdrawal by Subject|0|||
16951001|NCT01262976|38094741|FG003|Up to Year 2|Withdrawal by Subject|0|||
16951002|NCT01262976|38094742|FG004|Up to Year 2|Withdrawal by Subject|0|||
16951003|NCT01262976|38094743|FG005|Up to Year 2|Withdrawal by Subject|0|||
16951004|NCT01262976|38094738|FG000|Up to Year 2|Migrated/moved from study area|0|||
16951005|NCT01262976|38094739|FG001|Up to Year 2|Migrated/moved from study area|0|||
16951006|NCT01262976|38094740|FG002|Up to Year 2|Migrated/moved from study area|0|||
16951007|NCT01262976|38094741|FG003|Up to Year 2|Migrated/moved from study area|2|||
16951008|NCT01262976|38094742|FG004|Up to Year 2|Migrated/moved from study area|1|||
16951009|NCT01262976|38094743|FG005|Up to Year 2|Migrated/moved from study area|2|||
16951010|NCT01262976|38094738|FG000|Up to Year 2|Lost to Follow-up|1|||
16951011|NCT01262976|38094739|FG001|Up to Year 2|Lost to Follow-up|1|||
16951012|NCT01262976|38094740|FG002|Up to Year 2|Lost to Follow-up|2|||
16951013|NCT01262976|38094741|FG003|Up to Year 2|Lost to Follow-up|2|||
16951014|NCT01262976|38094742|FG004|Up to Year 2|Lost to Follow-up|3|||
16951015|NCT01262976|38094743|FG005|Up to Year 2|Lost to Follow-up|3|||
16951016|NCT01262976|38094738|FG000|Up to Year 2|Subjects with unknown completion status|0|||
16951017|NCT01262976|38094739|FG001|Up to Year 2|Subjects with unknown completion status|0|||
16951018|NCT01262976|38094740|FG002|Up to Year 2|Subjects with unknown completion status|1|||
16951019|NCT01262976|38094741|FG003|Up to Year 2|Subjects with unknown completion status|0|||
16951020|NCT01262976|38094742|FG004|Up to Year 2|Subjects with unknown completion status|0|||
16951021|NCT01262976|38094743|FG005|Up to Year 2|Subjects with unknown completion status|0|||
16951022|NCT01262976|38094738|FG000|Up to Year 2|Other|3|||
16951023|NCT01262976|38094739|FG001|Up to Year 2|Other|0|||
16951024|NCT01262976|38094740|FG002|Up to Year 2|Other|0|||
16951025|NCT01262976|38094741|FG003|Up to Year 2|Other|0|||
16951026|NCT01262976|38094742|FG004|Up to Year 2|Other|0|||
17127768|NCT03276728|38268333|FG003|Overall Study|Lost to Follow-up|2|||
17127769|NCT03276728|38268334|FG004|Overall Study|Lost to Follow-up|0|||
17127770|NCT03276728|38268335|FG005|Overall Study|Lost to Follow-up|0|||
16951027|NCT01262976|38094743|FG005|Up to Year 2|Other|0|||
16951028|NCT01262976|38094738|FG000|Up to Year 3|Serious Adverse Event|0|||
16951029|NCT01262976|38094739|FG001|Up to Year 3|Serious Adverse Event|0|||
16951030|NCT01262976|38094740|FG002|Up to Year 3|Serious Adverse Event|2|||
16951031|NCT01262976|38094741|FG003|Up to Year 3|Serious Adverse Event|0|||
16951032|NCT01262976|38094742|FG004|Up to Year 3|Serious Adverse Event|0|||
16951033|NCT01262976|38094743|FG005|Up to Year 3|Serious Adverse Event|0|||
16951034|NCT01262976|38094738|FG000|Up to Year 3|Withdrawal by Subject|1|||
16951035|NCT01262976|38094739|FG001|Up to Year 3|Withdrawal by Subject|0|||
16951036|NCT01262976|38094740|FG002|Up to Year 3|Withdrawal by Subject|0|||
16951037|NCT01262976|38094741|FG003|Up to Year 3|Withdrawal by Subject|0|||
16951038|NCT01262976|38094742|FG004|Up to Year 3|Withdrawal by Subject|0|||
16951039|NCT01262976|38094743|FG005|Up to Year 3|Withdrawal by Subject|0|||
16951040|NCT01262976|38094738|FG000|Up to Year 3|Migrated/moved from study area|0|||
16951041|NCT01262976|38094739|FG001|Up to Year 3|Migrated/moved from study area|0|||
16951042|NCT01262976|38094740|FG002|Up to Year 3|Migrated/moved from study area|0|||
16951043|NCT01262976|38094741|FG003|Up to Year 3|Migrated/moved from study area|2|||
16951044|NCT01262976|38094742|FG004|Up to Year 3|Migrated/moved from study area|1|||
16951045|NCT01262976|38094743|FG005|Up to Year 3|Migrated/moved from study area|1|||
16951046|NCT01262976|38094738|FG000|Up to Year 3|Lost to Follow-up|2|||
16951047|NCT01262976|38094739|FG001|Up to Year 3|Lost to Follow-up|2|||
16951048|NCT01262976|38094740|FG002|Up to Year 3|Lost to Follow-up|4|||
16951049|NCT01262976|38094741|FG003|Up to Year 3|Lost to Follow-up|3|||
16951050|NCT01262976|38094742|FG004|Up to Year 3|Lost to Follow-up|1|||
16951051|NCT01262976|38094743|FG005|Up to Year 3|Lost to Follow-up|3|||
16951052|NCT01262976|38094738|FG000|Up to Year 3|Subjects with unknown completion status|0|||
16951053|NCT01262976|38094739|FG001|Up to Year 3|Subjects with unknown completion status|0|||
16951054|NCT01262976|38094740|FG002|Up to Year 3|Subjects with unknown completion status|1|||
16951055|NCT01262976|38094741|FG003|Up to Year 3|Subjects with unknown completion status|0|||
16951056|NCT01262976|38094742|FG004|Up to Year 3|Subjects with unknown completion status|0|||
16951057|NCT01262976|38094743|FG005|Up to Year 3|Subjects with unknown completion status|0|||
16951058|NCT01262976|38094738|FG000|Up to Year 3|Other|3|||
16951059|NCT01262976|38094739|FG001|Up to Year 3|Other|0|||
16951060|NCT01262976|38094740|FG002|Up to Year 3|Other|0|||
16951061|NCT01262976|38094741|FG003|Up to Year 3|Other|0|||
16951062|NCT01262976|38094742|FG004|Up to Year 3|Other|0|||
16951063|NCT01262976|38094743|FG005|Up to Year 3|Other|0|||
16951064|NCT01300286|38094758|FG000|Overall Study|did not get dosed|1|||
16951065|NCT01300052|38094765|FG000|Overall Study|Adverse Event|3|||
16951066|NCT01300052|38094766|FG001|Overall Study|Adverse Event|0|||
16951067|NCT01300052|38094765|FG000|Overall Study|Withdrawal by Subject|2|||
16951068|NCT01300052|38094766|FG001|Overall Study|Withdrawal by Subject|2|||
16951069|NCT01300052|38094765|FG000|Overall Study|Protocol Violation|1|||
16951070|NCT01300052|38094766|FG001|Overall Study|Protocol Violation|1|||
16951071|NCT01299896|38094774|FG000|Overall Study|Withdrawal by Subject|1|||
16951072|NCT01299896|38094775|FG001|Overall Study|Withdrawal by Subject|7|||
16951073|NCT01299896|38094774|FG000|Overall Study|Lost to Follow-up|0|||
16951074|NCT01299896|38094775|FG001|Overall Study|Lost to Follow-up|11|||
16951075|NCT01299584|38094781|FG000|Overall Study|Protocol Violation|9|||
16951076|NCT01236573|38094796|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16951077|NCT01236573|38094797|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16951078|NCT01236573|38094798|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16951079|NCT01236573|38094799|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16951080|NCT01236573|38094800|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16951081|NCT01236573|38094801|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16951082|NCT01236573|38094802|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
16951083|NCT01236573|38094803|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16951084|NCT01236573|38094804|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
16951085|NCT01236573|38094805|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
16951086|NCT01236573|38094806|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16951087|NCT01236573|38094796|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951088|NCT01236573|38094797|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951089|NCT01236573|38094798|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951090|NCT01236573|38094799|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951091|NCT01236573|38094800|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951092|NCT01236573|38094801|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951093|NCT01236573|38094802|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951094|NCT01236573|38094803|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951095|NCT01236573|38094804|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
16951096|NCT01236573|38094805|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951097|NCT01236573|38094806|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16951098|NCT01236573|38094796|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951099|NCT01236573|38094797|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951100|NCT01236573|38094798|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951101|NCT01236573|38094799|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951102|NCT01236573|38094800|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951103|NCT01236573|38094801|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951104|NCT01236573|38094802|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951105|NCT01236573|38094803|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951106|NCT01236573|38094804|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951107|NCT01236573|38094805|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16951108|NCT01236573|38094806|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
16951109|NCT01236339|38094833|FG000|Overall Study|Termination of study by sponsor|11|||
16951110|NCT01236339|38094834|FG001|Overall Study|Termination of study by sponsor|13|||
16951111|NCT01262898|38094845|FG000|Overall Study|Protocol Violation|1|||
16951112|NCT01262898|38094846|FG001|Overall Study|Protocol Violation|1|||
16951113|NCT01262898|38094847|FG002|Overall Study|Protocol Violation|0|||
16951114|NCT01262898|38094848|FG003|Overall Study|Protocol Violation|0|||
16951115|NCT01262898|38094845|FG000|Overall Study|Lost to Follow-up|1|||
16951116|NCT01262898|38094846|FG001|Overall Study|Lost to Follow-up|0|||
16951117|NCT01262898|38094847|FG002|Overall Study|Lost to Follow-up|0|||
16951118|NCT01262898|38094848|FG003|Overall Study|Lost to Follow-up|0|||
16951119|NCT01262898|38094845|FG000|Overall Study|Withdrawal by Subject|1|||
16951120|NCT01262898|38094846|FG001|Overall Study|Withdrawal by Subject|1|||
16951121|NCT01262898|38094847|FG002|Overall Study|Withdrawal by Subject|0|||
16951122|NCT01262898|38094848|FG003|Overall Study|Withdrawal by Subject|0|||
16951123|NCT01262820|38094861|FG000|Overall Study|Adverse Event|5|||
16951124|NCT01262820|38094861|FG000|Overall Study|Lack of Efficacy|9|||
16951125|NCT01262820|38094861|FG000|Overall Study|Drug held for 21+ days|1|||
16951126|NCT01057810|38094867|FG000|Overall Study|Disease progression|156|||
16951127|NCT01057810|38094868|FG001|Overall Study|Disease progression|197|||
16951128|NCT01057810|38094867|FG000|Overall Study|Study drug toxicity|5|||
16951129|NCT01057810|38094868|FG001|Overall Study|Study drug toxicity|114|||
16951130|NCT01057810|38094867|FG000|Overall Study|Adverse event unrelated to study drug|13|||
16951131|NCT01057810|38094868|FG001|Overall Study|Adverse event unrelated to study drug|29|||
16951132|NCT01057810|38094867|FG000|Overall Study|Withdrawal by Subject|10|||
16951133|NCT01057810|38094868|FG001|Overall Study|Withdrawal by Subject|25|||
16951134|NCT01057810|38094867|FG000|Overall Study|Death|2|||
16951135|NCT01057810|38094868|FG001|Overall Study|Death|12|||
16951136|NCT01057810|38094867|FG000|Overall Study|Maximum clinical benefit|5|||
16951137|NCT01057810|38094868|FG001|Overall Study|Maximum clinical benefit|5|||
16951138|NCT01057810|38094867|FG000|Overall Study|Poor/non-compliance|0|||
16951139|NCT01057810|38094868|FG001|Overall Study|Poor/non-compliance|1|||
16951140|NCT01057810|38094867|FG000|Overall Study|No longer met study criteria|0|||
16951141|NCT01057810|38094868|FG001|Overall Study|No longer met study criteria|1|||
16951142|NCT01057810|38094867|FG000|Overall Study|Other|7|||
16951143|NCT01057810|38094868|FG001|Overall Study|Other|14|||
16951144|NCT01262352|38094876|FG000|Period 1|Illness after randomization|1|||
16951145|NCT01262352|38094877|FG001|Period 1|Illness after randomization|0|||
16951146|NCT01262352|38094876|FG000|Washout|Adverse Event|1|||
16951147|NCT01262352|38094877|FG001|Washout|Adverse Event|1|||
16951148|NCT01262352|38094876|FG000|Washout|Extended Washout|0|||
16951149|NCT01262352|38094877|FG001|Washout|Extended Washout|1|||
16951150|NCT01299272|38094883|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
16951151|NCT01299272|38094884|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
16951152|NCT01299272|38094885|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
16951153|NCT01299272|38094886|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
16951154|NCT01299272|38094883|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
16951155|NCT01299272|38094884|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
16951156|NCT01299272|38094885|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
16951157|NCT01299272|38094886|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
16951158|NCT01299272|38094883|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
16951159|NCT01299272|38094884|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
16951160|NCT01299272|38094885|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
16951161|NCT01299272|38094886|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
16951162|NCT01299272|38094883|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
16951163|NCT01299272|38094884|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
16951164|NCT01299272|38094885|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
16951165|NCT01299272|38094886|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
16951166|NCT01299272|38094883|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
16951167|NCT01299272|38094884|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
16951168|NCT01299272|38094885|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
16951169|NCT01299272|38094886|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
16951170|NCT01299272|38094883|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
16951171|NCT01299272|38094884|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
16951172|NCT01299272|38094885|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
16951173|NCT01299272|38094886|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
16951174|NCT01299272|38094883|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
16951175|NCT01299272|38094884|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
16951176|NCT01299272|38094885|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
16951177|NCT01299272|38094886|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
16951178|NCT01299272|38094883|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
16951179|NCT01299272|38094884|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
16951180|NCT01299272|38094885|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
16951181|NCT01299272|38094886|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
16951182|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
16951183|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
16951184|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
16951185|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
16951186|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
16951187|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
16951188|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
16951189|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
16951190|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
16951191|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
16951192|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
16951193|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
16951194|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
16951195|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
16951196|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
16951197|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
16951198|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
16951199|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
16951200|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
16951201|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
16951202|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
16951203|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
16951204|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
16951205|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
16951206|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
16951207|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
16951208|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
16951209|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
16951210|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
16951211|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
16951212|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
16951213|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
16951214|NCT01299272|38094883|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
16951215|NCT01299272|38094884|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
16951216|NCT01299272|38094885|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
16951217|NCT01299272|38094886|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
16951218|NCT01299272|38094883|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
16951219|NCT01299272|38094884|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
16951220|NCT01299272|38094885|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
16951221|NCT01299272|38094886|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
16951222|NCT01299272|38094883|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
16951223|NCT01299272|38094884|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
17127771|NCT03276728|38268336|FG006|Overall Study|Lost to Follow-up|0|||
17127772|NCT03276728|38268337|FG007|Overall Study|Lost to Follow-up|0|||
17127773|NCT03276728|38268330|FG000|Overall Study|Withdrawal by Subject|0|||
17127774|NCT03276728|38268331|FG001|Overall Study|Withdrawal by Subject|0|||
17127775|NCT03276728|38268332|FG002|Overall Study|Withdrawal by Subject|0|||
17127776|NCT03276728|38268333|FG003|Overall Study|Withdrawal by Subject|3|||
17127777|NCT03276728|38268334|FG004|Overall Study|Withdrawal by Subject|0|||
17127778|NCT03276728|38268335|FG005|Overall Study|Withdrawal by Subject|0|||
17127779|NCT03276728|38268336|FG006|Overall Study|Withdrawal by Subject|0|||
17127780|NCT03276728|38268337|FG007|Overall Study|Withdrawal by Subject|0|||
17127781|NCT03276728|38268330|FG000|Overall Study|Decision by sponsor|0|||
17127782|NCT03276728|38268331|FG001|Overall Study|Decision by sponsor|0|||
17127783|NCT03276728|38268332|FG002|Overall Study|Decision by sponsor|0|||
17127784|NCT03276728|38268333|FG003|Overall Study|Decision by sponsor|0|||
17127785|NCT03276728|38268334|FG004|Overall Study|Decision by sponsor|1|||
17127786|NCT03276728|38268335|FG005|Overall Study|Decision by sponsor|0|||
17127787|NCT03276728|38268336|FG006|Overall Study|Decision by sponsor|2|||
17127788|NCT03276728|38268337|FG007|Overall Study|Decision by sponsor|1|||
17127789|NCT03275246|38268357|FG000|Overall Study|Protocol Violation|5|||
17127790|NCT03275246|38268357|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
17127791|NCT02940860|38268363|FG000|Overall Study|Non-serious AE|1|||
17127792|NCT02940860|38268364|FG001|Overall Study|Non-serious AE|2|||
17127793|NCT02940860|38268363|FG000|Overall Study|Serious AE|7|||
17127794|NCT02940860|38268364|FG001|Overall Study|Serious AE|3|||
17127795|NCT02940860|38268363|FG000|Overall Study|Withdrawal by Subject|19|||
17127796|NCT02940860|38268364|FG001|Overall Study|Withdrawal by Subject|9|||
17127797|NCT02940860|38268363|FG000|Overall Study|Lost to Follow-up|13|||
17127798|NCT02940860|38268364|FG001|Overall Study|Lost to Follow-up|7|||
17127799|NCT02940860|38268363|FG000|Overall Study|Physician Decision|5|||
17127800|NCT02940860|38268364|FG001|Overall Study|Physician Decision|3|||
17127801|NCT02940860|38268363|FG000|Overall Study|Sponsor Decision|0|||
17127802|NCT02940860|38268364|FG001|Overall Study|Sponsor Decision|1|||
17127803|NCT02940860|38268363|FG000|Overall Study|Protocol Violation|0|||
17127804|NCT02940860|38268364|FG001|Overall Study|Protocol Violation|2|||
17127805|NCT02940860|38268363|FG000|Overall Study|Death|3|||
17127806|NCT02940860|38268364|FG001|Overall Study|Death|2|||
17127807|NCT02940860|38268363|FG000|Overall Study|Moved, poor venous access, transport|6|||
17127808|NCT02940860|38268364|FG001|Overall Study|Moved, poor venous access, transport|4|||
17127809|NCT02940860|38268363|FG000|Overall Study|Not treated|2|||
17127810|NCT02940860|38268364|FG001|Overall Study|Not treated|2|||
17127811|NCT03309020|38268374|FG000|Overall Study|Death|1|||
17127812|NCT03309020|38268375|FG001|Overall Study|Death|0|||
17127813|NCT03309020|38268374|FG000|Overall Study|Did not undergo surgery|2|||
17127814|NCT03309020|38268375|FG001|Overall Study|Did not undergo surgery|1|||
17127815|NCT02806960|38268383|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
17127816|NCT02806960|38268384|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
17127817|NCT02806960|38268385|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
16951224|NCT01299272|38094885|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
16951225|NCT01299272|38094886|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
16951226|NCT01299272|38094883|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
16951227|NCT01299272|38094884|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
16951228|NCT01299272|38094885|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
16951229|NCT01299272|38094886|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
16951230|NCT01299272|38094883|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
16951231|NCT01299272|38094884|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
16951232|NCT01299272|38094885|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
16951233|NCT01299272|38094886|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
16951234|NCT01299272|38094883|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
16951235|NCT01299272|38094884|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
16951236|NCT01299272|38094885|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
16951237|NCT01299272|38094886|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
16951238|NCT01299272|38094883|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
16951239|NCT01299272|38094884|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
16951240|NCT01299272|38094885|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
16951241|NCT01299272|38094886|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
16951242|NCT01299272|38094883|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
16951243|NCT01299272|38094884|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
16951244|NCT01299272|38094885|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
16951245|NCT01299272|38094886|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
16951246|NCT01299272|38094883|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
16951247|NCT01299272|38094884|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
16951248|NCT01299272|38094885|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
16951249|NCT01299272|38094886|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
16951250|NCT01299116|38094903|FG000|Overall Study|Lost to Follow-up|65|||
16951251|NCT01299116|38094904|FG001|Overall Study|Lost to Follow-up|9|||
16951252|NCT01299116|38094905|FG002|Overall Study|Lost to Follow-up|11|||
16951253|NCT01299038|38094918|FG000|Overall Study|Withdrawal by Subject|1|||
16951254|NCT01299038|38094919|FG001|Overall Study|Withdrawal by Subject|0|||
16951255|NCT01298648|38094925|FG000|Overall Study|Withdrawal by Subject|2|||
16951256|NCT01298648|38094925|FG000|Overall Study|Lost to Follow-up|21|||
16951257|NCT01261338|38094931|FG000|Overall Study|Withdrawal by Subject|3|||
16951258|NCT01261338|38094932|FG001|Overall Study|Withdrawal by Subject|2|||
16951259|NCT01260948|38094940|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
16951260|NCT01260948|38094941|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
16951261|NCT01260948|38094940|FG000|Second Intervention|Emesis|0|||
16951262|NCT01260948|38094941|FG001|Second Intervention|Emesis|1|||
16951263|NCT01025284|38094950|FG000|Overall Study|Investigator Decision|0|||
17127818|NCT02806960|38268386|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
17127819|NCT03718143|38268396|FG000|Overall Study|Death|1|||
17127820|NCT03718143|38268397|FG001|Overall Study|Death|0|||
17127821|NCT03718143|38268398|FG002|Overall Study|Death|0|||
17127822|NCT03718143|38268396|FG000|Overall Study|Progression of Disease|1|||
17127823|NCT03718143|38268397|FG001|Overall Study|Progression of Disease|0|||
17127824|NCT03718143|38268398|FG002|Overall Study|Progression of Disease|0|||
17127825|NCT03718143|38268396|FG000|Overall Study|Withdrawal of Informed Consent|1|||
17127826|NCT03718143|38268397|FG001|Overall Study|Withdrawal of Informed Consent|2|||
17127827|NCT03718143|38268398|FG002|Overall Study|Withdrawal of Informed Consent|1|||
17127828|NCT03274466|38268408|FG000|Overall Study|Withdrawal by Subject|7|||
17127829|NCT03274466|38268409|FG001|Overall Study|Withdrawal by Subject|3|||
17127830|NCT03274466|38268408|FG000|Overall Study|Protocol Specified Withdrawal|5|||
17127831|NCT03274466|38268409|FG001|Overall Study|Protocol Specified Withdrawal|11|||
17127832|NCT03274466|38268408|FG000|Overall Study|Lost to Follow-up|5|||
17127833|NCT03274466|38268409|FG001|Overall Study|Lost to Follow-up|7|||
17127834|NCT03274466|38268408|FG000|Overall Study|Subject Non-compliance|0|||
17127835|NCT03274466|38268409|FG001|Overall Study|Subject Non-compliance|1|||
17127836|NCT03274466|38268408|FG000|Overall Study|Adverse Event|3|||
17127837|NCT03274466|38268409|FG001|Overall Study|Adverse Event|3|||
17127838|NCT03274466|38268408|FG000|Overall Study|Physician Decision|0|||
17127839|NCT03274466|38268409|FG001|Overall Study|Physician Decision|1|||
17127840|NCT03274466|38268408|FG000|Overall Study|Protocol Violation|3|||
17127841|NCT03274466|38268409|FG001|Overall Study|Protocol Violation|3|||
17127842|NCT02806726|38268415|FG000|Overall Study|Lost to Follow-up|1|||
17127843|NCT02806414|38268420|FG000|Overall Study|Lost to Follow-up|2|||
17127844|NCT02806024|38268426|FG000|Overall Study|Night Delivery|1|||
17127845|NCT02806024|38268427|FG001|Overall Study|Night Delivery|1|||
17127846|NCT02806024|38268426|FG000|Overall Study|DVT during antepartum admission|0|||
17127847|NCT02806024|38268427|FG001|Overall Study|DVT during antepartum admission|1|||
17127848|NCT02805790|38268435|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
17127849|NCT02805790|38268436|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
17127850|NCT02802592|38268442|FG000|Overall Study|Study terminated due to loss of funding|4|||
17127851|NCT02803138|38268447|FG000|Overall Study|Failure to return|38|||
17127852|NCT02803138|38268447|FG000|Overall Study|Insufficient virological response|2|||
17127853|NCT02803138|38268447|FG000|Overall Study|Withdrawn consent|1|||
17127854|NCT02803138|38268447|FG000|Overall Study|Death|1|||
17127855|NCT02803138|38268447|FG000|Overall Study|Other, not specified|28|||
17127856|NCT02801578|38268453|FG000|Overall Study|Adverse Event|2|||
17127857|NCT02799472|38268459|FG000|Overall Study|Withdrawal by Subject|2|||
17127858|NCT02799472|38268460|FG001|Overall Study|Withdrawal by Subject|4|||
17127859|NCT02799472|38268459|FG000|Overall Study|Lack of Efficacy|2|||
17127860|NCT02799472|38268460|FG001|Overall Study|Lack of Efficacy|0|||
17127861|NCT02799472|38268459|FG000|Overall Study|Lost to Follow-up|0|||
17127862|NCT02799472|38268460|FG001|Overall Study|Lost to Follow-up|1|||
17127863|NCT03245450|38268473|FG000|Overall Study|Radiological disease progression|3|||
17127864|NCT03245450|38268474|FG001|Overall Study|Radiological disease progression|3|||
17127865|NCT03245450|38268475|FG002|Overall Study|Radiological disease progression|2|||
17127866|NCT03245450|38268476|FG003|Overall Study|Radiological disease progression|2|||
17127867|NCT03245450|38268477|FG004|Overall Study|Radiological disease progression|7|||
17127868|NCT03245450|38268478|FG005|Overall Study|Radiological disease progression|6|||
17127869|NCT03245450|38268479|FG006|Overall Study|Radiological disease progression|6|||
17127870|NCT03245450|38268473|FG000|Overall Study|Clinical disease progression|0|||
17127871|NCT03245450|38268474|FG001|Overall Study|Clinical disease progression|0|||
17127872|NCT03245450|38268475|FG002|Overall Study|Clinical disease progression|1|||
17127873|NCT03245450|38268476|FG003|Overall Study|Clinical disease progression|0|||
17127874|NCT03245450|38268477|FG004|Overall Study|Clinical disease progression|0|||
17127875|NCT03245450|38268478|FG005|Overall Study|Clinical disease progression|2|||
17127876|NCT03245450|38268479|FG006|Overall Study|Clinical disease progression|0|||
17127877|NCT03245450|38268473|FG000|Overall Study|Other|0|||
16951264|NCT01025284|38094951|FG001|Overall Study|Investigator Decision|1|||
16951265|NCT01025284|38094952|FG002|Overall Study|Investigator Decision|0|||
16951266|NCT01025284|38094950|FG000|Overall Study|Withdrawal by Subject|0|||
16951267|NCT01025284|38094951|FG001|Overall Study|Withdrawal by Subject|1|||
16951268|NCT01025284|38094952|FG002|Overall Study|Withdrawal by Subject|0|||
16951269|NCT01021852|38094970|FG000|Treatment Period 1|Adverse Event|3|||
16951270|NCT01021852|38094971|FG001|Treatment Period 1|Adverse Event|1|||
16951271|NCT01021852|38094972|FG002|Treatment Period 1|Adverse Event|1|||
16951272|NCT01021852|38094973|FG003|Treatment Period 1|Adverse Event|0|||
16951273|NCT01021852|38094974|FG004|Treatment Period 1|Adverse Event|2|||
16951274|NCT01021852|38094975|FG005|Treatment Period 1|Adverse Event|2|||
16951275|NCT01021852|38094976|FG006|Treatment Period 1|Adverse Event|0|||
16951276|NCT01021852|38094977|FG007|Treatment Period 1|Adverse Event|0|||
16951277|NCT01021852|38094970|FG000|Treatment Period 1|Pregnancy|0|||
16951278|NCT01021852|38094971|FG001|Treatment Period 1|Pregnancy|0|||
16951279|NCT01021852|38094972|FG002|Treatment Period 1|Pregnancy|1|||
16951280|NCT01021852|38094973|FG003|Treatment Period 1|Pregnancy|0|||
16951281|NCT01021852|38094974|FG004|Treatment Period 1|Pregnancy|0|||
16951282|NCT01021852|38094975|FG005|Treatment Period 1|Pregnancy|0|||
16951283|NCT01021852|38094976|FG006|Treatment Period 1|Pregnancy|0|||
16951284|NCT01021852|38094977|FG007|Treatment Period 1|Pregnancy|0|||
16951285|NCT01021852|38094970|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16951286|NCT01021852|38094971|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16951287|NCT01021852|38094972|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16951288|NCT01021852|38094973|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16951289|NCT01021852|38094974|FG004|Treatment Period 1|Withdrawal by Subject|1|||
16951290|NCT01021852|38094975|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16951291|NCT01021852|38094976|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16951292|NCT01021852|38094977|FG007|Treatment Period 1|Withdrawal by Subject|1|||
16951293|NCT01021852|38094970|FG000|Treatment Period 1|Not Treated|0|||
16951294|NCT01021852|38094971|FG001|Treatment Period 1|Not Treated|0|||
16951295|NCT01021852|38094972|FG002|Treatment Period 1|Not Treated|0|||
16951296|NCT01021852|38094973|FG003|Treatment Period 1|Not Treated|2|||
16951297|NCT01021852|38094974|FG004|Treatment Period 1|Not Treated|0|||
16951298|NCT01021852|38094975|FG005|Treatment Period 1|Not Treated|0|||
16951299|NCT01021852|38094976|FG006|Treatment Period 1|Not Treated|0|||
16951300|NCT01021852|38094977|FG007|Treatment Period 1|Not Treated|0|||
16951301|NCT01021852|38094970|FG000|Washout Period-Placebo|Adverse Event|0|||
16951302|NCT01021852|38094971|FG001|Washout Period-Placebo|Adverse Event|0|||
16951303|NCT01021852|38094972|FG002|Washout Period-Placebo|Adverse Event|0|||
16951304|NCT01021852|38094973|FG003|Washout Period-Placebo|Adverse Event|1|||
16951305|NCT01021852|38094974|FG004|Washout Period-Placebo|Adverse Event|0|||
16951306|NCT01021852|38094975|FG005|Washout Period-Placebo|Adverse Event|1|||
16951307|NCT01021852|38094976|FG006|Washout Period-Placebo|Adverse Event|0|||
16951308|NCT01021852|38094977|FG007|Washout Period-Placebo|Adverse Event|0|||
16951309|NCT01021852|38094970|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
16951310|NCT01021852|38094971|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
16951311|NCT01021852|38094972|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
16951312|NCT01021852|38094973|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
16951313|NCT01021852|38094974|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
16951314|NCT01021852|38094975|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
16951315|NCT01021852|38094976|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
16951316|NCT01021852|38094977|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
16951317|NCT01021852|38094970|FG000|Washout Period-Placebo|Protocol Violation|0|||
16951318|NCT01021852|38094971|FG001|Washout Period-Placebo|Protocol Violation|0|||
16951319|NCT01021852|38094972|FG002|Washout Period-Placebo|Protocol Violation|0|||
16951320|NCT01021852|38094973|FG003|Washout Period-Placebo|Protocol Violation|0|||
16951321|NCT01021852|38094974|FG004|Washout Period-Placebo|Protocol Violation|0|||
16951322|NCT01021852|38094975|FG005|Washout Period-Placebo|Protocol Violation|0|||
16951323|NCT01021852|38094976|FG006|Washout Period-Placebo|Protocol Violation|1|||
16951324|NCT01021852|38094977|FG007|Washout Period-Placebo|Protocol Violation|0|||
16951325|NCT01021852|38094970|FG000|Washout Period-No Drug|Adverse Event|1|||
16951326|NCT01021852|38094971|FG001|Washout Period-No Drug|Adverse Event|0|||
16951327|NCT01021852|38094972|FG002|Washout Period-No Drug|Adverse Event|0|||
16951328|NCT01021852|38094973|FG003|Washout Period-No Drug|Adverse Event|0|||
16951329|NCT01021852|38094974|FG004|Washout Period-No Drug|Adverse Event|0|||
16951330|NCT01021852|38094975|FG005|Washout Period-No Drug|Adverse Event|1|||
16951331|NCT01021852|38094976|FG006|Washout Period-No Drug|Adverse Event|0|||
16951332|NCT01021852|38094977|FG007|Washout Period-No Drug|Adverse Event|0|||
16951333|NCT01021852|38094970|FG000|Treatment Period 2|Adverse Event|0|||
16951334|NCT01021852|38094971|FG001|Treatment Period 2|Adverse Event|1|||
16951335|NCT01021852|38094972|FG002|Treatment Period 2|Adverse Event|0|||
16951336|NCT01021852|38094973|FG003|Treatment Period 2|Adverse Event|0|||
16951337|NCT01021852|38094974|FG004|Treatment Period 2|Adverse Event|1|||
16951338|NCT01021852|38094975|FG005|Treatment Period 2|Adverse Event|0|||
16951339|NCT01021852|38094976|FG006|Treatment Period 2|Adverse Event|1|||
16951340|NCT01021852|38094977|FG007|Treatment Period 2|Adverse Event|0|||
16951341|NCT01021852|38094970|FG000|Treatment Period 2|Lack of Efficacy|0|||
16951342|NCT01021852|38094971|FG001|Treatment Period 2|Lack of Efficacy|0|||
16951343|NCT01021852|38094972|FG002|Treatment Period 2|Lack of Efficacy|0|||
16951344|NCT01021852|38094973|FG003|Treatment Period 2|Lack of Efficacy|0|||
16951345|NCT01021852|38094974|FG004|Treatment Period 2|Lack of Efficacy|0|||
16951346|NCT01021852|38094975|FG005|Treatment Period 2|Lack of Efficacy|1|||
16951347|NCT01021852|38094976|FG006|Treatment Period 2|Lack of Efficacy|0|||
16951348|NCT01021852|38094977|FG007|Treatment Period 2|Lack of Efficacy|0|||
16951349|NCT01021852|38094970|FG000|Treatment Period 2|Physician Decision|0|||
16951350|NCT01021852|38094971|FG001|Treatment Period 2|Physician Decision|0|||
16951351|NCT01021852|38094972|FG002|Treatment Period 2|Physician Decision|1|||
16951352|NCT01021852|38094973|FG003|Treatment Period 2|Physician Decision|0|||
16951353|NCT01021852|38094974|FG004|Treatment Period 2|Physician Decision|0|||
16951354|NCT01021852|38094975|FG005|Treatment Period 2|Physician Decision|0|||
16951355|NCT01021852|38094976|FG006|Treatment Period 2|Physician Decision|0|||
16951356|NCT01021852|38094977|FG007|Treatment Period 2|Physician Decision|0|||
16951357|NCT01021852|38094970|FG000|Treatment Period 2|Protocol Violation|0|||
16951358|NCT01021852|38094971|FG001|Treatment Period 2|Protocol Violation|0|||
16951359|NCT01021852|38094972|FG002|Treatment Period 2|Protocol Violation|0|||
16951360|NCT01021852|38094973|FG003|Treatment Period 2|Protocol Violation|0|||
16951361|NCT01021852|38094974|FG004|Treatment Period 2|Protocol Violation|1|||
16951362|NCT01021852|38094975|FG005|Treatment Period 2|Protocol Violation|0|||
16951363|NCT01021852|38094976|FG006|Treatment Period 2|Protocol Violation|1|||
16951364|NCT01021852|38094977|FG007|Treatment Period 2|Protocol Violation|0|||
16951365|NCT01021852|38094970|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16951366|NCT01021852|38094971|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16951367|NCT01021852|38094972|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16951368|NCT01021852|38094973|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16951369|NCT01021852|38094974|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16951370|NCT01021852|38094975|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16951371|NCT01021852|38094976|FG006|Treatment Period 2|Withdrawal by Subject|1|||
16951372|NCT01021852|38094977|FG007|Treatment Period 2|Withdrawal by Subject|2|||
16951373|NCT01056718|38094991|FG000|Overall Study|Withdrawal by Subject|2|||
16951374|NCT01056718|38094991|FG000|Overall Study|Ischemia on baseline stress test|1|||
16951375|NCT01298570|38094998|FG000|Overall Study|Disease progression, relapse during acti|64|||
16951376|NCT01298570|38094999|FG001|Overall Study|Disease progression, relapse during acti|40|||
16951377|NCT01298570|38094998|FG000|Overall Study|Adverse Event|20|||
16951378|NCT01298570|38094999|FG001|Overall Study|Adverse Event|2|||
16951379|NCT01298570|38094998|FG000|Overall Study|Withdrawal by Subject|21|||
16951380|NCT01298570|38094999|FG001|Overall Study|Withdrawal by Subject|6|||
16951381|NCT01298570|38094998|FG000|Overall Study|Treatment delay > 4 weeks|4|||
16951382|NCT01298570|38094999|FG001|Overall Study|Treatment delay > 4 weeks|5|||
16951383|NCT01298570|38094998|FG000|Overall Study|Physician Decision|4|||
16951384|NCT01298570|38094999|FG001|Overall Study|Physician Decision|2|||
16951385|NCT01298570|38094998|FG000|Overall Study|Other complicating disease|2|||
16951386|NCT01298570|38094999|FG001|Overall Study|Other complicating disease|1|||
16951387|NCT01298570|38094998|FG000|Overall Study|Surgery|2|||
16951388|NCT01298570|38094999|FG001|Overall Study|Surgery|1|||
16951389|NCT01298570|38094998|FG000|Overall Study|Symptomatic progression/deterioration|3|||
16951390|NCT01298570|38094999|FG001|Overall Study|Symptomatic progression/deterioration|2|||
16951391|NCT01298570|38094998|FG000|Overall Study|Death|0|||
16951392|NCT01298570|38094999|FG001|Overall Study|Death|1|||
16951393|NCT01298570|38094998|FG000|Overall Study|Ineligibility|0|||
16951394|NCT01298570|38094999|FG001|Overall Study|Ineligibility|1|||
16951395|NCT01259856|38095007|FG000|Overall Study|Adverse Event|12|||
16951396|NCT01259856|38095008|FG001|Overall Study|Adverse Event|9|||
16951397|NCT01259856|38095007|FG000|Overall Study|Death|0|||
16951398|NCT01259856|38095008|FG001|Overall Study|Death|1|||
16951399|NCT01259856|38095007|FG000|Overall Study|Lack of Efficacy|3|||
16951400|NCT01259856|38095008|FG001|Overall Study|Lack of Efficacy|1|||
16951401|NCT01259856|38095007|FG000|Overall Study|Lost to Follow-up|1|||
16951402|NCT01259856|38095008|FG001|Overall Study|Lost to Follow-up|1|||
16951403|NCT01259856|38095007|FG000|Overall Study|Physician Decision|2|||
16951404|NCT01259856|38095008|FG001|Overall Study|Physician Decision|1|||
16951405|NCT01259856|38095007|FG000|Overall Study|Withdrawal by Subject|9|||
16951406|NCT01259856|38095008|FG001|Overall Study|Withdrawal by Subject|10|||
16951407|NCT01259856|38095007|FG000|Overall Study|Treatment never started|0|||
16951408|NCT01259856|38095008|FG001|Overall Study|Treatment never started|6|||
16951409|NCT01259856|38095007|FG000|Overall Study|Study closure by sponsor|40|||
16951410|NCT01259856|38095008|FG001|Overall Study|Study closure by sponsor|41|||
16951411|NCT01259856|38095007|FG000|Overall Study|Patient developed other disease|0|||
16951412|NCT01259856|38095008|FG001|Overall Study|Patient developed other disease|1|||
16951413|NCT01259856|38095007|FG000|Overall Study|Transfer to another study|0|||
16951414|NCT01259856|38095008|FG001|Overall Study|Transfer to another study|1|||
16951415|NCT01259856|38095007|FG000|Overall Study|Unknown/missing|2|||
16951416|NCT01259856|38095008|FG001|Overall Study|Unknown/missing|2|||
16951417|NCT01020838|38095014|FG000|Overall Study|Death|90|||
16951418|NCT01020838|38095014|FG000|Overall Study|Adverse Event|1|||
16951419|NCT01020838|38095014|FG000|Overall Study|Withdrawal by Subject|9|||
16951420|NCT01020838|38095014|FG000|Overall Study|Lost to Follow-up|6|||
16951421|NCT01020838|38095014|FG000|Overall Study|Most common: Study ended by sponsor|77|||
16951422|NCT01259466|38095029|FG000|Overall Study|Withdrawal by Subject|1|||
16951423|NCT01259466|38095030|FG001|Overall Study|Withdrawal by Subject|9|||
16951424|NCT01259388|38095038|FG000|Overall Study|Adverse Event|3|||
16951425|NCT01259388|38095039|FG001|Overall Study|Adverse Event|0|||
16951426|NCT01259388|38095038|FG000|Overall Study|Withdrawal by Subject|1|||
16951427|NCT01259388|38095039|FG001|Overall Study|Withdrawal by Subject|1|||
16951428|NCT01259388|38095038|FG000|Overall Study|Physician Decision|1|||
17127878|NCT03245450|38268474|FG001|Overall Study|Other|0|||
17127879|NCT03245450|38268475|FG002|Overall Study|Other|0|||
17127880|NCT03245450|38268476|FG003|Overall Study|Other|1|||
17127881|NCT03245450|38268477|FG004|Overall Study|Other|1|||
17127882|NCT03245450|38268478|FG005|Overall Study|Other|1|||
16951429|NCT01259388|38095039|FG001|Overall Study|Physician Decision|0|||
16951430|NCT01298492|38095045|FG000|Overall Study|Death|2|||
16951431|NCT01298492|38095045|FG000|Overall Study|Insufficient Clinical Response|22|||
16951432|NCT01298492|38095045|FG000|Overall Study|Lost to Follow-up|12|||
16951433|NCT01298492|38095045|FG000|Overall Study|Withdrawal by Subject|47|||
16951434|NCT01298492|38095045|FG000|Overall Study|Other (Unspecified)|7|||
16951435|NCT01298492|38095045|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
16951436|NCT01298492|38095045|FG000|Overall Study|Protocol Violation|2|||
16951437|NCT01298492|38095045|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
16951438|NCT01298492|38095045|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
16951439|NCT01297322|38095051|FG000|Overall Study|Lost to Follow-up|1|||
16951440|NCT01297322|38095052|FG001|Overall Study|Lost to Follow-up|0|||
16951441|NCT01297322|38095051|FG000|Overall Study|Withdrawal by Subject|0|||
16951442|NCT01297322|38095052|FG001|Overall Study|Withdrawal by Subject|1|||
16951443|NCT01297322|38095051|FG000|Overall Study|Protocol Violation|0|||
16951444|NCT01297322|38095052|FG001|Overall Study|Protocol Violation|3|||
16951445|NCT01297244|38095061|FG000|Overall Study|Progressive disease|22|||
16951446|NCT01297244|38095062|FG001|Overall Study|Progressive disease|3|||
17127883|NCT03245450|38268479|FG006|Overall Study|Other|1|||
17127884|NCT03245450|38268473|FG000|Overall Study|Withdrawal by Subject|0|||
17127885|NCT03245450|38268474|FG001|Overall Study|Withdrawal by Subject|1|||
16951447|NCT01297244|38095061|FG000|Overall Study|Adverse Event|9|||
16951448|NCT01297244|38095062|FG001|Overall Study|Adverse Event|1|||
16951449|NCT01297244|38095061|FG000|Overall Study|Death|1|||
16951450|NCT01297244|38095062|FG001|Overall Study|Death|1|||
16951451|NCT01297244|38095061|FG000|Overall Study|Clinical progression|1|||
16951452|NCT01297244|38095062|FG001|Overall Study|Clinical progression|1|||
16951453|NCT01297244|38095061|FG000|Overall Study|Withdrawal by Subject|2|||
16951454|NCT01297244|38095062|FG001|Overall Study|Withdrawal by Subject|0|||
16951455|NCT03456726|38095075|FG000|Overall Study|Disease Progression|6|||
16951456|NCT03456726|38095076|FG001|Overall Study|Disease Progression|1|||
16951457|NCT03456726|38095075|FG000|Overall Study|Adverse Event|4|||
16951458|NCT03456726|38095076|FG001|Overall Study|Adverse Event|2|||
16951459|NCT03456726|38095075|FG000|Overall Study|Withdrawal by Subject|1|||
16951460|NCT03456726|38095076|FG001|Overall Study|Withdrawal by Subject|0|||
16951461|NCT03456726|38095075|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
16951462|NCT03456726|38095076|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
16951463|NCT03181932|38095084|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
16951464|NCT03181932|38095085|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
16951465|NCT03181932|38095084|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
16951466|NCT03181932|38095085|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
16951467|NCT03181932|38095084|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
17127886|NCT03245450|38268475|FG002|Overall Study|Withdrawal by Subject|0|||
17127887|NCT03245450|38268476|FG003|Overall Study|Withdrawal by Subject|0|||
17127888|NCT03245450|38268477|FG004|Overall Study|Withdrawal by Subject|0|||
17127889|NCT03245450|38268478|FG005|Overall Study|Withdrawal by Subject|0|||
17127890|NCT03245450|38268479|FG006|Overall Study|Withdrawal by Subject|0|||
17127891|NCT03245450|38268473|FG000|Overall Study|Adverse Event|0|||
17127892|NCT03245450|38268474|FG001|Overall Study|Adverse Event|0|||
17127893|NCT03245450|38268475|FG002|Overall Study|Adverse Event|0|||
17127894|NCT03245450|38268476|FG003|Overall Study|Adverse Event|0|||
17127895|NCT03245450|38268477|FG004|Overall Study|Adverse Event|1|||
17127896|NCT03245450|38268478|FG005|Overall Study|Adverse Event|0|||
17127897|NCT03245450|38268479|FG006|Overall Study|Adverse Event|2|||
17127898|NCT03712917|38268504|FG000|Overall Study|Pregnancy|0|||
17127899|NCT03712917|38268505|FG001|Overall Study|Pregnancy|0|||
16951468|NCT03181932|38095085|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
16951469|NCT03181932|38095084|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
17127900|NCT03712917|38268506|FG002|Overall Study|Pregnancy|1|||
17127901|NCT03712917|38268504|FG000|Overall Study|Adverse Event|0|||
17127902|NCT03712917|38268505|FG001|Overall Study|Adverse Event|4|||
17127903|NCT03712917|38268506|FG002|Overall Study|Adverse Event|3|||
17127904|NCT03712917|38268504|FG000|Overall Study|Lost to Follow-up|9|||
16951470|NCT03181932|38095085|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
16951471|NCT03181932|38095084|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
16951472|NCT03181932|38095085|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
16951473|NCT03181932|38095084|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
16951474|NCT03181932|38095085|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
16951475|NCT03181932|38095084|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
16951476|NCT03181932|38095085|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
16951477|NCT03181932|38095084|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
16951478|NCT03181932|38095085|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
16951479|NCT03181932|38095084|FG000|Period 2 (Open-label Period)|Reason missing|2|||
16951480|NCT03181932|38095085|FG001|Period 2 (Open-label Period)|Reason missing|0|||
16951481|NCT02864862|38095095|FG000|Overall Study|Lost to Follow-up|1|||
16951482|NCT02864862|38095096|FG001|Overall Study|Lost to Follow-up|0|||
16951483|NCT02864862|38095097|FG002|Overall Study|Lost to Follow-up|1|||
16951484|NCT02864862|38095095|FG000|Overall Study|Protocol Violation|0|||
16951485|NCT02864862|38095096|FG001|Overall Study|Protocol Violation|0|||
16951486|NCT02864862|38095097|FG002|Overall Study|Protocol Violation|1|||
16951487|NCT01598298|38095109|FG000|Overall Study|Not eligible|5|||
16951488|NCT01598298|38095110|FG001|Overall Study|Not eligible|5|||
16951489|NCT01598298|38095109|FG000|Overall Study|Adverse Event|21|||
16951490|NCT01598298|38095110|FG001|Overall Study|Adverse Event|19|||
16951491|NCT01598298|38095109|FG000|Overall Study|Progression/relapse|0|||
16951492|NCT01598298|38095110|FG001|Overall Study|Progression/relapse|2|||
16951493|NCT01598298|38095109|FG000|Overall Study|Withdrawal by Subject|10|||
16951494|NCT01598298|38095110|FG001|Overall Study|Withdrawal by Subject|15|||
16951495|NCT01598298|38095109|FG000|Overall Study|Other reason (not protocol specified)|4|||
16951496|NCT01598298|38095110|FG001|Overall Study|Other reason (not protocol specified)|0|||
16951497|NCT01235949|38095134|FG000|Primary Phase|Migrated/moved from study area|1|||
16951498|NCT01235949|38095135|FG001|Primary Phase|Migrated/moved from study area|1|||
16951499|NCT01235949|38095136|FG002|Primary Phase|Migrated/moved from study area|0|||
16951500|NCT01235949|38095137|FG003|Primary Phase|Migrated/moved from study area|0|||
16951501|NCT01235949|38095138|FG004|Primary Phase|Migrated/moved from study area|1|||
16951502|NCT01235949|38095139|FG005|Primary Phase|Migrated/moved from study area|2|||
16951503|NCT01235949|38095140|FG006|Primary Phase|Migrated/moved from study area|0|||
16951504|NCT01235949|38095141|FG007|Primary Phase|Migrated/moved from study area|0|||
16951505|NCT01235949|38095142|FG008|Primary Phase|Migrated/moved from study area|0|||
16951506|NCT01235949|38095143|FG009|Primary Phase|Migrated/moved from study area|0|||
16951507|NCT01235949|38095144|FG010|Primary Phase|Migrated/moved from study area|0|||
16951508|NCT01235949|38095145|FG011|Primary Phase|Migrated/moved from study area|0|||
16951509|NCT01235949|38095146|FG012|Primary Phase|Migrated/moved from study area|0|||
16951510|NCT01235949|38095147|FG013|Primary Phase|Migrated/moved from study area|0|||
16951511|NCT01235949|38095148|FG014|Primary Phase|Migrated/moved from study area|0|||
16951512|NCT01235949|38095149|FG015|Primary Phase|Migrated/moved from study area|0|||
16951513|NCT01235949|38095150|FG016|Primary Phase|Migrated/moved from study area|0|||
16951514|NCT01235949|38095151|FG017|Primary Phase|Migrated/moved from study area|0|||
16951515|NCT01235949|38095134|FG000|Primary Phase|Adverse Event|0|||
16951516|NCT01235949|38095135|FG001|Primary Phase|Adverse Event|0|||
16951517|NCT01235949|38095136|FG002|Primary Phase|Adverse Event|0|||
16951518|NCT01235949|38095137|FG003|Primary Phase|Adverse Event|1|||
16951519|NCT01235949|38095138|FG004|Primary Phase|Adverse Event|0|||
16951520|NCT01235949|38095139|FG005|Primary Phase|Adverse Event|0|||
16951521|NCT01235949|38095140|FG006|Primary Phase|Adverse Event|0|||
16951522|NCT01235949|38095141|FG007|Primary Phase|Adverse Event|0|||
16951523|NCT01235949|38095142|FG008|Primary Phase|Adverse Event|0|||
17127905|NCT03712917|38268505|FG001|Overall Study|Lost to Follow-up|4|||
17127906|NCT03712917|38268506|FG002|Overall Study|Lost to Follow-up|5|||
16951524|NCT01235949|38095143|FG009|Primary Phase|Adverse Event|0|||
16951525|NCT01235949|38095144|FG010|Primary Phase|Adverse Event|0|||
16951526|NCT01235949|38095145|FG011|Primary Phase|Adverse Event|0|||
16951527|NCT01235949|38095146|FG012|Primary Phase|Adverse Event|0|||
16951528|NCT01235949|38095147|FG013|Primary Phase|Adverse Event|0|||
16951529|NCT01235949|38095148|FG014|Primary Phase|Adverse Event|0|||
16951530|NCT01235949|38095149|FG015|Primary Phase|Adverse Event|0|||
16951531|NCT01235949|38095150|FG016|Primary Phase|Adverse Event|0|||
16951532|NCT01235949|38095151|FG017|Primary Phase|Adverse Event|0|||
16951533|NCT01235949|38095134|FG000|Primary Phase|Withdrawal by Subject|3|||
16951534|NCT01235949|38095135|FG001|Primary Phase|Withdrawal by Subject|2|||
16951535|NCT01235949|38095136|FG002|Primary Phase|Withdrawal by Subject|2|||
16951536|NCT01235949|38095137|FG003|Primary Phase|Withdrawal by Subject|0|||
16951537|NCT01235949|38095138|FG004|Primary Phase|Withdrawal by Subject|0|||
16951538|NCT01235949|38095139|FG005|Primary Phase|Withdrawal by Subject|3|||
16951539|NCT01235949|38095140|FG006|Primary Phase|Withdrawal by Subject|0|||
16951540|NCT01235949|38095141|FG007|Primary Phase|Withdrawal by Subject|0|||
16951541|NCT01235949|38095142|FG008|Primary Phase|Withdrawal by Subject|0|||
16951542|NCT01235949|38095143|FG009|Primary Phase|Withdrawal by Subject|0|||
16951543|NCT01235949|38095144|FG010|Primary Phase|Withdrawal by Subject|0|||
16951544|NCT01235949|38095145|FG011|Primary Phase|Withdrawal by Subject|0|||
16951545|NCT01235949|38095146|FG012|Primary Phase|Withdrawal by Subject|0|||
16951546|NCT01235949|38095147|FG013|Primary Phase|Withdrawal by Subject|0|||
16951547|NCT01235949|38095148|FG014|Primary Phase|Withdrawal by Subject|0|||
16951548|NCT01235949|38095149|FG015|Primary Phase|Withdrawal by Subject|0|||
16951549|NCT01235949|38095150|FG016|Primary Phase|Withdrawal by Subject|0|||
16951550|NCT01235949|38095151|FG017|Primary Phase|Withdrawal by Subject|0|||
16951551|NCT01235949|38095134|FG000|Primary Phase|Lost to Follow-up|0|||
16951552|NCT01235949|38095135|FG001|Primary Phase|Lost to Follow-up|0|||
16951553|NCT01235949|38095136|FG002|Primary Phase|Lost to Follow-up|1|||
16951554|NCT01235949|38095137|FG003|Primary Phase|Lost to Follow-up|1|||
16951555|NCT01235949|38095138|FG004|Primary Phase|Lost to Follow-up|0|||
16951556|NCT01235949|38095139|FG005|Primary Phase|Lost to Follow-up|2|||
16951557|NCT01235949|38095140|FG006|Primary Phase|Lost to Follow-up|0|||
16951558|NCT01235949|38095141|FG007|Primary Phase|Lost to Follow-up|0|||
16951559|NCT01235949|38095142|FG008|Primary Phase|Lost to Follow-up|0|||
16951560|NCT01235949|38095143|FG009|Primary Phase|Lost to Follow-up|0|||
16951561|NCT01235949|38095144|FG010|Primary Phase|Lost to Follow-up|0|||
16951562|NCT01235949|38095145|FG011|Primary Phase|Lost to Follow-up|0|||
16951563|NCT01235949|38095146|FG012|Primary Phase|Lost to Follow-up|0|||
16951564|NCT01235949|38095147|FG013|Primary Phase|Lost to Follow-up|0|||
16951565|NCT01235949|38095148|FG014|Primary Phase|Lost to Follow-up|0|||
17127907|NCT02748694|38268529|FG000|Overall Study|Voluntary Withdrawal|0|||
16951566|NCT01235949|38095149|FG015|Primary Phase|Lost to Follow-up|0|||
16951567|NCT01235949|38095150|FG016|Primary Phase|Lost to Follow-up|0|||
16951568|NCT01235949|38095151|FG017|Primary Phase|Lost to Follow-up|0|||
16951569|NCT01235949|38095134|FG000|Booster Phase|Migrated/moved from study area|0|||
16951570|NCT01235949|38095135|FG001|Booster Phase|Migrated/moved from study area|0|||
16951571|NCT01235949|38095136|FG002|Booster Phase|Migrated/moved from study area|0|||
16951572|NCT01235949|38095137|FG003|Booster Phase|Migrated/moved from study area|0|||
16951573|NCT01235949|38095138|FG004|Booster Phase|Migrated/moved from study area|0|||
16951574|NCT01235949|38095139|FG005|Booster Phase|Migrated/moved from study area|0|||
16951575|NCT01235949|38095140|FG006|Booster Phase|Migrated/moved from study area|0|||
16951576|NCT01235949|38095141|FG007|Booster Phase|Migrated/moved from study area|0|||
16951577|NCT01235949|38095142|FG008|Booster Phase|Migrated/moved from study area|0|||
17127908|NCT02748694|38268530|FG001|Overall Study|Voluntary Withdrawal|0|||
17127909|NCT02748694|38268531|FG002|Overall Study|Voluntary Withdrawal|0|||
17127910|NCT02748694|38268532|FG003|Overall Study|Voluntary Withdrawal|0|||
17127911|NCT02748694|38268533|FG004|Overall Study|Voluntary Withdrawal|0|||
17127912|NCT02748694|38268534|FG005|Overall Study|Voluntary Withdrawal|0|||
17127913|NCT02748694|38268535|FG006|Overall Study|Voluntary Withdrawal|0|||
17127914|NCT02748694|38268536|FG007|Overall Study|Voluntary Withdrawal|0|||
17127915|NCT02748694|38268537|FG008|Overall Study|Voluntary Withdrawal|0|||
17127916|NCT02748694|38268538|FG009|Overall Study|Voluntary Withdrawal|0|||
17127917|NCT02748694|38268539|FG010|Overall Study|Voluntary Withdrawal|0|||
16951578|NCT01235949|38095143|FG009|Booster Phase|Migrated/moved from study area|0|||
16951579|NCT01235949|38095144|FG010|Booster Phase|Migrated/moved from study area|0|||
16951580|NCT01235949|38095145|FG011|Booster Phase|Migrated/moved from study area|1|||
16951581|NCT01235949|38095146|FG012|Booster Phase|Migrated/moved from study area|1|||
16951582|NCT01235949|38095147|FG013|Booster Phase|Migrated/moved from study area|0|||
16951583|NCT01235949|38095148|FG014|Booster Phase|Migrated/moved from study area|0|||
16951584|NCT01235949|38095149|FG015|Booster Phase|Migrated/moved from study area|0|||
16951585|NCT01235949|38095150|FG016|Booster Phase|Migrated/moved from study area|0|||
16951586|NCT01235949|38095151|FG017|Booster Phase|Migrated/moved from study area|1|||
16951587|NCT01235949|38095134|FG000|Booster Phase|Adverse Event|0|||
16951588|NCT01235949|38095135|FG001|Booster Phase|Adverse Event|0|||
16951589|NCT01235949|38095136|FG002|Booster Phase|Adverse Event|0|||
16951590|NCT01235949|38095137|FG003|Booster Phase|Adverse Event|0|||
16951591|NCT01235949|38095138|FG004|Booster Phase|Adverse Event|0|||
16951592|NCT01235949|38095139|FG005|Booster Phase|Adverse Event|0|||
16951593|NCT01235949|38095140|FG006|Booster Phase|Adverse Event|0|||
16951594|NCT01235949|38095141|FG007|Booster Phase|Adverse Event|0|||
16951595|NCT01235949|38095142|FG008|Booster Phase|Adverse Event|0|||
16951596|NCT01235949|38095143|FG009|Booster Phase|Adverse Event|0|||
16951597|NCT01235949|38095144|FG010|Booster Phase|Adverse Event|0|||
16951598|NCT01235949|38095145|FG011|Booster Phase|Adverse Event|0|||
16951599|NCT01235949|38095146|FG012|Booster Phase|Adverse Event|0|||
16951600|NCT01235949|38095147|FG013|Booster Phase|Adverse Event|0|||
16951601|NCT01235949|38095148|FG014|Booster Phase|Adverse Event|0|||
16951602|NCT01235949|38095149|FG015|Booster Phase|Adverse Event|1|||
16951603|NCT01235949|38095150|FG016|Booster Phase|Adverse Event|0|||
16951604|NCT01235949|38095151|FG017|Booster Phase|Adverse Event|0|||
16951605|NCT01235949|38095134|FG000|Booster Phase|Withdrawal by Subject|0|||
16951606|NCT01235949|38095135|FG001|Booster Phase|Withdrawal by Subject|0|||
16951607|NCT01235949|38095136|FG002|Booster Phase|Withdrawal by Subject|0|||
16951608|NCT01235949|38095137|FG003|Booster Phase|Withdrawal by Subject|0|||
16951609|NCT01235949|38095138|FG004|Booster Phase|Withdrawal by Subject|0|||
16951610|NCT01235949|38095139|FG005|Booster Phase|Withdrawal by Subject|0|||
16951611|NCT01235949|38095140|FG006|Booster Phase|Withdrawal by Subject|0|||
16951612|NCT01235949|38095141|FG007|Booster Phase|Withdrawal by Subject|1|||
16951613|NCT01235949|38095142|FG008|Booster Phase|Withdrawal by Subject|1|||
16951614|NCT01235949|38095143|FG009|Booster Phase|Withdrawal by Subject|0|||
16951615|NCT01235949|38095144|FG010|Booster Phase|Withdrawal by Subject|1|||
16951616|NCT01235949|38095145|FG011|Booster Phase|Withdrawal by Subject|1|||
16951617|NCT01235949|38095146|FG012|Booster Phase|Withdrawal by Subject|2|||
16951618|NCT01235949|38095147|FG013|Booster Phase|Withdrawal by Subject|0|||
16951619|NCT01235949|38095148|FG014|Booster Phase|Withdrawal by Subject|2|||
16951620|NCT01235949|38095149|FG015|Booster Phase|Withdrawal by Subject|0|||
16951621|NCT01235949|38095150|FG016|Booster Phase|Withdrawal by Subject|0|||
16951622|NCT01235949|38095151|FG017|Booster Phase|Withdrawal by Subject|0|||
16951623|NCT01235949|38095134|FG000|Booster Phase|Lost to Follow-up|0|||
16774260|NCT03347123|37713583|FG002|Overall Study|Withdrawal by Subject|0|||
16951624|NCT01235949|38095135|FG001|Booster Phase|Lost to Follow-up|0|||
16951625|NCT01235949|38095136|FG002|Booster Phase|Lost to Follow-up|0|||
16951626|NCT01235949|38095137|FG003|Booster Phase|Lost to Follow-up|0|||
16951627|NCT01235949|38095138|FG004|Booster Phase|Lost to Follow-up|0|||
16774261|NCT03347123|37713584|FG003|Overall Study|Withdrawal by Subject|0|||
16774262|NCT03347123|37713585|FG004|Overall Study|Withdrawal by Subject|0|||
16774263|NCT03347123|37713586|FG005|Overall Study|Withdrawal by Subject|0|||
16951628|NCT01235949|38095139|FG005|Booster Phase|Lost to Follow-up|0|||
16951629|NCT01235949|38095140|FG006|Booster Phase|Lost to Follow-up|0|||
16951630|NCT01235949|38095141|FG007|Booster Phase|Lost to Follow-up|0|||
16951631|NCT01235949|38095142|FG008|Booster Phase|Lost to Follow-up|1|||
16951632|NCT01235949|38095143|FG009|Booster Phase|Lost to Follow-up|1|||
16951633|NCT01235949|38095144|FG010|Booster Phase|Lost to Follow-up|1|||
16951634|NCT01235949|38095145|FG011|Booster Phase|Lost to Follow-up|1|||
16951635|NCT01235949|38095146|FG012|Booster Phase|Lost to Follow-up|0|||
16951636|NCT01235949|38095147|FG013|Booster Phase|Lost to Follow-up|0|||
16951637|NCT01235949|38095148|FG014|Booster Phase|Lost to Follow-up|0|||
16951638|NCT01235949|38095149|FG015|Booster Phase|Lost to Follow-up|0|||
16951639|NCT01235949|38095150|FG016|Booster Phase|Lost to Follow-up|0|||
16951640|NCT01235949|38095151|FG017|Booster Phase|Lost to Follow-up|1|||
16951641|NCT01235793|38095189|FG000|Overall Study|Death|6|||
16951642|NCT01258998|38095194|FG000|Overall Study|Ineligible|1|||
16951643|NCT01235715|38095200|FG000|Overall Study|Physician Decision|0|||
16951644|NCT01235715|38095201|FG001|Overall Study|Physician Decision|2|||
16951645|NCT01235403|38095208|FG000|Overall Study|Adverse Event|14|||
16951646|NCT01235403|38095208|FG000|Overall Study|Lost to Follow-up|2|||
16951647|NCT01235403|38095208|FG000|Overall Study|Withdrawal by Subject|4|||
16951648|NCT01235403|38095208|FG000|Overall Study|Lack of Efficacy|2|||
16951649|NCT01235403|38095208|FG000|Overall Study|Other reasons for premature termination|4|||
17127918|NCT02748694|38268540|FG011|Overall Study|Voluntary Withdrawal|0|||
17127919|NCT02748694|38268541|FG012|Overall Study|Voluntary Withdrawal|0|||
17127920|NCT02748694|38268542|FG013|Overall Study|Voluntary Withdrawal|0|||
17127921|NCT02748694|38268543|FG014|Overall Study|Voluntary Withdrawal|2|||
17127922|NCT02800642|38268599|FG000|Overall Study|Death|3|||
17127923|NCT02800642|38268599|FG000|Overall Study|Other|10|||
17127924|NCT02800642|38268599|FG000|Overall Study|Physician Decision|2|||
17127925|NCT02800642|38268599|FG000|Overall Study|Adverse Event|6|||
17127926|NCT02800642|38268599|FG000|Overall Study|Withdrawal by Subject|3|||
16774264|NCT03347123|37713587|FG006|Overall Study|Withdrawal by Subject|0|||
17127927|NCT02800642|38268599|FG000|Overall Study|Lost to Follow-up|1|||
17127928|NCT02799784|38268603|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
17127929|NCT02799784|38268604|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
17127930|NCT02799784|38268603|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
16774265|NCT03347123|37713581|FG000|Overall Study|Reason not Specified|3|||
16774266|NCT03347123|37713582|FG001|Overall Study|Reason not Specified|4|||
17127931|NCT02799784|38268604|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
17127932|NCT02799784|38268603|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
17127933|NCT02799784|38268604|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
16951650|NCT01024036|38095214|FG000|Blinded Treatment|Adverse Event|1|||
16951651|NCT01024036|38095215|FG001|Blinded Treatment|Adverse Event|1|||
16951652|NCT01024036|38095214|FG000|Blinded Treatment|Lack of Efficacy|16|||
16951653|NCT01024036|38095215|FG001|Blinded Treatment|Lack of Efficacy|14|||
16951654|NCT01024036|38095214|FG000|Blinded Treatment|Physician Decision|1|||
16951655|NCT01024036|38095215|FG001|Blinded Treatment|Physician Decision|0|||
16951656|NCT01024036|38095214|FG000|Blinded Treatment|Death|0|||
16951657|NCT01024036|38095215|FG001|Blinded Treatment|Death|2|||
16951658|NCT01024036|38095214|FG000|Blinded Treatment|Withdrawal by Subject|4|||
16951659|NCT01024036|38095215|FG001|Blinded Treatment|Withdrawal by Subject|3|||
16951660|NCT01024036|38095214|FG000|Unblinded Treatment|Adverse Event|0|||
16951661|NCT01024036|38095215|FG001|Unblinded Treatment|Adverse Event|1|||
16951662|NCT01024036|38095214|FG000|Unblinded Treatment|Lack of Efficacy|0|||
16951663|NCT01024036|38095215|FG001|Unblinded Treatment|Lack of Efficacy|2|||
16951664|NCT01024036|38095214|FG000|Follow-Up Period|Lost to Follow-up|1|||
16951665|NCT01024036|38095215|FG001|Follow-Up Period|Lost to Follow-up|1|||
16951666|NCT01024036|38095214|FG000|Follow-Up Period|Withdrawal by Subject|0|||
16951667|NCT01024036|38095215|FG001|Follow-Up Period|Withdrawal by Subject|1|||
16951668|NCT01024036|38095214|FG000|Follow-Up Period|Adverse Event|4|||
16951669|NCT01024036|38095215|FG001|Follow-Up Period|Adverse Event|1|||
16951670|NCT01234467|38095224|FG000|Overall Study|Adverse Event|3|||
16951671|NCT01234467|38095224|FG000|Overall Study|Death|2|||
16951672|NCT01234467|38095224|FG000|Overall Study|Withdrawal by Subject|2|||
16951673|NCT01234467|38095224|FG000|Overall Study|Disease Progression|2|||
16774267|NCT03347123|37713583|FG002|Overall Study|Reason not Specified|0|||
16774268|NCT03347123|37713584|FG003|Overall Study|Reason not Specified|0|||
16774269|NCT03347123|37713585|FG004|Overall Study|Reason not Specified|0|||
16774270|NCT03347123|37713586|FG005|Overall Study|Reason not Specified|0|||
16774271|NCT03347123|37713587|FG006|Overall Study|Reason not Specified|0|||
16774272|NCT02133742|37713598|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
16774273|NCT02133742|37713598|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
16774274|NCT02133742|37713598|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
16774275|NCT02133742|37713598|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
16951674|NCT01234467|38095224|FG000|Overall Study|Clinical deterioration|1|||
16951675|NCT01234467|38095224|FG000|Overall Study|Physician Decision|1|||
16951676|NCT01234467|38095224|FG000|Overall Study|Other complicating disease (stroke)|1|||
16951677|NCT01233999|38095228|FG000|Overall Study|Withdrawal by Subject|1|||
16951678|NCT01233999|38095228|FG000|Overall Study|Lost to Follow-up|1|||
16774276|NCT02133742|37713598|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
16774277|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
16774278|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
16774279|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
16774280|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
16774281|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
16774282|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
16951679|NCT01233687|38095232|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
16951680|NCT01233687|38095232|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
16951681|NCT01233687|38095232|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
16951682|NCT01023958|38095236|FG000|Overall Study|Progressive disease|48|||
16951683|NCT01023958|38095236|FG000|Overall Study|Other adverse event|1|||
16951684|NCT01023958|38095236|FG000|Overall Study|Refused to continue medication|1|||
16951685|NCT01233609|38095242|FG000|Overall Study|Death|1|||
16951686|NCT01233609|38095243|FG001|Overall Study|Death|0|||
16951687|NCT01233609|38095242|FG000|Overall Study|Lost to Follow-up|3|||
16951688|NCT01233609|38095243|FG001|Overall Study|Lost to Follow-up|1|||
16951689|NCT01233609|38095242|FG000|Overall Study|Adverse Event|2|||
16951690|NCT01233609|38095243|FG001|Overall Study|Adverse Event|1|||
16951691|NCT01233609|38095242|FG000|Overall Study|Withdrawal by Subject|3|||
16951692|NCT01233609|38095243|FG001|Overall Study|Withdrawal by Subject|0|||
16951693|NCT01232283|38095259|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
16951694|NCT01232283|38095260|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
16951695|NCT01232283|38095261|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16951696|NCT01232283|38095262|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16951697|NCT01232283|38095263|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16951698|NCT01232283|38095264|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16951699|NCT01232283|38095265|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16951700|NCT01232283|38095266|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16951701|NCT01232283|38095267|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16951702|NCT01232283|38095268|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16951703|NCT01232283|38095259|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
16951704|NCT01232283|38095260|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
16951705|NCT01232283|38095261|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16951706|NCT01232283|38095262|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16951707|NCT01232283|38095263|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16951708|NCT01232283|38095264|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16951709|NCT01232283|38095265|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16951710|NCT01232283|38095266|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16951711|NCT01232283|38095267|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16951712|NCT01232283|38095268|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16774283|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
16774284|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
16774285|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
16774286|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
16774287|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
16774288|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
16774289|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
16774290|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
16774291|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
16774292|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
16774293|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
16774294|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
16774295|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
16951713|NCT01232283|38095259|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
16951714|NCT01232283|38095260|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16951715|NCT01232283|38095261|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16774296|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
16774297|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
16951716|NCT01232283|38095262|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16951717|NCT01232283|38095263|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16951718|NCT01232283|38095264|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16951719|NCT01232283|38095265|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16951720|NCT01232283|38095266|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16951721|NCT01232283|38095267|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16951722|NCT01232283|38095268|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16951723|NCT01232283|38095259|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
16951724|NCT01232283|38095260|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
16951725|NCT01232283|38095261|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16951726|NCT01232283|38095262|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16951727|NCT01232283|38095263|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16951728|NCT01232283|38095264|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16951729|NCT01232283|38095265|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16951730|NCT01232283|38095266|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16951731|NCT01232283|38095267|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16951732|NCT01232283|38095268|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16951733|NCT01232283|38095259|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
16951734|NCT01232283|38095260|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
16951735|NCT01232283|38095261|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16951736|NCT01232283|38095262|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16951737|NCT01232283|38095263|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16951738|NCT01232283|38095264|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16951739|NCT01232283|38095265|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16951740|NCT01232283|38095266|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16951741|NCT01232283|38095267|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16951742|NCT01232283|38095268|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16951743|NCT01232283|38095259|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
16951744|NCT01232283|38095260|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
16951745|NCT01232283|38095261|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16951746|NCT01232283|38095262|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16951747|NCT01232283|38095263|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16951748|NCT01232283|38095264|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16951749|NCT01232283|38095265|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16951750|NCT01232283|38095266|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16951751|NCT01232283|38095267|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16951752|NCT01232283|38095268|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16951753|NCT01232283|38095259|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
16951754|NCT01232283|38095260|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
16951755|NCT01232283|38095261|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16951756|NCT01232283|38095262|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16951757|NCT01232283|38095263|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16951758|NCT01232283|38095264|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16951759|NCT01232283|38095265|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16951760|NCT01232283|38095266|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16951761|NCT01232283|38095267|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16951762|NCT01232283|38095268|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16951763|NCT01232283|38095259|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16951764|NCT01232283|38095260|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16951765|NCT01232283|38095261|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
16951766|NCT01232283|38095262|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
16951767|NCT01232283|38095263|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16951768|NCT01232283|38095264|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16951769|NCT01232283|38095265|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16951770|NCT01232283|38095266|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16951771|NCT01232283|38095267|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16951772|NCT01232283|38095268|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16951773|NCT01232283|38095259|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16951774|NCT01232283|38095260|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16951775|NCT01232283|38095261|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
16951776|NCT01232283|38095262|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
16951777|NCT01232283|38095263|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16951778|NCT01232283|38095264|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16951779|NCT01232283|38095265|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16951780|NCT01232283|38095266|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16951781|NCT01232283|38095267|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16951782|NCT01232283|38095268|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16951783|NCT01232283|38095259|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951784|NCT01232283|38095260|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951785|NCT01232283|38095261|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
16951786|NCT01232283|38095262|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951787|NCT01232283|38095263|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951788|NCT01232283|38095264|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951789|NCT01232283|38095265|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951790|NCT01232283|38095266|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951791|NCT01232283|38095267|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951792|NCT01232283|38095268|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16951793|NCT01232283|38095259|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16951794|NCT01232283|38095260|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16951795|NCT01232283|38095261|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
16951796|NCT01232283|38095262|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
16951797|NCT01232283|38095263|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16951798|NCT01232283|38095264|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16951799|NCT01232283|38095265|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16951800|NCT01232283|38095266|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16951801|NCT01232283|38095267|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16951802|NCT01232283|38095268|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
17127934|NCT02799784|38268603|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
17127935|NCT02799784|38268604|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
17127936|NCT02799784|38268603|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
17127937|NCT02799784|38268604|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
17127938|NCT02799784|38268603|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
17127939|NCT02799784|38268604|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
17127940|NCT01333072|38268612|FG000|Overall Study|Lost to Follow-up|3|||
17127941|NCT01333072|38268613|FG001|Overall Study|Lost to Follow-up|0|||
17127942|NCT01333072|38268612|FG000|Overall Study|Adverse Event|2|||
17127943|NCT01333072|38268613|FG001|Overall Study|Adverse Event|4|||
17127944|NCT01333072|38268612|FG000|Overall Study|Physician Decision|1|||
17127945|NCT01333072|38268613|FG001|Overall Study|Physician Decision|0|||
17127946|NCT01315353|38268622|FG000|Overall Study|Death|2|||
17127947|NCT01315353|38268623|FG001|Overall Study|Death|1|||
17127948|NCT01315353|38268624|FG002|Overall Study|Death|0|||
17127949|NCT01315353|38268622|FG000|Overall Study|Withdrawal by Subject|2|||
17127950|NCT01315353|38268623|FG001|Overall Study|Withdrawal by Subject|6|||
17127951|NCT01315353|38268624|FG002|Overall Study|Withdrawal by Subject|1|||
17127952|NCT01315353|38268622|FG000|Overall Study|Lost to Follow-up|13|||
17127953|NCT01315353|38268623|FG001|Overall Study|Lost to Follow-up|6|||
17127954|NCT01315353|38268624|FG002|Overall Study|Lost to Follow-up|6|||
17127955|NCT01315353|38268622|FG000|Overall Study|Unwilling to adhere to requirements|5|||
17127956|NCT01315353|38268623|FG001|Overall Study|Unwilling to adhere to requirements|5|||
17127957|NCT01315353|38268624|FG002|Overall Study|Unwilling to adhere to requirements|4|||
17127958|NCT01315353|38268622|FG000|Overall Study|Site closing|7|||
17127959|NCT01315353|38268623|FG001|Overall Study|Site closing|4|||
17127960|NCT01315353|38268624|FG002|Overall Study|Site closing|0|||
17127961|NCT01315353|38268622|FG000|Overall Study|Taken off study by site in error|0|||
17127962|NCT01315353|38268623|FG001|Overall Study|Taken off study by site in error|1|||
17127963|NCT01315353|38268624|FG002|Overall Study|Taken off study by site in error|0|||
17127964|NCT01315353|38268622|FG000|Overall Study|Inadvertent randomization/assignment|0|||
17127965|NCT01315353|38268623|FG001|Overall Study|Inadvertent randomization/assignment|0|||
17127966|NCT01315353|38268624|FG002|Overall Study|Inadvertent randomization/assignment|2|||
17127967|NCT03712449|38268634|FG000|Overall Study|Withdraw Consent|0|||
16951803|NCT01232283|38095259|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16951804|NCT01232283|38095260|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16951805|NCT01232283|38095261|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
16951806|NCT01232283|38095262|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
16951807|NCT01232283|38095263|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16951808|NCT01232283|38095264|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16951809|NCT01232283|38095265|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16951810|NCT01232283|38095266|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16951811|NCT01232283|38095267|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16951812|NCT01232283|38095268|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16951813|NCT01232283|38095259|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
16951814|NCT01232283|38095260|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
16951815|NCT01232283|38095261|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
16951816|NCT01232283|38095262|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
16951817|NCT01232283|38095263|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
16951818|NCT01232283|38095264|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
16951819|NCT01232283|38095265|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
16951820|NCT01232283|38095266|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
16951821|NCT01232283|38095267|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
16951822|NCT01232283|38095268|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
16951823|NCT01232283|38095259|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16951824|NCT01232283|38095260|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16951825|NCT01232283|38095261|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16951826|NCT01232283|38095262|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16951827|NCT01232283|38095263|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
16951828|NCT01232283|38095264|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
16951829|NCT01232283|38095265|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16951830|NCT01232283|38095266|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
16951831|NCT01232283|38095267|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16951832|NCT01232283|38095268|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16951833|NCT01232283|38095259|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16951834|NCT01232283|38095260|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16951835|NCT01232283|38095261|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16951836|NCT01232283|38095262|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16951837|NCT01232283|38095263|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
16951838|NCT01232283|38095264|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16951839|NCT01232283|38095265|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
16951840|NCT01232283|38095266|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
16951841|NCT01232283|38095267|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16951842|NCT01232283|38095268|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16951843|NCT01232283|38095259|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16951844|NCT01232283|38095260|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16951845|NCT01232283|38095261|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16951846|NCT01232283|38095262|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16951847|NCT01232283|38095263|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
16951848|NCT01232283|38095264|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
16951849|NCT01232283|38095265|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
16774298|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
17127968|NCT03712449|38268635|FG001|Overall Study|Withdraw Consent|1|||
16774299|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
16774300|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
16774301|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
16774302|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
16774303|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
16774304|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
16774305|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
16774306|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
16774307|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
16774308|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
16774309|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
16774310|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
16774311|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
16774312|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
16774313|NCT02198794|37713604|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
16774314|NCT02198794|37713605|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
16774315|NCT02198794|37713606|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
16774316|NCT02198794|37713607|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
16951850|NCT01232283|38095266|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
16951851|NCT01232283|38095267|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16951852|NCT01232283|38095268|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16951853|NCT01232283|38095259|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951854|NCT01232283|38095260|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951855|NCT01232283|38095261|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951856|NCT01232283|38095262|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951857|NCT01232283|38095263|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
16951858|NCT01232283|38095264|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951859|NCT01232283|38095265|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951860|NCT01232283|38095266|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951861|NCT01232283|38095267|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951862|NCT01232283|38095268|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16951863|NCT01232283|38095259|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16951864|NCT01232283|38095260|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16951865|NCT01232283|38095261|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16951866|NCT01232283|38095262|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16951867|NCT01232283|38095263|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
16951868|NCT01232283|38095264|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16951869|NCT01232283|38095265|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
16774317|NCT02198794|37713604|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
16951870|NCT01232283|38095266|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
16951871|NCT01232283|38095267|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16951872|NCT01232283|38095268|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16951873|NCT01232283|38095259|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951874|NCT01232283|38095260|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951875|NCT01232283|38095261|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951876|NCT01232283|38095262|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951877|NCT01232283|38095263|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951878|NCT01232283|38095264|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951879|NCT01232283|38095265|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951880|NCT01232283|38095266|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
16951881|NCT01232283|38095267|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951882|NCT01232283|38095268|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16951883|NCT01232283|38095259|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951884|NCT01232283|38095260|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951885|NCT01232283|38095261|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951886|NCT01232283|38095262|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951887|NCT01232283|38095263|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951888|NCT01232283|38095264|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
16951889|NCT01232283|38095265|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951890|NCT01232283|38095266|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951891|NCT01232283|38095267|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951892|NCT01232283|38095268|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16951893|NCT01232283|38095259|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16951894|NCT01232283|38095260|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16951895|NCT01232283|38095261|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16951896|NCT01232283|38095262|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16774318|NCT02198794|37713605|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
16951897|NCT01232283|38095263|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16951898|NCT01232283|38095264|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16951899|NCT01232283|38095265|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16951900|NCT01232283|38095266|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16951901|NCT01232283|38095267|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
16951902|NCT01232283|38095268|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
16951903|NCT01232283|38095259|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16951904|NCT01232283|38095260|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16951905|NCT01232283|38095261|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16951906|NCT01232283|38095262|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16951907|NCT01232283|38095263|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16951908|NCT01232283|38095264|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16951909|NCT01232283|38095265|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16951910|NCT01232283|38095266|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16951911|NCT01232283|38095267|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
16951912|NCT01232283|38095268|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
16951913|NCT01232283|38095259|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16951914|NCT01232283|38095260|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16951915|NCT01232283|38095261|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16951916|NCT01232283|38095262|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16951917|NCT01232283|38095263|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16951918|NCT01232283|38095264|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16951919|NCT01232283|38095265|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16951920|NCT01232283|38095266|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16951921|NCT01232283|38095267|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
16951922|NCT01232283|38095268|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
17127969|NCT03517540|38268645|FG000|Overall Study|Protocol Violation|2|||
17127970|NCT03517540|38268646|FG001|Overall Study|Protocol Violation|0|||
17127971|NCT03517540|38268647|FG002|Overall Study|Protocol Violation|0|||
17127972|NCT03517540|38268648|FG003|Overall Study|Protocol Violation|1|||
17127973|NCT03517540|38268645|FG000|Overall Study|Adverse Event|9|||
17127974|NCT03517540|38268646|FG001|Overall Study|Adverse Event|3|||
17127975|NCT03517540|38268647|FG002|Overall Study|Adverse Event|8|||
17127976|NCT03517540|38268648|FG003|Overall Study|Adverse Event|1|||
17127977|NCT03517540|38268645|FG000|Overall Study|Withdrawal by Subject|3|||
17127978|NCT03517540|38268646|FG001|Overall Study|Withdrawal by Subject|4|||
17127979|NCT03517540|38268647|FG002|Overall Study|Withdrawal by Subject|1|||
16951923|NCT01232283|38095259|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16951924|NCT01232283|38095260|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16951925|NCT01232283|38095261|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16951926|NCT01232283|38095262|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16951927|NCT01232283|38095263|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16951928|NCT01232283|38095264|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16951929|NCT01232283|38095265|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16951930|NCT01232283|38095266|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16951931|NCT01232283|38095267|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
16951932|NCT01232283|38095268|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
16951933|NCT01232283|38095259|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16951934|NCT01232283|38095260|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16951935|NCT01232283|38095261|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16951936|NCT01232283|38095262|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16951937|NCT01232283|38095263|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16951938|NCT01232283|38095264|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16951939|NCT01232283|38095265|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16951940|NCT01232283|38095266|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16951941|NCT01232283|38095267|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
16951942|NCT01232283|38095268|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
16951943|NCT01232283|38095259|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16951944|NCT01232283|38095260|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16951945|NCT01232283|38095261|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16951946|NCT01232283|38095262|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16951947|NCT01232283|38095263|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16951948|NCT01232283|38095264|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16951949|NCT01232283|38095265|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16951950|NCT01232283|38095266|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
17127980|NCT03517540|38268648|FG003|Overall Study|Withdrawal by Subject|3|||
17127981|NCT02799082|38268660|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
16951951|NCT01232283|38095267|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
16951952|NCT01232283|38095268|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16951953|NCT01232283|38095259|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951954|NCT01232283|38095260|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951955|NCT01232283|38095261|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951956|NCT01232283|38095262|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951957|NCT01232283|38095263|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951958|NCT01232283|38095264|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951959|NCT01232283|38095265|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951960|NCT01232283|38095266|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951961|NCT01232283|38095267|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
16951962|NCT01232283|38095268|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16951963|NCT01232283|38095259|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16951964|NCT01232283|38095260|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16951965|NCT01232283|38095261|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16951966|NCT01232283|38095262|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16951967|NCT01232283|38095263|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16951968|NCT01232283|38095264|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16774319|NCT02198794|37713606|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
16774320|NCT02198794|37713607|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
16774321|NCT02198794|37713604|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
16774322|NCT02198794|37713605|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
16774323|NCT02198794|37713606|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
16774324|NCT02198794|37713607|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
16774325|NCT02198794|37713604|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
16774326|NCT02198794|37713605|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
16774327|NCT02198794|37713606|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
16774328|NCT02198794|37713607|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
16951969|NCT01232283|38095265|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16951970|NCT01232283|38095266|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16951971|NCT01232283|38095267|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
16951972|NCT01232283|38095268|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
16951973|NCT01232127|38095290|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
16951974|NCT01232127|38095291|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
16951975|NCT01232127|38095292|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
16951976|NCT01258608|38095306|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
16951977|NCT01258608|38095307|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
16951978|NCT01258608|38095306|FG000|Overall Study|Clinical progression|1|||
16951979|NCT01258608|38095307|FG001|Overall Study|Clinical progression|0|||
16951980|NCT01258608|38095306|FG000|Overall Study|Sponsor decision|0|||
16951981|NCT01258608|38095307|FG001|Overall Study|Sponsor decision|1|||
16951982|NCT01258608|38095306|FG000|Overall Study|Physician Decision|6|||
16951983|NCT01258608|38095307|FG001|Overall Study|Physician Decision|1|||
16951984|NCT01258608|38095306|FG000|Overall Study|Lost to Follow-up|0|||
16951985|NCT01258608|38095307|FG001|Overall Study|Lost to Follow-up|1|||
16951986|NCT01258608|38095306|FG000|Overall Study|Lack of compliance|1|||
16951987|NCT01258608|38095307|FG001|Overall Study|Lack of compliance|0|||
16951988|NCT01258608|38095306|FG000|Overall Study|Lack of Efficacy|0|||
16951989|NCT01258608|38095307|FG001|Overall Study|Lack of Efficacy|1|||
16951990|NCT01258608|38095306|FG000|Overall Study|Adverse Event|6|||
16951991|NCT01258608|38095307|FG001|Overall Study|Adverse Event|10|||
16951992|NCT01258608|38095306|FG000|Overall Study|Withdrawal by Subject|6|||
16951993|NCT01258608|38095307|FG001|Overall Study|Withdrawal by Subject|5|||
16951994|NCT01015612|38095314|FG000|Overall Study|Death|113|||
16951995|NCT01015612|38095314|FG000|Overall Study|Withdrawal by Subject|40|||
16951996|NCT01231659|38095318|FG000|Overall Study|Adverse Event|9|||
16951997|NCT01231659|38095318|FG000|Overall Study|Disease Progression|48|||
16951998|NCT01231659|38095318|FG000|Overall Study|Death|2|||
16951999|NCT01231659|38095318|FG000|Overall Study|Patient refused to complete study visit|1|||
16952000|NCT01231659|38095318|FG000|Overall Study|Other protocol defined criteria|12|||
16952001|NCT01054222|38095322|FG000|Overall Study|Lack of Efficacy|1|||
16952002|NCT01054222|38095322|FG000|Overall Study|Lost to Follow-up|4|||
16952003|NCT01054222|38095322|FG000|Overall Study|Withdrawal by Subject|6|||
16952004|NCT01052428|38095328|FG000|Overall Study|Death|1|||
16952005|NCT01052428|38095329|FG001|Overall Study|Death|0|||
16952006|NCT01052428|38095328|FG000|Overall Study|Withdrawal by Subject|0|||
16952007|NCT01052428|38095329|FG001|Overall Study|Withdrawal by Subject|1|||
16952008|NCT01052272|38095339|FG000|Overall Study|Death|0|||
16952009|NCT01052272|38095340|FG001|Overall Study|Death|0|||
16952010|NCT01052272|38095341|FG002|Overall Study|Death|1|||
16952011|NCT01052272|38095342|FG003|Overall Study|Death|1|||
16952012|NCT01052272|38095339|FG000|Overall Study|Physician Decision|0|||
16952013|NCT01052272|38095340|FG001|Overall Study|Physician Decision|1|||
16952014|NCT01052272|38095341|FG002|Overall Study|Physician Decision|0|||
16952015|NCT01052272|38095342|FG003|Overall Study|Physician Decision|0|||
16952016|NCT01052272|38095339|FG000|Overall Study|patient refuses follow-up|5|||
16952017|NCT01052272|38095340|FG001|Overall Study|patient refuses follow-up|4|||
16952018|NCT01052272|38095341|FG002|Overall Study|patient refuses follow-up|2|||
16952019|NCT01052272|38095342|FG003|Overall Study|patient refuses follow-up|4|||
16952020|NCT01052272|38095339|FG000|Overall Study|Withdrawal by Subject|0|||
16952021|NCT01052272|38095340|FG001|Overall Study|Withdrawal by Subject|2|||
16952022|NCT01052272|38095341|FG002|Overall Study|Withdrawal by Subject|3|||
16952023|NCT01052272|38095342|FG003|Overall Study|Withdrawal by Subject|2|||
16952024|NCT01052272|38095339|FG000|Overall Study|placed in long-term care|0|||
16952025|NCT01052272|38095340|FG001|Overall Study|placed in long-term care|0|||
16952026|NCT01052272|38095341|FG002|Overall Study|placed in long-term care|1|||
16952027|NCT01052272|38095342|FG003|Overall Study|placed in long-term care|0|||
16952028|NCT01052272|38095339|FG000|Overall Study|decline in health|0|||
16952029|NCT01052272|38095340|FG001|Overall Study|decline in health|0|||
16952030|NCT01052272|38095341|FG002|Overall Study|decline in health|1|||
16952031|NCT01052272|38095342|FG003|Overall Study|decline in health|0|||
16952032|NCT01257204|38095355|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
16952033|NCT01257204|38095356|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
16952034|NCT01257204|38095357|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
16952035|NCT01257204|38095355|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
16952036|NCT01257204|38095356|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
16952037|NCT01257204|38095357|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
16952038|NCT01257204|38095355|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
16952039|NCT01257204|38095356|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
16952040|NCT01257204|38095357|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
16952041|NCT01257204|38095355|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
16952042|NCT01257204|38095356|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
16952043|NCT01257204|38095357|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
16952044|NCT01257204|38095355|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
16952045|NCT01257204|38095356|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
16952046|NCT01257204|38095357|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
16952047|NCT01257204|38095355|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
16952048|NCT01257204|38095356|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
16952049|NCT01257204|38095357|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
16952050|NCT01257204|38095355|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
16952051|NCT01257204|38095356|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
16952052|NCT01257204|38095357|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
16952053|NCT01257204|38095355|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
16952054|NCT01257204|38095356|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
16952055|NCT01257204|38095357|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
16952056|NCT01257204|38095355|FG000|Follow-up Period (up to Week 48)|Other|0|||
16952057|NCT01257204|38095356|FG001|Follow-up Period (up to Week 48)|Other|0|||
16952058|NCT01257204|38095357|FG002|Follow-up Period (up to Week 48)|Other|5|||
16952059|NCT01231581|38095379|FG000|Overall Study|Lost to Follow-up|2|||
16952060|NCT01231581|38095380|FG001|Overall Study|Lost to Follow-up|2|||
16952061|NCT01231581|38095379|FG000|Overall Study|Withdrawal by Subject|6|||
16952062|NCT01231581|38095380|FG001|Overall Study|Withdrawal by Subject|9|||
16952063|NCT01231581|38095379|FG000|Overall Study|Study Closed/Terminated|6|||
16952064|NCT01231581|38095380|FG001|Overall Study|Study Closed/Terminated|5|||
16952065|NCT01231581|38095379|FG000|Overall Study|Death|65|||
16952066|NCT01231581|38095380|FG001|Overall Study|Death|64|||
16952067|NCT01231581|38095379|FG000|Overall Study|Ongoing|1|||
16952068|NCT01231581|38095380|FG001|Overall Study|Ongoing|0|||
16952069|NCT01050634|38095386|FG000|Overall Study|Enrolled, but Not Treated|56|||
16952070|NCT01050634|38095386|FG000|Overall Study|Death|2|||
16952071|NCT01050634|38095386|FG000|Overall Study|Adverse Event|42|||
16952072|NCT01050634|38095386|FG000|Overall Study|Lost to Follow-up|2|||
16952073|NCT01050634|38095386|FG000|Overall Study|Other|21|||
16952074|NCT01050634|38095386|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
16952075|NCT01020526|38095390|FG000|Overall Study|Withdrawal by Subject|5|||
16952076|NCT01020526|38095390|FG000|Overall Study|Other reasons|3|||
16952077|NCT01020526|38095390|FG000|Overall Study|Insufficient clinical response|3|||
16952078|NCT01020526|38095390|FG000|Overall Study|Lost to Follow-up|1|||
16952079|NCT01020526|38095390|FG000|Overall Study|Adverse Event|2|||
16952080|NCT01020448|38095394|FG000|Pre-assignment|Adverse Event|6|||
16952081|NCT01020448|38095394|FG000|Pre-assignment|Withdrawal by Subject|5|||
16952082|NCT01020448|38095394|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
16952083|NCT01020448|38095394|FG000|Treatment|Adverse Event|11|||
16952084|NCT01020448|38095394|FG000|Treatment|Consent Withdrawn|3|||
16952085|NCT01020448|38095394|FG000|Treatment|Disease Progression|2|||
16952086|NCT01020448|38095394|FG000|Treatment|Lack of Efficacy|8|||
16952087|NCT01020448|38095394|FG000|Treatment|Lost to Follow-up|2|||
16952088|NCT01256658|38095401|FG000|Period 1|Lost to Follow-up|837|||
16952089|NCT01256658|38095402|FG001|Period 1|Lost to Follow-up|661|||
16952090|NCT01256658|38095401|FG000|Period 1|Withdrawal by Subject|35|||
16952091|NCT01256658|38095402|FG001|Period 1|Withdrawal by Subject|43|||
16952092|NCT01256658|38095401|FG000|Period 1|Death|48|||
16952093|NCT01256658|38095402|FG001|Period 1|Death|44|||
16952094|NCT01256502|38095411|FG000|Overall Study|Had scaffold removed|4|||
16952095|NCT01256502|38095411|FG000|Overall Study|Personal reasons|5|||
16952096|NCT01256502|38095411|FG000|Overall Study|Protocol deviation|1|||
16952097|NCT01256190|38095422|FG000|Overall Study|Lost to Follow-up|2|||
16952098|NCT01256190|38095423|FG001|Overall Study|Lost to Follow-up|0|||
16952099|NCT01255722|38095432|FG000|Overall Study|Adverse Event|0|||
16952100|NCT01255722|38095433|FG001|Overall Study|Adverse Event|1|||
16952101|NCT01255722|38095434|FG002|Overall Study|Adverse Event|1|||
16952102|NCT01255722|38095432|FG000|Overall Study|asymptomatic patient|1|||
16952103|NCT01255722|38095433|FG001|Overall Study|asymptomatic patient|0|||
16952104|NCT01255722|38095434|FG002|Overall Study|asymptomatic patient|0|||
16952105|NCT01255722|38095432|FG000|Overall Study|beta-blocker contraindicated|2|||
16952106|NCT01255722|38095433|FG001|Overall Study|beta-blocker contraindicated|0|||
16952107|NCT01255722|38095434|FG002|Overall Study|beta-blocker contraindicated|0|||
16952108|NCT01231503|38095451|FG000|Overall Study|Adverse Event|0|||
16952109|NCT01231503|38095452|FG001|Overall Study|Adverse Event|0|||
16952110|NCT01231503|38095453|FG002|Overall Study|Adverse Event|0|||
16952111|NCT01231503|38095454|FG003|Overall Study|Adverse Event|0|||
16952112|NCT01231503|38095455|FG004|Overall Study|Adverse Event|0|||
16952113|NCT01231503|38095456|FG005|Overall Study|Adverse Event|1|||
16952114|NCT01231503|38095457|FG006|Overall Study|Adverse Event|0|||
16952115|NCT01231503|38095458|FG007|Overall Study|Adverse Event|0|||
16952116|NCT01231503|38095451|FG000|Overall Study|Adverse event, serious fatal|0|||
16952117|NCT01231503|38095452|FG001|Overall Study|Adverse event, serious fatal|0|||
16952118|NCT01231503|38095453|FG002|Overall Study|Adverse event, serious fatal|1|||
16952119|NCT01231503|38095454|FG003|Overall Study|Adverse event, serious fatal|1|||
16952120|NCT01231503|38095455|FG004|Overall Study|Adverse event, serious fatal|0|||
16952121|NCT01231503|38095456|FG005|Overall Study|Adverse event, serious fatal|1|||
16952122|NCT01231503|38095457|FG006|Overall Study|Adverse event, serious fatal|0|||
16952123|NCT01231503|38095458|FG007|Overall Study|Adverse event, serious fatal|0|||
16952124|NCT01231503|38095451|FG000|Overall Study|Withdrawal by Subject|6|||
16952125|NCT01231503|38095452|FG001|Overall Study|Withdrawal by Subject|3|||
16952126|NCT01231503|38095453|FG002|Overall Study|Withdrawal by Subject|3|||
16952127|NCT01231503|38095454|FG003|Overall Study|Withdrawal by Subject|1|||
16952128|NCT01231503|38095455|FG004|Overall Study|Withdrawal by Subject|3|||
16952129|NCT01231503|38095456|FG005|Overall Study|Withdrawal by Subject|5|||
16952130|NCT01231503|38095457|FG006|Overall Study|Withdrawal by Subject|1|||
16952131|NCT01231503|38095458|FG007|Overall Study|Withdrawal by Subject|2|||
16952132|NCT01231503|38095451|FG000|Overall Study|Lost to Follow-up|8|||
16952133|NCT01231503|38095452|FG001|Overall Study|Lost to Follow-up|10|||
16952134|NCT01231503|38095453|FG002|Overall Study|Lost to Follow-up|8|||
16952135|NCT01231503|38095454|FG003|Overall Study|Lost to Follow-up|5|||
16952136|NCT01231503|38095455|FG004|Overall Study|Lost to Follow-up|7|||
16952137|NCT01231503|38095456|FG005|Overall Study|Lost to Follow-up|9|||
16952138|NCT01231503|38095457|FG006|Overall Study|Lost to Follow-up|6|||
16952139|NCT01231503|38095458|FG007|Overall Study|Lost to Follow-up|6|||
16952140|NCT01231503|38095451|FG000|Overall Study|Protocol Violation|0|||
16952141|NCT01231503|38095452|FG001|Overall Study|Protocol Violation|0|||
16952142|NCT01231503|38095453|FG002|Overall Study|Protocol Violation|0|||
16952143|NCT01231503|38095454|FG003|Overall Study|Protocol Violation|1|||
16952144|NCT01231503|38095455|FG004|Overall Study|Protocol Violation|0|||
16952145|NCT01231503|38095456|FG005|Overall Study|Protocol Violation|0|||
16952146|NCT01231503|38095457|FG006|Overall Study|Protocol Violation|0|||
16952147|NCT01231503|38095458|FG007|Overall Study|Protocol Violation|0|||
16952148|NCT01230489|38095486|FG000|Overall Study|Death|2|||
16952149|NCT01230489|38095486|FG000|Overall Study|Adverse Event|2|||
16952150|NCT01230489|38095486|FG000|Overall Study|Treatment modality changed|1|||
16952151|NCT01229397|38095492|FG000|Overall Study|Withdrawal by Subject|3|||
16952152|NCT01229397|38095493|FG001|Overall Study|Withdrawal by Subject|3|||
16952153|NCT01229397|38095492|FG000|Overall Study|Lost to Follow-up|7|||
16952154|NCT01229397|38095493|FG001|Overall Study|Lost to Follow-up|6|||
16952155|NCT01229397|38095492|FG000|Overall Study|Migrated/moved from study area|1|||
16952156|NCT01229397|38095493|FG001|Overall Study|Migrated/moved from study area|0|||
16952157|NCT01228071|38095503|FG000|Overall Study|Protocol Violation|1|||
16952158|NCT01228071|38095503|FG000|Overall Study|Withdrawal by Subject|1|||
16952159|NCT01008475|38095514|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
16952160|NCT01008475|38095515|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
16952161|NCT01008475|38095516|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
16952162|NCT01008475|38095517|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
16952163|NCT01008475|38095518|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
16952164|NCT01008475|38095519|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
16952165|NCT01008475|38095520|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
16952166|NCT01226745|38095542|FG000|Overall Study|Did not complete schedule of assessments|8|||
16952167|NCT01226745|38095543|FG001|Overall Study|Did not complete schedule of assessments|3|||
16952168|NCT01226745|38095544|FG002|Overall Study|Did not complete schedule of assessments|6|||
16952169|NCT01226745|38095545|FG003|Overall Study|Did not complete schedule of assessments|0|||
16952170|NCT01226745|38095546|FG004|Overall Study|Did not complete schedule of assessments|0|||
16952171|NCT01226745|38095547|FG005|Overall Study|Did not complete schedule of assessments|1|||
16952172|NCT01226745|38095542|FG000|Overall Study|Lost to Follow-up|2|||
16952173|NCT01226745|38095543|FG001|Overall Study|Lost to Follow-up|6|||
16952174|NCT01226745|38095544|FG002|Overall Study|Lost to Follow-up|6|||
16952175|NCT01226745|38095545|FG003|Overall Study|Lost to Follow-up|1|||
16952176|NCT01226745|38095546|FG004|Overall Study|Lost to Follow-up|1|||
16952177|NCT01226745|38095547|FG005|Overall Study|Lost to Follow-up|2|||
16952178|NCT01226745|38095542|FG000|Overall Study|Death|1|||
16952179|NCT01226745|38095543|FG001|Overall Study|Death|0|||
16952180|NCT01226745|38095544|FG002|Overall Study|Death|0|||
16952181|NCT01226745|38095545|FG003|Overall Study|Death|0|||
16952182|NCT01226745|38095546|FG004|Overall Study|Death|0|||
16952183|NCT01226745|38095547|FG005|Overall Study|Death|1|||
16952184|NCT01226745|38095542|FG000|Overall Study|Other|6|||
16952185|NCT01226745|38095543|FG001|Overall Study|Other|7|||
16952186|NCT01226745|38095544|FG002|Overall Study|Other|8|||
16952187|NCT01226745|38095545|FG003|Overall Study|Other|4|||
16952188|NCT01226745|38095546|FG004|Overall Study|Other|3|||
16952189|NCT01226745|38095547|FG005|Overall Study|Other|1|||
16952190|NCT01226511|38095564|FG000|Acute Treatment Period|Adverse Event|7|||
16952191|NCT01226511|38095565|FG001|Acute Treatment Period|Adverse Event|6|||
16952192|NCT01226511|38095564|FG000|Acute Treatment Period|Lack of Efficacy|2|||
16952193|NCT01226511|38095565|FG001|Acute Treatment Period|Lack of Efficacy|1|||
16952194|NCT01226511|38095564|FG000|Acute Treatment Period|Lost to Follow-up|3|||
16952195|NCT01226511|38095565|FG001|Acute Treatment Period|Lost to Follow-up|6|||
16952196|NCT01226511|38095564|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
16952197|NCT01226511|38095565|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
16952198|NCT01226511|38095564|FG000|Acute Treatment Period|Protocol Violation|5|||
16952199|NCT01226511|38095565|FG001|Acute Treatment Period|Protocol Violation|5|||
16952200|NCT01226511|38095564|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
16952201|NCT01226511|38095565|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
16952202|NCT01226511|38095564|FG000|Extension Treatment Period|Adverse Event|8|||
16952203|NCT01226511|38095565|FG001|Extension Treatment Period|Adverse Event|8|||
16952204|NCT01226511|38095564|FG000|Extension Treatment Period|Lack of Efficacy|3|||
16952205|NCT01226511|38095565|FG001|Extension Treatment Period|Lack of Efficacy|2|||
16952206|NCT01226511|38095564|FG000|Extension Treatment Period|Lost to Follow-up|4|||
16952207|NCT01226511|38095565|FG001|Extension Treatment Period|Lost to Follow-up|3|||
16952208|NCT01226511|38095564|FG000|Extension Treatment Period|Protocol Violation|2|||
16952209|NCT01226511|38095565|FG001|Extension Treatment Period|Protocol Violation|2|||
16952210|NCT01226511|38095564|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
16952211|NCT01226511|38095565|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
16952212|NCT01226511|38095564|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
16952213|NCT01226511|38095565|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
16952214|NCT01226511|38095564|FG000|Extension Treatment Period|Sponsor Decision|1|||
16952215|NCT01226511|38095565|FG001|Extension Treatment Period|Sponsor Decision|1|||
16952216|NCT01226511|38095564|FG000|Taper Period|Adverse Event|1|||
16952217|NCT01226511|38095565|FG001|Taper Period|Adverse Event|0|||
16952218|NCT01226511|38095564|FG000|Taper Period|Lost to Follow-up|2|||
16952219|NCT01226511|38095565|FG001|Taper Period|Lost to Follow-up|2|||
16952220|NCT01226511|38095564|FG000|Taper Period|Protocol Violation|1|||
16952221|NCT01226511|38095565|FG001|Taper Period|Protocol Violation|0|||
16952222|NCT01226511|38095564|FG000|Taper Period|Parent/Caregiver Decision|1|||
16952223|NCT01226511|38095565|FG001|Taper Period|Parent/Caregiver Decision|1|||
16952224|NCT01226121|38095580|FG000|Overall Study|Lost to Follow-up|2|||
16952225|NCT01226121|38095581|FG001|Overall Study|Lost to Follow-up|0|||
16952226|NCT01226121|38095582|FG002|Overall Study|Lost to Follow-up|1|||
16952227|NCT01226043|38095592|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
16952228|NCT01226043|38095593|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
16952229|NCT01226043|38095594|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
16952230|NCT01226043|38095595|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
16952231|NCT01226043|38095592|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
16952232|NCT01226043|38095593|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
16952233|NCT01226043|38095594|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
16952234|NCT01226043|38095595|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
16952235|NCT01226043|38095592|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
16952236|NCT01226043|38095593|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
16952237|NCT01226043|38095594|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
16952238|NCT01226043|38095595|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
16952239|NCT01226043|38095592|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
16952240|NCT01226043|38095593|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
16952241|NCT01226043|38095594|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
16952242|NCT01226043|38095595|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
16952243|NCT01226043|38095592|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
16952244|NCT01226043|38095593|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
16952245|NCT01226043|38095594|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
16952246|NCT01226043|38095595|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
16952247|NCT01226043|38095592|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
16952248|NCT01226043|38095593|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
16952249|NCT01226043|38095594|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
16952250|NCT01226043|38095595|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
16952251|NCT01226043|38095592|FG000|6-week Re-randomization Phase|Adverse Event|0|||
16952252|NCT01226043|38095593|FG001|6-week Re-randomization Phase|Adverse Event|0|||
16952253|NCT01226043|38095594|FG002|6-week Re-randomization Phase|Adverse Event|1|||
16952254|NCT01226043|38095595|FG003|6-week Re-randomization Phase|Adverse Event|1|||
16952255|NCT01226043|38095592|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
16952256|NCT01226043|38095593|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
16952257|NCT01226043|38095594|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
16952258|NCT01226043|38095595|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
16952259|NCT01226043|38095592|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
16952260|NCT01226043|38095593|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
16952261|NCT01226043|38095594|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
16952262|NCT01226043|38095595|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
16952263|NCT01226043|38095592|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
16952264|NCT01226043|38095593|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
16952265|NCT01226043|38095594|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
16952266|NCT01226043|38095595|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
16952267|NCT01226043|38095592|FG000|6-week Re-randomization Phase|Physician Decision|0|||
16952268|NCT01226043|38095593|FG001|6-week Re-randomization Phase|Physician Decision|0|||
16952269|NCT01226043|38095594|FG002|6-week Re-randomization Phase|Physician Decision|3|||
16952270|NCT01226043|38095595|FG003|6-week Re-randomization Phase|Physician Decision|2|||
16952271|NCT01226043|38095592|FG000|6-week Re-randomization Phase|completed in error|0|||
16952272|NCT01226043|38095593|FG001|6-week Re-randomization Phase|completed in error|0|||
16952273|NCT01226043|38095594|FG002|6-week Re-randomization Phase|completed in error|0|||
16952274|NCT01226043|38095595|FG003|6-week Re-randomization Phase|completed in error|1|||
16952275|NCT01226043|38095592|FG000|30-week Observational Phase|Adverse Event|0|||
16952276|NCT01226043|38095593|FG001|30-week Observational Phase|Adverse Event|0|||
16952277|NCT01226043|38095594|FG002|30-week Observational Phase|Adverse Event|1|||
16952278|NCT01226043|38095595|FG003|30-week Observational Phase|Adverse Event|1|||
16952279|NCT01226043|38095592|FG000|30-week Observational Phase|Protocol Violation|0|||
16952280|NCT01226043|38095593|FG001|30-week Observational Phase|Protocol Violation|0|||
16952281|NCT01226043|38095594|FG002|30-week Observational Phase|Protocol Violation|0|||
16952282|NCT01226043|38095595|FG003|30-week Observational Phase|Protocol Violation|1|||
16952283|NCT01226043|38095592|FG000|30-week Observational Phase|Lost to Follow-up|0|||
16952284|NCT01226043|38095593|FG001|30-week Observational Phase|Lost to Follow-up|0|||
16952285|NCT01226043|38095594|FG002|30-week Observational Phase|Lost to Follow-up|2|||
16952286|NCT01226043|38095595|FG003|30-week Observational Phase|Lost to Follow-up|2|||
16952287|NCT01226043|38095592|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
16952288|NCT01226043|38095593|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
16952289|NCT01226043|38095594|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
16952290|NCT01226043|38095595|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
17127982|NCT02799082|38268661|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
17127983|NCT02799082|38268660|FG000|Overall Study|Protocol Violation|0|||
17127984|NCT02799082|38268661|FG001|Overall Study|Protocol Violation|1|||
17127985|NCT03710889|38268667|FG000|Overall Study|Adverse Event|2|||
17127986|NCT03710889|38268667|FG000|Overall Study|Protocol Deviation|1|||
17127987|NCT02797678|38268671|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
17127988|NCT02797678|38268672|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
17127989|NCT02797678|38268673|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
17127990|NCT02797678|38268674|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
17127991|NCT02797678|38268671|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
17127992|NCT02797678|38268672|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
17127993|NCT02797678|38268673|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
17127994|NCT02797678|38268674|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
17127995|NCT02797678|38268671|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
17127996|NCT02797678|38268672|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
17127997|NCT02797678|38268673|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
17127998|NCT02797678|38268674|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
17127999|NCT03308942|38268692|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
17128000|NCT03308942|38268693|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
17128001|NCT03308942|38268694|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
17128002|NCT03308942|38268695|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
17128003|NCT03308942|38268696|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
17128004|NCT03308942|38268692|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
17128005|NCT03308942|38268693|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
17128006|NCT03308942|38268694|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
17128007|NCT03308942|38268695|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
17128008|NCT03308942|38268696|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
17128009|NCT03308942|38268692|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
17128010|NCT03308942|38268693|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
17128011|NCT03308942|38268694|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
17128012|NCT03308942|38268695|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
17128013|NCT03308942|38268696|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
17128014|NCT03308942|38268692|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
17128015|NCT03308942|38268693|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
17128016|NCT03308942|38268694|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
17128017|NCT03308942|38268695|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
17128018|NCT03308942|38268696|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
17128019|NCT03308942|38268692|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
17128020|NCT03308942|38268693|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
17128021|NCT03308942|38268694|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
16952291|NCT01226043|38095592|FG000|30-week Observational Phase|Physician Decision|0|||
16952292|NCT01226043|38095593|FG001|30-week Observational Phase|Physician Decision|0|||
16952293|NCT01226043|38095594|FG002|30-week Observational Phase|Physician Decision|2|||
16952294|NCT01226043|38095595|FG003|30-week Observational Phase|Physician Decision|2|||
16952295|NCT01001377|38095627|FG000|Overall Study|Ineligibility determined|2|||
16952296|NCT01001377|38095628|FG001|Overall Study|Ineligibility determined|0|||
16952297|NCT01001377|38095627|FG000|Overall Study|Withdrawal by Subject|19|||
16952298|NCT01001377|38095628|FG001|Overall Study|Withdrawal by Subject|20|||
16952299|NCT01001377|38095627|FG000|Overall Study|Lost to Follow-up|14|||
16952300|NCT01001377|38095628|FG001|Overall Study|Lost to Follow-up|17|||
16952301|NCT01001377|38095627|FG000|Overall Study|Death|391|||
16952302|NCT01001377|38095628|FG001|Overall Study|Death|384|||
16952303|NCT01225887|38095634|FG000|Overall Study|Ineligible:required test not done|2|||
16952304|NCT01225887|38095634|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
16952305|NCT01225887|38095634|FG000|Overall Study|Ineligible:inadequate pathology|2|||
16952306|NCT01001299|38095638|FG000|Overall Study|Insufficient Therapeutic Response|20|||
16952307|NCT01001299|38095638|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
16952308|NCT01001299|38095638|FG000|Overall Study|Death|1|||
16952309|NCT01001299|38095638|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
16952310|NCT01001299|38095638|FG000|Overall Study|Withdrew Consent|1|||
16952311|NCT01296932|38095651|FG000|Overall Study|Dose limiting toxicity|0|||
16952312|NCT01296932|38095652|FG001|Overall Study|Dose limiting toxicity|0|||
16952313|NCT01296932|38095653|FG002|Overall Study|Dose limiting toxicity|0|||
16952314|NCT01296932|38095654|FG003|Overall Study|Dose limiting toxicity|0|||
16952315|NCT01296932|38095655|FG004|Overall Study|Dose limiting toxicity|0|||
16952316|NCT01296932|38095656|FG005|Overall Study|Dose limiting toxicity|0|||
16952317|NCT01296932|38095657|FG006|Overall Study|Dose limiting toxicity|1|||
16952318|NCT01296932|38095658|FG007|Overall Study|Dose limiting toxicity|0|||
16952319|NCT01296932|38095659|FG008|Overall Study|Dose limiting toxicity|1|||
16952320|NCT01296932|38095651|FG000|Overall Study|Progressive disease|2|||
16952321|NCT01296932|38095652|FG001|Overall Study|Progressive disease|0|||
16952322|NCT01296932|38095653|FG002|Overall Study|Progressive disease|1|||
16952323|NCT01296932|38095654|FG003|Overall Study|Progressive disease|1|||
16952324|NCT01296932|38095655|FG004|Overall Study|Progressive disease|2|||
16952325|NCT01296932|38095656|FG005|Overall Study|Progressive disease|3|||
16952326|NCT01296932|38095657|FG006|Overall Study|Progressive disease|1|||
16952327|NCT01296932|38095658|FG007|Overall Study|Progressive disease|0|||
16952328|NCT01296932|38095659|FG008|Overall Study|Progressive disease|0|||
16952329|NCT01296932|38095651|FG000|Overall Study|Withdrawal by Subject|0|||
16952330|NCT01296932|38095652|FG001|Overall Study|Withdrawal by Subject|0|||
16952331|NCT01296932|38095653|FG002|Overall Study|Withdrawal by Subject|1|||
16952332|NCT01296932|38095654|FG003|Overall Study|Withdrawal by Subject|1|||
16952333|NCT01296932|38095655|FG004|Overall Study|Withdrawal by Subject|0|||
16952334|NCT01296932|38095656|FG005|Overall Study|Withdrawal by Subject|0|||
16952335|NCT01296932|38095657|FG006|Overall Study|Withdrawal by Subject|3|||
16952336|NCT01296932|38095658|FG007|Overall Study|Withdrawal by Subject|0|||
16952337|NCT01296932|38095659|FG008|Overall Study|Withdrawal by Subject|0|||
16952338|NCT01296932|38095651|FG000|Overall Study|Adverse Event|1|||
16952339|NCT01296932|38095652|FG001|Overall Study|Adverse Event|1|||
16952340|NCT01296932|38095653|FG002|Overall Study|Adverse Event|1|||
16952341|NCT01296932|38095654|FG003|Overall Study|Adverse Event|2|||
16952342|NCT01296932|38095655|FG004|Overall Study|Adverse Event|1|||
16952343|NCT01296932|38095656|FG005|Overall Study|Adverse Event|0|||
16952344|NCT01296932|38095657|FG006|Overall Study|Adverse Event|0|||
16952345|NCT01296932|38095658|FG007|Overall Study|Adverse Event|0|||
16952346|NCT01296932|38095659|FG008|Overall Study|Adverse Event|1|||
16952347|NCT01296932|38095651|FG000|Overall Study|Investigator decision|0|||
16952348|NCT01296932|38095652|FG001|Overall Study|Investigator decision|1|||
16952349|NCT01296932|38095653|FG002|Overall Study|Investigator decision|0|||
16952350|NCT01296932|38095654|FG003|Overall Study|Investigator decision|1|||
16952351|NCT01296932|38095655|FG004|Overall Study|Investigator decision|0|||
16952352|NCT01296932|38095656|FG005|Overall Study|Investigator decision|0|||
16952353|NCT01296932|38095657|FG006|Overall Study|Investigator decision|1|||
16952354|NCT01296932|38095658|FG007|Overall Study|Investigator decision|0|||
16952355|NCT01296932|38095659|FG008|Overall Study|Investigator decision|1|||
16952356|NCT01296932|38095651|FG000|Overall Study|No clinical benefit anymore|0|||
16952357|NCT01296932|38095652|FG001|Overall Study|No clinical benefit anymore|1|||
16952358|NCT01296932|38095653|FG002|Overall Study|No clinical benefit anymore|0|||
16952359|NCT01296932|38095654|FG003|Overall Study|No clinical benefit anymore|0|||
16952360|NCT01296932|38095655|FG004|Overall Study|No clinical benefit anymore|0|||
16952361|NCT01296932|38095656|FG005|Overall Study|No clinical benefit anymore|0|||
16952362|NCT01296932|38095657|FG006|Overall Study|No clinical benefit anymore|0|||
16952363|NCT01296932|38095658|FG007|Overall Study|No clinical benefit anymore|0|||
16952364|NCT01296932|38095659|FG008|Overall Study|No clinical benefit anymore|0|||
16952365|NCT01296932|38095651|FG000|Overall Study|Physician Decision|0|||
16952366|NCT01296932|38095652|FG001|Overall Study|Physician Decision|0|||
16952367|NCT01296932|38095653|FG002|Overall Study|Physician Decision|1|||
16952368|NCT01296932|38095654|FG003|Overall Study|Physician Decision|0|||
16952369|NCT01296932|38095655|FG004|Overall Study|Physician Decision|0|||
16952370|NCT01296932|38095656|FG005|Overall Study|Physician Decision|0|||
16952371|NCT01296932|38095657|FG006|Overall Study|Physician Decision|0|||
16952372|NCT01296932|38095658|FG007|Overall Study|Physician Decision|0|||
16952373|NCT01296932|38095659|FG008|Overall Study|Physician Decision|0|||
16952374|NCT01296932|38095651|FG000|Overall Study|IV problems, administration not possible|0|||
16952375|NCT01296932|38095652|FG001|Overall Study|IV problems, administration not possible|0|||
16952376|NCT01296932|38095653|FG002|Overall Study|IV problems, administration not possible|1|||
16952377|NCT01296932|38095654|FG003|Overall Study|IV problems, administration not possible|0|||
16952378|NCT01296932|38095655|FG004|Overall Study|IV problems, administration not possible|0|||
16952379|NCT01296932|38095656|FG005|Overall Study|IV problems, administration not possible|0|||
16952380|NCT01296932|38095657|FG006|Overall Study|IV problems, administration not possible|0|||
16952381|NCT01296932|38095658|FG007|Overall Study|IV problems, administration not possible|0|||
16952382|NCT01296932|38095659|FG008|Overall Study|IV problems, administration not possible|0|||
16952383|NCT01296932|38095651|FG000|Overall Study|per protocol|0|||
16952384|NCT01296932|38095652|FG001|Overall Study|per protocol|0|||
16952385|NCT01296932|38095653|FG002|Overall Study|per protocol|1|||
16952386|NCT01296932|38095654|FG003|Overall Study|per protocol|1|||
16952387|NCT01296932|38095655|FG004|Overall Study|per protocol|0|||
16952388|NCT01296932|38095656|FG005|Overall Study|per protocol|0|||
16952389|NCT01296932|38095657|FG006|Overall Study|per protocol|0|||
16952390|NCT01296932|38095658|FG007|Overall Study|per protocol|0|||
16952391|NCT01296932|38095659|FG008|Overall Study|per protocol|0|||
16952392|NCT01296932|38095651|FG000|Overall Study|Low benefit and too many side effects|0|||
16952393|NCT01296932|38095652|FG001|Overall Study|Low benefit and too many side effects|0|||
16952394|NCT01296932|38095653|FG002|Overall Study|Low benefit and too many side effects|0|||
16952395|NCT01296932|38095654|FG003|Overall Study|Low benefit and too many side effects|0|||
16952396|NCT01296932|38095655|FG004|Overall Study|Low benefit and too many side effects|0|||
16952397|NCT01296932|38095656|FG005|Overall Study|Low benefit and too many side effects|0|||
16952398|NCT01296932|38095657|FG006|Overall Study|Low benefit and too many side effects|0|||
16952399|NCT01296932|38095658|FG007|Overall Study|Low benefit and too many side effects|1|||
16952400|NCT01296932|38095659|FG008|Overall Study|Low benefit and too many side effects|0|||
16952401|NCT01296932|38095651|FG000|Overall Study|No adequate treatment response|0|||
16952402|NCT01296932|38095652|FG001|Overall Study|No adequate treatment response|0|||
16952403|NCT01296932|38095653|FG002|Overall Study|No adequate treatment response|0|||
17128022|NCT03308942|38268695|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
17128023|NCT03308942|38268696|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
17128024|NCT03308942|38268692|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
17128025|NCT03308942|38268693|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
16952404|NCT01296932|38095654|FG003|Overall Study|No adequate treatment response|0|||
16952405|NCT01296932|38095655|FG004|Overall Study|No adequate treatment response|0|||
16952406|NCT01296932|38095656|FG005|Overall Study|No adequate treatment response|0|||
16952407|NCT01296932|38095657|FG006|Overall Study|No adequate treatment response|0|||
16952408|NCT01296932|38095658|FG007|Overall Study|No adequate treatment response|1|||
16952409|NCT01296932|38095659|FG008|Overall Study|No adequate treatment response|0|||
16952410|NCT01296932|38095651|FG000|Overall Study|Dosage already reduced, AE still present|0|||
16952411|NCT01296932|38095652|FG001|Overall Study|Dosage already reduced, AE still present|0|||
16952412|NCT01296932|38095653|FG002|Overall Study|Dosage already reduced, AE still present|0|||
16952413|NCT01296932|38095654|FG003|Overall Study|Dosage already reduced, AE still present|0|||
16952414|NCT01296932|38095655|FG004|Overall Study|Dosage already reduced, AE still present|0|||
16952415|NCT01296932|38095656|FG005|Overall Study|Dosage already reduced, AE still present|0|||
16952416|NCT01296932|38095657|FG006|Overall Study|Dosage already reduced, AE still present|0|||
16952417|NCT01296932|38095658|FG007|Overall Study|Dosage already reduced, AE still present|0|||
16952418|NCT01296932|38095659|FG008|Overall Study|Dosage already reduced, AE still present|1|||
16952419|NCT01296698|38095682|FG000|Overall Study|Adverse Event|1|||
16952420|NCT01296698|38095683|FG001|Overall Study|Adverse Event|0|||
16952421|NCT01296698|38095682|FG000|Overall Study|Death|1|||
16952422|NCT01296698|38095683|FG001|Overall Study|Death|0|||
16952423|NCT01296698|38095682|FG000|Overall Study|Lost to Follow-up|19|||
16952424|NCT01296698|38095683|FG001|Overall Study|Lost to Follow-up|1|||
16952425|NCT01296698|38095682|FG000|Overall Study|Withdrawal by Subject|12|||
16952426|NCT01296698|38095683|FG001|Overall Study|Withdrawal by Subject|0|||
16952427|NCT01296698|38095682|FG000|Overall Study|Difficulty Contacting Subject|2|||
16952428|NCT01296698|38095683|FG001|Overall Study|Difficulty Contacting Subject|0|||
16952429|NCT01296698|38095682|FG000|Overall Study|Study Terminated by Sponsor|209|||
16952430|NCT01296698|38095683|FG001|Overall Study|Study Terminated by Sponsor|12|||
16952431|NCT01001221|38095693|FG000|Overall Study|Adverse Event|1|||
16952432|NCT01001221|38095694|FG001|Overall Study|Adverse Event|2|||
16952433|NCT01001221|38095695|FG002|Overall Study|Adverse Event|0|||
16952434|NCT01001221|38095696|FG003|Overall Study|Adverse Event|2|||
16952435|NCT01001221|38095697|FG004|Overall Study|Adverse Event|0|||
16952436|NCT01001221|38095693|FG000|Overall Study|Disease progression|3|||
16952437|NCT01001221|38095694|FG001|Overall Study|Disease progression|2|||
16952438|NCT01001221|38095695|FG002|Overall Study|Disease progression|2|||
16952439|NCT01001221|38095696|FG003|Overall Study|Disease progression|4|||
16952440|NCT01001221|38095697|FG004|Overall Study|Disease progression|0|||
16952441|NCT01001221|38095693|FG000|Overall Study|Other|1|||
16952442|NCT01001221|38095694|FG001|Overall Study|Other|1|||
16952443|NCT01001221|38095695|FG002|Overall Study|Other|0|||
16952444|NCT01001221|38095696|FG003|Overall Study|Other|0|||
16952445|NCT01001221|38095697|FG004|Overall Study|Other|0|||
16952446|NCT01001221|38095693|FG000|Overall Study|Not treated; protocol exclusion|0|||
16952447|NCT01001221|38095694|FG001|Overall Study|Not treated; protocol exclusion|0|||
16952448|NCT01001221|38095695|FG002|Overall Study|Not treated; protocol exclusion|1|||
16952449|NCT01001221|38095696|FG003|Overall Study|Not treated; protocol exclusion|0|||
16952450|NCT01001221|38095697|FG004|Overall Study|Not treated; protocol exclusion|0|||
16952451|NCT01296152|38095708|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
16952452|NCT01002547|38095715|FG000|Overall Study|Withdrawal by Subject|4|||
16952453|NCT01002547|38095716|FG001|Overall Study|Withdrawal by Subject|0|||
16952454|NCT01002547|38095717|FG002|Overall Study|Withdrawal by Subject|5|||
16952455|NCT01002547|38095715|FG000|Overall Study|Lost to Follow-up|2|||
16952456|NCT01002547|38095716|FG001|Overall Study|Lost to Follow-up|1|||
16952457|NCT01002547|38095717|FG002|Overall Study|Lost to Follow-up|1|||
16952458|NCT01002547|38095715|FG000|Overall Study|Physician Decision|1|||
16952459|NCT01002547|38095716|FG001|Overall Study|Physician Decision|0|||
16952460|NCT01002547|38095717|FG002|Overall Study|Physician Decision|0|||
17128026|NCT03308942|38268694|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
17128027|NCT03308942|38268695|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
17128028|NCT03308942|38268696|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
17128029|NCT03308942|38268692|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
17128030|NCT03308942|38268693|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
17128031|NCT03308942|38268694|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
16952461|NCT01002547|38095715|FG000|Overall Study|Death|0|||
16952462|NCT01002547|38095716|FG001|Overall Study|Death|2|||
16952463|NCT01002547|38095717|FG002|Overall Study|Death|2|||
16952464|NCT01002547|38095715|FG000|Overall Study|Adverse Event|1|||
16952465|NCT01002547|38095716|FG001|Overall Study|Adverse Event|0|||
16952466|NCT01002547|38095717|FG002|Overall Study|Adverse Event|0|||
16952467|NCT01225731|38095730|FG000|Part 1|Did not meet eligibility criteria|1|||
16952468|NCT01225731|38095731|FG001|Part 1|Did not meet eligibility criteria|0|||
16952469|NCT01225731|38095732|FG002|Part 1|Did not meet eligibility criteria|0|||
16952470|NCT01225731|38095733|FG003|Part 1|Did not meet eligibility criteria|0|||
16952471|NCT01225731|38095734|FG004|Part 1|Did not meet eligibility criteria|1|||
16952472|NCT01225731|38095735|FG005|Part 1|Did not meet eligibility criteria|0|||
16952473|NCT01225731|38095736|FG006|Part 1|Did not meet eligibility criteria|0|||
16952474|NCT01225731|38095737|FG007|Part 1|Did not meet eligibility criteria|0|||
16952475|NCT01225731|38095738|FG008|Part 1|Did not meet eligibility criteria|0|||
16952476|NCT01225731|38095739|FG009|Part 1|Did not meet eligibility criteria|0|||
16952477|NCT01225731|38095740|FG010|Part 1|Did not meet eligibility criteria|0|||
16952478|NCT01225731|38095741|FG011|Part 1|Did not meet eligibility criteria|0|||
16952479|NCT01225731|38095742|FG012|Part 1|Did not meet eligibility criteria|0|||
16952480|NCT01225731|38095730|FG000|Part 1|Adverse Event|1|||
16952481|NCT01225731|38095731|FG001|Part 1|Adverse Event|2|||
16952482|NCT01225731|38095732|FG002|Part 1|Adverse Event|1|||
16952483|NCT01225731|38095733|FG003|Part 1|Adverse Event|1|||
16952484|NCT01225731|38095734|FG004|Part 1|Adverse Event|1|||
16952485|NCT01225731|38095735|FG005|Part 1|Adverse Event|0|||
16952486|NCT01225731|38095736|FG006|Part 1|Adverse Event|0|||
16952487|NCT01225731|38095737|FG007|Part 1|Adverse Event|0|||
16952488|NCT01225731|38095738|FG008|Part 1|Adverse Event|0|||
16952489|NCT01225731|38095739|FG009|Part 1|Adverse Event|0|||
16952490|NCT01225731|38095740|FG010|Part 1|Adverse Event|0|||
16952491|NCT01225731|38095741|FG011|Part 1|Adverse Event|0|||
16952492|NCT01225731|38095742|FG012|Part 1|Adverse Event|0|||
16952493|NCT01225731|38095730|FG000|Part 1|Withdrawal by Subject|0|||
16952494|NCT01225731|38095731|FG001|Part 1|Withdrawal by Subject|3|||
16952495|NCT01225731|38095732|FG002|Part 1|Withdrawal by Subject|0|||
16952496|NCT01225731|38095733|FG003|Part 1|Withdrawal by Subject|0|||
16952497|NCT01225731|38095734|FG004|Part 1|Withdrawal by Subject|4|||
16952498|NCT01225731|38095735|FG005|Part 1|Withdrawal by Subject|0|||
16952499|NCT01225731|38095736|FG006|Part 1|Withdrawal by Subject|0|||
16952500|NCT01225731|38095737|FG007|Part 1|Withdrawal by Subject|0|||
16952501|NCT01225731|38095738|FG008|Part 1|Withdrawal by Subject|0|||
16952502|NCT01225731|38095739|FG009|Part 1|Withdrawal by Subject|0|||
16952503|NCT01225731|38095740|FG010|Part 1|Withdrawal by Subject|0|||
16952504|NCT01225731|38095741|FG011|Part 1|Withdrawal by Subject|0|||
16952505|NCT01225731|38095742|FG012|Part 1|Withdrawal by Subject|0|||
16952506|NCT01225731|38095730|FG000|Part 1|Protocol Violation|0|||
16952507|NCT01225731|38095731|FG001|Part 1|Protocol Violation|0|||
16952508|NCT01225731|38095732|FG002|Part 1|Protocol Violation|0|||
16952509|NCT01225731|38095733|FG003|Part 1|Protocol Violation|1|||
16952510|NCT01225731|38095734|FG004|Part 1|Protocol Violation|0|||
16952511|NCT01225731|38095735|FG005|Part 1|Protocol Violation|0|||
16952512|NCT01225731|38095736|FG006|Part 1|Protocol Violation|0|||
16952513|NCT01225731|38095737|FG007|Part 1|Protocol Violation|0|||
16952514|NCT01225731|38095738|FG008|Part 1|Protocol Violation|0|||
16952515|NCT01225731|38095739|FG009|Part 1|Protocol Violation|0|||
17128032|NCT03308942|38268695|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
17128033|NCT03308942|38268696|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
17128034|NCT03308786|38268709|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
17128035|NCT03274076|38268716|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
17128036|NCT03274076|38268717|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
16952516|NCT01225731|38095740|FG010|Part 1|Protocol Violation|0|||
16952517|NCT01225731|38095741|FG011|Part 1|Protocol Violation|0|||
16952518|NCT01225731|38095742|FG012|Part 1|Protocol Violation|0|||
16952519|NCT01225731|38095730|FG000|Part 2|Protocol Violation|0|||
16952520|NCT01225731|38095731|FG001|Part 2|Protocol Violation|0|||
16952521|NCT01225731|38095732|FG002|Part 2|Protocol Violation|0|||
16952522|NCT01225731|38095733|FG003|Part 2|Protocol Violation|0|||
16952523|NCT01225731|38095734|FG004|Part 2|Protocol Violation|0|||
16952524|NCT01225731|38095735|FG005|Part 2|Protocol Violation|1|||
16952525|NCT01225731|38095736|FG006|Part 2|Protocol Violation|0|||
16952526|NCT01225731|38095737|FG007|Part 2|Protocol Violation|0|||
16952527|NCT01225731|38095738|FG008|Part 2|Protocol Violation|1|||
16952528|NCT01225731|38095739|FG009|Part 2|Protocol Violation|0|||
16952529|NCT01225731|38095740|FG010|Part 2|Protocol Violation|0|||
16952530|NCT01225731|38095741|FG011|Part 2|Protocol Violation|0|||
16952531|NCT01225731|38095742|FG012|Part 2|Protocol Violation|0|||
16952532|NCT01225731|38095730|FG000|Part 2|Adverse Event|0|||
16952533|NCT01225731|38095731|FG001|Part 2|Adverse Event|0|||
16952534|NCT01225731|38095732|FG002|Part 2|Adverse Event|0|||
16952535|NCT01225731|38095733|FG003|Part 2|Adverse Event|0|||
16952536|NCT01225731|38095734|FG004|Part 2|Adverse Event|0|||
16952537|NCT01225731|38095735|FG005|Part 2|Adverse Event|0|||
16952538|NCT01225731|38095736|FG006|Part 2|Adverse Event|4|||
16952539|NCT01225731|38095737|FG007|Part 2|Adverse Event|4|||
16952540|NCT01225731|38095738|FG008|Part 2|Adverse Event|2|||
16952541|NCT01225731|38095739|FG009|Part 2|Adverse Event|0|||
16952542|NCT01225731|38095740|FG010|Part 2|Adverse Event|0|||
16952543|NCT01225731|38095741|FG011|Part 2|Adverse Event|0|||
16952544|NCT01225731|38095742|FG012|Part 2|Adverse Event|0|||
16952545|NCT01225731|38095730|FG000|Part 2|Lack of Efficacy|0|||
16952546|NCT01225731|38095731|FG001|Part 2|Lack of Efficacy|0|||
16952547|NCT01225731|38095732|FG002|Part 2|Lack of Efficacy|0|||
16952548|NCT01225731|38095733|FG003|Part 2|Lack of Efficacy|0|||
16952549|NCT01225731|38095734|FG004|Part 2|Lack of Efficacy|0|||
16952550|NCT01225731|38095735|FG005|Part 2|Lack of Efficacy|1|||
16952551|NCT01225731|38095736|FG006|Part 2|Lack of Efficacy|0|||
16952552|NCT01225731|38095737|FG007|Part 2|Lack of Efficacy|12|||
16952553|NCT01225731|38095738|FG008|Part 2|Lack of Efficacy|3|||
16952554|NCT01225731|38095739|FG009|Part 2|Lack of Efficacy|0|||
16952555|NCT01225731|38095740|FG010|Part 2|Lack of Efficacy|0|||
16952556|NCT01225731|38095741|FG011|Part 2|Lack of Efficacy|0|||
16952557|NCT01225731|38095742|FG012|Part 2|Lack of Efficacy|0|||
16952558|NCT01225731|38095730|FG000|Part 2|Pregnancy|0|||
17128037|NCT03274076|38268718|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
17128038|NCT03274076|38268719|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
17128039|NCT03274076|38268716|FG000|24 Weeks Open Label|Adverse Event|0|||
16952559|NCT01225731|38095731|FG001|Part 2|Pregnancy|0|||
16952560|NCT01225731|38095732|FG002|Part 2|Pregnancy|0|||
16952561|NCT01225731|38095733|FG003|Part 2|Pregnancy|0|||
16952562|NCT01225731|38095734|FG004|Part 2|Pregnancy|0|||
16952563|NCT01225731|38095735|FG005|Part 2|Pregnancy|0|||
16952564|NCT01225731|38095736|FG006|Part 2|Pregnancy|1|||
16952565|NCT01225731|38095737|FG007|Part 2|Pregnancy|0|||
16952566|NCT01225731|38095738|FG008|Part 2|Pregnancy|1|||
16952567|NCT01225731|38095739|FG009|Part 2|Pregnancy|0|||
16952568|NCT01225731|38095740|FG010|Part 2|Pregnancy|0|||
16952569|NCT01225731|38095741|FG011|Part 2|Pregnancy|0|||
16952570|NCT01225731|38095742|FG012|Part 2|Pregnancy|0|||
16952571|NCT01225731|38095730|FG000|Part 2|Lost to Follow-up|0|||
16952572|NCT01225731|38095731|FG001|Part 2|Lost to Follow-up|0|||
16952573|NCT01225731|38095732|FG002|Part 2|Lost to Follow-up|0|||
16952574|NCT01225731|38095733|FG003|Part 2|Lost to Follow-up|0|||
16952575|NCT01225731|38095734|FG004|Part 2|Lost to Follow-up|0|||
16952576|NCT01225731|38095735|FG005|Part 2|Lost to Follow-up|0|||
16952577|NCT01225731|38095736|FG006|Part 2|Lost to Follow-up|0|||
16952578|NCT01225731|38095737|FG007|Part 2|Lost to Follow-up|3|||
16952579|NCT01225731|38095738|FG008|Part 2|Lost to Follow-up|1|||
16952580|NCT01225731|38095739|FG009|Part 2|Lost to Follow-up|0|||
16952581|NCT01225731|38095740|FG010|Part 2|Lost to Follow-up|0|||
16952582|NCT01225731|38095741|FG011|Part 2|Lost to Follow-up|0|||
16952583|NCT01225731|38095742|FG012|Part 2|Lost to Follow-up|0|||
16952584|NCT01225731|38095730|FG000|Part 2|Physician Decision|0|||
16952585|NCT01225731|38095731|FG001|Part 2|Physician Decision|0|||
16952586|NCT01225731|38095732|FG002|Part 2|Physician Decision|0|||
16952587|NCT01225731|38095733|FG003|Part 2|Physician Decision|0|||
16952588|NCT01225731|38095734|FG004|Part 2|Physician Decision|0|||
16952589|NCT01225731|38095735|FG005|Part 2|Physician Decision|0|||
16952590|NCT01225731|38095736|FG006|Part 2|Physician Decision|0|||
16952591|NCT01225731|38095737|FG007|Part 2|Physician Decision|2|||
16952592|NCT01225731|38095738|FG008|Part 2|Physician Decision|2|||
16952593|NCT01225731|38095739|FG009|Part 2|Physician Decision|0|||
16952594|NCT01225731|38095740|FG010|Part 2|Physician Decision|0|||
16952595|NCT01225731|38095741|FG011|Part 2|Physician Decision|0|||
16952596|NCT01225731|38095742|FG012|Part 2|Physician Decision|0|||
16952597|NCT01225731|38095730|FG000|Part 2|Withdrawal by Subject|0|||
16952598|NCT01225731|38095731|FG001|Part 2|Withdrawal by Subject|0|||
16952599|NCT01225731|38095732|FG002|Part 2|Withdrawal by Subject|0|||
16952600|NCT01225731|38095733|FG003|Part 2|Withdrawal by Subject|0|||
16952601|NCT01225731|38095734|FG004|Part 2|Withdrawal by Subject|0|||
16952602|NCT01225731|38095735|FG005|Part 2|Withdrawal by Subject|1|||
16952603|NCT01225731|38095736|FG006|Part 2|Withdrawal by Subject|3|||
16952604|NCT01225731|38095737|FG007|Part 2|Withdrawal by Subject|4|||
16952605|NCT01225731|38095738|FG008|Part 2|Withdrawal by Subject|1|||
16952606|NCT01225731|38095739|FG009|Part 2|Withdrawal by Subject|0|||
16952607|NCT01225731|38095740|FG010|Part 2|Withdrawal by Subject|0|||
16952608|NCT01225731|38095741|FG011|Part 2|Withdrawal by Subject|0|||
16952609|NCT01225731|38095742|FG012|Part 2|Withdrawal by Subject|0|||
16952610|NCT01225731|38095730|FG000|Part 3|Adverse Event|0|||
16952611|NCT01225731|38095731|FG001|Part 3|Adverse Event|0|||
16952612|NCT01225731|38095732|FG002|Part 3|Adverse Event|0|||
16952613|NCT01225731|38095733|FG003|Part 3|Adverse Event|0|||
16952614|NCT01225731|38095734|FG004|Part 3|Adverse Event|0|||
16952615|NCT01225731|38095735|FG005|Part 3|Adverse Event|0|||
16952616|NCT01225731|38095736|FG006|Part 3|Adverse Event|0|||
16952617|NCT01225731|38095737|FG007|Part 3|Adverse Event|0|||
16952618|NCT01225731|38095738|FG008|Part 3|Adverse Event|0|||
16952619|NCT01225731|38095739|FG009|Part 3|Adverse Event|0|||
16952620|NCT01225731|38095740|FG010|Part 3|Adverse Event|1|||
16952621|NCT01225731|38095741|FG011|Part 3|Adverse Event|1|||
16952622|NCT01225731|38095742|FG012|Part 3|Adverse Event|0|||
16952623|NCT01225731|38095730|FG000|Part 3|Lost to Follow-up|0|||
16952624|NCT01225731|38095731|FG001|Part 3|Lost to Follow-up|0|||
16952625|NCT01225731|38095732|FG002|Part 3|Lost to Follow-up|0|||
16952626|NCT01225731|38095733|FG003|Part 3|Lost to Follow-up|0|||
16952627|NCT01225731|38095734|FG004|Part 3|Lost to Follow-up|0|||
16952628|NCT01225731|38095735|FG005|Part 3|Lost to Follow-up|0|||
16952629|NCT01225731|38095736|FG006|Part 3|Lost to Follow-up|0|||
16952630|NCT01225731|38095737|FG007|Part 3|Lost to Follow-up|0|||
16952631|NCT01225731|38095738|FG008|Part 3|Lost to Follow-up|0|||
16952632|NCT01225731|38095739|FG009|Part 3|Lost to Follow-up|0|||
16952633|NCT01225731|38095740|FG010|Part 3|Lost to Follow-up|1|||
16952634|NCT01225731|38095741|FG011|Part 3|Lost to Follow-up|2|||
16952635|NCT01225731|38095742|FG012|Part 3|Lost to Follow-up|1|||
16952636|NCT01225731|38095730|FG000|Part 3|Physician Decision|0|||
16952637|NCT01225731|38095731|FG001|Part 3|Physician Decision|0|||
16952638|NCT01225731|38095732|FG002|Part 3|Physician Decision|0|||
16952639|NCT01225731|38095733|FG003|Part 3|Physician Decision|0|||
16952640|NCT01225731|38095734|FG004|Part 3|Physician Decision|0|||
16952641|NCT01225731|38095735|FG005|Part 3|Physician Decision|0|||
16952642|NCT01225731|38095736|FG006|Part 3|Physician Decision|0|||
16952643|NCT01225731|38095737|FG007|Part 3|Physician Decision|0|||
16952644|NCT01225731|38095738|FG008|Part 3|Physician Decision|0|||
16952645|NCT01225731|38095739|FG009|Part 3|Physician Decision|0|||
16952646|NCT01225731|38095740|FG010|Part 3|Physician Decision|0|||
16952647|NCT01225731|38095741|FG011|Part 3|Physician Decision|1|||
16952648|NCT01225731|38095742|FG012|Part 3|Physician Decision|2|||
16952649|NCT01225731|38095730|FG000|Part 3|Withdrawal by Subject|0|||
16952650|NCT01225731|38095731|FG001|Part 3|Withdrawal by Subject|0|||
16952651|NCT01225731|38095732|FG002|Part 3|Withdrawal by Subject|0|||
16952652|NCT01225731|38095733|FG003|Part 3|Withdrawal by Subject|0|||
16952653|NCT01225731|38095734|FG004|Part 3|Withdrawal by Subject|0|||
16952654|NCT01225731|38095735|FG005|Part 3|Withdrawal by Subject|0|||
16952655|NCT01225731|38095736|FG006|Part 3|Withdrawal by Subject|0|||
16952656|NCT01225731|38095737|FG007|Part 3|Withdrawal by Subject|0|||
16952657|NCT01225731|38095738|FG008|Part 3|Withdrawal by Subject|0|||
16952658|NCT01225731|38095739|FG009|Part 3|Withdrawal by Subject|0|||
16952659|NCT01225731|38095740|FG010|Part 3|Withdrawal by Subject|4|||
16952660|NCT01225731|38095741|FG011|Part 3|Withdrawal by Subject|6|||
16952661|NCT01225731|38095742|FG012|Part 3|Withdrawal by Subject|4|||
16952662|NCT01007149|38095773|FG000|Overall Study|Administrative problems|0|||
16952663|NCT01007149|38095774|FG001|Overall Study|Administrative problems|1|||
16952664|NCT00998335|38095782|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
16952665|NCT00998335|38095783|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
16952666|NCT01294670|38095800|FG000|Overall Study|Not treated|1|||
16952667|NCT01294670|38095801|FG001|Overall Study|Not treated|0|||
16952668|NCT01294670|38095802|FG002|Overall Study|Not treated|0|||
16952669|NCT01294670|38095803|FG003|Overall Study|Not treated|0|||
16952670|NCT01294670|38095804|FG004|Overall Study|Not treated|0|||
16952671|NCT01006603|38095818|FG000|Overall Study|Withdrawal by Subject|17|||
16952672|NCT01006603|38095819|FG001|Overall Study|Withdrawal by Subject|19|||
16952673|NCT01006603|38095818|FG000|Overall Study|Lost to Follow-up|0|||
16952674|NCT01006603|38095819|FG001|Overall Study|Lost to Follow-up|1|||
16952675|NCT01006603|38095818|FG000|Overall Study|Safety reason|1|||
16952676|NCT01006603|38095819|FG001|Overall Study|Safety reason|1|||
16952677|NCT01006603|38095818|FG000|Overall Study|Protocol Violation|1|||
16952678|NCT01006603|38095819|FG001|Overall Study|Protocol Violation|3|||
16952679|NCT01006603|38095818|FG000|Overall Study|Incorrect enrolment|0|||
16952680|NCT01006603|38095819|FG001|Overall Study|Incorrect enrolment|2|||
16952681|NCT01006603|38095818|FG000|Overall Study|Adverse Event|15|||
16952682|NCT01006603|38095819|FG001|Overall Study|Adverse Event|7|||
16952683|NCT01006603|38095818|FG000|Overall Study|Death|1|||
16952684|NCT01006603|38095819|FG001|Overall Study|Death|1|||
16952685|NCT01006603|38095818|FG000|Overall Study|Study specific discontinuation criteria|33|||
16952686|NCT01006603|38095819|FG001|Overall Study|Study specific discontinuation criteria|34|||
16952687|NCT01006603|38095818|FG000|Overall Study|Other|3|||
16952688|NCT01006603|38095819|FG001|Overall Study|Other|7|||
17128040|NCT03274076|38268717|FG001|24 Weeks Open Label|Adverse Event|0|||
16952689|NCT00997321|38095827|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
16952690|NCT00997321|38095828|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
16952691|NCT01294592|38095842|FG000|Overall Study|Adverse Event|28|||
16952692|NCT01294592|38095843|FG001|Overall Study|Adverse Event|13|||
16952693|NCT01294592|38095842|FG000|Overall Study|Lack of Efficacy|7|||
16952694|NCT01294592|38095843|FG001|Overall Study|Lack of Efficacy|5|||
16952695|NCT01294592|38095842|FG000|Overall Study|Protocol Violation|1|||
16952696|NCT01294592|38095843|FG001|Overall Study|Protocol Violation|7|||
16952697|NCT01294592|38095842|FG000|Overall Study|Lost to Follow-up|7|||
16952698|NCT01294592|38095843|FG001|Overall Study|Lost to Follow-up|9|||
16952699|NCT01294592|38095842|FG000|Overall Study|Physician Decision|6|||
16952700|NCT01294592|38095843|FG001|Overall Study|Physician Decision|11|||
16952701|NCT01294592|38095842|FG000|Overall Study|Withdrawal by Subject|28|||
16952702|NCT01294592|38095843|FG001|Overall Study|Withdrawal by Subject|28|||
16952703|NCT00997243|38095852|FG000|Overall Study|Early termination of study by sponsor|7|||
16952704|NCT01294514|38095856|FG000|Overall Study|Excluded due to Arrhythmia|1|||
16952705|NCT00999661|38095864|FG000|Overall Study|Lost to Follow-up|59|||
16952706|NCT00999661|38095864|FG000|Overall Study|Adverse Event|1|||
16952707|NCT00999661|38095864|FG000|Overall Study|Withdrawal by Subject|1|||
16952708|NCT00999661|38095864|FG000|Overall Study|Not meeting eligibility criteria|9|||
16952709|NCT01294436|38095870|FG000|Overall Study|Adverse Event|10|||
16952710|NCT01294436|38095871|FG001|Overall Study|Adverse Event|17|||
17128041|NCT03274076|38268718|FG002|24 Weeks Open Label|Adverse Event|2|||
16952711|NCT01294436|38095870|FG000|Overall Study|Withdrawal by Subject|11|||
16952712|NCT01294436|38095871|FG001|Overall Study|Withdrawal by Subject|28|||
16952713|NCT01294436|38095870|FG000|Overall Study|subject no longer meets study criteria|5|||
16952714|NCT01294436|38095871|FG001|Overall Study|subject no longer meets study criteria|20|||
16952715|NCT01294436|38095870|FG000|Overall Study|poor/non-compliance|2|||
16952716|NCT01294436|38095871|FG001|Overall Study|poor/non-compliance|5|||
16952717|NCT00995371|38095879|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
16952718|NCT00995371|38095880|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
16952719|NCT01294358|38095888|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
16952720|NCT01294358|38095889|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
16952721|NCT01294358|38095890|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
16952722|NCT01294358|38095891|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
16952723|NCT01294358|38095892|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
16952724|NCT01294358|38095888|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
16952725|NCT01294358|38095889|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
16952726|NCT01294358|38095890|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
16952727|NCT01294358|38095891|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
16952728|NCT01294358|38095892|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
16952729|NCT01294358|38095888|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
16952730|NCT01294358|38095889|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
16952731|NCT01294358|38095890|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
16952732|NCT01294358|38095891|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
16952733|NCT01294358|38095892|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
16952734|NCT01294358|38095888|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
16952735|NCT01294358|38095889|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
16952736|NCT01294358|38095890|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
16952737|NCT01294358|38095891|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
16952738|NCT01294358|38095892|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
16952739|NCT00994279|38095911|FG000|Overall Study|Withdrawal by Subject|2|||
16952740|NCT00994279|38095912|FG001|Overall Study|Withdrawal by Subject|2|||
16952741|NCT00994279|38095911|FG000|Overall Study|Toxicity|1|||
16952742|NCT00994279|38095912|FG001|Overall Study|Toxicity|0|||
16952743|NCT00994279|38095911|FG000|Overall Study|Multiple reasons|1|||
16952744|NCT00994279|38095912|FG001|Overall Study|Multiple reasons|3|||
16952745|NCT01294046|38095918|FG000|Overall Study|Infection and surgical explant|1|||
16952746|NCT01294046|38095918|FG000|Overall Study|Eligibility criteria expanded|1|||
16952747|NCT01294046|38095918|FG000|Overall Study|Stimulation response inadqequate|1|||
16952748|NCT01224639|38095933|FG000|Overall Study|Withdrawal by Subject|0|||
16952749|NCT01224639|38095934|FG001|Overall Study|Withdrawal by Subject|0|||
16952750|NCT01224639|38095935|FG002|Overall Study|Withdrawal by Subject|0|||
16952751|NCT01224639|38095936|FG003|Overall Study|Withdrawal by Subject|0|||
16952752|NCT01224639|38095937|FG004|Overall Study|Withdrawal by Subject|2|||
16952753|NCT01224639|38095938|FG005|Overall Study|Withdrawal by Subject|0|||
16952754|NCT01224639|38095939|FG006|Overall Study|Withdrawal by Subject|1|||
16952755|NCT01224639|38095940|FG007|Overall Study|Withdrawal by Subject|1|||
16952756|NCT01224639|38095933|FG000|Overall Study|Adverse Event|0|||
16952757|NCT01224639|38095934|FG001|Overall Study|Adverse Event|0|||
16952758|NCT01224639|38095935|FG002|Overall Study|Adverse Event|0|||
16952759|NCT01224639|38095936|FG003|Overall Study|Adverse Event|0|||
16952760|NCT01224639|38095937|FG004|Overall Study|Adverse Event|0|||
16952761|NCT01224639|38095938|FG005|Overall Study|Adverse Event|0|||
16952762|NCT01224639|38095939|FG006|Overall Study|Adverse Event|0|||
16952763|NCT01224639|38095940|FG007|Overall Study|Adverse Event|1|||
16952764|NCT01293968|38095960|FG000|Overall Study|non-cooperation|3|||
16952765|NCT01293968|38095961|FG001|Overall Study|non-cooperation|3|||
16952766|NCT01293032|38095971|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
16952767|NCT01293032|38095972|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
16952768|NCT01293032|38095973|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
16952769|NCT01293032|38095974|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
16952770|NCT01293032|38095971|FG000|Treatment|Adverse Event|0|||
16952771|NCT01293032|38095972|FG001|Treatment|Adverse Event|0|||
16952772|NCT01293032|38095973|FG002|Treatment|Adverse Event|1|||
16952773|NCT01293032|38095974|FG003|Treatment|Adverse Event|1|||
16952774|NCT01293032|38095971|FG000|Treatment|Withdrawal by Subject|2|||
16952775|NCT01293032|38095972|FG001|Treatment|Withdrawal by Subject|4|||
16952776|NCT01293032|38095973|FG002|Treatment|Withdrawal by Subject|0|||
16952777|NCT01293032|38095974|FG003|Treatment|Withdrawal by Subject|0|||
16952778|NCT01293032|38095971|FG000|Treatment|Disease Progression, relapse|0|||
16952779|NCT01293032|38095972|FG001|Treatment|Disease Progression, relapse|1|||
16952780|NCT01293032|38095973|FG002|Treatment|Disease Progression, relapse|0|||
16952781|NCT01293032|38095974|FG003|Treatment|Disease Progression, relapse|0|||
16952782|NCT01292876|38095981|FG000|Overall Study|Physician Decision|4|||
16952783|NCT01224171|38095989|FG000|Overall Study|Adverse Event|8|||
16952784|NCT01224171|38095990|FG001|Overall Study|Adverse Event|4|||
16952785|NCT01224171|38095989|FG000|Overall Study|Protocol Violation|0|||
16952786|NCT01224171|38095990|FG001|Overall Study|Protocol Violation|1|||
16952787|NCT01224171|38095989|FG000|Overall Study|Lack of Efficacy|5|||
16952788|NCT01224171|38095990|FG001|Overall Study|Lack of Efficacy|1|||
16952789|NCT01224171|38095989|FG000|Overall Study|Withdrawal of Consent|2|||
16952790|NCT01224171|38095990|FG001|Overall Study|Withdrawal of Consent|4|||
16952791|NCT01224171|38095989|FG000|Overall Study|Lost to Follow-up|0|||
16952792|NCT01224171|38095990|FG001|Overall Study|Lost to Follow-up|3|||
16952793|NCT01292486|38095996|FG000|Overall Study|Protocol Violation|2|||
16952794|NCT01292486|38095996|FG000|Overall Study|Did not meet screening criteria|2|||
16952795|NCT01292486|38095996|FG000|Overall Study|Adverse Event|1|||
16952796|NCT01292486|38095996|FG000|Overall Study|Physician Decision|1|||
16952797|NCT01223937|38096003|FG000|Overall Study|Withdrawal by Subject|3|||
16952798|NCT01223937|38096004|FG001|Overall Study|Withdrawal by Subject|2|||
16952799|NCT01223937|38096003|FG000|Overall Study|Lost to Follow-up|1|||
16952800|NCT01223937|38096004|FG001|Overall Study|Lost to Follow-up|4|||
16952801|NCT01223937|38096003|FG000|Overall Study|Adverse Event|1|||
16952802|NCT01223937|38096004|FG001|Overall Study|Adverse Event|4|||
16952803|NCT01223937|38096003|FG000|Overall Study|Protocol Violation|8|||
16952804|NCT01223937|38096004|FG001|Overall Study|Protocol Violation|7|||
16952805|NCT01223937|38096003|FG000|Overall Study|Other|4|||
16952806|NCT01223937|38096004|FG001|Overall Study|Other|1|||
16952807|NCT01290224|38096010|FG000|Overall Study|Adverse Event|1|||
16952808|NCT01290224|38096010|FG000|Overall Study|Refused Further Treatment|4|||
16952809|NCT01223235|38096016|FG000|Overall Study|Withdrawal by Subject|1|||
16952810|NCT01290068|38096022|FG000|Overall Study|Adverse Event|1|||
16952811|NCT01290068|38096023|FG001|Overall Study|Adverse Event|3|||
16952812|NCT01290068|38096022|FG000|Overall Study|Lost to Follow-up|3|||
16952813|NCT01290068|38096023|FG001|Overall Study|Lost to Follow-up|0|||
16952814|NCT01290068|38096022|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
16952815|NCT01290068|38096023|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
16952816|NCT01290068|38096022|FG000|Overall Study|Other|3|||
16952817|NCT01290068|38096023|FG001|Overall Study|Other|1|||
16952818|NCT00998881|38096031|FG000|Overall Study|Adverse Event|2|||
16952819|NCT00998881|38096032|FG001|Overall Study|Adverse Event|2|||
16952820|NCT00998881|38096031|FG000|Overall Study|Lack of Efficacy|1|||
16952821|NCT00998881|38096032|FG001|Overall Study|Lack of Efficacy|0|||
16952822|NCT00998881|38096031|FG000|Overall Study|Physician Decision|3|||
16952823|NCT00998881|38096032|FG001|Overall Study|Physician Decision|0|||
16952824|NCT00998881|38096031|FG000|Overall Study|Withdrawal by Subject|1|||
16952825|NCT00998881|38096032|FG001|Overall Study|Withdrawal by Subject|0|||
16952826|NCT00998881|38096031|FG000|Overall Study|Personal matter|1|||
16952827|NCT00998881|38096032|FG001|Overall Study|Personal matter|0|||
16952828|NCT01222767|38096038|FG000|Overall Study|Progressive disease|13|||
16952829|NCT01222767|38096038|FG000|Overall Study|Adverse Event|2|||
16952830|NCT01222767|38096038|FG000|Overall Study|Surgical resection|1|||
16952831|NCT01222767|38096038|FG000|Overall Study|Never treated|1|||
16952832|NCT00993967|38096042|FG000|Overall Study|Adverse Event|8|||
16952833|NCT00993967|38096042|FG000|Overall Study|Death|1|||
16952834|NCT00993967|38096042|FG000|Overall Study|Lost to Follow-up|14|||
16952835|NCT00993967|38096042|FG000|Overall Study|Withdrawal by Subject|36|||
16952836|NCT00993967|38096042|FG000|Overall Study|Protocol Violation|2|||
16952837|NCT01222533|38096046|FG000|Overall Study|Adverse Event|5|||
16952838|NCT01222533|38096046|FG000|Overall Study|Withdrawal by Subject|5|||
16952839|NCT01222533|38096046|FG000|Overall Study|Other|4|||
16952840|NCT01221753|38096058|FG000|Overall Study|Adverse Event|1|||
16952841|NCT01221597|38096064|FG000|Overall Study|Adverse Event|4|||
16952842|NCT01221597|38096065|FG001|Overall Study|Adverse Event|1|||
16952843|NCT01221597|38096064|FG000|Overall Study|Withdrawal by Subject|20|||
16952844|NCT01221597|38096065|FG001|Overall Study|Withdrawal by Subject|6|||
16952845|NCT01221597|38096064|FG000|Overall Study|Lost to Follow-up|6|||
16952846|NCT01221597|38096065|FG001|Overall Study|Lost to Follow-up|5|||
16952847|NCT01221597|38096064|FG000|Overall Study|Protocol Violation|1|||
16952848|NCT01221597|38096065|FG001|Overall Study|Protocol Violation|0|||
16952849|NCT01221597|38096064|FG000|Overall Study|Other|3|||
16952850|NCT01221597|38096065|FG001|Overall Study|Other|4|||
16952851|NCT01221597|38096064|FG000|Overall Study|Death|2|||
16952852|NCT01221597|38096065|FG001|Overall Study|Death|0|||
16952853|NCT01221363|38096074|FG000|Overall Study|Pregnancy|1|||
16952854|NCT01221363|38096075|FG001|Overall Study|Pregnancy|0|||
16952855|NCT01221363|38096074|FG000|Overall Study|Withdrawal by Subject|11|||
16952856|NCT01221363|38096075|FG001|Overall Study|Withdrawal by Subject|5|||
16952857|NCT01221285|38096081|FG000|Overall Study|Withdrawal by Subject|1|||
16952858|NCT01014988|38096091|FG000|Overall Study|Adverse Event|20|||
16952859|NCT01014988|38096092|FG001|Overall Study|Adverse Event|0|||
16952860|NCT01014988|38096093|FG002|Overall Study|Adverse Event|1|||
16952861|NCT01014988|38096094|FG003|Overall Study|Adverse Event|0|||
16774329|NCT02198794|37713604|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
16774330|NCT02198794|37713605|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
16774331|NCT02198794|37713606|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
16774332|NCT02198794|37713607|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
16774333|NCT02198794|37713604|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
16774334|NCT02198794|37713605|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
16774335|NCT02198794|37713606|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
16774336|NCT02198794|37713607|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
16774337|NCT02133664|37713618|FG000|Overall Study|Lost to Follow-up|2|||
16774338|NCT02133664|37713619|FG001|Overall Study|Lost to Follow-up|1|||
16774339|NCT02133664|37713618|FG000|Overall Study|Adverse Event|3|||
16952862|NCT01014988|38096095|FG004|Overall Study|Adverse Event|1|||
16952863|NCT01014988|38096096|FG005|Overall Study|Adverse Event|3|||
16952864|NCT01014988|38096091|FG000|Overall Study|Lost to Follow-up|1|||
16952865|NCT01014988|38096092|FG001|Overall Study|Lost to Follow-up|0|||
16952866|NCT01014988|38096093|FG002|Overall Study|Lost to Follow-up|1|||
16952867|NCT01014988|38096094|FG003|Overall Study|Lost to Follow-up|0|||
16952868|NCT01014988|38096095|FG004|Overall Study|Lost to Follow-up|0|||
16952869|NCT01014988|38096096|FG005|Overall Study|Lost to Follow-up|0|||
16952870|NCT01014988|38096091|FG000|Overall Study|Physician Decision|1|||
16952871|NCT01014988|38096092|FG001|Overall Study|Physician Decision|0|||
16952872|NCT01014988|38096093|FG002|Overall Study|Physician Decision|0|||
16952873|NCT01014988|38096094|FG003|Overall Study|Physician Decision|0|||
16952874|NCT01014988|38096095|FG004|Overall Study|Physician Decision|0|||
16952875|NCT01014988|38096096|FG005|Overall Study|Physician Decision|0|||
16952876|NCT01014988|38096091|FG000|Overall Study|Withdrawal by Subject|1|||
16952877|NCT01014988|38096092|FG001|Overall Study|Withdrawal by Subject|0|||
16952878|NCT01014988|38096093|FG002|Overall Study|Withdrawal by Subject|0|||
16952879|NCT01014988|38096094|FG003|Overall Study|Withdrawal by Subject|0|||
16952880|NCT01014988|38096095|FG004|Overall Study|Withdrawal by Subject|0|||
16952881|NCT01014988|38096096|FG005|Overall Study|Withdrawal by Subject|0|||
16952882|NCT01014910|38096120|FG000|Overall Study|Withdrawal by Subject|0|||
16952883|NCT01014910|38096121|FG001|Overall Study|Withdrawal by Subject|2|||
16952884|NCT01019980|38096129|FG000|Overall Study|Drug not available.|2|||
16952885|NCT01019980|38096130|FG001|Overall Study|Drug not available.|0|||
16952886|NCT00993499|38096142|FG000|Run-in Period (8 Days)|Adverse Event|0|||
16952887|NCT00993499|38096143|FG001|Run-in Period (8 Days)|Adverse Event|1|||
16952888|NCT00993499|38096144|FG002|Run-in Period (8 Days)|Adverse Event|0|||
16952889|NCT00993499|38096145|FG003|Run-in Period (8 Days)|Adverse Event|0|||
16952890|NCT00993499|38096146|FG004|Run-in Period (8 Days)|Adverse Event|0|||
16952891|NCT00993499|38096147|FG005|Run-in Period (8 Days)|Adverse Event|0|||
16952892|NCT00993499|38096142|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
16952893|NCT00993499|38096143|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16952894|NCT00993499|38096144|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16952895|NCT00993499|38096145|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16952896|NCT00993499|38096146|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16952897|NCT00993499|38096147|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16952898|NCT00993499|38096142|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
16952899|NCT00993499|38096143|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
16952900|NCT00993499|38096144|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
16952901|NCT00993499|38096145|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
16952902|NCT00993499|38096146|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
16952903|NCT00993499|38096147|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
16952904|NCT00993499|38096142|FG000|Run-in Period (8 Days)|Progressive disease|0|||
16952905|NCT00993499|38096143|FG001|Run-in Period (8 Days)|Progressive disease|1|||
16952906|NCT00993499|38096144|FG002|Run-in Period (8 Days)|Progressive disease|1|||
16952907|NCT00993499|38096145|FG003|Run-in Period (8 Days)|Progressive disease|0|||
16952908|NCT00993499|38096146|FG004|Run-in Period (8 Days)|Progressive disease|0|||
16952909|NCT00993499|38096147|FG005|Run-in Period (8 Days)|Progressive disease|0|||
16952910|NCT00993499|38096142|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
16952911|NCT00993499|38096143|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
16952912|NCT00993499|38096144|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
16952913|NCT00993499|38096145|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
16952914|NCT00993499|38096146|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
16952915|NCT00993499|38096147|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
16952916|NCT00993499|38096142|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
16952917|NCT00993499|38096143|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
16952918|NCT00993499|38096144|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
16952919|NCT00993499|38096145|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
16952920|NCT00993499|38096146|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
16952921|NCT00993499|38096147|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
16952922|NCT00993499|38096142|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
16952923|NCT00993499|38096143|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
16952924|NCT00993499|38096144|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
16952925|NCT00993499|38096145|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
17128042|NCT03274076|38268719|FG003|24 Weeks Open Label|Adverse Event|0|||
17128043|NCT03274076|38268716|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
17128044|NCT03274076|38268717|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
17128045|NCT03274076|38268718|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
17128046|NCT03274076|38268719|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
16774340|NCT02133664|37713619|FG001|Overall Study|Adverse Event|6|||
16952926|NCT00993499|38096146|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
16952927|NCT00993499|38096147|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
16952928|NCT00993499|38096142|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
17128047|NCT02797522|38268749|FG000|Overall Study|Study Terminated by Sponsor|0|||
17128048|NCT02797522|38268750|FG001|Overall Study|Study Terminated by Sponsor|0|||
17128049|NCT02797522|38268751|FG002|Overall Study|Study Terminated by Sponsor|0|||
17128050|NCT02797522|38268752|FG003|Overall Study|Study Terminated by Sponsor|0|||
17128051|NCT02797522|38268753|FG004|Overall Study|Study Terminated by Sponsor|0|||
17128052|NCT02797522|38268754|FG005|Overall Study|Study Terminated by Sponsor|0|||
17128053|NCT02797522|38268755|FG006|Overall Study|Study Terminated by Sponsor|0|||
17128054|NCT02797522|38268756|FG007|Overall Study|Study Terminated by Sponsor|4|||
17128055|NCT02797522|38268757|FG008|Overall Study|Study Terminated by Sponsor|2|||
17128056|NCT02797522|38268758|FG009|Overall Study|Study Terminated by Sponsor|4|||
17128057|NCT02797522|38268759|FG010|Overall Study|Study Terminated by Sponsor|1|||
17128058|NCT02659514|38268789|FG000|Overall Study|Adverse Event|3|||
17128059|NCT02659514|38268790|FG001|Overall Study|Adverse Event|12|||
17128060|NCT02659514|38268789|FG000|Overall Study|Disease Progression|23|||
17128061|NCT02659514|38268790|FG001|Overall Study|Disease Progression|13|||
17128062|NCT02659514|38268789|FG000|Overall Study|Withdrawal by Subject|0|||
17128063|NCT02659514|38268790|FG001|Overall Study|Withdrawal by Subject|4|||
17128064|NCT02659514|38268789|FG000|Overall Study|Lost to Follow-up|0|||
17128065|NCT02659514|38268790|FG001|Overall Study|Lost to Follow-up|1|||
17128066|NCT02659514|38268789|FG000|Overall Study|Death|6|||
17128067|NCT02659514|38268790|FG001|Overall Study|Death|1|||
17128068|NCT02659514|38268789|FG000|Overall Study|Reason Unspecified|0|||
17128069|NCT02659514|38268790|FG001|Overall Study|Reason Unspecified|3|||
17128070|NCT04570670|38268798|FG000|Overall Study|Withdrawal by Subject|1|||
16952929|NCT00993499|38096143|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16952930|NCT00993499|38096144|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
16952931|NCT00993499|38096145|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16952932|NCT00993499|38096146|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16952933|NCT00993499|38096147|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16952934|NCT00993499|38096142|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16952935|NCT00993499|38096143|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
16952936|NCT00993499|38096144|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16952937|NCT00993499|38096145|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16952938|NCT00993499|38096146|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16952939|NCT00993499|38096147|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16952940|NCT00993499|38096142|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
16952941|NCT00993499|38096143|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
16952942|NCT00993499|38096144|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
16952943|NCT00993499|38096145|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
16952944|NCT00993499|38096146|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
16952945|NCT00993499|38096147|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
16952946|NCT00993499|38096142|FG000|Discontinued After Starting Course 3|DLT|1|||
16952947|NCT00993499|38096143|FG001|Discontinued After Starting Course 3|DLT|0|||
16952948|NCT00993499|38096144|FG002|Discontinued After Starting Course 3|DLT|2|||
16952949|NCT00993499|38096145|FG003|Discontinued After Starting Course 3|DLT|1|||
16952950|NCT00993499|38096146|FG004|Discontinued After Starting Course 3|DLT|0|||
16952951|NCT00993499|38096147|FG005|Discontinued After Starting Course 3|DLT|0|||
16952952|NCT00993499|38096142|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
16952953|NCT00993499|38096143|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
16952954|NCT00993499|38096144|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
16952955|NCT00993499|38096145|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
17128071|NCT04570670|38268799|FG001|Overall Study|Withdrawal by Subject|0|||
17128072|NCT02797132|38268805|FG000|Part A (15 Days)|Adverse Event|1|||
17128073|NCT02797132|38268805|FG000|Part B (24 Weeks)|Adverse Event|3|||
17128074|NCT03270644|38268818|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
17128075|NCT03270644|38268818|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
17128076|NCT03269552|38268829|FG000|Overall Study|Adverse Event|2|||
17128077|NCT02796664|38268836|FG000|Overall Study|Withdrawal by Subject|0|||
17128078|NCT02796664|38268837|FG001|Overall Study|Withdrawal by Subject|3|||
17128079|NCT02796664|38268836|FG000|Overall Study|Noncompliance|1|||
17128080|NCT02796664|38268837|FG001|Overall Study|Noncompliance|1|||
17128081|NCT02796664|38268836|FG000|Overall Study|Death|0|||
17128082|NCT02796664|38268837|FG001|Overall Study|Death|1|||
17128083|NCT01370356|38268847|FG000|Overall Study|Death|1|||
17128084|NCT01370356|38268848|FG001|Overall Study|Death|0|||
17128085|NCT01370356|38268847|FG000|Overall Study|Lack of Efficacy|6|||
16952956|NCT00993499|38096146|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
16952957|NCT00993499|38096147|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
16952958|NCT01014442|38096163|FG000|Overall Study|Adverse Event|0|||
16952959|NCT01014442|38096164|FG001|Overall Study|Adverse Event|8|||
16952960|NCT01014442|38096163|FG000|Overall Study|Withdrawal by Subject|4|||
16952961|NCT01014442|38096164|FG001|Overall Study|Withdrawal by Subject|4|||
16952962|NCT01014442|38096163|FG000|Overall Study|Protocol Violation|2|||
16952963|NCT01014442|38096164|FG001|Overall Study|Protocol Violation|5|||
16952964|NCT01014442|38096163|FG000|Overall Study|Lack of Compliance|0|||
16952965|NCT01014442|38096164|FG001|Overall Study|Lack of Compliance|1|||
16952966|NCT01014442|38096163|FG000|Overall Study|Unspecified Reason|1|||
16952967|NCT01014442|38096164|FG001|Overall Study|Unspecified Reason|1|||
16952968|NCT00996307|38096178|FG000|Overall Study|Adverse Event|0|||
16952969|NCT00996307|38096179|FG001|Overall Study|Adverse Event|1|||
16952970|NCT00996307|38096180|FG002|Overall Study|Adverse Event|0|||
16952971|NCT00996307|38096181|FG003|Overall Study|Adverse Event|0|||
16952972|NCT00996307|38096178|FG000|Overall Study|Withdrawal by Subject|3|||
16952973|NCT00996307|38096179|FG001|Overall Study|Withdrawal by Subject|2|||
16952974|NCT00996307|38096180|FG002|Overall Study|Withdrawal by Subject|5|||
16952975|NCT00996307|38096181|FG003|Overall Study|Withdrawal by Subject|5|||
16952976|NCT00996307|38096178|FG000|Overall Study|Lost to Follow-up|13|||
16952977|NCT00996307|38096179|FG001|Overall Study|Lost to Follow-up|13|||
16952978|NCT00996307|38096180|FG002|Overall Study|Lost to Follow-up|7|||
16952979|NCT00996307|38096181|FG003|Overall Study|Lost to Follow-up|15|||
16952980|NCT00996307|38096178|FG000|Overall Study|Administrative reason|0|||
16952981|NCT00996307|38096179|FG001|Overall Study|Administrative reason|1|||
16952982|NCT00996307|38096180|FG002|Overall Study|Administrative reason|0|||
16952983|NCT00996307|38096181|FG003|Overall Study|Administrative reason|0|||
16952984|NCT00996307|38096178|FG000|Overall Study|Unable to classify|4|||
16952985|NCT00996307|38096179|FG001|Overall Study|Unable to classify|0|||
16952986|NCT00996307|38096180|FG002|Overall Study|Unable to classify|2|||
16952987|NCT00996307|38096181|FG003|Overall Study|Unable to classify|1|||
16952988|NCT01219959|38096211|FG000|Overall Study|Adverse Event|6|||
16952989|NCT01219959|38096212|FG001|Overall Study|Adverse Event|14|||
16952990|NCT01219959|38096211|FG000|Overall Study|Physician Decision|0|||
17128086|NCT01370356|38268848|FG001|Overall Study|Lack of Efficacy|28|||
16952991|NCT01219959|38096212|FG001|Overall Study|Physician Decision|4|||
16952992|NCT01219959|38096211|FG000|Overall Study|Withdrawal by Subject|0|||
16952993|NCT01219959|38096212|FG001|Overall Study|Withdrawal by Subject|2|||
16952994|NCT01219959|38096211|FG000|Overall Study|Renal Transplantation|0|||
16952995|NCT01219959|38096212|FG001|Overall Study|Renal Transplantation|3|||
16952996|NCT01219959|38096211|FG000|Overall Study|Other|1|||
16952997|NCT01219959|38096212|FG001|Overall Study|Other|0|||
16952998|NCT00993421|38096225|FG000|Overall Study|Adverse Event|2|||
16952999|NCT00993421|38096226|FG001|Overall Study|Adverse Event|7|||
16953000|NCT00993421|38096227|FG002|Overall Study|Adverse Event|6|||
16953001|NCT00993421|38096228|FG003|Overall Study|Adverse Event|9|||
16953002|NCT00993421|38096229|FG004|Overall Study|Adverse Event|5|||
16953003|NCT00993421|38096230|FG005|Overall Study|Adverse Event|7|||
17128087|NCT01370356|38268847|FG000|Overall Study|Lost to Follow-up|76|||
17128088|NCT01370356|38268848|FG001|Overall Study|Lost to Follow-up|81|||
17128089|NCT01370356|38268847|FG000|Overall Study|Withdrawal by Subject|54|||
17128090|NCT01370356|38268848|FG001|Overall Study|Withdrawal by Subject|59|||
17128091|NCT01370356|38268847|FG000|Overall Study|Reason not specified|39|||
17128092|NCT01370356|38268848|FG001|Overall Study|Reason not specified|43|||
17128093|NCT01370356|38268847|FG000|Overall Study|Protocol Violation|3|||
17128094|NCT01370356|38268848|FG001|Overall Study|Protocol Violation|3|||
16953004|NCT00993421|38096231|FG006|Overall Study|Adverse Event|1|||
16953005|NCT00993421|38096225|FG000|Overall Study|Sponsor Decision|36|||
16953006|NCT00993421|38096226|FG001|Overall Study|Sponsor Decision|31|||
16953007|NCT00993421|38096227|FG002|Overall Study|Sponsor Decision|28|||
16953008|NCT00993421|38096228|FG003|Overall Study|Sponsor Decision|30|||
16953009|NCT00993421|38096229|FG004|Overall Study|Sponsor Decision|38|||
16953010|NCT00993421|38096230|FG005|Overall Study|Sponsor Decision|30|||
16953011|NCT00993421|38096231|FG006|Overall Study|Sponsor Decision|29|||
16953012|NCT00993421|38096225|FG000|Overall Study|Lost to Follow-up|3|||
16953013|NCT00993421|38096226|FG001|Overall Study|Lost to Follow-up|5|||
16953014|NCT00993421|38096227|FG002|Overall Study|Lost to Follow-up|5|||
16953015|NCT00993421|38096228|FG003|Overall Study|Lost to Follow-up|0|||
16953016|NCT00993421|38096229|FG004|Overall Study|Lost to Follow-up|0|||
16953017|NCT00993421|38096230|FG005|Overall Study|Lost to Follow-up|0|||
16953018|NCT00993421|38096231|FG006|Overall Study|Lost to Follow-up|6|||
16953019|NCT00993421|38096225|FG000|Overall Study|Withdrawal by Subject|3|||
16953020|NCT00993421|38096226|FG001|Overall Study|Withdrawal by Subject|2|||
16953021|NCT00993421|38096227|FG002|Overall Study|Withdrawal by Subject|3|||
16953022|NCT00993421|38096228|FG003|Overall Study|Withdrawal by Subject|3|||
16953023|NCT00993421|38096229|FG004|Overall Study|Withdrawal by Subject|3|||
16953024|NCT00993421|38096230|FG005|Overall Study|Withdrawal by Subject|5|||
16953025|NCT00993421|38096231|FG006|Overall Study|Withdrawal by Subject|3|||
16953026|NCT00993421|38096225|FG000|Overall Study|Death|0|||
16953027|NCT00993421|38096226|FG001|Overall Study|Death|0|||
16953028|NCT00993421|38096227|FG002|Overall Study|Death|0|||
16953029|NCT00993421|38096228|FG003|Overall Study|Death|0|||
16953030|NCT00993421|38096229|FG004|Overall Study|Death|0|||
16953031|NCT00993421|38096230|FG005|Overall Study|Death|0|||
16953032|NCT00993421|38096231|FG006|Overall Study|Death|1|||
16953033|NCT00993421|38096225|FG000|Overall Study|Entry Criteria Exclusion|0|||
16953034|NCT00993421|38096226|FG001|Overall Study|Entry Criteria Exclusion|0|||
16953035|NCT00993421|38096227|FG002|Overall Study|Entry Criteria Exclusion|1|||
16953036|NCT00993421|38096228|FG003|Overall Study|Entry Criteria Exclusion|3|||
16953037|NCT00993421|38096229|FG004|Overall Study|Entry Criteria Exclusion|0|||
16953038|NCT00993421|38096230|FG005|Overall Study|Entry Criteria Exclusion|1|||
16953039|NCT00993421|38096231|FG006|Overall Study|Entry Criteria Exclusion|0|||
16953040|NCT00993421|38096225|FG000|Overall Study|Physician Decision|0|||
16953041|NCT00993421|38096226|FG001|Overall Study|Physician Decision|0|||
16953042|NCT00993421|38096227|FG002|Overall Study|Physician Decision|0|||
16953043|NCT00993421|38096228|FG003|Overall Study|Physician Decision|0|||
16953044|NCT00993421|38096229|FG004|Overall Study|Physician Decision|0|||
17128095|NCT01370356|38268847|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
16953045|NCT00993421|38096230|FG005|Overall Study|Physician Decision|1|||
16953046|NCT00993421|38096231|FG006|Overall Study|Physician Decision|1|||
16953047|NCT00993421|38096225|FG000|Overall Study|Protocol Violation|0|||
16953048|NCT00993421|38096226|FG001|Overall Study|Protocol Violation|0|||
16953049|NCT00993421|38096227|FG002|Overall Study|Protocol Violation|0|||
16953050|NCT00993421|38096228|FG003|Overall Study|Protocol Violation|0|||
16953051|NCT00993421|38096229|FG004|Overall Study|Protocol Violation|0|||
16953052|NCT00993421|38096230|FG005|Overall Study|Protocol Violation|2|||
16953053|NCT00993421|38096231|FG006|Overall Study|Protocol Violation|1|||
17128096|NCT01370356|38268848|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
17128097|NCT01370356|38268847|FG000|Overall Study|AE Not Related to Study Drug|1|||
17128098|NCT01370356|38268848|FG001|Overall Study|AE Not Related to Study Drug|4|||
17128099|NCT02794870|38268856|FG000|Overall Study|Withdrawal by Subject|2|||
17128100|NCT02794870|38268857|FG001|Overall Study|Withdrawal by Subject|0|||
17128101|NCT01370590|38268865|FG000|Period 1|Adverse Event|8|||
17128102|NCT01370590|38268866|FG001|Period 1|Adverse Event|4|||
17128103|NCT01370590|38268865|FG000|Period 1|Lost to Follow-up|2|||
17128104|NCT01370590|38268866|FG001|Period 1|Lost to Follow-up|2|||
17128105|NCT01370590|38268865|FG000|Period 1|Protocol Violation|2|||
17128106|NCT01370590|38268866|FG001|Period 1|Protocol Violation|2|||
17128107|NCT01370590|38268865|FG000|Period 1|Withdrawal by Subject|4|||
17128108|NCT01370590|38268866|FG001|Period 1|Withdrawal by Subject|2|||
17128109|NCT01370590|38268865|FG000|Period 1|Could not access randomization system|0|||
17128110|NCT01370590|38268866|FG001|Period 1|Could not access randomization system|1|||
17128111|NCT01370590|38268865|FG000|Crossover Washout Period|Adverse Event|1|||
17128112|NCT01370590|38268866|FG001|Crossover Washout Period|Adverse Event|4|||
17128113|NCT01370590|38268865|FG000|Crossover Washout Period|Lost to Follow-up|2|||
16953054|NCT01014208|38096249|FG000|Overall Study|Lost to Follow-up|2|||
16953055|NCT01014208|38096250|FG001|Overall Study|Lost to Follow-up|5|||
16953056|NCT01014208|38096249|FG000|Overall Study|Participant Withdrew Consent|12|||
16953057|NCT01014208|38096250|FG001|Overall Study|Participant Withdrew Consent|12|||
16953058|NCT01014208|38096249|FG000|Overall Study|Did Not Receive Study Drug|2|||
16953059|NCT01014208|38096250|FG001|Overall Study|Did Not Receive Study Drug|0|||
16953060|NCT01014208|38096249|FG000|Overall Study|Study Closed/terminated|78|||
17128114|NCT01370590|38268866|FG001|Crossover Washout Period|Lost to Follow-up|0|||
17128115|NCT01370590|38268865|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
17128116|NCT01370590|38268866|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
17128117|NCT01370590|38268865|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
17128118|NCT01370590|38268866|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
17128119|NCT01370590|38268865|FG000|Period 2|Adverse Event|0|||
17128120|NCT01370590|38268866|FG001|Period 2|Adverse Event|1|||
16953061|NCT01014208|38096250|FG001|Overall Study|Study Closed/terminated|83|||
16953062|NCT00991939|38096258|FG000|Overall Study|Lost to Follow-up|0|||
16953063|NCT00991939|38096259|FG001|Overall Study|Lost to Follow-up|1|||
16953064|NCT00991939|38096258|FG000|Overall Study|Withdrawal by Subject|1|||
16953065|NCT00991939|38096259|FG001|Overall Study|Withdrawal by Subject|0|||
16953066|NCT00991939|38096258|FG000|Overall Study|Entire study terminated|4|||
16953067|NCT00991939|38096259|FG001|Overall Study|Entire study terminated|1|||
16953068|NCT00993265|38096269|FG000|Overall Study|Adverse Event|1|||
16953069|NCT00993265|38096270|FG001|Overall Study|Adverse Event|0|||
16953070|NCT00993265|38096269|FG000|Overall Study|Changed dose of concomitant drug|2|||
16953071|NCT00993265|38096270|FG001|Overall Study|Changed dose of concomitant drug|0|||
16953072|NCT00993265|38096269|FG000|Overall Study|Non-compliant with study medication|1|||
16953073|NCT00993265|38096270|FG001|Overall Study|Non-compliant with study medication|0|||
16953074|NCT04211389|38096278|FG000|Overall Study|Adverse Event|1|||
16953075|NCT04211389|38096279|FG001|Overall Study|Adverse Event|2|||
16953076|NCT04211389|38096278|FG000|Overall Study|Lost to Follow-up|15|||
16953077|NCT04211389|38096279|FG001|Overall Study|Lost to Follow-up|7|||
16953078|NCT04211389|38096278|FG000|Overall Study|Protocol Violation|0|||
16953079|NCT04211389|38096279|FG001|Overall Study|Protocol Violation|1|||
16953080|NCT04211389|38096278|FG000|Overall Study|Withdrawal by Subject|10|||
16953081|NCT04211389|38096279|FG001|Overall Study|Withdrawal by Subject|11|||
16953082|NCT00993031|38096287|FG000|Overall Study|Death|0|||
16953083|NCT00993031|38096288|FG001|Overall Study|Death|1|||
16953084|NCT00993031|38096287|FG000|Overall Study|Physician Decision|0|||
16953085|NCT00993031|38096288|FG001|Overall Study|Physician Decision|2|||
17128121|NCT01370590|38268865|FG000|Period 2|Withdrawal by Subject|1|||
16953086|NCT00993031|38096287|FG000|Overall Study|Withdrawal by Subject|3|||
16953087|NCT00993031|38096288|FG001|Overall Study|Withdrawal by Subject|3|||
16953088|NCT00993031|38096287|FG000|Overall Study|Lost to Follow-up|19|||
16953089|NCT00993031|38096288|FG001|Overall Study|Lost to Follow-up|13|||
16953090|NCT01010776|38096298|FG000|Main Phase|Withdrawal by Subject|14|||
16953091|NCT01010776|38096298|FG000|Main Phase|Lack of Efficacy|8|||
16953092|NCT01010776|38096298|FG000|Main Phase|Adverse Event|7|||
16953093|NCT01010776|38096298|FG000|Main Phase|Lost to Follow-up|6|||
16953094|NCT01010776|38096298|FG000|Main Phase|Non-compliance to study medication|5|||
16953095|NCT01010776|38096298|FG000|Main Phase|Selection failure|2|||
16953096|NCT01010776|38096298|FG000|Main Phase|Inform consent withdrawal|1|||
16953097|NCT01010776|38096298|FG000|Main Phase|Other|1|||
16953098|NCT01010776|38096298|FG000|Main Phase|Did not received study medication|5|||
16953099|NCT01010776|38096298|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
16953100|NCT01010776|38096298|FG000|Extension Phase|Other|3|||
16953101|NCT01018810|38096318|FG000|Overall Study|Withdrawal by Subject|0|||
16953102|NCT01018810|38096319|FG001|Overall Study|Withdrawal by Subject|1|||
16953103|NCT01018810|38096320|FG002|Overall Study|Withdrawal by Subject|0|||
16953104|NCT01018810|38096321|FG003|Overall Study|Withdrawal by Subject|0|||
16953105|NCT01018810|38096322|FG004|Overall Study|Withdrawal by Subject|0|||
16953106|NCT01018810|38096318|FG000|Overall Study|Sponsor Decision|2|||
16953107|NCT01018810|38096319|FG001|Overall Study|Sponsor Decision|0|||
16953108|NCT01018810|38096320|FG002|Overall Study|Sponsor Decision|1|||
16953109|NCT01018810|38096321|FG003|Overall Study|Sponsor Decision|1|||
16953110|NCT01018810|38096322|FG004|Overall Study|Sponsor Decision|1|||
16953111|NCT01018732|38096337|FG000|Overall Study|Lost to Follow-up|0|||
16953112|NCT01018732|38096338|FG001|Overall Study|Lost to Follow-up|0|||
16953113|NCT01018732|38096339|FG002|Overall Study|Lost to Follow-up|3|||
16953114|NCT01018732|38096337|FG000|Overall Study|Protocol Violation|1|||
16953115|NCT01018732|38096338|FG001|Overall Study|Protocol Violation|1|||
16953116|NCT01018732|38096339|FG002|Overall Study|Protocol Violation|0|||
16953117|NCT01018732|38096337|FG000|Overall Study|Inappropriate Enrollment|0|||
16953118|NCT01018732|38096338|FG001|Overall Study|Inappropriate Enrollment|1|||
16953119|NCT01018732|38096339|FG002|Overall Study|Inappropriate Enrollment|0|||
16953120|NCT01018732|38096337|FG000|Overall Study|Unable to Classify|0|||
16953121|NCT01018732|38096338|FG001|Overall Study|Unable to Classify|0|||
16953122|NCT01018732|38096339|FG002|Overall Study|Unable to Classify|1|||
17128122|NCT01370590|38268866|FG001|Period 2|Withdrawal by Subject|1|||
17128123|NCT05200455|38268877|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
17128124|NCT04646109|38268884|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
17128125|NCT04646109|38268885|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
16953123|NCT01218867|38096358|FG000|Overall Study|Death during treatment|0|||
16953124|NCT01218867|38096359|FG001|Overall Study|Death during treatment|0|||
16953125|NCT01218867|38096360|FG002|Overall Study|Death during treatment|0|||
16953126|NCT01218867|38096361|FG003|Overall Study|Death during treatment|0|||
16953127|NCT01218867|38096362|FG004|Overall Study|Death during treatment|0|||
16953128|NCT01218867|38096363|FG005|Overall Study|Death during treatment|0|||
17128126|NCT04601103|38268895|FG000|Overall Study|Needed crown & cleaning|0|||
17128127|NCT04601103|38268896|FG001|Overall Study|Needed crown & cleaning|0|||
17128128|NCT04601103|38268897|FG002|Overall Study|Needed crown & cleaning|1|||
17128129|NCT04601103|38268895|FG000|Overall Study|study was terminated|18|||
17128130|NCT04601103|38268896|FG001|Overall Study|study was terminated|18|||
17128131|NCT04601103|38268897|FG002|Overall Study|study was terminated|16|||
17128132|NCT04502979|38268907|FG000|Overall Study|Lost to Follow-up|1|||
17128133|NCT04502979|38268908|FG001|Overall Study|Lost to Follow-up|3|||
17128134|NCT04502979|38268907|FG000|Overall Study|Withdrawal by Subject|2|||
17128135|NCT04502979|38268908|FG001|Overall Study|Withdrawal by Subject|1|||
17128136|NCT04590027|38268916|FG000|Overall Study|Lost to Follow-up|17|||
17128137|NCT04590027|38268917|FG001|Overall Study|Lost to Follow-up|14|||
17128138|NCT04590027|38268916|FG000|Overall Study|Protocol Violation|0|||
17128139|NCT04590027|38268917|FG001|Overall Study|Protocol Violation|3|||
17128140|NCT04587453|38268929|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
17128141|NCT04587453|38268930|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
17128142|NCT02793232|38268947|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
17128143|NCT02793232|38268948|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
17128144|NCT02793232|38268949|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
17128145|NCT02793232|38268950|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
17128146|NCT02793232|38268951|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
16953129|NCT01218867|38096364|FG006|Overall Study|Death during treatment|1|||
16953130|NCT01218867|38096365|FG007|Overall Study|Death during treatment|0|||
16953131|NCT01218867|38096366|FG008|Overall Study|Death during treatment|0|||
16953132|NCT01218867|38096367|FG009|Overall Study|Death during treatment|0|||
16953133|NCT01218867|38096368|FG010|Overall Study|Death during treatment|0|||
16953134|NCT01018264|38096405|FG000|Overall Study|Withdrawal by Subject|1|||
16953135|NCT01018264|38096406|FG001|Overall Study|Withdrawal by Subject|0|||
16953136|NCT01018264|38096405|FG000|Overall Study|Lost to Follow-up|0|||
16953137|NCT01018264|38096406|FG001|Overall Study|Lost to Follow-up|1|||
16953138|NCT01018186|38096415|FG000|2-week Run-in Period|Protocol Violation|1|||
16953139|NCT01018186|38096416|FG001|2-week Run-in Period|Protocol Violation|0|||
16953140|NCT01018186|38096417|FG002|2-week Run-in Period|Protocol Violation|0|||
16953141|NCT01018186|38096418|FG003|2-week Run-in Period|Protocol Violation|0|||
16953142|NCT01018186|38096415|FG000|2-week Run-in Period|Lost to Follow-up|2|||
16953143|NCT01018186|38096416|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16953144|NCT01018186|38096417|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16953145|NCT01018186|38096418|FG003|2-week Run-in Period|Lost to Follow-up|0|||
16953146|NCT01018186|38096415|FG000|2-week Run-in Period|Physician Decision|3|||
16953147|NCT01018186|38096416|FG001|2-week Run-in Period|Physician Decision|0|||
16953148|NCT01018186|38096417|FG002|2-week Run-in Period|Physician Decision|0|||
16953149|NCT01018186|38096418|FG003|2-week Run-in Period|Physician Decision|0|||
16953150|NCT01018186|38096415|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
16953151|NCT01018186|38096416|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16953152|NCT01018186|38096417|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16953153|NCT01018186|38096418|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
16953154|NCT01018186|38096415|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
16953155|NCT01018186|38096416|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16953156|NCT01018186|38096417|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16953157|NCT01018186|38096418|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16953158|NCT01018186|38096415|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
16953159|NCT01018186|38096416|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
16953160|NCT01018186|38096417|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
16953161|NCT01018186|38096418|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
16953162|NCT01018186|38096415|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
16953163|NCT01018186|38096416|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
16953164|NCT01018186|38096417|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
17128147|NCT02793232|38268952|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
17128148|NCT02793232|38268953|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
16953165|NCT01018186|38096418|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
16953166|NCT01018186|38096415|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
16953167|NCT01018186|38096416|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
16953168|NCT01018186|38096417|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
16953169|NCT01018186|38096418|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
16953170|NCT01018186|38096415|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
16953171|NCT01018186|38096416|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
16953172|NCT01018186|38096417|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
16953173|NCT01018186|38096418|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
16953174|NCT01018186|38096415|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
16953175|NCT01018186|38096416|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
16953176|NCT01018186|38096417|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
16953177|NCT01018186|38096418|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
16953178|NCT01018186|38096415|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
16953179|NCT01018186|38096416|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
16953180|NCT01018186|38096417|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
16953181|NCT01018186|38096418|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
16953182|NCT01018186|38096415|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
17128149|NCT02793232|38268954|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
17128150|NCT02793232|38268955|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
17128151|NCT04584645|38268991|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
17128152|NCT04584645|38268992|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
17128153|NCT03695367|38269018|FG000|Overall Study|Missed the Day 28 visit.|1|||
17128154|NCT03695367|38269019|FG001|Overall Study|Missed the Day 28 visit.|0|||
17128155|NCT03695367|38269018|FG000|Overall Study|Lost to Follow-up|0|||
17128156|NCT03695367|38269019|FG001|Overall Study|Lost to Follow-up|1|||
17128157|NCT03695367|38269018|FG000|Overall Study|Withdrawal by Subject|0|||
17128158|NCT03695367|38269019|FG001|Overall Study|Withdrawal by Subject|1|||
17128159|NCT03695367|38269018|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
17188983|NCT01063153|38341937|FG001|Overall Study|Withdrawal by Subject|1|||
17188984|NCT01063153|38341936|FG000|Overall Study|Physician Decision|0|||
16953183|NCT01018186|38096416|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
16953184|NCT01018186|38096417|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
16953185|NCT01018186|38096418|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
16953186|NCT00987337|38096433|FG000|Overall Study|Adverse Event|10|||
16953187|NCT00987337|38096434|FG001|Overall Study|Adverse Event|9|||
16953188|NCT00987337|38096435|FG002|Overall Study|Adverse Event|8|||
16953189|NCT00987337|38096433|FG000|Overall Study|Insufficient Virologic Response|10|||
16953190|NCT00987337|38096434|FG001|Overall Study|Insufficient Virologic Response|7|||
16953191|NCT00987337|38096435|FG002|Overall Study|Insufficient Virologic Response|12|||
16953192|NCT00987337|38096433|FG000|Overall Study|Virologic Breakthrough|2|||
16953193|NCT00987337|38096434|FG001|Overall Study|Virologic Breakthrough|2|||
16953194|NCT00987337|38096435|FG002|Overall Study|Virologic Breakthrough|8|||
16953195|NCT00987337|38096433|FG000|Overall Study|Lost to Follow-up|10|||
16953196|NCT00987337|38096434|FG001|Overall Study|Lost to Follow-up|6|||
16953197|NCT00987337|38096435|FG002|Overall Study|Lost to Follow-up|2|||
16953198|NCT00987337|38096433|FG000|Overall Study|Withdrawal by Subject|6|||
16953199|NCT00987337|38096434|FG001|Overall Study|Withdrawal by Subject|9|||
16953200|NCT00987337|38096435|FG002|Overall Study|Withdrawal by Subject|9|||
16953201|NCT00987337|38096433|FG000|Overall Study|Other|0|||
16953202|NCT00987337|38096434|FG001|Overall Study|Other|2|||
17188985|NCT01063153|38341937|FG001|Overall Study|Physician Decision|4|||
17188986|NCT01062841|38341949|FG000|Overall Study|Indwelling Device Removed|41|||
17188987|NCT01062841|38341950|FG001|Overall Study|Indwelling Device Removed|48|||
17188988|NCT01062841|38341949|FG000|Overall Study|Death|3|||
17188989|NCT01062841|38341950|FG001|Overall Study|Death|5|||
17188990|NCT01062841|38341949|FG000|Overall Study|Withdrawal by Subject|2|||
17188991|NCT01062841|38341950|FG001|Overall Study|Withdrawal by Subject|0|||
17188992|NCT01062841|38341949|FG000|Overall Study|Withdrawal by Study|3|||
17188993|NCT01062841|38341950|FG001|Overall Study|Withdrawal by Study|0|||
17188994|NCT02505334|38341958|FG000|Main Treatment Period|Adverse Event|3|||
17188995|NCT02505334|38341959|FG001|Main Treatment Period|Adverse Event|3|||
16953203|NCT00987337|38096435|FG002|Overall Study|Other|5|||
16953204|NCT00987337|38096433|FG000|Overall Study|Protocol Violation|1|||
16953205|NCT00987337|38096434|FG001|Overall Study|Protocol Violation|0|||
16953206|NCT00987337|38096435|FG002|Overall Study|Protocol Violation|2|||
16953207|NCT00987337|38096433|FG000|Overall Study|Participant Relapsed|18|||
16953208|NCT00987337|38096434|FG001|Overall Study|Participant Relapsed|20|||
16953209|NCT00987337|38096435|FG002|Overall Study|Participant Relapsed|5|||
16953210|NCT00992407|38096447|FG000|Overall Study|Protocol Violation|2|||
16953211|NCT00992407|38096448|FG001|Overall Study|Protocol Violation|1|||
16953212|NCT00992407|38096447|FG000|Overall Study|Lost to Follow-up|3|||
16953213|NCT00992407|38096448|FG001|Overall Study|Lost to Follow-up|3|||
16953214|NCT00992407|38096447|FG000|Overall Study|Adverse Event|3|||
16953215|NCT00992407|38096448|FG001|Overall Study|Adverse Event|2|||
16953216|NCT00992407|38096447|FG000|Overall Study|protocol Violation & Adverse events|2|||
16953217|NCT00992407|38096448|FG001|Overall Study|protocol Violation & Adverse events|4|||
16953218|NCT00992407|38096447|FG000|Overall Study|Other|2|||
16953219|NCT00992407|38096448|FG001|Overall Study|Other|0|||
16953220|NCT00992407|38096447|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
16953221|NCT00992407|38096448|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
16953222|NCT00992407|38096447|FG000|Overall Study|Study medication not administered|17|||
16953223|NCT00992407|38096448|FG001|Overall Study|Study medication not administered|13|||
16953224|NCT00986479|38096459|FG000|Period 1|Improved mood|1|||
16953225|NCT00986479|38096460|FG001|Period 1|Improved mood|0|||
16953226|NCT00986479|38096459|FG000|Period 1|Administrative reasons|1|||
16953227|NCT00986479|38096460|FG001|Period 1|Administrative reasons|0|||
16953228|NCT00986245|38096466|FG000|First Intervention|Poor compliance|8|||
16953229|NCT00986245|38096467|FG001|First Intervention|Poor compliance|4|||
17128160|NCT03695367|38269019|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
17128161|NCT02794480|38269027|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
17128162|NCT02794480|38269028|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
16953230|NCT00986245|38096466|FG000|First Intervention|Lack of Efficacy|1|||
16953231|NCT00986245|38096467|FG001|First Intervention|Lack of Efficacy|2|||
16953232|NCT00986245|38096466|FG000|First Intervention|Withdrawal by Subject|0|||
16953233|NCT00986245|38096467|FG001|First Intervention|Withdrawal by Subject|1|||
16953234|NCT00986245|38096466|FG000|First Intervention|Protocol Violation|0|||
16953235|NCT00986245|38096467|FG001|First Intervention|Protocol Violation|1|||
16953236|NCT00986245|38096466|FG000|First Intervention|Out of indication|1|||
16953237|NCT00986245|38096467|FG001|First Intervention|Out of indication|0|||
16953238|NCT00986245|38096466|FG000|Second Intervention|Poor compliance|1|||
16953239|NCT00986245|38096467|FG001|Second Intervention|Poor compliance|0|||
16953240|NCT00986245|38096466|FG000|Second Intervention|Lost to Follow-up|1|||
16953241|NCT00986245|38096467|FG001|Second Intervention|Lost to Follow-up|0|||
16953242|NCT00986245|38096466|FG000|Second Intervention|Protocol Violation|0|||
16953243|NCT00986245|38096467|FG001|Second Intervention|Protocol Violation|1|||
16953244|NCT00989833|38096481|FG000|Overall Study|Lost to Follow-up|0|||
16953245|NCT00989833|38096482|FG001|Overall Study|Lost to Follow-up|1|||
16953246|NCT00989833|38096483|FG002|Overall Study|Lost to Follow-up|0|||
16953247|NCT00989833|38096481|FG000|Overall Study|Protocol Violation|1|||
16953248|NCT00989833|38096482|FG001|Overall Study|Protocol Violation|2|||
16953249|NCT00989833|38096483|FG002|Overall Study|Protocol Violation|1|||
16953250|NCT00989833|38096481|FG000|Overall Study|Withdrawal by Subject|0|||
16953251|NCT00989833|38096482|FG001|Overall Study|Withdrawal by Subject|0|||
16953252|NCT00989833|38096483|FG002|Overall Study|Withdrawal by Subject|1|||
16953253|NCT00989833|38096481|FG000|Overall Study|Incorrectly randomized|1|||
16953254|NCT00989833|38096482|FG001|Overall Study|Incorrectly randomized|0|||
16953255|NCT00989833|38096483|FG002|Overall Study|Incorrectly randomized|0|||
16953256|NCT01218477|38096495|FG000|Overall Study|Disease progression|2|||
16953257|NCT01218477|38096496|FG001|Overall Study|Disease progression|3|||
16953258|NCT01218477|38096497|FG002|Overall Study|Disease progression|6|||
16953259|NCT01218477|38096498|FG003|Overall Study|Disease progression|2|||
16953260|NCT01218477|38096495|FG000|Overall Study|Study drug toxicity|0|||
16953261|NCT01218477|38096496|FG001|Overall Study|Study drug toxicity|2|||
16953262|NCT01218477|38096497|FG002|Overall Study|Study drug toxicity|5|||
16953263|NCT01218477|38096498|FG003|Overall Study|Study drug toxicity|0|||
16953264|NCT01218477|38096495|FG000|Overall Study|No longer meets study criteria|1|||
16953265|NCT01218477|38096496|FG001|Overall Study|No longer meets study criteria|0|||
16953266|NCT01218477|38096497|FG002|Overall Study|No longer meets study criteria|0|||
16953267|NCT01218477|38096498|FG003|Overall Study|No longer meets study criteria|0|||
16953268|NCT01218477|38096495|FG000|Overall Study|Withdrawal by Subject|0|||
16953269|NCT01218477|38096496|FG001|Overall Study|Withdrawal by Subject|0|||
17128163|NCT02794480|38269029|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
16953270|NCT01218477|38096497|FG002|Overall Study|Withdrawal by Subject|1|||
16953271|NCT01218477|38096498|FG003|Overall Study|Withdrawal by Subject|0|||
16953272|NCT01218477|38096495|FG000|Overall Study|Prepared for cell transplantation|0|||
16953273|NCT01218477|38096496|FG001|Overall Study|Prepared for cell transplantation|1|||
16953274|NCT01218477|38096497|FG002|Overall Study|Prepared for cell transplantation|1|||
16953275|NCT01218477|38096498|FG003|Overall Study|Prepared for cell transplantation|0|||
16953276|NCT01218477|38096495|FG000|Overall Study|Administrative reason by sponsor|0|||
16953277|NCT01218477|38096496|FG001|Overall Study|Administrative reason by sponsor|0|||
16953278|NCT01218477|38096497|FG002|Overall Study|Administrative reason by sponsor|1|||
16953279|NCT01218477|38096498|FG003|Overall Study|Administrative reason by sponsor|0|||
16953280|NCT01218477|38096495|FG000|Overall Study|Maximum clinical benefit|0|||
17128164|NCT02794480|38269030|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
17128165|NCT02794480|38269027|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
17128166|NCT02794480|38269028|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
17128167|NCT02794480|38269029|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
17128168|NCT02794480|38269030|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
17128169|NCT02794480|38269027|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
17128170|NCT02794480|38269028|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
17128171|NCT02794480|38269029|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
17128172|NCT02794480|38269030|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
17128173|NCT02794480|38269027|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
17128174|NCT02794480|38269028|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
17128175|NCT02794480|38269029|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
17128176|NCT02794480|38269030|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
17128177|NCT02794480|38269027|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
17128178|NCT02794480|38269028|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
17128179|NCT02794480|38269029|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
17128180|NCT02794480|38269030|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
17128181|NCT04558125|38269038|FG000|Overall Study|Death|1|||
17128182|NCT02793622|38269044|FG000|Overall Study|Lost to Follow-up|31|||
17128183|NCT02793622|38269045|FG001|Overall Study|Lost to Follow-up|19|||
17128184|NCT02793622|38269044|FG000|Overall Study|Withdrawal by Subject|21|||
17128185|NCT02793622|38269045|FG001|Overall Study|Withdrawal by Subject|17|||
17128186|NCT02793622|38269044|FG000|Overall Study|Adverse Event|0|||
16953281|NCT01218477|38096496|FG001|Overall Study|Maximum clinical benefit|2|||
16953282|NCT01218477|38096497|FG002|Overall Study|Maximum clinical benefit|0|||
16953283|NCT01218477|38096498|FG003|Overall Study|Maximum clinical benefit|0|||
16953284|NCT01218243|38096514|FG000|Overall Study|Lack of Efficacy|1|||
16953285|NCT01218243|38096515|FG001|Overall Study|Lack of Efficacy|1|||
16953286|NCT01218243|38096514|FG000|Overall Study|Lost to Follow-up|3|||
16953287|NCT01218243|38096515|FG001|Overall Study|Lost to Follow-up|3|||
16953288|NCT01218243|38096514|FG000|Overall Study|Protocol Violation|5|||
16953289|NCT01218243|38096515|FG001|Overall Study|Protocol Violation|10|||
16953290|NCT00989287|38096523|FG000|Overall Study|Adverse Event|1|||
16953291|NCT00989287|38096524|FG001|Overall Study|Adverse Event|0|||
16953292|NCT00989287|38096523|FG000|Overall Study|Lost to Follow-up|0|||
16953293|NCT00989287|38096524|FG001|Overall Study|Lost to Follow-up|1|||
16953294|NCT01218087|38096545|FG000|Overall Study|Death|2|||
16953295|NCT01218087|38096546|FG001|Overall Study|Death|1|||
16953296|NCT01218087|38096545|FG000|Overall Study|Withdrawal by Subject|5|||
16953297|NCT01218087|38096546|FG001|Overall Study|Withdrawal by Subject|0|||
16953298|NCT01218087|38096545|FG000|Overall Study|Transferred|8|||
16953299|NCT01218087|38096546|FG001|Overall Study|Transferred|5|||
16953300|NCT01218009|38096554|FG000|Overall Study|Protocol Violation|2|||
16953301|NCT01218009|38096555|FG001|Overall Study|Protocol Violation|1|||
16953302|NCT01218009|38096554|FG000|Overall Study|Withdrawal by Subject|3|||
16953303|NCT01218009|38096555|FG001|Overall Study|Withdrawal by Subject|1|||
16953304|NCT01218009|38096554|FG000|Overall Study|Sponsor terminated study|161|||
16953305|NCT01218009|38096555|FG001|Overall Study|Sponsor terminated study|163|||
16953306|NCT00992017|38096561|FG000|Overall Study|Lost to Follow-up|2|||
16953307|NCT00992017|38096561|FG000|Overall Study|Withdrawal by Subject|2|||
16953308|NCT00992017|38096561|FG000|Overall Study|Unable to get to clinic|5|||
16953309|NCT00992017|38096561|FG000|Overall Study|Not adhere to study requirements|1|||
16953310|NCT01217463|38096572|FG000|Overall Study|Adverse Event|8|||
16953311|NCT01217463|38096573|FG001|Overall Study|Adverse Event|5|||
16953312|NCT01217463|38096572|FG000|Overall Study|Physician Decision|0|||
16953313|NCT01217463|38096573|FG001|Overall Study|Physician Decision|1|||
16953314|NCT01217463|38096572|FG000|Overall Study|Withdrawal by Subject|3|||
16953315|NCT01217463|38096573|FG001|Overall Study|Withdrawal by Subject|0|||
16953316|NCT01217463|38096572|FG000|Overall Study|Surgery on the Target Limb|0|||
16953317|NCT01217463|38096573|FG001|Overall Study|Surgery on the Target Limb|1|||
16953318|NCT01217463|38096572|FG000|Overall Study|Patient Non-compliant|1|||
16953319|NCT01217463|38096573|FG001|Overall Study|Patient Non-compliant|0|||
16953320|NCT01217463|38096572|FG000|Overall Study|Other|1|||
16953321|NCT01217463|38096573|FG001|Overall Study|Other|1|||
16953322|NCT01217307|38096583|FG000|Overall Study|Withdrawal by Subject|0|||
16953323|NCT01217307|38096584|FG001|Overall Study|Withdrawal by Subject|1|||
16953324|NCT01217229|38096590|FG000|Overall Study|Adverse Event|1|||
16953325|NCT01217229|38096590|FG000|Overall Study|Disease progression, deterioration|2|||
16953326|NCT01217229|38096590|FG000|Overall Study|Disease progression, Cheson criteria|14|||
16953327|NCT01217229|38096590|FG000|Overall Study|Protocol Violation|1|||
16953328|NCT01217229|38096590|FG000|Overall Study|Disease progression not confirmed|2|||
16953329|NCT01013740|38096596|FG000|Overall Study|Lost to Follow-up|3|||
16953330|NCT01013740|38096597|FG001|Overall Study|Lost to Follow-up|5|||
16953331|NCT01013740|38096596|FG000|Overall Study|Physician Decision|2|||
16953332|NCT01013740|38096597|FG001|Overall Study|Physician Decision|0|||
16953333|NCT01013740|38096596|FG000|Overall Study|Withdrawal by Subject|2|||
16953334|NCT01013740|38096597|FG001|Overall Study|Withdrawal by Subject|10|||
16953335|NCT01013740|38096596|FG000|Overall Study|study close / terminated : done in error|2|||
16953336|NCT01013740|38096597|FG001|Overall Study|study close / terminated : done in error|1|||
16953337|NCT01013740|38096596|FG000|Overall Study|Missing|2|||
16953338|NCT01013740|38096597|FG001|Overall Study|Missing|1|||
16953339|NCT01013740|38096596|FG000|Overall Study|Ongoing: Study records not completed|0|||
16953340|NCT01013740|38096597|FG001|Overall Study|Ongoing: Study records not completed|2|||
16953341|NCT01013350|38096607|FG000|Overall Study|Lost to Follow-up|15|||
16953342|NCT01013350|38096608|FG001|Overall Study|Lost to Follow-up|95|||
16953343|NCT01013350|38096607|FG000|Overall Study|Adverse Event|0|||
16953344|NCT01013350|38096608|FG001|Overall Study|Adverse Event|1|||
16953345|NCT01013350|38096607|FG000|Overall Study|Physician Decision|4|||
16953346|NCT01013350|38096608|FG001|Overall Study|Physician Decision|20|||
16953347|NCT01013350|38096607|FG000|Overall Study|Withdrawal by Subject|15|||
16953348|NCT01013350|38096608|FG001|Overall Study|Withdrawal by Subject|38|||
16953349|NCT01013350|38096607|FG000|Overall Study|Death|3|||
16953350|NCT01013350|38096608|FG001|Overall Study|Death|5|||
16953351|NCT01013350|38096607|FG000|Overall Study|Participant entered interventional study|0|||
16953352|NCT01013350|38096608|FG001|Overall Study|Participant entered interventional study|8|||
16953353|NCT01013350|38096607|FG000|Overall Study|Other|1|||
16953354|NCT01013350|38096608|FG001|Overall Study|Other|25|||
16953355|NCT01018030|38096618|FG000|Overall Study|Adverse Event|10|||
16953356|NCT01018030|38096619|FG001|Overall Study|Adverse Event|5|||
16953357|NCT01018030|38096620|FG002|Overall Study|Adverse Event|5|||
16953358|NCT01018030|38096618|FG000|Overall Study|Withdrawal by Subject|2|||
16953359|NCT01018030|38096619|FG001|Overall Study|Withdrawal by Subject|2|||
16953360|NCT01018030|38096620|FG002|Overall Study|Withdrawal by Subject|4|||
16953361|NCT01018030|38096618|FG000|Overall Study|Lost to Follow-up|2|||
16953362|NCT01018030|38096619|FG001|Overall Study|Lost to Follow-up|0|||
16953363|NCT01018030|38096620|FG002|Overall Study|Lost to Follow-up|3|||
16953364|NCT01018030|38096618|FG000|Overall Study|Protocol Violation|2|||
16953365|NCT01018030|38096619|FG001|Overall Study|Protocol Violation|1|||
16953366|NCT01018030|38096620|FG002|Overall Study|Protocol Violation|0|||
16953367|NCT01018030|38096618|FG000|Overall Study|Physician Decision|1|||
16953368|NCT01018030|38096619|FG001|Overall Study|Physician Decision|0|||
16953369|NCT01018030|38096620|FG002|Overall Study|Physician Decision|1|||
16953370|NCT01018030|38096618|FG000|Overall Study|Lack of Efficacy|1|||
16953371|NCT01018030|38096619|FG001|Overall Study|Lack of Efficacy|0|||
16953372|NCT01018030|38096620|FG002|Overall Study|Lack of Efficacy|0|||
16953373|NCT01018030|38096618|FG000|Overall Study|Did Not Receive Study Drug|1|||
16953374|NCT01018030|38096619|FG001|Overall Study|Did Not Receive Study Drug|3|||
16953375|NCT01018030|38096620|FG002|Overall Study|Did Not Receive Study Drug|0|||
16953376|NCT01217073|38096636|FG000|Base Period|Adverse Event|1|||
16953377|NCT01217073|38096637|FG001|Base Period|Adverse Event|0|||
16953378|NCT01217073|38096638|FG002|Base Period|Adverse Event|1|||
16953379|NCT01217073|38096639|FG003|Base Period|Adverse Event|0|||
16953380|NCT01217073|38096640|FG004|Base Period|Adverse Event|4|||
16953381|NCT01217073|38096641|FG005|Base Period|Adverse Event|1|||
16953382|NCT01217073|38096642|FG006|Base Period|Adverse Event|0|||
16953383|NCT01217073|38096643|FG007|Base Period|Adverse Event|0|||
16953384|NCT01217073|38096636|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
16953385|NCT01217073|38096637|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16953386|NCT01217073|38096638|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16953387|NCT01217073|38096639|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16953388|NCT01217073|38096640|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16953389|NCT01217073|38096641|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16953390|NCT01217073|38096642|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16953391|NCT01217073|38096643|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16953392|NCT01217073|38096636|FG000|Base Period|Excluded medication|0|||
16953393|NCT01217073|38096637|FG001|Base Period|Excluded medication|0|||
16953394|NCT01217073|38096638|FG002|Base Period|Excluded medication|0|||
16953395|NCT01217073|38096639|FG003|Base Period|Excluded medication|0|||
16953396|NCT01217073|38096640|FG004|Base Period|Excluded medication|1|||
16953397|NCT01217073|38096641|FG005|Base Period|Excluded medication|0|||
16953398|NCT01217073|38096642|FG006|Base Period|Excluded medication|0|||
16953399|NCT01217073|38096643|FG007|Base Period|Excluded medication|0|||
16953400|NCT01217073|38096636|FG000|Base Period|Lack of Efficacy|0|||
16953401|NCT01217073|38096637|FG001|Base Period|Lack of Efficacy|0|||
16953402|NCT01217073|38096638|FG002|Base Period|Lack of Efficacy|0|||
16953403|NCT01217073|38096639|FG003|Base Period|Lack of Efficacy|0|||
16953404|NCT01217073|38096640|FG004|Base Period|Lack of Efficacy|0|||
16953405|NCT01217073|38096641|FG005|Base Period|Lack of Efficacy|1|||
16953406|NCT01217073|38096642|FG006|Base Period|Lack of Efficacy|0|||
16953407|NCT01217073|38096643|FG007|Base Period|Lack of Efficacy|0|||
16953408|NCT01217073|38096636|FG000|Base Period|Lost to Follow-up|0|||
16953409|NCT01217073|38096637|FG001|Base Period|Lost to Follow-up|0|||
16953410|NCT01217073|38096638|FG002|Base Period|Lost to Follow-up|1|||
16953411|NCT01217073|38096639|FG003|Base Period|Lost to Follow-up|1|||
16953412|NCT01217073|38096640|FG004|Base Period|Lost to Follow-up|3|||
16953413|NCT01217073|38096641|FG005|Base Period|Lost to Follow-up|0|||
16953414|NCT01217073|38096642|FG006|Base Period|Lost to Follow-up|0|||
16953415|NCT01217073|38096643|FG007|Base Period|Lost to Follow-up|0|||
16953416|NCT01217073|38096636|FG000|Base Period|Physician Decision|0|||
16953417|NCT01217073|38096637|FG001|Base Period|Physician Decision|0|||
16953418|NCT01217073|38096638|FG002|Base Period|Physician Decision|0|||
16953419|NCT01217073|38096639|FG003|Base Period|Physician Decision|0|||
16953420|NCT01217073|38096640|FG004|Base Period|Physician Decision|1|||
16953421|NCT01217073|38096641|FG005|Base Period|Physician Decision|0|||
16953422|NCT01217073|38096642|FG006|Base Period|Physician Decision|0|||
16953423|NCT01217073|38096643|FG007|Base Period|Physician Decision|0|||
17128187|NCT02793622|38269045|FG001|Overall Study|Adverse Event|1|||
17128188|NCT02793622|38269044|FG000|Overall Study|Protocol Violation|1|||
17128189|NCT02793622|38269045|FG001|Overall Study|Protocol Violation|5|||
17128190|NCT04493931|38269058|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
17128191|NCT04493931|38269059|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
17128192|NCT04493931|38269060|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
17128193|NCT04493931|38269061|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
17128194|NCT04493931|38269062|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
17128195|NCT04493931|38269063|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
17128196|NCT04493931|38269064|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
17128197|NCT04493931|38269058|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
17128198|NCT04493931|38269059|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
17128199|NCT04493931|38269060|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
17128200|NCT04493931|38269061|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
17128201|NCT04493931|38269062|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
17128202|NCT04493931|38269063|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
17128203|NCT04493931|38269064|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
17128204|NCT04493931|38269058|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
17128205|NCT04493931|38269059|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
17128206|NCT04493931|38269060|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
17128207|NCT04493931|38269061|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
17128208|NCT04493931|38269062|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
17128209|NCT04493931|38269063|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
17128210|NCT04493931|38269064|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
17128211|NCT04493931|38269058|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
17128212|NCT04493931|38269059|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
17128213|NCT04493931|38269060|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
17128214|NCT04493931|38269061|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
17128215|NCT04493931|38269062|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
17128216|NCT04493931|38269063|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
17128217|NCT04493931|38269064|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
17128218|NCT03437278|38269097|FG000|Overall Study|Adverse Event|0|||
17128219|NCT03437278|38269098|FG001|Overall Study|Adverse Event|0|||
17128220|NCT03437278|38269099|FG002|Overall Study|Adverse Event|1|||
17128221|NCT03437278|38269097|FG000|Overall Study|Progressive disease|1|||
17128222|NCT03437278|38269098|FG001|Overall Study|Progressive disease|0|||
17128223|NCT03437278|38269099|FG002|Overall Study|Progressive disease|0|||
17128224|NCT03437278|38269097|FG000|Overall Study|Physician Decision|1|||
17128225|NCT03437278|38269098|FG001|Overall Study|Physician Decision|0|||
17128226|NCT03437278|38269099|FG002|Overall Study|Physician Decision|1|||
17128227|NCT04553913|38269109|FG000|Overall Study|patient's block resolved prior to PACU|1|||
17128228|NCT04553913|38269109|FG000|Overall Study|did not use the device properly|5|||
17128229|NCT04490499|38269114|FG000|Overall Study|Withdrawal by Subject|2|||
17128230|NCT01332994|38269118|FG000|Overall Study|Adverse Event|34|||
17128231|NCT01332994|38269118|FG000|Overall Study|Death|1|||
17128232|NCT01332994|38269118|FG000|Overall Study|Lack of Efficacy|1|||
16953424|NCT01217073|38096636|FG000|Base Period|Protocol Violation|1|||
16953425|NCT01217073|38096637|FG001|Base Period|Protocol Violation|0|||
16953426|NCT01217073|38096638|FG002|Base Period|Protocol Violation|0|||
16953427|NCT01217073|38096639|FG003|Base Period|Protocol Violation|0|||
16953428|NCT01217073|38096640|FG004|Base Period|Protocol Violation|1|||
16953429|NCT01217073|38096641|FG005|Base Period|Protocol Violation|2|||
17128233|NCT01332994|38269118|FG000|Overall Study|Lost to Follow-up|4|||
17128234|NCT01332994|38269118|FG000|Overall Study|Protocol Violation|6|||
17128235|NCT01332994|38269118|FG000|Overall Study|Withdrawal by Subject|15|||
17128236|NCT01332994|38269118|FG000|Overall Study|Administrative Problem|2|||
17128237|NCT01332994|38269118|FG000|Overall Study|Other|8|||
17128238|NCT03698331|38269124|FG000|Overall Study|Adverse Event|2|||
17128239|NCT03698331|38269125|FG001|Overall Study|Adverse Event|3|||
17128240|NCT03698331|38269124|FG000|Overall Study|Withdrawal by Subject|1|||
17128241|NCT03698331|38269125|FG001|Overall Study|Withdrawal by Subject|1|||
17128242|NCT03698331|38269124|FG000|Overall Study|Lost to Follow-up|0|||
17128243|NCT03698331|38269125|FG001|Overall Study|Lost to Follow-up|2|||
17128244|NCT03698331|38269124|FG000|Overall Study|Non-compliance with study drug|1|||
17128245|NCT03698331|38269125|FG001|Overall Study|Non-compliance with study drug|0|||
17128246|NCT04889625|38269131|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
17128247|NCT04889625|38269132|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
17128248|NCT04889625|38269131|FG000|Period 1|Subject out of window|0|||
17128249|NCT04889625|38269132|FG001|Period 1|Subject out of window|1|||
17128250|NCT04889625|38269131|FG000|Period 1|Wrong add power dispensed|0|||
16953430|NCT01217073|38096642|FG006|Base Period|Protocol Violation|0|||
16953431|NCT01217073|38096643|FG007|Base Period|Protocol Violation|0|||
16953432|NCT01217073|38096636|FG000|Base Period|Withdrawal by Subject|4|||
16953433|NCT01217073|38096637|FG001|Base Period|Withdrawal by Subject|5|||
16953434|NCT01217073|38096638|FG002|Base Period|Withdrawal by Subject|5|||
16953435|NCT01217073|38096639|FG003|Base Period|Withdrawal by Subject|1|||
16953436|NCT01217073|38096640|FG004|Base Period|Withdrawal by Subject|5|||
16953437|NCT01217073|38096641|FG005|Base Period|Withdrawal by Subject|5|||
16953438|NCT01217073|38096642|FG006|Base Period|Withdrawal by Subject|0|||
16953439|NCT01217073|38096643|FG007|Base Period|Withdrawal by Subject|0|||
16953440|NCT01217073|38096636|FG000|Extension Period|Adverse Event|0|||
16953441|NCT01217073|38096637|FG001|Extension Period|Adverse Event|0|||
16953442|NCT01217073|38096638|FG002|Extension Period|Adverse Event|0|||
16953443|NCT01217073|38096639|FG003|Extension Period|Adverse Event|0|||
16953444|NCT01217073|38096640|FG004|Extension Period|Adverse Event|0|||
16953445|NCT01217073|38096641|FG005|Extension Period|Adverse Event|0|||
16953446|NCT01217073|38096642|FG006|Extension Period|Adverse Event|19|||
16953447|NCT01217073|38096643|FG007|Extension Period|Adverse Event|5|||
16953448|NCT01217073|38096636|FG000|Extension Period|ALT/AST|0|||
16953449|NCT01217073|38096637|FG001|Extension Period|ALT/AST|0|||
16953450|NCT01217073|38096638|FG002|Extension Period|ALT/AST|0|||
16953451|NCT01217073|38096639|FG003|Extension Period|ALT/AST|0|||
16953452|NCT01217073|38096640|FG004|Extension Period|ALT/AST|0|||
16953453|NCT01217073|38096641|FG005|Extension Period|ALT/AST|0|||
16953454|NCT01217073|38096642|FG006|Extension Period|ALT/AST|2|||
16953455|NCT01217073|38096643|FG007|Extension Period|ALT/AST|0|||
16953456|NCT01217073|38096636|FG000|Extension Period|Contraindication to study medication|0|||
16953457|NCT01217073|38096637|FG001|Extension Period|Contraindication to study medication|0|||
16953458|NCT01217073|38096638|FG002|Extension Period|Contraindication to study medication|0|||
16953459|NCT01217073|38096639|FG003|Extension Period|Contraindication to study medication|0|||
17128251|NCT04889625|38269132|FG001|Period 1|Wrong add power dispensed|1|||
17128252|NCT04889625|38269131|FG000|Period 1|Discontinued due to fitting guide error|1|||
17128253|NCT04889625|38269132|FG001|Period 1|Discontinued due to fitting guide error|1|||
17128254|NCT04889625|38269131|FG000|Period 2|Test article no longer available|1|||
16953460|NCT01217073|38096640|FG004|Extension Period|Contraindication to study medication|0|||
16953461|NCT01217073|38096641|FG005|Extension Period|Contraindication to study medication|0|||
16953462|NCT01217073|38096642|FG006|Extension Period|Contraindication to study medication|1|||
16953463|NCT01217073|38096643|FG007|Extension Period|Contraindication to study medication|0|||
16953464|NCT01217073|38096636|FG000|Extension Period|Creatinine/eGFR|0|||
16953465|NCT01217073|38096637|FG001|Extension Period|Creatinine/eGFR|0|||
16953466|NCT01217073|38096638|FG002|Extension Period|Creatinine/eGFR|0|||
16953467|NCT01217073|38096639|FG003|Extension Period|Creatinine/eGFR|0|||
16953468|NCT01217073|38096640|FG004|Extension Period|Creatinine/eGFR|0|||
16953469|NCT01217073|38096641|FG005|Extension Period|Creatinine/eGFR|0|||
16953470|NCT01217073|38096642|FG006|Extension Period|Creatinine/eGFR|11|||
16953471|NCT01217073|38096643|FG007|Extension Period|Creatinine/eGFR|1|||
16953472|NCT01217073|38096636|FG000|Extension Period|Death|0|||
16953473|NCT01217073|38096637|FG001|Extension Period|Death|0|||
16953474|NCT01217073|38096638|FG002|Extension Period|Death|0|||
16953475|NCT01217073|38096639|FG003|Extension Period|Death|0|||
16953476|NCT01217073|38096640|FG004|Extension Period|Death|0|||
16953477|NCT01217073|38096641|FG005|Extension Period|Death|0|||
16953478|NCT01217073|38096642|FG006|Extension Period|Death|1|||
16953479|NCT01217073|38096643|FG007|Extension Period|Death|0|||
16953480|NCT01217073|38096636|FG000|Extension Period|Excluded medication|0|||
16953481|NCT01217073|38096637|FG001|Extension Period|Excluded medication|0|||
16953482|NCT01217073|38096638|FG002|Extension Period|Excluded medication|0|||
16953483|NCT01217073|38096639|FG003|Extension Period|Excluded medication|0|||
16953484|NCT01217073|38096640|FG004|Extension Period|Excluded medication|0|||
16953485|NCT01217073|38096641|FG005|Extension Period|Excluded medication|0|||
16953486|NCT01217073|38096642|FG006|Extension Period|Excluded medication|2|||
16953487|NCT01217073|38096643|FG007|Extension Period|Excluded medication|0|||
16953488|NCT01217073|38096636|FG000|Extension Period|Lack of Efficacy|0|||
16953489|NCT01217073|38096637|FG001|Extension Period|Lack of Efficacy|0|||
16953490|NCT01217073|38096638|FG002|Extension Period|Lack of Efficacy|0|||
17128255|NCT04889625|38269132|FG001|Period 2|Test article no longer available|0|||
17128256|NCT04889625|38269131|FG000|Period 2|Incorrect lens dispensed|1|||
17128257|NCT04889625|38269132|FG001|Period 2|Incorrect lens dispensed|0|||
17128258|NCT04889625|38269131|FG000|Period 2|Wrong add power dispensed|0|||
17128259|NCT04889625|38269132|FG001|Period 2|Wrong add power dispensed|1|||
17128260|NCT04883541|38269140|FG000|Overall Study|Not attending regular yoga class|16|||
17128261|NCT04883541|38269141|FG001|Overall Study|Not attending regular yoga class|0|||
17128262|NCT04883541|38269140|FG000|Overall Study|Not attending the pregnancy school|0|||
17128263|NCT04883541|38269141|FG001|Overall Study|Not attending the pregnancy school|9|||
17128264|NCT04882995|38269149|FG000|Overall Study|Withdrawal by Subject|1|||
17128265|NCT04882995|38269150|FG001|Overall Study|Withdrawal by Subject|2|||
17128266|NCT04882995|38269149|FG000|Overall Study|Protocol Violation|4|||
17128267|NCT04882995|38269150|FG001|Overall Study|Protocol Violation|4|||
17128268|NCT04882995|38269149|FG000|Overall Study|Surgery postponed due to COVID|1|||
17128269|NCT04882995|38269150|FG001|Overall Study|Surgery postponed due to COVID|1|||
17128270|NCT04483011|38269158|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
17128271|NCT04483011|38269159|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
17128272|NCT04545567|38269169|FG000|Overall Study|tested positive for SARS-co-V2|1|||
16953491|NCT01217073|38096639|FG003|Extension Period|Lack of Efficacy|0|||
16953492|NCT01217073|38096640|FG004|Extension Period|Lack of Efficacy|0|||
16953493|NCT01217073|38096641|FG005|Extension Period|Lack of Efficacy|0|||
16953494|NCT01217073|38096642|FG006|Extension Period|Lack of Efficacy|3|||
16953495|NCT01217073|38096643|FG007|Extension Period|Lack of Efficacy|0|||
16953496|NCT01217073|38096636|FG000|Extension Period|Lost to Follow-up|0|||
17128273|NCT04545567|38269170|FG001|Overall Study|tested positive for SARS-co-V2|1|||
17128274|NCT04545567|38269169|FG000|Overall Study|Withdrawal by Subject|0|||
17128275|NCT04545567|38269170|FG001|Overall Study|Withdrawal by Subject|1|||
17128276|NCT04534491|38269176|FG000|Overall Study|Not completed end-of-study interview|24|||
17128277|NCT04534491|38269176|FG000|Overall Study|Non-users|70|||
17128278|NCT04534491|38269176|FG000|Overall Study|Non-verifiable users|58|||
17128279|NCT03694821|38269183|FG000|Overall Study|Study terminated|4|||
17128280|NCT03694821|38269184|FG001|Overall Study|Study terminated|8|||
17128281|NCT03694821|38269185|FG002|Overall Study|Study terminated|4|||
17128282|NCT04531527|38269193|FG000|Overall Study|Found to be Ineligible|3|||
17128283|NCT04474197|38269201|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
17128284|NCT04474197|38269202|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
17128285|NCT04474197|38269203|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
17128286|NCT04474197|38269204|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
17128287|NCT02079766|38269221|FG000|Overall Study|Physician Decision|1|||
17128288|NCT02079766|38269222|FG001|Overall Study|Physician Decision|0|||
17128289|NCT02079766|38269221|FG000|Overall Study|Withdrawal by Subject|1|||
17128290|NCT02079766|38269222|FG001|Overall Study|Withdrawal by Subject|0|||
17128291|NCT04841577|38269230|FG000|Overall Study|Adverse Event|5|||
17128292|NCT04841577|38269231|FG001|Overall Study|Adverse Event|10|||
17128293|NCT04841577|38269230|FG000|Overall Study|Lost to Follow-up|8|||
17128294|NCT04841577|38269231|FG001|Overall Study|Lost to Follow-up|7|||
17128295|NCT04841577|38269230|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
17128296|NCT04841577|38269231|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
16953497|NCT01217073|38096637|FG001|Extension Period|Lost to Follow-up|0|||
16953498|NCT01217073|38096638|FG002|Extension Period|Lost to Follow-up|0|||
16953499|NCT01217073|38096639|FG003|Extension Period|Lost to Follow-up|0|||
16953500|NCT01217073|38096640|FG004|Extension Period|Lost to Follow-up|0|||
16953501|NCT01217073|38096641|FG005|Extension Period|Lost to Follow-up|0|||
16953502|NCT01217073|38096642|FG006|Extension Period|Lost to Follow-up|9|||
16953503|NCT01217073|38096643|FG007|Extension Period|Lost to Follow-up|1|||
16953504|NCT01217073|38096636|FG000|Extension Period|Non-compliance with study drug|0|||
16953505|NCT01217073|38096637|FG001|Extension Period|Non-compliance with study drug|0|||
16953506|NCT01217073|38096638|FG002|Extension Period|Non-compliance with study drug|0|||
16953507|NCT01217073|38096639|FG003|Extension Period|Non-compliance with study drug|0|||
16953508|NCT01217073|38096640|FG004|Extension Period|Non-compliance with study drug|0|||
16953509|NCT01217073|38096641|FG005|Extension Period|Non-compliance with study drug|0|||
16953510|NCT01217073|38096642|FG006|Extension Period|Non-compliance with study drug|0|||
16953511|NCT01217073|38096643|FG007|Extension Period|Non-compliance with study drug|1|||
16953512|NCT01217073|38096636|FG000|Extension Period|Physician Decision|0|||
16953513|NCT01217073|38096637|FG001|Extension Period|Physician Decision|0|||
16953514|NCT01217073|38096638|FG002|Extension Period|Physician Decision|0|||
16953515|NCT01217073|38096639|FG003|Extension Period|Physician Decision|0|||
16953516|NCT01217073|38096640|FG004|Extension Period|Physician Decision|0|||
16953517|NCT01217073|38096641|FG005|Extension Period|Physician Decision|0|||
16953518|NCT01217073|38096642|FG006|Extension Period|Physician Decision|4|||
16953519|NCT01217073|38096643|FG007|Extension Period|Physician Decision|1|||
16953520|NCT01217073|38096636|FG000|Extension Period|Protocol Violation|0|||
16953521|NCT01217073|38096637|FG001|Extension Period|Protocol Violation|0|||
16953522|NCT01217073|38096638|FG002|Extension Period|Protocol Violation|0|||
16953523|NCT01217073|38096639|FG003|Extension Period|Protocol Violation|0|||
17128297|NCT04841577|38269230|FG000|Overall Study|Other|0|||
16953524|NCT01217073|38096640|FG004|Extension Period|Protocol Violation|0|||
16774341|NCT02133508|37713625|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
16774342|NCT02133508|37713625|FG000|Overall Study|Death|12|||
16953525|NCT01217073|38096641|FG005|Extension Period|Protocol Violation|0|||
16953526|NCT01217073|38096642|FG006|Extension Period|Protocol Violation|2|||
17128298|NCT04841577|38269231|FG001|Overall Study|Other|1|||
17128299|NCT04529109|38269237|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
16774343|NCT02133508|37713625|FG000|Overall Study|Lost to Follow-up|2|||
16953527|NCT01217073|38096643|FG007|Extension Period|Protocol Violation|1|||
16953528|NCT01217073|38096636|FG000|Extension Period|Site discontinued study participation|0|||
16953529|NCT01217073|38096637|FG001|Extension Period|Site discontinued study participation|0|||
17128300|NCT04529109|38269238|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
17128301|NCT04528641|38269250|FG000|Overall Study|Withdrawal by Subject|0|||
17128302|NCT04528641|38269251|FG001|Overall Study|Withdrawal by Subject|0|||
17128303|NCT04528641|38269252|FG002|Overall Study|Withdrawal by Subject|0|||
17128304|NCT04528641|38269253|FG003|Overall Study|Withdrawal by Subject|1|||
16953530|NCT01217073|38096638|FG002|Extension Period|Site discontinued study participation|0|||
16953531|NCT01217073|38096639|FG003|Extension Period|Site discontinued study participation|0|||
16953532|NCT01217073|38096640|FG004|Extension Period|Site discontinued study participation|0|||
16953533|NCT01217073|38096641|FG005|Extension Period|Site discontinued study participation|0|||
16953534|NCT01217073|38096642|FG006|Extension Period|Site discontinued study participation|7|||
16953535|NCT01217073|38096643|FG007|Extension Period|Site discontinued study participation|2|||
16953536|NCT01217073|38096636|FG000|Extension Period|Withdrawal by Subject|0|||
16953537|NCT01217073|38096637|FG001|Extension Period|Withdrawal by Subject|0|||
16953538|NCT01217073|38096638|FG002|Extension Period|Withdrawal by Subject|0|||
16953539|NCT01217073|38096639|FG003|Extension Period|Withdrawal by Subject|0|||
16953540|NCT01217073|38096640|FG004|Extension Period|Withdrawal by Subject|0|||
16953541|NCT01217073|38096641|FG005|Extension Period|Withdrawal by Subject|0|||
16953542|NCT01217073|38096642|FG006|Extension Period|Withdrawal by Subject|30|||
16953543|NCT01217073|38096643|FG007|Extension Period|Withdrawal by Subject|8|||
16953544|NCT00985621|38096671|FG000|Overall Study|Adverse Event|2|||
16953545|NCT00985621|38096672|FG001|Overall Study|Adverse Event|3|||
16953546|NCT00985621|38096673|FG002|Overall Study|Adverse Event|4|||
16953547|NCT00985621|38096674|FG003|Overall Study|Adverse Event|16|||
16953548|NCT00985621|38096671|FG000|Overall Study|Lack of Efficacy|10|||
16953549|NCT00985621|38096672|FG001|Overall Study|Lack of Efficacy|6|||
16953550|NCT00985621|38096673|FG002|Overall Study|Lack of Efficacy|5|||
16953551|NCT00985621|38096674|FG003|Overall Study|Lack of Efficacy|12|||
16953552|NCT00985621|38096671|FG000|Overall Study|Lost to Follow-up|2|||
16953553|NCT00985621|38096672|FG001|Overall Study|Lost to Follow-up|3|||
16953554|NCT00985621|38096673|FG002|Overall Study|Lost to Follow-up|4|||
16953555|NCT00985621|38096674|FG003|Overall Study|Lost to Follow-up|4|||
16953556|NCT00985621|38096671|FG000|Overall Study|Study Terminated by Sponsor|89|||
16953557|NCT00985621|38096672|FG001|Overall Study|Study Terminated by Sponsor|108|||
16953558|NCT00985621|38096673|FG002|Overall Study|Study Terminated by Sponsor|99|||
16953559|NCT00985621|38096674|FG003|Overall Study|Study Terminated by Sponsor|92|||
16953560|NCT00985621|38096671|FG000|Overall Study|Protocol Violation|1|||
16953561|NCT00985621|38096672|FG001|Overall Study|Protocol Violation|1|||
16953562|NCT00985621|38096673|FG002|Overall Study|Protocol Violation|1|||
16953563|NCT00985621|38096674|FG003|Overall Study|Protocol Violation|0|||
16953564|NCT00985621|38096671|FG000|Overall Study|Withdrawal by Subject|8|||
16953565|NCT00985621|38096672|FG001|Overall Study|Withdrawal by Subject|10|||
16953566|NCT00985621|38096673|FG002|Overall Study|Withdrawal by Subject|8|||
16953567|NCT00985621|38096674|FG003|Overall Study|Withdrawal by Subject|12|||
16953568|NCT00985621|38096671|FG000|Overall Study|Other|1|||
16953569|NCT00985621|38096672|FG001|Overall Study|Other|0|||
16953570|NCT00985621|38096673|FG002|Overall Study|Other|0|||
16953571|NCT00985621|38096674|FG003|Overall Study|Other|0|||
16953572|NCT00985621|38096671|FG000|Overall Study|Randomized but not Treated|1|||
16953573|NCT00985621|38096672|FG001|Overall Study|Randomized but not Treated|0|||
16953574|NCT00985621|38096673|FG002|Overall Study|Randomized but not Treated|2|||
16953575|NCT00985621|38096674|FG003|Overall Study|Randomized but not Treated|1|||
16953576|NCT01215981|38096688|FG000|Overall Study|Physician Decision|0|||
17128305|NCT04528641|38269254|FG004|Overall Study|Withdrawal by Subject|0|||
16953577|NCT01215981|38096689|FG001|Overall Study|Physician Decision|1|||
16953578|NCT01215981|38096688|FG000|Overall Study|Protocol Violation|1|||
16953579|NCT01215981|38096689|FG001|Overall Study|Protocol Violation|0|||
16953580|NCT01215981|38096688|FG000|Overall Study|Withdrawal by Subject|1|||
16953581|NCT01215981|38096689|FG001|Overall Study|Withdrawal by Subject|0|||
16953582|NCT01215513|38096695|FG000|Overall Study|Not completed CS42|9|||
16953583|NCT01215513|38096695|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
16953584|NCT01215513|38096695|FG000|Overall Study|Adverse event (CS42A)|2|||
16953585|NCT01215513|38096695|FG000|Overall Study|Physician decision (CS42A)|6|||
16953586|NCT01215513|38096695|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
16953587|NCT01215513|38096695|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
16953588|NCT01215435|38096702|FG000|Overall Study|Adverse Event|1|||
16953589|NCT01215435|38096703|FG001|Overall Study|Adverse Event|0|||
16953590|NCT01215435|38096702|FG000|Overall Study|Protocol Violation|2|||
16953591|NCT01215435|38096703|FG001|Overall Study|Protocol Violation|0|||
16953592|NCT01215435|38096702|FG000|Overall Study|Withdrawal Criteria|8|||
16953593|NCT01215435|38096703|FG001|Overall Study|Withdrawal Criteria|11|||
16953594|NCT01215435|38096702|FG000|Overall Study|Lost to Follow-up|3|||
16953595|NCT01215435|38096703|FG001|Overall Study|Lost to Follow-up|0|||
16953596|NCT01215435|38096702|FG000|Overall Study|Unclassified|5|||
16953597|NCT01215435|38096703|FG001|Overall Study|Unclassified|5|||
16953598|NCT01215357|38096709|FG000|Overall Study|Withdrawal by Subject|3|||
16953599|NCT01215357|38096709|FG000|Overall Study|Protocol Violation|9|||
16953600|NCT00984295|38096716|FG000|Overall Study|Lost to Follow-up|31|||
16953601|NCT00984295|38096717|FG001|Overall Study|Lost to Follow-up|12|||
16953602|NCT00984295|38096718|FG002|Overall Study|Lost to Follow-up|13|||
16953603|NCT00984295|38096716|FG000|Overall Study|Protocol Violation|2|||
16953604|NCT00984295|38096717|FG001|Overall Study|Protocol Violation|1|||
16953605|NCT00984295|38096718|FG002|Overall Study|Protocol Violation|4|||
16953606|NCT00984295|38096716|FG000|Overall Study|Withdrawal by Subject|18|||
16953607|NCT00984295|38096717|FG001|Overall Study|Withdrawal by Subject|9|||
16953608|NCT00984295|38096718|FG002|Overall Study|Withdrawal by Subject|12|||
16953609|NCT00984295|38096716|FG000|Overall Study|CAE - discontinued test vaccine|0|||
16953610|NCT00984295|38096717|FG001|Overall Study|CAE - discontinued test vaccine|1|||
16953611|NCT00984295|38096718|FG002|Overall Study|CAE - discontinued test vaccine|3|||
16953612|NCT00984295|38096716|FG000|Overall Study|Missed one or more blood samplings|3|||
16953613|NCT00984295|38096717|FG001|Overall Study|Missed one or more blood samplings|7|||
16953614|NCT00984295|38096718|FG002|Overall Study|Missed one or more blood samplings|2|||
16953615|NCT00984295|38096716|FG000|Overall Study|Incomplete safety follow-up|11|||
16953616|NCT00984295|38096717|FG001|Overall Study|Incomplete safety follow-up|2|||
16953617|NCT00984295|38096718|FG002|Overall Study|Incomplete safety follow-up|3|||
16953618|NCT01017952|38096730|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
16953619|NCT01017952|38096731|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16953620|NCT01017952|38096732|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16953621|NCT01017952|38096733|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16953622|NCT01017952|38096734|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16953623|NCT01017952|38096730|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
16953624|NCT01017952|38096731|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
16953625|NCT01017952|38096732|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
16953626|NCT01017952|38096733|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
16953627|NCT01017952|38096734|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
16953628|NCT01017952|38096730|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
16953629|NCT01017952|38096731|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
16953630|NCT01017952|38096732|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
16953631|NCT01017952|38096733|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
16953632|NCT01017952|38096734|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
16953633|NCT01017952|38096730|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
16953634|NCT01017952|38096731|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16953635|NCT01017952|38096732|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16953636|NCT01017952|38096733|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16953637|NCT01017952|38096734|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16953638|NCT01017952|38096730|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
16953639|NCT01017952|38096731|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
16953640|NCT01017952|38096732|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
17128306|NCT04528641|38269255|FG005|Overall Study|Withdrawal by Subject|1|||
16953641|NCT01017952|38096733|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
16953642|NCT01017952|38096734|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
16953643|NCT01017952|38096730|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
16953644|NCT01017952|38096731|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16953645|NCT01017952|38096732|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16953646|NCT01017952|38096733|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16953647|NCT01017952|38096734|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16953648|NCT01017952|38096730|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
16953649|NCT01017952|38096731|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
16953650|NCT01017952|38096732|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
16953651|NCT01017952|38096733|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
16953652|NCT01017952|38096734|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
16953653|NCT01017952|38096730|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16953654|NCT01017952|38096731|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
16953655|NCT01017952|38096732|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
16953656|NCT01017952|38096733|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
16953657|NCT01017952|38096734|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
16953658|NCT01017952|38096730|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
16953659|NCT01017952|38096731|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
16953660|NCT01017952|38096732|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
16953661|NCT01017952|38096733|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
16953662|NCT01017952|38096734|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
16953663|NCT01017952|38096730|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
16953664|NCT01017952|38096731|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
16953665|NCT01017952|38096732|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
16953666|NCT01017952|38096733|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
16953667|NCT01017952|38096734|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
16953668|NCT01017952|38096730|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16953669|NCT01017952|38096731|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
16953670|NCT01017952|38096732|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
16953671|NCT01017952|38096733|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
16953672|NCT01017952|38096734|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
16953673|NCT01017952|38096730|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16953674|NCT01017952|38096731|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
16953675|NCT01017952|38096732|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
16953676|NCT01017952|38096733|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16953677|NCT01017952|38096734|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16953678|NCT01017952|38096730|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16953679|NCT01017952|38096731|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
16953680|NCT01017952|38096732|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
16953681|NCT01017952|38096733|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
16953682|NCT01017952|38096734|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
16953683|NCT01017952|38096730|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
16953684|NCT01017952|38096731|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
16953685|NCT01017952|38096732|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
16953686|NCT01017952|38096733|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
16953687|NCT01017952|38096734|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
16953688|NCT01214655|38096747|FG000|Part A|Progressive Disease|7|||
16953689|NCT01214655|38096748|FG001|Part A|Progressive Disease|0|||
16953690|NCT01214655|38096749|FG002|Part A|Progressive Disease|0|||
16953691|NCT01214655|38096747|FG000|Part A|Physician Decision|1|||
16953692|NCT01214655|38096748|FG001|Part A|Physician Decision|0|||
16953693|NCT01214655|38096749|FG002|Part A|Physician Decision|0|||
16953694|NCT01214655|38096747|FG000|Part B|Progressive disease|0|||
16953695|NCT01214655|38096748|FG001|Part B|Progressive disease|10|||
16953696|NCT01214655|38096749|FG002|Part B|Progressive disease|0|||
16953697|NCT01214655|38096747|FG000|Part B|Death|0|||
16953698|NCT01214655|38096748|FG001|Part B|Death|1|||
16953699|NCT01214655|38096749|FG002|Part B|Death|0|||
16953700|NCT01214655|38096747|FG000|Part B|Withdrawal by Subject|0|||
16953701|NCT01214655|38096748|FG001|Part B|Withdrawal by Subject|2|||
16953702|NCT01214655|38096749|FG002|Part B|Withdrawal by Subject|0|||
16953703|NCT01214655|38096747|FG000|Part C|Progressive Disease|0|||
16953704|NCT01214655|38096748|FG001|Part C|Progressive Disease|0|||
16953705|NCT01214655|38096749|FG002|Part C|Progressive Disease|5|||
16953706|NCT01214655|38096747|FG000|Part C|Death|0|||
16953707|NCT01214655|38096748|FG001|Part C|Death|0|||
16953708|NCT01214655|38096749|FG002|Part C|Death|1|||
16953709|NCT01214655|38096747|FG000|Part C|Physician Decision|0|||
16953710|NCT01214655|38096748|FG001|Part C|Physician Decision|0|||
16953711|NCT01214655|38096749|FG002|Part C|Physician Decision|1|||
16953712|NCT01017874|38096797|FG000|Overall Study|Withdrawal by Subject|23|||
16953713|NCT01017874|38096798|FG001|Overall Study|Withdrawal by Subject|20|||
16953714|NCT01017874|38096797|FG000|Overall Study|Sponsor decision|3|||
16953715|NCT01017874|38096798|FG001|Overall Study|Sponsor decision|1|||
16953716|NCT01017874|38096797|FG000|Overall Study|Lost to Follow-up|3|||
16953717|NCT01017874|38096798|FG001|Overall Study|Lost to Follow-up|2|||
16953718|NCT01017874|38096797|FG000|Overall Study|Physician Decision|1|||
16953719|NCT01017874|38096798|FG001|Overall Study|Physician Decision|3|||
16953720|NCT01015768|38096804|FG000|Overall Study|Some subject data unuseable|4|||
16953721|NCT01015768|38096805|FG001|Overall Study|Some subject data unuseable|4|||
16953722|NCT04426630|38096813|FG000|Overall Study|Death|4|||
16953723|NCT04426630|38096813|FG000|Overall Study|Lost to Follow-up|2|||
16953724|NCT01010230|38096819|FG000|Overall Study|Withdrawal by Subject|6|||
16953725|NCT01010230|38096820|FG001|Overall Study|Withdrawal by Subject|5|||
16953726|NCT01010230|38096819|FG000|Overall Study|Lost to Follow-up|4|||
16953727|NCT01010230|38096820|FG001|Overall Study|Lost to Follow-up|2|||
16953728|NCT01009840|38096826|FG000|Overall Study|Lost to Follow-up|1|||
16953729|NCT01009840|38096826|FG000|Overall Study|Adverse Event|4|||
16953730|NCT01009840|38096826|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
16953731|NCT01009840|38096826|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
16953732|NCT01009840|38096826|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
16953733|NCT00982657|38096834|FG000|Overall Study|Death|1|||
16953734|NCT00982657|38096835|FG001|Overall Study|Death|0|||
16953735|NCT00982657|38096836|FG002|Overall Study|Death|1|||
16953736|NCT00982657|38096837|FG003|Overall Study|Death|1|||
16953737|NCT00982657|38096834|FG000|Overall Study|Withdrawal by Subject|0|||
16953738|NCT00982657|38096835|FG001|Overall Study|Withdrawal by Subject|0|||
16953739|NCT00982657|38096836|FG002|Overall Study|Withdrawal by Subject|1|||
16953740|NCT00982657|38096837|FG003|Overall Study|Withdrawal by Subject|3|||
16953741|NCT00982657|38096834|FG000|Overall Study|Other|0|||
16953742|NCT00982657|38096835|FG001|Overall Study|Other|0|||
16953743|NCT00982657|38096836|FG002|Overall Study|Other|0|||
16953744|NCT00982657|38096837|FG003|Overall Study|Other|4|||
16953745|NCT00982657|38096834|FG000|Overall Study|On going at date of cut-off|0|||
16953746|NCT00982657|38096835|FG001|Overall Study|On going at date of cut-off|0|||
16953747|NCT00982657|38096836|FG002|Overall Study|On going at date of cut-off|0|||
16953748|NCT00982657|38096837|FG003|Overall Study|On going at date of cut-off|1|||
16953749|NCT01005316|38096860|FG000|Overall Study|Adverse Event|0|||
16953750|NCT01005316|38096861|FG001|Overall Study|Adverse Event|0|||
16953751|NCT01005316|38096862|FG002|Overall Study|Adverse Event|0|||
16953752|NCT01005316|38096863|FG003|Overall Study|Adverse Event|1|||
16953753|NCT01005316|38096860|FG000|Overall Study|Death|20|||
16953754|NCT01005316|38096861|FG001|Overall Study|Death|5|||
16953755|NCT01005316|38096862|FG002|Overall Study|Death|1|||
16953756|NCT01005316|38096863|FG003|Overall Study|Death|15|||
16953757|NCT01005316|38096860|FG000|Overall Study|Study Termination|5|||
16953758|NCT01005316|38096861|FG001|Overall Study|Study Termination|63|||
16953759|NCT01005316|38096862|FG002|Overall Study|Study Termination|9|||
16953760|NCT01005316|38096863|FG003|Overall Study|Study Termination|85|||
16953761|NCT01005316|38096860|FG000|Overall Study|Lost to Follow-up|1|||
16953762|NCT01005316|38096861|FG001|Overall Study|Lost to Follow-up|3|||
16953763|NCT01005316|38096862|FG002|Overall Study|Lost to Follow-up|0|||
16953764|NCT01005316|38096863|FG003|Overall Study|Lost to Follow-up|2|||
16953765|NCT01005316|38096860|FG000|Overall Study|Physician Decision|6|||
16953766|NCT01005316|38096861|FG001|Overall Study|Physician Decision|0|||
16953767|NCT01005316|38096862|FG002|Overall Study|Physician Decision|0|||
16953768|NCT01005316|38096863|FG003|Overall Study|Physician Decision|0|||
16953769|NCT01005316|38096860|FG000|Overall Study|Sponsor Decision|6|||
16953770|NCT01005316|38096861|FG001|Overall Study|Sponsor Decision|3|||
16953771|NCT01005316|38096862|FG002|Overall Study|Sponsor Decision|0|||
16953772|NCT01005316|38096863|FG003|Overall Study|Sponsor Decision|0|||
16953773|NCT01005316|38096860|FG000|Overall Study|Withdrawal by Subject|1|||
16953774|NCT01005316|38096861|FG001|Overall Study|Withdrawal by Subject|1|||
16953775|NCT01005316|38096862|FG002|Overall Study|Withdrawal by Subject|0|||
16953776|NCT01005316|38096863|FG003|Overall Study|Withdrawal by Subject|2|||
16953777|NCT01005316|38096860|FG000|Overall Study|Consented to Another Study|2|||
16953778|NCT01005316|38096861|FG001|Overall Study|Consented to Another Study|0|||
16953779|NCT01005316|38096862|FG002|Overall Study|Consented to Another Study|0|||
16953780|NCT01005316|38096863|FG003|Overall Study|Consented to Another Study|0|||
16953781|NCT01005316|38096860|FG000|Overall Study|Delisted|8|||
16774344|NCT02133352|37713629|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
16774345|NCT02167594|37713636|FG000|Overall Study|Withdrawal by Subject|2|||
16953782|NCT01005316|38096861|FG001|Overall Study|Delisted|0|||
16953783|NCT01005316|38096862|FG002|Overall Study|Delisted|0|||
16953784|NCT01005316|38096863|FG003|Overall Study|Delisted|0|||
16953785|NCT01005316|38096860|FG000|Overall Study|Transferred Care|1|||
16953786|NCT01005316|38096861|FG001|Overall Study|Transferred Care|0|||
16953787|NCT01005316|38096862|FG002|Overall Study|Transferred Care|1|||
16953788|NCT01005316|38096863|FG003|Overall Study|Transferred Care|3|||
16953789|NCT01005316|38096860|FG000|Overall Study|Retransplanted|0|||
16953790|NCT01005316|38096861|FG001|Overall Study|Retransplanted|1|||
16953791|NCT01005316|38096862|FG002|Overall Study|Retransplanted|0|||
16953792|NCT01005316|38096863|FG003|Overall Study|Retransplanted|0|||
16953793|NCT01004848|38096876|FG000|Overall Study|Lost to Follow-up|55|||
16953794|NCT01004848|38096877|FG001|Overall Study|Lost to Follow-up|45|||
16953795|NCT01009294|38096885|FG000|Overall Study|Study discontinued by Sponsor|6|||
16953796|NCT01009060|38096891|FG000|Overall Study|Adverse Event|1|||
16953797|NCT01009060|38096892|FG001|Overall Study|Adverse Event|2|||
16953798|NCT01009060|38096891|FG000|Overall Study|Protocol Violation|0|||
16953799|NCT01009060|38096892|FG001|Overall Study|Protocol Violation|1|||
16953800|NCT01009060|38096891|FG000|Overall Study|Lost to Follow-up|1|||
16953801|NCT01009060|38096892|FG001|Overall Study|Lost to Follow-up|0|||
16953802|NCT01009060|38096891|FG000|Overall Study|Physician Decision|1|||
16953803|NCT01009060|38096892|FG001|Overall Study|Physician Decision|1|||
16953804|NCT01009060|38096891|FG000|Overall Study|Withdrawal by Subject|1|||
16953805|NCT01009060|38096892|FG001|Overall Study|Withdrawal by Subject|1|||
16953806|NCT00988429|38096905|FG000|Overall Study|Adverse Event|9|||
16953807|NCT00988429|38096906|FG001|Overall Study|Adverse Event|21|||
16953808|NCT00988429|38096907|FG002|Overall Study|Adverse Event|45|||
16953809|NCT00988429|38096905|FG000|Overall Study|Lack of Efficacy|0|||
16953810|NCT00988429|38096906|FG001|Overall Study|Lack of Efficacy|0|||
16953811|NCT00988429|38096907|FG002|Overall Study|Lack of Efficacy|1|||
16953812|NCT00988429|38096905|FG000|Overall Study|Non-Compliance with Study Drug|5|||
16953813|NCT00988429|38096906|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16953814|NCT00988429|38096907|FG002|Overall Study|Non-Compliance with Study Drug|3|||
16953815|NCT00988429|38096905|FG000|Overall Study|Physician Decision|1|||
16953816|NCT00988429|38096906|FG001|Overall Study|Physician Decision|0|||
16953817|NCT00988429|38096907|FG002|Overall Study|Physician Decision|3|||
16953818|NCT00988429|38096905|FG000|Overall Study|Pregnancy|2|||
16953819|NCT00988429|38096906|FG001|Overall Study|Pregnancy|1|||
16953820|NCT00988429|38096907|FG002|Overall Study|Pregnancy|0|||
16953821|NCT00988429|38096905|FG000|Overall Study|Protocol Violation|4|||
16953822|NCT00988429|38096906|FG001|Overall Study|Protocol Violation|3|||
16953823|NCT00988429|38096907|FG002|Overall Study|Protocol Violation|3|||
16953824|NCT00988429|38096905|FG000|Overall Study|Withdrawal by Subject|7|||
16953825|NCT00988429|38096906|FG001|Overall Study|Withdrawal by Subject|7|||
16953826|NCT00988429|38096907|FG002|Overall Study|Withdrawal by Subject|12|||
16953827|NCT00988429|38096905|FG000|Overall Study|Administrative Reasons|1|||
16953828|NCT00988429|38096906|FG001|Overall Study|Administrative Reasons|2|||
16953829|NCT00988429|38096907|FG002|Overall Study|Administrative Reasons|1|||
16953830|NCT00988429|38096905|FG000|Overall Study|other reasons|8|||
16953831|NCT00988429|38096906|FG001|Overall Study|other reasons|8|||
16953832|NCT00988429|38096907|FG002|Overall Study|other reasons|1|||
16953833|NCT01008904|38096916|FG000|Overall Study|Lost to Follow-up|1|||
16953834|NCT01008904|38096916|FG000|Overall Study|Adverse Event|2|||
16953835|NCT01008904|38096916|FG000|Overall Study|unexpected unrelated surgery|1|||
16953836|NCT01004614|38096924|FG000|Washout|Withdrawal by Subject|0|||
16953837|NCT01004614|38096925|FG001|Washout|Withdrawal by Subject|1|||
16953838|NCT01004614|38096926|FG002|Washout|Withdrawal by Subject|0|||
16953839|NCT01004614|38096927|FG003|Washout|Withdrawal by Subject|0|||
16953840|NCT00981409|38096939|FG000|Overall Study|Adverse Event|4|||
16953841|NCT00981409|38096940|FG001|Overall Study|Adverse Event|0|||
16953842|NCT00981409|38096939|FG000|Overall Study|Protocol Violation|0|||
16953843|NCT00981409|38096940|FG001|Overall Study|Protocol Violation|1|||
16953844|NCT00981409|38096939|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
16953845|NCT00981409|38096940|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
16953846|NCT01008748|38096946|FG000|Overall Study|Lost to Follow-up|80|||
16953847|NCT01008748|38096946|FG000|Overall Study|Other|1|||
16953848|NCT01004146|38096952|FG000|Overall Study|Withdrawal by Subject|4|||
16953849|NCT01004146|38096953|FG001|Overall Study|Withdrawal by Subject|5|||
16953850|NCT01012414|38096959|FG000|Overall Study|Withdrawal by Subject|2|||
16953851|NCT01012414|38096959|FG000|Overall Study|Lost to Follow-up|1|||
16953852|NCT01012414|38096959|FG000|Overall Study|Trial was stopped before completed|7|||
16953853|NCT00975715|38096967|FG000|Titration Period|Adverse Event|6|||
16953854|NCT00975715|38096968|FG001|Titration Period|Adverse Event|0|||
16953855|NCT00975715|38096967|FG000|Titration Period|Protocol Violation|1|||
16953856|NCT00975715|38096968|FG001|Titration Period|Protocol Violation|0|||
16953857|NCT00975715|38096967|FG000|Maintenance Period|Adverse Event|2|||
16953858|NCT00975715|38096968|FG001|Maintenance Period|Adverse Event|1|||
16953859|NCT03962491|38096976|FG000|Overall Study|Lost to Follow-up|4|||
16953860|NCT03962491|38096977|FG001|Overall Study|Lost to Follow-up|5|||
16953861|NCT00978757|38096985|FG000|Overall Study|Physician Decision|1|||
16953862|NCT00978757|38096986|FG001|Overall Study|Physician Decision|3|||
16953863|NCT01214421|38096996|FG000|Overall Study|Lost to Follow-up|7|||
16953864|NCT01214421|38096997|FG001|Overall Study|Lost to Follow-up|3|||
16953865|NCT01214421|38096998|FG002|Overall Study|Lost to Follow-up|7|||
16953866|NCT01214421|38096999|FG003|Overall Study|Lost to Follow-up|3|||
16953867|NCT01214421|38096996|FG000|Overall Study|Adverse Event|16|||
16953868|NCT01214421|38096997|FG001|Overall Study|Adverse Event|35|||
16953869|NCT01214421|38096998|FG002|Overall Study|Adverse Event|14|||
16953870|NCT01214421|38096999|FG003|Overall Study|Adverse Event|3|||
16953871|NCT01214421|38096996|FG000|Overall Study|Sponsor Discontinued Site|1|||
16953872|NCT01214421|38096997|FG001|Overall Study|Sponsor Discontinued Site|2|||
16953873|NCT01214421|38096998|FG002|Overall Study|Sponsor Discontinued Site|0|||
16953874|NCT01214421|38096999|FG003|Overall Study|Sponsor Discontinued Site|0|||
16953875|NCT01214421|38096996|FG000|Overall Study|Withdrawal Criteria Met|3|||
16953876|NCT01214421|38096997|FG001|Overall Study|Withdrawal Criteria Met|0|||
16953877|NCT01214421|38096998|FG002|Overall Study|Withdrawal Criteria Met|2|||
16953878|NCT01214421|38096999|FG003|Overall Study|Withdrawal Criteria Met|1|||
16953879|NCT01214421|38096996|FG000|Overall Study|Physician Decision|2|||
16953880|NCT01214421|38096997|FG001|Overall Study|Physician Decision|0|||
16953881|NCT01214421|38096998|FG002|Overall Study|Physician Decision|4|||
16953882|NCT01214421|38096999|FG003|Overall Study|Physician Decision|0|||
16953883|NCT01214421|38096996|FG000|Overall Study|Withdrawal by Subject|21|||
16953884|NCT01214421|38096997|FG001|Overall Study|Withdrawal by Subject|18|||
16953885|NCT01214421|38096998|FG002|Overall Study|Withdrawal by Subject|11|||
16953886|NCT01214421|38096999|FG003|Overall Study|Withdrawal by Subject|2|||
16953887|NCT04102111|38097011|FG000|Overall Study|Withdrawal by Subject|2|||
16953888|NCT04102111|38097012|FG001|Overall Study|Withdrawal by Subject|3|||
16953889|NCT04102111|38097011|FG000|Overall Study|Adverse Event|1|||
16953890|NCT04102111|38097012|FG001|Overall Study|Adverse Event|1|||
16953891|NCT04102111|38097011|FG000|Overall Study|Study terminated by sponsor|1|||
16953892|NCT04102111|38097012|FG001|Overall Study|Study terminated by sponsor|3|||
16953893|NCT01214187|38097020|FG000|Overall Study|Adverse Event|6|||
16953894|NCT01214187|38097021|FG001|Overall Study|Adverse Event|2|||
16953895|NCT01214187|38097020|FG000|Overall Study|Death|1|||
16953896|NCT01214187|38097021|FG001|Overall Study|Death|1|||
16953897|NCT01214187|38097020|FG000|Overall Study|Withdrawal by Subject|0|||
16953898|NCT01214187|38097021|FG001|Overall Study|Withdrawal by Subject|3|||
16953899|NCT01003990|38097030|FG000|Overall Study|Adverse Event|8|||
16953900|NCT01003990|38097031|FG001|Overall Study|Adverse Event|5|||
16953901|NCT01003990|38097032|FG002|Overall Study|Adverse Event|11|||
16953902|NCT01003990|38097030|FG000|Overall Study|Death|0|||
16953903|NCT01003990|38097031|FG001|Overall Study|Death|8|||
16953904|NCT01003990|38097032|FG002|Overall Study|Death|1|||
16953905|NCT01003990|38097030|FG000|Overall Study|Lack of Efficacy|10|||
16953906|NCT01003990|38097031|FG001|Overall Study|Lack of Efficacy|2|||
16953907|NCT01003990|38097032|FG002|Overall Study|Lack of Efficacy|3|||
16953908|NCT01003990|38097030|FG000|Overall Study|Lost to Follow-up|30|||
16953909|NCT01003990|38097031|FG001|Overall Study|Lost to Follow-up|12|||
16953910|NCT01003990|38097032|FG002|Overall Study|Lost to Follow-up|7|||
16953911|NCT01003990|38097030|FG000|Overall Study|Reasons Not Identified|14|||
16953912|NCT01003990|38097031|FG001|Overall Study|Reasons Not Identified|13|||
16953913|NCT01003990|38097032|FG002|Overall Study|Reasons Not Identified|8|||
16953914|NCT01003990|38097030|FG000|Overall Study|Poor/Non-compliance|4|||
16953915|NCT01003990|38097031|FG001|Overall Study|Poor/Non-compliance|3|||
16953916|NCT01003990|38097032|FG002|Overall Study|Poor/Non-compliance|2|||
16953917|NCT01003990|38097030|FG000|Overall Study|Pregnancy|10|||
16953918|NCT01003990|38097031|FG001|Overall Study|Pregnancy|2|||
16953919|NCT01003990|38097032|FG002|Overall Study|Pregnancy|4|||
16953920|NCT01003990|38097030|FG000|Overall Study|No Longer Met Study Criteria|4|||
16953921|NCT01003990|38097031|FG001|Overall Study|No Longer Met Study Criteria|1|||
17128307|NCT04527471|38269274|FG000|Overall Study|Adverse Event|1|||
16953922|NCT01003990|38097032|FG002|Overall Study|No Longer Met Study Criteria|0|||
16953923|NCT01003990|38097030|FG000|Overall Study|Subject Withdrew Consent|12|||
16953924|NCT01003990|38097031|FG001|Overall Study|Subject Withdrew Consent|5|||
16953925|NCT01003990|38097032|FG002|Overall Study|Subject Withdrew Consent|7|||
16953926|NCT01003210|38097042|FG000|Overall Study|Lost to Follow-up|1|||
16953927|NCT01003210|38097043|FG001|Overall Study|Lost to Follow-up|3|||
16953928|NCT01002820|38097049|FG000|Overall Study|Adverse Event|1|||
16953929|NCT01002820|38097049|FG000|Overall Study|Withdrawal by Subject|2|||
16953930|NCT01002820|38097049|FG000|Overall Study|Lack of Efficacy|1|||
16953931|NCT01012258|38097053|FG000|Overall Study|Death|14|||
16953932|NCT01012258|38097053|FG000|Overall Study|Lost to Follow-up|1|||
16953933|NCT01012258|38097053|FG000|Overall Study|Adverse Event|1|||
16953934|NCT01012258|38097053|FG000|Overall Study|Progressive Disease (PD)|18|||
16953935|NCT01012258|38097053|FG000|Overall Study|Symptomatic Deterioration|1|||
16953936|NCT01012258|38097053|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
16953937|NCT01012258|38097053|FG000|Overall Study|Another Tumor Discovered|1|||
16953938|NCT01012258|38097053|FG000|Overall Study|Ongoing|29|||
16953939|NCT01011946|38097058|FG000|Overall Study|Transferred to another hospital|2|||
16953940|NCT01011946|38097058|FG000|Overall Study|No pathological lab value|1|||
16953941|NCT00975481|38097062|FG000|Second Intervention Period|Adverse Event|2|||
16953942|NCT00975481|38097063|FG001|Second Intervention Period|Adverse Event|1|||
16953943|NCT00975481|38097064|FG002|Second Intervention Period|Adverse Event|0|||
16953944|NCT00975481|38097065|FG003|Second Intervention Period|Adverse Event|0|||
16953945|NCT00975481|38097066|FG004|Second Intervention Period|Adverse Event|0|||
16953946|NCT00975481|38097067|FG005|Second Intervention Period|Adverse Event|0|||
16953947|NCT00975481|38097062|FG000|Second Intervention Period|Withdrawal by Subject|0|||
16953948|NCT00975481|38097063|FG001|Second Intervention Period|Withdrawal by Subject|0|||
16953949|NCT00975481|38097064|FG002|Second Intervention Period|Withdrawal by Subject|1|||
16953950|NCT00975481|38097065|FG003|Second Intervention Period|Withdrawal by Subject|0|||
16953951|NCT00975481|38097066|FG004|Second Intervention Period|Withdrawal by Subject|0|||
16953952|NCT00975481|38097067|FG005|Second Intervention Period|Withdrawal by Subject|0|||
16953953|NCT00975481|38097062|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
16953954|NCT00975481|38097063|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
16953955|NCT00975481|38097064|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
16953956|NCT00975481|38097065|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
16953957|NCT00975481|38097066|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
16953958|NCT00975481|38097067|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
16953959|NCT00975481|38097062|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
16953960|NCT00975481|38097063|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
16953961|NCT00975481|38097064|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
16953962|NCT00975481|38097065|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
16953963|NCT00975481|38097066|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
16953964|NCT00975481|38097067|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
16953965|NCT01011868|38097088|FG000|After Week 18 Follow-up|Adverse Event|8|||
16953966|NCT01011868|38097089|FG001|After Week 18 Follow-up|Adverse Event|6|||
16953967|NCT01011868|38097090|FG002|After Week 18 Follow-up|Adverse Event|13|||
16953968|NCT01011868|38097088|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
16953969|NCT01011868|38097089|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
16953970|NCT01011868|38097090|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
16953971|NCT01011868|38097088|FG000|After Week 18 Follow-up|Protocol Violation|1|||
16953972|NCT01011868|38097089|FG001|After Week 18 Follow-up|Protocol Violation|1|||
16953973|NCT01011868|38097090|FG002|After Week 18 Follow-up|Protocol Violation|1|||
16953974|NCT01011868|38097088|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
16953975|NCT01011868|38097089|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
16953976|NCT01011868|38097090|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
16953977|NCT01011868|38097088|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
16953978|NCT01011868|38097089|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
16953979|NCT01011868|38097090|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
16953980|NCT01011868|38097088|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
16953981|NCT01011868|38097089|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
16953982|NCT01011868|38097090|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
16953983|NCT01011868|38097088|FG000|After Week 78 Follow-up|Adverse Event|14|||
16953984|NCT01011868|38097089|FG001|After Week 78 Follow-up|Adverse Event|18|||
16953985|NCT01011868|38097090|FG002|After Week 78 Follow-up|Adverse Event|21|||
16953986|NCT01011868|38097088|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
16953987|NCT01011868|38097089|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
16953988|NCT01011868|38097090|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
16953989|NCT01011868|38097088|FG000|After Week 78 Follow-up|Protocol Violation|9|||
16953990|NCT01011868|38097089|FG001|After Week 78 Follow-up|Protocol Violation|1|||
16953991|NCT01011868|38097090|FG002|After Week 78 Follow-up|Protocol Violation|2|||
16953992|NCT01011868|38097088|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
16953993|NCT01011868|38097089|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
16953994|NCT01011868|38097090|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
16953995|NCT01011868|38097088|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
16953996|NCT01011868|38097089|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
16953997|NCT01011868|38097090|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
16953998|NCT01011868|38097088|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
16953999|NCT01011868|38097089|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
16954000|NCT01011868|38097090|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
16954001|NCT01213251|38097101|FG000|Overall Study|Death|2|||
16954002|NCT01213251|38097102|FG001|Overall Study|Death|1|||
16954003|NCT01213251|38097103|FG002|Overall Study|Death|2|||
16954004|NCT01213251|38097101|FG000|Overall Study|Exit|3|||
16954005|NCT01213251|38097102|FG001|Overall Study|Exit|2|||
16954006|NCT01213251|38097103|FG002|Overall Study|Exit|8|||
16954007|NCT01213251|38097101|FG000|Overall Study|Protocol Violation|1|||
16954008|NCT01213251|38097102|FG001|Overall Study|Protocol Violation|1|||
16954009|NCT01213251|38097103|FG002|Overall Study|Protocol Violation|0|||
16954010|NCT01213251|38097101|FG000|Overall Study|Missed 18-Month Follow-up|0|||
16954011|NCT01213251|38097102|FG001|Overall Study|Missed 18-Month Follow-up|0|||
16954012|NCT01213251|38097103|FG002|Overall Study|Missed 18-Month Follow-up|1|||
16954013|NCT01213173|38097118|FG000|Overall Study|Protocol Violation|2|||
16954014|NCT01213173|38097119|FG001|Overall Study|Protocol Violation|0|||
16954015|NCT01213173|38097118|FG000|Overall Study|Adverse Event|4|||
16954016|NCT01213173|38097119|FG001|Overall Study|Adverse Event|8|||
16954017|NCT01213173|38097118|FG000|Overall Study|Withdrawal by Subject|5|||
16954018|NCT01213173|38097119|FG001|Overall Study|Withdrawal by Subject|5|||
16954019|NCT01213173|38097118|FG000|Overall Study|Incorrect Enrollment|1|||
16954020|NCT01213173|38097119|FG001|Overall Study|Incorrect Enrollment|3|||
16954021|NCT01212159|38097127|FG000|Overall Study|Withdrawal by Subject|12|||
16954022|NCT01212159|38097128|FG001|Overall Study|Withdrawal by Subject|12|||
16954023|NCT00973765|38097136|FG000|Overall Study|Lost to Follow-up|8|||
16954024|NCT00973765|38097137|FG001|Overall Study|Lost to Follow-up|14|||
16954025|NCT01211769|38097147|FG000|Overall Study|Lost to Follow-up|7|||
16954026|NCT01211769|38097148|FG001|Overall Study|Lost to Follow-up|9|||
16954027|NCT01211769|38097149|FG002|Overall Study|Lost to Follow-up|5|||
16954028|NCT01211769|38097150|FG003|Overall Study|Lost to Follow-up|9|||
16954029|NCT01211769|38097147|FG000|Overall Study|Physician Decision|2|||
16954030|NCT01211769|38097148|FG001|Overall Study|Physician Decision|0|||
16954031|NCT01211769|38097149|FG002|Overall Study|Physician Decision|2|||
16954032|NCT01211769|38097150|FG003|Overall Study|Physician Decision|1|||
16954033|NCT01211769|38097147|FG000|Overall Study|Adverse Event|0|||
16954034|NCT01211769|38097148|FG001|Overall Study|Adverse Event|1|||
16954035|NCT01211769|38097149|FG002|Overall Study|Adverse Event|1|||
16954036|NCT01211769|38097150|FG003|Overall Study|Adverse Event|1|||
16954037|NCT01211613|38097163|FG000|Overall Study|Lost to Follow-up|2|||
16954038|NCT01211613|38097164|FG001|Overall Study|Lost to Follow-up|2|||
16954039|NCT01211613|38097165|FG002|Overall Study|Lost to Follow-up|2|||
16954040|NCT01211613|38097163|FG000|Overall Study|Withdrawal by Subject|1|||
16954041|NCT01211613|38097164|FG001|Overall Study|Withdrawal by Subject|0|||
16954042|NCT01211613|38097165|FG002|Overall Study|Withdrawal by Subject|0|||
16954043|NCT01211535|38097175|FG000|Overall Study|Adverse Event|0|||
16954044|NCT01211535|38097176|FG001|Overall Study|Adverse Event|1|||
16954045|NCT01011556|38097186|FG000|Overall Study|Adverse Event|1|||
16954046|NCT01011556|38097187|FG001|Overall Study|Adverse Event|3|||
16954047|NCT01011556|38097188|FG002|Overall Study|Adverse Event|2|||
16954048|NCT01011556|38097189|FG003|Overall Study|Adverse Event|1|||
16954049|NCT01011556|38097186|FG000|Overall Study|Lost to Follow-up|1|||
16954050|NCT01011556|38097187|FG001|Overall Study|Lost to Follow-up|0|||
16954051|NCT01011556|38097188|FG002|Overall Study|Lost to Follow-up|0|||
16954052|NCT01011556|38097189|FG003|Overall Study|Lost to Follow-up|0|||
16954053|NCT01011556|38097186|FG000|Overall Study|Physician Decision|1|||
16954054|NCT01011556|38097187|FG001|Overall Study|Physician Decision|0|||
16954055|NCT01011556|38097188|FG002|Overall Study|Physician Decision|0|||
16954056|NCT01011556|38097189|FG003|Overall Study|Physician Decision|1|||
16954057|NCT01011556|38097186|FG000|Overall Study|Protocol Violation|0|||
16954058|NCT01011556|38097187|FG001|Overall Study|Protocol Violation|1|||
16954059|NCT01011556|38097188|FG002|Overall Study|Protocol Violation|0|||
16954060|NCT01011556|38097189|FG003|Overall Study|Protocol Violation|0|||
16954061|NCT01011556|38097186|FG000|Overall Study|Withdrawal by Subject|1|||
16954062|NCT01011556|38097187|FG001|Overall Study|Withdrawal by Subject|2|||
16954063|NCT01011556|38097188|FG002|Overall Study|Withdrawal by Subject|4|||
16954064|NCT01011556|38097189|FG003|Overall Study|Withdrawal by Subject|4|||
16954065|NCT01011556|38097186|FG000|Overall Study|Sponsor decision|0|||
16954066|NCT01011556|38097187|FG001|Overall Study|Sponsor decision|1|||
16954067|NCT01011556|38097188|FG002|Overall Study|Sponsor decision|1|||
16954068|NCT01011556|38097189|FG003|Overall Study|Sponsor decision|2|||
16954069|NCT01011556|38097186|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
16954070|NCT01011556|38097187|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
16954071|NCT01011556|38097188|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
16954072|NCT01011556|38097189|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
16954073|NCT01211145|38097206|FG000|Overall Study|Reason not specified|3|||
16954074|NCT01211145|38097207|FG001|Overall Study|Reason not specified|2|||
16954075|NCT01211145|38097208|FG002|Overall Study|Reason not specified|2|||
16954076|NCT01211145|38097209|FG003|Overall Study|Reason not specified|1|||
16954077|NCT01211145|38097206|FG000|Overall Study|Lost to Follow-up|3|||
16954078|NCT01211145|38097207|FG001|Overall Study|Lost to Follow-up|2|||
16954079|NCT01211145|38097208|FG002|Overall Study|Lost to Follow-up|1|||
16954080|NCT01211145|38097209|FG003|Overall Study|Lost to Follow-up|2|||
16954081|NCT01211145|38097206|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16954082|NCT01211145|38097207|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16954083|NCT01211145|38097208|FG002|Overall Study|Study-specific withdrawal criteria|0|||
16954084|NCT01211145|38097209|FG003|Overall Study|Study-specific withdrawal criteria|0|||
16954085|NCT01211145|38097206|FG000|Overall Study|Severe noncompliance to protocol|1|||
16954086|NCT01211145|38097207|FG001|Overall Study|Severe noncompliance to protocol|0|||
16954087|NCT01211145|38097208|FG002|Overall Study|Severe noncompliance to protocol|0|||
16954088|NCT01211145|38097209|FG003|Overall Study|Severe noncompliance to protocol|0|||
16954089|NCT01211145|38097206|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
16954090|NCT01211145|38097207|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
16954091|NCT01211145|38097208|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
16954092|NCT01211145|38097209|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
16954093|NCT01211145|38097206|FG000|Overall Study|Patient decision|2|||
16954094|NCT01211145|38097207|FG001|Overall Study|Patient decision|1|||
16954095|NCT01211145|38097208|FG002|Overall Study|Patient decision|0|||
16954096|NCT01211145|38097209|FG003|Overall Study|Patient decision|2|||
16954097|NCT00977665|38097221|FG000|Overall Study|Withdrawal by Subject|1|||
16954098|NCT00977665|38097222|FG001|Overall Study|Withdrawal by Subject|3|||
16954099|NCT00977665|38097221|FG000|Overall Study|Physician Decision|2|||
16954100|NCT00977665|38097222|FG001|Overall Study|Physician Decision|1|||
16954101|NCT00977665|38097221|FG000|Overall Study|Sponsor requested withdrawal|0|||
16954102|NCT00977665|38097222|FG001|Overall Study|Sponsor requested withdrawal|1|||
16954103|NCT00977665|38097221|FG000|Overall Study|Lost to Follow-up|1|||
16954104|NCT00977665|38097222|FG001|Overall Study|Lost to Follow-up|0|||
16954105|NCT00977665|38097221|FG000|Overall Study|Death|3|||
16954106|NCT00977665|38097222|FG001|Overall Study|Death|2|||
16954107|NCT00977665|38097221|FG000|Overall Study|Adverse Event|14|||
16954108|NCT00977665|38097222|FG001|Overall Study|Adverse Event|7|||
16954109|NCT00977665|38097221|FG000|Overall Study|Treatment failure|0|||
16954110|NCT00977665|38097222|FG001|Overall Study|Treatment failure|1|||
16954111|NCT01210443|38097228|FG000|Overall Study|Study terminated by sponsor|2|||
16954112|NCT01007812|38097232|FG000|Period 1, One Week|Lost to Follow-up|0|||
16954113|NCT01007812|38097233|FG001|Period 1, One Week|Lost to Follow-up|1|||
16954114|NCT01007812|38097232|FG000|Period 1, One Week|Discomfort|1|||
16954115|NCT01007812|38097233|FG001|Period 1, One Week|Discomfort|0|||
16954116|NCT01208961|38097239|FG000|High-Fat Period III|Protocol Violation|1|||
16954117|NCT01208961|38097240|FG001|High-Fat Period III|Protocol Violation|0|||
16954118|NCT01001572|38097247|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
16954119|NCT01001572|38097248|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
16954120|NCT01001572|38097249|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
16954121|NCT01001572|38097247|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
16954122|NCT01001572|38097248|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
16954123|NCT01001572|38097249|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
16954124|NCT01001572|38097247|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
16954125|NCT01001572|38097248|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
16954126|NCT01001572|38097249|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
16954127|NCT01001572|38097247|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
16954128|NCT01001572|38097248|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
16954129|NCT01001572|38097249|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
16954130|NCT01001572|38097247|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
16954131|NCT01001572|38097248|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
16954132|NCT01001572|38097249|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
16954133|NCT01001572|38097247|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
16954134|NCT01001572|38097248|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
16954135|NCT01001572|38097249|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
16954136|NCT01001572|38097247|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
16954137|NCT01001572|38097248|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
16954138|NCT01001572|38097249|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
16954139|NCT01001572|38097247|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
16954140|NCT01001572|38097248|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
16954141|NCT01001572|38097249|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
16954142|NCT01001572|38097247|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
16954143|NCT01001572|38097248|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
16954144|NCT01001572|38097249|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
16954145|NCT01001572|38097247|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16954146|NCT01001572|38097248|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
16954147|NCT01001572|38097249|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
16954148|NCT01001572|38097247|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
16954149|NCT01001572|38097248|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
16954150|NCT01001572|38097249|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
16954151|NCT01001572|38097247|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
16954152|NCT01001572|38097248|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
16954153|NCT01001572|38097249|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
16954154|NCT01001572|38097247|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
16954155|NCT01001572|38097248|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
16954156|NCT01001572|38097249|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
16954157|NCT01001572|38097247|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16954158|NCT01001572|38097248|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16954159|NCT01001572|38097249|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16954160|NCT01208415|38097255|FG000|Overall Study|Death|1|||
16954161|NCT01208415|38097255|FG000|Overall Study|Lost to Follow-up|2|||
16954162|NCT01208415|38097255|FG000|Overall Study|Withdrawal by Subject|3|||
16954163|NCT01208415|38097255|FG000|Overall Study|Device not placed|1|||
16954164|NCT01208415|38097255|FG000|Overall Study|Still be eligible for follow-up|33|||
16954165|NCT01208337|38097259|FG000|Overall Study|Death|3|||
16954166|NCT01208181|38097275|FG000|Part 1|Withdrawal by Subject|11|||
16954167|NCT01208181|38097276|FG001|Part 1|Withdrawal by Subject|10|||
16954168|NCT01208181|38097277|FG002|Part 1|Withdrawal by Subject|0|||
16954169|NCT01208181|38097278|FG003|Part 1|Withdrawal by Subject|0|||
16954170|NCT01208181|38097279|FG004|Part 1|Withdrawal by Subject|0|||
16954171|NCT01208181|38097275|FG000|Part 1|Technical problem|5|||
16954172|NCT01208181|38097276|FG001|Part 1|Technical problem|0|||
16954173|NCT01208181|38097277|FG002|Part 1|Technical problem|0|||
16954174|NCT01208181|38097278|FG003|Part 1|Technical problem|0|||
16954175|NCT01208181|38097279|FG004|Part 1|Technical problem|0|||
16954176|NCT01208181|38097275|FG000|Part 1|Protocol Violation|10|||
16954177|NCT01208181|38097276|FG001|Part 1|Protocol Violation|5|||
16954178|NCT01208181|38097277|FG002|Part 1|Protocol Violation|0|||
16954179|NCT01208181|38097278|FG003|Part 1|Protocol Violation|0|||
16954180|NCT01208181|38097279|FG004|Part 1|Protocol Violation|0|||
16954181|NCT01208181|38097275|FG000|Part 1|Physician Decision|4|||
16954182|NCT01208181|38097276|FG001|Part 1|Physician Decision|0|||
16954183|NCT01208181|38097277|FG002|Part 1|Physician Decision|0|||
16954184|NCT01208181|38097278|FG003|Part 1|Physician Decision|0|||
16954185|NCT01208181|38097279|FG004|Part 1|Physician Decision|0|||
16954186|NCT01208181|38097275|FG000|Part 1|Non-compliance with study drug|1|||
16954187|NCT01208181|38097276|FG001|Part 1|Non-compliance with study drug|1|||
16954188|NCT01208181|38097277|FG002|Part 1|Non-compliance with study drug|0|||
16954189|NCT01208181|38097278|FG003|Part 1|Non-compliance with study drug|0|||
16954190|NCT01208181|38097279|FG004|Part 1|Non-compliance with study drug|0|||
16954191|NCT01208181|38097275|FG000|Part 1|Lost to Follow-up|5|||
16954192|NCT01208181|38097276|FG001|Part 1|Lost to Follow-up|3|||
16954193|NCT01208181|38097277|FG002|Part 1|Lost to Follow-up|0|||
16954194|NCT01208181|38097278|FG003|Part 1|Lost to Follow-up|0|||
16954195|NCT01208181|38097279|FG004|Part 1|Lost to Follow-up|1|||
16954196|NCT01208181|38097275|FG000|Part 1|Lack of Efficacy|37|||
16954197|NCT01208181|38097276|FG001|Part 1|Lack of Efficacy|12|||
16954198|NCT01208181|38097277|FG002|Part 1|Lack of Efficacy|0|||
16954199|NCT01208181|38097278|FG003|Part 1|Lack of Efficacy|0|||
16954200|NCT01208181|38097279|FG004|Part 1|Lack of Efficacy|17|||
16954201|NCT01208181|38097275|FG000|Part 1|Adverse Event|26|||
16954202|NCT01208181|38097276|FG001|Part 1|Adverse Event|24|||
16954203|NCT01208181|38097277|FG002|Part 1|Adverse Event|0|||
16954204|NCT01208181|38097278|FG003|Part 1|Adverse Event|0|||
16954205|NCT01208181|38097279|FG004|Part 1|Adverse Event|4|||
16954206|NCT01208181|38097275|FG000|Part 2|Adverse Event|0|||
16954207|NCT01208181|38097276|FG001|Part 2|Adverse Event|0|||
16954208|NCT01208181|38097277|FG002|Part 2|Adverse Event|6|||
16954209|NCT01208181|38097278|FG003|Part 2|Adverse Event|7|||
16954210|NCT01208181|38097279|FG004|Part 2|Adverse Event|0|||
16954211|NCT01208181|38097275|FG000|Part 2|Withdrawal by Subject|0|||
16954212|NCT01208181|38097276|FG001|Part 2|Withdrawal by Subject|0|||
16954213|NCT01208181|38097277|FG002|Part 2|Withdrawal by Subject|1|||
16954214|NCT01208181|38097278|FG003|Part 2|Withdrawal by Subject|1|||
16954215|NCT01208181|38097279|FG004|Part 2|Withdrawal by Subject|0|||
16954216|NCT01208181|38097275|FG000|Part 2|Protocol Violation|0|||
16954217|NCT01208181|38097276|FG001|Part 2|Protocol Violation|0|||
16954218|NCT01208181|38097277|FG002|Part 2|Protocol Violation|1|||
16954219|NCT01208181|38097278|FG003|Part 2|Protocol Violation|0|||
16954220|NCT01208181|38097279|FG004|Part 2|Protocol Violation|0|||
16954221|NCT01208181|38097275|FG000|Part 2|Physician Decision|0|||
16954222|NCT01208181|38097276|FG001|Part 2|Physician Decision|0|||
16954223|NCT01208181|38097277|FG002|Part 2|Physician Decision|1|||
16954224|NCT01208181|38097278|FG003|Part 2|Physician Decision|2|||
16954225|NCT01208181|38097279|FG004|Part 2|Physician Decision|0|||
16954226|NCT01208181|38097275|FG000|Part 2|Non-compliance with study drug|0|||
16954227|NCT01208181|38097276|FG001|Part 2|Non-compliance with study drug|0|||
16954228|NCT01208181|38097277|FG002|Part 2|Non-compliance with study drug|1|||
16954229|NCT01208181|38097278|FG003|Part 2|Non-compliance with study drug|1|||
16954230|NCT01208181|38097279|FG004|Part 2|Non-compliance with study drug|0|||
16954231|NCT01208181|38097275|FG000|Part 2|Lost to Follow-up|0|||
16954232|NCT01208181|38097276|FG001|Part 2|Lost to Follow-up|0|||
16954233|NCT01208181|38097277|FG002|Part 2|Lost to Follow-up|1|||
16954234|NCT01208181|38097278|FG003|Part 2|Lost to Follow-up|2|||
16954235|NCT01208181|38097279|FG004|Part 2|Lost to Follow-up|0|||
16954236|NCT01208181|38097275|FG000|Part 2|Lack of Efficacy|0|||
16954237|NCT01208181|38097276|FG001|Part 2|Lack of Efficacy|0|||
16954238|NCT01208181|38097277|FG002|Part 2|Lack of Efficacy|5|||
16954239|NCT01208181|38097278|FG003|Part 2|Lack of Efficacy|7|||
16954240|NCT01208181|38097279|FG004|Part 2|Lack of Efficacy|0|||
16954241|NCT01208103|38097296|FG000|Overall Study|Adverse Event|1|||
16954242|NCT01208103|38097296|FG000|Overall Study|Withdrawal by Subject|1|||
16954243|NCT01206777|38097301|FG000|Overall Study|Death|1|||
16954244|NCT01206777|38097301|FG000|Overall Study|Adverse Event|1|||
16954245|NCT01001494|38097308|FG000|Overall Study|Adverse Event|8|||
16954246|NCT01001494|38097309|FG001|Overall Study|Adverse Event|4|||
16954247|NCT01001494|38097310|FG002|Overall Study|Adverse Event|6|||
16954248|NCT01001494|38097308|FG000|Overall Study|Protocol Violation|0|||
16954249|NCT01001494|38097309|FG001|Overall Study|Protocol Violation|1|||
16954250|NCT01001494|38097310|FG002|Overall Study|Protocol Violation|1|||
16954251|NCT01001494|38097308|FG000|Overall Study|Lost to Follow-up|2|||
16954252|NCT01001494|38097309|FG001|Overall Study|Lost to Follow-up|0|||
16954253|NCT01001494|38097310|FG002|Overall Study|Lost to Follow-up|1|||
16954254|NCT01001494|38097308|FG000|Overall Study|Withdrawal by Subject|9|||
16954255|NCT01001494|38097309|FG001|Overall Study|Withdrawal by Subject|7|||
16954256|NCT01001494|38097310|FG002|Overall Study|Withdrawal by Subject|17|||
16954257|NCT01001494|38097308|FG000|Overall Study|COPD exacerbation|3|||
16954258|NCT01001494|38097309|FG001|Overall Study|COPD exacerbation|4|||
16954259|NCT01001494|38097310|FG002|Overall Study|COPD exacerbation|5|||
16954260|NCT01001494|38097308|FG000|Overall Study|Lack of Efficacy|2|||
16954261|NCT01001494|38097309|FG001|Overall Study|Lack of Efficacy|0|||
16954262|NCT01001494|38097310|FG002|Overall Study|Lack of Efficacy|8|||
16954263|NCT01001494|38097308|FG000|Overall Study|Other|0|||
16954264|NCT01001494|38097309|FG001|Overall Study|Other|1|||
16954265|NCT01001494|38097310|FG002|Overall Study|Other|3|||
16954266|NCT01205685|38097318|FG000|Overall Study|Disease Progression|10|||
16954267|NCT01205685|38097318|FG000|Overall Study|Withdrawal by Subject|1|||
16954268|NCT01205529|38097322|FG000|Overall Study|Procedure Cancelled|4|||
16954269|NCT01205529|38097322|FG000|Overall Study|Withdrawal by Subject|2|||
16954270|NCT01205529|38097322|FG000|Overall Study|Physician Decision|4|||
16954271|NCT01205529|38097322|FG000|Overall Study|Unstable post op|15|||
16954272|NCT01205529|38097322|FG000|Overall Study|No longer met criteria|30|||
16954273|NCT01205451|38097328|FG000|Overall Study|Lost to Follow-up|1|||
16954274|NCT01205451|38097329|FG001|Overall Study|Lost to Follow-up|1|||
16954275|NCT01205451|38097328|FG000|Overall Study|Withdrawal by Subject|5|||
16954276|NCT01205451|38097329|FG001|Overall Study|Withdrawal by Subject|9|||
16954277|NCT01001104|38097339|FG000|Overall Study|Adverse Event|2|||
16954278|NCT01001104|38097340|FG001|Overall Study|Adverse Event|1|||
16954279|NCT01001104|38097341|FG002|Overall Study|Adverse Event|0|||
16954280|NCT01001104|38097342|FG003|Overall Study|Adverse Event|0|||
16954281|NCT01001104|38097339|FG000|Overall Study|Lost to Follow-up|0|||
16954282|NCT01001104|38097340|FG001|Overall Study|Lost to Follow-up|0|||
16954283|NCT01001104|38097341|FG002|Overall Study|Lost to Follow-up|1|||
16954284|NCT01001104|38097342|FG003|Overall Study|Lost to Follow-up|0|||
16954285|NCT01001104|38097339|FG000|Overall Study|Entry Criteria Not Met|0|||
16954286|NCT01001104|38097340|FG001|Overall Study|Entry Criteria Not Met|0|||
16954287|NCT01001104|38097341|FG002|Overall Study|Entry Criteria Not Met|0|||
16954288|NCT01001104|38097342|FG003|Overall Study|Entry Criteria Not Met|1|||
16954289|NCT01001104|38097339|FG000|Overall Study|Withdrawal by Subject|0|||
16954290|NCT01001104|38097340|FG001|Overall Study|Withdrawal by Subject|0|||
16954291|NCT01001104|38097341|FG002|Overall Study|Withdrawal by Subject|0|||
16954292|NCT01001104|38097342|FG003|Overall Study|Withdrawal by Subject|2|||
16954293|NCT00998764|38097357|FG000|Overall Study|Lack of Efficacy|3|||
16954294|NCT00998764|38097358|FG001|Overall Study|Lack of Efficacy|6|||
16954295|NCT00998764|38097357|FG000|Overall Study|Adverse Event|17|||
16954296|NCT00998764|38097358|FG001|Overall Study|Adverse Event|12|||
16954297|NCT00998764|38097357|FG000|Overall Study|Withdrawal by Subject|19|||
16954298|NCT00998764|38097358|FG001|Overall Study|Withdrawal by Subject|25|||
16954299|NCT00998764|38097357|FG000|Overall Study|Physician Decision|3|||
16954300|NCT00998764|38097358|FG001|Overall Study|Physician Decision|3|||
16954301|NCT00998764|38097357|FG000|Overall Study|Death|3|||
16954302|NCT00998764|38097358|FG001|Overall Study|Death|1|||
16954303|NCT00998764|38097357|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
16954304|NCT00998764|38097358|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
16954305|NCT00998764|38097357|FG000|Overall Study|Protocol Violation|0|||
16954306|NCT00998764|38097358|FG001|Overall Study|Protocol Violation|1|||
16954307|NCT00998764|38097357|FG000|Overall Study|Failed to Return|1|||
16954308|NCT00998764|38097358|FG001|Overall Study|Failed to Return|1|||
16954309|NCT00998764|38097357|FG000|Overall Study|Lost to Follow-up|1|||
16954310|NCT00998764|38097358|FG001|Overall Study|Lost to Follow-up|1|||
16954311|NCT00998764|38097357|FG000|Overall Study|Loss of Caregiver|0|||
16954312|NCT00998764|38097358|FG001|Overall Study|Loss of Caregiver|3|||
16954313|NCT00998764|38097357|FG000|Overall Study|Other|4|||
16954314|NCT00998764|38097358|FG001|Overall Study|Other|4|||
16954315|NCT00998764|38097357|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
16954316|NCT00998764|38097358|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
16954317|NCT01204671|38097371|FG000|Overall Study|Adverse Event|4|||
16954318|NCT01204671|38097372|FG001|Overall Study|Adverse Event|3|||
16954319|NCT01204671|38097373|FG002|Overall Study|Adverse Event|3|||
16954320|NCT01204671|38097374|FG003|Overall Study|Adverse Event|3|||
16954321|NCT01204671|38097375|FG004|Overall Study|Adverse Event|1|||
16954322|NCT01204671|38097371|FG000|Overall Study|Withdrawal by Subject|2|||
16954323|NCT01204671|38097372|FG001|Overall Study|Withdrawal by Subject|3|||
16954324|NCT01204671|38097373|FG002|Overall Study|Withdrawal by Subject|4|||
16954325|NCT01204671|38097374|FG003|Overall Study|Withdrawal by Subject|5|||
16954326|NCT01204671|38097375|FG004|Overall Study|Withdrawal by Subject|3|||
16954327|NCT01204671|38097371|FG000|Overall Study|Lost to Follow-up|7|||
16954328|NCT01204671|38097372|FG001|Overall Study|Lost to Follow-up|8|||
16954329|NCT01204671|38097373|FG002|Overall Study|Lost to Follow-up|6|||
16954330|NCT01204671|38097374|FG003|Overall Study|Lost to Follow-up|4|||
16954331|NCT01204671|38097375|FG004|Overall Study|Lost to Follow-up|0|||
16954332|NCT01204671|38097371|FG000|Overall Study|Unknown Completion Status|1|||
16954333|NCT01204671|38097372|FG001|Overall Study|Unknown Completion Status|1|||
16954334|NCT01204671|38097373|FG002|Overall Study|Unknown Completion Status|0|||
16954335|NCT01204671|38097374|FG003|Overall Study|Unknown Completion Status|0|||
16954336|NCT01204671|38097375|FG004|Overall Study|Unknown Completion Status|0|||
16954337|NCT01204671|38097371|FG000|Overall Study|Physician Decision|0|||
16954338|NCT01204671|38097372|FG001|Overall Study|Physician Decision|0|||
16954339|NCT01204671|38097373|FG002|Overall Study|Physician Decision|0|||
16954340|NCT01204671|38097374|FG003|Overall Study|Physician Decision|1|||
16954341|NCT01204671|38097375|FG004|Overall Study|Physician Decision|0|||
16954342|NCT01202955|38097393|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
16954343|NCT01202955|38097394|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
16954344|NCT01202877|38097403|FG000|Overall Study|Disease Progression|0|||
16954345|NCT01202877|38097404|FG001|Overall Study|Disease Progression|1|||
16954346|NCT01202877|38097405|FG002|Overall Study|Disease Progression|2|||
16954347|NCT01202877|38097403|FG000|Overall Study|Adverse Event|0|||
16954348|NCT01202877|38097404|FG001|Overall Study|Adverse Event|0|||
16954349|NCT01202877|38097405|FG002|Overall Study|Adverse Event|2|||
16954350|NCT01202877|38097403|FG000|Overall Study|Withdrawal by Subject|0|||
16954351|NCT01202877|38097404|FG001|Overall Study|Withdrawal by Subject|0|||
16954352|NCT01202877|38097405|FG002|Overall Study|Withdrawal by Subject|1|||
16954353|NCT01202877|38097403|FG000|Overall Study|Death|0|||
16954354|NCT01202877|38097404|FG001|Overall Study|Death|0|||
16954355|NCT01202877|38097405|FG002|Overall Study|Death|1|||
16954356|NCT01202409|38097413|FG000|Overall Study|Adverse Event|1|||
16954357|NCT01202409|38097413|FG000|Overall Study|Ineligible - KRAS mutants|7|||
16954358|NCT01202175|38097419|FG000|Overall Study|Lost to Follow-up|2|||
16954359|NCT01202175|38097419|FG000|Overall Study|Withdrawal by Subject|1|||
16954360|NCT01202175|38097419|FG000|Overall Study|Adverse Event|2|||
16954361|NCT01201785|38097424|FG000|Overall Study|Lost to Follow-up|16|||
16954362|NCT01201317|38097431|FG000|Overall Study|Withdrawal by Subject|5|||
16954363|NCT01201317|38097432|FG001|Overall Study|Withdrawal by Subject|0|||
16954364|NCT01201317|38097433|FG002|Overall Study|Withdrawal by Subject|3|||
16954365|NCT01201317|38097431|FG000|Overall Study|Adverse Event|2|||
16954366|NCT01201317|38097432|FG001|Overall Study|Adverse Event|2|||
16954367|NCT01201317|38097433|FG002|Overall Study|Adverse Event|2|||
16954368|NCT01201317|38097431|FG000|Overall Study|Screen failure|1|||
16954369|NCT01201317|38097432|FG001|Overall Study|Screen failure|1|||
16954370|NCT01201317|38097433|FG002|Overall Study|Screen failure|0|||
16954371|NCT01201317|38097431|FG000|Overall Study|Protocol Violation|0|||
16954372|NCT01201317|38097432|FG001|Overall Study|Protocol Violation|1|||
16954373|NCT01201317|38097433|FG002|Overall Study|Protocol Violation|1|||
16954374|NCT01201317|38097431|FG000|Overall Study|Death|0|||
16954375|NCT01201317|38097432|FG001|Overall Study|Death|1|||
16954376|NCT01201317|38097433|FG002|Overall Study|Death|0|||
16954377|NCT01201317|38097431|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16954378|NCT01201317|38097432|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16954379|NCT01201317|38097433|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16954380|NCT01201317|38097431|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
16954381|NCT01201317|38097432|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
16954382|NCT01201317|38097433|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
16954383|NCT01201317|38097431|FG000|Overall Study|Decrease in renal function|0|||
16954384|NCT01201317|38097432|FG001|Overall Study|Decrease in renal function|1|||
16954385|NCT01201317|38097433|FG002|Overall Study|Decrease in renal function|0|||
16954386|NCT01201317|38097431|FG000|Overall Study|Lack of Efficacy|1|||
16954387|NCT01201317|38097432|FG001|Overall Study|Lack of Efficacy|0|||
16954388|NCT01201317|38097433|FG002|Overall Study|Lack of Efficacy|0|||
16954389|NCT01201317|38097431|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
16954390|NCT01201317|38097432|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
16954391|NCT01201317|38097433|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
16954392|NCT01200069|38097443|FG000|Overall Study|Withdrawal by Subject|0|||
16954393|NCT01200069|38097444|FG001|Overall Study|Withdrawal by Subject|1|||
16954394|NCT01199601|38097495|FG000|Overall Study|Lost to Follow-up|47|||
16954395|NCT01199601|38097496|FG001|Overall Study|Lost to Follow-up|66|||
16954396|NCT01199601|38097495|FG000|Overall Study|Withdrawal by Subject|15|||
16954397|NCT01199601|38097496|FG001|Overall Study|Withdrawal by Subject|3|||
16954398|NCT01199601|38097495|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
16954399|NCT01199601|38097496|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
16954400|NCT01199289|38097506|FG000|Overall Study|Ineligibility determined|2|||
16954401|NCT01199289|38097507|FG001|Overall Study|Ineligibility determined|1|||
16954402|NCT01199289|38097508|FG002|Overall Study|Ineligibility determined|0|||
16954403|NCT01199289|38097509|FG003|Overall Study|Ineligibility determined|0|||
16954404|NCT01199289|38097506|FG000|Overall Study|Protocol Violation|1|||
16954405|NCT01199289|38097507|FG001|Overall Study|Protocol Violation|0|||
16954406|NCT01199289|38097508|FG002|Overall Study|Protocol Violation|0|||
16954407|NCT01199289|38097509|FG003|Overall Study|Protocol Violation|1|||
16954408|NCT01199289|38097506|FG000|Overall Study|Noncompliance|1|||
16954409|NCT01199289|38097507|FG001|Overall Study|Noncompliance|0|||
16954410|NCT01199289|38097508|FG002|Overall Study|Noncompliance|2|||
16954411|NCT01199289|38097509|FG003|Overall Study|Noncompliance|0|||
16954412|NCT01199289|38097506|FG000|Overall Study|Adverse Event|0|||
16954413|NCT01199289|38097507|FG001|Overall Study|Adverse Event|3|||
16954414|NCT01199289|38097508|FG002|Overall Study|Adverse Event|1|||
16954415|NCT01199289|38097509|FG003|Overall Study|Adverse Event|4|||
16954416|NCT01199289|38097506|FG000|Overall Study|Full consent withdrawn|2|||
16954417|NCT01199289|38097507|FG001|Overall Study|Full consent withdrawn|2|||
16954418|NCT01199289|38097508|FG002|Overall Study|Full consent withdrawn|2|||
16954419|NCT01199289|38097509|FG003|Overall Study|Full consent withdrawn|3|||
16954420|NCT01199289|38097506|FG000|Overall Study|Administrative decision|0|||
16954421|NCT01199289|38097507|FG001|Overall Study|Administrative decision|0|||
16954422|NCT01199289|38097508|FG002|Overall Study|Administrative decision|0|||
16954423|NCT01199289|38097509|FG003|Overall Study|Administrative decision|1|||
16954424|NCT01199289|38097506|FG000|Overall Study|Lost to Follow-up|0|||
16954425|NCT01199289|38097507|FG001|Overall Study|Lost to Follow-up|0|||
16954426|NCT01199289|38097508|FG002|Overall Study|Lost to Follow-up|0|||
16954427|NCT01199289|38097509|FG003|Overall Study|Lost to Follow-up|1|||
16954428|NCT01199289|38097506|FG000|Overall Study|Protocol-specified criteria|3|||
16954429|NCT01199289|38097507|FG001|Overall Study|Protocol-specified criteria|0|||
16954430|NCT01199289|38097508|FG002|Overall Study|Protocol-specified criteria|0|||
16954431|NCT01199289|38097509|FG003|Overall Study|Protocol-specified criteria|1|||
16954432|NCT01199289|38097506|FG000|Overall Study|Pregnancy|0|||
16954433|NCT01199289|38097507|FG001|Overall Study|Pregnancy|1|||
16954434|NCT01199289|38097508|FG002|Overall Study|Pregnancy|0|||
16954435|NCT01199289|38097509|FG003|Overall Study|Pregnancy|1|||
16954436|NCT01199055|38097525|FG000|Overall Study|Death|0|||
16954437|NCT01199055|38097526|FG001|Overall Study|Death|1|||
16954438|NCT01199055|38097527|FG002|Overall Study|Death|0|||
16954439|NCT01199055|38097525|FG000|Overall Study|Physician Decision|0|||
16954440|NCT01199055|38097526|FG001|Overall Study|Physician Decision|1|||
16954441|NCT01199055|38097527|FG002|Overall Study|Physician Decision|1|||
16954442|NCT01199055|38097525|FG000|Overall Study|Progressive disease|2|||
16954443|NCT01199055|38097526|FG001|Overall Study|Progressive disease|1|||
16954444|NCT01199055|38097527|FG002|Overall Study|Progressive disease|2|||
16954445|NCT01199055|38097525|FG000|Overall Study|Withdrawal by Subject|0|||
16954446|NCT01199055|38097526|FG001|Overall Study|Withdrawal by Subject|0|||
16954447|NCT01199055|38097527|FG002|Overall Study|Withdrawal by Subject|1|||
16954448|NCT01198977|38097539|FG000|Overall Study|Lost to Follow-up|1|||
16954449|NCT01198977|38097540|FG001|Overall Study|Lost to Follow-up|0|||
16954450|NCT01198587|38097552|FG000|Overall Study|Lost to Follow-up|8|||
16954451|NCT01198587|38097553|FG001|Overall Study|Lost to Follow-up|0|||
16954452|NCT01198587|38097554|FG002|Overall Study|Lost to Follow-up|9|||
16954453|NCT01198587|38097555|FG003|Overall Study|Lost to Follow-up|0|||
16954454|NCT01198509|38097576|FG000|Overall Study|Withdrawal by Subject|1|||
16954455|NCT01198509|38097577|FG001|Overall Study|Withdrawal by Subject|0|||
16954456|NCT01198509|38097578|FG002|Overall Study|Withdrawal by Subject|0|||
16954457|NCT01198509|38097579|FG003|Overall Study|Withdrawal by Subject|0|||
16954458|NCT01198509|38097580|FG004|Overall Study|Withdrawal by Subject|0|||
16954459|NCT01198509|38097581|FG005|Overall Study|Withdrawal by Subject|0|||
16774346|NCT02167594|37713637|FG001|Overall Study|Withdrawal by Subject|0|||
16774347|NCT02167594|37713638|FG002|Overall Study|Withdrawal by Subject|0|||
16954460|NCT01198275|38097595|FG000|Overall Study|Adverse Event|2|||
16954461|NCT01198275|38097596|FG001|Overall Study|Adverse Event|3|||
16954462|NCT01198275|38097595|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
16954463|NCT01198275|38097596|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
16954464|NCT01197417|38097604|FG000|Overall Study|Physician Decision|3|||
16954465|NCT01197417|38097605|FG001|Overall Study|Physician Decision|2|||
16954466|NCT01197417|38097604|FG000|Overall Study|Withdrawal by Subject|2|||
16954467|NCT01197417|38097605|FG001|Overall Study|Withdrawal by Subject|4|||
16954468|NCT01197417|38097604|FG000|Overall Study|Site miscommunication|0|||
16954469|NCT01197417|38097605|FG001|Overall Study|Site miscommunication|1|||
16954470|NCT01197417|38097604|FG000|Overall Study|Subject transferred to intensive care|0|||
16954471|NCT01197417|38097605|FG001|Overall Study|Subject transferred to intensive care|1|||
16954472|NCT01197417|38097604|FG000|Overall Study|Not consented in time to receive drug|0|||
16954473|NCT01197417|38097605|FG001|Overall Study|Not consented in time to receive drug|1|||
16954474|NCT01197417|38097604|FG000|Overall Study|Hypotension|1|||
16954475|NCT01197417|38097605|FG001|Overall Study|Hypotension|2|||
16954476|NCT01197417|38097604|FG000|Overall Study|Found to be ineligible|2|||
16954477|NCT01197417|38097605|FG001|Overall Study|Found to be ineligible|5|||
16954478|NCT01197417|38097604|FG000|Overall Study|No 25-hour magnesium level|0|||
16954479|NCT01197417|38097605|FG001|Overall Study|No 25-hour magnesium level|2|||
16954480|NCT00977431|38097616|FG000|Overall Study|Other than listed|1|||
16954481|NCT00977431|38097617|FG001|Overall Study|Other than listed|0|||
16954482|NCT00977431|38097618|FG002|Overall Study|Other than listed|0|||
16954483|NCT00977431|38097619|FG003|Overall Study|Other than listed|0|||
16954484|NCT00977431|38097620|FG004|Overall Study|Other than listed|2|||
16954485|NCT00977431|38097616|FG000|Overall Study|Protocol Violation|0|||
16954486|NCT00977431|38097617|FG001|Overall Study|Protocol Violation|0|||
16954487|NCT00977431|38097618|FG002|Overall Study|Protocol Violation|1|||
16954488|NCT00977431|38097619|FG003|Overall Study|Protocol Violation|0|||
16954489|NCT00977431|38097620|FG004|Overall Study|Protocol Violation|0|||
16954490|NCT00977431|38097616|FG000|Overall Study|Adverse Event|3|||
16954491|NCT00977431|38097617|FG001|Overall Study|Adverse Event|0|||
16954492|NCT00977431|38097618|FG002|Overall Study|Adverse Event|4|||
16954493|NCT00977431|38097619|FG003|Overall Study|Adverse Event|0|||
16954494|NCT00977431|38097620|FG004|Overall Study|Adverse Event|6|||
16954495|NCT00977431|38097616|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
16954496|NCT00977431|38097617|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
16954497|NCT00977431|38097618|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
16954498|NCT00977431|38097619|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
16954499|NCT00977431|38097620|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
16954500|NCT00977431|38097616|FG000|Overall Study|Progressive disease|2|||
16954501|NCT00977431|38097617|FG001|Overall Study|Progressive disease|6|||
16954502|NCT00977431|38097618|FG002|Overall Study|Progressive disease|1|||
16954503|NCT00977431|38097619|FG003|Overall Study|Progressive disease|3|||
16954504|NCT00977431|38097620|FG004|Overall Study|Progressive disease|5|||
16954505|NCT00977197|38097638|FG000|Overall Study|Withdrawal by Subject|3|||
16954506|NCT00977197|38097639|FG001|Overall Study|Withdrawal by Subject|4|||
16954507|NCT00977197|38097638|FG000|Overall Study|Adverse Event|3|||
16954508|NCT00977197|38097639|FG001|Overall Study|Adverse Event|1|||
16954509|NCT00977197|38097638|FG000|Overall Study|Lack of Efficacy|1|||
16954510|NCT00977197|38097639|FG001|Overall Study|Lack of Efficacy|0|||
16954511|NCT00977197|38097638|FG000|Overall Study|Lost to Follow-up|1|||
16954512|NCT00977197|38097639|FG001|Overall Study|Lost to Follow-up|3|||
16954513|NCT00977197|38097638|FG000|Overall Study|Nonadherence|1|||
16954514|NCT00977197|38097639|FG001|Overall Study|Nonadherence|1|||
16954515|NCT00974311|38097647|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
16954516|NCT00974311|38097648|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
16954517|NCT00974311|38097647|FG000|DB Phase (up to 24 Months)|Death|561|||
16954518|NCT00974311|38097648|FG001|DB Phase (up to 24 Months)|Death|298|||
16954519|NCT00974311|38097647|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
16954520|NCT00974311|38097648|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
16954521|NCT00974311|38097647|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
16954522|NCT00974311|38097648|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
16954523|NCT00974311|38097647|FG000|DB Phase (up to 24 Months)|Other|1|||
16954524|NCT00974311|38097648|FG001|DB Phase (up to 24 Months)|Other|0|||
16954525|NCT00974311|38097647|FG000|OLE Phase (up to 77 Months)|Death|14|||
16954526|NCT00974311|38097648|FG001|OLE Phase (up to 77 Months)|Death|21|||
16954527|NCT00974311|38097647|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
16954528|NCT00974311|38097648|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
16954529|NCT00974311|38097647|FG000|OLE Phase (up to 77 Months)|Other|15|||
16954530|NCT00974311|38097648|FG001|OLE Phase (up to 77 Months)|Other|2|||
16954531|NCT00974311|38097647|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
16954532|NCT00974311|38097648|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
16954533|NCT00974233|38097657|FG000|Induction Chemoimmunotherapy|Death|2|||
16954534|NCT00974233|38097657|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
16954535|NCT00974233|38097657|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
16954536|NCT00974233|38097657|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
16954537|NCT00974233|38097657|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
16954538|NCT00974233|38097657|FG000|Maintenance Lenalidomide|Adverse Event|8|||
16954539|NCT00973921|38097669|FG000|Overall Study|IVUS results were not available|9|||
16954540|NCT00972595|38097673|FG000|Period 1|Adverse Event|1|||
16954541|NCT00972595|38097674|FG001|Period 1|Adverse Event|0|||
16954542|NCT01196091|38097683|FG000|Overall Study|Adverse Event|22|||
16954543|NCT01196091|38097684|FG001|Overall Study|Adverse Event|27|||
16954544|NCT01196091|38097685|FG002|Overall Study|Adverse Event|26|||
16954545|NCT01196091|38097683|FG000|Overall Study|Death|3|||
16954546|NCT01196091|38097684|FG001|Overall Study|Death|2|||
16954547|NCT01196091|38097685|FG002|Overall Study|Death|2|||
16954548|NCT01196091|38097683|FG000|Overall Study|Entry Criteria Not Met|11|||
16954549|NCT01196091|38097684|FG001|Overall Study|Entry Criteria Not Met|11|||
16954550|NCT01196091|38097685|FG002|Overall Study|Entry Criteria Not Met|10|||
16954551|NCT01196091|38097683|FG000|Overall Study|Lack of Efficacy|15|||
16954552|NCT01196091|38097684|FG001|Overall Study|Lack of Efficacy|12|||
16954553|NCT01196091|38097685|FG002|Overall Study|Lack of Efficacy|17|||
16954554|NCT01196091|38097683|FG000|Overall Study|Lost to Follow-up|5|||
16954555|NCT01196091|38097684|FG001|Overall Study|Lost to Follow-up|5|||
16954556|NCT01196091|38097685|FG002|Overall Study|Lost to Follow-up|6|||
16954557|NCT01196091|38097683|FG000|Overall Study|Parent/Caregiver Decision|0|||
16954558|NCT01196091|38097684|FG001|Overall Study|Parent/Caregiver Decision|0|||
16954559|NCT01196091|38097685|FG002|Overall Study|Parent/Caregiver Decision|1|||
16954560|NCT01196091|38097683|FG000|Overall Study|Withdrawal by Subject|16|||
16954561|NCT01196091|38097684|FG001|Overall Study|Withdrawal by Subject|19|||
16954562|NCT01196091|38097685|FG002|Overall Study|Withdrawal by Subject|22|||
16954563|NCT01196091|38097683|FG000|Overall Study|Physician Decision|3|||
16954564|NCT01196091|38097684|FG001|Overall Study|Physician Decision|3|||
16954565|NCT01196091|38097685|FG002|Overall Study|Physician Decision|4|||
16954566|NCT01196091|38097683|FG000|Overall Study|Protocol Violation|1|||
16954567|NCT01196091|38097684|FG001|Overall Study|Protocol Violation|3|||
16954568|NCT01196091|38097685|FG002|Overall Study|Protocol Violation|3|||
16954569|NCT01196091|38097683|FG000|Overall Study|Sponsor Decision|6|||
16954570|NCT01196091|38097684|FG001|Overall Study|Sponsor Decision|5|||
16954571|NCT01196091|38097685|FG002|Overall Study|Sponsor Decision|4|||
16954572|NCT01196091|38097683|FG000|Overall Study|Excluded Site|5|||
16954573|NCT01196091|38097684|FG001|Overall Study|Excluded Site|11|||
16954574|NCT01196091|38097685|FG002|Overall Study|Excluded Site|8|||
16954575|NCT01196091|38097683|FG000|Overall Study|Randomized, No Study Drug Received|1|||
16954576|NCT01196091|38097684|FG001|Overall Study|Randomized, No Study Drug Received|0|||
16954577|NCT01196091|38097685|FG002|Overall Study|Randomized, No Study Drug Received|1|||
16954578|NCT01195623|38097700|FG000|Overall Study|Lost to Follow-up|35|||
16954579|NCT01195623|38097701|FG001|Overall Study|Lost to Follow-up|37|||
16954580|NCT01195545|38097707|FG000|Overall Study|Protocol Violation|4|||
16954581|NCT01194999|38097711|FG000|Overall Study|Lost to Follow-up|17|||
16954582|NCT01194531|38097717|FG000|Overall Study|Withdrawal by Subject|1|||
16954583|NCT01194531|38097718|FG001|Overall Study|Withdrawal by Subject|0|||
16954584|NCT01194531|38097717|FG000|Overall Study|Protocol Violation|4|||
16954585|NCT01194531|38097718|FG001|Overall Study|Protocol Violation|1|||
16954586|NCT01194531|38097717|FG000|Overall Study|Physician Decision|0|||
16954587|NCT01194531|38097718|FG001|Overall Study|Physician Decision|2|||
16954588|NCT00972517|38097724|FG000|Overall Study|Adverse Event|0|||
16954589|NCT00972517|38097725|FG001|Overall Study|Adverse Event|0|||
16954590|NCT00972517|38097726|FG002|Overall Study|Adverse Event|0|||
16954591|NCT00972517|38097727|FG003|Overall Study|Adverse Event|1|||
16954592|NCT00972517|38097728|FG004|Overall Study|Adverse Event|0|||
16954593|NCT00972517|38097729|FG005|Overall Study|Adverse Event|0|||
16954594|NCT00972517|38097724|FG000|Overall Study|Withdrawal by Subject|0|||
16954595|NCT00972517|38097725|FG001|Overall Study|Withdrawal by Subject|1|||
16954596|NCT00972517|38097726|FG002|Overall Study|Withdrawal by Subject|0|||
16954597|NCT00972517|38097727|FG003|Overall Study|Withdrawal by Subject|2|||
16954598|NCT00972517|38097728|FG004|Overall Study|Withdrawal by Subject|1|||
16954599|NCT00972517|38097729|FG005|Overall Study|Withdrawal by Subject|0|||
16954600|NCT00972283|38097751|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
16954601|NCT00972283|38097752|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
16954602|NCT00972283|38097751|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
16954603|NCT00972283|38097752|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
16954604|NCT00972283|38097751|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
16954605|NCT00972283|38097752|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
16954606|NCT00972283|38097751|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
16954607|NCT00972283|38097752|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
16954608|NCT00972283|38097751|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
16954609|NCT00972283|38097752|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
17128308|NCT04527471|38269275|FG001|Overall Study|Adverse Event|0|||
17128309|NCT04527471|38269274|FG000|Overall Study|Lost to Follow-up|1|||
16954610|NCT00972283|38097751|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
16954611|NCT00972283|38097752|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
16954612|NCT00972283|38097751|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
16954613|NCT00972283|38097752|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
16954614|NCT00972283|38097751|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
16954615|NCT00972283|38097752|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
16954616|NCT00972283|38097751|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
16954617|NCT00972283|38097752|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
16954618|NCT00972283|38097751|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
16954619|NCT00972283|38097752|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
16954620|NCT01194219|38097760|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
16954621|NCT01194219|38097761|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
16954622|NCT01194219|38097762|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16954623|NCT01194219|38097763|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16954624|NCT01194219|38097764|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16954625|NCT01194219|38097765|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16954626|NCT01194219|38097766|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16954627|NCT01194219|38097767|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16954628|NCT01194219|38097768|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16954629|NCT01194219|38097769|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16954630|NCT01194219|38097760|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
16954631|NCT01194219|38097761|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
16954632|NCT01194219|38097762|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16954633|NCT01194219|38097763|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16954634|NCT01194219|38097764|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16954635|NCT01194219|38097765|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16954636|NCT01194219|38097766|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16954637|NCT01194219|38097767|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16954638|NCT01194219|38097768|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16954639|NCT01194219|38097769|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16954640|NCT01194219|38097760|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
16954641|NCT01194219|38097761|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954642|NCT01194219|38097762|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954643|NCT01194219|38097763|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954644|NCT01194219|38097764|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954645|NCT01194219|38097765|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954646|NCT01194219|38097766|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954647|NCT01194219|38097767|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954648|NCT01194219|38097768|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954649|NCT01194219|38097769|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16954650|NCT01194219|38097760|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
16954651|NCT01194219|38097761|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
16954652|NCT01194219|38097762|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16954653|NCT01194219|38097763|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16954654|NCT01194219|38097764|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16954655|NCT01194219|38097765|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16954656|NCT01194219|38097766|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16954657|NCT01194219|38097767|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16954658|NCT01194219|38097768|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16954659|NCT01194219|38097769|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16954660|NCT01194219|38097760|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954661|NCT01194219|38097761|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
16954662|NCT01194219|38097762|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954663|NCT01194219|38097763|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954664|NCT01194219|38097764|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954665|NCT01194219|38097765|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954666|NCT01194219|38097766|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954667|NCT01194219|38097767|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954668|NCT01194219|38097768|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954669|NCT01194219|38097769|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16954670|NCT01194219|38097760|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
16954671|NCT01194219|38097761|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
16954672|NCT01194219|38097762|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16954673|NCT01194219|38097763|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16954674|NCT01194219|38097764|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16954675|NCT01194219|38097765|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16954676|NCT01194219|38097766|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16954677|NCT01194219|38097767|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16954678|NCT01194219|38097768|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16954679|NCT01194219|38097769|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16954680|NCT01194219|38097760|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
16954681|NCT01194219|38097761|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
16954682|NCT01194219|38097762|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16954683|NCT01194219|38097763|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16954684|NCT01194219|38097764|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16954685|NCT01194219|38097765|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16954686|NCT01194219|38097766|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16954687|NCT01194219|38097767|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16954688|NCT01194219|38097768|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16954689|NCT01194219|38097769|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16954690|NCT01194219|38097760|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
16954691|NCT01194219|38097761|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
16954692|NCT01194219|38097762|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16954693|NCT01194219|38097763|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16954694|NCT01194219|38097764|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16954695|NCT01194219|38097765|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
17128310|NCT04527471|38269275|FG001|Overall Study|Lost to Follow-up|0|||
16954696|NCT01194219|38097766|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16954697|NCT01194219|38097767|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16954698|NCT01194219|38097768|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16954699|NCT01194219|38097769|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16954700|NCT01194219|38097760|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
16954701|NCT01194219|38097761|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
16954702|NCT01194219|38097762|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
16954703|NCT01194219|38097763|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
16954704|NCT01194219|38097764|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
16954705|NCT01194219|38097765|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
16954706|NCT01194219|38097766|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
16954707|NCT01194219|38097767|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
16954708|NCT01194219|38097768|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
16954709|NCT01194219|38097769|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
16954710|NCT01194219|38097760|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16954711|NCT01194219|38097761|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16954712|NCT01194219|38097762|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
16954713|NCT01194219|38097763|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
16954714|NCT01194219|38097764|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16954715|NCT01194219|38097765|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16954716|NCT01194219|38097766|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16954717|NCT01194219|38097767|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16954718|NCT01194219|38097768|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16954719|NCT01194219|38097769|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16954720|NCT01194219|38097760|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16954721|NCT01194219|38097761|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16954722|NCT01194219|38097762|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
16954723|NCT01194219|38097763|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
16954724|NCT01194219|38097764|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16954725|NCT01194219|38097765|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16954726|NCT01194219|38097766|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16954727|NCT01194219|38097767|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16954728|NCT01194219|38097768|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16954729|NCT01194219|38097769|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16954730|NCT01194219|38097760|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16954731|NCT01194219|38097761|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16954732|NCT01194219|38097762|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
16954733|NCT01194219|38097763|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
16954734|NCT01194219|38097764|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16954735|NCT01194219|38097765|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16954736|NCT01194219|38097766|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16954737|NCT01194219|38097767|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16954738|NCT01194219|38097768|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16954739|NCT01194219|38097769|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
17128311|NCT04471935|38269281|FG000|Overall Study|Withdrawal by Subject|1|||
17128312|NCT04471935|38269281|FG000|Overall Study|Deemed ineligible to participate|1|||
17128313|NCT04468347|38269289|FG000|Overall Study|Withdrawal by Subject|0|||
17128314|NCT04468347|38269290|FG001|Overall Study|Withdrawal by Subject|1|||
17128315|NCT04468347|38269291|FG002|Overall Study|Withdrawal by Subject|3|||
17128316|NCT04468347|38269292|FG003|Overall Study|Withdrawal by Subject|3|||
17128317|NCT04468347|38269289|FG000|Overall Study|Lost to Follow-up|0|||
17128318|NCT04468347|38269290|FG001|Overall Study|Lost to Follow-up|0|||
17128319|NCT04468347|38269291|FG002|Overall Study|Lost to Follow-up|1|||
17128320|NCT04468347|38269292|FG003|Overall Study|Lost to Follow-up|1|||
17128321|NCT04468347|38269289|FG000|Overall Study|Physician Decision|1|||
17128322|NCT04468347|38269290|FG001|Overall Study|Physician Decision|0|||
17128323|NCT04468347|38269291|FG002|Overall Study|Physician Decision|2|||
17128324|NCT04468347|38269292|FG003|Overall Study|Physician Decision|0|||
17128325|NCT04468347|38269289|FG000|Overall Study|Protocol Violation|1|||
17128326|NCT04468347|38269290|FG001|Overall Study|Protocol Violation|0|||
17128327|NCT04468347|38269291|FG002|Overall Study|Protocol Violation|0|||
17128328|NCT04468347|38269292|FG003|Overall Study|Protocol Violation|0|||
17128329|NCT04822701|38269308|FG000|Overall Study|Not treated|2|||
16774348|NCT02167594|37713636|FG000|Overall Study|Death|0|||
16954740|NCT01194219|38097760|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
17128330|NCT04822701|38269309|FG001|Overall Study|Not treated|0|||
17128331|NCT04822701|38269308|FG000|Overall Study|Lost to Follow-up|1|||
17128332|NCT04822701|38269309|FG001|Overall Study|Lost to Follow-up|0|||
17128333|NCT04822701|38269308|FG000|Overall Study|Withdrawal by Subject|1|||
17128334|NCT04822701|38269309|FG001|Overall Study|Withdrawal by Subject|0|||
17128335|NCT04461795|38269315|FG000|Overall Study|Lost to Follow-up|2|||
17128336|NCT04461795|38269315|FG000|Overall Study|Withdrawal by Subject|2|||
17128337|NCT04461795|38269315|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
17128338|NCT04461015|38269322|FG000|Overall Study|IV access lost during the study|0|||
17128339|NCT04461015|38269323|FG001|Overall Study|IV access lost during the study|1|||
17128340|NCT04461015|38269322|FG000|Overall Study|Withdrawal by Subject|0|||
17128341|NCT04461015|38269323|FG001|Overall Study|Withdrawal by Subject|1|||
17128342|NCT04810221|38269329|FG000|Overall Study|Physician Decision|3|||
17128343|NCT03694353|38269333|FG000|Overall Study|Withdrawal by Subject|1|||
17128344|NCT03694353|38269333|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
17128345|NCT04521777|38269337|FG000|Overall Study|Death|2|||
17128346|NCT04521777|38269337|FG000|Overall Study|Withdrawal by Subject|2|||
17128347|NCT03700671|38269343|FG000|Overall Study|Lack of Efficacy|1|||
17128348|NCT03700671|38269344|FG001|Overall Study|Lack of Efficacy|2|||
17128349|NCT04779879|38269358|FG000|Part A: Up to Day 29|ongoing in the study|8|||
17128350|NCT04779879|38269359|FG001|Part A: Up to Day 29|ongoing in the study|22|||
17128351|NCT04779879|38269360|FG002|Part A: Up to Day 29|ongoing in the study|0|||
17128352|NCT04779879|38269361|FG003|Part A: Up to Day 29|ongoing in the study|0|||
17128353|NCT04779879|38269362|FG004|Part A: Up to Day 29|ongoing in the study|0|||
17128354|NCT04779879|38269363|FG005|Part A: Up to Day 29|ongoing in the study|0|||
17128355|NCT04779879|38269358|FG000|Part B: Up to Day 29|Ongoing in the study|0|||
17128356|NCT04779879|38269359|FG001|Part B: Up to Day 29|Ongoing in the study|0|||
17128357|NCT04779879|38269360|FG002|Part B: Up to Day 29|Ongoing in the study|84|||
17128358|NCT04779879|38269361|FG003|Part B: Up to Day 29|Ongoing in the study|82|||
17128359|NCT04779879|38269362|FG004|Part B: Up to Day 29|Ongoing in the study|0|||
17128360|NCT04779879|38269363|FG005|Part B: Up to Day 29|Ongoing in the study|0|||
17128361|NCT04779879|38269358|FG000|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
17128362|NCT04779879|38269359|FG001|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
17128363|NCT04779879|38269360|FG002|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
17128364|NCT04779879|38269361|FG003|Part B: Up to Day 29|Randomized, but did not receive treatment|1|||
17128365|NCT04779879|38269362|FG004|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
17128366|NCT04779879|38269363|FG005|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
17128367|NCT04779879|38269358|FG000|Part C: Up to Day 29|Ongoing in the study|0|||
17128368|NCT04779879|38269359|FG001|Part C: Up to Day 29|Ongoing in the study|0|||
17128369|NCT04779879|38269360|FG002|Part C: Up to Day 29|Ongoing in the study|0|||
17128370|NCT04779879|38269361|FG003|Part C: Up to Day 29|Ongoing in the study|0|||
17128371|NCT04779879|38269362|FG004|Part C: Up to Day 29|Ongoing in the study|78|||
17128372|NCT04779879|38269363|FG005|Part C: Up to Day 29|Ongoing in the study|77|||
17128373|NCT04779879|38269358|FG000|Part C: Up to Day 29|Death|0|||
17128374|NCT04779879|38269359|FG001|Part C: Up to Day 29|Death|0|||
17128375|NCT04779879|38269360|FG002|Part C: Up to Day 29|Death|0|||
17128376|NCT04779879|38269361|FG003|Part C: Up to Day 29|Death|0|||
17128377|NCT04779879|38269362|FG004|Part C: Up to Day 29|Death|0|||
17128378|NCT04779879|38269363|FG005|Part C: Up to Day 29|Death|1|||
17128379|NCT04779879|38269358|FG000|Part C: Up to Day 29|Withdrawal by Subject|0|||
17128380|NCT04779879|38269359|FG001|Part C: Up to Day 29|Withdrawal by Subject|0|||
17128381|NCT04779879|38269360|FG002|Part C: Up to Day 29|Withdrawal by Subject|0|||
17128382|NCT04779879|38269361|FG003|Part C: Up to Day 29|Withdrawal by Subject|0|||
17128383|NCT04779879|38269362|FG004|Part C: Up to Day 29|Withdrawal by Subject|1|||
17128384|NCT04779879|38269363|FG005|Part C: Up to Day 29|Withdrawal by Subject|0|||
17128385|NCT04764669|38269383|FG000|Overall Study|Adverse Event|1|||
17128386|NCT04764669|38269384|FG001|Overall Study|Adverse Event|0|||
17128387|NCT04764669|38269385|FG002|Overall Study|Adverse Event|1|||
17128388|NCT04764669|38269386|FG003|Overall Study|Adverse Event|0|||
17128389|NCT04764669|38269383|FG000|Overall Study|Subject Choice|0|||
17128390|NCT04764669|38269384|FG001|Overall Study|Subject Choice|0|||
17128391|NCT04764669|38269385|FG002|Overall Study|Subject Choice|1|||
17128392|NCT04764669|38269386|FG003|Overall Study|Subject Choice|0|||
17128393|NCT04764669|38269383|FG000|Overall Study|Withdrawal by Subject|2|||
17128394|NCT04764669|38269384|FG001|Overall Study|Withdrawal by Subject|0|||
16954741|NCT01194219|38097761|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16954742|NCT01194219|38097762|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
16954743|NCT01194219|38097763|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16954744|NCT01194219|38097764|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16954745|NCT01194219|38097765|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16954746|NCT01194219|38097766|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16954747|NCT01194219|38097767|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
17128395|NCT04764669|38269385|FG002|Overall Study|Withdrawal by Subject|0|||
17128396|NCT04764669|38269386|FG003|Overall Study|Withdrawal by Subject|0|||
17128397|NCT04439253|38269396|FG000|Overall Study|Adverse Event|1|||
17128398|NCT04439253|38269396|FG000|Overall Study|Disease progression|2|||
17128399|NCT04439253|38269396|FG000|Overall Study|Complicating disease|1|||
17128400|NCT04438785|38269402|FG000|Overall Study|change of weight, give up intervention|2|||
17128401|NCT04438785|38269403|FG001|Overall Study|change of weight, give up intervention|10|||
16954748|NCT01194219|38097768|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16954749|NCT01194219|38097769|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16954750|NCT01194219|38097760|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954751|NCT01194219|38097761|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954752|NCT01194219|38097762|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954753|NCT01194219|38097763|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
16954754|NCT01194219|38097764|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954755|NCT01194219|38097765|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954756|NCT01194219|38097766|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954757|NCT01194219|38097767|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954758|NCT01194219|38097768|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954759|NCT01194219|38097769|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16954760|NCT01194219|38097760|FG000|Maintenance Phase Weeks16-32|Other|0|||
16954761|NCT01194219|38097761|FG001|Maintenance Phase Weeks16-32|Other|0|||
16954762|NCT01194219|38097762|FG002|Maintenance Phase Weeks16-32|Other|2|||
16954763|NCT01194219|38097763|FG003|Maintenance Phase Weeks16-32|Other|1|||
16954764|NCT01194219|38097764|FG004|Maintenance Phase Weeks16-32|Other|0|||
16954765|NCT01194219|38097765|FG005|Maintenance Phase Weeks16-32|Other|0|||
16954766|NCT01194219|38097766|FG006|Maintenance Phase Weeks16-32|Other|0|||
16954767|NCT01194219|38097767|FG007|Maintenance Phase Weeks16-32|Other|0|||
16954768|NCT01194219|38097768|FG008|Maintenance Phase Weeks16-32|Other|0|||
16954769|NCT01194219|38097769|FG009|Maintenance Phase Weeks16-32|Other|0|||
16954770|NCT01194219|38097760|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16954771|NCT01194219|38097761|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16954772|NCT01194219|38097762|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16954773|NCT01194219|38097763|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16954774|NCT01194219|38097764|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16954775|NCT01194219|38097765|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
16954776|NCT01194219|38097766|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
16954777|NCT01194219|38097767|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
16954778|NCT01194219|38097768|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16954779|NCT01194219|38097769|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16954780|NCT01194219|38097760|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16954781|NCT01194219|38097761|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16954782|NCT01194219|38097762|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16954783|NCT01194219|38097763|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16954784|NCT01194219|38097764|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
16954785|NCT01194219|38097765|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
16954786|NCT01194219|38097766|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
16954787|NCT01194219|38097767|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
16954788|NCT01194219|38097768|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16954789|NCT01194219|38097769|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16954790|NCT01194219|38097760|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16954791|NCT01194219|38097761|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16954792|NCT01194219|38097762|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16954793|NCT01194219|38097763|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16954794|NCT01194219|38097764|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
16954795|NCT01194219|38097765|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16954796|NCT01194219|38097766|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
16954797|NCT01194219|38097767|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16954798|NCT01194219|38097768|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16954799|NCT01194219|38097769|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16954800|NCT01194219|38097760|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16954801|NCT01194219|38097761|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16954802|NCT01194219|38097762|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16954803|NCT01194219|38097763|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16954804|NCT01194219|38097764|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
16954805|NCT01194219|38097765|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16954806|NCT01194219|38097766|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
16954807|NCT01194219|38097767|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
16954808|NCT01194219|38097768|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16954809|NCT01194219|38097769|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16954810|NCT01194219|38097760|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16954811|NCT01194219|38097761|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16774349|NCT02167594|37713637|FG001|Overall Study|Death|1|||
16774350|NCT02167594|37713638|FG002|Overall Study|Death|0|||
17128402|NCT04741503|38269411|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
17128403|NCT04741503|38269412|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
17128404|NCT04741503|38269413|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
17128405|NCT04741503|38269411|FG000|Initial Enrollment|Overquotas removed|0|||
17128406|NCT04741503|38269412|FG001|Initial Enrollment|Overquotas removed|0|||
17128407|NCT04741503|38269413|FG002|Initial Enrollment|Overquotas removed|186|||
16954812|NCT01194219|38097762|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16954813|NCT01194219|38097763|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16954814|NCT01194219|38097764|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
16954815|NCT01194219|38097765|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
16954816|NCT01194219|38097766|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
16954817|NCT01194219|38097767|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16954818|NCT01194219|38097768|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16954819|NCT01194219|38097769|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16954820|NCT01194219|38097760|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954821|NCT01194219|38097761|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954822|NCT01194219|38097762|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954823|NCT01194219|38097763|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954824|NCT01194219|38097764|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954825|NCT01194219|38097765|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954826|NCT01194219|38097766|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954827|NCT01194219|38097767|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
16954828|NCT01194219|38097768|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954829|NCT01194219|38097769|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16954830|NCT01194219|38097760|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954831|NCT01194219|38097761|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954832|NCT01194219|38097762|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954833|NCT01194219|38097763|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954834|NCT01194219|38097764|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954835|NCT01194219|38097765|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954836|NCT01194219|38097766|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
16954837|NCT01194219|38097767|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954838|NCT01194219|38097768|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954839|NCT01194219|38097769|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16954840|NCT01194219|38097760|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16954841|NCT01194219|38097761|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16954842|NCT01194219|38097762|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16954843|NCT01194219|38097763|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16954844|NCT01194219|38097764|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16954845|NCT01194219|38097765|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16954846|NCT01194219|38097766|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16954847|NCT01194219|38097767|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16954848|NCT01194219|38097768|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
16954849|NCT01194219|38097769|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
16954850|NCT01194219|38097760|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16954851|NCT01194219|38097761|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16954852|NCT01194219|38097762|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16954853|NCT01194219|38097763|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16954854|NCT01194219|38097764|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16954855|NCT01194219|38097765|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16954856|NCT01194219|38097766|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16954857|NCT01194219|38097767|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16954858|NCT01194219|38097768|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
16954859|NCT01194219|38097769|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
16954860|NCT01194219|38097760|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16954861|NCT01194219|38097761|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16954862|NCT01194219|38097762|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16954863|NCT01194219|38097763|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16954864|NCT01194219|38097764|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16954865|NCT01194219|38097765|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16954866|NCT01194219|38097766|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16954867|NCT01194219|38097767|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16954868|NCT01194219|38097768|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
16954869|NCT01194219|38097769|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
16954870|NCT01194219|38097760|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16954871|NCT01194219|38097761|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16954872|NCT01194219|38097762|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16954873|NCT01194219|38097763|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16954874|NCT01194219|38097764|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16954875|NCT01194219|38097765|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16954876|NCT01194219|38097766|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16954877|NCT01194219|38097767|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16954878|NCT01194219|38097768|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
16954879|NCT01194219|38097769|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
16954880|NCT01194219|38097760|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
16954881|NCT01194219|38097761|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
16954882|NCT01194219|38097762|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
16954883|NCT01194219|38097763|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
16954884|NCT01194219|38097764|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
16954885|NCT01194219|38097765|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
16954886|NCT01194219|38097766|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
16954887|NCT01194219|38097767|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
16954888|NCT01194219|38097768|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
16954889|NCT01194219|38097769|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
16954890|NCT01194219|38097760|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16954891|NCT01194219|38097761|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16954892|NCT01194219|38097762|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16954893|NCT01194219|38097763|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16954894|NCT01194219|38097764|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16954895|NCT01194219|38097765|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16954896|NCT01194219|38097766|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16954897|NCT01194219|38097767|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16954898|NCT01194219|38097768|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
16954899|NCT01194219|38097769|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
16954900|NCT01194219|38097760|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954901|NCT01194219|38097761|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954902|NCT01194219|38097762|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954903|NCT01194219|38097763|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954904|NCT01194219|38097764|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954905|NCT01194219|38097765|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954906|NCT01194219|38097766|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954907|NCT01194219|38097767|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954908|NCT01194219|38097768|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
16954909|NCT01194219|38097769|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16954910|NCT01194219|38097760|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16954911|NCT01194219|38097761|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16954912|NCT01194219|38097762|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16954913|NCT01194219|38097763|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16954914|NCT01194219|38097764|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16954915|NCT01194219|38097765|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16954916|NCT01194219|38097766|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16954917|NCT01194219|38097767|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16954918|NCT01194219|38097768|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
16954919|NCT01194219|38097769|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
16954920|NCT00969709|38097796|FG000|Overall Study|Adverse Event|3|||
16954921|NCT00969709|38097797|FG001|Overall Study|Adverse Event|13|||
16954922|NCT00969709|38097798|FG002|Overall Study|Adverse Event|26|||
16954923|NCT00969709|38097799|FG003|Overall Study|Adverse Event|12|||
16954924|NCT00969709|38097796|FG000|Overall Study|Lack of Efficacy|7|||
16954925|NCT00969709|38097797|FG001|Overall Study|Lack of Efficacy|4|||
16954926|NCT00969709|38097798|FG002|Overall Study|Lack of Efficacy|1|||
16954927|NCT00969709|38097799|FG003|Overall Study|Lack of Efficacy|3|||
16954928|NCT00969709|38097796|FG000|Overall Study|Protocol Violation|9|||
16954929|NCT00969709|38097797|FG001|Overall Study|Protocol Violation|5|||
16954930|NCT00969709|38097798|FG002|Overall Study|Protocol Violation|9|||
16954931|NCT00969709|38097799|FG003|Overall Study|Protocol Violation|10|||
16954932|NCT00969709|38097796|FG000|Overall Study|Withdrawal by Subject|9|||
16954933|NCT00969709|38097797|FG001|Overall Study|Withdrawal by Subject|12|||
16954934|NCT00969709|38097798|FG002|Overall Study|Withdrawal by Subject|11|||
16954935|NCT00969709|38097799|FG003|Overall Study|Withdrawal by Subject|23|||
16954936|NCT00969709|38097796|FG000|Overall Study|Lost to Follow-up|10|||
16954937|NCT00969709|38097797|FG001|Overall Study|Lost to Follow-up|14|||
16954938|NCT00969709|38097798|FG002|Overall Study|Lost to Follow-up|8|||
16954939|NCT00969709|38097799|FG003|Overall Study|Lost to Follow-up|15|||
16954940|NCT00969709|38097796|FG000|Overall Study|Other reasons|0|||
16954941|NCT00969709|38097797|FG001|Overall Study|Other reasons|0|||
16954942|NCT00969709|38097798|FG002|Overall Study|Other reasons|3|||
16954943|NCT00969709|38097799|FG003|Overall Study|Other reasons|0|||
17128408|NCT04741503|38269411|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
17128409|NCT04741503|38269412|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
17128410|NCT04741503|38269413|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
17128411|NCT04734873|38269422|FG000|Overall Study|Lost to Follow-up|1|||
16774351|NCT02555657|37713649|FG000|Overall Study|Death|274|||
16954944|NCT01193517|38097816|FG000|Overall Study|Early Progression|1|||
16954945|NCT01193517|38097817|FG001|Overall Study|Early Progression|0|||
16954946|NCT01193517|38097818|FG002|Overall Study|Early Progression|0|||
16954947|NCT01193283|38097827|FG000|Overall Study|Death|1|||
16954948|NCT00971425|38097833|FG000|Overall Study|Adverse Event|1|||
16954949|NCT00971425|38097834|FG001|Overall Study|Adverse Event|1|||
16954950|NCT00971425|38097833|FG000|Overall Study|Withdrawal by Subject|0|||
16954951|NCT00971425|38097834|FG001|Overall Study|Withdrawal by Subject|1|||
16954952|NCT01193127|38097844|FG000|Randomized|Surgery Cancelled|0|||
16954953|NCT01193127|38097845|FG001|Randomized|Surgery Cancelled|0|||
16954954|NCT01193127|38097846|FG002|Randomized|Surgery Cancelled|0|||
16954955|NCT01193127|38097847|FG003|Randomized|Surgery Cancelled|1|||
16954956|NCT01193127|38097844|FG000|Treated|Withdrawal by Subject|0|||
16954957|NCT01193127|38097845|FG001|Treated|Withdrawal by Subject|0|||
16954958|NCT01193127|38097846|FG002|Treated|Withdrawal by Subject|0|||
16954959|NCT01193127|38097847|FG003|Treated|Withdrawal by Subject|1|||
16954960|NCT01192815|38097859|FG000|Overall Study|Withdrawal by Subject|1|||
16954961|NCT01192815|38097859|FG000|Overall Study|Lack of Efficacy|1|||
16954962|NCT01192347|38097863|FG000|Overall Study|Death|3|||
16954963|NCT01192347|38097863|FG000|Overall Study|Lost to Follow-up|3|||
16954964|NCT01192347|38097863|FG000|Overall Study|Withdrawal by Subject|1|||
16954965|NCT01192347|38097863|FG000|Overall Study|Adverse Event|1|||
16954966|NCT01192347|38097863|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
16954967|NCT01192347|38097863|FG000|Overall Study|Patient seen in different hospital|1|||
16954968|NCT01192347|38097863|FG000|Overall Study|Patient not visiting hospital regularly|1|||
16954969|NCT01192347|38097863|FG000|Overall Study|Patient did not show up for visits|1|||
16954970|NCT01192191|38097869|FG000|Overall Study|Adverse Event|7|||
16954971|NCT01192191|38097870|FG001|Overall Study|Adverse Event|12|||
16954972|NCT01192191|38097869|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
16954973|NCT01192191|38097870|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
16954974|NCT01192191|38097869|FG000|Overall Study|Lost to Follow-up|0|||
16954975|NCT01192191|38097870|FG001|Overall Study|Lost to Follow-up|1|||
16954976|NCT01192191|38097869|FG000|Overall Study|Withdrawal by Subject|1|||
16954977|NCT01192191|38097870|FG001|Overall Study|Withdrawal by Subject|6|||
16954978|NCT01307267|38097899|FG000|Overall Study|Death|4|||
16954979|NCT01307267|38097900|FG001|Overall Study|Death|3|||
16954980|NCT01307267|38097901|FG002|Overall Study|Death|5|||
16954981|NCT01307267|38097902|FG003|Overall Study|Death|3|||
16954982|NCT01307267|38097903|FG004|Overall Study|Death|1|||
16954983|NCT01307267|38097904|FG005|Overall Study|Death|26|||
16954984|NCT01307267|38097905|FG006|Overall Study|Death|2|||
16954985|NCT01307267|38097906|FG007|Overall Study|Death|2|||
16954986|NCT01307267|38097907|FG008|Overall Study|Death|21|||
16954987|NCT01307267|38097908|FG009|Overall Study|Death|2|||
16954988|NCT01307267|38097909|FG010|Overall Study|Death|3|||
16954989|NCT01307267|38097910|FG011|Overall Study|Death|9|||
16954990|NCT01307267|38097911|FG012|Overall Study|Death|0|||
16954991|NCT01307267|38097912|FG013|Overall Study|Death|0|||
16954992|NCT01307267|38097913|FG014|Overall Study|Death|0|||
16954993|NCT01307267|38097914|FG015|Overall Study|Death|0|||
16954994|NCT01307267|38097915|FG016|Overall Study|Death|1|||
16954995|NCT01307267|38097916|FG017|Overall Study|Death|1|||
16954996|NCT01307267|38097917|FG018|Overall Study|Death|2|||
16954997|NCT01307267|38097918|FG019|Overall Study|Death|8|||
16954998|NCT01307267|38097919|FG020|Overall Study|Death|1|||
16954999|NCT01307267|38097920|FG021|Overall Study|Death|2|||
16955000|NCT01307267|38097921|FG022|Overall Study|Death|2|||
16955001|NCT01307267|38097899|FG000|Overall Study|Lost to Follow-up|0|||
16955002|NCT01307267|38097900|FG001|Overall Study|Lost to Follow-up|0|||
16955003|NCT01307267|38097901|FG002|Overall Study|Lost to Follow-up|0|||
16955004|NCT01307267|38097902|FG003|Overall Study|Lost to Follow-up|0|||
16955005|NCT01307267|38097903|FG004|Overall Study|Lost to Follow-up|0|||
16955006|NCT01307267|38097904|FG005|Overall Study|Lost to Follow-up|7|||
16955007|NCT01307267|38097905|FG006|Overall Study|Lost to Follow-up|0|||
16955008|NCT01307267|38097906|FG007|Overall Study|Lost to Follow-up|0|||
16955009|NCT01307267|38097907|FG008|Overall Study|Lost to Follow-up|1|||
16955010|NCT01307267|38097908|FG009|Overall Study|Lost to Follow-up|2|||
16955011|NCT01307267|38097909|FG010|Overall Study|Lost to Follow-up|1|||
16955012|NCT01307267|38097910|FG011|Overall Study|Lost to Follow-up|0|||
16955013|NCT01307267|38097911|FG012|Overall Study|Lost to Follow-up|0|||
16955014|NCT01307267|38097912|FG013|Overall Study|Lost to Follow-up|0|||
16955015|NCT01307267|38097913|FG014|Overall Study|Lost to Follow-up|0|||
16955016|NCT01307267|38097914|FG015|Overall Study|Lost to Follow-up|0|||
16955017|NCT01307267|38097915|FG016|Overall Study|Lost to Follow-up|0|||
16955018|NCT01307267|38097916|FG017|Overall Study|Lost to Follow-up|0|||
16955019|NCT01307267|38097917|FG018|Overall Study|Lost to Follow-up|0|||
16955020|NCT01307267|38097918|FG019|Overall Study|Lost to Follow-up|2|||
16955021|NCT01307267|38097919|FG020|Overall Study|Lost to Follow-up|0|||
16955022|NCT01307267|38097920|FG021|Overall Study|Lost to Follow-up|0|||
16955023|NCT01307267|38097921|FG022|Overall Study|Lost to Follow-up|0|||
16955024|NCT01307267|38097899|FG000|Overall Study|Withdrawal by Subject|0|||
16955025|NCT01307267|38097900|FG001|Overall Study|Withdrawal by Subject|0|||
16955026|NCT01307267|38097901|FG002|Overall Study|Withdrawal by Subject|0|||
16955027|NCT01307267|38097902|FG003|Overall Study|Withdrawal by Subject|0|||
16955028|NCT01307267|38097903|FG004|Overall Study|Withdrawal by Subject|0|||
16955029|NCT01307267|38097904|FG005|Overall Study|Withdrawal by Subject|1|||
16955030|NCT01307267|38097905|FG006|Overall Study|Withdrawal by Subject|0|||
16955031|NCT01307267|38097906|FG007|Overall Study|Withdrawal by Subject|1|||
16955032|NCT01307267|38097907|FG008|Overall Study|Withdrawal by Subject|5|||
16955033|NCT01307267|38097908|FG009|Overall Study|Withdrawal by Subject|1|||
16955034|NCT01307267|38097909|FG010|Overall Study|Withdrawal by Subject|1|||
16955035|NCT01307267|38097910|FG011|Overall Study|Withdrawal by Subject|1|||
16955036|NCT01307267|38097911|FG012|Overall Study|Withdrawal by Subject|0|||
16955037|NCT01307267|38097912|FG013|Overall Study|Withdrawal by Subject|0|||
16955038|NCT01307267|38097913|FG014|Overall Study|Withdrawal by Subject|0|||
16955039|NCT01307267|38097914|FG015|Overall Study|Withdrawal by Subject|0|||
16955040|NCT01307267|38097915|FG016|Overall Study|Withdrawal by Subject|0|||
16955041|NCT01307267|38097916|FG017|Overall Study|Withdrawal by Subject|0|||
16955042|NCT01307267|38097917|FG018|Overall Study|Withdrawal by Subject|0|||
16955043|NCT01307267|38097918|FG019|Overall Study|Withdrawal by Subject|3|||
16955044|NCT01307267|38097919|FG020|Overall Study|Withdrawal by Subject|0|||
16955045|NCT01307267|38097920|FG021|Overall Study|Withdrawal by Subject|0|||
16955046|NCT01307267|38097921|FG022|Overall Study|Withdrawal by Subject|0|||
16955047|NCT01307267|38097899|FG000|Overall Study|Other|0|||
16955048|NCT01307267|38097900|FG001|Overall Study|Other|0|||
16955049|NCT01307267|38097901|FG002|Overall Study|Other|0|||
16955050|NCT01307267|38097902|FG003|Overall Study|Other|0|||
16955051|NCT01307267|38097903|FG004|Overall Study|Other|0|||
16955052|NCT01307267|38097904|FG005|Overall Study|Other|7|||
16955053|NCT01307267|38097905|FG006|Overall Study|Other|0|||
16955054|NCT01307267|38097906|FG007|Overall Study|Other|1|||
16955055|NCT01307267|38097907|FG008|Overall Study|Other|3|||
16955056|NCT01307267|38097908|FG009|Overall Study|Other|0|||
16955057|NCT01307267|38097909|FG010|Overall Study|Other|1|||
16955058|NCT01307267|38097910|FG011|Overall Study|Other|1|||
16955059|NCT01307267|38097911|FG012|Overall Study|Other|1|||
16955060|NCT01307267|38097912|FG013|Overall Study|Other|0|||
16955061|NCT01307267|38097913|FG014|Overall Study|Other|2|||
16955062|NCT01307267|38097914|FG015|Overall Study|Other|1|||
16955063|NCT01307267|38097915|FG016|Overall Study|Other|0|||
16955064|NCT01307267|38097916|FG017|Overall Study|Other|0|||
16955065|NCT01307267|38097917|FG018|Overall Study|Other|0|||
16955066|NCT01307267|38097918|FG019|Overall Study|Other|19|||
16955067|NCT01307267|38097919|FG020|Overall Study|Other|2|||
16955068|NCT01307267|38097920|FG021|Overall Study|Other|3|||
16955069|NCT01307267|38097921|FG022|Overall Study|Other|2|||
16955070|NCT01307111|38097983|FG000|IUD Insertion|Lost to Follow-up|2|||
16955071|NCT01307111|38097984|FG001|IUD Insertion|Lost to Follow-up|0|||
16955072|NCT01307111|38097983|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
16955073|NCT01307111|38097984|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
16955074|NCT01306877|38097992|FG000|Overall Study|Lost to Follow-up|3|||
16955075|NCT01306877|38097993|FG001|Overall Study|Lost to Follow-up|3|||
16955076|NCT01306877|38097992|FG000|Overall Study|Physician Decision|0|||
16955077|NCT01306877|38097993|FG001|Overall Study|Physician Decision|1|||
16955078|NCT01191801|38098001|FG000|Overall Study|Death|36|||
16955079|NCT01191801|38098002|FG001|Overall Study|Death|12|||
16955080|NCT01191801|38098001|FG000|Overall Study|Lack of Efficacy|176|||
16955081|NCT01191801|38098002|FG001|Overall Study|Lack of Efficacy|258|||
16955082|NCT01191801|38098001|FG000|Overall Study|Adverse Event|9|||
16955083|NCT01191801|38098002|FG001|Overall Study|Adverse Event|8|||
16955084|NCT01191801|38098001|FG000|Overall Study|Protocol Violation|2|||
16955085|NCT01191801|38098002|FG001|Overall Study|Protocol Violation|4|||
16955086|NCT01191801|38098001|FG000|Overall Study|Physician Decision|47|||
16955087|NCT01191801|38098002|FG001|Overall Study|Physician Decision|24|||
16955088|NCT01191801|38098001|FG000|Overall Study|Withdrawal by Subject|1|||
16955089|NCT01191801|38098002|FG001|Overall Study|Withdrawal by Subject|4|||
16955090|NCT01191801|38098001|FG000|Overall Study|Not Provided|45|||
16955091|NCT01191801|38098002|FG001|Overall Study|Not Provided|27|||
16955092|NCT01306643|38098008|FG000|Overall Study|Adverse Event|5|||
16955093|NCT01306643|38098008|FG000|Overall Study|Disease Progression|7|||
16955094|NCT01306643|38098008|FG000|Overall Study|Other: Change in Eligibility Status|1|||
16955095|NCT01306331|38098014|FG000|Overall Study|Adverse Event|28|||
16955096|NCT01306331|38098015|FG001|Overall Study|Adverse Event|25|||
16955097|NCT01306331|38098014|FG000|Overall Study|Lost to Follow-up|321|||
16955098|NCT01306331|38098015|FG001|Overall Study|Lost to Follow-up|323|||
16955099|NCT01306331|38098014|FG000|Overall Study|Physician Decision|26|||
16955100|NCT01306331|38098015|FG001|Overall Study|Physician Decision|22|||
16955101|NCT01306331|38098014|FG000|Overall Study|Pregnancy|136|||
16955102|NCT01306331|38098015|FG001|Overall Study|Pregnancy|151|||
16955103|NCT01306331|38098014|FG000|Overall Study|Protocol Violation|154|||
16955104|NCT01306331|38098015|FG001|Overall Study|Protocol Violation|124|||
16955105|NCT01306331|38098014|FG000|Overall Study|Withdrawal by Subject|163|||
16955106|NCT01306331|38098015|FG001|Overall Study|Withdrawal by Subject|152|||
16955107|NCT01306331|38098014|FG000|Overall Study|Not sexually active|29|||
16955108|NCT01306331|38098015|FG001|Overall Study|Not sexually active|28|||
16955109|NCT01306331|38098014|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
16955110|NCT01306331|38098015|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
16955111|NCT01306331|38098014|FG000|Overall Study|Other|34|||
16955112|NCT01306331|38098015|FG001|Overall Study|Other|32|||
16955113|NCT01306253|38098023|FG000|Overall Study|Lost to Follow-up|1|||
16955114|NCT01306253|38098024|FG001|Overall Study|Lost to Follow-up|1|||
16955115|NCT01305941|38098030|FG000|Overall Study|Adverse Event|6|||
16955116|NCT01305941|38098030|FG000|Overall Study|Clinical decline|2|||
16955117|NCT01305941|38098030|FG000|Overall Study|Withdrawal by Subject|1|||
16955118|NCT01305941|38098030|FG000|Overall Study|Death|1|||
16955119|NCT01305239|38098034|FG000|Overall Study|Adverse Event|22|||
16955120|NCT01305239|38098034|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
16955121|NCT01304693|38098043|FG000|Overall Study|Adverse Event|0|||
16955122|NCT01304693|38098044|FG001|Overall Study|Adverse Event|0|||
16955123|NCT01304693|38098045|FG002|Overall Study|Adverse Event|0|||
16955124|NCT01304693|38098046|FG003|Overall Study|Adverse Event|0|||
16955125|NCT01304693|38098047|FG004|Overall Study|Adverse Event|1|||
16955126|NCT01304693|38098043|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
16955127|NCT01304693|38098044|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
16955128|NCT01304693|38098045|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
16955129|NCT01304693|38098046|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
16955130|NCT01304693|38098047|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
16955131|NCT01304147|38098059|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
16955132|NCT01304147|38098060|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
16955133|NCT01303445|38098066|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
16955134|NCT01303445|38098067|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
16955135|NCT01303445|38098066|FG000|Second Intervention (7 Days)|Adverse Event|0|||
16955136|NCT01303445|38098067|FG001|Second Intervention (7 Days)|Adverse Event|2|||
16955137|NCT01303445|38098066|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
16955138|NCT01303445|38098067|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
16955139|NCT01303445|38098066|FG000|Washout (14 Days)|Protocol Violation|1|||
16955140|NCT01303445|38098067|FG001|Washout (14 Days)|Protocol Violation|0|||
16955141|NCT01303445|38098066|FG000|Washout (14 Days)|Lost to Follow-up|0|||
16955142|NCT01303445|38098067|FG001|Washout (14 Days)|Lost to Follow-up|2|||
16955143|NCT01303445|38098066|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
16955144|NCT01303445|38098067|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
16955145|NCT01303445|38098066|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
16955146|NCT01303445|38098067|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
16955147|NCT01188681|38098081|FG000|Overall Study|bladder cancer|0|||
16955148|NCT01188681|38098082|FG001|Overall Study|bladder cancer|0|||
16955149|NCT01188681|38098083|FG002|Overall Study|bladder cancer|1|||
16955150|NCT01188681|38098084|FG003|Overall Study|bladder cancer|0|||
16955151|NCT01188681|38098081|FG000|Overall Study|Withdrawal by Subject|0|||
16955152|NCT01188681|38098082|FG001|Overall Study|Withdrawal by Subject|0|||
16955153|NCT01188681|38098083|FG002|Overall Study|Withdrawal by Subject|0|||
16955154|NCT01188681|38098084|FG003|Overall Study|Withdrawal by Subject|1|||
16955155|NCT01302899|38098100|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
16955156|NCT01302899|38098101|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
16955157|NCT01302899|38098100|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
16955158|NCT01302899|38098101|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
16955159|NCT01187901|38098113|FG000|Overall Study|Protocol Violation|1|||
16955160|NCT01187901|38098114|FG001|Overall Study|Protocol Violation|0|||
16955161|NCT01187901|38098113|FG000|Overall Study|Lost to Follow-up|1|||
16955162|NCT01187901|38098114|FG001|Overall Study|Lost to Follow-up|2|||
16955163|NCT01187901|38098113|FG000|Overall Study|Unrelated Health Reasons|1|||
16955164|NCT01187901|38098114|FG001|Overall Study|Unrelated Health Reasons|2|||
16955165|NCT01187901|38098113|FG000|Overall Study|Suspected Allergic Reaction|1|||
16955166|NCT01187901|38098114|FG001|Overall Study|Suspected Allergic Reaction|1|||
16955167|NCT01187901|38098113|FG000|Overall Study|Adverse Event|3|||
16955168|NCT01187901|38098114|FG001|Overall Study|Adverse Event|0|||
16955169|NCT01187901|38098113|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
16955170|NCT01187901|38098114|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
16955171|NCT01187901|38098113|FG000|Overall Study|Pregnancy|0|||
16955172|NCT01187901|38098114|FG001|Overall Study|Pregnancy|2|||
16955173|NCT01302119|38098122|FG000|Overall Study|Withdrawal by Subject|30|||
16955174|NCT01302119|38098123|FG001|Overall Study|Withdrawal by Subject|20|||
16955175|NCT01302119|38098122|FG000|Overall Study|Lost to Follow-up|10|||
16955176|NCT01302119|38098123|FG001|Overall Study|Lost to Follow-up|4|||
16955177|NCT01302119|38098122|FG000|Overall Study|Adverse Event|2|||
16955178|NCT01302119|38098123|FG001|Overall Study|Adverse Event|1|||
16955179|NCT01302119|38098122|FG000|Overall Study|Non-compliance|4|||
16955180|NCT01302119|38098123|FG001|Overall Study|Non-compliance|2|||
16955181|NCT01302119|38098122|FG000|Overall Study|Non-specific|4|||
16955182|NCT01302119|38098123|FG001|Overall Study|Non-specific|1|||
16955183|NCT01302041|38098129|FG000|Overall Study|Death|5|||
16955184|NCT01302041|38098129|FG000|Overall Study|Withdrawal by Subject|4|||
16955185|NCT01302041|38098129|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
16955186|NCT01302041|38098129|FG000|Overall Study|Other-Miscellaneous Reason|2|||
16955187|NCT01301729|38098134|FG000|Overall Study|Withdrawal by Subject|2|||
16955188|NCT01301729|38098134|FG000|Overall Study|Participant did not Return for Treatment|1|||
16955189|NCT01301729|38098134|FG000|Overall Study|Violated Selection Criteria|1|||
16955190|NCT01187043|38098144|FG000|Overall Study|Adverse Event|0|||
16955191|NCT01187043|38098145|FG001|Overall Study|Adverse Event|0|||
16955192|NCT01187043|38098146|FG002|Overall Study|Adverse Event|0|||
16955193|NCT01187043|38098147|FG003|Overall Study|Adverse Event|0|||
16955194|NCT01187043|38098148|FG004|Overall Study|Adverse Event|1|||
16955195|NCT01187043|38098144|FG000|Overall Study|Unable to make scheduled visits|1|||
16955196|NCT01187043|38098145|FG001|Overall Study|Unable to make scheduled visits|0|||
16955197|NCT01187043|38098146|FG002|Overall Study|Unable to make scheduled visits|4|||
16955198|NCT01187043|38098147|FG003|Overall Study|Unable to make scheduled visits|0|||
16955199|NCT01187043|38098148|FG004|Overall Study|Unable to make scheduled visits|1|||
16955200|NCT01186809|38098160|FG000|Overall Study|Death|30|||
16955201|NCT01186419|38098166|FG000|Overall Study|Withdrawal by Subject|5|||
16955202|NCT01186419|38098167|FG001|Overall Study|Withdrawal by Subject|3|||
16955203|NCT01186419|38098166|FG000|Overall Study|Adverse Event|1|||
16955204|NCT01186419|38098167|FG001|Overall Study|Adverse Event|2|||
16955205|NCT01186419|38098166|FG000|Overall Study|Physician Decision|0|||
16955206|NCT01186419|38098167|FG001|Overall Study|Physician Decision|3|||
16955207|NCT01186419|38098166|FG000|Overall Study|Other|1|||
16955208|NCT01186419|38098167|FG001|Overall Study|Other|1|||
16955209|NCT01301027|38098174|FG000|Overall Study|Physician Decision|2|||
16955210|NCT01301027|38098175|FG001|Overall Study|Physician Decision|0|||
16955211|NCT01301027|38098174|FG000|Overall Study|Withdrawal by Subject|2|||
16955212|NCT01301027|38098175|FG001|Overall Study|Withdrawal by Subject|3|||
16955213|NCT01301027|38098174|FG000|Overall Study|Adverse Event|0|||
16955214|NCT01301027|38098175|FG001|Overall Study|Adverse Event|2|||
16955215|NCT01301027|38098174|FG000|Overall Study|Fracture|1|||
16955216|NCT01301027|38098175|FG001|Overall Study|Fracture|3|||
16955217|NCT01301027|38098174|FG000|Overall Study|Transplant|0|||
16955218|NCT01301027|38098175|FG001|Overall Study|Transplant|2|||
16955219|NCT01301027|38098174|FG000|Overall Study|Volume Overload|3|||
16955220|NCT01301027|38098175|FG001|Overall Study|Volume Overload|0|||
16955221|NCT01185639|38098181|FG000|Overall Study|Progressed and didn't receive therapy|2|||
16955222|NCT01185561|38098187|FG000|Overall Study|Lost to Follow-up|0|||
16955223|NCT01185561|38098188|FG001|Overall Study|Lost to Follow-up|4|||
16955224|NCT01185561|38098187|FG000|Overall Study|Withdrawal by Subject|2|||
16955225|NCT01185561|38098188|FG001|Overall Study|Withdrawal by Subject|8|||
16955226|NCT01185249|38098194|FG000|Overall Study|Patients discharged or change in status|42|||
16955227|NCT01185171|38098199|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
16955228|NCT01185171|38098199|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
16955229|NCT01185171|38098199|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
16955230|NCT01185171|38098199|FG000|Maintenance|Elevated liver transaminases|3|||
16955231|NCT01185171|38098199|FG000|Maintenance|Rush|2|||
16955232|NCT01185171|38098199|FG000|Maintenance|Diarrhea|1|||
16955233|NCT01185171|38098199|FG000|Maintenance|Xerostomia|1|||
16955234|NCT01185171|38098199|FG000|Maintenance|Nausea|1|||
16955235|NCT01185171|38098199|FG000|Maintenance|Comorbid Illness|2|||
16955236|NCT01185171|38098199|FG000|Maintenance|Withdrawal by Subject|1|||
16955237|NCT01185171|38098199|FG000|Maintenance|Disease Recurrence|1|||
16955238|NCT01184859|38098208|FG000|Period 1: Single Dose|Insufficient urine production|0|||
16955239|NCT01184859|38098209|FG001|Period 1: Single Dose|Insufficient urine production|1|||
16955240|NCT01184859|38098210|FG002|Period 1: Single Dose|Insufficient urine production|0|||
16955241|NCT01184859|38098211|FG003|Period 1: Single Dose|Insufficient urine production|0|||
16955242|NCT01184859|38098212|FG004|Period 1: Single Dose|Insufficient urine production|0|||
16955243|NCT01184859|38098208|FG000|Period 1: Single Dose|Protocol Violation|0|||
16955244|NCT01184859|38098209|FG001|Period 1: Single Dose|Protocol Violation|1|||
16955245|NCT01184859|38098210|FG002|Period 1: Single Dose|Protocol Violation|0|||
16955246|NCT01184859|38098211|FG003|Period 1: Single Dose|Protocol Violation|0|||
16955247|NCT01184859|38098212|FG004|Period 1: Single Dose|Protocol Violation|0|||
16955248|NCT01184859|38098208|FG000|Period 1: Single Dose|Adverse Event|0|||
16955249|NCT01184859|38098209|FG001|Period 1: Single Dose|Adverse Event|0|||
16955250|NCT01184859|38098210|FG002|Period 1: Single Dose|Adverse Event|0|||
16955251|NCT01184859|38098211|FG003|Period 1: Single Dose|Adverse Event|0|||
16955252|NCT01184859|38098212|FG004|Period 1: Single Dose|Adverse Event|1|||
16955253|NCT01184859|38098208|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
16955254|NCT01184859|38098209|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
16955255|NCT01184859|38098210|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
16955256|NCT01184859|38098211|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
16955257|NCT01184859|38098212|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
16955258|NCT01184859|38098208|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
16955259|NCT01184859|38098209|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
16955260|NCT01184859|38098210|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
16955261|NCT01184859|38098211|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
16955262|NCT01184859|38098212|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
16955263|NCT01184079|38098231|FG000|Overall Study|Lost to Follow-up|14|||
16955264|NCT01184079|38098232|FG001|Overall Study|Lost to Follow-up|2|||
16955265|NCT01190865|38098240|FG000|Overall Study|Withdrawal by Subject|1|||
16955266|NCT01190865|38098240|FG000|Overall Study|Non-compliance|2|||
16955267|NCT01190475|38098247|FG000|Overall Study|Withdrawal by Subject|0|||
16955268|NCT01190475|38098248|FG001|Overall Study|Withdrawal by Subject|0|||
16955269|NCT01190475|38098249|FG002|Overall Study|Withdrawal by Subject|1|||
16955270|NCT01289990|38098272|FG000|Overall Study|Death|0|||
16955271|NCT01289990|38098273|FG001|Overall Study|Death|0|||
16955272|NCT01289990|38098274|FG002|Overall Study|Death|0|||
16955273|NCT01289990|38098275|FG003|Overall Study|Death|1|||
16955274|NCT01289990|38098276|FG004|Overall Study|Death|2|||
16955275|NCT01289990|38098277|FG005|Overall Study|Death|1|||
16955276|NCT01289990|38098278|FG006|Overall Study|Death|0|||
16955277|NCT01289990|38098279|FG007|Overall Study|Death|0|||
16955278|NCT01289990|38098280|FG008|Overall Study|Death|0|||
16955279|NCT01289990|38098281|FG009|Overall Study|Death|0|||
16955280|NCT01289990|38098282|FG010|Overall Study|Death|0|||
16955281|NCT01289990|38098283|FG011|Overall Study|Death|1|||
16955282|NCT01289990|38098284|FG012|Overall Study|Death|0|||
16955283|NCT01289990|38098272|FG000|Overall Study|Lost to Follow-up|3|||
16955284|NCT01289990|38098273|FG001|Overall Study|Lost to Follow-up|2|||
16955285|NCT01289990|38098274|FG002|Overall Study|Lost to Follow-up|5|||
16955286|NCT01289990|38098275|FG003|Overall Study|Lost to Follow-up|5|||
16955287|NCT01289990|38098276|FG004|Overall Study|Lost to Follow-up|3|||
16955288|NCT01289990|38098277|FG005|Overall Study|Lost to Follow-up|4|||
16955289|NCT01289990|38098278|FG006|Overall Study|Lost to Follow-up|2|||
16955290|NCT01289990|38098279|FG007|Overall Study|Lost to Follow-up|2|||
16955291|NCT01289990|38098280|FG008|Overall Study|Lost to Follow-up|1|||
16955292|NCT01289990|38098281|FG009|Overall Study|Lost to Follow-up|4|||
16955293|NCT01289990|38098282|FG010|Overall Study|Lost to Follow-up|2|||
16955294|NCT01289990|38098283|FG011|Overall Study|Lost to Follow-up|1|||
16955295|NCT01289990|38098284|FG012|Overall Study|Lost to Follow-up|2|||
16955296|NCT01289990|38098272|FG000|Overall Study|Withdrawal by Subject|15|||
16955297|NCT01289990|38098273|FG001|Overall Study|Withdrawal by Subject|14|||
16955298|NCT01289990|38098274|FG002|Overall Study|Withdrawal by Subject|12|||
16955299|NCT01289990|38098275|FG003|Overall Study|Withdrawal by Subject|13|||
16955300|NCT01289990|38098276|FG004|Overall Study|Withdrawal by Subject|8|||
16955301|NCT01289990|38098277|FG005|Overall Study|Withdrawal by Subject|7|||
16955302|NCT01289990|38098278|FG006|Overall Study|Withdrawal by Subject|13|||
16955303|NCT01289990|38098279|FG007|Overall Study|Withdrawal by Subject|9|||
16955304|NCT01289990|38098280|FG008|Overall Study|Withdrawal by Subject|12|||
16955305|NCT01289990|38098281|FG009|Overall Study|Withdrawal by Subject|13|||
16955306|NCT01289990|38098282|FG010|Overall Study|Withdrawal by Subject|11|||
16955307|NCT01289990|38098283|FG011|Overall Study|Withdrawal by Subject|13|||
16955308|NCT01289990|38098284|FG012|Overall Study|Withdrawal by Subject|16|||
16955309|NCT01289990|38098272|FG000|Overall Study|discontinued in preceding trial|18|||
16955310|NCT01289990|38098273|FG001|Overall Study|discontinued in preceding trial|20|||
16955311|NCT01289990|38098274|FG002|Overall Study|discontinued in preceding trial|41|||
16955312|NCT01289990|38098275|FG003|Overall Study|discontinued in preceding trial|17|||
16955313|NCT01289990|38098276|FG004|Overall Study|discontinued in preceding trial|11|||
16955314|NCT01289990|38098277|FG005|Overall Study|discontinued in preceding trial|12|||
16955315|NCT01289990|38098278|FG006|Overall Study|discontinued in preceding trial|18|||
17128412|NCT04734873|38269423|FG001|Overall Study|Lost to Follow-up|3|||
17128413|NCT04734873|38269424|FG002|Overall Study|Lost to Follow-up|2|||
17128414|NCT04734873|38269422|FG000|Overall Study|Randomized but not dosed|1|||
17128415|NCT04734873|38269423|FG001|Overall Study|Randomized but not dosed|0|||
16955316|NCT01289990|38098279|FG007|Overall Study|discontinued in preceding trial|8|||
16955317|NCT01289990|38098280|FG008|Overall Study|discontinued in preceding trial|17|||
16955318|NCT01289990|38098281|FG009|Overall Study|discontinued in preceding trial|21|||
16955319|NCT01289990|38098282|FG010|Overall Study|discontinued in preceding trial|17|||
16955320|NCT01289990|38098283|FG011|Overall Study|discontinued in preceding trial|17|||
16955321|NCT01289990|38098284|FG012|Overall Study|discontinued in preceding trial|24|||
16955322|NCT01289990|38098272|FG000|Overall Study|did not continue in extension|41|||
16955323|NCT01289990|38098273|FG001|Overall Study|did not continue in extension|45|||
16955324|NCT01289990|38098274|FG002|Overall Study|did not continue in extension|51|||
16955325|NCT01289990|38098275|FG003|Overall Study|did not continue in extension|51|||
16955326|NCT01289990|38098276|FG004|Overall Study|did not continue in extension|48|||
16955327|NCT01289990|38098277|FG005|Overall Study|did not continue in extension|50|||
16955328|NCT01289990|38098278|FG006|Overall Study|did not continue in extension|54|||
16955329|NCT01289990|38098279|FG007|Overall Study|did not continue in extension|36|||
16955330|NCT01289990|38098280|FG008|Overall Study|did not continue in extension|44|||
16955331|NCT01289990|38098281|FG009|Overall Study|did not continue in extension|48|||
16955332|NCT01289990|38098282|FG010|Overall Study|did not continue in extension|45|||
16955333|NCT01289990|38098283|FG011|Overall Study|did not continue in extension|34|||
16955334|NCT01289990|38098284|FG012|Overall Study|did not continue in extension|56|||
16955335|NCT01289990|38098272|FG000|Overall Study|Not treated|0|||
16955336|NCT01289990|38098273|FG001|Overall Study|Not treated|0|||
16955337|NCT01289990|38098274|FG002|Overall Study|Not treated|0|||
16955338|NCT01289990|38098275|FG003|Overall Study|Not treated|0|||
16955339|NCT01289990|38098276|FG004|Overall Study|Not treated|0|||
16955340|NCT01289990|38098277|FG005|Overall Study|Not treated|0|||
16955341|NCT01289990|38098278|FG006|Overall Study|Not treated|1|||
16955342|NCT01289990|38098279|FG007|Overall Study|Not treated|0|||
16955343|NCT01289990|38098280|FG008|Overall Study|Not treated|1|||
16955344|NCT01289990|38098281|FG009|Overall Study|Not treated|0|||
16955345|NCT01289990|38098282|FG010|Overall Study|Not treated|1|||
16955346|NCT01289990|38098283|FG011|Overall Study|Not treated|2|||
16955347|NCT01289990|38098284|FG012|Overall Study|Not treated|0|||
16955348|NCT01190007|38098312|FG000|Overall Study|Withdrawal by Subject|4|||
16955349|NCT01190007|38098312|FG000|Overall Study|Adverse Event|8|||
16955350|NCT01190007|38098312|FG000|Overall Study|Difficulty of visit for complications|1|||
16955351|NCT01190007|38098312|FG000|Overall Study|Participant was arrested|1|||
16955352|NCT01189461|38098316|FG000|Overall Study|Lack of Efficacy|13|||
16955353|NCT01189461|38098316|FG000|Overall Study|Lost to Follow-up|1|||
16955354|NCT01189461|38098316|FG000|Overall Study|Withdrawal by Subject|6|||
16955355|NCT01189461|38098316|FG000|Overall Study|Protocol Violation|1|||
16955356|NCT01189461|38098316|FG000|Overall Study|Adverse Event|2|||
16955357|NCT01189461|38098316|FG000|Overall Study|Did not meet entrance criteria|3|||
16955358|NCT01189461|38098316|FG000|Overall Study|Other|8|||
16955359|NCT01189227|38098322|FG000|Overall Study|Study terminated due to low accrual|6|||
16955360|NCT01189227|38098323|FG001|Overall Study|Study terminated due to low accrual|3|||
16955361|NCT01300247|38098331|FG000|Overall Study|Death|1|||
16955362|NCT01300247|38098332|FG001|Overall Study|Death|1|||
16955363|NCT01300247|38098331|FG000|Overall Study|Lost to Follow-up|2|||
16955364|NCT01300247|38098332|FG001|Overall Study|Lost to Follow-up|0|||
16955365|NCT01300247|38098331|FG000|Overall Study|Withdrawal by Subject|1|||
16955366|NCT01300247|38098332|FG001|Overall Study|Withdrawal by Subject|0|||
16955367|NCT01300247|38098331|FG000|Overall Study|Non-Compliance|0|||
16955368|NCT01300247|38098332|FG001|Overall Study|Non-Compliance|1|||
16955369|NCT01289678|38098338|FG000|Overall Study|Physician Decision|6|||
16955370|NCT01289210|38098342|FG000|Overall Study|Adverse Event|1|||
16955371|NCT01183221|38098348|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
16955372|NCT01183221|38098349|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
16955373|NCT01183143|38098355|FG000|Overall Study|Protocol Violation|115|||
16955374|NCT01183143|38098355|FG000|Overall Study|Withdrawal by Subject|19|||
16955375|NCT01183143|38098355|FG000|Overall Study|Subject Questionnaires not returned|5|||
16955376|NCT01183143|38098355|FG000|Overall Study|Subjects enrolled, but not treated|11|||
16955377|NCT01183065|38098359|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
16955378|NCT01182441|38098365|FG000|Overall Study|Patient Still in Follow-up|152|||
16955379|NCT01182441|38098366|FG001|Overall Study|Patient Still in Follow-up|72|||
16955380|NCT01182441|38098365|FG000|Overall Study|Death|37|||
16955381|NCT01182441|38098366|FG001|Overall Study|Death|25|||
16955382|NCT01182441|38098365|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
16955383|NCT01182441|38098366|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
16955384|NCT01182441|38098365|FG000|Overall Study|Lost to Follow-up|5|||
16955385|NCT01182441|38098366|FG001|Overall Study|Lost to Follow-up|8|||
16955386|NCT01182441|38098365|FG000|Overall Study|Withdrawal by Subject|6|||
16955387|NCT01182441|38098366|FG001|Overall Study|Withdrawal by Subject|13|||
16955388|NCT01182441|38098365|FG000|Overall Study|Implant Not Attempted|4|||
16955389|NCT01182441|38098366|FG001|Overall Study|Implant Not Attempted|0|||
16955390|NCT01182441|38098365|FG000|Overall Study|Adverse Event|2|||
16955391|NCT01182441|38098366|FG001|Overall Study|Adverse Event|0|||
16955392|NCT01182441|38098365|FG000|Overall Study|Physician Decision|1|||
16955393|NCT01182441|38098366|FG001|Overall Study|Physician Decision|1|||
16955394|NCT01182285|38098372|FG000|First Intervention Week 1-10|Disease progression|1|||
16955395|NCT01182285|38098373|FG001|First Intervention Week 1-10|Disease progression|0|||
16955396|NCT01182285|38098374|FG002|First Intervention Week 1-10|Disease progression|0|||
16955397|NCT01182285|38098372|FG000|First Intervention Week 1-10|Adverse Event|1|||
16955398|NCT01182285|38098373|FG001|First Intervention Week 1-10|Adverse Event|0|||
16955399|NCT01182285|38098374|FG002|First Intervention Week 1-10|Adverse Event|0|||
16955400|NCT01182285|38098372|FG000|First Intervention Week 1-10|Non-compliance|1|||
16955401|NCT01182285|38098373|FG001|First Intervention Week 1-10|Non-compliance|0|||
16955402|NCT01182285|38098374|FG002|First Intervention Week 1-10|Non-compliance|0|||
16955403|NCT01182285|38098372|FG000|Third Intervention Week 11-52|Disease Progression|0|||
16955404|NCT01182285|38098373|FG001|Third Intervention Week 11-52|Disease Progression|0|||
16955405|NCT01182285|38098374|FG002|Third Intervention Week 11-52|Disease Progression|6|||
16955406|NCT01182285|38098372|FG000|Third Intervention Week 11-52|Other|0|||
16955407|NCT01182285|38098373|FG001|Third Intervention Week 11-52|Other|0|||
16955408|NCT01182285|38098374|FG002|Third Intervention Week 11-52|Other|2|||
16955409|NCT01182207|38098383|FG000|First Intervention|Positive Hepatitis Results|0|||
16955410|NCT01182207|38098384|FG001|First Intervention|Positive Hepatitis Results|1|||
16955411|NCT01182207|38098383|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
16955412|NCT01182207|38098384|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
16955413|NCT01181895|38098393|FG000|Overall Study|Adverse Event|3|||
16955414|NCT01181895|38098394|FG001|Overall Study|Adverse Event|1|||
16955415|NCT01181895|38098395|FG002|Overall Study|Adverse Event|1|||
16955416|NCT01181895|38098393|FG000|Overall Study|Lack of Efficacy|8|||
16955417|NCT01181895|38098394|FG001|Overall Study|Lack of Efficacy|9|||
16955418|NCT01181895|38098395|FG002|Overall Study|Lack of Efficacy|9|||
16955419|NCT01181895|38098393|FG000|Overall Study|Protocol Violation|2|||
16955420|NCT01181895|38098394|FG001|Overall Study|Protocol Violation|1|||
16955421|NCT01181895|38098395|FG002|Overall Study|Protocol Violation|0|||
16955422|NCT01181895|38098393|FG000|Overall Study|Lost to Follow-up|0|||
16955423|NCT01181895|38098394|FG001|Overall Study|Lost to Follow-up|1|||
16955424|NCT01181895|38098395|FG002|Overall Study|Lost to Follow-up|2|||
16955425|NCT01181895|38098393|FG000|Overall Study|Investigator Discretion|1|||
16955426|NCT01181895|38098394|FG001|Overall Study|Investigator Discretion|2|||
16955427|NCT01181895|38098395|FG002|Overall Study|Investigator Discretion|1|||
16955428|NCT01181895|38098393|FG000|Overall Study|Withdrawal by Subject|3|||
16955429|NCT01181895|38098394|FG001|Overall Study|Withdrawal by Subject|0|||
16955430|NCT01181895|38098395|FG002|Overall Study|Withdrawal by Subject|5|||
16955431|NCT01181271|38098403|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
16955432|NCT01181271|38098403|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
16955433|NCT01181271|38098403|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
16955434|NCT01181271|38098403|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
16955435|NCT01180647|38098409|FG000|Overall Study|Lost to Follow-up|5|||
16955436|NCT01180647|38098410|FG001|Overall Study|Lost to Follow-up|6|||
16955437|NCT00969553|38098425|FG000|Overall Study|Progressive disease (PD)|2|||
16955438|NCT00969553|38098426|FG001|Overall Study|Progressive disease (PD)|2|||
16955439|NCT00969553|38098427|FG002|Overall Study|Progressive disease (PD)|6|||
16955440|NCT00969553|38098428|FG003|Overall Study|Progressive disease (PD)|9|||
16955441|NCT00969553|38098429|FG004|Overall Study|Progressive disease (PD)|2|||
16955442|NCT00969553|38098430|FG005|Overall Study|Progressive disease (PD)|4|||
16955443|NCT00969553|38098431|FG006|Overall Study|Progressive disease (PD)|2|||
16955444|NCT00969553|38098432|FG007|Overall Study|Progressive disease (PD)|12|||
16955445|NCT00969553|38098433|FG008|Overall Study|Progressive disease (PD)|3|||
16955446|NCT00969553|38098425|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
16955447|NCT00969553|38098426|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
16955448|NCT00969553|38098427|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
16955449|NCT00969553|38098428|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
16955450|NCT00969553|38098429|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
16955451|NCT00969553|38098430|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
16955452|NCT00969553|38098431|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
16955453|NCT00969553|38098432|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
16955454|NCT00969553|38098433|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
16955455|NCT00969553|38098425|FG000|Overall Study|Other Adverse Event|0|||
16955456|NCT00969553|38098426|FG001|Overall Study|Other Adverse Event|0|||
16955457|NCT00969553|38098427|FG002|Overall Study|Other Adverse Event|0|||
16955458|NCT00969553|38098428|FG003|Overall Study|Other Adverse Event|1|||
16955459|NCT00969553|38098429|FG004|Overall Study|Other Adverse Event|0|||
16955460|NCT00969553|38098430|FG005|Overall Study|Other Adverse Event|0|||
16955461|NCT00969553|38098431|FG006|Overall Study|Other Adverse Event|1|||
16955462|NCT00969553|38098432|FG007|Overall Study|Other Adverse Event|0|||
16955463|NCT00969553|38098433|FG008|Overall Study|Other Adverse Event|0|||
16955464|NCT00969553|38098425|FG000|Overall Study|Refused cont. medication|1|||
16955465|NCT00969553|38098426|FG001|Overall Study|Refused cont. medication|1|||
16955466|NCT00969553|38098427|FG002|Overall Study|Refused cont. medication|0|||
16955467|NCT00969553|38098428|FG003|Overall Study|Refused cont. medication|2|||
16955468|NCT00969553|38098429|FG004|Overall Study|Refused cont. medication|0|||
16955469|NCT00969553|38098430|FG005|Overall Study|Refused cont. medication|0|||
16955470|NCT00969553|38098431|FG006|Overall Study|Refused cont. medication|0|||
16955471|NCT00969553|38098432|FG007|Overall Study|Refused cont. medication|1|||
16955472|NCT00969553|38098433|FG008|Overall Study|Refused cont. medication|0|||
16955473|NCT00969553|38098425|FG000|Overall Study|Not specified above|0|||
16955474|NCT00969553|38098426|FG001|Overall Study|Not specified above|0|||
16955475|NCT00969553|38098427|FG002|Overall Study|Not specified above|0|||
16955476|NCT00969553|38098428|FG003|Overall Study|Not specified above|4|||
16955477|NCT00969553|38098429|FG004|Overall Study|Not specified above|0|||
16955478|NCT00969553|38098430|FG005|Overall Study|Not specified above|0|||
16955479|NCT00969553|38098431|FG006|Overall Study|Not specified above|1|||
16955480|NCT00969553|38098432|FG007|Overall Study|Not specified above|1|||
16955481|NCT00969553|38098433|FG008|Overall Study|Not specified above|0|||
16955482|NCT01179477|38098461|FG000|Overall Study|Death|542|||
16955483|NCT01179477|38098461|FG000|Overall Study|Unsuccessful implant|80|||
16955484|NCT01179477|38098461|FG000|Overall Study|Non-death withdrawal|438|||
16955485|NCT01179477|38098461|FG000|Overall Study|Did not complete final visit|27|||
16955486|NCT01179399|38098465|FG000|Overall Study|Adverse Event|1|||
16955487|NCT01179399|38098465|FG000|Overall Study|Lack of Efficacy|30|||
16955488|NCT01179399|38098465|FG000|Overall Study|Withdrawal by Subject|1|||
16955489|NCT01178853|38098471|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
16955490|NCT01178853|38098472|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
16955491|NCT01178853|38098471|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
16955492|NCT01178853|38098472|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
16955493|NCT01178853|38098471|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
16955494|NCT01178853|38098472|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
16955495|NCT01178853|38098471|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
16955496|NCT01178853|38098472|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
16955497|NCT01178853|38098471|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
16955498|NCT01178853|38098472|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
16955499|NCT01178385|38098480|FG000|Overall Study|Withdrawal by Subject|2|||
16955500|NCT01178385|38098481|FG001|Overall Study|Withdrawal by Subject|0|||
16955501|NCT01288976|38098490|FG000|Overall Study|Withdrawal by Subject|58|||
16955502|NCT01288976|38098491|FG001|Overall Study|Withdrawal by Subject|12|||
16955503|NCT01288976|38098492|FG002|Overall Study|Withdrawal by Subject|9|||
16955504|NCT01288976|38098490|FG000|Overall Study|Death|98|||
16955505|NCT01288976|38098491|FG001|Overall Study|Death|6|||
16955506|NCT01288976|38098492|FG002|Overall Study|Death|4|||
16955507|NCT01288976|38098490|FG000|Overall Study|Data unavailable|22|||
16955508|NCT01288976|38098491|FG001|Overall Study|Data unavailable|9|||
16955509|NCT01288976|38098492|FG002|Overall Study|Data unavailable|7|||
16955510|NCT00970489|38098500|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
16955511|NCT00970489|38098501|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
16955512|NCT00968617|38098507|FG000|Overall Study|Study terminated by sponsor|6|||
16955513|NCT00968539|38098513|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
16955514|NCT00968539|38098514|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
16955515|NCT00976573|38098523|FG000|Overall Study|Ineligible|0|||
16955516|NCT00976573|38098524|FG001|Overall Study|Ineligible|1|||
16955517|NCT00976573|38098523|FG000|Overall Study|Cancel prior to receiving treatment|4|||
16955518|NCT00976573|38098524|FG001|Overall Study|Cancel prior to receiving treatment|2|||
16955519|NCT00976495|38098533|FG000|Overall Study|Withdrawal by Subject|0|||
16955520|NCT00976495|38098534|FG001|Overall Study|Withdrawal by Subject|1|||
16955521|NCT00976495|38098535|FG002|Overall Study|Withdrawal by Subject|0|||
16955522|NCT01288430|38098553|FG000|Part 1|Progressive disease|2|||
16955523|NCT01288430|38098554|FG001|Part 1|Progressive disease|1|||
16955524|NCT01288430|38098555|FG002|Part 1|Progressive disease|1|||
17128416|NCT04734873|38269424|FG002|Overall Study|Randomized but not dosed|1|||
17128417|NCT04724733|38269435|FG000|Overall Study|Lost to Follow-up|1|||
16955525|NCT01288430|38098556|FG003|Part 1|Progressive disease|6|||
16955526|NCT01288430|38098557|FG004|Part 1|Progressive disease|2|||
16955527|NCT01288430|38098558|FG005|Part 1|Progressive disease|4|||
16955528|NCT01288430|38098559|FG006|Part 1|Progressive disease|2|||
16955529|NCT01288430|38098560|FG007|Part 1|Progressive disease|0|||
16955530|NCT01288430|38098561|FG008|Part 1|Progressive disease|0|||
16955531|NCT01288430|38098562|FG009|Part 1|Progressive disease|0|||
16955532|NCT01288430|38098553|FG000|Part 1|Clinical disease progression|0|||
16955533|NCT01288430|38098554|FG001|Part 1|Clinical disease progression|0|||
16955534|NCT01288430|38098555|FG002|Part 1|Clinical disease progression|1|||
16955535|NCT01288430|38098556|FG003|Part 1|Clinical disease progression|0|||
16955536|NCT01288430|38098557|FG004|Part 1|Clinical disease progression|0|||
16955537|NCT01288430|38098558|FG005|Part 1|Clinical disease progression|2|||
16955538|NCT01288430|38098559|FG006|Part 1|Clinical disease progression|2|||
16955539|NCT01288430|38098560|FG007|Part 1|Clinical disease progression|0|||
16955540|NCT01288430|38098561|FG008|Part 1|Clinical disease progression|0|||
16955541|NCT01288430|38098562|FG009|Part 1|Clinical disease progression|0|||
16955542|NCT01288430|38098553|FG000|Part 1|Death due to disease progression|0|||
16955543|NCT01288430|38098554|FG001|Part 1|Death due to disease progression|0|||
16955544|NCT01288430|38098555|FG002|Part 1|Death due to disease progression|0|||
16955545|NCT01288430|38098556|FG003|Part 1|Death due to disease progression|0|||
16955546|NCT01288430|38098557|FG004|Part 1|Death due to disease progression|1|||
16955547|NCT01288430|38098558|FG005|Part 1|Death due to disease progression|0|||
16955548|NCT01288430|38098559|FG006|Part 1|Death due to disease progression|0|||
16955549|NCT01288430|38098560|FG007|Part 1|Death due to disease progression|0|||
16955550|NCT01288430|38098561|FG008|Part 1|Death due to disease progression|0|||
16955551|NCT01288430|38098562|FG009|Part 1|Death due to disease progression|0|||
16955552|NCT01288430|38098553|FG000|Part 1|Adverse Event|0|||
16955553|NCT01288430|38098554|FG001|Part 1|Adverse Event|0|||
16955554|NCT01288430|38098555|FG002|Part 1|Adverse Event|3|||
16955555|NCT01288430|38098556|FG003|Part 1|Adverse Event|1|||
16955556|NCT01288430|38098557|FG004|Part 1|Adverse Event|0|||
16955557|NCT01288430|38098558|FG005|Part 1|Adverse Event|0|||
16955558|NCT01288430|38098559|FG006|Part 1|Adverse Event|2|||
16955559|NCT01288430|38098560|FG007|Part 1|Adverse Event|0|||
16774352|NCT02555657|37713650|FG001|Overall Study|Death|262|||
16955560|NCT01288430|38098561|FG008|Part 1|Adverse Event|0|||
16955561|NCT01288430|38098562|FG009|Part 1|Adverse Event|0|||
16955562|NCT01288430|38098553|FG000|Part 1|Other|0|||
16955563|NCT01288430|38098554|FG001|Part 1|Other|2|||
16955564|NCT01288430|38098555|FG002|Part 1|Other|0|||
16955565|NCT01288430|38098556|FG003|Part 1|Other|0|||
16955566|NCT01288430|38098557|FG004|Part 1|Other|0|||
16955567|NCT01288430|38098558|FG005|Part 1|Other|0|||
16955568|NCT01288430|38098559|FG006|Part 1|Other|1|||
16955569|NCT01288430|38098560|FG007|Part 1|Other|0|||
16955570|NCT01288430|38098561|FG008|Part 1|Other|0|||
16955571|NCT01288430|38098562|FG009|Part 1|Other|0|||
16955572|NCT01288430|38098553|FG000|Part 2|Progressive disease|0|||
16955573|NCT01288430|38098554|FG001|Part 2|Progressive disease|0|||
16955574|NCT01288430|38098555|FG002|Part 2|Progressive disease|0|||
16955575|NCT01288430|38098556|FG003|Part 2|Progressive disease|0|||
16955576|NCT01288430|38098557|FG004|Part 2|Progressive disease|0|||
16955577|NCT01288430|38098558|FG005|Part 2|Progressive disease|0|||
16955578|NCT01288430|38098559|FG006|Part 2|Progressive disease|0|||
16955579|NCT01288430|38098560|FG007|Part 2|Progressive disease|8|||
16955580|NCT01288430|38098561|FG008|Part 2|Progressive disease|7|||
16955581|NCT01288430|38098562|FG009|Part 2|Progressive disease|2|||
16955582|NCT01288430|38098553|FG000|Part 2|Clinical disease progression|0|||
16955583|NCT01288430|38098554|FG001|Part 2|Clinical disease progression|0|||
16955584|NCT01288430|38098555|FG002|Part 2|Clinical disease progression|0|||
16955585|NCT01288430|38098556|FG003|Part 2|Clinical disease progression|0|||
16955586|NCT01288430|38098557|FG004|Part 2|Clinical disease progression|0|||
16955587|NCT01288430|38098558|FG005|Part 2|Clinical disease progression|0|||
16955588|NCT01288430|38098559|FG006|Part 2|Clinical disease progression|0|||
16955589|NCT01288430|38098560|FG007|Part 2|Clinical disease progression|2|||
16955590|NCT01288430|38098561|FG008|Part 2|Clinical disease progression|0|||
16955591|NCT01288430|38098562|FG009|Part 2|Clinical disease progression|0|||
16955592|NCT01288430|38098553|FG000|Part 2|Withdrawal by Subject|0|||
16955593|NCT01288430|38098554|FG001|Part 2|Withdrawal by Subject|0|||
16955594|NCT01288430|38098555|FG002|Part 2|Withdrawal by Subject|0|||
16955595|NCT01288430|38098556|FG003|Part 2|Withdrawal by Subject|0|||
16955596|NCT01288430|38098557|FG004|Part 2|Withdrawal by Subject|0|||
16955597|NCT01288430|38098558|FG005|Part 2|Withdrawal by Subject|0|||
16955598|NCT01288430|38098559|FG006|Part 2|Withdrawal by Subject|0|||
16955599|NCT01288430|38098560|FG007|Part 2|Withdrawal by Subject|1|||
16955600|NCT01288430|38098561|FG008|Part 2|Withdrawal by Subject|4|||
16955601|NCT01288430|38098562|FG009|Part 2|Withdrawal by Subject|0|||
16955602|NCT01288430|38098553|FG000|Part 2|Adverse Event|0|||
16955603|NCT01288430|38098554|FG001|Part 2|Adverse Event|0|||
16955604|NCT01288430|38098555|FG002|Part 2|Adverse Event|0|||
16955605|NCT01288430|38098556|FG003|Part 2|Adverse Event|0|||
16955606|NCT01288430|38098557|FG004|Part 2|Adverse Event|0|||
16955607|NCT01288430|38098558|FG005|Part 2|Adverse Event|0|||
16955608|NCT01288430|38098559|FG006|Part 2|Adverse Event|0|||
16955609|NCT01288430|38098560|FG007|Part 2|Adverse Event|1|||
16955610|NCT01288430|38098561|FG008|Part 2|Adverse Event|1|||
16955611|NCT01288430|38098562|FG009|Part 2|Adverse Event|0|||
16955612|NCT01288430|38098553|FG000|Part 2|Other|0|||
16955613|NCT01288430|38098554|FG001|Part 2|Other|0|||
16955614|NCT01288430|38098555|FG002|Part 2|Other|0|||
16955615|NCT01288430|38098556|FG003|Part 2|Other|0|||
16955616|NCT01288430|38098557|FG004|Part 2|Other|0|||
16955617|NCT01288430|38098558|FG005|Part 2|Other|0|||
16955618|NCT01288430|38098559|FG006|Part 2|Other|0|||
16955619|NCT01288430|38098560|FG007|Part 2|Other|0|||
16955620|NCT01288430|38098561|FG008|Part 2|Other|0|||
16955621|NCT01288430|38098562|FG009|Part 2|Other|1|||
16955622|NCT01287416|38098591|FG000|Pre-post Training|Withdrawal by Subject|17|||
16955623|NCT01287416|38098592|FG001|Pre-post Training|Withdrawal by Subject|24|||
16955624|NCT01287416|38098591|FG000|Pre-post Training|Lost to Follow-up|5|||
16955625|NCT01287416|38098592|FG001|Pre-post Training|Lost to Follow-up|1|||
16955626|NCT01287416|38098591|FG000|6 Month Follow-up|Lost to Follow-up|3|||
16955627|NCT01287416|38098592|FG001|6 Month Follow-up|Lost to Follow-up|2|||
16955628|NCT00998296|38098609|FG000|Overall Study|Progressive disease|0|||
16955629|NCT00998296|38098610|FG001|Overall Study|Progressive disease|1|||
16955630|NCT00998296|38098611|FG002|Overall Study|Progressive disease|0|||
16955631|NCT00998296|38098612|FG003|Overall Study|Progressive disease|0|||
16955632|NCT00998296|38098613|FG004|Overall Study|Progressive disease|0|||
16955633|NCT00998296|38098614|FG005|Overall Study|Progressive disease|0|||
16955634|NCT00998296|38098615|FG006|Overall Study|Progressive disease|1|||
16955635|NCT00998296|38098616|FG007|Overall Study|Progressive disease|0|||
16955636|NCT00998296|38098617|FG008|Overall Study|Progressive disease|0|||
16955637|NCT00998296|38098618|FG009|Overall Study|Progressive disease|14|||
16955638|NCT00998296|38098619|FG010|Overall Study|Progressive disease|5|||
16955639|NCT00998296|38098609|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
16955640|NCT00998296|38098610|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
16955641|NCT00998296|38098611|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
16955642|NCT00998296|38098612|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
16955643|NCT00998296|38098613|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
16955644|NCT00998296|38098614|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
16955645|NCT00998296|38098615|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
16955646|NCT00998296|38098616|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
16955647|NCT00998296|38098617|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
16955648|NCT00998296|38098618|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
16955649|NCT00998296|38098619|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
16955650|NCT00998296|38098609|FG000|Overall Study|Other adverse event|0|||
16955651|NCT00998296|38098610|FG001|Overall Study|Other adverse event|0|||
16955652|NCT00998296|38098611|FG002|Overall Study|Other adverse event|0|||
16955653|NCT00998296|38098612|FG003|Overall Study|Other adverse event|0|||
16955654|NCT00998296|38098613|FG004|Overall Study|Other adverse event|1|||
16955655|NCT00998296|38098614|FG005|Overall Study|Other adverse event|0|||
16955656|NCT00998296|38098615|FG006|Overall Study|Other adverse event|0|||
16955657|NCT00998296|38098616|FG007|Overall Study|Other adverse event|0|||
16955658|NCT00998296|38098617|FG008|Overall Study|Other adverse event|0|||
16955659|NCT00998296|38098618|FG009|Overall Study|Other adverse event|1|||
16955660|NCT00998296|38098619|FG010|Overall Study|Other adverse event|2|||
16955661|NCT00998296|38098609|FG000|Overall Study|Refused to continue taking trial med.|0|||
16955662|NCT00998296|38098610|FG001|Overall Study|Refused to continue taking trial med.|0|||
16955663|NCT00998296|38098611|FG002|Overall Study|Refused to continue taking trial med.|0|||
16955664|NCT00998296|38098612|FG003|Overall Study|Refused to continue taking trial med.|0|||
16955665|NCT00998296|38098613|FG004|Overall Study|Refused to continue taking trial med.|0|||
16955666|NCT00998296|38098614|FG005|Overall Study|Refused to continue taking trial med.|0|||
16955667|NCT00998296|38098615|FG006|Overall Study|Refused to continue taking trial med.|0|||
16955668|NCT00998296|38098616|FG007|Overall Study|Refused to continue taking trial med.|0|||
16955669|NCT00998296|38098617|FG008|Overall Study|Refused to continue taking trial med.|0|||
16955670|NCT00998296|38098618|FG009|Overall Study|Refused to continue taking trial med.|2|||
16955671|NCT00998296|38098619|FG010|Overall Study|Refused to continue taking trial med.|0|||
17128418|NCT04724733|38269436|FG001|Overall Study|Lost to Follow-up|1|||
17128419|NCT04724733|38269437|FG002|Overall Study|Lost to Follow-up|1|||
17128420|NCT04435665|38269449|FG000|Overall Study|Lost to Follow-up|0|||
17128421|NCT04435665|38269450|FG001|Overall Study|Lost to Follow-up|0|||
17128422|NCT04435665|38269451|FG002|Overall Study|Lost to Follow-up|0|||
16955672|NCT00998296|38098609|FG000|Overall Study|Reason other than those specified above|0|||
16955673|NCT00998296|38098610|FG001|Overall Study|Reason other than those specified above|0|||
16955674|NCT00998296|38098611|FG002|Overall Study|Reason other than those specified above|0|||
16955675|NCT00998296|38098612|FG003|Overall Study|Reason other than those specified above|0|||
16955676|NCT00998296|38098613|FG004|Overall Study|Reason other than those specified above|0|||
16955677|NCT00998296|38098614|FG005|Overall Study|Reason other than those specified above|0|||
16955678|NCT00998296|38098615|FG006|Overall Study|Reason other than those specified above|0|||
16955679|NCT00998296|38098616|FG007|Overall Study|Reason other than those specified above|0|||
16955680|NCT00998296|38098617|FG008|Overall Study|Reason other than those specified above|0|||
16955681|NCT00998296|38098618|FG009|Overall Study|Reason other than those specified above|1|||
16955682|NCT00998296|38098619|FG010|Overall Study|Reason other than those specified above|0|||
16955683|NCT01178073|38098651|FG000|Overall Study|Adverse Event|34|||
16955684|NCT01178073|38098652|FG001|Overall Study|Adverse Event|27|||
16955685|NCT01178073|38098653|FG002|Overall Study|Adverse Event|24|||
16955686|NCT01178073|38098651|FG000|Overall Study|Protocol Violation|1|||
16955687|NCT01178073|38098652|FG001|Overall Study|Protocol Violation|1|||
16955688|NCT01178073|38098653|FG002|Overall Study|Protocol Violation|1|||
16955689|NCT01178073|38098651|FG000|Overall Study|Lost to Follow-up|2|||
17128423|NCT04435665|38269452|FG003|Overall Study|Lost to Follow-up|1|||
17128424|NCT04428411|38269462|FG000|Overall Study|Lost to Follow-up|114|||
16955690|NCT01178073|38098652|FG001|Overall Study|Lost to Follow-up|0|||
17128425|NCT04422561|38269471|FG000|Overall Study|Lost to Follow-up|25|||
16955691|NCT01178073|38098653|FG002|Overall Study|Lost to Follow-up|3|||
16955692|NCT01178073|38098651|FG000|Overall Study|Physician Decision|14|||
16955693|NCT01178073|38098652|FG001|Overall Study|Physician Decision|10|||
16955694|NCT01178073|38098653|FG002|Overall Study|Physician Decision|10|||
16955695|NCT01178073|38098651|FG000|Overall Study|Withdrawal by Subject|10|||
16955696|NCT01178073|38098652|FG001|Overall Study|Withdrawal by Subject|6|||
16955697|NCT01178073|38098653|FG002|Overall Study|Withdrawal by Subject|8|||
16955698|NCT01178073|38098651|FG000|Overall Study|Missing Completion Status|1|||
16955699|NCT01178073|38098652|FG001|Overall Study|Missing Completion Status|0|||
16955700|NCT01178073|38098653|FG002|Overall Study|Missing Completion Status|0|||
16955701|NCT00997984|38098665|FG000|Overall Study|Adverse Event|1|||
16955702|NCT00997984|38098666|FG001|Overall Study|Adverse Event|8|||
16955703|NCT00997984|38098667|FG002|Overall Study|Adverse Event|8|||
16955704|NCT00997984|38098665|FG000|Overall Study|Protocol Violation|1|||
16955705|NCT00997984|38098666|FG001|Overall Study|Protocol Violation|3|||
16955706|NCT00997984|38098667|FG002|Overall Study|Protocol Violation|0|||
16955707|NCT00997984|38098665|FG000|Overall Study|Withdrawal by Subject|6|||
16955708|NCT00997984|38098666|FG001|Overall Study|Withdrawal by Subject|9|||
16955709|NCT00997984|38098667|FG002|Overall Study|Withdrawal by Subject|5|||
16955710|NCT00997984|38098665|FG000|Overall Study|Lost to Follow-up|8|||
16955711|NCT00997984|38098666|FG001|Overall Study|Lost to Follow-up|5|||
16955712|NCT00997984|38098667|FG002|Overall Study|Lost to Follow-up|4|||
16955713|NCT00997984|38098665|FG000|Overall Study|Lack of Efficacy|20|||
16955714|NCT00997984|38098666|FG001|Overall Study|Lack of Efficacy|6|||
16955715|NCT00997984|38098667|FG002|Overall Study|Lack of Efficacy|3|||
16955716|NCT00997984|38098665|FG000|Overall Study|Met exclusion criteria|1|||
16955717|NCT00997984|38098666|FG001|Overall Study|Met exclusion criteria|0|||
16955718|NCT00997984|38098667|FG002|Overall Study|Met exclusion criteria|0|||
16955719|NCT00997984|38098665|FG000|Overall Study|non-compliance|0|||
16955720|NCT00997984|38098666|FG001|Overall Study|non-compliance|2|||
16955721|NCT00997984|38098667|FG002|Overall Study|non-compliance|3|||
16955722|NCT00997984|38098665|FG000|Overall Study|Wrong medication dispensed|0|||
16955723|NCT00997984|38098666|FG001|Overall Study|Wrong medication dispensed|1|||
16955724|NCT00997984|38098667|FG002|Overall Study|Wrong medication dispensed|0|||
16955725|NCT00997984|38098665|FG000|Overall Study|Suicidal ideation|0|||
16955726|NCT00997984|38098666|FG001|Overall Study|Suicidal ideation|0|||
16955727|NCT00997984|38098667|FG002|Overall Study|Suicidal ideation|1|||
16955728|NCT00997984|38098665|FG000|Overall Study|Work schedule|0|||
16955729|NCT00997984|38098666|FG001|Overall Study|Work schedule|0|||
16955730|NCT00997984|38098667|FG002|Overall Study|Work schedule|2|||
16955731|NCT01177293|38098677|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
16955732|NCT01177293|38098678|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
16955733|NCT01177137|38098687|FG000|Overall Study|Withdrawal by Subject|10|||
16955734|NCT01177137|38098688|FG001|Overall Study|Withdrawal by Subject|10|||
16955735|NCT01177137|38098689|FG002|Overall Study|Withdrawal by Subject|2|||
16955736|NCT01177059|38098700|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
16955737|NCT01177059|38098700|FG000|Overall Study|Withdrew consent|2|||
16955738|NCT01177059|38098700|FG000|Overall Study|Lost to Follow-up|18|||
16955739|NCT01176513|38098704|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
16955740|NCT01299389|38098710|FG000|Double-blind|Adverse Event|45|||
16955741|NCT01299389|38098711|FG001|Double-blind|Adverse Event|27|||
16955742|NCT01299389|38098712|FG002|Double-blind|Adverse Event|0|||
16955743|NCT01299389|38098713|FG003|Double-blind|Adverse Event|0|||
16955744|NCT01299389|38098710|FG000|Double-blind|Lack of Efficacy|45|||
16955745|NCT01299389|38098711|FG001|Double-blind|Lack of Efficacy|21|||
16955746|NCT01299389|38098712|FG002|Double-blind|Lack of Efficacy|0|||
16955747|NCT01299389|38098713|FG003|Double-blind|Lack of Efficacy|0|||
16955748|NCT01299389|38098710|FG000|Double-blind|Lost to Follow-up|2|||
16955749|NCT01299389|38098711|FG001|Double-blind|Lost to Follow-up|1|||
16955750|NCT01299389|38098712|FG002|Double-blind|Lost to Follow-up|0|||
16955751|NCT01299389|38098713|FG003|Double-blind|Lost to Follow-up|0|||
16955752|NCT01299389|38098710|FG000|Double-blind|Withdrawal by Subject|16|||
16955753|NCT01299389|38098711|FG001|Double-blind|Withdrawal by Subject|13|||
16955754|NCT01299389|38098712|FG002|Double-blind|Withdrawal by Subject|0|||
16955755|NCT01299389|38098713|FG003|Double-blind|Withdrawal by Subject|0|||
16955756|NCT01299389|38098710|FG000|Double-blind|Other|1|||
16955757|NCT01299389|38098711|FG001|Double-blind|Other|1|||
16955758|NCT01299389|38098712|FG002|Double-blind|Other|0|||
16955759|NCT01299389|38098713|FG003|Double-blind|Other|0|||
16955760|NCT01299389|38098710|FG000|Double-blind|"fail to meet study population criteria"|0|||
16955761|NCT01299389|38098711|FG001|Double-blind|"fail to meet study population criteria"|1|||
16955762|NCT01299389|38098712|FG002|Double-blind|"fail to meet study population criteria"|0|||
16955763|NCT01299389|38098713|FG003|Double-blind|"fail to meet study population criteria"|0|||
16955764|NCT01299389|38098710|FG000|Post-observational|Other|0|||
16955765|NCT01299389|38098711|FG001|Post-observational|Other|0|||
16955766|NCT01299389|38098712|FG002|Post-observational|Other|12|||
16955767|NCT01299389|38098713|FG003|Post-observational|Other|6|||
16955768|NCT01298999|38098724|FG000|Overall Study|Physician Decision|0|||
16955769|NCT01298999|38098725|FG001|Overall Study|Physician Decision|1|||
16955770|NCT01298999|38098724|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
16955771|NCT01298999|38098725|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
16955772|NCT01007032|38098735|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
16955773|NCT01007032|38098736|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
16955774|NCT01007032|38098737|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
16955775|NCT01007032|38098738|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
16955776|NCT01007032|38098735|FG000|Overall Study|Withdrawal by Subject|0|||
16955777|NCT01007032|38098736|FG001|Overall Study|Withdrawal by Subject|0|||
16955778|NCT01007032|38098737|FG002|Overall Study|Withdrawal by Subject|0|||
16955779|NCT01007032|38098738|FG003|Overall Study|Withdrawal by Subject|1|||
16955780|NCT00976027|38098755|FG000|Overall Study|Serious Adverse Event|36|||
16955781|NCT00976027|38098756|FG001|Overall Study|Serious Adverse Event|17|||
16955782|NCT00976027|38098755|FG000|Overall Study|Adverse Event|0|||
16955783|NCT00976027|38098756|FG001|Overall Study|Adverse Event|2|||
16955784|NCT00976027|38098755|FG000|Overall Study|Protocol Violation|60|||
16955785|NCT00976027|38098756|FG001|Overall Study|Protocol Violation|27|||
16955786|NCT00976027|38098755|FG000|Overall Study|Lost to Follow-up|208|||
16955787|NCT00976027|38098756|FG001|Overall Study|Lost to Follow-up|103|||
16955788|NCT00976027|38098755|FG000|Overall Study|Withdrawal by Subject|107|||
16955789|NCT00976027|38098756|FG001|Overall Study|Withdrawal by Subject|66|||
16955790|NCT01298765|38098762|FG000|Titration Period|Adverse Event|26|||
16955791|NCT01298765|38098762|FG000|Titration Period|Death|1|||
16955792|NCT01298765|38098762|FG000|Titration Period|Lack of Efficacy|21|||
16955793|NCT01298765|38098762|FG000|Titration Period|Lost to Follow-up|9|||
16955794|NCT01298765|38098762|FG000|Titration Period|Physician Decision|1|||
16955795|NCT01298765|38098762|FG000|Titration Period|Withdrawal by Subject|10|||
16955796|NCT01298765|38098762|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
16955797|NCT01298765|38098762|FG000|Long-Term Treatment Period|Adverse Event|19|||
16955798|NCT01298765|38098762|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
16955799|NCT01298765|38098762|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
16955800|NCT01298765|38098762|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
16955801|NCT01298765|38098762|FG000|Long-Term Treatment Period|Physician Decision|1|||
16955802|NCT01298765|38098762|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
16955803|NCT00997438|38098769|FG000|Overall Study|Blood draw difficulty|2|||
16955804|NCT00997438|38098770|FG001|Overall Study|Blood draw difficulty|0|||
16955805|NCT00997438|38098771|FG002|Overall Study|Blood draw difficulty|1|||
16955806|NCT00997438|38098769|FG000|Overall Study|Withdrawal by Subject|1|||
16955807|NCT00997438|38098770|FG001|Overall Study|Withdrawal by Subject|1|||
16955808|NCT00997438|38098771|FG002|Overall Study|Withdrawal by Subject|0|||
16955809|NCT00997438|38098769|FG000|Overall Study|Exclusion criteria at visit 1|2|||
16955810|NCT00997438|38098770|FG001|Overall Study|Exclusion criteria at visit 1|2|||
16955811|NCT00997438|38098771|FG002|Overall Study|Exclusion criteria at visit 1|3|||
16955812|NCT00997126|38098782|FG000|Overall Study|Physician Decision|7|||
16955813|NCT00997126|38098783|FG001|Overall Study|Physician Decision|11|||
16955814|NCT01000636|38098789|FG000|Overall Study|Withdrawal by Subject|1|||
16955815|NCT01000636|38098789|FG000|Overall Study|Adverse Event|1|||
16955816|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Adverse Event|33|||
16955817|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
16955818|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
16955819|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
16955820|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Physician Decision|6|||
16955821|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
16955822|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
16955823|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
16955824|NCT00965419|38098793|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
16955825|NCT00965419|38098793|FG000|Follow-up Phase|Adverse Event|9|||
16955826|NCT00965419|38098793|FG000|Follow-up Phase|Protocol Violation|4|||
16955827|NCT00965419|38098793|FG000|Follow-up Phase|Withdrawal by Subject|8|||
16955828|NCT00965419|38098793|FG000|Follow-up Phase|Physician Decision|4|||
16955829|NCT00965419|38098793|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
16955830|NCT00965419|38098793|FG000|Follow-up Phase|Lack of Efficacy|28|||
16955831|NCT01000480|38098798|FG000|Induction Phase|Adverse Event|2|||
16955832|NCT01000480|38098798|FG000|Induction Phase|Lost to Follow-up|1|||
17128426|NCT04422561|38269472|FG001|Overall Study|Lost to Follow-up|11|||
17128427|NCT01369498|38269482|FG000|Overall Study|Lack of Efficacy|9|||
17128428|NCT01369498|38269483|FG001|Overall Study|Lack of Efficacy|9|||
17128429|NCT01369498|38269484|FG002|Overall Study|Lack of Efficacy|1|||
17128430|NCT01369498|38269485|FG003|Overall Study|Lack of Efficacy|3|||
17128431|NCT01369498|38269482|FG000|Overall Study|Adverse Event|1|||
17128432|NCT01369498|38269483|FG001|Overall Study|Adverse Event|2|||
17128433|NCT01369498|38269484|FG002|Overall Study|Adverse Event|0|||
17128434|NCT01369498|38269485|FG003|Overall Study|Adverse Event|1|||
17128435|NCT01369498|38269482|FG000|Overall Study|Withdrawal of Consent|0|||
17128436|NCT01369498|38269483|FG001|Overall Study|Withdrawal of Consent|1|||
17128437|NCT01369498|38269484|FG002|Overall Study|Withdrawal of Consent|1|||
17128438|NCT01369498|38269485|FG003|Overall Study|Withdrawal of Consent|1|||
17128439|NCT01369498|38269482|FG000|Overall Study|Death|0|||
17128440|NCT01369498|38269483|FG001|Overall Study|Death|0|||
17128441|NCT01369498|38269484|FG002|Overall Study|Death|1|||
17128442|NCT01369498|38269485|FG003|Overall Study|Death|0|||
17128443|NCT01369498|38269482|FG000|Overall Study|Investigator's Discretion|1|||
17128444|NCT01369498|38269483|FG001|Overall Study|Investigator's Discretion|0|||
17128445|NCT01369498|38269484|FG002|Overall Study|Investigator's Discretion|1|||
17128446|NCT01369498|38269485|FG003|Overall Study|Investigator's Discretion|3|||
17128447|NCT01369498|38269482|FG000|Overall Study|Unknown Reason|1|||
17128448|NCT01369498|38269483|FG001|Overall Study|Unknown Reason|0|||
17128449|NCT01369498|38269484|FG002|Overall Study|Unknown Reason|11|||
17128450|NCT01369498|38269485|FG003|Overall Study|Unknown Reason|6|||
17128451|NCT01369498|38269482|FG000|Overall Study|Disease Progression|0|||
17128452|NCT01369498|38269483|FG001|Overall Study|Disease Progression|0|||
17128453|NCT01369498|38269484|FG002|Overall Study|Disease Progression|0|||
17128454|NCT01369498|38269485|FG003|Overall Study|Disease Progression|1|||
17128455|NCT04709835|38269499|FG000|Overall Study|Withdrawal by Subject|0|||
17128456|NCT04709835|38269500|FG001|Overall Study|Withdrawal by Subject|1|||
17128457|NCT04709835|38269501|FG002|Overall Study|Withdrawal by Subject|0|||
17128458|NCT04407507|38269515|FG000|Overall Study|Withdrawal by Subject|0|||
17128459|NCT04407507|38269516|FG001|Overall Study|Withdrawal by Subject|1|||
17128460|NCT04698993|38269524|FG000|Overall Study|PCR results not accessible|2|||
17128461|NCT04698993|38269525|FG001|Overall Study|PCR results not accessible|7|||
17128462|NCT04698993|38269524|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
17128463|NCT04698993|38269525|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
17128464|NCT04359771|38269533|FG000|Overall Study|Lack of Efficacy|2|||
17128465|NCT04359771|38269534|FG001|Overall Study|Lack of Efficacy|2|||
17128466|NCT04356573|38269542|FG000|Overall Study|Didn't Qualify|1|||
17128467|NCT04356573|38269543|FG001|Overall Study|Didn't Qualify|0|||
16955833|NCT01000480|38098798|FG000|Induction Phase|Physician Decision|1|||
16955834|NCT01000480|38098798|FG000|Induction Phase|Entry Criteria Not Met|3|||
16955835|NCT01000480|38098798|FG000|Concurrent Therapy Phase|Adverse Event|4|||
16955836|NCT01000480|38098798|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
16955837|NCT01000480|38098798|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
16955838|NCT01000480|38098798|FG000|Concurrent Therapy Phase|Physician Decision|1|||
16955839|NCT00965341|38098804|FG000|Overall Study|Withdrew consent|1|||
16955840|NCT00965341|38098805|FG001|Overall Study|Withdrew consent|5|||
16955841|NCT00965341|38098804|FG000|Overall Study|Lost to Follow-up|1|||
16955842|NCT00965341|38098805|FG001|Overall Study|Lost to Follow-up|0|||
16955843|NCT00965341|38098804|FG000|Overall Study|Transportation issues|4|||
16955844|NCT00965341|38098805|FG001|Overall Study|Transportation issues|3|||
16955845|NCT01175811|38098813|FG000|Overall Study|Adverse Event|1|||
16955846|NCT01175811|38098814|FG001|Overall Study|Adverse Event|1|||
16955847|NCT01175811|38098813|FG000|Overall Study|Entry criteria not met|3|||
16955848|NCT01175811|38098814|FG001|Overall Study|Entry criteria not met|1|||
16955849|NCT01175811|38098813|FG000|Overall Study|Lack of Efficacy|1|||
16955850|NCT01175811|38098814|FG001|Overall Study|Lack of Efficacy|0|||
16955851|NCT01175811|38098813|FG000|Overall Study|Lost to Follow-up|3|||
16955852|NCT01175811|38098814|FG001|Overall Study|Lost to Follow-up|2|||
16955853|NCT01175811|38098813|FG000|Overall Study|Physician Decision|1|||
16955854|NCT01175811|38098814|FG001|Overall Study|Physician Decision|1|||
16955855|NCT01175811|38098813|FG000|Overall Study|Protocol Violation|1|||
16955856|NCT01175811|38098814|FG001|Overall Study|Protocol Violation|2|||
16955857|NCT01175811|38098813|FG000|Overall Study|Withdrawal by Subject|6|||
16955858|NCT01175811|38098814|FG001|Overall Study|Withdrawal by Subject|7|||
16955859|NCT00965263|38098822|FG000|Overall Study|Physician Decision|2|||
16955860|NCT00965263|38098823|FG001|Overall Study|Physician Decision|0|||
17128468|NCT04352127|38269559|FG000|Overall Study|Unable to obtain readings|4|||
17128469|NCT04352127|38269560|FG001|Overall Study|Unable to obtain readings|1|||
17128470|NCT04351269|38269569|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
17128471|NCT04351269|38269570|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
16955861|NCT00965263|38098822|FG000|Overall Study|Family emergency|0|||
16955862|NCT00965263|38098823|FG001|Overall Study|Family emergency|1|||
16955863|NCT00965263|38098822|FG000|Overall Study|Protocol Violation|0|||
16955864|NCT00965263|38098823|FG001|Overall Study|Protocol Violation|2|||
16955865|NCT00965185|38098849|FG000|Overall Study|Lost to Follow-up|2|||
16955866|NCT00965185|38098850|FG001|Overall Study|Lost to Follow-up|0|||
16955867|NCT00965185|38098849|FG000|Overall Study|Withdrawal by Subject|0|||
16955868|NCT00965185|38098850|FG001|Overall Study|Withdrawal by Subject|1|||
16955869|NCT01174563|38098858|FG000|Overall Study|Progressive Disease|45|||
16955870|NCT01174563|38098858|FG000|Overall Study|Death|5|||
16955871|NCT01174563|38098858|FG000|Overall Study|Investigator's Discretion|5|||
16955872|NCT01174563|38098858|FG000|Overall Study|Participant Withdrew Consent|3|||
16955873|NCT01174563|38098858|FG000|Overall Study|Rash Adverse Event|1|||
16955874|NCT01174563|38098858|FG000|Overall Study|Sponsor's decision|1|||
16955875|NCT01298531|38098864|FG000|Overall Study|Lack of Efficacy|0|||
16955876|NCT01298531|38098865|FG001|Overall Study|Lack of Efficacy|1|||
16955877|NCT01298531|38098864|FG000|Overall Study|Lost to Follow-up|2|||
16955878|NCT01298531|38098865|FG001|Overall Study|Lost to Follow-up|0|||
16955879|NCT01298531|38098864|FG000|Overall Study|Protocol Violation|1|||
16955880|NCT01298531|38098865|FG001|Overall Study|Protocol Violation|1|||
16955881|NCT01298531|38098864|FG000|Overall Study|Adverse Event|4|||
16955882|NCT01298531|38098865|FG001|Overall Study|Adverse Event|3|||
16955883|NCT01298531|38098864|FG000|Overall Study|Does not meet entrance criteria|0|||
16955884|NCT01298531|38098865|FG001|Overall Study|Does not meet entrance criteria|1|||
16955885|NCT01298531|38098864|FG000|Overall Study|Other|2|||
16955886|NCT01298531|38098865|FG001|Overall Study|Other|1|||
16955887|NCT01174173|38098872|FG000|Overall Study|drug-drug interaction|1|||
16955888|NCT00964795|38098877|FG000|Overall Study|Withdrawal by Subject|79|||
16955889|NCT00964795|38098877|FG000|Overall Study|Adverse Event|12|||
16955890|NCT00964795|38098877|FG000|Overall Study|Death|14|||
16955891|NCT00964795|38098877|FG000|Overall Study|Lost to Follow-up|7|||
16955892|NCT00964795|38098877|FG000|Overall Study|Termination of Study by Sponsor|169|||
16955893|NCT00964795|38098877|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
16955894|NCT00964795|38098877|FG000|Overall Study|Other|23|||
16955895|NCT01173471|38098886|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16955896|NCT01173471|38098887|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16955897|NCT01173471|38098888|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
16955898|NCT01173471|38098889|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
17128472|NCT04351269|38269571|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
17128473|NCT04351269|38269569|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
17128474|NCT04351269|38269570|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
17128475|NCT04351269|38269571|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
17128476|NCT04351269|38269569|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
17128477|NCT04351269|38269570|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
17128478|NCT04351269|38269571|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
17128479|NCT04351269|38269569|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
16955899|NCT01173471|38098886|FG000|Overall Study|Condition under investigation worsened|2|||
16955900|NCT01173471|38098887|FG001|Overall Study|Condition under investigation worsened|0|||
16955901|NCT01173471|38098888|FG002|Overall Study|Condition under investigation worsened|0|||
16955902|NCT01173471|38098889|FG003|Overall Study|Condition under investigation worsened|0|||
16955903|NCT01173471|38098886|FG000|Overall Study|Lost to Follow-up|0|||
16955904|NCT01173471|38098887|FG001|Overall Study|Lost to Follow-up|0|||
16955905|NCT01173471|38098888|FG002|Overall Study|Lost to Follow-up|1|||
16955906|NCT01173471|38098889|FG003|Overall Study|Lost to Follow-up|0|||
16955907|NCT01173471|38098886|FG000|Overall Study|Reason given as Other|0|||
16955908|NCT01173471|38098887|FG001|Overall Study|Reason given as Other|0|||
16955909|NCT01173471|38098888|FG002|Overall Study|Reason given as Other|1|||
16955910|NCT01173471|38098889|FG003|Overall Study|Reason given as Other|0|||
16955911|NCT01172847|38098899|FG000|Overall Study|Withdrawal by Subject|3|||
16955912|NCT00966355|38098912|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
16955913|NCT00966355|38098913|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
16955914|NCT00966355|38098914|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
16774353|NCT02555657|37713649|FG000|Overall Study|Physician Decision|0|||
16955915|NCT00966355|38098912|FG000|Overall Study|newly diagnosed advanced HCC|11|||
16955916|NCT00966355|38098913|FG001|Overall Study|newly diagnosed advanced HCC|12|||
16955917|NCT00966355|38098914|FG002|Overall Study|newly diagnosed advanced HCC|10|||
16955918|NCT00966355|38098912|FG000|Overall Study|Lost to Follow-up|5|||
16955919|NCT00966355|38098913|FG001|Overall Study|Lost to Follow-up|4|||
16955920|NCT00966355|38098914|FG002|Overall Study|Lost to Follow-up|3|||
16955921|NCT01172535|38098922|FG000|Overall Study|Death|3|||
16955922|NCT01172535|38098922|FG000|Overall Study|Withdrawal by Subject|2|||
16955923|NCT01172535|38098922|FG000|Overall Study|Lost to Follow-up|1|||
16955924|NCT01172535|38098922|FG000|Overall Study|Ineligible at study entry|1|||
16955925|NCT01172535|38098922|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
16955926|NCT00966277|38098931|FG000|Overall Study|Withdrawal by Subject|3|||
16955927|NCT00966277|38098932|FG001|Overall Study|Withdrawal by Subject|0|||
16955928|NCT00966277|38098931|FG000|Overall Study|Ineligible|1|||
16955929|NCT00966277|38098932|FG001|Overall Study|Ineligible|3|||
16955930|NCT00966277|38098931|FG000|Overall Study|Treatment Plan Changed|0|||
16955931|NCT00966277|38098932|FG001|Overall Study|Treatment Plan Changed|1|||
16955932|NCT01298141|38098938|FG000|Overall Study|Adverse Event|3|||
16955933|NCT01298141|38098938|FG000|Overall Study|Refusal of Required Study Procedures|1|||
16955934|NCT01298141|38098938|FG000|Overall Study|Withdrawal by Subject|6|||
16955935|NCT01298141|38098938|FG000|Overall Study|Termination of Study by the Investigator|5|||
16955936|NCT01298141|38098938|FG000|Overall Study|Other|5|||
16955937|NCT01298141|38098938|FG000|Overall Study|Lost to Follow-up|1|||
17128480|NCT04351269|38269570|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
17128481|NCT04351269|38269571|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
17128482|NCT04351269|38269569|FG000|Overall Study|Lost to Follow-up|1|||
16955938|NCT01298141|38098938|FG000|Overall Study|Death|6|||
16955939|NCT01298141|38098938|FG000|Overall Study|Not treated|4|||
16955940|NCT01171989|38098945|FG000|Overall Study|Lost to Follow-up|0|||
16955941|NCT01171989|38098946|FG001|Overall Study|Lost to Follow-up|0|||
16955942|NCT01171989|38098947|FG002|Overall Study|Lost to Follow-up|1|||
16955943|NCT01297517|38098958|FG000|Overall Study|Adverse Event|21|||
17128483|NCT04351269|38269570|FG001|Overall Study|Lost to Follow-up|3|||
17128484|NCT04351269|38269571|FG002|Overall Study|Lost to Follow-up|0|||
17128485|NCT04348851|38269586|FG000|Post-Test 1|Withdrawal by Subject|0|||
17128486|NCT04348851|38269587|FG001|Post-Test 1|Withdrawal by Subject|1|||
16955944|NCT01297517|38098959|FG001|Overall Study|Adverse Event|7|||
16955945|NCT01297517|38098960|FG002|Overall Study|Adverse Event|16|||
16955946|NCT01297517|38098958|FG000|Overall Study|Lost to Follow-up|1|||
16955947|NCT01297517|38098959|FG001|Overall Study|Lost to Follow-up|0|||
16955948|NCT01297517|38098960|FG002|Overall Study|Lost to Follow-up|1|||
16955949|NCT01297517|38098958|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
16955950|NCT01297517|38098959|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
16955951|NCT01297517|38098960|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
16955952|NCT01297517|38098958|FG000|Overall Study|Noncompliance|1|||
16955953|NCT01297517|38098959|FG001|Overall Study|Noncompliance|0|||
16955954|NCT01297517|38098960|FG002|Overall Study|Noncompliance|0|||
16955955|NCT01297517|38098958|FG000|Overall Study|Protocol Violation|1|||
16955956|NCT01297517|38098959|FG001|Overall Study|Protocol Violation|1|||
16955957|NCT01297517|38098960|FG002|Overall Study|Protocol Violation|1|||
17128487|NCT04348851|38269588|FG002|Post-Test 1|Withdrawal by Subject|0|||
17128488|NCT04348851|38269589|FG003|Post-Test 1|Withdrawal by Subject|0|||
17128489|NCT04348851|38269586|FG000|Post-Test 1|Lost to Follow-up|0|||
17128490|NCT04348851|38269587|FG001|Post-Test 1|Lost to Follow-up|1|||
17128491|NCT04348851|38269588|FG002|Post-Test 1|Lost to Follow-up|0|||
17128492|NCT04348851|38269589|FG003|Post-Test 1|Lost to Follow-up|0|||
17128493|NCT04348851|38269586|FG000|Post-Test 2|Stroke survivor death|0|||
17128494|NCT04348851|38269587|FG001|Post-Test 2|Stroke survivor death|1|||
16955958|NCT01297517|38098958|FG000|Overall Study|Inadequate Control of IOP|1|||
16955959|NCT01297517|38098959|FG001|Overall Study|Inadequate Control of IOP|1|||
16955960|NCT01297517|38098960|FG002|Overall Study|Inadequate Control of IOP|2|||
16955961|NCT01171677|38098970|FG000|Overall Study|Withdrawal by Subject|0|||
16955962|NCT01171677|38098971|FG001|Overall Study|Withdrawal by Subject|3|||
16955963|NCT01171677|38098970|FG000|Overall Study|Adverse Event|1|||
16955964|NCT01171677|38098971|FG001|Overall Study|Adverse Event|0|||
16955965|NCT01171677|38098970|FG000|Overall Study|completed <70% IntenSati classes|5|||
16955966|NCT01171677|38098971|FG001|Overall Study|completed <70% IntenSati classes|0|||
16955967|NCT01171521|38098977|FG000|Overall Study|Lost to Follow-up|5|||
16955968|NCT01171521|38098977|FG000|Overall Study|screen failure|1|||
16955969|NCT01296347|38098983|FG000|Allocation|Withdrawal by Subject|1|||
17128495|NCT04348851|38269588|FG002|Post-Test 2|Stroke survivor death|0|||
17128496|NCT04348851|38269589|FG003|Post-Test 2|Stroke survivor death|1|||
17128497|NCT04346199|38269601|FG000|Overall Study|Death|8|||
17128498|NCT04346199|38269602|FG001|Overall Study|Death|9|||
17128499|NCT04346199|38269601|FG000|Overall Study|Lost to Follow-up|0|||
17128500|NCT04346199|38269602|FG001|Overall Study|Lost to Follow-up|1|||
17128501|NCT04346199|38269601|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
17128502|NCT04346199|38269602|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
16955970|NCT01296347|38098984|FG001|Allocation|Withdrawal by Subject|2|||
17128503|NCT04346199|38269601|FG000|Overall Study|Withdrawal by Subject|5|||
17128504|NCT04346199|38269602|FG001|Overall Study|Withdrawal by Subject|1|||
17128505|NCT04345653|38269608|FG000|Overall Study|Withdrawal by Subject|2|||
17128506|NCT04342689|38269615|FG000|Overall Study|Withdrawal by Subject|32|||
17128507|NCT04342689|38269616|FG001|Overall Study|Withdrawal by Subject|33|||
17128508|NCT04342689|38269615|FG000|Overall Study|Lost to Follow-up|10|||
17128509|NCT04342689|38269616|FG001|Overall Study|Lost to Follow-up|12|||
17128510|NCT04169373|38269628|FG000|Overall Study|Adverse Event|1|||
17128511|NCT04169373|38269629|FG001|Overall Study|Adverse Event|0|||
17128512|NCT04169373|38269630|FG002|Overall Study|Adverse Event|1|||
17128513|NCT04169373|38269631|FG003|Overall Study|Adverse Event|2|||
17128514|NCT04169373|38269628|FG000|Overall Study|Withdrawal by Subject|2|||
17128515|NCT04169373|38269629|FG001|Overall Study|Withdrawal by Subject|0|||
17128516|NCT04169373|38269630|FG002|Overall Study|Withdrawal by Subject|5|||
17128517|NCT04169373|38269631|FG003|Overall Study|Withdrawal by Subject|6|||
17128518|NCT04169373|38269628|FG000|Overall Study|Lost to Follow-up|1|||
17128519|NCT04169373|38269629|FG001|Overall Study|Lost to Follow-up|1|||
17128520|NCT04169373|38269630|FG002|Overall Study|Lost to Follow-up|0|||
17128521|NCT04169373|38269631|FG003|Overall Study|Lost to Follow-up|1|||
16955971|NCT01296347|38098983|FG000|Allocation|Lack of Efficacy|1|||
16955972|NCT01296347|38098984|FG001|Allocation|Lack of Efficacy|2|||
16955973|NCT01296347|38098983|FG000|Allocation|not received infusion|1|||
16955974|NCT01296347|38098984|FG001|Allocation|not received infusion|0|||
16955975|NCT01296347|38098983|FG000|6 Week Follow up|Death|0|||
16955976|NCT01296347|38098984|FG001|6 Week Follow up|Death|1|||
16955977|NCT01296347|38098983|FG000|3 Month Follow up|Death|1|||
16955978|NCT01296347|38098984|FG001|3 Month Follow up|Death|0|||
16955979|NCT01296347|38098983|FG000|3 Month Follow up|Lost to Follow-up|0|||
17128522|NCT04169373|38269628|FG000|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
17128523|NCT04169373|38269629|FG001|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
17128524|NCT04169373|38269630|FG002|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
17128525|NCT04169373|38269631|FG003|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
17128526|NCT04169373|38269628|FG000|Overall Study|Other|1|||
17128527|NCT04169373|38269629|FG001|Overall Study|Other|3|||
17128528|NCT04169373|38269630|FG002|Overall Study|Other|3|||
17128529|NCT04169373|38269631|FG003|Overall Study|Other|5|||
17128530|NCT04169061|38269641|FG000|Overall Study|Adverse Event|2|||
17128531|NCT04169061|38269641|FG000|Overall Study|Death|1|||
16774354|NCT02555657|37713650|FG001|Overall Study|Physician Decision|1|||
16955980|NCT01296347|38098984|FG001|3 Month Follow up|Lost to Follow-up|1|||
16955981|NCT01296347|38098983|FG000|6 Month Follow up|Death|2|||
16955982|NCT01296347|38098984|FG001|6 Month Follow up|Death|1|||
16955983|NCT01296347|38098983|FG000|6 Month Follow up|Lost to Follow-up|0|||
16955984|NCT01296347|38098984|FG001|6 Month Follow up|Lost to Follow-up|1|||
16955985|NCT01296347|38098983|FG000|12 Month Follow up|Lost to Follow-up|3|||
16955986|NCT01296347|38098984|FG001|12 Month Follow up|Lost to Follow-up|1|||
16955987|NCT01296347|38098983|FG000|12 Month Follow up|Death|1|||
16955988|NCT01296347|38098984|FG001|12 Month Follow up|Death|1|||
16955989|NCT01296347|38098983|FG000|12 Month Follow up|Withdrawal by Subject|0|||
16955990|NCT01296347|38098984|FG001|12 Month Follow up|Withdrawal by Subject|1|||
16955991|NCT01296035|38098993|FG000|Overall Study|Withdrawal by Subject|1|||
16955992|NCT01294787|38098997|FG000|Period 1|Adverse Event|0|||
16955993|NCT01294787|38098998|FG001|Period 1|Adverse Event|0|||
16955994|NCT01294787|38098999|FG002|Period 1|Adverse Event|0|||
16955995|NCT01294787|38099000|FG003|Period 1|Adverse Event|0|||
16955996|NCT01294787|38099001|FG004|Period 1|Adverse Event|1|||
16955997|NCT01294787|38099002|FG005|Period 1|Adverse Event|0|||
16955998|NCT01294787|38098997|FG000|Period 1|Withdrawal by Subject|0|||
16955999|NCT01294787|38098998|FG001|Period 1|Withdrawal by Subject|0|||
16956000|NCT01294787|38098999|FG002|Period 1|Withdrawal by Subject|0|||
16956001|NCT01294787|38099000|FG003|Period 1|Withdrawal by Subject|1|||
16956002|NCT01294787|38099001|FG004|Period 1|Withdrawal by Subject|1|||
16956003|NCT01294787|38099002|FG005|Period 1|Withdrawal by Subject|1|||
16774355|NCT02555657|37713649|FG000|Overall Study|Sponsor Decision|27|||
16956004|NCT01294787|38098997|FG000|Period 1|Administrative problem|0|||
16956005|NCT01294787|38098998|FG001|Period 1|Administrative problem|0|||
16956006|NCT01294787|38098999|FG002|Period 1|Administrative problem|1|||
16956007|NCT01294787|38099000|FG003|Period 1|Administrative problem|0|||
16956008|NCT01294787|38099001|FG004|Period 1|Administrative problem|0|||
16956009|NCT01294787|38099002|FG005|Period 1|Administrative problem|1|||
16956010|NCT01294787|38098997|FG000|Period 2|Adverse Event|0|||
16956011|NCT01294787|38098998|FG001|Period 2|Adverse Event|3|||
16956012|NCT01294787|38098999|FG002|Period 2|Adverse Event|0|||
16956013|NCT01294787|38099000|FG003|Period 2|Adverse Event|1|||
16956014|NCT01294787|38099001|FG004|Period 2|Adverse Event|0|||
16956015|NCT01294787|38099002|FG005|Period 2|Adverse Event|0|||
16956016|NCT01294787|38098997|FG000|Period 2|No longer needs study drug|0|||
16956017|NCT01294787|38098998|FG001|Period 2|No longer needs study drug|0|||
16956018|NCT01294787|38098999|FG002|Period 2|No longer needs study drug|0|||
16956019|NCT01294787|38099000|FG003|Period 2|No longer needs study drug|1|||
16956020|NCT01294787|38099001|FG004|Period 2|No longer needs study drug|0|||
16956021|NCT01294787|38099002|FG005|Period 2|No longer needs study drug|0|||
17128532|NCT04169061|38269641|FG000|Overall Study|Withdrawal by Subject|1|||
17128533|NCT04169061|38269641|FG000|Overall Study|Protocol Violation|1|||
17128534|NCT02792218|38269647|FG000|Overall Study|Patient/guardian decision|15|||
17128535|NCT02792218|38269648|FG001|Overall Study|Patient/guardian decision|42|||
17128536|NCT02792218|38269647|FG000|Overall Study|Adverse Event|15|||
17128537|NCT02792218|38269648|FG001|Overall Study|Adverse Event|14|||
17128538|NCT02792218|38269647|FG000|Overall Study|Lost to Follow-up|10|||
17128539|NCT02792218|38269648|FG001|Overall Study|Lost to Follow-up|5|||
17128540|NCT02792218|38269647|FG000|Overall Study|Lack of Efficacy|1|||
17128541|NCT02792218|38269648|FG001|Overall Study|Lack of Efficacy|12|||
17128542|NCT02792218|38269647|FG000|Overall Study|Physician Decision|4|||
17128543|NCT02792218|38269648|FG001|Overall Study|Physician Decision|4|||
17128544|NCT02792218|38269647|FG000|Overall Study|Protocol deviation|3|||
17128545|NCT02792218|38269648|FG001|Overall Study|Protocol deviation|2|||
17128546|NCT02792218|38269647|FG000|Overall Study|New therapy for study indication|0|||
17128547|NCT02792218|38269648|FG001|Overall Study|New therapy for study indication|1|||
17128548|NCT02792218|38269647|FG000|Overall Study|Non-compliance with study treatment|0|||
17128549|NCT02792218|38269648|FG001|Overall Study|Non-compliance with study treatment|1|||
17128550|NCT02792218|38269647|FG000|Overall Study|Pregnancy|1|||
17128551|NCT02792218|38269648|FG001|Overall Study|Pregnancy|0|||
17128552|NCT00153101|38269659|FG000|Overall Study|Lost to Follow-up|14|||
17128553|NCT00153101|38269660|FG001|Overall Study|Lost to Follow-up|14|||
17128554|NCT00153101|38269661|FG002|Overall Study|Lost to Follow-up|12|||
17128555|NCT00153101|38269662|FG003|Overall Study|Lost to Follow-up|5|||
17128556|NCT00153101|38269663|FG004|Overall Study|Lost to Follow-up|5|||
17128557|NCT00153101|38269659|FG000|Overall Study|Withdrawal by Subject|3|||
17128558|NCT00153101|38269660|FG001|Overall Study|Withdrawal by Subject|4|||
17128559|NCT00153101|38269661|FG002|Overall Study|Withdrawal by Subject|3|||
16774356|NCT02555657|37713650|FG001|Overall Study|Sponsor Decision|15|||
16774357|NCT02555657|37713649|FG000|Overall Study|Withdrawal by Subject|11|||
16774358|NCT02555657|37713650|FG001|Overall Study|Withdrawal by Subject|32|||
16774359|NCT02195518|37713682|FG000|Overall Study|Adverse Event|1|||
16774360|NCT02195518|37713682|FG000|Overall Study|Protocol Violation|4|||
16774361|NCT02195518|37713682|FG000|Overall Study|Pregnancy|2|||
16774362|NCT02195518|37713682|FG000|Overall Study|Withdrawal by Subject|1|||
16774363|NCT02195518|37713682|FG000|Overall Study|Lost to Follow-up|1|||
16774364|NCT03032705|37713705|FG000|Overall Study|Lost to Follow-up|16|||
16774365|NCT03032705|37713706|FG001|Overall Study|Lost to Follow-up|17|||
16774366|NCT03032705|37713705|FG000|Overall Study|did not quality|6|||
16774367|NCT03032705|37713706|FG001|Overall Study|did not quality|6|||
16774368|NCT04476251|37713712|FG000|Overall Study|Not treated|1|||
16774369|NCT03795233|37713718|FG000|Overall Study|Withdrawal by Subject|2|||
16774370|NCT03795233|37713719|FG001|Overall Study|Withdrawal by Subject|1|||
16774371|NCT03795233|37713718|FG000|Overall Study|Lost to Follow-up|1|||
16774372|NCT03795233|37713719|FG001|Overall Study|Lost to Follow-up|0|||
16774373|NCT03795233|37713718|FG000|Overall Study|Death|1|||
16774374|NCT03795233|37713719|FG001|Overall Study|Death|0|||
16774375|NCT03645863|37713728|FG000|Overall Study|Withdrawal by Subject|1|||
16774376|NCT03645863|37713729|FG001|Overall Study|Withdrawal by Subject|0|||
16774377|NCT03645863|37713730|FG002|Overall Study|Withdrawal by Subject|0|||
16774378|NCT03564119|37713740|FG000|Overall Study|Adverse Event|4|||
16774379|NCT03564119|37713741|FG001|Overall Study|Adverse Event|0|||
16774380|NCT03564119|37713740|FG000|Overall Study|Lost to Follow-up|1|||
16774381|NCT03564119|37713741|FG001|Overall Study|Lost to Follow-up|4|||
16774382|NCT03564119|37713740|FG000|Overall Study|Protocol Violation|1|||
16774383|NCT03564119|37713741|FG001|Overall Study|Protocol Violation|0|||
16774384|NCT03564119|37713740|FG000|Overall Study|Withdrawal by Subject|9|||
16774385|NCT03564119|37713741|FG001|Overall Study|Withdrawal by Subject|4|||
17128560|NCT00153101|38269662|FG003|Overall Study|Withdrawal by Subject|3|||
17128561|NCT00153101|38269663|FG004|Overall Study|Withdrawal by Subject|5|||
17128562|NCT04401579|38269679|FG000|Overall Study|Death|23|||
17128563|NCT04401579|38269680|FG001|Overall Study|Death|36|||
17128564|NCT04401579|38269679|FG000|Overall Study|Lost to Follow-up|40|||
17128565|NCT04401579|38269680|FG001|Overall Study|Lost to Follow-up|41|||
17128566|NCT04401579|38269679|FG000|Overall Study|Withdrawal by Subject|8|||
16774386|NCT03564119|37713740|FG000|Overall Study|Other Than Specified|0|||
16774387|NCT03564119|37713741|FG001|Overall Study|Other Than Specified|1|||
17128567|NCT04401579|38269680|FG001|Overall Study|Withdrawal by Subject|16|||
16774388|NCT04531241|37713747|FG000|Period 1|Withdrawal by Subject|2|||
16774389|NCT04531241|37713748|FG001|Period 1|Withdrawal by Subject|0|||
17128568|NCT04401579|38269679|FG000|Overall Study|Physician Decision|1|||
17128569|NCT04401579|38269680|FG001|Overall Study|Physician Decision|2|||
17128570|NCT04401579|38269679|FG000|Overall Study|Became ineligible after enrollment|1|||
16774390|NCT04531241|37713747|FG000|Period 1|Dispesed incorrect lens power|1|||
16774391|NCT04531241|37713748|FG001|Period 1|Dispesed incorrect lens power|0|||
16774392|NCT04531241|37713747|FG000|Period 1|Protocol Violation|1|||
16774393|NCT04531241|37713748|FG001|Period 1|Protocol Violation|0|||
16774394|NCT04531241|37713747|FG000|Period 1|No longer eligible|0|||
16774395|NCT04531241|37713748|FG001|Period 1|No longer eligible|1|||
16774396|NCT04531241|37713747|FG000|Period 1|Lens Discomfort|0|||
16774397|NCT04531241|37713748|FG001|Period 1|Lens Discomfort|1|||
17128571|NCT04401579|38269680|FG001|Overall Study|Became ineligible after enrollment|1|||
17128572|NCT04401579|38269679|FG000|Overall Study|Enrolled but treatment not administered|7|||
17128573|NCT04401579|38269680|FG001|Overall Study|Enrolled but treatment not administered|9|||
17128574|NCT04401579|38269679|FG000|Overall Study|Adverse Event|2|||
17128575|NCT04401579|38269680|FG001|Overall Study|Adverse Event|1|||
17128576|NCT04401579|38269679|FG000|Overall Study|Scheduling error|1|||
17128577|NCT04401579|38269680|FG001|Overall Study|Scheduling error|2|||
17128578|NCT04401579|38269679|FG000|Overall Study|Transferred to another hospital|1|||
17128579|NCT04401579|38269680|FG001|Overall Study|Transferred to another hospital|2|||
17128580|NCT04161807|38269686|FG000|Overall Study|Withdrawal by Subject|2|||
17128581|NCT04161807|38269686|FG000|Overall Study|Performed only 1 treatment|2|||
17128582|NCT04401423|38269692|FG000|Overall Study|Withdrawal by Subject|3|||
17128583|NCT04401423|38269693|FG001|Overall Study|Withdrawal by Subject|1|||
17128584|NCT04401423|38269692|FG000|Overall Study|Physician Decision|2|||
17128585|NCT04401423|38269693|FG001|Overall Study|Physician Decision|1|||
17128586|NCT04399161|38269704|FG000|Overall Study|Withdrawal by Subject|1|||
17128587|NCT04399161|38269705|FG001|Overall Study|Withdrawal by Subject|0|||
17128588|NCT04399161|38269706|FG002|Overall Study|Withdrawal by Subject|2|||
17128589|NCT04399161|38269704|FG000|Overall Study|Protocol Violation|1|||
17128590|NCT04399161|38269705|FG001|Overall Study|Protocol Violation|2|||
16774398|NCT04531241|37713747|FG000|Period 2|Covid-19 Related|1|||
16774399|NCT04531241|37713748|FG001|Period 2|Covid-19 Related|1|||
16774400|NCT03181529|37713756|FG000|Overall Study|Withdrawal by Subject|1|||
16774401|NCT03181529|37713757|FG001|Overall Study|Withdrawal by Subject|1|||
16774402|NCT03181529|37713756|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
17128591|NCT04399161|38269706|FG002|Overall Study|Protocol Violation|0|||
17128592|NCT02076178|38269716|FG000|Oral Phase|Adverse Event|0|||
17128593|NCT02076178|38269717|FG001|Oral Phase|Adverse Event|7|||
17128594|NCT02076178|38269716|FG000|Oral Phase|Withdrawal by Subject|0|||
17128595|NCT02076178|38269717|FG001|Oral Phase|Withdrawal by Subject|4|||
17128596|NCT02076178|38269716|FG000|Oral Phase|Physician Decision|0|||
17128597|NCT02076178|38269717|FG001|Oral Phase|Physician Decision|1|||
17128598|NCT02076178|38269716|FG000|Injection Phase|Protocol defined stopping criteria|1|||
17128599|NCT02076178|38269717|FG001|Injection Phase|Protocol defined stopping criteria|0|||
17128600|NCT02076178|38269716|FG000|Injection Phase|Withdrawal by Subject|0|||
17128601|NCT02076178|38269717|FG001|Injection Phase|Withdrawal by Subject|3|||
17128602|NCT02076178|38269716|FG000|Injection Phase|Physician Decision|0|||
17128603|NCT02076178|38269717|FG001|Injection Phase|Physician Decision|3|||
17128604|NCT02076178|38269716|FG000|Injection Phase|Lost to Follow-up|0|||
17128605|NCT02076178|38269717|FG001|Injection Phase|Lost to Follow-up|1|||
17128606|NCT04160091|38269729|FG000|Overall Study|Terminated by Sponsor|7|||
17128607|NCT04160091|38269730|FG001|Overall Study|Terminated by Sponsor|3|||
17128608|NCT04160091|38269731|FG002|Overall Study|Terminated by Sponsor|5|||
17128609|NCT04160091|38269732|FG003|Overall Study|Terminated by Sponsor|2|||
17128610|NCT04160091|38269729|FG000|Overall Study|Noncompliance|0|||
17128611|NCT04160091|38269730|FG001|Overall Study|Noncompliance|0|||
17128612|NCT04160091|38269731|FG002|Overall Study|Noncompliance|0|||
17128613|NCT04160091|38269732|FG003|Overall Study|Noncompliance|1|||
17128614|NCT04160091|38269729|FG000|Overall Study|Withdrawal by Subject|0|||
17128615|NCT04160091|38269730|FG001|Overall Study|Withdrawal by Subject|0|||
17128616|NCT04160091|38269731|FG002|Overall Study|Withdrawal by Subject|0|||
17128617|NCT04160091|38269732|FG003|Overall Study|Withdrawal by Subject|1|||
17128618|NCT00149825|38269744|FG000|Overall Study|Intolerance to medication side effects|1|||
17128619|NCT00149825|38269745|FG001|Overall Study|Intolerance to medication side effects|2|||
17128620|NCT00149825|38269744|FG000|Overall Study|Time commitments|2|||
17128621|NCT00149825|38269745|FG001|Overall Study|Time commitments|1|||
17128622|NCT00149825|38269744|FG000|Overall Study|Not liking insomnia therapy|1|||
17128623|NCT00149825|38269745|FG001|Overall Study|Not liking insomnia therapy|0|||
17128624|NCT00149825|38269744|FG000|Overall Study|Other|1|||
17128625|NCT00149825|38269745|FG001|Overall Study|Other|0|||
17128626|NCT04397757|38269753|FG000|Overall Study|Death|3|||
17128627|NCT04397757|38269754|FG001|Overall Study|Death|11|||
17128628|NCT04397757|38269753|FG000|Overall Study|Withdrawal by Subject|2|||
17128629|NCT04397757|38269754|FG001|Overall Study|Withdrawal by Subject|0|||
17128630|NCT04397757|38269753|FG000|Overall Study|Lost to Follow-up|4|||
17128631|NCT04397757|38269754|FG001|Overall Study|Lost to Follow-up|3|||
17128632|NCT02792062|38269771|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
17128633|NCT02792062|38269772|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
17128634|NCT02792062|38269773|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
17128635|NCT02792062|38269774|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
17128636|NCT02792062|38269775|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
17128637|NCT02792062|38269776|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
17128638|NCT00196937|38269787|FG000|Overall Study|Serious Adverse Event|1|||
17128639|NCT00196937|38269788|FG001|Overall Study|Serious Adverse Event|0|||
17128640|NCT00196937|38269789|FG002|Overall Study|Serious Adverse Event|0|||
17128641|NCT00196937|38269787|FG000|Overall Study|Non-serious adverse event|1|||
17128642|NCT00196937|38269788|FG001|Overall Study|Non-serious adverse event|1|||
17128643|NCT00196937|38269789|FG002|Overall Study|Non-serious adverse event|1|||
17128644|NCT00196937|38269787|FG000|Overall Study|Withdrawal by Subject|0|||
17128645|NCT00196937|38269788|FG001|Overall Study|Withdrawal by Subject|0|||
17128646|NCT00196937|38269789|FG002|Overall Study|Withdrawal by Subject|2|||
17128647|NCT00196937|38269787|FG000|Overall Study|Lost to Follow-up|4|||
17128648|NCT00196937|38269788|FG001|Overall Study|Lost to Follow-up|3|||
17128649|NCT00196937|38269789|FG002|Overall Study|Lost to Follow-up|3|||
17128650|NCT00196937|38269787|FG000|Overall Study|Other|3|||
17128651|NCT00196937|38269788|FG001|Overall Study|Other|1|||
17128652|NCT00196937|38269789|FG002|Overall Study|Other|1|||
17128653|NCT04397445|38269798|FG000|Overall Study|Withdrawal by Subject|1|||
17128654|NCT04397445|38269799|FG001|Overall Study|Withdrawal by Subject|0|||
17128655|NCT04397445|38269800|FG002|Overall Study|Withdrawal by Subject|0|||
17128656|NCT04397445|38269801|FG003|Overall Study|Withdrawal by Subject|0|||
17128657|NCT00191945|38269818|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
17128658|NCT00191945|38269819|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
17128659|NCT00191945|38269818|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
17128660|NCT00191945|38269819|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
17128661|NCT00191945|38269818|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
17128662|NCT00191945|38269819|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
17128663|NCT00191945|38269818|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
17128664|NCT00191945|38269819|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
17128665|NCT01369342|38269829|FG000|Overall Study|Withdrawal by Subject|7|||
17128666|NCT01369342|38269830|FG001|Overall Study|Withdrawal by Subject|7|||
17128667|NCT01369342|38269831|FG002|Overall Study|Withdrawal by Subject|2|||
17128668|NCT01369342|38269829|FG000|Overall Study|Lost to Follow-up|5|||
17128669|NCT01369342|38269830|FG001|Overall Study|Lost to Follow-up|2|||
17128670|NCT01369342|38269831|FG002|Overall Study|Lost to Follow-up|1|||
17128671|NCT01369342|38269829|FG000|Overall Study|Not Treated|1|||
17128672|NCT01369342|38269830|FG001|Overall Study|Not Treated|0|||
17128673|NCT01369342|38269831|FG002|Overall Study|Not Treated|0|||
17128674|NCT00191477|38269841|FG000|Overall Study|Tumor Recurrence|49|||
17128675|NCT00191477|38269842|FG001|Overall Study|Tumor Recurrence|48|||
17128676|NCT00191477|38269841|FG000|Overall Study|Death, Study Disease|1|||
17128677|NCT00191477|38269842|FG001|Overall Study|Death, Study Disease|1|||
17128678|NCT00191477|38269841|FG000|Overall Study|Death, Other Cause|3|||
17128679|NCT00191477|38269842|FG001|Overall Study|Death, Other Cause|6|||
17128680|NCT00191477|38269841|FG000|Overall Study|Lost to Follow-up|23|||
17128681|NCT00191477|38269842|FG001|Overall Study|Lost to Follow-up|21|||
17128682|NCT00191477|38269841|FG000|Overall Study|Protocol Violation|1|||
17128683|NCT00191477|38269842|FG001|Overall Study|Protocol Violation|1|||
17128684|NCT00191477|38269841|FG000|Overall Study|Treatment Change|2|||
17128685|NCT00191477|38269842|FG001|Overall Study|Treatment Change|0|||
17128686|NCT00191477|38269841|FG000|Overall Study|Withdrawal by Subject|2|||
17128687|NCT00191477|38269842|FG001|Overall Study|Withdrawal by Subject|0|||
17128688|NCT00191477|38269841|FG000|Overall Study|Other|2|||
17128689|NCT00191477|38269842|FG001|Overall Study|Other|0|||
17128690|NCT00191477|38269841|FG000|Overall Study|Not Eligible|41|||
17128691|NCT00191477|38269842|FG001|Overall Study|Not Eligible|38|||
17128692|NCT00191477|38269841|FG000|Overall Study|Pathological Specimen Lost|1|||
17128693|NCT00191477|38269842|FG001|Overall Study|Pathological Specimen Lost|0|||
17128694|NCT00191477|38269841|FG000|Overall Study|Discontinued Prior to Instillation|13|||
17128695|NCT00191477|38269842|FG001|Overall Study|Discontinued Prior to Instillation|14|||
17128696|NCT04320615|38269850|FG000|Overall Study|Withdrawal by Subject|4|||
17128697|NCT04320615|38269851|FG001|Overall Study|Withdrawal by Subject|10|||
17128698|NCT04320615|38269850|FG000|Overall Study|Physician Decision|2|||
17128699|NCT04320615|38269851|FG001|Overall Study|Physician Decision|0|||
17128700|NCT04320615|38269850|FG000|Overall Study|Other|2|||
17128701|NCT04320615|38269851|FG001|Overall Study|Other|0|||
16956022|NCT01294787|38098997|FG000|Period 3|Adverse Event|0|||
16956023|NCT01294787|38098998|FG001|Period 3|Adverse Event|0|||
16956024|NCT01294787|38098999|FG002|Period 3|Adverse Event|0|||
16956025|NCT01294787|38099000|FG003|Period 3|Adverse Event|0|||
16956026|NCT01294787|38099001|FG004|Period 3|Adverse Event|1|||
16956027|NCT01294787|38099002|FG005|Period 3|Adverse Event|0|||
16956028|NCT01294553|38099013|FG000|Overall Study|Duplicated Participants|1|||
16956029|NCT01294553|38099013|FG000|Overall Study|Protocol Violation|268|||
16956030|NCT01294397|38099018|FG000|Overall Study|Withdrawal by Subject|1|||
16956031|NCT01294397|38099018|FG000|Overall Study|Administrative Decision|1|||
16956032|NCT01293695|38099026|FG000|Overall Study|Withdrawal by Subject|7|||
16956033|NCT01293695|38099027|FG001|Overall Study|Withdrawal by Subject|1|||
16956034|NCT01293695|38099026|FG000|Overall Study|Lost to Follow-up|8|||
16956035|NCT01293695|38099027|FG001|Overall Study|Lost to Follow-up|6|||
16956036|NCT01293539|38099036|FG000|Overall Study|Physician Decision|1|||
16956037|NCT01292837|38099040|FG000|Overall Study|Adverse Event|1|||
16956038|NCT01292837|38099040|FG000|Overall Study|Further treatment determined|1|||
16956039|NCT00965731|38099046|FG000|Overall Study|Death|0|||
16956040|NCT00965731|38099047|FG001|Overall Study|Death|4|||
16956041|NCT00965731|38099046|FG000|Overall Study|Withdrawal by Subject|0|||
16956042|NCT00965731|38099047|FG001|Overall Study|Withdrawal by Subject|1|||
16956043|NCT00965731|38099046|FG000|Overall Study|Other|7|||
16956044|NCT00965731|38099047|FG001|Overall Study|Other|15|||
16956045|NCT00965575|38099060|FG000|Overall Study|subject unwillingness to swallow study c|1|||
16956046|NCT00965575|38099061|FG001|Overall Study|subject unwillingness to swallow study c|0|||
16956047|NCT00965497|38099069|FG000|Overall Study|Physician Decision|1|||
16956048|NCT00963937|38099076|FG000|Overall Study|Protocol Violation|1|||
16956049|NCT00963937|38099077|FG001|Overall Study|Protocol Violation|1|||
16956050|NCT00963937|38099078|FG002|Overall Study|Protocol Violation|0|||
16956051|NCT00963937|38099076|FG000|Overall Study|Physician Decision|18|||
16956052|NCT00963937|38099077|FG001|Overall Study|Physician Decision|10|||
16956053|NCT00963937|38099078|FG002|Overall Study|Physician Decision|4|||
16956054|NCT01170663|38099091|FG000|Overall Study|Lost to Follow-up|3|||
16956055|NCT01170663|38099092|FG001|Overall Study|Lost to Follow-up|9|||
16956056|NCT01170663|38099091|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
16956057|NCT01170663|38099092|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
16956058|NCT01170273|38099100|FG000|Overall Study|Lost to Follow-up|6|||
16956059|NCT01170273|38099101|FG001|Overall Study|Lost to Follow-up|8|||
16956060|NCT01170273|38099100|FG000|Overall Study|Protocol Violation|1|||
16956061|NCT01170273|38099101|FG001|Overall Study|Protocol Violation|0|||
16956062|NCT01170273|38099100|FG000|Overall Study|Death|1|||
16956063|NCT01170273|38099101|FG001|Overall Study|Death|0|||
16956064|NCT01170273|38099100|FG000|Overall Study|Adverse Event|0|||
16956065|NCT01170273|38099101|FG001|Overall Study|Adverse Event|1|||
16956066|NCT01170039|38099109|FG000|Overall Study|Withdrawal by Subject|5|||
16956067|NCT01170039|38099110|FG001|Overall Study|Withdrawal by Subject|3|||
16956068|NCT01170039|38099109|FG000|Overall Study|Lack of funding, drug not available|3|||
16956069|NCT01170039|38099110|FG001|Overall Study|Lack of funding, drug not available|3|||
16956070|NCT01169649|38099116|FG000|Overall Study|Patient Not Treated|3|||
16956071|NCT01169493|38099126|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
16956072|NCT01169493|38099127|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
16956073|NCT01169493|38099128|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
16956074|NCT01169493|38099129|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
16956075|NCT01169493|38099130|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
16956076|NCT01169493|38099131|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
16956077|NCT01169493|38099126|FG000|Period 3 (6 Months)|Adverse Event|0|||
16956078|NCT01169493|38099127|FG001|Period 3 (6 Months)|Adverse Event|1|||
16956079|NCT01169493|38099128|FG002|Period 3 (6 Months)|Adverse Event|0|||
16956080|NCT01169493|38099129|FG003|Period 3 (6 Months)|Adverse Event|0|||
16956081|NCT01169493|38099130|FG004|Period 3 (6 Months)|Adverse Event|0|||
16956082|NCT01169493|38099131|FG005|Period 3 (6 Months)|Adverse Event|0|||
16956083|NCT01169493|38099126|FG000|Period 3 (6 Months)|Physician Decision|0|||
16956084|NCT01169493|38099127|FG001|Period 3 (6 Months)|Physician Decision|1|||
16956085|NCT01169493|38099128|FG002|Period 3 (6 Months)|Physician Decision|1|||
16956086|NCT01169493|38099129|FG003|Period 3 (6 Months)|Physician Decision|0|||
16956087|NCT01169493|38099130|FG004|Period 3 (6 Months)|Physician Decision|0|||
16956088|NCT01169493|38099131|FG005|Period 3 (6 Months)|Physician Decision|0|||
16956089|NCT01169337|38099142|FG000|Overall Study|Lack of Efficacy|5|||
16956090|NCT01169337|38099143|FG001|Overall Study|Lack of Efficacy|7|||
16956091|NCT01169337|38099144|FG002|Overall Study|Lack of Efficacy|0|||
16956092|NCT01169337|38099142|FG000|Overall Study|Adverse Event|12|||
16956093|NCT01169337|38099143|FG001|Overall Study|Adverse Event|18|||
16956094|NCT01169337|38099144|FG002|Overall Study|Adverse Event|0|||
16956095|NCT01169337|38099142|FG000|Overall Study|Death|2|||
16956096|NCT01169337|38099143|FG001|Overall Study|Death|0|||
16956097|NCT01169337|38099144|FG002|Overall Study|Death|0|||
16956098|NCT01169337|38099142|FG000|Overall Study|Withdrawal by Subject|11|||
16956099|NCT01169337|38099143|FG001|Overall Study|Withdrawal by Subject|11|||
16956100|NCT01169337|38099144|FG002|Overall Study|Withdrawal by Subject|6|||
16956101|NCT01169337|38099142|FG000|Overall Study|Noncompliance|2|||
16956102|NCT01169337|38099143|FG001|Overall Study|Noncompliance|0|||
16956103|NCT01169337|38099144|FG002|Overall Study|Noncompliance|0|||
16956104|NCT01169337|38099142|FG000|Overall Study|Other complicating disease|1|||
16956105|NCT01169337|38099143|FG001|Overall Study|Other complicating disease|1|||
16956106|NCT01169337|38099144|FG002|Overall Study|Other complicating disease|0|||
16956107|NCT01169337|38099142|FG000|Overall Study|Physician Decision|1|||
16956108|NCT01169337|38099143|FG001|Overall Study|Physician Decision|5|||
16956109|NCT01169337|38099144|FG002|Overall Study|Physician Decision|0|||
16956110|NCT01169337|38099142|FG000|Overall Study|Alternative therapy|0|||
16956111|NCT01169337|38099143|FG001|Overall Study|Alternative therapy|2|||
16956112|NCT01169337|38099144|FG002|Overall Study|Alternative therapy|0|||
16956113|NCT01169337|38099142|FG000|Overall Study|Changed hospital|0|||
16956114|NCT01169337|38099143|FG001|Overall Study|Changed hospital|1|||
17128702|NCT04320615|38269850|FG000|Overall Study|Lost to Follow-up|5|||
17128703|NCT04320615|38269851|FG001|Overall Study|Lost to Follow-up|23|||
16956115|NCT01169337|38099144|FG002|Overall Study|Changed hospital|0|||
16956116|NCT01169337|38099142|FG000|Overall Study|Never started treatment|0|||
16956117|NCT01169337|38099143|FG001|Overall Study|Never started treatment|2|||
16956118|NCT01169337|38099144|FG002|Overall Study|Never started treatment|0|||
16956119|NCT01169337|38099142|FG000|Overall Study|Reason not reported|1|||
16956120|NCT01169337|38099143|FG001|Overall Study|Reason not reported|0|||
16956121|NCT01169337|38099144|FG002|Overall Study|Reason not reported|0|||
16956122|NCT01169337|38099142|FG000|Overall Study|Continuing lenalidomide|9|||
16956123|NCT01169337|38099143|FG001|Overall Study|Continuing lenalidomide|43|||
16956124|NCT01169337|38099144|FG002|Overall Study|Continuing lenalidomide|0|||
16956125|NCT01287104|38099156|FG000|Overall Study|Patient developed progressive disease|1|||
16956126|NCT01287104|38099157|FG001|Overall Study|Patient developed progressive disease|1|||
16956127|NCT01287104|38099158|FG002|Overall Study|Patient developed progressive disease|3|||
16956128|NCT01287104|38099159|FG003|Overall Study|Patient developed progressive disease|2|||
16956129|NCT01287104|38099156|FG000|Overall Study|Donor anaphylaxis|0|||
16956130|NCT01287104|38099157|FG001|Overall Study|Donor anaphylaxis|1|||
16956131|NCT01287104|38099158|FG002|Overall Study|Donor anaphylaxis|0|||
16956132|NCT01287104|38099159|FG003|Overall Study|Donor anaphylaxis|1|||
16956133|NCT01287104|38099156|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
16956134|NCT01287104|38099157|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
16956135|NCT01287104|38099158|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
16956136|NCT01287104|38099159|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
16956137|NCT01287104|38099156|FG000|Overall Study|Low donor chimerism|0|||
16956138|NCT01287104|38099157|FG001|Overall Study|Low donor chimerism|1|||
16956139|NCT01287104|38099158|FG002|Overall Study|Low donor chimerism|0|||
16956140|NCT01287104|38099159|FG003|Overall Study|Low donor chimerism|0|||
16956141|NCT01287104|38099156|FG000|Overall Study|NK cells did not meet release criteria|0|||
16956142|NCT01287104|38099157|FG001|Overall Study|NK cells did not meet release criteria|1|||
16956143|NCT01287104|38099158|FG002|Overall Study|NK cells did not meet release criteria|0|||
16956144|NCT01287104|38099159|FG003|Overall Study|NK cells did not meet release criteria|0|||
16956145|NCT01286558|38099178|FG000|Overall Study|Adverse Event|1|||
16956146|NCT01286558|38099179|FG001|Overall Study|Adverse Event|1|||
16956147|NCT01286558|38099178|FG000|Overall Study|Withdrawal by Subject|0|||
16956148|NCT01286558|38099179|FG001|Overall Study|Withdrawal by Subject|1|||
16956149|NCT01169103|38099187|FG000|Overall Study|Lost to Follow-up|3|||
16956150|NCT01169103|38099188|FG001|Overall Study|Lost to Follow-up|3|||
16956151|NCT01169103|38099187|FG000|Overall Study|Withdrawal by Subject|3|||
16956152|NCT01169103|38099188|FG001|Overall Study|Withdrawal by Subject|1|||
16956153|NCT01286480|38099196|FG000|Overall Study|Withdrawal by Subject|5|||
16956154|NCT01286480|38099197|FG001|Overall Study|Withdrawal by Subject|3|||
16956155|NCT01286168|38099203|FG000|Overall Study|Withdrawal by Subject|1|||
16956156|NCT01286168|38099203|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
16956157|NCT01286012|38099210|FG000|Overall Study|Adverse Event|3|||
16956158|NCT01286012|38099211|FG001|Overall Study|Adverse Event|3|||
16956159|NCT01286012|38099210|FG000|Overall Study|Death|2|||
16956160|NCT01286012|38099211|FG001|Overall Study|Death|3|||
16956161|NCT01286012|38099210|FG000|Overall Study|Protocol Violation|1|||
16956162|NCT01286012|38099211|FG001|Overall Study|Protocol Violation|1|||
16956163|NCT01286012|38099210|FG000|Overall Study|Withdrawal by Subject|4|||
16956164|NCT01286012|38099211|FG001|Overall Study|Withdrawal by Subject|4|||
16956165|NCT01286012|38099210|FG000|Overall Study|Physician Decision|2|||
16956166|NCT01286012|38099211|FG001|Overall Study|Physician Decision|0|||
16956167|NCT01286012|38099210|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
17128704|NCT04320615|38269850|FG000|Overall Study|Death|35|||
16956168|NCT01286012|38099211|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
16956169|NCT00963547|38099222|FG000|Overall Study|Adverse Event|0|||
16956170|NCT00963547|38099223|FG001|Overall Study|Adverse Event|1|||
16956171|NCT00963547|38099224|FG002|Overall Study|Adverse Event|0|||
16956172|NCT00963547|38099225|FG003|Overall Study|Adverse Event|1|||
16956173|NCT00963547|38099226|FG004|Overall Study|Adverse Event|0|||
16956174|NCT00963547|38099227|FG005|Overall Study|Adverse Event|0|||
16956175|NCT00963547|38099228|FG006|Overall Study|Adverse Event|0|||
16956176|NCT00963547|38099222|FG000|Overall Study|Physician Decision|1|||
16956177|NCT00963547|38099223|FG001|Overall Study|Physician Decision|1|||
16956178|NCT00963547|38099224|FG002|Overall Study|Physician Decision|0|||
16956179|NCT00963547|38099225|FG003|Overall Study|Physician Decision|0|||
16956180|NCT00963547|38099226|FG004|Overall Study|Physician Decision|0|||
16956181|NCT00963547|38099227|FG005|Overall Study|Physician Decision|0|||
16956182|NCT00963547|38099228|FG006|Overall Study|Physician Decision|0|||
16956183|NCT00963547|38099222|FG000|Overall Study|Progressive Disease|3|||
16956184|NCT00963547|38099223|FG001|Overall Study|Progressive Disease|8|||
16956185|NCT00963547|38099224|FG002|Overall Study|Progressive Disease|9|||
16956186|NCT00963547|38099225|FG003|Overall Study|Progressive Disease|5|||
16956187|NCT00963547|38099226|FG004|Overall Study|Progressive Disease|0|||
16956188|NCT00963547|38099227|FG005|Overall Study|Progressive Disease|0|||
16956189|NCT00963547|38099228|FG006|Overall Study|Progressive Disease|0|||
16956190|NCT00963547|38099222|FG000|Overall Study|Withdrawal by Subject|0|||
16956191|NCT00963547|38099223|FG001|Overall Study|Withdrawal by Subject|0|||
16956192|NCT00963547|38099224|FG002|Overall Study|Withdrawal by Subject|3|||
16956193|NCT00963547|38099225|FG003|Overall Study|Withdrawal by Subject|0|||
16956194|NCT00963547|38099226|FG004|Overall Study|Withdrawal by Subject|0|||
16956195|NCT00963547|38099227|FG005|Overall Study|Withdrawal by Subject|0|||
16956196|NCT00963547|38099228|FG006|Overall Study|Withdrawal by Subject|0|||
16956197|NCT00963547|38099222|FG000|Overall Study|Reason Unknown|0|||
16956198|NCT00963547|38099223|FG001|Overall Study|Reason Unknown|1|||
16956199|NCT00963547|38099224|FG002|Overall Study|Reason Unknown|0|||
16956200|NCT00963547|38099225|FG003|Overall Study|Reason Unknown|0|||
16956201|NCT00963547|38099226|FG004|Overall Study|Reason Unknown|0|||
16956202|NCT00963547|38099227|FG005|Overall Study|Reason Unknown|0|||
16956203|NCT00963547|38099228|FG006|Overall Study|Reason Unknown|0|||
16956204|NCT01285310|38099244|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
16956205|NCT01285310|38099245|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
16956206|NCT01285310|38099246|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
16956207|NCT01285310|38099247|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
16956208|NCT01285310|38099248|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
16956209|NCT01285310|38099244|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
16956210|NCT01285310|38099245|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
16956211|NCT01285310|38099246|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
16956212|NCT01285310|38099247|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
16956213|NCT01285310|38099248|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
16956214|NCT01285310|38099244|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
16956215|NCT01285310|38099245|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
17128705|NCT04320615|38269851|FG001|Overall Study|Death|71|||
17128706|NCT00149747|38269863|FG000|Overall Study|Death|1|||
17128707|NCT00149747|38269864|FG001|Overall Study|Death|0|||
17128708|NCT00149747|38269863|FG000|Overall Study|Withdrawal by Subject|3|||
17128709|NCT00149747|38269864|FG001|Overall Study|Withdrawal by Subject|3|||
17128710|NCT00187889|38269872|FG000|Overall Study|Withdrawal by Subject|6|||
16956216|NCT01285310|38099246|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
16956217|NCT01285310|38099247|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
16956218|NCT01285310|38099248|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
17128711|NCT00187889|38269873|FG001|Overall Study|Withdrawal by Subject|4|||
17128712|NCT00148343|38269882|FG000|Overall Study|Withdrawal by Subject|12|||
17128713|NCT00148343|38269883|FG001|Overall Study|Withdrawal by Subject|7|||
17128714|NCT00148343|38269882|FG000|Overall Study|Physician Decision|3|||
17128715|NCT00148343|38269883|FG001|Overall Study|Physician Decision|4|||
17128716|NCT04150341|38269889|FG000|Overall Study|Physician Decision|0|||
17128717|NCT04150341|38269890|FG001|Overall Study|Physician Decision|0|||
16956219|NCT01285310|38099244|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
16956220|NCT01285310|38099245|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
16956221|NCT01285310|38099246|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
16956222|NCT01285310|38099247|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
16956223|NCT01285310|38099248|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
16956224|NCT01285310|38099244|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
16956225|NCT01285310|38099245|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
16956226|NCT01285310|38099246|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
16956227|NCT01285310|38099247|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
17128718|NCT04150341|38269891|FG002|Overall Study|Physician Decision|1|||
16956228|NCT01285310|38099248|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
16956229|NCT01285310|38099244|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
16956230|NCT01285310|38099245|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
16956231|NCT01285310|38099246|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
16956232|NCT01285310|38099247|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
16956233|NCT01285310|38099248|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
16956234|NCT01285310|38099244|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
16956235|NCT01285310|38099245|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
16956236|NCT01285310|38099246|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
16956237|NCT01285310|38099247|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
16956238|NCT01285310|38099248|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
16956239|NCT01285310|38099244|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
16956240|NCT01285310|38099245|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
16956241|NCT01285310|38099246|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
16956242|NCT01285310|38099247|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
16956243|NCT01285310|38099248|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
16956244|NCT01285310|38099244|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
16956245|NCT01285310|38099245|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
16956246|NCT01285310|38099246|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
16956247|NCT01285310|38099247|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
16956248|NCT01285310|38099248|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
16956249|NCT01285310|38099244|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
16956250|NCT01285310|38099245|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
16956251|NCT01285310|38099246|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
16956252|NCT01285310|38099247|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
16956253|NCT01285310|38099248|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
16956254|NCT01285310|38099244|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
16956255|NCT01285310|38099245|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
16956256|NCT01285310|38099246|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
16956257|NCT01285310|38099247|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
16956258|NCT01285310|38099248|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
16956259|NCT01285310|38099244|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
16956260|NCT01285310|38099245|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
16956261|NCT01285310|38099246|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
16956262|NCT01285310|38099247|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
16956263|NCT01285310|38099248|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
16956264|NCT01254630|38099290|FG000|Overall Study|Adverse Event|36|||
16956265|NCT01254630|38099291|FG001|Overall Study|Adverse Event|15|||
16956266|NCT01254630|38099292|FG002|Overall Study|Adverse Event|40|||
16956267|NCT01254630|38099293|FG003|Overall Study|Adverse Event|8|||
16956268|NCT01254630|38099290|FG000|Overall Study|Death|461|||
16956269|NCT01254630|38099291|FG001|Overall Study|Death|151|||
16956270|NCT01254630|38099292|FG002|Overall Study|Death|478|||
16956271|NCT01254630|38099293|FG003|Overall Study|Death|139|||
16956272|NCT01254630|38099290|FG000|Overall Study|Lost to Follow-up|80|||
16956273|NCT01254630|38099291|FG001|Overall Study|Lost to Follow-up|26|||
17128719|NCT04150341|38269892|FG003|Overall Study|Physician Decision|0|||
16956274|NCT01254630|38099292|FG002|Overall Study|Lost to Follow-up|89|||
16956275|NCT01254630|38099293|FG003|Overall Study|Lost to Follow-up|32|||
16956276|NCT01254630|38099290|FG000|Overall Study|Physician Decision|24|||
16956277|NCT01254630|38099291|FG001|Overall Study|Physician Decision|8|||
16956278|NCT01254630|38099292|FG002|Overall Study|Physician Decision|16|||
16956279|NCT01254630|38099293|FG003|Overall Study|Physician Decision|7|||
16956280|NCT01254630|38099290|FG000|Overall Study|Withdrawal by Subject|201|||
16956281|NCT01254630|38099291|FG001|Overall Study|Withdrawal by Subject|94|||
16956282|NCT01254630|38099292|FG002|Overall Study|Withdrawal by Subject|188|||
16956283|NCT01254630|38099293|FG003|Overall Study|Withdrawal by Subject|89|||
16956284|NCT01254630|38099290|FG000|Overall Study|Study terminated by sponsor|0|||
16956285|NCT01254630|38099291|FG001|Overall Study|Study terminated by sponsor|994|||
16956286|NCT01254630|38099292|FG002|Overall Study|Study terminated by sponsor|0|||
16956287|NCT01254630|38099293|FG003|Overall Study|Study terminated by sponsor|1010|||
16956288|NCT01254630|38099290|FG000|Overall Study|Status not recorded|0|||
16956289|NCT01254630|38099291|FG001|Overall Study|Status not recorded|0|||
16956290|NCT01254630|38099292|FG002|Overall Study|Status not recorded|1|||
16956291|NCT01254630|38099293|FG003|Overall Study|Status not recorded|0|||
16956292|NCT01284140|38099303|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
16956293|NCT01284140|38099304|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
17128720|NCT04150341|38269893|FG004|Overall Study|Physician Decision|0|||
16956294|NCT01284140|38099303|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
16956295|NCT01284140|38099304|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
16956296|NCT01254318|38099310|FG000|Overall Study|Lost to Follow-up|5|||
16956297|NCT01254318|38099310|FG000|Overall Study|Death|47|||
16956298|NCT01284062|38099318|FG000|Overall Study|Adverse Event|4|||
16956299|NCT01284062|38099319|FG001|Overall Study|Adverse Event|5|||
16956300|NCT01284062|38099320|FG002|Overall Study|Adverse Event|0|||
17128721|NCT04150341|38269894|FG005|Overall Study|Physician Decision|0|||
17128722|NCT04150341|38269889|FG000|Overall Study|Adverse Event|0|||
17128723|NCT04150341|38269890|FG001|Overall Study|Adverse Event|0|||
17128724|NCT04150341|38269891|FG002|Overall Study|Adverse Event|0|||
17128725|NCT04150341|38269892|FG003|Overall Study|Adverse Event|0|||
17128726|NCT04150341|38269893|FG004|Overall Study|Adverse Event|1|||
17128727|NCT04150341|38269894|FG005|Overall Study|Adverse Event|0|||
17128728|NCT00148109|38269906|FG000|Overall Study|Lack of Efficacy|10|||
17128729|NCT00148109|38269907|FG001|Overall Study|Lack of Efficacy|18|||
17128730|NCT00148109|38269906|FG000|Overall Study|Adverse Event|0|||
17128731|NCT00148109|38269907|FG001|Overall Study|Adverse Event|2|||
17128732|NCT00148109|38269906|FG000|Overall Study|Withdrawal by Subject|2|||
17128733|NCT00148109|38269907|FG001|Overall Study|Withdrawal by Subject|0|||
17128734|NCT00186485|38269913|FG000|Overall Study|Lost to Follow-up|3|||
17128735|NCT00147251|38269919|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
17128736|NCT00147251|38269920|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
17128737|NCT04390191|38269930|FG000|Overall Study|Withdrawal by Subject|1|||
17128738|NCT04390191|38269931|FG001|Overall Study|Withdrawal by Subject|0|||
17128739|NCT04147611|38269939|FG000|Overall Study|Physician Decision|0|||
17128740|NCT04147611|38269940|FG001|Overall Study|Physician Decision|1|||
17128741|NCT04405076|38269952|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
17128742|NCT04405076|38269953|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
17128743|NCT04405076|38269954|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
17128744|NCT04405076|38269955|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
17128745|NCT04405076|38269956|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
17128746|NCT04405076|38269957|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
17128747|NCT04405076|38269958|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
17128748|NCT04405076|38269959|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
17128749|NCT04405076|38269960|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
17128750|NCT04405076|38269952|FG000|Part A (Blinded Phase)|Physician Decision|1|||
17128751|NCT04405076|38269953|FG001|Part A (Blinded Phase)|Physician Decision|2|||
17128752|NCT04405076|38269954|FG002|Part A (Blinded Phase)|Physician Decision|0|||
17128753|NCT04405076|38269955|FG003|Part A (Blinded Phase)|Physician Decision|0|||
17128754|NCT04405076|38269956|FG004|Part A (Blinded Phase)|Physician Decision|0|||
17128755|NCT04405076|38269957|FG005|Part A (Blinded Phase)|Physician Decision|0|||
17128756|NCT04405076|38269958|FG006|Part A (Blinded Phase)|Physician Decision|0|||
17128757|NCT04405076|38269959|FG007|Part A (Blinded Phase)|Physician Decision|0|||
17128758|NCT04405076|38269960|FG008|Part A (Blinded Phase)|Physician Decision|0|||
16782544|NCT02561247|37722146|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
16956301|NCT01284062|38099321|FG003|Overall Study|Adverse Event|5|||
17128759|NCT04405076|38269952|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
17128760|NCT04405076|38269953|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
17128761|NCT04405076|38269954|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
17128762|NCT04405076|38269955|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
17128763|NCT04405076|38269956|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
17128764|NCT04405076|38269957|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
17128765|NCT04405076|38269958|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
17128766|NCT04405076|38269959|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
17128767|NCT04405076|38269960|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
17128768|NCT04405076|38269952|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
17128769|NCT04405076|38269953|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
17128770|NCT04405076|38269954|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
17128771|NCT04405076|38269955|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
17128772|NCT04405076|38269956|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
17128773|NCT04405076|38269957|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
17128774|NCT04405076|38269958|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
17128775|NCT04405076|38269959|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
17128776|NCT04405076|38269960|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
17128777|NCT04405076|38269952|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
17128778|NCT04405076|38269953|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
17128779|NCT04405076|38269954|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
17128780|NCT04405076|38269955|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
17128781|NCT04405076|38269956|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
17128782|NCT04405076|38269957|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
17128783|NCT04405076|38269958|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
17128784|NCT04405076|38269959|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
17128785|NCT04405076|38269960|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
17128786|NCT04405076|38269952|FG000|Part A (Blinded Phase)|Other than Specified|0|||
17128787|NCT04405076|38269953|FG001|Part A (Blinded Phase)|Other than Specified|0|||
17128788|NCT04405076|38269954|FG002|Part A (Blinded Phase)|Other than Specified|3|||
17128789|NCT04405076|38269955|FG003|Part A (Blinded Phase)|Other than Specified|0|||
17128790|NCT04405076|38269956|FG004|Part A (Blinded Phase)|Other than Specified|0|||
17128791|NCT04405076|38269957|FG005|Part A (Blinded Phase)|Other than Specified|0|||
17128792|NCT04405076|38269958|FG006|Part A (Blinded Phase)|Other than Specified|0|||
17128793|NCT04405076|38269959|FG007|Part A (Blinded Phase)|Other than Specified|0|||
17128794|NCT04405076|38269960|FG008|Part A (Blinded Phase)|Other than Specified|0|||
17128795|NCT04405076|38269952|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
17128796|NCT04405076|38269953|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
17128797|NCT04405076|38269954|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
17128798|NCT04405076|38269955|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
17128799|NCT04405076|38269956|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
17128800|NCT04405076|38269957|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
17128801|NCT04405076|38269958|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
17128802|NCT04405076|38269959|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
17128803|NCT04405076|38269960|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
17128804|NCT04405076|38269952|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
17128805|NCT04405076|38269953|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
17128806|NCT04405076|38269954|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
17128807|NCT04405076|38269955|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
17128808|NCT04405076|38269956|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
17128809|NCT04405076|38269957|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
17128810|NCT04405076|38269958|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
17128811|NCT04405076|38269959|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
17128812|NCT04405076|38269960|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
17128813|NCT04405076|38269952|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
17128814|NCT04405076|38269953|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
17128815|NCT04405076|38269954|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
17128816|NCT04405076|38269955|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
17128817|NCT04405076|38269956|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
17128818|NCT04405076|38269957|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
17128819|NCT04405076|38269958|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
17128820|NCT04405076|38269959|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
17128821|NCT04405076|38269960|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
17128822|NCT04405076|38269952|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
17128823|NCT04405076|38269953|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
17128824|NCT04405076|38269954|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
17128825|NCT04405076|38269955|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
17128826|NCT04405076|38269956|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
17128827|NCT04405076|38269957|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
17128828|NCT04405076|38269958|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
17128829|NCT04405076|38269959|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
17128830|NCT04405076|38269960|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
17128831|NCT04405076|38269952|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
17128832|NCT04405076|38269953|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
17128833|NCT04405076|38269954|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
17128834|NCT04405076|38269955|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16956302|NCT01284062|38099318|FG000|Overall Study|Lack of Efficacy|3|||
16956303|NCT01284062|38099319|FG001|Overall Study|Lack of Efficacy|2|||
16956304|NCT01284062|38099320|FG002|Overall Study|Lack of Efficacy|2|||
16956305|NCT01284062|38099321|FG003|Overall Study|Lack of Efficacy|1|||
16956306|NCT01284062|38099318|FG000|Overall Study|Medication error without adverse event|0|||
16956307|NCT01284062|38099319|FG001|Overall Study|Medication error without adverse event|0|||
16956308|NCT01284062|38099320|FG002|Overall Study|Medication error without adverse event|1|||
16956309|NCT01284062|38099321|FG003|Overall Study|Medication error without adverse event|0|||
16956310|NCT01284062|38099318|FG000|Overall Study|Protocol Violation|1|||
16956311|NCT01284062|38099319|FG001|Overall Study|Protocol Violation|0|||
16956312|NCT01284062|38099320|FG002|Overall Study|Protocol Violation|0|||
16956313|NCT01284062|38099321|FG003|Overall Study|Protocol Violation|2|||
16956314|NCT01284062|38099318|FG000|Overall Study|Withdrawal by Subject|3|||
16956315|NCT01284062|38099319|FG001|Overall Study|Withdrawal by Subject|1|||
16956316|NCT01284062|38099320|FG002|Overall Study|Withdrawal by Subject|2|||
16956317|NCT01284062|38099321|FG003|Overall Study|Withdrawal by Subject|5|||
16956318|NCT01284062|38099318|FG000|Overall Study|Other|0|||
16956319|NCT01284062|38099319|FG001|Overall Study|Other|0|||
16956320|NCT01284062|38099320|FG002|Overall Study|Other|0|||
16956321|NCT01284062|38099321|FG003|Overall Study|Other|1|||
16956322|NCT01284062|38099318|FG000|Overall Study|Site Closed|0|||
16956323|NCT01284062|38099319|FG001|Overall Study|Site Closed|0|||
16782545|NCT02061592|37722152|FG000|Period 1|Withdrawal by Subject|1|||
16956324|NCT01284062|38099320|FG002|Overall Study|Site Closed|1|||
16956325|NCT01284062|38099321|FG003|Overall Study|Site Closed|0|||
16956326|NCT01253304|38099338|FG000|Overall Study|Adverse Event|0|||
16956327|NCT01253304|38099339|FG001|Overall Study|Adverse Event|0|||
16956328|NCT01253304|38099340|FG002|Overall Study|Adverse Event|0|||
17128835|NCT04405076|38269956|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
17128836|NCT04405076|38269957|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
17128837|NCT04405076|38269958|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
17128838|NCT04405076|38269959|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
17128839|NCT04405076|38269960|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
17128840|NCT04311177|38269988|FG000|Overall Study|Adverse Event|3|||
17128841|NCT04311177|38269989|FG001|Overall Study|Adverse Event|1|||
17128842|NCT04311177|38269988|FG000|Overall Study|Physician Decision|4|||
17128843|NCT04311177|38269989|FG001|Overall Study|Physician Decision|3|||
17128844|NCT04311177|38269988|FG000|Overall Study|Withdrawal by Subject|1|||
17128845|NCT04311177|38269989|FG001|Overall Study|Withdrawal by Subject|0|||
17128846|NCT03267212|38269995|FG000|First Intervention|Lost to Follow-up|0|||
17128847|NCT03267212|38269996|FG001|First Intervention|Lost to Follow-up|2|||
17128848|NCT03267212|38269995|FG000|First Intervention|Withdrawal by Subject|1|||
17128849|NCT03267212|38269996|FG001|First Intervention|Withdrawal by Subject|1|||
17128850|NCT03267212|38269995|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
17128851|NCT03267212|38269996|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
17128852|NCT04292535|38270016|FG000|Overall Study|Withdrawal by Subject|0|||
17128853|NCT04292535|38270017|FG001|Overall Study|Withdrawal by Subject|0|||
17128854|NCT04292535|38270018|FG002|Overall Study|Withdrawal by Subject|0|||
17128855|NCT04292535|38270019|FG003|Overall Study|Withdrawal by Subject|0|||
17128856|NCT04292535|38270020|FG004|Overall Study|Withdrawal by Subject|0|||
17128857|NCT04292535|38270021|FG005|Overall Study|Withdrawal by Subject|0|||
17128858|NCT04292535|38270022|FG006|Overall Study|Withdrawal by Subject|0|||
17128859|NCT04292535|38270023|FG007|Overall Study|Withdrawal by Subject|1|||
17128860|NCT04292535|38270024|FG008|Overall Study|Withdrawal by Subject|0|||
17128861|NCT04292535|38270025|FG009|Overall Study|Withdrawal by Subject|0|||
17128862|NCT04292535|38270026|FG010|Overall Study|Withdrawal by Subject|0|||
17128863|NCT04292535|38270027|FG011|Overall Study|Withdrawal by Subject|0|||
17128864|NCT04292535|38270028|FG012|Overall Study|Withdrawal by Subject|0|||
17128865|NCT04292535|38270029|FG013|Overall Study|Withdrawal by Subject|0|||
17128866|NCT04292535|38270016|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128867|NCT04292535|38270017|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128868|NCT04292535|38270018|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128869|NCT04292535|38270019|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128870|NCT04292535|38270020|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128871|NCT04292535|38270021|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128872|NCT04292535|38270022|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128873|NCT04292535|38270023|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
17128874|NCT04292535|38270024|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128875|NCT04292535|38270025|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128876|NCT04292535|38270026|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128877|NCT04292535|38270027|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
17128878|NCT04292535|38270028|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
17128879|NCT04292535|38270029|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
17128880|NCT04292535|38270016|FG000|Overall Study|Report of Dizziness|0|||
17128881|NCT04292535|38270017|FG001|Overall Study|Report of Dizziness|0|||
17128882|NCT04292535|38270018|FG002|Overall Study|Report of Dizziness|0|||
17128883|NCT04292535|38270019|FG003|Overall Study|Report of Dizziness|0|||
17128884|NCT04292535|38270020|FG004|Overall Study|Report of Dizziness|0|||
17128885|NCT04292535|38270021|FG005|Overall Study|Report of Dizziness|0|||
17128886|NCT04292535|38270022|FG006|Overall Study|Report of Dizziness|0|||
17128887|NCT04292535|38270023|FG007|Overall Study|Report of Dizziness|0|||
17128888|NCT04292535|38270024|FG008|Overall Study|Report of Dizziness|0|||
17128889|NCT04292535|38270025|FG009|Overall Study|Report of Dizziness|0|||
17128890|NCT04292535|38270026|FG010|Overall Study|Report of Dizziness|0|||
17128891|NCT04292535|38270027|FG011|Overall Study|Report of Dizziness|0|||
17128892|NCT04292535|38270028|FG012|Overall Study|Report of Dizziness|0|||
17128893|NCT04292535|38270029|FG013|Overall Study|Report of Dizziness|1|||
17128894|NCT04292535|38270016|FG000|Overall Study|Equipment Failure|0|||
17128895|NCT04292535|38270017|FG001|Overall Study|Equipment Failure|0|||
17128896|NCT04292535|38270018|FG002|Overall Study|Equipment Failure|0|||
17128897|NCT04292535|38270019|FG003|Overall Study|Equipment Failure|0|||
17128898|NCT04292535|38270020|FG004|Overall Study|Equipment Failure|0|||
17128899|NCT04292535|38270021|FG005|Overall Study|Equipment Failure|0|||
17128900|NCT04292535|38270022|FG006|Overall Study|Equipment Failure|0|||
17128901|NCT04292535|38270023|FG007|Overall Study|Equipment Failure|0|||
17128902|NCT04292535|38270024|FG008|Overall Study|Equipment Failure|0|||
17128903|NCT04292535|38270025|FG009|Overall Study|Equipment Failure|0|||
17128904|NCT04292535|38270026|FG010|Overall Study|Equipment Failure|0|||
17128905|NCT04292535|38270027|FG011|Overall Study|Equipment Failure|1|||
17128906|NCT04292535|38270028|FG012|Overall Study|Equipment Failure|0|||
17128907|NCT04292535|38270029|FG013|Overall Study|Equipment Failure|0|||
16782546|NCT02061592|37722153|FG001|Period 1|Withdrawal by Subject|0|||
16956329|NCT01253304|38099341|FG003|Overall Study|Adverse Event|1|||
17128908|NCT04385199|38270061|FG000|Overall Study|Withdrawal by Subject|1|||
17128909|NCT04385199|38270062|FG001|Overall Study|Withdrawal by Subject|0|||
17128910|NCT04284813|38270068|FG000|Overall Study|Withdrawal by Subject|1|||
17128911|NCT03263780|38270072|FG000|Overall Study|Withdrawal by Subject|3|||
17128912|NCT03263780|38270072|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
17128913|NCT02791438|38270078|FG000|Treatment Period|Adverse Event|1|||
17128914|NCT02791438|38270079|FG001|Treatment Period|Adverse Event|0|||
17128915|NCT02791438|38270078|FG000|Treatment Period|Withdrawal by Subject|0|||
17128916|NCT02791438|38270079|FG001|Treatment Period|Withdrawal by Subject|1|||
17128917|NCT02791438|38270078|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
17128918|NCT02791438|38270079|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
17128919|NCT03712124|38270087|FG000|Overall Study|Protocol Violation|1|||
17128920|NCT03712124|38270088|FG001|Overall Study|Protocol Violation|0|||
17128921|NCT02791516|38270102|FG000|Overall Study|Withdrawal by Subject|1|||
17128922|NCT02791516|38270103|FG001|Overall Study|Withdrawal by Subject|1|||
17128923|NCT03263702|38270111|FG000|Overall Study|Lost to Follow-up|2|||
17128924|NCT03263702|38270112|FG001|Overall Study|Lost to Follow-up|2|||
17128925|NCT03263702|38270111|FG000|Overall Study|Withdrawal by Subject|1|||
17128926|NCT03263702|38270112|FG001|Overall Study|Withdrawal by Subject|2|||
17128927|NCT03692871|38270120|FG000|Overall Study|Death|1|||
17128928|NCT03692871|38270121|FG001|Overall Study|Death|1|||
17128929|NCT03692871|38270120|FG000|Overall Study|Lost to Follow-up|24|||
17128930|NCT03692871|38270121|FG001|Overall Study|Lost to Follow-up|9|||
17128931|NCT03692871|38270120|FG000|Overall Study|Physician Decision|22|||
17128932|NCT03692871|38270121|FG001|Overall Study|Physician Decision|7|||
17128933|NCT03692871|38270120|FG000|Overall Study|Protocol Deviation|1|||
17128934|NCT03692871|38270121|FG001|Overall Study|Protocol Deviation|0|||
17128935|NCT03692871|38270120|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
16956330|NCT01253226|38099356|FG000|Overall Study|Adverse Event|0|||
16956331|NCT01253226|38099357|FG001|Overall Study|Adverse Event|0|||
16956332|NCT01253226|38099358|FG002|Overall Study|Adverse Event|1|||
16956333|NCT01253226|38099359|FG003|Overall Study|Adverse Event|0|||
16956334|NCT01253226|38099360|FG004|Overall Study|Adverse Event|0|||
16956335|NCT01253226|38099356|FG000|Overall Study|Death|0|||
16956336|NCT01253226|38099357|FG001|Overall Study|Death|1|||
17128936|NCT03692871|38270121|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
17128937|NCT04384107|38270129|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
17128938|NCT04384107|38270130|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
17128939|NCT04384107|38270129|FG000|Overall Study|Lost to Follow-up|1|||
17128940|NCT04384107|38270130|FG001|Overall Study|Lost to Follow-up|0|||
17128941|NCT04130919|38270139|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
17128942|NCT04130919|38270140|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
17128943|NCT04130919|38270141|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
17128944|NCT04130919|38270142|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
17128945|NCT04130919|38270143|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
17128946|NCT04130919|38270144|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
17128947|NCT04130919|38270139|FG000|Blinded Treatment Phase|Adverse Event|0|||
17128948|NCT04130919|38270140|FG001|Blinded Treatment Phase|Adverse Event|0|||
17128949|NCT04130919|38270141|FG002|Blinded Treatment Phase|Adverse Event|1|||
17128950|NCT04130919|38270142|FG003|Blinded Treatment Phase|Adverse Event|0|||
17128951|NCT04130919|38270143|FG004|Blinded Treatment Phase|Adverse Event|0|||
17128952|NCT04130919|38270144|FG005|Blinded Treatment Phase|Adverse Event|0|||
16782547|NCT02061592|37722152|FG000|Period 1|Protocol Violation|1|||
16956337|NCT01253226|38099358|FG002|Overall Study|Death|0|||
17128953|NCT04130919|38270139|FG000|Blinded Treatment Phase|Disease worsening|0|||
17128954|NCT04130919|38270140|FG001|Blinded Treatment Phase|Disease worsening|0|||
17128955|NCT04130919|38270141|FG002|Blinded Treatment Phase|Disease worsening|1|||
17128956|NCT04130919|38270142|FG003|Blinded Treatment Phase|Disease worsening|0|||
17128957|NCT04130919|38270143|FG004|Blinded Treatment Phase|Disease worsening|0|||
17128958|NCT04130919|38270144|FG005|Blinded Treatment Phase|Disease worsening|0|||
17128959|NCT04130919|38270139|FG000|Blinded Treatment Phase|Investigator's decision|0|||
17128960|NCT04130919|38270140|FG001|Blinded Treatment Phase|Investigator's decision|1|||
17128961|NCT04130919|38270141|FG002|Blinded Treatment Phase|Investigator's decision|0|||
17128962|NCT04130919|38270142|FG003|Blinded Treatment Phase|Investigator's decision|0|||
17128963|NCT04130919|38270143|FG004|Blinded Treatment Phase|Investigator's decision|0|||
17128964|NCT04130919|38270144|FG005|Blinded Treatment Phase|Investigator's decision|0|||
17128965|NCT04130919|38270139|FG000|Blinded Treatment Phase|Withdrew consent|1|||
17128966|NCT04130919|38270140|FG001|Blinded Treatment Phase|Withdrew consent|0|||
17128967|NCT04130919|38270141|FG002|Blinded Treatment Phase|Withdrew consent|0|||
17128968|NCT04130919|38270142|FG003|Blinded Treatment Phase|Withdrew consent|0|||
17128969|NCT04130919|38270143|FG004|Blinded Treatment Phase|Withdrew consent|0|||
17128970|NCT04130919|38270144|FG005|Blinded Treatment Phase|Withdrew consent|0|||
17128971|NCT04130919|38270139|FG000|Open-label Treatment Phase|Withdrew consent|0|||
17128972|NCT04130919|38270140|FG001|Open-label Treatment Phase|Withdrew consent|0|||
17128973|NCT04130919|38270141|FG002|Open-label Treatment Phase|Withdrew consent|0|||
17128974|NCT04130919|38270142|FG003|Open-label Treatment Phase|Withdrew consent|1|||
17128975|NCT04130919|38270143|FG004|Open-label Treatment Phase|Withdrew consent|1|||
17128976|NCT04130919|38270144|FG005|Open-label Treatment Phase|Withdrew consent|1|||
17128977|NCT04130919|38270139|FG000|Open-label Treatment Phase|Disease worsening|0|||
17128978|NCT04130919|38270140|FG001|Open-label Treatment Phase|Disease worsening|0|||
17128979|NCT04130919|38270141|FG002|Open-label Treatment Phase|Disease worsening|0|||
17128980|NCT04130919|38270142|FG003|Open-label Treatment Phase|Disease worsening|1|||
17128981|NCT04130919|38270143|FG004|Open-label Treatment Phase|Disease worsening|0|||
17128982|NCT04130919|38270144|FG005|Open-label Treatment Phase|Disease worsening|1|||
17128983|NCT04130919|38270139|FG000|Open-label Treatment Phase|Investigator's decision|0|||
17128984|NCT04130919|38270140|FG001|Open-label Treatment Phase|Investigator's decision|0|||
17128985|NCT04130919|38270141|FG002|Open-label Treatment Phase|Investigator's decision|0|||
17128986|NCT04130919|38270142|FG003|Open-label Treatment Phase|Investigator's decision|1|||
17128987|NCT04130919|38270143|FG004|Open-label Treatment Phase|Investigator's decision|0|||
17128988|NCT04130919|38270144|FG005|Open-label Treatment Phase|Investigator's decision|0|||
17128989|NCT04130919|38270139|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
17128990|NCT04130919|38270140|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
17128991|NCT04130919|38270141|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
17128992|NCT04130919|38270142|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
17128993|NCT04130919|38270143|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
17128994|NCT04130919|38270144|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
17128995|NCT04130919|38270139|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
17128996|NCT04130919|38270140|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
17128997|NCT04130919|38270141|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
17128998|NCT04130919|38270142|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
17128999|NCT04130919|38270143|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
17129000|NCT04130919|38270144|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
17129001|NCT04128267|38270158|FG000|Overall Study|Withdrawal by Subject|6|||
17129002|NCT04128267|38270158|FG000|Overall Study|Death|2|||
17129003|NCT04128267|38270158|FG000|Overall Study|Disease progression|1|||
17129004|NCT04128267|38270158|FG000|Overall Study|Participant had other medical issues|4|||
17129005|NCT04128267|38270158|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
17129006|NCT03691779|38270162|FG000|Part B (24 Weeks)|Adverse Event|0|||
17129007|NCT03691779|38270163|FG001|Part B (24 Weeks)|Adverse Event|1|||
17129008|NCT03691779|38270162|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
17129009|NCT03691779|38270163|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
17129010|NCT04258995|38270172|FG000|Overall Study|Lost to Follow-up|1|||
17129011|NCT04258995|38270173|FG001|Overall Study|Lost to Follow-up|1|||
17129012|NCT04247061|38270179|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
17129013|NCT04247061|38270179|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
17129014|NCT04247061|38270179|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
17129015|NCT04241133|38270185|FG000|Overall Study|COVID19 Precautions|14|||
17129016|NCT04241133|38270186|FG001|Overall Study|COVID19 Precautions|34|||
17129017|NCT04123665|38270194|FG000|Overall Study|Withdrawal by Subject|7|||
17129018|NCT04123665|38270195|FG001|Overall Study|Withdrawal by Subject|0|||
17129019|NCT04123665|38270194|FG000|Overall Study|Lost to Follow-up|1|||
17129020|NCT04123665|38270195|FG001|Overall Study|Lost to Follow-up|0|||
17129021|NCT03981614|38270204|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
17129022|NCT03981614|38270205|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
17129023|NCT03981614|38270206|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
17129024|NCT04232943|38270220|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
17129025|NCT04232943|38270221|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
17129026|NCT04232943|38270222|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
17129027|NCT04232943|38270220|FG000|Overall Study|Withdrawal by Subject|1|||
17129028|NCT04232943|38270221|FG001|Overall Study|Withdrawal by Subject|1|||
17129029|NCT04232943|38270222|FG002|Overall Study|Withdrawal by Subject|0|||
17129030|NCT03694275|38270233|FG000|Overall Study|Adverse Event|0|||
16956338|NCT01253226|38099359|FG003|Overall Study|Death|0|||
16956339|NCT01253226|38099360|FG004|Overall Study|Death|0|||
17129031|NCT03694275|38270234|FG001|Overall Study|Adverse Event|1|||
17129032|NCT03694275|38270233|FG000|Overall Study|Reason not Specified|0|||
17129033|NCT03694275|38270234|FG001|Overall Study|Reason not Specified|1|||
17129034|NCT04230213|38270241|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
17129035|NCT04230213|38270242|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
17129036|NCT04230213|38270243|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
17129037|NCT04230213|38270241|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
17129038|NCT04230213|38270242|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
17129039|NCT04230213|38270243|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
16956340|NCT01253226|38099356|FG000|Overall Study|Physician Decision|0|||
16956341|NCT01253226|38099357|FG001|Overall Study|Physician Decision|0|||
16956342|NCT01253226|38099358|FG002|Overall Study|Physician Decision|0|||
16956343|NCT01253226|38099359|FG003|Overall Study|Physician Decision|0|||
16956344|NCT01253226|38099360|FG004|Overall Study|Physician Decision|2|||
16956345|NCT01253226|38099356|FG000|Overall Study|Withdrawal by Subject|0|||
16956346|NCT01253226|38099357|FG001|Overall Study|Withdrawal by Subject|0|||
16956347|NCT01253226|38099358|FG002|Overall Study|Withdrawal by Subject|0|||
16956348|NCT01253226|38099359|FG003|Overall Study|Withdrawal by Subject|1|||
16956349|NCT01253226|38099360|FG004|Overall Study|Withdrawal by Subject|0|||
16956350|NCT01252290|38099372|FG000|Overall Study|Withdrawal by Subject|1|||
17129040|NCT04230213|38270241|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
17129041|NCT04230213|38270242|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
17129042|NCT04230213|38270243|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
17129043|NCT04230213|38270241|FG000|TP2: Week 10 to Week 16|Other|0|||
17129044|NCT04230213|38270242|FG001|TP2: Week 10 to Week 16|Other|2|||
17129045|NCT04230213|38270243|FG002|TP2: Week 10 to Week 16|Other|1|||
17129046|NCT04230213|38270241|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
17129047|NCT04230213|38270242|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
17129048|NCT04230213|38270243|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
17129049|NCT04230213|38270241|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
17129050|NCT04230213|38270242|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
17129051|NCT04230213|38270243|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
17129052|NCT04230213|38270241|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
17129053|NCT04230213|38270242|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
17129054|NCT04230213|38270243|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
17129055|NCT04230213|38270241|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
17129056|NCT04230213|38270242|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
17129057|NCT04230213|38270243|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
17129058|NCT04230213|38270241|FG000|TP3: Week 16 to Week 22|Other|0|||
17129059|NCT04230213|38270242|FG001|TP3: Week 16 to Week 22|Other|1|||
17129060|NCT04230213|38270243|FG002|TP3: Week 16 to Week 22|Other|3|||
17129061|NCT04230213|38270241|FG000|TP4: Week 22 to Week 32|Other|0|||
17129062|NCT04230213|38270242|FG001|TP4: Week 22 to Week 32|Other|5|||
17129063|NCT04230213|38270243|FG002|TP4: Week 22 to Week 32|Other|5|||
17129064|NCT04230213|38270241|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
17129065|NCT04230213|38270242|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
17129066|NCT04230213|38270243|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
17129067|NCT04230213|38270241|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
17129068|NCT04230213|38270242|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
17129069|NCT04230213|38270243|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
17129070|NCT04230213|38270241|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
17129071|NCT04230213|38270242|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
17129072|NCT04230213|38270243|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
17129073|NCT04230213|38270241|FG000|Follow up: Week 32 to Week 36|Other|0|||
17129074|NCT04230213|38270242|FG001|Follow up: Week 32 to Week 36|Other|1|||
17129075|NCT04230213|38270243|FG002|Follow up: Week 32 to Week 36|Other|1|||
17129076|NCT04222725|38270255|FG000|Overall Study|Adverse Event|0|||
17129077|NCT04222725|38270256|FG001|Overall Study|Adverse Event|1|||
17129078|NCT04222725|38270257|FG002|Overall Study|Adverse Event|0|||
17129079|NCT04222725|38270258|FG003|Overall Study|Adverse Event|0|||
17129080|NCT04213989|38270270|FG000|Overall Study|Withdrawal by Subject|3|||
17129081|NCT04213989|38270271|FG001|Overall Study|Withdrawal by Subject|2|||
17129082|NCT04213989|38270270|FG000|Overall Study|Physician Decision|1|||
17129083|NCT04213989|38270271|FG001|Overall Study|Physician Decision|0|||
17129084|NCT04213989|38270270|FG000|Overall Study|Lost to Follow-up|0|||
17129085|NCT04213989|38270271|FG001|Overall Study|Lost to Follow-up|4|||
17129086|NCT03242252|38270280|FG000|Overall Study|At the Participant's own Request|18|||
17129087|NCT03242252|38270281|FG001|Overall Study|At the Participant's own Request|10|||
17129088|NCT03242252|38270282|FG002|Overall Study|At the Participant's own Request|15|||
17129089|NCT03242252|38270280|FG000|Overall Study|Adverse Event|8|||
17129090|NCT03242252|38270281|FG001|Overall Study|Adverse Event|6|||
16956351|NCT01252134|38099376|FG000|Period 1, 8 Hours|Personal Reasons|0|||
16956352|NCT01252134|38099377|FG001|Period 1, 8 Hours|Personal Reasons|1|||
16956353|NCT01252134|38099378|FG002|Period 1, 8 Hours|Personal Reasons|1|||
17129091|NCT03242252|38270282|FG002|Overall Study|Adverse Event|9|||
17129092|NCT03242252|38270280|FG000|Overall Study|Poor Compliance to Protocol|0|||
17129093|NCT03242252|38270281|FG001|Overall Study|Poor Compliance to Protocol|2|||
17129094|NCT03242252|38270282|FG002|Overall Study|Poor Compliance to Protocol|3|||
17129095|NCT03242252|38270280|FG000|Overall Study|Study Terminated by Sponsor|1|||
17129096|NCT03242252|38270281|FG001|Overall Study|Study Terminated by Sponsor|0|||
17129097|NCT03242252|38270282|FG002|Overall Study|Study Terminated by Sponsor|0|||
17129098|NCT03242252|38270280|FG000|Overall Study|Reason not Specified|4|||
17129099|NCT03242252|38270281|FG001|Overall Study|Reason not Specified|4|||
17129100|NCT03242252|38270282|FG002|Overall Study|Reason not Specified|1|||
17129101|NCT03242252|38270280|FG000|Overall Study|Lost to Follow-up|5|||
17129102|NCT03242252|38270281|FG001|Overall Study|Lost to Follow-up|1|||
17129103|NCT03242252|38270282|FG002|Overall Study|Lost to Follow-up|4|||
17129104|NCT04109391|38270299|FG000|Overall Study|Adverse Event|2|||
17129105|NCT04109391|38270300|FG001|Overall Study|Adverse Event|2|||
17129106|NCT04109391|38270301|FG002|Overall Study|Adverse Event|0|||
17129107|NCT04109391|38270299|FG000|Overall Study|Withdrawal by Subject|2|||
17129108|NCT04109391|38270300|FG001|Overall Study|Withdrawal by Subject|0|||
17129109|NCT04109391|38270301|FG002|Overall Study|Withdrawal by Subject|0|||
17129110|NCT04109391|38270299|FG000|Overall Study|Pregnancy|1|||
16956354|NCT01252134|38099379|FG003|Period 1, 8 Hours|Personal Reasons|0|||
16956355|NCT01252134|38099380|FG004|Period 1, 8 Hours|Personal Reasons|0|||
16956356|NCT01252134|38099381|FG005|Period 1, 8 Hours|Personal Reasons|0|||
16956357|NCT01251744|38099391|FG000|Overall Study|Lost to Follow-up|1|||
16956358|NCT01251744|38099392|FG001|Overall Study|Lost to Follow-up|0|||
16956359|NCT01251354|38099405|FG000|Overall Study|Adverse Event|1|||
16956360|NCT01251354|38099405|FG000|Overall Study|Investigator's Decision|1|||
16956361|NCT01251354|38099405|FG000|Overall Study|Disease Progression|4|||
16956362|NCT01251276|38099411|FG000|Overall Study|Protocol Violation|1|||
16956363|NCT01251276|38099412|FG001|Overall Study|Protocol Violation|0|||
16956364|NCT01251276|38099411|FG000|Overall Study|Lost to Follow-up|0|||
16956365|NCT01251276|38099412|FG001|Overall Study|Lost to Follow-up|1|||
16956366|NCT01251120|38099420|FG000|Overall Study|Lack of Efficacy|0|||
16956367|NCT01251120|38099421|FG001|Overall Study|Lack of Efficacy|1|||
16956368|NCT01250418|38099429|FG000|Overall Study|monitor data failure|1|||
16956369|NCT01250418|38099430|FG001|Overall Study|monitor data failure|1|||
16956370|NCT01292603|38099441|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16956371|NCT01292603|38099442|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16956372|NCT01292603|38099443|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16956373|NCT01292603|38099444|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
16956374|NCT01292603|38099445|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16956375|NCT01292603|38099446|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16956376|NCT01292603|38099441|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
16956377|NCT01292603|38099442|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
16956378|NCT01292603|38099443|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
16956379|NCT01292603|38099444|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
16956380|NCT01292603|38099445|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
16956381|NCT01292603|38099446|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
16956382|NCT01292603|38099441|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16956383|NCT01292603|38099442|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16956384|NCT01292603|38099443|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16956385|NCT01292603|38099444|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
16956386|NCT01292603|38099445|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16956387|NCT01292603|38099446|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16956388|NCT01292603|38099441|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16956389|NCT01292603|38099442|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16956390|NCT01292603|38099443|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16956391|NCT01292603|38099444|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
16956392|NCT01292603|38099445|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16956393|NCT01292603|38099446|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16956394|NCT01292603|38099441|FG000|Part 1: Regular Follow-Up Period|Death|3|||
16956395|NCT01292603|38099442|FG001|Part 1: Regular Follow-Up Period|Death|1|||
16956396|NCT01292603|38099443|FG002|Part 1: Regular Follow-Up Period|Death|3|||
16956397|NCT01292603|38099444|FG003|Part 1: Regular Follow-Up Period|Death|1|||
16956398|NCT01292603|38099445|FG004|Part 1: Regular Follow-Up Period|Death|0|||
16956399|NCT01292603|38099446|FG005|Part 1: Regular Follow-Up Period|Death|0|||
16956400|NCT01292603|38099441|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
16956401|NCT01292603|38099442|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
16956402|NCT01292603|38099443|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
16956403|NCT01292603|38099444|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
16956404|NCT01292603|38099445|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
16956405|NCT01292603|38099446|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
16956406|NCT01292603|38099441|FG000|Part 2: Dose Confirmation Period|Death|0|||
16956407|NCT01292603|38099442|FG001|Part 2: Dose Confirmation Period|Death|0|||
16956408|NCT01292603|38099443|FG002|Part 2: Dose Confirmation Period|Death|0|||
16956409|NCT01292603|38099444|FG003|Part 2: Dose Confirmation Period|Death|0|||
16956410|NCT01292603|38099445|FG004|Part 2: Dose Confirmation Period|Death|1|||
16956411|NCT01292603|38099446|FG005|Part 2: Dose Confirmation Period|Death|0|||
16956412|NCT01292603|38099441|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
16956413|NCT01292603|38099442|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
16956414|NCT01292603|38099443|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
16956415|NCT01292603|38099444|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
16956416|NCT01292603|38099445|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
16956417|NCT01292603|38099446|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
16956418|NCT01292603|38099441|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
16956419|NCT01292603|38099442|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
16956420|NCT01292603|38099443|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
16956421|NCT01292603|38099444|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
16956422|NCT01292603|38099445|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
16956423|NCT01292603|38099446|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
17129111|NCT04109391|38270300|FG001|Overall Study|Pregnancy|0|||
17129112|NCT04109391|38270301|FG002|Overall Study|Pregnancy|0|||
17129113|NCT04109391|38270299|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
17129114|NCT04109391|38270300|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
17129115|NCT04109391|38270301|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
17129116|NCT04109391|38270299|FG000|Overall Study|Lost to Follow-up|0|||
17129117|NCT04109391|38270300|FG001|Overall Study|Lost to Follow-up|0|||
17129118|NCT04109391|38270301|FG002|Overall Study|Lost to Follow-up|1|||
17129119|NCT04109391|38270299|FG000|Overall Study|Lack of Efficacy|2|||
17129120|NCT04109391|38270300|FG001|Overall Study|Lack of Efficacy|2|||
17129121|NCT04109391|38270301|FG002|Overall Study|Lack of Efficacy|3|||
17129122|NCT04106817|38270312|FG000|Overall Study|Lost to Follow-up|1|||
17129123|NCT04106817|38270313|FG001|Overall Study|Lost to Follow-up|0|||
17129124|NCT04106817|38270314|FG002|Overall Study|Lost to Follow-up|0|||
17129125|NCT04097925|38270322|FG000|Overall Study|Withdrawal by Subject|1|||
17129126|NCT04195893|38270326|FG000|Second Intervention|Withdrawal by Subject|1|||
17129127|NCT04195893|38270327|FG001|Second Intervention|Withdrawal by Subject|0|||
17129128|NCT04195581|38270333|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
17129129|NCT04195581|38270333|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
17129130|NCT04195581|38270333|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
17129131|NCT04195581|38270333|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
17129132|NCT04195581|38270333|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
17129133|NCT04195581|38270333|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
17129134|NCT04096365|38270351|FG000|Overall Study|Adverse Event|1|||
17129135|NCT04194489|38270355|FG000|Overall Study|Withdrawal by Subject|5|||
17129136|NCT04194489|38270355|FG000|Overall Study|Lost to Follow-up|48|||
17129137|NCT03260894|38270361|FG000|Overall Study|Death|6|||
17129138|NCT03260894|38270362|FG001|Overall Study|Death|8|||
17129139|NCT03260894|38270361|FG000|Overall Study|Withdrawal by Subject|4|||
17129140|NCT03260894|38270362|FG001|Overall Study|Withdrawal by Subject|11|||
17129141|NCT03260894|38270361|FG000|Overall Study|On-going at clinical cut off date|36|||
17129142|NCT03260894|38270362|FG001|Overall Study|On-going at clinical cut off date|31|||
17129143|NCT04094883|38270368|FG000|Overall Study|Withdrawal by Subject|1|||
17129144|NCT01368562|38270372|FG000|Overall Study|Adverse Event|1|||
17129145|NCT01368562|38270372|FG000|Overall Study|Disease progression|1|||
17129146|NCT01368562|38270372|FG000|Overall Study|Lost to Follow-up|1|||
17129147|NCT01368562|38270372|FG000|Overall Study|Death|6|||
17129148|NCT01368562|38270372|FG000|Overall Study|Unresponsive to treatment|5|||
17129149|NCT01368562|38270372|FG000|Overall Study|Other|3|||
17129150|NCT01368562|38270372|FG000|Overall Study|Other than specified|2|||
17129151|NCT03242018|38270379|FG000|Overall Study|Adverse Event|7|||
17129152|NCT03242018|38270380|FG001|Overall Study|Adverse Event|7|||
17129153|NCT03242018|38270381|FG002|Overall Study|Adverse Event|6|||
17129154|NCT03242018|38270379|FG000|Overall Study|Lost to Follow-up|2|||
17129155|NCT03242018|38270380|FG001|Overall Study|Lost to Follow-up|2|||
17129156|NCT03242018|38270381|FG002|Overall Study|Lost to Follow-up|2|||
17129157|NCT03242018|38270379|FG000|Overall Study|At the Participant's Own Request|5|||
17129158|NCT03242018|38270380|FG001|Overall Study|At the Participant's Own Request|1|||
17129159|NCT03242018|38270381|FG002|Overall Study|At the Participant's Own Request|4|||
17129160|NCT03242018|38270379|FG000|Overall Study|Reason Not Specified|3|||
17129161|NCT03242018|38270380|FG001|Overall Study|Reason Not Specified|4|||
17129162|NCT03242018|38270381|FG002|Overall Study|Reason Not Specified|1|||
17129163|NCT03242018|38270379|FG000|Overall Study|Study Terminated by Sponsor|1|||
17129164|NCT03242018|38270380|FG001|Overall Study|Study Terminated by Sponsor|0|||
17129165|NCT03242018|38270381|FG002|Overall Study|Study Terminated by Sponsor|1|||
17129166|NCT02789176|38270394|FG000|Overall Study|Death|0|||
16956424|NCT01292603|38099441|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
17129167|NCT02789176|38270395|FG001|Overall Study|Death|0|||
17129168|NCT02789176|38270396|FG002|Overall Study|Death|3|||
17129169|NCT02789176|38270397|FG003|Overall Study|Death|0|||
17129170|NCT02789176|38270394|FG000|Overall Study|Withdrawal by Subject|0|||
17129171|NCT02789176|38270395|FG001|Overall Study|Withdrawal by Subject|0|||
17129172|NCT02789176|38270396|FG002|Overall Study|Withdrawal by Subject|1|||
17129173|NCT02789176|38270397|FG003|Overall Study|Withdrawal by Subject|0|||
17129174|NCT02789176|38270394|FG000|Overall Study|Lost to Follow-up|8|||
17129175|NCT02789176|38270395|FG001|Overall Study|Lost to Follow-up|2|||
17129176|NCT02789176|38270396|FG002|Overall Study|Lost to Follow-up|6|||
17129177|NCT02789176|38270397|FG003|Overall Study|Lost to Follow-up|1|||
17129178|NCT03259490|38270409|FG000|Period 1|Withdrawal by Subject|0|||
17129179|NCT03259490|38270410|FG001|Period 1|Withdrawal by Subject|1|||
17129180|NCT03259490|38270409|FG000|Period 2|Protocol Violation|1|||
17129181|NCT03259490|38270410|FG001|Period 2|Protocol Violation|0|||
17129182|NCT03259334|38270419|FG000|Overall Study|Adverse Event|3|||
17129183|NCT03259334|38270420|FG001|Overall Study|Adverse Event|8|||
17129184|NCT03259334|38270421|FG002|Overall Study|Adverse Event|5|||
17129185|NCT03259334|38270419|FG000|Overall Study|Withdrawal by Subject|4|||
17129186|NCT03259334|38270420|FG001|Overall Study|Withdrawal by Subject|2|||
17129187|NCT03259334|38270421|FG002|Overall Study|Withdrawal by Subject|4|||
17129188|NCT03259334|38270419|FG000|Overall Study|Physician Decision|1|||
17129189|NCT03259334|38270420|FG001|Overall Study|Physician Decision|0|||
17129190|NCT03259334|38270421|FG002|Overall Study|Physician Decision|0|||
17129191|NCT03259334|38270419|FG000|Overall Study|Lost to Follow-up|0|||
17129192|NCT03259334|38270420|FG001|Overall Study|Lost to Follow-up|2|||
17129193|NCT03259334|38270421|FG002|Overall Study|Lost to Follow-up|1|||
17129194|NCT03259334|38270419|FG000|Overall Study|Protocol Deviation|0|||
17129195|NCT03259334|38270420|FG001|Overall Study|Protocol Deviation|3|||
17129196|NCT03259334|38270421|FG002|Overall Study|Protocol Deviation|2|||
17129197|NCT03259334|38270419|FG000|Overall Study|Lack of Efficacy|2|||
17129198|NCT03259334|38270420|FG001|Overall Study|Lack of Efficacy|0|||
17129199|NCT03259334|38270421|FG002|Overall Study|Lack of Efficacy|1|||
17129200|NCT03259334|38270419|FG000|Overall Study|Randomized but never treated|0|||
17129201|NCT03259334|38270420|FG001|Overall Study|Randomized but never treated|2|||
17129202|NCT03259334|38270421|FG002|Overall Study|Randomized but never treated|0|||
17129203|NCT01331824|38270429|FG000|Overall Study|Adverse Event|2|||
17129204|NCT01331824|38270429|FG000|Overall Study|Death|1|||
17129205|NCT01331824|38270429|FG000|Overall Study|Disease Progression|9|||
17129206|NCT01331824|38270429|FG000|Overall Study|Withdrawal by Subject|1|||
17129207|NCT03258710|38270433|FG000|Overall Study|Adverse Event|1|||
17129208|NCT03258710|38270433|FG000|Overall Study|Protocol-defined stopping criteria|1|||
17129209|NCT03258710|38270433|FG000|Overall Study|Physician Decision|1|||
17129210|NCT03240692|38270437|FG000|Overall Study|Physician Decision|1|||
17129211|NCT03240692|38270437|FG000|Overall Study|Withdrawal by Subject|1|||
17129212|NCT03233048|38270441|FG000|Overall Study|Withdrawal by Subject|1|||
17129213|NCT04178967|38270447|FG000|Overall Study|Adverse Event|4|||
17129214|NCT04178967|38270448|FG001|Overall Study|Adverse Event|6|||
17129215|NCT04178967|38270447|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
17129216|NCT04178967|38270448|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
17129217|NCT04178967|38270447|FG000|Overall Study|Lack of Efficacy|3|||
17129218|NCT04178967|38270448|FG001|Overall Study|Lack of Efficacy|1|||
17129219|NCT04178967|38270447|FG000|Overall Study|Protocol Violation|0|||
17129220|NCT04178967|38270448|FG001|Overall Study|Protocol Violation|7|||
17129221|NCT04178967|38270447|FG000|Overall Study|Withdrawal by Subject|8|||
17129222|NCT04178967|38270448|FG001|Overall Study|Withdrawal by Subject|7|||
17129223|NCT04178967|38270447|FG000|Overall Study|Lost to Follow-up|2|||
17129224|NCT04178967|38270448|FG001|Overall Study|Lost to Follow-up|0|||
17129225|NCT02937740|38270456|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
17129226|NCT02937740|38270457|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
17129227|NCT02937740|38270456|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
17129228|NCT02937740|38270457|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
17129229|NCT02937740|38270456|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
17129230|NCT02937740|38270457|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
17129231|NCT02937740|38270456|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
17129232|NCT02937740|38270457|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
17129233|NCT02937740|38270456|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
17129234|NCT02937740|38270457|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
17129235|NCT02937740|38270456|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
17129236|NCT02937740|38270457|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
17129237|NCT04173741|38270480|FG000|Overall Study|IVC measurement cannot be done|1|||
16782548|NCT02061592|37722153|FG001|Period 1|Protocol Violation|0|||
17129238|NCT04173741|38270481|FG001|Overall Study|IVC measurement cannot be done|1|||
17129239|NCT03231800|38270489|FG000|Overall Study|Lost to Follow-up|0|||
17129240|NCT03231800|38270490|FG001|Overall Study|Lost to Follow-up|2|||
17129241|NCT03231800|38270489|FG000|Overall Study|Protocol Violation|1|||
17129242|NCT03231800|38270490|FG001|Overall Study|Protocol Violation|1|||
16956425|NCT01292603|38099442|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
16956426|NCT01292603|38099443|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
16956427|NCT01292603|38099444|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
16956428|NCT01292603|38099445|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
16956429|NCT01292603|38099446|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
16956430|NCT01292603|38099441|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
16956431|NCT01292603|38099442|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
16956432|NCT01292603|38099443|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
16956433|NCT01292603|38099444|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
16956434|NCT01292603|38099445|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
16956435|NCT01292603|38099446|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
16956436|NCT01292603|38099441|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16956437|NCT01292603|38099442|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16956438|NCT01292603|38099443|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16956439|NCT01292603|38099444|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16956440|NCT01292603|38099445|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16956441|NCT01292603|38099446|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
16956442|NCT01292603|38099441|FG000|Part 2: Regular Follow-Up|Death|0|||
16956443|NCT01292603|38099442|FG001|Part 2: Regular Follow-Up|Death|0|||
16956444|NCT01292603|38099443|FG002|Part 2: Regular Follow-Up|Death|0|||
16956445|NCT01292603|38099444|FG003|Part 2: Regular Follow-Up|Death|0|||
16956446|NCT01292603|38099445|FG004|Part 2: Regular Follow-Up|Death|6|||
16956447|NCT01292603|38099446|FG005|Part 2: Regular Follow-Up|Death|3|||
16956448|NCT01292603|38099441|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
16956449|NCT01292603|38099442|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
16956450|NCT01292603|38099443|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
16956451|NCT01292603|38099444|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
16956452|NCT01292603|38099445|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
16956453|NCT01292603|38099446|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
16956454|NCT01292603|38099441|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
16956455|NCT01292603|38099442|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
16956456|NCT01292603|38099443|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
16956457|NCT01292603|38099444|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
17129243|NCT03231800|38270489|FG000|Overall Study|reason not provided|2|||
17129244|NCT03231800|38270490|FG001|Overall Study|reason not provided|0|||
17129245|NCT04085601|38270498|FG000|Overall Study|Lost to Follow-up|1|||
17129246|NCT04085601|38270499|FG001|Overall Study|Lost to Follow-up|0|||
17129247|NCT04085601|38270498|FG000|Overall Study|Death|1|||
17129248|NCT04085601|38270499|FG001|Overall Study|Death|1|||
17129249|NCT03230864|38270508|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
17129250|NCT03230864|38270509|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
17129251|NCT03230864|38270510|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
17129252|NCT03230864|38270511|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
17129253|NCT03230864|38270508|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
17129254|NCT03230864|38270509|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
17129255|NCT03230864|38270510|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
17129256|NCT03230864|38270511|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
17129257|NCT03230864|38270508|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
17129258|NCT03230864|38270509|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
17129259|NCT03230864|38270510|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
17129260|NCT03230864|38270511|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
17129261|NCT03230864|38270508|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
17129262|NCT03230864|38270509|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
17129263|NCT03230864|38270510|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
17129264|NCT03230864|38270511|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
17129265|NCT03230864|38270508|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
17129266|NCT03230864|38270509|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
17129267|NCT03230864|38270510|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
17129268|NCT03230864|38270511|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
17129269|NCT03230864|38270508|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
17129270|NCT03230864|38270509|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
17129271|NCT03230864|38270510|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
17129272|NCT03230864|38270511|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
17129273|NCT03230864|38270508|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
17129274|NCT03230864|38270509|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
17129275|NCT03230864|38270510|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
17129276|NCT03230864|38270511|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
17129277|NCT03230864|38270508|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
17129278|NCT03230864|38270509|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
17129279|NCT03230864|38270510|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
17129280|NCT03230864|38270511|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
17129281|NCT03230864|38270508|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
17129282|NCT03230864|38270509|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
17129283|NCT03230864|38270510|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
17129284|NCT03230864|38270511|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
17129285|NCT03230864|38270508|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
17129286|NCT03230864|38270509|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
17129287|NCT03230864|38270510|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
17129288|NCT03230864|38270511|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
17129289|NCT04085367|38270523|FG000|Overall Study|Adverse Event|1|||
17129290|NCT04085367|38270524|FG001|Overall Study|Adverse Event|1|||
17129291|NCT04085367|38270523|FG000|Overall Study|Withdrawal by Subject|13|||
17129292|NCT04085367|38270524|FG001|Overall Study|Withdrawal by Subject|4|||
17129293|NCT04085367|38270523|FG000|Overall Study|Lost to Follow-up|3|||
17129294|NCT04085367|38270524|FG001|Overall Study|Lost to Follow-up|1|||
17129295|NCT04085367|38270523|FG000|Overall Study|Other unspecified|2|||
17129296|NCT04085367|38270524|FG001|Overall Study|Other unspecified|1|||
17129297|NCT04085367|38270523|FG000|Overall Study|Status Unknown|1|||
17129298|NCT04085367|38270524|FG001|Overall Study|Status Unknown|1|||
17129299|NCT03228836|38270530|FG000|Overall Study|Adverse Event|3|||
17129300|NCT03228836|38270530|FG000|Overall Study|Withdrawal by Subject|1|||
17129301|NCT03228836|38270530|FG000|Overall Study|Death|1|||
17129302|NCT03228836|38270530|FG000|Overall Study|Physician Decision|1|||
17129303|NCT03228836|38270530|FG000|Overall Study|Disease Progression|7|||
17129304|NCT03228836|38270530|FG000|Overall Study|Other|4|||
17129305|NCT02937350|38270537|FG000|Overall Study|Withdrawal by Subject|0|||
17129306|NCT02937350|38270538|FG001|Overall Study|Withdrawal by Subject|1|||
17129307|NCT02937350|38270539|FG002|Overall Study|Withdrawal by Subject|0|||
17129308|NCT04085289|38270548|FG000|Overall Study|Withdrawal by Subject|0|||
17129309|NCT04085289|38270549|FG001|Overall Study|Withdrawal by Subject|0|||
17129310|NCT04085289|38270550|FG002|Overall Study|Withdrawal by Subject|1|||
17129311|NCT04080297|38270559|FG000|Overall Study|Adverse Event|1|||
17129312|NCT04080297|38270560|FG001|Overall Study|Adverse Event|3|||
17129313|NCT04080297|38270559|FG000|Overall Study|concurrent illness|1|||
17129314|NCT04080297|38270560|FG001|Overall Study|concurrent illness|0|||
17129315|NCT04014075|38270566|FG000|Overall Study|Progressive Disease|39|||
17129316|NCT04014075|38270566|FG000|Overall Study|Adverse Event|9|||
17129317|NCT04014075|38270566|FG000|Overall Study|Clinical Progression|2|||
17129318|NCT04014075|38270566|FG000|Overall Study|Death|2|||
17129319|NCT04014075|38270566|FG000|Overall Study|Withdrawal by Subject|2|||
17129320|NCT04014075|38270566|FG000|Overall Study|Miscellaneous|1|||
17129321|NCT04014075|38270566|FG000|Overall Study|Physician Decision|1|||
17129322|NCT04013529|38270572|FG000|Overall Study|Withdrawal by Subject|1|||
17129323|NCT04013529|38270573|FG001|Overall Study|Withdrawal by Subject|1|||
17129324|NCT04011735|38270582|FG000|Overall Study|Withdrawal by Subject|1|||
17129325|NCT04011735|38270583|FG001|Overall Study|Withdrawal by Subject|0|||
17129326|NCT04011735|38270584|FG002|Overall Study|Withdrawal by Subject|1|||
17129327|NCT04011735|38270582|FG000|Overall Study|Met exclusion criteria after study entry|0|||
17129328|NCT04011735|38270583|FG001|Overall Study|Met exclusion criteria after study entry|1|||
17129329|NCT04011735|38270584|FG002|Overall Study|Met exclusion criteria after study entry|0|||
17129330|NCT04009629|38270596|FG000|Overall Study|Withdrawal by Subject|2|||
17129331|NCT04009629|38270597|FG001|Overall Study|Withdrawal by Subject|0|||
17129332|NCT04007367|38270606|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
17129333|NCT04007367|38270607|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
17129334|NCT04007367|38270608|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
17129335|NCT04007367|38270606|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
17129336|NCT04007367|38270607|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
17129337|NCT04007367|38270608|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
17129338|NCT04007367|38270606|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
17129339|NCT04007367|38270607|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
17129340|NCT04007367|38270608|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
17129341|NCT04007367|38270606|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
17129342|NCT04007367|38270607|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
17129343|NCT04007367|38270608|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
17129344|NCT04007367|38270606|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
17129345|NCT04007367|38270607|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
17129346|NCT04007367|38270608|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
17129347|NCT03694197|38270618|FG000|Overall Study|Adverse Event|9|||
17129348|NCT03694197|38270618|FG000|Overall Study|Protocol became inconvenient to participate|1|||
17129349|NCT03694197|38270618|FG000|Overall Study|Physician Decision|4|||
17129350|NCT03694197|38270618|FG000|Overall Study|Study terminated by sponsor|1350|||
17129351|NCT03694197|38270618|FG000|Overall Study|Participant moved|5|||
17129352|NCT03694197|38270618|FG000|Overall Study|Participant withdrew consent|10|||
17129353|NCT03694197|38270618|FG000|Overall Study|Related to IMP administration|1|||
17129354|NCT03694197|38270618|FG000|Overall Study|Not disclosed|5|||
17129355|NCT04365699|38270625|FG000|Overall Study|Death|2|||
17129356|NCT04365699|38270626|FG001|Overall Study|Death|5|||
17129357|NCT04365699|38270627|FG002|Overall Study|Death|15|||
17129358|NCT04005885|38270635|FG000|First Intervention|Withdrawal by Subject|1|||
17129359|NCT04005885|38270636|FG001|First Intervention|Withdrawal by Subject|1|||
17129360|NCT04005885|38270635|FG000|Second Intervention|Withdrawal by Subject|0|||
17129361|NCT04005885|38270636|FG001|Second Intervention|Withdrawal by Subject|2|||
17129362|NCT04003623|38270649|FG000|Overall Study|Withdrawal by Subject|1|||
17129363|NCT04003623|38270650|FG001|Overall Study|Withdrawal by Subject|0|||
17129364|NCT04480424|38270658|FG000|Overall Study|Withdrawal by Subject|0|||
17129365|NCT04480424|38270659|FG001|Overall Study|Withdrawal by Subject|2|||
17129366|NCT04480424|38270658|FG000|Overall Study|Lost to Follow-up|3|||
17129367|NCT04480424|38270659|FG001|Overall Study|Lost to Follow-up|3|||
17129368|NCT04480424|38270658|FG000|Overall Study|Death|14|||
17129369|NCT04480424|38270659|FG001|Overall Study|Death|16|||
17129370|NCT04480424|38270658|FG000|Overall Study|Reason not Specified|5|||
17129371|NCT04480424|38270659|FG001|Overall Study|Reason not Specified|5|||
17129372|NCT03256526|38270668|FG000|Overall Study|Adverse Event|1|||
17129373|NCT03256526|38270669|FG001|Overall Study|Adverse Event|0|||
17129374|NCT03256526|38270670|FG002|Overall Study|Adverse Event|1|||
17129375|NCT03256526|38270668|FG000|Overall Study|Lost to Follow-up|1|||
17129376|NCT03256526|38270669|FG001|Overall Study|Lost to Follow-up|0|||
17129377|NCT03256526|38270670|FG002|Overall Study|Lost to Follow-up|2|||
17129378|NCT03255980|38270682|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
17129379|NCT03255980|38270683|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
16956458|NCT01292603|38099445|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
16956459|NCT01292603|38099446|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
16956460|NCT01292603|38099441|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
17129380|NCT03255980|38270684|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
17129381|NCT03255980|38270685|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
17129382|NCT03255980|38270682|FG000|Overall Study|Adverse Event|1|||
17129383|NCT03255980|38270683|FG001|Overall Study|Adverse Event|1|||
17129384|NCT03255980|38270684|FG002|Overall Study|Adverse Event|0|||
17129385|NCT03255980|38270685|FG003|Overall Study|Adverse Event|1|||
17129386|NCT03255980|38270682|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
17129387|NCT03255980|38270683|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
17129388|NCT03255980|38270684|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
17129389|NCT03255980|38270685|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
16956461|NCT01292603|38099442|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16956462|NCT01292603|38099443|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16956463|NCT01292603|38099444|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16956464|NCT01292603|38099445|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16956465|NCT01292603|38099446|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
16956466|NCT01292603|38099441|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
16956467|NCT01292603|38099442|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
16956468|NCT01292603|38099443|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
16956469|NCT01292603|38099444|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
16956470|NCT01292603|38099445|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
16956471|NCT01292603|38099446|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
16956472|NCT01292603|38099441|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
16956473|NCT01292603|38099442|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
16956474|NCT01292603|38099443|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
16956475|NCT01292603|38099444|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
16956476|NCT01292603|38099445|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
16956477|NCT01292603|38099446|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
16956478|NCT01292603|38099441|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
16956479|NCT01292603|38099442|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
16956480|NCT01292603|38099443|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
16956481|NCT01292603|38099444|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
16956482|NCT01292603|38099445|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
16956483|NCT01292603|38099446|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
16956484|NCT01292603|38099441|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
16956485|NCT01292603|38099442|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
16956486|NCT01292603|38099443|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
16956487|NCT01292603|38099444|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
16956488|NCT01292603|38099445|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
16956489|NCT01292603|38099446|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
16956490|NCT01292603|38099441|FG000|Overall Survival Status|Death|3|||
16956491|NCT01292603|38099442|FG001|Overall Survival Status|Death|1|||
17129390|NCT03255980|38270682|FG000|Overall Study|Lost to Follow-up|1|||
17129391|NCT03255980|38270683|FG001|Overall Study|Lost to Follow-up|1|||
17129392|NCT03255980|38270684|FG002|Overall Study|Lost to Follow-up|0|||
17129393|NCT03255980|38270685|FG003|Overall Study|Lost to Follow-up|3|||
17129394|NCT03255980|38270682|FG000|Overall Study|Withdrawal by Subject|0|||
17129395|NCT03255980|38270683|FG001|Overall Study|Withdrawal by Subject|1|||
17129396|NCT03255980|38270684|FG002|Overall Study|Withdrawal by Subject|0|||
17129397|NCT03255980|38270685|FG003|Overall Study|Withdrawal by Subject|3|||
17129398|NCT03228212|38270695|FG000|Period 1|Adverse Event|1|||
17129399|NCT03228212|38270696|FG001|Period 1|Adverse Event|0|||
17129400|NCT03228212|38270695|FG000|Period 1|no longer meets eligibility criteria|0|||
17129401|NCT03228212|38270696|FG001|Period 1|no longer meets eligibility criteria|1|||
17129402|NCT03228212|38270695|FG000|Period 2|Lost to Follow-up|1|||
17129403|NCT03228212|38270696|FG001|Period 2|Lost to Follow-up|0|||
17129404|NCT04003155|38270705|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
17129405|NCT04003155|38270706|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
17129406|NCT04003155|38270707|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
17129407|NCT04003155|38270708|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
17129408|NCT04003155|38270709|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
17129409|NCT04003155|38270705|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
17129410|NCT04003155|38270706|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
17129411|NCT04003155|38270707|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
17129412|NCT04003155|38270708|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
17129413|NCT04003155|38270709|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
17129414|NCT04003155|38270705|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
17129415|NCT04003155|38270706|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
17129416|NCT04003155|38270707|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
17129417|NCT04003155|38270708|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
17129418|NCT04003155|38270709|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
16956492|NCT01292603|38099443|FG002|Overall Survival Status|Death|3|||
16956493|NCT01292603|38099444|FG003|Overall Survival Status|Death|1|||
16956494|NCT01292603|38099445|FG004|Overall Survival Status|Death|16|||
16956495|NCT01292603|38099446|FG005|Overall Survival Status|Death|10|||
16956496|NCT01292057|38099469|FG000|Overall Study|Protocol Violation|1|||
16956497|NCT01292057|38099470|FG001|Overall Study|Protocol Violation|1|||
16956498|NCT01292057|38099469|FG000|Overall Study|Lost to Follow-up|1|||
16956499|NCT01292057|38099470|FG001|Overall Study|Lost to Follow-up|1|||
16956500|NCT01291277|38099478|FG000|Overall Study|Death|2|||
16956501|NCT01291277|38099479|FG001|Overall Study|Death|2|||
16956502|NCT01291277|38099478|FG000|Overall Study|Lost to Follow-up|3|||
16956503|NCT01291277|38099479|FG001|Overall Study|Lost to Follow-up|1|||
16956504|NCT01290887|38099487|FG000|Overall Study|Adverse Event|6|||
16956505|NCT01290887|38099488|FG001|Overall Study|Adverse Event|11|||
16956506|NCT01290887|38099487|FG000|Overall Study|Lack of Efficacy|4|||
16956507|NCT01290887|38099488|FG001|Overall Study|Lack of Efficacy|5|||
16956508|NCT01290887|38099487|FG000|Overall Study|Withdrawal by Subject|26|||
16956509|NCT01290887|38099488|FG001|Overall Study|Withdrawal by Subject|32|||
16956510|NCT01290887|38099487|FG000|Overall Study|Protocol Violation|2|||
16956511|NCT01290887|38099488|FG001|Overall Study|Protocol Violation|1|||
16956512|NCT01290887|38099487|FG000|Overall Study|Lost to Follow-up|4|||
16956513|NCT01290887|38099488|FG001|Overall Study|Lost to Follow-up|4|||
16956514|NCT01290887|38099487|FG000|Overall Study|Non-compliance to study procedures|0|||
16956515|NCT01290887|38099488|FG001|Overall Study|Non-compliance to study procedures|1|||
16956516|NCT01290887|38099487|FG000|Overall Study|Non-compliance to study medications|1|||
16956517|NCT01290887|38099488|FG001|Overall Study|Non-compliance to study medications|0|||
16956518|NCT01290887|38099487|FG000|Overall Study|Sponsor closure of study|420|||
16956519|NCT01290887|38099488|FG001|Overall Study|Sponsor closure of study|476|||
16956520|NCT01290887|38099487|FG000|Overall Study|Other|3|||
16956521|NCT01290887|38099488|FG001|Overall Study|Other|6|||
16956522|NCT01290731|38099494|FG000|Overall Study|Withdrawal by Subject|1|||
16956523|NCT01290341|38099500|FG000|Overall Study|Protocol Violation|7|||
16956524|NCT01290341|38099501|FG001|Overall Study|Protocol Violation|3|||
16956525|NCT01290341|38099500|FG000|Overall Study|Adverse Event|1|||
16956526|NCT01290341|38099501|FG001|Overall Study|Adverse Event|0|||
16956527|NCT01290341|38099500|FG000|Overall Study|Lost to Follow-up|21|||
16956528|NCT01290341|38099501|FG001|Overall Study|Lost to Follow-up|10|||
16956529|NCT01290341|38099500|FG000|Overall Study|Withdrawal by Subject|19|||
16956530|NCT01290341|38099501|FG001|Overall Study|Withdrawal by Subject|5|||
16956531|NCT01290341|38099500|FG000|Overall Study|Negative baseline culture and others|44|||
16956532|NCT01290341|38099501|FG001|Overall Study|Negative baseline culture and others|11|||
16956533|NCT01290263|38099509|FG000|Overall Study|Adverse Event|0|||
16956534|NCT01290263|38099510|FG001|Overall Study|Adverse Event|0|||
16956535|NCT01290263|38099511|FG002|Overall Study|Adverse Event|0|||
16956536|NCT01290263|38099512|FG003|Overall Study|Adverse Event|1|||
16956537|NCT01290263|38099513|FG004|Overall Study|Adverse Event|1|||
16956538|NCT01290263|38099509|FG000|Overall Study|Lack of Efficacy|8|||
16956539|NCT01290263|38099510|FG001|Overall Study|Lack of Efficacy|2|||
16956540|NCT01290263|38099511|FG002|Overall Study|Lack of Efficacy|7|||
16956541|NCT01290263|38099512|FG003|Overall Study|Lack of Efficacy|24|||
16956542|NCT01290263|38099513|FG004|Overall Study|Lack of Efficacy|33|||
16956543|NCT01290263|38099509|FG000|Overall Study|Withdrawal by Subject|3|||
16956544|NCT01290263|38099510|FG001|Overall Study|Withdrawal by Subject|1|||
16956545|NCT01290263|38099511|FG002|Overall Study|Withdrawal by Subject|0|||
16956546|NCT01290263|38099512|FG003|Overall Study|Withdrawal by Subject|1|||
16956547|NCT01290263|38099513|FG004|Overall Study|Withdrawal by Subject|2|||
16956548|NCT01290263|38099509|FG000|Overall Study|Participant Non-Compliance|0|||
16782549|NCT02061592|37722152|FG000|Period 2|Lost to Follow-up|0|||
16956549|NCT01290263|38099510|FG001|Overall Study|Participant Non-Compliance|0|||
16956550|NCT01290263|38099511|FG002|Overall Study|Participant Non-Compliance|0|||
16956551|NCT01290263|38099512|FG003|Overall Study|Participant Non-Compliance|1|||
17129419|NCT04003155|38270705|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
17129420|NCT04003155|38270706|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
17129421|NCT04003155|38270707|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
17129422|NCT04003155|38270708|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
17129423|NCT04003155|38270709|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
17129424|NCT04003155|38270705|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
17129425|NCT04003155|38270706|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
17129426|NCT04003155|38270707|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
17129427|NCT04003155|38270708|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
17129428|NCT04003155|38270709|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
17129429|NCT04003155|38270705|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
17129430|NCT04003155|38270706|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
17129431|NCT04003155|38270707|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
17129432|NCT04003155|38270708|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
17129433|NCT04003155|38270709|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
17129434|NCT04003155|38270705|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
17129435|NCT04003155|38270706|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
17129436|NCT04003155|38270707|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
17129437|NCT04003155|38270708|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
17129438|NCT04003155|38270709|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
17129439|NCT04003155|38270705|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
17129440|NCT04003155|38270706|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
17129441|NCT04003155|38270707|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
17129442|NCT04003155|38270708|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
17129443|NCT04003155|38270709|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
17129444|NCT04003155|38270705|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
17129445|NCT04003155|38270706|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
17129446|NCT04003155|38270707|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
17129447|NCT04003155|38270708|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
17129448|NCT04003155|38270709|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
17129449|NCT04000815|38270730|FG000|Overall Study|Lost to Follow-up|9|||
17129450|NCT04000815|38270731|FG001|Overall Study|Lost to Follow-up|2|||
17129451|NCT04000815|38270732|FG002|Overall Study|Lost to Follow-up|3|||
17129452|NCT04000815|38270730|FG000|Overall Study|Withdrawal by Subject|4|||
17129453|NCT04000815|38270731|FG001|Overall Study|Withdrawal by Subject|3|||
17129454|NCT04000815|38270732|FG002|Overall Study|Withdrawal by Subject|2|||
17129455|NCT04000815|38270730|FG000|Overall Study|Right ovarian cyst occured|1|||
17129456|NCT04000815|38270731|FG001|Overall Study|Right ovarian cyst occured|0|||
17129457|NCT04000815|38270732|FG002|Overall Study|Right ovarian cyst occured|0|||
17129458|NCT04000815|38270730|FG000|Overall Study|Hypertension occured on follow up|0|||
17129459|NCT04000815|38270731|FG001|Overall Study|Hypertension occured on follow up|0|||
17129460|NCT04000815|38270732|FG002|Overall Study|Hypertension occured on follow up|2|||
17129461|NCT04000581|38270742|FG000|Overall Study|Withdrawal by Subject|0|||
17129462|NCT04000581|38270743|FG001|Overall Study|Withdrawal by Subject|1|||
17129463|NCT03848403|38270749|FG000|Period 2 (Day 8)|Adverse Event|1|||
17129464|NCT03848403|38270750|FG001|Period 2 (Day 8)|Adverse Event|2|||
17129465|NCT03848403|38270751|FG002|Period 2 (Day 8)|Adverse Event|2|||
17129466|NCT03848403|38270749|FG000|Period 2 (Day 8)|Physician Decision|0|||
17129467|NCT03848403|38270750|FG001|Period 2 (Day 8)|Physician Decision|1|||
17129468|NCT03848403|38270751|FG002|Period 2 (Day 8)|Physician Decision|0|||
17129469|NCT03848403|38270749|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
17129470|NCT03848403|38270750|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
17129471|NCT03848403|38270751|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
17129472|NCT03995355|38270761|FG000|Overall Study|Adverse Event|1|||
17129473|NCT03995355|38270762|FG001|Overall Study|Adverse Event|0|||
17129474|NCT03995355|38270761|FG000|Overall Study|Withdrawal by Subject|1|||
17129475|NCT03995355|38270762|FG001|Overall Study|Withdrawal by Subject|0|||
17129476|NCT03995355|38270761|FG000|Overall Study|Scheduling Issues|0|||
17129477|NCT03995355|38270762|FG001|Overall Study|Scheduling Issues|1|||
17129478|NCT04054011|38270768|FG000|Overall Study|COVID|3|||
17129479|NCT04053465|38270776|FG000|Overall Study|Withdrawal by Subject|4|||
17129480|NCT04053465|38270777|FG001|Overall Study|Withdrawal by Subject|4|||
17129481|NCT00143507|38270785|FG000|Overall Study|Death|572|||
17129482|NCT00143507|38270786|FG001|Overall Study|Death|547|||
17129483|NCT00143507|38270785|FG000|Overall Study|Withdrawal by Subject|114|||
17129484|NCT00143507|38270786|FG001|Overall Study|Withdrawal by Subject|102|||
17129485|NCT00143507|38270785|FG000|Overall Study|Lost to Follow-up|1|||
17129486|NCT00143507|38270786|FG001|Overall Study|Lost to Follow-up|0|||
17129487|NCT00143507|38270785|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
17129488|NCT00143507|38270786|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
17129489|NCT03988803|38270792|FG000|Period 2|Prematurely discontinued from medication|2|||
17129490|NCT03988803|38270792|FG000|Period 2|Adverse Event|1|||
17129491|NCT00181883|38270800|FG000|Overall Study|Lack of Efficacy|2|||
16956552|NCT01290263|38099513|FG004|Overall Study|Participant Non-Compliance|1|||
16956553|NCT01290029|38099521|FG000|Overall Study|Other|2|||
16956554|NCT01289639|38099528|FG000|Overall Study|Lost to Follow-up|1|||
16956555|NCT01289639|38099529|FG001|Overall Study|Lost to Follow-up|0|||
16956556|NCT01289639|38099530|FG002|Overall Study|Lost to Follow-up|0|||
16956557|NCT01289015|38099540|FG000|Overall Study|Protocol Violation|12|||
16956558|NCT01289015|38099541|FG001|Overall Study|Protocol Violation|9|||
16956559|NCT01289015|38099540|FG000|Overall Study|Adverse Event|3|||
16956560|NCT01289015|38099541|FG001|Overall Study|Adverse Event|0|||
16956561|NCT01289015|38099540|FG000|Overall Study|Lost to Follow-up|33|||
16956562|NCT01289015|38099541|FG001|Overall Study|Lost to Follow-up|17|||
16956563|NCT01289015|38099540|FG000|Overall Study|Withdrawal by Subject|17|||
16956564|NCT01289015|38099541|FG001|Overall Study|Withdrawal by Subject|8|||
16956565|NCT01289015|38099540|FG000|Overall Study|Disease progression|1|||
16956566|NCT01289015|38099541|FG001|Overall Study|Disease progression|0|||
16956567|NCT01289015|38099540|FG000|Overall Study|Negative baseline culture and others|33|||
16956568|NCT01289015|38099541|FG001|Overall Study|Negative baseline culture and others|20|||
16956569|NCT01288937|38099549|FG000|Overall Study|Adverse Event|1|||
16956570|NCT01288937|38099550|FG001|Overall Study|Adverse Event|0|||
16956571|NCT01288469|38099559|FG000|Overall Study|Adverse Event|4|||
16956572|NCT01288469|38099560|FG001|Overall Study|Adverse Event|1|||
16956573|NCT01288469|38099561|FG002|Overall Study|Adverse Event|1|||
16956574|NCT01288469|38099559|FG000|Overall Study|Poor compliance to protocol|0|||
16956575|NCT01288469|38099560|FG001|Overall Study|Poor compliance to protocol|1|||
16956576|NCT01288469|38099561|FG002|Overall Study|Poor compliance to protocol|0|||
16956577|NCT01288469|38099559|FG000|Overall Study|Participant Moved|1|||
16956578|NCT01288469|38099560|FG001|Overall Study|Participant Moved|0|||
16956579|NCT01288469|38099561|FG002|Overall Study|Participant Moved|0|||
16956580|NCT01288469|38099559|FG000|Overall Study|Consent withdrawn by subject|1|||
16956581|NCT01288469|38099560|FG001|Overall Study|Consent withdrawn by subject|1|||
16956582|NCT01288469|38099561|FG002|Overall Study|Consent withdrawn by subject|1|||
16956583|NCT01288469|38099559|FG000|Overall Study|Exclusion criteria finally met|1|||
16956584|NCT01288469|38099560|FG001|Overall Study|Exclusion criteria finally met|0|||
16956585|NCT01288469|38099561|FG002|Overall Study|Exclusion criteria finally met|0|||
16956586|NCT01288079|38099573|FG000|Overall Study|Withdrawal by Subject|2|||
16956587|NCT01288079|38099574|FG001|Overall Study|Withdrawal by Subject|4|||
16956588|NCT01288079|38099575|FG002|Overall Study|Withdrawal by Subject|1|||
16956589|NCT01288079|38099576|FG003|Overall Study|Withdrawal by Subject|0|||
16956590|NCT01288079|38099573|FG000|Overall Study|Adverse Event|2|||
16956591|NCT01288079|38099574|FG001|Overall Study|Adverse Event|1|||
16956592|NCT01288079|38099575|FG002|Overall Study|Adverse Event|2|||
16956593|NCT01288079|38099576|FG003|Overall Study|Adverse Event|3|||
16956594|NCT01288079|38099573|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
16956595|NCT01288079|38099574|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
16956596|NCT01288079|38099575|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
16956597|NCT01288079|38099576|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
16956598|NCT01288079|38099573|FG000|Overall Study|Condition under Investigation Worsened|0|||
16956599|NCT01288079|38099574|FG001|Overall Study|Condition under Investigation Worsened|0|||
16956600|NCT01288079|38099575|FG002|Overall Study|Condition under Investigation Worsened|0|||
16956601|NCT01288079|38099576|FG003|Overall Study|Condition under Investigation Worsened|1|||
16956602|NCT01288079|38099573|FG000|Overall Study|Lack of Efficacy|2|||
16956603|NCT01288079|38099574|FG001|Overall Study|Lack of Efficacy|2|||
17129492|NCT00181883|38270800|FG000|Overall Study|Treatment Limiting AEs|3|||
17129493|NCT00181883|38270800|FG000|Overall Study|Withdrawal by Subject|4|||
17129494|NCT00181883|38270800|FG000|Overall Study|Lost to Follow-up|1|||
17129495|NCT00180713|38270806|FG000|Overall Study|Withdrawal by Subject|2|||
17129496|NCT00180713|38270807|FG001|Overall Study|Withdrawal by Subject|0|||
17129497|NCT00180713|38270806|FG000|Overall Study|Adverse Event|3|||
17129498|NCT00180713|38270807|FG001|Overall Study|Adverse Event|3|||
17129499|NCT03988023|38270815|FG000|Overall Study|Non-compliance|3|||
17129500|NCT03988023|38270816|FG001|Overall Study|Non-compliance|0|||
17129501|NCT03988023|38270815|FG000|Overall Study|Withdrawal by Subject|39|||
17129502|NCT03988023|38270816|FG001|Overall Study|Withdrawal by Subject|37|||
17129503|NCT03988023|38270815|FG000|Overall Study|Adverse Event|0|||
17129504|NCT03988023|38270816|FG001|Overall Study|Adverse Event|2|||
17129505|NCT03988023|38270815|FG000|Overall Study|Physician Decision|0|||
17129506|NCT03988023|38270816|FG001|Overall Study|Physician Decision|1|||
17129507|NCT03988023|38270815|FG000|Overall Study|Lost to Follow-up|5|||
17129508|NCT03988023|38270816|FG001|Overall Study|Lost to Follow-up|8|||
17129509|NCT03988023|38270815|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
17129510|NCT03988023|38270816|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
17129511|NCT03988023|38270815|FG000|Overall Study|Lack of Efficacy|3|||
17129512|NCT03988023|38270816|FG001|Overall Study|Lack of Efficacy|1|||
17129513|NCT03988023|38270815|FG000|Overall Study|COVID-19 pandemic|225|||
17129514|NCT03988023|38270816|FG001|Overall Study|COVID-19 pandemic|227|||
17129515|NCT04052139|38270825|FG000|Overall Study|Lost to Follow-up|2|||
17129516|NCT04052139|38270826|FG001|Overall Study|Lost to Follow-up|0|||
17129517|NCT04052139|38270827|FG002|Overall Study|Lost to Follow-up|0|||
17129518|NCT04052139|38270825|FG000|Overall Study|Withdrawal by Subject|1|||
17129519|NCT04052139|38270826|FG001|Overall Study|Withdrawal by Subject|0|||
17129520|NCT04052139|38270827|FG002|Overall Study|Withdrawal by Subject|0|||
17129521|NCT03984825|38270835|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
17129522|NCT03984825|38270835|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
17129523|NCT03984825|38270835|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
17129524|NCT03981861|38270844|FG000|Overall Study|Withdrawal by Subject|3|||
17129525|NCT01332266|38270853|FG000|Phase 1b|Death|3|||
17129526|NCT01332266|38270854|FG001|Phase 1b|Death|3|||
17129527|NCT01332266|38270855|FG002|Phase 1b|Death|2|||
17129528|NCT01332266|38270856|FG003|Phase 1b|Death|0|||
17129529|NCT01332266|38270857|FG004|Phase 1b|Death|0|||
17129530|NCT01332266|38270853|FG000|Phase 1b|Lost to Follow-up|0|||
17129531|NCT01332266|38270854|FG001|Phase 1b|Lost to Follow-up|1|||
17129532|NCT01332266|38270855|FG002|Phase 1b|Lost to Follow-up|0|||
17129533|NCT01332266|38270856|FG003|Phase 1b|Lost to Follow-up|0|||
17129534|NCT01332266|38270857|FG004|Phase 1b|Lost to Follow-up|0|||
17129535|NCT01332266|38270853|FG000|Phase 1b|Withdrawal by Subject|1|||
17129536|NCT01332266|38270854|FG001|Phase 1b|Withdrawal by Subject|1|||
17129537|NCT01332266|38270855|FG002|Phase 1b|Withdrawal by Subject|1|||
17129538|NCT01332266|38270856|FG003|Phase 1b|Withdrawal by Subject|0|||
17129539|NCT01332266|38270857|FG004|Phase 1b|Withdrawal by Subject|0|||
17129540|NCT01332266|38270853|FG000|Phase 2|Death|0|||
17129541|NCT01332266|38270854|FG001|Phase 2|Death|0|||
17129542|NCT01332266|38270855|FG002|Phase 2|Death|0|||
17129543|NCT01332266|38270856|FG003|Phase 2|Death|33|||
17129544|NCT01332266|38270857|FG004|Phase 2|Death|36|||
17129545|NCT01332266|38270853|FG000|Phase 2|Lost to Follow-up|0|||
17129546|NCT01332266|38270854|FG001|Phase 2|Lost to Follow-up|0|||
17129547|NCT01332266|38270855|FG002|Phase 2|Lost to Follow-up|0|||
17129548|NCT01332266|38270856|FG003|Phase 2|Lost to Follow-up|2|||
17129549|NCT01332266|38270857|FG004|Phase 2|Lost to Follow-up|0|||
17129550|NCT01332266|38270853|FG000|Phase 2|Physician Decision|0|||
17129551|NCT01332266|38270854|FG001|Phase 2|Physician Decision|0|||
17129552|NCT01332266|38270855|FG002|Phase 2|Physician Decision|0|||
17129553|NCT01332266|38270856|FG003|Phase 2|Physician Decision|3|||
17129554|NCT01332266|38270857|FG004|Phase 2|Physician Decision|1|||
17129555|NCT01332266|38270853|FG000|Phase 2|Symptomatic deterioration|0|||
17129556|NCT01332266|38270854|FG001|Phase 2|Symptomatic deterioration|0|||
17129557|NCT01332266|38270855|FG002|Phase 2|Symptomatic deterioration|0|||
17129558|NCT01332266|38270856|FG003|Phase 2|Symptomatic deterioration|0|||
17129559|NCT01332266|38270857|FG004|Phase 2|Symptomatic deterioration|1|||
17129560|NCT01332266|38270853|FG000|Phase 2|Progression Disease|0|||
17129561|NCT01332266|38270854|FG001|Phase 2|Progression Disease|0|||
17129562|NCT01332266|38270855|FG002|Phase 2|Progression Disease|0|||
17129563|NCT01332266|38270856|FG003|Phase 2|Progression Disease|2|||
17129564|NCT01332266|38270857|FG004|Phase 2|Progression Disease|1|||
17129565|NCT01332266|38270853|FG000|Phase 2|Withdrawal by Subject|0|||
17129566|NCT01332266|38270854|FG001|Phase 2|Withdrawal by Subject|0|||
17129567|NCT01332266|38270855|FG002|Phase 2|Withdrawal by Subject|0|||
17129568|NCT01332266|38270856|FG003|Phase 2|Withdrawal by Subject|2|||
17129569|NCT01332266|38270857|FG004|Phase 2|Withdrawal by Subject|2|||
17129570|NCT03255824|38270872|FG000|Overall Study|Under-sedation|2|||
17129571|NCT03255824|38270873|FG001|Overall Study|Under-sedation|1|||
17129572|NCT03238352|38270882|FG000|Overall Study|Lost to Follow-up|0|||
17129573|NCT03238352|38270883|FG001|Overall Study|Lost to Follow-up|2|||
17129574|NCT03238352|38270884|FG002|Overall Study|Lost to Follow-up|1|||
17129575|NCT03238352|38270882|FG000|Overall Study|Withdrawal by Subject|0|||
17129576|NCT03238352|38270883|FG001|Overall Study|Withdrawal by Subject|1|||
17129577|NCT03238352|38270884|FG002|Overall Study|Withdrawal by Subject|0|||
17129578|NCT00180479|38270894|FG000|Overall Study|Death|4|||
17129579|NCT00180479|38270895|FG001|Overall Study|Death|2|||
17129580|NCT00180479|38270894|FG000|Overall Study|Lost to Follow-up|9|||
17129581|NCT00180479|38270895|FG001|Overall Study|Lost to Follow-up|7|||
17129582|NCT00180479|38270894|FG000|Overall Study|Withdrawal by Subject|3|||
17129583|NCT00180479|38270895|FG001|Overall Study|Withdrawal by Subject|3|||
17129584|NCT00180479|38270894|FG000|Overall Study|Informed consent not signed|0|||
17129585|NCT00180479|38270895|FG001|Overall Study|Informed consent not signed|1|||
17129586|NCT03224234|38270905|FG000|Main Study|Lost to Follow-up|5|||
17129587|NCT03224234|38270906|FG001|Main Study|Lost to Follow-up|5|||
17129588|NCT02955069|38270920|FG000|Overall Study|Adverse Event|7|||
17129589|NCT02955069|38270921|FG001|Overall Study|Adverse Event|2|||
17129590|NCT02955069|38270920|FG000|Overall Study|Death|7|||
17129591|NCT02955069|38270921|FG001|Overall Study|Death|3|||
17129592|NCT02955069|38270920|FG000|Overall Study|Physician Decision|10|||
17129593|NCT02955069|38270921|FG001|Overall Study|Physician Decision|2|||
17129594|NCT02955069|38270920|FG000|Overall Study|Progressive disease|64|||
17129595|NCT02955069|38270921|FG001|Overall Study|Progressive disease|13|||
17129596|NCT02955069|38270920|FG000|Overall Study|Study terminated by sponsor|4|||
17129597|NCT02955069|38270921|FG001|Overall Study|Study terminated by sponsor|0|||
17129598|NCT02955069|38270920|FG000|Overall Study|Subject/Guardian decision|3|||
17129599|NCT02955069|38270921|FG001|Overall Study|Subject/Guardian decision|1|||
17129600|NCT03254108|38270934|FG000|Overall Study|Adverse Event|0|||
17129601|NCT03254108|38270935|FG001|Overall Study|Adverse Event|2|||
17129602|NCT03254108|38270936|FG002|Overall Study|Adverse Event|0|||
17129603|NCT03254108|38270937|FG003|Overall Study|Adverse Event|1|||
17129604|NCT03254108|38270938|FG004|Overall Study|Adverse Event|1|||
17129605|NCT03254108|38270934|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
17129606|NCT03254108|38270935|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
17129607|NCT03254108|38270936|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
17129608|NCT03254108|38270937|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
16956604|NCT01288079|38099575|FG002|Overall Study|Lack of Efficacy|0|||
17129609|NCT03254108|38270938|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
17129610|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
17129611|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
17129612|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
17129613|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
17129614|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
17129615|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
17129616|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
17129617|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
17129618|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
17129619|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
17129620|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
17129621|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
17129622|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
17129623|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
17129624|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
17129625|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
17129626|NCT03773978|38270962|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
17129627|NCT03773978|38270963|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
17129628|NCT03773978|38270962|FG000|DBW Period|Adverse Event|2|||
17129629|NCT03773978|38270963|FG001|DBW Period|Adverse Event|2|||
17129630|NCT03773978|38270962|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
17129631|NCT03773978|38270963|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
17129632|NCT03773978|38270962|FG000|DBW Period|Withdrawal by Subject|2|||
17129633|NCT03773978|38270963|FG001|DBW Period|Withdrawal by Subject|1|||
17129634|NCT03773978|38270962|FG000|DBW Period|Due to epidemic or pandemic|5|||
17129635|NCT03773978|38270963|FG001|DBW Period|Due to epidemic or pandemic|6|||
17129636|NCT03773978|38270962|FG000|DBW Period|Study team decision|1|||
17129637|NCT03773978|38270963|FG001|DBW Period|Study team decision|0|||
17129638|NCT03253796|38270979|FG000|Period 1: Run-In|Adverse Event|4|||
17129639|NCT03253796|38270980|FG001|Period 1: Run-In|Adverse Event|0|||
17129640|NCT03253796|38270981|FG002|Period 1: Run-In|Adverse Event|0|||
17129641|NCT03253796|38270982|FG003|Period 1: Run-In|Adverse Event|0|||
17129642|NCT03253796|38270983|FG004|Period 1: Run-In|Adverse Event|0|||
17129643|NCT03253796|38270979|FG000|Period 1: Run-In|Lack of Efficacy|1|||
17129644|NCT03253796|38270980|FG001|Period 1: Run-In|Lack of Efficacy|0|||
17129645|NCT03253796|38270981|FG002|Period 1: Run-In|Lack of Efficacy|0|||
17129646|NCT03253796|38270982|FG003|Period 1: Run-In|Lack of Efficacy|0|||
17129647|NCT03253796|38270983|FG004|Period 1: Run-In|Lack of Efficacy|0|||
17129648|NCT03253796|38270979|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
17129649|NCT03253796|38270980|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
17129650|NCT03253796|38270981|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
17129651|NCT03253796|38270982|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
17129652|NCT03253796|38270983|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
17129653|NCT03253796|38270979|FG000|Period 1: Run-In|Protocol Violation|5|||
17129654|NCT03253796|38270980|FG001|Period 1: Run-In|Protocol Violation|0|||
17129655|NCT03253796|38270981|FG002|Period 1: Run-In|Protocol Violation|0|||
17129656|NCT03253796|38270982|FG003|Period 1: Run-In|Protocol Violation|0|||
17129657|NCT03253796|38270983|FG004|Period 1: Run-In|Protocol Violation|0|||
17129658|NCT03253796|38270979|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
17129659|NCT03253796|38270980|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
17129660|NCT03253796|38270981|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
17129661|NCT03253796|38270982|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
17129662|NCT03253796|38270983|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
17129663|NCT03253796|38270979|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
17129664|NCT03253796|38270980|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
17129665|NCT03253796|38270981|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
16956605|NCT01288079|38099576|FG003|Overall Study|Lack of Efficacy|2|||
16956606|NCT01288079|38099573|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
16956607|NCT01288079|38099574|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
16956608|NCT01288079|38099575|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
16956609|NCT01288079|38099576|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
16956610|NCT01288079|38099573|FG000|Overall Study|Lost to Follow-up|1|||
16956611|NCT01288079|38099574|FG001|Overall Study|Lost to Follow-up|1|||
16956612|NCT01288079|38099575|FG002|Overall Study|Lost to Follow-up|1|||
16956613|NCT01288079|38099576|FG003|Overall Study|Lost to Follow-up|0|||
16956614|NCT01288079|38099573|FG000|Overall Study|Other or Study Termination|11|||
16956615|NCT01288079|38099574|FG001|Overall Study|Other or Study Termination|15|||
16956616|NCT01288079|38099575|FG002|Overall Study|Other or Study Termination|14|||
16956617|NCT01288079|38099576|FG003|Overall Study|Other or Study Termination|8|||
16956618|NCT01287221|38099588|FG000|Overall Study|Lack of Perceived Benefit|1|||
16956619|NCT01287221|38099589|FG001|Overall Study|Lack of Perceived Benefit|1|||
16956620|NCT01287221|38099588|FG000|Overall Study|Adverse Event|3|||
16956621|NCT01287221|38099589|FG001|Overall Study|Adverse Event|3|||
16956622|NCT01287221|38099588|FG000|Overall Study|Withdrawal by Subject|0|||
16956623|NCT01287221|38099589|FG001|Overall Study|Withdrawal by Subject|1|||
16956624|NCT01168401|38099606|FG000|Overall Study|Lost to Follow-up|1|||
16956625|NCT01168401|38099607|FG001|Overall Study|Lost to Follow-up|1|||
16956626|NCT01168401|38099608|FG002|Overall Study|Lost to Follow-up|2|||
16956627|NCT01168401|38099609|FG003|Overall Study|Lost to Follow-up|1|||
16956628|NCT01168401|38099610|FG004|Overall Study|Lost to Follow-up|0|||
16956629|NCT01168401|38099611|FG005|Overall Study|Lost to Follow-up|0|||
16956630|NCT01168401|38099612|FG006|Overall Study|Lost to Follow-up|0|||
16956631|NCT01168401|38099613|FG007|Overall Study|Lost to Follow-up|0|||
16956632|NCT01168401|38099614|FG008|Overall Study|Lost to Follow-up|0|||
16956633|NCT01168401|38099615|FG009|Overall Study|Lost to Follow-up|0|||
16956634|NCT01168401|38099616|FG010|Overall Study|Lost to Follow-up|0|||
16956635|NCT01168401|38099606|FG000|Overall Study|Withdrawal by Subject|0|||
16956636|NCT01168401|38099607|FG001|Overall Study|Withdrawal by Subject|0|||
16956637|NCT01168401|38099608|FG002|Overall Study|Withdrawal by Subject|0|||
16956638|NCT01168401|38099609|FG003|Overall Study|Withdrawal by Subject|1|||
16956639|NCT01168401|38099610|FG004|Overall Study|Withdrawal by Subject|0|||
16956640|NCT01168401|38099611|FG005|Overall Study|Withdrawal by Subject|0|||
16956641|NCT01168401|38099612|FG006|Overall Study|Withdrawal by Subject|0|||
16956642|NCT01168401|38099613|FG007|Overall Study|Withdrawal by Subject|0|||
16956643|NCT01168401|38099614|FG008|Overall Study|Withdrawal by Subject|0|||
16956644|NCT01168401|38099615|FG009|Overall Study|Withdrawal by Subject|0|||
16956645|NCT01168401|38099616|FG010|Overall Study|Withdrawal by Subject|0|||
16956646|NCT01287065|38099640|FG000|Treatment Period 1|Adverse Event|0|||
16956647|NCT01287065|38099641|FG001|Treatment Period 1|Adverse Event|0|||
16956648|NCT01287065|38099642|FG002|Treatment Period 1|Adverse Event|0|||
16956649|NCT01287065|38099643|FG003|Treatment Period 1|Adverse Event|0|||
16956650|NCT01287065|38099644|FG004|Treatment Period 1|Adverse Event|1|||
16956651|NCT01287065|38099645|FG005|Treatment Period 1|Adverse Event|0|||
16956652|NCT01287065|38099640|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16956653|NCT01287065|38099641|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16956654|NCT01287065|38099642|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16956655|NCT01287065|38099643|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16956656|NCT01287065|38099644|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16956657|NCT01287065|38099645|FG005|Treatment Period 1|Withdrawal by Subject|1|||
16956658|NCT01167153|38099655|FG000|Overall Study|Non-effective therapy|1|||
16956659|NCT01167153|38099656|FG001|Overall Study|Non-effective therapy|4|||
16956660|NCT01167153|38099655|FG000|Overall Study|AE including clinical laboratory AE|2|||
16956661|NCT01167153|38099656|FG001|Overall Study|AE including clinical laboratory AE|8|||
16956662|NCT01167153|38099655|FG000|Overall Study|Hypotension|1|||
16956663|NCT01167153|38099656|FG001|Overall Study|Hypotension|0|||
16956664|NCT01167153|38099655|FG000|Overall Study|Lost to Follow-up|7|||
16956665|NCT01167153|38099656|FG001|Overall Study|Lost to Follow-up|9|||
16956666|NCT01167153|38099655|FG000|Overall Study|Non-compliance to concomitant medication|0|||
16956667|NCT01167153|38099656|FG001|Overall Study|Non-compliance to concomitant medication|2|||
16956668|NCT01167153|38099655|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
16956669|NCT01167153|38099656|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
16956670|NCT01167153|38099655|FG000|Overall Study|Withdrawal consent|1|||
16956671|NCT01167153|38099656|FG001|Overall Study|Withdrawal consent|1|||
16956672|NCT01167153|38099655|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
16956673|NCT01167153|38099656|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
16956674|NCT01166763|38099662|FG000|Overall Study|Withdrawal by Subject|3|||
16956675|NCT01166373|38099670|FG000|Overall Study|Lost to Follow-up|3|||
16956676|NCT01166373|38099671|FG001|Overall Study|Lost to Follow-up|2|||
16956677|NCT01166373|38099672|FG002|Overall Study|Lost to Follow-up|2|||
16956678|NCT01166373|38099673|FG003|Overall Study|Lost to Follow-up|2|||
17129666|NCT03253796|38270982|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
17129667|NCT03253796|38270983|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
17129668|NCT03253796|38270979|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
17129669|NCT03253796|38270980|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
17129670|NCT03253796|38270981|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
17129671|NCT03253796|38270982|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
17129672|NCT03253796|38270983|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
17129673|NCT03253796|38270979|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
17129674|NCT03253796|38270980|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
17129675|NCT03253796|38270981|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
17129676|NCT03253796|38270982|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
17129677|NCT03253796|38270983|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
17129678|NCT03253796|38270979|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
17129679|NCT03253796|38270980|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
17129680|NCT03253796|38270981|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
17129681|NCT03253796|38270982|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
17129682|NCT03253796|38270983|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
17129683|NCT03253796|38270979|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
17129684|NCT03253796|38270980|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
17129685|NCT03253796|38270981|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
17129686|NCT03253796|38270982|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
17129687|NCT03253796|38270983|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
17129688|NCT03253796|38270979|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
17129689|NCT03253796|38270980|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
17129690|NCT03253796|38270981|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
17129691|NCT03253796|38270982|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
17129692|NCT03253796|38270983|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
17129693|NCT03682107|38271003|FG000|Overall Study|Withdrawal by Subject|0|||
17129694|NCT03682107|38271004|FG001|Overall Study|Withdrawal by Subject|1|||
17129695|NCT03682107|38271005|FG002|Overall Study|Withdrawal by Subject|0|||
17129696|NCT03682107|38271006|FG003|Overall Study|Withdrawal by Subject|0|||
17129697|NCT03682107|38271007|FG004|Overall Study|Withdrawal by Subject|0|||
17129698|NCT03673046|38271021|FG000|Overall Study|Adverse Event|1|||
17129699|NCT03673046|38271022|FG001|Overall Study|Adverse Event|1|||
17129700|NCT03673046|38271021|FG000|Overall Study|Withdrawal by Subject|8|||
17129701|NCT03673046|38271022|FG001|Overall Study|Withdrawal by Subject|2|||
17129702|NCT02956005|38271028|FG000|Overall Study|Not eligible|1|||
17129703|NCT02956005|38271028|FG000|Overall Study|Withdrawal by Subject|3|||
17129704|NCT02956005|38271028|FG000|Overall Study|Physician Decision|12|||
17129705|NCT03253094|38271038|FG000|Overall Study|Adverse Event|2|||
17129706|NCT03253094|38271039|FG001|Overall Study|Adverse Event|0|||
17129707|NCT03253094|38271040|FG002|Overall Study|Adverse Event|0|||
17129708|NCT03253094|38271041|FG003|Overall Study|Adverse Event|0|||
17129709|NCT03253094|38271042|FG004|Overall Study|Adverse Event|0|||
17129710|NCT03253094|38271043|FG005|Overall Study|Adverse Event|0|||
17129711|NCT03253094|38271038|FG000|Overall Study|Lack of Efficacy|0|||
17129712|NCT03253094|38271039|FG001|Overall Study|Lack of Efficacy|0|||
17129713|NCT03253094|38271040|FG002|Overall Study|Lack of Efficacy|2|||
17129714|NCT03253094|38271041|FG003|Overall Study|Lack of Efficacy|1|||
17129715|NCT03253094|38271042|FG004|Overall Study|Lack of Efficacy|2|||
17129716|NCT03253094|38271043|FG005|Overall Study|Lack of Efficacy|1|||
17129717|NCT03253094|38271038|FG000|Overall Study|Lost to Follow-up|0|||
17129718|NCT03253094|38271039|FG001|Overall Study|Lost to Follow-up|0|||
17129719|NCT03253094|38271040|FG002|Overall Study|Lost to Follow-up|1|||
17129720|NCT03253094|38271041|FG003|Overall Study|Lost to Follow-up|1|||
17129721|NCT03253094|38271042|FG004|Overall Study|Lost to Follow-up|0|||
17129722|NCT03253094|38271043|FG005|Overall Study|Lost to Follow-up|1|||
17129723|NCT03253094|38271038|FG000|Overall Study|Physician Decision|1|||
17129724|NCT03253094|38271039|FG001|Overall Study|Physician Decision|0|||
17129725|NCT03253094|38271040|FG002|Overall Study|Physician Decision|0|||
17129726|NCT03253094|38271041|FG003|Overall Study|Physician Decision|1|||
17129727|NCT03253094|38271042|FG004|Overall Study|Physician Decision|0|||
17129728|NCT03253094|38271043|FG005|Overall Study|Physician Decision|2|||
17129729|NCT03253094|38271038|FG000|Overall Study|Withdrawal by Subject|1|||
17129730|NCT03253094|38271039|FG001|Overall Study|Withdrawal by Subject|2|||
17129731|NCT03253094|38271040|FG002|Overall Study|Withdrawal by Subject|1|||
17129732|NCT03253094|38271041|FG003|Overall Study|Withdrawal by Subject|0|||
17129733|NCT03253094|38271042|FG004|Overall Study|Withdrawal by Subject|3|||
17129734|NCT03253094|38271043|FG005|Overall Study|Withdrawal by Subject|0|||
17129735|NCT03253094|38271038|FG000|Overall Study|Other|0|||
17129736|NCT03253094|38271039|FG001|Overall Study|Other|1|||
17129737|NCT03253094|38271040|FG002|Overall Study|Other|2|||
17129738|NCT03253094|38271041|FG003|Overall Study|Other|1|||
17129739|NCT03253094|38271042|FG004|Overall Study|Other|0|||
17129740|NCT03253094|38271043|FG005|Overall Study|Other|0|||
17129741|NCT03654885|38271059|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
17129742|NCT03654885|38271060|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
17129743|NCT03654885|38271059|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
17129744|NCT03654885|38271060|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
17129745|NCT03654885|38271059|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
17129746|NCT03654885|38271060|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
17129747|NCT03654885|38271059|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
17129748|NCT03654885|38271060|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
17129749|NCT03654885|38271059|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
17129750|NCT03654885|38271060|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
17129751|NCT03654885|38271059|FG000|Overall Study|Adverse Event in Study Eye|3|||
17129752|NCT03654885|38271060|FG001|Overall Study|Adverse Event in Study Eye|0|||
17129753|NCT03654885|38271059|FG000|Overall Study|Consent Withdrawn|1|||
17129754|NCT03654885|38271060|FG001|Overall Study|Consent Withdrawn|0|||
17129755|NCT03654885|38271059|FG000|Overall Study|Death|3|||
17129756|NCT03654885|38271060|FG001|Overall Study|Death|1|||
17129757|NCT03654885|38271059|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
17129758|NCT03654885|38271060|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
17129759|NCT03654885|38271059|FG000|Overall Study|Lost to Follow-up|3|||
17129760|NCT03654885|38271060|FG001|Overall Study|Lost to Follow-up|3|||
17129761|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
17129762|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
17129763|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
17129764|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
17129765|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
17129766|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
17129767|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
17129768|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
17129769|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
17129770|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
17129771|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
17129772|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
17129773|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Death|3|||
17129774|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Death|1|||
17129775|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
17129776|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
17129777|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Adverse Event|7|||
17129778|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Adverse Event|8|||
17129779|NCT03236246|38271068|FG000|24-Week Dose Titration Period|Captured as Other|1|||
17129780|NCT03236246|38271069|FG001|24-Week Dose Titration Period|Captured as Other|2|||
17129781|NCT03236246|38271068|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
17129782|NCT03236246|38271069|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
17129783|NCT03236246|38271068|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
17129784|NCT03236246|38271069|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
17129785|NCT03236246|38271068|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
17129786|NCT03236246|38271069|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
17129787|NCT03236246|38271068|FG000|24-Week Dose Maintenance Period|Death|0|||
17129788|NCT03236246|38271069|FG001|24-Week Dose Maintenance Period|Death|1|||
17129789|NCT03236246|38271068|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
17129790|NCT03236246|38271069|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
17129791|NCT02937584|38271075|FG000|Period 1|Adverse Event|1|||
17129792|NCT02937584|38271076|FG001|Period 1|Adverse Event|2|||
17129793|NCT02937584|38271075|FG000|Washout|Adverse Event|0|||
17129794|NCT02937584|38271076|FG001|Washout|Adverse Event|1|||
17129795|NCT00179621|38271085|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
17129796|NCT00179621|38271086|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
17129797|NCT00179621|38271087|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
17129798|NCT00179621|38271088|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
17129799|NCT00179621|38271085|FG000|Double-Blind Period|Adverse Event|2|||
17129800|NCT00179621|38271086|FG001|Double-Blind Period|Adverse Event|7|||
17129801|NCT00179621|38271087|FG002|Double-Blind Period|Adverse Event|4|||
17129802|NCT00179621|38271088|FG003|Double-Blind Period|Adverse Event|0|||
17129803|NCT00179621|38271085|FG000|Double-Blind Period|Withdrawal by Subject|2|||
17129804|NCT00179621|38271086|FG001|Double-Blind Period|Withdrawal by Subject|1|||
17129805|NCT00179621|38271087|FG002|Double-Blind Period|Withdrawal by Subject|3|||
17129806|NCT00179621|38271088|FG003|Double-Blind Period|Withdrawal by Subject|0|||
17129807|NCT00179621|38271085|FG000|Double-Blind Period|Death|0|||
17129808|NCT00179621|38271086|FG001|Double-Blind Period|Death|1|||
17129809|NCT00179621|38271087|FG002|Double-Blind Period|Death|2|||
17129810|NCT00179621|38271088|FG003|Double-Blind Period|Death|0|||
17129811|NCT00179621|38271085|FG000|Double-Blind Period|Protocol Violation|1|||
17129812|NCT00179621|38271086|FG001|Double-Blind Period|Protocol Violation|0|||
17129813|NCT00179621|38271087|FG002|Double-Blind Period|Protocol Violation|0|||
17129814|NCT00179621|38271088|FG003|Double-Blind Period|Protocol Violation|0|||
17129815|NCT00179621|38271085|FG000|Double-Blind Period|Other|0|||
17129816|NCT00179621|38271086|FG001|Double-Blind Period|Other|2|||
17129817|NCT00179621|38271087|FG002|Double-Blind Period|Other|2|||
17129818|NCT00179621|38271088|FG003|Double-Blind Period|Other|0|||
17129819|NCT00179621|38271085|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
17129820|NCT00179621|38271086|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
17129821|NCT00179621|38271087|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
17129822|NCT00179621|38271088|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
17129823|NCT00179621|38271085|FG000|Open-Label Period|Adverse Event|0|||
17129824|NCT00179621|38271086|FG001|Open-Label Period|Adverse Event|6|||
17129825|NCT00179621|38271087|FG002|Open-Label Period|Adverse Event|5|||
17129826|NCT00179621|38271088|FG003|Open-Label Period|Adverse Event|6|||
17129827|NCT00179621|38271085|FG000|Open-Label Period|Withdrawal by Subject|0|||
17129828|NCT00179621|38271086|FG001|Open-Label Period|Withdrawal by Subject|2|||
17129829|NCT00179621|38271087|FG002|Open-Label Period|Withdrawal by Subject|2|||
17129830|NCT00179621|38271088|FG003|Open-Label Period|Withdrawal by Subject|2|||
17129831|NCT00179621|38271085|FG000|Open-Label Period|Death|0|||
17129832|NCT00179621|38271086|FG001|Open-Label Period|Death|0|||
17129833|NCT00179621|38271087|FG002|Open-Label Period|Death|1|||
17129834|NCT00179621|38271088|FG003|Open-Label Period|Death|2|||
17129835|NCT00179621|38271085|FG000|Open-Label Period|Other|0|||
17129836|NCT00179621|38271086|FG001|Open-Label Period|Other|1|||
17129837|NCT00179621|38271087|FG002|Open-Label Period|Other|1|||
17129838|NCT00179621|38271088|FG003|Open-Label Period|Other|2|||
17129839|NCT03235544|38271101|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
17129840|NCT03235544|38271102|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
17129841|NCT03235544|38271103|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
17129842|NCT03235544|38271104|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
17129843|NCT03235544|38271101|FG000|Overall Study|Death|11|||
17129844|NCT03235544|38271102|FG001|Overall Study|Death|23|||
17129845|NCT03235544|38271103|FG002|Overall Study|Death|11|||
17129846|NCT03235544|38271104|FG003|Overall Study|Death|20|||
17129847|NCT03235544|38271101|FG000|Overall Study|Lost to Follow-up|0|||
17129848|NCT03235544|38271102|FG001|Overall Study|Lost to Follow-up|1|||
17129849|NCT03235544|38271103|FG002|Overall Study|Lost to Follow-up|0|||
17129850|NCT03235544|38271104|FG003|Overall Study|Lost to Follow-up|1|||
17129851|NCT03235544|38271101|FG000|Overall Study|Withdrawal by Participant|0|||
17129852|NCT03235544|38271102|FG001|Overall Study|Withdrawal by Participant|0|||
16956679|NCT01166373|38099670|FG000|Overall Study|Withdrawal by Subject|1|||
17129853|NCT03235544|38271103|FG002|Overall Study|Withdrawal by Participant|1|||
17129854|NCT03235544|38271104|FG003|Overall Study|Withdrawal by Participant|0|||
17129855|NCT03235544|38271101|FG000|Overall Study|Reason not Specified|0|||
17129856|NCT03235544|38271102|FG001|Overall Study|Reason not Specified|4|||
17129857|NCT03235544|38271103|FG002|Overall Study|Reason not Specified|0|||
17129858|NCT03235544|38271104|FG003|Overall Study|Reason not Specified|1|||
17129859|NCT00179309|38271117|FG000|Treatment|Toxicity|2|||
17129860|NCT00179309|38271118|FG001|Treatment|Toxicity|3|||
17129861|NCT00179309|38271117|FG000|Treatment|Withdrawal by Subject|1|||
17129862|NCT00179309|38271118|FG001|Treatment|Withdrawal by Subject|2|||
17129863|NCT00179309|38271117|FG000|Treatment|Allergy|1|||
17129864|NCT00179309|38271118|FG001|Treatment|Allergy|0|||
17129865|NCT00178685|38271139|FG000|Overall Study|Death|3|||
17129866|NCT00178685|38271140|FG001|Overall Study|Death|3|||
17129867|NCT00178685|38271141|FG002|Overall Study|Death|6|||
17129868|NCT00178685|38271139|FG000|Overall Study|Lost to Follow-up|100|||
17129869|NCT00178685|38271140|FG001|Overall Study|Lost to Follow-up|187|||
17129870|NCT00178685|38271141|FG002|Overall Study|Lost to Follow-up|183|||
17129871|NCT00178685|38271139|FG000|Overall Study|Withdrawal by Subject|8|||
17129872|NCT00178685|38271140|FG001|Overall Study|Withdrawal by Subject|14|||
17129873|NCT00178685|38271141|FG002|Overall Study|Withdrawal by Subject|7|||
17129874|NCT02933528|38271149|FG000|Overall Study|Lost to Follow-up|2|||
17129875|NCT00177671|38271155|FG000|Overall Study|Withdrawal by Subject|5|||
17129876|NCT00177671|38271156|FG001|Overall Study|Withdrawal by Subject|6|||
17129877|NCT00177671|38271155|FG000|Overall Study|medical complications|2|||
17129878|NCT00177671|38271156|FG001|Overall Study|medical complications|0|||
17129879|NCT00177671|38271155|FG000|Overall Study|Adverse Event|6|||
17129880|NCT00177671|38271156|FG001|Overall Study|Adverse Event|0|||
17129881|NCT00177671|38271155|FG000|Overall Study|Physician Decision|12|||
17129882|NCT00177671|38271156|FG001|Overall Study|Physician Decision|8|||
17129883|NCT02933060|38271164|FG000|Overall Study|Withdrawal by Subject|0|||
17129884|NCT02933060|38271165|FG001|Overall Study|Withdrawal by Subject|1|||
17129885|NCT03235154|38271171|FG000|Overall Study|Withdrawal by Subject|1|||
17129886|NCT03235154|38271171|FG000|Overall Study|Adverse Event|1|||
17129887|NCT03235154|38271171|FG000|Overall Study|Lost to Follow-up|2|||
17129888|NCT03234608|38271179|FG000|Overall Study|Lost to Follow-up|23|||
17129889|NCT03234608|38271180|FG001|Overall Study|Lost to Follow-up|21|||
17129890|NCT02112916|38271190|FG000|Overall Study|Adverse Event|6|||
17129891|NCT02112916|38271191|FG001|Overall Study|Adverse Event|9|||
17129892|NCT02112916|38271192|FG002|Overall Study|Adverse Event|3|||
17129893|NCT02112916|38271193|FG003|Overall Study|Adverse Event|2|||
17129894|NCT02112916|38271190|FG000|Overall Study|Death|9|||
17129895|NCT02112916|38271191|FG001|Overall Study|Death|9|||
17129896|NCT02112916|38271192|FG002|Overall Study|Death|3|||
17129897|NCT02112916|38271193|FG003|Overall Study|Death|4|||
17129898|NCT02112916|38271190|FG000|Overall Study|Lost to Follow-up|1|||
17129899|NCT02112916|38271191|FG001|Overall Study|Lost to Follow-up|0|||
17129900|NCT02112916|38271192|FG002|Overall Study|Lost to Follow-up|0|||
17129901|NCT02112916|38271193|FG003|Overall Study|Lost to Follow-up|0|||
17129902|NCT02112916|38271190|FG000|Overall Study|Physician Decision|94|||
17129903|NCT02112916|38271191|FG001|Overall Study|Physician Decision|72|||
17129904|NCT02112916|38271192|FG002|Overall Study|Physician Decision|24|||
17129905|NCT02112916|38271193|FG003|Overall Study|Physician Decision|15|||
17129906|NCT02112916|38271190|FG000|Overall Study|Withdrawal by Subject|5|||
17129907|NCT02112916|38271191|FG001|Overall Study|Withdrawal by Subject|3|||
17129908|NCT02112916|38271192|FG002|Overall Study|Withdrawal by Subject|1|||
17129909|NCT02112916|38271193|FG003|Overall Study|Withdrawal by Subject|1|||
17129910|NCT02112916|38271190|FG000|Overall Study|Ineligible|4|||
17129911|NCT02112916|38271191|FG001|Overall Study|Ineligible|8|||
17129912|NCT02112916|38271192|FG002|Overall Study|Ineligible|3|||
17129913|NCT02112916|38271193|FG003|Overall Study|Ineligible|8|||
17129914|NCT02112916|38271190|FG000|Overall Study|Inevaluable|6|||
17129915|NCT02112916|38271191|FG001|Overall Study|Inevaluable|4|||
17129916|NCT02112916|38271192|FG002|Overall Study|Inevaluable|5|||
17129917|NCT02112916|38271193|FG003|Overall Study|Inevaluable|5|||
17129918|NCT02112916|38271190|FG000|Overall Study|Refusal of further protocol therapy|19|||
17129919|NCT02112916|38271191|FG001|Overall Study|Refusal of further protocol therapy|16|||
17129920|NCT02112916|38271192|FG002|Overall Study|Refusal of further protocol therapy|1|||
17129921|NCT02112916|38271193|FG003|Overall Study|Refusal of further protocol therapy|7|||
17129922|NCT02112916|38271190|FG000|Overall Study|Development of SMN|1|||
17129923|NCT02112916|38271191|FG001|Overall Study|Development of SMN|0|||
17129924|NCT02112916|38271192|FG002|Overall Study|Development of SMN|0|||
17129925|NCT02112916|38271193|FG003|Overall Study|Development of SMN|1|||
17129926|NCT02112916|38271190|FG000|Overall Study|Relapse/Progression|10|||
17129927|NCT02112916|38271191|FG001|Overall Study|Relapse/Progression|18|||
17129928|NCT02112916|38271192|FG002|Overall Study|Relapse/Progression|15|||
17129929|NCT02112916|38271193|FG003|Overall Study|Relapse/Progression|2|||
17129930|NCT02112916|38271190|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
17129931|NCT02112916|38271191|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
17129932|NCT02112916|38271192|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
17129933|NCT02112916|38271193|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
17129934|NCT02112916|38271190|FG000|Overall Study|Still on Therapy|44|||
17129935|NCT02112916|38271191|FG001|Overall Study|Still on Therapy|47|||
17129936|NCT02112916|38271192|FG002|Overall Study|Still on Therapy|3|||
17129937|NCT02112916|38271193|FG003|Overall Study|Still on Therapy|2|||
17129938|NCT02112916|38271190|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
17129939|NCT02112916|38271191|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
17129940|NCT02112916|38271192|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
17129941|NCT02112916|38271193|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
17129942|NCT02112916|38271190|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
17129943|NCT02112916|38271191|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
17129944|NCT02112916|38271192|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
17129945|NCT02112916|38271193|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
17129946|NCT03248882|38271213|FG000|Overall Study|Adverse Event|3|||
17129947|NCT03248882|38271214|FG001|Overall Study|Adverse Event|3|||
17129948|NCT03248882|38271215|FG002|Overall Study|Adverse Event|2|||
17129949|NCT03248882|38271216|FG003|Overall Study|Adverse Event|6|||
17129950|NCT03248882|38271217|FG004|Overall Study|Adverse Event|9|||
17129951|NCT03248882|38271213|FG000|Overall Study|Lost to Follow-up|0|||
17129952|NCT03248882|38271214|FG001|Overall Study|Lost to Follow-up|0|||
17129953|NCT03248882|38271215|FG002|Overall Study|Lost to Follow-up|0|||
17129954|NCT03248882|38271216|FG003|Overall Study|Lost to Follow-up|0|||
17129955|NCT03248882|38271217|FG004|Overall Study|Lost to Follow-up|1|||
17129956|NCT03248882|38271213|FG000|Overall Study|Protocol Violation|2|||
17129957|NCT03248882|38271214|FG001|Overall Study|Protocol Violation|0|||
17129958|NCT03248882|38271215|FG002|Overall Study|Protocol Violation|2|||
17129959|NCT03248882|38271216|FG003|Overall Study|Protocol Violation|0|||
17129960|NCT03248882|38271217|FG004|Overall Study|Protocol Violation|1|||
17129961|NCT03248882|38271213|FG000|Overall Study|Withdrawal by Subject|2|||
17129962|NCT03248882|38271214|FG001|Overall Study|Withdrawal by Subject|2|||
17129963|NCT03248882|38271215|FG002|Overall Study|Withdrawal by Subject|3|||
17129964|NCT03248882|38271216|FG003|Overall Study|Withdrawal by Subject|4|||
17129965|NCT03248882|38271217|FG004|Overall Study|Withdrawal by Subject|2|||
17129966|NCT03233438|38271231|FG000|Overall Study|Lost to Follow-up|4|||
17129967|NCT03233438|38271232|FG001|Overall Study|Lost to Follow-up|9|||
17129968|NCT03233438|38271231|FG000|Overall Study|Withdrawal by Subject|2|||
17129969|NCT03233438|38271232|FG001|Overall Study|Withdrawal by Subject|1|||
17129970|NCT03233438|38271231|FG000|Overall Study|No recording of dalbavancin|0|||
17129971|NCT03233438|38271232|FG001|Overall Study|No recording of dalbavancin|1|||
17129972|NCT01368406|38271240|FG000|Overall Study|Lost to Follow-up|8|||
17129973|NCT01368406|38271241|FG001|Overall Study|Lost to Follow-up|4|||
17129974|NCT01368406|38271240|FG000|Overall Study|Withdrawal by Subject|8|||
16956680|NCT01166373|38099671|FG001|Overall Study|Withdrawal by Subject|2|||
16956681|NCT01166373|38099672|FG002|Overall Study|Withdrawal by Subject|2|||
16956682|NCT01166373|38099673|FG003|Overall Study|Withdrawal by Subject|3|||
16956683|NCT01166373|38099670|FG000|Overall Study|Physician Decision|1|||
16956684|NCT01166373|38099671|FG001|Overall Study|Physician Decision|0|||
16956685|NCT01166373|38099672|FG002|Overall Study|Physician Decision|0|||
16956686|NCT01166373|38099673|FG003|Overall Study|Physician Decision|0|||
16956687|NCT00963235|38099685|FG000|Overall Study|Withdrawal by Subject|22|||
16956688|NCT00963235|38099685|FG000|Overall Study|Lost to Follow-up|14|||
16956689|NCT00963235|38099685|FG000|Overall Study|Failed to return|9|||
16956690|NCT00963235|38099685|FG000|Overall Study|Protocol Violation|7|||
16956691|NCT00963235|38099685|FG000|Overall Study|Adverse Event|5|||
16956692|NCT00963235|38099685|FG000|Overall Study|Physician Decision|2|||
16956693|NCT00963235|38099685|FG000|Overall Study|Other|1|||
16956694|NCT01165281|38099694|FG000|Overall Study|Adverse Event|12|||
16956695|NCT01165281|38099695|FG001|Overall Study|Adverse Event|14|||
16956696|NCT01165281|38099694|FG000|Overall Study|Death|3|||
16956697|NCT01165281|38099695|FG001|Overall Study|Death|4|||
16956698|NCT01165281|38099694|FG000|Overall Study|Lack of Efficacy|4|||
16956699|NCT01165281|38099695|FG001|Overall Study|Lack of Efficacy|1|||
16956700|NCT01165281|38099694|FG000|Overall Study|Lost to Follow-up|0|||
16956701|NCT01165281|38099695|FG001|Overall Study|Lost to Follow-up|1|||
16956702|NCT01165281|38099694|FG000|Overall Study|Physician Decision|8|||
16956703|NCT01165281|38099695|FG001|Overall Study|Physician Decision|1|||
16956704|NCT01165281|38099694|FG000|Overall Study|Protocol Violation|6|||
16956705|NCT01165281|38099695|FG001|Overall Study|Protocol Violation|5|||
16956706|NCT01165281|38099694|FG000|Overall Study|Withdrawal by Subject|8|||
16956707|NCT01165281|38099695|FG001|Overall Study|Withdrawal by Subject|7|||
16956708|NCT01165281|38099694|FG000|Overall Study|Noncompliance with Study Drug|1|||
16956709|NCT01165281|38099695|FG001|Overall Study|Noncompliance with Study Drug|4|||
16956710|NCT01165281|38099694|FG000|Overall Study|Progressive Disease|10|||
16956711|NCT01165281|38099695|FG001|Overall Study|Progressive Disease|14|||
16956712|NCT01165281|38099694|FG000|Overall Study|Other|6|||
16956713|NCT01165281|38099695|FG001|Overall Study|Other|0|||
16956714|NCT01165203|38099703|FG000|Active Phase|Serious Adverse Event|1|||
16956715|NCT01165203|38099704|FG001|Active Phase|Serious Adverse Event|0|||
16956716|NCT01165203|38099703|FG000|Active Phase|Withdrawal by Subject|2|||
16956717|NCT01165203|38099704|FG001|Active Phase|Withdrawal by Subject|1|||
16956718|NCT01165203|38099703|FG000|Active Phase|Migrated/moved from study area|0|||
16956719|NCT01165203|38099704|FG001|Active Phase|Migrated/moved from study area|1|||
17129975|NCT01368406|38271241|FG001|Overall Study|Withdrawal by Subject|4|||
17129976|NCT01368406|38271240|FG000|Overall Study|relapse of the disease|3|||
17129977|NCT01368406|38271241|FG001|Overall Study|relapse of the disease|2|||
17129978|NCT01368406|38271240|FG000|Overall Study|started working|2|||
17129979|NCT01368406|38271241|FG001|Overall Study|started working|3|||
17129980|NCT00175877|38271247|FG000|Overall Study|Adverse Event|136|||
17129981|NCT00175877|38271247|FG000|Overall Study|Withdrawal by Subject|141|||
17129982|NCT00175877|38271247|FG000|Overall Study|Lost to Follow-up|9|||
17129983|NCT00175877|38271247|FG000|Overall Study|Lack of Efficacy|26|||
17129984|NCT00175877|38271247|FG000|Overall Study|Protocol Violation|15|||
17129985|NCT00175877|38271247|FG000|Overall Study|Other Reason|20|||
17129986|NCT00175877|38271247|FG000|Overall Study|AE & Other|1|||
17129987|NCT00175877|38271247|FG000|Overall Study|Withdrawal by subject & Other|1|||
17129988|NCT02788474|38271253|FG000|Double Blind Treatment Period|Not treated|1|||
17129989|NCT02788474|38271254|FG001|Double Blind Treatment Period|Not treated|0|||
17129990|NCT02788474|38271253|FG000|Double Blind Treatment Period|Patient's refusal|3|||
17129991|NCT02788474|38271254|FG001|Double Blind Treatment Period|Patient's refusal|0|||
17129992|NCT02788474|38271253|FG000|Double Blind Treatment Period|Adverse Event|6|||
17129993|NCT02788474|38271254|FG001|Double Blind Treatment Period|Adverse Event|4|||
17129994|NCT02788474|38271253|FG000|Open Label Treatment Period|Adverse Event|29|||
17129995|NCT02788474|38271254|FG001|Open Label Treatment Period|Adverse Event|9|||
17129996|NCT02788474|38271253|FG000|Open Label Treatment Period|Other than reason specified|1|||
17129997|NCT02788474|38271254|FG001|Open Label Treatment Period|Other than reason specified|0|||
17129998|NCT02788474|38271253|FG000|Open Label Treatment Period|Patient's refusal|1|||
17129999|NCT02788474|38271254|FG001|Open Label Treatment Period|Patient's refusal|3|||
17130000|NCT02788474|38271253|FG000|Open Label Treatment Period|Non-compliance|1|||
17130001|NCT02788474|38271254|FG001|Open Label Treatment Period|Non-compliance|0|||
17130002|NCT03248492|38271266|FG000|Overall Study|Ongoing|23|||
17130003|NCT03248492|38271267|FG001|Overall Study|Ongoing|26|||
17130004|NCT03248492|38271268|FG002|Overall Study|Ongoing|3|||
17130005|NCT03248492|38271269|FG003|Overall Study|Ongoing|85|||
16782550|NCT02061592|37722153|FG001|Period 2|Lost to Follow-up|1|||
17130006|NCT03248492|38271270|FG004|Overall Study|Ongoing|2|||
17130007|NCT03248492|38271266|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
17130008|NCT03248492|38271267|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
17130009|NCT03248492|38271268|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
17130010|NCT03248492|38271269|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
17130011|NCT03248492|38271270|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
17130012|NCT03248492|38271266|FG000|Overall Study|Adverse Event|6|||
16956720|NCT01165203|38099703|FG000|Active Phase|Lost to Follow-up|2|||
16956721|NCT01165203|38099704|FG001|Active Phase|Lost to Follow-up|0|||
16956722|NCT01165203|38099703|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
16956723|NCT01165203|38099704|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
16956724|NCT01165203|38099703|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
16956725|NCT01165203|38099704|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
16956726|NCT01165203|38099703|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
16956727|NCT01165203|38099704|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
16956728|NCT01165203|38099703|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
16956729|NCT01165203|38099704|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
16956730|NCT01165203|38099703|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
16956731|NCT01165203|38099704|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
16956732|NCT00960661|38099719|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
16956733|NCT00960661|38099720|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
16956734|NCT00960661|38099721|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
16956735|NCT00960661|38099719|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
16956736|NCT00960661|38099720|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
16956737|NCT00960661|38099721|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
16956738|NCT00960661|38099719|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
16956739|NCT00960661|38099720|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
16956740|NCT00960661|38099721|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
16956741|NCT00960661|38099719|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
16956742|NCT00960661|38099720|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
16956743|NCT00960661|38099721|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
16956744|NCT00960661|38099719|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
16956745|NCT00960661|38099720|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
17130013|NCT03248492|38271267|FG001|Overall Study|Adverse Event|6|||
17130014|NCT03248492|38271268|FG002|Overall Study|Adverse Event|8|||
17130015|NCT03248492|38271269|FG003|Overall Study|Adverse Event|8|||
17130016|NCT03248492|38271270|FG004|Overall Study|Adverse Event|1|||
17130017|NCT03248492|38271266|FG000|Overall Study|Withdrawal by Subject|3|||
17130018|NCT03248492|38271267|FG001|Overall Study|Withdrawal by Subject|3|||
17130019|NCT03248492|38271268|FG002|Overall Study|Withdrawal by Subject|0|||
17130020|NCT03248492|38271269|FG003|Overall Study|Withdrawal by Subject|3|||
17130021|NCT03248492|38271270|FG004|Overall Study|Withdrawal by Subject|1|||
17130022|NCT03248492|38271266|FG000|Overall Study|Physician Decision|1|||
17130023|NCT03248492|38271267|FG001|Overall Study|Physician Decision|0|||
17130024|NCT03248492|38271268|FG002|Overall Study|Physician Decision|1|||
17130025|NCT03248492|38271269|FG003|Overall Study|Physician Decision|2|||
17130026|NCT03248492|38271270|FG004|Overall Study|Physician Decision|0|||
17130027|NCT03248492|38271266|FG000|Overall Study|Death|1|||
17130028|NCT03248492|38271267|FG001|Overall Study|Death|0|||
17130029|NCT03248492|38271268|FG002|Overall Study|Death|0|||
17130030|NCT03248492|38271269|FG003|Overall Study|Death|6|||
17130031|NCT03248492|38271270|FG004|Overall Study|Death|0|||
17130032|NCT03248492|38271266|FG000|Overall Study|Other|0|||
17130033|NCT03248492|38271267|FG001|Overall Study|Other|1|||
17130034|NCT03248492|38271268|FG002|Overall Study|Other|0|||
17130035|NCT03248492|38271269|FG003|Overall Study|Other|4|||
17130036|NCT03248492|38271270|FG004|Overall Study|Other|0|||
17130037|NCT03247556|38271293|FG000|Overall Study|Adverse Event|1|||
17130038|NCT03247556|38271294|FG001|Overall Study|Adverse Event|4|||
17130039|NCT03247556|38271295|FG002|Overall Study|Adverse Event|5|||
17130040|NCT03247556|38271293|FG000|Overall Study|Lost to Follow-up|5|||
17130041|NCT03247556|38271294|FG001|Overall Study|Lost to Follow-up|5|||
17130042|NCT03247556|38271295|FG002|Overall Study|Lost to Follow-up|4|||
17130043|NCT03247556|38271293|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
17130044|NCT03247556|38271294|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
17130045|NCT03247556|38271295|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
17130046|NCT03247556|38271293|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
17130047|NCT03247556|38271294|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
17130048|NCT03247556|38271295|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
17130049|NCT03247556|38271293|FG000|Overall Study|Protocol Violation|2|||
17130050|NCT03247556|38271294|FG001|Overall Study|Protocol Violation|0|||
17130051|NCT03247556|38271295|FG002|Overall Study|Protocol Violation|1|||
17130052|NCT03247556|38271293|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
17130053|NCT03247556|38271294|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
17130054|NCT03247556|38271295|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
17130055|NCT03216746|38271307|FG000|Overall Study|Lost to Follow-up|6|||
17130056|NCT03216746|38271308|FG001|Overall Study|Lost to Follow-up|8|||
17130057|NCT03216746|38271309|FG002|Overall Study|Lost to Follow-up|5|||
17130058|NCT03216746|38271310|FG003|Overall Study|Lost to Follow-up|6|||
17130059|NCT02787304|38271324|FG000|Overall Study|Adverse Event|9|||
17130060|NCT02787304|38271325|FG001|Overall Study|Adverse Event|3|||
17130061|NCT02787304|38271326|FG002|Overall Study|Adverse Event|8|||
17130062|NCT02787304|38271327|FG003|Overall Study|Adverse Event|1|||
17130063|NCT02787304|38271324|FG000|Overall Study|Withdrawal by Subject|1|||
17130064|NCT02787304|38271325|FG001|Overall Study|Withdrawal by Subject|4|||
17130065|NCT02787304|38271326|FG002|Overall Study|Withdrawal by Subject|0|||
17130066|NCT02787304|38271327|FG003|Overall Study|Withdrawal by Subject|0|||
17130067|NCT02787304|38271324|FG000|Overall Study|Lost to Follow-up|1|||
17130068|NCT02787304|38271325|FG001|Overall Study|Lost to Follow-up|0|||
17130069|NCT02787304|38271326|FG002|Overall Study|Lost to Follow-up|0|||
17130070|NCT02787304|38271327|FG003|Overall Study|Lost to Follow-up|1|||
17130071|NCT02787304|38271324|FG000|Overall Study|Noncompliance with study drug|0|||
17130072|NCT02787304|38271325|FG001|Overall Study|Noncompliance with study drug|0|||
17130073|NCT02787304|38271326|FG002|Overall Study|Noncompliance with study drug|1|||
17130074|NCT02787304|38271327|FG003|Overall Study|Noncompliance with study drug|0|||
17130075|NCT02787304|38271324|FG000|Overall Study|Physician Decision|0|||
17130076|NCT02787304|38271325|FG001|Overall Study|Physician Decision|0|||
17130077|NCT02787304|38271326|FG002|Overall Study|Physician Decision|1|||
17130078|NCT02787304|38271327|FG003|Overall Study|Physician Decision|0|||
17130079|NCT02787304|38271324|FG000|Overall Study|Study terminated by sponsor|25|||
17130080|NCT02787304|38271325|FG001|Overall Study|Study terminated by sponsor|31|||
17130081|NCT02787304|38271326|FG002|Overall Study|Study terminated by sponsor|31|||
17130082|NCT02787304|38271327|FG003|Overall Study|Study terminated by sponsor|32|||
17130083|NCT03215810|38271337|FG000|Overall Study|Still responding to nivolumab|1|||
17130084|NCT03215810|38271337|FG000|Overall Study|Insufficient TIL growth|1|||
17130085|NCT03215810|38271337|FG000|Overall Study|Decline in performance status|1|||
17130086|NCT03215810|38271337|FG000|Overall Study|Withdrawal by Subject|1|||
17130087|NCT02932904|38271345|FG000|Overall Study|Reason not Specified|1|||
17130088|NCT02932904|38271346|FG001|Overall Study|Reason not Specified|0|||
17130089|NCT02932904|38271347|FG002|Overall Study|Reason not Specified|2|||
17130090|NCT02932904|38271348|FG003|Overall Study|Reason not Specified|2|||
17130091|NCT02932904|38271345|FG000|Overall Study|Noncompliance with Study Drug|2|||
17130092|NCT02932904|38271346|FG001|Overall Study|Noncompliance with Study Drug|3|||
17130093|NCT02932904|38271347|FG002|Overall Study|Noncompliance with Study Drug|3|||
17130094|NCT02932904|38271348|FG003|Overall Study|Noncompliance with Study Drug|4|||
17130095|NCT02932904|38271345|FG000|Overall Study|Pregnancy|0|||
17130096|NCT02932904|38271346|FG001|Overall Study|Pregnancy|1|||
17130097|NCT02932904|38271347|FG002|Overall Study|Pregnancy|1|||
17130098|NCT02932904|38271348|FG003|Overall Study|Pregnancy|0|||
17130099|NCT02932904|38271345|FG000|Overall Study|Study Termination|0|||
17130100|NCT02932904|38271346|FG001|Overall Study|Study Termination|1|||
17130101|NCT02932904|38271347|FG002|Overall Study|Study Termination|0|||
17130102|NCT02932904|38271348|FG003|Overall Study|Study Termination|0|||
17130103|NCT02932904|38271345|FG000|Overall Study|Voluntary Withdrawal|2|||
17130104|NCT02932904|38271346|FG001|Overall Study|Voluntary Withdrawal|1|||
17130105|NCT02932904|38271347|FG002|Overall Study|Voluntary Withdrawal|4|||
17130106|NCT02932904|38271348|FG003|Overall Study|Voluntary Withdrawal|2|||
17130107|NCT02932904|38271345|FG000|Overall Study|Lost to Follow-up|5|||
17130108|NCT02932904|38271346|FG001|Overall Study|Lost to Follow-up|3|||
17130109|NCT02932904|38271347|FG002|Overall Study|Lost to Follow-up|6|||
17130110|NCT02932904|38271348|FG003|Overall Study|Lost to Follow-up|0|||
17130111|NCT02932904|38271345|FG000|Overall Study|Significant Protocol Deviation|2|||
17130112|NCT02932904|38271346|FG001|Overall Study|Significant Protocol Deviation|3|||
17130113|NCT02932904|38271347|FG002|Overall Study|Significant Protocol Deviation|6|||
17130114|NCT02932904|38271348|FG003|Overall Study|Significant Protocol Deviation|1|||
17130115|NCT02932904|38271345|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
17130116|NCT02932904|38271346|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
17130117|NCT02932904|38271347|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
17130118|NCT02932904|38271348|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
17130119|NCT02932904|38271345|FG000|Overall Study|Randomized But Not Treated|1|||
17130120|NCT02932904|38271346|FG001|Overall Study|Randomized But Not Treated|1|||
17130121|NCT02932904|38271347|FG002|Overall Study|Randomized But Not Treated|0|||
17130122|NCT02932904|38271348|FG003|Overall Study|Randomized But Not Treated|2|||
17130123|NCT02542293|38271363|FG000|Overall Study|Death|367|||
17130124|NCT02542293|38271364|FG001|Overall Study|Death|377|||
17130125|NCT02542293|38271363|FG000|Overall Study|Withdrawal by Subject|8|||
17130126|NCT02542293|38271364|FG001|Overall Study|Withdrawal by Subject|19|||
17130127|NCT00688376|38271379|FG000|Double-Blind Phase|Adverse Event|4|||
17130128|NCT00688376|38271380|FG001|Double-Blind Phase|Adverse Event|4|||
17130129|NCT00688376|38271379|FG000|Double-Blind Phase|Protocol Violation|1|||
17130130|NCT00688376|38271380|FG001|Double-Blind Phase|Protocol Violation|2|||
17130131|NCT00688376|38271379|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
16956746|NCT00960661|38099721|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
16956747|NCT00960661|38099719|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
16956748|NCT00960661|38099720|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
16956749|NCT00960661|38099721|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
16956750|NCT00960661|38099719|FG000|Interventional Phase|Adverse Event|0|||
16956751|NCT00960661|38099720|FG001|Interventional Phase|Adverse Event|17|||
16956752|NCT00960661|38099721|FG002|Interventional Phase|Adverse Event|8|||
16956753|NCT00960661|38099719|FG000|Interventional Phase|Death|0|||
16956754|NCT00960661|38099720|FG001|Interventional Phase|Death|1|||
16956755|NCT00960661|38099721|FG002|Interventional Phase|Death|0|||
16956756|NCT00960661|38099719|FG000|Interventional Phase|Lost to Follow-up|0|||
16956757|NCT00960661|38099720|FG001|Interventional Phase|Lost to Follow-up|0|||
16956758|NCT00960661|38099721|FG002|Interventional Phase|Lost to Follow-up|2|||
16956759|NCT00960661|38099719|FG000|Interventional Phase|entry criteria not met|0|||
16956760|NCT00960661|38099720|FG001|Interventional Phase|entry criteria not met|3|||
16956761|NCT00960661|38099721|FG002|Interventional Phase|entry criteria not met|0|||
16956762|NCT00960661|38099719|FG000|Interventional Phase|Protocol Violation|0|||
16956763|NCT00960661|38099720|FG001|Interventional Phase|Protocol Violation|7|||
16956764|NCT00960661|38099721|FG002|Interventional Phase|Protocol Violation|2|||
16956765|NCT00960661|38099719|FG000|Interventional Phase|Withdrawal by Subject|0|||
16956766|NCT00960661|38099720|FG001|Interventional Phase|Withdrawal by Subject|18|||
16956767|NCT00960661|38099721|FG002|Interventional Phase|Withdrawal by Subject|29|||
16956768|NCT00960661|38099719|FG000|Interventional Phase|Physician Decision|0|||
16956769|NCT00960661|38099720|FG001|Interventional Phase|Physician Decision|3|||
16956770|NCT00960661|38099721|FG002|Interventional Phase|Physician Decision|5|||
16956771|NCT00960661|38099719|FG000|Interventional Phase|sponsor decision|0|||
16956772|NCT00960661|38099720|FG001|Interventional Phase|sponsor decision|1|||
16956773|NCT00960661|38099721|FG002|Interventional Phase|sponsor decision|0|||
16956774|NCT00960661|38099719|FG000|Interventional Phase|Lack of Efficacy|0|||
16956775|NCT00960661|38099720|FG001|Interventional Phase|Lack of Efficacy|2|||
16956776|NCT00960661|38099721|FG002|Interventional Phase|Lack of Efficacy|0|||
16956777|NCT01164891|38099727|FG000|Overall Study|Disease Progression|5|||
16956778|NCT01164891|38099727|FG000|Overall Study|Adverse Event|1|||
16956779|NCT00960193|38099732|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
16956780|NCT00960115|38099741|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
16956781|NCT00960115|38099742|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
16956782|NCT00959647|38099748|FG000|Overall Study|Adverse Event|2|||
16956783|NCT00959647|38099748|FG000|Overall Study|Progressive disease|6|||
16956784|NCT00959647|38099748|FG000|Overall Study|Study terminated by sponsor|4|||
16956785|NCT00959647|38099748|FG000|Overall Study|Withdrawal by Subject|7|||
16956786|NCT00957931|38099752|FG000|Overall Study|Death|4|||
16956787|NCT00957853|38099759|FG000|Overall Study|Withdrawal by Subject|1|||
16956788|NCT00957853|38099760|FG001|Overall Study|Withdrawal by Subject|0|||
16956789|NCT00957853|38099761|FG002|Overall Study|Withdrawal by Subject|0|||
16956790|NCT00957229|38099771|FG000|Study Start|Adverse Event|0|||
16956791|NCT00957229|38099772|FG001|Study Start|Adverse Event|3|||
16956792|NCT00957229|38099771|FG000|Study Start|Disease Progression|1|||
16956793|NCT00957229|38099772|FG001|Study Start|Disease Progression|0|||
16956794|NCT00957229|38099771|FG000|Reallocated to or Continued Vismodegib|Death|1|||
16956795|NCT00957229|38099772|FG001|Reallocated to or Continued Vismodegib|Death|1|||
16956796|NCT00957229|38099771|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
16956797|NCT00957229|38099772|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
16956798|NCT02604511|38099778|FG000|Overall Study|Adverse Event|3|||
16956799|NCT02604511|38099778|FG000|Overall Study|Disease Progression|4|||
16956800|NCT02604511|38099778|FG000|Overall Study|Withdrawal by Subject|3|||
16956801|NCT02604511|38099778|FG000|Overall Study|Participant ineligible|1|||
16956802|NCT02604511|38099778|FG000|Overall Study|Intercurrent illness|1|||
16956803|NCT00956839|38099786|FG000|Overall Study|Lost to Follow-up|3|||
16956804|NCT00956839|38099787|FG001|Overall Study|Lost to Follow-up|0|||
16956805|NCT00956839|38099788|FG002|Overall Study|Lost to Follow-up|3|||
16956806|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
16956807|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
16956808|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
16956809|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Death|0|||
16956810|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Death|0|||
16956811|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Death|1|||
16956812|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
16956813|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
16956814|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
17130132|NCT00688376|38271380|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
17130133|NCT00688376|38271379|FG000|Double-Blind Phase|Not treated|0|||
17130134|NCT00688376|38271380|FG001|Double-Blind Phase|Not treated|1|||
17130135|NCT00688376|38271379|FG000|Blinded Extension Phase|Adverse Event|3|||
17130136|NCT00688376|38271380|FG001|Blinded Extension Phase|Adverse Event|4|||
17130137|NCT00688376|38271379|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
17130138|NCT00688376|38271380|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
17130139|NCT00688376|38271379|FG000|Blinded Extension Phase|Physician Decision|1|||
17130140|NCT00688376|38271380|FG001|Blinded Extension Phase|Physician Decision|0|||
17130141|NCT00688376|38271379|FG000|Blinded Extension Phase|Other|1|||
17130142|NCT00688376|38271380|FG001|Blinded Extension Phase|Other|0|||
17130143|NCT03214952|38271388|FG000|Overall Study|Protocol Deviation|45|||
17130144|NCT03214952|38271388|FG000|Overall Study|Case Report Forms Uncollected|13|||
17130145|NCT01367704|38271394|FG000|Overall Study|Lost to Follow-up|47|||
17130146|NCT01367704|38271395|FG001|Overall Study|Lost to Follow-up|161|||
17130147|NCT03214094|38271401|FG000|Overall Study|Case Report Forms Uncollected|14|||
17130148|NCT03214094|38271401|FG000|Overall Study|Protocol Deviation|46|||
17130149|NCT01367236|38271407|FG000|Overall Study|Withdrawal by Subject|3|||
17130150|NCT01367236|38271408|FG001|Overall Study|Withdrawal by Subject|1|||
17130151|NCT03681951|38271422|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
17130152|NCT03681951|38271423|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
17130153|NCT03681951|38271424|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
17130154|NCT03681951|38271425|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
17130155|NCT03681951|38271426|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
17130156|NCT03681951|38271427|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
17130157|NCT03681951|38271428|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
17130158|NCT03681951|38271429|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
17130159|NCT03681951|38271422|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
17130160|NCT03681951|38271423|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
17130161|NCT03681951|38271424|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
17130162|NCT03681951|38271425|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
17130163|NCT03681951|38271426|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
17130164|NCT03681951|38271427|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
17130165|NCT03681951|38271428|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
17130166|NCT03681951|38271429|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
17130167|NCT03681951|38271422|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
17130168|NCT03681951|38271423|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
17130169|NCT03681951|38271424|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
17130170|NCT03681951|38271425|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
17130171|NCT03681951|38271426|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
17130172|NCT03681951|38271427|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
17130173|NCT03681951|38271428|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
17130174|NCT03681951|38271429|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
17130175|NCT03681405|38271454|FG000|Overall Study|Found to be ineligible after randomized|1|||
17130176|NCT03681405|38271455|FG001|Overall Study|Found to be ineligible after randomized|0|||
17130177|NCT00174785|38271465|FG000|Overall Study|Adverse Event|293|||
17130178|NCT00174785|38271466|FG001|Overall Study|Adverse Event|191|||
17130179|NCT00174785|38271465|FG000|Overall Study|Protocol Violation|14|||
17130180|NCT00174785|38271466|FG001|Overall Study|Protocol Violation|14|||
17130181|NCT00174785|38271465|FG000|Overall Study|Withdrawal by Subject|173|||
17130182|NCT00174785|38271466|FG001|Overall Study|Withdrawal by Subject|175|||
17130183|NCT00174785|38271465|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
17130184|NCT00174785|38271466|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
17130185|NCT00174785|38271465|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
17130186|NCT00174785|38271466|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
17130187|NCT00174785|38271465|FG000|Overall Study|Other prohibited medication|5|||
17130188|NCT00174785|38271466|FG001|Overall Study|Other prohibited medication|3|||
17130189|NCT00174785|38271465|FG000|Overall Study|Family request|6|||
17130190|NCT00174785|38271466|FG001|Overall Study|Family request|8|||
17130191|NCT00174785|38271465|FG000|Overall Study|Not pre-specified/Not coded|56|||
17130192|NCT00174785|38271466|FG001|Overall Study|Not pre-specified/Not coded|70|||
17130193|NCT03681093|38271475|FG000|Overall Study|Subject decision|0|||
17130194|NCT03681093|38271476|FG001|Overall Study|Subject decision|2|||
17130195|NCT03681093|38271477|FG002|Overall Study|Subject decision|1|||
17130196|NCT00166517|38271487|FG000|Overall Study|Lost to Follow-up|1|||
17130197|NCT00166517|38271488|FG001|Overall Study|Lost to Follow-up|0|||
17130198|NCT00166517|38271487|FG000|Overall Study|Protocol Violation|4|||
17130199|NCT00166517|38271488|FG001|Overall Study|Protocol Violation|1|||
17130200|NCT00166517|38271487|FG000|Overall Study|Withdrawal by Subject|0|||
16782551|NCT01663623|37722163|FG000|Overall Study|Adverse Event|3|||
16956815|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
17130201|NCT00166517|38271488|FG001|Overall Study|Withdrawal by Subject|1|||
17130202|NCT00166439|38271494|FG000|Overall Study|Ineligible|5|||
17130203|NCT00138671|38271500|FG000|Overall Study|Death|0|||
17130204|NCT00138671|38271501|FG001|Overall Study|Death|3|||
17130205|NCT00138671|38271500|FG000|Overall Study|Adverse Event|6|||
17130206|NCT00138671|38271501|FG001|Overall Study|Adverse Event|3|||
17130207|NCT00138671|38271500|FG000|Overall Study|Lost to Follow-up|1|||
17130208|NCT00138671|38271501|FG001|Overall Study|Lost to Follow-up|2|||
17130209|NCT00138671|38271500|FG000|Overall Study|Withdrawal by Subject|3|||
17130210|NCT00138671|38271501|FG001|Overall Study|Withdrawal by Subject|5|||
17130211|NCT00138671|38271500|FG000|Overall Study|Other|3|||
17130212|NCT00138671|38271501|FG001|Overall Study|Other|3|||
17130213|NCT01367158|38271520|FG000|Overall Study|Withdrew consent|0|||
17130214|NCT01367158|38271521|FG001|Overall Study|Withdrew consent|2|||
17130215|NCT01367158|38271522|FG002|Overall Study|Withdrew consent|1|||
17130216|NCT01367158|38271523|FG003|Overall Study|Withdrew consent|0|||
17130217|NCT01367158|38271524|FG004|Overall Study|Withdrew consent|2|||
17130218|NCT01367158|38271525|FG005|Overall Study|Withdrew consent|0|||
17130219|NCT01367158|38271526|FG006|Overall Study|Withdrew consent|0|||
17130220|NCT01367158|38271527|FG007|Overall Study|Withdrew consent|1|||
17130221|NCT01367158|38271528|FG008|Overall Study|Withdrew consent|0|||
17130222|NCT01367158|38271529|FG009|Overall Study|Withdrew consent|0|||
17130223|NCT01367158|38271530|FG010|Overall Study|Withdrew consent|0|||
17130224|NCT01367158|38271520|FG000|Overall Study|Lost to Follow-up|0|||
17130225|NCT01367158|38271521|FG001|Overall Study|Lost to Follow-up|0|||
17130226|NCT01367158|38271522|FG002|Overall Study|Lost to Follow-up|0|||
17130227|NCT01367158|38271523|FG003|Overall Study|Lost to Follow-up|1|||
17130228|NCT01367158|38271524|FG004|Overall Study|Lost to Follow-up|0|||
17130229|NCT01367158|38271525|FG005|Overall Study|Lost to Follow-up|2|||
17130230|NCT01367158|38271526|FG006|Overall Study|Lost to Follow-up|0|||
17130231|NCT01367158|38271527|FG007|Overall Study|Lost to Follow-up|1|||
17130232|NCT01367158|38271528|FG008|Overall Study|Lost to Follow-up|0|||
17130233|NCT01367158|38271529|FG009|Overall Study|Lost to Follow-up|0|||
17130234|NCT01367158|38271530|FG010|Overall Study|Lost to Follow-up|1|||
17130235|NCT01367158|38271520|FG000|Overall Study|Protocol Violation|0|||
17130236|NCT01367158|38271521|FG001|Overall Study|Protocol Violation|1|||
17130237|NCT01367158|38271522|FG002|Overall Study|Protocol Violation|0|||
17130238|NCT01367158|38271523|FG003|Overall Study|Protocol Violation|0|||
17130239|NCT01367158|38271524|FG004|Overall Study|Protocol Violation|0|||
17130240|NCT01367158|38271525|FG005|Overall Study|Protocol Violation|0|||
17130241|NCT01367158|38271526|FG006|Overall Study|Protocol Violation|0|||
17130242|NCT01367158|38271527|FG007|Overall Study|Protocol Violation|0|||
17130243|NCT01367158|38271528|FG008|Overall Study|Protocol Violation|0|||
17130244|NCT01367158|38271529|FG009|Overall Study|Protocol Violation|0|||
17130245|NCT01367158|38271530|FG010|Overall Study|Protocol Violation|0|||
16782552|NCT01663623|37722164|FG001|Overall Study|Adverse Event|7|||
16956816|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
16956817|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
16956818|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
16956819|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
16956820|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
16956821|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Graft loss|0|||
16956822|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Graft loss|0|||
16956823|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Graft loss|7|||
16956824|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
16956825|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
16956826|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
16956827|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
16956828|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
16956829|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
16956830|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
16956831|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
16956832|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
16956833|NCT00956293|38099798|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
16956834|NCT00956293|38099799|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
16956835|NCT00956293|38099800|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
16956836|NCT00956293|38099798|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
17130246|NCT00130637|38271565|FG000|Overall Study|Adverse Event|2|||
17130247|NCT00130637|38271565|FG000|Overall Study|Withdrawal by Subject|1|||
17130248|NCT03679767|38271573|FG000|Overall Study|Death|16|||
17130249|NCT03679767|38271574|FG001|Overall Study|Death|10|||
17130250|NCT03679767|38271575|FG002|Overall Study|Death|16|||
17130251|NCT03679767|38271576|FG003|Overall Study|Death|10|||
17130252|NCT03679767|38271573|FG000|Overall Study|Lost to Follow-up|1|||
17130253|NCT03679767|38271574|FG001|Overall Study|Lost to Follow-up|0|||
17130254|NCT03679767|38271575|FG002|Overall Study|Lost to Follow-up|1|||
17130255|NCT03679767|38271576|FG003|Overall Study|Lost to Follow-up|1|||
16956837|NCT00956293|38099799|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
16956838|NCT00956293|38099800|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
16956839|NCT00956293|38099798|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
16956840|NCT00956293|38099799|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
16956841|NCT00956293|38099800|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
16956842|NCT00956293|38099798|FG000|Main Period (Randomization)|Adverse Event|0|||
16956843|NCT00956293|38099799|FG001|Main Period (Randomization)|Adverse Event|15|||
16956844|NCT00956293|38099800|FG002|Main Period (Randomization)|Adverse Event|0|||
16956845|NCT00956293|38099798|FG000|Follow-up Period|Follow-up period was terminated.|20|||
16956846|NCT00956293|38099799|FG001|Follow-up Period|Follow-up period was terminated.|32|||
16956847|NCT00956293|38099800|FG002|Follow-up Period|Follow-up period was terminated.|0|||
16956848|NCT00955825|38099808|FG000|Overall Study|Adverse Event|15|||
16956849|NCT00955825|38099809|FG001|Overall Study|Adverse Event|2|||
16956850|NCT00955825|38099808|FG000|Overall Study|Withdrawal by Subject|4|||
16956851|NCT00955825|38099809|FG001|Overall Study|Withdrawal by Subject|6|||
16956852|NCT00955825|38099808|FG000|Overall Study|Any other reason not above-mentioned|7|||
16956853|NCT00955825|38099809|FG001|Overall Study|Any other reason not above-mentioned|9|||
16956854|NCT01164579|38099818|FG000|Overall Study|Lack of Efficacy|0|||
16956855|NCT01164579|38099819|FG001|Overall Study|Lack of Efficacy|0|||
16956856|NCT01164579|38099820|FG002|Overall Study|Lack of Efficacy|6|||
16956857|NCT01164579|38099818|FG000|Overall Study|Lost to Follow-up|1|||
16956858|NCT01164579|38099819|FG001|Overall Study|Lost to Follow-up|1|||
16956859|NCT01164579|38099820|FG002|Overall Study|Lost to Follow-up|0|||
16956860|NCT01164579|38099818|FG000|Overall Study|Withdrawal by Subject|2|||
16956861|NCT01164579|38099819|FG001|Overall Study|Withdrawal by Subject|5|||
16956862|NCT01164579|38099820|FG002|Overall Study|Withdrawal by Subject|3|||
16956863|NCT01164579|38099818|FG000|Overall Study|Protocol Violation|0|||
16956864|NCT01164579|38099819|FG001|Overall Study|Protocol Violation|1|||
16956865|NCT01164579|38099820|FG002|Overall Study|Protocol Violation|2|||
16956866|NCT01164579|38099818|FG000|Overall Study|Adverse Event|4|||
16956867|NCT01164579|38099819|FG001|Overall Study|Adverse Event|2|||
16956868|NCT01164579|38099820|FG002|Overall Study|Adverse Event|5|||
16956869|NCT01164579|38099818|FG000|Overall Study|Reason not specified|1|||
16956870|NCT01164579|38099819|FG001|Overall Study|Reason not specified|0|||
16956871|NCT01164579|38099820|FG002|Overall Study|Reason not specified|0|||
16956872|NCT00958789|38099829|FG000|Overall Study|Death|5|||
16956873|NCT00958789|38099829|FG000|Overall Study|Lost to Follow-up|14|||
16956874|NCT00958789|38099829|FG000|Overall Study|Withdrawal by Subject|17|||
16956875|NCT00958789|38099829|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
16956876|NCT00958789|38099829|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
16956877|NCT00958789|38099829|FG000|Overall Study|Subject terminated|2|||
16956878|NCT00958789|38099829|FG000|Overall Study|Revision|7|||
16956879|NCT02445391|38099840|FG000|Overall Study|No active protocol treatment|3|||
16956880|NCT02445391|38099841|FG001|Overall Study|No active protocol treatment|0|||
16956881|NCT02445391|38099842|FG002|Overall Study|No active protocol treatment|0|||
16956882|NCT02445391|38099840|FG000|Overall Study|Adverse Event|0|||
16956883|NCT02445391|38099841|FG001|Overall Study|Adverse Event|21|||
16956884|NCT02445391|38099842|FG002|Overall Study|Adverse Event|12|||
16956885|NCT02445391|38099840|FG000|Overall Study|Alternative therapy|0|||
16956886|NCT02445391|38099841|FG001|Overall Study|Alternative therapy|0|||
16956887|NCT02445391|38099842|FG002|Overall Study|Alternative therapy|1|||
17130256|NCT03679767|38271573|FG000|Overall Study|Withdrawal by Subject|0|||
17130257|NCT03679767|38271574|FG001|Overall Study|Withdrawal by Subject|0|||
17130258|NCT03679767|38271575|FG002|Overall Study|Withdrawal by Subject|0|||
17130259|NCT03679767|38271576|FG003|Overall Study|Withdrawal by Subject|1|||
17130260|NCT03679767|38271573|FG000|Overall Study|Follow-up Completed|4|||
17130261|NCT03679767|38271574|FG001|Overall Study|Follow-up Completed|1|||
17130262|NCT03679767|38271575|FG002|Overall Study|Follow-up Completed|3|||
17130263|NCT03679767|38271576|FG003|Overall Study|Follow-up Completed|5|||
17130264|NCT03679767|38271573|FG000|Overall Study|Ongoing|14|||
17130265|NCT03679767|38271574|FG001|Overall Study|Ongoing|12|||
17130266|NCT03679767|38271575|FG002|Overall Study|Ongoing|9|||
17130267|NCT03679767|38271576|FG003|Overall Study|Ongoing|17|||
17130268|NCT00130247|38271590|FG000|Overall Study|Pregnancy|1|||
17130269|NCT00130247|38271591|FG001|Overall Study|Pregnancy|0|||
17130270|NCT00130247|38271590|FG000|Overall Study|Post-randomization exclusion|1|||
17130271|NCT00130247|38271591|FG001|Overall Study|Post-randomization exclusion|2|||
17130272|NCT00130247|38271590|FG000|Overall Study|Not compliant with DOT|0|||
17130273|NCT00130247|38271591|FG001|Overall Study|Not compliant with DOT|2|||
16956888|NCT02445391|38099840|FG000|Overall Study|Disease progression|0|||
16956889|NCT02445391|38099841|FG001|Overall Study|Disease progression|7|||
16956890|NCT02445391|38099842|FG002|Overall Study|Disease progression|22|||
16956891|NCT02445391|38099840|FG000|Overall Study|Complicating disease|0|||
16956892|NCT02445391|38099841|FG001|Overall Study|Complicating disease|2|||
16956893|NCT02445391|38099842|FG002|Overall Study|Complicating disease|1|||
16956894|NCT02445391|38099840|FG000|Overall Study|Withdrawal by Subject|0|||
17130274|NCT03678285|38271597|FG000|Overall Study|Adverse Event|2|||
17130275|NCT03678285|38271597|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
17130276|NCT03678285|38271597|FG000|Overall Study|Dehydrated prior to start of workout|1|||
17130277|NCT04032171|38271603|FG000|Overall Study|Study Termination|1|||
17130278|NCT04032171|38271604|FG001|Overall Study|Study Termination|0|||
17130279|NCT00137423|38271612|FG000|Overall Study|Adverse Event|7|||
17130280|NCT00137423|38271613|FG001|Overall Study|Adverse Event|9|||
17130281|NCT00137423|38271612|FG000|Overall Study|consent withdrawn|1|||
17130282|NCT00137423|38271613|FG001|Overall Study|consent withdrawn|1|||
17130283|NCT00137423|38271612|FG000|Overall Study|Lack of Efficacy|31|||
17130284|NCT00137423|38271613|FG001|Overall Study|Lack of Efficacy|33|||
17130285|NCT00137423|38271612|FG000|Overall Study|Death|0|||
17130286|NCT00137423|38271613|FG001|Overall Study|Death|1|||
17130287|NCT02786836|38271623|FG000|Overall Study|Death|1|||
17130288|NCT02786836|38271623|FG000|Overall Study|Lack of Efficacy|2|||
17130289|NCT02786836|38271623|FG000|Overall Study|Protocol Violation|3|||
17130290|NCT02786836|38271623|FG000|Overall Study|Withdrawal by Subject|3|||
17130291|NCT02786836|38271623|FG000|Overall Study|Liver Transplantation|2|||
17130292|NCT02786836|38271623|FG000|Overall Study|Device or Pharmacy Issues|3|||
17130293|NCT00129935|38271630|FG000|Overall Study|Adverse Event|18|||
17130294|NCT00129935|38271631|FG001|Overall Study|Adverse Event|56|||
17130295|NCT00129935|38271630|FG000|Overall Study|Death|1|||
17130296|NCT00129935|38271631|FG001|Overall Study|Death|1|||
17130297|NCT00129935|38271630|FG000|Overall Study|Withdrawal by Subject|7|||
17130298|NCT00129935|38271631|FG001|Overall Study|Withdrawal by Subject|20|||
17130299|NCT00129935|38271630|FG000|Overall Study|Protocol Violation|0|||
17130300|NCT00129935|38271631|FG001|Overall Study|Protocol Violation|4|||
17130301|NCT00129935|38271630|FG000|Overall Study|Physician Decision|3|||
17130302|NCT00129935|38271631|FG001|Overall Study|Physician Decision|4|||
17130303|NCT00129935|38271630|FG000|Overall Study|Recurrence|1|||
17130304|NCT00129935|38271631|FG001|Overall Study|Recurrence|3|||
17130305|NCT00129935|38271630|FG000|Overall Study|Second primary|0|||
17130306|NCT00129935|38271631|FG001|Overall Study|Second primary|1|||
17130307|NCT00129935|38271630|FG000|Overall Study|Other|3|||
17130308|NCT00129935|38271631|FG001|Overall Study|Other|2|||
17130309|NCT00129935|38271630|FG000|Overall Study|Crossed to the other arm|2|||
17130310|NCT00129935|38271631|FG001|Overall Study|Crossed to the other arm|1|||
17130311|NCT00129935|38271630|FG000|Overall Study|Incorrect study treatment|1|||
16956895|NCT02445391|38099841|FG001|Overall Study|Withdrawal by Subject|4|||
16956896|NCT02445391|38099842|FG002|Overall Study|Withdrawal by Subject|9|||
16956897|NCT02445391|38099840|FG000|Overall Study|Financial issue|0|||
16956898|NCT02445391|38099841|FG001|Overall Study|Financial issue|0|||
16956899|NCT02445391|38099842|FG002|Overall Study|Financial issue|2|||
16956900|NCT02445391|38099840|FG000|Overall Study|Still on treatment|0|||
16956901|NCT02445391|38099841|FG001|Overall Study|Still on treatment|7|||
16956902|NCT02445391|38099842|FG002|Overall Study|Still on treatment|16|||
16956903|NCT02445391|38099840|FG000|Overall Study|Not start protocol therapy|0|||
16956904|NCT02445391|38099841|FG001|Overall Study|Not start protocol therapy|12|||
16956905|NCT02445391|38099842|FG002|Overall Study|Not start protocol therapy|9|||
16956906|NCT01246986|38099858|FG000|Overall Study|Lost to Follow-up|0|||
16956907|NCT01246986|38099859|FG001|Overall Study|Lost to Follow-up|1|||
16956908|NCT01246986|38099860|FG002|Overall Study|Lost to Follow-up|3|||
16956909|NCT01246986|38099861|FG003|Overall Study|Lost to Follow-up|0|||
16956910|NCT01246986|38099862|FG004|Overall Study|Lost to Follow-up|0|||
16956911|NCT01246986|38099863|FG005|Overall Study|Lost to Follow-up|1|||
16956912|NCT01246986|38099864|FG006|Overall Study|Lost to Follow-up|0|||
16956913|NCT01246986|38099858|FG000|Overall Study|Withdrawal by Subject|3|||
16956914|NCT01246986|38099859|FG001|Overall Study|Withdrawal by Subject|4|||
16956915|NCT01246986|38099860|FG002|Overall Study|Withdrawal by Subject|3|||
16956916|NCT01246986|38099861|FG003|Overall Study|Withdrawal by Subject|0|||
17130312|NCT00129935|38271631|FG001|Overall Study|Incorrect study treatment|0|||
17130313|NCT00137267|38271639|FG000|Overall Study|Lost to Follow-up|15|||
17130314|NCT00137267|38271640|FG001|Overall Study|Lost to Follow-up|21|||
17130315|NCT00137111|38271650|FG000|Total Therapy|Death|35|||
17130316|NCT00137111|38271651|FG001|Total Therapy|Death|0|||
17130317|NCT00137111|38271652|FG002|Total Therapy|Death|0|||
17130318|NCT00137111|38271653|FG003|Total Therapy|Death|0|||
17130319|NCT00137111|38271650|FG000|Total Therapy|Non Compliance|5|||
17130320|NCT00137111|38271651|FG001|Total Therapy|Non Compliance|0|||
17130321|NCT00137111|38271652|FG002|Total Therapy|Non Compliance|0|||
17130322|NCT00137111|38271653|FG003|Total Therapy|Non Compliance|0|||
17130323|NCT00136955|38271660|FG000|Overall Study|Adverse Event|8|||
17130324|NCT00136955|38271660|FG000|Overall Study|Lost to Follow-up|1|||
17130325|NCT00136955|38271660|FG000|Overall Study|Withdrawal by Subject|2|||
17130326|NCT00136955|38271660|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
17130327|NCT00135707|38271666|FG000|Overall Study|Lost to Follow-up|94|||
17130328|NCT00135707|38271667|FG001|Overall Study|Lost to Follow-up|89|||
17130329|NCT00135707|38271666|FG000|Overall Study|Withdrawal by Subject|0|||
17130330|NCT00135707|38271667|FG001|Overall Study|Withdrawal by Subject|1|||
17130331|NCT00135707|38271666|FG000|Overall Study|Institutional review board request|1|||
17130332|NCT00135707|38271667|FG001|Overall Study|Institutional review board request|0|||
17130333|NCT00129701|38271677|FG000|Overall Study|Withdrawal by Subject|33|||
17130334|NCT00129623|38271686|FG000|Overall Study|Adverse Event|3|||
17130335|NCT00129623|38271687|FG001|Overall Study|Adverse Event|7|||
17130336|NCT00129623|38271686|FG000|Overall Study|Refused Treatment|5|||
17130337|NCT00129623|38271687|FG001|Overall Study|Refused Treatment|3|||
17130338|NCT00129623|38271686|FG000|Overall Study|Failure to Return|1|||
17130339|NCT00129623|38271687|FG001|Overall Study|Failure to Return|1|||
17130340|NCT00129623|38271686|FG000|Overall Study|Relocated job out of state|1|||
17130341|NCT00129623|38271687|FG001|Overall Study|Relocated job out of state|0|||
17130342|NCT00129623|38271686|FG000|Overall Study|Uncertainty to return|0|||
17130343|NCT00129623|38271687|FG001|Overall Study|Uncertainty to return|1|||
17130344|NCT00129545|38271698|FG000|Overall Study|Death|5|||
17130345|NCT00129545|38271699|FG001|Overall Study|Death|60|||
17130346|NCT00129545|38271700|FG002|Overall Study|Death|44|||
17130347|NCT00129545|38271698|FG000|Overall Study|Withdrawal by Subject|3|||
17130348|NCT00129545|38271699|FG001|Overall Study|Withdrawal by Subject|18|||
17130349|NCT00129545|38271700|FG002|Overall Study|Withdrawal by Subject|44|||
17130350|NCT00129545|38271698|FG000|Overall Study|Lost to Follow-up|2|||
17130351|NCT00129545|38271699|FG001|Overall Study|Lost to Follow-up|22|||
17130352|NCT00129545|38271700|FG002|Overall Study|Lost to Follow-up|13|||
17130353|NCT00129545|38271698|FG000|Overall Study|Physician Decision|0|||
17130354|NCT00129545|38271699|FG001|Overall Study|Physician Decision|3|||
17130355|NCT00129545|38271700|FG002|Overall Study|Physician Decision|10|||
17130356|NCT00129545|38271698|FG000|Overall Study|Device not implanted|16|||
17130357|NCT00129545|38271699|FG001|Overall Study|Device not implanted|61|||
17130358|NCT00129545|38271700|FG002|Overall Study|Device not implanted|0|||
17130359|NCT00129467|38271710|FG000|Received Intervention|Death|1|||
17130360|NCT00129467|38271711|FG001|Received Intervention|Death|1|||
17130361|NCT00129467|38271710|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
17130362|NCT00129467|38271711|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
17130363|NCT00129467|38271710|FG000|Received Intervention|Delirium|2|||
17130364|NCT00129467|38271711|FG001|Received Intervention|Delirium|0|||
17130365|NCT00129467|38271710|FG000|Received Intervention|Withdrawal by Subject|1|||
17130366|NCT00129467|38271711|FG001|Received Intervention|Withdrawal by Subject|0|||
17130367|NCT00129467|38271710|FG000|Received Intervention|Nausea|1|||
17130368|NCT00129467|38271711|FG001|Received Intervention|Nausea|0|||
17130369|NCT00129467|38271710|FG000|Received Intervention|Intolerance to citalopram|0|||
17130370|NCT00129467|38271711|FG001|Received Intervention|Intolerance to citalopram|1|||
17130371|NCT00129467|38271710|FG000|Received Intervention|Dizzyness, fatigue|0|||
17130372|NCT00129467|38271711|FG001|Received Intervention|Dizzyness, fatigue|1|||
17130373|NCT00129467|38271710|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
17130374|NCT00129467|38271711|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
17130375|NCT00129467|38271710|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
17130376|NCT00129467|38271711|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
17130377|NCT00129311|38271719|FG000|Overall Study|Withdrawal by Subject|12|||
17130378|NCT00129311|38271720|FG001|Overall Study|Withdrawal by Subject|19|||
17130379|NCT00133991|38271726|FG000|Overall Study|Death|4|||
17130380|NCT02784106|38271732|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
17130381|NCT02784106|38271733|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
17130382|NCT02784106|38271734|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
17130383|NCT02784106|38271735|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
17130384|NCT02784106|38271732|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
17130385|NCT02784106|38271733|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
17130386|NCT02784106|38271734|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
17130387|NCT02784106|38271735|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
17130388|NCT02784106|38271732|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
17130389|NCT02784106|38271733|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
17130390|NCT02784106|38271734|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
17130391|NCT02784106|38271735|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
17130392|NCT02784106|38271732|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
17130393|NCT02784106|38271733|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
17130394|NCT02784106|38271734|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
17130395|NCT02784106|38271735|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
17130396|NCT02784106|38271732|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
17130397|NCT02784106|38271733|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
17130398|NCT02784106|38271734|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
17130399|NCT02784106|38271735|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
17130400|NCT02784106|38271732|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
17130401|NCT02784106|38271733|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
17130402|NCT02784106|38271734|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
17130403|NCT02784106|38271735|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
17130404|NCT02785900|38271746|FG000|Overall Study|Study Termination by Sponsor|64|||
17130405|NCT02785900|38271747|FG001|Overall Study|Study Termination by Sponsor|81|||
17130406|NCT02785900|38271746|FG000|Overall Study|Death|46|||
17130407|NCT02785900|38271747|FG001|Overall Study|Death|32|||
17130408|NCT02785900|38271746|FG000|Overall Study|Withdrawal by Subject|4|||
17130409|NCT02785900|38271747|FG001|Overall Study|Withdrawal by Subject|8|||
17130410|NCT02785900|38271746|FG000|Overall Study|Physician Decision|3|||
17130411|NCT02785900|38271747|FG001|Overall Study|Physician Decision|2|||
17130412|NCT00127205|38271756|FG000|Overall Study|Adverse Event|228|||
17130413|NCT00127205|38271757|FG001|Overall Study|Adverse Event|387|||
17130414|NCT00127205|38271758|FG002|Overall Study|Adverse Event|273|||
17130415|NCT00127205|38271756|FG000|Overall Study|Death|8|||
17130416|NCT00127205|38271757|FG001|Overall Study|Death|6|||
17130417|NCT00127205|38271758|FG002|Overall Study|Death|5|||
17130418|NCT00127205|38271756|FG000|Overall Study|Withdrawal by Subject|318|||
17130419|NCT00127205|38271757|FG001|Overall Study|Withdrawal by Subject|310|||
17130420|NCT00127205|38271758|FG002|Overall Study|Withdrawal by Subject|172|||
17130421|NCT00127205|38271756|FG000|Overall Study|Other-non protocol specified|142|||
17130422|NCT00127205|38271757|FG001|Overall Study|Other-non protocol specified|129|||
17130423|NCT00127205|38271758|FG002|Overall Study|Other-non protocol specified|77|||
17130424|NCT00127205|38271756|FG000|Overall Study|Data not reported|6|||
17130425|NCT00127205|38271757|FG001|Overall Study|Data not reported|10|||
17130426|NCT00127205|38271758|FG002|Overall Study|Data not reported|1|||
17130427|NCT00127205|38271756|FG000|Overall Study|Progression|127|||
17130428|NCT00127205|38271757|FG001|Overall Study|Progression|131|||
17130429|NCT00127205|38271758|FG002|Overall Study|Progression|84|||
17130430|NCT02785588|38271768|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
17130431|NCT02785588|38271768|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
17130432|NCT03670641|38271772|FG000|Overall Study|Lost to Follow-up|3|||
17130433|NCT04029519|38271779|FG000|Overall Study|Protocol Violation|1|||
17130434|NCT04029519|38271779|FG000|Overall Study|Withdrawal by Subject|3|||
17130435|NCT04029519|38271779|FG000|Overall Study|Lost to Follow-up|1|||
17130436|NCT03669861|38271783|FG000|Overall Study|Disease Flare|5|||
17130437|NCT03669861|38271783|FG000|Overall Study|Lack of Efficacy|2|||
17130438|NCT00127127|38271791|FG000|Overall Study|Adverse Event|0|||
17130439|NCT00127127|38271792|FG001|Overall Study|Adverse Event|2|||
17130440|NCT00127127|38271793|FG002|Overall Study|Adverse Event|0|||
17130441|NCT00127127|38271794|FG003|Overall Study|Adverse Event|1|||
17130442|NCT00127127|38271791|FG000|Overall Study|Lack of Efficacy|1|||
17130443|NCT00127127|38271792|FG001|Overall Study|Lack of Efficacy|3|||
17130444|NCT00127127|38271793|FG002|Overall Study|Lack of Efficacy|0|||
17130445|NCT00127127|38271794|FG003|Overall Study|Lack of Efficacy|2|||
17130446|NCT03669549|38271831|FG000|Overall Study|Adverse Event|4|||
17130447|NCT03669549|38271831|FG000|Overall Study|Withdrawal by Subject|1|||
17130448|NCT03669549|38271831|FG000|Overall Study|Study terminated by the Sponsor|1|||
17130449|NCT00126659|38271842|FG000|Overall Study|Adverse Event|0|||
17130450|NCT00126659|38271843|FG001|Overall Study|Adverse Event|0|||
17130451|NCT00126659|38271844|FG002|Overall Study|Adverse Event|2|||
17130452|NCT04022733|38271852|FG000|Overall Study|conversion to open surgery|3|||
17130453|NCT04022733|38271853|FG001|Overall Study|conversion to open surgery|2|||
17130454|NCT04022733|38271852|FG000|Overall Study|bradycardia|0|||
17130455|NCT04022733|38271853|FG001|Overall Study|bradycardia|1|||
17130456|NCT03669081|38271861|FG000|Overall Study|Data could not be validated|1|||
17130457|NCT03669081|38271862|FG001|Overall Study|Data could not be validated|1|||
17130458|NCT03667053|38271871|FG000|Overall Study|Withdrawal by Subject|1|||
17130459|NCT03667053|38271872|FG001|Overall Study|Withdrawal by Subject|0|||
17130460|NCT03667053|38271873|FG002|Overall Study|Withdrawal by Subject|0|||
17130461|NCT03631407|38271890|FG000|Overall Study|Withdrawal by Subject|3|||
17130462|NCT03631407|38271891|FG001|Overall Study|Withdrawal by Subject|2|||
17130463|NCT03631407|38271890|FG000|Overall Study|Sponsor Decision|0|||
17130464|NCT03631407|38271891|FG001|Overall Study|Sponsor Decision|2|||
17130465|NCT03631407|38271890|FG000|Overall Study|Death|16|||
17130466|NCT03631407|38271891|FG001|Overall Study|Death|16|||
17130467|NCT03631407|38271890|FG000|Overall Study|Randomized by mistake without study treatment|1|||
17130468|NCT03631407|38271891|FG001|Overall Study|Randomized by mistake without study treatment|0|||
17130469|NCT03630393|38271908|FG000|Overall Study|Death|1|||
17130470|NCT03630393|38271909|FG001|Overall Study|Death|0|||
17130471|NCT03628599|38271926|FG000|Overall Study|Adverse Event|0|||
17130472|NCT03628599|38271927|FG001|Overall Study|Adverse Event|1|||
17130473|NCT03627195|38271953|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
17130474|NCT03627195|38271954|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
17130475|NCT03627195|38271955|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
17130476|NCT03627195|38271956|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
17130477|NCT03627195|38271957|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
17130478|NCT03627195|38271958|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
17130479|NCT00126581|38271974|FG000|Overall Study|Adverse Event|3|||
17130480|NCT00126581|38271975|FG001|Overall Study|Adverse Event|7|||
17130481|NCT00126581|38271974|FG000|Overall Study|Death|3|||
17130482|NCT00126581|38271975|FG001|Overall Study|Death|2|||
17130483|NCT00126581|38271974|FG000|Overall Study|Withdrawal by Subject|1|||
17130484|NCT00126581|38271975|FG001|Overall Study|Withdrawal by Subject|4|||
17130485|NCT00126581|38271974|FG000|Overall Study|Alternative therapy|3|||
17130486|NCT00126581|38271975|FG001|Overall Study|Alternative therapy|3|||
17130487|NCT00126581|38271974|FG000|Overall Study|Other illness/MD discretion|3|||
17130488|NCT00126581|38271975|FG001|Overall Study|Other illness/MD discretion|4|||
17130489|NCT03704584|38271985|FG000|Overall Study|Withdrawal by Subject|1|||
17130490|NCT03704584|38271986|FG001|Overall Study|Withdrawal by Subject|0|||
17130491|NCT03662997|38271996|FG000|Overall Study|Adverse Event|0|||
17130492|NCT03662997|38271997|FG001|Overall Study|Adverse Event|2|||
17130493|NCT03662997|38271998|FG002|Overall Study|Adverse Event|0|||
17130494|NCT03662997|38271999|FG003|Overall Study|Adverse Event|0|||
17130495|NCT03648879|38272011|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
17130496|NCT03647709|38272015|FG000|Overall Study|Lost to Follow-up|5|||
17130497|NCT03647709|38272015|FG000|Overall Study|Physician Decision|6|||
17130498|NCT03647709|38272015|FG000|Overall Study|Withdrawal by Subject|3|||
17130499|NCT03661983|38272021|FG000|Open Label Stabilization Phase|Adverse Event|5|||
17130500|NCT03661983|38272022|FG001|Open Label Stabilization Phase|Adverse Event|0|||
17130501|NCT03661983|38272023|FG002|Open Label Stabilization Phase|Adverse Event|0|||
17130502|NCT03661983|38272024|FG003|Open Label Stabilization Phase|Adverse Event|0|||
17130503|NCT03661983|38272021|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
17130504|NCT03661983|38272022|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
17130505|NCT03661983|38272023|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
17130506|NCT03661983|38272024|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
17130507|NCT03661983|38272021|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
17130508|NCT03661983|38272022|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
17130509|NCT03661983|38272023|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
17130510|NCT03661983|38272024|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
17130511|NCT03661983|38272021|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
17130512|NCT03661983|38272022|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
17130513|NCT03661983|38272023|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
17130514|NCT03661983|38272024|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
17130515|NCT03661983|38272021|FG000|Double-blind Randomized Phase|Adverse Event|0|||
17130516|NCT03661983|38272022|FG001|Double-blind Randomized Phase|Adverse Event|1|||
17130517|NCT03661983|38272023|FG002|Double-blind Randomized Phase|Adverse Event|0|||
17130518|NCT03661983|38272024|FG003|Double-blind Randomized Phase|Adverse Event|0|||
17130519|NCT03661983|38272021|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
17130520|NCT03661983|38272022|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
17130521|NCT03661983|38272023|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
17130522|NCT03661983|38272024|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
17130523|NCT03661983|38272021|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
17130524|NCT03661983|38272022|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
17130525|NCT03661983|38272023|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
17130526|NCT03661983|38272024|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
17130527|NCT03661983|38272021|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
17130528|NCT03661983|38272022|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
17130529|NCT03661983|38272023|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
17130530|NCT03661983|38272024|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
17130531|NCT02783170|38272035|FG000|Overall Study|Randomized but not Vaccinated|1|||
17130532|NCT02783170|38272036|FG001|Overall Study|Randomized but not Vaccinated|0|||
17130533|NCT03646305|38272047|FG000|Overall Study|Lost to Follow-up|4|||
17130534|NCT03646305|38272048|FG001|Overall Study|Lost to Follow-up|2|||
17130535|NCT03646305|38272049|FG002|Overall Study|Lost to Follow-up|2|||
17130536|NCT03646305|38272050|FG003|Overall Study|Lost to Follow-up|1|||
17130537|NCT03646305|38272047|FG000|Overall Study|Withdrawal by Subject|1|||
17130538|NCT03646305|38272048|FG001|Overall Study|Withdrawal by Subject|0|||
17130539|NCT03646305|38272049|FG002|Overall Study|Withdrawal by Subject|0|||
17130540|NCT03646305|38272050|FG003|Overall Study|Withdrawal by Subject|1|||
17130541|NCT02782780|38272066|FG000|Overall Study|dropped out after randomization.|7|||
17130542|NCT02782780|38272067|FG001|Overall Study|dropped out after randomization.|5|||
17130543|NCT02782780|38272066|FG000|Overall Study|Protocol Violation|0|||
17130544|NCT02782780|38272067|FG001|Overall Study|Protocol Violation|2|||
17130545|NCT00126503|38272079|FG000|Overall Study|disease progression|23|||
17130546|NCT00126503|38272080|FG001|Overall Study|disease progression|14|||
17130547|NCT00126503|38272079|FG000|Overall Study|Withdrawal by Subject|0|||
17130548|NCT00126503|38272080|FG001|Overall Study|Withdrawal by Subject|1|||
17130549|NCT00126503|38272079|FG000|Overall Study|alternative therapy|1|||
17130550|NCT00126503|38272080|FG001|Overall Study|alternative therapy|1|||
17130551|NCT00126503|38272079|FG000|Overall Study|other complicating disease|4|||
17130552|NCT00126503|38272080|FG001|Overall Study|other complicating disease|1|||
17130553|NCT00126503|38272079|FG000|Overall Study|Death|3|||
17130554|NCT00126503|38272080|FG001|Overall Study|Death|0|||
17130555|NCT00126503|38272079|FG000|Overall Study|Adverse Event|13|||
17130556|NCT00126503|38272080|FG001|Overall Study|Adverse Event|3|||
17130557|NCT00126503|38272079|FG000|Overall Study|non-compliant|1|||
17130558|NCT00126503|38272080|FG001|Overall Study|non-compliant|0|||
17130559|NCT00126503|38272079|FG000|Overall Study|Physician Decision|2|||
17130560|NCT00126503|38272080|FG001|Overall Study|Physician Decision|1|||
17130561|NCT00126425|38272092|FG000|Overall Study|Withdrawal by Subject|17|||
17130562|NCT00126425|38272093|FG001|Overall Study|Withdrawal by Subject|1|||
17130563|NCT00126425|38272092|FG000|Overall Study|Lost to Follow-up|8|||
17130564|NCT00126425|38272093|FG001|Overall Study|Lost to Follow-up|4|||
17130565|NCT00126425|38272092|FG000|Overall Study|Protocol Violation|9|||
17130566|NCT00126425|38272093|FG001|Overall Study|Protocol Violation|6|||
17130567|NCT00126425|38272092|FG000|Overall Study|Adverse Event|1|||
17130568|NCT00126425|38272093|FG001|Overall Study|Adverse Event|0|||
17130569|NCT00126425|38272092|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
17130570|NCT00126425|38272093|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
17130571|NCT00126425|38272092|FG000|Overall Study|Other|5|||
17130572|NCT00126425|38272093|FG001|Overall Study|Other|0|||
17130573|NCT00126191|38272101|FG000|Overall Study|Physician Decision|0|||
17130574|NCT00126191|38272102|FG001|Overall Study|Physician Decision|1|||
17130575|NCT00126191|38272101|FG000|Overall Study|Death|0|||
17130576|NCT00126191|38272102|FG001|Overall Study|Death|1|||
17130577|NCT03248128|38272110|FG000|Overall Study|Lost to Follow-up|1|||
17130578|NCT03248128|38272111|FG001|Overall Study|Lost to Follow-up|0|||
17130579|NCT03248128|38272110|FG000|Overall Study|Withdrawal by Subject|16|||
17130580|NCT03248128|38272111|FG001|Overall Study|Withdrawal by Subject|14|||
17130581|NCT03248128|38272110|FG000|Overall Study|Site Closed|4|||
17130582|NCT03248128|38272111|FG001|Overall Study|Site Closed|3|||
17130583|NCT03248128|38272110|FG000|Overall Study|Randomized, but did not receive treatment|1|||
17130584|NCT03248128|38272111|FG001|Overall Study|Randomized, but did not receive treatment|3|||
17130585|NCT00124943|38272124|FG000|Phase II|Adverse Event|0|||
17130586|NCT00124943|38272125|FG001|Phase II|Adverse Event|2|||
17130587|NCT00124943|38272126|FG002|Phase II|Adverse Event|0|||
17130588|NCT00124943|38272127|FG003|Phase II|Adverse Event|1|||
16956917|NCT01246986|38099862|FG004|Overall Study|Withdrawal by Subject|4|||
16956918|NCT01246986|38099863|FG005|Overall Study|Withdrawal by Subject|0|||
17130589|NCT00124943|38272124|FG000|Phase II|Protocol Violation|0|||
17130590|NCT00124943|38272125|FG001|Phase II|Protocol Violation|0|||
17130591|NCT00124943|38272126|FG002|Phase II|Protocol Violation|0|||
17130592|NCT00124943|38272127|FG003|Phase II|Protocol Violation|1|||
17130593|NCT00124943|38272124|FG000|Phase II|Lost to Follow-up|0|||
17130594|NCT00124943|38272125|FG001|Phase II|Lost to Follow-up|0|||
17130595|NCT00124943|38272126|FG002|Phase II|Lost to Follow-up|0|||
17130596|NCT00124943|38272127|FG003|Phase II|Lost to Follow-up|1|||
17130597|NCT00124943|38272124|FG000|Phase II|Withdrawal by Subject|0|||
17130598|NCT00124943|38272125|FG001|Phase II|Withdrawal by Subject|0|||
17130599|NCT00124943|38272126|FG002|Phase II|Withdrawal by Subject|0|||
17130600|NCT00124943|38272127|FG003|Phase II|Withdrawal by Subject|2|||
17130601|NCT00124709|38272139|FG000|Overall Study|Randomized but did not take medication|3|||
17130602|NCT00124709|38272140|FG001|Overall Study|Randomized but did not take medication|1|||
17130603|NCT00124709|38272139|FG000|Overall Study|Adverse Event|3|||
17130604|NCT00124709|38272140|FG001|Overall Study|Adverse Event|0|||
17130605|NCT00124709|38272139|FG000|Overall Study|Lack of Efficacy|5|||
17130606|NCT00124709|38272140|FG001|Overall Study|Lack of Efficacy|10|||
17130607|NCT00124709|38272139|FG000|Overall Study|Protocol Violation|3|||
17130608|NCT00124709|38272140|FG001|Overall Study|Protocol Violation|5|||
17130609|NCT00124709|38272139|FG000|Overall Study|Withdrawal by Subject|127|||
17130610|NCT00124709|38272140|FG001|Overall Study|Withdrawal by Subject|136|||
17130611|NCT00124709|38272139|FG000|Overall Study|Lost to Follow-up|114|||
17130612|NCT00124709|38272140|FG001|Overall Study|Lost to Follow-up|120|||
17130613|NCT00108862|38272148|FG000|Overall Study|Death|31|||
17130614|NCT00108862|38272149|FG001|Overall Study|Death|37|||
17130615|NCT00108862|38272148|FG000|Overall Study|Withdrawal by Subject|10|||
17130616|NCT00108862|38272149|FG001|Overall Study|Withdrawal by Subject|6|||
17130617|NCT00108862|38272148|FG000|Overall Study|Lost to Follow-up|27|||
17130618|NCT00108862|38272149|FG001|Overall Study|Lost to Follow-up|19|||
17130619|NCT00564850|38272155|FG000|Overall Study|Protocol Violation|2|||
17130620|NCT00561340|38272161|FG000|Overall Study|refused to drink pediasure|6|||
17130621|NCT00561340|38272162|FG001|Overall Study|refused to drink pediasure|0|||
17130622|NCT00108628|38272170|FG000|Overall Study|Withdrawal by Subject|17|||
17130623|NCT00108628|38272171|FG001|Overall Study|Withdrawal by Subject|9|||
17130624|NCT00108628|38272170|FG000|Overall Study|Lack of Efficacy|2|||
17130625|NCT00108628|38272171|FG001|Overall Study|Lack of Efficacy|1|||
17130626|NCT00108628|38272170|FG000|Overall Study|Death|1|||
17130627|NCT00108628|38272171|FG001|Overall Study|Death|0|||
17130628|NCT02715856|38272179|FG000|Overall Study|Software Issues|12|||
17130629|NCT02715856|38272180|FG001|Overall Study|Software Issues|7|||
17130630|NCT02715856|38272179|FG000|Overall Study|Death|6|||
17130631|NCT02715856|38272180|FG001|Overall Study|Death|5|||
17130632|NCT02715856|38272179|FG000|Overall Study|Non- Compliant|0|||
17130633|NCT02715856|38272180|FG001|Overall Study|Non- Compliant|40|||
17130634|NCT00108160|38272188|FG000|Overall Study|Lost to Follow-up|25|||
17130635|NCT00108160|38272189|FG001|Overall Study|Lost to Follow-up|12|||
17028459|NCT00783224|38172828|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
17028460|NCT00783224|38172829|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
17028461|NCT00783224|38172830|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
17028462|NCT00783224|38172831|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
17130636|NCT00108160|38272188|FG000|Overall Study|Death|1|||
17130637|NCT00108160|38272189|FG001|Overall Study|Death|2|||
17130638|NCT00108160|38272188|FG000|Overall Study|Withdrawal by Subject|4|||
17130639|NCT00108160|38272189|FG001|Overall Study|Withdrawal by Subject|2|||
17130640|NCT00108160|38272188|FG000|Overall Study|Protocol Violation|9|||
17130641|NCT00108160|38272189|FG001|Overall Study|Protocol Violation|5|||
17130642|NCT01366846|38272201|FG000|Overall Study|Withdrawal by Subject|2|||
17130643|NCT01366846|38272202|FG001|Overall Study|Withdrawal by Subject|0|||
17130644|NCT01366846|38272203|FG002|Overall Study|Withdrawal by Subject|0|||
17130645|NCT01366846|38272204|FG003|Overall Study|Withdrawal by Subject|0|||
17130646|NCT01366846|38272201|FG000|Overall Study|Communication Difficulties|1|||
17130647|NCT01366846|38272202|FG001|Overall Study|Communication Difficulties|4|||
17130648|NCT01366846|38272203|FG002|Overall Study|Communication Difficulties|0|||
17130649|NCT01366846|38272204|FG003|Overall Study|Communication Difficulties|1|||
17130650|NCT01366846|38272201|FG000|Overall Study|Scheduling Conflicts|0|||
17130651|NCT01366846|38272202|FG001|Overall Study|Scheduling Conflicts|0|||
17130652|NCT01366846|38272203|FG002|Overall Study|Scheduling Conflicts|1|||
17130653|NCT01366846|38272204|FG003|Overall Study|Scheduling Conflicts|0|||
17130654|NCT00108082|38272220|FG000|Overall Study|Adverse Event|14|||
17130655|NCT00108082|38272221|FG001|Overall Study|Adverse Event|12|||
17130656|NCT00108082|38272222|FG002|Overall Study|Adverse Event|17|||
17130657|NCT00108082|38272220|FG000|Overall Study|Lost to Follow-up|6|||
17130658|NCT00108082|38272221|FG001|Overall Study|Lost to Follow-up|3|||
17130659|NCT00108082|38272222|FG002|Overall Study|Lost to Follow-up|7|||
17130660|NCT00108082|38272220|FG000|Overall Study|Consent Withdrawn|3|||
17130661|NCT00108082|38272221|FG001|Overall Study|Consent Withdrawn|3|||
17130662|NCT00108082|38272222|FG002|Overall Study|Consent Withdrawn|5|||
17130663|NCT00108082|38272220|FG000|Overall Study|Protocol Violation|1|||
17130664|NCT00108082|38272221|FG001|Overall Study|Protocol Violation|2|||
17130665|NCT00108082|38272222|FG002|Overall Study|Protocol Violation|0|||
17130666|NCT00108082|38272220|FG000|Overall Study|Lack of Efficacy|3|||
17130667|NCT00108082|38272221|FG001|Overall Study|Lack of Efficacy|1|||
17130668|NCT00108082|38272222|FG002|Overall Study|Lack of Efficacy|2|||
17130669|NCT00108082|38272220|FG000|Overall Study|Amendment 4: > Month 12|5|||
17130670|NCT00108082|38272221|FG001|Overall Study|Amendment 4: > Month 12|7|||
17130671|NCT00108082|38272222|FG002|Overall Study|Amendment 4: > Month 12|5|||
17130672|NCT00108082|38272220|FG000|Overall Study|Woman of Child-bearing Potential|2|||
17130673|NCT00108082|38272221|FG001|Overall Study|Woman of Child-bearing Potential|0|||
17130674|NCT00108082|38272222|FG002|Overall Study|Woman of Child-bearing Potential|2|||
17130675|NCT00108082|38272220|FG000|Overall Study|Incorrectly Randomized|0|||
17130676|NCT00108082|38272221|FG001|Overall Study|Incorrectly Randomized|0|||
17130677|NCT00108082|38272222|FG002|Overall Study|Incorrectly Randomized|2|||
17130678|NCT00108082|38272220|FG000|Overall Study|Non-compliance|1|||
17130679|NCT00108082|38272221|FG001|Overall Study|Non-compliance|0|||
17130680|NCT00108082|38272222|FG002|Overall Study|Non-compliance|2|||
17130681|NCT00108082|38272220|FG000|Overall Study|Stopped Study Medication|0|||
17130682|NCT00108082|38272221|FG001|Overall Study|Stopped Study Medication|0|||
17130683|NCT00108082|38272222|FG002|Overall Study|Stopped Study Medication|1|||
17130684|NCT00108082|38272220|FG000|Overall Study|Site Closed Study|0|||
17130685|NCT00108082|38272221|FG001|Overall Study|Site Closed Study|2|||
17130686|NCT00108082|38272222|FG002|Overall Study|Site Closed Study|0|||
17130687|NCT00108082|38272220|FG000|Overall Study|Protocol Amendment|0|||
17130688|NCT00108082|38272221|FG001|Overall Study|Protocol Amendment|1|||
17130689|NCT00108082|38272222|FG002|Overall Study|Protocol Amendment|0|||
17130690|NCT00108082|38272220|FG000|Overall Study|Study Medication Not Tapered|0|||
17130691|NCT00108082|38272221|FG001|Overall Study|Study Medication Not Tapered|1|||
17130692|NCT00108082|38272222|FG002|Overall Study|Study Medication Not Tapered|0|||
17130693|NCT00108082|38272220|FG000|Overall Study|Subject Left Site Location|1|||
17130694|NCT00108082|38272221|FG001|Overall Study|Subject Left Site Location|0|||
17130695|NCT00108082|38272222|FG002|Overall Study|Subject Left Site Location|0|||
17130696|NCT00108082|38272220|FG000|Overall Study|Investigator Not at Site|1|||
17130697|NCT00108082|38272221|FG001|Overall Study|Investigator Not at Site|0|||
17130698|NCT00108082|38272222|FG002|Overall Study|Investigator Not at Site|0|||
17130699|NCT00108082|38272220|FG000|Overall Study|Blood Pressure Not Controlled|1|||
17130700|NCT00108082|38272221|FG001|Overall Study|Blood Pressure Not Controlled|0|||
17130701|NCT00108082|38272222|FG002|Overall Study|Blood Pressure Not Controlled|0|||
17130702|NCT00104884|38272230|FG000|Overall Study|Disease progression|4|||
17130703|NCT00104728|38272238|FG000|Overall Study|screen failures|19|||
17130704|NCT02781844|38272246|FG000|Treatment Period 1|Adverse Event|0|||
17130705|NCT02781844|38272247|FG001|Treatment Period 1|Adverse Event|0|||
17130706|NCT02781844|38272248|FG002|Treatment Period 1|Adverse Event|0|||
17130707|NCT02781844|38272249|FG003|Treatment Period 1|Adverse Event|0|||
17130708|NCT02781844|38272250|FG004|Treatment Period 1|Adverse Event|0|||
17130709|NCT02781844|38272251|FG005|Treatment Period 1|Adverse Event|1|||
17130710|NCT02781844|38272252|FG006|Treatment Period 1|Adverse Event|0|||
17130711|NCT02781844|38272253|FG007|Treatment Period 1|Adverse Event|0|||
17130712|NCT02775916|38272271|FG000|Overall Study|Adverse Event|1|||
17130713|NCT02775916|38272272|FG001|Overall Study|Adverse Event|0|||
17130714|NCT02775916|38272271|FG000|Overall Study|Subject/Guardian Decision|2|||
17130715|NCT02775916|38272272|FG001|Overall Study|Subject/Guardian Decision|0|||
17130716|NCT03622593|38272281|FG000|Overall Study|Withdrawal by Subject|11|||
17130717|NCT03622593|38272282|FG001|Overall Study|Withdrawal by Subject|9|||
17130718|NCT03622593|38272283|FG002|Overall Study|Withdrawal by Subject|13|||
17130719|NCT03622593|38272281|FG000|Overall Study|Death|12|||
17130720|NCT03622593|38272282|FG001|Overall Study|Death|9|||
17130721|NCT03622593|38272283|FG002|Overall Study|Death|10|||
17130722|NCT03622593|38272281|FG000|Overall Study|Lost to Follow-up|11|||
17130723|NCT03622593|38272282|FG001|Overall Study|Lost to Follow-up|5|||
17130724|NCT03622593|38272283|FG002|Overall Study|Lost to Follow-up|8|||
17130725|NCT03622593|38272281|FG000|Overall Study|Adverse Event|4|||
17130726|NCT03622593|38272282|FG001|Overall Study|Adverse Event|5|||
17130727|NCT03622593|38272283|FG002|Overall Study|Adverse Event|6|||
17130728|NCT03622593|38272281|FG000|Overall Study|Physician Decision|2|||
17130729|NCT03622593|38272282|FG001|Overall Study|Physician Decision|1|||
17130730|NCT03622593|38272283|FG002|Overall Study|Physician Decision|6|||
17130731|NCT03622593|38272281|FG000|Overall Study|Other|2|||
17130732|NCT03622593|38272282|FG001|Overall Study|Other|2|||
17130733|NCT03622593|38272283|FG002|Overall Study|Other|3|||
17130734|NCT03622593|38272281|FG000|Overall Study|Protocol Violation|0|||
17130735|NCT03622593|38272282|FG001|Overall Study|Protocol Violation|0|||
17130736|NCT03622593|38272283|FG002|Overall Study|Protocol Violation|1|||
17130737|NCT03622593|38272281|FG000|Overall Study|Pregnancy|0|||
17130738|NCT03622593|38272282|FG001|Overall Study|Pregnancy|0|||
17130739|NCT03622593|38272283|FG002|Overall Study|Pregnancy|1|||
17130740|NCT00122681|38272294|FG000|Overall Study|Adverse Event|20|||
17130741|NCT00122681|38272295|FG001|Overall Study|Adverse Event|16|||
17130742|NCT00122681|38272294|FG000|Overall Study|Lost to Follow-up|1080|||
17130743|NCT00122681|38272295|FG001|Overall Study|Lost to Follow-up|1097|||
17130744|NCT00122681|38272294|FG000|Overall Study|Protocol Violation|7|||
17130745|NCT00122681|38272295|FG001|Overall Study|Protocol Violation|10|||
17130746|NCT00122681|38272294|FG000|Overall Study|Withdrawal by Subject|257|||
17130747|NCT00122681|38272295|FG001|Overall Study|Withdrawal by Subject|251|||
17130748|NCT00122681|38272294|FG000|Overall Study|Personal reasons|150|||
16956919|NCT01246986|38099864|FG006|Overall Study|Withdrawal by Subject|0|||
16956920|NCT01164501|38099898|FG000|Overall Study|Not treated|2|||
16956921|NCT01164501|38099899|FG001|Overall Study|Not treated|0|||
16956922|NCT01164501|38099900|FG002|Overall Study|Not treated|1|||
16956923|NCT01164501|38099898|FG000|Overall Study|Adverse Event|18|||
16956924|NCT01164501|38099899|FG001|Overall Study|Adverse Event|4|||
16956925|NCT01164501|38099900|FG002|Overall Study|Adverse Event|21|||
16956926|NCT01164501|38099898|FG000|Overall Study|Lack of Efficacy|0|||
16956927|NCT01164501|38099899|FG001|Overall Study|Lack of Efficacy|0|||
16956928|NCT01164501|38099900|FG002|Overall Study|Lack of Efficacy|1|||
16956929|NCT01164501|38099898|FG000|Overall Study|Non compliant with protocol|1|||
16956930|NCT01164501|38099899|FG001|Overall Study|Non compliant with protocol|1|||
16956931|NCT01164501|38099900|FG002|Overall Study|Non compliant with protocol|4|||
16956932|NCT01164501|38099898|FG000|Overall Study|Lost to Follow-up|3|||
16956933|NCT01164501|38099899|FG001|Overall Study|Lost to Follow-up|0|||
16956934|NCT01164501|38099900|FG002|Overall Study|Lost to Follow-up|3|||
16956935|NCT01164501|38099898|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
16956936|NCT01164501|38099899|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
16956937|NCT01164501|38099900|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
16956938|NCT01164501|38099898|FG000|Overall Study|Other reason not defined above|9|||
16956939|NCT01164501|38099899|FG001|Overall Study|Other reason not defined above|1|||
16956940|NCT01164501|38099900|FG002|Overall Study|Other reason not defined above|4|||
16956941|NCT00958711|38099912|FG000|Overall Study|Withdrawal by Subject|0|||
16956942|NCT00958711|38099913|FG001|Overall Study|Withdrawal by Subject|4|||
16956943|NCT00958711|38099912|FG000|Overall Study|Physician Decision|5|||
16956944|NCT00958711|38099913|FG001|Overall Study|Physician Decision|7|||
16956945|NCT00958711|38099912|FG000|Overall Study|Lost to Follow-up|4|||
16956946|NCT00958711|38099913|FG001|Overall Study|Lost to Follow-up|1|||
16956947|NCT00958711|38099912|FG000|Overall Study|Other|2|||
16956948|NCT00958711|38099913|FG001|Overall Study|Other|5|||
16956949|NCT00958711|38099912|FG000|Overall Study|Death|1|||
16956950|NCT00958711|38099913|FG001|Overall Study|Death|2|||
16956951|NCT00958711|38099912|FG000|Overall Study|Adverse Event|1|||
16956952|NCT00958711|38099913|FG001|Overall Study|Adverse Event|2|||
16956953|NCT01163721|38099921|FG000|Overall Study|Adverse Event|5|||
16956954|NCT01163721|38099922|FG001|Overall Study|Adverse Event|6|||
16956955|NCT01163721|38099921|FG000|Overall Study|Withdrawal by Subject|3|||
16956956|NCT01163721|38099922|FG001|Overall Study|Withdrawal by Subject|4|||
16956957|NCT01163721|38099921|FG000|Overall Study|Lost to Follow-up|0|||
16956958|NCT01163721|38099922|FG001|Overall Study|Lost to Follow-up|1|||
16956959|NCT01163721|38099921|FG000|Overall Study|Physician Decision|0|||
16956960|NCT01163721|38099922|FG001|Overall Study|Physician Decision|1|||
16956961|NCT00958243|38099934|FG000|Overall Study|Withdrawal by Subject|0|||
16956962|NCT00958243|38099935|FG001|Overall Study|Withdrawal by Subject|1|||
16956963|NCT00958243|38099936|FG002|Overall Study|Withdrawal by Subject|3|||
16956964|NCT00958243|38099937|FG003|Overall Study|Withdrawal by Subject|1|||
16956965|NCT00958243|38099938|FG004|Overall Study|Withdrawal by Subject|1|||
16956966|NCT00958243|38099939|FG005|Overall Study|Withdrawal by Subject|5|||
16956967|NCT00958243|38099934|FG000|Overall Study|Lost to Follow-up|2|||
16956968|NCT00958243|38099935|FG001|Overall Study|Lost to Follow-up|5|||
16956969|NCT00958243|38099936|FG002|Overall Study|Lost to Follow-up|11|||
16956970|NCT00958243|38099937|FG003|Overall Study|Lost to Follow-up|2|||
16956971|NCT00958243|38099938|FG004|Overall Study|Lost to Follow-up|8|||
16956972|NCT00958243|38099939|FG005|Overall Study|Lost to Follow-up|5|||
16956973|NCT01241760|38099961|FG000|Overall Study|Adverse Event|1|||
16956974|NCT01241760|38099962|FG001|Overall Study|Adverse Event|0|||
16956975|NCT01241760|38099961|FG000|Overall Study|Lost to Follow-up|18|||
16956976|NCT01241760|38099962|FG001|Overall Study|Lost to Follow-up|22|||
16956977|NCT01241760|38099961|FG000|Overall Study|Withdrawal by Subject|13|||
16956978|NCT01241760|38099962|FG001|Overall Study|Withdrawal by Subject|13|||
16956979|NCT01241760|38099961|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
16956980|NCT01241760|38099962|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
16956981|NCT01241760|38099961|FG000|Overall Study|Other|1|||
16956982|NCT01241760|38099962|FG001|Overall Study|Other|1|||
16956983|NCT00958165|38099969|FG000|Overall Study|Lost to Follow-up|5|||
16956984|NCT00958165|38099969|FG000|Overall Study|Not eligible|9|||
16956985|NCT00958009|38099973|FG000|Overall Study|Adverse Event|1|||
16956986|NCT00958009|38099973|FG000|Overall Study|Subject found device difficult to use|1|||
16956987|NCT00953407|38099982|FG000|Overall Study|Failed inclusion criteria|1|||
16956988|NCT00953407|38099983|FG001|Overall Study|Failed inclusion criteria|1|||
16956989|NCT00953407|38099984|FG002|Overall Study|Failed inclusion criteria|1|||
17130749|NCT00122681|38272295|FG001|Overall Study|Personal reasons|147|||
17130750|NCT02774278|38272309|FG000|Overall Study|Lack of Efficacy|199|||
17130751|NCT02774278|38272309|FG000|Overall Study|Death|29|||
17130752|NCT02774278|38272309|FG000|Overall Study|Adverse event/intercurrent illness|16|||
17130753|NCT02774278|38272309|FG000|Overall Study|Refused treatment/did not cooperate|9|||
17130754|NCT02774278|38272309|FG000|Overall Study|Administrative reasons|6|||
17130755|NCT02774278|38272309|FG000|Overall Study|Withdrawal by Subject|3|||
17130756|NCT02774278|38272309|FG000|Overall Study|Protocol Violation|2|||
17130757|NCT03621189|38272315|FG000|Overall Study|Withdrawal by Subject|0|||
17130758|NCT03621189|38272316|FG001|Overall Study|Withdrawal by Subject|3|||
17130759|NCT03621189|38272315|FG000|Overall Study|Physician Decision|0|||
17130760|NCT03621189|38272316|FG001|Overall Study|Physician Decision|2|||
17130761|NCT00122135|38272325|FG000|Overall Study|Withdrawal by Subject|3|||
17130762|NCT00122135|38272326|FG001|Overall Study|Withdrawal by Subject|0|||
17130763|NCT03645057|38272336|FG000|Randomization to Baseline|Lost to Follow-up|1|||
17130764|NCT03645057|38272337|FG001|Randomization to Baseline|Lost to Follow-up|0|||
17130765|NCT03645057|38272338|FG002|Randomization to Baseline|Lost to Follow-up|1|||
17130766|NCT03645057|38272339|FG003|Randomization to Baseline|Lost to Follow-up|0|||
17130767|NCT03645057|38272336|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
17130768|NCT03645057|38272337|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
17130769|NCT03645057|38272338|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
17130770|NCT03645057|38272339|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
17130771|NCT03645057|38272336|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
17130772|NCT03645057|38272337|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
17130773|NCT03645057|38272338|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
17130774|NCT03645057|38272339|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
17130775|NCT03645057|38272336|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
17130776|NCT03645057|38272337|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
17130777|NCT03645057|38272338|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
17130778|NCT03645057|38272339|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
17130779|NCT00132041|38272345|FG000|Baseline|Ineligible|6|||
17130780|NCT00132041|38272345|FG000|3 Months Post Ablation|Transplant|1|||
17130781|NCT00132041|38272345|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
17130782|NCT00132041|38272345|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
17130783|NCT00132041|38272345|FG000|6 Months Post Ablation|Death|2|||
17130784|NCT00132041|38272345|FG000|6 Months Post Ablation|Transplant|6|||
17130785|NCT00132041|38272345|FG000|9 Months Post Ablation|Death|1|||
17130786|NCT00132041|38272345|FG000|9 Months Post Ablation|Transplant|1|||
17130787|NCT00132041|38272345|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
17130788|NCT00132041|38272345|FG000|12 Months Post Ablation|Death|1|||
17130789|NCT00132041|38272345|FG000|12 Months Post Ablation|Transplant|1|||
17130790|NCT00132041|38272345|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
17130791|NCT00132041|38272345|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
17130792|NCT00132041|38272345|FG000|15 Months Post Ablation|Death|1|||
17130793|NCT00132041|38272345|FG000|15 Months Post Ablation|Transplant|5|||
17130794|NCT00132041|38272345|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
17130795|NCT00132041|38272345|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
17130796|NCT00132041|38272345|FG000|18 Months Post Ablation|Transplant|1|||
17130797|NCT00132041|38272345|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
17130798|NCT00132041|38272345|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
17130799|NCT03643575|38272355|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
17130800|NCT03643575|38272356|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
17130801|NCT03643575|38272357|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
17130802|NCT03643575|38272358|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
17130803|NCT03643575|38272359|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
17130804|NCT03643575|38272360|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
17130805|NCT03643575|38272355|FG000|Washout: 7 Days|Adverse Event|1|||
17130806|NCT03643575|38272356|FG001|Washout: 7 Days|Adverse Event|0|||
17130807|NCT03643575|38272357|FG002|Washout: 7 Days|Adverse Event|0|||
17130808|NCT03643575|38272358|FG003|Washout: 7 Days|Adverse Event|0|||
17130809|NCT03643575|38272359|FG004|Washout: 7 Days|Adverse Event|0|||
17130810|NCT03643575|38272360|FG005|Washout: 7 Days|Adverse Event|0|||
17130811|NCT03643575|38272355|FG000|Washout: 7 Days|Non compliance check in|0|||
17130812|NCT03643575|38272356|FG001|Washout: 7 Days|Non compliance check in|1|||
17130813|NCT03643575|38272357|FG002|Washout: 7 Days|Non compliance check in|0|||
17130814|NCT03643575|38272358|FG003|Washout: 7 Days|Non compliance check in|0|||
17130815|NCT03643575|38272359|FG004|Washout: 7 Days|Non compliance check in|0|||
17130816|NCT03643575|38272360|FG005|Washout: 7 Days|Non compliance check in|0|||
17130817|NCT02768194|38272368|FG000|Period 1|Adverse Event|0|||
17130818|NCT02768194|38272369|FG001|Period 1|Adverse Event|0|||
17130819|NCT02768194|38272370|FG002|Period 1|Adverse Event|0|||
17130820|NCT02768194|38272371|FG003|Period 1|Adverse Event|1|||
17130821|NCT02768194|38272372|FG004|Period 1|Adverse Event|0|||
17130822|NCT02768194|38272373|FG005|Period 1|Adverse Event|0|||
17130823|NCT02768194|38272368|FG000|Period 2|Other (Reason not specified)|1|||
17130824|NCT02768194|38272369|FG001|Period 2|Other (Reason not specified)|0|||
17130825|NCT02768194|38272370|FG002|Period 2|Other (Reason not specified)|0|||
17130826|NCT02768194|38272371|FG003|Period 2|Other (Reason not specified)|0|||
17130827|NCT02768194|38272372|FG004|Period 2|Other (Reason not specified)|0|||
17130828|NCT02768194|38272373|FG005|Period 2|Other (Reason not specified)|0|||
17130829|NCT02768194|38272368|FG000|Period 3|Other (Reason not specified)|0|||
17130830|NCT02768194|38272369|FG001|Period 3|Other (Reason not specified)|1|||
17130831|NCT02768194|38272370|FG002|Period 3|Other (Reason not specified)|0|||
17130832|NCT02768194|38272371|FG003|Period 3|Other (Reason not specified)|0|||
17130833|NCT02768194|38272372|FG004|Period 3|Other (Reason not specified)|0|||
17130834|NCT02768194|38272373|FG005|Period 3|Other (Reason not specified)|0|||
17130835|NCT00130793|38272383|FG000|Overall Study|Lost to Follow-up|1|||
17130836|NCT00130793|38272384|FG001|Overall Study|Lost to Follow-up|4|||
17130837|NCT00130793|38272383|FG000|Overall Study|Withdrew consent|2|||
17130838|NCT00130793|38272384|FG001|Overall Study|Withdrew consent|0|||
17130839|NCT03818399|38272391|FG000|Overall Study|Lost to Follow-up|11|||
17130840|NCT03818399|38272391|FG000|Overall Study|Withdrawal by Subject|1|||
17130841|NCT03818399|38272391|FG000|Overall Study|Protocol Violation|2|||
17130842|NCT03642873|38272395|FG000|Third Intervention (1 Day)|Screen failure|0|||
17130843|NCT03642873|38272396|FG001|Third Intervention (1 Day)|Screen failure|0|||
17130844|NCT03642873|38272397|FG002|Third Intervention (1 Day)|Screen failure|0|||
17130845|NCT03642873|38272398|FG003|Third Intervention (1 Day)|Screen failure|0|||
17130846|NCT03642873|38272399|FG004|Third Intervention (1 Day)|Screen failure|1|||
17130847|NCT03642873|38272400|FG005|Third Intervention (1 Day)|Screen failure|0|||
17130848|NCT03818321|38272414|FG000|Overall Study|Withdrawal by Subject|1|||
17130849|NCT03818321|38272415|FG001|Overall Study|Withdrawal by Subject|2|||
17130850|NCT03616977|38272421|FG000|Period 1|Physician Decision|0|||
17130851|NCT03616977|38272422|FG001|Period 1|Physician Decision|1|||
17130852|NCT03616977|38272421|FG000|Period 3|Adverse Event|1|||
17130853|NCT03616977|38272422|FG001|Period 3|Adverse Event|1|||
17130854|NCT02767570|38272431|FG000|Overall Study|Lost to Follow-up|3|||
17130855|NCT02767570|38272432|FG001|Overall Study|Lost to Follow-up|0|||
17130856|NCT02767570|38272431|FG000|Overall Study|COVID shutdown|2|||
17130857|NCT02767570|38272432|FG001|Overall Study|COVID shutdown|5|||
17130858|NCT02767570|38272431|FG000|Overall Study|Increased pain|2|||
17130859|NCT02767570|38272432|FG001|Overall Study|Increased pain|0|||
17130860|NCT02767570|38272431|FG000|Overall Study|Withdrawal by Subject|1|||
17130861|NCT02767570|38272432|FG001|Overall Study|Withdrawal by Subject|3|||
17130862|NCT02767570|38272431|FG000|Overall Study|Unrelated medical issue|1|||
17130863|NCT02767570|38272432|FG001|Overall Study|Unrelated medical issue|1|||
17130864|NCT02767570|38272431|FG000|Overall Study|Received intra-articular injection|0|||
17130865|NCT02767570|38272432|FG001|Overall Study|Received intra-articular injection|1|||
17130866|NCT03816761|38272441|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
17130867|NCT03816761|38272442|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
17130868|NCT03816761|38272443|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
17130869|NCT03816761|38272444|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
17130870|NCT03816761|38272445|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
17130871|NCT03816761|38272446|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
17130872|NCT03816761|38272441|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
17130873|NCT03816761|38272442|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
17130874|NCT03816761|38272443|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
17130875|NCT03816761|38272444|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
17130876|NCT03816761|38272445|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
17130877|NCT03816761|38272446|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
17130878|NCT02770612|38272468|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
17130879|NCT03575871|38272475|FG000|Overall Study|Adverse Event|5|||
17130880|NCT03575871|38272476|FG001|Overall Study|Adverse Event|5|||
17130881|NCT03575871|38272477|FG002|Overall Study|Adverse Event|8|||
17130882|NCT03575871|38272475|FG000|Overall Study|Death|1|||
17130883|NCT03575871|38272476|FG001|Overall Study|Death|0|||
17130884|NCT03575871|38272477|FG002|Overall Study|Death|0|||
17130885|NCT03575871|38272475|FG000|Overall Study|Lack of Efficacy|5|||
17130886|NCT03575871|38272476|FG001|Overall Study|Lack of Efficacy|4|||
17130887|NCT03575871|38272477|FG002|Overall Study|Lack of Efficacy|7|||
17130888|NCT03575871|38272475|FG000|Overall Study|Lost to Follow-up|1|||
17130889|NCT03575871|38272476|FG001|Overall Study|Lost to Follow-up|1|||
17130890|NCT03575871|38272477|FG002|Overall Study|Lost to Follow-up|1|||
17130891|NCT03575871|38272475|FG000|Overall Study|Protocol Deviation|1|||
17130892|NCT03575871|38272476|FG001|Overall Study|Protocol Deviation|1|||
17130893|NCT03575871|38272477|FG002|Overall Study|Protocol Deviation|1|||
17130894|NCT03575871|38272475|FG000|Overall Study|Withdrawal by Subject|6|||
17130895|NCT03575871|38272476|FG001|Overall Study|Withdrawal by Subject|1|||
17130896|NCT03575871|38272477|FG002|Overall Study|Withdrawal by Subject|9|||
17130897|NCT03575871|38272475|FG000|Overall Study|Other than specified|2|||
17130898|NCT03575871|38272476|FG001|Overall Study|Other than specified|2|||
17130899|NCT03575871|38272477|FG002|Overall Study|Other than specified|0|||
17130900|NCT03642717|38272485|FG000|Overall Study|Lost to Follow-up|2|||
17130901|NCT03642717|38272485|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
17130902|NCT03642717|38272485|FG000|Overall Study|Taken study drug prior to contract date|3|||
17130903|NCT02766478|38272492|FG000|Overall Study|Withdrawal by Subject|1|||
17130904|NCT02766478|38272493|FG001|Overall Study|Withdrawal by Subject|1|||
17130905|NCT02766400|38272501|FG000|Overall Study|Death|1|||
17130906|NCT02766400|38272502|FG001|Overall Study|Death|2|||
17130907|NCT02766400|38272501|FG000|Overall Study|Withdrawal by Subject|1|||
17130908|NCT02766400|38272502|FG001|Overall Study|Withdrawal by Subject|0|||
17130909|NCT00104650|38272511|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
17130910|NCT00104650|38272512|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
17130911|NCT00104650|38272513|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
17130912|NCT00104650|38272511|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
17130913|NCT00104650|38272512|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
17130914|NCT00104650|38272513|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
17130915|NCT00104650|38272511|FG000|Treatment Period (25 Weeks)|Death|7|||
17130916|NCT00104650|38272512|FG001|Treatment Period (25 Weeks)|Death|5|||
17130917|NCT00104650|38272513|FG002|Treatment Period (25 Weeks)|Death|6|||
17130918|NCT00104650|38272511|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
17130919|NCT00104650|38272512|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
17130920|NCT00104650|38272513|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
17130921|NCT00104650|38272511|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
17130922|NCT00104650|38272512|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
17130923|NCT00104650|38272513|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
17130924|NCT00104650|38272511|FG000|Treatment Period (25 Weeks)|Other|1|||
17130925|NCT00104650|38272512|FG001|Treatment Period (25 Weeks)|Other|0|||
17130926|NCT00104650|38272513|FG002|Treatment Period (25 Weeks)|Other|0|||
17130927|NCT00104650|38272511|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
17130928|NCT00104650|38272512|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
17130929|NCT00104650|38272513|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
17130930|NCT00104650|38272511|FG000|Follow-up Period|Physician Decision|1|||
17130931|NCT00104650|38272512|FG001|Follow-up Period|Physician Decision|1|||
17130932|NCT00104650|38272513|FG002|Follow-up Period|Physician Decision|0|||
17130933|NCT00104650|38272511|FG000|Follow-up Period|Adverse Event|1|||
17130934|NCT00104650|38272512|FG001|Follow-up Period|Adverse Event|0|||
17130935|NCT00104650|38272513|FG002|Follow-up Period|Adverse Event|1|||
17130936|NCT00104650|38272511|FG000|Follow-up Period|Withdrawal by Subject|0|||
17130937|NCT00104650|38272512|FG001|Follow-up Period|Withdrawal by Subject|3|||
17130938|NCT00104650|38272513|FG002|Follow-up Period|Withdrawal by Subject|3|||
17130939|NCT00104650|38272511|FG000|Follow-up Period|Death|6|||
17130940|NCT00104650|38272512|FG001|Follow-up Period|Death|6|||
17130941|NCT00104650|38272513|FG002|Follow-up Period|Death|4|||
17130942|NCT00104650|38272511|FG000|Follow-up Period|Disease progression|3|||
17130943|NCT00104650|38272512|FG001|Follow-up Period|Disease progression|1|||
17130944|NCT00104650|38272513|FG002|Follow-up Period|Disease progression|0|||
17130945|NCT00104650|38272511|FG000|Follow-up Period|Lost to Follow-up|0|||
17130946|NCT00104650|38272512|FG001|Follow-up Period|Lost to Follow-up|1|||
17130947|NCT00104650|38272513|FG002|Follow-up Period|Lost to Follow-up|2|||
17130948|NCT00104650|38272511|FG000|Follow-up Period|Other|0|||
17130949|NCT00104650|38272512|FG001|Follow-up Period|Other|1|||
17130950|NCT00104650|38272513|FG002|Follow-up Period|Other|0|||
17130951|NCT03732807|38272528|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
17130952|NCT03732807|38272529|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
17130953|NCT03732807|38272530|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
17130954|NCT03732807|38272531|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
17130955|NCT03732807|38272532|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
17130956|NCT03732807|38272533|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
17130957|NCT03732807|38272534|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
17130958|NCT03732807|38272528|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
17130959|NCT03732807|38272529|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
17130960|NCT03732807|38272530|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
17130961|NCT03732807|38272531|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
17130962|NCT03732807|38272532|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
17130963|NCT03732807|38272533|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
17130964|NCT03732807|38272534|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
17130965|NCT03732807|38272528|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
17130966|NCT03732807|38272529|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
17130967|NCT03732807|38272530|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
17130968|NCT03732807|38272531|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
17130969|NCT03732807|38272532|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
17130970|NCT03732807|38272533|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
17130971|NCT03732807|38272534|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
17130972|NCT03732807|38272528|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
17130973|NCT03732807|38272529|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
17130974|NCT03732807|38272530|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
17130975|NCT03732807|38272531|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
17130976|NCT03732807|38272532|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
17130977|NCT03732807|38272533|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
17130978|NCT03732807|38272534|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
17130979|NCT03732807|38272528|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
17130980|NCT03732807|38272529|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
17130981|NCT03732807|38272530|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
17130982|NCT03732807|38272531|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
17130983|NCT03732807|38272532|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
17130984|NCT03732807|38272533|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
17130985|NCT03732807|38272534|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
17130986|NCT03732807|38272528|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
17130987|NCT03732807|38272529|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
17130988|NCT03732807|38272530|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
17130989|NCT03732807|38272531|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
17130990|NCT03732807|38272532|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
17130991|NCT03732807|38272533|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
17130992|NCT03732807|38272534|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
17130993|NCT03732807|38272528|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
17130994|NCT03732807|38272529|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
17130995|NCT03732807|38272530|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
17130996|NCT03732807|38272531|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
17130997|NCT03732807|38272532|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
17130998|NCT03732807|38272533|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
17130999|NCT03732807|38272534|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
17131000|NCT03732807|38272528|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
17131001|NCT03732807|38272529|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
17131002|NCT03732807|38272530|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
17131003|NCT03732807|38272531|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
17131004|NCT03732807|38272532|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
17131005|NCT03732807|38272533|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
17131006|NCT03732807|38272534|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
17131007|NCT03732807|38272528|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
17131008|NCT03732807|38272529|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
17131009|NCT03732807|38272530|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
17131010|NCT03732807|38272531|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
17131011|NCT03732807|38272532|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
17131012|NCT03732807|38272533|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
17131013|NCT03732807|38272534|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
17131014|NCT03732807|38272528|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
17131015|NCT03732807|38272529|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
17131016|NCT03732807|38272530|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
17131017|NCT03732807|38272531|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
17131018|NCT03732807|38272532|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
17131019|NCT03732807|38272533|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
17131020|NCT03732807|38272534|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
17131021|NCT03732807|38272528|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
17131022|NCT03732807|38272529|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
17131023|NCT03732807|38272530|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
17131024|NCT03732807|38272531|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
17131025|NCT03732807|38272532|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
16956990|NCT00953407|38099985|FG003|Overall Study|Failed inclusion criteria|1|||
16956991|NCT00953407|38099986|FG004|Overall Study|Failed inclusion criteria|1|||
16956992|NCT00953407|38099982|FG000|Overall Study|Lost to Follow-up|0|||
16956993|NCT00953407|38099983|FG001|Overall Study|Lost to Follow-up|0|||
16956994|NCT00953407|38099984|FG002|Overall Study|Lost to Follow-up|0|||
16956995|NCT00953407|38099985|FG003|Overall Study|Lost to Follow-up|1|||
16956996|NCT00953407|38099986|FG004|Overall Study|Lost to Follow-up|0|||
16956997|NCT00953329|38099998|FG000|Overall Study|Lack of Efficacy|1|||
16956998|NCT00953017|38100006|FG000|Overall Study|DId not show up for colonoscopy|4|||
16956999|NCT00953017|38100007|FG001|Overall Study|DId not show up for colonoscopy|4|||
16957000|NCT00953017|38100008|FG002|Overall Study|DId not show up for colonoscopy|5|||
16957001|NCT00953017|38100009|FG003|Overall Study|DId not show up for colonoscopy|4|||
16957002|NCT00953017|38100006|FG000|Overall Study|Incomplete data|1|||
16957003|NCT00953017|38100007|FG001|Overall Study|Incomplete data|1|||
16957004|NCT00953017|38100008|FG002|Overall Study|Incomplete data|0|||
16957005|NCT00953017|38100009|FG003|Overall Study|Incomplete data|0|||
16957006|NCT00953017|38100006|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
16957007|NCT00953017|38100007|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
16957008|NCT00953017|38100008|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
16957009|NCT00953017|38100009|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
16957010|NCT00953017|38100006|FG000|Overall Study|Brown stool prior to procedure|0|||
16957011|NCT00953017|38100007|FG001|Overall Study|Brown stool prior to procedure|0|||
16957012|NCT00953017|38100008|FG002|Overall Study|Brown stool prior to procedure|1|||
16957013|NCT00953017|38100009|FG003|Overall Study|Brown stool prior to procedure|0|||
16957014|NCT00952705|38100022|FG000|Overall Study|Lost to Follow-up|24|||
16957015|NCT00952705|38100023|FG001|Overall Study|Lost to Follow-up|8|||
16957016|NCT00952705|38100024|FG002|Overall Study|Lost to Follow-up|9|||
16957017|NCT00952705|38100022|FG000|Overall Study|Withdrawal by Subject|2|||
16957018|NCT00952705|38100023|FG001|Overall Study|Withdrawal by Subject|1|||
16957019|NCT00952705|38100024|FG002|Overall Study|Withdrawal by Subject|1|||
16957020|NCT00952705|38100022|FG000|Overall Study|Death|2|||
16957021|NCT00952705|38100023|FG001|Overall Study|Death|0|||
16957022|NCT00952705|38100024|FG002|Overall Study|Death|0|||
16957023|NCT00952705|38100022|FG000|Overall Study|Incarcerated post dose|5|||
16957024|NCT00952705|38100023|FG001|Overall Study|Incarcerated post dose|0|||
16957025|NCT00952705|38100024|FG002|Overall Study|Incarcerated post dose|0|||
16957026|NCT00952705|38100022|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
16957027|NCT00952705|38100023|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
16957028|NCT00952705|38100024|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
16957029|NCT00955357|38100038|FG000|Titration Phase|Adverse Event|9|||
16957030|NCT00955357|38100039|FG001|Titration Phase|Adverse Event|46|||
16957031|NCT00955357|38100038|FG000|Titration Phase|Lack of Efficacy|0|||
16957032|NCT00955357|38100039|FG001|Titration Phase|Lack of Efficacy|2|||
16957033|NCT00955357|38100038|FG000|Titration Phase|Protocol Violation|3|||
16957034|NCT00955357|38100039|FG001|Titration Phase|Protocol Violation|7|||
16957035|NCT00955357|38100038|FG000|Titration Phase|Lost to Follow-up|1|||
17131026|NCT03732807|38272533|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
17131027|NCT03732807|38272534|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
17131028|NCT03732807|38272528|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
17131029|NCT03732807|38272529|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
17131030|NCT03732807|38272530|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
17131031|NCT03732807|38272531|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
17131032|NCT03732807|38272532|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
17131033|NCT03732807|38272533|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
17131034|NCT03732807|38272534|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
17131035|NCT03732807|38272528|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
17131036|NCT03732807|38272529|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
17131037|NCT03732807|38272530|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
17131038|NCT03732807|38272531|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
17131039|NCT03732807|38272532|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
17131040|NCT03732807|38272533|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
17131041|NCT03732807|38272534|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
17131042|NCT03732807|38272528|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
17131043|NCT03732807|38272529|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
17131044|NCT03732807|38272530|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
17131045|NCT03732807|38272531|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
17131046|NCT03732807|38272532|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
17131047|NCT03732807|38272533|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
17131048|NCT03732807|38272534|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
17131049|NCT00104416|38272553|FG000|Double-Blind Phase|Adverse Event|2|||
17131050|NCT00104416|38272554|FG001|Double-Blind Phase|Adverse Event|1|||
17131051|NCT00104416|38272555|FG002|Double-Blind Phase|Adverse Event|0|||
17131052|NCT00104416|38272556|FG003|Double-Blind Phase|Adverse Event|0|||
17131053|NCT00104416|38272557|FG004|Double-Blind Phase|Adverse Event|0|||
17131054|NCT00104416|38272553|FG000|Double-Blind Phase|Lost to Follow-up|0|||
17131055|NCT00104416|38272554|FG001|Double-Blind Phase|Lost to Follow-up|1|||
17131056|NCT00104416|38272555|FG002|Double-Blind Phase|Lost to Follow-up|0|||
17131057|NCT00104416|38272556|FG003|Double-Blind Phase|Lost to Follow-up|0|||
17131058|NCT00104416|38272557|FG004|Double-Blind Phase|Lost to Follow-up|0|||
17131059|NCT00104416|38272553|FG000|Double-Blind Phase|Protocol Violation|0|||
17131060|NCT00104416|38272554|FG001|Double-Blind Phase|Protocol Violation|1|||
17131061|NCT00104416|38272555|FG002|Double-Blind Phase|Protocol Violation|0|||
17131062|NCT00104416|38272556|FG003|Double-Blind Phase|Protocol Violation|0|||
17131063|NCT00104416|38272557|FG004|Double-Blind Phase|Protocol Violation|0|||
17131064|NCT00104416|38272553|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
17131065|NCT00104416|38272554|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
17131066|NCT00104416|38272555|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
17131067|NCT00104416|38272556|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
17131068|NCT00104416|38272557|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
17131069|NCT00104416|38272553|FG000|Double-Blind Phase|Pregnancy|1|||
17131070|NCT00104416|38272554|FG001|Double-Blind Phase|Pregnancy|0|||
17131071|NCT00104416|38272555|FG002|Double-Blind Phase|Pregnancy|0|||
17131072|NCT00104416|38272556|FG003|Double-Blind Phase|Pregnancy|0|||
17131073|NCT00104416|38272557|FG004|Double-Blind Phase|Pregnancy|0|||
17131074|NCT00104416|38272553|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
17131075|NCT00104416|38272554|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
17131076|NCT00104416|38272555|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
16957036|NCT00955357|38100039|FG001|Titration Phase|Lost to Follow-up|3|||
16957037|NCT00955357|38100038|FG000|Titration Phase|Withdrawal by Subject|3|||
16957038|NCT00955357|38100039|FG001|Titration Phase|Withdrawal by Subject|5|||
16957039|NCT00955357|38100038|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
16957040|NCT00955357|38100039|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
16957041|NCT00955357|38100038|FG000|Titration Phase|Study medication not tolerated|0|||
16957042|NCT00955357|38100039|FG001|Titration Phase|Study medication not tolerated|1|||
16957043|NCT00955357|38100038|FG000|Titration Phase|Non compliance to study procedures|0|||
16957044|NCT00955357|38100039|FG001|Titration Phase|Non compliance to study procedures|1|||
16957045|NCT00955357|38100038|FG000|Maintenance Phase|Adverse Event|3|||
16957046|NCT00955357|38100039|FG001|Maintenance Phase|Adverse Event|23|||
16957047|NCT00955357|38100038|FG000|Maintenance Phase|Lack of Efficacy|0|||
16957048|NCT00955357|38100039|FG001|Maintenance Phase|Lack of Efficacy|4|||
16957049|NCT00955357|38100038|FG000|Maintenance Phase|Protocol Violation|2|||
16957050|NCT00955357|38100039|FG001|Maintenance Phase|Protocol Violation|6|||
16957051|NCT00955357|38100038|FG000|Maintenance Phase|Lost to Follow-up|2|||
16957052|NCT00955357|38100039|FG001|Maintenance Phase|Lost to Follow-up|7|||
16957053|NCT00955357|38100038|FG000|Maintenance Phase|Withdrawal by Subject|4|||
16957054|NCT00955357|38100039|FG001|Maintenance Phase|Withdrawal by Subject|4|||
16957055|NCT00955357|38100038|FG000|Maintenance Phase|Patient moving out of area|0|||
16957056|NCT00955357|38100039|FG001|Maintenance Phase|Patient moving out of area|1|||
16957057|NCT00955357|38100038|FG000|Maintenance Phase|Non compliance to study procedures|1|||
16957058|NCT00955357|38100039|FG001|Maintenance Phase|Non compliance to study procedures|0|||
16957059|NCT00955279|38100048|FG000|Overall Study|Other|0|||
16957060|NCT00955279|38100049|FG001|Overall Study|Other|0|||
16957061|NCT00955279|38100050|FG002|Overall Study|Other|3|||
16957062|NCT00955279|38100048|FG000|Overall Study|Death|1|||
16957063|NCT00955279|38100049|FG001|Overall Study|Death|1|||
16957064|NCT00955279|38100050|FG002|Overall Study|Death|1|||
16957065|NCT00955279|38100048|FG000|Overall Study|Lost to Follow-up|0|||
16957066|NCT00955279|38100049|FG001|Overall Study|Lost to Follow-up|3|||
16957067|NCT00955279|38100050|FG002|Overall Study|Lost to Follow-up|1|||
16957068|NCT00955279|38100048|FG000|Overall Study|Withdrawal by Subject|2|||
16957069|NCT00955279|38100049|FG001|Overall Study|Withdrawal by Subject|0|||
16957070|NCT00955279|38100050|FG002|Overall Study|Withdrawal by Subject|3|||
16957071|NCT00954733|38100058|FG000|Overall Study|blood gas machine did not work|1|||
16957072|NCT00954421|38100062|FG000|Screening|screen failures|3|||
16957073|NCT00954421|38100062|FG000|6 Months of DBS|Withdrawal by Subject|1|||
16957074|NCT00954421|38100062|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
16957075|NCT01241448|38100072|FG000|Overall Study|Adverse Event|1|||
16957076|NCT01241448|38100073|FG001|Overall Study|Adverse Event|0|||
16957077|NCT01241448|38100074|FG002|Overall Study|Adverse Event|2|||
16957078|NCT01241448|38100075|FG003|Overall Study|Adverse Event|2|||
16957079|NCT01241448|38100072|FG000|Overall Study|Lost to Follow-up|2|||
16957080|NCT01241448|38100073|FG001|Overall Study|Lost to Follow-up|1|||
16782553|NCT01663623|37722163|FG000|Overall Study|Lack of Efficacy|5|||
17131077|NCT00104416|38272556|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
17131078|NCT00104416|38272557|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
17131079|NCT00104416|38272553|FG000|Continuation Phase|Adverse Event|0|||
17131080|NCT00104416|38272554|FG001|Continuation Phase|Adverse Event|0|||
17131081|NCT00104416|38272555|FG002|Continuation Phase|Adverse Event|2|||
17131082|NCT00104416|38272556|FG003|Continuation Phase|Adverse Event|0|||
17131083|NCT00104416|38272557|FG004|Continuation Phase|Adverse Event|2|||
17131084|NCT00104416|38272553|FG000|Continuation Phase|Lost to Follow-up|0|||
17131085|NCT00104416|38272554|FG001|Continuation Phase|Lost to Follow-up|0|||
17131086|NCT00104416|38272555|FG002|Continuation Phase|Lost to Follow-up|1|||
17131087|NCT00104416|38272556|FG003|Continuation Phase|Lost to Follow-up|0|||
17131088|NCT00104416|38272557|FG004|Continuation Phase|Lost to Follow-up|1|||
17131089|NCT00104416|38272553|FG000|Continuation Phase|Withdrawal by Subject|0|||
17131090|NCT00104416|38272554|FG001|Continuation Phase|Withdrawal by Subject|0|||
17131091|NCT00104416|38272555|FG002|Continuation Phase|Withdrawal by Subject|2|||
17131092|NCT00104416|38272556|FG003|Continuation Phase|Withdrawal by Subject|1|||
17131093|NCT00104416|38272557|FG004|Continuation Phase|Withdrawal by Subject|1|||
17131094|NCT00104416|38272553|FG000|Continuation Phase|Pregnancy|0|||
17131095|NCT00104416|38272554|FG001|Continuation Phase|Pregnancy|0|||
17131096|NCT00104416|38272555|FG002|Continuation Phase|Pregnancy|1|||
17131097|NCT00104416|38272556|FG003|Continuation Phase|Pregnancy|1|||
17131098|NCT00104416|38272557|FG004|Continuation Phase|Pregnancy|0|||
17131099|NCT00104416|38272553|FG000|Continuation Phase|Non-compliance|0|||
17131100|NCT00104416|38272554|FG001|Continuation Phase|Non-compliance|0|||
17131101|NCT00104416|38272555|FG002|Continuation Phase|Non-compliance|0|||
17131102|NCT00104416|38272556|FG003|Continuation Phase|Non-compliance|0|||
17131103|NCT00104416|38272557|FG004|Continuation Phase|Non-compliance|1|||
17131104|NCT03639987|38272571|FG000|Overall Study|Study terminated by sponsor|26|||
17131105|NCT03639987|38272572|FG001|Overall Study|Study terminated by sponsor|25|||
17131106|NCT03639987|38272571|FG000|Overall Study|Lost to Follow-up|0|||
17131107|NCT03639987|38272572|FG001|Overall Study|Lost to Follow-up|1|||
17131108|NCT02766088|38272578|FG000|Overall Study|Sponsor study termination|498|||
17131109|NCT02766088|38272578|FG000|Overall Study|Migrated/moved from the study area|1|||
17131110|NCT02766088|38272578|FG000|Overall Study|Lost to Follow-up|5|||
17131111|NCT02766088|38272578|FG000|Overall Study|Other|1|||
17131112|NCT02766088|38272578|FG000|Overall Study|Death|1|||
17131113|NCT03639675|38272582|FG000|Overall Study|Withdrawal by Subject|1|||
17131114|NCT03635775|38272590|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
17131115|NCT03635775|38272591|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
17131116|NCT03635775|38272592|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
17131117|NCT03635775|38272593|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
17131118|NCT03610581|38272605|FG000|Overall Study|Study terminated by sponsor|2|||
17131119|NCT03610581|38272606|FG001|Overall Study|Study terminated by sponsor|0|||
17131120|NCT03610581|38272605|FG000|Overall Study|Other|0|||
17131121|NCT03610581|38272606|FG001|Overall Study|Other|1|||
17131122|NCT03610581|38272605|FG000|Overall Study|Withdrawal by Subject|1|||
17131123|NCT03610581|38272606|FG001|Overall Study|Withdrawal by Subject|0|||
17131124|NCT03610269|38272612|FG000|Overall Study|Physician Decision|10|||
17131125|NCT03610269|38272612|FG000|Overall Study|Protocol Violation|1|||
17131126|NCT03610269|38272612|FG000|Overall Study|Unable to draw blood|1|||
16957081|NCT01241448|38100074|FG002|Overall Study|Lost to Follow-up|1|||
16782554|NCT01663623|37722164|FG001|Overall Study|Lack of Efficacy|6|||
17131127|NCT03610269|38272612|FG000|Overall Study|Screen fail|4|||
17131128|NCT00121667|38272620|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
17131129|NCT00121667|38272621|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
17131130|NCT00121667|38272622|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
17131131|NCT00121667|38272623|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
17131132|NCT00121667|38272620|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
17131133|NCT00121667|38272621|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
17131134|NCT00121667|38272622|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
17131135|NCT00121667|38272623|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
17131136|NCT00121667|38272620|FG000|Short Term (ST) Period|Adverse Event|5|||
17131137|NCT00121667|38272621|FG001|Short Term (ST) Period|Adverse Event|6|||
17131138|NCT00121667|38272622|FG002|Short Term (ST) Period|Adverse Event|5|||
17131139|NCT00121667|38272623|FG003|Short Term (ST) Period|Adverse Event|3|||
17131140|NCT00121667|38272620|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
17131141|NCT00121667|38272621|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
17131142|NCT00121667|38272622|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
17131143|NCT00121667|38272623|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
17131144|NCT00121667|38272620|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
17131145|NCT00121667|38272621|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
17131146|NCT00121667|38272622|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
17131147|NCT00121667|38272623|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
17131148|NCT00121667|38272620|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
17131149|NCT00121667|38272621|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
17131150|NCT00121667|38272622|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
17131151|NCT00121667|38272623|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
17131152|NCT00121667|38272620|FG000|Short Term (ST) Period|Other Reason|3|||
17131153|NCT00121667|38272621|FG001|Short Term (ST) Period|Other Reason|0|||
17131154|NCT00121667|38272622|FG002|Short Term (ST) Period|Other Reason|0|||
17131155|NCT00121667|38272623|FG003|Short Term (ST) Period|Other Reason|0|||
17131156|NCT00121667|38272620|FG000|Short Term (ST) Period|Death|0|||
17131157|NCT00121667|38272621|FG001|Short Term (ST) Period|Death|0|||
17131158|NCT00121667|38272622|FG002|Short Term (ST) Period|Death|0|||
17131159|NCT00121667|38272623|FG003|Short Term (ST) Period|Death|1|||
17131160|NCT00121667|38272620|FG000|Short Term (ST) Period|Pregnancy|0|||
17131161|NCT00121667|38272621|FG001|Short Term (ST) Period|Pregnancy|0|||
17131162|NCT00121667|38272622|FG002|Short Term (ST) Period|Pregnancy|0|||
17131163|NCT00121667|38272623|FG003|Short Term (ST) Period|Pregnancy|1|||
17131164|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
17131165|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
17131166|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
17131167|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
17131168|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
17131169|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
17131170|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
17131171|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
17131172|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
17131173|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
17131174|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
17131175|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
17131176|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
17131177|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
17131178|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
17131179|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
17131180|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
17131181|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
17131182|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
17131183|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
17131184|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
17131185|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
17131186|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
17131187|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
17131188|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
17131189|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
17131190|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
17131191|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
17131192|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
17131193|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
17131194|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
17131195|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
17131196|NCT00121667|38272620|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
17131197|NCT00121667|38272621|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
17131198|NCT00121667|38272622|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
17131199|NCT00121667|38272623|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
17131200|NCT02954601|38272637|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
17131201|NCT02954601|38272638|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
17131202|NCT02954601|38272639|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
17131203|NCT02954601|38272640|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
17131204|NCT03633903|38272652|FG000|Overall Study|Withdrawal by Subject|1|||
17131205|NCT03633903|38272653|FG001|Overall Study|Withdrawal by Subject|2|||
17131206|NCT03633903|38272652|FG000|Overall Study|Lost to Follow-up|5|||
17131207|NCT03633903|38272653|FG001|Overall Study|Lost to Follow-up|5|||
17131208|NCT03607695|38272659|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
17131209|NCT03607695|38272659|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
17131210|NCT03633825|38272665|FG000|Enrollment|Did not post on network|5066|||
17131211|NCT03633825|38272666|FG001|Enrollment|Did not post on network|5080|||
17131212|NCT03633825|38272665|FG000|Enrollment|Post not classified as crisis|13967|||
17131213|NCT03633825|38272666|FG001|Enrollment|Post not classified as crisis|13757|||
17131214|NCT03633825|38272665|FG000|Follow up|Lost to Follow-up|478|||
17131215|NCT03633825|38272666|FG001|Follow up|Lost to Follow-up|450|||
17131216|NCT03557775|38272675|FG000|Overall Study|Withdrawal by Subject|1|||
17131217|NCT03557775|38272676|FG001|Overall Study|Withdrawal by Subject|2|||
17131218|NCT03557775|38272677|FG002|Overall Study|Withdrawal by Subject|4|||
17131219|NCT03557775|38272675|FG000|Overall Study|Physician Decision|0|||
17131220|NCT03557775|38272676|FG001|Overall Study|Physician Decision|1|||
17131221|NCT03557775|38272677|FG002|Overall Study|Physician Decision|0|||
17131222|NCT00121199|38272685|FG000|Overall Study|Adverse Event|11|||
17131223|NCT00121199|38272685|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
17131224|NCT00121199|38272685|FG000|Overall Study|Progression/Relapse|1|||
17131225|NCT00121199|38272685|FG000|Overall Study|Death|3|||
17131226|NCT00121199|38272685|FG000|Overall Study|Other - Not Protocol Specified|3|||
17131227|NCT00121199|38272685|FG000|Overall Study|Ineligible|9|||
17131228|NCT00119405|38272689|FG000|Overall Study|Withdrawal by Subject|1|||
17131229|NCT00119015|38272695|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
17131230|NCT00119015|38272696|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
17131231|NCT00119015|38272697|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
17131232|NCT01981850|38272710|FG000|Main Phase Stage 1|Death|2|||
17131233|NCT01981850|38272711|FG001|Main Phase Stage 1|Death|0|||
17131234|NCT01981850|38272712|FG002|Main Phase Stage 1|Death|0|||
17131235|NCT01981850|38272713|FG003|Main Phase Stage 1|Death|0|||
17131236|NCT01981850|38272714|FG004|Main Phase Stage 1|Death|0|||
17131237|NCT01981850|38272715|FG005|Main Phase Stage 1|Death|0|||
17131238|NCT01981850|38272716|FG006|Main Phase Stage 1|Death|0|||
17131239|NCT01981850|38272717|FG007|Main Phase Stage 1|Death|0|||
17131240|NCT01981850|38272718|FG008|Main Phase Stage 1|Death|0|||
17131241|NCT01981850|38272719|FG009|Main Phase Stage 1|Death|0|||
17131242|NCT01981850|38272710|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
17131243|NCT01981850|38272711|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131244|NCT01981850|38272712|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131245|NCT01981850|38272713|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131246|NCT01981850|38272714|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131247|NCT01981850|38272715|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131248|NCT01981850|38272716|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131249|NCT01981850|38272717|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131250|NCT01981850|38272718|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131251|NCT01981850|38272719|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
17131252|NCT01981850|38272710|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
17131253|NCT01981850|38272711|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
17131254|NCT01981850|38272712|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
17131255|NCT01981850|38272713|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
16957082|NCT01241448|38100075|FG003|Overall Study|Lost to Follow-up|1|||
16957083|NCT01241448|38100072|FG000|Overall Study|Physician Decision|0|||
16957084|NCT01241448|38100073|FG001|Overall Study|Physician Decision|2|||
16957085|NCT01241448|38100074|FG002|Overall Study|Physician Decision|0|||
16957086|NCT01241448|38100075|FG003|Overall Study|Physician Decision|0|||
16957087|NCT01241448|38100072|FG000|Overall Study|Protocol Violation|10|||
16957088|NCT01241448|38100073|FG001|Overall Study|Protocol Violation|5|||
16957089|NCT01241448|38100074|FG002|Overall Study|Protocol Violation|3|||
16957090|NCT01241448|38100075|FG003|Overall Study|Protocol Violation|6|||
16957091|NCT01241448|38100072|FG000|Overall Study|Sponsor Decision|17|||
16957092|NCT01241448|38100073|FG001|Overall Study|Sponsor Decision|14|||
16957093|NCT01241448|38100074|FG002|Overall Study|Sponsor Decision|12|||
16957094|NCT01241448|38100075|FG003|Overall Study|Sponsor Decision|6|||
16957095|NCT01241448|38100072|FG000|Overall Study|Withdrawal by Subject|4|||
16957096|NCT01241448|38100073|FG001|Overall Study|Withdrawal by Subject|5|||
16957097|NCT01241448|38100074|FG002|Overall Study|Withdrawal by Subject|3|||
16957098|NCT01241448|38100075|FG003|Overall Study|Withdrawal by Subject|6|||
16957099|NCT01241448|38100072|FG000|Overall Study|Excluded due to data integrity issues|3|||
16957100|NCT01241448|38100073|FG001|Overall Study|Excluded due to data integrity issues|2|||
16957101|NCT01241448|38100074|FG002|Overall Study|Excluded due to data integrity issues|2|||
16957102|NCT01241448|38100075|FG003|Overall Study|Excluded due to data integrity issues|2|||
16957103|NCT01240356|38100088|FG000|Overall Study|Withdrawal by Subject|2|||
16957104|NCT01240356|38100089|FG001|Overall Study|Withdrawal by Subject|0|||
16957105|NCT01240356|38100088|FG000|Overall Study|MRI contraindication|1|||
16957106|NCT01240356|38100089|FG001|Overall Study|MRI contraindication|0|||
16957107|NCT01239732|38100098|FG000|Overall Study|Termination of study per protocol|667|||
16957108|NCT01239732|38100098|FG000|Overall Study|Death|226|||
16957109|NCT01239732|38100098|FG000|Overall Study|Withdrawal by Subject|87|||
16957110|NCT01239732|38100098|FG000|Overall Study|Adverse Event|6|||
16957111|NCT01239732|38100098|FG000|Overall Study|Protocol Violation|3|||
16957112|NCT01239732|38100098|FG000|Overall Study|Participant non compliance|5|||
16957113|NCT01239732|38100098|FG000|Overall Study|Study termination by sponsor|2|||
16957114|NCT01239732|38100098|FG000|Overall Study|Investigator's decision|4|||
16957115|NCT01239732|38100098|FG000|Overall Study|Treatment failure|2|||
16957116|NCT01239732|38100098|FG000|Overall Study|Other|19|||
16957117|NCT02227147|38100104|FG000|Controlled Treatment Period|Adverse Event|4|||
16957118|NCT02227147|38100105|FG001|Controlled Treatment Period|Adverse Event|3|||
16957119|NCT02227147|38100104|FG000|Controlled Treatment Period|Other|2|||
16957120|NCT02227147|38100105|FG001|Controlled Treatment Period|Other|0|||
16957121|NCT02227147|38100104|FG000|Follow-up Period|Other|3|||
16957122|NCT02227147|38100105|FG001|Follow-up Period|Other|5|||
16957123|NCT00948025|38100117|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
16957124|NCT00948025|38100118|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
16957125|NCT00948025|38100117|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
16957126|NCT00948025|38100118|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
16957127|NCT00948025|38100117|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
16957128|NCT00948025|38100118|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
16957129|NCT00947011|38100125|FG000|Overall Study|Study was terminated,PI left institution|12|||
16957130|NCT01239342|38100133|FG000|Overall Study|Adverse Event|1|||
16957131|NCT01239342|38100134|FG001|Overall Study|Adverse Event|0|||
16957132|NCT01239342|38100133|FG000|Overall Study|Withdrawal by Subject|1|||
17131256|NCT01981850|38272714|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
17131257|NCT01981850|38272715|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
17131258|NCT01981850|38272716|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
17131259|NCT01981850|38272717|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
17131260|NCT01981850|38272718|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
17131261|NCT01981850|38272719|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
17131262|NCT01981850|38272710|FG000|Main Phase Stage 1|Various reasons|0|||
17131263|NCT01981850|38272711|FG001|Main Phase Stage 1|Various reasons|0|||
17131264|NCT01981850|38272712|FG002|Main Phase Stage 1|Various reasons|2|||
17131265|NCT01981850|38272713|FG003|Main Phase Stage 1|Various reasons|0|||
17131266|NCT01981850|38272714|FG004|Main Phase Stage 1|Various reasons|0|||
17131267|NCT01981850|38272715|FG005|Main Phase Stage 1|Various reasons|0|||
17131268|NCT01981850|38272716|FG006|Main Phase Stage 1|Various reasons|0|||
17131269|NCT01981850|38272717|FG007|Main Phase Stage 1|Various reasons|0|||
17131270|NCT01981850|38272718|FG008|Main Phase Stage 1|Various reasons|0|||
17131271|NCT01981850|38272719|FG009|Main Phase Stage 1|Various reasons|0|||
17131272|NCT01981850|38272710|FG000|Main Phase Stage 2|Adverse Event|0|||
17131273|NCT01981850|38272711|FG001|Main Phase Stage 2|Adverse Event|0|||
17131274|NCT01981850|38272712|FG002|Main Phase Stage 2|Adverse Event|0|||
17131275|NCT01981850|38272713|FG003|Main Phase Stage 2|Adverse Event|0|||
17131276|NCT01981850|38272714|FG004|Main Phase Stage 2|Adverse Event|6|||
17131277|NCT01981850|38272715|FG005|Main Phase Stage 2|Adverse Event|5|||
17131278|NCT01981850|38272716|FG006|Main Phase Stage 2|Adverse Event|7|||
17131279|NCT01981850|38272717|FG007|Main Phase Stage 2|Adverse Event|0|||
17131280|NCT01981850|38272718|FG008|Main Phase Stage 2|Adverse Event|0|||
17131281|NCT01981850|38272719|FG009|Main Phase Stage 2|Adverse Event|0|||
17131282|NCT01981850|38272710|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
17131283|NCT01981850|38272711|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
17131284|NCT01981850|38272712|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
17131285|NCT01981850|38272713|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
17131286|NCT01981850|38272714|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
17131287|NCT01981850|38272715|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
17131288|NCT01981850|38272716|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
17131289|NCT01981850|38272717|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
17131290|NCT01981850|38272718|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
17131291|NCT01981850|38272719|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
17131292|NCT01981850|38272710|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
17131293|NCT01981850|38272711|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
17131294|NCT01981850|38272712|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
17131295|NCT01981850|38272713|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
17131296|NCT01981850|38272714|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
17131297|NCT01981850|38272715|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
17131298|NCT01981850|38272716|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
17131299|NCT01981850|38272717|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
17131300|NCT01981850|38272718|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
17131301|NCT01981850|38272719|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
17131302|NCT01981850|38272710|FG000|Main Phase Stage 2|Various reasons|0|||
17131303|NCT01981850|38272711|FG001|Main Phase Stage 2|Various reasons|0|||
17131304|NCT01981850|38272712|FG002|Main Phase Stage 2|Various reasons|0|||
17131305|NCT01981850|38272713|FG003|Main Phase Stage 2|Various reasons|0|||
17131306|NCT01981850|38272714|FG004|Main Phase Stage 2|Various reasons|2|||
17131307|NCT01981850|38272715|FG005|Main Phase Stage 2|Various reasons|0|||
17131308|NCT01981850|38272716|FG006|Main Phase Stage 2|Various reasons|1|||
17131309|NCT01981850|38272717|FG007|Main Phase Stage 2|Various reasons|0|||
17131310|NCT01981850|38272718|FG008|Main Phase Stage 2|Various reasons|0|||
17131311|NCT01981850|38272719|FG009|Main Phase Stage 2|Various reasons|0|||
17131312|NCT01981850|38272710|FG000|Main Phase Stage 2|Progressive Disease|0|||
17131313|NCT01981850|38272711|FG001|Main Phase Stage 2|Progressive Disease|0|||
17131314|NCT01981850|38272712|FG002|Main Phase Stage 2|Progressive Disease|0|||
17131315|NCT01981850|38272713|FG003|Main Phase Stage 2|Progressive Disease|0|||
17131316|NCT01981850|38272714|FG004|Main Phase Stage 2|Progressive Disease|0|||
17131317|NCT01981850|38272715|FG005|Main Phase Stage 2|Progressive Disease|6|||
17131318|NCT01981850|38272716|FG006|Main Phase Stage 2|Progressive Disease|6|||
17131319|NCT01981850|38272717|FG007|Main Phase Stage 2|Progressive Disease|0|||
17131320|NCT01981850|38272718|FG008|Main Phase Stage 2|Progressive Disease|0|||
17131321|NCT01981850|38272719|FG009|Main Phase Stage 2|Progressive Disease|0|||
17131322|NCT01981850|38272710|FG000|Open Label Extension (OLE)|Adverse Event|0|||
17131323|NCT01981850|38272711|FG001|Open Label Extension (OLE)|Adverse Event|0|||
17131324|NCT01981850|38272712|FG002|Open Label Extension (OLE)|Adverse Event|0|||
17131325|NCT01981850|38272713|FG003|Open Label Extension (OLE)|Adverse Event|0|||
17131326|NCT01981850|38272714|FG004|Open Label Extension (OLE)|Adverse Event|0|||
17131327|NCT01981850|38272715|FG005|Open Label Extension (OLE)|Adverse Event|0|||
16957133|NCT01239342|38100134|FG001|Overall Study|Withdrawal by Subject|5|||
16957134|NCT01239342|38100133|FG000|Overall Study|Reason Unknown|1|||
16957135|NCT01239342|38100134|FG001|Overall Study|Reason Unknown|1|||
16957136|NCT00946309|38100142|FG000|Overall Study|Protocol Violation|1|||
16957137|NCT00946309|38100143|FG001|Overall Study|Protocol Violation|0|||
16957138|NCT00946309|38100142|FG000|Overall Study|Lost to Follow-up|0|||
16957139|NCT00946309|38100143|FG001|Overall Study|Lost to Follow-up|1|||
16957140|NCT00946309|38100142|FG000|Overall Study|Procedure cancelled/discontinued|0|||
16957141|NCT00946309|38100143|FG001|Overall Study|Procedure cancelled/discontinued|3|||
16957142|NCT01236534|38100152|FG000|Overall Study|Adverse Event|3|||
16957143|NCT01236534|38100153|FG001|Overall Study|Adverse Event|0|||
16957144|NCT01235598|38100161|FG000|Overall Study|Adverse Event|0|||
16957145|NCT01235598|38100162|FG001|Overall Study|Adverse Event|3|||
16957146|NCT01235598|38100161|FG000|Overall Study|Lack of Efficacy|0|||
16957147|NCT01235598|38100162|FG001|Overall Study|Lack of Efficacy|1|||
16957148|NCT01235598|38100161|FG000|Overall Study|Withdrawal by Subject|1|||
16957149|NCT01235598|38100162|FG001|Overall Study|Withdrawal by Subject|0|||
16957150|NCT01235442|38100171|FG000|Overall Study|Lost to Follow-up|12|||
16957151|NCT01235442|38100172|FG001|Overall Study|Lost to Follow-up|10|||
16957152|NCT01235442|38100171|FG000|Overall Study|Death|0|||
16957153|NCT01235442|38100172|FG001|Overall Study|Death|2|||
16957154|NCT01235442|38100171|FG000|Overall Study|Pregnancy|1|||
16957155|NCT01235442|38100172|FG001|Overall Study|Pregnancy|1|||
16957156|NCT01235442|38100171|FG000|Overall Study|Ineligibility determined|5|||
16957157|NCT01235442|38100172|FG001|Overall Study|Ineligibility determined|4|||
16957158|NCT01235442|38100171|FG000|Overall Study|Protocol Violation|3|||
16957159|NCT01235442|38100172|FG001|Overall Study|Protocol Violation|3|||
16957160|NCT01235442|38100171|FG000|Overall Study|Adverse Event|4|||
16957161|NCT01235442|38100172|FG001|Overall Study|Adverse Event|6|||
16957162|NCT01235442|38100171|FG000|Overall Study|Withdrawal by Subject|15|||
16957163|NCT01235442|38100172|FG001|Overall Study|Withdrawal by Subject|9|||
16957164|NCT01235442|38100171|FG000|Overall Study|Lack of Efficacy|1|||
16957165|NCT01235442|38100172|FG001|Overall Study|Lack of Efficacy|3|||
16957166|NCT01235442|38100171|FG000|Overall Study|Noncompliance|1|||
16957167|NCT01235442|38100172|FG001|Overall Study|Noncompliance|2|||
16957168|NCT01235442|38100171|FG000|Overall Study|Administrative decision|1|||
16957169|NCT01235442|38100172|FG001|Overall Study|Administrative decision|2|||
16957170|NCT01235442|38100171|FG000|Overall Study|Other unspecified|1|||
16957171|NCT01235442|38100172|FG001|Overall Study|Other unspecified|2|||
16957172|NCT01163253|38100180|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
16957173|NCT01163253|38100181|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
16957174|NCT01163253|38100180|FG000|Overall Study|Study Terminated by Sponsor|978|||
16957175|NCT01163253|38100181|FG001|Overall Study|Study Terminated by Sponsor|349|||
16957176|NCT01163253|38100180|FG000|Overall Study|Protocol Violation|43|||
16957177|NCT01163253|38100181|FG001|Overall Study|Protocol Violation|12|||
16957178|NCT01163253|38100180|FG000|Overall Study|Withdrawal by Subject|199|||
16957179|NCT01163253|38100181|FG001|Overall Study|Withdrawal by Subject|50|||
16957180|NCT01163253|38100180|FG000|Overall Study|Medication Error|1|||
16957181|NCT01163253|38100181|FG001|Overall Study|Medication Error|0|||
16957182|NCT01163253|38100180|FG000|Overall Study|Lost to Follow-up|125|||
16957183|NCT01163253|38100181|FG001|Overall Study|Lost to Follow-up|23|||
16957184|NCT01163253|38100180|FG000|Overall Study|Insufficient Clinical Response|423|||
16957185|NCT01163253|38100181|FG001|Overall Study|Insufficient Clinical Response|29|||
16957186|NCT01163253|38100180|FG000|Overall Study|Adverse Event|300|||
17131328|NCT01981850|38272716|FG006|Open Label Extension (OLE)|Adverse Event|0|||
17131329|NCT01981850|38272717|FG007|Open Label Extension (OLE)|Adverse Event|2|||
17131330|NCT01981850|38272718|FG008|Open Label Extension (OLE)|Adverse Event|1|||
17131331|NCT01981850|38272719|FG009|Open Label Extension (OLE)|Adverse Event|8|||
17131332|NCT01981850|38272710|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
17131333|NCT01981850|38272711|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
17131334|NCT01981850|38272712|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
17131335|NCT01981850|38272713|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
17131336|NCT01981850|38272714|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
17131337|NCT01981850|38272715|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
17131338|NCT01981850|38272716|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
17131339|NCT01981850|38272717|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
17131340|NCT01981850|38272718|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
17131341|NCT01981850|38272719|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
17131342|NCT01981850|38272710|FG000|Open Label Extension (OLE)|Various reasons|0|||
17131343|NCT01981850|38272711|FG001|Open Label Extension (OLE)|Various reasons|0|||
17131344|NCT01981850|38272712|FG002|Open Label Extension (OLE)|Various reasons|0|||
17131345|NCT01981850|38272713|FG003|Open Label Extension (OLE)|Various reasons|0|||
17131346|NCT01981850|38272714|FG004|Open Label Extension (OLE)|Various reasons|0|||
17131347|NCT01981850|38272715|FG005|Open Label Extension (OLE)|Various reasons|0|||
17131348|NCT01981850|38272716|FG006|Open Label Extension (OLE)|Various reasons|0|||
17131349|NCT01981850|38272717|FG007|Open Label Extension (OLE)|Various reasons|3|||
17131350|NCT01981850|38272718|FG008|Open Label Extension (OLE)|Various reasons|1|||
17131351|NCT01981850|38272719|FG009|Open Label Extension (OLE)|Various reasons|3|||
17131352|NCT01981850|38272710|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
17131353|NCT01981850|38272711|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
17131354|NCT01981850|38272712|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
17131355|NCT01981850|38272713|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
17131356|NCT01981850|38272714|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
17131357|NCT01981850|38272715|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
17131358|NCT01981850|38272716|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
17131359|NCT01981850|38272717|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
17131360|NCT01981850|38272718|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
17131361|NCT01981850|38272719|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
17131362|NCT01981850|38272710|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131363|NCT01981850|38272711|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131364|NCT01981850|38272712|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131365|NCT01981850|38272713|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131366|NCT01981850|38272714|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131367|NCT01981850|38272715|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131368|NCT01981850|38272716|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131369|NCT01981850|38272717|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131370|NCT01981850|38272718|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
17131371|NCT01981850|38272719|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
17131372|NCT01981850|38272710|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131373|NCT01981850|38272711|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131374|NCT01981850|38272712|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131375|NCT01981850|38272713|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131376|NCT01981850|38272714|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131377|NCT01981850|38272715|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131378|NCT01981850|38272716|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131379|NCT01981850|38272717|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131380|NCT01981850|38272718|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
17131381|NCT01981850|38272719|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
17131382|NCT03557307|38272751|FG000|To End of OCS Reduction Phase|Withdrawal by Subject|10|||
17131383|NCT03557307|38272751|FG000|To End of OCS Reduction Phase|Adverse Event|7|||
17131384|NCT03557307|38272751|FG000|To End of OCS Reduction Phase|Protocol Violation|6|||
17131385|NCT03557307|38272751|FG000|To End of OCS Reduction Phase|Lost to Follow-up|5|||
17131386|NCT03557307|38272751|FG000|To End of OCS Reduction Phase|other|3|||
17131387|NCT03557307|38272751|FG000|To End of OCS Reduction Phase|Death|2|||
17131388|NCT03557307|38272751|FG000|To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
17131389|NCT03557307|38272751|FG000|Maintenance Phase|Adverse Event|4|||
17131390|NCT03557307|38272751|FG000|Maintenance Phase|Death|3|||
17131391|NCT03557307|38272751|FG000|Maintenance Phase|Lost to Follow-up|2|||
17131392|NCT03557307|38272751|FG000|Maintenance Phase|Pregnancy|2|||
17131393|NCT03557307|38272751|FG000|Maintenance Phase|Protocol Violation|11|||
17131394|NCT03557307|38272751|FG000|Maintenance Phase|Withdrawal by Subject|2|||
17131395|NCT03557307|38272751|FG000|Maintenance Phase|other|3|||
17131396|NCT00118703|38272757|FG000|Overall Study|Protocol Violation|1|||
17131397|NCT00118703|38272758|FG001|Overall Study|Protocol Violation|0|||
17131398|NCT00118703|38272757|FG000|Overall Study|Adverse Event|1|||
17131399|NCT00118703|38272758|FG001|Overall Study|Adverse Event|1|||
17131400|NCT00118703|38272757|FG000|Overall Study|Participant took two different treatment|0|||
17131401|NCT00118703|38272758|FG001|Overall Study|Participant took two different treatment|1|||
17131402|NCT00118703|38272757|FG000|Overall Study|Withdrawal by Subject|2|||
17131403|NCT00118703|38272758|FG001|Overall Study|Withdrawal by Subject|5|||
17131404|NCT00118703|38272757|FG000|Overall Study|Lost to Follow-up|1|||
17131405|NCT00118703|38272758|FG001|Overall Study|Lost to Follow-up|2|||
17131406|NCT00104104|38272766|FG000|Overall Study|Adverse Event|8|||
17131407|NCT00104104|38272767|FG001|Overall Study|Adverse Event|8|||
17131408|NCT00104104|38272766|FG000|Overall Study|Abnormal laboratory value(s)|20|||
17131409|NCT00104104|38272767|FG001|Overall Study|Abnormal laboratory value(s)|14|||
17131410|NCT00104104|38272766|FG000|Overall Study|Lack of Efficacy|0|||
17131411|NCT00104104|38272767|FG001|Overall Study|Lack of Efficacy|3|||
17131412|NCT00104104|38272766|FG000|Overall Study|Condition no longer requires study drug|7|||
17131413|NCT00104104|38272767|FG001|Overall Study|Condition no longer requires study drug|4|||
17131414|NCT00104104|38272766|FG000|Overall Study|Protocol Violation|5|||
17131415|NCT00104104|38272767|FG001|Overall Study|Protocol Violation|2|||
17131416|NCT00104104|38272766|FG000|Overall Study|Withdrawal by Subject|11|||
17131417|NCT00104104|38272767|FG001|Overall Study|Withdrawal by Subject|15|||
17131418|NCT00104104|38272766|FG000|Overall Study|Lost to Follow-up|3|||
17131419|NCT00104104|38272767|FG001|Overall Study|Lost to Follow-up|7|||
17131420|NCT00104104|38272766|FG000|Overall Study|Administrative problems|12|||
17131421|NCT00104104|38272767|FG001|Overall Study|Administrative problems|13|||
17131422|NCT00104104|38272766|FG000|Overall Study|Death|9|||
17131423|NCT00104104|38272767|FG001|Overall Study|Death|6|||
17131424|NCT03557151|38272775|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
17131425|NCT03557151|38272776|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
17131426|NCT03557151|38272775|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
17131427|NCT03557151|38272776|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
17131428|NCT03557151|38272775|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
17131429|NCT03557151|38272776|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
17131430|NCT00115739|38272784|FG000|Overall Study|Lost to Follow-up|3|||
17131431|NCT01347086|38272800|FG000|Overall Study|failed screening visit|0|||
17131432|NCT01347086|38272801|FG001|Overall Study|failed screening visit|0|||
17131433|NCT01347086|38272802|FG002|Overall Study|failed screening visit|1|||
17131434|NCT01347086|38272803|FG003|Overall Study|failed screening visit|0|||
17131435|NCT01347086|38272804|FG004|Overall Study|failed screening visit|0|||
17131436|NCT01347086|38272805|FG005|Overall Study|failed screening visit|0|||
17131437|NCT01347086|38272806|FG006|Overall Study|failed screening visit|1|||
17131438|NCT01347086|38272807|FG007|Overall Study|failed screening visit|1|||
17131439|NCT01347086|38272808|FG008|Overall Study|failed screening visit|0|||
17131440|NCT01347086|38272809|FG009|Overall Study|failed screening visit|1|||
17131441|NCT03605745|38272841|FG000|Overall Study|Study was terminated for business reasons|47|||
17131442|NCT03246152|38272845|FG000|Overall Study|Lost to Follow-up|2|||
17131443|NCT03246152|38272845|FG000|Overall Study|Protocol Violation|1|||
17131444|NCT03571581|38272849|FG000|Overall Study|Death|2|||
17131445|NCT03571581|38272849|FG000|Overall Study|Withdrawal by Subject|2|||
17131446|NCT00115349|38272858|FG000|Overall Study|Study closed due to low enrollment.|11|||
17131447|NCT00115349|38272859|FG001|Overall Study|Study closed due to low enrollment.|9|||
17131448|NCT00115037|38272867|FG000|Phase1|Lost to Follow-up|16|||
17131449|NCT00115037|38272868|FG001|Phase1|Lost to Follow-up|23|||
17131450|NCT00115037|38272869|FG002|Phase1|Lost to Follow-up|0|||
17131451|NCT00115037|38272870|FG003|Phase1|Lost to Follow-up|0|||
17131452|NCT00115037|38272871|FG004|Phase1|Lost to Follow-up|0|||
17131453|NCT00115037|38272872|FG005|Phase1|Lost to Follow-up|0|||
17131454|NCT00115037|38272867|FG000|Phase1|Withdrawal by Subject|9|||
17131455|NCT00115037|38272868|FG001|Phase1|Withdrawal by Subject|4|||
17131456|NCT00115037|38272869|FG002|Phase1|Withdrawal by Subject|0|||
17131457|NCT00115037|38272870|FG003|Phase1|Withdrawal by Subject|0|||
17131458|NCT00115037|38272871|FG004|Phase1|Withdrawal by Subject|0|||
17131459|NCT00115037|38272872|FG005|Phase1|Withdrawal by Subject|0|||
17131460|NCT00115037|38272867|FG000|Phase2|Death|0|||
17131461|NCT00115037|38272868|FG001|Phase2|Death|0|||
17131462|NCT00115037|38272869|FG002|Phase2|Death|1|||
17131463|NCT00115037|38272870|FG003|Phase2|Death|0|||
17131464|NCT00115037|38272871|FG004|Phase2|Death|0|||
17131465|NCT00115037|38272872|FG005|Phase2|Death|1|||
17131466|NCT00115037|38272867|FG000|Phase2|Withdrawal by Subject|0|||
17131467|NCT00115037|38272868|FG001|Phase2|Withdrawal by Subject|0|||
17131468|NCT00115037|38272869|FG002|Phase2|Withdrawal by Subject|2|||
17131469|NCT00115037|38272870|FG003|Phase2|Withdrawal by Subject|1|||
17131470|NCT00115037|38272871|FG004|Phase2|Withdrawal by Subject|2|||
17131471|NCT00115037|38272872|FG005|Phase2|Withdrawal by Subject|1|||
17131472|NCT00115037|38272867|FG000|Phase2|Lost to Follow-up|0|||
17131473|NCT00115037|38272868|FG001|Phase2|Lost to Follow-up|0|||
17131474|NCT00115037|38272869|FG002|Phase2|Lost to Follow-up|12|||
17131475|NCT00115037|38272870|FG003|Phase2|Lost to Follow-up|14|||
17131476|NCT00115037|38272871|FG004|Phase2|Lost to Follow-up|4|||
17131477|NCT00115037|38272872|FG005|Phase2|Lost to Follow-up|10|||
17131478|NCT03555435|38272889|FG000|Overall Study|Lost to Follow-up|17|||
17131479|NCT03555435|38272890|FG001|Overall Study|Lost to Follow-up|19|||
17131480|NCT03555435|38272891|FG002|Overall Study|Lost to Follow-up|8|||
17131481|NCT03214640|38272903|FG000|Overall Study|Protocol Violation|1|||
17131482|NCT03214640|38272904|FG001|Overall Study|Protocol Violation|2|||
17131483|NCT03214640|38272905|FG002|Overall Study|Protocol Violation|1|||
17131484|NCT03214640|38272906|FG003|Overall Study|Protocol Violation|4|||
17131485|NCT03214406|38272918|FG000|Overall Study|did not meet enrollment criteria|9|||
17131486|NCT03214406|38272919|FG001|Overall Study|did not meet enrollment criteria|13|||
17131487|NCT03214406|38272918|FG000|Overall Study|Withdrawal by Subject|1|||
17131488|NCT03214406|38272919|FG001|Overall Study|Withdrawal by Subject|0|||
17131489|NCT03214406|38272918|FG000|Overall Study|Lost to Follow-up|0|||
17131490|NCT03214406|38272919|FG001|Overall Study|Lost to Follow-up|2|||
17131491|NCT03213938|38272927|FG000|Overall Study|Lost to Follow-up|4|||
17131492|NCT03213938|38272928|FG001|Overall Study|Lost to Follow-up|3|||
17131493|NCT03213938|38272927|FG000|Overall Study|Lack of Efficacy|1|||
17131494|NCT03213938|38272928|FG001|Overall Study|Lack of Efficacy|0|||
17131495|NCT03213938|38272927|FG000|Overall Study|Decline to participate|5|||
16957187|NCT01163253|38100181|FG001|Overall Study|Adverse Event|78|||
16957188|NCT01163253|38100180|FG000|Overall Study|Death|17|||
16957189|NCT01163253|38100181|FG001|Overall Study|Death|5|||
16957190|NCT01163253|38100180|FG000|Overall Study|Ongoing|13|||
16957191|NCT01163253|38100181|FG001|Overall Study|Ongoing|4|||
16957192|NCT01163253|38100180|FG000|Overall Study|Other Unspecified|170|||
16957193|NCT01163253|38100181|FG001|Overall Study|Other Unspecified|34|||
16957194|NCT01162863|38100190|FG000|Overall Study|Lack of Efficacy|1|||
16957195|NCT01162863|38100191|FG001|Overall Study|Lack of Efficacy|0|||
16957196|NCT01162863|38100192|FG002|Overall Study|Lack of Efficacy|0|||
16957197|NCT01162863|38100190|FG000|Overall Study|Adverse Event|0|||
16957198|NCT01162863|38100191|FG001|Overall Study|Adverse Event|1|||
16957199|NCT01162863|38100192|FG002|Overall Study|Adverse Event|0|||
16957200|NCT01162473|38100202|FG000|Overall Study|Adverse Event|2|||
16957201|NCT01162473|38100203|FG001|Overall Study|Adverse Event|1|||
16957202|NCT01162473|38100202|FG000|Overall Study|Withdrawal by Subject|0|||
16957203|NCT01162473|38100203|FG001|Overall Study|Withdrawal by Subject|4|||
16957204|NCT01162239|38100213|FG000|Treatment Phase|Withdrawal by Subject|1|||
16957205|NCT01162239|38100214|FG001|Treatment Phase|Withdrawal by Subject|3|||
16957206|NCT01162239|38100215|FG002|Treatment Phase|Withdrawal by Subject|2|||
16957207|NCT01162239|38100216|FG003|Treatment Phase|Withdrawal by Subject|3|||
16957208|NCT01162239|38100213|FG000|Treatment Phase|Death|0|||
16957209|NCT01162239|38100214|FG001|Treatment Phase|Death|0|||
16957210|NCT01162239|38100215|FG002|Treatment Phase|Death|0|||
16957211|NCT01162239|38100216|FG003|Treatment Phase|Death|1|||
16957212|NCT01162239|38100213|FG000|Treatment Phase|Lost to Follow-up|5|||
16957213|NCT01162239|38100214|FG001|Treatment Phase|Lost to Follow-up|4|||
16957214|NCT01162239|38100215|FG002|Treatment Phase|Lost to Follow-up|2|||
16957215|NCT01162239|38100216|FG003|Treatment Phase|Lost to Follow-up|1|||
16957216|NCT01162239|38100213|FG000|Extended Follow-up|Lost to Follow-up|8|||
16957217|NCT01162239|38100214|FG001|Extended Follow-up|Lost to Follow-up|13|||
16957218|NCT01162239|38100215|FG002|Extended Follow-up|Lost to Follow-up|8|||
16957219|NCT01162239|38100216|FG003|Extended Follow-up|Lost to Follow-up|6|||
16957220|NCT01161537|38100227|FG000|Part B|Withdrawal by Subject|2|||
16957221|NCT01234350|38100238|FG000|Overall Study|Adverse Event|277|||
16957222|NCT01234350|38100239|FG001|Overall Study|Adverse Event|92|||
16957223|NCT01234350|38100238|FG000|Overall Study|Withdrawal by Subject|61|||
16957224|NCT01234350|38100239|FG001|Overall Study|Withdrawal by Subject|36|||
16957225|NCT01234350|38100238|FG000|Overall Study|Lost to Follow-up|115|||
16957226|NCT01234350|38100239|FG001|Overall Study|Lost to Follow-up|47|||
16957227|NCT01234350|38100238|FG000|Overall Study|Covers a diverse set of reasons|234|||
16957228|NCT01234350|38100239|FG001|Overall Study|Covers a diverse set of reasons|92|||
16957229|NCT01233258|38100250|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
16957230|NCT01233258|38100251|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
16957231|NCT01233258|38100252|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
16957232|NCT01233258|38100253|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
16957233|NCT01233258|38100254|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
17131496|NCT03213938|38272928|FG001|Overall Study|Decline to participate|4|||
17131497|NCT03213938|38272927|FG000|Overall Study|Without reason|4|||
17131498|NCT03213938|38272928|FG001|Overall Study|Without reason|5|||
17131499|NCT03604497|38272934|FG000|Overall Study|Protocol Violation|52|||
17131500|NCT03213626|38272942|FG000|Overall Study|Adverse Event|1|||
17131501|NCT03213626|38272942|FG000|Overall Study|Progressive Disease|6|||
17131502|NCT03604341|38272948|FG000|Overall Study|Withdrawal by Subject|1|||
17131503|NCT03604341|38272949|FG001|Overall Study|Withdrawal by Subject|1|||
17131504|NCT03604341|38272948|FG000|Overall Study|Adverse Event|1|||
17131505|NCT03604341|38272949|FG001|Overall Study|Adverse Event|0|||
17131506|NCT03604341|38272948|FG000|Overall Study|Protocol Violation|0|||
17131507|NCT03604341|38272949|FG001|Overall Study|Protocol Violation|1|||
17131508|NCT03603639|38272955|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
17131509|NCT03603639|38272956|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
17131510|NCT03603639|38272957|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
17131511|NCT03603639|38272958|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
17131512|NCT03603639|38272959|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
17131513|NCT03603639|38272960|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
17131514|NCT03603639|38272955|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
17131515|NCT03603639|38272956|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
17131516|NCT03603639|38272957|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
17131517|NCT03603639|38272958|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
17131518|NCT03603639|38272959|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
17131519|NCT03603639|38272960|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
17131520|NCT00114959|38272974|FG000|Overall Study|Lack of Efficacy|6|||
17131521|NCT00114959|38272974|FG000|Overall Study|Physician Decision|1|||
17131522|NCT00114959|38272974|FG000|Overall Study|Death|1|||
17131523|NCT02778100|38272980|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
17131524|NCT02778100|38272981|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
17131525|NCT00118157|38272989|FG000|Overall Study|Adverse Event|2|||
17131526|NCT00118157|38272989|FG000|Overall Study|Death|8|||
17131527|NCT00118157|38272989|FG000|Overall Study|Withdrawal by Subject|2|||
17131528|NCT02762500|38272996|FG000|Overall Study|Lack of Efficacy|1|||
17131529|NCT02762500|38272997|FG001|Overall Study|Lack of Efficacy|0|||
17131530|NCT02762500|38272996|FG000|Overall Study|Withdrawal by Subject|1|||
17131531|NCT02762500|38272997|FG001|Overall Study|Withdrawal by Subject|1|||
17131532|NCT02762500|38272996|FG000|Overall Study|Adverse Event|0|||
17131533|NCT02762500|38272997|FG001|Overall Study|Adverse Event|2|||
17131534|NCT03552549|38273005|FG000|Overall Study|Disease progression|25|||
17131535|NCT03552549|38273006|FG001|Overall Study|Disease progression|17|||
17131536|NCT03552549|38273005|FG000|Overall Study|Adverse event in first 12 months|12|||
17131537|NCT03552549|38273006|FG001|Overall Study|Adverse event in first 12 months|8|||
17131538|NCT03552549|38273005|FG000|Overall Study|Withdrawal by Subject|7|||
17131539|NCT03552549|38273006|FG001|Overall Study|Withdrawal by Subject|7|||
17131540|NCT03552549|38273005|FG000|Overall Study|Unknown (no reason provided)|4|||
17131541|NCT03552549|38273006|FG001|Overall Study|Unknown (no reason provided)|2|||
17131542|NCT03552549|38273005|FG000|Overall Study|Not in participant's best interest|2|||
17131543|NCT03552549|38273006|FG001|Overall Study|Not in participant's best interest|1|||
17131544|NCT03552549|38273005|FG000|Overall Study|Did not complete study treatment|2|||
17131545|NCT03552549|38273006|FG001|Overall Study|Did not complete study treatment|3|||
17131546|NCT03552549|38273005|FG000|Overall Study|Did not meet eligibility criteria|1|||
17131547|NCT03552549|38273006|FG001|Overall Study|Did not meet eligibility criteria|0|||
17131548|NCT03552549|38273005|FG000|Overall Study|Administrative|0|||
17131549|NCT03552549|38273006|FG001|Overall Study|Administrative|14|||
16957234|NCT01233258|38100255|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
17131550|NCT00117845|38273012|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
17131551|NCT02761642|38273016|FG000|Overall Study|Did not Receive Study Treatment|3|||
17131552|NCT02761642|38273016|FG000|Overall Study|Adverse Event|13|||
17131553|NCT02761642|38273016|FG000|Overall Study|Withdrawal by Subject|2|||
17131554|NCT02761642|38273016|FG000|Overall Study|Non-compliant|7|||
17131555|NCT02761642|38273016|FG000|Overall Study|Death|3|||
17131556|NCT02761642|38273016|FG000|Overall Study|Lack of Efficacy|20|||
17131557|NCT02761642|38273016|FG000|Overall Study|Physician Decision|1|||
17131558|NCT02761642|38273016|FG000|Overall Study|Reason Unspecified|21|||
17131559|NCT00113555|38273020|FG000|Overall Study|Baseline Failure|59|||
17131560|NCT00113555|38273020|FG000|Overall Study|Permanently Explanted|7|||
17131561|NCT00113555|38273020|FG000|Overall Study|Death|1|||
17131562|NCT00113555|38273020|FG000|Overall Study|Missed Followup|4|||
17131563|NCT00113555|38273020|FG000|Overall Study|Lost to Follow-up|8|||
17131564|NCT03189524|38273028|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
17131565|NCT03189524|38273029|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
17131566|NCT03189524|38273030|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
17131567|NCT03189524|38273028|FG000|Overall Study|Death|2|||
17131568|NCT03189524|38273029|FG001|Overall Study|Death|2|||
17131569|NCT03189524|38273030|FG002|Overall Study|Death|1|||
17131570|NCT03189524|38273028|FG000|Overall Study|Lost to Follow-up|1|||
17131571|NCT03189524|38273029|FG001|Overall Study|Lost to Follow-up|0|||
17131572|NCT03189524|38273030|FG002|Overall Study|Lost to Follow-up|8|||
17131573|NCT03189524|38273028|FG000|Overall Study|Withdrawal by Subject|1|||
17131574|NCT03189524|38273029|FG001|Overall Study|Withdrawal by Subject|1|||
17131575|NCT03189524|38273030|FG002|Overall Study|Withdrawal by Subject|3|||
17131576|NCT03189524|38273028|FG000|Overall Study|Progressive Disease|0|||
17131577|NCT03189524|38273029|FG001|Overall Study|Progressive Disease|2|||
17131578|NCT03189524|38273030|FG002|Overall Study|Progressive Disease|0|||
17131579|NCT03600909|38273045|FG000|Overall Study|Not treated|0|||
17131580|NCT03600909|38273046|FG001|Overall Study|Not treated|3|||
17131581|NCT03600909|38273047|FG002|Overall Study|Not treated|0|||
17131582|NCT03189446|38273055|FG000|Overall Study|Adverse Event|2|||
17131583|NCT03189446|38273055|FG000|Overall Study|Withdrawal by Subject|2|||
17131584|NCT03189446|38273055|FG000|Overall Study|Physician Decision|1|||
17131585|NCT03212690|38273059|FG000|Overall Study|Protocol Violation|1|||
17131586|NCT03568461|38273063|FG000|Overall Study|Death|7|||
17131587|NCT03568461|38273063|FG000|Overall Study|Physician Decision|5|||
17131588|NCT03568461|38273063|FG000|Overall Study|Subject decision|5|||
17131589|NCT03568461|38273063|FG000|Overall Study|Lost to Follow-up|1|||
17131590|NCT03188120|38273067|FG000|Overall Study|Adverse Event|4|||
17131591|NCT03188120|38273067|FG000|Overall Study|Insufficient Effectiveness|8|||
17131592|NCT03188120|38273067|FG000|Overall Study|Improved|12|||
17131593|NCT03188120|38273067|FG000|Overall Study|Lost to Follow-up|7|||
17131594|NCT03188120|38273067|FG000|Overall Study|Other than specified|3|||
17131595|NCT03188120|38273067|FG000|Overall Study|No visit after the first visit|13|||
17131596|NCT02895945|38273073|FG000|Overall Study|Physician Decision|2|||
17131597|NCT02895945|38273074|FG001|Overall Study|Physician Decision|1|||
17131598|NCT02777554|38273082|FG000|Overall Study|Adverse Event|4|||
17131599|NCT02777554|38273083|FG001|Overall Study|Adverse Event|4|||
17131600|NCT02777554|38273084|FG002|Overall Study|Adverse Event|0|||
17131601|NCT02777554|38273085|FG003|Overall Study|Adverse Event|1|||
17131602|NCT02777554|38273086|FG004|Overall Study|Adverse Event|0|||
17131603|NCT02777554|38273087|FG005|Overall Study|Adverse Event|0|||
17131604|NCT02777554|38273082|FG000|Overall Study|Withdrawal by Subject|3|||
17131605|NCT02777554|38273083|FG001|Overall Study|Withdrawal by Subject|1|||
17131606|NCT02777554|38273084|FG002|Overall Study|Withdrawal by Subject|1|||
17131607|NCT02777554|38273085|FG003|Overall Study|Withdrawal by Subject|0|||
17131608|NCT02777554|38273086|FG004|Overall Study|Withdrawal by Subject|0|||
17131609|NCT02777554|38273087|FG005|Overall Study|Withdrawal by Subject|0|||
17131610|NCT02777554|38273082|FG000|Overall Study|Discharged early due to hurricane|22|||
17131611|NCT02777554|38273083|FG001|Overall Study|Discharged early due to hurricane|20|||
17131612|NCT02777554|38273084|FG002|Overall Study|Discharged early due to hurricane|0|||
17131613|NCT02777554|38273085|FG003|Overall Study|Discharged early due to hurricane|0|||
17131614|NCT02777554|38273086|FG004|Overall Study|Discharged early due to hurricane|0|||
17131615|NCT02777554|38273087|FG005|Overall Study|Discharged early due to hurricane|0|||
17131616|NCT02777554|38273082|FG000|Overall Study|Other - Miscellaneous|1|||
17131617|NCT02777554|38273083|FG001|Overall Study|Other - Miscellaneous|0|||
17131618|NCT02777554|38273084|FG002|Overall Study|Other - Miscellaneous|0|||
17131619|NCT02777554|38273085|FG003|Overall Study|Other - Miscellaneous|0|||
17131620|NCT02777554|38273086|FG004|Overall Study|Other - Miscellaneous|0|||
17131621|NCT02777554|38273087|FG005|Overall Study|Other - Miscellaneous|0|||
17131622|NCT03550209|38273111|FG000|Overall Study|Lost to Follow-up|1|||
17131623|NCT03550209|38273112|FG001|Overall Study|Lost to Follow-up|0|||
17131624|NCT03550209|38273113|FG002|Overall Study|Lost to Follow-up|1|||
17131625|NCT03550209|38273114|FG003|Overall Study|Lost to Follow-up|0|||
17131626|NCT03550209|38273111|FG000|Overall Study|Withdrawal by Subject|0|||
17131627|NCT03550209|38273112|FG001|Overall Study|Withdrawal by Subject|3|||
17131628|NCT03550209|38273113|FG002|Overall Study|Withdrawal by Subject|1|||
17131629|NCT03550209|38273114|FG003|Overall Study|Withdrawal by Subject|2|||
17131630|NCT03550209|38273111|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
17131631|NCT03550209|38273112|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
17131632|NCT03550209|38273113|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
17131633|NCT03550209|38273114|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
17131634|NCT02764762|38273124|FG000|Overall Study|Adverse Event|5|||
17131635|NCT02764762|38273124|FG000|Overall Study|Voluntary Withdrawal|3|||
17131636|NCT02764762|38273124|FG000|Overall Study|Significant Deviation|1|||
17131637|NCT03032510|38273130|FG000|Overall Study|Adverse Event|5|||
17131638|NCT03032510|38273131|FG001|Overall Study|Adverse Event|2|||
17131639|NCT03032510|38273130|FG000|Overall Study|Lost to Follow-up|8|||
17131640|NCT03032510|38273131|FG001|Overall Study|Lost to Follow-up|7|||
17131641|NCT03032510|38273130|FG000|Overall Study|Withdrawal by Subject|8|||
17131642|NCT03032510|38273131|FG001|Overall Study|Withdrawal by Subject|7|||
17131643|NCT03032510|38273130|FG000|Overall Study|Subject noncompliance|4|||
17131644|NCT03032510|38273131|FG001|Overall Study|Subject noncompliance|2|||
17131645|NCT03032510|38273130|FG000|Overall Study|Physician Decision|2|||
17131646|NCT03032510|38273131|FG001|Overall Study|Physician Decision|0|||
17131647|NCT03599349|38273141|FG000|Overall Study|Lost to Follow-up|1|||
17131648|NCT03599193|38273151|FG000|Overall Study|Adverse Event|0|||
17131649|NCT03599193|38273152|FG001|Overall Study|Adverse Event|2|||
17131650|NCT03599193|38273151|FG000|Overall Study|Withdrawal by Subject|1|||
17131651|NCT03599193|38273152|FG001|Overall Study|Withdrawal by Subject|0|||
17131652|NCT03599193|38273151|FG000|Overall Study|Protocol Violation|1|||
17131653|NCT03599193|38273152|FG001|Overall Study|Protocol Violation|0|||
17131654|NCT03599193|38273151|FG000|Overall Study|Lost to Follow-up|0|||
17131655|NCT03599193|38273152|FG001|Overall Study|Lost to Follow-up|1|||
17131656|NCT03166124|38273161|FG000|Treatment Period 1|Adverse Event|0|||
17131657|NCT03166124|38273162|FG001|Treatment Period 1|Adverse Event|0|||
17131658|NCT03166124|38273163|FG002|Treatment Period 1|Adverse Event|1|||
17131659|NCT03166124|38273164|FG003|Treatment Period 1|Adverse Event|0|||
17131660|NCT03166124|38273161|FG000|Wash-out Period|Withdrawal by Subject|0|||
17131661|NCT03166124|38273162|FG001|Wash-out Period|Withdrawal by Subject|1|||
17131662|NCT03166124|38273163|FG002|Wash-out Period|Withdrawal by Subject|0|||
17131663|NCT03166124|38273164|FG003|Wash-out Period|Withdrawal by Subject|1|||
17131664|NCT03166124|38273161|FG000|Wash-out Period|Adverse Event|0|||
17131665|NCT03166124|38273162|FG001|Wash-out Period|Adverse Event|1|||
17131666|NCT03166124|38273163|FG002|Wash-out Period|Adverse Event|1|||
17131667|NCT03166124|38273164|FG003|Wash-out Period|Adverse Event|0|||
17131668|NCT03567291|38273175|FG000|Period I|Adverse Event|14|||
17131669|NCT03567291|38273176|FG001|Period I|Adverse Event|0|||
17131670|NCT03567291|38273177|FG002|Period I|Adverse Event|0|||
17131671|NCT03567291|38273178|FG003|Period I|Adverse Event|0|||
17131672|NCT03567291|38273175|FG000|Period I|Protocol Violation|1|||
17131673|NCT03567291|38273176|FG001|Period I|Protocol Violation|0|||
17131674|NCT03567291|38273177|FG002|Period I|Protocol Violation|0|||
17131675|NCT03567291|38273178|FG003|Period I|Protocol Violation|0|||
17131676|NCT03567291|38273175|FG000|Period I|Withdrawal by Subject|23|||
17131677|NCT03567291|38273176|FG001|Period I|Withdrawal by Subject|0|||
17131678|NCT03567291|38273177|FG002|Period I|Withdrawal by Subject|0|||
17131679|NCT03567291|38273178|FG003|Period I|Withdrawal by Subject|0|||
17131680|NCT03567291|38273175|FG000|Period I|Lost to Follow-up|2|||
17131681|NCT03567291|38273176|FG001|Period I|Lost to Follow-up|0|||
17131682|NCT03567291|38273177|FG002|Period I|Lost to Follow-up|0|||
17131683|NCT03567291|38273178|FG003|Period I|Lost to Follow-up|0|||
17131684|NCT03567291|38273175|FG000|Period I|Terminated by sponsor|44|||
17131685|NCT03567291|38273176|FG001|Period I|Terminated by sponsor|0|||
17131686|NCT03567291|38273177|FG002|Period I|Terminated by sponsor|0|||
17131687|NCT03567291|38273178|FG003|Period I|Terminated by sponsor|0|||
17131688|NCT03567291|38273175|FG000|Period I|Missing or unknown|7|||
17131689|NCT03567291|38273176|FG001|Period I|Missing or unknown|0|||
17131690|NCT03567291|38273177|FG002|Period I|Missing or unknown|0|||
17131691|NCT03567291|38273178|FG003|Period I|Missing or unknown|0|||
17131692|NCT03567291|38273175|FG000|Period II|Adverse Event|0|||
17131693|NCT03567291|38273176|FG001|Period II|Adverse Event|1|||
17131694|NCT03567291|38273177|FG002|Period II|Adverse Event|0|||
17131695|NCT03567291|38273178|FG003|Period II|Adverse Event|0|||
17131696|NCT03567291|38273175|FG000|Period II|Missing or unknown|0|||
17131697|NCT03567291|38273176|FG001|Period II|Missing or unknown|2|||
17131698|NCT03567291|38273177|FG002|Period II|Missing or unknown|1|||
17131699|NCT03567291|38273178|FG003|Period II|Missing or unknown|0|||
17131700|NCT03567291|38273175|FG000|Period III|Adverse Event|0|||
17131701|NCT03567291|38273176|FG001|Period III|Adverse Event|0|||
17131702|NCT03567291|38273177|FG002|Period III|Adverse Event|0|||
16957235|NCT01233258|38100250|FG000|First Intervention (6 Months)|Protocol Violation|0|||
16957236|NCT01233258|38100251|FG001|First Intervention (6 Months)|Protocol Violation|0|||
16957237|NCT01233258|38100252|FG002|First Intervention (6 Months)|Protocol Violation|1|||
16957238|NCT01233258|38100253|FG003|First Intervention (6 Months)|Protocol Violation|0|||
16957239|NCT01233258|38100254|FG004|First Intervention (6 Months)|Protocol Violation|0|||
16957240|NCT01233258|38100255|FG005|First Intervention (6 Months)|Protocol Violation|0|||
16957241|NCT01233258|38100250|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
16957242|NCT01233258|38100251|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
16957243|NCT01233258|38100252|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
16957244|NCT01233258|38100253|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
16957245|NCT01233258|38100254|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
16774403|NCT03181529|37713757|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
16774404|NCT03470441|37713771|FG000|Overall Study|Death|0|||
16774405|NCT03470441|37713772|FG001|Overall Study|Death|1|||
16774406|NCT03470441|37713773|FG002|Overall Study|Death|1|||
16957246|NCT01233258|38100255|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
16957247|NCT01232868|38100272|FG000|Overall Study|Lost to Follow-up|2|||
16957248|NCT01232868|38100273|FG001|Overall Study|Lost to Follow-up|4|||
16957249|NCT01232790|38100279|FG000|Randomization|Withdrawal by Subject|2|||
16957250|NCT01232790|38100280|FG001|Randomization|Withdrawal by Subject|0|||
16957251|NCT01232790|38100279|FG000|Randomization|Protocol Violation|0|||
16957252|NCT01232790|38100280|FG001|Randomization|Protocol Violation|1|||
16957253|NCT01232790|38100279|FG000|Randomization|Physician Decision|0|||
16957254|NCT01232790|38100280|FG001|Randomization|Physician Decision|1|||
16957255|NCT01232790|38100279|FG000|Initial Assessment|Withdrawal by Subject|0|||
16957256|NCT01232790|38100280|FG001|Initial Assessment|Withdrawal by Subject|1|||
16957257|NCT01232790|38100279|FG000|First Crossover|Withdrawal by Subject|1|||
16957258|NCT01232790|38100280|FG001|First Crossover|Withdrawal by Subject|0|||
16957259|NCT01232790|38100279|FG000|Second Crossover|Withdrawal by Subject|1|||
16957260|NCT01232790|38100280|FG001|Second Crossover|Withdrawal by Subject|2|||
16957261|NCT01232556|38100298|FG000|Overall Study|Withdrawal by Subject|21|||
16957262|NCT01232556|38100299|FG001|Overall Study|Withdrawal by Subject|17|||
16957263|NCT01232556|38100298|FG000|Overall Study|Death|97|||
16957264|NCT01232556|38100299|FG001|Overall Study|Death|97|||
16957265|NCT01232556|38100298|FG000|Overall Study|Lost to Follow-up|0|||
16957266|NCT01232556|38100299|FG001|Overall Study|Lost to Follow-up|2|||
16957267|NCT01232556|38100298|FG000|Overall Study|Terminated by Sponsor|35|||
16957268|NCT01232556|38100299|FG001|Overall Study|Terminated by Sponsor|51|||
16957269|NCT01232556|38100298|FG000|Overall Study|Other|6|||
16957270|NCT01232556|38100299|FG001|Overall Study|Other|4|||
16957271|NCT00946153|38100310|FG000|Phase 2|Adverse Event|0|||
16957272|NCT00946153|38100311|FG001|Phase 2|Adverse Event|0|||
16957273|NCT00946153|38100312|FG002|Phase 2|Adverse Event|0|||
16957274|NCT00946153|38100313|FG003|Phase 2|Adverse Event|0|||
16957275|NCT00946153|38100314|FG004|Phase 2|Adverse Event|6|||
16957276|NCT00946153|38100310|FG000|Phase 2|Need more reduction of dose|0|||
16957277|NCT00946153|38100311|FG001|Phase 2|Need more reduction of dose|0|||
16957278|NCT00946153|38100312|FG002|Phase 2|Need more reduction of dose|0|||
16957279|NCT00946153|38100313|FG003|Phase 2|Need more reduction of dose|0|||
16957280|NCT00946153|38100314|FG004|Phase 2|Need more reduction of dose|2|||
16957281|NCT00946153|38100310|FG000|Phase 2|Physician Decision|0|||
16957282|NCT00946153|38100311|FG001|Phase 2|Physician Decision|0|||
16957283|NCT00946153|38100312|FG002|Phase 2|Physician Decision|0|||
16957284|NCT00946153|38100313|FG003|Phase 2|Physician Decision|0|||
16957285|NCT00946153|38100314|FG004|Phase 2|Physician Decision|1|||
16957286|NCT00946153|38100310|FG000|Phase 2|14 days washout for recovery due to AE|0|||
16957287|NCT00946153|38100311|FG001|Phase 2|14 days washout for recovery due to AE|0|||
16957288|NCT00946153|38100312|FG002|Phase 2|14 days washout for recovery due to AE|0|||
16957289|NCT00946153|38100313|FG003|Phase 2|14 days washout for recovery due to AE|0|||
16957290|NCT00946153|38100314|FG004|Phase 2|14 days washout for recovery due to AE|4|||
16957291|NCT01160289|38100336|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
16957292|NCT01160289|38100337|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16957293|NCT01160289|38100338|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16957294|NCT01160289|38100339|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16957295|NCT01160289|38100340|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16957296|NCT01160289|38100341|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16957297|NCT01160289|38100336|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
17131703|NCT03567291|38273178|FG003|Period III|Adverse Event|4|||
17131704|NCT03567291|38273175|FG000|Period III|Withdrawal by Subject|0|||
17131705|NCT03567291|38273176|FG001|Period III|Withdrawal by Subject|0|||
17131706|NCT03567291|38273177|FG002|Period III|Withdrawal by Subject|0|||
17131707|NCT03567291|38273178|FG003|Period III|Withdrawal by Subject|4|||
17131708|NCT03567291|38273175|FG000|Period III|Lost to Follow-up|0|||
17131709|NCT03567291|38273176|FG001|Period III|Lost to Follow-up|0|||
17131710|NCT03567291|38273177|FG002|Period III|Lost to Follow-up|0|||
17131711|NCT03567291|38273178|FG003|Period III|Lost to Follow-up|1|||
17131712|NCT03567291|38273175|FG000|Period III|Terminated by sponsor|0|||
17131713|NCT03567291|38273176|FG001|Period III|Terminated by sponsor|0|||
17131714|NCT03567291|38273177|FG002|Period III|Terminated by sponsor|0|||
17131715|NCT03567291|38273178|FG003|Period III|Terminated by sponsor|68|||
17131716|NCT03567291|38273175|FG000|Period III|Missing or unknown|0|||
17131717|NCT03567291|38273176|FG001|Period III|Missing or unknown|0|||
17131718|NCT03567291|38273177|FG002|Period III|Missing or unknown|0|||
17131719|NCT03567291|38273178|FG003|Period III|Missing or unknown|8|||
17131720|NCT02777242|38273184|FG000|Overall Study|Other|2|||
17131721|NCT02777242|38273184|FG000|Overall Study|Lost to Follow-up|1|||
17131722|NCT02777242|38273184|FG000|Overall Study|Multiple|1|||
17131723|NCT02777242|38273184|FG000|Overall Study|Sponsor's request|1|||
17131724|NCT02777242|38273184|FG000|Overall Study|Withdrawal by Subject|1|||
17131725|NCT03212144|38273190|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
17131726|NCT03212144|38273191|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
17131727|NCT03212144|38273190|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
17131728|NCT03212144|38273191|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
17131729|NCT03566979|38273201|FG000|Overall Study|Withdrawal by Subject|2|||
17131730|NCT03566979|38273202|FG001|Overall Study|Withdrawal by Subject|0|||
17131731|NCT03566979|38273203|FG002|Overall Study|Withdrawal by Subject|1|||
17131732|NCT03566979|38273204|FG003|Overall Study|Withdrawal by Subject|1|||
17131733|NCT03566979|38273201|FG000|Overall Study|Lost to Follow-up|2|||
17131734|NCT03566979|38273202|FG001|Overall Study|Lost to Follow-up|7|||
17131735|NCT03566979|38273203|FG002|Overall Study|Lost to Follow-up|9|||
17131736|NCT03566979|38273204|FG003|Overall Study|Lost to Follow-up|5|||
17131737|NCT03566979|38273201|FG000|Overall Study|Adverse Event|1|||
17131738|NCT03566979|38273202|FG001|Overall Study|Adverse Event|0|||
17131739|NCT03566979|38273203|FG002|Overall Study|Adverse Event|0|||
17131740|NCT03566979|38273204|FG003|Overall Study|Adverse Event|0|||
17131741|NCT00116831|38273216|FG000|Overall Study|Adverse Event|14|||
17131742|NCT00116831|38273217|FG001|Overall Study|Adverse Event|16|||
17131743|NCT00116831|38273216|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
17131744|NCT00116831|38273217|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
17131745|NCT00116831|38273216|FG000|Overall Study|Lost to Follow-up|8|||
17131746|NCT00116831|38273217|FG001|Overall Study|Lost to Follow-up|6|||
17131747|NCT00116831|38273216|FG000|Overall Study|Protocol Violation|3|||
17131748|NCT00116831|38273217|FG001|Overall Study|Protocol Violation|6|||
17131749|NCT00116831|38273216|FG000|Overall Study|Hypoglycaemic events|1|||
17131750|NCT00116831|38273217|FG001|Overall Study|Hypoglycaemic events|0|||
17131751|NCT00116831|38273216|FG000|Overall Study|Low haemoglobin on screening|1|||
17131752|NCT00116831|38273217|FG001|Overall Study|Low haemoglobin on screening|0|||
17131753|NCT00116831|38273216|FG000|Overall Study|Withdrawn investigational product|1|||
17131754|NCT00116831|38273217|FG001|Overall Study|Withdrawn investigational product|0|||
17131755|NCT00116831|38273216|FG000|Overall Study|Withdrawal by Subject|32|||
17131756|NCT00116831|38273217|FG001|Overall Study|Withdrawal by Subject|32|||
17131757|NCT00116831|38273216|FG000|Overall Study|Insufficient therapeutic effect|0|||
17131758|NCT00116831|38273217|FG001|Overall Study|Insufficient therapeutic effect|1|||
17131759|NCT00116831|38273216|FG000|Overall Study|Missing data for participant|1|||
17131760|NCT00116831|38273217|FG001|Overall Study|Missing data for participant|0|||
17131761|NCT02777086|38273225|FG000|Overall Study|Lost to Follow-up|96|||
17131762|NCT02777086|38273226|FG001|Overall Study|Lost to Follow-up|99|||
17131763|NCT03549429|38273234|FG000|Overall Study|Protocol Violation|5|||
17131764|NCT03549429|38273235|FG001|Overall Study|Protocol Violation|3|||
17131765|NCT02784704|38273245|FG000|Overall Study|Adverse Event|4|||
17131766|NCT02784704|38273246|FG001|Overall Study|Adverse Event|2|||
17131767|NCT02784704|38273245|FG000|Overall Study|Lost to Follow-up|6|||
17131768|NCT02784704|38273246|FG001|Overall Study|Lost to Follow-up|4|||
17131769|NCT02784704|38273245|FG000|Overall Study|Withdrawal by Subject|1|||
17131770|NCT02784704|38273246|FG001|Overall Study|Withdrawal by Subject|3|||
17131771|NCT02784704|38273245|FG000|Overall Study|Subject Non Compliance|2|||
17131772|NCT02784704|38273246|FG001|Overall Study|Subject Non Compliance|0|||
17131773|NCT03566823|38273257|FG000|Overall Study|Lack of Efficacy|0|||
17131774|NCT03566823|38273258|FG001|Overall Study|Lack of Efficacy|1|||
17131775|NCT03566823|38273259|FG002|Overall Study|Lack of Efficacy|0|||
17131776|NCT03566823|38273257|FG000|Overall Study|Withdrawal by Subject|1|||
17131777|NCT03566823|38273258|FG001|Overall Study|Withdrawal by Subject|2|||
17131778|NCT03566823|38273259|FG002|Overall Study|Withdrawal by Subject|0|||
17131779|NCT03566823|38273257|FG000|Overall Study|Adverse Event|1|||
17131780|NCT03566823|38273258|FG001|Overall Study|Adverse Event|0|||
17131781|NCT03566823|38273259|FG002|Overall Study|Adverse Event|2|||
17131782|NCT03549117|38273269|FG000|Overall Study|Withdrawal by Subject|1|||
17131783|NCT03549117|38273270|FG001|Overall Study|Withdrawal by Subject|0|||
17131784|NCT03183908|38273278|FG000|Overall Study|Missing Symptom Diary Data|0|||
17131785|NCT03183908|38273279|FG001|Overall Study|Missing Symptom Diary Data|2|||
17131786|NCT03565887|38273291|FG000|Overall Study|Adverse Event|1|||
17131787|NCT03565887|38273292|FG001|Overall Study|Adverse Event|0|||
17131788|NCT03565887|38273291|FG000|Overall Study|Withdrawal by Subject|0|||
17131789|NCT03565887|38273292|FG001|Overall Study|Withdrawal by Subject|2|||
17131790|NCT03183518|38273298|FG000|Overall Study|Other (Not specified)|2|||
17131791|NCT03183518|38273298|FG000|Overall Study|Other (Withdrawal of consent)|1|||
17131792|NCT00116753|38273306|FG000|Overall Study|Adverse Event|16|||
17131793|NCT00116753|38273307|FG001|Overall Study|Adverse Event|10|||
17131794|NCT00116753|38273308|FG002|Overall Study|Adverse Event|7|||
17131795|NCT00116753|38273306|FG000|Overall Study|Withdrawal by Subject|11|||
17131796|NCT00116753|38273307|FG001|Overall Study|Withdrawal by Subject|12|||
17131797|NCT00116753|38273308|FG002|Overall Study|Withdrawal by Subject|8|||
17131798|NCT00116753|38273306|FG000|Overall Study|Lost to Follow-up|0|||
17131799|NCT00116753|38273307|FG001|Overall Study|Lost to Follow-up|2|||
17131800|NCT00116753|38273308|FG002|Overall Study|Lost to Follow-up|1|||
17131801|NCT00116753|38273306|FG000|Overall Study|Protocol Violation|0|||
17131802|NCT00116753|38273307|FG001|Overall Study|Protocol Violation|0|||
17131803|NCT00116753|38273308|FG002|Overall Study|Protocol Violation|1|||
17131804|NCT00116753|38273306|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
17131805|NCT00116753|38273307|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
17131806|NCT00116753|38273308|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
17131807|NCT00116753|38273306|FG000|Overall Study|Disease Progression|3|||
17131808|NCT00116753|38273307|FG001|Overall Study|Disease Progression|4|||
17131809|NCT00116753|38273308|FG002|Overall Study|Disease Progression|3|||
17131810|NCT00116753|38273306|FG000|Overall Study|Abnormal Echocardiogram|0|||
17131811|NCT00116753|38273307|FG001|Overall Study|Abnormal Echocardiogram|0|||
17131812|NCT00116753|38273308|FG002|Overall Study|Abnormal Echocardiogram|1|||
17131813|NCT00116753|38273306|FG000|Overall Study|Progressive Parkinson's Disease|1|||
17131814|NCT00116753|38273307|FG001|Overall Study|Progressive Parkinson's Disease|0|||
17131815|NCT00116753|38273308|FG002|Overall Study|Progressive Parkinson's Disease|0|||
17131816|NCT00116753|38273306|FG000|Overall Study|Dosing Error|0|||
17131817|NCT00116753|38273307|FG001|Overall Study|Dosing Error|1|||
17131818|NCT00116753|38273308|FG002|Overall Study|Dosing Error|0|||
17131819|NCT00113399|38273327|FG000|Overall Study|Death|1|||
17131820|NCT00113399|38273328|FG001|Overall Study|Death|1|||
17131821|NCT00113399|38273327|FG000|Overall Study|Withdrawal by Subject|1|||
17131822|NCT00113399|38273328|FG001|Overall Study|Withdrawal by Subject|2|||
17131823|NCT00113399|38273327|FG000|Overall Study|Complete Response|0|||
17131824|NCT00113399|38273328|FG001|Overall Study|Complete Response|1|||
17131825|NCT00113399|38273327|FG000|Overall Study|Other|0|||
17131826|NCT00113399|38273328|FG001|Overall Study|Other|1|||
17131827|NCT00113087|38273336|FG000|Overall Study|Death or Transplant|14|||
17131828|NCT00113087|38273337|FG001|Overall Study|Death or Transplant|16|||
17131829|NCT00113087|38273336|FG000|Overall Study|Family or MD withdrew subject|10|||
17131830|NCT00113087|38273337|FG001|Overall Study|Family or MD withdrew subject|5|||
17131831|NCT00112463|38273343|FG000|Overall Study|Physician Decision|1|||
17131832|NCT00112463|38273343|FG000|Overall Study|Progression|30|||
17131833|NCT00112463|38273343|FG000|Overall Study|Second Primary|1|||
17131834|NCT00112463|38273343|FG000|Overall Study|Toxicity|3|||
17131835|NCT00112463|38273343|FG000|Overall Study|Withdrawal by Subject|2|||
17131836|NCT00112463|38273343|FG000|Overall Study|Never started treatment|2|||
17131837|NCT03548415|38273353|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
17131838|NCT03548415|38273354|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
17131839|NCT03548415|38273355|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
17131840|NCT03548415|38273356|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
17131841|NCT03548415|38273357|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
17131842|NCT00112385|38273373|FG000|Overall Study|Lost to Follow-up|1|||
17131843|NCT00112385|38273374|FG001|Overall Study|Lost to Follow-up|0|||
17131844|NCT00112385|38273373|FG000|Overall Study|Withdrawal by Subject|0|||
17131845|NCT00112385|38273374|FG001|Overall Study|Withdrawal by Subject|1|||
17131846|NCT03548337|38273382|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
17131847|NCT03548337|38273383|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
17131848|NCT03548337|38273382|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
17131849|NCT03548337|38273383|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
17131850|NCT03548337|38273382|FG000|Infant Series|Lost to Follow-up|2|||
17131851|NCT03548337|38273383|FG001|Infant Series|Lost to Follow-up|1|||
17131852|NCT03548337|38273382|FG000|Infant Series|Adverse Event|0|||
17131853|NCT03548337|38273383|FG001|Infant Series|Adverse Event|2|||
17131854|NCT03548337|38273382|FG000|Infant Series|Randomized but Not Vaccinated|1|||
17131855|NCT03548337|38273383|FG001|Infant Series|Randomized but Not Vaccinated|0|||
17131856|NCT03548337|38273382|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
17131857|NCT03548337|38273383|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
17131858|NCT03596151|38273395|FG000|Overall Study|Withdrawal by Subject|1|||
17131859|NCT03547635|38273402|FG000|Overall Study|Adverse Event|5|||
17131860|NCT03547635|38273403|FG001|Overall Study|Adverse Event|2|||
17131861|NCT03547635|38273404|FG002|Overall Study|Adverse Event|3|||
17131862|NCT03547635|38273402|FG000|Overall Study|Lost to Follow-up|1|||
17131863|NCT03547635|38273403|FG001|Overall Study|Lost to Follow-up|3|||
17131864|NCT03547635|38273404|FG002|Overall Study|Lost to Follow-up|4|||
17131865|NCT03547635|38273402|FG000|Overall Study|Withdrawal by Subject|1|||
17131866|NCT03547635|38273403|FG001|Overall Study|Withdrawal by Subject|0|||
17131867|NCT03547635|38273404|FG002|Overall Study|Withdrawal by Subject|0|||
17131868|NCT03547635|38273402|FG000|Overall Study|Withdrawal By PI|0|||
17131869|NCT03547635|38273403|FG001|Overall Study|Withdrawal By PI|1|||
17131870|NCT03547635|38273404|FG002|Overall Study|Withdrawal By PI|0|||
17131871|NCT03547635|38273402|FG000|Overall Study|Withdrawal by Sponsor|0|||
17131872|NCT03547635|38273403|FG001|Overall Study|Withdrawal by Sponsor|0|||
17131873|NCT03547635|38273404|FG002|Overall Study|Withdrawal by Sponsor|1|||
17131874|NCT03547635|38273402|FG000|Overall Study|Errant Randomization before Treatment|0|||
17131875|NCT03547635|38273403|FG001|Overall Study|Errant Randomization before Treatment|1|||
17131876|NCT03547635|38273404|FG002|Overall Study|Errant Randomization before Treatment|0|||
17131877|NCT03547635|38273402|FG000|Overall Study|Withdrawal by Subject|1|||
17131878|NCT03547635|38273403|FG001|Overall Study|Withdrawal by Subject|0|||
17131879|NCT03547635|38273404|FG002|Overall Study|Withdrawal by Subject|0|||
17131880|NCT03182738|38273458|FG000|Overall Study|Lost to Follow-up|9|||
17131881|NCT03182738|38273459|FG001|Overall Study|Lost to Follow-up|3|||
17131882|NCT03182738|38273458|FG000|Overall Study|Pregnancy|0|||
17131883|NCT03182738|38273459|FG001|Overall Study|Pregnancy|1|||
17131884|NCT03182738|38273458|FG000|Overall Study|Withdrawal by Subject|0|||
17131885|NCT03182738|38273459|FG001|Overall Study|Withdrawal by Subject|1|||
17131886|NCT03547167|38273467|FG000|Overall Study|Withdrawal by Subject|34|||
17131887|NCT03547167|38273468|FG001|Overall Study|Withdrawal by Subject|12|||
17131888|NCT03547167|38273467|FG000|Overall Study|Screen Failure|0|||
17131889|NCT03547167|38273468|FG001|Overall Study|Screen Failure|1|||
17131890|NCT03547167|38273467|FG000|Overall Study|Lost to Follow-up|59|||
17131891|NCT03547167|38273468|FG001|Overall Study|Lost to Follow-up|15|||
17131892|NCT03547167|38273467|FG000|Overall Study|Death|4|||
17131893|NCT03547167|38273468|FG001|Overall Study|Death|2|||
17131894|NCT03560739|38273482|FG000|Overall Study|Adverse Event|0|||
17131895|NCT03560739|38273483|FG001|Overall Study|Adverse Event|1|||
17131896|NCT03560739|38273484|FG002|Overall Study|Adverse Event|0|||
17131897|NCT03560739|38273485|FG003|Overall Study|Adverse Event|0|||
17131898|NCT00101686|38273505|FG000|Overall Study|Progressive Disease|37|||
17131899|NCT00101686|38273506|FG001|Overall Study|Progressive Disease|28|||
17131900|NCT00101686|38273507|FG002|Overall Study|Progressive Disease|37|||
17131901|NCT00101686|38273508|FG003|Overall Study|Progressive Disease|38|||
17131902|NCT00101686|38273509|FG004|Overall Study|Progressive Disease|28|||
17131903|NCT00101686|38273510|FG005|Overall Study|Progressive Disease|25|||
17131904|NCT00101686|38273511|FG006|Overall Study|Progressive Disease|5|||
17131905|NCT00101686|38273512|FG007|Overall Study|Progressive Disease|7|||
17131906|NCT00101686|38273513|FG008|Overall Study|Progressive Disease|10|||
17131907|NCT00101686|38273514|FG009|Overall Study|Progressive Disease|8|||
17131908|NCT00101686|38273505|FG000|Overall Study|initiation other anti-cancer treatment|4|||
17131909|NCT00101686|38273506|FG001|Overall Study|initiation other anti-cancer treatment|3|||
17131910|NCT00101686|38273507|FG002|Overall Study|initiation other anti-cancer treatment|4|||
17131911|NCT00101686|38273508|FG003|Overall Study|initiation other anti-cancer treatment|3|||
17131912|NCT00101686|38273509|FG004|Overall Study|initiation other anti-cancer treatment|1|||
17131913|NCT00101686|38273510|FG005|Overall Study|initiation other anti-cancer treatment|1|||
17131914|NCT00101686|38273511|FG006|Overall Study|initiation other anti-cancer treatment|2|||
17131915|NCT00101686|38273512|FG007|Overall Study|initiation other anti-cancer treatment|2|||
17131916|NCT00101686|38273513|FG008|Overall Study|initiation other anti-cancer treatment|3|||
17131917|NCT00101686|38273514|FG009|Overall Study|initiation other anti-cancer treatment|3|||
17131918|NCT00101686|38273505|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
17131919|NCT00101686|38273506|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
17131920|NCT00101686|38273507|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
17131921|NCT00101686|38273508|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
17131922|NCT00101686|38273509|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
17131923|NCT00101686|38273510|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
17131924|NCT00101686|38273511|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
17131925|NCT00101686|38273512|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
17131926|NCT00101686|38273513|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
17131927|NCT00101686|38273514|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
17131928|NCT00101686|38273505|FG000|Overall Study|unacceptable toxicity|3|||
17131929|NCT00101686|38273506|FG001|Overall Study|unacceptable toxicity|9|||
17131930|NCT00101686|38273507|FG002|Overall Study|unacceptable toxicity|10|||
17131931|NCT00101686|38273508|FG003|Overall Study|unacceptable toxicity|6|||
17131932|NCT00101686|38273509|FG004|Overall Study|unacceptable toxicity|16|||
17131933|NCT00101686|38273510|FG005|Overall Study|unacceptable toxicity|10|||
17131934|NCT00101686|38273511|FG006|Overall Study|unacceptable toxicity|4|||
17131935|NCT00101686|38273512|FG007|Overall Study|unacceptable toxicity|2|||
17131936|NCT00101686|38273513|FG008|Overall Study|unacceptable toxicity|1|||
17131937|NCT00101686|38273514|FG009|Overall Study|unacceptable toxicity|4|||
17131938|NCT00101686|38273505|FG000|Overall Study|Randomized but did not receive treament|1|||
17131939|NCT00101686|38273506|FG001|Overall Study|Randomized but did not receive treament|6|||
17131940|NCT00101686|38273507|FG002|Overall Study|Randomized but did not receive treament|2|||
17131941|NCT00101686|38273508|FG003|Overall Study|Randomized but did not receive treament|2|||
17131942|NCT00101686|38273509|FG004|Overall Study|Randomized but did not receive treament|2|||
17131943|NCT00101686|38273510|FG005|Overall Study|Randomized but did not receive treament|2|||
17131944|NCT00101686|38273511|FG006|Overall Study|Randomized but did not receive treament|0|||
17131945|NCT00101686|38273512|FG007|Overall Study|Randomized but did not receive treament|1|||
17131946|NCT00101686|38273513|FG008|Overall Study|Randomized but did not receive treament|0|||
17131947|NCT00101686|38273514|FG009|Overall Study|Randomized but did not receive treament|1|||
17131948|NCT00101686|38273505|FG000|Overall Study|intercurrent non-cancer related illness|0|||
17131949|NCT00101686|38273506|FG001|Overall Study|intercurrent non-cancer related illness|0|||
17131950|NCT00101686|38273507|FG002|Overall Study|intercurrent non-cancer related illness|2|||
17131951|NCT00101686|38273508|FG003|Overall Study|intercurrent non-cancer related illness|0|||
17131952|NCT00101686|38273509|FG004|Overall Study|intercurrent non-cancer related illness|1|||
17131953|NCT00101686|38273510|FG005|Overall Study|intercurrent non-cancer related illness|3|||
17131954|NCT00101686|38273511|FG006|Overall Study|intercurrent non-cancer related illness|1|||
17131955|NCT00101686|38273512|FG007|Overall Study|intercurrent non-cancer related illness|0|||
17131956|NCT00101686|38273513|FG008|Overall Study|intercurrent non-cancer related illness|1|||
17131957|NCT00101686|38273514|FG009|Overall Study|intercurrent non-cancer related illness|1|||
17131958|NCT00101686|38273505|FG000|Overall Study|Physician Decision|10|||
17131959|NCT00101686|38273506|FG001|Overall Study|Physician Decision|13|||
17131960|NCT00101686|38273507|FG002|Overall Study|Physician Decision|6|||
17131961|NCT00101686|38273508|FG003|Overall Study|Physician Decision|7|||
16957298|NCT01160289|38100337|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16957299|NCT01160289|38100338|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16957300|NCT01160289|38100339|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16957301|NCT01160289|38100340|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16957302|NCT01160289|38100341|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16957303|NCT01160289|38100336|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
16957304|NCT01160289|38100337|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16957305|NCT01160289|38100338|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16957306|NCT01160289|38100339|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16957307|NCT01160289|38100340|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16957308|NCT01160289|38100341|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16957309|NCT01160289|38100336|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
16957310|NCT01160289|38100337|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16957311|NCT01160289|38100338|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16957312|NCT01160289|38100339|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16957313|NCT01160289|38100340|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16957314|NCT01160289|38100341|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16957315|NCT01160289|38100336|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
16957316|NCT01160289|38100337|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16957317|NCT01160289|38100338|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16957318|NCT01160289|38100339|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16957319|NCT01160289|38100340|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16957320|NCT01160289|38100341|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16957321|NCT01160289|38100336|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
17131962|NCT00101686|38273509|FG004|Overall Study|Physician Decision|8|||
17131963|NCT00101686|38273510|FG005|Overall Study|Physician Decision|9|||
17131964|NCT00101686|38273511|FG006|Overall Study|Physician Decision|5|||
17131965|NCT00101686|38273512|FG007|Overall Study|Physician Decision|5|||
17131966|NCT00101686|38273513|FG008|Overall Study|Physician Decision|1|||
17131967|NCT00101686|38273514|FG009|Overall Study|Physician Decision|1|||
17131968|NCT00101686|38273505|FG000|Overall Study|Other|1|||
17131969|NCT00101686|38273506|FG001|Overall Study|Other|4|||
17131970|NCT00101686|38273507|FG002|Overall Study|Other|1|||
17131971|NCT00101686|38273508|FG003|Overall Study|Other|6|||
17131972|NCT00101686|38273509|FG004|Overall Study|Other|2|||
17131973|NCT00101686|38273510|FG005|Overall Study|Other|12|||
17131974|NCT00101686|38273511|FG006|Overall Study|Other|1|||
17131975|NCT00101686|38273512|FG007|Overall Study|Other|5|||
17131976|NCT00101686|38273513|FG008|Overall Study|Other|3|||
17131977|NCT00101686|38273514|FG009|Overall Study|Other|3|||
17131978|NCT00101686|38273505|FG000|Overall Study|Withdrawal by Subject|9|||
17131979|NCT00101686|38273506|FG001|Overall Study|Withdrawal by Subject|8|||
17131980|NCT00101686|38273507|FG002|Overall Study|Withdrawal by Subject|6|||
17131981|NCT00101686|38273508|FG003|Overall Study|Withdrawal by Subject|8|||
17131982|NCT00101686|38273509|FG004|Overall Study|Withdrawal by Subject|8|||
17131983|NCT00101686|38273510|FG005|Overall Study|Withdrawal by Subject|7|||
17131984|NCT00101686|38273511|FG006|Overall Study|Withdrawal by Subject|7|||
17131985|NCT00101686|38273512|FG007|Overall Study|Withdrawal by Subject|7|||
17131986|NCT00101686|38273513|FG008|Overall Study|Withdrawal by Subject|8|||
17131987|NCT00101686|38273514|FG009|Overall Study|Withdrawal by Subject|9|||
17131988|NCT00101452|38273534|FG000|Overall Study|Adverse Event|2|||
17131989|NCT00101452|38273535|FG001|Overall Study|Adverse Event|0|||
17131990|NCT00101452|38273536|FG002|Overall Study|Adverse Event|1|||
17131991|NCT00101452|38273534|FG000|Overall Study|Lost to Follow-up|13|||
17131992|NCT00101452|38273535|FG001|Overall Study|Lost to Follow-up|8|||
17131993|NCT00101452|38273536|FG002|Overall Study|Lost to Follow-up|14|||
17131994|NCT00101452|38273534|FG000|Overall Study|Withdrawal by Subject|10|||
17131995|NCT00101452|38273535|FG001|Overall Study|Withdrawal by Subject|14|||
17131996|NCT00101452|38273536|FG002|Overall Study|Withdrawal by Subject|9|||
17131997|NCT00101452|38273534|FG000|Overall Study|Baseline Fail|2|||
17131998|NCT00101452|38273535|FG001|Overall Study|Baseline Fail|1|||
17131999|NCT00101452|38273536|FG002|Overall Study|Baseline Fail|2|||
17132000|NCT00101452|38273534|FG000|Overall Study|Physician Decision|0|||
17132001|NCT00101452|38273535|FG001|Overall Study|Physician Decision|3|||
17132002|NCT00101452|38273536|FG002|Overall Study|Physician Decision|2|||
17132003|NCT00101452|38273534|FG000|Overall Study|Protocol Violation|2|||
17132004|NCT00101452|38273535|FG001|Overall Study|Protocol Violation|1|||
17132005|NCT00101452|38273536|FG002|Overall Study|Protocol Violation|3|||
17132006|NCT00101452|38273534|FG000|Overall Study|Other|15|||
17132007|NCT00101452|38273535|FG001|Overall Study|Other|16|||
17132008|NCT00101452|38273536|FG002|Overall Study|Other|12|||
17132009|NCT03546621|38273552|FG000|Overall Study|Withdrawal by Subject|0|||
17132010|NCT03546621|38273553|FG001|Overall Study|Withdrawal by Subject|1|||
17132011|NCT03546621|38273554|FG002|Overall Study|Withdrawal by Subject|2|||
17132012|NCT03546621|38273555|FG003|Overall Study|Withdrawal by Subject|1|||
17132013|NCT03546621|38273552|FG000|Overall Study|Lost to Follow-up|0|||
17132014|NCT03546621|38273553|FG001|Overall Study|Lost to Follow-up|1|||
17132015|NCT03546621|38273554|FG002|Overall Study|Lost to Follow-up|0|||
17132016|NCT03546621|38273555|FG003|Overall Study|Lost to Follow-up|0|||
17132017|NCT03546621|38273552|FG000|Overall Study|Adverse Event|0|||
17132018|NCT03546621|38273553|FG001|Overall Study|Adverse Event|1|||
17132019|NCT03546621|38273554|FG002|Overall Study|Adverse Event|0|||
17132020|NCT03546621|38273555|FG003|Overall Study|Adverse Event|1|||
17132021|NCT03546621|38273552|FG000|Overall Study|Progressive disease|0|||
17132022|NCT03546621|38273553|FG001|Overall Study|Progressive disease|0|||
17132023|NCT03546621|38273554|FG002|Overall Study|Progressive disease|0|||
17132024|NCT03546621|38273555|FG003|Overall Study|Progressive disease|1|||
17132025|NCT02761330|38273565|FG000|Treatment Week 1|Withdrawal by Subject|0|||
17132026|NCT02761330|38273566|FG001|Treatment Week 1|Withdrawal by Subject|0|||
17132027|NCT02761330|38273567|FG002|Treatment Week 1|Withdrawal by Subject|0|||
17132028|NCT02761330|38273568|FG003|Treatment Week 1|Withdrawal by Subject|1|||
17132029|NCT02761330|38273569|FG004|Treatment Week 1|Withdrawal by Subject|0|||
17132030|NCT02761330|38273570|FG005|Treatment Week 1|Withdrawal by Subject|1|||
17132031|NCT03559257|38273586|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
17132032|NCT03559257|38273587|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
17132033|NCT03559257|38273586|FG000|Double Blind Treatment Period|Protocol Violation|1|||
17132034|NCT03559257|38273587|FG001|Double Blind Treatment Period|Protocol Violation|4|||
17132035|NCT03559257|38273586|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
17132036|NCT03559257|38273587|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
17132037|NCT03559257|38273586|FG000|Double Blind Treatment Period|Adverse Event|0|||
17132038|NCT03559257|38273587|FG001|Double Blind Treatment Period|Adverse Event|1|||
17132039|NCT03559257|38273586|FG000|Double Blind Treatment Period|Screen Failure|0|||
17132040|NCT03559257|38273587|FG001|Double Blind Treatment Period|Screen Failure|1|||
17132041|NCT03559257|38273586|FG000|Open-label Treatment Period|Adverse Event|1|||
17132042|NCT03559257|38273587|FG001|Open-label Treatment Period|Adverse Event|4|||
17132043|NCT03559257|38273586|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
17132044|NCT03559257|38273587|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
17132045|NCT03559257|38273586|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
17132046|NCT03559257|38273587|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
17132047|NCT03559257|38273586|FG000|Open-label Treatment Period|Protocol Violation|2|||
17132048|NCT03559257|38273587|FG001|Open-label Treatment Period|Protocol Violation|0|||
17132049|NCT03559257|38273586|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
17132050|NCT03559257|38273587|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
17132051|NCT03559257|38273586|FG000|Open-label Treatment Period|Physician Decision|0|||
17132052|NCT03559257|38273587|FG001|Open-label Treatment Period|Physician Decision|1|||
17132053|NCT02892513|38273598|FG000|Overall Study|Withdrawal by Subject|0|||
17132054|NCT02892513|38273599|FG001|Overall Study|Withdrawal by Subject|1|||
17132055|NCT03558555|38273607|FG000|Overall Study|Lost to Follow-up|2|||
17132056|NCT03558555|38273608|FG001|Overall Study|Lost to Follow-up|1|||
17132057|NCT03541317|38273616|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
17132058|NCT03541317|38273617|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
17132059|NCT03541317|38273618|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
17132060|NCT03541317|38273619|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
17132061|NCT03541317|38273620|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
17132062|NCT03541317|38273621|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
17132063|NCT03590613|38273633|FG000|Period 2, 4 Days|Physician Decision|0|||
17132064|NCT03590613|38273634|FG001|Period 2, 4 Days|Physician Decision|0|||
17132065|NCT03590613|38273635|FG002|Period 2, 4 Days|Physician Decision|0|||
17132066|NCT03590613|38273636|FG003|Period 2, 4 Days|Physician Decision|1|||
17132067|NCT03557931|38273652|FG000|Overall Study|Adverse Event|4|||
17132068|NCT03557931|38273653|FG001|Overall Study|Adverse Event|6|||
17132069|NCT03557931|38273654|FG002|Overall Study|Adverse Event|1|||
17132070|NCT03557931|38273652|FG000|Overall Study|Lost to Follow-up|4|||
17132071|NCT03557931|38273653|FG001|Overall Study|Lost to Follow-up|4|||
17132072|NCT03557931|38273654|FG002|Overall Study|Lost to Follow-up|1|||
17132073|NCT03557931|38273652|FG000|Overall Study|Protocol Violation|1|||
17132074|NCT03557931|38273653|FG001|Overall Study|Protocol Violation|4|||
17132075|NCT03557931|38273654|FG002|Overall Study|Protocol Violation|1|||
17132076|NCT03557931|38273652|FG000|Overall Study|Withdrawal by Subject|14|||
17132077|NCT03557931|38273653|FG001|Overall Study|Withdrawal by Subject|0|||
17132078|NCT03557931|38273654|FG002|Overall Study|Withdrawal by Subject|7|||
17132079|NCT03557931|38273652|FG000|Overall Study|Miscellaneous|8|||
17132080|NCT03557931|38273653|FG001|Overall Study|Miscellaneous|5|||
17132081|NCT03557931|38273654|FG002|Overall Study|Miscellaneous|3|||
17132082|NCT03522675|38273664|FG000|Overall Study|Screen fail|1|||
17132083|NCT03522675|38273664|FG000|Overall Study|Non-reactive to histamine|1|||
17132084|NCT00294047|38273674|FG000|Month 48|Adverse Event|28|||
17132085|NCT00294047|38273675|FG001|Month 48|Adverse Event|13|||
17132086|NCT00294047|38273674|FG000|Month 48|Protocol Violation|4|||
17132087|NCT00294047|38273675|FG001|Month 48|Protocol Violation|4|||
17132088|NCT00294047|38273674|FG000|Month 48|Withdrawal by Subject|111|||
17132089|NCT00294047|38273675|FG001|Month 48|Withdrawal by Subject|115|||
17132090|NCT00294047|38273674|FG000|Month 48|Lost to Follow-up|272|||
17132091|NCT00294047|38273675|FG001|Month 48|Lost to Follow-up|287|||
17132092|NCT00294047|38273674|FG000|Month 48|Other|10|||
17132093|NCT00294047|38273675|FG001|Month 48|Other|14|||
17132094|NCT00294047|38273674|FG000|Month 84|Adverse Event|4|||
17132095|NCT00294047|38273675|FG001|Month 84|Adverse Event|2|||
17132096|NCT00294047|38273674|FG000|Month 84|Protocol Violation|1|||
17132097|NCT00294047|38273675|FG001|Month 84|Protocol Violation|1|||
17132098|NCT00294047|38273674|FG000|Month 84|Withdrawal by Subject|33|||
17132099|NCT00294047|38273675|FG001|Month 84|Withdrawal by Subject|31|||
17132100|NCT00294047|38273674|FG000|Month 84|Lost to Follow-up|187|||
17132101|NCT00294047|38273675|FG001|Month 84|Lost to Follow-up|190|||
17132102|NCT00294047|38273674|FG000|Month 84|Absent Cervix|2|||
17132103|NCT00294047|38273675|FG001|Month 84|Absent Cervix|0|||
17132104|NCT00294047|38273674|FG000|Month 84|Work related reasons|4|||
17132105|NCT00294047|38273675|FG001|Month 84|Work related reasons|2|||
17132106|NCT00294047|38273674|FG000|Month 84|Center closed, subject did not transfer|1|||
17132107|NCT00294047|38273675|FG001|Month 84|Center closed, subject did not transfer|0|||
17132108|NCT00294047|38273674|FG000|Month 84|Family problems|2|||
17132109|NCT00294047|38273675|FG001|Month 84|Family problems|2|||
17132110|NCT00294047|38273674|FG000|Month 84|Lack of time|3|||
17132111|NCT00294047|38273675|FG001|Month 84|Lack of time|1|||
17132112|NCT00294047|38273674|FG000|Month 84|Personal reason|2|||
17132113|NCT00294047|38273675|FG001|Month 84|Personal reason|4|||
17132114|NCT00294047|38273674|FG000|Month 84|Subject does not want male physician|1|||
17132115|NCT00294047|38273675|FG001|Month 84|Subject does not want male physician|0|||
17132116|NCT00294047|38273674|FG000|Month 84|Transport reimbursement delayed|0|||
17132117|NCT00294047|38273675|FG001|Month 84|Transport reimbursement delayed|1|||
17132118|NCT00294047|38273674|FG000|Month 84|Unable to reach study site|1|||
17132119|NCT00294047|38273675|FG001|Month 84|Unable to reach study site|0|||
17132120|NCT00294047|38273674|FG000|Month 84|Under investigation locally|1|||
17132121|NCT00294047|38273675|FG001|Month 84|Under investigation locally|0|||
17132122|NCT00294047|38273674|FG000|Month 84|Visit missed|0|||
17132123|NCT00294047|38273675|FG001|Month 84|Visit missed|1|||
17132124|NCT00294047|38273674|FG000|Month 84|No consent for Month 84 Follow-up|731|||
17132125|NCT00294047|38273675|FG001|Month 84|No consent for Month 84 Follow-up|754|||
17132126|NCT00293813|38273685|FG000|Overall Study|Physician Decision|0|||
17132127|NCT00293813|38273686|FG001|Overall Study|Physician Decision|1|||
17132128|NCT00293813|38273687|FG002|Overall Study|Physician Decision|0|||
17132129|NCT00293813|38273685|FG000|Overall Study|Adverse Event|3|||
17132130|NCT00293813|38273686|FG001|Overall Study|Adverse Event|1|||
17132131|NCT00293813|38273687|FG002|Overall Study|Adverse Event|1|||
17132132|NCT00293813|38273685|FG000|Overall Study|Withdrawal by Subject|7|||
17132133|NCT00293813|38273686|FG001|Overall Study|Withdrawal by Subject|4|||
17132134|NCT00293813|38273687|FG002|Overall Study|Withdrawal by Subject|4|||
17132135|NCT00293813|38273685|FG000|Overall Study|Lost to Follow-up|3|||
17132136|NCT00293813|38273686|FG001|Overall Study|Lost to Follow-up|2|||
17132137|NCT00293813|38273687|FG002|Overall Study|Lost to Follow-up|3|||
17132138|NCT00293813|38273685|FG000|Overall Study|Noncompliance|0|||
17132139|NCT00293813|38273686|FG001|Overall Study|Noncompliance|1|||
17132140|NCT00293813|38273687|FG002|Overall Study|Noncompliance|0|||
17132141|NCT00293579|38273695|FG000|Overall Study|Withdrawal by Subject|1|||
17132142|NCT00293423|38273702|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
17132143|NCT00293423|38273703|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
17132144|NCT00293423|38273702|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
17132145|NCT00293423|38273703|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
17132146|NCT00293423|38273702|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
17132147|NCT00293423|38273703|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
17132148|NCT00293423|38273702|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
17132149|NCT00293423|38273703|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
17132150|NCT00293423|38273702|FG000|Surgical Resection|processing error during surgical resection|1|||
17132151|NCT00293423|38273703|FG001|Surgical Resection|processing error during surgical resection|0|||
17132152|NCT00293423|38273702|FG000|Surgical Resection|Withdrawal by Subject|4|||
17132153|NCT00293423|38273703|FG001|Surgical Resection|Withdrawal by Subject|0|||
17132154|NCT00293423|38273702|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
17132155|NCT00293423|38273703|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
17132156|NCT03538743|38273718|FG000|Overall Study|Adverse Event|0|||
17132157|NCT03538743|38273719|FG001|Overall Study|Adverse Event|0|||
17132158|NCT03538743|38273720|FG002|Overall Study|Adverse Event|1|||
17132159|NCT03538743|38273721|FG003|Overall Study|Adverse Event|1|||
17132160|NCT03538743|38273722|FG004|Overall Study|Adverse Event|0|||
17132161|NCT03538743|38273723|FG005|Overall Study|Adverse Event|0|||
17132162|NCT03538743|38273724|FG006|Overall Study|Adverse Event|0|||
17132163|NCT03538743|38273725|FG007|Overall Study|Adverse Event|0|||
17132164|NCT03538743|38273726|FG008|Overall Study|Adverse Event|0|||
17132165|NCT03538743|38273718|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
17132166|NCT03538743|38273719|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
17132167|NCT03538743|38273720|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
17132168|NCT03538743|38273721|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
17132169|NCT03538743|38273722|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
17132170|NCT03538743|38273723|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
17132171|NCT03538743|38273724|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
17132172|NCT03538743|38273725|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
17132173|NCT03538743|38273726|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
17132174|NCT03538743|38273718|FG000|Overall Study|Withdrawal by Subject|0|||
17132175|NCT03538743|38273719|FG001|Overall Study|Withdrawal by Subject|0|||
17132176|NCT03538743|38273720|FG002|Overall Study|Withdrawal by Subject|0|||
17132177|NCT03538743|38273721|FG003|Overall Study|Withdrawal by Subject|1|||
17132178|NCT03538743|38273722|FG004|Overall Study|Withdrawal by Subject|0|||
17132179|NCT03538743|38273723|FG005|Overall Study|Withdrawal by Subject|0|||
17132180|NCT03538743|38273724|FG006|Overall Study|Withdrawal by Subject|0|||
17132181|NCT03538743|38273725|FG007|Overall Study|Withdrawal by Subject|0|||
17132182|NCT03538743|38273726|FG008|Overall Study|Withdrawal by Subject|0|||
17132183|NCT03521817|38273756|FG000|Overall Study|Protocol Violation|0|||
17132184|NCT03521817|38273757|FG001|Overall Study|Protocol Violation|1|||
17132185|NCT03538431|38273763|FG000|Overall Study|Physician Decision|0|||
17132186|NCT03538431|38273764|FG001|Overall Study|Physician Decision|1|||
17132187|NCT03538431|38273763|FG000|Overall Study|Withdrawal by Subject|1|||
17132188|NCT03538431|38273764|FG001|Overall Study|Withdrawal by Subject|0|||
17132189|NCT03521193|38273774|FG000|Overall Study|Withdrawal by Subject|8|||
17132190|NCT03521193|38273775|FG001|Overall Study|Withdrawal by Subject|0|||
17132191|NCT03521193|38273774|FG000|Overall Study|non compliant to ASA treatment|8|||
17132192|NCT03521193|38273775|FG001|Overall Study|non compliant to ASA treatment|0|||
17132193|NCT03538041|38273784|FG000|12-Week Treatment Period|Adverse Event|1|||
17132194|NCT03538041|38273785|FG001|12-Week Treatment Period|Adverse Event|1|||
17132195|NCT03538041|38273784|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
17132196|NCT03538041|38273785|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
17132197|NCT03538041|38273784|FG000|Treatment Extension Period|Adverse Event|4|||
17132198|NCT03538041|38273785|FG001|Treatment Extension Period|Adverse Event|0|||
17132199|NCT03538041|38273784|FG000|Treatment Extension Period|Physician Decision|1|||
17132200|NCT03538041|38273785|FG001|Treatment Extension Period|Physician Decision|0|||
17132201|NCT03538041|38273784|FG000|Treatment Extension Period|Lack of Efficacy|1|||
17132202|NCT03538041|38273785|FG001|Treatment Extension Period|Lack of Efficacy|3|||
17132203|NCT03538041|38273784|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
17132204|NCT03538041|38273785|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
17132205|NCT03521115|38273796|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
17132206|NCT03521115|38273797|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
17132207|NCT03521115|38273796|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
17132208|NCT03521115|38273797|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
17132209|NCT00293267|38273811|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
17132210|NCT00293267|38273812|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
17132211|NCT00293267|38273811|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
17132212|NCT00293267|38273812|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
17132213|NCT00293267|38273811|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
17132214|NCT00293267|38273812|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
17132215|NCT00293267|38273811|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
17132216|NCT00293267|38273812|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
17132217|NCT00293267|38273811|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
17132218|NCT00293267|38273812|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
17132219|NCT00293267|38273811|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
17132220|NCT00293267|38273812|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
17132221|NCT00293267|38273811|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
17132222|NCT00293267|38273812|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
17132223|NCT00293267|38273811|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
17132224|NCT00293267|38273812|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
17132225|NCT00293267|38273811|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
17132226|NCT00293267|38273812|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
17132227|NCT00293267|38273811|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
17132228|NCT00293267|38273812|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
17132229|NCT00293267|38273811|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
17132230|NCT00293267|38273812|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
17132231|NCT00293267|38273811|FG000|Extension - Double-Blind Week 49-156|Death|3|||
17132232|NCT00293267|38273812|FG001|Extension - Double-Blind Week 49-156|Death|0|||
17132233|NCT00293267|38273811|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
17132234|NCT00293267|38273812|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
17132235|NCT00293267|38273811|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
17132236|NCT00293267|38273812|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
17132237|NCT00293267|38273811|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
17132238|NCT00293267|38273812|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
17132239|NCT00293267|38273811|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
17132240|NCT00293267|38273812|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
17132241|NCT00293267|38273811|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
17132242|NCT00293267|38273812|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
17132243|NCT00293267|38273811|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
17132244|NCT00293267|38273812|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
17132245|NCT00293267|38273811|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
17132246|NCT00293267|38273812|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
17132247|NCT00293267|38273811|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
17132248|NCT00293267|38273812|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
17132249|NCT00293267|38273811|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
17132250|NCT00293267|38273812|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
17132251|NCT00293267|38273811|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
17132252|NCT00293267|38273812|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
17132253|NCT00293267|38273811|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
17132254|NCT00293267|38273812|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
17132255|NCT00293267|38273811|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
17132256|NCT00293267|38273812|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
17132257|NCT00293267|38273811|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
17132258|NCT00293267|38273812|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
17132259|NCT00293267|38273811|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
17132260|NCT00293267|38273812|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
17132261|NCT00293267|38273811|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
17132262|NCT00293267|38273812|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
17132263|NCT00293267|38273811|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
17132264|NCT00293267|38273812|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
17132265|NCT03520959|38273822|FG000|Overall Study|Study terminated by Sponsor|0|||
17132266|NCT03520959|38273823|FG001|Overall Study|Study terminated by Sponsor|1|||
17132267|NCT03537261|38273831|FG000|Overall Study|Lost to Follow-up|4|||
17132268|NCT03537261|38273832|FG001|Overall Study|Lost to Follow-up|5|||
17132269|NCT03537261|38273831|FG000|Overall Study|Withdrawal by Subject|4|||
17132270|NCT03537261|38273832|FG001|Overall Study|Withdrawal by Subject|6|||
17132271|NCT03537261|38273831|FG000|Overall Study|Did not return study questionnaires|0|||
17132272|NCT03537261|38273832|FG001|Overall Study|Did not return study questionnaires|1|||
17132273|NCT03536949|38273840|FG000|Overall Study|Adverse Event|4|||
17132274|NCT03536949|38273841|FG001|Overall Study|Adverse Event|0|||
17132275|NCT03536949|38273840|FG000|Overall Study|Lost to Follow-up|2|||
17132276|NCT03536949|38273841|FG001|Overall Study|Lost to Follow-up|1|||
16957322|NCT01160289|38100337|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16957323|NCT01160289|38100338|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16957324|NCT01160289|38100339|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16957325|NCT01160289|38100340|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16957326|NCT01160289|38100341|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16957327|NCT01160289|38100336|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
16957328|NCT01160289|38100337|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16957329|NCT01160289|38100338|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16957330|NCT01160289|38100339|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16957331|NCT01160289|38100340|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16957332|NCT01160289|38100341|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
17132277|NCT03536949|38273840|FG000|Overall Study|Withdrawal by Subject|6|||
17132278|NCT03536949|38273841|FG001|Overall Study|Withdrawal by Subject|0|||
17132279|NCT03536949|38273840|FG000|Overall Study|Non-compliance|2|||
17132280|NCT03536949|38273841|FG001|Overall Study|Non-compliance|1|||
17132281|NCT03588741|38273847|FG000|Overall Study|Withdrawal by Subject|1|||
17132282|NCT00111917|38273853|FG000|Overall Study|Withdrawal by Subject|1|||
17132283|NCT00111917|38273854|FG001|Overall Study|Withdrawal by Subject|1|||
17132284|NCT03520569|38273864|FG000|Overall Study|Withdrawal by Subject|1|||
17132285|NCT00111839|38273877|FG000|Overall Study|Disease Progression|30|||
17132286|NCT00111839|38273878|FG001|Overall Study|Disease Progression|33|||
17132287|NCT00111839|38273879|FG002|Overall Study|Disease Progression|33|||
17132288|NCT00111839|38273877|FG000|Overall Study|Adverse Event|5|||
17132289|NCT00111839|38273878|FG001|Overall Study|Adverse Event|3|||
17132290|NCT00111839|38273879|FG002|Overall Study|Adverse Event|1|||
17132291|NCT00111839|38273877|FG000|Overall Study|Protocol Violation|2|||
17132292|NCT00111839|38273878|FG001|Overall Study|Protocol Violation|4|||
17132293|NCT00111839|38273879|FG002|Overall Study|Protocol Violation|2|||
17132294|NCT00111839|38273877|FG000|Overall Study|Death|1|||
17132295|NCT00111839|38273878|FG001|Overall Study|Death|1|||
17132296|NCT00111839|38273879|FG002|Overall Study|Death|6|||
17132297|NCT00111839|38273877|FG000|Overall Study|Withdrawal by Subject|2|||
17132298|NCT00111839|38273878|FG001|Overall Study|Withdrawal by Subject|2|||
17132299|NCT00111839|38273879|FG002|Overall Study|Withdrawal by Subject|2|||
17132300|NCT00111839|38273877|FG000|Overall Study|Lost to Follow-up|1|||
17132301|NCT00111839|38273878|FG001|Overall Study|Lost to Follow-up|0|||
17132302|NCT00111839|38273879|FG002|Overall Study|Lost to Follow-up|0|||
17132303|NCT00111839|38273877|FG000|Overall Study|Logistical Constraint|1|||
17132304|NCT00111839|38273878|FG001|Overall Study|Logistical Constraint|0|||
17132305|NCT00111839|38273879|FG002|Overall Study|Logistical Constraint|0|||
17132306|NCT00111839|38273877|FG000|Overall Study|Other|6|||
17132307|NCT00111839|38273878|FG001|Overall Study|Other|3|||
17132308|NCT00111839|38273879|FG002|Overall Study|Other|3|||
17132309|NCT00111839|38273877|FG000|Overall Study|Randomized but Not Treated|0|||
17132310|NCT00111839|38273878|FG001|Overall Study|Randomized but Not Treated|0|||
17132311|NCT00111839|38273879|FG002|Overall Study|Randomized but Not Treated|2|||
17132312|NCT00111761|38273889|FG000|Part 1|Physician Decision|0|||
17132313|NCT00111761|38273890|FG001|Part 1|Physician Decision|1|||
17132314|NCT00111761|38273889|FG000|Part 1|Death|0|||
17132315|NCT00111761|38273890|FG001|Part 1|Death|2|||
17132316|NCT00111761|38273889|FG000|Part 1|Other|0|||
17132317|NCT00111761|38273890|FG001|Part 1|Other|1|||
17132318|NCT00111761|38273889|FG000|Part 1|Withdrawal by Subject|0|||
17132319|NCT00111761|38273890|FG001|Part 1|Withdrawal by Subject|1|||
17132320|NCT00111761|38273889|FG000|Part 2|Adverse Event|1|||
17132321|NCT00111761|38273890|FG001|Part 2|Adverse Event|0|||
17132322|NCT00111761|38273889|FG000|Part 2|Physician Decision|1|||
17132323|NCT00111761|38273890|FG001|Part 2|Physician Decision|0|||
17132324|NCT00111761|38273889|FG000|Part 2|Death|1|||
17132325|NCT00111761|38273890|FG001|Part 2|Death|0|||
17132326|NCT00111761|38273889|FG000|Part 2|Disease progression|3|||
17132327|NCT00111761|38273890|FG001|Part 2|Disease progression|0|||
17132328|NCT00111761|38273889|FG000|Part 2|Protocol-specified criteria|1|||
17132329|NCT00111761|38273890|FG001|Part 2|Protocol-specified criteria|0|||
17132330|NCT00111761|38273889|FG000|Part 2|Other|1|||
17132331|NCT00111761|38273890|FG001|Part 2|Other|0|||
17132332|NCT03519867|38273906|FG000|Overall Study|Adverse Event|1|||
17132333|NCT03519867|38273907|FG001|Overall Study|Adverse Event|1|||
17132334|NCT03519867|38273908|FG002|Overall Study|Adverse Event|0|||
17132335|NCT03519867|38273909|FG003|Overall Study|Adverse Event|0|||
17132336|NCT03519867|38273910|FG004|Overall Study|Adverse Event|0|||
17132337|NCT03519867|38273911|FG005|Overall Study|Adverse Event|0|||
17132338|NCT03519867|38273912|FG006|Overall Study|Adverse Event|0|||
17132339|NCT03519867|38273913|FG007|Overall Study|Adverse Event|0|||
17132340|NCT03519867|38273914|FG008|Overall Study|Adverse Event|0|||
17132341|NCT03519867|38273915|FG009|Overall Study|Adverse Event|0|||
17132342|NCT03519867|38273906|FG000|Overall Study|Protocol Violation|0|||
17132343|NCT03519867|38273907|FG001|Overall Study|Protocol Violation|0|||
17132344|NCT03519867|38273908|FG002|Overall Study|Protocol Violation|0|||
17132345|NCT03519867|38273909|FG003|Overall Study|Protocol Violation|0|||
17132346|NCT03519867|38273910|FG004|Overall Study|Protocol Violation|0|||
17132347|NCT03519867|38273911|FG005|Overall Study|Protocol Violation|1|||
17132348|NCT03519867|38273912|FG006|Overall Study|Protocol Violation|0|||
17132349|NCT03519867|38273913|FG007|Overall Study|Protocol Violation|0|||
17132350|NCT03519867|38273914|FG008|Overall Study|Protocol Violation|0|||
17132351|NCT03519867|38273915|FG009|Overall Study|Protocol Violation|0|||
17132352|NCT03519867|38273906|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132353|NCT03519867|38273907|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132354|NCT03519867|38273908|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132355|NCT03519867|38273909|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132356|NCT03519867|38273910|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132357|NCT03519867|38273911|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132358|NCT03519867|38273912|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
17132359|NCT03519867|38273913|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132360|NCT03519867|38273914|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132361|NCT03519867|38273915|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
17132362|NCT03519867|38273906|FG000|Overall Study|Admin. of other reversal agent|1|||
17132363|NCT03519867|38273907|FG001|Overall Study|Admin. of other reversal agent|1|||
17132364|NCT03519867|38273908|FG002|Overall Study|Admin. of other reversal agent|0|||
17132365|NCT03519867|38273909|FG003|Overall Study|Admin. of other reversal agent|0|||
17132366|NCT03519867|38273910|FG004|Overall Study|Admin. of other reversal agent|0|||
17132367|NCT03519867|38273911|FG005|Overall Study|Admin. of other reversal agent|1|||
17132368|NCT03519867|38273912|FG006|Overall Study|Admin. of other reversal agent|0|||
17132369|NCT03519867|38273913|FG007|Overall Study|Admin. of other reversal agent|0|||
17132370|NCT03519867|38273914|FG008|Overall Study|Admin. of other reversal agent|0|||
17132371|NCT03519867|38273915|FG009|Overall Study|Admin. of other reversal agent|0|||
17132372|NCT03519867|38273906|FG000|Overall Study|Reason not provided|1|||
17132373|NCT03519867|38273907|FG001|Overall Study|Reason not provided|1|||
17132374|NCT03519867|38273908|FG002|Overall Study|Reason not provided|1|||
17132375|NCT03519867|38273909|FG003|Overall Study|Reason not provided|1|||
17132376|NCT03519867|38273910|FG004|Overall Study|Reason not provided|0|||
17132377|NCT03519867|38273911|FG005|Overall Study|Reason not provided|1|||
17132378|NCT03519867|38273912|FG006|Overall Study|Reason not provided|0|||
17132379|NCT03519867|38273913|FG007|Overall Study|Reason not provided|1|||
17132380|NCT03519867|38273914|FG008|Overall Study|Reason not provided|1|||
17132381|NCT03519867|38273915|FG009|Overall Study|Reason not provided|0|||
17132382|NCT03519087|38273939|FG000|Clinic Evaluation|Physician Decision|15|||
17132383|NCT03519087|38273940|FG001|Clinic Evaluation|Physician Decision|18|||
17132384|NCT03519087|38273941|FG002|Clinic Evaluation|Physician Decision|0|||
17132385|NCT03519087|38273942|FG003|Clinic Evaluation|Physician Decision|0|||
17132386|NCT03519087|38273943|FG004|Clinic Evaluation|Physician Decision|0|||
17132387|NCT03519087|38273939|FG000|Clinic Evaluation|Protocol Violation|1|||
17132388|NCT03519087|38273940|FG001|Clinic Evaluation|Protocol Violation|0|||
17132389|NCT03519087|38273941|FG002|Clinic Evaluation|Protocol Violation|0|||
17132390|NCT03519087|38273942|FG003|Clinic Evaluation|Protocol Violation|0|||
17132391|NCT03519087|38273943|FG004|Clinic Evaluation|Protocol Violation|0|||
17132392|NCT03519087|38273939|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
17132393|NCT03519087|38273940|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
17132394|NCT03519087|38273941|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
17132395|NCT03519087|38273942|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
17132396|NCT03519087|38273943|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
17132397|NCT03519087|38273939|FG000|Re-randomization for Treatment|Not appropriate|2|||
17132398|NCT03519087|38273940|FG001|Re-randomization for Treatment|Not appropriate|3|||
17132399|NCT03519087|38273941|FG002|Re-randomization for Treatment|Not appropriate|0|||
17132400|NCT03519087|38273942|FG003|Re-randomization for Treatment|Not appropriate|0|||
17132401|NCT03519087|38273943|FG004|Re-randomization for Treatment|Not appropriate|0|||
17132402|NCT03519087|38273939|FG000|Laboratory Testing|Lost to Follow-up|0|||
17132403|NCT03519087|38273940|FG001|Laboratory Testing|Lost to Follow-up|0|||
17132404|NCT03519087|38273941|FG002|Laboratory Testing|Lost to Follow-up|2|||
17132405|NCT03519087|38273942|FG003|Laboratory Testing|Lost to Follow-up|3|||
17132406|NCT03519087|38273943|FG004|Laboratory Testing|Lost to Follow-up|6|||
17132407|NCT03519087|38273939|FG000|Laboratory Testing|Protocol Violation|0|||
17132408|NCT03519087|38273940|FG001|Laboratory Testing|Protocol Violation|0|||
17132409|NCT03519087|38273941|FG002|Laboratory Testing|Protocol Violation|0|||
17132410|NCT03519087|38273942|FG003|Laboratory Testing|Protocol Violation|1|||
17132411|NCT03519087|38273943|FG004|Laboratory Testing|Protocol Violation|0|||
17132412|NCT02763046|38273962|FG000|Overall Study|Adverse Event|5|||
17132413|NCT02763046|38273963|FG001|Overall Study|Adverse Event|4|||
17132414|NCT02763046|38273964|FG002|Overall Study|Adverse Event|0|||
17132415|NCT02763046|38273962|FG000|Overall Study|Lack of Efficacy|1|||
17132416|NCT02763046|38273963|FG001|Overall Study|Lack of Efficacy|1|||
17132417|NCT02763046|38273964|FG002|Overall Study|Lack of Efficacy|3|||
17132418|NCT02763046|38273962|FG000|Overall Study|Physician Decision|1|||
17132419|NCT02763046|38273963|FG001|Overall Study|Physician Decision|0|||
17132420|NCT02763046|38273964|FG002|Overall Study|Physician Decision|1|||
17132421|NCT02763046|38273962|FG000|Overall Study|Subject/guardian decision|2|||
17132422|NCT02763046|38273963|FG001|Overall Study|Subject/guardian decision|0|||
17132423|NCT02763046|38273964|FG002|Overall Study|Subject/guardian decision|4|||
17132424|NCT03518073|38273981|FG000|Overall Study|Adverse Event|2|||
17132425|NCT03518073|38273982|FG001|Overall Study|Adverse Event|4|||
17132426|NCT03518073|38273983|FG002|Overall Study|Adverse Event|2|||
17132427|NCT03518073|38273981|FG000|Overall Study|Death|2|||
17132428|NCT03518073|38273982|FG001|Overall Study|Death|1|||
17132429|NCT03518073|38273983|FG002|Overall Study|Death|3|||
17132430|NCT03518073|38273981|FG000|Overall Study|Lost to Follow-up|1|||
17132431|NCT03518073|38273982|FG001|Overall Study|Lost to Follow-up|0|||
17132432|NCT03518073|38273983|FG002|Overall Study|Lost to Follow-up|1|||
17132433|NCT03518073|38273981|FG000|Overall Study|Physician Decision|5|||
17132434|NCT03518073|38273982|FG001|Overall Study|Physician Decision|0|||
17132435|NCT03518073|38273983|FG002|Overall Study|Physician Decision|2|||
17132436|NCT03518073|38273981|FG000|Overall Study|Progressive disease|1|||
17132437|NCT03518073|38273982|FG001|Overall Study|Progressive disease|1|||
17132438|NCT03518073|38273983|FG002|Overall Study|Progressive disease|1|||
17132439|NCT03518073|38273981|FG000|Overall Study|Protocol Violation|1|||
17132440|NCT03518073|38273982|FG001|Overall Study|Protocol Violation|0|||
17132441|NCT03518073|38273983|FG002|Overall Study|Protocol Violation|0|||
17132442|NCT03518073|38273981|FG000|Overall Study|Withdrawal by Subject|30|||
17132443|NCT03518073|38273982|FG001|Overall Study|Withdrawal by Subject|34|||
17132444|NCT03518073|38273983|FG002|Overall Study|Withdrawal by Subject|29|||
17132445|NCT03518073|38273981|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
17132446|NCT03518073|38273982|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
17132447|NCT03518073|38273983|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
17132448|NCT03518073|38273981|FG000|Overall Study|Covid-19|1|||
17132449|NCT03518073|38273982|FG001|Overall Study|Covid-19|2|||
17132450|NCT03518073|38273983|FG002|Overall Study|Covid-19|1|||
17132451|NCT02759692|38273993|FG000|Period 1|Test article no longer available|1|||
17132452|NCT02759692|38273994|FG001|Period 1|Test article no longer available|1|||
17132453|NCT02759692|38273993|FG000|Period 1|No longer meets eligibility criteria.|1|||
17132454|NCT02759692|38273994|FG001|Period 1|No longer meets eligibility criteria.|0|||
17132455|NCT02759692|38273993|FG000|Period 1|Miss-Randomized|1|||
17132456|NCT02759692|38273994|FG001|Period 1|Miss-Randomized|1|||
17132457|NCT02759692|38273993|FG000|Period 2|Lost to Follow-up|1|||
17132458|NCT02759692|38273994|FG001|Period 2|Lost to Follow-up|0|||
17132459|NCT02759692|38273993|FG000|Period 2|Test article no longer available|0|||
17132460|NCT02759692|38273994|FG001|Period 2|Test article no longer available|1|||
17132461|NCT03586167|38274002|FG000|Overall Study|Other|1|||
17132462|NCT03586167|38274003|FG001|Overall Study|Other|0|||
17132463|NCT02762578|38274011|FG000|Overall Study|Adverse Event|1|||
17132464|NCT02762578|38274012|FG001|Overall Study|Adverse Event|6|||
17132465|NCT02762578|38274011|FG000|Overall Study|Protocol Violation|4|||
17132466|NCT02762578|38274012|FG001|Overall Study|Protocol Violation|2|||
17132467|NCT02762578|38274011|FG000|Overall Study|Withdrawal by Subject|4|||
17132468|NCT02762578|38274012|FG001|Overall Study|Withdrawal by Subject|2|||
17132469|NCT02762578|38274011|FG000|Overall Study|Unclassified|6|||
17132470|NCT02762578|38274012|FG001|Overall Study|Unclassified|0|||
17132471|NCT03514641|38274022|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
17132472|NCT03514641|38274023|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
17132473|NCT03514641|38274024|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
17132474|NCT03514641|38274025|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
17132475|NCT03514641|38274022|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
17132476|NCT03514641|38274023|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
17132477|NCT03514641|38274024|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
17132478|NCT03514641|38274025|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
17132479|NCT03514641|38274022|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
17132480|NCT03514641|38274023|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
17132481|NCT03514641|38274024|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
17132482|NCT03514641|38274025|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
17132483|NCT03514641|38274022|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
17132484|NCT03514641|38274023|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
17132485|NCT03514641|38274024|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
17132486|NCT03514641|38274025|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
17132487|NCT03514641|38274022|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
17132488|NCT03514641|38274023|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
17132489|NCT03514641|38274024|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
17132490|NCT03514641|38274025|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
17132491|NCT03514641|38274022|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
17132492|NCT03514641|38274023|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
17132493|NCT03514641|38274024|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
17132494|NCT03514641|38274025|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
17132495|NCT03514641|38274022|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
17132496|NCT03514641|38274023|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
17132497|NCT03514641|38274024|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
17132498|NCT03514641|38274025|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
17132499|NCT03514641|38274022|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
17132500|NCT03514641|38274023|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
17132501|NCT03514641|38274024|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
17132502|NCT03514641|38274025|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
17132503|NCT03514641|38274022|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
17132504|NCT03514641|38274023|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
17132505|NCT03514641|38274024|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
17132506|NCT03514641|38274025|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
17132507|NCT03514641|38274022|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
17132508|NCT03514641|38274023|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
17132509|NCT03514641|38274024|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
17132510|NCT03514641|38274025|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
17132511|NCT03514641|38274022|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
17132512|NCT03514641|38274023|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
17132513|NCT03514641|38274024|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
17132514|NCT03514641|38274025|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
17132515|NCT03514641|38274022|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
17132516|NCT03514641|38274023|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
17132517|NCT03514641|38274024|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
17132518|NCT03514641|38274025|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
17132519|NCT00100828|38274037|FG000|Overall Study|Physician Decision|6|||
17132520|NCT00100048|38274046|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
17132521|NCT00100048|38274047|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
17132522|NCT00100048|38274048|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
17132523|NCT00100048|38274049|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
17132524|NCT00100048|38274050|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
17132525|NCT00100048|38274051|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
17132526|NCT00100048|38274046|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
17132527|NCT00100048|38274047|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
17132528|NCT00100048|38274048|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
17132529|NCT00100048|38274049|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
17132530|NCT00100048|38274050|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
17132531|NCT00100048|38274051|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
17132532|NCT00100048|38274046|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
17132533|NCT00100048|38274047|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
17132534|NCT00100048|38274048|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
17132535|NCT00100048|38274049|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
17132536|NCT00100048|38274050|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
17132537|NCT00100048|38274051|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
17132538|NCT00100048|38274046|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
17132539|NCT00100048|38274047|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
17132540|NCT00100048|38274048|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
17132541|NCT00100048|38274049|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
17132542|NCT00100048|38274050|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
17132543|NCT00100048|38274051|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
17132544|NCT00100048|38274046|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
17132545|NCT00100048|38274047|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
17132546|NCT00100048|38274048|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
17132547|NCT00100048|38274049|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
17132548|NCT00100048|38274050|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
17132549|NCT00100048|38274051|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
17132550|NCT00100048|38274046|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
17132551|NCT00100048|38274047|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
17132552|NCT00100048|38274048|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
17132553|NCT00100048|38274049|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
17132554|NCT00100048|38274050|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
17132555|NCT00100048|38274051|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
17132556|NCT00100048|38274046|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
17132557|NCT00100048|38274047|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
16957333|NCT01160289|38100336|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
16957334|NCT01160289|38100337|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16957335|NCT01160289|38100338|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16957336|NCT01160289|38100339|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16957337|NCT01160289|38100340|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16957338|NCT01160289|38100341|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16957339|NCT01160289|38100336|FG000|Post-Randomization Period|Adverse Event|0|||
16957340|NCT01160289|38100337|FG001|Post-Randomization Period|Adverse Event|4|||
16957341|NCT01160289|38100338|FG002|Post-Randomization Period|Adverse Event|4|||
16957342|NCT01160289|38100339|FG003|Post-Randomization Period|Adverse Event|2|||
16957343|NCT01160289|38100340|FG004|Post-Randomization Period|Adverse Event|0|||
16957344|NCT01160289|38100341|FG005|Post-Randomization Period|Adverse Event|0|||
16957345|NCT01160289|38100336|FG000|Post-Randomization Period|Death|0|||
16957346|NCT01160289|38100337|FG001|Post-Randomization Period|Death|0|||
16957347|NCT01160289|38100338|FG002|Post-Randomization Period|Death|0|||
16957348|NCT01160289|38100339|FG003|Post-Randomization Period|Death|1|||
16957349|NCT01160289|38100340|FG004|Post-Randomization Period|Death|0|||
16957350|NCT01160289|38100341|FG005|Post-Randomization Period|Death|0|||
16957351|NCT01160289|38100336|FG000|Post-Randomization Period|Lack of Efficacy|0|||
16957352|NCT01160289|38100337|FG001|Post-Randomization Period|Lack of Efficacy|1|||
16957353|NCT01160289|38100338|FG002|Post-Randomization Period|Lack of Efficacy|0|||
16957354|NCT01160289|38100339|FG003|Post-Randomization Period|Lack of Efficacy|3|||
16957355|NCT01160289|38100340|FG004|Post-Randomization Period|Lack of Efficacy|0|||
16957356|NCT01160289|38100341|FG005|Post-Randomization Period|Lack of Efficacy|0|||
16957357|NCT01160289|38100336|FG000|Post-Randomization Period|Lost to Follow-up|0|||
16957358|NCT01160289|38100337|FG001|Post-Randomization Period|Lost to Follow-up|3|||
16957359|NCT01160289|38100338|FG002|Post-Randomization Period|Lost to Follow-up|2|||
16957360|NCT01160289|38100339|FG003|Post-Randomization Period|Lost to Follow-up|5|||
16957361|NCT01160289|38100340|FG004|Post-Randomization Period|Lost to Follow-up|3|||
16957362|NCT01160289|38100341|FG005|Post-Randomization Period|Lost to Follow-up|4|||
16957363|NCT01160289|38100336|FG000|Post-Randomization Period|Physician Decision|0|||
16957364|NCT01160289|38100337|FG001|Post-Randomization Period|Physician Decision|0|||
16957365|NCT01160289|38100338|FG002|Post-Randomization Period|Physician Decision|1|||
16957366|NCT01160289|38100339|FG003|Post-Randomization Period|Physician Decision|0|||
16957367|NCT01160289|38100340|FG004|Post-Randomization Period|Physician Decision|0|||
16957368|NCT01160289|38100341|FG005|Post-Randomization Period|Physician Decision|0|||
16957369|NCT01160289|38100336|FG000|Post-Randomization Period|Protocol Violation|0|||
16957370|NCT01160289|38100337|FG001|Post-Randomization Period|Protocol Violation|4|||
16957371|NCT01160289|38100338|FG002|Post-Randomization Period|Protocol Violation|2|||
16957372|NCT01160289|38100339|FG003|Post-Randomization Period|Protocol Violation|0|||
16957373|NCT01160289|38100340|FG004|Post-Randomization Period|Protocol Violation|1|||
16957374|NCT01160289|38100341|FG005|Post-Randomization Period|Protocol Violation|3|||
16957375|NCT01160289|38100336|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
16957376|NCT01160289|38100337|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
16957377|NCT01160289|38100338|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
16957378|NCT01160289|38100339|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
16957379|NCT01160289|38100340|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
16957380|NCT01160289|38100341|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
16957381|NCT01160289|38100336|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
16957382|NCT01160289|38100337|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
16957383|NCT01160289|38100338|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
16957384|NCT01160289|38100339|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
16957385|NCT01160289|38100340|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
16957386|NCT01160289|38100341|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
16957387|NCT01160289|38100336|FG000|Post-Randomization Period|Sponsor Decision|0|||
16957388|NCT01160289|38100337|FG001|Post-Randomization Period|Sponsor Decision|1|||
16957389|NCT01160289|38100338|FG002|Post-Randomization Period|Sponsor Decision|0|||
16957390|NCT01160289|38100339|FG003|Post-Randomization Period|Sponsor Decision|0|||
16957391|NCT01160289|38100340|FG004|Post-Randomization Period|Sponsor Decision|0|||
16957392|NCT01160289|38100341|FG005|Post-Randomization Period|Sponsor Decision|0|||
16957393|NCT01159665|38100360|FG000|Overall Study|Withdrawal by Subject|0|||
16957394|NCT01159665|38100361|FG001|Overall Study|Withdrawal by Subject|1|||
16957395|NCT01159665|38100362|FG002|Overall Study|Withdrawal by Subject|0|||
16957396|NCT01159665|38100363|FG003|Overall Study|Withdrawal by Subject|0|||
16957397|NCT01159665|38100364|FG004|Overall Study|Withdrawal by Subject|0|||
16957398|NCT01159665|38100365|FG005|Overall Study|Withdrawal by Subject|0|||
17132558|NCT00100048|38274048|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
17132559|NCT00100048|38274049|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
17132560|NCT00100048|38274050|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
17132561|NCT00100048|38274051|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
17132562|NCT00100048|38274046|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
17132563|NCT00100048|38274047|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
17132564|NCT00100048|38274048|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
17132565|NCT00100048|38274049|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
17132566|NCT00100048|38274050|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
17132567|NCT00100048|38274051|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
17132568|NCT02757430|38274076|FG000|Overall Study|Physician Decision|6|||
17132569|NCT02757430|38274076|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
17132570|NCT02757430|38274076|FG000|Overall Study|No informed consent|1|||
17132571|NCT02757430|38274076|FG000|Overall Study|No procedure performed|2|||
17132572|NCT02757352|38274092|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
17132573|NCT02757352|38274093|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
17132574|NCT02757352|38274094|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
17132575|NCT02757352|38274095|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
17132576|NCT02757352|38274096|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
17132577|NCT02757352|38274097|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
17132578|NCT02757352|38274098|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
17132579|NCT02757352|38274099|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
17132580|NCT02757352|38274100|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
17132581|NCT02757352|38274101|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
17132582|NCT02757352|38274092|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132583|NCT02757352|38274093|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132584|NCT02757352|38274094|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
17132585|NCT02757352|38274095|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132586|NCT02757352|38274096|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132587|NCT02757352|38274097|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132588|NCT02757352|38274098|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132589|NCT02757352|38274099|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132590|NCT02757352|38274100|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132591|NCT02757352|38274101|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
17132592|NCT02757352|38274092|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
17132593|NCT02757352|38274093|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
17132594|NCT02757352|38274094|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
17132595|NCT02757352|38274095|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
17132596|NCT02757352|38274096|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
17132597|NCT02757352|38274097|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
17132598|NCT02757352|38274098|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
17132599|NCT02757352|38274099|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
17132600|NCT02757352|38274100|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
17132601|NCT02757352|38274101|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
17132602|NCT02757352|38274092|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132603|NCT02757352|38274093|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
17132604|NCT02757352|38274094|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132605|NCT02757352|38274095|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132606|NCT02757352|38274096|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132607|NCT02757352|38274097|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132608|NCT02757352|38274098|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132609|NCT02757352|38274099|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132610|NCT02757352|38274100|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132611|NCT02757352|38274101|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
17132612|NCT02757352|38274092|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132613|NCT02757352|38274093|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
17132614|NCT02757352|38274094|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132615|NCT02757352|38274095|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132616|NCT02757352|38274096|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132617|NCT02757352|38274097|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132618|NCT02757352|38274098|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132619|NCT02757352|38274099|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132620|NCT02757352|38274100|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132621|NCT02757352|38274101|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132622|NCT02757352|38274092|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
17132623|NCT02757352|38274093|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
17132624|NCT02757352|38274094|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
17132625|NCT02757352|38274095|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132626|NCT02757352|38274096|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132627|NCT02757352|38274097|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132628|NCT02757352|38274098|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132629|NCT02757352|38274099|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132630|NCT02757352|38274100|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132631|NCT02757352|38274101|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132632|NCT02757352|38274092|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
17132633|NCT02757352|38274093|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
17132634|NCT02757352|38274094|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
17132635|NCT02757352|38274095|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
17132636|NCT02757352|38274096|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
17132637|NCT02757352|38274097|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
17132638|NCT02757352|38274098|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
17132639|NCT02757352|38274099|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
17132640|NCT02757352|38274100|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
17132641|NCT02757352|38274101|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
17132642|NCT02757352|38274092|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
17132643|NCT02757352|38274093|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
17132644|NCT02757352|38274094|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
17132645|NCT02757352|38274095|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
17132646|NCT02757352|38274096|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
17132647|NCT02757352|38274097|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
17132648|NCT02757352|38274098|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
17132649|NCT02757352|38274099|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
17132650|NCT02757352|38274100|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
17132651|NCT02757352|38274101|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
17132652|NCT02757352|38274092|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132653|NCT02757352|38274093|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132654|NCT02757352|38274094|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132655|NCT02757352|38274095|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
17132656|NCT02757352|38274096|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
17132657|NCT02757352|38274097|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
17132658|NCT02757352|38274098|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16957399|NCT01159431|38100381|FG000|Overall Study|Adverse Event|1|||
16957400|NCT01159431|38100382|FG001|Overall Study|Adverse Event|2|||
16957401|NCT01159431|38100381|FG000|Overall Study|non-compliance|1|||
16957402|NCT01159431|38100382|FG001|Overall Study|non-compliance|1|||
16957403|NCT01159431|38100381|FG000|Overall Study|Lack of Efficacy|0|||
16957404|NCT01159431|38100382|FG001|Overall Study|Lack of Efficacy|3|||
16957405|NCT01158261|38100395|FG000|Overall Study|Lost to Follow-up|9|||
16957406|NCT01158261|38100395|FG000|Overall Study|Death|7|||
16957407|NCT01158261|38100395|FG000|Overall Study|Withdrawal by Subject|1|||
16957408|NCT01157169|38100401|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
16957409|NCT01157169|38100402|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
16957410|NCT01157169|38100401|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
16957411|NCT01157169|38100402|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
16957412|NCT01231620|38100411|FG000|Overall Study|Physician Decision|3|||
16957413|NCT01231620|38100412|FG001|Overall Study|Physician Decision|5|||
16957414|NCT01231620|38100413|FG002|Overall Study|Physician Decision|10|||
16957415|NCT01231620|38100411|FG000|Overall Study|Death|12|||
16957416|NCT01231620|38100412|FG001|Overall Study|Death|14|||
16957417|NCT01231620|38100413|FG002|Overall Study|Death|11|||
16957418|NCT01231620|38100411|FG000|Overall Study|Adverse Event|2|||
16957419|NCT01231620|38100412|FG001|Overall Study|Adverse Event|2|||
16957420|NCT01231620|38100413|FG002|Overall Study|Adverse Event|1|||
16957421|NCT01231620|38100411|FG000|Overall Study|Withdrawal by Subject|6|||
16957422|NCT01231620|38100412|FG001|Overall Study|Withdrawal by Subject|6|||
16957423|NCT01231620|38100413|FG002|Overall Study|Withdrawal by Subject|8|||
16957424|NCT01231620|38100411|FG000|Overall Study|Lost to Follow-up|3|||
16957425|NCT01231620|38100412|FG001|Overall Study|Lost to Follow-up|4|||
16957426|NCT01231620|38100413|FG002|Overall Study|Lost to Follow-up|9|||
16957427|NCT01809691|38100423|FG000|Overall Study|Currently on Treatment|192|||
16957428|NCT01809691|38100424|FG001|Overall Study|Currently on Treatment|100|||
16957429|NCT01809691|38100423|FG000|Overall Study|No Protocol Treatment|10|||
17132659|NCT02757352|38274099|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132660|NCT02757352|38274100|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132661|NCT02757352|38274101|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
17132662|NCT02757352|38274092|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132663|NCT02757352|38274093|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132664|NCT02757352|38274094|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132665|NCT02757352|38274095|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132666|NCT02757352|38274096|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
17132667|NCT02757352|38274097|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132668|NCT02757352|38274098|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132669|NCT02757352|38274099|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132670|NCT02757352|38274100|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132671|NCT02757352|38274101|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
17132672|NCT02757352|38274092|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132673|NCT02757352|38274093|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132674|NCT02757352|38274094|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132675|NCT02757352|38274095|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132676|NCT02757352|38274096|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132677|NCT02757352|38274097|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
17132678|NCT02757352|38274098|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132679|NCT02757352|38274099|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132680|NCT02757352|38274100|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132681|NCT02757352|38274101|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
17132682|NCT02757352|38274092|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132683|NCT02757352|38274093|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132684|NCT02757352|38274094|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132685|NCT02757352|38274095|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
17132686|NCT02757352|38274096|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
17132687|NCT02757352|38274097|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
17132688|NCT02757352|38274098|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132689|NCT02757352|38274099|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132690|NCT02757352|38274100|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132691|NCT02757352|38274101|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
17132692|NCT02757352|38274092|FG000|Follow-Up Period|Adverse Event|0|||
17132693|NCT02757352|38274093|FG001|Follow-Up Period|Adverse Event|0|||
17132694|NCT02757352|38274094|FG002|Follow-Up Period|Adverse Event|0|||
17132695|NCT02757352|38274095|FG003|Follow-Up Period|Adverse Event|0|||
17132696|NCT02757352|38274096|FG004|Follow-Up Period|Adverse Event|0|||
17132697|NCT02757352|38274097|FG005|Follow-Up Period|Adverse Event|0|||
17132698|NCT02757352|38274098|FG006|Follow-Up Period|Adverse Event|1|||
17132699|NCT02757352|38274099|FG007|Follow-Up Period|Adverse Event|0|||
17132700|NCT02757352|38274100|FG008|Follow-Up Period|Adverse Event|2|||
17132701|NCT02757352|38274101|FG009|Follow-Up Period|Adverse Event|0|||
17132702|NCT02757352|38274092|FG000|Follow-Up Period|Lost to Follow-up|0|||
17132703|NCT02757352|38274093|FG001|Follow-Up Period|Lost to Follow-up|0|||
17132704|NCT02757352|38274094|FG002|Follow-Up Period|Lost to Follow-up|0|||
17132705|NCT02757352|38274095|FG003|Follow-Up Period|Lost to Follow-up|0|||
17132706|NCT02757352|38274096|FG004|Follow-Up Period|Lost to Follow-up|0|||
17132707|NCT02757352|38274097|FG005|Follow-Up Period|Lost to Follow-up|0|||
17132708|NCT02757352|38274098|FG006|Follow-Up Period|Lost to Follow-up|0|||
17132709|NCT02757352|38274099|FG007|Follow-Up Period|Lost to Follow-up|0|||
17132710|NCT02757352|38274100|FG008|Follow-Up Period|Lost to Follow-up|1|||
17132711|NCT02757352|38274101|FG009|Follow-Up Period|Lost to Follow-up|0|||
17132712|NCT02757352|38274092|FG000|Follow-Up Period|Lack of Efficacy|0|||
17132713|NCT02757352|38274093|FG001|Follow-Up Period|Lack of Efficacy|0|||
17132714|NCT02757352|38274094|FG002|Follow-Up Period|Lack of Efficacy|0|||
17132715|NCT02757352|38274095|FG003|Follow-Up Period|Lack of Efficacy|0|||
17132716|NCT02757352|38274096|FG004|Follow-Up Period|Lack of Efficacy|0|||
17132717|NCT02757352|38274097|FG005|Follow-Up Period|Lack of Efficacy|0|||
17132718|NCT02757352|38274098|FG006|Follow-Up Period|Lack of Efficacy|0|||
17132719|NCT02757352|38274099|FG007|Follow-Up Period|Lack of Efficacy|0|||
17132720|NCT02757352|38274100|FG008|Follow-Up Period|Lack of Efficacy|1|||
17132721|NCT02757352|38274101|FG009|Follow-Up Period|Lack of Efficacy|1|||
17132722|NCT02757352|38274092|FG000|Follow-Up Period|Withdrawal by Subject|0|||
17132723|NCT02757352|38274093|FG001|Follow-Up Period|Withdrawal by Subject|0|||
17132724|NCT02757352|38274094|FG002|Follow-Up Period|Withdrawal by Subject|0|||
17132725|NCT02757352|38274095|FG003|Follow-Up Period|Withdrawal by Subject|0|||
17132726|NCT02757352|38274096|FG004|Follow-Up Period|Withdrawal by Subject|0|||
17132727|NCT02757352|38274097|FG005|Follow-Up Period|Withdrawal by Subject|0|||
17132728|NCT02757352|38274098|FG006|Follow-Up Period|Withdrawal by Subject|0|||
17132729|NCT02757352|38274099|FG007|Follow-Up Period|Withdrawal by Subject|1|||
17132730|NCT02757352|38274100|FG008|Follow-Up Period|Withdrawal by Subject|6|||
17132731|NCT02757352|38274101|FG009|Follow-Up Period|Withdrawal by Subject|2|||
17132732|NCT04588480|38274134|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
17132733|NCT04588480|38274135|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
17132734|NCT04588480|38274136|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
17132735|NCT04588480|38274134|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
17132736|NCT04588480|38274135|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
17132737|NCT04588480|38274136|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
17132738|NCT02756650|38274143|FG000|Overall Study|Physician Decision|1|||
17132739|NCT02756650|38274143|FG000|Overall Study|Adverse Event|1|||
17132740|NCT00110357|38274149|FG000|Overall Study|Deterioration without progression|2|||
17132741|NCT00110357|38274150|FG001|Overall Study|Deterioration without progression|0|||
17132742|NCT00110357|38274149|FG000|Overall Study|Disease progression/relapse|20|||
17132743|NCT00110357|38274150|FG001|Overall Study|Disease progression/relapse|15|||
17132744|NCT00110357|38274149|FG000|Overall Study|Study Closure|1|||
17132745|NCT00110357|38274150|FG001|Overall Study|Study Closure|0|||
17132746|NCT00110357|38274149|FG000|Overall Study|Study Drug Toxicity|1|||
17132747|NCT00110357|38274150|FG001|Overall Study|Study Drug Toxicity|3|||
17132748|NCT00110357|38274149|FG000|Overall Study|Withdrawal by Subject|3|||
17132749|NCT00110357|38274150|FG001|Overall Study|Withdrawal by Subject|1|||
17132750|NCT02752906|38274185|FG000|Overall Study|Protocol Violation|2|||
17132751|NCT02752906|38274186|FG001|Overall Study|Protocol Violation|1|||
17132752|NCT02752906|38274185|FG000|Overall Study|Withdrawal by Subject|2|||
17132753|NCT02752906|38274186|FG001|Overall Study|Withdrawal by Subject|2|||
17132754|NCT02752906|38274185|FG000|Overall Study|Lost to Follow-up|3|||
17132755|NCT02752906|38274186|FG001|Overall Study|Lost to Follow-up|2|||
17132756|NCT02756338|38274192|FG000|Overall Study|Withdrawn by Investigator|1|||
17132757|NCT02756338|38274192|FG000|Overall Study|Device Replaced with Pacemaker|4|||
17132758|NCT00293033|38274196|FG000|Open-label Titration Period|Adverse Event|10|||
17132759|NCT00293033|38274196|FG000|Open-label Titration Period|Death|3|||
17132760|NCT00293033|38274196|FG000|Open-label Titration Period|Lack of Efficacy|5|||
17132761|NCT00293033|38274196|FG000|Open-label Titration Period|Protocol Violation|2|||
17132762|NCT00293033|38274196|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
17132763|NCT00293033|38274196|FG000|Open-label Titration Period|Noncompliance and other|27|||
17132764|NCT00293033|38274196|FG000|Double-blind Treatment Period|Adverse Event|3|||
17132765|NCT00293033|38274196|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
17132766|NCT00293033|38274196|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
17132767|NCT00293033|38274196|FG000|Double-blind Treatment Period|Noncompliance|4|||
17132768|NCT02756182|38274204|FG000|Overall Study|StudyTechnical Difficulties|4|||
17132769|NCT03823703|38274213|FG000|Overall Study|Sponsor request|0|||
17132770|NCT03823703|38274214|FG001|Overall Study|Sponsor request|3|||
17132771|NCT03823703|38274215|FG002|Overall Study|Sponsor request|4|||
17132772|NCT03823703|38274213|FG000|Overall Study|Adverse Event|3|||
17132773|NCT03823703|38274214|FG001|Overall Study|Adverse Event|1|||
17132774|NCT03823703|38274215|FG002|Overall Study|Adverse Event|0|||
17132775|NCT03823703|38274213|FG000|Overall Study|Withdrawal by Subject|0|||
17132776|NCT03823703|38274214|FG001|Overall Study|Withdrawal by Subject|1|||
17132777|NCT03823703|38274215|FG002|Overall Study|Withdrawal by Subject|0|||
17132778|NCT00109577|38274225|FG000|Overall Study|Withdrawal by Subject|3|||
17132779|NCT00109577|38274226|FG001|Overall Study|Withdrawal by Subject|3|||
17132780|NCT02755090|38274234|FG000|Overall Study|equipment malfunction|1|||
17132781|NCT02755090|38274235|FG001|Overall Study|equipment malfunction|0|||
17132782|NCT00109343|38274244|FG000|Overall Study|Adverse Event|1|||
17132783|NCT00109343|38274245|FG001|Overall Study|Adverse Event|0|||
17132784|NCT00109343|38274246|FG002|Overall Study|Adverse Event|2|||
17132785|NCT00109343|38274244|FG000|Overall Study|Lack of Efficacy|1|||
17132786|NCT00109343|38274245|FG001|Overall Study|Lack of Efficacy|0|||
17132787|NCT00109343|38274246|FG002|Overall Study|Lack of Efficacy|0|||
17132788|NCT00109343|38274244|FG000|Overall Study|Lost to Follow-up|35|||
17132789|NCT00109343|38274245|FG001|Overall Study|Lost to Follow-up|20|||
17132790|NCT00109343|38274246|FG002|Overall Study|Lost to Follow-up|14|||
17132791|NCT00109343|38274244|FG000|Overall Study|Protocol Violation|1|||
17132792|NCT00109343|38274245|FG001|Overall Study|Protocol Violation|2|||
17132793|NCT00109343|38274246|FG002|Overall Study|Protocol Violation|2|||
17132794|NCT00109343|38274244|FG000|Overall Study|Withdrawal by Subject|15|||
17132795|NCT00109343|38274245|FG001|Overall Study|Withdrawal by Subject|11|||
17132796|NCT00109343|38274246|FG002|Overall Study|Withdrawal by Subject|10|||
17132797|NCT00109343|38274244|FG000|Overall Study|Subject Moved|6|||
17132798|NCT00109343|38274245|FG001|Overall Study|Subject Moved|2|||
17132799|NCT00109343|38274246|FG002|Overall Study|Subject Moved|1|||
17132800|NCT00109343|38274244|FG000|Overall Study|Other|5|||
17132801|NCT00109343|38274245|FG001|Overall Study|Other|2|||
17132802|NCT00109343|38274246|FG002|Overall Study|Other|1|||
17132803|NCT00108485|38274256|FG000|Overall Study|Withdrawal by Subject|3|||
17132804|NCT00108485|38274257|FG001|Overall Study|Withdrawal by Subject|0|||
17132805|NCT00108485|38274256|FG000|Overall Study|Lost to Follow-up|0|||
17132806|NCT00108485|38274257|FG001|Overall Study|Lost to Follow-up|2|||
17132807|NCT00107783|38274265|FG000|Overall Study|Adverse Event|0|||
17132808|NCT00107783|38274266|FG001|Overall Study|Adverse Event|2|||
17132809|NCT00107783|38274265|FG000|Overall Study|Death|0|||
17132810|NCT00107783|38274266|FG001|Overall Study|Death|1|||
17132811|NCT00107783|38274265|FG000|Overall Study|Withdrawal by Subject|2|||
17132812|NCT00107783|38274266|FG001|Overall Study|Withdrawal by Subject|0|||
17132813|NCT00107783|38274265|FG000|Overall Study|Second hip replacement|1|||
17132814|NCT00107783|38274266|FG001|Overall Study|Second hip replacement|1|||
17132815|NCT00095303|38274274|FG000|Main Study|Lost to Follow-up|91|||
17132816|NCT00095303|38274275|FG001|Main Study|Lost to Follow-up|87|||
17132817|NCT00095303|38274274|FG000|Follow Up Study|Lost to Follow-up|59|||
17132818|NCT00095303|38274275|FG001|Follow Up Study|Lost to Follow-up|58|||
17132819|NCT00105521|38274285|FG000|Overall Study|Other|1|||
17132820|NCT00105521|38274286|FG001|Overall Study|Other|1|||
17132821|NCT00105521|38274287|FG002|Overall Study|Other|2|||
17132822|NCT00105521|38274288|FG003|Overall Study|Other|0|||
17132823|NCT00105521|38274285|FG000|Overall Study|Adverse Event|10|||
17132824|NCT00105521|38274286|FG001|Overall Study|Adverse Event|4|||
17132825|NCT00105521|38274287|FG002|Overall Study|Adverse Event|10|||
17132826|NCT00105521|38274288|FG003|Overall Study|Adverse Event|8|||
17132827|NCT00105521|38274285|FG000|Overall Study|Withdrawal by Subject|1|||
17132828|NCT00105521|38274286|FG001|Overall Study|Withdrawal by Subject|0|||
17132829|NCT00105521|38274287|FG002|Overall Study|Withdrawal by Subject|1|||
17132830|NCT00105521|38274288|FG003|Overall Study|Withdrawal by Subject|4|||
17132831|NCT00105521|38274285|FG000|Overall Study|Lack of Efficacy|0|||
17132832|NCT00105521|38274286|FG001|Overall Study|Lack of Efficacy|0|||
17132833|NCT00105521|38274287|FG002|Overall Study|Lack of Efficacy|0|||
17132834|NCT00105521|38274288|FG003|Overall Study|Lack of Efficacy|1|||
17132835|NCT00105521|38274285|FG000|Overall Study|Protocol Violation|3|||
17132836|NCT00105521|38274286|FG001|Overall Study|Protocol Violation|5|||
17132837|NCT00105521|38274287|FG002|Overall Study|Protocol Violation|4|||
17132838|NCT00105521|38274288|FG003|Overall Study|Protocol Violation|4|||
17132839|NCT00105521|38274285|FG000|Overall Study|Lost to Follow-up|0|||
17132840|NCT00105521|38274286|FG001|Overall Study|Lost to Follow-up|1|||
17132841|NCT00105521|38274287|FG002|Overall Study|Lost to Follow-up|0|||
17132842|NCT00105521|38274288|FG003|Overall Study|Lost to Follow-up|0|||
17132843|NCT00291551|38274298|FG000|Overall Study|Death|7|||
17132844|NCT00291551|38274298|FG000|Overall Study|Withdrawal by Subject|6|||
17132845|NCT02752048|38274322|FG000|Overall Study|Withdrawal by Subject|0|||
17132846|NCT02752048|38274323|FG001|Overall Study|Withdrawal by Subject|0|||
17132847|NCT02752048|38274324|FG002|Overall Study|Withdrawal by Subject|3|||
17132848|NCT00095147|38274339|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
17132849|NCT00095147|38274340|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
17132850|NCT00095147|38274341|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
17132851|NCT00095147|38274342|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
17132852|NCT00095147|38274343|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
17132853|NCT00095147|38274339|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
17132854|NCT00095147|38274340|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
17132855|NCT00095147|38274341|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
17132856|NCT00095147|38274342|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
17132857|NCT00095147|38274343|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
17132858|NCT00095147|38274339|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
17132859|NCT00095147|38274340|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
17132860|NCT00095147|38274341|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
17132861|NCT00095147|38274342|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
17132862|NCT00095147|38274343|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
17132863|NCT00095147|38274339|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
17132864|NCT00095147|38274340|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
17132865|NCT00095147|38274341|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
17132866|NCT00095147|38274342|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
17132867|NCT00095147|38274343|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
17132868|NCT00095147|38274339|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
17132869|NCT00095147|38274340|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
17132870|NCT00095147|38274341|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
17132871|NCT00095147|38274342|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
17132872|NCT00095147|38274343|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
17132873|NCT00095147|38274339|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
17132874|NCT00095147|38274340|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
17132875|NCT00095147|38274341|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
17132876|NCT00095147|38274342|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
17132877|NCT00095147|38274343|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
17132878|NCT00095147|38274339|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
17132879|NCT00095147|38274340|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
17132880|NCT00095147|38274341|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
17132881|NCT00095147|38274342|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
17132882|NCT00095147|38274343|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
17132883|NCT00095147|38274339|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
17132884|NCT00095147|38274340|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
17132885|NCT00095147|38274341|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
17132886|NCT00095147|38274342|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
17132887|NCT00095147|38274343|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
17132888|NCT00095147|38274339|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
17132889|NCT00095147|38274340|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
17132890|NCT00095147|38274341|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
17132891|NCT00095147|38274342|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
17132892|NCT00095147|38274343|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
17132893|NCT00095147|38274339|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
17132894|NCT00095147|38274340|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
17132895|NCT00095147|38274341|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
17132896|NCT00095147|38274342|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
17132897|NCT00095147|38274343|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
17132898|NCT00095147|38274339|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
17132899|NCT00095147|38274340|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
17132900|NCT00095147|38274341|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
17132901|NCT00095147|38274342|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
17132902|NCT00095147|38274343|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
17132903|NCT00095147|38274339|FG000|Long-term Extension Period|Death|0|||
17132904|NCT00095147|38274340|FG001|Long-term Extension Period|Death|0|||
17132905|NCT00095147|38274341|FG002|Long-term Extension Period|Death|0|||
17132906|NCT00095147|38274342|FG003|Long-term Extension Period|Death|0|||
17132907|NCT00095147|38274343|FG004|Long-term Extension Period|Death|3|||
17132908|NCT00095147|38274339|FG000|Long-term Extension Period|Adverse Event|0|||
17132909|NCT00095147|38274340|FG001|Long-term Extension Period|Adverse Event|0|||
17132910|NCT00095147|38274341|FG002|Long-term Extension Period|Adverse Event|0|||
17132911|NCT00095147|38274342|FG003|Long-term Extension Period|Adverse Event|0|||
17132912|NCT00095147|38274343|FG004|Long-term Extension Period|Adverse Event|11|||
17132913|NCT00095147|38274339|FG000|Long-term Extension Period|Lack of Efficacy|0|||
17132914|NCT00095147|38274340|FG001|Long-term Extension Period|Lack of Efficacy|0|||
17132915|NCT00095147|38274341|FG002|Long-term Extension Period|Lack of Efficacy|0|||
17132916|NCT00095147|38274342|FG003|Long-term Extension Period|Lack of Efficacy|0|||
17132917|NCT00095147|38274343|FG004|Long-term Extension Period|Lack of Efficacy|9|||
17132918|NCT00095147|38274339|FG000|Long-term Extension Period|Lost to Follow-up|0|||
17132919|NCT00095147|38274340|FG001|Long-term Extension Period|Lost to Follow-up|0|||
17132920|NCT00095147|38274341|FG002|Long-term Extension Period|Lost to Follow-up|0|||
17132921|NCT00095147|38274342|FG003|Long-term Extension Period|Lost to Follow-up|0|||
17132922|NCT00095147|38274343|FG004|Long-term Extension Period|Lost to Follow-up|6|||
17132923|NCT00095147|38274339|FG000|Long-term Extension Period|Withdrawal of consent|0|||
17132924|NCT00095147|38274340|FG001|Long-term Extension Period|Withdrawal of consent|0|||
17132925|NCT00095147|38274341|FG002|Long-term Extension Period|Withdrawal of consent|0|||
17132926|NCT00095147|38274342|FG003|Long-term Extension Period|Withdrawal of consent|0|||
17132927|NCT00095147|38274343|FG004|Long-term Extension Period|Withdrawal of consent|12|||
17132928|NCT00095147|38274339|FG000|Long-term Extension Period|Pregnancy|0|||
17132929|NCT00095147|38274340|FG001|Long-term Extension Period|Pregnancy|0|||
17132930|NCT00095147|38274341|FG002|Long-term Extension Period|Pregnancy|0|||
17132931|NCT00095147|38274342|FG003|Long-term Extension Period|Pregnancy|0|||
17132932|NCT00095147|38274343|FG004|Long-term Extension Period|Pregnancy|1|||
17132933|NCT00095147|38274339|FG000|Long-term Extension Period|No longer meets study criteria|0|||
16957430|NCT01809691|38100424|FG001|Overall Study|No Protocol Treatment|11|||
16957431|NCT01809691|38100423|FG000|Overall Study|Adverse Event|80|||
16957432|NCT01809691|38100424|FG001|Overall Study|Adverse Event|21|||
16957433|NCT01809691|38100423|FG000|Overall Study|Disease Progression|226|||
16957434|NCT01809691|38100424|FG001|Overall Study|Disease Progression|372|||
16957435|NCT01809691|38100423|FG000|Overall Study|Death|26|||
16957436|NCT01809691|38100424|FG001|Overall Study|Death|13|||
16957437|NCT01809691|38100423|FG000|Overall Study|Participant Refusal|70|||
16957438|NCT01809691|38100424|FG001|Overall Study|Participant Refusal|72|||
16957439|NCT01809691|38100423|FG000|Overall Study|Other, Not Specified|34|||
16957440|NCT01809691|38100424|FG001|Overall Study|Other, Not Specified|52|||
16957441|NCT01231464|38100432|FG000|Overall Study|Adverse Event|0|||
16957442|NCT01231464|38100433|FG001|Overall Study|Adverse Event|1|||
16957443|NCT01231464|38100432|FG000|Overall Study|Protocol Violation|1|||
16957444|NCT01231464|38100433|FG001|Overall Study|Protocol Violation|2|||
16957445|NCT01231464|38100432|FG000|Overall Study|Lost to Follow-up|1|||
16957446|NCT01231464|38100433|FG001|Overall Study|Lost to Follow-up|2|||
16957447|NCT01231464|38100432|FG000|Overall Study|Withdrawal by Subject|3|||
16957448|NCT01231464|38100433|FG001|Overall Study|Withdrawal by Subject|2|||
16957449|NCT01156311|38100443|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
16957450|NCT01156311|38100444|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
16957451|NCT01156311|38100445|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
16957452|NCT01156311|38100446|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
16957453|NCT01156311|38100443|FG000|2-Month Monotherapy Period|Physician Decision|0|||
16957454|NCT01156311|38100444|FG001|2-Month Monotherapy Period|Physician Decision|1|||
16957455|NCT01156311|38100445|FG002|2-Month Monotherapy Period|Physician Decision|0|||
16957456|NCT01156311|38100446|FG003|2-Month Monotherapy Period|Physician Decision|0|||
16957457|NCT01156311|38100443|FG000|2-Month Monotherapy Period|Other|1|||
16957458|NCT01156311|38100444|FG001|2-Month Monotherapy Period|Other|0|||
16957459|NCT01156311|38100445|FG002|2-Month Monotherapy Period|Other|0|||
16957460|NCT01156311|38100446|FG003|2-Month Monotherapy Period|Other|0|||
16957461|NCT01156311|38100443|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
16957462|NCT01156311|38100444|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
16957463|NCT01156311|38100445|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
16957464|NCT01156311|38100446|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
16957465|NCT01156311|38100443|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
16957466|NCT01156311|38100444|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
16957467|NCT01156311|38100445|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
16957468|NCT01156311|38100446|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
16957469|NCT01156311|38100443|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
16957470|NCT01156311|38100444|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
16957471|NCT01156311|38100445|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
16957472|NCT01156311|38100446|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
16957473|NCT01156311|38100443|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
16957474|NCT01156311|38100444|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
16957475|NCT01156311|38100445|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
16957476|NCT01156311|38100446|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
16957477|NCT01156311|38100443|FG000|6-month Add-on Therapy Period|Other|0|||
16957478|NCT01156311|38100444|FG001|6-month Add-on Therapy Period|Other|0|||
16957479|NCT01156311|38100445|FG002|6-month Add-on Therapy Period|Other|1|||
16957480|NCT01156311|38100446|FG003|6-month Add-on Therapy Period|Other|2|||
16957481|NCT01230060|38100457|FG000|Overall Study|Withdrawal by Subject|1|||
16957482|NCT01155531|38100465|FG000|Overall Study|Adverse Event|0|||
16957483|NCT01155531|38100466|FG001|Overall Study|Adverse Event|0|||
17132934|NCT00095147|38274340|FG001|Long-term Extension Period|No longer meets study criteria|0|||
17132935|NCT00095147|38274341|FG002|Long-term Extension Period|No longer meets study criteria|0|||
17132936|NCT00095147|38274342|FG003|Long-term Extension Period|No longer meets study criteria|0|||
17132937|NCT00095147|38274343|FG004|Long-term Extension Period|No longer meets study criteria|1|||
17132938|NCT00095147|38274339|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
17132939|NCT00095147|38274340|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
17132940|NCT00095147|38274341|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
17132941|NCT00095147|38274342|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
17132942|NCT00095147|38274343|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
17132943|NCT00095147|38274339|FG000|Long-term Extension Period|Leaving country|0|||
17132944|NCT00095147|38274340|FG001|Long-term Extension Period|Leaving country|0|||
17132945|NCT00095147|38274341|FG002|Long-term Extension Period|Leaving country|0|||
17132946|NCT00095147|38274342|FG003|Long-term Extension Period|Leaving country|0|||
17132947|NCT00095147|38274343|FG004|Long-term Extension Period|Leaving country|1|||
17132948|NCT02751580|38274361|FG000|Overall Study|Lost to Follow-up|4|||
17132949|NCT02751580|38274361|FG000|Overall Study|Death|2|||
17132950|NCT02751502|38274365|FG000|Overall Study|Lack of funding|4|||
17132951|NCT02257918|38274372|FG000|Overall Study|Lost to Follow-up|4|||
17132952|NCT02257918|38274373|FG001|Overall Study|Lost to Follow-up|1|||
17132953|NCT02257918|38274374|FG002|Overall Study|Lost to Follow-up|0|||
17132954|NCT02257918|38274372|FG000|Overall Study|Withdrawal by Subject|0|||
17132955|NCT02257918|38274373|FG001|Overall Study|Withdrawal by Subject|0|||
17132956|NCT02257918|38274374|FG002|Overall Study|Withdrawal by Subject|1|||
17132957|NCT02257918|38274372|FG000|Overall Study|Pregnancy|0|||
16957484|NCT01155531|38100467|FG002|Overall Study|Adverse Event|1|||
16957485|NCT01155531|38100468|FG003|Overall Study|Adverse Event|0|||
16957486|NCT01155531|38100465|FG000|Overall Study|Lost to Follow-up|0|||
16957487|NCT01155531|38100466|FG001|Overall Study|Lost to Follow-up|0|||
16957488|NCT01155531|38100467|FG002|Overall Study|Lost to Follow-up|0|||
16957489|NCT01155531|38100468|FG003|Overall Study|Lost to Follow-up|1|||
16957490|NCT01155531|38100465|FG000|Overall Study|Withdrawal by Subject|1|||
16957491|NCT01155531|38100466|FG001|Overall Study|Withdrawal by Subject|0|||
16957492|NCT01155531|38100467|FG002|Overall Study|Withdrawal by Subject|1|||
16957493|NCT01155531|38100468|FG003|Overall Study|Withdrawal by Subject|0|||
16957494|NCT01155219|38100480|FG000|Overall Study|Adverse Event|3|||
16957495|NCT01155219|38100481|FG001|Overall Study|Adverse Event|1|||
16957496|NCT01155219|38100480|FG000|Overall Study|non-medical reason|1|||
16957497|NCT01155219|38100481|FG001|Overall Study|non-medical reason|2|||
16957498|NCT01229436|38100487|FG000|Overall Study|Withdrawal by Subject|2|||
16957499|NCT01229436|38100487|FG000|Overall Study|Lost to Follow-up|3|||
16957500|NCT01155141|38100491|FG000|Overall Study|Withdrawal by Subject|1|||
16957501|NCT01155141|38100491|FG000|Overall Study|Screen Failure|1|||
16957502|NCT01155063|38100495|FG000|Overall Study|Adverse Event|1|||
16957503|NCT01155063|38100495|FG000|Overall Study|Withdrawal by Subject|1|||
16957504|NCT01155063|38100495|FG000|Overall Study|Study terminated by sponsor|87|||
16957505|NCT01154673|38100501|FG000|Overall Study|Lost to Follow-up|1|||
16957506|NCT01154673|38100502|FG001|Overall Study|Lost to Follow-up|0|||
16957507|NCT01154673|38100501|FG000|Overall Study|moved out of province|1|||
16957508|NCT01154673|38100502|FG001|Overall Study|moved out of province|0|||
16957509|NCT01154283|38100510|FG000|0-6 Weeks|Withdrawal by Subject|7|||
17132958|NCT02257918|38274373|FG001|Overall Study|Pregnancy|0|||
17132959|NCT02257918|38274374|FG002|Overall Study|Pregnancy|1|||
17132960|NCT02751424|38274391|FG000|Part 2|Adverse Event|0|||
17132961|NCT02751424|38274392|FG001|Part 2|Adverse Event|0|||
17132962|NCT02751424|38274393|FG002|Part 2|Adverse Event|0|||
17132963|NCT02751424|38274394|FG003|Part 2|Adverse Event|0|||
17132964|NCT02751424|38274395|FG004|Part 2|Adverse Event|0|||
17132965|NCT02751424|38274396|FG005|Part 2|Adverse Event|0|||
17132966|NCT02751424|38274397|FG006|Part 2|Adverse Event|0|||
17132967|NCT02751424|38274398|FG007|Part 2|Adverse Event|5|||
17132968|NCT02751424|38274399|FG008|Part 2|Adverse Event|0|||
17132969|NCT00094835|38274429|FG000|Overall Study|Physician Decision|1|||
17132970|NCT00094835|38274430|FG001|Overall Study|Physician Decision|0|||
17132971|NCT00094835|38274431|FG002|Overall Study|Physician Decision|0|||
17132972|NCT00094835|38274432|FG003|Overall Study|Physician Decision|0|||
17132973|NCT00094835|38274433|FG004|Overall Study|Physician Decision|0|||
17132974|NCT00094835|38274434|FG005|Overall Study|Physician Decision|1|||
17132975|NCT00094835|38274435|FG006|Overall Study|Physician Decision|0|||
17132976|NCT00094835|38274429|FG000|Overall Study|Withdrawal by Subject|0|||
17132977|NCT00094835|38274430|FG001|Overall Study|Withdrawal by Subject|0|||
17132978|NCT00094835|38274431|FG002|Overall Study|Withdrawal by Subject|0|||
17132979|NCT00094835|38274432|FG003|Overall Study|Withdrawal by Subject|0|||
17132980|NCT00094835|38274433|FG004|Overall Study|Withdrawal by Subject|0|||
17132981|NCT00094835|38274434|FG005|Overall Study|Withdrawal by Subject|0|||
17132982|NCT00094835|38274435|FG006|Overall Study|Withdrawal by Subject|1|||
17132983|NCT00094835|38274429|FG000|Overall Study|Lost to Follow-up|0|||
17132984|NCT00094835|38274430|FG001|Overall Study|Lost to Follow-up|0|||
17132985|NCT00094835|38274431|FG002|Overall Study|Lost to Follow-up|0|||
17132986|NCT00094835|38274432|FG003|Overall Study|Lost to Follow-up|0|||
17132987|NCT00094835|38274433|FG004|Overall Study|Lost to Follow-up|1|||
17132988|NCT00094835|38274434|FG005|Overall Study|Lost to Follow-up|0|||
17132989|NCT00094835|38274435|FG006|Overall Study|Lost to Follow-up|0|||
17132990|NCT00094835|38274429|FG000|Overall Study|Death|1|||
17132991|NCT00094835|38274430|FG001|Overall Study|Death|0|||
17132992|NCT00094835|38274431|FG002|Overall Study|Death|0|||
17132993|NCT00094835|38274432|FG003|Overall Study|Death|0|||
17132994|NCT00094835|38274433|FG004|Overall Study|Death|1|||
16957510|NCT01154283|38100511|FG001|0-6 Weeks|Withdrawal by Subject|2|||
16957511|NCT01154283|38100510|FG000|0-6 Weeks|Death|0|||
17132995|NCT00094835|38274434|FG005|Overall Study|Death|0|||
17132996|NCT00094835|38274435|FG006|Overall Study|Death|0|||
17132997|NCT00094835|38274429|FG000|Overall Study|Non-compliance|1|||
17132998|NCT00094835|38274430|FG001|Overall Study|Non-compliance|2|||
17132999|NCT00094835|38274431|FG002|Overall Study|Non-compliance|2|||
17133000|NCT00094835|38274432|FG003|Overall Study|Non-compliance|0|||
17133001|NCT00094835|38274433|FG004|Overall Study|Non-compliance|2|||
17133002|NCT00094835|38274434|FG005|Overall Study|Non-compliance|2|||
17133003|NCT00094835|38274435|FG006|Overall Study|Non-compliance|1|||
17133004|NCT00094835|38274429|FG000|Overall Study|Other|1|||
17133005|NCT00094835|38274430|FG001|Overall Study|Other|1|||
17133006|NCT00094835|38274431|FG002|Overall Study|Other|1|||
17133007|NCT00094835|38274432|FG003|Overall Study|Other|1|||
17133008|NCT00094835|38274433|FG004|Overall Study|Other|0|||
17133009|NCT00094835|38274434|FG005|Overall Study|Other|0|||
17133010|NCT00094835|38274435|FG006|Overall Study|Other|0|||
17133011|NCT00094757|38274459|FG000|Overall Study|Adverse Event|11|||
17133012|NCT00094757|38274460|FG001|Overall Study|Adverse Event|9|||
17133013|NCT00094757|38274461|FG002|Overall Study|Adverse Event|6|||
17133014|NCT00094757|38274459|FG000|Overall Study|Lack of Efficacy|11|||
17133015|NCT00094757|38274460|FG001|Overall Study|Lack of Efficacy|15|||
17133016|NCT00094757|38274461|FG002|Overall Study|Lack of Efficacy|8|||
17133017|NCT00094757|38274459|FG000|Overall Study|Lost to Follow-up|3|||
17133018|NCT00094757|38274460|FG001|Overall Study|Lost to Follow-up|5|||
17133019|NCT00094757|38274461|FG002|Overall Study|Lost to Follow-up|6|||
17133020|NCT00094757|38274459|FG000|Overall Study|Patient Moved|2|||
17133021|NCT00094757|38274460|FG001|Overall Study|Patient Moved|1|||
17133022|NCT00094757|38274461|FG002|Overall Study|Patient Moved|1|||
17133023|NCT00094757|38274459|FG000|Overall Study|Protocol Violation|8|||
17133024|NCT00094757|38274460|FG001|Overall Study|Protocol Violation|5|||
17133025|NCT00094757|38274461|FG002|Overall Study|Protocol Violation|3|||
17133026|NCT00094757|38274459|FG000|Overall Study|Withdrawal by Subject|14|||
17133027|NCT00094757|38274460|FG001|Overall Study|Withdrawal by Subject|21|||
17133028|NCT00094757|38274461|FG002|Overall Study|Withdrawal by Subject|5|||
17133029|NCT00094757|38274459|FG000|Overall Study|Other|3|||
17133030|NCT00094757|38274460|FG001|Overall Study|Other|3|||
17133031|NCT00094757|38274461|FG002|Overall Study|Other|1|||
17133032|NCT00094757|38274459|FG000|Overall Study|Protocol specified discontinuation|1|||
17133033|NCT00094757|38274460|FG001|Overall Study|Protocol specified discontinuation|3|||
17133034|NCT00094757|38274461|FG002|Overall Study|Protocol specified discontinuation|0|||
17133035|NCT00082433|38274471|FG000|Overall Study|Adverse Event|12|||
17133036|NCT00082433|38274472|FG001|Overall Study|Adverse Event|17|||
17133037|NCT00082433|38274471|FG000|Overall Study|Death|8|||
17133038|NCT00082433|38274472|FG001|Overall Study|Death|18|||
17133039|NCT00082433|38274471|FG000|Overall Study|Disease Progression/Relapse|270|||
17133040|NCT00082433|38274472|FG001|Overall Study|Disease Progression/Relapse|388|||
17133041|NCT00082433|38274471|FG000|Overall Study|Physician Decision|50|||
17133042|NCT00082433|38274472|FG001|Overall Study|Physician Decision|61|||
17133043|NCT00082433|38274471|FG000|Overall Study|Lost to Follow-up|1|||
17133044|NCT00082433|38274472|FG001|Overall Study|Lost to Follow-up|2|||
17133045|NCT00082433|38274471|FG000|Overall Study|Study Drug Toxicity|179|||
17133046|NCT00082433|38274472|FG001|Overall Study|Study Drug Toxicity|66|||
17133047|NCT00082433|38274471|FG000|Overall Study|Withdrawal by Subject|55|||
17133048|NCT00082433|38274472|FG001|Overall Study|Withdrawal by Subject|30|||
17133049|NCT00082433|38274471|FG000|Overall Study|Still On Treatment|2|||
17133050|NCT00082433|38274472|FG001|Overall Study|Still On Treatment|1|||
17133051|NCT00082433|38274471|FG000|Overall Study|Not Treated|12|||
17133052|NCT00082433|38274472|FG001|Overall Study|Not Treated|11|||
17133053|NCT00082433|38274471|FG000|Overall Study|Ineligible|2|||
17133054|NCT00082433|38274472|FG001|Overall Study|Ineligible|1|||
17133055|NCT00082433|38274471|FG000|Overall Study|Noncompliance|2|||
17133056|NCT00082433|38274472|FG001|Overall Study|Noncompliance|1|||
17133057|NCT00082433|38274471|FG000|Overall Study|New primary cancer|1|||
17133058|NCT00082433|38274472|FG001|Overall Study|New primary cancer|0|||
17133059|NCT00082433|38274471|FG000|Overall Study|Impending surgery|0|||
17133060|NCT00082433|38274472|FG001|Overall Study|Impending surgery|1|||
17133061|NCT00094445|38274478|FG000|Overall Study|Withdrawal by Subject|3|||
17133062|NCT00094445|38274478|FG000|Overall Study|Lost to Follow-up|1|||
17133063|NCT00094445|38274478|FG000|Overall Study|Progressive Disease|2|||
17133064|NCT00082355|38274482|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
17133065|NCT00082355|38274482|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
17133066|NCT00082355|38274482|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
17133067|NCT00094055|38274486|FG000|Overall Study|Adverse Event|11|||
17133068|NCT00094055|38274486|FG000|Overall Study|Death|4|||
17133069|NCT00094055|38274486|FG000|Overall Study|Lack of Efficacy|17|||
17133070|NCT00094055|38274486|FG000|Overall Study|Lost to Follow-up|2|||
17133071|NCT00094055|38274486|FG000|Overall Study|progressive disease|2|||
17133072|NCT00094055|38274486|FG000|Overall Study|clinical progression|1|||
17133073|NCT00094055|38274486|FG000|Overall Study|roll-over to another study|14|||
17133074|NCT00094055|38274486|FG000|Overall Study|Withdrawal by Subject|9|||
17133075|NCT00099983|38274492|FG000|Overall Study|Lost to Follow-up|2|||
17133076|NCT00099983|38274493|FG001|Overall Study|Lost to Follow-up|3|||
17133077|NCT00099983|38274492|FG000|Overall Study|Missing Source Documents|14|||
17133078|NCT00099983|38274493|FG001|Overall Study|Missing Source Documents|15|||
17133079|NCT00099983|38274492|FG000|Overall Study|Withdrawal by Subject|3|||
17133080|NCT00099983|38274493|FG001|Overall Study|Withdrawal by Subject|2|||
17133081|NCT00099983|38274492|FG000|Overall Study|Adverse Event|1|||
17133082|NCT00099983|38274493|FG001|Overall Study|Adverse Event|1|||
17133083|NCT00099983|38274492|FG000|Overall Study|Lack of Efficacy|0|||
17133084|NCT00099983|38274493|FG001|Overall Study|Lack of Efficacy|1|||
17133085|NCT00099983|38274492|FG000|Overall Study|Unable to return for appointments|1|||
17133086|NCT00099983|38274493|FG001|Overall Study|Unable to return for appointments|1|||
17133087|NCT00099983|38274492|FG000|Overall Study|Moved|1|||
17133088|NCT00099983|38274493|FG001|Overall Study|Moved|0|||
17133089|NCT00099983|38274492|FG000|Overall Study|Other psychiatric problem|1|||
17133090|NCT00099983|38274493|FG001|Overall Study|Other psychiatric problem|0|||
17133091|NCT00099983|38274492|FG000|Overall Study|Incarcerated|0|||
17133092|NCT00099983|38274493|FG001|Overall Study|Incarcerated|1|||
17133093|NCT00099983|38274492|FG000|Overall Study|Intolerant of burden of visits|0|||
17133094|NCT00099983|38274493|FG001|Overall Study|Intolerant of burden of visits|1|||
17133095|NCT00099983|38274492|FG000|Overall Study|Other issue|1|||
17133096|NCT00099983|38274493|FG001|Overall Study|Other issue|0|||
17133097|NCT00099359|38274502|FG000|Overall Study|Death|11|||
17133098|NCT00099359|38274503|FG001|Overall Study|Death|15|||
17133099|NCT00099359|38274504|FG002|Overall Study|Death|17|||
17133100|NCT00099359|38274502|FG000|Overall Study|Withdrawal by Subject|19|||
17133101|NCT00099359|38274503|FG001|Overall Study|Withdrawal by Subject|19|||
17133102|NCT00099359|38274504|FG002|Overall Study|Withdrawal by Subject|23|||
17133103|NCT00099359|38274502|FG000|Overall Study|Lost to Follow-up|15|||
17133104|NCT00099359|38274503|FG001|Overall Study|Lost to Follow-up|24|||
17133105|NCT00099359|38274504|FG002|Overall Study|Lost to Follow-up|24|||
17133106|NCT00099359|38274502|FG000|Overall Study|moved out of area|9|||
17133107|NCT00099359|38274503|FG001|Overall Study|moved out of area|7|||
17133108|NCT00099359|38274504|FG002|Overall Study|moved out of area|4|||
17133109|NCT00092495|38274526|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
17133110|NCT00092495|38274527|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
17133111|NCT00092495|38274528|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
17133112|NCT00092495|38274529|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
17133113|NCT00092495|38274530|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
17133114|NCT00092495|38274526|FG000|Base Study Vaccination Period|Extended|0|||
17133115|NCT00092495|38274527|FG001|Base Study Vaccination Period|Extended|0|||
17133116|NCT00092495|38274528|FG002|Base Study Vaccination Period|Extended|0|||
17133117|NCT00092495|38274529|FG003|Base Study Vaccination Period|Extended|1|||
17133118|NCT00092495|38274530|FG004|Base Study Vaccination Period|Extended|0|||
17133119|NCT00092495|38274526|FG000|Base Study Vaccination Period|*Clinical AE|1|||
17133120|NCT00092495|38274527|FG001|Base Study Vaccination Period|*Clinical AE|0|||
17133121|NCT00092495|38274528|FG002|Base Study Vaccination Period|*Clinical AE|1|||
17133122|NCT00092495|38274529|FG003|Base Study Vaccination Period|*Clinical AE|2|||
17133123|NCT00092495|38274530|FG004|Base Study Vaccination Period|*Clinical AE|0|||
16774407|NCT03470441|37713774|FG003|Overall Study|Death|0|||
17133124|NCT00092495|38274526|FG000|Base Study Vaccination Period|*Other reasons|1|||
17133125|NCT00092495|38274527|FG001|Base Study Vaccination Period|*Other reasons|0|||
17133126|NCT00092495|38274528|FG002|Base Study Vaccination Period|*Other reasons|0|||
17133127|NCT00092495|38274529|FG003|Base Study Vaccination Period|*Other reasons|1|||
17133128|NCT00092495|38274530|FG004|Base Study Vaccination Period|*Other reasons|0|||
17133129|NCT00092495|38274526|FG000|Base Study Vaccination Period|*Pregnancy|0|||
17133130|NCT00092495|38274527|FG001|Base Study Vaccination Period|*Pregnancy|2|||
17133131|NCT00092495|38274528|FG002|Base Study Vaccination Period|*Pregnancy|5|||
17133132|NCT00092495|38274529|FG003|Base Study Vaccination Period|*Pregnancy|7|||
17133133|NCT00092495|38274530|FG004|Base Study Vaccination Period|*Pregnancy|0|||
17133134|NCT00092495|38274526|FG000|Base Study Vaccination Period|Adverse Event|1|||
16774408|NCT03470441|37713771|FG000|Overall Study|Adverse Event|0|||
17133135|NCT00092495|38274527|FG001|Base Study Vaccination Period|Adverse Event|0|||
17133136|NCT00092495|38274528|FG002|Base Study Vaccination Period|Adverse Event|0|||
16774409|NCT03470441|37713772|FG001|Overall Study|Adverse Event|0|||
17133137|NCT00092495|38274529|FG003|Base Study Vaccination Period|Adverse Event|3|||
17133138|NCT00092495|38274530|FG004|Base Study Vaccination Period|Adverse Event|0|||
17133139|NCT00092495|38274526|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
17133140|NCT00092495|38274527|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
17133141|NCT00092495|38274528|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
17133142|NCT00092495|38274529|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
17133143|NCT00092495|38274530|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
17133144|NCT00092495|38274526|FG000|Base Study Vaccination Period|Moved|3|||
17133145|NCT00092495|38274527|FG001|Base Study Vaccination Period|Moved|1|||
17133146|NCT00092495|38274528|FG002|Base Study Vaccination Period|Moved|2|||
17133147|NCT00092495|38274529|FG003|Base Study Vaccination Period|Moved|2|||
17133148|NCT00092495|38274530|FG004|Base Study Vaccination Period|Moved|0|||
17133149|NCT00092495|38274526|FG000|Base Study Vaccination Period|Other|1|||
17133150|NCT00092495|38274527|FG001|Base Study Vaccination Period|Other|1|||
17133151|NCT00092495|38274528|FG002|Base Study Vaccination Period|Other|0|||
17133152|NCT00092495|38274529|FG003|Base Study Vaccination Period|Other|2|||
17133153|NCT00092495|38274530|FG004|Base Study Vaccination Period|Other|0|||
17133154|NCT00092495|38274526|FG000|Base Study Vaccination Period|Pregnancy|2|||
17133155|NCT00092495|38274527|FG001|Base Study Vaccination Period|Pregnancy|0|||
17133156|NCT00092495|38274528|FG002|Base Study Vaccination Period|Pregnancy|0|||
17133157|NCT00092495|38274529|FG003|Base Study Vaccination Period|Pregnancy|0|||
17133158|NCT00092495|38274530|FG004|Base Study Vaccination Period|Pregnancy|0|||
17133159|NCT00092495|38274526|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
17133160|NCT00092495|38274527|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
17133161|NCT00092495|38274528|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
17133162|NCT00092495|38274529|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
17133163|NCT00092495|38274530|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
17133164|NCT00092495|38274526|FG000|Base Study Vaccination Period|Protocol Violation|1|||
17133165|NCT00092495|38274527|FG001|Base Study Vaccination Period|Protocol Violation|0|||
17133166|NCT00092495|38274528|FG002|Base Study Vaccination Period|Protocol Violation|0|||
17133167|NCT00092495|38274529|FG003|Base Study Vaccination Period|Protocol Violation|0|||
17133168|NCT00092495|38274530|FG004|Base Study Vaccination Period|Protocol Violation|0|||
17133169|NCT00092495|38274526|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
17133170|NCT00092495|38274527|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
17133171|NCT00092495|38274528|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
17133172|NCT00092495|38274529|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
17133173|NCT00092495|38274530|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
17133174|NCT00092495|38274526|FG000|Base Study Follow-up Period|Extended|0|||
17133175|NCT00092495|38274527|FG001|Base Study Follow-up Period|Extended|0|||
17133176|NCT00092495|38274528|FG002|Base Study Follow-up Period|Extended|1|||
17133177|NCT00092495|38274529|FG003|Base Study Follow-up Period|Extended|2|||
17133178|NCT00092495|38274530|FG004|Base Study Follow-up Period|Extended|0|||
17133179|NCT00092495|38274526|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
17133180|NCT00092495|38274527|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
17133181|NCT00092495|38274528|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
17133182|NCT00092495|38274529|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
17133183|NCT00092495|38274530|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
17133184|NCT00092495|38274526|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
17133185|NCT00092495|38274527|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
17133186|NCT00092495|38274528|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
17133187|NCT00092495|38274529|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
17133188|NCT00092495|38274530|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
17133189|NCT00092417|38274545|FG000|Overall Study|Lost to Follow-up|2|||
17133190|NCT00092417|38274546|FG001|Overall Study|Lost to Follow-up|0|||
17133191|NCT00092417|38274545|FG000|Overall Study|Withdrawal by Subject|2|||
17133192|NCT00092417|38274546|FG001|Overall Study|Withdrawal by Subject|1|||
17133193|NCT00092417|38274545|FG000|Overall Study|Other|1|||
17133194|NCT00092417|38274546|FG001|Overall Study|Other|0|||
17133195|NCT00091949|38274554|FG000|Overall Study|Withdrawal by Subject|117|||
17133196|NCT00091949|38274555|FG001|Overall Study|Withdrawal by Subject|110|||
17133197|NCT00091949|38274554|FG000|Overall Study|Lost to Follow-up|58|||
17133198|NCT00091949|38274555|FG001|Overall Study|Lost to Follow-up|41|||
17133199|NCT02258542|38274565|FG000|Overall Study|eg. not made to the visit|7|||
17133200|NCT02258542|38274566|FG001|Overall Study|eg. not made to the visit|4|||
17133201|NCT02258542|38274567|FG002|Overall Study|eg. not made to the visit|0|||
17133202|NCT02258542|38274568|FG003|Overall Study|eg. not made to the visit|1|||
17133203|NCT02258542|38274565|FG000|Overall Study|study specific discount. criteria|1|||
17133204|NCT02258542|38274566|FG001|Overall Study|study specific discount. criteria|1|||
17133205|NCT02258542|38274567|FG002|Overall Study|study specific discount. criteria|0|||
17133206|NCT02258542|38274568|FG003|Overall Study|study specific discount. criteria|0|||
17133207|NCT02258542|38274565|FG000|Overall Study|Withdrawal by Subject|20|||
17133208|NCT02258542|38274566|FG001|Overall Study|Withdrawal by Subject|20|||
17133209|NCT02258542|38274567|FG002|Overall Study|Withdrawal by Subject|7|||
17133210|NCT02258542|38274568|FG003|Overall Study|Withdrawal by Subject|1|||
17133211|NCT02258542|38274565|FG000|Overall Study|Lost to Follow-up|5|||
17133212|NCT02258542|38274566|FG001|Overall Study|Lost to Follow-up|12|||
17133213|NCT02258542|38274567|FG002|Overall Study|Lost to Follow-up|1|||
17133214|NCT02258542|38274568|FG003|Overall Study|Lost to Follow-up|2|||
17133215|NCT02258542|38274565|FG000|Overall Study|Death|5|||
17133216|NCT02258542|38274566|FG001|Overall Study|Death|4|||
17133217|NCT02258542|38274567|FG002|Overall Study|Death|0|||
17133218|NCT02258542|38274568|FG003|Overall Study|Death|1|||
17133219|NCT02258542|38274565|FG000|Overall Study|Adverse Event|3|||
17133220|NCT02258542|38274566|FG001|Overall Study|Adverse Event|4|||
17133221|NCT02258542|38274567|FG002|Overall Study|Adverse Event|0|||
17133222|NCT02258542|38274568|FG003|Overall Study|Adverse Event|0|||
17133223|NCT02258542|38274565|FG000|Overall Study|Protocol Violation|1|||
17133224|NCT02258542|38274566|FG001|Overall Study|Protocol Violation|2|||
17133225|NCT02258542|38274567|FG002|Overall Study|Protocol Violation|0|||
17133226|NCT02258542|38274568|FG003|Overall Study|Protocol Violation|0|||
17133227|NCT02258542|38274565|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
17133228|NCT02258542|38274566|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
17133229|NCT02258542|38274567|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
17133230|NCT02258542|38274568|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
17133231|NCT00091793|38274598|FG000|Overall Study|Adverse Event|1|||
17133232|NCT00091793|38274599|FG001|Overall Study|Adverse Event|2|||
17133233|NCT00091793|38274598|FG000|Overall Study|Withdrawal by Subject|10|||
17133234|NCT00091793|38274599|FG001|Overall Study|Withdrawal by Subject|15|||
17133235|NCT00091793|38274598|FG000|Overall Study|Ineligibility determined|2|||
17133236|NCT00091793|38274599|FG001|Overall Study|Ineligibility determined|0|||
17133237|NCT00091793|38274598|FG000|Overall Study|Lost to Follow-up|7|||
17133238|NCT00091793|38274599|FG001|Overall Study|Lost to Follow-up|5|||
17133239|NCT00091793|38274598|FG000|Overall Study|Noncompliance|2|||
17133240|NCT00091793|38274599|FG001|Overall Study|Noncompliance|0|||
17133241|NCT00091793|38274598|FG000|Overall Study|Other|2|||
17133242|NCT00091793|38274599|FG001|Overall Study|Other|0|||
17133243|NCT00098813|38274605|FG000|Overall Study|Death|8|||
17133244|NCT00098813|38274605|FG000|Overall Study|Protocol Violation|1|||
17133245|NCT00098813|38274605|FG000|Overall Study|Withdrawal by Subject|7|||
16957512|NCT01154283|38100511|FG001|0-6 Weeks|Death|1|||
16957513|NCT01154283|38100510|FG000|7-12 Weeks|Death|1|||
17133246|NCT00098813|38274605|FG000|Overall Study|Progression of Disease|1|||
17133247|NCT00098813|38274605|FG000|Overall Study|Other complicating disease|1|||
17133248|NCT00098813|38274605|FG000|Overall Study|Reversal of RAI resistance|1|||
17133249|NCT00091169|38274611|FG000|Overall Study|Disease progression|3|||
17133250|NCT00091169|38274612|FG001|Overall Study|Disease progression|1|||
17133251|NCT00091169|38274611|FG000|Overall Study|Adverse Event|11|||
17133252|NCT00091169|38274612|FG001|Overall Study|Adverse Event|17|||
17133253|NCT00091169|38274611|FG000|Overall Study|Death|4|||
17133254|NCT00091169|38274612|FG001|Overall Study|Death|1|||
17133255|NCT00091169|38274611|FG000|Overall Study|Withdrawal by Subject|10|||
17133256|NCT00091169|38274612|FG001|Overall Study|Withdrawal by Subject|13|||
17133257|NCT00091169|38274611|FG000|Overall Study|Other|3|||
17133258|NCT00091169|38274612|FG001|Overall Study|Other|4|||
17133259|NCT00091169|38274611|FG000|Overall Study|Not start protocol therapy|26|||
17133260|NCT00091169|38274612|FG001|Overall Study|Not start protocol therapy|17|||
17133261|NCT00090857|38274622|FG000|Overall Study|Lost to Follow-up|0|||
17133262|NCT00090857|38274623|FG001|Overall Study|Lost to Follow-up|1|||
17133263|NCT00090857|38274622|FG000|Overall Study|Withdrawal by Subject|2|||
17133264|NCT00090857|38274623|FG001|Overall Study|Withdrawal by Subject|0|||
17133265|NCT00090857|38274622|FG000|Overall Study|Adverse Event|2|||
17133266|NCT00090857|38274623|FG001|Overall Study|Adverse Event|2|||
17133267|NCT00090779|38274631|FG000|Step 1|Withdrawal by Subject|4|||
17133268|NCT00090779|38274632|FG001|Step 1|Withdrawal by Subject|2|||
17133269|NCT00090779|38274631|FG000|Step 1|Lost to Follow-up|3|||
17133270|NCT00090779|38274632|FG001|Step 1|Lost to Follow-up|2|||
17133271|NCT00090779|38274631|FG000|Step 1|Death|0|||
17133272|NCT00090779|38274632|FG001|Step 1|Death|2|||
17133273|NCT00090779|38274631|FG000|Step 1|Physician Decision|1|||
17133274|NCT00090779|38274632|FG001|Step 1|Physician Decision|0|||
17133275|NCT00090779|38274631|FG000|Step 1|Pregnancy|1|||
17133276|NCT00090779|38274632|FG001|Step 1|Pregnancy|0|||
17133277|NCT00090779|38274631|FG000|Step 1|Non-compliance to study requirements|0|||
17133278|NCT00090779|38274632|FG001|Step 1|Non-compliance to study requirements|1|||
17133279|NCT00090779|38274631|FG000|Step 1|Subject relocated|2|||
17133280|NCT00090779|38274632|FG001|Step 1|Subject relocated|8|||
17133281|NCT00090779|38274631|FG000|Step 2|Off study per study closure|6|||
17133282|NCT00090779|38274632|FG001|Step 2|Off study per study closure|16|||
17133283|NCT00090779|38274631|FG000|Step 2|Subject relocated|0|||
17133284|NCT00090779|38274632|FG001|Step 2|Subject relocated|1|||
17133285|NCT00090779|38274631|FG000|Step 2|Non-compliance to study requirements|0|||
17133286|NCT00090779|38274632|FG001|Step 2|Non-compliance to study requirements|1|||
17133287|NCT00090779|38274631|FG000|Step 3|Initiation of ART and off extended study|3|||
17133288|NCT00090779|38274632|FG001|Step 3|Initiation of ART and off extended study|2|||
17133289|NCT00090779|38274631|FG000|Step 3|Off extended study due to study closure|4|||
17133290|NCT00090779|38274632|FG001|Step 3|Off extended study due to study closure|3|||
17133291|NCT00098345|38274638|FG000|Overall Study|Adverse Event|7|||
17133292|NCT00098345|38274638|FG000|Overall Study|Withdrawal by Subject|2|||
17133293|NCT00098345|38274638|FG000|Overall Study|progression|4|||
17133294|NCT02224456|38274642|FG000|Overall Study|Lack of Efficacy|1|||
17133295|NCT02224456|38274642|FG000|Overall Study|Lost to Follow-up|15|||
17133296|NCT02224456|38274642|FG000|Overall Study|Withdrawal by Subject|9|||
17133297|NCT02224456|38274642|FG000|Overall Study|Physician Decision|3|||
17133298|NCT02224456|38274642|FG000|Overall Study|Death|2|||
17133299|NCT02224456|38274642|FG000|Overall Study|Pregnancy|4|||
17133300|NCT02224456|38274642|FG000|Overall Study|Protocol Violation|1|||
17133301|NCT02224456|38274642|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
17133302|NCT00097721|38274648|FG000|Overall Study|Adverse Event|8|||
17133303|NCT00097721|38274649|FG001|Overall Study|Adverse Event|1|||
17133304|NCT00097721|38274648|FG000|Overall Study|Withdrawal by Subject|6|||
17133305|NCT00097721|38274649|FG001|Overall Study|Withdrawal by Subject|1|||
17133306|NCT00097721|38274648|FG000|Overall Study|Progressive Disease|55|||
17133307|NCT00097721|38274649|FG001|Overall Study|Progressive Disease|27|||
17133308|NCT00097721|38274648|FG000|Overall Study|Physician Decision|1|||
17133309|NCT00097721|38274649|FG001|Overall Study|Physician Decision|3|||
17133310|NCT00097721|38274648|FG000|Overall Study|Reason not given|1|||
17133311|NCT00097721|38274649|FG001|Overall Study|Reason not given|1|||
17133312|NCT03553498|38274657|FG000|Overall Study|Missing primary outcome|1|||
17133313|NCT03553498|38274658|FG001|Overall Study|Missing primary outcome|2|||
17133314|NCT00096941|38274664|FG000|Overall Study|disease progression|3|||
17133315|NCT00096785|38274670|FG000|Overall Study|Lost to Follow-up|1|||
17133316|NCT00096785|38274671|FG001|Overall Study|Lost to Follow-up|0|||
17133317|NCT00096785|38274670|FG000|Overall Study|Withdrawal by Subject|0|||
17133318|NCT00096785|38274671|FG001|Overall Study|Withdrawal by Subject|1|||
17133319|NCT00096785|38274670|FG000|Overall Study|Relocated|1|||
17133320|NCT00096785|38274671|FG001|Overall Study|Relocated|0|||
17133321|NCT00090545|38274679|FG000|Overall Study|Disease progression on study|21|||
17133322|NCT00090545|38274680|FG001|Overall Study|Disease progression on study|17|||
17133323|NCT00090545|38274679|FG000|Overall Study|Refused further treatment|1|||
17133324|NCT00090545|38274680|FG001|Overall Study|Refused further treatment|4|||
17133325|NCT00090545|38274679|FG000|Overall Study|Death|0|||
17133326|NCT00090545|38274680|FG001|Overall Study|Death|1|||
17133327|NCT00090545|38274679|FG000|Overall Study|Adverse Event|0|||
17133328|NCT00090545|38274680|FG001|Overall Study|Adverse Event|2|||
17133329|NCT03249376|38274690|FG000|Overall Study|Adverse Event|11|||
17133330|NCT03249376|38274691|FG001|Overall Study|Adverse Event|5|||
17133331|NCT03249376|38274690|FG000|Overall Study|Lack of Efficacy|2|||
17133332|NCT03249376|38274691|FG001|Overall Study|Lack of Efficacy|4|||
17133333|NCT03249376|38274690|FG000|Overall Study|Protocol Violation|3|||
17133334|NCT03249376|38274691|FG001|Overall Study|Protocol Violation|2|||
17133335|NCT03249376|38274690|FG000|Overall Study|Physician Decision|0|||
17133336|NCT03249376|38274691|FG001|Overall Study|Physician Decision|2|||
17133337|NCT03249376|38274690|FG000|Overall Study|Withdrawal by Subject|3|||
17133338|NCT03249376|38274691|FG001|Overall Study|Withdrawal by Subject|9|||
17133339|NCT03249376|38274690|FG000|Overall Study|LTFU|2|||
17133340|NCT03249376|38274691|FG001|Overall Study|LTFU|1|||
17133341|NCT00070109|38274702|FG000|Overall Study|Death|1|||
17133342|NCT00070109|38274703|FG001|Overall Study|Death|1|||
17133343|NCT00070109|38274704|FG002|Overall Study|Death|0|||
17133344|NCT00070109|38274705|FG003|Overall Study|Death|0|||
17133345|NCT00070109|38274706|FG004|Overall Study|Death|1|||
17133346|NCT00070109|38274702|FG000|Overall Study|Lack of Efficacy|6|||
17133347|NCT00070109|38274703|FG001|Overall Study|Lack of Efficacy|4|||
17133348|NCT00070109|38274704|FG002|Overall Study|Lack of Efficacy|5|||
17133349|NCT00070109|38274705|FG003|Overall Study|Lack of Efficacy|15|||
17133350|NCT00070109|38274706|FG004|Overall Study|Lack of Efficacy|5|||
17133351|NCT00070109|38274702|FG000|Overall Study|Physician Decision|1|||
17133352|NCT00070109|38274703|FG001|Overall Study|Physician Decision|0|||
17133353|NCT00070109|38274704|FG002|Overall Study|Physician Decision|0|||
17133354|NCT00070109|38274705|FG003|Overall Study|Physician Decision|0|||
17133355|NCT00070109|38274706|FG004|Overall Study|Physician Decision|0|||
17133356|NCT00070109|38274702|FG000|Overall Study|Withdrawal by Subject|0|||
17133357|NCT00070109|38274703|FG001|Overall Study|Withdrawal by Subject|1|||
17133358|NCT00070109|38274704|FG002|Overall Study|Withdrawal by Subject|1|||
17133359|NCT00070109|38274705|FG003|Overall Study|Withdrawal by Subject|0|||
17133360|NCT00070109|38274706|FG004|Overall Study|Withdrawal by Subject|0|||
17133361|NCT00070109|38274702|FG000|Overall Study|Adverse Event|0|||
17133362|NCT00070109|38274703|FG001|Overall Study|Adverse Event|0|||
17133363|NCT00070109|38274704|FG002|Overall Study|Adverse Event|2|||
17133364|NCT00070109|38274705|FG003|Overall Study|Adverse Event|4|||
17133365|NCT00070109|38274706|FG004|Overall Study|Adverse Event|2|||
17133366|NCT00070109|38274702|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
17133367|NCT00070109|38274703|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
17133368|NCT00070109|38274704|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
17133369|NCT00070109|38274705|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
17133370|NCT00070109|38274706|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
17133371|NCT00090233|38274727|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
17133372|NCT00090233|38274728|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
17133373|NCT00090233|38274727|FG000|Overall Study|Adverse Event|214|||
17133374|NCT00090233|38274728|FG001|Overall Study|Adverse Event|198|||
17133375|NCT00090233|38274727|FG000|Overall Study|Lost to Follow-up|68|||
17133376|NCT00090233|38274728|FG001|Overall Study|Lost to Follow-up|95|||
17133377|NCT00090233|38274727|FG000|Overall Study|Protocol Violation|960|||
17133378|NCT00090233|38274728|FG001|Overall Study|Protocol Violation|1022|||
17133379|NCT00090233|38274727|FG000|Overall Study|Withdrawal by Subject|182|||
17133380|NCT00090233|38274728|FG001|Overall Study|Withdrawal by Subject|211|||
17133381|NCT00090233|38274727|FG000|Overall Study|Moved|203|||
17133382|NCT00090233|38274728|FG001|Overall Study|Moved|189|||
17133383|NCT00090233|38274727|FG000|Overall Study|Other|1211|||
17133384|NCT00090233|38274728|FG001|Overall Study|Other|1160|||
17133385|NCT00090233|38274727|FG000|Overall Study|Data not available at data cut-off point|1552|||
17133386|NCT00090233|38274728|FG001|Overall Study|Data not available at data cut-off point|1563|||
17133387|NCT00069953|38274738|FG000|Overall Study|Protocol Violation|2|||
17133388|NCT03118570|38274747|FG000|Overall Study|Adverse Event|2|||
17133389|NCT03118570|38274748|FG001|Overall Study|Adverse Event|0|||
17133390|NCT03118570|38274749|FG002|Overall Study|Adverse Event|0|||
17133391|NCT03118570|38274750|FG003|Overall Study|Adverse Event|0|||
17133392|NCT03118570|38274751|FG004|Overall Study|Adverse Event|3|||
17133393|NCT03118570|38274747|FG000|Overall Study|Withdrawal by Subject|0|||
17133394|NCT03118570|38274748|FG001|Overall Study|Withdrawal by Subject|1|||
17133395|NCT03118570|38274749|FG002|Overall Study|Withdrawal by Subject|4|||
17133396|NCT03118570|38274750|FG003|Overall Study|Withdrawal by Subject|0|||
17133397|NCT03118570|38274751|FG004|Overall Study|Withdrawal by Subject|1|||
17133398|NCT03118570|38274747|FG000|Overall Study|Lost to Follow-up|2|||
17133399|NCT03118570|38274748|FG001|Overall Study|Lost to Follow-up|3|||
17133400|NCT03118570|38274749|FG002|Overall Study|Lost to Follow-up|1|||
17133401|NCT03118570|38274750|FG003|Overall Study|Lost to Follow-up|0|||
17133402|NCT03118570|38274751|FG004|Overall Study|Lost to Follow-up|1|||
17133403|NCT03118570|38274747|FG000|Overall Study|Other, Not Specified|1|||
17133404|NCT03118570|38274748|FG001|Overall Study|Other, Not Specified|3|||
17133405|NCT03118570|38274749|FG002|Overall Study|Other, Not Specified|0|||
17133406|NCT03118570|38274750|FG003|Overall Study|Other, Not Specified|0|||
17133407|NCT03118570|38274751|FG004|Overall Study|Other, Not Specified|0|||
17133408|NCT02750800|38274770|FG000|Overall Study|Adverse Event|18|||
17133409|NCT02750800|38274770|FG000|Overall Study|Lost to Follow-up|12|||
17133410|NCT02750800|38274770|FG000|Overall Study|Investigator decision|53|||
17133411|NCT02750800|38274770|FG000|Overall Study|Patient request|12|||
17133412|NCT02750800|38274770|FG000|Overall Study|Other, not specified|3|||
17133413|NCT01329562|38274790|FG000|Overall Study|Protocol Violation|5|||
17133414|NCT01329562|38274791|FG001|Overall Study|Protocol Violation|3|||
17133415|NCT01329562|38274790|FG000|Overall Study|Lost to Follow-up|1|||
17133416|NCT01329562|38274791|FG001|Overall Study|Lost to Follow-up|1|||
17133417|NCT01329562|38274790|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
17133418|NCT01329562|38274791|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
17133419|NCT01329562|38274790|FG000|Overall Study|Physician Decision|0|||
17133420|NCT01329562|38274791|FG001|Overall Study|Physician Decision|1|||
17133421|NCT00069641|38274802|FG000|Overall Study|Death|1|||
17133422|NCT00069641|38274803|FG001|Overall Study|Death|0|||
17133423|NCT00069641|38274804|FG002|Overall Study|Death|1|||
17133424|NCT03653026|38274815|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
17133425|NCT03653026|38274816|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
17133426|NCT03653026|38274817|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
17133427|NCT03653026|38274818|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
17133428|NCT03653026|38274815|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
17133429|NCT03653026|38274816|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
17133430|NCT03653026|38274817|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
17133431|NCT03653026|38274818|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
17133432|NCT03653026|38274815|FG000|Part 1: Placebo-controlled Period|Other|0|||
17133433|NCT03653026|38274816|FG001|Part 1: Placebo-controlled Period|Other|3|||
17133434|NCT03653026|38274817|FG002|Part 1: Placebo-controlled Period|Other|0|||
17133435|NCT03653026|38274818|FG003|Part 1: Placebo-controlled Period|Other|0|||
17133436|NCT03653026|38274815|FG000|Part 2: Open-label Extension|Adverse Event|0|||
17133437|NCT03653026|38274816|FG001|Part 2: Open-label Extension|Adverse Event|0|||
17133438|NCT03653026|38274817|FG002|Part 2: Open-label Extension|Adverse Event|1|||
17133439|NCT03653026|38274818|FG003|Part 2: Open-label Extension|Adverse Event|1|||
17133440|NCT03653026|38274815|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
17133441|NCT03653026|38274816|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
17133442|NCT03653026|38274817|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
17133443|NCT03653026|38274818|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
17133444|NCT03653026|38274815|FG000|Part 2: Open-label Extension|Other|0|||
17133445|NCT03653026|38274816|FG001|Part 2: Open-label Extension|Other|0|||
17133446|NCT03653026|38274817|FG002|Part 2: Open-label Extension|Other|1|||
17133447|NCT03653026|38274818|FG003|Part 2: Open-label Extension|Other|2|||
17133448|NCT01329328|38274829|FG000|Overall Study|Withdrawal by Subject|2|||
17133449|NCT01329328|38274830|FG001|Overall Study|Withdrawal by Subject|4|||
17133450|NCT01329328|38274831|FG002|Overall Study|Withdrawal by Subject|3|||
17133451|NCT01337986|38274841|FG000|Overall Study|Adverse Event|2|||
17133452|NCT01337986|38274842|FG001|Overall Study|Adverse Event|2|||
17133453|NCT01337986|38274841|FG000|Overall Study|Lost to Follow-up|1|||
17133454|NCT01337986|38274842|FG001|Overall Study|Lost to Follow-up|0|||
17133455|NCT01337986|38274841|FG000|Overall Study|Protocol Violation|0|||
17133456|NCT01337986|38274842|FG001|Overall Study|Protocol Violation|3|||
17133457|NCT01337674|38274866|FG000|Treatment Period 1|Adverse Event|0|||
17133458|NCT01337674|38274867|FG001|Treatment Period 1|Adverse Event|1|||
17133459|NCT01337674|38274868|FG002|Treatment Period 1|Adverse Event|0|||
17133460|NCT01337674|38274869|FG003|Treatment Period 1|Adverse Event|0|||
17133461|NCT01337674|38274866|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
17133462|NCT01337674|38274867|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
17133463|NCT01337674|38274868|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
17133464|NCT01337674|38274869|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
17133465|NCT01337674|38274866|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17133466|NCT01337674|38274867|FG001|Treatment Period 2|Withdrawal by Subject|0|||
17133467|NCT01337674|38274868|FG002|Treatment Period 2|Withdrawal by Subject|1|||
17133468|NCT01337674|38274869|FG003|Treatment Period 2|Withdrawal by Subject|0|||
17133469|NCT02750410|38274884|FG000|Double-Blind Treatment Period|Adverse Event|2|||
17133470|NCT02750410|38274885|FG001|Double-Blind Treatment Period|Adverse Event|2|||
17133471|NCT02750410|38274884|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
17133472|NCT02750410|38274885|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
17133473|NCT02750410|38274884|FG000|Open-Label Extension Period|Adverse Event|5|||
17133474|NCT02750410|38274885|FG001|Open-Label Extension Period|Adverse Event|3|||
17133475|NCT02750410|38274884|FG000|Open-Label Extension Period|Protocol Violation|0|||
17133476|NCT02750410|38274885|FG001|Open-Label Extension Period|Protocol Violation|1|||
17133477|NCT02750410|38274884|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
17133478|NCT02750410|38274885|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
17133479|NCT02750332|38274895|FG000|Treatment Period 1|Withdrawal by Subject|0|||
17133480|NCT02750332|38274896|FG001|Treatment Period 1|Withdrawal by Subject|1|||
17133481|NCT01337596|38274911|FG000|Overall Study|Withdrawal by Subject|0|||
17133482|NCT01337596|38274912|FG001|Overall Study|Withdrawal by Subject|0|||
17133483|NCT01337596|38274913|FG002|Overall Study|Withdrawal by Subject|0|||
17133484|NCT01337596|38274914|FG003|Overall Study|Withdrawal by Subject|0|||
17133485|NCT01337596|38274915|FG004|Overall Study|Withdrawal by Subject|2|||
17133486|NCT01337596|38274916|FG005|Overall Study|Withdrawal by Subject|0|||
17133487|NCT01337596|38274917|FG006|Overall Study|Withdrawal by Subject|0|||
17133488|NCT01337596|38274918|FG007|Overall Study|Withdrawal by Subject|0|||
17133489|NCT01337596|38274919|FG008|Overall Study|Withdrawal by Subject|0|||
17133490|NCT00069095|38274948|FG000|Primary Treatment Phase|Ongoing|0|||
17133491|NCT00069095|38274949|FG001|Primary Treatment Phase|Ongoing|0|||
17133492|NCT00069095|38274950|FG002|Primary Treatment Phase|Ongoing|5|||
17133493|NCT00069095|38274951|FG003|Primary Treatment Phase|Ongoing|7|||
17133494|NCT00069095|38274952|FG004|Primary Treatment Phase|Ongoing|7|||
17133495|NCT00069095|38274953|FG005|Primary Treatment Phase|Ongoing|4|||
17133496|NCT00069095|38274948|FG000|Primary Treatment Phase|Admin/Other|29|||
17133497|NCT00069095|38274949|FG001|Primary Treatment Phase|Admin/Other|38|||
17133498|NCT00069095|38274950|FG002|Primary Treatment Phase|Admin/Other|31|||
17133499|NCT00069095|38274951|FG003|Primary Treatment Phase|Admin/Other|45|||
17133500|NCT00069095|38274952|FG004|Primary Treatment Phase|Admin/Other|48|||
17133501|NCT00069095|38274953|FG005|Primary Treatment Phase|Admin/Other|42|||
17133502|NCT00069095|38274948|FG000|Primary Treatment Phase|Adverse Event|99|||
17133503|NCT00069095|38274949|FG001|Primary Treatment Phase|Adverse Event|92|||
17133504|NCT00069095|38274950|FG002|Primary Treatment Phase|Adverse Event|71|||
17133505|NCT00069095|38274951|FG003|Primary Treatment Phase|Adverse Event|72|||
17133506|NCT00069095|38274952|FG004|Primary Treatment Phase|Adverse Event|109|||
17133507|NCT00069095|38274953|FG005|Primary Treatment Phase|Adverse Event|101|||
17133508|NCT00069095|38274948|FG000|Primary Treatment Phase|Death|14|||
17133509|NCT00069095|38274949|FG001|Primary Treatment Phase|Death|8|||
17133510|NCT00069095|38274950|FG002|Primary Treatment Phase|Death|2|||
17133511|NCT00069095|38274951|FG003|Primary Treatment Phase|Death|5|||
17133512|NCT00069095|38274952|FG004|Primary Treatment Phase|Death|8|||
17133513|NCT00069095|38274953|FG005|Primary Treatment Phase|Death|8|||
17133514|NCT00069095|38274948|FG000|Primary Treatment Phase|Failure to return|5|||
17133515|NCT00069095|38274949|FG001|Primary Treatment Phase|Failure to return|5|||
17133516|NCT00069095|38274950|FG002|Primary Treatment Phase|Failure to return|0|||
17133517|NCT00069095|38274951|FG003|Primary Treatment Phase|Failure to return|0|||
17133518|NCT00069095|38274952|FG004|Primary Treatment Phase|Failure to return|0|||
17133519|NCT00069095|38274953|FG005|Primary Treatment Phase|Failure to return|2|||
17133520|NCT00069095|38274948|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
17133521|NCT00069095|38274949|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
17133522|NCT00069095|38274950|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
17133523|NCT00069095|38274951|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
17133524|NCT00069095|38274952|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
17133525|NCT00069095|38274953|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
17133526|NCT00069095|38274948|FG000|Primary Treatment Phase|Refused treatment|15|||
17133527|NCT00069095|38274949|FG001|Primary Treatment Phase|Refused treatment|26|||
17133528|NCT00069095|38274950|FG002|Primary Treatment Phase|Refused treatment|17|||
17133529|NCT00069095|38274951|FG003|Primary Treatment Phase|Refused treatment|31|||
17133530|NCT00069095|38274952|FG004|Primary Treatment Phase|Refused treatment|24|||
17133531|NCT00069095|38274953|FG005|Primary Treatment Phase|Refused treatment|27|||
17133532|NCT00069095|38274948|FG000|Primary Treatment Phase|Withdrew|2|||
17133533|NCT00069095|38274949|FG001|Primary Treatment Phase|Withdrew|3|||
17133534|NCT00069095|38274950|FG002|Primary Treatment Phase|Withdrew|8|||
17133535|NCT00069095|38274951|FG003|Primary Treatment Phase|Withdrew|2|||
17133536|NCT00069095|38274952|FG004|Primary Treatment Phase|Withdrew|4|||
17133537|NCT00069095|38274953|FG005|Primary Treatment Phase|Withdrew|9|||
17133538|NCT00069095|38274948|FG000|Primary Treatment Phase|Other Violation|0|||
17133539|NCT00069095|38274949|FG001|Primary Treatment Phase|Other Violation|1|||
17133540|NCT00069095|38274950|FG002|Primary Treatment Phase|Other Violation|1|||
17133541|NCT00069095|38274951|FG003|Primary Treatment Phase|Other Violation|1|||
17133542|NCT00069095|38274952|FG004|Primary Treatment Phase|Other Violation|0|||
17133543|NCT00069095|38274953|FG005|Primary Treatment Phase|Other Violation|1|||
17133544|NCT00069095|38274948|FG000|Primary Treatment Phase|Violation criteria|0|||
17133545|NCT00069095|38274949|FG001|Primary Treatment Phase|Violation criteria|2|||
17133546|NCT00069095|38274950|FG002|Primary Treatment Phase|Violation criteria|4|||
17133547|NCT00069095|38274951|FG003|Primary Treatment Phase|Violation criteria|3|||
17133548|NCT00069095|38274952|FG004|Primary Treatment Phase|Violation criteria|1|||
17133549|NCT00069095|38274953|FG005|Primary Treatment Phase|Violation criteria|5|||
17133550|NCT00069095|38274948|FG000|Post-study Treatment Phase|Missing reason|1|||
17133551|NCT00069095|38274949|FG001|Post-study Treatment Phase|Missing reason|3|||
17133552|NCT00069095|38274950|FG002|Post-study Treatment Phase|Missing reason|12|||
17133553|NCT00069095|38274951|FG003|Post-study Treatment Phase|Missing reason|8|||
17133554|NCT00069095|38274952|FG004|Post-study Treatment Phase|Missing reason|18|||
17133555|NCT00069095|38274953|FG005|Post-study Treatment Phase|Missing reason|17|||
17133556|NCT00069095|38274948|FG000|Post-study Treatment Phase|Adverse Event|2|||
17133557|NCT00069095|38274949|FG001|Post-study Treatment Phase|Adverse Event|3|||
17133558|NCT00069095|38274950|FG002|Post-study Treatment Phase|Adverse Event|1|||
17133559|NCT00069095|38274951|FG003|Post-study Treatment Phase|Adverse Event|0|||
17133560|NCT00069095|38274952|FG004|Post-study Treatment Phase|Adverse Event|5|||
17133561|NCT00069095|38274953|FG005|Post-study Treatment Phase|Adverse Event|1|||
17133562|NCT00069095|38274948|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
17133563|NCT00069095|38274949|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
17133564|NCT00069095|38274950|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
17133565|NCT00069095|38274951|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
17133566|NCT00069095|38274952|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
17133567|NCT00069095|38274953|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
17133568|NCT00069095|38274948|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
17133569|NCT00069095|38274949|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
17133570|NCT00069095|38274950|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
17133571|NCT00069095|38274951|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
17133572|NCT00069095|38274952|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
17133573|NCT00069095|38274953|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
17133574|NCT00069095|38274948|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
17133575|NCT00069095|38274949|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
17133576|NCT00069095|38274950|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
17133577|NCT00069095|38274951|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
17133578|NCT00069095|38274952|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
17133579|NCT00069095|38274953|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
17133580|NCT00069095|38274948|FG000|Post-study Treatment Phase|Participant had complete response|1|||
17133581|NCT00069095|38274949|FG001|Post-study Treatment Phase|Participant had complete response|1|||
17133582|NCT00069095|38274950|FG002|Post-study Treatment Phase|Participant had complete response|0|||
17133583|NCT00069095|38274951|FG003|Post-study Treatment Phase|Participant had complete response|0|||
17133584|NCT00069095|38274952|FG004|Post-study Treatment Phase|Participant had complete response|0|||
17133585|NCT00069095|38274953|FG005|Post-study Treatment Phase|Participant had complete response|0|||
17133586|NCT00069095|38274948|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
17133587|NCT00069095|38274949|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
17133588|NCT00069095|38274950|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
17133589|NCT00069095|38274951|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
17133590|NCT00069095|38274952|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
17133591|NCT00069095|38274953|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
17133592|NCT00069095|38274948|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
17133593|NCT00069095|38274949|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
17133594|NCT00069095|38274950|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
17133595|NCT00069095|38274951|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
17133596|NCT00069095|38274952|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
17133597|NCT00069095|38274953|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
17133598|NCT00069095|38274948|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
17133599|NCT00069095|38274949|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
17133600|NCT00069095|38274950|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
17133601|NCT00069095|38274951|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
17133602|NCT00069095|38274952|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
17133603|NCT00069095|38274953|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
17133604|NCT00069095|38274948|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
17133605|NCT00069095|38274949|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
17133606|NCT00069095|38274950|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
17133607|NCT00069095|38274951|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
17133608|NCT00069095|38274952|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
17133609|NCT00069095|38274953|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
17133610|NCT00069095|38274948|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
17133611|NCT00069095|38274949|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
17133612|NCT00069095|38274950|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
17133613|NCT00069095|38274951|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
17133614|NCT00069095|38274952|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
17133615|NCT00069095|38274953|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
17133616|NCT00069095|38274948|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
17133617|NCT00069095|38274949|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
17133618|NCT00069095|38274950|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
17133619|NCT00069095|38274951|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
17133620|NCT00069095|38274952|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
17133621|NCT00069095|38274953|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
17133622|NCT00069095|38274948|FG000|Post-study Treatment Phase|Surgery|0|||
17133623|NCT00069095|38274949|FG001|Post-study Treatment Phase|Surgery|0|||
17133624|NCT00069095|38274950|FG002|Post-study Treatment Phase|Surgery|0|||
17133625|NCT00069095|38274951|FG003|Post-study Treatment Phase|Surgery|1|||
17133626|NCT00069095|38274952|FG004|Post-study Treatment Phase|Surgery|1|||
17133627|NCT00069095|38274953|FG005|Post-study Treatment Phase|Surgery|0|||
17133628|NCT00069095|38274948|FG000|Post-study Treatment Phase|Death|0|||
17133629|NCT00069095|38274949|FG001|Post-study Treatment Phase|Death|0|||
17133630|NCT00069095|38274950|FG002|Post-study Treatment Phase|Death|0|||
17133631|NCT00069095|38274951|FG003|Post-study Treatment Phase|Death|0|||
17133632|NCT00069095|38274952|FG004|Post-study Treatment Phase|Death|1|||
17133633|NCT00069095|38274953|FG005|Post-study Treatment Phase|Death|0|||
17133634|NCT00069095|38274948|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
17133635|NCT00069095|38274949|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
17133636|NCT00069095|38274950|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
17133637|NCT00069095|38274951|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
17133638|NCT00069095|38274952|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
17133639|NCT00069095|38274953|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
17133640|NCT00069095|38274948|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
17133641|NCT00069095|38274949|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
17133642|NCT00069095|38274950|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
17133643|NCT00069095|38274951|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
17133644|NCT00069095|38274952|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
17133645|NCT00069095|38274953|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
17133646|NCT00069095|38274948|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
17133647|NCT00069095|38274949|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
17133648|NCT00069095|38274950|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
17133649|NCT00069095|38274951|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
17133650|NCT00069095|38274952|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
17133651|NCT00069095|38274953|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
17133652|NCT00069095|38274948|FG000|Post-study Treatment Phase|Investigator decision|0|||
17133653|NCT00069095|38274949|FG001|Post-study Treatment Phase|Investigator decision|0|||
17133654|NCT00069095|38274950|FG002|Post-study Treatment Phase|Investigator decision|0|||
17133655|NCT00069095|38274951|FG003|Post-study Treatment Phase|Investigator decision|0|||
17133656|NCT00069095|38274952|FG004|Post-study Treatment Phase|Investigator decision|0|||
17133657|NCT00069095|38274953|FG005|Post-study Treatment Phase|Investigator decision|1|||
17133658|NCT00069095|38274948|FG000|Follow-up Phase|Death|174|||
17133659|NCT00069095|38274949|FG001|Follow-up Phase|Death|206|||
17133660|NCT00069095|38274950|FG002|Follow-up Phase|Death|120|||
17133661|NCT00069095|38274951|FG003|Follow-up Phase|Death|112|||
17133662|NCT00069095|38274952|FG004|Follow-up Phase|Death|92|||
17133663|NCT00069095|38274953|FG005|Follow-up Phase|Death|101|||
17133664|NCT00086411|38274969|FG000|Overall Study|Lost to Follow-up|11|||
17133665|NCT00086411|38274970|FG001|Overall Study|Lost to Follow-up|11|||
17133666|NCT00086411|38274971|FG002|Overall Study|Lost to Follow-up|13|||
17133667|NCT00086411|38274972|FG003|Overall Study|Lost to Follow-up|12|||
17133668|NCT00068393|38274983|FG000|Overall Study|Adverse Event|2|||
17133669|NCT00068393|38274983|FG000|Overall Study|Death|3|||
17133670|NCT00068393|38274983|FG000|Overall Study|Withdrawal by Subject|3|||
17133671|NCT00068393|38274983|FG000|Overall Study|Alternative treatment|1|||
17133672|NCT00068393|38274983|FG000|Overall Study|Quality of life worsening|1|||
17133673|NCT00068237|38274987|FG000|Overall Study|Ineligible|3|||
17133674|NCT00068237|38274987|FG000|Overall Study|No protocol treatment received|2|||
17133675|NCT03809039|38275000|FG000|Part 1|Withdrawal by Subject|1|||
17133676|NCT03809039|38275001|FG001|Part 1|Withdrawal by Subject|0|||
17133677|NCT03809039|38275002|FG002|Part 1|Withdrawal by Subject|0|||
17133678|NCT03809039|38275003|FG003|Part 1|Withdrawal by Subject|1|||
17133679|NCT03809039|38275004|FG004|Part 1|Withdrawal by Subject|0|||
17133680|NCT03809039|38275005|FG005|Part 1|Withdrawal by Subject|0|||
17133681|NCT03809039|38275006|FG006|Part 1|Withdrawal by Subject|0|||
17133682|NCT03809039|38275007|FG007|Part 1|Withdrawal by Subject|0|||
17133683|NCT03809039|38275008|FG008|Part 1|Withdrawal by Subject|0|||
17133684|NCT03809039|38275000|FG000|Part 3|Withdrawn by study termination|0|||
17133685|NCT03809039|38275001|FG001|Part 3|Withdrawn by study termination|0|||
17133686|NCT03809039|38275002|FG002|Part 3|Withdrawn by study termination|0|||
17133687|NCT03809039|38275003|FG003|Part 3|Withdrawn by study termination|0|||
17133688|NCT03809039|38275004|FG004|Part 3|Withdrawn by study termination|0|||
17133689|NCT03809039|38275005|FG005|Part 3|Withdrawn by study termination|0|||
17133690|NCT03809039|38275006|FG006|Part 3|Withdrawn by study termination|0|||
17133691|NCT03809039|38275007|FG007|Part 3|Withdrawn by study termination|2|||
17133692|NCT03809039|38275008|FG008|Part 3|Withdrawn by study termination|6|||
17133693|NCT00055601|38275043|FG000|Overall Study|Protocol Violation|1|||
17133694|NCT00055601|38275044|FG001|Overall Study|Protocol Violation|1|||
17133695|NCT00055601|38275043|FG000|Overall Study|No protocol treatment received|1|||
17133696|NCT00055601|38275044|FG001|Overall Study|No protocol treatment received|1|||
17133697|NCT03806231|38275052|FG000|Overall Study|Physician Decision|1|||
17133698|NCT03806231|38275053|FG001|Overall Study|Physician Decision|0|||
17133699|NCT03806231|38275052|FG000|Overall Study|Withdrawal by Subject|1|||
17133700|NCT03806231|38275053|FG001|Overall Study|Withdrawal by Subject|0|||
17133701|NCT00054275|38275059|FG000|Overall Study|Withdrawal by Subject|4|||
17133702|NCT00054275|38275059|FG000|Overall Study|Adverse Event|5|||
17133703|NCT00054275|38275059|FG000|Overall Study|Progressive disease in cycle 1|1|||
17133704|NCT00054275|38275059|FG000|Overall Study|Physician Decision|1|||
17133705|NCT00053417|38275067|FG000|Overall Study|Adverse Event|1|||
17133706|NCT00053417|38275068|FG001|Overall Study|Adverse Event|0|||
17133707|NCT00053417|38275069|FG002|Overall Study|Adverse Event|1|||
17133708|NCT00053417|38275070|FG003|Overall Study|Adverse Event|5|||
17133709|NCT00053417|38275067|FG000|Overall Study|Non-Compliance|0|||
17133710|NCT00053417|38275068|FG001|Overall Study|Non-Compliance|0|||
17133711|NCT00053417|38275069|FG002|Overall Study|Non-Compliance|0|||
17133712|NCT00053417|38275070|FG003|Overall Study|Non-Compliance|1|||
17133713|NCT00053417|38275067|FG000|Overall Study|Withdrawal by Subject|0|||
17133714|NCT00053417|38275068|FG001|Overall Study|Withdrawal by Subject|1|||
17133715|NCT00053417|38275069|FG002|Overall Study|Withdrawal by Subject|0|||
17133716|NCT00053417|38275070|FG003|Overall Study|Withdrawal by Subject|0|||
17133717|NCT00053417|38275067|FG000|Overall Study|Lost to Follow-up|1|||
17133718|NCT00053417|38275068|FG001|Overall Study|Lost to Follow-up|1|||
17133719|NCT00053417|38275069|FG002|Overall Study|Lost to Follow-up|0|||
17133720|NCT00053417|38275070|FG003|Overall Study|Lost to Follow-up|0|||
17133721|NCT00052715|38275080|FG000|Overall Study|wrong histology|1|||
17133722|NCT00051311|38275086|FG000|Overall Study|Starting new study|0|||
17133723|NCT00051311|38275087|FG001|Overall Study|Starting new study|1|||
17133724|NCT00051311|38275086|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
17133725|NCT00051311|38275087|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
17133726|NCT00051311|38275086|FG000|Overall Study|Death of recipient|8|||
17133727|NCT00051311|38275087|FG001|Overall Study|Death of recipient|8|||
17133728|NCT00051311|38275086|FG000|Overall Study|Recipient taken off study|4|||
17133729|NCT00051311|38275087|FG001|Overall Study|Recipient taken off study|4|||
17133730|NCT00049673|38275093|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
17133731|NCT00049673|38275094|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
17133732|NCT00049517|38275102|FG000|Induction|Disease progression|0|||
17133733|NCT00049517|38275103|FG001|Induction|Disease progression|0|||
17133734|NCT00049517|38275104|FG002|Induction|Disease progression|0|||
17133735|NCT00049517|38275105|FG003|Induction|Disease progression|0|||
17133736|NCT00049517|38275106|FG004|Induction|Disease progression|18|||
17133737|NCT00049517|38275107|FG005|Induction|Disease progression|11|||
17133738|NCT00049517|38275102|FG000|Induction|Adverse Event|0|||
17133739|NCT00049517|38275103|FG001|Induction|Adverse Event|0|||
17133740|NCT00049517|38275104|FG002|Induction|Adverse Event|0|||
17133741|NCT00049517|38275105|FG003|Induction|Adverse Event|0|||
17133742|NCT00049517|38275106|FG004|Induction|Adverse Event|5|||
17133743|NCT00049517|38275107|FG005|Induction|Adverse Event|7|||
17133744|NCT00049517|38275102|FG000|Induction|Death|0|||
17133745|NCT00049517|38275103|FG001|Induction|Death|0|||
17133746|NCT00049517|38275104|FG002|Induction|Death|0|||
17133747|NCT00049517|38275105|FG003|Induction|Death|0|||
17133748|NCT00049517|38275106|FG004|Induction|Death|9|||
17133749|NCT00049517|38275107|FG005|Induction|Death|6|||
17133750|NCT00049517|38275102|FG000|Induction|Withdrawal by Subject|0|||
17133751|NCT00049517|38275103|FG001|Induction|Withdrawal by Subject|0|||
17133752|NCT00049517|38275104|FG002|Induction|Withdrawal by Subject|0|||
17133753|NCT00049517|38275105|FG003|Induction|Withdrawal by Subject|0|||
17133754|NCT00049517|38275106|FG004|Induction|Withdrawal by Subject|1|||
17133755|NCT00049517|38275107|FG005|Induction|Withdrawal by Subject|3|||
17133756|NCT00049517|38275102|FG000|Induction|Alternative therapy|0|||
17133757|NCT00049517|38275103|FG001|Induction|Alternative therapy|0|||
17133758|NCT00049517|38275104|FG002|Induction|Alternative therapy|0|||
17133759|NCT00049517|38275105|FG003|Induction|Alternative therapy|0|||
17133760|NCT00049517|38275106|FG004|Induction|Alternative therapy|2|||
17133761|NCT00049517|38275107|FG005|Induction|Alternative therapy|2|||
17133762|NCT00049517|38275102|FG000|Induction|Other complicating disease|0|||
17133763|NCT00049517|38275103|FG001|Induction|Other complicating disease|0|||
17133764|NCT00049517|38275104|FG002|Induction|Other complicating disease|0|||
17133765|NCT00049517|38275105|FG003|Induction|Other complicating disease|0|||
17133766|NCT00049517|38275106|FG004|Induction|Other complicating disease|3|||
17133767|NCT00049517|38275107|FG005|Induction|Other complicating disease|0|||
17133768|NCT00049517|38275102|FG000|Induction|Reasons not reported|0|||
17133769|NCT00049517|38275103|FG001|Induction|Reasons not reported|0|||
17133770|NCT00049517|38275104|FG002|Induction|Reasons not reported|0|||
17133771|NCT00049517|38275105|FG003|Induction|Reasons not reported|0|||
17133772|NCT00049517|38275106|FG004|Induction|Reasons not reported|22|||
17133773|NCT00049517|38275107|FG005|Induction|Reasons not reported|25|||
17133774|NCT00049517|38275102|FG000|Conditioning/Transplant|Disease progression|14|||
17133775|NCT00049517|38275103|FG001|Conditioning/Transplant|Disease progression|6|||
17133776|NCT00049517|38275104|FG002|Conditioning/Transplant|Disease progression|10|||
17133777|NCT00049517|38275105|FG003|Conditioning/Transplant|Disease progression|6|||
17133778|NCT00049517|38275106|FG004|Conditioning/Transplant|Disease progression|0|||
17133779|NCT00049517|38275107|FG005|Conditioning/Transplant|Disease progression|0|||
17133780|NCT00049517|38275102|FG000|Conditioning/Transplant|Adverse Event|2|||
17133781|NCT00049517|38275103|FG001|Conditioning/Transplant|Adverse Event|1|||
17133782|NCT00049517|38275104|FG002|Conditioning/Transplant|Adverse Event|4|||
17133783|NCT00049517|38275105|FG003|Conditioning/Transplant|Adverse Event|8|||
17133784|NCT00049517|38275106|FG004|Conditioning/Transplant|Adverse Event|0|||
17133785|NCT00049517|38275107|FG005|Conditioning/Transplant|Adverse Event|0|||
17133786|NCT00049517|38275102|FG000|Conditioning/Transplant|Death|1|||
17133787|NCT00049517|38275103|FG001|Conditioning/Transplant|Death|0|||
17133788|NCT00049517|38275104|FG002|Conditioning/Transplant|Death|0|||
17133789|NCT00049517|38275105|FG003|Conditioning/Transplant|Death|2|||
17133790|NCT00049517|38275106|FG004|Conditioning/Transplant|Death|0|||
17133791|NCT00049517|38275107|FG005|Conditioning/Transplant|Death|0|||
17133792|NCT00049517|38275102|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
17133793|NCT00049517|38275103|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
17133794|NCT00049517|38275104|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
17133795|NCT00049517|38275105|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
17133796|NCT00049517|38275106|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
17133797|NCT00049517|38275107|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
17133798|NCT00049517|38275102|FG000|Conditioning/Transplant|Alternative therapy|4|||
17133799|NCT00049517|38275103|FG001|Conditioning/Transplant|Alternative therapy|4|||
17133800|NCT00049517|38275104|FG002|Conditioning/Transplant|Alternative therapy|2|||
17133801|NCT00049517|38275105|FG003|Conditioning/Transplant|Alternative therapy|1|||
17133802|NCT00049517|38275106|FG004|Conditioning/Transplant|Alternative therapy|1|||
17133803|NCT00049517|38275107|FG005|Conditioning/Transplant|Alternative therapy|0|||
17133804|NCT00049517|38275102|FG000|Conditioning/Transplant|Other complicating disease|2|||
17133805|NCT00049517|38275103|FG001|Conditioning/Transplant|Other complicating disease|0|||
17133806|NCT00049517|38275104|FG002|Conditioning/Transplant|Other complicating disease|0|||
17133807|NCT00049517|38275105|FG003|Conditioning/Transplant|Other complicating disease|4|||
17133808|NCT00049517|38275106|FG004|Conditioning/Transplant|Other complicating disease|0|||
17133809|NCT00049517|38275107|FG005|Conditioning/Transplant|Other complicating disease|1|||
17133810|NCT00049517|38275102|FG000|Conditioning/Transplant|Reasons not reported|25|||
17133811|NCT00049517|38275103|FG001|Conditioning/Transplant|Reasons not reported|31|||
17133812|NCT00049517|38275104|FG002|Conditioning/Transplant|Reasons not reported|18|||
17133813|NCT00049517|38275105|FG003|Conditioning/Transplant|Reasons not reported|15|||
17133814|NCT00049517|38275106|FG004|Conditioning/Transplant|Reasons not reported|5|||
17133815|NCT00049517|38275107|FG005|Conditioning/Transplant|Reasons not reported|5|||
17133816|NCT00049127|38275120|FG000|Overall Study|Withdrawal by Subject|0|||
17133817|NCT00049127|38275121|FG001|Overall Study|Withdrawal by Subject|0|||
17133818|NCT00049127|38275122|FG002|Overall Study|Withdrawal by Subject|1|||
17133819|NCT00049127|38275123|FG003|Overall Study|Withdrawal by Subject|0|||
17133820|NCT00049127|38275124|FG004|Overall Study|Withdrawal by Subject|0|||
17133821|NCT00066365|38275138|FG000|Overall Study|Adverse Event|1|||
17133822|NCT00066365|38275139|FG001|Overall Study|Adverse Event|0|||
17133823|NCT00066365|38275138|FG000|Overall Study|Lack of Efficacy|15|||
17133824|NCT00066365|38275139|FG001|Overall Study|Lack of Efficacy|12|||
17133825|NCT00066365|38275138|FG000|Overall Study|Physician Decision|1|||
17133826|NCT00066365|38275139|FG001|Overall Study|Physician Decision|0|||
17133827|NCT00066365|38275138|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
17133828|NCT00066365|38275139|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
17133829|NCT00066365|38275138|FG000|Overall Study|Ineligible|4|||
17133830|NCT00066365|38275139|FG001|Overall Study|Ineligible|2|||
17133831|NCT00048581|38275149|FG000|Double-Blind Period|Adverse Event|9|||
17133832|NCT00048581|38275150|FG001|Double-Blind Period|Adverse Event|5|||
17133833|NCT00048581|38275151|FG002|Double-Blind Period|Adverse Event|0|||
17133834|NCT00048581|38275149|FG000|Double-Blind Period|Lack of Efficacy|14|||
17133835|NCT00048581|38275150|FG001|Double-Blind Period|Lack of Efficacy|27|||
16774410|NCT03470441|37713773|FG002|Overall Study|Adverse Event|0|||
16957514|NCT01154283|38100511|FG001|7-12 Weeks|Death|0|||
16957515|NCT01154283|38100510|FG000|7-12 Weeks|Withdrawal by Subject|0|||
16957516|NCT01154283|38100511|FG001|7-12 Weeks|Withdrawal by Subject|1|||
16957517|NCT00944125|38100517|FG000|3 to 6 Months|Withdrawal by Subject|0|||
16957518|NCT00944125|38100518|FG001|3 to 6 Months|Withdrawal by Subject|2|||
16957519|NCT00944125|38100517|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
16957520|NCT00944125|38100518|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
16957521|NCT00912223|38100524|FG000|Overall Study|Withdrawal by Subject|1|||
16957522|NCT00912223|38100524|FG000|Overall Study|Not transplanted|1|||
16957523|NCT00912223|38100524|FG000|Overall Study|Transformed disease|1|||
16957524|NCT01154127|38100530|FG000|Period 1 (21 Days)|Adverse Event|3|||
16957525|NCT01154127|38100531|FG001|Period 1 (21 Days)|Adverse Event|4|||
16957526|NCT01154127|38100530|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
16957527|NCT01154127|38100531|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
16957528|NCT01154127|38100530|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
16957529|NCT01154127|38100531|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
16957530|NCT01154127|38100530|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
16957531|NCT01154127|38100531|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
16957532|NCT01154127|38100530|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
16957533|NCT01154127|38100531|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
16957534|NCT01228734|38100539|FG000|Overall Study|Randomized, but not treated|0|||
16957535|NCT01228734|38100540|FG001|Overall Study|Randomized, but not treated|4|||
16957536|NCT01227954|38100546|FG000|Overall Study|Protocol Violation|6|||
16957537|NCT01227954|38100546|FG000|Overall Study|No protocol treatment|7|||
16957538|NCT01153971|38100550|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
16957539|NCT01153971|38100550|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
16957540|NCT01153971|38100550|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
16957541|NCT01153971|38100550|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
16957542|NCT01153971|38100550|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
16957543|NCT01153971|38100550|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
16957544|NCT01153971|38100550|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
16957545|NCT01153893|38100556|FG000|Overall Study|Adverse Event|1|||
16957546|NCT01153893|38100557|FG001|Overall Study|Adverse Event|0|||
16957547|NCT00951379|38100565|FG000|Overall Study|Adverse Event|4|||
16957548|NCT00951379|38100566|FG001|Overall Study|Adverse Event|1|||
16957549|NCT00951379|38100565|FG000|Overall Study|Withdrawal by Subject|1|||
16957550|NCT00951379|38100566|FG001|Overall Study|Withdrawal by Subject|0|||
16957551|NCT00951379|38100565|FG000|Overall Study|Noncompliance|1|||
16957552|NCT00951379|38100566|FG001|Overall Study|Noncompliance|0|||
16957553|NCT00951379|38100565|FG000|Overall Study|Disease Progression|0|||
16957554|NCT00951379|38100566|FG001|Overall Study|Disease Progression|1|||
16957555|NCT01153815|38100582|FG000|Overall Study|Adverse Event|3|||
16957556|NCT01153815|38100583|FG001|Overall Study|Adverse Event|1|||
16957557|NCT01153815|38100582|FG000|Overall Study|Withdrawal by Subject|6|||
16957558|NCT01153815|38100583|FG001|Overall Study|Withdrawal by Subject|4|||
16957559|NCT01153425|38100591|FG000|Overall Study|Withdrawal by Subject|3|||
16957560|NCT01153425|38100592|FG001|Overall Study|Withdrawal by Subject|3|||
16957561|NCT01153347|38100603|FG000|Overall Study|Withdrawal by Subject|7|||
16957562|NCT01153347|38100604|FG001|Overall Study|Withdrawal by Subject|7|||
16957563|NCT01153347|38100605|FG002|Overall Study|Withdrawal by Subject|7|||
17133836|NCT00048581|38275151|FG002|Double-Blind Period|Lack of Efficacy|0|||
17133837|NCT00048581|38275149|FG000|Double-Blind Period|Lost to Follow-up|5|||
17133838|NCT00048581|38275150|FG001|Double-Blind Period|Lost to Follow-up|0|||
16774411|NCT03470441|37713774|FG003|Overall Study|Adverse Event|1|||
16957564|NCT01153347|38100606|FG003|Overall Study|Withdrawal by Subject|7|||
16957565|NCT01153347|38100603|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16957566|NCT01153347|38100604|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16957567|NCT01153347|38100605|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
16957568|NCT01153347|38100606|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
16957569|NCT01153347|38100603|FG000|Overall Study|Adverse Event|3|||
16957570|NCT01153347|38100604|FG001|Overall Study|Adverse Event|9|||
16957571|NCT01153347|38100605|FG002|Overall Study|Adverse Event|21|||
16957572|NCT01153347|38100606|FG003|Overall Study|Adverse Event|7|||
16957573|NCT01153347|38100603|FG000|Overall Study|Severe non-compliance to protocol|6|||
16957574|NCT01153347|38100604|FG001|Overall Study|Severe non-compliance to protocol|7|||
16957575|NCT01153347|38100605|FG002|Overall Study|Severe non-compliance to protocol|4|||
16957576|NCT01153347|38100606|FG003|Overall Study|Severe non-compliance to protocol|3|||
16957577|NCT01153347|38100603|FG000|Overall Study|Condition under investigation worsened|1|||
16957578|NCT01153347|38100604|FG001|Overall Study|Condition under investigation worsened|1|||
16957579|NCT01153347|38100605|FG002|Overall Study|Condition under investigation worsened|0|||
16957580|NCT01153347|38100606|FG003|Overall Study|Condition under investigation worsened|0|||
16957581|NCT01153347|38100603|FG000|Overall Study|Lack of Efficacy|2|||
16957582|NCT01153347|38100604|FG001|Overall Study|Lack of Efficacy|2|||
16957583|NCT01153347|38100605|FG002|Overall Study|Lack of Efficacy|0|||
16957584|NCT01153347|38100606|FG003|Overall Study|Lack of Efficacy|4|||
16957585|NCT01153347|38100603|FG000|Overall Study|Study-specific withdrawal criteria|4|||
16957586|NCT01153347|38100604|FG001|Overall Study|Study-specific withdrawal criteria|3|||
16957587|NCT01153347|38100605|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16957588|NCT01153347|38100606|FG003|Overall Study|Study-specific withdrawal criteria|2|||
16957589|NCT01153347|38100603|FG000|Overall Study|Lost to Follow-up|4|||
16957590|NCT01153347|38100604|FG001|Overall Study|Lost to Follow-up|9|||
16957591|NCT01153347|38100605|FG002|Overall Study|Lost to Follow-up|11|||
16957592|NCT01153347|38100606|FG003|Overall Study|Lost to Follow-up|8|||
16957593|NCT01153347|38100603|FG000|Overall Study|Other|5|||
16957594|NCT01153347|38100604|FG001|Overall Study|Other|5|||
16957595|NCT01153347|38100605|FG002|Overall Study|Other|4|||
16957596|NCT01153347|38100606|FG003|Overall Study|Other|0|||
16957597|NCT01153347|38100603|FG000|Overall Study|Death|1|||
16957598|NCT01153347|38100604|FG001|Overall Study|Death|0|||
16957599|NCT01153347|38100605|FG002|Overall Study|Death|0|||
16957600|NCT01153347|38100606|FG003|Overall Study|Death|0|||
16957601|NCT01153269|38100616|FG000|Overall Study|Withdrawal by Subject|1|||
16957602|NCT01153269|38100616|FG000|Overall Study|Antiretroviral therapy break|1|||
16957603|NCT01152021|38100625|FG000|Overall Study|Adverse Event|4|||
16957604|NCT01152021|38100626|FG001|Overall Study|Adverse Event|4|||
16957605|NCT01152021|38100625|FG000|Overall Study|Study drug had expired|1|||
16957606|NCT01152021|38100626|FG001|Overall Study|Study drug had expired|0|||
16957607|NCT01152021|38100625|FG000|Overall Study|Physician Decision|1|||
16957608|NCT01152021|38100626|FG001|Overall Study|Physician Decision|1|||
16957609|NCT01152021|38100625|FG000|Overall Study|No access to study drug in Pharmacy|0|||
16957610|NCT01152021|38100626|FG001|Overall Study|No access to study drug in Pharmacy|1|||
16957611|NCT01151085|38100634|FG000|Overall Study|Lost to Follow-up|31|||
16957612|NCT01151085|38100634|FG000|Overall Study|Protocol Violation|25|||
16957613|NCT01149681|38100645|FG000|Overall Study|Withdrawal by Subject|7|||
16957614|NCT01149681|38100645|FG000|Overall Study|Progressive disease|1|||
16957615|NCT01149681|38100645|FG000|Overall Study|Physician Decision|2|||
16957616|NCT01149681|38100645|FG000|Overall Study|adverse events nonrelated study drug|2|||
16957617|NCT01149369|38100652|FG000|Overall Study|Adverse Event|6|||
16957618|NCT01149369|38100653|FG001|Overall Study|Adverse Event|3|||
16957619|NCT01740427|38100661|FG000|Overall Study|Ongoing|45|||
16957620|NCT01740427|38100662|FG001|Overall Study|Ongoing|5|||
16957621|NCT01740427|38100661|FG000|Overall Study|Objective Progression or Relapse|281|||
16957622|NCT01740427|38100662|FG001|Overall Study|Objective Progression or Relapse|171|||
16957623|NCT01740427|38100661|FG000|Overall Study|Adverse Event|31|||
16957624|NCT01740427|38100662|FG001|Overall Study|Adverse Event|9|||
16957625|NCT01740427|38100661|FG000|Overall Study|Global Deterioration of Health Status|28|||
16957626|NCT01740427|38100662|FG001|Overall Study|Global Deterioration of Health Status|12|||
16957627|NCT01740427|38100661|FG000|Overall Study|Participant Refused Continued Treatment|26|||
16957628|NCT01740427|38100662|FG001|Overall Study|Participant Refused Continued Treatment|15|||
16957629|NCT01740427|38100661|FG000|Overall Study|Unspecified reasons|15|||
16957630|NCT01740427|38100662|FG001|Overall Study|Unspecified reasons|4|||
16957631|NCT01740427|38100661|FG000|Overall Study|Death|10|||
16957632|NCT01740427|38100662|FG001|Overall Study|Death|3|||
16957633|NCT01740427|38100661|FG000|Overall Study|Protocol Violation|5|||
17133839|NCT00048581|38275151|FG002|Double-Blind Period|Lost to Follow-up|0|||
17133840|NCT00048581|38275149|FG000|Double-Blind Period|Withdrawal by Subject|5|||
17133841|NCT00048581|38275150|FG001|Double-Blind Period|Withdrawal by Subject|2|||
16957634|NCT01740427|38100662|FG001|Overall Study|Protocol Violation|3|||
16957635|NCT01740427|38100661|FG000|Overall Study|Lost to Follow-up|2|||
16957636|NCT01740427|38100662|FG001|Overall Study|Lost to Follow-up|0|||
16957637|NCT01740427|38100661|FG000|Overall Study|Site Terminated by Sponsor|1|||
16957638|NCT01740427|38100662|FG001|Overall Study|Site Terminated by Sponsor|0|||
16957639|NCT01149057|38100668|FG000|Overall Study|Lack of Efficacy|16|||
16957640|NCT01149057|38100668|FG000|Overall Study|Adverse Event|13|||
16957641|NCT01149057|38100668|FG000|Overall Study|Withdrawal by Subject|9|||
16957642|NCT01149057|38100668|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
16957643|NCT01149057|38100668|FG000|Overall Study|B Cell Depletion|4|||
16957644|NCT01149057|38100668|FG000|Overall Study|Participant Non-Compliance|2|||
16957645|NCT01149057|38100668|FG000|Overall Study|Lost to Follow-up|1|||
16957646|NCT01149057|38100668|FG000|Overall Study|High Parathyroid Hormone Value|1|||
16957647|NCT01149057|38100668|FG000|Overall Study|Other|6|||
16957648|NCT01227564|38100675|FG000|Overall Study|No Longer Willing to Participate|4|||
16957649|NCT01227564|38100676|FG001|Overall Study|No Longer Willing to Participate|2|||
16957650|NCT01227564|38100677|FG002|Overall Study|No Longer Willing to Participate|5|||
16957651|NCT01227564|38100675|FG000|Overall Study|Participant moved to another town|0|||
16957652|NCT01227564|38100676|FG001|Overall Study|Participant moved to another town|0|||
16957653|NCT01227564|38100677|FG002|Overall Study|Participant moved to another town|1|||
16957654|NCT01148979|38100693|FG000|Overall Study|Lost to Follow-up|0|||
16957655|NCT01148979|38100694|FG001|Overall Study|Lost to Follow-up|1|||
16957656|NCT01148511|38100702|FG000|Exposed to Study Drug|Protocol Violation|2|||
16957657|NCT01148511|38100703|FG001|Exposed to Study Drug|Protocol Violation|0|||
16957658|NCT01148511|38100704|FG002|Exposed to Study Drug|Protocol Violation|0|||
16957659|NCT01148511|38100702|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
16957660|NCT01148511|38100703|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
16957661|NCT01148511|38100704|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
16957662|NCT01148511|38100702|FG000|Randomized|Adverse Event|0|||
16957663|NCT01148511|38100703|FG001|Randomized|Adverse Event|1|||
16957664|NCT01148511|38100704|FG002|Randomized|Adverse Event|0|||
16957665|NCT01148511|38100702|FG000|Randomized|Protocol Violation|0|||
16957666|NCT01148511|38100703|FG001|Randomized|Protocol Violation|2|||
16957667|NCT01148511|38100704|FG002|Randomized|Protocol Violation|1|||
16957668|NCT01148511|38100702|FG000|Randomized|Lost to Follow-up|0|||
16957669|NCT01148511|38100703|FG001|Randomized|Lost to Follow-up|1|||
16957670|NCT01148511|38100704|FG002|Randomized|Lost to Follow-up|1|||
16957671|NCT01148511|38100702|FG000|Randomized|Consent withdrawal|0|||
16957672|NCT01148511|38100703|FG001|Randomized|Consent withdrawal|5|||
16957673|NCT01148511|38100704|FG002|Randomized|Consent withdrawal|3|||
16957674|NCT01148511|38100702|FG000|Randomized|Other|0|||
16957675|NCT01148511|38100703|FG001|Randomized|Other|1|||
16957676|NCT01148511|38100704|FG002|Randomized|Other|1|||
16957677|NCT00547339|38100715|FG000|Overall Study|Physician Decision|0|||
16957678|NCT00547339|38100716|FG001|Overall Study|Physician Decision|0|||
16957679|NCT00547339|38100717|FG002|Overall Study|Physician Decision|1|||
16957680|NCT00547339|38100718|FG003|Overall Study|Physician Decision|0|||
16957681|NCT01227252|38100741|FG000|Overall Study|Sponsor Decision|0|||
16957682|NCT01227252|38100742|FG001|Overall Study|Sponsor Decision|1|||
16957683|NCT01227252|38100743|FG002|Overall Study|Sponsor Decision|0|||
16957684|NCT01227252|38100744|FG003|Overall Study|Sponsor Decision|0|||
16957685|NCT01227252|38100741|FG000|Overall Study|Lost to Follow-up|0|||
16957686|NCT01227252|38100742|FG001|Overall Study|Lost to Follow-up|1|||
16957687|NCT01227252|38100743|FG002|Overall Study|Lost to Follow-up|0|||
16957688|NCT01227252|38100744|FG003|Overall Study|Lost to Follow-up|0|||
16957689|NCT01227252|38100741|FG000|Overall Study|Withdrawal by Subject|0|||
16957690|NCT01227252|38100742|FG001|Overall Study|Withdrawal by Subject|1|||
16957691|NCT01227252|38100743|FG002|Overall Study|Withdrawal by Subject|0|||
16957692|NCT01227252|38100744|FG003|Overall Study|Withdrawal by Subject|0|||
16957693|NCT01661881|38100757|FG000|Overall Study|Disease Progression|1|||
16957694|NCT01227018|38100761|FG000|Overall Study|Disease progression|9|||
16957695|NCT01227018|38100761|FG000|Overall Study|Toxicity|2|||
16957696|NCT01227018|38100761|FG000|Overall Study|Withdrew after beginning treatment|4|||
16957697|NCT01226472|38100775|FG000|Overall Study|Progressive Disease|1|||
16957698|NCT01225146|38100781|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
16957699|NCT01225146|38100782|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
16957700|NCT01223196|38100792|FG000|Overall Study|Lost to Follow-up|2|||
16957701|NCT01223196|38100793|FG001|Overall Study|Lost to Follow-up|0|||
16957702|NCT01223196|38100792|FG000|Overall Study|Physician Decision|1|||
16957703|NCT01223196|38100793|FG001|Overall Study|Physician Decision|0|||
16957704|NCT01223196|38100792|FG000|Overall Study|Withdrawal by Subject|1|||
16957705|NCT01223196|38100793|FG001|Overall Study|Withdrawal by Subject|0|||
16957706|NCT01222416|38100803|FG000|Overall Study|ineligible;metastasis|3|||
16957707|NCT01222416|38100804|FG001|Overall Study|ineligible;metastasis|0|||
16957708|NCT01222416|38100803|FG000|Overall Study|Adverse Event|4|||
16957709|NCT01222416|38100804|FG001|Overall Study|Adverse Event|0|||
16957710|NCT01222416|38100803|FG000|Overall Study|Withdrawal by Subject|5|||
16957711|NCT01222416|38100804|FG001|Overall Study|Withdrawal by Subject|0|||
16957712|NCT01222416|38100803|FG000|Overall Study|scheduling|6|||
16957713|NCT01222416|38100804|FG001|Overall Study|scheduling|0|||
16957714|NCT01222416|38100803|FG000|Overall Study|missed view/scan|1|||
16957715|NCT01222416|38100804|FG001|Overall Study|missed view/scan|0|||
16957716|NCT01222416|38100803|FG000|Overall Study|Death|1|||
16957717|NCT01222416|38100804|FG001|Overall Study|Death|0|||
16957718|NCT01222104|38100810|FG000|Overall Study|Lost to Follow-up|37|||
16957719|NCT01222104|38100810|FG000|Overall Study|Death|10|||
16957720|NCT01221948|38100820|FG000|Overall Study|Physician Decision|5|||
16957721|NCT01221948|38100820|FG000|Overall Study|Withdrawal by Subject|2|||
16957722|NCT01221948|38100820|FG000|Overall Study|not disclosed|2|||
16957723|NCT01221948|38100820|FG000|Overall Study|Death|1|||
16957724|NCT01221948|38100820|FG000|Overall Study|Protocol Violation|4|||
16957725|NCT01221090|38100828|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
16957726|NCT01221090|38100829|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
16957727|NCT01221090|38100830|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
16957728|NCT01221090|38100831|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
16957729|NCT01221090|38100828|FG000|Overall Study|Withdrawal by Subject|0|||
16957730|NCT01221090|38100829|FG001|Overall Study|Withdrawal by Subject|22|||
16957731|NCT01221090|38100830|FG002|Overall Study|Withdrawal by Subject|27|||
16957732|NCT01221090|38100831|FG003|Overall Study|Withdrawal by Subject|2|||
16957733|NCT00950911|38100843|FG000|Overall Study|Adverse Event|0|||
16957734|NCT00950911|38100844|FG001|Overall Study|Adverse Event|2|||
16957735|NCT00950911|38100843|FG000|Overall Study|Death|4|||
16957736|NCT00950911|38100844|FG001|Overall Study|Death|6|||
16957737|NCT00950911|38100843|FG000|Overall Study|Disease progression|2|||
16957738|NCT00950911|38100844|FG001|Overall Study|Disease progression|2|||
16957739|NCT00950911|38100843|FG000|Overall Study|Consent withdrawn|1|||
16957740|NCT00950911|38100844|FG001|Overall Study|Consent withdrawn|3|||
16957741|NCT00950911|38100843|FG000|Overall Study|Administrative decision|3|||
16957742|NCT00950911|38100844|FG001|Overall Study|Administrative decision|1|||
16957743|NCT00950911|38100843|FG000|Overall Study|Ineligibility determined|1|||
16957744|NCT00950911|38100844|FG001|Overall Study|Ineligibility determined|0|||
16957745|NCT00950911|38100843|FG000|Overall Study|Noncompliance|1|||
16957746|NCT00950911|38100844|FG001|Overall Study|Noncompliance|0|||
16957747|NCT00950911|38100843|FG000|Overall Study|Poor performance status|0|||
16957748|NCT00950911|38100844|FG001|Overall Study|Poor performance status|1|||
16957749|NCT01220856|38100852|FG000|Overall Study|graft loss|3|||
16957750|NCT01220856|38100853|FG001|Overall Study|graft loss|3|||
16957751|NCT01220856|38100852|FG000|Overall Study|Lost to Follow-up|1|||
16957752|NCT01220856|38100853|FG001|Overall Study|Lost to Follow-up|0|||
16957753|NCT01218594|38100862|FG000|Overall Study|Death|1|||
16957754|NCT01218594|38100862|FG000|Overall Study|Withdrawal by Subject|3|||
16957755|NCT01218594|38100862|FG000|Overall Study|Adverse Event|2|||
16957756|NCT01218594|38100862|FG000|Overall Study|Physician Decision|6|||
16957757|NCT01610557|38100870|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
16957758|NCT01610557|38100871|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
16957759|NCT01610557|38100872|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
16957760|NCT01610557|38100873|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
17133842|NCT00048581|38275151|FG002|Double-Blind Period|Withdrawal by Subject|0|||
17133843|NCT00048581|38275149|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
17133844|NCT00048581|38275150|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
17133845|NCT00048581|38275151|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
17133846|NCT00048581|38275149|FG000|Double-Blind Period|Investigator Decision|1|||
16957761|NCT01610557|38100874|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
16957762|NCT01610557|38100870|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
16957763|NCT01610557|38100871|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
16957764|NCT01610557|38100872|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
16957765|NCT01610557|38100873|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
16957766|NCT01610557|38100874|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
16957767|NCT00943735|38100885|FG000|Overall Study|Adverse Event|12|||
16957768|NCT00943735|38100885|FG000|Overall Study|Withdrawal by Subject|8|||
16957769|NCT00943735|38100885|FG000|Overall Study|Death|1|||
16957770|NCT00943735|38100885|FG000|Overall Study|Other|8|||
16957771|NCT00943735|38100885|FG000|Overall Study|Other|3|||
16957772|NCT00943579|38100891|FG000|Overall Study|Adverse Event|4|||
16957773|NCT00943579|38100892|FG001|Overall Study|Adverse Event|3|||
16957774|NCT00943579|38100891|FG000|Overall Study|Lack of Efficacy|2|||
16957775|NCT00943579|38100892|FG001|Overall Study|Lack of Efficacy|2|||
16957776|NCT00489307|38100903|FG000|Overall Study|Death|1|||
16957777|NCT00489307|38100904|FG001|Overall Study|Death|1|||
16957778|NCT00489307|38100903|FG000|Overall Study|Lost to Follow-up|2|||
16957779|NCT00489307|38100904|FG001|Overall Study|Lost to Follow-up|2|||
16957780|NCT00489307|38100903|FG000|Overall Study|Physician Decision|1|||
16957781|NCT00489307|38100904|FG001|Overall Study|Physician Decision|0|||
16957782|NCT00489307|38100903|FG000|Overall Study|Withdrawal by Subject|2|||
16957783|NCT00489307|38100904|FG001|Overall Study|Withdrawal by Subject|4|||
16957784|NCT00489307|38100903|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
16957785|NCT00489307|38100904|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
16957786|NCT00489307|38100903|FG000|Overall Study|Surgery after assignment|1|||
16957787|NCT00489307|38100904|FG001|Overall Study|Surgery after assignment|0|||
16957788|NCT00489307|38100903|FG000|Overall Study|Did not fill up the forms|2|||
16957789|NCT00489307|38100904|FG001|Overall Study|Did not fill up the forms|1|||
16957790|NCT00489307|38100903|FG000|Overall Study|Patient or family refusal|5|||
16957791|NCT00489307|38100904|FG001|Overall Study|Patient or family refusal|9|||
16957792|NCT01147809|38100916|FG000|Phase I (168 Days)|Adverse Event|0|||
16957793|NCT01147809|38100917|FG001|Phase I (168 Days)|Adverse Event|0|||
16957794|NCT01147809|38100918|FG002|Phase I (168 Days)|Adverse Event|0|||
16957795|NCT01147809|38100919|FG003|Phase I (168 Days)|Adverse Event|1|||
16957796|NCT01147809|38100920|FG004|Phase I (168 Days)|Adverse Event|0|||
16957797|NCT01147809|38100921|FG005|Phase I (168 Days)|Adverse Event|0|||
16957798|NCT01147809|38100916|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
16957799|NCT01147809|38100917|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
16957800|NCT01147809|38100918|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
16957801|NCT01147809|38100919|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
16957802|NCT01147809|38100920|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
16957803|NCT01147809|38100921|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
16957804|NCT01147809|38100916|FG000|Phase I (168 Days)|Physician Decision|0|||
16957805|NCT01147809|38100917|FG001|Phase I (168 Days)|Physician Decision|1|||
16957806|NCT01147809|38100918|FG002|Phase I (168 Days)|Physician Decision|2|||
16957807|NCT01147809|38100919|FG003|Phase I (168 Days)|Physician Decision|0|||
16957808|NCT01147809|38100920|FG004|Phase I (168 Days)|Physician Decision|0|||
16957809|NCT01147809|38100921|FG005|Phase I (168 Days)|Physician Decision|0|||
16957810|NCT01147809|38100916|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
16957811|NCT01147809|38100917|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
16957812|NCT01147809|38100918|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
16957813|NCT01147809|38100919|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
16957814|NCT01147809|38100920|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
16957815|NCT01147809|38100921|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
16957816|NCT01147809|38100916|FG000|Phase II (168 Days)|Adverse Event|0|||
16957817|NCT01147809|38100917|FG001|Phase II (168 Days)|Adverse Event|0|||
16957818|NCT01147809|38100918|FG002|Phase II (168 Days)|Adverse Event|0|||
16957819|NCT01147809|38100919|FG003|Phase II (168 Days)|Adverse Event|0|||
16957820|NCT01147809|38100920|FG004|Phase II (168 Days)|Adverse Event|3|||
16957821|NCT01147809|38100921|FG005|Phase II (168 Days)|Adverse Event|6|||
16957822|NCT01147809|38100916|FG000|Phase II (168 Days)|Protocol Violation|0|||
16957823|NCT01147809|38100917|FG001|Phase II (168 Days)|Protocol Violation|0|||
16957824|NCT01147809|38100918|FG002|Phase II (168 Days)|Protocol Violation|0|||
16957825|NCT01147809|38100919|FG003|Phase II (168 Days)|Protocol Violation|0|||
16957826|NCT01147809|38100920|FG004|Phase II (168 Days)|Protocol Violation|0|||
16957827|NCT01147809|38100921|FG005|Phase II (168 Days)|Protocol Violation|1|||
16957828|NCT01147809|38100916|FG000|Phase II (168 Days)|Physician Decision|0|||
16957829|NCT01147809|38100917|FG001|Phase II (168 Days)|Physician Decision|0|||
16957830|NCT01147809|38100918|FG002|Phase II (168 Days)|Physician Decision|0|||
16957831|NCT01147809|38100919|FG003|Phase II (168 Days)|Physician Decision|0|||
16957832|NCT01147809|38100920|FG004|Phase II (168 Days)|Physician Decision|5|||
16957833|NCT01147809|38100921|FG005|Phase II (168 Days)|Physician Decision|11|||
16957834|NCT01147809|38100916|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
16957835|NCT01147809|38100917|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
16957836|NCT01147809|38100918|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
16957837|NCT01147809|38100919|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
16957838|NCT01147809|38100920|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
16957839|NCT01147809|38100921|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
16957840|NCT01147809|38100916|FG000|Phase II (168 Days)|Ongoing|0|||
16957841|NCT01147809|38100917|FG001|Phase II (168 Days)|Ongoing|0|||
16957842|NCT01147809|38100918|FG002|Phase II (168 Days)|Ongoing|0|||
16957843|NCT01147809|38100919|FG003|Phase II (168 Days)|Ongoing|0|||
16957844|NCT01147809|38100920|FG004|Phase II (168 Days)|Ongoing|1|||
16957845|NCT01147809|38100921|FG005|Phase II (168 Days)|Ongoing|0|||
16957846|NCT00943111|38100938|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
16957847|NCT00943111|38100939|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
16957848|NCT00943111|38100940|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
16957849|NCT00943111|38100938|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
16957850|NCT00943111|38100939|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
16957851|NCT00943111|38100940|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
16957852|NCT00943111|38100938|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
16957853|NCT00943111|38100939|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
16957854|NCT00943111|38100940|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
16957855|NCT00943111|38100938|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
16957856|NCT00943111|38100939|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
16957857|NCT00943111|38100940|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
16957858|NCT00943111|38100938|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
16957859|NCT00943111|38100939|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
16957860|NCT00943111|38100940|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
16957861|NCT00943111|38100938|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
16957862|NCT00943111|38100939|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
16957863|NCT00943111|38100940|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
16957864|NCT00943111|38100938|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
16957865|NCT00943111|38100939|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
16957866|NCT00943111|38100940|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
16957867|NCT00943111|38100938|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
16957868|NCT00943111|38100939|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
16957869|NCT00943111|38100940|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
16957870|NCT01147497|38100949|FG000|Overall Study|failed insertion|2|||
16957871|NCT01147497|38100950|FG001|Overall Study|failed insertion|0|||
16957872|NCT01147341|38100958|FG000|Double Blind Period|Lack of Efficacy|1|||
16957873|NCT01147341|38100959|FG001|Double Blind Period|Lack of Efficacy|1|||
16957874|NCT01147341|38100958|FG000|Double Blind Period|Withdrawal by Subject|0|||
16957875|NCT01147341|38100959|FG001|Double Blind Period|Withdrawal by Subject|1|||
16957876|NCT01147341|38100958|FG000|Open Label Period|Lack of Efficacy|3|||
16957877|NCT01147341|38100959|FG001|Open Label Period|Lack of Efficacy|0|||
16957878|NCT01147341|38100958|FG000|Open Label Period|Subject moved|1|||
16957879|NCT01147341|38100959|FG001|Open Label Period|Subject moved|0|||
16957880|NCT00950755|38100965|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
16957881|NCT00950755|38100965|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
16957882|NCT00950755|38100965|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
16957883|NCT00950755|38100965|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
16957884|NCT00950755|38100965|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
16957885|NCT00950755|38100965|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
16957886|NCT00950755|38100965|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
16957887|NCT00950755|38100965|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
16957888|NCT00950755|38100965|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
16957889|NCT00950755|38100965|FG000|Long-Term Follow-Up|Death|8|||
16957890|NCT01147107|38100971|FG000|Overall Study|Lack of Efficacy|5|||
16957891|NCT01147107|38100972|FG001|Overall Study|Lack of Efficacy|0|||
16957892|NCT01147107|38100971|FG000|Overall Study|Withdrawal by Subject|1|||
16957893|NCT01147107|38100972|FG001|Overall Study|Withdrawal by Subject|1|||
16957894|NCT00942409|38100978|FG000|Overall Study|Lack of Efficacy|1|||
16957895|NCT00942409|38100978|FG000|Overall Study|study drug unavailable|2|||
16957896|NCT01146951|38100984|FG000|Overall Study|Adverse Event|4|||
16957897|NCT01146951|38100985|FG001|Overall Study|Adverse Event|1|||
16957898|NCT01146873|38100993|FG000|Overall Study|Transfer out|0|||
16957899|NCT01146873|38100994|FG001|Overall Study|Transfer out|6|||
16957900|NCT01146795|38101000|FG000|Overall Study|Withdrawal by Subject|4|||
16957901|NCT01146795|38101000|FG000|Overall Study|Adverse Event|6|||
16957902|NCT01146795|38101000|FG000|Overall Study|Still in treatment at study closure|10|||
16957903|NCT01146561|38101004|FG000|Overall Study|Withdrawal by Subject|1|||
16957904|NCT01146561|38101004|FG000|Overall Study|Lost to Follow-up|1|||
16957905|NCT00942175|38101012|FG000|Overall Study|Adverse Event|2|||
16957906|NCT00942175|38101013|FG001|Overall Study|Adverse Event|1|||
16957907|NCT00942175|38101014|FG002|Overall Study|Adverse Event|0|||
16957908|NCT00942175|38101015|FG003|Overall Study|Adverse Event|0|||
16957909|NCT00942175|38101012|FG000|Overall Study|Protocol Violation|0|||
16957910|NCT00942175|38101013|FG001|Overall Study|Protocol Violation|1|||
16957911|NCT00942175|38101014|FG002|Overall Study|Protocol Violation|2|||
16957912|NCT00942175|38101015|FG003|Overall Study|Protocol Violation|0|||
16957913|NCT00942175|38101012|FG000|Overall Study|Pregnancy|0|||
16957914|NCT00942175|38101013|FG001|Overall Study|Pregnancy|0|||
17133847|NCT00048581|38275150|FG001|Double-Blind Period|Investigator Decision|0|||
17133848|NCT00048581|38275151|FG002|Double-Blind Period|Investigator Decision|0|||
17133849|NCT00048581|38275149|FG000|Open-Label Period|Death|0|||
17133850|NCT00048581|38275150|FG001|Open-Label Period|Death|0|||
16957915|NCT00942175|38101014|FG002|Overall Study|Pregnancy|0|||
16957916|NCT00942175|38101015|FG003|Overall Study|Pregnancy|1|||
16957917|NCT00942175|38101012|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
16957918|NCT00942175|38101013|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
16774412|NCT03470441|37713771|FG000|Overall Study|Withdrawal by Subject|1|||
16957919|NCT00942175|38101014|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
16957920|NCT00942175|38101015|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
16957921|NCT00942175|38101012|FG000|Overall Study|Low Platelet Count|0|||
16957922|NCT00942175|38101013|FG001|Overall Study|Low Platelet Count|2|||
16957923|NCT00942175|38101014|FG002|Overall Study|Low Platelet Count|0|||
16957924|NCT00942175|38101015|FG003|Overall Study|Low Platelet Count|0|||
16957925|NCT01145625|38101035|FG000|Overall Study|Lost to Follow-up|8|||
16957926|NCT01145625|38101036|FG001|Overall Study|Lost to Follow-up|9|||
16957927|NCT01145625|38101035|FG000|Overall Study|Adverse Event|6|||
16957928|NCT01145625|38101036|FG001|Overall Study|Adverse Event|4|||
16957929|NCT01145625|38101035|FG000|Overall Study|Protocol Violation|3|||
16957930|NCT01145625|38101036|FG001|Overall Study|Protocol Violation|1|||
16957931|NCT01145625|38101035|FG000|Overall Study|Withdrawal by Subject|7|||
16957932|NCT01145625|38101036|FG001|Overall Study|Withdrawal by Subject|16|||
16957933|NCT01145625|38101035|FG000|Overall Study|Pregnancy|0|||
16957934|NCT01145625|38101036|FG001|Overall Study|Pregnancy|1|||
16957935|NCT01144377|38101047|FG000|52 Week Treatment Period|Adverse Event|0|||
16957936|NCT01144377|38101048|FG001|52 Week Treatment Period|Adverse Event|0|||
16957937|NCT01144377|38101049|FG002|52 Week Treatment Period|Adverse Event|3|||
16957938|NCT01144377|38101050|FG003|52 Week Treatment Period|Adverse Event|2|||
16957939|NCT01144377|38101051|FG004|52 Week Treatment Period|Adverse Event|1|||
16957940|NCT01144377|38101047|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
16957941|NCT01144377|38101048|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
16957942|NCT01144377|38101049|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
16957943|NCT01144377|38101050|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
16957944|NCT01144377|38101051|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
16957945|NCT01144377|38101047|FG000|52 Week Treatment Period|Protocol Violation|0|||
16957946|NCT01144377|38101048|FG001|52 Week Treatment Period|Protocol Violation|0|||
16957947|NCT01144377|38101049|FG002|52 Week Treatment Period|Protocol Violation|0|||
16957948|NCT01144377|38101050|FG003|52 Week Treatment Period|Protocol Violation|0|||
16957949|NCT01144377|38101051|FG004|52 Week Treatment Period|Protocol Violation|1|||
16957950|NCT01144377|38101047|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
16957951|NCT01144377|38101048|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
16957952|NCT01144377|38101049|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
16957953|NCT01144377|38101050|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
16957954|NCT01144377|38101051|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
16957955|NCT01144377|38101047|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
16957956|NCT01144377|38101048|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
16957957|NCT01144377|38101049|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
16957958|NCT01144377|38101050|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
16957959|NCT01144377|38101051|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
16957960|NCT01144377|38101047|FG000|52 Week Treatment Period|Sponsor Decision|0|||
16957961|NCT01144377|38101048|FG001|52 Week Treatment Period|Sponsor Decision|0|||
16957962|NCT01144377|38101049|FG002|52 Week Treatment Period|Sponsor Decision|0|||
16957963|NCT01144377|38101050|FG003|52 Week Treatment Period|Sponsor Decision|0|||
16957964|NCT01144377|38101051|FG004|52 Week Treatment Period|Sponsor Decision|1|||
16957965|NCT01144377|38101047|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
16957966|NCT01144377|38101048|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
16957967|NCT01144377|38101049|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
16957968|NCT01144377|38101050|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
16957969|NCT01144377|38101051|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
16957970|NCT01144377|38101047|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
16957971|NCT01144377|38101048|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
16957972|NCT01144377|38101049|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
16957973|NCT01144377|38101050|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
16774413|NCT03470441|37713772|FG001|Overall Study|Withdrawal by Subject|4|||
16774414|NCT03470441|37713773|FG002|Overall Study|Withdrawal by Subject|1|||
16957974|NCT01144377|38101051|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
16957975|NCT01144377|38101047|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
16957976|NCT01144377|38101048|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
16957977|NCT01144377|38101049|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
16957978|NCT01144377|38101050|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
16957979|NCT01144377|38101051|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
16957980|NCT00950599|38101073|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957981|NCT00950599|38101074|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957982|NCT00950599|38101075|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957983|NCT00950599|38101076|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
16957984|NCT00950599|38101077|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957985|NCT00950599|38101078|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957986|NCT00950599|38101079|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957987|NCT00950599|38101080|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957988|NCT00950599|38101081|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957989|NCT00950599|38101082|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16957990|NCT00950599|38101073|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16957991|NCT00950599|38101074|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16957992|NCT00950599|38101075|FG002|Double-Blind Treatment Period|Adverse Event|1|||
16957993|NCT00950599|38101076|FG003|Double-Blind Treatment Period|Adverse Event|1|||
16957994|NCT00950599|38101077|FG004|Double-Blind Treatment Period|Adverse Event|1|||
16957995|NCT00950599|38101078|FG005|Double-Blind Treatment Period|Adverse Event|1|||
16957996|NCT00950599|38101079|FG006|Double-Blind Treatment Period|Adverse Event|0|||
16957997|NCT00950599|38101080|FG007|Double-Blind Treatment Period|Adverse Event|0|||
16957998|NCT00950599|38101081|FG008|Double-Blind Treatment Period|Adverse Event|0|||
16957999|NCT00950599|38101082|FG009|Double-Blind Treatment Period|Adverse Event|0|||
16958000|NCT00950599|38101073|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
16958001|NCT00950599|38101074|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
16958002|NCT00950599|38101075|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
16958003|NCT00950599|38101076|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
16958004|NCT00950599|38101077|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
16958005|NCT00950599|38101078|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
16958006|NCT00950599|38101079|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
16958007|NCT00950599|38101080|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
16958008|NCT00950599|38101081|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
16958009|NCT00950599|38101082|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
16958010|NCT00950599|38101073|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16958011|NCT00950599|38101074|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
16958012|NCT00950599|38101075|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
16958013|NCT00950599|38101076|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
16958014|NCT00950599|38101077|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
16958015|NCT00950599|38101078|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
16958016|NCT00950599|38101079|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
16958017|NCT00950599|38101080|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
16958018|NCT00950599|38101081|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
16958019|NCT00950599|38101082|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
16958020|NCT00950599|38101073|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
16958021|NCT00950599|38101074|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
16958022|NCT00950599|38101075|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16958023|NCT00950599|38101076|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16958024|NCT00950599|38101077|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16958025|NCT00950599|38101078|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16958026|NCT00950599|38101079|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16958027|NCT00950599|38101080|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
16958028|NCT00950599|38101081|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16958029|NCT00950599|38101082|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16958030|NCT00950599|38101073|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16958031|NCT00950599|38101074|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16958032|NCT00950599|38101075|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16958033|NCT00950599|38101076|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16958034|NCT00950599|38101077|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
16958035|NCT00950599|38101078|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
16958036|NCT00950599|38101079|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16958037|NCT00950599|38101080|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16774415|NCT03470441|37713774|FG003|Overall Study|Withdrawal by Subject|3|||
16774416|NCT03361865|37713786|FG000|Overall Study|Death|17|||
16774417|NCT03361865|37713787|FG001|Overall Study|Death|18|||
16774418|NCT03361865|37713786|FG000|Overall Study|Physician Decision|1|||
16774419|NCT03361865|37713787|FG001|Overall Study|Physician Decision|9|||
16774420|NCT03361865|37713786|FG000|Overall Study|Withdrawal by Subject|1|||
16774421|NCT03361865|37713787|FG001|Overall Study|Withdrawal by Subject|0|||
16774422|NCT02149121|37713801|FG000|Main Study Period|Lack of Efficacy|2|||
16774423|NCT02149121|37713802|FG001|Main Study Period|Lack of Efficacy|2|||
16774424|NCT02149121|37713803|FG002|Main Study Period|Lack of Efficacy|1|||
16774425|NCT02149121|37713804|FG003|Main Study Period|Lack of Efficacy|0|||
16774426|NCT02149121|37713805|FG004|Main Study Period|Lack of Efficacy|0|||
16774427|NCT02149121|37713806|FG005|Main Study Period|Lack of Efficacy|0|||
16774428|NCT02149121|37713807|FG006|Main Study Period|Lack of Efficacy|0|||
16774429|NCT02149121|37713801|FG000|Main Study Period|Withdrawal by Subject|9|||
16774430|NCT02149121|37713802|FG001|Main Study Period|Withdrawal by Subject|5|||
16774431|NCT02149121|37713803|FG002|Main Study Period|Withdrawal by Subject|1|||
16774432|NCT02149121|37713804|FG003|Main Study Period|Withdrawal by Subject|0|||
16774433|NCT02149121|37713805|FG004|Main Study Period|Withdrawal by Subject|0|||
16774434|NCT02149121|37713806|FG005|Main Study Period|Withdrawal by Subject|0|||
16774435|NCT02149121|37713807|FG006|Main Study Period|Withdrawal by Subject|0|||
16774436|NCT02149121|37713801|FG000|Main Study Period|Adverse Event|2|||
16774437|NCT02149121|37713802|FG001|Main Study Period|Adverse Event|5|||
16774438|NCT02149121|37713803|FG002|Main Study Period|Adverse Event|1|||
16774439|NCT02149121|37713804|FG003|Main Study Period|Adverse Event|0|||
16774440|NCT02149121|37713805|FG004|Main Study Period|Adverse Event|0|||
16774441|NCT02149121|37713806|FG005|Main Study Period|Adverse Event|0|||
16774442|NCT02149121|37713807|FG006|Main Study Period|Adverse Event|0|||
16774443|NCT02149121|37713801|FG000|Main Study Period|Protocol Violation|2|||
16774444|NCT02149121|37713802|FG001|Main Study Period|Protocol Violation|0|||
16774445|NCT02149121|37713803|FG002|Main Study Period|Protocol Violation|0|||
16774446|NCT02149121|37713804|FG003|Main Study Period|Protocol Violation|0|||
16774447|NCT02149121|37713805|FG004|Main Study Period|Protocol Violation|0|||
16774448|NCT02149121|37713806|FG005|Main Study Period|Protocol Violation|0|||
16774449|NCT02149121|37713807|FG006|Main Study Period|Protocol Violation|0|||
16774450|NCT02149121|37713801|FG000|Main Study Period|Lost to Follow-up|2|||
16774451|NCT02149121|37713802|FG001|Main Study Period|Lost to Follow-up|1|||
16774452|NCT02149121|37713803|FG002|Main Study Period|Lost to Follow-up|0|||
16774453|NCT02149121|37713804|FG003|Main Study Period|Lost to Follow-up|0|||
16774454|NCT02149121|37713805|FG004|Main Study Period|Lost to Follow-up|0|||
16774455|NCT02149121|37713806|FG005|Main Study Period|Lost to Follow-up|0|||
16774456|NCT02149121|37713807|FG006|Main Study Period|Lost to Follow-up|0|||
16774457|NCT02149121|37713801|FG000|Main Study Period|Death|1|||
16774458|NCT02149121|37713802|FG001|Main Study Period|Death|0|||
16774459|NCT02149121|37713803|FG002|Main Study Period|Death|0|||
16774460|NCT02149121|37713804|FG003|Main Study Period|Death|0|||
16774461|NCT02149121|37713805|FG004|Main Study Period|Death|0|||
16774462|NCT02149121|37713806|FG005|Main Study Period|Death|0|||
16774463|NCT02149121|37713807|FG006|Main Study Period|Death|0|||
16774464|NCT02149121|37713801|FG000|Main Study Period|Physician Decision|1|||
16774465|NCT02149121|37713802|FG001|Main Study Period|Physician Decision|0|||
16774466|NCT02149121|37713803|FG002|Main Study Period|Physician Decision|0|||
16774467|NCT02149121|37713804|FG003|Main Study Period|Physician Decision|0|||
16774468|NCT02149121|37713805|FG004|Main Study Period|Physician Decision|0|||
16774469|NCT02149121|37713806|FG005|Main Study Period|Physician Decision|0|||
16774470|NCT02149121|37713807|FG006|Main Study Period|Physician Decision|0|||
16774471|NCT02149121|37713801|FG000|Main Study Period|Developed any malignancy|0|||
16774472|NCT02149121|37713802|FG001|Main Study Period|Developed any malignancy|1|||
16774473|NCT02149121|37713803|FG002|Main Study Period|Developed any malignancy|1|||
16774474|NCT02149121|37713804|FG003|Main Study Period|Developed any malignancy|0|||
16774475|NCT02149121|37713805|FG004|Main Study Period|Developed any malignancy|0|||
16774476|NCT02149121|37713806|FG005|Main Study Period|Developed any malignancy|0|||
16774477|NCT02149121|37713807|FG006|Main Study Period|Developed any malignancy|0|||
16774478|NCT02149121|37713801|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
16774479|NCT02149121|37713802|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
16774480|NCT02149121|37713803|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
16774481|NCT02149121|37713804|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
16774482|NCT02149121|37713805|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
16774483|NCT02149121|37713806|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
16774484|NCT02149121|37713807|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
16774485|NCT02149121|37713801|FG000|Main Study Period|Disease progression|0|||
16774486|NCT02149121|37713802|FG001|Main Study Period|Disease progression|1|||
16774487|NCT02149121|37713803|FG002|Main Study Period|Disease progression|0|||
16774488|NCT02149121|37713804|FG003|Main Study Period|Disease progression|0|||
16774489|NCT02149121|37713805|FG004|Main Study Period|Disease progression|0|||
16774490|NCT02149121|37713806|FG005|Main Study Period|Disease progression|0|||
16774491|NCT02149121|37713807|FG006|Main Study Period|Disease progression|0|||
16774492|NCT02149121|37713801|FG000|Extension Study Period|Withdrawal by Subject|0|||
16774493|NCT02149121|37713802|FG001|Extension Study Period|Withdrawal by Subject|0|||
16774494|NCT02149121|37713803|FG002|Extension Study Period|Withdrawal by Subject|0|||
16774495|NCT02149121|37713804|FG003|Extension Study Period|Withdrawal by Subject|1|||
16774496|NCT02149121|37713805|FG004|Extension Study Period|Withdrawal by Subject|0|||
16774497|NCT02149121|37713806|FG005|Extension Study Period|Withdrawal by Subject|2|||
16774498|NCT02149121|37713807|FG006|Extension Study Period|Withdrawal by Subject|0|||
16774499|NCT01865617|37713859|FG000|Overall Study|Death|27|||
16774500|NCT01865617|37713860|FG001|Overall Study|Death|3|||
16774501|NCT01865617|37713861|FG002|Overall Study|Death|1|||
16774502|NCT01865617|37713862|FG003|Overall Study|Death|1|||
16774503|NCT01865617|37713863|FG004|Overall Study|Death|5|||
16774504|NCT01865617|37713864|FG005|Overall Study|Death|1|||
16774505|NCT01865617|37713865|FG006|Overall Study|Death|11|||
16774506|NCT01865617|37713866|FG007|Overall Study|Death|1|||
16774507|NCT01865617|37713867|FG008|Overall Study|Death|11|||
16774508|NCT01865617|37713868|FG009|Overall Study|Death|3|||
16774509|NCT01865617|37713869|FG010|Overall Study|Death|32|||
16774510|NCT01865617|37713870|FG011|Overall Study|Death|6|||
16774511|NCT01865617|37713871|FG012|Overall Study|Death|13|||
16774512|NCT01865617|37713859|FG000|Overall Study|Lost to Follow-up|2|||
16774513|NCT01865617|37713860|FG001|Overall Study|Lost to Follow-up|0|||
16774514|NCT01865617|37713861|FG002|Overall Study|Lost to Follow-up|0|||
16774515|NCT01865617|37713862|FG003|Overall Study|Lost to Follow-up|0|||
16774516|NCT01865617|37713863|FG004|Overall Study|Lost to Follow-up|0|||
16774517|NCT01865617|37713864|FG005|Overall Study|Lost to Follow-up|0|||
16774518|NCT01865617|37713865|FG006|Overall Study|Lost to Follow-up|0|||
16774519|NCT01865617|37713866|FG007|Overall Study|Lost to Follow-up|0|||
16774520|NCT01865617|37713867|FG008|Overall Study|Lost to Follow-up|0|||
16774521|NCT01865617|37713868|FG009|Overall Study|Lost to Follow-up|0|||
16774522|NCT01865617|37713869|FG010|Overall Study|Lost to Follow-up|0|||
16774523|NCT01865617|37713870|FG011|Overall Study|Lost to Follow-up|0|||
16774524|NCT01865617|37713871|FG012|Overall Study|Lost to Follow-up|0|||
16774525|NCT01865617|37713859|FG000|Overall Study|Withdrawal by Subject|1|||
16774526|NCT01865617|37713860|FG001|Overall Study|Withdrawal by Subject|0|||
16774527|NCT01865617|37713861|FG002|Overall Study|Withdrawal by Subject|0|||
16774528|NCT01865617|37713862|FG003|Overall Study|Withdrawal by Subject|0|||
16774529|NCT01865617|37713863|FG004|Overall Study|Withdrawal by Subject|0|||
16774530|NCT01865617|37713864|FG005|Overall Study|Withdrawal by Subject|0|||
16774531|NCT01865617|37713865|FG006|Overall Study|Withdrawal by Subject|0|||
16774532|NCT01865617|37713866|FG007|Overall Study|Withdrawal by Subject|0|||
16774533|NCT01865617|37713867|FG008|Overall Study|Withdrawal by Subject|0|||
16774534|NCT01865617|37713868|FG009|Overall Study|Withdrawal by Subject|0|||
16774535|NCT01865617|37713869|FG010|Overall Study|Withdrawal by Subject|0|||
16774536|NCT01865617|37713870|FG011|Overall Study|Withdrawal by Subject|0|||
16774537|NCT01865617|37713871|FG012|Overall Study|Withdrawal by Subject|0|||
16774538|NCT01865617|37713859|FG000|Overall Study|Patient proceeded to new therapy|0|||
16774539|NCT01865617|37713860|FG001|Overall Study|Patient proceeded to new therapy|0|||
16774540|NCT01865617|37713861|FG002|Overall Study|Patient proceeded to new therapy|0|||
16774541|NCT01865617|37713862|FG003|Overall Study|Patient proceeded to new therapy|0|||
16774542|NCT01865617|37713863|FG004|Overall Study|Patient proceeded to new therapy|2|||
16774543|NCT01865617|37713864|FG005|Overall Study|Patient proceeded to new therapy|0|||
16774544|NCT01865617|37713865|FG006|Overall Study|Patient proceeded to new therapy|0|||
16774545|NCT01865617|37713866|FG007|Overall Study|Patient proceeded to new therapy|0|||
16774546|NCT01865617|37713867|FG008|Overall Study|Patient proceeded to new therapy|0|||
16774547|NCT01865617|37713868|FG009|Overall Study|Patient proceeded to new therapy|0|||
16774548|NCT01865617|37713869|FG010|Overall Study|Patient proceeded to new therapy|0|||
16774549|NCT01865617|37713870|FG011|Overall Study|Patient proceeded to new therapy|0|||
16774550|NCT01865617|37713871|FG012|Overall Study|Patient proceeded to new therapy|0|||
16774551|NCT01865617|37713859|FG000|Overall Study|Other|0|||
16774552|NCT01865617|37713860|FG001|Overall Study|Other|0|||
16774553|NCT01865617|37713861|FG002|Overall Study|Other|0|||
16774554|NCT01865617|37713862|FG003|Overall Study|Other|0|||
16774555|NCT01865617|37713863|FG004|Overall Study|Other|0|||
16774556|NCT01865617|37713864|FG005|Overall Study|Other|0|||
16774557|NCT01865617|37713865|FG006|Overall Study|Other|1|||
16774558|NCT01865617|37713866|FG007|Overall Study|Other|0|||
16958038|NCT00950599|38101081|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16958039|NCT00950599|38101082|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16958040|NCT00950599|38101073|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
16958041|NCT00950599|38101074|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
17133851|NCT00048581|38275151|FG002|Open-Label Period|Death|4|||
17133852|NCT00048581|38275149|FG000|Open-Label Period|Adverse Event|0|||
17133853|NCT00048581|38275150|FG001|Open-Label Period|Adverse Event|0|||
17133854|NCT00048581|38275151|FG002|Open-Label Period|Adverse Event|37|||
17133855|NCT00048581|38275149|FG000|Open-Label Period|Lack of Efficacy|0|||
17133856|NCT00048581|38275150|FG001|Open-Label Period|Lack of Efficacy|0|||
17133857|NCT00048581|38275151|FG002|Open-Label Period|Lack of Efficacy|69|||
17133858|NCT00048581|38275149|FG000|Open-Label Period|Lost to Follow-up|0|||
17133859|NCT00048581|38275150|FG001|Open-Label Period|Lost to Follow-up|0|||
17133860|NCT00048581|38275151|FG002|Open-Label Period|Lost to Follow-up|14|||
17133861|NCT00048581|38275149|FG000|Open-Label Period|Withdrawal by Subject|0|||
17133862|NCT00048581|38275150|FG001|Open-Label Period|Withdrawal by Subject|0|||
17133863|NCT00048581|38275151|FG002|Open-Label Period|Withdrawal by Subject|20|||
17133864|NCT00048581|38275149|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
17133865|NCT00048581|38275150|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
17133866|NCT00048581|38275151|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
17133867|NCT00048581|38275149|FG000|Open-Label Period|Poor/Non-compliance|0|||
17133868|NCT00048581|38275150|FG001|Open-Label Period|Poor/Non-compliance|0|||
17133869|NCT00048581|38275151|FG002|Open-Label Period|Poor/Non-compliance|5|||
17133870|NCT00048581|38275149|FG000|Open-Label Period|Pregnancy|0|||
17133871|NCT00048581|38275150|FG001|Open-Label Period|Pregnancy|0|||
17133872|NCT00048581|38275151|FG002|Open-Label Period|Pregnancy|7|||
17133873|NCT00048581|38275149|FG000|Open-Label Period|Study Site Closure|0|||
17133874|NCT00048581|38275150|FG001|Open-Label Period|Study Site Closure|0|||
17133875|NCT00048581|38275151|FG002|Open-Label Period|Study Site Closure|2|||
16958042|NCT00950599|38101075|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
16958043|NCT00950599|38101076|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
17133876|NCT00048581|38275149|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
17133877|NCT00048581|38275150|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
17133878|NCT00048581|38275151|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
16774559|NCT01865617|37713867|FG008|Overall Study|Other|0|||
16774560|NCT01865617|37713868|FG009|Overall Study|Other|0|||
17133879|NCT00048581|38275149|FG000|Open-Label Period|Problem With Transportation To Site|0|||
17133880|NCT00048581|38275150|FG001|Open-Label Period|Problem With Transportation To Site|0|||
17133881|NCT00048581|38275151|FG002|Open-Label Period|Problem With Transportation To Site|1|||
17133882|NCT00048581|38275149|FG000|Open-Label Period|Primary Investigator Retired|0|||
17133883|NCT00048581|38275150|FG001|Open-Label Period|Primary Investigator Retired|0|||
17133884|NCT00048581|38275151|FG002|Open-Label Period|Primary Investigator Retired|2|||
17133885|NCT00048581|38275149|FG000|Open-Label Period|Study Ended By Sponsor|0|||
17133886|NCT00048581|38275150|FG001|Open-Label Period|Study Ended By Sponsor|0|||
16774561|NCT01865617|37713869|FG010|Overall Study|Other|0|||
16774562|NCT01865617|37713870|FG011|Overall Study|Other|0|||
16774563|NCT01865617|37713871|FG012|Overall Study|Other|0|||
16774564|NCT01328431|37713919|FG000|Baseline|Protocol Violation|0|||
16774565|NCT01328431|37713920|FG001|Baseline|Protocol Violation|2|||
16774566|NCT01328431|37713919|FG000|1 Month (1M)|Lost to Follow-up|55|||
16774567|NCT01328431|37713920|FG001|1 Month (1M)|Lost to Follow-up|58|||
16774568|NCT01328431|37713919|FG000|3 Month (3M)|Death|2|||
16774569|NCT01328431|37713920|FG001|3 Month (3M)|Death|2|||
16774570|NCT01328431|37713919|FG000|3 Month (3M)|Lost to Follow-up|75|||
16774571|NCT01328431|37713920|FG001|3 Month (3M)|Lost to Follow-up|70|||
16774572|NCT01328431|37713919|FG000|12 Month (12M)|Death|2|||
16774573|NCT01328431|37713920|FG001|12 Month (12M)|Death|6|||
16774574|NCT01328431|37713919|FG000|12 Month (12M)|Lost to Follow-up|82|||
16774575|NCT01328431|37713920|FG001|12 Month (12M)|Lost to Follow-up|91|||
16774576|NCT00893789|37713930|FG000|Overall Study|Withdrawal by Subject|3|||
16774577|NCT00893789|37713931|FG001|Overall Study|Withdrawal by Subject|1|||
16774578|NCT00893789|37713932|FG002|Overall Study|Withdrawal by Subject|3|||
16774579|NCT00893789|37713933|FG003|Overall Study|Withdrawal by Subject|1|||
16774580|NCT00893789|37713930|FG000|Overall Study|Noncompliance With Study Drug|1|||
16774581|NCT00893789|37713931|FG001|Overall Study|Noncompliance With Study Drug|0|||
16774582|NCT00893789|37713932|FG002|Overall Study|Noncompliance With Study Drug|1|||
16774583|NCT00893789|37713933|FG003|Overall Study|Noncompliance With Study Drug|2|||
16774584|NCT00893789|37713930|FG000|Overall Study|Noncompliance With Study Procedures|1|||
16774585|NCT00893789|37713931|FG001|Overall Study|Noncompliance With Study Procedures|0|||
16774586|NCT00893789|37713932|FG002|Overall Study|Noncompliance With Study Procedures|0|||
16774587|NCT00893789|37713933|FG003|Overall Study|Noncompliance With Study Procedures|0|||
16774588|NCT00893789|37713930|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
16774589|NCT00893789|37713931|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
16774590|NCT00893789|37713932|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
16774591|NCT00893789|37713933|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
16774592|NCT00893789|37713930|FG000|Overall Study|Adverse Event|0|||
16774593|NCT00893789|37713931|FG001|Overall Study|Adverse Event|2|||
16774594|NCT00893789|37713932|FG002|Overall Study|Adverse Event|1|||
16774595|NCT00893789|37713933|FG003|Overall Study|Adverse Event|5|||
16774596|NCT00893789|37713930|FG000|Overall Study|Protocol Violation|0|||
16774597|NCT00893789|37713931|FG001|Overall Study|Protocol Violation|1|||
16774598|NCT00893789|37713932|FG002|Overall Study|Protocol Violation|1|||
16774599|NCT00893789|37713933|FG003|Overall Study|Protocol Violation|4|||
16774600|NCT00893789|37713930|FG000|Overall Study|Lost to Follow-up|0|||
16774601|NCT00893789|37713931|FG001|Overall Study|Lost to Follow-up|0|||
16774602|NCT00893789|37713932|FG002|Overall Study|Lost to Follow-up|0|||
16774603|NCT00893789|37713933|FG003|Overall Study|Lost to Follow-up|1|||
16774604|NCT02164864|37713946|FG000|Overall Study|Trial disease worsening|7|||
16774605|NCT02164864|37713947|FG001|Overall Study|Trial disease worsening|5|||
16774606|NCT02164864|37713948|FG002|Overall Study|Trial disease worsening|1|||
16774607|NCT02164864|37713946|FG000|Overall Study|Other pre-existing disease worsening|6|||
16774608|NCT02164864|37713947|FG001|Overall Study|Other pre-existing disease worsening|4|||
16774609|NCT02164864|37713948|FG002|Overall Study|Other pre-existing disease worsening|9|||
16774610|NCT02164864|37713946|FG000|Overall Study|Other Adverse Event (AE)|52|||
16774611|NCT02164864|37713947|FG001|Overall Study|Other Adverse Event (AE)|32|||
16774612|NCT02164864|37713948|FG002|Overall Study|Other Adverse Event (AE)|49|||
16774613|NCT02164864|37713946|FG000|Overall Study|Protocol Violation|2|||
16774614|NCT02164864|37713947|FG001|Overall Study|Protocol Violation|4|||
16774615|NCT02164864|37713948|FG002|Overall Study|Protocol Violation|1|||
16774616|NCT02164864|37713946|FG000|Overall Study|Lost to Follow-up|4|||
17133887|NCT00048581|38275151|FG002|Open-Label Period|Study Ended By Sponsor|1|||
17133888|NCT00048347|38275164|FG000|Overall Study|Screen failure|2|||
16774617|NCT02164864|37713947|FG001|Overall Study|Lost to Follow-up|3|||
16774618|NCT02164864|37713948|FG002|Overall Study|Lost to Follow-up|2|||
16774619|NCT02164864|37713946|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
16774620|NCT02164864|37713947|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
16774621|NCT02164864|37713948|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
16774622|NCT02164864|37713946|FG000|Overall Study|Other than stated|3|||
16774623|NCT02164864|37713947|FG001|Overall Study|Other than stated|4|||
16774624|NCT02164864|37713948|FG002|Overall Study|Other than stated|14|||
16774625|NCT02419807|37713959|FG000|Overall Study|Withdrawal by Subject|4|||
16774626|NCT02419807|37713959|FG000|Overall Study|Physician Decision|1|||
16774627|NCT02419807|37713959|FG000|Overall Study|Protocol Violation|5|||
16774628|NCT03857867|37713963|FG000|Overall Study|Physician Decision|1|||
16774629|NCT01628926|37713971|FG000|Overall Study|Adverse Event|13|||
16774630|NCT01628926|37713972|FG001|Overall Study|Adverse Event|11|||
16774631|NCT01628926|37713973|FG002|Overall Study|Adverse Event|9|||
16774632|NCT01628926|37713971|FG000|Overall Study|Lack of Efficacy|2|||
16774633|NCT01628926|37713972|FG001|Overall Study|Lack of Efficacy|1|||
16774634|NCT01628926|37713973|FG002|Overall Study|Lack of Efficacy|5|||
16774635|NCT01628926|37713971|FG000|Overall Study|Withdrawal by Subject|6|||
16774636|NCT01628926|37713972|FG001|Overall Study|Withdrawal by Subject|4|||
16774637|NCT01628926|37713973|FG002|Overall Study|Withdrawal by Subject|2|||
16774638|NCT01628926|37713971|FG000|Overall Study|Protocol Violation|0|||
16774639|NCT01628926|37713972|FG001|Overall Study|Protocol Violation|1|||
16774640|NCT01628926|37713973|FG002|Overall Study|Protocol Violation|0|||
16774641|NCT01628926|37713971|FG000|Overall Study|Discontinuation criteria|3|||
16774642|NCT01628926|37713972|FG001|Overall Study|Discontinuation criteria|4|||
16774643|NCT01628926|37713973|FG002|Overall Study|Discontinuation criteria|0|||
16774644|NCT01628926|37713971|FG000|Overall Study|Physician Decision|2|||
16774645|NCT01628926|37713972|FG001|Overall Study|Physician Decision|2|||
16774646|NCT01628926|37713973|FG002|Overall Study|Physician Decision|1|||
16774647|NCT01628848|37713984|FG000|Overall Study|Adverse Event|9|||
16774648|NCT01628848|37713985|FG001|Overall Study|Adverse Event|7|||
16774649|NCT01628848|37713984|FG000|Overall Study|Lack of Efficacy|0|||
16774650|NCT01628848|37713985|FG001|Overall Study|Lack of Efficacy|4|||
16774651|NCT01628848|37713984|FG000|Overall Study|Withdrawal by Subject|0|||
16774652|NCT01628848|37713985|FG001|Overall Study|Withdrawal by Subject|2|||
16774653|NCT01628848|37713984|FG000|Overall Study|Physician Decision|3|||
16774654|NCT01628848|37713985|FG001|Overall Study|Physician Decision|1|||
16774655|NCT02164318|37713995|FG000|Overall Study|Withdrawal by Subject|0|||
16774656|NCT02164318|37713996|FG001|Overall Study|Withdrawal by Subject|1|||
16774657|NCT02164318|37713997|FG002|Overall Study|Withdrawal by Subject|0|||
16774658|NCT02164318|37713998|FG003|Overall Study|Withdrawal by Subject|1|||
16774659|NCT03436199|37714011|FG000|Overall Study|Adverse Event|15|||
16774660|NCT03436199|37714012|FG001|Overall Study|Adverse Event|40|||
16774661|NCT03436199|37714013|FG002|Overall Study|Adverse Event|7|||
16774662|NCT03436199|37714011|FG000|Overall Study|Withdrawal by Subject|4|||
16774663|NCT03436199|37714012|FG001|Overall Study|Withdrawal by Subject|10|||
16774664|NCT03436199|37714013|FG002|Overall Study|Withdrawal by Subject|3|||
16774665|NCT03436199|37714011|FG000|Overall Study|Lost to Follow-up|1|||
16774666|NCT03436199|37714012|FG001|Overall Study|Lost to Follow-up|0|||
16774667|NCT03436199|37714013|FG002|Overall Study|Lost to Follow-up|2|||
16774668|NCT03436199|37714011|FG000|Overall Study|Protocol Violation|1|||
16774669|NCT03436199|37714012|FG001|Overall Study|Protocol Violation|1|||
16774670|NCT03436199|37714013|FG002|Overall Study|Protocol Violation|0|||
16774671|NCT03436199|37714011|FG000|Overall Study|Physician Decision|0|||
16774672|NCT03436199|37714012|FG001|Overall Study|Physician Decision|1|||
16774673|NCT03436199|37714013|FG002|Overall Study|Physician Decision|0|||
16774674|NCT03436199|37714011|FG000|Overall Study|Could not return to clinic|1|||
16774675|NCT03436199|37714012|FG001|Overall Study|Could not return to clinic|0|||
16774676|NCT03436199|37714013|FG002|Overall Study|Could not return to clinic|0|||
16774677|NCT03436199|37714011|FG000|Overall Study|Withdrawn per physician|0|||
16774678|NCT03436199|37714012|FG001|Overall Study|Withdrawn per physician|1|||
16774679|NCT03436199|37714013|FG002|Overall Study|Withdrawn per physician|0|||
16774680|NCT02131636|37714023|FG000|Overall Study|Personal Reasons|4|||
16774681|NCT02131636|37714024|FG001|Overall Study|Personal Reasons|4|||
16774682|NCT02131636|37714023|FG000|Overall Study|Lost to Follow-up|4|||
16774683|NCT02131636|37714024|FG001|Overall Study|Lost to Follow-up|0|||
16774684|NCT02131636|37714023|FG000|Overall Study|Adverse Event|4|||
16774685|NCT02131636|37714024|FG001|Overall Study|Adverse Event|1|||
16774686|NCT02131324|37714032|FG000|Overall Study|Withdrawal by Subject|1|||
16774687|NCT02131324|37714033|FG001|Overall Study|Withdrawal by Subject|2|||
16774688|NCT02131324|37714032|FG000|Overall Study|Lost to Follow-up|1|||
16774689|NCT02131324|37714033|FG001|Overall Study|Lost to Follow-up|1|||
16774690|NCT02734693|37714042|FG000|Overall Study|Adverse Event|1|||
16774691|NCT02734693|37714043|FG001|Overall Study|Adverse Event|3|||
16774692|NCT02734693|37714044|FG002|Overall Study|Adverse Event|3|||
16774693|NCT02734693|37714042|FG000|Overall Study|Lack of Efficacy|1|||
16774694|NCT02734693|37714043|FG001|Overall Study|Lack of Efficacy|0|||
16774695|NCT02734693|37714044|FG002|Overall Study|Lack of Efficacy|0|||
16774696|NCT02734693|37714042|FG000|Overall Study|Lost to Follow-up|2|||
16774697|NCT02734693|37714043|FG001|Overall Study|Lost to Follow-up|0|||
16774698|NCT02734693|37714044|FG002|Overall Study|Lost to Follow-up|0|||
16774699|NCT02734693|37714042|FG000|Overall Study|Protocol Violation|1|||
16774700|NCT02734693|37714043|FG001|Overall Study|Protocol Violation|0|||
16774701|NCT02734693|37714044|FG002|Overall Study|Protocol Violation|0|||
16774702|NCT02734693|37714042|FG000|Overall Study|Withdrawal by Subject|1|||
16774703|NCT02734693|37714043|FG001|Overall Study|Withdrawal by Subject|0|||
16774704|NCT02734693|37714044|FG002|Overall Study|Withdrawal by Subject|0|||
16774705|NCT02193880|37714052|FG000|Overall Study|patients did not collect enough HPC|3|||
16774706|NCT03846427|37714056|FG000|Overall Study|Death|7|||
16774707|NCT03846427|37714056|FG000|Overall Study|Withdrawal by Subject|2|||
16774708|NCT03846427|37714056|FG000|Overall Study|Remaining in study|59|||
16774709|NCT01378325|37714062|FG000|Overall Study|Protocol Violation|0|||
16774710|NCT01378325|37714063|FG001|Overall Study|Protocol Violation|1|||
16774711|NCT01093573|37714072|FG000|Overall Study|Physician Decision|0|||
16774712|NCT01093573|37714073|FG001|Overall Study|Physician Decision|0|||
16774713|NCT01093573|37714074|FG002|Overall Study|Physician Decision|1|||
16774714|NCT01093573|37714072|FG000|Overall Study|Insurance Denied|0|||
16774715|NCT01093573|37714073|FG001|Overall Study|Insurance Denied|0|||
16774716|NCT01093573|37714074|FG002|Overall Study|Insurance Denied|1|||
16774717|NCT02733367|37714102|FG000|Overall Study|Withdrawal by Subject|6|||
16774718|NCT02087423|37714110|FG000|Overall Study|Withdrawal by Subject|20|||
16774719|NCT02087423|37714111|FG001|Overall Study|Withdrawal by Subject|20|||
16774720|NCT02087423|37714112|FG002|Overall Study|Withdrawal by Subject|3|||
16774721|NCT02087423|37714110|FG000|Overall Study|Death|68|||
16774722|NCT02087423|37714111|FG001|Overall Study|Death|207|||
16774723|NCT02087423|37714112|FG002|Overall Study|Death|40|||
16774724|NCT02087423|37714110|FG000|Overall Study|Lost to Follow-up|0|||
16774725|NCT02087423|37714111|FG001|Overall Study|Lost to Follow-up|2|||
16774726|NCT02087423|37714112|FG002|Overall Study|Lost to Follow-up|0|||
16774727|NCT02087423|37714110|FG000|Overall Study|Terminated from study at final DCO|23|||
16774728|NCT02087423|37714111|FG001|Overall Study|Terminated from study at final DCO|36|||
16774729|NCT02087423|37714112|FG002|Overall Study|Terminated from study at final DCO|25|||
16774730|NCT03688555|37714124|FG000|Treatment Period|Adverse Event|0|||
16774731|NCT03688555|37714125|FG001|Treatment Period|Adverse Event|0|||
16774732|NCT03688555|37714126|FG002|Treatment Period|Adverse Event|1|||
16774733|NCT01328951|37714168|FG000|Overall Study|Disease Progression|17|||
16774734|NCT01328951|37714169|FG001|Overall Study|Disease Progression|14|||
16774735|NCT01328951|37714168|FG000|Overall Study|Adverse Event|2|||
16774736|NCT01328951|37714169|FG001|Overall Study|Adverse Event|0|||
16774737|NCT01328951|37714168|FG000|Overall Study|Death|243|||
16774738|NCT01328951|37714169|FG001|Overall Study|Death|258|||
16774739|NCT01328951|37714168|FG000|Overall Study|Lost to Follow-up|6|||
16774740|NCT01328951|37714169|FG001|Overall Study|Lost to Follow-up|7|||
16774741|NCT01328951|37714168|FG000|Overall Study|Withdrawal by Subject|6|||
16774742|NCT01328951|37714169|FG001|Overall Study|Withdrawal by Subject|6|||
16774743|NCT01328951|37714168|FG000|Overall Study|Study Closed by the Sponsor|36|||
16774744|NCT01328951|37714169|FG001|Overall Study|Study Closed by the Sponsor|31|||
16774745|NCT01328951|37714168|FG000|Overall Study|Other|11|||
16774746|NCT01328951|37714169|FG001|Overall Study|Other|6|||
16774747|NCT02611817|37714182|FG000|Open-label Induction Phase|Reason not Specified|9|||
16774748|NCT02611817|37714183|FG001|Open-label Induction Phase|Reason not Specified|0|||
16774749|NCT02611817|37714184|FG002|Open-label Induction Phase|Reason not Specified|0|||
16774750|NCT02611817|37714182|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
16774751|NCT02611817|37714183|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
16774752|NCT02611817|37714184|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
16774753|NCT02611817|37714182|FG000|Open-label Induction Phase|Pregnancy|1|||
16774754|NCT02611817|37714183|FG001|Open-label Induction Phase|Pregnancy|0|||
16774755|NCT02611817|37714184|FG002|Open-label Induction Phase|Pregnancy|0|||
16774756|NCT02611817|37714182|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
16774757|NCT02611817|37714183|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
16774758|NCT02611817|37714184|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
16774759|NCT02611817|37714182|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
16774760|NCT02611817|37714183|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
16774761|NCT02611817|37714184|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
16774762|NCT02611817|37714182|FG000|Open-label Induction Phase|Protocol Violation|5|||
16774763|NCT02611817|37714183|FG001|Open-label Induction Phase|Protocol Violation|0|||
16774764|NCT02611817|37714184|FG002|Open-label Induction Phase|Protocol Violation|0|||
16958044|NCT00950599|38101077|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
16774765|NCT02611817|37714182|FG000|Open-label Induction Phase|Adverse Event|16|||
16774766|NCT02611817|37714183|FG001|Open-label Induction Phase|Adverse Event|0|||
16774767|NCT02611817|37714184|FG002|Open-label Induction Phase|Adverse Event|0|||
16774768|NCT02611817|37714182|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
16774769|NCT02611817|37714183|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
16774770|NCT02611817|37714184|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
16774771|NCT02611817|37714182|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
16774772|NCT02611817|37714183|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
16774773|NCT02611817|37714184|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
16774774|NCT02611817|37714182|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
16774775|NCT02611817|37714183|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
16774776|NCT02611817|37714184|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
16774777|NCT02611817|37714182|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
16774778|NCT02611817|37714183|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
16774779|NCT02611817|37714184|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
16774780|NCT02611817|37714182|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
16774781|NCT02611817|37714183|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
16774782|NCT02611817|37714184|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
16774783|NCT02611817|37714182|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
16774784|NCT02611817|37714183|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
16774785|NCT02611817|37714184|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
16774786|NCT02611817|37714182|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
16774787|NCT02611817|37714183|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
16774788|NCT02611817|37714184|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
16774789|NCT02735915|37714191|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
16774790|NCT02735915|37714191|FG000|Overall Study|Withdrawal following SAE|2|||
16774791|NCT02735915|37714191|FG000|Overall Study|Withdrawal by Subject|1|||
16774792|NCT02557139|37714200|FG000|Overall Study|Significant liver elevation|1|||
16774793|NCT02557139|37714201|FG001|Overall Study|Significant liver elevation|0|||
16774794|NCT02557139|37714202|FG002|Overall Study|Significant liver elevation|1|||
16774795|NCT02557139|37714200|FG000|Overall Study|Withdrawal by Subject|1|||
16774796|NCT02557139|37714201|FG001|Overall Study|Withdrawal by Subject|0|||
16774797|NCT02557139|37714202|FG002|Overall Study|Withdrawal by Subject|0|||
16774798|NCT02557139|37714200|FG000|Overall Study|Illness of prohibited medication|0|||
16774799|NCT02557139|37714201|FG001|Overall Study|Illness of prohibited medication|0|||
16774800|NCT02557139|37714202|FG002|Overall Study|Illness of prohibited medication|1|||
16774801|NCT01328717|37714219|FG000|Overall Study|Adverse Event|1|||
16774802|NCT01677741|37714231|FG000|Overall Study|Death|0|||
16774803|NCT01677741|37714232|FG001|Overall Study|Death|0|||
16774804|NCT01677741|37714233|FG002|Overall Study|Death|0|||
16774805|NCT01677741|37714234|FG003|Overall Study|Death|1|||
16774806|NCT01677741|37714235|FG004|Overall Study|Death|0|||
16774807|NCT01677741|37714236|FG005|Overall Study|Death|1|||
16774808|NCT01677741|37714237|FG006|Overall Study|Death|0|||
16774809|NCT01677741|37714238|FG007|Overall Study|Death|0|||
16774810|NCT01677741|37714231|FG000|Overall Study|Withdrawal by Subject|2|||
16774811|NCT01677741|37714232|FG001|Overall Study|Withdrawal by Subject|7|||
16774812|NCT01677741|37714233|FG002|Overall Study|Withdrawal by Subject|5|||
16774813|NCT01677741|37714234|FG003|Overall Study|Withdrawal by Subject|4|||
16774814|NCT01677741|37714235|FG004|Overall Study|Withdrawal by Subject|11|||
16774815|NCT01677741|37714236|FG005|Overall Study|Withdrawal by Subject|20|||
16774816|NCT01677741|37714237|FG006|Overall Study|Withdrawal by Subject|4|||
16774817|NCT01677741|37714238|FG007|Overall Study|Withdrawal by Subject|2|||
16774818|NCT01677741|37714231|FG000|Overall Study|Enrolled in a rollover study|0|||
16774819|NCT01677741|37714232|FG001|Overall Study|Enrolled in a rollover study|3|||
16774820|NCT01677741|37714233|FG002|Overall Study|Enrolled in a rollover study|2|||
16774821|NCT01677741|37714234|FG003|Overall Study|Enrolled in a rollover study|1|||
16774822|NCT01677741|37714235|FG004|Overall Study|Enrolled in a rollover study|6|||
16774823|NCT01677741|37714236|FG005|Overall Study|Enrolled in a rollover study|6|||
16774824|NCT01677741|37714237|FG006|Overall Study|Enrolled in a rollover study|7|||
16774825|NCT01677741|37714238|FG007|Overall Study|Enrolled in a rollover study|0|||
16774826|NCT01677741|37714231|FG000|Overall Study|Progressive disease|1|||
16774827|NCT01677741|37714232|FG001|Overall Study|Progressive disease|0|||
16774828|NCT01677741|37714233|FG002|Overall Study|Progressive disease|1|||
16774829|NCT01677741|37714234|FG003|Overall Study|Progressive disease|0|||
16774830|NCT01677741|37714235|FG004|Overall Study|Progressive disease|0|||
16774831|NCT01677741|37714236|FG005|Overall Study|Progressive disease|1|||
16774832|NCT01677741|37714237|FG006|Overall Study|Progressive disease|0|||
16774833|NCT01677741|37714238|FG007|Overall Study|Progressive disease|0|||
16774834|NCT02659059|37714292|FG000|Overall Study|Completed|1|||
16774835|NCT02659059|37714293|FG001|Overall Study|Completed|0|||
16774836|NCT02659059|37714292|FG000|Overall Study|Other reasons|8|||
16774837|NCT02659059|37714293|FG001|Overall Study|Other reasons|2|||
16774838|NCT02659059|37714292|FG000|Overall Study|Disease Progression|120|||
16774839|NCT02659059|37714293|FG001|Overall Study|Disease Progression|16|||
16774840|NCT02659059|37714292|FG000|Overall Study|Study Drug toxicity|37|||
16774841|NCT02659059|37714293|FG001|Overall Study|Study Drug toxicity|9|||
16774842|NCT02659059|37714292|FG000|Overall Study|Death|2|||
16774843|NCT02659059|37714293|FG001|Overall Study|Death|1|||
16774844|NCT02659059|37714292|FG000|Overall Study|Adverse Event unrelated to Study drug|22|||
16774845|NCT02659059|37714293|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
16774846|NCT02659059|37714292|FG000|Overall Study|Participant request to discontinue study treatment|5|||
16774847|NCT02659059|37714293|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16774848|NCT02659059|37714292|FG000|Overall Study|Participant withdrew consent|4|||
16774849|NCT02659059|37714293|FG001|Overall Study|Participant withdrew consent|0|||
16774850|NCT02659059|37714292|FG000|Overall Study|Lost to Follow-up|1|||
16774851|NCT02659059|37714293|FG001|Overall Study|Lost to Follow-up|0|||
16774852|NCT01677507|37714300|FG000|Initial Assignment|Adverse Event|0|||
16774853|NCT01677507|37714301|FG001|Initial Assignment|Adverse Event|1|||
16774854|NCT01677507|37714300|FG000|Initial Assignment|Protocol Violation|0|||
16774855|NCT01677507|37714301|FG001|Initial Assignment|Protocol Violation|1|||
16774856|NCT01677507|37714300|FG000|Second Assigment|Withdrawal by Subject|2|||
16774857|NCT01677507|37714301|FG001|Second Assigment|Withdrawal by Subject|2|||
16774858|NCT01677507|37714300|FG000|Second Assigment|Adverse Event|1|||
16774859|NCT01677507|37714301|FG001|Second Assigment|Adverse Event|3|||
16774860|NCT03126539|37714311|FG000|Overall Study|Lost to Follow-up|1|||
16774861|NCT03126539|37714312|FG001|Overall Study|Lost to Follow-up|1|||
16774862|NCT03126539|37714313|FG002|Overall Study|Lost to Follow-up|1|||
16774863|NCT03126539|37714314|FG003|Overall Study|Lost to Follow-up|0|||
16774864|NCT03126539|37714315|FG004|Overall Study|Lost to Follow-up|0|||
16774865|NCT02732951|37714330|FG000|Overall Study|Other than listed|1|||
16774866|NCT02732951|37714331|FG001|Overall Study|Other than listed|0|||
16774867|NCT02732951|37714330|FG000|Overall Study|Lost to Follow-up|0|||
16774868|NCT02732951|37714331|FG001|Overall Study|Lost to Follow-up|1|||
16774869|NCT02732951|37714330|FG000|Overall Study|Adverse Event|4|||
16774870|NCT02732951|37714331|FG001|Overall Study|Adverse Event|4|||
16774871|NCT02732951|37714330|FG000|Overall Study|Protocol Violation|0|||
16774872|NCT02732951|37714331|FG001|Overall Study|Protocol Violation|1|||
16774873|NCT01377233|37714342|FG000|Open-label|Adverse Event|1|||
16774874|NCT01377233|37714343|FG001|Open-label|Adverse Event|0|||
16774875|NCT01377233|37714344|FG002|Open-label|Adverse Event|0|||
16774876|NCT01377233|37714345|FG003|Open-label|Adverse Event|0|||
16774877|NCT01377233|37714346|FG004|Open-label|Adverse Event|0|||
16774878|NCT01377233|37714342|FG000|Open-label|Withdrawal by Subject|3|||
16774879|NCT01377233|37714343|FG001|Open-label|Withdrawal by Subject|0|||
16774880|NCT01377233|37714344|FG002|Open-label|Withdrawal by Subject|0|||
16774881|NCT01377233|37714345|FG003|Open-label|Withdrawal by Subject|0|||
16774882|NCT01377233|37714346|FG004|Open-label|Withdrawal by Subject|0|||
16774883|NCT01377233|37714342|FG000|Double-blind|Adverse Event|0|||
16774884|NCT01377233|37714343|FG001|Double-blind|Adverse Event|1|||
16774885|NCT01377233|37714344|FG002|Double-blind|Adverse Event|2|||
16774886|NCT01377233|37714345|FG003|Double-blind|Adverse Event|2|||
16774887|NCT01377233|37714346|FG004|Double-blind|Adverse Event|0|||
16774888|NCT01377233|37714342|FG000|Double-blind|Protocol Violation|0|||
16774889|NCT01377233|37714343|FG001|Double-blind|Protocol Violation|0|||
16774890|NCT01377233|37714344|FG002|Double-blind|Protocol Violation|0|||
16774891|NCT01377233|37714345|FG003|Double-blind|Protocol Violation|0|||
16774892|NCT01377233|37714346|FG004|Double-blind|Protocol Violation|1|||
16774893|NCT01377233|37714342|FG000|Double-blind|Withdrawal by Subject|0|||
16774894|NCT01377233|37714343|FG001|Double-blind|Withdrawal by Subject|0|||
16774895|NCT01377233|37714344|FG002|Double-blind|Withdrawal by Subject|0|||
16774896|NCT01377233|37714345|FG003|Double-blind|Withdrawal by Subject|1|||
16774897|NCT01377233|37714346|FG004|Double-blind|Withdrawal by Subject|0|||
16774898|NCT01377233|37714342|FG000|Double-blind|Administrative or other|0|||
16774899|NCT01377233|37714343|FG001|Double-blind|Administrative or other|0|||
16774900|NCT01377233|37714344|FG002|Double-blind|Administrative or other|0|||
16774901|NCT01377233|37714345|FG003|Double-blind|Administrative or other|1|||
16774902|NCT01377233|37714346|FG004|Double-blind|Administrative or other|1|||
16958045|NCT00950599|38101078|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
16774903|NCT03248531|37714365|FG000|Overall Study|Adverse Event|0|||
16774904|NCT03248531|37714366|FG001|Overall Study|Adverse Event|0|||
16774905|NCT03248531|37714367|FG002|Overall Study|Adverse Event|1|||
16774906|NCT03248531|37714365|FG000|Overall Study|Lost to Follow-up|1|||
16774907|NCT03248531|37714366|FG001|Overall Study|Lost to Follow-up|0|||
16774908|NCT03248531|37714367|FG002|Overall Study|Lost to Follow-up|5|||
16774909|NCT03248531|37714365|FG000|Overall Study|Withdrawal by Subject|3|||
16774910|NCT03248531|37714366|FG001|Overall Study|Withdrawal by Subject|3|||
16774911|NCT03248531|37714367|FG002|Overall Study|Withdrawal by Subject|2|||
16774912|NCT03248531|37714365|FG000|Overall Study|Sponsor Request|0|||
16774913|NCT03248531|37714366|FG001|Overall Study|Sponsor Request|2|||
16774914|NCT03248531|37714367|FG002|Overall Study|Sponsor Request|0|||
16774915|NCT02656329|37714384|FG000|Overall Study|Lost to Follow-up|2|||
17133889|NCT00065507|38275170|FG000|Overall Study|Death|16|||
16774916|NCT02656329|37714385|FG001|Overall Study|Lost to Follow-up|3|||
16774917|NCT02656329|37714384|FG000|Overall Study|Withdrawal by Subject|7|||
16774918|NCT02656329|37714385|FG001|Overall Study|Withdrawal by Subject|6|||
16774919|NCT02656329|37714384|FG000|Overall Study|Study termination by Sponsor|150|||
16774920|NCT02656329|37714385|FG001|Overall Study|Study termination by Sponsor|142|||
16774921|NCT02656329|37714384|FG000|Overall Study|Other than specified above|5|||
16774922|NCT02656329|37714385|FG001|Overall Study|Other than specified above|6|||
16774923|NCT03776357|37714392|FG000|Overall Study|Lost to Follow-up|3|||
16774924|NCT02181413|37714398|FG000|Overall Study|Adverse Event|7|||
16774925|NCT02181413|37714399|FG001|Overall Study|Adverse Event|24|||
16774926|NCT02181413|37714398|FG000|Overall Study|Progressive Disease|121|||
16774927|NCT02181413|37714399|FG001|Overall Study|Progressive Disease|143|||
16774928|NCT02181413|37714398|FG000|Overall Study|Withdrawal by Subject|5|||
16774929|NCT02181413|37714399|FG001|Overall Study|Withdrawal by Subject|8|||
16774930|NCT02181413|37714398|FG000|Overall Study|Reason Not Specified|19|||
16774931|NCT02181413|37714399|FG001|Overall Study|Reason Not Specified|20|||
16774932|NCT02181413|37714398|FG000|Overall Study|Ongoing Study Treatment|0|||
16774933|NCT02181413|37714399|FG001|Overall Study|Ongoing Study Treatment|1|||
16774934|NCT02181413|37714398|FG000|Overall Study|Lost to Follow-up|0|||
16774935|NCT02181413|37714399|FG001|Overall Study|Lost to Follow-up|1|||
16774936|NCT02734433|37714407|FG000|Overall Study|Disease progression|1|||
16774937|NCT02734433|37714408|FG001|Overall Study|Disease progression|5|||
16774938|NCT02734433|37714407|FG000|Overall Study|Clinical progression|0|||
16774939|NCT02734433|37714408|FG001|Overall Study|Clinical progression|1|||
16774940|NCT02734433|37714407|FG000|Overall Study|Withdrawal by Subject|1|||
16774941|NCT02734433|37714408|FG001|Overall Study|Withdrawal by Subject|2|||
16774942|NCT02452424|37714434|FG000|Overall Study|Death|2|||
16774943|NCT02452424|37714435|FG001|Overall Study|Death|2|||
16774944|NCT02452424|37714436|FG002|Overall Study|Death|2|||
16774945|NCT02452424|37714437|FG003|Overall Study|Death|6|||
16774946|NCT02452424|37714438|FG004|Overall Study|Death|2|||
16774947|NCT02452424|37714439|FG005|Overall Study|Death|0|||
16774948|NCT02452424|37714440|FG006|Overall Study|Death|5|||
16774949|NCT02452424|37714441|FG007|Overall Study|Death|1|||
16774950|NCT02452424|37714442|FG008|Overall Study|Death|3|||
16774951|NCT02452424|37714443|FG009|Overall Study|Death|1|||
16774952|NCT02452424|37714444|FG010|Overall Study|Death|0|||
16774953|NCT02452424|37714434|FG000|Overall Study|Lost to Follow-up|0|||
16774954|NCT02452424|37714435|FG001|Overall Study|Lost to Follow-up|1|||
16774955|NCT02452424|37714436|FG002|Overall Study|Lost to Follow-up|1|||
16774956|NCT02452424|37714437|FG003|Overall Study|Lost to Follow-up|0|||
16774957|NCT02452424|37714438|FG004|Overall Study|Lost to Follow-up|0|||
16774958|NCT02452424|37714439|FG005|Overall Study|Lost to Follow-up|0|||
16774959|NCT02452424|37714440|FG006|Overall Study|Lost to Follow-up|0|||
16774960|NCT02452424|37714441|FG007|Overall Study|Lost to Follow-up|0|||
16774961|NCT02452424|37714442|FG008|Overall Study|Lost to Follow-up|0|||
16774962|NCT02452424|37714443|FG009|Overall Study|Lost to Follow-up|0|||
16774963|NCT02452424|37714444|FG010|Overall Study|Lost to Follow-up|0|||
16774964|NCT02452424|37714434|FG000|Overall Study|Withdrawal by Subject|0|||
16774965|NCT02452424|37714435|FG001|Overall Study|Withdrawal by Subject|0|||
16774966|NCT02452424|37714436|FG002|Overall Study|Withdrawal by Subject|3|||
16774967|NCT02452424|37714437|FG003|Overall Study|Withdrawal by Subject|2|||
16774968|NCT02452424|37714438|FG004|Overall Study|Withdrawal by Subject|0|||
16774969|NCT02452424|37714439|FG005|Overall Study|Withdrawal by Subject|0|||
16774970|NCT02452424|37714440|FG006|Overall Study|Withdrawal by Subject|1|||
16774971|NCT02452424|37714441|FG007|Overall Study|Withdrawal by Subject|0|||
16774972|NCT02452424|37714442|FG008|Overall Study|Withdrawal by Subject|1|||
16774973|NCT02452424|37714443|FG009|Overall Study|Withdrawal by Subject|1|||
16774974|NCT02452424|37714444|FG010|Overall Study|Withdrawal by Subject|0|||
16774975|NCT02452424|37714434|FG000|Overall Study|Other|0|||
16774976|NCT02452424|37714435|FG001|Overall Study|Other|0|||
16774977|NCT02452424|37714436|FG002|Overall Study|Other|1|||
16774978|NCT02452424|37714437|FG003|Overall Study|Other|0|||
16774979|NCT02452424|37714438|FG004|Overall Study|Other|0|||
16774980|NCT02452424|37714439|FG005|Overall Study|Other|1|||
16774981|NCT02452424|37714440|FG006|Overall Study|Other|4|||
16774982|NCT02452424|37714441|FG007|Overall Study|Other|3|||
16774983|NCT02452424|37714442|FG008|Overall Study|Other|0|||
16774984|NCT02452424|37714443|FG009|Overall Study|Other|0|||
16774985|NCT02452424|37714444|FG010|Overall Study|Other|1|||
16774986|NCT02452424|37714434|FG000|Overall Study|Progressive disease (per RECIST)|0|||
16774987|NCT02452424|37714435|FG001|Overall Study|Progressive disease (per RECIST)|0|||
16774988|NCT02452424|37714436|FG002|Overall Study|Progressive disease (per RECIST)|0|||
16774989|NCT02452424|37714437|FG003|Overall Study|Progressive disease (per RECIST)|0|||
16774990|NCT02452424|37714438|FG004|Overall Study|Progressive disease (per RECIST)|0|||
16774991|NCT02452424|37714439|FG005|Overall Study|Progressive disease (per RECIST)|0|||
16774992|NCT02452424|37714440|FG006|Overall Study|Progressive disease (per RECIST)|0|||
16774993|NCT02452424|37714441|FG007|Overall Study|Progressive disease (per RECIST)|0|||
16774994|NCT02452424|37714442|FG008|Overall Study|Progressive disease (per RECIST)|2|||
16774995|NCT02452424|37714443|FG009|Overall Study|Progressive disease (per RECIST)|0|||
16774996|NCT02452424|37714444|FG010|Overall Study|Progressive disease (per RECIST)|0|||
16774997|NCT02452424|37714434|FG000|Overall Study|Adverse Event|0|||
16774998|NCT02452424|37714435|FG001|Overall Study|Adverse Event|0|||
16774999|NCT02452424|37714436|FG002|Overall Study|Adverse Event|0|||
16775000|NCT02452424|37714437|FG003|Overall Study|Adverse Event|0|||
16775001|NCT02452424|37714438|FG004|Overall Study|Adverse Event|0|||
16775002|NCT02452424|37714439|FG005|Overall Study|Adverse Event|0|||
16775003|NCT02452424|37714440|FG006|Overall Study|Adverse Event|0|||
16775004|NCT02452424|37714441|FG007|Overall Study|Adverse Event|0|||
16775005|NCT02452424|37714442|FG008|Overall Study|Adverse Event|0|||
16775006|NCT02452424|37714443|FG009|Overall Study|Adverse Event|0|||
16775007|NCT02452424|37714444|FG010|Overall Study|Adverse Event|1|||
16775008|NCT02419508|37714472|FG000|Overall Study|Adverse Event|9|||
16775009|NCT02419508|37714473|FG001|Overall Study|Adverse Event|3|||
16775010|NCT02419508|37714472|FG000|Overall Study|Withdrawal by Subject|1|||
16775011|NCT02419508|37714473|FG001|Overall Study|Withdrawal by Subject|0|||
16775012|NCT02419508|37714472|FG000|Overall Study|Other - Reason not specified|0|||
16775013|NCT02419508|37714473|FG001|Overall Study|Other - Reason not specified|1|||
16775014|NCT01328249|37714481|FG000|Overall Study|Adverse Event|3|||
16775015|NCT01328249|37714482|FG001|Overall Study|Adverse Event|0|||
16775016|NCT01328249|37714481|FG000|Overall Study|Disease progression|1|||
16775017|NCT01328249|37714482|FG001|Overall Study|Disease progression|0|||
16775018|NCT01328249|37714481|FG000|Overall Study|Withdrawal by Subject|1|||
16775019|NCT01328249|37714482|FG001|Overall Study|Withdrawal by Subject|1|||
16775020|NCT01328249|37714481|FG000|Overall Study|Moved before end of treatment visit|1|||
16775021|NCT01328249|37714482|FG001|Overall Study|Moved before end of treatment visit|0|||
16775022|NCT01328249|37714481|FG000|Overall Study|Subject choice|1|||
16775023|NCT01328249|37714482|FG001|Overall Study|Subject choice|1|||
16775024|NCT01328249|37714481|FG000|Overall Study|Protocol Violation|0|||
16775025|NCT01328249|37714482|FG001|Overall Study|Protocol Violation|1|||
16775026|NCT01651052|37714490|FG000|Overall Study|Death|21|||
16775027|NCT01651052|37714490|FG000|Overall Study|Explant|1|||
16775028|NCT01651052|37714490|FG000|Overall Study|Withdrawal by Subject|1|||
16775029|NCT01651052|37714490|FG000|Overall Study|Lost to Follow-up|3|||
16775030|NCT02388074|37714494|FG000|Overall Study|Lost in Transit|2|||
16775031|NCT02388074|37714494|FG000|Overall Study|Sample Not Returned|1|||
16775032|NCT01602549|37714500|FG000|Overall Study|Protocol Violation|0|||
16775033|NCT01602549|37714501|FG001|Overall Study|Protocol Violation|1|||
16775034|NCT01602549|37714500|FG000|Overall Study|Withdrawal by Subject|1|||
16775035|NCT01602549|37714501|FG001|Overall Study|Withdrawal by Subject|0|||
16775036|NCT02427464|37714511|FG000|Overall Study|Adverse Event|6|||
16775037|NCT02427464|37714512|FG001|Overall Study|Adverse Event|1|||
16775038|NCT02427464|37714511|FG000|Overall Study|Lost to Follow-up|16|||
16775039|NCT02427464|37714512|FG001|Overall Study|Lost to Follow-up|5|||
16775040|NCT02427464|37714511|FG000|Overall Study|Physician Decision|2|||
16775041|NCT02427464|37714512|FG001|Overall Study|Physician Decision|0|||
16775042|NCT02427464|37714511|FG000|Overall Study|Withdrawal by Subject|10|||
16775043|NCT02427464|37714512|FG001|Overall Study|Withdrawal by Subject|8|||
16775044|NCT02427464|37714511|FG000|Overall Study|Noncompliance|16|||
16775045|NCT02427464|37714512|FG001|Overall Study|Noncompliance|10|||
16775046|NCT02426918|37714521|FG000|Overall Study|Adverse Event|2|||
16775047|NCT02426918|37714522|FG001|Overall Study|Adverse Event|2|||
16775048|NCT02426918|37714523|FG002|Overall Study|Adverse Event|0|||
16775049|NCT02426918|37714521|FG000|Overall Study|Physician Decision|1|||
16775050|NCT02426918|37714522|FG001|Overall Study|Physician Decision|1|||
16775051|NCT02426918|37714523|FG002|Overall Study|Physician Decision|1|||
16775052|NCT02426918|37714521|FG000|Overall Study|Withdrawal by Subject|5|||
16775053|NCT02426918|37714522|FG001|Overall Study|Withdrawal by Subject|5|||
16775054|NCT02426918|37714523|FG002|Overall Study|Withdrawal by Subject|4|||
16775055|NCT02426918|37714521|FG000|Overall Study|Other|9|||
16775056|NCT02426918|37714522|FG001|Overall Study|Other|11|||
16775057|NCT02426918|37714523|FG002|Overall Study|Other|9|||
16775058|NCT02387840|37714537|FG000|Overall Study|Death|0|||
16775059|NCT02387840|37714538|FG001|Overall Study|Death|0|||
16775060|NCT02387840|37714539|FG002|Overall Study|Death|0|||
16775061|NCT02387840|37714540|FG003|Overall Study|Death|0|||
16775062|NCT02387840|37714541|FG004|Overall Study|Death|0|||
16775063|NCT02387840|37714542|FG005|Overall Study|Death|1|||
16775064|NCT02426684|37714562|FG000|Overall Study|Physician Decision|1|||
16775065|NCT02387762|37714568|FG000|Overall Study|Withdrawal by Subject|1|||
16775066|NCT02387762|37714569|FG001|Overall Study|Withdrawal by Subject|0|||
16775067|NCT02418182|37714577|FG000|Overall Study|Unable to re-consent|18|||
16775068|NCT02418182|37714578|FG001|Overall Study|Unable to re-consent|15|||
16775069|NCT02418182|37714577|FG000|Overall Study|Lost to Follow-up|0|||
16775070|NCT02418182|37714578|FG001|Overall Study|Lost to Follow-up|2|||
16775071|NCT02387372|37714599|FG000|Overall Study|Not Treated|1|||
16775072|NCT02387372|37714600|FG001|Overall Study|Not Treated|0|||
16775073|NCT02426138|37714616|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16775074|NCT02426138|37714617|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16775075|NCT02657343|37714636|FG000|Overall Study|Death|0|||
16775076|NCT02657343|37714637|FG001|Overall Study|Death|2|||
16775077|NCT02657343|37714638|FG002|Overall Study|Death|0|||
16775078|NCT02657343|37714639|FG003|Overall Study|Death|0|||
16775079|NCT02657343|37714640|FG004|Overall Study|Death|0|||
16775080|NCT02657343|37714641|FG005|Overall Study|Death|0|||
16775081|NCT02657343|37714636|FG000|Overall Study|Patient went to hospice|1|||
16775082|NCT02657343|37714637|FG001|Overall Study|Patient went to hospice|0|||
16775083|NCT02657343|37714638|FG002|Overall Study|Patient went to hospice|0|||
16775084|NCT02657343|37714639|FG003|Overall Study|Patient went to hospice|0|||
16775085|NCT02657343|37714640|FG004|Overall Study|Patient went to hospice|0|||
16775086|NCT02657343|37714641|FG005|Overall Study|Patient went to hospice|0|||
16775087|NCT02657343|37714636|FG000|Overall Study|Withdrawal by Subject|0|||
16775088|NCT02657343|37714637|FG001|Overall Study|Withdrawal by Subject|0|||
16775089|NCT02657343|37714638|FG002|Overall Study|Withdrawal by Subject|0|||
16775090|NCT02657343|37714639|FG003|Overall Study|Withdrawal by Subject|0|||
16775091|NCT02657343|37714640|FG004|Overall Study|Withdrawal by Subject|1|||
16775092|NCT02657343|37714641|FG005|Overall Study|Withdrawal by Subject|0|||
16958046|NCT00950599|38101079|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
16958047|NCT00950599|38101080|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
16958048|NCT00950599|38101081|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
16958049|NCT00950599|38101082|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
16958050|NCT00950599|38101073|FG000|Follow-Up Period|Adverse Event|0|||
16775099|NCT02425826|37714667|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
16775100|NCT02425826|37714668|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
16867919|NCT01537081|37840927|FG000|Overall Study|Withdrawal by Subject|6|||
16867920|NCT01537081|37840928|FG001|Overall Study|Withdrawal by Subject|11|||
16867921|NCT01537081|37840929|FG002|Overall Study|Withdrawal by Subject|3|||
16867922|NCT01537081|37840927|FG000|Overall Study|Physician Decision|5|||
16867923|NCT01537081|37840928|FG001|Overall Study|Physician Decision|6|||
16867924|NCT01537081|37840929|FG002|Overall Study|Physician Decision|0|||
16867925|NCT01537081|37840927|FG000|Overall Study|Sponsor decision|0|||
16867926|NCT01537081|37840928|FG001|Overall Study|Sponsor decision|1|||
16867927|NCT01537081|37840929|FG002|Overall Study|Sponsor decision|0|||
16867928|NCT01537081|37840927|FG000|Overall Study|Assigned but never dosed|1|||
16867929|NCT01537081|37840928|FG001|Overall Study|Assigned but never dosed|0|||
16867930|NCT01537081|37840929|FG002|Overall Study|Assigned but never dosed|0|||
16867931|NCT01564459|37840941|FG000|Run-In|Adverse Event|7|||
16867932|NCT01564459|37840942|FG001|Run-In|Adverse Event|0|||
16867933|NCT01564459|37840943|FG002|Run-In|Adverse Event|0|||
16867934|NCT01564459|37840941|FG000|Run-In|Lost to Follow-up|1|||
16867935|NCT01564459|37840942|FG001|Run-In|Lost to Follow-up|0|||
16867936|NCT01564459|37840943|FG002|Run-In|Lost to Follow-up|0|||
16867937|NCT01564459|37840941|FG000|Run-In|Non-compliance with study drug|2|||
16867938|NCT01564459|37840942|FG001|Run-In|Non-compliance with study drug|0|||
16867939|NCT01564459|37840943|FG002|Run-In|Non-compliance with study drug|0|||
16867940|NCT01564459|37840941|FG000|Run-In|Protocol Violation|1|||
16867941|NCT01564459|37840942|FG001|Run-In|Protocol Violation|0|||
16867942|NCT01564459|37840943|FG002|Run-In|Protocol Violation|0|||
16867943|NCT01564459|37840941|FG000|Run-In|Withdrawal by Subject|1|||
16867944|NCT01564459|37840942|FG001|Run-In|Withdrawal by Subject|0|||
16867945|NCT01564459|37840943|FG002|Run-In|Withdrawal by Subject|0|||
16867946|NCT01564459|37840941|FG000|Double-blind Treatment|Adverse Event|0|||
16867947|NCT01564459|37840942|FG001|Double-blind Treatment|Adverse Event|0|||
16867948|NCT01564459|37840943|FG002|Double-blind Treatment|Adverse Event|1|||
16867949|NCT01555073|37840958|FG000|Overall Study|Lost to Follow-up|1|||
16867950|NCT01555073|37840959|FG001|Overall Study|Lost to Follow-up|2|||
16867951|NCT01555073|37840960|FG002|Overall Study|Lost to Follow-up|0|||
16867952|NCT01555073|37840961|FG003|Overall Study|Lost to Follow-up|5|||
16867953|NCT01582243|37840971|FG000|Overall Study|Withdrawal by Subject|1|||
16867954|NCT01582243|37840971|FG000|Overall Study|Adverse Event|1|||
16867955|NCT01582243|37840971|FG000|Overall Study|Lost to Follow-up|1|||
16867956|NCT01536535|37840977|FG000|Overall Study|Withdrawal by Subject|10|||
16867957|NCT01536535|37840978|FG001|Overall Study|Withdrawal by Subject|5|||
16775101|NCT02425826|37714669|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
16775102|NCT02425826|37714667|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
16775103|NCT02425826|37714668|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
16775104|NCT02425826|37714669|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
16775105|NCT02425826|37714667|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
16775106|NCT02425826|37714668|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
16775107|NCT02425826|37714669|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
16775108|NCT02425826|37714667|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
16775109|NCT02425826|37714668|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
16775110|NCT02425826|37714669|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
16775111|NCT02425826|37714667|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
16775112|NCT02425826|37714668|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
16775113|NCT02425826|37714669|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
16775114|NCT02425826|37714667|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
16775115|NCT02425826|37714668|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
16775116|NCT02425826|37714669|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
16775117|NCT02425826|37714667|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
16775118|NCT02425826|37714668|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
16775119|NCT02425826|37714669|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
16775120|NCT02425826|37714667|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
16775121|NCT02425826|37714668|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
16775122|NCT02425826|37714669|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
16775123|NCT02425826|37714667|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
16775124|NCT02425826|37714668|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
16775125|NCT02425826|37714669|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
16775126|NCT02425826|37714667|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
16775127|NCT02425826|37714668|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
16775128|NCT02425826|37714669|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
16775129|NCT02656173|37714681|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
16775130|NCT02656173|37714682|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
16775131|NCT02656173|37714681|FG000|Overall Study|Adverse Event|7|||
16775132|NCT02656173|37714682|FG001|Overall Study|Adverse Event|5|||
16775133|NCT02656173|37714681|FG000|Overall Study|Withdrawal by Subject|1|||
16775134|NCT02656173|37714682|FG001|Overall Study|Withdrawal by Subject|3|||
16775135|NCT02656173|37714681|FG000|Overall Study|Protocol Violation|0|||
16775136|NCT02656173|37714682|FG001|Overall Study|Protocol Violation|1|||
16775137|NCT02656173|37714681|FG000|Overall Study|Miscellaneous|2|||
16775138|NCT02656173|37714682|FG001|Overall Study|Miscellaneous|0|||
16958051|NCT00950599|38101074|FG001|Follow-Up Period|Adverse Event|0|||
16958052|NCT00950599|38101075|FG002|Follow-Up Period|Adverse Event|0|||
16958053|NCT00950599|38101076|FG003|Follow-Up Period|Adverse Event|0|||
16958054|NCT00950599|38101077|FG004|Follow-Up Period|Adverse Event|0|||
16958055|NCT00950599|38101078|FG005|Follow-Up Period|Adverse Event|0|||
16958056|NCT00950599|38101079|FG006|Follow-Up Period|Adverse Event|0|||
16958057|NCT00950599|38101080|FG007|Follow-Up Period|Adverse Event|0|||
16958058|NCT00950599|38101081|FG008|Follow-Up Period|Adverse Event|1|||
16958059|NCT00950599|38101082|FG009|Follow-Up Period|Adverse Event|0|||
16958060|NCT00950599|38101073|FG000|Follow-Up Period|Lack of Efficacy|0|||
16958061|NCT00950599|38101074|FG001|Follow-Up Period|Lack of Efficacy|0|||
16958062|NCT00950599|38101075|FG002|Follow-Up Period|Lack of Efficacy|0|||
16958063|NCT00950599|38101076|FG003|Follow-Up Period|Lack of Efficacy|0|||
16958064|NCT00950599|38101077|FG004|Follow-Up Period|Lack of Efficacy|0|||
16958065|NCT00950599|38101078|FG005|Follow-Up Period|Lack of Efficacy|0|||
16958066|NCT00950599|38101079|FG006|Follow-Up Period|Lack of Efficacy|0|||
16958067|NCT00950599|38101080|FG007|Follow-Up Period|Lack of Efficacy|0|||
16958068|NCT00950599|38101081|FG008|Follow-Up Period|Lack of Efficacy|3|||
16958069|NCT00950599|38101082|FG009|Follow-Up Period|Lack of Efficacy|0|||
16958070|NCT00950599|38101073|FG000|Follow-Up Period|Lost to Follow-up|0|||
16958071|NCT00950599|38101074|FG001|Follow-Up Period|Lost to Follow-up|0|||
16958072|NCT00950599|38101075|FG002|Follow-Up Period|Lost to Follow-up|0|||
16958073|NCT00950599|38101076|FG003|Follow-Up Period|Lost to Follow-up|0|||
16958074|NCT00950599|38101077|FG004|Follow-Up Period|Lost to Follow-up|0|||
16958075|NCT00950599|38101078|FG005|Follow-Up Period|Lost to Follow-up|0|||
16958076|NCT00950599|38101079|FG006|Follow-Up Period|Lost to Follow-up|0|||
16958077|NCT00950599|38101080|FG007|Follow-Up Period|Lost to Follow-up|0|||
16958078|NCT00950599|38101081|FG008|Follow-Up Period|Lost to Follow-up|5|||
16958079|NCT00950599|38101082|FG009|Follow-Up Period|Lost to Follow-up|1|||
16958080|NCT00950599|38101073|FG000|Follow-Up Period|Physician Decision|0|||
16958081|NCT00950599|38101074|FG001|Follow-Up Period|Physician Decision|0|||
16958082|NCT00950599|38101075|FG002|Follow-Up Period|Physician Decision|0|||
16958083|NCT00950599|38101076|FG003|Follow-Up Period|Physician Decision|0|||
16958084|NCT00950599|38101077|FG004|Follow-Up Period|Physician Decision|0|||
16775139|NCT02656017|37714692|FG000|Overall Study|Study burden|3|||
16775140|NCT02656017|37714693|FG001|Overall Study|Study burden|3|||
16775141|NCT02656017|37714692|FG000|Overall Study|Adverse Event|2|||
16775142|NCT02656017|37714693|FG001|Overall Study|Adverse Event|1|||
16775143|NCT02656017|37714692|FG000|Overall Study|Unable/unwilling to take study medication|2|||
16775144|NCT02656017|37714693|FG001|Overall Study|Unable/unwilling to take study medication|1|||
16775145|NCT02656017|37714692|FG000|Overall Study|Began Tolvaptan|1|||
16775146|NCT02656017|37714693|FG001|Overall Study|Began Tolvaptan|1|||
16775147|NCT02656017|37714692|FG000|Overall Study|Withdrawal by Subject|1|||
16775148|NCT02656017|37714693|FG001|Overall Study|Withdrawal by Subject|0|||
16775149|NCT02655237|37714701|FG000|Overall Study|Adverse Event|10|||
16775150|NCT02655237|37714702|FG001|Overall Study|Adverse Event|7|||
16775151|NCT02655237|37714701|FG000|Overall Study|Protocol Deviation|2|||
16775152|NCT02655237|37714702|FG001|Overall Study|Protocol Deviation|0|||
16775153|NCT02655237|37714701|FG000|Overall Study|Withdrawal by Participant|1|||
16775154|NCT02655237|37714702|FG001|Overall Study|Withdrawal by Participant|2|||
16775155|NCT02655237|37714701|FG000|Overall Study|Lack of Efficacy|0|||
16775156|NCT02655237|37714702|FG001|Overall Study|Lack of Efficacy|1|||
16775157|NCT02655237|37714701|FG000|Overall Study|Recovery Leading to Surgery|2|||
16775158|NCT02655237|37714702|FG001|Overall Study|Recovery Leading to Surgery|1|||
16775159|NCT02655237|37714701|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
16775160|NCT02655237|37714702|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
16775161|NCT02655237|37714701|FG000|Overall Study|Randomized but Not Treated|1|||
16775162|NCT02655237|37714702|FG001|Overall Study|Randomized but Not Treated|0|||
16775163|NCT02657031|37714710|FG000|Overall Study|Adverse Event|1|||
16775164|NCT02657031|37714711|FG001|Overall Study|Adverse Event|2|||
16775165|NCT04375397|37714739|FG000|Overall Study|Death|1|||
16775166|NCT04375397|37714740|FG001|Overall Study|Death|1|||
16775167|NCT04375397|37714739|FG000|Overall Study|Withdrew consent|2|||
16775168|NCT04375397|37714740|FG001|Overall Study|Withdrew consent|0|||
16775169|NCT04375397|37714739|FG000|Overall Study|Lost to Follow-up|6|||
16775170|NCT04375397|37714740|FG001|Overall Study|Lost to Follow-up|4|||
16775171|NCT04375397|37714739|FG000|Overall Study|Other, not specified|0|||
16775172|NCT04375397|37714740|FG001|Overall Study|Other, not specified|1|||
16775173|NCT02387216|37714748|FG000|Overall Study|Progressive disease|2|||
16775174|NCT02387216|37714749|FG001|Overall Study|Progressive disease|0|||
16775175|NCT02387216|37714748|FG000|Overall Study|Withdrawal by Subject|3|||
16775176|NCT02387216|37714749|FG001|Overall Study|Withdrawal by Subject|5|||
16775177|NCT02387216|37714748|FG000|Overall Study|Physician Decision|2|||
16775178|NCT02387216|37714749|FG001|Overall Study|Physician Decision|0|||
16775179|NCT02387216|37714748|FG000|Overall Study|Sponsor Decision|28|||
16775180|NCT02387216|37714749|FG001|Overall Study|Sponsor Decision|12|||
16775181|NCT02387216|37714748|FG000|Overall Study|Death|60|||
16775182|NCT02387216|37714749|FG001|Overall Study|Death|23|||
16775183|NCT02387216|37714748|FG000|Overall Study|Other|5|||
16775184|NCT02387216|37714749|FG001|Overall Study|Other|4|||
16775185|NCT02387216|37714748|FG000|Overall Study|Lost to Follow-up|0|||
16775186|NCT02387216|37714749|FG001|Overall Study|Lost to Follow-up|3|||
16775187|NCT02417246|37714757|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
16775188|NCT02417246|37714758|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
16775189|NCT02417246|37714757|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
16775190|NCT02417246|37714758|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
16775191|NCT02417246|37714757|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
16775192|NCT02417246|37714758|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
16775193|NCT02417246|37714757|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
16775194|NCT02417246|37714758|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
16775195|NCT02424734|37714769|FG000|Overall Study|Treatment stopped to be discharged home|2|||
16775196|NCT02424734|37714770|FG001|Overall Study|Treatment stopped to be discharged home|2|||
16775197|NCT02424734|37714771|FG002|Overall Study|Treatment stopped to be discharged home|0|||
16775198|NCT02424578|37714782|FG000|Overall Study|Withdrawal by Subject|0|||
16775199|NCT02424578|37714783|FG001|Overall Study|Withdrawal by Subject|1|||
16775200|NCT02416934|37714791|FG000|Overall Study|given steroids|1|||
16775201|NCT02416934|37714792|FG001|Overall Study|given steroids|2|||
16775202|NCT02416934|37714791|FG000|Overall Study|Lost to Follow-up|0|||
16775203|NCT02416934|37714792|FG001|Overall Study|Lost to Follow-up|2|||
16775204|NCT02416934|37714791|FG000|Overall Study|Withdrawal by Subject|1|||
16775205|NCT02416934|37714792|FG001|Overall Study|Withdrawal by Subject|0|||
16775206|NCT02416934|37714791|FG000|Overall Study|recruited during continuing renewal proc|0|||
16775207|NCT02416934|37714792|FG001|Overall Study|recruited during continuing renewal proc|1|||
16775208|NCT02416934|37714791|FG000|Overall Study|Protocol Violation|0|||
16775209|NCT02416934|37714792|FG001|Overall Study|Protocol Violation|1|||
16775210|NCT02416934|37714791|FG000|Overall Study|surgery started late|0|||
16775211|NCT02416934|37714792|FG001|Overall Study|surgery started late|1|||
16775212|NCT02416934|37714791|FG000|Overall Study|re-operation|1|||
16775213|NCT02416934|37714792|FG001|Overall Study|re-operation|0|||
16775214|NCT02819635|37714812|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
16775215|NCT02819635|37714813|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
16775216|NCT02819635|37714814|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
16775217|NCT02819635|37714815|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
16775218|NCT02819635|37714816|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
16775219|NCT02819635|37714817|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
16775220|NCT02819635|37714818|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
16775221|NCT02819635|37714819|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16775222|NCT02819635|37714820|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16775223|NCT02819635|37714821|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16775224|NCT02819635|37714822|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16775225|NCT02819635|37714823|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16775226|NCT02819635|37714812|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775227|NCT02819635|37714813|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775228|NCT02819635|37714814|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775229|NCT02819635|37714815|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775230|NCT02819635|37714816|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
16775231|NCT02819635|37714817|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
16775232|NCT02819635|37714818|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
16775233|NCT02819635|37714819|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775234|NCT02819635|37714820|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775235|NCT02819635|37714821|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775236|NCT02819635|37714822|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775237|NCT02819635|37714823|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16775238|NCT02819635|37714812|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775239|NCT02819635|37714813|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775240|NCT02819635|37714814|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775241|NCT02819635|37714815|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775242|NCT02819635|37714816|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775243|NCT02819635|37714817|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
16775244|NCT02819635|37714818|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
16775245|NCT02819635|37714819|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775246|NCT02819635|37714820|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775247|NCT02819635|37714821|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775248|NCT02819635|37714822|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775249|NCT02819635|37714823|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16775250|NCT02819635|37714812|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775251|NCT02819635|37714813|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775252|NCT02819635|37714814|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775253|NCT02819635|37714815|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775254|NCT02819635|37714816|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775255|NCT02819635|37714817|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775256|NCT02819635|37714818|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
16775257|NCT02819635|37714819|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775258|NCT02819635|37714820|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775259|NCT02819635|37714821|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775260|NCT02819635|37714822|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775261|NCT02819635|37714823|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16775262|NCT02819635|37714812|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
16775263|NCT02819635|37714813|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
16775264|NCT02819635|37714814|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
16775265|NCT02819635|37714815|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
16775266|NCT02819635|37714816|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
16775267|NCT02819635|37714817|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
16775268|NCT02819635|37714818|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
16775269|NCT02819635|37714819|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16775270|NCT02819635|37714820|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16775271|NCT02819635|37714821|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16775272|NCT02819635|37714822|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16775273|NCT02819635|37714823|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16775274|NCT02819635|37714812|FG000|Substudy 2, Part 2|Adverse Event|0|||
16775275|NCT02819635|37714813|FG001|Substudy 2, Part 2|Adverse Event|0|||
16775276|NCT02819635|37714814|FG002|Substudy 2, Part 2|Adverse Event|0|||
16775277|NCT02819635|37714815|FG003|Substudy 2, Part 2|Adverse Event|0|||
16775278|NCT02819635|37714816|FG004|Substudy 2, Part 2|Adverse Event|0|||
16775279|NCT02819635|37714817|FG005|Substudy 2, Part 2|Adverse Event|4|||
16775280|NCT02819635|37714818|FG006|Substudy 2, Part 2|Adverse Event|0|||
16775281|NCT02819635|37714819|FG007|Substudy 2, Part 2|Adverse Event|0|||
16775282|NCT02819635|37714820|FG008|Substudy 2, Part 2|Adverse Event|0|||
16775283|NCT02819635|37714821|FG009|Substudy 2, Part 2|Adverse Event|0|||
16775284|NCT02819635|37714822|FG010|Substudy 2, Part 2|Adverse Event|0|||
16775285|NCT02819635|37714823|FG011|Substudy 2, Part 2|Adverse Event|0|||
16775286|NCT02819635|37714812|FG000|Substudy 2, Part 2|Withdrew consent|0|||
16775287|NCT02819635|37714813|FG001|Substudy 2, Part 2|Withdrew consent|0|||
16775288|NCT02819635|37714814|FG002|Substudy 2, Part 2|Withdrew consent|0|||
16775289|NCT02819635|37714815|FG003|Substudy 2, Part 2|Withdrew consent|0|||
16775290|NCT02819635|37714816|FG004|Substudy 2, Part 2|Withdrew consent|0|||
16775291|NCT02819635|37714817|FG005|Substudy 2, Part 2|Withdrew consent|3|||
16775292|NCT02819635|37714818|FG006|Substudy 2, Part 2|Withdrew consent|1|||
16775293|NCT02819635|37714819|FG007|Substudy 2, Part 2|Withdrew consent|0|||
16775294|NCT02819635|37714820|FG008|Substudy 2, Part 2|Withdrew consent|0|||
16775295|NCT02819635|37714821|FG009|Substudy 2, Part 2|Withdrew consent|0|||
16775296|NCT02819635|37714822|FG010|Substudy 2, Part 2|Withdrew consent|0|||
16775297|NCT02819635|37714823|FG011|Substudy 2, Part 2|Withdrew consent|0|||
16775298|NCT02819635|37714812|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
16775299|NCT02819635|37714813|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
16775300|NCT02819635|37714814|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
16775301|NCT02819635|37714815|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
16775302|NCT02819635|37714816|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
16775303|NCT02819635|37714817|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
16775304|NCT02819635|37714818|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
16775305|NCT02819635|37714819|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
16775306|NCT02819635|37714820|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
16775307|NCT02819635|37714821|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
16775308|NCT02819635|37714822|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
16775309|NCT02819635|37714823|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
16775310|NCT02819635|37714812|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775311|NCT02819635|37714813|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775312|NCT02819635|37714814|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775313|NCT02819635|37714815|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775314|NCT02819635|37714816|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775315|NCT02819635|37714817|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775316|NCT02819635|37714818|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
16775317|NCT02819635|37714819|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775318|NCT02819635|37714820|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775319|NCT02819635|37714821|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775320|NCT02819635|37714822|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775321|NCT02819635|37714823|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16775322|NCT02819635|37714812|FG000|Substudy 2, Part 2|Other, not specified|0|||
16775323|NCT02819635|37714813|FG001|Substudy 2, Part 2|Other, not specified|0|||
16775324|NCT02819635|37714814|FG002|Substudy 2, Part 2|Other, not specified|0|||
16775325|NCT02819635|37714815|FG003|Substudy 2, Part 2|Other, not specified|0|||
16775326|NCT02819635|37714816|FG004|Substudy 2, Part 2|Other, not specified|0|||
16775327|NCT02819635|37714817|FG005|Substudy 2, Part 2|Other, not specified|4|||
16775328|NCT02819635|37714818|FG006|Substudy 2, Part 2|Other, not specified|8|||
16775329|NCT02819635|37714819|FG007|Substudy 2, Part 2|Other, not specified|0|||
16775330|NCT02819635|37714820|FG008|Substudy 2, Part 2|Other, not specified|0|||
16775331|NCT02819635|37714821|FG009|Substudy 2, Part 2|Other, not specified|0|||
16775332|NCT02819635|37714822|FG010|Substudy 2, Part 2|Other, not specified|0|||
16775333|NCT02819635|37714823|FG011|Substudy 2, Part 2|Other, not specified|0|||
16775334|NCT02819635|37714812|FG000|Substudy 3|Adverse Event|0|||
16775335|NCT02819635|37714813|FG001|Substudy 3|Adverse Event|0|||
16775336|NCT02819635|37714814|FG002|Substudy 3|Adverse Event|0|||
16775337|NCT02819635|37714815|FG003|Substudy 3|Adverse Event|0|||
16775338|NCT02819635|37714816|FG004|Substudy 3|Adverse Event|0|||
16775339|NCT02819635|37714817|FG005|Substudy 3|Adverse Event|0|||
16775340|NCT02819635|37714818|FG006|Substudy 3|Adverse Event|0|||
16775341|NCT02819635|37714819|FG007|Substudy 3|Adverse Event|0|||
16775342|NCT02819635|37714820|FG008|Substudy 3|Adverse Event|32|||
16775343|NCT02819635|37714821|FG009|Substudy 3|Adverse Event|3|||
16775344|NCT02819635|37714822|FG010|Substudy 3|Adverse Event|12|||
16775345|NCT02819635|37714823|FG011|Substudy 3|Adverse Event|18|||
16775346|NCT02819635|37714812|FG000|Substudy 3|Withdrew consent|0|||
16775347|NCT02819635|37714813|FG001|Substudy 3|Withdrew consent|0|||
16775348|NCT02819635|37714814|FG002|Substudy 3|Withdrew consent|0|||
16775349|NCT02819635|37714815|FG003|Substudy 3|Withdrew consent|0|||
16775350|NCT02819635|37714816|FG004|Substudy 3|Withdrew consent|0|||
16775351|NCT02819635|37714817|FG005|Substudy 3|Withdrew consent|0|||
16775352|NCT02819635|37714818|FG006|Substudy 3|Withdrew consent|0|||
16775353|NCT02819635|37714819|FG007|Substudy 3|Withdrew consent|0|||
16775354|NCT02819635|37714820|FG008|Substudy 3|Withdrew consent|11|||
16775355|NCT02819635|37714821|FG009|Substudy 3|Withdrew consent|1|||
16775356|NCT02819635|37714822|FG010|Substudy 3|Withdrew consent|4|||
16775357|NCT02819635|37714823|FG011|Substudy 3|Withdrew consent|9|||
16775358|NCT02819635|37714812|FG000|Substudy 3|Lost to Follow-up|0|||
16775359|NCT02819635|37714813|FG001|Substudy 3|Lost to Follow-up|0|||
16775360|NCT02819635|37714814|FG002|Substudy 3|Lost to Follow-up|0|||
16775361|NCT02819635|37714815|FG003|Substudy 3|Lost to Follow-up|0|||
16775362|NCT02819635|37714816|FG004|Substudy 3|Lost to Follow-up|0|||
16775363|NCT02819635|37714817|FG005|Substudy 3|Lost to Follow-up|0|||
16775364|NCT02819635|37714818|FG006|Substudy 3|Lost to Follow-up|0|||
16775365|NCT02819635|37714819|FG007|Substudy 3|Lost to Follow-up|0|||
16775366|NCT02819635|37714820|FG008|Substudy 3|Lost to Follow-up|1|||
16775367|NCT02819635|37714821|FG009|Substudy 3|Lost to Follow-up|0|||
16775368|NCT02819635|37714822|FG010|Substudy 3|Lost to Follow-up|1|||
16775369|NCT02819635|37714823|FG011|Substudy 3|Lost to Follow-up|1|||
16775370|NCT02819635|37714812|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775371|NCT02819635|37714813|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775372|NCT02819635|37714814|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775373|NCT02819635|37714815|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775374|NCT02819635|37714816|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775375|NCT02819635|37714817|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775376|NCT02819635|37714818|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775377|NCT02819635|37714819|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775378|NCT02819635|37714820|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775379|NCT02819635|37714821|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775380|NCT02819635|37714822|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
16775381|NCT02819635|37714823|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
16775382|NCT02819635|37714812|FG000|Substudy 3|Other, not specified|0|||
16775383|NCT02819635|37714813|FG001|Substudy 3|Other, not specified|0|||
16775384|NCT02819635|37714814|FG002|Substudy 3|Other, not specified|0|||
16775385|NCT02819635|37714815|FG003|Substudy 3|Other, not specified|0|||
16775386|NCT02819635|37714816|FG004|Substudy 3|Other, not specified|0|||
16775387|NCT02819635|37714817|FG005|Substudy 3|Other, not specified|0|||
16775388|NCT02819635|37714818|FG006|Substudy 3|Other, not specified|0|||
16775389|NCT02819635|37714819|FG007|Substudy 3|Other, not specified|0|||
16775390|NCT02819635|37714820|FG008|Substudy 3|Other, not specified|202|||
16775391|NCT02819635|37714821|FG009|Substudy 3|Other, not specified|5|||
16775392|NCT02819635|37714822|FG010|Substudy 3|Other, not specified|89|||
16775393|NCT02819635|37714823|FG011|Substudy 3|Other, not specified|39|||
16775394|NCT02424344|37714858|FG000|Overall Study|Lack of Efficacy|0|||
16775395|NCT02424344|37714859|FG001|Overall Study|Lack of Efficacy|1|||
16775396|NCT02424344|37714858|FG000|Overall Study|Withdrawal by Subject|2|||
16775397|NCT02424344|37714859|FG001|Overall Study|Withdrawal by Subject|1|||
16775398|NCT02424344|37714858|FG000|Overall Study|Lost to Follow-up|1|||
16775399|NCT02424344|37714859|FG001|Overall Study|Lost to Follow-up|0|||
16775400|NCT02424344|37714858|FG000|Overall Study|Adverse Event|4|||
16775401|NCT02424344|37714859|FG001|Overall Study|Adverse Event|8|||
16775402|NCT02423798|37714865|FG000|Overall Study|Withdrawal by Subject|3|||
16775403|NCT01651208|37714888|FG000|Overall Study|Lost to Follow-up|14|||
16775404|NCT01651208|37714889|FG001|Overall Study|Lost to Follow-up|16|||
16775405|NCT02383940|37714898|FG000|Overall Study|Adverse Event|1|||
16775406|NCT02383940|37714899|FG001|Overall Study|Adverse Event|0|||
16775407|NCT02383940|37714898|FG000|Overall Study|Lost to Follow-up|2|||
16775408|NCT02383940|37714899|FG001|Overall Study|Lost to Follow-up|2|||
16775409|NCT02383940|37714898|FG000|Overall Study|Physician Decision|2|||
16775410|NCT02383940|37714899|FG001|Overall Study|Physician Decision|0|||
16775411|NCT02383940|37714898|FG000|Overall Study|Withdrawal by Subject|1|||
16775412|NCT02383940|37714899|FG001|Overall Study|Withdrawal by Subject|1|||
16775413|NCT02383940|37714898|FG000|Overall Study|Randomized but not treated|2|||
16775414|NCT02383940|37714899|FG001|Overall Study|Randomized but not treated|0|||
16775415|NCT02383940|37714898|FG000|Overall Study|Other than specified above|1|||
16775416|NCT02383940|37714899|FG001|Overall Study|Other than specified above|0|||
16775417|NCT02383862|37714907|FG000|3 Month Follow up|Lost to Follow-up|23|||
16775418|NCT02383862|37714908|FG001|3 Month Follow up|Lost to Follow-up|21|||
16775419|NCT02383472|37714923|FG000|Overall Study|Withdrawal by Subject|1|||
16775420|NCT02383472|37714924|FG001|Overall Study|Withdrawal by Subject|1|||
16775421|NCT02234323|37714932|FG000|All Enrolled|Not Treated: Completed study in database|2|||
16775422|NCT02234323|37714932|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
16775423|NCT02234323|37714932|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
16775424|NCT02234323|37714932|FG000|All Treated|Death|1|||
16775425|NCT02234323|37714932|FG000|All Treated|Physician Decision|5|||
16775426|NCT02234323|37714932|FG000|All Treated|Lack of Efficacy|3|||
16775427|NCT02234323|37714932|FG000|All Treated|Exceeded lab value limit|2|||
16775428|NCT02234323|37714932|FG000|All Treated|Other|7|||
16958085|NCT00950599|38101078|FG005|Follow-Up Period|Physician Decision|0|||
16958086|NCT00950599|38101079|FG006|Follow-Up Period|Physician Decision|0|||
16958087|NCT00950599|38101080|FG007|Follow-Up Period|Physician Decision|0|||
16958088|NCT00950599|38101081|FG008|Follow-Up Period|Physician Decision|1|||
16958089|NCT00950599|38101082|FG009|Follow-Up Period|Physician Decision|0|||
16958090|NCT00950599|38101073|FG000|Follow-Up Period|Poor/Noncompliance|0|||
16958091|NCT00950599|38101074|FG001|Follow-Up Period|Poor/Noncompliance|0|||
16958092|NCT00950599|38101075|FG002|Follow-Up Period|Poor/Noncompliance|0|||
16958093|NCT00950599|38101076|FG003|Follow-Up Period|Poor/Noncompliance|0|||
16958094|NCT00950599|38101077|FG004|Follow-Up Period|Poor/Noncompliance|0|||
16958095|NCT00950599|38101078|FG005|Follow-Up Period|Poor/Noncompliance|0|||
16958096|NCT00950599|38101079|FG006|Follow-Up Period|Poor/Noncompliance|0|||
16958097|NCT00950599|38101080|FG007|Follow-Up Period|Poor/Noncompliance|0|||
16958098|NCT00950599|38101081|FG008|Follow-Up Period|Poor/Noncompliance|1|||
16958099|NCT00950599|38101082|FG009|Follow-Up Period|Poor/Noncompliance|0|||
16958100|NCT00950599|38101073|FG000|Follow-Up Period|Subject withdrew Consent|0|||
16958101|NCT00950599|38101074|FG001|Follow-Up Period|Subject withdrew Consent|0|||
16958102|NCT00950599|38101075|FG002|Follow-Up Period|Subject withdrew Consent|0|||
16958103|NCT00950599|38101076|FG003|Follow-Up Period|Subject withdrew Consent|0|||
16958104|NCT00950599|38101077|FG004|Follow-Up Period|Subject withdrew Consent|0|||
16958105|NCT00950599|38101078|FG005|Follow-Up Period|Subject withdrew Consent|0|||
16958106|NCT00950599|38101079|FG006|Follow-Up Period|Subject withdrew Consent|0|||
16958107|NCT00950599|38101080|FG007|Follow-Up Period|Subject withdrew Consent|0|||
16958108|NCT00950599|38101081|FG008|Follow-Up Period|Subject withdrew Consent|2|||
16958109|NCT00950599|38101082|FG009|Follow-Up Period|Subject withdrew Consent|1|||
16958110|NCT01144299|38101107|FG000|Overall Study|Lost to Follow-up|1|||
16958111|NCT01144299|38101108|FG001|Overall Study|Lost to Follow-up|0|||
16958112|NCT01144299|38101107|FG000|Overall Study|Withdrawal by Subject|1|||
16958113|NCT01144299|38101108|FG001|Overall Study|Withdrawal by Subject|0|||
16958114|NCT01143207|38101114|FG000|Overall Study|Lost to Follow-up|2|||
16958115|NCT01143051|38101124|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
16958116|NCT01143051|38101125|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
16958117|NCT01143051|38101126|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
16958118|NCT01143051|38101127|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
16958119|NCT01143051|38101128|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
16958120|NCT01143051|38101129|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
16958121|NCT01143051|38101124|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
16958122|NCT01143051|38101125|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
16958123|NCT01143051|38101126|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
16958124|NCT01143051|38101127|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
16958125|NCT01143051|38101128|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
16958126|NCT01143051|38101129|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
16958127|NCT01142661|38101139|FG000|Overall Study|Adverse Event|2|||
16958128|NCT01142661|38101139|FG000|Overall Study|Withdrawal by Subject|1|||
16775429|NCT02414828|37714942|FG000|Overall Study|Lost to Follow-up|0|||
16775430|NCT02414828|37714943|FG001|Overall Study|Lost to Follow-up|1|||
16775431|NCT02414828|37714944|FG002|Overall Study|Lost to Follow-up|1|||
16775432|NCT02414828|37714945|FG003|Overall Study|Lost to Follow-up|2|||
16775433|NCT02413346|37714958|FG000|Overall Study|Adverse Event|6|||
16775434|NCT02413346|37714959|FG001|Overall Study|Adverse Event|6|||
16775435|NCT02413346|37714958|FG000|Overall Study|Withdrawal by Subject|30|||
16775436|NCT02413346|37714959|FG001|Overall Study|Withdrawal by Subject|40|||
16775437|NCT02413346|37714958|FG000|Overall Study|Lost to Follow-up|17|||
16775438|NCT02413346|37714959|FG001|Overall Study|Lost to Follow-up|21|||
16775439|NCT02413346|37714958|FG000|Overall Study|Protocol Violation|2|||
16775440|NCT02413346|37714959|FG001|Overall Study|Protocol Violation|0|||
16775441|NCT02413346|37714958|FG000|Overall Study|Other Miscellaneous Reasons|4|||
16775442|NCT02413346|37714959|FG001|Overall Study|Other Miscellaneous Reasons|3|||
16775443|NCT03390101|37714972|FG000|Weeks 0-12|Withdrawal by Subject|0|||
16775444|NCT03390101|37714973|FG001|Weeks 0-12|Withdrawal by Subject|1|||
16775445|NCT03390101|37714974|FG002|Weeks 0-12|Withdrawal by Subject|1|||
16775446|NCT03390101|37714972|FG000|Weeks 0-12|Lost to Follow-up|0|||
16867958|NCT01536535|37840977|FG000|Overall Study|Lost to Follow-up|4|||
16775447|NCT03390101|37714973|FG001|Weeks 0-12|Lost to Follow-up|1|||
16775448|NCT03390101|37714974|FG002|Weeks 0-12|Lost to Follow-up|0|||
16775449|NCT03390101|37714972|FG000|Weeks 12-54|Withdrawal by Subject|0|||
16775450|NCT03390101|37714973|FG001|Weeks 12-54|Withdrawal by Subject|3|||
16775451|NCT03390101|37714974|FG002|Weeks 12-54|Withdrawal by Subject|1|||
16775452|NCT03390101|37714972|FG000|Weeks 12-54|Pregnancy|1|||
16775453|NCT03390101|37714973|FG001|Weeks 12-54|Pregnancy|0|||
16775454|NCT03390101|37714974|FG002|Weeks 12-54|Pregnancy|0|||
16775455|NCT03390101|37714972|FG000|Weeks 12-54|Adverse Event|2|||
16775456|NCT03390101|37714973|FG001|Weeks 12-54|Adverse Event|1|||
16775457|NCT03390101|37714974|FG002|Weeks 12-54|Adverse Event|1|||
16775458|NCT02732639|37714982|FG000|Overall Study|Lost to Follow-up|1|||
16775459|NCT02732561|37714988|FG000|Overall Study|Lost to Follow-up|1|||
16775460|NCT02732561|37714989|FG001|Overall Study|Lost to Follow-up|1|||
16775461|NCT02732561|37714988|FG000|Overall Study|Withdrawal by Subject|1|||
16775462|NCT02732561|37714989|FG001|Overall Study|Withdrawal by Subject|0|||
16775463|NCT02412878|37714997|FG000|Overall Study|Withdrawal by Subject|19|||
16775464|NCT02412878|37714998|FG001|Overall Study|Withdrawal by Subject|10|||
16775465|NCT02412878|37714997|FG000|Overall Study|Lost to Follow-up|2|||
16775466|NCT02412878|37714998|FG001|Overall Study|Lost to Follow-up|3|||
16775467|NCT02380742|37715006|FG000|Overall Study|Withdrawal by Subject|1|||
16775468|NCT02380742|37715007|FG001|Overall Study|Withdrawal by Subject|0|||
16775469|NCT02922725|37715016|FG000|Overall Study|Withdrawal by Subject|1|||
16775470|NCT02922725|37715017|FG001|Overall Study|Withdrawal by Subject|0|||
16775471|NCT02922725|37715018|FG002|Overall Study|Withdrawal by Subject|0|||
16775472|NCT02805257|37715027|FG000|Overall Study|Lost to Follow-up|7|||
16775473|NCT02805257|37715028|FG001|Overall Study|Lost to Follow-up|6|||
16775474|NCT02805257|37715027|FG000|Overall Study|Death|0|||
16775475|NCT02805257|37715028|FG001|Overall Study|Death|1|||
16775476|NCT04794803|37715036|FG000|Overall Study|Death|1|||
16775477|NCT04794803|37715037|FG001|Overall Study|Death|3|||
16775478|NCT04794803|37715036|FG000|Overall Study|Lost to Follow-up|2|||
16775479|NCT04794803|37715037|FG001|Overall Study|Lost to Follow-up|2|||
16775480|NCT04794803|37715036|FG000|Overall Study|Withdrawal by Subject|1|||
16775481|NCT04794803|37715037|FG001|Overall Study|Withdrawal by Subject|0|||
16775482|NCT04794803|37715036|FG000|Overall Study|Physician Decision|1|||
16775483|NCT04794803|37715037|FG001|Overall Study|Physician Decision|1|||
16775484|NCT04794803|37715036|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
16775485|NCT04794803|37715037|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
16775486|NCT04794803|37715036|FG000|Overall Study|Refused to continue the treatment|1|||
16775487|NCT04794803|37715037|FG001|Overall Study|Refused to continue the treatment|0|||
16775488|NCT04794803|37715036|FG000|Overall Study|Patient admitted to ICU|0|||
16775489|NCT04794803|37715037|FG001|Overall Study|Patient admitted to ICU|1|||
16775490|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
16958129|NCT01142661|38101139|FG000|Overall Study|Physician Decision|1|||
16958130|NCT01142193|38101145|FG000|Overall Study|Adverse Event|12|||
16958131|NCT01142193|38101146|FG001|Overall Study|Adverse Event|4|||
16958132|NCT01142193|38101145|FG000|Overall Study|Lack of Efficacy|2|||
16958133|NCT01142193|38101146|FG001|Overall Study|Lack of Efficacy|1|||
16958134|NCT01142193|38101145|FG000|Overall Study|Physician Decision|1|||
16958135|NCT01142193|38101146|FG001|Overall Study|Physician Decision|1|||
16958136|NCT01142193|38101145|FG000|Overall Study|Withdrawal by Subject|4|||
16958137|NCT01142193|38101146|FG001|Overall Study|Withdrawal by Subject|3|||
16958138|NCT01142193|38101145|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
16958139|NCT01142193|38101146|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
16958140|NCT01142193|38101145|FG000|Overall Study|Other|1|||
16958141|NCT01142193|38101146|FG001|Overall Study|Other|2|||
16958142|NCT01142115|38101152|FG000|First Intervention|Lack of Efficacy|1|||
16958143|NCT01142115|38101153|FG001|First Intervention|Lack of Efficacy|1|||
16958144|NCT01142115|38101152|FG000|First Intervention|Adverse Event|1|||
16958145|NCT01142115|38101153|FG001|First Intervention|Adverse Event|0|||
16958146|NCT01140477|38101160|FG000|Overall Study|Lost to Follow-up|4|||
16958147|NCT01140477|38101161|FG001|Overall Study|Lost to Follow-up|0|||
16958148|NCT01140477|38101160|FG000|Overall Study|Withdrawal by Subject|1|||
16958149|NCT01140477|38101161|FG001|Overall Study|Withdrawal by Subject|4|||
16958150|NCT01140477|38101160|FG000|Overall Study|Surgical complication preventing implant|2|||
16958151|NCT01140477|38101161|FG001|Overall Study|Surgical complication preventing implant|0|||
16958152|NCT01140477|38101160|FG000|Overall Study|Death|1|||
16958153|NCT01140477|38101161|FG001|Overall Study|Death|1|||
16958154|NCT01140477|38101160|FG000|Overall Study|Subject explanted|0|||
16958155|NCT01140477|38101161|FG001|Overall Study|Subject explanted|1|||
16958156|NCT01139775|38101170|FG000|Overall Study|Adverse Event|0|||
16958157|NCT01139775|38101171|FG001|Overall Study|Adverse Event|6|||
16775491|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16775492|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16775493|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16775494|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16775495|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16775496|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16775497|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
16775498|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16775499|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16775500|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16775501|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16775502|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16775503|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16775504|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16775505|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
16775506|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16775507|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16775508|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16775509|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16775510|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16775511|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16775512|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16775513|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
16775514|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16775515|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16775516|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16775517|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16775518|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16775519|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16775520|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
16775521|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16775522|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16775523|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16775524|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16775525|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16775526|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16775527|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
16775528|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16775529|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16775530|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16775531|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16775532|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16775533|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16775534|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16775535|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
16775536|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16775537|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16775538|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16775539|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16775540|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16775541|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16775542|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
16775543|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16775544|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16775545|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16775546|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16775547|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16775548|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16775549|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16775550|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
16775551|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16775552|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16775553|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16775554|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16775555|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16775556|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16775557|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
16775558|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16775559|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16775560|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16775561|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16958158|NCT01139775|38101172|FG002|Overall Study|Adverse Event|2|||
16958159|NCT01139775|38101170|FG000|Overall Study|Protocol Violation|0|||
16958160|NCT01139775|38101171|FG001|Overall Study|Protocol Violation|5|||
16958161|NCT01139775|38101172|FG002|Overall Study|Protocol Violation|0|||
16958162|NCT01139775|38101170|FG000|Overall Study|Withdrawal by Subject|1|||
16958163|NCT01139775|38101171|FG001|Overall Study|Withdrawal by Subject|0|||
16958164|NCT01139775|38101172|FG002|Overall Study|Withdrawal by Subject|2|||
16958165|NCT01139775|38101170|FG000|Overall Study|Physician Decision|0|||
16958166|NCT01139775|38101171|FG001|Overall Study|Physician Decision|2|||
16958167|NCT01139775|38101172|FG002|Overall Study|Physician Decision|2|||
16958168|NCT01283516|38101191|FG000|Overall Study|Adverse Event|0|||
16958169|NCT01283516|38101192|FG001|Overall Study|Adverse Event|0|||
16958170|NCT01283516|38101193|FG002|Overall Study|Adverse Event|0|||
16958171|NCT01283516|38101194|FG003|Overall Study|Adverse Event|0|||
16958172|NCT01283516|38101195|FG004|Overall Study|Adverse Event|0|||
16958173|NCT01283516|38101196|FG005|Overall Study|Adverse Event|0|||
16958174|NCT01283516|38101197|FG006|Overall Study|Adverse Event|2|||
16958175|NCT01283516|38101198|FG007|Overall Study|Adverse Event|0|||
16958176|NCT01283516|38101199|FG008|Overall Study|Adverse Event|28|||
16958177|NCT01283516|38101191|FG000|Overall Study|Death|0|||
16958178|NCT01283516|38101192|FG001|Overall Study|Death|0|||
16958179|NCT01283516|38101193|FG002|Overall Study|Death|0|||
16958180|NCT01283516|38101194|FG003|Overall Study|Death|0|||
16958181|NCT01283516|38101195|FG004|Overall Study|Death|0|||
16958182|NCT01283516|38101196|FG005|Overall Study|Death|1|||
16958183|NCT01283516|38101197|FG006|Overall Study|Death|0|||
16958184|NCT01283516|38101198|FG007|Overall Study|Death|1|||
16958185|NCT01283516|38101199|FG008|Overall Study|Death|12|||
16958186|NCT01283516|38101191|FG000|Overall Study|Disease Progression|2|||
16958187|NCT01283516|38101192|FG001|Overall Study|Disease Progression|2|||
16958188|NCT01283516|38101193|FG002|Overall Study|Disease Progression|3|||
16958189|NCT01283516|38101194|FG003|Overall Study|Disease Progression|3|||
16958190|NCT01283516|38101195|FG004|Overall Study|Disease Progression|13|||
16958191|NCT01283516|38101196|FG005|Overall Study|Disease Progression|8|||
16958192|NCT01283516|38101197|FG006|Overall Study|Disease Progression|6|||
16958193|NCT01283516|38101198|FG007|Overall Study|Disease Progression|3|||
16958194|NCT01283516|38101199|FG008|Overall Study|Disease Progression|139|||
16958195|NCT01283516|38101191|FG000|Overall Study|Withdrawal by Subject|0|||
16958196|NCT01283516|38101192|FG001|Overall Study|Withdrawal by Subject|0|||
16958197|NCT01283516|38101193|FG002|Overall Study|Withdrawal by Subject|0|||
16958198|NCT01283516|38101194|FG003|Overall Study|Withdrawal by Subject|0|||
16958199|NCT01283516|38101195|FG004|Overall Study|Withdrawal by Subject|1|||
16958200|NCT01283516|38101196|FG005|Overall Study|Withdrawal by Subject|0|||
16958201|NCT01283516|38101197|FG006|Overall Study|Withdrawal by Subject|1|||
16958202|NCT01283516|38101198|FG007|Overall Study|Withdrawal by Subject|0|||
16958203|NCT01283516|38101199|FG008|Overall Study|Withdrawal by Subject|36|||
16958204|NCT01283516|38101191|FG000|Overall Study|Administrative problems|0|||
16958205|NCT01283516|38101192|FG001|Overall Study|Administrative problems|0|||
16958206|NCT01283516|38101193|FG002|Overall Study|Administrative problems|0|||
16958207|NCT01283516|38101194|FG003|Overall Study|Administrative problems|0|||
16958208|NCT01283516|38101195|FG004|Overall Study|Administrative problems|0|||
16958209|NCT01283516|38101196|FG005|Overall Study|Administrative problems|1|||
16958210|NCT01283516|38101197|FG006|Overall Study|Administrative problems|1|||
16958211|NCT01283516|38101198|FG007|Overall Study|Administrative problems|1|||
16958212|NCT01283516|38101199|FG008|Overall Study|Administrative problems|39|||
16958213|NCT01283516|38101191|FG000|Overall Study|Lost to Follow-up|0|||
16958214|NCT01283516|38101192|FG001|Overall Study|Lost to Follow-up|0|||
16958215|NCT01283516|38101193|FG002|Overall Study|Lost to Follow-up|0|||
16958216|NCT01283516|38101194|FG003|Overall Study|Lost to Follow-up|0|||
16958217|NCT01283516|38101195|FG004|Overall Study|Lost to Follow-up|0|||
17133890|NCT00065507|38275171|FG001|Overall Study|Death|17|||
16958218|NCT01283516|38101196|FG005|Overall Study|Lost to Follow-up|0|||
16958219|NCT01283516|38101197|FG006|Overall Study|Lost to Follow-up|0|||
16958220|NCT01283516|38101198|FG007|Overall Study|Lost to Follow-up|0|||
16958221|NCT01283516|38101199|FG008|Overall Study|Lost to Follow-up|1|||
16867959|NCT01536535|37840978|FG001|Overall Study|Lost to Follow-up|6|||
16867960|NCT01536535|37840977|FG000|Overall Study|Physician Decision|1|||
16782555|NCT01663623|37722163|FG000|Overall Study|Protocol Violation|0|||
16782556|NCT01663623|37722164|FG001|Overall Study|Protocol Violation|1|||
16775562|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16775563|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16775564|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
16775565|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16775566|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16775567|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16775568|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16775569|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16775570|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16958222|NCT01137435|38101227|FG000|Overall Study|Lost to Follow-up|24|||
16958223|NCT01137435|38101227|FG000|Overall Study|Off label usage|4|||
16958224|NCT01283282|38101231|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
16958225|NCT01283282|38101232|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
16958226|NCT01283282|38101231|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
16958227|NCT01283282|38101232|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
16958228|NCT01283282|38101231|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
16958229|NCT01283282|38101232|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
16958230|NCT01282814|38101241|FG000|First Intervention|Emesis During Dosing Interval|0|||
16958231|NCT01282814|38101242|FG001|First Intervention|Emesis During Dosing Interval|3|||
16958232|NCT01282814|38101241|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
16958233|NCT01282814|38101242|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16958234|NCT00941863|38101253|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
16958235|NCT00941863|38101254|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
16958236|NCT00941863|38101255|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
16958237|NCT00941863|38101256|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
16958238|NCT00941863|38101257|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
16958239|NCT00941863|38101253|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
16958240|NCT00941863|38101254|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
16958241|NCT00941863|38101255|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
16958242|NCT00941863|38101256|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
16958243|NCT00941863|38101257|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
17133891|NCT00065507|38275170|FG000|Overall Study|Adverse Event|4|||
16775571|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
16775572|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16775573|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16775574|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16775575|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16775576|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16775577|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16775578|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16775579|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
16775580|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16775581|NCT01791595|37715050|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16775582|NCT01791595|37715051|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16775583|NCT01791595|37715052|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16775584|NCT01791595|37715053|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16775585|NCT01791595|37715054|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16775586|NCT01791595|37715055|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
16775587|NCT01791595|37715056|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16775588|NCT01791595|37715050|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16775589|NCT01791595|37715051|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16775590|NCT01791595|37715052|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16775591|NCT01791595|37715053|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16775592|NCT01791595|37715054|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16775593|NCT01791595|37715055|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16775594|NCT01791595|37715056|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
16775595|NCT01791595|37715050|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16775596|NCT01791595|37715051|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16775597|NCT01791595|37715052|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16775598|NCT01791595|37715053|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16775599|NCT01791595|37715054|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16775600|NCT01791595|37715055|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16775601|NCT01791595|37715056|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
16775602|NCT01791595|37715050|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16775603|NCT01791595|37715051|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16775604|NCT01791595|37715052|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16775605|NCT01791595|37715053|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16775606|NCT01791595|37715054|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16775607|NCT01791595|37715055|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16775608|NCT01791595|37715056|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
16775609|NCT01791595|37715050|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16775610|NCT01791595|37715051|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16775611|NCT01791595|37715052|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16775612|NCT01791595|37715053|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16775613|NCT01791595|37715054|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16775614|NCT01791595|37715055|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16775615|NCT01791595|37715056|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
16775616|NCT01559363|37715109|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
16775617|NCT01559363|37715110|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
16775618|NCT01559363|37715111|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
16775619|NCT01559363|37715112|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
16775620|NCT01559363|37715113|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
16958244|NCT00941863|38101253|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
16958245|NCT00941863|38101254|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
16958246|NCT00941863|38101255|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
16958247|NCT00941863|38101256|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
16958248|NCT00941863|38101257|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
16958249|NCT00941863|38101253|FG000|Until Primary Completion Date (PCD)|Death|0|||
16958250|NCT00941863|38101254|FG001|Until Primary Completion Date (PCD)|Death|0|||
16958251|NCT00941863|38101255|FG002|Until Primary Completion Date (PCD)|Death|1|||
16958252|NCT00941863|38101256|FG003|Until Primary Completion Date (PCD)|Death|2|||
16958253|NCT00941863|38101257|FG004|Until Primary Completion Date (PCD)|Death|7|||
16958254|NCT00941863|38101253|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
16958255|NCT00941863|38101254|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
16958256|NCT00941863|38101255|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
16958257|NCT00941863|38101256|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
16958258|NCT00941863|38101257|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
16958259|NCT00941863|38101253|FG000|Continued After PCD|Withdrawal by Subject|0|||
16958260|NCT00941863|38101254|FG001|Continued After PCD|Withdrawal by Subject|0|||
16958261|NCT00941863|38101255|FG002|Continued After PCD|Withdrawal by Subject|0|||
16958262|NCT00941863|38101256|FG003|Continued After PCD|Withdrawal by Subject|0|||
16958263|NCT00941863|38101257|FG004|Continued After PCD|Withdrawal by Subject|1|||
16958264|NCT00941863|38101253|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
16958265|NCT00941863|38101254|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
16958266|NCT00941863|38101255|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
16958267|NCT00941863|38101256|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
16958268|NCT00941863|38101257|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
16958269|NCT01282424|38101273|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
16958270|NCT01282424|38101273|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
16958271|NCT01282424|38101273|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
16958272|NCT01282424|38101273|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
16958273|NCT01282424|38101273|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
16958274|NCT01282424|38101273|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
16958275|NCT01282424|38101273|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
16958276|NCT01282424|38101273|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
16958277|NCT01281956|38101277|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
16958278|NCT01281956|38101278|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
16958279|NCT01279850|38101287|FG000|Overall Study|Protocol Violation|50|||
16958280|NCT01279850|38101287|FG000|Overall Study|No Drug Administration Information|7|||
16958281|NCT01279850|38101287|FG000|Overall Study|No Visit After Treatment|34|||
16958282|NCT00949975|38101295|FG000|Overall Study|Voluntary discontinuation|6|||
16958283|NCT00949975|38101296|FG001|Overall Study|Voluntary discontinuation|5|||
16958284|NCT00949975|38101297|FG002|Overall Study|Voluntary discontinuation|3|||
16958285|NCT00949975|38101298|FG003|Overall Study|Voluntary discontinuation|6|||
16958286|NCT00949975|38101295|FG000|Overall Study|Adverse Event|11|||
16958287|NCT00949975|38101296|FG001|Overall Study|Adverse Event|11|||
16958288|NCT00949975|38101297|FG002|Overall Study|Adverse Event|10|||
16958289|NCT00949975|38101298|FG003|Overall Study|Adverse Event|10|||
16958290|NCT00949975|38101295|FG000|Overall Study|Safety reason|0|||
16958291|NCT00949975|38101296|FG001|Overall Study|Safety reason|1|||
16958292|NCT00949975|38101297|FG002|Overall Study|Safety reason|0|||
16958293|NCT00949975|38101298|FG003|Overall Study|Safety reason|0|||
16958294|NCT00949975|38101295|FG000|Overall Study|Study-specific criteria|0|||
16775621|NCT01559363|37715114|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
16775622|NCT01559363|37715109|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
16775623|NCT01559363|37715110|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
16775624|NCT01559363|37715111|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
16775625|NCT01559363|37715112|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
16775626|NCT01559363|37715113|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
16775627|NCT01559363|37715114|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
16775628|NCT01559363|37715109|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
16775629|NCT01559363|37715110|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
16775630|NCT01559363|37715111|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
16775631|NCT01559363|37715112|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
16775632|NCT01559363|37715113|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
16775633|NCT01559363|37715114|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
16775634|NCT01559363|37715109|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
16775635|NCT01559363|37715110|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
16775636|NCT01559363|37715111|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
16775637|NCT01559363|37715112|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
16775638|NCT01559363|37715113|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
16775639|NCT01559363|37715114|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
16775640|NCT01559363|37715109|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16775641|NCT01559363|37715110|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
16775642|NCT01559363|37715111|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16775643|NCT01559363|37715112|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16775644|NCT01559363|37715113|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16775645|NCT01559363|37715114|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16775646|NCT01559363|37715109|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
16775647|NCT01559363|37715110|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
16775648|NCT01559363|37715111|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
16775649|NCT01559363|37715112|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
16775650|NCT01559363|37715113|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
16775651|NCT01559363|37715114|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
16775652|NCT01559363|37715109|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16775653|NCT01559363|37715110|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16775654|NCT01559363|37715111|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16775655|NCT01559363|37715112|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
16775656|NCT01559363|37715113|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16775657|NCT01559363|37715114|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16775658|NCT02732327|37715136|FG000|Overall Study|Protocol Violation|0|||
16775659|NCT02732327|37715137|FG001|Overall Study|Protocol Violation|1|||
16775660|NCT03179605|37715143|FG000|Overall Study|Withdrawal by Subject|1|||
16775661|NCT02412722|37715153|FG000|Overall Study|Adverse Event|0|||
16775662|NCT02412722|37715154|FG001|Overall Study|Adverse Event|2|||
16775663|NCT02412722|37715155|FG002|Overall Study|Adverse Event|0|||
16775664|NCT02412722|37715156|FG003|Overall Study|Adverse Event|3|||
16775665|NCT02412722|37715157|FG004|Overall Study|Adverse Event|0|||
16775666|NCT02412722|37715158|FG005|Overall Study|Adverse Event|3|||
16775667|NCT02412722|37715153|FG000|Overall Study|Progressive Disease|6|||
16775668|NCT02412722|37715154|FG001|Overall Study|Progressive Disease|4|||
16775669|NCT02412722|37715155|FG002|Overall Study|Progressive Disease|4|||
16775670|NCT02412722|37715156|FG003|Overall Study|Progressive Disease|9|||
16775671|NCT02412722|37715157|FG004|Overall Study|Progressive Disease|3|||
16775672|NCT02412722|37715158|FG005|Overall Study|Progressive Disease|3|||
16775673|NCT02412722|37715153|FG000|Overall Study|Withdrawal by Subject|2|||
16775674|NCT02412722|37715154|FG001|Overall Study|Withdrawal by Subject|0|||
16775675|NCT02412722|37715155|FG002|Overall Study|Withdrawal by Subject|1|||
16775676|NCT02412722|37715156|FG003|Overall Study|Withdrawal by Subject|2|||
16775677|NCT02412722|37715157|FG004|Overall Study|Withdrawal by Subject|1|||
16775678|NCT02412722|37715158|FG005|Overall Study|Withdrawal by Subject|1|||
16775679|NCT02412722|37715153|FG000|Overall Study|Lost to Follow-up|0|||
16775680|NCT02412722|37715154|FG001|Overall Study|Lost to Follow-up|0|||
16775681|NCT02412722|37715155|FG002|Overall Study|Lost to Follow-up|0|||
16775682|NCT02412722|37715156|FG003|Overall Study|Lost to Follow-up|0|||
16775683|NCT02412722|37715157|FG004|Overall Study|Lost to Follow-up|1|||
16775684|NCT02412722|37715158|FG005|Overall Study|Lost to Follow-up|0|||
16775685|NCT02412722|37715153|FG000|Overall Study|Received drug in run-in and discontinued|0|||
16775686|NCT02412722|37715154|FG001|Overall Study|Received drug in run-in and discontinued|2|||
16775687|NCT02412722|37715155|FG002|Overall Study|Received drug in run-in and discontinued|0|||
16775688|NCT02412722|37715156|FG003|Overall Study|Received drug in run-in and discontinued|0|||
16775689|NCT02412722|37715157|FG004|Overall Study|Received drug in run-in and discontinued|0|||
16775690|NCT02412722|37715158|FG005|Overall Study|Received drug in run-in and discontinued|0|||
16775691|NCT02412722|37715153|FG000|Overall Study|Reason not Specified|3|||
16775692|NCT02412722|37715154|FG001|Overall Study|Reason not Specified|0|||
16775693|NCT02412722|37715155|FG002|Overall Study|Reason not Specified|2|||
16775694|NCT02412722|37715156|FG003|Overall Study|Reason not Specified|1|||
16775695|NCT02412722|37715157|FG004|Overall Study|Reason not Specified|2|||
16775696|NCT02412722|37715158|FG005|Overall Study|Reason not Specified|6|||
16775697|NCT03074695|37715194|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
16775698|NCT03074695|37715195|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
16775699|NCT03074695|37715194|FG000|Overall Study|Research staff not available|1|||
16775700|NCT03074695|37715195|FG001|Overall Study|Research staff not available|2|||
16775701|NCT03074695|37715194|FG000|Overall Study|Did not receive neuraxial block|2|||
16775702|NCT03074695|37715195|FG001|Overall Study|Did not receive neuraxial block|2|||
16775703|NCT03469999|37715201|FG000|Overall Study|Lost to Follow-up|2|||
16775704|NCT02379728|37715208|FG000|Overall Study|Lost to Follow-up|1|||
16775705|NCT02379728|37715209|FG001|Overall Study|Lost to Follow-up|0|||
16775706|NCT02379728|37715210|FG002|Overall Study|Lost to Follow-up|3|||
16775707|NCT02379728|37715211|FG003|Overall Study|Lost to Follow-up|0|||
16775708|NCT02379728|37715208|FG000|Overall Study|Withdrawal by Subject|5|||
16775709|NCT02379728|37715209|FG001|Overall Study|Withdrawal by Subject|0|||
16775710|NCT02379728|37715210|FG002|Overall Study|Withdrawal by Subject|5|||
16775711|NCT02379728|37715211|FG003|Overall Study|Withdrawal by Subject|3|||
16775712|NCT02379728|37715208|FG000|Overall Study|Protocol Violation|0|||
16775713|NCT02379728|37715209|FG001|Overall Study|Protocol Violation|0|||
16775714|NCT02379728|37715210|FG002|Overall Study|Protocol Violation|2|||
16775715|NCT02379728|37715211|FG003|Overall Study|Protocol Violation|0|||
16775716|NCT03463993|37715222|FG000|Overall Study|Lost to Follow-up|7|||
16775717|NCT03463993|37715223|FG001|Overall Study|Lost to Follow-up|8|||
16775718|NCT03463993|37715222|FG000|Overall Study|Withdrawal by Subject|2|||
16775719|NCT03463993|37715223|FG001|Overall Study|Withdrawal by Subject|0|||
16775720|NCT03463993|37715222|FG000|Overall Study|Protocol Violation|4|||
16775721|NCT03463993|37715223|FG001|Overall Study|Protocol Violation|1|||
16775722|NCT03463993|37715222|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
16775723|NCT03463993|37715223|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
16775724|NCT03463993|37715222|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
16867961|NCT01536535|37840978|FG001|Overall Study|Physician Decision|1|||
17133892|NCT00065507|38275171|FG001|Overall Study|Adverse Event|3|||
16775725|NCT03463993|37715223|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
16775726|NCT02412488|37715238|FG000|Overall Study|Lost to Follow-up|10|||
16775727|NCT02412488|37715238|FG000|Overall Study|Withdrawal by Subject|5|||
16775728|NCT02412488|37715238|FG000|Overall Study|Physician Decision|1|||
16775729|NCT02412488|37715238|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
16775730|NCT02412488|37715238|FG000|Overall Study|Reveal LINQ explant|1|||
16775731|NCT02378480|37715244|FG000|Overall Study|Physician Decision|1|||
16775732|NCT02378480|37715245|FG001|Overall Study|Physician Decision|1|||
16775733|NCT02378480|37715244|FG000|Overall Study|Death|1|||
16775734|NCT02378480|37715245|FG001|Overall Study|Death|2|||
16775735|NCT02378480|37715244|FG000|Overall Study|Randomized, but Not Treated|6|||
16775736|NCT02378480|37715245|FG001|Overall Study|Randomized, but Not Treated|4|||
16775737|NCT02378480|37715244|FG000|Overall Study|Adverse Event|0|||
16775738|NCT02378480|37715245|FG001|Overall Study|Adverse Event|1|||
16775739|NCT02378480|37715244|FG000|Overall Study|Missed EOT/PTE Visit|1|||
16775740|NCT02378480|37715245|FG001|Overall Study|Missed EOT/PTE Visit|2|||
16775741|NCT02378480|37715244|FG000|Overall Study|Withdrawal by Subject|9|||
16775742|NCT02378480|37715245|FG001|Overall Study|Withdrawal by Subject|4|||
16775743|NCT02378480|37715244|FG000|Overall Study|Lost to Follow-up|10|||
16775744|NCT02378480|37715245|FG001|Overall Study|Lost to Follow-up|18|||
16775745|NCT02345330|37715251|FG000|Overall Study|Death|1|||
16775746|NCT02345330|37715251|FG000|Overall Study|Progressive Disease|2|||
16775747|NCT02411396|37715255|FG000|Overall Study|Lost to Follow-up|31|||
16775748|NCT02411396|37715255|FG000|Overall Study|Death|10|||
16775749|NCT02345252|37715276|FG000|Double-Blind Phase|Adverse Event|2|||
16775750|NCT02345252|37715277|FG001|Double-Blind Phase|Adverse Event|3|||
16775751|NCT02345252|37715276|FG000|Double-Blind Phase|Death|1|||
16775752|NCT02345252|37715277|FG001|Double-Blind Phase|Death|2|||
16775753|NCT02345252|37715276|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16775754|NCT02345252|37715277|FG001|Double-Blind Phase|Lack of Efficacy|0|||
16775755|NCT02345252|37715276|FG000|Double-Blind Phase|Investigator's Discretion|4|||
16775756|NCT02345252|37715277|FG001|Double-Blind Phase|Investigator's Discretion|6|||
16775757|NCT02345252|37715276|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16775758|NCT02345252|37715277|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
16775759|NCT02345252|37715276|FG000|Double-Blind Phase|Protocol Violation|2|||
16775760|NCT02345252|37715277|FG001|Double-Blind Phase|Protocol Violation|1|||
16775761|NCT02345252|37715276|FG000|Double-Blind Phase|Withdrew Consent|21|||
16775762|NCT02345252|37715277|FG001|Double-Blind Phase|Withdrew Consent|23|||
16775763|NCT02345252|37715276|FG000|Double-Blind Phase|Lost to Follow-up|8|||
16775764|NCT02345252|37715277|FG001|Double-Blind Phase|Lost to Follow-up|10|||
16775765|NCT02345252|37715276|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
17133893|NCT00065507|38275170|FG000|Overall Study|Lack of Efficacy|0|||
16775766|NCT02345252|37715277|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
16782557|NCT01663623|37722163|FG000|Overall Study|Other-Study closed/terminated|1|||
16775767|NCT01239797|37715287|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
16775768|NCT01239797|37715288|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
16775769|NCT01239797|37715287|FG000|Randomized Participants|Participant withdrew consent|1|||
16958295|NCT00949975|38101296|FG001|Overall Study|Study-specific criteria|1|||
16958296|NCT00949975|38101297|FG002|Overall Study|Study-specific criteria|1|||
16958297|NCT00949975|38101298|FG003|Overall Study|Study-specific criteria|0|||
16958298|NCT00949975|38101295|FG000|Overall Study|Incorrect enrolment|5|||
16958299|NCT00949975|38101296|FG001|Overall Study|Incorrect enrolment|10|||
16958300|NCT00949975|38101297|FG002|Overall Study|Incorrect enrolment|4|||
16958301|NCT00949975|38101298|FG003|Overall Study|Incorrect enrolment|7|||
16958302|NCT00949975|38101295|FG000|Overall Study|Severe non-compliance|3|||
16958303|NCT00949975|38101296|FG001|Overall Study|Severe non-compliance|1|||
16958304|NCT00949975|38101297|FG002|Overall Study|Severe non-compliance|0|||
16958305|NCT00949975|38101298|FG003|Overall Study|Severe non-compliance|2|||
16958306|NCT00949975|38101295|FG000|Overall Study|Lost to Follow-up|1|||
16958307|NCT00949975|38101296|FG001|Overall Study|Lost to Follow-up|0|||
16958308|NCT00949975|38101297|FG002|Overall Study|Lost to Follow-up|1|||
16958309|NCT00949975|38101298|FG003|Overall Study|Lost to Follow-up|3|||
16958310|NCT00949975|38101295|FG000|Overall Study|Other|1|||
16958311|NCT00949975|38101296|FG001|Overall Study|Other|0|||
16958312|NCT00949975|38101297|FG002|Overall Study|Other|0|||
16958313|NCT00949975|38101298|FG003|Overall Study|Other|0|||
16958314|NCT00939055|38101310|FG000|Overall Study|Discontinuation prior to procedure|4|||
16958315|NCT00939055|38101311|FG001|Overall Study|Discontinuation prior to procedure|0|||
16958316|NCT01136967|38101320|FG000|Overall Study|Adverse Event|9|||
16958317|NCT01136967|38101321|FG001|Overall Study|Adverse Event|12|||
16958318|NCT01136967|38101320|FG000|Overall Study|Participant Choice|8|||
16958319|NCT01136967|38101321|FG001|Overall Study|Participant Choice|3|||
16958320|NCT01136967|38101320|FG000|Overall Study|Lost to Follow-up|0|||
16958321|NCT01136967|38101321|FG001|Overall Study|Lost to Follow-up|1|||
16958322|NCT01136967|38101320|FG000|Overall Study|Withdrawal by Subject|1|||
16958323|NCT01136967|38101321|FG001|Overall Study|Withdrawal by Subject|2|||
16958324|NCT01136967|38101320|FG000|Overall Study|Clinical Progression|3|||
16958325|NCT01136967|38101321|FG001|Overall Study|Clinical Progression|5|||
16958326|NCT01136967|38101320|FG000|Overall Study|Radiation|1|||
16958327|NCT01136967|38101321|FG001|Overall Study|Radiation|0|||
16958328|NCT01136967|38101320|FG000|Overall Study|Non-compliance|1|||
16958329|NCT01136967|38101321|FG001|Overall Study|Non-compliance|0|||
16958330|NCT01136967|38101320|FG000|Overall Study|Investigator's Choice|1|||
16958331|NCT01136967|38101321|FG001|Overall Study|Investigator's Choice|1|||
16958332|NCT01136967|38101320|FG000|Overall Study|Increase in Lesion Size|0|||
16958333|NCT01136967|38101321|FG001|Overall Study|Increase in Lesion Size|2|||
16958334|NCT01136967|38101320|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
16958335|NCT01136967|38101321|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
16958336|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
16958337|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
16958338|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
16958339|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
16958340|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
16958341|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
16958342|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
16958343|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
16958344|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
16958345|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
16958346|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
16958347|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
16775770|NCT01239797|37715288|FG001|Randomized Participants|Participant withdrew consent|7|||
16775771|NCT01239797|37715287|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
16775772|NCT01239797|37715288|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
16775773|NCT01239797|37715287|FG000|Treated Participants|Disease progression|185|||
16775774|NCT01239797|37715288|FG001|Treated Participants|Disease progression|185|||
16775775|NCT01239797|37715287|FG000|Treated Participants|Study drug toxicity|39|||
16775776|NCT01239797|37715288|FG001|Treated Participants|Study drug toxicity|45|||
16775777|NCT01239797|37715287|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
16775778|NCT01239797|37715288|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
16775779|NCT01239797|37715287|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
16775780|NCT01239797|37715288|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
16775781|NCT01239797|37715287|FG000|Treated Participants|Administrative reason by sponsor|13|||
16775782|NCT01239797|37715288|FG001|Treated Participants|Administrative reason by sponsor|4|||
16775783|NCT01239797|37715287|FG000|Treated Participants|Other reasons|14|||
16775784|NCT01239797|37715288|FG001|Treated Participants|Other reasons|14|||
16775785|NCT01239797|37715287|FG000|Treated Participants|Participant withdrew consent|6|||
16775786|NCT01239797|37715288|FG001|Treated Participants|Participant withdrew consent|11|||
16775787|NCT01239797|37715287|FG000|Treated Participants|Death|1|||
16775788|NCT01239797|37715288|FG001|Treated Participants|Death|1|||
16775789|NCT01239797|37715287|FG000|Treated Participants|Participant no longer meets study criteria|1|||
16775790|NCT01239797|37715288|FG001|Treated Participants|Participant no longer meets study criteria|1|||
16775791|NCT01239797|37715287|FG000|Treated Participants|Poor/non-compliance|0|||
16775792|NCT01239797|37715288|FG001|Treated Participants|Poor/non-compliance|1|||
16775793|NCT02639065|37715294|FG000|Study Treatment|Disease Progression|11|||
16775794|NCT02639065|37715294|FG000|Study Treatment|Adverse Event|8|||
16775795|NCT02639065|37715294|FG000|Study Treatment|Withdrawal by Subject|1|||
16775796|NCT02639065|37715294|FG000|Follow up|Withdrawal by Subject|1|||
16775797|NCT02639065|37715294|FG000|Follow up|Symptomatic Deterioration|2|||
16775798|NCT02639065|37715294|FG000|Follow up|Death|2|||
16775799|NCT02639065|37715294|FG000|Follow up|Study Terminated|1|||
16775800|NCT02639065|37715294|FG000|Follow up|Disease Progression|3|||
16775801|NCT01236521|37715300|FG000|Overall Study|Withdrawal by Subject|12|||
16775802|NCT01236521|37715301|FG001|Overall Study|Withdrawal by Subject|17|||
16775803|NCT01236521|37715300|FG000|Overall Study|Death|2|||
16775804|NCT01236521|37715301|FG001|Overall Study|Death|1|||
16775805|NCT01236521|37715300|FG000|Overall Study|Lost to Follow-up|9|||
16775806|NCT01236521|37715301|FG001|Overall Study|Lost to Follow-up|7|||
16775807|NCT01092143|37715312|FG000|Overall Study|Adverse Event|10|||
16775808|NCT01092143|37715313|FG001|Overall Study|Adverse Event|5|||
16775809|NCT01092143|37715314|FG002|Overall Study|Adverse Event|1|||
16775810|NCT01092143|37715315|FG003|Overall Study|Adverse Event|4|||
16775811|NCT01092143|37715316|FG004|Overall Study|Adverse Event|3|||
16775812|NCT01092143|37715312|FG000|Overall Study|Lost to Follow-up|1|||
16775813|NCT01092143|37715313|FG001|Overall Study|Lost to Follow-up|0|||
16775814|NCT01092143|37715314|FG002|Overall Study|Lost to Follow-up|1|||
16775815|NCT01092143|37715315|FG003|Overall Study|Lost to Follow-up|0|||
16775816|NCT01092143|37715316|FG004|Overall Study|Lost to Follow-up|0|||
16775817|NCT01092143|37715312|FG000|Overall Study|Consent withdrawn|2|||
16775818|NCT01092143|37715313|FG001|Overall Study|Consent withdrawn|1|||
16775819|NCT01092143|37715314|FG002|Overall Study|Consent withdrawn|0|||
16775820|NCT01092143|37715315|FG003|Overall Study|Consent withdrawn|1|||
16775821|NCT01092143|37715316|FG004|Overall Study|Consent withdrawn|3|||
16775822|NCT01092143|37715312|FG000|Overall Study|Not treated|0|||
16775823|NCT01092143|37715313|FG001|Overall Study|Not treated|0|||
16775824|NCT01092143|37715314|FG002|Overall Study|Not treated|1|||
16775825|NCT01092143|37715315|FG003|Overall Study|Not treated|0|||
16775826|NCT01092143|37715316|FG004|Overall Study|Not treated|0|||
16958348|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
16958349|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
16958350|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
16958351|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
16958352|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
16958353|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
16958354|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
16958355|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
16958356|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
16958357|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
16958358|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
16958359|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
16958360|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
16958361|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
16958362|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
16958363|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
16958364|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
16958365|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
16958366|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
16958367|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
16958368|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
16958369|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
16958370|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
16958371|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
16958372|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
16958373|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
16958374|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
16958375|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
16958376|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
16958377|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
16958378|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
16958379|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
16958380|NCT01218516|38101329|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
16958381|NCT01218516|38101330|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
16958382|NCT01218516|38101331|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
17133894|NCT00065507|38275171|FG001|Overall Study|Lack of Efficacy|6|||
16775827|NCT01092143|37715312|FG000|Overall Study|did not reversibility criteria|0|||
16775828|NCT01092143|37715313|FG001|Overall Study|did not reversibility criteria|0|||
16775829|NCT01092143|37715314|FG002|Overall Study|did not reversibility criteria|1|||
16775830|NCT01092143|37715315|FG003|Overall Study|did not reversibility criteria|0|||
16775831|NCT01092143|37715316|FG004|Overall Study|did not reversibility criteria|0|||
16775832|NCT01092143|37715312|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
16775833|NCT01092143|37715313|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
16775834|NCT01092143|37715314|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
16775835|NCT01092143|37715315|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
16775836|NCT01092143|37715316|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
16775837|NCT01092143|37715312|FG000|Overall Study|Ineligible patient|1|||
16775838|NCT01092143|37715313|FG001|Overall Study|Ineligible patient|0|||
16775839|NCT01092143|37715314|FG002|Overall Study|Ineligible patient|0|||
16775840|NCT01092143|37715315|FG003|Overall Study|Ineligible patient|0|||
16775841|NCT01092143|37715316|FG004|Overall Study|Ineligible patient|0|||
16775842|NCT01092143|37715312|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
16775843|NCT01092143|37715313|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
16775844|NCT01092143|37715314|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
16775845|NCT01092143|37715315|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
16775846|NCT01092143|37715316|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
16775847|NCT01092143|37715312|FG000|Overall Study|Patient travel|0|||
16775848|NCT01092143|37715313|FG001|Overall Study|Patient travel|0|||
16775849|NCT01092143|37715314|FG002|Overall Study|Patient travel|0|||
16775850|NCT01092143|37715315|FG003|Overall Study|Patient travel|0|||
16775851|NCT01092143|37715316|FG004|Overall Study|Patient travel|1|||
16775852|NCT01092143|37715312|FG000|Overall Study|Non compliance with study medication|0|||
16775853|NCT01092143|37715313|FG001|Overall Study|Non compliance with study medication|0|||
16775854|NCT01092143|37715314|FG002|Overall Study|Non compliance with study medication|0|||
16775855|NCT01092143|37715315|FG003|Overall Study|Non compliance with study medication|0|||
16775856|NCT01092143|37715316|FG004|Overall Study|Non compliance with study medication|1|||
16775857|NCT01092143|37715312|FG000|Overall Study|Randomized by mistake|0|||
16775858|NCT01092143|37715313|FG001|Overall Study|Randomized by mistake|0|||
16775859|NCT01092143|37715314|FG002|Overall Study|Randomized by mistake|0|||
16775860|NCT01092143|37715315|FG003|Overall Study|Randomized by mistake|1|||
16775861|NCT01092143|37715316|FG004|Overall Study|Randomized by mistake|0|||
16775862|NCT01092143|37715312|FG000|Overall Study|Pregnancy|0|||
16775863|NCT01092143|37715313|FG001|Overall Study|Pregnancy|0|||
16775864|NCT01092143|37715314|FG002|Overall Study|Pregnancy|0|||
16775865|NCT01092143|37715315|FG003|Overall Study|Pregnancy|1|||
16775866|NCT01092143|37715316|FG004|Overall Study|Pregnancy|0|||
16775867|NCT02377466|37715330|FG000|Overall Study|Other: Randomized and not treated|0|||
16775868|NCT02377466|37715331|FG001|Overall Study|Other: Randomized and not treated|2|||
16775869|NCT00950989|37715348|FG000|Overall Study|Death|0|||
16775870|NCT00950989|37715349|FG001|Overall Study|Death|0|||
16775871|NCT00950989|37715350|FG002|Overall Study|Death|1|||
16775872|NCT00950989|37715351|FG003|Overall Study|Death|0|||
16775873|NCT00950989|37715348|FG000|Overall Study|Administrative Decision|0|||
16775874|NCT00950989|37715349|FG001|Overall Study|Administrative Decision|1|||
16775875|NCT00950989|37715350|FG002|Overall Study|Administrative Decision|0|||
16775876|NCT00950989|37715351|FG003|Overall Study|Administrative Decision|0|||
16775877|NCT00950989|37715348|FG000|Overall Study|Disease Progression|0|||
16775878|NCT00950989|37715349|FG001|Overall Study|Disease Progression|0|||
16775879|NCT00950989|37715350|FG002|Overall Study|Disease Progression|1|||
16775880|NCT00950989|37715351|FG003|Overall Study|Disease Progression|0|||
16775881|NCT00950989|37715348|FG000|Overall Study|Withdrawal by Subject|2|||
16775882|NCT00950989|37715349|FG001|Overall Study|Withdrawal by Subject|1|||
16775883|NCT00950989|37715350|FG002|Overall Study|Withdrawal by Subject|0|||
16775884|NCT00950989|37715351|FG003|Overall Study|Withdrawal by Subject|0|||
16775885|NCT00950989|37715348|FG000|Overall Study|Adverse Event|2|||
16775886|NCT00950989|37715349|FG001|Overall Study|Adverse Event|1|||
16775887|NCT00950989|37715350|FG002|Overall Study|Adverse Event|1|||
16775888|NCT00950989|37715351|FG003|Overall Study|Adverse Event|0|||
16775889|NCT00593567|37715366|FG000|Overall Study|Adverse Event|2|||
16775890|NCT00593567|37715367|FG001|Overall Study|Adverse Event|0|||
16775891|NCT00593567|37715366|FG000|Overall Study|Physician Decision|2|||
16775892|NCT00593567|37715367|FG001|Overall Study|Physician Decision|0|||
16775893|NCT00593567|37715366|FG000|Overall Study|Protocol Violation|13|||
16775894|NCT00593567|37715367|FG001|Overall Study|Protocol Violation|7|||
16775895|NCT00593567|37715366|FG000|Overall Study|Lack of Efficacy|2|||
16775896|NCT00593567|37715367|FG001|Overall Study|Lack of Efficacy|1|||
16775897|NCT00593567|37715366|FG000|Overall Study|Withdrawal by Subject|1|||
16775898|NCT00593567|37715367|FG001|Overall Study|Withdrawal by Subject|2|||
16775899|NCT02411084|37715375|FG000|Overall Study|Lack of Efficacy|6|||
16775900|NCT02411084|37715376|FG001|Overall Study|Lack of Efficacy|3|||
16775901|NCT02411084|37715375|FG000|Overall Study|Death|5|||
16775902|NCT02411084|37715376|FG001|Overall Study|Death|4|||
16775903|NCT02411084|37715375|FG000|Overall Study|Adverse Event|2|||
16775904|NCT02411084|37715376|FG001|Overall Study|Adverse Event|1|||
16775905|NCT02411084|37715375|FG000|Overall Study|Other reasons|0|||
16775906|NCT02411084|37715376|FG001|Overall Study|Other reasons|5|||
16775907|NCT01602315|37715389|FG000|Overall Study|Protocol Violation|0|||
16775908|NCT01602315|37715390|FG001|Overall Study|Protocol Violation|0|||
16775909|NCT01602315|37715391|FG002|Overall Study|Protocol Violation|0|||
16775910|NCT01602315|37715392|FG003|Overall Study|Protocol Violation|0|||
16775911|NCT01602315|37715393|FG004|Overall Study|Protocol Violation|0|||
16775912|NCT01602315|37715394|FG005|Overall Study|Protocol Violation|1|||
16775913|NCT01602315|37715395|FG006|Overall Study|Protocol Violation|0|||
16775914|NCT01602315|37715389|FG000|Overall Study|Physician Decision|2|||
16775915|NCT01602315|37715390|FG001|Overall Study|Physician Decision|0|||
16775916|NCT01602315|37715391|FG002|Overall Study|Physician Decision|0|||
16775917|NCT01602315|37715392|FG003|Overall Study|Physician Decision|0|||
16775918|NCT01602315|37715393|FG004|Overall Study|Physician Decision|2|||
16775919|NCT01602315|37715394|FG005|Overall Study|Physician Decision|1|||
16775920|NCT01602315|37715395|FG006|Overall Study|Physician Decision|1|||
16775921|NCT01602315|37715389|FG000|Overall Study|Disease progression|6|||
16775922|NCT01602315|37715390|FG001|Overall Study|Disease progression|3|||
16775923|NCT01602315|37715391|FG002|Overall Study|Disease progression|10|||
16775924|NCT01602315|37715392|FG003|Overall Study|Disease progression|1|||
16775925|NCT01602315|37715393|FG004|Overall Study|Disease progression|41|||
16775926|NCT01602315|37715394|FG005|Overall Study|Disease progression|12|||
16775927|NCT01602315|37715395|FG006|Overall Study|Disease progression|15|||
16775928|NCT01602315|37715389|FG000|Overall Study|Death|1|||
16775929|NCT01602315|37715390|FG001|Overall Study|Death|1|||
16775930|NCT01602315|37715391|FG002|Overall Study|Death|1|||
16775931|NCT01602315|37715392|FG003|Overall Study|Death|1|||
16775932|NCT01602315|37715393|FG004|Overall Study|Death|7|||
16775933|NCT01602315|37715394|FG005|Overall Study|Death|2|||
16775934|NCT01602315|37715395|FG006|Overall Study|Death|2|||
16775935|NCT01602315|37715389|FG000|Overall Study|Withdrawal by Subject|2|||
16775936|NCT01602315|37715390|FG001|Overall Study|Withdrawal by Subject|0|||
16775937|NCT01602315|37715391|FG002|Overall Study|Withdrawal by Subject|2|||
16775938|NCT01602315|37715392|FG003|Overall Study|Withdrawal by Subject|0|||
16775939|NCT01602315|37715393|FG004|Overall Study|Withdrawal by Subject|6|||
16775940|NCT01602315|37715394|FG005|Overall Study|Withdrawal by Subject|0|||
16775941|NCT01602315|37715395|FG006|Overall Study|Withdrawal by Subject|1|||
16775942|NCT01602315|37715389|FG000|Overall Study|Adverse Event|5|||
16775943|NCT01602315|37715390|FG001|Overall Study|Adverse Event|1|||
16775944|NCT01602315|37715391|FG002|Overall Study|Adverse Event|5|||
16775945|NCT01602315|37715392|FG003|Overall Study|Adverse Event|4|||
16775946|NCT01602315|37715393|FG004|Overall Study|Adverse Event|15|||
16775947|NCT01602315|37715394|FG005|Overall Study|Adverse Event|3|||
16775948|NCT01602315|37715395|FG006|Overall Study|Adverse Event|9|||
16775949|NCT01602315|37715389|FG000|Overall Study|Subject/guardian decision|0|||
16775950|NCT01602315|37715390|FG001|Overall Study|Subject/guardian decision|0|||
16775951|NCT01602315|37715391|FG002|Overall Study|Subject/guardian decision|0|||
16775952|NCT01602315|37715392|FG003|Overall Study|Subject/guardian decision|0|||
16775953|NCT01602315|37715393|FG004|Overall Study|Subject/guardian decision|0|||
16775954|NCT01602315|37715394|FG005|Overall Study|Subject/guardian decision|0|||
16775955|NCT01602315|37715395|FG006|Overall Study|Subject/guardian decision|1|||
16775956|NCT01602315|37715389|FG000|Overall Study|Cross-over patients to combo treatment|0|||
16775957|NCT01602315|37715390|FG001|Overall Study|Cross-over patients to combo treatment|0|||
16775958|NCT01602315|37715391|FG002|Overall Study|Cross-over patients to combo treatment|0|||
16775959|NCT01602315|37715392|FG003|Overall Study|Cross-over patients to combo treatment|0|||
16775960|NCT01602315|37715393|FG004|Overall Study|Cross-over patients to combo treatment|0|||
16775961|NCT01602315|37715394|FG005|Overall Study|Cross-over patients to combo treatment|16|||
16775962|NCT01602315|37715395|FG006|Overall Study|Cross-over patients to combo treatment|0|||
16775963|NCT02344004|37715433|FG000|Overall Study|Adverse Event|11|||
16775964|NCT02344004|37715434|FG001|Overall Study|Adverse Event|1|||
16775965|NCT02344004|37715433|FG000|Overall Study|Death|9|||
16775966|NCT02344004|37715434|FG001|Overall Study|Death|7|||
16775967|NCT02344004|37715433|FG000|Overall Study|Physician Decision|4|||
16775968|NCT02344004|37715434|FG001|Overall Study|Physician Decision|1|||
16775969|NCT02344004|37715433|FG000|Overall Study|Withdrawal by Subject|22|||
16775970|NCT02344004|37715434|FG001|Overall Study|Withdrawal by Subject|5|||
16775971|NCT02344004|37715433|FG000|Overall Study|Rescue Medication|2|||
16775972|NCT02344004|37715434|FG001|Overall Study|Rescue Medication|0|||
16775973|NCT02344004|37715433|FG000|Overall Study|Other Not Specified|12|||
16775974|NCT02344004|37715434|FG001|Overall Study|Other Not Specified|0|||
16775975|NCT02344004|37715433|FG000|Overall Study|Protocol Violation|1|||
16775976|NCT02344004|37715434|FG001|Overall Study|Protocol Violation|0|||
16775977|NCT01328093|37715443|FG000|Double-Blind Phase|Adverse Event|78|||
16775978|NCT01328093|37715444|FG001|Double-Blind Phase|Adverse Event|15|||
16775979|NCT01328093|37715443|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
16775980|NCT01328093|37715444|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
16775981|NCT01328093|37715443|FG000|Double-Blind Phase|Lost to Follow-up|39|||
16775982|NCT01328093|37715444|FG001|Double-Blind Phase|Lost to Follow-up|14|||
16775983|NCT01328093|37715443|FG000|Double-Blind Phase|Protocol Violation|30|||
16775984|NCT01328093|37715444|FG001|Double-Blind Phase|Protocol Violation|10|||
16775985|NCT01328093|37715443|FG000|Double-Blind Phase|Lack of Efficacy|55|||
16775986|NCT01328093|37715444|FG001|Double-Blind Phase|Lack of Efficacy|13|||
16775987|NCT01328093|37715443|FG000|Double-Blind Phase|Sponsor Decision|17|||
16775988|NCT01328093|37715444|FG001|Double-Blind Phase|Sponsor Decision|3|||
16775989|NCT01328093|37715443|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
16775990|NCT01328093|37715444|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
16775991|NCT01328093|37715443|FG000|Double-Blind Phase|Scheduling conflict|8|||
16775992|NCT01328093|37715444|FG001|Double-Blind Phase|Scheduling conflict|3|||
16775993|NCT01328093|37715443|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
16775994|NCT01328093|37715444|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
16775995|NCT01328093|37715443|FG000|Double-Blind Phase|Death|1|||
16775996|NCT01328093|37715444|FG001|Double-Blind Phase|Death|0|||
16775997|NCT01328093|37715443|FG000|Open-Label Phase|Sponsor Decision|98|||
16775998|NCT01328093|37715444|FG001|Open-Label Phase|Sponsor Decision|34|||
16775999|NCT01328093|37715443|FG000|Open-Label Phase|Protocol Violation|8|||
16776000|NCT01328093|37715444|FG001|Open-Label Phase|Protocol Violation|3|||
16776001|NCT01328093|37715443|FG000|Open-Label Phase|Lost to Follow-up|10|||
16776002|NCT01328093|37715444|FG001|Open-Label Phase|Lost to Follow-up|1|||
16776003|NCT01328093|37715443|FG000|Open-Label Phase|Adverse Event|10|||
16776004|NCT01328093|37715444|FG001|Open-Label Phase|Adverse Event|4|||
16776005|NCT01328093|37715443|FG000|Open-Label Phase|Lack of Efficacy|5|||
16776006|NCT01328093|37715444|FG001|Open-Label Phase|Lack of Efficacy|6|||
16776007|NCT01328093|37715443|FG000|Open-Label Phase|Withdrawal by Subject|4|||
16776008|NCT01328093|37715444|FG001|Open-Label Phase|Withdrawal by Subject|1|||
16776009|NCT01328093|37715443|FG000|Open-Label Phase|Scheduling conflict|2|||
16776010|NCT01328093|37715444|FG001|Open-Label Phase|Scheduling conflict|1|||
16776011|NCT01328093|37715443|FG000|Open-Label Phase|Subject is moving or has moved|2|||
16776012|NCT01328093|37715444|FG001|Open-Label Phase|Subject is moving or has moved|0|||
16776013|NCT01328093|37715443|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
16776014|NCT01328093|37715444|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
16776015|NCT02654145|37715451|FG000|Overall Study|Lack of Efficacy|1|||
16776016|NCT02654145|37715451|FG000|Overall Study|Protocol Violation|1|||
16776017|NCT02654145|37715451|FG000|Overall Study|Withdrawal by Subject|5|||
16776018|NCT01111565|37715455|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
16776019|NCT01111565|37715456|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
16776020|NCT01111565|37715457|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
16776021|NCT01111565|37715458|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
16776022|NCT01111565|37715459|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
16776023|NCT01111565|37715455|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
16776024|NCT01111565|37715456|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
16776025|NCT01111565|37715457|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
16776026|NCT01111565|37715458|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
16776027|NCT01111565|37715459|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
16776028|NCT01111565|37715455|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
16776029|NCT01111565|37715456|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
16776030|NCT01111565|37715457|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
16776031|NCT01111565|37715458|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
16776032|NCT01111565|37715459|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
16776033|NCT01111565|37715455|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
16776034|NCT01111565|37715456|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
16776035|NCT01111565|37715457|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
16776036|NCT01111565|37715458|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
16776037|NCT01111565|37715459|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
16776038|NCT01111565|37715455|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
16776039|NCT01111565|37715456|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
16776040|NCT01111565|37715457|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
16776041|NCT01111565|37715458|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
16776042|NCT01111565|37715459|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
16776043|NCT01111565|37715455|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
16776044|NCT01111565|37715456|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
16776045|NCT01111565|37715457|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
16867962|NCT01536535|37840977|FG000|Overall Study|Participant moved|0|||
16958383|NCT01218516|38101332|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
16958384|NCT00938431|38101345|FG000|Overall Study|Adverse Event|5|||
16958385|NCT00938431|38101346|FG001|Overall Study|Adverse Event|8|||
16958386|NCT00938431|38101347|FG002|Overall Study|Adverse Event|6|||
16958387|NCT00938431|38101345|FG000|Overall Study|Lack of Efficacy|0|||
16958388|NCT00938431|38101346|FG001|Overall Study|Lack of Efficacy|1|||
16958389|NCT00938431|38101347|FG002|Overall Study|Lack of Efficacy|0|||
16958390|NCT00938431|38101345|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
16958391|NCT00938431|38101346|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
16958392|NCT00938431|38101347|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
16958393|NCT00938431|38101345|FG000|Overall Study|Dosing compliance issue|0|||
16958394|NCT00938431|38101346|FG001|Overall Study|Dosing compliance issue|0|||
16958395|NCT00938431|38101347|FG002|Overall Study|Dosing compliance issue|1|||
16958396|NCT00938431|38101345|FG000|Overall Study|Reached maximum dose early|0|||
16958397|NCT00938431|38101346|FG001|Overall Study|Reached maximum dose early|0|||
16958398|NCT00938431|38101347|FG002|Overall Study|Reached maximum dose early|1|||
16958399|NCT01136811|38101359|FG000|Overall Study|Physician Decision|11|||
16958400|NCT00949117|38101365|FG000|Overall Study|Lack of Efficacy|2|||
16958401|NCT00949117|38101366|FG001|Overall Study|Lack of Efficacy|3|||
16958402|NCT00949117|38101365|FG000|Overall Study|Protocol Violation|1|||
16958403|NCT00949117|38101366|FG001|Overall Study|Protocol Violation|1|||
16958404|NCT00949117|38101365|FG000|Overall Study|Adverse Event|0|||
16958405|NCT00949117|38101366|FG001|Overall Study|Adverse Event|1|||
16958406|NCT00938041|38101374|FG000|Overall Study|Lost to Follow-up|6|||
16958407|NCT00938041|38101374|FG000|Overall Study|Received Alternative Therapy|1|||
16958408|NCT00938041|38101374|FG000|Overall Study|Progressive Disease|5|||
16958409|NCT00938041|38101374|FG000|Overall Study|Death|12|||
16958410|NCT00938041|38101374|FG000|Overall Study|Adrenal Insufficiency|3|||
16958411|NCT01218438|38101378|FG000|Epoch 1|Physician Decision|2|||
16958412|NCT01218438|38101378|FG000|Epoch 1|Adverse Event|1|||
16958413|NCT01218438|38101378|FG000|Epoch 3|Withdrawal by Subject|3|||
16958414|NCT01218438|38101378|FG000|Epoch 3|Adverse Event|1|||
16958415|NCT01218438|38101378|FG000|Epoch 4|Physician Decision|1|||
16958416|NCT01218438|38101378|FG000|Epoch 4|Withdrawal by Subject|2|||
16958417|NCT00935701|38101452|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
16958418|NCT01277510|38101459|FG000|Double-blind Phase|Non-compliance|0|||
16958419|NCT01277510|38101460|FG001|Double-blind Phase|Non-compliance|1|||
16958420|NCT01277510|38101459|FG000|Double-blind Phase|Adverse Event|1|||
16958421|NCT01277510|38101460|FG001|Double-blind Phase|Adverse Event|0|||
16958422|NCT01277510|38101459|FG000|Double-blind Phase|Withdrawal by Subject|2|||
16776046|NCT01111565|37715458|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
16776047|NCT01111565|37715459|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
16776048|NCT01111565|37715455|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
16776049|NCT01111565|37715456|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
16776050|NCT01111565|37715457|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
16776051|NCT01111565|37715458|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
16776052|NCT01111565|37715459|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
16776053|NCT01111565|37715455|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16776054|NCT01111565|37715456|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16776055|NCT01111565|37715457|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16776056|NCT01111565|37715458|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
16776057|NCT01111565|37715459|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16776058|NCT01111565|37715455|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16776059|NCT01111565|37715456|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16776060|NCT01111565|37715457|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
16776061|NCT01111565|37715458|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16776062|NCT01111565|37715459|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16776063|NCT01111565|37715455|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
16776064|NCT01111565|37715456|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
16776065|NCT01111565|37715457|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
16776066|NCT01111565|37715458|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
16776067|NCT01111565|37715459|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
16776068|NCT01111565|37715455|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
16776069|NCT01111565|37715456|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
16776070|NCT01111565|37715457|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
16867963|NCT01536535|37840978|FG001|Overall Study|Participant moved|1|||
16958423|NCT01277510|38101460|FG001|Double-blind Phase|Withdrawal by Subject|0|||
16958424|NCT01277510|38101459|FG000|Double-blind Phase|Administrative decision|7|||
16958425|NCT01277510|38101460|FG001|Double-blind Phase|Administrative decision|9|||
16958426|NCT01277510|38101459|FG000|Double-blind Phase|Death|0|||
16958427|NCT01277510|38101460|FG001|Double-blind Phase|Death|1|||
16958428|NCT01277510|38101459|FG000|Double-blind Phase|Protocol-specified criteria|2|||
16958429|NCT01277510|38101460|FG001|Double-blind Phase|Protocol-specified criteria|6|||
16958430|NCT01277510|38101459|FG000|Double-blind Phase|Other|1|||
16958431|NCT01277510|38101460|FG001|Double-blind Phase|Other|1|||
16958432|NCT01277510|38101459|FG000|Open-label Phase|Administrative decision|4|||
16958433|NCT01277510|38101460|FG001|Open-label Phase|Administrative decision|3|||
16958434|NCT01277510|38101459|FG000|Open-label Phase|Protocol-specified criteria|1|||
16958435|NCT01277510|38101460|FG001|Open-label Phase|Protocol-specified criteria|0|||
16958436|NCT01277510|38101459|FG000|Open-label Phase|Never received investigational product|2|||
16958437|NCT01277510|38101460|FG001|Open-label Phase|Never received investigational product|0|||
16958438|NCT00937495|38101468|FG000|Overall Study|Protocol Violation|2|||
16958439|NCT01268306|38101472|FG000|Overall Study|Lost to Follow-up|1|||
16958440|NCT00936715|38101476|FG000|Overall Study|Investigators Discretion|1|||
16776071|NCT01111565|37715458|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
16776072|NCT01111565|37715459|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
16776073|NCT01111565|37715455|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
16958441|NCT00936715|38101476|FG000|Overall Study|Protocol Violation|1|||
16958442|NCT00936715|38101476|FG000|Overall Study|Safety or Tolerability Reasons|4|||
16958443|NCT01268150|38101480|FG000|Treatment Phase|Progression of disease|18|||
16958444|NCT01268150|38101480|FG000|Treatment Phase|Adverse Event|3|||
16958445|NCT01268150|38101480|FG000|Treatment Phase|Withdrawal by Subject|3|||
16958446|NCT01268150|38101480|FG000|Treatment Phase|Other|4|||
16958447|NCT01268150|38101480|FG000|Extension Phase|Adverse Event|3|||
16958448|NCT01268150|38101480|FG000|Extension Phase|Disease progression|18|||
16958449|NCT01268150|38101480|FG000|Extension Phase|Other|6|||
16958450|NCT01267994|38101484|FG000|Overall Study|Adverse Event|2|||
16958451|NCT00934843|38101491|FG000|Overall Study|Protocol Violation|0|||
16958452|NCT00934843|38101492|FG001|Overall Study|Protocol Violation|1|||
16958453|NCT01266902|38101500|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
16958454|NCT01266902|38101501|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
16958455|NCT01266902|38101502|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
16958456|NCT01266902|38101500|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
16958457|NCT01266902|38101501|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
16958458|NCT01266902|38101502|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
16958459|NCT01266902|38101500|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
16958460|NCT01266902|38101501|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
16958461|NCT01266902|38101502|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
16958462|NCT01266902|38101500|FG000|Period 1 (Main Study)|Adverse Event|3|||
16958463|NCT01266902|38101501|FG001|Period 1 (Main Study)|Adverse Event|11|||
16958464|NCT01266902|38101502|FG002|Period 1 (Main Study)|Adverse Event|0|||
16958465|NCT01266902|38101500|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
16958466|NCT01266902|38101501|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
16958467|NCT01266902|38101502|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
16958468|NCT01266902|38101500|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
16958469|NCT01266902|38101501|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
16958470|NCT01266902|38101502|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
16958471|NCT01266902|38101500|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
16958472|NCT01266902|38101501|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
16958473|NCT01266902|38101502|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
16958474|NCT01266902|38101500|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
16958475|NCT01266902|38101501|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
16958476|NCT01266902|38101502|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
16958477|NCT01266902|38101500|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
16958478|NCT01266902|38101501|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
16958479|NCT01266902|38101502|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
16958480|NCT01266902|38101500|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
16958481|NCT01266902|38101501|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
16958482|NCT01266902|38101502|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
16958483|NCT01266824|38101512|FG000|Overall Study|Study terminated prior to completion|2|||
16958484|NCT01266824|38101513|FG001|Overall Study|Study terminated prior to completion|3|||
16958485|NCT01266590|38101519|FG000|Overall Study|Adverse Event|3|||
16958486|NCT01266590|38101519|FG000|Overall Study|Lost to Follow-up|1|||
16958487|NCT01266590|38101519|FG000|Overall Study|Withdrawal by Subject|1|||
16958488|NCT01266590|38101519|FG000|Overall Study|Physician Decision|1|||
16958489|NCT01266122|38101528|FG000|Overall Study|Lost to Follow-up|6|||
16958490|NCT01266122|38101529|FG001|Overall Study|Lost to Follow-up|6|||
16958491|NCT01265498|38101537|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
16958492|NCT01265498|38101538|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
16958493|NCT01265420|38101544|FG000|Overall Study|Lost to Follow-up|1|||
16958494|NCT01264718|38101550|FG000|Overall Study|Lost to Follow-up|3|||
16958495|NCT01264718|38101551|FG001|Overall Study|Lost to Follow-up|2|||
16958496|NCT01264718|38101550|FG000|Overall Study|Withdrawal by Subject|9|||
16958497|NCT01264718|38101551|FG001|Overall Study|Withdrawal by Subject|15|||
16958498|NCT01264718|38101550|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
16958499|NCT01264718|38101551|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
16958500|NCT01264016|38101557|FG000|Overall Study|Withdrawal by Subject|1|||
16958501|NCT01264016|38101557|FG000|Overall Study|Felt faint at sight of blood|1|||
16958502|NCT01263782|38101566|FG000|Overall Study|Death|0|||
16958503|NCT01263782|38101567|FG001|Overall Study|Death|0|||
16958504|NCT01263782|38101568|FG002|Overall Study|Death|1|||
16958505|NCT01263782|38101569|FG003|Overall Study|Death|0|||
16958506|NCT01263782|38101566|FG000|Overall Study|Progressive disease|0|||
16958507|NCT01263782|38101567|FG001|Overall Study|Progressive disease|0|||
16958508|NCT01263782|38101568|FG002|Overall Study|Progressive disease|0|||
16958509|NCT01263782|38101569|FG003|Overall Study|Progressive disease|1|||
16958510|NCT01263782|38101566|FG000|Overall Study|Too early|0|||
16958511|NCT01263782|38101567|FG001|Overall Study|Too early|0|||
16958512|NCT01263782|38101568|FG002|Overall Study|Too early|1|||
16958513|NCT01263782|38101569|FG003|Overall Study|Too early|0|||
16958514|NCT01263782|38101566|FG000|Overall Study|Inevaluable|0|||
16958515|NCT01263782|38101567|FG001|Overall Study|Inevaluable|0|||
16958516|NCT01263782|38101568|FG002|Overall Study|Inevaluable|1|||
16958517|NCT01263782|38101569|FG003|Overall Study|Inevaluable|0|||
16958518|NCT01263704|38101579|FG000|Overall Study|Progressive disease|18|||
16958519|NCT01263704|38101579|FG000|Overall Study|Adverse Event|3|||
16958520|NCT01263704|38101579|FG000|Overall Study|Death|2|||
16958521|NCT01263704|38101579|FG000|Overall Study|Patient withdrew consent|2|||
16958522|NCT01263704|38101579|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
16958523|NCT01263704|38101579|FG000|Overall Study|Lost to Follow-up|1|||
16958524|NCT01263704|38101579|FG000|Overall Study|Colon metastases|1|||
16958525|NCT01263704|38101579|FG000|Overall Study|Principal Investigator (PI) decision|1|||
16958526|NCT01263470|38101589|FG000|Overall Study|Adverse Event|2|||
16958527|NCT01263470|38101590|FG001|Overall Study|Adverse Event|2|||
16958528|NCT01263470|38101591|FG002|Overall Study|Adverse Event|1|||
16958529|NCT01263470|38101592|FG003|Overall Study|Adverse Event|1|||
16958530|NCT01263470|38101593|FG004|Overall Study|Adverse Event|2|||
16958531|NCT01263470|38101594|FG005|Overall Study|Adverse Event|2|||
16958532|NCT01263470|38101589|FG000|Overall Study|Protocol Violation|0|||
16958533|NCT01263470|38101590|FG001|Overall Study|Protocol Violation|1|||
16958534|NCT01263470|38101591|FG002|Overall Study|Protocol Violation|0|||
16958535|NCT01263470|38101592|FG003|Overall Study|Protocol Violation|0|||
16958536|NCT01263470|38101593|FG004|Overall Study|Protocol Violation|0|||
16958537|NCT01263470|38101594|FG005|Overall Study|Protocol Violation|1|||
16958538|NCT01263470|38101589|FG000|Overall Study|Withdrawal by Subject|0|||
16958539|NCT01263470|38101590|FG001|Overall Study|Withdrawal by Subject|1|||
16958540|NCT01263470|38101591|FG002|Overall Study|Withdrawal by Subject|1|||
16958541|NCT01263470|38101592|FG003|Overall Study|Withdrawal by Subject|2|||
16958542|NCT01263470|38101593|FG004|Overall Study|Withdrawal by Subject|0|||
16958543|NCT01263470|38101594|FG005|Overall Study|Withdrawal by Subject|2|||
16958544|NCT01263470|38101589|FG000|Overall Study|Lack of Efficacy|0|||
16958545|NCT01263470|38101590|FG001|Overall Study|Lack of Efficacy|0|||
16958546|NCT01263470|38101591|FG002|Overall Study|Lack of Efficacy|2|||
16958547|NCT01263470|38101592|FG003|Overall Study|Lack of Efficacy|0|||
16958548|NCT01263470|38101593|FG004|Overall Study|Lack of Efficacy|0|||
16958549|NCT01263470|38101594|FG005|Overall Study|Lack of Efficacy|0|||
16958550|NCT01263470|38101589|FG000|Overall Study|Participant Unavailability|0|||
16958551|NCT01263470|38101590|FG001|Overall Study|Participant Unavailability|1|||
16958552|NCT01263470|38101591|FG002|Overall Study|Participant Unavailability|0|||
16958553|NCT01263470|38101592|FG003|Overall Study|Participant Unavailability|0|||
16958554|NCT01263470|38101593|FG004|Overall Study|Participant Unavailability|0|||
16958555|NCT01263470|38101594|FG005|Overall Study|Participant Unavailability|0|||
16958556|NCT01263470|38101589|FG000|Overall Study|Study Drug Non-compliance|0|||
16958557|NCT01263470|38101590|FG001|Overall Study|Study Drug Non-compliance|0|||
16958558|NCT01263470|38101591|FG002|Overall Study|Study Drug Non-compliance|0|||
16958559|NCT01263470|38101592|FG003|Overall Study|Study Drug Non-compliance|0|||
16958560|NCT01263470|38101593|FG004|Overall Study|Study Drug Non-compliance|1|||
16958561|NCT01263470|38101594|FG005|Overall Study|Study Drug Non-compliance|0|||
16958562|NCT01262456|38101611|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
16958563|NCT01262456|38101612|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
16958564|NCT01262456|38101613|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
16958565|NCT01262456|38101611|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
16958566|NCT01262456|38101612|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
16958567|NCT01262456|38101613|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
16958568|NCT01262456|38101611|FG000|3-Month Double-Blind Period|Adverse Event|6|||
16958569|NCT01262456|38101612|FG001|3-Month Double-Blind Period|Adverse Event|4|||
16958570|NCT01262456|38101613|FG002|3-Month Double-Blind Period|Adverse Event|8|||
16958571|NCT01262456|38101611|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
16958572|NCT01262456|38101612|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
16958573|NCT01262456|38101613|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
16958574|NCT01262456|38101611|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
16958575|NCT01262456|38101612|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
16958576|NCT01262456|38101613|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
16958577|NCT01262456|38101611|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
16958578|NCT01262456|38101612|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
16776074|NCT01111565|37715456|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
16776075|NCT01111565|37715457|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
16776076|NCT01111565|37715458|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
16776077|NCT01111565|37715459|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
16776078|NCT02343458|37715473|FG000|Overall Study|Adverse Event|15|||
16776079|NCT02343458|37715474|FG001|Overall Study|Adverse Event|14|||
16776080|NCT02343458|37715475|FG002|Overall Study|Adverse Event|15|||
16776081|NCT02343458|37715476|FG003|Overall Study|Adverse Event|3|||
16776082|NCT02343458|37715473|FG000|Overall Study|Lack of Efficacy|3|||
16776083|NCT02343458|37715474|FG001|Overall Study|Lack of Efficacy|8|||
16776084|NCT02343458|37715475|FG002|Overall Study|Lack of Efficacy|4|||
16776085|NCT02343458|37715476|FG003|Overall Study|Lack of Efficacy|8|||
16958579|NCT01262456|38101613|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
16958580|NCT01262456|38101611|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
16958581|NCT01262456|38101612|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
16958582|NCT01262456|38101613|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
16958583|NCT01262456|38101611|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
16958584|NCT01262456|38101612|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
16958585|NCT01262456|38101613|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
16958586|NCT01262456|38101611|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
16958587|NCT01262456|38101612|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
16958588|NCT01262456|38101613|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
16958589|NCT00932893|38101631|FG000|Overall Study|Death|115|||
16958590|NCT00932893|38101632|FG001|Overall Study|Death|24|||
16958591|NCT00932893|38101631|FG000|Overall Study|Lost to Follow-up|8|||
16958592|NCT00932893|38101632|FG001|Overall Study|Lost to Follow-up|0|||
16958593|NCT00932893|38101631|FG000|Overall Study|Withdrawal by Subject|5|||
16958594|NCT00932893|38101632|FG001|Overall Study|Withdrawal by Subject|2|||
16958595|NCT00932893|38101631|FG000|Overall Study|Other|5|||
16958596|NCT00932893|38101632|FG001|Overall Study|Other|144|||
16958597|NCT01260896|38101641|FG000|First Intervention|Withdrawn Due to Emesis|2|||
16958598|NCT01260896|38101642|FG001|First Intervention|Withdrawn Due to Emesis|0|||
16958599|NCT00932737|38101650|FG000|Overall Study|Not treated in second episode|1|||
16958600|NCT00932737|38101651|FG001|Overall Study|Not treated in second episode|0|||
16958601|NCT00932737|38101650|FG000|Overall Study|Adverse Event|0|||
16958602|NCT00932737|38101651|FG001|Overall Study|Adverse Event|1|||
16958603|NCT00939523|38101657|FG000|Overall Study|Lack of Efficacy|1|||
16958604|NCT00939523|38101657|FG000|Overall Study|Physician Decision|2|||
16958605|NCT01260584|38101665|FG000|Period 1|Protocol Violation|0|||
16958606|NCT01260584|38101666|FG001|Period 1|Protocol Violation|0|||
16958607|NCT01260584|38101667|FG002|Period 1|Protocol Violation|1|||
16958608|NCT01260584|38101668|FG003|Period 1|Protocol Violation|1|||
16958609|NCT01260584|38101665|FG000|Period 1|Adverse Event|0|||
16776086|NCT02343458|37715473|FG000|Overall Study|Withdrawal by Subject|18|||
16776087|NCT02343458|37715474|FG001|Overall Study|Withdrawal by Subject|17|||
16776088|NCT02343458|37715475|FG002|Overall Study|Withdrawal by Subject|23|||
16958610|NCT01260584|38101666|FG001|Period 1|Adverse Event|0|||
16958611|NCT01260584|38101667|FG002|Period 1|Adverse Event|1|||
16958612|NCT01260584|38101668|FG003|Period 1|Adverse Event|0|||
16958613|NCT01260584|38101665|FG000|Period 2|Protocol Violation|0|||
16958614|NCT01260584|38101666|FG001|Period 2|Protocol Violation|2|||
16958615|NCT01260584|38101667|FG002|Period 2|Protocol Violation|3|||
16958616|NCT01260584|38101668|FG003|Period 2|Protocol Violation|1|||
16958617|NCT01260584|38101665|FG000|Period 2|Adverse Event|1|||
16958618|NCT01260584|38101666|FG001|Period 2|Adverse Event|0|||
16958619|NCT01260584|38101667|FG002|Period 2|Adverse Event|2|||
16958620|NCT01260584|38101668|FG003|Period 2|Adverse Event|0|||
16958621|NCT01260584|38101665|FG000|Period 2|Withdrawal by Subject|0|||
16776089|NCT02343458|37715476|FG003|Overall Study|Withdrawal by Subject|14|||
16958622|NCT01260584|38101666|FG001|Period 2|Withdrawal by Subject|1|||
16958623|NCT01260584|38101667|FG002|Period 2|Withdrawal by Subject|0|||
16958624|NCT01260584|38101668|FG003|Period 2|Withdrawal by Subject|0|||
16958625|NCT00927589|38101678|FG000|Overall Study|Death|1|||
16958626|NCT00927589|38101678|FG000|Overall Study|Physician Decision|1|||
16958627|NCT00927589|38101678|FG000|Overall Study|Withdrawal by Subject|3|||
16958628|NCT00927589|38101678|FG000|Overall Study|Adverse Event|2|||
16776090|NCT02343458|37715473|FG000|Overall Study|Physician Decision|1|||
16958629|NCT00927589|38101678|FG000|Overall Study|Disease Progression|8|||
16958630|NCT00927589|38101678|FG000|Overall Study|Non-compliance|1|||
16958631|NCT00932425|38101684|FG000|Overall Study|Lost to Follow-up|0|||
16958632|NCT00932425|38101685|FG001|Overall Study|Lost to Follow-up|1|||
16776091|NCT02343458|37715474|FG001|Overall Study|Physician Decision|4|||
16776092|NCT02343458|37715475|FG002|Overall Study|Physician Decision|2|||
16776093|NCT02343458|37715476|FG003|Overall Study|Physician Decision|2|||
16776094|NCT02343458|37715473|FG000|Overall Study|Lost to Follow-up|5|||
16958633|NCT00932425|38101684|FG000|Overall Study|Withdrawal by Subject|0|||
16958634|NCT00932425|38101685|FG001|Overall Study|Withdrawal by Subject|1|||
16776095|NCT02343458|37715474|FG001|Overall Study|Lost to Follow-up|5|||
16776096|NCT02343458|37715475|FG002|Overall Study|Lost to Follow-up|3|||
16776097|NCT02343458|37715476|FG003|Overall Study|Lost to Follow-up|1|||
16776098|NCT02343458|37715473|FG000|Overall Study|Protocol Violation|2|||
16776099|NCT02343458|37715474|FG001|Overall Study|Protocol Violation|5|||
16776100|NCT02343458|37715475|FG002|Overall Study|Protocol Violation|2|||
16958635|NCT00932113|38101693|FG000|Overall Study|Lost to Follow-up|1|||
16958636|NCT00932113|38101694|FG001|Overall Study|Lost to Follow-up|0|||
16776101|NCT02343458|37715476|FG003|Overall Study|Protocol Violation|2|||
16776102|NCT02343458|37715473|FG000|Overall Study|Protocol Specified Criteria|17|||
16776103|NCT02343458|37715474|FG001|Overall Study|Protocol Specified Criteria|13|||
16776104|NCT02343458|37715475|FG002|Overall Study|Protocol Specified Criteria|14|||
16776105|NCT02343458|37715476|FG003|Overall Study|Protocol Specified Criteria|8|||
16776106|NCT01328041|37715499|FG000|Overall Study|Adverse Event|7|||
16958637|NCT00931801|38101703|FG000|Overall Study|Adverse Event|0|||
16958638|NCT00931801|38101704|FG001|Overall Study|Adverse Event|0|||
16958639|NCT00931801|38101705|FG002|Overall Study|Adverse Event|1|||
16958640|NCT00931801|38101703|FG000|Overall Study|Lost to Follow-up|0|||
16958641|NCT00931801|38101704|FG001|Overall Study|Lost to Follow-up|1|||
16958642|NCT00931801|38101705|FG002|Overall Study|Lost to Follow-up|0|||
16958643|NCT00931801|38101703|FG000|Overall Study|Withdrawal by Subject|1|||
16958644|NCT00931801|38101704|FG001|Overall Study|Withdrawal by Subject|0|||
16958645|NCT00931801|38101705|FG002|Overall Study|Withdrawal by Subject|0|||
16958646|NCT00931801|38101703|FG000|Overall Study|Confirmed Virologic Failure|0|||
16958647|NCT00931801|38101704|FG001|Overall Study|Confirmed Virologic Failure|0|||
16958648|NCT00931801|38101705|FG002|Overall Study|Confirmed Virologic Failure|3|||
16958649|NCT00931723|38101719|FG000|Overall Study|Withdrawal by Subject|11|||
16958650|NCT00931723|38101720|FG001|Overall Study|Withdrawal by Subject|13|||
16958651|NCT00931723|38101719|FG000|Overall Study|Adverse Event|6|||
16958652|NCT00931723|38101720|FG001|Overall Study|Adverse Event|13|||
16958653|NCT00931723|38101719|FG000|Overall Study|Lithium found in blood|0|||
16958654|NCT00931723|38101720|FG001|Overall Study|Lithium found in blood|1|||
16776107|NCT01328041|37715499|FG000|Overall Study|Lack of Efficacy|27|||
16776108|NCT01328041|37715499|FG000|Overall Study|Protocol Violation|7|||
16776109|NCT01328041|37715499|FG000|Overall Study|Lost to Follow-up|7|||
16776110|NCT01328041|37715499|FG000|Overall Study|Physician Decision|2|||
16776111|NCT01328041|37715499|FG000|Overall Study|Withdrawal by Subject|7|||
16776112|NCT02410772|37715506|FG000|Overall Study|Death|3|||
16776113|NCT02410772|37715507|FG001|Overall Study|Death|4|||
16776114|NCT02410772|37715508|FG002|Overall Study|Death|8|||
16776115|NCT02410772|37715506|FG000|Overall Study|Lost to Follow-up|31|||
16958655|NCT00931723|38101719|FG000|Overall Study|Condition under investigation worsened|1|||
16958656|NCT00931723|38101720|FG001|Overall Study|Condition under investigation worsened|2|||
16958657|NCT00931723|38101719|FG000|Overall Study|Lost to Follow-up|1|||
16958658|NCT00931723|38101720|FG001|Overall Study|Lost to Follow-up|2|||
16958659|NCT00931723|38101719|FG000|Overall Study|Study-specific discontinuation criteria|1|||
16958660|NCT00931723|38101720|FG001|Overall Study|Study-specific discontinuation criteria|1|||
16776116|NCT02410772|37715507|FG001|Overall Study|Lost to Follow-up|23|||
16776117|NCT02410772|37715508|FG002|Overall Study|Lost to Follow-up|22|||
16776118|NCT02410772|37715506|FG000|Overall Study|Pregnancy|8|||
16958661|NCT00931723|38101719|FG000|Overall Study|Severe non-compliance to protocol|2|||
16958662|NCT00931723|38101720|FG001|Overall Study|Severe non-compliance to protocol|0|||
16958663|NCT00931723|38101719|FG000|Overall Study|Safety reasons|0|||
16958664|NCT00931723|38101720|FG001|Overall Study|Safety reasons|1|||
16958665|NCT00931723|38101719|FG000|Overall Study|Took prohibited concomitant medication|0|||
16958666|NCT00931723|38101720|FG001|Overall Study|Took prohibited concomitant medication|1|||
16958667|NCT00931723|38101719|FG000|Overall Study|Lack or insufficient theraputic response|2|||
16958668|NCT00931723|38101720|FG001|Overall Study|Lack or insufficient theraputic response|5|||
16776119|NCT02410772|37715507|FG001|Overall Study|Pregnancy|4|||
16958669|NCT00931723|38101719|FG000|Overall Study|Sponsor decision|1|||
16958670|NCT00931723|38101720|FG001|Overall Study|Sponsor decision|0|||
16958671|NCT00931723|38101719|FG000|Overall Study|Late hospital discharge|1|||
16958672|NCT00931723|38101720|FG001|Overall Study|Late hospital discharge|0|||
16958673|NCT00931411|38101728|FG000|First Intervention - 42 Days|Adverse Event|2|||
16958674|NCT00931411|38101729|FG001|First Intervention - 42 Days|Adverse Event|3|||
16958675|NCT00931411|38101728|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
16958676|NCT00931411|38101729|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
16958677|NCT00931411|38101728|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
16958678|NCT00931411|38101729|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
16958679|NCT00931255|38101741|FG000|Overall Study|Follow up biopsy not done|2|||
16958680|NCT00931255|38101742|FG001|Overall Study|Follow up biopsy not done|3|||
16958681|NCT00930553|38101748|FG000|Overall Study|Adverse Event|1|||
16958682|NCT00930553|38101748|FG000|Overall Study|Lack of Efficacy|7|||
16958683|NCT00930553|38101748|FG000|Overall Study|Physician Decision|39|||
16958684|NCT00930553|38101748|FG000|Overall Study|Protocol Violation|1|||
16958685|NCT00930553|38101748|FG000|Overall Study|Pregnancy|1|||
16958686|NCT00930553|38101748|FG000|Overall Study|Withdrawal by Subject|88|||
16958687|NCT00930553|38101748|FG000|Overall Study|Lost to Follow-up|25|||
16958688|NCT00930553|38101748|FG000|Overall Study|Death|9|||
16958689|NCT00930553|38101748|FG000|Overall Study|Study terminated by sponsor|24|||
16958690|NCT00930553|38101748|FG000|Overall Study|Other than specified above|28|||
16958691|NCT00929695|38101772|FG000|Overall Study|Death|2|||
16958692|NCT00929695|38101773|FG001|Overall Study|Death|1|||
16958693|NCT00929695|38101772|FG000|Overall Study|Withdrawal by Subject|0|||
16958694|NCT00929695|38101773|FG001|Overall Study|Withdrawal by Subject|2|||
16958695|NCT00929695|38101772|FG000|Overall Study|discharge home|4|||
16958696|NCT00929695|38101773|FG001|Overall Study|discharge home|3|||
16958697|NCT00929695|38101772|FG000|Overall Study|incorrect stratification|2|||
16958698|NCT00929695|38101773|FG001|Overall Study|incorrect stratification|0|||
16958699|NCT00927355|38101786|FG000|Overall Study|Adverse Event|1|||
16958700|NCT00927355|38101787|FG001|Overall Study|Adverse Event|1|||
16958701|NCT00923845|38101807|FG000|Induction Therapy|Poor performance status|0|||
16958702|NCT00923845|38101808|FG001|Induction Therapy|Poor performance status|2|||
16958703|NCT00922987|38101815|FG000|Overall Study|Insufficient clinical response|1|||
16958704|NCT00922987|38101815|FG000|Overall Study|Protocol Violation|2|||
16958705|NCT00922987|38101815|FG000|Overall Study|Adverse Event|1|||
16958706|NCT00928135|38101821|FG000|Overall Study|Withdrawal by Subject|1|||
16958707|NCT00928135|38101822|FG001|Overall Study|Withdrawal by Subject|0|||
16958708|NCT00928057|38101830|FG000|Overall Study|Adverse Event|1|||
16958709|NCT00928057|38101831|FG001|Overall Study|Adverse Event|2|||
16958710|NCT00928057|38101830|FG000|Overall Study|Withdrawal by Subject|1|||
16958711|NCT00928057|38101831|FG001|Overall Study|Withdrawal by Subject|0|||
16958712|NCT00928057|38101830|FG000|Overall Study|Lost to Follow-up|0|||
16958713|NCT00928057|38101831|FG001|Overall Study|Lost to Follow-up|1|||
16958714|NCT00928057|38101830|FG000|Overall Study|Protocol Violation|0|||
16958715|NCT00928057|38101831|FG001|Overall Study|Protocol Violation|1|||
16958716|NCT00927901|38101847|FG000|Treatment Period 1|Subject withdrew consent|0|||
16958717|NCT00927901|38101848|FG001|Treatment Period 1|Subject withdrew consent|0|||
16958718|NCT00927901|38101849|FG002|Treatment Period 1|Subject withdrew consent|1|||
16958719|NCT00927901|38101850|FG003|Treatment Period 1|Subject withdrew consent|0|||
16776120|NCT02410772|37715508|FG002|Overall Study|Pregnancy|5|||
16776121|NCT02410772|37715506|FG000|Overall Study|Protocol Violation|8|||
16776122|NCT02410772|37715507|FG001|Overall Study|Protocol Violation|8|||
16776123|NCT02410772|37715508|FG002|Overall Study|Protocol Violation|4|||
16776124|NCT02410772|37715506|FG000|Overall Study|Baseline Drug Resistance|49|||
16776125|NCT02410772|37715507|FG001|Overall Study|Baseline Drug Resistance|40|||
16958720|NCT00927901|38101847|FG000|Treatment Period 4|Adverse Event|0|||
16958721|NCT00927901|38101848|FG001|Treatment Period 4|Adverse Event|0|||
16958722|NCT00927901|38101849|FG002|Treatment Period 4|Adverse Event|0|||
16958723|NCT00927901|38101850|FG003|Treatment Period 4|Adverse Event|1|||
16958724|NCT00927901|38101847|FG000|Treatment Period 4|Subject withdrew consent|0|||
16776126|NCT02410772|37715508|FG002|Overall Study|Baseline Drug Resistance|51|||
16776127|NCT02410772|37715506|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
16776128|NCT02410772|37715507|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
16776129|NCT02410772|37715508|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
16958725|NCT00927901|38101848|FG001|Treatment Period 4|Subject withdrew consent|0|||
16958726|NCT00927901|38101849|FG002|Treatment Period 4|Subject withdrew consent|1|||
16958727|NCT00927901|38101850|FG003|Treatment Period 4|Subject withdrew consent|0|||
16958728|NCT01218204|38101865|FG000|Part B Washout|Adverse Event|0|||
16958729|NCT01218204|38101866|FG001|Part B Washout|Adverse Event|1|||
16958730|NCT01218204|38101867|FG002|Part B Washout|Adverse Event|0|||
16958731|NCT01218204|38101868|FG003|Part B Washout|Adverse Event|0|||
16958732|NCT01218204|38101865|FG000|Part B Washout|Lost to Follow-up|0|||
16958733|NCT01218204|38101866|FG001|Part B Washout|Lost to Follow-up|2|||
16958734|NCT01218204|38101867|FG002|Part B Washout|Lost to Follow-up|0|||
16776130|NCT02410772|37715506|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
16776131|NCT02410772|37715507|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
16958735|NCT01218204|38101868|FG003|Part B Washout|Lost to Follow-up|0|||
16958736|NCT01218204|38101865|FG000|Part B Washout|Physician Decision|0|||
16958737|NCT01218204|38101866|FG001|Part B Washout|Physician Decision|14|||
16958738|NCT01218204|38101867|FG002|Part B Washout|Physician Decision|0|||
16958739|NCT01218204|38101868|FG003|Part B Washout|Physician Decision|0|||
16958740|NCT01218204|38101865|FG000|Part B Washout|Withdrawal by Subject|0|||
16958741|NCT01218204|38101866|FG001|Part B Washout|Withdrawal by Subject|14|||
16958742|NCT01218204|38101867|FG002|Part B Washout|Withdrawal by Subject|0|||
16958743|NCT01218204|38101868|FG003|Part B Washout|Withdrawal by Subject|0|||
16958744|NCT01218204|38101865|FG000|Part B Washout|Reached defined stopping criteria|0|||
16958745|NCT01218204|38101866|FG001|Part B Washout|Reached defined stopping criteria|2|||
16958746|NCT01218204|38101867|FG002|Part B Washout|Reached defined stopping criteria|0|||
16776132|NCT02410772|37715508|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
16776133|NCT01648790|37715525|FG000|Treatment 3|Withdrawal by Subject|0|||
16776134|NCT01648790|37715526|FG001|Treatment 3|Withdrawal by Subject|0|||
16958747|NCT01218204|38101868|FG003|Part B Washout|Reached defined stopping criteria|0|||
16958748|NCT01218204|38101865|FG000|Part B Washout|Did not meet continuation criteria|0|||
16958749|NCT01218204|38101866|FG001|Part B Washout|Did not meet continuation criteria|112|||
16958750|NCT01218204|38101867|FG002|Part B Washout|Did not meet continuation criteria|0|||
16958751|NCT01218204|38101868|FG003|Part B Washout|Did not meet continuation criteria|0|||
16958752|NCT01218204|38101865|FG000|Part B Run-in|Adverse Event|0|||
16958753|NCT01218204|38101866|FG001|Part B Run-in|Adverse Event|0|||
16958754|NCT01218204|38101867|FG002|Part B Run-in|Adverse Event|1|||
16958755|NCT01218204|38101868|FG003|Part B Run-in|Adverse Event|0|||
16958756|NCT01218204|38101865|FG000|Part B Run-in|Protocol Violation|0|||
16958757|NCT01218204|38101866|FG001|Part B Run-in|Protocol Violation|0|||
16958758|NCT01218204|38101867|FG002|Part B Run-in|Protocol Violation|2|||
16958759|NCT01218204|38101868|FG003|Part B Run-in|Protocol Violation|0|||
16958760|NCT01218204|38101865|FG000|Part B Run-in|Withdrawal by Subject|0|||
16958761|NCT01218204|38101866|FG001|Part B Run-in|Withdrawal by Subject|0|||
16958762|NCT01218204|38101867|FG002|Part B Run-in|Withdrawal by Subject|3|||
16958763|NCT01218204|38101868|FG003|Part B Run-in|Withdrawal by Subject|0|||
16958764|NCT01218204|38101865|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
16958765|NCT01218204|38101866|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
16958766|NCT01218204|38101867|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
16958767|NCT01218204|38101868|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
16958768|NCT01218204|38101865|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
16958769|NCT01218204|38101866|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
16958770|NCT01218204|38101867|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
16958771|NCT01218204|38101868|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
16958772|NCT00926575|38101917|FG000|Overall Study|Adverse Event|1|||
16958773|NCT00926575|38101918|FG001|Overall Study|Adverse Event|1|||
16958774|NCT00926575|38101917|FG000|Overall Study|Death|4|||
16958775|NCT00926575|38101918|FG001|Overall Study|Death|4|||
16958776|NCT00926575|38101917|FG000|Overall Study|Lost to Follow-up|1|||
16958777|NCT00926575|38101918|FG001|Overall Study|Lost to Follow-up|1|||
16958778|NCT00926575|38101917|FG000|Overall Study|Physician Decision|1|||
16958779|NCT00926575|38101918|FG001|Overall Study|Physician Decision|2|||
16958780|NCT00926575|38101917|FG000|Overall Study|Protocol Violation|1|||
16958781|NCT00926575|38101918|FG001|Overall Study|Protocol Violation|0|||
16958782|NCT00926575|38101917|FG000|Overall Study|Withdrawal by Subject|8|||
16958783|NCT00926575|38101918|FG001|Overall Study|Withdrawal by Subject|9|||
16958784|NCT01218126|38101928|FG000|Overall Study|Adverse Event|8|||
16958785|NCT01218126|38101929|FG001|Overall Study|Adverse Event|10|||
16958786|NCT01218126|38101930|FG002|Overall Study|Adverse Event|12|||
16958787|NCT01218126|38101931|FG003|Overall Study|Adverse Event|16|||
16958788|NCT01218126|38101928|FG000|Overall Study|Lack of Efficacy|7|||
16958789|NCT01218126|38101929|FG001|Overall Study|Lack of Efficacy|2|||
16958790|NCT01218126|38101930|FG002|Overall Study|Lack of Efficacy|2|||
16958791|NCT01218126|38101931|FG003|Overall Study|Lack of Efficacy|6|||
16958792|NCT01218126|38101928|FG000|Overall Study|Protocol Violation|5|||
16958793|NCT01218126|38101929|FG001|Overall Study|Protocol Violation|2|||
16958794|NCT01218126|38101930|FG002|Overall Study|Protocol Violation|2|||
16958795|NCT01218126|38101931|FG003|Overall Study|Protocol Violation|3|||
16958796|NCT01218126|38101928|FG000|Overall Study|Protocol-defined stopping criteria|1|||
16958797|NCT01218126|38101929|FG001|Overall Study|Protocol-defined stopping criteria|1|||
16958798|NCT01218126|38101930|FG002|Overall Study|Protocol-defined stopping criteria|0|||
16958799|NCT01218126|38101931|FG003|Overall Study|Protocol-defined stopping criteria|0|||
16958800|NCT01218126|38101928|FG000|Overall Study|Lost to Follow-up|0|||
16958801|NCT01218126|38101929|FG001|Overall Study|Lost to Follow-up|0|||
16958802|NCT01218126|38101930|FG002|Overall Study|Lost to Follow-up|0|||
16958803|NCT01218126|38101931|FG003|Overall Study|Lost to Follow-up|2|||
16958804|NCT01218126|38101928|FG000|Overall Study|Physician Decision|1|||
16958805|NCT01218126|38101929|FG001|Overall Study|Physician Decision|2|||
16958806|NCT01218126|38101930|FG002|Overall Study|Physician Decision|4|||
16958807|NCT01218126|38101931|FG003|Overall Study|Physician Decision|2|||
16958808|NCT01218126|38101928|FG000|Overall Study|Withdrawal by Subject|2|||
16958809|NCT01218126|38101929|FG001|Overall Study|Withdrawal by Subject|5|||
16958810|NCT01218126|38101930|FG002|Overall Study|Withdrawal by Subject|4|||
16958811|NCT01218126|38101931|FG003|Overall Study|Withdrawal by Subject|6|||
16958812|NCT01217892|38101945|FG000|Overall Study|Adverse Event|1|||
16958813|NCT01217892|38101946|FG001|Overall Study|Adverse Event|1|||
16958814|NCT01217892|38101947|FG002|Overall Study|Adverse Event|1|||
16958815|NCT01217892|38101948|FG003|Overall Study|Adverse Event|0|||
16958816|NCT01217892|38101945|FG000|Overall Study|Withdrawal by Subject|0|||
16958817|NCT01217892|38101946|FG001|Overall Study|Withdrawal by Subject|2|||
16958818|NCT01217892|38101947|FG002|Overall Study|Withdrawal by Subject|1|||
16958819|NCT01217892|38101948|FG003|Overall Study|Withdrawal by Subject|0|||
16958820|NCT01217892|38101945|FG000|Overall Study|Lab value|1|||
16958821|NCT01217892|38101946|FG001|Overall Study|Lab value|0|||
16958822|NCT01217892|38101947|FG002|Overall Study|Lab value|1|||
16958823|NCT01217892|38101948|FG003|Overall Study|Lab value|0|||
16958824|NCT01217892|38101945|FG000|Overall Study|Subject no longer meets study criteria|5|||
16958825|NCT01217892|38101946|FG001|Overall Study|Subject no longer meets study criteria|2|||
16958826|NCT01217892|38101947|FG002|Overall Study|Subject no longer meets study criteria|4|||
16958827|NCT01217892|38101948|FG003|Overall Study|Subject no longer meets study criteria|8|||
16958828|NCT01217892|38101945|FG000|Overall Study|Incorrect enrollment|0|||
16958829|NCT01217892|38101946|FG001|Overall Study|Incorrect enrollment|1|||
16958830|NCT01217892|38101947|FG002|Overall Study|Incorrect enrollment|1|||
16958831|NCT01217892|38101948|FG003|Overall Study|Incorrect enrollment|0|||
16958832|NCT01217892|38101945|FG000|Overall Study|Poor/Non-Compliance|0|||
16958833|NCT01217892|38101946|FG001|Overall Study|Poor/Non-Compliance|0|||
16958834|NCT01217892|38101947|FG002|Overall Study|Poor/Non-Compliance|1|||
16958835|NCT01217892|38101948|FG003|Overall Study|Poor/Non-Compliance|0|||
16958836|NCT01217814|38101961|FG000|Overall Study|Adverse Event|1|||
16958837|NCT01217814|38101962|FG001|Overall Study|Adverse Event|1|||
16958838|NCT01217814|38101963|FG002|Overall Study|Adverse Event|0|||
16958839|NCT01217814|38101961|FG000|Overall Study|Lack of Efficacy|0|||
16958840|NCT01217814|38101962|FG001|Overall Study|Lack of Efficacy|0|||
16958841|NCT01217814|38101963|FG002|Overall Study|Lack of Efficacy|1|||
16958842|NCT01217190|38101974|FG000|Second Dosing|Withdrawal by Subject|0|||
16958843|NCT01217190|38101975|FG001|Second Dosing|Withdrawal by Subject|2|||
16958844|NCT01136733|38101991|FG000|Phase 1b|Adverse Event|0|||
16958845|NCT01136733|38101992|FG001|Phase 1b|Adverse Event|3|||
16958846|NCT01136733|38101993|FG002|Phase 1b|Adverse Event|1|||
16958847|NCT01136733|38101994|FG003|Phase 1b|Adverse Event|0|||
16958848|NCT01136733|38101995|FG004|Phase 1b|Adverse Event|0|||
16958849|NCT01136733|38101996|FG005|Phase 1b|Adverse Event|0|||
16958850|NCT01136733|38101997|FG006|Phase 1b|Adverse Event|0|||
16958851|NCT01136733|38101991|FG000|Phase 1b|Participant Choice|0|||
16958852|NCT01136733|38101992|FG001|Phase 1b|Participant Choice|0|||
16958853|NCT01136733|38101993|FG002|Phase 1b|Participant Choice|1|||
16958854|NCT01136733|38101994|FG003|Phase 1b|Participant Choice|0|||
16958855|NCT01136733|38101995|FG004|Phase 1b|Participant Choice|0|||
16958856|NCT01136733|38101996|FG005|Phase 1b|Participant Choice|0|||
16958857|NCT01136733|38101997|FG006|Phase 1b|Participant Choice|0|||
16958858|NCT01136733|38101991|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
16958859|NCT01136733|38101992|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
16958860|NCT01136733|38101993|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
16958861|NCT01136733|38101994|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
16958862|NCT01136733|38101995|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
16958863|NCT01136733|38101996|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
16958864|NCT01136733|38101997|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
16958865|NCT01136733|38101991|FG000|Phase 1b|Clinical Progression|1|||
16958866|NCT01136733|38101992|FG001|Phase 1b|Clinical Progression|1|||
16958867|NCT01136733|38101993|FG002|Phase 1b|Clinical Progression|0|||
16958868|NCT01136733|38101994|FG003|Phase 1b|Clinical Progression|0|||
16958869|NCT01136733|38101995|FG004|Phase 1b|Clinical Progression|0|||
16958870|NCT01136733|38101996|FG005|Phase 1b|Clinical Progression|0|||
16958871|NCT01136733|38101997|FG006|Phase 1b|Clinical Progression|0|||
16958872|NCT01136733|38101991|FG000|Phase 2|Disease Progression|0|||
16958873|NCT01136733|38101992|FG001|Phase 2|Disease Progression|0|||
16958874|NCT01136733|38101993|FG002|Phase 2|Disease Progression|0|||
16958875|NCT01136733|38101994|FG003|Phase 2|Disease Progression|0|||
16958876|NCT01136733|38101995|FG004|Phase 2|Disease Progression|30|||
16958877|NCT01136733|38101996|FG005|Phase 2|Disease Progression|32|||
16958878|NCT01136733|38101997|FG006|Phase 2|Disease Progression|38|||
16958879|NCT01136733|38101991|FG000|Phase 2|Adverse Event|0|||
16958880|NCT01136733|38101992|FG001|Phase 2|Adverse Event|0|||
16958881|NCT01136733|38101993|FG002|Phase 2|Adverse Event|0|||
16958882|NCT01136733|38101994|FG003|Phase 2|Adverse Event|0|||
16958883|NCT01136733|38101995|FG004|Phase 2|Adverse Event|11|||
16958884|NCT01136733|38101996|FG005|Phase 2|Adverse Event|13|||
16958885|NCT01136733|38101997|FG006|Phase 2|Adverse Event|5|||
16958886|NCT01136733|38101991|FG000|Phase 2|Participant Choice|0|||
16958887|NCT01136733|38101992|FG001|Phase 2|Participant Choice|0|||
16958888|NCT01136733|38101993|FG002|Phase 2|Participant Choice|0|||
16958889|NCT01136733|38101994|FG003|Phase 2|Participant Choice|0|||
16958890|NCT01136733|38101995|FG004|Phase 2|Participant Choice|3|||
16958891|NCT01136733|38101996|FG005|Phase 2|Participant Choice|0|||
16958892|NCT01136733|38101997|FG006|Phase 2|Participant Choice|1|||
16776135|NCT01648790|37715527|FG002|Treatment 3|Withdrawal by Subject|0|||
16776136|NCT01648790|37715528|FG003|Treatment 3|Withdrawal by Subject|1|||
16776137|NCT01648790|37715529|FG004|Treatment 3|Withdrawal by Subject|0|||
16776138|NCT01936857|37715552|FG000|Overall Study|Sent to prison or 06 center|11|||
16776139|NCT01936857|37715553|FG001|Overall Study|Sent to prison or 06 center|12|||
16776140|NCT01936857|37715552|FG000|Overall Study|Lost to Follow-up|10|||
16776141|NCT01936857|37715553|FG001|Overall Study|Lost to Follow-up|7|||
16776142|NCT01936857|37715552|FG000|Overall Study|Death|7|||
16776143|NCT01936857|37715553|FG001|Overall Study|Death|3|||
16776144|NCT01936857|37715552|FG000|Overall Study|Moved|2|||
16776145|NCT01936857|37715553|FG001|Overall Study|Moved|1|||
16776146|NCT01936857|37715552|FG000|Overall Study|Withdrawal by Subject|1|||
16958893|NCT01136733|38101991|FG000|Phase 2|Administrative-Withdrew Consent|0|||
16958894|NCT01136733|38101992|FG001|Phase 2|Administrative-Withdrew Consent|0|||
16958895|NCT01136733|38101993|FG002|Phase 2|Administrative-Withdrew Consent|0|||
16958896|NCT01136733|38101994|FG003|Phase 2|Administrative-Withdrew Consent|0|||
16958897|NCT01136733|38101995|FG004|Phase 2|Administrative-Withdrew Consent|1|||
16958898|NCT01136733|38101996|FG005|Phase 2|Administrative-Withdrew Consent|0|||
16958899|NCT01136733|38101997|FG006|Phase 2|Administrative-Withdrew Consent|0|||
16958900|NCT01136733|38101991|FG000|Phase 2|Other|0|||
16958901|NCT01136733|38101992|FG001|Phase 2|Other|0|||
16958902|NCT01136733|38101993|FG002|Phase 2|Other|0|||
16958903|NCT01136733|38101994|FG003|Phase 2|Other|0|||
16958904|NCT01136733|38101995|FG004|Phase 2|Other|6|||
16776147|NCT01936857|37715553|FG001|Overall Study|Withdrawal by Subject|0|||
16776148|NCT01936857|37715552|FG000|Overall Study|Side effect of medication|1|||
16776149|NCT01936857|37715553|FG001|Overall Study|Side effect of medication|0|||
16958905|NCT01136733|38101996|FG005|Phase 2|Other|7|||
16958906|NCT01136733|38101997|FG006|Phase 2|Other|6|||
16958907|NCT01136655|38102027|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
16776150|NCT01936857|37715552|FG000|Overall Study|Other|2|||
16776151|NCT01936857|37715553|FG001|Overall Study|Other|2|||
16776152|NCT01602224|37715562|FG000|Overall Study|Adverse Event|0|||
16958908|NCT01136655|38102027|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
16958909|NCT01136655|38102027|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
16958910|NCT01136655|38102027|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
16958911|NCT01135017|38102042|FG000|Overall Study|Adverse Event|3|||
16958912|NCT01135017|38102043|FG001|Overall Study|Adverse Event|8|||
16958913|NCT01135017|38102042|FG000|Overall Study|Other than above|3|||
16776153|NCT01602224|37715563|FG001|Overall Study|Adverse Event|1|||
16958914|NCT01135017|38102043|FG001|Overall Study|Other than above|4|||
16958915|NCT01134939|38102057|FG000|Overall Study|Adverse Event|9|||
16958916|NCT01134939|38102058|FG001|Overall Study|Adverse Event|3|||
16958917|NCT01134939|38102059|FG002|Overall Study|Adverse Event|4|||
16958918|NCT01134939|38102060|FG003|Overall Study|Adverse Event|5|||
16958919|NCT01134939|38102061|FG004|Overall Study|Adverse Event|5|||
16958920|NCT01134939|38102062|FG005|Overall Study|Adverse Event|5|||
16958921|NCT01134939|38102063|FG006|Overall Study|Adverse Event|1|||
16958922|NCT01134939|38102064|FG007|Overall Study|Adverse Event|0|||
16958923|NCT01134939|38102057|FG000|Overall Study|Lack of Efficacy|2|||
16958924|NCT01134939|38102058|FG001|Overall Study|Lack of Efficacy|5|||
16958925|NCT01134939|38102059|FG002|Overall Study|Lack of Efficacy|1|||
16958926|NCT01134939|38102060|FG003|Overall Study|Lack of Efficacy|0|||
16958927|NCT01134939|38102061|FG004|Overall Study|Lack of Efficacy|3|||
16958928|NCT01134939|38102062|FG005|Overall Study|Lack of Efficacy|0|||
16958929|NCT01134939|38102063|FG006|Overall Study|Lack of Efficacy|1|||
16958930|NCT01134939|38102064|FG007|Overall Study|Lack of Efficacy|0|||
16958931|NCT01134939|38102057|FG000|Overall Study|Lost to Follow-up|2|||
16958932|NCT01134939|38102058|FG001|Overall Study|Lost to Follow-up|3|||
16958933|NCT01134939|38102059|FG002|Overall Study|Lost to Follow-up|0|||
16958934|NCT01134939|38102060|FG003|Overall Study|Lost to Follow-up|1|||
16958935|NCT01134939|38102061|FG004|Overall Study|Lost to Follow-up|2|||
16958936|NCT01134939|38102062|FG005|Overall Study|Lost to Follow-up|1|||
16958937|NCT01134939|38102063|FG006|Overall Study|Lost to Follow-up|0|||
16958938|NCT01134939|38102064|FG007|Overall Study|Lost to Follow-up|0|||
16958939|NCT01134939|38102057|FG000|Overall Study|Death|0|||
16958940|NCT01134939|38102058|FG001|Overall Study|Death|1|||
16958941|NCT01134939|38102059|FG002|Overall Study|Death|0|||
16958942|NCT01134939|38102060|FG003|Overall Study|Death|0|||
16958943|NCT01134939|38102061|FG004|Overall Study|Death|0|||
16776154|NCT01602224|37715564|FG002|Overall Study|Adverse Event|0|||
16776155|NCT01602224|37715562|FG000|Overall Study|Investigator Decison|1|||
16776156|NCT01602224|37715563|FG001|Overall Study|Investigator Decison|0|||
16776157|NCT01602224|37715564|FG002|Overall Study|Investigator Decison|0|||
16776158|NCT01602224|37715562|FG000|Overall Study|Lost to Follow-up|0|||
16776159|NCT01602224|37715563|FG001|Overall Study|Lost to Follow-up|0|||
16776160|NCT01602224|37715564|FG002|Overall Study|Lost to Follow-up|1|||
16776161|NCT01602224|37715562|FG000|Overall Study|Protocol Violation|0|||
16776162|NCT01602224|37715563|FG001|Overall Study|Protocol Violation|1|||
16776163|NCT01602224|37715564|FG002|Overall Study|Protocol Violation|0|||
16776164|NCT01602224|37715562|FG000|Overall Study|Sponsor Decision|2|||
16776165|NCT01602224|37715563|FG001|Overall Study|Sponsor Decision|3|||
16776166|NCT01602224|37715564|FG002|Overall Study|Sponsor Decision|2|||
16776167|NCT01602224|37715562|FG000|Overall Study|Withdrawal by Subject|5|||
16776168|NCT01602224|37715563|FG001|Overall Study|Withdrawal by Subject|3|||
16776169|NCT01602224|37715564|FG002|Overall Study|Withdrawal by Subject|3|||
16776170|NCT04498247|37715582|FG000|Overall Study|Lost to Follow-up|0|||
16776171|NCT04498247|37715583|FG001|Overall Study|Lost to Follow-up|0|||
16776172|NCT04498247|37715584|FG002|Overall Study|Lost to Follow-up|0|||
16776173|NCT04498247|37715585|FG003|Overall Study|Lost to Follow-up|1|||
16776174|NCT04498247|37715586|FG004|Overall Study|Lost to Follow-up|0|||
16958944|NCT01134939|38102062|FG005|Overall Study|Death|0|||
16958945|NCT01134939|38102063|FG006|Overall Study|Death|0|||
16958946|NCT01134939|38102064|FG007|Overall Study|Death|0|||
16958947|NCT01134939|38102057|FG000|Overall Study|Termination page not available|4|||
16958948|NCT01134939|38102058|FG001|Overall Study|Termination page not available|6|||
16958949|NCT01134939|38102059|FG002|Overall Study|Termination page not available|5|||
16958950|NCT01134939|38102060|FG003|Overall Study|Termination page not available|8|||
16958951|NCT01134939|38102061|FG004|Overall Study|Termination page not available|0|||
16958952|NCT01134939|38102062|FG005|Overall Study|Termination page not available|3|||
16958953|NCT01134939|38102063|FG006|Overall Study|Termination page not available|7|||
16958954|NCT01134939|38102064|FG007|Overall Study|Termination page not available|0|||
16958955|NCT01134783|38102080|FG000|Overall Study|Pregnancy|16|||
16958956|NCT01134783|38102081|FG001|Overall Study|Pregnancy|8|||
16958957|NCT01134783|38102080|FG000|Overall Study|Withdrawal by Subject|15|||
16958958|NCT01134783|38102081|FG001|Overall Study|Withdrawal by Subject|9|||
16958959|NCT01134783|38102080|FG000|Overall Study|Lost to Follow-up|5|||
16958960|NCT01134783|38102081|FG001|Overall Study|Lost to Follow-up|20|||
16958961|NCT01134705|38102093|FG000|Overall Study|Adverse Event|1|||
16958962|NCT01134705|38102094|FG001|Overall Study|Adverse Event|7|||
16958963|NCT01134705|38102093|FG000|Overall Study|Withdrawal by Subject|6|||
16958964|NCT01134705|38102094|FG001|Overall Study|Withdrawal by Subject|6|||
16958965|NCT01134705|38102093|FG000|Overall Study|Pregnancy|1|||
16958966|NCT01134705|38102094|FG001|Overall Study|Pregnancy|0|||
16776175|NCT04498247|37715587|FG005|Overall Study|Lost to Follow-up|0|||
16776176|NCT04498247|37715588|FG006|Overall Study|Lost to Follow-up|0|||
16776177|NCT04498247|37715589|FG007|Overall Study|Lost to Follow-up|0|||
16958967|NCT01134705|38102093|FG000|Overall Study|Lost to Follow-up|5|||
16958968|NCT01134705|38102094|FG001|Overall Study|Lost to Follow-up|2|||
16958969|NCT01134705|38102093|FG000|Overall Study|Protocol Violation|1|||
16958970|NCT01134705|38102094|FG001|Overall Study|Protocol Violation|1|||
16958971|NCT01134705|38102093|FG000|Overall Study|Other|1|||
16958972|NCT01134705|38102094|FG001|Overall Study|Other|6|||
16958973|NCT00927823|38102100|FG000|Continuous Dosing Period|Death|0|||
16958974|NCT00927823|38102101|FG001|Continuous Dosing Period|Death|0|||
16958975|NCT00927823|38102102|FG002|Continuous Dosing Period|Death|6|||
16958976|NCT00927823|38102103|FG003|Continuous Dosing Period|Death|0|||
16958977|NCT00927823|38102100|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
16958978|NCT00927823|38102101|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
16958979|NCT00927823|38102102|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
16958980|NCT00927823|38102103|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
16958981|NCT00927823|38102100|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
16958982|NCT00927823|38102101|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
16958983|NCT00927823|38102102|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
16958984|NCT00927823|38102103|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
16958985|NCT00927823|38102100|FG000|Continuous Dosing Period|Other|1|||
16958986|NCT00927823|38102101|FG001|Continuous Dosing Period|Other|2|||
16958987|NCT00927823|38102102|FG002|Continuous Dosing Period|Other|9|||
16958988|NCT00927823|38102103|FG003|Continuous Dosing Period|Other|3|||
16958989|NCT01134627|38102122|FG000|Overall Study|Adverse Event|47|||
16958990|NCT01134627|38102123|FG001|Overall Study|Adverse Event|31|||
16958991|NCT01134627|38102122|FG000|Overall Study|Lost to Follow-up|1|||
16958992|NCT01134627|38102123|FG001|Overall Study|Lost to Follow-up|2|||
16776178|NCT04498247|37715582|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
16958993|NCT01134627|38102122|FG000|Overall Study|Protocol Violation|3|||
16958994|NCT01134627|38102123|FG001|Overall Study|Protocol Violation|5|||
16958995|NCT01134627|38102122|FG000|Overall Study|Lack of Efficacy|2|||
16958996|NCT01134627|38102123|FG001|Overall Study|Lack of Efficacy|12|||
16958997|NCT01134627|38102122|FG000|Overall Study|Withdrawal by Subject|4|||
16958998|NCT01134627|38102123|FG001|Overall Study|Withdrawal by Subject|3|||
16958999|NCT01134627|38102122|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
16959000|NCT01134627|38102123|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
16959001|NCT01134627|38102122|FG000|Overall Study|Other|11|||
16959002|NCT01134627|38102123|FG001|Overall Study|Other|14|||
16959003|NCT01134393|38102129|FG000|Overall Study|Adverse Event|18|||
16959004|NCT01134393|38102129|FG000|Overall Study|Lack of Efficacy|2|||
16959005|NCT01134393|38102129|FG000|Overall Study|Protocol Violation|12|||
16959006|NCT01134393|38102129|FG000|Overall Study|Lost to Follow-up|3|||
16959007|NCT01134393|38102129|FG000|Overall Study|Withdrawal by Subject|11|||
16959008|NCT01134393|38102129|FG000|Overall Study|Other|6|||
16776179|NCT04498247|37715583|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
16776180|NCT04498247|37715584|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
16776181|NCT04498247|37715585|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
16776182|NCT04498247|37715586|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
16776183|NCT04498247|37715587|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
16776184|NCT04498247|37715588|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
16776185|NCT04498247|37715589|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
16776186|NCT04498247|37715582|FG000|Overall Study|Withdrawal by Subject|0|||
16776187|NCT04498247|37715583|FG001|Overall Study|Withdrawal by Subject|8|||
16776188|NCT04498247|37715584|FG002|Overall Study|Withdrawal by Subject|0|||
16776189|NCT04498247|37715585|FG003|Overall Study|Withdrawal by Subject|7|||
16776190|NCT04498247|37715586|FG004|Overall Study|Withdrawal by Subject|0|||
16776191|NCT04498247|37715587|FG005|Overall Study|Withdrawal by Subject|0|||
16776192|NCT04498247|37715588|FG006|Overall Study|Withdrawal by Subject|1|||
16776193|NCT04498247|37715589|FG007|Overall Study|Withdrawal by Subject|0|||
16776194|NCT04498247|37715582|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16776195|NCT04498247|37715583|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
16776196|NCT04498247|37715584|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16776197|NCT04498247|37715585|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
16776198|NCT04498247|37715586|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16776199|NCT04498247|37715587|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16776200|NCT04498247|37715588|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
16776201|NCT04498247|37715589|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16959009|NCT00922441|38102137|FG000|Overall Study|Protocol Violation|0|||
16959010|NCT00922441|38102138|FG001|Overall Study|Protocol Violation|0|||
16959011|NCT00922441|38102139|FG002|Overall Study|Protocol Violation|2|||
16959012|NCT00922441|38102137|FG000|Overall Study|Withdrawal by Subject|0|||
16959013|NCT00922441|38102138|FG001|Overall Study|Withdrawal by Subject|0|||
16959014|NCT00922441|38102139|FG002|Overall Study|Withdrawal by Subject|1|||
16959015|NCT01217112|38102152|FG000|Overall Study|Adverse Event|0|||
16959016|NCT01217112|38102153|FG001|Overall Study|Adverse Event|2|||
16776202|NCT03887117|37715617|FG000|Overall Study|Discontinued prematurely|0|||
16776203|NCT03887117|37715618|FG001|Overall Study|Discontinued prematurely|1|||
16776204|NCT03887117|37715619|FG002|Overall Study|Discontinued prematurely|1|||
16776205|NCT03887117|37715620|FG003|Overall Study|Discontinued prematurely|2|||
16776206|NCT04038385|37715641|FG000|Overall Study|Completed baseline assessment only|7|||
16959017|NCT01217112|38102154|FG002|Overall Study|Adverse Event|0|||
16959018|NCT01217112|38102155|FG003|Overall Study|Adverse Event|2|||
16959019|NCT01217112|38102156|FG004|Overall Study|Adverse Event|0|||
16959020|NCT01217112|38102152|FG000|Overall Study|Withdrawal by Subject|0|||
16959021|NCT01217112|38102153|FG001|Overall Study|Withdrawal by Subject|0|||
16959022|NCT01217112|38102154|FG002|Overall Study|Withdrawal by Subject|1|||
16959023|NCT01217112|38102155|FG003|Overall Study|Withdrawal by Subject|0|||
16959024|NCT01217112|38102156|FG004|Overall Study|Withdrawal by Subject|0|||
16959025|NCT01217112|38102152|FG000|Overall Study|Physician Decision|0|||
16959026|NCT01217112|38102153|FG001|Overall Study|Physician Decision|0|||
16959027|NCT01217112|38102154|FG002|Overall Study|Physician Decision|0|||
16959028|NCT01217112|38102155|FG003|Overall Study|Physician Decision|0|||
16959029|NCT01217112|38102156|FG004|Overall Study|Physician Decision|1|||
16959030|NCT01216332|38102170|FG000|Overall Study|Withdrawal by Subject|4|||
16959031|NCT01216332|38102171|FG001|Overall Study|Withdrawal by Subject|0|||
16959032|NCT00922207|38102180|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
16959033|NCT00922207|38102181|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
16959034|NCT00922207|38102182|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
16959035|NCT00922207|38102180|FG000|Overall Study|Insufficient Therapeutic Response|0|||
16959036|NCT00922207|38102181|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16959037|NCT00922207|38102182|FG002|Overall Study|Insufficient Therapeutic Response|1|||
16959038|NCT00922207|38102180|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
16959039|NCT00922207|38102181|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
16959040|NCT00922207|38102182|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
16959041|NCT00922207|38102180|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
16959042|NCT00922207|38102181|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
16959043|NCT00922207|38102182|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
16776207|NCT04038385|37715642|FG001|Overall Study|Completed baseline assessment only|4|||
16959044|NCT00922207|38102180|FG000|Overall Study|Withdrew Consent|2|||
16959045|NCT00922207|38102181|FG001|Overall Study|Withdrew Consent|5|||
16959046|NCT00922207|38102182|FG002|Overall Study|Withdrew Consent|2|||
16959047|NCT00922207|38102180|FG000|Overall Study|Abnormality of Laboratory Test|0|||
16959048|NCT00922207|38102181|FG001|Overall Study|Abnormality of Laboratory Test|1|||
16959049|NCT00922207|38102182|FG002|Overall Study|Abnormality of Laboratory Test|1|||
16959050|NCT01134315|38102192|FG000|Overall Study|Adverse Event|1|||
16959051|NCT01134315|38102193|FG001|Overall Study|Adverse Event|2|||
16959052|NCT01134315|38102192|FG000|Overall Study|Other Reason|8|||
16959053|NCT01134315|38102193|FG001|Overall Study|Other Reason|17|||
16959054|NCT01216176|38102202|FG000|Overall Study|Adverse Event|0|||
16959055|NCT01216176|38102203|FG001|Overall Study|Adverse Event|8|||
16959056|NCT01216176|38102204|FG002|Overall Study|Adverse Event|0|||
16959057|NCT01216176|38102202|FG000|Overall Study|Physician Decision|0|||
16959058|NCT01216176|38102203|FG001|Overall Study|Physician Decision|0|||
16959059|NCT01216176|38102204|FG002|Overall Study|Physician Decision|1|||
16959060|NCT01133847|38102216|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
16959061|NCT01133847|38102217|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
16959062|NCT01133847|38102218|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
16959063|NCT01133847|38102216|FG000|Follow-Up Phase|Lost to Follow-up|1|||
16959064|NCT01133847|38102217|FG001|Follow-Up Phase|Lost to Follow-up|3|||
16959065|NCT01133847|38102218|FG002|Follow-Up Phase|Lost to Follow-up|7|||
16959066|NCT01133379|38102230|FG000|Overall Study|Withdrawal by Subject|0|||
16959067|NCT01133379|38102231|FG001|Overall Study|Withdrawal by Subject|1|||
16959068|NCT01133379|38102232|FG002|Overall Study|Withdrawal by Subject|1|||
16959069|NCT01133379|38102230|FG000|Overall Study|Lost to Follow-up|1|||
16959070|NCT01133379|38102231|FG001|Overall Study|Lost to Follow-up|1|||
16959071|NCT01133379|38102232|FG002|Overall Study|Lost to Follow-up|1|||
16959072|NCT01133067|38102240|FG000|Overall Study|Death|136|||
16959073|NCT01133067|38102240|FG000|Overall Study|Lost to Follow-up|3|||
16959074|NCT01132755|38102244|FG000|Overall Study|Procedure not done due to medical reason|23|||
16959075|NCT01132755|38102244|FG000|Overall Study|Protocol Violation|15|||
16959076|NCT01132755|38102244|FG000|Overall Study|Withdrawal by Subject|4|||
16959077|NCT00919711|38102250|FG000|Overall Study|Withdrawal by Subject|15|||
16959078|NCT00919711|38102251|FG001|Overall Study|Withdrawal by Subject|7|||
16959079|NCT00919711|38102250|FG000|Overall Study|Adverse Event|13|||
16959080|NCT00919711|38102251|FG001|Overall Study|Adverse Event|3|||
16959081|NCT00919711|38102250|FG000|Overall Study|Other|1|||
16959082|NCT00919711|38102251|FG001|Overall Study|Other|2|||
16959083|NCT00919711|38102250|FG000|Overall Study|Administrative Decision|0|||
16959084|NCT00919711|38102251|FG001|Overall Study|Administrative Decision|1|||
16959085|NCT00919711|38102250|FG000|Overall Study|Lost to Follow-up|2|||
16959086|NCT00919711|38102251|FG001|Overall Study|Lost to Follow-up|0|||
16959087|NCT00919711|38102250|FG000|Overall Study|Death|1|||
16959088|NCT00919711|38102251|FG001|Overall Study|Death|0|||
16959089|NCT00919711|38102250|FG000|Overall Study|Noncompliance|1|||
16959090|NCT00919711|38102251|FG001|Overall Study|Noncompliance|0|||
16959091|NCT01131585|38102259|FG000|Overall Study|Adverse Event|0|||
16959092|NCT01131585|38102260|FG001|Overall Study|Adverse Event|2|||
16959093|NCT01131585|38102259|FG000|Overall Study|Abnormal laboratory value|1|||
16959094|NCT01131585|38102260|FG001|Overall Study|Abnormal laboratory value|0|||
16959095|NCT01131585|38102259|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16959096|NCT01131585|38102260|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16959097|NCT01131585|38102259|FG000|Overall Study|Protocol Violation|2|||
16959098|NCT01131585|38102260|FG001|Overall Study|Protocol Violation|1|||
16959099|NCT01131585|38102259|FG000|Overall Study|Withdrawal by Subject|3|||
16959100|NCT01131585|38102260|FG001|Overall Study|Withdrawal by Subject|3|||
16959101|NCT01131585|38102259|FG000|Overall Study|Lost to Follow-up|0|||
16959102|NCT01131585|38102260|FG001|Overall Study|Lost to Follow-up|1|||
16959103|NCT01131585|38102259|FG000|Overall Study|Administrative problems|1|||
16959104|NCT01131585|38102260|FG001|Overall Study|Administrative problems|1|||
16959105|NCT01131585|38102259|FG000|Overall Study|Study termination|78|||
16959106|NCT01131585|38102260|FG001|Overall Study|Study termination|32|||
16959107|NCT01131507|38102266|FG000|Overall Study|Adverse Event|1|||
16959108|NCT01131507|38102266|FG000|Overall Study|Lost to Follow-up|1|||
16959109|NCT01131507|38102266|FG000|Overall Study|Withdrawal by Subject|1|||
16959110|NCT01131351|38102272|FG000|Overall Study|Adverse Event|0|||
16959111|NCT01131351|38102273|FG001|Overall Study|Adverse Event|2|||
16959112|NCT01131351|38102272|FG000|Overall Study|Protocol Deviation|0|||
16959113|NCT01131351|38102273|FG001|Overall Study|Protocol Deviation|1|||
16959114|NCT00919633|38102283|FG000|Overall Study|Adverse Event|1|||
16959115|NCT00919633|38102284|FG001|Overall Study|Adverse Event|9|||
16959116|NCT00919633|38102285|FG002|Overall Study|Adverse Event|12|||
16959117|NCT00919633|38102286|FG003|Overall Study|Adverse Event|10|||
16959118|NCT00919633|38102283|FG000|Overall Study|Death|0|||
16959119|NCT00919633|38102284|FG001|Overall Study|Death|0|||
16959120|NCT00919633|38102285|FG002|Overall Study|Death|2|||
16959121|NCT00919633|38102286|FG003|Overall Study|Death|0|||
16959122|NCT00919633|38102283|FG000|Overall Study|Lack of Efficacy|17|||
16959123|NCT00919633|38102284|FG001|Overall Study|Lack of Efficacy|3|||
16959124|NCT00919633|38102285|FG002|Overall Study|Lack of Efficacy|2|||
16959125|NCT00919633|38102286|FG003|Overall Study|Lack of Efficacy|3|||
16959126|NCT00919633|38102283|FG000|Overall Study|Withdrawal by Subject|1|||
16959127|NCT00919633|38102284|FG001|Overall Study|Withdrawal by Subject|2|||
16959128|NCT00919633|38102285|FG002|Overall Study|Withdrawal by Subject|4|||
16959129|NCT00919633|38102286|FG003|Overall Study|Withdrawal by Subject|3|||
16959130|NCT00919633|38102283|FG000|Overall Study|Lost to Follow-up|3|||
16959131|NCT00919633|38102284|FG001|Overall Study|Lost to Follow-up|1|||
16959132|NCT00919633|38102285|FG002|Overall Study|Lost to Follow-up|0|||
16959133|NCT00919633|38102286|FG003|Overall Study|Lost to Follow-up|2|||
16959134|NCT00919633|38102283|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
16959135|NCT00919633|38102284|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
16959136|NCT00919633|38102285|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
16959137|NCT00919633|38102286|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
16959138|NCT00919633|38102283|FG000|Overall Study|Protocol Violation|0|||
16959139|NCT00919633|38102284|FG001|Overall Study|Protocol Violation|0|||
16959140|NCT00919633|38102285|FG002|Overall Study|Protocol Violation|0|||
16959141|NCT00919633|38102286|FG003|Overall Study|Protocol Violation|1|||
16959142|NCT00919633|38102283|FG000|Overall Study|Physician Decision|0|||
16959143|NCT00919633|38102284|FG001|Overall Study|Physician Decision|0|||
16959144|NCT00919633|38102285|FG002|Overall Study|Physician Decision|0|||
16959145|NCT00919633|38102286|FG003|Overall Study|Physician Decision|1|||
16959146|NCT00919633|38102283|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
16959147|NCT00919633|38102284|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
16776208|NCT04038385|37715641|FG000|Overall Study|Moved out of area|4|||
16959148|NCT00919633|38102285|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
16959149|NCT00919633|38102286|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
16776209|NCT04038385|37715642|FG001|Overall Study|Moved out of area|2|||
16776210|NCT04038385|37715641|FG000|Overall Study|Discontinued study involvement|6|||
16959150|NCT00919633|38102283|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
16959151|NCT00919633|38102284|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
16959152|NCT00919633|38102285|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
16959153|NCT00919633|38102286|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
16959154|NCT01130883|38102296|FG000|Overall Study|Patient Noncompliance|6|||
16959155|NCT01130883|38102296|FG000|Overall Study|Reason Unknown|1|||
16959156|NCT01130883|38102296|FG000|Overall Study|Adverse Event|3|||
16959157|NCT00926029|38102303|FG000|Overall Study|Lost to Follow-up|2|||
16959158|NCT00926029|38102304|FG001|Overall Study|Lost to Follow-up|1|||
16959159|NCT00926029|38102305|FG002|Overall Study|Lost to Follow-up|1|||
16959160|NCT01130493|38102315|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
16959161|NCT01130493|38102316|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
16959162|NCT01130493|38102317|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
16959163|NCT01130493|38102315|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
16959164|NCT01130493|38102316|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
16959165|NCT01130493|38102317|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
16959166|NCT01130493|38102315|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
16959167|NCT01130493|38102316|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
16959168|NCT01130493|38102317|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
16959169|NCT01130493|38102315|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
16959170|NCT01130493|38102316|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
16959171|NCT01130493|38102317|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
16959172|NCT01130493|38102315|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
16959173|NCT01130493|38102316|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
16959174|NCT01130493|38102317|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
16959175|NCT01130493|38102315|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
16959176|NCT01130493|38102316|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
16959177|NCT01130493|38102317|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
16959178|NCT01130493|38102315|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
16959179|NCT01130493|38102316|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
16959180|NCT01130493|38102317|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
16959181|NCT01130493|38102315|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
16959182|NCT01130493|38102316|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
16959183|NCT01130493|38102317|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
16959184|NCT01130493|38102315|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
16959185|NCT01130493|38102316|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
16959186|NCT01130493|38102317|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
16959187|NCT01130493|38102315|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
16959188|NCT01130493|38102316|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
16959189|NCT01130493|38102317|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
16959190|NCT01130493|38102315|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
16959191|NCT01130493|38102316|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
16959192|NCT01130493|38102317|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
16959193|NCT01130493|38102315|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
16959194|NCT01130493|38102316|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
16959195|NCT01130493|38102317|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
16959196|NCT01130493|38102315|FG000|Part 2: OLE|Adverse Event|0|||
16959197|NCT01130493|38102316|FG001|Part 2: OLE|Adverse Event|2|||
16959198|NCT01130493|38102317|FG002|Part 2: OLE|Adverse Event|1|||
16959199|NCT01130493|38102315|FG000|Part 2: OLE|Withdrawal by Subject|0|||
16959200|NCT01130493|38102316|FG001|Part 2: OLE|Withdrawal by Subject|1|||
16959201|NCT01130493|38102317|FG002|Part 2: OLE|Withdrawal by Subject|4|||
16959202|NCT01130337|38102328|FG000|Overall Study|Withdrawal by Subject|3|||
16959203|NCT01130337|38102328|FG000|Overall Study|Principal investigator decision|1|||
16959204|NCT01130337|38102328|FG000|Overall Study|Death|1|||
16959205|NCT01130337|38102328|FG000|Overall Study|Disease progression|1|||
16959206|NCT01130337|38102328|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
16959207|NCT01130337|38102328|FG000|Overall Study|Surgical resection (R2)|1|||
16959208|NCT01130103|38102334|FG000|Randomized Treatment|Adverse Event|1|||
16959209|NCT01130103|38102335|FG001|Randomized Treatment|Adverse Event|1|||
16959210|NCT01130103|38102334|FG000|Randomized Treatment|Lost to Follow-up|1|||
16959211|NCT01130103|38102335|FG001|Randomized Treatment|Lost to Follow-up|0|||
16776211|NCT04038385|37715642|FG001|Overall Study|Discontinued study involvement|1|||
16776212|NCT00783263|37715652|FG000|Overall Study|Adverse Event|3|||
16776213|NCT00783263|37715653|FG001|Overall Study|Adverse Event|0|||
16776214|NCT00783263|37715654|FG002|Overall Study|Adverse Event|2|||
16959212|NCT01130103|38102334|FG000|Randomized Treatment|Protocol Violation|3|||
16959213|NCT01130103|38102335|FG001|Randomized Treatment|Protocol Violation|2|||
16959214|NCT01130103|38102334|FG000|Randomized Treatment|Withdrawal by Subject|1|||
16959215|NCT01130103|38102335|FG001|Randomized Treatment|Withdrawal by Subject|2|||
16959216|NCT01130103|38102334|FG000|Maintenance Treatment|Lack of Efficacy|0|||
16959217|NCT01130103|38102335|FG001|Maintenance Treatment|Lack of Efficacy|1|||
16959218|NCT01130103|38102334|FG000|Maintenance Treatment|Lost to Follow-up|1|||
16959219|NCT01130103|38102335|FG001|Maintenance Treatment|Lost to Follow-up|1|||
16776215|NCT00783263|37715655|FG003|Overall Study|Adverse Event|1|||
16776216|NCT00783263|37715652|FG000|Overall Study|Lost to Follow-up|1|||
16776217|NCT00783263|37715653|FG001|Overall Study|Lost to Follow-up|1|||
16776218|NCT00783263|37715654|FG002|Overall Study|Lost to Follow-up|0|||
16776219|NCT00783263|37715655|FG003|Overall Study|Lost to Follow-up|0|||
16776220|NCT00783263|37715652|FG000|Overall Study|Withdrawal by Subject|0|||
16959220|NCT01130103|38102334|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
16959221|NCT01130103|38102335|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
16776221|NCT00783263|37715653|FG001|Overall Study|Withdrawal by Subject|1|||
16776222|NCT00783263|37715654|FG002|Overall Study|Withdrawal by Subject|1|||
16776223|NCT00783263|37715655|FG003|Overall Study|Withdrawal by Subject|2|||
16776224|NCT03987919|37715682|FG000|Overall Study|Adverse Event|1|||
16776225|NCT03987919|37715683|FG001|Overall Study|Adverse Event|4|||
16776226|NCT03987919|37715684|FG002|Overall Study|Adverse Event|1|||
16776227|NCT03987919|37715685|FG003|Overall Study|Adverse Event|3|||
16776228|NCT03987919|37715682|FG000|Overall Study|Death|4|||
16776229|NCT03987919|37715683|FG001|Overall Study|Death|4|||
16776230|NCT03987919|37715684|FG002|Overall Study|Death|4|||
16776231|NCT03987919|37715685|FG003|Overall Study|Death|1|||
16776232|NCT03987919|37715682|FG000|Overall Study|Lost to Follow-up|5|||
16776233|NCT03987919|37715683|FG001|Overall Study|Lost to Follow-up|6|||
16776234|NCT03987919|37715684|FG002|Overall Study|Lost to Follow-up|8|||
16776235|NCT03987919|37715685|FG003|Overall Study|Lost to Follow-up|12|||
16776236|NCT03987919|37715682|FG000|Overall Study|Physician Decision|0|||
16776237|NCT03987919|37715683|FG001|Overall Study|Physician Decision|2|||
16776238|NCT03987919|37715684|FG002|Overall Study|Physician Decision|0|||
16776239|NCT03987919|37715685|FG003|Overall Study|Physician Decision|4|||
16776240|NCT03987919|37715682|FG000|Overall Study|Pregnancy|1|||
16959222|NCT01129557|38102344|FG000|Overall Study|Adverse Event|1|||
16959223|NCT01129557|38102345|FG001|Overall Study|Adverse Event|2|||
16959224|NCT01129557|38102346|FG002|Overall Study|Adverse Event|2|||
16959225|NCT01129557|38102344|FG000|Overall Study|Novartis terminated study early|3|||
16959226|NCT01129557|38102345|FG001|Overall Study|Novartis terminated study early|3|||
16959227|NCT01129557|38102346|FG002|Overall Study|Novartis terminated study early|2|||
16959228|NCT01129011|38102367|FG000|Overall Study|Adverse Event|20|||
16959229|NCT01129011|38102368|FG001|Overall Study|Adverse Event|30|||
16959230|NCT01129011|38102367|FG000|Overall Study|Withdrawal by Subject|24|||
16959231|NCT01129011|38102368|FG001|Overall Study|Withdrawal by Subject|8|||
16959232|NCT01129011|38102367|FG000|Overall Study|Lost to Follow-up|6|||
16959233|NCT01129011|38102368|FG001|Overall Study|Lost to Follow-up|7|||
16959234|NCT01129011|38102367|FG000|Overall Study|Duodenal Ulcer|2|||
16959235|NCT01129011|38102368|FG001|Overall Study|Duodenal Ulcer|8|||
16959236|NCT01129011|38102367|FG000|Overall Study|misc|7|||
16959237|NCT01129011|38102368|FG001|Overall Study|misc|4|||
16959238|NCT01215942|38102376|FG000|Treatment Period|Adverse Event|15|||
16959239|NCT01215942|38102377|FG001|Treatment Period|Adverse Event|26|||
16959240|NCT01215942|38102376|FG000|Treatment Period|Death|2|||
16959241|NCT01215942|38102377|FG001|Treatment Period|Death|4|||
16959242|NCT01215942|38102376|FG000|Treatment Period|Lack of Efficacy|23|||
16959243|NCT01215942|38102377|FG001|Treatment Period|Lack of Efficacy|62|||
16959244|NCT01215942|38102376|FG000|Treatment Period|Lost to Follow-up|3|||
16959245|NCT01215942|38102377|FG001|Treatment Period|Lost to Follow-up|4|||
16959246|NCT01215942|38102376|FG000|Treatment Period|Withdrawal by Subject|17|||
16959247|NCT01215942|38102377|FG001|Treatment Period|Withdrawal by Subject|40|||
16959248|NCT01215942|38102376|FG000|Treatment Period|Physician Decision|5|||
16959249|NCT01215942|38102377|FG001|Treatment Period|Physician Decision|5|||
16959250|NCT01215942|38102376|FG000|Treatment Period|Protocol Violation|0|||
16959251|NCT01215942|38102377|FG001|Treatment Period|Protocol Violation|1|||
16959252|NCT01215942|38102376|FG000|Treatment Period|Sponsor Decision|349|||
16959253|NCT01215942|38102377|FG001|Treatment Period|Sponsor Decision|530|||
16959254|NCT01215942|38102376|FG000|Post-Treatment Follow-Up Period|Death|0|||
16959255|NCT01215942|38102377|FG001|Post-Treatment Follow-Up Period|Death|1|||
16959256|NCT01215942|38102376|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
16959257|NCT01215942|38102377|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
16959258|NCT01215942|38102376|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
16959259|NCT01215942|38102377|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
16776241|NCT03987919|37715683|FG001|Overall Study|Pregnancy|0|||
16776242|NCT03987919|37715684|FG002|Overall Study|Pregnancy|1|||
16959260|NCT01215942|38102376|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
16776243|NCT03987919|37715685|FG003|Overall Study|Pregnancy|1|||
16959261|NCT01215942|38102377|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
16959262|NCT01215942|38102376|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
16959263|NCT01215942|38102377|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
16959264|NCT00919867|38102400|FG000|First Intervention|Withdrawal by Subject|0|||
16959265|NCT00919867|38102401|FG001|First Intervention|Withdrawal by Subject|0|||
16959266|NCT00919867|38102402|FG002|First Intervention|Withdrawal by Subject|1|||
16959267|NCT00919867|38102403|FG003|First Intervention|Withdrawal by Subject|0|||
16959268|NCT00919867|38102404|FG004|First Intervention|Withdrawal by Subject|0|||
16959269|NCT00919867|38102405|FG005|First Intervention|Withdrawal by Subject|0|||
16959270|NCT00919867|38102400|FG000|First Intervention|Physician Decision|0|||
16959271|NCT00919867|38102401|FG001|First Intervention|Physician Decision|0|||
16959272|NCT00919867|38102402|FG002|First Intervention|Physician Decision|0|||
16959273|NCT00919867|38102403|FG003|First Intervention|Physician Decision|0|||
16959274|NCT00919867|38102404|FG004|First Intervention|Physician Decision|0|||
16959275|NCT00919867|38102405|FG005|First Intervention|Physician Decision|1|||
16959276|NCT01128621|38102415|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
16959277|NCT01128621|38102416|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
16959278|NCT00918463|38102438|FG000|Overall Study|Death|1|||
16776244|NCT03987919|37715682|FG000|Overall Study|Protocol Violation|0|||
16776245|NCT03987919|37715683|FG001|Overall Study|Protocol Violation|1|||
16776246|NCT03987919|37715684|FG002|Overall Study|Protocol Violation|0|||
16776247|NCT03987919|37715685|FG003|Overall Study|Protocol Violation|0|||
16776248|NCT03987919|37715682|FG000|Overall Study|Site terminated by Sponsor|0|||
16776249|NCT03987919|37715683|FG001|Overall Study|Site terminated by Sponsor|0|||
16959279|NCT00918463|38102438|FG000|Overall Study|Lack of Efficacy|1|||
16959280|NCT01128543|38102442|FG000|Overall Study|Withdrawal by Subject|3|||
16959281|NCT01128543|38102442|FG000|Overall Study|Protocol Violation|1|||
16959282|NCT01128387|38102448|FG000|Overall Study|Physician Decision|0|||
16959283|NCT01128387|38102449|FG001|Overall Study|Physician Decision|1|||
16959284|NCT01214850|38102458|FG000|Overall Study|Withdrawal by Subject|38|||
16776250|NCT03987919|37715684|FG002|Overall Study|Site terminated by Sponsor|0|||
16776251|NCT03987919|37715685|FG003|Overall Study|Site terminated by Sponsor|1|||
16776252|NCT03987919|37715682|FG000|Overall Study|Withdrawal by Subject|7|||
16776253|NCT03987919|37715683|FG001|Overall Study|Withdrawal by Subject|7|||
16776254|NCT03987919|37715684|FG002|Overall Study|Withdrawal by Subject|8|||
16776255|NCT03987919|37715685|FG003|Overall Study|Withdrawal by Subject|4|||
16776256|NCT03987919|37715682|FG000|Overall Study|Other - as reported by the investigator|1|||
16776257|NCT03987919|37715683|FG001|Overall Study|Other - as reported by the investigator|3|||
16776258|NCT03987919|37715684|FG002|Overall Study|Other - as reported by the investigator|2|||
16776259|NCT03987919|37715685|FG003|Overall Study|Other - as reported by the investigator|0|||
16776260|NCT00535405|37715705|FG000|Overall Study|Adverse Event|6|||
16776261|NCT00535405|37715706|FG001|Overall Study|Adverse Event|8|||
16776262|NCT00535405|37715707|FG002|Overall Study|Adverse Event|3|||
16776263|NCT00535405|37715708|FG003|Overall Study|Adverse Event|8|||
16776264|NCT00535405|37715709|FG004|Overall Study|Adverse Event|6|||
16776265|NCT00535405|37715705|FG000|Overall Study|Lost to Follow-up|1|||
16776266|NCT00535405|37715706|FG001|Overall Study|Lost to Follow-up|3|||
16776267|NCT00535405|37715707|FG002|Overall Study|Lost to Follow-up|3|||
16776268|NCT00535405|37715708|FG003|Overall Study|Lost to Follow-up|2|||
16776269|NCT00535405|37715709|FG004|Overall Study|Lost to Follow-up|1|||
16776270|NCT00535405|37715705|FG000|Overall Study|Physician Decision|3|||
16776271|NCT00535405|37715706|FG001|Overall Study|Physician Decision|2|||
16776272|NCT00535405|37715707|FG002|Overall Study|Physician Decision|0|||
16776273|NCT00535405|37715708|FG003|Overall Study|Physician Decision|1|||
16776274|NCT00535405|37715709|FG004|Overall Study|Physician Decision|1|||
16776275|NCT00535405|37715705|FG000|Overall Study|Protocol Violation|2|||
16959285|NCT01214850|38102459|FG001|Overall Study|Withdrawal by Subject|31|||
16959286|NCT01214850|38102460|FG002|Overall Study|Withdrawal by Subject|28|||
16959287|NCT01214850|38102458|FG000|Overall Study|Lost to Follow-up|124|||
16959288|NCT01214850|38102459|FG001|Overall Study|Lost to Follow-up|98|||
16959289|NCT01214850|38102460|FG002|Overall Study|Lost to Follow-up|123|||
16959290|NCT01214850|38102458|FG000|Overall Study|Protocol Violation|5|||
16959291|NCT01214850|38102459|FG001|Overall Study|Protocol Violation|5|||
16959292|NCT01214850|38102460|FG002|Overall Study|Protocol Violation|6|||
16959293|NCT01214850|38102458|FG000|Overall Study|Adverse event or death|11|||
16959294|NCT01214850|38102459|FG001|Overall Study|Adverse event or death|8|||
16959295|NCT01214850|38102460|FG002|Overall Study|Adverse event or death|3|||
16959296|NCT01214850|38102458|FG000|Overall Study|Inappropriate enrollment|2|||
16776276|NCT00535405|37715706|FG001|Overall Study|Protocol Violation|2|||
16776277|NCT00535405|37715707|FG002|Overall Study|Protocol Violation|2|||
16776278|NCT00535405|37715708|FG003|Overall Study|Protocol Violation|1|||
16776279|NCT00535405|37715709|FG004|Overall Study|Protocol Violation|0|||
16776280|NCT00535405|37715705|FG000|Overall Study|Withdrawal by Subject|5|||
16776281|NCT00535405|37715706|FG001|Overall Study|Withdrawal by Subject|11|||
16776282|NCT00535405|37715707|FG002|Overall Study|Withdrawal by Subject|10|||
16959297|NCT01214850|38102459|FG001|Overall Study|Inappropriate enrollment|1|||
16776283|NCT00535405|37715708|FG003|Overall Study|Withdrawal by Subject|10|||
16959298|NCT01214850|38102460|FG002|Overall Study|Inappropriate enrollment|0|||
16959299|NCT01214850|38102458|FG000|Overall Study|Administrative reason|1|||
16959300|NCT01214850|38102459|FG001|Overall Study|Administrative reason|0|||
16959301|NCT01214850|38102460|FG002|Overall Study|Administrative reason|0|||
16959302|NCT01214850|38102458|FG000|Overall Study|Unable to classify|2|||
16959303|NCT01214850|38102459|FG001|Overall Study|Unable to classify|1|||
16959304|NCT01214850|38102460|FG002|Overall Study|Unable to classify|1|||
16959305|NCT01128153|38102473|FG000|Overall Study|Adverse Event|1|||
16959306|NCT01128153|38102474|FG001|Overall Study|Adverse Event|3|||
16959307|NCT01128153|38102473|FG000|Overall Study|Condition under investigation worsened|8|||
16959308|NCT01128153|38102474|FG001|Overall Study|Condition under investigation worsened|7|||
16776284|NCT00535405|37715709|FG004|Overall Study|Withdrawal by Subject|8|||
16776285|NCT00271817|37715724|FG000|Part 1|Adverse Event|68|||
16776286|NCT00271817|37715725|FG001|Part 1|Adverse Event|25|||
16776287|NCT00271817|37715726|FG002|Part 1|Adverse Event|156|||
16776288|NCT00271817|37715724|FG000|Part 1|Lost to Follow-up|6|||
16959309|NCT01128153|38102473|FG000|Overall Study|Withdrawal by Subject|2|||
16959310|NCT01128153|38102474|FG001|Overall Study|Withdrawal by Subject|3|||
16959311|NCT01128153|38102473|FG000|Overall Study|Incorrect enrolment to study|2|||
16959312|NCT01128153|38102474|FG001|Overall Study|Incorrect enrolment to study|1|||
16959313|NCT01128153|38102473|FG000|Overall Study|Protocol Violation|2|||
16776289|NCT00271817|37715725|FG001|Part 1|Lost to Follow-up|8|||
16776290|NCT00271817|37715726|FG002|Part 1|Lost to Follow-up|24|||
16776291|NCT00271817|37715724|FG000|Part 1|Protocol Violation|5|||
16959314|NCT01128153|38102474|FG001|Overall Study|Protocol Violation|0|||
16959315|NCT01128153|38102473|FG000|Overall Study|Developed discontinuation criteria|1|||
16959316|NCT01128153|38102474|FG001|Overall Study|Developed discontinuation criteria|1|||
16959317|NCT00925015|38102483|FG000|Overall Study|Adverse Event|1|||
16959318|NCT00925015|38102484|FG001|Overall Study|Adverse Event|2|||
16959319|NCT00925015|38102485|FG002|Overall Study|Adverse Event|1|||
16959320|NCT00925015|38102483|FG000|Overall Study|Physician Decision|0|||
16959321|NCT00925015|38102484|FG001|Overall Study|Physician Decision|1|||
16959322|NCT00925015|38102485|FG002|Overall Study|Physician Decision|0|||
16959323|NCT00925015|38102483|FG000|Overall Study|Progressive Disease|7|||
16959324|NCT00925015|38102484|FG001|Overall Study|Progressive Disease|3|||
16959325|NCT00925015|38102485|FG002|Overall Study|Progressive Disease|4|||
16959326|NCT00925015|38102483|FG000|Overall Study|Withdrawal by Subject|0|||
16959327|NCT00925015|38102484|FG001|Overall Study|Withdrawal by Subject|0|||
16959328|NCT00925015|38102485|FG002|Overall Study|Withdrawal by Subject|1|||
16959329|NCT01127763|38102497|FG000|Overall Study|Adverse Event|2|||
16959330|NCT01127763|38102497|FG000|Overall Study|Withdrawal by Subject|1|||
16959331|NCT01127763|38102497|FG000|Overall Study|Physician Decision|2|||
16959332|NCT01127607|38102507|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
16959333|NCT01127607|38102508|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
16959334|NCT01127607|38102507|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
16959335|NCT01127607|38102508|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
16959336|NCT00924781|38102535|FG000|Overall Study|Study terminated by sponsor|12|||
16959337|NCT00924781|38102536|FG001|Overall Study|Study terminated by sponsor|10|||
16959338|NCT01127451|38102554|FG000|Overall Study|Other|2|||
16959339|NCT01127451|38102555|FG001|Overall Study|Other|1|||
16959340|NCT01127451|38102554|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
16959341|NCT01127451|38102555|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
16959342|NCT01127451|38102554|FG000|Overall Study|Death|22|||
16959343|NCT01127451|38102555|FG001|Overall Study|Death|17|||
16959344|NCT01127451|38102554|FG000|Overall Study|Lost to Follow-up|3|||
16959345|NCT01127451|38102555|FG001|Overall Study|Lost to Follow-up|0|||
16959346|NCT01127451|38102554|FG000|Overall Study|Administrative Reason by Sponsor|2|||
16959347|NCT01127451|38102555|FG001|Overall Study|Administrative Reason by Sponsor|2|||
16959348|NCT01127373|38102561|FG000|Overall Study|Not Treated|3|||
16959349|NCT01127373|38102561|FG000|Overall Study|Lost to Follow-up|7|||
16959350|NCT01127373|38102561|FG000|Overall Study|Withdrawal by Subject|1|||
16959351|NCT01127373|38102561|FG000|Overall Study|Disease progression|1|||
16959352|NCT01127139|38102565|FG000|Overall Study|Adverse Event|40|||
16959353|NCT01127139|38102565|FG000|Overall Study|Incompliance|12|||
16959354|NCT01127139|38102565|FG000|Overall Study|Lack of Efficacy|4|||
16959355|NCT01127139|38102565|FG000|Overall Study|Reason not specified|1|||
16959356|NCT01214616|38102576|FG000|Overall Study|Progressive disease|2|||
16959357|NCT01214616|38102577|FG001|Overall Study|Progressive disease|2|||
16959358|NCT01214616|38102578|FG002|Overall Study|Progressive disease|2|||
16959359|NCT01214616|38102579|FG003|Overall Study|Progressive disease|4|||
16959360|NCT01214616|38102576|FG000|Overall Study|Dose limiting toxicity|0|||
16776292|NCT00271817|37715725|FG001|Part 1|Protocol Violation|4|||
16776293|NCT00271817|37715726|FG002|Part 1|Protocol Violation|7|||
16959361|NCT01214616|38102577|FG001|Overall Study|Dose limiting toxicity|2|||
16959362|NCT01214616|38102578|FG002|Overall Study|Dose limiting toxicity|0|||
16959363|NCT01214616|38102579|FG003|Overall Study|Dose limiting toxicity|0|||
16959364|NCT01214616|38102576|FG000|Overall Study|Other adverse events|0|||
16959365|NCT01214616|38102577|FG001|Overall Study|Other adverse events|1|||
16959366|NCT01214616|38102578|FG002|Overall Study|Other adverse events|1|||
16959367|NCT01214616|38102579|FG003|Overall Study|Other adverse events|1|||
16959368|NCT01214616|38102576|FG000|Overall Study|Withdrawal by Subject|1|||
16959369|NCT01214616|38102577|FG001|Overall Study|Withdrawal by Subject|0|||
16959370|NCT01214616|38102578|FG002|Overall Study|Withdrawal by Subject|0|||
16959371|NCT01214616|38102579|FG003|Overall Study|Withdrawal by Subject|1|||
16959372|NCT01213836|38102599|FG000|Period 1, First Intervention|Adverse Event|2|||
16959373|NCT01213836|38102600|FG001|Period 1, First Intervention|Adverse Event|1|||
16959374|NCT01213836|38102599|FG000|Period 1, First Intervention|Protocol Violation|0|||
16959375|NCT01213836|38102600|FG001|Period 1, First Intervention|Protocol Violation|1|||
16959376|NCT01213836|38102599|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
16959377|NCT01213836|38102600|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
16959378|NCT01127061|38102611|FG000|Overall Study|Lost to Follow-up|7|||
16959379|NCT01127061|38102612|FG001|Overall Study|Lost to Follow-up|10|||
16959380|NCT01127061|38102611|FG000|Overall Study|Physician Decision|3|||
16959381|NCT01127061|38102612|FG001|Overall Study|Physician Decision|3|||
16959382|NCT00924703|38102618|FG000|Overall Study|Withdrawal by Subject|11|||
16959383|NCT00924703|38102618|FG000|Overall Study|Physician Decision|5|||
16959384|NCT00924703|38102618|FG000|Overall Study|Lost to Follow-up|3|||
16959385|NCT00924703|38102618|FG000|Overall Study|Adverse Event|2|||
16959386|NCT00924703|38102618|FG000|Overall Study|Withdrawal by Sponsor|1|||
16959387|NCT01213524|38102624|FG000|Baseline|Withdrawal by Subject|5|||
16959388|NCT01213524|38102624|FG000|Baseline|high breath alcohol levels|1|||
16959389|NCT01213524|38102624|FG000|Baseline|Physician Decision|1|||
16959390|NCT01213524|38102624|FG000|Session 2|Withdrawal by Subject|5|||
16959391|NCT01213524|38102624|FG000|Session 3|Withdrawal by Subject|4|||
16959392|NCT01213524|38102624|FG000|Session 4|Physician Decision|1|||
16959393|NCT01213524|38102624|FG000|Session 4|Withdrawal by Subject|2|||
16959394|NCT01212744|38102635|FG000|Overall Study|Withdrawal by Subject|1|||
16959395|NCT01212588|38102643|FG000|Overall Study|Physician Decision|0|||
16959396|NCT01212588|38102644|FG001|Overall Study|Physician Decision|1|||
16959397|NCT01212588|38102643|FG000|Overall Study|Protocol Violation|1|||
16959398|NCT01212588|38102644|FG001|Overall Study|Protocol Violation|1|||
16959399|NCT00918385|38102652|FG000|Monotherapy|Adverse Event|1|||
16959400|NCT00918385|38102653|FG001|Monotherapy|Adverse Event|6|||
16959401|NCT00918385|38102652|FG000|Monotherapy|Complicating illness|1|||
16959402|NCT00918385|38102653|FG001|Monotherapy|Complicating illness|0|||
16959403|NCT00918385|38102652|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
16959404|NCT00918385|38102653|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
16959405|NCT00918385|38102652|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
16959406|NCT00918385|38102653|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
16959407|NCT00918385|38102652|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
16959408|NCT00918385|38102653|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
16959409|NCT00918385|38102652|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
16959410|NCT00918385|38102653|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
16959411|NCT01211262|38102663|FG000|Overall Study|Progressive Disease|18|||
16959412|NCT01211262|38102664|FG001|Overall Study|Progressive Disease|9|||
16959413|NCT01211262|38102663|FG000|Overall Study|Adverse Event|4|||
16959414|NCT01211262|38102664|FG001|Overall Study|Adverse Event|0|||
16959415|NCT01211262|38102663|FG000|Overall Study|Withdrawal of Consent|1|||
16959416|NCT01211262|38102664|FG001|Overall Study|Withdrawal of Consent|0|||
16959417|NCT01211262|38102663|FG000|Overall Study|Other|0|||
16959418|NCT01211262|38102664|FG001|Overall Study|Other|1|||
16959419|NCT01211184|38102676|FG000|Overall Study|Withdrawal by Subject|0|||
16959420|NCT01211184|38102677|FG001|Overall Study|Withdrawal by Subject|2|||
16959421|NCT01211184|38102678|FG002|Overall Study|Withdrawal by Subject|1|||
16959422|NCT00924469|38102691|FG000|Overall Study|Adverse Event|2|||
16959423|NCT00924469|38102692|FG001|Overall Study|Adverse Event|0|||
16959424|NCT00924469|38102691|FG000|Overall Study|Withdrawal by Subject|0|||
16959425|NCT00924469|38102692|FG001|Overall Study|Withdrawal by Subject|1|||
16959426|NCT00924469|38102691|FG000|Overall Study|Lost to Follow-up|0|||
16959427|NCT00924469|38102692|FG001|Overall Study|Lost to Follow-up|1|||
16959428|NCT00924313|38102698|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
16959429|NCT01209780|38102706|FG000|Overall Study|Adverse Event|0|||
16959430|NCT01209780|38102707|FG001|Overall Study|Adverse Event|1|||
16959431|NCT01209780|38102708|FG002|Overall Study|Adverse Event|0|||
16959432|NCT01209780|38102709|FG003|Overall Study|Adverse Event|0|||
16959433|NCT01209780|38102710|FG004|Overall Study|Adverse Event|0|||
16959434|NCT01209780|38102706|FG000|Overall Study|Withdrawal by Subject|9|||
16959435|NCT01209780|38102707|FG001|Overall Study|Withdrawal by Subject|2|||
16959436|NCT01209780|38102708|FG002|Overall Study|Withdrawal by Subject|1|||
16959437|NCT01209780|38102709|FG003|Overall Study|Withdrawal by Subject|1|||
16959438|NCT01209780|38102710|FG004|Overall Study|Withdrawal by Subject|0|||
17133895|NCT00065507|38275170|FG000|Overall Study|Poor/Non-compliance|3|||
16776294|NCT00271817|37715724|FG000|Part 1|Patient Moved|3|||
16959439|NCT01209780|38102706|FG000|Overall Study|Lost to Follow-up|17|||
16959440|NCT01209780|38102707|FG001|Overall Study|Lost to Follow-up|12|||
16959441|NCT01209780|38102708|FG002|Overall Study|Lost to Follow-up|3|||
16959442|NCT01209780|38102709|FG003|Overall Study|Lost to Follow-up|9|||
16959443|NCT01209780|38102710|FG004|Overall Study|Lost to Follow-up|4|||
16959444|NCT01209780|38102706|FG000|Overall Study|Protocol Violation|0|||
16959445|NCT01209780|38102707|FG001|Overall Study|Protocol Violation|1|||
16959446|NCT01209780|38102708|FG002|Overall Study|Protocol Violation|0|||
16959447|NCT01209780|38102709|FG003|Overall Study|Protocol Violation|0|||
16959448|NCT01209780|38102710|FG004|Overall Study|Protocol Violation|0|||
16959449|NCT01209780|38102706|FG000|Overall Study|Inappropriate enrollment|0|||
16959450|NCT01209780|38102707|FG001|Overall Study|Inappropriate enrollment|2|||
16959451|NCT01209780|38102708|FG002|Overall Study|Inappropriate enrollment|0|||
16959452|NCT01209780|38102709|FG003|Overall Study|Inappropriate enrollment|0|||
16959453|NCT01209780|38102710|FG004|Overall Study|Inappropriate enrollment|1|||
16959454|NCT00916357|38102723|FG000|Period 1|Withdrawal by Subject|1|||
16959455|NCT00916357|38102724|FG001|Period 1|Withdrawal by Subject|0|||
16959456|NCT00916357|38102725|FG002|Period 1|Withdrawal by Subject|0|||
16959457|NCT00916357|38102726|FG003|Period 1|Withdrawal by Subject|0|||
16959458|NCT00916357|38102727|FG004|Period 1|Withdrawal by Subject|0|||
16959459|NCT00916357|38102728|FG005|Period 1|Withdrawal by Subject|0|||
16959460|NCT00916357|38102723|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
16959461|NCT00916357|38102724|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
16959462|NCT00916357|38102725|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
16959463|NCT00916357|38102726|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
16959464|NCT00916357|38102727|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
16959465|NCT00916357|38102728|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
16959466|NCT01209624|38102737|FG000|Overall Study|Death|2|||
16959467|NCT01209624|38102737|FG000|Overall Study|Adverse Event|13|||
16959468|NCT01209624|38102737|FG000|Overall Study|Lack of Efficacy|17|||
16959469|NCT01209624|38102737|FG000|Overall Study|Lost to Follow-up|290|||
16959470|NCT01209624|38102737|FG000|Overall Study|Other|4|||
16959471|NCT00916279|38102741|FG000|Overall Study|Death|2|||
16959472|NCT00916279|38102741|FG000|Overall Study|Lost to Follow-up|2|||
16959473|NCT01209078|38102750|FG000|Overall Study|Adverse Event|5|||
16959474|NCT01209078|38102751|FG001|Overall Study|Adverse Event|0|||
16959475|NCT01209078|38102750|FG000|Overall Study|Lost to Follow-up|4|||
16959476|NCT01209078|38102751|FG001|Overall Study|Lost to Follow-up|0|||
16959477|NCT01209078|38102750|FG000|Overall Study|Physician Decision|5|||
16959478|NCT01209078|38102751|FG001|Overall Study|Physician Decision|2|||
16959479|NCT01209078|38102750|FG000|Overall Study|Withdrawal by Subject|2|||
16959480|NCT01209078|38102751|FG001|Overall Study|Withdrawal by Subject|1|||
16959481|NCT01207596|38102759|FG000|Overall Study|Physician Decision|4|||
16959482|NCT01207596|38102759|FG000|Overall Study|Lack of Efficacy|1|||
16959483|NCT01207596|38102759|FG000|Overall Study|Adverse Event|3|||
16959484|NCT01207596|38102759|FG000|Overall Study|Withdrawal by Subject|1|||
16959485|NCT00915343|38102763|FG000|Part B - Open Label Period|Treatment switch|0|||
16959486|NCT00915343|38102764|FG001|Part B - Open Label Period|Treatment switch|0|||
16959487|NCT00915343|38102765|FG002|Part B - Open Label Period|Treatment switch|1|||
16959488|NCT00915343|38102763|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
16959489|NCT00915343|38102764|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
16959490|NCT00915343|38102765|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
16959491|NCT00911989|38102777|FG000|Overall Study|Adverse Event|1|||
16959492|NCT00910273|38102783|FG000|Overall Study|Lack of Efficacy|6|||
16959493|NCT00910273|38102784|FG001|Overall Study|Lack of Efficacy|9|||
16959494|NCT00910273|38102783|FG000|Overall Study|Adverse Event|1|||
16959495|NCT00910273|38102784|FG001|Overall Study|Adverse Event|1|||
16959496|NCT00910273|38102783|FG000|Overall Study|Withdrawal by Subject|1|||
16959497|NCT00910273|38102784|FG001|Overall Study|Withdrawal by Subject|0|||
16959498|NCT00910273|38102783|FG000|Overall Study|Discontinuation of study by sponsor|8|||
16959499|NCT00910273|38102784|FG001|Overall Study|Discontinuation of study by sponsor|2|||
16959500|NCT00910273|38102783|FG000|Overall Study|Protocol Violation|1|||
16959501|NCT00910273|38102784|FG001|Overall Study|Protocol Violation|0|||
16959502|NCT00910273|38102783|FG000|Overall Study|Lost to Follow-up|1|||
16959503|NCT00910273|38102784|FG001|Overall Study|Lost to Follow-up|1|||
16959504|NCT00910039|38102790|FG000|Overall Study|Physician Decision|1|||
16959505|NCT00909181|38102798|FG000|Overall Study|Lost to Follow-up|39|||
16959506|NCT00909181|38102799|FG001|Overall Study|Lost to Follow-up|18|||
16959507|NCT00909181|38102800|FG002|Overall Study|Lost to Follow-up|33|||
16959508|NCT01286987|38102823|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
16959509|NCT01286987|38102824|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
16959510|NCT01286987|38102825|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
16959511|NCT01286987|38102826|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
16959512|NCT01286987|38102827|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
16959513|NCT01286987|38102828|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
16959514|NCT01286987|38102829|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
16959515|NCT01286987|38102830|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
16959516|NCT01286987|38102831|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
16959517|NCT01286987|38102832|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
16959518|NCT01286987|38102833|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
16959519|NCT01286987|38102834|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
16959520|NCT01286987|38102835|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
16959521|NCT01286987|38102836|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
16959522|NCT01286987|38102837|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
16959523|NCT01286987|38102823|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
16959524|NCT01286987|38102824|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
16959525|NCT01286987|38102825|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
16959526|NCT01286987|38102826|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
16959527|NCT01286987|38102827|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
16959528|NCT01286987|38102828|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
16959529|NCT01286987|38102829|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
16959530|NCT01286987|38102830|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
16959531|NCT01286987|38102831|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
16959532|NCT01286987|38102832|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
16959533|NCT01286987|38102833|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
16959534|NCT01286987|38102834|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
16959535|NCT01286987|38102835|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
16959536|NCT01286987|38102836|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
16959537|NCT01286987|38102837|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
16959538|NCT01286987|38102823|FG000|Part 1: Dose Escalation|Physician Decision|0|||
16959539|NCT01286987|38102824|FG001|Part 1: Dose Escalation|Physician Decision|0|||
16959540|NCT01286987|38102825|FG002|Part 1: Dose Escalation|Physician Decision|0|||
16959541|NCT01286987|38102826|FG003|Part 1: Dose Escalation|Physician Decision|0|||
16959542|NCT01286987|38102827|FG004|Part 1: Dose Escalation|Physician Decision|1|||
16959543|NCT01286987|38102828|FG005|Part 1: Dose Escalation|Physician Decision|0|||
16959544|NCT01286987|38102829|FG006|Part 1: Dose Escalation|Physician Decision|0|||
16959545|NCT01286987|38102830|FG007|Part 1: Dose Escalation|Physician Decision|0|||
16959546|NCT01286987|38102831|FG008|Part 1: Dose Escalation|Physician Decision|0|||
16959547|NCT01286987|38102832|FG009|Part 1: Dose Escalation|Physician Decision|0|||
16959548|NCT01286987|38102833|FG010|Part 1: Dose Escalation|Physician Decision|0|||
16959549|NCT01286987|38102834|FG011|Part 1: Dose Escalation|Physician Decision|0|||
16959550|NCT01286987|38102835|FG012|Part 1: Dose Escalation|Physician Decision|0|||
16959551|NCT01286987|38102836|FG013|Part 1: Dose Escalation|Physician Decision|0|||
16959552|NCT01286987|38102837|FG014|Part 1: Dose Escalation|Physician Decision|0|||
16959553|NCT01286987|38102823|FG000|Part 2: Dose Expansion|Death|0|||
16959554|NCT01286987|38102824|FG001|Part 2: Dose Expansion|Death|0|||
16959555|NCT01286987|38102825|FG002|Part 2: Dose Expansion|Death|0|||
16959556|NCT01286987|38102826|FG003|Part 2: Dose Expansion|Death|0|||
16959557|NCT01286987|38102827|FG004|Part 2: Dose Expansion|Death|0|||
16959558|NCT01286987|38102828|FG005|Part 2: Dose Expansion|Death|0|||
16959559|NCT01286987|38102829|FG006|Part 2: Dose Expansion|Death|0|||
16959560|NCT01286987|38102830|FG007|Part 2: Dose Expansion|Death|0|||
16776295|NCT00271817|37715725|FG001|Part 1|Patient Moved|1|||
16776296|NCT00271817|37715726|FG002|Part 1|Patient Moved|5|||
16776297|NCT00271817|37715724|FG000|Part 1|Withdrawal by Subject|23|||
16776298|NCT00271817|37715725|FG001|Part 1|Withdrawal by Subject|17|||
16776299|NCT00271817|37715726|FG002|Part 1|Withdrawal by Subject|45|||
16776300|NCT00271817|37715724|FG000|Part 1|LDL < 50 mg/dL|1|||
16776301|NCT00271817|37715725|FG001|Part 1|LDL < 50 mg/dL|4|||
16959561|NCT01286987|38102831|FG008|Part 2: Dose Expansion|Death|0|||
16959562|NCT01286987|38102832|FG009|Part 2: Dose Expansion|Death|0|||
16959563|NCT01286987|38102833|FG010|Part 2: Dose Expansion|Death|0|||
16959564|NCT01286987|38102834|FG011|Part 2: Dose Expansion|Death|0|||
16959565|NCT01286987|38102835|FG012|Part 2: Dose Expansion|Death|1|||
16959566|NCT01286987|38102836|FG013|Part 2: Dose Expansion|Death|1|||
16959567|NCT01286987|38102837|FG014|Part 2: Dose Expansion|Death|0|||
16959568|NCT01286987|38102823|FG000|Part 2: Dose Expansion|Physician Decision|0|||
16959569|NCT01286987|38102824|FG001|Part 2: Dose Expansion|Physician Decision|0|||
16959570|NCT01286987|38102825|FG002|Part 2: Dose Expansion|Physician Decision|0|||
16959571|NCT01286987|38102826|FG003|Part 2: Dose Expansion|Physician Decision|0|||
16959572|NCT01286987|38102827|FG004|Part 2: Dose Expansion|Physician Decision|0|||
16959573|NCT01286987|38102828|FG005|Part 2: Dose Expansion|Physician Decision|0|||
16959574|NCT01286987|38102829|FG006|Part 2: Dose Expansion|Physician Decision|0|||
16959575|NCT01286987|38102830|FG007|Part 2: Dose Expansion|Physician Decision|0|||
16959576|NCT01286987|38102831|FG008|Part 2: Dose Expansion|Physician Decision|0|||
16959577|NCT01286987|38102832|FG009|Part 2: Dose Expansion|Physician Decision|0|||
16959578|NCT01286987|38102833|FG010|Part 2: Dose Expansion|Physician Decision|1|||
16959579|NCT01286987|38102834|FG011|Part 2: Dose Expansion|Physician Decision|1|||
16959580|NCT01286987|38102835|FG012|Part 2: Dose Expansion|Physician Decision|0|||
16959581|NCT01286987|38102836|FG013|Part 2: Dose Expansion|Physician Decision|1|||
16776302|NCT00271817|37715726|FG002|Part 1|LDL < 50 mg/dL|48|||
16959582|NCT01286987|38102837|FG014|Part 2: Dose Expansion|Physician Decision|0|||
16959583|NCT01286987|38102823|FG000|Part 2: Dose Expansion|Other|0|||
16959584|NCT01286987|38102824|FG001|Part 2: Dose Expansion|Other|0|||
16776303|NCT00271817|37715724|FG000|Part 2|Adverse Event|0|||
16776304|NCT00271817|37715725|FG001|Part 2|Adverse Event|17|||
16959585|NCT01286987|38102825|FG002|Part 2: Dose Expansion|Other|0|||
16959586|NCT01286987|38102826|FG003|Part 2: Dose Expansion|Other|0|||
16959587|NCT01286987|38102827|FG004|Part 2: Dose Expansion|Other|0|||
16959588|NCT01286987|38102828|FG005|Part 2: Dose Expansion|Other|0|||
16959589|NCT01286987|38102829|FG006|Part 2: Dose Expansion|Other|0|||
16959590|NCT01286987|38102830|FG007|Part 2: Dose Expansion|Other|0|||
16959591|NCT01286987|38102831|FG008|Part 2: Dose Expansion|Other|0|||
16959592|NCT01286987|38102832|FG009|Part 2: Dose Expansion|Other|0|||
16959593|NCT01286987|38102833|FG010|Part 2: Dose Expansion|Other|0|||
16959594|NCT01286987|38102834|FG011|Part 2: Dose Expansion|Other|0|||
16959595|NCT01286987|38102835|FG012|Part 2: Dose Expansion|Other|0|||
16959596|NCT01286987|38102836|FG013|Part 2: Dose Expansion|Other|1|||
16959597|NCT01286987|38102837|FG014|Part 2: Dose Expansion|Other|0|||
16959598|NCT01286987|38102823|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
16959599|NCT01286987|38102824|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
16959600|NCT01286987|38102825|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
16959601|NCT01286987|38102826|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
16959602|NCT01286987|38102827|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
16959603|NCT01286987|38102828|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
16959604|NCT01286987|38102829|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
16959605|NCT01286987|38102830|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
16959606|NCT01286987|38102831|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
16959607|NCT01286987|38102832|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
16959608|NCT01286987|38102833|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
16959609|NCT01286987|38102834|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
16959610|NCT01286987|38102835|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
16959611|NCT01286987|38102836|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
16959612|NCT01286987|38102837|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
16959613|NCT01286987|38102823|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
16959614|NCT01286987|38102824|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
16776305|NCT00271817|37715726|FG002|Part 2|Adverse Event|33|||
16776306|NCT00271817|37715724|FG000|Part 2|Lack of Efficacy|0|||
16776307|NCT00271817|37715725|FG001|Part 2|Lack of Efficacy|1|||
16776308|NCT00271817|37715726|FG002|Part 2|Lack of Efficacy|6|||
16776309|NCT00271817|37715724|FG000|Part 2|Lost to Follow-up|0|||
16959615|NCT01286987|38102825|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
16776310|NCT00271817|37715725|FG001|Part 2|Lost to Follow-up|6|||
16776311|NCT00271817|37715726|FG002|Part 2|Lost to Follow-up|18|||
16959616|NCT01286987|38102826|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
16959617|NCT01286987|38102827|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
16959618|NCT01286987|38102828|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
16959619|NCT01286987|38102829|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
16959620|NCT01286987|38102830|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
16959621|NCT01286987|38102831|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
16959622|NCT01286987|38102832|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
16959623|NCT01286987|38102833|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
16959624|NCT01286987|38102834|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
16959625|NCT01286987|38102835|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
16959626|NCT01286987|38102836|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
16959627|NCT01286987|38102837|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
16959628|NCT01286987|38102823|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959629|NCT01286987|38102824|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16776312|NCT00271817|37715724|FG000|Part 2|Protocol Violation|0|||
16776313|NCT00271817|37715725|FG001|Part 2|Protocol Violation|3|||
16776314|NCT00271817|37715726|FG002|Part 2|Protocol Violation|5|||
16959630|NCT01286987|38102825|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959631|NCT01286987|38102826|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16776315|NCT00271817|37715724|FG000|Part 2|Patient Moved|0|||
16776316|NCT00271817|37715725|FG001|Part 2|Patient Moved|0|||
16776317|NCT00271817|37715726|FG002|Part 2|Patient Moved|5|||
16776318|NCT00271817|37715724|FG000|Part 2|Withdrawal by Subject|0|||
16959632|NCT01286987|38102827|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959633|NCT01286987|38102828|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959634|NCT01286987|38102829|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959635|NCT01286987|38102830|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959636|NCT01286987|38102831|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959637|NCT01286987|38102832|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959638|NCT01286987|38102833|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
16959639|NCT01286987|38102834|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959640|NCT01286987|38102835|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959641|NCT01286987|38102836|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959642|NCT01286987|38102837|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16959643|NCT01286753|38102880|FG000|Overall Study|Adverse Event|7|||
16959644|NCT01286753|38102881|FG001|Overall Study|Adverse Event|6|||
16959645|NCT01286753|38102880|FG000|Overall Study|Progression|11|||
16959646|NCT01286753|38102881|FG001|Overall Study|Progression|13|||
16959647|NCT01286753|38102880|FG000|Overall Study|Refused Treatment|1|||
16959648|NCT01286753|38102881|FG001|Overall Study|Refused Treatment|0|||
16959649|NCT01286753|38102880|FG000|Overall Study|Withdrawal of Consent|0|||
16959650|NCT01286753|38102881|FG001|Overall Study|Withdrawal of Consent|2|||
16959651|NCT01286753|38102880|FG000|Overall Study|Discontinued to Join Extension Study|6|||
16959652|NCT01286753|38102881|FG001|Overall Study|Discontinued to Join Extension Study|4|||
16959653|NCT01286753|38102880|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
16959654|NCT01286753|38102881|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
16959655|NCT01286129|38102890|FG000|Overall Study|Withdrawal by Subject|4|||
16959656|NCT01286129|38102891|FG001|Overall Study|Withdrawal by Subject|1|||
16959657|NCT01286129|38102890|FG000|Overall Study|Could not comply with study requirements|4|||
17133896|NCT00065507|38275171|FG001|Overall Study|Poor/Non-compliance|2|||
17133897|NCT00065507|38275170|FG000|Overall Study|Lost to Follow-up|3|||
16959658|NCT01286129|38102891|FG001|Overall Study|Could not comply with study requirements|4|||
16959659|NCT01285349|38102902|FG000|Overall Study|Lost to Follow-up|27|||
16959660|NCT01285349|38102903|FG001|Overall Study|Lost to Follow-up|20|||
16959661|NCT01285349|38102904|FG002|Overall Study|Lost to Follow-up|27|||
16959662|NCT01284959|38102916|FG000|Overall Study|Withdrawal by Subject|1|||
16959663|NCT01284959|38102917|FG001|Overall Study|Withdrawal by Subject|0|||
16959664|NCT01284959|38102918|FG002|Overall Study|Withdrawal by Subject|0|||
16959665|NCT01284959|38102916|FG000|Overall Study|Adverse Event|0|||
16959666|NCT01284959|38102917|FG001|Overall Study|Adverse Event|0|||
16959667|NCT01284959|38102918|FG002|Overall Study|Adverse Event|1|||
16959668|NCT01284491|38102926|FG000|Overall Study|Study termination|13|||
16959669|NCT01283009|38102934|FG000|Overall Study|Death|83|||
16959670|NCT01283009|38102935|FG001|Overall Study|Death|78|||
16959671|NCT01283009|38102934|FG000|Overall Study|Study ended early|23|||
16959672|NCT01283009|38102935|FG001|Overall Study|Study ended early|26|||
16959673|NCT01283009|38102934|FG000|Overall Study|Withdrawal by Subject|10|||
16959674|NCT01283009|38102935|FG001|Overall Study|Withdrawal by Subject|8|||
16959675|NCT01283009|38102934|FG000|Overall Study|Physician Decision|1|||
16959676|NCT01283009|38102935|FG001|Overall Study|Physician Decision|1|||
16959677|NCT01283009|38102934|FG000|Overall Study|Lost to Follow-up|1|||
16959678|NCT01283009|38102935|FG001|Overall Study|Lost to Follow-up|0|||
16959679|NCT01283009|38102934|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
16959680|NCT01283009|38102935|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
16959681|NCT01282463|38102944|FG000|Overall Study|Lost to Follow-up|1|||
16959682|NCT01282463|38102945|FG001|Overall Study|Lost to Follow-up|0|||
16959683|NCT01282463|38102946|FG002|Overall Study|Lost to Follow-up|0|||
16959684|NCT01282463|38102944|FG000|Overall Study|Withdrawal by Subject|6|||
16959685|NCT01282463|38102945|FG001|Overall Study|Withdrawal by Subject|2|||
16959686|NCT01282463|38102946|FG002|Overall Study|Withdrawal by Subject|3|||
16959687|NCT01282463|38102944|FG000|Overall Study|"Never Treated Death"|0|||
16959688|NCT01282463|38102945|FG001|Overall Study|"Never Treated Death"|1|||
16959689|NCT01282463|38102946|FG002|Overall Study|"Never Treated Death"|0|||
16959690|NCT01282463|38102944|FG000|Overall Study|"Never Treated PD"|0|||
16959691|NCT01282463|38102945|FG001|Overall Study|"Never Treated PD"|1|||
16776319|NCT00271817|37715725|FG001|Part 2|Withdrawal by Subject|2|||
16776320|NCT00271817|37715726|FG002|Part 2|Withdrawal by Subject|13|||
16776321|NCT00271817|37715724|FG000|Part 2|LDL < 50 mg/dL|0|||
16776322|NCT00271817|37715725|FG001|Part 2|LDL < 50 mg/dL|3|||
16776323|NCT00271817|37715726|FG002|Part 2|LDL < 50 mg/dL|4|||
16776324|NCT02731157|37715738|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
16776325|NCT03268811|37715746|FG000|Overall Study|Adverse Event|0|||
16959692|NCT01282463|38102946|FG002|Overall Study|"Never Treated PD"|0|||
16959693|NCT01282463|38102944|FG000|Overall Study|Protocol Violation|0|||
16959694|NCT01282463|38102945|FG001|Overall Study|Protocol Violation|0|||
16959695|NCT01282463|38102946|FG002|Overall Study|Protocol Violation|1|||
16959696|NCT01282463|38102944|FG000|Overall Study|Physician Decision|1|||
16959697|NCT01282463|38102945|FG001|Overall Study|Physician Decision|0|||
16959698|NCT01282463|38102946|FG002|Overall Study|Physician Decision|0|||
16776326|NCT03268811|37715747|FG001|Overall Study|Adverse Event|1|||
16776327|NCT02732015|37715756|FG000|Overall Study|Lost to Follow-up|0|||
16776328|NCT02732015|37715757|FG001|Overall Study|Lost to Follow-up|1|||
16867964|NCT01554527|37840988|FG000|Overall Study|Withdrawal by Subject|1|||
16867965|NCT01554527|37840989|FG001|Overall Study|Withdrawal by Subject|0|||
16959699|NCT01282229|38102962|FG000|Overall Study|Protocol Violation|2|||
16959700|NCT01281917|38102980|FG000|Overall Study|Withdrawal by Subject|1|||
16959701|NCT01281839|38102986|FG000|Overall Study|Lost to Follow-up|6|||
16959702|NCT01281839|38102987|FG001|Overall Study|Lost to Follow-up|3|||
16959703|NCT01281839|38102986|FG000|Overall Study|Withdrawal by Subject|4|||
16959704|NCT01281839|38102987|FG001|Overall Study|Withdrawal by Subject|10|||
16959705|NCT01281839|38102986|FG000|Overall Study|Reason not specified|0|||
16959706|NCT01281839|38102987|FG001|Overall Study|Reason not specified|1|||
16959707|NCT01281137|38102995|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
16959708|NCT01281137|38102996|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
16867966|NCT01554527|37840990|FG002|Overall Study|Withdrawal by Subject|3|||
16867967|NCT01554527|37840988|FG000|Overall Study|Lost to Follow-up|0|||
16867968|NCT01554527|37840989|FG001|Overall Study|Lost to Follow-up|0|||
16867969|NCT01554527|37840990|FG002|Overall Study|Lost to Follow-up|4|||
16867970|NCT01554527|37840988|FG000|Overall Study|Physician Decision|0|||
16867971|NCT01554527|37840989|FG001|Overall Study|Physician Decision|0|||
16867972|NCT01554527|37840990|FG002|Overall Study|Physician Decision|1|||
16959709|NCT01281137|38102995|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
16959710|NCT01281137|38102996|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
16959711|NCT01281137|38102995|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
16959712|NCT01281137|38102996|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
16959713|NCT01281137|38102995|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
16959714|NCT01281137|38102996|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
16959715|NCT01281137|38102995|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
16776329|NCT01441115|37715777|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
16776330|NCT02006147|37715788|FG000|Overall Study|Protocol Violation|1|||
16776331|NCT02006147|37715789|FG001|Overall Study|Protocol Violation|1|||
16776332|NCT02006147|37715790|FG002|Overall Study|Protocol Violation|0|||
16776333|NCT02006147|37715791|FG003|Overall Study|Protocol Violation|0|||
16776334|NCT02006147|37715788|FG000|Overall Study|Withdrawal by Subject|0|||
16776335|NCT02006147|37715789|FG001|Overall Study|Withdrawal by Subject|1|||
16776336|NCT02006147|37715790|FG002|Overall Study|Withdrawal by Subject|0|||
16776337|NCT02006147|37715791|FG003|Overall Study|Withdrawal by Subject|0|||
16959716|NCT01281137|38102996|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
16959717|NCT01280981|38103020|FG000|Overall Study|Withdrawal by Subject|11|||
16959718|NCT01280981|38103020|FG000|Overall Study|Protocol Violation|2|||
16959719|NCT01280981|38103020|FG000|Overall Study|Lack of Efficacy|13|||
16959720|NCT01280981|38103020|FG000|Overall Study|Lost to Follow-up|3|||
16959721|NCT01280981|38103020|FG000|Overall Study|Adverse Event|6|||
16959722|NCT01280981|38103020|FG000|Overall Study|Irregular or discontinued menses|3|||
16959723|NCT01280981|38103020|FG000|Overall Study|Failed to return|45|||
16959724|NCT01280981|38103020|FG000|Overall Study|Non-compliance with protocol|3|||
16959725|NCT01280981|38103020|FG000|Overall Study|Withdrawal of consent|3|||
16959726|NCT01280981|38103020|FG000|Overall Study|Elective surgery|2|||
16959727|NCT01280981|38103020|FG000|Overall Study|Study site closure|1|||
16959728|NCT01280903|38103026|FG000|Overall Study|Lost to Follow-up|23|||
16959729|NCT01280903|38103027|FG001|Overall Study|Lost to Follow-up|16|||
16959730|NCT01280591|38103037|FG000|Overall Study|Withdrawal by Subject|0|||
16959731|NCT01280591|38103038|FG001|Overall Study|Withdrawal by Subject|0|||
16959732|NCT01280591|38103039|FG002|Overall Study|Withdrawal by Subject|0|||
16959733|NCT01280591|38103040|FG003|Overall Study|Withdrawal by Subject|2|||
16959734|NCT01280591|38103037|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
16959735|NCT01280591|38103038|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
16959736|NCT01280591|38103039|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
16959737|NCT01280591|38103040|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
16959738|NCT01280357|38103050|FG000|Overall Study|Excluded no internal monitoring|14|||
16959739|NCT01280357|38103050|FG000|Overall Study|IInsufficient data/No data supplied|12|||
16959740|NCT01274351|38103057|FG000|Overall Study|Lost to Follow-up|1|||
16959741|NCT01274351|38103057|FG000|Overall Study|patient not compliant with the protocol|1|||
16959742|NCT01274351|38103057|FG000|Overall Study|Pregnancy|1|||
16959743|NCT01274351|38103057|FG000|Overall Study|Death|2|||
16959744|NCT01274351|38103057|FG000|Overall Study|Withdrawal by Subject|3|||
16959745|NCT01274351|38103057|FG000|Overall Study|Adverse Event|8|||
16959746|NCT01274351|38103057|FG000|Overall Study|progression of disease|3|||
16959747|NCT01274351|38103057|FG000|Overall Study|hospitalization|1|||
16959748|NCT01271933|38103061|FG000|Single-Blind Phase|Lack of Efficacy|37|||
16959749|NCT01271933|38103062|FG001|Single-Blind Phase|Lack of Efficacy|0|||
16959750|NCT01271933|38103063|FG002|Single-Blind Phase|Lack of Efficacy|0|||
16959751|NCT01271933|38103061|FG000|Single-Blind Phase|Lost to Follow-up|10|||
16959752|NCT01271933|38103062|FG001|Single-Blind Phase|Lost to Follow-up|0|||
16959753|NCT01271933|38103063|FG002|Single-Blind Phase|Lost to Follow-up|0|||
16959754|NCT01271933|38103061|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
16959755|NCT01271933|38103062|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
16959756|NCT01271933|38103063|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
16959757|NCT01271933|38103061|FG000|Single-Blind Phase|Protocol Violation|3|||
16959758|NCT01271933|38103062|FG001|Single-Blind Phase|Protocol Violation|0|||
16959759|NCT01271933|38103063|FG002|Single-Blind Phase|Protocol Violation|0|||
16959760|NCT01271933|38103061|FG000|Single-Blind Phase|Adverse Event|52|||
16959761|NCT01271933|38103062|FG001|Single-Blind Phase|Adverse Event|0|||
16959762|NCT01271933|38103063|FG002|Single-Blind Phase|Adverse Event|0|||
16959763|NCT01271933|38103061|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
16959764|NCT01271933|38103062|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
16959765|NCT01271933|38103063|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
16959766|NCT01271933|38103061|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
16959767|NCT01271933|38103062|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
16959768|NCT01271933|38103063|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
16959769|NCT01271933|38103061|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
16959770|NCT01271933|38103062|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
16959771|NCT01271933|38103063|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
16959772|NCT01271933|38103061|FG000|Double-Blind Phase|Randomized but not treated|0|||
16959773|NCT01271933|38103062|FG001|Double-Blind Phase|Randomized but not treated|0|||
16959774|NCT01271933|38103063|FG002|Double-Blind Phase|Randomized but not treated|1|||
16959775|NCT01271933|38103061|FG000|Double-Blind Phase|Lack of Efficacy|0|||
16959776|NCT01271933|38103062|FG001|Double-Blind Phase|Lack of Efficacy|6|||
16959777|NCT01271933|38103063|FG002|Double-Blind Phase|Lack of Efficacy|9|||
16959778|NCT01271933|38103061|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16959779|NCT01271933|38103062|FG001|Double-Blind Phase|Lost to Follow-up|1|||
16959780|NCT01271933|38103063|FG002|Double-Blind Phase|Lost to Follow-up|1|||
16959781|NCT01271933|38103061|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16959782|NCT01271933|38103062|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
16959783|NCT01271933|38103063|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
16776338|NCT02006147|37715788|FG000|Overall Study|Withdrawal by Sponsor|1|||
16776339|NCT02006147|37715789|FG001|Overall Study|Withdrawal by Sponsor|0|||
16776340|NCT02006147|37715790|FG002|Overall Study|Withdrawal by Sponsor|0|||
16959784|NCT01271933|38103061|FG000|Double-Blind Phase|Adverse Event|0|||
16959785|NCT01271933|38103062|FG001|Double-Blind Phase|Adverse Event|3|||
16959786|NCT01271933|38103063|FG002|Double-Blind Phase|Adverse Event|0|||
16959787|NCT01271933|38103061|FG000|Double-Blind Phase|Participant request-personal reason|0|||
16959788|NCT01271933|38103062|FG001|Double-Blind Phase|Participant request-personal reason|1|||
16959789|NCT01271933|38103063|FG002|Double-Blind Phase|Participant request-personal reason|0|||
16959790|NCT01269125|38103076|FG000|Overall Study|Adverse Event|3|||
16959791|NCT01269125|38103077|FG001|Overall Study|Adverse Event|5|||
16959792|NCT01269125|38103078|FG002|Overall Study|Adverse Event|0|||
16959793|NCT01269125|38103076|FG000|Overall Study|Lost to Follow-up|4|||
16959794|NCT01269125|38103077|FG001|Overall Study|Lost to Follow-up|0|||
16959795|NCT01269125|38103078|FG002|Overall Study|Lost to Follow-up|0|||
16959796|NCT01268891|38103088|FG000|Overall Study|Adverse Event|3|||
16959797|NCT01268891|38103089|FG001|Overall Study|Adverse Event|7|||
16959798|NCT01268891|38103088|FG000|Overall Study|Lack of Efficacy|1|||
16959799|NCT01268891|38103089|FG001|Overall Study|Lack of Efficacy|0|||
16959800|NCT01268891|38103088|FG000|Overall Study|Withdrawal of Consent|3|||
16959801|NCT01268891|38103089|FG001|Overall Study|Withdrawal of Consent|1|||
16959802|NCT01268891|38103088|FG000|Overall Study|Administrative or other reason(s)|1|||
16959803|NCT01268891|38103089|FG001|Overall Study|Administrative or other reason(s)|0|||
16959804|NCT01268501|38103095|FG000|Overall Study|Lost to Follow-up|1|||
16959805|NCT01268501|38103095|FG000|Overall Study|Withdrawal by Subject|3|||
16959806|NCT01268501|38103095|FG000|Overall Study|Unacceptable Subjective Vision|3|||
16959807|NCT01268501|38103095|FG000|Overall Study|Handling Difficulties|2|||
16959808|NCT01268267|38103099|FG000|Overall Study|Protocol Violation|1|||
16959809|NCT01267253|38103104|FG000|Overall Study|Ineligible - required test not done|1|||
16959810|NCT01267253|38103104|FG000|Overall Study|Inevaluable-never received study treatme|2|||
16959811|NCT01267175|38103108|FG000|Overall Study|Withdrawal by Subject|1|||
16959812|NCT01267175|38103108|FG000|Overall Study|Lost to Follow-up|1|||
16959813|NCT01266317|38103112|FG000|Overall Study|Withdrawal by Subject|2|||
16959814|NCT01266161|38103118|FG000|Overall Study|Ineligible|1|||
16959815|NCT01266161|38103119|FG001|Overall Study|Ineligible|0|||
16959816|NCT01266161|38103118|FG000|Overall Study|Lack of Efficacy|0|||
16959817|NCT01266161|38103119|FG001|Overall Study|Lack of Efficacy|1|||
16959818|NCT01266161|38103118|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
16959819|NCT01266161|38103119|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
16959820|NCT01265849|38103128|FG000|Overall Study|Randomized//Treatment not initiated|1|||
16959821|NCT01265849|38103129|FG001|Overall Study|Randomized//Treatment not initiated|4|||
16959822|NCT01265849|38103130|FG002|Overall Study|Randomized//Treatment not initiated|0|||
16959823|NCT01265849|38103128|FG000|Overall Study|Physician Decision|1|||
16959824|NCT01265849|38103129|FG001|Overall Study|Physician Decision|2|||
16959825|NCT01265849|38103130|FG002|Overall Study|Physician Decision|0|||
16959826|NCT01265849|38103128|FG000|Overall Study|Lost to Follow-up|18|||
16959827|NCT01265849|38103129|FG001|Overall Study|Lost to Follow-up|15|||
16959828|NCT01265849|38103130|FG002|Overall Study|Lost to Follow-up|5|||
16959829|NCT01265849|38103128|FG000|Overall Study|Not otherwise specified|1|||
16959830|NCT01265849|38103129|FG001|Overall Study|Not otherwise specified|6|||
16959831|NCT01265849|38103130|FG002|Overall Study|Not otherwise specified|1|||
16959832|NCT01265849|38103128|FG000|Overall Study|Withdrawal by Subject|25|||
16959833|NCT01265849|38103129|FG001|Overall Study|Withdrawal by Subject|34|||
16959834|NCT01265849|38103130|FG002|Overall Study|Withdrawal by Subject|13|||
16776341|NCT02006147|37715791|FG003|Overall Study|Withdrawal by Sponsor|0|||
16776342|NCT02732119|37715802|FG000|Phase I|Adverse Event|1|||
16959835|NCT01265615|38103146|FG000|Overall Study|Protocol Violation|2|||
16959836|NCT01265615|38103147|FG001|Overall Study|Protocol Violation|2|||
16959837|NCT01265615|38103148|FG002|Overall Study|Protocol Violation|4|||
16959838|NCT01265615|38103149|FG003|Overall Study|Protocol Violation|3|||
16959839|NCT01264835|38103159|FG000|Overall Study|Lost to Follow-up|1|||
16959840|NCT01264679|38103163|FG000|Overall Study|Participation in Another Clinical Trial|1|||
16959841|NCT01264679|38103163|FG000|Overall Study|Physician Decision|1|||
16959842|NCT01264679|38103163|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
16959843|NCT01264679|38103163|FG000|Overall Study|Withdrawal by Subject|1|||
16959844|NCT01263665|38103168|FG000|Overall Study|Withdrew Consent|1|||
16959845|NCT01263665|38103168|FG000|Overall Study|Lost to Follow-up|3|||
16959846|NCT01263665|38103168|FG000|Overall Study|Death|2|||
16959847|NCT01263665|38103168|FG000|Overall Study|Amputation above the ankle|1|||
16959848|NCT01263665|38103168|FG000|Overall Study|Surgical Bypass|2|||
16959849|NCT01263509|38103174|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
16959850|NCT01263509|38103175|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
16959851|NCT01263509|38103176|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
16959852|NCT01263509|38103177|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
16959853|NCT01263509|38103174|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16959854|NCT01263509|38103175|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
16959855|NCT01263509|38103176|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16959856|NCT01263509|38103177|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
16959857|NCT01263509|38103174|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16959858|NCT01263509|38103175|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16959859|NCT01263509|38103176|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16959860|NCT01263509|38103177|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16959861|NCT01263509|38103174|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
16959862|NCT01263509|38103175|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
16959863|NCT01263509|38103176|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16959864|NCT01263509|38103177|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16959865|NCT01263509|38103174|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
16959866|NCT01263509|38103175|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
16959867|NCT01263509|38103176|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
16959868|NCT01263509|38103177|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
16959869|NCT01263197|38103185|FG000|First Intervention (Period 1)|Adverse Event|0|||
16959870|NCT01263197|38103186|FG001|First Intervention (Period 1)|Adverse Event|0|||
16959871|NCT01263197|38103187|FG002|First Intervention (Period 1)|Adverse Event|0|||
16959872|NCT01263197|38103188|FG003|First Intervention (Period 1)|Adverse Event|0|||
16959873|NCT01263197|38103189|FG004|First Intervention (Period 1)|Adverse Event|0|||
16959874|NCT01263197|38103190|FG005|First Intervention (Period 1)|Adverse Event|1|||
16959875|NCT01263197|38103185|FG000|Washout Period 1|Protocol Violation|0|||
16959876|NCT01263197|38103186|FG001|Washout Period 1|Protocol Violation|0|||
16959877|NCT01263197|38103187|FG002|Washout Period 1|Protocol Violation|0|||
16959878|NCT01263197|38103188|FG003|Washout Period 1|Protocol Violation|0|||
16959879|NCT01263197|38103189|FG004|Washout Period 1|Protocol Violation|1|||
16959880|NCT01263197|38103190|FG005|Washout Period 1|Protocol Violation|0|||
16959881|NCT01263197|38103185|FG000|Washout Period 2|Physician Decision|0|||
16959882|NCT01263197|38103186|FG001|Washout Period 2|Physician Decision|0|||
16959883|NCT01263197|38103187|FG002|Washout Period 2|Physician Decision|0|||
16959884|NCT01263197|38103188|FG003|Washout Period 2|Physician Decision|0|||
16959885|NCT01263197|38103189|FG004|Washout Period 2|Physician Decision|0|||
16959886|NCT01263197|38103190|FG005|Washout Period 2|Physician Decision|1|||
16959887|NCT01263197|38103185|FG000|Washout Period 2|Protocol Violation|0|||
16959888|NCT01263197|38103186|FG001|Washout Period 2|Protocol Violation|0|||
16959889|NCT01263197|38103187|FG002|Washout Period 2|Protocol Violation|0|||
16959890|NCT01263197|38103188|FG003|Washout Period 2|Protocol Violation|1|||
16959891|NCT01263197|38103189|FG004|Washout Period 2|Protocol Violation|0|||
16959892|NCT01263197|38103190|FG005|Washout Period 2|Protocol Violation|0|||
16959893|NCT01263197|38103185|FG000|Third Intervention (Period 3)|Adverse Event|0|||
16959894|NCT01263197|38103186|FG001|Third Intervention (Period 3)|Adverse Event|1|||
16959895|NCT01263197|38103187|FG002|Third Intervention (Period 3)|Adverse Event|0|||
16959896|NCT01263197|38103188|FG003|Third Intervention (Period 3)|Adverse Event|0|||
16959897|NCT01263197|38103189|FG004|Third Intervention (Period 3)|Adverse Event|0|||
16959898|NCT01263197|38103190|FG005|Third Intervention (Period 3)|Adverse Event|0|||
16959899|NCT01263119|38103204|FG000|Period 1|Protocol Violation|2|||
16959900|NCT01263119|38103204|FG000|Period 2|Adverse Event|2|||
16959901|NCT01262651|38103214|FG000|Overall Study|Adverse Event|40|||
16959902|NCT01262651|38103215|FG001|Overall Study|Adverse Event|35|||
16959903|NCT01262651|38103214|FG000|Overall Study|Withdrawal by Subject|15|||
16776343|NCT02732119|37715803|FG001|Phase I|Adverse Event|3|||
16959904|NCT01262651|38103215|FG001|Overall Study|Withdrawal by Subject|11|||
16959905|NCT01262651|38103214|FG000|Overall Study|Withdrawal by Investigator|2|||
16959906|NCT01262651|38103215|FG001|Overall Study|Withdrawal by Investigator|2|||
16959907|NCT01262651|38103214|FG000|Overall Study|Met Withdrawal Criteria|1|||
16959908|NCT01262651|38103215|FG001|Overall Study|Met Withdrawal Criteria|0|||
16959909|NCT01262573|38103223|FG000|Overall Study|Withdrawal by Subject|0|||
16959910|NCT01262573|38103224|FG001|Overall Study|Withdrawal by Subject|1|||
16959911|NCT01262027|38103230|FG000|Overall Study|Adverse Event|1|||
16959912|NCT01262027|38103230|FG000|Overall Study|Withdrawal by Subject|3|||
16959913|NCT01262027|38103230|FG000|Overall Study|Protocol Violation|1|||
16959914|NCT01261793|38103237|FG000|Overall Study|Lack of Efficacy|44|||
16959915|NCT01261793|38103238|FG001|Overall Study|Lack of Efficacy|37|||
16959916|NCT01261793|38103239|FG002|Overall Study|Lack of Efficacy|32|||
16959917|NCT01261793|38103237|FG000|Overall Study|Protocol Violation|3|||
17133898|NCT00065507|38275171|FG001|Overall Study|Lost to Follow-up|0|||
17133899|NCT00065507|38275170|FG000|Overall Study|Subject Withdrew Consent|2|||
17133900|NCT00065507|38275171|FG001|Overall Study|Subject Withdrew Consent|1|||
17133901|NCT00065507|38275170|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
17133902|NCT00065507|38275171|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
17133903|NCT00065429|38275188|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
17133904|NCT00065429|38275189|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
17133905|NCT00065429|38275190|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
17133906|NCT00065429|38275191|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
17133907|NCT00065429|38275192|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
17133908|NCT00065429|38275193|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
17133909|NCT00065429|38275194|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
17133910|NCT00065429|38275188|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
17133911|NCT00065429|38275189|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
17133912|NCT00065429|38275190|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
17133913|NCT00065429|38275191|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
17133914|NCT00065429|38275192|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
17133915|NCT00065429|38275193|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
17133916|NCT00065429|38275194|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
17133917|NCT00065429|38275188|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
17133918|NCT00065429|38275189|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
17133919|NCT00065429|38275190|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
17133920|NCT00065429|38275191|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
17133921|NCT00065429|38275192|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
17133922|NCT00065429|38275193|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
17133923|NCT00065429|38275194|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
17133924|NCT00065429|38275188|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
16776344|NCT02732119|37715804|FG002|Phase I|Adverse Event|1|||
16776345|NCT02732119|37715805|FG003|Phase I|Adverse Event|0|||
16776346|NCT02732119|37715806|FG004|Phase I|Adverse Event|0|||
16776347|NCT02732119|37715802|FG000|Phase I|Progressive disease|7|||
16959918|NCT01261793|38103238|FG001|Overall Study|Protocol Violation|5|||
16959919|NCT01261793|38103239|FG002|Overall Study|Protocol Violation|6|||
16959920|NCT01261793|38103237|FG000|Overall Study|Lost to Follow-up|10|||
16776348|NCT02732119|37715803|FG001|Phase I|Progressive disease|3|||
16776349|NCT02732119|37715804|FG002|Phase I|Progressive disease|2|||
16776350|NCT02732119|37715805|FG003|Phase I|Progressive disease|0|||
16776351|NCT02732119|37715806|FG004|Phase I|Progressive disease|0|||
16776352|NCT02732119|37715802|FG000|Phase I|Protocol deviation|0|||
16776353|NCT02732119|37715803|FG001|Phase I|Protocol deviation|1|||
16776354|NCT02732119|37715804|FG002|Phase I|Protocol deviation|0|||
16776355|NCT02732119|37715805|FG003|Phase I|Protocol deviation|0|||
16776356|NCT02732119|37715806|FG004|Phase I|Protocol deviation|0|||
16776357|NCT02732119|37715802|FG000|Phase I|Physician Decision|0|||
16776358|NCT02732119|37715803|FG001|Phase I|Physician Decision|3|||
16776359|NCT02732119|37715804|FG002|Phase I|Physician Decision|4|||
16776360|NCT02732119|37715805|FG003|Phase I|Physician Decision|0|||
16776361|NCT02732119|37715806|FG004|Phase I|Physician Decision|0|||
16776362|NCT02732119|37715802|FG000|Phase II|Adverse Event|0|||
16776363|NCT02732119|37715803|FG001|Phase II|Adverse Event|0|||
16776364|NCT02732119|37715804|FG002|Phase II|Adverse Event|0|||
16776365|NCT02732119|37715805|FG003|Phase II|Adverse Event|3|||
16776366|NCT02732119|37715806|FG004|Phase II|Adverse Event|3|||
16776367|NCT02732119|37715802|FG000|Phase II|Death|0|||
17133925|NCT00065429|38275189|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
17133926|NCT00065429|38275190|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
17133927|NCT00065429|38275191|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
17133928|NCT00065429|38275192|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
17133929|NCT00065429|38275193|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
16776368|NCT02732119|37715803|FG001|Phase II|Death|0|||
16776369|NCT02732119|37715804|FG002|Phase II|Death|0|||
17133930|NCT00065429|38275194|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
17133931|NCT00065429|38275188|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
17133932|NCT00065429|38275189|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
17133933|NCT00065429|38275190|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
16959921|NCT01261793|38103238|FG001|Overall Study|Lost to Follow-up|3|||
16959922|NCT01261793|38103239|FG002|Overall Study|Lost to Follow-up|7|||
16959923|NCT01261793|38103237|FG000|Overall Study|Withdrawal by Subject|12|||
16959924|NCT01261793|38103238|FG001|Overall Study|Withdrawal by Subject|14|||
16959925|NCT01261793|38103239|FG002|Overall Study|Withdrawal by Subject|14|||
16959926|NCT01261793|38103237|FG000|Overall Study|Death|3|||
16959927|NCT01261793|38103238|FG001|Overall Study|Death|1|||
16959928|NCT01261793|38103239|FG002|Overall Study|Death|0|||
16959929|NCT01261793|38103237|FG000|Overall Study|Adverse Event|9|||
16959930|NCT01261793|38103238|FG001|Overall Study|Adverse Event|24|||
16959931|NCT01261793|38103239|FG002|Overall Study|Adverse Event|19|||
16959932|NCT01261793|38103237|FG000|Overall Study|Patient non-availability|1|||
16959933|NCT01261793|38103238|FG001|Overall Study|Patient non-availability|1|||
16959934|NCT01261793|38103239|FG002|Overall Study|Patient non-availability|1|||
16959935|NCT01261793|38103237|FG000|Overall Study|Suspected pregnancy|1|||
16959936|NCT01261793|38103238|FG001|Overall Study|Suspected pregnancy|1|||
16959937|NCT01261793|38103239|FG002|Overall Study|Suspected pregnancy|0|||
16959938|NCT01261793|38103237|FG000|Overall Study|Patient non-compliance|1|||
16959939|NCT01261793|38103238|FG001|Overall Study|Patient non-compliance|0|||
16959940|NCT01261793|38103239|FG002|Overall Study|Patient non-compliance|1|||
16959941|NCT01261793|38103237|FG000|Overall Study|Patient pregnant|1|||
16959942|NCT01261793|38103238|FG001|Overall Study|Patient pregnant|0|||
16959943|NCT01261793|38103239|FG002|Overall Study|Patient pregnant|0|||
16959944|NCT01261793|38103237|FG000|Overall Study|Outside the study area|0|||
16959945|NCT01261793|38103238|FG001|Overall Study|Outside the study area|2|||
16959946|NCT01261793|38103239|FG002|Overall Study|Outside the study area|1|||
16959947|NCT01261793|38103237|FG000|Overall Study|Lack of efficacy & patient not available|0|||
16959948|NCT01261793|38103238|FG001|Overall Study|Lack of efficacy & patient not available|1|||
16959949|NCT01261793|38103239|FG002|Overall Study|Lack of efficacy & patient not available|0|||
16959950|NCT01261793|38103237|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
16959951|NCT01261793|38103238|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
16959952|NCT01261793|38103239|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
16776370|NCT02732119|37715805|FG003|Phase II|Death|1|||
16959953|NCT01261793|38103237|FG000|Overall Study|Randomization error|0|||
16959954|NCT01261793|38103238|FG001|Overall Study|Randomization error|1|||
16959955|NCT01261793|38103239|FG002|Overall Study|Randomization error|0|||
16776371|NCT02732119|37715806|FG004|Phase II|Death|0|||
16959956|NCT01261793|38103237|FG000|Overall Study|Patient unable to start IV line|0|||
16959957|NCT01261793|38103238|FG001|Overall Study|Patient unable to start IV line|0|||
16959958|NCT01261793|38103239|FG002|Overall Study|Patient unable to start IV line|1|||
16959959|NCT01261325|38103250|FG000|Overall Study|Lack of Efficacy|1|||
16959960|NCT01261325|38103251|FG001|Overall Study|Lack of Efficacy|1|||
16959961|NCT01261325|38103252|FG002|Overall Study|Lack of Efficacy|0|||
16959962|NCT01261325|38103250|FG000|Overall Study|Withdrawal by Subject|2|||
16959963|NCT01261325|38103251|FG001|Overall Study|Withdrawal by Subject|2|||
16959964|NCT01261325|38103252|FG002|Overall Study|Withdrawal by Subject|4|||
16959965|NCT01261325|38103250|FG000|Overall Study|SAE, non-fatal|1|||
16959966|NCT01261325|38103251|FG001|Overall Study|SAE, non-fatal|5|||
16959967|NCT01261325|38103252|FG002|Overall Study|SAE, non-fatal|1|||
16959968|NCT01261325|38103250|FG000|Overall Study|AE, non-serious non-fatal|9|||
16959969|NCT01261325|38103251|FG001|Overall Study|AE, non-serious non-fatal|15|||
16959970|NCT01261325|38103252|FG002|Overall Study|AE, non-serious non-fatal|13|||
16959971|NCT01261325|38103250|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16776372|NCT02732119|37715802|FG000|Phase II|Progressive dissease|0|||
16776373|NCT02732119|37715803|FG001|Phase II|Progressive dissease|0|||
16776374|NCT02732119|37715804|FG002|Phase II|Progressive dissease|0|||
16776375|NCT02732119|37715805|FG003|Phase II|Progressive dissease|30|||
16776376|NCT02732119|37715806|FG004|Phase II|Progressive dissease|23|||
16776377|NCT02732119|37715802|FG000|Phase II|Study terminated by sponsor|0|||
16959972|NCT01261325|38103251|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16959973|NCT01261325|38103252|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16959974|NCT01261325|38103250|FG000|Overall Study|Non Compliance|2|||
16959975|NCT01261325|38103251|FG001|Overall Study|Non Compliance|0|||
16959976|NCT01261325|38103252|FG002|Overall Study|Non Compliance|0|||
16959977|NCT01261325|38103250|FG000|Overall Study|Patient Randomized by Mistake|0|||
16959978|NCT01261325|38103251|FG001|Overall Study|Patient Randomized by Mistake|1|||
16959979|NCT01261325|38103252|FG002|Overall Study|Patient Randomized by Mistake|0|||
16959980|NCT01261325|38103250|FG000|Overall Study|Erroneously Randomized|1|||
16959981|NCT01261325|38103251|FG001|Overall Study|Erroneously Randomized|0|||
16959982|NCT01261325|38103252|FG002|Overall Study|Erroneously Randomized|0|||
16959983|NCT01261325|38103250|FG000|Overall Study|Screen Failure|1|||
16959984|NCT01261325|38103251|FG001|Overall Study|Screen Failure|0|||
16959985|NCT01261325|38103252|FG002|Overall Study|Screen Failure|0|||
16959986|NCT01261325|38103250|FG000|Overall Study|Randomized in Error|0|||
16959987|NCT01261325|38103251|FG001|Overall Study|Randomized in Error|0|||
16959988|NCT01261325|38103252|FG002|Overall Study|Randomized in Error|1|||
16959989|NCT01261325|38103250|FG000|Overall Study|Protocol Violation|0|||
16959990|NCT01261325|38103251|FG001|Overall Study|Protocol Violation|3|||
16959991|NCT01261325|38103252|FG002|Overall Study|Protocol Violation|1|||
16959992|NCT01261325|38103250|FG000|Overall Study|Lost to Follow-up|0|||
16959993|NCT01261325|38103251|FG001|Overall Study|Lost to Follow-up|1|||
16959994|NCT01261325|38103252|FG002|Overall Study|Lost to Follow-up|3|||
16959995|NCT01261325|38103250|FG000|Overall Study|AE, serious fatal|0|||
16959996|NCT01261325|38103251|FG001|Overall Study|AE, serious fatal|0|||
16959997|NCT01261325|38103252|FG002|Overall Study|AE, serious fatal|2|||
16959998|NCT01260701|38103263|FG000|Overall Study|Adverse Event|9|||
16959999|NCT01260701|38103263|FG000|Overall Study|Withdrawal by Subject|2|||
16960000|NCT01260701|38103263|FG000|Overall Study|Progression|53|||
16960001|NCT01260701|38103263|FG000|Overall Study|Death|2|||
16960002|NCT01260701|38103263|FG000|Overall Study|Not protocol specified|3|||
16960003|NCT01260701|38103263|FG000|Overall Study|Under review|1|||
16960004|NCT01260701|38103263|FG000|Overall Study|Ineligible|4|||
16960005|NCT01260701|38103263|FG000|Overall Study|Did not begin protocol therapy|1|||
16960006|NCT01260467|38103267|FG000|Overall Study|Withdrawal by Subject|2|||
16960007|NCT01260311|38103273|FG000|Overall Study|Adverse Event|11|||
16960008|NCT01260311|38103273|FG000|Overall Study|Lack of Efficacy|4|||
16960009|NCT01260311|38103273|FG000|Overall Study|Lost to Follow-up|25|||
16960010|NCT01260311|38103273|FG000|Overall Study|Withdrawal by Subject|6|||
16960011|NCT01260311|38103273|FG000|Overall Study|Financial Constraints|77|||
16960012|NCT01260311|38103273|FG000|Overall Study|Gone to Province|2|||
16960013|NCT01260311|38103273|FG000|Overall Study|Medication Stopped|1|||
16960014|NCT01260311|38103273|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
16960015|NCT01259375|38103277|FG000|Overall Study|Adverse Event|1|||
16960016|NCT01940471|38103294|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
16960017|NCT01940471|38103295|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
16960018|NCT01940471|38103294|FG000|Double-Blind Phase|Withdrew Consent|13|||
16960019|NCT01940471|38103295|FG001|Double-Blind Phase|Withdrew Consent|7|||
16960020|NCT01940471|38103294|FG000|Double-Blind Phase|Adverse Event|1|||
16960021|NCT01940471|38103295|FG001|Double-Blind Phase|Adverse Event|2|||
16960022|NCT01940471|38103294|FG000|Double-Blind Phase|Lost to Follow-up|3|||
16960023|NCT01940471|38103295|FG001|Double-Blind Phase|Lost to Follow-up|2|||
16960024|NCT01940471|38103294|FG000|Double-Blind Phase|Pregnancy|2|||
16960025|NCT01940471|38103295|FG001|Double-Blind Phase|Pregnancy|1|||
16867973|NCT01563913|37841001|FG000|Overall Study|Physician Decision|1|||
16960026|NCT01940471|38103294|FG000|Double-Blind Phase|Investigator's Discretion|5|||
16960027|NCT01940471|38103295|FG001|Double-Blind Phase|Investigator's Discretion|0|||
16960028|NCT01940471|38103294|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16960029|NCT01940471|38103295|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16960030|NCT01940471|38103294|FG000|Double-Blind Phase|Protocol-Specified Criteria|1|||
16960031|NCT01940471|38103295|FG001|Double-Blind Phase|Protocol-Specified Criteria|0|||
16960032|NCT01940471|38103294|FG000|Double-Blind Phase|Death|1|||
16960033|NCT01940471|38103295|FG001|Double-Blind Phase|Death|0|||
16960034|NCT01940471|38103294|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16960035|NCT01940471|38103295|FG001|Double-Blind Phase|Lack of Efficacy|0|||
16960036|NCT01940471|38103294|FG000|Double-Blind Phase|Protocol Violation|0|||
16960037|NCT01940471|38103295|FG001|Double-Blind Phase|Protocol Violation|1|||
16960038|NCT01940471|38103294|FG000|Double-Blind Phase|Still in Double-Blind Phase|539|||
16960039|NCT01940471|38103295|FG001|Double-Blind Phase|Still in Double-Blind Phase|270|||
16960040|NCT01940471|38103294|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14|||
16960041|NCT01940471|38103295|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8|||
16960042|NCT01321073|38103302|FG000|Overall Study|Did not attempt implant|4|||
16960043|NCT01321073|38103302|FG000|Overall Study|Death|3|||
16960044|NCT01259297|38103314|FG000|Double Blind Randomized Period|Death|1|||
16960045|NCT01259297|38103315|FG001|Double Blind Randomized Period|Death|1|||
16960046|NCT01259297|38103316|FG002|Double Blind Randomized Period|Death|1|||
16960047|NCT01259297|38103317|FG003|Double Blind Randomized Period|Death|2|||
16960048|NCT01259297|38103318|FG004|Double Blind Randomized Period|Death|1|||
16960049|NCT01259297|38103319|FG005|Double Blind Randomized Period|Death|5|||
16960050|NCT01259297|38103320|FG006|Double Blind Randomized Period|Death|2|||
16960051|NCT01259297|38103321|FG007|Double Blind Randomized Period|Death|1|||
16960052|NCT01259297|38103314|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16960053|NCT01259297|38103315|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16960054|NCT01259297|38103316|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
16960055|NCT01259297|38103317|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
16960056|NCT01259297|38103318|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
16960057|NCT01259297|38103319|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16960058|NCT01259297|38103320|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16960059|NCT01259297|38103321|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16960060|NCT01259297|38103314|FG000|Double Blind Randomized Period|Other reasons|0|||
16960061|NCT01259297|38103315|FG001|Double Blind Randomized Period|Other reasons|1|||
16960062|NCT01259297|38103316|FG002|Double Blind Randomized Period|Other reasons|0|||
16960063|NCT01259297|38103317|FG003|Double Blind Randomized Period|Other reasons|0|||
16960064|NCT01259297|38103318|FG004|Double Blind Randomized Period|Other reasons|1|||
16960065|NCT01259297|38103319|FG005|Double Blind Randomized Period|Other reasons|2|||
16960066|NCT01259297|38103320|FG006|Double Blind Randomized Period|Other reasons|3|||
16960067|NCT01259297|38103321|FG007|Double Blind Randomized Period|Other reasons|1|||
16960068|NCT01126437|38103341|FG000|Overall Study|Not treated|11|||
16960069|NCT01126437|38103342|FG001|Overall Study|Not treated|18|||
16960070|NCT01126437|38103343|FG002|Overall Study|Not treated|19|||
16960071|NCT01126437|38103341|FG000|Overall Study|Sites with data irregularities/fraud|6|||
16960072|NCT01126437|38103342|FG001|Overall Study|Sites with data irregularities/fraud|6|||
16960073|NCT01126437|38103343|FG002|Overall Study|Sites with data irregularities/fraud|7|||
16960074|NCT01126437|38103341|FG000|Overall Study|Adverse Event|602|||
16960075|NCT01126437|38103342|FG001|Overall Study|Adverse Event|606|||
16960076|NCT01126437|38103343|FG002|Overall Study|Adverse Event|635|||
16960077|NCT01126437|38103341|FG000|Overall Study|Lack of Efficacy|65|||
16960078|NCT01126437|38103342|FG001|Overall Study|Lack of Efficacy|60|||
16960079|NCT01126437|38103343|FG002|Overall Study|Lack of Efficacy|59|||
16960080|NCT01126437|38103341|FG000|Overall Study|Protocol Violation|64|||
16960081|NCT01126437|38103342|FG001|Overall Study|Protocol Violation|66|||
16960082|NCT01126437|38103343|FG002|Overall Study|Protocol Violation|41|||
16960083|NCT01126437|38103341|FG000|Overall Study|Lost to Follow-up|52|||
16960084|NCT01126437|38103342|FG001|Overall Study|Lost to Follow-up|63|||
16960085|NCT01126437|38103343|FG002|Overall Study|Lost to Follow-up|55|||
16960086|NCT01126437|38103341|FG000|Overall Study|Withdrawal by Subject|331|||
16960087|NCT01126437|38103342|FG001|Overall Study|Withdrawal by Subject|335|||
16960088|NCT01126437|38103343|FG002|Overall Study|Withdrawal by Subject|319|||
16960089|NCT01126437|38103341|FG000|Overall Study|Other reason not specified|210|||
16960090|NCT01126437|38103342|FG001|Overall Study|Other reason not specified|176|||
16960091|NCT01126437|38103343|FG002|Overall Study|Other reason not specified|178|||
16960092|NCT01258595|38103353|FG000|Overall Study|Lost to Follow-up|1|||
16960093|NCT01258595|38103354|FG001|Overall Study|Lost to Follow-up|0|||
16960094|NCT01258595|38103353|FG000|Overall Study|Withdrawal by Subject|0|||
16960095|NCT01258595|38103354|FG001|Overall Study|Withdrawal by Subject|1|||
16960096|NCT01257737|38103362|FG000|Overall Study|Lost to Follow-up|1|||
16960097|NCT01257737|38103363|FG001|Overall Study|Lost to Follow-up|2|||
16960098|NCT01257737|38103362|FG000|Overall Study|Liver transplant|1|||
16960099|NCT01257737|38103363|FG001|Overall Study|Liver transplant|0|||
16960100|NCT01257737|38103362|FG000|Overall Study|Relocation out of the country|0|||
16960101|NCT01257737|38103363|FG001|Overall Study|Relocation out of the country|1|||
16776378|NCT02732119|37715803|FG001|Phase II|Study terminated by sponsor|0|||
16776379|NCT02732119|37715804|FG002|Phase II|Study terminated by sponsor|0|||
16776380|NCT02732119|37715805|FG003|Phase II|Study terminated by sponsor|2|||
16776381|NCT02732119|37715806|FG004|Phase II|Study terminated by sponsor|2|||
16776382|NCT02732119|37715802|FG000|Phase II|Other|0|||
16776383|NCT02732119|37715803|FG001|Phase II|Other|0|||
16776384|NCT02732119|37715804|FG002|Phase II|Other|0|||
16776385|NCT02732119|37715805|FG003|Phase II|Other|2|||
16776386|NCT02732119|37715806|FG004|Phase II|Other|0|||
16776387|NCT02732119|37715802|FG000|Phase II|Physician Decision|0|||
16776388|NCT02732119|37715803|FG001|Phase II|Physician Decision|0|||
16776389|NCT02732119|37715804|FG002|Phase II|Physician Decision|0|||
16776390|NCT02732119|37715805|FG003|Phase II|Physician Decision|8|||
16776391|NCT02732119|37715806|FG004|Phase II|Physician Decision|5|||
16776392|NCT03252925|37715829|FG000|Overall Study|Withdrawal by Subject|1|||
16776393|NCT03252925|37715830|FG001|Overall Study|Withdrawal by Subject|0|||
16776394|NCT03252925|37715829|FG000|Overall Study|Protocol Violation|6|||
16776395|NCT03252925|37715830|FG001|Overall Study|Protocol Violation|0|||
16776396|NCT03252925|37715829|FG000|Overall Study|Adverse Event|1|||
16776397|NCT03252925|37715830|FG001|Overall Study|Adverse Event|0|||
16776398|NCT03252925|37715829|FG000|Overall Study|Lost to Follow-up|6|||
16776399|NCT03252925|37715830|FG001|Overall Study|Lost to Follow-up|6|||
16776400|NCT01327885|37715838|FG000|Overall Study|Disease progression-according to RECIST|173|||
16776401|NCT01327885|37715839|FG001|Overall Study|Disease progression-according to RECIST|165|||
16776402|NCT01327885|37715838|FG000|Overall Study|Clinical progression|24|||
16776403|NCT01327885|37715839|FG001|Overall Study|Clinical progression|27|||
16776404|NCT01327885|37715838|FG000|Overall Study|Adverse Event|14|||
16776405|NCT01327885|37715839|FG001|Overall Study|Adverse Event|10|||
16776406|NCT01327885|37715838|FG000|Overall Study|Subject choice|5|||
16776407|NCT01327885|37715839|FG001|Overall Study|Subject choice|10|||
16960102|NCT01257737|38103362|FG000|Overall Study|Withdrew from study|0|||
16960103|NCT01257737|38103363|FG001|Overall Study|Withdrew from study|1|||
16960104|NCT01126359|38103370|FG000|First Intervention (20-minutes)|Physician Decision|0|||
16960105|NCT01126359|38103371|FG001|First Intervention (20-minutes)|Physician Decision|1|||
16960106|NCT01125813|38103381|FG000|Overall Study|Death|1|||
16960107|NCT01125813|38103381|FG000|Overall Study|Withdrawal by Subject|1|||
16776408|NCT01327885|37715838|FG000|Overall Study|Other|8|||
16776409|NCT01327885|37715839|FG001|Overall Study|Other|6|||
16776410|NCT01327885|37715838|FG000|Overall Study|Withdrawal of consent from study|3|||
16776411|NCT01327885|37715839|FG001|Overall Study|Withdrawal of consent from study|4|||
16776412|NCT01327885|37715838|FG000|Overall Study|Not treated|1|||
16776413|NCT01327885|37715839|FG001|Overall Study|Not treated|1|||
16776414|NCT01327885|37715838|FG000|Overall Study|Administrative decision|0|||
16776415|NCT01327885|37715839|FG001|Overall Study|Administrative decision|1|||
16776416|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
16776417|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
16776418|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
16776419|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
16776420|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
16776421|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
16776422|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
16776423|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
16776424|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
16960108|NCT01125813|38103381|FG000|Overall Study|Screen Failures|4|||
16960109|NCT00996892|38103385|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
16960110|NCT00996892|38103386|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
16960111|NCT00996892|38103387|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
16960112|NCT00996892|38103388|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
16960113|NCT00996892|38103389|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
16960114|NCT00996892|38103390|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
16960115|NCT00996892|38103391|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
16960116|NCT00996892|38103392|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
16960117|NCT00996892|38103393|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
16960118|NCT00996892|38103394|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
16960119|NCT00996892|38103395|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
16960120|NCT00996892|38103396|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
16960121|NCT00996892|38103397|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
16960122|NCT00996892|38103398|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
16960123|NCT00996892|38103399|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
16960124|NCT00996892|38103400|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
16960125|NCT00996892|38103401|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
16960126|NCT00996892|38103402|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
16960127|NCT00996892|38103403|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
16960128|NCT00996892|38103404|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
16960129|NCT00996892|38103385|FG000|Dose-Escalation Stage 1|Death|1|||
16960130|NCT00996892|38103386|FG001|Dose-Escalation Stage 1|Death|0|||
16960131|NCT00996892|38103387|FG002|Dose-Escalation Stage 1|Death|0|||
16960132|NCT00996892|38103388|FG003|Dose-Escalation Stage 1|Death|0|||
16960133|NCT00996892|38103389|FG004|Dose-Escalation Stage 1|Death|0|||
16960134|NCT00996892|38103390|FG005|Dose-Escalation Stage 1|Death|1|||
16960135|NCT00996892|38103391|FG006|Dose-Escalation Stage 1|Death|0|||
16960136|NCT00996892|38103392|FG007|Dose-Escalation Stage 1|Death|0|||
16960137|NCT00996892|38103393|FG008|Dose-Escalation Stage 1|Death|0|||
16960138|NCT00996892|38103394|FG009|Dose-Escalation Stage 1|Death|0|||
16960139|NCT00996892|38103395|FG010|Dose-Escalation Stage 1|Death|0|||
16960140|NCT00996892|38103396|FG011|Dose-Escalation Stage 1|Death|0|||
16960141|NCT00996892|38103397|FG012|Dose-Escalation Stage 1|Death|0|||
16960142|NCT00996892|38103398|FG013|Dose-Escalation Stage 1|Death|0|||
16960143|NCT00996892|38103399|FG014|Dose-Escalation Stage 1|Death|0|||
16960144|NCT00996892|38103400|FG015|Dose-Escalation Stage 1|Death|0|||
16960145|NCT00996892|38103401|FG016|Dose-Escalation Stage 1|Death|0|||
16960146|NCT00996892|38103402|FG017|Dose-Escalation Stage 1|Death|0|||
16960147|NCT00996892|38103403|FG018|Dose-Escalation Stage 1|Death|0|||
16960148|NCT00996892|38103404|FG019|Dose-Escalation Stage 1|Death|0|||
16960149|NCT00996892|38103385|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
16960150|NCT00996892|38103386|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
16960151|NCT00996892|38103387|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
16960152|NCT00996892|38103388|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
16960153|NCT00996892|38103389|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
16960154|NCT00996892|38103390|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
16960155|NCT00996892|38103391|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
16960156|NCT00996892|38103392|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
16960157|NCT00996892|38103393|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
16960158|NCT00996892|38103394|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
16960159|NCT00996892|38103395|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
16776425|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
16776426|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
16960160|NCT00996892|38103396|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
16960161|NCT00996892|38103397|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
16960162|NCT00996892|38103398|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
16960163|NCT00996892|38103399|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
16960164|NCT00996892|38103400|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
16960165|NCT00996892|38103401|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
16960166|NCT00996892|38103402|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
16960167|NCT00996892|38103403|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
16960168|NCT00996892|38103404|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
16960169|NCT00996892|38103385|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960170|NCT00996892|38103386|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
16960171|NCT00996892|38103387|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960172|NCT00996892|38103388|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
16960173|NCT00996892|38103389|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
16960174|NCT00996892|38103390|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
16960175|NCT00996892|38103391|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
16960176|NCT00996892|38103392|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960177|NCT00996892|38103393|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960178|NCT00996892|38103394|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960179|NCT00996892|38103395|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960180|NCT00996892|38103396|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960181|NCT00996892|38103397|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960182|NCT00996892|38103398|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960183|NCT00996892|38103399|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960184|NCT00996892|38103400|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960185|NCT00996892|38103401|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960186|NCT00996892|38103402|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960187|NCT00996892|38103403|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960188|NCT00996892|38103404|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16960189|NCT00996892|38103385|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
16960190|NCT00996892|38103386|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
16960191|NCT00996892|38103387|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
16960192|NCT00996892|38103388|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
16960193|NCT00996892|38103389|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
16960194|NCT00996892|38103390|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
16960195|NCT00996892|38103391|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
16960196|NCT00996892|38103392|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
16960197|NCT00996892|38103393|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
16960198|NCT00996892|38103394|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
16960199|NCT00996892|38103395|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
16960200|NCT00996892|38103396|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
16960201|NCT00996892|38103397|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
16960202|NCT00996892|38103398|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
16960203|NCT00996892|38103399|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
16960204|NCT00996892|38103400|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
16960205|NCT00996892|38103401|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
16960206|NCT00996892|38103402|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
16960207|NCT00996892|38103403|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
16960208|NCT00996892|38103404|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
16960209|NCT00996892|38103385|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
16960210|NCT00996892|38103386|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
16960211|NCT00996892|38103387|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
16960212|NCT00996892|38103388|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
16960213|NCT00996892|38103389|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
16960214|NCT00996892|38103390|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
16960215|NCT00996892|38103391|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
16960216|NCT00996892|38103392|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
16960217|NCT00996892|38103393|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
16960218|NCT00996892|38103394|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
16960219|NCT00996892|38103395|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
16960220|NCT00996892|38103396|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
16960221|NCT00996892|38103397|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
16960222|NCT00996892|38103398|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
16960223|NCT00996892|38103399|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
16960224|NCT00996892|38103400|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
16776427|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
16776428|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
16776429|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
16960225|NCT00996892|38103401|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
16960226|NCT00996892|38103402|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
16960227|NCT00996892|38103403|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
16960228|NCT00996892|38103404|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
16960229|NCT00996892|38103385|FG000|Dose-Escalation Stage 1A|Death|0|||
16960230|NCT00996892|38103386|FG001|Dose-Escalation Stage 1A|Death|0|||
16960231|NCT00996892|38103387|FG002|Dose-Escalation Stage 1A|Death|0|||
16960232|NCT00996892|38103388|FG003|Dose-Escalation Stage 1A|Death|0|||
16960233|NCT00996892|38103389|FG004|Dose-Escalation Stage 1A|Death|0|||
16960234|NCT00996892|38103390|FG005|Dose-Escalation Stage 1A|Death|0|||
16960235|NCT00996892|38103391|FG006|Dose-Escalation Stage 1A|Death|0|||
16960236|NCT00996892|38103392|FG007|Dose-Escalation Stage 1A|Death|0|||
16960237|NCT00996892|38103393|FG008|Dose-Escalation Stage 1A|Death|0|||
16960238|NCT00996892|38103394|FG009|Dose-Escalation Stage 1A|Death|2|||
16960239|NCT00996892|38103395|FG010|Dose-Escalation Stage 1A|Death|0|||
16960240|NCT00996892|38103396|FG011|Dose-Escalation Stage 1A|Death|1|||
16960241|NCT00996892|38103397|FG012|Dose-Escalation Stage 1A|Death|1|||
16960242|NCT00996892|38103398|FG013|Dose-Escalation Stage 1A|Death|0|||
16960243|NCT00996892|38103399|FG014|Dose-Escalation Stage 1A|Death|0|||
16960244|NCT00996892|38103400|FG015|Dose-Escalation Stage 1A|Death|0|||
16960245|NCT00996892|38103401|FG016|Dose-Escalation Stage 1A|Death|0|||
16960246|NCT00996892|38103402|FG017|Dose-Escalation Stage 1A|Death|0|||
16960247|NCT00996892|38103403|FG018|Dose-Escalation Stage 1A|Death|0|||
16960248|NCT00996892|38103404|FG019|Dose-Escalation Stage 1A|Death|0|||
16960249|NCT00996892|38103385|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
16960250|NCT00996892|38103386|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
16960251|NCT00996892|38103387|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
16960252|NCT00996892|38103388|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
16960253|NCT00996892|38103389|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
16960254|NCT00996892|38103390|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
16960255|NCT00996892|38103391|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
16960256|NCT00996892|38103392|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
16960257|NCT00996892|38103393|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
16960258|NCT00996892|38103394|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
16960259|NCT00996892|38103395|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
16960260|NCT00996892|38103396|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
16960261|NCT00996892|38103397|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
16960262|NCT00996892|38103398|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
16960263|NCT00996892|38103399|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
16960264|NCT00996892|38103400|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
16960265|NCT00996892|38103401|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
16960266|NCT00996892|38103402|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
16960267|NCT00996892|38103403|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
16960268|NCT00996892|38103404|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
16960269|NCT00996892|38103385|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960270|NCT00996892|38103386|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960271|NCT00996892|38103387|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960272|NCT00996892|38103388|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960273|NCT00996892|38103389|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960274|NCT00996892|38103390|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960275|NCT00996892|38103391|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960276|NCT00996892|38103392|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960277|NCT00996892|38103393|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960278|NCT00996892|38103394|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
16960279|NCT00996892|38103395|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
16960280|NCT00996892|38103396|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
16960281|NCT00996892|38103397|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
16960282|NCT00996892|38103398|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960283|NCT00996892|38103399|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960284|NCT00996892|38103400|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960285|NCT00996892|38103401|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960286|NCT00996892|38103402|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960287|NCT00996892|38103403|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960288|NCT00996892|38103404|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16960289|NCT00996892|38103385|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
16960290|NCT00996892|38103386|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
16960291|NCT00996892|38103387|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
16960292|NCT00996892|38103388|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
16960293|NCT00996892|38103389|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
16960294|NCT00996892|38103390|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
16960295|NCT00996892|38103391|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
16960296|NCT00996892|38103392|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
16960297|NCT00996892|38103393|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
16960298|NCT00996892|38103394|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
16960299|NCT00996892|38103395|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
16960300|NCT00996892|38103396|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
16960301|NCT00996892|38103397|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
16960302|NCT00996892|38103398|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
16960303|NCT00996892|38103399|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
16960304|NCT00996892|38103400|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
16960305|NCT00996892|38103401|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
16960306|NCT00996892|38103402|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
16960307|NCT00996892|38103403|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
16960308|NCT00996892|38103404|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
16960309|NCT00996892|38103385|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
16960310|NCT00996892|38103386|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
16960311|NCT00996892|38103387|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
16960312|NCT00996892|38103388|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
16960313|NCT00996892|38103389|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
16960314|NCT00996892|38103390|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
16960315|NCT00996892|38103391|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
16960316|NCT00996892|38103392|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
16960317|NCT00996892|38103393|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
16960318|NCT00996892|38103394|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
16960319|NCT00996892|38103395|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
16960320|NCT00996892|38103396|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
16960321|NCT00996892|38103397|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
16960322|NCT00996892|38103398|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
16960323|NCT00996892|38103399|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
16960324|NCT00996892|38103400|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
16960325|NCT00996892|38103401|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
16960326|NCT00996892|38103402|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
16960327|NCT00996892|38103403|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
16960328|NCT00996892|38103404|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
16960329|NCT00996892|38103385|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
16960330|NCT00996892|38103386|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
16960331|NCT00996892|38103387|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
16960332|NCT00996892|38103388|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
16960333|NCT00996892|38103389|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
16960334|NCT00996892|38103390|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
16960335|NCT00996892|38103391|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
16960336|NCT00996892|38103392|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
16960337|NCT00996892|38103393|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
16960338|NCT00996892|38103394|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
16960339|NCT00996892|38103395|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
16960340|NCT00996892|38103396|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
16960341|NCT00996892|38103397|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
16960342|NCT00996892|38103398|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
16960343|NCT00996892|38103399|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
16960344|NCT00996892|38103400|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
16960345|NCT00996892|38103401|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
16960346|NCT00996892|38103402|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
16960347|NCT00996892|38103403|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
16960348|NCT00996892|38103404|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
16960349|NCT00996892|38103385|FG000|Expansion Stage 2|Adverse Event|0|||
16960350|NCT00996892|38103386|FG001|Expansion Stage 2|Adverse Event|0|||
16960351|NCT00996892|38103387|FG002|Expansion Stage 2|Adverse Event|0|||
16960352|NCT00996892|38103388|FG003|Expansion Stage 2|Adverse Event|0|||
16960353|NCT00996892|38103389|FG004|Expansion Stage 2|Adverse Event|0|||
16960354|NCT00996892|38103390|FG005|Expansion Stage 2|Adverse Event|0|||
16960355|NCT00996892|38103391|FG006|Expansion Stage 2|Adverse Event|0|||
16960356|NCT00996892|38103392|FG007|Expansion Stage 2|Adverse Event|0|||
16960357|NCT00996892|38103393|FG008|Expansion Stage 2|Adverse Event|0|||
16960358|NCT00996892|38103394|FG009|Expansion Stage 2|Adverse Event|0|||
16960359|NCT00996892|38103395|FG010|Expansion Stage 2|Adverse Event|0|||
16960360|NCT00996892|38103396|FG011|Expansion Stage 2|Adverse Event|0|||
16960361|NCT00996892|38103397|FG012|Expansion Stage 2|Adverse Event|0|||
16960362|NCT00996892|38103398|FG013|Expansion Stage 2|Adverse Event|0|||
16960363|NCT00996892|38103399|FG014|Expansion Stage 2|Adverse Event|0|||
16960364|NCT00996892|38103400|FG015|Expansion Stage 2|Adverse Event|0|||
16960365|NCT00996892|38103401|FG016|Expansion Stage 2|Adverse Event|0|||
16960366|NCT00996892|38103402|FG017|Expansion Stage 2|Adverse Event|0|||
16960367|NCT00996892|38103403|FG018|Expansion Stage 2|Adverse Event|3|||
16960368|NCT00996892|38103404|FG019|Expansion Stage 2|Adverse Event|0|||
16960369|NCT00996892|38103385|FG000|Expansion Stage 2|Death|0|||
16960370|NCT00996892|38103386|FG001|Expansion Stage 2|Death|0|||
16960371|NCT00996892|38103387|FG002|Expansion Stage 2|Death|0|||
16960372|NCT00996892|38103388|FG003|Expansion Stage 2|Death|0|||
16960373|NCT00996892|38103389|FG004|Expansion Stage 2|Death|0|||
16960374|NCT00996892|38103390|FG005|Expansion Stage 2|Death|0|||
16960375|NCT00996892|38103391|FG006|Expansion Stage 2|Death|0|||
16960376|NCT00996892|38103392|FG007|Expansion Stage 2|Death|0|||
16960377|NCT00996892|38103393|FG008|Expansion Stage 2|Death|0|||
16960378|NCT00996892|38103394|FG009|Expansion Stage 2|Death|0|||
16960379|NCT00996892|38103395|FG010|Expansion Stage 2|Death|0|||
16960380|NCT00996892|38103396|FG011|Expansion Stage 2|Death|0|||
16960381|NCT00996892|38103397|FG012|Expansion Stage 2|Death|0|||
16960382|NCT00996892|38103398|FG013|Expansion Stage 2|Death|0|||
16960383|NCT00996892|38103399|FG014|Expansion Stage 2|Death|0|||
16960384|NCT00996892|38103400|FG015|Expansion Stage 2|Death|0|||
16960385|NCT00996892|38103401|FG016|Expansion Stage 2|Death|0|||
16960386|NCT00996892|38103402|FG017|Expansion Stage 2|Death|0|||
16960387|NCT00996892|38103403|FG018|Expansion Stage 2|Death|2|||
16960388|NCT00996892|38103404|FG019|Expansion Stage 2|Death|0|||
16960389|NCT00996892|38103385|FG000|Expansion Stage 2|Physician Decision|0|||
16960390|NCT00996892|38103386|FG001|Expansion Stage 2|Physician Decision|0|||
16960391|NCT00996892|38103387|FG002|Expansion Stage 2|Physician Decision|0|||
16776430|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
16776431|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
16776432|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
16960392|NCT00996892|38103388|FG003|Expansion Stage 2|Physician Decision|0|||
16960393|NCT00996892|38103389|FG004|Expansion Stage 2|Physician Decision|0|||
16960394|NCT00996892|38103390|FG005|Expansion Stage 2|Physician Decision|0|||
16776433|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16776434|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16776435|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16776436|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Death|2|||
16960395|NCT00996892|38103391|FG006|Expansion Stage 2|Physician Decision|0|||
16960396|NCT00996892|38103392|FG007|Expansion Stage 2|Physician Decision|0|||
16960397|NCT00996892|38103393|FG008|Expansion Stage 2|Physician Decision|0|||
16960398|NCT00996892|38103394|FG009|Expansion Stage 2|Physician Decision|0|||
16960399|NCT00996892|38103395|FG010|Expansion Stage 2|Physician Decision|0|||
16960400|NCT00996892|38103396|FG011|Expansion Stage 2|Physician Decision|0|||
16960401|NCT00996892|38103397|FG012|Expansion Stage 2|Physician Decision|0|||
16960402|NCT00996892|38103398|FG013|Expansion Stage 2|Physician Decision|0|||
16960403|NCT00996892|38103399|FG014|Expansion Stage 2|Physician Decision|0|||
16960404|NCT00996892|38103400|FG015|Expansion Stage 2|Physician Decision|0|||
16960405|NCT00996892|38103401|FG016|Expansion Stage 2|Physician Decision|0|||
16960406|NCT00996892|38103402|FG017|Expansion Stage 2|Physician Decision|0|||
16960407|NCT00996892|38103403|FG018|Expansion Stage 2|Physician Decision|1|||
16960408|NCT00996892|38103404|FG019|Expansion Stage 2|Physician Decision|0|||
16960409|NCT00996892|38103385|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
16960410|NCT00996892|38103386|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
16960411|NCT00996892|38103387|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
16960412|NCT00996892|38103388|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
16960413|NCT00996892|38103389|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
16960414|NCT00996892|38103390|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
16960415|NCT00996892|38103391|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
16776437|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Death|2|||
16776438|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Death|0|||
16776439|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Death|0|||
16776440|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Death|0|||
16776441|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
16776442|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
16776443|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
16776444|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
16776445|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
16776446|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
16960416|NCT00996892|38103392|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
16960417|NCT00996892|38103393|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
16960418|NCT00996892|38103394|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
16960419|NCT00996892|38103395|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
16960420|NCT00996892|38103396|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
16960421|NCT00996892|38103397|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
16960422|NCT00996892|38103398|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
16960423|NCT00996892|38103399|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
16960424|NCT00996892|38103400|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
16960425|NCT00996892|38103401|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
16960426|NCT00996892|38103402|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
16960427|NCT00996892|38103403|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
16960428|NCT00996892|38103404|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
16960429|NCT00996892|38103385|FG000|Expansion Stage 2|Disease Progression|0|||
16960430|NCT00996892|38103386|FG001|Expansion Stage 2|Disease Progression|0|||
16776447|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
16776448|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
16960431|NCT00996892|38103387|FG002|Expansion Stage 2|Disease Progression|0|||
16960432|NCT00996892|38103388|FG003|Expansion Stage 2|Disease Progression|0|||
16960433|NCT00996892|38103389|FG004|Expansion Stage 2|Disease Progression|0|||
16960434|NCT00996892|38103390|FG005|Expansion Stage 2|Disease Progression|0|||
16960435|NCT00996892|38103391|FG006|Expansion Stage 2|Disease Progression|0|||
16960436|NCT00996892|38103392|FG007|Expansion Stage 2|Disease Progression|0|||
16960437|NCT00996892|38103393|FG008|Expansion Stage 2|Disease Progression|0|||
16960438|NCT00996892|38103394|FG009|Expansion Stage 2|Disease Progression|0|||
16960439|NCT00996892|38103395|FG010|Expansion Stage 2|Disease Progression|0|||
16960440|NCT00996892|38103396|FG011|Expansion Stage 2|Disease Progression|0|||
16960441|NCT00996892|38103397|FG012|Expansion Stage 2|Disease Progression|0|||
16960442|NCT00996892|38103398|FG013|Expansion Stage 2|Disease Progression|0|||
16960443|NCT00996892|38103399|FG014|Expansion Stage 2|Disease Progression|0|||
16960444|NCT00996892|38103400|FG015|Expansion Stage 2|Disease Progression|0|||
16960445|NCT00996892|38103401|FG016|Expansion Stage 2|Disease Progression|0|||
16960446|NCT00996892|38103402|FG017|Expansion Stage 2|Disease Progression|0|||
16960447|NCT00996892|38103403|FG018|Expansion Stage 2|Disease Progression|28|||
16960448|NCT00996892|38103404|FG019|Expansion Stage 2|Disease Progression|0|||
16960449|NCT00996892|38103385|FG000|Expansion Stage 2A|Adverse Event|0|||
16960450|NCT00996892|38103386|FG001|Expansion Stage 2A|Adverse Event|0|||
16960451|NCT00996892|38103387|FG002|Expansion Stage 2A|Adverse Event|0|||
16960452|NCT00996892|38103388|FG003|Expansion Stage 2A|Adverse Event|0|||
16960453|NCT00996892|38103389|FG004|Expansion Stage 2A|Adverse Event|0|||
16960454|NCT00996892|38103390|FG005|Expansion Stage 2A|Adverse Event|0|||
16960455|NCT00996892|38103391|FG006|Expansion Stage 2A|Adverse Event|0|||
16960456|NCT00996892|38103392|FG007|Expansion Stage 2A|Adverse Event|0|||
16960457|NCT00996892|38103393|FG008|Expansion Stage 2A|Adverse Event|0|||
16960458|NCT00996892|38103394|FG009|Expansion Stage 2A|Adverse Event|0|||
16960459|NCT00996892|38103395|FG010|Expansion Stage 2A|Adverse Event|0|||
16960460|NCT00996892|38103396|FG011|Expansion Stage 2A|Adverse Event|0|||
16960461|NCT00996892|38103397|FG012|Expansion Stage 2A|Adverse Event|0|||
16960462|NCT00996892|38103398|FG013|Expansion Stage 2A|Adverse Event|0|||
16960463|NCT00996892|38103399|FG014|Expansion Stage 2A|Adverse Event|0|||
16960464|NCT00996892|38103400|FG015|Expansion Stage 2A|Adverse Event|0|||
16960465|NCT00996892|38103401|FG016|Expansion Stage 2A|Adverse Event|0|||
16960466|NCT00996892|38103402|FG017|Expansion Stage 2A|Adverse Event|0|||
16960467|NCT00996892|38103403|FG018|Expansion Stage 2A|Adverse Event|0|||
16960468|NCT00996892|38103404|FG019|Expansion Stage 2A|Adverse Event|8|||
16960469|NCT00996892|38103385|FG000|Expansion Stage 2A|Physician Decision|0|||
16960470|NCT00996892|38103386|FG001|Expansion Stage 2A|Physician Decision|0|||
16960471|NCT00996892|38103387|FG002|Expansion Stage 2A|Physician Decision|0|||
16960472|NCT00996892|38103388|FG003|Expansion Stage 2A|Physician Decision|0|||
16960473|NCT00996892|38103389|FG004|Expansion Stage 2A|Physician Decision|0|||
16960474|NCT00996892|38103390|FG005|Expansion Stage 2A|Physician Decision|0|||
16960475|NCT00996892|38103391|FG006|Expansion Stage 2A|Physician Decision|0|||
16960476|NCT00996892|38103392|FG007|Expansion Stage 2A|Physician Decision|0|||
16960477|NCT00996892|38103393|FG008|Expansion Stage 2A|Physician Decision|0|||
16960478|NCT00996892|38103394|FG009|Expansion Stage 2A|Physician Decision|0|||
16960479|NCT00996892|38103395|FG010|Expansion Stage 2A|Physician Decision|0|||
16960480|NCT00996892|38103396|FG011|Expansion Stage 2A|Physician Decision|0|||
16960481|NCT00996892|38103397|FG012|Expansion Stage 2A|Physician Decision|0|||
16960482|NCT00996892|38103398|FG013|Expansion Stage 2A|Physician Decision|0|||
16960483|NCT00996892|38103399|FG014|Expansion Stage 2A|Physician Decision|0|||
16960484|NCT00996892|38103400|FG015|Expansion Stage 2A|Physician Decision|0|||
16960485|NCT00996892|38103401|FG016|Expansion Stage 2A|Physician Decision|0|||
16960486|NCT00996892|38103402|FG017|Expansion Stage 2A|Physician Decision|0|||
16960487|NCT00996892|38103403|FG018|Expansion Stage 2A|Physician Decision|0|||
16960488|NCT00996892|38103404|FG019|Expansion Stage 2A|Physician Decision|2|||
16960489|NCT00996892|38103385|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
16960490|NCT00996892|38103386|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
16960491|NCT00996892|38103387|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
16960492|NCT00996892|38103388|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
16960493|NCT00996892|38103389|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
16960494|NCT00996892|38103390|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
16960495|NCT00996892|38103391|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
16960496|NCT00996892|38103392|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
16960497|NCT00996892|38103393|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
16960498|NCT00996892|38103394|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
16960499|NCT00996892|38103395|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
16960500|NCT00996892|38103396|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
16960501|NCT00996892|38103397|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
16960502|NCT00996892|38103398|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
16960503|NCT00996892|38103399|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
16960504|NCT00996892|38103400|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
16960505|NCT00996892|38103401|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
16960506|NCT00996892|38103402|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
16960507|NCT00996892|38103403|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
16960508|NCT00996892|38103404|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
16960509|NCT00996892|38103385|FG000|Expansion Stage 2A|Disease Progression|0|||
16960510|NCT00996892|38103386|FG001|Expansion Stage 2A|Disease Progression|0|||
16960511|NCT00996892|38103387|FG002|Expansion Stage 2A|Disease Progression|0|||
16960512|NCT00996892|38103388|FG003|Expansion Stage 2A|Disease Progression|0|||
16960513|NCT00996892|38103389|FG004|Expansion Stage 2A|Disease Progression|0|||
16960514|NCT00996892|38103390|FG005|Expansion Stage 2A|Disease Progression|0|||
16960515|NCT00996892|38103391|FG006|Expansion Stage 2A|Disease Progression|0|||
16960516|NCT00996892|38103392|FG007|Expansion Stage 2A|Disease Progression|0|||
16960517|NCT00996892|38103393|FG008|Expansion Stage 2A|Disease Progression|0|||
16960518|NCT00996892|38103394|FG009|Expansion Stage 2A|Disease Progression|0|||
16960519|NCT00996892|38103395|FG010|Expansion Stage 2A|Disease Progression|0|||
16960520|NCT00996892|38103396|FG011|Expansion Stage 2A|Disease Progression|0|||
16960521|NCT00996892|38103397|FG012|Expansion Stage 2A|Disease Progression|0|||
16960522|NCT00996892|38103398|FG013|Expansion Stage 2A|Disease Progression|0|||
16960523|NCT00996892|38103399|FG014|Expansion Stage 2A|Disease Progression|0|||
16960524|NCT00996892|38103400|FG015|Expansion Stage 2A|Disease Progression|0|||
16960525|NCT00996892|38103401|FG016|Expansion Stage 2A|Disease Progression|0|||
16960526|NCT00996892|38103402|FG017|Expansion Stage 2A|Disease Progression|0|||
16960527|NCT00996892|38103403|FG018|Expansion Stage 2A|Disease Progression|0|||
16960528|NCT00996892|38103404|FG019|Expansion Stage 2A|Disease Progression|31|||
16960529|NCT01257581|38103468|FG000|Overall Study|Early Termination|3|||
16960530|NCT01257581|38103469|FG001|Overall Study|Early Termination|1|||
16960531|NCT01257581|38103470|FG002|Overall Study|Early Termination|2|||
16960532|NCT01257581|38103468|FG000|Overall Study|Death|2|||
16960533|NCT01257581|38103469|FG001|Overall Study|Death|2|||
16960534|NCT01257581|38103470|FG002|Overall Study|Death|4|||
16960535|NCT01257503|38103480|FG000|Overall Study|Lost to Follow-up|7|||
16960536|NCT01257503|38103481|FG001|Overall Study|Lost to Follow-up|10|||
16960537|NCT01257503|38103480|FG000|Overall Study|Over 5 years old at enrollment|0|||
16960538|NCT01257503|38103481|FG001|Overall Study|Over 5 years old at enrollment|1|||
16960539|NCT01257503|38103480|FG000|Overall Study|strep culture positive at enrollment|1|||
16960540|NCT01257503|38103481|FG001|Overall Study|strep culture positive at enrollment|0|||
16960541|NCT00995566|38103487|FG000|Overall Study|Adverse Event|2|||
16960542|NCT00995566|38103487|FG000|Overall Study|Early study termination|52|||
16960543|NCT01257425|38103493|FG000|Overall Study|Lack of Efficacy|3|||
16960544|NCT01257425|38103494|FG001|Overall Study|Lack of Efficacy|3|||
16960545|NCT01257425|38103493|FG000|Overall Study|Adverse Event|1|||
16960546|NCT01257425|38103494|FG001|Overall Study|Adverse Event|1|||
16960547|NCT01257425|38103493|FG000|Overall Study|Protocol Violation|1|||
16960548|NCT01257425|38103494|FG001|Overall Study|Protocol Violation|1|||
16960549|NCT01257425|38103493|FG000|Overall Study|Withdrawal by Subject|0|||
16960550|NCT01257425|38103494|FG001|Overall Study|Withdrawal by Subject|1|||
16960551|NCT01257425|38103493|FG000|Overall Study|Death|1|||
16960552|NCT01257425|38103494|FG001|Overall Study|Death|0|||
16960553|NCT00995488|38103500|FG000|Overall Study|Withdrawal by Subject|1|||
16960554|NCT01256879|38103504|FG000|Overall Study|Withdrawal by Subject|1|||
16960555|NCT01125189|38103517|FG000|Treatment Period|Lack of Efficacy|15|||
16960556|NCT01125189|38103518|FG001|Treatment Period|Lack of Efficacy|18|||
16960557|NCT01125189|38103519|FG002|Treatment Period|Lack of Efficacy|25|||
16960558|NCT01125189|38103517|FG000|Treatment Period|Adverse Event|7|||
16960559|NCT01125189|38103518|FG001|Treatment Period|Adverse Event|8|||
16960560|NCT01125189|38103519|FG002|Treatment Period|Adverse Event|8|||
16960561|NCT01125189|38103517|FG000|Treatment Period|Withdrawal by Subject|3|||
16960562|NCT01125189|38103518|FG001|Treatment Period|Withdrawal by Subject|1|||
16960563|NCT01125189|38103519|FG002|Treatment Period|Withdrawal by Subject|1|||
16960564|NCT01125189|38103517|FG000|Treatment Period|Death|1|||
16960565|NCT01125189|38103518|FG001|Treatment Period|Death|0|||
16960566|NCT01125189|38103519|FG002|Treatment Period|Death|0|||
16960567|NCT01125189|38103517|FG000|Treatment Period|Lost to Follow-up|1|||
16960568|NCT01125189|38103518|FG001|Treatment Period|Lost to Follow-up|2|||
16960569|NCT01125189|38103519|FG002|Treatment Period|Lost to Follow-up|1|||
16960570|NCT01125189|38103517|FG000|Treatment Period|Poor compliance/noncompliance|0|||
16960571|NCT01125189|38103518|FG001|Treatment Period|Poor compliance/noncompliance|1|||
16960572|NCT01125189|38103519|FG002|Treatment Period|Poor compliance/noncompliance|0|||
16960573|NCT01125189|38103517|FG000|Treatment Period|Participants requested to discontinue|1|||
16960574|NCT01125189|38103518|FG001|Treatment Period|Participants requested to discontinue|3|||
16960575|NCT01125189|38103519|FG002|Treatment Period|Participants requested to discontinue|4|||
16960576|NCT01125189|38103517|FG000|Treatment Period|Other reasons|1|||
16960577|NCT01125189|38103518|FG001|Treatment Period|Other reasons|1|||
16960578|NCT01125189|38103519|FG002|Treatment Period|Other reasons|0|||
16960579|NCT01125189|38103517|FG000|Treatment Period|Completed 24 week treatment period only|2|||
16960580|NCT01125189|38103518|FG001|Treatment Period|Completed 24 week treatment period only|1|||
16960581|NCT01125189|38103519|FG002|Treatment Period|Completed 24 week treatment period only|2|||
16960582|NCT01125189|38103517|FG000|Follow up Period|Withdrawal by Subject|3|||
16960583|NCT01125189|38103518|FG001|Follow up Period|Withdrawal by Subject|2|||
16960584|NCT01125189|38103519|FG002|Follow up Period|Withdrawal by Subject|5|||
16960585|NCT01125189|38103517|FG000|Follow up Period|Death|1|||
16960586|NCT01125189|38103518|FG001|Follow up Period|Death|0|||
16960587|NCT01125189|38103519|FG002|Follow up Period|Death|0|||
16960588|NCT01125189|38103517|FG000|Follow up Period|Lost to Follow-up|12|||
16960589|NCT01125189|38103518|FG001|Follow up Period|Lost to Follow-up|9|||
16960590|NCT01125189|38103519|FG002|Follow up Period|Lost to Follow-up|6|||
16960591|NCT01125189|38103517|FG000|Follow up Period|Other reasons|4|||
16960592|NCT01125189|38103518|FG001|Follow up Period|Other reasons|4|||
16960593|NCT01125189|38103519|FG002|Follow up Period|Other reasons|5|||
16960594|NCT01256567|38103530|FG000|Overall Study|Withdrawal by Subject|1|||
16960595|NCT00996736|38103537|FG000|Overall Study|Death|1|||
16960596|NCT00996736|38103538|FG001|Overall Study|Death|1|||
16960597|NCT00996736|38103537|FG000|Overall Study|Lost to Follow-up|15|||
16960598|NCT00996736|38103538|FG001|Overall Study|Lost to Follow-up|14|||
16960599|NCT00996736|38103537|FG000|Overall Study|Visit not within 3-month window|5|||
16960600|NCT00996736|38103538|FG001|Overall Study|Visit not within 3-month window|3|||
16960601|NCT00996658|38103546|FG000|Overall Study|Adverse Event|2|||
16960602|NCT00996658|38103547|FG001|Overall Study|Adverse Event|5|||
16960603|NCT00996658|38103546|FG000|Overall Study|Protocol Violation|0|||
16960604|NCT00996658|38103547|FG001|Overall Study|Protocol Violation|1|||
16960605|NCT00996658|38103546|FG000|Overall Study|Lost to Follow-up|2|||
16960606|NCT00996658|38103547|FG001|Overall Study|Lost to Follow-up|5|||
16960607|NCT00996658|38103546|FG000|Overall Study|Non-compliance issues|3|||
16960608|NCT00996658|38103547|FG001|Overall Study|Non-compliance issues|3|||
16960609|NCT00996658|38103546|FG000|Overall Study|Other|9|||
16960610|NCT00996658|38103547|FG001|Overall Study|Other|7|||
16960611|NCT01124643|38103553|FG000|Overall Study|Death|1|||
16960612|NCT01256411|38103561|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
16960613|NCT01256411|38103562|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
16960614|NCT01256411|38103563|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
16960615|NCT01256411|38103564|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
16960616|NCT01256411|38103565|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
16960617|NCT01256411|38103566|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
16960618|NCT01256411|38103561|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
16960619|NCT01256411|38103562|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
16960620|NCT01256411|38103563|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
16960621|NCT01256411|38103564|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
16960622|NCT01256411|38103565|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
16960623|NCT01256411|38103566|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
16960624|NCT01256411|38103561|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
16960625|NCT01256411|38103562|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
16960626|NCT01256411|38103563|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
16960627|NCT01256411|38103564|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
16960628|NCT01256411|38103565|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
16960629|NCT01256411|38103566|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
16960630|NCT01256411|38103561|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
16960631|NCT01256411|38103562|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
16960632|NCT01256411|38103563|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
16960633|NCT01256411|38103564|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
16960634|NCT01256411|38103565|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
16960635|NCT01256411|38103566|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
16960636|NCT01256411|38103561|FG000|Extension by Maximum Treatment|Adverse Event|4|||
16960637|NCT01256411|38103562|FG001|Extension by Maximum Treatment|Adverse Event|2|||
16960638|NCT01256411|38103563|FG002|Extension by Maximum Treatment|Adverse Event|1|||
16960639|NCT01256411|38103564|FG003|Extension by Maximum Treatment|Adverse Event|0|||
16960640|NCT01256411|38103565|FG004|Extension by Maximum Treatment|Adverse Event|0|||
16960641|NCT01256411|38103566|FG005|Extension by Maximum Treatment|Adverse Event|0|||
16960642|NCT01256411|38103561|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
16960643|NCT01256411|38103562|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
16960644|NCT01256411|38103563|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
16960645|NCT01256411|38103564|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
16960646|NCT01256411|38103565|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
16776449|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
16776450|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
16776451|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
16776452|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
16776453|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
16960647|NCT01256411|38103566|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
16960648|NCT01256411|38103561|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16960649|NCT01256411|38103562|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16960650|NCT01256411|38103563|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16960651|NCT01256411|38103564|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16960652|NCT01256411|38103565|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16960653|NCT01256411|38103566|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
16960654|NCT01256411|38103561|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16960655|NCT01256411|38103562|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16960656|NCT01256411|38103563|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16960657|NCT01256411|38103564|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16960658|NCT01256411|38103565|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
16960659|NCT01256411|38103566|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16960660|NCT01256411|38103561|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
16960661|NCT01256411|38103562|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
16960662|NCT01256411|38103563|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
16960663|NCT01256411|38103564|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
16960664|NCT01256411|38103565|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
16960665|NCT01256411|38103566|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
16960666|NCT01256411|38103561|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
16960667|NCT01256411|38103562|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
16960668|NCT01256411|38103563|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
16960669|NCT01256411|38103564|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
16960670|NCT01256411|38103565|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
16960671|NCT01256411|38103566|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
16960672|NCT00996580|38103580|FG000|Overall Study|Adverse Event|466|||
16960673|NCT00996580|38103580|FG000|Overall Study|Lost to Follow-up|480|||
16960674|NCT00996580|38103580|FG000|Overall Study|Noncompliance with the protocol|137|||
16960675|NCT00996580|38103580|FG000|Overall Study|Physician Decision|5|||
16960676|NCT00996580|38103580|FG000|Overall Study|Pregnancy|68|||
16960677|NCT00996580|38103580|FG000|Overall Study|Protocol Violation|16|||
16960678|NCT00996580|38103580|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
16960679|NCT00996580|38103580|FG000|Overall Study|Withdrawal by Subject|217|||
16960680|NCT00996580|38103580|FG000|Overall Study|Other|29|||
16960681|NCT01124175|38103589|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
16960682|NCT01124175|38103590|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
16960683|NCT01256177|38103598|FG000|Overall Study|Withdrawal by Subject|23|||
16960684|NCT01256177|38103599|FG001|Overall Study|Withdrawal by Subject|22|||
16960685|NCT01256177|38103598|FG000|Overall Study|Lost to Follow-up|2|||
16960686|NCT01256177|38103599|FG001|Overall Study|Lost to Follow-up|2|||
16960687|NCT01256177|38103598|FG000|Overall Study|Adverse Event|8|||
16960688|NCT01256177|38103599|FG001|Overall Study|Adverse Event|9|||
16960689|NCT01256177|38103598|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
16960690|NCT01256177|38103599|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
16960691|NCT01256177|38103598|FG000|Overall Study|Condition under Investigation Worsened|1|||
16960692|NCT01256177|38103599|FG001|Overall Study|Condition under Investigation Worsened|0|||
16960693|NCT01256177|38103598|FG000|Overall Study|Lack of Efficacy|11|||
16960694|NCT01256177|38103599|FG001|Overall Study|Lack of Efficacy|2|||
16960695|NCT01256177|38103598|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
16960696|NCT01256177|38103599|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
16960697|NCT00999544|38103605|FG000|Overall Study|Withdrawal by Subject|1|||
16960698|NCT01124097|38103642|FG000|Overall Study|Withdrawal by Subject|4|||
16960699|NCT01124097|38103643|FG001|Overall Study|Withdrawal by Subject|3|||
16960700|NCT01124097|38103644|FG002|Overall Study|Withdrawal by Subject|2|||
16960701|NCT01124097|38103645|FG003|Overall Study|Withdrawal by Subject|3|||
16960702|NCT01124097|38103642|FG000|Overall Study|Lack of Efficacy|2|||
16960703|NCT01124097|38103643|FG001|Overall Study|Lack of Efficacy|3|||
16960704|NCT01124097|38103644|FG002|Overall Study|Lack of Efficacy|1|||
16960705|NCT01124097|38103645|FG003|Overall Study|Lack of Efficacy|3|||
16960706|NCT01124097|38103642|FG000|Overall Study|Adverse Event|24|||
16960707|NCT01124097|38103643|FG001|Overall Study|Adverse Event|15|||
16960708|NCT01124097|38103644|FG002|Overall Study|Adverse Event|15|||
16960709|NCT01124097|38103645|FG003|Overall Study|Adverse Event|7|||
16960710|NCT01124097|38103642|FG000|Overall Study|Protocol Violation|2|||
16960711|NCT01124097|38103643|FG001|Overall Study|Protocol Violation|0|||
17133934|NCT00065429|38275191|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
17133935|NCT00065429|38275192|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
16960712|NCT01124097|38103644|FG002|Overall Study|Protocol Violation|2|||
16960713|NCT01124097|38103645|FG003|Overall Study|Protocol Violation|1|||
16960714|NCT01124097|38103642|FG000|Overall Study|Physician Decision|2|||
16960715|NCT01124097|38103643|FG001|Overall Study|Physician Decision|1|||
16960716|NCT01124097|38103644|FG002|Overall Study|Physician Decision|0|||
16960717|NCT01124097|38103645|FG003|Overall Study|Physician Decision|0|||
16960718|NCT01123941|38103657|FG000|Overall Study|Lost to Follow-up|2|||
16960719|NCT01123941|38103658|FG001|Overall Study|Lost to Follow-up|1|||
16960720|NCT01123395|38103664|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
16960721|NCT01123395|38103665|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
16960722|NCT01255787|38103675|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
16960723|NCT01255787|38103676|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
16960724|NCT01255787|38103677|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
16960725|NCT01255787|38103678|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
16960726|NCT01255787|38103675|FG000|Overall Study|Major Protocol Deviation|1|||
16960727|NCT01255787|38103676|FG001|Overall Study|Major Protocol Deviation|1|||
16960728|NCT01255787|38103677|FG002|Overall Study|Major Protocol Deviation|0|||
16960729|NCT01255787|38103678|FG003|Overall Study|Major Protocol Deviation|4|||
16960730|NCT01255787|38103675|FG000|Overall Study|Lost to Follow-up|1|||
16960731|NCT01255787|38103676|FG001|Overall Study|Lost to Follow-up|2|||
16960732|NCT01255787|38103677|FG002|Overall Study|Lost to Follow-up|4|||
16960733|NCT01255787|38103678|FG003|Overall Study|Lost to Follow-up|2|||
16960734|NCT01255787|38103675|FG000|Overall Study|Withdrawal of Consent|3|||
16960735|NCT01255787|38103676|FG001|Overall Study|Withdrawal of Consent|9|||
16960736|NCT01255787|38103677|FG002|Overall Study|Withdrawal of Consent|3|||
16960737|NCT01255787|38103678|FG003|Overall Study|Withdrawal of Consent|4|||
16960738|NCT01255787|38103675|FG000|Overall Study|Pregnancy|0|||
16960739|NCT01255787|38103676|FG001|Overall Study|Pregnancy|0|||
16960740|NCT01255787|38103677|FG002|Overall Study|Pregnancy|0|||
16960741|NCT01255787|38103678|FG003|Overall Study|Pregnancy|1|||
16960742|NCT01255787|38103675|FG000|Overall Study|Lack of Efficacy|2|||
16960743|NCT01255787|38103676|FG001|Overall Study|Lack of Efficacy|2|||
16960744|NCT01255787|38103677|FG002|Overall Study|Lack of Efficacy|2|||
16960745|NCT01255787|38103678|FG003|Overall Study|Lack of Efficacy|2|||
16960746|NCT01255787|38103675|FG000|Overall Study|Noncompliance with Study Drug|3|||
16960747|NCT01255787|38103676|FG001|Overall Study|Noncompliance with Study Drug|1|||
16960748|NCT01255787|38103677|FG002|Overall Study|Noncompliance with Study Drug|0|||
16960749|NCT01255787|38103678|FG003|Overall Study|Noncompliance with Study Drug|0|||
16960750|NCT01123161|38103690|FG000|Overall Study|Lost to Follow-up|1|||
16960751|NCT01123161|38103691|FG001|Overall Study|Lost to Follow-up|0|||
16960752|NCT01123161|38103690|FG000|Overall Study|Withdrawal by Subject|1|||
16960753|NCT01123161|38103691|FG001|Overall Study|Withdrawal by Subject|0|||
16960754|NCT01255631|38103702|FG000|Overall Study|poor enrollment, no data analyzed|9|||
16960755|NCT01255631|38103703|FG001|Overall Study|poor enrollment, no data analyzed|6|||
16960756|NCT00999466|38103712|FG000|Main Part|Withdrawal by Subject|0|||
16960757|NCT00999466|38103713|FG001|Main Part|Withdrawal by Subject|0|||
16960758|NCT00999466|38103714|FG002|Main Part|Withdrawal by Subject|2|||
16960759|NCT00999466|38103712|FG000|Main Part|Adverse Event|0|||
16960760|NCT00999466|38103713|FG001|Main Part|Adverse Event|4|||
16960761|NCT00999466|38103714|FG002|Main Part|Adverse Event|2|||
16960762|NCT01255163|38103724|FG000|Overall Study|Withdrawal by Subject|1|||
16960763|NCT01255163|38103725|FG001|Overall Study|Withdrawal by Subject|0|||
16960764|NCT01255163|38103724|FG000|Overall Study|Lost to Follow-up|2|||
16960765|NCT01255163|38103725|FG001|Overall Study|Lost to Follow-up|0|||
16960766|NCT01255163|38103724|FG000|Overall Study|Adverse Event|0|||
16960767|NCT01255163|38103725|FG001|Overall Study|Adverse Event|2|||
16960768|NCT01255163|38103724|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
16960769|NCT01255163|38103725|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
16960770|NCT01123083|38103735|FG000|Overall Study|Investigator recommendation|1|||
16960771|NCT01123083|38103736|FG001|Overall Study|Investigator recommendation|1|||
16960772|NCT01123083|38103735|FG000|Overall Study|Administrative reasons|0|||
16960773|NCT01123083|38103736|FG001|Overall Study|Administrative reasons|4|||
16960774|NCT01123083|38103735|FG000|Overall Study|Lost to Follow-up|2|||
16960775|NCT01123083|38103736|FG001|Overall Study|Lost to Follow-up|6|||
16960776|NCT01123083|38103735|FG000|Overall Study|Adverse Event|1|||
16960777|NCT01123083|38103736|FG001|Overall Study|Adverse Event|0|||
16960778|NCT01123083|38103735|FG000|Overall Study|Withdrew for another reason not covered|0|||
16960779|NCT01123083|38103736|FG001|Overall Study|Withdrew for another reason not covered|1|||
16960780|NCT01123083|38103735|FG000|Overall Study|Participant/legal representative request|7|||
16960781|NCT01123083|38103736|FG001|Overall Study|Participant/legal representative request|3|||
16960782|NCT01254305|38103745|FG000|Overall Study|Adverse Event|6|||
16960783|NCT01254305|38103746|FG001|Overall Study|Adverse Event|3|||
16960784|NCT01254305|38103747|FG002|Overall Study|Adverse Event|2|||
16867974|NCT01563913|37841002|FG001|Overall Study|Physician Decision|0|||
16960785|NCT01254305|38103745|FG000|Overall Study|Lack of Efficacy|1|||
16960786|NCT01254305|38103746|FG001|Overall Study|Lack of Efficacy|0|||
16960787|NCT01254305|38103747|FG002|Overall Study|Lack of Efficacy|1|||
16776454|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
16960788|NCT01254305|38103745|FG000|Overall Study|Protocol Violation|1|||
16960789|NCT01254305|38103746|FG001|Overall Study|Protocol Violation|7|||
16960790|NCT01254305|38103747|FG002|Overall Study|Protocol Violation|3|||
16960791|NCT01254305|38103745|FG000|Overall Study|Withdrawal by Subject|4|||
16960792|NCT01254305|38103746|FG001|Overall Study|Withdrawal by Subject|2|||
16960793|NCT01254305|38103747|FG002|Overall Study|Withdrawal by Subject|4|||
16960794|NCT01254305|38103745|FG000|Overall Study|Lost to Follow-up|10|||
16960795|NCT01254305|38103746|FG001|Overall Study|Lost to Follow-up|6|||
16960796|NCT01254305|38103747|FG002|Overall Study|Lost to Follow-up|5|||
16960797|NCT01254305|38103745|FG000|Overall Study|Other Reasons|0|||
16960798|NCT01254305|38103746|FG001|Overall Study|Other Reasons|0|||
16960799|NCT01254305|38103747|FG002|Overall Study|Other Reasons|2|||
16960800|NCT01122927|38103758|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
16960801|NCT01122927|38103759|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
16960802|NCT01122927|38103758|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
16960803|NCT01122927|38103759|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
16960804|NCT01122927|38103758|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
16960805|NCT01122927|38103759|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
16960806|NCT01122927|38103758|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
16960807|NCT01122927|38103759|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
16960808|NCT01122927|38103758|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
16960809|NCT01122927|38103759|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
16960810|NCT01122927|38103758|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
16960811|NCT01122927|38103759|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
16960812|NCT01122927|38103758|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
16960813|NCT01122927|38103759|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
16960814|NCT01122927|38103758|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
16960815|NCT01122927|38103759|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
16960816|NCT01122927|38103758|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
16960817|NCT01122927|38103759|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
16960818|NCT01122927|38103758|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
16960819|NCT01122927|38103759|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
16960820|NCT01122927|38103758|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
16960821|NCT01122927|38103759|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
16960822|NCT01122927|38103758|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
16960823|NCT01122927|38103759|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
16776455|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
16776456|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
16776457|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
16776458|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
16776459|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
16776460|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
16776461|NCT03420781|37715870|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
16776462|NCT03420781|37715871|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
16776463|NCT03420781|37715872|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
16960824|NCT01254227|38103769|FG000|Overall Study|Withdrawal by Subject|6|||
16960825|NCT01254227|38103769|FG000|Overall Study|Lost to Follow-up|6|||
16960826|NCT01254227|38103769|FG000|Overall Study|Adverse Event|5|||
16960827|NCT01254227|38103769|FG000|Overall Study|Abnormal test procedure result|5|||
16960828|NCT01254227|38103769|FG000|Overall Study|Administrative problems|2|||
16960829|NCT01254227|38103769|FG000|Overall Study|Death|1|||
16960830|NCT01254227|38103769|FG000|Overall Study|Protocol deviation|1|||
16960831|NCT00995410|38103773|FG000|Overall Study|Adverse Event|51|||
16960832|NCT00995410|38103773|FG000|Overall Study|Withdrawal by Subject|7|||
16960833|NCT00995410|38103773|FG000|Overall Study|Lost to Follow-up|2|||
16960834|NCT00995410|38103773|FG000|Overall Study|Misc|28|||
16960835|NCT00995020|38103779|FG000|Overall Study|margin analysis not performed|2|||
16960836|NCT00995020|38103780|FG001|Overall Study|margin analysis not performed|5|||
16960837|NCT00995020|38103779|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
16960838|NCT00995020|38103780|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
16960839|NCT01122381|38103790|FG000|Overall Study|study terminated early|0|||
16960840|NCT01122381|38103791|FG001|Overall Study|study terminated early|1|||
16960841|NCT00996034|38103797|FG000|Overall Study|Lost to Follow-up|2|||
16776464|NCT03420781|37715873|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
16776465|NCT03420781|37715874|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
16776466|NCT03420781|37715870|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
16776467|NCT03420781|37715871|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
16776468|NCT03420781|37715872|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
16776469|NCT03420781|37715873|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
16960842|NCT00996034|38103797|FG000|Overall Study|withdrawn by PI|1|||
16960843|NCT01253447|38103801|FG000|Overall Study|Adverse Event|2|||
16960844|NCT01121991|38103806|FG000|Overall Study|Lack of Ovarian Response|2|||
16960845|NCT01121991|38103806|FG000|Overall Study|No Oocytes Retrieved|3|||
16960846|NCT01121991|38103806|FG000|Overall Study|No Fertilization|1|||
16960847|NCT00994240|38103812|FG000|Overall Study|Lost to Follow-up|3|||
16776470|NCT03420781|37715874|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
16776471|NCT03420781|37715870|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
16776472|NCT03420781|37715871|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
16776473|NCT03420781|37715872|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
16960848|NCT00994240|38103813|FG001|Overall Study|Lost to Follow-up|2|||
16960849|NCT00994240|38103812|FG000|Overall Study|Withdrawal by Subject|1|||
16960850|NCT00994240|38103813|FG001|Overall Study|Withdrawal by Subject|0|||
16960851|NCT00994240|38103812|FG000|Overall Study|study termination|2|||
16960852|NCT00994240|38103813|FG001|Overall Study|study termination|3|||
16960853|NCT01253369|38103819|FG000|Overall Study|Adverse Event|4|||
16776474|NCT03420781|37715873|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
16776475|NCT03420781|37715874|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
16960854|NCT01253369|38103819|FG000|Overall Study|Withdrawal by Subject|2|||
16960855|NCT01253369|38103819|FG000|Overall Study|Death|1|||
16960856|NCT01253369|38103819|FG000|Overall Study|Progressive disease|23|||
16960857|NCT01253369|38103819|FG000|Overall Study|Not Evaluable|3|||
16960858|NCT01121913|38103823|FG000|First Intervention Period|Adverse Event|0|||
16776476|NCT03420781|37715870|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
16776477|NCT03420781|37715871|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
16776478|NCT03420781|37715872|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
16776479|NCT03420781|37715873|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
16776480|NCT03420781|37715874|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
16960859|NCT01121913|38103824|FG001|First Intervention Period|Adverse Event|0|||
16960860|NCT01121913|38103825|FG002|First Intervention Period|Adverse Event|1|||
16960861|NCT01121913|38103826|FG003|First Intervention Period|Adverse Event|0|||
16776481|NCT03269695|37715892|FG000|Overall Study|Adverse Event|2|||
16776482|NCT03269695|37715893|FG001|Overall Study|Adverse Event|1|||
16776483|NCT03269695|37715892|FG000|Overall Study|Lack of Efficacy|0|||
16776484|NCT03269695|37715893|FG001|Overall Study|Lack of Efficacy|1|||
16776485|NCT03269695|37715892|FG000|Overall Study|Withdrawal by Subject|0|||
16776486|NCT03269695|37715893|FG001|Overall Study|Withdrawal by Subject|1|||
16776487|NCT02766335|37715902|FG000|Initial Registration|Adverse Event|6|||
16776488|NCT02766335|37715903|FG001|Initial Registration|Adverse Event|3|||
16776489|NCT02766335|37715904|FG002|Initial Registration|Adverse Event|0|||
16776490|NCT02766335|37715902|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
16776491|NCT02766335|37715903|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
16960862|NCT01121913|38103823|FG000|First Washout Period|Withdrawal by Subject|1|||
16960863|NCT01121913|38103824|FG001|First Washout Period|Withdrawal by Subject|0|||
16960864|NCT01121913|38103825|FG002|First Washout Period|Withdrawal by Subject|0|||
16960865|NCT01121913|38103826|FG003|First Washout Period|Withdrawal by Subject|0|||
16960866|NCT01121913|38103823|FG000|Second Intervention Period|Adverse Event|0|||
16960867|NCT01121913|38103824|FG001|Second Intervention Period|Adverse Event|0|||
16960868|NCT01121913|38103825|FG002|Second Intervention Period|Adverse Event|1|||
16960869|NCT01121913|38103826|FG003|Second Intervention Period|Adverse Event|0|||
16960870|NCT01121913|38103823|FG000|Second Washout Period|Withdrawal by Subject|0|||
16960871|NCT01121913|38103824|FG001|Second Washout Period|Withdrawal by Subject|0|||
16960872|NCT01121913|38103825|FG002|Second Washout Period|Withdrawal by Subject|1|||
16960873|NCT01121913|38103826|FG003|Second Washout Period|Withdrawal by Subject|0|||
16960874|NCT01121913|38103823|FG000|Third Washout Period|Adverse Event|1|||
16960875|NCT01121913|38103824|FG001|Third Washout Period|Adverse Event|0|||
16960876|NCT01121913|38103825|FG002|Third Washout Period|Adverse Event|0|||
16960877|NCT01121913|38103826|FG003|Third Washout Period|Adverse Event|0|||
16960878|NCT00994162|38103838|FG000|Overall Study|Withdrawal by Subject|1|||
16960879|NCT00994162|38103838|FG000|Overall Study|Lost to Follow-up|2|||
16960880|NCT00994162|38103838|FG000|Overall Study|Product Complaint|1|||
16960881|NCT00994162|38103838|FG000|Overall Study|Poor Compliance|5|||
16960882|NCT00994162|38103838|FG000|Overall Study|Lack of Response|3|||
16960883|NCT00994162|38103838|FG000|Overall Study|Discharged from Hospital|4|||
16960884|NCT00994162|38103838|FG000|Overall Study|Death|2|||
16960885|NCT00994162|38103838|FG000|Overall Study|Care Transferred to Another Physician|2|||
16960886|NCT00994162|38103838|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
16960887|NCT00994162|38103838|FG000|Overall Study|Physician Decision|2|||
16960888|NCT00994162|38103838|FG000|Overall Study|Surrounding Wound Erythematous|1|||
16960889|NCT00994162|38103838|FG000|Overall Study|Machine Losing Vaccum|1|||
16960890|NCT00994162|38103838|FG000|Overall Study|Patient Lived Too Far Away|1|||
16960891|NCT00994162|38103838|FG000|Overall Study|Above Knee Amputation|1|||
16960892|NCT00994162|38103838|FG000|Overall Study|Reason Not Reported By Site|1|||
16960893|NCT00993928|38103845|FG000|Overall Study|Withdrawal by Subject|4|||
16960894|NCT00993928|38103846|FG001|Overall Study|Withdrawal by Subject|7|||
16960895|NCT00993928|38103845|FG000|Overall Study|ineligible|1|||
16960896|NCT00993928|38103846|FG001|Overall Study|ineligible|0|||
16960897|NCT01253291|38103861|FG000|Overall Study|Withdrawal by Subject|1|||
16960898|NCT01253291|38103862|FG001|Overall Study|Withdrawal by Subject|1|||
16960899|NCT01253291|38103863|FG002|Overall Study|Withdrawal by Subject|0|||
16960900|NCT01253291|38103864|FG003|Overall Study|Withdrawal by Subject|0|||
16960901|NCT01253291|38103865|FG004|Overall Study|Withdrawal by Subject|0|||
16960902|NCT01253291|38103861|FG000|Overall Study|Adverse Event|0|||
16960903|NCT01253291|38103862|FG001|Overall Study|Adverse Event|1|||
16960904|NCT01253291|38103863|FG002|Overall Study|Adverse Event|0|||
16960905|NCT01253291|38103864|FG003|Overall Study|Adverse Event|0|||
16960906|NCT01253291|38103865|FG004|Overall Study|Adverse Event|0|||
16960907|NCT01253291|38103861|FG000|Overall Study|Lack of Efficacy|1|||
16960908|NCT01253291|38103862|FG001|Overall Study|Lack of Efficacy|0|||
16960909|NCT01253291|38103863|FG002|Overall Study|Lack of Efficacy|0|||
16960910|NCT01253291|38103864|FG003|Overall Study|Lack of Efficacy|0|||
16776492|NCT02766335|37715904|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
16960911|NCT01253291|38103865|FG004|Overall Study|Lack of Efficacy|0|||
16960912|NCT01253291|38103861|FG000|Overall Study|Physician Decision|2|||
16960913|NCT01253291|38103862|FG001|Overall Study|Physician Decision|0|||
16960914|NCT01253291|38103863|FG002|Overall Study|Physician Decision|0|||
16960915|NCT01253291|38103864|FG003|Overall Study|Physician Decision|0|||
16960916|NCT01253291|38103865|FG004|Overall Study|Physician Decision|2|||
16960917|NCT01121757|38103880|FG000|First Drug|Death|1|||
16960918|NCT01121757|38103881|FG001|First Drug|Death|0|||
16960919|NCT01121757|38103880|FG000|First Drug|Disease Progression|0|||
16960920|NCT01121757|38103881|FG001|First Drug|Disease Progression|2|||
16960921|NCT01121757|38103880|FG000|Combination|Physician Decision|0|||
16960922|NCT01121757|38103881|FG001|Combination|Physician Decision|1|||
16776493|NCT02766335|37715902|FG000|Initial Registration|Progression/relapse|49|||
16776494|NCT02766335|37715903|FG001|Initial Registration|Progression/relapse|15|||
16776495|NCT02766335|37715904|FG002|Initial Registration|Progression/relapse|0|||
16960923|NCT01121757|38103880|FG000|Combination|Disease Progression|2|||
16960924|NCT01121757|38103881|FG001|Combination|Disease Progression|0|||
16960925|NCT01253135|38103889|FG000|Original Protocol|Protocol Amendment|15|||
16960926|NCT01253135|38103889|FG000|Amended Protocol|Non-compliance|1|||
16960927|NCT00993616|38103897|FG000|Overall Study|No tumor at entry|1|||
16960928|NCT00993616|38103897|FG000|Overall Study|Never treated|1|||
16960929|NCT01120899|38103907|FG000|Overall Study|Withdrawal by Subject|3|||
16960930|NCT01120275|38103911|FG000|Overall Study|Adverse Event|3|||
16960931|NCT01120275|38103911|FG000|Overall Study|Progression|27|||
16960932|NCT01120275|38103911|FG000|Overall Study|Ineligible|3|||
16960933|NCT01120275|38103911|FG000|Overall Study|Withdrawal by Subject|1|||
16960934|NCT01120275|38103911|FG000|Overall Study|Refusal|1|||
16960935|NCT01120275|38103911|FG000|Overall Study|Not specific|1|||
16960936|NCT00991510|38103918|FG000|Period I (Days 1-14)|Adverse Event|1|||
16960937|NCT00991510|38103919|FG001|Period I (Days 1-14)|Adverse Event|0|||
16960938|NCT00991510|38103918|FG000|Period III (Days 29-112)|Adverse Event|1|||
16960939|NCT00991510|38103919|FG001|Period III (Days 29-112)|Adverse Event|1|||
16960940|NCT01119963|38103931|FG000|Overall Study|Lost to Follow-up|1|||
16960941|NCT01119963|38103932|FG001|Overall Study|Lost to Follow-up|1|||
16960942|NCT01252667|38103946|FG000|Overall Study|Transplant aborted post-conditioning|0|||
16960943|NCT01252667|38103947|FG001|Overall Study|Transplant aborted post-conditioning|0|||
16960944|NCT01252667|38103948|FG002|Overall Study|Transplant aborted post-conditioning|0|||
16960945|NCT01252667|38103949|FG003|Overall Study|Transplant aborted post-conditioning|0|||
16960946|NCT01252667|38103950|FG004|Overall Study|Transplant aborted post-conditioning|0|||
16960947|NCT01252667|38103951|FG005|Overall Study|Transplant aborted post-conditioning|1|||
16960948|NCT01119105|38103968|FG000|Overall Study|Withdrawal by Subject|1|||
16960949|NCT01119105|38103969|FG001|Overall Study|Withdrawal by Subject|1|||
16960950|NCT01119105|38103970|FG002|Overall Study|Withdrawal by Subject|1|||
16960951|NCT01119105|38103968|FG000|Overall Study|Lost to Follow-up|0|||
16960952|NCT01119105|38103969|FG001|Overall Study|Lost to Follow-up|2|||
16960953|NCT01119105|38103970|FG002|Overall Study|Lost to Follow-up|5|||
16960954|NCT01119105|38103968|FG000|Overall Study|Adverse Event|1|||
16960955|NCT01119105|38103969|FG001|Overall Study|Adverse Event|0|||
16960956|NCT01119105|38103970|FG002|Overall Study|Adverse Event|1|||
16960957|NCT01119105|38103968|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
16960958|NCT01119105|38103969|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
16960959|NCT01119105|38103970|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
16960960|NCT01119105|38103968|FG000|Overall Study|Other|1|||
16960961|NCT01119105|38103969|FG001|Overall Study|Other|1|||
16960962|NCT01119105|38103970|FG002|Overall Study|Other|0|||
16960963|NCT01118949|38103978|FG000|Overall Study|Adverse Event|5|||
16960964|NCT01118949|38103978|FG000|Overall Study|Withdrawal by Subject|4|||
16960965|NCT01252355|38103985|FG000|Overall Study|Adverse Event|9|||
16960966|NCT01252355|38103986|FG001|Overall Study|Adverse Event|17|||
16960967|NCT01252355|38103987|FG002|Overall Study|Adverse Event|22|||
16960968|NCT01252355|38103985|FG000|Overall Study|Lack of Efficacy|6|||
16960969|NCT01252355|38103986|FG001|Overall Study|Lack of Efficacy|4|||
16960970|NCT01252355|38103987|FG002|Overall Study|Lack of Efficacy|2|||
16960971|NCT01252355|38103985|FG000|Overall Study|Lost to Follow-up|0|||
16960972|NCT01252355|38103986|FG001|Overall Study|Lost to Follow-up|0|||
16960973|NCT01252355|38103987|FG002|Overall Study|Lost to Follow-up|1|||
16960974|NCT01252355|38103985|FG000|Overall Study|Poor Compliance to Protocol|1|||
16960975|NCT01252355|38103986|FG001|Overall Study|Poor Compliance to Protocol|1|||
16960976|NCT01252355|38103987|FG002|Overall Study|Poor Compliance to Protocol|1|||
16960977|NCT01252355|38103985|FG000|Overall Study|Progressive Disease|2|||
16960978|NCT01252355|38103986|FG001|Overall Study|Progressive Disease|0|||
16960979|NCT01252355|38103987|FG002|Overall Study|Progressive Disease|0|||
16960980|NCT01252355|38103985|FG000|Overall Study|Sponsor Early Termination of Study|149|||
16960981|NCT01252355|38103986|FG001|Overall Study|Sponsor Early Termination of Study|149|||
16960982|NCT01252355|38103987|FG002|Overall Study|Sponsor Early Termination of Study|146|||
16960983|NCT01252355|38103985|FG000|Overall Study|Randomized but not Treated|2|||
16960984|NCT01252355|38103986|FG001|Overall Study|Randomized but not Treated|0|||
16960985|NCT01252355|38103987|FG002|Overall Study|Randomized but not Treated|0|||
16960986|NCT01252355|38103985|FG000|Overall Study|Other Than Above|8|||
16960987|NCT01252355|38103986|FG001|Overall Study|Other Than Above|7|||
16960988|NCT01252355|38103987|FG002|Overall Study|Other Than Above|7|||
16960989|NCT01118325|38103998|FG000|Overall Study|Adverse Event|1|||
16960990|NCT01118325|38103999|FG001|Overall Study|Adverse Event|0|||
16960991|NCT01118325|38104000|FG002|Overall Study|Adverse Event|1|||
16960992|NCT01117857|38104021|FG000|Overall Study|Lost to Follow-up|4|||
16960993|NCT01117857|38104021|FG000|Overall Study|Withdrawal by Subject|4|||
16960994|NCT01117857|38104021|FG000|Overall Study|Physician Decision|1|||
16960995|NCT01251965|38104028|FG000|Overall Study|Participant/physician decision|1|||
16776496|NCT02766335|37715902|FG000|Initial Registration|Death|1|||
16776497|NCT02766335|37715903|FG001|Initial Registration|Death|3|||
16960996|NCT01251965|38104029|FG001|Overall Study|Participant/physician decision|2|||
16960997|NCT01251965|38104030|FG002|Overall Study|Participant/physician decision|0|||
16776498|NCT02766335|37715904|FG002|Initial Registration|Death|0|||
16776499|NCT02766335|37715902|FG000|Initial Registration|not protocol specified|1|||
16776500|NCT02766335|37715903|FG001|Initial Registration|not protocol specified|9|||
16776501|NCT02766335|37715904|FG002|Initial Registration|not protocol specified|0|||
16776502|NCT02766335|37715902|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
16867975|NCT01563913|37841001|FG000|Overall Study|Spouse Passed Away|1|||
16960998|NCT01251965|38104028|FG000|Overall Study|Death|0|||
16960999|NCT01251965|38104029|FG001|Overall Study|Death|0|||
16961000|NCT01251965|38104030|FG002|Overall Study|Death|11|||
16961001|NCT01251887|38104042|FG000|Overall Study|Scheduling conflict|1|||
16961002|NCT01251887|38104043|FG001|Overall Study|Scheduling conflict|2|||
16961003|NCT01251887|38104044|FG002|Overall Study|Scheduling conflict|2|||
16961004|NCT01251887|38104042|FG000|Overall Study|Physician Decision|0|||
16961005|NCT01251887|38104043|FG001|Overall Study|Physician Decision|1|||
16961006|NCT01251887|38104044|FG002|Overall Study|Physician Decision|0|||
16961007|NCT00991276|38104058|FG000|First Intervention Period|Adverse Event|0|||
16961008|NCT00991276|38104059|FG001|First Intervention Period|Adverse Event|1|||
16961009|NCT00991276|38104060|FG002|First Intervention Period|Adverse Event|0|||
16961010|NCT00991276|38104061|FG003|First Intervention Period|Adverse Event|1|||
16961011|NCT00991276|38104062|FG004|First Intervention Period|Adverse Event|0|||
16961012|NCT00991276|38104063|FG005|First Intervention Period|Adverse Event|0|||
16961013|NCT00991276|38104058|FG000|First Intervention Period|Protocol Violation|0|||
16961014|NCT00991276|38104059|FG001|First Intervention Period|Protocol Violation|0|||
16961015|NCT00991276|38104060|FG002|First Intervention Period|Protocol Violation|0|||
16961016|NCT00991276|38104061|FG003|First Intervention Period|Protocol Violation|0|||
16961017|NCT00991276|38104062|FG004|First Intervention Period|Protocol Violation|2|||
16961018|NCT00991276|38104063|FG005|First Intervention Period|Protocol Violation|0|||
16961019|NCT00991276|38104058|FG000|First Intervention Period|Insufficient clinical response|0|||
16961020|NCT00991276|38104059|FG001|First Intervention Period|Insufficient clinical response|0|||
16961021|NCT00991276|38104060|FG002|First Intervention Period|Insufficient clinical response|0|||
16961022|NCT00991276|38104061|FG003|First Intervention Period|Insufficient clinical response|0|||
16961023|NCT00991276|38104062|FG004|First Intervention Period|Insufficient clinical response|1|||
16961024|NCT00991276|38104063|FG005|First Intervention Period|Insufficient clinical response|0|||
16961025|NCT00991276|38104058|FG000|First Intervention Period|Other|0|||
16961026|NCT00991276|38104059|FG001|First Intervention Period|Other|0|||
16961027|NCT00991276|38104060|FG002|First Intervention Period|Other|0|||
16961028|NCT00991276|38104061|FG003|First Intervention Period|Other|1|||
16961029|NCT00991276|38104062|FG004|First Intervention Period|Other|1|||
16961030|NCT00991276|38104063|FG005|First Intervention Period|Other|0|||
16961031|NCT00991276|38104058|FG000|First Intervention Period|Withdrawal by Subject|0|||
16961032|NCT00991276|38104059|FG001|First Intervention Period|Withdrawal by Subject|1|||
16961033|NCT00991276|38104060|FG002|First Intervention Period|Withdrawal by Subject|0|||
16961034|NCT00991276|38104061|FG003|First Intervention Period|Withdrawal by Subject|1|||
16961035|NCT00991276|38104062|FG004|First Intervention Period|Withdrawal by Subject|0|||
16961036|NCT00991276|38104063|FG005|First Intervention Period|Withdrawal by Subject|1|||
16961037|NCT00991276|38104058|FG000|First Intervention Period|Lost to Follow-up|0|||
16961038|NCT00991276|38104059|FG001|First Intervention Period|Lost to Follow-up|1|||
16961039|NCT00991276|38104060|FG002|First Intervention Period|Lost to Follow-up|0|||
16961040|NCT00991276|38104061|FG003|First Intervention Period|Lost to Follow-up|1|||
16776503|NCT02766335|37715903|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
16776504|NCT02766335|37715904|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
16776505|NCT02766335|37715902|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
16776506|NCT02766335|37715903|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
16961041|NCT00991276|38104062|FG004|First Intervention Period|Lost to Follow-up|0|||
16961042|NCT00991276|38104063|FG005|First Intervention Period|Lost to Follow-up|0|||
16961043|NCT00991276|38104058|FG000|Second Intervention Period|Adverse Event|0|||
16961044|NCT00991276|38104059|FG001|Second Intervention Period|Adverse Event|2|||
16961045|NCT00991276|38104060|FG002|Second Intervention Period|Adverse Event|0|||
16961046|NCT00991276|38104061|FG003|Second Intervention Period|Adverse Event|1|||
16961047|NCT00991276|38104062|FG004|Second Intervention Period|Adverse Event|1|||
16961048|NCT00991276|38104063|FG005|Second Intervention Period|Adverse Event|0|||
16961049|NCT00991276|38104058|FG000|Second Intervention Period|Protocol Violation|1|||
16961050|NCT00991276|38104059|FG001|Second Intervention Period|Protocol Violation|0|||
16961051|NCT00991276|38104060|FG002|Second Intervention Period|Protocol Violation|0|||
16961052|NCT00991276|38104061|FG003|Second Intervention Period|Protocol Violation|0|||
16961053|NCT00991276|38104062|FG004|Second Intervention Period|Protocol Violation|0|||
16961054|NCT00991276|38104063|FG005|Second Intervention Period|Protocol Violation|0|||
16961055|NCT00991276|38104058|FG000|Second Intervention Period|Other|0|||
16961056|NCT00991276|38104059|FG001|Second Intervention Period|Other|0|||
16776507|NCT02766335|37715904|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
16776508|NCT00462943|37715913|FG000|Overall Study|Failure to achieve a response|5|||
16776509|NCT00462943|37715914|FG001|Overall Study|Failure to achieve a response|5|||
16776510|NCT00462943|37715915|FG002|Overall Study|Failure to achieve a response|1|||
16776511|NCT00462943|37715913|FG000|Overall Study|Adverse Event|6|||
16776512|NCT00462943|37715914|FG001|Overall Study|Adverse Event|4|||
16961057|NCT00991276|38104060|FG002|Second Intervention Period|Other|0|||
16961058|NCT00991276|38104061|FG003|Second Intervention Period|Other|1|||
16961059|NCT00991276|38104062|FG004|Second Intervention Period|Other|0|||
16961060|NCT00991276|38104063|FG005|Second Intervention Period|Other|1|||
16961061|NCT00991276|38104058|FG000|Third Intervention Period|Protocol Violation|1|||
16961062|NCT00991276|38104059|FG001|Third Intervention Period|Protocol Violation|0|||
16961063|NCT00991276|38104060|FG002|Third Intervention Period|Protocol Violation|0|||
16961064|NCT00991276|38104061|FG003|Third Intervention Period|Protocol Violation|0|||
16961065|NCT00991276|38104062|FG004|Third Intervention Period|Protocol Violation|0|||
16961066|NCT00991276|38104063|FG005|Third Intervention Period|Protocol Violation|0|||
16961067|NCT00991276|38104058|FG000|Third Intervention Period|Other|0|||
16961068|NCT00991276|38104059|FG001|Third Intervention Period|Other|0|||
16961069|NCT00991276|38104060|FG002|Third Intervention Period|Other|0|||
16961070|NCT00991276|38104061|FG003|Third Intervention Period|Other|0|||
16961071|NCT00991276|38104062|FG004|Third Intervention Period|Other|0|||
16961072|NCT00991276|38104063|FG005|Third Intervention Period|Other|1|||
16961073|NCT00991276|38104058|FG000|Third Intervention Period|Adverse Event|0|||
16961074|NCT00991276|38104059|FG001|Third Intervention Period|Adverse Event|0|||
16961075|NCT00991276|38104060|FG002|Third Intervention Period|Adverse Event|1|||
16776513|NCT00462943|37715915|FG002|Overall Study|Adverse Event|1|||
16776514|NCT00462943|37715913|FG000|Overall Study|Protocol Violation|1|||
16961076|NCT00991276|38104061|FG003|Third Intervention Period|Adverse Event|0|||
16961077|NCT00991276|38104062|FG004|Third Intervention Period|Adverse Event|0|||
16961078|NCT00991276|38104063|FG005|Third Intervention Period|Adverse Event|0|||
16961079|NCT00991276|38104058|FG000|Third Intervention Period|Withdrawal by Subject|0|||
16961080|NCT00991276|38104059|FG001|Third Intervention Period|Withdrawal by Subject|0|||
16961081|NCT00991276|38104060|FG002|Third Intervention Period|Withdrawal by Subject|0|||
16961082|NCT00991276|38104061|FG003|Third Intervention Period|Withdrawal by Subject|1|||
16961083|NCT00991276|38104062|FG004|Third Intervention Period|Withdrawal by Subject|0|||
16961084|NCT00991276|38104063|FG005|Third Intervention Period|Withdrawal by Subject|0|||
16776515|NCT00462943|37715914|FG001|Overall Study|Protocol Violation|0|||
16776516|NCT00462943|37715915|FG002|Overall Study|Protocol Violation|0|||
16961085|NCT00990652|38104072|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
16961086|NCT00990652|38104072|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
16961087|NCT00990340|38104079|FG000|First 14-day Treatment|Not Compliant|2|||
16961088|NCT00990340|38104080|FG001|First 14-day Treatment|Not Compliant|1|||
16961089|NCT00990340|38104079|FG000|First 14-day Treatment|Lost to Follow-up|2|||
16961090|NCT00990340|38104080|FG001|First 14-day Treatment|Lost to Follow-up|1|||
16961091|NCT00990340|38104079|FG000|First 14-day Treatment|Protocol Violation|2|||
16961092|NCT00990340|38104080|FG001|First 14-day Treatment|Protocol Violation|2|||
16961093|NCT01207440|38104095|FG000|Overall Study|Adverse Event|46|||
16961094|NCT01207440|38104096|FG001|Overall Study|Adverse Event|11|||
16961095|NCT01207440|38104097|FG002|Overall Study|Adverse Event|7|||
16961096|NCT01207440|38104098|FG003|Overall Study|Adverse Event|2|||
16961097|NCT01207440|38104099|FG004|Overall Study|Adverse Event|6|||
16961098|NCT01207440|38104100|FG005|Overall Study|Adverse Event|6|||
16961099|NCT01207440|38104101|FG006|Overall Study|Adverse Event|2|||
16961100|NCT01207440|38104095|FG000|Overall Study|Death|6|||
16961101|NCT01207440|38104096|FG001|Overall Study|Death|3|||
16961102|NCT01207440|38104097|FG002|Overall Study|Death|2|||
16961103|NCT01207440|38104098|FG003|Overall Study|Death|2|||
16961104|NCT01207440|38104099|FG004|Overall Study|Death|7|||
16961105|NCT01207440|38104100|FG005|Overall Study|Death|5|||
16961106|NCT01207440|38104101|FG006|Overall Study|Death|1|||
16867976|NCT01563913|37841002|FG001|Overall Study|Spouse Passed Away|0|||
16961107|NCT01207440|38104095|FG000|Overall Study|Lack of Efficacy|13|||
16961108|NCT01207440|38104096|FG001|Overall Study|Lack of Efficacy|2|||
16961109|NCT01207440|38104097|FG002|Overall Study|Lack of Efficacy|5|||
16961110|NCT01207440|38104098|FG003|Overall Study|Lack of Efficacy|1|||
16961111|NCT01207440|38104099|FG004|Overall Study|Lack of Efficacy|2|||
16961112|NCT01207440|38104100|FG005|Overall Study|Lack of Efficacy|3|||
16961113|NCT01207440|38104101|FG006|Overall Study|Lack of Efficacy|0|||
16961114|NCT01207440|38104095|FG000|Overall Study|Lost to Follow-up|0|||
16961115|NCT01207440|38104096|FG001|Overall Study|Lost to Follow-up|0|||
16961116|NCT01207440|38104097|FG002|Overall Study|Lost to Follow-up|2|||
16961117|NCT01207440|38104098|FG003|Overall Study|Lost to Follow-up|1|||
16961118|NCT01207440|38104099|FG004|Overall Study|Lost to Follow-up|0|||
16961119|NCT01207440|38104100|FG005|Overall Study|Lost to Follow-up|0|||
16961120|NCT01207440|38104101|FG006|Overall Study|Lost to Follow-up|0|||
16961121|NCT01207440|38104095|FG000|Overall Study|Non-compliance with Study Drug|3|||
16961122|NCT01207440|38104096|FG001|Overall Study|Non-compliance with Study Drug|0|||
16961123|NCT01207440|38104097|FG002|Overall Study|Non-compliance with Study Drug|1|||
16961124|NCT01207440|38104098|FG003|Overall Study|Non-compliance with Study Drug|0|||
16961125|NCT01207440|38104099|FG004|Overall Study|Non-compliance with Study Drug|0|||
16961126|NCT01207440|38104100|FG005|Overall Study|Non-compliance with Study Drug|0|||
16961127|NCT01207440|38104101|FG006|Overall Study|Non-compliance with Study Drug|0|||
16961128|NCT01207440|38104095|FG000|Overall Study|Physician Decision|6|||
16961129|NCT01207440|38104096|FG001|Overall Study|Physician Decision|5|||
16961130|NCT01207440|38104097|FG002|Overall Study|Physician Decision|5|||
16961131|NCT01207440|38104098|FG003|Overall Study|Physician Decision|0|||
16961132|NCT01207440|38104099|FG004|Overall Study|Physician Decision|1|||
16961133|NCT01207440|38104100|FG005|Overall Study|Physician Decision|0|||
16961134|NCT01207440|38104101|FG006|Overall Study|Physician Decision|0|||
16961135|NCT01207440|38104095|FG000|Overall Study|Progressive Disease|19|||
16961136|NCT01207440|38104096|FG001|Overall Study|Progressive Disease|10|||
16961137|NCT01207440|38104097|FG002|Overall Study|Progressive Disease|19|||
16961138|NCT01207440|38104098|FG003|Overall Study|Progressive Disease|7|||
16961139|NCT01207440|38104099|FG004|Overall Study|Progressive Disease|23|||
16961140|NCT01207440|38104100|FG005|Overall Study|Progressive Disease|27|||
16961141|NCT01207440|38104101|FG006|Overall Study|Progressive Disease|0|||
16776517|NCT00462943|37715913|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
16776518|NCT00462943|37715914|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
16776519|NCT00462943|37715915|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
16776520|NCT00462943|37715913|FG000|Overall Study|Disease Progression|15|||
16776521|NCT00462943|37715914|FG001|Overall Study|Disease Progression|15|||
16776522|NCT00462943|37715915|FG002|Overall Study|Disease Progression|9|||
16776523|NCT00462943|37715913|FG000|Overall Study|Death|5|||
16776524|NCT00462943|37715914|FG001|Overall Study|Death|2|||
16776525|NCT00462943|37715915|FG002|Overall Study|Death|7|||
16776526|NCT00462943|37715913|FG000|Overall Study|Stem Cell Transplant|1|||
16776527|NCT00462943|37715914|FG001|Overall Study|Stem Cell Transplant|1|||
16776528|NCT00462943|37715915|FG002|Overall Study|Stem Cell Transplant|0|||
16776529|NCT00462943|37715913|FG000|Overall Study|Bone Marrow Transplant|1|||
16776530|NCT00462943|37715914|FG001|Overall Study|Bone Marrow Transplant|0|||
16776531|NCT00462943|37715915|FG002|Overall Study|Bone Marrow Transplant|0|||
16776532|NCT00462943|37715913|FG000|Overall Study|Required Lymphocyte Infusion|1|||
16776533|NCT00462943|37715914|FG001|Overall Study|Required Lymphocyte Infusion|0|||
16776534|NCT00462943|37715915|FG002|Overall Study|Required Lymphocyte Infusion|0|||
16776535|NCT00462943|37715913|FG000|Overall Study|Transplant - not specified|1|||
16961142|NCT01207440|38104095|FG000|Overall Study|Protocol Violation|2|||
16961143|NCT01207440|38104096|FG001|Overall Study|Protocol Violation|0|||
16961144|NCT01207440|38104097|FG002|Overall Study|Protocol Violation|0|||
16961145|NCT01207440|38104098|FG003|Overall Study|Protocol Violation|0|||
16961146|NCT01207440|38104099|FG004|Overall Study|Protocol Violation|0|||
16961147|NCT01207440|38104100|FG005|Overall Study|Protocol Violation|0|||
16961148|NCT01207440|38104101|FG006|Overall Study|Protocol Violation|0|||
16961149|NCT01207440|38104095|FG000|Overall Study|Site Terminated by Sponsor|69|||
16961150|NCT01207440|38104096|FG001|Overall Study|Site Terminated by Sponsor|19|||
16961151|NCT01207440|38104097|FG002|Overall Study|Site Terminated by Sponsor|12|||
16961152|NCT01207440|38104098|FG003|Overall Study|Site Terminated by Sponsor|2|||
16961153|NCT01207440|38104099|FG004|Overall Study|Site Terminated by Sponsor|3|||
16961154|NCT01207440|38104100|FG005|Overall Study|Site Terminated by Sponsor|0|||
16961155|NCT01207440|38104101|FG006|Overall Study|Site Terminated by Sponsor|2|||
16961156|NCT01207440|38104095|FG000|Overall Study|Withdrawal by Subject|29|||
16961157|NCT01207440|38104096|FG001|Overall Study|Withdrawal by Subject|4|||
16961158|NCT01207440|38104097|FG002|Overall Study|Withdrawal by Subject|5|||
16961159|NCT01207440|38104098|FG003|Overall Study|Withdrawal by Subject|3|||
16961160|NCT01207440|38104099|FG004|Overall Study|Withdrawal by Subject|2|||
16961161|NCT01207440|38104100|FG005|Overall Study|Withdrawal by Subject|2|||
16961162|NCT01207440|38104101|FG006|Overall Study|Withdrawal by Subject|0|||
16961163|NCT01207440|38104095|FG000|Overall Study|Reason Not Specified|10|||
16961164|NCT01207440|38104096|FG001|Overall Study|Reason Not Specified|10|||
16961165|NCT01207440|38104097|FG002|Overall Study|Reason Not Specified|7|||
16961166|NCT01207440|38104098|FG003|Overall Study|Reason Not Specified|0|||
16961167|NCT01207440|38104099|FG004|Overall Study|Reason Not Specified|4|||
16961168|NCT01207440|38104100|FG005|Overall Study|Reason Not Specified|3|||
16961169|NCT01207440|38104101|FG006|Overall Study|Reason Not Specified|0|||
16961170|NCT00990184|38104123|FG000|Overall Study|Physician Decision|1|||
16961171|NCT00986830|38104129|FG000|Overall Study|Death|1|||
16961172|NCT00986830|38104129|FG000|Overall Study|Lost to Follow-up|1|||
16961173|NCT00986830|38104129|FG000|Overall Study|Lack of Efficacy|1|||
16961174|NCT00986830|38104129|FG000|Overall Study|Unable to access sinus with device|5|||
16961175|NCT00990106|38104135|FG000|Overall Study|"too busy to continue"|1|||
16961176|NCT00990106|38104136|FG001|Overall Study|"too busy to continue"|2|||
16961177|NCT00990106|38104135|FG000|Overall Study|Lost to Follow-up|1|||
16961178|NCT00990106|38104136|FG001|Overall Study|Lost to Follow-up|3|||
16961179|NCT00990106|38104135|FG000|Overall Study|Withdrawal by Subject|2|||
16961180|NCT00990106|38104136|FG001|Overall Study|Withdrawal by Subject|1|||
16961181|NCT00990106|38104135|FG000|Overall Study|opted for open label prazosin|1|||
16961182|NCT00990106|38104136|FG001|Overall Study|opted for open label prazosin|1|||
16961183|NCT00990106|38104135|FG000|Overall Study|relocation/deployment|4|||
16961184|NCT00990106|38104136|FG001|Overall Study|relocation/deployment|1|||
16961185|NCT00990106|38104135|FG000|Overall Study|started exclusionary medication|0|||
16961186|NCT00990106|38104136|FG001|Overall Study|started exclusionary medication|1|||
16961187|NCT00990106|38104135|FG000|Overall Study|planned major surgery|0|||
16961188|NCT00990106|38104136|FG001|Overall Study|planned major surgery|1|||
16961189|NCT00990106|38104135|FG000|Overall Study|scheduling conflicts|0|||
16961190|NCT00990106|38104136|FG001|Overall Study|scheduling conflicts|2|||
16961191|NCT00983476|38104145|FG000|Overall Study|Did not receive intervention|17|||
16961192|NCT00983476|38104146|FG001|Overall Study|Did not receive intervention|22|||
16961193|NCT00983476|38104147|FG002|Overall Study|Did not receive intervention|0|||
16961194|NCT00982228|38104163|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
16961195|NCT00982228|38104164|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
16961196|NCT00982228|38104163|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
16961197|NCT00982228|38104164|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
16961198|NCT00982228|38104163|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
16961199|NCT00982228|38104164|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
16961200|NCT00982228|38104163|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
16961201|NCT00982228|38104164|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
16961202|NCT00982228|38104163|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
16961203|NCT00982228|38104164|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
16961204|NCT00982228|38104163|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
16961205|NCT00982228|38104164|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
16961206|NCT00982228|38104163|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
16961207|NCT00982228|38104164|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
16961208|NCT00982228|38104163|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
16961209|NCT00982228|38104164|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
16961210|NCT00982228|38104163|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
16961211|NCT00982228|38104164|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
16961212|NCT00982228|38104163|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
16961213|NCT00982228|38104164|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
16961214|NCT01260350|38104190|FG000|Overall Study|Lack of Efficacy|0|||
16961215|NCT01260350|38104191|FG001|Overall Study|Lack of Efficacy|0|||
16961216|NCT01260350|38104192|FG002|Overall Study|Lack of Efficacy|0|||
16961217|NCT01260350|38104193|FG003|Overall Study|Lack of Efficacy|0|||
16961218|NCT01260350|38104194|FG004|Overall Study|Lack of Efficacy|0|||
16961219|NCT01260350|38104195|FG005|Overall Study|Lack of Efficacy|0|||
16961220|NCT01260350|38104196|FG006|Overall Study|Lack of Efficacy|0|||
16961221|NCT01260350|38104197|FG007|Overall Study|Lack of Efficacy|0|||
16961222|NCT01260350|38104198|FG008|Overall Study|Lack of Efficacy|0|||
16961223|NCT01260350|38104199|FG009|Overall Study|Lack of Efficacy|0|||
16961224|NCT01260350|38104200|FG010|Overall Study|Lack of Efficacy|0|||
16961225|NCT01260350|38104201|FG011|Overall Study|Lack of Efficacy|0|||
16961226|NCT01260350|38104202|FG012|Overall Study|Lack of Efficacy|0|||
16961227|NCT01260350|38104203|FG013|Overall Study|Lack of Efficacy|0|||
16961228|NCT01260350|38104204|FG014|Overall Study|Lack of Efficacy|0|||
16961229|NCT01260350|38104205|FG015|Overall Study|Lack of Efficacy|0|||
16961230|NCT01260350|38104206|FG016|Overall Study|Lack of Efficacy|0|||
16961231|NCT01260350|38104207|FG017|Overall Study|Lack of Efficacy|1|||
16961232|NCT01260350|38104208|FG018|Overall Study|Lack of Efficacy|0|||
16961233|NCT01260350|38104209|FG019|Overall Study|Lack of Efficacy|0|||
16961234|NCT01260350|38104210|FG020|Overall Study|Lack of Efficacy|3|||
16961235|NCT01260350|38104211|FG021|Overall Study|Lack of Efficacy|0|||
16961236|NCT01260350|38104190|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961237|NCT01260350|38104191|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961238|NCT01260350|38104192|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961239|NCT01260350|38104193|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961240|NCT01260350|38104194|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961241|NCT01260350|38104195|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961242|NCT01260350|38104196|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961243|NCT01260350|38104197|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961244|NCT01260350|38104198|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
16961245|NCT01260350|38104199|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961246|NCT01260350|38104200|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961247|NCT01260350|38104201|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961248|NCT01260350|38104202|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961249|NCT01260350|38104203|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961250|NCT01260350|38104204|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961251|NCT01260350|38104205|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961252|NCT01260350|38104206|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961253|NCT01260350|38104207|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961254|NCT01260350|38104208|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961255|NCT01260350|38104209|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961256|NCT01260350|38104210|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961257|NCT01260350|38104211|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16961258|NCT01260194|38104265|FG000|Overall Study|Withdrawal of Consent|1|||
16961259|NCT01259726|38104273|FG000|Overall Study|Death|1|||
16961260|NCT01259726|38104274|FG001|Overall Study|Death|0|||
16961261|NCT01259726|38104275|FG002|Overall Study|Death|0|||
16961262|NCT01259726|38104276|FG003|Overall Study|Death|0|||
16961263|NCT01259726|38104273|FG000|Overall Study|Physician Decision|2|||
16961264|NCT01259726|38104274|FG001|Overall Study|Physician Decision|0|||
16961265|NCT01259726|38104275|FG002|Overall Study|Physician Decision|1|||
16961266|NCT01259726|38104276|FG003|Overall Study|Physician Decision|1|||
16961267|NCT01259726|38104273|FG000|Overall Study|Withdrawal by Subject|1|||
16961268|NCT01259726|38104274|FG001|Overall Study|Withdrawal by Subject|3|||
16961269|NCT01259726|38104275|FG002|Overall Study|Withdrawal by Subject|2|||
16961270|NCT01259726|38104276|FG003|Overall Study|Withdrawal by Subject|1|||
16961271|NCT01259726|38104273|FG000|Overall Study|Lost to Follow-up|1|||
16961272|NCT01259726|38104274|FG001|Overall Study|Lost to Follow-up|1|||
16961273|NCT01259726|38104275|FG002|Overall Study|Lost to Follow-up|1|||
16961274|NCT01259726|38104276|FG003|Overall Study|Lost to Follow-up|3|||
16961275|NCT01259492|38104290|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
16961276|NCT01259492|38104291|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
16961277|NCT01259492|38104292|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
16961278|NCT01259492|38104293|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
16961279|NCT01259492|38104290|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
16961280|NCT01259492|38104291|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
16961281|NCT01259492|38104292|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
16961282|NCT01259492|38104293|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
16961283|NCT01259492|38104290|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
16961284|NCT01259492|38104291|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
16961285|NCT01259492|38104292|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
16961286|NCT01259492|38104293|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
16961287|NCT01259492|38104290|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
16961288|NCT01259492|38104291|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
16961289|NCT01259492|38104292|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
16961290|NCT01259492|38104293|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
16961291|NCT01259492|38104290|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
16961292|NCT01259492|38104291|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
16961293|NCT01259492|38104292|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
16961294|NCT01259492|38104293|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
16961295|NCT01259492|38104290|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
16961296|NCT01259492|38104291|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
16961297|NCT01259492|38104292|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
16961298|NCT01259492|38104293|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
16961299|NCT01259492|38104290|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
16961300|NCT01259492|38104291|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
16961301|NCT01259492|38104292|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
16961302|NCT01259492|38104293|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
16961303|NCT01259492|38104290|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
16961304|NCT01259492|38104291|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
16961305|NCT01259492|38104292|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
16961306|NCT01259492|38104293|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
16961307|NCT01259492|38104290|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
16961308|NCT01259492|38104291|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
16961309|NCT01259492|38104292|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
16961310|NCT01259492|38104293|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
16961311|NCT01259492|38104290|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
16961312|NCT01259492|38104291|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
16961313|NCT01259492|38104292|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
16961314|NCT01259492|38104293|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
16961315|NCT01259492|38104290|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
16961316|NCT01259492|38104291|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
16961317|NCT01259492|38104292|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
16776536|NCT00462943|37715914|FG001|Overall Study|Transplant - not specified|0|||
16776537|NCT00462943|37715915|FG002|Overall Study|Transplant - not specified|1|||
16776538|NCT00462943|37715913|FG000|Overall Study|Physician Decision|1|||
16776539|NCT00462943|37715914|FG001|Overall Study|Physician Decision|0|||
16776540|NCT00462943|37715915|FG002|Overall Study|Physician Decision|0|||
16776541|NCT00462943|37715913|FG000|Overall Study|Withdrawal by Subject|0|||
16776542|NCT00462943|37715914|FG001|Overall Study|Withdrawal by Subject|1|||
16776543|NCT00462943|37715915|FG002|Overall Study|Withdrawal by Subject|0|||
16776544|NCT02730793|37715939|FG000|Overall Study|Physician Decision|0|||
16776545|NCT02730793|37715940|FG001|Overall Study|Physician Decision|1|||
16776546|NCT02730793|37715939|FG000|Overall Study|Withdrawal by Subject|0|||
16776547|NCT02730793|37715940|FG001|Overall Study|Withdrawal by Subject|1|||
16776548|NCT02855125|37715948|FG000|Overall Study|Withdrawal by Subject|2|||
16776549|NCT02855125|37715949|FG001|Overall Study|Withdrawal by Subject|2|||
16776550|NCT02855125|37715948|FG000|Overall Study|Clinical Disease Progression|5|||
16776551|NCT02855125|37715949|FG001|Overall Study|Clinical Disease Progression|4|||
16776552|NCT02855125|37715948|FG000|Overall Study|Radiologic Disease Progression|36|||
16776553|NCT02855125|37715949|FG001|Overall Study|Radiologic Disease Progression|39|||
16961318|NCT01259492|38104293|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
16961319|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
16961320|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
16961321|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
16961322|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
16961323|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
16961324|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
16961325|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
16961326|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
16961327|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
16776554|NCT02855125|37715948|FG000|Overall Study|Adverse Event|11|||
16776555|NCT02855125|37715949|FG001|Overall Study|Adverse Event|7|||
16961328|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
16961329|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
16961330|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
16961331|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
16776556|NCT02855125|37715948|FG000|Overall Study|Physician Decision|1|||
16776557|NCT02855125|37715949|FG001|Overall Study|Physician Decision|0|||
16776558|NCT02855125|37715948|FG000|Overall Study|On Treatment|9|||
16776559|NCT02855125|37715949|FG001|Overall Study|On Treatment|11|||
16776560|NCT02855125|37715948|FG000|Overall Study|Randomized but not treated|0|||
16776561|NCT02855125|37715949|FG001|Overall Study|Randomized but not treated|1|||
16776562|NCT02730871|37715972|FG000|Overall Study|Adverse Event|6|||
16961332|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
16961333|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
16961334|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
16961335|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
16961336|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
16961337|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
16776563|NCT02730871|37715973|FG001|Overall Study|Adverse Event|0|||
16776564|NCT03376789|37715981|FG000|Overall Study|Withdrawal by Subject|3|||
16776565|NCT03376789|37715982|FG001|Overall Study|Withdrawal by Subject|5|||
16776566|NCT03376789|37715981|FG000|Overall Study|Protocol Violation|0|||
16776567|NCT03376789|37715982|FG001|Overall Study|Protocol Violation|1|||
16776568|NCT03376789|37715981|FG000|Overall Study|Adverse Event|0|||
16776569|NCT03376789|37715982|FG001|Overall Study|Adverse Event|1|||
16776570|NCT03376789|37715981|FG000|Overall Study|Lost to Follow-up|1|||
16776571|NCT03376789|37715982|FG001|Overall Study|Lost to Follow-up|1|||
16961338|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
16961339|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
16961340|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
16961341|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
16961342|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
16961343|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
16961344|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
16961345|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
16961346|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
16961347|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
16961348|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
16961349|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
16961350|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
16961351|NCT01259492|38104290|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
16961352|NCT01259492|38104291|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
16961353|NCT01259492|38104292|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
16961354|NCT01259492|38104293|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
16961355|NCT01117623|38104310|FG000|Overall Study|Adverse Event|0|||
16961356|NCT01117623|38104311|FG001|Overall Study|Adverse Event|2|||
16961357|NCT01117623|38104312|FG002|Overall Study|Adverse Event|4|||
16961358|NCT01117623|38104313|FG003|Overall Study|Adverse Event|0|||
16961359|NCT01117623|38104314|FG004|Overall Study|Adverse Event|2|||
16961360|NCT01117623|38104315|FG005|Overall Study|Adverse Event|0|||
16961361|NCT01117623|38104316|FG006|Overall Study|Adverse Event|0|||
16961362|NCT01117623|38104317|FG007|Overall Study|Adverse Event|2|||
16961363|NCT01117623|38104310|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
16961364|NCT01117623|38104311|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
16961365|NCT01117623|38104312|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
16961366|NCT01117623|38104313|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
16961367|NCT01117623|38104314|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
16961368|NCT01117623|38104315|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
16961369|NCT01117623|38104316|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
16961370|NCT01117623|38104317|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
16961371|NCT01117623|38104310|FG000|Overall Study|Withdrawal by Subject|0|||
16961372|NCT01117623|38104311|FG001|Overall Study|Withdrawal by Subject|0|||
16961373|NCT01117623|38104312|FG002|Overall Study|Withdrawal by Subject|2|||
16961374|NCT01117623|38104313|FG003|Overall Study|Withdrawal by Subject|0|||
16961375|NCT01117623|38104314|FG004|Overall Study|Withdrawal by Subject|0|||
16961376|NCT01117623|38104315|FG005|Overall Study|Withdrawal by Subject|1|||
16961377|NCT01117623|38104316|FG006|Overall Study|Withdrawal by Subject|1|||
16961378|NCT01117623|38104317|FG007|Overall Study|Withdrawal by Subject|1|||
16961379|NCT01117623|38104310|FG000|Overall Study|Non-compliance with study medication|0|||
16961380|NCT01117623|38104311|FG001|Overall Study|Non-compliance with study medication|0|||
16961381|NCT01117623|38104312|FG002|Overall Study|Non-compliance with study medication|0|||
16961382|NCT01117623|38104313|FG003|Overall Study|Non-compliance with study medication|0|||
16961383|NCT01117623|38104314|FG004|Overall Study|Non-compliance with study medication|0|||
16961384|NCT01117623|38104315|FG005|Overall Study|Non-compliance with study medication|0|||
16961385|NCT01117623|38104316|FG006|Overall Study|Non-compliance with study medication|0|||
16961386|NCT01117623|38104317|FG007|Overall Study|Non-compliance with study medication|1|||
16961387|NCT01117623|38104310|FG000|Overall Study|Invest. text: completed all planned txs|0|||
16961388|NCT01117623|38104311|FG001|Overall Study|Invest. text: completed all planned txs|0|||
16961389|NCT01117623|38104312|FG002|Overall Study|Invest. text: completed all planned txs|0|||
16961390|NCT01117623|38104313|FG003|Overall Study|Invest. text: completed all planned txs|0|||
16961391|NCT01117623|38104314|FG004|Overall Study|Invest. text: completed all planned txs|0|||
16961392|NCT01117623|38104315|FG005|Overall Study|Invest. text: completed all planned txs|1|||
16961393|NCT01117623|38104316|FG006|Overall Study|Invest. text: completed all planned txs|0|||
16961394|NCT01117623|38104317|FG007|Overall Study|Invest. text: completed all planned txs|0|||
16961395|NCT01116687|38104337|FG000|Overall Study|Withdrawal by Subject|4|||
16961396|NCT01114737|38104343|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
16961397|NCT01114737|38104344|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
16961398|NCT01114737|38104343|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
16961399|NCT01114737|38104344|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
16961400|NCT01114737|38104343|FG000|Randomized Treatment Period|Pregnancy|1|||
16961401|NCT01114737|38104344|FG001|Randomized Treatment Period|Pregnancy|0|||
16961402|NCT01114737|38104343|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
16961403|NCT01114737|38104344|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
16961404|NCT01114737|38104343|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
16961405|NCT01114737|38104344|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
16961406|NCT01114737|38104343|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
16961407|NCT01114737|38104344|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
16961408|NCT01113879|38104367|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
16961409|NCT01113879|38104368|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
16961410|NCT00979576|38104379|FG000|Combination Treatment Phase|Progressive disease|3|||
16961411|NCT00979576|38104380|FG001|Combination Treatment Phase|Progressive disease|1|||
16961412|NCT00979576|38104381|FG002|Combination Treatment Phase|Progressive disease|5|||
16961413|NCT00979576|38104379|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
16961414|NCT00979576|38104380|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
16961415|NCT00979576|38104381|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
16961416|NCT00979576|38104379|FG000|Combination Treatment Phase|Adverse Event|0|||
16961417|NCT00979576|38104380|FG001|Combination Treatment Phase|Adverse Event|2|||
16961418|NCT00979576|38104381|FG002|Combination Treatment Phase|Adverse Event|2|||
16961419|NCT00979576|38104379|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
16961420|NCT00979576|38104380|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
16961421|NCT00979576|38104381|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
16961422|NCT00979420|38104394|FG000|Overall Study|Adverse Event|1|||
16961423|NCT00979420|38104395|FG001|Overall Study|Adverse Event|0|||
16961424|NCT00979420|38104396|FG002|Overall Study|Adverse Event|0|||
16961425|NCT00979420|38104397|FG003|Overall Study|Adverse Event|0|||
16961426|NCT00979420|38104394|FG000|Overall Study|Lack of Efficacy|3|||
16961427|NCT00979420|38104395|FG001|Overall Study|Lack of Efficacy|0|||
16961428|NCT00979420|38104396|FG002|Overall Study|Lack of Efficacy|1|||
16961429|NCT00979420|38104397|FG003|Overall Study|Lack of Efficacy|1|||
16961430|NCT00979420|38104394|FG000|Overall Study|Other reasons not related to Viramune|3|||
16961431|NCT00979420|38104395|FG001|Overall Study|Other reasons not related to Viramune|0|||
16961432|NCT00979420|38104396|FG002|Overall Study|Other reasons not related to Viramune|0|||
16961433|NCT00979420|38104397|FG003|Overall Study|Other reasons not related to Viramune|1|||
16961434|NCT02702180|38104408|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16961435|NCT02702180|38104409|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
16961436|NCT02702180|38104410|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16961437|NCT02702180|38104408|FG000|Double-blind Treatment Period|Adverse Event|0|||
16961438|NCT02702180|38104409|FG001|Double-blind Treatment Period|Adverse Event|0|||
16961439|NCT02702180|38104410|FG002|Double-blind Treatment Period|Adverse Event|1|||
16961440|NCT02702180|38104408|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16961441|NCT02702180|38104409|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
16961442|NCT02702180|38104410|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
16961443|NCT02702180|38104408|FG000|Double-blind Treatment Period|Protocol Violation|0|||
16961444|NCT02702180|38104409|FG001|Double-blind Treatment Period|Protocol Violation|0|||
16961445|NCT02702180|38104410|FG002|Double-blind Treatment Period|Protocol Violation|2|||
16961446|NCT02702180|38104408|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
16961447|NCT02702180|38104409|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
16961448|NCT02702180|38104410|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
16961449|NCT02702180|38104408|FG000|Open-label Treatment Period|Withdrawn in error|0|||
16961450|NCT02702180|38104409|FG001|Open-label Treatment Period|Withdrawn in error|0|||
16961451|NCT02702180|38104410|FG002|Open-label Treatment Period|Withdrawn in error|1|||
16961452|NCT00980980|38104422|FG000|Overall Study|Withdrawal by Hospital|0|||
16961453|NCT00980980|38104423|FG001|Overall Study|Withdrawal by Hospital|1|||
16961454|NCT00980980|38104424|FG002|Overall Study|Withdrawal by Hospital|0|||
16961455|NCT00980200|38104435|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
16961456|NCT00980200|38104436|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
16961457|NCT00980200|38104437|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
16961458|NCT00980200|38104438|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
16961459|NCT00980200|38104439|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
16961460|NCT00980200|38104435|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
16776572|NCT03376789|37715981|FG000|Overall Study|Per sponsor due to noncompliance|1|||
16776573|NCT03376789|37715982|FG001|Overall Study|Per sponsor due to noncompliance|0|||
16776574|NCT03376789|37715981|FG000|Overall Study|Subject off study medication|0|||
16776575|NCT03376789|37715982|FG001|Overall Study|Subject off study medication|1|||
16776576|NCT04032093|37715998|FG000|Overall Study|Lost to Follow-up|7|||
16776577|NCT04032093|37715999|FG001|Overall Study|Lost to Follow-up|7|||
16961461|NCT00980200|38104436|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
16961462|NCT00980200|38104437|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
17133936|NCT00065429|38275193|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
17133937|NCT00065429|38275194|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
17133938|NCT00065429|38275188|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
17133939|NCT00065429|38275189|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16776578|NCT04032093|37716000|FG002|Overall Study|Lost to Follow-up|6|||
16776579|NCT04032093|37716001|FG003|Overall Study|Lost to Follow-up|10|||
16776580|NCT04032093|37716002|FG004|Overall Study|Lost to Follow-up|13|||
16776581|NCT04032093|37716003|FG005|Overall Study|Lost to Follow-up|7|||
16776582|NCT04032093|37716004|FG006|Overall Study|Lost to Follow-up|7|||
16776583|NCT04032093|37716005|FG007|Overall Study|Lost to Follow-up|5|||
16776584|NCT04032093|37716006|FG008|Overall Study|Lost to Follow-up|9|||
16776585|NCT04032093|37716007|FG009|Overall Study|Lost to Follow-up|12|||
16776586|NCT04032093|37715998|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16776587|NCT04032093|37715999|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16776588|NCT04032093|37716000|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
16776589|NCT04032093|37716001|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
16776590|NCT04032093|37716002|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
16776591|NCT04032093|37716003|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
16776592|NCT04032093|37716004|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
16776593|NCT04032093|37716005|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
16776594|NCT04032093|37716006|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
16776595|NCT04032093|37716007|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
16776596|NCT04032093|37715998|FG000|Overall Study|Other|1|||
16776597|NCT04032093|37715999|FG001|Overall Study|Other|0|||
16776598|NCT04032093|37716000|FG002|Overall Study|Other|0|||
16776599|NCT04032093|37716001|FG003|Overall Study|Other|1|||
16776600|NCT04032093|37716002|FG004|Overall Study|Other|1|||
16776601|NCT04032093|37716003|FG005|Overall Study|Other|0|||
16776602|NCT04032093|37716004|FG006|Overall Study|Other|0|||
16776603|NCT04032093|37716005|FG007|Overall Study|Other|0|||
16776604|NCT04032093|37716006|FG008|Overall Study|Other|0|||
16776605|NCT04032093|37716007|FG009|Overall Study|Other|1|||
16776606|NCT04032093|37715998|FG000|Overall Study|Withdrawal by Subject|1|||
16776607|NCT04032093|37715999|FG001|Overall Study|Withdrawal by Subject|3|||
16776608|NCT04032093|37716000|FG002|Overall Study|Withdrawal by Subject|2|||
16776609|NCT04032093|37716001|FG003|Overall Study|Withdrawal by Subject|2|||
16776610|NCT04032093|37716002|FG004|Overall Study|Withdrawal by Subject|3|||
16776611|NCT04032093|37716003|FG005|Overall Study|Withdrawal by Subject|0|||
16776612|NCT04032093|37716004|FG006|Overall Study|Withdrawal by Subject|0|||
16776613|NCT04032093|37716005|FG007|Overall Study|Withdrawal by Subject|0|||
16776614|NCT04032093|37716006|FG008|Overall Study|Withdrawal by Subject|0|||
16776615|NCT04032093|37716007|FG009|Overall Study|Withdrawal by Subject|0|||
16776616|NCT04032093|37715998|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16776617|NCT04032093|37715999|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16776618|NCT04032093|37716000|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16776619|NCT04032093|37716001|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16776620|NCT04032093|37716002|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
16776621|NCT04032093|37716003|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
16776622|NCT04032093|37716004|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
16776623|NCT04032093|37716005|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
16776624|NCT04032093|37716006|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
16776625|NCT04032093|37716007|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
16776626|NCT04032093|37715998|FG000|Overall Study|Adverse Event|0|||
16776627|NCT04032093|37715999|FG001|Overall Study|Adverse Event|0|||
16776628|NCT04032093|37716000|FG002|Overall Study|Adverse Event|0|||
16776629|NCT04032093|37716001|FG003|Overall Study|Adverse Event|0|||
16776630|NCT04032093|37716002|FG004|Overall Study|Adverse Event|0|||
16776631|NCT04032093|37716003|FG005|Overall Study|Adverse Event|0|||
16776632|NCT04032093|37716004|FG006|Overall Study|Adverse Event|0|||
16776633|NCT04032093|37716005|FG007|Overall Study|Adverse Event|0|||
16776634|NCT04032093|37716006|FG008|Overall Study|Adverse Event|0|||
16776635|NCT04032093|37716007|FG009|Overall Study|Adverse Event|1|||
16776636|NCT04032093|37715998|FG000|Overall Study|Physician Decision|0|||
16776637|NCT04032093|37715999|FG001|Overall Study|Physician Decision|0|||
16776638|NCT04032093|37716000|FG002|Overall Study|Physician Decision|0|||
16776639|NCT04032093|37716001|FG003|Overall Study|Physician Decision|0|||
16776640|NCT04032093|37716002|FG004|Overall Study|Physician Decision|0|||
16776641|NCT04032093|37716003|FG005|Overall Study|Physician Decision|1|||
16776642|NCT04032093|37716004|FG006|Overall Study|Physician Decision|0|||
16776643|NCT04032093|37716005|FG007|Overall Study|Physician Decision|0|||
16776644|NCT04032093|37716006|FG008|Overall Study|Physician Decision|0|||
16776645|NCT04032093|37716007|FG009|Overall Study|Physician Decision|0|||
16776646|NCT01675167|37716031|FG000|Open-label Titration Phase|Adverse Event|81|||
16961463|NCT00980200|38104438|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
16961464|NCT00980200|38104439|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
16961465|NCT00979654|38104451|FG000|Overall Study|Lost to Follow-up|1|||
16961466|NCT00979654|38104451|FG000|Overall Study|Withdrawal by Subject|22|||
16961467|NCT00979654|38104451|FG000|Overall Study|Death|1|||
16961468|NCT00979654|38104451|FG000|Overall Study|Lack of Efficacy|6|||
16961469|NCT00979654|38104451|FG000|Overall Study|Adverse Event|1|||
16961470|NCT00979654|38104451|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
16961471|NCT00979654|38104451|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
16961472|NCT00979654|38104451|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
16961473|NCT00979654|38104451|FG000|Overall Study|Serious Adverse Event|1|||
16961474|NCT00979654|38104451|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
16961475|NCT00978562|38104455|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
16961476|NCT02865460|38104463|FG000|Overall Study|Adverse Event|1|||
16961477|NCT02865460|38104464|FG001|Overall Study|Adverse Event|0|||
16961478|NCT02865460|38104463|FG000|Overall Study|Withdrawal by Subject|1|||
16961479|NCT02865460|38104464|FG001|Overall Study|Withdrawal by Subject|1|||
16961480|NCT02865460|38104463|FG000|Overall Study|Lost to Follow-up|7|||
16961481|NCT02865460|38104464|FG001|Overall Study|Lost to Follow-up|4|||
16961482|NCT02865460|38104463|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
16961483|NCT02865460|38104464|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
16961484|NCT00946712|38104472|FG000|Overall Study|Adverse Event|118|||
16961485|NCT00946712|38104473|FG001|Overall Study|Adverse Event|124|||
16961486|NCT00946712|38104472|FG000|Overall Study|Disease progression|308|||
16961487|NCT00946712|38104473|FG001|Overall Study|Disease progression|404|||
16961488|NCT00946712|38104472|FG000|Overall Study|Death|21|||
16961489|NCT00946712|38104473|FG001|Overall Study|Death|22|||
16961490|NCT00946712|38104472|FG000|Overall Study|No treatment given|25|||
16961491|NCT00946712|38104473|FG001|Overall Study|No treatment given|29|||
16961492|NCT00946712|38104472|FG000|Overall Study|Other reasons|61|||
16961493|NCT00946712|38104473|FG001|Overall Study|Other reasons|73|||
16961494|NCT00946712|38104472|FG000|Overall Study|On Treatment|0|||
16961495|NCT00946712|38104473|FG001|Overall Study|On Treatment|4|||
16961496|NCT00946712|38104472|FG000|Overall Study|Ineligible|14|||
16961497|NCT00946712|38104473|FG001|Overall Study|Ineligible|6|||
16961498|NCT01206816|38104487|FG000|Overall Study|Protocol Violation|0|||
16961499|NCT01206816|38104488|FG001|Overall Study|Protocol Violation|0|||
16961500|NCT01206816|38104489|FG002|Overall Study|Protocol Violation|1|||
16961501|NCT01206816|38104490|FG003|Overall Study|Protocol Violation|0|||
16961502|NCT01206816|38104491|FG004|Overall Study|Protocol Violation|0|||
16961503|NCT01206816|38104492|FG005|Overall Study|Protocol Violation|0|||
16961504|NCT01206816|38104493|FG006|Overall Study|Protocol Violation|0|||
16961505|NCT01206816|38104487|FG000|Overall Study|Withdrawal by Subject|0|||
16961506|NCT01206816|38104488|FG001|Overall Study|Withdrawal by Subject|0|||
16961507|NCT01206816|38104489|FG002|Overall Study|Withdrawal by Subject|1|||
16961508|NCT01206816|38104490|FG003|Overall Study|Withdrawal by Subject|0|||
16961509|NCT01206816|38104491|FG004|Overall Study|Withdrawal by Subject|0|||
16961510|NCT01206816|38104492|FG005|Overall Study|Withdrawal by Subject|0|||
16961511|NCT01206816|38104493|FG006|Overall Study|Withdrawal by Subject|0|||
16961512|NCT01206816|38104487|FG000|Overall Study|Progressive disease|3|||
16776647|NCT01675167|37716032|FG001|Open-label Titration Phase|Adverse Event|0|||
16961513|NCT01206816|38104488|FG001|Overall Study|Progressive disease|3|||
16961514|NCT01206816|38104489|FG002|Overall Study|Progressive disease|13|||
16961515|NCT01206816|38104490|FG003|Overall Study|Progressive disease|3|||
16961516|NCT01206816|38104491|FG004|Overall Study|Progressive disease|3|||
16961517|NCT01206816|38104492|FG005|Overall Study|Progressive disease|16|||
16961518|NCT01206816|38104493|FG006|Overall Study|Progressive disease|3|||
16961519|NCT01206816|38104487|FG000|Overall Study|Other AE|0|||
16961520|NCT01206816|38104488|FG001|Overall Study|Other AE|0|||
16961521|NCT01206816|38104489|FG002|Overall Study|Other AE|4|||
16961522|NCT01206816|38104490|FG003|Overall Study|Other AE|0|||
16776648|NCT01675167|37716033|FG002|Open-label Titration Phase|Adverse Event|0|||
16961523|NCT01206816|38104491|FG004|Overall Study|Other AE|0|||
16961524|NCT01206816|38104492|FG005|Overall Study|Other AE|3|||
16961525|NCT01206816|38104493|FG006|Overall Study|Other AE|2|||
16961526|NCT01206816|38104487|FG000|Overall Study|other than stated above|0|||
16961527|NCT01206816|38104488|FG001|Overall Study|other than stated above|0|||
16961528|NCT01206816|38104489|FG002|Overall Study|other than stated above|1|||
16961529|NCT01206816|38104490|FG003|Overall Study|other than stated above|0|||
16961530|NCT01206816|38104491|FG004|Overall Study|other than stated above|0|||
16961531|NCT01206816|38104492|FG005|Overall Study|other than stated above|0|||
16961532|NCT01206816|38104493|FG006|Overall Study|other than stated above|1|||
16961533|NCT01206582|38104515|FG000|Overall Study|Withdrew prior to study|1|||
16961534|NCT01206582|38104516|FG001|Overall Study|Withdrew prior to study|0|||
16961535|NCT01206582|38104515|FG000|Overall Study|Discontinued intervention before week 8|1|||
16961536|NCT01206582|38104516|FG001|Overall Study|Discontinued intervention before week 8|2|||
16961537|NCT01259102|38104527|FG000|Overall Study|Adverse Event|1|||
16961538|NCT01259102|38104528|FG001|Overall Study|Adverse Event|0|||
16961539|NCT01259102|38104529|FG002|Overall Study|Adverse Event|1|||
16961540|NCT01259102|38104530|FG003|Overall Study|Adverse Event|1|||
16961541|NCT01259102|38104531|FG004|Overall Study|Adverse Event|0|||
16961542|NCT01259102|38104527|FG000|Overall Study|Other|0|||
16961543|NCT01259102|38104528|FG001|Overall Study|Other|0|||
16961544|NCT01259102|38104529|FG002|Overall Study|Other|1|||
16961545|NCT01259102|38104530|FG003|Overall Study|Other|1|||
16961546|NCT01259102|38104531|FG004|Overall Study|Other|1|||
16961547|NCT00978250|38104547|FG000|Overall Study|Late determination of ineligibility|0|||
16961548|NCT00978250|38104548|FG001|Overall Study|Late determination of ineligibility|1|||
16961549|NCT00978250|38104549|FG002|Overall Study|Late determination of ineligibility|0|||
16961550|NCT00978250|38104550|FG003|Overall Study|Late determination of ineligibility|1|||
16961551|NCT01259024|38104562|FG000|Overall Study|Physician Decision|1|||
16776649|NCT01675167|37716031|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
16776650|NCT01675167|37716032|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
16776651|NCT01675167|37716033|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
16961552|NCT01257698|38104568|FG000|Overall Study|Protocol Violation|4|||
16961553|NCT01257698|38104569|FG001|Overall Study|Protocol Violation|0|||
16961554|NCT01257542|38104577|FG000|Overall Study|Protocol Violation|3|||
16961555|NCT01257542|38104578|FG001|Overall Study|Protocol Violation|5|||
16961556|NCT01257542|38104577|FG000|Overall Study|Withdrawal by Subject|0|||
16961557|NCT01257542|38104578|FG001|Overall Study|Withdrawal by Subject|2|||
16961558|NCT01257230|38104587|FG000|Overall Study|Not Treated|0|||
16961559|NCT01257230|38104588|FG001|Overall Study|Not Treated|0|||
16961560|NCT01257230|38104589|FG002|Overall Study|Not Treated|1|||
16961561|NCT01257230|38104587|FG000|Overall Study|Adverse Event|2|||
16961562|NCT01257230|38104588|FG001|Overall Study|Adverse Event|0|||
16961563|NCT01257230|38104589|FG002|Overall Study|Adverse Event|0|||
16961564|NCT01257230|38104587|FG000|Overall Study|Lack of Efficacy|0|||
16961565|NCT01257230|38104588|FG001|Overall Study|Lack of Efficacy|1|||
16961566|NCT01257230|38104589|FG002|Overall Study|Lack of Efficacy|0|||
16961567|NCT01257230|38104587|FG000|Overall Study|Protocol Violation|3|||
16961568|NCT01257230|38104588|FG001|Overall Study|Protocol Violation|0|||
16961569|NCT01257230|38104589|FG002|Overall Study|Protocol Violation|1|||
16961570|NCT01257230|38104587|FG000|Overall Study|Withdrawal by Subject|0|||
16961571|NCT01257230|38104588|FG001|Overall Study|Withdrawal by Subject|4|||
16961572|NCT01257230|38104589|FG002|Overall Study|Withdrawal by Subject|1|||
16961573|NCT01257230|38104587|FG000|Overall Study|Other reason not defined above|1|||
16961574|NCT01257230|38104588|FG001|Overall Study|Other reason not defined above|5|||
16961575|NCT01257230|38104589|FG002|Overall Study|Other reason not defined above|3|||
16961576|NCT01113801|38104602|FG000|Overall Study|Adverse Event|4|||
16961577|NCT01113801|38104603|FG001|Overall Study|Adverse Event|0|||
16961578|NCT01113801|38104604|FG002|Overall Study|Adverse Event|2|||
16961579|NCT01113801|38104605|FG003|Overall Study|Adverse Event|6|||
16961580|NCT01113801|38104602|FG000|Overall Study|Death|4|||
16961581|NCT01113801|38104603|FG001|Overall Study|Death|5|||
16961582|NCT01113801|38104604|FG002|Overall Study|Death|3|||
16961583|NCT01113801|38104605|FG003|Overall Study|Death|4|||
16961584|NCT01113801|38104602|FG000|Overall Study|Protocol Violation|0|||
16961585|NCT01113801|38104603|FG001|Overall Study|Protocol Violation|1|||
16961586|NCT01113801|38104604|FG002|Overall Study|Protocol Violation|0|||
16961587|NCT01113801|38104605|FG003|Overall Study|Protocol Violation|0|||
16961588|NCT01113801|38104602|FG000|Overall Study|Withdrawal by Subject|9|||
16961589|NCT01113801|38104603|FG001|Overall Study|Withdrawal by Subject|7|||
16961590|NCT01113801|38104604|FG002|Overall Study|Withdrawal by Subject|7|||
16961591|NCT01113801|38104605|FG003|Overall Study|Withdrawal by Subject|8|||
16961592|NCT01113801|38104602|FG000|Overall Study|Physician Decision|2|||
16961593|NCT01113801|38104603|FG001|Overall Study|Physician Decision|2|||
16961594|NCT01113801|38104604|FG002|Overall Study|Physician Decision|3|||
16961595|NCT01113801|38104605|FG003|Overall Study|Physician Decision|3|||
16961596|NCT01113801|38104602|FG000|Overall Study|Sponsor Decision|15|||
16776652|NCT01675167|37716031|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
16776653|NCT01675167|37716032|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
16961597|NCT01113801|38104603|FG001|Overall Study|Sponsor Decision|21|||
16961598|NCT01113801|38104604|FG002|Overall Study|Sponsor Decision|20|||
16961599|NCT01113801|38104605|FG003|Overall Study|Sponsor Decision|15|||
16961600|NCT01113801|38104602|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
16961601|NCT01113801|38104603|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
16961602|NCT01113801|38104604|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
16776654|NCT01675167|37716033|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
16776655|NCT01675167|37716031|FG000|Open-label Titration Phase|Protocol Violation|43|||
16961603|NCT01113801|38104605|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
16961604|NCT01256684|38104618|FG000|Overall Study|Adverse Event|1|||
16961605|NCT01256684|38104619|FG001|Overall Study|Adverse Event|4|||
16961606|NCT01256684|38104620|FG002|Overall Study|Adverse Event|2|||
16961607|NCT01256684|38104618|FG000|Overall Study|Withdrawal by Subject|4|||
16961608|NCT01256684|38104619|FG001|Overall Study|Withdrawal by Subject|0|||
16961609|NCT01256684|38104620|FG002|Overall Study|Withdrawal by Subject|2|||
16961610|NCT01256684|38104618|FG000|Overall Study|Physician Decision|0|||
16961611|NCT01256684|38104619|FG001|Overall Study|Physician Decision|1|||
16961612|NCT01256684|38104620|FG002|Overall Study|Physician Decision|0|||
16961613|NCT01256684|38104618|FG000|Overall Study|Lack of Efficacy|0|||
16961614|NCT01256684|38104619|FG001|Overall Study|Lack of Efficacy|1|||
16961615|NCT01256684|38104620|FG002|Overall Study|Lack of Efficacy|1|||
16961616|NCT01256684|38104618|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
16961617|NCT01256684|38104619|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
16961618|NCT01256684|38104620|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
16961619|NCT01204710|38104630|FG000|Randomization Treatment|Lost to Follow-up|1|||
16961620|NCT01204710|38104631|FG001|Randomization Treatment|Lost to Follow-up|0|||
16961621|NCT01204710|38104630|FG000|Randomization Treatment|Withdrawal by Subject|6|||
16961622|NCT01204710|38104631|FG001|Randomization Treatment|Withdrawal by Subject|5|||
16961623|NCT01204710|38104630|FG000|Randomization Treatment|Physician Decision|3|||
16961624|NCT01204710|38104631|FG001|Randomization Treatment|Physician Decision|2|||
16961625|NCT01204710|38104630|FG000|Randomization Treatment|Entry criteria not met|0|||
16961626|NCT01204710|38104631|FG001|Randomization Treatment|Entry criteria not met|1|||
16961627|NCT01204710|38104630|FG000|Randomization Treatment|Adverse Event|4|||
16961628|NCT01204710|38104631|FG001|Randomization Treatment|Adverse Event|2|||
16961629|NCT01204710|38104630|FG000|Randomization Treatment|Sponsor Decision|0|||
16961630|NCT01204710|38104631|FG001|Randomization Treatment|Sponsor Decision|1|||
16961631|NCT01204710|38104630|FG000|Randomization Treatment|Worsening of General condition|0|||
16961632|NCT01204710|38104631|FG001|Randomization Treatment|Worsening of General condition|1|||
16961633|NCT01204710|38104630|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
16961634|NCT01204710|38104631|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
16961635|NCT01204710|38104630|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
16776656|NCT01675167|37716032|FG001|Open-label Titration Phase|Protocol Violation|0|||
16776657|NCT01675167|37716033|FG002|Open-label Titration Phase|Protocol Violation|0|||
16776658|NCT01675167|37716031|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
16776659|NCT01675167|37716032|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
16776660|NCT01675167|37716033|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
16776661|NCT01675167|37716031|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
16776662|NCT01675167|37716032|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
16776663|NCT01675167|37716033|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
16776664|NCT01675167|37716031|FG000|Open-label Titration Phase|Other|55|||
16776665|NCT01675167|37716032|FG001|Open-label Titration Phase|Other|0|||
16776666|NCT01675167|37716033|FG002|Open-label Titration Phase|Other|0|||
16776667|NCT01675167|37716031|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
16776668|NCT01675167|37716032|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
16776669|NCT01675167|37716033|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
16776670|NCT01675167|37716031|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16776671|NCT01675167|37716032|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
16776672|NCT01675167|37716033|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
16776673|NCT01675167|37716031|FG000|Double-blind Treatment Phase|Adverse Event|0|||
16776674|NCT01675167|37716032|FG001|Double-blind Treatment Phase|Adverse Event|5|||
16776675|NCT01675167|37716033|FG002|Double-blind Treatment Phase|Adverse Event|13|||
16776676|NCT01675167|37716031|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
16776677|NCT01675167|37716032|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
16776678|NCT01675167|37716033|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
16776679|NCT01675167|37716031|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16776680|NCT01675167|37716032|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
16776681|NCT01675167|37716033|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
16776682|NCT01675167|37716031|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
16776683|NCT01675167|37716032|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
16776684|NCT01675167|37716033|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
16776685|NCT01675167|37716031|FG000|Double-blind Treatment Phase|Other|0|||
16961636|NCT01204710|38104631|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
16961637|NCT01204710|38104630|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
16961638|NCT01204710|38104631|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
16776686|NCT01675167|37716032|FG001|Double-blind Treatment Phase|Other|7|||
16776687|NCT01675167|37716033|FG002|Double-blind Treatment Phase|Other|5|||
16776688|NCT01675011|37716043|FG000|Overall Study|Trial terminated by Sponsor|3|||
16776689|NCT01675011|37716044|FG001|Overall Study|Trial terminated by Sponsor|1|||
16776690|NCT02649231|37716072|FG000|Overall Study|Adverse Event|0|||
16776691|NCT02649231|37716073|FG001|Overall Study|Adverse Event|0|||
16961639|NCT01204710|38104630|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
16776692|NCT02649231|37716074|FG002|Overall Study|Adverse Event|0|||
16776693|NCT02649231|37716075|FG003|Overall Study|Adverse Event|1|||
16776694|NCT02649231|37716072|FG000|Overall Study|Lost to Follow-up|2|||
16776695|NCT02649231|37716073|FG001|Overall Study|Lost to Follow-up|1|||
16776696|NCT02649231|37716074|FG002|Overall Study|Lost to Follow-up|1|||
16961640|NCT01204710|38104631|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
16961641|NCT01256450|38104646|FG000|Open-label Titration|Adverse Event|39|||
16961642|NCT01256450|38104647|FG001|Open-label Titration|Adverse Event|0|||
16961643|NCT01256450|38104648|FG002|Open-label Titration|Adverse Event|0|||
16961644|NCT01256450|38104646|FG000|Open-label Titration|Lost to Follow-up|7|||
16961645|NCT01256450|38104647|FG001|Open-label Titration|Lost to Follow-up|0|||
16961646|NCT01256450|38104648|FG002|Open-label Titration|Lost to Follow-up|0|||
16961647|NCT01256450|38104646|FG000|Open-label Titration|Lack of analgesic effect|30|||
16961648|NCT01256450|38104647|FG001|Open-label Titration|Lack of analgesic effect|0|||
16961649|NCT01256450|38104648|FG002|Open-label Titration|Lack of analgesic effect|0|||
16961650|NCT01256450|38104646|FG000|Open-label Titration|Non-compliance|9|||
16961651|NCT01256450|38104647|FG001|Open-label Titration|Non-compliance|0|||
16961652|NCT01256450|38104648|FG002|Open-label Titration|Non-compliance|0|||
16961653|NCT01256450|38104646|FG000|Open-label Titration|Screen failure|1|||
16961654|NCT01256450|38104647|FG001|Open-label Titration|Screen failure|0|||
16961655|NCT01256450|38104648|FG002|Open-label Titration|Screen failure|0|||
16961656|NCT01256450|38104646|FG000|Open-label Titration|Other|13|||
16961657|NCT01256450|38104647|FG001|Open-label Titration|Other|0|||
16961658|NCT01256450|38104648|FG002|Open-label Titration|Other|0|||
16961659|NCT01256450|38104646|FG000|Double-blind Treatment|Adverse Event|0|||
16961660|NCT01256450|38104647|FG001|Double-blind Treatment|Adverse Event|8|||
16961661|NCT01256450|38104648|FG002|Double-blind Treatment|Adverse Event|6|||
16961662|NCT01256450|38104646|FG000|Double-blind Treatment|Lost to Follow-up|0|||
16961663|NCT01256450|38104647|FG001|Double-blind Treatment|Lost to Follow-up|1|||
16961664|NCT01256450|38104648|FG002|Double-blind Treatment|Lost to Follow-up|7|||
16961665|NCT01256450|38104646|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
16961666|NCT01256450|38104647|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
16961667|NCT01256450|38104648|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
16961668|NCT01256450|38104646|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
16961669|NCT01256450|38104647|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
16961670|NCT01256450|38104648|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
16961671|NCT01256450|38104646|FG000|Double-blind Treatment|Non-compliance|0|||
16961672|NCT01256450|38104647|FG001|Double-blind Treatment|Non-compliance|5|||
16961673|NCT01256450|38104648|FG002|Double-blind Treatment|Non-compliance|4|||
16961674|NCT01256450|38104646|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
16961675|NCT01256450|38104647|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
16961676|NCT01256450|38104648|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
16961677|NCT01256450|38104646|FG000|Double-blind Treatment|Other|0|||
16961678|NCT01256450|38104647|FG001|Double-blind Treatment|Other|9|||
16961679|NCT01256450|38104648|FG002|Double-blind Treatment|Other|12|||
16961680|NCT01204398|38104655|FG000|Overall Study|Adverse Event|1|||
16961681|NCT01111851|38104661|FG000|Overall Study|All planned PET scans were not obtained.|2|||
16961682|NCT01111851|38104662|FG001|Overall Study|All planned PET scans were not obtained.|0|||
16961683|NCT01256294|38104668|FG000|Overall Study|Adverse Event|1|||
16776697|NCT02649231|37716075|FG003|Overall Study|Lost to Follow-up|0|||
16961684|NCT01256294|38104669|FG001|Overall Study|Adverse Event|0|||
16961685|NCT01256294|38104668|FG000|Overall Study|Withdrawal by Subject|1|||
16961686|NCT01256294|38104669|FG001|Overall Study|Withdrawal by Subject|1|||
16961687|NCT01256294|38104668|FG000|Overall Study|Protocol deviation|2|||
16776698|NCT02649231|37716072|FG000|Overall Study|Withdrawal by Subject|0|||
16961688|NCT01256294|38104669|FG001|Overall Study|Protocol deviation|1|||
16961689|NCT01256060|38104675|FG000|Overall Study|Lost to Follow-up|0|||
16961690|NCT01256060|38104676|FG001|Overall Study|Lost to Follow-up|1|||
16961691|NCT01256060|38104677|FG002|Overall Study|Lost to Follow-up|0|||
17133940|NCT00065429|38275190|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16867977|NCT01553747|37841011|FG000|Overall Study|Protocol Violation|0|||
16961692|NCT01256060|38104678|FG003|Overall Study|Lost to Follow-up|0|||
16961693|NCT01255904|38104686|FG000|Overall Study|Physician Decision|1|||
16776699|NCT02649231|37716073|FG001|Overall Study|Withdrawal by Subject|1|||
16776700|NCT02649231|37716074|FG002|Overall Study|Withdrawal by Subject|0|||
16776701|NCT02649231|37716075|FG003|Overall Study|Withdrawal by Subject|1|||
16776702|NCT02649231|37716072|FG000|Overall Study|Protocol Violation|2|||
16776703|NCT02649231|37716073|FG001|Overall Study|Protocol Violation|1|||
16776704|NCT02649231|37716074|FG002|Overall Study|Protocol Violation|1|||
16776705|NCT02649231|37716075|FG003|Overall Study|Protocol Violation|0|||
16776706|NCT01376245|37716089|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
16776707|NCT01376245|37716090|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
16776708|NCT01376245|37716091|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
16776709|NCT01376245|37716092|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
16776710|NCT01376245|37716093|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
16776711|NCT01376245|37716089|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
16776712|NCT01376245|37716090|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
16776713|NCT01376245|37716091|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
16776714|NCT01376245|37716092|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
16776715|NCT01376245|37716093|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
16961694|NCT01255904|38104687|FG001|Overall Study|Physician Decision|4|||
16961695|NCT01255670|38104695|FG000|Overall Study|Adverse Event|10|||
16961696|NCT01255670|38104696|FG001|Overall Study|Adverse Event|10|||
16961697|NCT01255670|38104695|FG000|Overall Study|Lost to Follow-up|16|||
16961698|NCT01255670|38104696|FG001|Overall Study|Lost to Follow-up|10|||
16961699|NCT01255592|38104704|FG000|Overall Study|Adverse Event|5|||
16961700|NCT01255592|38104705|FG001|Overall Study|Adverse Event|0|||
16961701|NCT01255592|38104704|FG000|Overall Study|Withdrawal by Subject|1|||
16961702|NCT01255592|38104705|FG001|Overall Study|Withdrawal by Subject|0|||
16961703|NCT01255592|38104704|FG000|Overall Study|Other|0|||
16961704|NCT01255592|38104705|FG001|Overall Study|Other|1|||
16961705|NCT01255436|38104714|FG000|Overall Study|Lost to Follow-up|178|||
16961706|NCT01255436|38104715|FG001|Overall Study|Lost to Follow-up|191|||
16961707|NCT01255436|38104714|FG000|Overall Study|Death, stroke, or MI|4|||
16961708|NCT01255436|38104715|FG001|Overall Study|Death, stroke, or MI|3|||
16961709|NCT01203930|38104723|FG000|Overall Study|Disease Progression|0|||
16961710|NCT01203930|38104724|FG001|Overall Study|Disease Progression|4|||
16961711|NCT01203930|38104723|FG000|Overall Study|Death|3|||
16961712|NCT01203930|38104724|FG001|Overall Study|Death|1|||
16961713|NCT01203930|38104723|FG000|Overall Study|Withdrew Consent|1|||
16961714|NCT01203930|38104724|FG001|Overall Study|Withdrew Consent|10|||
16961715|NCT01203930|38104723|FG000|Overall Study|Investigator Request|0|||
16961716|NCT01203930|38104724|FG001|Overall Study|Investigator Request|8|||
16961717|NCT01203930|38104723|FG000|Overall Study|Study Terminated by Sponsor|0|||
16961718|NCT01203930|38104724|FG001|Overall Study|Study Terminated by Sponsor|12|||
16961719|NCT01203930|38104723|FG000|Overall Study|Poor tolerance of study drug|0|||
16961720|NCT01203930|38104724|FG001|Overall Study|Poor tolerance of study drug|1|||
16961721|NCT01203930|38104723|FG000|Overall Study|Adverse Event|17|||
16961722|NCT01203930|38104724|FG001|Overall Study|Adverse Event|5|||
16961723|NCT01254890|38104734|FG000|Overall Study|Ineligible|0|||
16961724|NCT01254890|38104735|FG001|Overall Study|Ineligible|3|||
16961725|NCT01254890|38104734|FG000|Overall Study|Withdrawal by Subject|1|||
16961726|NCT01254890|38104735|FG001|Overall Study|Withdrawal by Subject|2|||
16961727|NCT01254890|38104734|FG000|Overall Study|Disease Progression|0|||
16961728|NCT01254890|38104735|FG001|Overall Study|Disease Progression|5|||
16961729|NCT01203852|38104740|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
16961730|NCT01203852|38104740|FG000|Washout 2 Weeks|Physician Decision|46|||
16961731|NCT01105533|38104747|FG000|Overall Study|Death|0|||
16961732|NCT01105533|38104748|FG001|Overall Study|Death|0|||
16961733|NCT01105533|38104749|FG002|Overall Study|Death|0|||
16961734|NCT01105533|38104750|FG003|Overall Study|Death|0|||
16961735|NCT01105533|38104751|FG004|Overall Study|Death|1|||
16961736|NCT01105533|38104752|FG005|Overall Study|Death|0|||
16961737|NCT01105533|38104753|FG006|Overall Study|Death|0|||
16961738|NCT01105533|38104754|FG007|Overall Study|Death|0|||
16961739|NCT01105533|38104755|FG008|Overall Study|Death|0|||
16961740|NCT01105533|38104747|FG000|Overall Study|Lack of Efficacy|1|||
16961741|NCT01105533|38104748|FG001|Overall Study|Lack of Efficacy|1|||
16961742|NCT01105533|38104749|FG002|Overall Study|Lack of Efficacy|3|||
16961743|NCT01105533|38104750|FG003|Overall Study|Lack of Efficacy|3|||
16961744|NCT01105533|38104751|FG004|Overall Study|Lack of Efficacy|4|||
16961745|NCT01105533|38104752|FG005|Overall Study|Lack of Efficacy|5|||
16961746|NCT01105533|38104753|FG006|Overall Study|Lack of Efficacy|3|||
16961747|NCT01105533|38104754|FG007|Overall Study|Lack of Efficacy|2|||
16961748|NCT01105533|38104755|FG008|Overall Study|Lack of Efficacy|9|||
17133941|NCT00065429|38275191|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16776716|NCT01376245|37716089|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
16961749|NCT01105533|38104747|FG000|Overall Study|Adverse Event|0|||
16961750|NCT01105533|38104748|FG001|Overall Study|Adverse Event|0|||
16961751|NCT01105533|38104749|FG002|Overall Study|Adverse Event|0|||
16961752|NCT01105533|38104750|FG003|Overall Study|Adverse Event|0|||
16961753|NCT01105533|38104751|FG004|Overall Study|Adverse Event|1|||
16961754|NCT01105533|38104752|FG005|Overall Study|Adverse Event|2|||
16961755|NCT01105533|38104753|FG006|Overall Study|Adverse Event|2|||
16961756|NCT01105533|38104754|FG007|Overall Study|Adverse Event|0|||
16961757|NCT01105533|38104755|FG008|Overall Study|Adverse Event|1|||
16961758|NCT01105533|38104747|FG000|Overall Study|Other|0|||
16961759|NCT01105533|38104748|FG001|Overall Study|Other|0|||
16961760|NCT01105533|38104749|FG002|Overall Study|Other|0|||
16961761|NCT01105533|38104750|FG003|Overall Study|Other|0|||
16961762|NCT01105533|38104751|FG004|Overall Study|Other|1|||
16961763|NCT01105533|38104752|FG005|Overall Study|Other|0|||
16961764|NCT01105533|38104753|FG006|Overall Study|Other|3|||
16961765|NCT01105533|38104754|FG007|Overall Study|Other|1|||
16776717|NCT01376245|37716090|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
16776718|NCT01376245|37716091|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
16776719|NCT01376245|37716092|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
16776720|NCT01376245|37716093|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
16961766|NCT01105533|38104755|FG008|Overall Study|Other|2|||
16961767|NCT01105533|38104747|FG000|Overall Study|Physician Decision|0|||
16961768|NCT01105533|38104748|FG001|Overall Study|Physician Decision|0|||
16961769|NCT01105533|38104749|FG002|Overall Study|Physician Decision|0|||
16961770|NCT01105533|38104750|FG003|Overall Study|Physician Decision|0|||
16961771|NCT01105533|38104751|FG004|Overall Study|Physician Decision|0|||
16961772|NCT01105533|38104752|FG005|Overall Study|Physician Decision|0|||
16961773|NCT01105533|38104753|FG006|Overall Study|Physician Decision|0|||
16961774|NCT01105533|38104754|FG007|Overall Study|Physician Decision|1|||
16961775|NCT01105533|38104755|FG008|Overall Study|Physician Decision|0|||
16961776|NCT01203072|38104773|FG000|Overall Study|Adverse Event|5|||
16961777|NCT01203072|38104774|FG001|Overall Study|Adverse Event|3|||
16961778|NCT01203072|38104775|FG002|Overall Study|Adverse Event|2|||
16961779|NCT01203072|38104776|FG003|Overall Study|Adverse Event|4|||
16961780|NCT01203072|38104777|FG004|Overall Study|Adverse Event|2|||
16961781|NCT01203072|38104773|FG000|Overall Study|Lack of Efficacy|1|||
16961782|NCT01203072|38104774|FG001|Overall Study|Lack of Efficacy|0|||
16961783|NCT01203072|38104775|FG002|Overall Study|Lack of Efficacy|0|||
16961784|NCT01203072|38104776|FG003|Overall Study|Lack of Efficacy|0|||
16961785|NCT01203072|38104777|FG004|Overall Study|Lack of Efficacy|0|||
16961786|NCT01203072|38104773|FG000|Overall Study|Lost to Follow-up|0|||
16961787|NCT01203072|38104774|FG001|Overall Study|Lost to Follow-up|1|||
16961788|NCT01203072|38104775|FG002|Overall Study|Lost to Follow-up|0|||
16961789|NCT01203072|38104776|FG003|Overall Study|Lost to Follow-up|0|||
16961790|NCT01203072|38104777|FG004|Overall Study|Lost to Follow-up|0|||
16961791|NCT01203072|38104773|FG000|Overall Study|Protocol Violation|2|||
16961792|NCT01203072|38104774|FG001|Overall Study|Protocol Violation|0|||
16961793|NCT01203072|38104775|FG002|Overall Study|Protocol Violation|0|||
16961794|NCT01203072|38104776|FG003|Overall Study|Protocol Violation|0|||
16961795|NCT01203072|38104777|FG004|Overall Study|Protocol Violation|1|||
16961796|NCT01203072|38104773|FG000|Overall Study|Withdrawal by Subject|2|||
16961797|NCT01203072|38104774|FG001|Overall Study|Withdrawal by Subject|2|||
16961798|NCT01203072|38104775|FG002|Overall Study|Withdrawal by Subject|1|||
16961799|NCT01203072|38104776|FG003|Overall Study|Withdrawal by Subject|2|||
16961800|NCT01203072|38104777|FG004|Overall Study|Withdrawal by Subject|3|||
16961801|NCT01105377|38104791|FG000|Overall Study|Withdrawal by Subject|0|||
16961802|NCT01105377|38104792|FG001|Overall Study|Withdrawal by Subject|1|||
16961803|NCT01105065|38104798|FG000|Overall Study|Adverse Event|5|||
16961804|NCT01105065|38104798|FG000|Overall Study|Technical Problems|1|||
16961805|NCT01111539|38104804|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
16961806|NCT01111539|38104805|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16961807|NCT01111539|38104806|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16961808|NCT01111539|38104807|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16961809|NCT01111539|38104808|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16961810|NCT01111539|38104804|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
16776721|NCT01376245|37716089|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
16776722|NCT01376245|37716090|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
16776723|NCT01376245|37716091|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
16776724|NCT01376245|37716092|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
16776725|NCT01376245|37716093|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
16776726|NCT01376245|37716089|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
16776727|NCT01376245|37716090|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
16961811|NCT01111539|38104805|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16961812|NCT01111539|38104806|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16961813|NCT01111539|38104807|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16961814|NCT01111539|38104808|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16961815|NCT01111539|38104804|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
16961816|NCT01111539|38104805|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16776728|NCT01376245|37716091|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
16776729|NCT01376245|37716092|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
16776730|NCT01376245|37716093|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
16776731|NCT01376245|37716089|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
16776732|NCT01376245|37716090|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
16776733|NCT01376245|37716091|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
16776734|NCT01376245|37716092|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
16776735|NCT01376245|37716093|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
16776736|NCT01376245|37716089|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
16776737|NCT01376245|37716090|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
16961817|NCT01111539|38104806|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16961818|NCT01111539|38104807|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16961819|NCT01111539|38104808|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16961820|NCT01111539|38104804|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
16961821|NCT01111539|38104805|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
16961822|NCT01111539|38104806|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
16961823|NCT01111539|38104807|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
16961824|NCT01111539|38104808|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
16961825|NCT01111539|38104804|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
16961826|NCT01111539|38104805|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
16961827|NCT01111539|38104806|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
16961828|NCT01111539|38104807|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
16961829|NCT01111539|38104808|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
16961830|NCT01111539|38104804|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
16961831|NCT01111539|38104805|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16961832|NCT01111539|38104806|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16961833|NCT01111539|38104807|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16961834|NCT01111539|38104808|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16961835|NCT01111539|38104804|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
16961836|NCT01111539|38104805|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
16961837|NCT01111539|38104806|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
16961838|NCT01111539|38104807|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
16776738|NCT01376245|37716091|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
16961839|NCT01111539|38104808|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
16961840|NCT01111539|38104804|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16961841|NCT01111539|38104805|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16961842|NCT01111539|38104806|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
16961843|NCT01111539|38104807|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16961844|NCT01111539|38104808|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
16961845|NCT01111539|38104804|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16961846|NCT01111539|38104805|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16961847|NCT01111539|38104806|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
16961848|NCT01111539|38104807|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16961849|NCT01111539|38104808|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
16961850|NCT01111539|38104804|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
16961851|NCT01111539|38104805|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
16961852|NCT01111539|38104806|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
16961853|NCT01111539|38104807|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
16961854|NCT01111539|38104808|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
16961855|NCT01111539|38104804|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
16961856|NCT01111539|38104805|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
16961857|NCT01111539|38104806|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
16961858|NCT01111539|38104807|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
16961859|NCT01111539|38104808|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
16961860|NCT01111539|38104804|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
16961861|NCT01111539|38104805|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
16961862|NCT01111539|38104806|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
16961863|NCT01111539|38104807|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
16961864|NCT01111539|38104808|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
16961865|NCT01111539|38104804|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
16961866|NCT01111539|38104805|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
16961867|NCT01111539|38104806|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
16961868|NCT01111539|38104807|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
16961869|NCT01111539|38104808|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
16961870|NCT01111539|38104804|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16961871|NCT01111539|38104805|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16961872|NCT01111539|38104806|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16961873|NCT01111539|38104807|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16961874|NCT01111539|38104808|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
16961875|NCT01111461|38104818|FG000|Overall Study|Adverse Event|32|||
16776739|NCT01376245|37716092|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
16776740|NCT01376245|37716093|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
16776741|NCT01376245|37716089|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16776742|NCT01376245|37716090|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
16776743|NCT01376245|37716091|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16776744|NCT01376245|37716092|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
16961876|NCT01111461|38104818|FG000|Overall Study|Participant choice|11|||
16961877|NCT01111461|38104818|FG000|Overall Study|Lost to Follow-up|1|||
16776745|NCT01376245|37716093|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
16776746|NCT01376245|37716089|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16776747|NCT01376245|37716090|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
16776748|NCT01376245|37716091|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
16776749|NCT01376245|37716092|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
16776750|NCT01376245|37716093|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16776751|NCT01376245|37716089|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16776752|NCT01376245|37716090|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
16961878|NCT01111461|38104818|FG000|Overall Study|Withdrawal by Subject|1|||
16961879|NCT01111461|38104818|FG000|Overall Study|Other|6|||
16961880|NCT01111149|38104825|FG000|Overall Study|Protocol Violation|1|||
16961881|NCT01111149|38104826|FG001|Overall Study|Protocol Violation|1|||
16961882|NCT01111149|38104827|FG002|Overall Study|Protocol Violation|2|||
16961883|NCT01111149|38104825|FG000|Overall Study|Withdrawal by Subject|1|||
16961884|NCT01111149|38104826|FG001|Overall Study|Withdrawal by Subject|0|||
16961885|NCT01111149|38104827|FG002|Overall Study|Withdrawal by Subject|2|||
16961886|NCT01254656|38104838|FG000|Overall Study|Discontinued due to termination of study|40|||
16961887|NCT01254656|38104839|FG001|Overall Study|Discontinued due to termination of study|39|||
16961888|NCT01254656|38104840|FG002|Overall Study|Discontinued due to termination of study|13|||
16961889|NCT01254656|38104838|FG000|Overall Study|Lack of Efficacy|3|||
16961890|NCT01254656|38104839|FG001|Overall Study|Lack of Efficacy|0|||
16961891|NCT01254656|38104840|FG002|Overall Study|Lack of Efficacy|0|||
16961892|NCT01254656|38104838|FG000|Overall Study|Lost to Follow-up|1|||
16961893|NCT01254656|38104839|FG001|Overall Study|Lost to Follow-up|0|||
16961894|NCT01254656|38104840|FG002|Overall Study|Lost to Follow-up|2|||
16961895|NCT01254656|38104838|FG000|Overall Study|Withdrawal by Subject|2|||
16961896|NCT01254656|38104839|FG001|Overall Study|Withdrawal by Subject|2|||
16961897|NCT01254656|38104840|FG002|Overall Study|Withdrawal by Subject|1|||
16961898|NCT01254656|38104838|FG000|Overall Study|Pregnancy|0|||
16961899|NCT01254656|38104839|FG001|Overall Study|Pregnancy|0|||
16961900|NCT01254656|38104840|FG002|Overall Study|Pregnancy|2|||
16961901|NCT01254656|38104838|FG000|Overall Study|Adverse Event|1|||
16961902|NCT01254656|38104839|FG001|Overall Study|Adverse Event|1|||
16961903|NCT01254656|38104840|FG002|Overall Study|Adverse Event|0|||
16961904|NCT01254656|38104838|FG000|Overall Study|Death|0|||
16961905|NCT01254656|38104839|FG001|Overall Study|Death|1|||
16961906|NCT01254656|38104840|FG002|Overall Study|Death|0|||
16961907|NCT01110915|38104850|FG000|Overall Study|Death|2|||
16961908|NCT01110915|38104851|FG001|Overall Study|Death|1|||
16961909|NCT01110915|38104850|FG000|Overall Study|Lost to Follow-up|1|||
16961910|NCT01110915|38104851|FG001|Overall Study|Lost to Follow-up|0|||
16961911|NCT01110915|38104850|FG000|Overall Study|Withdrawal by Subject|7|||
16961912|NCT01110915|38104851|FG001|Overall Study|Withdrawal by Subject|1|||
16961913|NCT01254344|38104860|FG000|Overall Study|Adverse Event|2|||
16961914|NCT01254344|38104861|FG001|Overall Study|Adverse Event|5|||
16961915|NCT01254344|38104860|FG000|Overall Study|Physician Decision|7|||
16961916|NCT01254344|38104861|FG001|Overall Study|Physician Decision|4|||
16961917|NCT01254344|38104860|FG000|Overall Study|Protocol Violation|1|||
16961918|NCT01254344|38104861|FG001|Overall Study|Protocol Violation|4|||
16961919|NCT01254344|38104860|FG000|Overall Study|Withdrawal by Subject|3|||
16961920|NCT01254344|38104861|FG001|Overall Study|Withdrawal by Subject|6|||
16961921|NCT01102803|38104869|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
16961922|NCT01102803|38104870|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
16961923|NCT01102803|38104869|FG000|Post to Follow-Up|Lost to Follow-up|1|||
16961924|NCT01102803|38104870|FG001|Post to Follow-Up|Lost to Follow-up|3|||
16961925|NCT01254188|38104878|FG000|Overall Study|Disease Progression|6|||
16961926|NCT01254188|38104878|FG000|Overall Study|Protocol Violation|6|||
16961927|NCT01254188|38104878|FG000|Overall Study|Pregnancy|2|||
16961928|NCT01254188|38104878|FG000|Overall Study|Death|4|||
16961929|NCT01254188|38104878|FG000|Overall Study|Lost to Follow-up|5|||
16961930|NCT01254188|38104878|FG000|Overall Study|Withdrawal by Subject|7|||
16961931|NCT01254188|38104878|FG000|Overall Study|Adverse Event|43|||
16961932|NCT01254188|38104878|FG000|Overall Study|per investigator discretion|20|||
16961933|NCT01109979|38104884|FG000|Overall Study|Physician Decision|2|||
16961934|NCT01109979|38104885|FG001|Overall Study|Physician Decision|0|||
16961935|NCT01109979|38104884|FG000|Overall Study|Withdrawal by Subject|0|||
16961936|NCT01109979|38104885|FG001|Overall Study|Withdrawal by Subject|1|||
16961937|NCT01102491|38104893|FG000|Overall Study|Protocol Violation|11|||
16961938|NCT01102491|38104894|FG001|Overall Study|Protocol Violation|12|||
16961939|NCT01102257|38104902|FG000|Overall Study|Adverse Event|1|||
16961940|NCT01102257|38104903|FG001|Overall Study|Adverse Event|0|||
16961941|NCT01102257|38104902|FG000|Overall Study|Adverse Event|1|||
16961942|NCT01102257|38104903|FG001|Overall Study|Adverse Event|0|||
16961943|NCT01253564|38104909|FG000|Overall Study|Disease Progression|22|||
16961944|NCT01253564|38104909|FG000|Overall Study|Withdrawal by Subject|1|||
16961945|NCT01253564|38104909|FG000|Overall Study|Serious Adverse Event|1|||
16961946|NCT01108809|38104913|FG000|Overall Study|Adverse Event|3|||
16961947|NCT01108809|38104913|FG000|Overall Study|Lost to Follow-up|1|||
16961948|NCT01253408|38104921|FG000|Overall Study|Adverse Event|0|||
16961949|NCT01253408|38104922|FG001|Overall Study|Adverse Event|1|||
16961950|NCT01253408|38104923|FG002|Overall Study|Adverse Event|0|||
16961951|NCT01253174|38104931|FG000|Period 1|Randomized but not treated|0|||
16961952|NCT01253174|38104932|FG001|Period 1|Randomized but not treated|1|||
16961953|NCT01253174|38104933|FG002|Period 1|Randomized but not treated|1|||
16961954|NCT01253174|38104934|FG003|Period 1|Randomized but not treated|0|||
16961955|NCT01253174|38104935|FG004|Period 1|Randomized but not treated|1|||
16961956|NCT01253174|38104936|FG005|Period 1|Randomized but not treated|0|||
16961957|NCT01253174|38104931|FG000|Period 2|Adverse Event|0|||
16961958|NCT01253174|38104932|FG001|Period 2|Adverse Event|0|||
16961959|NCT01253174|38104933|FG002|Period 2|Adverse Event|1|||
16961960|NCT01253174|38104934|FG003|Period 2|Adverse Event|0|||
16961961|NCT01253174|38104935|FG004|Period 2|Adverse Event|0|||
16961962|NCT01253174|38104936|FG005|Period 2|Adverse Event|0|||
16961963|NCT01253174|38104931|FG000|Period 3|Withdrawal by Subject|0|||
16961964|NCT01253174|38104932|FG001|Period 3|Withdrawal by Subject|1|||
16961965|NCT01253174|38104933|FG002|Period 3|Withdrawal by Subject|0|||
16961966|NCT01253174|38104934|FG003|Period 3|Withdrawal by Subject|0|||
16961967|NCT01253174|38104935|FG004|Period 3|Withdrawal by Subject|1|||
16961968|NCT01253174|38104936|FG005|Period 3|Withdrawal by Subject|0|||
16961969|NCT01253174|38104931|FG000|Period 3|Pregnancy|0|||
16961970|NCT01253174|38104932|FG001|Period 3|Pregnancy|0|||
16961971|NCT01253174|38104933|FG002|Period 3|Pregnancy|1|||
16961972|NCT01253174|38104934|FG003|Period 3|Pregnancy|0|||
16961973|NCT01253174|38104935|FG004|Period 3|Pregnancy|0|||
16961974|NCT01253174|38104936|FG005|Period 3|Pregnancy|0|||
16961975|NCT01108731|38104947|FG000|Overall Study|Withdrawal by Subject|1|||
16961976|NCT01108731|38104948|FG001|Overall Study|Withdrawal by Subject|1|||
16961977|NCT01108731|38104947|FG000|Overall Study|Adverse Event|3|||
16961978|NCT01108731|38104948|FG001|Overall Study|Adverse Event|3|||
16776753|NCT01376245|37716091|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16776754|NCT01376245|37716092|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16776755|NCT01376245|37716093|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16776756|NCT01376245|37716089|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
16776757|NCT01376245|37716090|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
16776758|NCT01376245|37716091|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
16776759|NCT01376245|37716092|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
16776760|NCT01376245|37716093|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
16776761|NCT01376245|37716089|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16776762|NCT01376245|37716090|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
16776763|NCT01376245|37716091|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16776764|NCT01376245|37716092|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
16776765|NCT01376245|37716093|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
16776766|NCT01674621|37716108|FG000|Overall Study|Adverse Event|3|||
16776767|NCT01674621|37716109|FG001|Overall Study|Adverse Event|2|||
16776768|NCT01674621|37716110|FG002|Overall Study|Adverse Event|5|||
16961979|NCT01253018|38104956|FG000|Overall Study|Lost to Follow-up|1|||
16961980|NCT01253018|38104957|FG001|Overall Study|Lost to Follow-up|1|||
16961981|NCT01253018|38104956|FG000|Overall Study|Robot Repair Issues|2|||
16961982|NCT01253018|38104957|FG001|Overall Study|Robot Repair Issues|0|||
16961983|NCT01253018|38104956|FG000|Overall Study|Withdrawal by Subject|1|||
16961984|NCT01253018|38104957|FG001|Overall Study|Withdrawal by Subject|1|||
16961985|NCT01108341|38104964|FG000|Overall Study|Death|2|||
16961986|NCT01108341|38104964|FG000|Overall Study|Withdrawal by Subject|1|||
16961987|NCT01108341|38104964|FG000|Overall Study|Lost to Follow-up|1|||
16961988|NCT01108341|38104964|FG000|Overall Study|Other|1|||
16961989|NCT01108263|38104970|FG000|Overall Study|Adverse Event|0|||
16961990|NCT01108263|38104971|FG001|Overall Study|Adverse Event|1|||
16961991|NCT01108185|38104977|FG000|Overall Study|Non-compliance|15|||
16961992|NCT01108185|38104977|FG000|Overall Study|Lost to Follow-up|12|||
16961993|NCT01252940|38104983|FG000|Main Study Phase|Randomized but not treated|4|||
16961994|NCT01252940|38104984|FG001|Main Study Phase|Randomized but not treated|2|||
16961995|NCT01252940|38104983|FG000|Main Study Phase|Adverse Event|3|||
16961996|NCT01252940|38104984|FG001|Main Study Phase|Adverse Event|1|||
16961997|NCT01252940|38104983|FG000|Main Study Phase|Lack of Efficacy|1|||
16961998|NCT01252940|38104984|FG001|Main Study Phase|Lack of Efficacy|0|||
16961999|NCT01252940|38104983|FG000|Main Study Phase|Lost to Follow-up|6|||
16962000|NCT01252940|38104984|FG001|Main Study Phase|Lost to Follow-up|1|||
16962001|NCT01252940|38104983|FG000|Main Study Phase|Physician Decision|1|||
16962002|NCT01252940|38104984|FG001|Main Study Phase|Physician Decision|0|||
16962003|NCT01252940|38104983|FG000|Main Study Phase|Protocol Violation|4|||
16962004|NCT01252940|38104984|FG001|Main Study Phase|Protocol Violation|2|||
16962005|NCT01252940|38104983|FG000|Main Study Phase|Withdrawal by Subject|6|||
16962006|NCT01252940|38104984|FG001|Main Study Phase|Withdrawal by Subject|5|||
16962007|NCT01252940|38104983|FG000|Main Study Phase|Subject Non-compliance|1|||
16962008|NCT01252940|38104984|FG001|Main Study Phase|Subject Non-compliance|1|||
16962009|NCT01252940|38104983|FG000|Extension Phase|Adverse Event|2|||
16962010|NCT01252940|38104984|FG001|Extension Phase|Adverse Event|1|||
16962011|NCT01252940|38104983|FG000|Extension Phase|Lack of Efficacy|1|||
16962012|NCT01252940|38104984|FG001|Extension Phase|Lack of Efficacy|0|||
16962013|NCT01252940|38104983|FG000|Extension Phase|Lost to Follow-up|5|||
16962014|NCT01252940|38104984|FG001|Extension Phase|Lost to Follow-up|0|||
16962015|NCT01252940|38104983|FG000|Extension Phase|Physician Decision|0|||
16962016|NCT01252940|38104984|FG001|Extension Phase|Physician Decision|1|||
16962017|NCT01252940|38104983|FG000|Extension Phase|Subject Non-compliance|1|||
16962018|NCT01252940|38104984|FG001|Extension Phase|Subject Non-compliance|0|||
16962019|NCT01252940|38104983|FG000|Extension Phase|Withdrawal by Subject|1|||
16962020|NCT01252940|38104984|FG001|Extension Phase|Withdrawal by Subject|1|||
16962021|NCT01252238|38104994|FG000|Overall Study|Sponsor terminated study|4|||
16962022|NCT01252238|38104995|FG001|Overall Study|Sponsor terminated study|4|||
16962023|NCT01252238|38104996|FG002|Overall Study|Sponsor terminated study|4|||
16962024|NCT01101477|38105010|FG000|Overall Study|Protocol Violation|5|||
16962025|NCT01101477|38105011|FG001|Overall Study|Protocol Violation|3|||
16962026|NCT01101477|38105012|FG002|Overall Study|Protocol Violation|1|||
16962027|NCT01251770|38105022|FG000|Overall Study|Protocol Violation|13|||
16962028|NCT01251770|38105023|FG001|Overall Study|Protocol Violation|7|||
16962029|NCT01101321|38105029|FG000|Period 1|Withdrawal by Subject|1|||
16962030|NCT01101321|38105030|FG001|Period 1|Withdrawal by Subject|1|||
16962031|NCT01101321|38105029|FG000|Period 1|Adverse Event|3|||
16962032|NCT01101321|38105030|FG001|Period 1|Adverse Event|3|||
16962033|NCT01101165|38105036|FG000|Period 1|Adverse Event|1|||
16962034|NCT01101165|38105037|FG001|Period 1|Adverse Event|2|||
16962035|NCT01101165|38105036|FG000|Period 1|Withdrawal by Subject|0|||
16962036|NCT01101165|38105037|FG001|Period 1|Withdrawal by Subject|2|||
16962037|NCT01101165|38105036|FG000|Period 1|Positive Drug Screen|0|||
16962038|NCT01101165|38105037|FG001|Period 1|Positive Drug Screen|1|||
16962039|NCT01101165|38105036|FG000|Period 1|Lost to Follow-up|1|||
16962040|NCT01101165|38105037|FG001|Period 1|Lost to Follow-up|0|||
16962041|NCT01101165|38105036|FG000|Period 2|Withdrawal by Subject|3|||
16962042|NCT01101165|38105037|FG001|Period 2|Withdrawal by Subject|1|||
16962043|NCT01101165|38105036|FG000|Period 2|Adverse Event|1|||
16962044|NCT01101165|38105037|FG001|Period 2|Adverse Event|0|||
16962045|NCT01100853|38105045|FG000|Overall Study|Lost to Follow-up|11|||
16962046|NCT01100853|38105046|FG001|Overall Study|Lost to Follow-up|6|||
16962047|NCT01100853|38105045|FG000|Overall Study|Received <4 study injections|10|||
16962048|NCT01100853|38105046|FG001|Overall Study|Received <4 study injections|13|||
16962049|NCT01100853|38105045|FG000|Overall Study|Withdrawal by Subject|6|||
16962050|NCT01100853|38105046|FG001|Overall Study|Withdrawal by Subject|4|||
16962051|NCT01100307|38105054|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
16962052|NCT01100307|38105055|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
16962053|NCT01100307|38105054|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
16962054|NCT01100307|38105055|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
16962055|NCT01100307|38105054|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
16962056|NCT01100307|38105055|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
16962057|NCT01100307|38105054|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
16962058|NCT01100307|38105055|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
16962059|NCT01100307|38105054|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
16962060|NCT01100307|38105055|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
16962061|NCT01100307|38105054|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
16962062|NCT01100307|38105055|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
16962063|NCT01100073|38105063|FG000|Overall Study|Lack of Efficacy|4|||
16962064|NCT01100073|38105063|FG000|Overall Study|Insufficient Tolerability|21|||
16962065|NCT01100073|38105063|FG000|Overall Study|Withdrawal by Subject|13|||
16962066|NCT01100073|38105063|FG000|Overall Study|Lost to Follow-up|39|||
16962067|NCT01100073|38105063|FG000|Overall Study|Lack of effect + patient's wish|2|||
16962068|NCT01100073|38105063|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
16962069|NCT01100073|38105063|FG000|Overall Study|Other|8|||
16962070|NCT01100073|38105063|FG000|Overall Study|Missing|5|||
16962071|NCT01099917|38105067|FG000|Overall Study|Adverse Event|3|||
16962072|NCT01099917|38105067|FG000|Overall Study|Not Treated|24|||
16962073|NCT01099215|38105073|FG000|Overall Study|Withdrawal by Subject|1|||
16962074|NCT01099215|38105074|FG001|Overall Study|Withdrawal by Subject|0|||
16962075|NCT01099215|38105073|FG000|Overall Study|Adverse Event|0|||
16962076|NCT01099215|38105074|FG001|Overall Study|Adverse Event|1|||
16962077|NCT01097655|38105110|FG000|Overall Study|Withdrawal by Subject|1|||
16962078|NCT01097655|38105110|FG000|Overall Study|Subject Documented Twice|1|||
16962079|NCT01097655|38105110|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
16962080|NCT01107405|38105119|FG000|Overall Study|Adverse Event|1|||
16962081|NCT01107405|38105120|FG001|Overall Study|Adverse Event|1|||
16962082|NCT01107405|38105121|FG002|Overall Study|Adverse Event|0|||
16962083|NCT01107405|38105122|FG003|Overall Study|Adverse Event|0|||
16962084|NCT01107405|38105123|FG004|Overall Study|Adverse Event|2|||
16962085|NCT01107405|38105119|FG000|Overall Study|Withdrawal by Subject|1|||
16962086|NCT01107405|38105120|FG001|Overall Study|Withdrawal by Subject|0|||
16962087|NCT01107405|38105121|FG002|Overall Study|Withdrawal by Subject|1|||
16962088|NCT01107405|38105122|FG003|Overall Study|Withdrawal by Subject|2|||
16962089|NCT01107405|38105123|FG004|Overall Study|Withdrawal by Subject|1|||
16962090|NCT01107405|38105119|FG000|Overall Study|Protocol Violation|0|||
16962091|NCT01107405|38105120|FG001|Overall Study|Protocol Violation|0|||
16962092|NCT01107405|38105121|FG002|Overall Study|Protocol Violation|1|||
16962093|NCT01107405|38105122|FG003|Overall Study|Protocol Violation|1|||
16962094|NCT01107405|38105123|FG004|Overall Study|Protocol Violation|0|||
16962095|NCT01097577|38105137|FG000|Overall Study|Adverse Event|0|||
16962096|NCT01097577|38105138|FG001|Overall Study|Adverse Event|1|||
16962097|NCT01097421|38105144|FG000|Overall Study|Adverse Event|8|||
16962098|NCT01097421|38105144|FG000|Overall Study|Protocol Violation|2|||
16962099|NCT01097421|38105144|FG000|Overall Study|Lost to Follow-up|1|||
16962100|NCT01097421|38105144|FG000|Overall Study|Withdrawal by Subject|3|||
16962101|NCT01251614|38105151|FG000|Overall Study|Adverse Event|1|||
16962102|NCT01251614|38105152|FG001|Overall Study|Adverse Event|0|||
16962103|NCT01251614|38105153|FG002|Overall Study|Adverse Event|1|||
16962104|NCT01251614|38105151|FG000|Overall Study|Lack of Efficacy|1|||
16962105|NCT01251614|38105152|FG001|Overall Study|Lack of Efficacy|9|||
16962106|NCT01251614|38105153|FG002|Overall Study|Lack of Efficacy|4|||
16962107|NCT01251614|38105151|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
16962108|NCT01251614|38105152|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
16962109|NCT01251614|38105153|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
16962110|NCT01251614|38105151|FG000|Overall Study|Pregnancy|0|||
16962111|NCT01251614|38105152|FG001|Overall Study|Pregnancy|0|||
16962112|NCT01251614|38105153|FG002|Overall Study|Pregnancy|2|||
16962113|NCT01251614|38105151|FG000|Overall Study|Loss of Disease Control|0|||
16962114|NCT01251614|38105152|FG001|Overall Study|Loss of Disease Control|1|||
16962115|NCT01251614|38105153|FG002|Overall Study|Loss of Disease Control|0|||
16962116|NCT01251614|38105151|FG000|Overall Study|Withdrawal by Subject|0|||
16962117|NCT01251614|38105152|FG001|Overall Study|Withdrawal by Subject|2|||
16962118|NCT01251614|38105153|FG002|Overall Study|Withdrawal by Subject|1|||
16962119|NCT01251614|38105151|FG000|Overall Study|Lost to Follow-up|0|||
16962120|NCT01251614|38105152|FG001|Overall Study|Lost to Follow-up|1|||
16962121|NCT01251614|38105153|FG002|Overall Study|Lost to Follow-up|0|||
16962122|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
16962123|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
16962124|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
16776769|NCT01674621|37716111|FG003|Overall Study|Adverse Event|5|||
16776770|NCT01674621|37716112|FG004|Overall Study|Adverse Event|1|||
16776771|NCT01674621|37716108|FG000|Overall Study|Inability to Complete Study Procedures|0|||
16776772|NCT01674621|37716109|FG001|Overall Study|Inability to Complete Study Procedures|0|||
16776773|NCT01674621|37716110|FG002|Overall Study|Inability to Complete Study Procedures|0|||
16776774|NCT01674621|37716111|FG003|Overall Study|Inability to Complete Study Procedures|0|||
16776775|NCT01674621|37716112|FG004|Overall Study|Inability to Complete Study Procedures|2|||
16776776|NCT01674621|37716108|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
16776777|NCT01674621|37716109|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
16776778|NCT01674621|37716110|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
16962125|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
16962126|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
16962127|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
16962128|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
16962129|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
16962130|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
16962131|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
16962132|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
16962133|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
16962134|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
16962135|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
16962136|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
16962137|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
16962138|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
16962139|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16962140|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
16962141|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
16962142|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
16962143|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16962144|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16962145|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16962146|NCT01106625|38105174|FG000|Core Period: Baseline to Week 26|Other|8|||
16962147|NCT01106625|38105175|FG001|Core Period: Baseline to Week 26|Other|7|||
16962148|NCT01106625|38105176|FG002|Core Period: Baseline to Week 26|Other|4|||
16962149|NCT01106625|38105174|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
16962150|NCT01106625|38105175|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
16962151|NCT01106625|38105176|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
16962152|NCT01106625|38105174|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
16962153|NCT01106625|38105175|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
16962154|NCT01106625|38105176|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
16962155|NCT01106625|38105174|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16962156|NCT01106625|38105175|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16962157|NCT01106625|38105176|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
16867978|NCT01553747|37841012|FG001|Overall Study|Protocol Violation|2|||
16962158|NCT01106625|38105174|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16962159|NCT01106625|38105175|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16962160|NCT01106625|38105176|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16962161|NCT01106625|38105174|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
16962162|NCT01106625|38105175|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16962163|NCT01106625|38105176|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16962164|NCT01106625|38105174|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
16962165|NCT01106625|38105175|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
16962166|NCT01106625|38105176|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
16962167|NCT01106625|38105174|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
16962168|NCT01106625|38105175|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
16962169|NCT01106625|38105176|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
16962170|NCT01106625|38105174|FG000|Extension Period: Week 26 to Week 52|Other|5|||
16962171|NCT01106625|38105175|FG001|Extension Period: Week 26 to Week 52|Other|5|||
16962172|NCT01106625|38105176|FG002|Extension Period: Week 26 to Week 52|Other|4|||
16962173|NCT01251380|38105187|FG000|Overall Study|Other (Not otherwise specified)|12|||
16962174|NCT01251380|38105187|FG000|Overall Study|Withdrawal by Subject|6|||
16962175|NCT01251380|38105187|FG000|Overall Study|Lack of Efficacy|1|||
16962176|NCT01251380|38105187|FG000|Overall Study|Adverse Event|1|||
16962177|NCT01251380|38105187|FG000|Overall Study|Lost to Follow-up|2|||
16962178|NCT01251146|38105198|FG000|Overall Study|Lost to Follow-up|3|||
16776779|NCT01674621|37716111|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
16776780|NCT01674621|37716112|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
16776781|NCT01674621|37716108|FG000|Overall Study|Withdrawal by Subject|2|||
16962179|NCT01251146|38105199|FG001|Overall Study|Lost to Follow-up|10|||
16962180|NCT01096017|38105205|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
16962181|NCT01096017|38105206|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
16962182|NCT01106157|38105214|FG000|Overall Study|Withdrawal by Subject|1|||
16962183|NCT01106157|38105215|FG001|Overall Study|Withdrawal by Subject|0|||
16962184|NCT01094301|38105221|FG000|Trial Stage|Withdrawal by Subject|1|||
16776782|NCT01674621|37716109|FG001|Overall Study|Withdrawal by Subject|5|||
16776783|NCT01674621|37716110|FG002|Overall Study|Withdrawal by Subject|2|||
16962185|NCT01094301|38105221|FG000|Implant Stage|Adverse Event|1|||
16962186|NCT01094301|38105221|FG000|Implant Stage|Protocol Violation|1|||
16962187|NCT01094301|38105221|FG000|Implant Stage|Withdrawal by Subject|2|||
16962188|NCT01094301|38105221|FG000|Implant Stage|No return of pain|4|||
16962189|NCT01093755|38105229|FG000|Overall Study|Withdrawal by Subject|3|||
16962190|NCT01093755|38105230|FG001|Overall Study|Withdrawal by Subject|4|||
16776784|NCT01674621|37716111|FG003|Overall Study|Withdrawal by Subject|0|||
16776785|NCT01674621|37716112|FG004|Overall Study|Withdrawal by Subject|1|||
16776786|NCT01674621|37716108|FG000|Overall Study|Other than specified|0|||
16776787|NCT01674621|37716109|FG001|Overall Study|Other than specified|1|||
16776788|NCT01674621|37716110|FG002|Overall Study|Other than specified|0|||
16776789|NCT01674621|37716111|FG003|Overall Study|Other than specified|0|||
16776790|NCT01674621|37716112|FG004|Overall Study|Other than specified|2|||
16776791|NCT02730169|37716129|FG000|Overall Study|Protocol Violation|1|||
16962191|NCT01093599|38105238|FG000|Overall Study|Lost to Follow-up|32|||
16962192|NCT01093599|38105239|FG001|Overall Study|Lost to Follow-up|46|||
16962193|NCT01092663|38105247|FG000|Overall Study|Withdrawal by Subject|3|||
16962194|NCT01092663|38105248|FG001|Overall Study|Withdrawal by Subject|2|||
16962195|NCT01092663|38105247|FG000|Overall Study|Glucose >300mg/dL|1|||
16962196|NCT01092663|38105248|FG001|Overall Study|Glucose >300mg/dL|0|||
16962197|NCT01092663|38105247|FG000|Overall Study|High fasting triglyceride|2|||
16962198|NCT01092663|38105248|FG001|Overall Study|High fasting triglyceride|0|||
16962199|NCT01092663|38105247|FG000|Overall Study|Adverse Event|1|||
16962200|NCT01092663|38105248|FG001|Overall Study|Adverse Event|1|||
16962201|NCT01092663|38105247|FG000|Overall Study|Protocol Violation|0|||
16776792|NCT02730169|37716130|FG001|Overall Study|Protocol Violation|0|||
16776793|NCT02730169|37716131|FG002|Overall Study|Protocol Violation|0|||
16962202|NCT01092663|38105248|FG001|Overall Study|Protocol Violation|1|||
16962203|NCT01078623|38105259|FG000|Treatment Period 1|Adverse Event|1|||
16962204|NCT01078623|38105260|FG001|Treatment Period 1|Adverse Event|1|||
16776794|NCT02730169|37716132|FG003|Overall Study|Protocol Violation|1|||
16776795|NCT02730169|37716129|FG000|Overall Study|Adverse Event|2|||
16962205|NCT01078623|38105261|FG002|Treatment Period 1|Adverse Event|1|||
16962206|NCT01078623|38105262|FG003|Treatment Period 1|Adverse Event|0|||
16962207|NCT01078623|38105263|FG004|Treatment Period 1|Adverse Event|0|||
16962208|NCT01078623|38105264|FG005|Treatment Period 1|Adverse Event|0|||
16962209|NCT01078623|38105265|FG006|Treatment Period 1|Adverse Event|1|||
16962210|NCT01078623|38105266|FG007|Treatment Period 1|Adverse Event|0|||
16962211|NCT01078623|38105267|FG008|Treatment Period 1|Adverse Event|1|||
16962212|NCT01078623|38105268|FG009|Treatment Period 1|Adverse Event|1|||
16776796|NCT02730169|37716130|FG001|Overall Study|Adverse Event|3|||
16776797|NCT02730169|37716131|FG002|Overall Study|Adverse Event|3|||
16776798|NCT02730169|37716132|FG003|Overall Study|Adverse Event|0|||
16776799|NCT02730169|37716129|FG000|Overall Study|Adverse Event of Special Interest|0|||
16776800|NCT02730169|37716130|FG001|Overall Study|Adverse Event of Special Interest|1|||
16776801|NCT02730169|37716131|FG002|Overall Study|Adverse Event of Special Interest|2|||
16776802|NCT02730169|37716132|FG003|Overall Study|Adverse Event of Special Interest|0|||
16776803|NCT02730169|37716129|FG000|Overall Study|Withdrawal by Subject|6|||
16962213|NCT01078623|38105269|FG010|Treatment Period 1|Adverse Event|0|||
16962214|NCT01078623|38105270|FG011|Treatment Period 1|Adverse Event|0|||
16776804|NCT02730169|37716130|FG001|Overall Study|Withdrawal by Subject|11|||
16776805|NCT02730169|37716131|FG002|Overall Study|Withdrawal by Subject|6|||
16776806|NCT02730169|37716132|FG003|Overall Study|Withdrawal by Subject|8|||
16776807|NCT02730169|37716129|FG000|Overall Study|Lost to Follow-up|5|||
16776808|NCT02730169|37716130|FG001|Overall Study|Lost to Follow-up|6|||
16776809|NCT02730169|37716131|FG002|Overall Study|Lost to Follow-up|5|||
16776810|NCT02730169|37716132|FG003|Overall Study|Lost to Follow-up|6|||
16776811|NCT02730169|37716129|FG000|Overall Study|Other|0|||
16776812|NCT02730169|37716130|FG001|Overall Study|Other|0|||
16776813|NCT02730169|37716131|FG002|Overall Study|Other|1|||
16776814|NCT02730169|37716132|FG003|Overall Study|Other|1|||
16776815|NCT02648217|37716144|FG000|Overall Study|Adverse Event|0|||
16776816|NCT02648217|37716145|FG001|Overall Study|Adverse Event|1|||
16776817|NCT02648217|37716144|FG000|Overall Study|Lost to Follow-up|1|||
16776818|NCT02648217|37716145|FG001|Overall Study|Lost to Follow-up|1|||
16776819|NCT02648217|37716144|FG000|Overall Study|Withdrawal by Subject|4|||
16776820|NCT02648217|37716145|FG001|Overall Study|Withdrawal by Subject|3|||
16776821|NCT02648217|37716144|FG000|Overall Study|Unclassified|5|||
16776822|NCT02648217|37716145|FG001|Overall Study|Unclassified|0|||
16962215|NCT01078623|38105271|FG012|Treatment Period 1|Adverse Event|0|||
16962216|NCT01078623|38105272|FG013|Treatment Period 1|Adverse Event|0|||
16962217|NCT01078623|38105273|FG014|Treatment Period 1|Adverse Event|0|||
16962218|NCT01078623|38105274|FG015|Treatment Period 1|Adverse Event|0|||
16962219|NCT01078623|38105275|FG016|Treatment Period 1|Adverse Event|0|||
16962220|NCT01078623|38105276|FG017|Treatment Period 1|Adverse Event|0|||
16962221|NCT01078623|38105277|FG018|Treatment Period 1|Adverse Event|0|||
16962222|NCT01078623|38105278|FG019|Treatment Period 1|Adverse Event|0|||
16962223|NCT01078623|38105259|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16962224|NCT01078623|38105260|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16962225|NCT01078623|38105261|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16776823|NCT00709735|37716153|FG000|Overall Study|Lost to Follow-up|1|||
16962226|NCT01078623|38105262|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16962227|NCT01078623|38105263|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16962228|NCT01078623|38105264|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16962229|NCT01078623|38105265|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16962230|NCT01078623|38105266|FG007|Treatment Period 1|Withdrawal by Subject|1|||
16962231|NCT01078623|38105267|FG008|Treatment Period 1|Withdrawal by Subject|0|||
16962232|NCT01078623|38105268|FG009|Treatment Period 1|Withdrawal by Subject|0|||
16962233|NCT01078623|38105269|FG010|Treatment Period 1|Withdrawal by Subject|1|||
16962234|NCT01078623|38105270|FG011|Treatment Period 1|Withdrawal by Subject|0|||
16962235|NCT01078623|38105271|FG012|Treatment Period 1|Withdrawal by Subject|0|||
16962236|NCT01078623|38105272|FG013|Treatment Period 1|Withdrawal by Subject|0|||
16962237|NCT01078623|38105273|FG014|Treatment Period 1|Withdrawal by Subject|0|||
16962238|NCT01078623|38105274|FG015|Treatment Period 1|Withdrawal by Subject|0|||
16962239|NCT01078623|38105275|FG016|Treatment Period 1|Withdrawal by Subject|0|||
16962240|NCT01078623|38105276|FG017|Treatment Period 1|Withdrawal by Subject|0|||
16776824|NCT00709735|37716154|FG001|Overall Study|Lost to Follow-up|1|||
16776825|NCT00709735|37716153|FG000|Overall Study|Relapse into Opioid Abuse|0|||
16776826|NCT00709735|37716154|FG001|Overall Study|Relapse into Opioid Abuse|1|||
16776827|NCT00709735|37716153|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
16776828|NCT00709735|37716154|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
16962241|NCT01078623|38105277|FG018|Treatment Period 1|Withdrawal by Subject|0|||
16962242|NCT01078623|38105278|FG019|Treatment Period 1|Withdrawal by Subject|0|||
16962243|NCT01078623|38105259|FG000|Treatment Period 1|Protocol Violation|0|||
16962244|NCT01078623|38105260|FG001|Treatment Period 1|Protocol Violation|0|||
16962245|NCT01078623|38105261|FG002|Treatment Period 1|Protocol Violation|0|||
16962246|NCT01078623|38105262|FG003|Treatment Period 1|Protocol Violation|0|||
16962247|NCT01078623|38105263|FG004|Treatment Period 1|Protocol Violation|0|||
16962248|NCT01078623|38105264|FG005|Treatment Period 1|Protocol Violation|1|||
16962249|NCT01078623|38105265|FG006|Treatment Period 1|Protocol Violation|0|||
16962250|NCT01078623|38105266|FG007|Treatment Period 1|Protocol Violation|0|||
16962251|NCT01078623|38105267|FG008|Treatment Period 1|Protocol Violation|0|||
16962252|NCT01078623|38105268|FG009|Treatment Period 1|Protocol Violation|0|||
16962253|NCT01078623|38105269|FG010|Treatment Period 1|Protocol Violation|0|||
16962254|NCT01078623|38105270|FG011|Treatment Period 1|Protocol Violation|0|||
16962255|NCT01078623|38105271|FG012|Treatment Period 1|Protocol Violation|0|||
16962256|NCT01078623|38105272|FG013|Treatment Period 1|Protocol Violation|0|||
16962257|NCT01078623|38105273|FG014|Treatment Period 1|Protocol Violation|0|||
16962258|NCT01078623|38105274|FG015|Treatment Period 1|Protocol Violation|0|||
16962259|NCT01078623|38105275|FG016|Treatment Period 1|Protocol Violation|0|||
16962260|NCT01078623|38105276|FG017|Treatment Period 1|Protocol Violation|0|||
16962261|NCT01078623|38105277|FG018|Treatment Period 1|Protocol Violation|0|||
16962262|NCT01078623|38105278|FG019|Treatment Period 1|Protocol Violation|0|||
16962263|NCT01078623|38105259|FG000|Treatment Period 2|Adverse Event|0|||
16962264|NCT01078623|38105260|FG001|Treatment Period 2|Adverse Event|0|||
16962265|NCT01078623|38105261|FG002|Treatment Period 2|Adverse Event|0|||
16962266|NCT01078623|38105262|FG003|Treatment Period 2|Adverse Event|0|||
16962267|NCT01078623|38105263|FG004|Treatment Period 2|Adverse Event|0|||
16962268|NCT01078623|38105264|FG005|Treatment Period 2|Adverse Event|0|||
16962269|NCT01078623|38105265|FG006|Treatment Period 2|Adverse Event|1|||
16962270|NCT01078623|38105266|FG007|Treatment Period 2|Adverse Event|0|||
16962271|NCT01078623|38105267|FG008|Treatment Period 2|Adverse Event|0|||
16962272|NCT01078623|38105268|FG009|Treatment Period 2|Adverse Event|0|||
16962273|NCT01078623|38105269|FG010|Treatment Period 2|Adverse Event|0|||
16962274|NCT01078623|38105270|FG011|Treatment Period 2|Adverse Event|0|||
16962275|NCT01078623|38105271|FG012|Treatment Period 2|Adverse Event|0|||
16962276|NCT01078623|38105272|FG013|Treatment Period 2|Adverse Event|0|||
16962277|NCT01078623|38105273|FG014|Treatment Period 2|Adverse Event|0|||
16962278|NCT01078623|38105274|FG015|Treatment Period 2|Adverse Event|0|||
16962279|NCT01078623|38105275|FG016|Treatment Period 2|Adverse Event|0|||
16962280|NCT01078623|38105276|FG017|Treatment Period 2|Adverse Event|0|||
16962281|NCT01078623|38105277|FG018|Treatment Period 2|Adverse Event|1|||
16962282|NCT01078623|38105278|FG019|Treatment Period 2|Adverse Event|0|||
16962283|NCT01078623|38105259|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16962284|NCT01078623|38105260|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16962285|NCT01078623|38105261|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16962286|NCT01078623|38105262|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16962287|NCT01078623|38105263|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16962288|NCT01078623|38105264|FG005|Treatment Period 2|Withdrawal by Subject|1|||
16962289|NCT01078623|38105265|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16962290|NCT01078623|38105266|FG007|Treatment Period 2|Withdrawal by Subject|0|||
16962291|NCT01078623|38105267|FG008|Treatment Period 2|Withdrawal by Subject|0|||
16962292|NCT01078623|38105268|FG009|Treatment Period 2|Withdrawal by Subject|0|||
16962293|NCT01078623|38105269|FG010|Treatment Period 2|Withdrawal by Subject|0|||
16962294|NCT01078623|38105270|FG011|Treatment Period 2|Withdrawal by Subject|0|||
16962295|NCT01078623|38105271|FG012|Treatment Period 2|Withdrawal by Subject|0|||
16962296|NCT01078623|38105272|FG013|Treatment Period 2|Withdrawal by Subject|0|||
16962297|NCT01078623|38105273|FG014|Treatment Period 2|Withdrawal by Subject|0|||
16962298|NCT01078623|38105274|FG015|Treatment Period 2|Withdrawal by Subject|0|||
16962299|NCT01078623|38105275|FG016|Treatment Period 2|Withdrawal by Subject|0|||
16962300|NCT01078623|38105276|FG017|Treatment Period 2|Withdrawal by Subject|0|||
16962301|NCT01078623|38105277|FG018|Treatment Period 2|Withdrawal by Subject|0|||
16962302|NCT01078623|38105278|FG019|Treatment Period 2|Withdrawal by Subject|0|||
16962303|NCT01078623|38105259|FG000|Treatment Period 3|Adverse Event|0|||
16962304|NCT01078623|38105260|FG001|Treatment Period 3|Adverse Event|0|||
16962305|NCT01078623|38105261|FG002|Treatment Period 3|Adverse Event|0|||
16962306|NCT01078623|38105262|FG003|Treatment Period 3|Adverse Event|0|||
16962307|NCT01078623|38105263|FG004|Treatment Period 3|Adverse Event|1|||
16962308|NCT01078623|38105264|FG005|Treatment Period 3|Adverse Event|0|||
16962309|NCT01078623|38105265|FG006|Treatment Period 3|Adverse Event|0|||
16962310|NCT01078623|38105266|FG007|Treatment Period 3|Adverse Event|0|||
16962311|NCT01078623|38105267|FG008|Treatment Period 3|Adverse Event|0|||
16962312|NCT01078623|38105268|FG009|Treatment Period 3|Adverse Event|0|||
16962313|NCT01078623|38105269|FG010|Treatment Period 3|Adverse Event|0|||
16962314|NCT01078623|38105270|FG011|Treatment Period 3|Adverse Event|0|||
16962315|NCT01078623|38105271|FG012|Treatment Period 3|Adverse Event|0|||
16962316|NCT01078623|38105272|FG013|Treatment Period 3|Adverse Event|1|||
16962317|NCT01078623|38105273|FG014|Treatment Period 3|Adverse Event|0|||
16962318|NCT01078623|38105274|FG015|Treatment Period 3|Adverse Event|0|||
16962319|NCT01078623|38105275|FG016|Treatment Period 3|Adverse Event|0|||
16962320|NCT01078623|38105276|FG017|Treatment Period 3|Adverse Event|0|||
16962321|NCT01078623|38105277|FG018|Treatment Period 3|Adverse Event|0|||
16962322|NCT01078623|38105278|FG019|Treatment Period 3|Adverse Event|0|||
16962323|NCT01078623|38105259|FG000|Treatment Period 4|Adverse Event|0|||
16962324|NCT01078623|38105260|FG001|Treatment Period 4|Adverse Event|0|||
16962325|NCT01078623|38105261|FG002|Treatment Period 4|Adverse Event|1|||
16962326|NCT01078623|38105262|FG003|Treatment Period 4|Adverse Event|0|||
16962327|NCT01078623|38105263|FG004|Treatment Period 4|Adverse Event|0|||
16962328|NCT01078623|38105264|FG005|Treatment Period 4|Adverse Event|0|||
16962329|NCT01078623|38105265|FG006|Treatment Period 4|Adverse Event|0|||
16962330|NCT01078623|38105266|FG007|Treatment Period 4|Adverse Event|0|||
16962331|NCT01078623|38105267|FG008|Treatment Period 4|Adverse Event|0|||
16962332|NCT01078623|38105268|FG009|Treatment Period 4|Adverse Event|0|||
16962333|NCT01078623|38105269|FG010|Treatment Period 4|Adverse Event|0|||
16962334|NCT01078623|38105270|FG011|Treatment Period 4|Adverse Event|0|||
16962335|NCT01078623|38105271|FG012|Treatment Period 4|Adverse Event|0|||
16962336|NCT01078623|38105272|FG013|Treatment Period 4|Adverse Event|0|||
16962337|NCT01078623|38105273|FG014|Treatment Period 4|Adverse Event|0|||
16962338|NCT01078623|38105274|FG015|Treatment Period 4|Adverse Event|0|||
16962339|NCT01078623|38105275|FG016|Treatment Period 4|Adverse Event|0|||
16962340|NCT01078623|38105276|FG017|Treatment Period 4|Adverse Event|0|||
16962341|NCT01078623|38105277|FG018|Treatment Period 4|Adverse Event|0|||
16962342|NCT01078623|38105278|FG019|Treatment Period 4|Adverse Event|0|||
16962343|NCT01078623|38105259|FG000|Treatment Period 4|Withdrawal by Subject|0|||
16962344|NCT01078623|38105260|FG001|Treatment Period 4|Withdrawal by Subject|0|||
16962345|NCT01078623|38105261|FG002|Treatment Period 4|Withdrawal by Subject|0|||
16962346|NCT01078623|38105262|FG003|Treatment Period 4|Withdrawal by Subject|0|||
16962347|NCT01078623|38105263|FG004|Treatment Period 4|Withdrawal by Subject|0|||
16962348|NCT01078623|38105264|FG005|Treatment Period 4|Withdrawal by Subject|0|||
16962349|NCT01078623|38105265|FG006|Treatment Period 4|Withdrawal by Subject|0|||
16962350|NCT01078623|38105266|FG007|Treatment Period 4|Withdrawal by Subject|0|||
16962351|NCT01078623|38105267|FG008|Treatment Period 4|Withdrawal by Subject|0|||
16962352|NCT01078623|38105268|FG009|Treatment Period 4|Withdrawal by Subject|0|||
16962353|NCT01078623|38105269|FG010|Treatment Period 4|Withdrawal by Subject|0|||
16962354|NCT01078623|38105270|FG011|Treatment Period 4|Withdrawal by Subject|0|||
16962355|NCT01078623|38105271|FG012|Treatment Period 4|Withdrawal by Subject|0|||
16962356|NCT01078623|38105272|FG013|Treatment Period 4|Withdrawal by Subject|0|||
16962357|NCT01078623|38105273|FG014|Treatment Period 4|Withdrawal by Subject|0|||
16962358|NCT01078623|38105274|FG015|Treatment Period 4|Withdrawal by Subject|1|||
16962359|NCT01078623|38105275|FG016|Treatment Period 4|Withdrawal by Subject|0|||
16962360|NCT01078623|38105276|FG017|Treatment Period 4|Withdrawal by Subject|0|||
16962361|NCT01078623|38105277|FG018|Treatment Period 4|Withdrawal by Subject|0|||
16962362|NCT01078623|38105278|FG019|Treatment Period 4|Withdrawal by Subject|0|||
16962363|NCT01092507|38105292|FG000|Overall Study|Withdrawal by Subject|2|||
16962364|NCT01092507|38105293|FG001|Overall Study|Withdrawal by Subject|0|||
16962365|NCT01078545|38105299|FG000|Overall Study|Lost to Follow-up|13|||
16962366|NCT01078545|38105299|FG000|Overall Study|Physician Decision|6|||
16962367|NCT01078545|38105299|FG000|Overall Study|Withdrawal by Subject|3|||
16962368|NCT01078545|38105299|FG000|Overall Study|Death|3|||
16962369|NCT01078545|38105299|FG000|Overall Study|Participant moved to another physician|1|||
16962370|NCT01202760|38105306|FG000|Overall Study|Entry Criteria Not Met|0|||
16962371|NCT01202760|38105307|FG001|Overall Study|Entry Criteria Not Met|3|||
16962372|NCT01202760|38105308|FG002|Overall Study|Entry Criteria Not Met|1|||
16962373|NCT01202760|38105306|FG000|Overall Study|Adverse Event|11|||
16962374|NCT01202760|38105307|FG001|Overall Study|Adverse Event|9|||
16962375|NCT01202760|38105308|FG002|Overall Study|Adverse Event|10|||
16962376|NCT01202760|38105306|FG000|Overall Study|Death|2|||
16962377|NCT01202760|38105307|FG001|Overall Study|Death|1|||
16962378|NCT01202760|38105308|FG002|Overall Study|Death|0|||
16962379|NCT01202760|38105306|FG000|Overall Study|Lack of Efficacy|6|||
16962380|NCT01202760|38105307|FG001|Overall Study|Lack of Efficacy|8|||
16962381|NCT01202760|38105308|FG002|Overall Study|Lack of Efficacy|7|||
16962382|NCT01202760|38105306|FG000|Overall Study|Lost to Follow-up|0|||
16962383|NCT01202760|38105307|FG001|Overall Study|Lost to Follow-up|2|||
16962384|NCT01202760|38105308|FG002|Overall Study|Lost to Follow-up|1|||
16962385|NCT01202760|38105306|FG000|Overall Study|Parent / Caregiver Decision|0|||
16962386|NCT01202760|38105307|FG001|Overall Study|Parent / Caregiver Decision|1|||
16962387|NCT01202760|38105308|FG002|Overall Study|Parent / Caregiver Decision|0|||
16962388|NCT01202760|38105306|FG000|Overall Study|Withdrawal by Subject|17|||
16962389|NCT01202760|38105307|FG001|Overall Study|Withdrawal by Subject|18|||
16962390|NCT01202760|38105308|FG002|Overall Study|Withdrawal by Subject|14|||
16962391|NCT01202760|38105306|FG000|Overall Study|Physician Decision|0|||
16962392|NCT01202760|38105307|FG001|Overall Study|Physician Decision|1|||
16962393|NCT01202760|38105308|FG002|Overall Study|Physician Decision|0|||
16962394|NCT01202760|38105306|FG000|Overall Study|Protocol Violation|7|||
16962395|NCT01202760|38105307|FG001|Overall Study|Protocol Violation|5|||
16962396|NCT01202760|38105308|FG002|Overall Study|Protocol Violation|2|||
16962397|NCT01202760|38105306|FG000|Overall Study|Sponsor Decision|4|||
16962398|NCT01202760|38105307|FG001|Overall Study|Sponsor Decision|4|||
16962399|NCT01202760|38105308|FG002|Overall Study|Sponsor Decision|0|||
16962400|NCT01091259|38105328|FG000|Overall Study|Adverse Event|3|||
16962401|NCT01091259|38105328|FG000|Overall Study|Lack of Efficacy|2|||
16962402|NCT01091103|38105332|FG000|Overall Study|Adverse Event|1|||
16962403|NCT01091103|38105332|FG000|Overall Study|Progressive Disease|3|||
16962404|NCT01078389|38105340|FG000|Overall Study|Adverse Event|10|||
16962405|NCT01078389|38105341|FG001|Overall Study|Adverse Event|6|||
16962406|NCT01078389|38105340|FG000|Overall Study|Major Protocol Deviation|2|||
16962407|NCT01078389|38105341|FG001|Overall Study|Major Protocol Deviation|0|||
16962408|NCT01078389|38105340|FG000|Overall Study|Lost to Follow-up|23|||
16962409|NCT01078389|38105341|FG001|Overall Study|Lost to Follow-up|23|||
16962410|NCT01078389|38105340|FG000|Overall Study|Voluntary Withdrawal|20|||
16962411|NCT01078389|38105341|FG001|Overall Study|Voluntary Withdrawal|36|||
16962412|NCT01078389|38105340|FG000|Overall Study|Other|9|||
16962413|NCT01078389|38105341|FG001|Overall Study|Other|2|||
16962414|NCT01090323|38105349|FG000|Overall Study|Adverse Event|12|||
16776829|NCT02647905|37716160|FG000|Overall Study|Lost to Follow-up|1|||
16962415|NCT01090323|38105350|FG001|Overall Study|Adverse Event|2|||
16962416|NCT01090323|38105349|FG000|Overall Study|Abnormal Lab Values|3|||
16962417|NCT01090323|38105350|FG001|Overall Study|Abnormal Lab Values|1|||
16962418|NCT01090323|38105349|FG000|Overall Study|Abnormal Test Procedure Results|2|||
16962419|NCT01090323|38105350|FG001|Overall Study|Abnormal Test Procedure Results|0|||
16962420|NCT01090323|38105349|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16962421|NCT01090323|38105350|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16962422|NCT01090323|38105349|FG000|Overall Study|Condition no longer requires drug|5|||
16962423|NCT01090323|38105350|FG001|Overall Study|Condition no longer requires drug|4|||
16962424|NCT01090323|38105349|FG000|Overall Study|Protocol Violation|2|||
16962425|NCT01090323|38105350|FG001|Overall Study|Protocol Violation|1|||
16962426|NCT01090323|38105349|FG000|Overall Study|Withdrew consent|33|||
16962427|NCT01090323|38105350|FG001|Overall Study|Withdrew consent|11|||
16962428|NCT01090323|38105349|FG000|Overall Study|Lost to Follow-up|11|||
16962429|NCT01090323|38105350|FG001|Overall Study|Lost to Follow-up|6|||
16962430|NCT01090323|38105349|FG000|Overall Study|Administrative problems|6|||
16962431|NCT01090323|38105350|FG001|Overall Study|Administrative problems|4|||
16962432|NCT01090323|38105349|FG000|Overall Study|Death|1|||
16962433|NCT01090323|38105350|FG001|Overall Study|Death|2|||
16776830|NCT02647905|37716160|FG000|Overall Study|Withdrawal by Subject|2|||
16776831|NCT04185909|37716164|FG000|Overall Study|Lost to Follow-up|1|||
16776832|NCT04076943|37716168|FG000|Overall Study|Withdrawal by Subject|12|||
16776833|NCT04076943|37716168|FG000|Overall Study|Adverse Event|1|||
16776834|NCT04076943|37716168|FG000|Overall Study|Progressive Disease|2|||
16776835|NCT04076943|37716168|FG000|Overall Study|Death|13|||
16962434|NCT01090323|38105349|FG000|Overall Study|Stopped end of core|7|||
16962435|NCT01090323|38105350|FG001|Overall Study|Stopped end of core|0|||
16962436|NCT01090323|38105349|FG000|Overall Study|Stopped end of extension 1#|3|||
16962437|NCT01090323|38105350|FG001|Overall Study|Stopped end of extension 1#|1|||
16962438|NCT01078155|38105356|FG000|Overall Study|Adverse Event|7|||
16962439|NCT01078155|38105356|FG000|Overall Study|Lack of Efficacy|16|||
16962440|NCT01078155|38105356|FG000|Overall Study|Participant's Decision|6|||
16962441|NCT01078155|38105356|FG000|Overall Study|Lost to Follow-up|15|||
16962442|NCT01201356|38105360|FG000|Overall Study|Adverse Event|170|||
16962443|NCT01201356|38105360|FG000|Overall Study|Abnormal laboratory value(s)|51|||
16962444|NCT01201356|38105360|FG000|Overall Study|Abnormal test procedure result(s)|3|||
16962445|NCT01201356|38105360|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
16962446|NCT01201356|38105360|FG000|Overall Study|Condition no longer requires study drug|12|||
16962447|NCT01201356|38105360|FG000|Overall Study|Withdrawal by Subject|144|||
16962448|NCT01201356|38105360|FG000|Overall Study|Lost to Follow-up|50|||
16962449|NCT01201356|38105360|FG000|Overall Study|administrative problems|74|||
16962450|NCT01201356|38105360|FG000|Overall Study|Death|16|||
16962451|NCT01201356|38105360|FG000|Overall Study|Protocol Violation|12|||
16962452|NCT01200810|38105366|FG000|Overall Study|Physician Decision|1|||
16962453|NCT01200810|38105367|FG001|Overall Study|Physician Decision|0|||
16962454|NCT01200810|38105366|FG000|Overall Study|Withdrawal by Subject|1|||
16962455|NCT01200810|38105367|FG001|Overall Study|Withdrawal by Subject|2|||
16962456|NCT01200810|38105366|FG000|Overall Study|Sponsor stopped making study drug|3|||
16867979|NCT01553747|37841013|FG002|Overall Study|Protocol Violation|0|||
16962457|NCT01200810|38105367|FG001|Overall Study|Sponsor stopped making study drug|3|||
16962458|NCT01200342|38105373|FG000|Overall Study|Disease Progression|1|||
16962459|NCT01199016|38105377|FG000|Overall Study|No longer meets eligibility criteria|4|||
16962460|NCT01199016|38105377|FG000|Overall Study|Entrance criteria|5|||
16962461|NCT01199016|38105377|FG000|Overall Study|Protocol Violation|9|||
16962462|NCT01199016|38105377|FG000|Overall Study|Other|13|||
16962463|NCT01199016|38105377|FG000|Overall Study|Withdrawal by Subject|21|||
16962464|NCT01199016|38105377|FG000|Overall Study|Lost to Follow-up|25|||
16962465|NCT01198548|38105381|FG000|Overall Study|Disease Progression|9|||
16962466|NCT01198548|38105381|FG000|Overall Study|Administrative Decision|1|||
16962467|NCT01198470|38105385|FG000|Overall Study|Adverse Event|2|||
16962468|NCT00977938|38105393|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
16962469|NCT00977938|38105394|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
16962470|NCT00977938|38105395|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
16962471|NCT00977938|38105396|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
16962472|NCT00977938|38105393|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
16962473|NCT00977938|38105394|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
16962474|NCT00977938|38105395|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
16962475|NCT00977938|38105396|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
16962476|NCT00977938|38105393|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
16962477|NCT00977938|38105394|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
16962478|NCT00977938|38105395|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
16962479|NCT00977938|38105396|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
16962480|NCT00977938|38105393|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
16962481|NCT00977938|38105394|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
16962482|NCT00977938|38105395|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
16962483|NCT00977938|38105396|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
16962484|NCT00977938|38105393|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
16962485|NCT00977938|38105394|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
16962486|NCT00977938|38105395|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
16962487|NCT00977938|38105396|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
16962488|NCT00977938|38105393|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
16962489|NCT00977938|38105394|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
16962490|NCT00977938|38105395|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
16962491|NCT00977938|38105396|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
16962492|NCT02716675|38105411|FG000|Overall Study|Death|2|||
16962493|NCT02716675|38105412|FG001|Overall Study|Death|3|||
16962494|NCT02716675|38105413|FG002|Overall Study|Death|0|||
16962495|NCT02716675|38105411|FG000|Overall Study|Physician Decision|2|||
16962496|NCT02716675|38105412|FG001|Overall Study|Physician Decision|1|||
16962497|NCT02716675|38105413|FG002|Overall Study|Physician Decision|1|||
16962498|NCT02716675|38105411|FG000|Overall Study|Lost to Follow-up|100|||
16962499|NCT02716675|38105412|FG001|Overall Study|Lost to Follow-up|87|||
16962500|NCT02716675|38105413|FG002|Overall Study|Lost to Follow-up|99|||
16962501|NCT02716675|38105411|FG000|Overall Study|Withdrawal by Subject|22|||
16962502|NCT02716675|38105412|FG001|Overall Study|Withdrawal by Subject|25|||
16962503|NCT02716675|38105413|FG002|Overall Study|Withdrawal by Subject|20|||
16962504|NCT02716675|38105411|FG000|Overall Study|Protocol Violation|0|||
16962505|NCT02716675|38105412|FG001|Overall Study|Protocol Violation|3|||
16962506|NCT02716675|38105413|FG002|Overall Study|Protocol Violation|1|||
16962507|NCT02716675|38105411|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
16962508|NCT02716675|38105412|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
16962509|NCT02716675|38105413|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
16962510|NCT02716675|38105411|FG000|Overall Study|Other|38|||
16962511|NCT02716675|38105412|FG001|Overall Study|Other|47|||
16962512|NCT02716675|38105413|FG002|Overall Study|Other|48|||
16962513|NCT00977548|38105426|FG000|Overall Study|Ineligible|4|||
16962514|NCT00977548|38105426|FG000|Overall Study|Adverse Event|8|||
16962515|NCT00977548|38105426|FG000|Overall Study|Withdrawal by Subject|1|||
16962516|NCT01090011|38105430|FG000|Overall Study|Progressive disease|128|||
16962517|NCT01090011|38105430|FG000|Overall Study|Adverse Event|32|||
16962518|NCT01090011|38105430|FG000|Overall Study|Protocol Violation|1|||
16962519|NCT01090011|38105430|FG000|Overall Study|Refusal to start/continue medication|5|||
16962520|NCT01090011|38105430|FG000|Overall Study|Other reason not defined above|5|||
16962521|NCT01251653|38105451|FG000|Overall Study|Progressive Disease|1|||
16962522|NCT01251653|38105452|FG001|Overall Study|Progressive Disease|7|||
16962523|NCT01251653|38105453|FG002|Overall Study|Progressive Disease|16|||
16962524|NCT01251653|38105454|FG003|Overall Study|Progressive Disease|4|||
16962525|NCT01251653|38105455|FG004|Overall Study|Progressive Disease|0|||
16962526|NCT01251653|38105456|FG005|Overall Study|Progressive Disease|17|||
16962527|NCT01251653|38105457|FG006|Overall Study|Progressive Disease|14|||
16962528|NCT01251653|38105458|FG007|Overall Study|Progressive Disease|7|||
16962529|NCT01251653|38105459|FG008|Overall Study|Progressive Disease|5|||
16776836|NCT04076943|37716168|FG000|Overall Study|Other than specified|6|||
16962530|NCT01251653|38105451|FG000|Overall Study|Dose-limiting toxicity|0|||
16962531|NCT01251653|38105452|FG001|Overall Study|Dose-limiting toxicity|1|||
16962532|NCT01251653|38105453|FG002|Overall Study|Dose-limiting toxicity|1|||
16962533|NCT01251653|38105454|FG003|Overall Study|Dose-limiting toxicity|1|||
16962534|NCT01251653|38105455|FG004|Overall Study|Dose-limiting toxicity|0|||
16962535|NCT01251653|38105456|FG005|Overall Study|Dose-limiting toxicity|0|||
16962536|NCT01251653|38105457|FG006|Overall Study|Dose-limiting toxicity|2|||
16962537|NCT01251653|38105458|FG007|Overall Study|Dose-limiting toxicity|0|||
16962538|NCT01251653|38105459|FG008|Overall Study|Dose-limiting toxicity|0|||
16962539|NCT01251653|38105451|FG000|Overall Study|Adverse Event|1|||
16962540|NCT01251653|38105452|FG001|Overall Study|Adverse Event|0|||
16962541|NCT01251653|38105453|FG002|Overall Study|Adverse Event|2|||
16962542|NCT01251653|38105454|FG003|Overall Study|Adverse Event|1|||
16962543|NCT01251653|38105455|FG004|Overall Study|Adverse Event|1|||
16962544|NCT01251653|38105456|FG005|Overall Study|Adverse Event|0|||
16962545|NCT01251653|38105457|FG006|Overall Study|Adverse Event|2|||
16962546|NCT01251653|38105458|FG007|Overall Study|Adverse Event|2|||
16962547|NCT01251653|38105459|FG008|Overall Study|Adverse Event|1|||
16962548|NCT01251653|38105451|FG000|Overall Study|Withdrawal by Subject|1|||
16962549|NCT01251653|38105452|FG001|Overall Study|Withdrawal by Subject|0|||
16962550|NCT01251653|38105453|FG002|Overall Study|Withdrawal by Subject|1|||
16962551|NCT01251653|38105454|FG003|Overall Study|Withdrawal by Subject|0|||
16962552|NCT01251653|38105455|FG004|Overall Study|Withdrawal by Subject|1|||
16962553|NCT01251653|38105456|FG005|Overall Study|Withdrawal by Subject|1|||
16962554|NCT01251653|38105457|FG006|Overall Study|Withdrawal by Subject|0|||
16962555|NCT01251653|38105458|FG007|Overall Study|Withdrawal by Subject|1|||
16962556|NCT01251653|38105459|FG008|Overall Study|Withdrawal by Subject|0|||
16962557|NCT01251653|38105451|FG000|Overall Study|Other reason not mentioned above|0|||
16962558|NCT01251653|38105452|FG001|Overall Study|Other reason not mentioned above|0|||
16962559|NCT01251653|38105453|FG002|Overall Study|Other reason not mentioned above|0|||
16962560|NCT01251653|38105454|FG003|Overall Study|Other reason not mentioned above|0|||
16962561|NCT01251653|38105455|FG004|Overall Study|Other reason not mentioned above|0|||
16962562|NCT01251653|38105456|FG005|Overall Study|Other reason not mentioned above|0|||
16962563|NCT01251653|38105457|FG006|Overall Study|Other reason not mentioned above|0|||
16962564|NCT01251653|38105458|FG007|Overall Study|Other reason not mentioned above|2|||
16962565|NCT01251653|38105459|FG008|Overall Study|Other reason not mentioned above|0|||
16962566|NCT00910663|38105497|FG000|Period 1|Withdrawal by Subject|0|||
16962567|NCT00910663|38105498|FG001|Period 1|Withdrawal by Subject|1|||
16962568|NCT01077375|38105506|FG000|Overall Study|Adverse Event|2|||
16962569|NCT01077375|38105507|FG001|Overall Study|Adverse Event|15|||
16962570|NCT01077375|38105506|FG000|Overall Study|Lack of Efficacy|6|||
16962571|NCT01077375|38105507|FG001|Overall Study|Lack of Efficacy|8|||
16962572|NCT01077375|38105506|FG000|Overall Study|Withdrawal by Subject|0|||
16962573|NCT01077375|38105507|FG001|Overall Study|Withdrawal by Subject|6|||
16962574|NCT01077375|38105506|FG000|Overall Study|Lost to Follow-up|2|||
16962575|NCT01077375|38105507|FG001|Overall Study|Lost to Follow-up|5|||
16962576|NCT01077375|38105506|FG000|Overall Study|Other Reason|0|||
16962577|NCT01077375|38105507|FG001|Overall Study|Other Reason|1|||
17133942|NCT00065429|38275192|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
16776837|NCT00708643|37716174|FG000|Overall Study|Adverse Event|0|||
16962578|NCT01250873|38105515|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
16962579|NCT01250873|38105515|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
16962580|NCT01250171|38105524|FG000|Overall Study|Administrative reasons|1|||
16962581|NCT01250171|38105525|FG001|Overall Study|Administrative reasons|0|||
16962582|NCT01250171|38105526|FG002|Overall Study|Administrative reasons|0|||
16962583|NCT01077063|38105536|FG000|Overall Study|Adverse Event|3|||
16962584|NCT01077063|38105537|FG001|Overall Study|Adverse Event|0|||
16962585|NCT01077063|38105536|FG000|Overall Study|Death|1|||
16962586|NCT01077063|38105537|FG001|Overall Study|Death|1|||
16962587|NCT01077063|38105536|FG000|Overall Study|Withdrawal by Subject|0|||
16962588|NCT01077063|38105537|FG001|Overall Study|Withdrawal by Subject|2|||
16962589|NCT01248065|38105545|FG000|Overall Study|Lost to Follow-up|3|||
16962590|NCT01248065|38105546|FG001|Overall Study|Lost to Follow-up|5|||
16962591|NCT01248065|38105545|FG000|Overall Study|Withdrawal by Subject|14|||
16962592|NCT01248065|38105546|FG001|Overall Study|Withdrawal by Subject|11|||
16962593|NCT01248065|38105545|FG000|Overall Study|Adverse Event|3|||
16962594|NCT01248065|38105546|FG001|Overall Study|Adverse Event|0|||
16962595|NCT01248065|38105545|FG000|Overall Study|Third treatment failure event|3|||
16962596|NCT01248065|38105546|FG001|Overall Study|Third treatment failure event|1|||
16962597|NCT01248065|38105545|FG000|Overall Study|Other|3|||
16962598|NCT01248065|38105546|FG001|Overall Study|Other|5|||
16962599|NCT01250756|38105554|FG000|Infant Series|Withdrawal by Subject|4|||
16962600|NCT01250756|38105555|FG001|Infant Series|Withdrawal by Subject|5|||
16962601|NCT01250756|38105554|FG000|Infant Series|Randomized, Not Vaccinated|2|||
16962602|NCT01250756|38105555|FG001|Infant Series|Randomized, Not Vaccinated|2|||
16962603|NCT01250756|38105554|FG000|Infant Series|Other|22|||
16962604|NCT01250756|38105555|FG001|Infant Series|Other|0|||
16962605|NCT01250756|38105554|FG000|After Infant Series|Adverse Event|5|||
16962606|NCT01250756|38105555|FG001|After Infant Series|Adverse Event|2|||
16962607|NCT01250756|38105554|FG000|After Infant Series|Withdrawal by Subject|4|||
16962608|NCT01250756|38105555|FG001|After Infant Series|Withdrawal by Subject|1|||
16962609|NCT01250756|38105554|FG000|After Infant Series|Other|2|||
16962610|NCT01250756|38105555|FG001|After Infant Series|Other|1|||
16776838|NCT00708643|37716175|FG001|Overall Study|Adverse Event|1|||
16776839|NCT01285557|37716238|FG000|Overall Study|Death|173|||
16776840|NCT01285557|37716239|FG001|Overall Study|Death|90|||
16776841|NCT01285557|37716238|FG000|Overall Study|Lost to Follow-up|6|||
16776842|NCT01285557|37716239|FG001|Overall Study|Lost to Follow-up|2|||
16776843|NCT01285557|37716238|FG000|Overall Study|Withdrew Consent|6|||
16776844|NCT01285557|37716239|FG001|Overall Study|Withdrew Consent|1|||
16776845|NCT01285557|37716238|FG000|Overall Study|Sponsor Study Termination|23|||
16776846|NCT01285557|37716239|FG001|Overall Study|Sponsor Study Termination|13|||
16776847|NCT01285557|37716238|FG000|Overall Study|Randomized but not treated|1|||
16776848|NCT01285557|37716239|FG001|Overall Study|Randomized but not treated|1|||
16776849|NCT01285557|37716238|FG000|Overall Study|Study follow-up ongoing|28|||
16776850|NCT01285557|37716239|FG001|Overall Study|Study follow-up ongoing|14|||
16776851|NCT01285557|37716238|FG000|Overall Study|Sponsor Decision|2|||
16776852|NCT01285557|37716239|FG001|Overall Study|Sponsor Decision|1|||
16776853|NCT01376167|37716301|FG000|Overall Study|Lost to Follow-up|2|||
16776854|NCT01376167|37716302|FG001|Overall Study|Lost to Follow-up|4|||
16776855|NCT01376167|37716303|FG002|Overall Study|Lost to Follow-up|2|||
16776856|NCT01376167|37716301|FG000|Overall Study|Physician Decision|1|||
16776857|NCT01376167|37716302|FG001|Overall Study|Physician Decision|1|||
16776858|NCT01376167|37716303|FG002|Overall Study|Physician Decision|0|||
16776859|NCT01376167|37716301|FG000|Overall Study|Withdrawal by Subject|1|||
16776860|NCT01376167|37716302|FG001|Overall Study|Withdrawal by Subject|5|||
16776861|NCT01376167|37716303|FG002|Overall Study|Withdrawal by Subject|4|||
16962611|NCT01250756|38105554|FG000|Toddler Dose|Adverse Event|0|||
16776862|NCT02647281|37716323|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16962612|NCT01250756|38105555|FG001|Toddler Dose|Adverse Event|1|||
16962613|NCT01250756|38105554|FG000|After Toddler Dose|Adverse Event|0|||
16962614|NCT01250756|38105555|FG001|After Toddler Dose|Adverse Event|1|||
16962615|NCT01250054|38105567|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
16962616|NCT01250054|38105568|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
16962617|NCT00977470|38105576|FG000|Overall Study|Lack of Efficacy|32|||
16962618|NCT00977470|38105577|FG001|Overall Study|Lack of Efficacy|30|||
16776863|NCT02647281|37716324|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16776864|NCT02647281|37716325|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16962619|NCT00977470|38105576|FG000|Overall Study|Physician Decision|2|||
16962620|NCT00977470|38105577|FG001|Overall Study|Physician Decision|0|||
16962621|NCT00977470|38105576|FG000|Overall Study|Adverse Event|1|||
16962622|NCT00977470|38105577|FG001|Overall Study|Adverse Event|2|||
16962623|NCT00977470|38105576|FG000|Overall Study|Protocol Violation|1|||
16962624|NCT00977470|38105577|FG001|Overall Study|Protocol Violation|0|||
16962625|NCT00977470|38105576|FG000|Overall Study|Withdrawal by Subject|0|||
16962626|NCT00977470|38105577|FG001|Overall Study|Withdrawal by Subject|2|||
16962627|NCT00977470|38105576|FG000|Overall Study|Death|0|||
16962628|NCT00977470|38105577|FG001|Overall Study|Death|2|||
16962629|NCT00977470|38105576|FG000|Overall Study|clinical decline|0|||
16962630|NCT00977470|38105577|FG001|Overall Study|clinical decline|1|||
16962631|NCT00977470|38105576|FG000|Overall Study|prolonged recovery post-surgery|0|||
16962632|NCT00977470|38105577|FG001|Overall Study|prolonged recovery post-surgery|1|||
16962633|NCT00977470|38105576|FG000|Overall Study|Still on-study|2|||
16962634|NCT00977470|38105577|FG001|Overall Study|Still on-study|0|||
16962635|NCT01245374|38105583|FG000|Overall Study|Protocol Violation|1|||
16962636|NCT01245374|38105583|FG000|Overall Study|Withdrawal by Subject|3|||
16962637|NCT00977314|38105590|FG000|Overall Study|Withdrawal by Subject|1|||
16962638|NCT00977314|38105591|FG001|Overall Study|Withdrawal by Subject|0|||
16962639|NCT00977314|38105590|FG000|Overall Study|Physician Decision|1|||
16962640|NCT00977314|38105591|FG001|Overall Study|Physician Decision|0|||
16962641|NCT01087203|38105599|FG000|Overall Study|Lost to Follow-up|2|||
16962642|NCT01087203|38105600|FG001|Overall Study|Lost to Follow-up|0|||
16962643|NCT01087203|38105599|FG000|Overall Study|Withdrawal by Subject|2|||
16962644|NCT01087203|38105600|FG001|Overall Study|Withdrawal by Subject|6|||
16962645|NCT01087203|38105599|FG000|Overall Study|Lack of Efficacy|1|||
16962646|NCT01087203|38105600|FG001|Overall Study|Lack of Efficacy|2|||
16962647|NCT01087203|38105599|FG000|Overall Study|Study terminated by sponsor|27|||
16962648|NCT01087203|38105600|FG001|Overall Study|Study terminated by sponsor|27|||
16962649|NCT01246583|38105611|FG000|Overall Study|Lost to Follow-up|0|||
16962650|NCT01246583|38105612|FG001|Overall Study|Lost to Follow-up|0|||
16962651|NCT01246583|38105613|FG002|Overall Study|Lost to Follow-up|0|||
16962652|NCT01246583|38105614|FG003|Overall Study|Lost to Follow-up|1|||
16962653|NCT01246583|38105611|FG000|Overall Study|Protocol Violation|0|||
16962654|NCT01246583|38105612|FG001|Overall Study|Protocol Violation|0|||
16962655|NCT01246583|38105613|FG002|Overall Study|Protocol Violation|1|||
16962656|NCT01246583|38105614|FG003|Overall Study|Protocol Violation|0|||
16962657|NCT01246583|38105611|FG000|Overall Study|Withdrawal by Subject|1|||
16962658|NCT01246583|38105612|FG001|Overall Study|Withdrawal by Subject|0|||
16962659|NCT01246583|38105613|FG002|Overall Study|Withdrawal by Subject|0|||
16962660|NCT01246583|38105614|FG003|Overall Study|Withdrawal by Subject|0|||
16962661|NCT01084239|38105627|FG000|28-Day Follow-up|Lost to Follow-up|4|||
16962662|NCT01084239|38105628|FG001|28-Day Follow-up|Lost to Follow-up|9|||
16962663|NCT01244906|38105636|FG000|Overall Study|Death|2|||
16962664|NCT01244906|38105636|FG000|Overall Study|Progression of disease post treatment|6|||
16962665|NCT01080807|38105642|FG000|Overall Study|Adverse Event|9|||
16962666|NCT01080807|38105643|FG001|Overall Study|Adverse Event|1|||
16962667|NCT01080807|38105642|FG000|Overall Study|Lack of Efficacy|0|||
16962668|NCT01080807|38105643|FG001|Overall Study|Lack of Efficacy|1|||
16962669|NCT01080807|38105642|FG000|Overall Study|Withdrawal by Subject|7|||
16962670|NCT01080807|38105643|FG001|Overall Study|Withdrawal by Subject|2|||
16962671|NCT01080807|38105642|FG000|Overall Study|Protocol Violation|7|||
16962672|NCT01080807|38105643|FG001|Overall Study|Protocol Violation|6|||
16962673|NCT01080807|38105642|FG000|Overall Study|Lost to Follow-up|6|||
16962674|NCT01080807|38105643|FG001|Overall Study|Lost to Follow-up|4|||
16962675|NCT01080807|38105642|FG000|Overall Study|Noncompliance with drug administration|1|||
16962676|NCT01080807|38105643|FG001|Overall Study|Noncompliance with drug administration|1|||
16962677|NCT01080807|38105642|FG000|Overall Study|Noncompliance to study procedures|1|||
16962678|NCT01080807|38105643|FG001|Overall Study|Noncompliance to study procedures|1|||
16962679|NCT01080807|38105642|FG000|Overall Study|Began working day shift|0|||
16962680|NCT01080807|38105643|FG001|Overall Study|Began working day shift|2|||
16962681|NCT01080807|38105642|FG000|Overall Study|Laid off or terminated from job|1|||
16962682|NCT01080807|38105643|FG001|Overall Study|Laid off or terminated from job|2|||
16962683|NCT01080807|38105642|FG000|Overall Study|Stopped working consistent night shifts|0|||
16962684|NCT01080807|38105643|FG001|Overall Study|Stopped working consistent night shifts|1|||
16962685|NCT01080807|38105642|FG000|Overall Study|Work schedule changing|1|||
16962686|NCT01080807|38105643|FG001|Overall Study|Work schedule changing|1|||
16962687|NCT01080807|38105642|FG000|Overall Study|Work schedule and travel|0|||
16962688|NCT01080807|38105643|FG001|Overall Study|Work schedule and travel|1|||
16962689|NCT01080807|38105642|FG000|Overall Study|Switched to first shift|1|||
16962690|NCT01080807|38105643|FG001|Overall Study|Switched to first shift|0|||
16962691|NCT01080807|38105642|FG000|Overall Study|Moved away without notifying center|1|||
16962692|NCT01080807|38105643|FG001|Overall Study|Moved away without notifying center|0|||
16962693|NCT01076361|38105649|FG000|Overall Study|22 leads were excluded from analysis|21|||
16962694|NCT01079949|38105655|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
16962695|NCT01079949|38105656|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
16962696|NCT01079949|38105655|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
16962697|NCT01079949|38105656|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
16962698|NCT01079949|38105655|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
16962699|NCT01079949|38105656|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
16962700|NCT01079949|38105655|FG000|Overall Study|Randomized but not treated|1|||
16962701|NCT01079949|38105656|FG001|Overall Study|Randomized but not treated|0|||
16962702|NCT00910429|38105664|FG000|Overall Study|Death|18|||
16962703|NCT00910429|38105665|FG001|Overall Study|Death|12|||
16962704|NCT00910429|38105664|FG000|Overall Study|Withdrawal by Subject|3|||
16962705|NCT00910429|38105665|FG001|Overall Study|Withdrawal by Subject|2|||
16962706|NCT00910429|38105664|FG000|Overall Study|Protocol Violation|1|||
16962707|NCT00910429|38105665|FG001|Overall Study|Protocol Violation|0|||
16962708|NCT00910429|38105664|FG000|Overall Study|Lost to Follow-up|2|||
16962709|NCT00910429|38105665|FG001|Overall Study|Lost to Follow-up|1|||
16962710|NCT00910429|38105664|FG000|Overall Study|Adverse Event|10|||
16962711|NCT00910429|38105665|FG001|Overall Study|Adverse Event|5|||
16962712|NCT00910429|38105664|FG000|Overall Study|Drug non-compliance|1|||
16962713|NCT00910429|38105665|FG001|Overall Study|Drug non-compliance|0|||
16962714|NCT00910429|38105664|FG000|Overall Study|Lack of Efficacy|4|||
16962715|NCT00910429|38105665|FG001|Overall Study|Lack of Efficacy|1|||
16962716|NCT00909727|38105673|FG000|Overall Study|Adverse Event|1|||
16962717|NCT00909727|38105674|FG001|Overall Study|Adverse Event|0|||
16962718|NCT00909727|38105673|FG000|Overall Study|Wrong Genotype|1|||
16962719|NCT00909727|38105674|FG001|Overall Study|Wrong Genotype|0|||
16962720|NCT00909727|38105673|FG000|Overall Study|Withdrawal of Consent|1|||
16962721|NCT00909727|38105674|FG001|Overall Study|Withdrawal of Consent|0|||
16962722|NCT00909727|38105673|FG000|Overall Study|Prohibited Medication|1|||
16962723|NCT00909727|38105674|FG001|Overall Study|Prohibited Medication|0|||
16962724|NCT00977080|38105684|FG000|Overall Study|Adverse Event|2|||
16962725|NCT00977080|38105685|FG001|Overall Study|Adverse Event|7|||
16962726|NCT00977080|38105686|FG002|Overall Study|Adverse Event|7|||
16962727|NCT00977080|38105687|FG003|Overall Study|Adverse Event|7|||
16962728|NCT00977080|38105684|FG000|Overall Study|Withdrawal by Subject|1|||
16962729|NCT00977080|38105685|FG001|Overall Study|Withdrawal by Subject|5|||
16962730|NCT00977080|38105686|FG002|Overall Study|Withdrawal by Subject|1|||
16962731|NCT00977080|38105687|FG003|Overall Study|Withdrawal by Subject|5|||
16962732|NCT00977080|38105684|FG000|Overall Study|Protocol Violation|7|||
16962733|NCT00977080|38105685|FG001|Overall Study|Protocol Violation|3|||
16962734|NCT00977080|38105686|FG002|Overall Study|Protocol Violation|4|||
16962735|NCT00977080|38105687|FG003|Overall Study|Protocol Violation|3|||
16962736|NCT00977080|38105684|FG000|Overall Study|Noncompliance|0|||
16962737|NCT00977080|38105685|FG001|Overall Study|Noncompliance|2|||
16962738|NCT00977080|38105686|FG002|Overall Study|Noncompliance|1|||
16962739|NCT00977080|38105687|FG003|Overall Study|Noncompliance|0|||
16962740|NCT00977080|38105684|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
16962741|NCT00977080|38105685|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
16962742|NCT00977080|38105686|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
16962743|NCT00977080|38105687|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
16962744|NCT00977080|38105684|FG000|Overall Study|Required kidney transplantation|1|||
16962745|NCT00977080|38105685|FG001|Overall Study|Required kidney transplantation|3|||
16962746|NCT00977080|38105686|FG002|Overall Study|Required kidney transplantation|3|||
16962747|NCT00977080|38105687|FG003|Overall Study|Required kidney transplantation|1|||
16962748|NCT00977080|38105684|FG000|Overall Study|Travel for family reasons|1|||
16962749|NCT00977080|38105685|FG001|Overall Study|Travel for family reasons|0|||
16962750|NCT00977080|38105686|FG002|Overall Study|Travel for family reasons|0|||
16962751|NCT00977080|38105687|FG003|Overall Study|Travel for family reasons|0|||
16962752|NCT00975676|38105699|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
16962753|NCT00975676|38105700|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
16962754|NCT00975286|38105713|FG000|Overall Study|Adverse Event|9|||
16962755|NCT00975286|38105714|FG001|Overall Study|Adverse Event|19|||
16776865|NCT02647281|37716326|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16776866|NCT02647281|37716327|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16776867|NCT02647281|37716328|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16776868|NCT02647281|37716329|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16962756|NCT00975286|38105713|FG000|Overall Study|Protocol Violation|1|||
16962757|NCT00975286|38105714|FG001|Overall Study|Protocol Violation|2|||
16962758|NCT00975286|38105713|FG000|Overall Study|Withdrawal by Subject|0|||
16962759|NCT00975286|38105714|FG001|Overall Study|Withdrawal by Subject|2|||
16962760|NCT00975286|38105713|FG000|Overall Study|Familial and Personal Reasons|2|||
16962761|NCT00975286|38105714|FG001|Overall Study|Familial and Personal Reasons|2|||
16962762|NCT00975286|38105713|FG000|Overall Study|Poor Compliance to Protocol|0|||
16962763|NCT00975286|38105714|FG001|Overall Study|Poor Compliance to Protocol|2|||
16962764|NCT00975286|38105713|FG000|Overall Study|Sponsor Decision|0|||
16962765|NCT00975286|38105714|FG001|Overall Study|Sponsor Decision|2|||
16962766|NCT00907777|38105722|FG000|Overall Study|Withdrawal by Subject|0|||
16962767|NCT00907777|38105723|FG001|Overall Study|Withdrawal by Subject|1|||
16962768|NCT00908011|38105731|FG000|Overall Study|Withdrawal by Subject|2|||
16962769|NCT00908011|38105732|FG001|Overall Study|Withdrawal by Subject|2|||
16962770|NCT00976456|38105740|FG000|Overall Study|Adverse Event|17|||
16962771|NCT00976456|38105741|FG001|Overall Study|Adverse Event|22|||
16962772|NCT00976456|38105740|FG000|Overall Study|Death|7|||
16962773|NCT00976456|38105741|FG001|Overall Study|Death|9|||
16962774|NCT00976456|38105740|FG000|Overall Study|Lack of Efficacy|5|||
16962775|NCT00976456|38105741|FG001|Overall Study|Lack of Efficacy|2|||
16962776|NCT00976456|38105740|FG000|Overall Study|Withdrawal by Subject|3|||
16962777|NCT00976456|38105741|FG001|Overall Study|Withdrawal by Subject|1|||
16962778|NCT00976456|38105740|FG000|Overall Study|screening failure, unknown|11|||
16962779|NCT00976456|38105741|FG001|Overall Study|screening failure, unknown|4|||
16962780|NCT01243151|38105752|FG000|Overall Study|Adverse Event|0|||
16962781|NCT01243151|38105753|FG001|Overall Study|Adverse Event|1|||
16962782|NCT01243151|38105754|FG002|Overall Study|Adverse Event|0|||
16962783|NCT01243151|38105755|FG003|Overall Study|Adverse Event|0|||
16962784|NCT01243151|38105756|FG004|Overall Study|Adverse Event|0|||
16962785|NCT01243151|38105752|FG000|Overall Study|Protocol Violation|0|||
16962786|NCT01243151|38105753|FG001|Overall Study|Protocol Violation|0|||
16962787|NCT01243151|38105754|FG002|Overall Study|Protocol Violation|1|||
16962788|NCT01243151|38105755|FG003|Overall Study|Protocol Violation|0|||
16962789|NCT01243151|38105756|FG004|Overall Study|Protocol Violation|0|||
16962790|NCT01243151|38105752|FG000|Overall Study|Other|0|||
16962791|NCT01243151|38105753|FG001|Overall Study|Other|0|||
16962792|NCT01243151|38105754|FG002|Overall Study|Other|0|||
16962793|NCT01243151|38105755|FG003|Overall Study|Other|1|||
16962794|NCT01243151|38105756|FG004|Overall Study|Other|0|||
16962795|NCT01243151|38105752|FG000|Overall Study|Randomized but not treated|0|||
16962796|NCT01243151|38105753|FG001|Overall Study|Randomized but not treated|0|||
16962797|NCT01243151|38105754|FG002|Overall Study|Randomized but not treated|0|||
16962798|NCT01243151|38105755|FG003|Overall Study|Randomized but not treated|1|||
16962799|NCT01243151|38105756|FG004|Overall Study|Randomized but not treated|0|||
16962800|NCT00993148|38105772|FG000|Overall Study|Lost to Follow-up|2|||
16962801|NCT00993148|38105772|FG000|Overall Study|never initiated treatment|1|||
16962802|NCT00907621|38105778|FG000|Overall Study|Lost to Follow-up|6|||
16962803|NCT00907621|38105779|FG001|Overall Study|Lost to Follow-up|3|||
16962804|NCT00907621|38105778|FG000|Overall Study|intercurrent febrile illness|1|||
16962805|NCT00907621|38105779|FG001|Overall Study|intercurrent febrile illness|1|||
16962806|NCT00907153|38105798|FG000|Overall Study|Lost to Follow-up|1|||
16962807|NCT00907153|38105799|FG001|Overall Study|Lost to Follow-up|1|||
16962808|NCT00907153|38105798|FG000|Overall Study|Withdrawal by Subject|1|||
16962809|NCT00907153|38105799|FG001|Overall Study|Withdrawal by Subject|3|||
16962810|NCT00904033|38105809|FG000|Overall Study|Withdrawal by Subject|1|||
16962811|NCT00904033|38105810|FG001|Overall Study|Withdrawal by Subject|1|||
16962812|NCT00904033|38105811|FG002|Overall Study|Withdrawal by Subject|0|||
16962813|NCT00904033|38105812|FG003|Overall Study|Withdrawal by Subject|0|||
16962814|NCT00904033|38105809|FG000|Overall Study|Physician Decision|0|||
16962815|NCT00904033|38105810|FG001|Overall Study|Physician Decision|0|||
16962816|NCT00904033|38105811|FG002|Overall Study|Physician Decision|1|||
16962817|NCT00904033|38105812|FG003|Overall Study|Physician Decision|0|||
16962818|NCT00904033|38105809|FG000|Overall Study|Unable to obtain final blood draw|0|||
16962819|NCT00904033|38105810|FG001|Overall Study|Unable to obtain final blood draw|0|||
16776869|NCT02647281|37716330|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16776870|NCT02647281|37716331|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
16776871|NCT02729545|37716362|FG000|Overall Study|Pregnancy|1|||
16776872|NCT02729545|37716363|FG001|Overall Study|Pregnancy|1|||
16962820|NCT00904033|38105811|FG002|Overall Study|Unable to obtain final blood draw|0|||
16962821|NCT00904033|38105812|FG003|Overall Study|Unable to obtain final blood draw|2|||
16962822|NCT00903877|38105823|FG000|Overall Study|Did not meet study criteria|33|||
16962823|NCT00903877|38105823|FG000|Overall Study|Withdrawal by Subject|3|||
16962824|NCT00903877|38105823|FG000|Overall Study|Adverse Event|2|||
16962825|NCT00903877|38105823|FG000|Overall Study|Lost to Follow-up|1|||
16962826|NCT00903877|38105823|FG000|Overall Study|Participation put on hold|4|||
16962827|NCT01241591|38105831|FG000|Overall Study|Lack of Efficacy|5|||
16962828|NCT01241591|38105832|FG001|Overall Study|Lack of Efficacy|2|||
16962829|NCT01241591|38105833|FG002|Overall Study|Lack of Efficacy|2|||
16962830|NCT01241591|38105834|FG003|Overall Study|Lack of Efficacy|3|||
16962831|NCT01241591|38105831|FG000|Overall Study|Protocol Violation|5|||
16962832|NCT01241591|38105832|FG001|Overall Study|Protocol Violation|2|||
16962833|NCT01241591|38105833|FG002|Overall Study|Protocol Violation|3|||
16962834|NCT01241591|38105834|FG003|Overall Study|Protocol Violation|0|||
16962835|NCT01241591|38105831|FG000|Overall Study|Lost to Follow-up|1|||
16962836|NCT01241591|38105832|FG001|Overall Study|Lost to Follow-up|2|||
16962837|NCT01241591|38105833|FG002|Overall Study|Lost to Follow-up|2|||
16962838|NCT01241591|38105834|FG003|Overall Study|Lost to Follow-up|2|||
16962839|NCT01241591|38105831|FG000|Overall Study|Screen Failure|3|||
16962840|NCT01241591|38105832|FG001|Overall Study|Screen Failure|2|||
16962841|NCT01241591|38105833|FG002|Overall Study|Screen Failure|1|||
16962842|NCT01241591|38105834|FG003|Overall Study|Screen Failure|0|||
16962843|NCT01241591|38105831|FG000|Overall Study|Withdrawal by Subject|6|||
16962844|NCT01241591|38105832|FG001|Overall Study|Withdrawal by Subject|4|||
16962845|NCT01241591|38105833|FG002|Overall Study|Withdrawal by Subject|2|||
16962846|NCT01241591|38105834|FG003|Overall Study|Withdrawal by Subject|2|||
16962847|NCT01241591|38105831|FG000|Overall Study|Other|0|||
16962848|NCT01241591|38105832|FG001|Overall Study|Other|1|||
16776873|NCT02729545|37716362|FG000|Overall Study|Lost to Follow-up|0|||
16776874|NCT02729545|37716363|FG001|Overall Study|Lost to Follow-up|1|||
16776875|NCT02729545|37716362|FG000|Overall Study|Withdrawal by Subject|2|||
16776876|NCT02729545|37716363|FG001|Overall Study|Withdrawal by Subject|3|||
16776877|NCT01376089|37716371|FG000|Overall Study|Patient received no contrast media|3|||
16776878|NCT01376089|37716372|FG001|Overall Study|Patient received no contrast media|4|||
16776879|NCT00706849|37716384|FG000|Treatment Period|Adverse Event|0|||
16776880|NCT00706849|37716385|FG001|Treatment Period|Adverse Event|9|||
16776881|NCT00706849|37716384|FG000|Treatment Period|Other|0|||
16776882|NCT00706849|37716385|FG001|Treatment Period|Other|1|||
16962849|NCT01241591|38105833|FG002|Overall Study|Other|0|||
16776883|NCT00706849|37716384|FG000|Follow-up Period|Withdrawal by Subject|0|||
16776884|NCT00706849|37716385|FG001|Follow-up Period|Withdrawal by Subject|2|||
16776885|NCT00706849|37716384|FG000|Follow-up Period|Protocol non-compliance|0|||
16776886|NCT00706849|37716385|FG001|Follow-up Period|Protocol non-compliance|1|||
16776887|NCT00707161|37716391|FG000|Overall Study|Physician Decision|6|||
16776888|NCT02130466|37716409|FG000|Overall Study|Death|4|||
16776889|NCT02130466|37716410|FG001|Overall Study|Death|1|||
16776890|NCT02130466|37716411|FG002|Overall Study|Death|1|||
16776891|NCT02130466|37716412|FG003|Overall Study|Death|3|||
16776892|NCT02130466|37716413|FG004|Overall Study|Death|2|||
16776893|NCT02130466|37716414|FG005|Overall Study|Death|30|||
16776894|NCT02130466|37716415|FG006|Overall Study|Death|45|||
16776895|NCT02130466|37716416|FG007|Overall Study|Death|2|||
16776896|NCT02130466|37716417|FG008|Overall Study|Death|3|||
16776897|NCT02130466|37716418|FG009|Overall Study|Death|4|||
16776898|NCT02130466|37716419|FG010|Overall Study|Death|5|||
16776899|NCT02130466|37716420|FG011|Overall Study|Death|3|||
16776900|NCT02130466|37716421|FG012|Overall Study|Death|11|||
16776901|NCT02130466|37716422|FG013|Overall Study|Death|7|||
16776902|NCT02130466|37716409|FG000|Overall Study|Lost to Follow-up|1|||
16776903|NCT02130466|37716410|FG001|Overall Study|Lost to Follow-up|0|||
16776904|NCT02130466|37716411|FG002|Overall Study|Lost to Follow-up|0|||
16776905|NCT02130466|37716412|FG003|Overall Study|Lost to Follow-up|0|||
16776906|NCT02130466|37716413|FG004|Overall Study|Lost to Follow-up|0|||
16776907|NCT02130466|37716414|FG005|Overall Study|Lost to Follow-up|1|||
16776908|NCT02130466|37716415|FG006|Overall Study|Lost to Follow-up|0|||
16776909|NCT02130466|37716416|FG007|Overall Study|Lost to Follow-up|0|||
16776910|NCT02130466|37716417|FG008|Overall Study|Lost to Follow-up|0|||
16776911|NCT02130466|37716418|FG009|Overall Study|Lost to Follow-up|0|||
16776912|NCT02130466|37716419|FG010|Overall Study|Lost to Follow-up|0|||
16776913|NCT02130466|37716420|FG011|Overall Study|Lost to Follow-up|0|||
16776914|NCT02130466|37716421|FG012|Overall Study|Lost to Follow-up|1|||
16776915|NCT02130466|37716422|FG013|Overall Study|Lost to Follow-up|0|||
16776916|NCT02130466|37716409|FG000|Overall Study|Physician Decision|0|||
16776917|NCT02130466|37716410|FG001|Overall Study|Physician Decision|0|||
16776918|NCT02130466|37716411|FG002|Overall Study|Physician Decision|0|||
16776919|NCT02130466|37716412|FG003|Overall Study|Physician Decision|0|||
16776920|NCT02130466|37716413|FG004|Overall Study|Physician Decision|0|||
16776921|NCT02130466|37716414|FG005|Overall Study|Physician Decision|1|||
16776922|NCT02130466|37716415|FG006|Overall Study|Physician Decision|1|||
16776923|NCT02130466|37716416|FG007|Overall Study|Physician Decision|0|||
16776924|NCT02130466|37716417|FG008|Overall Study|Physician Decision|0|||
16776925|NCT02130466|37716418|FG009|Overall Study|Physician Decision|0|||
16776926|NCT02130466|37716419|FG010|Overall Study|Physician Decision|0|||
16776927|NCT02130466|37716420|FG011|Overall Study|Physician Decision|0|||
16776928|NCT02130466|37716421|FG012|Overall Study|Physician Decision|0|||
16776929|NCT02130466|37716422|FG013|Overall Study|Physician Decision|0|||
16776930|NCT02130466|37716409|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16776931|NCT02130466|37716410|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
16776932|NCT02130466|37716411|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16776933|NCT02130466|37716412|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
16776934|NCT02130466|37716413|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
16776935|NCT02130466|37716414|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
16776936|NCT02130466|37716415|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
16776937|NCT02130466|37716416|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16776938|NCT02130466|37716417|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
16776939|NCT02130466|37716418|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16776940|NCT02130466|37716419|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16776941|NCT02130466|37716420|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
16776942|NCT02130466|37716421|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
16776943|NCT02130466|37716422|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
16776944|NCT02130466|37716409|FG000|Overall Study|Withdrawal by Subject|1|||
16776945|NCT02130466|37716410|FG001|Overall Study|Withdrawal by Subject|0|||
16776946|NCT02130466|37716411|FG002|Overall Study|Withdrawal by Subject|0|||
16776947|NCT02130466|37716412|FG003|Overall Study|Withdrawal by Subject|0|||
16776948|NCT02130466|37716413|FG004|Overall Study|Withdrawal by Subject|0|||
16776949|NCT02130466|37716414|FG005|Overall Study|Withdrawal by Subject|1|||
16776950|NCT02130466|37716415|FG006|Overall Study|Withdrawal by Subject|0|||
16776951|NCT02130466|37716416|FG007|Overall Study|Withdrawal by Subject|0|||
16776952|NCT02130466|37716417|FG008|Overall Study|Withdrawal by Subject|1|||
16776953|NCT02130466|37716418|FG009|Overall Study|Withdrawal by Subject|0|||
16776954|NCT02130466|37716419|FG010|Overall Study|Withdrawal by Subject|0|||
16776955|NCT02130466|37716420|FG011|Overall Study|Withdrawal by Subject|0|||
16776956|NCT02130466|37716421|FG012|Overall Study|Withdrawal by Subject|0|||
16776957|NCT02130466|37716422|FG013|Overall Study|Withdrawal by Subject|0|||
16776958|NCT02163538|37716471|FG000|Overall Study|Protocol Violation|1|||
16776959|NCT02163538|37716472|FG001|Overall Study|Protocol Violation|0|||
16776960|NCT02163538|37716471|FG000|Overall Study|Physician Decision|0|||
16776961|NCT02163538|37716472|FG001|Overall Study|Physician Decision|1|||
16776962|NCT02163226|37716480|FG000|Overall Study|Death|2|||
16776963|NCT02163226|37716481|FG001|Overall Study|Death|1|||
16776964|NCT02163226|37716480|FG000|Overall Study|Withdrawal by Subject|5|||
16776965|NCT02163226|37716481|FG001|Overall Study|Withdrawal by Subject|2|||
16776966|NCT02163226|37716480|FG000|Overall Study|Returned home, local radiotherapy|3|||
16776967|NCT02163226|37716481|FG001|Overall Study|Returned home, local radiotherapy|0|||
16776968|NCT02163226|37716480|FG000|Overall Study|Repeat imaging showed no disease|2|||
16776969|NCT02163226|37716481|FG001|Overall Study|Repeat imaging showed no disease|0|||
16776970|NCT02163226|37716480|FG000|Overall Study|Incomplete radiotherapy|3|||
16776971|NCT02163226|37716481|FG001|Overall Study|Incomplete radiotherapy|0|||
16776972|NCT02163226|37716480|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
16776973|NCT02163226|37716481|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
16776974|NCT02163226|37716480|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
16776975|NCT02163226|37716481|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
16776976|NCT02163226|37716480|FG000|Overall Study|ineligible|0|||
16776977|NCT02163226|37716481|FG001|Overall Study|ineligible|3|||
16776978|NCT02193178|37716487|FG000|Overall Study|Lost to Follow-up|1|||
16776979|NCT02193178|37716487|FG000|Overall Study|Dry eyes|1|||
16776980|NCT02129608|37716508|FG000|Overall Study|Lost to Follow-up|0|||
16776981|NCT02129608|37716509|FG001|Overall Study|Lost to Follow-up|1|||
16776982|NCT02129608|37716510|FG002|Overall Study|Lost to Follow-up|1|||
16776983|NCT02129608|37716508|FG000|Overall Study|Withdrawal by Subject|0|||
16776984|NCT02129608|37716509|FG001|Overall Study|Withdrawal by Subject|0|||
16776985|NCT02129608|37716510|FG002|Overall Study|Withdrawal by Subject|2|||
16776986|NCT01631188|37716518|FG000|Overall Study|Physician Decision|75|||
16776987|NCT02129062|37716522|FG000|Overall Study|Death|1|||
16776988|NCT02129062|37716522|FG000|Overall Study|Disease Progression|2|||
16776989|NCT02162758|37716528|FG000|Overall Study|Study termination|0|||
16776990|NCT02162758|37716529|FG001|Overall Study|Study termination|1|||
16776991|NCT02192164|37716535|FG000|Overall Study|Other|8|||
16776992|NCT02192164|37716535|FG000|Overall Study|Withdrawal by Subject|1|||
16776993|NCT02192164|37716535|FG000|Overall Study|Physician Decision|4|||
16776994|NCT02192164|37716535|FG000|Overall Study|Did not meet the exclusion criteria|1|||
16776995|NCT02191618|37716542|FG000|Overall Study|Withdrawal by Subject|3|||
16776996|NCT02191618|37716542|FG000|Overall Study|Missed Visit|4|||
16776997|NCT02646891|37716556|FG000|Overall Study|Adverse Event|0|||
16776998|NCT02646891|37716557|FG001|Overall Study|Adverse Event|1|||
16776999|NCT02646891|37716558|FG002|Overall Study|Adverse Event|0|||
16777000|NCT02646891|37716559|FG003|Overall Study|Adverse Event|0|||
16777001|NCT02646891|37716560|FG004|Overall Study|Adverse Event|0|||
16777002|NCT02646891|37716561|FG005|Overall Study|Adverse Event|0|||
16777003|NCT02646891|37716562|FG006|Overall Study|Adverse Event|0|||
16777004|NCT02646891|37716563|FG007|Overall Study|Adverse Event|0|||
16777005|NCT02646891|37716564|FG008|Overall Study|Adverse Event|0|||
16777006|NCT02646891|37716565|FG009|Overall Study|Adverse Event|0|||
16777007|NCT02646891|37716556|FG000|Overall Study|Lost to Follow-up|0|||
16777008|NCT02646891|37716557|FG001|Overall Study|Lost to Follow-up|0|||
16777009|NCT02646891|37716558|FG002|Overall Study|Lost to Follow-up|0|||
16777010|NCT02646891|37716559|FG003|Overall Study|Lost to Follow-up|0|||
16777011|NCT02646891|37716560|FG004|Overall Study|Lost to Follow-up|0|||
16777012|NCT02646891|37716561|FG005|Overall Study|Lost to Follow-up|0|||
16777013|NCT02646891|37716562|FG006|Overall Study|Lost to Follow-up|2|||
16777014|NCT02646891|37716563|FG007|Overall Study|Lost to Follow-up|2|||
16777015|NCT02646891|37716564|FG008|Overall Study|Lost to Follow-up|2|||
16777016|NCT02646891|37716565|FG009|Overall Study|Lost to Follow-up|2|||
16777017|NCT02646891|37716556|FG000|Overall Study|Protocol Violation|0|||
16777018|NCT02646891|37716557|FG001|Overall Study|Protocol Violation|0|||
16777019|NCT02646891|37716558|FG002|Overall Study|Protocol Violation|0|||
16777020|NCT02646891|37716559|FG003|Overall Study|Protocol Violation|0|||
16777021|NCT02646891|37716560|FG004|Overall Study|Protocol Violation|0|||
16777022|NCT02646891|37716561|FG005|Overall Study|Protocol Violation|0|||
16777023|NCT02646891|37716562|FG006|Overall Study|Protocol Violation|1|||
16777024|NCT02646891|37716563|FG007|Overall Study|Protocol Violation|1|||
16777025|NCT02646891|37716564|FG008|Overall Study|Protocol Violation|0|||
16777026|NCT02646891|37716565|FG009|Overall Study|Protocol Violation|0|||
16777027|NCT02646891|37716556|FG000|Overall Study|Withdrawal by Subject|2|||
16777028|NCT02646891|37716557|FG001|Overall Study|Withdrawal by Subject|0|||
16777029|NCT02646891|37716558|FG002|Overall Study|Withdrawal by Subject|1|||
16777030|NCT02646891|37716559|FG003|Overall Study|Withdrawal by Subject|0|||
16777031|NCT02646891|37716560|FG004|Overall Study|Withdrawal by Subject|0|||
16777032|NCT02646891|37716561|FG005|Overall Study|Withdrawal by Subject|0|||
16777033|NCT02646891|37716562|FG006|Overall Study|Withdrawal by Subject|5|||
16777034|NCT02646891|37716563|FG007|Overall Study|Withdrawal by Subject|9|||
16777035|NCT02646891|37716564|FG008|Overall Study|Withdrawal by Subject|7|||
16777036|NCT02646891|37716565|FG009|Overall Study|Withdrawal by Subject|3|||
16777037|NCT02646891|37716556|FG000|Overall Study|Death|0|||
16777038|NCT02646891|37716557|FG001|Overall Study|Death|0|||
16777039|NCT02646891|37716558|FG002|Overall Study|Death|0|||
16777040|NCT02646891|37716559|FG003|Overall Study|Death|0|||
16777041|NCT02646891|37716560|FG004|Overall Study|Death|0|||
16777042|NCT02646891|37716561|FG005|Overall Study|Death|0|||
16777043|NCT02646891|37716562|FG006|Overall Study|Death|1|||
16777044|NCT02646891|37716563|FG007|Overall Study|Death|1|||
16777045|NCT02646891|37716564|FG008|Overall Study|Death|1|||
16777046|NCT02646891|37716565|FG009|Overall Study|Death|0|||
16777047|NCT02646423|37716620|FG000|Overall Study|Adverse Event|5|||
16777048|NCT02646423|37716621|FG001|Overall Study|Adverse Event|7|||
16777049|NCT02646423|37716620|FG000|Overall Study|Ineligible|2|||
16777050|NCT02646423|37716621|FG001|Overall Study|Ineligible|1|||
16777051|NCT02647359|37716647|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
16777052|NCT02647359|37716648|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
16777053|NCT02647359|37716647|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
16777054|NCT02647359|37716648|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
16777055|NCT02647359|37716647|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
16777056|NCT02647359|37716648|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
16777057|NCT02647359|37716647|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
16777058|NCT02647359|37716648|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
16777059|NCT02647359|37716647|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
16777060|NCT02647359|37716648|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
16777061|NCT02647359|37716647|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
16777062|NCT02647359|37716648|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
16777063|NCT02645409|37716660|FG000|Overall Study|Withdrawal by Subject|3|||
16777064|NCT02645409|37716661|FG001|Overall Study|Withdrawal by Subject|0|||
16777065|NCT02645409|37716660|FG000|Overall Study|Physician Decision|1|||
16777066|NCT02645409|37716661|FG001|Overall Study|Physician Decision|0|||
16777067|NCT01597479|37716668|FG000|Overall Study|Protocol Violation|1|||
16777068|NCT01597479|37716669|FG001|Overall Study|Protocol Violation|0|||
16777069|NCT01597479|37716668|FG000|Overall Study|Lost to Follow-up|1|||
16777070|NCT01597479|37716669|FG001|Overall Study|Lost to Follow-up|0|||
16777071|NCT04248465|37716678|FG000|Randomized-Controlled Period|Death|12|||
16777072|NCT04248465|37716679|FG001|Randomized-Controlled Period|Death|5|||
16777073|NCT04248465|37716678|FG000|Randomized-Controlled Period|Adverse Event|2|||
16777074|NCT04248465|37716679|FG001|Randomized-Controlled Period|Adverse Event|0|||
16777075|NCT04248465|37716678|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
16777076|NCT04248465|37716679|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
16777077|NCT04248465|37716678|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
16777078|NCT04248465|37716679|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
16777079|NCT04248465|37716678|FG000|Randomized-Controlled Period|Physician Decision|1|||
16777080|NCT04248465|37716679|FG001|Randomized-Controlled Period|Physician Decision|1|||
16777081|NCT04248465|37716678|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
16777082|NCT04248465|37716679|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
16777083|NCT04248465|37716678|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
16777084|NCT04248465|37716679|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
16777085|NCT04248465|37716678|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
16777086|NCT04248465|37716679|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
16777087|NCT02643693|37716687|FG000|Overall Study|Physician Decision|0|||
16777088|NCT02643693|37716688|FG001|Overall Study|Physician Decision|1|||
16777089|NCT02643693|37716689|FG002|Overall Study|Physician Decision|0|||
16777090|NCT02643693|37716690|FG003|Overall Study|Physician Decision|0|||
16777091|NCT02643693|37716691|FG004|Overall Study|Physician Decision|0|||
16777092|NCT02643693|37716692|FG005|Overall Study|Physician Decision|0|||
16777093|NCT02643693|37716687|FG000|Overall Study|Withdrawal by Subject|0|||
16777094|NCT02643693|37716688|FG001|Overall Study|Withdrawal by Subject|1|||
16777095|NCT02643693|37716689|FG002|Overall Study|Withdrawal by Subject|0|||
16777096|NCT02643693|37716690|FG003|Overall Study|Withdrawal by Subject|0|||
16777097|NCT02643693|37716691|FG004|Overall Study|Withdrawal by Subject|0|||
16777098|NCT02643693|37716692|FG005|Overall Study|Withdrawal by Subject|0|||
16777099|NCT02643693|37716687|FG000|Overall Study|Protocol Adherence Issues|2|||
16777100|NCT02643693|37716688|FG001|Overall Study|Protocol Adherence Issues|0|||
16777101|NCT02643693|37716689|FG002|Overall Study|Protocol Adherence Issues|1|||
16777102|NCT02643693|37716690|FG003|Overall Study|Protocol Adherence Issues|0|||
16777103|NCT02643693|37716691|FG004|Overall Study|Protocol Adherence Issues|0|||
16777104|NCT02643693|37716692|FG005|Overall Study|Protocol Adherence Issues|1|||
16777105|NCT02726113|37716702|FG000|Total Enrollment|Physician Decision|0|||
16777106|NCT02726113|37716703|FG001|Total Enrollment|Physician Decision|1|||
16777107|NCT02726113|37716702|FG000|Total Enrollment|Protocol Violation|1|||
16777108|NCT02726113|37716703|FG001|Total Enrollment|Protocol Violation|0|||
16777109|NCT02726113|37716702|FG000|Total Enrollment|Withdrawal by Subject|2|||
16777110|NCT02726113|37716703|FG001|Total Enrollment|Withdrawal by Subject|1|||
16777111|NCT02726113|37716702|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
16777112|NCT02726113|37716703|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
16777113|NCT02726113|37716702|FG000|Genomic Analysis|Protocol Violation|1|||
16777114|NCT02726113|37716703|FG001|Genomic Analysis|Protocol Violation|0|||
16777115|NCT02726113|37716702|FG000|Genomic Analysis|Withdrawal by Subject|2|||
16777116|NCT02726113|37716703|FG001|Genomic Analysis|Withdrawal by Subject|1|||
16777117|NCT02726113|37716702|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
16777118|NCT02726113|37716703|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
16777119|NCT01361919|37716721|FG000|Overall Study|technical issues|10|||
16777120|NCT01361919|37716722|FG001|Overall Study|technical issues|12|||
16777121|NCT01361919|37716723|FG002|Overall Study|technical issues|10|||
16777122|NCT01361607|37716733|FG000|Overall Study|Adverse Event|38|||
16777123|NCT01361607|37716734|FG001|Overall Study|Adverse Event|29|||
16777124|NCT01361607|37716733|FG000|Overall Study|Withdrawal by Subject|19|||
16777125|NCT01361607|37716734|FG001|Overall Study|Withdrawal by Subject|8|||
16777126|NCT01361607|37716733|FG000|Overall Study|Withdrawal by Investigator|5|||
16777127|NCT01361607|37716734|FG001|Overall Study|Withdrawal by Investigator|3|||
16777128|NCT01361607|37716733|FG000|Overall Study|Lost to Follow-up|1|||
16777129|NCT01361607|37716734|FG001|Overall Study|Lost to Follow-up|0|||
16777130|NCT01361607|37716733|FG000|Overall Study|Met Withdrawal Criteria|1|||
16777131|NCT01361607|37716734|FG001|Overall Study|Met Withdrawal Criteria|1|||
16777132|NCT02642679|37716741|FG000|Overall Study|Withdrawal by Subject|1|||
16777133|NCT02642679|37716741|FG000|Overall Study|Physician Decision|1|||
16777134|NCT02642679|37716741|FG000|Overall Study|Physician Decision|1|||
16777135|NCT00705523|37716747|FG000|Overall Study|Lost to Follow-up|2|||
16777136|NCT00705523|37716748|FG001|Overall Study|Lost to Follow-up|3|||
16777137|NCT02725411|37716757|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
16777138|NCT02725411|37716758|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
16777139|NCT02725411|37716759|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
16777140|NCT02725411|37716757|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
16777141|NCT02725411|37716758|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
16777142|NCT02725411|37716759|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
16777143|NCT02725411|37716757|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
16777144|NCT02725411|37716758|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
16777145|NCT02725411|37716759|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
16777146|NCT02725411|37716757|FG000|Treatment Period (56 Weeks)|Other|1|||
16777147|NCT02725411|37716758|FG001|Treatment Period (56 Weeks)|Other|4|||
16777148|NCT02725411|37716759|FG002|Treatment Period (56 Weeks)|Other|5|||
16777149|NCT02725411|37716757|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
16777150|NCT02725411|37716758|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
16777151|NCT02725411|37716759|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
16777152|NCT02725411|37716757|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
16777153|NCT02725411|37716758|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
16777154|NCT02725411|37716759|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
16777155|NCT02725411|37716757|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
16777156|NCT02725411|37716758|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
16777157|NCT02725411|37716759|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
16777158|NCT02725411|37716757|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
16777159|NCT02725411|37716758|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
16777160|NCT02725411|37716759|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
16777161|NCT02725411|37716757|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
16777162|NCT02725411|37716758|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
16777163|NCT02725411|37716759|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
16777164|NCT02725411|37716757|FG000|Follow-up Period (24 Weeks)|Other|1|||
16962850|NCT01241591|38105834|FG003|Overall Study|Other|1|||
16962851|NCT01241591|38105831|FG000|Overall Study|Adverse Event|3|||
16777165|NCT02725411|37716758|FG001|Follow-up Period (24 Weeks)|Other|4|||
16777166|NCT02725411|37716759|FG002|Follow-up Period (24 Weeks)|Other|2|||
16777167|NCT02725411|37716757|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
16777168|NCT02725411|37716758|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
16777169|NCT02725411|37716759|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
16777170|NCT02190604|37716795|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777171|NCT02190604|37716796|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777172|NCT02190604|37716797|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777173|NCT02190604|37716798|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777174|NCT02190604|37716799|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777175|NCT02190604|37716800|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777176|NCT02190604|37716801|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777177|NCT02190604|37716802|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777178|NCT02190604|37716803|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777179|NCT02190604|37716804|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777180|NCT02190604|37716805|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777181|NCT02190604|37716806|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777182|NCT02190604|37716807|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777183|NCT02190604|37716808|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777184|NCT02190604|37716809|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
16777185|NCT02190604|37716810|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777186|NCT02190604|37716811|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777187|NCT02190604|37716812|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777188|NCT02190604|37716813|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16777189|NCT02190604|37716795|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777190|NCT02190604|37716796|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777191|NCT02190604|37716797|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777192|NCT02190604|37716798|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777193|NCT02190604|37716799|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777194|NCT02190604|37716800|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777195|NCT02190604|37716801|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777196|NCT02190604|37716802|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777197|NCT02190604|37716803|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777198|NCT02190604|37716804|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777199|NCT02190604|37716805|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777200|NCT02190604|37716806|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777201|NCT02190604|37716807|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777202|NCT02190604|37716808|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
16777203|NCT02190604|37716809|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777204|NCT02190604|37716810|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777205|NCT02190604|37716811|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777206|NCT02190604|37716812|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777207|NCT02190604|37716813|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16777208|NCT02127970|37716872|FG000|Overall Study|Adverse Event|2|||
16777209|NCT02127970|37716873|FG001|Overall Study|Adverse Event|1|||
16777210|NCT02127970|37716872|FG000|Overall Study|Death|1|||
16777211|NCT02127970|37716873|FG001|Overall Study|Death|1|||
16777212|NCT02127970|37716872|FG000|Overall Study|Lost to Follow-up|14|||
16777213|NCT02127970|37716873|FG001|Overall Study|Lost to Follow-up|14|||
16777214|NCT02127970|37716872|FG000|Overall Study|Reason not Specified|4|||
16777215|NCT02127970|37716873|FG001|Overall Study|Reason not Specified|7|||
16777216|NCT02127970|37716872|FG000|Overall Study|Pregnancy|0|||
16777217|NCT02127970|37716873|FG001|Overall Study|Pregnancy|1|||
16777218|NCT02127970|37716872|FG000|Overall Study|Subject Withdrew Consent|5|||
16777219|NCT02127970|37716873|FG001|Overall Study|Subject Withdrew Consent|3|||
16777220|NCT03549871|37716881|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
16777221|NCT03549871|37716882|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
16777222|NCT03549871|37716881|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
16777223|NCT03549871|37716882|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
16962852|NCT01241591|38105832|FG001|Overall Study|Adverse Event|11|||
16777224|NCT03549871|37716881|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
16777225|NCT03549871|37716882|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
16777226|NCT03549871|37716881|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
16777227|NCT03549871|37716882|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
16777228|NCT03549871|37716881|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
16777229|NCT03549871|37716882|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
16777230|NCT03549871|37716881|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
16777231|NCT03549871|37716882|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
16777232|NCT03549871|37716881|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
16777233|NCT03549871|37716882|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
16777234|NCT03549871|37716881|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
16777235|NCT03549871|37716882|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
16777236|NCT03549871|37716881|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
16777237|NCT03549871|37716882|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
16777238|NCT03549871|37716881|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
16777239|NCT03549871|37716882|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
16777240|NCT03549871|37716881|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
16777241|NCT03549871|37716882|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
16777242|NCT00705367|37716905|FG000|Long-term Extension Period|Adverse Event|2|||
16777243|NCT00705367|37716906|FG001|Long-term Extension Period|Adverse Event|0|||
16777244|NCT00705367|37716905|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
16777245|NCT00705367|37716906|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
16777246|NCT00705367|37716905|FG000|Long-term Extension Period|Lack of Efficacy|1|||
16777247|NCT00705367|37716906|FG001|Long-term Extension Period|Lack of Efficacy|0|||
16777248|NCT00705367|37716905|FG000|Long-term Extension Period|No longer met study criteria|1|||
16777249|NCT00705367|37716906|FG001|Long-term Extension Period|No longer met study criteria|0|||
16777250|NCT00705367|37716905|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
16777251|NCT00705367|37716906|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
16777252|NCT02864251|37716917|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
16777253|NCT02864251|37716918|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
16777254|NCT02864251|37716919|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
16777255|NCT02864251|37716917|FG000|Pre-Treatment|Withdrawal by Participant|0|||
16777256|NCT02864251|37716918|FG001|Pre-Treatment|Withdrawal by Participant|0|||
16777257|NCT02864251|37716919|FG002|Pre-Treatment|Withdrawal by Participant|4|||
16777258|NCT02864251|37716917|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
16777259|NCT02864251|37716918|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
16777260|NCT02864251|37716919|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
16777261|NCT02864251|37716917|FG000|Pre-Treatment|Other Reasons|0|||
16777262|NCT02864251|37716918|FG001|Pre-Treatment|Other Reasons|1|||
16777263|NCT02864251|37716919|FG002|Pre-Treatment|Other Reasons|1|||
16777264|NCT02864251|37716917|FG000|Treatment|Disease Progression|109|||
16777265|NCT02864251|37716918|FG001|Treatment|Disease Progression|52|||
16777266|NCT02864251|37716919|FG002|Treatment|Disease Progression|100|||
16777267|NCT02864251|37716917|FG000|Treatment|Study Drug Toxicity|9|||
16777268|NCT02864251|37716918|FG001|Treatment|Study Drug Toxicity|4|||
16777269|NCT02864251|37716919|FG002|Treatment|Study Drug Toxicity|10|||
16777270|NCT02864251|37716917|FG000|Treatment|Death|0|||
16777271|NCT02864251|37716918|FG001|Treatment|Death|2|||
16777272|NCT02864251|37716919|FG002|Treatment|Death|3|||
16777273|NCT02864251|37716917|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
16777274|NCT02864251|37716918|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
16777275|NCT02864251|37716919|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
16777276|NCT02864251|37716917|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
16777277|NCT02864251|37716918|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
16777278|NCT02864251|37716919|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
16777279|NCT02864251|37716917|FG000|Treatment|Withdrawal by Participant|8|||
16777280|NCT02864251|37716918|FG001|Treatment|Withdrawal by Participant|5|||
16777281|NCT02864251|37716919|FG002|Treatment|Withdrawal by Participant|13|||
16777282|NCT02864251|37716917|FG000|Treatment|Maximum Clinical Benefit|1|||
16777283|NCT02864251|37716918|FG001|Treatment|Maximum Clinical Benefit|0|||
16777284|NCT02864251|37716919|FG002|Treatment|Maximum Clinical Benefit|1|||
16777285|NCT02864251|37716917|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
16777286|NCT02864251|37716918|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
16777287|NCT02864251|37716919|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
16777288|NCT02864251|37716917|FG000|Treatment|Other Reasons|0|||
16777289|NCT02864251|37716918|FG001|Treatment|Other Reasons|1|||
16777290|NCT02864251|37716919|FG002|Treatment|Other Reasons|3|||
16777291|NCT02864251|37716917|FG000|Treatment|Not Reported|1|||
16777292|NCT02864251|37716918|FG001|Treatment|Not Reported|0|||
16777293|NCT02864251|37716919|FG002|Treatment|Not Reported|0|||
16777294|NCT02864251|37716917|FG000|Treatment|Ongoing Treatment|1|||
16777295|NCT02864251|37716918|FG001|Treatment|Ongoing Treatment|0|||
16777296|NCT02864251|37716919|FG002|Treatment|Ongoing Treatment|2|||
16777297|NCT00705289|37716927|FG000|Overall Study|Subject or treating physician's choice|131|||
16777298|NCT02038777|37716956|FG000|Overall Study|Death|0|||
16777299|NCT02038777|37716957|FG001|Overall Study|Death|2|||
16777300|NCT02038777|37716958|FG002|Overall Study|Death|0|||
16777301|NCT02038777|37716959|FG003|Overall Study|Death|1|||
16777302|NCT02038777|37716960|FG004|Overall Study|Death|2|||
16777303|NCT02038777|37716961|FG005|Overall Study|Death|4|||
16777304|NCT02038777|37716962|FG006|Overall Study|Death|0|||
16777305|NCT02038777|37716963|FG007|Overall Study|Death|10|||
16777306|NCT02038777|37716956|FG000|Overall Study|Lost to Follow-up|0|||
16777307|NCT02038777|37716957|FG001|Overall Study|Lost to Follow-up|0|||
16777308|NCT02038777|37716958|FG002|Overall Study|Lost to Follow-up|0|||
16777309|NCT02038777|37716959|FG003|Overall Study|Lost to Follow-up|1|||
16777310|NCT02038777|37716960|FG004|Overall Study|Lost to Follow-up|0|||
16777311|NCT02038777|37716961|FG005|Overall Study|Lost to Follow-up|0|||
16777312|NCT02038777|37716962|FG006|Overall Study|Lost to Follow-up|0|||
16777313|NCT02038777|37716963|FG007|Overall Study|Lost to Follow-up|0|||
16777314|NCT02038777|37716956|FG000|Overall Study|Other|0|||
16777315|NCT02038777|37716957|FG001|Overall Study|Other|1|||
16777316|NCT02038777|37716958|FG002|Overall Study|Other|0|||
16777317|NCT02038777|37716959|FG003|Overall Study|Other|2|||
16777318|NCT02038777|37716960|FG004|Overall Study|Other|1|||
16777319|NCT02038777|37716961|FG005|Overall Study|Other|0|||
16777320|NCT02038777|37716962|FG006|Overall Study|Other|0|||
16777321|NCT02038777|37716963|FG007|Overall Study|Other|0|||
16777322|NCT02038777|37716956|FG000|Overall Study|Randomized but not treated|0|||
16777323|NCT02038777|37716957|FG001|Overall Study|Randomized but not treated|1|||
16777324|NCT02038777|37716958|FG002|Overall Study|Randomized but not treated|0|||
16777325|NCT02038777|37716959|FG003|Overall Study|Randomized but not treated|0|||
16777326|NCT02038777|37716960|FG004|Overall Study|Randomized but not treated|0|||
16777327|NCT02038777|37716961|FG005|Overall Study|Randomized but not treated|0|||
16777328|NCT02038777|37716962|FG006|Overall Study|Randomized but not treated|0|||
16777329|NCT02038777|37716963|FG007|Overall Study|Randomized but not treated|0|||
16777330|NCT02038777|37716956|FG000|Overall Study|Started Chemotherapy|1|||
16777331|NCT02038777|37716957|FG001|Overall Study|Started Chemotherapy|0|||
16777332|NCT02038777|37716958|FG002|Overall Study|Started Chemotherapy|3|||
16777333|NCT02038777|37716959|FG003|Overall Study|Started Chemotherapy|0|||
16777334|NCT02038777|37716960|FG004|Overall Study|Started Chemotherapy|0|||
16777335|NCT02038777|37716961|FG005|Overall Study|Started Chemotherapy|0|||
16777336|NCT02038777|37716962|FG006|Overall Study|Started Chemotherapy|0|||
16777337|NCT02038777|37716963|FG007|Overall Study|Started Chemotherapy|0|||
16777338|NCT00703963|37716982|FG000|Overall Study|Withdrawal by Subject|7|||
16777339|NCT00703963|37716983|FG001|Overall Study|Withdrawal by Subject|13|||
16777340|NCT00703963|37716982|FG000|Overall Study|Physician Decision|0|||
16777341|NCT00703963|37716983|FG001|Overall Study|Physician Decision|1|||
16777342|NCT02721355|37716991|FG000|Overall Study|Lost to Follow-up|6|||
16777343|NCT02721355|37716992|FG001|Overall Study|Lost to Follow-up|1|||
16777344|NCT02733991|37717000|FG000|Overall Study|Adverse Event|1|||
16777345|NCT02733991|37717001|FG001|Overall Study|Adverse Event|0|||
16777346|NCT02733991|37717000|FG000|Overall Study|Withdrawal by Subject|0|||
16777347|NCT02733991|37717001|FG001|Overall Study|Withdrawal by Subject|5|||
16777348|NCT00702949|37717010|FG000|Overall Study|Refusal|3|||
16777349|NCT00702949|37717011|FG001|Overall Study|Refusal|2|||
16777350|NCT00702949|37717012|FG002|Overall Study|Refusal|2|||
16777351|NCT00702949|37717010|FG000|Overall Study|Adverse Event|1|||
16777352|NCT00702949|37717011|FG001|Overall Study|Adverse Event|6|||
16777353|NCT00702949|37717012|FG002|Overall Study|Adverse Event|3|||
16777354|NCT00702949|37717010|FG000|Overall Study|Other Medical Reason/unknown|1|||
16777355|NCT00702949|37717011|FG001|Overall Study|Other Medical Reason/unknown|1|||
16777356|NCT00702949|37717012|FG002|Overall Study|Other Medical Reason/unknown|3|||
16777357|NCT00702715|37717024|FG000|Overall Study|Lost to Follow-up|1|||
16777358|NCT00702715|37717025|FG001|Overall Study|Lost to Follow-up|0|||
16777359|NCT00702403|37717031|FG000|From Consent to Engraftment|Progressive leukemia|6|||
16777360|NCT00702403|37717031|FG000|From Consent to Engraftment|Critically ill|2|||
16777361|NCT00702403|37717031|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
16777362|NCT00702403|37717031|FG000|From Consent to Engraftment|Myocardial infarction|1|||
16777363|NCT00702403|37717031|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
16777364|NCT00702403|37717031|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
16777365|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
16777366|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
16777367|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Non-compliance|2|||
16777368|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
16777369|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
16777370|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Suicide|1|||
16777371|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
16777372|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
16777373|NCT00702403|37717031|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
16777374|NCT00702325|37717040|FG000|Overall Study|Adverse Event|1|||
16777375|NCT00702325|37717041|FG001|Overall Study|Adverse Event|0|||
16777376|NCT00702325|37717040|FG000|Overall Study|Withdrawal by Subject|7|||
16777377|NCT00702325|37717041|FG001|Overall Study|Withdrawal by Subject|7|||
16777378|NCT00702325|37717040|FG000|Overall Study|Lost to Follow-up|3|||
16777379|NCT00702325|37717041|FG001|Overall Study|Lost to Follow-up|4|||
16777380|NCT00702325|37717040|FG000|Overall Study|Incorrect enrollment|5|||
16777381|NCT00702325|37717041|FG001|Overall Study|Incorrect enrollment|7|||
16777382|NCT00702325|37717040|FG000|Overall Study|Developed study discontinuation criteria|18|||
16777383|NCT00702325|37717041|FG001|Overall Study|Developed study discontinuation criteria|28|||
16777384|NCT00702325|37717040|FG000|Overall Study|Severe noncompliance to protocol|3|||
16777385|NCT00702325|37717041|FG001|Overall Study|Severe noncompliance to protocol|3|||
16777386|NCT00702325|37717040|FG000|Overall Study|Termination due to lab results|1|||
16777387|NCT00702325|37717041|FG001|Overall Study|Termination due to lab results|0|||
16777388|NCT00702325|37717040|FG000|Overall Study|Didn't follow study medication dosage|0|||
16777389|NCT00702325|37717041|FG001|Overall Study|Didn't follow study medication dosage|2|||
16777390|NCT00702325|37717040|FG000|Overall Study|Withdrew consent|0|||
16777391|NCT00702325|37717041|FG001|Overall Study|Withdrew consent|1|||
16777392|NCT00702325|37717040|FG000|Overall Study|Incorrectly Discontinued|0|||
16777393|NCT00702325|37717041|FG001|Overall Study|Incorrectly Discontinued|1|||
16867980|NCT01553747|37841011|FG000|Overall Study|Voluntarily withdrew|70|||
16777394|NCT02719171|37717052|FG000|Overall Study|Adverse Event|1|||
16777395|NCT02719171|37717053|FG001|Overall Study|Adverse Event|2|||
16777396|NCT02719171|37717054|FG002|Overall Study|Adverse Event|0|||
16777397|NCT02719171|37717055|FG003|Overall Study|Adverse Event|0|||
16777398|NCT02719171|37717056|FG004|Overall Study|Adverse Event|2|||
16777399|NCT02719171|37717052|FG000|Overall Study|Lost to Follow-up|0|||
16777400|NCT02719171|37717053|FG001|Overall Study|Lost to Follow-up|0|||
16777401|NCT02719171|37717054|FG002|Overall Study|Lost to Follow-up|1|||
16777402|NCT02719171|37717055|FG003|Overall Study|Lost to Follow-up|0|||
16962853|NCT01241591|38105833|FG002|Overall Study|Adverse Event|12|||
16962854|NCT01241591|38105834|FG003|Overall Study|Adverse Event|4|||
16962855|NCT00906373|38105846|FG000|Overall Study|Withdrawal by Subject|0|||
16962856|NCT00906373|38105847|FG001|Overall Study|Withdrawal by Subject|5|||
16962857|NCT00906373|38105846|FG000|Overall Study|Other|0|||
16962858|NCT00906373|38105847|FG001|Overall Study|Other|1|||
16962859|NCT00906373|38105846|FG000|Overall Study|Still on treatment at cutoff date|0|||
16962860|NCT00906373|38105847|FG001|Overall Study|Still on treatment at cutoff date|2|||
16962861|NCT00905437|38105856|FG000|Overall Study|Adverse Event|3|||
16962862|NCT00905437|38105857|FG001|Overall Study|Adverse Event|2|||
16962863|NCT00905437|38105856|FG000|Overall Study|Lost to Follow-up|0|||
16962864|NCT00905437|38105857|FG001|Overall Study|Lost to Follow-up|1|||
16962865|NCT00905437|38105856|FG000|Overall Study|Withdrawal by Subject|0|||
16962866|NCT00905437|38105857|FG001|Overall Study|Withdrawal by Subject|1|||
16962867|NCT00905437|38105856|FG000|Overall Study|Other|5|||
16962868|NCT00905437|38105857|FG001|Overall Study|Other|6|||
16962869|NCT01238861|38105869|FG000|Overall Study|Lost to Follow-up|4|||
16962870|NCT01238861|38105870|FG001|Overall Study|Lost to Follow-up|2|||
16962871|NCT01238861|38105871|FG002|Overall Study|Lost to Follow-up|3|||
16962872|NCT01238861|38105872|FG003|Overall Study|Lost to Follow-up|1|||
16962873|NCT01238861|38105873|FG004|Overall Study|Lost to Follow-up|1|||
16962874|NCT01238861|38105874|FG005|Overall Study|Lost to Follow-up|2|||
16962875|NCT01238861|38105869|FG000|Overall Study|Unplanned surgery|1|||
16962876|NCT01238861|38105870|FG001|Overall Study|Unplanned surgery|0|||
16962877|NCT01238861|38105871|FG002|Overall Study|Unplanned surgery|0|||
16962878|NCT01238861|38105872|FG003|Overall Study|Unplanned surgery|0|||
16962879|NCT01238861|38105873|FG004|Overall Study|Unplanned surgery|0|||
16962880|NCT01238861|38105874|FG005|Overall Study|Unplanned surgery|0|||
16962881|NCT01238861|38105869|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
16962882|NCT01238861|38105870|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
16962883|NCT01238861|38105871|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
16962884|NCT01238861|38105872|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
16962885|NCT01238861|38105873|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
16962886|NCT01238861|38105874|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
16962887|NCT01238861|38105869|FG000|Overall Study|Incorrect enrollment/randomization|0|||
16777403|NCT02719171|37717056|FG004|Overall Study|Lost to Follow-up|0|||
16962888|NCT01238861|38105870|FG001|Overall Study|Incorrect enrollment/randomization|0|||
16962889|NCT01238861|38105871|FG002|Overall Study|Incorrect enrollment/randomization|1|||
16962890|NCT01238861|38105872|FG003|Overall Study|Incorrect enrollment/randomization|0|||
16962891|NCT01238861|38105873|FG004|Overall Study|Incorrect enrollment/randomization|1|||
16962892|NCT01238861|38105874|FG005|Overall Study|Incorrect enrollment/randomization|0|||
16962893|NCT01238861|38105869|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
16962894|NCT01238861|38105870|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
16777404|NCT02719171|37717052|FG000|Overall Study|Subject Withdrawal|0|||
16777405|NCT02719171|37717053|FG001|Overall Study|Subject Withdrawal|2|||
16777406|NCT02719171|37717054|FG002|Overall Study|Subject Withdrawal|2|||
16777407|NCT02719171|37717055|FG003|Overall Study|Subject Withdrawal|1|||
16777408|NCT02719171|37717056|FG004|Overall Study|Subject Withdrawal|0|||
16777409|NCT02719171|37717052|FG000|Overall Study|Other|0|||
16777410|NCT02719171|37717053|FG001|Overall Study|Other|0|||
16777411|NCT02719171|37717054|FG002|Overall Study|Other|0|||
16777412|NCT02719171|37717055|FG003|Overall Study|Other|1|||
16777413|NCT02719171|37717056|FG004|Overall Study|Other|0|||
16777414|NCT02718625|37717073|FG000|Overall Study|Adverse Event|0|||
16777415|NCT02718625|37717074|FG001|Overall Study|Adverse Event|1|||
16777416|NCT02718625|37717073|FG000|Overall Study|Termination of Study by Sponsor|0|||
16777417|NCT02718625|37717074|FG001|Overall Study|Termination of Study by Sponsor|1|||
16777418|NCT02716987|37717086|FG000|Overall Study|Ligand synthesis failure|0|||
16777419|NCT02716987|37717087|FG001|Overall Study|Ligand synthesis failure|0|||
16777420|NCT02716987|37717088|FG002|Overall Study|Ligand synthesis failure|1|||
16777421|NCT02716987|37717089|FG003|Overall Study|Ligand synthesis failure|0|||
16777422|NCT02716987|37717090|FG004|Overall Study|Ligand synthesis failure|0|||
16777423|NCT02716987|37717091|FG005|Overall Study|Ligand synthesis failure|0|||
16777424|NCT02716987|37717086|FG000|Overall Study|Withdrawal by Subject|0|||
16777425|NCT02716987|37717087|FG001|Overall Study|Withdrawal by Subject|0|||
16777426|NCT02716987|37717088|FG002|Overall Study|Withdrawal by Subject|0|||
16777427|NCT02716987|37717089|FG003|Overall Study|Withdrawal by Subject|0|||
16777428|NCT02716987|37717090|FG004|Overall Study|Withdrawal by Subject|1|||
16777429|NCT02716987|37717091|FG005|Overall Study|Withdrawal by Subject|1|||
16777430|NCT00701779|37717116|FG000|Overall Study|Adverse Event|6|||
16777431|NCT00701779|37717116|FG000|Overall Study|Lost to Follow-up|1|||
16777432|NCT00701779|37717116|FG000|Overall Study|Withdrawal by Subject|2|||
16777433|NCT03707977|37717139|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
16777434|NCT03707977|37717140|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
16777435|NCT03707977|37717141|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
16777436|NCT03707977|37717139|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
16777437|NCT03707977|37717140|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
16777438|NCT03707977|37717141|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
16777439|NCT03332095|37717166|FG000|Overall Study|Lost to Follow-up|1|||
16777440|NCT03332095|37717167|FG001|Overall Study|Lost to Follow-up|0|||
16777441|NCT03332095|37717166|FG000|Overall Study|Pregnancy|0|||
16777442|NCT03332095|37717167|FG001|Overall Study|Pregnancy|1|||
16777443|NCT02764489|37717174|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
16777444|NCT02764489|37717175|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
16777445|NCT02764489|37717174|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
16777446|NCT02764489|37717175|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
16777447|NCT02764489|37717174|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
16777448|NCT02764489|37717175|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
16777449|NCT02764489|37717174|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
16777450|NCT02764489|37717175|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
16777451|NCT02001623|37717200|FG000|Overall Study|Disease Progression|2|||
16777452|NCT02001623|37717201|FG001|Overall Study|Disease Progression|2|||
16777453|NCT02001623|37717202|FG002|Overall Study|Disease Progression|3|||
16777454|NCT02001623|37717203|FG003|Overall Study|Disease Progression|2|||
16777455|NCT02001623|37717204|FG004|Overall Study|Disease Progression|3|||
16777456|NCT02001623|37717205|FG005|Overall Study|Disease Progression|2|||
16777457|NCT02001623|37717206|FG006|Overall Study|Disease Progression|3|||
16777458|NCT02001623|37717207|FG007|Overall Study|Disease Progression|3|||
16777459|NCT02001623|37717208|FG008|Overall Study|Disease Progression|7|||
16777460|NCT02001623|37717209|FG009|Overall Study|Disease Progression|40|||
16777461|NCT02001623|37717210|FG010|Overall Study|Disease Progression|5|||
16777462|NCT02001623|37717211|FG011|Overall Study|Disease Progression|9|||
16777463|NCT02001623|37717212|FG012|Overall Study|Disease Progression|9|||
16777464|NCT02001623|37717213|FG013|Overall Study|Disease Progression|20|||
16777465|NCT02001623|37717214|FG014|Overall Study|Disease Progression|9|||
16777466|NCT02001623|37717200|FG000|Overall Study|Physician Decision|0|||
16777467|NCT02001623|37717201|FG001|Overall Study|Physician Decision|0|||
16777468|NCT02001623|37717202|FG002|Overall Study|Physician Decision|0|||
16777469|NCT02001623|37717203|FG003|Overall Study|Physician Decision|0|||
16777470|NCT02001623|37717204|FG004|Overall Study|Physician Decision|0|||
16777471|NCT02001623|37717205|FG005|Overall Study|Physician Decision|0|||
16777472|NCT02001623|37717206|FG006|Overall Study|Physician Decision|0|||
16777473|NCT02001623|37717207|FG007|Overall Study|Physician Decision|0|||
16777474|NCT02001623|37717208|FG008|Overall Study|Physician Decision|3|||
16777475|NCT02001623|37717209|FG009|Overall Study|Physician Decision|2|||
16777476|NCT02001623|37717210|FG010|Overall Study|Physician Decision|3|||
16777477|NCT02001623|37717211|FG011|Overall Study|Physician Decision|3|||
16777478|NCT02001623|37717212|FG012|Overall Study|Physician Decision|1|||
16777479|NCT02001623|37717213|FG013|Overall Study|Physician Decision|2|||
16777480|NCT02001623|37717214|FG014|Overall Study|Physician Decision|1|||
16777481|NCT02001623|37717200|FG000|Overall Study|Death|0|||
16777482|NCT02001623|37717201|FG001|Overall Study|Death|1|||
16777483|NCT02001623|37717202|FG002|Overall Study|Death|0|||
16777484|NCT02001623|37717203|FG003|Overall Study|Death|0|||
16777485|NCT02001623|37717204|FG004|Overall Study|Death|0|||
16777486|NCT02001623|37717205|FG005|Overall Study|Death|0|||
16777487|NCT02001623|37717206|FG006|Overall Study|Death|0|||
16777488|NCT02001623|37717207|FG007|Overall Study|Death|0|||
16777489|NCT02001623|37717208|FG008|Overall Study|Death|0|||
16777490|NCT02001623|37717209|FG009|Overall Study|Death|0|||
16777491|NCT02001623|37717210|FG010|Overall Study|Death|0|||
16777492|NCT02001623|37717211|FG011|Overall Study|Death|0|||
16777493|NCT02001623|37717212|FG012|Overall Study|Death|0|||
16777494|NCT02001623|37717213|FG013|Overall Study|Death|0|||
16777495|NCT02001623|37717214|FG014|Overall Study|Death|0|||
16777496|NCT02001623|37717200|FG000|Overall Study|Adverse Event|0|||
16777497|NCT02001623|37717201|FG001|Overall Study|Adverse Event|0|||
16777498|NCT02001623|37717202|FG002|Overall Study|Adverse Event|0|||
16777499|NCT02001623|37717203|FG003|Overall Study|Adverse Event|0|||
16777500|NCT02001623|37717204|FG004|Overall Study|Adverse Event|0|||
16777501|NCT02001623|37717205|FG005|Overall Study|Adverse Event|1|||
16777502|NCT02001623|37717206|FG006|Overall Study|Adverse Event|0|||
16777503|NCT02001623|37717207|FG007|Overall Study|Adverse Event|3|||
16777504|NCT02001623|37717208|FG008|Overall Study|Adverse Event|4|||
16777505|NCT02001623|37717209|FG009|Overall Study|Adverse Event|6|||
16777506|NCT02001623|37717210|FG010|Overall Study|Adverse Event|4|||
16777507|NCT02001623|37717211|FG011|Overall Study|Adverse Event|0|||
16777508|NCT02001623|37717212|FG012|Overall Study|Adverse Event|3|||
16777509|NCT02001623|37717213|FG013|Overall Study|Adverse Event|5|||
16777510|NCT02001623|37717214|FG014|Overall Study|Adverse Event|6|||
16777511|NCT02001623|37717200|FG000|Overall Study|Other - Miscellaneous|0|||
16777512|NCT02001623|37717201|FG001|Overall Study|Other - Miscellaneous|0|||
16777513|NCT02001623|37717202|FG002|Overall Study|Other - Miscellaneous|0|||
16777514|NCT02001623|37717203|FG003|Overall Study|Other - Miscellaneous|0|||
16777515|NCT02001623|37717204|FG004|Overall Study|Other - Miscellaneous|0|||
16777516|NCT02001623|37717205|FG005|Overall Study|Other - Miscellaneous|0|||
16777517|NCT02001623|37717206|FG006|Overall Study|Other - Miscellaneous|0|||
16777518|NCT02001623|37717207|FG007|Overall Study|Other - Miscellaneous|0|||
16777519|NCT02001623|37717208|FG008|Overall Study|Other - Miscellaneous|0|||
16777520|NCT02001623|37717209|FG009|Overall Study|Other - Miscellaneous|1|||
16777521|NCT02001623|37717210|FG010|Overall Study|Other - Miscellaneous|0|||
16777522|NCT02001623|37717211|FG011|Overall Study|Other - Miscellaneous|0|||
16777523|NCT02001623|37717212|FG012|Overall Study|Other - Miscellaneous|0|||
16777524|NCT02001623|37717213|FG013|Overall Study|Other - Miscellaneous|1|||
16777525|NCT02001623|37717214|FG014|Overall Study|Other - Miscellaneous|0|||
16777526|NCT02001623|37717200|FG000|Overall Study|Withdrawal by Subject|1|||
16777527|NCT02001623|37717201|FG001|Overall Study|Withdrawal by Subject|0|||
16777528|NCT02001623|37717202|FG002|Overall Study|Withdrawal by Subject|0|||
16777529|NCT02001623|37717203|FG003|Overall Study|Withdrawal by Subject|0|||
16777530|NCT02001623|37717204|FG004|Overall Study|Withdrawal by Subject|0|||
16777531|NCT02001623|37717205|FG005|Overall Study|Withdrawal by Subject|0|||
16777532|NCT02001623|37717206|FG006|Overall Study|Withdrawal by Subject|0|||
16777533|NCT02001623|37717207|FG007|Overall Study|Withdrawal by Subject|0|||
16777534|NCT02001623|37717208|FG008|Overall Study|Withdrawal by Subject|1|||
16777535|NCT02001623|37717209|FG009|Overall Study|Withdrawal by Subject|3|||
16777536|NCT02001623|37717210|FG010|Overall Study|Withdrawal by Subject|2|||
16777537|NCT02001623|37717211|FG011|Overall Study|Withdrawal by Subject|2|||
16777538|NCT02001623|37717212|FG012|Overall Study|Withdrawal by Subject|1|||
16777539|NCT02001623|37717213|FG013|Overall Study|Withdrawal by Subject|5|||
16777540|NCT02001623|37717214|FG014|Overall Study|Withdrawal by Subject|2|||
16777541|NCT02001623|37717200|FG000|Overall Study|Lost to Follow-up|0|||
16777542|NCT02001623|37717201|FG001|Overall Study|Lost to Follow-up|0|||
16777543|NCT02001623|37717202|FG002|Overall Study|Lost to Follow-up|0|||
16777544|NCT02001623|37717203|FG003|Overall Study|Lost to Follow-up|0|||
16777545|NCT02001623|37717204|FG004|Overall Study|Lost to Follow-up|0|||
16777546|NCT02001623|37717205|FG005|Overall Study|Lost to Follow-up|0|||
16777547|NCT02001623|37717206|FG006|Overall Study|Lost to Follow-up|0|||
16777548|NCT02001623|37717207|FG007|Overall Study|Lost to Follow-up|0|||
16777549|NCT02001623|37717208|FG008|Overall Study|Lost to Follow-up|0|||
16777550|NCT02001623|37717209|FG009|Overall Study|Lost to Follow-up|1|||
16777551|NCT02001623|37717210|FG010|Overall Study|Lost to Follow-up|0|||
16777552|NCT02001623|37717211|FG011|Overall Study|Lost to Follow-up|0|||
16777553|NCT02001623|37717212|FG012|Overall Study|Lost to Follow-up|0|||
16777554|NCT02001623|37717213|FG013|Overall Study|Lost to Follow-up|0|||
16777555|NCT02001623|37717214|FG014|Overall Study|Lost to Follow-up|0|||
16777556|NCT02001623|37717200|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
16777557|NCT02001623|37717201|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
16777558|NCT02001623|37717202|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
16777559|NCT02001623|37717203|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
16777560|NCT02001623|37717204|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
16777561|NCT02001623|37717205|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
16777562|NCT02001623|37717206|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
16777563|NCT02001623|37717207|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
16777564|NCT02001623|37717208|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
16777565|NCT02001623|37717209|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
16777566|NCT02001623|37717210|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
16777567|NCT02001623|37717211|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
16777568|NCT02001623|37717212|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
16777569|NCT02001623|37717213|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
16777570|NCT02001623|37717214|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
16777571|NCT02001623|37717200|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
16777572|NCT02001623|37717201|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
16777573|NCT02001623|37717202|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
16777574|NCT02001623|37717203|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
16777575|NCT02001623|37717204|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
16777576|NCT02001623|37717205|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
16777577|NCT02001623|37717206|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
16777578|NCT02001623|37717207|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
16777579|NCT02001623|37717208|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
16777580|NCT02001623|37717209|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
16777581|NCT02001623|37717210|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
16777582|NCT02001623|37717211|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
16777583|NCT02001623|37717212|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
16777584|NCT02001623|37717213|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
16777585|NCT02001623|37717214|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
16777586|NCT02713867|37717265|FG000|Randomization|Other Reason|2|||
16777587|NCT02713867|37717266|FG001|Randomization|Other Reason|1|||
16777588|NCT02713867|37717265|FG000|Randomization|Participant Withdrew consent|0|||
16777589|NCT02713867|37717266|FG001|Randomization|Participant Withdrew consent|2|||
16777590|NCT02713867|37717265|FG000|Treatment Period|Other Reasons|22|||
16777591|NCT02713867|37717266|FG001|Treatment Period|Other Reasons|28|||
16777592|NCT02713867|37717265|FG000|Treatment Period|Administrative reason by sponsor|21|||
16777593|NCT02713867|37717266|FG001|Treatment Period|Administrative reason by sponsor|16|||
16777594|NCT02713867|37717265|FG000|Treatment Period|No longer meets study criteria|2|||
16777595|NCT02713867|37717266|FG001|Treatment Period|No longer meets study criteria|1|||
16777596|NCT02713867|37717265|FG000|Treatment Period|Poor/Non Compliance|1|||
16777597|NCT02713867|37717266|FG001|Treatment Period|Poor/Non Compliance|0|||
16777598|NCT02713867|37717265|FG000|Treatment Period|Maximum Clinical Benefit|5|||
16777599|NCT02713867|37717266|FG001|Treatment Period|Maximum Clinical Benefit|6|||
16777600|NCT02713867|37717265|FG000|Treatment Period|Withdrew consent|3|||
16777601|NCT02713867|37717266|FG001|Treatment Period|Withdrew consent|6|||
16777602|NCT02713867|37717265|FG000|Treatment Period|Requested to Discontinue|8|||
16777603|NCT02713867|37717266|FG001|Treatment Period|Requested to Discontinue|8|||
16777604|NCT02713867|37717265|FG000|Treatment Period|AE unrelated to Study Drug|11|||
16777605|NCT02713867|37717266|FG001|Treatment Period|AE unrelated to Study Drug|10|||
16777606|NCT02713867|37717265|FG000|Treatment Period|Death|7|||
16777607|NCT02713867|37717266|FG001|Treatment Period|Death|3|||
16777608|NCT02713867|37717265|FG000|Treatment Period|Study Drug Toxicity|16|||
16777609|NCT02713867|37717266|FG001|Treatment Period|Study Drug Toxicity|19|||
16777610|NCT02713867|37717265|FG000|Treatment Period|Disease Progression|82|||
16777611|NCT02713867|37717266|FG001|Treatment Period|Disease Progression|83|||
16777612|NCT01854775|37717275|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
16777613|NCT01854775|37717276|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
16777614|NCT01854775|37717277|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
16777615|NCT01854775|37717275|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
16777616|NCT01854775|37717276|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
16777617|NCT01854775|37717277|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
16777618|NCT01854775|37717275|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
16777619|NCT01854775|37717276|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
16777620|NCT01854775|37717277|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
16777621|NCT01854775|37717275|FG000|Extension Phase|Pregnancy|3|||
16777622|NCT01854775|37717276|FG001|Extension Phase|Pregnancy|0|||
16777623|NCT01854775|37717277|FG002|Extension Phase|Pregnancy|0|||
16777624|NCT01854775|37717275|FG000|Extension Phase|Investigator's Discretion|1|||
16777625|NCT01854775|37717276|FG001|Extension Phase|Investigator's Discretion|0|||
16777626|NCT01854775|37717277|FG002|Extension Phase|Investigator's Discretion|0|||
16777627|NCT01854775|37717275|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
16777628|NCT01854775|37717276|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
16777629|NCT01854775|37717277|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
16777630|NCT01854775|37717275|FG000|Extension Phase|Lost to Follow-up|2|||
16777631|NCT01854775|37717276|FG001|Extension Phase|Lost to Follow-up|0|||
16777632|NCT01854775|37717277|FG002|Extension Phase|Lost to Follow-up|0|||
16777633|NCT01854775|37717275|FG000|Extension Phase|Still on Study|32|||
16777634|NCT01854775|37717276|FG001|Extension Phase|Still on Study|47|||
16777635|NCT01854775|37717277|FG002|Extension Phase|Still on Study|18|||
16777636|NCT02730455|37717288|FG000|Overall Study|Death|5|||
16777637|NCT02730455|37717289|FG001|Overall Study|Death|6|||
16777638|NCT02730455|37717290|FG002|Overall Study|Death|4|||
16777639|NCT02730455|37717288|FG000|Overall Study|Consent withdrawn|2|||
16777640|NCT02730455|37717289|FG001|Overall Study|Consent withdrawn|4|||
16777641|NCT02730455|37717290|FG002|Overall Study|Consent withdrawn|1|||
16777642|NCT02730455|37717288|FG000|Overall Study|Lost to Follow-up|3|||
16777643|NCT02730455|37717289|FG001|Overall Study|Lost to Follow-up|1|||
16777644|NCT02730455|37717290|FG002|Overall Study|Lost to Follow-up|4|||
16777645|NCT02730455|37717288|FG000|Overall Study|Other|1|||
16777646|NCT02730455|37717289|FG001|Overall Study|Other|1|||
16777647|NCT02730455|37717290|FG002|Overall Study|Other|2|||
16777648|NCT02730455|37717288|FG000|Overall Study|Other|2|||
16777649|NCT02730455|37717289|FG001|Overall Study|Other|2|||
16777650|NCT02730455|37717290|FG002|Overall Study|Other|0|||
16777651|NCT04440449|37717300|FG000|Overall Study|Lost to Follow-up|2|||
16777652|NCT04440449|37717301|FG001|Overall Study|Lost to Follow-up|0|||
16777653|NCT00701311|37717308|FG000|Overall Study|Lack of Efficacy|3|||
16777654|NCT00701311|37717308|FG000|Overall Study|Adverse Event|3|||
16777655|NCT00701311|37717308|FG000|Overall Study|Withdrawal by Subject|2|||
16777656|NCT02730377|37717318|FG000|Overall Study|Other|5|||
16777657|NCT02730377|37717319|FG001|Overall Study|Other|4|||
16777658|NCT02730377|37717318|FG000|Overall Study|Death|1|||
16777659|NCT02730377|37717319|FG001|Overall Study|Death|8|||
16777660|NCT02730377|37717318|FG000|Overall Study|Inadequate glycaemic control|368|||
16777661|NCT02730377|37717319|FG001|Overall Study|Inadequate glycaemic control|473|||
16777662|NCT02730377|37717318|FG000|Overall Study|Adverse Event|79|||
16777663|NCT02730377|37717319|FG001|Overall Study|Adverse Event|41|||
16777664|NCT02730377|37717318|FG000|Overall Study|Protocol Violation|23|||
16777665|NCT02730377|37717319|FG001|Overall Study|Protocol Violation|30|||
16777666|NCT02730377|37717318|FG000|Overall Study|Lack of Efficacy|4|||
16777667|NCT02730377|37717319|FG001|Overall Study|Lack of Efficacy|13|||
16777668|NCT02730377|37717318|FG000|Overall Study|Pregnancy|0|||
16777669|NCT02730377|37717319|FG001|Overall Study|Pregnancy|1|||
16777670|NCT02730377|37717318|FG000|Overall Study|Withdrawal by Subject|45|||
16777671|NCT02730377|37717319|FG001|Overall Study|Withdrawal by Subject|42|||
16777672|NCT02730377|37717318|FG000|Overall Study|Lost to Follow-up|25|||
16777673|NCT02730377|37717319|FG001|Overall Study|Lost to Follow-up|21|||
16777674|NCT02714569|37717336|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
16777675|NCT02714569|37717337|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
16777676|NCT02714569|37717338|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
16777677|NCT02714569|37717339|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
16777678|NCT02714569|37717340|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
16777679|NCT02714569|37717341|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
16777680|NCT02714569|37717342|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
16777681|NCT02714569|37717343|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
16777682|NCT02714569|37717344|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
16777683|NCT02714569|37717345|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
16777684|NCT02714569|37717346|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
16777685|NCT02714569|37717336|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777686|NCT02714569|37717337|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777687|NCT02714569|37717338|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777688|NCT02714569|37717339|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
16777689|NCT02714569|37717340|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777690|NCT02714569|37717341|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777691|NCT02714569|37717342|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777692|NCT02714569|37717343|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777693|NCT02714569|37717344|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777694|NCT02714569|37717345|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777695|NCT02714569|37717346|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16777696|NCT02714569|37717336|FG000|Part A Third Intervention|Adverse Event|0|||
16777697|NCT02714569|37717337|FG001|Part A Third Intervention|Adverse Event|0|||
16777698|NCT02714569|37717338|FG002|Part A Third Intervention|Adverse Event|1|||
16777699|NCT02714569|37717339|FG003|Part A Third Intervention|Adverse Event|0|||
16777700|NCT02714569|37717340|FG004|Part A Third Intervention|Adverse Event|0|||
16777701|NCT02714569|37717341|FG005|Part A Third Intervention|Adverse Event|0|||
16777702|NCT02714569|37717342|FG006|Part A Third Intervention|Adverse Event|0|||
16777703|NCT02714569|37717343|FG007|Part A Third Intervention|Adverse Event|0|||
16777704|NCT02714569|37717344|FG008|Part A Third Intervention|Adverse Event|0|||
16777705|NCT02714569|37717345|FG009|Part A Third Intervention|Adverse Event|0|||
16777706|NCT02714569|37717346|FG010|Part A Third Intervention|Adverse Event|0|||
16777707|NCT02714569|37717336|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
16777708|NCT02714569|37717337|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777709|NCT02714569|37717338|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777710|NCT02714569|37717339|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777711|NCT02714569|37717340|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777712|NCT02714569|37717341|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
16777713|NCT02714569|37717342|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777714|NCT02714569|37717343|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777715|NCT02714569|37717344|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777716|NCT02714569|37717345|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777717|NCT02714569|37717346|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16777718|NCT02714569|37717336|FG000|Part B (Overall)|Lost to Follow-up|0|||
16777719|NCT02714569|37717337|FG001|Part B (Overall)|Lost to Follow-up|0|||
16777720|NCT02714569|37717338|FG002|Part B (Overall)|Lost to Follow-up|0|||
16777721|NCT02714569|37717339|FG003|Part B (Overall)|Lost to Follow-up|0|||
16777722|NCT02714569|37717340|FG004|Part B (Overall)|Lost to Follow-up|0|||
16777723|NCT02714569|37717341|FG005|Part B (Overall)|Lost to Follow-up|0|||
16777724|NCT02714569|37717342|FG006|Part B (Overall)|Lost to Follow-up|1|||
16777725|NCT02714569|37717343|FG007|Part B (Overall)|Lost to Follow-up|0|||
16777726|NCT02714569|37717344|FG008|Part B (Overall)|Lost to Follow-up|0|||
16777727|NCT02714569|37717345|FG009|Part B (Overall)|Lost to Follow-up|0|||
16777728|NCT02714569|37717346|FG010|Part B (Overall)|Lost to Follow-up|0|||
16777729|NCT02714569|37717336|FG000|Part B (Overall)|Withdrawal by Subject|0|||
16777730|NCT02714569|37717337|FG001|Part B (Overall)|Withdrawal by Subject|0|||
16777731|NCT02714569|37717338|FG002|Part B (Overall)|Withdrawal by Subject|0|||
16777732|NCT02714569|37717339|FG003|Part B (Overall)|Withdrawal by Subject|0|||
16777733|NCT02714569|37717340|FG004|Part B (Overall)|Withdrawal by Subject|0|||
16777734|NCT02714569|37717341|FG005|Part B (Overall)|Withdrawal by Subject|0|||
16777735|NCT02714569|37717342|FG006|Part B (Overall)|Withdrawal by Subject|0|||
16777736|NCT02714569|37717343|FG007|Part B (Overall)|Withdrawal by Subject|1|||
16777737|NCT02714569|37717344|FG008|Part B (Overall)|Withdrawal by Subject|0|||
16777738|NCT02714569|37717345|FG009|Part B (Overall)|Withdrawal by Subject|1|||
16777739|NCT02714569|37717346|FG010|Part B (Overall)|Withdrawal by Subject|0|||
16777740|NCT02714569|37717336|FG000|Part B (Overall)|Adverse Event|0|||
16777741|NCT02714569|37717337|FG001|Part B (Overall)|Adverse Event|0|||
16777742|NCT02714569|37717338|FG002|Part B (Overall)|Adverse Event|0|||
16777743|NCT02714569|37717339|FG003|Part B (Overall)|Adverse Event|0|||
16777744|NCT02714569|37717340|FG004|Part B (Overall)|Adverse Event|0|||
16777745|NCT02714569|37717341|FG005|Part B (Overall)|Adverse Event|0|||
16777746|NCT02714569|37717342|FG006|Part B (Overall)|Adverse Event|0|||
16777747|NCT02714569|37717343|FG007|Part B (Overall)|Adverse Event|0|||
16777748|NCT02714569|37717344|FG008|Part B (Overall)|Adverse Event|0|||
16777749|NCT02714569|37717345|FG009|Part B (Overall)|Adverse Event|1|||
16777750|NCT02714569|37717346|FG010|Part B (Overall)|Adverse Event|0|||
16777751|NCT02713789|37717409|FG000|Overall Study|Lost to Follow-up|0|||
16777752|NCT02713789|37717410|FG001|Overall Study|Lost to Follow-up|1|||
16777753|NCT02713789|37717411|FG002|Overall Study|Lost to Follow-up|1|||
16777754|NCT04086121|37717419|FG000|Overall Study|Other than listed|8|||
16777755|NCT04086121|37717419|FG000|Overall Study|Withdrawal by Subject|3|||
16777756|NCT04086121|37717419|FG000|Overall Study|Lost to Follow-up|2|||
16777757|NCT04086121|37717419|FG000|Overall Study|Adverse Event|1|||
16777758|NCT02729909|37717426|FG000|Overall Study|Lost to Follow-up|0|||
16777759|NCT02729909|37717427|FG001|Overall Study|Lost to Follow-up|1|||
16777760|NCT02729909|37717426|FG000|Overall Study|Lack of Efficacy|0|||
16777761|NCT02729909|37717427|FG001|Overall Study|Lack of Efficacy|2|||
16777762|NCT02729909|37717426|FG000|Overall Study|Significant Protocol Deviation|0|||
16777763|NCT02729909|37717427|FG001|Overall Study|Significant Protocol Deviation|2|||
16777764|NCT02729909|37717426|FG000|Overall Study|Voluntary Withdrawal|1|||
16777765|NCT02729909|37717427|FG001|Overall Study|Voluntary Withdrawal|0|||
16777766|NCT02713243|37717435|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
16777767|NCT02713243|37717436|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
16777768|NCT02713243|37717435|FG000|Overall Study|Administrative problems|0|||
16777769|NCT02713243|37717436|FG001|Overall Study|Administrative problems|1|||
16777770|NCT02713243|37717435|FG000|Overall Study|Protocol deviation|0|||
16777771|NCT02713243|37717436|FG001|Overall Study|Protocol deviation|1|||
16777772|NCT03434041|37717444|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
16777773|NCT03434041|37717445|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
16777774|NCT03434041|37717444|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
16777775|NCT03434041|37717445|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
16777776|NCT03434041|37717444|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
16777777|NCT03434041|37717445|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
16777778|NCT03434041|37717444|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
16777779|NCT03434041|37717445|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
16777780|NCT03434041|37717444|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
16777781|NCT03434041|37717445|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
16777782|NCT03434041|37717444|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
16777783|NCT03434041|37717445|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
16777784|NCT03434041|37717444|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
16777785|NCT03434041|37717445|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
16777786|NCT03434041|37717444|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
16777787|NCT03434041|37717445|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
16777788|NCT03434041|37717444|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
16777789|NCT03434041|37717445|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
16777790|NCT03434041|37717444|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
16777791|NCT03434041|37717445|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
16777792|NCT03434041|37717444|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
16777793|NCT03434041|37717445|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
16777794|NCT00708461|37717460|FG000|Overall Study|Lost to Follow-up|18|||
16777795|NCT00708461|37717461|FG001|Overall Study|Lost to Follow-up|11|||
16777796|NCT00708461|37717460|FG000|Overall Study|Withdrawal by Subject|8|||
16777797|NCT00708461|37717461|FG001|Overall Study|Withdrawal by Subject|9|||
16777798|NCT00708461|37717460|FG000|Overall Study|left workforce|115|||
16777799|NCT00708461|37717461|FG001|Overall Study|left workforce|180|||
16777800|NCT00700999|37717469|FG000|Overall Study|Lost to Follow-up|7|||
16777801|NCT00700999|37717470|FG001|Overall Study|Lost to Follow-up|7|||
16777802|NCT00700999|37717469|FG000|Overall Study|Excluded - did not meet study criteria|0|||
16777803|NCT00700999|37717470|FG001|Overall Study|Excluded - did not meet study criteria|1|||
16777804|NCT00700999|37717469|FG000|Overall Study|Withdrawal by Subject|8|||
16777805|NCT00700999|37717470|FG001|Overall Study|Withdrawal by Subject|1|||
16777806|NCT02729831|37717480|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
16777807|NCT02729831|37717481|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
16777808|NCT02729831|37717482|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
16777809|NCT02729831|37717483|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
16777810|NCT02729831|37717480|FG000|1 Week Post-visit|Lost to Follow-up|43|||
16777811|NCT02729831|37717481|FG001|1 Week Post-visit|Lost to Follow-up|40|||
16777812|NCT02729831|37717482|FG002|1 Week Post-visit|Lost to Follow-up|38|||
16777813|NCT02729831|37717483|FG003|1 Week Post-visit|Lost to Follow-up|36|||
16777814|NCT02729831|37717480|FG000|6 Month Follow-up|Lost to Follow-up|54|||
16777815|NCT02729831|37717481|FG001|6 Month Follow-up|Lost to Follow-up|51|||
16777816|NCT02729831|37717482|FG002|6 Month Follow-up|Lost to Follow-up|48|||
16777817|NCT02729831|37717483|FG003|6 Month Follow-up|Lost to Follow-up|42|||
16777818|NCT02729831|37717480|FG000|6 Month Follow-up|Death|1|||
16777819|NCT02729831|37717481|FG001|6 Month Follow-up|Death|3|||
16777820|NCT02729831|37717482|FG002|6 Month Follow-up|Death|0|||
16777821|NCT02729831|37717483|FG003|6 Month Follow-up|Death|1|||
16777822|NCT02729753|37717495|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
16777823|NCT02729753|37717496|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
16777824|NCT00709319|37717505|FG000|Overall Study|Death|4|||
16777825|NCT00709319|37717505|FG000|Overall Study|Withdrawal by Subject|2|||
16777826|NCT02729051|37717550|FG000|Overall Study|Adverse Event|21|||
16777827|NCT02729051|37717551|FG001|Overall Study|Adverse Event|11|||
16777828|NCT02729051|37717550|FG000|Overall Study|Lack of Efficacy|1|||
16777829|NCT02729051|37717551|FG001|Overall Study|Lack of Efficacy|1|||
16777830|NCT02729051|37717550|FG000|Overall Study|Lost to Follow-up|1|||
16777831|NCT02729051|37717551|FG001|Overall Study|Lost to Follow-up|2|||
16777832|NCT02729051|37717550|FG000|Overall Study|Physician Decision|1|||
16777833|NCT02729051|37717551|FG001|Overall Study|Physician Decision|1|||
16777834|NCT02729051|37717550|FG000|Overall Study|Withdrawal by Subject|6|||
16777835|NCT02729051|37717551|FG001|Overall Study|Withdrawal by Subject|17|||
16777836|NCT00707993|37717559|FG000|Overall Study|Adverse Event|16|||
16777837|NCT00707993|37717560|FG001|Overall Study|Adverse Event|20|||
16777838|NCT00707993|37717559|FG000|Overall Study|Protocol Violation|4|||
16777839|NCT00707993|37717560|FG001|Overall Study|Protocol Violation|7|||
16777840|NCT00707993|37717559|FG000|Overall Study|Lost to Follow-up|0|||
16777841|NCT00707993|37717560|FG001|Overall Study|Lost to Follow-up|4|||
16777842|NCT00707993|37717559|FG000|Overall Study|Withdrawal by Subject|12|||
16777843|NCT00707993|37717560|FG001|Overall Study|Withdrawal by Subject|16|||
16777844|NCT00707993|37717559|FG000|Overall Study|Hyperglycemic Rescue|55|||
16777845|NCT00707993|37717560|FG001|Overall Study|Hyperglycemic Rescue|47|||
16777846|NCT00707993|37717559|FG000|Overall Study|Other|2|||
16777847|NCT00707993|37717560|FG001|Overall Study|Other|0|||
16777848|NCT00708227|37717570|FG000|Overall Study|Physician Decision|0|||
16777849|NCT00708227|37717571|FG001|Overall Study|Physician Decision|3|||
16777850|NCT00708227|37717572|FG002|Overall Study|Physician Decision|1|||
16777851|NCT00708227|37717573|FG003|Overall Study|Physician Decision|2|||
16777852|NCT00708227|37717570|FG000|Overall Study|Withdrawal by Subject|1|||
16777853|NCT00708227|37717571|FG001|Overall Study|Withdrawal by Subject|2|||
16777854|NCT00708227|37717572|FG002|Overall Study|Withdrawal by Subject|0|||
16777855|NCT00708227|37717573|FG003|Overall Study|Withdrawal by Subject|1|||
16777856|NCT02425891|37717605|FG000|Overall Study|Death|333|||
16777857|NCT02425891|37717606|FG001|Overall Study|Death|314|||
16777858|NCT02425891|37717605|FG000|Overall Study|Lost to Follow-up|4|||
16777859|NCT02425891|37717606|FG001|Overall Study|Lost to Follow-up|6|||
16777860|NCT02425891|37717605|FG000|Overall Study|Non-Compliance|1|||
16777861|NCT02425891|37717606|FG001|Overall Study|Non-Compliance|1|||
16777862|NCT02425891|37717605|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
16777863|NCT02425891|37717606|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
16777864|NCT02425891|37717605|FG000|Overall Study|Physician Decision|0|||
16777865|NCT02425891|37717606|FG001|Overall Study|Physician Decision|1|||
16777866|NCT02425891|37717605|FG000|Overall Study|Protocol Violation|1|||
16777867|NCT02425891|37717606|FG001|Overall Study|Protocol Violation|1|||
16777868|NCT02425891|37717605|FG000|Overall Study|Study Terminated By Sponsor|85|||
16777869|NCT02425891|37717606|FG001|Overall Study|Study Terminated By Sponsor|95|||
16777870|NCT02425891|37717605|FG000|Overall Study|Withdrawal by Subject|27|||
16777871|NCT02425891|37717606|FG001|Overall Study|Withdrawal by Subject|32|||
16777872|NCT03241225|37717616|FG000|Overall Study|Lost to Follow-up|2|||
16777873|NCT03241225|37717617|FG001|Overall Study|Lost to Follow-up|1|||
16777874|NCT03241225|37717616|FG000|Overall Study|Protocol Violation|4|||
16777875|NCT03241225|37717617|FG001|Overall Study|Protocol Violation|1|||
16777876|NCT03241225|37717616|FG000|Overall Study|Withdrawal by Subject|1|||
16777877|NCT03241225|37717617|FG001|Overall Study|Withdrawal by Subject|0|||
16777878|NCT01597245|37717627|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
16777879|NCT01597245|37717628|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
16777880|NCT01597245|37717629|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
16777881|NCT01597245|37717630|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
16777882|NCT01597245|37717631|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777883|NCT01597245|37717632|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777884|NCT01597245|37717633|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777885|NCT01597245|37717634|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777886|NCT01597245|37717635|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777887|NCT01597245|37717636|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777888|NCT01597245|37717637|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777889|NCT01597245|37717638|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777890|NCT01597245|37717639|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777891|NCT01597245|37717640|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777892|NCT01597245|37717641|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777893|NCT01597245|37717642|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777894|NCT01597245|37717643|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777895|NCT01597245|37717644|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777896|NCT01597245|37717645|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777897|NCT01597245|37717646|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777898|NCT01597245|37717647|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16777899|NCT01597245|37717627|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
16777900|NCT01597245|37717628|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
16777901|NCT01597245|37717629|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
16777902|NCT01597245|37717630|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
16777903|NCT01597245|37717631|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777904|NCT01597245|37717632|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777905|NCT01597245|37717633|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777906|NCT01597245|37717634|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777907|NCT01597245|37717635|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777908|NCT01597245|37717636|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777909|NCT01597245|37717637|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777910|NCT01597245|37717638|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777911|NCT01597245|37717639|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777912|NCT01597245|37717640|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777913|NCT01597245|37717641|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777914|NCT01597245|37717642|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777915|NCT01597245|37717643|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777916|NCT01597245|37717644|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777917|NCT01597245|37717645|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777918|NCT01597245|37717646|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777919|NCT01597245|37717647|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16777920|NCT01597245|37717627|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
16777921|NCT01597245|37717628|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
16777922|NCT01597245|37717629|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
16777923|NCT01597245|37717630|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
16777924|NCT01597245|37717631|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777925|NCT01597245|37717632|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777926|NCT01597245|37717633|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777927|NCT01597245|37717634|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777928|NCT01597245|37717635|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777929|NCT01597245|37717636|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777930|NCT01597245|37717637|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777931|NCT01597245|37717638|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777932|NCT01597245|37717639|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777933|NCT01597245|37717640|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777934|NCT01597245|37717641|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777935|NCT01597245|37717642|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777936|NCT01597245|37717643|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777937|NCT01597245|37717644|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777938|NCT01597245|37717645|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777939|NCT01597245|37717646|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777940|NCT01597245|37717647|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16777941|NCT01597245|37717627|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
16777942|NCT01597245|37717628|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
16777943|NCT01597245|37717629|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
16777944|NCT01597245|37717630|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777945|NCT01597245|37717631|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777946|NCT01597245|37717632|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777947|NCT01597245|37717633|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777948|NCT01597245|37717634|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777949|NCT01597245|37717635|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777950|NCT01597245|37717636|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777951|NCT01597245|37717637|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777952|NCT01597245|37717638|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777953|NCT01597245|37717639|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777954|NCT01597245|37717640|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777955|NCT01597245|37717641|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777956|NCT01597245|37717642|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777957|NCT01597245|37717643|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777958|NCT01597245|37717644|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777959|NCT01597245|37717645|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777960|NCT01597245|37717646|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777961|NCT01597245|37717647|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16777962|NCT01597245|37717627|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
16777963|NCT01597245|37717628|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777964|NCT01597245|37717629|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777965|NCT01597245|37717630|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
16777966|NCT01597245|37717631|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777967|NCT01597245|37717632|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777968|NCT01597245|37717633|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777969|NCT01597245|37717634|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777970|NCT01597245|37717635|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777971|NCT01597245|37717636|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777972|NCT01597245|37717637|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777973|NCT01597245|37717638|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777974|NCT01597245|37717639|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777975|NCT01597245|37717640|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777976|NCT01597245|37717641|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777977|NCT01597245|37717642|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777978|NCT01597245|37717643|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777979|NCT01597245|37717644|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777980|NCT01597245|37717645|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777981|NCT01597245|37717646|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777982|NCT01597245|37717647|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16777983|NCT01597245|37717627|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
16777984|NCT01597245|37717628|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
16777985|NCT01597245|37717629|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
16777986|NCT01597245|37717630|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777987|NCT01597245|37717631|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777988|NCT01597245|37717632|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777989|NCT01597245|37717633|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777990|NCT01597245|37717634|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777991|NCT01597245|37717635|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777992|NCT01597245|37717636|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777993|NCT01597245|37717637|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777994|NCT01597245|37717638|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777995|NCT01597245|37717639|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777996|NCT01597245|37717640|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777997|NCT01597245|37717641|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777998|NCT01597245|37717642|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16777999|NCT01597245|37717643|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16778000|NCT01597245|37717644|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16778001|NCT01597245|37717645|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16778002|NCT01597245|37717646|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16778003|NCT01597245|37717647|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16778004|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778005|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778006|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778007|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778008|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778009|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
16778010|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
16778011|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778012|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778013|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778014|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778015|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778016|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778017|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778018|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778019|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778020|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778021|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778022|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778023|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778024|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16778025|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778026|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778027|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778028|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778029|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
16778030|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
16778031|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
16778032|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
16778033|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778034|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
16778035|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778036|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778037|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778038|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778039|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778040|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778041|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778042|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778043|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778044|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778045|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16778046|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778047|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778048|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778049|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778050|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778051|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
16778052|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778053|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778054|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
16778055|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778056|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
16778057|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
16778058|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
16778059|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778060|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778061|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778062|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778063|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778064|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778065|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778066|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16778067|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778068|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778069|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778070|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778071|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
16778072|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
16778073|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
16778074|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
16778075|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
16778076|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
16778077|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
16778078|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
16778079|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
16778080|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778081|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778082|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778083|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778084|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778085|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778086|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778087|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16778088|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778089|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778090|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778091|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778092|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
16778093|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
16778094|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
16778095|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778096|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
16778097|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
16778098|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
16778099|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
16778100|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
16778101|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778102|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778103|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778104|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778105|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778106|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778107|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778108|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16778109|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778110|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778111|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778112|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778113|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
16778114|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778115|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778116|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778117|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
16778118|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
16778119|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
16778120|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778121|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
16778122|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778123|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778124|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778125|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778126|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778127|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778128|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778129|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16778130|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778131|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778132|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778133|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778134|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
16778135|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
16778136|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
16778137|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778138|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
16778139|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
16778140|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
16778141|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
16778142|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
16778143|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778144|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778145|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778146|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778147|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778148|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778149|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778150|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16778151|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778152|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778153|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778154|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778155|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778156|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16778157|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778158|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778159|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16778160|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16778161|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16778162|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16778163|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778164|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778165|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778166|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778167|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778168|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778169|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778170|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778171|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16778172|NCT01597245|37717627|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778173|NCT01597245|37717628|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778174|NCT01597245|37717629|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778175|NCT01597245|37717630|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778176|NCT01597245|37717631|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778177|NCT01597245|37717632|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778178|NCT01597245|37717633|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778179|NCT01597245|37717634|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778180|NCT01597245|37717635|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778181|NCT01597245|37717636|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778182|NCT01597245|37717637|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
16778183|NCT01597245|37717638|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778184|NCT01597245|37717639|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778185|NCT01597245|37717640|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778186|NCT01597245|37717641|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778187|NCT01597245|37717642|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778188|NCT01597245|37717643|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778189|NCT01597245|37717644|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778190|NCT01597245|37717645|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778191|NCT01597245|37717646|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778192|NCT01597245|37717647|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16778193|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778194|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778195|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778196|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778197|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778198|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778199|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778200|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778201|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778202|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778203|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778204|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778205|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778206|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
16778207|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
16778208|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
16778209|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778210|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778211|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778212|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778213|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16778214|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778215|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778216|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778217|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778218|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778219|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778220|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778221|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778222|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778223|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778224|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778225|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778226|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778227|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
16778228|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
16778229|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
16778230|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778231|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778232|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778233|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778234|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16778235|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778236|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778237|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778238|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778239|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778240|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778241|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778242|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778243|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778244|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778245|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778246|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778247|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778248|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778249|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
16778250|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
16778251|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778252|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778253|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778254|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778255|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16778256|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778257|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778258|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778259|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778260|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778261|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778262|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778263|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778264|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778265|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778266|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778267|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778268|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778269|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778270|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
16778271|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
16778272|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778273|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778274|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778275|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778276|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16778277|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778278|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778279|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778280|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778281|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778282|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778283|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778284|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778285|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778286|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778287|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778288|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778289|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778290|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
16778291|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
16778292|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
16778293|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778294|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778295|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778296|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778297|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16778298|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778299|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778300|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778301|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778302|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778303|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778304|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778305|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778306|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778307|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778308|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778309|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778310|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778311|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778312|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
16778313|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
16778314|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778315|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778316|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778317|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778318|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
16778319|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778320|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778321|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778322|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778323|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778324|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778325|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778326|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778327|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778328|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778329|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778330|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778331|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778332|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778333|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
16778334|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
16778335|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778336|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778337|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778338|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778339|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16778340|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778341|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778342|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778343|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778344|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778345|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16867981|NCT01553747|37841012|FG001|Overall Study|Voluntarily withdrew|66|||
16778346|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778347|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778348|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778349|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778350|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778351|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778352|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778353|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778354|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
16778355|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
16778356|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778357|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778358|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778359|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778360|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16778361|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778362|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778363|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778364|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778365|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778366|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778367|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778368|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778369|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778370|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778371|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778372|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778373|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778374|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778375|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
16778376|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
16778377|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778378|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778379|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778380|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778381|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16778382|NCT01597245|37717627|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778383|NCT01597245|37717628|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778384|NCT01597245|37717629|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
17133943|NCT00065429|38275193|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16778385|NCT01597245|37717630|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778386|NCT01597245|37717631|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16962895|NCT01238861|38105871|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
16962896|NCT01238861|38105872|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
16962897|NCT01238861|38105873|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
16962898|NCT01238861|38105874|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
16962899|NCT01238861|38105869|FG000|Overall Study|Subject moved out of state/area|0|||
16962900|NCT01238861|38105870|FG001|Overall Study|Subject moved out of state/area|0|||
16962901|NCT01238861|38105871|FG002|Overall Study|Subject moved out of state/area|1|||
16962902|NCT01238861|38105872|FG003|Overall Study|Subject moved out of state/area|1|||
16962903|NCT01238861|38105873|FG004|Overall Study|Subject moved out of state/area|0|||
16962904|NCT01238861|38105874|FG005|Overall Study|Subject moved out of state/area|0|||
16962905|NCT01238861|38105869|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
16962906|NCT01238861|38105870|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
16962907|NCT01238861|38105871|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
16962908|NCT01238861|38105872|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
16962909|NCT01238861|38105873|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
16962910|NCT01238861|38105874|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
16962911|NCT01238861|38105869|FG000|Overall Study|Personal problems|0|||
16962912|NCT01238861|38105870|FG001|Overall Study|Personal problems|0|||
16962913|NCT01238861|38105871|FG002|Overall Study|Personal problems|0|||
16962914|NCT01238861|38105872|FG003|Overall Study|Personal problems|1|||
16962915|NCT01238861|38105873|FG004|Overall Study|Personal problems|0|||
16962916|NCT01238861|38105874|FG005|Overall Study|Personal problems|0|||
16962917|NCT01238861|38105869|FG000|Overall Study|Unable to continue visits|0|||
16962918|NCT01238861|38105870|FG001|Overall Study|Unable to continue visits|0|||
16962919|NCT01238861|38105871|FG002|Overall Study|Unable to continue visits|0|||
16962920|NCT01238861|38105872|FG003|Overall Study|Unable to continue visits|1|||
16962921|NCT01238861|38105873|FG004|Overall Study|Unable to continue visits|0|||
16962922|NCT01238861|38105874|FG005|Overall Study|Unable to continue visits|1|||
16962923|NCT01238861|38105869|FG000|Overall Study|Serious adverse event|0|||
16962924|NCT01238861|38105870|FG001|Overall Study|Serious adverse event|0|||
16962925|NCT01238861|38105871|FG002|Overall Study|Serious adverse event|0|||
16962926|NCT01238861|38105872|FG003|Overall Study|Serious adverse event|0|||
16962927|NCT01238861|38105873|FG004|Overall Study|Serious adverse event|0|||
16962928|NCT01238861|38105874|FG005|Overall Study|Serious adverse event|1|||
16962929|NCT01238861|38105869|FG000|Overall Study|Lack of compliance|0|||
16962930|NCT01238861|38105870|FG001|Overall Study|Lack of compliance|0|||
16962931|NCT01238861|38105871|FG002|Overall Study|Lack of compliance|0|||
16962932|NCT01238861|38105872|FG003|Overall Study|Lack of compliance|0|||
16962933|NCT01238861|38105873|FG004|Overall Study|Lack of compliance|0|||
16962934|NCT01238861|38105874|FG005|Overall Study|Lack of compliance|1|||
16962935|NCT01238861|38105869|FG000|Overall Study|Adverse Event|0|||
16962936|NCT01238861|38105870|FG001|Overall Study|Adverse Event|1|||
16962937|NCT01238861|38105871|FG002|Overall Study|Adverse Event|0|||
16962938|NCT01238861|38105872|FG003|Overall Study|Adverse Event|0|||
16962939|NCT01238861|38105873|FG004|Overall Study|Adverse Event|0|||
16962940|NCT01238861|38105874|FG005|Overall Study|Adverse Event|0|||
16962941|NCT01238861|38105869|FG000|Overall Study|Withdrawal by Subject|6|||
16962942|NCT01238861|38105870|FG001|Overall Study|Withdrawal by Subject|5|||
16962943|NCT01238861|38105871|FG002|Overall Study|Withdrawal by Subject|4|||
16962944|NCT01238861|38105872|FG003|Overall Study|Withdrawal by Subject|8|||
16962945|NCT01238861|38105873|FG004|Overall Study|Withdrawal by Subject|10|||
16962946|NCT01238861|38105874|FG005|Overall Study|Withdrawal by Subject|9|||
16962947|NCT00903409|38105897|FG000|Overall Study|Adverse Event|11|||
16962948|NCT00903409|38105898|FG001|Overall Study|Adverse Event|9|||
16962949|NCT00903409|38105897|FG000|Overall Study|Non-compliance with Protocol|1|||
16962950|NCT00903409|38105898|FG001|Overall Study|Non-compliance with Protocol|1|||
16962951|NCT00903409|38105897|FG000|Overall Study|Laboratory Abnormality|2|||
16778387|NCT01597245|37717632|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778388|NCT01597245|37717633|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778389|NCT01597245|37717634|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778390|NCT01597245|37717635|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778391|NCT01597245|37717636|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778392|NCT01597245|37717637|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778393|NCT01597245|37717638|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778394|NCT01597245|37717639|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778395|NCT01597245|37717640|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
16778396|NCT01597245|37717641|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778397|NCT01597245|37717642|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778398|NCT01597245|37717643|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778399|NCT01597245|37717644|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778400|NCT01597245|37717645|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778401|NCT01597245|37717646|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778402|NCT01597245|37717647|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16778403|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778404|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778405|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778406|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778407|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778408|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778409|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778410|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778411|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778412|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778413|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778414|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778415|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778416|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778417|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778418|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16778419|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
16778420|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
16778421|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
16778422|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
16778423|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
16778424|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778425|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778426|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778427|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778428|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778429|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778430|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778431|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778432|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778433|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778434|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778435|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778436|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778437|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778438|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778439|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778440|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16778441|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
16778442|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
16778443|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
16778444|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
16778445|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778446|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778447|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778448|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778449|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778450|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778451|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778452|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778453|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778454|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778455|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778456|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778457|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778458|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778459|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778460|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778461|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
16778462|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778463|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16778464|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
16778465|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
16778466|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778467|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778468|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778469|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778470|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778471|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778472|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778473|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778474|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778475|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778476|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778477|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778478|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778479|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778480|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778481|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778482|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778483|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16778484|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
16778485|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
16778486|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
16778487|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778488|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778489|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778490|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778491|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778492|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778493|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778494|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778495|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778496|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778497|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778498|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778499|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778500|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778501|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778502|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778503|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
16778504|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778505|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16778506|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
16778507|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
16778508|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778509|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778510|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778511|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778512|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778513|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778514|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778515|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778516|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778517|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778518|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778519|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778520|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778521|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778522|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778523|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778524|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
16778525|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778526|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16778527|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
16778528|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
16778529|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778530|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778531|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778532|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778533|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778534|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778535|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778536|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778537|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778538|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778539|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778540|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778541|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778542|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778543|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778544|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778545|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
16778546|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778547|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778548|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
16778549|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16778550|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778551|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778552|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778553|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778554|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778555|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778556|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778557|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778558|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778559|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778560|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778561|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778562|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778563|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778564|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778565|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778566|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
16778567|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778568|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778569|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
16778570|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16778571|NCT01597245|37717627|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778572|NCT01597245|37717628|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778573|NCT01597245|37717629|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778574|NCT01597245|37717630|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778575|NCT01597245|37717631|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778576|NCT01597245|37717632|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778577|NCT01597245|37717633|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778578|NCT01597245|37717634|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778579|NCT01597245|37717635|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778580|NCT01597245|37717636|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778581|NCT01597245|37717637|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778582|NCT01597245|37717638|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778583|NCT01597245|37717639|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778584|NCT01597245|37717640|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778585|NCT01597245|37717641|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778586|NCT01597245|37717642|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778587|NCT01597245|37717643|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778588|NCT01597245|37717644|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778589|NCT01597245|37717645|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778590|NCT01597245|37717646|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
16778591|NCT01597245|37717647|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16778592|NCT00707057|37717682|FG000|Overall Study|Withdrawal by Subject|8|||
16778593|NCT00707057|37717683|FG001|Overall Study|Withdrawal by Subject|3|||
16778594|NCT00707057|37717682|FG000|Overall Study|Dosed incorrectly|0|||
16778595|NCT00707057|37717683|FG001|Overall Study|Dosed incorrectly|1|||
16778596|NCT02639247|37717691|FG000|Overall Study|Lost to Follow-up|2|||
16778597|NCT02639247|37717692|FG001|Overall Study|Lost to Follow-up|1|||
16778598|NCT02639247|37717691|FG000|Overall Study|Death|2|||
16778599|NCT02639247|37717692|FG001|Overall Study|Death|0|||
16778600|NCT02639247|37717691|FG000|Overall Study|Withdrew Consent|0|||
16778601|NCT02639247|37717692|FG001|Overall Study|Withdrew Consent|1|||
16778602|NCT02639247|37717691|FG000|Overall Study|Protocol Violation|1|||
16778603|NCT02639247|37717692|FG001|Overall Study|Protocol Violation|0|||
16778604|NCT00706901|37717701|FG000|Overall Study|Lost to Follow-up|2|||
16778605|NCT00706901|37717702|FG001|Overall Study|Lost to Follow-up|3|||
16778606|NCT00706901|37717703|FG002|Overall Study|Lost to Follow-up|2|||
16778607|NCT00706901|37717701|FG000|Overall Study|Withdrawal by Subject|4|||
16778608|NCT00706901|37717702|FG001|Overall Study|Withdrawal by Subject|2|||
16778609|NCT00706901|37717703|FG002|Overall Study|Withdrawal by Subject|5|||
16778610|NCT00706901|37717701|FG000|Overall Study|In Jail|1|||
16778611|NCT00706901|37717702|FG001|Overall Study|In Jail|0|||
16778612|NCT00706901|37717703|FG002|Overall Study|In Jail|1|||
16778613|NCT00706901|37717701|FG000|Overall Study|Death|1|||
16778614|NCT00706901|37717702|FG001|Overall Study|Death|0|||
16778615|NCT00706901|37717703|FG002|Overall Study|Death|0|||
16778616|NCT01673373|37717712|FG000|Overall Study|Death|2|||
16778617|NCT01236547|37717721|FG000|Overall Study|Protocol Violation|0|||
16778618|NCT01236547|37717722|FG001|Overall Study|Protocol Violation|1|||
16778619|NCT01236547|37717723|FG002|Overall Study|Protocol Violation|1|||
16778620|NCT01236547|37717724|FG003|Overall Study|Protocol Violation|6|||
16778621|NCT01236547|37717725|FG004|Overall Study|Protocol Violation|12|||
16778622|NCT02167945|37717738|FG000|Overall Study|Adverse Event|16|||
16778623|NCT02167945|37717738|FG000|Overall Study|Withdrew Consent|42|||
16778624|NCT02167945|37717738|FG000|Overall Study|Lost to Follow-up|122|||
16778625|NCT02167945|37717738|FG000|Overall Study|COVID-19 logistical restrictions|6|||
16778626|NCT02167945|37717738|FG000|Overall Study|Other, not specified|63|||
16778627|NCT01991977|37717750|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
16778628|NCT01991977|37717750|FG000|Overall Study|Withdrew after start of treatment|5|||
16778629|NCT01375075|37717760|FG000|Overall Study|Adverse Event|0|||
16778630|NCT01375075|37717761|FG001|Overall Study|Adverse Event|0|||
16778631|NCT01375075|37717762|FG002|Overall Study|Adverse Event|3|||
16778632|NCT01375075|37717763|FG003|Overall Study|Adverse Event|1|||
16778633|NCT01375075|37717764|FG004|Overall Study|Adverse Event|0|||
16778634|NCT01375075|37717765|FG005|Overall Study|Adverse Event|1|||
16778635|NCT01375075|37717760|FG000|Overall Study|Entry Criterion Not Met|1|||
16778636|NCT01375075|37717761|FG001|Overall Study|Entry Criterion Not Met|0|||
16778637|NCT01375075|37717762|FG002|Overall Study|Entry Criterion Not Met|0|||
16778638|NCT01375075|37717763|FG003|Overall Study|Entry Criterion Not Met|0|||
16778639|NCT01375075|37717764|FG004|Overall Study|Entry Criterion Not Met|0|||
16778640|NCT01375075|37717765|FG005|Overall Study|Entry Criterion Not Met|1|||
16778641|NCT01375075|37717760|FG000|Overall Study|Withdrawal by Subject|0|||
16778642|NCT01375075|37717761|FG001|Overall Study|Withdrawal by Subject|1|||
16778643|NCT01375075|37717762|FG002|Overall Study|Withdrawal by Subject|0|||
16778644|NCT01375075|37717763|FG003|Overall Study|Withdrawal by Subject|0|||
16778645|NCT01375075|37717764|FG004|Overall Study|Withdrawal by Subject|0|||
16778646|NCT01375075|37717765|FG005|Overall Study|Withdrawal by Subject|1|||
16778647|NCT00706433|37717787|FG000|Overall Study|Lost to Follow-up|3|||
16778648|NCT00706433|37717788|FG001|Overall Study|Lost to Follow-up|1|||
16778649|NCT00706433|37717789|FG002|Overall Study|Lost to Follow-up|6|||
16778650|NCT00706433|37717790|FG003|Overall Study|Lost to Follow-up|0|||
16778651|NCT00706433|37717787|FG000|Overall Study|Withdrawal by Subject|1|||
16778652|NCT00706433|37717788|FG001|Overall Study|Withdrawal by Subject|2|||
16778653|NCT00706433|37717789|FG002|Overall Study|Withdrawal by Subject|3|||
16778654|NCT00706433|37717790|FG003|Overall Study|Withdrawal by Subject|1|||
16778655|NCT00706433|37717787|FG000|Overall Study|Adverse Event|0|||
16778656|NCT00706433|37717788|FG001|Overall Study|Adverse Event|0|||
16778657|NCT00706433|37717789|FG002|Overall Study|Adverse Event|1|||
16778658|NCT00706433|37717790|FG003|Overall Study|Adverse Event|0|||
16778659|NCT00706433|37717787|FG000|Overall Study|Protocol Violation|1|||
16778660|NCT00706433|37717788|FG001|Overall Study|Protocol Violation|0|||
16778661|NCT00706433|37717789|FG002|Overall Study|Protocol Violation|0|||
16778662|NCT00706433|37717790|FG003|Overall Study|Protocol Violation|0|||
16778663|NCT00706433|37717787|FG000|Overall Study|new job|0|||
16778664|NCT00706433|37717788|FG001|Overall Study|new job|0|||
16778665|NCT00706433|37717789|FG002|Overall Study|new job|0|||
16778666|NCT00706433|37717790|FG003|Overall Study|new job|1|||
16778667|NCT02638623|37717802|FG000|Overall Study|Surgery timing|5|||
16778668|NCT02638623|37717803|FG001|Overall Study|Surgery timing|6|||
16778669|NCT02638623|37717802|FG000|Overall Study|Not given intervention|2|||
16778670|NCT02638623|37717803|FG001|Overall Study|Not given intervention|0|||
16778671|NCT02637141|37717812|FG000|Overall Study|Adverse Event|1|||
16778672|NCT02637141|37717813|FG001|Overall Study|Adverse Event|1|||
16778673|NCT02637141|37717814|FG002|Overall Study|Adverse Event|0|||
16778674|NCT02637141|37717812|FG000|Overall Study|Withdrawal by Subject|1|||
16778675|NCT02637141|37717813|FG001|Overall Study|Withdrawal by Subject|1|||
16778676|NCT02637141|37717814|FG002|Overall Study|Withdrawal by Subject|1|||
16778677|NCT02637063|37717825|FG000|Overall Study|Lost to Follow-up|3|||
16778678|NCT02637063|37717826|FG001|Overall Study|Lost to Follow-up|2|||
16778679|NCT02637063|37717827|FG002|Overall Study|Lost to Follow-up|3|||
16778680|NCT02637063|37717825|FG000|Overall Study|Withdrawal by Subject|2|||
16778681|NCT02637063|37717826|FG001|Overall Study|Withdrawal by Subject|2|||
16778682|NCT02637063|37717827|FG002|Overall Study|Withdrawal by Subject|3|||
16778683|NCT02635737|37717835|FG000|Overall Study|Protocol Violation|1|||
16778684|NCT02636907|37717839|FG000|Autoinjector Assessment Period|Adverse Event|2|||
16778685|NCT02636907|37717839|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
16778686|NCT02636907|37717839|FG000|Extension Phase|Adverse Event|2|||
16778687|NCT02636907|37717839|FG000|Extension Phase|Withdrawal by Subject|4|||
16778688|NCT02636907|37717839|FG000|Extension Phase|Physician Decision|1|||
16778689|NCT02636907|37717839|FG000|Extension Phase|Lost to Follow-up|2|||
16778690|NCT02636907|37717839|FG000|Extension Phase|Lack of Efficacy|1|||
16778691|NCT01374919|37717843|FG000|Overall Study|Withdrawal by Subject|2|||
16778692|NCT02726945|37717854|FG000|Overall Study|Withdrawal by Subject|0|||
16778693|NCT02726945|37717855|FG001|Overall Study|Withdrawal by Subject|0|||
16778694|NCT02726945|37717856|FG002|Overall Study|Withdrawal by Subject|1|||
16778695|NCT02726945|37717854|FG000|Overall Study|Elected to have total knee replacement|0|||
16778696|NCT02726945|37717855|FG001|Overall Study|Elected to have total knee replacement|1|||
16778697|NCT02726945|37717856|FG002|Overall Study|Elected to have total knee replacement|0|||
16778698|NCT02635347|37717866|FG000|Overall Study|Failed screening|20|||
16778699|NCT02635347|37717867|FG001|Overall Study|Failed screening|7|||
16778700|NCT02726399|37717887|FG000|Overall Study|Participant Non-Compliance|1|||
16778701|NCT02726399|37717887|FG000|Overall Study|Adverse Event|2|||
16778702|NCT02726399|37717887|FG000|Overall Study|Progression of disease|4|||
16778703|NCT02634801|37717894|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
16778704|NCT02634801|37717895|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
16778705|NCT02634801|37717896|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
16778706|NCT02634801|37717894|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
16778707|NCT02634801|37717895|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
16778708|NCT02634801|37717896|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
16778709|NCT02634801|37717894|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
16778710|NCT02634801|37717895|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
16778711|NCT02634801|37717896|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
16778712|NCT02634801|37717894|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
16778713|NCT02634801|37717895|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
16778714|NCT02634801|37717896|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
16778715|NCT02634801|37717894|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
16778716|NCT02634801|37717895|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
16778717|NCT02634801|37717896|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
16778718|NCT02634801|37717894|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
16778719|NCT02634801|37717895|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
16778720|NCT02634801|37717896|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
16778721|NCT02634801|37717894|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
16778722|NCT02634801|37717895|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
16778723|NCT02634801|37717896|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
16778724|NCT02634801|37717894|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
16778725|NCT02634801|37717895|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
16778726|NCT02634801|37717896|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
16778727|NCT02634801|37717894|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
16778728|NCT02634801|37717895|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
16778729|NCT02634801|37717896|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
16778730|NCT02634801|37717894|FG000|Follow-up Period|Lost to Follow-up|3|||
16778731|NCT02634801|37717895|FG001|Follow-up Period|Lost to Follow-up|1|||
16778732|NCT02634801|37717896|FG002|Follow-up Period|Lost to Follow-up|2|||
16778733|NCT02634801|37717894|FG000|Follow-up Period|Physician Decision|0|||
16778734|NCT02634801|37717895|FG001|Follow-up Period|Physician Decision|0|||
16778735|NCT02634801|37717896|FG002|Follow-up Period|Physician Decision|1|||
16778736|NCT02634801|37717894|FG000|Follow-up Period|Withdrawal by Subject|1|||
16778737|NCT02634801|37717895|FG001|Follow-up Period|Withdrawal by Subject|2|||
16778738|NCT02634801|37717896|FG002|Follow-up Period|Withdrawal by Subject|5|||
16778739|NCT02634801|37717894|FG000|Follow-up Period|Adverse Event|1|||
16778740|NCT02634801|37717895|FG001|Follow-up Period|Adverse Event|5|||
16778741|NCT02634801|37717896|FG002|Follow-up Period|Adverse Event|0|||
16778742|NCT02724839|37717911|FG000|Overall Study|Withdrawal by Subject|1|||
16778743|NCT02724839|37717912|FG001|Overall Study|Withdrawal by Subject|1|||
16778744|NCT02724839|37717913|FG002|Overall Study|Withdrawal by Subject|0|||
16778745|NCT02724839|37717911|FG000|Overall Study|Lost to Follow-up|0|||
16778746|NCT02724839|37717912|FG001|Overall Study|Lost to Follow-up|3|||
16778747|NCT02724839|37717913|FG002|Overall Study|Lost to Follow-up|2|||
16778748|NCT02724839|37717911|FG000|Overall Study|Physician Decision|0|||
16778749|NCT02724839|37717912|FG001|Overall Study|Physician Decision|0|||
16778750|NCT02724839|37717913|FG002|Overall Study|Physician Decision|3|||
16778751|NCT01375751|37717931|FG000|Overall Study|Other|0|||
16778752|NCT01375751|37717932|FG001|Overall Study|Other|1|||
16778753|NCT01375751|37717933|FG002|Overall Study|Other|0|||
16778754|NCT00705575|37717943|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16778755|NCT00705575|37717944|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16778756|NCT00705575|37717943|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16778757|NCT00705575|37717944|FG001|Overall Study|Abnormal test procedure result(s)|12|||
16778758|NCT00705575|37717943|FG000|Overall Study|Adverse Event|11|||
16778759|NCT00705575|37717944|FG001|Overall Study|Adverse Event|15|||
16778760|NCT00705575|37717943|FG000|Overall Study|Lost to Follow-up|3|||
16778761|NCT00705575|37717944|FG001|Overall Study|Lost to Follow-up|4|||
16778762|NCT00705575|37717943|FG000|Overall Study|Protocol Violation|2|||
16778763|NCT00705575|37717944|FG001|Overall Study|Protocol Violation|2|||
16778764|NCT00705575|37717943|FG000|Overall Study|Withdrawal by Subject|5|||
16778765|NCT00705575|37717944|FG001|Overall Study|Withdrawal by Subject|10|||
16778766|NCT02636595|37717950|FG000|Overall Study|Lost to Follow-up|1|||
16778767|NCT02636595|37717950|FG000|Overall Study|Other|1|||
16778768|NCT02636361|37717954|FG000|Period 4|Physician Decision|0|||
16778769|NCT02636361|37717955|FG001|Period 4|Physician Decision|0|||
16778770|NCT02636361|37717956|FG002|Period 4|Physician Decision|0|||
16778771|NCT02636361|37717957|FG003|Period 4|Physician Decision|1|||
16778772|NCT02636361|37717958|FG004|Period 4|Physician Decision|0|||
16778773|NCT02636283|37717974|FG000|Overall Study|Adverse Event|2|||
16778774|NCT02636283|37717975|FG001|Overall Study|Adverse Event|0|||
16778775|NCT02636283|37717974|FG000|Overall Study|Trial Terminated Prematurely|0|||
16778776|NCT02636283|37717975|FG001|Overall Study|Trial Terminated Prematurely|3|||
16778777|NCT04430855|37717983|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
16778778|NCT04430855|37717984|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
16778779|NCT04430855|37717983|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
16778780|NCT04430855|37717984|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
16778781|NCT04430855|37717983|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
16778782|NCT04430855|37717984|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
16778783|NCT04430855|37717983|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
16778784|NCT04430855|37717984|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
16778785|NCT04430855|37717983|FG000|Period 1 (Weeks 1-12)|Other|0|||
16778786|NCT04430855|37717984|FG001|Period 1 (Weeks 1-12)|Other|1|||
16778787|NCT04430855|37717983|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
16778788|NCT04430855|37717984|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
16778789|NCT04430855|37717983|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
16778790|NCT04430855|37717984|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
16778791|NCT04430855|37717983|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
16778792|NCT04430855|37717984|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
16778793|NCT01375673|37717994|FG000|Overall Study|Withdrawal by Subject|0|||
16778794|NCT01375673|37717995|FG001|Overall Study|Withdrawal by Subject|1|||
16778795|NCT03652961|37718001|FG000|Overall Study|Lost to Follow-up|3|||
16778796|NCT03652961|37718001|FG000|Overall Study|Screen Failure|1|||
16778797|NCT02723591|37718007|FG000|Overall Study|Adverse Event|48|||
16778798|NCT02723591|37718008|FG001|Overall Study|Adverse Event|40|||
16778799|NCT02723591|37718007|FG000|Overall Study|Death|2|||
16778800|NCT02723591|37718008|FG001|Overall Study|Death|2|||
16778801|NCT02723591|37718007|FG000|Overall Study|Lack of Efficacy|4|||
16778802|NCT02723591|37718008|FG001|Overall Study|Lack of Efficacy|3|||
16778803|NCT02723591|37718007|FG000|Overall Study|Lost to Follow-up|1|||
16778804|NCT02723591|37718008|FG001|Overall Study|Lost to Follow-up|7|||
16778805|NCT02723591|37718007|FG000|Overall Study|Protocol Violation|20|||
16778806|NCT02723591|37718008|FG001|Overall Study|Protocol Violation|23|||
16778807|NCT02723591|37718007|FG000|Overall Study|Withdrawal by Subject|4|||
16778808|NCT02723591|37718008|FG001|Overall Study|Withdrawal by Subject|8|||
16778809|NCT02723591|37718007|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
16778810|NCT02723591|37718008|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
16778811|NCT02723591|37718007|FG000|Overall Study|Miscellaneous|5|||
16778812|NCT02723591|37718008|FG001|Overall Study|Miscellaneous|6|||
16778813|NCT00705341|37718016|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
16778814|NCT00705341|37718017|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
16778815|NCT00705341|37718018|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
16778816|NCT00705341|37718019|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
16778817|NCT00705341|37718016|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
16778818|NCT00705341|37718017|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
16778819|NCT00705341|37718018|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
16778820|NCT00705341|37718019|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
16778821|NCT02723201|37718030|FG000|Second Intervention Period|Protocol Violation|1|||
16778822|NCT02723201|37718031|FG001|Second Intervention Period|Protocol Violation|0|||
16778823|NCT02723201|37718032|FG002|Second Intervention Period|Protocol Violation|0|||
16778824|NCT02723201|37718030|FG000|Second Intervention Period|Adverse Event|1|||
16778825|NCT02723201|37718031|FG001|Second Intervention Period|Adverse Event|0|||
16778826|NCT02723201|37718032|FG002|Second Intervention Period|Adverse Event|0|||
16778827|NCT03846479|37718046|FG000|Overall Study|Death|8|||
16778828|NCT03846479|37718046|FG000|Overall Study|Lost to Follow-up|1|||
16778829|NCT00705263|37718050|FG000|Overall Study|Withdrawal by Subject|2|||
16778830|NCT00704405|37718068|FG000|Overall Study (NC Population)|Adverse Event|1|||
16778831|NCT00704405|37718069|FG001|Overall Study (NC Population)|Adverse Event|0|||
16778832|NCT00704405|37718070|FG002|Overall Study (NC Population)|Adverse Event|0|||
16778833|NCT00704405|37718071|FG003|Overall Study (NC Population)|Adverse Event|0|||
16778834|NCT00704405|37718072|FG004|Overall Study (NC Population)|Adverse Event|0|||
16778835|NCT00704405|37718068|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
16778836|NCT00704405|37718069|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
16778837|NCT00704405|37718070|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
16778838|NCT00704405|37718071|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
16778839|NCT00704405|37718072|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
16778840|NCT00704405|37718068|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
16778841|NCT00704405|37718069|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
16778842|NCT00704405|37718070|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
16778843|NCT00704405|37718071|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
16778844|NCT00704405|37718072|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
16778845|NCT00704405|37718068|FG000|Overall Study (NC Population)|Other|0|||
16778846|NCT00704405|37718069|FG001|Overall Study (NC Population)|Other|0|||
16778847|NCT00704405|37718070|FG002|Overall Study (NC Population)|Other|0|||
16778848|NCT00704405|37718071|FG003|Overall Study (NC Population)|Other|0|||
16778849|NCT00704405|37718072|FG004|Overall Study (NC Population)|Other|1|||
16778850|NCT00704405|37718068|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
16778851|NCT00704405|37718069|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
16778852|NCT00704405|37718070|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
16778853|NCT00704405|37718071|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
16778854|NCT00704405|37718072|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
16778855|NCT00704405|37718068|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
16778856|NCT00704405|37718069|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
16778857|NCT00704405|37718070|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
16778858|NCT00704405|37718071|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
16778859|NCT00704405|37718072|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
16778860|NCT01534481|37718092|FG000|Overall Study|Lost to Follow-up|29|||
16778861|NCT01534481|37718093|FG001|Overall Study|Lost to Follow-up|24|||
16778862|NCT01534481|37718092|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
16778863|NCT01534481|37718093|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
16778864|NCT00704171|37718101|FG000|Overall Study|Withdrawal by Subject|1|||
16778865|NCT00704171|37718102|FG001|Overall Study|Withdrawal by Subject|0|||
16778866|NCT00703781|37718110|FG000|Overall Study|Withdrawal by Subject|1|||
16778867|NCT00703781|37718111|FG001|Overall Study|Withdrawal by Subject|2|||
16778868|NCT00703781|37718110|FG000|Overall Study|Cancelled surgery|1|||
16778869|NCT00703781|37718111|FG001|Overall Study|Cancelled surgery|0|||
16778870|NCT00703157|37718119|FG000|Overall Study|Lost to Follow-up|0|||
16778871|NCT00703157|37718120|FG001|Overall Study|Lost to Follow-up|1|||
16778872|NCT00703157|37718119|FG000|Overall Study|source data permanently lost/ other|4|||
16778873|NCT00703157|37718120|FG001|Overall Study|source data permanently lost/ other|1|||
16778874|NCT03307967|37718128|FG000|Overall Study|Lost to Follow-up|4|||
16778875|NCT02722967|37718135|FG000|Overall Study|Adverse Event|1|||
16778876|NCT02722967|37718136|FG001|Overall Study|Adverse Event|0|||
16778877|NCT02722967|37718137|FG002|Overall Study|Adverse Event|0|||
16778878|NCT02722967|37718135|FG000|Overall Study|Lost to Follow-up|0|||
16778879|NCT02722967|37718136|FG001|Overall Study|Lost to Follow-up|1|||
16778880|NCT02722967|37718137|FG002|Overall Study|Lost to Follow-up|0|||
16778881|NCT02722967|37718135|FG000|Overall Study|Non-compliance with patch wearing|2|||
16778882|NCT02722967|37718136|FG001|Overall Study|Non-compliance with patch wearing|1|||
16778883|NCT02722967|37718137|FG002|Overall Study|Non-compliance with patch wearing|1|||
16778884|NCT02722967|37718135|FG000|Overall Study|Withdrawal by Subject|1|||
16778885|NCT02722967|37718136|FG001|Overall Study|Withdrawal by Subject|0|||
16778886|NCT02722967|37718137|FG002|Overall Study|Withdrawal by Subject|1|||
16778887|NCT02722967|37718135|FG000|Overall Study|Physician Decision|1|||
16778888|NCT02722967|37718136|FG001|Overall Study|Physician Decision|0|||
16778889|NCT02722967|37718137|FG002|Overall Study|Physician Decision|0|||
16778890|NCT02722967|37718135|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
16778891|NCT02722967|37718136|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
16778892|NCT02722967|37718137|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
16778893|NCT02722499|37718148|FG000|Overall Study|Lost to Follow-up|2|||
16778894|NCT02722499|37718149|FG001|Overall Study|Lost to Follow-up|0|||
16778895|NCT02722499|37718150|FG002|Overall Study|Lost to Follow-up|1|||
16778896|NCT02721875|37718160|FG000|Overall Study|Progressive disease/relapse|1|||
16778897|NCT02721875|37718161|FG001|Overall Study|Progressive disease/relapse|0|||
16778898|NCT02721251|37718170|FG000|Overall Study|Withdrawal by Subject|8|||
16778899|NCT02721251|37718171|FG001|Overall Study|Withdrawal by Subject|7|||
16778900|NCT02721251|37718172|FG002|Overall Study|Withdrawal by Subject|9|||
16778901|NCT02721251|37718170|FG000|Overall Study|poor adherence|2|||
16778902|NCT02721251|37718171|FG001|Overall Study|poor adherence|2|||
16778903|NCT02721251|37718172|FG002|Overall Study|poor adherence|2|||
16778904|NCT00702221|37718183|FG000|Overall Study|Adverse Event|4|||
16778905|NCT00702221|37718184|FG001|Overall Study|Adverse Event|3|||
16778906|NCT02634333|37718192|FG000|Overall Study|Completed out of Window|3|||
16778907|NCT02634333|37718193|FG001|Overall Study|Completed out of Window|2|||
16778908|NCT02634333|37718192|FG000|Overall Study|Missed Visit|5|||
16778909|NCT02634333|37718193|FG001|Overall Study|Missed Visit|2|||
16778910|NCT02634333|37718192|FG000|Overall Study|Lost to Follow-up|12|||
16778911|NCT02634333|37718193|FG001|Overall Study|Lost to Follow-up|7|||
16778912|NCT02634333|37718192|FG000|Overall Study|Withdrawal by Subject|9|||
16778913|NCT02634333|37718193|FG001|Overall Study|Withdrawal by Subject|13|||
16778914|NCT02634333|37718192|FG000|Overall Study|Death|11|||
16778915|NCT02634333|37718193|FG001|Overall Study|Death|8|||
16778916|NCT00702143|37718203|FG000|Overall Study|Lost to Follow-up|0|||
16778917|NCT00702143|37718204|FG001|Overall Study|Lost to Follow-up|0|||
16778918|NCT00702143|37718205|FG002|Overall Study|Lost to Follow-up|1|||
16778919|NCT00702923|37718211|FG000|Overall Study|Adverse Event|1|||
16778920|NCT02633787|37718216|FG000|Overall Study|Withdrawal by Subject|1|||
16778921|NCT02719691|37718227|FG000|Overall Study|Physician Decision|0|||
16778922|NCT02719691|37718228|FG001|Overall Study|Physician Decision|0|||
16778923|NCT02719691|37718229|FG002|Overall Study|Physician Decision|1|||
16778924|NCT02719691|37718230|FG003|Overall Study|Physician Decision|0|||
16778925|NCT02719691|37718231|FG004|Overall Study|Physician Decision|0|||
16778926|NCT02719691|37718232|FG005|Overall Study|Physician Decision|0|||
16778927|NCT02719691|37718233|FG006|Overall Study|Physician Decision|0|||
16778928|NCT02719691|37718227|FG000|Overall Study|Withdrawal by Subject|0|||
16778929|NCT02719691|37718228|FG001|Overall Study|Withdrawal by Subject|0|||
16778930|NCT02719691|37718229|FG002|Overall Study|Withdrawal by Subject|0|||
16778931|NCT02719691|37718230|FG003|Overall Study|Withdrawal by Subject|0|||
16778932|NCT02719691|37718231|FG004|Overall Study|Withdrawal by Subject|0|||
16778933|NCT02719691|37718232|FG005|Overall Study|Withdrawal by Subject|1|||
16778934|NCT02719691|37718233|FG006|Overall Study|Withdrawal by Subject|0|||
16778935|NCT02720081|37718252|FG000|Overall Study|Adverse Event|0|||
16778936|NCT02720081|37718253|FG001|Overall Study|Adverse Event|3|||
16778937|NCT02720081|37718252|FG000|Overall Study|Protocol Violation|4|||
16778938|NCT02720081|37718253|FG001|Overall Study|Protocol Violation|1|||
16778939|NCT04248933|37718259|FG000|Overall Study|Lost to Follow-up|9|||
16778940|NCT04248933|37718259|FG000|Overall Study|Withdrawal by Subject|2|||
16778941|NCT02718131|37718265|FG000|Overall Study|Withdrawal by Subject|1|||
16778942|NCT02718131|37718266|FG001|Overall Study|Withdrawal by Subject|0|||
16778943|NCT02718131|37718265|FG000|Overall Study|Adverse Event|1|||
16778944|NCT02718131|37718266|FG001|Overall Study|Adverse Event|0|||
16778945|NCT02718131|37718265|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
16778946|NCT02718131|37718266|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
16778947|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
16778948|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
16778949|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
16778950|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
16778951|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
16778952|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
16778953|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
16778954|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16778955|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16778956|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16778957|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
16778958|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
16778959|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
16778960|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
16778961|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
16778962|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
16778963|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
16778964|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
16778965|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
16778966|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
16778967|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
16778968|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
16778969|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
16778970|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
16778971|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
16778972|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
16778973|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
16778974|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
16778975|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
16778976|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
16778977|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
16867982|NCT01553747|37841013|FG002|Overall Study|Voluntarily withdrew|74|||
16778978|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
16778979|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
16778980|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
16778981|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
16778982|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
16778983|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
16778984|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
16778985|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
16778986|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
16778987|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
16778988|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
16778989|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
16778990|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
16778991|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
16778992|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
16778993|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
16778994|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
16778995|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
16778996|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
16778997|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
16778998|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
16962952|NCT00903409|38105898|FG001|Overall Study|Laboratory Abnormality|0|||
16962953|NCT00903409|38105897|FG000|Overall Study|Withdrawal by Subject|8|||
16962954|NCT00903409|38105898|FG001|Overall Study|Withdrawal by Subject|8|||
16962955|NCT00903409|38105897|FG000|Overall Study|Other|2|||
16962956|NCT00903409|38105898|FG001|Overall Study|Other|3|||
16962957|NCT00903409|38105897|FG000|Overall Study|Lost to Follow-up|2|||
16962958|NCT00903409|38105898|FG001|Overall Study|Lost to Follow-up|6|||
16962959|NCT01237223|38105912|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
16962960|NCT01237223|38105913|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16962961|NCT01237223|38105914|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16962962|NCT01237223|38105915|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16962963|NCT01237223|38105916|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16962964|NCT01237223|38105917|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16962965|NCT01237223|38105912|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
16962966|NCT01237223|38105913|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16962967|NCT01237223|38105914|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16962968|NCT01237223|38105915|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16962969|NCT01237223|38105916|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16962970|NCT01237223|38105917|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16962971|NCT01237223|38105912|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
16962972|NCT01237223|38105913|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16962973|NCT01237223|38105914|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16962974|NCT01237223|38105915|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16962975|NCT01237223|38105916|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16962976|NCT01237223|38105917|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16962977|NCT01237223|38105912|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
16962978|NCT01237223|38105913|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16962979|NCT01237223|38105914|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16962980|NCT01237223|38105915|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16962981|NCT01237223|38105916|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16962982|NCT01237223|38105917|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16962983|NCT01237223|38105912|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
16962984|NCT01237223|38105913|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16962985|NCT01237223|38105914|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16962986|NCT01237223|38105915|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16962987|NCT01237223|38105916|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16962988|NCT01237223|38105917|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16962989|NCT01237223|38105912|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
16962990|NCT01237223|38105913|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
16962991|NCT01237223|38105914|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
16962992|NCT01237223|38105915|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
16962993|NCT01237223|38105916|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
16962994|NCT01237223|38105917|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
16962995|NCT01237223|38105912|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
16962996|NCT01237223|38105913|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
16962997|NCT01237223|38105914|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
16962998|NCT01237223|38105915|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
16962999|NCT01237223|38105916|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
16963000|NCT01237223|38105917|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
16963001|NCT01237223|38105912|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
16963002|NCT01237223|38105913|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
16963003|NCT01237223|38105914|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
16778999|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
16779000|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
16779001|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
16779002|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
16779003|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
16779004|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
16779005|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
16779006|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
16779007|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
16779008|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
16779009|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
16779010|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
16779011|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
16779012|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
16779013|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
16779014|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
16779015|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
16779016|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
16779017|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
16779018|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
16779019|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
16779020|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
16779021|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
16779022|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
16779023|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
16779024|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
16963004|NCT01237223|38105915|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
16963005|NCT01237223|38105916|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
16963006|NCT01237223|38105917|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
16963007|NCT01237223|38105912|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16963008|NCT01237223|38105913|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16963009|NCT01237223|38105914|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16963010|NCT01237223|38105915|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16963011|NCT01237223|38105916|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16963012|NCT01237223|38105917|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
16963013|NCT01237223|38105912|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
16963014|NCT01237223|38105913|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
16963015|NCT01237223|38105914|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
16963016|NCT01237223|38105915|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
16963017|NCT01237223|38105916|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
16963018|NCT01237223|38105917|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
16963019|NCT01236755|38105933|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
16963020|NCT01236755|38105933|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
16963021|NCT01236755|38105933|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
16963022|NCT01236755|38105933|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
16963023|NCT01236365|38105940|FG000|Overall Study|Lost to Follow-up|0|||
16963024|NCT01236365|38105941|FG001|Overall Study|Lost to Follow-up|2|||
16963025|NCT01236365|38105940|FG000|Overall Study|Moved Out of State|1|||
16963026|NCT01236365|38105941|FG001|Overall Study|Moved Out of State|0|||
16963027|NCT01236365|38105940|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
16963028|NCT01236365|38105941|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
16963029|NCT01235975|38105961|FG000|Overall Study|Serious Adverse Event|0|||
16963030|NCT01235975|38105962|FG001|Overall Study|Serious Adverse Event|1|||
16963031|NCT01235975|38105961|FG000|Overall Study|Withdrawal by Subject|8|||
16963032|NCT01235975|38105962|FG001|Overall Study|Withdrawal by Subject|2|||
16963033|NCT01235975|38105961|FG000|Overall Study|Migrated/moved from study area|2|||
16963034|NCT01235975|38105962|FG001|Overall Study|Migrated/moved from study area|1|||
16963035|NCT01235975|38105961|FG000|Overall Study|Lost to Follow-up|7|||
16963036|NCT01235975|38105962|FG001|Overall Study|Lost to Follow-up|3|||
16963037|NCT00903331|38105970|FG000|Overall Study|Death|4|||
16963038|NCT00903331|38105971|FG001|Overall Study|Death|8|||
16963039|NCT00903331|38105970|FG000|Overall Study|Withdrawal of consent|1|||
16963040|NCT00903331|38105971|FG001|Overall Study|Withdrawal of consent|8|||
16963041|NCT00903331|38105970|FG000|Overall Study|Lung transplant|0|||
16963042|NCT00903331|38105971|FG001|Overall Study|Lung transplant|2|||
16963043|NCT01235741|38105980|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
16963044|NCT01235741|38105981|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
16779025|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
16779026|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
16963045|NCT01235741|38105982|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
16963046|NCT01235741|38105980|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
16963047|NCT01235741|38105981|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
16963048|NCT01235741|38105982|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
16963049|NCT01235741|38105980|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
16963050|NCT01235741|38105981|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
16963051|NCT01235741|38105982|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
16963052|NCT01235741|38105980|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
16963053|NCT01235741|38105981|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
16963054|NCT01235741|38105982|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
16963055|NCT01235741|38105980|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
16963056|NCT01235741|38105981|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
16963057|NCT01235741|38105982|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
16963058|NCT01235741|38105980|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
16963059|NCT01235741|38105981|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
16963060|NCT01235741|38105982|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
16963061|NCT01235741|38105980|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
16963062|NCT01235741|38105981|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
16963063|NCT01235741|38105982|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
16963064|NCT01235741|38105980|FG000|Randomized to Treatment|Adverse Event|0|||
16963065|NCT01235741|38105981|FG001|Randomized to Treatment|Adverse Event|1|||
16963066|NCT01235741|38105982|FG002|Randomized to Treatment|Adverse Event|1|||
16963067|NCT01235741|38105980|FG000|Randomized to Treatment|Sponsor terminated study|0|||
16963068|NCT01235741|38105981|FG001|Randomized to Treatment|Sponsor terminated study|35|||
16963069|NCT01235741|38105982|FG002|Randomized to Treatment|Sponsor terminated study|34|||
16963070|NCT01235741|38105980|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
16963071|NCT01235741|38105981|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
16963072|NCT01235741|38105982|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
16963073|NCT01235741|38105980|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
16963074|NCT01235741|38105981|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
16963075|NCT01235741|38105982|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
16963076|NCT01235741|38105980|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
16963077|NCT01235741|38105981|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
16963078|NCT01235741|38105982|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
16963079|NCT01235507|38105994|FG000|Overall Study|Adverse Event|1|||
16963080|NCT01235507|38105994|FG000|Overall Study|Withdrawal by Subject|1|||
16963081|NCT01235351|38106000|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
16963082|NCT01235351|38106001|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
16963083|NCT01076205|38106011|FG000|Overall Study|Adverse Drug Reaction|299|||
16963084|NCT01076205|38106011|FG000|Overall Study|Lack of Effectiveness|1423|||
16963085|NCT01076205|38106011|FG000|Overall Study|Other Reason|1075|||
16963086|NCT01076205|38106011|FG000|Overall Study|Unknown Reason|71|||
16963087|NCT01076205|38106011|FG000|Overall Study|Lost to Follow-up|3151|||
16963088|NCT01234883|38106033|FG000|Overall Study|Early treatment release|8|||
16963089|NCT01234883|38106034|FG001|Overall Study|Early treatment release|10|||
16963090|NCT01234883|38106033|FG000|Overall Study|Parent/guardian withdrew consent|1|||
16963091|NCT01234883|38106034|FG001|Overall Study|Parent/guardian withdrew consent|2|||
16963092|NCT01234883|38106033|FG000|Overall Study|Technical difficulties with IV infusion|0|||
16963093|NCT01234883|38106034|FG001|Overall Study|Technical difficulties with IV infusion|1|||
16963094|NCT01234883|38106033|FG000|Overall Study|Inclusion/exclusion failure|1|||
16963095|NCT01234883|38106034|FG001|Overall Study|Inclusion/exclusion failure|0|||
16963096|NCT01234649|38106042|FG000|Overall Study|Withdrawal by Subject|32|||
16963097|NCT01234649|38106043|FG001|Overall Study|Withdrawal by Subject|26|||
16963098|NCT01234649|38106042|FG000|Overall Study|Pregnancy|6|||
16963099|NCT01234649|38106043|FG001|Overall Study|Pregnancy|6|||
16963100|NCT01234649|38106042|FG000|Overall Study|intolerant to side effects|4|||
16963101|NCT01234649|38106043|FG001|Overall Study|intolerant to side effects|3|||
16963102|NCT01234649|38106042|FG000|Overall Study|Allergic reaction|1|||
16963103|NCT01234649|38106043|FG001|Overall Study|Allergic reaction|0|||
16963104|NCT01234649|38106042|FG000|Overall Study|Lack of Efficacy|0|||
16963105|NCT01234649|38106043|FG001|Overall Study|Lack of Efficacy|3|||
16963106|NCT01075815|38106051|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
16963107|NCT01075815|38106052|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
16963108|NCT01075815|38106051|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
16963109|NCT01075815|38106052|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
16963110|NCT01075815|38106051|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
16963111|NCT01075815|38106052|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
16963112|NCT01075191|38106058|FG000|Overall Study|Death|1|||
16963113|NCT01075191|38106058|FG000|Overall Study|Intensification|3|||
16963114|NCT01075191|38106058|FG000|Overall Study|Co-morbidities|1|||
16963115|NCT01075191|38106058|FG000|Overall Study|Adverse Event|4|||
16963116|NCT01075191|38106058|FG000|Overall Study|Noncompliance|3|||
16963117|NCT01075191|38106058|FG000|Overall Study|Therapy Break|3|||
16963118|NCT01075191|38106058|FG000|Overall Study|Patient's Wish|2|||
16963119|NCT01075191|38106058|FG000|Overall Study|Unknown Reasons|1|||
16963120|NCT00905359|38106064|FG000|Overall Study|Lost to Follow-up|17|||
16963121|NCT00905359|38106065|FG001|Overall Study|Lost to Follow-up|10|||
16963122|NCT00905359|38106064|FG000|Overall Study|Death|2|||
16963123|NCT00905359|38106065|FG001|Overall Study|Death|0|||
16963124|NCT00905359|38106064|FG000|Overall Study|Withdrawal consent|5|||
16963125|NCT00905359|38106065|FG001|Overall Study|Withdrawal consent|6|||
16963126|NCT01072149|38106071|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963127|NCT01072149|38106072|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963128|NCT01072149|38106073|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16963129|NCT01072149|38106074|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963130|NCT01072149|38106075|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963131|NCT01072149|38106076|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963132|NCT01072149|38106077|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963133|NCT01072149|38106078|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963134|NCT01072149|38106079|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963135|NCT01072149|38106080|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963136|NCT01072149|38106081|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963137|NCT01072149|38106082|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963138|NCT01072149|38106083|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963139|NCT01072149|38106084|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963140|NCT01072149|38106085|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963141|NCT01072149|38106086|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963142|NCT01072149|38106087|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963143|NCT01072149|38106088|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16963144|NCT01072149|38106071|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963145|NCT01072149|38106072|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963146|NCT01072149|38106073|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963147|NCT01072149|38106074|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963148|NCT01072149|38106075|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963149|NCT01072149|38106076|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963150|NCT01072149|38106077|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963151|NCT01072149|38106078|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963152|NCT01072149|38106079|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963153|NCT01072149|38106080|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16779027|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
16779028|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
16779029|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
16779030|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
16779031|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
16779032|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
16779033|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
16779034|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
16779035|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
16779036|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
16779037|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
16779038|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
16779039|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
16779040|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
16779041|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
16779042|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
16779043|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
16779044|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
16779045|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
16779046|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
16779047|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
16779048|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
16779049|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
16779050|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
16779051|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
16779052|NCT02717195|37718301|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
16779053|NCT02717195|37718302|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
16779054|NCT02717195|37718303|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
16963154|NCT01072149|38106081|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963155|NCT01072149|38106082|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16779055|NCT02717195|37718304|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
16779056|NCT02717195|37718305|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
16779057|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
16779058|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
16779059|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
16779060|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
16779061|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
16779062|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
16779063|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
16779064|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
16779065|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
16779066|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
16779067|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
16779068|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
16779069|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
16779070|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
16779071|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
16963156|NCT01072149|38106083|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963157|NCT01072149|38106084|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963158|NCT01072149|38106085|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963159|NCT01072149|38106086|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963160|NCT01072149|38106087|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16963161|NCT01072149|38106088|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
16963162|NCT01072149|38106071|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963163|NCT01072149|38106072|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963164|NCT01072149|38106073|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963165|NCT01072149|38106074|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963166|NCT01072149|38106075|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963167|NCT01072149|38106076|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963168|NCT01072149|38106077|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963169|NCT01072149|38106078|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963170|NCT01072149|38106079|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963171|NCT01072149|38106080|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963172|NCT01072149|38106081|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
16963173|NCT01072149|38106082|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963174|NCT01072149|38106083|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963175|NCT01072149|38106084|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963176|NCT01072149|38106085|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963177|NCT01072149|38106086|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963178|NCT01072149|38106087|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963179|NCT01072149|38106088|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16963180|NCT01072149|38106071|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963181|NCT01072149|38106072|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
16963182|NCT01072149|38106073|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963183|NCT01072149|38106074|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16779072|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
16963184|NCT01072149|38106075|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963185|NCT01072149|38106076|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963186|NCT01072149|38106077|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963187|NCT01072149|38106078|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16779073|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
16779074|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
16779075|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
16779076|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
16779077|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16779078|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16779079|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
16779080|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
16779081|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
16779082|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
16779083|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
16779084|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
16779085|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
16779086|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
16779087|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
16779088|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
16779089|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
16779090|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
16779091|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
16779092|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
16779093|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
16779094|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
16779095|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
16779096|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
16779097|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
16779098|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
16779099|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
16779100|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
16779101|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
16779102|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
16779103|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
16779104|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
16779105|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
16779106|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
16779107|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
16779108|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
16963188|NCT01072149|38106079|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963189|NCT01072149|38106080|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963190|NCT01072149|38106081|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963191|NCT01072149|38106082|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963192|NCT01072149|38106083|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963193|NCT01072149|38106084|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963194|NCT01072149|38106085|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963195|NCT01072149|38106086|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963196|NCT01072149|38106087|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963197|NCT01072149|38106088|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16963198|NCT01072149|38106071|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963199|NCT01072149|38106072|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963200|NCT01072149|38106073|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
16779109|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
16779110|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
16779111|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
16779112|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
16779113|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
16779114|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
16779115|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
16779116|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
16779117|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
16779118|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
16779119|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
16779120|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
16779121|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
16779122|NCT02717195|37718301|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
16779123|NCT02717195|37718302|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
16779124|NCT02717195|37718303|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
16779125|NCT02717195|37718304|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
16779126|NCT02717195|37718305|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
16779127|NCT00701441|37718320|FG000|Overall Study|failure in cpap compliance|0|||
16779128|NCT00701441|37718321|FG001|Overall Study|failure in cpap compliance|4|||
16779129|NCT02628873|37718333|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
16779130|NCT02628873|37718334|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
16779131|NCT02628873|37718333|FG000|Second Test (1 Hour)|Physician Decision|1|||
16963201|NCT01072149|38106074|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963202|NCT01072149|38106075|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963203|NCT01072149|38106076|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963204|NCT01072149|38106077|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963205|NCT01072149|38106078|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963206|NCT01072149|38106079|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16779132|NCT02628873|37718334|FG001|Second Test (1 Hour)|Physician Decision|0|||
16779133|NCT02629965|37718344|FG000|Period 1|Adverse Event|1|||
16779134|NCT02629965|37718345|FG001|Period 1|Adverse Event|0|||
16779135|NCT02629965|37718344|FG000|Period 1|Unexpected worsening of disease|2|||
16779136|NCT02629965|37718345|FG001|Period 1|Unexpected worsening of disease|0|||
16779137|NCT02629965|37718344|FG000|Period 1|Other than listed above|1|||
16779138|NCT02629965|37718345|FG001|Period 1|Other than listed above|2|||
16779139|NCT02629965|37718344|FG000|Period 2|Adverse Event|1|||
16779140|NCT02629965|37718345|FG001|Period 2|Adverse Event|0|||
16779141|NCT01671111|37718351|FG000|Overall Study|Adverse Event|2|||
16779142|NCT01671111|37718351|FG000|Overall Study|Lack of Efficacy|1|||
16779143|NCT01671111|37718351|FG000|Overall Study|Withdrawal by Subject|2|||
16779144|NCT01671111|37718351|FG000|Overall Study|Physician Decision|1|||
16779145|NCT01671111|37718351|FG000|Overall Study|Other|24|||
16779146|NCT01671345|37718357|FG000|Overall Study|Lost to Follow-up|10|||
16963207|NCT01072149|38106080|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963208|NCT01072149|38106081|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963209|NCT01072149|38106082|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963210|NCT01072149|38106083|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963211|NCT01072149|38106084|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963212|NCT01072149|38106085|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963213|NCT01072149|38106086|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963214|NCT01072149|38106087|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963215|NCT01072149|38106088|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16963216|NCT01072149|38106071|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963217|NCT01072149|38106072|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963218|NCT01072149|38106073|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
16779147|NCT01671345|37718358|FG001|Overall Study|Lost to Follow-up|6|||
16779148|NCT01671345|37718357|FG000|Overall Study|visit with non-participating physician|3|||
16779149|NCT01671345|37718358|FG001|Overall Study|visit with non-participating physician|3|||
16779150|NCT04338321|37718380|FG000|Overall Study|Adverse Event|4|||
16779151|NCT04338321|37718381|FG001|Overall Study|Adverse Event|10|||
16963219|NCT01072149|38106074|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963220|NCT01072149|38106075|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963221|NCT01072149|38106076|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963222|NCT01072149|38106077|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963223|NCT01072149|38106078|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
16963224|NCT01072149|38106079|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963225|NCT01072149|38106080|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963226|NCT01072149|38106081|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963227|NCT01072149|38106082|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963228|NCT01072149|38106083|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963229|NCT01072149|38106084|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963230|NCT01072149|38106085|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963231|NCT01072149|38106086|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963232|NCT01072149|38106087|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963233|NCT01072149|38106088|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
16963234|NCT01072149|38106071|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
16963235|NCT01072149|38106072|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
16963236|NCT01072149|38106073|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
16963237|NCT01072149|38106074|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
16963238|NCT01072149|38106075|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
16963239|NCT01072149|38106076|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
16963240|NCT01072149|38106077|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
16963241|NCT01072149|38106078|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
16963242|NCT01072149|38106079|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
16779152|NCT04338321|37718380|FG000|Overall Study|Death|1|||
16779153|NCT04338321|37718381|FG001|Overall Study|Death|1|||
16779154|NCT04338321|37718380|FG000|Overall Study|Lost to Follow-up|4|||
16779155|NCT04338321|37718381|FG001|Overall Study|Lost to Follow-up|9|||
16963243|NCT01072149|38106080|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
16963244|NCT01072149|38106081|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
16963245|NCT01072149|38106082|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
16963246|NCT01072149|38106083|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
16963247|NCT01072149|38106084|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
16963248|NCT01072149|38106085|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
16963249|NCT01072149|38106086|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
16963250|NCT01072149|38106087|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
16963251|NCT01072149|38106088|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
16963252|NCT01072149|38106071|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963253|NCT01072149|38106072|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963254|NCT01072149|38106073|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963255|NCT01072149|38106074|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963256|NCT01072149|38106075|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963257|NCT01072149|38106076|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963258|NCT01072149|38106077|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963259|NCT01072149|38106078|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963260|NCT01072149|38106079|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963261|NCT01072149|38106080|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963262|NCT01072149|38106081|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963263|NCT01072149|38106082|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963264|NCT01072149|38106083|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963265|NCT01072149|38106084|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963266|NCT01072149|38106085|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963267|NCT01072149|38106086|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
16963268|NCT01072149|38106087|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963269|NCT01072149|38106088|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16963270|NCT01072149|38106071|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
16963271|NCT01072149|38106072|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
16963272|NCT01072149|38106073|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
16963273|NCT01072149|38106074|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
16963274|NCT01072149|38106075|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
16963275|NCT01072149|38106076|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
16963276|NCT01072149|38106077|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
16963277|NCT01072149|38106078|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
16963278|NCT01072149|38106079|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
16963279|NCT01072149|38106080|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
16963280|NCT01072149|38106081|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
16963281|NCT01072149|38106082|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
16963282|NCT01072149|38106083|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
16963283|NCT01072149|38106084|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
16963284|NCT01072149|38106085|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
16963285|NCT01072149|38106086|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
16963286|NCT01072149|38106087|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
16963287|NCT01072149|38106088|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
16963288|NCT01072149|38106071|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963289|NCT01072149|38106072|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963290|NCT01072149|38106073|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963291|NCT01072149|38106074|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963292|NCT01072149|38106075|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963293|NCT01072149|38106076|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963294|NCT01072149|38106077|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963295|NCT01072149|38106078|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963296|NCT01072149|38106079|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963297|NCT01072149|38106080|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963298|NCT01072149|38106081|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963299|NCT01072149|38106082|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963300|NCT01072149|38106083|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
16963301|NCT01072149|38106084|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963302|NCT01072149|38106085|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963303|NCT01072149|38106086|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963304|NCT01072149|38106087|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963305|NCT01072149|38106088|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16963306|NCT01072149|38106071|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963307|NCT01072149|38106072|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963308|NCT01072149|38106073|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
16963309|NCT01072149|38106074|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963310|NCT01072149|38106075|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963311|NCT01072149|38106076|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963312|NCT01072149|38106077|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963313|NCT01072149|38106078|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963314|NCT01072149|38106079|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963315|NCT01072149|38106080|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963316|NCT01072149|38106081|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963317|NCT01072149|38106082|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16779156|NCT04338321|37718380|FG000|Overall Study|Withdrawal by Subject|45|||
16779157|NCT04338321|37718381|FG001|Overall Study|Withdrawal by Subject|69|||
16779158|NCT04338321|37718380|FG000|Overall Study|Physician Decision|5|||
16779159|NCT04338321|37718381|FG001|Overall Study|Physician Decision|9|||
16779160|NCT04338321|37718380|FG000|Overall Study|Other|3|||
16779161|NCT04338321|37718381|FG001|Overall Study|Other|10|||
16779162|NCT02487095|37718397|FG000|Dose Expansion|Unable to scan/restage participant|0|||
16779163|NCT02487095|37718398|FG001|Dose Expansion|Unable to scan/restage participant|0|||
16779164|NCT02487095|37718399|FG002|Dose Expansion|Unable to scan/restage participant|0|||
16779165|NCT02487095|37718400|FG003|Dose Expansion|Unable to scan/restage participant|0|||
16779166|NCT02487095|37718401|FG004|Dose Expansion|Unable to scan/restage participant|1|||
16963318|NCT01072149|38106083|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963319|NCT01072149|38106084|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
16963320|NCT01072149|38106085|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963321|NCT01072149|38106086|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963322|NCT01072149|38106087|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16963323|NCT01072149|38106088|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16779167|NCT03855137|37718424|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
16779168|NCT03855137|37718425|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
16779169|NCT03855137|37718426|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
16963324|NCT01071915|38106098|FG000|Overall Study|Adverse Event|3|||
16963325|NCT01071915|38106098|FG000|Overall Study|Physician Decision|2|||
16963326|NCT01071915|38106098|FG000|Overall Study|Withdrawal by Subject|2|||
16963327|NCT01071915|38106098|FG000|Overall Study|Miscellaneous Reasons|2|||
16963328|NCT00904969|38106102|FG000|Overall Study|Lost to Follow-up|4|||
16963329|NCT00904969|38106102|FG000|Overall Study|Withdrawal by Subject|3|||
16963330|NCT00904969|38106102|FG000|Overall Study|Additional Treatments|11|||
16963331|NCT00904969|38106102|FG000|Overall Study|Case Aborted; Subject Exited|1|||
16963332|NCT01070979|38106124|FG000|Overall Study|Adverse Event|2|||
16963333|NCT01070979|38106125|FG001|Overall Study|Adverse Event|3|||
16963334|NCT01070979|38106126|FG002|Overall Study|Adverse Event|3|||
16963335|NCT01070979|38106124|FG000|Overall Study|Lost to Follow-up|2|||
16963336|NCT01070979|38106125|FG001|Overall Study|Lost to Follow-up|1|||
16963337|NCT01070979|38106126|FG002|Overall Study|Lost to Follow-up|1|||
16963338|NCT01070979|38106124|FG000|Overall Study|Protocol Violation|0|||
16963339|NCT01070979|38106125|FG001|Overall Study|Protocol Violation|2|||
16963340|NCT01070979|38106126|FG002|Overall Study|Protocol Violation|6|||
16963341|NCT01070979|38106124|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
16963342|NCT01070979|38106125|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
16963343|NCT01070979|38106126|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
16963344|NCT01070979|38106124|FG000|Overall Study|Withdrawal by Subject|3|||
16963345|NCT01070979|38106125|FG001|Overall Study|Withdrawal by Subject|1|||
16963346|NCT01070979|38106126|FG002|Overall Study|Withdrawal by Subject|1|||
16963347|NCT01070979|38106124|FG000|Overall Study|No study drug taken|0|||
16963348|NCT01070979|38106125|FG001|Overall Study|No study drug taken|1|||
16963349|NCT01070979|38106126|FG002|Overall Study|No study drug taken|0|||
16963350|NCT01234337|38106136|FG000|Overall Study|Adverse Event|58|||
16963351|NCT01234337|38106137|FG001|Overall Study|Adverse Event|21|||
16963352|NCT01234337|38106136|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
16963353|NCT01234337|38106137|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
16963354|NCT01234337|38106136|FG000|Overall Study|Investi. decision not protocol driven|5|||
16963355|NCT01234337|38106137|FG001|Overall Study|Investi. decision not protocol driven|6|||
16963356|NCT01234337|38106136|FG000|Overall Study|Non-compliant with study medication|3|||
16963357|NCT01234337|38106137|FG001|Overall Study|Non-compliant with study medication|2|||
16963358|NCT01234337|38106136|FG000|Overall Study|Randomized but not treated|6|||
16963359|NCT01234337|38106137|FG001|Overall Study|Randomized but not treated|4|||
16963360|NCT01234337|38106136|FG000|Overall Study|Lost to Follow-up|0|||
16963361|NCT01234337|38106137|FG001|Overall Study|Lost to Follow-up|1|||
16963362|NCT01234337|38106136|FG000|Overall Study|Protocol Violation|2|||
16963363|NCT01234337|38106137|FG001|Overall Study|Protocol Violation|3|||
16963364|NCT01234337|38106136|FG000|Overall Study|Withdrawal by Subject|11|||
16963365|NCT01234337|38106137|FG001|Overall Study|Withdrawal by Subject|9|||
16779170|NCT03855137|37718424|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
16867983|NCT01553747|37841011|FG000|Overall Study|Adverse event or SAE|32|||
16779171|NCT03855137|37718425|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
16779172|NCT03855137|37718426|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
16779173|NCT03855137|37718424|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
16779174|NCT03855137|37718425|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
16867984|NCT01553747|37841012|FG001|Overall Study|Adverse event or SAE|28|||
16779175|NCT03855137|37718426|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
16963366|NCT01234337|38106136|FG000|Overall Study|Death|0|||
16963367|NCT01234337|38106137|FG001|Overall Study|Death|1|||
16963368|NCT01234337|38106136|FG000|Overall Study|Switch to commercial drug|0|||
16963369|NCT01234337|38106137|FG001|Overall Study|Switch to commercial drug|1|||
16963370|NCT01070043|38106145|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
16963371|NCT01070043|38106146|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
16963372|NCT01070043|38106147|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
16963373|NCT01070043|38106145|FG000|Double-Blind Treatment|Adverse Event|0|||
16963374|NCT01070043|38106146|FG001|Double-Blind Treatment|Adverse Event|0|||
16963375|NCT01070043|38106147|FG002|Double-Blind Treatment|Adverse Event|2|||
16963376|NCT01074255|38106153|FG000|Overall Study|Did not receive EMEND|2|||
16963377|NCT01073943|38106159|FG000|Overall Study|Withdrawal by Subject|8|||
16963378|NCT01073943|38106160|FG001|Overall Study|Withdrawal by Subject|2|||
16963379|NCT01073943|38106159|FG000|Overall Study|Protocol Violation|2|||
16963380|NCT01073943|38106160|FG001|Overall Study|Protocol Violation|1|||
16963381|NCT01073943|38106159|FG000|Overall Study|Adverse Event|1|||
16963382|NCT01073943|38106160|FG001|Overall Study|Adverse Event|1|||
16963383|NCT01073943|38106159|FG000|Overall Study|Lost to Follow-up|0|||
16963384|NCT01073943|38106160|FG001|Overall Study|Lost to Follow-up|2|||
16963385|NCT01073943|38106159|FG000|Overall Study|Power outage; colonoscopy not done|1|||
16963386|NCT01073943|38106160|FG001|Overall Study|Power outage; colonoscopy not done|0|||
16963387|NCT01073943|38106159|FG000|Overall Study|Subject forgot|0|||
16963388|NCT01073943|38106160|FG001|Overall Study|Subject forgot|1|||
16963389|NCT01073943|38106159|FG000|Overall Study|Unable to return for follow-up|0|||
16963390|NCT01073943|38106160|FG001|Overall Study|Unable to return for follow-up|1|||
16963391|NCT01073943|38106159|FG000|Overall Study|Could not tolerate prep|1|||
16963392|NCT01073943|38106160|FG001|Overall Study|Could not tolerate prep|0|||
16963393|NCT01073865|38106168|FG000|Overall Study|Reasons other than below|19|||
16963394|NCT01073865|38106169|FG001|Overall Study|Reasons other than below|31|||
16963395|NCT01073865|38106168|FG000|Overall Study|Lost to Follow-up|1|||
16963396|NCT01073865|38106169|FG001|Overall Study|Lost to Follow-up|1|||
16963397|NCT01073865|38106168|FG000|Overall Study|Death|3|||
16779176|NCT03855137|37718424|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
16779177|NCT03855137|37718425|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
16963398|NCT01073865|38106169|FG001|Overall Study|Death|2|||
16963399|NCT01073865|38106168|FG000|Overall Study|Withdrawal by Subject|5|||
16963400|NCT01073865|38106169|FG001|Overall Study|Withdrawal by Subject|5|||
16963401|NCT04862065|38106178|FG000|Screening|Protocol Violation|54|||
16963402|NCT04862065|38106179|FG001|Screening|Protocol Violation|0|||
16963403|NCT04862065|38106180|FG002|Screening|Protocol Violation|0|||
16963404|NCT04862065|38106178|FG000|Screening|Insufficient Sample|1|||
16963405|NCT04862065|38106179|FG001|Screening|Insufficient Sample|0|||
16963406|NCT04862065|38106180|FG002|Screening|Insufficient Sample|0|||
16963407|NCT04862065|38106178|FG000|Follow-Up|Lost to Follow-up|3|||
16963408|NCT04862065|38106179|FG001|Follow-Up|Lost to Follow-up|0|||
16779178|NCT03855137|37718426|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
16963409|NCT04862065|38106180|FG002|Follow-Up|Lost to Follow-up|0|||
16963410|NCT01073631|38106186|FG000|Overall Study|Death|82|||
16963411|NCT01073631|38106186|FG000|Overall Study|Adverse Event|24|||
16779179|NCT03855137|37718424|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
16779180|NCT03855137|37718425|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
16963412|NCT01073631|38106186|FG000|Overall Study|Other|63|||
16963413|NCT01073163|38106190|FG000|Overall Study|Adverse Event|1|||
16963414|NCT01073163|38106190|FG000|Overall Study|Disease Progression|1|||
16779181|NCT03855137|37718426|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
16963415|NCT01073163|38106190|FG000|Overall Study|Early termination|1|||
16963416|NCT01233869|38106202|FG000|Initial Treatment Period (24 Months)|Death|1|||
16963417|NCT01233869|38106203|FG001|Initial Treatment Period (24 Months)|Death|0|||
16779182|NCT03855137|37718424|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
16963418|NCT01233869|38106204|FG002|Initial Treatment Period (24 Months)|Death|0|||
16779183|NCT03855137|37718425|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
16779184|NCT03855137|37718426|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
16779185|NCT03855137|37718424|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
16779186|NCT03855137|37718425|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
16779187|NCT03855137|37718426|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
16779188|NCT03855137|37718424|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
16779189|NCT03855137|37718425|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
16779190|NCT03855137|37718426|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
16779191|NCT03855137|37718424|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
16779192|NCT03855137|37718425|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
16779193|NCT03855137|37718426|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
16779194|NCT03855137|37718424|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
16779195|NCT03855137|37718425|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
16779196|NCT03855137|37718426|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
16779197|NCT00701363|37718448|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
16779198|NCT00701363|37718449|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
16779199|NCT00701363|37718450|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
16779200|NCT00701363|37718451|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
16779201|NCT00701363|37718448|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
16779202|NCT00701363|37718449|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
16779203|NCT00701363|37718450|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
16779204|NCT00701363|37718451|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
16779205|NCT00701363|37718448|FG000|Treatment Phase 1|Adverse Event|7|||
16779206|NCT00701363|37718449|FG001|Treatment Phase 1|Adverse Event|0|||
16779207|NCT00701363|37718450|FG002|Treatment Phase 1|Adverse Event|0|||
16779208|NCT00701363|37718451|FG003|Treatment Phase 1|Adverse Event|0|||
16779209|NCT00701363|37718448|FG000|Treatment Phase 1|Protocol Violation|1|||
16779210|NCT00701363|37718449|FG001|Treatment Phase 1|Protocol Violation|0|||
16779211|NCT00701363|37718450|FG002|Treatment Phase 1|Protocol Violation|0|||
16779212|NCT00701363|37718451|FG003|Treatment Phase 1|Protocol Violation|0|||
16779213|NCT00701363|37718448|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
16779214|NCT00701363|37718449|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
16963419|NCT01233869|38106205|FG003|Initial Treatment Period (24 Months)|Death|0|||
16963420|NCT01233869|38106202|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
16963421|NCT01233869|38106203|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
16963422|NCT01233869|38106204|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
16963423|NCT01233869|38106205|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
16963424|NCT01233869|38106202|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
16963425|NCT01233869|38106203|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
16963426|NCT01233869|38106204|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
16963427|NCT01233869|38106205|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
16963428|NCT01233869|38106202|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
16963429|NCT01233869|38106203|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
16963430|NCT01233869|38106204|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
16963431|NCT01233869|38106205|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
16963432|NCT01233869|38106202|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
16963433|NCT01233869|38106203|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
16963434|NCT01233869|38106204|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
16963435|NCT01233869|38106205|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
16963436|NCT01233869|38106202|FG000|Extended Treatment Period (46 Months)|Other|3|||
16963437|NCT01233869|38106203|FG001|Extended Treatment Period (46 Months)|Other|0|||
16963438|NCT01233869|38106204|FG002|Extended Treatment Period (46 Months)|Other|0|||
16779215|NCT00701363|37718450|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
16779216|NCT00701363|37718451|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
16779217|NCT00701363|37718448|FG000|Treatment Phase 1|Lack of Efficacy|1|||
16779218|NCT00701363|37718449|FG001|Treatment Phase 1|Lack of Efficacy|0|||
16779219|NCT00701363|37718450|FG002|Treatment Phase 1|Lack of Efficacy|0|||
16779220|NCT00701363|37718451|FG003|Treatment Phase 1|Lack of Efficacy|0|||
16779221|NCT00701363|37718448|FG000|Treatment Phase 2|Adverse Event|0|||
16963439|NCT01233869|38106205|FG003|Extended Treatment Period (46 Months)|Other|3|||
16963440|NCT01233869|38106202|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
16963441|NCT01233869|38106203|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
16963442|NCT01233869|38106204|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
16963443|NCT01233869|38106205|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
16963444|NCT01072929|38106218|FG000|Overall Study|Adverse Event|8|||
16963445|NCT01072929|38106219|FG001|Overall Study|Adverse Event|11|||
16963446|NCT01072929|38106220|FG002|Overall Study|Adverse Event|2|||
16963447|NCT01072929|38106218|FG000|Overall Study|Lack of Efficacy|7|||
16963448|NCT01072929|38106219|FG001|Overall Study|Lack of Efficacy|4|||
16963449|NCT01072929|38106220|FG002|Overall Study|Lack of Efficacy|0|||
16963450|NCT01072929|38106218|FG000|Overall Study|Withdrawal by Subject|7|||
16963451|NCT01072929|38106219|FG001|Overall Study|Withdrawal by Subject|15|||
16963452|NCT01072929|38106220|FG002|Overall Study|Withdrawal by Subject|3|||
16963453|NCT01072929|38106218|FG000|Overall Study|Protocol Violation|13|||
16963454|NCT01072929|38106219|FG001|Overall Study|Protocol Violation|11|||
16963455|NCT01072929|38106220|FG002|Overall Study|Protocol Violation|2|||
16963456|NCT01072929|38106218|FG000|Overall Study|Lost to Follow-up|8|||
16963457|NCT01072929|38106219|FG001|Overall Study|Lost to Follow-up|4|||
16963458|NCT01072929|38106220|FG002|Overall Study|Lost to Follow-up|1|||
16963459|NCT01072929|38106218|FG000|Overall Study|Noncompliance with study medication|0|||
16963460|NCT01072929|38106219|FG001|Overall Study|Noncompliance with study medication|3|||
16963461|NCT01072929|38106220|FG002|Overall Study|Noncompliance with study medication|0|||
16963462|NCT01072929|38106218|FG000|Overall Study|Noncompliance with study procedures|1|||
16963463|NCT01072929|38106219|FG001|Overall Study|Noncompliance with study procedures|0|||
16963464|NCT01072929|38106220|FG002|Overall Study|Noncompliance with study procedures|1|||
16963465|NCT01072929|38106218|FG000|Overall Study|Other|0|||
16963466|NCT01072929|38106219|FG001|Overall Study|Other|3|||
16963467|NCT01072929|38106220|FG002|Overall Study|Other|0|||
16963468|NCT01231607|38106234|FG000|Overall Study|Adverse Event|0|||
16963469|NCT01231607|38106235|FG001|Overall Study|Adverse Event|8|||
16963470|NCT01231607|38106236|FG002|Overall Study|Adverse Event|4|||
16963471|NCT01231607|38106237|FG003|Overall Study|Adverse Event|4|||
16963472|NCT01231607|38106238|FG004|Overall Study|Adverse Event|5|||
16963473|NCT01231607|38106234|FG000|Overall Study|Lost to Follow-up|13|||
16963474|NCT01231607|38106235|FG001|Overall Study|Lost to Follow-up|11|||
16963475|NCT01231607|38106236|FG002|Overall Study|Lost to Follow-up|10|||
16963476|NCT01231607|38106237|FG003|Overall Study|Lost to Follow-up|10|||
16963477|NCT01231607|38106238|FG004|Overall Study|Lost to Follow-up|4|||
16963478|NCT01231607|38106234|FG000|Overall Study|Physician Decision|4|||
16963479|NCT01231607|38106235|FG001|Overall Study|Physician Decision|4|||
16963480|NCT01231607|38106236|FG002|Overall Study|Physician Decision|3|||
16963481|NCT01231607|38106237|FG003|Overall Study|Physician Decision|5|||
16963482|NCT01231607|38106238|FG004|Overall Study|Physician Decision|4|||
16963483|NCT01231607|38106234|FG000|Overall Study|Protocol Violation|3|||
16963484|NCT01231607|38106235|FG001|Overall Study|Protocol Violation|2|||
16963485|NCT01231607|38106236|FG002|Overall Study|Protocol Violation|0|||
16963486|NCT01231607|38106237|FG003|Overall Study|Protocol Violation|2|||
16963487|NCT01231607|38106238|FG004|Overall Study|Protocol Violation|2|||
16963488|NCT01231607|38106234|FG000|Overall Study|Withdrawal by Subject|9|||
16963489|NCT01231607|38106235|FG001|Overall Study|Withdrawal by Subject|9|||
16963490|NCT01231607|38106236|FG002|Overall Study|Withdrawal by Subject|14|||
16963491|NCT01231607|38106237|FG003|Overall Study|Withdrawal by Subject|17|||
16963492|NCT01231607|38106238|FG004|Overall Study|Withdrawal by Subject|9|||
16963493|NCT01231373|38106257|FG000|Overall Study|Withdrew consent prior to randomization|2|||
16963494|NCT01231373|38106258|FG001|Overall Study|Withdrew consent prior to randomization|1|||
16963495|NCT01231373|38106259|FG002|Overall Study|Withdrew consent prior to randomization|0|||
16963496|NCT01231373|38106260|FG003|Overall Study|Withdrew consent prior to randomization|0|||
16963497|NCT01231373|38106257|FG000|Overall Study|Lost to Follow-up|0|||
16963498|NCT01231373|38106258|FG001|Overall Study|Lost to Follow-up|0|||
16963499|NCT01231373|38106259|FG002|Overall Study|Lost to Follow-up|0|||
16963500|NCT01231373|38106260|FG003|Overall Study|Lost to Follow-up|1|||
16963501|NCT01231373|38106257|FG000|Overall Study|Withdrew Consent|1|||
16963502|NCT01231373|38106258|FG001|Overall Study|Withdrew Consent|0|||
16963503|NCT01231373|38106259|FG002|Overall Study|Withdrew Consent|0|||
16963504|NCT01231373|38106260|FG003|Overall Study|Withdrew Consent|0|||
16963505|NCT00975130|38106272|FG000|Study Part 1|Adverse Event|150|||
16963506|NCT00975130|38106273|FG001|Study Part 1|Adverse Event|0|||
16963507|NCT00975130|38106274|FG002|Study Part 1|Adverse Event|0|||
16963508|NCT00975130|38106272|FG000|Study Part 1|Lost to Follow-up|19|||
16963509|NCT00975130|38106273|FG001|Study Part 1|Lost to Follow-up|0|||
16963510|NCT00975130|38106274|FG002|Study Part 1|Lost to Follow-up|0|||
16963511|NCT00975130|38106272|FG000|Study Part 1|Withdrawal by Subject|61|||
16963512|NCT00975130|38106273|FG001|Study Part 1|Withdrawal by Subject|0|||
16963513|NCT00975130|38106274|FG002|Study Part 1|Withdrawal by Subject|0|||
16963514|NCT00975130|38106272|FG000|Study Part 1|Protocol Violation|13|||
16963515|NCT00975130|38106273|FG001|Study Part 1|Protocol Violation|0|||
16963516|NCT00975130|38106274|FG002|Study Part 1|Protocol Violation|0|||
16963517|NCT00975130|38106272|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
16963518|NCT00975130|38106273|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
16963519|NCT00975130|38106274|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
16963520|NCT00975130|38106272|FG000|Study Part 1|Administrative|4|||
16963521|NCT00975130|38106273|FG001|Study Part 1|Administrative|0|||
16963522|NCT00975130|38106274|FG002|Study Part 1|Administrative|0|||
16963523|NCT00975130|38106272|FG000|Study Part 1|Withdrew Consent|24|||
16963524|NCT00975130|38106273|FG001|Study Part 1|Withdrew Consent|0|||
16963525|NCT00975130|38106274|FG002|Study Part 1|Withdrew Consent|0|||
16963526|NCT00975130|38106272|FG000|Study Part 2|Adverse Event|0|||
16963527|NCT00975130|38106273|FG001|Study Part 2|Adverse Event|14|||
16963528|NCT00975130|38106274|FG002|Study Part 2|Adverse Event|7|||
16963529|NCT00975130|38106272|FG000|Study Part 2|Lost to Follow-up|0|||
16963530|NCT00975130|38106273|FG001|Study Part 2|Lost to Follow-up|0|||
16963531|NCT00975130|38106274|FG002|Study Part 2|Lost to Follow-up|1|||
16963532|NCT00975130|38106272|FG000|Study Part 2|Withdrawal by Subject|0|||
16963533|NCT00975130|38106273|FG001|Study Part 2|Withdrawal by Subject|13|||
16963534|NCT00975130|38106274|FG002|Study Part 2|Withdrawal by Subject|5|||
16963535|NCT00975130|38106272|FG000|Study Part 2|Withdrew Consent|0|||
16963536|NCT00975130|38106273|FG001|Study Part 2|Withdrew Consent|6|||
16963537|NCT00975130|38106274|FG002|Study Part 2|Withdrew Consent|2|||
16963538|NCT00975130|38106272|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
16963539|NCT00975130|38106273|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
16963540|NCT00975130|38106274|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
16963541|NCT00975130|38106272|FG000|Study Part 2|Administrative|0|||
16963542|NCT00975130|38106273|FG001|Study Part 2|Administrative|1|||
16963543|NCT00975130|38106274|FG002|Study Part 2|Administrative|0|||
16963544|NCT00975130|38106272|FG000|Study Part 2|Protocol Violation|0|||
16963545|NCT00975130|38106273|FG001|Study Part 2|Protocol Violation|0|||
16963546|NCT00975130|38106274|FG002|Study Part 2|Protocol Violation|1|||
16997726|NCT01010633|38141718|FG000|Overall Study|Withdrawal by Subject|2|||
16997727|NCT01010633|38141719|FG001|Overall Study|Withdrawal by Subject|1|||
16997728|NCT01010633|38141718|FG000|Overall Study|Investigator decision|0|||
16997729|NCT01010633|38141719|FG001|Overall Study|Investigator decision|1|||
16997730|NCT00733954|38141727|FG000|Overall Study|Lost to Follow-up|5|||
16997731|NCT00733954|38141728|FG001|Overall Study|Lost to Follow-up|2|||
16997732|NCT00733954|38141727|FG000|Overall Study|Protocol Violation|1|||
16997733|NCT00733954|38141728|FG001|Overall Study|Protocol Violation|0|||
16997734|NCT00733954|38141727|FG000|Overall Study|Withdrawal by Subject|2|||
16997735|NCT00733954|38141728|FG001|Overall Study|Withdrawal by Subject|0|||
16997736|NCT00733408|38141734|FG000|Overall Study|Adverse Event|4|||
16997737|NCT01010867|38141738|FG000|Overall Study|< 50% adherence to probiotic|1|||
16997738|NCT00576823|38141745|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
16997739|NCT00576823|38141746|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
16997740|NCT00576823|38141747|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
16997741|NCT00576823|38141745|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
16997742|NCT00576823|38141746|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
16997743|NCT00576823|38141747|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
16997744|NCT00732940|38141760|FG000|Overall Study|Withdrawal by Subject|1|||
16997745|NCT00732940|38141761|FG001|Overall Study|Withdrawal by Subject|2|||
16997746|NCT00732940|38141760|FG000|Overall Study|Adverse Event|0|||
16963547|NCT01230827|38106291|FG000|Overall Study|Lost to Follow-up|0|||
16963548|NCT01230827|38106292|FG001|Overall Study|Lost to Follow-up|0|||
16963549|NCT01230827|38106293|FG002|Overall Study|Lost to Follow-up|1|||
16963550|NCT01230827|38106294|FG003|Overall Study|Lost to Follow-up|3|||
16963551|NCT01230827|38106291|FG000|Overall Study|Withdrawal by Subject|1|||
16963552|NCT01230827|38106292|FG001|Overall Study|Withdrawal by Subject|0|||
16963553|NCT01230827|38106293|FG002|Overall Study|Withdrawal by Subject|3|||
16963554|NCT01230827|38106294|FG003|Overall Study|Withdrawal by Subject|2|||
16963555|NCT01230827|38106291|FG000|Overall Study|Lack of Efficacy|14|||
16963556|NCT01230827|38106292|FG001|Overall Study|Lack of Efficacy|1|||
16963557|NCT01230827|38106293|FG002|Overall Study|Lack of Efficacy|2|||
16963558|NCT01230827|38106294|FG003|Overall Study|Lack of Efficacy|3|||
16963559|NCT01230827|38106291|FG000|Overall Study|Adverse Event|4|||
16963560|NCT01230827|38106292|FG001|Overall Study|Adverse Event|2|||
16963561|NCT01230827|38106293|FG002|Overall Study|Adverse Event|3|||
16963562|NCT01230827|38106294|FG003|Overall Study|Adverse Event|7|||
16963563|NCT01230827|38106291|FG000|Overall Study|Recovery|0|||
16963564|NCT01230827|38106292|FG001|Overall Study|Recovery|6|||
16963565|NCT01230827|38106293|FG002|Overall Study|Recovery|0|||
16963566|NCT01230827|38106294|FG003|Overall Study|Recovery|0|||
16963567|NCT01230827|38106291|FG000|Overall Study|Study terminated by Sponsor|0|||
16963568|NCT01230827|38106292|FG001|Overall Study|Study terminated by Sponsor|2|||
16963569|NCT01230827|38106293|FG002|Overall Study|Study terminated by Sponsor|56|||
16963570|NCT01230827|38106294|FG003|Overall Study|Study terminated by Sponsor|63|||
16963571|NCT01230749|38106306|FG000|Overall Study|Adverse Event|0|||
16963572|NCT01230749|38106307|FG001|Overall Study|Adverse Event|0|||
16963573|NCT01230749|38106308|FG002|Overall Study|Adverse Event|0|||
16779222|NCT00701363|37718449|FG001|Treatment Phase 2|Adverse Event|0|||
16779223|NCT00701363|37718450|FG002|Treatment Phase 2|Adverse Event|1|||
16867985|NCT01553747|37841013|FG002|Overall Study|Adverse event or SAE|19|||
16963574|NCT01230749|38106309|FG003|Overall Study|Adverse Event|1|||
16963575|NCT01230749|38106306|FG000|Overall Study|Physician Decision|0|||
16963576|NCT01230749|38106307|FG001|Overall Study|Physician Decision|0|||
16963577|NCT01230749|38106308|FG002|Overall Study|Physician Decision|1|||
16963578|NCT01230749|38106309|FG003|Overall Study|Physician Decision|0|||
16963579|NCT01230749|38106306|FG000|Overall Study|Withdrawal by Subject|0|||
16963580|NCT01230749|38106307|FG001|Overall Study|Withdrawal by Subject|1|||
16963581|NCT01230749|38106308|FG002|Overall Study|Withdrawal by Subject|0|||
16963582|NCT01230749|38106309|FG003|Overall Study|Withdrawal by Subject|0|||
16963583|NCT01230749|38106306|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
16963584|NCT01230749|38106307|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
16963585|NCT01230749|38106308|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
16963586|NCT01230749|38106309|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
16963587|NCT00903175|38106324|FG000|Period 1 - First Line|Adverse Event|36|||
16963588|NCT00903175|38106325|FG001|Period 1 - First Line|Adverse Event|50|||
16779224|NCT00701363|37718451|FG003|Treatment Phase 2|Adverse Event|0|||
16963589|NCT00903175|38106324|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
16963590|NCT00903175|38106325|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
16963591|NCT00903175|38106324|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
16963592|NCT00903175|38106325|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
16963593|NCT00903175|38106324|FG000|Period 1 - First Line|Protocol Violation|3|||
16963594|NCT00903175|38106325|FG001|Period 1 - First Line|Protocol Violation|3|||
16963595|NCT00903175|38106324|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
16963596|NCT00903175|38106325|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
16963597|NCT00903175|38106324|FG000|Period 1 - First Line|Administrative problems|12|||
16963598|NCT00903175|38106325|FG001|Period 1 - First Line|Administrative problems|13|||
16963599|NCT00903175|38106324|FG000|Period 1 - First Line|Death|17|||
16963600|NCT00903175|38106325|FG001|Period 1 - First Line|Death|10|||
16963601|NCT00903175|38106324|FG000|Period 2 - Second Line|Missing|1|||
16963602|NCT00903175|38106325|FG001|Period 2 - Second Line|Missing|0|||
16963603|NCT00903175|38106324|FG000|Period 2 - Second Line|Adverse Event|16|||
16963604|NCT00903175|38106325|FG001|Period 2 - Second Line|Adverse Event|20|||
16963605|NCT00903175|38106324|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
16963606|NCT00903175|38106325|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
16963607|NCT00903175|38106324|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
16963608|NCT00903175|38106325|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
16963609|NCT00903175|38106324|FG000|Period 2 - Second Line|Administrative problems|19|||
16963610|NCT00903175|38106325|FG001|Period 2 - Second Line|Administrative problems|9|||
16963611|NCT00903175|38106324|FG000|Period 2 - Second Line|Death|5|||
16963612|NCT00903175|38106325|FG001|Period 2 - Second Line|Death|2|||
16963613|NCT01229735|38106333|FG000|Overall Study|Lack of Efficacy|8|||
16963614|NCT01229735|38106334|FG001|Overall Study|Lack of Efficacy|8|||
16963615|NCT01229735|38106333|FG000|Overall Study|Protocol Violation|13|||
16963616|NCT01229735|38106334|FG001|Overall Study|Protocol Violation|8|||
16963617|NCT01229735|38106333|FG000|Overall Study|Lost to Follow-up|0|||
16963618|NCT01229735|38106334|FG001|Overall Study|Lost to Follow-up|2|||
16963619|NCT01229735|38106333|FG000|Overall Study|Withdrawal by Subject|18|||
16963620|NCT01229735|38106334|FG001|Overall Study|Withdrawal by Subject|17|||
16963621|NCT01229735|38106333|FG000|Overall Study|Other Reason|13|||
16963622|NCT01229735|38106334|FG001|Overall Study|Other Reason|10|||
16963623|NCT01229735|38106333|FG000|Overall Study|SAE, non-fatal|0|||
16963624|NCT01229735|38106334|FG001|Overall Study|SAE, non-fatal|4|||
16963625|NCT01229735|38106333|FG000|Overall Study|AE, non-serious non-fatal|13|||
16963626|NCT01229735|38106334|FG001|Overall Study|AE, non-serious non-fatal|17|||
16963627|NCT01229735|38106333|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16963628|NCT01229735|38106334|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16963629|NCT00974974|38106353|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
16963630|NCT00974974|38106354|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
16963631|NCT00974974|38106353|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
16963632|NCT00974974|38106354|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
16963633|NCT00974974|38106353|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
16963634|NCT00974974|38106354|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
16963635|NCT00974974|38106353|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
16963636|NCT00974974|38106354|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
16963637|NCT00974974|38106353|FG000|IR CD-LD Dose Adjustment|Various|0|||
16963638|NCT00974974|38106354|FG001|IR CD-LD Dose Adjustment|Various|9|||
16963639|NCT00974974|38106353|FG000|IPX066 Dose Conversion|Adverse Event|23|||
16963640|NCT00974974|38106354|FG001|IPX066 Dose Conversion|Adverse Event|0|||
16963641|NCT00974974|38106353|FG000|IPX066 Dose Conversion|Death|2|||
16963642|NCT00974974|38106354|FG001|IPX066 Dose Conversion|Death|0|||
16963643|NCT00974974|38106353|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
16963644|NCT00974974|38106354|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
16963645|NCT00974974|38106353|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
16963646|NCT00974974|38106354|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
16963647|NCT00974974|38106353|FG000|IPX066 Dose Conversion|Various|3|||
16963648|NCT00974974|38106354|FG001|IPX066 Dose Conversion|Various|0|||
16963649|NCT00974974|38106353|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
16963650|NCT00974974|38106354|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
16963651|NCT00974974|38106353|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
16963652|NCT00974974|38106354|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
16963653|NCT00974974|38106353|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
16963654|NCT00974974|38106354|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
16963655|NCT00974974|38106353|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
16963656|NCT00974974|38106354|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
16963657|NCT00974974|38106353|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
16963658|NCT00974974|38106354|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
16963659|NCT00974974|38106353|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
16963660|NCT00974974|38106354|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
16963661|NCT00974974|38106353|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
16963662|NCT00974974|38106354|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
16963663|NCT00974974|38106353|FG000|Maintenance - Double Blind Treatment|Various|4|||
16963664|NCT00974974|38106354|FG001|Maintenance - Double Blind Treatment|Various|0|||
16963665|NCT00992992|38106360|FG000|Overall Study|Lost to Follow-up|3|||
16963666|NCT00992992|38106360|FG000|Overall Study|Death|16|||
16963667|NCT00992992|38106360|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
16963668|NCT00992992|38106360|FG000|Overall Study|Sponsor Closed the Study|4|||
16963669|NCT00992836|38106364|FG000|Overall Study|Lost to Follow-up|1|||
16963670|NCT00992836|38106364|FG000|Overall Study|Withdrawal by Subject|2|||
16963671|NCT00992836|38106364|FG000|Overall Study|Protocol Violation|2|||
16963672|NCT00992446|38106374|FG000|Overall Study|Disease Progression|1|||
16963673|NCT00992446|38106374|FG000|Overall Study|Withdrawal by Subject|2|||
16963674|NCT00992446|38106374|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
16963675|NCT00970294|38106378|FG000|Overall Study|Physician Decision|4|||
16963676|NCT00970294|38106378|FG000|Overall Study|Withdrawal by Subject|1|||
16963677|NCT00969436|38106385|FG000|Overall Study|Protocol Violation|1|||
16963678|NCT00969436|38106386|FG001|Overall Study|Protocol Violation|3|||
16963679|NCT00969436|38106387|FG002|Overall Study|Protocol Violation|0|||
16963680|NCT00969436|38106385|FG000|Overall Study|Migrated/moved from study area|12|||
16963681|NCT00969436|38106386|FG001|Overall Study|Migrated/moved from study area|10|||
16963682|NCT00969436|38106387|FG002|Overall Study|Migrated/moved from study area|2|||
16779225|NCT00701363|37718448|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
16779226|NCT00701363|37718449|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
16779227|NCT00701363|37718450|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
16779228|NCT00701363|37718451|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
16779229|NCT01670877|37718475|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16779230|NCT01670877|37718476|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
16779231|NCT01670877|37718477|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16779232|NCT01670877|37718478|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16779233|NCT01670877|37718479|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16779234|NCT01670877|37718480|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16779235|NCT01670877|37718475|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16779236|NCT01670877|37718476|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16779237|NCT01670877|37718477|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
16779238|NCT01670877|37718478|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16779239|NCT01670877|37718479|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16779240|NCT01670877|37718480|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16779241|NCT01670877|37718475|FG000|Part I and Part 2|Grade 2 vomiting|0|||
16779242|NCT01670877|37718476|FG001|Part I and Part 2|Grade 2 vomiting|0|||
16779243|NCT01670877|37718477|FG002|Part I and Part 2|Grade 2 vomiting|0|||
16779244|NCT01670877|37718478|FG003|Part I and Part 2|Grade 2 vomiting|1|||
16779245|NCT01670877|37718479|FG004|Part I and Part 2|Grade 2 vomiting|0|||
16779246|NCT01670877|37718480|FG005|Part I and Part 2|Grade 2 vomiting|0|||
16779247|NCT01670877|37718475|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16779248|NCT01670877|37718476|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16779249|NCT01670877|37718477|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16963683|NCT00969436|38106385|FG000|Overall Study|Father - serious health problem|0|||
16779250|NCT01670877|37718478|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
16779251|NCT01670877|37718479|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16779252|NCT01670877|37718480|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16779253|NCT01670877|37718475|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16779254|NCT01670877|37718476|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16779255|NCT01670877|37718477|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16779256|NCT01670877|37718478|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
16779257|NCT01670877|37718479|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16779258|NCT01670877|37718480|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16779259|NCT00701129|37718494|FG000|Overall Study|Death|2|||
16779260|NCT01670721|37718498|FG000|Overall Study|Participant's decision|15|||
16779261|NCT01670721|37718498|FG000|Overall Study|Other than specified above|38|||
16779262|NCT02711137|37718517|FG000|Overall Study|Death|1|||
16779263|NCT02711137|37718518|FG001|Overall Study|Death|4|||
16779264|NCT02711137|37718519|FG002|Overall Study|Death|5|||
16779265|NCT02711137|37718520|FG003|Overall Study|Death|5|||
16963684|NCT00969436|38106386|FG001|Overall Study|Father - serious health problem|0|||
16963685|NCT00969436|38106387|FG002|Overall Study|Father - serious health problem|1|||
16963686|NCT00969436|38106385|FG000|Overall Study|Parents personal problem|0|||
16963687|NCT00969436|38106386|FG001|Overall Study|Parents personal problem|0|||
16963688|NCT00969436|38106387|FG002|Overall Study|Parents personal problem|1|||
16963689|NCT00969436|38106385|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
16963690|NCT00969436|38106386|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
16963691|NCT00969436|38106387|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
16963692|NCT00969436|38106385|FG000|Overall Study|Withdrawal by Subject|3|||
16963693|NCT00969436|38106386|FG001|Overall Study|Withdrawal by Subject|0|||
16963694|NCT00969436|38106387|FG002|Overall Study|Withdrawal by Subject|2|||
16963695|NCT00969436|38106385|FG000|Overall Study|Lost to Follow-up|8|||
16963696|NCT00969436|38106386|FG001|Overall Study|Lost to Follow-up|8|||
16963697|NCT00969436|38106387|FG002|Overall Study|Lost to Follow-up|5|||
16963698|NCT00900757|38106395|FG000|Overall Study|screen failure|19|||
16963699|NCT00969280|38106401|FG000|Overall Study|Protocol Violation|2|||
16963700|NCT00969280|38106402|FG001|Overall Study|Protocol Violation|1|||
16963701|NCT00969280|38106401|FG000|Overall Study|Withdrawal by Subject|0|||
16963702|NCT00969280|38106402|FG001|Overall Study|Withdrawal by Subject|1|||
16963703|NCT00969280|38106401|FG000|Overall Study|infection of influenza A(H1N1)|0|||
16963704|NCT00969280|38106402|FG001|Overall Study|infection of influenza A(H1N1)|1|||
16963705|NCT00969124|38106408|FG000|Overall Study|Protocol Violation|2|||
16963706|NCT00969124|38106408|FG000|Overall Study|Inadequate bowel preparation|15|||
16963707|NCT00969124|38106408|FG000|Overall Study|Inability to reach cecum|9|||
16963708|NCT00969124|38106408|FG000|Overall Study|Previously unrecognized disease|3|||
16963709|NCT00969124|38106408|FG000|Overall Study|Technical error|1|||
16963710|NCT00900601|38106413|FG000|Overall Study|Physician Decision|1|||
16963711|NCT00901927|38106440|FG000|Overall Study|Lack of Efficacy|1|||
16963712|NCT00901927|38106440|FG000|Overall Study|Protocol Violation|3|||
16963713|NCT00901927|38106440|FG000|Overall Study|Withdrawal by Subject|2|||
16963714|NCT00968968|38106446|FG000|Overall Study|Study closed/terminated|10|||
16963715|NCT00968968|38106447|FG001|Overall Study|Study closed/terminated|10|||
16963716|NCT00968968|38106446|FG000|Overall Study|Protocol defined stopping criteria|3|||
16963717|NCT00968968|38106447|FG001|Overall Study|Protocol defined stopping criteria|1|||
16963718|NCT00968968|38106446|FG000|Overall Study|Withdrawal by Subject|2|||
16779266|NCT02711137|37718521|FG004|Overall Study|Death|3|||
16779267|NCT02711137|37718522|FG005|Overall Study|Death|1|||
16779268|NCT02711137|37718523|FG006|Overall Study|Death|61|||
16779269|NCT02711137|37718524|FG007|Overall Study|Death|3|||
16779270|NCT02711137|37718525|FG008|Overall Study|Death|0|||
16963719|NCT00968968|38106447|FG001|Overall Study|Withdrawal by Subject|0|||
16963720|NCT00968968|38106446|FG000|Overall Study|Physician Decision|1|||
16963721|NCT00968968|38106447|FG001|Overall Study|Physician Decision|2|||
16963722|NCT00968968|38106446|FG000|Overall Study|Lost to Follow-up|0|||
16963723|NCT00968968|38106447|FG001|Overall Study|Lost to Follow-up|1|||
16779271|NCT02711137|37718526|FG009|Overall Study|Death|1|||
16779272|NCT02711137|37718527|FG010|Overall Study|Death|1|||
16779273|NCT02711137|37718528|FG011|Overall Study|Death|1|||
16779274|NCT02711137|37718529|FG012|Overall Study|Death|0|||
16779275|NCT02711137|37718530|FG013|Overall Study|Death|0|||
16779276|NCT02711137|37718531|FG014|Overall Study|Death|0|||
16779277|NCT02711137|37718517|FG000|Overall Study|Study Terminated by Sponsor|0|||
16779278|NCT02711137|37718518|FG001|Overall Study|Study Terminated by Sponsor|0|||
16963724|NCT00973102|38106456|FG000|Overall Study|Protocol Violation|1|||
16963725|NCT00973102|38106457|FG001|Overall Study|Protocol Violation|0|||
16963726|NCT00973102|38106456|FG000|Overall Study|Prisoner|0|||
16963727|NCT00973102|38106457|FG001|Overall Study|Prisoner|1|||
16963728|NCT00901459|38106463|FG000|Overall Study|Withdrawal by Subject|6|||
16963729|NCT00896233|38106474|FG000|Overall Study|Claustrophobia during MRI|1|||
16963730|NCT00899431|38106499|FG000|Overall Study|Physician Decision|1|||
16963731|NCT00899431|38106500|FG001|Overall Study|Physician Decision|0|||
16963732|NCT00899431|38106501|FG002|Overall Study|Physician Decision|0|||
16963733|NCT00899353|38106512|FG000|Overall Study|Adverse Event|2|||
16963734|NCT00899353|38106512|FG000|Overall Study|Lost to Follow-up|1|||
16963735|NCT00899353|38106512|FG000|Overall Study|Withdrawal by Subject|2|||
16963736|NCT00898807|38106535|FG000|Overall Study|Withdrawal by Subject|5|||
16963737|NCT00898807|38106536|FG001|Overall Study|Withdrawal by Subject|3|||
16963738|NCT00898807|38106535|FG000|Overall Study|Family pressure to discontinue|2|||
16963739|NCT00898807|38106536|FG001|Overall Study|Family pressure to discontinue|2|||
16963740|NCT00898807|38106535|FG000|Overall Study|Lost to Follow-up|1|||
16963741|NCT00898807|38106536|FG001|Overall Study|Lost to Follow-up|3|||
16963742|NCT00898807|38106535|FG000|Overall Study|Death|0|||
16963743|NCT00898807|38106536|FG001|Overall Study|Death|1|||
16963744|NCT01229267|38106547|FG000|Overall Study|Adverse Event|4|||
16963745|NCT01229267|38106548|FG001|Overall Study|Adverse Event|6|||
16963746|NCT01229267|38106549|FG002|Overall Study|Adverse Event|3|||
16963747|NCT01229267|38106550|FG003|Overall Study|Adverse Event|2|||
16963748|NCT01229267|38106551|FG004|Overall Study|Adverse Event|10|||
16963749|NCT01229267|38106547|FG000|Overall Study|Death|40|||
16963750|NCT01229267|38106548|FG001|Overall Study|Death|37|||
16963751|NCT01229267|38106549|FG002|Overall Study|Death|35|||
16963752|NCT01229267|38106550|FG003|Overall Study|Death|13|||
16963753|NCT01229267|38106551|FG004|Overall Study|Death|103|||
16963754|NCT01229267|38106547|FG000|Overall Study|Withdrawal by Subject|23|||
16963755|NCT01229267|38106548|FG001|Overall Study|Withdrawal by Subject|22|||
16963756|NCT01229267|38106549|FG002|Overall Study|Withdrawal by Subject|32|||
16963757|NCT01229267|38106550|FG003|Overall Study|Withdrawal by Subject|14|||
16963758|NCT01229267|38106551|FG004|Overall Study|Withdrawal by Subject|59|||
16963759|NCT01229267|38106547|FG000|Overall Study|Protocol Violation|0|||
16963760|NCT01229267|38106548|FG001|Overall Study|Protocol Violation|1|||
16963761|NCT01229267|38106549|FG002|Overall Study|Protocol Violation|0|||
16963762|NCT01229267|38106550|FG003|Overall Study|Protocol Violation|0|||
16963763|NCT01229267|38106551|FG004|Overall Study|Protocol Violation|0|||
16963764|NCT01229267|38106547|FG000|Overall Study|Progressive disease|0|||
16963765|NCT01229267|38106548|FG001|Overall Study|Progressive disease|0|||
16963766|NCT01229267|38106549|FG002|Overall Study|Progressive disease|0|||
16963767|NCT01229267|38106550|FG003|Overall Study|Progressive disease|0|||
16963768|NCT01229267|38106551|FG004|Overall Study|Progressive disease|1|||
16963769|NCT01229267|38106547|FG000|Overall Study|Physician Decision|8|||
16963770|NCT01229267|38106548|FG001|Overall Study|Physician Decision|11|||
16963771|NCT01229267|38106549|FG002|Overall Study|Physician Decision|8|||
16963772|NCT01229267|38106550|FG003|Overall Study|Physician Decision|3|||
16963773|NCT01229267|38106551|FG004|Overall Study|Physician Decision|25|||
16963774|NCT01229267|38106547|FG000|Overall Study|Lost to Follow-up|6|||
16963775|NCT01229267|38106548|FG001|Overall Study|Lost to Follow-up|5|||
16963776|NCT01229267|38106549|FG002|Overall Study|Lost to Follow-up|8|||
16963777|NCT01229267|38106550|FG003|Overall Study|Lost to Follow-up|3|||
16963778|NCT01229267|38106551|FG004|Overall Study|Lost to Follow-up|22|||
16963779|NCT00897715|38106560|FG000|Overall Study|Lost to Follow-up|0|||
16963780|NCT00897715|38106561|FG001|Overall Study|Lost to Follow-up|1|||
16963781|NCT00897715|38106560|FG000|Overall Study|Physician Decision|1|||
16963782|NCT00897715|38106561|FG001|Overall Study|Physician Decision|0|||
16963783|NCT00897715|38106560|FG000|Overall Study|increased risk of infection|1|||
16963784|NCT00897715|38106561|FG001|Overall Study|increased risk of infection|0|||
16963785|NCT01229111|38106567|FG000|Overall Study|Death|1|||
16963786|NCT00894361|38106573|FG000|Overall Study|deaths and less than 2 years followup|24|||
16963787|NCT00894361|38106574|FG001|Overall Study|deaths and less than 2 years followup|64|||
16963788|NCT01228175|38106584|FG000|Overall Study|Lost to Follow-up|64|||
16779279|NCT02711137|37718519|FG002|Overall Study|Study Terminated by Sponsor|1|||
16779280|NCT02711137|37718520|FG003|Overall Study|Study Terminated by Sponsor|0|||
16779281|NCT02711137|37718521|FG004|Overall Study|Study Terminated by Sponsor|0|||
16963789|NCT01228175|38106585|FG001|Overall Study|Lost to Follow-up|50|||
16963790|NCT01228175|38106584|FG000|Overall Study|Withdrawal by Subject|1|||
16963791|NCT01228175|38106585|FG001|Overall Study|Withdrawal by Subject|2|||
16963792|NCT01228175|38106584|FG000|Overall Study|Physician Decision|1|||
16963793|NCT01228175|38106585|FG001|Overall Study|Physician Decision|1|||
16963794|NCT01228019|38106591|FG000|Overall Study|Dose Violation|70|||
16779282|NCT02711137|37718522|FG005|Overall Study|Study Terminated by Sponsor|0|||
16779283|NCT02711137|37718523|FG006|Overall Study|Study Terminated by Sponsor|1|||
16779284|NCT02711137|37718524|FG007|Overall Study|Study Terminated by Sponsor|0|||
16779285|NCT02711137|37718525|FG008|Overall Study|Study Terminated by Sponsor|0|||
16963795|NCT01228019|38106591|FG000|Overall Study|Duplicate enrollment|1|||
16963796|NCT01228019|38106591|FG000|Overall Study|Missing pre-treatment data|72|||
16963797|NCT01228019|38106591|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
16963798|NCT01228019|38106591|FG000|Overall Study|Violation of Entry Criterion|9|||
16963799|NCT02987959|38106595|FG000|Overall Study|Grantor stopped supply of drugs|6|||
16963800|NCT01227707|38106599|FG000|Overall Study|Adverse Event|10|||
16963801|NCT01227707|38106599|FG000|Overall Study|Progression of disease|3|||
16963802|NCT01227707|38106599|FG000|Overall Study|Withdrawal by Subject|1|||
16963803|NCT01227707|38106599|FG000|Overall Study|Patient non-compliance|3|||
16963804|NCT01227707|38106599|FG000|Overall Study|Medical decision|6|||
16963805|NCT01227707|38106599|FG000|Overall Study|Death|1|||
16963806|NCT00895843|38106605|FG000|Overall Study|Protocol Violation|12|||
16963807|NCT00895843|38106606|FG001|Overall Study|Protocol Violation|12|||
16963808|NCT00895453|38106615|FG000|Overall Study|Lost to Follow-up|25|||
16963809|NCT00895453|38106616|FG001|Overall Study|Lost to Follow-up|25|||
16963810|NCT00895453|38106617|FG002|Overall Study|Lost to Follow-up|23|||
16963811|NCT00893971|38106625|FG000|Overall Study|Physician Decision|3|||
16963812|NCT00893737|38106638|FG000|Overall Study|Adverse Event|4|||
16963813|NCT00893737|38106638|FG000|Overall Study|Withdrawal by Subject|2|||
16963814|NCT00893737|38106638|FG000|Overall Study|Lost to Follow-up|6|||
16963815|NCT00893113|38106644|FG000|Overall Study|Lost to Follow-up|4|||
16963816|NCT00893113|38106645|FG001|Overall Study|Lost to Follow-up|8|||
16963817|NCT00893113|38106644|FG000|Overall Study|Early Termination|1|||
16963818|NCT00893113|38106645|FG001|Overall Study|Early Termination|1|||
16963819|NCT00893113|38106644|FG000|Overall Study|Withdrew Consent|8|||
16963820|NCT00893113|38106645|FG001|Overall Study|Withdrew Consent|7|||
16963821|NCT00892957|38106653|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
16963822|NCT00892957|38106654|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
16963823|NCT00892957|38106653|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
16963824|NCT00892957|38106654|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
16963825|NCT00968812|38106677|FG000|Overall Study|Adverse Event|30|||
16963826|NCT00968812|38106678|FG001|Overall Study|Adverse Event|46|||
16963827|NCT00968812|38106679|FG002|Overall Study|Adverse Event|33|||
16963828|NCT00968812|38106677|FG000|Overall Study|Death|2|||
16963829|NCT00968812|38106678|FG001|Overall Study|Death|2|||
16963830|NCT00968812|38106679|FG002|Overall Study|Death|1|||
16963831|NCT00968812|38106677|FG000|Overall Study|Lack of Efficacy|9|||
16963832|NCT00968812|38106678|FG001|Overall Study|Lack of Efficacy|7|||
16963833|NCT00968812|38106679|FG002|Overall Study|Lack of Efficacy|16|||
16963834|NCT00968812|38106677|FG000|Overall Study|Lost to Follow-up|17|||
16963835|NCT00968812|38106678|FG001|Overall Study|Lost to Follow-up|12|||
16963836|NCT00968812|38106679|FG002|Overall Study|Lost to Follow-up|11|||
16963837|NCT00968812|38106677|FG000|Overall Study|Physician Decision|8|||
16963838|NCT00968812|38106678|FG001|Overall Study|Physician Decision|5|||
16963839|NCT00968812|38106679|FG002|Overall Study|Physician Decision|9|||
17028463|NCT00783224|38172828|FG000|Overall Study|Inappropriate as a study subject|0|||
16963840|NCT00968812|38106677|FG000|Overall Study|Protocol Violation|7|||
16963841|NCT00968812|38106678|FG001|Overall Study|Protocol Violation|4|||
16963842|NCT00968812|38106679|FG002|Overall Study|Protocol Violation|3|||
17028464|NCT00783224|38172829|FG001|Overall Study|Inappropriate as a study subject|0|||
16963843|NCT00968812|38106677|FG000|Overall Study|Withdrawal by Subject|17|||
16963844|NCT00968812|38106678|FG001|Overall Study|Withdrawal by Subject|23|||
16963845|NCT00968812|38106679|FG002|Overall Study|Withdrawal by Subject|25|||
16963846|NCT00968812|38106677|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
16963847|NCT00968812|38106678|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
16963848|NCT00968812|38106679|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
16963849|NCT00968812|38106677|FG000|Overall Study|Noncompliance with study drug|4|||
16963850|NCT00968812|38106678|FG001|Overall Study|Noncompliance with study drug|1|||
16963851|NCT00968812|38106679|FG002|Overall Study|Noncompliance with study drug|6|||
16963852|NCT00968812|38106677|FG000|Overall Study|Unable to take rescue therapy|12|||
16963853|NCT00968812|38106678|FG001|Overall Study|Unable to take rescue therapy|12|||
16963854|NCT00968812|38106679|FG002|Overall Study|Unable to take rescue therapy|17|||
16963855|NCT00968812|38106677|FG000|Overall Study|Other|25|||
16963856|NCT00968812|38106678|FG001|Overall Study|Other|37|||
16963857|NCT00968812|38106679|FG002|Overall Study|Other|40|||
16963858|NCT00992056|38106692|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
16963859|NCT00992056|38106693|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
16963860|NCT00992056|38106692|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
16963861|NCT00992056|38106693|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
16963862|NCT00972322|38106701|FG000|Overall Study|Adverse Event|2|||
16963863|NCT00972322|38106702|FG001|Overall Study|Adverse Event|1|||
16963864|NCT00972322|38106701|FG000|Overall Study|Positive drug screen|0|||
16963865|NCT00972322|38106702|FG001|Overall Study|Positive drug screen|1|||
16963866|NCT00972322|38106701|FG000|Overall Study|Lost to Follow-up|0|||
16963867|NCT00972322|38106702|FG001|Overall Study|Lost to Follow-up|1|||
16963868|NCT00972322|38106701|FG000|Overall Study|Consistently high glucose values|1|||
16963869|NCT00972322|38106702|FG001|Overall Study|Consistently high glucose values|0|||
16963870|NCT00967798|38106710|FG000|Overall Study|Withdrawal by Subject|5|||
16963871|NCT00967798|38106711|FG001|Overall Study|Withdrawal by Subject|2|||
16963872|NCT00967798|38106710|FG000|Overall Study|Lost to Follow-up|4|||
16963873|NCT00967798|38106711|FG001|Overall Study|Lost to Follow-up|1|||
16963874|NCT00965458|38106719|FG000|Overall Study|Adverse Event|1|||
16963875|NCT00965458|38106720|FG001|Overall Study|Adverse Event|0|||
16963876|NCT00965458|38106719|FG000|Overall Study|Lost to Follow-up|1|||
16963877|NCT00965458|38106720|FG001|Overall Study|Lost to Follow-up|3|||
16963878|NCT00965458|38106719|FG000|Overall Study|Withdrawal by Subject|0|||
16963879|NCT00965458|38106720|FG001|Overall Study|Withdrawal by Subject|1|||
16963880|NCT00972244|38106733|FG000|Overall Study|Incorrect Enrolment|1|||
16963881|NCT00972244|38106734|FG001|Overall Study|Incorrect Enrolment|0|||
16963882|NCT00972244|38106735|FG002|Overall Study|Incorrect Enrolment|0|||
16963883|NCT00972244|38106736|FG003|Overall Study|Incorrect Enrolment|0|||
16963884|NCT00972244|38106737|FG004|Overall Study|Incorrect Enrolment|0|||
16963885|NCT00972244|38106733|FG000|Overall Study|Adverse Event|0|||
16963886|NCT00972244|38106734|FG001|Overall Study|Adverse Event|1|||
16963887|NCT00972244|38106735|FG002|Overall Study|Adverse Event|1|||
16963888|NCT00972244|38106736|FG003|Overall Study|Adverse Event|0|||
16963889|NCT00972244|38106737|FG004|Overall Study|Adverse Event|0|||
16963890|NCT00972244|38106733|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
16963891|NCT00972244|38106734|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
16963892|NCT00972244|38106735|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
16963893|NCT00972244|38106736|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
16963894|NCT00972244|38106737|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
16963895|NCT00972244|38106733|FG000|Overall Study|Withdrawal by Subject|1|||
16963896|NCT00972244|38106734|FG001|Overall Study|Withdrawal by Subject|2|||
16963897|NCT00972244|38106735|FG002|Overall Study|Withdrawal by Subject|1|||
16963898|NCT00972244|38106736|FG003|Overall Study|Withdrawal by Subject|0|||
16779286|NCT02711137|37718526|FG009|Overall Study|Study Terminated by Sponsor|0|||
16779287|NCT02711137|37718527|FG010|Overall Study|Study Terminated by Sponsor|0|||
16779288|NCT02711137|37718528|FG011|Overall Study|Study Terminated by Sponsor|0|||
16779289|NCT02711137|37718529|FG012|Overall Study|Study Terminated by Sponsor|0|||
16779290|NCT02711137|37718530|FG013|Overall Study|Study Terminated by Sponsor|0|||
16779291|NCT02711137|37718531|FG014|Overall Study|Study Terminated by Sponsor|0|||
16963899|NCT00972244|38106737|FG004|Overall Study|Withdrawal by Subject|1|||
16963900|NCT00972244|38106733|FG000|Overall Study|Safety|0|||
16963901|NCT00972244|38106734|FG001|Overall Study|Safety|0|||
16963902|NCT00972244|38106735|FG002|Overall Study|Safety|0|||
16963903|NCT00972244|38106736|FG003|Overall Study|Safety|0|||
16963904|NCT00972244|38106737|FG004|Overall Study|Safety|1|||
16963905|NCT00972244|38106733|FG000|Overall Study|Death|1|||
16963906|NCT00972244|38106734|FG001|Overall Study|Death|0|||
16963907|NCT00972244|38106735|FG002|Overall Study|Death|0|||
16963908|NCT00972244|38106736|FG003|Overall Study|Death|0|||
16963909|NCT00972244|38106737|FG004|Overall Study|Death|0|||
16963910|NCT00972244|38106733|FG000|Overall Study|Various|0|||
16963911|NCT00972244|38106734|FG001|Overall Study|Various|0|||
16963912|NCT00972244|38106735|FG002|Overall Study|Various|0|||
16963913|NCT00972244|38106736|FG003|Overall Study|Various|0|||
16963914|NCT00972244|38106737|FG004|Overall Study|Various|2|||
16963915|NCT00892723|38106752|FG000|Overall Study|Lost to Follow-up|1|||
16963916|NCT00892723|38106753|FG001|Overall Study|Lost to Follow-up|3|||
16963917|NCT00892723|38106754|FG002|Overall Study|Lost to Follow-up|1|||
16779292|NCT02711137|37718517|FG000|Overall Study|Physician Decision|1|||
16779293|NCT02711137|37718518|FG001|Overall Study|Physician Decision|0|||
16779294|NCT02711137|37718519|FG002|Overall Study|Physician Decision|2|||
16779295|NCT02711137|37718520|FG003|Overall Study|Physician Decision|1|||
16779296|NCT02711137|37718521|FG004|Overall Study|Physician Decision|1|||
16779297|NCT02711137|37718522|FG005|Overall Study|Physician Decision|0|||
16779298|NCT02711137|37718523|FG006|Overall Study|Physician Decision|12|||
16779299|NCT02711137|37718524|FG007|Overall Study|Physician Decision|2|||
16779300|NCT02711137|37718525|FG008|Overall Study|Physician Decision|1|||
16779301|NCT02711137|37718526|FG009|Overall Study|Physician Decision|1|||
16779302|NCT02711137|37718527|FG010|Overall Study|Physician Decision|3|||
16779303|NCT02711137|37718528|FG011|Overall Study|Physician Decision|2|||
16779304|NCT02711137|37718529|FG012|Overall Study|Physician Decision|1|||
16779305|NCT02711137|37718530|FG013|Overall Study|Physician Decision|1|||
16779306|NCT02711137|37718531|FG014|Overall Study|Physician Decision|2|||
16779307|NCT02711137|37718517|FG000|Overall Study|Other|0|||
16779308|NCT02711137|37718518|FG001|Overall Study|Other|1|||
16779309|NCT02711137|37718519|FG002|Overall Study|Other|0|||
16779310|NCT02711137|37718520|FG003|Overall Study|Other|0|||
16779311|NCT02711137|37718521|FG004|Overall Study|Other|0|||
16779312|NCT02711137|37718522|FG005|Overall Study|Other|0|||
16779313|NCT02711137|37718523|FG006|Overall Study|Other|3|||
16779314|NCT02711137|37718524|FG007|Overall Study|Other|0|||
16779315|NCT02711137|37718525|FG008|Overall Study|Other|0|||
16779316|NCT02711137|37718526|FG009|Overall Study|Other|0|||
16779317|NCT02711137|37718527|FG010|Overall Study|Other|0|||
16963918|NCT00892723|38106752|FG000|Overall Study|Withdrawal by Subject|1|||
16963919|NCT00892723|38106753|FG001|Overall Study|Withdrawal by Subject|1|||
16963920|NCT00892723|38106754|FG002|Overall Study|Withdrawal by Subject|1|||
16963921|NCT03811912|38106797|FG000|Overall Study|Withdrew Consent|4|||
16963922|NCT03811912|38106798|FG001|Overall Study|Withdrew Consent|2|||
16963923|NCT00971932|38106804|FG000|Overall Study|Withdrawal by Subject|1|||
16963924|NCT00971932|38106804|FG000|Overall Study|Investigator's decision|2|||
16963925|NCT00971932|38106804|FG000|Overall Study|Ongoing|4|||
16779318|NCT02711137|37718528|FG011|Overall Study|Other|0|||
16779319|NCT02711137|37718529|FG012|Overall Study|Other|0|||
16779320|NCT02711137|37718530|FG013|Overall Study|Other|0|||
16779321|NCT02711137|37718531|FG014|Overall Study|Other|1|||
16779322|NCT02711137|37718517|FG000|Overall Study|Withdrawal by Subject|1|||
16779323|NCT02711137|37718518|FG001|Overall Study|Withdrawal by Subject|0|||
16779324|NCT02711137|37718519|FG002|Overall Study|Withdrawal by Subject|0|||
16779325|NCT02711137|37718520|FG003|Overall Study|Withdrawal by Subject|1|||
16779326|NCT02711137|37718521|FG004|Overall Study|Withdrawal by Subject|1|||
16779327|NCT02711137|37718522|FG005|Overall Study|Withdrawal by Subject|0|||
16779328|NCT02711137|37718523|FG006|Overall Study|Withdrawal by Subject|7|||
16779329|NCT02711137|37718524|FG007|Overall Study|Withdrawal by Subject|0|||
16779330|NCT02711137|37718525|FG008|Overall Study|Withdrawal by Subject|0|||
16779331|NCT02711137|37718526|FG009|Overall Study|Withdrawal by Subject|0|||
16779332|NCT02711137|37718527|FG010|Overall Study|Withdrawal by Subject|0|||
16779333|NCT02711137|37718528|FG011|Overall Study|Withdrawal by Subject|0|||
16779334|NCT02711137|37718529|FG012|Overall Study|Withdrawal by Subject|0|||
16779335|NCT02711137|37718530|FG013|Overall Study|Withdrawal by Subject|1|||
16779336|NCT02711137|37718531|FG014|Overall Study|Withdrawal by Subject|0|||
16779337|NCT02711137|37718517|FG000|Overall Study|Lost to Follow-up|1|||
16779338|NCT02711137|37718518|FG001|Overall Study|Lost to Follow-up|0|||
16779339|NCT02711137|37718519|FG002|Overall Study|Lost to Follow-up|0|||
16779340|NCT02711137|37718520|FG003|Overall Study|Lost to Follow-up|0|||
16779341|NCT02711137|37718521|FG004|Overall Study|Lost to Follow-up|0|||
16779342|NCT02711137|37718522|FG005|Overall Study|Lost to Follow-up|0|||
16779343|NCT02711137|37718523|FG006|Overall Study|Lost to Follow-up|2|||
16779344|NCT02711137|37718524|FG007|Overall Study|Lost to Follow-up|0|||
16779345|NCT02711137|37718525|FG008|Overall Study|Lost to Follow-up|0|||
16779346|NCT02711137|37718526|FG009|Overall Study|Lost to Follow-up|0|||
16779347|NCT02711137|37718527|FG010|Overall Study|Lost to Follow-up|0|||
16779348|NCT02711137|37718528|FG011|Overall Study|Lost to Follow-up|0|||
16779349|NCT02711137|37718529|FG012|Overall Study|Lost to Follow-up|0|||
16779350|NCT02711137|37718530|FG013|Overall Study|Lost to Follow-up|0|||
16779351|NCT02711137|37718531|FG014|Overall Study|Lost to Follow-up|0|||
16963926|NCT00970684|38106808|FG000|Overall Study|Lack of Efficacy|5|||
16779352|NCT02151981|37718570|FG000|Overall Study|Death|184|||
16779353|NCT02151981|37718571|FG001|Overall Study|Death|88|||
16779354|NCT02151981|37718570|FG000|Overall Study|Lost to Follow-up|7|||
16779355|NCT02151981|37718571|FG001|Overall Study|Lost to Follow-up|1|||
16779356|NCT02151981|37718570|FG000|Overall Study|Withdrawal by Subject|27|||
16779357|NCT02151981|37718571|FG001|Overall Study|Withdrawal by Subject|21|||
16779358|NCT02151981|37718570|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
16779359|NCT02151981|37718571|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
16779360|NCT02151981|37718570|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16963927|NCT00970684|38106808|FG000|Overall Study|Adverse Event|4|||
16963928|NCT00970684|38106808|FG000|Overall Study|Withdrawal by Subject|1|||
16963929|NCT00967330|38106814|FG000|Overall Study|Protocol Violation|3|||
16963930|NCT00967330|38106815|FG001|Overall Study|Protocol Violation|4|||
16963931|NCT00967330|38106814|FG000|Overall Study|Regular|10|||
16963932|NCT00967330|38106815|FG001|Overall Study|Regular|3|||
16963933|NCT00967330|38106814|FG000|Overall Study|Withdrawal by Subject|6|||
16963934|NCT00967330|38106815|FG001|Overall Study|Withdrawal by Subject|0|||
16963935|NCT00967330|38106814|FG000|Overall Study|Lost to Follow-up|1|||
16963936|NCT00967330|38106815|FG001|Overall Study|Lost to Follow-up|1|||
16963937|NCT00967330|38106814|FG000|Overall Study|Death|102|||
16963938|NCT00967330|38106815|FG001|Overall Study|Death|51|||
16963939|NCT00967330|38106814|FG000|Overall Study|Severe protocol deviation|0|||
16963940|NCT00967330|38106815|FG001|Overall Study|Severe protocol deviation|1|||
16963941|NCT00967018|38106821|FG000|Overall Study|Adverse Event|2|||
16963942|NCT00967018|38106821|FG000|Overall Study|Physician Decision|7|||
16963943|NCT00967018|38106821|FG000|Overall Study|Lost to Follow-up|2|||
16963944|NCT00967018|38106821|FG000|Overall Study|Withdrawal by Subject|1|||
16963945|NCT00967018|38106821|FG000|Overall Study|Miscellaneous Reasons|9|||
16963946|NCT00965146|38106825|FG000|Overall Study|Death|7|||
16963947|NCT00965146|38106825|FG000|Overall Study|Lost to Follow-up|22|||
16963948|NCT00965146|38106825|FG000|Overall Study|Withdrawal by Subject|17|||
16963949|NCT00965146|38106825|FG000|Overall Study|Unable to return|1|||
16963950|NCT00965146|38106825|FG000|Overall Study|Unwilling to return|11|||
16963951|NCT00965146|38106825|FG000|Overall Study|Intercurrent illness|1|||
16963952|NCT00965146|38106825|FG000|Overall Study|Revision / Removal of Study Implant|6|||
16963953|NCT00965146|38106825|FG000|Overall Study|Overall Study Termination|145|||
17028465|NCT00783224|38172830|FG002|Overall Study|Inappropriate as a study subject|0|||
17028466|NCT00783224|38172831|FG003|Overall Study|Inappropriate as a study subject|1|||
16963954|NCT00966940|38106831|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
16963955|NCT00966940|38106832|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
16963956|NCT00966940|38106831|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
16963957|NCT00966940|38106832|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
16963958|NCT00965848|38106838|FG000|Overall Study|Protocol Violation|3|||
16963959|NCT00965848|38106839|FG001|Overall Study|Protocol Violation|0|||
16963960|NCT00965848|38106840|FG002|Overall Study|Protocol Violation|1|||
16963961|NCT00965848|38106838|FG000|Overall Study|Death|11|||
16963962|NCT00965848|38106839|FG001|Overall Study|Death|1|||
16963963|NCT00965848|38106840|FG002|Overall Study|Death|5|||
16963964|NCT00965848|38106838|FG000|Overall Study|Lost to Follow-up|0|||
16963965|NCT00965848|38106839|FG001|Overall Study|Lost to Follow-up|0|||
16963966|NCT00965848|38106840|FG002|Overall Study|Lost to Follow-up|1|||
16963967|NCT00965848|38106838|FG000|Overall Study|Withdrawal by Subject|1|||
16963968|NCT00965848|38106839|FG001|Overall Study|Withdrawal by Subject|0|||
16963969|NCT00965848|38106840|FG002|Overall Study|Withdrawal by Subject|0|||
16963970|NCT00965848|38106838|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
16963971|NCT00965848|38106839|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
16963972|NCT00965848|38106840|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
16963973|NCT00965848|38106838|FG000|Overall Study|Not Clinically Evaluable|7|||
16963974|NCT00965848|38106839|FG001|Overall Study|Not Clinically Evaluable|1|||
16963975|NCT00965848|38106840|FG002|Overall Study|Not Clinically Evaluable|1|||
16963976|NCT00965848|38106838|FG000|Overall Study|Other|5|||
16963977|NCT00965848|38106839|FG001|Overall Study|Other|0|||
16963978|NCT00965848|38106840|FG002|Overall Study|Other|1|||
16963979|NCT00961636|38106851|FG000|Overall Study|Adverse Event|35|||
16963980|NCT00961636|38106852|FG001|Overall Study|Adverse Event|54|||
16963981|NCT00961636|38106853|FG002|Overall Study|Adverse Event|13|||
16963982|NCT00961636|38106851|FG000|Overall Study|Flushing Symptoms|29|||
16963983|NCT00961636|38106852|FG001|Overall Study|Flushing Symptoms|46|||
16963984|NCT00961636|38106853|FG002|Overall Study|Flushing Symptoms|3|||
16963985|NCT00961636|38106851|FG000|Overall Study|Lost to Follow-up|2|||
16963986|NCT00961636|38106852|FG001|Overall Study|Lost to Follow-up|3|||
16963987|NCT00961636|38106853|FG002|Overall Study|Lost to Follow-up|1|||
16963988|NCT00961636|38106851|FG000|Overall Study|Physician Decision|3|||
16963989|NCT00961636|38106852|FG001|Overall Study|Physician Decision|1|||
16963990|NCT00961636|38106853|FG002|Overall Study|Physician Decision|1|||
16963991|NCT00961636|38106851|FG000|Overall Study|Protocol Violation|9|||
16963992|NCT00961636|38106852|FG001|Overall Study|Protocol Violation|5|||
16963993|NCT00961636|38106853|FG002|Overall Study|Protocol Violation|1|||
16963994|NCT00961636|38106851|FG000|Overall Study|Withdrawal by Subject|29|||
16963995|NCT00961636|38106852|FG001|Overall Study|Withdrawal by Subject|22|||
16963996|NCT00961636|38106853|FG002|Overall Study|Withdrawal by Subject|13|||
16963997|NCT00964678|38106861|FG000|Overall Study|Physician Decision|4|||
16963998|NCT00964366|38106868|FG000|Overall Study|Did not qualify at Day 1|1|||
16963999|NCT00964366|38106869|FG001|Overall Study|Did not qualify at Day 1|0|||
16964000|NCT00964366|38106868|FG000|Overall Study|Withdrawal by Subject|0|||
16964001|NCT00964366|38106869|FG001|Overall Study|Withdrawal by Subject|1|||
16964002|NCT00960154|38106877|FG000|Overall Study|Study termination|25|||
16964003|NCT00960154|38106878|FG001|Overall Study|Study termination|25|||
16964004|NCT00960076|38106886|FG000|Overall Study|Adverse Event|1|||
16964005|NCT00960076|38106887|FG001|Overall Study|Adverse Event|7|||
16964006|NCT00960076|38106886|FG000|Overall Study|No longer met study criteria|1|||
16964007|NCT00960076|38106887|FG001|Overall Study|No longer met study criteria|5|||
16964008|NCT00960076|38106886|FG000|Overall Study|Withdrawal by Subject|1|||
16964009|NCT00960076|38106887|FG001|Overall Study|Withdrawal by Subject|2|||
16964010|NCT00960076|38106886|FG000|Overall Study|Lost to Follow-up|3|||
16964011|NCT00960076|38106887|FG001|Overall Study|Lost to Follow-up|3|||
16964012|NCT00960076|38106886|FG000|Overall Study|Severe non-compliance to protocol|1|||
16964013|NCT00960076|38106887|FG001|Overall Study|Severe non-compliance to protocol|2|||
16964014|NCT00960076|38106886|FG000|Overall Study|Hyperglycemia|1|||
16964015|NCT00960076|38106887|FG001|Overall Study|Hyperglycemia|5|||
16964016|NCT00960076|38106886|FG000|Overall Study|Did not attend the termination visit|0|||
16964017|NCT00960076|38106887|FG001|Overall Study|Did not attend the termination visit|1|||
16964018|NCT01227629|38106903|FG000|Overall Study|Adverse Event|2|||
16964019|NCT01227629|38106904|FG001|Overall Study|Adverse Event|2|||
16964020|NCT01227629|38106905|FG002|Overall Study|Adverse Event|1|||
16964021|NCT01227629|38106906|FG003|Overall Study|Adverse Event|6|||
16964022|NCT01227629|38106907|FG004|Overall Study|Adverse Event|1|||
16964023|NCT01227629|38106908|FG005|Overall Study|Adverse Event|1|||
16964024|NCT01227629|38106909|FG006|Overall Study|Adverse Event|6|||
16964025|NCT01227629|38106910|FG007|Overall Study|Adverse Event|6|||
16964026|NCT01227629|38106911|FG008|Overall Study|Adverse Event|4|||
16964027|NCT01227629|38106912|FG009|Overall Study|Adverse Event|0|||
16964028|NCT01227629|38106903|FG000|Overall Study|Protocol Violation|0|||
16964029|NCT01227629|38106904|FG001|Overall Study|Protocol Violation|0|||
16964030|NCT01227629|38106905|FG002|Overall Study|Protocol Violation|0|||
16964031|NCT01227629|38106906|FG003|Overall Study|Protocol Violation|1|||
16964032|NCT01227629|38106907|FG004|Overall Study|Protocol Violation|0|||
16964033|NCT01227629|38106908|FG005|Overall Study|Protocol Violation|0|||
16964034|NCT01227629|38106909|FG006|Overall Study|Protocol Violation|0|||
16964035|NCT01227629|38106910|FG007|Overall Study|Protocol Violation|0|||
16964036|NCT01227629|38106911|FG008|Overall Study|Protocol Violation|0|||
16964037|NCT01227629|38106912|FG009|Overall Study|Protocol Violation|0|||
16964038|NCT01227629|38106903|FG000|Overall Study|Lost to Follow-up|0|||
16964039|NCT01227629|38106904|FG001|Overall Study|Lost to Follow-up|0|||
16964040|NCT01227629|38106905|FG002|Overall Study|Lost to Follow-up|0|||
16964041|NCT01227629|38106906|FG003|Overall Study|Lost to Follow-up|0|||
16964042|NCT01227629|38106907|FG004|Overall Study|Lost to Follow-up|1|||
16964043|NCT01227629|38106908|FG005|Overall Study|Lost to Follow-up|0|||
16964044|NCT01227629|38106909|FG006|Overall Study|Lost to Follow-up|0|||
16964045|NCT01227629|38106910|FG007|Overall Study|Lost to Follow-up|0|||
16964046|NCT01227629|38106911|FG008|Overall Study|Lost to Follow-up|0|||
16964047|NCT01227629|38106912|FG009|Overall Study|Lost to Follow-up|0|||
16964048|NCT01227629|38106903|FG000|Overall Study|Withdrawal by Subject|0|||
16964049|NCT01227629|38106904|FG001|Overall Study|Withdrawal by Subject|0|||
16964050|NCT01227629|38106905|FG002|Overall Study|Withdrawal by Subject|0|||
16964051|NCT01227629|38106906|FG003|Overall Study|Withdrawal by Subject|0|||
16964052|NCT01227629|38106907|FG004|Overall Study|Withdrawal by Subject|0|||
16964053|NCT01227629|38106908|FG005|Overall Study|Withdrawal by Subject|0|||
16964054|NCT01227629|38106909|FG006|Overall Study|Withdrawal by Subject|2|||
16964055|NCT01227629|38106910|FG007|Overall Study|Withdrawal by Subject|0|||
16964056|NCT01227629|38106911|FG008|Overall Study|Withdrawal by Subject|0|||
16964057|NCT01227629|38106912|FG009|Overall Study|Withdrawal by Subject|1|||
16964058|NCT01227629|38106903|FG000|Overall Study|Other|0|||
16964059|NCT01227629|38106904|FG001|Overall Study|Other|0|||
16964060|NCT01227629|38106905|FG002|Overall Study|Other|0|||
16964061|NCT01227629|38106906|FG003|Overall Study|Other|1|||
16964062|NCT01227629|38106907|FG004|Overall Study|Other|0|||
16964063|NCT01227629|38106908|FG005|Overall Study|Other|0|||
16964064|NCT01227629|38106909|FG006|Overall Study|Other|0|||
16964065|NCT01227629|38106910|FG007|Overall Study|Other|0|||
16964066|NCT01227629|38106911|FG008|Overall Study|Other|2|||
16964067|NCT01227629|38106912|FG009|Overall Study|Other|1|||
16964068|NCT00963820|38106958|FG000|Dose Escalation Phase|Progressive Disease|3|||
16964069|NCT00963820|38106959|FG001|Dose Escalation Phase|Progressive Disease|3|||
16964070|NCT00963820|38106960|FG002|Dose Escalation Phase|Progressive Disease|3|||
16779361|NCT02151981|37718571|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16964071|NCT00963820|38106961|FG003|Dose Escalation Phase|Progressive Disease|3|||
16964072|NCT00963820|38106962|FG004|Dose Escalation Phase|Progressive Disease|4|||
16964073|NCT00963820|38106963|FG005|Dose Escalation Phase|Progressive Disease|3|||
16964074|NCT00963820|38106964|FG006|Dose Escalation Phase|Progressive Disease|3|||
16964075|NCT00963820|38106965|FG007|Dose Escalation Phase|Progressive Disease|2|||
16964076|NCT00963820|38106966|FG008|Dose Escalation Phase|Progressive Disease|0|||
16964077|NCT00963820|38106967|FG009|Dose Escalation Phase|Progressive Disease|0|||
16964078|NCT00963820|38106968|FG010|Dose Escalation Phase|Progressive Disease|0|||
16964079|NCT00963820|38106969|FG011|Dose Escalation Phase|Progressive Disease|0|||
16964080|NCT00963820|38106958|FG000|Dose Escalation Phase|Adverse Event|0|||
16964081|NCT00963820|38106959|FG001|Dose Escalation Phase|Adverse Event|0|||
16964082|NCT00963820|38106960|FG002|Dose Escalation Phase|Adverse Event|0|||
16964083|NCT00963820|38106961|FG003|Dose Escalation Phase|Adverse Event|0|||
16964084|NCT00963820|38106962|FG004|Dose Escalation Phase|Adverse Event|0|||
16964085|NCT00963820|38106963|FG005|Dose Escalation Phase|Adverse Event|0|||
16964086|NCT00963820|38106964|FG006|Dose Escalation Phase|Adverse Event|3|||
16964087|NCT00963820|38106965|FG007|Dose Escalation Phase|Adverse Event|1|||
16964088|NCT00963820|38106966|FG008|Dose Escalation Phase|Adverse Event|0|||
16964089|NCT00963820|38106967|FG009|Dose Escalation Phase|Adverse Event|0|||
16964090|NCT00963820|38106968|FG010|Dose Escalation Phase|Adverse Event|0|||
16964091|NCT00963820|38106969|FG011|Dose Escalation Phase|Adverse Event|0|||
16964092|NCT00963820|38106958|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16964093|NCT00963820|38106959|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16964094|NCT00963820|38106960|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16964095|NCT00963820|38106961|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16964096|NCT00963820|38106962|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
16964097|NCT00963820|38106963|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
16964098|NCT00963820|38106964|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
16964099|NCT00963820|38106965|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
16964100|NCT00963820|38106966|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
16964101|NCT00963820|38106967|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
16964102|NCT00963820|38106968|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
16964103|NCT00963820|38106969|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
16964104|NCT00963820|38106958|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964105|NCT00963820|38106959|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16779362|NCT02151981|37718570|FG000|Overall Study|Patient had no clinical benefit|1|||
16779363|NCT02151981|37718571|FG001|Overall Study|Patient had no clinical benefit|0|||
16779364|NCT02151981|37718570|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
16779365|NCT02151981|37718571|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
16779366|NCT02151981|37718570|FG000|Overall Study|Study terminated|0|||
16779367|NCT02151981|37718571|FG001|Overall Study|Study terminated|1|||
16779368|NCT02710045|37718580|FG000|Overall Study|Death|1|||
16779369|NCT02710045|37718581|FG001|Overall Study|Death|2|||
16779370|NCT02710045|37718582|FG002|Overall Study|Death|0|||
16779371|NCT02710045|37718580|FG000|Overall Study|Withdrawal by Subject|6|||
16779372|NCT02710045|37718581|FG001|Overall Study|Withdrawal by Subject|6|||
16964106|NCT00963820|38106960|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964107|NCT00963820|38106961|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964108|NCT00963820|38106962|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964109|NCT00963820|38106963|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964110|NCT00963820|38106964|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
16964111|NCT00963820|38106965|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964112|NCT00963820|38106966|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16779373|NCT02710045|37718582|FG002|Overall Study|Withdrawal by Subject|2|||
16779374|NCT02710045|37718580|FG000|Overall Study|Protocol Violation|1|||
16779375|NCT02710045|37718581|FG001|Overall Study|Protocol Violation|2|||
16964113|NCT00963820|38106967|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964114|NCT00963820|38106968|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964115|NCT00963820|38106969|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16964116|NCT00963820|38106958|FG000|Expansion Phase|Progressive Disease|0|||
16964117|NCT00963820|38106959|FG001|Expansion Phase|Progressive Disease|0|||
16964118|NCT00963820|38106960|FG002|Expansion Phase|Progressive Disease|0|||
16964119|NCT00963820|38106961|FG003|Expansion Phase|Progressive Disease|0|||
16964120|NCT00963820|38106962|FG004|Expansion Phase|Progressive Disease|0|||
16964121|NCT00963820|38106963|FG005|Expansion Phase|Progressive Disease|0|||
16964122|NCT00963820|38106964|FG006|Expansion Phase|Progressive Disease|0|||
16964123|NCT00963820|38106965|FG007|Expansion Phase|Progressive Disease|0|||
16964124|NCT00963820|38106966|FG008|Expansion Phase|Progressive Disease|8|||
16964125|NCT00963820|38106967|FG009|Expansion Phase|Progressive Disease|6|||
16964126|NCT00963820|38106968|FG010|Expansion Phase|Progressive Disease|4|||
16964127|NCT00963820|38106969|FG011|Expansion Phase|Progressive Disease|2|||
16964128|NCT00963820|38106958|FG000|Expansion Phase|Adverse Event|0|||
16964129|NCT00963820|38106959|FG001|Expansion Phase|Adverse Event|0|||
16964130|NCT00963820|38106960|FG002|Expansion Phase|Adverse Event|0|||
16964131|NCT00963820|38106961|FG003|Expansion Phase|Adverse Event|0|||
16964132|NCT00963820|38106962|FG004|Expansion Phase|Adverse Event|0|||
16964133|NCT00963820|38106963|FG005|Expansion Phase|Adverse Event|0|||
16964134|NCT00963820|38106964|FG006|Expansion Phase|Adverse Event|0|||
16964135|NCT00963820|38106965|FG007|Expansion Phase|Adverse Event|0|||
16964136|NCT00963820|38106966|FG008|Expansion Phase|Adverse Event|1|||
16964137|NCT00963820|38106967|FG009|Expansion Phase|Adverse Event|3|||
16964138|NCT00963820|38106968|FG010|Expansion Phase|Adverse Event|0|||
16964139|NCT00963820|38106969|FG011|Expansion Phase|Adverse Event|0|||
16964140|NCT00963820|38106958|FG000|Expansion Phase|Withdrawal by Subject|0|||
16964141|NCT00963820|38106959|FG001|Expansion Phase|Withdrawal by Subject|0|||
16964142|NCT00963820|38106960|FG002|Expansion Phase|Withdrawal by Subject|0|||
16964143|NCT00963820|38106961|FG003|Expansion Phase|Withdrawal by Subject|0|||
16964144|NCT00963820|38106962|FG004|Expansion Phase|Withdrawal by Subject|0|||
16964145|NCT00963820|38106963|FG005|Expansion Phase|Withdrawal by Subject|0|||
16964146|NCT00963820|38106964|FG006|Expansion Phase|Withdrawal by Subject|0|||
16964147|NCT00963820|38106965|FG007|Expansion Phase|Withdrawal by Subject|0|||
16964148|NCT00963820|38106966|FG008|Expansion Phase|Withdrawal by Subject|1|||
16964149|NCT00963820|38106967|FG009|Expansion Phase|Withdrawal by Subject|0|||
16964150|NCT00963820|38106968|FG010|Expansion Phase|Withdrawal by Subject|1|||
16964151|NCT00963820|38106969|FG011|Expansion Phase|Withdrawal by Subject|1|||
16964152|NCT00963820|38106958|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964153|NCT00963820|38106959|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964154|NCT00963820|38106960|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964155|NCT00963820|38106961|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964156|NCT00963820|38106962|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964157|NCT00963820|38106963|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964158|NCT00963820|38106964|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964159|NCT00963820|38106965|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964160|NCT00963820|38106966|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964161|NCT00963820|38106967|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964162|NCT00963820|38106968|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16964163|NCT00963820|38106969|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
16964164|NCT01227395|38106988|FG000|Overall Study|Protocol Violation|0|||
16964165|NCT01227395|38106989|FG001|Overall Study|Protocol Violation|1|||
16964166|NCT01226459|38107016|FG000|Overall Study|Adverse Event|2|||
16964167|NCT01226459|38107017|FG001|Overall Study|Adverse Event|8|||
16964168|NCT01226459|38107016|FG000|Overall Study|Protocol Violation|4|||
16964169|NCT01226459|38107017|FG001|Overall Study|Protocol Violation|3|||
16779376|NCT02710045|37718582|FG002|Overall Study|Protocol Violation|3|||
16779377|NCT02710045|37718580|FG000|Overall Study|Lost to Follow-up|3|||
16779378|NCT02710045|37718581|FG001|Overall Study|Lost to Follow-up|6|||
16779379|NCT02710045|37718582|FG002|Overall Study|Lost to Follow-up|7|||
16964170|NCT01226459|38107016|FG000|Overall Study|Withdrawal by Subject|10|||
16964171|NCT01226459|38107017|FG001|Overall Study|Withdrawal by Subject|13|||
16964172|NCT01226459|38107016|FG000|Overall Study|Lost to Follow-up|4|||
16964173|NCT01226459|38107017|FG001|Overall Study|Lost to Follow-up|8|||
16964174|NCT01226459|38107016|FG000|Overall Study|Pregnancy|1|||
16964175|NCT01226459|38107017|FG001|Overall Study|Pregnancy|0|||
16964176|NCT01225991|38107023|FG000|Overall Study|Withdrawal by Subject|6|||
16964177|NCT00959374|38107027|FG000|Overall Study|Withdrawal by Subject|2|||
16964178|NCT00959374|38107027|FG000|Overall Study|Lost to Follow-up|14|||
16964179|NCT00959374|38107027|FG000|Overall Study|Death|1|||
16964180|NCT00959374|38107027|FG000|Overall Study|Protocol Violation|1|||
16964181|NCT00959374|38107027|FG000|Overall Study|Implant Removed/Not Replaced|4|||
16964182|NCT00959374|38107027|FG000|Overall Study|Physician Decision|1|||
16964183|NCT01225835|38107037|FG000|Overall Study|Completed protocol|2|||
16964184|NCT01225835|38107038|FG001|Overall Study|Completed protocol|1|||
16964185|NCT01225835|38107037|FG000|Overall Study|Did not meet hCG criterion|2|||
16964186|NCT01225835|38107038|FG001|Overall Study|Did not meet hCG criterion|0|||
16964187|NCT01225835|38107037|FG000|Overall Study|Adverse Event|2|||
16964188|NCT01225835|38107038|FG001|Overall Study|Adverse Event|1|||
16964189|NCT01225835|38107037|FG000|Overall Study|Other|1|||
16964190|NCT01225835|38107038|FG001|Overall Study|Other|1|||
16964191|NCT02923180|38107050|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
16964192|NCT02923180|38107050|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
16964193|NCT00962650|38107054|FG000|Overall Study|Transgastric DP was not completed|2|||
16964194|NCT00958828|38107062|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
16964195|NCT00958828|38107063|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
16964196|NCT00958828|38107062|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
16964197|NCT00958828|38107063|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
16964198|NCT00960934|38107075|FG000|Overall Study|Adverse Event|2|||
16964199|NCT00960934|38107076|FG001|Overall Study|Adverse Event|3|||
16964200|NCT00960934|38107077|FG002|Overall Study|Adverse Event|3|||
16964201|NCT00960934|38107078|FG003|Overall Study|Adverse Event|2|||
16964202|NCT00960934|38107079|FG004|Overall Study|Adverse Event|4|||
16964203|NCT00960934|38107080|FG005|Overall Study|Adverse Event|3|||
16964204|NCT00960934|38107075|FG000|Overall Study|Lack of Efficacy|1|||
16964205|NCT00960934|38107076|FG001|Overall Study|Lack of Efficacy|0|||
16964206|NCT00960934|38107077|FG002|Overall Study|Lack of Efficacy|0|||
16964207|NCT00960934|38107078|FG003|Overall Study|Lack of Efficacy|0|||
16964208|NCT00960934|38107079|FG004|Overall Study|Lack of Efficacy|0|||
16964209|NCT00960934|38107080|FG005|Overall Study|Lack of Efficacy|0|||
16964210|NCT00960934|38107075|FG000|Overall Study|Lost to Follow-up|0|||
16964211|NCT00960934|38107076|FG001|Overall Study|Lost to Follow-up|1|||
16964212|NCT00960934|38107077|FG002|Overall Study|Lost to Follow-up|0|||
16964213|NCT00960934|38107078|FG003|Overall Study|Lost to Follow-up|0|||
16964214|NCT00960934|38107079|FG004|Overall Study|Lost to Follow-up|0|||
16964215|NCT00960934|38107080|FG005|Overall Study|Lost to Follow-up|0|||
16964216|NCT00960934|38107075|FG000|Overall Study|Other|2|||
16964217|NCT00960934|38107076|FG001|Overall Study|Other|1|||
16964218|NCT00960934|38107077|FG002|Overall Study|Other|5|||
16964219|NCT00960934|38107078|FG003|Overall Study|Other|4|||
16964220|NCT00960934|38107079|FG004|Overall Study|Other|2|||
16964221|NCT00960934|38107080|FG005|Overall Study|Other|2|||
16964222|NCT00960934|38107075|FG000|Overall Study|Physician Decision|0|||
16964223|NCT00960934|38107076|FG001|Overall Study|Physician Decision|1|||
16964224|NCT00960934|38107077|FG002|Overall Study|Physician Decision|0|||
16964225|NCT00960934|38107078|FG003|Overall Study|Physician Decision|0|||
16964226|NCT00960934|38107079|FG004|Overall Study|Physician Decision|0|||
16964227|NCT00960934|38107080|FG005|Overall Study|Physician Decision|0|||
16964228|NCT00960934|38107075|FG000|Overall Study|Progressive Disease|1|||
16964229|NCT00960934|38107076|FG001|Overall Study|Progressive Disease|1|||
16964230|NCT00960934|38107077|FG002|Overall Study|Progressive Disease|0|||
16964231|NCT00960934|38107078|FG003|Overall Study|Progressive Disease|0|||
16964232|NCT00960934|38107079|FG004|Overall Study|Progressive Disease|1|||
16964233|NCT00960934|38107080|FG005|Overall Study|Progressive Disease|1|||
16964234|NCT00960934|38107075|FG000|Overall Study|Protocol Violation|3|||
16964235|NCT00960934|38107076|FG001|Overall Study|Protocol Violation|4|||
16964236|NCT00960934|38107077|FG002|Overall Study|Protocol Violation|0|||
16964237|NCT00960934|38107078|FG003|Overall Study|Protocol Violation|3|||
16964238|NCT00960934|38107079|FG004|Overall Study|Protocol Violation|3|||
16964239|NCT00960934|38107080|FG005|Overall Study|Protocol Violation|2|||
16964240|NCT00960934|38107075|FG000|Overall Study|Withdrawal by Subject|5|||
16964241|NCT00960934|38107076|FG001|Overall Study|Withdrawal by Subject|6|||
16964242|NCT00960934|38107077|FG002|Overall Study|Withdrawal by Subject|4|||
16964243|NCT00960934|38107078|FG003|Overall Study|Withdrawal by Subject|5|||
16964244|NCT00960934|38107079|FG004|Overall Study|Withdrawal by Subject|5|||
16964245|NCT00960934|38107080|FG005|Overall Study|Withdrawal by Subject|7|||
16964246|NCT00960934|38107075|FG000|Overall Study|Study Terminated by Sponsor|50|||
16964247|NCT00960934|38107076|FG001|Overall Study|Study Terminated by Sponsor|46|||
16964248|NCT00960934|38107077|FG002|Overall Study|Study Terminated by Sponsor|52|||
16964249|NCT00960934|38107078|FG003|Overall Study|Study Terminated by Sponsor|50|||
16964250|NCT00960934|38107079|FG004|Overall Study|Study Terminated by Sponsor|49|||
16964251|NCT00960934|38107080|FG005|Overall Study|Study Terminated by Sponsor|49|||
16964252|NCT00892177|38107097|FG000|Phase II|Ineligible|0|||
16964253|NCT00892177|38107098|FG001|Phase II|Ineligible|0|||
16964254|NCT00892177|38107099|FG002|Phase II|Ineligible|0|||
16964255|NCT00892177|38107100|FG003|Phase II|Ineligible|0|||
16964256|NCT00892177|38107101|FG004|Phase II|Ineligible|1|||
16964257|NCT00892177|38107102|FG005|Phase II|Ineligible|1|||
16964258|NCT00892177|38107097|FG000|Phase II|Withdrawal by Subject|0|||
16964259|NCT00892177|38107098|FG001|Phase II|Withdrawal by Subject|0|||
16964260|NCT00892177|38107099|FG002|Phase II|Withdrawal by Subject|0|||
16964261|NCT00892177|38107100|FG003|Phase II|Withdrawal by Subject|0|||
16964262|NCT00892177|38107101|FG004|Phase II|Withdrawal by Subject|4|||
16964263|NCT00892177|38107102|FG005|Phase II|Withdrawal by Subject|1|||
16964264|NCT00962104|38107119|FG000|Overall Study|Adverse Event|10|||
16964265|NCT00962104|38107120|FG001|Overall Study|Adverse Event|3|||
16964266|NCT00962104|38107119|FG000|Overall Study|Entry Criteria Not Met|1|||
16779380|NCT02710045|37718580|FG000|Overall Study|Physician Decision|0|||
16779381|NCT02710045|37718581|FG001|Overall Study|Physician Decision|0|||
16779382|NCT02710045|37718582|FG002|Overall Study|Physician Decision|1|||
16779383|NCT02710045|37718580|FG000|Overall Study|Poor Attendance|0|||
16779384|NCT02710045|37718581|FG001|Overall Study|Poor Attendance|1|||
16779385|NCT02710045|37718582|FG002|Overall Study|Poor Attendance|0|||
16779386|NCT02714153|37718590|FG000|Overall Study|Death|1|||
16779387|NCT04369469|37718596|FG000|Overall Study|Lost to Follow-up|2|||
16779388|NCT04369469|37718597|FG001|Overall Study|Lost to Follow-up|4|||
16779389|NCT04369469|37718596|FG000|Overall Study|Physician Decision|2|||
16779390|NCT04369469|37718597|FG001|Overall Study|Physician Decision|1|||
16779391|NCT04369469|37718596|FG000|Overall Study|Withdrawal by Subject|2|||
16779392|NCT04369469|37718597|FG001|Overall Study|Withdrawal by Subject|3|||
16779393|NCT04369469|37718596|FG000|Overall Study|Adverse Event|1|||
16779394|NCT04369469|37718597|FG001|Overall Study|Adverse Event|0|||
16779395|NCT04369469|37718596|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
16779396|NCT04369469|37718597|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
16779397|NCT04369469|37718596|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
16779398|NCT04369469|37718597|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
16964267|NCT00962104|38107120|FG001|Overall Study|Entry Criteria Not Met|2|||
16964268|NCT00962104|38107119|FG000|Overall Study|Lack of Efficacy|0|||
16964269|NCT00962104|38107120|FG001|Overall Study|Lack of Efficacy|1|||
16964270|NCT00962104|38107119|FG000|Overall Study|Lost to Follow-up|10|||
16964271|NCT00962104|38107120|FG001|Overall Study|Lost to Follow-up|4|||
16964272|NCT00962104|38107119|FG000|Overall Study|Physician Decision|1|||
16964273|NCT00962104|38107120|FG001|Overall Study|Physician Decision|0|||
16964274|NCT00962104|38107119|FG000|Overall Study|Protocol Violation|6|||
16964275|NCT00962104|38107120|FG001|Overall Study|Protocol Violation|8|||
16964276|NCT00962104|38107119|FG000|Overall Study|Sponsor Decision|0|||
16964277|NCT00962104|38107120|FG001|Overall Study|Sponsor Decision|1|||
16964278|NCT00962104|38107119|FG000|Overall Study|Withdrawal by Subject|10|||
16964279|NCT00962104|38107120|FG001|Overall Study|Withdrawal by Subject|6|||
16964280|NCT00962104|38107119|FG000|Overall Study|Other|2|||
16964281|NCT00962104|38107120|FG001|Overall Study|Other|0|||
16964282|NCT02821000|38107126|FG000|Overall Study|Death|44|||
16964283|NCT02821000|38107126|FG000|Overall Study|Withdrawal by Subject|1|||
16964284|NCT02821000|38107126|FG000|Overall Study|Ongoing in Study|58|||
16964285|NCT00892099|38107133|FG000|Overall Study|Death|1|||
16964286|NCT00892099|38107134|FG001|Overall Study|Death|0|||
16964287|NCT00892099|38107135|FG002|Overall Study|Death|1|||
16964288|NCT00892099|38107133|FG000|Overall Study|Adverse Event|1|||
16964289|NCT00892099|38107134|FG001|Overall Study|Adverse Event|0|||
16964290|NCT00892099|38107135|FG002|Overall Study|Adverse Event|0|||
16964291|NCT00892099|38107133|FG000|Overall Study|replocated|1|||
16964292|NCT00892099|38107134|FG001|Overall Study|replocated|0|||
16964293|NCT00892099|38107135|FG002|Overall Study|replocated|2|||
16964294|NCT00892099|38107133|FG000|Overall Study|Prolonged hospitalization|1|||
16964295|NCT00892099|38107134|FG001|Overall Study|Prolonged hospitalization|0|||
16964296|NCT00892099|38107135|FG002|Overall Study|Prolonged hospitalization|1|||
16964297|NCT00892099|38107133|FG000|Overall Study|no further details|1|||
16964298|NCT00892099|38107134|FG001|Overall Study|no further details|0|||
16964299|NCT00892099|38107135|FG002|Overall Study|no further details|1|||
16964300|NCT00892099|38107133|FG000|Overall Study|kidney function recovered|0|||
16964301|NCT00892099|38107134|FG001|Overall Study|kidney function recovered|1|||
16964302|NCT00892099|38107135|FG002|Overall Study|kidney function recovered|0|||
16964303|NCT00892099|38107133|FG000|Overall Study|investigator decision|0|||
16964304|NCT00892099|38107134|FG001|Overall Study|investigator decision|0|||
16964305|NCT00892099|38107135|FG002|Overall Study|investigator decision|1|||
16964306|NCT00892099|38107133|FG000|Overall Study|Lost to Follow-up|0|||
16964307|NCT00892099|38107134|FG001|Overall Study|Lost to Follow-up|0|||
16964308|NCT00892099|38107135|FG002|Overall Study|Lost to Follow-up|1|||
16964309|NCT00960856|38107143|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16964310|NCT00960856|38107144|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
16964311|NCT00960856|38107145|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
16964312|NCT00960856|38107146|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
16964313|NCT00960856|38107143|FG000|Washout Period of 7 Days|Adverse Event|0|||
16964314|NCT00960856|38107144|FG001|Washout Period of 7 Days|Adverse Event|0|||
16964315|NCT00960856|38107145|FG002|Washout Period of 7 Days|Adverse Event|1|||
16964316|NCT00960856|38107146|FG003|Washout Period of 7 Days|Adverse Event|0|||
16964317|NCT00958438|38107159|FG000|Overall Study|Protocol Violation|3|||
16964318|NCT00958438|38107160|FG001|Overall Study|Protocol Violation|2|||
16964319|NCT00958438|38107161|FG002|Overall Study|Protocol Violation|2|||
16964320|NCT00958438|38107159|FG000|Overall Study|Withdrawal by Subject|4|||
16964321|NCT00958438|38107160|FG001|Overall Study|Withdrawal by Subject|2|||
16964322|NCT00958438|38107161|FG002|Overall Study|Withdrawal by Subject|1|||
16964323|NCT00958438|38107159|FG000|Overall Study|Adverse Event|0|||
16964324|NCT00958438|38107160|FG001|Overall Study|Adverse Event|3|||
16964325|NCT00958438|38107161|FG002|Overall Study|Adverse Event|0|||
16964326|NCT00958438|38107159|FG000|Overall Study|Physician Decision|1|||
16964327|NCT00958438|38107160|FG001|Overall Study|Physician Decision|0|||
16964328|NCT00958438|38107161|FG002|Overall Study|Physician Decision|1|||
16964329|NCT00958438|38107159|FG000|Overall Study|Other than specified above|2|||
16964330|NCT00958438|38107160|FG001|Overall Study|Other than specified above|3|||
16779399|NCT04369469|37718596|FG000|Overall Study|Unable to Provide Consent|0|||
16779400|NCT04369469|37718597|FG001|Overall Study|Unable to Provide Consent|1|||
16779401|NCT01670097|37718618|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
16779402|NCT01670097|37718619|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
16779403|NCT01670097|37718618|FG000|Overall Study|Study burden|1|||
16779404|NCT01670097|37718619|FG001|Overall Study|Study burden|0|||
16964331|NCT00958438|38107161|FG002|Overall Study|Other than specified above|2|||
16964332|NCT00958360|38107171|FG000|Overall Study|Withdrawal by Subject|3|||
16964333|NCT00958360|38107172|FG001|Overall Study|Withdrawal by Subject|1|||
16964334|NCT00958360|38107171|FG000|Overall Study|Death|6|||
16964335|NCT00958360|38107172|FG001|Overall Study|Death|7|||
16964336|NCT00958360|38107171|FG000|Overall Study|Physician Decision|2|||
16964337|NCT00958360|38107172|FG001|Overall Study|Physician Decision|1|||
16964338|NCT00958360|38107171|FG000|Overall Study|Lost to Follow-up|0|||
16964339|NCT00958360|38107172|FG001|Overall Study|Lost to Follow-up|1|||
16964340|NCT00888433|38107180|FG000|Overall Study|Withdrawal by Subject|1|||
16964341|NCT00888433|38107181|FG001|Overall Study|Withdrawal by Subject|2|||
16964342|NCT00888433|38107180|FG000|Overall Study|Missed Visit|2|||
16964343|NCT00888433|38107181|FG001|Overall Study|Missed Visit|1|||
16964344|NCT01243424|38107189|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
16964345|NCT01243424|38107190|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
16964346|NCT01243424|38107189|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
16964347|NCT01243424|38107190|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
16964348|NCT01243424|38107189|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
16964349|NCT01243424|38107190|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
16964350|NCT01243424|38107189|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
16964351|NCT01243424|38107190|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
16964352|NCT01243424|38107189|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
16964353|NCT01243424|38107190|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
16964354|NCT01243424|38107189|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
16779405|NCT01670097|37718618|FG000|Overall Study|COPD exacerbation|0|||
16779406|NCT01670097|37718619|FG001|Overall Study|COPD exacerbation|1|||
16779407|NCT01670097|37718618|FG000|Overall Study|Neutropenia|0|||
16867986|NCT01553747|37841011|FG000|Overall Study|Physician decision: other|10|||
16964355|NCT01243424|38107190|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
16964356|NCT01243424|38107189|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
16964357|NCT01243424|38107190|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
16964358|NCT01243424|38107189|FG000|Discontinuation From Treatment|Not treated|5|||
16964359|NCT01243424|38107190|FG001|Discontinuation From Treatment|Not treated|4|||
16964360|NCT01243424|38107189|FG000|Discontinuation From Treatment|Adverse Event|457|||
16964361|NCT01243424|38107190|FG001|Discontinuation From Treatment|Adverse Event|523|||
16964362|NCT01243424|38107189|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
16964363|NCT01243424|38107190|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
16964364|NCT01243424|38107189|FG000|Discontinuation From Treatment|Protocol Violation|46|||
16964365|NCT01243424|38107190|FG001|Discontinuation From Treatment|Protocol Violation|47|||
16964366|NCT01243424|38107189|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
16964367|NCT01243424|38107190|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
16964368|NCT01243424|38107189|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
16964369|NCT01243424|38107190|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
16964370|NCT01243424|38107189|FG000|Discontinuation From Treatment|Other than listed above|230|||
16964371|NCT01243424|38107190|FG001|Discontinuation From Treatment|Other than listed above|211|||
16964372|NCT00887809|38107199|FG000|Overall Study|Patient Not Treated|3|||
16964373|NCT00887809|38107200|FG001|Overall Study|Patient Not Treated|0|||
16964374|NCT00887809|38107199|FG000|Overall Study|Death|1|||
16964375|NCT00887809|38107200|FG001|Overall Study|Death|0|||
16964376|NCT00958126|38107214|FG000|Overall Study|Serious Adverse Event|0|||
16964377|NCT00958126|38107215|FG001|Overall Study|Serious Adverse Event|2|||
16964378|NCT00958126|38107216|FG002|Overall Study|Serious Adverse Event|0|||
16964379|NCT00958126|38107217|FG003|Overall Study|Serious Adverse Event|0|||
16964380|NCT00958126|38107218|FG004|Overall Study|Serious Adverse Event|0|||
16964381|NCT00958126|38107219|FG005|Overall Study|Serious Adverse Event|0|||
16964382|NCT00958126|38107220|FG006|Overall Study|Serious Adverse Event|1|||
16964383|NCT00958126|38107221|FG007|Overall Study|Serious Adverse Event|0|||
16964384|NCT00958126|38107214|FG000|Overall Study|Withdrawal by Subject|0|||
16964385|NCT00958126|38107215|FG001|Overall Study|Withdrawal by Subject|2|||
16964386|NCT00958126|38107216|FG002|Overall Study|Withdrawal by Subject|0|||
16964387|NCT00958126|38107217|FG003|Overall Study|Withdrawal by Subject|0|||
16964388|NCT00958126|38107218|FG004|Overall Study|Withdrawal by Subject|0|||
16964389|NCT00958126|38107219|FG005|Overall Study|Withdrawal by Subject|0|||
16964390|NCT00958126|38107220|FG006|Overall Study|Withdrawal by Subject|0|||
16964391|NCT00958126|38107221|FG007|Overall Study|Withdrawal by Subject|0|||
16964392|NCT00958126|38107214|FG000|Overall Study|Moved away from study area|0|||
16964393|NCT00958126|38107215|FG001|Overall Study|Moved away from study area|0|||
16964394|NCT00958126|38107216|FG002|Overall Study|Moved away from study area|1|||
16964395|NCT00958126|38107217|FG003|Overall Study|Moved away from study area|1|||
16964396|NCT00958126|38107218|FG004|Overall Study|Moved away from study area|0|||
16964397|NCT00958126|38107219|FG005|Overall Study|Moved away from study area|0|||
16964398|NCT00958126|38107220|FG006|Overall Study|Moved away from study area|0|||
16964399|NCT00958126|38107221|FG007|Overall Study|Moved away from study area|0|||
16964400|NCT00958126|38107214|FG000|Overall Study|Lost to Follow-up|1|||
16964401|NCT00958126|38107215|FG001|Overall Study|Lost to Follow-up|5|||
16964402|NCT00958126|38107216|FG002|Overall Study|Lost to Follow-up|9|||
16964403|NCT00958126|38107217|FG003|Overall Study|Lost to Follow-up|8|||
16964404|NCT00958126|38107218|FG004|Overall Study|Lost to Follow-up|0|||
16964405|NCT00958126|38107219|FG005|Overall Study|Lost to Follow-up|0|||
16964406|NCT00958126|38107220|FG006|Overall Study|Lost to Follow-up|0|||
16964407|NCT00958126|38107221|FG007|Overall Study|Lost to Follow-up|0|||
16964408|NCT00958126|38107214|FG000|Overall Study|Sponsor/Investigator decision|0|||
16964409|NCT00958126|38107215|FG001|Overall Study|Sponsor/Investigator decision|0|||
16964410|NCT00958126|38107216|FG002|Overall Study|Sponsor/Investigator decision|0|||
16964411|NCT00958126|38107217|FG003|Overall Study|Sponsor/Investigator decision|1|||
16964412|NCT00958126|38107218|FG004|Overall Study|Sponsor/Investigator decision|0|||
16964413|NCT00958126|38107219|FG005|Overall Study|Sponsor/Investigator decision|0|||
16964414|NCT00958126|38107220|FG006|Overall Study|Sponsor/Investigator decision|0|||
16964415|NCT00958126|38107221|FG007|Overall Study|Sponsor/Investigator decision|0|||
16964416|NCT00958126|38107214|FG000|Overall Study|Other Reason|0|||
16964417|NCT00958126|38107215|FG001|Overall Study|Other Reason|0|||
16964418|NCT00958126|38107216|FG002|Overall Study|Other Reason|0|||
16964419|NCT00958126|38107217|FG003|Overall Study|Other Reason|1|||
16964420|NCT00958126|38107218|FG004|Overall Study|Other Reason|0|||
16964421|NCT00958126|38107219|FG005|Overall Study|Other Reason|1|||
16964422|NCT00958126|38107220|FG006|Overall Study|Other Reason|0|||
16964423|NCT00958126|38107221|FG007|Overall Study|Other Reason|0|||
16964424|NCT00887341|38107245|FG000|Overall Study|Refused treatment|1|||
16964425|NCT00887341|38107246|FG001|Overall Study|Refused treatment|0|||
16964426|NCT00887341|38107245|FG000|Overall Study|Withdrawal by Subject|1|||
16964427|NCT00887341|38107246|FG001|Overall Study|Withdrawal by Subject|1|||
16964428|NCT00887341|38107245|FG000|Overall Study|Adverse Event|0|||
16779408|NCT01670097|37718619|FG001|Overall Study|Neutropenia|1|||
16779409|NCT01670097|37718618|FG000|Overall Study|Clinical deterioration|0|||
16779410|NCT01670097|37718619|FG001|Overall Study|Clinical deterioration|1|||
16779411|NCT01670097|37718618|FG000|Overall Study|Disease progression|0|||
16779412|NCT01670097|37718619|FG001|Overall Study|Disease progression|1|||
16779413|NCT01670019|37718627|FG000|Overall Study|Adverse Event|3|||
16964429|NCT00887341|38107246|FG001|Overall Study|Adverse Event|1|||
16964430|NCT00887341|38107245|FG000|Overall Study|Lost to Follow-up|0|||
16964431|NCT00887341|38107246|FG001|Overall Study|Lost to Follow-up|1|||
16964432|NCT00886795|38107252|FG000|Overall Study|Lack of Efficacy|1|||
16964433|NCT00889681|38107269|FG000|Overall Study|Not meeting qualification Criteria|2|||
16964434|NCT00889681|38107269|FG000|Overall Study|Insurance disapproval|1|||
16964435|NCT00957658|38107273|FG000|Overall Study|Death|1|||
16964436|NCT00957658|38107273|FG000|Overall Study|Lost to Follow-up|4|||
16964437|NCT00957658|38107273|FG000|Overall Study|Withdrawal by Subject|12|||
16964438|NCT00957658|38107273|FG000|Overall Study|Revision|1|||
16964439|NCT00957658|38107273|FG000|Overall Study|Incomplete 2 yr data|28|||
16964440|NCT00957658|38107273|FG000|Overall Study|Site termination|10|||
16964441|NCT00957658|38107273|FG000|Overall Study|unwilling/unable to return|2|||
16964442|NCT00957658|38107273|FG000|Overall Study|surgery cancelled|2|||
16964443|NCT00957658|38107273|FG000|Overall Study|Protocol Violation|5|||
16964444|NCT00953680|38107279|FG000|Period 1|Withdrawal by Subject|0|||
16964445|NCT00953680|38107280|FG001|Period 1|Withdrawal by Subject|1|||
16964446|NCT00890929|38107286|FG000|Overall Study|Death before treatment|2|||
16964447|NCT00890929|38107286|FG000|Overall Study|Withdrawal by Subject|3|||
16964448|NCT00890929|38107286|FG000|Overall Study|Physician Decision|1|||
16964449|NCT00886639|38107290|FG000|Overall Study|acute exacerbation|14|||
16964450|NCT00886639|38107290|FG000|Overall Study|non-compliance|2|||
16964451|NCT00889603|38107294|FG000|Overall Study|Adverse Event|7|||
16779414|NCT01670019|37718628|FG001|Overall Study|Adverse Event|0|||
16779415|NCT01670019|37718627|FG000|Overall Study|Withdrawal by Subject|6|||
16779416|NCT01670019|37718628|FG001|Overall Study|Withdrawal by Subject|0|||
16779417|NCT01669629|37718634|FG000|Period 1|protocol deviation|1|||
16779418|NCT01669629|37718635|FG001|Period 1|protocol deviation|2|||
16964452|NCT00889603|38107294|FG000|Overall Study|Death|3|||
16964453|NCT00889603|38107294|FG000|Overall Study|Lost to Follow-up|19|||
16964454|NCT00889603|38107294|FG000|Overall Study|No longer willing to participant in stud|4|||
16964455|NCT00889603|38107294|FG000|Overall Study|Other|4|||
16964456|NCT00886483|38107300|FG000|Overall Study|Lost to Follow-up|0|||
16964457|NCT00886483|38107301|FG001|Overall Study|Lost to Follow-up|1|||
16964458|NCT00886483|38107300|FG000|Overall Study|Pursue medications|1|||
16964459|NCT00886483|38107301|FG001|Overall Study|Pursue medications|2|||
16964460|NCT00886483|38107300|FG000|Overall Study|Distance to center, poor grades|1|||
16964461|NCT00886483|38107301|FG001|Overall Study|Distance to center, poor grades|0|||
16964462|NCT00886015|38107317|FG000|Overall Study|Death|0|||
16964463|NCT00886015|38107318|FG001|Overall Study|Death|2|||
16964464|NCT00890695|38107326|FG000|Overall Study|Protocol Violation|1|||
16964465|NCT00890695|38107327|FG001|Overall Study|Protocol Violation|0|||
16964466|NCT00957580|38107336|FG000|Overall Study|Ongoing at data cut-off|0|||
16964467|NCT00957580|38107337|FG001|Overall Study|Ongoing at data cut-off|1|||
16964468|NCT00957580|38107338|FG002|Overall Study|Ongoing at data cut-off|0|||
16964469|NCT00957580|38107336|FG000|Overall Study|Enrolled but not treated|0|||
16964470|NCT00957580|38107337|FG001|Overall Study|Enrolled but not treated|1|||
16964471|NCT00957580|38107338|FG002|Overall Study|Enrolled but not treated|0|||
16964472|NCT00957424|38107359|FG000|Overall Study|Lost to Follow-up|19|||
16964473|NCT00957424|38107359|FG000|Overall Study|Protocol Violation|3|||
16964474|NCT00957424|38107359|FG000|Overall Study|Withdrawal by Subject|1|||
16964475|NCT01061151|38107367|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
16964476|NCT01061151|38107368|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
16964477|NCT01061151|38107369|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
16964478|NCT01061151|38107370|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
16964479|NCT01061151|38107367|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
16964480|NCT01061151|38107368|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
16964481|NCT01061151|38107369|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
16964482|NCT01061151|38107370|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
16964483|NCT01061151|38107367|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
16964484|NCT01061151|38107368|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
16964485|NCT01061151|38107369|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
16964486|NCT01061151|38107370|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
16964487|NCT01061151|38107367|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
16964488|NCT01061151|38107368|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
16964489|NCT01061151|38107369|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
16964490|NCT01061151|38107370|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
16964491|NCT01061151|38107367|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
16779419|NCT00701051|37718643|FG000|Screening|Failed Screening|40|||
16964492|NCT01061151|38107368|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
16779420|NCT00701051|37718644|FG001|Screening|Failed Screening|0|||
16779421|NCT00701051|37718645|FG002|Screening|Failed Screening|0|||
16779422|NCT00701051|37718643|FG000|Screening|Time conflicts|19|||
16779423|NCT00701051|37718644|FG001|Screening|Time conflicts|0|||
16779424|NCT00701051|37718645|FG002|Screening|Time conflicts|0|||
16779425|NCT00701051|37718643|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
16779426|NCT00701051|37718644|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
16779427|NCT00701051|37718645|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
16779428|NCT00700817|37718656|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
16779429|NCT00700817|37718657|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
16779430|NCT00700817|37718658|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
16779431|NCT00700817|37718659|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
16779432|NCT00700817|37718660|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
16779433|NCT00700817|37718656|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
16779434|NCT00700817|37718657|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
16779435|NCT00700817|37718658|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
16779436|NCT00700817|37718659|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
16964493|NCT01061151|38107369|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
16964494|NCT01061151|38107370|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
16964495|NCT01061151|38107367|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
16964496|NCT01061151|38107368|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
16964497|NCT01061151|38107369|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
16964498|NCT01061151|38107370|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
16964499|NCT01061151|38107367|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
16964500|NCT01061151|38107368|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
16964501|NCT01061151|38107369|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
16964502|NCT01061151|38107370|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
16964503|NCT01061151|38107367|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
16964504|NCT01061151|38107368|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
16964505|NCT01061151|38107369|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
16964506|NCT01061151|38107370|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
16964507|NCT01061151|38107367|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
16964508|NCT01061151|38107368|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
16964509|NCT01061151|38107369|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
16964510|NCT01061151|38107370|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
16964511|NCT01061151|38107367|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
16964512|NCT01061151|38107368|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
16964513|NCT01061151|38107369|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
16964514|NCT01061151|38107370|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
16964515|NCT01061151|38107367|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
16964516|NCT01061151|38107368|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
16964517|NCT01061151|38107369|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
16964518|NCT01061151|38107370|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
16964519|NCT01061151|38107367|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
16964520|NCT01061151|38107368|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
16964521|NCT01061151|38107369|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
16964522|NCT01061151|38107370|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
16964523|NCT01061151|38107367|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
16964524|NCT01061151|38107368|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
16964525|NCT01061151|38107369|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
16964526|NCT01061151|38107370|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
16964527|NCT01061151|38107367|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
16964528|NCT01061151|38107368|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
16964529|NCT01061151|38107369|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
16964530|NCT01061151|38107370|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
16964531|NCT01061151|38107367|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
16964532|NCT01061151|38107368|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
16964533|NCT01061151|38107369|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
16964534|NCT01061151|38107370|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
16964535|NCT01241552|38107394|FG000|Overall Study|Lack of Efficacy|1|||
16964536|NCT01241552|38107395|FG001|Overall Study|Lack of Efficacy|0|||
16964537|NCT01241552|38107396|FG002|Overall Study|Lack of Efficacy|0|||
16964538|NCT01241552|38107397|FG003|Overall Study|Lack of Efficacy|0|||
16964539|NCT01241552|38107394|FG000|Overall Study|Death|26|||
16964540|NCT01241552|38107395|FG001|Overall Study|Death|30|||
16964541|NCT01241552|38107396|FG002|Overall Study|Death|20|||
16779437|NCT00700817|37718660|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
16964542|NCT01241552|38107397|FG003|Overall Study|Death|25|||
16964543|NCT01241552|38107394|FG000|Overall Study|Adverse Event|1|||
16964544|NCT01241552|38107395|FG001|Overall Study|Adverse Event|1|||
16964545|NCT01241552|38107396|FG002|Overall Study|Adverse Event|0|||
16964546|NCT01241552|38107397|FG003|Overall Study|Adverse Event|0|||
16964547|NCT01241552|38107394|FG000|Overall Study|Technical Problems|2|||
16964548|NCT01241552|38107395|FG001|Overall Study|Technical Problems|0|||
16964549|NCT01241552|38107396|FG002|Overall Study|Technical Problems|2|||
16964550|NCT01241552|38107397|FG003|Overall Study|Technical Problems|2|||
16964551|NCT01241552|38107394|FG000|Overall Study|Progressive Disease|0|||
16964552|NCT01241552|38107395|FG001|Overall Study|Progressive Disease|0|||
16964553|NCT01241552|38107396|FG002|Overall Study|Progressive Disease|1|||
16964554|NCT01241552|38107397|FG003|Overall Study|Progressive Disease|2|||
16964555|NCT01241552|38107394|FG000|Overall Study|Protocol Violation|0|||
16779438|NCT00700817|37718656|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
16779439|NCT00700817|37718657|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
16779440|NCT00700817|37718658|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
16779441|NCT00700817|37718659|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
16779442|NCT00700817|37718660|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
16779443|NCT00700817|37718656|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
16779444|NCT00700817|37718657|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
16779445|NCT00700817|37718658|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
16779446|NCT00700817|37718659|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
16779447|NCT00700817|37718660|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
16779448|NCT00700817|37718656|FG000|Week 0-26 (Main Period)|Unclassified|14|||
16779449|NCT00700817|37718657|FG001|Week 0-26 (Main Period)|Unclassified|4|||
16779450|NCT00700817|37718658|FG002|Week 0-26 (Main Period)|Unclassified|8|||
16779451|NCT00700817|37718659|FG003|Week 0-26 (Main Period)|Unclassified|0|||
16779452|NCT00700817|37718660|FG004|Week 0-26 (Main Period)|Unclassified|0|||
16964556|NCT01241552|38107395|FG001|Overall Study|Protocol Violation|2|||
16964557|NCT01241552|38107396|FG002|Overall Study|Protocol Violation|6|||
16964558|NCT01241552|38107397|FG003|Overall Study|Protocol Violation|1|||
16964559|NCT01241552|38107394|FG000|Overall Study|Withdrawal by Subject|7|||
16964560|NCT01241552|38107395|FG001|Overall Study|Withdrawal by Subject|15|||
16964561|NCT01241552|38107396|FG002|Overall Study|Withdrawal by Subject|14|||
16964562|NCT01241552|38107397|FG003|Overall Study|Withdrawal by Subject|15|||
16964563|NCT01241552|38107394|FG000|Overall Study|Physician Decision|2|||
16964564|NCT01241552|38107395|FG001|Overall Study|Physician Decision|4|||
16964565|NCT01241552|38107396|FG002|Overall Study|Physician Decision|2|||
16964566|NCT01241552|38107397|FG003|Overall Study|Physician Decision|3|||
16964567|NCT01241552|38107394|FG000|Overall Study|Lost to Follow-up|2|||
16964568|NCT01241552|38107395|FG001|Overall Study|Lost to Follow-up|11|||
16964569|NCT01241552|38107396|FG002|Overall Study|Lost to Follow-up|15|||
16964570|NCT01241552|38107397|FG003|Overall Study|Lost to Follow-up|16|||
16964571|NCT00948922|38107410|FG000|Overall Study|Did not start study treatment|2|||
16964572|NCT00948922|38107411|FG001|Overall Study|Did not start study treatment|5|||
16964573|NCT00948922|38107412|FG002|Overall Study|Did not start study treatment|0|||
16964574|NCT00948922|38107410|FG000|Overall Study|Withdrawal by Subject|0|||
16964575|NCT00948922|38107411|FG001|Overall Study|Withdrawal by Subject|2|||
16964576|NCT00948922|38107412|FG002|Overall Study|Withdrawal by Subject|1|||
16964577|NCT00948922|38107410|FG000|Overall Study|Death|3|||
16964578|NCT00948922|38107411|FG001|Overall Study|Death|0|||
16964579|NCT00948922|38107412|FG002|Overall Study|Death|0|||
16964580|NCT00948922|38107410|FG000|Overall Study|Disease progression|0|||
16964581|NCT00948922|38107411|FG001|Overall Study|Disease progression|1|||
16964582|NCT00948922|38107412|FG002|Overall Study|Disease progression|0|||
16964583|NCT00948922|38107410|FG000|Overall Study|Insurance issues|1|||
16964584|NCT00948922|38107411|FG001|Overall Study|Insurance issues|0|||
16964585|NCT00948922|38107412|FG002|Overall Study|Insurance issues|0|||
16964586|NCT00948922|38107410|FG000|Overall Study|Transplant eligibility issues|2|||
16964587|NCT00948922|38107411|FG001|Overall Study|Transplant eligibility issues|3|||
16964588|NCT00948922|38107412|FG002|Overall Study|Transplant eligibility issues|0|||
16964589|NCT00948922|38107410|FG000|Overall Study|Not evaluable at time of analysis|0|||
16779453|NCT00700817|37718656|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
16964590|NCT00948922|38107411|FG001|Overall Study|Not evaluable at time of analysis|3|||
16964591|NCT00948922|38107412|FG002|Overall Study|Not evaluable at time of analysis|0|||
16964592|NCT01239992|38107424|FG000|Overall Study|Withdrawal by Subject|2|||
16997747|NCT00732940|38141761|FG001|Overall Study|Adverse Event|1|||
16964593|NCT01072539|38107428|FG000|Overall Study|Treated prior to the Site Initiation|1|||
16964594|NCT01072539|38107428|FG000|Overall Study|Protocol Violation|2|||
16964595|NCT01239680|38107434|FG000|Overall Study|Withdrawal by Subject|2|||
16964596|NCT01239680|38107435|FG001|Overall Study|Withdrawal by Subject|0|||
16964597|NCT01238900|38107441|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
16964598|NCT01238900|38107441|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
16964599|NCT01238822|38107446|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
16964600|NCT01238588|38107456|FG000|Overall Study|Withdrawal by Subject|1|||
16964601|NCT01238588|38107456|FG000|Overall Study|Physician Decision|2|||
16964602|NCT01047501|38107463|FG000|Overall Study|Adverse Event|7|||
16964603|NCT01047501|38107464|FG001|Overall Study|Adverse Event|8|||
16964604|NCT01047501|38107465|FG002|Overall Study|Adverse Event|5|||
16964605|NCT01047501|38107463|FG000|Overall Study|Withdrew Consent|6|||
16964606|NCT01047501|38107464|FG001|Overall Study|Withdrew Consent|2|||
16964607|NCT01047501|38107465|FG002|Overall Study|Withdrew Consent|4|||
16964608|NCT01047501|38107463|FG000|Overall Study|Lost to Follow-up|0|||
16964609|NCT01047501|38107464|FG001|Overall Study|Lost to Follow-up|1|||
16964610|NCT01047501|38107465|FG002|Overall Study|Lost to Follow-up|1|||
16964611|NCT01047501|38107463|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
16964612|NCT01047501|38107464|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
16964613|NCT01047501|38107465|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
16964614|NCT01047501|38107463|FG000|Overall Study|Death|1|||
16964615|NCT01047501|38107464|FG001|Overall Study|Death|0|||
16964616|NCT01047501|38107465|FG002|Overall Study|Death|0|||
16964617|NCT01047501|38107463|FG000|Overall Study|Other discontinuation|1|||
16964618|NCT01047501|38107464|FG001|Overall Study|Other discontinuation|0|||
16964619|NCT01047501|38107465|FG002|Overall Study|Other discontinuation|1|||
16964620|NCT01047501|38107463|FG000|Overall Study|Investigator judgement|0|||
16964621|NCT01047501|38107464|FG001|Overall Study|Investigator judgement|0|||
16964622|NCT01047501|38107465|FG002|Overall Study|Investigator judgement|1|||
16964623|NCT01238120|38107477|FG000|Overall Study|Withdrawal by Subject|4|||
16964624|NCT01238120|38107478|FG001|Overall Study|Withdrawal by Subject|1|||
16964625|NCT01238120|38107479|FG002|Overall Study|Withdrawal by Subject|2|||
16964626|NCT01238120|38107480|FG003|Overall Study|Withdrawal by Subject|5|||
16964627|NCT01238120|38107477|FG000|Overall Study|Lost to Follow-up|2|||
16964628|NCT01238120|38107478|FG001|Overall Study|Lost to Follow-up|0|||
16964629|NCT01238120|38107479|FG002|Overall Study|Lost to Follow-up|1|||
16964630|NCT01238120|38107480|FG003|Overall Study|Lost to Follow-up|1|||
16964631|NCT01238120|38107477|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
16964632|NCT01238120|38107478|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
16964633|NCT01238120|38107479|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
16964634|NCT01238120|38107480|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
16964635|NCT01237340|38107490|FG000|Overall Study|Adverse Event|3|||
16964636|NCT01237340|38107490|FG000|Overall Study|Withdrawal by Subject|1|||
16964637|NCT01237340|38107490|FG000|Overall Study|Early termination of the trial|36|||
16964638|NCT01045707|38107499|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
16964639|NCT01045707|38107500|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
16964640|NCT01045707|38107499|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
16964641|NCT01045707|38107500|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
16964642|NCT01045707|38107499|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
16964643|NCT01045707|38107500|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
16964644|NCT01045707|38107499|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
16964645|NCT01045707|38107500|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
16964646|NCT01045707|38107499|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
16779454|NCT00700817|37718657|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
16779455|NCT00700817|37718658|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
16779456|NCT00700817|37718659|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
16779457|NCT00700817|37718660|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
16779458|NCT00700817|37718656|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
16779459|NCT00700817|37718657|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
16779460|NCT00700817|37718658|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
16779461|NCT00700817|37718659|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
16779462|NCT00700817|37718660|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
16964647|NCT01045707|38107500|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
16997748|NCT00732940|38141760|FG000|Overall Study|Lost to Follow-up|1|||
16964648|NCT01045707|38107499|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
16964649|NCT01045707|38107500|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
16964650|NCT01045707|38107499|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
16964651|NCT01045707|38107500|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
16964652|NCT01045707|38107499|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
16964653|NCT01045707|38107500|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
16964654|NCT01045707|38107499|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
16964655|NCT01045707|38107500|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
16964656|NCT01054599|38107508|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
16964657|NCT01054599|38107509|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
16964658|NCT01054599|38107508|FG000|Overall Study|Protocol Violation|1|||
16964659|NCT01054599|38107509|FG001|Overall Study|Protocol Violation|0|||
16964660|NCT01054599|38107508|FG000|Overall Study|Spells/seizure-like episodes|1|||
16964661|NCT01054599|38107509|FG001|Overall Study|Spells/seizure-like episodes|1|||
16964662|NCT01054599|38107508|FG000|Overall Study|Timing/scheduling difficulties|1|||
16964663|NCT01054599|38107509|FG001|Overall Study|Timing/scheduling difficulties|1|||
16964664|NCT01054599|38107508|FG000|Overall Study|Visual impairment, WTAR <80|0|||
16964665|NCT01054599|38107509|FG001|Overall Study|Visual impairment, WTAR <80|1|||
16964666|NCT01054599|38107508|FG000|Overall Study|Lost to Follow-up|0|||
16964667|NCT01054599|38107509|FG001|Overall Study|Lost to Follow-up|2|||
16964668|NCT01054599|38107508|FG000|Overall Study|Adverse Event|0|||
16964669|NCT01054599|38107509|FG001|Overall Study|Adverse Event|1|||
16964670|NCT01054599|38107508|FG000|Overall Study|Withdrawal by Subject|0|||
16964671|NCT01054599|38107509|FG001|Overall Study|Withdrawal by Subject|1|||
16964672|NCT01236560|38107521|FG000|Overall Study|Adverse Event|0|||
16964673|NCT01236560|38107522|FG001|Overall Study|Adverse Event|2|||
16964674|NCT01236560|38107523|FG002|Overall Study|Adverse Event|1|||
16964675|NCT01236560|38107524|FG003|Overall Study|Adverse Event|3|||
16964676|NCT01236560|38107525|FG004|Overall Study|Adverse Event|0|||
16964677|NCT01236560|38107526|FG005|Overall Study|Adverse Event|0|||
16964678|NCT01236560|38107521|FG000|Overall Study|Death|0|||
16964679|NCT01236560|38107522|FG001|Overall Study|Death|1|||
16964680|NCT01236560|38107523|FG002|Overall Study|Death|0|||
16964681|NCT01236560|38107524|FG003|Overall Study|Death|1|||
16964682|NCT01236560|38107525|FG004|Overall Study|Death|0|||
16779463|NCT00700817|37718656|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
16779464|NCT00700817|37718657|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
16779465|NCT00700817|37718658|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
16779466|NCT00700817|37718659|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
16779467|NCT00700817|37718660|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
16779468|NCT00700817|37718656|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
16779469|NCT00700817|37718657|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
16779470|NCT00700817|37718658|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
16779471|NCT00700817|37718659|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
16779472|NCT00700817|37718660|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
16779473|NCT00700817|37718656|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
16779474|NCT00700817|37718657|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
16779475|NCT00700817|37718658|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
16779476|NCT00700817|37718659|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
16779477|NCT00700817|37718660|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
16779478|NCT00700817|37718656|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
16779479|NCT00700817|37718657|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
16779480|NCT00700817|37718658|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
16779481|NCT00700817|37718659|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
16779482|NCT00700817|37718660|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
16779483|NCT00700817|37718656|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
16779484|NCT00700817|37718657|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
16779485|NCT00700817|37718658|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
16779486|NCT00700817|37718659|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
16779487|NCT00700817|37718660|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
16779488|NCT00700817|37718656|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
16779489|NCT00700817|37718657|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
16779490|NCT00700817|37718658|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
16779491|NCT00700817|37718659|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
16779492|NCT00700817|37718660|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
16964683|NCT01236560|38107526|FG005|Overall Study|Death|0|||
16964684|NCT01236560|38107521|FG000|Overall Study|Lost to Follow-up|0|||
16964685|NCT01236560|38107522|FG001|Overall Study|Lost to Follow-up|1|||
16964686|NCT01236560|38107523|FG002|Overall Study|Lost to Follow-up|1|||
16964687|NCT01236560|38107524|FG003|Overall Study|Lost to Follow-up|0|||
16964688|NCT01236560|38107525|FG004|Overall Study|Lost to Follow-up|0|||
16964689|NCT01236560|38107526|FG005|Overall Study|Lost to Follow-up|0|||
16964690|NCT01236560|38107521|FG000|Overall Study|Physician Decision|0|||
16964691|NCT01236560|38107522|FG001|Overall Study|Physician Decision|1|||
16964692|NCT01236560|38107523|FG002|Overall Study|Physician Decision|8|||
16964693|NCT01236560|38107524|FG003|Overall Study|Physician Decision|0|||
16964694|NCT01236560|38107525|FG004|Overall Study|Physician Decision|0|||
16964695|NCT01236560|38107526|FG005|Overall Study|Physician Decision|0|||
16779493|NCT00700817|37718656|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
16779494|NCT00700817|37718657|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
16779495|NCT00700817|37718658|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
16964696|NCT01236560|38107521|FG000|Overall Study|Withdrawal by Subject|0|||
16964697|NCT01236560|38107522|FG001|Overall Study|Withdrawal by Subject|0|||
16964698|NCT01236560|38107523|FG002|Overall Study|Withdrawal by Subject|1|||
16964699|NCT01236560|38107524|FG003|Overall Study|Withdrawal by Subject|2|||
16964700|NCT01236560|38107525|FG004|Overall Study|Withdrawal by Subject|0|||
16964701|NCT01236560|38107526|FG005|Overall Study|Withdrawal by Subject|0|||
16779496|NCT00700817|37718659|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
16779497|NCT00700817|37718660|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
16964702|NCT01236560|38107521|FG000|Overall Study|Progressive disease|5|||
16964703|NCT01236560|38107522|FG001|Overall Study|Progressive disease|19|||
16964704|NCT01236560|38107523|FG002|Overall Study|Progressive disease|9|||
16964705|NCT01236560|38107524|FG003|Overall Study|Progressive disease|16|||
16964706|NCT01236560|38107525|FG004|Overall Study|Progressive disease|0|||
16964707|NCT01236560|38107526|FG005|Overall Study|Progressive disease|0|||
16964708|NCT00948766|38107538|FG000|Core Study|Adverse Event|73|||
16964709|NCT00948766|38107539|FG001|Core Study|Adverse Event|51|||
16964710|NCT00948766|38107538|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
16964711|NCT00948766|38107539|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
16964712|NCT00948766|38107538|FG000|Core Study|Patient Withdrew Consent|27|||
16964713|NCT00948766|38107539|FG001|Core Study|Patient Withdrew Consent|46|||
16964714|NCT00948766|38107538|FG000|Core Study|Lost to Follow-up|3|||
16964715|NCT00948766|38107539|FG001|Core Study|Lost to Follow-up|2|||
16964716|NCT00948766|38107538|FG000|Core Study|Administrative Problems|2|||
16964717|NCT00948766|38107539|FG001|Core Study|Administrative Problems|2|||
16964718|NCT00948766|38107538|FG000|Core Study|Death|1|||
16964719|NCT00948766|38107539|FG001|Core Study|Death|1|||
16964720|NCT00948766|38107538|FG000|Core Study|Protocol Deviation|8|||
16964721|NCT00948766|38107539|FG001|Core Study|Protocol Deviation|10|||
16964722|NCT00948766|38107538|FG000|Extension Study|Adverse Event|43|||
16964723|NCT00948766|38107539|FG001|Extension Study|Adverse Event|0|||
16964724|NCT00948766|38107538|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
16964725|NCT00948766|38107539|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
16964726|NCT00948766|38107538|FG000|Extension Study|Study Drug No Longer Required|1|||
16964727|NCT00948766|38107539|FG001|Extension Study|Study Drug No Longer Required|0|||
16964728|NCT00948766|38107538|FG000|Extension Study|Patient Withdrew Consent|32|||
16964729|NCT00948766|38107539|FG001|Extension Study|Patient Withdrew Consent|0|||
16964730|NCT00948766|38107538|FG000|Extension Study|Lost to Follow-up|8|||
16964731|NCT00948766|38107539|FG001|Extension Study|Lost to Follow-up|0|||
16964732|NCT00948766|38107538|FG000|Extension Study|Administrative Problems|1|||
16964733|NCT00948766|38107539|FG001|Extension Study|Administrative Problems|0|||
16964734|NCT00948766|38107538|FG000|Extension Study|Death|4|||
16964735|NCT00948766|38107539|FG001|Extension Study|Death|0|||
16964736|NCT01053663|38107549|FG000|Overall Study|Death|2|||
16964737|NCT01053663|38107549|FG000|Overall Study|Lost to Follow-up|1|||
16964738|NCT01053663|38107549|FG000|Overall Study|Poor IV Access|1|||
16964739|NCT01053663|38107549|FG000|Overall Study|Transferred to Another Hospital|1|||
16964740|NCT01053663|38107549|FG000|Overall Study|Negative Influenza Diagnosis|1|||
16964741|NCT01235546|38107561|FG000|Overall Study|Staff error, medication not administered|1|||
16964742|NCT01235546|38107562|FG001|Overall Study|Staff error, medication not administered|0|||
16964743|NCT01235546|38107561|FG000|Overall Study|Protocol Violation|1|||
16964744|NCT01235546|38107562|FG001|Overall Study|Protocol Violation|1|||
16779498|NCT00700817|37718656|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
16779499|NCT00700817|37718657|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
16779500|NCT00700817|37718658|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
16779501|NCT00700817|37718659|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
16964745|NCT01053429|38107577|FG000|Overall Study|Adverse Event|64|||
16964746|NCT01053429|38107577|FG000|Overall Study|Other|309|||
16964747|NCT01233284|38107581|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
16964748|NCT01233284|38107582|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16964749|NCT01233284|38107583|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16964750|NCT01233284|38107584|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16964751|NCT01233284|38107585|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16964752|NCT01233284|38107581|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16964753|NCT01233284|38107582|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
16964754|NCT01233284|38107583|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16964755|NCT01233284|38107584|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16964756|NCT01233284|38107585|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16964757|NCT01233284|38107581|FG000|Period 1 (4 Weeks)|Other|0|||
16964758|NCT01233284|38107582|FG001|Period 1 (4 Weeks)|Other|0|||
16964759|NCT01233284|38107583|FG002|Period 1 (4 Weeks)|Other|1|||
16964760|NCT01233284|38107584|FG003|Period 1 (4 Weeks)|Other|0|||
16964761|NCT01233284|38107585|FG004|Period 1 (4 Weeks)|Other|0|||
16964762|NCT01233284|38107581|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16964763|NCT01233284|38107582|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16964764|NCT01233284|38107583|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
16964765|NCT01233284|38107584|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16964766|NCT01233284|38107585|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16964767|NCT01233284|38107581|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16964768|NCT01233284|38107582|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16964769|NCT01233284|38107583|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
16964770|NCT01233284|38107584|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16964771|NCT01233284|38107585|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16964772|NCT01233284|38107581|FG000|Period 3 (4 Weeks)|Other|0|||
16964773|NCT01233284|38107582|FG001|Period 3 (4 Weeks)|Other|0|||
16964774|NCT01233284|38107583|FG002|Period 3 (4 Weeks)|Other|0|||
16964775|NCT01233284|38107584|FG003|Period 3 (4 Weeks)|Other|1|||
16964776|NCT01233284|38107585|FG004|Period 3 (4 Weeks)|Other|0|||
16964777|NCT01233284|38107581|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
16964778|NCT01233284|38107582|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
16964779|NCT01233284|38107583|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
16964780|NCT01233284|38107584|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
16964781|NCT01233284|38107585|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
16964782|NCT01233284|38107581|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
16964783|NCT01233284|38107582|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
16964784|NCT01233284|38107583|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
16964785|NCT01233284|38107584|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
16964786|NCT01233284|38107585|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
16964787|NCT00948688|38107595|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
16964788|NCT00948688|38107596|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
16964789|NCT00948688|38107595|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
16964790|NCT00948688|38107596|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
16964791|NCT00948688|38107595|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
16964792|NCT00948688|38107596|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
16964793|NCT01233050|38107605|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
16964794|NCT01233050|38107606|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
16964795|NCT01232894|38107614|FG000|Overall Study|Lost to Follow-up|0|||
16964796|NCT01232894|38107615|FG001|Overall Study|Lost to Follow-up|1|||
16964797|NCT01232894|38107614|FG000|Overall Study|Death|1|||
16964798|NCT01232894|38107615|FG001|Overall Study|Death|0|||
16964799|NCT01232894|38107614|FG000|Overall Study|Protocol Violation|1|||
16964800|NCT01232894|38107615|FG001|Overall Study|Protocol Violation|1|||
16964801|NCT01232894|38107614|FG000|Overall Study|Withdrawal by Subject|8|||
16964802|NCT01232894|38107615|FG001|Overall Study|Withdrawal by Subject|5|||
16964803|NCT01232894|38107614|FG000|Overall Study|Physician Decision|2|||
16964804|NCT01232894|38107615|FG001|Overall Study|Physician Decision|1|||
16964805|NCT01049217|38107623|FG000|Overall Study|Adverse Event|2|||
16964806|NCT01049217|38107624|FG001|Overall Study|Adverse Event|1|||
16964807|NCT01049217|38107623|FG000|Overall Study|Lack of Efficacy|1|||
16964808|NCT01049217|38107624|FG001|Overall Study|Lack of Efficacy|1|||
16964809|NCT01049217|38107623|FG000|Overall Study|Lost to Follow-up|3|||
16964810|NCT01049217|38107624|FG001|Overall Study|Lost to Follow-up|8|||
16964811|NCT01049217|38107623|FG000|Overall Study|Withdrawal by Subject|4|||
16964812|NCT01049217|38107624|FG001|Overall Study|Withdrawal by Subject|3|||
16964813|NCT01049217|38107623|FG000|Overall Study|Protocol Violation|1|||
16964814|NCT01049217|38107624|FG001|Overall Study|Protocol Violation|3|||
16964815|NCT01049217|38107623|FG000|Overall Study|Pregnancy|1|||
16964816|NCT01049217|38107624|FG001|Overall Study|Pregnancy|0|||
16964817|NCT01049217|38107623|FG000|Overall Study|Study Terminated by Sponsor|43|||
16964818|NCT01049217|38107624|FG001|Overall Study|Study Terminated by Sponsor|43|||
16964819|NCT01049217|38107623|FG000|Overall Study|Other|1|||
16964820|NCT01049217|38107624|FG001|Overall Study|Other|2|||
16964821|NCT01049217|38107623|FG000|Overall Study|Randomized but not Treated|0|||
16964822|NCT01049217|38107624|FG001|Overall Study|Randomized but not Treated|2|||
16964823|NCT01232738|38107630|FG000|Overall Study|Death|3|||
16964824|NCT01232738|38107630|FG000|Overall Study|Physician Decision|2|||
16964825|NCT01232738|38107630|FG000|Overall Study|Lost to Follow-up|1|||
16964826|NCT01232738|38107630|FG000|Overall Study|Withdrawal by Subject|2|||
16964827|NCT01232738|38107630|FG000|Overall Study|Adverse Event|5|||
16964828|NCT00957268|38107643|FG000|Overall Study|Voluntary Withdrawal|0|||
16964829|NCT00957268|38107644|FG001|Overall Study|Voluntary Withdrawal|0|||
16964830|NCT00957268|38107645|FG002|Overall Study|Voluntary Withdrawal|1|||
16964831|NCT00957268|38107646|FG003|Overall Study|Voluntary Withdrawal|0|||
16964832|NCT00957268|38107647|FG004|Overall Study|Voluntary Withdrawal|0|||
16964833|NCT01230788|38107659|FG000|Overall Study|Prescribed exclusion drug|1|||
16964834|NCT01230710|38107663|FG000|Overall Study|Disease Progression|41|||
16964835|NCT01230710|38107663|FG000|Overall Study|Lost to Follow-up|3|||
16964836|NCT01230710|38107663|FG000|Overall Study|Death|4|||
16964837|NCT01230710|38107663|FG000|Overall Study|Withdrawal of Consent|1|||
16964838|NCT01230554|38107667|FG000|Overall Study|Lost to Follow-up|2|||
16964839|NCT01230554|38107667|FG000|Overall Study|Inability to maintain visit schedule|1|||
16964840|NCT01040793|38107671|FG000|Overall Study|Adverse Event|5|||
16964841|NCT01040793|38107672|FG001|Overall Study|Adverse Event|3|||
16964842|NCT01040793|38107673|FG002|Overall Study|Adverse Event|0|||
16964843|NCT01040793|38107674|FG003|Overall Study|Adverse Event|2|||
16964844|NCT01040793|38107675|FG004|Overall Study|Adverse Event|2|||
16964845|NCT01040793|38107676|FG005|Overall Study|Adverse Event|1|||
16964846|NCT01040793|38107671|FG000|Overall Study|Protocol Violation|1|||
16964847|NCT01040793|38107672|FG001|Overall Study|Protocol Violation|1|||
16964848|NCT01040793|38107673|FG002|Overall Study|Protocol Violation|1|||
16964849|NCT01040793|38107674|FG003|Overall Study|Protocol Violation|0|||
16964850|NCT01040793|38107675|FG004|Overall Study|Protocol Violation|1|||
16964851|NCT01040793|38107676|FG005|Overall Study|Protocol Violation|0|||
16964852|NCT01040793|38107671|FG000|Overall Study|Lost to Follow-up|0|||
16964853|NCT01040793|38107672|FG001|Overall Study|Lost to Follow-up|1|||
16964854|NCT01040793|38107673|FG002|Overall Study|Lost to Follow-up|1|||
16964855|NCT01040793|38107674|FG003|Overall Study|Lost to Follow-up|0|||
16964856|NCT01040793|38107675|FG004|Overall Study|Lost to Follow-up|0|||
16964857|NCT01040793|38107676|FG005|Overall Study|Lost to Follow-up|0|||
16964858|NCT01040793|38107671|FG000|Overall Study|Withdrawal by Subject|0|||
16964859|NCT01040793|38107672|FG001|Overall Study|Withdrawal by Subject|0|||
16964860|NCT01040793|38107673|FG002|Overall Study|Withdrawal by Subject|0|||
16964861|NCT01040793|38107674|FG003|Overall Study|Withdrawal by Subject|2|||
16964862|NCT01040793|38107675|FG004|Overall Study|Withdrawal by Subject|0|||
16964863|NCT01040793|38107676|FG005|Overall Study|Withdrawal by Subject|0|||
16964864|NCT01040793|38107671|FG000|Overall Study|Other reasons not listed above|0|||
16964865|NCT01040793|38107672|FG001|Overall Study|Other reasons not listed above|0|||
16964866|NCT01040793|38107673|FG002|Overall Study|Other reasons not listed above|1|||
16964867|NCT01040793|38107674|FG003|Overall Study|Other reasons not listed above|0|||
16964868|NCT01040793|38107675|FG004|Overall Study|Other reasons not listed above|1|||
16964869|NCT01040793|38107676|FG005|Overall Study|Other reasons not listed above|0|||
16964870|NCT00948064|38107689|FG000|Phase I|No treatment received|1|||
16964871|NCT00948064|38107690|FG001|Phase I|No treatment received|0|||
16964872|NCT00948064|38107691|FG002|Phase I|No treatment received|0|||
16964873|NCT00948064|38107689|FG000|Phase II|Physician Decision|0|||
16964874|NCT00948064|38107690|FG001|Phase II|Physician Decision|0|||
16964875|NCT00948064|38107691|FG002|Phase II|Physician Decision|1|||
16964876|NCT00948064|38107689|FG000|Phase II|Withdrawal by Subject|0|||
16964877|NCT00948064|38107690|FG001|Phase II|Withdrawal by Subject|1|||
16964878|NCT00948064|38107691|FG002|Phase II|Withdrawal by Subject|0|||
16779502|NCT00700817|37718660|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
16964879|NCT00953524|38107705|FG000|Overall Study|Adverse Event|2|||
16964880|NCT00953524|38107706|FG001|Overall Study|Adverse Event|0|||
16964881|NCT00953524|38107707|FG002|Overall Study|Adverse Event|1|||
16964882|NCT00953524|38107708|FG003|Overall Study|Adverse Event|2|||
16964883|NCT00953524|38107705|FG000|Overall Study|Protocol Violation|18|||
16964884|NCT00953524|38107706|FG001|Overall Study|Protocol Violation|10|||
16964885|NCT00953524|38107707|FG002|Overall Study|Protocol Violation|11|||
16779503|NCT02625909|37718672|FG000|Overall Study|Death|2|||
16779504|NCT02625909|37718673|FG001|Overall Study|Death|0|||
16779505|NCT02625909|37718672|FG000|Overall Study|Lost to Follow-up|3|||
16779506|NCT02625909|37718673|FG001|Overall Study|Lost to Follow-up|5|||
16779507|NCT02625909|37718672|FG000|Overall Study|Lack of Efficacy|9|||
16779508|NCT02625909|37718673|FG001|Overall Study|Lack of Efficacy|2|||
16779509|NCT02625909|37718672|FG000|Overall Study|Reinfection|3|||
16779510|NCT02625909|37718673|FG001|Overall Study|Reinfection|2|||
16779511|NCT02623959|37718681|FG000|Overall Study|Progression|0|||
16779512|NCT02623959|37718682|FG001|Overall Study|Progression|1|||
16779513|NCT00700739|37718692|FG000|Overall Study|Lost to Follow-up|4|||
16779514|NCT00700739|37718693|FG001|Overall Study|Lost to Follow-up|4|||
16867987|NCT01553747|37841012|FG001|Overall Study|Physician decision: other|8|||
16867988|NCT01553747|37841013|FG002|Overall Study|Physician decision: other|7|||
16964886|NCT00953524|38107708|FG003|Overall Study|Protocol Violation|6|||
16964887|NCT00953524|38107705|FG000|Overall Study|Lost to Follow-up|0|||
16964888|NCT00953524|38107706|FG001|Overall Study|Lost to Follow-up|1|||
16964889|NCT00953524|38107707|FG002|Overall Study|Lost to Follow-up|1|||
16964890|NCT00953524|38107708|FG003|Overall Study|Lost to Follow-up|0|||
16964891|NCT00953524|38107705|FG000|Overall Study|Withdrawal by Subject|2|||
16779515|NCT02623335|37718702|FG000|Overall Study|Death|8|||
16779516|NCT02623335|37718703|FG001|Overall Study|Death|7|||
16779517|NCT02623335|37718702|FG000|Overall Study|Lost to Follow-up|15|||
16964892|NCT00953524|38107706|FG001|Overall Study|Withdrawal by Subject|4|||
16779518|NCT02623335|37718703|FG001|Overall Study|Lost to Follow-up|23|||
16779519|NCT02623335|37718702|FG000|Overall Study|Withdrawal by Subject|2|||
16779520|NCT02623335|37718703|FG001|Overall Study|Withdrawal by Subject|5|||
16779521|NCT02623335|37718702|FG000|Overall Study|Protocol Violation|2|||
16779522|NCT02623335|37718703|FG001|Overall Study|Protocol Violation|1|||
16779523|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
16779524|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
16964893|NCT00953524|38107707|FG002|Overall Study|Withdrawal by Subject|1|||
16964894|NCT00953524|38107708|FG003|Overall Study|Withdrawal by Subject|0|||
16964895|NCT01040403|38107727|FG000|Overall Study|Adverse Event|10|||
16964896|NCT01040403|38107727|FG000|Overall Study|Protocol Violation|2|||
16964897|NCT01040403|38107727|FG000|Overall Study|Lost to Follow-up|1|||
16964898|NCT01040403|38107727|FG000|Overall Study|Not treated|1|||
16964899|NCT01040403|38107727|FG000|Overall Study|Other reason not defined above|6|||
16964900|NCT00957034|38107749|FG000|Overall Study|Adverse Event|0|||
16964901|NCT00957034|38107750|FG001|Overall Study|Adverse Event|1|||
16964902|NCT00957034|38107751|FG002|Overall Study|Adverse Event|1|||
16964903|NCT00957034|38107749|FG000|Overall Study|Sponsor Terminated Study|6|||
16964904|NCT00957034|38107750|FG001|Overall Study|Sponsor Terminated Study|1|||
16964905|NCT00957034|38107751|FG002|Overall Study|Sponsor Terminated Study|5|||
16964906|NCT00957034|38107749|FG000|Overall Study|Withdrawal by Subject|0|||
16964907|NCT00957034|38107750|FG001|Overall Study|Withdrawal by Subject|2|||
16964908|NCT00957034|38107751|FG002|Overall Study|Withdrawal by Subject|0|||
16964909|NCT00953056|38107774|FG000|Overall Study|Withdrew Consent|0|||
16964910|NCT00953056|38107775|FG001|Overall Study|Withdrew Consent|0|||
16964911|NCT00953056|38107776|FG002|Overall Study|Withdrew Consent|0|||
16964912|NCT00953056|38107777|FG003|Overall Study|Withdrew Consent|0|||
16964913|NCT00953056|38107778|FG004|Overall Study|Withdrew Consent|2|||
16964914|NCT00953056|38107779|FG005|Overall Study|Withdrew Consent|3|||
16964915|NCT00953056|38107774|FG000|Overall Study|Serious Adverse Event|0|||
16964916|NCT00953056|38107775|FG001|Overall Study|Serious Adverse Event|0|||
16964917|NCT00953056|38107776|FG002|Overall Study|Serious Adverse Event|0|||
16964918|NCT00953056|38107777|FG003|Overall Study|Serious Adverse Event|0|||
16964919|NCT00953056|38107778|FG004|Overall Study|Serious Adverse Event|0|||
16964920|NCT00953056|38107779|FG005|Overall Study|Serious Adverse Event|1|||
16964921|NCT00952822|38107804|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
16964922|NCT00952822|38107805|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
16964923|NCT00952822|38107806|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
16964924|NCT00952822|38107807|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
16964925|NCT00952822|38107804|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
16964926|NCT00952822|38107805|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
16779525|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
16779526|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
16779527|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
16779528|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
16779529|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
16779530|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
16964927|NCT00952822|38107806|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
16964928|NCT00952822|38107807|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
16964929|NCT01038297|38107821|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
16964930|NCT01038297|38107822|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
16964931|NCT01038297|38107823|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
16964932|NCT00955708|38107840|FG000|Overall Study|Death|269|||
16964933|NCT00955708|38107840|FG000|Overall Study|Lost to Follow-up|72|||
16964934|NCT00955708|38107840|FG000|Overall Study|Physician Decision|36|||
16964935|NCT00955708|38107840|FG000|Overall Study|Protocol Violation|134|||
16779531|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
16779532|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
16779533|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
16779534|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
16779535|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
16779536|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
16779537|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
16779538|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
16779539|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
16779540|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
16779541|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
16964936|NCT00955708|38107840|FG000|Overall Study|Registry Conclusion|186|||
16964937|NCT00955708|38107840|FG000|Overall Study|Product removed from service|94|||
16964938|NCT00955708|38107840|FG000|Overall Study|Patient Refused to participate further|116|||
16964939|NCT00955708|38107840|FG000|Overall Study|Closure of study location|60|||
16779542|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
16779543|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
16779544|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
16779545|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
16779546|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
16964940|NCT00955708|38107840|FG000|Overall Study|Patient changed care provider/moved|91|||
16964941|NCT01037985|38107844|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
16964942|NCT01037985|38107845|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
16964943|NCT01037985|38107844|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
16964944|NCT01037985|38107845|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
16779547|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
16779548|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
16779549|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
16867989|NCT01553747|37841011|FG000|Overall Study|Lost to Follow-up|11|||
16964945|NCT01037985|38107844|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
16964946|NCT01037985|38107845|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
16964947|NCT01037985|38107844|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
16964948|NCT01037985|38107845|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
16964949|NCT00955474|38107857|FG000|Overall Study|Physician Decision|7|||
16964950|NCT00955474|38107858|FG001|Overall Study|Physician Decision|5|||
16964951|NCT01229150|38107870|FG000|Overall Study|Toxicity|2|||
16964952|NCT01229150|38107871|FG001|Overall Study|Toxicity|2|||
16964953|NCT01229150|38107872|FG002|Overall Study|Toxicity|0|||
16964954|NCT01229150|38107873|FG003|Overall Study|Toxicity|0|||
16964955|NCT00952588|38107889|FG000|Overall Study|Death|28|||
16964956|NCT00952588|38107890|FG001|Overall Study|Death|13|||
16964957|NCT00952588|38107889|FG000|Overall Study|Withdrawal by Subject|2|||
16964958|NCT00952588|38107890|FG001|Overall Study|Withdrawal by Subject|5|||
16964959|NCT00952588|38107889|FG000|Overall Study|Adverse Event|2|||
16964960|NCT00952588|38107890|FG001|Overall Study|Adverse Event|3|||
16964961|NCT00952588|38107889|FG000|Overall Study|Lost to Follow-up|2|||
16964962|NCT00952588|38107890|FG001|Overall Study|Lost to Follow-up|0|||
16964963|NCT00952588|38107889|FG000|Overall Study|Physician Decision|0|||
16964964|NCT00952588|38107890|FG001|Overall Study|Physician Decision|1|||
16964965|NCT00952588|38107889|FG000|Overall Study|Lack of Efficacy|2|||
16964966|NCT00952588|38107890|FG001|Overall Study|Lack of Efficacy|2|||
16964967|NCT01227902|38107900|FG000|Overall Study|Adverse Event|12|||
16964968|NCT01227902|38107901|FG001|Overall Study|Adverse Event|8|||
16964969|NCT01227902|38107902|FG002|Overall Study|Adverse Event|11|||
16964970|NCT01227902|38107903|FG003|Overall Study|Adverse Event|4|||
16964971|NCT01227902|38107900|FG000|Overall Study|Lack of Efficacy|1|||
16964972|NCT01227902|38107901|FG001|Overall Study|Lack of Efficacy|2|||
16964973|NCT01227902|38107902|FG002|Overall Study|Lack of Efficacy|2|||
16964974|NCT01227902|38107903|FG003|Overall Study|Lack of Efficacy|1|||
16964975|NCT01227902|38107900|FG000|Overall Study|Protocol Violation|1|||
16964976|NCT01227902|38107901|FG001|Overall Study|Protocol Violation|0|||
16964977|NCT01227902|38107902|FG002|Overall Study|Protocol Violation|0|||
16964978|NCT01227902|38107903|FG003|Overall Study|Protocol Violation|0|||
16964979|NCT01227902|38107900|FG000|Overall Study|Lost to Follow-up|0|||
16964980|NCT01227902|38107901|FG001|Overall Study|Lost to Follow-up|0|||
16964981|NCT01227902|38107902|FG002|Overall Study|Lost to Follow-up|1|||
16964982|NCT01227902|38107903|FG003|Overall Study|Lost to Follow-up|2|||
16964983|NCT01227902|38107900|FG000|Overall Study|Physician Decision|0|||
16964984|NCT01227902|38107901|FG001|Overall Study|Physician Decision|1|||
16964985|NCT01227902|38107902|FG002|Overall Study|Physician Decision|1|||
16964986|NCT01227902|38107903|FG003|Overall Study|Physician Decision|0|||
16964987|NCT01227902|38107900|FG000|Overall Study|Withdrawal by Subject|4|||
16964988|NCT01227902|38107901|FG001|Overall Study|Withdrawal by Subject|2|||
16964989|NCT01227902|38107902|FG002|Overall Study|Withdrawal by Subject|4|||
16964990|NCT01227902|38107903|FG003|Overall Study|Withdrawal by Subject|3|||
16964991|NCT00946192|38107917|FG000|Overall Study|Lost to Follow-up|6|||
16964992|NCT00946192|38107918|FG001|Overall Study|Lost to Follow-up|11|||
16964993|NCT00946192|38107919|FG002|Overall Study|Lost to Follow-up|9|||
16964994|NCT00946192|38107917|FG000|Overall Study|Withdrawal by Subject|10|||
16964995|NCT00946192|38107918|FG001|Overall Study|Withdrawal by Subject|7|||
16964996|NCT00946192|38107919|FG002|Overall Study|Withdrawal by Subject|3|||
16964997|NCT00946192|38107917|FG000|Overall Study|Did not start medication|2|||
16964998|NCT00946192|38107918|FG001|Overall Study|Did not start medication|0|||
16964999|NCT00946192|38107919|FG002|Overall Study|Did not start medication|0|||
16965000|NCT01037127|38107929|FG000|Overall Study|Lost to Follow-up|2|||
16965001|NCT01037127|38107930|FG001|Overall Study|Lost to Follow-up|4|||
16965002|NCT01037127|38107929|FG000|Overall Study|Physician Decision|1|||
16965003|NCT01037127|38107930|FG001|Overall Study|Physician Decision|0|||
16965004|NCT01037127|38107929|FG000|Overall Study|Study Closed Terminated|2|||
16965005|NCT01037127|38107930|FG001|Overall Study|Study Closed Terminated|17|||
16965006|NCT00946114|38107948|FG000|Overall Study|Death|5|||
16965007|NCT00946114|38107949|FG001|Overall Study|Death|2|||
16965008|NCT00946114|38107948|FG000|Overall Study|Other|1|||
16965009|NCT00946114|38107949|FG001|Overall Study|Other|0|||
16965010|NCT00946114|38107948|FG000|Overall Study|Withdrawal by Subject|2|||
16965011|NCT00946114|38107949|FG001|Overall Study|Withdrawal by Subject|0|||
16965012|NCT01038921|38107957|FG000|Overall Study|Withdrawal by Subject|1|||
16965013|NCT01038921|38107958|FG001|Overall Study|Withdrawal by Subject|0|||
16965014|NCT01038921|38107957|FG000|Overall Study|Physician Decision|1|||
16965015|NCT01038921|38107958|FG001|Overall Study|Physician Decision|0|||
16965016|NCT01038687|38107967|FG000|Overall Study|Adverse Event|0|||
16965017|NCT01038687|38107968|FG001|Overall Study|Adverse Event|2|||
16965018|NCT01038687|38107969|FG002|Overall Study|Adverse Event|1|||
16965019|NCT01081912|38107977|FG000|Conversion/Titration|Adverse Event|47|||
16965020|NCT01081912|38107978|FG001|Conversion/Titration|Adverse Event|0|||
16965021|NCT01081912|38107979|FG002|Conversion/Titration|Adverse Event|0|||
16965022|NCT01081912|38107977|FG000|Conversion/Titration|Lack of Efficacy|17|||
16965023|NCT01081912|38107978|FG001|Conversion/Titration|Lack of Efficacy|0|||
16965024|NCT01081912|38107979|FG002|Conversion/Titration|Lack of Efficacy|0|||
16965025|NCT01081912|38107977|FG000|Conversion/Titration|Lost to Follow-up|5|||
16965026|NCT01081912|38107978|FG001|Conversion/Titration|Lost to Follow-up|0|||
16965027|NCT01081912|38107979|FG002|Conversion/Titration|Lost to Follow-up|0|||
16965028|NCT01081912|38107977|FG000|Conversion/Titration|Physician Decision|2|||
16965029|NCT01081912|38107978|FG001|Conversion/Titration|Physician Decision|0|||
16965030|NCT01081912|38107979|FG002|Conversion/Titration|Physician Decision|0|||
16965031|NCT01081912|38107977|FG000|Conversion/Titration|Protocol Violation|67|||
16965032|NCT01081912|38107978|FG001|Conversion/Titration|Protocol Violation|0|||
16965033|NCT01081912|38107979|FG002|Conversion/Titration|Protocol Violation|0|||
16965034|NCT01081912|38107977|FG000|Conversion/Titration|Withdrawal by Subject|23|||
16965035|NCT01081912|38107978|FG001|Conversion/Titration|Withdrawal by Subject|0|||
16965036|NCT01081912|38107979|FG002|Conversion/Titration|Withdrawal by Subject|0|||
16965037|NCT01081912|38107977|FG000|Conversion/Titration|Non-Compliance|47|||
16965038|NCT01081912|38107978|FG001|Conversion/Titration|Non-Compliance|0|||
16965039|NCT01081912|38107979|FG002|Conversion/Titration|Non-Compliance|0|||
16965040|NCT01081912|38107977|FG000|Maintenance Treatment|Adverse Event|0|||
16965041|NCT01081912|38107978|FG001|Maintenance Treatment|Adverse Event|2|||
16965042|NCT01081912|38107979|FG002|Maintenance Treatment|Adverse Event|12|||
16965043|NCT01081912|38107977|FG000|Maintenance Treatment|Lack of Efficacy|0|||
16965044|NCT01081912|38107978|FG001|Maintenance Treatment|Lack of Efficacy|14|||
16965045|NCT01081912|38107979|FG002|Maintenance Treatment|Lack of Efficacy|64|||
16965046|NCT01081912|38107977|FG000|Maintenance Treatment|Lost to Follow-up|0|||
16965047|NCT01081912|38107978|FG001|Maintenance Treatment|Lost to Follow-up|1|||
16965048|NCT01081912|38107979|FG002|Maintenance Treatment|Lost to Follow-up|0|||
16965049|NCT01081912|38107977|FG000|Maintenance Treatment|Physician Decision|0|||
16965050|NCT01081912|38107978|FG001|Maintenance Treatment|Physician Decision|0|||
16965051|NCT01081912|38107979|FG002|Maintenance Treatment|Physician Decision|1|||
16965052|NCT01081912|38107977|FG000|Maintenance Treatment|Protocol Violation|0|||
16965053|NCT01081912|38107978|FG001|Maintenance Treatment|Protocol Violation|1|||
16965054|NCT01081912|38107979|FG002|Maintenance Treatment|Protocol Violation|2|||
16867990|NCT01553747|37841012|FG001|Overall Study|Lost to Follow-up|5|||
16965055|NCT01081912|38107977|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
16779550|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
16779551|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
16779552|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
16779553|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
16779554|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
16965056|NCT01081912|38107978|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
16965057|NCT01081912|38107979|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
16965058|NCT01081912|38107977|FG000|Maintenance Treatment|Non-Compliance|0|||
16965059|NCT01081912|38107978|FG001|Maintenance Treatment|Non-Compliance|4|||
16965060|NCT01081912|38107979|FG002|Maintenance Treatment|Non-Compliance|7|||
16965061|NCT01081912|38107977|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
16965062|NCT01081912|38107978|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
16965063|NCT01081912|38107979|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
16965064|NCT01038609|38107991|FG000|Overall Study|Adverse Event|0|||
16965065|NCT01038609|38107992|FG001|Overall Study|Adverse Event|0|||
16965066|NCT01038609|38107993|FG002|Overall Study|Adverse Event|1|||
16965067|NCT01038609|38107994|FG003|Overall Study|Adverse Event|0|||
16965068|NCT01038609|38107995|FG004|Overall Study|Adverse Event|0|||
16965069|NCT01038609|38107991|FG000|Overall Study|Dosing Error|0|||
16965070|NCT01038609|38107992|FG001|Overall Study|Dosing Error|0|||
16965071|NCT01038609|38107993|FG002|Overall Study|Dosing Error|0|||
16965072|NCT01038609|38107994|FG003|Overall Study|Dosing Error|1|||
16965073|NCT01038609|38107995|FG004|Overall Study|Dosing Error|1|||
16965074|NCT01038609|38107991|FG000|Overall Study|Death in the Family|1|||
16965075|NCT01038609|38107992|FG001|Overall Study|Death in the Family|0|||
16965076|NCT01038609|38107993|FG002|Overall Study|Death in the Family|0|||
16965077|NCT01038609|38107994|FG003|Overall Study|Death in the Family|0|||
16965078|NCT01038609|38107995|FG004|Overall Study|Death in the Family|0|||
16965079|NCT01038609|38107991|FG000|Overall Study|Refusal of Blood Draws|0|||
16965080|NCT01038609|38107992|FG001|Overall Study|Refusal of Blood Draws|1|||
16965081|NCT01038609|38107993|FG002|Overall Study|Refusal of Blood Draws|0|||
16965082|NCT01038609|38107994|FG003|Overall Study|Refusal of Blood Draws|0|||
16965083|NCT01038609|38107995|FG004|Overall Study|Refusal of Blood Draws|0|||
16965084|NCT02357134|38108011|FG000|Overall Study|Lost to Follow-up|1|||
16965085|NCT02357134|38108012|FG001|Overall Study|Lost to Follow-up|0|||
16965086|NCT02357134|38108013|FG002|Overall Study|Lost to Follow-up|0|||
16965087|NCT02357134|38108014|FG003|Overall Study|Lost to Follow-up|0|||
16965088|NCT00745420|38108024|FG000|Overall Study|Ineligible|1|||
16965089|NCT02853370|38108028|FG000|Overall Study|Physician Decision|1|||
16965090|NCT02853370|38108028|FG000|Overall Study|Lack of Efficacy|2|||
16965091|NCT02853370|38108028|FG000|Overall Study|Death|1|||
16965092|NCT02853370|38108028|FG000|Overall Study|Adverse Event|4|||
16965093|NCT02853370|38108028|FG000|Overall Study|Withdrawal by Subject|3|||
16965094|NCT01879072|38108033|FG000|Overall Study|Withdrawal by Subject|121|||
16965095|NCT01879072|38108033|FG000|Overall Study|Not Transplanted|30|||
16965096|NCT00954538|38108039|FG000|Part III|Withdrawal by Subject|0|||
16965097|NCT00954538|38108040|FG001|Part III|Withdrawal by Subject|0|||
16965098|NCT00954538|38108041|FG002|Part III|Withdrawal by Subject|0|||
16965099|NCT00954538|38108042|FG003|Part III|Withdrawal by Subject|0|||
16965100|NCT00954538|38108043|FG004|Part III|Withdrawal by Subject|1|||
16965101|NCT00954538|38108044|FG005|Part III|Withdrawal by Subject|0|||
16965102|NCT00943852|38108053|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16965103|NCT00943852|38108054|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16965104|NCT00943852|38108055|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16965105|NCT00943852|38108056|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
16965106|NCT00943852|38108057|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16965107|NCT00943852|38108058|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16997749|NCT00732940|38141761|FG001|Overall Study|Lost to Follow-up|0|||
16965108|NCT00943852|38108059|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16965109|NCT00943852|38108060|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16965110|NCT00943852|38108061|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16965111|NCT00943852|38108062|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16965112|NCT00943852|38108053|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965113|NCT00943852|38108054|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965114|NCT00943852|38108055|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965115|NCT00943852|38108056|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965116|NCT00943852|38108057|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965117|NCT00943852|38108058|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
16965118|NCT00943852|38108059|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965119|NCT00943852|38108060|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965120|NCT00943852|38108061|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965121|NCT00943852|38108062|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16965122|NCT00943852|38108053|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965123|NCT00943852|38108054|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965124|NCT00943852|38108055|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965125|NCT00943852|38108056|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965126|NCT00943852|38108057|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965127|NCT00943852|38108058|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965128|NCT00943852|38108059|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
16965129|NCT00943852|38108060|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965130|NCT00943852|38108061|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965131|NCT00943852|38108062|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16965132|NCT00943852|38108053|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965133|NCT00943852|38108054|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965134|NCT00943852|38108055|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965135|NCT00943852|38108056|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965136|NCT00943852|38108057|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965137|NCT00943852|38108058|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965138|NCT00943852|38108059|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965139|NCT00943852|38108060|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
16965140|NCT00943852|38108061|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965141|NCT00943852|38108062|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16965142|NCT00943852|38108053|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
16965143|NCT00943852|38108054|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16965144|NCT00943852|38108055|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
16779555|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
16779556|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
16965145|NCT00943852|38108056|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
16965146|NCT00943852|38108057|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16965147|NCT00943852|38108058|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16965148|NCT00943852|38108059|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
16965149|NCT00943852|38108060|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16965150|NCT00943852|38108061|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16965151|NCT00943852|38108062|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16965152|NCT00952276|38108077|FG000|Overall Study|Withdrawal by Subject|1|||
16965153|NCT00952276|38108078|FG001|Overall Study|Withdrawal by Subject|0|||
16965154|NCT00952276|38108079|FG002|Overall Study|Withdrawal by Subject|0|||
16965155|NCT00952276|38108080|FG003|Overall Study|Withdrawal by Subject|1|||
16965156|NCT00952276|38108081|FG004|Overall Study|Withdrawal by Subject|0|||
16965157|NCT00943384|38108093|FG000|Overall Study|Dispositioned prior to treatment|23|||
16965158|NCT00943384|38108093|FG000|Overall Study|Treated off protocol-protocol violation|5|||
16965159|NCT00943384|38108093|FG000|Overall Study|Lost to Follow-up|16|||
16965160|NCT00943384|38108093|FG000|Overall Study|Withdrawal by Subject|5|||
16965161|NCT00943306|38108097|FG000|Overall Study|Physician Decision|1|||
16965162|NCT00943306|38108097|FG000|Overall Study|Death|1|||
16965163|NCT00943306|38108097|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
16965164|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
16965165|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
16965166|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
16779557|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
16779558|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
16779559|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
16779560|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
16779561|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
16779562|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
16779563|NCT00700427|37718713|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
16779564|NCT00700427|37718714|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
16779565|NCT00700427|37718715|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
16779566|NCT00700427|37718716|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
16779567|NCT00700427|37718717|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
16779568|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
16779569|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
16779570|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
16779571|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
16779572|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
16965167|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
16965168|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
16965169|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
16965170|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
16965171|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
16965172|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
16965173|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
16965174|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
16965175|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
16965176|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
16965177|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
16965178|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
16965179|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
16965180|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
16779573|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
16779574|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
16779575|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
16779576|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
16779577|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
16779578|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
16779579|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
16779580|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
16779581|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
16779582|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
16867991|NCT01553747|37841013|FG002|Overall Study|Lost to Follow-up|6|||
16867992|NCT01553747|37841011|FG000|Overall Study|Sponsor decision, specify|7|||
16867993|NCT01553747|37841012|FG001|Overall Study|Sponsor decision, specify|5|||
16867994|NCT01553747|37841013|FG002|Overall Study|Sponsor decision, specify|0|||
16867995|NCT01553747|37841011|FG000|Overall Study|Physician decision: lack of efficacy|1|||
16867996|NCT01553747|37841012|FG001|Overall Study|Physician decision: lack of efficacy|5|||
16965181|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
16965182|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
16965183|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
16965184|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
16965185|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
16965186|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
16965187|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
16965188|NCT01198002|38108104|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
16965189|NCT01198002|38108105|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
16965190|NCT01198002|38108106|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
16965191|NCT01198002|38108104|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
16965192|NCT01198002|38108105|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
16965193|NCT01198002|38108106|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
16965194|NCT01198002|38108104|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
16867997|NCT01553747|37841013|FG002|Overall Study|Physician decision: lack of efficacy|3|||
16867998|NCT01536379|37841026|FG000|Overall Study|Adverse Event|1|||
16965195|NCT01198002|38108105|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
16867999|NCT01536379|37841027|FG001|Overall Study|Adverse Event|2|||
16868000|NCT01536379|37841026|FG000|Overall Study|Withdrawal by Subject|1|||
16868001|NCT01536379|37841027|FG001|Overall Study|Withdrawal by Subject|1|||
16868002|NCT01536145|37841033|FG000|Overall Study|Progressive disease|3|||
16965196|NCT01198002|38108106|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
16965197|NCT01198002|38108104|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
16965198|NCT01198002|38108105|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
16965199|NCT01198002|38108106|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
16965200|NCT01198002|38108104|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
16965201|NCT01198002|38108105|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
16965202|NCT01198002|38108106|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
16965203|NCT01198002|38108104|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
16965204|NCT01198002|38108105|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
16997750|NCT00962390|38141771|FG000|Overall Study|Adverse Event|0|||
16779583|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
16779584|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
16779585|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
16779586|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
16779587|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
16779588|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
16779589|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
16779590|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
16779591|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
16779592|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
16779593|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
16779594|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
16779595|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
16779596|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
16779597|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
16965205|NCT01198002|38108106|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
16965206|NCT01198002|38108104|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
16965207|NCT01198002|38108105|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
16965208|NCT01198002|38108106|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
16965209|NCT01197534|38108139|FG000|Overall Study|Not reported|16|||
16965210|NCT01197534|38108140|FG001|Overall Study|Not reported|10|||
16965211|NCT01197534|38108141|FG002|Overall Study|Not reported|16|||
16965212|NCT01197534|38108139|FG000|Overall Study|Enrolment in long term extension|57|||
16965213|NCT01197534|38108140|FG001|Overall Study|Enrolment in long term extension|66|||
16965214|NCT01197534|38108141|FG002|Overall Study|Enrolment in long term extension|119|||
16965215|NCT01197534|38108139|FG000|Overall Study|Severe non-compliance to protocol|3|||
16965216|NCT01197534|38108140|FG001|Overall Study|Severe non-compliance to protocol|4|||
16965217|NCT01197534|38108141|FG002|Overall Study|Severe non-compliance to protocol|1|||
16965218|NCT01197534|38108139|FG000|Overall Study|Lack of therapeutic response|9|||
16965219|NCT01197534|38108140|FG001|Overall Study|Lack of therapeutic response|4|||
16965220|NCT01197534|38108141|FG002|Overall Study|Lack of therapeutic response|9|||
16965221|NCT01197534|38108139|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
16965222|NCT01197534|38108140|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
16965223|NCT01197534|38108141|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
16965224|NCT01197534|38108139|FG000|Overall Study|Lost to Follow-up|1|||
16965225|NCT01197534|38108140|FG001|Overall Study|Lost to Follow-up|4|||
16965226|NCT01197534|38108141|FG002|Overall Study|Lost to Follow-up|2|||
16965227|NCT01197534|38108139|FG000|Overall Study|Adverse Event|35|||
16965228|NCT01197534|38108140|FG001|Overall Study|Adverse Event|36|||
16965229|NCT01197534|38108141|FG002|Overall Study|Adverse Event|24|||
16965230|NCT01197378|38108152|FG000|Overall Study|Adverse Event|3|||
16965231|NCT01197378|38108152|FG000|Overall Study|Withdrawal by Subject|1|||
16965232|NCT01197378|38108152|FG000|Overall Study|Physician Decision|1|||
16965233|NCT01197378|38108152|FG000|Overall Study|Other|2|||
16965234|NCT01197300|38108158|FG000|Overall Study|Lost to Follow-up|0|||
16965235|NCT01197300|38108159|FG001|Overall Study|Lost to Follow-up|1|||
16779598|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
16779599|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
16779600|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
16779601|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
16779602|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
16779603|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
16779604|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
16779605|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
16965236|NCT01197300|38108158|FG000|Overall Study|Protocol Violation|0|||
16965237|NCT01197300|38108159|FG001|Overall Study|Protocol Violation|1|||
16965238|NCT01196988|38108174|FG000|Overall Study|Adverse Event|1|||
16965239|NCT01196988|38108175|FG001|Overall Study|Adverse Event|2|||
16965240|NCT01196988|38108176|FG002|Overall Study|Adverse Event|0|||
16965241|NCT01196988|38108177|FG003|Overall Study|Adverse Event|0|||
16965242|NCT01196988|38108174|FG000|Overall Study|Withdrawal by Subject|5|||
16965243|NCT01196988|38108175|FG001|Overall Study|Withdrawal by Subject|1|||
16965244|NCT01196988|38108176|FG002|Overall Study|Withdrawal by Subject|4|||
16965245|NCT01196988|38108177|FG003|Overall Study|Withdrawal by Subject|0|||
16965246|NCT01196988|38108174|FG000|Overall Study|Lost to Follow-up|16|||
16965247|NCT01196988|38108175|FG001|Overall Study|Lost to Follow-up|29|||
16965248|NCT01196988|38108176|FG002|Overall Study|Lost to Follow-up|21|||
16965249|NCT01196988|38108177|FG003|Overall Study|Lost to Follow-up|1|||
16965250|NCT01196988|38108174|FG000|Overall Study|Other|2|||
16965251|NCT01196988|38108175|FG001|Overall Study|Other|0|||
16965252|NCT01196988|38108176|FG002|Overall Study|Other|0|||
16965253|NCT01196988|38108177|FG003|Overall Study|Other|0|||
16965254|NCT01196052|38108188|FG000|Overall Study|Adverse Event|9|||
16965255|NCT01196052|38108188|FG000|Overall Study|Lost to Follow-up|1|||
16965256|NCT01196052|38108188|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
16965257|NCT01196052|38108188|FG000|Overall Study|Reason not Specified|5|||
16965258|NCT01196052|38108188|FG000|Overall Study|Withdrawal by Subject|6|||
16965259|NCT01195662|38108195|FG000|Double Blind Treatment Period|Adverse Event|4|||
16965260|NCT01195662|38108196|FG001|Double Blind Treatment Period|Adverse Event|1|||
16965261|NCT01195662|38108197|FG002|Double Blind Treatment Period|Adverse Event|2|||
16965262|NCT01195662|38108195|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
16965263|NCT01195662|38108196|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
16965264|NCT01195662|38108197|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
16965265|NCT01195662|38108195|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
16965266|NCT01195662|38108196|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
16997751|NCT00962390|38141772|FG001|Overall Study|Adverse Event|0|||
16965267|NCT01195662|38108197|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
16965268|NCT01195662|38108195|FG000|Double Blind Treatment Period|Administrative reason|2|||
16965269|NCT01195662|38108196|FG001|Double Blind Treatment Period|Administrative reason|1|||
16965270|NCT01195662|38108197|FG002|Double Blind Treatment Period|Administrative reason|1|||
16965271|NCT01195662|38108195|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
16965272|NCT01195662|38108196|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
16965273|NCT01195662|38108197|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
16965274|NCT01195662|38108195|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
16965275|NCT01195662|38108196|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
16965276|NCT01195662|38108197|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
16965277|NCT01195662|38108195|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
16965278|NCT01195662|38108196|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
16965279|NCT01195662|38108197|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
16965280|NCT01195662|38108195|FG000|Double Blind Treatment Period|Non-specified|3|||
16965281|NCT01195662|38108196|FG001|Double Blind Treatment Period|Non-specified|0|||
16965282|NCT01195662|38108197|FG002|Double Blind Treatment Period|Non-specified|0|||
16965283|NCT01195662|38108195|FG000|Double Blind Treatment Period|Missing disposition information|0|||
16779606|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
16779607|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
16965284|NCT01195662|38108196|FG001|Double Blind Treatment Period|Missing disposition information|1|||
16965285|NCT01195662|38108197|FG002|Double Blind Treatment Period|Missing disposition information|1|||
16965286|NCT01195662|38108195|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
16965287|NCT01195662|38108196|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
16965288|NCT01195662|38108197|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
16965289|NCT01195662|38108195|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
16965290|NCT01195662|38108196|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
16965291|NCT01195662|38108197|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
16965292|NCT01195272|38108206|FG000|Overall Study|Adverse Event|1|||
16965293|NCT01195272|38108206|FG000|Overall Study|Lack of Efficacy|3|||
16965294|NCT01194804|38108210|FG000|Overall Study|Withdrawal by Subject|1|||
16965295|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
16965296|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
16965297|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
16965298|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
16965299|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
16965300|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
16965301|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
16965302|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
16965303|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
16965304|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
16965305|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
16965306|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
16965307|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
16965308|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
16965309|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
16965310|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
16965311|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
16965312|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
16965313|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
16965314|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
16965315|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
16965316|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
16965317|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
16965318|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
16965319|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Other|0|||
16965320|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Other|1|||
16965321|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Other|0|||
16965322|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Other|0|||
16965323|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
16965324|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
16965325|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
16965326|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
16965327|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
16965328|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
16965329|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
16965330|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
16965331|NCT01194414|38108234|FG000|24 Weeks Double Blind Period|Death|0|||
16965332|NCT01194414|38108235|FG001|24 Weeks Double Blind Period|Death|1|||
17028467|NCT00782834|38172840|FG000|Treatment Phase|fibrous tumor not GIST|1|||
17028468|NCT00584805|38172844|FG000|Overall Study|No longer at risk of exposure|39|||
17028469|NCT00584805|38172844|FG000|Overall Study|Relocation|36|||
17028470|NCT00584805|38172844|FG000|Overall Study|Withdrawal by Subject|18|||
17028471|NCT00584805|38172844|FG000|Overall Study|Non-compliance|1|||
16965333|NCT01194414|38108236|FG002|24 Weeks Double Blind Period|Death|0|||
16965334|NCT01194414|38108237|FG003|24 Weeks Double Blind Period|Death|0|||
16965335|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
16965336|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
16965337|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
16965338|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
16965339|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
16965340|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
16965341|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
16965342|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
16965343|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
16965344|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
16965345|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
16965346|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
16965347|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
16965348|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
16965349|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
16965350|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
16965351|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
16965352|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
16965353|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
16965354|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
16965355|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
16965356|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
16965357|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
16965358|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
16965359|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Other|2|||
16965360|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Other|1|||
16965361|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Other|0|||
16965362|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Other|0|||
16965363|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
16965364|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
16965365|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
16965366|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
16965367|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
16965368|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
16965369|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
16965370|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
16965371|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
16965372|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
16965373|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
16965374|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
16965375|NCT01194414|38108234|FG000|72 Weeks Open Label Extension|Death|1|||
16965376|NCT01194414|38108235|FG001|72 Weeks Open Label Extension|Death|2|||
16965377|NCT01194414|38108236|FG002|72 Weeks Open Label Extension|Death|0|||
16965378|NCT01194414|38108237|FG003|72 Weeks Open Label Extension|Death|2|||
16965379|NCT01194258|38108249|FG000|Titration Period|Withdrawal by Subject|6|||
16965380|NCT01194258|38108250|FG001|Titration Period|Withdrawal by Subject|0|||
16779608|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
16779609|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
16965381|NCT01194258|38108251|FG002|Titration Period|Withdrawal by Subject|0|||
16965382|NCT01194258|38108252|FG003|Titration Period|Withdrawal by Subject|0|||
16965383|NCT01194258|38108253|FG004|Titration Period|Withdrawal by Subject|0|||
16965384|NCT01194258|38108249|FG000|Titration Period|Lost to Follow-up|2|||
16965385|NCT01194258|38108250|FG001|Titration Period|Lost to Follow-up|0|||
16965386|NCT01194258|38108251|FG002|Titration Period|Lost to Follow-up|0|||
16965387|NCT01194258|38108252|FG003|Titration Period|Lost to Follow-up|0|||
16965388|NCT01194258|38108253|FG004|Titration Period|Lost to Follow-up|0|||
16965389|NCT01194258|38108249|FG000|Titration Period|Titration failure|3|||
17028472|NCT00584805|38172844|FG000|Overall Study|Lost to follow up|3|||
17028473|NCT00584805|38172844|FG000|Overall Study|Screen failures|2|||
16965390|NCT01194258|38108250|FG001|Titration Period|Titration failure|0|||
16965391|NCT01194258|38108251|FG002|Titration Period|Titration failure|0|||
16965392|NCT01194258|38108252|FG003|Titration Period|Titration failure|0|||
16965393|NCT01194258|38108253|FG004|Titration Period|Titration failure|0|||
16965394|NCT01194258|38108249|FG000|Period 1 (12 Weeks)|Death|0|||
16965395|NCT01194258|38108250|FG001|Period 1 (12 Weeks)|Death|0|||
16965396|NCT01194258|38108251|FG002|Period 1 (12 Weeks)|Death|0|||
16965397|NCT01194258|38108252|FG003|Period 1 (12 Weeks)|Death|0|||
16965398|NCT01194258|38108253|FG004|Period 1 (12 Weeks)|Death|1|||
16965399|NCT01194258|38108249|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16965400|NCT01194258|38108250|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16965401|NCT01194258|38108251|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16965402|NCT01194258|38108252|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16965403|NCT01194258|38108253|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
16965404|NCT01194258|38108249|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
16965405|NCT01194258|38108250|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
16779610|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
16779611|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
16779612|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
16779613|NCT00700427|37718713|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
16779614|NCT00700427|37718714|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
16779615|NCT00700427|37718715|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
16779616|NCT00700427|37718716|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
16779617|NCT00700427|37718717|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
16779618|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
16779619|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
16779620|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
16779621|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
16965406|NCT01194258|38108251|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
16965407|NCT01194258|38108252|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
16965408|NCT01194258|38108253|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
16965409|NCT01194258|38108249|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16965410|NCT01194258|38108250|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16965411|NCT01194258|38108251|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16965412|NCT01194258|38108252|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16965413|NCT01194258|38108253|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16965414|NCT01193556|38108266|FG000|Overall Study|Study termination|26|||
16965415|NCT01193556|38108267|FG001|Overall Study|Study termination|25|||
16965416|NCT00951496|38108280|FG000|Overall Study|Did not initiate study treatment|10|||
16965417|NCT00951496|38108281|FG001|Overall Study|Did not initiate study treatment|8|||
16965418|NCT00951496|38108282|FG002|Overall Study|Did not initiate study treatment|13|||
16965419|NCT01193244|38108295|FG000|Overall Study|Withdrawal by Subject|79|||
16965420|NCT01193244|38108296|FG001|Overall Study|Withdrawal by Subject|97|||
16965421|NCT01193244|38108295|FG000|Overall Study|Other|303|||
16965422|NCT01193244|38108296|FG001|Overall Study|Other|278|||
16965423|NCT01193244|38108295|FG000|Overall Study|Lost to Follow-up|6|||
16965424|NCT01193244|38108296|FG001|Overall Study|Lost to Follow-up|15|||
16965425|NCT01192152|38108302|FG000|Period 1|left prematurely (while on treatment B)|0|||
16965426|NCT01192152|38108303|FG001|Period 1|left prematurely (while on treatment B)|1|||
16965427|NCT01192152|38108302|FG000|Period 3|family emergency|1|||
16965428|NCT01192152|38108303|FG001|Period 3|family emergency|0|||
16965429|NCT01191840|38108313|FG000|Overall Study|withdrew consent|2|||
16965430|NCT01191840|38108314|FG001|Overall Study|withdrew consent|1|||
16965431|NCT01191840|38108313|FG000|Overall Study|Subject discontinued treatment|1|||
16965432|NCT01191840|38108314|FG001|Overall Study|Subject discontinued treatment|2|||
16965433|NCT01191840|38108313|FG000|Overall Study|Lost to Follow-up|4|||
16965434|NCT01191840|38108314|FG001|Overall Study|Lost to Follow-up|6|||
16965435|NCT01191840|38108313|FG000|Overall Study|Non Staph Infection|4|||
16779622|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
16779623|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
16779624|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
16779625|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
16779626|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
16779627|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
16779628|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
16779629|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
16779630|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
16779631|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
16779632|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
16779633|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
16779634|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
16779635|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
16779636|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
16779637|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
16779638|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
16779639|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
16779640|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
16779641|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
16779642|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
16779643|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
16779644|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
16779645|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
16779646|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
16779647|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
16779648|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
16779649|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
16779650|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
16779651|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
16779652|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
16779653|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
16779654|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
16779655|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
16779656|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
16779657|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
16779658|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
16779659|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
16779660|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
16779661|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
16779662|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
16779663|NCT00700427|37718713|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
16779664|NCT00700427|37718714|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
16779665|NCT00700427|37718715|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
16779666|NCT00700427|37718716|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
16779667|NCT00700427|37718717|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
16779668|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
16779669|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
16779670|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
16779671|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
16779672|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
16779673|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
16779674|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
16779675|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
16779676|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
16779677|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
16779678|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
16779679|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
16779680|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
16779681|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
16779682|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
16779683|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
16779684|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
16779685|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
16868003|NCT01536145|37841034|FG001|Overall Study|Progressive disease|4|||
16779686|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
16779687|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
16779688|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
16779689|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
16779690|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
16779691|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
16779692|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
16779693|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
16779694|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
16779695|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
16779696|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
16779697|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
16779698|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
16779699|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
16779700|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
16779701|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
16779702|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
16779703|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
16779704|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
16779705|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
16779706|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
16779707|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
16779708|NCT00700427|37718713|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
16779709|NCT00700427|37718714|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
16779710|NCT00700427|37718715|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
16779711|NCT00700427|37718716|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
16779712|NCT00700427|37718717|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
16779713|NCT02128763|37718727|FG000|Overall Study|Death|1|||
16779714|NCT02128763|37718728|FG001|Overall Study|Death|0|||
16779715|NCT02128763|37718727|FG000|Overall Study|Lost to Follow-up|19|||
16779716|NCT02128763|37718728|FG001|Overall Study|Lost to Follow-up|16|||
16779717|NCT02124772|37718750|FG000|Overall Study|Lack of Efficacy|2|||
16779718|NCT02124772|37718751|FG001|Overall Study|Lack of Efficacy|0|||
16779719|NCT02124772|37718752|FG002|Overall Study|Lack of Efficacy|0|||
16779720|NCT02124772|37718753|FG003|Overall Study|Lack of Efficacy|1|||
16779721|NCT02124772|37718754|FG004|Overall Study|Lack of Efficacy|2|||
16779722|NCT02124772|37718755|FG005|Overall Study|Lack of Efficacy|3|||
16779723|NCT02124772|37718756|FG006|Overall Study|Lack of Efficacy|0|||
16779724|NCT02124772|37718757|FG007|Overall Study|Lack of Efficacy|2|||
16965436|NCT01191840|38108314|FG001|Overall Study|Non Staph Infection|3|||
16779725|NCT02124772|37718758|FG008|Overall Study|Lack of Efficacy|0|||
16779726|NCT02124772|37718759|FG009|Overall Study|Lack of Efficacy|1|||
16779727|NCT02124772|37718760|FG010|Overall Study|Lack of Efficacy|0|||
16779728|NCT02124772|37718761|FG011|Overall Study|Lack of Efficacy|0|||
16779729|NCT02124772|37718762|FG012|Overall Study|Lack of Efficacy|1|||
16779730|NCT02124772|37718750|FG000|Overall Study|Adverse Event|1|||
16779731|NCT02124772|37718751|FG001|Overall Study|Adverse Event|4|||
16779732|NCT02124772|37718752|FG002|Overall Study|Adverse Event|1|||
16779733|NCT02124772|37718753|FG003|Overall Study|Adverse Event|5|||
16779734|NCT02124772|37718754|FG004|Overall Study|Adverse Event|2|||
16779735|NCT02124772|37718755|FG005|Overall Study|Adverse Event|1|||
16779736|NCT02124772|37718756|FG006|Overall Study|Adverse Event|1|||
16779737|NCT02124772|37718757|FG007|Overall Study|Adverse Event|5|||
16779738|NCT02124772|37718758|FG008|Overall Study|Adverse Event|0|||
16779739|NCT02124772|37718759|FG009|Overall Study|Adverse Event|3|||
16779740|NCT02124772|37718760|FG010|Overall Study|Adverse Event|1|||
16779741|NCT02124772|37718761|FG011|Overall Study|Adverse Event|3|||
16779742|NCT02124772|37718762|FG012|Overall Study|Adverse Event|1|||
16779743|NCT02124772|37718750|FG000|Overall Study|Withdrawal consent|0|||
16779744|NCT02124772|37718751|FG001|Overall Study|Withdrawal consent|1|||
16779745|NCT02124772|37718752|FG002|Overall Study|Withdrawal consent|1|||
16965437|NCT01191840|38108313|FG000|Overall Study|ineligible at enrollment|1|||
16965438|NCT01191840|38108314|FG001|Overall Study|ineligible at enrollment|0|||
16965439|NCT01191840|38108313|FG000|Overall Study|IRB approval lapse|0|||
16965440|NCT01191840|38108314|FG001|Overall Study|IRB approval lapse|2|||
16965441|NCT01191840|38108313|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
16965442|NCT01191840|38108314|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
16965443|NCT01191840|38108313|FG000|Overall Study|Withdrawal by Subject|2|||
16965444|NCT01191840|38108314|FG001|Overall Study|Withdrawal by Subject|0|||
16965445|NCT00943072|38108326|FG000|Overall Study|Adverse Event|0|||
16965446|NCT00943072|38108327|FG001|Overall Study|Adverse Event|3|||
16965447|NCT00943072|38108326|FG000|Overall Study|Death|0|||
16965448|NCT00943072|38108327|FG001|Overall Study|Death|2|||
16965449|NCT00943072|38108326|FG000|Overall Study|Withdrawal by Subject|3|||
16965450|NCT00943072|38108327|FG001|Overall Study|Withdrawal by Subject|1|||
16965451|NCT00943072|38108326|FG000|Overall Study|Protocol Violation|0|||
16965452|NCT00943072|38108327|FG001|Overall Study|Protocol Violation|1|||
16965453|NCT00943072|38108326|FG000|Overall Study|Lost to Follow-up|1|||
16965454|NCT00943072|38108327|FG001|Overall Study|Lost to Follow-up|2|||
16965455|NCT00943072|38108326|FG000|Overall Study|Lack of Efficacy|0|||
16965456|NCT00943072|38108327|FG001|Overall Study|Lack of Efficacy|4|||
16965457|NCT00943072|38108326|FG000|Overall Study|Other|1|||
16965458|NCT00943072|38108327|FG001|Overall Study|Other|1|||
16965459|NCT00942994|38108337|FG000|Overall Study|Adverse Event|7|||
16965460|NCT00942994|38108338|FG001|Overall Study|Adverse Event|4|||
16965461|NCT00942994|38108337|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16965462|NCT00942994|38108338|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16965463|NCT00942994|38108337|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16965464|NCT00942994|38108338|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16965465|NCT00942994|38108337|FG000|Overall Study|Patient withdrew consent|5|||
16965466|NCT00942994|38108338|FG001|Overall Study|Patient withdrew consent|8|||
16965467|NCT00942994|38108337|FG000|Overall Study|Lost to Follow-up|1|||
16965468|NCT00942994|38108338|FG001|Overall Study|Lost to Follow-up|4|||
16965469|NCT00942994|38108337|FG000|Overall Study|Protocol deviation|1|||
16965470|NCT00942994|38108338|FG001|Overall Study|Protocol deviation|2|||
16965471|NCT00942604|38108346|FG000|Overall Study|Protocol Violation|1|||
16965472|NCT00942604|38108347|FG001|Overall Study|Protocol Violation|1|||
16779746|NCT02124772|37718753|FG003|Overall Study|Withdrawal consent|1|||
16779747|NCT02124772|37718754|FG004|Overall Study|Withdrawal consent|0|||
16779748|NCT02124772|37718755|FG005|Overall Study|Withdrawal consent|1|||
16779749|NCT02124772|37718756|FG006|Overall Study|Withdrawal consent|1|||
16779750|NCT02124772|37718757|FG007|Overall Study|Withdrawal consent|0|||
16779751|NCT02124772|37718758|FG008|Overall Study|Withdrawal consent|0|||
16779752|NCT02124772|37718759|FG009|Overall Study|Withdrawal consent|1|||
16779753|NCT02124772|37718760|FG010|Overall Study|Withdrawal consent|0|||
16779754|NCT02124772|37718761|FG011|Overall Study|Withdrawal consent|1|||
16779755|NCT02124772|37718762|FG012|Overall Study|Withdrawal consent|0|||
16779756|NCT02124772|37718750|FG000|Overall Study|Investigator discretion|0|||
16965473|NCT00942604|38108346|FG000|Overall Study|Adverse Event|0|||
16779757|NCT02124772|37718751|FG001|Overall Study|Investigator discretion|2|||
16779758|NCT02124772|37718752|FG002|Overall Study|Investigator discretion|2|||
16779759|NCT02124772|37718753|FG003|Overall Study|Investigator discretion|1|||
16779760|NCT02124772|37718754|FG004|Overall Study|Investigator discretion|1|||
16779761|NCT02124772|37718755|FG005|Overall Study|Investigator discretion|0|||
16779762|NCT02124772|37718756|FG006|Overall Study|Investigator discretion|1|||
16779763|NCT02124772|37718757|FG007|Overall Study|Investigator discretion|0|||
16779764|NCT02124772|37718758|FG008|Overall Study|Investigator discretion|0|||
16779765|NCT02124772|37718759|FG009|Overall Study|Investigator discretion|1|||
16868004|NCT01536145|37841035|FG002|Overall Study|Progressive disease|1|||
16965474|NCT00942604|38108347|FG001|Overall Study|Adverse Event|1|||
16965475|NCT00942604|38108346|FG000|Overall Study|Withdrawal by Subject|0|||
16965476|NCT00942604|38108347|FG001|Overall Study|Withdrawal by Subject|1|||
16965477|NCT00942604|38108346|FG000|Overall Study|Patient relocation|1|||
16965478|NCT00942604|38108347|FG001|Overall Study|Patient relocation|1|||
16965479|NCT01188564|38108355|FG000|Double-blind Phase|randomized not treated|1|||
16965480|NCT01188564|38108356|FG001|Double-blind Phase|randomized not treated|0|||
16965481|NCT01187550|38108364|FG000|Overall Study|Protocol Violation|3|||
16965482|NCT01187550|38108365|FG001|Overall Study|Protocol Violation|1|||
16965483|NCT01187550|38108364|FG000|Overall Study|Other|3|||
16965484|NCT01187550|38108365|FG001|Overall Study|Other|0|||
16965485|NCT01187550|38108364|FG000|Overall Study|Randomized but not treated|8|||
16965486|NCT01187550|38108365|FG001|Overall Study|Randomized but not treated|0|||
16965487|NCT01186770|38108375|FG000|Overall Study|Ineligibility|0|||
17028474|NCT00765674|38172854|FG000|Overall Study|Adverse Event|7|||
17028475|NCT00765674|38172855|FG001|Overall Study|Adverse Event|2|||
17028476|NCT00765674|38172856|FG002|Overall Study|Adverse Event|8|||
17028477|NCT00765674|38172857|FG003|Overall Study|Adverse Event|11|||
17028478|NCT00765674|38172854|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
17028479|NCT00765674|38172855|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
17028480|NCT00765674|38172856|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
17028481|NCT00765674|38172857|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
17028482|NCT00765674|38172854|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
17028483|NCT00765674|38172855|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
17028484|NCT00765674|38172856|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
17028485|NCT00765674|38172857|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
17028486|NCT00765674|38172854|FG000|Overall Study|Lack of Efficacy|2|||
17028487|NCT00765674|38172855|FG001|Overall Study|Lack of Efficacy|3|||
16965488|NCT01186770|38108376|FG001|Overall Study|Ineligibility|0|||
16965489|NCT01186770|38108377|FG002|Overall Study|Ineligibility|2|||
16965490|NCT01186770|38108378|FG003|Overall Study|Ineligibility|0|||
16965491|NCT01186770|38108375|FG000|Overall Study|Protocol Violation|7|||
16965492|NCT01186770|38108376|FG001|Overall Study|Protocol Violation|9|||
16965493|NCT01186770|38108377|FG002|Overall Study|Protocol Violation|12|||
16965494|NCT01186770|38108378|FG003|Overall Study|Protocol Violation|14|||
16965495|NCT01186770|38108375|FG000|Overall Study|Adverse Event|2|||
16965496|NCT01186770|38108376|FG001|Overall Study|Adverse Event|9|||
16965497|NCT01186770|38108377|FG002|Overall Study|Adverse Event|7|||
16965498|NCT01186770|38108378|FG003|Overall Study|Adverse Event|9|||
16965499|NCT01186770|38108375|FG000|Overall Study|Withdrawal by Subject|15|||
16965500|NCT01186770|38108376|FG001|Overall Study|Withdrawal by Subject|13|||
16965501|NCT01186770|38108377|FG002|Overall Study|Withdrawal by Subject|11|||
16965502|NCT01186770|38108378|FG003|Overall Study|Withdrawal by Subject|17|||
16965503|NCT01186770|38108375|FG000|Overall Study|Lost to Follow-up|10|||
16965504|NCT01186770|38108376|FG001|Overall Study|Lost to Follow-up|6|||
16965505|NCT01186770|38108377|FG002|Overall Study|Lost to Follow-up|14|||
16965506|NCT01186770|38108378|FG003|Overall Study|Lost to Follow-up|9|||
16965507|NCT01186770|38108375|FG000|Overall Study|Insufficient response to treatment|7|||
16965508|NCT01186770|38108376|FG001|Overall Study|Insufficient response to treatment|8|||
16965509|NCT01186770|38108377|FG002|Overall Study|Insufficient response to treatment|5|||
16965510|NCT01186770|38108378|FG003|Overall Study|Insufficient response to treatment|7|||
16965511|NCT01186770|38108375|FG000|Overall Study|Other than specified|0|||
16965512|NCT01186770|38108376|FG001|Overall Study|Other than specified|1|||
16965513|NCT01186770|38108377|FG002|Overall Study|Other than specified|1|||
16965514|NCT01186770|38108378|FG003|Overall Study|Other than specified|2|||
16965515|NCT01186692|38108388|FG000|Overall Study|Not Catheterized|11|||
16965516|NCT01186692|38108388|FG000|Overall Study|Futher testing contraindicated implant|19|||
16965517|NCT01186692|38108388|FG000|Overall Study|Adverse Event|2|||
16965518|NCT01186458|38108396|FG000|Overall Study|Adverse Event|1|||
16965519|NCT01185834|38108400|FG000|Overall Study|Lost to Follow-up|2|||
16965520|NCT01185834|38108400|FG000|Overall Study|Discomfort|4|||
16965521|NCT01185834|38108400|FG000|Overall Study|Biomicroscopy|4|||
16965522|NCT01185834|38108400|FG000|Overall Study|Time/Job Conflict|2|||
16965523|NCT01185834|38108400|FG000|Overall Study|Early exit - Site error|2|||
16965524|NCT01185600|38108406|FG000|Overall Study|Adverse Event|1|||
16965525|NCT01185600|38108407|FG001|Overall Study|Adverse Event|1|||
16965526|NCT01185600|38108406|FG000|Overall Study|Death|0|||
16965527|NCT01185600|38108407|FG001|Overall Study|Death|1|||
16965528|NCT01185600|38108406|FG000|Overall Study|Lost to Follow-up|0|||
16965529|NCT01185600|38108407|FG001|Overall Study|Lost to Follow-up|5|||
16965530|NCT01185600|38108406|FG000|Overall Study|Physician Decision|29|||
16965531|NCT01185600|38108407|FG001|Overall Study|Physician Decision|35|||
16965532|NCT01185600|38108406|FG000|Overall Study|Withdrawal by Subject|1|||
16965533|NCT01185600|38108407|FG001|Overall Study|Withdrawal by Subject|1|||
16965534|NCT01185600|38108406|FG000|Overall Study|Hold by DSMB|1|||
16965535|NCT01185600|38108407|FG001|Overall Study|Hold by DSMB|2|||
16965536|NCT01185522|38108416|FG000|Overall Study|Lack of Efficacy|28|||
16965537|NCT01185522|38108416|FG000|Overall Study|Lost to Follow-up|19|||
16965538|NCT01185522|38108416|FG000|Overall Study|Withdrawal by Subject|10|||
16965539|NCT01185522|38108416|FG000|Overall Study|Poor tolerance|39|||
16965540|NCT01185522|38108416|FG000|Overall Study|Other reasons|12|||
16965541|NCT01185366|38108423|FG000|First Line Therapy|Insurance Coverage Denied|1|||
16965542|NCT01185366|38108424|FG001|First Line Therapy|Insurance Coverage Denied|1|||
16965543|NCT01185366|38108423|FG000|First Line Therapy|Withdrawal by Subject|1|||
16965544|NCT01185366|38108424|FG001|First Line Therapy|Withdrawal by Subject|0|||
16965545|NCT01185366|38108423|FG000|First Line Therapy|Lack of Metastatic Site|1|||
16965546|NCT01185366|38108424|FG001|First Line Therapy|Lack of Metastatic Site|0|||
16965547|NCT01185366|38108423|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
16965548|NCT01185366|38108424|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
16965549|NCT01185366|38108423|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
16965550|NCT01185366|38108424|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
16965551|NCT01185366|38108423|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
16965552|NCT01185366|38108424|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
16965553|NCT01185366|38108423|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
16965554|NCT01185366|38108424|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
16965555|NCT01185288|38108434|FG000|Overall Study|Adverse Event|7|||
16965556|NCT01185288|38108435|FG001|Overall Study|Adverse Event|6|||
16965557|NCT01185288|38108434|FG000|Overall Study|Withdrawal by Subject|6|||
16965558|NCT01185288|38108435|FG001|Overall Study|Withdrawal by Subject|4|||
16965559|NCT01185288|38108434|FG000|Overall Study|Lost to Follow-up|2|||
16965560|NCT01185288|38108435|FG001|Overall Study|Lost to Follow-up|5|||
16965561|NCT01185288|38108434|FG000|Overall Study|Lack of Efficacy|2|||
16965562|NCT01185288|38108435|FG001|Overall Study|Lack of Efficacy|0|||
16965563|NCT01185288|38108434|FG000|Overall Study|Investigator discretion|1|||
16965564|NCT01185288|38108435|FG001|Overall Study|Investigator discretion|0|||
16965565|NCT01185288|38108434|FG000|Overall Study|Did not meet inclusion criteria|1|||
16965566|NCT01185288|38108435|FG001|Overall Study|Did not meet inclusion criteria|0|||
16965567|NCT01185288|38108434|FG000|Overall Study|Noncompliance|0|||
16965568|NCT01185288|38108435|FG001|Overall Study|Noncompliance|1|||
16965569|NCT01184508|38108443|FG000|Overall Study|Adverse Event|4|||
16965570|NCT01184508|38108444|FG001|Overall Study|Adverse Event|6|||
16965571|NCT01184508|38108443|FG000|Overall Study|Lack of Efficacy|1|||
16965572|NCT01184508|38108444|FG001|Overall Study|Lack of Efficacy|1|||
16965573|NCT01184508|38108443|FG000|Overall Study|Lost to Follow-up|1|||
16965574|NCT01184508|38108444|FG001|Overall Study|Lost to Follow-up|1|||
16965575|NCT01184508|38108443|FG000|Overall Study|Physician Decision|1|||
16965576|NCT01184508|38108444|FG001|Overall Study|Physician Decision|0|||
16965577|NCT01184508|38108443|FG000|Overall Study|Protocol Violation|3|||
16965578|NCT01184508|38108444|FG001|Overall Study|Protocol Violation|1|||
16965579|NCT01184508|38108443|FG000|Overall Study|Sponsor Decision|5|||
16965580|NCT01184508|38108444|FG001|Overall Study|Sponsor Decision|2|||
16965581|NCT01184508|38108443|FG000|Overall Study|Withdrawal by Subject|1|||
16965582|NCT01184508|38108444|FG001|Overall Study|Withdrawal by Subject|3|||
16965583|NCT01184508|38108443|FG000|Overall Study|Randomized, Not Treated|0|||
16965584|NCT01184508|38108444|FG001|Overall Study|Randomized, Not Treated|1|||
16965585|NCT01184118|38108451|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
16965586|NCT01184118|38108451|FG000|Overall Study|No physiologic confirmation of asthma|8|||
16965587|NCT01184118|38108451|FG000|Overall Study|FEV1 <60% predicted|2|||
16965588|NCT01184118|38108451|FG000|Overall Study|Exclusionary medical condition|2|||
16965589|NCT01184118|38108451|FG000|Overall Study|Withdrawal by Subject|5|||
16965590|NCT01183884|38108455|FG000|Overall Study|Progressive Disease|26|||
16965591|NCT01183884|38108455|FG000|Overall Study|Adverse Event|3|||
16965592|NCT01183884|38108455|FG000|Overall Study|Withdrawal by Subject|1|||
16965593|NCT01183884|38108455|FG000|Overall Study|Other Complicating Disease|3|||
16965594|NCT01183884|38108455|FG000|Overall Study|Not Treated|1|||
16965595|NCT01183884|38108455|FG000|Overall Study|Other|4|||
16965596|NCT01183260|38108461|FG000|Overall Study|Intraop screen failure|2|||
16965597|NCT01183260|38108462|FG001|Overall Study|Intraop screen failure|0|||
16965598|NCT01183260|38108461|FG000|Overall Study|Withdrawal by Subject|1|||
16965599|NCT01183260|38108462|FG001|Overall Study|Withdrawal by Subject|1|||
16965600|NCT01183260|38108461|FG000|Overall Study|Revised within 30 days|0|||
16965601|NCT01183260|38108462|FG001|Overall Study|Revised within 30 days|1|||
16965602|NCT01183260|38108461|FG000|Overall Study|Death|1|||
16965603|NCT01183260|38108462|FG001|Overall Study|Death|0|||
16965604|NCT01191762|38108470|FG000|Overall Study|Adverse Event|1|||
16965605|NCT01191762|38108471|FG001|Overall Study|Adverse Event|0|||
16965606|NCT01723774|38108480|FG000|Neoadjuvant|Ki67 > 10%|4|||
16965607|NCT01723774|38108481|FG001|Neoadjuvant|Ki67 > 10%|0|||
16965608|NCT01723774|38108482|FG002|Neoadjuvant|Ki67 > 10%|10|||
16965609|NCT01723774|38108483|FG003|Neoadjuvant|Ki67 > 10%|0|||
16965610|NCT01723774|38108480|FG000|Neoadjuvant|Withdrawal by Subject|3|||
16965611|NCT01723774|38108481|FG001|Neoadjuvant|Withdrawal by Subject|1|||
16965612|NCT01723774|38108482|FG002|Neoadjuvant|Withdrawal by Subject|0|||
16965613|NCT01723774|38108483|FG003|Neoadjuvant|Withdrawal by Subject|0|||
16965614|NCT01723774|38108480|FG000|Neoadjuvant|Disease progression|0|||
16965615|NCT01723774|38108481|FG001|Neoadjuvant|Disease progression|1|||
16965616|NCT01723774|38108482|FG002|Neoadjuvant|Disease progression|1|||
16965617|NCT01723774|38108483|FG003|Neoadjuvant|Disease progression|0|||
16965618|NCT01723774|38108480|FG000|Neoadjuvant|Adverse Event|0|||
16965619|NCT01723774|38108481|FG001|Neoadjuvant|Adverse Event|1|||
16965620|NCT01723774|38108482|FG002|Neoadjuvant|Adverse Event|2|||
16965621|NCT01723774|38108483|FG003|Neoadjuvant|Adverse Event|0|||
16965622|NCT01723774|38108480|FG000|Neoadjuvant|High estradiol|0|||
16965623|NCT01723774|38108481|FG001|Neoadjuvant|High estradiol|1|||
16965624|NCT01723774|38108482|FG002|Neoadjuvant|High estradiol|0|||
16965625|NCT01723774|38108483|FG003|Neoadjuvant|High estradiol|0|||
16965626|NCT01723774|38108480|FG000|Adjuvant|Still on active treatment|0|||
16965627|NCT01723774|38108481|FG001|Adjuvant|Still on active treatment|0|||
16965628|NCT01723774|38108482|FG002|Adjuvant|Still on active treatment|0|||
16965629|NCT01723774|38108483|FG003|Adjuvant|Still on active treatment|1|||
16965630|NCT01190514|38108492|FG000|First Intervention (Period 1)|Adverse Event|1|||
16965631|NCT01190514|38108493|FG001|First Intervention (Period 1)|Adverse Event|0|||
16965632|NCT01190514|38108494|FG002|First Intervention (Period 1)|Adverse Event|0|||
16965633|NCT01190514|38108495|FG003|First Intervention (Period 1)|Adverse Event|0|||
16965634|NCT01190514|38108492|FG000|Third Intervention (Period 3)|Adverse Event|1|||
16965635|NCT01190514|38108493|FG001|Third Intervention (Period 3)|Adverse Event|0|||
16965636|NCT01190514|38108494|FG002|Third Intervention (Period 3)|Adverse Event|0|||
16965637|NCT01190514|38108495|FG003|Third Intervention (Period 3)|Adverse Event|0|||
16965638|NCT01190436|38108505|FG000|Overall Study|Lost to Follow-up|35|||
16965639|NCT01190436|38108505|FG000|Overall Study|Other|4|||
16965640|NCT01035255|38108512|FG000|Overall Study|Death|724|||
16965641|NCT01035255|38108513|FG001|Overall Study|Death|844|||
16965642|NCT01035255|38108512|FG000|Overall Study|Lost to Follow-up|2|||
16965643|NCT01035255|38108513|FG001|Overall Study|Lost to Follow-up|5|||
16965644|NCT01035255|38108512|FG000|Overall Study|patient's request|15|||
16965645|NCT01035255|38108513|FG001|Overall Study|patient's request|13|||
16965646|NCT01190124|38108522|FG000|Overall Study|Death|3|||
16965647|NCT01190124|38108523|FG001|Overall Study|Death|0|||
16965648|NCT01190124|38108524|FG002|Overall Study|Death|0|||
16965649|NCT01190124|38108522|FG000|Overall Study|Therapeutic Failure|12|||
16965650|NCT01190124|38108523|FG001|Overall Study|Therapeutic Failure|0|||
16965651|NCT01190124|38108524|FG002|Overall Study|Therapeutic Failure|1|||
16965652|NCT01190124|38108522|FG000|Overall Study|Lost to Follow-up|2|||
16965653|NCT01190124|38108523|FG001|Overall Study|Lost to Follow-up|0|||
16965654|NCT01190124|38108524|FG002|Overall Study|Lost to Follow-up|0|||
16965655|NCT01189890|38108537|FG000|Overall Study|Adverse Event|3|||
16965656|NCT01189890|38108538|FG001|Overall Study|Adverse Event|4|||
16965657|NCT01189890|38108537|FG000|Overall Study|Lack of Efficacy|7|||
16965658|NCT01189890|38108538|FG001|Overall Study|Lack of Efficacy|2|||
16965659|NCT01189890|38108537|FG000|Overall Study|Lost to Follow-up|1|||
16965660|NCT01189890|38108538|FG001|Overall Study|Lost to Follow-up|7|||
16965661|NCT01189890|38108537|FG000|Overall Study|Protocol Violation|1|||
16965662|NCT01189890|38108538|FG001|Overall Study|Protocol Violation|5|||
16965663|NCT01189890|38108537|FG000|Overall Study|Withdrawal by Subject|15|||
16965664|NCT01189890|38108538|FG001|Overall Study|Withdrawal by Subject|11|||
16965665|NCT01189890|38108537|FG000|Overall Study|Non Compliance|0|||
16965666|NCT01189890|38108538|FG001|Overall Study|Non Compliance|1|||
16965667|NCT01189890|38108537|FG000|Overall Study|Physician Decision|5|||
16965668|NCT01189890|38108538|FG001|Overall Study|Physician Decision|4|||
16965669|NCT01189890|38108537|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
16965670|NCT01189890|38108538|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
16965671|NCT01189812|38108546|FG000|Overall Study|Withdrawal by Subject|2|||
16965672|NCT01189812|38108547|FG001|Overall Study|Withdrawal by Subject|3|||
16965673|NCT01189812|38108546|FG000|Overall Study|Adverse Event|1|||
16965674|NCT01189812|38108547|FG001|Overall Study|Adverse Event|0|||
16965675|NCT01189812|38108546|FG000|Overall Study|Out of Window|4|||
16965676|NCT01189812|38108547|FG001|Overall Study|Out of Window|3|||
16965677|NCT01189812|38108546|FG000|Overall Study|Moved out of State|1|||
16965678|NCT01189812|38108547|FG001|Overall Study|Moved out of State|2|||
16965679|NCT00950950|38108555|FG000|Overall Study|Adverse Event|1|||
16965680|NCT00950950|38108556|FG001|Overall Study|Adverse Event|0|||
16965681|NCT00950950|38108555|FG000|Overall Study|Withdrawal by Subject|0|||
16965682|NCT00950950|38108556|FG001|Overall Study|Withdrawal by Subject|1|||
16965683|NCT00950872|38108563|FG000|Overall Study|Withdrawal by Subject|1|||
16965684|NCT00950872|38108563|FG000|Overall Study|Did not have surgery|2|||
16965685|NCT01189500|38108567|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
16965686|NCT01189500|38108567|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
16965687|NCT00938860|38108576|FG000|Overall Study|Adverse Event|2|||
16965688|NCT00938860|38108577|FG001|Overall Study|Adverse Event|1|||
16965689|NCT00938860|38108576|FG000|Overall Study|Abnormal laboratory values|2|||
16965690|NCT00938860|38108577|FG001|Overall Study|Abnormal laboratory values|2|||
16965691|NCT00938860|38108576|FG000|Overall Study|Withdrawal by Subject|11|||
16965692|NCT00938860|38108577|FG001|Overall Study|Withdrawal by Subject|8|||
16965693|NCT00938860|38108576|FG000|Overall Study|Lost to Follow-up|4|||
16965694|NCT00938860|38108577|FG001|Overall Study|Lost to Follow-up|4|||
16965695|NCT00938860|38108576|FG000|Overall Study|Administration problems|2|||
16965696|NCT00938860|38108577|FG001|Overall Study|Administration problems|0|||
16965697|NCT00938860|38108576|FG000|Overall Study|Death|1|||
16965698|NCT00938860|38108577|FG001|Overall Study|Death|1|||
16965699|NCT00938860|38108576|FG000|Overall Study|Protocol Violation|3|||
16965700|NCT00938860|38108577|FG001|Overall Study|Protocol Violation|1|||
16965701|NCT00938470|38108585|FG000|Overall Study|Disease Progression|3|||
16965702|NCT00938470|38108586|FG001|Overall Study|Disease Progression|0|||
16965703|NCT00938470|38108585|FG000|Overall Study|Alternate Treatment|1|||
16965704|NCT00938470|38108586|FG001|Overall Study|Alternate Treatment|0|||
16965705|NCT00938470|38108585|FG000|Overall Study|Death|3|||
16965706|NCT00938470|38108586|FG001|Overall Study|Death|2|||
16965707|NCT00938470|38108585|FG000|Overall Study|Other Reason|0|||
16965708|NCT00938470|38108586|FG001|Overall Study|Other Reason|1|||
16965709|NCT00938392|38108594|FG000|Overall Study|Adverse Event|0|||
16965710|NCT00938392|38108595|FG001|Overall Study|Adverse Event|1|||
16965711|NCT00938392|38108594|FG000|Overall Study|Withdrawal by Subject|0|||
16779766|NCT02124772|37718760|FG010|Overall Study|Investigator discretion|0|||
16779767|NCT02124772|37718761|FG011|Overall Study|Investigator discretion|1|||
16779768|NCT02124772|37718762|FG012|Overall Study|Investigator discretion|0|||
16779769|NCT02124772|37718750|FG000|Overall Study|Progressive disease|0|||
16779770|NCT02124772|37718751|FG001|Overall Study|Progressive disease|0|||
16779771|NCT02124772|37718752|FG002|Overall Study|Progressive disease|0|||
16779772|NCT02124772|37718753|FG003|Overall Study|Progressive disease|0|||
16779773|NCT02124772|37718754|FG004|Overall Study|Progressive disease|0|||
16779774|NCT02124772|37718755|FG005|Overall Study|Progressive disease|0|||
16779775|NCT02124772|37718756|FG006|Overall Study|Progressive disease|1|||
16779776|NCT02124772|37718757|FG007|Overall Study|Progressive disease|1|||
16779777|NCT02124772|37718758|FG008|Overall Study|Progressive disease|0|||
16779778|NCT02124772|37718759|FG009|Overall Study|Progressive disease|0|||
16779779|NCT02124772|37718760|FG010|Overall Study|Progressive disease|0|||
16779780|NCT02124772|37718761|FG011|Overall Study|Progressive disease|0|||
16779781|NCT02124772|37718762|FG012|Overall Study|Progressive disease|0|||
16779782|NCT02124772|37718750|FG000|Overall Study|Other|0|||
16779783|NCT02124772|37718751|FG001|Overall Study|Other|7|||
16779784|NCT02124772|37718752|FG002|Overall Study|Other|2|||
16779785|NCT02124772|37718753|FG003|Overall Study|Other|5|||
16779786|NCT02124772|37718754|FG004|Overall Study|Other|4|||
16779787|NCT02124772|37718755|FG005|Overall Study|Other|3|||
16779788|NCT02124772|37718756|FG006|Overall Study|Other|4|||
16779789|NCT02124772|37718757|FG007|Overall Study|Other|1|||
16779790|NCT02124772|37718758|FG008|Overall Study|Other|1|||
16779791|NCT02124772|37718759|FG009|Overall Study|Other|1|||
16779792|NCT02124772|37718760|FG010|Overall Study|Other|1|||
16779793|NCT02124772|37718761|FG011|Overall Study|Other|1|||
16779794|NCT02124772|37718762|FG012|Overall Study|Other|0|||
16779795|NCT02159950|37718816|FG000|Overall Study|Adverse Event|0|||
16779796|NCT02159950|37718817|FG001|Overall Study|Adverse Event|1|||
16779797|NCT02159950|37718816|FG000|Overall Study|Progression|0|||
16779798|NCT02159950|37718817|FG001|Overall Study|Progression|1|||
16779799|NCT02159482|37718823|FG000|Overall Study|Withdrawal by Subject|2|||
16779800|NCT02159482|37718823|FG000|Overall Study|Physician Decision|3|||
16779801|NCT02622321|37718831|FG000|Overall Study|Withdrawal by Subject|2|||
16779802|NCT02622321|37718832|FG001|Overall Study|Withdrawal by Subject|0|||
16779803|NCT02622321|37718833|FG002|Overall Study|Withdrawal by Subject|0|||
16779804|NCT02622321|37718834|FG003|Overall Study|Withdrawal by Subject|0|||
16779805|NCT02622321|37718831|FG000|Overall Study|Death|0|||
16779806|NCT02622321|37718832|FG001|Overall Study|Death|0|||
16779807|NCT02622321|37718833|FG002|Overall Study|Death|1|||
16779808|NCT02622321|37718834|FG003|Overall Study|Death|0|||
16965712|NCT00938392|38108595|FG001|Overall Study|Withdrawal by Subject|1|||
16965713|NCT00938392|38108594|FG000|Overall Study|Lost to Follow-up|2|||
16779809|NCT02622321|37718831|FG000|Overall Study|Physician Decision|1|||
16779810|NCT02622321|37718832|FG001|Overall Study|Physician Decision|0|||
16779811|NCT02622321|37718833|FG002|Overall Study|Physician Decision|0|||
16779812|NCT02622321|37718834|FG003|Overall Study|Physician Decision|0|||
16779813|NCT02187172|37718860|FG000|Overall Study|Lost to Follow-up|1|||
16779814|NCT02187172|37718861|FG001|Overall Study|Lost to Follow-up|2|||
16779815|NCT02187172|37718860|FG000|Overall Study|Lack of Efficacy|1|||
16779816|NCT02187172|37718861|FG001|Overall Study|Lack of Efficacy|2|||
16779817|NCT02187172|37718860|FG000|Overall Study|Adverse Event|0|||
16779818|NCT02187172|37718861|FG001|Overall Study|Adverse Event|1|||
16779819|NCT02187172|37718860|FG000|Overall Study|Physician Decision|1|||
16779820|NCT02187172|37718861|FG001|Overall Study|Physician Decision|1|||
16779821|NCT02621931|37718872|FG000|Overall Study|Death|0|||
16779822|NCT02621931|37718873|FG001|Overall Study|Death|1|||
16779823|NCT02621931|37718874|FG002|Overall Study|Death|0|||
16779824|NCT02621931|37718872|FG000|Overall Study|Adverse Event|8|||
16779825|NCT02621931|37718873|FG001|Overall Study|Adverse Event|5|||
16779826|NCT02621931|37718874|FG002|Overall Study|Adverse Event|7|||
16779827|NCT02621931|37718872|FG000|Overall Study|Withdrawal by Subject|12|||
16779828|NCT02621931|37718873|FG001|Overall Study|Withdrawal by Subject|10|||
16779829|NCT02621931|37718874|FG002|Overall Study|Withdrawal by Subject|11|||
16779830|NCT02621931|37718872|FG000|Overall Study|Protocol Violation|2|||
16779831|NCT02621931|37718873|FG001|Overall Study|Protocol Violation|2|||
16779832|NCT02621931|37718874|FG002|Overall Study|Protocol Violation|2|||
16779833|NCT02621931|37718872|FG000|Overall Study|Pregnancy|2|||
16779834|NCT02621931|37718873|FG001|Overall Study|Pregnancy|0|||
16779835|NCT02621931|37718874|FG002|Overall Study|Pregnancy|0|||
16779836|NCT02621931|37718872|FG000|Overall Study|Noncompliance to study procedures|0|||
16779837|NCT02621931|37718873|FG001|Overall Study|Noncompliance to study procedures|1|||
16779838|NCT02621931|37718874|FG002|Overall Study|Noncompliance to study procedures|2|||
16779839|NCT02621931|37718872|FG000|Overall Study|Lost to Follow-up|8|||
16779840|NCT02621931|37718873|FG001|Overall Study|Lost to Follow-up|7|||
16779841|NCT02621931|37718874|FG002|Overall Study|Lost to Follow-up|10|||
16779842|NCT02621931|37718872|FG000|Overall Study|Lack of Efficacy|0|||
16779843|NCT02621931|37718873|FG001|Overall Study|Lack of Efficacy|0|||
16779844|NCT02621931|37718874|FG002|Overall Study|Lack of Efficacy|1|||
16779845|NCT02621931|37718872|FG000|Overall Study|Other|1|||
16779846|NCT02621931|37718873|FG001|Overall Study|Other|1|||
16779847|NCT02621931|37718874|FG002|Overall Study|Other|3|||
16779848|NCT02621073|37718886|FG000|Overall Study|Lost to Follow-up|0|||
16779849|NCT02621073|37718887|FG001|Overall Study|Lost to Follow-up|1|||
16779850|NCT02621073|37718886|FG000|Overall Study|Physician Decision|3|||
16779851|NCT02621073|37718887|FG001|Overall Study|Physician Decision|2|||
16779852|NCT02158936|37718895|FG000|Overall Study|Study closed/ terminated|57|||
16779853|NCT02158936|37718896|FG001|Overall Study|Study closed/ terminated|77|||
16779854|NCT02158936|37718895|FG000|Overall Study|Azacitidine tx discontinued|53|||
16779855|NCT02158936|37718896|FG001|Overall Study|Azacitidine tx discontinued|46|||
16779856|NCT02158936|37718895|FG000|Overall Study|Adverse Event|39|||
16779857|NCT02158936|37718896|FG001|Overall Study|Adverse Event|24|||
16779858|NCT02158936|37718895|FG000|Overall Study|Withdrawal by Subject|15|||
16779859|NCT02158936|37718896|FG001|Overall Study|Withdrawal by Subject|16|||
16779860|NCT02158936|37718895|FG000|Overall Study|Physician Decision|15|||
16779861|NCT02158936|37718896|FG001|Overall Study|Physician Decision|13|||
16779862|NCT02158936|37718895|FG000|Overall Study|Lost to Follow-up|0|||
16779863|NCT02158936|37718896|FG001|Overall Study|Lost to Follow-up|1|||
16779864|NCT02158546|37718906|FG000|Overall Study|Physician Decision|0|||
16779865|NCT02158546|37718907|FG001|Overall Study|Physician Decision|1|||
16779866|NCT02158546|37718908|FG002|Overall Study|Physician Decision|0|||
16779867|NCT02158546|37718909|FG003|Overall Study|Physician Decision|0|||
16779868|NCT02158546|37718906|FG000|Overall Study|Non-compliance|0|||
16779869|NCT02158546|37718907|FG001|Overall Study|Non-compliance|1|||
16779870|NCT02158546|37718908|FG002|Overall Study|Non-compliance|0|||
16779871|NCT02158546|37718909|FG003|Overall Study|Non-compliance|1|||
16779872|NCT02158546|37718906|FG000|Overall Study|Failure to meet eligibility criteria|0|||
16779873|NCT02158546|37718907|FG001|Overall Study|Failure to meet eligibility criteria|1|||
16779874|NCT02158546|37718908|FG002|Overall Study|Failure to meet eligibility criteria|0|||
16779875|NCT02158546|37718909|FG003|Overall Study|Failure to meet eligibility criteria|0|||
16779876|NCT02158546|37718906|FG000|Overall Study|Lack of Efficacy|1|||
16779877|NCT02158546|37718907|FG001|Overall Study|Lack of Efficacy|1|||
16779878|NCT02158546|37718908|FG002|Overall Study|Lack of Efficacy|0|||
16779879|NCT02158546|37718909|FG003|Overall Study|Lack of Efficacy|0|||
16779880|NCT02158546|37718906|FG000|Overall Study|Adverse Event|2|||
16779881|NCT02158546|37718907|FG001|Overall Study|Adverse Event|2|||
16779882|NCT02158546|37718908|FG002|Overall Study|Adverse Event|0|||
16779883|NCT02158546|37718909|FG003|Overall Study|Adverse Event|0|||
16779884|NCT02158546|37718906|FG000|Overall Study|Withdrawal by Subject|6|||
16779885|NCT02158546|37718907|FG001|Overall Study|Withdrawal by Subject|2|||
16779886|NCT02158546|37718908|FG002|Overall Study|Withdrawal by Subject|1|||
16779887|NCT02158546|37718909|FG003|Overall Study|Withdrawal by Subject|0|||
16779888|NCT02158546|37718906|FG000|Overall Study|Lost to Follow-up|5|||
16779889|NCT02158546|37718907|FG001|Overall Study|Lost to Follow-up|4|||
16779890|NCT02158546|37718908|FG002|Overall Study|Lost to Follow-up|0|||
16779891|NCT02158546|37718909|FG003|Overall Study|Lost to Follow-up|1|||
16779892|NCT02158546|37718906|FG000|Overall Study|Site Excluded|5|||
16779893|NCT02158546|37718907|FG001|Overall Study|Site Excluded|5|||
16779894|NCT02158546|37718908|FG002|Overall Study|Site Excluded|3|||
16779895|NCT02158546|37718909|FG003|Overall Study|Site Excluded|4|||
16779896|NCT02123446|37718919|FG000|Washout Period (1 Day)|Physician Decision|1|||
16779897|NCT02123446|37718920|FG001|Washout Period (1 Day)|Physician Decision|0|||
16779898|NCT02123134|37718928|FG000|Overall Study|Withdrawal of consent|3|||
16779899|NCT02123134|37718929|FG001|Overall Study|Withdrawal of consent|2|||
16779900|NCT02123134|37718928|FG000|Overall Study|Administrative decision|0|||
16779901|NCT02123134|37718929|FG001|Overall Study|Administrative decision|1|||
16779902|NCT02185534|37718941|FG000|First Period|Withdrawal by Subject|0|||
16779903|NCT02185534|37718942|FG001|First Period|Withdrawal by Subject|0|||
16779904|NCT02185534|37718943|FG002|First Period|Withdrawal by Subject|0|||
16779905|NCT02185534|37718944|FG003|First Period|Withdrawal by Subject|1|||
16779906|NCT02185534|37718945|FG004|First Period|Withdrawal by Subject|0|||
16779907|NCT02185534|37718946|FG005|First Period|Withdrawal by Subject|0|||
16779908|NCT02185534|37718941|FG000|First Washout Period|Withdrawal by Subject|1|||
16779909|NCT02185534|37718942|FG001|First Washout Period|Withdrawal by Subject|0|||
16779910|NCT02185534|37718943|FG002|First Washout Period|Withdrawal by Subject|0|||
16779911|NCT02185534|37718944|FG003|First Washout Period|Withdrawal by Subject|0|||
16779912|NCT02185534|37718945|FG004|First Washout Period|Withdrawal by Subject|1|||
16779913|NCT02185534|37718946|FG005|First Washout Period|Withdrawal by Subject|0|||
16779914|NCT02185534|37718941|FG000|First Washout Period|Protocol Violation|0|||
16779915|NCT02185534|37718942|FG001|First Washout Period|Protocol Violation|0|||
16779916|NCT02185534|37718943|FG002|First Washout Period|Protocol Violation|0|||
16779917|NCT02185534|37718944|FG003|First Washout Period|Protocol Violation|0|||
16779918|NCT02185534|37718945|FG004|First Washout Period|Protocol Violation|0|||
16779919|NCT02185534|37718946|FG005|First Washout Period|Protocol Violation|1|||
16779920|NCT02121808|37718955|FG000|Overall Study|Technical problem|3|||
16779921|NCT02157376|37718966|FG000|Overall Study|Death|10|||
16779922|NCT02157376|37718967|FG001|Overall Study|Death|4|||
16779923|NCT02157376|37718966|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16779924|NCT02157376|37718967|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16779925|NCT02157376|37718966|FG000|Overall Study|Withdrawal by Subject|3|||
16779926|NCT02157376|37718967|FG001|Overall Study|Withdrawal by Subject|8|||
16779927|NCT02157376|37718966|FG000|Overall Study|Not treated|8|||
16779928|NCT02157376|37718967|FG001|Overall Study|Not treated|3|||
16779929|NCT02157376|37718966|FG000|Overall Study|Investigator's misjudgement|1|||
16779930|NCT02157376|37718967|FG001|Overall Study|Investigator's misjudgement|2|||
16779931|NCT02157298|37718975|FG000|Overall Study|Adverse Event|1|||
16779932|NCT02157298|37718976|FG001|Overall Study|Adverse Event|0|||
16779933|NCT02157298|37718975|FG000|Overall Study|Subject no longer meets study criteria|1|||
16779934|NCT02157298|37718976|FG001|Overall Study|Subject no longer meets study criteria|2|||
16779935|NCT02157298|37718975|FG000|Overall Study|Poor/Non-compliance|1|||
16779936|NCT02157298|37718976|FG001|Overall Study|Poor/Non-compliance|0|||
16779937|NCT02157298|37718975|FG000|Overall Study|Withdrawal by Subject|1|||
16779938|NCT02157298|37718976|FG001|Overall Study|Withdrawal by Subject|0|||
16779939|NCT02184988|37718982|FG000|Overall Study|Pregnancy|2|||
16779940|NCT02184988|37718982|FG000|Overall Study|Adverse Event|2|||
16779941|NCT02184988|37718982|FG000|Overall Study|moving away/travelling/unable to complet|6|||
16779942|NCT02184988|37718982|FG000|Overall Study|work scheduling issues|4|||
16779943|NCT02184988|37718982|FG000|Overall Study|various other reasons|9|||
16779944|NCT02184988|37718982|FG000|Overall Study|Lost to Follow-up|32|||
16779945|NCT02121262|37718988|FG000|Overall Study|Adverse Event|6|||
16779946|NCT02121262|37718989|FG001|Overall Study|Adverse Event|3|||
16779947|NCT02121262|37718988|FG000|Overall Study|Lack of Efficacy|3|||
16779948|NCT02121262|37718989|FG001|Overall Study|Lack of Efficacy|0|||
16779949|NCT02121262|37718988|FG000|Overall Study|Personal Reasons|19|||
16779950|NCT02121262|37718989|FG001|Overall Study|Personal Reasons|5|||
16779951|NCT02121262|37718988|FG000|Overall Study|Protocol Violation|1|||
16779952|NCT02121262|37718989|FG001|Overall Study|Protocol Violation|1|||
16779953|NCT02121262|37718988|FG000|Overall Study|Participant Dropped-out|0|||
16779954|NCT02121262|37718989|FG001|Overall Study|Participant Dropped-out|1|||
16779955|NCT02121262|37718988|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
16779956|NCT02121262|37718989|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
16779957|NCT02121262|37718988|FG000|Overall Study|Consent Withdrawn|1|||
16779958|NCT02121262|37718989|FG001|Overall Study|Consent Withdrawn|0|||
16779959|NCT02120950|37718997|FG000|Overall Study|Adverse Event|5|||
16779960|NCT02120950|37718998|FG001|Overall Study|Adverse Event|4|||
16779961|NCT02120950|37718999|FG002|Overall Study|Adverse Event|3|||
16779962|NCT02120950|37718997|FG000|Overall Study|Death|3|||
16779963|NCT02120950|37718998|FG001|Overall Study|Death|0|||
16779964|NCT02120950|37718999|FG002|Overall Study|Death|1|||
16779965|NCT02120950|37718997|FG000|Overall Study|Withdrawal by Subject|6|||
16779966|NCT02120950|37718998|FG001|Overall Study|Withdrawal by Subject|3|||
16779967|NCT02120950|37718999|FG002|Overall Study|Withdrawal by Subject|2|||
16779968|NCT02120950|37718997|FG000|Overall Study|Protocol Violation|1|||
16779969|NCT02120950|37718998|FG001|Overall Study|Protocol Violation|1|||
16779970|NCT02120950|37718999|FG002|Overall Study|Protocol Violation|7|||
16779971|NCT02120950|37718997|FG000|Overall Study|Other reasons|5|||
16779972|NCT02120950|37718998|FG001|Overall Study|Other reasons|4|||
16779973|NCT02120950|37718999|FG002|Overall Study|Other reasons|1|||
16779974|NCT02120950|37718997|FG000|Overall Study|Lost to Follow-up|0|||
16779975|NCT02120950|37718998|FG001|Overall Study|Lost to Follow-up|2|||
16779976|NCT02120950|37718999|FG002|Overall Study|Lost to Follow-up|1|||
16779977|NCT02120794|37719006|FG000|Overall Study|Withdrawal by Subject|43|||
16779978|NCT02120794|37719006|FG000|Overall Study|Adverse Event|10|||
16779979|NCT02120794|37719006|FG000|Overall Study|Physician Decision|4|||
16779980|NCT02120794|37719006|FG000|Overall Study|Due to insurance coverage|1|||
16779981|NCT02184442|37719012|FG000|Overall Study|Death|61|||
16779982|NCT02184442|37719013|FG001|Overall Study|Death|65|||
16779983|NCT02184442|37719012|FG000|Overall Study|Withdrawal by Subject|3|||
16779984|NCT02184442|37719013|FG001|Overall Study|Withdrawal by Subject|11|||
16779985|NCT02155738|37719023|FG000|Overall Study|Missing critical information|1|||
16779986|NCT02155738|37719024|FG001|Overall Study|Missing critical information|0|||
16779987|NCT02155738|37719025|FG002|Overall Study|Missing critical information|0|||
16779988|NCT02155738|37719026|FG003|Overall Study|Missing critical information|1|||
16779989|NCT02181790|37719038|FG000|Overall Study|study terminated|2|||
16779990|NCT02181790|37719039|FG001|Overall Study|study terminated|0|||
16779991|NCT02618967|37719055|FG000|Overall Study|Lost to Follow-up|0|||
16779992|NCT02618967|37719056|FG001|Overall Study|Lost to Follow-up|0|||
16779993|NCT02618967|37719057|FG002|Overall Study|Lost to Follow-up|1|||
16779994|NCT02618967|37719058|FG003|Overall Study|Lost to Follow-up|0|||
16779995|NCT02618967|37719059|FG004|Overall Study|Lost to Follow-up|2|||
16779996|NCT02618967|37719060|FG005|Overall Study|Lost to Follow-up|0|||
16779997|NCT02618967|37719061|FG006|Overall Study|Lost to Follow-up|0|||
16779998|NCT02618967|37719062|FG007|Overall Study|Lost to Follow-up|0|||
16779999|NCT02618967|37719055|FG000|Overall Study|Withdrawal by Subject|1|||
16780000|NCT02618967|37719056|FG001|Overall Study|Withdrawal by Subject|0|||
16780001|NCT02618967|37719057|FG002|Overall Study|Withdrawal by Subject|0|||
16780002|NCT02618967|37719058|FG003|Overall Study|Withdrawal by Subject|0|||
16780003|NCT02618967|37719059|FG004|Overall Study|Withdrawal by Subject|0|||
16780004|NCT02618967|37719060|FG005|Overall Study|Withdrawal by Subject|0|||
16965714|NCT00938392|38108595|FG001|Overall Study|Lost to Follow-up|2|||
16965715|NCT01022853|38108606|FG000|Overall Study|Progressive disease|2|||
16965716|NCT01022853|38108607|FG001|Overall Study|Progressive disease|3|||
16965717|NCT01022853|38108608|FG002|Overall Study|Progressive disease|11|||
16965718|NCT01022853|38108609|FG003|Overall Study|Progressive disease|7|||
16965719|NCT01022853|38108610|FG004|Overall Study|Progressive disease|1|||
16965720|NCT01022853|38108606|FG000|Overall Study|Dose-limiting toxicity|0|||
16965721|NCT01022853|38108607|FG001|Overall Study|Dose-limiting toxicity|0|||
16965722|NCT01022853|38108608|FG002|Overall Study|Dose-limiting toxicity|0|||
16965723|NCT01022853|38108609|FG003|Overall Study|Dose-limiting toxicity|0|||
16780005|NCT02618967|37719061|FG006|Overall Study|Withdrawal by Subject|0|||
16780006|NCT02618967|37719062|FG007|Overall Study|Withdrawal by Subject|0|||
16780007|NCT02616783|37719082|FG000|Overall Study|Randomized but Not Treated|1|||
16780008|NCT02616783|37719083|FG001|Overall Study|Randomized but Not Treated|0|||
16780009|NCT02616783|37719082|FG000|Overall Study|Adverse Event|1|||
16780010|NCT02616783|37719083|FG001|Overall Study|Adverse Event|0|||
16780011|NCT02616783|37719082|FG000|Overall Study|Death|1|||
16780012|NCT02616783|37719083|FG001|Overall Study|Death|0|||
16780013|NCT02616783|37719082|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16780014|NCT02616783|37719083|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16780015|NCT02616783|37719082|FG000|Overall Study|Protocol Violation|1|||
16965724|NCT01022853|38108610|FG004|Overall Study|Dose-limiting toxicity|1|||
16965725|NCT01022853|38108606|FG000|Overall Study|Withdrawal by Subject|0|||
16965726|NCT01022853|38108607|FG001|Overall Study|Withdrawal by Subject|1|||
16965727|NCT01022853|38108608|FG002|Overall Study|Withdrawal by Subject|1|||
16965728|NCT01022853|38108609|FG003|Overall Study|Withdrawal by Subject|1|||
16965729|NCT01022853|38108610|FG004|Overall Study|Withdrawal by Subject|0|||
16965730|NCT01022853|38108606|FG000|Overall Study|Other not stated above|1|||
16965731|NCT01022853|38108607|FG001|Overall Study|Other not stated above|0|||
16965732|NCT01022853|38108608|FG002|Overall Study|Other not stated above|1|||
16965733|NCT01022853|38108609|FG003|Overall Study|Other not stated above|0|||
16965734|NCT01022853|38108610|FG004|Overall Study|Other not stated above|0|||
16965735|NCT01034709|38108627|FG000|Overall Study|Protocol Violation|9|||
16965736|NCT01034709|38108628|FG001|Overall Study|Protocol Violation|16|||
16965737|NCT00937768|38108636|FG000|Overall Study|Refused Further Treatment|3|||
16965738|NCT00937768|38108637|FG001|Overall Study|Refused Further Treatment|2|||
16965739|NCT00937768|38108636|FG000|Overall Study|Disease Progression|1|||
16965740|NCT00937768|38108637|FG001|Overall Study|Disease Progression|1|||
16965741|NCT00937768|38108636|FG000|Overall Study|Alternate Treatment|0|||
16965742|NCT00937768|38108637|FG001|Overall Study|Alternate Treatment|1|||
16965743|NCT00937768|38108636|FG000|Overall Study|No Further Funding|4|||
16965744|NCT00937768|38108637|FG001|Overall Study|No Further Funding|4|||
16965745|NCT00940888|38108643|FG000|Overall Study|Unsuccessful Implant|4|||
16965746|NCT00940888|38108643|FG000|Overall Study|Death|461|||
16965747|NCT00940888|38108643|FG000|Overall Study|Withdrawn - Non-Death|364|||
16965748|NCT00940888|38108643|FG000|Overall Study|Lost to Follow-up|6|||
16965749|NCT01189266|38108650|FG000|Overall Study|Adverse Event|1|||
16965750|NCT01189266|38108651|FG001|Overall Study|Adverse Event|0|||
16965751|NCT01189266|38108652|FG002|Overall Study|Adverse Event|5|||
16965752|NCT01189266|38108650|FG000|Overall Study|Death|0|||
16965753|NCT01189266|38108651|FG001|Overall Study|Death|0|||
16965754|NCT01189266|38108652|FG002|Overall Study|Death|5|||
16965755|NCT01189266|38108650|FG000|Overall Study|Lack of Efficacy|4|||
16965756|NCT01189266|38108651|FG001|Overall Study|Lack of Efficacy|5|||
16965757|NCT01189266|38108652|FG002|Overall Study|Lack of Efficacy|44|||
16965758|NCT01189266|38108650|FG000|Overall Study|Physician Decision|0|||
16965759|NCT01189266|38108651|FG001|Overall Study|Physician Decision|0|||
16965760|NCT01189266|38108652|FG002|Overall Study|Physician Decision|1|||
16965761|NCT01189266|38108650|FG000|Overall Study|Protocol Violation|0|||
16965762|NCT01189266|38108651|FG001|Overall Study|Protocol Violation|1|||
16965763|NCT01189266|38108652|FG002|Overall Study|Protocol Violation|1|||
16965764|NCT01189266|38108650|FG000|Overall Study|Withdrawal by Subject|0|||
16965765|NCT01189266|38108651|FG001|Overall Study|Withdrawal by Subject|0|||
16965766|NCT01189266|38108652|FG002|Overall Study|Withdrawal by Subject|1|||
16965767|NCT01189266|38108650|FG000|Overall Study|Patient refuses further therapy|1|||
16965768|NCT01189266|38108651|FG001|Overall Study|Patient refuses further therapy|0|||
16965769|NCT01189266|38108652|FG002|Overall Study|Patient refuses further therapy|7|||
16965770|NCT01189266|38108650|FG000|Overall Study|No treatment|0|||
16965771|NCT01189266|38108651|FG001|Overall Study|No treatment|0|||
16965772|NCT01189266|38108652|FG002|Overall Study|No treatment|1|||
16965773|NCT01189032|38108664|FG000|Overall Study|Adverse Event|1|||
16965774|NCT01189032|38108665|FG001|Overall Study|Adverse Event|3|||
16965775|NCT01189032|38108666|FG002|Overall Study|Adverse Event|4|||
16965776|NCT01189032|38108664|FG000|Overall Study|Lack of Efficacy|2|||
16965777|NCT01189032|38108665|FG001|Overall Study|Lack of Efficacy|3|||
16965778|NCT01189032|38108666|FG002|Overall Study|Lack of Efficacy|0|||
16965779|NCT01189032|38108664|FG000|Overall Study|Withdrawal by Subject|1|||
16965780|NCT01189032|38108665|FG001|Overall Study|Withdrawal by Subject|0|||
16965781|NCT01189032|38108666|FG002|Overall Study|Withdrawal by Subject|1|||
16965782|NCT01189032|38108664|FG000|Overall Study|Protocol Violation|1|||
16965783|NCT01189032|38108665|FG001|Overall Study|Protocol Violation|1|||
16965784|NCT01189032|38108666|FG002|Overall Study|Protocol Violation|1|||
16965785|NCT01188798|38108676|FG000|Overall Study|Death|0|||
16965786|NCT01188798|38108677|FG001|Overall Study|Death|1|||
16965787|NCT01188798|38108676|FG000|Overall Study|Required additional transplant|1|||
16965788|NCT01188798|38108677|FG001|Overall Study|Required additional transplant|1|||
16965789|NCT01188798|38108676|FG000|Overall Study|Protocol closure|1|||
16965790|NCT01188798|38108677|FG001|Overall Study|Protocol closure|1|||
16965791|NCT01183104|38108686|FG000|Overall Study|Adverse Event|8|||
16965792|NCT01183104|38108687|FG001|Overall Study|Adverse Event|6|||
16965793|NCT01183104|38108686|FG000|Overall Study|Death|0|||
16965794|NCT01183104|38108687|FG001|Overall Study|Death|1|||
16965795|NCT01183104|38108686|FG000|Overall Study|Lost to Follow-up|14|||
16965796|NCT01183104|38108687|FG001|Overall Study|Lost to Follow-up|7|||
16965797|NCT01183104|38108686|FG000|Overall Study|Physician Decision|5|||
16965798|NCT01183104|38108687|FG001|Overall Study|Physician Decision|8|||
16965799|NCT01183104|38108686|FG000|Overall Study|Withdrawal by Subject|6|||
16965800|NCT01183104|38108687|FG001|Overall Study|Withdrawal by Subject|11|||
16965801|NCT01183104|38108686|FG000|Overall Study|Nonparticipation in Extension Study|39|||
16965802|NCT01183104|38108687|FG001|Overall Study|Nonparticipation in Extension Study|50|||
16965803|NCT01183104|38108686|FG000|Overall Study|Did not receive study drug|5|||
16965804|NCT01183104|38108687|FG001|Overall Study|Did not receive study drug|9|||
16965805|NCT01163292|38108695|FG000|Overall Study|Lack of Efficacy|9|||
16965806|NCT01163292|38108696|FG001|Overall Study|Lack of Efficacy|0|||
16965807|NCT01163292|38108695|FG000|Overall Study|Adverse Event|6|||
16965808|NCT01163292|38108696|FG001|Overall Study|Adverse Event|0|||
16965809|NCT01163292|38108695|FG000|Overall Study|Initiation of biological therapy|0|||
16965810|NCT01163292|38108696|FG001|Overall Study|Initiation of biological therapy|15|||
16965811|NCT01163292|38108695|FG000|Overall Study|Sufficient response to adalimumab|8|||
16965812|NCT01163292|38108696|FG001|Overall Study|Sufficient response to adalimumab|0|||
16965813|NCT01163292|38108695|FG000|Overall Study|Refusal to receive adalimumab|7|||
16965814|NCT01163292|38108696|FG001|Overall Study|Refusal to receive adalimumab|0|||
16965815|NCT01163292|38108695|FG000|Overall Study|Economic reasons|6|||
16965816|NCT01163292|38108696|FG001|Overall Study|Economic reasons|0|||
16965817|NCT01163292|38108695|FG000|Overall Study|No further visits|5|||
16965818|NCT01163292|38108696|FG001|Overall Study|No further visits|7|||
16965819|NCT00950248|38108704|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
16965820|NCT00950248|38108705|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
16965821|NCT00950248|38108706|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
16965822|NCT00950248|38108704|FG000|Year 1: Baseline|worsening of symptoms|2|||
16965823|NCT00950248|38108705|FG001|Year 1: Baseline|worsening of symptoms|0|||
16965824|NCT00950248|38108706|FG002|Year 1: Baseline|worsening of symptoms|0|||
16965825|NCT00950248|38108704|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
16965826|NCT00950248|38108705|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
16965827|NCT00950248|38108706|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
16965828|NCT00950248|38108704|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
16965829|NCT00950248|38108705|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
16965830|NCT00950248|38108706|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
16965831|NCT00950248|38108704|FG000|Year 2&3 Treatment Randomization|Death|0|||
16965832|NCT00950248|38108705|FG001|Year 2&3 Treatment Randomization|Death|0|||
16965833|NCT00950248|38108706|FG002|Year 2&3 Treatment Randomization|Death|1|||
16965834|NCT00950248|38108704|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
16965835|NCT00950248|38108705|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
16965836|NCT00950248|38108706|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
16965837|NCT00950170|38108713|FG000|Overall Study|Parent/Legal Guardian Request|1|||
16965838|NCT00950170|38108713|FG000|Overall Study|Adverse Event|2|||
16965839|NCT00950170|38108713|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
16965840|NCT01227824|38108737|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
16965841|NCT01227824|38108738|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
16965842|NCT01227824|38108739|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
16965843|NCT01227824|38108737|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
16965844|NCT01227824|38108738|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
16965845|NCT01227824|38108739|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
16965846|NCT01227824|38108737|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
16965847|NCT01227824|38108738|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
16965848|NCT01227824|38108739|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
16965849|NCT01227824|38108737|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
16965850|NCT01227824|38108738|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
16965851|NCT01227824|38108739|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
16965852|NCT01227824|38108737|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
16965853|NCT01227824|38108738|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
16965854|NCT01227824|38108739|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
16965855|NCT01227824|38108737|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
16965856|NCT01227824|38108738|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
16965857|NCT01227824|38108739|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
16965858|NCT01227824|38108737|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
16965859|NCT01227824|38108738|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
16965860|NCT01227824|38108739|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
16965861|NCT01227824|38108737|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
16965862|NCT01227824|38108738|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
16965863|NCT01227824|38108739|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
16965864|NCT01227824|38108737|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
16965865|NCT01227824|38108738|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
16965866|NCT01227824|38108739|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
16965867|NCT01227824|38108737|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
16965868|NCT01227824|38108738|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
16965869|NCT01227824|38108739|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
16965870|NCT01227824|38108737|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
16965871|NCT01227824|38108738|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
16965872|NCT01227824|38108739|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
16965873|NCT01227824|38108737|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
16965874|NCT01227824|38108738|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
16965875|NCT01227824|38108739|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
16965876|NCT01227824|38108737|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
16965877|NCT01227824|38108738|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
16965878|NCT01227824|38108739|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
16965879|NCT01227824|38108737|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
16965880|NCT01227824|38108738|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
16965881|NCT01227824|38108739|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
16965882|NCT01227824|38108737|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
16965883|NCT01227824|38108738|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
16965884|NCT01227824|38108739|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
16965885|NCT00949702|38108746|FG000|Overall Study|Death|40|||
16965886|NCT00949702|38108746|FG000|Overall Study|Disease progression|7|||
16965887|NCT00949702|38108746|FG000|Overall Study|Withdrawal of consent|1|||
16965888|NCT01034631|38108753|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
16965889|NCT01034631|38108754|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
16965890|NCT01034631|38108755|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
16965891|NCT01034631|38108753|FG000|Phase II|Not Evaluable per protocol|0|||
16965892|NCT01034631|38108754|FG001|Phase II|Not Evaluable per protocol|0|||
16965893|NCT01034631|38108755|FG002|Phase II|Not Evaluable per protocol|2|||
16780016|NCT02616783|37719083|FG001|Overall Study|Protocol Violation|1|||
16965894|NCT01034631|38108753|FG000|Phase II|Determined Ineligible per protocol|0|||
16965895|NCT01034631|38108754|FG001|Phase II|Determined Ineligible per protocol|1|||
16965896|NCT01034631|38108755|FG002|Phase II|Determined Ineligible per protocol|0|||
16965897|NCT01227668|38108767|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
16965898|NCT01227668|38108768|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
16965899|NCT01227668|38108767|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
16965900|NCT01227668|38108768|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
16965901|NCT01227668|38108767|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
16965902|NCT01227668|38108768|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
16965903|NCT01227668|38108767|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
16965904|NCT01227668|38108768|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
16965905|NCT01227668|38108767|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
16965906|NCT01227668|38108768|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
16965907|NCT01227668|38108767|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
16965908|NCT01227668|38108768|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
16965909|NCT01227668|38108767|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
16965910|NCT01227668|38108768|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
16965911|NCT01227668|38108767|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
16965912|NCT01227668|38108768|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
16965913|NCT01227668|38108767|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
16965914|NCT01227668|38108768|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
16965915|NCT01227668|38108767|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
16965916|NCT01227668|38108768|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
16965917|NCT01227668|38108767|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
16965918|NCT01227668|38108768|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
16965919|NCT01227668|38108767|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
16965920|NCT01227668|38108768|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
16965921|NCT01227512|38108780|FG000|Overall Study|Physician Decision|6|||
16965922|NCT01227512|38108781|FG001|Overall Study|Physician Decision|6|||
16965923|NCT01227512|38108780|FG000|Overall Study|Adverse Event|4|||
16965924|NCT01227512|38108781|FG001|Overall Study|Adverse Event|3|||
16965925|NCT01227512|38108780|FG000|Overall Study|Withdrawal by Subject|3|||
16965926|NCT01227512|38108781|FG001|Overall Study|Withdrawal by Subject|0|||
16965927|NCT01227512|38108780|FG000|Overall Study|Participant met withdrawal criteria|0|||
16965928|NCT01227512|38108781|FG001|Overall Study|Participant met withdrawal criteria|1|||
16965929|NCT01227278|38108791|FG000|Overall Study|Withdrawal by Subject|4|||
16965930|NCT01227278|38108792|FG001|Overall Study|Withdrawal by Subject|4|||
16965931|NCT01227278|38108791|FG000|Overall Study|Death|0|||
16965932|NCT01227278|38108792|FG001|Overall Study|Death|2|||
16965933|NCT01227278|38108791|FG000|Overall Study|Other|1|||
16965934|NCT01227278|38108792|FG001|Overall Study|Other|2|||
16965935|NCT01034397|38108800|FG000|Overall Study|Lack of compliance|0|||
16965936|NCT01034397|38108801|FG001|Overall Study|Lack of compliance|1|||
16965937|NCT01034397|38108800|FG000|Overall Study|Lack of Efficacy|3|||
16965938|NCT01034397|38108801|FG001|Overall Study|Lack of Efficacy|0|||
16965939|NCT01034397|38108800|FG000|Overall Study|Adverse Event|4|||
16965940|NCT01034397|38108801|FG001|Overall Study|Adverse Event|0|||
16965941|NCT01034397|38108800|FG000|Overall Study|Other|0|||
16965942|NCT01034397|38108801|FG001|Overall Study|Other|1|||
16965943|NCT01227044|38108818|FG000|Overall Study|Lost to Follow-up|5|||
16965944|NCT01227044|38108819|FG001|Overall Study|Lost to Follow-up|7|||
16965945|NCT01227044|38108818|FG000|Overall Study|Discontinued Intervention|1|||
16965946|NCT01227044|38108819|FG001|Overall Study|Discontinued Intervention|2|||
16965947|NCT01225952|38108828|FG000|Overall Study|Lost to Follow-up|1|||
16965948|NCT01225952|38108829|FG001|Overall Study|Lost to Follow-up|0|||
16965949|NCT01225952|38108830|FG002|Overall Study|Lost to Follow-up|0|||
16965950|NCT01225952|38108828|FG000|Overall Study|Study Eye Explanted|0|||
16965951|NCT01225952|38108829|FG001|Overall Study|Study Eye Explanted|0|||
16965952|NCT01225952|38108830|FG002|Overall Study|Study Eye Explanted|1|||
16965953|NCT01225952|38108828|FG000|Overall Study|Withdrawal by Subject|4|||
16965954|NCT01225952|38108829|FG001|Overall Study|Withdrawal by Subject|4|||
16965955|NCT01225952|38108830|FG002|Overall Study|Withdrawal by Subject|5|||
16965956|NCT01225952|38108828|FG000|Overall Study|Surgical complications|1|||
16965957|NCT01225952|38108829|FG001|Overall Study|Surgical complications|0|||
16965958|NCT01225952|38108830|FG002|Overall Study|Surgical complications|0|||
16965959|NCT01034163|38108840|FG000|Overall Study|Treatment completed as per protocol|8|||
16965960|NCT01034163|38108841|FG001|Overall Study|Treatment completed as per protocol|7|||
16965961|NCT01034163|38108840|FG000|Overall Study|Withdrawal by Subject|8|||
16965962|NCT01034163|38108841|FG001|Overall Study|Withdrawal by Subject|2|||
16965963|NCT01034163|38108840|FG000|Overall Study|Protocol deviation|1|||
16965964|NCT01034163|38108841|FG001|Overall Study|Protocol deviation|0|||
16965965|NCT01034163|38108840|FG000|Overall Study|Disease progression|3|||
16965966|NCT01034163|38108841|FG001|Overall Study|Disease progression|4|||
16965967|NCT01034163|38108840|FG000|Overall Study|Adverse Event|6|||
16965968|NCT01034163|38108841|FG001|Overall Study|Adverse Event|0|||
16965969|NCT01034163|38108840|FG000|Overall Study|Administrative problems|0|||
16965970|NCT01034163|38108841|FG001|Overall Study|Administrative problems|1|||
16965971|NCT01034163|38108840|FG000|Overall Study|Abnormal laboratory value|1|||
16965972|NCT01034163|38108841|FG001|Overall Study|Abnormal laboratory value|0|||
16965973|NCT01033851|38108849|FG000|Overall Study|Withdrawal by Subject|3|||
16965974|NCT01033851|38108850|FG001|Overall Study|Withdrawal by Subject|7|||
16965975|NCT01162122|38108858|FG000|Overall Study|Withdrawal by Subject|52|||
16965976|NCT01162122|38108859|FG001|Overall Study|Withdrawal by Subject|43|||
16965977|NCT01162122|38108858|FG000|Overall Study|Lost to Follow-up|73|||
16965978|NCT01162122|38108859|FG001|Overall Study|Lost to Follow-up|91|||
16965979|NCT01162122|38108858|FG000|Overall Study|Adverse Event|3|||
16965980|NCT01162122|38108859|FG001|Overall Study|Adverse Event|2|||
16965981|NCT01162122|38108858|FG000|Overall Study|Death|51|||
16965982|NCT01162122|38108859|FG001|Overall Study|Death|46|||
16965983|NCT01162122|38108858|FG000|Overall Study|Protocol Violation|2|||
16965984|NCT01162122|38108859|FG001|Overall Study|Protocol Violation|2|||
16965985|NCT01162122|38108858|FG000|Overall Study|Inappropriate enrollment|5|||
16965986|NCT01162122|38108859|FG001|Overall Study|Inappropriate enrollment|4|||
16965987|NCT01162122|38108858|FG000|Overall Study|Administrative reason|1|||
16965988|NCT01162122|38108859|FG001|Overall Study|Administrative reason|1|||
16965989|NCT01162122|38108858|FG000|Overall Study|Unable to classify|3|||
16965990|NCT01162122|38108859|FG001|Overall Study|Unable to classify|7|||
16965991|NCT01162122|38108858|FG000|Overall Study|Missing primary reason|1|||
16965992|NCT01162122|38108859|FG001|Overall Study|Missing primary reason|0|||
16965993|NCT01033071|38108871|FG000|Overall Study|Adverse Event|28|||
16965994|NCT01033071|38108872|FG001|Overall Study|Adverse Event|51|||
16965995|NCT01033071|38108873|FG002|Overall Study|Adverse Event|26|||
16965996|NCT01033071|38108871|FG000|Overall Study|Protocol Violation|0|||
16965997|NCT01033071|38108872|FG001|Overall Study|Protocol Violation|2|||
16965998|NCT01033071|38108873|FG002|Overall Study|Protocol Violation|1|||
16965999|NCT01033071|38108871|FG000|Overall Study|Lost to Follow-up|4|||
16966000|NCT01033071|38108872|FG001|Overall Study|Lost to Follow-up|5|||
16966001|NCT01033071|38108873|FG002|Overall Study|Lost to Follow-up|5|||
16966002|NCT01033071|38108871|FG000|Overall Study|Withdrawal by Subject|17|||
16966003|NCT01033071|38108872|FG001|Overall Study|Withdrawal by Subject|14|||
16966004|NCT01033071|38108873|FG002|Overall Study|Withdrawal by Subject|11|||
16966005|NCT01033071|38108871|FG000|Overall Study|Lack of Efficacy|0|||
16966006|NCT01033071|38108872|FG001|Overall Study|Lack of Efficacy|1|||
16966007|NCT01033071|38108873|FG002|Overall Study|Lack of Efficacy|1|||
16966008|NCT01033071|38108871|FG000|Overall Study|Other|6|||
16966009|NCT01033071|38108872|FG001|Overall Study|Other|4|||
16966010|NCT01033071|38108873|FG002|Overall Study|Other|3|||
16966011|NCT01032915|38108885|FG000|Overall Study|Adverse Event|2|||
16966012|NCT01032915|38108886|FG001|Overall Study|Adverse Event|2|||
16966013|NCT01032915|38108887|FG002|Overall Study|Adverse Event|1|||
16966014|NCT01032915|38108888|FG003|Overall Study|Adverse Event|1|||
16966015|NCT01032915|38108885|FG000|Overall Study|Abnormal test procedure result|0|||
16966016|NCT01032915|38108886|FG001|Overall Study|Abnormal test procedure result|0|||
16966017|NCT01032915|38108887|FG002|Overall Study|Abnormal test procedure result|1|||
16966018|NCT01032915|38108888|FG003|Overall Study|Abnormal test procedure result|0|||
16966019|NCT01032915|38108885|FG000|Overall Study|Withdrawal by Subject|0|||
16966020|NCT01032915|38108886|FG001|Overall Study|Withdrawal by Subject|3|||
16966021|NCT01032915|38108887|FG002|Overall Study|Withdrawal by Subject|1|||
16966022|NCT01032915|38108888|FG003|Overall Study|Withdrawal by Subject|1|||
16966023|NCT01032915|38108885|FG000|Overall Study|Administrative reasons|5|||
16966024|NCT01032915|38108886|FG001|Overall Study|Administrative reasons|6|||
16966025|NCT01032915|38108887|FG002|Overall Study|Administrative reasons|4|||
16966026|NCT01032915|38108888|FG003|Overall Study|Administrative reasons|4|||
16966027|NCT01032915|38108885|FG000|Overall Study|Protocol Violation|1|||
16966028|NCT01032915|38108886|FG001|Overall Study|Protocol Violation|0|||
16966029|NCT01032915|38108887|FG002|Overall Study|Protocol Violation|0|||
16966030|NCT01032915|38108888|FG003|Overall Study|Protocol Violation|1|||
16966031|NCT01161498|38108900|FG000|Overall Study|Disease Progression|0|||
16966032|NCT01161498|38108901|FG001|Overall Study|Disease Progression|1|||
16966033|NCT01180998|38108910|FG000|Overall Study|Poor Vision|0|||
16966034|NCT01180998|38108911|FG001|Overall Study|Poor Vision|2|||
16966035|NCT01180998|38108912|FG002|Overall Study|Poor Vision|2|||
16966036|NCT01180998|38108910|FG000|Overall Study|Lost to Follow-up|0|||
16966037|NCT01180998|38108911|FG001|Overall Study|Lost to Follow-up|0|||
16966038|NCT01180998|38108912|FG002|Overall Study|Lost to Follow-up|1|||
16966039|NCT01180998|38108910|FG000|Overall Study|Protocol Violation|1|||
16966040|NCT01180998|38108911|FG001|Overall Study|Protocol Violation|2|||
16966041|NCT01180998|38108912|FG002|Overall Study|Protocol Violation|0|||
16966042|NCT01180998|38108910|FG000|Overall Study|Withdrawal by Subject|0|||
16966043|NCT01180998|38108911|FG001|Overall Study|Withdrawal by Subject|0|||
16966044|NCT01180998|38108912|FG002|Overall Study|Withdrawal by Subject|1|||
16966045|NCT01180998|38108910|FG000|Overall Study|Poor comfort|3|||
16966046|NCT01180998|38108911|FG001|Overall Study|Poor comfort|0|||
16966047|NCT01180998|38108912|FG002|Overall Study|Poor comfort|4|||
16966048|NCT01180998|38108910|FG000|Overall Study|Poor lens handling|0|||
16966049|NCT01180998|38108911|FG001|Overall Study|Poor lens handling|0|||
16966050|NCT01180998|38108912|FG002|Overall Study|Poor lens handling|2|||
16966051|NCT01029795|38108923|FG000|Overall Study|Entry Criteria Not Met|2|||
16966052|NCT01029795|38108924|FG001|Overall Study|Entry Criteria Not Met|1|||
16966053|NCT01029795|38108923|FG000|Overall Study|Physician Decision|2|||
16966054|NCT01029795|38108924|FG001|Overall Study|Physician Decision|1|||
16966055|NCT01029795|38108923|FG000|Overall Study|Sponsor Decision|11|||
16966056|NCT01029795|38108924|FG001|Overall Study|Sponsor Decision|17|||
16966057|NCT01029795|38108923|FG000|Overall Study|Withdrawal by Subject|1|||
16966058|NCT01029795|38108924|FG001|Overall Study|Withdrawal by Subject|3|||
16966059|NCT01032837|38108934|FG000|Overall Study|Adverse event/internal illness|0|||
16966060|NCT01032837|38108935|FG001|Overall Study|Adverse event/internal illness|1|||
16966061|NCT01032837|38108936|FG002|Overall Study|Adverse event/internal illness|0|||
16966062|NCT01032837|38108937|FG003|Overall Study|Adverse event/internal illness|1|||
16966063|NCT01032837|38108934|FG000|Overall Study|Withdrew consent|0|||
16966064|NCT01032837|38108935|FG001|Overall Study|Withdrew consent|2|||
16966065|NCT01032837|38108936|FG002|Overall Study|Withdrew consent|0|||
16966066|NCT01032837|38108937|FG003|Overall Study|Withdrew consent|1|||
16966067|NCT01032837|38108934|FG000|Overall Study|Failed to return|0|||
16966068|NCT01032837|38108935|FG001|Overall Study|Failed to return|0|||
16966069|NCT01032837|38108936|FG002|Overall Study|Failed to return|1|||
16966070|NCT01032837|38108937|FG003|Overall Study|Failed to return|0|||
16966071|NCT01032837|38108934|FG000|Overall Study|Refused treatment|0|||
16966072|NCT01032837|38108935|FG001|Overall Study|Refused treatment|0|||
16966073|NCT01032837|38108936|FG002|Overall Study|Refused treatment|0|||
16966074|NCT01032837|38108937|FG003|Overall Study|Refused treatment|1|||
16966075|NCT01180296|38108949|FG000|Overall Study|Protocol Violation|1|||
16966076|NCT01180296|38108950|FG001|Overall Study|Protocol Violation|2|||
16966077|NCT01160640|38108960|FG000|Overall Study|Physician Decision|3|||
16966078|NCT01160640|38108961|FG001|Overall Study|Physician Decision|3|||
16966079|NCT01160640|38108960|FG000|Overall Study|Incarceration|1|||
16966080|NCT01160640|38108961|FG001|Overall Study|Incarceration|0|||
16966081|NCT01160640|38108960|FG000|Overall Study|Withdrawal by Subject|0|||
16966082|NCT01160640|38108961|FG001|Overall Study|Withdrawal by Subject|3|||
16966083|NCT01160484|38108969|FG000|Overall Study|Lack of Efficacy|9|||
16966084|NCT01160484|38108969|FG000|Overall Study|Adverse Event|6|||
16966085|NCT01160484|38108969|FG000|Overall Study|Withdrawal by Subject|2|||
16966086|NCT01160484|38108969|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
16966087|NCT01032291|38108976|FG000|Safety Lead-in|Adverse Event|1|||
16966088|NCT01032291|38108977|FG001|Safety Lead-in|Adverse Event|0|||
16966089|NCT01032291|38108978|FG002|Safety Lead-in|Adverse Event|0|||
16966090|NCT01032291|38108976|FG000|Safety Lead-in|Death|1|||
16966091|NCT01032291|38108977|FG001|Safety Lead-in|Death|0|||
16966092|NCT01032291|38108978|FG002|Safety Lead-in|Death|0|||
16966093|NCT01032291|38108976|FG000|Proof of Concept|Adverse Event|0|||
16966094|NCT01032291|38108977|FG001|Proof of Concept|Adverse Event|5|||
16966095|NCT01032291|38108978|FG002|Proof of Concept|Adverse Event|1|||
16966096|NCT01032291|38108976|FG000|Proof of Concept|Death|0|||
16966097|NCT01032291|38108977|FG001|Proof of Concept|Death|1|||
16966098|NCT01032291|38108978|FG002|Proof of Concept|Death|2|||
16966099|NCT01032291|38108976|FG000|Proof of Concept|Lack of Efficacy|0|||
16966100|NCT01032291|38108977|FG001|Proof of Concept|Lack of Efficacy|1|||
16966101|NCT01032291|38108978|FG002|Proof of Concept|Lack of Efficacy|0|||
16966102|NCT01032291|38108976|FG000|Proof of Concept|Never Received Study Drug|0|||
16966103|NCT01032291|38108977|FG001|Proof of Concept|Never Received Study Drug|1|||
16966104|NCT01032291|38108978|FG002|Proof of Concept|Never Received Study Drug|0|||
16966105|NCT01159938|38108992|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
16966106|NCT01159938|38108993|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
16966107|NCT01159938|38108994|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
16966108|NCT01159938|38108995|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
16966109|NCT01159938|38108996|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
16966110|NCT01029405|38109021|FG000|Overall Study|Withdrawal by Subject|0|||
16966111|NCT01029405|38109022|FG001|Overall Study|Withdrawal by Subject|1|||
16966112|NCT01029405|38109023|FG002|Overall Study|Withdrawal by Subject|2|||
16966113|NCT01029405|38109024|FG003|Overall Study|Withdrawal by Subject|0|||
16966114|NCT01029405|38109021|FG000|Overall Study|Protocol Violation|0|||
16966115|NCT01029405|38109022|FG001|Overall Study|Protocol Violation|0|||
16966116|NCT01029405|38109023|FG002|Overall Study|Protocol Violation|0|||
16966117|NCT01029405|38109024|FG003|Overall Study|Protocol Violation|1|||
16966118|NCT01029405|38109021|FG000|Overall Study|Adverse Event|0|||
16966119|NCT01029405|38109022|FG001|Overall Study|Adverse Event|0|||
16966120|NCT01029405|38109023|FG002|Overall Study|Adverse Event|1|||
16966121|NCT01029405|38109024|FG003|Overall Study|Adverse Event|1|||
16966122|NCT01029405|38109021|FG000|Overall Study|Lost to Follow-up|2|||
16966123|NCT01029405|38109022|FG001|Overall Study|Lost to Follow-up|1|||
16966124|NCT01029405|38109023|FG002|Overall Study|Lost to Follow-up|1|||
16966125|NCT01029405|38109024|FG003|Overall Study|Lost to Follow-up|2|||
16966126|NCT01029405|38109021|FG000|Overall Study|Other|0|||
16966127|NCT01029405|38109022|FG001|Overall Study|Other|1|||
16966128|NCT01029405|38109023|FG002|Overall Study|Other|0|||
16966129|NCT01029405|38109024|FG003|Overall Study|Other|1|||
16966130|NCT01021683|38109034|FG000|Overall Study|Lack of Efficacy|12|||
16966131|NCT01021683|38109034|FG000|Overall Study|Recovery of neutrophil count|51|||
16966132|NCT01021683|38109034|FG000|Overall Study|Other|8|||
16966133|NCT01021293|38109040|FG000|Overall Study|Serious Adverse Event|2|||
16966134|NCT01021293|38109041|FG001|Overall Study|Serious Adverse Event|1|||
16966135|NCT01021293|38109040|FG000|Overall Study|Adverse Event|2|||
16966136|NCT01021293|38109041|FG001|Overall Study|Adverse Event|1|||
16966137|NCT01021293|38109040|FG000|Overall Study|Withdrawal by Subject|1|||
16966138|NCT01021293|38109041|FG001|Overall Study|Withdrawal by Subject|3|||
16966139|NCT01021293|38109040|FG000|Overall Study|Migrated/moved from study area|6|||
16966140|NCT01021293|38109041|FG001|Overall Study|Migrated/moved from study area|18|||
16966141|NCT01021293|38109040|FG000|Overall Study|Lost to Follow-up|1|||
16966142|NCT01021293|38109041|FG001|Overall Study|Lost to Follow-up|1|||
16966143|NCT04625725|38109050|FG000|Overall Study|Death|4|||
16966144|NCT04625725|38109051|FG001|Overall Study|Death|4|||
16966145|NCT04625725|38109050|FG000|Overall Study|Lost to Follow-up|11|||
16966146|NCT04625725|38109051|FG001|Overall Study|Lost to Follow-up|8|||
16966147|NCT04625725|38109050|FG000|Overall Study|Physician Decision|1|||
16966148|NCT04625725|38109051|FG001|Overall Study|Physician Decision|0|||
16966149|NCT04625725|38109050|FG000|Overall Study|Withdrawal by Subject|56|||
16966150|NCT04625725|38109051|FG001|Overall Study|Withdrawal by Subject|32|||
16966151|NCT04625725|38109050|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
16966152|NCT04625725|38109051|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
16966153|NCT04625725|38109050|FG000|Overall Study|Ongoing in study|3409|||
16966154|NCT04625725|38109051|FG001|Overall Study|Ongoing in study|1700|||
16966155|NCT04625725|38109050|FG000|Overall Study|Protocol Deviation|1|||
16966156|NCT04625725|38109051|FG001|Overall Study|Protocol Deviation|0|||
16966157|NCT01021215|38109059|FG000|Overall Study|Lost to Follow-up|3|||
16966158|NCT01021215|38109060|FG001|Overall Study|Lost to Follow-up|0|||
16966159|NCT01021137|38109070|FG000|Overall Study|Lost to Follow-up|9|||
16966160|NCT01021137|38109071|FG001|Overall Study|Lost to Follow-up|4|||
16966161|NCT01021137|38109072|FG002|Overall Study|Lost to Follow-up|2|||
16966162|NCT01021137|38109073|FG003|Overall Study|Lost to Follow-up|6|||
16966163|NCT01021137|38109070|FG000|Overall Study|Withdrawal by Subject|1|||
16966164|NCT01021137|38109071|FG001|Overall Study|Withdrawal by Subject|0|||
16966165|NCT01021137|38109072|FG002|Overall Study|Withdrawal by Subject|0|||
16966166|NCT01021137|38109073|FG003|Overall Study|Withdrawal by Subject|3|||
16966167|NCT01020981|38109086|FG000|Overall Study|Did not return mailed survey|74|||
16966168|NCT01020981|38109087|FG001|Overall Study|Did not return mailed survey|58|||
16966169|NCT01020981|38109086|FG000|Overall Study|Survey returned undeliverable|8|||
16966170|NCT01020981|38109087|FG001|Overall Study|Survey returned undeliverable|32|||
16966171|NCT01020981|38109086|FG000|Overall Study|Participant declined to complete survey|2|||
16966172|NCT01020981|38109087|FG001|Overall Study|Participant declined to complete survey|0|||
16966173|NCT01020747|38109095|FG000|Overall Study|Withdrawal by Subject|1|||
16966174|NCT01020435|38109102|FG000|Overall Study|Lost to Follow-up|0|||
16966175|NCT01020435|38109103|FG001|Overall Study|Lost to Follow-up|1|||
16966176|NCT01031979|38109112|FG000|Overall Study|Lost to Follow-up|5|||
16966177|NCT01031979|38109113|FG001|Overall Study|Lost to Follow-up|4|||
16966178|NCT01020123|38109126|FG000|Main Period|Withdrawal by Subject|6|||
16966179|NCT01020123|38109127|FG001|Main Period|Withdrawal by Subject|5|||
16966180|NCT01020123|38109128|FG002|Main Period|Withdrawal by Subject|3|||
16966181|NCT01020123|38109129|FG003|Main Period|Withdrawal by Subject|1|||
16966182|NCT01020123|38109130|FG004|Main Period|Withdrawal by Subject|6|||
16966183|NCT01020123|38109131|FG005|Main Period|Withdrawal by Subject|3|||
16966184|NCT01020123|38109132|FG006|Main Period|Withdrawal by Subject|2|||
16966185|NCT01020123|38109126|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
16966186|NCT01020123|38109127|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
16966187|NCT01020123|38109128|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
16966188|NCT01020123|38109129|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
16966189|NCT01020123|38109130|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
16966190|NCT01020123|38109131|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
16966191|NCT01020123|38109132|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
16966192|NCT01020123|38109126|FG000|Main Period|Adverse Event|5|||
16966193|NCT01020123|38109127|FG001|Main Period|Adverse Event|2|||
16966194|NCT01020123|38109128|FG002|Main Period|Adverse Event|2|||
16966195|NCT01020123|38109129|FG003|Main Period|Adverse Event|1|||
16966196|NCT01020123|38109130|FG004|Main Period|Adverse Event|1|||
16966197|NCT01020123|38109131|FG005|Main Period|Adverse Event|2|||
16966198|NCT01020123|38109132|FG006|Main Period|Adverse Event|1|||
16966199|NCT01020123|38109126|FG000|Main Period|Protocol Violation|4|||
16966200|NCT01020123|38109127|FG001|Main Period|Protocol Violation|4|||
16966201|NCT01020123|38109128|FG002|Main Period|Protocol Violation|2|||
16966202|NCT01020123|38109129|FG003|Main Period|Protocol Violation|5|||
16966203|NCT01020123|38109130|FG004|Main Period|Protocol Violation|2|||
16966204|NCT01020123|38109131|FG005|Main Period|Protocol Violation|3|||
16966205|NCT01020123|38109132|FG006|Main Period|Protocol Violation|2|||
16966206|NCT01020123|38109126|FG000|Main Period|Lost to Follow-up|0|||
16966207|NCT01020123|38109127|FG001|Main Period|Lost to Follow-up|2|||
16966208|NCT01020123|38109128|FG002|Main Period|Lost to Follow-up|0|||
16966209|NCT01020123|38109129|FG003|Main Period|Lost to Follow-up|0|||
16966210|NCT01020123|38109130|FG004|Main Period|Lost to Follow-up|0|||
16966211|NCT01020123|38109131|FG005|Main Period|Lost to Follow-up|0|||
16966212|NCT01020123|38109132|FG006|Main Period|Lost to Follow-up|0|||
16966213|NCT01020123|38109126|FG000|Main Period|Unclasified|2|||
16966214|NCT01020123|38109127|FG001|Main Period|Unclasified|0|||
16966215|NCT01020123|38109128|FG002|Main Period|Unclasified|1|||
16966216|NCT01020123|38109129|FG003|Main Period|Unclasified|0|||
16966217|NCT01020123|38109130|FG004|Main Period|Unclasified|1|||
16966218|NCT01020123|38109131|FG005|Main Period|Unclasified|3|||
16966219|NCT01020123|38109132|FG006|Main Period|Unclasified|6|||
16966220|NCT01020123|38109126|FG000|Extention Period|Withdrawal by Subject|2|||
16966221|NCT01020123|38109127|FG001|Extention Period|Withdrawal by Subject|1|||
16966222|NCT01020123|38109128|FG002|Extention Period|Withdrawal by Subject|1|||
16966223|NCT01020123|38109129|FG003|Extention Period|Withdrawal by Subject|0|||
16966224|NCT01020123|38109130|FG004|Extention Period|Withdrawal by Subject|0|||
16966225|NCT01020123|38109131|FG005|Extention Period|Withdrawal by Subject|0|||
16966226|NCT01020123|38109132|FG006|Extention Period|Withdrawal by Subject|0|||
16966227|NCT01020123|38109126|FG000|Extention Period|Adverse Event|0|||
16966228|NCT01020123|38109127|FG001|Extention Period|Adverse Event|0|||
16966229|NCT01020123|38109128|FG002|Extention Period|Adverse Event|0|||
16966230|NCT01020123|38109129|FG003|Extention Period|Adverse Event|1|||
16966231|NCT01020123|38109130|FG004|Extention Period|Adverse Event|0|||
16966232|NCT01020123|38109131|FG005|Extention Period|Adverse Event|0|||
16966233|NCT01020123|38109132|FG006|Extention Period|Adverse Event|0|||
16966234|NCT01020123|38109126|FG000|Extention Period|Protocol Violation|1|||
16966235|NCT01020123|38109127|FG001|Extention Period|Protocol Violation|1|||
16966236|NCT01020123|38109128|FG002|Extention Period|Protocol Violation|1|||
16966237|NCT01020123|38109129|FG003|Extention Period|Protocol Violation|0|||
16966238|NCT01020123|38109130|FG004|Extention Period|Protocol Violation|0|||
16966239|NCT01020123|38109131|FG005|Extention Period|Protocol Violation|0|||
16966240|NCT01020123|38109132|FG006|Extention Period|Protocol Violation|1|||
16966241|NCT01020123|38109126|FG000|Extention Period|Lost to Follow-up|0|||
16966242|NCT01020123|38109127|FG001|Extention Period|Lost to Follow-up|0|||
16997752|NCT00962390|38141773|FG002|Overall Study|Adverse Event|3|||
16966243|NCT01020123|38109128|FG002|Extention Period|Lost to Follow-up|0|||
16966244|NCT01020123|38109129|FG003|Extention Period|Lost to Follow-up|0|||
16966245|NCT01020123|38109130|FG004|Extention Period|Lost to Follow-up|0|||
16966246|NCT01020123|38109131|FG005|Extention Period|Lost to Follow-up|2|||
16966247|NCT01020123|38109132|FG006|Extention Period|Lost to Follow-up|0|||
16966248|NCT01028391|38109173|FG000|Overall Study|Adverse Event|4|||
16966249|NCT01028391|38109174|FG001|Overall Study|Adverse Event|0|||
16966250|NCT01028391|38109173|FG000|Overall Study|Lack of Efficacy|0|||
16966251|NCT01028391|38109174|FG001|Overall Study|Lack of Efficacy|2|||
16966252|NCT01028391|38109173|FG000|Overall Study|Lost to Follow-up|3|||
16966253|NCT01028391|38109174|FG001|Overall Study|Lost to Follow-up|4|||
16966254|NCT01028391|38109173|FG000|Overall Study|Physician Decision|0|||
16966255|NCT01028391|38109174|FG001|Overall Study|Physician Decision|1|||
16966256|NCT01028391|38109173|FG000|Overall Study|Withdrawal by Subject|6|||
16966257|NCT01028391|38109174|FG001|Overall Study|Withdrawal by Subject|3|||
16966258|NCT01028391|38109173|FG000|Overall Study|Needed excluded medication|1|||
16966259|NCT01028391|38109174|FG001|Overall Study|Needed excluded medication|1|||
16966260|NCT01179672|38109182|FG000|Overall Study|Adverse Event|17|||
16966261|NCT01179672|38109183|FG001|Overall Study|Adverse Event|8|||
16966262|NCT01179672|38109182|FG000|Overall Study|Withdrawal by Subject|10|||
16966263|NCT01179672|38109183|FG001|Overall Study|Withdrawal by Subject|12|||
16966264|NCT01179672|38109182|FG000|Overall Study|Entry Criteria Not Met|0|||
16966265|NCT01179672|38109183|FG001|Overall Study|Entry Criteria Not Met|2|||
16966266|NCT01179672|38109182|FG000|Overall Study|Lost to Follow-up|0|||
16966267|NCT01179672|38109183|FG001|Overall Study|Lost to Follow-up|1|||
16966268|NCT01179672|38109182|FG000|Overall Study|Protocol Violation|2|||
16966269|NCT01179672|38109183|FG001|Overall Study|Protocol Violation|2|||
16966270|NCT01179672|38109182|FG000|Overall Study|Physician Decision|1|||
16966271|NCT01179672|38109183|FG001|Overall Study|Physician Decision|1|||
16966272|NCT01030965|38109197|FG000|Overall Study|Lack of Efficacy|3|||
16966273|NCT01030965|38109198|FG001|Overall Study|Lack of Efficacy|2|||
16966274|NCT01030965|38109199|FG002|Overall Study|Lack of Efficacy|0|||
16966275|NCT01030965|38109200|FG003|Overall Study|Lack of Efficacy|3|||
16966276|NCT01030965|38109197|FG000|Overall Study|Protocol Violation|1|||
16966277|NCT01030965|38109198|FG001|Overall Study|Protocol Violation|1|||
16966278|NCT01030965|38109199|FG002|Overall Study|Protocol Violation|1|||
16966279|NCT01030965|38109200|FG003|Overall Study|Protocol Violation|1|||
16966280|NCT01030965|38109197|FG000|Overall Study|Adverse Event|0|||
16966281|NCT01030965|38109198|FG001|Overall Study|Adverse Event|1|||
16966282|NCT01030965|38109199|FG002|Overall Study|Adverse Event|2|||
16966283|NCT01030965|38109200|FG003|Overall Study|Adverse Event|1|||
16966284|NCT01030965|38109197|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
16966285|NCT01030965|38109198|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
16966286|NCT01030965|38109199|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
16966287|NCT01030965|38109200|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
16966288|NCT01030965|38109197|FG000|Overall Study|Withdrawal by Subject|0|||
16966289|NCT01030965|38109198|FG001|Overall Study|Withdrawal by Subject|1|||
17028488|NCT00765674|38172856|FG002|Overall Study|Lack of Efficacy|1|||
16966290|NCT01030965|38109199|FG002|Overall Study|Withdrawal by Subject|0|||
16966291|NCT01030965|38109200|FG003|Overall Study|Withdrawal by Subject|2|||
16966292|NCT01179516|38109213|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
16966293|NCT01179516|38109214|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
16966294|NCT01179516|38109215|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
16966295|NCT01179516|38109213|FG000|Overall Study|Lack of Efficacy|4|||
16966296|NCT01179516|38109214|FG001|Overall Study|Lack of Efficacy|2|||
16966297|NCT01179516|38109215|FG002|Overall Study|Lack of Efficacy|0|||
16966298|NCT01179516|38109213|FG000|Overall Study|Noncompliance with Study Drug|2|||
16966299|NCT01179516|38109214|FG001|Overall Study|Noncompliance with Study Drug|0|||
16966300|NCT01179516|38109215|FG002|Overall Study|Noncompliance with Study Drug|1|||
16966301|NCT01179516|38109213|FG000|Overall Study|Protocol Deviations|4|||
16966302|NCT01179516|38109214|FG001|Overall Study|Protocol Deviations|3|||
16966303|NCT01179516|38109215|FG002|Overall Study|Protocol Deviations|3|||
16966304|NCT01179516|38109213|FG000|Overall Study|Withdrawal of Consent|2|||
16966305|NCT01179516|38109214|FG001|Overall Study|Withdrawal of Consent|6|||
16966306|NCT01179516|38109215|FG002|Overall Study|Withdrawal of Consent|10|||
16966307|NCT01179516|38109213|FG000|Overall Study|Lost to Follow-up|7|||
16966308|NCT01179516|38109214|FG001|Overall Study|Lost to Follow-up|7|||
16966309|NCT01179516|38109215|FG002|Overall Study|Lost to Follow-up|3|||
16966310|NCT01179516|38109213|FG000|Overall Study|Other|2|||
16966311|NCT01179516|38109214|FG001|Overall Study|Other|0|||
16966312|NCT01179516|38109215|FG002|Overall Study|Other|2|||
16966313|NCT01018953|38109223|FG000|Overall Study|Adverse Event|2|||
16966314|NCT01018953|38109223|FG000|Overall Study|Withdrawal by Subject|1|||
16966315|NCT01018953|38109223|FG000|Overall Study|Study termination by sponsor|5|||
16966316|NCT01158924|38109230|FG000|Overall Study|Withdrawal by Subject|1|||
16966317|NCT01158924|38109231|FG001|Overall Study|Withdrawal by Subject|2|||
16966318|NCT01158924|38109230|FG000|Overall Study|Lost to Follow-up|0|||
16966319|NCT01158924|38109231|FG001|Overall Study|Lost to Follow-up|1|||
16966320|NCT01027845|38109239|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
16966321|NCT01027845|38109240|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
16966322|NCT01027845|38109241|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
16966323|NCT01027845|38109242|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
16966324|NCT01027845|38109239|FG000|Primary Vaccination Phase|Adverse Event|1|||
16966325|NCT01027845|38109240|FG001|Primary Vaccination Phase|Adverse Event|0|||
16966326|NCT01027845|38109241|FG002|Primary Vaccination Phase|Adverse Event|0|||
16966327|NCT01027845|38109242|FG003|Primary Vaccination Phase|Adverse Event|0|||
16966328|NCT01027845|38109239|FG000|Primary Vaccination Phase|Protocol Violation|1|||
16966329|NCT01027845|38109240|FG001|Primary Vaccination Phase|Protocol Violation|0|||
16966330|NCT01027845|38109241|FG002|Primary Vaccination Phase|Protocol Violation|0|||
16966331|NCT01027845|38109242|FG003|Primary Vaccination Phase|Protocol Violation|0|||
16966332|NCT01027845|38109239|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
16966333|NCT01027845|38109240|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
16966334|NCT01027845|38109241|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
16966335|NCT01027845|38109242|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
16966336|NCT01027845|38109239|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
16966337|NCT01027845|38109240|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
16966338|NCT01027845|38109241|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
16966339|NCT01027845|38109242|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
16966340|NCT01027845|38109239|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
16966341|NCT01027845|38109240|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
16966342|NCT01027845|38109241|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
16966343|NCT01027845|38109242|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
16966344|NCT01017549|38109251|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
16966345|NCT01017549|38109251|FG000|One-year Follow-up|Lost to Follow-up|2|||
16966346|NCT01017549|38109251|FG000|One-year Follow-up|Withdrawal by Subject|5|||
16966347|NCT01017549|38109251|FG000|5 Year Follow-up|Lost to Follow-up|9|||
16966348|NCT01017549|38109251|FG000|5 Year Follow-up|Mastectomy|3|||
16966349|NCT01030341|38109255|FG000|Overall Study|Withdrawal by Subject|1|||
16966350|NCT01030341|38109255|FG000|Overall Study|Lost to Follow-up|2|||
16966351|NCT01026831|38109261|FG000|Overall Study|Adverse Event|4|||
16966352|NCT01026831|38109262|FG001|Overall Study|Adverse Event|3|||
16966353|NCT01026831|38109261|FG000|Overall Study|Lost to Follow-up|2|||
16966354|NCT01026831|38109262|FG001|Overall Study|Lost to Follow-up|0|||
16966355|NCT01026831|38109261|FG000|Overall Study|Physician Decision|1|||
16966356|NCT01026831|38109262|FG001|Overall Study|Physician Decision|1|||
16966357|NCT01026831|38109261|FG000|Overall Study|Protocol Violation|0|||
16966358|NCT01026831|38109262|FG001|Overall Study|Protocol Violation|2|||
16966359|NCT01026831|38109261|FG000|Overall Study|Withdrawal by Subject|7|||
16966360|NCT01026831|38109262|FG001|Overall Study|Withdrawal by Subject|5|||
16966361|NCT01016067|38109270|FG000|Overall Study|Lost to Follow-up|1|||
16966362|NCT01016067|38109271|FG001|Overall Study|Lost to Follow-up|2|||
16966363|NCT01016067|38109270|FG000|Overall Study|Physician Decision|1|||
16966364|NCT01016067|38109271|FG001|Overall Study|Physician Decision|1|||
16966365|NCT01016067|38109270|FG000|Overall Study|Withdrew due to Relocation|0|||
16966366|NCT01016067|38109271|FG001|Overall Study|Withdrew due to Relocation|1|||
16966367|NCT01015833|38109279|FG000|Overall Study|Death|1|||
16966368|NCT01015833|38109280|FG001|Overall Study|Death|0|||
16966369|NCT01015833|38109279|FG000|Overall Study|Withdrawal by Subject|3|||
16966370|NCT01015833|38109280|FG001|Overall Study|Withdrawal by Subject|2|||
16966371|NCT01015833|38109279|FG000|Overall Study|Adverse Event|0|||
16966372|NCT01015833|38109280|FG001|Overall Study|Adverse Event|1|||
16966373|NCT01015833|38109279|FG000|Overall Study|Physician Decision|2|||
16966374|NCT01015833|38109280|FG001|Overall Study|Physician Decision|0|||
16966375|NCT01015833|38109279|FG000|Overall Study|Symptomatic deterioration|0|||
16966376|NCT01015833|38109280|FG001|Overall Study|Symptomatic deterioration|1|||
16966377|NCT01015833|38109279|FG000|Overall Study|Other|5|||
16966378|NCT01015833|38109280|FG001|Overall Study|Other|1|||
16966379|NCT01015833|38109279|FG000|Overall Study|Motor Vehicle Accidents|1|||
16966380|NCT01015833|38109280|FG001|Overall Study|Motor Vehicle Accidents|0|||
16966381|NCT01015833|38109279|FG000|Overall Study|Did not start treatment|1|||
16966382|NCT01015833|38109280|FG001|Overall Study|Did not start treatment|0|||
16966383|NCT01015677|38109298|FG000|Overall Study|Adverse Event|0|||
16966384|NCT01015677|38109299|FG001|Overall Study|Adverse Event|1|||
16966385|NCT01015677|38109300|FG002|Overall Study|Adverse Event|0|||
16966386|NCT01015677|38109298|FG000|Overall Study|Lack of Efficacy|0|||
16966387|NCT01015677|38109299|FG001|Overall Study|Lack of Efficacy|1|||
16966388|NCT01015677|38109300|FG002|Overall Study|Lack of Efficacy|0|||
16966389|NCT01015677|38109298|FG000|Overall Study|Protocol Violation|0|||
16966390|NCT01015677|38109299|FG001|Overall Study|Protocol Violation|1|||
16966391|NCT01015677|38109300|FG002|Overall Study|Protocol Violation|0|||
16966392|NCT01015677|38109298|FG000|Overall Study|Withdrawal by Subject|1|||
16966393|NCT01015677|38109299|FG001|Overall Study|Withdrawal by Subject|1|||
16966394|NCT01015677|38109300|FG002|Overall Study|Withdrawal by Subject|0|||
16966395|NCT01225211|38109349|FG000|Overall Study|Adverse Event|0|||
16966396|NCT01225211|38109350|FG001|Overall Study|Adverse Event|0|||
16966397|NCT01225211|38109351|FG002|Overall Study|Adverse Event|1|||
16966398|NCT01225211|38109352|FG003|Overall Study|Adverse Event|0|||
16966399|NCT01225211|38109353|FG004|Overall Study|Adverse Event|0|||
16966400|NCT01225211|38109354|FG005|Overall Study|Adverse Event|0|||
16966401|NCT01225211|38109355|FG006|Overall Study|Adverse Event|0|||
16966402|NCT01225211|38109356|FG007|Overall Study|Adverse Event|0|||
16966403|NCT01225211|38109357|FG008|Overall Study|Adverse Event|0|||
16966404|NCT01225211|38109358|FG009|Overall Study|Adverse Event|1|||
16966405|NCT01225211|38109349|FG000|Overall Study|Withdrawal by Subject|0|||
16966406|NCT01225211|38109350|FG001|Overall Study|Withdrawal by Subject|0|||
16966407|NCT01225211|38109351|FG002|Overall Study|Withdrawal by Subject|0|||
16966408|NCT01225211|38109352|FG003|Overall Study|Withdrawal by Subject|0|||
16966409|NCT01225211|38109353|FG004|Overall Study|Withdrawal by Subject|0|||
16966410|NCT01225211|38109354|FG005|Overall Study|Withdrawal by Subject|0|||
16966411|NCT01225211|38109355|FG006|Overall Study|Withdrawal by Subject|1|||
16966412|NCT01225211|38109356|FG007|Overall Study|Withdrawal by Subject|0|||
16966413|NCT01225211|38109357|FG008|Overall Study|Withdrawal by Subject|1|||
16966414|NCT01225211|38109358|FG009|Overall Study|Withdrawal by Subject|3|||
16966415|NCT01225211|38109349|FG000|Overall Study|Other|0|||
16966416|NCT01225211|38109350|FG001|Overall Study|Other|0|||
16966417|NCT01225211|38109351|FG002|Overall Study|Other|0|||
16966418|NCT01225211|38109352|FG003|Overall Study|Other|0|||
16966419|NCT01225211|38109353|FG004|Overall Study|Other|0|||
16966420|NCT01225211|38109354|FG005|Overall Study|Other|0|||
16966421|NCT01225211|38109355|FG006|Overall Study|Other|0|||
16966422|NCT01225211|38109356|FG007|Overall Study|Other|0|||
16966423|NCT01225211|38109357|FG008|Overall Study|Other|0|||
16966424|NCT01225211|38109358|FG009|Overall Study|Other|1|||
16966425|NCT01224821|38109441|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
16966426|NCT01224821|38109441|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
16966427|NCT01224821|38109441|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
16966428|NCT01224821|38109441|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
16966429|NCT01224821|38109441|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
16966430|NCT01224821|38109441|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
16966431|NCT01224821|38109441|FG000|Long-Term Follow-Up|Death|2|||
16966432|NCT01224821|38109441|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
16966433|NCT01224431|38109458|FG000|Overall Study|not randomized|0|||
16966434|NCT01224431|38109459|FG001|Overall Study|not randomized|4|||
16966435|NCT01224431|38109458|FG000|Overall Study|no video record|0|||
16966436|NCT01224431|38109459|FG001|Overall Study|no video record|1|||
16966437|NCT01223183|38109469|FG000|Imaging Day 1|Physician Decision|0|||
16966438|NCT01223183|38109470|FG001|Imaging Day 1|Physician Decision|1|||
16966439|NCT01223183|38109469|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
16966440|NCT01223183|38109470|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
16966441|NCT01223183|38109469|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
16966442|NCT01223183|38109470|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
16966443|NCT01223027|38109479|FG000|Overall Study|Adverse Event|20|||
16966444|NCT01223027|38109480|FG001|Overall Study|Adverse Event|10|||
16966445|NCT01223027|38109479|FG000|Overall Study|Death|42|||
16966446|NCT01223027|38109480|FG001|Overall Study|Death|42|||
16966447|NCT01223027|38109479|FG000|Overall Study|Lost to Follow-up|2|||
16966448|NCT01223027|38109480|FG001|Overall Study|Lost to Follow-up|1|||
16966449|NCT01223027|38109479|FG000|Overall Study|Physician Decision|4|||
16966450|NCT01223027|38109480|FG001|Overall Study|Physician Decision|8|||
16966451|NCT01223027|38109479|FG000|Overall Study|Progressive Disease|167|||
16966452|NCT01223027|38109480|FG001|Overall Study|Progressive Disease|183|||
16966453|NCT01223027|38109479|FG000|Overall Study|Protocol Violation|2|||
16966454|NCT01223027|38109480|FG001|Overall Study|Protocol Violation|1|||
16966455|NCT01223027|38109479|FG000|Overall Study|Subject/guardian decicion|18|||
16966456|NCT01223027|38109480|FG001|Overall Study|Subject/guardian decicion|16|||
16966457|NCT01223027|38109479|FG000|Overall Study|New therapy for study indication|17|||
16966458|NCT01223027|38109480|FG001|Overall Study|New therapy for study indication|8|||
16966459|NCT01223027|38109479|FG000|Overall Study|Study terminated by sponsor|2|||
16966460|NCT01223027|38109480|FG001|Overall Study|Study terminated by sponsor|8|||
16966461|NCT01015287|38109488|FG000|Overall Study|Death|21|||
16966462|NCT01015287|38109489|FG001|Overall Study|Death|16|||
16966463|NCT01015287|38109488|FG000|Overall Study|Adverse Event|1|||
16966464|NCT01015287|38109489|FG001|Overall Study|Adverse Event|0|||
16966465|NCT01015287|38109488|FG000|Overall Study|Sponsor Decision|3|||
16966466|NCT01015287|38109489|FG001|Overall Study|Sponsor Decision|7|||
16966467|NCT01015287|38109488|FG000|Overall Study|Physician Decision|19|||
16966468|NCT01015287|38109489|FG001|Overall Study|Physician Decision|21|||
16966469|NCT01015287|38109488|FG000|Overall Study|Withdrawal by Subject|14|||
16966470|NCT01015287|38109489|FG001|Overall Study|Withdrawal by Subject|19|||
16966471|NCT01015287|38109488|FG000|Overall Study|Entry Criteria not Met|11|||
16966472|NCT01015287|38109489|FG001|Overall Study|Entry Criteria not Met|14|||
16966473|NCT01015287|38109488|FG000|Overall Study|Lost to Follow-up|2|||
16966474|NCT01015287|38109489|FG001|Overall Study|Lost to Follow-up|1|||
16966475|NCT01015287|38109488|FG000|Overall Study|Protocol Violation|1|||
16966476|NCT01015287|38109489|FG001|Overall Study|Protocol Violation|1|||
16966477|NCT01015131|38109497|FG000|Overall Study|Physician Decision|1|||
16966478|NCT01015131|38109497|FG000|Overall Study|Protocol Violation|1|||
16966479|NCT01015131|38109497|FG000|Overall Study|Withdrawal by Subject|2|||
16966480|NCT01015131|38109497|FG000|Overall Study|Other Protocol Specified Criteria|4|||
16966481|NCT01222715|38109503|FG000|Overall Study|Adverse Event|0|||
16966482|NCT01222715|38109504|FG001|Overall Study|Adverse Event|4|||
16966483|NCT01222715|38109503|FG000|Overall Study|Death|0|||
16966484|NCT01222715|38109504|FG001|Overall Study|Death|1|||
16966485|NCT01222715|38109503|FG000|Overall Study|Lack of Efficacy|22|||
16966486|NCT01222715|38109504|FG001|Overall Study|Lack of Efficacy|14|||
16966487|NCT01222715|38109503|FG000|Overall Study|Physician Decision|12|||
16966488|NCT01222715|38109504|FG001|Overall Study|Physician Decision|2|||
16966489|NCT01222715|38109503|FG000|Overall Study|Refusal of further protocol therapy|0|||
16966490|NCT01222715|38109504|FG001|Overall Study|Refusal of further protocol therapy|4|||
16966491|NCT01222715|38109503|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
16966492|NCT01222715|38109504|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
16966493|NCT01222715|38109503|FG000|Overall Study|Ineligible|0|||
16966494|NCT01222715|38109504|FG001|Overall Study|Ineligible|1|||
16966495|NCT01222715|38109503|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
16966496|NCT01222715|38109504|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
16966497|NCT01222403|38109512|FG000|Overall Study|Inappropriate enrollment|0|||
16966498|NCT01222403|38109513|FG001|Overall Study|Inappropriate enrollment|2|||
16966499|NCT01222247|38109521|FG000|Overall Study|Lost to Follow-up|2|||
16966500|NCT01222247|38109522|FG001|Overall Study|Lost to Follow-up|2|||
16966501|NCT01014975|38109528|FG000|Overall Study|Withdrawal by Subject|1|||
16966502|NCT01014975|38109529|FG001|Overall Study|Withdrawal by Subject|0|||
16966503|NCT01014975|38109530|FG002|Overall Study|Withdrawal by Subject|1|||
16966504|NCT01014975|38109528|FG000|Overall Study|Death|3|||
16966505|NCT01014975|38109529|FG001|Overall Study|Death|3|||
16966506|NCT01014975|38109530|FG002|Overall Study|Death|4|||
16966507|NCT01014975|38109528|FG000|Overall Study|Lost to Follow-up|0|||
16966508|NCT01014975|38109529|FG001|Overall Study|Lost to Follow-up|0|||
16966509|NCT01014975|38109530|FG002|Overall Study|Lost to Follow-up|1|||
16966510|NCT01221623|38109540|FG000|Overall Study|Withdrawal by Subject|19|||
16966511|NCT01221623|38109541|FG001|Overall Study|Withdrawal by Subject|8|||
16966512|NCT01221623|38109540|FG000|Overall Study|Lost to Follow-up|7|||
16966513|NCT01221623|38109541|FG001|Overall Study|Lost to Follow-up|1|||
16966514|NCT01221623|38109540|FG000|Overall Study|Adverse Event|6|||
16966515|NCT01221623|38109541|FG001|Overall Study|Adverse Event|3|||
16966516|NCT01221623|38109540|FG000|Overall Study|Death|1|||
16780017|NCT02616783|37719082|FG000|Overall Study|Withdrew Consent|1|||
16780018|NCT02616783|37719083|FG001|Overall Study|Withdrew Consent|1|||
16780019|NCT02616393|37719092|FG000|Overall Study|Death|5|||
16780020|NCT02616393|37719093|FG001|Overall Study|Death|12|||
16780021|NCT02616393|37719094|FG002|Overall Study|Death|1|||
16780022|NCT02616393|37719092|FG000|Overall Study|Termination by Sponsor|4|||
16966517|NCT01221623|38109541|FG001|Overall Study|Death|0|||
16966518|NCT01221623|38109540|FG000|Overall Study|Other|5|||
16780023|NCT02616393|37719093|FG001|Overall Study|Termination by Sponsor|5|||
16780024|NCT02616393|37719094|FG002|Overall Study|Termination by Sponsor|2|||
16780025|NCT02616393|37719092|FG000|Overall Study|Other|3|||
16966519|NCT01221623|38109541|FG001|Overall Study|Other|2|||
16966520|NCT01014585|38109551|FG000|Overall Study|Adverse Event|0|||
16966521|NCT01014585|38109552|FG001|Overall Study|Adverse Event|2|||
16966522|NCT01014585|38109553|FG002|Overall Study|Adverse Event|0|||
16966523|NCT01014585|38109554|FG003|Overall Study|Adverse Event|3|||
16966524|NCT01014585|38109551|FG000|Overall Study|Withdrawal by Subject|2|||
16966525|NCT01014585|38109552|FG001|Overall Study|Withdrawal by Subject|0|||
16966526|NCT01014585|38109553|FG002|Overall Study|Withdrawal by Subject|1|||
16966527|NCT01014585|38109554|FG003|Overall Study|Withdrawal by Subject|3|||
16966528|NCT01014585|38109551|FG000|Overall Study|Lost to Follow-up|0|||
16966529|NCT01014585|38109552|FG001|Overall Study|Lost to Follow-up|0|||
16966530|NCT01014585|38109553|FG002|Overall Study|Lost to Follow-up|0|||
16966531|NCT01014585|38109554|FG003|Overall Study|Lost to Follow-up|2|||
16966532|NCT01014585|38109551|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
16966533|NCT01014585|38109552|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
16966534|NCT01014585|38109553|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
16966535|NCT01014585|38109554|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
16966536|NCT01221233|38109566|FG000|Overall Study|Withdrawal by Subject|3|||
16966537|NCT01221233|38109567|FG001|Overall Study|Withdrawal by Subject|1|||
16966538|NCT01220609|38109573|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
16966539|NCT01220609|38109573|FG000|Overall Study|Ineligible- Wrong cell type|1|||
16966540|NCT01220609|38109573|FG000|Overall Study|Ineligible-Never treated|1|||
16966541|NCT01220297|38109585|FG000|Overall Study|Death|2|||
16966542|NCT01220297|38109585|FG000|Overall Study|Lost to Follow-up|1|||
16966543|NCT01219985|38109591|FG000|Overall Study|Physician Decision|20|||
16966544|NCT01218659|38109599|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
16966545|NCT01218659|38109600|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
16966546|NCT01218659|38109601|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
16966547|NCT01218659|38109599|FG000|18-Month Randomized Period|Did not receive study drug|0|||
16966548|NCT01218659|38109600|FG001|18-Month Randomized Period|Did not receive study drug|3|||
16966549|NCT01218659|38109601|FG002|18-Month Randomized Period|Did not receive study drug|0|||
16966550|NCT01218659|38109599|FG000|12-Month OLE|Withdrawal by Subject|0|||
16966551|NCT01218659|38109600|FG001|12-Month OLE|Withdrawal by Subject|0|||
16966552|NCT01218659|38109601|FG002|12-Month OLE|Withdrawal by Subject|2|||
16966553|NCT01218659|38109599|FG000|12-Month OLE|Physician Decision|0|||
16966554|NCT01218659|38109600|FG001|12-Month OLE|Physician Decision|0|||
16966555|NCT01218659|38109601|FG002|12-Month OLE|Physician Decision|1|||
16966556|NCT01218659|38109599|FG000|12-Month OLE|Lost to Follow-up|0|||
16966557|NCT01218659|38109600|FG001|12-Month OLE|Lost to Follow-up|0|||
16966558|NCT01218659|38109601|FG002|12-Month OLE|Lost to Follow-up|1|||
16966559|NCT01218659|38109599|FG000|12-Month OLE|Pregnancy|0|||
16966560|NCT01218659|38109600|FG001|12-Month OLE|Pregnancy|0|||
16966561|NCT01218659|38109601|FG002|12-Month OLE|Pregnancy|1|||
16966562|NCT01218659|38109599|FG000|12-Month OLE|Lack of Efficacy|0|||
16966563|NCT01218659|38109600|FG001|12-Month OLE|Lack of Efficacy|0|||
16966564|NCT01218659|38109601|FG002|12-Month OLE|Lack of Efficacy|1|||
16966565|NCT01218659|38109599|FG000|12-Month OLE|Declined to participate in the OLE|0|||
16966566|NCT01218659|38109600|FG001|12-Month OLE|Declined to participate in the OLE|0|||
16966567|NCT01218659|38109601|FG002|12-Month OLE|Declined to participate in the OLE|4|||
16966568|NCT00940498|38109616|FG000|Overall Study|Death|2|||
16966569|NCT00940498|38109617|FG001|Overall Study|Death|0|||
16966570|NCT00940498|38109618|FG002|Overall Study|Death|0|||
16966571|NCT00940498|38109619|FG003|Overall Study|Death|1|||
16966572|NCT00940498|38109620|FG004|Overall Study|Death|5|||
16966573|NCT00940498|38109621|FG005|Overall Study|Death|0|||
16966574|NCT00940498|38109622|FG006|Overall Study|Death|1|||
16966575|NCT00940498|38109623|FG007|Overall Study|Death|0|||
16966576|NCT00940498|38109616|FG000|Overall Study|Lost to Follow-up|1|||
16966577|NCT00940498|38109617|FG001|Overall Study|Lost to Follow-up|1|||
16966578|NCT00940498|38109618|FG002|Overall Study|Lost to Follow-up|2|||
16966579|NCT00940498|38109619|FG003|Overall Study|Lost to Follow-up|0|||
16966580|NCT00940498|38109620|FG004|Overall Study|Lost to Follow-up|1|||
16966581|NCT00940498|38109621|FG005|Overall Study|Lost to Follow-up|0|||
16966582|NCT00940498|38109622|FG006|Overall Study|Lost to Follow-up|0|||
16966583|NCT00940498|38109623|FG007|Overall Study|Lost to Follow-up|1|||
16966584|NCT00940498|38109616|FG000|Overall Study|Disease Progression|0|||
16966585|NCT00940498|38109617|FG001|Overall Study|Disease Progression|0|||
16966586|NCT00940498|38109618|FG002|Overall Study|Disease Progression|1|||
16966587|NCT00940498|38109619|FG003|Overall Study|Disease Progression|1|||
16966588|NCT00940498|38109620|FG004|Overall Study|Disease Progression|0|||
16966589|NCT00940498|38109621|FG005|Overall Study|Disease Progression|1|||
16966590|NCT00940498|38109622|FG006|Overall Study|Disease Progression|0|||
16966591|NCT00940498|38109623|FG007|Overall Study|Disease Progression|0|||
16966592|NCT00940498|38109616|FG000|Overall Study|Physician Decision|0|||
16966593|NCT00940498|38109617|FG001|Overall Study|Physician Decision|0|||
16966594|NCT00940498|38109618|FG002|Overall Study|Physician Decision|0|||
16966595|NCT00940498|38109619|FG003|Overall Study|Physician Decision|0|||
16966596|NCT00940498|38109620|FG004|Overall Study|Physician Decision|2|||
16966597|NCT00940498|38109621|FG005|Overall Study|Physician Decision|0|||
17133944|NCT00065429|38275194|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
17133945|NCT00065429|38275188|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
17133946|NCT00065429|38275189|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
17133947|NCT00065429|38275190|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
17133948|NCT00065429|38275191|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
17133949|NCT00065429|38275192|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
17133950|NCT00065429|38275193|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
17133951|NCT00065429|38275194|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
17133952|NCT00048035|38275211|FG000|Core Period|Early Withdrawals|4|||
17133953|NCT00048035|38275212|FG001|Core Period|Early Withdrawals|2|||
17133954|NCT00048035|38275213|FG002|Core Period|Early Withdrawals|1|||
17133955|NCT00048035|38275214|FG003|Core Period|Early Withdrawals|1|||
17133956|NCT00048035|38275215|FG004|Core Period|Early Withdrawals|1|||
17133957|NCT00048035|38275216|FG005|Core Period|Early Withdrawals|1|||
17133958|NCT00048035|38275217|FG006|Core Period|Early Withdrawals|0|||
17133959|NCT00048035|38275218|FG007|Core Period|Early Withdrawals|0|||
17133960|NCT00048035|38275211|FG000|Extension Year 1|Early Withdrawals|0|||
17133961|NCT00048035|38275212|FG001|Extension Year 1|Early Withdrawals|0|||
17133962|NCT00048035|38275213|FG002|Extension Year 1|Early Withdrawals|0|||
17133963|NCT00048035|38275214|FG003|Extension Year 1|Early Withdrawals|0|||
17133964|NCT00048035|38275215|FG004|Extension Year 1|Early Withdrawals|0|||
17133965|NCT00048035|38275216|FG005|Extension Year 1|Early Withdrawals|0|||
17133966|NCT00048035|38275217|FG006|Extension Year 1|Early Withdrawals|11|||
17133967|NCT00048035|38275218|FG007|Extension Year 1|Early Withdrawals|11|||
17133968|NCT00048035|38275211|FG000|Extension Year 2|Early Withdrawals|0|||
17133969|NCT00048035|38275212|FG001|Extension Year 2|Early Withdrawals|0|||
16780026|NCT02616393|37719093|FG001|Overall Study|Other|0|||
17133970|NCT00048035|38275213|FG002|Extension Year 2|Early Withdrawals|0|||
17133971|NCT00048035|38275214|FG003|Extension Year 2|Early Withdrawals|0|||
17133972|NCT00048035|38275215|FG004|Extension Year 2|Early Withdrawals|0|||
17133973|NCT00048035|38275216|FG005|Extension Year 2|Early Withdrawals|0|||
17133974|NCT00048035|38275217|FG006|Extension Year 2|Early Withdrawals|3|||
17133975|NCT00048035|38275218|FG007|Extension Year 2|Early Withdrawals|3|||
16966598|NCT00940498|38109622|FG006|Overall Study|Physician Decision|0|||
16966599|NCT00940498|38109623|FG007|Overall Study|Physician Decision|0|||
16966600|NCT00940498|38109616|FG000|Overall Study|Not treated due to disease related pain|0|||
16966601|NCT00940498|38109617|FG001|Overall Study|Not treated due to disease related pain|0|||
16966602|NCT00940498|38109618|FG002|Overall Study|Not treated due to disease related pain|0|||
16966603|NCT00940498|38109619|FG003|Overall Study|Not treated due to disease related pain|0|||
16966604|NCT00940498|38109620|FG004|Overall Study|Not treated due to disease related pain|1|||
16966605|NCT00940498|38109621|FG005|Overall Study|Not treated due to disease related pain|0|||
16966606|NCT00940498|38109622|FG006|Overall Study|Not treated due to disease related pain|0|||
16966607|NCT00940498|38109623|FG007|Overall Study|Not treated due to disease related pain|0|||
16966608|NCT00940342|38109650|FG000|Overall Study|Adverse Event|0|||
16966609|NCT00940342|38109651|FG001|Overall Study|Adverse Event|2|||
16966610|NCT00940342|38109652|FG002|Overall Study|Adverse Event|1|||
16966611|NCT00936910|38109660|FG000|Overall Study|Lack of Efficacy|3|||
16966612|NCT00940108|38109669|FG000|Overall Study|Adverse Event|2|||
16966613|NCT00940108|38109670|FG001|Overall Study|Adverse Event|4|||
16966614|NCT00940108|38109671|FG002|Overall Study|Adverse Event|0|||
16966615|NCT00940108|38109672|FG003|Overall Study|Adverse Event|2|||
16966616|NCT00940108|38109669|FG000|Overall Study|Withdrew Consent|2|||
16966617|NCT00940108|38109670|FG001|Overall Study|Withdrew Consent|1|||
16966618|NCT00940108|38109671|FG002|Overall Study|Withdrew Consent|0|||
16966619|NCT00940108|38109672|FG003|Overall Study|Withdrew Consent|1|||
16966620|NCT00940108|38109669|FG000|Overall Study|Dose 2 contraindicated|1|||
16966621|NCT00940108|38109670|FG001|Overall Study|Dose 2 contraindicated|1|||
16966622|NCT00940108|38109671|FG002|Overall Study|Dose 2 contraindicated|0|||
16966623|NCT00940108|38109672|FG003|Overall Study|Dose 2 contraindicated|1|||
16966624|NCT00940108|38109669|FG000|Overall Study|Declined further vaccination|0|||
16966625|NCT00940108|38109670|FG001|Overall Study|Declined further vaccination|1|||
16966626|NCT00940108|38109671|FG002|Overall Study|Declined further vaccination|3|||
16966627|NCT00940108|38109672|FG003|Overall Study|Declined further vaccination|0|||
16966628|NCT00940108|38109669|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
16966629|NCT00940108|38109670|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
16966630|NCT00940108|38109671|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
16966631|NCT00940108|38109672|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
16966632|NCT00940108|38109669|FG000|Overall Study|Viral illness after Dose 1|0|||
16966633|NCT00940108|38109670|FG001|Overall Study|Viral illness after Dose 1|1|||
16966634|NCT00940108|38109671|FG002|Overall Study|Viral illness after Dose 1|0|||
16966635|NCT00940108|38109672|FG003|Overall Study|Viral illness after Dose 1|0|||
16966636|NCT00940108|38109669|FG000|Overall Study|Diagnosed with H1N1|0|||
16966637|NCT00940108|38109670|FG001|Overall Study|Diagnosed with H1N1|0|||
16966638|NCT00940108|38109671|FG002|Overall Study|Diagnosed with H1N1|0|||
16966639|NCT00940108|38109672|FG003|Overall Study|Diagnosed with H1N1|1|||
16966640|NCT00936598|38109684|FG000|Overall Study|Withdrawal by Subject|1|||
16966641|NCT00936598|38109685|FG001|Overall Study|Withdrawal by Subject|0|||
16966642|NCT00936598|38109684|FG000|Overall Study|Ineligible after consent|1|||
16966643|NCT00936598|38109685|FG001|Overall Study|Ineligible after consent|0|||
16966644|NCT01025817|38109693|FG000|Completed Study Medication|Adverse Event|66|||
16966645|NCT01025817|38109694|FG001|Completed Study Medication|Adverse Event|39|||
16966646|NCT01025817|38109693|FG000|Completed Study Medication|Protocol Deviation|9|||
16966647|NCT01025817|38109694|FG001|Completed Study Medication|Protocol Deviation|8|||
16966648|NCT01025817|38109693|FG000|Completed Study Medication|Withdrawal by Subject|8|||
16966649|NCT01025817|38109694|FG001|Completed Study Medication|Withdrawal by Subject|9|||
16966650|NCT01025817|38109693|FG000|Completed Study Medication|Administrative problems|7|||
16966651|NCT01025817|38109694|FG001|Completed Study Medication|Administrative problems|5|||
16966652|NCT01025817|38109693|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
16966653|NCT01025817|38109694|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
16966654|NCT01025817|38109693|FG000|Completed Study Medication|Abnormal test procedure|4|||
16966655|NCT01025817|38109694|FG001|Completed Study Medication|Abnormal test procedure|0|||
16966656|NCT01025817|38109693|FG000|Completed Study Medication|Graft loss|2|||
16966657|NCT01025817|38109694|FG001|Completed Study Medication|Graft loss|5|||
16966658|NCT01025817|38109693|FG000|Completed Study Medication|Death|2|||
16966659|NCT01025817|38109694|FG001|Completed Study Medication|Death|2|||
16966660|NCT01025817|38109693|FG000|Completed Study Medication|Abnormal lab values|0|||
16966661|NCT01025817|38109694|FG001|Completed Study Medication|Abnormal lab values|2|||
16966662|NCT01025817|38109693|FG000|Completed Study Medication|Subject no longer required study drug|0|||
16966663|NCT01025817|38109694|FG001|Completed Study Medication|Subject no longer required study drug|1|||
16966664|NCT01025817|38109693|FG000|Completed Study Medication|Lost to Follow-up|0|||
16966665|NCT01025817|38109694|FG001|Completed Study Medication|Lost to Follow-up|1|||
16966666|NCT01025817|38109693|FG000|Completed Study|Withdrawal by Subject|8|||
16966667|NCT01025817|38109694|FG001|Completed Study|Withdrawal by Subject|16|||
16966668|NCT01025817|38109693|FG000|Completed Study|Death|6|||
16966669|NCT01025817|38109694|FG001|Completed Study|Death|5|||
16966670|NCT01025817|38109693|FG000|Completed Study|Missing|2|||
16966671|NCT01025817|38109694|FG001|Completed Study|Missing|0|||
16966672|NCT01025817|38109693|FG000|Completed Study|Lost to Follow-up|0|||
16966673|NCT01025817|38109694|FG001|Completed Study|Lost to Follow-up|1|||
16966674|NCT00939640|38109700|FG000|Overall Study|Physician Decision|1|||
16966675|NCT01218113|38109712|FG000|Overall Study|Withdrawal by Subject|1|||
16966676|NCT01218113|38109713|FG001|Overall Study|Withdrawal by Subject|0|||
16966677|NCT01218113|38109714|FG002|Overall Study|Withdrawal by Subject|1|||
16966678|NCT01218113|38109712|FG000|Overall Study|Lost to Follow-up|4|||
16966679|NCT01218113|38109713|FG001|Overall Study|Lost to Follow-up|1|||
16966680|NCT01218113|38109714|FG002|Overall Study|Lost to Follow-up|4|||
16966681|NCT01218113|38109712|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
16966682|NCT01218113|38109713|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
16966683|NCT01218113|38109714|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
16966684|NCT03873493|38109729|FG000|Overall Study|Withdrawal by Subject|1|||
16966685|NCT03873493|38109729|FG000|Overall Study|Death|9|||
16966686|NCT03873493|38109729|FG000|Overall Study|Lost to Follow-up|1|||
16966687|NCT03873493|38109729|FG000|Overall Study|Study Terminated by Sponsor|1|||
16966688|NCT03873493|38109729|FG000|Overall Study|Other|2|||
16966689|NCT00939484|38109749|FG000|Overall Study|Progression/Relapse|8|||
16966690|NCT00939484|38109750|FG001|Overall Study|Progression/Relapse|20|||
16966691|NCT00939484|38109751|FG002|Overall Study|Progression/Relapse|3|||
16966692|NCT01010217|38109766|FG000|Overall Study|Lost to Follow-up|4|||
16966693|NCT01010217|38109767|FG001|Overall Study|Lost to Follow-up|5|||
16966694|NCT01010217|38109768|FG002|Overall Study|Lost to Follow-up|1|||
16966695|NCT01010217|38109769|FG003|Overall Study|Lost to Follow-up|0|||
16966696|NCT01010217|38109770|FG004|Overall Study|Lost to Follow-up|0|||
16966697|NCT01010217|38109766|FG000|Overall Study|Withdrawal by Subject|1|||
16966698|NCT01010217|38109767|FG001|Overall Study|Withdrawal by Subject|0|||
16966699|NCT01010217|38109768|FG002|Overall Study|Withdrawal by Subject|0|||
16997753|NCT00962390|38141774|FG003|Overall Study|Adverse Event|1|||
16966700|NCT01010217|38109769|FG003|Overall Study|Withdrawal by Subject|0|||
16966701|NCT01010217|38109770|FG004|Overall Study|Withdrawal by Subject|0|||
16966702|NCT01010217|38109766|FG000|Overall Study|Physician Decision|0|||
16966703|NCT01010217|38109767|FG001|Overall Study|Physician Decision|0|||
16966704|NCT01010217|38109768|FG002|Overall Study|Physician Decision|0|||
16966705|NCT01010217|38109769|FG003|Overall Study|Physician Decision|6|||
16966706|NCT01010217|38109770|FG004|Overall Study|Physician Decision|3|||
16966707|NCT01013961|38109784|FG000|Overall Study|Adverse Event|2|||
16966708|NCT01013961|38109785|FG001|Overall Study|Adverse Event|2|||
16966709|NCT01013961|38109784|FG000|Overall Study|Withdrawal by Subject|1|||
16966710|NCT01013961|38109785|FG001|Overall Study|Withdrawal by Subject|0|||
16966711|NCT01013961|38109784|FG000|Overall Study|Physician Decision|0|||
16966712|NCT01013961|38109785|FG001|Overall Study|Physician Decision|1|||
16966713|NCT01217957|38109796|FG000|Phase 1|Withdrawal by Patient|1|||
16966714|NCT01217957|38109797|FG001|Phase 1|Withdrawal by Patient|0|||
16966715|NCT01217957|38109798|FG002|Phase 1|Withdrawal by Patient|1|||
16966716|NCT01217957|38109799|FG003|Phase 1|Withdrawal by Patient|1|||
16966717|NCT01217957|38109800|FG004|Phase 1|Withdrawal by Patient|0|||
16966718|NCT01217957|38109796|FG000|Phase 2|Withdrawal by Patient|0|||
16966719|NCT01217957|38109797|FG001|Phase 2|Withdrawal by Patient|0|||
16966720|NCT01217957|38109798|FG002|Phase 2|Withdrawal by Patient|0|||
16966721|NCT01217957|38109799|FG003|Phase 2|Withdrawal by Patient|0|||
16966722|NCT01217957|38109800|FG004|Phase 2|Withdrawal by Patient|1|||
16966723|NCT00939094|38109823|FG000|Overall Study|Adverse Event|9|||
16966724|NCT00939094|38109824|FG001|Overall Study|Adverse Event|0|||
16966725|NCT00939094|38109823|FG000|Overall Study|Withdrawal by Subject|1|||
16966726|NCT00939094|38109824|FG001|Overall Study|Withdrawal by Subject|6|||
16966727|NCT00939094|38109823|FG000|Overall Study|Lost to Follow-up|1|||
16966728|NCT00939094|38109824|FG001|Overall Study|Lost to Follow-up|1|||
16966729|NCT00939094|38109823|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16966730|NCT00939094|38109824|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16966731|NCT00939094|38109823|FG000|Overall Study|Severe non-compliance to protocol|0|||
16966732|NCT00939094|38109824|FG001|Overall Study|Severe non-compliance to protocol|1|||
16966733|NCT00939094|38109823|FG000|Overall Study|Study stopped by sponsor|0|||
16966734|NCT00939094|38109824|FG001|Overall Study|Study stopped by sponsor|2|||
16966735|NCT00939094|38109823|FG000|Overall Study|Abnormal ECG findings|1|||
16966736|NCT00939094|38109824|FG001|Overall Study|Abnormal ECG findings|0|||
16966737|NCT01217801|38109832|FG000|Period 1|Protocol Violation|1|||
16966738|NCT01217801|38109833|FG001|Period 1|Protocol Violation|1|||
16966739|NCT01217801|38109832|FG000|Period 1|Withdrawal by Subject|0|||
16966740|NCT01217801|38109833|FG001|Period 1|Withdrawal by Subject|1|||
16966741|NCT00935818|38109841|FG000|Overall Study|Withdrawal by Subject|45|||
16966742|NCT00935818|38109842|FG001|Overall Study|Withdrawal by Subject|50|||
16966743|NCT00935818|38109841|FG000|Overall Study|Lost to Follow-up|40|||
16966744|NCT00935818|38109842|FG001|Overall Study|Lost to Follow-up|42|||
16966745|NCT00935818|38109841|FG000|Overall Study|Adverse Event|6|||
16966746|NCT00935818|38109842|FG001|Overall Study|Adverse Event|7|||
16966747|NCT00935818|38109841|FG000|Overall Study|Physician Decision|0|||
16966748|NCT00935818|38109842|FG001|Overall Study|Physician Decision|1|||
16966749|NCT01216319|38109848|FG000|Overall Study|Lost to Follow-up|2|||
16966750|NCT01216319|38109848|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
16966751|NCT00936208|38109854|FG000|Overall Study|Protocol Violation|37|||
16966752|NCT00936208|38109855|FG001|Overall Study|Protocol Violation|22|||
16966753|NCT01216163|38109864|FG000|Overall Study|Withdrawal by Subject|1|||
16966754|NCT01216163|38109865|FG001|Overall Study|Withdrawal by Subject|1|||
16966755|NCT01216163|38109866|FG002|Overall Study|Withdrawal by Subject|0|||
16966756|NCT00933244|38109877|FG000|Overall Study|Withdrawal by Subject|5|||
16966757|NCT00933244|38109878|FG001|Overall Study|Withdrawal by Subject|1|||
16966758|NCT00933244|38109879|FG002|Overall Study|Withdrawal by Subject|3|||
16966759|NCT00930046|38109889|FG000|Overall Study|Wound catheter malfunctioned|1|||
16966760|NCT00930046|38109890|FG001|Overall Study|Wound catheter malfunctioned|2|||
16966761|NCT00935584|38109898|FG000|Overall Study|Withdrawal by Subject|9|||
16966762|NCT00935584|38109899|FG001|Overall Study|Withdrawal by Subject|0|||
16966763|NCT00935584|38109898|FG000|Overall Study|Death|3|||
16966764|NCT00935584|38109899|FG001|Overall Study|Death|0|||
16966765|NCT00935584|38109898|FG000|Overall Study|Lost to Follow-up|8|||
16966766|NCT00935584|38109899|FG001|Overall Study|Lost to Follow-up|0|||
16966767|NCT00935584|38109898|FG000|Overall Study|No show|9|||
16966768|NCT00935584|38109899|FG001|Overall Study|No show|0|||
16966769|NCT00935584|38109898|FG000|Overall Study|Relocated|3|||
16966770|NCT00935584|38109899|FG001|Overall Study|Relocated|0|||
16966771|NCT00935584|38109898|FG000|Overall Study|Patient changed provider|3|||
16966772|NCT00935584|38109899|FG001|Overall Study|Patient changed provider|0|||
16966773|NCT00935584|38109898|FG000|Overall Study|Provider dropped out of study|14|||
16966774|NCT00935584|38109899|FG001|Overall Study|Provider dropped out of study|4|||
16966775|NCT01215851|38109909|FG000|Treatment Period|Adverse Event|1|||
16966776|NCT01215851|38109910|FG001|Treatment Period|Adverse Event|1|||
16966777|NCT01215851|38109911|FG002|Treatment Period|Adverse Event|1|||
16966778|NCT01215851|38109912|FG003|Treatment Period|Adverse Event|3|||
16966779|NCT01215851|38109913|FG004|Treatment Period|Adverse Event|0|||
16966780|NCT01215851|38109914|FG005|Treatment Period|Adverse Event|1|||
16966781|NCT01215851|38109909|FG000|Follow up Period|Lost to Follow-up|0|||
16966782|NCT01215851|38109910|FG001|Follow up Period|Lost to Follow-up|0|||
16966783|NCT01215851|38109911|FG002|Follow up Period|Lost to Follow-up|0|||
16966784|NCT01215851|38109912|FG003|Follow up Period|Lost to Follow-up|0|||
16966785|NCT01215851|38109913|FG004|Follow up Period|Lost to Follow-up|0|||
16966786|NCT01215851|38109914|FG005|Follow up Period|Lost to Follow-up|1|||
16966787|NCT00933166|38109929|FG000|Overall Study|Lost to Follow-up|4|||
16966788|NCT00933166|38109929|FG000|Overall Study|Lack of Efficacy|9|||
16966789|NCT00933166|38109929|FG000|Overall Study|Unavailable|4|||
16966790|NCT00933166|38109929|FG000|Overall Study|Withdrawal by Subject|1|||
16966791|NCT00935272|38109935|FG000|Overall Study|Lost to Follow-up|10|||
16966792|NCT00935272|38109936|FG001|Overall Study|Lost to Follow-up|3|||
16966793|NCT00935272|38109935|FG000|Overall Study|Withdrawal by Subject|8|||
16966794|NCT00935272|38109936|FG001|Overall Study|Withdrawal by Subject|2|||
16966795|NCT00935272|38109935|FG000|Overall Study|Physician Decision|1|||
16966796|NCT00935272|38109936|FG001|Overall Study|Physician Decision|0|||
16966797|NCT00935272|38109935|FG000|Overall Study|Protocol Violation|0|||
16966798|NCT00935272|38109936|FG001|Overall Study|Protocol Violation|1|||
16966799|NCT01010061|38109945|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
16966800|NCT01010061|38109946|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
16966801|NCT01010061|38109945|FG000|Overall Study|Disease Progression|2|||
16966802|NCT01010061|38109946|FG001|Overall Study|Disease Progression|8|||
16966803|NCT01010061|38109945|FG000|Overall Study|Withdrew Consent|5|||
16966804|NCT01010061|38109946|FG001|Overall Study|Withdrew Consent|1|||
16966805|NCT01010061|38109945|FG000|Overall Study|Death|3|||
16966806|NCT01010061|38109946|FG001|Overall Study|Death|6|||
16966807|NCT01010061|38109945|FG000|Overall Study|Administrative/Other|0|||
16966808|NCT01010061|38109946|FG001|Overall Study|Administrative/Other|1|||
16966809|NCT01010061|38109945|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
16966810|NCT01010061|38109946|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
16966811|NCT01010061|38109945|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16966812|NCT01010061|38109946|FG001|Overall Study|Insufficient Therapeutic Response|5|||
16966813|NCT01010061|38109945|FG000|Overall Study|Violation of Selection Criteria|0|||
16966814|NCT01010061|38109946|FG001|Overall Study|Violation of Selection Criteria|1|||
16966815|NCT01010061|38109945|FG000|Overall Study|Did Not Receive Treatment|2|||
16966816|NCT01010061|38109946|FG001|Overall Study|Did Not Receive Treatment|2|||
16966817|NCT00929734|38109966|FG000|Overall Study|Lost to Follow-up|2|||
16966818|NCT00929734|38109967|FG001|Overall Study|Lost to Follow-up|1|||
16966819|NCT00929734|38109966|FG000|Overall Study|Withdrawal by Subject|0|||
16966820|NCT00929734|38109967|FG001|Overall Study|Withdrawal by Subject|2|||
16966821|NCT01013883|38109975|FG000|Overall Study|Lost to Follow-up|2|||
16966822|NCT01013883|38109976|FG001|Overall Study|Lost to Follow-up|2|||
16966823|NCT01009983|38109982|FG000|Overall Study|necessary scans not completed|1|||
16966824|NCT01215227|38109996|FG000|Overall Study|Adverse Event|11|||
16966825|NCT01215227|38109997|FG001|Overall Study|Adverse Event|11|||
16966826|NCT01215227|38109998|FG002|Overall Study|Adverse Event|4|||
16966827|NCT01215227|38109999|FG003|Overall Study|Adverse Event|8|||
16966828|NCT01215227|38110000|FG004|Overall Study|Adverse Event|7|||
16966829|NCT01215227|38110001|FG005|Overall Study|Adverse Event|6|||
16966830|NCT01215227|38109996|FG000|Overall Study|Treatment Failure|8|||
16966831|NCT01215227|38109997|FG001|Overall Study|Treatment Failure|4|||
16966832|NCT01215227|38109998|FG002|Overall Study|Treatment Failure|1|||
16966833|NCT01215227|38109999|FG003|Overall Study|Treatment Failure|5|||
16966834|NCT01215227|38110000|FG004|Overall Study|Treatment Failure|1|||
16966835|NCT01215227|38110001|FG005|Overall Study|Treatment Failure|1|||
16966836|NCT01215227|38109996|FG000|Overall Study|Lost to Follow-up|1|||
16966837|NCT01215227|38109997|FG001|Overall Study|Lost to Follow-up|4|||
16966838|NCT01215227|38109998|FG002|Overall Study|Lost to Follow-up|1|||
16966839|NCT01215227|38109999|FG003|Overall Study|Lost to Follow-up|1|||
16966840|NCT01215227|38110000|FG004|Overall Study|Lost to Follow-up|1|||
16966841|NCT01215227|38110001|FG005|Overall Study|Lost to Follow-up|2|||
16966842|NCT01215227|38109996|FG000|Overall Study|Subject Withdrew Consent|16|||
16966843|NCT01215227|38109997|FG001|Overall Study|Subject Withdrew Consent|20|||
16966844|NCT01215227|38109998|FG002|Overall Study|Subject Withdrew Consent|7|||
16966845|NCT01215227|38109999|FG003|Overall Study|Subject Withdrew Consent|10|||
16966846|NCT01215227|38110000|FG004|Overall Study|Subject Withdrew Consent|11|||
16966847|NCT01215227|38110001|FG005|Overall Study|Subject Withdrew Consent|8|||
16966848|NCT01215227|38109996|FG000|Overall Study|Non-Compliance With Protocol|2|||
16966849|NCT01215227|38109997|FG001|Overall Study|Non-Compliance With Protocol|6|||
16966850|NCT01215227|38109998|FG002|Overall Study|Non-Compliance With Protocol|1|||
16966851|NCT01215227|38109999|FG003|Overall Study|Non-Compliance With Protocol|0|||
16966852|NCT01215227|38110000|FG004|Overall Study|Non-Compliance With Protocol|0|||
16966853|NCT01215227|38110001|FG005|Overall Study|Non-Compliance With Protocol|0|||
16966854|NCT01215227|38109996|FG000|Overall Study|Administrative|83|||
16966855|NCT01215227|38109997|FG001|Overall Study|Administrative|73|||
16966856|NCT01215227|38109998|FG002|Overall Study|Administrative|42|||
16966857|NCT01215227|38109999|FG003|Overall Study|Administrative|24|||
16966858|NCT01215227|38110000|FG004|Overall Study|Administrative|28|||
16966859|NCT01215227|38110001|FG005|Overall Study|Administrative|40|||
16966860|NCT01215227|38109996|FG000|Overall Study|Missing Status|0|||
16966861|NCT01215227|38109997|FG001|Overall Study|Missing Status|1|||
16966862|NCT01215227|38109998|FG002|Overall Study|Missing Status|0|||
16966863|NCT01215227|38109999|FG003|Overall Study|Missing Status|0|||
16966864|NCT01215227|38110000|FG004|Overall Study|Missing Status|0|||
16966865|NCT01215227|38110001|FG005|Overall Study|Missing Status|0|||
16966866|NCT01215227|38109996|FG000|Overall Study|Randomized but not treated|0|||
16966867|NCT01215227|38109997|FG001|Overall Study|Randomized but not treated|0|||
16966868|NCT01215227|38109998|FG002|Overall Study|Randomized but not treated|1|||
16966869|NCT01215227|38109999|FG003|Overall Study|Randomized but not treated|1|||
16966870|NCT01215227|38110000|FG004|Overall Study|Randomized but not treated|0|||
16966871|NCT01215227|38110001|FG005|Overall Study|Randomized but not treated|1|||
16966872|NCT01009515|38110015|FG000|Overall Study|Withdrawal by Subject|3|||
16966873|NCT01214915|38110019|FG000|Overall Study|Adverse Event|8|||
16966874|NCT01214915|38110019|FG000|Overall Study|Lack of Efficacy|3|||
16966875|NCT01009281|38110023|FG000|Overall Study|Administrative problems|7|||
16966876|NCT01009203|38110027|FG000|Overall Study|Withdrawal by Subject|1|||
16966877|NCT01009203|38110027|FG000|Overall Study|Adverse Event|5|||
16780027|NCT02616393|37719094|FG002|Overall Study|Other|0|||
16966878|NCT01009203|38110027|FG000|Overall Study|Treatment-unrelated death|1|||
16966879|NCT01009047|38110033|FG000|Overall Study|Adverse Event|5|||
16966880|NCT01009047|38110034|FG001|Overall Study|Adverse Event|0|||
16966881|NCT01009047|38110033|FG000|Overall Study|Lost to Follow-up|0|||
16780028|NCT02616393|37719092|FG000|Overall Study|Withdrawal by Subject|1|||
16966882|NCT01009047|38110034|FG001|Overall Study|Lost to Follow-up|2|||
16966883|NCT01009047|38110033|FG000|Overall Study|Lack of Efficacy|4|||
16966884|NCT01009047|38110034|FG001|Overall Study|Lack of Efficacy|11|||
16966885|NCT01009047|38110033|FG000|Overall Study|Withdrawal by consent|16|||
16966886|NCT01009047|38110034|FG001|Overall Study|Withdrawal by consent|11|||
16966887|NCT01009047|38110033|FG000|Overall Study|Other|3|||
16966888|NCT01009047|38110034|FG001|Overall Study|Other|2|||
16966889|NCT01025193|38110040|FG000|Overall Study|Protocol Violation|1|||
16966890|NCT01025193|38110040|FG000|Overall Study|Adverse Event|3|||
16966891|NCT01025037|38110048|FG000|Overall Study|Adverse Event|3|||
16966892|NCT01025037|38110048|FG000|Overall Study|Lost to Follow-up|7|||
16966893|NCT01025037|38110048|FG000|Overall Study|Withdrawal by Subject|1|||
16966894|NCT01214837|38110055|FG000|Overall Study|Death|0|||
16966895|NCT01214837|38110056|FG001|Overall Study|Death|0|||
16966896|NCT01214837|38110057|FG002|Overall Study|Death|1|||
16966897|NCT01214837|38110055|FG000|Overall Study|Adverse Event|1|||
16966898|NCT01214837|38110056|FG001|Overall Study|Adverse Event|2|||
16966899|NCT01214837|38110057|FG002|Overall Study|Adverse Event|1|||
16966900|NCT01214837|38110055|FG000|Overall Study|Withdrawal by Subject|27|||
16966901|NCT01214837|38110056|FG001|Overall Study|Withdrawal by Subject|36|||
16966902|NCT01214837|38110057|FG002|Overall Study|Withdrawal by Subject|28|||
16966903|NCT01214837|38110055|FG000|Overall Study|Lost to Follow-up|20|||
16966904|NCT01214837|38110056|FG001|Overall Study|Lost to Follow-up|15|||
16966905|NCT01214837|38110057|FG002|Overall Study|Lost to Follow-up|21|||
16966906|NCT01214837|38110055|FG000|Overall Study|Inappropriate Enrolment|0|||
16966907|NCT01214837|38110056|FG001|Overall Study|Inappropriate Enrolment|1|||
16966908|NCT01214837|38110057|FG002|Overall Study|Inappropriate Enrolment|2|||
16966909|NCT01214837|38110055|FG000|Overall Study|Administrative Reason|2|||
16966910|NCT01214837|38110056|FG001|Overall Study|Administrative Reason|6|||
16966911|NCT01214837|38110057|FG002|Overall Study|Administrative Reason|4|||
16966912|NCT01214837|38110055|FG000|Overall Study|Protocol Violation|3|||
16966913|NCT01214837|38110056|FG001|Overall Study|Protocol Violation|1|||
16966914|NCT01214837|38110057|FG002|Overall Study|Protocol Violation|5|||
16966915|NCT01214837|38110055|FG000|Overall Study|Unable to Classify|1|||
16966916|NCT01214837|38110056|FG001|Overall Study|Unable to Classify|3|||
16966917|NCT01214837|38110057|FG002|Overall Study|Unable to Classify|0|||
16966918|NCT01024959|38110066|FG000|Overall Study|ineligible|12|||
16966919|NCT01024959|38110066|FG000|Overall Study|results not evaluable|12|||
16966920|NCT01024959|38110066|FG000|Overall Study|missing results required for analysis|17|||
16966921|NCT03672175|38110078|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
16966922|NCT03672175|38110079|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
16966923|NCT03672175|38110080|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
16966924|NCT03672175|38110078|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
16966925|NCT03672175|38110079|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
16966926|NCT03672175|38110080|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
16966927|NCT03672175|38110078|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
16966928|NCT03672175|38110079|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
16966929|NCT03672175|38110080|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
16966930|NCT03672175|38110078|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
16966931|NCT03672175|38110079|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
16966932|NCT03672175|38110080|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
16966933|NCT03672175|38110078|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
16966934|NCT03672175|38110079|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
16966935|NCT03672175|38110080|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
16966936|NCT03672175|38110078|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
16966937|NCT03672175|38110079|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
16966938|NCT03672175|38110080|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
16966939|NCT03672175|38110078|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
16966940|NCT03672175|38110079|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
16966941|NCT03672175|38110080|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
16966942|NCT03672175|38110078|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
16966943|NCT03672175|38110079|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
16966944|NCT03672175|38110080|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
16966945|NCT03672175|38110078|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
16966946|NCT03672175|38110079|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
16966947|NCT03672175|38110080|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
16966948|NCT03672175|38110078|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
16966949|NCT03672175|38110079|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
16966950|NCT03672175|38110080|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
16966951|NCT03672175|38110078|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
16966952|NCT03672175|38110079|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
16966953|NCT03672175|38110080|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
16966954|NCT03672175|38110078|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
16966955|NCT03672175|38110079|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
16966956|NCT03672175|38110080|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
16966957|NCT01008423|38110108|FG000|Overall Study|Adverse Event|13|||
16966958|NCT01008423|38110109|FG001|Overall Study|Adverse Event|6|||
16966959|NCT01008423|38110108|FG000|Overall Study|Withdrawal by Subject|4|||
16966960|NCT01008423|38110109|FG001|Overall Study|Withdrawal by Subject|7|||
16966961|NCT01008423|38110108|FG000|Overall Study|Lost to Follow-up|0|||
16966962|NCT01008423|38110109|FG001|Overall Study|Lost to Follow-up|2|||
16966963|NCT01008423|38110108|FG000|Overall Study|Low Cortisol|0|||
16966964|NCT01008423|38110109|FG001|Overall Study|Low Cortisol|1|||
16966965|NCT01008423|38110108|FG000|Overall Study|Lack of Efficacy|0|||
16966966|NCT01008423|38110109|FG001|Overall Study|Lack of Efficacy|5|||
16966967|NCT01008423|38110108|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
16966968|NCT01008423|38110109|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
16966969|NCT01008423|38110108|FG000|Overall Study|Personal Conflict|1|||
16966970|NCT01008423|38110109|FG001|Overall Study|Personal Conflict|0|||
16966971|NCT01008423|38110108|FG000|Overall Study|Other|0|||
16966972|NCT01008423|38110109|FG001|Overall Study|Other|1|||
16966973|NCT01012947|38110120|FG000|Overall Study|Lost to Follow-up|131|||
16966974|NCT01012947|38110121|FG001|Overall Study|Lost to Follow-up|135|||
16966975|NCT01012947|38110122|FG002|Overall Study|Lost to Follow-up|130|||
16966976|NCT01012947|38110123|FG003|Overall Study|Lost to Follow-up|118|||
16966977|NCT01012947|38110124|FG004|Overall Study|Lost to Follow-up|142|||
16966978|NCT01214603|38110156|FG000|Overall Study|Adverse Event|0|||
16966979|NCT01214603|38110157|FG001|Overall Study|Adverse Event|0|||
16966980|NCT01214603|38110158|FG002|Overall Study|Adverse Event|1|||
16966981|NCT01214603|38110156|FG000|Overall Study|Death|1|||
16966982|NCT01214603|38110157|FG001|Overall Study|Death|0|||
16966983|NCT01214603|38110158|FG002|Overall Study|Death|0|||
16966984|NCT01214603|38110156|FG000|Overall Study|Progressive Disease|4|||
16966985|NCT01214603|38110157|FG001|Overall Study|Progressive Disease|1|||
16966986|NCT01214603|38110158|FG002|Overall Study|Progressive Disease|3|||
16966987|NCT01212185|38110169|FG000|Overall Study|Protocol Violation|2|||
16966988|NCT01212185|38110170|FG001|Overall Study|Protocol Violation|1|||
16966989|NCT01995175|38110176|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
16966990|NCT01995175|38110176|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
16966991|NCT01995175|38110176|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
16966992|NCT01995175|38110176|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
16966993|NCT01995175|38110176|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
16966994|NCT01995175|38110176|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
16966995|NCT01995175|38110176|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
16966996|NCT01995175|38110176|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
16997754|NCT00962390|38141771|FG000|Overall Study|Lost to Follow-up|2|||
17028489|NCT00765674|38172857|FG003|Overall Study|Lack of Efficacy|2|||
16966997|NCT01995175|38110176|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
16966998|NCT02243605|38110256|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
16966999|NCT02243605|38110257|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
16967000|NCT02243605|38110256|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
16967001|NCT02243605|38110257|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
16967002|NCT02243605|38110256|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
16967003|NCT02243605|38110257|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
16967004|NCT02243605|38110256|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
16967005|NCT02243605|38110257|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
16967006|NCT02243605|38110256|FG000|Stage 2 - Final Analysis Population|Progression|0|||
16967007|NCT02243605|38110257|FG001|Stage 2 - Final Analysis Population|Progression|1|||
16967008|NCT01752907|38110274|FG000|Overall Study|Withdrawal by Subject|4|||
16967009|NCT01752907|38110275|FG001|Overall Study|Withdrawal by Subject|10|||
16967010|NCT01752907|38110274|FG000|Overall Study|Lost to Follow-up|2|||
16967011|NCT01752907|38110275|FG001|Overall Study|Lost to Follow-up|1|||
16967012|NCT01752907|38110274|FG000|Overall Study|Decision by Sponsor|6|||
16967013|NCT01752907|38110275|FG001|Overall Study|Decision by Sponsor|9|||
16967014|NCT03439189|38110281|FG000|Overall Study|Protocol Violation|19|||
16967015|NCT03439189|38110281|FG000|Overall Study|Lack of Efficacy|63|||
16967016|NCT01211483|38110290|FG000|Phase 1b|Death|6|||
16967017|NCT01211483|38110291|FG001|Phase 1b|Death|0|||
16967018|NCT01211483|38110292|FG002|Phase 1b|Death|0|||
16967019|NCT01211483|38110293|FG003|Phase 1b|Death|0|||
16967020|NCT01211483|38110290|FG000|Phase 1b|Withdrawal by Subject|1|||
16967021|NCT01211483|38110291|FG001|Phase 1b|Withdrawal by Subject|0|||
16967022|NCT01211483|38110292|FG002|Phase 1b|Withdrawal by Subject|0|||
16967023|NCT01211483|38110293|FG003|Phase 1b|Withdrawal by Subject|0|||
16967024|NCT01211483|38110290|FG000|Phase 2|Lost to Follow-up|0|||
16967025|NCT01211483|38110291|FG001|Phase 2|Lost to Follow-up|1|||
16967026|NCT01211483|38110292|FG002|Phase 2|Lost to Follow-up|1|||
16967027|NCT01211483|38110293|FG003|Phase 2|Lost to Follow-up|2|||
16967028|NCT01211483|38110290|FG000|Phase 2|Death|0|||
16967029|NCT01211483|38110291|FG001|Phase 2|Death|64|||
16967030|NCT01211483|38110292|FG002|Phase 2|Death|53|||
16967031|NCT01211483|38110293|FG003|Phase 2|Death|53|||
16967032|NCT01211483|38110290|FG000|Phase 2|Withdrawal by Subject|0|||
16967033|NCT01211483|38110291|FG001|Phase 2|Withdrawal by Subject|1|||
16967034|NCT01211483|38110292|FG002|Phase 2|Withdrawal by Subject|10|||
16967035|NCT01211483|38110293|FG003|Phase 2|Withdrawal by Subject|5|||
16967036|NCT01211483|38110290|FG000|Phase 2|Study terminated by Sponsor|0|||
16967037|NCT01211483|38110291|FG001|Phase 2|Study terminated by Sponsor|6|||
16967038|NCT01211483|38110292|FG002|Phase 2|Study terminated by Sponsor|8|||
16967039|NCT01211483|38110293|FG003|Phase 2|Study terminated by Sponsor|11|||
16967040|NCT01210001|38110310|FG000|Overall Study|Not treated|1|||
16967041|NCT01210001|38110311|FG001|Overall Study|Not treated|0|||
16967042|NCT01210001|38110312|FG002|Overall Study|Not treated|0|||
16967043|NCT01210001|38110310|FG000|Overall Study|Adverse Event|4|||
16967044|NCT01210001|38110311|FG001|Overall Study|Adverse Event|2|||
16967045|NCT01210001|38110312|FG002|Overall Study|Adverse Event|5|||
16967046|NCT01210001|38110310|FG000|Overall Study|Non compliant with protocol|2|||
16967047|NCT01210001|38110311|FG001|Overall Study|Non compliant with protocol|2|||
16967048|NCT01210001|38110312|FG002|Overall Study|Non compliant with protocol|3|||
16967049|NCT01210001|38110310|FG000|Overall Study|Lost to Follow-up|4|||
16967050|NCT01210001|38110311|FG001|Overall Study|Lost to Follow-up|3|||
16967051|NCT01210001|38110312|FG002|Overall Study|Lost to Follow-up|2|||
16967052|NCT01210001|38110310|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
16967053|NCT01210001|38110311|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
16967054|NCT01210001|38110312|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
16967055|NCT01210001|38110310|FG000|Overall Study|Other reason not defined above|2|||
16967056|NCT01210001|38110311|FG001|Overall Study|Other reason not defined above|2|||
16967057|NCT01210001|38110312|FG002|Overall Study|Other reason not defined above|1|||
16967058|NCT01209689|38110353|FG000|Overall Study|Insufficient Therapeutic Response|7|||
16967059|NCT01209689|38110354|FG001|Overall Study|Insufficient Therapeutic Response|2|||
16967060|NCT01209689|38110353|FG000|Overall Study|Refused Treatment|8|||
16967061|NCT01209689|38110354|FG001|Overall Study|Refused Treatment|3|||
16967062|NCT01209689|38110353|FG000|Overall Study|Adverse Event|4|||
16967063|NCT01209689|38110354|FG001|Overall Study|Adverse Event|0|||
16967064|NCT01209689|38110353|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
16967065|NCT01209689|38110354|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
16967066|NCT01209689|38110353|FG000|Overall Study|Failure to Return|3|||
16967067|NCT01209689|38110354|FG001|Overall Study|Failure to Return|0|||
16967068|NCT01209689|38110353|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
16967069|NCT01209689|38110354|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
16967070|NCT01209143|38110362|FG000|Overall Study|Adverse Event|2|||
16967071|NCT01209143|38110363|FG001|Overall Study|Adverse Event|1|||
16967072|NCT01209143|38110362|FG000|Overall Study|Death|0|||
16967073|NCT01209143|38110363|FG001|Overall Study|Death|1|||
16967074|NCT01209143|38110362|FG000|Overall Study|Physician Decision|3|||
16967075|NCT01209143|38110363|FG001|Overall Study|Physician Decision|1|||
16967076|NCT01209143|38110362|FG000|Overall Study|Lost to Follow-up|1|||
16967077|NCT01209143|38110363|FG001|Overall Study|Lost to Follow-up|0|||
16967078|NCT01209143|38110362|FG000|Overall Study|Withdrawal by Subject|2|||
16967079|NCT01209143|38110363|FG001|Overall Study|Withdrawal by Subject|1|||
16967080|NCT01209143|38110362|FG000|Overall Study|Disease progression|11|||
16967081|NCT01209143|38110363|FG001|Overall Study|Disease progression|16|||
16967082|NCT01023789|38110382|FG000|3 - Year Visit|Death|29|||
16967083|NCT01023789|38110382|FG000|3 - Year Visit|Withdrawal of consent|1|||
16967084|NCT01023789|38110382|FG000|3 - Year Visit|Lost to Follow-up|13|||
16967085|NCT01208207|38110389|FG000|Part I|Adverse Event|19|||
16967086|NCT01208207|38110390|FG001|Part I|Adverse Event|2|||
16967087|NCT01208207|38110391|FG002|Part I|Adverse Event|6|||
16967088|NCT01208207|38110392|FG003|Part I|Adverse Event|0|||
16967089|NCT01208207|38110393|FG004|Part I|Adverse Event|0|||
16967090|NCT01208207|38110394|FG005|Part I|Adverse Event|0|||
16967091|NCT01208207|38110395|FG006|Part I|Adverse Event|0|||
16967092|NCT01208207|38110389|FG000|Part I|Lack of Efficacy|21|||
16967093|NCT01208207|38110390|FG001|Part I|Lack of Efficacy|3|||
16967094|NCT01208207|38110391|FG002|Part I|Lack of Efficacy|2|||
16967095|NCT01208207|38110392|FG003|Part I|Lack of Efficacy|0|||
16967096|NCT01208207|38110393|FG004|Part I|Lack of Efficacy|0|||
16967097|NCT01208207|38110394|FG005|Part I|Lack of Efficacy|0|||
16967098|NCT01208207|38110395|FG006|Part I|Lack of Efficacy|0|||
16967099|NCT01208207|38110389|FG000|Part I|Lost to Follow-up|6|||
16967100|NCT01208207|38110390|FG001|Part I|Lost to Follow-up|1|||
16967101|NCT01208207|38110391|FG002|Part I|Lost to Follow-up|0|||
16967102|NCT01208207|38110392|FG003|Part I|Lost to Follow-up|0|||
16967103|NCT01208207|38110393|FG004|Part I|Lost to Follow-up|0|||
16967104|NCT01208207|38110394|FG005|Part I|Lost to Follow-up|0|||
16967105|NCT01208207|38110395|FG006|Part I|Lost to Follow-up|0|||
16967106|NCT01208207|38110389|FG000|Part I|Non-Compliance With Study Drug|1|||
16967107|NCT01208207|38110390|FG001|Part I|Non-Compliance With Study Drug|0|||
16967108|NCT01208207|38110391|FG002|Part I|Non-Compliance With Study Drug|1|||
16967109|NCT01208207|38110392|FG003|Part I|Non-Compliance With Study Drug|0|||
16967110|NCT01208207|38110393|FG004|Part I|Non-Compliance With Study Drug|0|||
16967111|NCT01208207|38110394|FG005|Part I|Non-Compliance With Study Drug|0|||
16967112|NCT01208207|38110395|FG006|Part I|Non-Compliance With Study Drug|0|||
16967113|NCT01208207|38110389|FG000|Part I|Physician Decision|0|||
16967114|NCT01208207|38110390|FG001|Part I|Physician Decision|1|||
16967115|NCT01208207|38110391|FG002|Part I|Physician Decision|0|||
16967116|NCT01208207|38110392|FG003|Part I|Physician Decision|0|||
16967117|NCT01208207|38110393|FG004|Part I|Physician Decision|0|||
16967118|NCT01208207|38110394|FG005|Part I|Physician Decision|0|||
16967119|NCT01208207|38110395|FG006|Part I|Physician Decision|0|||
16967120|NCT01208207|38110389|FG000|Part I|Progressive Disease|1|||
16967121|NCT01208207|38110390|FG001|Part I|Progressive Disease|0|||
16967122|NCT01208207|38110391|FG002|Part I|Progressive Disease|0|||
16967123|NCT01208207|38110392|FG003|Part I|Progressive Disease|0|||
16967124|NCT01208207|38110393|FG004|Part I|Progressive Disease|0|||
16967125|NCT01208207|38110394|FG005|Part I|Progressive Disease|0|||
16967126|NCT01208207|38110395|FG006|Part I|Progressive Disease|0|||
16967127|NCT01208207|38110389|FG000|Part I|Protocol Violation|8|||
16967128|NCT01208207|38110390|FG001|Part I|Protocol Violation|0|||
16967129|NCT01208207|38110391|FG002|Part I|Protocol Violation|2|||
16967130|NCT01208207|38110392|FG003|Part I|Protocol Violation|0|||
16967131|NCT01208207|38110393|FG004|Part I|Protocol Violation|0|||
16967132|NCT01208207|38110394|FG005|Part I|Protocol Violation|0|||
16967133|NCT01208207|38110395|FG006|Part I|Protocol Violation|0|||
16967134|NCT01208207|38110389|FG000|Part I|Withdrawal by Subject|14|||
16967135|NCT01208207|38110390|FG001|Part I|Withdrawal by Subject|4|||
16967136|NCT01208207|38110391|FG002|Part I|Withdrawal by Subject|4|||
16967137|NCT01208207|38110392|FG003|Part I|Withdrawal by Subject|0|||
16967138|NCT01208207|38110393|FG004|Part I|Withdrawal by Subject|0|||
16967139|NCT01208207|38110394|FG005|Part I|Withdrawal by Subject|0|||
16967140|NCT01208207|38110395|FG006|Part I|Withdrawal by Subject|0|||
16967141|NCT01208207|38110389|FG000|Part II|Withdrawal by Subject|0|||
16967142|NCT01208207|38110390|FG001|Part II|Withdrawal by Subject|0|||
16967143|NCT01208207|38110391|FG002|Part II|Withdrawal by Subject|0|||
16967144|NCT01208207|38110392|FG003|Part II|Withdrawal by Subject|10|||
16967145|NCT01208207|38110393|FG004|Part II|Withdrawal by Subject|9|||
16967146|NCT01208207|38110394|FG005|Part II|Withdrawal by Subject|3|||
16967147|NCT01208207|38110395|FG006|Part II|Withdrawal by Subject|5|||
16967148|NCT01208207|38110389|FG000|Part II|Adverse Event|0|||
16967149|NCT01208207|38110390|FG001|Part II|Adverse Event|0|||
16967150|NCT01208207|38110391|FG002|Part II|Adverse Event|0|||
16967151|NCT01208207|38110392|FG003|Part II|Adverse Event|5|||
16967152|NCT01208207|38110393|FG004|Part II|Adverse Event|9|||
16967153|NCT01208207|38110394|FG005|Part II|Adverse Event|4|||
16967154|NCT01208207|38110395|FG006|Part II|Adverse Event|2|||
16967155|NCT01208207|38110389|FG000|Part II|Lack of Efficacy|0|||
16967156|NCT01208207|38110390|FG001|Part II|Lack of Efficacy|0|||
16967157|NCT01208207|38110391|FG002|Part II|Lack of Efficacy|0|||
16967158|NCT01208207|38110392|FG003|Part II|Lack of Efficacy|6|||
16967159|NCT01208207|38110393|FG004|Part II|Lack of Efficacy|4|||
16967160|NCT01208207|38110394|FG005|Part II|Lack of Efficacy|3|||
16967161|NCT01208207|38110395|FG006|Part II|Lack of Efficacy|3|||
16967162|NCT01208207|38110389|FG000|Part II|Lost to Follow-up|0|||
16967163|NCT01208207|38110390|FG001|Part II|Lost to Follow-up|0|||
16967164|NCT01208207|38110391|FG002|Part II|Lost to Follow-up|0|||
16967165|NCT01208207|38110392|FG003|Part II|Lost to Follow-up|4|||
16780029|NCT02616393|37719093|FG001|Overall Study|Withdrawal by Subject|1|||
16780030|NCT02616393|37719094|FG002|Overall Study|Withdrawal by Subject|0|||
16780031|NCT02616393|37719092|FG000|Overall Study|Lost to Follow-up|0|||
16780032|NCT02616393|37719093|FG001|Overall Study|Lost to Follow-up|2|||
16967166|NCT01208207|38110393|FG004|Part II|Lost to Follow-up|0|||
16967167|NCT01208207|38110394|FG005|Part II|Lost to Follow-up|2|||
16967168|NCT01208207|38110395|FG006|Part II|Lost to Follow-up|1|||
16967169|NCT01208207|38110389|FG000|Part II|Non-Compliance With Study Drug|0|||
16967170|NCT01208207|38110390|FG001|Part II|Non-Compliance With Study Drug|0|||
16967171|NCT01208207|38110391|FG002|Part II|Non-Compliance With Study Drug|0|||
16967172|NCT01208207|38110392|FG003|Part II|Non-Compliance With Study Drug|4|||
16967173|NCT01208207|38110393|FG004|Part II|Non-Compliance With Study Drug|1|||
16967174|NCT01208207|38110394|FG005|Part II|Non-Compliance With Study Drug|1|||
16967175|NCT01208207|38110395|FG006|Part II|Non-Compliance With Study Drug|0|||
16967176|NCT01208207|38110389|FG000|Part II|Physician Decision|0|||
16967177|NCT01208207|38110390|FG001|Part II|Physician Decision|0|||
16967178|NCT01208207|38110391|FG002|Part II|Physician Decision|0|||
16967179|NCT01208207|38110392|FG003|Part II|Physician Decision|1|||
16967180|NCT01208207|38110393|FG004|Part II|Physician Decision|0|||
16967181|NCT01208207|38110394|FG005|Part II|Physician Decision|2|||
16967182|NCT01208207|38110395|FG006|Part II|Physician Decision|0|||
16967183|NCT01208207|38110389|FG000|Part II|Protocol Violation|0|||
16967184|NCT01208207|38110390|FG001|Part II|Protocol Violation|0|||
16967185|NCT01208207|38110391|FG002|Part II|Protocol Violation|0|||
16967186|NCT01208207|38110392|FG003|Part II|Protocol Violation|1|||
16967187|NCT01208207|38110393|FG004|Part II|Protocol Violation|0|||
16967188|NCT01208207|38110394|FG005|Part II|Protocol Violation|0|||
16967189|NCT01208207|38110395|FG006|Part II|Protocol Violation|0|||
16967190|NCT01208207|38110389|FG000|Part II|Technical Problems|0|||
16967191|NCT01208207|38110390|FG001|Part II|Technical Problems|0|||
16967192|NCT01208207|38110391|FG002|Part II|Technical Problems|0|||
16967193|NCT01208207|38110392|FG003|Part II|Technical Problems|1|||
16967194|NCT01208207|38110393|FG004|Part II|Technical Problems|0|||
16967195|NCT01208207|38110394|FG005|Part II|Technical Problems|1|||
16967196|NCT01208207|38110395|FG006|Part II|Technical Problems|0|||
16967197|NCT01012713|38110426|FG000|Overall Study|Lack of Efficacy|3|||
16967198|NCT01007253|38110431|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
16967199|NCT01007253|38110432|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
16967200|NCT01007253|38110433|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
16967201|NCT01007253|38110434|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
16967202|NCT01006707|38110444|FG000|Study Session 1|Lost to Follow-up|2|||
16967203|NCT01006707|38110445|FG001|Study Session 1|Lost to Follow-up|0|||
16967204|NCT01006707|38110446|FG002|Study Session 1|Lost to Follow-up|0|||
16967205|NCT01006707|38110444|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
16967206|NCT01006707|38110445|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
16967207|NCT01006707|38110446|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
16967208|NCT01006629|38110454|FG000|Overall Study|Adverse Event|1|||
16967209|NCT01006629|38110454|FG000|Overall Study|Parent refused to continue participation|1|||
16780033|NCT02616393|37719094|FG002|Overall Study|Lost to Follow-up|0|||
16780034|NCT02155660|37719122|FG000|Overall Study|Other Reason|8|||
16868005|NCT01536145|37841036|FG003|Overall Study|Progressive disease|2|||
16967210|NCT01006629|38110454|FG000|Overall Study|Parent unable to perform site visit|4|||
16967211|NCT01012323|38110458|FG000|Overall Study|Investigator Judgment|1|||
16967212|NCT01011933|38110462|FG000|Overall Study|Wrong cell type|1|||
16967213|NCT01011933|38110462|FG000|Overall Study|Improper pre-protocol Rx|1|||
16967214|NCT01011933|38110462|FG000|Overall Study|Inadequate pathology|1|||
16967215|NCT01011933|38110462|FG000|Overall Study|Never treated|1|||
16967216|NCT01011465|38110484|FG000|Overall Study|Withdrawal by Subject|2|||
16967217|NCT01011465|38110485|FG001|Overall Study|Withdrawal by Subject|1|||
16967218|NCT01011465|38110486|FG002|Overall Study|Withdrawal by Subject|0|||
16967219|NCT01011465|38110487|FG003|Overall Study|Withdrawal by Subject|0|||
16967220|NCT01011465|38110488|FG004|Overall Study|Withdrawal by Subject|1|||
16967221|NCT01011465|38110489|FG005|Overall Study|Withdrawal by Subject|0|||
16967222|NCT01011465|38110490|FG006|Overall Study|Withdrawal by Subject|1|||
16967223|NCT01011465|38110491|FG007|Overall Study|Withdrawal by Subject|0|||
16967224|NCT01011387|38110516|FG000|Overall Study|Withdrawal by Subject|3|||
16967225|NCT01011387|38110516|FG000|Overall Study|Adverse Event|2|||
16967226|NCT01011387|38110516|FG000|Overall Study|Protocol Violation|1|||
16967227|NCT01011309|38110523|FG000|Overall Study|Adverse Event|2|||
16967228|NCT01011309|38110524|FG001|Overall Study|Adverse Event|1|||
16967229|NCT01011309|38110525|FG002|Overall Study|Adverse Event|2|||
16967230|NCT01011309|38110523|FG000|Overall Study|Lack of Efficacy|0|||
16967231|NCT01011309|38110524|FG001|Overall Study|Lack of Efficacy|1|||
16967232|NCT01011309|38110525|FG002|Overall Study|Lack of Efficacy|0|||
16967233|NCT01011309|38110523|FG000|Overall Study|Protocol Violation|0|||
16967234|NCT01011309|38110524|FG001|Overall Study|Protocol Violation|1|||
16967235|NCT01011309|38110525|FG002|Overall Study|Protocol Violation|3|||
16967236|NCT01011153|38110536|FG000|Overall Study|Less than 78 cases completed|8|||
16967237|NCT01011153|38110537|FG001|Overall Study|Less than 78 cases completed|11|||
16967238|NCT01011153|38110538|FG002|Overall Study|Less than 78 cases completed|9|||
16967239|NCT00997893|38110570|FG000|Overall Study|Adverse Event|1|||
16967240|NCT00997893|38110571|FG001|Overall Study|Adverse Event|0|||
16967241|NCT00997893|38110572|FG002|Overall Study|Adverse Event|0|||
16967242|NCT00997893|38110570|FG000|Overall Study|Unable to meet study timelines|1|||
16967243|NCT00997893|38110571|FG001|Overall Study|Unable to meet study timelines|0|||
16967244|NCT00997893|38110572|FG002|Overall Study|Unable to meet study timelines|0|||
16967245|NCT00997893|38110570|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
16967246|NCT00997893|38110571|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
16967247|NCT00997893|38110572|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
16967248|NCT02905825|38110589|FG000|Overall Study|Protocol Violation|11|||
16967249|NCT02905825|38110589|FG000|Overall Study|Device Malfunction|1|||
16967250|NCT01208051|38110598|FG000|Total Enrollment|Withdrawal by Subject|0|||
16967251|NCT01208051|38110599|FG001|Total Enrollment|Withdrawal by Subject|1|||
16967252|NCT01208051|38110600|FG002|Total Enrollment|Withdrawal by Subject|0|||
16967253|NCT01208051|38110601|FG003|Total Enrollment|Withdrawal by Subject|0|||
16967254|NCT01208051|38110602|FG004|Total Enrollment|Withdrawal by Subject|2|||
16967255|NCT01208051|38110598|FG000|Total Enrollment|Brain metastases|0|||
16967256|NCT01208051|38110599|FG001|Total Enrollment|Brain metastases|0|||
16967257|NCT01208051|38110600|FG002|Total Enrollment|Brain metastases|1|||
16967258|NCT01208051|38110601|FG003|Total Enrollment|Brain metastases|0|||
16967259|NCT01208051|38110602|FG004|Total Enrollment|Brain metastases|0|||
16967260|NCT02860039|38110620|FG000|Overall Study|Death|4|||
16967261|NCT02860039|38110621|FG001|Overall Study|Death|0|||
16967262|NCT02860039|38110620|FG000|Overall Study|Lost to Follow-up|2|||
16967263|NCT02860039|38110621|FG001|Overall Study|Lost to Follow-up|2|||
16967264|NCT02860039|38110620|FG000|Overall Study|Protocol Violation|3|||
16967265|NCT02860039|38110621|FG001|Overall Study|Protocol Violation|1|||
16967266|NCT02860039|38110620|FG000|Overall Study|Withdrawal by Subject|1|||
16967267|NCT02860039|38110621|FG001|Overall Study|Withdrawal by Subject|0|||
16967268|NCT02860039|38110620|FG000|Overall Study|Not otherwise eligible|1|||
16967269|NCT02860039|38110621|FG001|Overall Study|Not otherwise eligible|1|||
16967270|NCT01207583|38110630|FG000|Overall Study|Withdrawal by Subject|0|||
16967271|NCT01207583|38110631|FG001|Overall Study|Withdrawal by Subject|3|||
16967272|NCT01207583|38110632|FG002|Overall Study|Withdrawal by Subject|1|||
16967273|NCT01207583|38110630|FG000|Overall Study|Participant failed to return|1|||
16967274|NCT01207583|38110631|FG001|Overall Study|Participant failed to return|0|||
16967275|NCT01207583|38110632|FG002|Overall Study|Participant failed to return|0|||
16967276|NCT01207583|38110630|FG000|Overall Study|Lost to Follow-up|0|||
16967277|NCT01207583|38110631|FG001|Overall Study|Lost to Follow-up|2|||
16967278|NCT01207583|38110632|FG002|Overall Study|Lost to Follow-up|0|||
16967279|NCT01207427|38110656|FG000|Double-blind Treatment Period|Adverse Event|0|||
16967280|NCT01207427|38110657|FG001|Double-blind Treatment Period|Adverse Event|1|||
16967281|NCT01207427|38110658|FG002|Double-blind Treatment Period|Adverse Event|0|||
16967282|NCT01207427|38110656|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16967283|NCT01207427|38110657|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
16967284|NCT01207427|38110658|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
16967285|NCT01207427|38110656|FG000|Double-blind Treatment Period|Protocol Violation|2|||
16967286|NCT01207427|38110657|FG001|Double-blind Treatment Period|Protocol Violation|1|||
16967287|NCT01207427|38110658|FG002|Double-blind Treatment Period|Protocol Violation|1|||
16967288|NCT01207427|38110656|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16967289|NCT01207427|38110657|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
16967290|NCT01207427|38110658|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16967291|NCT04713553|38110671|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
16967292|NCT04713553|38110672|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
16967293|NCT04713553|38110673|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
16967294|NCT04713553|38110674|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
16967295|NCT04713553|38110675|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
16967296|NCT04713553|38110676|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
16967297|NCT04713553|38110677|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
16967298|NCT04713553|38110671|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16967299|NCT04713553|38110672|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16967300|NCT04713553|38110673|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16967301|NCT04713553|38110674|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
16967302|NCT04713553|38110675|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16967303|NCT04713553|38110676|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16967304|NCT04713553|38110677|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16967305|NCT04713553|38110671|FG000|Primary Study (2 Months)|Other|1|||
16967306|NCT04713553|38110672|FG001|Primary Study (2 Months)|Other|2|||
16967307|NCT04713553|38110673|FG002|Primary Study (2 Months)|Other|0|||
16967308|NCT04713553|38110674|FG003|Primary Study (2 Months)|Other|0|||
16967309|NCT04713553|38110675|FG004|Primary Study (2 Months)|Other|1|||
16967310|NCT04713553|38110676|FG005|Primary Study (2 Months)|Other|0|||
16967311|NCT04713553|38110677|FG006|Primary Study (2 Months)|Other|0|||
16967312|NCT04713553|38110671|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
16967313|NCT04713553|38110672|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
16967314|NCT04713553|38110673|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
16967315|NCT04713553|38110674|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
16967316|NCT04713553|38110675|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
16967317|NCT04713553|38110676|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
16967318|NCT04713553|38110677|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
16967319|NCT04713553|38110671|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
16967320|NCT04713553|38110672|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
16967321|NCT04713553|38110673|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
16967322|NCT04713553|38110674|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
16967323|NCT04713553|38110675|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
16967324|NCT04713553|38110676|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
16967325|NCT04713553|38110677|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
16967326|NCT01206101|38110700|FG000|Overall Study|Adverse Event|1|||
16967327|NCT01206101|38110701|FG001|Overall Study|Adverse Event|0|||
16967328|NCT01206101|38110700|FG000|Overall Study|Physician Decision|0|||
16967329|NCT01206101|38110701|FG001|Overall Study|Physician Decision|1|||
16967330|NCT01206101|38110700|FG000|Overall Study|Unclassified|1|||
16967331|NCT01206101|38110701|FG001|Overall Study|Unclassified|0|||
16967332|NCT01205165|38110707|FG000|Overall Study|Lost to Follow-up|2|||
16967333|NCT00997503|38110712|FG000|Overall Study|Death|53|||
16967334|NCT00997503|38110712|FG000|Overall Study|Withdrawal by Subject|76|||
16967335|NCT00997503|38110712|FG000|Overall Study|Lost to Follow-up|33|||
16967336|NCT00997503|38110712|FG000|Overall Study|Adverse Event|3|||
16967337|NCT00997503|38110712|FG000|Overall Study|Physician Decision|10|||
16967338|NCT00997503|38110712|FG000|Overall Study|Missed 12-month follow-up|85|||
16967339|NCT00997503|38110712|FG000|Overall Study|Other reason|13|||
16967340|NCT01204775|38110721|FG000|Overall Study|Poor/non-compliance|0|||
16967341|NCT01204775|38110722|FG001|Overall Study|Poor/non-compliance|1|||
16967342|NCT01204775|38110721|FG000|Overall Study|Withdrawal by Subject|1|||
16967343|NCT01204775|38110722|FG001|Overall Study|Withdrawal by Subject|0|||
16967344|NCT00997035|38110730|FG000|3-week Followup Visit|Lost to Follow-up|9|||
16967345|NCT00997035|38110731|FG001|3-week Followup Visit|Lost to Follow-up|6|||
16967346|NCT00997035|38110730|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
16967347|NCT00997035|38110731|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
16967348|NCT01204697|38110749|FG000|Overall Study|Death|26|||
16967349|NCT01204697|38110750|FG001|Overall Study|Death|27|||
16967350|NCT01204697|38110749|FG000|Overall Study|Lost to Follow-up|3|||
16967351|NCT01204697|38110750|FG001|Overall Study|Lost to Follow-up|4|||
16967352|NCT01204697|38110749|FG000|Overall Study|Withdrawal by Subject|2|||
16967353|NCT01204697|38110750|FG001|Overall Study|Withdrawal by Subject|4|||
16967354|NCT01204697|38110749|FG000|Overall Study|Randomized, but not treated|0|||
16967355|NCT01204697|38110750|FG001|Overall Study|Randomized, but not treated|1|||
16967356|NCT01001325|38110758|FG000|Overall Study|Lost to Follow-up|16|||
16967357|NCT01001325|38110759|FG001|Overall Study|Lost to Follow-up|10|||
16967358|NCT01001325|38110758|FG000|Overall Study|Protocol Violation|2|||
16967359|NCT01001325|38110759|FG001|Overall Study|Protocol Violation|0|||
16967360|NCT01203917|38110765|FG000|Overall Study|Death|29|||
16967361|NCT01203917|38110765|FG000|Overall Study|Lost to Follow-up|2|||
16967362|NCT01203917|38110765|FG000|Overall Study|Withdrawal by Subject|3|||
16967363|NCT01203917|38110765|FG000|Overall Study|Due to objective disease progression|1|||
16967364|NCT01203917|38110765|FG000|Overall Study|Due to EGFR M+I patient|1|||
16967365|NCT01202903|38110771|FG000|Overall Study|Administrative Probelms|1|||
16967366|NCT01202903|38110772|FG001|Overall Study|Administrative Probelms|4|||
16967367|NCT01202903|38110771|FG000|Overall Study|Protocol Violation|0|||
16967368|NCT01202903|38110772|FG001|Overall Study|Protocol Violation|1|||
16967369|NCT01202903|38110771|FG000|Overall Study|Death|1|||
16967370|NCT01202903|38110772|FG001|Overall Study|Death|0|||
16967371|NCT01202903|38110771|FG000|Overall Study|Lost to Follow-up|1|||
16967372|NCT01202903|38110772|FG001|Overall Study|Lost to Follow-up|1|||
16967373|NCT01202903|38110771|FG000|Overall Study|Lack of Efficacy|1|||
16967374|NCT01202903|38110772|FG001|Overall Study|Lack of Efficacy|3|||
16967375|NCT01202903|38110771|FG000|Overall Study|Adverse Event|3|||
16967376|NCT01202903|38110772|FG001|Overall Study|Adverse Event|3|||
16967377|NCT01202903|38110771|FG000|Overall Study|Withdrawal by Subject|4|||
16967378|NCT01202903|38110772|FG001|Overall Study|Withdrawal by Subject|4|||
16967379|NCT01001169|38110780|FG000|Overall Study|Withdrawal by Subject|2|||
16967380|NCT01001169|38110781|FG001|Overall Study|Withdrawal by Subject|1|||
16967381|NCT01202747|38110795|FG000|Overall Study|Withdrawal by Subject|1|||
16967382|NCT00996801|38110805|FG000|Overall Study|Adverse Event|6|||
16967383|NCT00996801|38110806|FG001|Overall Study|Adverse Event|4|||
16967384|NCT00996801|38110807|FG002|Overall Study|Adverse Event|12|||
16967385|NCT00996801|38110808|FG003|Overall Study|Adverse Event|17|||
16967386|NCT00996801|38110809|FG004|Overall Study|Adverse Event|31|||
16967387|NCT00996801|38110810|FG005|Overall Study|Adverse Event|3|||
16967388|NCT00996801|38110805|FG000|Overall Study|Lack of Efficacy|3|||
16967389|NCT00996801|38110806|FG001|Overall Study|Lack of Efficacy|0|||
16967390|NCT00996801|38110807|FG002|Overall Study|Lack of Efficacy|1|||
16967391|NCT00996801|38110808|FG003|Overall Study|Lack of Efficacy|3|||
16967392|NCT00996801|38110809|FG004|Overall Study|Lack of Efficacy|0|||
16967393|NCT00996801|38110810|FG005|Overall Study|Lack of Efficacy|1|||
16967394|NCT00996801|38110805|FG000|Overall Study|Lost to Follow-up|0|||
16967395|NCT00996801|38110806|FG001|Overall Study|Lost to Follow-up|0|||
16967396|NCT00996801|38110807|FG002|Overall Study|Lost to Follow-up|0|||
16967397|NCT00996801|38110808|FG003|Overall Study|Lost to Follow-up|3|||
16967398|NCT00996801|38110809|FG004|Overall Study|Lost to Follow-up|3|||
16967399|NCT00996801|38110810|FG005|Overall Study|Lost to Follow-up|2|||
16967400|NCT00996801|38110805|FG000|Overall Study|Physician Decision|0|||
16967401|NCT00996801|38110806|FG001|Overall Study|Physician Decision|0|||
16967402|NCT00996801|38110807|FG002|Overall Study|Physician Decision|0|||
16967403|NCT00996801|38110808|FG003|Overall Study|Physician Decision|1|||
16967404|NCT00996801|38110809|FG004|Overall Study|Physician Decision|0|||
16967405|NCT00996801|38110810|FG005|Overall Study|Physician Decision|0|||
16967406|NCT00996801|38110805|FG000|Overall Study|Progressive Disease|0|||
16967407|NCT00996801|38110806|FG001|Overall Study|Progressive Disease|1|||
16868006|NCT01536145|37841037|FG004|Overall Study|Progressive disease|1|||
16967408|NCT00996801|38110807|FG002|Overall Study|Progressive Disease|0|||
16967409|NCT00996801|38110808|FG003|Overall Study|Progressive Disease|0|||
16967410|NCT00996801|38110809|FG004|Overall Study|Progressive Disease|0|||
16967411|NCT00996801|38110810|FG005|Overall Study|Progressive Disease|0|||
16967412|NCT00996801|38110805|FG000|Overall Study|Protocol Violation|3|||
16967413|NCT00996801|38110806|FG001|Overall Study|Protocol Violation|4|||
16967414|NCT00996801|38110807|FG002|Overall Study|Protocol Violation|1|||
16967415|NCT00996801|38110808|FG003|Overall Study|Protocol Violation|2|||
16967416|NCT00996801|38110809|FG004|Overall Study|Protocol Violation|3|||
16967417|NCT00996801|38110810|FG005|Overall Study|Protocol Violation|4|||
16967418|NCT00996801|38110805|FG000|Overall Study|Study Terminated by Sponsor|0|||
16967419|NCT00996801|38110806|FG001|Overall Study|Study Terminated by Sponsor|1|||
16967420|NCT00996801|38110807|FG002|Overall Study|Study Terminated by Sponsor|0|||
16967421|NCT00996801|38110808|FG003|Overall Study|Study Terminated by Sponsor|0|||
16967422|NCT00996801|38110809|FG004|Overall Study|Study Terminated by Sponsor|46|||
16967423|NCT00996801|38110810|FG005|Overall Study|Study Terminated by Sponsor|0|||
16967424|NCT00996801|38110805|FG000|Overall Study|Withdrawal by Subject|8|||
16967425|NCT00996801|38110806|FG001|Overall Study|Withdrawal by Subject|6|||
16967426|NCT00996801|38110807|FG002|Overall Study|Withdrawal by Subject|9|||
16967427|NCT00996801|38110808|FG003|Overall Study|Withdrawal by Subject|5|||
16967428|NCT00996801|38110809|FG004|Overall Study|Withdrawal by Subject|5|||
16967429|NCT00996801|38110810|FG005|Overall Study|Withdrawal by Subject|9|||
16967430|NCT00996489|38110826|FG000|Overall Study|Device failure|45|||
16967431|NCT00996489|38110826|FG000|Overall Study|Discontinued|116|||
16967432|NCT01000311|38110832|FG000|Overall Study|Adverse Event|2|||
16967433|NCT01000311|38110833|FG001|Overall Study|Adverse Event|5|||
16967434|NCT01000311|38110832|FG000|Overall Study|Withdrawal by Subject|16|||
16967435|NCT01000311|38110833|FG001|Overall Study|Withdrawal by Subject|24|||
16967436|NCT01000311|38110832|FG000|Overall Study|Lost to Follow-up|15|||
16967437|NCT01000311|38110833|FG001|Overall Study|Lost to Follow-up|24|||
16967438|NCT01000311|38110832|FG000|Overall Study|Protocol Violation|1|||
16967439|NCT01000311|38110833|FG001|Overall Study|Protocol Violation|2|||
16967440|NCT01000311|38110832|FG000|Overall Study|Inappropriate enrollment|2|||
16967441|NCT01000311|38110833|FG001|Overall Study|Inappropriate enrollment|0|||
16967442|NCT01000311|38110832|FG000|Overall Study|Administrative reason|9|||
16967443|NCT01000311|38110833|FG001|Overall Study|Administrative reason|15|||
16967444|NCT01003899|38110839|FG000|Overall Study|Other Adverse Event|8|||
16967445|NCT01003899|38110839|FG000|Overall Study|Not entered|4|||
16967446|NCT01003899|38110839|FG000|Overall Study|Not treated|1|||
16967447|NCT01003899|38110839|FG000|Overall Study|Progressive disease|34|||
16967448|NCT01000155|38110843|FG000|Overall Study|Withdrawal by Subject|1|||
16967449|NCT01000155|38110843|FG000|Overall Study|Adverse Event|1|||
16967450|NCT00999921|38110849|FG000|Overall Study|Lost to Follow-up|10|||
16967451|NCT00999921|38110850|FG001|Overall Study|Lost to Follow-up|19|||
16967452|NCT01002573|38110861|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
16967453|NCT01002573|38110862|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
16967454|NCT00999687|38110868|FG000|First Intervention|Withdrawal by Subject|1|||
16967455|NCT00999687|38110868|FG000|Second Intervention|Withdrawal by Subject|2|||
16967456|NCT00999687|38110868|FG000|Second Intervention|Lack of Efficacy|1|||
16967457|NCT00996333|38110874|FG000|Overall Study|Screen failure|1|||
16967458|NCT00996333|38110874|FG000|Overall Study|Withdrawal by Subject|1|||
16967459|NCT00996333|38110874|FG000|Overall Study|Death|4|||
16967460|NCT00996333|38110874|FG000|Overall Study|Adverse Event|1|||
16967461|NCT00996333|38110874|FG000|Overall Study|Physician Decision|1|||
16967462|NCT00996333|38110874|FG000|Overall Study|Other|5|||
16967463|NCT00995865|38110881|FG000|Overall Study|Protocol Violation|2|||
16967464|NCT00995865|38110882|FG001|Overall Study|Protocol Violation|0|||
16967465|NCT00995865|38110883|FG002|Overall Study|Protocol Violation|0|||
16967466|NCT00995865|38110881|FG000|Overall Study|Lost to Follow-up|0|||
16967467|NCT00995865|38110882|FG001|Overall Study|Lost to Follow-up|0|||
16967468|NCT00995865|38110883|FG002|Overall Study|Lost to Follow-up|1|||
16967469|NCT00995709|38110899|FG000|Overall Study|Adverse Event|4|||
16967470|NCT00995709|38110900|FG001|Overall Study|Adverse Event|2|||
16967471|NCT00995709|38110901|FG002|Overall Study|Adverse Event|0|||
16967472|NCT00995709|38110899|FG000|Overall Study|Lack of Efficacy|0|||
16967473|NCT00995709|38110900|FG001|Overall Study|Lack of Efficacy|1|||
16967474|NCT00995709|38110901|FG002|Overall Study|Lack of Efficacy|4|||
16967475|NCT00995709|38110899|FG000|Overall Study|Withdrawal by Subject|0|||
16967476|NCT00995709|38110900|FG001|Overall Study|Withdrawal by Subject|4|||
16967477|NCT00995709|38110901|FG002|Overall Study|Withdrawal by Subject|1|||
16967478|NCT00995709|38110899|FG000|Overall Study|Lost to Follow-up|1|||
16967479|NCT00995709|38110900|FG001|Overall Study|Lost to Follow-up|0|||
16967480|NCT00995709|38110901|FG002|Overall Study|Lost to Follow-up|0|||
16967481|NCT00995709|38110899|FG000|Overall Study|Death|0|||
16967482|NCT00995709|38110900|FG001|Overall Study|Death|1|||
16967483|NCT00995709|38110901|FG002|Overall Study|Death|0|||
16967484|NCT00995709|38110899|FG000|Overall Study|Protocol Violation|2|||
16967485|NCT00995709|38110900|FG001|Overall Study|Protocol Violation|1|||
16967486|NCT00995709|38110901|FG002|Overall Study|Protocol Violation|0|||
16967487|NCT00998985|38110923|FG000|Overall Study|Withdrawal by Subject|0|||
16967488|NCT00998985|38110924|FG001|Overall Study|Withdrawal by Subject|0|||
16967489|NCT00998985|38110925|FG002|Overall Study|Withdrawal by Subject|0|||
16967490|NCT00998985|38110926|FG003|Overall Study|Withdrawal by Subject|0|||
16967491|NCT00998985|38110927|FG004|Overall Study|Withdrawal by Subject|0|||
16967492|NCT00998985|38110928|FG005|Overall Study|Withdrawal by Subject|0|||
16967493|NCT00998985|38110929|FG006|Overall Study|Withdrawal by Subject|0|||
16967494|NCT00998985|38110930|FG007|Overall Study|Withdrawal by Subject|0|||
16868007|NCT01536145|37841038|FG005|Overall Study|Progressive disease|2|||
16868008|NCT01536145|37841039|FG006|Overall Study|Progressive disease|1|||
16967495|NCT00998985|38110931|FG008|Overall Study|Withdrawal by Subject|1|||
16967496|NCT00998985|38110932|FG009|Overall Study|Withdrawal by Subject|0|||
16967497|NCT00998985|38110933|FG010|Overall Study|Withdrawal by Subject|0|||
16967498|NCT00998985|38110934|FG011|Overall Study|Withdrawal by Subject|0|||
16967499|NCT00998985|38110935|FG012|Overall Study|Withdrawal by Subject|0|||
16967500|NCT00998985|38110936|FG013|Overall Study|Withdrawal by Subject|0|||
16967501|NCT00998985|38110923|FG000|Overall Study|Protocol Violation|0|||
16967502|NCT00998985|38110924|FG001|Overall Study|Protocol Violation|0|||
16967503|NCT00998985|38110925|FG002|Overall Study|Protocol Violation|0|||
16967504|NCT00998985|38110926|FG003|Overall Study|Protocol Violation|0|||
16967505|NCT00998985|38110927|FG004|Overall Study|Protocol Violation|0|||
16967506|NCT00998985|38110928|FG005|Overall Study|Protocol Violation|1|||
16967507|NCT00998985|38110929|FG006|Overall Study|Protocol Violation|0|||
16967508|NCT00998985|38110930|FG007|Overall Study|Protocol Violation|0|||
16967509|NCT00998985|38110931|FG008|Overall Study|Protocol Violation|0|||
16967510|NCT00998985|38110932|FG009|Overall Study|Protocol Violation|0|||
16967511|NCT00998985|38110933|FG010|Overall Study|Protocol Violation|0|||
16967512|NCT00998985|38110934|FG011|Overall Study|Protocol Violation|0|||
16967513|NCT00998985|38110935|FG012|Overall Study|Protocol Violation|0|||
16967514|NCT00998985|38110936|FG013|Overall Study|Protocol Violation|0|||
16967515|NCT00995553|38110983|FG000|Overall Study|Withdrawal by Subject|2|||
16967516|NCT00995553|38110984|FG001|Overall Study|Withdrawal by Subject|6|||
16967517|NCT00991887|38110992|FG000|Overall Study|Lost to Follow-up|2|||
16967518|NCT00991887|38110993|FG001|Overall Study|Lost to Follow-up|1|||
16967519|NCT01002339|38111002|FG000|Overall Study|Withdrawal by Subject|0|||
16967520|NCT01002339|38111003|FG001|Overall Study|Withdrawal by Subject|1|||
16967521|NCT01002339|38111004|FG002|Overall Study|Withdrawal by Subject|0|||
16967522|NCT01002339|38111002|FG000|Overall Study|Incorrect treatment assignment|0|||
16967523|NCT01002339|38111003|FG001|Overall Study|Incorrect treatment assignment|0|||
16967524|NCT01002339|38111004|FG002|Overall Study|Incorrect treatment assignment|1|||
16967525|NCT01002339|38111002|FG000|Overall Study|Protocol Violation|0|||
16967526|NCT01002339|38111003|FG001|Overall Study|Protocol Violation|0|||
16967527|NCT01002339|38111004|FG002|Overall Study|Protocol Violation|2|||
16967528|NCT01002339|38111002|FG000|Overall Study|Lung cancer detected before transplant|0|||
16967529|NCT01002339|38111003|FG001|Overall Study|Lung cancer detected before transplant|0|||
16967530|NCT01002339|38111004|FG002|Overall Study|Lung cancer detected before transplant|1|||
16967531|NCT01002339|38111002|FG000|Overall Study|Randomized. Not transplanted|0|||
16967532|NCT01002339|38111003|FG001|Overall Study|Randomized. Not transplanted|0|||
16967533|NCT01002339|38111004|FG002|Overall Study|Randomized. Not transplanted|1|||
16967534|NCT01002105|38111014|FG000|Overall Study|Lost to Follow-up|10|||
16967535|NCT01002105|38111015|FG001|Overall Study|Lost to Follow-up|16|||
16967536|NCT01002105|38111014|FG000|Overall Study|non compliance|5|||
16967537|NCT01002105|38111015|FG001|Overall Study|non compliance|3|||
16967538|NCT01002105|38111014|FG000|Overall Study|condition worsened|4|||
16967539|NCT01002105|38111015|FG001|Overall Study|condition worsened|2|||
16967540|NCT02605993|38111028|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
16967541|NCT02605993|38111029|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
16967542|NCT02605993|38111030|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
16967543|NCT02605993|38111031|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
16967544|NCT00995085|38111041|FG000|Overall Study|Withdrawal by Subject|5|||
16967545|NCT00603733|38111047|FG000|Active Phase ITT|Adverse Event|8|||
16967546|NCT00603733|38111048|FG001|Active Phase ITT|Adverse Event|7|||
16967547|NCT00603733|38111047|FG000|Active Phase ITT|Withdrawal by Subject|0|||
16967548|NCT00603733|38111048|FG001|Active Phase ITT|Withdrawal by Subject|3|||
16967549|NCT00603733|38111047|FG000|Active Phase ITT|Lost to Follow-up|0|||
16967550|NCT00603733|38111048|FG001|Active Phase ITT|Lost to Follow-up|1|||
16967551|NCT00603733|38111047|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
16868009|NCT01536145|37841040|FG007|Overall Study|Progressive disease|2|||
16967552|NCT00603733|38111048|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
16967553|NCT00603733|38111047|FG000|Active Phase ITT|Lack of Efficacy|1|||
16967554|NCT00603733|38111048|FG001|Active Phase ITT|Lack of Efficacy|2|||
16967555|NCT00603733|38111047|FG000|Active Phase ITT|Subject moved, site closed|1|||
16967556|NCT00603733|38111048|FG001|Active Phase ITT|Subject moved, site closed|1|||
16967557|NCT00603733|38111047|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
16967558|NCT00603733|38111048|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
16967559|NCT00603733|38111047|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
16967560|NCT00603733|38111048|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
16967561|NCT00603733|38111047|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
16967562|NCT00603733|38111048|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
16967563|NCT00603733|38111047|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
16967564|NCT00603733|38111048|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
16967565|NCT00603733|38111047|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
16967566|NCT00603733|38111048|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
16967567|NCT00603733|38111047|FG000|Maintenance Phase ITT|Adverse Event|3|||
16967568|NCT00603733|38111048|FG001|Maintenance Phase ITT|Adverse Event|6|||
16967569|NCT00603733|38111047|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
16967570|NCT00603733|38111048|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
16967571|NCT00603733|38111047|FG000|Maintenance Phase ITT|Protocol Violation|1|||
16967572|NCT00603733|38111048|FG001|Maintenance Phase ITT|Protocol Violation|1|||
16967573|NCT00603733|38111047|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
16967574|NCT00603733|38111048|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
16967575|NCT00603733|38111047|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
16967576|NCT00603733|38111048|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
16967577|NCT00603733|38111047|FG000|Maintenance Phase ITT|Physician Decision|0|||
16967578|NCT00603733|38111048|FG001|Maintenance Phase ITT|Physician Decision|1|||
16967579|NCT00603733|38111047|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
16967580|NCT00603733|38111048|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
16967581|NCT04631107|38111054|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
16967582|NCT04631107|38111054|FG000|Second Intervention (1 Night)|Adverse Event|1|||
16967583|NCT04631107|38111054|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
16967584|NCT04631107|38111054|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
16967585|NCT00995007|38111064|FG000|Overall Study|Withdrew consent|1|||
16967586|NCT00995007|38111065|FG001|Overall Study|Withdrew consent|0|||
16967587|NCT00995007|38111064|FG000|Overall Study|Refused further treatment|8|||
16967588|NCT00995007|38111065|FG001|Overall Study|Refused further treatment|2|||
16967589|NCT00995007|38111064|FG000|Overall Study|Toxicity|8|||
16967590|NCT00995007|38111065|FG001|Overall Study|Toxicity|0|||
16967591|NCT00994461|38111083|FG000|Overall Study|Adverse Event|2|||
16967592|NCT00994461|38111084|FG001|Overall Study|Adverse Event|1|||
16967593|NCT00994461|38111085|FG002|Overall Study|Adverse Event|0|||
16967594|NCT00993915|38111093|FG000|Overall Study|Insufficient clinical response|3|||
16967595|NCT00993915|38111093|FG000|Overall Study|Withdrawal by Subject|2|||
16967596|NCT00993915|38111093|FG000|Overall Study|Other|1|||
16967597|NCT00993915|38111093|FG000|Overall Study|Ongoing|3|||
16967598|NCT01202591|38111103|FG000|Overall Study|Adverse Event|2|||
16967599|NCT01202591|38111104|FG001|Overall Study|Adverse Event|1|||
16967600|NCT01202591|38111105|FG002|Overall Study|Adverse Event|4|||
16967601|NCT01202591|38111106|FG003|Overall Study|Adverse Event|4|||
16967602|NCT01202591|38111107|FG004|Overall Study|Adverse Event|0|||
16967603|NCT01202591|38111108|FG005|Overall Study|Adverse Event|0|||
16967604|NCT01202591|38111103|FG000|Overall Study|Other reason as per investigator|3|||
16967605|NCT01202591|38111104|FG001|Overall Study|Other reason as per investigator|4|||
16967606|NCT01202591|38111105|FG002|Overall Study|Other reason as per investigator|7|||
16967607|NCT01202591|38111106|FG003|Overall Study|Other reason as per investigator|3|||
16967608|NCT01202591|38111107|FG004|Overall Study|Other reason as per investigator|1|||
16967609|NCT01202591|38111108|FG005|Overall Study|Other reason as per investigator|3|||
16967610|NCT01202591|38111103|FG000|Overall Study|Withdrawal by Subject|0|||
16967611|NCT01202591|38111104|FG001|Overall Study|Withdrawal by Subject|0|||
16967612|NCT01202591|38111105|FG002|Overall Study|Withdrawal by Subject|0|||
16967613|NCT01202591|38111106|FG003|Overall Study|Withdrawal by Subject|0|||
16967614|NCT01202591|38111107|FG004|Overall Study|Withdrawal by Subject|2|||
16967615|NCT01202591|38111108|FG005|Overall Study|Withdrawal by Subject|1|||
16967616|NCT01202591|38111103|FG000|Overall Study|Objective Disease Progression|0|||
16967617|NCT01202591|38111104|FG001|Overall Study|Objective Disease Progression|0|||
16967618|NCT01202591|38111105|FG002|Overall Study|Objective Disease Progression|0|||
16967619|NCT01202591|38111106|FG003|Overall Study|Objective Disease Progression|0|||
16967620|NCT01202591|38111107|FG004|Overall Study|Objective Disease Progression|2|||
16967621|NCT01202591|38111108|FG005|Overall Study|Objective Disease Progression|0|||
16967622|NCT01202279|38111124|FG000|Overall Study|Adverse Event|8|||
16967623|NCT01202279|38111125|FG001|Overall Study|Adverse Event|6|||
16967624|NCT01202279|38111124|FG000|Overall Study|Withdrawal by Subject|13|||
16967625|NCT01202279|38111125|FG001|Overall Study|Withdrawal by Subject|10|||
16967626|NCT01202279|38111124|FG000|Overall Study|Physician Decision|0|||
16967627|NCT01202279|38111125|FG001|Overall Study|Physician Decision|1|||
16967628|NCT01202279|38111124|FG000|Overall Study|Lost to Follow-up|10|||
16967629|NCT01202279|38111125|FG001|Overall Study|Lost to Follow-up|7|||
16967630|NCT01202279|38111124|FG000|Overall Study|Protocol Violation|1|||
16967631|NCT01202279|38111125|FG001|Overall Study|Protocol Violation|1|||
16967632|NCT01202279|38111124|FG000|Overall Study|study compliance|5|||
16967633|NCT01202279|38111125|FG001|Overall Study|study compliance|2|||
16967634|NCT01201967|38111133|FG000|Overall Study|Lost to Follow-up|6|||
16967635|NCT01201967|38111134|FG001|Overall Study|Lost to Follow-up|5|||
16967636|NCT01201811|38111150|FG000|Overall Study|Adverse Event|6|||
16967637|NCT01201811|38111150|FG000|Overall Study|Disease progression|3|||
16967638|NCT01201811|38111150|FG000|Overall Study|Withdrawal by Subject|3|||
16967639|NCT01201811|38111150|FG000|Overall Study|Death|4|||
16967640|NCT01201811|38111150|FG000|Overall Study|Treatment Failure|2|||
16967641|NCT01201811|38111150|FG000|Overall Study|Physician Decision|1|||
16967642|NCT01201343|38111154|FG000|Overall Study|Adverse Event|6|||
16967643|NCT01201343|38111154|FG000|Overall Study|Withdrawal by Subject|5|||
16967644|NCT01201343|38111154|FG000|Overall Study|Lost to Follow-up|2|||
16967645|NCT01201343|38111154|FG000|Overall Study|Lack of Efficacy|2|||
16967646|NCT01201343|38111154|FG000|Overall Study|Participant wrongly included in trial|1|||
16967647|NCT01201343|38111154|FG000|Overall Study|Randomized, not treated|3|||
16967648|NCT01201265|38111158|FG000|Overall Study|Death|14|||
16967649|NCT01201265|38111158|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16967650|NCT01201265|38111158|FG000|Overall Study|Lost to Follow-up|10|||
16967651|NCT01201265|38111158|FG000|Overall Study|Withdrawal by Subject|7|||
16967652|NCT01201265|38111158|FG000|Overall Study|Disease Progression|4|||
16967653|NCT04246801|38111164|FG000|Overall Study|Adverse Event|1|||
16967654|NCT04246801|38111165|FG001|Overall Study|Adverse Event|1|||
16967655|NCT04246801|38111164|FG000|Overall Study|Protocol Violation|1|||
16967656|NCT04246801|38111165|FG001|Overall Study|Protocol Violation|1|||
16967657|NCT04246801|38111164|FG000|Overall Study|Lack of Efficacy|0|||
16967658|NCT04246801|38111165|FG001|Overall Study|Lack of Efficacy|2|||
16967659|NCT04246801|38111164|FG000|Overall Study|Lost to Follow-up|1|||
16967660|NCT04246801|38111165|FG001|Overall Study|Lost to Follow-up|1|||
16967661|NCT04246801|38111164|FG000|Overall Study|Withdrawal by Subject|2|||
16967662|NCT04246801|38111165|FG001|Overall Study|Withdrawal by Subject|1|||
16967663|NCT01200797|38111171|FG000|Overall Study|symptomatic deterioration|2|||
16967664|NCT01200797|38111171|FG000|Overall Study|Adverse Event|4|||
16967665|NCT01200797|38111171|FG000|Overall Study|Disease Progression|13|||
16967666|NCT01200485|38111176|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
16967667|NCT01200485|38111177|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
16967668|NCT01200485|38111178|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
16967669|NCT01200485|38111176|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
16967670|NCT01200485|38111177|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
16967671|NCT01200485|38111178|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
16967672|NCT01200407|38111185|FG000|Overall Study|Lost to Follow-up|56|||
16967673|NCT01200407|38111185|FG000|Overall Study|Adverse Event|3|||
16967674|NCT01200407|38111185|FG000|Overall Study|Withdrawal by Subject|4|||
16967675|NCT01200407|38111185|FG000|Overall Study|Other|19|||
16967676|NCT01200329|38111189|FG000|Overall Study|Lack of financial coverage|2|||
16967677|NCT01200329|38111189|FG000|Overall Study|Progressive disease|1|||
16967678|NCT01199939|38111193|FG000|Overall Study|Adverse Event|4|||
16967679|NCT01199939|38111193|FG000|Overall Study|Protocol Violation|3|||
16967680|NCT01199939|38111193|FG000|Overall Study|Lost to Follow-up|2|||
16967681|NCT01199939|38111193|FG000|Overall Study|Reached a virologic endpoint|4|||
16967682|NCT01199861|38111199|FG000|Overall Study|Administrative problems|1|||
16967683|NCT01199861|38111200|FG001|Overall Study|Administrative problems|0|||
16967684|NCT01199861|38111199|FG000|Overall Study|Adverse Event|1|||
16967685|NCT01199861|38111200|FG001|Overall Study|Adverse Event|0|||
16967686|NCT01199705|38111220|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
16967687|NCT01199471|38111235|FG000|Overall Study|Protocol Violation|4|||
16967688|NCT01199471|38111235|FG000|Overall Study|Withdrawal by Subject|1|||
16967689|NCT01199471|38111235|FG000|Overall Study|Physician Decision|1|||
16967690|NCT01198145|38111242|FG000|Overall Study|Withdrawal by Subject|1|||
16967691|NCT01198145|38111243|FG001|Overall Study|Withdrawal by Subject|1|||
16967692|NCT01197911|38111253|FG000|Overall Study|Adverse Event|0|||
16967693|NCT01197911|38111254|FG001|Overall Study|Adverse Event|0|||
16967694|NCT01197911|38111255|FG002|Overall Study|Adverse Event|1|||
16967695|NCT01197755|38111267|FG000|Overall Study|Adverse Event|8|||
16967696|NCT01197755|38111268|FG001|Overall Study|Adverse Event|10|||
16967697|NCT01197755|38111269|FG002|Overall Study|Adverse Event|10|||
16967698|NCT01197755|38111267|FG000|Overall Study|Study-specific discontinuation criteria|2|||
16967699|NCT01197755|38111268|FG001|Overall Study|Study-specific discontinuation criteria|1|||
16967700|NCT01197755|38111269|FG002|Overall Study|Study-specific discontinuation criteria|0|||
16967701|NCT01197755|38111267|FG000|Overall Study|Entered the long-term extension study|18|||
16967702|NCT01197755|38111268|FG001|Overall Study|Entered the long-term extension study|21|||
16967703|NCT01197755|38111269|FG002|Overall Study|Entered the long-term extension study|35|||
16967704|NCT01197755|38111267|FG000|Overall Study|Lack of therapeutic response|0|||
16967705|NCT01197755|38111268|FG001|Overall Study|Lack of therapeutic response|7|||
16967706|NCT01197755|38111269|FG002|Overall Study|Lack of therapeutic response|4|||
16967707|NCT01197755|38111267|FG000|Overall Study|Severe non-compliance to the protocol|2|||
16967708|NCT01197755|38111268|FG001|Overall Study|Severe non-compliance to the protocol|1|||
16967709|NCT01197755|38111269|FG002|Overall Study|Severe non-compliance to the protocol|2|||
16967710|NCT01197755|38111267|FG000|Overall Study|Withdrawal by Subject|1|||
16967711|NCT01197755|38111268|FG001|Overall Study|Withdrawal by Subject|0|||
16967712|NCT01197755|38111269|FG002|Overall Study|Withdrawal by Subject|0|||
16967713|NCT01197755|38111267|FG000|Overall Study|Lost to Follow-up|0|||
16967714|NCT01197755|38111268|FG001|Overall Study|Lost to Follow-up|0|||
16967715|NCT01197755|38111269|FG002|Overall Study|Lost to Follow-up|1|||
16967716|NCT01197755|38111267|FG000|Overall Study|eg, change in circumstances|7|||
16967717|NCT01197755|38111268|FG001|Overall Study|eg, change in circumstances|3|||
16967718|NCT01197755|38111269|FG002|Overall Study|eg, change in circumstances|2|||
16967719|NCT01179048|38111281|FG000|Overall Study|Withdrawn - does not allow contact|4|||
16967720|NCT01179048|38111282|FG001|Overall Study|Withdrawn - does not allow contact|8|||
16967721|NCT01179048|38111281|FG000|Overall Study|Lost to Follow-up|8|||
16967722|NCT01179048|38111282|FG001|Overall Study|Lost to Follow-up|9|||
16967723|NCT01179048|38111281|FG000|Overall Study|Alive|127|||
16967724|NCT01179048|38111282|FG001|Overall Study|Alive|142|||
16967725|NCT00603265|38111291|FG000|Overall Study|Adverse Event|2|||
16967726|NCT00603265|38111292|FG001|Overall Study|Adverse Event|11|||
16967727|NCT00603265|38111293|FG002|Overall Study|Adverse Event|1|||
16967728|NCT00603265|38111291|FG000|Overall Study|Withdrawal by Subject|1|||
16967729|NCT00603265|38111292|FG001|Overall Study|Withdrawal by Subject|2|||
16967730|NCT00603265|38111293|FG002|Overall Study|Withdrawal by Subject|1|||
16967731|NCT00603265|38111291|FG000|Overall Study|Lack of Efficacy|3|||
16967732|NCT00603265|38111292|FG001|Overall Study|Lack of Efficacy|0|||
16967733|NCT00603265|38111293|FG002|Overall Study|Lack of Efficacy|3|||
16967734|NCT00603265|38111291|FG000|Overall Study|Lost to Follow-up|0|||
16967735|NCT00603265|38111292|FG001|Overall Study|Lost to Follow-up|1|||
16967736|NCT00603265|38111293|FG002|Overall Study|Lost to Follow-up|0|||
16967737|NCT00603265|38111291|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
16967738|NCT00603265|38111292|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
16967739|NCT00603265|38111293|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
16967740|NCT00603265|38111291|FG000|Overall Study|Participant Left Country, No Responses|0|||
16967741|NCT00603265|38111292|FG001|Overall Study|Participant Left Country, No Responses|1|||
16967742|NCT00603265|38111293|FG002|Overall Study|Participant Left Country, No Responses|0|||
16967743|NCT00603265|38111291|FG000|Overall Study|Protocol Violation|1|||
16967744|NCT00603265|38111292|FG001|Overall Study|Protocol Violation|0|||
16967745|NCT00603265|38111293|FG002|Overall Study|Protocol Violation|0|||
16967746|NCT04010227|38111303|FG000|Overall Study|Death|1|||
16967747|NCT04010227|38111304|FG001|Overall Study|Death|2|||
16967748|NCT04010227|38111303|FG000|Overall Study|Medical Reasons|4|||
16967749|NCT04010227|38111304|FG001|Overall Study|Medical Reasons|3|||
16967750|NCT04010227|38111303|FG000|Overall Study|Withdrawal by Subject|2|||
16967751|NCT04010227|38111304|FG001|Overall Study|Withdrawal by Subject|0|||
16967752|NCT04010227|38111303|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
16967753|NCT04010227|38111304|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
16967754|NCT01158534|38111311|FG000|Overall Study|Withdrawal by Subject|1|||
16967755|NCT01158534|38111311|FG000|Overall Study|Death|1|||
16967756|NCT01158534|38111311|FG000|Overall Study|Other|1|||
16967757|NCT01158378|38111317|FG000|Overall Study|Death|4|||
16967758|NCT01158378|38111318|FG001|Overall Study|Death|5|||
16967759|NCT01158378|38111317|FG000|Overall Study|Lost to Follow-up|2|||
16967760|NCT01158378|38111318|FG001|Overall Study|Lost to Follow-up|4|||
16967761|NCT01158378|38111317|FG000|Overall Study|Withdrawal by Subject|4|||
16967762|NCT01158378|38111318|FG001|Overall Study|Withdrawal by Subject|0|||
16967763|NCT00602797|38111325|FG000|Overall Study|Adverse Event|1|||
16967764|NCT01158222|38111330|FG000|Overall Study|Not eligible for intermediate phase|17|||
16967765|NCT01197521|38111337|FG000|Overall Study|Not reported|24|||
16967766|NCT01197521|38111338|FG001|Overall Study|Not reported|25|||
16967767|NCT01197521|38111339|FG002|Overall Study|Not reported|21|||
16967768|NCT01197521|38111337|FG000|Overall Study|Enrolment in long term extension|42|||
16967769|NCT01197521|38111338|FG001|Overall Study|Enrolment in long term extension|36|||
16967770|NCT01197521|38111339|FG002|Overall Study|Enrolment in long term extension|87|||
16967771|NCT01197521|38111337|FG000|Overall Study|Severe non-compliance to protocol|1|||
16967772|NCT01197521|38111338|FG001|Overall Study|Severe non-compliance to protocol|3|||
16967773|NCT01197521|38111339|FG002|Overall Study|Severe non-compliance to protocol|3|||
16967774|NCT01197521|38111337|FG000|Overall Study|Lack of therapeutic response|2|||
16967775|NCT01197521|38111338|FG001|Overall Study|Lack of therapeutic response|3|||
16967776|NCT01197521|38111339|FG002|Overall Study|Lack of therapeutic response|4|||
16967777|NCT01197521|38111337|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
16967778|NCT01197521|38111338|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
16967779|NCT01197521|38111339|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
16967780|NCT01197521|38111337|FG000|Overall Study|Lost to Follow-up|3|||
16967781|NCT01197521|38111338|FG001|Overall Study|Lost to Follow-up|2|||
16967782|NCT01197521|38111339|FG002|Overall Study|Lost to Follow-up|2|||
16967783|NCT01197521|38111337|FG000|Overall Study|Adverse Event|25|||
16967784|NCT01197521|38111338|FG001|Overall Study|Adverse Event|28|||
16967785|NCT01197521|38111339|FG002|Overall Study|Adverse Event|24|||
16967786|NCT01157676|38111352|FG000|Randomization|Death|1|||
16967787|NCT01157676|38111353|FG001|Randomization|Death|1|||
16967788|NCT01157676|38111352|FG000|Randomization|unresectable|2|||
16967789|NCT01157676|38111353|FG001|Randomization|unresectable|3|||
16967790|NCT01157676|38111352|FG000|Randomization|Withdrawal by Subject|17|||
16967791|NCT01157676|38111353|FG001|Randomization|Withdrawal by Subject|13|||
16967792|NCT01157676|38111352|FG000|Randomization|Physician Decision|1|||
16967793|NCT01157676|38111353|FG001|Randomization|Physician Decision|0|||
16967794|NCT01157676|38111352|FG000|Surgery|underwent open cystectomy|0|||
16967795|NCT01157676|38111353|FG001|Surgery|underwent open cystectomy|4|||
16967796|NCT01157676|38111352|FG000|Surgery|converted to open procedure|0|||
16967797|NCT01157676|38111353|FG001|Surgery|converted to open procedure|5|||
16967798|NCT01157676|38111352|FG000|Surgery|underwent robotic cystectomy|1|||
16967799|NCT01157676|38111353|FG001|Surgery|underwent robotic cystectomy|0|||
16967800|NCT00991341|38111367|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
16967801|NCT00991341|38111368|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
16967802|NCT00991341|38111367|FG000|Overall Study|Death|3|||
16967803|NCT00991341|38111368|FG001|Overall Study|Death|0|||
16967804|NCT00991341|38111367|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
16967805|NCT00991341|38111368|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
16967806|NCT00991341|38111367|FG000|Overall Study|Physician Decision|1|||
16967807|NCT00991341|38111368|FG001|Overall Study|Physician Decision|2|||
16997755|NCT00962390|38141772|FG001|Overall Study|Lost to Follow-up|2|||
16967808|NCT00991341|38111367|FG000|Overall Study|Withdrawal by Subject|3|||
16967809|NCT00991341|38111368|FG001|Overall Study|Withdrawal by Subject|4|||
16967810|NCT00990249|38111374|FG000|Overall Study|Disease Progression|8|||
16967811|NCT00990249|38111374|FG000|Overall Study|Non-Compliance|1|||
16967812|NCT00990249|38111374|FG000|Overall Study|Death|2|||
16967813|NCT00990249|38111374|FG000|Overall Study|Not treated|2|||
16967814|NCT02846545|38111380|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
16967815|NCT02846545|38111381|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
16967816|NCT02846545|38111380|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
16967817|NCT02846545|38111381|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
16967818|NCT02846545|38111380|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
16967819|NCT02846545|38111381|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
16967820|NCT02846545|38111380|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
16967821|NCT02846545|38111381|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
16997756|NCT00962390|38141773|FG002|Overall Study|Lost to Follow-up|0|||
16967822|NCT02846545|38111380|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
16967823|NCT02846545|38111381|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
16967824|NCT00990093|38111391|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
16967825|NCT00990093|38111392|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
16967826|NCT00990093|38111391|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
16967827|NCT00990093|38111392|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
16967828|NCT00990093|38111391|FG000|Test Period 1 (1-14 Days)|Other|1|||
16967829|NCT00990093|38111392|FG001|Test Period 1 (1-14 Days)|Other|0|||
16967830|NCT00990093|38111391|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
16967831|NCT00990093|38111392|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
16967832|NCT00990093|38111391|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
16967833|NCT00990093|38111392|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
16967834|NCT00990093|38111391|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
16967835|NCT00990093|38111392|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
16967836|NCT00990093|38111391|FG000|Test Period 2 (15-28 Days)|Other|0|||
16967837|NCT00990093|38111392|FG001|Test Period 2 (15-28 Days)|Other|1|||
16967838|NCT00984165|38111402|FG000|Overall Study|Death on study|2|||
16967839|NCT00984165|38111403|FG001|Overall Study|Death on study|0|||
16967840|NCT00984165|38111404|FG002|Overall Study|Death on study|0|||
16967841|NCT00984165|38111405|FG003|Overall Study|Death on study|0|||
16967842|NCT00984165|38111402|FG000|Overall Study|Disease progression on study|5|||
16967843|NCT00984165|38111403|FG001|Overall Study|Disease progression on study|1|||
16967844|NCT00984165|38111404|FG002|Overall Study|Disease progression on study|0|||
16967845|NCT00984165|38111405|FG003|Overall Study|Disease progression on study|0|||
16967846|NCT00984165|38111402|FG000|Overall Study|Death of recipient|0|||
16967847|NCT00984165|38111403|FG001|Overall Study|Death of recipient|0|||
16967848|NCT00984165|38111404|FG002|Overall Study|Death of recipient|0|||
16967849|NCT00984165|38111405|FG003|Overall Study|Death of recipient|1|||
16967850|NCT00984165|38111402|FG000|Overall Study|New protocol|0|||
16967851|NCT00984165|38111403|FG001|Overall Study|New protocol|0|||
16967852|NCT00984165|38111404|FG002|Overall Study|New protocol|0|||
16967853|NCT00984165|38111405|FG003|Overall Study|New protocol|1|||
16967854|NCT00984165|38111402|FG000|Overall Study|P+/donor pair removed from protocol|0|||
16967855|NCT00984165|38111403|FG001|Overall Study|P+/donor pair removed from protocol|0|||
16967856|NCT00984165|38111404|FG002|Overall Study|P+/donor pair removed from protocol|0|||
16967857|NCT00984165|38111405|FG003|Overall Study|P+/donor pair removed from protocol|1|||
16967858|NCT00984165|38111402|FG000|Overall Study|removed with a pair recipient|0|||
16967859|NCT00984165|38111403|FG001|Overall Study|removed with a pair recipient|0|||
16967860|NCT00984165|38111404|FG002|Overall Study|removed with a pair recipient|0|||
16967861|NCT00984165|38111405|FG003|Overall Study|removed with a pair recipient|1|||
16967862|NCT00993291|38111416|FG000|Overall Study|Withdrawal by Subject|1|||
16967863|NCT01196975|38111425|FG000|Overall Study|Adverse Event|2|||
16967864|NCT01196975|38111426|FG001|Overall Study|Adverse Event|2|||
16967865|NCT01196975|38111427|FG002|Overall Study|Adverse Event|0|||
16967866|NCT01196975|38111428|FG003|Overall Study|Adverse Event|0|||
16967867|NCT01196975|38111429|FG004|Overall Study|Adverse Event|2|||
16967868|NCT01196975|38111425|FG000|Overall Study|Withdrawal by Subject|2|||
16967869|NCT01196975|38111426|FG001|Overall Study|Withdrawal by Subject|1|||
16967870|NCT01196975|38111427|FG002|Overall Study|Withdrawal by Subject|0|||
16780035|NCT02155660|37719123|FG001|Overall Study|Other Reason|6|||
16967871|NCT01196975|38111428|FG003|Overall Study|Withdrawal by Subject|1|||
16967872|NCT01196975|38111429|FG004|Overall Study|Withdrawal by Subject|0|||
16967873|NCT01196975|38111425|FG000|Overall Study|Lost to Follow-up|11|||
16967874|NCT01196975|38111426|FG001|Overall Study|Lost to Follow-up|6|||
17133976|NCT00047879|38275235|FG000|Overall Study|Progressive disease|4|||
16967875|NCT01196975|38111427|FG002|Overall Study|Lost to Follow-up|5|||
16967876|NCT01196975|38111428|FG003|Overall Study|Lost to Follow-up|5|||
16967877|NCT01196975|38111429|FG004|Overall Study|Lost to Follow-up|11|||
16967878|NCT00992589|38111464|FG000|Open-Label Phase|Adverse Event|4|||
16967879|NCT00992589|38111465|FG001|Open-Label Phase|Adverse Event|0|||
16967880|NCT00992589|38111466|FG002|Open-Label Phase|Adverse Event|0|||
16780036|NCT02155660|37719124|FG002|Overall Study|Other Reason|10|||
16780037|NCT02155660|37719125|FG003|Overall Study|Other Reason|10|||
16780038|NCT02155660|37719122|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16780039|NCT02155660|37719123|FG001|Overall Study|Study-specific withdrawal criteria|1|||
16780040|NCT02155660|37719124|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16780041|NCT02155660|37719125|FG003|Overall Study|Study-specific withdrawal criteria|1|||
16967881|NCT00992589|38111467|FG003|Open-Label Phase|Adverse Event|0|||
16967882|NCT00992589|38111464|FG000|Open-Label Phase|Withdrawal by Subject|20|||
16967883|NCT00992589|38111465|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16967884|NCT00992589|38111466|FG002|Open-Label Phase|Withdrawal by Subject|0|||
16967885|NCT00992589|38111467|FG003|Open-Label Phase|Withdrawal by Subject|0|||
16967886|NCT00992589|38111464|FG000|Open-Label Phase|Lost to Follow-up|1|||
16967887|NCT00992589|38111465|FG001|Open-Label Phase|Lost to Follow-up|0|||
16967888|NCT00992589|38111466|FG002|Open-Label Phase|Lost to Follow-up|0|||
16780042|NCT02155660|37719122|FG000|Overall Study|Severe non-compliance|0|||
16780043|NCT02155660|37719123|FG001|Overall Study|Severe non-compliance|4|||
16780044|NCT02155660|37719124|FG002|Overall Study|Severe non-compliance|0|||
16780045|NCT02155660|37719125|FG003|Overall Study|Severe non-compliance|1|||
16780046|NCT02155660|37719122|FG000|Overall Study|Adverse Event|2|||
16780047|NCT02155660|37719123|FG001|Overall Study|Adverse Event|6|||
16780048|NCT02155660|37719124|FG002|Overall Study|Adverse Event|3|||
16780049|NCT02155660|37719125|FG003|Overall Study|Adverse Event|1|||
16780050|NCT02155660|37719122|FG000|Overall Study|Lost to Follow-up|3|||
16780051|NCT02155660|37719123|FG001|Overall Study|Lost to Follow-up|6|||
16780052|NCT02155660|37719124|FG002|Overall Study|Lost to Follow-up|5|||
16967889|NCT00992589|38111467|FG003|Open-Label Phase|Lost to Follow-up|0|||
16967890|NCT00992589|38111464|FG000|Open-Label Phase|Protocol Violation|3|||
16967891|NCT00992589|38111465|FG001|Open-Label Phase|Protocol Violation|0|||
16967892|NCT00992589|38111466|FG002|Open-Label Phase|Protocol Violation|0|||
16967893|NCT00992589|38111467|FG003|Open-Label Phase|Protocol Violation|0|||
16967894|NCT00992589|38111464|FG000|Open-Label Phase|Physician Decision|4|||
16967895|NCT00992589|38111465|FG001|Open-Label Phase|Physician Decision|0|||
16967896|NCT00992589|38111466|FG002|Open-Label Phase|Physician Decision|0|||
16967897|NCT00992589|38111467|FG003|Open-Label Phase|Physician Decision|0|||
16967898|NCT00992589|38111464|FG000|Open-Label Phase|Other|45|||
16967899|NCT00992589|38111465|FG001|Open-Label Phase|Other|0|||
16967900|NCT00992589|38111466|FG002|Open-Label Phase|Other|0|||
16967901|NCT00992589|38111467|FG003|Open-Label Phase|Other|0|||
16967902|NCT00992589|38111464|FG000|Double-Blind Phase|Adverse Event|0|||
16967903|NCT00992589|38111465|FG001|Double-Blind Phase|Adverse Event|6|||
16967904|NCT00992589|38111466|FG002|Double-Blind Phase|Adverse Event|2|||
16967905|NCT00992589|38111467|FG003|Double-Blind Phase|Adverse Event|3|||
16967906|NCT00992589|38111464|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16967907|NCT00992589|38111465|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
16967908|NCT00992589|38111466|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
16967909|NCT00992589|38111467|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
16967910|NCT00992589|38111464|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16967911|NCT00992589|38111465|FG001|Double-Blind Phase|Lost to Follow-up|0|||
16967912|NCT00992589|38111466|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16967913|NCT00992589|38111467|FG003|Double-Blind Phase|Lost to Follow-up|2|||
16967914|NCT00992589|38111464|FG000|Double-Blind Phase|Other|0|||
16967915|NCT00992589|38111465|FG001|Double-Blind Phase|Other|1|||
16967916|NCT00992589|38111466|FG002|Double-Blind Phase|Other|6|||
16967917|NCT00992589|38111467|FG003|Double-Blind Phase|Other|3|||
16967918|NCT01196741|38111487|FG000|Overall Study|Disease progression|34|||
16967919|NCT01196741|38111488|FG001|Overall Study|Disease progression|14|||
16967920|NCT01196741|38111487|FG000|Overall Study|Adverse Event|10|||
16967921|NCT01196741|38111488|FG001|Overall Study|Adverse Event|6|||
16967922|NCT01196741|38111487|FG000|Overall Study|Serious Adverse Event|3|||
16967923|NCT01196741|38111488|FG001|Overall Study|Serious Adverse Event|1|||
16967924|NCT01196741|38111487|FG000|Overall Study|Dose limiting Adverse Event|2|||
16967925|NCT01196741|38111488|FG001|Overall Study|Dose limiting Adverse Event|1|||
16967926|NCT01196741|38111487|FG000|Overall Study|Withdrawal by Subject|3|||
16967927|NCT01196741|38111488|FG001|Overall Study|Withdrawal by Subject|0|||
16967928|NCT01196741|38111487|FG000|Overall Study|Other reason|3|||
16967929|NCT01196741|38111488|FG001|Overall Study|Other reason|3|||
16967930|NCT01196741|38111487|FG000|Overall Study|Other|3|||
16967931|NCT01196741|38111488|FG001|Overall Study|Other|2|||
16967932|NCT01196741|38111487|FG000|Overall Study|Protocol Violation|2|||
16967933|NCT01196741|38111488|FG001|Overall Study|Protocol Violation|1|||
16967934|NCT00983385|38111494|FG000|Observation Period|Not eligible to be dosed|20|||
16967935|NCT00983385|38111494|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
16967936|NCT00992511|38111517|FG000|Overall Study|Migrated/moved from study area|1|||
16967937|NCT00992511|38111518|FG001|Overall Study|Migrated/moved from study area|0|||
16967938|NCT00992511|38111519|FG002|Overall Study|Migrated/moved from study area|1|||
16967939|NCT00992511|38111520|FG003|Overall Study|Migrated/moved from study area|2|||
16967940|NCT00992511|38111517|FG000|Overall Study|Lost to Follow-up|1|||
16967941|NCT00992511|38111518|FG001|Overall Study|Lost to Follow-up|0|||
16967942|NCT00992511|38111519|FG002|Overall Study|Lost to Follow-up|0|||
16967943|NCT00992511|38111520|FG003|Overall Study|Lost to Follow-up|2|||
16967944|NCT00992511|38111517|FG000|Overall Study|Withdrawal by Subject|0|||
16967945|NCT00992511|38111518|FG001|Overall Study|Withdrawal by Subject|0|||
16967946|NCT00992511|38111519|FG002|Overall Study|Withdrawal by Subject|1|||
16967947|NCT00992511|38111520|FG003|Overall Study|Withdrawal by Subject|1|||
16967948|NCT01196429|38111532|FG000|Overall Study|Ineligible - inadequate pathology|1|||
16967949|NCT01196429|38111533|FG001|Overall Study|Ineligible - inadequate pathology|0|||
16967950|NCT01196429|38111532|FG000|Overall Study|Ineligible - wrong cell type|1|||
16967951|NCT01196429|38111533|FG001|Overall Study|Ineligible - wrong cell type|0|||
16967952|NCT01196429|38111532|FG000|Overall Study|Refused - Never Treated|1|||
16967953|NCT01196429|38111533|FG001|Overall Study|Refused - Never Treated|0|||
16967954|NCT01157364|38111547|FG000|Overall Study|Other Reasons|1|||
16967955|NCT01157364|38111548|FG001|Overall Study|Other Reasons|1|||
16967956|NCT01157364|38111549|FG002|Overall Study|Other Reasons|2|||
16967957|NCT01157364|38111550|FG003|Overall Study|Other Reasons|1|||
16967958|NCT01157364|38111551|FG004|Overall Study|Other Reasons|0|||
16967959|NCT01157364|38111552|FG005|Overall Study|Other Reasons|0|||
16967960|NCT01157364|38111547|FG000|Overall Study|Personal Reasons|0|||
16967961|NCT01157364|38111548|FG001|Overall Study|Personal Reasons|2|||
16967962|NCT01157364|38111549|FG002|Overall Study|Personal Reasons|0|||
16967963|NCT01157364|38111550|FG003|Overall Study|Personal Reasons|0|||
16967964|NCT01157364|38111551|FG004|Overall Study|Personal Reasons|1|||
16967965|NCT01157364|38111552|FG005|Overall Study|Personal Reasons|1|||
16967966|NCT01157364|38111547|FG000|Overall Study|Lost to Follow-up|1|||
16967967|NCT01157364|38111548|FG001|Overall Study|Lost to Follow-up|0|||
16967968|NCT01157364|38111549|FG002|Overall Study|Lost to Follow-up|1|||
16967969|NCT01157364|38111550|FG003|Overall Study|Lost to Follow-up|0|||
16967970|NCT01157364|38111551|FG004|Overall Study|Lost to Follow-up|0|||
16967971|NCT01157364|38111552|FG005|Overall Study|Lost to Follow-up|0|||
16967972|NCT01157364|38111547|FG000|Overall Study|Lack of Efficacy|0|||
16967973|NCT01157364|38111548|FG001|Overall Study|Lack of Efficacy|0|||
16967974|NCT01157364|38111549|FG002|Overall Study|Lack of Efficacy|0|||
16967975|NCT01157364|38111550|FG003|Overall Study|Lack of Efficacy|1|||
16967976|NCT01157364|38111551|FG004|Overall Study|Lack of Efficacy|0|||
16967977|NCT01157364|38111552|FG005|Overall Study|Lack of Efficacy|0|||
16967978|NCT01157364|38111547|FG000|Overall Study|Adverse Event|0|||
16967979|NCT01157364|38111548|FG001|Overall Study|Adverse Event|1|||
16967980|NCT01157364|38111549|FG002|Overall Study|Adverse Event|1|||
16967981|NCT01157364|38111550|FG003|Overall Study|Adverse Event|0|||
16967982|NCT01157364|38111551|FG004|Overall Study|Adverse Event|1|||
16967983|NCT01157364|38111552|FG005|Overall Study|Adverse Event|0|||
16967984|NCT01195415|38111566|FG000|Overall Study|No repeat biopsy due to progression|2|||
16967985|NCT01195103|38111573|FG000|Overall Study|Withdrawal by Subject|1|||
16967986|NCT01195103|38111574|FG001|Overall Study|Withdrawal by Subject|0|||
16967987|NCT01195103|38111575|FG002|Overall Study|Withdrawal by Subject|0|||
16967988|NCT01194869|38111583|FG000|Overall Study|Disease Progression|2|||
16967989|NCT01194869|38111583|FG000|Overall Study|Toxicity|2|||
16967990|NCT01177800|38111589|FG000|Overall Study|Adverse Event|9|||
16967991|NCT01177800|38111590|FG001|Overall Study|Adverse Event|3|||
16967992|NCT01177800|38111589|FG000|Overall Study|Protocol Violation|0|||
16967993|NCT01177800|38111590|FG001|Overall Study|Protocol Violation|1|||
16967994|NCT01177800|38111589|FG000|Overall Study|Physician Decision|1|||
16967995|NCT01177800|38111590|FG001|Overall Study|Physician Decision|0|||
16967996|NCT01177800|38111589|FG000|Overall Study|Withdrawal of informed consent|0|||
16967997|NCT01177800|38111590|FG001|Overall Study|Withdrawal of informed consent|1|||
16967998|NCT01177722|38111600|FG000|Overall Study|Serious Adverse Event|0|||
16967999|NCT01177722|38111601|FG001|Overall Study|Serious Adverse Event|0|||
16968000|NCT01177722|38111602|FG002|Overall Study|Serious Adverse Event|1|||
16968001|NCT01177722|38111603|FG003|Overall Study|Serious Adverse Event|0|||
16968002|NCT01177722|38111600|FG000|Overall Study|Protocol Violation|0|||
16968003|NCT01177722|38111601|FG001|Overall Study|Protocol Violation|0|||
16968004|NCT01177722|38111602|FG002|Overall Study|Protocol Violation|1|||
16968005|NCT01177722|38111603|FG003|Overall Study|Protocol Violation|0|||
16968006|NCT01177722|38111600|FG000|Overall Study|Lost to Follow-up|3|||
16968007|NCT01177722|38111601|FG001|Overall Study|Lost to Follow-up|4|||
16968008|NCT01177722|38111602|FG002|Overall Study|Lost to Follow-up|3|||
16968009|NCT01177722|38111603|FG003|Overall Study|Lost to Follow-up|1|||
16968010|NCT01177722|38111600|FG000|Overall Study|Withdrawal by Subject|10|||
16968011|NCT01177722|38111601|FG001|Overall Study|Withdrawal by Subject|6|||
16968012|NCT01177722|38111602|FG002|Overall Study|Withdrawal by Subject|4|||
16968013|NCT01177722|38111603|FG003|Overall Study|Withdrawal by Subject|6|||
16968014|NCT01177410|38111617|FG000|Overall Study|Adverse Event|0|||
16968015|NCT01177410|38111618|FG001|Overall Study|Adverse Event|2|||
16968016|NCT01177410|38111619|FG002|Overall Study|Adverse Event|2|||
16968017|NCT01177410|38111617|FG000|Overall Study|Withdrawal by Subject|1|||
16780053|NCT02155660|37719125|FG003|Overall Study|Lost to Follow-up|8|||
16780054|NCT02155660|37719122|FG000|Overall Study|Death|17|||
16780055|NCT02155660|37719123|FG001|Overall Study|Death|19|||
16780056|NCT02155660|37719124|FG002|Overall Study|Death|17|||
16780057|NCT02155660|37719125|FG003|Overall Study|Death|19|||
16780058|NCT02155660|37719122|FG000|Overall Study|Withdrawal by Subject|28|||
16780059|NCT02155660|37719123|FG001|Overall Study|Withdrawal by Subject|31|||
16780060|NCT02155660|37719124|FG002|Overall Study|Withdrawal by Subject|24|||
16780061|NCT02155660|37719125|FG003|Overall Study|Withdrawal by Subject|21|||
16780062|NCT02119936|37719135|FG000|Overall Study|Lost to Follow-up|10|||
16780063|NCT02181634|37719139|FG000|Overall Study|Lack of Efficacy|33|||
16968018|NCT01177410|38111618|FG001|Overall Study|Withdrawal by Subject|4|||
16968019|NCT01177410|38111619|FG002|Overall Study|Withdrawal by Subject|3|||
16968020|NCT01177410|38111617|FG000|Overall Study|Lost to Follow-up|0|||
16968021|NCT01177410|38111618|FG001|Overall Study|Lost to Follow-up|1|||
16968022|NCT01177410|38111619|FG002|Overall Study|Lost to Follow-up|0|||
16968023|NCT01156116|38111629|FG000|Overall Study|Withdrawal by Subject|3|||
16968024|NCT01156116|38111630|FG001|Overall Study|Withdrawal by Subject|1|||
16968025|NCT01156116|38111629|FG000|Overall Study|CPAP intolerance|2|||
16968026|NCT01156116|38111630|FG001|Overall Study|CPAP intolerance|0|||
16968027|NCT01155726|38111636|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
16968028|NCT01155726|38111637|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
16968029|NCT01155726|38111638|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
16968030|NCT01155726|38111639|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
16968031|NCT01155570|38111661|FG000|Overall Study|Adverse Event|39|||
16780064|NCT02181634|37719139|FG000|Overall Study|Adverse Event|17|||
16968032|NCT01155570|38111661|FG000|Overall Study|Lack of Efficacy|46|||
16968033|NCT01155570|38111661|FG000|Overall Study|Participant's Economic Reasons|17|||
16968034|NCT01155570|38111661|FG000|Overall Study|No Hospital Visits|7|||
16968035|NCT01155570|38111661|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
16968036|NCT01155570|38111661|FG000|Overall Study|Adverse Event + Other Reasons|7|||
16968037|NCT01155570|38111661|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
16968038|NCT01155570|38111661|FG000|Overall Study|Other Reasons|23|||
16968039|NCT01155024|38111667|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
16968040|NCT01155024|38111668|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
16968041|NCT01155024|38111667|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
16968042|NCT01155024|38111668|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
16968043|NCT01155024|38111667|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
16968044|NCT01155024|38111668|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
16968045|NCT01176240|38111679|FG000|Study 306A|Lack of Efficacy|2|||
16968046|NCT01176240|38111680|FG001|Study 306A|Lack of Efficacy|1|||
16968047|NCT01176240|38111679|FG000|Study 306A|Protocol Violation|0|||
16968048|NCT01176240|38111680|FG001|Study 306A|Protocol Violation|1|||
16968049|NCT01176240|38111679|FG000|Study 306A|Withdrawal by Subject|0|||
16968050|NCT01176240|38111680|FG001|Study 306A|Withdrawal by Subject|1|||
16968051|NCT01176240|38111679|FG000|Study 306A|Stop due to diverse problems|1|||
16968052|NCT01176240|38111680|FG001|Study 306A|Stop due to diverse problems|0|||
16968053|NCT01176240|38111679|FG000|Study 306B|Lack of Efficacy|5|||
16968054|NCT01176240|38111680|FG001|Study 306B|Lack of Efficacy|3|||
16968055|NCT01176240|38111679|FG000|Study 306B|Adverse Event|10|||
16968056|NCT01176240|38111680|FG001|Study 306B|Adverse Event|5|||
16968057|NCT01176240|38111679|FG000|Study 306B|Protocol Violation|2|||
16968058|NCT01176240|38111680|FG001|Study 306B|Protocol Violation|3|||
16968059|NCT01176240|38111679|FG000|Study 306B|Withdrawal by Subject|4|||
16968060|NCT01176240|38111680|FG001|Study 306B|Withdrawal by Subject|1|||
16968061|NCT01176240|38111679|FG000|Study 306B|Physician Decision|2|||
16968062|NCT01176240|38111680|FG001|Study 306B|Physician Decision|1|||
16968063|NCT01176240|38111679|FG000|Study 306B|Supine Hypertension|1|||
16968064|NCT01176240|38111680|FG001|Study 306B|Supine Hypertension|2|||
16968065|NCT01176240|38111679|FG000|Study 306B|Lost to Follow-up|0|||
16968066|NCT01176240|38111680|FG001|Study 306B|Lost to Follow-up|1|||
16968067|NCT01176240|38111679|FG000|Study 306B|withdrew prior to dosing|2|||
16968068|NCT01176240|38111680|FG001|Study 306B|withdrew prior to dosing|1|||
16968069|NCT00988221|38111689|FG000|Part I|Adverse Event|0|||
16968070|NCT00988221|38111690|FG001|Part I|Adverse Event|1|||
16968071|NCT00988221|38111691|FG002|Part I|Adverse Event|2|||
16968072|NCT00988221|38111692|FG003|Part I|Adverse Event|0|||
16968073|NCT00988221|38111689|FG000|Part I|Insufficient Therapeutic Response|4|||
16968074|NCT00988221|38111690|FG001|Part I|Insufficient Therapeutic Response|6|||
16968075|NCT00988221|38111691|FG002|Part I|Insufficient Therapeutic Response|5|||
16968076|NCT00988221|38111692|FG003|Part I|Insufficient Therapeutic Response|0|||
16968077|NCT00988221|38111689|FG000|Part I|Refused Treatment|0|||
16968078|NCT00988221|38111690|FG001|Part I|Refused Treatment|2|||
16968079|NCT00988221|38111691|FG002|Part I|Refused Treatment|1|||
16968080|NCT00988221|38111692|FG003|Part I|Refused Treatment|0|||
16968081|NCT00988221|38111689|FG000|Part I|Lost to Follow-up|0|||
16968082|NCT00988221|38111690|FG001|Part I|Lost to Follow-up|1|||
16968083|NCT00988221|38111691|FG002|Part I|Lost to Follow-up|0|||
16968084|NCT00988221|38111692|FG003|Part I|Lost to Follow-up|0|||
16968085|NCT00988221|38111689|FG000|Part II|Adverse Event|1|||
16968086|NCT00988221|38111690|FG001|Part II|Adverse Event|0|||
16968087|NCT00988221|38111691|FG002|Part II|Adverse Event|0|||
16968088|NCT00988221|38111692|FG003|Part II|Adverse Event|1|||
16968089|NCT00988221|38111689|FG000|Part II|Withdrawal by Subject|0|||
16968090|NCT00988221|38111690|FG001|Part II|Withdrawal by Subject|0|||
16968091|NCT00988221|38111691|FG002|Part II|Withdrawal by Subject|2|||
16968092|NCT00988221|38111692|FG003|Part II|Withdrawal by Subject|2|||
16968093|NCT00988221|38111689|FG000|Part II|Reason not Specified|0|||
16968094|NCT00988221|38111690|FG001|Part II|Reason not Specified|0|||
16968095|NCT00988221|38111691|FG002|Part II|Reason not Specified|1|||
16968096|NCT00988221|38111692|FG003|Part II|Reason not Specified|0|||
16968097|NCT00988221|38111689|FG000|Part III|Adverse Event|1|||
16968098|NCT00988221|38111690|FG001|Part III|Adverse Event|0|||
16968099|NCT00988221|38111691|FG002|Part III|Adverse Event|1|||
16968100|NCT00988221|38111692|FG003|Part III|Adverse Event|0|||
16968101|NCT00988221|38111689|FG000|Part III|Insufficient Therapeutic Response|0|||
16968102|NCT00988221|38111690|FG001|Part III|Insufficient Therapeutic Response|1|||
16968103|NCT00988221|38111691|FG002|Part III|Insufficient Therapeutic Response|1|||
16968104|NCT00988221|38111692|FG003|Part III|Insufficient Therapeutic Response|0|||
16968105|NCT00988221|38111689|FG000|Part III|Refused Treatment|0|||
16968106|NCT00988221|38111690|FG001|Part III|Refused Treatment|0|||
16968107|NCT00988221|38111691|FG002|Part III|Refused Treatment|1|||
16968108|NCT00988221|38111692|FG003|Part III|Refused Treatment|0|||
16968109|NCT01149096|38111713|FG000|Overall Study|Lost to Follow-up|0|||
16968110|NCT01149096|38111714|FG001|Overall Study|Lost to Follow-up|1|||
16968111|NCT01175382|38111724|FG000|Overall Study|Lost to Follow-up|4|||
16968112|NCT01175382|38111725|FG001|Overall Study|Lost to Follow-up|3|||
16968113|NCT01175382|38111726|FG002|Overall Study|Lost to Follow-up|1|||
16968114|NCT01175382|38111724|FG000|Overall Study|Physician Decision|0|||
16968115|NCT01175382|38111725|FG001|Overall Study|Physician Decision|1|||
16968116|NCT01175382|38111726|FG002|Overall Study|Physician Decision|0|||
16968117|NCT01175382|38111724|FG000|Overall Study|Withdrawal by Subject|0|||
16968118|NCT01175382|38111725|FG001|Overall Study|Withdrawal by Subject|0|||
16968119|NCT01175382|38111726|FG002|Overall Study|Withdrawal by Subject|1|||
16968120|NCT01175382|38111724|FG000|Overall Study|No longer having problem|1|||
16968121|NCT01175382|38111725|FG001|Overall Study|No longer having problem|0|||
16968122|NCT01175382|38111726|FG002|Overall Study|No longer having problem|1|||
16968123|NCT01175382|38111724|FG000|Overall Study|Unable/unwilling to attend visits|3|||
16968124|NCT01175382|38111725|FG001|Overall Study|Unable/unwilling to attend visits|1|||
16968125|NCT01175382|38111726|FG002|Overall Study|Unable/unwilling to attend visits|2|||
16968126|NCT01175382|38111724|FG000|Overall Study|Unwilling to follow protocol|0|||
16968127|NCT01175382|38111725|FG001|Overall Study|Unwilling to follow protocol|1|||
16968128|NCT01175382|38111726|FG002|Overall Study|Unwilling to follow protocol|0|||
16968129|NCT01175382|38111724|FG000|Overall Study|Unable to tolerate study meds|0|||
16968130|NCT01175382|38111725|FG001|Overall Study|Unable to tolerate study meds|1|||
16968131|NCT01175382|38111726|FG002|Overall Study|Unable to tolerate study meds|1|||
16968132|NCT01194245|38111739|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
16968133|NCT01194245|38111740|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
16968134|NCT01194245|38111741|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
16968135|NCT01194245|38111742|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
16968136|NCT01194245|38111743|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
16968137|NCT01194245|38111739|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
16968138|NCT01194245|38111740|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
16968139|NCT01194245|38111741|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
16968140|NCT01194245|38111742|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
16968141|NCT01194245|38111743|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
16968142|NCT01194245|38111739|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
16968143|NCT01194245|38111740|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
16968144|NCT01194245|38111741|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
16968145|NCT01194245|38111742|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
16968146|NCT01194245|38111743|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
16968147|NCT01194245|38111739|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
16968148|NCT01194245|38111740|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
16968149|NCT01194245|38111741|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
16968150|NCT01194245|38111742|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
16968151|NCT01194245|38111743|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
16968152|NCT01194245|38111739|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16968153|NCT01194245|38111740|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16968154|NCT01194245|38111741|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16968155|NCT01194245|38111742|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16968156|NCT01194245|38111743|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
16968157|NCT01194245|38111739|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16968158|NCT01194245|38111740|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16968159|NCT01194245|38111741|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
16968160|NCT01194245|38111742|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
16968161|NCT01194245|38111743|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
16968162|NCT00979407|38111754|FG000|Overall Study|Withdrawal by Subject|3|||
16968163|NCT00979407|38111755|FG001|Overall Study|Withdrawal by Subject|4|||
16968164|NCT00979407|38111754|FG000|Overall Study|Lost to Follow-up|3|||
16968165|NCT00979407|38111755|FG001|Overall Study|Lost to Follow-up|3|||
16968166|NCT01148862|38111763|FG000|Second Intervention|Withdrawal by Subject|0|||
16968167|NCT01148862|38111764|FG001|Second Intervention|Withdrawal by Subject|2|||
16968168|NCT00975975|38111770|FG000|Overall Study|Death|6|||
16968169|NCT01193153|38111774|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
16968170|NCT01193153|38111775|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
16968171|NCT01193153|38111774|FG000|Open-label Lead in Period|Pregnancy|1|||
16968172|NCT01193153|38111775|FG001|Open-label Lead in Period|Pregnancy|0|||
16968173|NCT01193153|38111774|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
16968174|NCT01193153|38111775|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
16968175|NCT01193153|38111774|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
16968176|NCT01193153|38111775|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
16968177|NCT01193153|38111774|FG000|Open-label Lead in Period|Other|14|||
16968178|NCT01193153|38111775|FG001|Open-label Lead in Period|Other|0|||
16968179|NCT01193153|38111774|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
16968180|NCT01193153|38111775|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
16968181|NCT01193153|38111774|FG000|Open-label Lead in Period|Adverse Event|41|||
16968182|NCT01193153|38111775|FG001|Open-label Lead in Period|Adverse Event|0|||
16968183|NCT01193153|38111774|FG000|Open-label Lead in Period|Death|1|||
16968184|NCT01193153|38111775|FG001|Open-label Lead in Period|Death|0|||
16968185|NCT01193153|38111774|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
16968186|NCT01193153|38111775|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
16968187|NCT01193153|38111774|FG000|Open-label Stabilization Period|Adverse Event|9|||
16968188|NCT01193153|38111775|FG001|Open-label Stabilization Period|Adverse Event|0|||
16968189|NCT01193153|38111774|FG000|Open-label Stabilization Period|Death|2|||
16968190|NCT01193153|38111775|FG001|Open-label Stabilization Period|Death|0|||
16968191|NCT01193153|38111774|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
16968192|NCT01193153|38111775|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
16968193|NCT01193153|38111774|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
16968194|NCT01193153|38111775|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
16968195|NCT01193153|38111774|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
16968196|NCT01193153|38111775|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
16968197|NCT01193153|38111774|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
16968198|NCT01193153|38111775|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
16968199|NCT01193153|38111774|FG000|Open-label Stabilization Period|Other|8|||
16968200|NCT01193153|38111775|FG001|Open-label Stabilization Period|Other|0|||
16968201|NCT01193153|38111774|FG000|Double Blind Relapse Prevention Period|Other|2|||
16968202|NCT01193153|38111775|FG001|Double Blind Relapse Prevention Period|Other|3|||
16968203|NCT01193153|38111774|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
16968204|NCT01193153|38111775|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
16968205|NCT01193153|38111774|FG000|Double Blind Relapse Prevention Period|Death|2|||
16968206|NCT01193153|38111775|FG001|Double Blind Relapse Prevention Period|Death|0|||
16968207|NCT01193153|38111774|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
16968208|NCT01193153|38111775|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
16997757|NCT00962390|38141774|FG003|Overall Study|Lost to Follow-up|0|||
17133977|NCT00047879|38275236|FG001|Overall Study|Progressive disease|3|||
16968209|NCT01193153|38111774|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
16968210|NCT01193153|38111775|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
16968211|NCT01193153|38111774|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
16968212|NCT01193153|38111775|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
16968213|NCT01193153|38111774|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
16968214|NCT01193153|38111775|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
16968215|NCT01193153|38111774|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
16968216|NCT01193153|38111775|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
16968217|NCT01192295|38111786|FG000|Overall Study|Adverse Event|3|||
16968218|NCT01192295|38111787|FG001|Overall Study|Adverse Event|7|||
16968219|NCT01192295|38111786|FG000|Overall Study|Withdrawal by Subject|3|||
16968220|NCT01192295|38111787|FG001|Overall Study|Withdrawal by Subject|4|||
16968221|NCT01192295|38111786|FG000|Overall Study|Lost to Follow-up|0|||
16968222|NCT01192295|38111787|FG001|Overall Study|Lost to Follow-up|1|||
16968223|NCT01192295|38111786|FG000|Overall Study|Lack of Efficacy|0|||
16968224|NCT01192295|38111787|FG001|Overall Study|Lack of Efficacy|5|||
16968225|NCT01192295|38111786|FG000|Overall Study|Administrative|4|||
16968226|NCT01192295|38111787|FG001|Overall Study|Administrative|6|||
16968227|NCT01154166|38111797|FG000|Overall Study|Adverse Event|14|||
16968228|NCT01154166|38111798|FG001|Overall Study|Adverse Event|9|||
16968229|NCT01154166|38111797|FG000|Overall Study|Lost to Follow-up|1|||
16968230|NCT01154166|38111798|FG001|Overall Study|Lost to Follow-up|1|||
16968231|NCT01154166|38111797|FG000|Overall Study|Protocol Violation|4|||
16968232|NCT01154166|38111798|FG001|Overall Study|Protocol Violation|1|||
16968233|NCT01154166|38111797|FG000|Overall Study|Withdrawal by Subject|10|||
16968234|NCT01154166|38111798|FG001|Overall Study|Withdrawal by Subject|1|||
16968235|NCT01154166|38111797|FG000|Overall Study|Lack of Efficacy|3|||
16968236|NCT01154166|38111798|FG001|Overall Study|Lack of Efficacy|0|||
16968237|NCT01154166|38111797|FG000|Overall Study|Disease Progression|1|||
16968238|NCT01154166|38111798|FG001|Overall Study|Disease Progression|0|||
16968239|NCT01154166|38111797|FG000|Overall Study|Poor Compliance|1|||
16968240|NCT01154166|38111798|FG001|Overall Study|Poor Compliance|0|||
16968241|NCT01154088|38111807|FG000|Overall Study|Lost to Follow-up|4|||
16968242|NCT01154088|38111808|FG001|Overall Study|Lost to Follow-up|6|||
16968243|NCT01154088|38111809|FG002|Overall Study|Lost to Follow-up|7|||
16968244|NCT00975585|38111820|FG000|Overall Study|Adverse Event|0|||
16968245|NCT00975585|38111821|FG001|Overall Study|Adverse Event|4|||
16968246|NCT00975585|38111820|FG000|Overall Study|Lost to Follow-up|3|||
16968247|NCT00975585|38111821|FG001|Overall Study|Lost to Follow-up|5|||
16968248|NCT00975585|38111820|FG000|Overall Study|Withdrawal by Subject|2|||
16968249|NCT00975585|38111821|FG001|Overall Study|Withdrawal by Subject|1|||
16968250|NCT00975585|38111820|FG000|Overall Study|Lens issue|2|||
16968251|NCT00975585|38111821|FG001|Overall Study|Lens issue|2|||
16968252|NCT01181921|38111829|FG000|Overall Study|Lost to Follow-up|1|||
16968253|NCT01174446|38111833|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
16968254|NCT01174446|38111834|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
16968255|NCT01174446|38111835|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
16968256|NCT01174446|38111836|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
16968257|NCT01174446|38111833|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
16968258|NCT01174446|38111834|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
16968259|NCT01174446|38111835|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
16968260|NCT01174446|38111836|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
16968261|NCT01174446|38111833|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
16968262|NCT01174446|38111834|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
16968263|NCT01174446|38111835|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
16968264|NCT01174446|38111836|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
16968265|NCT01174446|38111833|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
16968266|NCT01174446|38111834|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
16968267|NCT01174446|38111835|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
16968268|NCT01174446|38111836|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
16968269|NCT00932698|38111894|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
16968270|NCT00932698|38111895|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
16968271|NCT00932698|38111896|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
16968272|NCT00932698|38111897|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
16968273|NCT00932698|38111898|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
16968274|NCT00932698|38111899|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
16968275|NCT00932698|38111900|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
16968276|NCT00932698|38111901|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
16968277|NCT00932698|38111902|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
16968278|NCT00932698|38111903|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
16968279|NCT00932698|38111904|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
16968280|NCT00932698|38111894|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16997758|NCT00962390|38141771|FG000|Overall Study|Protocol Violation|1|||
16968281|NCT00932698|38111895|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
16968282|NCT00932698|38111896|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16968283|NCT00932698|38111897|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
16968284|NCT00932698|38111898|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16968285|NCT00932698|38111899|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
16968286|NCT00932698|38111900|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
16968287|NCT00932698|38111901|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16968288|NCT00932698|38111902|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16968289|NCT00932698|38111903|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16968290|NCT00932698|38111904|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16968291|NCT00932698|38111894|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
16968292|NCT00932698|38111895|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
16968293|NCT00932698|38111896|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
16968294|NCT00932698|38111897|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
16968295|NCT00932698|38111898|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
16968296|NCT00932698|38111899|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
16968297|NCT00932698|38111900|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
16968298|NCT00932698|38111901|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
16968299|NCT00932698|38111902|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
16968300|NCT00932698|38111903|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
16968301|NCT00932698|38111904|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
16968302|NCT00932698|38111894|FG000|Part 1 (Dose Escalation)|Other|0|||
16968303|NCT00932698|38111895|FG001|Part 1 (Dose Escalation)|Other|0|||
16968304|NCT00932698|38111896|FG002|Part 1 (Dose Escalation)|Other|1|||
16968305|NCT00932698|38111897|FG003|Part 1 (Dose Escalation)|Other|0|||
16968306|NCT00932698|38111898|FG004|Part 1 (Dose Escalation)|Other|0|||
16968307|NCT00932698|38111899|FG005|Part 1 (Dose Escalation)|Other|0|||
16968308|NCT00932698|38111900|FG006|Part 1 (Dose Escalation)|Other|1|||
16968309|NCT00932698|38111901|FG007|Part 1 (Dose Escalation)|Other|0|||
16968310|NCT00932698|38111902|FG008|Part 1 (Dose Escalation)|Other|0|||
16968311|NCT00932698|38111903|FG009|Part 1 (Dose Escalation)|Other|0|||
16968312|NCT00932698|38111904|FG010|Part 1 (Dose Escalation)|Other|0|||
16968313|NCT00932698|38111894|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
16968314|NCT00932698|38111895|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
16968315|NCT00932698|38111896|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
16968316|NCT00932698|38111897|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
16968317|NCT00932698|38111898|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
16968318|NCT00932698|38111899|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
16968319|NCT00932698|38111900|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
16968320|NCT00932698|38111901|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
16968321|NCT00932698|38111902|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
16968322|NCT00932698|38111903|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
16968323|NCT00932698|38111904|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
16968324|NCT00932698|38111894|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16968325|NCT00932698|38111895|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16968326|NCT00932698|38111896|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16968327|NCT00932698|38111897|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16968328|NCT00932698|38111898|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16968329|NCT00932698|38111899|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16968330|NCT00932698|38111900|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16968331|NCT00932698|38111901|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
16968332|NCT00932698|38111902|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
16968333|NCT00932698|38111903|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
16968334|NCT00932698|38111904|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16968335|NCT00932698|38111894|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
16968336|NCT00932698|38111895|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
16968337|NCT00932698|38111896|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
16968338|NCT00932698|38111897|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
16968339|NCT00932698|38111898|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
16968340|NCT00932698|38111899|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
16968341|NCT00932698|38111900|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
16968342|NCT00932698|38111901|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
16968343|NCT00932698|38111902|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
16968344|NCT00932698|38111903|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
16968345|NCT00932698|38111904|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
16968346|NCT00978627|38111932|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
16968347|NCT00978627|38111933|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
16968348|NCT00978627|38111932|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
16968349|NCT00978627|38111933|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
16968350|NCT00978627|38111932|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
16968351|NCT00978627|38111933|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
16968352|NCT00978627|38111932|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
16968353|NCT00978627|38111933|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
16968354|NCT00978627|38111932|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
16968355|NCT00978627|38111933|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
16968356|NCT00978627|38111932|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
16968357|NCT00978627|38111933|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
16968358|NCT00978627|38111932|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
16968359|NCT00978627|38111933|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
16968360|NCT00978627|38111932|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
16968361|NCT00978627|38111933|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
16968362|NCT00978627|38111932|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
16968363|NCT00978627|38111933|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
16968364|NCT01181609|38111939|FG000|Overall Study|Adverse Event|1|||
16968365|NCT01181609|38111939|FG000|Overall Study|Withdrawal by Subject|1|||
16968366|NCT01181609|38111939|FG000|Overall Study|Lost to Follow-up|1|||
16968367|NCT01181609|38111939|FG000|Overall Study|Death|50|||
16968368|NCT01154010|38111945|FG000|Overall Study|Lost to Follow-up|0|||
16968369|NCT01154010|38111946|FG001|Overall Study|Lost to Follow-up|1|||
16968370|NCT01153698|38111952|FG000|Overall Study|Adverse Event|12|||
16968371|NCT01153698|38111952|FG000|Overall Study|Lost to Follow-up|4|||
16968372|NCT01153698|38111952|FG000|Overall Study|Withdrawal by Subject|2|||
16968373|NCT01153698|38111952|FG000|Overall Study|Switch to other anticoagulants|4|||
16968374|NCT01153698|38111952|FG000|Overall Study|Other|2|||
16968375|NCT01153698|38111952|FG000|Overall Study|Not treated with Pradaxa|5|||
16968376|NCT01174368|38111957|FG000|Overall Study|Withdrawal by Subject|1|||
16968377|NCT01147926|38111963|FG000|Overall Study|Subject Withdrew Consent|9|||
16968378|NCT01147926|38111964|FG001|Overall Study|Subject Withdrew Consent|10|||
16968379|NCT01147926|38111963|FG000|Overall Study|Adverse Event|7|||
16968380|NCT01147926|38111964|FG001|Overall Study|Adverse Event|6|||
16968381|NCT01147926|38111963|FG000|Overall Study|Subject Non-Compliant|5|||
16968382|NCT01147926|38111964|FG001|Overall Study|Subject Non-Compliant|4|||
16968383|NCT01147926|38111963|FG000|Overall Study|Principal investigator left hospital|1|||
16968384|NCT01147926|38111964|FG001|Overall Study|Principal investigator left hospital|3|||
16968385|NCT01147926|38111963|FG000|Overall Study|Selection criteria not met|3|||
16968386|NCT01147926|38111964|FG001|Overall Study|Selection criteria not met|1|||
16968387|NCT01147926|38111963|FG000|Overall Study|Lost to Follow-up|0|||
16968388|NCT01147926|38111964|FG001|Overall Study|Lost to Follow-up|2|||
16968389|NCT01147926|38111963|FG000|Overall Study|Sponsor's Decision|0|||
16968390|NCT01147926|38111964|FG001|Overall Study|Sponsor's Decision|1|||
16968391|NCT01147926|38111963|FG000|Overall Study|Lack of Efficacy|1|||
16968392|NCT01147926|38111964|FG001|Overall Study|Lack of Efficacy|0|||
16968393|NCT01147926|38111963|FG000|Overall Study|Too busy, no time for study|1|||
16968394|NCT01147926|38111964|FG001|Overall Study|Too busy, no time for study|0|||
16968395|NCT01147926|38111963|FG000|Overall Study|Went on holiday|0|||
16968396|NCT01147926|38111964|FG001|Overall Study|Went on holiday|1|||
16968397|NCT01147926|38111963|FG000|Overall Study|Colonoscopy result|0|||
16968398|NCT01147926|38111964|FG001|Overall Study|Colonoscopy result|1|||
16968399|NCT00975507|38111972|FG000|Overall Study|Adverse Event|1|||
16968400|NCT00975507|38111973|FG001|Overall Study|Adverse Event|0|||
16968401|NCT00975507|38111972|FG000|Overall Study|Lost to Follow-up|7|||
16968402|NCT00975507|38111973|FG001|Overall Study|Lost to Follow-up|1|||
16968403|NCT00975507|38111972|FG000|Overall Study|Protocol Violation|2|||
16968404|NCT00975507|38111973|FG001|Overall Study|Protocol Violation|0|||
16968405|NCT00975507|38111972|FG000|Overall Study|Withdrawal by Subject|10|||
16968406|NCT00975507|38111973|FG001|Overall Study|Withdrawal by Subject|3|||
16968407|NCT01147848|38111983|FG000|Run-in Period|Screen Failure|623|||
16968408|NCT01147848|38111984|FG001|Run-in Period|Screen Failure|0|||
16968409|NCT01147848|38111985|FG002|Run-in Period|Screen Failure|0|||
16968410|NCT01147848|38111983|FG000|Run-in Period|Run-in Failure|135|||
16968411|NCT01147848|38111984|FG001|Run-in Period|Run-in Failure|0|||
16968412|NCT01147848|38111985|FG002|Run-in Period|Run-in Failure|0|||
16968413|NCT01147848|38111983|FG000|Randomized Phase|Adverse Event|0|||
16968414|NCT01147848|38111984|FG001|Randomized Phase|Adverse Event|6|||
16968415|NCT01147848|38111985|FG002|Randomized Phase|Adverse Event|8|||
16968416|NCT01147848|38111983|FG000|Randomized Phase|Lack of Efficacy|0|||
16968417|NCT01147848|38111984|FG001|Randomized Phase|Lack of Efficacy|20|||
16968418|NCT01147848|38111985|FG002|Randomized Phase|Lack of Efficacy|11|||
16968419|NCT01147848|38111983|FG000|Randomized Phase|Protocol Violation|0|||
16968420|NCT01147848|38111984|FG001|Randomized Phase|Protocol Violation|7|||
16968421|NCT01147848|38111985|FG002|Randomized Phase|Protocol Violation|10|||
16968422|NCT01147848|38111983|FG000|Randomized Phase|Lost to Follow-up|0|||
16968423|NCT01147848|38111984|FG001|Randomized Phase|Lost to Follow-up|5|||
16968424|NCT01147848|38111985|FG002|Randomized Phase|Lost to Follow-up|7|||
16968425|NCT01147848|38111983|FG000|Randomized Phase|Physician Decision|0|||
16968426|NCT01147848|38111984|FG001|Randomized Phase|Physician Decision|0|||
16968427|NCT01147848|38111985|FG002|Randomized Phase|Physician Decision|1|||
16968428|NCT01147848|38111983|FG000|Randomized Phase|Withdrawal by Subject|0|||
16968429|NCT01147848|38111984|FG001|Randomized Phase|Withdrawal by Subject|7|||
16968430|NCT01147848|38111985|FG002|Randomized Phase|Withdrawal by Subject|9|||
16968431|NCT00929656|38111994|FG000|Overall Study|Lost to Follow-up|0|||
16968432|NCT00929656|38111995|FG001|Overall Study|Lost to Follow-up|1|||
16968433|NCT00977613|38112001|FG000|Overall Study|Lost to Follow-up|16|||
16968434|NCT01152996|38112005|FG000|Overall Study|Withdrawal by Subject|142|||
16968435|NCT01152996|38112005|FG000|Overall Study|Adverse Event|115|||
16968436|NCT01152996|38112005|FG000|Overall Study|Lost to Follow-up|112|||
16968437|NCT01152996|38112005|FG000|Overall Study|Lack of Efficacy|68|||
16968438|NCT01152996|38112005|FG000|Overall Study|Noncompliance|41|||
16968439|NCT01152996|38112005|FG000|Overall Study|Other|36|||
16968440|NCT01152996|38112005|FG000|Overall Study|Protocol Violation|22|||
16968441|NCT01152996|38112005|FG000|Overall Study|Elevated liver enzymes|1|||
16968442|NCT00979953|38112013|FG000|Overall Study|Adverse Event|5|||
16968443|NCT00979953|38112014|FG001|Overall Study|Adverse Event|2|||
16968444|NCT00979953|38112015|FG002|Overall Study|Adverse Event|17|||
16968445|NCT00979953|38112016|FG003|Overall Study|Adverse Event|4|||
16968446|NCT00979953|38112013|FG000|Overall Study|Lack of Efficacy|1|||
16968447|NCT00979953|38112014|FG001|Overall Study|Lack of Efficacy|2|||
16968448|NCT00979953|38112015|FG002|Overall Study|Lack of Efficacy|0|||
16968449|NCT00979953|38112016|FG003|Overall Study|Lack of Efficacy|0|||
16968450|NCT00979953|38112013|FG000|Overall Study|Lost to Follow-up|1|||
16968451|NCT00979953|38112014|FG001|Overall Study|Lost to Follow-up|1|||
16968452|NCT00979953|38112015|FG002|Overall Study|Lost to Follow-up|1|||
16968453|NCT00979953|38112016|FG003|Overall Study|Lost to Follow-up|0|||
16968454|NCT00979953|38112013|FG000|Overall Study|Withdrawal by Subject|0|||
16968455|NCT00979953|38112014|FG001|Overall Study|Withdrawal by Subject|0|||
16968456|NCT00979953|38112015|FG002|Overall Study|Withdrawal by Subject|2|||
16968457|NCT00979953|38112016|FG003|Overall Study|Withdrawal by Subject|1|||
16968458|NCT00979953|38112013|FG000|Overall Study|Protocol Violation|1|||
16968459|NCT00979953|38112014|FG001|Overall Study|Protocol Violation|0|||
16968460|NCT00979953|38112015|FG002|Overall Study|Protocol Violation|2|||
16968461|NCT00979953|38112016|FG003|Overall Study|Protocol Violation|2|||
16968462|NCT01181531|38112028|FG000|Overall Study|Other|17|||
16968463|NCT01181531|38112029|FG001|Overall Study|Other|12|||
16968464|NCT01181531|38112028|FG000|Overall Study|Partial consent by subject withdrawn|0|||
16968465|NCT01181531|38112029|FG001|Overall Study|Partial consent by subject withdrawn|1|||
16968466|NCT01181531|38112028|FG000|Overall Study|Physician Decision|3|||
16968467|NCT01181531|38112029|FG001|Overall Study|Physician Decision|1|||
16968468|NCT01181531|38112028|FG000|Overall Study|Noncompliance|2|||
16968469|NCT01181531|38112029|FG001|Overall Study|Noncompliance|2|||
16968470|NCT01181531|38112028|FG000|Overall Study|Ineligibility determined|1|||
16968471|NCT01181531|38112029|FG001|Overall Study|Ineligibility determined|2|||
16968472|NCT01181531|38112028|FG000|Overall Study|Protocol Specified Criteria|15|||
16968473|NCT01181531|38112029|FG001|Overall Study|Protocol Specified Criteria|8|||
16968474|NCT01181531|38112028|FG000|Overall Study|Pregnancy|0|||
16968475|NCT01181531|38112029|FG001|Overall Study|Pregnancy|1|||
16968476|NCT01181531|38112028|FG000|Overall Study|Withdrawal by Subject|8|||
16968477|NCT01181531|38112029|FG001|Overall Study|Withdrawal by Subject|7|||
16968478|NCT01181531|38112028|FG000|Overall Study|Protocol Violation|6|||
16968479|NCT01181531|38112029|FG001|Overall Study|Protocol Violation|6|||
16968480|NCT01181531|38112028|FG000|Overall Study|Death|9|||
16968481|NCT01181531|38112029|FG001|Overall Study|Death|12|||
16968482|NCT01181531|38112028|FG000|Overall Study|Adverse Event|0|||
16968483|NCT01181531|38112029|FG001|Overall Study|Adverse Event|1|||
16968484|NCT01152450|38112035|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
16968485|NCT01152450|38112036|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
16968486|NCT01152450|38112037|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
16968487|NCT01152450|38112038|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
16968488|NCT01152450|38112039|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
16968489|NCT01152450|38112040|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
16968490|NCT01152450|38112035|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
16968491|NCT01152450|38112036|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
16968492|NCT01152450|38112037|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
16968493|NCT01152450|38112038|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
16968494|NCT01152450|38112039|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
16968495|NCT01152450|38112040|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
16968496|NCT01152450|38112035|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16968497|NCT01152450|38112036|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
16968498|NCT01152450|38112037|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
16968499|NCT01152450|38112038|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16968500|NCT01152450|38112039|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16968501|NCT01152450|38112040|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16968502|NCT01181141|38112050|FG000|Overall Study|Adverse Event|2|||
16968503|NCT01181141|38112051|FG001|Overall Study|Adverse Event|1|||
16968504|NCT01181141|38112050|FG000|Overall Study|Lack of Efficacy|1|||
16968505|NCT01181141|38112051|FG001|Overall Study|Lack of Efficacy|0|||
16968506|NCT01181141|38112050|FG000|Overall Study|Lost to Follow-up|1|||
16968507|NCT01181141|38112051|FG001|Overall Study|Lost to Follow-up|1|||
16968508|NCT01181141|38112050|FG000|Overall Study|Physician Decision|2|||
16968509|NCT01181141|38112051|FG001|Overall Study|Physician Decision|0|||
16968510|NCT01181141|38112050|FG000|Overall Study|Protocol Violation|3|||
16968511|NCT01181141|38112051|FG001|Overall Study|Protocol Violation|1|||
16968512|NCT01181141|38112050|FG000|Overall Study|Withdrawal by Subject|3|||
16968513|NCT01181141|38112051|FG001|Overall Study|Withdrawal by Subject|1|||
16968514|NCT01173120|38112057|FG000|Overall Study|Lack of Efficacy|2|||
16968515|NCT01173120|38112057|FG000|Overall Study|Lost to Follow-up|1|||
16968516|NCT01173120|38112057|FG000|Overall Study|Participant Decision|2|||
16968517|NCT01173120|38112057|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
16968518|NCT01173120|38112057|FG000|Overall Study|Switch-Participant Decision|12|||
16968519|NCT01173120|38112057|FG000|Overall Study|Switch-Difficulty With Device|12|||
16968520|NCT00977379|38112065|FG000|Overall Study|Withdrawal by Subject|1|||
16968521|NCT00977379|38112066|FG001|Overall Study|Withdrawal by Subject|1|||
16968522|NCT00977379|38112065|FG000|Overall Study|Death|7|||
16968523|NCT00977379|38112066|FG001|Overall Study|Death|9|||
16968524|NCT00977379|38112065|FG000|Overall Study|Premature Study Termination|4|||
16968525|NCT00977379|38112066|FG001|Overall Study|Premature Study Termination|0|||
16968526|NCT00977379|38112065|FG000|Overall Study|Participant Moving House|0|||
16968527|NCT00977379|38112066|FG001|Overall Study|Participant Moving House|1|||
16968528|NCT00977379|38112065|FG000|Overall Study|Randomization Error|0|||
16968529|NCT00977379|38112066|FG001|Overall Study|Randomization Error|1|||
16968530|NCT01180985|38112072|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
16968531|NCT01180985|38112073|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
16968532|NCT01147536|38112080|FG000|Overall Study|Administrative study close|2|||
16968533|NCT01147536|38112080|FG000|Overall Study|Death|1|||
16968534|NCT01180049|38112086|FG000|Overall Study|Other|9|||
16968535|NCT01180049|38112087|FG001|Overall Study|Other|7|||
16968536|NCT01180049|38112086|FG000|Overall Study|Lost to Follow-up|8|||
16968537|NCT01180049|38112087|FG001|Overall Study|Lost to Follow-up|6|||
16968538|NCT01180049|38112086|FG000|Overall Study|Death|36|||
16968539|NCT01180049|38112087|FG001|Overall Study|Death|35|||
16968540|NCT01147458|38112093|FG000|First Intervention|Study terminated by sponsor|8|||
16968541|NCT01147458|38112094|FG001|First Intervention|Study terminated by sponsor|8|||
16968542|NCT01147458|38112095|FG002|First Intervention|Study terminated by sponsor|7|||
16968543|NCT01147458|38112096|FG003|First Intervention|Study terminated by sponsor|8|||
16968544|NCT01147458|38112093|FG000|First Intervention|Protocol Violation|2|||
16968545|NCT01147458|38112094|FG001|First Intervention|Protocol Violation|3|||
16968546|NCT01147458|38112095|FG002|First Intervention|Protocol Violation|2|||
16968547|NCT01147458|38112096|FG003|First Intervention|Protocol Violation|3|||
16968548|NCT01147458|38112093|FG000|First Intervention|Withdrawal by Subject|3|||
16968549|NCT01147458|38112094|FG001|First Intervention|Withdrawal by Subject|0|||
16968550|NCT01147458|38112095|FG002|First Intervention|Withdrawal by Subject|1|||
16968551|NCT01147458|38112096|FG003|First Intervention|Withdrawal by Subject|0|||
16968552|NCT01147458|38112093|FG000|First Intervention|Adverse Event|0|||
16968553|NCT01147458|38112094|FG001|First Intervention|Adverse Event|3|||
16968554|NCT01147458|38112095|FG002|First Intervention|Adverse Event|2|||
16968555|NCT01147458|38112096|FG003|First Intervention|Adverse Event|3|||
16968556|NCT01147458|38112093|FG000|First Intervention|Other|1|||
16968557|NCT01147458|38112094|FG001|First Intervention|Other|2|||
16968558|NCT01147458|38112095|FG002|First Intervention|Other|0|||
16968559|NCT01147458|38112096|FG003|First Intervention|Other|0|||
16968560|NCT01147458|38112093|FG000|Second Intervention|Study terminated by sponsor|7|||
16968561|NCT01147458|38112094|FG001|Second Intervention|Study terminated by sponsor|5|||
16968562|NCT01147458|38112095|FG002|Second Intervention|Study terminated by sponsor|5|||
16968563|NCT01147458|38112096|FG003|Second Intervention|Study terminated by sponsor|3|||
16968564|NCT01147458|38112093|FG000|Second Intervention|Protocol Violation|0|||
16968565|NCT01147458|38112094|FG001|Second Intervention|Protocol Violation|1|||
16968566|NCT01147458|38112095|FG002|Second Intervention|Protocol Violation|1|||
16968567|NCT01147458|38112096|FG003|Second Intervention|Protocol Violation|0|||
16968568|NCT01147458|38112093|FG000|Second Intervention|Withdrawal by Subject|0|||
16968569|NCT01147458|38112094|FG001|Second Intervention|Withdrawal by Subject|1|||
16968570|NCT01147458|38112095|FG002|Second Intervention|Withdrawal by Subject|0|||
16968571|NCT01147458|38112096|FG003|Second Intervention|Withdrawal by Subject|0|||
16968572|NCT01147458|38112093|FG000|Second Intervention|Adverse Event|2|||
16968573|NCT01147458|38112094|FG001|Second Intervention|Adverse Event|0|||
16968574|NCT01147458|38112095|FG002|Second Intervention|Adverse Event|1|||
16968575|NCT01147458|38112096|FG003|Second Intervention|Adverse Event|1|||
16968576|NCT01147458|38112093|FG000|Second Intervention|Other|0|||
16968577|NCT01147458|38112094|FG001|Second Intervention|Other|0|||
16968578|NCT01147458|38112095|FG002|Second Intervention|Other|1|||
16968579|NCT01147458|38112096|FG003|Second Intervention|Other|0|||
16968580|NCT01172808|38112112|FG000|Overall Study|Adverse Event|8|||
16968581|NCT01172808|38112113|FG001|Overall Study|Adverse Event|4|||
16968582|NCT01172808|38112114|FG002|Overall Study|Adverse Event|8|||
16968583|NCT01172808|38112115|FG003|Overall Study|Adverse Event|3|||
16968584|NCT01172808|38112112|FG000|Overall Study|Lack of Efficacy|1|||
16968585|NCT01172808|38112113|FG001|Overall Study|Lack of Efficacy|0|||
16968586|NCT01172808|38112114|FG002|Overall Study|Lack of Efficacy|0|||
16968587|NCT01172808|38112115|FG003|Overall Study|Lack of Efficacy|0|||
16968588|NCT01172808|38112112|FG000|Overall Study|Protocol Violation|2|||
16968589|NCT01172808|38112113|FG001|Overall Study|Protocol Violation|2|||
16968590|NCT01172808|38112114|FG002|Overall Study|Protocol Violation|2|||
16968591|NCT01172808|38112115|FG003|Overall Study|Protocol Violation|0|||
16968592|NCT01172808|38112112|FG000|Overall Study|Lost to Follow-up|0|||
16968593|NCT01172808|38112113|FG001|Overall Study|Lost to Follow-up|1|||
16968594|NCT01172808|38112114|FG002|Overall Study|Lost to Follow-up|1|||
16968595|NCT01172808|38112115|FG003|Overall Study|Lost to Follow-up|3|||
16968596|NCT01172808|38112112|FG000|Overall Study|Withdrawal by Subject|4|||
16968597|NCT01172808|38112113|FG001|Overall Study|Withdrawal by Subject|1|||
16968598|NCT01172808|38112114|FG002|Overall Study|Withdrawal by Subject|3|||
16968599|NCT01172808|38112115|FG003|Overall Study|Withdrawal by Subject|2|||
16968600|NCT01172808|38112112|FG000|Overall Study|Other|6|||
16968601|NCT01172808|38112113|FG001|Overall Study|Other|5|||
16968602|NCT01172808|38112114|FG002|Overall Study|Other|9|||
16968603|NCT01172808|38112115|FG003|Overall Study|Other|7|||
16968604|NCT04066491|38112128|FG000|Overall Study|Treatment ongoing|2|||
16968605|NCT04066491|38112129|FG001|Overall Study|Treatment ongoing|72|||
16968606|NCT04066491|38112130|FG002|Overall Study|Treatment ongoing|66|||
16968607|NCT04066491|38112128|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2|||
16968608|NCT04066491|38112129|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39|||
16968609|NCT04066491|38112130|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41|||
16968610|NCT04066491|38112128|FG000|Overall Study|Randomized, not treated|0|||
16968611|NCT04066491|38112129|FG001|Overall Study|Randomized, not treated|0|||
16968612|NCT04066491|38112130|FG002|Overall Study|Randomized, not treated|2|||
16968613|NCT01151280|38112139|FG000|Overall Study|Adverse Event|1|||
16968614|NCT01151280|38112139|FG000|Overall Study|Lack of Efficacy|3|||
16968615|NCT01149486|38112145|FG000|First Intervention|Adverse Event|0|||
16968616|NCT01149486|38112146|FG001|First Intervention|Adverse Event|1|||
16968630|NCT00601705|38112162|FG000|Overall Study|Withdrawal by Subject|1|||
16968631|NCT01179737|38112171|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
16968632|NCT01179737|38112172|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
16968633|NCT01179737|38112173|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
16968634|NCT01179737|38112174|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
16968635|NCT01179737|38112171|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
16968636|NCT01179737|38112172|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
16968637|NCT01179737|38112173|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
16968638|NCT01179737|38112174|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
16968639|NCT01179737|38112171|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
16968640|NCT01179737|38112172|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
16968641|NCT01179737|38112173|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
16968642|NCT01179737|38112174|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
16968643|NCT01179737|38112171|FG000|Cohort 1 & Cohort 2|Death|0|||
16968644|NCT01179737|38112172|FG001|Cohort 1 & Cohort 2|Death|0|||
16968645|NCT01179737|38112173|FG002|Cohort 1 & Cohort 2|Death|1|||
16968646|NCT01179737|38112174|FG003|Cohort 1 & Cohort 2|Death|0|||
16968647|NCT01179737|38112171|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
16968648|NCT01179737|38112172|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
16968649|NCT01179737|38112173|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
16968650|NCT01179737|38112174|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
16968651|NCT01179737|38112171|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
16968652|NCT01179737|38112172|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
16968653|NCT01179737|38112173|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
16968654|NCT01179737|38112174|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
16968655|NCT01179737|38112171|FG000|Extension|The study was terminated|3|||
16968656|NCT01179737|38112172|FG001|Extension|The study was terminated|0|||
16968657|NCT01179737|38112173|FG002|Extension|The study was terminated|0|||
16968658|NCT01179737|38112174|FG003|Extension|The study was terminated|0|||
16968659|NCT00929110|38112186|FG000|Overall Study|Adverse Event|40|||
16968660|NCT00929110|38112187|FG001|Overall Study|Adverse Event|29|||
16968661|NCT00929110|38112188|FG002|Overall Study|Adverse Event|18|||
16968662|NCT00929110|38112186|FG000|Overall Study|Subject withdrew consent|40|||
16968663|NCT00929110|38112187|FG001|Overall Study|Subject withdrew consent|23|||
16968664|NCT00929110|38112188|FG002|Overall Study|Subject withdrew consent|26|||
16968665|NCT00929110|38112186|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
16968666|NCT00929110|38112187|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
16968667|NCT00929110|38112188|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
16968668|NCT00929110|38112186|FG000|Overall Study|Lost to Follow-up|7|||
16968669|NCT00929110|38112187|FG001|Overall Study|Lost to Follow-up|7|||
16968670|NCT00929110|38112188|FG002|Overall Study|Lost to Follow-up|3|||
16968671|NCT00929110|38112186|FG000|Overall Study|Protocol deviation|5|||
16968672|NCT00929110|38112187|FG001|Overall Study|Protocol deviation|2|||
16968673|NCT00929110|38112188|FG002|Overall Study|Protocol deviation|4|||
16968674|NCT00929110|38112186|FG000|Overall Study|Administrative problems|4|||
16968675|NCT00929110|38112187|FG001|Overall Study|Administrative problems|1|||
16968676|NCT00929110|38112188|FG002|Overall Study|Administrative problems|2|||
16968677|NCT00929110|38112186|FG000|Overall Study|Death|2|||
16968678|NCT00929110|38112187|FG001|Overall Study|Death|2|||
16968679|NCT00929110|38112188|FG002|Overall Study|Death|2|||
16968680|NCT00929110|38112186|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16968681|NCT00929110|38112187|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16968682|NCT00929110|38112188|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16968683|NCT00929110|38112186|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16968684|NCT00929110|38112187|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16968685|NCT00929110|38112188|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16968686|NCT00929110|38112186|FG000|Overall Study|Patient inability to use the device|0|||
16968687|NCT00929110|38112187|FG001|Overall Study|Patient inability to use the device|1|||
16968688|NCT00929110|38112188|FG002|Overall Study|Patient inability to use the device|0|||
16968689|NCT01147068|38112203|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
16968690|NCT01147068|38112204|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16968691|NCT01147068|38112205|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16968692|NCT01147068|38112206|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16968693|NCT01147068|38112207|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16968694|NCT01147068|38112208|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
16968695|NCT01147068|38112209|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16968696|NCT01147068|38112203|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
16968697|NCT01147068|38112204|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
16968698|NCT01147068|38112205|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
16968699|NCT01147068|38112206|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
16968700|NCT01147068|38112207|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
16968701|NCT01147068|38112208|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
16968702|NCT01147068|38112209|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
16968703|NCT01147068|38112203|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
16968704|NCT01147068|38112204|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
16968705|NCT01147068|38112205|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
16968706|NCT01147068|38112206|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
16968707|NCT01147068|38112207|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
16968708|NCT01147068|38112208|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
16968709|NCT01147068|38112209|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
16968710|NCT01147068|38112203|FG000|Subjects That Received 2nd Dose|Other|0|||
16968711|NCT01147068|38112204|FG001|Subjects That Received 2nd Dose|Other|3|||
16968712|NCT01147068|38112205|FG002|Subjects That Received 2nd Dose|Other|3|||
16968713|NCT01147068|38112206|FG003|Subjects That Received 2nd Dose|Other|0|||
16968714|NCT01147068|38112207|FG004|Subjects That Received 2nd Dose|Other|1|||
16968715|NCT01147068|38112208|FG005|Subjects That Received 2nd Dose|Other|0|||
16968716|NCT01147068|38112209|FG006|Subjects That Received 2nd Dose|Other|0|||
16968717|NCT01147068|38112203|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
16968718|NCT01147068|38112204|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
16968719|NCT01147068|38112205|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
16968720|NCT01147068|38112206|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
16968721|NCT01147068|38112207|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
16968722|NCT01147068|38112208|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
16968723|NCT01147068|38112209|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
16968724|NCT01147068|38112203|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16968725|NCT01147068|38112204|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16968726|NCT01147068|38112205|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16968727|NCT01147068|38112206|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
16968728|NCT01147068|38112207|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16968729|NCT01147068|38112208|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16968730|NCT01147068|38112209|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16968731|NCT01147068|38112203|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
16968732|NCT01147068|38112204|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
16968733|NCT01147068|38112205|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
16968734|NCT01147068|38112206|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
16968735|NCT01147068|38112207|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
16968736|NCT01147068|38112208|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
16968737|NCT01147068|38112209|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
16968738|NCT01146912|38112232|FG000|Overall Study|Already received influenza vaccination|817|||
16968739|NCT01146912|38112233|FG001|Overall Study|Already received influenza vaccination|822|||
16968740|NCT01146912|38112234|FG002|Overall Study|Already received influenza vaccination|13|||
16968741|NCT01146912|38112235|FG003|Overall Study|Already received influenza vaccination|15|||
16997759|NCT00962390|38141772|FG001|Overall Study|Protocol Violation|0|||
16968742|NCT01146912|38112236|FG004|Overall Study|Already received influenza vaccination|41|||
16968743|NCT01146912|38112237|FG005|Overall Study|Already received influenza vaccination|61|||
16968744|NCT01146912|38112238|FG006|Overall Study|Already received influenza vaccination|56|||
16968745|NCT01146912|38112239|FG007|Overall Study|Already received influenza vaccination|0|||
16968746|NCT01146912|38112232|FG000|Overall Study|< 14 weeks gestational age|0|||
16968747|NCT01146912|38112233|FG001|Overall Study|< 14 weeks gestational age|0|||
16968748|NCT01146912|38112234|FG002|Overall Study|< 14 weeks gestational age|3|||
16968749|NCT01146912|38112235|FG003|Overall Study|< 14 weeks gestational age|2|||
16968750|NCT01146912|38112236|FG004|Overall Study|< 14 weeks gestational age|0|||
16968751|NCT01146912|38112237|FG005|Overall Study|< 14 weeks gestational age|0|||
16968752|NCT01146912|38112238|FG006|Overall Study|< 14 weeks gestational age|0|||
16968753|NCT01146912|38112239|FG007|Overall Study|< 14 weeks gestational age|0|||
16968754|NCT01146912|38112232|FG000|Overall Study|Duplicate patient|0|||
16968755|NCT01146912|38112233|FG001|Overall Study|Duplicate patient|0|||
16968756|NCT01146912|38112234|FG002|Overall Study|Duplicate patient|1|||
16968757|NCT01146912|38112235|FG003|Overall Study|Duplicate patient|0|||
16968758|NCT01146912|38112236|FG004|Overall Study|Duplicate patient|0|||
16968759|NCT01146912|38112237|FG005|Overall Study|Duplicate patient|0|||
16968760|NCT01146912|38112238|FG006|Overall Study|Duplicate patient|0|||
16968761|NCT01146912|38112239|FG007|Overall Study|Duplicate patient|0|||
16968762|NCT01134042|38112261|FG000|Overall Study|Adverse Event|3|||
16968763|NCT01134042|38112262|FG001|Overall Study|Adverse Event|7|||
16968764|NCT01134042|38112263|FG002|Overall Study|Adverse Event|2|||
16968765|NCT01134042|38112261|FG000|Overall Study|Lack of Efficacy|21|||
16968766|NCT01134042|38112262|FG001|Overall Study|Lack of Efficacy|6|||
16968767|NCT01134042|38112263|FG002|Overall Study|Lack of Efficacy|18|||
16968768|NCT01134042|38112261|FG000|Overall Study|Protocol Violation|5|||
16968769|NCT01134042|38112262|FG001|Overall Study|Protocol Violation|3|||
16968770|NCT01134042|38112263|FG002|Overall Study|Protocol Violation|5|||
16968771|NCT01134042|38112261|FG000|Overall Study|Lost to Follow-up|2|||
16968772|NCT01134042|38112262|FG001|Overall Study|Lost to Follow-up|0|||
16968773|NCT01134042|38112263|FG002|Overall Study|Lost to Follow-up|1|||
16968774|NCT01134042|38112261|FG000|Overall Study|Physician Decision|4|||
16968775|NCT01134042|38112262|FG001|Overall Study|Physician Decision|8|||
16968776|NCT01134042|38112263|FG002|Overall Study|Physician Decision|1|||
16968777|NCT01134042|38112261|FG000|Overall Study|Withdrawal by Subject|13|||
16968778|NCT01134042|38112262|FG001|Overall Study|Withdrawal by Subject|4|||
16968779|NCT01134042|38112263|FG002|Overall Study|Withdrawal by Subject|7|||
16968780|NCT01179347|38112274|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
16968781|NCT01179347|38112275|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
16968782|NCT01179347|38112274|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
16968783|NCT01179347|38112275|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
16968784|NCT01179347|38112274|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
16968785|NCT01179347|38112275|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
16968786|NCT01179347|38112274|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
16968787|NCT01179347|38112275|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
16968788|NCT01179347|38112274|FG000|Double-blind Period (12 Weeks)|Other|2|||
16968789|NCT01179347|38112275|FG001|Double-blind Period (12 Weeks)|Other|4|||
16968790|NCT01179347|38112274|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
16968791|NCT01179347|38112275|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
16968792|NCT01179347|38112274|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
16968793|NCT01179347|38112275|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
16968794|NCT01179347|38112274|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
16968795|NCT01179347|38112275|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
16968796|NCT01179347|38112274|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
16968797|NCT01179347|38112275|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
16968798|NCT01179347|38112274|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
16968799|NCT01179347|38112275|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
16968800|NCT01179347|38112274|FG000|Open-label Period (12 Weeks)|Other|7|||
16968801|NCT01179347|38112275|FG001|Open-label Period (12 Weeks)|Other|4|||
16968802|NCT01146288|38112285|FG000|First Intervention(1 Day)|Adverse Event|0|||
16968803|NCT01146288|38112286|FG001|First Intervention(1 Day)|Adverse Event|1|||
16968804|NCT01146054|38112293|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
16968805|NCT01146054|38112293|FG000|Overall Study|Rapid tumor progression|2|||
16968806|NCT01146054|38112293|FG000|Overall Study|Other illness precluded treatment|2|||
16968807|NCT01146054|38112293|FG000|Overall Study|Lost to Follow-up|1|||
16968808|NCT01145898|38112299|FG000|3-year Treatment|medication change by treating physician|3|||
16968809|NCT01145898|38112300|FG001|3-year Treatment|medication change by treating physician|16|||
16968810|NCT01133418|38112307|FG000|Overall Study|Lost to Follow-up|5|||
16968811|NCT01133418|38112308|FG001|Overall Study|Lost to Follow-up|6|||
16968812|NCT00931918|38112316|FG000|Overall Study|Adverse Event|4|||
16968813|NCT00931918|38112317|FG001|Overall Study|Adverse Event|6|||
16968814|NCT00931918|38112316|FG000|Overall Study|Progressive Disease|2|||
16968815|NCT00931918|38112317|FG001|Overall Study|Progressive Disease|1|||
16968816|NCT00931918|38112316|FG000|Overall Study|Symptomatic Deterioration|1|||
16968817|NCT00931918|38112317|FG001|Overall Study|Symptomatic Deterioration|0|||
16968818|NCT00931918|38112316|FG000|Overall Study|Withdrawal by Patient|3|||
16968819|NCT00931918|38112317|FG001|Overall Study|Withdrawal by Patient|4|||
16968820|NCT00931918|38112316|FG000|Overall Study|Other Reason not Specified|4|||
17133978|NCT00064337|38275242|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
17133979|NCT00064337|38275242|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
17133980|NCT00064337|38275242|FG000|PBSCC or Induction/PBSCC|Progression|3|||
17133981|NCT00064337|38275242|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
17133982|NCT00064337|38275242|FG000|PBSCC or Induction/PBSCC|Death|2|||
17133983|NCT00064337|38275242|FG000|Transplant|Adverse Event|9|||
17133984|NCT00064337|38275242|FG000|Transplant|Not protocol-specified|5|||
17133985|NCT00064337|38275242|FG000|Transplant|Death|3|||
17133986|NCT00064337|38275242|FG000|Transplant|Patient Refusal|2|||
17133987|NCT00064337|38275242|FG000|Transplant|Progression|2|||
17133988|NCT00064337|38275242|FG000|Maintenance|Adverse Event|3|||
17133989|NCT00064337|38275242|FG000|Maintenance|Progression|2|||
17133990|NCT00064337|38275242|FG000|Maintenance|On treatment at time of analysis|2|||
17133991|NCT00064337|38275242|FG000|Maintenance|Not protocol-specified|2|||
17133992|NCT00064337|38275242|FG000|Maintenance|Death|1|||
17133993|NCT00045305|38275249|FG000|Overall Study|Lack of Efficacy|6|||
17133994|NCT00045305|38275249|FG000|Overall Study|Adverse Event|3|||
17133995|NCT00045305|38275249|FG000|Overall Study|Death|3|||
16968821|NCT00931918|38112317|FG001|Overall Study|Other Reason not Specified|4|||
16968822|NCT00931918|38112316|FG000|Overall Study|Did not receive study drug|3|||
16968823|NCT00931918|38112317|FG001|Overall Study|Did not receive study drug|2|||
16968824|NCT01179191|38112323|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
16968825|NCT01179191|38112323|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
16968826|NCT01179191|38112323|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
16968827|NCT01179191|38112323|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
16968828|NCT01179191|38112323|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
16968829|NCT01179191|38112323|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
16968830|NCT01179191|38112323|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
16968831|NCT01179191|38112323|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
16968832|NCT01179191|38112323|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
16968833|NCT01179191|38112323|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
16968834|NCT01179191|38112323|FG000|Maintenance Phase (8 Weeks)|Other|66|||
16968835|NCT01169844|38112329|FG000|Overall Study|Adverse Event|0|||
16968836|NCT01169844|38112330|FG001|Overall Study|Adverse Event|1|||
16968837|NCT01169844|38112329|FG000|Overall Study|Patient withdrew consent|4|||
16968838|NCT01169844|38112330|FG001|Overall Study|Patient withdrew consent|0|||
16968839|NCT01169844|38112329|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16968840|NCT01169844|38112330|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16968841|NCT01132482|38112338|FG000|Overall Study|Adverse Event|1|||
16968842|NCT01132482|38112339|FG001|Overall Study|Adverse Event|0|||
16968843|NCT00931762|38112345|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
16968844|NCT00931762|38112345|FG000|Overall Study|Administrative Problems|5|||
16968845|NCT00931762|38112345|FG000|Overall Study|Death|1|||
16968846|NCT00931762|38112345|FG000|Overall Study|Disease Progression|3|||
16968847|NCT00931762|38112345|FG000|Overall Study|Adverse Event (s)|11|||
16968848|NCT00931762|38112345|FG000|Overall Study|Subject withdrew consent|13|||
16968849|NCT01132326|38112349|FG000|Overall Study|Lack of Efficacy|25|||
16968850|NCT01132326|38112349|FG000|Overall Study|Adverse Event|37|||
16968851|NCT01132326|38112349|FG000|Overall Study|Protocol Violation|1|||
16968852|NCT01132326|38112349|FG000|Overall Study|Lost to Follow-up|16|||
16968853|NCT01132326|38112349|FG000|Overall Study|Withdrawal by Subject|40|||
16968854|NCT01132326|38112349|FG000|Overall Study|Physician Decision|10|||
16968855|NCT01132326|38112349|FG000|Overall Study|Study Termination|80|||
16968856|NCT01132326|38112349|FG000|Overall Study|Declining Health|1|||
16968857|NCT01132326|38112349|FG000|Overall Study|Pregnancy|1|||
16968858|NCT01132326|38112349|FG000|Overall Study|Caregiver Withdrew Consent|1|||
16968859|NCT01132326|38112349|FG000|Overall Study|Death|5|||
16968860|NCT01132326|38112349|FG000|Overall Study|Subject Unable to Come To Visits|1|||
16968861|NCT01178411|38112353|FG000|Overall Study|Adverse Event|5|||
16968862|NCT01178411|38112353|FG000|Overall Study|Withdrawal by Subject|4|||
16968863|NCT01178411|38112353|FG000|Overall Study|Protocol Violation|1|||
16968864|NCT01178411|38112353|FG000|Overall Study|Progressive disease per RECIST|32|||
16968865|NCT01178411|38112353|FG000|Overall Study|Progressive disease per clinician|9|||
16968866|NCT01178411|38112353|FG000|Overall Study|Physician Decision|6|||
16968867|NCT01178411|38112353|FG000|Overall Study|Death|1|||
16968868|NCT01178411|38112353|FG000|Overall Study|No reason provided|1|||
16968869|NCT01178411|38112353|FG000|Overall Study|Drug manufacturing ended|1|||
16968870|NCT01145508|38112359|FG000|Overall Study|Adverse Event|1|||
16968871|NCT01145508|38112360|FG001|Overall Study|Adverse Event|0|||
16968872|NCT01145508|38112359|FG000|Overall Study|Death|1|||
16968873|NCT01145508|38112360|FG001|Overall Study|Death|0|||
16968874|NCT01145508|38112359|FG000|Overall Study|Physician Decision|2|||
17133996|NCT00045305|38275249|FG000|Overall Study|site error|2|||
16968875|NCT01145508|38112360|FG001|Overall Study|Physician Decision|1|||
16968876|NCT01145508|38112359|FG000|Overall Study|Never started treatment|1|||
16968877|NCT01145508|38112360|FG001|Overall Study|Never started treatment|1|||
16968878|NCT00931528|38112368|FG000|Overall Study|Protocol Violation|9|||
16968879|NCT00931528|38112369|FG001|Overall Study|Protocol Violation|12|||
16968880|NCT00931528|38112368|FG000|Overall Study|Withdrawal by Subject|4|||
16968881|NCT00931528|38112369|FG001|Overall Study|Withdrawal by Subject|12|||
16968882|NCT00931528|38112368|FG000|Overall Study|Lost to Follow-up|6|||
16968883|NCT00931528|38112369|FG001|Overall Study|Lost to Follow-up|13|||
16968884|NCT00931528|38112368|FG000|Overall Study|Assessment outside of Time Frame|22|||
16968885|NCT00931528|38112369|FG001|Overall Study|Assessment outside of Time Frame|23|||
16968886|NCT00975195|38112378|FG000|Overall Study|Adverse Event|108|||
16968887|NCT00975195|38112379|FG001|Overall Study|Adverse Event|101|||
16968888|NCT00975195|38112378|FG000|Overall Study|Lack of Efficacy|6|||
16968889|NCT00975195|38112379|FG001|Overall Study|Lack of Efficacy|6|||
16968890|NCT00975195|38112378|FG000|Overall Study|Protocol Violation|27|||
16968891|NCT00975195|38112379|FG001|Overall Study|Protocol Violation|23|||
16968892|NCT00975195|38112378|FG000|Overall Study|Lost to Follow-up|9|||
16968893|NCT00975195|38112379|FG001|Overall Study|Lost to Follow-up|7|||
16968894|NCT00975195|38112378|FG000|Overall Study|Withdrawal by Subject|48|||
16968895|NCT00975195|38112379|FG001|Overall Study|Withdrawal by Subject|61|||
16968896|NCT00975195|38112378|FG000|Overall Study|Other reason not defined above|29|||
16968897|NCT00975195|38112379|FG001|Overall Study|Other reason not defined above|33|||
16968898|NCT00975195|38112378|FG000|Overall Study|Not treated|1|||
16968899|NCT00975195|38112379|FG001|Overall Study|Not treated|2|||
16968900|NCT01145352|38112385|FG000|Overall Study|Found to have been registered twice|6|||
16968901|NCT01145352|38112385|FG000|Overall Study|Treated before marketing approval|4|||
16968902|NCT01145352|38112385|FG000|Overall Study|Syringe formulation was used|1|||
16968903|NCT01178099|38112393|FG000|Overall Study|Physician Decision|0|||
16968904|NCT01178099|38112394|FG001|Overall Study|Physician Decision|1|||
16968905|NCT01169532|38112404|FG000|Overall Study|Withdrawal by Subject|1|||
16968906|NCT00928564|38112410|FG000|Overall Study|Lost to Follow-up|6|||
16968907|NCT00928564|38112411|FG001|Overall Study|Lost to Follow-up|0|||
16968908|NCT01177943|38112419|FG000|First Intervention|Withdrawal by Subject|2|||
16968909|NCT01177943|38112420|FG001|First Intervention|Withdrawal by Subject|0|||
16968910|NCT01131312|38112429|FG000|Overall Study|Lost to Follow-up|425|||
16968911|NCT01131312|38112430|FG001|Overall Study|Lost to Follow-up|229|||
16968912|NCT01131312|38112431|FG002|Overall Study|Lost to Follow-up|351|||
16968913|NCT01177787|38112439|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
16968914|NCT01177787|38112439|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
16968915|NCT01177787|38112439|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
16968916|NCT00928486|38112451|FG000|Overall Study|Adverse Event|2|||
16968917|NCT00928486|38112451|FG000|Overall Study|Disease Progression|7|||
16968918|NCT00928486|38112451|FG000|Overall Study|Withdrawal by Subject|1|||
16968919|NCT01168596|38112457|FG000|Overall Study|Withdrawal by Subject|3|||
16968920|NCT01168596|38112458|FG001|Overall Study|Withdrawal by Subject|1|||
16968921|NCT01177553|38112466|FG000|Overall Study|babies not yet 6 months of age|1|||
16968922|NCT01177553|38112467|FG001|Overall Study|babies not yet 6 months of age|0|||
16968923|NCT00928408|38112473|FG000|Overall Study|Other|2|||
16968924|NCT00928408|38112473|FG000|Overall Study|Withdrawal by Subject|4|||
16968925|NCT00928408|38112473|FG000|Overall Study|Death|5|||
16968926|NCT00928408|38112473|FG000|Overall Study|Lost to Follow-up|12|||
16968927|NCT00928252|38112477|FG000|Overall Study|Physician Decision|3|||
16968928|NCT01177007|38112483|FG000|Overall Study|Lost to Follow-up|2|||
16968929|NCT01177007|38112483|FG000|Overall Study|Death|4|||
16968930|NCT01177007|38112483|FG000|Overall Study|Entered hospice care|5|||
16968931|NCT01177007|38112483|FG000|Overall Study|Required additional Y90 treatment|6|||
16968932|NCT01177007|38112483|FG000|Overall Study|Change in treatment modality|21|||
16968933|NCT00930982|38112491|FG000|Overall Study|Adverse Event|19|||
16968934|NCT00930982|38112492|FG001|Overall Study|Adverse Event|23|||
16968935|NCT00930982|38112491|FG000|Overall Study|Protocol Violation|1|||
16968936|NCT00930982|38112492|FG001|Overall Study|Protocol Violation|5|||
16968937|NCT00930982|38112491|FG000|Overall Study|Withdrawal by Subject|1|||
16968938|NCT00930982|38112492|FG001|Overall Study|Withdrawal by Subject|1|||
16968939|NCT01176773|38112498|FG000|Overall Study|Screen Failure|2|||
16968940|NCT01176773|38112498|FG000|Overall Study|Withdrew consent|1|||
16968941|NCT00928018|38112505|FG000|Overall Study|Withdrawal by Subject|1|||
16968942|NCT00928018|38112506|FG001|Overall Study|Withdrawal by Subject|0|||
16968943|NCT00927940|38112516|FG000|Overall Study|Death|1|||
16968944|NCT00927862|38112523|FG000|Overall Study|Missing data needed for endpt analyses|27|||
16968945|NCT00927862|38112524|FG001|Overall Study|Missing data needed for endpt analyses|45|||
16968946|NCT00976989|38112535|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
16968947|NCT00976989|38112536|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
16968948|NCT00976989|38112537|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
16968949|NCT00976989|38112535|FG000|Overall Study|Death|5|||
16968950|NCT00976989|38112536|FG001|Overall Study|Death|7|||
16968951|NCT00976989|38112537|FG002|Overall Study|Death|10|||
16968952|NCT00976989|38112535|FG000|Overall Study|Refused Treatment|4|||
16968953|NCT00976989|38112536|FG001|Overall Study|Refused Treatment|3|||
16968954|NCT00976989|38112537|FG002|Overall Study|Refused Treatment|5|||
16968955|NCT00976989|38112535|FG000|Overall Study|Failure to Return|2|||
16968956|NCT00976989|38112536|FG001|Overall Study|Failure to Return|1|||
16968957|NCT00976989|38112537|FG002|Overall Study|Failure to Return|0|||
16968958|NCT00976989|38112535|FG000|Overall Study|Recurrence of Disease|0|||
16968959|NCT00976989|38112536|FG001|Overall Study|Recurrence of Disease|1|||
16968960|NCT00976989|38112537|FG002|Overall Study|Recurrence of Disease|0|||
16968961|NCT00976989|38112535|FG000|Overall Study|Other|1|||
16968962|NCT00976989|38112536|FG001|Overall Study|Other|0|||
16968963|NCT00976989|38112537|FG002|Overall Study|Other|1|||
16968964|NCT00927784|38112547|FG000|Overall Study|Death|1|||
16968965|NCT00927784|38112548|FG001|Overall Study|Death|0|||
16968966|NCT00927784|38112547|FG000|Overall Study|Withdrawal by Subject|1|||
16968967|NCT00927784|38112548|FG001|Overall Study|Withdrawal by Subject|0|||
16968968|NCT00927472|38112556|FG000|Overall Study|Withdrawal by Subject|10|||
16968969|NCT00927472|38112557|FG001|Overall Study|Withdrawal by Subject|11|||
16968970|NCT00927472|38112556|FG000|Overall Study|Lost to Follow-up|1|||
16968971|NCT00927472|38112557|FG001|Overall Study|Lost to Follow-up|6|||
16968972|NCT00927472|38112556|FG000|Overall Study|Protocol Violation|0|||
16968973|NCT00927472|38112557|FG001|Overall Study|Protocol Violation|1|||
16968974|NCT00927472|38112556|FG000|Overall Study|Post treatment Assessment out of window|0|||
16968975|NCT00927472|38112557|FG001|Overall Study|Post treatment Assessment out of window|4|||
16968976|NCT00927394|38112565|FG000|Overall Study|Adverse Event|14|||
16968977|NCT00927394|38112566|FG001|Overall Study|Adverse Event|9|||
16968978|NCT00927394|38112565|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
16968979|NCT00927394|38112566|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
16968980|NCT00927394|38112565|FG000|Overall Study|Withdrawal by Subject|20|||
16968981|NCT00927394|38112566|FG001|Overall Study|Withdrawal by Subject|24|||
16968982|NCT00927394|38112565|FG000|Overall Study|Lost to Follow-up|8|||
16968983|NCT00927394|38112566|FG001|Overall Study|Lost to Follow-up|14|||
16968984|NCT00927394|38112565|FG000|Overall Study|Administrative Problem|1|||
16968985|NCT00927394|38112566|FG001|Overall Study|Administrative Problem|0|||
16968986|NCT00927394|38112565|FG000|Overall Study|Death|1|||
16968987|NCT00927394|38112566|FG001|Overall Study|Death|1|||
16968988|NCT00927394|38112565|FG000|Overall Study|Protocol deviation|16|||
16968989|NCT00927394|38112566|FG001|Overall Study|Protocol deviation|13|||
16968990|NCT00927394|38112565|FG000|Overall Study|Randomized in error|0|||
16968991|NCT00927394|38112566|FG001|Overall Study|Randomized in error|1|||
16968992|NCT00976911|38112575|FG000|Overall Study|Withdrawal by Subject|4|||
16968993|NCT00976911|38112576|FG001|Overall Study|Withdrawal by Subject|6|||
16968994|NCT00976911|38112575|FG000|Overall Study|Death|138|||
16968995|NCT00976911|38112576|FG001|Overall Study|Death|126|||
16968996|NCT00976911|38112575|FG000|Overall Study|Adverse Event|0|||
16968997|NCT00976911|38112576|FG001|Overall Study|Adverse Event|1|||
16968998|NCT00976911|38112575|FG000|Overall Study|Protocol Violation|2|||
16968999|NCT00976911|38112576|FG001|Overall Study|Protocol Violation|0|||
16969000|NCT00976911|38112575|FG000|Overall Study|Other|8|||
16969001|NCT00976911|38112576|FG001|Overall Study|Other|9|||
16969002|NCT00976911|38112575|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
16969003|NCT00976911|38112576|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
16969004|NCT00934648|38112582|FG000|Overall Study|Failure to return|8|||
16969005|NCT00934648|38112582|FG000|Overall Study|Withdrawal by Subject|1|||
16969006|NCT01175213|38112590|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
16969007|NCT01175213|38112591|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
16969008|NCT01175213|38112590|FG000|IGSC, 10%/rHuPH20|Death|1|||
16969009|NCT01175213|38112591|FG001|IGSC, 10%/rHuPH20|Death|0|||
16969010|NCT01175213|38112590|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
16969011|NCT01175213|38112591|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
16969012|NCT01175213|38112590|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
16969013|NCT01175213|38112591|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
16969014|NCT01175213|38112590|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
16969015|NCT01175213|38112591|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
16969016|NCT01175213|38112590|FG000|Safety Follow-up|Adverse Event|1|||
16969017|NCT01175213|38112591|FG001|Safety Follow-up|Adverse Event|0|||
16969018|NCT00974259|38112602|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
16969019|NCT00974259|38112603|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
16969020|NCT00927082|38112613|FG000|Overall Study|Lost to Follow-up|9|||
16969021|NCT00927082|38112614|FG001|Overall Study|Lost to Follow-up|8|||
16969022|NCT00927082|38112615|FG002|Overall Study|Lost to Follow-up|12|||
16969023|NCT00927082|38112616|FG003|Overall Study|Lost to Follow-up|16|||
16969024|NCT00927082|38112613|FG000|Overall Study|Withdrawal by Subject|3|||
16969025|NCT00927082|38112614|FG001|Overall Study|Withdrawal by Subject|2|||
16969026|NCT00927082|38112615|FG002|Overall Study|Withdrawal by Subject|7|||
16969027|NCT00927082|38112616|FG003|Overall Study|Withdrawal by Subject|2|||
16969028|NCT00927082|38112613|FG000|Overall Study|Death|0|||
16969029|NCT00927082|38112614|FG001|Overall Study|Death|0|||
16969030|NCT00927082|38112615|FG002|Overall Study|Death|1|||
16969031|NCT00927082|38112616|FG003|Overall Study|Death|0|||
16969032|NCT00927082|38112613|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
16969033|NCT00927082|38112614|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
16969034|NCT00927082|38112615|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
16969035|NCT00927082|38112616|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
16969036|NCT00976677|38112632|FG000|Overall Study|Adverse Event|1|||
16969037|NCT00976677|38112633|FG001|Overall Study|Adverse Event|0|||
16969038|NCT00976677|38112632|FG000|Overall Study|Withdrawal by Subject|0|||
16969039|NCT00976677|38112633|FG001|Overall Study|Withdrawal by Subject|2|||
16969040|NCT00976677|38112632|FG000|Overall Study|Disease progression|1|||
16969041|NCT00976677|38112633|FG001|Overall Study|Disease progression|1|||
16969042|NCT00976677|38112632|FG000|Overall Study|Trial unblinded|2|||
16969043|NCT00976677|38112633|FG001|Overall Study|Trial unblinded|2|||
16969044|NCT00976677|38112632|FG000|Overall Study|Unknown/Missing|1|||
16969045|NCT00976677|38112633|FG001|Overall Study|Unknown/Missing|0|||
16969046|NCT00926536|38112641|FG000|Overall Study|Physician Decision|1|||
16969047|NCT00926536|38112642|FG001|Overall Study|Physician Decision|2|||
16969048|NCT00923260|38112650|FG000|Overall Study|Lost to Follow-up|1|||
16969049|NCT00923260|38112651|FG001|Overall Study|Lost to Follow-up|1|||
16969050|NCT00934102|38112657|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
16969051|NCT00934102|38112658|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
16969052|NCT00934102|38112659|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
16969053|NCT00970281|38112678|FG000|Overall Study|Lack of Efficacy|1|||
16969054|NCT00970281|38112679|FG001|Overall Study|Lack of Efficacy|14|||
16969055|NCT00970281|38112678|FG000|Overall Study|Withdrawal by Subject|0|||
16969056|NCT00970281|38112679|FG001|Overall Study|Withdrawal by Subject|1|||
16969057|NCT00970281|38112678|FG000|Overall Study|Physician Decision|1|||
16969058|NCT00970281|38112679|FG001|Overall Study|Physician Decision|1|||
16969059|NCT00976209|38112687|FG000|Treatment Period 1|Protocol Violation|1|||
16969060|NCT00976209|38112688|FG001|Treatment Period 1|Protocol Violation|0|||
16969061|NCT00976209|38112687|FG000|Treatment Period 1|Lost to Follow-up|2|||
16969062|NCT00976209|38112688|FG001|Treatment Period 1|Lost to Follow-up|0|||
16969063|NCT00976209|38112687|FG000|Treatment Period 1|Other|0|||
16969064|NCT00976209|38112688|FG001|Treatment Period 1|Other|1|||
16969065|NCT00976209|38112687|FG000|Wash-out Period|Adverse Event|1|||
16969066|NCT00976209|38112688|FG001|Wash-out Period|Adverse Event|2|||
16780065|NCT02181634|37719139|FG000|Overall Study|Physician Decision|8|||
16969067|NCT00976209|38112687|FG000|Wash-out Period|Lost to Follow-up|1|||
16969068|NCT00976209|38112688|FG001|Wash-out Period|Lost to Follow-up|0|||
16969069|NCT00976209|38112687|FG000|Wash-out Period|Protocol Violation|1|||
16969070|NCT00976209|38112688|FG001|Wash-out Period|Protocol Violation|0|||
16969071|NCT00976209|38112687|FG000|Wash-out Period|Other|1|||
16969072|NCT00976209|38112688|FG001|Wash-out Period|Other|0|||
16969073|NCT00976209|38112687|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16969074|NCT00976209|38112688|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16969075|NCT00976209|38112687|FG000|Treatment Period 2|Lost to Follow-up|0|||
16969076|NCT00976209|38112688|FG001|Treatment Period 2|Lost to Follow-up|1|||
16969077|NCT00925990|38112695|FG000|Overall Study|Adverse Event|1|||
16969078|NCT00925990|38112696|FG001|Overall Study|Adverse Event|3|||
16969079|NCT00925990|38112695|FG000|Overall Study|Withdrawal by Subject|2|||
16969080|NCT00925990|38112696|FG001|Overall Study|Withdrawal by Subject|2|||
16969081|NCT00925990|38112695|FG000|Overall Study|Lost to Follow-up|1|||
16969082|NCT00925990|38112696|FG001|Overall Study|Lost to Follow-up|3|||
16969083|NCT00925990|38112695|FG000|Overall Study|Physician Decision|1|||
16969084|NCT00925990|38112696|FG001|Overall Study|Physician Decision|1|||
16969085|NCT00925990|38112695|FG000|Overall Study|moved out of state, missed medication|0|||
16969086|NCT00925990|38112696|FG001|Overall Study|moved out of state, missed medication|2|||
16969087|NCT01131078|38112705|FG000|Overall Study|Adverse Event|22|||
16969088|NCT01131078|38112706|FG001|Overall Study|Adverse Event|12|||
16969089|NCT01131078|38112707|FG002|Overall Study|Adverse Event|17|||
16969090|NCT01131078|38112705|FG000|Overall Study|Progressive Disease|58|||
16969091|NCT01131078|38112706|FG001|Overall Study|Progressive Disease|77|||
16969092|NCT01131078|38112707|FG002|Overall Study|Progressive Disease|71|||
16969093|NCT01131078|38112705|FG000|Overall Study|Protocol Violation|1|||
16969094|NCT01131078|38112706|FG001|Overall Study|Protocol Violation|0|||
16969095|NCT01131078|38112707|FG002|Overall Study|Protocol Violation|0|||
16969096|NCT01131078|38112705|FG000|Overall Study|Lost to Follow-up|1|||
16969097|NCT01131078|38112706|FG001|Overall Study|Lost to Follow-up|1|||
16969098|NCT01131078|38112707|FG002|Overall Study|Lost to Follow-up|1|||
16969099|NCT01131078|38112705|FG000|Overall Study|Withdrawal by Subject|2|||
16969100|NCT01131078|38112706|FG001|Overall Study|Withdrawal by Subject|4|||
16969101|NCT01131078|38112707|FG002|Overall Study|Withdrawal by Subject|3|||
16969102|NCT01131078|38112705|FG000|Overall Study|Non-compliance|3|||
16969103|NCT01131078|38112706|FG001|Overall Study|Non-compliance|0|||
16969104|NCT01131078|38112707|FG002|Overall Study|Non-compliance|0|||
16969105|NCT01131078|38112705|FG000|Overall Study|Physician Decision|10|||
16969106|NCT01131078|38112706|FG001|Overall Study|Physician Decision|6|||
16969107|NCT01131078|38112707|FG002|Overall Study|Physician Decision|8|||
16969108|NCT01131078|38112705|FG000|Overall Study|Death|4|||
16969109|NCT01131078|38112706|FG001|Overall Study|Death|0|||
16969110|NCT01131078|38112707|FG002|Overall Study|Death|2|||
16969111|NCT01131078|38112705|FG000|Overall Study|Other|0|||
16969112|NCT01131078|38112706|FG001|Overall Study|Other|1|||
16969113|NCT01131078|38112707|FG002|Overall Study|Other|0|||
16969114|NCT01167582|38112719|FG000|Overall Study|Lost to Follow-up|0|||
16969115|NCT01167582|38112720|FG001|Overall Study|Lost to Follow-up|1|||
16969116|NCT01167426|38112726|FG000|Overall Study|Lost to Follow-up|6|||
16969117|NCT01167426|38112726|FG000|Overall Study|Protocol Violation|1|||
16969118|NCT01167426|38112726|FG000|Overall Study|Withdrawal by Subject|2|||
16969119|NCT01167426|38112726|FG000|Overall Study|Sponsor Decision|1|||
16969120|NCT00968799|38112731|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
16969121|NCT00922636|38112740|FG000|Overall Study|Adverse Event|3|||
16969122|NCT00922636|38112741|FG001|Overall Study|Adverse Event|3|||
16969123|NCT00922636|38112742|FG002|Overall Study|Adverse Event|2|||
16969124|NCT00922636|38112743|FG003|Overall Study|Adverse Event|3|||
16969125|NCT00922636|38112744|FG004|Overall Study|Adverse Event|2|||
16969126|NCT00922636|38112740|FG000|Overall Study|Lack of Efficacy|1|||
16969127|NCT00922636|38112741|FG001|Overall Study|Lack of Efficacy|7|||
16969128|NCT00922636|38112742|FG002|Overall Study|Lack of Efficacy|3|||
16969129|NCT00922636|38112743|FG003|Overall Study|Lack of Efficacy|2|||
16969130|NCT00922636|38112744|FG004|Overall Study|Lack of Efficacy|4|||
16969131|NCT00922636|38112740|FG000|Overall Study|Sponsor Decision|0|||
16969132|NCT00922636|38112741|FG001|Overall Study|Sponsor Decision|0|||
16969133|NCT00922636|38112742|FG002|Overall Study|Sponsor Decision|2|||
16969134|NCT00922636|38112743|FG003|Overall Study|Sponsor Decision|0|||
16969135|NCT00922636|38112744|FG004|Overall Study|Sponsor Decision|0|||
16969136|NCT00922636|38112740|FG000|Overall Study|Withdrawal by Subject|0|||
16969137|NCT00922636|38112741|FG001|Overall Study|Withdrawal by Subject|0|||
16969138|NCT00922636|38112742|FG002|Overall Study|Withdrawal by Subject|5|||
16969139|NCT00922636|38112743|FG003|Overall Study|Withdrawal by Subject|2|||
16969140|NCT00922636|38112744|FG004|Overall Study|Withdrawal by Subject|4|||
16969141|NCT00922636|38112740|FG000|Overall Study|Protocol Violation|0|||
16969142|NCT00922636|38112741|FG001|Overall Study|Protocol Violation|0|||
16969143|NCT00922636|38112742|FG002|Overall Study|Protocol Violation|2|||
16969144|NCT00922636|38112743|FG003|Overall Study|Protocol Violation|2|||
16969145|NCT00922636|38112744|FG004|Overall Study|Protocol Violation|0|||
16969146|NCT00922636|38112740|FG000|Overall Study|Entry Criteria Not Met|0|||
16969147|NCT00922636|38112741|FG001|Overall Study|Entry Criteria Not Met|0|||
16969148|NCT00922636|38112742|FG002|Overall Study|Entry Criteria Not Met|1|||
16969149|NCT00922636|38112743|FG003|Overall Study|Entry Criteria Not Met|1|||
16969150|NCT00922636|38112744|FG004|Overall Study|Entry Criteria Not Met|0|||
16969151|NCT00922636|38112740|FG000|Overall Study|Parent/Caregiver Decision|2|||
16969152|NCT00922636|38112741|FG001|Overall Study|Parent/Caregiver Decision|4|||
16969153|NCT00922636|38112742|FG002|Overall Study|Parent/Caregiver Decision|3|||
16969154|NCT00922636|38112743|FG003|Overall Study|Parent/Caregiver Decision|5|||
16969155|NCT00922636|38112744|FG004|Overall Study|Parent/Caregiver Decision|2|||
16969156|NCT00922636|38112740|FG000|Overall Study|Lost to Follow-up|1|||
16969157|NCT00922636|38112741|FG001|Overall Study|Lost to Follow-up|2|||
16969158|NCT00922636|38112742|FG002|Overall Study|Lost to Follow-up|2|||
16969159|NCT00922636|38112743|FG003|Overall Study|Lost to Follow-up|2|||
16969160|NCT00922636|38112744|FG004|Overall Study|Lost to Follow-up|4|||
16969161|NCT01175135|38112765|FG000|Overall Study|Adverse Event|2|||
16969162|NCT01175135|38112766|FG001|Overall Study|Adverse Event|5|||
16969163|NCT01175135|38112767|FG002|Overall Study|Adverse Event|3|||
16969164|NCT01175135|38112768|FG003|Overall Study|Adverse Event|4|||
16969165|NCT01175135|38112765|FG000|Overall Study|Death|1|||
16969166|NCT01175135|38112766|FG001|Overall Study|Death|0|||
16969167|NCT01175135|38112767|FG002|Overall Study|Death|0|||
16969168|NCT01175135|38112768|FG003|Overall Study|Death|0|||
16969169|NCT01175135|38112765|FG000|Overall Study|Lack of Efficacy|4|||
16969170|NCT01175135|38112766|FG001|Overall Study|Lack of Efficacy|5|||
16969171|NCT01175135|38112767|FG002|Overall Study|Lack of Efficacy|0|||
16969172|NCT01175135|38112768|FG003|Overall Study|Lack of Efficacy|5|||
16969173|NCT01175135|38112765|FG000|Overall Study|Lost to Follow-up|1|||
16969174|NCT01175135|38112766|FG001|Overall Study|Lost to Follow-up|2|||
16969175|NCT01175135|38112767|FG002|Overall Study|Lost to Follow-up|0|||
16969176|NCT01175135|38112768|FG003|Overall Study|Lost to Follow-up|0|||
16969177|NCT01175135|38112765|FG000|Overall Study|Protocol Violation|1|||
16969178|NCT01175135|38112766|FG001|Overall Study|Protocol Violation|1|||
16969179|NCT01175135|38112767|FG002|Overall Study|Protocol Violation|0|||
16969180|NCT01175135|38112768|FG003|Overall Study|Protocol Violation|0|||
16969181|NCT01175135|38112765|FG000|Overall Study|Withdrawal by Subject|4|||
16969182|NCT01175135|38112766|FG001|Overall Study|Withdrawal by Subject|8|||
16969183|NCT01175135|38112767|FG002|Overall Study|Withdrawal by Subject|5|||
16969184|NCT01175135|38112768|FG003|Overall Study|Withdrawal by Subject|5|||
16969185|NCT01175135|38112765|FG000|Overall Study|Other|3|||
16969186|NCT01175135|38112766|FG001|Overall Study|Other|1|||
16969187|NCT01175135|38112767|FG002|Overall Study|Other|3|||
16969188|NCT01175135|38112768|FG003|Overall Study|Other|0|||
16969189|NCT01175135|38112765|FG000|Overall Study|Randomized But Not Treated|0|||
16969190|NCT01175135|38112766|FG001|Overall Study|Randomized But Not Treated|0|||
16969191|NCT01175135|38112767|FG002|Overall Study|Randomized But Not Treated|1|||
16969192|NCT01175135|38112768|FG003|Overall Study|Randomized But Not Treated|0|||
16969193|NCT00922480|38112780|FG000|Main Study|Protocol Violation|3|||
16969194|NCT00922480|38112781|FG001|Main Study|Protocol Violation|6|||
16969195|NCT00922480|38112780|FG000|Main Study|Adverse Event|6|||
16969196|NCT00922480|38112781|FG001|Main Study|Adverse Event|7|||
16969197|NCT00922480|38112780|FG000|Main Study|Lack of Efficacy|3|||
16969198|NCT00922480|38112781|FG001|Main Study|Lack of Efficacy|0|||
16969199|NCT00922480|38112780|FG000|Main Study|Withdrawal by Subject|20|||
16969200|NCT00922480|38112781|FG001|Main Study|Withdrawal by Subject|15|||
16969201|NCT00922480|38112780|FG000|Main Study|Lost to Follow-up|5|||
16969202|NCT00922480|38112781|FG001|Main Study|Lost to Follow-up|0|||
16969203|NCT00922480|38112780|FG000|Main Study|Physician Decision|0|||
16969204|NCT00922480|38112781|FG001|Main Study|Physician Decision|1|||
16969205|NCT00922480|38112780|FG000|Extension Study|Protocol Violation|3|||
16969206|NCT00922480|38112781|FG001|Extension Study|Protocol Violation|0|||
16969207|NCT00922480|38112780|FG000|Extension Study|Adverse Event|1|||
16969208|NCT00922480|38112781|FG001|Extension Study|Adverse Event|1|||
16969209|NCT00922480|38112780|FG000|Extension Study|Withdrawal by Subject|1|||
16969210|NCT00922480|38112781|FG001|Extension Study|Withdrawal by Subject|1|||
16969211|NCT00922480|38112780|FG000|Extension Study|Others|0|||
16969212|NCT00922480|38112781|FG001|Extension Study|Others|1|||
16969213|NCT00973479|38112791|FG000|Overall Study|Lost to Follow-up|0|||
16969214|NCT00973479|38112792|FG001|Overall Study|Lost to Follow-up|3|||
16969215|NCT00973479|38112791|FG000|Overall Study|Death|2|||
16969216|NCT00973479|38112792|FG001|Overall Study|Death|2|||
16969217|NCT00973479|38112791|FG000|Overall Study|Withdrawal by Subject|15|||
16969218|NCT00973479|38112792|FG001|Overall Study|Withdrawal by Subject|16|||
16969219|NCT00973479|38112791|FG000|Overall Study|Lack of Efficacy|5|||
16969220|NCT00973479|38112792|FG001|Overall Study|Lack of Efficacy|7|||
16969221|NCT00973479|38112791|FG000|Overall Study|Adverse Event|12|||
16969222|NCT00973479|38112792|FG001|Overall Study|Adverse Event|32|||
16969223|NCT00973479|38112791|FG000|Overall Study|Protocol Violation|2|||
16969224|NCT00973479|38112792|FG001|Overall Study|Protocol Violation|2|||
16969225|NCT00973479|38112791|FG000|Overall Study|Other|1|||
16969226|NCT00973479|38112792|FG001|Overall Study|Other|7|||
16969227|NCT01174043|38112800|FG000|Overall Study|Disease progression|5|||
16969228|NCT01174043|38112800|FG000|Overall Study|Adverse Event|3|||
16969229|NCT01174043|38112800|FG000|Overall Study|Death|1|||
16969230|NCT01174043|38112800|FG000|Overall Study|Withdrawal by Subject|2|||
16969231|NCT01173653|38112806|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
16969232|NCT01173653|38112807|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
16969233|NCT01172873|38112815|FG000|Overall Study|Withdrawal by Subject|3|||
16969234|NCT01172873|38112816|FG001|Overall Study|Withdrawal by Subject|2|||
16969235|NCT00925600|38112828|FG000|Overall Study|Withdrawal by Subject|16|||
16969236|NCT00925600|38112829|FG001|Overall Study|Withdrawal by Subject|14|||
16969237|NCT00925600|38112828|FG000|Overall Study|Death|4|||
16969238|NCT00925600|38112829|FG001|Overall Study|Death|3|||
16969239|NCT00925600|38112828|FG000|Overall Study|Lost to Follow-up|2|||
16969240|NCT00925600|38112829|FG001|Overall Study|Lost to Follow-up|2|||
16969241|NCT00925600|38112828|FG000|Overall Study|Disease Progression|1|||
16969242|NCT00925600|38112829|FG001|Overall Study|Disease Progression|3|||
16969243|NCT00925600|38112828|FG000|Overall Study|Administrative Decision|1|||
16969244|NCT00925600|38112829|FG001|Overall Study|Administrative Decision|1|||
16969245|NCT00925600|38112828|FG000|Overall Study|Noncompliance|2|||
16969246|NCT00925600|38112829|FG001|Overall Study|Noncompliance|0|||
16969247|NCT00925600|38112828|FG000|Overall Study|Ineligibility Determined|2|||
16969248|NCT00925600|38112829|FG001|Overall Study|Ineligibility Determined|0|||
16969249|NCT00925600|38112828|FG000|Overall Study|Protocol Deviation|0|||
16969250|NCT00925600|38112829|FG001|Overall Study|Protocol Deviation|1|||
16969251|NCT00925600|38112828|FG000|Overall Study|Requirement for Alternative Therapy|0|||
16969252|NCT00925600|38112829|FG001|Overall Study|Requirement for Alternative Therapy|1|||
16969253|NCT00925600|38112828|FG000|Overall Study|Other|3|||
16969254|NCT00925600|38112829|FG001|Overall Study|Other|1|||
16969255|NCT00925600|38112828|FG000|Overall Study|Adverse Event|1|||
16969256|NCT00925600|38112829|FG001|Overall Study|Adverse Event|2|||
16969257|NCT00968253|38112842|FG000|Overall Study|Death|0|||
16969258|NCT00968253|38112843|FG001|Overall Study|Death|0|||
16969259|NCT00968253|38112844|FG002|Overall Study|Death|2|||
16969260|NCT00968253|38112842|FG000|Overall Study|Withdrawal by Subject|0|||
16969261|NCT00968253|38112843|FG001|Overall Study|Withdrawal by Subject|0|||
16969262|NCT00968253|38112844|FG002|Overall Study|Withdrawal by Subject|1|||
16969263|NCT00968253|38112842|FG000|Overall Study|Disease Progression|0|||
16969264|NCT00968253|38112843|FG001|Overall Study|Disease Progression|3|||
16969265|NCT00968253|38112844|FG002|Overall Study|Disease Progression|3|||
16969266|NCT00968253|38112842|FG000|Overall Study|Adverse Event|0|||
16969267|NCT00968253|38112843|FG001|Overall Study|Adverse Event|0|||
16969268|NCT00968253|38112844|FG002|Overall Study|Adverse Event|1|||
16969269|NCT00964743|38112853|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
16969270|NCT00925522|38112857|FG000|Overall Study|study closed -- business decision|20|||
16969271|NCT01130532|38112864|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
16969272|NCT01130532|38112865|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
16969273|NCT01130532|38112866|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
16969274|NCT01130532|38112867|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
16969275|NCT01130532|38112864|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
16969276|NCT01130532|38112865|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
16969277|NCT01130532|38112866|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
16969278|NCT01130532|38112867|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
16969279|NCT01130532|38112864|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
16969280|NCT01130532|38112865|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
16969281|NCT01130532|38112866|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
16969282|NCT01130532|38112867|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
16969283|NCT01130532|38112864|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
16969284|NCT01130532|38112865|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
16969285|NCT01130532|38112866|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
16969286|NCT01130532|38112867|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
16969287|NCT01130532|38112864|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
16969288|NCT01130532|38112865|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
16969289|NCT01130532|38112866|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
16969290|NCT01130532|38112867|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
16969291|NCT01130532|38112864|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
16969292|NCT01130532|38112865|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
16969293|NCT01130532|38112866|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
16969294|NCT01130532|38112867|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
16969295|NCT01130532|38112864|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
16969296|NCT01130532|38112865|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
16969297|NCT01130532|38112866|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
16969298|NCT01130532|38112867|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
16969299|NCT01130532|38112864|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
16969300|NCT01130532|38112865|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
16969301|NCT01130532|38112866|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
16969302|NCT01130532|38112867|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
16969303|NCT01130532|38112864|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
16969304|NCT01130532|38112865|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
16969305|NCT01130532|38112866|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
16969306|NCT01130532|38112867|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
16969307|NCT01130532|38112864|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
16969308|NCT01130532|38112865|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
16969309|NCT01130532|38112866|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
16969310|NCT01130532|38112867|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
16969311|NCT01130532|38112864|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
16969312|NCT01130532|38112865|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
16969313|NCT01130532|38112866|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
16969314|NCT01130532|38112867|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
16969315|NCT00972777|38112881|FG000|Overall Study|Adverse Event|3|||
16969316|NCT00972777|38112882|FG001|Overall Study|Adverse Event|2|||
16969317|NCT00972777|38112881|FG000|Overall Study|Lost to Follow-up|0|||
16969318|NCT00972777|38112882|FG001|Overall Study|Lost to Follow-up|4|||
16969319|NCT00972777|38112881|FG000|Overall Study|Withdrawal by Subject|4|||
16969320|NCT00972777|38112882|FG001|Overall Study|Withdrawal by Subject|5|||
16969321|NCT00972777|38112881|FG000|Overall Study|Physician Decision|4|||
16969322|NCT00972777|38112882|FG001|Overall Study|Physician Decision|0|||
16969323|NCT00972777|38112881|FG000|Overall Study|Protocol Violation|0|||
16969324|NCT00972777|38112882|FG001|Overall Study|Protocol Violation|2|||
16969325|NCT00972777|38112881|FG000|Overall Study|Screening Failure|2|||
16969326|NCT00972777|38112882|FG001|Overall Study|Screening Failure|1|||
16969327|NCT00972777|38112881|FG000|Overall Study|Missed visit|1|||
16969328|NCT00972777|38112882|FG001|Overall Study|Missed visit|0|||
16969329|NCT00918736|38112888|FG000|Overall Study|Withdrawal by Subject|4|||
16969330|NCT01172639|38112897|FG000|Overall Study|Death|1|||
16969331|NCT01172639|38112898|FG001|Overall Study|Death|1|||
16969332|NCT01172639|38112899|FG002|Overall Study|Death|0|||
16969333|NCT01172639|38112900|FG003|Overall Study|Death|0|||
16969334|NCT01172639|38112901|FG004|Overall Study|Death|0|||
16969335|NCT01172639|38112897|FG000|Overall Study|Lost to Follow-up|9|||
16969336|NCT01172639|38112898|FG001|Overall Study|Lost to Follow-up|7|||
16969337|NCT01172639|38112899|FG002|Overall Study|Lost to Follow-up|11|||
16969338|NCT01172639|38112900|FG003|Overall Study|Lost to Follow-up|6|||
16969339|NCT01172639|38112901|FG004|Overall Study|Lost to Follow-up|6|||
16969340|NCT01172639|38112897|FG000|Overall Study|Withdrawal by Subject|3|||
16969341|NCT01172639|38112898|FG001|Overall Study|Withdrawal by Subject|3|||
16969342|NCT01172639|38112899|FG002|Overall Study|Withdrawal by Subject|5|||
16969343|NCT01172639|38112900|FG003|Overall Study|Withdrawal by Subject|5|||
16969344|NCT01172639|38112901|FG004|Overall Study|Withdrawal by Subject|0|||
16969345|NCT01144182|38112915|FG000|Overall Study|Death|5|||
16969346|NCT01144182|38112916|FG001|Overall Study|Death|6|||
16969347|NCT01144182|38112915|FG000|Overall Study|Withdrawal by Subject|3|||
16969348|NCT01144182|38112916|FG001|Overall Study|Withdrawal by Subject|6|||
16969349|NCT01144182|38112915|FG000|Overall Study|Lost to Follow-up|9|||
16969350|NCT01144182|38112916|FG001|Overall Study|Lost to Follow-up|9|||
16969351|NCT01225562|38112926|FG000|Overall Study|Withdrawal by Subject|52|||
16969352|NCT01225562|38112927|FG001|Overall Study|Withdrawal by Subject|50|||
16969353|NCT01225562|38112928|FG002|Overall Study|Withdrawal by Subject|52|||
16969354|NCT01225562|38112926|FG000|Overall Study|Lost to Follow-up|3|||
16969355|NCT01225562|38112927|FG001|Overall Study|Lost to Follow-up|6|||
16969356|NCT01225562|38112928|FG002|Overall Study|Lost to Follow-up|1|||
16969357|NCT00925288|38112938|FG000|Overall Study|Lost to Follow-up|9|||
16969358|NCT00925288|38112939|FG001|Overall Study|Lost to Follow-up|7|||
16969359|NCT01143714|38112949|FG000|Overall Study|Adverse Event|4|||
16969360|NCT01143714|38112950|FG001|Overall Study|Adverse Event|2|||
16969361|NCT01143714|38112949|FG000|Overall Study|Withdrawal by Subject|1|||
16969362|NCT01143714|38112950|FG001|Overall Study|Withdrawal by Subject|0|||
16969363|NCT01143714|38112949|FG000|Overall Study|Subject non-compliance|0|||
16969364|NCT01143714|38112950|FG001|Overall Study|Subject non-compliance|1|||
16969365|NCT01143714|38112949|FG000|Overall Study|wound closed = deemed healed|1|||
16969366|NCT01143714|38112950|FG001|Overall Study|wound closed = deemed healed|0|||
16969367|NCT01143714|38112949|FG000|Overall Study|wound size increased|1|||
16969368|NCT01143714|38112950|FG001|Overall Study|wound size increased|0|||
16969369|NCT00972543|38112971|FG000|Overall Study|Adverse Event|1|||
16969370|NCT00972543|38112972|FG001|Overall Study|Adverse Event|0|||
16969371|NCT00972543|38112971|FG000|Overall Study|Early study termination by sponsor|4|||
16969372|NCT00972543|38112972|FG001|Overall Study|Early study termination by sponsor|1|||
16969373|NCT00925132|38112978|FG000|Overall Study|Withdrawal by Subject|2|||
16969374|NCT00925132|38112979|FG001|Overall Study|Withdrawal by Subject|0|||
16969375|NCT00925132|38112980|FG002|Overall Study|Withdrawal by Subject|0|||
16969376|NCT00925132|38112981|FG003|Overall Study|Withdrawal by Subject|0|||
16969377|NCT00925132|38112982|FG004|Overall Study|Withdrawal by Subject|1|||
16969378|NCT00925132|38112978|FG000|Overall Study|Removed due to disease progression|0|||
16969379|NCT00925132|38112979|FG001|Overall Study|Removed due to disease progression|0|||
16969380|NCT00925132|38112980|FG002|Overall Study|Removed due to disease progression|0|||
16969381|NCT00925132|38112981|FG003|Overall Study|Removed due to disease progression|0|||
16969382|NCT00925132|38112982|FG004|Overall Study|Removed due to disease progression|4|||
16969383|NCT01143402|38112991|FG000|Overall Study|Rapid clinical decline|1|||
16969384|NCT01143402|38112992|FG001|Overall Study|Rapid clinical decline|1|||
16969385|NCT01143402|38112993|FG002|Overall Study|Rapid clinical decline|0|||
16969386|NCT01143402|38112991|FG000|Overall Study|Not Treated|0|||
16969387|NCT01143402|38112992|FG001|Overall Study|Not Treated|0|||
16969388|NCT01143402|38112993|FG002|Overall Study|Not Treated|1|||
16969389|NCT01171625|38113000|FG000|Overall Study|On-Protocol|67|||
16969390|NCT01171625|38113000|FG000|Overall Study|Death|38|||
16969391|NCT01171625|38113000|FG000|Overall Study|Withdrawal by Subject|31|||
16969392|NCT01171625|38113000|FG000|Overall Study|Explanted|10|||
16969393|NCT01171625|38113000|FG000|Overall Study|Lost to Follow-up|5|||
16969394|NCT01171625|38113000|FG000|Overall Study|Patient received valve-in-valve|3|||
16969395|NCT01171625|38113000|FG000|Overall Study|Other|1|||
16969396|NCT01171625|38113000|FG000|Overall Study|Consented but did not receive device|25|||
16969397|NCT00924898|38113012|FG000|Overall Study|Withdrawal by Subject|2|||
16969398|NCT01167192|38113021|FG000|Overall Study|Adverse Event|1|||
16969399|NCT01167192|38113021|FG000|Overall Study|Death|1|||
16969400|NCT01167192|38113021|FG000|Overall Study|Withdrawal by Subject|1|||
16969401|NCT01167192|38113021|FG000|Overall Study|Insurance denial|1|||
16969402|NCT01166958|38113027|FG000|Overall Study|Withdrawal by Subject|1|||
16969403|NCT01166958|38113028|FG001|Overall Study|Withdrawal by Subject|0|||
16969404|NCT01170221|38113036|FG000|Overall Study|Lost to Follow-up|22|||
16969405|NCT01170221|38113037|FG001|Overall Study|Lost to Follow-up|21|||
16969406|NCT01170221|38113036|FG000|Overall Study|Withdrawal by Subject|9|||
16969407|NCT01170221|38113037|FG001|Overall Study|Withdrawal by Subject|7|||
16969408|NCT01170221|38113036|FG000|Overall Study|Subject completed only screening and LFU|1|||
16969409|NCT01170221|38113037|FG001|Overall Study|Subject completed only screening and LFU|0|||
16969410|NCT01170221|38113036|FG000|Overall Study|Randomized but not treated|1|||
16969411|NCT01170221|38113037|FG001|Overall Study|Randomized but not treated|0|||
16969412|NCT01166646|38113045|FG000|Overall Study|Protocol Violation|0|||
16969413|NCT01166646|38113046|FG001|Overall Study|Protocol Violation|1|||
16969414|NCT01166646|38113045|FG000|Overall Study|Adverse Event|1|||
16969415|NCT01166646|38113046|FG001|Overall Study|Adverse Event|0|||
16969416|NCT01129284|38113055|FG000|Overall Study|Adverse Event|2|||
16969417|NCT01129284|38113056|FG001|Overall Study|Adverse Event|0|||
16969418|NCT01129284|38113057|FG002|Overall Study|Adverse Event|1|||
16969419|NCT01166568|38113068|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
16969420|NCT01166568|38113069|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
16969421|NCT01166568|38113070|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
16969422|NCT01166568|38113068|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
16969423|NCT01166568|38113069|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
16969424|NCT01166568|38113070|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
16969425|NCT01166568|38113068|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
16969426|NCT01166568|38113069|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
16780066|NCT02181634|37719139|FG000|Overall Study|Withdrawal by Subject|5|||
16969427|NCT01166568|38113070|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
16969428|NCT01166178|38113078|FG000|Overall Study|Withdrawal by Subject|1|||
16969429|NCT01166178|38113079|FG001|Overall Study|Withdrawal by Subject|0|||
16969430|NCT01166178|38113078|FG000|Overall Study|Study was terminated|20|||
16969431|NCT01166178|38113079|FG001|Overall Study|Study was terminated|8|||
16969432|NCT00924820|38113085|FG000|Overall Study|Death|2|||
16969433|NCT00924820|38113085|FG000|Overall Study|Ineligible, Screen Failure|5|||
16969434|NCT01225172|38113091|FG000|Overall Study|Subject decision to stop|1|||
16969435|NCT01225172|38113092|FG001|Overall Study|Subject decision to stop|0|||
16969436|NCT01225172|38113091|FG000|Overall Study|Subject request to discontinue treatment|3|||
16969437|NCT01225172|38113092|FG001|Overall Study|Subject request to discontinue treatment|1|||
16969438|NCT01225172|38113091|FG000|Overall Study|Subject no longer meets study criteria|1|||
16969439|NCT01225172|38113092|FG001|Overall Study|Subject no longer meets study criteria|0|||
16969440|NCT01225172|38113091|FG000|Overall Study|Withdrawal by Subject|1|||
16969441|NCT01225172|38113092|FG001|Overall Study|Withdrawal by Subject|0|||
16969442|NCT01143324|38113098|FG000|Overall Study|Lost to Follow-up|11|||
16969443|NCT01143324|38113098|FG000|Overall Study|Withdrawal by Subject|4|||
16969444|NCT01143324|38113098|FG000|Overall Study|Explant of the device|4|||
16969445|NCT01224782|38113102|FG000|Overall Study|Lost to Follow-up|177|||
16969446|NCT01224782|38113102|FG000|Overall Study|Withdrawal by Subject|16|||
16969447|NCT01224782|38113102|FG000|Overall Study|Death|14|||
16969448|NCT01224782|38113102|FG000|Overall Study|Improvement|13|||
16969449|NCT01224782|38113102|FG000|Overall Study|Adverse Event|12|||
16969450|NCT01224782|38113102|FG000|Overall Study|Adverse Reaction|11|||
16969451|NCT01224782|38113102|FG000|Overall Study|Noncompliance|10|||
16969452|NCT01224782|38113102|FG000|Overall Study|Other|4|||
16969453|NCT01224782|38113102|FG000|Overall Study|Start of Dialysis|3|||
16969454|NCT01224782|38113102|FG000|Overall Study|Change of Treatment|1|||
16969455|NCT01224782|38113102|FG000|Overall Study|Financial Reasons|1|||
16969456|NCT01224782|38113102|FG000|Overall Study|Deterioration|1|||
16969457|NCT01224782|38113102|FG000|Overall Study|Transplantation|1|||
16969458|NCT01224158|38113108|FG000|Overall Study|Withdrawal by Subject|1|||
16969459|NCT01224158|38113109|FG001|Overall Study|Withdrawal by Subject|0|||
16969460|NCT01129128|38113118|FG000|Overall Study|Lost to Follow-up|2|||
16969461|NCT01129128|38113119|FG001|Overall Study|Lost to Follow-up|2|||
16969462|NCT01129128|38113120|FG002|Overall Study|Lost to Follow-up|1|||
16969463|NCT01129128|38113118|FG000|Overall Study|Protocol Violation|0|||
16969464|NCT01129128|38113119|FG001|Overall Study|Protocol Violation|1|||
16969465|NCT01129128|38113120|FG002|Overall Study|Protocol Violation|0|||
16969466|NCT01129128|38113118|FG000|Overall Study|Withdrawal by Subject|0|||
16969467|NCT01129128|38113119|FG001|Overall Study|Withdrawal by Subject|1|||
16969468|NCT01129128|38113120|FG002|Overall Study|Withdrawal by Subject|3|||
16969469|NCT01129128|38113118|FG000|Overall Study|Physician Decision|1|||
16969470|NCT01129128|38113119|FG001|Overall Study|Physician Decision|0|||
16969471|NCT01129128|38113120|FG002|Overall Study|Physician Decision|0|||
16969472|NCT01222520|38113130|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
16969473|NCT01222520|38113131|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
16969474|NCT01222520|38113130|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
16969475|NCT01222520|38113131|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
16969476|NCT01222520|38113130|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
16969477|NCT01222520|38113131|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
16969478|NCT01222520|38113130|FG000|Double-blind Period|Adverse Event|0|||
16969479|NCT01222520|38113131|FG001|Double-blind Period|Adverse Event|1|||
16969480|NCT01222520|38113130|FG000|Double-blind Period|Lack of Efficacy|0|||
16969481|NCT01222520|38113131|FG001|Double-blind Period|Lack of Efficacy|1|||
16969482|NCT01222520|38113130|FG000|Double-blind Period|Study medication stolen|1|||
16969483|NCT01222520|38113131|FG001|Double-blind Period|Study medication stolen|0|||
16969484|NCT01221350|38113139|FG000|Overall Study|Discontinued intervention (GERD)|1|||
16969485|NCT01221350|38113140|FG001|Overall Study|Discontinued intervention (GERD)|0|||
16969486|NCT01221350|38113139|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
16969487|NCT01221350|38113140|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
16969488|NCT01221350|38113139|FG000|Overall Study|Withdrawal by Subject|4|||
16969489|NCT01221350|38113140|FG001|Overall Study|Withdrawal by Subject|2|||
16969490|NCT01221272|38113148|FG000|Period 1|Adverse Event|2|||
16969491|NCT01221272|38113149|FG001|Period 1|Adverse Event|0|||
16969492|NCT01221272|38113148|FG000|Period 1|Consent Withdrawal|0|||
16969493|NCT01221272|38113149|FG001|Period 1|Consent Withdrawal|1|||
16969494|NCT01221272|38113148|FG000|Period 1|Significant Dosing Noncompliance|0|||
16969495|NCT01221272|38113149|FG001|Period 1|Significant Dosing Noncompliance|1|||
16969496|NCT01221272|38113148|FG000|Period 2|Adverse Event|0|||
16969497|NCT01221272|38113149|FG001|Period 2|Adverse Event|2|||
16969498|NCT01220414|38113160|FG000|Overall Study|Withdrawal by Subject|1|||
16969499|NCT01220414|38113161|FG001|Overall Study|Withdrawal by Subject|0|||
16969500|NCT01220414|38113162|FG002|Overall Study|Withdrawal by Subject|0|||
16969501|NCT01220414|38113163|FG003|Overall Study|Withdrawal by Subject|1|||
16969502|NCT01128894|38113172|FG000|Overall Study|Adverse Event|31|||
16969503|NCT01128894|38113173|FG001|Overall Study|Adverse Event|41|||
16969504|NCT01128894|38113172|FG000|Overall Study|Protocol Violation|2|||
16969505|NCT01128894|38113173|FG001|Overall Study|Protocol Violation|1|||
16969506|NCT01128894|38113172|FG000|Overall Study|Noncompliance|4|||
16969507|NCT01128894|38113173|FG001|Overall Study|Noncompliance|5|||
16969508|NCT01128894|38113172|FG000|Overall Study|Lost to Follow-up|8|||
16969509|NCT01128894|38113173|FG001|Overall Study|Lost to Follow-up|8|||
16969510|NCT01128894|38113172|FG000|Overall Study|Withdrawal by Subject|10|||
16969511|NCT01128894|38113173|FG001|Overall Study|Withdrawal by Subject|12|||
16969512|NCT01128894|38113172|FG000|Overall Study|Physician Decision|2|||
16969513|NCT01128894|38113173|FG001|Overall Study|Physician Decision|1|||
16969514|NCT01128894|38113172|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
16969515|NCT01128894|38113173|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
16969516|NCT01220180|38113182|FG000|Overall Study|Lost to Follow-up|76|||
16969517|NCT01220180|38113182|FG000|Overall Study|Other|72|||
16969518|NCT01220180|38113182|FG000|Overall Study|Adverse Event|35|||
16969519|NCT01220180|38113182|FG000|Overall Study|Lack of Efficacy|22|||
16969520|NCT01220180|38113182|FG000|Overall Study|Death|1|||
16969521|NCT01220180|38113182|FG000|Overall Study|Randomized but not treated|1|||
16969522|NCT01220024|38113188|FG000|Overall Study|Lost to Follow-up|1|||
16969523|NCT01220024|38113189|FG001|Overall Study|Lost to Follow-up|1|||
16969524|NCT01128738|38113197|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
16969525|NCT01128738|38113198|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
16969526|NCT01128738|38113197|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
16969527|NCT01128738|38113198|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
16969528|NCT01128738|38113197|FG000|Second TP|Lost to Follow-up|0|||
16969529|NCT01128738|38113198|FG001|Second TP|Lost to Follow-up|1|||
16969530|NCT01128738|38113197|FG000|Second TP|Withdrawal by Subject|0|||
16969531|NCT01128738|38113198|FG001|Second TP|Withdrawal by Subject|2|||
16969532|NCT01143090|38113205|FG000|Overall Study|Lack of Efficacy|2|||
16969533|NCT01143090|38113205|FG000|Overall Study|Adverse Event|17|||
16969534|NCT01143090|38113205|FG000|Overall Study|Lost to Follow-up|9|||
16969535|NCT01143090|38113205|FG000|Overall Study|Protocol Violation|2|||
16969536|NCT01143090|38113205|FG000|Overall Study|Withdrawal by Subject|18|||
16969537|NCT01143090|38113205|FG000|Overall Study|Non-compliance with study drug|1|||
16969538|NCT01143090|38113205|FG000|Overall Study|Failure to meet eligibility criteria|1|||
16969539|NCT01143090|38113205|FG000|Overall Study|Administrative|1|||
16969540|NCT01165554|38113209|FG000|Overall Study|Withdrawal by Subject|23|||
16969541|NCT01218308|38113218|FG000|Overall Study|Adverse Event|1|||
16969542|NCT01218308|38113219|FG001|Overall Study|Adverse Event|2|||
16969543|NCT01218308|38113218|FG000|Overall Study|Protocol Violation|0|||
16969544|NCT01218308|38113219|FG001|Overall Study|Protocol Violation|2|||
16969545|NCT01218308|38113218|FG000|Overall Study|Withdrawal by Subject|61|||
16969546|NCT01218308|38113219|FG001|Overall Study|Withdrawal by Subject|64|||
16969547|NCT01218308|38113218|FG000|Overall Study|Lost to Follow-up|27|||
16969548|NCT01218308|38113219|FG001|Overall Study|Lost to Follow-up|31|||
16969549|NCT01218308|38113218|FG000|Overall Study|Other|14|||
16969550|NCT01218308|38113219|FG001|Overall Study|Other|21|||
16969551|NCT01165320|38113227|FG000|Overall Study|Clinical adverse experience|2|||
16969552|NCT01165320|38113228|FG001|Overall Study|Clinical adverse experience|1|||
16969553|NCT01165320|38113229|FG002|Overall Study|Clinical adverse experience|0|||
16969554|NCT01165320|38113227|FG000|Overall Study|Laboratory adverse experience|1|||
16969555|NCT01165320|38113228|FG001|Overall Study|Laboratory adverse experience|0|||
16969556|NCT01165320|38113229|FG002|Overall Study|Laboratory adverse experience|0|||
16969557|NCT01165320|38113227|FG000|Overall Study|Lack of Efficacy|0|||
16969558|NCT01165320|38113228|FG001|Overall Study|Lack of Efficacy|2|||
16969559|NCT01165320|38113229|FG002|Overall Study|Lack of Efficacy|0|||
16969560|NCT01165320|38113227|FG000|Overall Study|Reason unknown|0|||
16969561|NCT01165320|38113228|FG001|Overall Study|Reason unknown|1|||
16969562|NCT01165320|38113229|FG002|Overall Study|Reason unknown|0|||
16969563|NCT01217606|38113237|FG000|Initial Treatment Phase|Other Reasons|0|||
16969564|NCT01217606|38113238|FG001|Initial Treatment Phase|Other Reasons|2|||
16969565|NCT01217606|38113237|FG000|Initial Treatment Phase|Protocol Violation|3|||
16969566|NCT01217606|38113238|FG001|Initial Treatment Phase|Protocol Violation|2|||
16969567|NCT01217606|38113237|FG000|Initial Treatment Phase|Personal Reasons|0|||
16969568|NCT01217606|38113238|FG001|Initial Treatment Phase|Personal Reasons|2|||
16969569|NCT01217606|38113237|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
16969570|NCT01217606|38113238|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
16969571|NCT01217606|38113237|FG000|Initial Treatment Phase|Adverse Event|10|||
16969572|NCT01217606|38113238|FG001|Initial Treatment Phase|Adverse Event|6|||
16969573|NCT01217606|38113237|FG000|9-Month Masked Extension|Adverse Event|3|||
16969574|NCT01217606|38113238|FG001|9-Month Masked Extension|Adverse Event|6|||
16969575|NCT01217606|38113237|FG000|9-Month Masked Extension|Other Reasons|4|||
16969576|NCT01217606|38113238|FG001|9-Month Masked Extension|Other Reasons|4|||
16969577|NCT01217606|38113237|FG000|9-Month Masked Extension|Personal Reasons|2|||
16969578|NCT01217606|38113238|FG001|9-Month Masked Extension|Personal Reasons|1|||
16969579|NCT01217606|38113237|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
16969580|NCT01217606|38113238|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
16969581|NCT01217606|38113237|FG000|9-Month Masked Extension|Pregnancy|1|||
16969582|NCT01217606|38113238|FG001|9-Month Masked Extension|Pregnancy|0|||
16969583|NCT01217606|38113237|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
16969584|NCT01217606|38113238|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
16969585|NCT01128114|38113244|FG000|Overall Study|Treatment Withdrawn|6|||
16969586|NCT01128114|38113244|FG000|Overall Study|Screening Failed|2|||
16969587|NCT01217060|38113248|FG000|Overall Study|Withdrawal by Subject|1|||
16969588|NCT01216202|38113254|FG000|Overall Study|Withdrawal by Subject|8|||
16969589|NCT01216202|38113255|FG001|Overall Study|Withdrawal by Subject|0|||
16969590|NCT01216202|38113254|FG000|Overall Study|Death|0|||
16969591|NCT01216202|38113255|FG001|Overall Study|Death|2|||
16969592|NCT01216202|38113254|FG000|Overall Study|Lost to Follow-up|14|||
16969593|NCT01216202|38113255|FG001|Overall Study|Lost to Follow-up|0|||
16969594|NCT04816669|38113267|FG000|Part 1|Adverse Event|1|||
16969595|NCT04816669|38113268|FG001|Part 1|Adverse Event|1|||
16969596|NCT04816669|38113269|FG002|Part 1|Adverse Event|0|||
16969597|NCT04816669|38113270|FG003|Part 1|Adverse Event|0|||
16969598|NCT04816669|38113267|FG000|Part 1|Lost to Follow-up|2|||
16969599|NCT04816669|38113268|FG001|Part 1|Lost to Follow-up|2|||
16969600|NCT04816669|38113269|FG002|Part 1|Lost to Follow-up|0|||
16969601|NCT04816669|38113270|FG003|Part 1|Lost to Follow-up|0|||
16969602|NCT04816669|38113267|FG000|Part 1|Protocol Violation|0|||
16969603|NCT04816669|38113268|FG001|Part 1|Protocol Violation|1|||
16969604|NCT04816669|38113269|FG002|Part 1|Protocol Violation|0|||
16969605|NCT04816669|38113270|FG003|Part 1|Protocol Violation|0|||
16969606|NCT04816669|38113267|FG000|Part 1|Withdrawal by Subject|1|||
16969607|NCT04816669|38113268|FG001|Part 1|Withdrawal by Subject|2|||
16969608|NCT04816669|38113269|FG002|Part 1|Withdrawal by Subject|0|||
16969609|NCT04816669|38113270|FG003|Part 1|Withdrawal by Subject|0|||
16969610|NCT04816669|38113267|FG000|Part 2|Other|0|||
16969611|NCT04816669|38113268|FG001|Part 2|Other|0|||
16969612|NCT04816669|38113269|FG002|Part 2|Other|1|||
16969613|NCT04816669|38113270|FG003|Part 2|Other|0|||
16969614|NCT04816669|38113267|FG000|Part 2|Withdrawal by Subject|0|||
16969615|NCT04816669|38113268|FG001|Part 2|Withdrawal by Subject|0|||
16969616|NCT04816669|38113269|FG002|Part 2|Withdrawal by Subject|0|||
16969617|NCT04816669|38113270|FG003|Part 2|Withdrawal by Subject|1|||
16969618|NCT04816669|38113267|FG000|Part 2|Lost to Follow-up|0|||
16969619|NCT04816669|38113268|FG001|Part 2|Lost to Follow-up|0|||
16969620|NCT04816669|38113269|FG002|Part 2|Lost to Follow-up|1|||
16969621|NCT04816669|38113270|FG003|Part 2|Lost to Follow-up|0|||
16969622|NCT01165242|38113287|FG000|Overall Study|Unreachable Subjects|1|||
16969623|NCT01165242|38113288|FG001|Overall Study|Unreachable Subjects|0|||
16969624|NCT01165242|38113289|FG002|Overall Study|Unreachable Subjects|0|||
16969625|NCT01165242|38113287|FG000|Overall Study|Incarcerated Subjects|0|||
16969626|NCT01165242|38113288|FG001|Overall Study|Incarcerated Subjects|1|||
16969627|NCT01165242|38113289|FG002|Overall Study|Incarcerated Subjects|0|||
16969628|NCT01165242|38113287|FG000|Overall Study|Visit 2 Declined by Subject|0|||
16969629|NCT01165242|38113288|FG001|Overall Study|Visit 2 Declined by Subject|0|||
16969630|NCT01165242|38113289|FG002|Overall Study|Visit 2 Declined by Subject|1|||
16969631|NCT01165242|38113287|FG000|Overall Study|Withdrawal by Subject|0|||
16969632|NCT01165242|38113288|FG001|Overall Study|Withdrawal by Subject|2|||
16969633|NCT01165242|38113289|FG002|Overall Study|Withdrawal by Subject|2|||
16969634|NCT01165242|38113287|FG000|Overall Study|Extended Holiday|0|||
16969635|NCT01165242|38113288|FG001|Overall Study|Extended Holiday|0|||
16969636|NCT01165242|38113289|FG002|Overall Study|Extended Holiday|1|||
16969637|NCT01165242|38113287|FG000|Overall Study|Lost to Follow-up|9|||
16969638|NCT01165242|38113288|FG001|Overall Study|Lost to Follow-up|7|||
16969639|NCT01165242|38113289|FG002|Overall Study|Lost to Follow-up|10|||
16969640|NCT01170065|38113302|FG000|Overall Study|Adverse Event|17|||
16969641|NCT01170065|38113303|FG001|Overall Study|Adverse Event|50|||
16969642|NCT01170065|38113304|FG002|Overall Study|Adverse Event|10|||
16969643|NCT01170065|38113302|FG000|Overall Study|Lost to Follow-up|1|||
16969644|NCT01170065|38113303|FG001|Overall Study|Lost to Follow-up|4|||
16969645|NCT01170065|38113304|FG002|Overall Study|Lost to Follow-up|1|||
16969646|NCT01170065|38113302|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
16969647|NCT01170065|38113303|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
16969648|NCT01170065|38113304|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
16969649|NCT01170065|38113302|FG000|Overall Study|Reason other than specified|3|||
16969650|NCT01170065|38113303|FG001|Overall Study|Reason other than specified|8|||
16969651|NCT01170065|38113304|FG002|Overall Study|Reason other than specified|3|||
16969652|NCT01170065|38113302|FG000|Overall Study|Ongoing after planned observation time|5|||
16969653|NCT01170065|38113303|FG001|Overall Study|Ongoing after planned observation time|26|||
16969654|NCT01170065|38113304|FG002|Overall Study|Ongoing after planned observation time|10|||
16969655|NCT00966693|38113316|FG000|Overall Study|Adverse Event|0|||
16969656|NCT00966693|38113317|FG001|Overall Study|Adverse Event|0|||
16969657|NCT00966693|38113318|FG002|Overall Study|Adverse Event|1|||
16969658|NCT00966693|38113319|FG003|Overall Study|Adverse Event|2|||
16969659|NCT00966693|38113316|FG000|Overall Study|Death|0|||
16969660|NCT00966693|38113317|FG001|Overall Study|Death|0|||
16969661|NCT00966693|38113318|FG002|Overall Study|Death|1|||
16969662|NCT00966693|38113319|FG003|Overall Study|Death|0|||
16969663|NCT00966693|38113316|FG000|Overall Study|Withdrawal by Subject|1|||
16969664|NCT00966693|38113317|FG001|Overall Study|Withdrawal by Subject|0|||
16969665|NCT00966693|38113318|FG002|Overall Study|Withdrawal by Subject|0|||
16969666|NCT00966693|38113319|FG003|Overall Study|Withdrawal by Subject|5|||
16969667|NCT00966693|38113316|FG000|Overall Study|Disease Progression|0|||
16969668|NCT00966693|38113317|FG001|Overall Study|Disease Progression|0|||
16969669|NCT00966693|38113318|FG002|Overall Study|Disease Progression|1|||
16969670|NCT00966693|38113319|FG003|Overall Study|Disease Progression|16|||
16969671|NCT01215968|38113331|FG000|Overall Study|Adverse Event|0|||
16969672|NCT01215968|38113332|FG001|Overall Study|Adverse Event|2|||
16969673|NCT01215968|38113331|FG000|Overall Study|Protocol Violation|2|||
16969674|NCT01215968|38113332|FG001|Overall Study|Protocol Violation|4|||
16969675|NCT01215968|38113331|FG000|Overall Study|Not received study drug|0|||
16969676|NCT01215968|38113332|FG001|Overall Study|Not received study drug|1|||
16969677|NCT00963807|38113341|FG000|Overall Study|Physician Decision|2|||
16969678|NCT00963807|38113341|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
16969679|NCT00963807|38113341|FG000|Overall Study|Disease progression|15|||
16969680|NCT01142466|38113349|FG000|Overall Study|Adverse Event|2|||
16969681|NCT01142466|38113350|FG001|Overall Study|Adverse Event|1|||
16969682|NCT01142466|38113349|FG000|Overall Study|Withdrawal by Subject|1|||
16969683|NCT01142466|38113350|FG001|Overall Study|Withdrawal by Subject|1|||
16969684|NCT01215734|38113358|FG000|Overall Study|Death|0|||
16969685|NCT01215734|38113359|FG001|Overall Study|Death|1|||
16969686|NCT01169987|38113365|FG000|Overall Study|Withdrawal by Subject|3|||
16969687|NCT01169987|38113365|FG000|Overall Study|Lost to Follow-up|24|||
16969688|NCT01169987|38113365|FG000|Overall Study|Other|4|||
16969689|NCT01215422|38113379|FG000|Overall Study|Relocation|1|||
16969690|NCT01215422|38113380|FG001|Overall Study|Relocation|0|||
16969691|NCT01215422|38113381|FG002|Overall Study|Relocation|0|||
16969692|NCT01215422|38113382|FG003|Overall Study|Relocation|0|||
16969693|NCT01215422|38113379|FG000|Overall Study|Failed intubations|0|||
16969694|NCT01215422|38113380|FG001|Overall Study|Failed intubations|0|||
16969695|NCT01215422|38113381|FG002|Overall Study|Failed intubations|3|||
16969696|NCT01215422|38113382|FG003|Overall Study|Failed intubations|8|||
16969697|NCT01215422|38113379|FG000|Overall Study|Did not complete all intubations|7|||
16969698|NCT01215422|38113380|FG001|Overall Study|Did not complete all intubations|0|||
16969699|NCT01215422|38113381|FG002|Overall Study|Did not complete all intubations|0|||
16969700|NCT01215422|38113382|FG003|Overall Study|Did not complete all intubations|0|||
16969701|NCT00972153|38113407|FG000|Overall Study|Equipment malfunction during case|0|||
16969702|NCT00972153|38113408|FG001|Overall Study|Equipment malfunction during case|1|||
16969703|NCT00972153|38113409|FG002|Overall Study|Equipment malfunction during case|0|||
16969704|NCT00971997|38113417|FG000|Overall Study|Adverse Event|2|||
16969705|NCT00971997|38113417|FG000|Overall Study|Death|1|||
16969706|NCT00971997|38113417|FG000|Overall Study|Protocol Violation|4|||
16969707|NCT00971997|38113417|FG000|Overall Study|Withdrawal by Subject|5|||
16969708|NCT00971997|38113417|FG000|Overall Study|Physician Decision|7|||
16969709|NCT01142388|38113426|FG000|Overall Study|Lack of Efficacy|21|||
16969710|NCT01142388|38113427|FG001|Overall Study|Lack of Efficacy|31|||
16969711|NCT01142388|38113426|FG000|Overall Study|Adverse Event|9|||
16969712|NCT01142388|38113427|FG001|Overall Study|Adverse Event|5|||
16969713|NCT01142388|38113426|FG000|Overall Study|Death|3|||
16969714|NCT01142388|38113427|FG001|Overall Study|Death|2|||
16969715|NCT01142388|38113426|FG000|Overall Study|Withdrawal by Subject|5|||
16969716|NCT01142388|38113427|FG001|Overall Study|Withdrawal by Subject|3|||
16969717|NCT01142388|38113426|FG000|Overall Study|Alternative therapy|1|||
16969718|NCT01142388|38113427|FG001|Overall Study|Alternative therapy|0|||
16969719|NCT01142388|38113426|FG000|Overall Study|Other complications|0|||
16969720|NCT01142388|38113427|FG001|Overall Study|Other complications|2|||
16969721|NCT01142388|38113426|FG000|Overall Study|Other|1|||
16969722|NCT01142388|38113427|FG001|Overall Study|Other|1|||
16969723|NCT01142388|38113426|FG000|Overall Study|Never started therapy|7|||
16969724|NCT01142388|38113427|FG001|Overall Study|Never started therapy|3|||
16969725|NCT01127646|38113435|FG000|Overall Study|Entry Criteria Not Met|1|||
16969726|NCT01127646|38113436|FG001|Overall Study|Entry Criteria Not Met|0|||
16969727|NCT01127646|38113435|FG000|Overall Study|Protocol Violation|0|||
16969728|NCT01127646|38113436|FG001|Overall Study|Protocol Violation|1|||
16969729|NCT01215188|38113447|FG000|Overall Study|Lost to Follow-up|22|||
16969730|NCT01215188|38113448|FG001|Overall Study|Lost to Follow-up|22|||
16969731|NCT01215188|38113449|FG002|Overall Study|Lost to Follow-up|16|||
16969732|NCT01215188|38113447|FG000|Overall Study|Adverse Event|1|||
16969733|NCT01215188|38113448|FG001|Overall Study|Adverse Event|1|||
16969734|NCT01215188|38113449|FG002|Overall Study|Adverse Event|3|||
16969735|NCT01215188|38113447|FG000|Overall Study|Physician Decision|2|||
16969736|NCT01215188|38113448|FG001|Overall Study|Physician Decision|1|||
16969737|NCT01215188|38113449|FG002|Overall Study|Physician Decision|0|||
16969738|NCT01215188|38113447|FG000|Overall Study|Lack of Efficacy|0|||
16969739|NCT01215188|38113448|FG001|Overall Study|Lack of Efficacy|0|||
16969740|NCT01215188|38113449|FG002|Overall Study|Lack of Efficacy|1|||
16969741|NCT01215188|38113447|FG000|Overall Study|Protocol Violation|1|||
16969742|NCT01215188|38113448|FG001|Overall Study|Protocol Violation|1|||
16969743|NCT01215188|38113449|FG002|Overall Study|Protocol Violation|1|||
16969744|NCT01215188|38113447|FG000|Overall Study|Withdrawal by Subject|32|||
16969745|NCT01215188|38113448|FG001|Overall Study|Withdrawal by Subject|34|||
16969746|NCT01215188|38113449|FG002|Overall Study|Withdrawal by Subject|31|||
16969747|NCT01215032|38113457|FG000|Overall Study|Adverse Event|3|||
16969748|NCT01215032|38113457|FG000|Overall Study|Lack of Efficacy|17|||
16969749|NCT00962247|38113463|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
16969750|NCT00962247|38113463|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
16969751|NCT00918580|38113469|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
16969752|NCT00918580|38113469|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
16969753|NCT00918580|38113469|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
16969754|NCT00918580|38113469|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
16969755|NCT00918580|38113469|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
16969756|NCT00918580|38113469|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
16969757|NCT00918580|38113469|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
16969758|NCT00920686|38113479|FG000|Overall Study|Lost to Follow-up|2|||
16969759|NCT00920686|38113480|FG001|Overall Study|Lost to Follow-up|3|||
16969760|NCT00920686|38113481|FG002|Overall Study|Lost to Follow-up|1|||
16969761|NCT00920686|38113479|FG000|Overall Study|Study drug dosing criteria not met|17|||
16969762|NCT00920686|38113480|FG001|Overall Study|Study drug dosing criteria not met|19|||
16969763|NCT00920686|38113481|FG002|Overall Study|Study drug dosing criteria not met|12|||
16969764|NCT01214720|38113495|FG000|Overall Study|Alive and still on treatment|34|||
16969765|NCT01214720|38113496|FG001|Overall Study|Alive and still on treatment|18|||
16969766|NCT01214720|38113495|FG000|Overall Study|Alive and in follow-up|45|||
16969767|NCT01214720|38113496|FG001|Overall Study|Alive and in follow-up|48|||
16969768|NCT01214720|38113495|FG000|Overall Study|Lost to Follow-up|6|||
16969769|NCT01214720|38113496|FG001|Overall Study|Lost to Follow-up|2|||
16969770|NCT01142232|38113507|FG000|Overall Study|Adverse Event|1|||
17133997|NCT00064259|38275253|FG000|Overall Study|Adverse Event|1|||
16969771|NCT01142232|38113508|FG001|Overall Study|Adverse Event|2|||
16969772|NCT01142232|38113509|FG002|Overall Study|Adverse Event|1|||
16969773|NCT01142232|38113510|FG003|Overall Study|Adverse Event|0|||
16969774|NCT01142232|38113511|FG004|Overall Study|Adverse Event|4|||
16969775|NCT01142232|38113507|FG000|Overall Study|Death|0|||
16969776|NCT01142232|38113508|FG001|Overall Study|Death|0|||
16969777|NCT01142232|38113509|FG002|Overall Study|Death|0|||
16969778|NCT01142232|38113510|FG003|Overall Study|Death|0|||
16969779|NCT01142232|38113511|FG004|Overall Study|Death|1|||
16969780|NCT01142232|38113507|FG000|Overall Study|Disease Progression|2|||
16969781|NCT01142232|38113508|FG001|Overall Study|Disease Progression|0|||
16969782|NCT01142232|38113509|FG002|Overall Study|Disease Progression|1|||
16969783|NCT01142232|38113510|FG003|Overall Study|Disease Progression|2|||
16969784|NCT01142232|38113511|FG004|Overall Study|Disease Progression|12|||
16969785|NCT01142232|38113507|FG000|Overall Study|Withdrawal by Subject|0|||
16969786|NCT01142232|38113508|FG001|Overall Study|Withdrawal by Subject|0|||
16969787|NCT01142232|38113509|FG002|Overall Study|Withdrawal by Subject|0|||
16969788|NCT01142232|38113510|FG003|Overall Study|Withdrawal by Subject|1|||
16969789|NCT01142232|38113511|FG004|Overall Study|Withdrawal by Subject|3|||
16969790|NCT01142232|38113507|FG000|Overall Study|Physician Decision|0|||
16969791|NCT01142232|38113508|FG001|Overall Study|Physician Decision|1|||
16969792|NCT01142232|38113509|FG002|Overall Study|Physician Decision|0|||
16969793|NCT01142232|38113510|FG003|Overall Study|Physician Decision|2|||
16969794|NCT01142232|38113511|FG004|Overall Study|Physician Decision|10|||
16969795|NCT01142232|38113507|FG000|Overall Study|Alternative Therapy|0|||
16969796|NCT01142232|38113508|FG001|Overall Study|Alternative Therapy|1|||
16969797|NCT01142232|38113509|FG002|Overall Study|Alternative Therapy|1|||
16969798|NCT01142232|38113510|FG003|Overall Study|Alternative Therapy|0|||
16969799|NCT01142232|38113511|FG004|Overall Study|Alternative Therapy|1|||
16969800|NCT01142232|38113507|FG000|Overall Study|Off Trt for other complicating disease|0|||
16969801|NCT01142232|38113508|FG001|Overall Study|Off Trt for other complicating disease|0|||
16969802|NCT01142232|38113509|FG002|Overall Study|Off Trt for other complicating disease|0|||
16969803|NCT01142232|38113510|FG003|Overall Study|Off Trt for other complicating disease|0|||
16969804|NCT01142232|38113511|FG004|Overall Study|Off Trt for other complicating disease|1|||
16969805|NCT01142232|38113507|FG000|Overall Study|Noncompliance|0|||
16969806|NCT01142232|38113508|FG001|Overall Study|Noncompliance|0|||
16969807|NCT01142232|38113509|FG002|Overall Study|Noncompliance|0|||
16969808|NCT01142232|38113510|FG003|Overall Study|Noncompliance|0|||
16969809|NCT01142232|38113511|FG004|Overall Study|Noncompliance|2|||
16969810|NCT01140906|38113527|FG000|Overall Study|Adverse Event|7|||
16969811|NCT01140906|38113528|FG001|Overall Study|Adverse Event|10|||
16969812|NCT01140906|38113529|FG002|Overall Study|Adverse Event|17|||
16969813|NCT01140906|38113530|FG003|Overall Study|Adverse Event|7|||
16969814|NCT01140906|38113527|FG000|Overall Study|Lack of Efficacy|6|||
16969815|NCT01140906|38113528|FG001|Overall Study|Lack of Efficacy|8|||
16969816|NCT01140906|38113529|FG002|Overall Study|Lack of Efficacy|2|||
16969817|NCT01140906|38113530|FG003|Overall Study|Lack of Efficacy|1|||
16969818|NCT01140906|38113527|FG000|Overall Study|Non-compliance|0|||
16969819|NCT01140906|38113528|FG001|Overall Study|Non-compliance|1|||
16969820|NCT01140906|38113529|FG002|Overall Study|Non-compliance|0|||
16969821|NCT01140906|38113530|FG003|Overall Study|Non-compliance|1|||
16969822|NCT01140906|38113527|FG000|Overall Study|Protocol Violation|5|||
16969823|NCT01140906|38113528|FG001|Overall Study|Protocol Violation|3|||
16969824|NCT01140906|38113529|FG002|Overall Study|Protocol Violation|2|||
16969825|NCT01140906|38113530|FG003|Overall Study|Protocol Violation|1|||
16969826|NCT01140906|38113527|FG000|Overall Study|Withdrawal of consent|6|||
16969827|NCT01140906|38113528|FG001|Overall Study|Withdrawal of consent|6|||
16969828|NCT01140906|38113529|FG002|Overall Study|Withdrawal of consent|2|||
16969829|NCT01140906|38113530|FG003|Overall Study|Withdrawal of consent|2|||
16969830|NCT01140906|38113527|FG000|Overall Study|Lost to Follow-up|1|||
16969831|NCT01140906|38113528|FG001|Overall Study|Lost to Follow-up|1|||
16969832|NCT01140906|38113529|FG002|Overall Study|Lost to Follow-up|0|||
16969833|NCT01140906|38113530|FG003|Overall Study|Lost to Follow-up|2|||
16969834|NCT01140906|38113527|FG000|Overall Study|Administrative or other reason|0|||
16969835|NCT01140906|38113528|FG001|Overall Study|Administrative or other reason|5|||
16969836|NCT01140906|38113529|FG002|Overall Study|Administrative or other reason|3|||
16969837|NCT01140906|38113530|FG003|Overall Study|Administrative or other reason|2|||
16969838|NCT00962091|38113547|FG000|Overall Study|Withdrawal by Subject|1|||
16969839|NCT00962091|38113548|FG001|Overall Study|Withdrawal by Subject|2|||
16969840|NCT00962091|38113549|FG002|Overall Study|Withdrawal by Subject|1|||
16969841|NCT00962091|38113550|FG003|Overall Study|Withdrawal by Subject|1|||
16969842|NCT00962091|38113551|FG004|Overall Study|Withdrawal by Subject|0|||
16969843|NCT00962091|38113552|FG005|Overall Study|Withdrawal by Subject|1|||
16969844|NCT00962091|38113553|FG006|Overall Study|Withdrawal by Subject|0|||
16969845|NCT00962091|38113547|FG000|Overall Study|Adverse Event|0|||
16969846|NCT00962091|38113548|FG001|Overall Study|Adverse Event|0|||
16969847|NCT00962091|38113549|FG002|Overall Study|Adverse Event|0|||
16969848|NCT00962091|38113550|FG003|Overall Study|Adverse Event|0|||
16969849|NCT00962091|38113551|FG004|Overall Study|Adverse Event|0|||
16969850|NCT00962091|38113552|FG005|Overall Study|Adverse Event|0|||
16969851|NCT00962091|38113553|FG006|Overall Study|Adverse Event|1|||
16969852|NCT01163916|38113580|FG000|Overall Study|Withdrawal by Subject|2|||
16969853|NCT01163916|38113581|FG001|Overall Study|Withdrawal by Subject|0|||
16969854|NCT01163916|38113582|FG002|Overall Study|Withdrawal by Subject|2|||
16969855|NCT01163916|38113580|FG000|Overall Study|Adverse Event|2|||
16969856|NCT01163916|38113581|FG001|Overall Study|Adverse Event|0|||
16969857|NCT01163916|38113582|FG002|Overall Study|Adverse Event|1|||
16969858|NCT01163916|38113580|FG000|Overall Study|Lack of Efficacy|2|||
16969859|NCT01163916|38113581|FG001|Overall Study|Lack of Efficacy|0|||
16969860|NCT01163916|38113582|FG002|Overall Study|Lack of Efficacy|1|||
16969861|NCT01163916|38113580|FG000|Overall Study|Other|24|||
16969862|NCT01163916|38113581|FG001|Overall Study|Other|4|||
16969863|NCT01163916|38113582|FG002|Overall Study|Other|16|||
16969864|NCT01122576|38113598|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
16969865|NCT01122576|38113599|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
16969866|NCT01122576|38113600|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
16969867|NCT01122576|38113598|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
16969868|NCT01122576|38113599|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
16969869|NCT01122576|38113600|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
16969870|NCT01122576|38113598|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
16969871|NCT01122576|38113599|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
16969872|NCT01122576|38113600|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
16969873|NCT00965523|38113611|FG000|Study 221|Progressive Disease|4|||
16969874|NCT00965523|38113611|FG000|Study 221|Physician Decision|3|||
16969875|NCT00965523|38113611|FG000|Study 224|Progressive Disease|5|||
16969876|NCT00965523|38113611|FG000|Study 224|Physician Decision|1|||
16969877|NCT01122264|38113618|FG000|Overall Study|Adverse Event|6|||
16969878|NCT01122264|38113619|FG001|Overall Study|Adverse Event|5|||
16969879|NCT01122264|38113620|FG002|Overall Study|Adverse Event|7|||
16969880|NCT01122264|38113618|FG000|Overall Study|Death|1|||
16969881|NCT01122264|38113619|FG001|Overall Study|Death|0|||
16969882|NCT01122264|38113620|FG002|Overall Study|Death|0|||
16969883|NCT01122264|38113618|FG000|Overall Study|Lost to Follow-up|5|||
16969884|NCT01122264|38113619|FG001|Overall Study|Lost to Follow-up|9|||
16969885|NCT01122264|38113620|FG002|Overall Study|Lost to Follow-up|13|||
16969886|NCT01122264|38113618|FG000|Overall Study|Entry Criteria Not Met|1|||
16969887|NCT01122264|38113619|FG001|Overall Study|Entry Criteria Not Met|0|||
16969888|NCT01122264|38113620|FG002|Overall Study|Entry Criteria Not Met|0|||
16969889|NCT01122264|38113618|FG000|Overall Study|Protocol Violation|7|||
16969890|NCT01122264|38113619|FG001|Overall Study|Protocol Violation|7|||
16969891|NCT01122264|38113620|FG002|Overall Study|Protocol Violation|9|||
16969892|NCT01122264|38113618|FG000|Overall Study|Withdrawal by Subject|6|||
16969893|NCT01122264|38113619|FG001|Overall Study|Withdrawal by Subject|6|||
16969894|NCT01122264|38113620|FG002|Overall Study|Withdrawal by Subject|16|||
16969895|NCT01122264|38113618|FG000|Overall Study|Physician Decision|3|||
16969896|NCT01122264|38113619|FG001|Overall Study|Physician Decision|1|||
16969897|NCT01122264|38113620|FG002|Overall Study|Physician Decision|1|||
16969898|NCT01122264|38113618|FG000|Overall Study|Lack of Efficacy|3|||
16969899|NCT01122264|38113619|FG001|Overall Study|Lack of Efficacy|1|||
16969900|NCT01122264|38113620|FG002|Overall Study|Lack of Efficacy|1|||
16969901|NCT00920218|38113636|FG000|Overall Study|Serious Adverse Event|2|||
16969902|NCT00920218|38113637|FG001|Overall Study|Serious Adverse Event|0|||
16969903|NCT00920218|38113638|FG002|Overall Study|Serious Adverse Event|2|||
16969904|NCT00920218|38113639|FG003|Overall Study|Serious Adverse Event|1|||
16969905|NCT00920218|38113636|FG000|Overall Study|Withdrawal by Subject|0|||
16969906|NCT00920218|38113637|FG001|Overall Study|Withdrawal by Subject|3|||
16969907|NCT00920218|38113638|FG002|Overall Study|Withdrawal by Subject|2|||
16969908|NCT00920218|38113639|FG003|Overall Study|Withdrawal by Subject|0|||
16969909|NCT00920218|38113636|FG000|Overall Study|Migrated/moved from study area|0|||
16969910|NCT00920218|38113637|FG001|Overall Study|Migrated/moved from study area|0|||
16969911|NCT00920218|38113638|FG002|Overall Study|Migrated/moved from study area|1|||
16969912|NCT00920218|38113639|FG003|Overall Study|Migrated/moved from study area|0|||
16969913|NCT00920218|38113636|FG000|Overall Study|Lost to Follow-up|0|||
16969914|NCT00920218|38113637|FG001|Overall Study|Lost to Follow-up|1|||
16969915|NCT00920218|38113638|FG002|Overall Study|Lost to Follow-up|0|||
16969916|NCT00920218|38113639|FG003|Overall Study|Lost to Follow-up|3|||
16969917|NCT00920218|38113636|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
16969918|NCT00920218|38113637|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
16969919|NCT00920218|38113638|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
16969920|NCT00920218|38113639|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
16969921|NCT00920218|38113636|FG000|Overall Study|Other|0|||
16969922|NCT00920218|38113637|FG001|Overall Study|Other|0|||
16969923|NCT00920218|38113638|FG002|Overall Study|Other|1|||
16969924|NCT00920218|38113639|FG003|Overall Study|Other|0|||
16969925|NCT01121562|38113653|FG000|Overall Study|Objective progression or relapse|8|||
16969926|NCT01121562|38113653|FG000|Overall Study|Withdrawal by Subject|1|||
16969927|NCT01121562|38113653|FG000|Overall Study|Adverse Event|1|||
16969928|NCT01121562|38113653|FG000|Overall Study|Sponsor Decision|1|||
16969929|NCT01121562|38113653|FG000|Overall Study|Met study discontinuation criteria|1|||
16969930|NCT01121484|38113659|FG000|Overall Study|Adverse Event|12|||
16969931|NCT01121484|38113660|FG001|Overall Study|Adverse Event|5|||
16969932|NCT01121484|38113659|FG000|Overall Study|Lack of Efficacy|3|||
16969933|NCT01121484|38113660|FG001|Overall Study|Lack of Efficacy|11|||
16969934|NCT01121484|38113659|FG000|Overall Study|Lost to Follow-up|5|||
16969935|NCT01121484|38113660|FG001|Overall Study|Lost to Follow-up|9|||
16969936|NCT01121484|38113659|FG000|Overall Study|Physician Decision|0|||
16969937|NCT01121484|38113660|FG001|Overall Study|Physician Decision|3|||
16969938|NCT01121484|38113659|FG000|Overall Study|Protocol Violation|1|||
16969939|NCT01121484|38113660|FG001|Overall Study|Protocol Violation|0|||
16969940|NCT01121484|38113659|FG000|Overall Study|Withdrawal by Subject|8|||
16969941|NCT01121484|38113660|FG001|Overall Study|Withdrawal by Subject|7|||
16969942|NCT01121484|38113659|FG000|Overall Study|Discontinuation of study by sponsor|0|||
16969943|NCT01121484|38113660|FG001|Overall Study|Discontinuation of study by sponsor|1|||
16969944|NCT01121484|38113659|FG000|Overall Study|Other|3|||
16969945|NCT01121484|38113660|FG001|Overall Study|Other|3|||
16969946|NCT01121484|38113659|FG000|Overall Study|Randomized, not treated|1|||
16969947|NCT01121484|38113660|FG001|Overall Study|Randomized, not treated|4|||
16969948|NCT01169675|38113671|FG000|Overall Study|Progressive disease|13|||
16969949|NCT01169675|38113672|FG001|Overall Study|Progressive disease|2|||
16969950|NCT01169675|38113673|FG002|Overall Study|Progressive disease|5|||
16969951|NCT01169675|38113674|FG003|Overall Study|Progressive disease|15|||
16969952|NCT01169675|38113675|FG004|Overall Study|Progressive disease|1|||
16969953|NCT01169675|38113671|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16969954|NCT01169675|38113672|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16969955|NCT01169675|38113673|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16969956|NCT01169675|38113674|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16969957|NCT01169675|38113675|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16969958|NCT01169675|38113671|FG000|Overall Study|Adverse Event|5|||
16969959|NCT01169675|38113672|FG001|Overall Study|Adverse Event|1|||
16969960|NCT01169675|38113673|FG002|Overall Study|Adverse Event|2|||
16969961|NCT01169675|38113674|FG003|Overall Study|Adverse Event|0|||
16969962|NCT01169675|38113675|FG004|Overall Study|Adverse Event|0|||
16969963|NCT01169675|38113671|FG000|Overall Study|Withdrawal by Subject|1|||
16969964|NCT01169675|38113672|FG001|Overall Study|Withdrawal by Subject|0|||
16969965|NCT01169675|38113673|FG002|Overall Study|Withdrawal by Subject|0|||
16969966|NCT01169675|38113674|FG003|Overall Study|Withdrawal by Subject|1|||
16969967|NCT01169675|38113675|FG004|Overall Study|Withdrawal by Subject|2|||
16969968|NCT01169675|38113671|FG000|Overall Study|Other Reason Not Defined Above|0|||
16969969|NCT01169675|38113672|FG001|Overall Study|Other Reason Not Defined Above|0|||
16969970|NCT01169675|38113673|FG002|Overall Study|Other Reason Not Defined Above|0|||
16969971|NCT01169675|38113674|FG003|Overall Study|Other Reason Not Defined Above|1|||
16969972|NCT01169675|38113675|FG004|Overall Study|Other Reason Not Defined Above|1|||
16969973|NCT00924664|38113689|FG000|Overall Study|Adverse Event|23|||
16969974|NCT00924664|38113690|FG001|Overall Study|Adverse Event|39|||
16969975|NCT00924664|38113689|FG000|Overall Study|Lack of Efficacy|10|||
16969976|NCT00924664|38113690|FG001|Overall Study|Lack of Efficacy|15|||
16969977|NCT00924664|38113689|FG000|Overall Study|Lost to Follow-up|10|||
16969978|NCT00924664|38113690|FG001|Overall Study|Lost to Follow-up|12|||
16969979|NCT00924664|38113689|FG000|Overall Study|Withdrawal by Subject|47|||
16969980|NCT00924664|38113690|FG001|Overall Study|Withdrawal by Subject|71|||
16969981|NCT00924664|38113689|FG000|Overall Study|Protocol Violation|2|||
16969982|NCT00924664|38113690|FG001|Overall Study|Protocol Violation|5|||
16969983|NCT00924664|38113689|FG000|Overall Study|Pregnancy|1|||
16969984|NCT00924664|38113690|FG001|Overall Study|Pregnancy|1|||
16969985|NCT00924664|38113689|FG000|Overall Study|Death|0|||
16969986|NCT00924664|38113690|FG001|Overall Study|Death|2|||
16969987|NCT00924664|38113689|FG000|Overall Study|Study terminated by sponsor|199|||
16969988|NCT00924664|38113690|FG001|Overall Study|Study terminated by sponsor|330|||
16969989|NCT00924664|38113689|FG000|Overall Study|Other|29|||
16969990|NCT00924664|38113690|FG001|Overall Study|Other|52|||
16969991|NCT00924664|38113689|FG000|Overall Study|Randomized but not Treated|1|||
16969992|NCT00924664|38113690|FG001|Overall Study|Randomized but not Treated|0|||
16969993|NCT00600067|38113698|FG000|Overall Study|Adverse Event|0|||
16969994|NCT00600067|38113699|FG001|Overall Study|Adverse Event|1|||
16969995|NCT00600067|38113698|FG000|Overall Study|Lost to Follow-up|2|||
16969996|NCT00600067|38113699|FG001|Overall Study|Lost to Follow-up|3|||
16969997|NCT00600067|38113698|FG000|Overall Study|protocol non-compliance|0|||
16969998|NCT00600067|38113699|FG001|Overall Study|protocol non-compliance|3|||
16969999|NCT00600067|38113698|FG000|Overall Study|Lack of Efficacy|1|||
16970000|NCT00600067|38113699|FG001|Overall Study|Lack of Efficacy|0|||
16970001|NCT00970593|38113713|FG000|Overall Study|Adverse Event|1|||
16970002|NCT00970593|38113714|FG001|Overall Study|Adverse Event|1|||
16970003|NCT00970593|38113715|FG002|Overall Study|Adverse Event|0|||
16970004|NCT00970593|38113716|FG003|Overall Study|Adverse Event|0|||
16970005|NCT00970593|38113717|FG004|Overall Study|Adverse Event|0|||
16970006|NCT00970593|38113718|FG005|Overall Study|Adverse Event|0|||
16970007|NCT00970593|38113719|FG006|Overall Study|Adverse Event|0|||
16970008|NCT00970593|38113713|FG000|Overall Study|Discontinuation of study by sponsor|0|||
16970009|NCT00970593|38113714|FG001|Overall Study|Discontinuation of study by sponsor|0|||
16970010|NCT00970593|38113715|FG002|Overall Study|Discontinuation of study by sponsor|5|||
16970011|NCT00970593|38113716|FG003|Overall Study|Discontinuation of study by sponsor|0|||
16970012|NCT00970593|38113717|FG004|Overall Study|Discontinuation of study by sponsor|0|||
16970013|NCT00970593|38113718|FG005|Overall Study|Discontinuation of study by sponsor|0|||
16970014|NCT00970593|38113719|FG006|Overall Study|Discontinuation of study by sponsor|2|||
16970015|NCT00970593|38113713|FG000|Overall Study|Withdrawal by Subject|0|||
16970016|NCT00970593|38113714|FG001|Overall Study|Withdrawal by Subject|0|||
16970017|NCT00970593|38113715|FG002|Overall Study|Withdrawal by Subject|1|||
16970018|NCT00970593|38113716|FG003|Overall Study|Withdrawal by Subject|0|||
16970019|NCT00970593|38113717|FG004|Overall Study|Withdrawal by Subject|0|||
16970020|NCT00970593|38113718|FG005|Overall Study|Withdrawal by Subject|0|||
16970021|NCT00970593|38113719|FG006|Overall Study|Withdrawal by Subject|0|||
16970022|NCT00962013|38113739|FG000|Overall Study|Did not have surgery|1|||
16970023|NCT00962013|38113739|FG000|Overall Study|Death|8|||
16970024|NCT00962013|38113739|FG000|Overall Study|Lost to Follow-up|12|||
16970025|NCT00962013|38113739|FG000|Overall Study|Unable/Unwilling to return|6|||
16970026|NCT00962013|38113739|FG000|Overall Study|Withdrawal by Subject|8|||
16970027|NCT00962013|38113739|FG000|Overall Study|Removal of study device|3|||
16970028|NCT00962013|38113739|FG000|Overall Study|Site Termination|24|||
16970029|NCT00962013|38113739|FG000|Overall Study|No 5 year evaluation|6|||
16970030|NCT00970359|38113743|FG000|Overall Study|Not Treated|4|||
16970031|NCT01121406|38113749|FG000|Overall Study|Progressive disease RECIST|44|||
16970032|NCT01121406|38113750|FG001|Overall Study|Progressive disease RECIST|28|||
16970033|NCT01121406|38113749|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
16970034|NCT01121406|38113750|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
16970035|NCT01121406|38113749|FG000|Overall Study|Other AE|3|||
16970036|NCT01121406|38113750|FG001|Overall Study|Other AE|10|||
16970037|NCT01121406|38113749|FG000|Overall Study|Non-compliant with protocol|0|||
16970038|NCT01121406|38113750|FG001|Overall Study|Non-compliant with protocol|2|||
16970039|NCT01121406|38113749|FG000|Overall Study|Lost to Follow-up|0|||
16970040|NCT01121406|38113750|FG001|Overall Study|Lost to Follow-up|1|||
16970041|NCT01121406|38113749|FG000|Overall Study|Refused continuation of study med.|1|||
16970042|NCT01121406|38113750|FG001|Overall Study|Refused continuation of study med.|2|||
16970043|NCT01121406|38113749|FG000|Overall Study|Reason other than specified above|2|||
16970044|NCT01121406|38113750|FG001|Overall Study|Reason other than specified above|6|||
16970045|NCT01121406|38113749|FG000|Overall Study|Not treated|1|||
16970046|NCT01121406|38113750|FG001|Overall Study|Not treated|0|||
16970047|NCT00960687|38113759|FG000|Washout Period of 7 Days|Adverse Event|3|||
16970048|NCT00960687|38113760|FG001|Washout Period of 7 Days|Adverse Event|2|||
16970049|NCT00960687|38113759|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
16970050|NCT00960687|38113760|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16970051|NCT00920140|38113771|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
16970052|NCT00920140|38113772|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
16970053|NCT00920140|38113773|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
16780067|NCT02181634|37719139|FG000|Overall Study|Death|2|||
16970054|NCT00920140|38113774|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
17133998|NCT00064259|38275254|FG001|Overall Study|Adverse Event|0|||
16970055|NCT00920140|38113775|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
16970056|NCT00920140|38113771|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
16970057|NCT00920140|38113772|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
16970058|NCT00920140|38113773|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
16970059|NCT00920140|38113774|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
16970060|NCT00920140|38113775|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
16970061|NCT00920140|38113771|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
16970062|NCT00920140|38113772|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
16970063|NCT00920140|38113773|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
16970064|NCT00920140|38113774|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
16970065|NCT00920140|38113775|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
16970066|NCT00920140|38113771|FG000|Phase 2|Adverse Event|0|||
16970067|NCT00920140|38113772|FG001|Phase 2|Adverse Event|0|||
16970068|NCT00920140|38113773|FG002|Phase 2|Adverse Event|14|||
16970069|NCT00920140|38113774|FG003|Phase 2|Adverse Event|2|||
16970070|NCT00920140|38113775|FG004|Phase 2|Adverse Event|3|||
16970071|NCT00920140|38113771|FG000|Phase 2|Lack of Efficacy|0|||
16970072|NCT00920140|38113772|FG001|Phase 2|Lack of Efficacy|0|||
16970073|NCT00920140|38113773|FG002|Phase 2|Lack of Efficacy|29|||
16970074|NCT00920140|38113774|FG003|Phase 2|Lack of Efficacy|14|||
16970075|NCT00920140|38113775|FG004|Phase 2|Lack of Efficacy|5|||
16970076|NCT00920140|38113771|FG000|Phase 2|Lost to Follow-up|0|||
16970077|NCT00920140|38113772|FG001|Phase 2|Lost to Follow-up|0|||
16970078|NCT00920140|38113773|FG002|Phase 2|Lost to Follow-up|0|||
16970079|NCT00920140|38113774|FG003|Phase 2|Lost to Follow-up|1|||
16970080|NCT00920140|38113775|FG004|Phase 2|Lost to Follow-up|0|||
16970081|NCT00920140|38113771|FG000|Phase 2|Physician Decision|0|||
16970082|NCT00920140|38113772|FG001|Phase 2|Physician Decision|0|||
16970083|NCT00920140|38113773|FG002|Phase 2|Physician Decision|3|||
16970084|NCT00920140|38113774|FG003|Phase 2|Physician Decision|3|||
16970085|NCT00920140|38113775|FG004|Phase 2|Physician Decision|2|||
16970086|NCT00920140|38113771|FG000|Phase 2|Withdrawal by Subject|0|||
16970087|NCT00920140|38113772|FG001|Phase 2|Withdrawal by Subject|0|||
16970088|NCT00920140|38113773|FG002|Phase 2|Withdrawal by Subject|4|||
16970089|NCT00920140|38113774|FG003|Phase 2|Withdrawal by Subject|2|||
16970090|NCT00920140|38113775|FG004|Phase 2|Withdrawal by Subject|1|||
16970091|NCT01120782|38113788|FG000|Overall Study|Test article shipping error|11|||
16970092|NCT01120626|38113794|FG000|Overall Study|Withdrawal by Subject|1|||
16970093|NCT01120626|38113795|FG001|Overall Study|Withdrawal by Subject|0|||
16970094|NCT00924508|38113801|FG000|Overall Study|Withdrawal by Subject|3|||
16970095|NCT01139658|38113810|FG000|Overall Study|Adverse Event|10|||
16970096|NCT01139658|38113811|FG001|Overall Study|Adverse Event|27|||
16970097|NCT01139658|38113810|FG000|Overall Study|Lack of Efficacy|15|||
16970098|NCT01139658|38113811|FG001|Overall Study|Lack of Efficacy|7|||
16970099|NCT01139658|38113810|FG000|Overall Study|Withdrawal by Subject|2|||
16970100|NCT01139658|38113811|FG001|Overall Study|Withdrawal by Subject|4|||
16970101|NCT01139658|38113810|FG000|Overall Study|No documentation of treatment|1|||
16970102|NCT01139658|38113811|FG001|Overall Study|No documentation of treatment|0|||
16970103|NCT01139658|38113810|FG000|Overall Study|Other|28|||
16970104|NCT01139658|38113811|FG001|Overall Study|Other|75|||
16970105|NCT01139580|38113819|FG000|Overall Study|Adverse Event|5|||
16970106|NCT01139580|38113820|FG001|Overall Study|Adverse Event|4|||
16970107|NCT01139580|38113819|FG000|Overall Study|Lost to Follow-up|9|||
16970108|NCT01139580|38113820|FG001|Overall Study|Lost to Follow-up|1|||
16970109|NCT01139580|38113819|FG000|Overall Study|Lack of Efficacy|0|||
16970110|NCT01139580|38113820|FG001|Overall Study|Lack of Efficacy|2|||
16970111|NCT01139580|38113819|FG000|Overall Study|Withdrawal by Subject|6|||
16970112|NCT01139580|38113820|FG001|Overall Study|Withdrawal by Subject|9|||
16970113|NCT01139580|38113819|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
16970114|NCT01139580|38113820|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
16970115|NCT01139580|38113819|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
16970116|NCT01139580|38113820|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
16970117|NCT01139580|38113819|FG000|Overall Study|Misrandomized|1|||
16970118|NCT01139580|38113820|FG001|Overall Study|Misrandomized|0|||
16970119|NCT01139580|38113819|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
16970120|NCT01139580|38113820|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
16997760|NCT00962390|38141773|FG002|Overall Study|Protocol Violation|0|||
16970121|NCT01139580|38113819|FG000|Overall Study|Participant Randomization in Error|0|||
16970122|NCT01139580|38113820|FG001|Overall Study|Participant Randomization in Error|1|||
16970123|NCT00917644|38113826|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
16970124|NCT00917644|38113827|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
16970125|NCT00917644|38113826|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
16970126|NCT00917644|38113827|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
16970127|NCT00917644|38113826|FG000|Period 2: Second Intervention|family emergency|1|||
16970128|NCT00917644|38113827|FG001|Period 2: Second Intervention|family emergency|0|||
16970129|NCT01137786|38113835|FG000|Overall Study|Lost to Follow-up|0|||
16970130|NCT01137786|38113836|FG001|Overall Study|Lost to Follow-up|2|||
16970131|NCT01137786|38113835|FG000|Overall Study|Withdrawal by Subject|1|||
16970132|NCT01137786|38113836|FG001|Overall Study|Withdrawal by Subject|1|||
16970133|NCT00599755|38113844|FG000|Overall Study|Adverse Event|11|||
16970134|NCT00599755|38113844|FG000|Overall Study|Withdrawal by Subject|2|||
16970135|NCT00599755|38113844|FG000|Overall Study|Progression of Disease|3|||
16970136|NCT00599755|38113844|FG000|Overall Study|Other Reason|2|||
16970137|NCT00599755|38113844|FG000|Overall Study|No data available|1|||
16970138|NCT00600613|38113848|FG000|Overall Study|Protocol Deviation|1|||
16970139|NCT01125930|38113854|FG000|Overall Study|Adverse Event|0|||
16970140|NCT01125930|38113855|FG001|Overall Study|Adverse Event|1|||
16970141|NCT01125930|38113854|FG000|Overall Study|Withdrawal by Subject|1|||
16970142|NCT01125930|38113855|FG001|Overall Study|Withdrawal by Subject|6|||
16970143|NCT01125930|38113854|FG000|Overall Study|Protocol Violation|0|||
16970144|NCT01125930|38113855|FG001|Overall Study|Protocol Violation|1|||
16970145|NCT01125930|38113854|FG000|Overall Study|Lost to Follow-up|0|||
16970146|NCT01125930|38113855|FG001|Overall Study|Lost to Follow-up|2|||
16970147|NCT00918346|38113886|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
16970148|NCT00918346|38113887|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
16970149|NCT00913978|38113898|FG000|Overall Study|Surgeon choice|1|||
16970150|NCT00913978|38113899|FG001|Overall Study|Surgeon choice|3|||
16970151|NCT01137474|38113909|FG000|Overall Study|Adverse Event|3|||
16970152|NCT01137474|38113910|FG001|Overall Study|Adverse Event|5|||
16970153|NCT01137474|38113911|FG002|Overall Study|Adverse Event|1|||
16970154|NCT01137474|38113912|FG003|Overall Study|Adverse Event|3|||
16970155|NCT01137474|38113909|FG000|Overall Study|Withdrawal by Subject|7|||
16970156|NCT01137474|38113910|FG001|Overall Study|Withdrawal by Subject|2|||
16970157|NCT01137474|38113911|FG002|Overall Study|Withdrawal by Subject|6|||
16970158|NCT01137474|38113912|FG003|Overall Study|Withdrawal by Subject|9|||
16970159|NCT01137474|38113909|FG000|Overall Study|No longer met study criteria|6|||
16970160|NCT01137474|38113910|FG001|Overall Study|No longer met study criteria|1|||
16970161|NCT01137474|38113911|FG002|Overall Study|No longer met study criteria|0|||
16970162|NCT01137474|38113912|FG003|Overall Study|No longer met study criteria|5|||
16970163|NCT01137474|38113909|FG000|Overall Study|Lost to Follow-up|5|||
16970164|NCT01137474|38113910|FG001|Overall Study|Lost to Follow-up|1|||
16970165|NCT01137474|38113911|FG002|Overall Study|Lost to Follow-up|0|||
16970166|NCT01137474|38113912|FG003|Overall Study|Lost to Follow-up|2|||
16970167|NCT01137474|38113909|FG000|Overall Study|Lack of Efficacy|0|||
16970168|NCT01137474|38113910|FG001|Overall Study|Lack of Efficacy|0|||
16970169|NCT01137474|38113911|FG002|Overall Study|Lack of Efficacy|0|||
16970170|NCT01137474|38113912|FG003|Overall Study|Lack of Efficacy|2|||
16970171|NCT01137474|38113909|FG000|Overall Study|Other|3|||
16970172|NCT01137474|38113910|FG001|Overall Study|Other|1|||
16970173|NCT01137474|38113911|FG002|Overall Study|Other|0|||
16970174|NCT01137474|38113912|FG003|Overall Study|Other|0|||
16970175|NCT01137474|38113909|FG000|Overall Study|Pregnancy|0|||
16970176|NCT01137474|38113910|FG001|Overall Study|Pregnancy|1|||
16970177|NCT01137474|38113911|FG002|Overall Study|Pregnancy|0|||
16970178|NCT01137474|38113912|FG003|Overall Study|Pregnancy|0|||
16970179|NCT01137474|38113909|FG000|Overall Study|Administrative reason by sponsor|0|||
16970180|NCT01137474|38113910|FG001|Overall Study|Administrative reason by sponsor|1|||
16970181|NCT01137474|38113911|FG002|Overall Study|Administrative reason by sponsor|0|||
16970182|NCT01137474|38113912|FG003|Overall Study|Administrative reason by sponsor|0|||
16970183|NCT01168973|38113924|FG000|Overall Study|Progressive Disease|341|||
16970184|NCT01168973|38113925|FG001|Overall Study|Progressive Disease|429|||
16970185|NCT01168973|38113924|FG000|Overall Study|Adverse Event|94|||
16970186|NCT01168973|38113925|FG001|Overall Study|Adverse Event|55|||
16970187|NCT01168973|38113924|FG000|Overall Study|Withdrawal by Subject|90|||
16970188|NCT01168973|38113925|FG001|Overall Study|Withdrawal by Subject|53|||
16970189|NCT01168973|38113924|FG000|Overall Study|Death|42|||
16970190|NCT01168973|38113925|FG001|Overall Study|Death|45|||
16970191|NCT01168973|38113924|FG000|Overall Study|Physician Decision|37|||
16970192|NCT01168973|38113925|FG001|Overall Study|Physician Decision|19|||
16970193|NCT01168973|38113924|FG000|Overall Study|Sponsor Decision|2|||
16970194|NCT01168973|38113925|FG001|Overall Study|Sponsor Decision|1|||
16970195|NCT01168973|38113924|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
16970196|NCT01168973|38113925|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
16970197|NCT03918109|38113935|FG000|Overall Study|Withdrawal by Subject|0|||
16970198|NCT03918109|38113936|FG001|Overall Study|Withdrawal by Subject|0|||
16970199|NCT03918109|38113937|FG002|Overall Study|Withdrawal by Subject|2|||
16970200|NCT03918109|38113938|FG003|Overall Study|Withdrawal by Subject|1|||
16970201|NCT03918109|38113935|FG000|Overall Study|Lost to Follow-up|0|||
16970202|NCT03918109|38113936|FG001|Overall Study|Lost to Follow-up|0|||
16970203|NCT03918109|38113937|FG002|Overall Study|Lost to Follow-up|0|||
16970204|NCT03918109|38113938|FG003|Overall Study|Lost to Follow-up|1|||
16970205|NCT01168427|38113948|FG000|Overall Study|Patient exited prior to implant|1|||
16970206|NCT01124916|38113954|FG000|Overall Study|Lost to Follow-up|3|||
16970207|NCT01124916|38113955|FG001|Overall Study|Lost to Follow-up|2|||
16970208|NCT00916006|38113963|FG000|Overall Study|Adverse Event|1|||
16970209|NCT00916006|38113964|FG001|Overall Study|Adverse Event|1|||
16970210|NCT00916006|38113963|FG000|Overall Study|Withdrawal by Subject|2|||
16970211|NCT00916006|38113964|FG001|Overall Study|Withdrawal by Subject|5|||
16970212|NCT00916006|38113963|FG000|Overall Study|Protocol Violation|0|||
16970213|NCT00916006|38113964|FG001|Overall Study|Protocol Violation|1|||
16970214|NCT01168349|38113981|FG000|Overall Study|Death|157|||
16970215|NCT01168349|38113981|FG000|Overall Study|Lost to Follow-up|34|||
16970216|NCT01168349|38113981|FG000|Overall Study|Withdrawal by Subject|9|||
16970217|NCT01168349|38113981|FG000|Overall Study|Kidney transplantation|3|||
16970218|NCT01168349|38113981|FG000|Overall Study|Other|22|||
16970219|NCT01168349|38113981|FG000|Overall Study|Protocol Violation|76|||
16970220|NCT00915772|38114004|FG000|Overall Study|Adverse Event|12|||
16970221|NCT00915772|38114005|FG001|Overall Study|Adverse Event|13|||
16970222|NCT00915772|38114006|FG002|Overall Study|Adverse Event|11|||
16970223|NCT00915772|38114004|FG000|Overall Study|Protocol Violation|4|||
16970224|NCT00915772|38114005|FG001|Overall Study|Protocol Violation|1|||
16970225|NCT00915772|38114006|FG002|Overall Study|Protocol Violation|2|||
16970226|NCT00915772|38114004|FG000|Overall Study|Lost to Follow-up|1|||
16970227|NCT00915772|38114005|FG001|Overall Study|Lost to Follow-up|2|||
16970228|NCT00915772|38114006|FG002|Overall Study|Lost to Follow-up|2|||
16970229|NCT00915772|38114004|FG000|Overall Study|Lack of Efficacy|9|||
16970230|NCT00915772|38114005|FG001|Overall Study|Lack of Efficacy|15|||
16970231|NCT00915772|38114006|FG002|Overall Study|Lack of Efficacy|3|||
16970232|NCT00915772|38114004|FG000|Overall Study|Refused to continue trial medication|6|||
16970233|NCT00915772|38114005|FG001|Overall Study|Refused to continue trial medication|8|||
16970234|NCT00915772|38114006|FG002|Overall Study|Refused to continue trial medication|4|||
16970235|NCT00915772|38114004|FG000|Overall Study|Any other reason|4|||
16970236|NCT00915772|38114005|FG001|Overall Study|Any other reason|7|||
16970237|NCT00915772|38114006|FG002|Overall Study|Any other reason|7|||
16970238|NCT03848845|38114018|FG000|Overall Study|Lost to Follow-up|0|||
16970239|NCT03848845|38114019|FG001|Overall Study|Lost to Follow-up|1|||
16970240|NCT03848845|38114020|FG002|Overall Study|Lost to Follow-up|0|||
16970241|NCT03848845|38114018|FG000|Overall Study|Withdrawal by Subject|3|||
16970242|NCT03848845|38114019|FG001|Overall Study|Withdrawal by Subject|2|||
16970243|NCT03848845|38114020|FG002|Overall Study|Withdrawal by Subject|6|||
16970244|NCT03848845|38114018|FG000|Overall Study|In Follow-up|0|||
16970245|NCT03848845|38114019|FG001|Overall Study|In Follow-up|1|||
16970246|NCT03848845|38114020|FG002|Overall Study|In Follow-up|12|||
16970247|NCT03848845|38114018|FG000|Overall Study|On Study Treatment|0|||
16970248|NCT03848845|38114019|FG001|Overall Study|On Study Treatment|0|||
16970249|NCT03848845|38114020|FG002|Overall Study|On Study Treatment|4|||
16970250|NCT03848845|38114018|FG000|Overall Study|Physician Decision|0|||
16970251|NCT03848845|38114019|FG001|Overall Study|Physician Decision|0|||
16970252|NCT03848845|38114020|FG002|Overall Study|Physician Decision|1|||
16970253|NCT00912964|38114031|FG000|Overall Study|Eligibility criterion not met|1|||
16970254|NCT00912964|38114032|FG001|Overall Study|Eligibility criterion not met|1|||
16970255|NCT00912964|38114033|FG002|Overall Study|Eligibility criterion not met|0|||
16970256|NCT00912964|38114031|FG000|Overall Study|Adverse Event|15|||
16970257|NCT00912964|38114032|FG001|Overall Study|Adverse Event|18|||
16970258|NCT00912964|38114033|FG002|Overall Study|Adverse Event|12|||
16970259|NCT00912964|38114031|FG000|Overall Study|Lack of Efficacy|11|||
16970260|NCT00912964|38114032|FG001|Overall Study|Lack of Efficacy|4|||
16970261|NCT00912964|38114033|FG002|Overall Study|Lack of Efficacy|3|||
16970262|NCT00912964|38114031|FG000|Overall Study|Withdrawal by Subject|20|||
16970263|NCT00912964|38114032|FG001|Overall Study|Withdrawal by Subject|12|||
16970264|NCT00912964|38114033|FG002|Overall Study|Withdrawal by Subject|18|||
16970265|NCT00912964|38114031|FG000|Overall Study|Lost to Follow-up|4|||
16970266|NCT00912964|38114032|FG001|Overall Study|Lost to Follow-up|3|||
16970267|NCT00912964|38114033|FG002|Overall Study|Lost to Follow-up|3|||
16970268|NCT00912964|38114031|FG000|Overall Study|Protocol Violation|5|||
16970269|NCT00912964|38114032|FG001|Overall Study|Protocol Violation|3|||
16970270|NCT00912964|38114033|FG002|Overall Study|Protocol Violation|8|||
16970271|NCT00912964|38114031|FG000|Overall Study|Taking exclusionary medications|7|||
16970272|NCT00912964|38114032|FG001|Overall Study|Taking exclusionary medications|4|||
16970273|NCT00912964|38114033|FG002|Overall Study|Taking exclusionary medications|8|||
16970274|NCT00912964|38114031|FG000|Overall Study|Medical History|1|||
16970275|NCT00912964|38114032|FG001|Overall Study|Medical History|0|||
16970276|NCT00912964|38114033|FG002|Overall Study|Medical History|0|||
16970277|NCT00912964|38114031|FG000|Overall Study|Non-compliance with study procedures|2|||
16970278|NCT00912964|38114032|FG001|Overall Study|Non-compliance with study procedures|0|||
16970279|NCT00912964|38114033|FG002|Overall Study|Non-compliance with study procedures|0|||
16970280|NCT00912964|38114031|FG000|Overall Study|Violation of exclusion criterion|0|||
16970281|NCT00912964|38114032|FG001|Overall Study|Violation of exclusion criterion|0|||
16970282|NCT00912964|38114033|FG002|Overall Study|Violation of exclusion criterion|2|||
16970283|NCT00912964|38114031|FG000|Overall Study|Randomized but never received study drug|0|||
16970284|NCT00912964|38114032|FG001|Overall Study|Randomized but never received study drug|1|||
16970285|NCT00912964|38114033|FG002|Overall Study|Randomized but never received study drug|0|||
16970286|NCT00913744|38114043|FG000|Overall Study|Adverse Event|2|||
16970287|NCT00913744|38114044|FG001|Overall Study|Adverse Event|0|||
16970288|NCT00913744|38114043|FG000|Overall Study|Withdrawal by Subject|2|||
16970289|NCT00913744|38114044|FG001|Overall Study|Withdrawal by Subject|1|||
16970290|NCT00913744|38114043|FG000|Overall Study|Death|1|||
16970291|NCT00913744|38114044|FG001|Overall Study|Death|0|||
16970292|NCT00912808|38114052|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
16970293|NCT00912808|38114053|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
16970294|NCT00912808|38114052|FG000|Washout|Withdrawal by Subject|0|||
16970295|NCT00912808|38114053|FG001|Washout|Withdrawal by Subject|1|||
16970296|NCT00912808|38114052|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
16970297|NCT00912808|38114053|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
16970298|NCT00912808|38114052|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
16970299|NCT00912808|38114053|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
16970300|NCT00960531|38114070|FG000|Overall Study|Lack of Efficacy|1|||
16970301|NCT00960531|38114071|FG001|Overall Study|Lack of Efficacy|0|||
16970302|NCT00960531|38114072|FG002|Overall Study|Lack of Efficacy|0|||
16970303|NCT00960531|38114073|FG003|Overall Study|Lack of Efficacy|0|||
16970304|NCT00960531|38114074|FG004|Overall Study|Lack of Efficacy|0|||
16970305|NCT00960531|38114075|FG005|Overall Study|Lack of Efficacy|0|||
16970306|NCT00960531|38114076|FG006|Overall Study|Lack of Efficacy|0|||
16970307|NCT00960531|38114077|FG007|Overall Study|Lack of Efficacy|0|||
16970308|NCT00960531|38114078|FG008|Overall Study|Lack of Efficacy|0|||
16970309|NCT00960531|38114079|FG009|Overall Study|Lack of Efficacy|0|||
16970310|NCT00960531|38114070|FG000|Overall Study|Withdrawal by Subject|1|||
16970311|NCT00960531|38114071|FG001|Overall Study|Withdrawal by Subject|0|||
16970312|NCT00960531|38114072|FG002|Overall Study|Withdrawal by Subject|5|||
16970313|NCT00960531|38114073|FG003|Overall Study|Withdrawal by Subject|2|||
16970314|NCT00960531|38114074|FG004|Overall Study|Withdrawal by Subject|0|||
16970315|NCT00960531|38114075|FG005|Overall Study|Withdrawal by Subject|0|||
16970316|NCT00960531|38114076|FG006|Overall Study|Withdrawal by Subject|2|||
16970317|NCT00960531|38114077|FG007|Overall Study|Withdrawal by Subject|0|||
16970318|NCT00960531|38114078|FG008|Overall Study|Withdrawal by Subject|1|||
16970319|NCT00960531|38114079|FG009|Overall Study|Withdrawal by Subject|0|||
16970320|NCT00960531|38114070|FG000|Overall Study|Caregiver Request|2|||
16970321|NCT00960531|38114071|FG001|Overall Study|Caregiver Request|0|||
16970322|NCT00960531|38114072|FG002|Overall Study|Caregiver Request|6|||
16970323|NCT00960531|38114073|FG003|Overall Study|Caregiver Request|5|||
16970324|NCT00960531|38114074|FG004|Overall Study|Caregiver Request|0|||
16970325|NCT00960531|38114075|FG005|Overall Study|Caregiver Request|2|||
16970326|NCT00960531|38114076|FG006|Overall Study|Caregiver Request|3|||
16970327|NCT00960531|38114077|FG007|Overall Study|Caregiver Request|1|||
16970328|NCT00960531|38114078|FG008|Overall Study|Caregiver Request|3|||
16970329|NCT00960531|38114079|FG009|Overall Study|Caregiver Request|0|||
16970330|NCT00960531|38114070|FG000|Overall Study|Investigator Request|0|||
16970331|NCT00960531|38114071|FG001|Overall Study|Investigator Request|0|||
16970332|NCT00960531|38114072|FG002|Overall Study|Investigator Request|1|||
16970333|NCT00960531|38114073|FG003|Overall Study|Investigator Request|0|||
16970334|NCT00960531|38114074|FG004|Overall Study|Investigator Request|0|||
16970335|NCT00960531|38114075|FG005|Overall Study|Investigator Request|0|||
16970336|NCT00960531|38114076|FG006|Overall Study|Investigator Request|0|||
16970337|NCT00960531|38114077|FG007|Overall Study|Investigator Request|0|||
16970338|NCT00960531|38114078|FG008|Overall Study|Investigator Request|0|||
16970339|NCT00960531|38114079|FG009|Overall Study|Investigator Request|0|||
16970340|NCT00960531|38114070|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
16970341|NCT00960531|38114071|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
16970342|NCT00960531|38114072|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
16970343|NCT00960531|38114073|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
16970344|NCT00960531|38114074|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
16970345|NCT00960531|38114075|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
16970346|NCT00960531|38114076|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
16970347|NCT00960531|38114077|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
16970348|NCT00960531|38114078|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
16970349|NCT00960531|38114079|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
16970350|NCT00960531|38114070|FG000|Overall Study|Lost to Follow-up|0|||
16970351|NCT00960531|38114071|FG001|Overall Study|Lost to Follow-up|0|||
16970352|NCT00960531|38114072|FG002|Overall Study|Lost to Follow-up|1|||
16970353|NCT00960531|38114073|FG003|Overall Study|Lost to Follow-up|0|||
16970354|NCT00960531|38114074|FG004|Overall Study|Lost to Follow-up|0|||
16970355|NCT00960531|38114075|FG005|Overall Study|Lost to Follow-up|0|||
16970356|NCT00960531|38114076|FG006|Overall Study|Lost to Follow-up|1|||
16970357|NCT00960531|38114077|FG007|Overall Study|Lost to Follow-up|0|||
16970358|NCT00960531|38114078|FG008|Overall Study|Lost to Follow-up|0|||
16970359|NCT00960531|38114079|FG009|Overall Study|Lost to Follow-up|0|||
16970360|NCT00960531|38114070|FG000|Overall Study|Failed to Return|2|||
16970361|NCT00960531|38114071|FG001|Overall Study|Failed to Return|0|||
16970362|NCT00960531|38114072|FG002|Overall Study|Failed to Return|0|||
16970363|NCT00960531|38114073|FG003|Overall Study|Failed to Return|0|||
16970364|NCT00960531|38114074|FG004|Overall Study|Failed to Return|0|||
16970365|NCT00960531|38114075|FG005|Overall Study|Failed to Return|0|||
16970366|NCT00960531|38114076|FG006|Overall Study|Failed to Return|0|||
16970367|NCT00960531|38114077|FG007|Overall Study|Failed to Return|2|||
16970368|NCT00960531|38114078|FG008|Overall Study|Failed to Return|0|||
16970369|NCT00960531|38114079|FG009|Overall Study|Failed to Return|0|||
16970370|NCT00960531|38114070|FG000|Overall Study|Adverse Event (AE)|2|||
16970371|NCT00960531|38114071|FG001|Overall Study|Adverse Event (AE)|0|||
16970372|NCT00960531|38114072|FG002|Overall Study|Adverse Event (AE)|0|||
16970373|NCT00960531|38114073|FG003|Overall Study|Adverse Event (AE)|0|||
16970374|NCT00960531|38114074|FG004|Overall Study|Adverse Event (AE)|0|||
16970375|NCT00960531|38114075|FG005|Overall Study|Adverse Event (AE)|1|||
16970376|NCT00960531|38114076|FG006|Overall Study|Adverse Event (AE)|2|||
16970377|NCT00960531|38114077|FG007|Overall Study|Adverse Event (AE)|0|||
16970378|NCT00960531|38114078|FG008|Overall Study|Adverse Event (AE)|2|||
16970379|NCT00960531|38114079|FG009|Overall Study|Adverse Event (AE)|0|||
16970380|NCT00960531|38114070|FG000|Overall Study|Reason not Specified|2|||
16970381|NCT00960531|38114071|FG001|Overall Study|Reason not Specified|1|||
16970382|NCT00960531|38114072|FG002|Overall Study|Reason not Specified|13|||
16970383|NCT00960531|38114073|FG003|Overall Study|Reason not Specified|1|||
16970384|NCT00960531|38114074|FG004|Overall Study|Reason not Specified|2|||
16970385|NCT00960531|38114075|FG005|Overall Study|Reason not Specified|0|||
16970386|NCT00960531|38114076|FG006|Overall Study|Reason not Specified|16|||
16970387|NCT00960531|38114077|FG007|Overall Study|Reason not Specified|0|||
16970388|NCT00960531|38114078|FG008|Overall Study|Reason not Specified|8|||
16970389|NCT00960531|38114079|FG009|Overall Study|Reason not Specified|1|||
16970390|NCT00960375|38114107|FG000|Overall Study|Lost to Follow-up|20|||
16970391|NCT00960375|38114108|FG001|Overall Study|Lost to Follow-up|22|||
16970392|NCT00957801|38114131|FG000|Overall Study|Withdrawal by Subject|0|||
16970393|NCT00957801|38114132|FG001|Overall Study|Withdrawal by Subject|0|||
16970394|NCT00957801|38114133|FG002|Overall Study|Withdrawal by Subject|0|||
16970395|NCT00957801|38114134|FG003|Overall Study|Withdrawal by Subject|1|||
16970396|NCT00957723|38114144|FG000|Overall Study|Death|3|||
16970397|NCT00957723|38114144|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
16970398|NCT00957723|38114144|FG000|Overall Study|Lost to Follow-up|8|||
16970399|NCT00957723|38114144|FG000|Overall Study|Withdrawal by Subject|24|||
16970400|NCT00957723|38114144|FG000|Overall Study|Investigative Site Terminated|61|||
16970401|NCT00957723|38114144|FG000|Overall Study|Intercurrent Illness|2|||
16970402|NCT00957723|38114144|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
16970403|NCT03778021|38114152|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
16970404|NCT03778021|38114153|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
16970405|NCT00911170|38114162|FG000|Treatment Period|Randomized in error|1|||
16970406|NCT00911170|38114163|FG001|Treatment Period|Randomized in error|1|||
16970407|NCT00911170|38114162|FG000|Treatment Period|Ineligibility determined|1|||
16970408|NCT00911170|38114163|FG001|Treatment Period|Ineligibility determined|3|||
16970409|NCT00911170|38114162|FG000|Treatment Period|Protocol deviation|1|||
16970410|NCT00911170|38114163|FG001|Treatment Period|Protocol deviation|2|||
16970411|NCT00911170|38114162|FG000|Treatment Period|Adverse Event|9|||
16970412|NCT00911170|38114163|FG001|Treatment Period|Adverse Event|10|||
16970413|NCT00911170|38114162|FG000|Treatment Period|Withdrawal by Subject|4|||
16970414|NCT00911170|38114163|FG001|Treatment Period|Withdrawal by Subject|4|||
16970415|NCT00911170|38114162|FG000|Treatment Period|Disease progression|0|||
16970416|NCT00911170|38114163|FG001|Treatment Period|Disease progression|2|||
16970417|NCT00911170|38114162|FG000|Treatment Period|Physician Decision|5|||
16780068|NCT02181634|37719139|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
16970418|NCT00911170|38114163|FG001|Treatment Period|Physician Decision|5|||
16970419|NCT00911170|38114162|FG000|Treatment Period|Lost to Follow-up|0|||
16970420|NCT00911170|38114163|FG001|Treatment Period|Lost to Follow-up|1|||
16970421|NCT00911170|38114162|FG000|Treatment Period|Death|6|||
16970422|NCT00911170|38114163|FG001|Treatment Period|Death|9|||
16970423|NCT00911170|38114162|FG000|Long Term Follow-Up|Continuing in study|274|||
16970424|NCT00911170|38114163|FG001|Long Term Follow-Up|Continuing in study|269|||
16970425|NCT00911170|38114162|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
16970426|NCT00911170|38114163|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
16970427|NCT00911170|38114162|FG000|Long Term Follow-Up|Physician Decision|5|||
16970428|NCT00911170|38114163|FG001|Long Term Follow-Up|Physician Decision|4|||
16970429|NCT00911170|38114162|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
16970430|NCT00911170|38114163|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
16970431|NCT00911170|38114162|FG000|Long Term Follow-Up|Death|116|||
16970432|NCT00911170|38114163|FG001|Long Term Follow-Up|Death|121|||
16970433|NCT01167881|38114171|FG000|Overall Study|Adverse Event|47|||
16970434|NCT01167881|38114172|FG001|Overall Study|Adverse Event|51|||
16970435|NCT01167881|38114171|FG000|Overall Study|Lack of Efficacy|4|||
16970436|NCT01167881|38114172|FG001|Overall Study|Lack of Efficacy|7|||
16970437|NCT01167881|38114171|FG000|Overall Study|Non compliant with protocol|9|||
16970438|NCT01167881|38114172|FG001|Overall Study|Non compliant with protocol|18|||
16970439|NCT01167881|38114171|FG000|Overall Study|Lost to Follow-up|19|||
16970440|NCT01167881|38114172|FG001|Overall Study|Lost to Follow-up|20|||
16970441|NCT01167881|38114171|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
16970442|NCT01167881|38114172|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
16970443|NCT01167881|38114171|FG000|Overall Study|Not treated|4|||
16970444|NCT01167881|38114172|FG001|Overall Study|Not treated|0|||
16970445|NCT01167881|38114171|FG000|Overall Study|Other not defined above|31|||
16970446|NCT01167881|38114172|FG001|Overall Study|Other not defined above|55|||
16970447|NCT00960063|38114181|FG000|Overall Study|Adverse Event|1|||
16970448|NCT00960063|38114182|FG001|Overall Study|Adverse Event|0|||
16970449|NCT00960063|38114183|FG002|Overall Study|Adverse Event|0|||
16970450|NCT00960063|38114181|FG000|Overall Study|Progression of Disease|0|||
16970451|NCT00960063|38114182|FG001|Overall Study|Progression of Disease|0|||
16970452|NCT00960063|38114183|FG002|Overall Study|Progression of Disease|3|||
16970453|NCT00959907|38114193|FG000|Overall Study|Protocol Violation|0|||
16970454|NCT00959907|38114194|FG001|Overall Study|Protocol Violation|1|||
16970455|NCT00959907|38114193|FG000|Overall Study|Adverse Event|1|||
16970456|NCT00959907|38114194|FG001|Overall Study|Adverse Event|0|||
16970457|NCT00959907|38114193|FG000|Overall Study|Withdrawal by Subject|2|||
16970458|NCT00959907|38114194|FG001|Overall Study|Withdrawal by Subject|0|||
16970459|NCT00912340|38114203|FG000|Overall Study|Adverse Event|2|||
16970460|NCT00912340|38114204|FG001|Overall Study|Adverse Event|4|||
16970461|NCT00912340|38114205|FG002|Overall Study|Adverse Event|0|||
16970462|NCT00912340|38114203|FG000|Overall Study|Protocol revised to remove arm|0|||
16970463|NCT00912340|38114204|FG001|Overall Study|Protocol revised to remove arm|0|||
16970464|NCT00912340|38114205|FG002|Overall Study|Protocol revised to remove arm|4|||
16970465|NCT01167257|38114215|FG000|Overall Study|Lost to Follow-up|2|||
16970466|NCT01167257|38114216|FG001|Overall Study|Lost to Follow-up|2|||
16970467|NCT01167257|38114215|FG000|Overall Study|Withdrew consent|1|||
16970468|NCT01167257|38114216|FG001|Overall Study|Withdrew consent|1|||
16970469|NCT01119846|38114229|FG000|Overall Study|Adverse Event|1|||
16970470|NCT01119846|38114230|FG001|Overall Study|Adverse Event|0|||
16970471|NCT01119846|38114231|FG002|Overall Study|Adverse Event|6|||
16970472|NCT01119846|38114229|FG000|Overall Study|Physician Decision|1|||
16970473|NCT01119846|38114230|FG001|Overall Study|Physician Decision|0|||
16970474|NCT01119846|38114231|FG002|Overall Study|Physician Decision|0|||
16970475|NCT01119846|38114229|FG000|Overall Study|Protocol Violation|0|||
16970476|NCT01119846|38114230|FG001|Overall Study|Protocol Violation|0|||
16970477|NCT01119846|38114231|FG002|Overall Study|Protocol Violation|1|||
16970478|NCT01119846|38114229|FG000|Overall Study|Withdrawal by Subject|0|||
16970479|NCT01119846|38114230|FG001|Overall Study|Withdrawal by Subject|0|||
16970480|NCT01119846|38114231|FG002|Overall Study|Withdrawal by Subject|4|||
16970481|NCT01167179|38114268|FG000|Overall Study|disease recurrence|4|||
16970482|NCT01167179|38114269|FG001|Overall Study|disease recurrence|4|||
16970483|NCT01167179|38114268|FG000|Overall Study|Death|4|||
16970484|NCT01167179|38114269|FG001|Overall Study|Death|10|||
16970485|NCT01167179|38114268|FG000|Overall Study|Withdrawal by Subject|1|||
16970486|NCT01167179|38114269|FG001|Overall Study|Withdrawal by Subject|2|||
16970487|NCT01167179|38114268|FG000|Overall Study|diverse|6|||
16970488|NCT01167179|38114269|FG001|Overall Study|diverse|5|||
16970489|NCT01167023|38114342|FG000|Overall Study|Lost to Follow-up|0|||
16970490|NCT01167023|38114343|FG001|Overall Study|Lost to Follow-up|1|||
16970491|NCT01167023|38114344|FG002|Overall Study|Lost to Follow-up|1|||
16970492|NCT01167023|38114342|FG000|Overall Study|Screen Failure|0|||
16970493|NCT01167023|38114343|FG001|Overall Study|Screen Failure|1|||
16970494|NCT01167023|38114344|FG002|Overall Study|Screen Failure|0|||
16970495|NCT01167023|38114342|FG000|Overall Study|Sponsor Decision|0|||
16970496|NCT01167023|38114343|FG001|Overall Study|Sponsor Decision|1|||
16970497|NCT01167023|38114344|FG002|Overall Study|Sponsor Decision|0|||
16970498|NCT01167023|38114342|FG000|Overall Study|Withdrawal by Subject|0|||
16970499|NCT01167023|38114343|FG001|Overall Study|Withdrawal by Subject|0|||
16970500|NCT01167023|38114344|FG002|Overall Study|Withdrawal by Subject|1|||
16970501|NCT03484117|38114352|FG000|Overall Study|Lost to Follow-up|1|||
16970502|NCT03484117|38114353|FG001|Overall Study|Lost to Follow-up|3|||
16970503|NCT03484117|38114352|FG000|Overall Study|Declined participation in exit assess|1|||
16970504|NCT03484117|38114353|FG001|Overall Study|Declined participation in exit assess|1|||
16970505|NCT01166945|38114361|FG000|Randomized|diagnosed with Group A strep|4|||
16970506|NCT01166945|38114362|FG001|Randomized|diagnosed with Group A strep|4|||
16970507|NCT01166945|38114361|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
16970508|NCT01166945|38114362|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
16970509|NCT01166945|38114361|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
16970510|NCT01166945|38114362|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
16970511|NCT01166945|38114361|FG000|Day 30|Lost to Follow-up|4|||
16970512|NCT01166945|38114362|FG001|Day 30|Lost to Follow-up|3|||
16970513|NCT00910000|38114376|FG000|Overall Study|Adverse Event|0|||
16970514|NCT00910000|38114377|FG001|Overall Study|Adverse Event|3|||
16970515|NCT00910000|38114378|FG002|Overall Study|Adverse Event|2|||
16970516|NCT00910000|38114379|FG003|Overall Study|Adverse Event|2|||
16780069|NCT02181634|37719139|FG000|Overall Study|Ineligible|1|||
16780070|NCT02181634|37719139|FG000|Overall Study|Max number of dose reduction|1|||
16970517|NCT00910000|38114380|FG004|Overall Study|Adverse Event|0|||
16970518|NCT00910000|38114381|FG005|Overall Study|Adverse Event|1|||
16970519|NCT00910000|38114376|FG000|Overall Study|Withdrawal by Subject|0|||
16970520|NCT00910000|38114377|FG001|Overall Study|Withdrawal by Subject|0|||
16970521|NCT00910000|38114378|FG002|Overall Study|Withdrawal by Subject|1|||
16970522|NCT00910000|38114379|FG003|Overall Study|Withdrawal by Subject|0|||
16970523|NCT00910000|38114380|FG004|Overall Study|Withdrawal by Subject|1|||
16970524|NCT00910000|38114381|FG005|Overall Study|Withdrawal by Subject|0|||
16970525|NCT01119768|38114402|FG000|Treatment Period|Lack of Efficacy|18|||
16970526|NCT01119768|38114403|FG001|Treatment Period|Lack of Efficacy|25|||
16970527|NCT01165307|38114411|FG000|Overall Study|Lost to Follow-up|11|||
16970528|NCT01165307|38114412|FG001|Overall Study|Lost to Follow-up|3|||
16970529|NCT01165307|38114411|FG000|Overall Study|Withdrawal by Subject|2|||
16970530|NCT01165307|38114412|FG001|Overall Study|Withdrawal by Subject|0|||
16970531|NCT01165307|38114411|FG000|Overall Study|Subject not available for contact|1|||
16970532|NCT01165307|38114412|FG001|Overall Study|Subject not available for contact|0|||
16970533|NCT00960999|38114420|FG000|Overall Study|Withdrawal by Subject|1|||
16970534|NCT00960999|38114421|FG001|Overall Study|Withdrawal by Subject|0|||
16970535|NCT00960999|38114420|FG000|Overall Study|Protocol Violation|5|||
16970536|NCT00960999|38114421|FG001|Overall Study|Protocol Violation|2|||
16970537|NCT00960999|38114420|FG000|Overall Study|RT dose constraints not met|2|||
16970538|NCT00960999|38114421|FG001|Overall Study|RT dose constraints not met|0|||
16970539|NCT01124838|38114429|FG000|Overall Study|Miscellaneous|4|||
16970540|NCT01124838|38114430|FG001|Overall Study|Miscellaneous|2|||
16970541|NCT01124838|38114429|FG000|Overall Study|Adverse Event|7|||
16970542|NCT01124838|38114430|FG001|Overall Study|Adverse Event|11|||
16970543|NCT01124838|38114429|FG000|Overall Study|Lack of Efficacy|2|||
16970544|NCT01124838|38114430|FG001|Overall Study|Lack of Efficacy|0|||
16970545|NCT01124838|38114429|FG000|Overall Study|Withdrawal by Subject|3|||
16970546|NCT01124838|38114430|FG001|Overall Study|Withdrawal by Subject|2|||
16970547|NCT01124838|38114429|FG000|Overall Study|Lost to Follow-up|2|||
16970548|NCT01124838|38114430|FG001|Overall Study|Lost to Follow-up|0|||
16970549|NCT00959751|38114440|FG000|Overall Study|Lost to Follow-up|2|||
16970550|NCT00959751|38114441|FG001|Overall Study|Lost to Follow-up|3|||
16970551|NCT00959751|38114440|FG000|Overall Study|Consent Withdrawn|0|||
16970552|NCT00959751|38114441|FG001|Overall Study|Consent Withdrawn|1|||
16970553|NCT00959751|38114440|FG000|Overall Study|Non-compliance to Study Procedures|0|||
16970554|NCT00959751|38114441|FG001|Overall Study|Non-compliance to Study Procedures|1|||
16970555|NCT00959751|38114440|FG000|Overall Study|No migraine headache without aura|7|||
16970556|NCT00959751|38114441|FG001|Overall Study|No migraine headache without aura|7|||
16970557|NCT00910858|38114450|FG000|Pharmacokinetic Phase|Adverse Event|1|||
16970558|NCT00910858|38114451|FG001|Pharmacokinetic Phase|Adverse Event|0|||
16970559|NCT00910858|38114452|FG002|Pharmacokinetic Phase|Adverse Event|0|||
16970560|NCT00910858|38114450|FG000|Monotherapy Phase|Adverse Event|3|||
16970561|NCT00910858|38114451|FG001|Monotherapy Phase|Adverse Event|2|||
16970562|NCT00910858|38114452|FG002|Monotherapy Phase|Adverse Event|0|||
16970563|NCT00910858|38114450|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
16970564|NCT00910858|38114451|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
17133999|NCT00064259|38275255|FG002|Overall Study|Adverse Event|0|||
16970565|NCT00910858|38114452|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
16970566|NCT00910858|38114450|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
16970567|NCT00910858|38114451|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
17028490|NCT00765674|38172854|FG000|Overall Study|Protocol Violation|2|||
17028491|NCT00765674|38172855|FG001|Overall Study|Protocol Violation|0|||
17028492|NCT00765674|38172856|FG002|Overall Study|Protocol Violation|1|||
17028493|NCT00765674|38172857|FG003|Overall Study|Protocol Violation|0|||
17028494|NCT00765674|38172854|FG000|Overall Study|Withdrawal by Subject|5|||
17028495|NCT00765674|38172855|FG001|Overall Study|Withdrawal by Subject|7|||
17028496|NCT00765674|38172856|FG002|Overall Study|Withdrawal by Subject|3|||
17028497|NCT00765674|38172857|FG003|Overall Study|Withdrawal by Subject|8|||
17028498|NCT00765674|38172854|FG000|Overall Study|Lost to Follow-up|4|||
17028499|NCT00765674|38172855|FG001|Overall Study|Lost to Follow-up|6|||
17028500|NCT00765674|38172856|FG002|Overall Study|Lost to Follow-up|2|||
17028501|NCT00765674|38172857|FG003|Overall Study|Lost to Follow-up|1|||
17028502|NCT00765674|38172854|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
17028503|NCT00765674|38172855|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
17028504|NCT00765674|38172856|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
17028505|NCT00765674|38172857|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
17028506|NCT00765362|38172867|FG000|Overall Study|Death|9|||
17028507|NCT00765362|38172867|FG000|Overall Study|Adverse Event|2|||
17028508|NCT00765362|38172867|FG000|Overall Study|Protocol Violation|18|||
17028509|NCT00765362|38172867|FG000|Overall Study|Withdrawal by Subject|13|||
17028510|NCT00765362|38172867|FG000|Overall Study|Lost to Follow-up|95|||
17028511|NCT00586898|38172871|FG000|Overall Study|Adverse Event|1|||
16970568|NCT00910858|38114452|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
16970569|NCT00910858|38114450|FG000|Monotherapy Phase|Protocol Violation|1|||
16970570|NCT00910858|38114451|FG001|Monotherapy Phase|Protocol Violation|0|||
16970571|NCT00910858|38114452|FG002|Monotherapy Phase|Protocol Violation|0|||
16970572|NCT00910858|38114450|FG000|Monotherapy Phase|Other|3|||
16970573|NCT00910858|38114451|FG001|Monotherapy Phase|Other|4|||
16970574|NCT00910858|38114452|FG002|Monotherapy Phase|Other|2|||
16970575|NCT00910858|38114450|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
16970576|NCT00910858|38114451|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
16970577|NCT00910858|38114452|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
16970578|NCT00910858|38114450|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
16970579|NCT00910858|38114451|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
16970580|NCT00910858|38114452|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
16970581|NCT00910858|38114450|FG000|Combined Treatment Phase|Protocol Violation|1|||
16970582|NCT00910858|38114451|FG001|Combined Treatment Phase|Protocol Violation|0|||
16970583|NCT00910858|38114452|FG002|Combined Treatment Phase|Protocol Violation|0|||
16970584|NCT00910858|38114450|FG000|Combined Treatment Phase|Other|0|||
16970585|NCT00910858|38114451|FG001|Combined Treatment Phase|Other|2|||
16970586|NCT00910858|38114452|FG002|Combined Treatment Phase|Other|1|||
16970587|NCT00598975|38114470|FG000|Overall Study|Adverse Event|1|||
16970588|NCT00598975|38114471|FG001|Overall Study|Adverse Event|1|||
16970589|NCT00598975|38114470|FG000|Overall Study|Brain metastases|1|||
16970590|NCT00598975|38114471|FG001|Overall Study|Brain metastases|0|||
17028512|NCT00586898|38172871|FG000|Overall Study|Patiemt Non-compliance|1|||
17028513|NCT00586898|38172871|FG000|Overall Study|Evaluable for Toxicity Only|5|||
17028514|NCT04912245|38172875|FG000|Overall Study|Withdrawal by Subject|21|||
17028515|NCT04912245|38172876|FG001|Overall Study|Withdrawal by Subject|4|||
17028516|NCT04912245|38172875|FG000|Overall Study|Lost to Follow-up|5|||
17028517|NCT04912245|38172876|FG001|Overall Study|Lost to Follow-up|11|||
16970591|NCT00598975|38114470|FG000|Overall Study|Withdrawal by Subject|1|||
16997761|NCT00962390|38141774|FG003|Overall Study|Protocol Violation|0|||
16970592|NCT00598975|38114471|FG001|Overall Study|Withdrawal by Subject|1|||
16970593|NCT00598975|38114470|FG000|Overall Study|Withdrawal of consent|0|||
16970594|NCT00598975|38114471|FG001|Overall Study|Withdrawal of consent|1|||
16970595|NCT00598975|38114470|FG000|Overall Study|Disease progression|8|||
17028518|NCT00796991|38172883|FG000|Overall Study|Adverse Event|0|||
16970596|NCT00598975|38114471|FG001|Overall Study|Disease progression|3|||
16970597|NCT00598975|38114470|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
16970598|NCT00598975|38114471|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
16970599|NCT00957021|38114479|FG000|Overall Study|Death|5|||
16970600|NCT00957021|38114479|FG000|Overall Study|Lost to Follow-up|8|||
16970601|NCT00957021|38114479|FG000|Overall Study|Withdrawal by Subject|34|||
16970602|NCT00957021|38114479|FG000|Overall Study|No 2 yr ROM data|35|||
16970603|NCT00957021|38114479|FG000|Overall Study|Revised study component by 2 yr visit|8|||
16970604|NCT00957021|38114479|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
16970605|NCT00957021|38114479|FG000|Overall Study|Surgery Cancelled|9|||
16970606|NCT00957021|38114479|FG000|Overall Study|Termination due to language issue|2|||
16970607|NCT01124604|38114486|FG000|Overall Study|Adverse Event|10|||
16970608|NCT01124604|38114487|FG001|Overall Study|Adverse Event|1|||
16970609|NCT01124604|38114486|FG000|Overall Study|Lack of Efficacy|1|||
16970610|NCT01124604|38114487|FG001|Overall Study|Lack of Efficacy|0|||
16970611|NCT01124604|38114486|FG000|Overall Study|Withdrawal by Subject|4|||
16970612|NCT01124604|38114487|FG001|Overall Study|Withdrawal by Subject|0|||
16970613|NCT01124604|38114486|FG000|Overall Study|Disease Progression|0|||
16970614|NCT01124604|38114487|FG001|Overall Study|Disease Progression|1|||
16970615|NCT00909844|38114493|FG000|Overall Study|Adverse Event|1|||
16970616|NCT00909844|38114493|FG000|Overall Study|Withdrawal by Subject|1|||
16970617|NCT00909844|38114493|FG000|Overall Study|Lost to Follow-up|2|||
16970618|NCT01124448|38114500|FG000|Overall Study|Lost to Follow-up|0|||
17028519|NCT00796991|38172884|FG001|Overall Study|Adverse Event|0|||
17028520|NCT00796991|38172885|FG002|Overall Study|Adverse Event|1|||
17028521|NCT00796991|38172883|FG000|Overall Study|Death|2|||
17028522|NCT00796991|38172884|FG001|Overall Study|Death|0|||
17028523|NCT00796991|38172885|FG002|Overall Study|Death|0|||
17028524|NCT00796991|38172883|FG000|Overall Study|Disease Progression|10|||
17028525|NCT00796991|38172884|FG001|Overall Study|Disease Progression|9|||
17028526|NCT00796991|38172885|FG002|Overall Study|Disease Progression|7|||
17028527|NCT00796991|38172883|FG000|Overall Study|Study Drug Toxicity|3|||
17028528|NCT00796991|38172884|FG001|Overall Study|Study Drug Toxicity|3|||
17028529|NCT00796991|38172885|FG002|Overall Study|Study Drug Toxicity|5|||
17028530|NCT00796991|38172883|FG000|Overall Study|Withdrawal by Subject|0|||
17028531|NCT00796991|38172884|FG001|Overall Study|Withdrawal by Subject|0|||
17028532|NCT00796991|38172885|FG002|Overall Study|Withdrawal by Subject|1|||
17028533|NCT00799487|38172896|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
17028534|NCT00799487|38172897|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
17028535|NCT00799487|38172898|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
17028536|NCT00799487|38172896|FG000|Dose Adjustment Period|Adverse Event|2|||
16780071|NCT02181634|37719139|FG000|Overall Study|Symptomatic progression|1|||
16970619|NCT01124448|38114501|FG001|Overall Study|Lost to Follow-up|3|||
16970620|NCT01124448|38114500|FG000|Overall Study|Protocol Violation|2|||
16970621|NCT01124448|38114501|FG001|Overall Study|Protocol Violation|0|||
16970622|NCT01124292|38114510|FG000|Overall Study|Lost to Follow-up|2|||
16970623|NCT01124292|38114511|FG001|Overall Study|Lost to Follow-up|4|||
16970624|NCT01124292|38114512|FG002|Overall Study|Lost to Follow-up|3|||
16970625|NCT01124292|38114510|FG000|Overall Study|Physician Decision|0|||
16970626|NCT01124292|38114511|FG001|Overall Study|Physician Decision|3|||
16970627|NCT01124292|38114512|FG002|Overall Study|Physician Decision|2|||
16970628|NCT01124292|38114510|FG000|Overall Study|Withdrawal by Subject|0|||
16970629|NCT01124292|38114511|FG001|Overall Study|Withdrawal by Subject|6|||
16970630|NCT01124292|38114512|FG002|Overall Study|Withdrawal by Subject|2|||
16970631|NCT01124292|38114510|FG000|Overall Study|medical issue unrelated to the study|0|||
16970632|NCT01124292|38114511|FG001|Overall Study|medical issue unrelated to the study|0|||
16970633|NCT01124292|38114512|FG002|Overall Study|medical issue unrelated to the study|2|||
16970634|NCT01124292|38114510|FG000|Overall Study|piercing track closed|0|||
16970635|NCT01124292|38114511|FG001|Overall Study|piercing track closed|2|||
16970636|NCT01124292|38114512|FG002|Overall Study|piercing track closed|1|||
16970637|NCT01136772|38114525|FG000|Overall Study|Adverse Event|15|||
16970638|NCT01136772|38114526|FG001|Overall Study|Adverse Event|14|||
16970639|NCT01136772|38114525|FG000|Overall Study|Lack of Efficacy|42|||
17028537|NCT00799487|38172897|FG001|Dose Adjustment Period|Adverse Event|0|||
16970640|NCT01136772|38114526|FG001|Overall Study|Lack of Efficacy|39|||
16970641|NCT01136772|38114525|FG000|Overall Study|Administrative|14|||
16970642|NCT01136772|38114526|FG001|Overall Study|Administrative|12|||
16970643|NCT01136772|38114525|FG000|Overall Study|Withdrawal by Subject|33|||
16970644|NCT01136772|38114526|FG001|Overall Study|Withdrawal by Subject|36|||
16970645|NCT01136772|38114525|FG000|Overall Study|Did not receive injection|10|||
16970646|NCT01136772|38114526|FG001|Overall Study|Did not receive injection|7|||
16970647|NCT01136772|38114525|FG000|Overall Study|Did not follow up after first injection|2|||
16970648|NCT01136772|38114526|FG001|Overall Study|Did not follow up after first injection|2|||
16970649|NCT00909532|38114534|FG000|Overall Study|Adverse Event|4|||
16970650|NCT00909532|38114535|FG001|Overall Study|Adverse Event|1|||
16970651|NCT00909532|38114534|FG000|Overall Study|Pregnancy|0|||
16970652|NCT00909532|38114535|FG001|Overall Study|Pregnancy|1|||
16970653|NCT00909532|38114534|FG000|Overall Study|Prohibited Medication|2|||
16970654|NCT00909532|38114535|FG001|Overall Study|Prohibited Medication|1|||
16970655|NCT00909532|38114534|FG000|Overall Study|Withdrawal of Consent|1|||
16970656|NCT00909532|38114535|FG001|Overall Study|Withdrawal of Consent|1|||
16970657|NCT00909532|38114534|FG000|Overall Study|Noncompliance with Study Requirements|0|||
16970658|NCT00909532|38114535|FG001|Overall Study|Noncompliance with Study Requirements|2|||
16970659|NCT00909532|38114534|FG000|Overall Study|Physician Decision|1|||
16970660|NCT00909532|38114535|FG001|Overall Study|Physician Decision|0|||
16970661|NCT00909532|38114534|FG000|Overall Study|Wrong Genotype|1|||
16970662|NCT00909532|38114535|FG001|Overall Study|Wrong Genotype|0|||
16970663|NCT00909532|38114534|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
16970664|NCT00909532|38114535|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
16970665|NCT01136382|38114544|FG000|Overall Study|Other|8|||
16970666|NCT01136382|38114545|FG001|Overall Study|Other|3|||
16970667|NCT01136382|38114544|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
16970668|NCT01136382|38114545|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
16970669|NCT01136382|38114544|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
16970670|NCT01136382|38114545|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
16970671|NCT01136382|38114544|FG000|Overall Study|Withdrawal by Subject|4|||
16970672|NCT01136382|38114545|FG001|Overall Study|Withdrawal by Subject|1|||
16970673|NCT00912028|38114554|FG000|Overall Study|Lost to Follow-up|2|||
16970674|NCT00912028|38114555|FG001|Overall Study|Lost to Follow-up|3|||
16970675|NCT00912028|38114556|FG002|Overall Study|Lost to Follow-up|0|||
16970676|NCT00912028|38114557|FG003|Overall Study|Lost to Follow-up|1|||
16970677|NCT00912028|38114558|FG004|Overall Study|Lost to Follow-up|3|||
16970678|NCT00912028|38114554|FG000|Overall Study|Withdrawal by Subject|3|||
16970679|NCT00912028|38114555|FG001|Overall Study|Withdrawal by Subject|0|||
16970680|NCT00912028|38114556|FG002|Overall Study|Withdrawal by Subject|0|||
16970681|NCT00912028|38114557|FG003|Overall Study|Withdrawal by Subject|0|||
16970682|NCT00912028|38114558|FG004|Overall Study|Withdrawal by Subject|0|||
16970683|NCT02731729|38114570|FG000|Overall Study|Death|2|||
16970684|NCT02731729|38114571|FG001|Overall Study|Death|2|||
16970685|NCT02731729|38114570|FG000|Overall Study|Study terminated by Sponsor|6|||
16970686|NCT02731729|38114571|FG001|Overall Study|Study terminated by Sponsor|6|||
16970687|NCT02731729|38114570|FG000|Overall Study|Withdrawal by Subject|1|||
16970688|NCT02731729|38114571|FG001|Overall Study|Withdrawal by Subject|0|||
16970689|NCT01119066|38114581|FG000|Overall Study|Withdrawal by Subject|4|||
16970690|NCT01119066|38114582|FG001|Overall Study|Withdrawal by Subject|6|||
16970691|NCT01119066|38114583|FG002|Overall Study|Withdrawal by Subject|0|||
16970692|NCT01119066|38114584|FG003|Overall Study|Withdrawal by Subject|0|||
16970693|NCT01119066|38114581|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
16970694|NCT01119066|38114582|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
16970695|NCT01119066|38114583|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
16970696|NCT01119066|38114584|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
16970697|NCT01119066|38114581|FG000|Overall Study|Relapse identified before transplant|1|||
16970698|NCT01119066|38114582|FG001|Overall Study|Relapse identified before transplant|0|||
16970699|NCT01119066|38114583|FG002|Overall Study|Relapse identified before transplant|0|||
16970700|NCT01119066|38114584|FG003|Overall Study|Relapse identified before transplant|0|||
16970701|NCT01119066|38114581|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
16970702|NCT01119066|38114582|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
16970703|NCT01119066|38114583|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
16970704|NCT01119066|38114584|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
16970705|NCT01119066|38114581|FG000|Overall Study|Relapse identified before transplant|0|||
16970706|NCT01119066|38114582|FG001|Overall Study|Relapse identified before transplant|4|||
16970707|NCT01119066|38114583|FG002|Overall Study|Relapse identified before transplant|0|||
16970708|NCT01119066|38114584|FG003|Overall Study|Relapse identified before transplant|0|||
16970709|NCT00910624|38114598|FG000|Treatment Phase|Adverse Event|2|||
16970710|NCT00910624|38114599|FG001|Treatment Phase|Adverse Event|6|||
16970711|NCT00910624|38114600|FG002|Treatment Phase|Adverse Event|6|||
16970712|NCT00910624|38114601|FG003|Treatment Phase|Adverse Event|0|||
16970713|NCT00910624|38114598|FG000|Treatment Phase|Treatment Failure|23|||
16970714|NCT00910624|38114599|FG001|Treatment Phase|Treatment Failure|10|||
16970715|NCT00910624|38114600|FG002|Treatment Phase|Treatment Failure|0|||
16970716|NCT00910624|38114601|FG003|Treatment Phase|Treatment Failure|0|||
16970717|NCT00910624|38114598|FG000|Treatment Phase|Lost to Follow-up|0|||
16970718|NCT00910624|38114599|FG001|Treatment Phase|Lost to Follow-up|0|||
16970719|NCT00910624|38114600|FG002|Treatment Phase|Lost to Follow-up|1|||
16970720|NCT00910624|38114601|FG003|Treatment Phase|Lost to Follow-up|0|||
16970721|NCT00910624|38114598|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
16970722|NCT00910624|38114599|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
16970723|NCT00910624|38114600|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
16970724|NCT00910624|38114601|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
16970725|NCT00910624|38114598|FG000|Treatment Phase|Withdrawal by Subject|2|||
16970726|NCT00910624|38114599|FG001|Treatment Phase|Withdrawal by Subject|1|||
16970727|NCT00910624|38114600|FG002|Treatment Phase|Withdrawal by Subject|0|||
16970728|NCT00910624|38114601|FG003|Treatment Phase|Withdrawal by Subject|0|||
16970729|NCT00910624|38114598|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
16970730|NCT00910624|38114599|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
16970731|NCT00910624|38114600|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
16970732|NCT00910624|38114601|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
16970733|NCT00910624|38114598|FG000|Follow-Up Phase|Adverse Event|0|||
16970734|NCT00910624|38114599|FG001|Follow-Up Phase|Adverse Event|0|||
16970735|NCT00910624|38114600|FG002|Follow-Up Phase|Adverse Event|1|||
16970736|NCT00910624|38114601|FG003|Follow-Up Phase|Adverse Event|0|||
16970737|NCT00910624|38114598|FG000|Follow-Up Phase|Lost to Follow-up|3|||
16970738|NCT00910624|38114599|FG001|Follow-Up Phase|Lost to Follow-up|1|||
16970739|NCT00910624|38114600|FG002|Follow-Up Phase|Lost to Follow-up|2|||
16970740|NCT00910624|38114601|FG003|Follow-Up Phase|Lost to Follow-up|0|||
16970741|NCT00910624|38114598|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
16970742|NCT00910624|38114599|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
16970743|NCT00910624|38114600|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
16970744|NCT00910624|38114601|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
16970745|NCT00910624|38114598|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
16970746|NCT00910624|38114599|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
16970747|NCT00910624|38114600|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
16970748|NCT00910624|38114601|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
16970749|NCT00910624|38114598|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
16970750|NCT00910624|38114599|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
16970751|NCT00910624|38114600|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
16970752|NCT00910624|38114601|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
16970753|NCT00910624|38114598|FG000|Follow-Up Phase|Administrative|0|||
16970754|NCT00910624|38114599|FG001|Follow-Up Phase|Administrative|1|||
16970755|NCT00910624|38114600|FG002|Follow-Up Phase|Administrative|1|||
16970756|NCT00910624|38114601|FG003|Follow-Up Phase|Administrative|0|||
16970757|NCT01123980|38114615|FG000|Overall Study|Adverse Event|1|||
16970758|NCT01123980|38114616|FG001|Overall Study|Adverse Event|1|||
16970759|NCT01123980|38114615|FG000|Overall Study|Lack of Efficacy|1|||
16970760|NCT01123980|38114616|FG001|Overall Study|Lack of Efficacy|0|||
16970761|NCT01123980|38114615|FG000|Overall Study|Physician Decision|0|||
16970762|NCT01123980|38114616|FG001|Overall Study|Physician Decision|1|||
16970763|NCT01123980|38114615|FG000|Overall Study|Lost to Follow-up|0|||
16970764|NCT01123980|38114616|FG001|Overall Study|Lost to Follow-up|6|||
16970765|NCT01123980|38114615|FG000|Overall Study|Protocol Violation|6|||
16970766|NCT01123980|38114616|FG001|Overall Study|Protocol Violation|6|||
16970767|NCT01123980|38114615|FG000|Overall Study|Withdrawal by Subject|5|||
16970768|NCT01123980|38114616|FG001|Overall Study|Withdrawal by Subject|3|||
16970769|NCT01123980|38114615|FG000|Overall Study|Unclassified|6|||
16970770|NCT01123980|38114616|FG001|Overall Study|Unclassified|7|||
16970771|NCT01118520|38114625|FG000|Overall Study|AAA repair|9|||
16970772|NCT01118520|38114626|FG001|Overall Study|AAA repair|7|||
16970773|NCT01118520|38114627|FG002|Overall Study|AAA repair|9|||
16970774|NCT01118520|38114625|FG000|Overall Study|Adverse Event|3|||
16970775|NCT01118520|38114626|FG001|Overall Study|Adverse Event|3|||
16970776|NCT01118520|38114627|FG002|Overall Study|Adverse Event|3|||
16970777|NCT01118520|38114625|FG000|Overall Study|Withdrawal by Subject|8|||
16970778|NCT01118520|38114626|FG001|Overall Study|Withdrawal by Subject|13|||
16970779|NCT01118520|38114627|FG002|Overall Study|Withdrawal by Subject|8|||
16970780|NCT01135992|38114635|FG000|Overall Study|Adverse Event|1|||
16970781|NCT01135992|38114635|FG000|Overall Study|Lack of Efficacy|1|||
16970782|NCT01135992|38114635|FG000|Overall Study|Protocol Violation|2|||
16970783|NCT01135992|38114635|FG000|Overall Study|Withdrawal criteria|10|||
16970784|NCT01135992|38114635|FG000|Overall Study|Unclassified|7|||
16970785|NCT00959049|38114645|FG000|Overall Study|Adverse Event|1|||
16970786|NCT00959049|38114646|FG001|Overall Study|Adverse Event|0|||
16970787|NCT00959049|38114647|FG002|Overall Study|Adverse Event|0|||
16970788|NCT00959049|38114648|FG003|Overall Study|Adverse Event|0|||
16970789|NCT00959049|38114649|FG004|Overall Study|Adverse Event|0|||
16970790|NCT00959049|38114650|FG005|Overall Study|Adverse Event|0|||
16970791|NCT00959049|38114645|FG000|Overall Study|Lost to Follow-up|17|||
16970792|NCT00959049|38114646|FG001|Overall Study|Lost to Follow-up|5|||
16970793|NCT00959049|38114647|FG002|Overall Study|Lost to Follow-up|1|||
16970794|NCT00959049|38114648|FG003|Overall Study|Lost to Follow-up|10|||
16970795|NCT00959049|38114649|FG004|Overall Study|Lost to Follow-up|9|||
16970796|NCT00959049|38114650|FG005|Overall Study|Lost to Follow-up|1|||
16970797|NCT00959049|38114645|FG000|Overall Study|Contraindicated medication|0|||
16970798|NCT00959049|38114646|FG001|Overall Study|Contraindicated medication|0|||
16970799|NCT00959049|38114647|FG002|Overall Study|Contraindicated medication|0|||
16970800|NCT00959049|38114648|FG003|Overall Study|Contraindicated medication|1|||
16970801|NCT00959049|38114649|FG004|Overall Study|Contraindicated medication|0|||
16970802|NCT00959049|38114650|FG005|Overall Study|Contraindicated medication|0|||
16970803|NCT00959049|38114645|FG000|Overall Study|Withdrawal by Subject|0|||
16970804|NCT00959049|38114646|FG001|Overall Study|Withdrawal by Subject|2|||
16970805|NCT00959049|38114647|FG002|Overall Study|Withdrawal by Subject|0|||
16970806|NCT00959049|38114648|FG003|Overall Study|Withdrawal by Subject|0|||
16970807|NCT00959049|38114649|FG004|Overall Study|Withdrawal by Subject|0|||
16970808|NCT00959049|38114650|FG005|Overall Study|Withdrawal by Subject|0|||
16970809|NCT00956943|38114677|FG000|Overall Study|Lost to Follow-up|9|||
16970810|NCT00956943|38114678|FG001|Overall Study|Lost to Follow-up|10|||
16970811|NCT00958893|38114684|FG000|Overall Study|Study prematurely terminated|4|||
16970812|NCT01135914|38114691|FG000|Overall Study|Withdrawal by Subject|1|||
16970813|NCT01135914|38114692|FG001|Overall Study|Withdrawal by Subject|3|||
16970814|NCT01135914|38114693|FG002|Overall Study|Withdrawal by Subject|6|||
16970815|NCT01135914|38114691|FG000|Overall Study|Lost to Follow-up|1|||
16970816|NCT01135914|38114692|FG001|Overall Study|Lost to Follow-up|0|||
16970817|NCT01135914|38114693|FG002|Overall Study|Lost to Follow-up|1|||
16970818|NCT01135914|38114691|FG000|Overall Study|Protocol Violation|0|||
16970819|NCT01135914|38114692|FG001|Overall Study|Protocol Violation|0|||
16970820|NCT01135914|38114693|FG002|Overall Study|Protocol Violation|3|||
16970821|NCT01135914|38114691|FG000|Overall Study|Lack of Efficacy|2|||
16970822|NCT01135914|38114692|FG001|Overall Study|Lack of Efficacy|1|||
16970823|NCT01135914|38114693|FG002|Overall Study|Lack of Efficacy|10|||
16970824|NCT01135914|38114691|FG000|Overall Study|Adverse Event|0|||
16970825|NCT01135914|38114692|FG001|Overall Study|Adverse Event|1|||
16970826|NCT01135914|38114693|FG002|Overall Study|Adverse Event|2|||
16970827|NCT00907738|38114706|FG000|Overall Study|Adverse Event|2|||
16970828|NCT00907738|38114707|FG001|Overall Study|Adverse Event|0|||
16970829|NCT00907738|38114708|FG002|Overall Study|Adverse Event|1|||
16970830|NCT00907738|38114709|FG003|Overall Study|Adverse Event|0|||
16970831|NCT00907738|38114710|FG004|Overall Study|Adverse Event|0|||
16970832|NCT00907738|38114706|FG000|Overall Study|not specified or withdrew consent|3|||
16970833|NCT00907738|38114707|FG001|Overall Study|not specified or withdrew consent|0|||
16970834|NCT00907738|38114708|FG002|Overall Study|not specified or withdrew consent|0|||
16970835|NCT00907738|38114709|FG003|Overall Study|not specified or withdrew consent|0|||
16970836|NCT00907738|38114710|FG004|Overall Study|not specified or withdrew consent|0|||
16970837|NCT00907738|38114706|FG000|Overall Study|Disease progression|8|||
16970838|NCT00907738|38114707|FG001|Overall Study|Disease progression|1|||
16970839|NCT00907738|38114708|FG002|Overall Study|Disease progression|6|||
16970840|NCT00907738|38114709|FG003|Overall Study|Disease progression|4|||
16970841|NCT00907738|38114710|FG004|Overall Study|Disease progression|2|||
16970842|NCT01123356|38114726|FG000|Overall Study|Adverse Event|2|||
16970843|NCT01123356|38114726|FG000|Overall Study|Lack of Efficacy|4|||
16970844|NCT01123356|38114726|FG000|Overall Study|Withdrawal by Subject|1|||
16970845|NCT00908596|38114735|FG000|Overall Study|Other reasons|46|||
16970846|NCT00908596|38114736|FG001|Overall Study|Other reasons|6|||
16970847|NCT00908596|38114737|FG002|Overall Study|Other reasons|2|||
16970848|NCT00908596|38114738|FG003|Overall Study|Other reasons|0|||
16970849|NCT00908596|38114735|FG000|Overall Study|Lost to Follow-up|0|||
16970850|NCT00908596|38114736|FG001|Overall Study|Lost to Follow-up|1|||
16970851|NCT00908596|38114737|FG002|Overall Study|Lost to Follow-up|12|||
16970852|NCT00908596|38114738|FG003|Overall Study|Lost to Follow-up|4|||
16970853|NCT00908596|38114735|FG000|Overall Study|Death|0|||
16970854|NCT00908596|38114736|FG001|Overall Study|Death|5|||
16970855|NCT00908596|38114737|FG002|Overall Study|Death|57|||
16970856|NCT00908596|38114738|FG003|Overall Study|Death|32|||
16970857|NCT00908596|38114735|FG000|Overall Study|Protocol Violation|1|||
16970858|NCT00908596|38114736|FG001|Overall Study|Protocol Violation|0|||
16970859|NCT00908596|38114737|FG002|Overall Study|Protocol Violation|0|||
16970860|NCT00908596|38114738|FG003|Overall Study|Protocol Violation|0|||
16970861|NCT00908596|38114735|FG000|Overall Study|Withdrawal by Subject|0|||
16970862|NCT00908596|38114736|FG001|Overall Study|Withdrawal by Subject|1|||
16970863|NCT00908596|38114737|FG002|Overall Study|Withdrawal by Subject|3|||
16970864|NCT00908596|38114738|FG003|Overall Study|Withdrawal by Subject|1|||
16970865|NCT01118052|38114748|FG000|Overall Study|Never treated|2|||
16970866|NCT01123200|38114758|FG000|Overall Study|Withdrawal by Subject|1|||
16970867|NCT00955617|38114762|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
16970868|NCT00955617|38114763|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
16970869|NCT00955617|38114762|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
16970870|NCT00955617|38114763|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
16970871|NCT00955617|38114762|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
16970872|NCT00955617|38114763|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
16970873|NCT00955617|38114762|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
16970874|NCT00955617|38114763|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
16970875|NCT00958347|38114769|FG000|Overall Study|Death|43|||
16970876|NCT00958347|38114769|FG000|Overall Study|Withdrawal by Subject|23|||
16970877|NCT00958347|38114769|FG000|Overall Study|Lost to Follow-up|15|||
16970878|NCT00958347|38114769|FG000|Overall Study|revision/removal|10|||
16970879|NCT00958347|38114769|FG000|Overall Study|study termination|135|||
16970880|NCT00958191|38114773|FG000|Overall Study|Death|4|||
16970881|NCT00958191|38114773|FG000|Overall Study|Lost to Follow-up|5|||
16970882|NCT00958191|38114773|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
16970883|NCT00958191|38114773|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
16970884|NCT00958191|38114773|FG000|Overall Study|Revision of study device|4|||
16970885|NCT00958191|38114773|FG000|Overall Study|Site termination|11|||
16970886|NCT00958191|38114773|FG000|Overall Study|No 5 yr x-rays|56|||
16970887|NCT00960843|38114781|FG000|Overall Study|Lost to Follow-up|2|||
16970888|NCT00960843|38114782|FG001|Overall Study|Lost to Follow-up|0|||
16970889|NCT00960843|38114781|FG000|Overall Study|Protocol Violation|0|||
17134000|NCT00064259|38275256|FG003|Overall Study|Adverse Event|1|||
17134001|NCT00044213|38275265|FG000|Overall Study|Withdrawal by Subject|50|||
17134002|NCT00044213|38275266|FG001|Overall Study|Withdrawal by Subject|65|||
17134003|NCT00044213|38275267|FG002|Overall Study|Withdrawal by Subject|91|||
17134004|NCT00044213|38275268|FG003|Overall Study|Withdrawal by Subject|83|||
17134005|NCT00044213|38275265|FG000|Overall Study|Death|42|||
17134006|NCT00044213|38275266|FG001|Overall Study|Death|42|||
17134007|NCT00044213|38275267|FG002|Overall Study|Death|42|||
17134008|NCT00044213|38275268|FG003|Overall Study|Death|49|||
16970890|NCT00960843|38114782|FG001|Overall Study|Protocol Violation|4|||
16970891|NCT00960843|38114781|FG000|Overall Study|Repeated needle dislodgment|0|||
16970892|NCT00960843|38114782|FG001|Overall Study|Repeated needle dislodgment|1|||
17134009|NCT00044213|38275265|FG000|Overall Study|Lost to Follow-up|8|||
16970893|NCT01874353|38114790|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
16970894|NCT01874353|38114791|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
16970895|NCT01874353|38114792|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
16970896|NCT01874353|38114793|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
16970897|NCT01874353|38114790|FG000|Overall Study|Lost to Follow-up|2|||
16970898|NCT01874353|38114791|FG001|Overall Study|Lost to Follow-up|2|||
16970899|NCT01874353|38114792|FG002|Overall Study|Lost to Follow-up|2|||
16970900|NCT01874353|38114793|FG003|Overall Study|Lost to Follow-up|0|||
16970901|NCT01874353|38114790|FG000|Overall Study|Death|110|||
16970902|NCT01874353|38114791|FG001|Overall Study|Death|60|||
16970903|NCT01874353|38114792|FG002|Overall Study|Death|13|||
16970904|NCT01874353|38114793|FG003|Overall Study|Death|7|||
16970905|NCT01874353|38114790|FG000|Overall Study|Withdrawal by Subject|13|||
16970906|NCT01874353|38114791|FG001|Overall Study|Withdrawal by Subject|11|||
16970907|NCT01874353|38114792|FG002|Overall Study|Withdrawal by Subject|0|||
16970908|NCT01874353|38114793|FG003|Overall Study|Withdrawal by Subject|0|||
16970909|NCT02396199|38114805|FG000|Overall Study|Lost to Follow-up|1|||
16970910|NCT02396199|38114805|FG000|Overall Study|Death|4|||
16970911|NCT01605253|38114811|FG000|Overall Study|Physician Decision|3|||
16970912|NCT01605253|38114812|FG001|Overall Study|Physician Decision|2|||
16970913|NCT01605253|38114811|FG000|Overall Study|Lost to Follow-up|3|||
16970914|NCT01605253|38114812|FG001|Overall Study|Lost to Follow-up|1|||
16970915|NCT00955305|38114822|FG000|Overall Study|Disease progression|39|||
16970916|NCT00955305|38114823|FG001|Overall Study|Disease progression|41|||
16970917|NCT00955305|38114822|FG000|Overall Study|Adverse Event|22|||
16970918|NCT00955305|38114823|FG001|Overall Study|Adverse Event|22|||
16970919|NCT00955305|38114822|FG000|Overall Study|Death|2|||
16970920|NCT00955305|38114823|FG001|Overall Study|Death|1|||
16970921|NCT00955305|38114822|FG000|Overall Study|Withdrawal by Subject|5|||
16970922|NCT00955305|38114823|FG001|Overall Study|Withdrawal by Subject|4|||
16970923|NCT00955305|38114822|FG000|Overall Study|Alternative therapy|4|||
16970924|NCT00955305|38114823|FG001|Overall Study|Alternative therapy|0|||
16970925|NCT00955305|38114822|FG000|Overall Study|Other complicating disease|2|||
16970926|NCT00955305|38114823|FG001|Overall Study|Other complicating disease|4|||
16970927|NCT00955305|38114822|FG000|Overall Study|Physician Decision|1|||
16970928|NCT00955305|38114823|FG001|Overall Study|Physician Decision|0|||
16970929|NCT00955305|38114822|FG000|Overall Study|Continued presence of residual disease|0|||
16970930|NCT00955305|38114823|FG001|Overall Study|Continued presence of residual disease|1|||
16970931|NCT00955305|38114822|FG000|Overall Study|Functional decline|2|||
16970932|NCT00955305|38114823|FG001|Overall Study|Functional decline|0|||
16970933|NCT00955305|38114822|FG000|Overall Study|Maximum response achieved|0|||
16970934|NCT00955305|38114823|FG001|Overall Study|Maximum response achieved|1|||
16970935|NCT00955305|38114822|FG000|Overall Study|Lost to Follow-up|0|||
16970936|NCT00955305|38114823|FG001|Overall Study|Lost to Follow-up|1|||
16970937|NCT00955305|38114822|FG000|Overall Study|No off-treatment reason submitted|1|||
16970938|NCT00955305|38114823|FG001|Overall Study|No off-treatment reason submitted|0|||
16970939|NCT00955305|38114822|FG000|Overall Study|Never started protocol treatment|5|||
16970940|NCT00955305|38114823|FG001|Overall Study|Never started protocol treatment|5|||
16970941|NCT00955305|38114822|FG000|Overall Study|Ineligible|5|||
16970942|NCT00955305|38114823|FG001|Overall Study|Ineligible|7|||
16970943|NCT00598585|38114831|FG000|Overall Study|Lost to Follow-up|1|||
16970944|NCT00598585|38114832|FG001|Overall Study|Lost to Follow-up|0|||
16970945|NCT00953667|38114838|FG000|Overall Study|Lost to Follow-up|11|||
16970946|NCT00953667|38114838|FG000|Overall Study|Physician Decision|35|||
16970947|NCT00953667|38114838|FG000|Overall Study|Withdrawal by Subject|63|||
16970948|NCT00953667|38114838|FG000|Overall Study|Adverse Event|10|||
16970949|NCT00953667|38114838|FG000|Overall Study|poor venous access,unable to draw blood|4|||
16970950|NCT00883129|38114844|FG000|Overall Study|Adverse Event|7|||
16970951|NCT00883129|38114845|FG001|Overall Study|Adverse Event|15|||
16970952|NCT00883129|38114844|FG000|Overall Study|Withdrawal by Subject|8|||
16970953|NCT00883129|38114845|FG001|Overall Study|Withdrawal by Subject|9|||
16970954|NCT00883129|38114844|FG000|Overall Study|Non-compliance|3|||
16970955|NCT00883129|38114845|FG001|Overall Study|Non-compliance|6|||
16970956|NCT00883129|38114844|FG000|Overall Study|Lost to Follow-up|1|||
16970957|NCT00883129|38114845|FG001|Overall Study|Lost to Follow-up|2|||
16970958|NCT00883129|38114844|FG000|Overall Study|Death|1|||
16970959|NCT00883129|38114845|FG001|Overall Study|Death|2|||
16970960|NCT00883129|38114844|FG000|Overall Study|Defined Treatment Failure|0|||
16970961|NCT00883129|38114845|FG001|Overall Study|Defined Treatment Failure|2|||
16970962|NCT00905632|38114876|FG000|Overall Study|Adverse Event|0|||
16970963|NCT00905632|38114877|FG001|Overall Study|Adverse Event|0|||
16970964|NCT00905632|38114878|FG002|Overall Study|Adverse Event|0|||
16970965|NCT00905632|38114879|FG003|Overall Study|Adverse Event|0|||
16970966|NCT00905632|38114880|FG004|Overall Study|Adverse Event|0|||
16970967|NCT00905632|38114881|FG005|Overall Study|Adverse Event|1|||
16970968|NCT00905632|38114882|FG006|Overall Study|Adverse Event|4|||
16970969|NCT00954447|38114907|FG000|Overall Study|Adverse Event|33|||
16970970|NCT00954447|38114908|FG001|Overall Study|Adverse Event|25|||
16970971|NCT00954447|38114907|FG000|Overall Study|Lack of Efficacy|17|||
16970972|NCT00954447|38114908|FG001|Overall Study|Lack of Efficacy|3|||
16970973|NCT00954447|38114907|FG000|Overall Study|Protocol Violation|5|||
16970974|NCT00954447|38114908|FG001|Overall Study|Protocol Violation|7|||
16970975|NCT00954447|38114907|FG000|Overall Study|Lost to Follow-up|8|||
16970976|NCT00954447|38114908|FG001|Overall Study|Lost to Follow-up|14|||
16970977|NCT00954447|38114907|FG000|Overall Study|Withdrawal by Subject|26|||
16970978|NCT00954447|38114908|FG001|Overall Study|Withdrawal by Subject|21|||
16970979|NCT00954447|38114907|FG000|Overall Study|Other|21|||
16970980|NCT00954447|38114908|FG001|Overall Study|Other|18|||
16970981|NCT00904150|38114916|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
16970982|NCT00904150|38114917|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
16970983|NCT00904150|38114916|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
16970984|NCT00904150|38114917|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
16970985|NCT00903760|38114925|FG000|Overall Study|Disease Progression/Death|8|||
16970986|NCT00903760|38114926|FG001|Overall Study|Disease Progression/Death|6|||
16970987|NCT00903760|38114925|FG000|Overall Study|Stem Cell Transplant|8|||
16970988|NCT00903760|38114926|FG001|Overall Study|Stem Cell Transplant|4|||
16970989|NCT00903760|38114925|FG000|Overall Study|Physician Decision|1|||
16970990|NCT00903760|38114926|FG001|Overall Study|Physician Decision|2|||
16970991|NCT00903760|38114925|FG000|Overall Study|Death|0|||
16970992|NCT00903760|38114926|FG001|Overall Study|Death|1|||
16970993|NCT00903760|38114925|FG000|Overall Study|Lost to Follow-up|1|||
16970994|NCT00903760|38114926|FG001|Overall Study|Lost to Follow-up|0|||
16970995|NCT00903760|38114925|FG000|Overall Study|Withdrawal by Subject|1|||
16970996|NCT00903760|38114926|FG001|Overall Study|Withdrawal by Subject|2|||
16970997|NCT00903760|38114925|FG000|Overall Study|Off treatment for long period|0|||
16970998|NCT00903760|38114926|FG001|Overall Study|Off treatment for long period|1|||
16970999|NCT00883051|38114937|FG000|Overall Study|Lost to Follow-up|0|||
16971000|NCT00883051|38114938|FG001|Overall Study|Lost to Follow-up|0|||
16971001|NCT00883051|38114939|FG002|Overall Study|Lost to Follow-up|0|||
16971002|NCT00883051|38114940|FG003|Overall Study|Lost to Follow-up|0|||
16971003|NCT00883051|38114941|FG004|Overall Study|Lost to Follow-up|1|||
16971004|NCT00883051|38114937|FG000|Overall Study|Did not use study medication|24|||
16971005|NCT00883051|38114938|FG001|Overall Study|Did not use study medication|22|||
16971006|NCT00883051|38114939|FG002|Overall Study|Did not use study medication|29|||
16971007|NCT00883051|38114940|FG003|Overall Study|Did not use study medication|29|||
16971008|NCT00883051|38114941|FG004|Overall Study|Did not use study medication|17|||
16971009|NCT00903682|38114955|FG000|Overall Study|Adverse Event|6|||
16971010|NCT00903682|38114956|FG001|Overall Study|Adverse Event|13|||
16971011|NCT00903682|38114955|FG000|Overall Study|Lost to Follow-up|1|||
16971012|NCT00903682|38114956|FG001|Overall Study|Lost to Follow-up|0|||
16971013|NCT00903682|38114955|FG000|Overall Study|Withdrawal by Subject|5|||
16971014|NCT00903682|38114956|FG001|Overall Study|Withdrawal by Subject|0|||
16971015|NCT00903682|38114955|FG000|Overall Study|Pregnancy|0|||
16971016|NCT00903682|38114956|FG001|Overall Study|Pregnancy|1|||
16971017|NCT00903682|38114955|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
16971018|NCT00903682|38114956|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
16971019|NCT00903682|38114955|FG000|Overall Study|Subject Non-Compliant|1|||
16971020|NCT00903682|38114956|FG001|Overall Study|Subject Non-Compliant|0|||
16971021|NCT00903682|38114955|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
16971022|NCT00903682|38114956|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
16971023|NCT00903682|38114955|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
16971024|NCT00903682|38114956|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
16971025|NCT01117428|38114968|FG000|Overall Study|Lack of Efficacy|1|||
16971026|NCT01117428|38114969|FG001|Overall Study|Lack of Efficacy|0|||
16971027|NCT01117428|38114970|FG002|Overall Study|Lack of Efficacy|0|||
16971028|NCT01117428|38114971|FG003|Overall Study|Lack of Efficacy|0|||
16971029|NCT01117428|38114972|FG004|Overall Study|Lack of Efficacy|0|||
16971030|NCT01117428|38114973|FG005|Overall Study|Lack of Efficacy|0|||
16971031|NCT01117428|38114968|FG000|Overall Study|Adverse Event|4|||
16971032|NCT01117428|38114969|FG001|Overall Study|Adverse Event|0|||
16971033|NCT01117428|38114970|FG002|Overall Study|Adverse Event|0|||
16971034|NCT01117428|38114971|FG003|Overall Study|Adverse Event|0|||
16971035|NCT01117428|38114972|FG004|Overall Study|Adverse Event|1|||
16971036|NCT01117428|38114973|FG005|Overall Study|Adverse Event|2|||
16971037|NCT01117428|38114968|FG000|Overall Study|Death|0|||
16971038|NCT01117428|38114969|FG001|Overall Study|Death|1|||
16971039|NCT01117428|38114970|FG002|Overall Study|Death|2|||
16971040|NCT01117428|38114971|FG003|Overall Study|Death|0|||
16971041|NCT01117428|38114972|FG004|Overall Study|Death|0|||
16971042|NCT01117428|38114973|FG005|Overall Study|Death|1|||
16971043|NCT01117428|38114968|FG000|Overall Study|Physician Decision|0|||
16971044|NCT01117428|38114969|FG001|Overall Study|Physician Decision|1|||
16971045|NCT01117428|38114970|FG002|Overall Study|Physician Decision|0|||
16971046|NCT01117428|38114971|FG003|Overall Study|Physician Decision|0|||
16971047|NCT01117428|38114972|FG004|Overall Study|Physician Decision|0|||
16971048|NCT01117428|38114973|FG005|Overall Study|Physician Decision|0|||
16971049|NCT01117428|38114968|FG000|Overall Study|Withdrawal by Subject|0|||
16971050|NCT01117428|38114969|FG001|Overall Study|Withdrawal by Subject|0|||
16971051|NCT01117428|38114970|FG002|Overall Study|Withdrawal by Subject|1|||
16971052|NCT01117428|38114971|FG003|Overall Study|Withdrawal by Subject|0|||
16971053|NCT01117428|38114972|FG004|Overall Study|Withdrawal by Subject|0|||
16971054|NCT01117428|38114973|FG005|Overall Study|Withdrawal by Subject|0|||
16971055|NCT01117428|38114968|FG000|Overall Study|Progressive disease|15|||
16971056|NCT01117428|38114969|FG001|Overall Study|Progressive disease|27|||
16971057|NCT01117428|38114970|FG002|Overall Study|Progressive disease|10|||
16971058|NCT01117428|38114971|FG003|Overall Study|Progressive disease|12|||
16971059|NCT01117428|38114972|FG004|Overall Study|Progressive disease|16|||
16971060|NCT01117428|38114973|FG005|Overall Study|Progressive disease|17|||
16971061|NCT01135524|38115002|FG000|Overall Study|Withdrawal by Subject|14|||
16971062|NCT01135524|38115002|FG000|Overall Study|Adverse Event|20|||
16971063|NCT01135524|38115002|FG000|Overall Study|Lost to Follow-up|3|||
16971064|NCT01135524|38115002|FG000|Overall Study|Administrative|151|||
16971065|NCT01135524|38115002|FG000|Overall Study|Lack of Efficacy|8|||
16971066|NCT00948675|38115008|FG000|Overall Study|Lost to Follow-up|1|||
17134010|NCT00044213|38275266|FG001|Overall Study|Lost to Follow-up|5|||
16971067|NCT00948675|38115009|FG001|Overall Study|Lost to Follow-up|0|||
16971068|NCT00903370|38115017|FG000|Overall Study|Death|13|||
16971069|NCT00903370|38115018|FG001|Overall Study|Death|10|||
16971070|NCT00903370|38115017|FG000|Overall Study|Withdrawal by Subject|9|||
16971071|NCT00903370|38115018|FG001|Overall Study|Withdrawal by Subject|6|||
16971072|NCT00903370|38115017|FG000|Overall Study|Lost to Follow-up|6|||
16971073|NCT00903370|38115018|FG001|Overall Study|Lost to Follow-up|8|||
16971074|NCT01110408|38115026|FG000|Overall Study|Protocol Violation|1|||
16971075|NCT01110408|38115027|FG001|Overall Study|Protocol Violation|0|||
16971076|NCT00953043|38115035|FG000|Overall Study|Withdrawal by Subject|4|||
16971077|NCT00953043|38115036|FG001|Overall Study|Withdrawal by Subject|0|||
16971078|NCT00953043|38115035|FG000|Overall Study|Physician Decision|0|||
16971079|NCT00953043|38115036|FG001|Overall Study|Physician Decision|2|||
16971080|NCT01135134|38115044|FG000|Overall Study|Adverse Event|1|||
16971081|NCT01135134|38115045|FG001|Overall Study|Adverse Event|1|||
16971082|NCT01135134|38115044|FG000|Overall Study|Did not meet protocol eligibility|1|||
16971083|NCT01135134|38115045|FG001|Overall Study|Did not meet protocol eligibility|0|||
16971084|NCT00948441|38115053|FG000|Overall Study|no longer meet inclusion criteria|1|||
16971085|NCT00948441|38115054|FG001|Overall Study|no longer meet inclusion criteria|4|||
16971086|NCT01117350|38115064|FG000|Comparative Period|Not Treated|5|||
16971087|NCT01117350|38115065|FG001|Comparative Period|Not Treated|8|||
16971088|NCT01117350|38115064|FG000|Comparative Period|Adverse Event|6|||
16971089|NCT01117350|38115065|FG001|Comparative Period|Adverse Event|33|||
16971090|NCT01117350|38115064|FG000|Comparative Period|Lost to Follow-up|11|||
16971091|NCT01117350|38115065|FG001|Comparative Period|Lost to Follow-up|7|||
16971092|NCT01117350|38115064|FG000|Comparative Period|Withdrawal by Subject|9|||
16971093|NCT01117350|38115065|FG001|Comparative Period|Withdrawal by Subject|13|||
16971094|NCT01117350|38115064|FG000|Comparative Period|Protocol Violation|8|||
16971095|NCT01117350|38115065|FG001|Comparative Period|Protocol Violation|12|||
16971096|NCT01117350|38115064|FG000|Comparative Period|Lack of Efficacy|1|||
16971097|NCT01117350|38115065|FG001|Comparative Period|Lack of Efficacy|0|||
16971098|NCT01117350|38115064|FG000|Comparative Period|Physician Decision|0|||
16971099|NCT01117350|38115065|FG001|Comparative Period|Physician Decision|1|||
16971100|NCT01117350|38115064|FG000|Comparative Period|Move to another city/country|2|||
16971101|NCT01117350|38115065|FG001|Comparative Period|Move to another city/country|1|||
16971102|NCT01117350|38115064|FG000|Extension Period|Not included in extension, not treated|0|||
16971103|NCT01117350|38115065|FG001|Extension Period|Not included in extension, not treated|50|||
16971104|NCT01117350|38115064|FG000|Extension Period|Adverse Event|0|||
16971105|NCT01117350|38115065|FG001|Extension Period|Adverse Event|2|||
16971106|NCT01117350|38115064|FG000|Extension Period|Protocol Violation|0|||
16971107|NCT01117350|38115065|FG001|Extension Period|Protocol Violation|2|||
16971108|NCT01117350|38115064|FG000|Extension Period|Lost to Follow-up|0|||
16971109|NCT01117350|38115065|FG001|Extension Period|Lost to Follow-up|2|||
16971110|NCT01117350|38115064|FG000|Extension Period|Withdrawal by Subject|0|||
16971111|NCT01117350|38115065|FG001|Extension Period|Withdrawal by Subject|3|||
16971112|NCT01117350|38115064|FG000|Extension Period|Lack of Efficacy|0|||
16971113|NCT01117350|38115065|FG001|Extension Period|Lack of Efficacy|2|||
16971114|NCT01117350|38115064|FG000|Extension Period|Inclusion criteria not respected|0|||
16971115|NCT01117350|38115065|FG001|Extension Period|Inclusion criteria not respected|1|||
16971116|NCT01117350|38115064|FG000|Extension Period|Prohibited medication|0|||
16971117|NCT01117350|38115065|FG001|Extension Period|Prohibited medication|1|||
16971118|NCT00952731|38115076|FG000|Overall Study|Drug supply expired|1|||
16971119|NCT00952731|38115077|FG001|Overall Study|Drug supply expired|0|||
16971120|NCT00947427|38115085|FG000|Overall Study|Withdrawal by Subject|1|||
16971121|NCT00947427|38115086|FG001|Overall Study|Withdrawal by Subject|3|||
16971122|NCT00947427|38115085|FG000|Overall Study|Protocol Violation|0|||
16971123|NCT00947427|38115086|FG001|Overall Study|Protocol Violation|1|||
16971124|NCT01116882|38115094|FG000|30-day|Lost to Follow-up|50|||
16971125|NCT01116882|38115095|FG001|30-day|Lost to Follow-up|21|||
16971126|NCT01116882|38115094|FG000|30-day|Withdrawal by Subject|2|||
16971127|NCT01116882|38115095|FG001|30-day|Withdrawal by Subject|4|||
16971128|NCT01116882|38115094|FG000|30-day|Other Reasons|16|||
16971129|NCT01116882|38115095|FG001|30-day|Other Reasons|6|||
16971130|NCT01116882|38115094|FG000|12-month|Lost to Follow-up|111|||
16971131|NCT01116882|38115095|FG001|12-month|Lost to Follow-up|42|||
16971132|NCT01116882|38115094|FG000|12-month|Other Reasons|151|||
16971133|NCT01116882|38115095|FG001|12-month|Other Reasons|49|||
16971134|NCT01116882|38115094|FG000|12-month|Withdrawal by Subject|5|||
16971135|NCT01116882|38115095|FG001|12-month|Withdrawal by Subject|8|||
16971136|NCT00953745|38115106|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
16971137|NCT00953745|38115107|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
16971138|NCT00953745|38115106|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
16971139|NCT00953745|38115107|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
16971140|NCT00953745|38115106|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
16971141|NCT00953745|38115107|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
16971142|NCT00953745|38115106|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
16971143|NCT00953745|38115107|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
16971144|NCT00953745|38115106|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
16971145|NCT00953745|38115107|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
16971146|NCT00953745|38115106|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
16971147|NCT00953745|38115107|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
16971148|NCT00902746|38115124|FG000|Overall Study|Protocol Violation|7|||
16971149|NCT00902746|38115124|FG000|Overall Study|Withdrawal by Subject|16|||
16971150|NCT00902746|38115124|FG000|Overall Study|Adverse Event|8|||
16971151|NCT00902746|38115124|FG000|Overall Study|Lost to Follow-up|3|||
16971152|NCT00902746|38115124|FG000|Overall Study|Physician Decision|2|||
16971153|NCT00902668|38115137|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
16971154|NCT00947349|38115145|FG000|Triple Treatment Combination Period|Adverse Event|0|||
16971155|NCT00947349|38115146|FG001|Triple Treatment Combination Period|Adverse Event|1|||
16971156|NCT00947349|38115147|FG002|Triple Treatment Combination Period|Adverse Event|0|||
16971157|NCT00947349|38115148|FG003|Triple Treatment Combination Period|Adverse Event|0|||
16971158|NCT00947349|38115145|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
16971159|NCT00947349|38115146|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
16971160|NCT00947349|38115147|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
16971161|NCT00947349|38115148|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
16971162|NCT00947349|38115145|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
16971163|NCT00947349|38115146|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
16971164|NCT00947349|38115147|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
16971165|NCT00947349|38115148|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
16971166|NCT00947349|38115145|FG000|Overall Study Standard of Care|Other|0|||
16971167|NCT00947349|38115146|FG001|Overall Study Standard of Care|Other|0|||
16971168|NCT00947349|38115147|FG002|Overall Study Standard of Care|Other|0|||
16971169|NCT00947349|38115148|FG003|Overall Study Standard of Care|Other|1|||
16971170|NCT00947193|38115176|FG000|Overall Study|Lost to Follow-up|1|||
16971171|NCT00947193|38115177|FG001|Overall Study|Lost to Follow-up|0|||
16971172|NCT00947193|38115176|FG000|Overall Study|Withdrawal by Subject|1|||
16971173|NCT00947193|38115177|FG001|Overall Study|Withdrawal by Subject|0|||
16971174|NCT00947193|38115176|FG000|Overall Study|Factor VIII >1%|1|||
16971175|NCT00947193|38115177|FG001|Overall Study|Factor VIII >1%|0|||
16971176|NCT00947115|38115185|FG000|Overall Study|Missed reporting interval|3|||
16971177|NCT00947115|38115186|FG001|Overall Study|Missed reporting interval|4|||
16971178|NCT00947115|38115187|FG002|Overall Study|Missed reporting interval|2|||
16971179|NCT00947115|38115185|FG000|Overall Study|Physician Decision|0|||
16971180|NCT00947115|38115186|FG001|Overall Study|Physician Decision|2|||
16971181|NCT00947115|38115187|FG002|Overall Study|Physician Decision|0|||
17134011|NCT00044213|38275267|FG002|Overall Study|Lost to Follow-up|5|||
17134012|NCT00044213|38275268|FG003|Overall Study|Lost to Follow-up|4|||
17134013|NCT00064025|38275278|FG000|Overall Study|Ineligible|4|||
17134014|NCT00064025|38275278|FG000|Overall Study|Inevaluable|3|||
17134015|NCT02095132|38275293|FG000|Overall Study|Adverse Event|0|||
17134016|NCT02095132|38275294|FG001|Overall Study|Adverse Event|0|||
17134017|NCT02095132|38275295|FG002|Overall Study|Adverse Event|0|||
17134018|NCT02095132|38275296|FG003|Overall Study|Adverse Event|0|||
17134019|NCT02095132|38275297|FG004|Overall Study|Adverse Event|1|||
17134020|NCT02095132|38275298|FG005|Overall Study|Adverse Event|0|||
17134021|NCT02095132|38275299|FG006|Overall Study|Adverse Event|1|||
17134022|NCT02095132|38275300|FG007|Overall Study|Adverse Event|0|||
16971182|NCT00947115|38115185|FG000|Overall Study|Death|0|||
16971183|NCT00947115|38115186|FG001|Overall Study|Death|1|||
16971184|NCT00947115|38115187|FG002|Overall Study|Death|1|||
16971185|NCT00947115|38115185|FG000|Overall Study|Migrated from study area|2|||
16971186|NCT00947115|38115186|FG001|Overall Study|Migrated from study area|0|||
16971187|NCT00947115|38115187|FG002|Overall Study|Migrated from study area|0|||
16971188|NCT00947115|38115185|FG000|Overall Study|Withdrawal by Subject|1|||
16971189|NCT00947115|38115186|FG001|Overall Study|Withdrawal by Subject|3|||
16971190|NCT00947115|38115187|FG002|Overall Study|Withdrawal by Subject|4|||
16971191|NCT00947115|38115185|FG000|Overall Study|Lost to Follow-up|11|||
16971192|NCT00947115|38115186|FG001|Overall Study|Lost to Follow-up|12|||
16971193|NCT00947115|38115187|FG002|Overall Study|Lost to Follow-up|8|||
16971194|NCT00952419|38115198|FG000|Overall Study|Adverse Event|2|||
16971195|NCT00952419|38115199|FG001|Overall Study|Adverse Event|0|||
16971196|NCT00952419|38115200|FG002|Overall Study|Adverse Event|0|||
16971197|NCT00952419|38115198|FG000|Overall Study|Protocol Violation|3|||
16971198|NCT00952419|38115199|FG001|Overall Study|Protocol Violation|7|||
16971199|NCT00952419|38115200|FG002|Overall Study|Protocol Violation|0|||
16971200|NCT00952419|38115198|FG000|Overall Study|Withdrawal by Subject|1|||
16971201|NCT00952419|38115199|FG001|Overall Study|Withdrawal by Subject|3|||
16971202|NCT00952419|38115200|FG002|Overall Study|Withdrawal by Subject|0|||
16971203|NCT00902278|38115213|FG000|Overall Study|Physician Decision|1|||
16971204|NCT00902278|38115214|FG001|Overall Study|Physician Decision|0|||
16971205|NCT00902278|38115215|FG002|Overall Study|Physician Decision|2|||
16971206|NCT00902278|38115216|FG003|Overall Study|Physician Decision|0|||
16971207|NCT00902278|38115217|FG004|Overall Study|Physician Decision|1|||
17134023|NCT02095132|38275301|FG008|Overall Study|Adverse Event|0|||
16971208|NCT00902278|38115213|FG000|Overall Study|Lost to Follow-up|3|||
16971209|NCT00902278|38115214|FG001|Overall Study|Lost to Follow-up|2|||
16971210|NCT00902278|38115215|FG002|Overall Study|Lost to Follow-up|3|||
16971211|NCT00902278|38115216|FG003|Overall Study|Lost to Follow-up|0|||
16971212|NCT00902278|38115217|FG004|Overall Study|Lost to Follow-up|1|||
16971213|NCT01998633|38115231|FG000|Overall Study|Death|1|||
16971214|NCT00952341|38115241|FG000|Cycle 1|Adverse Event|4|||
16971215|NCT00952341|38115242|FG001|Cycle 1|Adverse Event|1|||
16971216|NCT00952341|38115241|FG000|Cycle 1|Withdrawal by Subject|3|||
16971217|NCT00952341|38115242|FG001|Cycle 1|Withdrawal by Subject|8|||
16971218|NCT00952341|38115241|FG000|Cycle 1|Protocol Violation|2|||
16971219|NCT00952341|38115242|FG001|Cycle 1|Protocol Violation|1|||
16971220|NCT00952341|38115241|FG000|Cycle 1|Lost to Follow-up|11|||
16971221|NCT00952341|38115242|FG001|Cycle 1|Lost to Follow-up|2|||
16971222|NCT00952341|38115241|FG000|Cycle 1|Physician Decision|0|||
16971223|NCT00952341|38115242|FG001|Cycle 1|Physician Decision|1|||
16971224|NCT00952341|38115241|FG000|Cycle 2|Withdrawal by Subject|1|||
16971225|NCT00952341|38115242|FG001|Cycle 2|Withdrawal by Subject|1|||
16971226|NCT00952341|38115241|FG000|Cycle 2|Protocol Violation|1|||
16971227|NCT00952341|38115242|FG001|Cycle 2|Protocol Violation|0|||
16971228|NCT00952341|38115241|FG000|Cycle 2|Lost to Follow-up|6|||
16971229|NCT00952341|38115242|FG001|Cycle 2|Lost to Follow-up|9|||
16971230|NCT00952341|38115241|FG000|Cycle 2|Physician Decision|1|||
16971231|NCT00952341|38115242|FG001|Cycle 2|Physician Decision|1|||
16971232|NCT00952341|38115241|FG000|Cycle 2|Progressive Disease|0|||
16971233|NCT00952341|38115242|FG001|Cycle 2|Progressive Disease|1|||
16971234|NCT00946881|38115248|FG000|First Treatment|Withdrawal by Subject|1|||
16971235|NCT00946881|38115248|FG000|First Treatment|Patient relocated to another state|1|||
16971236|NCT00946881|38115248|FG000|Retreatment|Withdrawal by Subject|1|||
16971237|NCT01214642|38115285|FG000|Overall Study|Progressive Disease|3|||
16971238|NCT01214642|38115286|FG001|Overall Study|Progressive Disease|2|||
16971239|NCT01214642|38115287|FG002|Overall Study|Progressive Disease|3|||
16971240|NCT01214642|38115288|FG003|Overall Study|Progressive Disease|5|||
16971241|NCT01214642|38115289|FG004|Overall Study|Progressive Disease|5|||
16971242|NCT01214642|38115290|FG005|Overall Study|Progressive Disease|3|||
16971243|NCT01214642|38115291|FG006|Overall Study|Progressive Disease|5|||
16971244|NCT01214642|38115292|FG007|Overall Study|Progressive Disease|3|||
16971245|NCT01214642|38115293|FG008|Overall Study|Progressive Disease|10|||
16971246|NCT01214642|38115294|FG009|Overall Study|Progressive Disease|2|||
16971247|NCT01214642|38115295|FG010|Overall Study|Progressive Disease|1|||
16971248|NCT01214642|38115296|FG011|Overall Study|Progressive Disease|4|||
16971249|NCT01214642|38115285|FG000|Overall Study|Adverse Event|0|||
16971250|NCT01214642|38115286|FG001|Overall Study|Adverse Event|1|||
16971251|NCT01214642|38115287|FG002|Overall Study|Adverse Event|0|||
16971252|NCT01214642|38115288|FG003|Overall Study|Adverse Event|0|||
16971253|NCT01214642|38115289|FG004|Overall Study|Adverse Event|0|||
16971254|NCT01214642|38115290|FG005|Overall Study|Adverse Event|0|||
16971255|NCT01214642|38115291|FG006|Overall Study|Adverse Event|1|||
16971256|NCT01214642|38115292|FG007|Overall Study|Adverse Event|0|||
16971257|NCT01214642|38115293|FG008|Overall Study|Adverse Event|0|||
16971258|NCT01214642|38115294|FG009|Overall Study|Adverse Event|1|||
16971259|NCT01214642|38115295|FG010|Overall Study|Adverse Event|1|||
16971260|NCT01214642|38115296|FG011|Overall Study|Adverse Event|0|||
16971261|NCT01214642|38115285|FG000|Overall Study|Death|0|||
16971262|NCT01214642|38115286|FG001|Overall Study|Death|0|||
16971263|NCT01214642|38115287|FG002|Overall Study|Death|1|||
16971264|NCT01214642|38115288|FG003|Overall Study|Death|0|||
16971265|NCT01214642|38115289|FG004|Overall Study|Death|0|||
16971266|NCT01214642|38115290|FG005|Overall Study|Death|0|||
16971267|NCT01214642|38115291|FG006|Overall Study|Death|0|||
16971268|NCT01214642|38115292|FG007|Overall Study|Death|0|||
16971269|NCT01214642|38115293|FG008|Overall Study|Death|0|||
16971270|NCT01214642|38115294|FG009|Overall Study|Death|0|||
16971271|NCT01214642|38115295|FG010|Overall Study|Death|1|||
16971272|NCT01214642|38115296|FG011|Overall Study|Death|0|||
16971273|NCT01214642|38115285|FG000|Overall Study|Withdrawal by Subject|0|||
16971274|NCT01214642|38115286|FG001|Overall Study|Withdrawal by Subject|0|||
16971275|NCT01214642|38115287|FG002|Overall Study|Withdrawal by Subject|1|||
16971276|NCT01214642|38115288|FG003|Overall Study|Withdrawal by Subject|0|||
16971277|NCT01214642|38115289|FG004|Overall Study|Withdrawal by Subject|0|||
16971278|NCT01214642|38115290|FG005|Overall Study|Withdrawal by Subject|0|||
16971279|NCT01214642|38115291|FG006|Overall Study|Withdrawal by Subject|0|||
16971280|NCT01214642|38115292|FG007|Overall Study|Withdrawal by Subject|0|||
16971281|NCT01214642|38115293|FG008|Overall Study|Withdrawal by Subject|3|||
16971282|NCT01214642|38115294|FG009|Overall Study|Withdrawal by Subject|1|||
16971283|NCT01214642|38115295|FG010|Overall Study|Withdrawal by Subject|1|||
16971284|NCT01214642|38115296|FG011|Overall Study|Withdrawal by Subject|0|||
16971285|NCT01214642|38115285|FG000|Overall Study|Physician Decision|0|||
16971286|NCT01214642|38115286|FG001|Overall Study|Physician Decision|0|||
16971287|NCT01214642|38115287|FG002|Overall Study|Physician Decision|1|||
16971288|NCT01214642|38115288|FG003|Overall Study|Physician Decision|1|||
16971289|NCT01214642|38115289|FG004|Overall Study|Physician Decision|1|||
16971290|NCT01214642|38115290|FG005|Overall Study|Physician Decision|0|||
16971291|NCT01214642|38115291|FG006|Overall Study|Physician Decision|0|||
16971292|NCT01214642|38115292|FG007|Overall Study|Physician Decision|0|||
16971293|NCT01214642|38115293|FG008|Overall Study|Physician Decision|0|||
16971294|NCT01214642|38115294|FG009|Overall Study|Physician Decision|0|||
16971295|NCT01214642|38115295|FG010|Overall Study|Physician Decision|0|||
16971296|NCT01214642|38115296|FG011|Overall Study|Physician Decision|2|||
16971297|NCT01214252|38115339|FG000|Overall Study|Not eligible per protocol|82|||
16971298|NCT01214174|38115347|FG000|Overall Study|Withdrawal by Subject|0|||
16971299|NCT01214174|38115348|FG001|Overall Study|Withdrawal by Subject|0|||
16971300|NCT01214174|38115349|FG002|Overall Study|Withdrawal by Subject|1|||
16971301|NCT00901342|38115357|FG000|Overall Study|Adverse Event|1|||
16971302|NCT00901342|38115357|FG000|Overall Study|Death|4|||
16971303|NCT00901342|38115357|FG000|Overall Study|Disease progression|1|||
16971304|NCT00901342|38115357|FG000|Overall Study|Withdrawal by Subject|9|||
16971305|NCT00901186|38115363|FG000|Overall Study|Lack of Efficacy|0|||
16971306|NCT00901186|38115364|FG001|Overall Study|Lack of Efficacy|1|||
16971307|NCT00901186|38115363|FG000|Overall Study|Abnormal laboratory values|0|||
16971308|NCT00901186|38115364|FG001|Overall Study|Abnormal laboratory values|1|||
16971309|NCT00901186|38115363|FG000|Overall Study|Lost to Follow-up|2|||
16971310|NCT00901186|38115364|FG001|Overall Study|Lost to Follow-up|0|||
16971311|NCT00901186|38115363|FG000|Overall Study|Adverse Event|2|||
16971312|NCT00901186|38115364|FG001|Overall Study|Adverse Event|4|||
16971313|NCT00901186|38115363|FG000|Overall Study|Administration problems|0|||
16971314|NCT00901186|38115364|FG001|Overall Study|Administration problems|1|||
16971315|NCT00901186|38115363|FG000|Overall Study|Protocol deviations|5|||
16971316|NCT00901186|38115364|FG001|Overall Study|Protocol deviations|4|||
16971317|NCT01213472|38115370|FG000|Overall Study|Recurrence/Progressive disease|25|||
16971318|NCT01213472|38115370|FG000|Overall Study|Withdrawal by Subject|1|||
16971319|NCT01213472|38115370|FG000|Overall Study|Physician Decision|1|||
16971320|NCT00900796|38115374|FG000|Phase 1|Lacked sufficient information|4|||
16971321|NCT00900796|38115374|FG000|Phase 1|Missing information at Week 16|7|||
16971322|NCT00900796|38115374|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
16971323|NCT00900796|38115374|FG000|Phase 2|Lost to Follow-up|5|||
16971324|NCT01213082|38115382|FG000|Overall Study|Lost to Follow-up|6|||
16971325|NCT01213082|38115383|FG001|Overall Study|Lost to Follow-up|7|||
16971326|NCT01213082|38115384|FG002|Overall Study|Lost to Follow-up|4|||
16971327|NCT01213082|38115382|FG000|Overall Study|Physician Decision|0|||
16971328|NCT01213082|38115383|FG001|Overall Study|Physician Decision|0|||
16971329|NCT01213082|38115384|FG002|Overall Study|Physician Decision|1|||
16971330|NCT00885703|38115399|FG000|Overall Study|Death|9|||
16971331|NCT00885703|38115400|FG001|Overall Study|Death|7|||
16971332|NCT00885703|38115401|FG002|Overall Study|Death|8|||
16971333|NCT00885703|38115402|FG003|Overall Study|Death|7|||
16971334|NCT00885703|38115403|FG004|Overall Study|Death|7|||
16971335|NCT00885703|38115404|FG005|Overall Study|Death|8|||
16971336|NCT00885703|38115405|FG006|Overall Study|Death|4|||
16971337|NCT00885703|38115399|FG000|Overall Study|Lost to Follow-up|0|||
16971338|NCT00885703|38115400|FG001|Overall Study|Lost to Follow-up|0|||
16971339|NCT00885703|38115401|FG002|Overall Study|Lost to Follow-up|1|||
16971340|NCT00885703|38115402|FG003|Overall Study|Lost to Follow-up|0|||
16971341|NCT00885703|38115403|FG004|Overall Study|Lost to Follow-up|0|||
16971342|NCT00885703|38115404|FG005|Overall Study|Lost to Follow-up|1|||
16971343|NCT00885703|38115405|FG006|Overall Study|Lost to Follow-up|0|||
16971344|NCT00885703|38115399|FG000|Overall Study|Withdrawal by Subject|0|||
16971345|NCT00885703|38115400|FG001|Overall Study|Withdrawal by Subject|0|||
16971346|NCT00885703|38115401|FG002|Overall Study|Withdrawal by Subject|0|||
16971347|NCT00885703|38115402|FG003|Overall Study|Withdrawal by Subject|1|||
16971348|NCT00885703|38115403|FG004|Overall Study|Withdrawal by Subject|3|||
16971349|NCT00885703|38115404|FG005|Overall Study|Withdrawal by Subject|1|||
16971350|NCT00885703|38115405|FG006|Overall Study|Withdrawal by Subject|1|||
16971351|NCT00885703|38115399|FG000|Overall Study|Ineligible (no CM)|1|||
16971352|NCT00885703|38115400|FG001|Overall Study|Ineligible (no CM)|3|||
16971353|NCT00885703|38115401|FG002|Overall Study|Ineligible (no CM)|2|||
16971354|NCT00885703|38115402|FG003|Overall Study|Ineligible (no CM)|1|||
16971355|NCT00885703|38115403|FG004|Overall Study|Ineligible (no CM)|2|||
16971356|NCT00885703|38115404|FG005|Overall Study|Ineligible (no CM)|3|||
16971357|NCT00885703|38115405|FG006|Overall Study|Ineligible (no CM)|1|||
16971358|NCT00901576|38115431|FG000|Second Intervention|Withdrawal by Subject|0|||
16971359|NCT00901576|38115432|FG001|Second Intervention|Withdrawal by Subject|0|||
16971360|NCT00901576|38115433|FG002|Second Intervention|Withdrawal by Subject|0|||
16971361|NCT00901576|38115434|FG003|Second Intervention|Withdrawal by Subject|1|||
16971362|NCT00901576|38115435|FG004|Second Intervention|Withdrawal by Subject|0|||
16971363|NCT00901576|38115436|FG005|Second Intervention|Withdrawal by Subject|1|||
16971364|NCT00901576|38115431|FG000|Second Intervention|Physician Decision|1|||
16971365|NCT00901576|38115432|FG001|Second Intervention|Physician Decision|0|||
16971366|NCT00901576|38115433|FG002|Second Intervention|Physician Decision|0|||
16971367|NCT00901576|38115434|FG003|Second Intervention|Physician Decision|0|||
16971368|NCT00901576|38115435|FG004|Second Intervention|Physician Decision|0|||
16971369|NCT00901576|38115436|FG005|Second Intervention|Physician Decision|0|||
16971370|NCT00882583|38115446|FG000|Overall Study|Physician Decision|1|||
16971371|NCT00882583|38115447|FG001|Overall Study|Physician Decision|0|||
16971372|NCT00882583|38115446|FG000|Overall Study|Adverse Event|0|||
16971373|NCT00882583|38115447|FG001|Overall Study|Adverse Event|1|||
16971374|NCT00900562|38115455|FG000|Overall Study|Progressive disease|9|||
16971375|NCT00900562|38115456|FG001|Overall Study|Progressive disease|5|||
16971376|NCT00900562|38115455|FG000|Overall Study|Toxicity|1|||
16971377|NCT00900562|38115456|FG001|Overall Study|Toxicity|0|||
16971378|NCT00900562|38115455|FG000|Overall Study|Death|1|||
16971379|NCT00900562|38115456|FG001|Overall Study|Death|1|||
16971380|NCT00900562|38115455|FG000|Overall Study|Withdrawal by Subject|0|||
16971381|NCT00900562|38115456|FG001|Overall Study|Withdrawal by Subject|1|||
16971382|NCT00900562|38115455|FG000|Overall Study|Unrelated adverse event|1|||
16971383|NCT00900562|38115456|FG001|Overall Study|Unrelated adverse event|0|||
16971384|NCT00599521|38115465|FG000|Overall Study|Lack of Efficacy|4|||
16971385|NCT00599521|38115466|FG001|Overall Study|Lack of Efficacy|8|||
16971386|NCT00599521|38115465|FG000|Overall Study|Adverse Event|4|||
16971387|NCT00599521|38115466|FG001|Overall Study|Adverse Event|1|||
16971388|NCT00599521|38115465|FG000|Overall Study|Withdrawal by Subject|28|||
16971389|NCT00599521|38115466|FG001|Overall Study|Withdrawal by Subject|34|||
16971390|NCT00599521|38115465|FG000|Overall Study|Protocol Violation|1|||
16971391|NCT00599521|38115466|FG001|Overall Study|Protocol Violation|1|||
16971392|NCT00599521|38115465|FG000|Overall Study|Lost to Follow-up|23|||
16971393|NCT00599521|38115466|FG001|Overall Study|Lost to Follow-up|23|||
16971394|NCT00599521|38115465|FG000|Overall Study|Pregnancy|0|||
16971395|NCT00599521|38115466|FG001|Overall Study|Pregnancy|2|||
16971396|NCT00882115|38115472|FG000|Overall Study|Withdrawal by Subject|3|||
16971397|NCT00882115|38115472|FG000|Overall Study|did not respond to DEP challe|6|||
16971398|NCT00881959|38115478|FG000|Overall Study|Lost to Follow-up|2|||
16971399|NCT00881959|38115479|FG001|Overall Study|Lost to Follow-up|4|||
16971400|NCT00884377|38115487|FG000|Overall Study|Withdrawal by Subject|1|||
16971401|NCT00884377|38115488|FG001|Overall Study|Withdrawal by Subject|0|||
16971402|NCT00884377|38115487|FG000|Overall Study|Could not confirm diagnosis|1|||
16971403|NCT00884377|38115488|FG001|Overall Study|Could not confirm diagnosis|0|||
16971404|NCT00884377|38115487|FG000|Overall Study|Physician Decision|0|||
16971405|NCT00884377|38115488|FG001|Overall Study|Physician Decision|1|||
16971406|NCT00884221|38115502|FG000|Overall Study|Withdrawal by Subject|0|||
16971407|NCT00884221|38115503|FG001|Overall Study|Withdrawal by Subject|3|||
16971408|NCT00884221|38115502|FG000|Overall Study|Adverse Event|6|||
16971409|NCT00884221|38115503|FG001|Overall Study|Adverse Event|3|||
16971410|NCT00884221|38115502|FG000|Overall Study|Protocol Violation|16|||
16971411|NCT00884221|38115503|FG001|Overall Study|Protocol Violation|13|||
16971412|NCT00884221|38115502|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
16971413|NCT00884221|38115503|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
16971414|NCT00899548|38115524|FG000|Overall Study|Physician Decision|3|||
16971415|NCT00899392|38115534|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
16971416|NCT00899392|38115535|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
16971417|NCT00690898|38115541|FG000|SCREENING|Screen failure|18|||
16971418|NCT00690898|38115541|FG000|TREATMENT|Adverse Event|3|||
16971419|NCT00690898|38115541|FG000|TREATMENT|Lack of Efficacy|18|||
16971420|NCT00690898|38115541|FG000|TREATMENT|Withdrawal by Subject|4|||
16971421|NCT00690898|38115541|FG000|TREATMENT|Other (not otherwise specified)|1|||
16971422|NCT00895414|38115545|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
16971423|NCT00895414|38115546|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
16971424|NCT00895414|38115545|FG000|First Intervention (14 Days)|Physician Decision|0|||
16971425|NCT00895414|38115546|FG001|First Intervention (14 Days)|Physician Decision|1|||
16971426|NCT01212770|38115555|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
16971427|NCT01212770|38115556|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
16971428|NCT01212770|38115557|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
16971429|NCT01212770|38115558|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16971430|NCT01212770|38115559|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16971431|NCT01212770|38115560|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16971432|NCT01212770|38115561|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16971433|NCT01212770|38115562|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16971434|NCT01212770|38115563|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16971435|NCT01212770|38115555|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
16971436|NCT01212770|38115556|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
16971437|NCT01212770|38115557|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
16971438|NCT01212770|38115558|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16971439|NCT01212770|38115559|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16971440|NCT01212770|38115560|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16971441|NCT01212770|38115561|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16971442|NCT01212770|38115562|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16971443|NCT01212770|38115563|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16971444|NCT01212770|38115555|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
16971445|NCT01212770|38115556|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
16971446|NCT01212770|38115557|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
16971447|NCT01212770|38115558|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16971448|NCT01212770|38115559|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16971449|NCT01212770|38115560|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16971450|NCT01212770|38115561|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16971451|NCT01212770|38115562|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16971452|NCT01212770|38115563|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16971453|NCT01212770|38115555|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16971454|NCT01212770|38115556|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16971455|NCT01212770|38115557|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
16971456|NCT01212770|38115558|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16971457|NCT01212770|38115559|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16971458|NCT01212770|38115560|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16971459|NCT01212770|38115561|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16971460|NCT01212770|38115562|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16971461|NCT01212770|38115563|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16971462|NCT01212770|38115555|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16971463|NCT01212770|38115556|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16971464|NCT01212770|38115557|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16971465|NCT01212770|38115558|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16971466|NCT01212770|38115559|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16971467|NCT01212770|38115560|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16971468|NCT01212770|38115561|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16971469|NCT01212770|38115562|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16971470|NCT01212770|38115563|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16971471|NCT01212770|38115555|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
16971472|NCT01212770|38115556|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
16971473|NCT01212770|38115557|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
16971474|NCT01212770|38115558|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16971475|NCT01212770|38115559|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16971476|NCT01212770|38115560|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16971477|NCT01212770|38115561|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16971478|NCT01212770|38115562|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16971479|NCT01212770|38115563|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16971480|NCT01212770|38115555|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16971481|NCT01212770|38115556|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
16971482|NCT01212770|38115557|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
16971483|NCT01212770|38115558|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
16971484|NCT01212770|38115559|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16971485|NCT01212770|38115560|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16971486|NCT01212770|38115561|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
16971487|NCT01212770|38115562|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16971488|NCT01212770|38115563|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16971489|NCT01212770|38115555|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
16971490|NCT01212770|38115556|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
16971491|NCT01212770|38115557|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
16971492|NCT01212770|38115558|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
16971493|NCT01212770|38115559|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
16971494|NCT01212770|38115560|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
16971495|NCT01212770|38115561|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
16971496|NCT01212770|38115562|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
16971497|NCT01212770|38115563|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
16971498|NCT01212770|38115555|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
16971499|NCT01212770|38115556|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
16971500|NCT01212770|38115557|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
16971501|NCT01212770|38115558|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
16971502|NCT01212770|38115559|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
16971503|NCT01212770|38115560|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
16971504|NCT01212770|38115561|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
16971505|NCT01212770|38115562|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
16971506|NCT01212770|38115563|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
16971507|NCT01212770|38115555|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16971508|NCT01212770|38115556|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16971509|NCT01212770|38115557|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
16971510|NCT01212770|38115558|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16971511|NCT01212770|38115559|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16971512|NCT01212770|38115560|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16971513|NCT01212770|38115561|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16971514|NCT01212770|38115562|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16971515|NCT01212770|38115563|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16971516|NCT01212770|38115555|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16971517|NCT01212770|38115556|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16971518|NCT01212770|38115557|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16971519|NCT01212770|38115558|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
16971520|NCT01212770|38115559|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16971521|NCT01212770|38115560|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16971522|NCT01212770|38115561|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16971523|NCT01212770|38115562|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16971524|NCT01212770|38115563|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16971525|NCT01212770|38115555|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16971526|NCT01212770|38115556|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16971527|NCT01212770|38115557|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
16971528|NCT01212770|38115558|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
16971529|NCT01212770|38115559|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16971530|NCT01212770|38115560|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16971531|NCT01212770|38115561|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16971532|NCT01212770|38115562|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16971533|NCT01212770|38115563|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16971534|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16971535|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
16971536|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
16971537|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16971538|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16971539|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16971540|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16971541|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16971542|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
16971543|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16971544|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
16971545|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
16971546|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16971547|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16971548|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16971549|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16971550|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
16971551|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
16971552|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16971553|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
16971554|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16971555|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16971556|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16971557|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16971558|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16971559|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16971560|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16971561|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16971562|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
16971563|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
16971564|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16971565|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16971566|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16971567|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16971568|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
16971569|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
16971570|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16971571|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
16971572|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
16971573|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16971574|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16971575|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16971576|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16971577|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
16971578|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
16971579|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16971580|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
16971581|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
16971582|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16971583|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16971584|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16971585|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16971586|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16971587|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
16971588|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16971589|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
16971590|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
16971591|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16971592|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16971593|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16971594|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16971595|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
16971596|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
16971597|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16971598|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
16971599|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
16971600|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16971601|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16971602|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16971603|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16971604|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
16971605|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
16971606|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16971607|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
16971608|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
16971609|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16971610|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16971611|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16971612|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16971613|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16971614|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16971615|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16971616|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
16971617|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16971618|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16971619|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16971620|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16971621|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16971622|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16971623|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16971624|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16971625|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16971626|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16971627|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16971628|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16971629|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16971630|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16971631|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
16971632|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16971633|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16971634|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
16971635|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
16971636|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16971637|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16971638|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16971639|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16971640|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
16971641|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
16971642|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16971643|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
16971644|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
16971645|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16971646|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16971647|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16971648|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16971649|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16971650|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
16971651|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16971652|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
16971653|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
16971654|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16971655|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16971656|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16971657|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16971658|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
16971659|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16971660|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16971661|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
16971662|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
16971663|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16971664|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16971665|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16971666|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16971667|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
16971668|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16971669|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16971670|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
16971671|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
16971672|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16971673|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16971674|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16971675|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16971676|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16971677|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16971678|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16971679|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16971680|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
16971681|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16971682|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16971683|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16971684|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16971685|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16971686|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16971687|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16971688|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
16971689|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16971690|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16971691|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16971692|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16971693|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16971694|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16971695|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
16971696|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
16971697|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
16971698|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
16971699|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
16971700|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
16971701|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
16971702|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
16971703|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
16971704|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
16971705|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16971706|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16971707|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
16971708|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16971709|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16971710|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16971711|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16971712|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16971713|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16971714|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16971715|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16971716|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
16971717|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16971718|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16971719|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16971720|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16971721|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16971722|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
16971723|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16971724|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16971725|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
16971726|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16971727|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16971728|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16971729|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16971730|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16971731|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16971732|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16971733|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
16971734|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16971735|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16971736|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16971737|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16971738|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16971739|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16971740|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16971741|NCT01212770|38115555|FG000|Long-term Safety Phase (Year 5)|Death|0|||
16971742|NCT01212770|38115556|FG001|Long-term Safety Phase (Year 5)|Death|0|||
16971743|NCT01212770|38115557|FG002|Long-term Safety Phase (Year 5)|Death|0|||
16971744|NCT01212770|38115558|FG003|Long-term Safety Phase (Year 5)|Death|0|||
16971745|NCT01212770|38115559|FG004|Long-term Safety Phase (Year 5)|Death|0|||
16971746|NCT01212770|38115560|FG005|Long-term Safety Phase (Year 5)|Death|0|||
16971747|NCT01212770|38115561|FG006|Long-term Safety Phase (Year 5)|Death|0|||
16971748|NCT01212770|38115562|FG007|Long-term Safety Phase (Year 5)|Death|1|||
16971749|NCT01212770|38115563|FG008|Long-term Safety Phase (Year 5)|Death|0|||
16971750|NCT00598273|38115588|FG000|Overall Study|Adverse Event|4|||
16971751|NCT00598273|38115589|FG001|Overall Study|Adverse Event|5|||
16971752|NCT00598273|38115590|FG002|Overall Study|Adverse Event|2|||
16971753|NCT00598273|38115588|FG000|Overall Study|Death|6|||
16971754|NCT00598273|38115589|FG001|Overall Study|Death|12|||
16971755|NCT00598273|38115590|FG002|Overall Study|Death|8|||
16971756|NCT00598273|38115588|FG000|Overall Study|Lost to Follow-up|8|||
16971757|NCT00598273|38115589|FG001|Overall Study|Lost to Follow-up|3|||
16971758|NCT00598273|38115590|FG002|Overall Study|Lost to Follow-up|5|||
16971759|NCT00598273|38115588|FG000|Overall Study|Physician Decision|0|||
16971760|NCT00598273|38115589|FG001|Overall Study|Physician Decision|0|||
16971761|NCT00598273|38115590|FG002|Overall Study|Physician Decision|1|||
16971762|NCT00598273|38115588|FG000|Overall Study|Withdrawal by Subject|12|||
16971763|NCT00598273|38115589|FG001|Overall Study|Withdrawal by Subject|10|||
16971764|NCT00598273|38115590|FG002|Overall Study|Withdrawal by Subject|10|||
16971765|NCT00598273|38115588|FG000|Overall Study|Noncompliance|3|||
16971766|NCT00598273|38115589|FG001|Overall Study|Noncompliance|2|||
16971767|NCT00598273|38115590|FG002|Overall Study|Noncompliance|3|||
16971768|NCT00598273|38115588|FG000|Overall Study|Relocation|0|||
16971769|NCT00598273|38115589|FG001|Overall Study|Relocation|2|||
16971770|NCT00598273|38115590|FG002|Overall Study|Relocation|4|||
16971771|NCT00598273|38115588|FG000|Overall Study|Renal transplant|1|||
16971772|NCT00598273|38115589|FG001|Overall Study|Renal transplant|0|||
16971773|NCT00598273|38115590|FG002|Overall Study|Renal transplant|1|||
16971774|NCT00598273|38115588|FG000|Overall Study|Site elected to close|1|||
16971775|NCT00598273|38115589|FG001|Overall Study|Site elected to close|0|||
16971776|NCT00598273|38115590|FG002|Overall Study|Site elected to close|0|||
16971777|NCT00598273|38115588|FG000|Overall Study|Started dialysis|6|||
16971778|NCT00598273|38115589|FG001|Overall Study|Started dialysis|4|||
16971779|NCT00598273|38115590|FG002|Overall Study|Started dialysis|5|||
16971780|NCT01211522|38115601|FG000|Overall Study|Withdrawal by Subject|3|||
16971781|NCT01211522|38115602|FG001|Overall Study|Withdrawal by Subject|7|||
16971782|NCT01211522|38115603|FG002|Overall Study|Withdrawal by Subject|5|||
16971783|NCT01211288|38115613|FG000|Overall Study|Lost to Follow-up|1|||
16971784|NCT01211288|38115614|FG001|Overall Study|Lost to Follow-up|1|||
16971785|NCT00883753|38115622|FG000|Overall Study|Adverse Event|37|||
16971786|NCT00883753|38115622|FG000|Overall Study|Death|2|||
16971787|NCT00883753|38115622|FG000|Overall Study|Insufficient therapeutic response|16|||
16971788|NCT00883753|38115622|FG000|Overall Study|Lost to Follow-up|4|||
16971789|NCT00883753|38115622|FG000|Overall Study|Violation of selection criteria at entry|7|||
16971790|NCT00883753|38115622|FG000|Overall Study|Protocol Violation|2|||
16971791|NCT00883753|38115622|FG000|Overall Study|Refused treatment|4|||
16971792|NCT00883753|38115622|FG000|Overall Study|Withdrew consent|10|||
16971793|NCT00883753|38115622|FG000|Overall Study|Investigator's decision|17|||
16971794|NCT00883753|38115622|FG000|Overall Study|Administrative/Other|8|||
16971795|NCT01210664|38115629|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
16971796|NCT01210664|38115630|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
16971797|NCT01210664|38115631|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
16971798|NCT01210664|38115632|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
16971799|NCT01210664|38115629|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
16971800|NCT01210664|38115630|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
16971801|NCT01210664|38115631|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
16971802|NCT01210664|38115632|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
16971803|NCT01210664|38115629|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
16971804|NCT01210664|38115630|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
16971805|NCT01210664|38115631|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
16971806|NCT01210664|38115632|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
16971807|NCT00881569|38115644|FG000|Overall Study|Disease progression|1|||
16971808|NCT00881569|38115645|FG001|Overall Study|Disease progression|1|||
16971809|NCT00881335|38115653|FG000|Overall Study|Lost to Follow-up|3|||
16971810|NCT00881335|38115654|FG001|Overall Study|Lost to Follow-up|2|||
16971811|NCT02382406|38115663|FG000|Study Treatment|Disease Progression|8|||
16971812|NCT02382406|38115664|FG001|Study Treatment|Disease Progression|0|||
16971813|NCT02382406|38115665|FG002|Study Treatment|Disease Progression|20|||
16971814|NCT02382406|38115663|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
16971815|NCT02382406|38115664|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
16971816|NCT02382406|38115665|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
16971817|NCT02382406|38115663|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
16971818|NCT02382406|38115664|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
16971819|NCT02382406|38115665|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
16971820|NCT02382406|38115663|FG000|Study Treatment|symptomatic deterioration|1|||
16971821|NCT02382406|38115664|FG001|Study Treatment|symptomatic deterioration|0|||
16971822|NCT02382406|38115665|FG002|Study Treatment|symptomatic deterioration|1|||
16971823|NCT02382406|38115663|FG000|Study Treatment|Death|0|||
16971824|NCT02382406|38115664|FG001|Study Treatment|Death|0|||
16971825|NCT02382406|38115665|FG002|Study Treatment|Death|2|||
16971826|NCT02382406|38115663|FG000|Follow up|Death|11|||
16971827|NCT02382406|38115664|FG001|Follow up|Death|0|||
16971828|NCT02382406|38115665|FG002|Follow up|Death|19|||
16971829|NCT02382406|38115663|FG000|Follow up|Symptomatic deterioration|1|||
16971830|NCT02382406|38115664|FG001|Follow up|Symptomatic deterioration|0|||
16971831|NCT02382406|38115665|FG002|Follow up|Symptomatic deterioration|1|||
16971832|NCT02382406|38115663|FG000|Follow up|Patient Refused Follow-up|1|||
16971833|NCT02382406|38115664|FG001|Follow up|Patient Refused Follow-up|0|||
16971834|NCT02382406|38115665|FG002|Follow up|Patient Refused Follow-up|0|||
16971835|NCT02382406|38115663|FG000|Follow up|Study Terminated|1|||
16971836|NCT02382406|38115664|FG001|Follow up|Study Terminated|0|||
16971837|NCT02382406|38115665|FG002|Follow up|Study Terminated|8|||
16971838|NCT02382406|38115663|FG000|Follow up|Withdrawal by Subject|0|||
16971839|NCT02382406|38115664|FG001|Follow up|Withdrawal by Subject|0|||
16971840|NCT02382406|38115665|FG002|Follow up|Withdrawal by Subject|2|||
16971841|NCT00879775|38115686|FG000|Overall Study|Lost to Follow-up|2|||
16971842|NCT00879775|38115687|FG001|Overall Study|Lost to Follow-up|1|||
16971843|NCT00894790|38115695|FG000|Overall Study|Protocol Violation|0|||
16971844|NCT00894790|38115696|FG001|Overall Study|Protocol Violation|1|||
16971845|NCT00894790|38115695|FG000|Overall Study|Lost to Follow-up|0|||
16971846|NCT00894790|38115696|FG001|Overall Study|Lost to Follow-up|1|||
16971847|NCT00894790|38115695|FG000|Overall Study|Did not meet entrance criteria|1|||
16971848|NCT00894790|38115696|FG001|Overall Study|Did not meet entrance criteria|0|||
16971849|NCT00879229|38115704|FG000|Overall Study|Study terminated by Sponsor|13|||
16971850|NCT00879229|38115705|FG001|Overall Study|Study terminated by Sponsor|12|||
16971851|NCT00879229|38115704|FG000|Overall Study|Death|4|||
16971852|NCT00879229|38115705|FG001|Overall Study|Death|2|||
16971853|NCT00879229|38115704|FG000|Overall Study|Adverse Event|2|||
16971854|NCT00879229|38115705|FG001|Overall Study|Adverse Event|0|||
16971855|NCT00879229|38115704|FG000|Overall Study|Withdrawal by Subject|1|||
16971856|NCT00879229|38115705|FG001|Overall Study|Withdrawal by Subject|0|||
16971857|NCT00879229|38115704|FG000|Overall Study|Clinical status did not improve|1|||
16971858|NCT00879229|38115705|FG001|Overall Study|Clinical status did not improve|0|||
16971859|NCT00879229|38115704|FG000|Overall Study|Other|1|||
16971860|NCT00879229|38115705|FG001|Overall Study|Other|0|||
16971861|NCT00878995|38115713|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
16971862|NCT00878995|38115714|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
16971863|NCT00879697|38115722|FG000|Overall Study|Physician Decision|2|||
16971864|NCT00879697|38115723|FG001|Overall Study|Physician Decision|2|||
16971865|NCT00894556|38115732|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
16971866|NCT00894556|38115733|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
16971867|NCT00894556|38115734|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
16971868|NCT00894556|38115735|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
16971869|NCT00894556|38115732|FG000|Treatment Phase|Lost to Follow-up|2|||
16971870|NCT00894556|38115733|FG001|Treatment Phase|Lost to Follow-up|3|||
16971871|NCT00894556|38115734|FG002|Treatment Phase|Lost to Follow-up|1|||
16971872|NCT00894556|38115735|FG003|Treatment Phase|Lost to Follow-up|0|||
16971873|NCT00894556|38115732|FG000|Treatment Phase|Lack of Qualifying Event|2|||
16971874|NCT00894556|38115733|FG001|Treatment Phase|Lack of Qualifying Event|1|||
16971875|NCT00894556|38115734|FG002|Treatment Phase|Lack of Qualifying Event|0|||
16971876|NCT00894556|38115735|FG003|Treatment Phase|Lack of Qualifying Event|0|||
16971877|NCT01210352|38115751|FG000|Overall Study|Adverse Event|0|||
16971878|NCT01210352|38115752|FG001|Overall Study|Adverse Event|0|||
16971879|NCT01210352|38115753|FG002|Overall Study|Adverse Event|0|||
16971880|NCT01210352|38115754|FG003|Overall Study|Adverse Event|0|||
16971881|NCT01210352|38115755|FG004|Overall Study|Adverse Event|0|||
16971882|NCT01210352|38115756|FG005|Overall Study|Adverse Event|0|||
16971883|NCT01210352|38115757|FG006|Overall Study|Adverse Event|0|||
16868010|NCT01536145|37841041|FG008|Overall Study|Progressive disease|1|||
16971884|NCT01210352|38115758|FG007|Overall Study|Adverse Event|2|||
16971885|NCT01210352|38115759|FG008|Overall Study|Adverse Event|1|||
16971886|NCT01210352|38115751|FG000|Overall Study|Lack of Efficacy|0|||
16971887|NCT01210352|38115752|FG001|Overall Study|Lack of Efficacy|0|||
16971888|NCT01210352|38115753|FG002|Overall Study|Lack of Efficacy|0|||
16971889|NCT01210352|38115754|FG003|Overall Study|Lack of Efficacy|0|||
16971890|NCT01210352|38115755|FG004|Overall Study|Lack of Efficacy|0|||
16971891|NCT01210352|38115756|FG005|Overall Study|Lack of Efficacy|0|||
16971892|NCT01210352|38115757|FG006|Overall Study|Lack of Efficacy|1|||
16971893|NCT01210352|38115758|FG007|Overall Study|Lack of Efficacy|0|||
16971894|NCT01210352|38115759|FG008|Overall Study|Lack of Efficacy|0|||
16971895|NCT01210352|38115751|FG000|Overall Study|Physician Decision|0|||
16971896|NCT01210352|38115752|FG001|Overall Study|Physician Decision|0|||
16971897|NCT01210352|38115753|FG002|Overall Study|Physician Decision|0|||
16971898|NCT01210352|38115754|FG003|Overall Study|Physician Decision|0|||
16971899|NCT01210352|38115755|FG004|Overall Study|Physician Decision|0|||
16971900|NCT01210352|38115756|FG005|Overall Study|Physician Decision|0|||
16971901|NCT01210352|38115757|FG006|Overall Study|Physician Decision|0|||
16971902|NCT01210352|38115758|FG007|Overall Study|Physician Decision|1|||
16971903|NCT01210352|38115759|FG008|Overall Study|Physician Decision|2|||
16971904|NCT01210352|38115751|FG000|Overall Study|Withdrawal by Subject|0|||
16971905|NCT01210352|38115752|FG001|Overall Study|Withdrawal by Subject|0|||
16971906|NCT01210352|38115753|FG002|Overall Study|Withdrawal by Subject|1|||
16971907|NCT01210352|38115754|FG003|Overall Study|Withdrawal by Subject|0|||
16971908|NCT01210352|38115755|FG004|Overall Study|Withdrawal by Subject|0|||
16971909|NCT01210352|38115756|FG005|Overall Study|Withdrawal by Subject|0|||
16971910|NCT01210352|38115757|FG006|Overall Study|Withdrawal by Subject|1|||
16971911|NCT01210352|38115758|FG007|Overall Study|Withdrawal by Subject|0|||
16971912|NCT01210352|38115759|FG008|Overall Study|Withdrawal by Subject|1|||
16971913|NCT01210352|38115751|FG000|Overall Study|Patient Discharged Early|0|||
16971914|NCT01210352|38115752|FG001|Overall Study|Patient Discharged Early|0|||
16971915|NCT01210352|38115753|FG002|Overall Study|Patient Discharged Early|1|||
16971916|NCT01210352|38115754|FG003|Overall Study|Patient Discharged Early|0|||
16971917|NCT01210352|38115755|FG004|Overall Study|Patient Discharged Early|0|||
16971918|NCT01210352|38115756|FG005|Overall Study|Patient Discharged Early|0|||
16971919|NCT01210352|38115757|FG006|Overall Study|Patient Discharged Early|0|||
16971920|NCT01210352|38115758|FG007|Overall Study|Patient Discharged Early|0|||
16971921|NCT01210352|38115759|FG008|Overall Study|Patient Discharged Early|0|||
16971922|NCT01210118|38115866|FG000|Overall Study|Lost to Follow-up|1|||
16971923|NCT01210118|38115867|FG001|Overall Study|Lost to Follow-up|1|||
16971924|NCT01210118|38115866|FG000|Overall Study|Protocol Violation|1|||
16971925|NCT01210118|38115867|FG001|Overall Study|Protocol Violation|1|||
16971926|NCT01210118|38115866|FG000|Overall Study|Spontaneous abortion|1|||
16971927|NCT01210118|38115867|FG001|Overall Study|Spontaneous abortion|3|||
16971928|NCT01208870|38115878|FG000|Overall Study|Lost to Follow-up|2|||
16971929|NCT01208870|38115879|FG001|Overall Study|Lost to Follow-up|8|||
16971930|NCT00880555|38115890|FG000|Overall Study|Physician Decision|0|||
16971931|NCT00880555|38115891|FG001|Overall Study|Physician Decision|8|||
16971932|NCT00880555|38115892|FG002|Overall Study|Physician Decision|0|||
16971933|NCT00880555|38115893|FG003|Overall Study|Physician Decision|2|||
16971934|NCT00880555|38115894|FG004|Overall Study|Physician Decision|1|||
16971935|NCT00880555|38115895|FG005|Overall Study|Physician Decision|0|||
16971936|NCT00880555|38115890|FG000|Overall Study|Withdrawal by Subject|1|||
16971937|NCT00880555|38115891|FG001|Overall Study|Withdrawal by Subject|1|||
16971938|NCT00880555|38115892|FG002|Overall Study|Withdrawal by Subject|0|||
16971939|NCT00880555|38115893|FG003|Overall Study|Withdrawal by Subject|0|||
16971940|NCT00880555|38115894|FG004|Overall Study|Withdrawal by Subject|0|||
16971941|NCT00880555|38115895|FG005|Overall Study|Withdrawal by Subject|0|||
16971942|NCT00880555|38115890|FG000|Overall Study|Lack of resources (hired rater)|9|||
16971943|NCT00880555|38115891|FG001|Overall Study|Lack of resources (hired rater)|7|||
16971944|NCT00880555|38115892|FG002|Overall Study|Lack of resources (hired rater)|5|||
16971945|NCT00880555|38115893|FG003|Overall Study|Lack of resources (hired rater)|0|||
16971946|NCT00880555|38115894|FG004|Overall Study|Lack of resources (hired rater)|0|||
16971947|NCT00880555|38115895|FG005|Overall Study|Lack of resources (hired rater)|0|||
16971948|NCT00880555|38115890|FG000|Overall Study|Death|0|||
16971949|NCT00880555|38115891|FG001|Overall Study|Death|0|||
16971950|NCT00880555|38115892|FG002|Overall Study|Death|0|||
16971951|NCT00880555|38115893|FG003|Overall Study|Death|0|||
16971952|NCT00880555|38115894|FG004|Overall Study|Death|0|||
16971953|NCT00880555|38115895|FG005|Overall Study|Death|1|||
16971954|NCT00880555|38115890|FG000|Overall Study|Lost to Follow-up|0|||
16971955|NCT00880555|38115891|FG001|Overall Study|Lost to Follow-up|1|||
16971956|NCT00880555|38115892|FG002|Overall Study|Lost to Follow-up|0|||
16971957|NCT00880555|38115893|FG003|Overall Study|Lost to Follow-up|0|||
16971958|NCT00880555|38115894|FG004|Overall Study|Lost to Follow-up|0|||
16971959|NCT00880555|38115895|FG005|Overall Study|Lost to Follow-up|0|||
16971960|NCT01208402|38115908|FG000|Overall Study|Withdrawal by Subject|1|||
16971961|NCT01208402|38115909|FG001|Overall Study|Withdrawal by Subject|0|||
16971962|NCT01208324|38115919|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
16971963|NCT01208324|38115920|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
16971964|NCT01208324|38115921|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
16971965|NCT01208324|38115922|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
16971966|NCT00880399|38115935|FG000|Overall Study|Adverse Event|4|||
16971967|NCT00880399|38115936|FG001|Overall Study|Adverse Event|6|||
16971968|NCT00880399|38115937|FG002|Overall Study|Adverse Event|5|||
16971969|NCT00880399|38115935|FG000|Overall Study|Lack of Efficacy|1|||
16971970|NCT00880399|38115936|FG001|Overall Study|Lack of Efficacy|4|||
16971971|NCT00880399|38115937|FG002|Overall Study|Lack of Efficacy|2|||
16971972|NCT00880399|38115935|FG000|Overall Study|Protocol Violation|4|||
16971973|NCT00880399|38115936|FG001|Overall Study|Protocol Violation|4|||
16971974|NCT00880399|38115937|FG002|Overall Study|Protocol Violation|6|||
16971975|NCT00880399|38115935|FG000|Overall Study|Study closed/terminated|3|||
16971976|NCT00880399|38115936|FG001|Overall Study|Study closed/terminated|7|||
16971977|NCT00880399|38115937|FG002|Overall Study|Study closed/terminated|4|||
16971978|NCT00880399|38115935|FG000|Overall Study|Lost to Follow-up|8|||
16971979|NCT00880399|38115936|FG001|Overall Study|Lost to Follow-up|5|||
16971980|NCT00880399|38115937|FG002|Overall Study|Lost to Follow-up|3|||
16971981|NCT00880399|38115935|FG000|Overall Study|Physician Decision|5|||
16971982|NCT00880399|38115936|FG001|Overall Study|Physician Decision|0|||
16971983|NCT00880399|38115937|FG002|Overall Study|Physician Decision|3|||
16971984|NCT00880399|38115935|FG000|Overall Study|Withdrawal by Subject|6|||
16971985|NCT00880399|38115936|FG001|Overall Study|Withdrawal by Subject|3|||
16971986|NCT00880399|38115937|FG002|Overall Study|Withdrawal by Subject|3|||
16971987|NCT01207388|38115945|FG000|Overall Study|Death|67|||
16971988|NCT01207388|38115945|FG000|Overall Study|Withdrawal by Subject|1|||
16971989|NCT01206764|38115957|FG000|Overall Study|Adverse Event|20|||
16971990|NCT01206764|38115957|FG000|Overall Study|Abnormal laboratory value|2|||
16971991|NCT01206764|38115957|FG000|Overall Study|Abnormal test procedure result|1|||
16971992|NCT01206764|38115957|FG000|Overall Study|Patient withdrew consent|5|||
16971993|NCT01206764|38115957|FG000|Overall Study|Lost to Follow-up|6|||
16971994|NCT01206764|38115957|FG000|Overall Study|Death|11|||
16971995|NCT01206764|38115957|FG000|Overall Study|New cancer therapy|2|||
16971996|NCT01206764|38115957|FG000|Overall Study|Disease progression|88|||
16971997|NCT01206764|38115957|FG000|Overall Study|Protocol deviation|3|||
16971998|NCT00894322|38115964|FG000|Overall Study|Withdrawal by Subject|1|||
16971999|NCT00894322|38115965|FG001|Overall Study|Withdrawal by Subject|0|||
16972000|NCT00894322|38115966|FG002|Overall Study|Withdrawal by Subject|0|||
16972001|NCT00596635|38115979|FG000|Overall Study|Lost to Follow-up|0|||
16972002|NCT00596635|38115980|FG001|Overall Study|Lost to Follow-up|2|||
16972003|NCT00596635|38115981|FG002|Overall Study|Lost to Follow-up|0|||
16972004|NCT00596635|38115979|FG000|Overall Study|Treatment for symptomatic UTI|4|||
16972005|NCT00596635|38115980|FG001|Overall Study|Treatment for symptomatic UTI|6|||
16972006|NCT00596635|38115981|FG002|Overall Study|Treatment for symptomatic UTI|3|||
16972007|NCT00596635|38115979|FG000|Overall Study|Hip fracture|2|||
16972008|NCT00596635|38115980|FG001|Overall Study|Hip fracture|3|||
16972009|NCT00596635|38115981|FG002|Overall Study|Hip fracture|3|||
16972010|NCT00596635|38115979|FG000|Overall Study|Could not provide urine specimen|1|||
16972011|NCT00596635|38115980|FG001|Overall Study|Could not provide urine specimen|2|||
16972012|NCT00596635|38115981|FG002|Overall Study|Could not provide urine specimen|2|||
16972013|NCT00894166|38115997|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
16972014|NCT00894166|38115998|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
16972015|NCT00894166|38115999|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
16972016|NCT00894166|38116000|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
16972017|NCT00894166|38116001|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
16972018|NCT00894166|38116002|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
16972019|NCT00894166|38116003|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
16972020|NCT00894166|38116004|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
16972021|NCT00894166|38115997|FG000|Overall Study|Death|0|||
16972022|NCT00894166|38115998|FG001|Overall Study|Death|0|||
16972023|NCT00894166|38115999|FG002|Overall Study|Death|0|||
16972024|NCT00894166|38116000|FG003|Overall Study|Death|1|||
16972025|NCT00894166|38116001|FG004|Overall Study|Death|0|||
16972026|NCT00894166|38116002|FG005|Overall Study|Death|0|||
16972027|NCT00894166|38116003|FG006|Overall Study|Death|0|||
16972028|NCT00894166|38116004|FG007|Overall Study|Death|0|||
16972029|NCT00880165|38116029|FG000|Overall Study|Withdrawal by Subject|27|||
16972030|NCT00880165|38116030|FG001|Overall Study|Withdrawal by Subject|23|||
16972031|NCT00880165|38116029|FG000|Overall Study|Not diagnosed with OSA|14|||
16972032|NCT00880165|38116030|FG001|Overall Study|Not diagnosed with OSA|8|||
16868011|NCT01536145|37841042|FG009|Overall Study|Progressive disease|3|||
16972033|NCT00880165|38116029|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
16972034|NCT00880165|38116030|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
16972035|NCT00880165|38116029|FG000|Overall Study|Lost to follow|9|||
16972036|NCT00880165|38116030|FG001|Overall Study|Lost to follow|15|||
16972037|NCT01165229|38116038|FG000|Overall Study|Serious Adverse Event|456|||
16972038|NCT01165229|38116039|FG001|Overall Study|Serious Adverse Event|487|||
16972039|NCT01165229|38116038|FG000|Overall Study|Non-Serious Adverse Event|47|||
16972040|NCT01165229|38116039|FG001|Overall Study|Non-Serious Adverse Event|15|||
16972041|NCT01165229|38116038|FG000|Overall Study|Protocol Violation|6|||
16972042|NCT01165229|38116039|FG001|Overall Study|Protocol Violation|8|||
16972043|NCT01165229|38116038|FG000|Overall Study|Withdrawal by Subject|387|||
16972044|NCT01165229|38116039|FG001|Overall Study|Withdrawal by Subject|396|||
16972045|NCT01165229|38116038|FG000|Overall Study|Migrated/moved from study area|51|||
16972046|NCT01165229|38116039|FG001|Overall Study|Migrated/moved from study area|46|||
16972047|NCT01165229|38116038|FG000|Overall Study|Lost to Follow-up|123|||
16972048|NCT01165229|38116039|FG001|Overall Study|Lost to Follow-up|133|||
16972049|NCT01165229|38116038|FG000|Overall Study|Suspected HZ Episode|2|||
16972050|NCT01165229|38116039|FG001|Overall Study|Suspected HZ Episode|2|||
16972051|NCT01165229|38116038|FG000|Overall Study|No reason from the subject|108|||
16972052|NCT01165229|38116039|FG001|Overall Study|No reason from the subject|102|||
16972053|NCT01165229|38116038|FG000|Overall Study|Unknown completion status|0|||
16972054|NCT01165229|38116039|FG001|Overall Study|Unknown completion status|1|||
16972055|NCT00596011|38116077|FG000|Overall Study|Withdrawal by Subject|2|||
16972056|NCT00596011|38116078|FG001|Overall Study|Withdrawal by Subject|3|||
16972057|NCT00596011|38116077|FG000|Overall Study|Adverse Event|11|||
16972058|NCT00596011|38116078|FG001|Overall Study|Adverse Event|7|||
16972059|NCT01163747|38116086|FG000|Overall Study|Adverse Event|0|||
16972060|NCT01163747|38116087|FG001|Overall Study|Adverse Event|5|||
16972061|NCT01163747|38116086|FG000|Overall Study|Insufficient Therapeutic Response|0|||
16972062|NCT01163747|38116087|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16972063|NCT01163747|38116086|FG000|Overall Study|Protocol Violation|0|||
16972064|NCT01163747|38116087|FG001|Overall Study|Protocol Violation|1|||
16972065|NCT01163747|38116086|FG000|Overall Study|Refused Treatment|6|||
16972066|NCT01163747|38116087|FG001|Overall Study|Refused Treatment|4|||
16972067|NCT01163279|38116095|FG000|Overall Study|Withdrawal by Subject|2|||
16972068|NCT01163279|38116096|FG001|Overall Study|Withdrawal by Subject|0|||
16972069|NCT01162499|38116103|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
16972070|NCT01162499|38116104|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
16972071|NCT01206140|38116114|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
16972072|NCT01206140|38116115|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
16972073|NCT01162421|38116123|FG000|Overall Study|Did not receive study drug|2|||
16972074|NCT01162421|38116124|FG001|Overall Study|Did not receive study drug|1|||
16972075|NCT01162421|38116123|FG000|Overall Study|Adverse Event|2|||
16972076|NCT01162421|38116124|FG001|Overall Study|Adverse Event|5|||
16972077|NCT01162421|38116123|FG000|Overall Study|Lost to Follow-up|0|||
16972078|NCT01162421|38116124|FG001|Overall Study|Lost to Follow-up|2|||
16972079|NCT01162421|38116123|FG000|Overall Study|Lack of Efficacy|2|||
16972080|NCT01162421|38116124|FG001|Overall Study|Lack of Efficacy|2|||
16972081|NCT01162421|38116123|FG000|Overall Study|Other|2|||
16972082|NCT01162421|38116124|FG001|Overall Study|Other|3|||
16972083|NCT01162343|38116130|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
16972084|NCT01162343|38116130|FG000|Overall Study|Refused psychiatrist assessment|12|||
16972085|NCT01188551|38116138|FG000|Overall Study|Pharmacy issues|1|||
16972086|NCT01188551|38116139|FG001|Overall Study|Pharmacy issues|0|||
16972087|NCT01188551|38116140|FG002|Overall Study|Pharmacy issues|0|||
16972088|NCT01188551|38116141|FG003|Overall Study|Pharmacy issues|0|||
16972089|NCT01161407|38116153|FG000|Overall Study|Protocol Violation|3|||
16972090|NCT01161407|38116154|FG001|Overall Study|Protocol Violation|1|||
16972091|NCT01161173|38116160|FG000|Overall Study|Protocol Violation|13|||
16972092|NCT01161173|38116160|FG000|Overall Study|Lost to Follow-up|7|||
16972093|NCT01161173|38116160|FG000|Overall Study|Progressive Disease|82|||
16972094|NCT01161173|38116160|FG000|Overall Study|Withdrawal of Consent|5|||
16972095|NCT01161173|38116160|FG000|Overall Study|Unacceptable Toxicity|21|||
16972096|NCT01161173|38116160|FG000|Overall Study|Death|194|||
16972097|NCT01161173|38116160|FG000|Overall Study|End of Study|2|||
16972098|NCT01161173|38116160|FG000|Overall Study|Reasons Not Specified|23|||
16972099|NCT01159769|38116164|FG000|Overall Study|Adverse Event|1|||
16972100|NCT01159691|38116168|FG000|Overall Study|Lost to Follow-up|2|||
16972101|NCT01159691|38116168|FG000|Overall Study|Unknown reasons|1|||
16972102|NCT01159691|38116168|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
16972103|NCT01159691|38116168|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
16972104|NCT01159691|38116168|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
16972105|NCT01159691|38116168|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
16972106|NCT01159691|38116168|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
16972107|NCT01159691|38116168|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
16972108|NCT01157897|38116176|FG000|Overall Study|Lost to Follow-up|2|||
16972109|NCT01157897|38116177|FG001|Overall Study|Lost to Follow-up|0|||
16972110|NCT01157897|38116178|FG002|Overall Study|Lost to Follow-up|0|||
16972111|NCT01157897|38116179|FG003|Overall Study|Lost to Follow-up|1|||
16972112|NCT01157897|38116176|FG000|Overall Study|Relocated|0|||
16972113|NCT01157897|38116177|FG001|Overall Study|Relocated|2|||
16972114|NCT01157897|38116178|FG002|Overall Study|Relocated|0|||
16972115|NCT01157897|38116179|FG003|Overall Study|Relocated|0|||
16972116|NCT01185821|38116194|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16972117|NCT01185821|38116195|FG001|Overall Study|Abnormal laboratory value(s)|2|||
16972118|NCT01185821|38116196|FG002|Overall Study|Abnormal laboratory value(s)|1|||
16972119|NCT01185821|38116197|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16972120|NCT01185821|38116198|FG004|Overall Study|Abnormal laboratory value(s)|0|||
16972121|NCT01185821|38116194|FG000|Overall Study|Protocol Violation|0|||
16972122|NCT01185821|38116195|FG001|Overall Study|Protocol Violation|0|||
16972123|NCT01185821|38116196|FG002|Overall Study|Protocol Violation|0|||
16972124|NCT01185821|38116197|FG003|Overall Study|Protocol Violation|1|||
16972125|NCT01185821|38116198|FG004|Overall Study|Protocol Violation|1|||
16972126|NCT01185821|38116194|FG000|Overall Study|Abnormal test procedure result|0|||
16972127|NCT01185821|38116195|FG001|Overall Study|Abnormal test procedure result|0|||
16972128|NCT01185821|38116196|FG002|Overall Study|Abnormal test procedure result|0|||
16972129|NCT01185821|38116197|FG003|Overall Study|Abnormal test procedure result|0|||
16972130|NCT01185821|38116198|FG004|Overall Study|Abnormal test procedure result|1|||
16972131|NCT01185821|38116194|FG000|Overall Study|Death|0|||
16972132|NCT01185821|38116195|FG001|Overall Study|Death|1|||
16972133|NCT01185821|38116196|FG002|Overall Study|Death|0|||
16972134|NCT01185821|38116197|FG003|Overall Study|Death|0|||
16972135|NCT01185821|38116198|FG004|Overall Study|Death|0|||
16972136|NCT01185821|38116194|FG000|Overall Study|Condition no longer required study drug|0|||
16972137|NCT01185821|38116195|FG001|Overall Study|Condition no longer required study drug|0|||
16972138|NCT01185821|38116196|FG002|Overall Study|Condition no longer required study drug|0|||
16972139|NCT01185821|38116197|FG003|Overall Study|Condition no longer required study drug|0|||
16972140|NCT01185821|38116198|FG004|Overall Study|Condition no longer required study drug|1|||
16972141|NCT01185821|38116194|FG000|Overall Study|Adverse Event|2|||
16972142|NCT01185821|38116195|FG001|Overall Study|Adverse Event|3|||
16972143|NCT01185821|38116196|FG002|Overall Study|Adverse Event|1|||
16972144|NCT01185821|38116197|FG003|Overall Study|Adverse Event|2|||
16972145|NCT01185821|38116198|FG004|Overall Study|Adverse Event|5|||
16972146|NCT01185821|38116194|FG000|Overall Study|Lack of Efficacy|0|||
16972147|NCT01185821|38116195|FG001|Overall Study|Lack of Efficacy|0|||
16972148|NCT01185821|38116196|FG002|Overall Study|Lack of Efficacy|3|||
16972149|NCT01185821|38116197|FG003|Overall Study|Lack of Efficacy|0|||
16972150|NCT01185821|38116198|FG004|Overall Study|Lack of Efficacy|9|||
16972151|NCT01185821|38116194|FG000|Overall Study|Withdrawal by Subject|3|||
16972152|NCT01185821|38116195|FG001|Overall Study|Withdrawal by Subject|2|||
16972153|NCT01185821|38116196|FG002|Overall Study|Withdrawal by Subject|2|||
16972154|NCT01185821|38116197|FG003|Overall Study|Withdrawal by Subject|1|||
16972155|NCT01185821|38116198|FG004|Overall Study|Withdrawal by Subject|3|||
16972156|NCT01185821|38116194|FG000|Overall Study|Lost to Follow-up|1|||
16972157|NCT01185821|38116195|FG001|Overall Study|Lost to Follow-up|1|||
16972158|NCT01185821|38116196|FG002|Overall Study|Lost to Follow-up|2|||
16972159|NCT01185821|38116197|FG003|Overall Study|Lost to Follow-up|1|||
16972160|NCT01185821|38116198|FG004|Overall Study|Lost to Follow-up|2|||
16972161|NCT01185821|38116194|FG000|Overall Study|Administrative problems|0|||
16972162|NCT01185821|38116195|FG001|Overall Study|Administrative problems|0|||
16972163|NCT01185821|38116196|FG002|Overall Study|Administrative problems|1|||
16972164|NCT01185821|38116197|FG003|Overall Study|Administrative problems|1|||
16972165|NCT01185821|38116198|FG004|Overall Study|Administrative problems|2|||
16972166|NCT00893464|38116220|FG000|Overall Study|Did not complete therapy/experience PD|0|||
16972167|NCT00893464|38116221|FG001|Overall Study|Did not complete therapy/experience PD|0|||
16972168|NCT00893464|38116222|FG002|Overall Study|Did not complete therapy/experience PD|0|||
16972169|NCT00893464|38116223|FG003|Overall Study|Did not complete therapy/experience PD|0|||
16972170|NCT00893464|38116224|FG004|Overall Study|Did not complete therapy/experience PD|0|||
16972171|NCT00893464|38116225|FG005|Overall Study|Did not complete therapy/experience PD|0|||
16972172|NCT00893464|38116226|FG006|Overall Study|Did not complete therapy/experience PD|2|||
16972173|NCT00893464|38116227|FG007|Overall Study|Did not complete therapy/experience PD|2|||
16972174|NCT00891904|38116250|FG000|Overall Study|Death|1|||
16972175|NCT00891904|38116250|FG000|Overall Study|Adverse Event|1|||
16972176|NCT01157351|38116256|FG000|Overall Study|Adverse Event|5|||
16972177|NCT01157351|38116257|FG001|Overall Study|Adverse Event|4|||
16972178|NCT01157351|38116256|FG000|Overall Study|Death|1|||
16972179|NCT01157351|38116257|FG001|Overall Study|Death|0|||
16972180|NCT01157351|38116256|FG000|Overall Study|Lost to Follow-up|53|||
16972181|NCT01157351|38116257|FG001|Overall Study|Lost to Follow-up|55|||
16972182|NCT01157351|38116256|FG000|Overall Study|Withdrawal by Subject|37|||
16972183|NCT01157351|38116257|FG001|Overall Study|Withdrawal by Subject|27|||
16972184|NCT01157351|38116256|FG000|Overall Study|Physician Decision|5|||
16972185|NCT01157351|38116257|FG001|Overall Study|Physician Decision|4|||
16972186|NCT01157351|38116256|FG000|Overall Study|Protocol Violation|0|||
16972187|NCT01157351|38116257|FG001|Overall Study|Protocol Violation|1|||
16972188|NCT01157351|38116256|FG000|Overall Study|Other|32|||
16972189|NCT01157351|38116257|FG001|Overall Study|Other|36|||
16972190|NCT01157351|38116256|FG000|Overall Study|Noncompliance with Study Drug|0|||
16972191|NCT01157351|38116257|FG001|Overall Study|Noncompliance with Study Drug|3|||
16972192|NCT01157351|38116256|FG000|Overall Study|Randomized but not Treated|4|||
16972193|NCT01157351|38116257|FG001|Overall Study|Randomized but not Treated|2|||
16972194|NCT01157117|38116266|FG000|Overall Study|Dosing Symptoms|0|||
16972195|NCT01157117|38116267|FG001|Overall Study|Dosing Symptoms|4|||
16972196|NCT01157117|38116268|FG002|Overall Study|Dosing Symptoms|0|||
16972197|NCT01157117|38116266|FG000|Overall Study|Withdrawal by Subject|4|||
16972198|NCT01157117|38116267|FG001|Overall Study|Withdrawal by Subject|1|||
16972199|NCT01157117|38116268|FG002|Overall Study|Withdrawal by Subject|1|||
16972200|NCT01157117|38116266|FG000|Overall Study|Lack of Efficacy|1|||
16972201|NCT01157117|38116267|FG001|Overall Study|Lack of Efficacy|1|||
16972202|NCT01157117|38116268|FG002|Overall Study|Lack of Efficacy|0|||
16972203|NCT01157117|38116266|FG000|Overall Study|Lost to Follow-up|0|||
16972204|NCT01157117|38116267|FG001|Overall Study|Lost to Follow-up|0|||
16972205|NCT01157117|38116268|FG002|Overall Study|Lost to Follow-up|1|||
16972206|NCT01157117|38116266|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
16972207|NCT01157117|38116267|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
16972208|NCT01157117|38116268|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
16972209|NCT00891202|38116278|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
16972210|NCT00891202|38116279|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
16972211|NCT00891202|38116280|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
16972212|NCT00891202|38116281|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
16972213|NCT00891202|38116278|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
16972214|NCT00891202|38116279|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
16972215|NCT00891202|38116280|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
16972216|NCT00891202|38116281|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
16972217|NCT00891202|38116278|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
16972218|NCT00891202|38116279|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
16972219|NCT00891202|38116280|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
16972220|NCT00891202|38116281|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
16972221|NCT00891202|38116278|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
16972222|NCT00891202|38116279|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
16972223|NCT00891202|38116280|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
16972224|NCT00891202|38116281|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
16972225|NCT01185509|38116291|FG000|Overall Study|Progression/Relapse|9|||
16972226|NCT01185509|38116292|FG001|Overall Study|Progression/Relapse|15|||
16972227|NCT01185509|38116291|FG000|Overall Study|Physician Decision|2|||
16972228|NCT01185509|38116292|FG001|Overall Study|Physician Decision|2|||
16972229|NCT01185509|38116291|FG000|Overall Study|Withdrawal by Subject|0|||
16972230|NCT01185509|38116292|FG001|Overall Study|Withdrawal by Subject|1|||
16972231|NCT01185509|38116291|FG000|Overall Study|Death|0|||
16972232|NCT01185509|38116292|FG001|Overall Study|Death|1|||
16972233|NCT01185509|38116291|FG000|Overall Study|Intercurrent Illness|0|||
16972234|NCT01185509|38116292|FG001|Overall Study|Intercurrent Illness|1|||
16972235|NCT00891046|38116304|FG000|Overall Study|Protocol Violation|1|||
16972236|NCT00891046|38116305|FG001|Overall Study|Protocol Violation|1|||
16972237|NCT00891046|38116306|FG002|Overall Study|Protocol Violation|0|||
16972238|NCT00891046|38116307|FG003|Overall Study|Protocol Violation|0|||
16972239|NCT00891046|38116308|FG004|Overall Study|Protocol Violation|1|||
16972240|NCT00891046|38116304|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
16972241|NCT00891046|38116305|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16972242|NCT00891046|38116306|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
16972243|NCT00891046|38116307|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
16972244|NCT00891046|38116308|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
16972245|NCT00891046|38116304|FG000|Overall Study|Administrative problems|0|||
16972246|NCT00891046|38116305|FG001|Overall Study|Administrative problems|0|||
16972247|NCT00891046|38116306|FG002|Overall Study|Administrative problems|0|||
16972248|NCT00891046|38116307|FG003|Overall Study|Administrative problems|0|||
16972249|NCT00891046|38116308|FG004|Overall Study|Administrative problems|1|||
16972250|NCT00891046|38116304|FG000|Overall Study|Participant no longer required drug|0|||
16972251|NCT00891046|38116305|FG001|Overall Study|Participant no longer required drug|2|||
16972252|NCT00891046|38116306|FG002|Overall Study|Participant no longer required drug|0|||
16972253|NCT00891046|38116307|FG003|Overall Study|Participant no longer required drug|0|||
16972254|NCT00891046|38116308|FG004|Overall Study|Participant no longer required drug|1|||
16972255|NCT00891046|38116304|FG000|Overall Study|Adverse Event|4|||
16972256|NCT00891046|38116305|FG001|Overall Study|Adverse Event|3|||
16972257|NCT00891046|38116306|FG002|Overall Study|Adverse Event|2|||
16972258|NCT00891046|38116307|FG003|Overall Study|Adverse Event|0|||
16972259|NCT00891046|38116308|FG004|Overall Study|Adverse Event|14|||
16972260|NCT00891046|38116304|FG000|Overall Study|Withdrawal by Subject|2|||
16972261|NCT00891046|38116305|FG001|Overall Study|Withdrawal by Subject|1|||
16972262|NCT00891046|38116306|FG002|Overall Study|Withdrawal by Subject|2|||
16972263|NCT00891046|38116307|FG003|Overall Study|Withdrawal by Subject|1|||
16972264|NCT00891046|38116308|FG004|Overall Study|Withdrawal by Subject|1|||
16972265|NCT00891046|38116304|FG000|Overall Study|Lost to Follow-up|0|||
16972266|NCT00891046|38116305|FG001|Overall Study|Lost to Follow-up|0|||
16972267|NCT00891046|38116306|FG002|Overall Study|Lost to Follow-up|0|||
16972268|NCT00891046|38116307|FG003|Overall Study|Lost to Follow-up|0|||
16972269|NCT00891046|38116308|FG004|Overall Study|Lost to Follow-up|1|||
16972270|NCT00889720|38116335|FG000|Overall Study|Withdrawal by Subject|4|||
16972271|NCT00889720|38116335|FG000|Overall Study|Other|4|||
16972272|NCT01116648|38116354|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
16972273|NCT01116648|38116355|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
16972274|NCT01116648|38116356|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
16972275|NCT01116648|38116357|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
16972276|NCT01116648|38116358|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
16972277|NCT01116648|38116359|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
16972278|NCT01116648|38116360|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
16972279|NCT01116648|38116361|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
16972280|NCT01116648|38116362|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
16972281|NCT01116648|38116363|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
16972282|NCT01116648|38116364|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
16972283|NCT01116648|38116365|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
16972284|NCT01116648|38116366|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
16972285|NCT01116648|38116367|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
16972286|NCT01116648|38116368|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
16972287|NCT00880087|38116395|FG000|Overall Study|Lost to Follow-up|0|||
16972288|NCT00880087|38116396|FG001|Overall Study|Lost to Follow-up|2|||
16972289|NCT00889252|38116404|FG000|Overall Study|Adverse Event|2|||
16972290|NCT00889252|38116405|FG001|Overall Study|Adverse Event|4|||
16972291|NCT00889252|38116404|FG000|Overall Study|Withdrawal by Subject|3|||
16972292|NCT00889252|38116405|FG001|Overall Study|Withdrawal by Subject|0|||
16972293|NCT00889252|38116404|FG000|Overall Study|Protocol Violation|2|||
16972294|NCT00889252|38116405|FG001|Overall Study|Protocol Violation|0|||
16972295|NCT01110330|38116414|FG000|Overall Study|Adverse Event|0|||
16972296|NCT01110330|38116415|FG001|Overall Study|Adverse Event|4|||
16972297|NCT01110330|38116416|FG002|Overall Study|Adverse Event|3|||
16972298|NCT01110330|38116414|FG000|Overall Study|Lack of Efficacy|3|||
16972299|NCT01110330|38116415|FG001|Overall Study|Lack of Efficacy|1|||
16972300|NCT01110330|38116416|FG002|Overall Study|Lack of Efficacy|1|||
16972301|NCT01110330|38116414|FG000|Overall Study|Lost to Follow-up|9|||
16972302|NCT01110330|38116415|FG001|Overall Study|Lost to Follow-up|10|||
16972303|NCT01110330|38116416|FG002|Overall Study|Lost to Follow-up|15|||
16972304|NCT01110330|38116414|FG000|Overall Study|Physician Decision|0|||
16972305|NCT01110330|38116415|FG001|Overall Study|Physician Decision|1|||
16972306|NCT01110330|38116416|FG002|Overall Study|Physician Decision|0|||
16972307|NCT01110330|38116414|FG000|Overall Study|Protocol Violation|2|||
16972308|NCT01110330|38116415|FG001|Overall Study|Protocol Violation|0|||
16972309|NCT01110330|38116416|FG002|Overall Study|Protocol Violation|4|||
16972310|NCT01110330|38116414|FG000|Overall Study|Withdrawal by Subject|0|||
16972311|NCT01110330|38116415|FG001|Overall Study|Withdrawal by Subject|6|||
16972312|NCT01110330|38116416|FG002|Overall Study|Withdrawal by Subject|2|||
16972313|NCT01110330|38116414|FG000|Overall Study|Other|1|||
16972314|NCT01110330|38116415|FG001|Overall Study|Other|1|||
16972315|NCT01110330|38116416|FG002|Overall Study|Other|1|||
16972316|NCT00596947|38116426|FG000|Overall Study|study halted due to low enrollment|5|||
16972317|NCT00596947|38116427|FG001|Overall Study|study halted due to low enrollment|3|||
16972318|NCT00596947|38116426|FG000|Overall Study|Lost to Follow-up|1|||
16972319|NCT00596947|38116427|FG001|Overall Study|Lost to Follow-up|0|||
16972320|NCT00888940|38116435|FG000|Overall Study|Adverse Event|12|||
16972321|NCT00888940|38116436|FG001|Overall Study|Adverse Event|3|||
16972322|NCT00888940|38116435|FG000|Overall Study|Lost to Follow-up|5|||
16972323|NCT00888940|38116436|FG001|Overall Study|Lost to Follow-up|5|||
16972324|NCT00888940|38116435|FG000|Overall Study|Randomized Not Treated|11|||
16972325|NCT00888940|38116436|FG001|Overall Study|Randomized Not Treated|13|||
16972326|NCT00595621|38116444|FG000|Open Label Run in|Adverse Event|1|||
16972327|NCT00595621|38116445|FG001|Open Label Run in|Adverse Event|0|||
16972328|NCT00595621|38116444|FG000|Open Label Run in|Physician Decision|1|||
16972329|NCT00595621|38116445|FG001|Open Label Run in|Physician Decision|0|||
16972330|NCT00595621|38116444|FG000|Open Label Run in|Withdrawal by Subject|1|||
16972331|NCT00595621|38116445|FG001|Open Label Run in|Withdrawal by Subject|0|||
16972332|NCT00595621|38116444|FG000|Randomization and Study|Adverse Event|2|||
16972333|NCT00595621|38116445|FG001|Randomization and Study|Adverse Event|0|||
16972334|NCT00595621|38116444|FG000|Randomization and Study|Withdrawal by Subject|0|||
16972335|NCT00595621|38116445|FG001|Randomization and Study|Withdrawal by Subject|1|||
16972336|NCT00888238|38116452|FG000|Washout Period After Period 2|Adverse Event|0|||
16972337|NCT00888238|38116453|FG001|Washout Period After Period 2|Adverse Event|0|||
16972338|NCT00888238|38116454|FG002|Washout Period After Period 2|Adverse Event|1|||
16972339|NCT00595465|38116463|FG000|Overall Study|Adverse Event|4|||
16972340|NCT00595465|38116464|FG001|Overall Study|Adverse Event|3|||
16972341|NCT00595465|38116465|FG002|Overall Study|Adverse Event|3|||
16972342|NCT00595465|38116463|FG000|Overall Study|Pregnancy|0|||
16972343|NCT00595465|38116464|FG001|Overall Study|Pregnancy|0|||
16972344|NCT00595465|38116465|FG002|Overall Study|Pregnancy|1|||
16972345|NCT00595465|38116463|FG000|Overall Study|Protocol Violation|2|||
16972346|NCT00595465|38116464|FG001|Overall Study|Protocol Violation|1|||
16972347|NCT00595465|38116465|FG002|Overall Study|Protocol Violation|0|||
16972348|NCT00595465|38116463|FG000|Overall Study|Lost to Follow-up|0|||
16972349|NCT00595465|38116464|FG001|Overall Study|Lost to Follow-up|0|||
16972350|NCT00595465|38116465|FG002|Overall Study|Lost to Follow-up|2|||
16972351|NCT00595465|38116463|FG000|Overall Study|administrative reason|0|||
16972352|NCT00595465|38116464|FG001|Overall Study|administrative reason|0|||
16972353|NCT00595465|38116465|FG002|Overall Study|administrative reason|1|||
16972354|NCT01205438|38116476|FG000|Overall Study|Adverse Event|19|||
16972355|NCT01205438|38116477|FG001|Overall Study|Adverse Event|17|||
16972356|NCT01205438|38116478|FG002|Overall Study|Adverse Event|24|||
16972357|NCT01205438|38116476|FG000|Overall Study|Death|1|||
16972358|NCT01205438|38116477|FG001|Overall Study|Death|1|||
16972359|NCT01205438|38116478|FG002|Overall Study|Death|3|||
16972360|NCT01205438|38116476|FG000|Overall Study|Entry Criteria Not Met|16|||
16972361|NCT01205438|38116477|FG001|Overall Study|Entry Criteria Not Met|15|||
16972362|NCT01205438|38116478|FG002|Overall Study|Entry Criteria Not Met|13|||
16972363|NCT01205438|38116476|FG000|Overall Study|Lack of Efficacy|14|||
16972364|NCT01205438|38116477|FG001|Overall Study|Lack of Efficacy|11|||
16972365|NCT01205438|38116478|FG002|Overall Study|Lack of Efficacy|14|||
16972366|NCT01205438|38116476|FG000|Overall Study|Lost to Follow-up|6|||
16972367|NCT01205438|38116477|FG001|Overall Study|Lost to Follow-up|7|||
16972368|NCT01205438|38116478|FG002|Overall Study|Lost to Follow-up|8|||
16972369|NCT01205438|38116476|FG000|Overall Study|Withdrawal by Subject|19|||
16972370|NCT01205438|38116477|FG001|Overall Study|Withdrawal by Subject|25|||
16972371|NCT01205438|38116478|FG002|Overall Study|Withdrawal by Subject|19|||
16972372|NCT01205438|38116476|FG000|Overall Study|Physician Decision|0|||
16972373|NCT01205438|38116477|FG001|Overall Study|Physician Decision|3|||
16972374|NCT01205438|38116478|FG002|Overall Study|Physician Decision|2|||
16972375|NCT01205438|38116476|FG000|Overall Study|Protocol Violation|2|||
16972376|NCT01205438|38116477|FG001|Overall Study|Protocol Violation|7|||
16972377|NCT01205438|38116478|FG002|Overall Study|Protocol Violation|4|||
16972378|NCT01205438|38116476|FG000|Overall Study|Sponsor Decision|0|||
16972379|NCT01205438|38116477|FG001|Overall Study|Sponsor Decision|1|||
16972380|NCT01205438|38116478|FG002|Overall Study|Sponsor Decision|1|||
16972381|NCT01104870|38116492|FG000|Overall Study|Adverse Event|1|||
16972382|NCT01104870|38116493|FG001|Overall Study|Adverse Event|1|||
16972383|NCT01104870|38116494|FG002|Overall Study|Adverse Event|0|||
16972384|NCT01104870|38116492|FG000|Overall Study|Death|0|||
16972385|NCT01104870|38116493|FG001|Overall Study|Death|0|||
16972386|NCT01104870|38116494|FG002|Overall Study|Death|1|||
16972387|NCT01104870|38116492|FG000|Overall Study|Withdrawal by Subject|0|||
16972388|NCT01104870|38116493|FG001|Overall Study|Withdrawal by Subject|0|||
16972389|NCT01104870|38116494|FG002|Overall Study|Withdrawal by Subject|1|||
16972390|NCT01104792|38116502|FG000|Overall Study|Adverse Event|77|||
16972391|NCT01104792|38116502|FG000|Overall Study|Insufficient Therapeutic Response|22|||
16972392|NCT01104792|38116502|FG000|Overall Study|Protocol Violation|45|||
16972393|NCT01104792|38116502|FG000|Overall Study|Withdrawal of Consent|179|||
16972394|NCT01104792|38116502|FG000|Overall Study|Lost to Follow-up|43|||
16972395|NCT01104792|38116502|FG000|Overall Study|Reasons Not Specified|27|||
16972396|NCT01104792|38116502|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
16972397|NCT01205126|38116508|FG000|Titration Phase|Adverse Event|5|||
16972398|NCT01205126|38116509|FG001|Titration Phase|Adverse Event|3|||
16972399|NCT01205126|38116508|FG000|Titration Phase|Withdrawal by Subject|5|||
16972400|NCT01205126|38116509|FG001|Titration Phase|Withdrawal by Subject|5|||
16972401|NCT01205126|38116508|FG000|Titration Phase|Lost to Follow-up|2|||
16972402|NCT01205126|38116509|FG001|Titration Phase|Lost to Follow-up|2|||
16972403|NCT01205126|38116508|FG000|Titration Phase|No stable titration dose|1|||
16972404|NCT01205126|38116509|FG001|Titration Phase|No stable titration dose|0|||
16972405|NCT01205126|38116508|FG000|Titration Phase|More than maximum dosage required|2|||
16972406|NCT01205126|38116509|FG001|Titration Phase|More than maximum dosage required|3|||
16972407|NCT01205126|38116508|FG000|Titration Phase|Other|8|||
16972408|NCT01205126|38116509|FG001|Titration Phase|Other|6|||
16972409|NCT01205126|38116508|FG000|Between Titration & Maintenance Phase|Other|0|||
16972410|NCT01205126|38116509|FG001|Between Titration & Maintenance Phase|Other|4|||
16972411|NCT01205126|38116508|FG000|Maintenance Phase|Adverse Event|3|||
16972412|NCT01205126|38116509|FG001|Maintenance Phase|Adverse Event|7|||
16972413|NCT01205126|38116508|FG000|Maintenance Phase|Death|4|||
16972414|NCT01205126|38116509|FG001|Maintenance Phase|Death|4|||
16972415|NCT01205126|38116508|FG000|Maintenance Phase|More than the maximum dosage required|5|||
16972416|NCT01205126|38116509|FG001|Maintenance Phase|More than the maximum dosage required|5|||
16972417|NCT01205126|38116508|FG000|Maintenance Phase|Prohibited drugs used|1|||
16972418|NCT01205126|38116509|FG001|Maintenance Phase|Prohibited drugs used|0|||
16972419|NCT01205126|38116508|FG000|Maintenance Phase|Other|11|||
16972420|NCT01205126|38116509|FG001|Maintenance Phase|Other|8|||
16972421|NCT01205126|38116508|FG000|Maintenance Phase|Lost to Follow-up|5|||
16972422|NCT01205126|38116509|FG001|Maintenance Phase|Lost to Follow-up|5|||
16972423|NCT01205126|38116508|FG000|Maintenance Phase|Withdrawal by Subject|8|||
16972424|NCT01205126|38116509|FG001|Maintenance Phase|Withdrawal by Subject|11|||
16972425|NCT00946647|38116520|FG000|Phase 1 Part|Adverse Event|2|||
16972426|NCT00946647|38116521|FG001|Phase 1 Part|Adverse Event|5|||
16972427|NCT00946647|38116522|FG002|Phase 1 Part|Adverse Event|3|||
16972428|NCT00946647|38116523|FG003|Phase 1 Part|Adverse Event|0|||
16972429|NCT00946647|38116524|FG004|Phase 1 Part|Adverse Event|0|||
16972430|NCT00946647|38116520|FG000|Phase 1 Part|Disease progression|3|||
16972431|NCT00946647|38116521|FG001|Phase 1 Part|Disease progression|6|||
16972432|NCT00946647|38116522|FG002|Phase 1 Part|Disease progression|1|||
16972433|NCT00946647|38116523|FG003|Phase 1 Part|Disease progression|0|||
16972434|NCT00946647|38116524|FG004|Phase 1 Part|Disease progression|0|||
16972435|NCT00946647|38116520|FG000|Phase 1 Part|Withdrawal by Subject|1|||
16972436|NCT00946647|38116521|FG001|Phase 1 Part|Withdrawal by Subject|4|||
16972437|NCT00946647|38116522|FG002|Phase 1 Part|Withdrawal by Subject|3|||
16972438|NCT00946647|38116523|FG003|Phase 1 Part|Withdrawal by Subject|0|||
16972439|NCT00946647|38116524|FG004|Phase 1 Part|Withdrawal by Subject|0|||
16972440|NCT00946647|38116520|FG000|Phase 1 Part|Abnormal values|0|||
16972441|NCT00946647|38116521|FG001|Phase 1 Part|Abnormal values|2|||
16972442|NCT00946647|38116522|FG002|Phase 1 Part|Abnormal values|0|||
16972443|NCT00946647|38116523|FG003|Phase 1 Part|Abnormal values|0|||
16972444|NCT00946647|38116524|FG004|Phase 1 Part|Abnormal values|0|||
16972445|NCT00946647|38116520|FG000|Phase 1 Part|Reason missing|0|||
16972446|NCT00946647|38116521|FG001|Phase 1 Part|Reason missing|1|||
16972447|NCT00946647|38116522|FG002|Phase 1 Part|Reason missing|0|||
16972448|NCT00946647|38116523|FG003|Phase 1 Part|Reason missing|0|||
16972449|NCT00946647|38116524|FG004|Phase 1 Part|Reason missing|0|||
16972450|NCT00946647|38116520|FG000|Phase ll Part|Untreated|0|||
16972451|NCT00946647|38116521|FG001|Phase ll Part|Untreated|0|||
16972452|NCT00946647|38116522|FG002|Phase ll Part|Untreated|0|||
16972453|NCT00946647|38116523|FG003|Phase ll Part|Untreated|0|||
16972454|NCT00946647|38116524|FG004|Phase ll Part|Untreated|2|||
16972455|NCT00946647|38116520|FG000|Phase ll Part|Adverse Event|0|||
16972456|NCT00946647|38116521|FG001|Phase ll Part|Adverse Event|0|||
16972457|NCT00946647|38116522|FG002|Phase ll Part|Adverse Event|0|||
16972458|NCT00946647|38116523|FG003|Phase ll Part|Adverse Event|10|||
16972459|NCT00946647|38116524|FG004|Phase ll Part|Adverse Event|6|||
16972460|NCT00946647|38116520|FG000|Phase ll Part|Withdrawal by Subject|0|||
16972461|NCT00946647|38116521|FG001|Phase ll Part|Withdrawal by Subject|0|||
16972462|NCT00946647|38116522|FG002|Phase ll Part|Withdrawal by Subject|0|||
16972463|NCT00946647|38116523|FG003|Phase ll Part|Withdrawal by Subject|8|||
16972464|NCT00946647|38116524|FG004|Phase ll Part|Withdrawal by Subject|6|||
16972465|NCT00946647|38116520|FG000|Phase ll Part|Administrative problems|0|||
16972466|NCT00946647|38116521|FG001|Phase ll Part|Administrative problems|0|||
16972467|NCT00946647|38116522|FG002|Phase ll Part|Administrative problems|0|||
16972468|NCT00946647|38116523|FG003|Phase ll Part|Administrative problems|3|||
16972469|NCT00946647|38116524|FG004|Phase ll Part|Administrative problems|8|||
16972470|NCT00946647|38116520|FG000|Phase ll Part|Death|0|||
16972471|NCT00946647|38116521|FG001|Phase ll Part|Death|0|||
16972472|NCT00946647|38116522|FG002|Phase ll Part|Death|0|||
16972473|NCT00946647|38116523|FG003|Phase ll Part|Death|7|||
16972474|NCT00946647|38116524|FG004|Phase ll Part|Death|4|||
16972475|NCT00946647|38116520|FG000|Phase ll Part|Disease progression|0|||
16972476|NCT00946647|38116521|FG001|Phase ll Part|Disease progression|0|||
16972477|NCT00946647|38116522|FG002|Phase ll Part|Disease progression|0|||
16972478|NCT00946647|38116523|FG003|Phase ll Part|Disease progression|6|||
16780072|NCT02181634|37719139|FG000|Overall Study|Patient opted to proceed to surgery|1|||
16780073|NCT01595529|37719145|FG000|Overall Study|Adverse Event|2|||
16780074|NCT01595529|37719146|FG001|Overall Study|Adverse Event|0|||
16972479|NCT00946647|38116524|FG004|Phase ll Part|Disease progression|14|||
16972480|NCT00946647|38116520|FG000|Phase ll Part|Protocol Violation|0|||
16972481|NCT00946647|38116521|FG001|Phase ll Part|Protocol Violation|0|||
16972482|NCT00946647|38116522|FG002|Phase ll Part|Protocol Violation|0|||
16972483|NCT00946647|38116523|FG003|Phase ll Part|Protocol Violation|4|||
16972484|NCT00946647|38116524|FG004|Phase ll Part|Protocol Violation|2|||
16972485|NCT00946647|38116520|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
16972486|NCT00946647|38116521|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
16972487|NCT00946647|38116522|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
16972488|NCT00946647|38116523|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
16972489|NCT00946647|38116524|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
16972490|NCT00946101|38116539|FG000|Overall Study|Lost to Follow-up|2|||
16972491|NCT00946101|38116540|FG001|Overall Study|Lost to Follow-up|1|||
16972492|NCT00946101|38116539|FG000|Overall Study|Withdrawal of consent|2|||
16972493|NCT00946101|38116540|FG001|Overall Study|Withdrawal of consent|0|||
16972494|NCT00946101|38116539|FG000|Overall Study|Physician Decision|0|||
16972495|NCT00946101|38116540|FG001|Overall Study|Physician Decision|1|||
16972496|NCT01109940|38116554|FG000|Overall Study|Administrative problems|2|||
16972497|NCT01109940|38116555|FG001|Overall Study|Administrative problems|0|||
16972498|NCT01109940|38116556|FG002|Overall Study|Administrative problems|0|||
16972499|NCT01109940|38116557|FG003|Overall Study|Administrative problems|0|||
16972500|NCT01109940|38116554|FG000|Overall Study|Serious Adverse Event|2|||
16972501|NCT01109940|38116555|FG001|Overall Study|Serious Adverse Event|1|||
16972502|NCT01109940|38116556|FG002|Overall Study|Serious Adverse Event|0|||
16972503|NCT01109940|38116557|FG003|Overall Study|Serious Adverse Event|0|||
16972504|NCT01109940|38116554|FG000|Overall Study|Lost to Follow-up|1|||
16972505|NCT01109940|38116555|FG001|Overall Study|Lost to Follow-up|0|||
16972506|NCT01109940|38116556|FG002|Overall Study|Lost to Follow-up|0|||
16972507|NCT01109940|38116557|FG003|Overall Study|Lost to Follow-up|0|||
16972508|NCT01109940|38116554|FG000|Overall Study|Patient withdrew consent|1|||
16972509|NCT01109940|38116555|FG001|Overall Study|Patient withdrew consent|1|||
16972510|NCT01109940|38116556|FG002|Overall Study|Patient withdrew consent|0|||
16972511|NCT01109940|38116557|FG003|Overall Study|Patient withdrew consent|0|||
16972512|NCT01109940|38116554|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16972513|NCT01109940|38116555|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16972514|NCT01109940|38116556|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
16972515|NCT01109940|38116557|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16972516|NCT00595309|38116567|FG000|Overall Study|Lost to Follow-up|1|||
16972517|NCT00595309|38116567|FG000|Overall Study|planned vaccination against yellow fever|1|||
16972518|NCT00595309|38116567|FG000|Overall Study|acute infection after V0|1|||
16972519|NCT00595309|38116567|FG000|Overall Study|personal reason|1|||
16780075|NCT01595529|37719145|FG000|Overall Study|Subject Non-Compliant|2|||
16780076|NCT01595529|37719146|FG001|Overall Study|Subject Non-Compliant|0|||
16780077|NCT01595529|37719145|FG000|Overall Study|Lost to Follow-up|8|||
16780078|NCT01595529|37719146|FG001|Overall Study|Lost to Follow-up|14|||
16972520|NCT00595075|38116573|FG000|Overall Study|Withdrawal by Subject|1|||
16972521|NCT00595075|38116574|FG001|Overall Study|Withdrawal by Subject|0|||
16972522|NCT00887224|38116583|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
16972523|NCT00887224|38116584|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
16972524|NCT00887224|38116585|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
16972525|NCT00887224|38116583|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
16972526|NCT00887224|38116584|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
16972527|NCT00887224|38116585|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
16972528|NCT00887224|38116583|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
16972529|NCT00887224|38116584|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
16972530|NCT00887224|38116585|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
16972531|NCT00887224|38116583|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
16972532|NCT00887224|38116584|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
16972533|NCT00887224|38116585|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
16972534|NCT00887224|38116583|FG000|Open-label Response (OLR) Phase|Other|1|||
16972535|NCT00887224|38116584|FG001|Open-label Response (OLR) Phase|Other|0|||
16972536|NCT00887224|38116585|FG002|Open-label Response (OLR) Phase|Other|0|||
16972537|NCT00887224|38116583|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
16972538|NCT00887224|38116584|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
16972539|NCT00887224|38116585|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
16972540|NCT00887224|38116583|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
16972541|NCT00887224|38116584|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
16972542|NCT00887224|38116585|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
16972543|NCT00887224|38116583|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
16972544|NCT00887224|38116584|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
16972545|NCT00887224|38116585|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
16780079|NCT01595529|37719145|FG000|Overall Study|Protocol Violation|1|||
16780080|NCT01595529|37719146|FG001|Overall Study|Protocol Violation|2|||
16972546|NCT00887224|38116583|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
16972547|NCT00887224|38116584|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
16972548|NCT00887224|38116585|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
16972549|NCT00887224|38116583|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
16972550|NCT00887224|38116584|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
16972551|NCT00887224|38116585|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
16972552|NCT00887224|38116583|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
16972553|NCT00887224|38116584|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
16972554|NCT00887224|38116585|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
16972555|NCT00887224|38116583|FG000|Open-label Stability (OLS) Phase|Other|1|||
16972556|NCT00887224|38116584|FG001|Open-label Stability (OLS) Phase|Other|0|||
16972557|NCT00887224|38116585|FG002|Open-label Stability (OLS) Phase|Other|0|||
16972558|NCT00887224|38116583|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
16972559|NCT00887224|38116584|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
16972560|NCT00887224|38116585|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
16972561|NCT00887224|38116583|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
16972562|NCT00887224|38116584|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
16972563|NCT00887224|38116585|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
16972564|NCT00887224|38116583|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
16972565|NCT00887224|38116584|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
16972566|NCT00887224|38116585|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
16972567|NCT00887224|38116583|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
16972568|NCT00887224|38116584|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
16972569|NCT00887224|38116585|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
16972570|NCT00887224|38116583|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
16972571|NCT00887224|38116584|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
16972572|NCT00887224|38116585|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
16972573|NCT00887224|38116583|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
16972574|NCT00887224|38116584|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
16972575|NCT00887224|38116585|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
16972576|NCT00887224|38116583|FG000|OL Taper Phase / OL Follow Up|Other|30|||
16972577|NCT00887224|38116584|FG001|OL Taper Phase / OL Follow Up|Other|0|||
16972578|NCT00887224|38116585|FG002|OL Taper Phase / OL Follow Up|Other|0|||
16972579|NCT00887224|38116583|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
16972580|NCT00887224|38116584|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
16972581|NCT00887224|38116585|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
16972582|NCT00887224|38116583|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
16972583|NCT00887224|38116584|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
16972584|NCT00887224|38116585|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
16972585|NCT00887224|38116583|FG000|Double-blind (DB) Phase|Adverse Event|0|||
16972586|NCT00887224|38116584|FG001|Double-blind (DB) Phase|Adverse Event|7|||
16972587|NCT00887224|38116585|FG002|Double-blind (DB) Phase|Adverse Event|2|||
16972588|NCT00887224|38116583|FG000|Double-blind (DB) Phase|Failed to return|0|||
16972589|NCT00887224|38116584|FG001|Double-blind (DB) Phase|Failed to return|2|||
16972590|NCT00887224|38116585|FG002|Double-blind (DB) Phase|Failed to return|2|||
16972591|NCT00887224|38116583|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
16972592|NCT00887224|38116584|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
16972593|NCT00887224|38116585|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
16972594|NCT00887224|38116583|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
16972595|NCT00887224|38116584|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
16972596|NCT00887224|38116585|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
16972597|NCT00887224|38116583|FG000|Double-blind (DB) Phase|Other|0|||
16972598|NCT00887224|38116584|FG001|Double-blind (DB) Phase|Other|2|||
16972599|NCT00887224|38116585|FG002|Double-blind (DB) Phase|Other|0|||
16972600|NCT00887224|38116583|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
16972601|NCT00887224|38116584|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
16972602|NCT00887224|38116585|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
16972603|NCT00887224|38116583|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
16972604|NCT00887224|38116584|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
16972605|NCT00887224|38116585|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
16972606|NCT00887224|38116583|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
16972607|NCT00887224|38116584|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
16972608|NCT00887224|38116585|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
16972609|NCT00887224|38116583|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
16972610|NCT00887224|38116584|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
16972611|NCT00887224|38116585|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
16972612|NCT00887224|38116583|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
16780081|NCT01595529|37719145|FG000|Overall Study|Physician Decision|1|||
16972613|NCT00887224|38116584|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
16972614|NCT00887224|38116585|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
16972615|NCT00887224|38116583|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
16972616|NCT00887224|38116584|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
16972617|NCT00887224|38116585|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
16972618|NCT00887224|38116583|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
16972619|NCT00887224|38116584|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
16972620|NCT00887224|38116585|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
16972621|NCT00887224|38116583|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
16972622|NCT00887224|38116584|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
16972623|NCT00887224|38116585|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
16972624|NCT00887224|38116583|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
16972625|NCT00887224|38116584|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
16972626|NCT00887224|38116585|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
16972627|NCT01109316|38116603|FG000|Study Period 1|Adverse Event|0|||
16972628|NCT01109316|38116604|FG001|Study Period 1|Adverse Event|0|||
16972629|NCT01109316|38116605|FG002|Study Period 1|Adverse Event|1|||
16972630|NCT01109316|38116606|FG003|Study Period 1|Adverse Event|0|||
16972631|NCT01109316|38116607|FG004|Study Period 1|Adverse Event|0|||
16972632|NCT01109316|38116608|FG005|Study Period 1|Adverse Event|0|||
16972633|NCT01109316|38116603|FG000|Study Period 1|Lost to Follow-up|0|||
16972634|NCT01109316|38116604|FG001|Study Period 1|Lost to Follow-up|0|||
16972635|NCT01109316|38116605|FG002|Study Period 1|Lost to Follow-up|1|||
16972636|NCT01109316|38116606|FG003|Study Period 1|Lost to Follow-up|1|||
16972637|NCT01109316|38116607|FG004|Study Period 1|Lost to Follow-up|0|||
16972638|NCT01109316|38116608|FG005|Study Period 1|Lost to Follow-up|0|||
16972639|NCT01109316|38116603|FG000|Study Period 1|Withdrawal by Subject|0|||
16972640|NCT01109316|38116604|FG001|Study Period 1|Withdrawal by Subject|0|||
16972641|NCT01109316|38116605|FG002|Study Period 1|Withdrawal by Subject|1|||
16972642|NCT01109316|38116606|FG003|Study Period 1|Withdrawal by Subject|0|||
16972643|NCT01109316|38116607|FG004|Study Period 1|Withdrawal by Subject|2|||
16972644|NCT01109316|38116608|FG005|Study Period 1|Withdrawal by Subject|0|||
16972645|NCT01109316|38116603|FG000|Study Period 1|Sponsor Decision|0|||
16972646|NCT01109316|38116604|FG001|Study Period 1|Sponsor Decision|0|||
16972647|NCT01109316|38116605|FG002|Study Period 1|Sponsor Decision|0|||
16972648|NCT01109316|38116606|FG003|Study Period 1|Sponsor Decision|0|||
16972649|NCT01109316|38116607|FG004|Study Period 1|Sponsor Decision|0|||
16972650|NCT01109316|38116608|FG005|Study Period 1|Sponsor Decision|2|||
16972651|NCT01109316|38116603|FG000|Study Period 2|Entry Criteria Not Met|0|||
16972652|NCT01109316|38116604|FG001|Study Period 2|Entry Criteria Not Met|1|||
16972653|NCT01109316|38116605|FG002|Study Period 2|Entry Criteria Not Met|0|||
16972654|NCT01109316|38116606|FG003|Study Period 2|Entry Criteria Not Met|0|||
16972655|NCT01109316|38116607|FG004|Study Period 2|Entry Criteria Not Met|0|||
16972656|NCT01109316|38116608|FG005|Study Period 2|Entry Criteria Not Met|0|||
16972657|NCT01109316|38116603|FG000|Study Period 2|Physician Decision|0|||
16972658|NCT01109316|38116604|FG001|Study Period 2|Physician Decision|0|||
16972659|NCT01109316|38116605|FG002|Study Period 2|Physician Decision|0|||
16972660|NCT01109316|38116606|FG003|Study Period 2|Physician Decision|1|||
16972661|NCT01109316|38116607|FG004|Study Period 2|Physician Decision|0|||
16972662|NCT01109316|38116608|FG005|Study Period 2|Physician Decision|0|||
16972663|NCT01109316|38116603|FG000|Study Period 2|Protocol Violation|1|||
16972664|NCT01109316|38116604|FG001|Study Period 2|Protocol Violation|0|||
16972665|NCT01109316|38116605|FG002|Study Period 2|Protocol Violation|0|||
16972666|NCT01109316|38116606|FG003|Study Period 2|Protocol Violation|0|||
16972667|NCT01109316|38116607|FG004|Study Period 2|Protocol Violation|0|||
16972668|NCT01109316|38116608|FG005|Study Period 2|Protocol Violation|0|||
16972669|NCT01109316|38116603|FG000|Study Period 2|Withdrawal by Subject|0|||
16972670|NCT01109316|38116604|FG001|Study Period 2|Withdrawal by Subject|0|||
16972671|NCT01109316|38116605|FG002|Study Period 2|Withdrawal by Subject|1|||
16972672|NCT01109316|38116606|FG003|Study Period 2|Withdrawal by Subject|0|||
16972673|NCT01109316|38116607|FG004|Study Period 2|Withdrawal by Subject|0|||
16972674|NCT01109316|38116608|FG005|Study Period 2|Withdrawal by Subject|1|||
16972675|NCT01109316|38116603|FG000|Study Period 3|Lost to Follow-up|0|||
16972676|NCT01109316|38116604|FG001|Study Period 3|Lost to Follow-up|0|||
16972677|NCT01109316|38116605|FG002|Study Period 3|Lost to Follow-up|0|||
16972678|NCT01109316|38116606|FG003|Study Period 3|Lost to Follow-up|0|||
16972679|NCT01109316|38116607|FG004|Study Period 3|Lost to Follow-up|1|||
16972680|NCT01109316|38116608|FG005|Study Period 3|Lost to Follow-up|0|||
16972681|NCT01109316|38116603|FG000|Study Period 3|Withdrawal by Subject|1|||
16972682|NCT01109316|38116604|FG001|Study Period 3|Withdrawal by Subject|0|||
16972683|NCT01109316|38116605|FG002|Study Period 3|Withdrawal by Subject|0|||
16972684|NCT01109316|38116606|FG003|Study Period 3|Withdrawal by Subject|0|||
16972685|NCT01109316|38116607|FG004|Study Period 3|Withdrawal by Subject|1|||
16972686|NCT01109316|38116608|FG005|Study Period 3|Withdrawal by Subject|0|||
16972687|NCT00887068|38116618|FG000|Overall Study|Withdrawal by Subject|2|||
16972688|NCT00887068|38116619|FG001|Overall Study|Withdrawal by Subject|0|||
16972689|NCT00887068|38116618|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
16972690|NCT00887068|38116619|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
16972691|NCT00941031|38116629|FG000|Induction Period|Lack of Efficacy|2|||
16972692|NCT00941031|38116630|FG001|Induction Period|Lack of Efficacy|1|||
16972693|NCT00941031|38116631|FG002|Induction Period|Lack of Efficacy|0|||
16972694|NCT00941031|38116632|FG003|Induction Period|Lack of Efficacy|5|||
16972695|NCT00941031|38116633|FG004|Induction Period|Lack of Efficacy|0|||
16972696|NCT00941031|38116634|FG005|Induction Period|Lack of Efficacy|0|||
16972697|NCT00941031|38116635|FG006|Induction Period|Lack of Efficacy|0|||
16972698|NCT00941031|38116629|FG000|Induction Period|Withdrawal by Subject|1|||
16972699|NCT00941031|38116630|FG001|Induction Period|Withdrawal by Subject|2|||
16972700|NCT00941031|38116631|FG002|Induction Period|Withdrawal by Subject|2|||
16972701|NCT00941031|38116632|FG003|Induction Period|Withdrawal by Subject|2|||
16972702|NCT00941031|38116633|FG004|Induction Period|Withdrawal by Subject|0|||
16972703|NCT00941031|38116634|FG005|Induction Period|Withdrawal by Subject|0|||
16972704|NCT00941031|38116635|FG006|Induction Period|Withdrawal by Subject|0|||
16972705|NCT00941031|38116629|FG000|Induction Period|Adminstative Problems|1|||
16972706|NCT00941031|38116630|FG001|Induction Period|Adminstative Problems|1|||
16972707|NCT00941031|38116631|FG002|Induction Period|Adminstative Problems|1|||
16972708|NCT00941031|38116632|FG003|Induction Period|Adminstative Problems|0|||
16972709|NCT00941031|38116633|FG004|Induction Period|Adminstative Problems|0|||
16972710|NCT00941031|38116634|FG005|Induction Period|Adminstative Problems|0|||
16972711|NCT00941031|38116635|FG006|Induction Period|Adminstative Problems|0|||
16972712|NCT00941031|38116629|FG000|Induction Period|Adverse Event|1|||
16972713|NCT00941031|38116630|FG001|Induction Period|Adverse Event|0|||
16972714|NCT00941031|38116631|FG002|Induction Period|Adverse Event|3|||
16972715|NCT00941031|38116632|FG003|Induction Period|Adverse Event|2|||
16972716|NCT00941031|38116633|FG004|Induction Period|Adverse Event|0|||
16972717|NCT00941031|38116634|FG005|Induction Period|Adverse Event|0|||
16972718|NCT00941031|38116635|FG006|Induction Period|Adverse Event|0|||
16972719|NCT00941031|38116629|FG000|Maintenance Period|Withdrawal by Subject|0|||
16972720|NCT00941031|38116630|FG001|Maintenance Period|Withdrawal by Subject|0|||
16972721|NCT00941031|38116631|FG002|Maintenance Period|Withdrawal by Subject|0|||
16972722|NCT00941031|38116632|FG003|Maintenance Period|Withdrawal by Subject|0|||
16972723|NCT00941031|38116633|FG004|Maintenance Period|Withdrawal by Subject|6|||
16972724|NCT00941031|38116634|FG005|Maintenance Period|Withdrawal by Subject|2|||
16972725|NCT00941031|38116635|FG006|Maintenance Period|Withdrawal by Subject|13|||
16972726|NCT00941031|38116629|FG000|Maintenance Period|Administrative Problems|0|||
16972727|NCT00941031|38116630|FG001|Maintenance Period|Administrative Problems|0|||
16972728|NCT00941031|38116631|FG002|Maintenance Period|Administrative Problems|0|||
16972729|NCT00941031|38116632|FG003|Maintenance Period|Administrative Problems|0|||
16972730|NCT00941031|38116633|FG004|Maintenance Period|Administrative Problems|1|||
16972731|NCT00941031|38116634|FG005|Maintenance Period|Administrative Problems|0|||
16972732|NCT00941031|38116635|FG006|Maintenance Period|Administrative Problems|1|||
16972733|NCT00941031|38116629|FG000|Maintenance Period|Protocol Violation|0|||
16972734|NCT00941031|38116630|FG001|Maintenance Period|Protocol Violation|0|||
16972735|NCT00941031|38116631|FG002|Maintenance Period|Protocol Violation|0|||
16972736|NCT00941031|38116632|FG003|Maintenance Period|Protocol Violation|0|||
16972737|NCT00941031|38116633|FG004|Maintenance Period|Protocol Violation|0|||
16972738|NCT00941031|38116634|FG005|Maintenance Period|Protocol Violation|0|||
16972739|NCT00941031|38116635|FG006|Maintenance Period|Protocol Violation|1|||
16972740|NCT00941031|38116629|FG000|Maintenance Period|Adverse Event|0|||
16972741|NCT00941031|38116630|FG001|Maintenance Period|Adverse Event|0|||
16972742|NCT00941031|38116631|FG002|Maintenance Period|Adverse Event|0|||
16972743|NCT00941031|38116632|FG003|Maintenance Period|Adverse Event|0|||
16972744|NCT00941031|38116633|FG004|Maintenance Period|Adverse Event|0|||
16972745|NCT00941031|38116634|FG005|Maintenance Period|Adverse Event|2|||
16972746|NCT00941031|38116635|FG006|Maintenance Period|Adverse Event|8|||
16972747|NCT00941031|38116629|FG000|Maintenance Period|Lost to Follow-up|0|||
16972748|NCT00941031|38116630|FG001|Maintenance Period|Lost to Follow-up|0|||
16972749|NCT00941031|38116631|FG002|Maintenance Period|Lost to Follow-up|0|||
16972750|NCT00941031|38116632|FG003|Maintenance Period|Lost to Follow-up|0|||
16972751|NCT00941031|38116633|FG004|Maintenance Period|Lost to Follow-up|2|||
16972752|NCT00941031|38116634|FG005|Maintenance Period|Lost to Follow-up|2|||
16972753|NCT00941031|38116635|FG006|Maintenance Period|Lost to Follow-up|7|||
16972754|NCT00941031|38116629|FG000|Maintenance Period|Lack of Efficacy|0|||
16972755|NCT00941031|38116630|FG001|Maintenance Period|Lack of Efficacy|0|||
16972756|NCT00941031|38116631|FG002|Maintenance Period|Lack of Efficacy|0|||
16972757|NCT00941031|38116632|FG003|Maintenance Period|Lack of Efficacy|0|||
16972758|NCT00941031|38116633|FG004|Maintenance Period|Lack of Efficacy|0|||
16972759|NCT00941031|38116634|FG005|Maintenance Period|Lack of Efficacy|0|||
16972760|NCT00941031|38116635|FG006|Maintenance Period|Lack of Efficacy|13|||
16972761|NCT00886834|38116656|FG000|Overall Study|Protocol Violation|0|||
16972762|NCT00886834|38116657|FG001|Overall Study|Protocol Violation|3|||
16972763|NCT00880009|38116663|FG000|Overall Study|Study terminated by sponsor|14|||
16972764|NCT00880009|38116663|FG000|Overall Study|Withdrawal by Subject|1|||
16972765|NCT00880009|38116663|FG000|Overall Study|Protocol Violation|1|||
16972766|NCT01104636|38116670|FG000|Overall Study|Lack of Efficacy|43|||
16972767|NCT01104636|38116670|FG000|Overall Study|Lost to Follow-up|24|||
16972768|NCT01104636|38116670|FG000|Overall Study|Withdrawal by Subject|4|||
16972769|NCT01104636|38116670|FG000|Overall Study|Other|43|||
16972770|NCT01104636|38116670|FG000|Overall Study|Study terminated by sponsor|1|||
16972771|NCT01104636|38116670|FG000|Overall Study|Pregnancy|2|||
16972772|NCT01104636|38116670|FG000|Overall Study|Adverse Event|40|||
16972773|NCT01104636|38116670|FG000|Overall Study|Ongoing|21|||
16972774|NCT01104558|38116674|FG000|Overall Study|Protocol Violation|6|||
16972775|NCT01104558|38116674|FG000|Overall Study|Missing of primary efficacy assessment|10|||
16972776|NCT01104558|38116674|FG000|Overall Study|Missing of genetic analysis results|1|||
16972777|NCT00886288|38116680|FG000|Overall Study|no respect of the 12 weeks period|657|||
16972778|NCT00886288|38116681|FG001|Overall Study|no respect of the 12 weeks period|227|||
16972779|NCT00886288|38116680|FG000|Overall Study|Lost to Follow-up|86|||
16972780|NCT00886288|38116681|FG001|Overall Study|Lost to Follow-up|0|||
16972781|NCT01204658|38116693|FG000|Primary Phase|Adverse Event|0|||
16972782|NCT01204658|38116694|FG001|Primary Phase|Adverse Event|0|||
16972783|NCT01204658|38116695|FG002|Primary Phase|Adverse Event|1|||
16972784|NCT01204658|38116696|FG003|Primary Phase|Adverse Event|0|||
16972785|NCT00951483|38116711|FG000|Overall Study|Physician Decision|4|||
16972786|NCT00951483|38116712|FG001|Overall Study|Physician Decision|0|||
16972787|NCT00951483|38116711|FG000|Overall Study|Withdrawal by Subject|15|||
16972788|NCT00951483|38116712|FG001|Overall Study|Withdrawal by Subject|0|||
16972789|NCT01104246|38116720|FG000|Overall Study|Withdrawal by Subject|1|||
16972790|NCT01104246|38116720|FG000|Overall Study|did not meet inclusion criteria|4|||
16972791|NCT01103778|38116724|FG000|Overall Study|Lost to Follow-up|1|||
16972792|NCT01103778|38116724|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
16972793|NCT01103778|38116724|FG000|Overall Study|Screen failure|1|||
16972794|NCT01103466|38116730|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
16972795|NCT01103466|38116731|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
16972796|NCT01103466|38116732|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
16972797|NCT01103466|38116730|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
16972798|NCT01103466|38116731|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
16972799|NCT01103466|38116732|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
16972800|NCT01103466|38116730|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
16972801|NCT01103466|38116731|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
16972802|NCT01103466|38116732|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
16972803|NCT01103466|38116730|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
16972804|NCT01103466|38116731|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
16972805|NCT01103466|38116732|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
16972806|NCT01103466|38116730|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
16972807|NCT01103466|38116731|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
16972808|NCT01103466|38116732|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
16972809|NCT01103466|38116730|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
16972810|NCT01103466|38116731|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
16972811|NCT01103466|38116732|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
16972812|NCT00945945|38116742|FG000|Overall Study|Adverse Event|15|||
16972813|NCT00945945|38116743|FG001|Overall Study|Adverse Event|35|||
16972814|NCT00945945|38116742|FG000|Overall Study|Withdrawal by Subject|7|||
16972815|NCT00945945|38116743|FG001|Overall Study|Withdrawal by Subject|10|||
16972816|NCT00945945|38116742|FG000|Overall Study|Lost to Follow-up|4|||
16972817|NCT00945945|38116743|FG001|Overall Study|Lost to Follow-up|5|||
16972818|NCT00945945|38116742|FG000|Overall Study|Lack of Efficacy|6|||
16972819|NCT00945945|38116743|FG001|Overall Study|Lack of Efficacy|2|||
16972820|NCT00945945|38116742|FG000|Overall Study|Protocol Violation|4|||
16972821|NCT00945945|38116743|FG001|Overall Study|Protocol Violation|2|||
16972822|NCT00945945|38116742|FG000|Overall Study|Entry Criteria Not Met|0|||
16972823|NCT00945945|38116743|FG001|Overall Study|Entry Criteria Not Met|1|||
16972824|NCT01203956|38116749|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
16972825|NCT01203956|38116750|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
16972826|NCT01103232|38116759|FG000|Overall Study|Withdrawal by Subject|1|||
16972827|NCT01103232|38116760|FG001|Overall Study|Withdrawal by Subject|1|||
16972828|NCT01103232|38116759|FG000|Overall Study|Protocol Violation|0|||
16972829|NCT01103232|38116760|FG001|Overall Study|Protocol Violation|1|||
16972830|NCT01112982|38116766|FG000|Overall Study|Withdrawal by Subject|1|||
16972831|NCT01112982|38116766|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
16972832|NCT01203878|38116776|FG000|Overall Study|Withdrawal by Subject|0|||
16972833|NCT01203878|38116777|FG001|Overall Study|Withdrawal by Subject|0|||
16972834|NCT01203878|38116778|FG002|Overall Study|Withdrawal by Subject|1|||
16972835|NCT01203878|38116776|FG000|Overall Study|Adverse Event|0|||
16972836|NCT01203878|38116777|FG001|Overall Study|Adverse Event|0|||
16972837|NCT01203878|38116778|FG002|Overall Study|Adverse Event|2|||
16972838|NCT01112514|38116785|FG000|Overall Study|Lost to Follow-up|1|||
16972839|NCT01203098|38116792|FG000|Overall Study|Adverse Event|3|||
16972840|NCT01203098|38116793|FG001|Overall Study|Adverse Event|1|||
16972841|NCT01203098|38116794|FG002|Overall Study|Adverse Event|7|||
16972842|NCT01203098|38116792|FG000|Overall Study|Lost to Follow-up|0|||
16972843|NCT01203098|38116793|FG001|Overall Study|Lost to Follow-up|0|||
16972844|NCT01203098|38116794|FG002|Overall Study|Lost to Follow-up|1|||
16972845|NCT01203098|38116792|FG000|Overall Study|Physician Decision|2|||
16972846|NCT01203098|38116793|FG001|Overall Study|Physician Decision|2|||
16972847|NCT01203098|38116794|FG002|Overall Study|Physician Decision|0|||
16972848|NCT01203098|38116792|FG000|Overall Study|Withdrawal by Subject|1|||
16972849|NCT01203098|38116793|FG001|Overall Study|Withdrawal by Subject|1|||
16972850|NCT01203098|38116794|FG002|Overall Study|Withdrawal by Subject|3|||
16972851|NCT00945555|38116802|FG000|Overall Study|Referred to another hospital|5|||
16972852|NCT00945555|38116802|FG000|Overall Study|Worsening condition, intensive care unit|1|||
16972853|NCT00945555|38116802|FG000|Overall Study|Withdrawal by Subject|2|||
16972854|NCT00945555|38116802|FG000|Overall Study|Participant continued treatment at home|1|||
16972855|NCT00945555|38116802|FG000|Overall Study|Death|18|||
16972856|NCT00945555|38116802|FG000|Overall Study|Other|1|||
16972857|NCT01108458|38116806|FG000|Overall Study|Withdrawal by Subject|1|||
16972858|NCT01108068|38116812|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
16972859|NCT01108068|38116813|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
16972860|NCT01201850|38116820|FG000|Overall Study|Tumor progression|4|||
16972861|NCT00951171|38116826|FG000|Overall Study|Adverse Event|2|||
16972862|NCT00951171|38116827|FG001|Overall Study|Adverse Event|0|||
16972863|NCT01200992|38116835|FG000|Overall Study|Study terminated early|35|||
16972864|NCT01200992|38116836|FG001|Overall Study|Study terminated early|41|||
16972865|NCT01200992|38116835|FG000|Overall Study|Randomized but not treated|2|||
16972866|NCT01200992|38116836|FG001|Overall Study|Randomized but not treated|0|||
16972867|NCT00878215|38116848|FG000|Overall Study|Determined to be ineligible|0|||
16972868|NCT00878215|38116849|FG001|Overall Study|Determined to be ineligible|10|||
16972869|NCT00878215|38116850|FG002|Overall Study|Determined to be ineligible|0|||
16972870|NCT00878215|38116851|FG003|Overall Study|Determined to be ineligible|0|||
16972871|NCT01200758|38116863|FG000|Stage I|Death|0|||
16972872|NCT01200758|38116864|FG001|Stage I|Death|1|||
16972873|NCT01200758|38116865|FG002|Stage I|Death|0|||
16972874|NCT01200758|38116866|FG003|Stage I|Death|0|||
16972875|NCT01200758|38116863|FG000|Stage I|Physician Decision|1|||
16972876|NCT01200758|38116864|FG001|Stage I|Physician Decision|1|||
16972877|NCT01200758|38116865|FG002|Stage I|Physician Decision|0|||
16972878|NCT01200758|38116866|FG003|Stage I|Physician Decision|0|||
16972879|NCT01200758|38116863|FG000|Stage I|Lack of Efficacy|2|||
16972880|NCT01200758|38116864|FG001|Stage I|Lack of Efficacy|1|||
16972881|NCT01200758|38116865|FG002|Stage I|Lack of Efficacy|0|||
16972882|NCT01200758|38116866|FG003|Stage I|Lack of Efficacy|0|||
16972883|NCT01200758|38116863|FG000|Stage I|Adverse Event|5|||
16972884|NCT01200758|38116864|FG001|Stage I|Adverse Event|5|||
16972885|NCT01200758|38116865|FG002|Stage I|Adverse Event|0|||
16972886|NCT01200758|38116866|FG003|Stage I|Adverse Event|0|||
16972887|NCT01200758|38116863|FG000|Stage I|Withdrawal by Subject|1|||
16972888|NCT01200758|38116864|FG001|Stage I|Withdrawal by Subject|2|||
16972889|NCT01200758|38116865|FG002|Stage I|Withdrawal by Subject|0|||
16972890|NCT01200758|38116866|FG003|Stage I|Withdrawal by Subject|0|||
16972891|NCT01200758|38116863|FG000|Stage I|Disease Progression|9|||
16972892|NCT01200758|38116864|FG001|Stage I|Disease Progression|7|||
16972893|NCT01200758|38116865|FG002|Stage I|Disease Progression|0|||
16972894|NCT01200758|38116866|FG003|Stage I|Disease Progression|0|||
16972895|NCT01200758|38116863|FG000|Stage 2|Disease Progression|0|||
16972896|NCT01200758|38116864|FG001|Stage 2|Disease Progression|0|||
16972897|NCT01200758|38116865|FG002|Stage 2|Disease Progression|16|||
16972898|NCT01200758|38116866|FG003|Stage 2|Disease Progression|21|||
16972899|NCT01200758|38116863|FG000|Stage 2|Lack of Efficacy|0|||
16972900|NCT01200758|38116864|FG001|Stage 2|Lack of Efficacy|0|||
16972901|NCT01200758|38116865|FG002|Stage 2|Lack of Efficacy|4|||
16972902|NCT01200758|38116866|FG003|Stage 2|Lack of Efficacy|2|||
16972903|NCT01200758|38116863|FG000|Stage 2|Physician Decision|0|||
16972904|NCT01200758|38116864|FG001|Stage 2|Physician Decision|0|||
16972905|NCT01200758|38116865|FG002|Stage 2|Physician Decision|5|||
16972906|NCT01200758|38116866|FG003|Stage 2|Physician Decision|7|||
16972907|NCT01200758|38116863|FG000|Stage 2|Adverse Event|0|||
16972908|NCT01200758|38116864|FG001|Stage 2|Adverse Event|0|||
16972909|NCT01200758|38116865|FG002|Stage 2|Adverse Event|5|||
16972910|NCT01200758|38116866|FG003|Stage 2|Adverse Event|9|||
16972911|NCT01200758|38116863|FG000|Stage 2|Withdrawal by Subject|0|||
16972912|NCT01200758|38116864|FG001|Stage 2|Withdrawal by Subject|0|||
16972913|NCT01200758|38116865|FG002|Stage 2|Withdrawal by Subject|4|||
16972914|NCT01200758|38116866|FG003|Stage 2|Withdrawal by Subject|1|||
16972915|NCT01200758|38116863|FG000|Stage 2|Lost to Follow-up|0|||
16972916|NCT01200758|38116864|FG001|Stage 2|Lost to Follow-up|0|||
16972917|NCT01200758|38116865|FG002|Stage 2|Lost to Follow-up|3|||
16972918|NCT01200758|38116866|FG003|Stage 2|Lost to Follow-up|1|||
16972919|NCT01200758|38116863|FG000|Stage 2|Protocol Violation|0|||
16972920|NCT01200758|38116864|FG001|Stage 2|Protocol Violation|0|||
16972921|NCT01200758|38116865|FG002|Stage 2|Protocol Violation|1|||
16972922|NCT01200758|38116866|FG003|Stage 2|Protocol Violation|4|||
16972923|NCT01200758|38116863|FG000|Stage 2|Death|0|||
16972924|NCT01200758|38116864|FG001|Stage 2|Death|0|||
16972925|NCT01200758|38116865|FG002|Stage 2|Death|3|||
16972926|NCT01200758|38116866|FG003|Stage 2|Death|5|||
16972927|NCT00876343|38116881|FG000|Overall Study|Adverse Event|7|||
16972928|NCT00876343|38116882|FG001|Overall Study|Adverse Event|8|||
16972929|NCT00876343|38116883|FG002|Overall Study|Adverse Event|2|||
16972930|NCT00876343|38116881|FG000|Overall Study|Withdrawal by Subject|4|||
16972931|NCT00876343|38116882|FG001|Overall Study|Withdrawal by Subject|4|||
16972932|NCT00876343|38116883|FG002|Overall Study|Withdrawal by Subject|3|||
16972933|NCT00876343|38116881|FG000|Overall Study|Lack of Efficacy|0|||
16972934|NCT00876343|38116882|FG001|Overall Study|Lack of Efficacy|0|||
16972935|NCT00876343|38116883|FG002|Overall Study|Lack of Efficacy|1|||
16972936|NCT00876343|38116881|FG000|Overall Study|Protocol Violation|4|||
16972937|NCT00876343|38116882|FG001|Overall Study|Protocol Violation|1|||
16972938|NCT00876343|38116883|FG002|Overall Study|Protocol Violation|1|||
16972939|NCT00876343|38116881|FG000|Overall Study|Physician Decision|0|||
16972940|NCT00876343|38116882|FG001|Overall Study|Physician Decision|1|||
16972941|NCT00876343|38116883|FG002|Overall Study|Physician Decision|1|||
16972942|NCT00876343|38116881|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
16972943|NCT00876343|38116882|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
16972944|NCT00876343|38116883|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
16972945|NCT00876343|38116881|FG000|Overall Study|Change of residence or other commitments|2|||
16972946|NCT00876343|38116882|FG001|Overall Study|Change of residence or other commitments|2|||
16972947|NCT00876343|38116883|FG002|Overall Study|Change of residence or other commitments|3|||
16972948|NCT01107912|38116895|FG000|Period 1|Adverse Event|0|||
16972949|NCT01107912|38116896|FG001|Period 1|Adverse Event|0|||
16972950|NCT01107912|38116897|FG002|Period 1|Adverse Event|0|||
16972951|NCT01107912|38116898|FG003|Period 1|Adverse Event|0|||
16972952|NCT01107912|38116899|FG004|Period 1|Adverse Event|2|||
16972953|NCT01107912|38116900|FG005|Period 1|Adverse Event|0|||
16972954|NCT01107912|38116895|FG000|Period 1|Physician Decision|0|||
16972955|NCT01107912|38116896|FG001|Period 1|Physician Decision|0|||
16972956|NCT01107912|38116897|FG002|Period 1|Physician Decision|0|||
16972957|NCT01107912|38116898|FG003|Period 1|Physician Decision|0|||
16972958|NCT01107912|38116899|FG004|Period 1|Physician Decision|1|||
16972959|NCT01107912|38116900|FG005|Period 1|Physician Decision|0|||
16972960|NCT01107912|38116895|FG000|Period 1|Withdrawal by Subject|1|||
16972961|NCT01107912|38116896|FG001|Period 1|Withdrawal by Subject|0|||
16972962|NCT01107912|38116897|FG002|Period 1|Withdrawal by Subject|0|||
16972963|NCT01107912|38116898|FG003|Period 1|Withdrawal by Subject|0|||
16972964|NCT01107912|38116899|FG004|Period 1|Withdrawal by Subject|0|||
16972965|NCT01107912|38116900|FG005|Period 1|Withdrawal by Subject|0|||
16972966|NCT01107912|38116895|FG000|Period 2|Physician Decision|0|||
16972967|NCT01107912|38116896|FG001|Period 2|Physician Decision|0|||
16972968|NCT01107912|38116897|FG002|Period 2|Physician Decision|1|||
16972969|NCT01107912|38116898|FG003|Period 2|Physician Decision|0|||
16972970|NCT01107912|38116899|FG004|Period 2|Physician Decision|0|||
16972971|NCT01107912|38116900|FG005|Period 2|Physician Decision|0|||
16972972|NCT01107912|38116895|FG000|Period 3|Adverse Event|0|||
16972973|NCT01107912|38116896|FG001|Period 3|Adverse Event|1|||
16972974|NCT01107912|38116897|FG002|Period 3|Adverse Event|1|||
16972975|NCT01107912|38116898|FG003|Period 3|Adverse Event|0|||
16972976|NCT01107912|38116899|FG004|Period 3|Adverse Event|0|||
16972977|NCT01107912|38116900|FG005|Period 3|Adverse Event|0|||
16972978|NCT01107912|38116895|FG000|Period 3|Withdrawal by Subject|0|||
16972979|NCT01107912|38116896|FG001|Period 3|Withdrawal by Subject|0|||
16972980|NCT01107912|38116897|FG002|Period 3|Withdrawal by Subject|0|||
16972981|NCT01107912|38116898|FG003|Period 3|Withdrawal by Subject|1|||
16972982|NCT01107912|38116899|FG004|Period 3|Withdrawal by Subject|0|||
16972983|NCT01107912|38116900|FG005|Period 3|Withdrawal by Subject|0|||
16972984|NCT01200524|38116918|FG000|Overall Study|Withdrawal by Subject|1|||
16972985|NCT01200524|38116919|FG001|Overall Study|Withdrawal by Subject|1|||
16972986|NCT01200524|38116920|FG002|Overall Study|Withdrawal by Subject|3|||
16972987|NCT01200524|38116918|FG000|Overall Study|Adverse Event|1|||
16972988|NCT01200524|38116919|FG001|Overall Study|Adverse Event|0|||
16972989|NCT01200524|38116920|FG002|Overall Study|Adverse Event|0|||
16972990|NCT01200524|38116918|FG000|Overall Study|Non availability of study nurse|0|||
16972991|NCT01200524|38116919|FG001|Overall Study|Non availability of study nurse|0|||
16972992|NCT01200524|38116920|FG002|Overall Study|Non availability of study nurse|1|||
16972993|NCT01100034|38116928|FG000|Overall Study|Lost to Follow-up|11|||
16972994|NCT01100034|38116928|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
16972995|NCT01100034|38116928|FG000|Overall Study|Withdrawal by Subject|4|||
16972996|NCT01100034|38116928|FG000|Overall Study|Sponsor decision|21|||
16972997|NCT01100034|38116928|FG000|Overall Study|Participated in another clinical trial|1|||
16972998|NCT01100034|38116928|FG000|Overall Study|Participants moved to another hospital|4|||
16972999|NCT01100034|38116928|FG000|Overall Study|Site closed due to non-responsiveness|1|||
16973000|NCT00876265|38116932|FG000|Overall Study|Miscellaneous reasons|4|||
16973001|NCT00876265|38116932|FG000|Overall Study|Lost to Follow-up|6|||
16973002|NCT00876265|38116932|FG000|Overall Study|Withdrawal by Subject|2|||
16973003|NCT01107444|38116940|FG000|Overall Study|Withdrawal by Subject|8|||
16973004|NCT01107444|38116941|FG001|Overall Study|Withdrawal by Subject|12|||
16973005|NCT01107444|38116940|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
16973006|NCT01107444|38116941|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
16973007|NCT00876187|38116955|FG000|Overall Study|Adverse Event|14|||
16973008|NCT00876187|38116956|FG001|Overall Study|Adverse Event|12|||
16973009|NCT00876187|38116957|FG002|Overall Study|Adverse Event|19|||
16973010|NCT00876187|38116958|FG003|Overall Study|Adverse Event|29|||
16973011|NCT00876187|38116959|FG004|Overall Study|Adverse Event|10|||
16973012|NCT00876187|38116955|FG000|Overall Study|Lack of Efficacy|59|||
16973013|NCT00876187|38116956|FG001|Overall Study|Lack of Efficacy|34|||
16973014|NCT00876187|38116957|FG002|Overall Study|Lack of Efficacy|45|||
16973015|NCT00876187|38116958|FG003|Overall Study|Lack of Efficacy|34|||
16973016|NCT00876187|38116959|FG004|Overall Study|Lack of Efficacy|59|||
16973017|NCT00876187|38116955|FG000|Overall Study|Lost to Follow-up|9|||
16973018|NCT00876187|38116956|FG001|Overall Study|Lost to Follow-up|10|||
16973019|NCT00876187|38116957|FG002|Overall Study|Lost to Follow-up|8|||
16973020|NCT00876187|38116958|FG003|Overall Study|Lost to Follow-up|8|||
16973021|NCT00876187|38116959|FG004|Overall Study|Lost to Follow-up|11|||
16973022|NCT00876187|38116955|FG000|Overall Study|Protocol Violation|6|||
16973023|NCT00876187|38116956|FG001|Overall Study|Protocol Violation|7|||
16973024|NCT00876187|38116957|FG002|Overall Study|Protocol Violation|7|||
16973025|NCT00876187|38116958|FG003|Overall Study|Protocol Violation|6|||
16973026|NCT00876187|38116959|FG004|Overall Study|Protocol Violation|3|||
16973027|NCT00876187|38116955|FG000|Overall Study|Withdrawal by Subject|16|||
16973028|NCT00876187|38116956|FG001|Overall Study|Withdrawal by Subject|26|||
16973029|NCT00876187|38116957|FG002|Overall Study|Withdrawal by Subject|32|||
16973030|NCT00876187|38116958|FG003|Overall Study|Withdrawal by Subject|38|||
16973031|NCT00876187|38116959|FG004|Overall Study|Withdrawal by Subject|37|||
16973032|NCT00876187|38116955|FG000|Overall Study|Entered extension study|101|||
16973033|NCT00876187|38116956|FG001|Overall Study|Entered extension study|120|||
16973034|NCT00876187|38116957|FG002|Overall Study|Entered extension study|156|||
16973035|NCT00876187|38116958|FG003|Overall Study|Entered extension study|151|||
16973036|NCT00876187|38116959|FG004|Overall Study|Entered extension study|144|||
16973037|NCT00876187|38116955|FG000|Overall Study|Randomized but not treated|3|||
16973038|NCT00876187|38116956|FG001|Overall Study|Randomized but not treated|1|||
16973039|NCT00876187|38116957|FG002|Overall Study|Randomized but not treated|3|||
16973040|NCT00876187|38116958|FG003|Overall Study|Randomized but not treated|2|||
16973041|NCT00876187|38116959|FG004|Overall Study|Randomized but not treated|3|||
16973042|NCT00876187|38116955|FG000|Overall Study|Other|2|||
16973043|NCT00876187|38116956|FG001|Overall Study|Other|5|||
16973044|NCT00876187|38116957|FG002|Overall Study|Other|9|||
16973045|NCT00876187|38116958|FG003|Overall Study|Other|7|||
16973046|NCT00876187|38116959|FG004|Overall Study|Other|4|||
16973047|NCT01102374|38116976|FG000|Overall Study|Death|9|||
16973048|NCT01102374|38116977|FG001|Overall Study|Death|13|||
16973049|NCT01102374|38116976|FG000|Overall Study|Lost to Follow-up|7|||
16973050|NCT01102374|38116977|FG001|Overall Study|Lost to Follow-up|6|||
16973051|NCT01106976|38116983|FG000|Overall Study|Lost to Follow-up|8|||
16973052|NCT00875485|38116989|FG000|Challenge Dose Epoch|Pregnancy|1|||
16973053|NCT00875485|38116990|FG001|Challenge Dose Epoch|Pregnancy|0|||
16973054|NCT04547140|38116998|FG000|Overall Study|Adverse Event|0|||
16973055|NCT04547140|38116999|FG001|Overall Study|Adverse Event|1|||
16973056|NCT04547140|38116998|FG000|Overall Study|Withdrawal by Subject|0|||
16973057|NCT04547140|38116999|FG001|Overall Study|Withdrawal by Subject|1|||
16973058|NCT04547140|38116998|FG000|Overall Study|Lost to Follow-up|3|||
16973059|NCT04547140|38116999|FG001|Overall Study|Lost to Follow-up|1|||
16973060|NCT04547140|38116998|FG000|Overall Study|Death|2|||
16973061|NCT04547140|38116999|FG001|Overall Study|Death|1|||
16973062|NCT04547140|38116998|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
16973063|NCT04547140|38116999|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
16973064|NCT04547140|38116998|FG000|Overall Study|Pregnancy|1|||
16973065|NCT04547140|38116999|FG001|Overall Study|Pregnancy|0|||
16973066|NCT04547140|38116998|FG000|Overall Study|Reason Not Specified|4|||
16973067|NCT04547140|38116999|FG001|Overall Study|Reason Not Specified|1|||
16973068|NCT01098474|38117011|FG000|Active Phase|Other|0|||
16973069|NCT01098474|38117012|FG001|Active Phase|Other|0|||
16973070|NCT01098474|38117013|FG002|Active Phase|Other|3|||
16973071|NCT01098474|38117014|FG003|Active Phase|Other|0|||
16973072|NCT01098474|38117015|FG004|Active Phase|Other|0|||
16973073|NCT01098474|38117016|FG005|Active Phase|Other|0|||
16973074|NCT01098474|38117011|FG000|Active Phase|Withdrawal by Subject|1|||
16973075|NCT01098474|38117012|FG001|Active Phase|Withdrawal by Subject|1|||
16973076|NCT01098474|38117013|FG002|Active Phase|Withdrawal by Subject|2|||
16973077|NCT01098474|38117014|FG003|Active Phase|Withdrawal by Subject|0|||
16973078|NCT01098474|38117015|FG004|Active Phase|Withdrawal by Subject|0|||
16973079|NCT01098474|38117016|FG005|Active Phase|Withdrawal by Subject|0|||
16973080|NCT01098474|38117011|FG000|Active Phase|Lost to Follow-up|1|||
16973081|NCT01098474|38117012|FG001|Active Phase|Lost to Follow-up|0|||
16973082|NCT01098474|38117013|FG002|Active Phase|Lost to Follow-up|0|||
16973083|NCT01098474|38117014|FG003|Active Phase|Lost to Follow-up|0|||
16973084|NCT01098474|38117015|FG004|Active Phase|Lost to Follow-up|0|||
16973085|NCT01098474|38117016|FG005|Active Phase|Lost to Follow-up|0|||
16973086|NCT01098474|38117011|FG000|Follow Up Phase|Travelled out of study area|0|||
16973087|NCT01098474|38117012|FG001|Follow Up Phase|Travelled out of study area|0|||
16973088|NCT01098474|38117013|FG002|Follow Up Phase|Travelled out of study area|0|||
16973089|NCT01098474|38117014|FG003|Follow Up Phase|Travelled out of study area|0|||
16973090|NCT01098474|38117015|FG004|Follow Up Phase|Travelled out of study area|1|||
16973091|NCT01098474|38117016|FG005|Follow Up Phase|Travelled out of study area|0|||
16973092|NCT01098474|38117011|FG000|Follow Up Phase|Other|0|||
16973093|NCT01098474|38117012|FG001|Follow Up Phase|Other|0|||
16973094|NCT01098474|38117013|FG002|Follow Up Phase|Other|0|||
16973095|NCT01098474|38117014|FG003|Follow Up Phase|Other|0|||
16973096|NCT01098474|38117015|FG004|Follow Up Phase|Other|0|||
16973097|NCT01098474|38117016|FG005|Follow Up Phase|Other|4|||
16973098|NCT01098474|38117011|FG000|Follow Up Phase|Withdrawal by Subject|0|||
16973099|NCT01098474|38117012|FG001|Follow Up Phase|Withdrawal by Subject|0|||
16973100|NCT01098474|38117013|FG002|Follow Up Phase|Withdrawal by Subject|0|||
16973101|NCT01098474|38117014|FG003|Follow Up Phase|Withdrawal by Subject|2|||
16973102|NCT01098474|38117015|FG004|Follow Up Phase|Withdrawal by Subject|0|||
16973103|NCT01098474|38117016|FG005|Follow Up Phase|Withdrawal by Subject|1|||
16973104|NCT01098474|38117011|FG000|Follow Up Phase|Lost to Follow-up|0|||
16973105|NCT01098474|38117012|FG001|Follow Up Phase|Lost to Follow-up|0|||
16973106|NCT01098474|38117013|FG002|Follow Up Phase|Lost to Follow-up|0|||
16973107|NCT01098474|38117014|FG003|Follow Up Phase|Lost to Follow-up|0|||
16973108|NCT01098474|38117015|FG004|Follow Up Phase|Lost to Follow-up|1|||
16973109|NCT01098474|38117016|FG005|Follow Up Phase|Lost to Follow-up|0|||
16973110|NCT01106898|38117040|FG000|Overall Study|Adverse Event|6|||
16973111|NCT00876733|38117048|FG000|Overall Study|Adverse Event|34|||
16973112|NCT00876733|38117049|FG001|Overall Study|Adverse Event|20|||
16973113|NCT00876733|38117050|FG002|Overall Study|Adverse Event|10|||
16973114|NCT00876733|38117051|FG003|Overall Study|Adverse Event|3|||
16973115|NCT00876733|38117048|FG000|Overall Study|Lack of Efficacy|17|||
16973116|NCT00876733|38117049|FG001|Overall Study|Lack of Efficacy|9|||
16973117|NCT00876733|38117050|FG002|Overall Study|Lack of Efficacy|10|||
16973118|NCT00876733|38117051|FG003|Overall Study|Lack of Efficacy|1|||
16973119|NCT00876733|38117048|FG000|Overall Study|Lost to Follow-up|26|||
16973120|NCT00876733|38117049|FG001|Overall Study|Lost to Follow-up|10|||
16973121|NCT00876733|38117050|FG002|Overall Study|Lost to Follow-up|3|||
16973122|NCT00876733|38117051|FG003|Overall Study|Lost to Follow-up|2|||
16973123|NCT00876733|38117048|FG000|Overall Study|Data not available|14|||
16973124|NCT00876733|38117049|FG001|Overall Study|Data not available|3|||
16973125|NCT00876733|38117050|FG002|Overall Study|Data not available|7|||
16973126|NCT00876733|38117051|FG003|Overall Study|Data not available|1|||
16973127|NCT00875017|38117071|FG000|First Intervention|Withdrawal by Subject|1|||
16973128|NCT00875017|38117072|FG001|First Intervention|Withdrawal by Subject|0|||
16973129|NCT00875017|38117073|FG002|First Intervention|Withdrawal by Subject|1|||
16973130|NCT00875017|38117074|FG003|First Intervention|Withdrawal by Subject|0|||
16973131|NCT00875017|38117075|FG004|First Intervention|Withdrawal by Subject|0|||
16973132|NCT00875017|38117076|FG005|First Intervention|Withdrawal by Subject|0|||
16973133|NCT00875017|38117071|FG000|First Intervention|Adverse Event|0|||
16973134|NCT00875017|38117072|FG001|First Intervention|Adverse Event|0|||
16973135|NCT00875017|38117073|FG002|First Intervention|Adverse Event|0|||
16973136|NCT00875017|38117074|FG003|First Intervention|Adverse Event|1|||
16973137|NCT00875017|38117075|FG004|First Intervention|Adverse Event|0|||
16973138|NCT00875017|38117076|FG005|First Intervention|Adverse Event|0|||
16973139|NCT00875017|38117071|FG000|First Intervention|Problems collecting rectal effluent|1|||
16973140|NCT00875017|38117072|FG001|First Intervention|Problems collecting rectal effluent|0|||
16973141|NCT00875017|38117073|FG002|First Intervention|Problems collecting rectal effluent|0|||
16973142|NCT00875017|38117074|FG003|First Intervention|Problems collecting rectal effluent|0|||
16973143|NCT00875017|38117075|FG004|First Intervention|Problems collecting rectal effluent|0|||
16973144|NCT00875017|38117076|FG005|First Intervention|Problems collecting rectal effluent|0|||
16973145|NCT00875017|38117071|FG000|First Intervention|Intolerance to nasogastric tube|0|||
16973146|NCT00875017|38117072|FG001|First Intervention|Intolerance to nasogastric tube|0|||
16973147|NCT00875017|38117073|FG002|First Intervention|Intolerance to nasogastric tube|0|||
16973148|NCT00875017|38117074|FG003|First Intervention|Intolerance to nasogastric tube|0|||
16973149|NCT00875017|38117075|FG004|First Intervention|Intolerance to nasogastric tube|1|||
16973150|NCT00875017|38117076|FG005|First Intervention|Intolerance to nasogastric tube|0|||
16973151|NCT00875017|38117071|FG000|Washout|Problem collecting rectal effluent|0|||
16973152|NCT00875017|38117072|FG001|Washout|Problem collecting rectal effluent|0|||
16973153|NCT00875017|38117073|FG002|Washout|Problem collecting rectal effluent|1|||
16973154|NCT00875017|38117074|FG003|Washout|Problem collecting rectal effluent|0|||
16973155|NCT00875017|38117075|FG004|Washout|Problem collecting rectal effluent|0|||
16973156|NCT00875017|38117076|FG005|Washout|Problem collecting rectal effluent|0|||
16973157|NCT00875017|38117071|FG000|Second Intervention|Adverse Event|0|||
16973158|NCT00875017|38117072|FG001|Second Intervention|Adverse Event|0|||
16973159|NCT00875017|38117073|FG002|Second Intervention|Adverse Event|0|||
16973160|NCT00875017|38117074|FG003|Second Intervention|Adverse Event|1|||
16973161|NCT00875017|38117075|FG004|Second Intervention|Adverse Event|0|||
16973162|NCT00875017|38117076|FG005|Second Intervention|Adverse Event|0|||
16973163|NCT00875017|38117071|FG000|Washout|Problems collecting rectal effluent|0|||
16973164|NCT00875017|38117072|FG001|Washout|Problems collecting rectal effluent|1|||
16973165|NCT00875017|38117073|FG002|Washout|Problems collecting rectal effluent|0|||
16973166|NCT00875017|38117074|FG003|Washout|Problems collecting rectal effluent|0|||
16973167|NCT00875017|38117075|FG004|Washout|Problems collecting rectal effluent|0|||
16973168|NCT00875017|38117076|FG005|Washout|Problems collecting rectal effluent|0|||
16973169|NCT00875017|38117071|FG000|Third Intervention|Adverse Event|0|||
16973170|NCT00875017|38117072|FG001|Third Intervention|Adverse Event|1|||
16973171|NCT00875017|38117073|FG002|Third Intervention|Adverse Event|1|||
16973172|NCT00875017|38117074|FG003|Third Intervention|Adverse Event|0|||
16973173|NCT00875017|38117075|FG004|Third Intervention|Adverse Event|0|||
16973174|NCT00875017|38117076|FG005|Third Intervention|Adverse Event|0|||
16973175|NCT00875017|38117071|FG000|Washout|Withdrawal by Subject|0|||
16973176|NCT00875017|38117072|FG001|Washout|Withdrawal by Subject|0|||
16973177|NCT00875017|38117073|FG002|Washout|Withdrawal by Subject|0|||
16973178|NCT00875017|38117074|FG003|Washout|Withdrawal by Subject|0|||
16973179|NCT00875017|38117075|FG004|Washout|Withdrawal by Subject|1|||
16973180|NCT00875017|38117076|FG005|Washout|Withdrawal by Subject|0|||
16973181|NCT00875017|38117071|FG000|Fourth Intervention|Inability to comply with fasting|0|||
16973182|NCT00875017|38117072|FG001|Fourth Intervention|Inability to comply with fasting|0|||
16973183|NCT00875017|38117073|FG002|Fourth Intervention|Inability to comply with fasting|0|||
16973184|NCT00875017|38117074|FG003|Fourth Intervention|Inability to comply with fasting|0|||
16973185|NCT00875017|38117075|FG004|Fourth Intervention|Inability to comply with fasting|0|||
16973186|NCT00875017|38117076|FG005|Fourth Intervention|Inability to comply with fasting|1|||
16973187|NCT00875797|38117101|FG000|Overall Study|Protocol Violation|6|||
16973188|NCT00875797|38117102|FG001|Overall Study|Protocol Violation|3|||
16973189|NCT00874939|38117128|FG000|Overall Study|Study terminated|4|||
16973190|NCT01185353|38117143|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
16973191|NCT01185353|38117144|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
16973192|NCT01185353|38117145|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
16973193|NCT01185353|38117146|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
16973194|NCT01185353|38117147|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
16973195|NCT01185353|38117148|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16973196|NCT01185353|38117149|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16973197|NCT01185353|38117150|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16973198|NCT01185353|38117151|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16973199|NCT01185353|38117152|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16973200|NCT01185353|38117143|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973201|NCT01185353|38117144|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973202|NCT01185353|38117145|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973203|NCT01185353|38117146|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973204|NCT01185353|38117147|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
16973205|NCT01185353|38117148|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973206|NCT01185353|38117149|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973207|NCT01185353|38117150|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973208|NCT01185353|38117151|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973209|NCT01185353|38117152|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16973210|NCT01185353|38117143|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
16973211|NCT01185353|38117144|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16973212|NCT01185353|38117145|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16973213|NCT01185353|38117146|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16973214|NCT01185353|38117147|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
16973215|NCT01185353|38117148|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16973216|NCT01185353|38117149|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16973217|NCT01185353|38117150|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16973218|NCT01185353|38117151|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16973219|NCT01185353|38117152|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16973220|NCT01185353|38117143|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16973221|NCT01185353|38117144|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16973222|NCT01185353|38117145|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
16973223|NCT01185353|38117146|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16973224|NCT01185353|38117147|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
16973225|NCT01185353|38117148|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16973226|NCT01185353|38117149|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16973227|NCT01185353|38117150|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16973228|NCT01185353|38117151|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16973229|NCT01185353|38117152|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16973230|NCT01185353|38117143|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973231|NCT01185353|38117144|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973232|NCT01185353|38117145|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973233|NCT01185353|38117146|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973234|NCT01185353|38117147|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
16973235|NCT01185353|38117148|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973236|NCT01185353|38117149|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973237|NCT01185353|38117150|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973238|NCT01185353|38117151|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973239|NCT01185353|38117152|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16973240|NCT01185353|38117143|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
16973241|NCT01185353|38117144|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16973242|NCT01185353|38117145|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16973243|NCT01185353|38117146|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16973244|NCT01185353|38117147|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
16973245|NCT01185353|38117148|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16973246|NCT01185353|38117149|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16973247|NCT01185353|38117150|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16973248|NCT01185353|38117151|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16973249|NCT01185353|38117152|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16973250|NCT01185353|38117143|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16973251|NCT01185353|38117144|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16973252|NCT01185353|38117145|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
16973253|NCT01185353|38117146|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16973254|NCT01185353|38117147|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16973255|NCT01185353|38117148|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
16973256|NCT01185353|38117149|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16973257|NCT01185353|38117150|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16973258|NCT01185353|38117151|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16973259|NCT01185353|38117152|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16973260|NCT01185353|38117143|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16973261|NCT01185353|38117144|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
16973262|NCT01185353|38117145|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16973263|NCT01185353|38117146|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
16973264|NCT01185353|38117147|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16973265|NCT01185353|38117148|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16973266|NCT01185353|38117149|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16973267|NCT01185353|38117150|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16973268|NCT01185353|38117151|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16973269|NCT01185353|38117152|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16973270|NCT01185353|38117143|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16973271|NCT01185353|38117144|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16973272|NCT01185353|38117145|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16973273|NCT01185353|38117146|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
16973274|NCT01185353|38117147|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16973275|NCT01185353|38117148|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16973276|NCT01185353|38117149|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
16973277|NCT01185353|38117150|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16973278|NCT01185353|38117151|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16973279|NCT01185353|38117152|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16973280|NCT01185353|38117143|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16973281|NCT01185353|38117144|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16973282|NCT01185353|38117145|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
16973283|NCT01185353|38117146|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
16973284|NCT01185353|38117147|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16973285|NCT01185353|38117148|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
16973286|NCT01185353|38117149|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
16973287|NCT01185353|38117150|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16973288|NCT01185353|38117151|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16973289|NCT01185353|38117152|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16973290|NCT01185353|38117143|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973291|NCT01185353|38117144|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973292|NCT01185353|38117145|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973293|NCT01185353|38117146|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973294|NCT01185353|38117147|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973295|NCT01185353|38117148|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973296|NCT01185353|38117149|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
16973297|NCT01185353|38117150|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973298|NCT01185353|38117151|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973299|NCT01185353|38117152|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16973300|NCT01185353|38117143|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16973301|NCT01185353|38117144|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16973302|NCT01185353|38117145|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16973303|NCT01185353|38117146|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16973304|NCT01185353|38117147|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16973305|NCT01185353|38117148|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16973306|NCT01185353|38117149|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16973307|NCT01185353|38117150|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
16973308|NCT01185353|38117151|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
16973309|NCT01185353|38117152|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
16973310|NCT01185353|38117143|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16973311|NCT01185353|38117144|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16973312|NCT01185353|38117145|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16973313|NCT01185353|38117146|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16973314|NCT01185353|38117147|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16973315|NCT01185353|38117148|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16780082|NCT01595529|37719146|FG001|Overall Study|Physician Decision|0|||
16973316|NCT01185353|38117149|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16973317|NCT01185353|38117150|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
16973318|NCT01185353|38117151|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
16973319|NCT01185353|38117152|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
16973320|NCT01185353|38117143|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16973321|NCT01185353|38117144|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16973322|NCT01185353|38117145|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16973323|NCT01185353|38117146|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16973324|NCT01185353|38117147|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16973325|NCT01185353|38117148|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16973326|NCT01185353|38117149|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16973327|NCT01185353|38117150|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
16973328|NCT01185353|38117151|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
16973329|NCT01185353|38117152|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
16973330|NCT01185353|38117143|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973331|NCT01185353|38117144|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973332|NCT01185353|38117145|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973333|NCT01185353|38117146|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973334|NCT01185353|38117147|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973335|NCT01185353|38117148|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973336|NCT01185353|38117149|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973337|NCT01185353|38117150|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973338|NCT01185353|38117151|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
16973339|NCT01185353|38117152|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16973340|NCT01185353|38117143|FG000|Part C (Weeks 24 Through 76)|Death|0|||
16973341|NCT01185353|38117144|FG001|Part C (Weeks 24 Through 76)|Death|0|||
16973342|NCT01185353|38117145|FG002|Part C (Weeks 24 Through 76)|Death|0|||
16973343|NCT01185353|38117146|FG003|Part C (Weeks 24 Through 76)|Death|0|||
16973344|NCT01185353|38117147|FG004|Part C (Weeks 24 Through 76)|Death|0|||
16973345|NCT01185353|38117148|FG005|Part C (Weeks 24 Through 76)|Death|0|||
16973346|NCT01185353|38117149|FG006|Part C (Weeks 24 Through 76)|Death|0|||
16973347|NCT01185353|38117150|FG007|Part C (Weeks 24 Through 76)|Death|0|||
16973348|NCT01185353|38117151|FG008|Part C (Weeks 24 Through 76)|Death|0|||
16973349|NCT01185353|38117152|FG009|Part C (Weeks 24 Through 76)|Death|1|||
16973350|NCT01185353|38117143|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973351|NCT01185353|38117144|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973352|NCT01185353|38117145|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973353|NCT01185353|38117146|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973354|NCT01185353|38117147|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973355|NCT01185353|38117148|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973356|NCT01185353|38117149|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973357|NCT01185353|38117150|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973358|NCT01185353|38117151|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16973359|NCT01185353|38117152|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
16973360|NCT01185353|38117143|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973361|NCT01185353|38117144|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973362|NCT01185353|38117145|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973363|NCT01185353|38117146|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973364|NCT01185353|38117147|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973365|NCT01185353|38117148|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973366|NCT01185353|38117149|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973367|NCT01185353|38117150|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973368|NCT01185353|38117151|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16973369|NCT01185353|38117152|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
16973370|NCT01185353|38117143|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973371|NCT01185353|38117144|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973372|NCT01185353|38117145|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973373|NCT01185353|38117146|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973374|NCT01185353|38117147|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973375|NCT01185353|38117148|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973376|NCT01185353|38117149|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973377|NCT01185353|38117150|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973378|NCT01185353|38117151|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
16973379|NCT01185353|38117152|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
16973380|NCT01185353|38117143|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16973381|NCT01185353|38117144|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16973382|NCT01185353|38117145|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16973383|NCT01185353|38117146|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16973384|NCT01185353|38117147|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16973385|NCT01185353|38117148|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16973386|NCT01185353|38117149|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16973387|NCT01185353|38117150|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
16973388|NCT01185353|38117151|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
16973389|NCT01185353|38117152|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16973390|NCT01185353|38117143|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16973391|NCT01185353|38117144|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16973392|NCT01185353|38117145|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16973393|NCT01185353|38117146|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16973394|NCT01185353|38117147|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16973395|NCT01185353|38117148|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16973396|NCT01185353|38117149|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16973397|NCT01185353|38117150|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
16973398|NCT01185353|38117151|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
16973399|NCT01185353|38117152|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
16973400|NCT01185353|38117143|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16973401|NCT01185353|38117144|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16973402|NCT01185353|38117145|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16973403|NCT01185353|38117146|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16973404|NCT01185353|38117147|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16973405|NCT01185353|38117148|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16973406|NCT01185353|38117149|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16973407|NCT01185353|38117150|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
16973408|NCT01185353|38117151|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
16973409|NCT01185353|38117152|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16973410|NCT00875563|38117191|FG000|Overall Study|Death|4|||
16973411|NCT00875563|38117191|FG000|Overall Study|Withdrawal by Subject|7|||
16973412|NCT00875563|38117191|FG000|Overall Study|No long-term (3-5 year) consent|6|||
16973413|NCT00875563|38117191|FG000|Overall Study|Still be eligible for follow-up|7|||
16973414|NCT01155869|38117197|FG000|Overall Study|Lost to Follow-up|3|||
16973415|NCT01155869|38117198|FG001|Overall Study|Lost to Follow-up|1|||
16973416|NCT01098240|38117204|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
16973417|NCT01098240|38117205|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
16973418|NCT01098240|38117206|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
16973419|NCT01098240|38117204|FG000|Open-Label Phase|Protocol Violation|4|||
16973420|NCT01098240|38117205|FG001|Open-Label Phase|Protocol Violation|0|||
16973421|NCT01098240|38117206|FG002|Open-Label Phase|Protocol Violation|0|||
16973422|NCT01098240|38117204|FG000|Open-Label Phase|Lost to Follow-up|13|||
16973423|NCT01098240|38117205|FG001|Open-Label Phase|Lost to Follow-up|0|||
16973424|NCT01098240|38117206|FG002|Open-Label Phase|Lost to Follow-up|0|||
16973425|NCT01098240|38117204|FG000|Open-Label Phase|Other|19|||
16973426|NCT01098240|38117205|FG001|Open-Label Phase|Other|0|||
16973427|NCT01098240|38117206|FG002|Open-Label Phase|Other|0|||
16973428|NCT01098240|38117204|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
16973429|NCT01098240|38117205|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
16973430|NCT01098240|38117206|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
16973431|NCT01098240|38117204|FG000|Open-Label Phase|Pregnancy|1|||
16973432|NCT01098240|38117205|FG001|Open-Label Phase|Pregnancy|0|||
16973433|NCT01098240|38117206|FG002|Open-Label Phase|Pregnancy|0|||
16973434|NCT01098240|38117204|FG000|Open-Label Phase|Withdrawal by Subject|9|||
16973435|NCT01098240|38117205|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16973436|NCT01098240|38117206|FG002|Open-Label Phase|Withdrawal by Subject|0|||
16973437|NCT01098240|38117204|FG000|Open-Label Phase|Adverse Event|12|||
16973438|NCT01098240|38117205|FG001|Open-Label Phase|Adverse Event|0|||
16973439|NCT01098240|38117206|FG002|Open-Label Phase|Adverse Event|0|||
16973440|NCT01098240|38117204|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
16973441|NCT01098240|38117205|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
16868012|NCT01536145|37841043|FG010|Overall Study|Progressive disease|3|||
16973442|NCT01098240|38117206|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
16973443|NCT01098240|38117204|FG000|Double-Blind Phase|Protocol Violation|0|||
16973444|NCT01098240|38117205|FG001|Double-Blind Phase|Protocol Violation|2|||
16973445|NCT01098240|38117206|FG002|Double-Blind Phase|Protocol Violation|4|||
16973446|NCT01098240|38117204|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16973447|NCT01098240|38117205|FG001|Double-Blind Phase|Lost to Follow-up|2|||
16973448|NCT01098240|38117206|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16973449|NCT01098240|38117204|FG000|Double-Blind Phase|Other|0|||
16973450|NCT01098240|38117205|FG001|Double-Blind Phase|Other|2|||
16973451|NCT01098240|38117206|FG002|Double-Blind Phase|Other|2|||
16973452|NCT01098240|38117204|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
16973453|NCT01098240|38117205|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
16973454|NCT01098240|38117206|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
16973455|NCT01098240|38117204|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
16973456|NCT01098240|38117205|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
16973457|NCT01098240|38117206|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
16973458|NCT01098240|38117204|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16973459|NCT01098240|38117205|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
16973460|NCT01098240|38117206|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
16973461|NCT01098240|38117204|FG000|Double-Blind Phase|Adverse Event|0|||
16973462|NCT01098240|38117205|FG001|Double-Blind Phase|Adverse Event|3|||
16973463|NCT01098240|38117206|FG002|Double-Blind Phase|Adverse Event|3|||
16973464|NCT01098162|38117213|FG000|Overall Study|Adverse Event|37|||
16973465|NCT01098162|38117213|FG000|Overall Study|Lack of Efficacy|4|||
16973466|NCT01098162|38117213|FG000|Overall Study|Wish of Patient|7|||
16973467|NCT01098162|38117213|FG000|Overall Study|Lost to Follow-up|9|||
16973468|NCT01098162|38117213|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
16973469|NCT01098162|38117213|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
16973470|NCT01098162|38117213|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
16973471|NCT01098162|38117213|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
16973472|NCT01098162|38117213|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
16973473|NCT01098162|38117213|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
16973474|NCT01098162|38117213|FG000|Overall Study|Other Reason|1|||
16973475|NCT01098162|38117213|FG000|Overall Study|Reason Unknown|26|||
16973476|NCT01097694|38117219|FG000|Overall Study|Adverse Event|5|||
16973477|NCT01097694|38117220|FG001|Overall Study|Adverse Event|0|||
16973478|NCT01097694|38117219|FG000|Overall Study|Lost to Follow-up|0|||
16973479|NCT01097694|38117220|FG001|Overall Study|Lost to Follow-up|3|||
16973480|NCT01097694|38117219|FG000|Overall Study|Withdrawal by Subject|3|||
16973481|NCT01097694|38117220|FG001|Overall Study|Withdrawal by Subject|1|||
16973482|NCT01102140|38117228|FG000|Overall Study|Lost to Follow-up|1|||
16973483|NCT01102140|38117229|FG001|Overall Study|Lost to Follow-up|0|||
16973484|NCT01102140|38117228|FG000|Overall Study|Investigator terminated study|2|||
16973485|NCT01102140|38117229|FG001|Overall Study|Investigator terminated study|2|||
16973486|NCT00874549|38117241|FG000|Overall Study|Adverse Event|0|||
16973487|NCT00874549|38117242|FG001|Overall Study|Adverse Event|0|||
16973488|NCT00874549|38117243|FG002|Overall Study|Adverse Event|1|||
16973489|NCT00874549|38117244|FG003|Overall Study|Adverse Event|0|||
16973490|NCT00874549|38117241|FG000|Overall Study|Protocol Violation|1|||
16973491|NCT00874549|38117242|FG001|Overall Study|Protocol Violation|0|||
16973492|NCT00874549|38117243|FG002|Overall Study|Protocol Violation|2|||
16973493|NCT00874549|38117244|FG003|Overall Study|Protocol Violation|1|||
16973494|NCT00874549|38117241|FG000|Overall Study|Lost to Follow-up|0|||
16973495|NCT00874549|38117242|FG001|Overall Study|Lost to Follow-up|0|||
16973496|NCT00874549|38117243|FG002|Overall Study|Lost to Follow-up|1|||
16973497|NCT00874549|38117244|FG003|Overall Study|Lost to Follow-up|0|||
16973498|NCT00874549|38117241|FG000|Overall Study|Withdrawal by Subject|0|||
16973499|NCT00874549|38117242|FG001|Overall Study|Withdrawal by Subject|1|||
16973500|NCT00874549|38117243|FG002|Overall Study|Withdrawal by Subject|0|||
16973501|NCT00874549|38117244|FG003|Overall Study|Withdrawal by Subject|1|||
16973502|NCT01155479|38117259|FG000|Part I|Adverse Event|13|||
16973503|NCT01155479|38117260|FG001|Part I|Adverse Event|8|||
16973504|NCT01155479|38117261|FG002|Part I|Adverse Event|18|||
16973505|NCT01155479|38117262|FG003|Part I|Adverse Event|7|||
16973506|NCT01155479|38117263|FG004|Part I|Adverse Event|6|||
16973507|NCT01155479|38117259|FG000|Part I|Administrative|2|||
16973508|NCT01155479|38117260|FG001|Part I|Administrative|2|||
16973509|NCT01155479|38117261|FG002|Part I|Administrative|2|||
16973510|NCT01155479|38117262|FG003|Part I|Administrative|0|||
16973511|NCT01155479|38117263|FG004|Part I|Administrative|0|||
16973512|NCT01155479|38117259|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
16973513|NCT01155479|38117260|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
16973514|NCT01155479|38117261|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
16973515|NCT01155479|38117262|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
16973516|NCT01155479|38117263|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
16973517|NCT01155479|38117259|FG000|Part I|Withdrawal by Subject|11|||
16973518|NCT01155479|38117260|FG001|Part I|Withdrawal by Subject|13|||
16973519|NCT01155479|38117261|FG002|Part I|Withdrawal by Subject|8|||
16973520|NCT01155479|38117262|FG003|Part I|Withdrawal by Subject|8|||
16973521|NCT01155479|38117263|FG004|Part I|Withdrawal by Subject|9|||
16973522|NCT01155479|38117259|FG000|Part I|Lost to Follow-up|0|||
16973523|NCT01155479|38117260|FG001|Part I|Lost to Follow-up|0|||
16973524|NCT01155479|38117261|FG002|Part I|Lost to Follow-up|1|||
16973525|NCT01155479|38117262|FG003|Part I|Lost to Follow-up|1|||
16973526|NCT01155479|38117263|FG004|Part I|Lost to Follow-up|0|||
16973527|NCT01155479|38117259|FG000|Part I|Treatment Failure|3|||
16973528|NCT01155479|38117260|FG001|Part I|Treatment Failure|0|||
16973529|NCT01155479|38117261|FG002|Part I|Treatment Failure|3|||
16973530|NCT01155479|38117262|FG003|Part I|Treatment Failure|1|||
16973531|NCT01155479|38117263|FG004|Part I|Treatment Failure|2|||
16973532|NCT01155479|38117259|FG000|Part I|Did Not Receive Treatment|4|||
16973533|NCT01155479|38117260|FG001|Part I|Did Not Receive Treatment|2|||
16973534|NCT01155479|38117261|FG002|Part I|Did Not Receive Treatment|2|||
16973535|NCT01155479|38117262|FG003|Part I|Did Not Receive Treatment|6|||
16973536|NCT01155479|38117263|FG004|Part I|Did Not Receive Treatment|1|||
16973537|NCT01155479|38117259|FG000|Part I|Non-Compliance with Protocol|2|||
16973538|NCT01155479|38117260|FG001|Part I|Non-Compliance with Protocol|1|||
16973539|NCT01155479|38117261|FG002|Part I|Non-Compliance with Protocol|3|||
16973540|NCT01155479|38117262|FG003|Part I|Non-Compliance with Protocol|3|||
16973541|NCT01155479|38117263|FG004|Part I|Non-Compliance with Protocol|2|||
16973542|NCT01155479|38117259|FG000|Part II|Adverse Event|7|||
16973543|NCT01155479|38117260|FG001|Part II|Adverse Event|6|||
16973544|NCT01155479|38117261|FG002|Part II|Adverse Event|8|||
16973545|NCT01155479|38117262|FG003|Part II|Adverse Event|3|||
16973546|NCT01155479|38117263|FG004|Part II|Adverse Event|4|||
16973547|NCT01155479|38117259|FG000|Part II|Administrative|43|||
16973548|NCT01155479|38117260|FG001|Part II|Administrative|49|||
16973549|NCT01155479|38117261|FG002|Part II|Administrative|36|||
16973550|NCT01155479|38117262|FG003|Part II|Administrative|38|||
16973551|NCT01155479|38117263|FG004|Part II|Administrative|46|||
16973552|NCT01155479|38117259|FG000|Part II|Withdrawal by Subject|8|||
16973553|NCT01155479|38117260|FG001|Part II|Withdrawal by Subject|4|||
16973554|NCT01155479|38117261|FG002|Part II|Withdrawal by Subject|12|||
16973555|NCT01155479|38117262|FG003|Part II|Withdrawal by Subject|7|||
16973556|NCT01155479|38117263|FG004|Part II|Withdrawal by Subject|3|||
16973557|NCT01155479|38117259|FG000|Part II|Lost to Follow-up|1|||
16973558|NCT01155479|38117260|FG001|Part II|Lost to Follow-up|0|||
16973559|NCT01155479|38117261|FG002|Part II|Lost to Follow-up|0|||
16973560|NCT01155479|38117262|FG003|Part II|Lost to Follow-up|0|||
16973561|NCT01155479|38117263|FG004|Part II|Lost to Follow-up|1|||
16973562|NCT01155479|38117259|FG000|Part II|Treatment Failure|0|||
16973563|NCT01155479|38117260|FG001|Part II|Treatment Failure|1|||
16973564|NCT01155479|38117261|FG002|Part II|Treatment Failure|2|||
16973565|NCT01155479|38117262|FG003|Part II|Treatment Failure|0|||
16973566|NCT01155479|38117263|FG004|Part II|Treatment Failure|1|||
16973567|NCT01155479|38117259|FG000|Part II|Non-Compliance with Protocol|0|||
16973568|NCT01155479|38117260|FG001|Part II|Non-Compliance with Protocol|1|||
16973569|NCT01155479|38117261|FG002|Part II|Non-Compliance with Protocol|0|||
16973570|NCT01155479|38117262|FG003|Part II|Non-Compliance with Protocol|2|||
16973571|NCT01155479|38117263|FG004|Part II|Non-Compliance with Protocol|0|||
16973572|NCT01155323|38117291|FG000|First Intervention|exclusion criteria|1|||
16973573|NCT01155323|38117292|FG001|First Intervention|exclusion criteria|1|||
16973574|NCT01155323|38117291|FG000|Second Intervention|Lost to Follow-up|1|||
16973575|NCT01155323|38117292|FG001|Second Intervention|Lost to Follow-up|1|||
16973576|NCT01155167|38117300|FG000|Overall Study|Insufficient ultrasound data|2|||
16973577|NCT01155167|38117301|FG001|Overall Study|Insufficient ultrasound data|0|||
16973578|NCT01155167|38117300|FG000|Overall Study|Access site changed to femoral artery|1|||
16973579|NCT01155167|38117301|FG001|Overall Study|Access site changed to femoral artery|0|||
16973580|NCT01106586|38117309|FG000|Overall Study|Adverse Event|9|||
16973581|NCT01106586|38117310|FG001|Overall Study|Adverse Event|15|||
16973582|NCT01106586|38117309|FG000|Overall Study|Death|1|||
16973583|NCT01106586|38117310|FG001|Overall Study|Death|3|||
16973584|NCT01106586|38117309|FG000|Overall Study|Pregnancy|2|||
16973585|NCT01106586|38117310|FG001|Overall Study|Pregnancy|2|||
16973586|NCT01106586|38117309|FG000|Overall Study|Lack of Efficacy|1|||
16973587|NCT01106586|38117310|FG001|Overall Study|Lack of Efficacy|0|||
16973588|NCT01106586|38117309|FG000|Overall Study|Investigator's Discretion|5|||
16973589|NCT01106586|38117310|FG001|Overall Study|Investigator's Discretion|8|||
16973590|NCT01106586|38117309|FG000|Overall Study|Withdrew Consent|18|||
16973591|NCT01106586|38117310|FG001|Overall Study|Withdrew Consent|30|||
16973592|NCT01106586|38117309|FG000|Overall Study|Lost to Follow-up|24|||
16973593|NCT01106586|38117310|FG001|Overall Study|Lost to Follow-up|20|||
16973594|NCT01106586|38117309|FG000|Overall Study|Participant Noncompliance|12|||
16973595|NCT01106586|38117310|FG001|Overall Study|Participant Noncompliance|10|||
16973596|NCT01106586|38117309|FG000|Overall Study|Protocol Violation|1|||
16973597|NCT01106586|38117310|FG001|Overall Study|Protocol Violation|0|||
16973598|NCT01106586|38117309|FG000|Overall Study|Participant Transferred to Another Study|212|||
16973599|NCT01106586|38117310|FG001|Overall Study|Participant Transferred to Another Study|197|||
16973600|NCT01155011|38117318|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
16973601|NCT01155011|38117319|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
16973602|NCT01155011|38117318|FG000|Baseline to 6 Months|investigator decision, moved|4|||
16973603|NCT01155011|38117319|FG001|Baseline to 6 Months|investigator decision, moved|5|||
16973604|NCT01155011|38117318|FG000|Baseline to 6 Months|Death|0|||
16973605|NCT01155011|38117319|FG001|Baseline to 6 Months|Death|1|||
16973606|NCT01155011|38117318|FG000|6 to 12 Months|Withdrawal by Subject|8|||
16973607|NCT01155011|38117319|FG001|6 to 12 Months|Withdrawal by Subject|5|||
16973608|NCT01155011|38117318|FG000|6 to 12 Months|Death|1|||
16973609|NCT01155011|38117319|FG001|6 to 12 Months|Death|5|||
16973610|NCT01106430|38117331|FG000|Overall Study|Adverse Event|8|||
16973611|NCT01106430|38117332|FG001|Overall Study|Adverse Event|10|||
16973612|NCT01106430|38117331|FG000|Overall Study|Lack of Efficacy|2|||
16973613|NCT01106430|38117332|FG001|Overall Study|Lack of Efficacy|13|||
16973614|NCT01106430|38117331|FG000|Overall Study|Lost to Follow-up|5|||
16973615|NCT01106430|38117332|FG001|Overall Study|Lost to Follow-up|1|||
16973616|NCT01106430|38117331|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
16973617|NCT01106430|38117332|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
16973618|NCT01106430|38117331|FG000|Overall Study|Moved Out Of State|0|||
16973619|NCT01106430|38117332|FG001|Overall Study|Moved Out Of State|1|||
16973620|NCT01106430|38117331|FG000|Overall Study|Refused To Take Medication|0|||
16973621|NCT01106430|38117332|FG001|Overall Study|Refused To Take Medication|1|||
16973622|NCT01106430|38117331|FG000|Overall Study|Noncompliance|0|||
16973623|NCT01106430|38117332|FG001|Overall Study|Noncompliance|1|||
16973624|NCT01106430|38117331|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
16973625|NCT01106430|38117332|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
16973626|NCT01106430|38117331|FG000|Overall Study|Previous Use Of Marijuana|1|||
16973627|NCT01106430|38117332|FG001|Overall Study|Previous Use Of Marijuana|0|||
16973628|NCT01106430|38117331|FG000|Overall Study|Protocol Violation|7|||
16973629|NCT01106430|38117332|FG001|Overall Study|Protocol Violation|2|||
16973630|NCT01106430|38117331|FG000|Overall Study|Withdrawal by Subject|8|||
16973631|NCT01106430|38117332|FG001|Overall Study|Withdrawal by Subject|4|||
16973632|NCT01154231|38117338|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
16973633|NCT01154231|38117338|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
16973634|NCT01154153|38117344|FG000|Overall Study|Poor compliance to protocol|2|||
16973635|NCT01154153|38117345|FG001|Overall Study|Poor compliance to protocol|0|||
16973636|NCT01154153|38117344|FG000|Overall Study|Unable to use labs|2|||
16973637|NCT01154153|38117345|FG001|Overall Study|Unable to use labs|3|||
16973638|NCT01154153|38117344|FG000|Overall Study|Withdrew consent|1|||
16973639|NCT01154153|38117345|FG001|Overall Study|Withdrew consent|0|||
16973640|NCT00874237|38117351|FG000|Overall Study|Physician Decision|0|||
16973641|NCT00874237|38117352|FG001|Overall Study|Physician Decision|1|||
16973642|NCT00874237|38117353|FG002|Overall Study|Physician Decision|0|||
16973643|NCT00874237|38117354|FG003|Overall Study|Physician Decision|0|||
16973644|NCT00874237|38117355|FG004|Overall Study|Physician Decision|0|||
16973645|NCT00874237|38117356|FG005|Overall Study|Physician Decision|0|||
16973646|NCT00874237|38117351|FG000|Overall Study|Withdrawal by Subject|0|||
16973647|NCT00874237|38117352|FG001|Overall Study|Withdrawal by Subject|0|||
16973648|NCT00874237|38117353|FG002|Overall Study|Withdrawal by Subject|1|||
16973649|NCT00874237|38117354|FG003|Overall Study|Withdrawal by Subject|0|||
16973650|NCT00874237|38117355|FG004|Overall Study|Withdrawal by Subject|0|||
16973651|NCT00874237|38117356|FG005|Overall Study|Withdrawal by Subject|0|||
16973652|NCT01153841|38117368|FG000|Overall Study|Adverse Event|1|||
16973653|NCT01153841|38117369|FG001|Overall Study|Adverse Event|0|||
16973654|NCT01153841|38117368|FG000|Overall Study|Withdrawal by Subject|1|||
16973655|NCT01153841|38117369|FG001|Overall Study|Withdrawal by Subject|0|||
16973656|NCT01153841|38117368|FG000|Overall Study|Protocol Violation|2|||
16973657|NCT01153841|38117369|FG001|Overall Study|Protocol Violation|0|||
16973658|NCT01153841|38117368|FG000|Overall Study|Lost to Follow-up|2|||
16973659|NCT01153841|38117369|FG001|Overall Study|Lost to Follow-up|0|||
16973660|NCT01153763|38117375|FG000|Overall Study|Study Closed|16|||
16973661|NCT01153763|38117375|FG000|Overall Study|Lost to Follow-up|1|||
16973662|NCT01153763|38117375|FG000|Overall Study|Physician Decision|2|||
16973663|NCT01153763|38117375|FG000|Overall Study|Withdrawal by Subject|2|||
16973664|NCT00871741|38117381|FG000|Overall Study|Premature study termination|9|||
16973665|NCT00871741|38117382|FG001|Overall Study|Premature study termination|7|||
16973666|NCT01152437|38117391|FG000|Overall Study|Other Adverse Event|8|||
16973667|NCT01152437|38117392|FG001|Overall Study|Other Adverse Event|1|||
16973668|NCT01152437|38117393|FG002|Overall Study|Other Adverse Event|7|||
16973669|NCT01152437|38117391|FG000|Overall Study|Not treated|0|||
16973670|NCT01152437|38117392|FG001|Overall Study|Not treated|1|||
16973671|NCT01152437|38117393|FG002|Overall Study|Not treated|2|||
16973672|NCT01152437|38117391|FG000|Overall Study|Progressive disease|27|||
16973673|NCT01152437|38117392|FG001|Overall Study|Progressive disease|13|||
16973674|NCT01152437|38117393|FG002|Overall Study|Progressive disease|32|||
16973675|NCT01152437|38117391|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
16973676|NCT01152437|38117392|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
16973677|NCT01152437|38117393|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
16973678|NCT01151579|38117405|FG000|Overall Study|Physician Decision|3|||
16973679|NCT01151579|38117406|FG001|Overall Study|Physician Decision|1|||
16973680|NCT01151579|38117405|FG000|Overall Study|Withdrawal by Subject|3|||
16973681|NCT01151579|38117406|FG001|Overall Study|Withdrawal by Subject|2|||
16973682|NCT01151579|38117405|FG000|Overall Study|Not meet inclusion criteria|6|||
16973683|NCT01151579|38117406|FG001|Overall Study|Not meet inclusion criteria|4|||
16973684|NCT01097616|38117415|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
16973685|NCT01097616|38117416|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
16973686|NCT01097616|38117417|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
16973687|NCT01097616|38117418|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16973688|NCT01097616|38117419|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16973689|NCT01097616|38117420|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16973690|NCT01097616|38117421|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16973691|NCT01097616|38117422|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16973692|NCT01097616|38117415|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
16973693|NCT01097616|38117416|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
16973694|NCT01097616|38117417|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
16973695|NCT01097616|38117418|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16973696|NCT01097616|38117419|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16973697|NCT01097616|38117420|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16973698|NCT01097616|38117421|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16973699|NCT01097616|38117422|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16973700|NCT01097616|38117415|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
16973701|NCT01097616|38117416|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
16973702|NCT01097616|38117417|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
16973703|NCT01097616|38117418|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16973704|NCT01097616|38117419|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16973705|NCT01097616|38117420|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16973706|NCT01097616|38117421|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16973707|NCT01097616|38117422|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16973708|NCT01097616|38117415|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
16973709|NCT01097616|38117416|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
16973710|NCT01097616|38117417|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16973711|NCT01097616|38117418|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16973712|NCT01097616|38117419|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16973713|NCT01097616|38117420|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16973714|NCT01097616|38117421|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16973715|NCT01097616|38117422|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16973716|NCT01097616|38117415|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
16973717|NCT01097616|38117416|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
16973718|NCT01097616|38117417|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
16973719|NCT01097616|38117418|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16973720|NCT01097616|38117419|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16973721|NCT01097616|38117420|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16973722|NCT01097616|38117421|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16973723|NCT01097616|38117422|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16973724|NCT01097616|38117415|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
16973725|NCT01097616|38117416|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
16973726|NCT01097616|38117417|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16973727|NCT01097616|38117418|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16973728|NCT01097616|38117419|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16973729|NCT01097616|38117420|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16973730|NCT01097616|38117421|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16973731|NCT01097616|38117422|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16973732|NCT01097616|38117415|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
16973733|NCT01097616|38117416|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
16973734|NCT01097616|38117417|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16973735|NCT01097616|38117418|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16973736|NCT01097616|38117419|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16973737|NCT01097616|38117420|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16973738|NCT01097616|38117421|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16973739|NCT01097616|38117422|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16973740|NCT01097616|38117415|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16973741|NCT01097616|38117416|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16973742|NCT01097616|38117417|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
16973743|NCT01097616|38117418|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16973744|NCT01097616|38117419|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16973745|NCT01097616|38117420|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16973746|NCT01097616|38117421|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16973747|NCT01097616|38117422|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16973748|NCT01097616|38117415|FG000|Optional DB EXT Phase|Adverse Event|0|||
16973749|NCT01097616|38117416|FG001|Optional DB EXT Phase|Adverse Event|7|||
16973750|NCT01097616|38117417|FG002|Optional DB EXT Phase|Adverse Event|2|||
16973751|NCT01097616|38117418|FG003|Optional DB EXT Phase|Adverse Event|0|||
16973752|NCT01097616|38117419|FG004|Optional DB EXT Phase|Adverse Event|0|||
16973753|NCT01097616|38117420|FG005|Optional DB EXT Phase|Adverse Event|0|||
16973754|NCT01097616|38117421|FG006|Optional DB EXT Phase|Adverse Event|0|||
16973755|NCT01097616|38117422|FG007|Optional DB EXT Phase|Adverse Event|0|||
16973756|NCT01097616|38117415|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
16973757|NCT01097616|38117416|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
16973758|NCT01097616|38117417|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
16973759|NCT01097616|38117418|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
16973760|NCT01097616|38117419|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
16973761|NCT01097616|38117420|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
16973762|NCT01097616|38117421|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
16973763|NCT01097616|38117422|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
16973764|NCT01097616|38117415|FG000|Optional DB EXT Phase|Protocol Violation|0|||
16973765|NCT01097616|38117416|FG001|Optional DB EXT Phase|Protocol Violation|2|||
16973766|NCT01097616|38117417|FG002|Optional DB EXT Phase|Protocol Violation|3|||
16973767|NCT01097616|38117418|FG003|Optional DB EXT Phase|Protocol Violation|0|||
16973768|NCT01097616|38117419|FG004|Optional DB EXT Phase|Protocol Violation|0|||
16973769|NCT01097616|38117420|FG005|Optional DB EXT Phase|Protocol Violation|0|||
16973770|NCT01097616|38117421|FG006|Optional DB EXT Phase|Protocol Violation|0|||
16973771|NCT01097616|38117422|FG007|Optional DB EXT Phase|Protocol Violation|0|||
16973772|NCT01097616|38117415|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
16973773|NCT01097616|38117416|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
16973774|NCT01097616|38117417|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
16973775|NCT01097616|38117418|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
16973776|NCT01097616|38117419|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
16973777|NCT01097616|38117420|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
16973778|NCT01097616|38117421|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
16973779|NCT01097616|38117422|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
16973780|NCT01097616|38117415|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
16973781|NCT01097616|38117416|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
16973782|NCT01097616|38117417|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
16973783|NCT01097616|38117418|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
16973784|NCT01097616|38117419|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
16973785|NCT01097616|38117420|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
16973786|NCT01097616|38117421|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
16973787|NCT01097616|38117422|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
16973788|NCT01097616|38117415|FG000|Optional DB EXT Phase|Physician Decision|1|||
16973789|NCT01097616|38117416|FG001|Optional DB EXT Phase|Physician Decision|0|||
16973790|NCT01097616|38117417|FG002|Optional DB EXT Phase|Physician Decision|0|||
16973791|NCT01097616|38117418|FG003|Optional DB EXT Phase|Physician Decision|0|||
16973792|NCT01097616|38117419|FG004|Optional DB EXT Phase|Physician Decision|0|||
16973793|NCT01097616|38117420|FG005|Optional DB EXT Phase|Physician Decision|0|||
16973794|NCT01097616|38117421|FG006|Optional DB EXT Phase|Physician Decision|0|||
16973795|NCT01097616|38117422|FG007|Optional DB EXT Phase|Physician Decision|0|||
16973796|NCT01097616|38117415|FG000|DB RO Phase|Adverse Event|0|||
16973797|NCT01097616|38117416|FG001|DB RO Phase|Adverse Event|0|||
16973798|NCT01097616|38117417|FG002|DB RO Phase|Adverse Event|0|||
16973799|NCT01097616|38117418|FG003|DB RO Phase|Adverse Event|0|||
16973800|NCT01097616|38117419|FG004|DB RO Phase|Adverse Event|0|||
16973801|NCT01097616|38117420|FG005|DB RO Phase|Adverse Event|0|||
16973802|NCT01097616|38117421|FG006|DB RO Phase|Adverse Event|1|||
16973803|NCT01097616|38117422|FG007|DB RO Phase|Adverse Event|0|||
16973804|NCT01097616|38117415|FG000|DB RO Phase|Withdrawal by Subject|0|||
16973805|NCT01097616|38117416|FG001|DB RO Phase|Withdrawal by Subject|0|||
16973806|NCT01097616|38117417|FG002|DB RO Phase|Withdrawal by Subject|0|||
16973807|NCT01097616|38117418|FG003|DB RO Phase|Withdrawal by Subject|0|||
16973808|NCT01097616|38117419|FG004|DB RO Phase|Withdrawal by Subject|0|||
16973809|NCT01097616|38117420|FG005|DB RO Phase|Withdrawal by Subject|1|||
16973810|NCT01097616|38117421|FG006|DB RO Phase|Withdrawal by Subject|0|||
16973811|NCT01097616|38117422|FG007|DB RO Phase|Withdrawal by Subject|0|||
16973812|NCT01097616|38117415|FG000|DB RO Phase|Lost to Follow-up|0|||
16973813|NCT01097616|38117416|FG001|DB RO Phase|Lost to Follow-up|0|||
16973814|NCT01097616|38117417|FG002|DB RO Phase|Lost to Follow-up|0|||
16973815|NCT01097616|38117418|FG003|DB RO Phase|Lost to Follow-up|1|||
16973816|NCT01097616|38117419|FG004|DB RO Phase|Lost to Follow-up|1|||
16973817|NCT01097616|38117420|FG005|DB RO Phase|Lost to Follow-up|0|||
16973818|NCT01097616|38117421|FG006|DB RO Phase|Lost to Follow-up|0|||
16973819|NCT01097616|38117422|FG007|DB RO Phase|Lost to Follow-up|1|||
16973820|NCT01097616|38117415|FG000|DB RO Phase|Not Treated in RO|0|||
16973821|NCT01097616|38117416|FG001|DB RO Phase|Not Treated in RO|0|||
16973822|NCT01097616|38117417|FG002|DB RO Phase|Not Treated in RO|0|||
16973823|NCT01097616|38117418|FG003|DB RO Phase|Not Treated in RO|0|||
16973824|NCT01097616|38117419|FG004|DB RO Phase|Not Treated in RO|0|||
16973825|NCT01097616|38117420|FG005|DB RO Phase|Not Treated in RO|1|||
16973826|NCT01097616|38117421|FG006|DB RO Phase|Not Treated in RO|0|||
16973827|NCT01097616|38117422|FG007|DB RO Phase|Not Treated in RO|0|||
16973828|NCT00871429|38117448|FG000|Overall Study|Lost to Follow-up|6|||
16973829|NCT00871429|38117448|FG000|Overall Study|Withdrawal by Subject|17|||
16973830|NCT00871429|38117448|FG000|Overall Study|Questionnaire not completed|1|||
16973831|NCT01151423|38117458|FG000|Overall Study|Study terminated by Sponsor|9|||
16973832|NCT01151423|38117459|FG001|Overall Study|Study terminated by Sponsor|10|||
16973833|NCT01151423|38117458|FG000|Overall Study|Protocol Violation|0|||
16973834|NCT01151423|38117459|FG001|Overall Study|Protocol Violation|1|||
16973835|NCT01151423|38117458|FG000|Overall Study|Physician Decision|1|||
16973836|NCT01151423|38117459|FG001|Overall Study|Physician Decision|1|||
16973837|NCT01151423|38117458|FG000|Overall Study|Pregnancy|0|||
16973838|NCT01151423|38117459|FG001|Overall Study|Pregnancy|1|||
16973839|NCT01151423|38117458|FG000|Overall Study|Death|0|||
16973840|NCT01151423|38117459|FG001|Overall Study|Death|1|||
16973841|NCT01151423|38117458|FG000|Overall Study|Adverse Event|3|||
16973842|NCT01151423|38117459|FG001|Overall Study|Adverse Event|0|||
16973843|NCT01151423|38117458|FG000|Overall Study|Withdrawal by Subject|1|||
16973844|NCT01151423|38117459|FG001|Overall Study|Withdrawal by Subject|3|||
16973845|NCT01151423|38117458|FG000|Overall Study|Lost to Follow-up|1|||
16973846|NCT01151423|38117459|FG001|Overall Study|Lost to Follow-up|0|||
16973847|NCT01151423|38117458|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
16973848|NCT01151423|38117459|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
16973849|NCT01151423|38117458|FG000|Overall Study|Participated in other clinical trial|1|||
16973850|NCT01151423|38117459|FG001|Overall Study|Participated in other clinical trial|0|||
16973851|NCT01151345|38117465|FG000|First Intervention Period|Protocol Violation|0|||
16973852|NCT01151345|38117466|FG001|First Intervention Period|Protocol Violation|1|||
16973853|NCT00593827|38117474|FG000|Overall Study|On Active Treatment/Pending|0|||
16973854|NCT00593827|38117475|FG001|Overall Study|On Active Treatment/Pending|2|||
16973855|NCT01150097|38117484|FG000|Months 24 to 36 Post-transplantation|Death|2|||
16973856|NCT01150097|38117485|FG001|Months 24 to 36 Post-transplantation|Death|0|||
16973857|NCT01150097|38117486|FG002|Months 24 to 36 Post-transplantation|Death|0|||
16973858|NCT01150097|38117484|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
16973859|NCT01150097|38117485|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
16973860|NCT01150097|38117486|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
16973861|NCT01150097|38117484|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
16973862|NCT01150097|38117485|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
16973863|NCT01150097|38117486|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
16973864|NCT01150097|38117484|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
16973865|NCT01150097|38117485|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
16973866|NCT01150097|38117486|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
16973867|NCT01150097|38117484|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
16973868|NCT01150097|38117485|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
16973869|NCT01150097|38117486|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
16973870|NCT01150097|38117484|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
16973871|NCT01150097|38117485|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
16973872|NCT01150097|38117486|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
16973873|NCT01150097|38117484|FG000|Months 24 to 48 Post-transplantation|Death|2|||
16973874|NCT01150097|38117485|FG001|Months 24 to 48 Post-transplantation|Death|0|||
16973875|NCT01150097|38117486|FG002|Months 24 to 48 Post-transplantation|Death|0|||
16973876|NCT01149863|38117496|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
16973877|NCT01149473|38117502|FG000|First Intervention|Adverse Event|1|||
16973878|NCT01149473|38117503|FG001|First Intervention|Adverse Event|1|||
16973879|NCT01149473|38117502|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16973880|NCT01149473|38117503|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
16973881|NCT00872989|38117511|FG000|Overall Study|Adverse Event|7|||
16973882|NCT00872989|38117512|FG001|Overall Study|Adverse Event|15|||
16973883|NCT00872989|38117511|FG000|Overall Study|Withdrawal by Subject|8|||
16973884|NCT00872989|38117512|FG001|Overall Study|Withdrawal by Subject|5|||
16973885|NCT00872989|38117511|FG000|Overall Study|Progression/relapse|47|||
16973886|NCT00872989|38117512|FG001|Overall Study|Progression/relapse|35|||
16973887|NCT00872989|38117511|FG000|Overall Study|Not protocol specified|3|||
16973888|NCT00872989|38117512|FG001|Overall Study|Not protocol specified|8|||
16973889|NCT01148771|38117526|FG000|Washout Period|Withdrawal by Subject|0|||
16973890|NCT01148771|38117527|FG001|Washout Period|Withdrawal by Subject|1|||
16973891|NCT01148693|38117539|FG000|Overall Study|Attempts for cannulation were failed|13|||
16973892|NCT01148693|38117540|FG001|Overall Study|Attempts for cannulation were failed|10|||
16973893|NCT00872599|38117546|FG000|Second Washout Period|Adverse Event|1|||
16973894|NCT00872599|38117547|FG001|Second Washout Period|Adverse Event|1|||
16973895|NCT01148537|38117556|FG000|Overall Study|Withdrawal by Subject|1|||
16973896|NCT01148537|38117557|FG001|Overall Study|Withdrawal by Subject|0|||
16973897|NCT01148537|38117558|FG002|Overall Study|Withdrawal by Subject|2|||
16973898|NCT01148537|38117556|FG000|Overall Study|Adverse Event|2|||
16973899|NCT01148537|38117557|FG001|Overall Study|Adverse Event|0|||
16973900|NCT01148537|38117558|FG002|Overall Study|Adverse Event|1|||
16973901|NCT01148459|38117569|FG000|Overall Study|Serious Adverse Event|5|||
16973902|NCT01148459|38117570|FG001|Overall Study|Serious Adverse Event|4|||
16973903|NCT01148459|38117569|FG000|Overall Study|Withdrawal by Subject|1|||
16973904|NCT01148459|38117570|FG001|Overall Study|Withdrawal by Subject|0|||
16973905|NCT01148459|38117569|FG000|Overall Study|Migrated/moved from study area|3|||
16973906|NCT01148459|38117570|FG001|Overall Study|Migrated/moved from study area|6|||
16973907|NCT01148459|38117569|FG000|Overall Study|Lost to Follow-up|2|||
16973908|NCT01148459|38117570|FG001|Overall Study|Lost to Follow-up|0|||
16973909|NCT01148459|38117569|FG000|Overall Study|Refusal|1|||
16973910|NCT01148459|38117570|FG001|Overall Study|Refusal|0|||
16973911|NCT01148459|38117569|FG000|Overall Study|Failure to comply with study procedures|0|||
16973912|NCT01148459|38117570|FG001|Overall Study|Failure to comply with study procedures|1|||
16973913|NCT00872521|38117579|FG000|Completed PAD Induction|Patient choice|0|||
16973914|NCT00872521|38117580|FG001|Completed PAD Induction|Patient choice|1|||
16973915|NCT00872521|38117581|FG002|Completed PAD Induction|Patient choice|0|||
16973916|NCT00872521|38117579|FG000|Completed PAD Induction|Disease progression|0|||
16973917|NCT00872521|38117580|FG001|Completed PAD Induction|Disease progression|2|||
16973918|NCT00872521|38117581|FG002|Completed PAD Induction|Disease progression|0|||
16973919|NCT00872521|38117579|FG000|Completed PAD Induction|Adverse Event|4|||
16973920|NCT00872521|38117580|FG001|Completed PAD Induction|Adverse Event|0|||
16973921|NCT00872521|38117581|FG002|Completed PAD Induction|Adverse Event|0|||
16973922|NCT00872521|38117579|FG000|Completed PAD Induction|Death|1|||
16973923|NCT00872521|38117580|FG001|Completed PAD Induction|Death|1|||
16973924|NCT00872521|38117581|FG002|Completed PAD Induction|Death|0|||
16973925|NCT00872521|38117579|FG000|Primary Endpoint Analysis|Other|1|||
16973926|NCT00872521|38117580|FG001|Primary Endpoint Analysis|Other|2|||
16973927|NCT00872521|38117581|FG002|Primary Endpoint Analysis|Other|0|||
16973928|NCT00872521|38117579|FG000|Primary Endpoint Analysis|Patient choice|0|||
16973929|NCT00872521|38117580|FG001|Primary Endpoint Analysis|Patient choice|1|||
16973930|NCT00872521|38117581|FG002|Primary Endpoint Analysis|Patient choice|0|||
16973931|NCT00872521|38117579|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
16973932|NCT00872521|38117580|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
16973933|NCT00872521|38117581|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
16973934|NCT00872521|38117579|FG000|Primary Endpoint Analysis|Patient response missing|0|||
16973935|NCT00872521|38117580|FG001|Primary Endpoint Analysis|Patient response missing|0|||
16973936|NCT00872521|38117581|FG002|Primary Endpoint Analysis|Patient response missing|1|||
16973937|NCT00872521|38117579|FG000|Completed 3-month Follow up|Other|0|||
16973938|NCT00872521|38117580|FG001|Completed 3-month Follow up|Other|2|||
16973939|NCT00872521|38117581|FG002|Completed 3-month Follow up|Other|0|||
16973940|NCT00872521|38117579|FG000|Completed 3-month Follow up|Physician Decision|0|||
16973941|NCT00872521|38117580|FG001|Completed 3-month Follow up|Physician Decision|1|||
16973942|NCT00872521|38117581|FG002|Completed 3-month Follow up|Physician Decision|0|||
16973943|NCT00872521|38117579|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
16973944|NCT00872521|38117580|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
16973945|NCT00872521|38117581|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
16973946|NCT01148225|38117600|FG000|Overall Study|Other|185|||
16973947|NCT01190891|38117609|FG000|Overall Study|Protocol Violation|1|||
16973948|NCT01190891|38117610|FG001|Overall Study|Protocol Violation|0|||
16973949|NCT01190891|38117609|FG000|Overall Study|Withdrawal by Subject|5|||
16973950|NCT01190891|38117610|FG001|Overall Study|Withdrawal by Subject|0|||
16973951|NCT00871975|38117616|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
16973952|NCT00871975|38117616|FG000|Overall Study|Catheters could not be inserted|1|||
16973953|NCT00871975|38117616|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
16973954|NCT00871975|38117616|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
16973955|NCT01190813|38117622|FG000|Overall Study|Lost to Follow-up|1|||
16973956|NCT01190813|38117623|FG001|Overall Study|Lost to Follow-up|2|||
16973957|NCT01190813|38117622|FG000|Overall Study|Withdrawal by Subject|2|||
16973958|NCT01190813|38117623|FG001|Overall Study|Withdrawal by Subject|1|||
16973959|NCT01190813|38117622|FG000|Overall Study|Refused study treatment after randomized|1|||
16973960|NCT01190813|38117623|FG001|Overall Study|Refused study treatment after randomized|0|||
16973961|NCT01190813|38117622|FG000|Overall Study|Adverse Event|0|||
16973962|NCT01190813|38117623|FG001|Overall Study|Adverse Event|1|||
16973963|NCT00870727|38117645|FG000|Overall Study|Lost to Follow-up|0|||
16973964|NCT00870727|38117646|FG001|Overall Study|Lost to Follow-up|1|||
16973965|NCT00870727|38117645|FG000|Overall Study|Lack of Efficacy|1|||
16973966|NCT00870727|38117646|FG001|Overall Study|Lack of Efficacy|3|||
16973967|NCT00870727|38117645|FG000|Overall Study|Adverse Event|0|||
16973968|NCT00870727|38117646|FG001|Overall Study|Adverse Event|1|||
16973969|NCT01147055|38117652|FG000|First Intervention Period|Lost to Follow-up|1|||
16973970|NCT01147055|38117653|FG001|First Intervention Period|Lost to Follow-up|0|||
16973971|NCT01146665|38117661|FG000|Overall Study|Withdrawal by Subject|10|||
16973972|NCT01146665|38117662|FG001|Overall Study|Withdrawal by Subject|16|||
16973973|NCT01145885|38117677|FG000|Overall Study|Progressive Disease|7|||
16973974|NCT01190267|38117689|FG000|Overall Study|Adverse Event|10|||
16973975|NCT01190267|38117690|FG001|Overall Study|Adverse Event|0|||
16973976|NCT01190267|38117689|FG000|Overall Study|Treatment Failure|8|||
16973977|NCT01190267|38117690|FG001|Overall Study|Treatment Failure|2|||
16973978|NCT01190267|38117689|FG000|Overall Study|Lost to Follow-up|2|||
16973979|NCT01190267|38117690|FG001|Overall Study|Lost to Follow-up|0|||
16973980|NCT01190267|38117689|FG000|Overall Study|Withdrawal by Subject|13|||
16973981|NCT01190267|38117690|FG001|Overall Study|Withdrawal by Subject|1|||
16973982|NCT01190267|38117689|FG000|Overall Study|Protocol Violation|8|||
16973983|NCT01190267|38117690|FG001|Overall Study|Protocol Violation|1|||
16973984|NCT00869089|38117696|FG000|Overall Study|Lost to Follow-up|1|||
16973985|NCT00869089|38117696|FG000|Overall Study|Withdrawal by Subject|1|||
16973986|NCT00869089|38117696|FG000|Overall Study|Screen Fail|1|||
16973987|NCT01190189|38117700|FG000|Overall Study|Lost to Follow-up|4|||
16973988|NCT01190189|38117700|FG000|Overall Study|Withdrawal by Subject|1|||
16973989|NCT01190189|38117700|FG000|Overall Study|Migrated/moved from study area|1|||
16973990|NCT00871117|38117706|FG000|Overall Study|Lost to Follow-up|5|||
16973991|NCT00871117|38117707|FG001|Overall Study|Lost to Follow-up|6|||
16973992|NCT00871117|38117706|FG000|Overall Study|Other|0|||
16973993|NCT00871117|38117707|FG001|Overall Study|Other|4|||
16973994|NCT01145495|38117714|FG000|Overall Study|Adverse Event|6|||
16973995|NCT01145495|38117714|FG000|Overall Study|Withdrawal by Subject|5|||
16973996|NCT01145495|38117714|FG000|Overall Study|Disease progression after respone|1|||
16973997|NCT00870103|38117718|FG000|Overall Study|Physician Decision|2|||
16973998|NCT00870103|38117718|FG000|Overall Study|Lost to Follow-up|2|||
16973999|NCT01145417|38117737|FG000|Overall Study|Death|1|||
16974000|NCT01145417|38117738|FG001|Overall Study|Death|0|||
16974001|NCT01145417|38117737|FG000|Overall Study|Lost to Follow-up|2|||
16974002|NCT01145417|38117738|FG001|Overall Study|Lost to Follow-up|1|||
16974003|NCT01145417|38117737|FG000|Overall Study|Withdrawal by Subject|1|||
16974004|NCT01145417|38117738|FG001|Overall Study|Withdrawal by Subject|2|||
16974005|NCT01145417|38117737|FG000|Overall Study|Pregnancy|1|||
16974006|NCT01145417|38117738|FG001|Overall Study|Pregnancy|0|||
16974007|NCT01145417|38117737|FG000|Overall Study|Adverse Event|0|||
16974008|NCT01145417|38117738|FG001|Overall Study|Adverse Event|1|||
16974009|NCT01145417|38117737|FG000|Overall Study|Study terminated by sponsor|35|||
16974010|NCT01145417|38117738|FG001|Overall Study|Study terminated by sponsor|43|||
16974011|NCT01145417|38117737|FG000|Overall Study|Other|1|||
16974012|NCT01145417|38117738|FG001|Overall Study|Other|0|||
16974013|NCT01144715|38117746|FG000|Overall Study|Lost to Follow-up|2|||
16974014|NCT01144715|38117747|FG001|Overall Study|Lost to Follow-up|1|||
16974015|NCT01144715|38117746|FG000|Overall Study|Withdrawal by Subject|2|||
16974016|NCT01144715|38117747|FG001|Overall Study|Withdrawal by Subject|1|||
16974017|NCT01144715|38117746|FG000|Overall Study|Adverse Event|0|||
16974018|NCT01144715|38117747|FG001|Overall Study|Adverse Event|1|||
16974019|NCT01189487|38117753|FG000|Overall Study|Lack of Efficacy|2|||
16974020|NCT01189487|38117753|FG000|Overall Study|Adverse Event|1|||
16974021|NCT01106352|38117762|FG000|Overall Study|Subjects untreated|0|||
16974022|NCT01106352|38117763|FG001|Overall Study|Subjects untreated|0|||
16974023|NCT01106352|38117764|FG002|Overall Study|Subjects untreated|0|||
16974024|NCT01106352|38117765|FG003|Overall Study|Subjects untreated|3|||
16974025|NCT01106352|38117766|FG004|Overall Study|Subjects untreated|4|||
16974026|NCT01106352|38117762|FG000|Overall Study|Sponsor Decision|1|||
16974027|NCT01106352|38117763|FG001|Overall Study|Sponsor Decision|0|||
16974028|NCT01106352|38117764|FG002|Overall Study|Sponsor Decision|0|||
16974029|NCT01106352|38117765|FG003|Overall Study|Sponsor Decision|0|||
16974030|NCT01106352|38117766|FG004|Overall Study|Sponsor Decision|0|||
16974031|NCT01106352|38117762|FG000|Overall Study|Too ill to come in for the visit|0|||
16974032|NCT01106352|38117763|FG001|Overall Study|Too ill to come in for the visit|0|||
16974033|NCT01106352|38117764|FG002|Overall Study|Too ill to come in for the visit|1|||
16974034|NCT01106352|38117765|FG003|Overall Study|Too ill to come in for the visit|0|||
16974035|NCT01106352|38117766|FG004|Overall Study|Too ill to come in for the visit|0|||
16974036|NCT01106352|38117762|FG000|Overall Study|Lost to Follow-up|0|||
16974037|NCT01106352|38117763|FG001|Overall Study|Lost to Follow-up|0|||
16974038|NCT01106352|38117764|FG002|Overall Study|Lost to Follow-up|0|||
16974039|NCT01106352|38117765|FG003|Overall Study|Lost to Follow-up|0|||
16974040|NCT01106352|38117766|FG004|Overall Study|Lost to Follow-up|1|||
16974041|NCT01106352|38117762|FG000|Overall Study|Death|0|||
16974042|NCT01106352|38117763|FG001|Overall Study|Death|0|||
16974043|NCT01106352|38117764|FG002|Overall Study|Death|1|||
16974044|NCT01106352|38117765|FG003|Overall Study|Death|3|||
16974045|NCT01106352|38117766|FG004|Overall Study|Death|1|||
16974046|NCT01106352|38117762|FG000|Overall Study|Disease progression|0|||
16974047|NCT01106352|38117763|FG001|Overall Study|Disease progression|0|||
16974048|NCT01106352|38117764|FG002|Overall Study|Disease progression|0|||
16974049|NCT01106352|38117765|FG003|Overall Study|Disease progression|1|||
16974050|NCT01106352|38117766|FG004|Overall Study|Disease progression|0|||
16974051|NCT01106352|38117762|FG000|Overall Study|Withdrawal by Subject|0|||
16974052|NCT01106352|38117763|FG001|Overall Study|Withdrawal by Subject|0|||
16974053|NCT01106352|38117764|FG002|Overall Study|Withdrawal by Subject|0|||
16974054|NCT01106352|38117765|FG003|Overall Study|Withdrawal by Subject|3|||
16974055|NCT01106352|38117766|FG004|Overall Study|Withdrawal by Subject|2|||
16974056|NCT01106352|38117762|FG000|Overall Study|Went on hospice|0|||
16974057|NCT01106352|38117763|FG001|Overall Study|Went on hospice|0|||
16974058|NCT01106352|38117764|FG002|Overall Study|Went on hospice|0|||
16974059|NCT01106352|38117765|FG003|Overall Study|Went on hospice|1|||
16974060|NCT01106352|38117766|FG004|Overall Study|Went on hospice|0|||
16974061|NCT01106352|38117762|FG000|Overall Study|Subject entered hospice|0|||
16974062|NCT01106352|38117763|FG001|Overall Study|Subject entered hospice|0|||
16974063|NCT01106352|38117764|FG002|Overall Study|Subject entered hospice|0|||
16974064|NCT01106352|38117765|FG003|Overall Study|Subject entered hospice|1|||
16974065|NCT01106352|38117766|FG004|Overall Study|Subject entered hospice|0|||
16974066|NCT01106352|38117762|FG000|Overall Study|Home hospice since July 2013|0|||
16974067|NCT01106352|38117763|FG001|Overall Study|Home hospice since July 2013|0|||
16974068|NCT01106352|38117764|FG002|Overall Study|Home hospice since July 2013|0|||
16974069|NCT01106352|38117765|FG003|Overall Study|Home hospice since July 2013|1|||
16974070|NCT01106352|38117766|FG004|Overall Study|Home hospice since July 2013|0|||
16974071|NCT01144403|38117782|FG000|Overall Study|Lost to Follow-up|3|||
16974072|NCT01144403|38117782|FG000|Overall Study|Death|1|||
16974073|NCT01144403|38117782|FG000|Overall Study|Adverse Event|1|||
16974074|NCT01143389|38117789|FG000|Overall Study|Lost to Follow-up|26|||
16974075|NCT01143389|38117790|FG001|Overall Study|Lost to Follow-up|25|||
16974076|NCT00868231|38117796|FG000|Treatment Period 1|Adverse Event|0|||
16974077|NCT00868231|38117797|FG001|Treatment Period 1|Adverse Event|0|||
16974078|NCT00868231|38117798|FG002|Treatment Period 1|Adverse Event|0|||
16974079|NCT00868231|38117799|FG003|Treatment Period 1|Adverse Event|0|||
16974080|NCT00868231|38117800|FG004|Treatment Period 1|Adverse Event|1|||
16974081|NCT00868231|38117801|FG005|Treatment Period 1|Adverse Event|0|||
16974082|NCT00868231|38117796|FG000|Treatment Period 2|Adverse Event|1|||
16974083|NCT00868231|38117797|FG001|Treatment Period 2|Adverse Event|0|||
16974084|NCT00868231|38117798|FG002|Treatment Period 2|Adverse Event|0|||
16974085|NCT00868231|38117799|FG003|Treatment Period 2|Adverse Event|0|||
16974086|NCT00868231|38117800|FG004|Treatment Period 2|Adverse Event|0|||
16974087|NCT00868231|38117801|FG005|Treatment Period 2|Adverse Event|0|||
16974088|NCT00868231|38117796|FG000|Treatment Period 3|Adverse Event|0|||
16974089|NCT00868231|38117797|FG001|Treatment Period 3|Adverse Event|0|||
16974090|NCT00868231|38117798|FG002|Treatment Period 3|Adverse Event|1|||
16974091|NCT00868231|38117799|FG003|Treatment Period 3|Adverse Event|0|||
16974092|NCT00868231|38117800|FG004|Treatment Period 3|Adverse Event|0|||
16974093|NCT00868231|38117801|FG005|Treatment Period 3|Adverse Event|0|||
16974094|NCT01101438|38117811|FG000|Overall Study|Withdrawal by Subject|8|||
16974095|NCT01101438|38117812|FG001|Overall Study|Withdrawal by Subject|9|||
16974096|NCT01143077|38117825|FG000|Overall Study|Lack of Efficacy|0|||
16974097|NCT01143077|38117826|FG001|Overall Study|Lack of Efficacy|2|||
16974098|NCT01143077|38117827|FG002|Overall Study|Lack of Efficacy|1|||
16974099|NCT01143077|38117825|FG000|Overall Study|Adverse Event|5|||
16974100|NCT01143077|38117826|FG001|Overall Study|Adverse Event|6|||
16974101|NCT01143077|38117827|FG002|Overall Study|Adverse Event|5|||
16974102|NCT01143077|38117825|FG000|Overall Study|Lost to Follow-up|2|||
16974103|NCT01143077|38117826|FG001|Overall Study|Lost to Follow-up|3|||
16974104|NCT01143077|38117827|FG002|Overall Study|Lost to Follow-up|4|||
16974105|NCT01143077|38117825|FG000|Overall Study|Protocol Violation|2|||
16974106|NCT01143077|38117826|FG001|Overall Study|Protocol Violation|0|||
16974107|NCT01143077|38117827|FG002|Overall Study|Protocol Violation|0|||
16974108|NCT01143077|38117825|FG000|Overall Study|Withdrawal by Subject|4|||
16974109|NCT01143077|38117826|FG001|Overall Study|Withdrawal by Subject|3|||
16974110|NCT01143077|38117827|FG002|Overall Study|Withdrawal by Subject|3|||
16974111|NCT01143077|38117825|FG000|Overall Study|Non-compliance with study drug|0|||
16974112|NCT01143077|38117826|FG001|Overall Study|Non-compliance with study drug|1|||
16974113|NCT01143077|38117827|FG002|Overall Study|Non-compliance with study drug|1|||
16974114|NCT01143077|38117825|FG000|Overall Study|Administrative|1|||
16974115|NCT01143077|38117826|FG001|Overall Study|Administrative|0|||
16974116|NCT01143077|38117827|FG002|Overall Study|Administrative|0|||
16974117|NCT01143077|38117825|FG000|Overall Study|Principal Investigator Decision|2|||
16974118|NCT01143077|38117826|FG001|Overall Study|Principal Investigator Decision|0|||
16974119|NCT01143077|38117827|FG002|Overall Study|Principal Investigator Decision|1|||
16974120|NCT01096446|38117837|FG000|Overall Study|Death|1|||
16974121|NCT01096446|38117838|FG001|Overall Study|Death|0|||
16974122|NCT01096446|38117837|FG000|Overall Study|Protocol Violation|2|||
16974123|NCT01096446|38117838|FG001|Overall Study|Protocol Violation|0|||
16974124|NCT00864721|38117843|FG000|Overall Study|Patient request|11|||
16974125|NCT00864721|38117843|FG000|Overall Study|Hospitalized|1|||
16974126|NCT00864721|38117843|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
16974127|NCT00864721|38117843|FG000|Overall Study|Adverse Event|21|||
16974128|NCT01095666|38117850|FG000|Overall Study|Lack of Efficacy|0|||
16974129|NCT01095666|38117851|FG001|Overall Study|Lack of Efficacy|0|||
16974130|NCT01095666|38117852|FG002|Overall Study|Lack of Efficacy|1|||
16974131|NCT01095666|38117850|FG000|Overall Study|Adverse Event|2|||
16974132|NCT01095666|38117851|FG001|Overall Study|Adverse Event|1|||
16974133|NCT01095666|38117852|FG002|Overall Study|Adverse Event|3|||
16974134|NCT01095666|38117850|FG000|Overall Study|Lost to Follow-up|2|||
16974135|NCT01095666|38117851|FG001|Overall Study|Lost to Follow-up|2|||
16974136|NCT01095666|38117852|FG002|Overall Study|Lost to Follow-up|0|||
16974137|NCT01095666|38117850|FG000|Overall Study|Withdrawal by Subject|6|||
16974138|NCT01095666|38117851|FG001|Overall Study|Withdrawal by Subject|6|||
16974139|NCT01095666|38117852|FG002|Overall Study|Withdrawal by Subject|1|||
16974140|NCT01095666|38117850|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
16974141|NCT01095666|38117851|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
16974142|NCT01095666|38117852|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
16974143|NCT01100658|38117860|FG000|Overall Study|Withdrawal by Subject|1|||
16974144|NCT01100502|38117866|FG000|Overall Study|Withdrawal by Subject|18|||
16974145|NCT01100502|38117867|FG001|Overall Study|Withdrawal by Subject|25|||
16974146|NCT01100502|38117866|FG000|Overall Study|Lost to Follow-up|13|||
16974147|NCT01100502|38117867|FG001|Overall Study|Lost to Follow-up|28|||
16974148|NCT01100502|38117866|FG000|Overall Study|Site request to end participation in study|0|||
16974149|NCT01100502|38117867|FG001|Overall Study|Site request to end participation in study|1|||
16974150|NCT01100502|38117866|FG000|Overall Study|Death|45|||
16974151|NCT01100502|38117867|FG001|Overall Study|Death|40|||
16974152|NCT01094886|38117873|FG000|Overall Study|Adverse Event|2|||
16974153|NCT01094886|38117873|FG000|Overall Study|Withdrawal by Subject|5|||
16974154|NCT01094808|38117880|FG000|Overall Study|Withdrawal by Subject|1|||
16974155|NCT01094808|38117881|FG001|Overall Study|Withdrawal by Subject|1|||
16974156|NCT01094808|38117882|FG002|Overall Study|Withdrawal by Subject|0|||
16974157|NCT00864253|38117892|FG000|Overall Study|Adverse Event|56|||
16974158|NCT00864253|38117893|FG001|Overall Study|Adverse Event|11|||
16974159|NCT00864253|38117892|FG000|Overall Study|Unrelated Adverse Event|3|||
16974160|NCT00864253|38117893|FG001|Overall Study|Unrelated Adverse Event|1|||
16974161|NCT00864253|38117892|FG000|Overall Study|Physician Decision|11|||
16974162|NCT00864253|38117893|FG001|Overall Study|Physician Decision|15|||
16974163|NCT00864253|38117892|FG000|Overall Study|Protocol Violation|0|||
16974164|NCT00864253|38117893|FG001|Overall Study|Protocol Violation|2|||
16974165|NCT00864253|38117892|FG000|Overall Study|Lost to Follow-up|1|||
16974166|NCT00864253|38117893|FG001|Overall Study|Lost to Follow-up|1|||
16974167|NCT00864253|38117892|FG000|Overall Study|Withdrawal by Subject|18|||
16974168|NCT00864253|38117893|FG001|Overall Study|Withdrawal by Subject|18|||
16974169|NCT00864253|38117892|FG000|Overall Study|Death|1|||
16974170|NCT00864253|38117893|FG001|Overall Study|Death|0|||
16974171|NCT00864253|38117892|FG000|Overall Study|Ongoing|2|||
16974172|NCT00864253|38117893|FG001|Overall Study|Ongoing|3|||
16974173|NCT00864253|38117892|FG000|Overall Study|Untreated|7|||
16974174|NCT00864253|38117893|FG001|Overall Study|Untreated|7|||
16974175|NCT01094730|38117901|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
16974176|NCT01094730|38117902|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
16974177|NCT01094730|38117901|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
16974178|NCT01094730|38117902|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
16974179|NCT01094730|38117901|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
16974180|NCT01094730|38117902|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
16974181|NCT01094730|38117901|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
16974182|NCT01094730|38117902|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
16974183|NCT01094730|38117901|FG000|Period 2 (14 Days)|Protocol Violation|2|||
16974184|NCT01094730|38117902|FG001|Period 2 (14 Days)|Protocol Violation|0|||
16974185|NCT01094730|38117901|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
16974186|NCT01094730|38117902|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
16974187|NCT01094730|38117901|FG000|Period 2 (14 Days)|Adverse Event|0|||
16974188|NCT01094730|38117902|FG001|Period 2 (14 Days)|Adverse Event|1|||
16974189|NCT01094730|38117901|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
16974190|NCT01094730|38117902|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
16974191|NCT00864097|38117917|FG000|Overall Study|Death|0|||
16974192|NCT00864097|38117918|FG001|Overall Study|Death|1|||
16974193|NCT00864097|38117919|FG002|Overall Study|Death|0|||
16974194|NCT00864097|38117920|FG003|Overall Study|Death|0|||
16974195|NCT00864097|38117917|FG000|Overall Study|Adverse Event|6|||
16974196|NCT00864097|38117918|FG001|Overall Study|Adverse Event|8|||
16974197|NCT00864097|38117919|FG002|Overall Study|Adverse Event|11|||
16974198|NCT00864097|38117920|FG003|Overall Study|Adverse Event|9|||
16974199|NCT00864097|38117917|FG000|Overall Study|Lack of Efficacy|9|||
16974200|NCT00864097|38117918|FG001|Overall Study|Lack of Efficacy|3|||
16974201|NCT00864097|38117919|FG002|Overall Study|Lack of Efficacy|7|||
16974202|NCT00864097|38117920|FG003|Overall Study|Lack of Efficacy|2|||
16974203|NCT00864097|38117917|FG000|Overall Study|Lost to Follow-up|0|||
16974204|NCT00864097|38117918|FG001|Overall Study|Lost to Follow-up|1|||
16974205|NCT00864097|38117919|FG002|Overall Study|Lost to Follow-up|0|||
16974206|NCT00864097|38117920|FG003|Overall Study|Lost to Follow-up|1|||
16974207|NCT00864097|38117917|FG000|Overall Study|Withdrawal by Subject|15|||
16974208|NCT00864097|38117918|FG001|Overall Study|Withdrawal by Subject|11|||
16974209|NCT00864097|38117919|FG002|Overall Study|Withdrawal by Subject|11|||
16974210|NCT00864097|38117920|FG003|Overall Study|Withdrawal by Subject|12|||
16974211|NCT00864097|38117917|FG000|Overall Study|Protocol Violation|2|||
16974212|NCT00864097|38117918|FG001|Overall Study|Protocol Violation|1|||
16974213|NCT00864097|38117919|FG002|Overall Study|Protocol Violation|0|||
16974214|NCT00864097|38117920|FG003|Overall Study|Protocol Violation|1|||
16974215|NCT00864097|38117917|FG000|Overall Study|Terminated by sponsor|105|||
16974216|NCT00864097|38117918|FG001|Overall Study|Terminated by sponsor|112|||
16974217|NCT00864097|38117919|FG002|Overall Study|Terminated by sponsor|102|||
16974218|NCT00864097|38117920|FG003|Overall Study|Terminated by sponsor|99|||
16974219|NCT00864097|38117917|FG000|Overall Study|Randomized but not treated|2|||
16974220|NCT00864097|38117918|FG001|Overall Study|Randomized but not treated|0|||
16974221|NCT00864097|38117919|FG002|Overall Study|Randomized but not treated|1|||
16974222|NCT00864097|38117920|FG003|Overall Study|Randomized but not treated|0|||
16974223|NCT00864097|38117917|FG000|Overall Study|Other|0|||
16974224|NCT00864097|38117918|FG001|Overall Study|Other|0|||
16974225|NCT00864097|38117919|FG002|Overall Study|Other|0|||
16974226|NCT00864097|38117920|FG003|Overall Study|Other|1|||
16974227|NCT01183013|38117937|FG000|Overall Study|Adverse Event|6|||
16974228|NCT01183013|38117938|FG001|Overall Study|Adverse Event|8|||
16974229|NCT01183013|38117939|FG002|Overall Study|Adverse Event|5|||
16974230|NCT01183013|38117940|FG003|Overall Study|Adverse Event|5|||
16974231|NCT01183013|38117941|FG004|Overall Study|Adverse Event|10|||
16974232|NCT01183013|38117942|FG005|Overall Study|Adverse Event|10|||
16974233|NCT01183013|38117943|FG006|Overall Study|Adverse Event|6|||
16974234|NCT01183013|38117937|FG000|Overall Study|Lack of Efficacy|3|||
16974235|NCT01183013|38117938|FG001|Overall Study|Lack of Efficacy|2|||
16974236|NCT01183013|38117939|FG002|Overall Study|Lack of Efficacy|1|||
16974237|NCT01183013|38117940|FG003|Overall Study|Lack of Efficacy|2|||
16974238|NCT01183013|38117941|FG004|Overall Study|Lack of Efficacy|1|||
16974239|NCT01183013|38117942|FG005|Overall Study|Lack of Efficacy|2|||
16974240|NCT01183013|38117943|FG006|Overall Study|Lack of Efficacy|0|||
16974241|NCT01183013|38117937|FG000|Overall Study|Protocol Violation|5|||
16974242|NCT01183013|38117938|FG001|Overall Study|Protocol Violation|2|||
16974243|NCT01183013|38117939|FG002|Overall Study|Protocol Violation|4|||
16974244|NCT01183013|38117940|FG003|Overall Study|Protocol Violation|0|||
16974245|NCT01183013|38117941|FG004|Overall Study|Protocol Violation|4|||
16974246|NCT01183013|38117942|FG005|Overall Study|Protocol Violation|3|||
16974247|NCT01183013|38117943|FG006|Overall Study|Protocol Violation|3|||
16974248|NCT01183013|38117937|FG000|Overall Study|Lost to Follow-up|7|||
16974249|NCT01183013|38117938|FG001|Overall Study|Lost to Follow-up|3|||
16974250|NCT01183013|38117939|FG002|Overall Study|Lost to Follow-up|4|||
16974251|NCT01183013|38117940|FG003|Overall Study|Lost to Follow-up|3|||
16974252|NCT01183013|38117941|FG004|Overall Study|Lost to Follow-up|2|||
16974253|NCT01183013|38117942|FG005|Overall Study|Lost to Follow-up|6|||
16974254|NCT01183013|38117943|FG006|Overall Study|Lost to Follow-up|5|||
16974255|NCT01183013|38117937|FG000|Overall Study|Withdrawal by Subject|9|||
16974256|NCT01183013|38117938|FG001|Overall Study|Withdrawal by Subject|13|||
16974257|NCT01183013|38117939|FG002|Overall Study|Withdrawal by Subject|10|||
16974258|NCT01183013|38117940|FG003|Overall Study|Withdrawal by Subject|8|||
16974259|NCT01183013|38117941|FG004|Overall Study|Withdrawal by Subject|7|||
16974260|NCT01183013|38117942|FG005|Overall Study|Withdrawal by Subject|9|||
16974261|NCT01183013|38117943|FG006|Overall Study|Withdrawal by Subject|10|||
16974262|NCT01183013|38117937|FG000|Overall Study|Reasons other than stated above|15|||
16974263|NCT01183013|38117938|FG001|Overall Study|Reasons other than stated above|11|||
16974264|NCT01183013|38117939|FG002|Overall Study|Reasons other than stated above|17|||
16974265|NCT01183013|38117940|FG003|Overall Study|Reasons other than stated above|12|||
16974266|NCT01183013|38117941|FG004|Overall Study|Reasons other than stated above|12|||
16974267|NCT01183013|38117942|FG005|Overall Study|Reasons other than stated above|15|||
16974268|NCT01183013|38117943|FG006|Overall Study|Reasons other than stated above|13|||
16974269|NCT01141283|38117967|FG000|Overall Study|Adverse Event|56|||
16974270|NCT01141283|38117967|FG000|Overall Study|Lost to Follow-up|4|||
16974271|NCT01141283|38117967|FG000|Overall Study|Withdrawal by Subject|14|||
16974272|NCT01141283|38117967|FG000|Overall Study|Administrative|4|||
16974273|NCT01141283|38117967|FG000|Overall Study|Lack of Efficacy|10|||
16974274|NCT00863707|38117973|FG000|Overall Study|Randomized, but drug not received|4|||
16974275|NCT00863707|38117974|FG001|Overall Study|Randomized, but drug not received|3|||
16974276|NCT01094184|38117982|FG000|Overall Study|Death|35|||
16974277|NCT01094184|38117983|FG001|Overall Study|Death|11|||
16974278|NCT01134731|38117992|FG000|Overall Study|Adverse Event|3|||
16974279|NCT01134731|38117993|FG001|Overall Study|Adverse Event|2|||
16974280|NCT01134731|38117994|FG002|Overall Study|Adverse Event|1|||
16974281|NCT01134731|38117992|FG000|Overall Study|Physician Decision|2|||
16974282|NCT01134731|38117993|FG001|Overall Study|Physician Decision|2|||
16974283|NCT01134731|38117994|FG002|Overall Study|Physician Decision|2|||
16974284|NCT01134731|38117992|FG000|Overall Study|Lack of Efficacy|0|||
16974285|NCT01134731|38117993|FG001|Overall Study|Lack of Efficacy|0|||
16974286|NCT01134731|38117994|FG002|Overall Study|Lack of Efficacy|1|||
16974287|NCT01134731|38117992|FG000|Overall Study|Withdrawal by Subject|3|||
16974288|NCT01134731|38117993|FG001|Overall Study|Withdrawal by Subject|3|||
16974289|NCT01134731|38117994|FG002|Overall Study|Withdrawal by Subject|1|||
16974290|NCT01134731|38117992|FG000|Overall Study|Lost to Follow-up|5|||
16974291|NCT01134731|38117993|FG001|Overall Study|Lost to Follow-up|4|||
16974292|NCT01134731|38117994|FG002|Overall Study|Lost to Follow-up|3|||
16974293|NCT01141205|38118005|FG000|Overall Study|Physician Decision|1|||
16974294|NCT01141205|38118006|FG001|Overall Study|Physician Decision|1|||
16974295|NCT01141205|38118005|FG000|Overall Study|Lost to Follow-up|1|||
16974296|NCT01141205|38118006|FG001|Overall Study|Lost to Follow-up|0|||
16974297|NCT01141205|38118005|FG000|Overall Study|Withdrawal by Subject|1|||
16974298|NCT01141205|38118006|FG001|Overall Study|Withdrawal by Subject|1|||
16974299|NCT01140503|38118016|FG000|Overall Study|Withdrawal by Subject|1|||
16974300|NCT00863317|38118022|FG000|Overall Study|Lost to Follow-up|8|||
16974301|NCT00863317|38118023|FG001|Overall Study|Lost to Follow-up|9|||
16974302|NCT01200368|38118032|FG000|Infant Series|Adverse Event|2|||
16974303|NCT01200368|38118033|FG001|Infant Series|Adverse Event|2|||
16974304|NCT01200368|38118034|FG002|Infant Series|Adverse Event|3|||
16974305|NCT01200368|38118032|FG000|Infant Series|Withdrawal by Subject|0|||
16974306|NCT01200368|38118033|FG001|Infant Series|Withdrawal by Subject|2|||
16974307|NCT01200368|38118034|FG002|Infant Series|Withdrawal by Subject|2|||
16974308|NCT01200368|38118032|FG000|Infant Series|Did not meet entrance criteria|0|||
16974309|NCT01200368|38118033|FG001|Infant Series|Did not meet entrance criteria|1|||
16974310|NCT01200368|38118034|FG002|Infant Series|Did not meet entrance criteria|0|||
16974311|NCT01200368|38118032|FG000|Infant Series|Randomized, not vaccinated|0|||
16974312|NCT01200368|38118033|FG001|Infant Series|Randomized, not vaccinated|1|||
16974313|NCT01200368|38118034|FG002|Infant Series|Randomized, not vaccinated|1|||
16974314|NCT01200368|38118032|FG000|Infant Series|Other|1|||
16974315|NCT01200368|38118033|FG001|Infant Series|Other|0|||
16974316|NCT01200368|38118034|FG002|Infant Series|Other|0|||
16974317|NCT01200368|38118032|FG000|After Infant Series|Adverse Event|6|||
16974318|NCT01200368|38118033|FG001|After Infant Series|Adverse Event|6|||
16974319|NCT01200368|38118034|FG002|After Infant Series|Adverse Event|3|||
16974320|NCT01200368|38118032|FG000|After Infant Series|Withdrawal by Subject|10|||
16974321|NCT01200368|38118033|FG001|After Infant Series|Withdrawal by Subject|8|||
16974322|NCT01200368|38118034|FG002|After Infant Series|Withdrawal by Subject|4|||
16974323|NCT01200368|38118032|FG000|After Infant Series|Lost to Follow-up|1|||
16974324|NCT01200368|38118033|FG001|After Infant Series|Lost to Follow-up|0|||
16974325|NCT01200368|38118034|FG002|After Infant Series|Lost to Follow-up|0|||
16974326|NCT01200368|38118032|FG000|After Infant Series|Other|1|||
16974327|NCT01200368|38118033|FG001|After Infant Series|Other|2|||
16974328|NCT01200368|38118034|FG002|After Infant Series|Other|2|||
16974329|NCT01200368|38118032|FG000|Toddler Dose|Adverse Event|0|||
16974330|NCT01200368|38118033|FG001|Toddler Dose|Adverse Event|3|||
16974331|NCT01200368|38118034|FG002|Toddler Dose|Adverse Event|1|||
16974332|NCT01079130|38118055|FG000|Overall Study|Adverse Event|1|||
16974333|NCT01079130|38118056|FG001|Overall Study|Adverse Event|1|||
16974334|NCT01079130|38118057|FG002|Overall Study|Adverse Event|0|||
16974335|NCT01079130|38118058|FG003|Overall Study|Adverse Event|1|||
16974336|NCT01079130|38118059|FG004|Overall Study|Adverse Event|5|||
16974337|NCT01079130|38118060|FG005|Overall Study|Adverse Event|1|||
16974338|NCT01079130|38118055|FG000|Overall Study|Administrative problems|1|||
16974339|NCT01079130|38118056|FG001|Overall Study|Administrative problems|3|||
16974340|NCT01079130|38118057|FG002|Overall Study|Administrative problems|0|||
16974341|NCT01079130|38118058|FG003|Overall Study|Administrative problems|0|||
16974342|NCT01079130|38118059|FG004|Overall Study|Administrative problems|0|||
16974343|NCT01079130|38118060|FG005|Overall Study|Administrative problems|1|||
16974344|NCT01079130|38118055|FG000|Overall Study|Withdrawal by Subject|0|||
16974345|NCT01079130|38118056|FG001|Overall Study|Withdrawal by Subject|1|||
16974346|NCT01079130|38118057|FG002|Overall Study|Withdrawal by Subject|0|||
16974347|NCT01079130|38118058|FG003|Overall Study|Withdrawal by Subject|0|||
16974348|NCT01079130|38118059|FG004|Overall Study|Withdrawal by Subject|1|||
16974349|NCT01079130|38118060|FG005|Overall Study|Withdrawal by Subject|3|||
16974350|NCT01079130|38118055|FG000|Overall Study|Protocol deviation|0|||
16974351|NCT01079130|38118056|FG001|Overall Study|Protocol deviation|2|||
16974352|NCT01079130|38118057|FG002|Overall Study|Protocol deviation|1|||
16974353|NCT01079130|38118058|FG003|Overall Study|Protocol deviation|2|||
16974354|NCT01079130|38118059|FG004|Overall Study|Protocol deviation|0|||
16974355|NCT01079130|38118060|FG005|Overall Study|Protocol deviation|0|||
16974356|NCT01079130|38118055|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16974357|NCT01079130|38118056|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16974358|NCT01079130|38118057|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16974359|NCT01079130|38118058|FG003|Overall Study|Abnormal test procedure result(s)|0|||
16974360|NCT01079130|38118059|FG004|Overall Study|Abnormal test procedure result(s)|1|||
16974361|NCT01079130|38118060|FG005|Overall Study|Abnormal test procedure result(s)|0|||
16974362|NCT01079130|38118055|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16974363|NCT01079130|38118056|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16974364|NCT01079130|38118057|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16974365|NCT01079130|38118058|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
16974366|NCT01079130|38118059|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
16974367|NCT01079130|38118060|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
16974368|NCT01079130|38118055|FG000|Overall Study|Lost to Follow-up|0|||
16974369|NCT01079130|38118056|FG001|Overall Study|Lost to Follow-up|0|||
16974370|NCT01079130|38118057|FG002|Overall Study|Lost to Follow-up|0|||
16974371|NCT01079130|38118058|FG003|Overall Study|Lost to Follow-up|0|||
16974372|NCT01079130|38118059|FG004|Overall Study|Lost to Follow-up|1|||
16974373|NCT01079130|38118060|FG005|Overall Study|Lost to Follow-up|0|||
16974374|NCT01078974|38118074|FG000|Overall Study|Adverse Event|3|||
16974375|NCT00869557|38118080|FG000|Randomized Phase|Lost to Follow-up|2|||
16974376|NCT00869557|38118081|FG001|Randomized Phase|Lost to Follow-up|1|||
16974377|NCT00869557|38118080|FG000|Randomized Phase|Investigator's Discretion|1|||
16974378|NCT00869557|38118081|FG001|Randomized Phase|Investigator's Discretion|0|||
16974379|NCT00869557|38118080|FG000|Randomized Phase|Withdrew Consent|0|||
16974380|NCT00869557|38118081|FG001|Randomized Phase|Withdrew Consent|1|||
16974381|NCT00869557|38118080|FG000|Extension Phase|Adverse Event|2|||
16974382|NCT00869557|38118081|FG001|Extension Phase|Adverse Event|2|||
16974383|NCT00869557|38118080|FG000|Extension Phase|Lack of Efficacy|1|||
16974384|NCT00869557|38118081|FG001|Extension Phase|Lack of Efficacy|0|||
16974385|NCT00869557|38118080|FG000|Extension Phase|Lost to Follow-up|3|||
16974386|NCT00869557|38118081|FG001|Extension Phase|Lost to Follow-up|1|||
16974387|NCT00869557|38118080|FG000|Extension Phase|Investigator's Discretion|2|||
16974388|NCT00869557|38118081|FG001|Extension Phase|Investigator's Discretion|0|||
16974389|NCT00869557|38118080|FG000|Extension Phase|Withdrew Consent|2|||
16974390|NCT00869557|38118081|FG001|Extension Phase|Withdrew Consent|0|||
16974391|NCT01200290|38118088|FG000|Treatment Period|Adverse Event|1|||
16974392|NCT01200290|38118088|FG000|Post-Treatment Follow-Up Period|Death|2|||
16974393|NCT01134263|38118097|FG000|Overall Study|Serious adverse event|2|||
16974394|NCT01134263|38118098|FG001|Overall Study|Serious adverse event|1|||
16974395|NCT01134263|38118099|FG002|Overall Study|Serious adverse event|1|||
16974396|NCT01134263|38118100|FG003|Overall Study|Serious adverse event|1|||
16974397|NCT01134263|38118101|FG004|Overall Study|Serious adverse event|1|||
16974398|NCT01134263|38118097|FG000|Overall Study|Other adverse event|1|||
16974399|NCT01134263|38118098|FG001|Overall Study|Other adverse event|2|||
16974400|NCT01134263|38118099|FG002|Overall Study|Other adverse event|5|||
16974401|NCT01134263|38118100|FG003|Overall Study|Other adverse event|3|||
16974402|NCT01134263|38118101|FG004|Overall Study|Other adverse event|0|||
16974403|NCT01134263|38118097|FG000|Overall Study|Protocol Violation|8|||
16974404|NCT01134263|38118098|FG001|Overall Study|Protocol Violation|7|||
16974405|NCT01134263|38118099|FG002|Overall Study|Protocol Violation|2|||
16974406|NCT01134263|38118100|FG003|Overall Study|Protocol Violation|4|||
16974407|NCT01134263|38118101|FG004|Overall Study|Protocol Violation|2|||
16974408|NCT01134263|38118097|FG000|Overall Study|Lost to Follow-up|4|||
16974409|NCT01134263|38118098|FG001|Overall Study|Lost to Follow-up|3|||
16974410|NCT01134263|38118099|FG002|Overall Study|Lost to Follow-up|5|||
16974411|NCT01134263|38118100|FG003|Overall Study|Lost to Follow-up|3|||
16974412|NCT01134263|38118101|FG004|Overall Study|Lost to Follow-up|1|||
16974413|NCT01134263|38118097|FG000|Overall Study|Withdrawal by Subject|8|||
16974414|NCT01134263|38118098|FG001|Overall Study|Withdrawal by Subject|6|||
16974415|NCT01134263|38118099|FG002|Overall Study|Withdrawal by Subject|16|||
16974416|NCT01134263|38118100|FG003|Overall Study|Withdrawal by Subject|7|||
16974417|NCT01134263|38118101|FG004|Overall Study|Withdrawal by Subject|5|||
16974418|NCT01134263|38118097|FG000|Overall Study|Enrolled, but not treated|1|||
16974419|NCT01134263|38118098|FG001|Overall Study|Enrolled, but not treated|1|||
16974420|NCT01134263|38118099|FG002|Overall Study|Enrolled, but not treated|0|||
16974421|NCT01134263|38118100|FG003|Overall Study|Enrolled, but not treated|1|||
16974422|NCT01134263|38118101|FG004|Overall Study|Enrolled, but not treated|0|||
16974423|NCT01199822|38118122|FG000|Overall Study|Investigator discontinued therapy|0|||
16974424|NCT01199822|38118123|FG001|Overall Study|Investigator discontinued therapy|1|||
16974425|NCT01199822|38118124|FG002|Overall Study|Investigator discontinued therapy|0|||
16974426|NCT01096056|38118141|FG000|Overall Study|Lost to Follow-up|0|||
16974427|NCT01096056|38118142|FG001|Overall Study|Lost to Follow-up|1|||
16974428|NCT00866359|38118150|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
16974429|NCT00866359|38118151|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
16974430|NCT00866359|38118152|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
16974431|NCT00866359|38118153|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
16974432|NCT00866359|38118150|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
16974433|NCT00866359|38118151|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
16974434|NCT00866359|38118152|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
16974435|NCT00866359|38118153|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
16974436|NCT00866359|38118150|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
16974437|NCT00866359|38118151|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
16974438|NCT00866359|38118152|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
16974439|NCT00866359|38118153|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
16974440|NCT00866359|38118150|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
16974441|NCT00866359|38118151|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
16974442|NCT00866359|38118152|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
16974443|NCT00866359|38118153|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
16974444|NCT00866359|38118150|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
16974445|NCT00866359|38118151|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
16974446|NCT00866359|38118152|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
16974447|NCT00866359|38118153|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
16974448|NCT00866359|38118150|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
16974449|NCT00866359|38118151|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
16974450|NCT00866359|38118152|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
16974451|NCT00866359|38118153|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
16974452|NCT01199198|38118182|FG000|Overall Study|Adverse Event|3|||
16974453|NCT01199198|38118183|FG001|Overall Study|Adverse Event|0|||
16974454|NCT01199198|38118182|FG000|Overall Study|Lost to Follow-up|1|||
16974455|NCT01199198|38118183|FG001|Overall Study|Lost to Follow-up|5|||
16974456|NCT01199198|38118182|FG000|Overall Study|Withdrawal by Subject|1|||
16974457|NCT01199198|38118183|FG001|Overall Study|Withdrawal by Subject|2|||
16974458|NCT01199198|38118182|FG000|Overall Study|ICU Transfer|1|||
16974459|NCT01199198|38118183|FG001|Overall Study|ICU Transfer|2|||
16974460|NCT01199198|38118182|FG000|Overall Study|Hospice-care transfer|1|||
16974461|NCT01199198|38118183|FG001|Overall Study|Hospice-care transfer|2|||
16974462|NCT01095978|38118189|FG000|Overall Study|Did not take Klacid SR|2|||
16974463|NCT01095978|38118189|FG000|Overall Study|Adverse Event|1|||
16974464|NCT01134107|38118197|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
16974465|NCT01134107|38118198|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
17134024|NCT02095132|38275293|FG000|Overall Study|Death|0|||
16974466|NCT01134107|38118197|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
16974467|NCT01134107|38118198|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
16974468|NCT01134107|38118197|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
16974469|NCT01134107|38118198|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
16974470|NCT01134107|38118197|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
16974471|NCT01134107|38118198|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
16974472|NCT01134107|38118197|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
16974473|NCT01134107|38118198|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
16974474|NCT01134107|38118197|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
16974475|NCT01134107|38118198|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
16974476|NCT01134107|38118197|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
16974477|NCT01134107|38118198|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
16974478|NCT01199042|38118204|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
16974479|NCT01199042|38118204|FG000|At Home (3 Months)|Lost to Follow-up|1|||
16974480|NCT01198574|38118217|FG000|Overall Study|Resigned from schools|4|||
16974481|NCT01198574|38118218|FG001|Overall Study|Resigned from schools|1|||
16974482|NCT01198574|38118219|FG002|Overall Study|Resigned from schools|1|||
16974483|NCT01198574|38118220|FG003|Overall Study|Resigned from schools|4|||
16974484|NCT01198028|38118230|FG000|Overall Study|Adverse Event|5|||
16974485|NCT01198028|38118230|FG000|Overall Study|Death|3|||
16974486|NCT01198028|38118230|FG000|Overall Study|Physician Decision|2|||
16974487|NCT01197950|38118237|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
16974488|NCT01197950|38118238|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
16974489|NCT01197950|38118239|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
16974490|NCT01092780|38118247|FG000|Washout Period 1|Adverse Event|0|||
16974491|NCT01092780|38118248|FG001|Washout Period 1|Adverse Event|1|||
16974492|NCT01092780|38118249|FG002|Washout Period 1|Adverse Event|0|||
16974493|NCT01092780|38118250|FG003|Washout Period 1|Adverse Event|0|||
16974494|NCT01092780|38118247|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
16974495|NCT01092780|38118248|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
16974496|NCT01092780|38118249|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
16974497|NCT01092780|38118250|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
16974498|NCT01092780|38118247|FG000|Washout Period 2|Adverse Event|0|||
16974499|NCT01092780|38118248|FG001|Washout Period 2|Adverse Event|1|||
16974500|NCT01092780|38118249|FG002|Washout Period 2|Adverse Event|1|||
16974501|NCT01092780|38118250|FG003|Washout Period 2|Adverse Event|0|||
16974502|NCT01092702|38118260|FG000|Overall Study|Withdrawal by Subject|7|||
16974503|NCT01092702|38118260|FG000|Overall Study|Lost to Follow-up|2|||
16974504|NCT01092546|38118264|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
16974505|NCT01197794|38118275|FG000|Overall Study|Adverse Event|3|||
16974506|NCT01197794|38118276|FG001|Overall Study|Adverse Event|2|||
16974507|NCT01197794|38118277|FG002|Overall Study|Adverse Event|4|||
16974508|NCT01197794|38118278|FG003|Overall Study|Adverse Event|4|||
16974509|NCT01197794|38118279|FG004|Overall Study|Adverse Event|4|||
16974510|NCT01197794|38118280|FG005|Overall Study|Adverse Event|2|||
16974511|NCT01197794|38118281|FG006|Overall Study|Adverse Event|3|||
16974512|NCT01197794|38118275|FG000|Overall Study|Protocol Violation|0|||
16974513|NCT01197794|38118276|FG001|Overall Study|Protocol Violation|0|||
16974514|NCT01197794|38118277|FG002|Overall Study|Protocol Violation|0|||
16974515|NCT01197794|38118278|FG003|Overall Study|Protocol Violation|0|||
16974516|NCT01197794|38118279|FG004|Overall Study|Protocol Violation|2|||
16780083|NCT01595529|37719145|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
16780084|NCT01595529|37719146|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
16780085|NCT01595529|37719145|FG000|Overall Study|Administrative Decision|1|||
16780086|NCT01595529|37719146|FG001|Overall Study|Administrative Decision|0|||
16780087|NCT01595529|37719145|FG000|Overall Study|Entry Failure/Screening Failure|6|||
16780088|NCT01595529|37719146|FG001|Overall Study|Entry Failure/Screening Failure|1|||
16780089|NCT02615145|37719155|FG000|Overall Study|Did Not Start Treatment|0|||
16780090|NCT02615145|37719156|FG001|Overall Study|Did Not Start Treatment|0|||
16780091|NCT02615145|37719157|FG002|Overall Study|Did Not Start Treatment|1|||
16780092|NCT02615145|37719158|FG003|Overall Study|Did Not Start Treatment|1|||
16780093|NCT02615145|37719155|FG000|Overall Study|Failure to Return|20|||
16780094|NCT02615145|37719156|FG001|Overall Study|Failure to Return|10|||
16780095|NCT02615145|37719157|FG002|Overall Study|Failure to Return|7|||
16780096|NCT02615145|37719158|FG003|Overall Study|Failure to Return|0|||
16780097|NCT02615145|37719155|FG000|Overall Study|Death|2|||
16974517|NCT01197794|38118280|FG005|Overall Study|Protocol Violation|0|||
16974518|NCT01197794|38118281|FG006|Overall Study|Protocol Violation|1|||
16974519|NCT01197794|38118275|FG000|Overall Study|Development of study withdrawal criteria|3|||
16974520|NCT01197794|38118276|FG001|Overall Study|Development of study withdrawal criteria|0|||
16780098|NCT02615145|37719156|FG001|Overall Study|Death|3|||
16780099|NCT02615145|37719157|FG002|Overall Study|Death|0|||
16780100|NCT02615145|37719158|FG003|Overall Study|Death|0|||
16780101|NCT02615145|37719155|FG000|Overall Study|Other, Not Specified|5|||
16780102|NCT02615145|37719156|FG001|Overall Study|Other, Not Specified|2|||
16780103|NCT02615145|37719157|FG002|Overall Study|Other, Not Specified|0|||
16780104|NCT02615145|37719158|FG003|Overall Study|Other, Not Specified|0|||
16780105|NCT02119156|37719187|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
16780106|NCT02119156|37719188|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
16780107|NCT02119156|37719189|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
16780108|NCT02119156|37719187|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
16780109|NCT02119156|37719188|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
16780110|NCT02119156|37719189|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
16780111|NCT02119156|37719187|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
16780112|NCT02119156|37719188|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
16780113|NCT02119156|37719189|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
16780114|NCT02119156|37719187|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
16780115|NCT02119156|37719188|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
16780116|NCT02119156|37719189|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
16780117|NCT02119156|37719187|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
16868013|NCT01536145|37841033|FG000|Overall Study|Withdrawal by Subject|0|||
16974521|NCT01197794|38118277|FG002|Overall Study|Development of study withdrawal criteria|0|||
16974522|NCT01197794|38118278|FG003|Overall Study|Development of study withdrawal criteria|1|||
16974523|NCT01197794|38118279|FG004|Overall Study|Development of study withdrawal criteria|0|||
16974524|NCT01197794|38118280|FG005|Overall Study|Development of study withdrawal criteria|0|||
16974525|NCT01197794|38118281|FG006|Overall Study|Development of study withdrawal criteria|1|||
16974526|NCT01197794|38118275|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
16974527|NCT01197794|38118276|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
16974528|NCT01197794|38118277|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
16974529|NCT01197794|38118278|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
16974530|NCT01197794|38118279|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
16974531|NCT01197794|38118280|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
16974532|NCT01197794|38118281|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
16974533|NCT01197794|38118275|FG000|Overall Study|Withdrawal by Subject|3|||
16974534|NCT01197794|38118276|FG001|Overall Study|Withdrawal by Subject|3|||
16974535|NCT01197794|38118277|FG002|Overall Study|Withdrawal by Subject|4|||
16974536|NCT01197794|38118278|FG003|Overall Study|Withdrawal by Subject|1|||
16974537|NCT01197794|38118279|FG004|Overall Study|Withdrawal by Subject|1|||
16974538|NCT01197794|38118280|FG005|Overall Study|Withdrawal by Subject|5|||
16974539|NCT01197794|38118281|FG006|Overall Study|Withdrawal by Subject|6|||
16974540|NCT01197794|38118275|FG000|Overall Study|Lost to Follow-up|1|||
16974541|NCT01197794|38118276|FG001|Overall Study|Lost to Follow-up|1|||
16974542|NCT01197794|38118277|FG002|Overall Study|Lost to Follow-up|0|||
16974543|NCT01197794|38118278|FG003|Overall Study|Lost to Follow-up|1|||
16974544|NCT01197794|38118279|FG004|Overall Study|Lost to Follow-up|0|||
16974545|NCT01197794|38118280|FG005|Overall Study|Lost to Follow-up|1|||
16974546|NCT01197794|38118281|FG006|Overall Study|Lost to Follow-up|0|||
16974547|NCT01197794|38118275|FG000|Overall Study|Other|1|||
16974548|NCT01197794|38118276|FG001|Overall Study|Other|1|||
16974549|NCT01197794|38118277|FG002|Overall Study|Other|3|||
16974550|NCT01197794|38118278|FG003|Overall Study|Other|0|||
16974551|NCT01197794|38118279|FG004|Overall Study|Other|2|||
16974552|NCT01197794|38118280|FG005|Overall Study|Other|2|||
16974553|NCT01197794|38118281|FG006|Overall Study|Other|4|||
16974554|NCT01078662|38118303|FG000|Overall Study|Death|41|||
16974555|NCT01078662|38118304|FG001|Overall Study|Death|103|||
16974556|NCT01078662|38118305|FG002|Overall Study|Death|18|||
16974557|NCT01078662|38118306|FG003|Overall Study|Death|5|||
16974558|NCT01078662|38118307|FG004|Overall Study|Death|8|||
16974559|NCT01078662|38118303|FG000|Overall Study|Patients reached data cut-off|12|||
16974560|NCT01078662|38118304|FG001|Overall Study|Patients reached data cut-off|53|||
16974561|NCT01078662|38118305|FG002|Overall Study|Patients reached data cut-off|2|||
16974562|NCT01078662|38118306|FG003|Overall Study|Patients reached data cut-off|2|||
16974563|NCT01078662|38118307|FG004|Overall Study|Patients reached data cut-off|3|||
16974564|NCT01078662|38118303|FG000|Overall Study|Withdrawal by Subject|4|||
16974565|NCT01078662|38118304|FG001|Overall Study|Withdrawal by Subject|11|||
16974566|NCT01078662|38118305|FG002|Overall Study|Withdrawal by Subject|1|||
16974567|NCT01078662|38118306|FG003|Overall Study|Withdrawal by Subject|0|||
16974568|NCT01078662|38118307|FG004|Overall Study|Withdrawal by Subject|0|||
16974569|NCT01078662|38118303|FG000|Overall Study|Protocol Violation|0|||
16974570|NCT01078662|38118304|FG001|Overall Study|Protocol Violation|1|||
16974571|NCT01078662|38118305|FG002|Overall Study|Protocol Violation|0|||
16974572|NCT01078662|38118306|FG003|Overall Study|Protocol Violation|0|||
16974573|NCT01078662|38118307|FG004|Overall Study|Protocol Violation|0|||
16974574|NCT01078662|38118303|FG000|Overall Study|Lost to Follow-up|1|||
16974575|NCT01078662|38118304|FG001|Overall Study|Lost to Follow-up|0|||
16974576|NCT01078662|38118305|FG002|Overall Study|Lost to Follow-up|0|||
16974577|NCT01078662|38118306|FG003|Overall Study|Lost to Follow-up|0|||
16974578|NCT01078662|38118307|FG004|Overall Study|Lost to Follow-up|0|||
16974579|NCT01091454|38118316|FG000|Overall Study|Ineligible|1|||
16974580|NCT01140347|38118322|FG000|Overall Study|Lost to Follow-up|5|||
16974581|NCT01140347|38118323|FG001|Overall Study|Lost to Follow-up|6|||
16974582|NCT01140347|38118322|FG000|Overall Study|Withdrawal by Subject|13|||
16974583|NCT01140347|38118323|FG001|Overall Study|Withdrawal by Subject|8|||
16974584|NCT01197560|38118331|FG000|Overall Study|Adverse Event|6|||
16974585|NCT01197560|38118332|FG001|Overall Study|Adverse Event|8|||
16974586|NCT01197560|38118331|FG000|Overall Study|Death|3|||
16974587|NCT01197560|38118332|FG001|Overall Study|Death|5|||
16974588|NCT01197560|38118331|FG000|Overall Study|Withdrawal by Subject|1|||
16974589|NCT01197560|38118332|FG001|Overall Study|Withdrawal by Subject|1|||
16974590|NCT01197560|38118331|FG000|Overall Study|Disease progression|40|||
16974591|NCT01197560|38118332|FG001|Overall Study|Disease progression|35|||
16974592|NCT01197560|38118331|FG000|Overall Study|Miscellaneous|4|||
16974593|NCT01197560|38118332|FG001|Overall Study|Miscellaneous|3|||
16974594|NCT01197560|38118331|FG000|Overall Study|Missing|0|||
16974595|NCT01197560|38118332|FG001|Overall Study|Missing|1|||
16974596|NCT01133405|38118349|FG000|Period 1|Withdrawal by Subject|0|||
16974597|NCT01133405|38118350|FG001|Period 1|Withdrawal by Subject|1|||
16974598|NCT01133405|38118351|FG002|Period 1|Withdrawal by Subject|0|||
16974599|NCT01133405|38118352|FG003|Period 1|Withdrawal by Subject|1|||
16974600|NCT01133405|38118353|FG004|Period 1|Withdrawal by Subject|0|||
16974601|NCT01133405|38118354|FG005|Period 1|Withdrawal by Subject|1|||
16974602|NCT01133405|38118355|FG006|Period 1|Withdrawal by Subject|0|||
16974603|NCT01133405|38118356|FG007|Period 1|Withdrawal by Subject|0|||
16974604|NCT01133405|38118357|FG008|Period 1|Withdrawal by Subject|0|||
16974605|NCT01133405|38118358|FG009|Period 1|Withdrawal by Subject|0|||
16974606|NCT01133405|38118349|FG000|Period 1|Physician Decision|0|||
16974607|NCT01133405|38118350|FG001|Period 1|Physician Decision|0|||
16974608|NCT01133405|38118351|FG002|Period 1|Physician Decision|0|||
16974609|NCT01133405|38118352|FG003|Period 1|Physician Decision|1|||
16974610|NCT01133405|38118353|FG004|Period 1|Physician Decision|0|||
16974611|NCT01133405|38118354|FG005|Period 1|Physician Decision|0|||
16974612|NCT01133405|38118355|FG006|Period 1|Physician Decision|0|||
16974613|NCT01133405|38118356|FG007|Period 1|Physician Decision|0|||
16974614|NCT01133405|38118357|FG008|Period 1|Physician Decision|0|||
16974615|NCT01133405|38118358|FG009|Period 1|Physician Decision|0|||
16974616|NCT01133405|38118349|FG000|Period 1|Discontinued after randomization|1|||
16974617|NCT01133405|38118350|FG001|Period 1|Discontinued after randomization|0|||
16974618|NCT01133405|38118351|FG002|Period 1|Discontinued after randomization|0|||
16974619|NCT01133405|38118352|FG003|Period 1|Discontinued after randomization|0|||
16974620|NCT01133405|38118353|FG004|Period 1|Discontinued after randomization|0|||
16974621|NCT01133405|38118354|FG005|Period 1|Discontinued after randomization|0|||
16974622|NCT01133405|38118355|FG006|Period 1|Discontinued after randomization|1|||
16974623|NCT01133405|38118356|FG007|Period 1|Discontinued after randomization|0|||
16974624|NCT01133405|38118357|FG008|Period 1|Discontinued after randomization|0|||
16974625|NCT01133405|38118358|FG009|Period 1|Discontinued after randomization|0|||
16974626|NCT01133405|38118349|FG000|Period 1|Received drug only in period 2|0|||
16974627|NCT01133405|38118350|FG001|Period 1|Received drug only in period 2|1|||
16974628|NCT01133405|38118351|FG002|Period 1|Received drug only in period 2|0|||
16974629|NCT01133405|38118352|FG003|Period 1|Received drug only in period 2|2|||
16974630|NCT01133405|38118353|FG004|Period 1|Received drug only in period 2|0|||
16974631|NCT01133405|38118354|FG005|Period 1|Received drug only in period 2|1|||
16974632|NCT01133405|38118355|FG006|Period 1|Received drug only in period 2|0|||
16974633|NCT01133405|38118356|FG007|Period 1|Received drug only in period 2|0|||
16974634|NCT01133405|38118357|FG008|Period 1|Received drug only in period 2|0|||
16974635|NCT01133405|38118358|FG009|Period 1|Received drug only in period 2|0|||
16974636|NCT01133405|38118349|FG000|Period 1|Received drug only in period 3|0|||
16974637|NCT01133405|38118350|FG001|Period 1|Received drug only in period 3|1|||
16974638|NCT01133405|38118351|FG002|Period 1|Received drug only in period 3|1|||
16974639|NCT01133405|38118352|FG003|Period 1|Received drug only in period 3|0|||
16974640|NCT01133405|38118353|FG004|Period 1|Received drug only in period 3|0|||
16974641|NCT01133405|38118354|FG005|Period 1|Received drug only in period 3|0|||
16974642|NCT01133405|38118355|FG006|Period 1|Received drug only in period 3|0|||
16974643|NCT01133405|38118356|FG007|Period 1|Received drug only in period 3|0|||
16974644|NCT01133405|38118357|FG008|Period 1|Received drug only in period 3|0|||
16974645|NCT01133405|38118358|FG009|Period 1|Received drug only in period 3|0|||
16974646|NCT01133405|38118349|FG000|Period 2|Adverse Event|0|||
16974647|NCT01133405|38118350|FG001|Period 2|Adverse Event|0|||
16974648|NCT01133405|38118351|FG002|Period 2|Adverse Event|1|||
16974649|NCT01133405|38118352|FG003|Period 2|Adverse Event|0|||
16974650|NCT01133405|38118353|FG004|Period 2|Adverse Event|0|||
16974651|NCT01133405|38118354|FG005|Period 2|Adverse Event|0|||
16974652|NCT01133405|38118355|FG006|Period 2|Adverse Event|0|||
16974653|NCT01133405|38118356|FG007|Period 2|Adverse Event|0|||
16974654|NCT01133405|38118357|FG008|Period 2|Adverse Event|0|||
16974655|NCT01133405|38118358|FG009|Period 2|Adverse Event|0|||
16974656|NCT01133405|38118349|FG000|Period 2|Withdrawal by Subject|0|||
16974657|NCT01133405|38118350|FG001|Period 2|Withdrawal by Subject|0|||
16974658|NCT01133405|38118351|FG002|Period 2|Withdrawal by Subject|0|||
16974659|NCT01133405|38118352|FG003|Period 2|Withdrawal by Subject|1|||
16974660|NCT01133405|38118353|FG004|Period 2|Withdrawal by Subject|0|||
16974661|NCT01133405|38118354|FG005|Period 2|Withdrawal by Subject|1|||
16974662|NCT01133405|38118355|FG006|Period 2|Withdrawal by Subject|0|||
16974663|NCT01133405|38118356|FG007|Period 2|Withdrawal by Subject|0|||
16974664|NCT01133405|38118357|FG008|Period 2|Withdrawal by Subject|0|||
16974665|NCT01133405|38118358|FG009|Period 2|Withdrawal by Subject|0|||
16974666|NCT01133405|38118349|FG000|Period 2|Entry Criteria Not Met|0|||
16974667|NCT01133405|38118350|FG001|Period 2|Entry Criteria Not Met|1|||
16974668|NCT01133405|38118351|FG002|Period 2|Entry Criteria Not Met|0|||
16974669|NCT01133405|38118352|FG003|Period 2|Entry Criteria Not Met|0|||
16974670|NCT01133405|38118353|FG004|Period 2|Entry Criteria Not Met|0|||
16974671|NCT01133405|38118354|FG005|Period 2|Entry Criteria Not Met|0|||
16974672|NCT01133405|38118355|FG006|Period 2|Entry Criteria Not Met|0|||
16974673|NCT01133405|38118356|FG007|Period 2|Entry Criteria Not Met|0|||
16974674|NCT01133405|38118357|FG008|Period 2|Entry Criteria Not Met|0|||
16974675|NCT01133405|38118358|FG009|Period 2|Entry Criteria Not Met|0|||
16974676|NCT01133405|38118349|FG000|Period 2|Physician Decision|0|||
16974677|NCT01133405|38118350|FG001|Period 2|Physician Decision|0|||
16974678|NCT01133405|38118351|FG002|Period 2|Physician Decision|0|||
16974679|NCT01133405|38118352|FG003|Period 2|Physician Decision|0|||
16974680|NCT01133405|38118353|FG004|Period 2|Physician Decision|0|||
16974681|NCT01133405|38118354|FG005|Period 2|Physician Decision|1|||
16974682|NCT01133405|38118355|FG006|Period 2|Physician Decision|0|||
16974683|NCT01133405|38118356|FG007|Period 2|Physician Decision|0|||
16974684|NCT01133405|38118357|FG008|Period 2|Physician Decision|0|||
16974685|NCT01133405|38118358|FG009|Period 2|Physician Decision|0|||
16974686|NCT01196078|38118390|FG000|Overall Study|Withdrawal by Subject|3|||
16974687|NCT01196078|38118391|FG001|Overall Study|Withdrawal by Subject|5|||
16974688|NCT01196078|38118390|FG000|Overall Study|Adverse Event|4|||
16974689|NCT01196078|38118391|FG001|Overall Study|Adverse Event|4|||
16974690|NCT01196078|38118390|FG000|Overall Study|Protocol Violation|2|||
16974691|NCT01196078|38118391|FG001|Overall Study|Protocol Violation|1|||
16974692|NCT01196078|38118390|FG000|Overall Study|Lack of Efficacy|17|||
16974693|NCT01196078|38118391|FG001|Overall Study|Lack of Efficacy|23|||
16974694|NCT01196078|38118390|FG000|Overall Study|Lost to Follow-up|1|||
16974695|NCT01196078|38118391|FG001|Overall Study|Lost to Follow-up|0|||
16974696|NCT01196078|38118390|FG000|Overall Study|Death|6|||
16974697|NCT01196078|38118391|FG001|Overall Study|Death|4|||
16974698|NCT01078584|38118397|FG000|Overall Study|Final Status Unknown|1073|||
16974699|NCT01078584|38118397|FG000|Overall Study|Lost to Follow-up|670|||
16974700|NCT01078584|38118397|FG000|Overall Study|Non-serious Adverse Event|577|||
16974701|NCT01078584|38118397|FG000|Overall Study|Withdrawal of Consent|244|||
16974702|NCT01078584|38118397|FG000|Overall Study|Physician Withdrew from Study|90|||
16974703|NCT01078584|38118397|FG000|Overall Study|Non-compliance|67|||
16974704|NCT01078584|38118397|FG000|Overall Study|Blood Pressure Controlled|49|||
16974705|NCT01078584|38118397|FG000|Overall Study|Physician Switched Medication|26|||
16974706|NCT01078584|38118397|FG000|Overall Study|Physician Discontinued Patient|12|||
16974707|NCT01078584|38118397|FG000|Overall Study|Lack of Efficacy|98|||
16974708|NCT01078584|38118397|FG000|Overall Study|Protocol Violation|75|||
16974709|NCT01078584|38118397|FG000|Overall Study|Serious Adverse Event|27|||
16974710|NCT01078584|38118397|FG000|Overall Study|Multiple Reasons|2|||
16974711|NCT01133171|38118417|FG000|Overall Study|Withdrawal by Subject|1|||
16974712|NCT01133171|38118418|FG001|Overall Study|Withdrawal by Subject|2|||
16974713|NCT01133171|38118419|FG002|Overall Study|Withdrawal by Subject|0|||
16974714|NCT01195844|38118427|FG000|Overall Study|Fecal sample not collected|40|||
16974715|NCT01132547|38118443|FG000|Overall Study|Withdrawal by Subject|3|||
16974716|NCT01132547|38118444|FG001|Overall Study|Withdrawal by Subject|1|||
16974717|NCT01132547|38118443|FG000|Overall Study|Death|1|||
16974718|NCT01132547|38118444|FG001|Overall Study|Death|0|||
16974719|NCT01194830|38118452|FG000|Overall Study|Adverse Event|3|||
16974720|NCT01194830|38118453|FG001|Overall Study|Adverse Event|2|||
16974721|NCT01194830|38118452|FG000|Overall Study|Protocol Violation|5|||
16974722|NCT01194830|38118453|FG001|Overall Study|Protocol Violation|4|||
16974723|NCT01194830|38118452|FG000|Overall Study|Lost to Follow-up|9|||
16974724|NCT01194830|38118453|FG001|Overall Study|Lost to Follow-up|7|||
16974725|NCT01194830|38118452|FG000|Overall Study|Withdrawal by Subject|2|||
16974726|NCT01194830|38118453|FG001|Overall Study|Withdrawal by Subject|1|||
16974727|NCT01194830|38118452|FG000|Overall Study|Lack of Efficacy|1|||
16974728|NCT01194830|38118453|FG001|Overall Study|Lack of Efficacy|1|||
16974729|NCT01194830|38118452|FG000|Overall Study|Non-compliance issues|4|||
16974730|NCT01194830|38118453|FG001|Overall Study|Non-compliance issues|4|||
16974731|NCT01194830|38118452|FG000|Overall Study|Other Reason|12|||
16974732|NCT01194830|38118453|FG001|Overall Study|Other Reason|8|||
16974733|NCT01194440|38118459|FG000|Baseline (First Dose)|Reason not specified|4|||
16974734|NCT01194440|38118459|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
16974735|NCT01194440|38118459|FG000|Baseline (First Dose)|Change in therapy|1|||
16974736|NCT01194440|38118459|FG000|Baseline (First Dose)|Adverse Event|1|||
16974737|NCT01194440|38118459|FG000|6-months (2nd Dose)|Change in therapy|4|||
16974738|NCT00951015|38118468|FG000|Randomization Phase 96 Week|Adverse Event|1|||
16974739|NCT00951015|38118469|FG001|Randomization Phase 96 Week|Adverse Event|1|||
16974740|NCT00951015|38118470|FG002|Randomization Phase 96 Week|Adverse Event|2|||
16974741|NCT00951015|38118471|FG003|Randomization Phase 96 Week|Adverse Event|5|||
16974742|NCT00951015|38118472|FG004|Randomization Phase 96 Week|Adverse Event|0|||
16974743|NCT00951015|38118468|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
16974744|NCT00951015|38118469|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
16974745|NCT00951015|38118470|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
16974746|NCT00951015|38118471|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
16974747|NCT00951015|38118472|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
16974748|NCT00951015|38118468|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
16974749|NCT00951015|38118469|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
16974750|NCT00951015|38118470|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
16974751|NCT00951015|38118471|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
16974752|NCT00951015|38118472|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
16974753|NCT00951015|38118468|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
16974754|NCT00951015|38118469|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
16974755|NCT00951015|38118470|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
16974756|NCT00951015|38118471|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
16974757|NCT00951015|38118472|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
16974758|NCT00951015|38118468|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
16974759|NCT00951015|38118469|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
16974760|NCT00951015|38118470|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
16974761|NCT00951015|38118471|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
16974762|NCT00951015|38118472|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
16974763|NCT00951015|38118468|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
16974764|NCT00951015|38118469|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
16974765|NCT00951015|38118470|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
16974766|NCT00951015|38118471|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
16974767|NCT00951015|38118472|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
16974768|NCT00951015|38118468|FG000|Open-label Phase|Adverse Event|0|||
16974769|NCT00951015|38118469|FG001|Open-label Phase|Adverse Event|0|||
16974770|NCT00951015|38118470|FG002|Open-label Phase|Adverse Event|0|||
16974771|NCT00951015|38118471|FG003|Open-label Phase|Adverse Event|0|||
16974772|NCT00951015|38118472|FG004|Open-label Phase|Adverse Event|3|||
16974773|NCT00951015|38118468|FG000|Open-label Phase|Lack of Efficacy|0|||
16974774|NCT00951015|38118469|FG001|Open-label Phase|Lack of Efficacy|0|||
16974775|NCT00951015|38118470|FG002|Open-label Phase|Lack of Efficacy|0|||
16974776|NCT00951015|38118471|FG003|Open-label Phase|Lack of Efficacy|0|||
16974777|NCT00951015|38118472|FG004|Open-label Phase|Lack of Efficacy|1|||
16974778|NCT00951015|38118468|FG000|Open-label Phase|Protocol Violation|0|||
16974779|NCT00951015|38118469|FG001|Open-label Phase|Protocol Violation|0|||
16974780|NCT00951015|38118470|FG002|Open-label Phase|Protocol Violation|0|||
16974781|NCT00951015|38118471|FG003|Open-label Phase|Protocol Violation|0|||
16974782|NCT00951015|38118472|FG004|Open-label Phase|Protocol Violation|12|||
16974783|NCT00951015|38118468|FG000|Open-label Phase|Lost to Follow-up|0|||
16974784|NCT00951015|38118469|FG001|Open-label Phase|Lost to Follow-up|0|||
16974785|NCT00951015|38118470|FG002|Open-label Phase|Lost to Follow-up|0|||
16974786|NCT00951015|38118471|FG003|Open-label Phase|Lost to Follow-up|0|||
16974787|NCT00951015|38118472|FG004|Open-label Phase|Lost to Follow-up|12|||
16974788|NCT00951015|38118468|FG000|Open-label Phase|Withdrawal by Subject|0|||
16974789|NCT00951015|38118469|FG001|Open-label Phase|Withdrawal by Subject|0|||
16974790|NCT00951015|38118470|FG002|Open-label Phase|Withdrawal by Subject|0|||
16974791|NCT00951015|38118471|FG003|Open-label Phase|Withdrawal by Subject|0|||
16974792|NCT00951015|38118472|FG004|Open-label Phase|Withdrawal by Subject|14|||
16974793|NCT00951015|38118468|FG000|Open-label Phase|Physician Decision|0|||
16974794|NCT00951015|38118469|FG001|Open-label Phase|Physician Decision|0|||
16974795|NCT00951015|38118470|FG002|Open-label Phase|Physician Decision|0|||
16974796|NCT00951015|38118471|FG003|Open-label Phase|Physician Decision|0|||
16974797|NCT00951015|38118472|FG004|Open-label Phase|Physician Decision|8|||
16974798|NCT01139021|38118501|FG000|Overall Study|Adverse Event|0|||
16974799|NCT01139021|38118502|FG001|Overall Study|Adverse Event|0|||
16974800|NCT01139021|38118503|FG002|Overall Study|Adverse Event|0|||
16974801|NCT01139021|38118504|FG003|Overall Study|Adverse Event|0|||
16974802|NCT01139021|38118505|FG004|Overall Study|Adverse Event|1|||
16974803|NCT01139021|38118506|FG005|Overall Study|Adverse Event|0|||
16974804|NCT01139021|38118501|FG000|Overall Study|Lost to Follow-up|0|||
16974805|NCT01139021|38118502|FG001|Overall Study|Lost to Follow-up|0|||
16974806|NCT01139021|38118503|FG002|Overall Study|Lost to Follow-up|0|||
16974807|NCT01139021|38118504|FG003|Overall Study|Lost to Follow-up|0|||
16974808|NCT01139021|38118505|FG004|Overall Study|Lost to Follow-up|2|||
16974809|NCT01139021|38118506|FG005|Overall Study|Lost to Follow-up|0|||
16974810|NCT01139021|38118501|FG000|Overall Study|Protocol Violation|1|||
16974811|NCT01139021|38118502|FG001|Overall Study|Protocol Violation|0|||
16974812|NCT01139021|38118503|FG002|Overall Study|Protocol Violation|0|||
16974813|NCT01139021|38118504|FG003|Overall Study|Protocol Violation|0|||
16974814|NCT01139021|38118505|FG004|Overall Study|Protocol Violation|2|||
16974815|NCT01139021|38118506|FG005|Overall Study|Protocol Violation|0|||
16974816|NCT01139021|38118501|FG000|Overall Study|Withdrawal by Subject|0|||
16974817|NCT01139021|38118502|FG001|Overall Study|Withdrawal by Subject|0|||
16974818|NCT01139021|38118503|FG002|Overall Study|Withdrawal by Subject|0|||
16974819|NCT01139021|38118504|FG003|Overall Study|Withdrawal by Subject|1|||
16974820|NCT01139021|38118505|FG004|Overall Study|Withdrawal by Subject|4|||
16780118|NCT02119156|37719188|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
16974821|NCT01139021|38118506|FG005|Overall Study|Withdrawal by Subject|0|||
16974822|NCT01193660|38118524|FG000|Overall Study|Withdrawal by Subject|2|||
16974823|NCT01193660|38118525|FG001|Overall Study|Withdrawal by Subject|3|||
16974824|NCT01193660|38118526|FG002|Overall Study|Withdrawal by Subject|1|||
16974825|NCT01193660|38118524|FG000|Overall Study|Death|1|||
16974826|NCT01193660|38118525|FG001|Overall Study|Death|0|||
16974827|NCT01193660|38118526|FG002|Overall Study|Death|0|||
16974828|NCT01193660|38118524|FG000|Overall Study|Physician Decision|1|||
16974829|NCT01193660|38118525|FG001|Overall Study|Physician Decision|0|||
16974830|NCT01193660|38118526|FG002|Overall Study|Physician Decision|1|||
16974831|NCT01076166|38118534|FG000|Overall Study|Adverse Event|3|||
16974832|NCT01076166|38118534|FG000|Overall Study|Symptoms improved/resolved|6|||
16974833|NCT01193582|38118545|FG000|Vaccination Series|Withdrawal by Subject|11|||
16974834|NCT01193582|38118546|FG001|Vaccination Series|Withdrawal by Subject|13|||
16974835|NCT01193582|38118547|FG002|Vaccination Series|Withdrawal by Subject|8|||
16974836|NCT01193582|38118548|FG003|Vaccination Series|Withdrawal by Subject|3|||
16974837|NCT01193582|38118545|FG000|12 Month Follow-up|Death|0|||
16974838|NCT01193582|38118546|FG001|12 Month Follow-up|Death|0|||
16974839|NCT01193582|38118547|FG002|12 Month Follow-up|Death|1|||
16974840|NCT01193582|38118548|FG003|12 Month Follow-up|Death|0|||
16974841|NCT01193582|38118545|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
16974842|NCT01193582|38118546|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
16974843|NCT01193582|38118547|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
16974844|NCT01193582|38118548|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
16974845|NCT00945477|38118560|FG000|Overall Study|Adverse Event|3|||
16974846|NCT00945477|38118560|FG000|Overall Study|Lack of Efficacy|2|||
16974847|NCT00945477|38118560|FG000|Overall Study|Withdrawal by Subject|1|||
16974848|NCT01076088|38118571|FG000|Overall Study|Adverse Event|1|||
16974849|NCT01076088|38118572|FG001|Overall Study|Adverse Event|6|||
16974850|NCT01076088|38118573|FG002|Overall Study|Adverse Event|3|||
16974851|NCT01076088|38118574|FG003|Overall Study|Adverse Event|2|||
16974852|NCT01076088|38118575|FG004|Overall Study|Adverse Event|3|||
16974853|NCT01076088|38118576|FG005|Overall Study|Adverse Event|3|||
16780119|NCT02119156|37719189|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
16780120|NCT02181556|37719204|FG000|Overall Study|Withdrawal by Subject|1|||
16780121|NCT02614131|37719215|FG000|Overall Study|Withdrawal by Subject|1|||
16780122|NCT02614131|37719216|FG001|Overall Study|Withdrawal by Subject|0|||
16780123|NCT02614131|37719217|FG002|Overall Study|Withdrawal by Subject|0|||
16780124|NCT02614131|37719218|FG003|Overall Study|Withdrawal by Subject|0|||
16780125|NCT02614131|37719219|FG004|Overall Study|Withdrawal by Subject|0|||
16974854|NCT01076088|38118571|FG000|Overall Study|Lost to Follow-up|1|||
16974855|NCT01076088|38118572|FG001|Overall Study|Lost to Follow-up|1|||
16974856|NCT01076088|38118573|FG002|Overall Study|Lost to Follow-up|0|||
16974857|NCT01076088|38118574|FG003|Overall Study|Lost to Follow-up|1|||
16974858|NCT01076088|38118575|FG004|Overall Study|Lost to Follow-up|1|||
16974859|NCT01076088|38118576|FG005|Overall Study|Lost to Follow-up|2|||
16974860|NCT01076088|38118571|FG000|Overall Study|Non-compliance with study drug|0|||
16974861|NCT01076088|38118572|FG001|Overall Study|Non-compliance with study drug|0|||
16780126|NCT02614131|37719220|FG005|Overall Study|Withdrawal by Subject|0|||
16780127|NCT02614131|37719221|FG006|Overall Study|Withdrawal by Subject|0|||
16780128|NCT02614131|37719215|FG000|Overall Study|Adverse Event|0|||
16780129|NCT02614131|37719216|FG001|Overall Study|Adverse Event|0|||
16780130|NCT02614131|37719217|FG002|Overall Study|Adverse Event|0|||
16780131|NCT02614131|37719218|FG003|Overall Study|Adverse Event|0|||
16974862|NCT01076088|38118573|FG002|Overall Study|Non-compliance with study drug|0|||
16974863|NCT01076088|38118574|FG003|Overall Study|Non-compliance with study drug|1|||
16974864|NCT01076088|38118575|FG004|Overall Study|Non-compliance with study drug|0|||
16974865|NCT01076088|38118576|FG005|Overall Study|Non-compliance with study drug|0|||
16974866|NCT01076088|38118571|FG000|Overall Study|Physician Decision|1|||
16974867|NCT01076088|38118572|FG001|Overall Study|Physician Decision|3|||
16974868|NCT01076088|38118573|FG002|Overall Study|Physician Decision|0|||
16974869|NCT01076088|38118574|FG003|Overall Study|Physician Decision|1|||
16974870|NCT01076088|38118575|FG004|Overall Study|Physician Decision|1|||
16974871|NCT01076088|38118576|FG005|Overall Study|Physician Decision|0|||
16974872|NCT01076088|38118571|FG000|Overall Study|Withdrawal by Subject|8|||
16974873|NCT01076088|38118572|FG001|Overall Study|Withdrawal by Subject|8|||
16974874|NCT01076088|38118573|FG002|Overall Study|Withdrawal by Subject|14|||
16974875|NCT01076088|38118574|FG003|Overall Study|Withdrawal by Subject|10|||
16974876|NCT01076088|38118575|FG004|Overall Study|Withdrawal by Subject|11|||
16974877|NCT01076088|38118576|FG005|Overall Study|Withdrawal by Subject|17|||
16974878|NCT01076088|38118571|FG000|Overall Study|Other protocol specified criteria|0|||
16974879|NCT01076088|38118572|FG001|Overall Study|Other protocol specified criteria|0|||
16974880|NCT01076088|38118573|FG002|Overall Study|Other protocol specified criteria|0|||
16974881|NCT01076088|38118574|FG003|Overall Study|Other protocol specified criteria|0|||
16974882|NCT01076088|38118575|FG004|Overall Study|Other protocol specified criteria|0|||
16974883|NCT01076088|38118576|FG005|Overall Study|Other protocol specified criteria|1|||
16974884|NCT01193348|38118591|FG000|Screening Period|Screen Failure|5|||
16974885|NCT01193348|38118591|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
16974886|NCT01193348|38118591|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
16974887|NCT01193348|38118591|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
16974888|NCT01193348|38118591|FG000|Extension Treatment Period|Physician Decision|1|||
16974889|NCT01193348|38118591|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
16974890|NCT00945321|38118600|FG000|Period 1|Adverse Event|0|||
16974891|NCT00945321|38118601|FG001|Period 1|Adverse Event|0|||
16974892|NCT00945321|38118602|FG002|Period 1|Adverse Event|0|||
16974893|NCT00945321|38118603|FG003|Period 1|Adverse Event|0|||
16974894|NCT00945321|38118604|FG004|Period 1|Adverse Event|1|||
16974895|NCT00945321|38118605|FG005|Period 1|Adverse Event|0|||
16974896|NCT00945321|38118600|FG000|Period 4|Lost to Follow-up|0|||
16974897|NCT00945321|38118601|FG001|Period 4|Lost to Follow-up|0|||
16974898|NCT00945321|38118602|FG002|Period 4|Lost to Follow-up|0|||
16974899|NCT00945321|38118603|FG003|Period 4|Lost to Follow-up|0|||
16974900|NCT00945321|38118604|FG004|Period 4|Lost to Follow-up|0|||
16974901|NCT00945321|38118605|FG005|Period 4|Lost to Follow-up|1|||
16974902|NCT00945243|38118623|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
16974903|NCT01192412|38118629|FG000|Overall Study|Lost to Follow-up|2|||
16974904|NCT01192412|38118630|FG001|Overall Study|Lost to Follow-up|1|||
16974905|NCT01192412|38118629|FG000|Overall Study|Withdrawal by Subject|2|||
16974906|NCT01192412|38118630|FG001|Overall Study|Withdrawal by Subject|1|||
16974907|NCT00944697|38118638|FG000|Overall Study|Withdrawal by Subject|1|||
16974908|NCT00944697|38118639|FG001|Overall Study|Withdrawal by Subject|1|||
16974909|NCT00944697|38118638|FG000|Overall Study|Adverse Event|0|||
16974910|NCT00944697|38118639|FG001|Overall Study|Adverse Event|3|||
16974911|NCT00944697|38118638|FG000|Overall Study|Administrative|1|||
16974912|NCT00944697|38118639|FG001|Overall Study|Administrative|1|||
16780132|NCT02614131|37719219|FG004|Overall Study|Adverse Event|0|||
16780133|NCT02614131|37719220|FG005|Overall Study|Adverse Event|0|||
16780134|NCT02614131|37719221|FG006|Overall Study|Adverse Event|1|||
16780135|NCT01903733|37719247|FG000|Overall Study|Death|23|||
16780136|NCT01903733|37719248|FG001|Overall Study|Death|54|||
16780137|NCT01903733|37719249|FG002|Overall Study|Death|30|||
16780138|NCT01903733|37719250|FG003|Overall Study|Death|98|||
16780139|NCT01903733|37719247|FG000|Overall Study|Participant refused further follow-up|35|||
16974913|NCT01192178|38118647|FG000|Overall Study|Withdrawal by Subject|6|||
16974914|NCT01192178|38118648|FG001|Overall Study|Withdrawal by Subject|10|||
16974915|NCT01192178|38118647|FG000|Overall Study|Protocol Violation|10|||
16974916|NCT01192178|38118648|FG001|Overall Study|Protocol Violation|3|||
16974917|NCT01192178|38118647|FG000|Overall Study|Physician Decision|2|||
16974918|NCT01192178|38118648|FG001|Overall Study|Physician Decision|4|||
16974919|NCT01192178|38118647|FG000|Overall Study|Lost to Follow-up|3|||
16974920|NCT01192178|38118648|FG001|Overall Study|Lost to Follow-up|3|||
16974921|NCT01192178|38118647|FG000|Overall Study|Adverse Event|2|||
16974922|NCT01192178|38118648|FG001|Overall Study|Adverse Event|1|||
16974923|NCT01192178|38118647|FG000|Overall Study|Lack of Efficacy|1|||
16974924|NCT01192178|38118648|FG001|Overall Study|Lack of Efficacy|2|||
16974925|NCT01192100|38118656|FG000|Overall Study|Withdrawal by Subject|0|||
16974926|NCT01192100|38118657|FG001|Overall Study|Withdrawal by Subject|0|||
16974927|NCT01192100|38118658|FG002|Overall Study|Withdrawal by Subject|0|||
16974928|NCT01192100|38118659|FG003|Overall Study|Withdrawal by Subject|0|||
16974929|NCT01192100|38118660|FG004|Overall Study|Withdrawal by Subject|1|||
16974930|NCT01192100|38118661|FG005|Overall Study|Withdrawal by Subject|0|||
16974931|NCT01192100|38118656|FG000|Overall Study|Protocol Violation|0|||
16974932|NCT01192100|38118657|FG001|Overall Study|Protocol Violation|0|||
16974933|NCT01192100|38118658|FG002|Overall Study|Protocol Violation|0|||
16974934|NCT01192100|38118659|FG003|Overall Study|Protocol Violation|1|||
16974935|NCT01192100|38118660|FG004|Overall Study|Protocol Violation|0|||
16974936|NCT01192100|38118661|FG005|Overall Study|Protocol Violation|0|||
16974937|NCT00869401|38118674|FG000|Overall Study|Withdrawal by Subject|0|||
16974938|NCT00869401|38118675|FG001|Overall Study|Withdrawal by Subject|0|||
16974939|NCT00869401|38118676|FG002|Overall Study|Withdrawal by Subject|0|||
16974940|NCT00869401|38118677|FG003|Overall Study|Withdrawal by Subject|5|||
16974941|NCT00869401|38118678|FG004|Overall Study|Withdrawal by Subject|3|||
16974942|NCT01076010|38118693|FG000|Overall Study|Death|15|||
16974943|NCT01076010|38118694|FG001|Overall Study|Death|1|||
16974944|NCT01076010|38118695|FG002|Overall Study|Death|0|||
16974945|NCT01076010|38118693|FG000|Overall Study|Adverse Event|7|||
16974946|NCT01076010|38118694|FG001|Overall Study|Adverse Event|2|||
16974947|NCT01076010|38118695|FG002|Overall Study|Adverse Event|0|||
16974948|NCT01076010|38118693|FG000|Overall Study|Progressive disease|90|||
16974949|NCT01076010|38118694|FG001|Overall Study|Progressive disease|30|||
16974950|NCT01076010|38118695|FG002|Overall Study|Progressive disease|1|||
16974951|NCT01076010|38118693|FG000|Overall Study|Lack of Efficacy|4|||
16974952|NCT01076010|38118694|FG001|Overall Study|Lack of Efficacy|0|||
16974953|NCT01076010|38118695|FG002|Overall Study|Lack of Efficacy|0|||
16974954|NCT01076010|38118693|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
16974955|NCT01076010|38118694|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
16974956|NCT01076010|38118695|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
16974957|NCT01076010|38118693|FG000|Overall Study|Significant Surgical Procedure|0|||
16974958|NCT01076010|38118694|FG001|Overall Study|Significant Surgical Procedure|1|||
16974959|NCT01076010|38118695|FG002|Overall Study|Significant Surgical Procedure|0|||
16974960|NCT01076010|38118693|FG000|Overall Study|Protocol Violation|0|||
16974961|NCT01076010|38118694|FG001|Overall Study|Protocol Violation|1|||
16974962|NCT01076010|38118695|FG002|Overall Study|Protocol Violation|0|||
16974963|NCT01076010|38118693|FG000|Overall Study|Noncompliance|1|||
16974964|NCT01076010|38118694|FG001|Overall Study|Noncompliance|1|||
16974965|NCT01076010|38118695|FG002|Overall Study|Noncompliance|0|||
16974966|NCT01076010|38118693|FG000|Overall Study|Withdrawal by Subject|3|||
16974967|NCT01076010|38118694|FG001|Overall Study|Withdrawal by Subject|0|||
16974968|NCT01076010|38118695|FG002|Overall Study|Withdrawal by Subject|1|||
16974969|NCT01076010|38118693|FG000|Overall Study|Other|5|||
16974970|NCT01076010|38118694|FG001|Overall Study|Other|2|||
16974971|NCT01076010|38118695|FG002|Overall Study|Other|0|||
16974972|NCT01075152|38118705|FG000|Overall Study|Withdrawal by Subject|1|||
16974973|NCT01075152|38118706|FG001|Overall Study|Withdrawal by Subject|0|||
16974974|NCT01078116|38118714|FG000|Overall Study|Lost to Follow-up|17|||
16974975|NCT01078116|38118714|FG000|Overall Study|Adverse Event|5|||
16974976|NCT01078116|38118714|FG000|Overall Study|Withdrawal by Subject|8|||
16974977|NCT01078116|38118714|FG000|Overall Study|Lack of effectiveness|15|||
16974978|NCT01078116|38118714|FG000|Overall Study|Case report form not completed|3|||
16974979|NCT00950859|38118720|FG000|Overall Study|Adverse Event|3|||
16974980|NCT00950859|38118721|FG001|Overall Study|Adverse Event|3|||
16974981|NCT00950859|38118720|FG000|Overall Study|Insufficient Viral Load Response|12|||
16974982|NCT00950859|38118721|FG001|Overall Study|Insufficient Viral Load Response|3|||
16974983|NCT00950859|38118720|FG000|Overall Study|Protocol Violation|1|||
16974984|NCT00950859|38118721|FG001|Overall Study|Protocol Violation|1|||
16974985|NCT00950859|38118720|FG000|Overall Study|Lost to Follow-up|0|||
16974986|NCT00950859|38118721|FG001|Overall Study|Lost to Follow-up|3|||
16974987|NCT00862849|38118727|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16974988|NCT00862849|38118728|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
16974989|NCT00862849|38118729|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16974990|NCT00862849|38118730|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16974991|NCT00862849|38118731|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16974992|NCT00862849|38118732|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16974993|NCT00862849|38118727|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16974994|NCT00862849|38118728|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
16974995|NCT00862849|38118729|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16974996|NCT00862849|38118730|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16974997|NCT00862849|38118731|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16974998|NCT00862849|38118732|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16974999|NCT01090050|38118742|FG000|Overall Study|Lost to Follow-up|0|||
16975000|NCT01090050|38118743|FG001|Overall Study|Lost to Follow-up|1|||
16975001|NCT01090050|38118742|FG000|Overall Study|Lack of Efficacy|1|||
16975002|NCT01090050|38118743|FG001|Overall Study|Lack of Efficacy|5|||
16975003|NCT01090050|38118742|FG000|Overall Study|Physician Decision|0|||
16975004|NCT01090050|38118743|FG001|Overall Study|Physician Decision|1|||
16975005|NCT00944229|38118753|FG000|Overall Study|Withdrawal by Subject|11|||
16975006|NCT00944229|38118753|FG000|Overall Study|Physician Decision|14|||
16975007|NCT01077960|38118757|FG000|Overall Study|Adverse Event|6|||
16975008|NCT01077960|38118757|FG000|Overall Study|Protocol Violation|3|||
16975009|NCT01077960|38118757|FG000|Overall Study|Lost to Follow-up|5|||
16975010|NCT01077960|38118757|FG000|Overall Study|Subject decision|1|||
16975011|NCT01077960|38118757|FG000|Overall Study|Reason unspecified|1|||
16975012|NCT01077804|38118761|FG000|Overall Study|Unreachable|102|||
16975013|NCT01077804|38118761|FG000|Overall Study|Refused to continue|79|||
16975014|NCT01077804|38118761|FG000|Overall Study|Other|18|||
16975015|NCT01075074|38118785|FG000|Overall Study|Surgeon changed to open incisional case|1|||
16975016|NCT01075074|38118786|FG001|Overall Study|Surgeon changed to open incisional case|2|||
16975017|NCT01075074|38118787|FG002|Overall Study|Surgeon changed to open incisional case|2|||
16975018|NCT00866281|38118801|FG000|Overall Study|Adverse Event|1|||
16975019|NCT00866281|38118802|FG001|Overall Study|Adverse Event|0|||
16975020|NCT00866281|38118801|FG000|Overall Study|Withdrawal by participants|3|||
16975021|NCT00866281|38118802|FG001|Overall Study|Withdrawal by participants|0|||
16975022|NCT00866281|38118801|FG000|Overall Study|Disease progression|3|||
16975023|NCT00866281|38118802|FG001|Overall Study|Disease progression|11|||
16975024|NCT00866281|38118801|FG000|Overall Study|New cancer therapy|0|||
16975025|NCT00866281|38118802|FG001|Overall Study|New cancer therapy|4|||
16975026|NCT01077258|38118811|FG000|Overall Study|Lost to Follow-up|1390|||
16975027|NCT01077258|38118811|FG000|Overall Study|Adverse drug reaction|218|||
16975028|NCT01077258|38118811|FG000|Overall Study|Lack of Efficacy|663|||
16975029|NCT01077258|38118811|FG000|Overall Study|Clinical remission|37|||
16975030|NCT01077258|38118811|FG000|Overall Study|Other reasons|260|||
16975031|NCT00943917|38118839|FG000|Stage I|Adverse Event|1|||
16975032|NCT00943917|38118840|FG001|Stage I|Adverse Event|2|||
16975033|NCT00943917|38118841|FG002|Stage I|Adverse Event|2|||
16975034|NCT00943917|38118842|FG003|Stage I|Adverse Event|0|||
16975035|NCT00943917|38118843|FG004|Stage I|Adverse Event|0|||
16975036|NCT00943917|38118844|FG005|Stage I|Adverse Event|0|||
16975037|NCT00943917|38118845|FG006|Stage I|Adverse Event|0|||
16975038|NCT00943917|38118846|FG007|Stage I|Adverse Event|0|||
16975039|NCT00943917|38118847|FG008|Stage I|Adverse Event|0|||
16975040|NCT00943917|38118848|FG009|Stage I|Adverse Event|0|||
16975041|NCT00943917|38118849|FG010|Stage I|Adverse Event|0|||
16975042|NCT00943917|38118850|FG011|Stage I|Adverse Event|0|||
16975043|NCT00943917|38118851|FG012|Stage I|Adverse Event|0|||
16975044|NCT00943917|38118852|FG013|Stage I|Adverse Event|0|||
16975045|NCT00943917|38118853|FG014|Stage I|Adverse Event|0|||
16975046|NCT00943917|38118839|FG000|Stage I|Lost to Follow-up|0|||
16975047|NCT00943917|38118840|FG001|Stage I|Lost to Follow-up|0|||
16780140|NCT01903733|37719248|FG001|Overall Study|Participant refused further follow-up|38|||
16780141|NCT01903733|37719249|FG002|Overall Study|Participant refused further follow-up|13|||
16780142|NCT01903733|37719250|FG003|Overall Study|Participant refused further follow-up|9|||
16780143|NCT01903733|37719247|FG000|Overall Study|Lost to Follow-up|18|||
16780144|NCT01903733|37719248|FG001|Overall Study|Lost to Follow-up|19|||
16780145|NCT01903733|37719249|FG002|Overall Study|Lost to Follow-up|6|||
16780146|NCT01903733|37719250|FG003|Overall Study|Lost to Follow-up|9|||
16780147|NCT01903733|37719247|FG000|Overall Study|Other|10|||
16780148|NCT01903733|37719248|FG001|Overall Study|Other|15|||
16780149|NCT01903733|37719249|FG002|Overall Study|Other|12|||
16780150|NCT01903733|37719250|FG003|Overall Study|Other|3|||
16780151|NCT01903733|37719247|FG000|Overall Study|Missing|2|||
16780152|NCT01903733|37719248|FG001|Overall Study|Missing|0|||
16780153|NCT01903733|37719249|FG002|Overall Study|Missing|0|||
16780154|NCT01903733|37719250|FG003|Overall Study|Missing|0|||
16780155|NCT01903733|37719247|FG000|Overall Study|Investigator request|18|||
16780156|NCT01903733|37719248|FG001|Overall Study|Investigator request|0|||
16780157|NCT01903733|37719249|FG002|Overall Study|Investigator request|0|||
16780158|NCT01903733|37719250|FG003|Overall Study|Investigator request|0|||
16780159|NCT01375205|37719272|FG000|Overall Study|Lost to Follow-up|15|||
16780160|NCT01375205|37719273|FG001|Overall Study|Lost to Follow-up|12|||
16975048|NCT00943917|38118841|FG002|Stage I|Lost to Follow-up|1|||
16975049|NCT00943917|38118842|FG003|Stage I|Lost to Follow-up|0|||
16975050|NCT00943917|38118843|FG004|Stage I|Lost to Follow-up|0|||
16975051|NCT00943917|38118844|FG005|Stage I|Lost to Follow-up|0|||
16975052|NCT00943917|38118845|FG006|Stage I|Lost to Follow-up|0|||
16975053|NCT00943917|38118846|FG007|Stage I|Lost to Follow-up|0|||
16975054|NCT00943917|38118847|FG008|Stage I|Lost to Follow-up|0|||
16975055|NCT00943917|38118848|FG009|Stage I|Lost to Follow-up|0|||
16975056|NCT00943917|38118849|FG010|Stage I|Lost to Follow-up|0|||
16975057|NCT00943917|38118850|FG011|Stage I|Lost to Follow-up|0|||
16975058|NCT00943917|38118851|FG012|Stage I|Lost to Follow-up|0|||
16975059|NCT00943917|38118852|FG013|Stage I|Lost to Follow-up|0|||
16975060|NCT00943917|38118853|FG014|Stage I|Lost to Follow-up|0|||
16975061|NCT00943917|38118839|FG000|Stage I|hyperglycemia|0|||
16975062|NCT00943917|38118840|FG001|Stage I|hyperglycemia|0|||
16975063|NCT00943917|38118841|FG002|Stage I|hyperglycemia|1|||
16975064|NCT00943917|38118842|FG003|Stage I|hyperglycemia|0|||
16975065|NCT00943917|38118843|FG004|Stage I|hyperglycemia|0|||
16975066|NCT00943917|38118844|FG005|Stage I|hyperglycemia|0|||
16975067|NCT00943917|38118845|FG006|Stage I|hyperglycemia|0|||
16975068|NCT00943917|38118846|FG007|Stage I|hyperglycemia|0|||
16975069|NCT00943917|38118847|FG008|Stage I|hyperglycemia|0|||
16975070|NCT00943917|38118848|FG009|Stage I|hyperglycemia|0|||
16975071|NCT00943917|38118849|FG010|Stage I|hyperglycemia|0|||
16975072|NCT00943917|38118850|FG011|Stage I|hyperglycemia|0|||
16975073|NCT00943917|38118851|FG012|Stage I|hyperglycemia|0|||
16975074|NCT00943917|38118852|FG013|Stage I|hyperglycemia|0|||
16975075|NCT00943917|38118853|FG014|Stage I|hyperglycemia|0|||
16975076|NCT00943917|38118839|FG000|Stage I|A1C elevation|1|||
16975077|NCT00943917|38118840|FG001|Stage I|A1C elevation|0|||
16975078|NCT00943917|38118841|FG002|Stage I|A1C elevation|0|||
16975079|NCT00943917|38118842|FG003|Stage I|A1C elevation|0|||
16975080|NCT00943917|38118843|FG004|Stage I|A1C elevation|0|||
16975081|NCT00943917|38118844|FG005|Stage I|A1C elevation|0|||
16975082|NCT00943917|38118845|FG006|Stage I|A1C elevation|0|||
16975083|NCT00943917|38118846|FG007|Stage I|A1C elevation|0|||
16975084|NCT00943917|38118847|FG008|Stage I|A1C elevation|0|||
16975085|NCT00943917|38118848|FG009|Stage I|A1C elevation|0|||
16975086|NCT00943917|38118849|FG010|Stage I|A1C elevation|0|||
16975087|NCT00943917|38118850|FG011|Stage I|A1C elevation|0|||
16975088|NCT00943917|38118851|FG012|Stage I|A1C elevation|0|||
16975089|NCT00943917|38118852|FG013|Stage I|A1C elevation|0|||
16975090|NCT00943917|38118853|FG014|Stage I|A1C elevation|0|||
16975091|NCT00943917|38118839|FG000|Stage I|Withdrawal by Subject|2|||
16975092|NCT00943917|38118840|FG001|Stage I|Withdrawal by Subject|1|||
16975093|NCT00943917|38118841|FG002|Stage I|Withdrawal by Subject|2|||
16975094|NCT00943917|38118842|FG003|Stage I|Withdrawal by Subject|0|||
16975095|NCT00943917|38118843|FG004|Stage I|Withdrawal by Subject|0|||
16975096|NCT00943917|38118844|FG005|Stage I|Withdrawal by Subject|0|||
16975097|NCT00943917|38118845|FG006|Stage I|Withdrawal by Subject|0|||
16975098|NCT00943917|38118846|FG007|Stage I|Withdrawal by Subject|0|||
16975099|NCT00943917|38118847|FG008|Stage I|Withdrawal by Subject|0|||
16975100|NCT00943917|38118848|FG009|Stage I|Withdrawal by Subject|0|||
16975101|NCT00943917|38118849|FG010|Stage I|Withdrawal by Subject|0|||
16975102|NCT00943917|38118850|FG011|Stage I|Withdrawal by Subject|0|||
16975103|NCT00943917|38118851|FG012|Stage I|Withdrawal by Subject|0|||
16975104|NCT00943917|38118852|FG013|Stage I|Withdrawal by Subject|0|||
16975105|NCT00943917|38118853|FG014|Stage I|Withdrawal by Subject|0|||
16975106|NCT00943917|38118839|FG000|Stage II|Adverse Event|0|||
16975107|NCT00943917|38118840|FG001|Stage II|Adverse Event|0|||
16975108|NCT00943917|38118841|FG002|Stage II|Adverse Event|0|||
16975109|NCT00943917|38118842|FG003|Stage II|Adverse Event|0|||
16975110|NCT00943917|38118843|FG004|Stage II|Adverse Event|0|||
16975111|NCT00943917|38118844|FG005|Stage II|Adverse Event|1|||
16975112|NCT00943917|38118845|FG006|Stage II|Adverse Event|3|||
16975113|NCT00943917|38118846|FG007|Stage II|Adverse Event|0|||
16975114|NCT00943917|38118847|FG008|Stage II|Adverse Event|1|||
16975115|NCT00943917|38118848|FG009|Stage II|Adverse Event|0|||
16975116|NCT00943917|38118849|FG010|Stage II|Adverse Event|0|||
16975117|NCT00943917|38118850|FG011|Stage II|Adverse Event|0|||
16975118|NCT00943917|38118851|FG012|Stage II|Adverse Event|0|||
16975119|NCT00943917|38118852|FG013|Stage II|Adverse Event|0|||
16975120|NCT00943917|38118853|FG014|Stage II|Adverse Event|0|||
16975121|NCT00943917|38118839|FG000|Stage II|Withdrawal by Subject|0|||
16975122|NCT00943917|38118840|FG001|Stage II|Withdrawal by Subject|0|||
16975123|NCT00943917|38118841|FG002|Stage II|Withdrawal by Subject|0|||
16975124|NCT00943917|38118842|FG003|Stage II|Withdrawal by Subject|0|||
16975125|NCT00943917|38118843|FG004|Stage II|Withdrawal by Subject|0|||
16975126|NCT00943917|38118844|FG005|Stage II|Withdrawal by Subject|1|||
16975127|NCT00943917|38118845|FG006|Stage II|Withdrawal by Subject|0|||
16975128|NCT00943917|38118846|FG007|Stage II|Withdrawal by Subject|0|||
16975129|NCT00943917|38118847|FG008|Stage II|Withdrawal by Subject|0|||
16975130|NCT00943917|38118848|FG009|Stage II|Withdrawal by Subject|0|||
16975131|NCT00943917|38118849|FG010|Stage II|Withdrawal by Subject|0|||
16975132|NCT00943917|38118850|FG011|Stage II|Withdrawal by Subject|0|||
16975133|NCT00943917|38118851|FG012|Stage II|Withdrawal by Subject|0|||
16975134|NCT00943917|38118852|FG013|Stage II|Withdrawal by Subject|0|||
16975135|NCT00943917|38118853|FG014|Stage II|Withdrawal by Subject|0|||
16975136|NCT00943917|38118839|FG000|Stage II|Pregnancy|0|||
16975137|NCT00943917|38118840|FG001|Stage II|Pregnancy|0|||
16975138|NCT00943917|38118841|FG002|Stage II|Pregnancy|0|||
16975139|NCT00943917|38118842|FG003|Stage II|Pregnancy|0|||
16975140|NCT00943917|38118843|FG004|Stage II|Pregnancy|0|||
16975141|NCT00943917|38118844|FG005|Stage II|Pregnancy|1|||
16975142|NCT00943917|38118845|FG006|Stage II|Pregnancy|0|||
16975143|NCT00943917|38118846|FG007|Stage II|Pregnancy|0|||
16975144|NCT00943917|38118847|FG008|Stage II|Pregnancy|0|||
16975145|NCT00943917|38118848|FG009|Stage II|Pregnancy|0|||
16975146|NCT00943917|38118849|FG010|Stage II|Pregnancy|0|||
16975147|NCT00943917|38118850|FG011|Stage II|Pregnancy|0|||
16975148|NCT00943917|38118851|FG012|Stage II|Pregnancy|0|||
16975149|NCT00943917|38118852|FG013|Stage II|Pregnancy|0|||
16975150|NCT00943917|38118853|FG014|Stage II|Pregnancy|0|||
16975151|NCT00943917|38118839|FG000|Stage II Continuation|Adverse Event|0|||
16975152|NCT00943917|38118840|FG001|Stage II Continuation|Adverse Event|0|||
16975153|NCT00943917|38118841|FG002|Stage II Continuation|Adverse Event|0|||
16975154|NCT00943917|38118842|FG003|Stage II Continuation|Adverse Event|0|||
16975155|NCT00943917|38118843|FG004|Stage II Continuation|Adverse Event|0|||
16975156|NCT00943917|38118844|FG005|Stage II Continuation|Adverse Event|0|||
16975157|NCT00943917|38118845|FG006|Stage II Continuation|Adverse Event|0|||
16975158|NCT00943917|38118846|FG007|Stage II Continuation|Adverse Event|0|||
16975159|NCT00943917|38118847|FG008|Stage II Continuation|Adverse Event|0|||
16975160|NCT00943917|38118848|FG009|Stage II Continuation|Adverse Event|0|||
16975161|NCT00943917|38118849|FG010|Stage II Continuation|Adverse Event|0|||
16975162|NCT00943917|38118850|FG011|Stage II Continuation|Adverse Event|1|||
16975163|NCT00943917|38118851|FG012|Stage II Continuation|Adverse Event|2|||
16975164|NCT00943917|38118852|FG013|Stage II Continuation|Adverse Event|1|||
16975165|NCT00943917|38118853|FG014|Stage II Continuation|Adverse Event|1|||
16975166|NCT00943917|38118839|FG000|Stage II Continuation|Withdrawal by Subject|0|||
16975167|NCT00943917|38118840|FG001|Stage II Continuation|Withdrawal by Subject|0|||
16975168|NCT00943917|38118841|FG002|Stage II Continuation|Withdrawal by Subject|0|||
16975169|NCT00943917|38118842|FG003|Stage II Continuation|Withdrawal by Subject|0|||
16975170|NCT00943917|38118843|FG004|Stage II Continuation|Withdrawal by Subject|0|||
16975171|NCT00943917|38118844|FG005|Stage II Continuation|Withdrawal by Subject|0|||
16975172|NCT00943917|38118845|FG006|Stage II Continuation|Withdrawal by Subject|0|||
16975173|NCT00943917|38118846|FG007|Stage II Continuation|Withdrawal by Subject|0|||
16975174|NCT00943917|38118847|FG008|Stage II Continuation|Withdrawal by Subject|0|||
16975175|NCT00943917|38118848|FG009|Stage II Continuation|Withdrawal by Subject|0|||
16975176|NCT00943917|38118849|FG010|Stage II Continuation|Withdrawal by Subject|0|||
16975177|NCT00943917|38118850|FG011|Stage II Continuation|Withdrawal by Subject|0|||
16975178|NCT00943917|38118851|FG012|Stage II Continuation|Withdrawal by Subject|0|||
16975179|NCT00943917|38118852|FG013|Stage II Continuation|Withdrawal by Subject|1|||
16975180|NCT00943917|38118853|FG014|Stage II Continuation|Withdrawal by Subject|3|||
16975181|NCT00943917|38118839|FG000|Stage II Continuation|Protocol Violation|0|||
16975182|NCT00943917|38118840|FG001|Stage II Continuation|Protocol Violation|0|||
16975183|NCT00943917|38118841|FG002|Stage II Continuation|Protocol Violation|0|||
16975184|NCT00943917|38118842|FG003|Stage II Continuation|Protocol Violation|0|||
16975185|NCT00943917|38118843|FG004|Stage II Continuation|Protocol Violation|0|||
16975186|NCT00943917|38118844|FG005|Stage II Continuation|Protocol Violation|0|||
16975187|NCT00943917|38118845|FG006|Stage II Continuation|Protocol Violation|0|||
16975188|NCT00943917|38118846|FG007|Stage II Continuation|Protocol Violation|0|||
16975189|NCT00943917|38118847|FG008|Stage II Continuation|Protocol Violation|0|||
16975190|NCT00943917|38118848|FG009|Stage II Continuation|Protocol Violation|1|||
16975191|NCT00943917|38118849|FG010|Stage II Continuation|Protocol Violation|0|||
16975192|NCT00943917|38118850|FG011|Stage II Continuation|Protocol Violation|1|||
16975193|NCT00943917|38118851|FG012|Stage II Continuation|Protocol Violation|0|||
16975194|NCT00943917|38118852|FG013|Stage II Continuation|Protocol Violation|0|||
16975195|NCT00943917|38118853|FG014|Stage II Continuation|Protocol Violation|0|||
16975196|NCT00943917|38118839|FG000|Stage II Continuation|hypoglycemia|0|||
16975197|NCT00943917|38118840|FG001|Stage II Continuation|hypoglycemia|0|||
16975198|NCT00943917|38118841|FG002|Stage II Continuation|hypoglycemia|0|||
16975199|NCT00943917|38118842|FG003|Stage II Continuation|hypoglycemia|0|||
16975200|NCT00943917|38118843|FG004|Stage II Continuation|hypoglycemia|0|||
16975201|NCT00943917|38118844|FG005|Stage II Continuation|hypoglycemia|0|||
16975202|NCT00943917|38118845|FG006|Stage II Continuation|hypoglycemia|0|||
16975203|NCT00943917|38118846|FG007|Stage II Continuation|hypoglycemia|0|||
16975204|NCT00943917|38118847|FG008|Stage II Continuation|hypoglycemia|0|||
16975205|NCT00943917|38118848|FG009|Stage II Continuation|hypoglycemia|0|||
16975206|NCT00943917|38118849|FG010|Stage II Continuation|hypoglycemia|0|||
16975207|NCT00943917|38118850|FG011|Stage II Continuation|hypoglycemia|0|||
16975208|NCT00943917|38118851|FG012|Stage II Continuation|hypoglycemia|1|||
16975209|NCT00943917|38118852|FG013|Stage II Continuation|hypoglycemia|0|||
16780161|NCT01375205|37719272|FG000|Overall Study|Withdrawal by Subject|6|||
16780162|NCT01375205|37719273|FG001|Overall Study|Withdrawal by Subject|1|||
16780163|NCT00700271|37719281|FG000|Overall Study|Adverse Event|4|||
16780164|NCT00700271|37719282|FG001|Overall Study|Adverse Event|6|||
16780165|NCT00700271|37719281|FG000|Overall Study|Protocol Violation|1|||
16780166|NCT00700271|37719282|FG001|Overall Study|Protocol Violation|0|||
16780167|NCT00700271|37719281|FG000|Overall Study|Administrative Reasons|1|||
16780168|NCT00700271|37719282|FG001|Overall Study|Administrative Reasons|0|||
16780169|NCT00700271|37719281|FG000|Overall Study|Withdrawal by Subject|6|||
16780170|NCT00700271|37719282|FG001|Overall Study|Withdrawal by Subject|4|||
16780171|NCT00700271|37719281|FG000|Overall Study|Lost to Follow-up|2|||
16780172|NCT00700271|37719282|FG001|Overall Study|Lost to Follow-up|2|||
16780173|NCT02613507|37719290|FG000|Overall Study|Disease Progression|237|||
16975210|NCT00943917|38118853|FG014|Stage II Continuation|hypoglycemia|0|||
16975211|NCT00943917|38118839|FG000|Stage II Continuation|A1C elevation|0|||
16975212|NCT00943917|38118840|FG001|Stage II Continuation|A1C elevation|0|||
16975213|NCT00943917|38118841|FG002|Stage II Continuation|A1C elevation|0|||
16975214|NCT00943917|38118842|FG003|Stage II Continuation|A1C elevation|0|||
16975215|NCT00943917|38118843|FG004|Stage II Continuation|A1C elevation|0|||
16975216|NCT00943917|38118844|FG005|Stage II Continuation|A1C elevation|0|||
16975217|NCT00943917|38118845|FG006|Stage II Continuation|A1C elevation|0|||
16975218|NCT00943917|38118846|FG007|Stage II Continuation|A1C elevation|0|||
16975219|NCT00943917|38118847|FG008|Stage II Continuation|A1C elevation|0|||
16975220|NCT00943917|38118848|FG009|Stage II Continuation|A1C elevation|0|||
16975221|NCT00943917|38118849|FG010|Stage II Continuation|A1C elevation|0|||
16975222|NCT00943917|38118850|FG011|Stage II Continuation|A1C elevation|0|||
16975223|NCT00943917|38118851|FG012|Stage II Continuation|A1C elevation|0|||
16975224|NCT00943917|38118852|FG013|Stage II Continuation|A1C elevation|1|||
16975225|NCT00943917|38118853|FG014|Stage II Continuation|A1C elevation|0|||
16975226|NCT01077024|38118888|FG000|Overall Study|Lost to Follow-up|20|||
16975227|NCT01077024|38118889|FG001|Overall Study|Lost to Follow-up|14|||
16975228|NCT01077024|38118888|FG000|Overall Study|Withdrawal by Subject|0|||
16975229|NCT01077024|38118889|FG001|Overall Study|Withdrawal by Subject|2|||
16975230|NCT01077024|38118888|FG000|Overall Study|Incarcerated|7|||
16975231|NCT01077024|38118889|FG001|Overall Study|Incarcerated|8|||
16975232|NCT01077024|38118888|FG000|Overall Study|Other|4|||
16975233|NCT01077024|38118889|FG001|Overall Study|Other|4|||
16975234|NCT01089582|38118895|FG000|Overall Study|Death|2|||
16975235|NCT01089582|38118895|FG000|Overall Study|Adverse Event|15|||
16975236|NCT01089582|38118895|FG000|Overall Study|Lost to Follow-up|8|||
16975237|NCT01089582|38118895|FG000|Overall Study|Other|4|||
16975238|NCT01089582|38118895|FG000|Overall Study|Withdrawal by Subject|1|||
16975239|NCT00862459|38118902|FG000|Overall Study|Lost to Follow-up|1|||
16975240|NCT00862459|38118903|FG001|Overall Study|Lost to Follow-up|2|||
16975241|NCT00862459|38118904|FG002|Overall Study|Lost to Follow-up|2|||
16975242|NCT00862459|38118902|FG000|Overall Study|Protocol Violation|1|||
16975243|NCT00862459|38118903|FG001|Overall Study|Protocol Violation|0|||
16975244|NCT00862459|38118904|FG002|Overall Study|Protocol Violation|0|||
16975245|NCT00862459|38118902|FG000|Overall Study|Withdrawal by Subject|1|||
16975246|NCT00862459|38118903|FG001|Overall Study|Withdrawal by Subject|1|||
16975247|NCT00862459|38118904|FG002|Overall Study|Withdrawal by Subject|3|||
16975248|NCT00862459|38118902|FG000|Overall Study|Adverse Event|0|||
16975249|NCT00862459|38118903|FG001|Overall Study|Adverse Event|1|||
16975250|NCT00862459|38118904|FG002|Overall Study|Adverse Event|0|||
16975251|NCT00862459|38118902|FG000|Overall Study|Personal reasons|1|||
16975252|NCT00862459|38118903|FG001|Overall Study|Personal reasons|0|||
16975253|NCT00862459|38118904|FG002|Overall Study|Personal reasons|0|||
16975254|NCT00862459|38118902|FG000|Overall Study|Operation|1|||
16975255|NCT00862459|38118903|FG001|Overall Study|Operation|1|||
16975256|NCT00862459|38118904|FG002|Overall Study|Operation|0|||
16975257|NCT00862459|38118902|FG000|Overall Study|Intravenous (IV) site problems|1|||
16975258|NCT00862459|38118903|FG001|Overall Study|Intravenous (IV) site problems|0|||
16975259|NCT00862459|38118904|FG002|Overall Study|Intravenous (IV) site problems|1|||
16975260|NCT00862459|38118902|FG000|Overall Study|Unable to hold still for imaging|0|||
16975261|NCT00862459|38118903|FG001|Overall Study|Unable to hold still for imaging|1|||
16975262|NCT00862459|38118904|FG002|Overall Study|Unable to hold still for imaging|0|||
16975263|NCT00862459|38118902|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
16975264|NCT00862459|38118903|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
16975265|NCT00862459|38118904|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
16975266|NCT00862459|38118902|FG000|Overall Study|Administrative problems|0|||
16975267|NCT00862459|38118903|FG001|Overall Study|Administrative problems|1|||
16975268|NCT00862459|38118904|FG002|Overall Study|Administrative problems|0|||
16975269|NCT00580047|38118916|FG000|Overall Study|Lost to Follow-up|1|||
16975270|NCT00580047|38118917|FG001|Overall Study|Lost to Follow-up|1|||
16975271|NCT00580047|38118918|FG002|Overall Study|Lost to Follow-up|0|||
16975272|NCT00580047|38118916|FG000|Overall Study|Withdrawal by Subject|1|||
16975273|NCT00580047|38118917|FG001|Overall Study|Withdrawal by Subject|1|||
16975274|NCT00580047|38118918|FG002|Overall Study|Withdrawal by Subject|2|||
16975275|NCT00580047|38118916|FG000|Overall Study|Withdrawal by Subject|1|||
16975276|NCT00580047|38118917|FG001|Overall Study|Withdrawal by Subject|0|||
16975277|NCT00580047|38118918|FG002|Overall Study|Withdrawal by Subject|0|||
16975278|NCT01074450|38118931|FG000|First Intervention|Emesis in Dosing Interval|0|||
16975279|NCT01074450|38118932|FG001|First Intervention|Emesis in Dosing Interval|2|||
16975280|NCT01074450|38118931|FG000|Second Intervention|Protocol Violation|1|||
16975281|NCT01074450|38118932|FG001|Second Intervention|Protocol Violation|0|||
16975282|NCT01074450|38118931|FG000|Second Intervention|Physician Decision|0|||
16975283|NCT01074450|38118932|FG001|Second Intervention|Physician Decision|1|||
16975284|NCT00943761|38118940|FG000|Overall Study|Lost to Follow-up|2|||
16975285|NCT00943761|38118941|FG001|Overall Study|Lost to Follow-up|0|||
16975286|NCT00943761|38118940|FG000|Overall Study|Withdrawal by Subject|2|||
16975287|NCT00943761|38118941|FG001|Overall Study|Withdrawal by Subject|1|||
16975288|NCT00949533|38118949|FG000|Overall Study|Lost to Follow-up|0|||
16975289|NCT00949533|38118950|FG001|Overall Study|Lost to Follow-up|1|||
16975290|NCT00866047|38118956|FG000|Treatment Period|Progressive disease|13|||
16975291|NCT00866047|38118956|FG000|Treatment Period|Adverse Event|16|||
16975292|NCT00866047|38118956|FG000|Treatment Period|Physician Decision|14|||
16975293|NCT00866047|38118956|FG000|Treatment Period|Withdrawal by Subject|5|||
16975294|NCT00866047|38118956|FG000|Follow-up Period|Lost to Follow-up|5|||
16975295|NCT00869323|38118960|FG000|Maintenance Therapy|concurrent illness|1|||
16975296|NCT01192022|38118968|FG000|Overall Study|Withdrawal of Consent|3|||
16975297|NCT01192022|38118969|FG001|Overall Study|Withdrawal of Consent|1|||
16975298|NCT01192022|38118970|FG002|Overall Study|Withdrawal of Consent|0|||
16975299|NCT01192022|38118971|FG003|Overall Study|Withdrawal of Consent|0|||
16975300|NCT01192022|38118972|FG004|Overall Study|Withdrawal of Consent|0|||
16975301|NCT01192022|38118968|FG000|Overall Study|Lost to Follow-up|4|||
16975302|NCT01192022|38118969|FG001|Overall Study|Lost to Follow-up|2|||
16975303|NCT01192022|38118970|FG002|Overall Study|Lost to Follow-up|1|||
16975304|NCT01192022|38118971|FG003|Overall Study|Lost to Follow-up|1|||
16975305|NCT01192022|38118972|FG004|Overall Study|Lost to Follow-up|0|||
16975306|NCT01192022|38118968|FG000|Overall Study|Adverse Event|1|||
16975307|NCT01192022|38118969|FG001|Overall Study|Adverse Event|0|||
16975308|NCT01192022|38118970|FG002|Overall Study|Adverse Event|0|||
16975309|NCT01192022|38118971|FG003|Overall Study|Adverse Event|0|||
16975310|NCT01192022|38118972|FG004|Overall Study|Adverse Event|0|||
16975311|NCT01192022|38118968|FG000|Overall Study|Fatal Adverse Event|4|||
16975312|NCT01192022|38118969|FG001|Overall Study|Fatal Adverse Event|6|||
16975313|NCT01192022|38118970|FG002|Overall Study|Fatal Adverse Event|0|||
16975314|NCT01192022|38118971|FG003|Overall Study|Fatal Adverse Event|0|||
16975315|NCT01192022|38118972|FG004|Overall Study|Fatal Adverse Event|1|||
16975316|NCT01192022|38118968|FG000|Overall Study|Physician withdrew-patient hardship|1|||
16975317|NCT01192022|38118969|FG001|Overall Study|Physician withdrew-patient hardship|0|||
16975318|NCT01192022|38118970|FG002|Overall Study|Physician withdrew-patient hardship|0|||
16975319|NCT01192022|38118971|FG003|Overall Study|Physician withdrew-patient hardship|0|||
16975320|NCT01192022|38118972|FG004|Overall Study|Physician withdrew-patient hardship|0|||
16975321|NCT01192022|38118968|FG000|Overall Study|Patient too sick from chemotherapy|0|||
16975322|NCT01192022|38118969|FG001|Overall Study|Patient too sick from chemotherapy|1|||
16975323|NCT01192022|38118970|FG002|Overall Study|Patient too sick from chemotherapy|0|||
16975324|NCT01192022|38118971|FG003|Overall Study|Patient too sick from chemotherapy|0|||
16975325|NCT01192022|38118972|FG004|Overall Study|Patient too sick from chemotherapy|0|||
16975326|NCT01192022|38118968|FG000|Overall Study|Patient needed surgery|0|||
16975327|NCT01192022|38118969|FG001|Overall Study|Patient needed surgery|1|||
16975328|NCT01192022|38118970|FG002|Overall Study|Patient needed surgery|0|||
16975329|NCT01192022|38118971|FG003|Overall Study|Patient needed surgery|0|||
16975330|NCT01192022|38118972|FG004|Overall Study|Patient needed surgery|0|||
16975331|NCT01192022|38118968|FG000|Overall Study|Parents did not allow all follow up|0|||
16975332|NCT01192022|38118969|FG001|Overall Study|Parents did not allow all follow up|0|||
16975333|NCT01192022|38118970|FG002|Overall Study|Parents did not allow all follow up|0|||
16975334|NCT01192022|38118971|FG003|Overall Study|Parents did not allow all follow up|1|||
16975335|NCT01192022|38118972|FG004|Overall Study|Parents did not allow all follow up|0|||
16975336|NCT01191944|38118985|FG000|Overall Study|Adverse Event|11|||
16975337|NCT01191944|38118986|FG001|Overall Study|Adverse Event|12|||
16975338|NCT01191944|38118985|FG000|Overall Study|Protocol Violation|1|||
16975339|NCT01191944|38118986|FG001|Overall Study|Protocol Violation|2|||
16975340|NCT01191944|38118985|FG000|Overall Study|Withdrawal by Subject|4|||
16975341|NCT01191944|38118986|FG001|Overall Study|Withdrawal by Subject|2|||
16975342|NCT01191944|38118985|FG000|Overall Study|Other|1|||
16975343|NCT01191944|38118986|FG001|Overall Study|Other|3|||
16975344|NCT01191788|38118994|FG000|Overall Study|Lost to Follow-up|21|||
16975345|NCT01191788|38118995|FG001|Overall Study|Lost to Follow-up|22|||
16975346|NCT00940875|38119004|FG000|Treatment Phase|Adverse Event|9|||
16975347|NCT00940875|38119005|FG001|Treatment Phase|Adverse Event|3|||
16975348|NCT00940875|38119004|FG000|Treatment Phase|Death|3|||
16975349|NCT00940875|38119005|FG001|Treatment Phase|Death|5|||
16975350|NCT00940875|38119004|FG000|Treatment Phase|Lack of Efficacy|1|||
16975351|NCT00940875|38119005|FG001|Treatment Phase|Lack of Efficacy|0|||
16975352|NCT00940875|38119004|FG000|Treatment Phase|Withdrawal by Subject|3|||
16975353|NCT00940875|38119005|FG001|Treatment Phase|Withdrawal by Subject|0|||
16975354|NCT00940875|38119004|FG000|Treatment Phase|Disease progression|9|||
16975355|NCT00940875|38119005|FG001|Treatment Phase|Disease progression|11|||
16975356|NCT00940875|38119004|FG000|Treatment Phase|Physician Decision|1|||
16975357|NCT00940875|38119005|FG001|Treatment Phase|Physician Decision|0|||
16975358|NCT00940875|38119004|FG000|Post-Study Treatment|Death|0|||
16975359|NCT00940875|38119005|FG001|Post-Study Treatment|Death|1|||
16975360|NCT00940875|38119004|FG000|Post-Study Treatment|Disease Progression|0|||
16975361|NCT00940875|38119005|FG001|Post-Study Treatment|Disease Progression|2|||
16975362|NCT00940485|38119014|FG000|Overall Study|HBeAb positive at Baseline|3|||
16975363|NCT00940485|38119015|FG001|Overall Study|HBeAb positive at Baseline|2|||
16975364|NCT00940485|38119014|FG000|Overall Study|Lost to Follow-up|2|||
16975365|NCT00940485|38119015|FG001|Overall Study|Lost to Follow-up|3|||
16975366|NCT00940485|38119014|FG000|Overall Study|Adverse Event|8|||
16975367|NCT00940485|38119015|FG001|Overall Study|Adverse Event|0|||
16975368|NCT00940485|38119014|FG000|Overall Study|Withdrawal by Subject|1|||
16975369|NCT00940485|38119015|FG001|Overall Study|Withdrawal by Subject|1|||
16975370|NCT00940485|38119014|FG000|Overall Study|Others|1|||
16975371|NCT00940485|38119015|FG001|Overall Study|Others|1|||
16975372|NCT00943605|38119023|FG000|Overall Study|Study termination|30|||
16975373|NCT00943605|38119024|FG001|Overall Study|Study termination|30|||
16975374|NCT01132313|38119042|FG000|Overall Study|Lack of Efficacy|1|||
16975375|NCT01132313|38119043|FG001|Overall Study|Lack of Efficacy|0|||
16975376|NCT01132313|38119044|FG002|Overall Study|Lack of Efficacy|0|||
16975377|NCT01132313|38119045|FG003|Overall Study|Lack of Efficacy|0|||
16975378|NCT01132313|38119046|FG004|Overall Study|Lack of Efficacy|0|||
16975379|NCT01132313|38119047|FG005|Overall Study|Lack of Efficacy|0|||
16975380|NCT01132313|38119048|FG006|Overall Study|Lack of Efficacy|0|||
16975381|NCT01132313|38119049|FG007|Overall Study|Lack of Efficacy|3|||
16975382|NCT01132313|38119050|FG008|Overall Study|Lack of Efficacy|14|||
16975383|NCT01132313|38119051|FG009|Overall Study|Lack of Efficacy|16|||
16975384|NCT01132313|38119052|FG010|Overall Study|Lack of Efficacy|0|||
16975385|NCT01132313|38119053|FG011|Overall Study|Lack of Efficacy|0|||
16975386|NCT01132313|38119042|FG000|Overall Study|Not treated|2|||
16975387|NCT01132313|38119043|FG001|Overall Study|Not treated|0|||
16975388|NCT01132313|38119044|FG002|Overall Study|Not treated|0|||
16975389|NCT01132313|38119045|FG003|Overall Study|Not treated|0|||
16975390|NCT01132313|38119046|FG004|Overall Study|Not treated|2|||
16975391|NCT01132313|38119047|FG005|Overall Study|Not treated|1|||
16975392|NCT01132313|38119048|FG006|Overall Study|Not treated|3|||
16975393|NCT01132313|38119049|FG007|Overall Study|Not treated|0|||
16975394|NCT01132313|38119050|FG008|Overall Study|Not treated|0|||
16975395|NCT01132313|38119051|FG009|Overall Study|Not treated|0|||
16975396|NCT01132313|38119052|FG010|Overall Study|Not treated|0|||
16975397|NCT01132313|38119053|FG011|Overall Study|Not treated|0|||
16975398|NCT01132313|38119042|FG000|Overall Study|Adverse Event|0|||
16975399|NCT01132313|38119043|FG001|Overall Study|Adverse Event|0|||
16975400|NCT01132313|38119044|FG002|Overall Study|Adverse Event|4|||
16975401|NCT01132313|38119045|FG003|Overall Study|Adverse Event|10|||
16975402|NCT01132313|38119046|FG004|Overall Study|Adverse Event|19|||
16975403|NCT01132313|38119047|FG005|Overall Study|Adverse Event|6|||
16975404|NCT01132313|38119048|FG006|Overall Study|Adverse Event|5|||
16975405|NCT01132313|38119049|FG007|Overall Study|Adverse Event|3|||
16975406|NCT01132313|38119050|FG008|Overall Study|Adverse Event|7|||
16975407|NCT01132313|38119051|FG009|Overall Study|Adverse Event|2|||
16975408|NCT01132313|38119052|FG010|Overall Study|Adverse Event|0|||
16975409|NCT01132313|38119053|FG011|Overall Study|Adverse Event|0|||
16975410|NCT01132313|38119042|FG000|Overall Study|Protocol Violation|0|||
16975411|NCT01132313|38119043|FG001|Overall Study|Protocol Violation|0|||
16975412|NCT01132313|38119044|FG002|Overall Study|Protocol Violation|0|||
16975413|NCT01132313|38119045|FG003|Overall Study|Protocol Violation|1|||
16975414|NCT01132313|38119046|FG004|Overall Study|Protocol Violation|0|||
16975415|NCT01132313|38119047|FG005|Overall Study|Protocol Violation|0|||
16975416|NCT01132313|38119048|FG006|Overall Study|Protocol Violation|0|||
16975417|NCT01132313|38119049|FG007|Overall Study|Protocol Violation|0|||
16975418|NCT01132313|38119050|FG008|Overall Study|Protocol Violation|0|||
16975419|NCT01132313|38119051|FG009|Overall Study|Protocol Violation|0|||
16975420|NCT01132313|38119052|FG010|Overall Study|Protocol Violation|0|||
16975421|NCT01132313|38119053|FG011|Overall Study|Protocol Violation|0|||
16975422|NCT01132313|38119042|FG000|Overall Study|Lost to Follow-up|0|||
16975423|NCT01132313|38119043|FG001|Overall Study|Lost to Follow-up|0|||
16975424|NCT01132313|38119044|FG002|Overall Study|Lost to Follow-up|1|||
16975425|NCT01132313|38119045|FG003|Overall Study|Lost to Follow-up|0|||
16975426|NCT01132313|38119046|FG004|Overall Study|Lost to Follow-up|0|||
16975427|NCT01132313|38119047|FG005|Overall Study|Lost to Follow-up|0|||
16975428|NCT01132313|38119048|FG006|Overall Study|Lost to Follow-up|0|||
16975429|NCT01132313|38119049|FG007|Overall Study|Lost to Follow-up|1|||
16975430|NCT01132313|38119050|FG008|Overall Study|Lost to Follow-up|0|||
16975431|NCT01132313|38119051|FG009|Overall Study|Lost to Follow-up|0|||
16975432|NCT01132313|38119052|FG010|Overall Study|Lost to Follow-up|0|||
16975433|NCT01132313|38119053|FG011|Overall Study|Lost to Follow-up|0|||
16975434|NCT01132313|38119042|FG000|Overall Study|Withdrawal by Subject|0|||
16975435|NCT01132313|38119043|FG001|Overall Study|Withdrawal by Subject|0|||
16975436|NCT01132313|38119044|FG002|Overall Study|Withdrawal by Subject|3|||
16975437|NCT01132313|38119045|FG003|Overall Study|Withdrawal by Subject|3|||
16975438|NCT01132313|38119046|FG004|Overall Study|Withdrawal by Subject|6|||
16975439|NCT01132313|38119047|FG005|Overall Study|Withdrawal by Subject|0|||
16975440|NCT01132313|38119048|FG006|Overall Study|Withdrawal by Subject|1|||
16975441|NCT01132313|38119049|FG007|Overall Study|Withdrawal by Subject|0|||
16975442|NCT01132313|38119050|FG008|Overall Study|Withdrawal by Subject|0|||
16975443|NCT01132313|38119051|FG009|Overall Study|Withdrawal by Subject|2|||
16975444|NCT01132313|38119052|FG010|Overall Study|Withdrawal by Subject|0|||
16975445|NCT01132313|38119053|FG011|Overall Study|Withdrawal by Subject|0|||
16975446|NCT01132313|38119042|FG000|Overall Study|Lack of antiviral response|0|||
16975447|NCT01132313|38119043|FG001|Overall Study|Lack of antiviral response|0|||
16975448|NCT01132313|38119044|FG002|Overall Study|Lack of antiviral response|12|||
16975449|NCT01132313|38119045|FG003|Overall Study|Lack of antiviral response|18|||
16975450|NCT01132313|38119046|FG004|Overall Study|Lack of antiviral response|18|||
16975451|NCT01132313|38119047|FG005|Overall Study|Lack of antiviral response|18|||
16975452|NCT01132313|38119048|FG006|Overall Study|Lack of antiviral response|21|||
16975453|NCT01132313|38119049|FG007|Overall Study|Lack of antiviral response|0|||
16975454|NCT01132313|38119050|FG008|Overall Study|Lack of antiviral response|0|||
16975455|NCT01132313|38119051|FG009|Overall Study|Lack of antiviral response|0|||
16975456|NCT01132313|38119052|FG010|Overall Study|Lack of antiviral response|1|||
16975457|NCT01132313|38119053|FG011|Overall Study|Lack of antiviral response|0|||
16975458|NCT01132313|38119042|FG000|Overall Study|Other reason not defined above|0|||
16975459|NCT01132313|38119043|FG001|Overall Study|Other reason not defined above|0|||
16975460|NCT01132313|38119044|FG002|Overall Study|Other reason not defined above|0|||
16975461|NCT01132313|38119045|FG003|Overall Study|Other reason not defined above|0|||
16975462|NCT01132313|38119046|FG004|Overall Study|Other reason not defined above|0|||
16975463|NCT01132313|38119047|FG005|Overall Study|Other reason not defined above|0|||
16975464|NCT01132313|38119048|FG006|Overall Study|Other reason not defined above|0|||
16975465|NCT01132313|38119049|FG007|Overall Study|Other reason not defined above|1|||
16975466|NCT01132313|38119050|FG008|Overall Study|Other reason not defined above|0|||
16975467|NCT01132313|38119051|FG009|Overall Study|Other reason not defined above|0|||
16975468|NCT01132313|38119052|FG010|Overall Study|Other reason not defined above|0|||
16975469|NCT01132313|38119053|FG011|Overall Study|Other reason not defined above|0|||
16975470|NCT00861757|38119088|FG000|Overall Study|Adverse Event|1|||
16975471|NCT00861757|38119089|FG001|Overall Study|Adverse Event|5|||
16975472|NCT00861757|38119090|FG002|Overall Study|Adverse Event|7|||
16975473|NCT00861757|38119091|FG003|Overall Study|Adverse Event|2|||
16975474|NCT00861757|38119088|FG000|Overall Study|Entry Criteria Not Met|1|||
16975475|NCT00861757|38119089|FG001|Overall Study|Entry Criteria Not Met|2|||
16975476|NCT00861757|38119090|FG002|Overall Study|Entry Criteria Not Met|1|||
16975477|NCT00861757|38119091|FG003|Overall Study|Entry Criteria Not Met|1|||
16975478|NCT00861757|38119088|FG000|Overall Study|Lack of Efficacy|3|||
16975479|NCT00861757|38119089|FG001|Overall Study|Lack of Efficacy|1|||
16975480|NCT00861757|38119090|FG002|Overall Study|Lack of Efficacy|0|||
16975481|NCT00861757|38119091|FG003|Overall Study|Lack of Efficacy|1|||
16975482|NCT00861757|38119088|FG000|Overall Study|Lost to Follow-up|1|||
16975483|NCT00861757|38119089|FG001|Overall Study|Lost to Follow-up|0|||
16975484|NCT00861757|38119090|FG002|Overall Study|Lost to Follow-up|1|||
16975485|NCT00861757|38119091|FG003|Overall Study|Lost to Follow-up|1|||
16975486|NCT00861757|38119088|FG000|Overall Study|Physician Decision|0|||
16975487|NCT00861757|38119089|FG001|Overall Study|Physician Decision|0|||
16975488|NCT00861757|38119090|FG002|Overall Study|Physician Decision|0|||
16975489|NCT00861757|38119091|FG003|Overall Study|Physician Decision|1|||
16975490|NCT00861757|38119088|FG000|Overall Study|Protocol Violation|2|||
16975491|NCT00861757|38119089|FG001|Overall Study|Protocol Violation|2|||
16975492|NCT00861757|38119090|FG002|Overall Study|Protocol Violation|4|||
16975493|NCT00861757|38119091|FG003|Overall Study|Protocol Violation|1|||
16975494|NCT00861757|38119088|FG000|Overall Study|Withdrawal by Subject|1|||
16975495|NCT00861757|38119089|FG001|Overall Study|Withdrawal by Subject|5|||
16975496|NCT00861757|38119090|FG002|Overall Study|Withdrawal by Subject|5|||
16975497|NCT00861757|38119091|FG003|Overall Study|Withdrawal by Subject|2|||
16975498|NCT01131455|38119108|FG000|Overall Study|Death of PI|6|||
16975499|NCT01131455|38119109|FG001|Overall Study|Death of PI|4|||
16975500|NCT01131455|38119110|FG002|Overall Study|Death of PI|0|||
16975501|NCT01138007|38119121|FG000|Overall Study|Adverse Event|4|||
16975502|NCT01138007|38119122|FG001|Overall Study|Adverse Event|12|||
16975503|NCT01138007|38119123|FG002|Overall Study|Adverse Event|9|||
16975504|NCT01138007|38119121|FG000|Overall Study|Lack of Efficacy|2|||
16975505|NCT01138007|38119122|FG001|Overall Study|Lack of Efficacy|0|||
16975506|NCT01138007|38119123|FG002|Overall Study|Lack of Efficacy|6|||
16975507|NCT01138007|38119121|FG000|Overall Study|Protocol Violation|2|||
16975508|NCT01138007|38119122|FG001|Overall Study|Protocol Violation|3|||
16975509|NCT01138007|38119123|FG002|Overall Study|Protocol Violation|2|||
16975510|NCT01138007|38119121|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
16975511|NCT01138007|38119122|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
16975512|NCT01138007|38119123|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
16975513|NCT01138007|38119121|FG000|Overall Study|Lost to Follow-up|3|||
16975514|NCT01138007|38119122|FG001|Overall Study|Lost to Follow-up|3|||
16975515|NCT01138007|38119123|FG002|Overall Study|Lost to Follow-up|5|||
16975516|NCT01138007|38119121|FG000|Overall Study|Physician Decision|0|||
16975517|NCT01138007|38119122|FG001|Overall Study|Physician Decision|5|||
16975518|NCT01138007|38119123|FG002|Overall Study|Physician Decision|3|||
16975519|NCT01138007|38119121|FG000|Overall Study|Withdrawal by Subject|5|||
16975520|NCT01138007|38119122|FG001|Overall Study|Withdrawal by Subject|6|||
16975521|NCT01138007|38119123|FG002|Overall Study|Withdrawal by Subject|15|||
16975522|NCT00865345|38119133|FG000|Overall Study|Withdrawal by Subject|2|||
16975523|NCT01131299|38119137|FG000|Overall Study|Withdrawal by Subject|4|||
16975524|NCT01131299|38119138|FG001|Overall Study|Withdrawal by Subject|7|||
16975525|NCT01130831|38119143|FG000|Overall Study|Withdrawal by Subject|7|||
16975526|NCT01130831|38119143|FG000|Overall Study|Death|4|||
16975527|NCT01130831|38119143|FG000|Overall Study|Information was missing|3|||
16975528|NCT01130597|38119159|FG000|Overall Study|Protocol-specified (High K+)|1|||
16975529|NCT01130597|38119159|FG000|Overall Study|Adverse Event|4|||
16975530|NCT01130597|38119159|FG000|Overall Study|Death|1|||
16975531|NCT01130597|38119159|FG000|Overall Study|Protocol Violation|1|||
16975532|NCT00939003|38119165|FG000|Double-blind Treatment Period|Adverse Event|1|||
16975533|NCT00939003|38119166|FG001|Double-blind Treatment Period|Adverse Event|1|||
16975534|NCT00939003|38119165|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16975535|NCT00939003|38119166|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
16975536|NCT00939003|38119165|FG000|Double-blind Treatment Period|Pregnancy|0|||
16975537|NCT00939003|38119166|FG001|Double-blind Treatment Period|Pregnancy|1|||
16975538|NCT00939003|38119165|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
16975539|NCT00939003|38119166|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
16975540|NCT00939003|38119165|FG000|Open-label Treatment Period|Adverse Event|4|||
16975541|NCT00939003|38119166|FG001|Open-label Treatment Period|Adverse Event|8|||
16975542|NCT00939003|38119165|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
16975543|NCT00939003|38119166|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
16975544|NCT00939003|38119165|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
16975545|NCT00939003|38119166|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
16975546|NCT00939003|38119165|FG000|Open-label Treatment Period|Pregnancy|1|||
16975547|NCT00939003|38119166|FG001|Open-label Treatment Period|Pregnancy|1|||
16975548|NCT00939003|38119165|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
16975549|NCT00939003|38119166|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
16975550|NCT00939003|38119165|FG000|Open-label Treatment Period|Site Closure|3|||
16975551|NCT00939003|38119166|FG001|Open-label Treatment Period|Site Closure|4|||
16975552|NCT01188668|38119175|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
16975553|NCT01188668|38119175|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
16975554|NCT01188668|38119175|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
16975555|NCT01130051|38119182|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
16975556|NCT01130051|38119183|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
16975557|NCT01130051|38119182|FG000|Washout Period of 14 Days|Protocol Violation|1|||
16975558|NCT01130051|38119183|FG001|Washout Period of 14 Days|Protocol Violation|1|||
16975559|NCT00865189|38119191|FG000|Overall Study|Other|1|||
16975560|NCT00865189|38119192|FG001|Overall Study|Other|2|||
16975561|NCT00865189|38119191|FG000|Overall Study|Death|4|||
16975562|NCT00865189|38119192|FG001|Overall Study|Death|11|||
16975563|NCT00865189|38119191|FG000|Overall Study|Lost to Follow-up|6|||
16975564|NCT00865189|38119192|FG001|Overall Study|Lost to Follow-up|6|||
16975565|NCT00865189|38119191|FG000|Overall Study|Withdrawal by Subject|1|||
16975566|NCT00865189|38119192|FG001|Overall Study|Withdrawal by Subject|0|||
16975567|NCT01182194|38119200|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
16975568|NCT01182194|38119201|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
16975569|NCT01181726|38119209|FG000|First Intervention|Adverse Event|1|||
16975570|NCT01181726|38119210|FG001|First Intervention|Adverse Event|0|||
16975571|NCT01137071|38119216|FG000|Overall Study|Disease Progression|11|||
16975572|NCT01137071|38119216|FG000|Overall Study|Withdrawal by Subject|2|||
16975573|NCT01137071|38119216|FG000|Overall Study|Wrongly Included|1|||
16975574|NCT00860743|38119231|FG000|Overall Study|Withdrawal by Subject|3|||
16975575|NCT00860743|38119232|FG001|Overall Study|Withdrawal by Subject|0|||
16975576|NCT01186796|38119240|FG000|Overall Study|Adverse Event|3|||
16975577|NCT01186796|38119241|FG001|Overall Study|Adverse Event|0|||
16975578|NCT01186796|38119240|FG000|Overall Study|Withdrawal by Subject|1|||
16975579|NCT01186796|38119241|FG001|Overall Study|Withdrawal by Subject|1|||
16975580|NCT01186796|38119240|FG000|Overall Study|Protocol Violation|0|||
16975581|NCT01186796|38119241|FG001|Overall Study|Protocol Violation|1|||
16975582|NCT01136915|38119249|FG000|Overall Study|Lost to Follow-up|2|||
16975583|NCT01136915|38119250|FG001|Overall Study|Lost to Follow-up|0|||
16975584|NCT01136915|38119249|FG000|Overall Study|Exclusion criterion met|0|||
16975585|NCT01136915|38119250|FG001|Overall Study|Exclusion criterion met|1|||
16975586|NCT00940017|38119258|FG000|Overall Study|did not meet entrance criteria|3|||
16975587|NCT00940017|38119258|FG000|Overall Study|Adverse Event|1|||
16975588|NCT01129583|38119264|FG000|Overall Study|Death|1|||
16975589|NCT01129583|38119265|FG001|Overall Study|Death|0|||
16975590|NCT01129583|38119264|FG000|Overall Study|Lost to Follow-up|1|||
16975591|NCT01129583|38119265|FG001|Overall Study|Lost to Follow-up|1|||
16975592|NCT01129583|38119264|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
16975593|NCT01129583|38119265|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
16975594|NCT01186328|38119271|FG000|Overall Study|Death|1|||
16975595|NCT01186328|38119272|FG001|Overall Study|Death|0|||
16975596|NCT01186328|38119273|FG002|Overall Study|Death|0|||
16975597|NCT00848497|38119280|FG000|Overall Study|Screen failure|2|||
16975598|NCT00848497|38119281|FG001|Overall Study|Screen failure|0|||
16975599|NCT00848497|38119280|FG000|Overall Study|Withdrawal by Subject|0|||
16975600|NCT00848497|38119281|FG001|Overall Study|Withdrawal by Subject|1|||
16975601|NCT00857623|38119291|FG000|Overall Study|Adverse Event|5|||
16975602|NCT00857623|38119292|FG001|Overall Study|Adverse Event|2|||
16975603|NCT00857623|38119291|FG000|Overall Study|Study-specific discontinuation criteria|5|||
16975604|NCT00857623|38119292|FG001|Overall Study|Study-specific discontinuation criteria|3|||
16975605|NCT00857623|38119291|FG000|Overall Study|Withdrawal by Subject|2|||
16975606|NCT00857623|38119292|FG001|Overall Study|Withdrawal by Subject|1|||
16975607|NCT00857623|38119291|FG000|Overall Study|Lack of Efficacy|1|||
16975608|NCT00857623|38119292|FG001|Overall Study|Lack of Efficacy|1|||
16975609|NCT00857623|38119291|FG000|Overall Study|Severe non-compliance to protocol|1|||
16975610|NCT00857623|38119292|FG001|Overall Study|Severe non-compliance to protocol|1|||
16975611|NCT00857623|38119291|FG000|Overall Study|Intake of prohibited medication|0|||
16975612|NCT00857623|38119292|FG001|Overall Study|Intake of prohibited medication|1|||
16975613|NCT00857623|38119291|FG000|Overall Study|Positive for HEP C|0|||
16975614|NCT00857623|38119292|FG001|Overall Study|Positive for HEP C|1|||
16975615|NCT01185782|38119300|FG000|Overall Study|Adverse Event|0|||
16975616|NCT01185782|38119301|FG001|Overall Study|Adverse Event|1|||
16975617|NCT01185782|38119300|FG000|Overall Study|Protocol Violation|1|||
16975618|NCT01185782|38119301|FG001|Overall Study|Protocol Violation|0|||
16975619|NCT01185782|38119300|FG000|Overall Study|Poor Response to Treatment|3|||
16975620|NCT01185782|38119301|FG001|Overall Study|Poor Response to Treatment|1|||
16975621|NCT01185782|38119300|FG000|Overall Study|Other|2|||
16975622|NCT01185782|38119301|FG001|Overall Study|Other|5|||
16975623|NCT01185782|38119300|FG000|Overall Study|Randomized but not treated|0|||
16975624|NCT01185782|38119301|FG001|Overall Study|Randomized but not treated|4|||
16975625|NCT01129115|38119311|FG000|Overall Study|Adverse Event|1|||
16975626|NCT01129115|38119312|FG001|Overall Study|Adverse Event|2|||
16975627|NCT01129115|38119313|FG002|Overall Study|Adverse Event|3|||
16975628|NCT01129115|38119314|FG003|Overall Study|Adverse Event|3|||
16975629|NCT01129115|38119311|FG000|Overall Study|Withdrawal by Subject|1|||
16975630|NCT01129115|38119312|FG001|Overall Study|Withdrawal by Subject|3|||
16975631|NCT01129115|38119313|FG002|Overall Study|Withdrawal by Subject|1|||
16975632|NCT01129115|38119314|FG003|Overall Study|Withdrawal by Subject|4|||
16975633|NCT01129115|38119311|FG000|Overall Study|Protocol Violation|0|||
16975634|NCT01129115|38119312|FG001|Overall Study|Protocol Violation|2|||
16975635|NCT01129115|38119313|FG002|Overall Study|Protocol Violation|2|||
16975636|NCT01129115|38119314|FG003|Overall Study|Protocol Violation|2|||
16975637|NCT01185704|38119326|FG000|Overall Study|Randomized but not treated|3|||
16975638|NCT01185704|38119327|FG001|Overall Study|Randomized but not treated|3|||
16975639|NCT01185704|38119326|FG000|Overall Study|Lack of ovarian response|5|||
16975640|NCT01185704|38119327|FG001|Overall Study|Lack of ovarian response|1|||
16975641|NCT01185704|38119326|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
16975642|NCT01185704|38119327|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
16975643|NCT01185704|38119326|FG000|Overall Study|Ectopic pregnancy|0|||
16975644|NCT01185704|38119327|FG001|Overall Study|Ectopic pregnancy|1|||
16975645|NCT01128959|38119333|FG000|Lead in Period|Adverse Event|3|||
16975646|NCT01128959|38119333|FG000|Treatment Period|Adverse Event|3|||
16975647|NCT01128959|38119333|FG000|Treatment Period|Withdrawal by Subject|1|||
16975648|NCT00859573|38119341|FG000|Overall Study|Withdrawal by Subject|4|||
16975649|NCT00859573|38119342|FG001|Overall Study|Withdrawal by Subject|1|||
16975650|NCT00859573|38119341|FG000|Overall Study|Physician Decision|1|||
16975651|NCT00859573|38119342|FG001|Overall Study|Physician Decision|1|||
16975652|NCT01136291|38119350|FG000|Overall Study|Lost to Follow-up|1|||
16975653|NCT01136291|38119351|FG001|Overall Study|Lost to Follow-up|1|||
16975654|NCT01185548|38119357|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
16975655|NCT01128569|38119370|FG000|Washout Period 1|Adverse Event|0|||
16975656|NCT01128569|38119371|FG001|Washout Period 1|Adverse Event|0|||
16975657|NCT01128569|38119372|FG002|Washout Period 1|Adverse Event|1|||
16975658|NCT01128569|38119373|FG003|Washout Period 1|Adverse Event|0|||
16975659|NCT01128569|38119374|FG004|Washout Period 1|Adverse Event|0|||
16975660|NCT01128569|38119375|FG005|Washout Period 1|Adverse Event|0|||
16975661|NCT01128569|38119370|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16975662|NCT01128569|38119371|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16975663|NCT01128569|38119372|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16975664|NCT01128569|38119373|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16975665|NCT01128569|38119374|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16975666|NCT01128569|38119375|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16975667|NCT01128413|38119385|FG000|Overall Study|Withdrawal by Subject|1|||
16975668|NCT01128413|38119386|FG001|Overall Study|Withdrawal by Subject|0|||
16975669|NCT01128413|38119385|FG000|Overall Study|NICOM Monitor Problems|2|||
16975670|NCT01128413|38119386|FG001|Overall Study|NICOM Monitor Problems|1|||
16975671|NCT01128413|38119385|FG000|Overall Study|Pt made DNR|1|||
16975672|NCT01128413|38119386|FG001|Overall Study|Pt made DNR|0|||
16975673|NCT01185080|38119395|FG000|Overall Study|Adverse Event|1|||
16975674|NCT01185080|38119396|FG001|Overall Study|Adverse Event|1|||
16975675|NCT01185080|38119397|FG002|Overall Study|Adverse Event|0|||
16975676|NCT01185080|38119395|FG000|Overall Study|Personal reasons|0|||
16975677|NCT01185080|38119396|FG001|Overall Study|Personal reasons|0|||
16975678|NCT01185080|38119397|FG002|Overall Study|Personal reasons|1|||
16975679|NCT01128179|38119407|FG000|Overall Study|Death|1|||
16975680|NCT01128179|38119408|FG001|Overall Study|Death|0|||
16975681|NCT01128179|38119407|FG000|Overall Study|Protocol Violation|1|||
16975682|NCT01128179|38119408|FG001|Overall Study|Protocol Violation|0|||
16975683|NCT01181102|38119416|FG000|Overall Study|Adverse Event|28|||
16975684|NCT01181102|38119417|FG001|Overall Study|Adverse Event|26|||
16975685|NCT01181102|38119416|FG000|Overall Study|Lack of Efficacy|3|||
16975686|NCT01181102|38119417|FG001|Overall Study|Lack of Efficacy|1|||
16975687|NCT01181102|38119416|FG000|Overall Study|Lost to Follow-up|2|||
16975688|NCT01181102|38119417|FG001|Overall Study|Lost to Follow-up|0|||
16975689|NCT01181102|38119416|FG000|Overall Study|Physician Decision|3|||
16975690|NCT01181102|38119417|FG001|Overall Study|Physician Decision|1|||
16975691|NCT01181102|38119416|FG000|Overall Study|Protocol Violation|5|||
16975692|NCT01181102|38119417|FG001|Overall Study|Protocol Violation|6|||
16975693|NCT01181102|38119416|FG000|Overall Study|Withdrawal by Subject|10|||
16975694|NCT01181102|38119417|FG001|Overall Study|Withdrawal by Subject|12|||
16975695|NCT00858637|38119425|FG000|Active Comparison Phase|Adverse Event|14|||
16975696|NCT00858637|38119426|FG001|Active Comparison Phase|Adverse Event|0|||
16975697|NCT00858637|38119427|FG002|Active Comparison Phase|Adverse Event|0|||
16975698|NCT00858637|38119428|FG003|Active Comparison Phase|Adverse Event|9|||
16975699|NCT00858637|38119429|FG004|Active Comparison Phase|Adverse Event|0|||
16975700|NCT00858637|38119430|FG005|Active Comparison Phase|Adverse Event|0|||
16975701|NCT00858637|38119425|FG000|Active Comparison Phase|Death|1|||
16975702|NCT00858637|38119426|FG001|Active Comparison Phase|Death|0|||
16975703|NCT00858637|38119427|FG002|Active Comparison Phase|Death|0|||
16975704|NCT00858637|38119428|FG003|Active Comparison Phase|Death|1|||
16975705|NCT00858637|38119429|FG004|Active Comparison Phase|Death|0|||
16780174|NCT02613507|37719291|FG001|Overall Study|Disease Progression|109|||
16975706|NCT00858637|38119430|FG005|Active Comparison Phase|Death|0|||
16975707|NCT00858637|38119425|FG000|Active Comparison Phase|Physician Decision|1|||
16975708|NCT00858637|38119426|FG001|Active Comparison Phase|Physician Decision|0|||
16975709|NCT00858637|38119427|FG002|Active Comparison Phase|Physician Decision|0|||
16975710|NCT00858637|38119428|FG003|Active Comparison Phase|Physician Decision|1|||
16975711|NCT00858637|38119429|FG004|Active Comparison Phase|Physician Decision|0|||
16975712|NCT00858637|38119430|FG005|Active Comparison Phase|Physician Decision|0|||
16975713|NCT00858637|38119425|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
16975714|NCT00858637|38119426|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
16975715|NCT00858637|38119427|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
17134025|NCT02095132|38275294|FG001|Overall Study|Death|0|||
16975716|NCT00858637|38119428|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
16975717|NCT00858637|38119429|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
16975718|NCT00858637|38119430|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
16975719|NCT00858637|38119425|FG000|Active Comparison Phase|Other Reasons|1|||
16975720|NCT00858637|38119426|FG001|Active Comparison Phase|Other Reasons|0|||
16975721|NCT00858637|38119427|FG002|Active Comparison Phase|Other Reasons|0|||
16975722|NCT00858637|38119428|FG003|Active Comparison Phase|Other Reasons|1|||
16975723|NCT00858637|38119429|FG004|Active Comparison Phase|Other Reasons|0|||
16975724|NCT00858637|38119430|FG005|Active Comparison Phase|Other Reasons|0|||
16975725|NCT00858637|38119425|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
16975726|NCT00858637|38119426|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
16975727|NCT00858637|38119427|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
16975728|NCT00858637|38119428|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
16975729|NCT00858637|38119429|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
16975730|NCT00858637|38119430|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
16975731|NCT00858637|38119425|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16975732|NCT00858637|38119426|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16975733|NCT00858637|38119427|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16975734|NCT00858637|38119428|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16975735|NCT00858637|38119429|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16975736|NCT00858637|38119430|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
16975737|NCT00858403|38119440|FG000|Overall Study|Withdrawal by Subject|1|||
16975738|NCT00858403|38119440|FG000|Overall Study|Death|3|||
16975739|NCT00858403|38119440|FG000|Overall Study|Disease Progression|1|||
16975740|NCT00858247|38119446|FG000|Baseline Assessment|Withdrawal by Subject|1|||
16975741|NCT00858247|38119447|FG001|Baseline Assessment|Withdrawal by Subject|1|||
16975742|NCT00858247|38119446|FG000|Baseline Assessment|Poor IV access|1|||
16975743|NCT00858247|38119447|FG001|Baseline Assessment|Poor IV access|0|||
16975744|NCT00858247|38119446|FG000|Baseline Assessment|Protocol Violation|0|||
16975745|NCT00858247|38119447|FG001|Baseline Assessment|Protocol Violation|1|||
16975746|NCT00858247|38119446|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
16975747|NCT00858247|38119447|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
16975748|NCT00838435|38119453|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
16975749|NCT00838435|38119453|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
16975750|NCT00838435|38119453|FG000|Part 2 (7 Years)|Adverse Event|2|||
16975751|NCT00838435|38119453|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
16975752|NCT00838435|38119453|FG000|Part 2 (7 Years)|Physician Decision|1|||
16975753|NCT00838435|38119453|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
16975754|NCT00838435|38119453|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
16975755|NCT00838201|38119462|FG000|Overall Study|Investigator decision, or other reasons|2|||
16975756|NCT00838201|38119463|FG001|Overall Study|Investigator decision, or other reasons|3|||
16975757|NCT00838201|38119462|FG000|Overall Study|Noncompliance|0|||
16975758|NCT00838201|38119463|FG001|Overall Study|Noncompliance|1|||
16975759|NCT00838201|38119462|FG000|Overall Study|Administrative decision|1|||
16975760|NCT00838201|38119463|FG001|Overall Study|Administrative decision|2|||
16975761|NCT00838201|38119462|FG000|Overall Study|Disease progression|3|||
16975762|NCT00838201|38119463|FG001|Overall Study|Disease progression|3|||
16975763|NCT00838201|38119462|FG000|Overall Study|Consent withdrawn|16|||
16975764|NCT00838201|38119463|FG001|Overall Study|Consent withdrawn|19|||
16975765|NCT00838201|38119462|FG000|Overall Study|Lost to Follow-up|4|||
16975766|NCT00838201|38119463|FG001|Overall Study|Lost to Follow-up|3|||
16975767|NCT00838201|38119462|FG000|Overall Study|Adverse Event|5|||
16975768|NCT00838201|38119463|FG001|Overall Study|Adverse Event|9|||
16975769|NCT00838201|38119462|FG000|Overall Study|Death|11|||
16975770|NCT00838201|38119463|FG001|Overall Study|Death|13|||
16975771|NCT00837967|38119469|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
16975772|NCT00837967|38119470|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
16975773|NCT02756806|38119476|FG000|Overall Study|Study terminated early|5|||
16975774|NCT00942357|38119482|FG000|Overall Study|Ineligible|37|||
16975775|NCT00942357|38119483|FG001|Overall Study|Ineligible|40|||
16975776|NCT04583956|38119491|FG000|Overall Study|Death|9|||
16975777|NCT04583956|38119492|FG001|Overall Study|Death|11|||
16975778|NCT04583956|38119491|FG000|Overall Study|Lost to Follow-up|7|||
16975779|NCT04583956|38119492|FG001|Overall Study|Lost to Follow-up|9|||
16975780|NCT04583956|38119491|FG000|Overall Study|Protocol Violation|2|||
16975781|NCT04583956|38119492|FG001|Overall Study|Protocol Violation|0|||
16975782|NCT04583956|38119491|FG000|Overall Study|Withdrawal by Subject|0|||
16975783|NCT04583956|38119492|FG001|Overall Study|Withdrawal by Subject|2|||
16975784|NCT04583956|38119491|FG000|Overall Study|Randomized but not dosed|2|||
16975785|NCT04583956|38119492|FG001|Overall Study|Randomized but not dosed|3|||
16975786|NCT04583956|38119491|FG000|Overall Study|Withdrawal of consent before product administration|1|||
16975787|NCT04583956|38119492|FG001|Overall Study|Withdrawal of consent before product administration|0|||
16975788|NCT00939783|38119498|FG000|Overall Study|Death|6|||
16975789|NCT00939783|38119498|FG000|Overall Study|Adverse Event|39|||
16975790|NCT00939783|38119498|FG000|Overall Study|Study Terminated by Sponsor|498|||
17134026|NCT02095132|38275295|FG002|Overall Study|Death|0|||
16975791|NCT00939783|38119498|FG000|Overall Study|Withdrawal by Subject|78|||
16975792|NCT00939783|38119498|FG000|Overall Study|Other|16|||
16975793|NCT00939783|38119498|FG000|Overall Study|Lost to Follow-up|8|||
16975794|NCT00939783|38119498|FG000|Overall Study|Protocol Violation|3|||
16975795|NCT00939783|38119498|FG000|Overall Study|Enrolled but not treated|1|||
16975796|NCT00939627|38119504|FG000|Overall Study|Disease Progression|16|||
16975797|NCT00939627|38119505|FG001|Overall Study|Disease Progression|12|||
16975798|NCT00939627|38119506|FG002|Overall Study|Disease Progression|0|||
16975799|NCT00939627|38119504|FG000|Overall Study|Adverse Event|6|||
16975800|NCT00939627|38119505|FG001|Overall Study|Adverse Event|7|||
16975801|NCT00939627|38119506|FG002|Overall Study|Adverse Event|0|||
16975802|NCT00939627|38119504|FG000|Overall Study|Death|0|||
16975803|NCT00939627|38119505|FG001|Overall Study|Death|2|||
16975804|NCT00939627|38119506|FG002|Overall Study|Death|0|||
16975805|NCT00939627|38119504|FG000|Overall Study|Withdrawal by Subject|2|||
16975806|NCT00939627|38119505|FG001|Overall Study|Withdrawal by Subject|4|||
16975807|NCT00939627|38119506|FG002|Overall Study|Withdrawal by Subject|0|||
16975808|NCT00939627|38119504|FG000|Overall Study|Other complicating disease|1|||
16975809|NCT00939627|38119505|FG001|Overall Study|Other complicating disease|1|||
16975810|NCT00939627|38119506|FG002|Overall Study|Other complicating disease|0|||
16975811|NCT00939627|38119504|FG000|Overall Study|Not compliant|2|||
16975812|NCT00939627|38119505|FG001|Overall Study|Not compliant|0|||
16975813|NCT00939627|38119506|FG002|Overall Study|Not compliant|0|||
16975814|NCT00939627|38119504|FG000|Overall Study|No off-tx reason given|0|||
16975815|NCT00939627|38119505|FG001|Overall Study|No off-tx reason given|2|||
16975816|NCT00939627|38119506|FG002|Overall Study|No off-tx reason given|0|||
16975817|NCT00937833|38119514|FG000|Overall Study|Protocol Violation|1|||
16975818|NCT00937833|38119515|FG001|Overall Study|Protocol Violation|2|||
16975819|NCT00937833|38119514|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
16975820|NCT00937833|38119515|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
16975821|NCT00937833|38119514|FG000|Overall Study|Lost to Follow-up|10|||
16975822|NCT00937833|38119515|FG001|Overall Study|Lost to Follow-up|8|||
16975823|NCT00937833|38119514|FG000|Overall Study|Withdrawal by Subject|4|||
16975824|NCT00937833|38119515|FG001|Overall Study|Withdrawal by Subject|6|||
16975825|NCT01135511|38119530|FG000|Overall Study|Adverse Event|0|||
16975826|NCT01135511|38119531|FG001|Overall Study|Adverse Event|1|||
16975827|NCT01135511|38119532|FG002|Overall Study|Adverse Event|2|||
16975828|NCT01135511|38119533|FG003|Overall Study|Adverse Event|0|||
16975829|NCT01135511|38119534|FG004|Overall Study|Adverse Event|0|||
16975830|NCT01135511|38119535|FG005|Overall Study|Adverse Event|1|||
16975831|NCT01135511|38119536|FG006|Overall Study|Adverse Event|0|||
16975832|NCT01135511|38119537|FG007|Overall Study|Adverse Event|1|||
16975833|NCT01135511|38119538|FG008|Overall Study|Adverse Event|0|||
16975834|NCT01135511|38119530|FG000|Overall Study|Lack of Efficacy|0|||
16975835|NCT01135511|38119531|FG001|Overall Study|Lack of Efficacy|1|||
16975836|NCT01135511|38119532|FG002|Overall Study|Lack of Efficacy|1|||
16975837|NCT01135511|38119533|FG003|Overall Study|Lack of Efficacy|2|||
16975838|NCT01135511|38119534|FG004|Overall Study|Lack of Efficacy|0|||
16975839|NCT01135511|38119535|FG005|Overall Study|Lack of Efficacy|0|||
16975840|NCT01135511|38119536|FG006|Overall Study|Lack of Efficacy|0|||
16975841|NCT01135511|38119537|FG007|Overall Study|Lack of Efficacy|0|||
16975842|NCT01135511|38119538|FG008|Overall Study|Lack of Efficacy|0|||
16975843|NCT01135511|38119530|FG000|Overall Study|Protocol Violation|0|||
16975844|NCT01135511|38119531|FG001|Overall Study|Protocol Violation|0|||
16975845|NCT01135511|38119532|FG002|Overall Study|Protocol Violation|3|||
16975846|NCT01135511|38119533|FG003|Overall Study|Protocol Violation|0|||
16975847|NCT01135511|38119534|FG004|Overall Study|Protocol Violation|0|||
16975848|NCT01135511|38119535|FG005|Overall Study|Protocol Violation|0|||
16975849|NCT01135511|38119536|FG006|Overall Study|Protocol Violation|0|||
16975850|NCT01135511|38119537|FG007|Overall Study|Protocol Violation|0|||
16975851|NCT01135511|38119538|FG008|Overall Study|Protocol Violation|0|||
16975852|NCT01135511|38119530|FG000|Overall Study|Pregnancy|0|||
16975853|NCT01135511|38119531|FG001|Overall Study|Pregnancy|0|||
16975854|NCT01135511|38119532|FG002|Overall Study|Pregnancy|0|||
16975855|NCT01135511|38119533|FG003|Overall Study|Pregnancy|1|||
16975856|NCT01135511|38119534|FG004|Overall Study|Pregnancy|0|||
16975857|NCT01135511|38119535|FG005|Overall Study|Pregnancy|0|||
16975858|NCT01135511|38119536|FG006|Overall Study|Pregnancy|0|||
16975859|NCT01135511|38119537|FG007|Overall Study|Pregnancy|0|||
16975860|NCT01135511|38119538|FG008|Overall Study|Pregnancy|0|||
16975861|NCT01135511|38119530|FG000|Overall Study|could not visit the clinic|0|||
16975862|NCT01135511|38119531|FG001|Overall Study|could not visit the clinic|1|||
16975863|NCT01135511|38119532|FG002|Overall Study|could not visit the clinic|2|||
16975864|NCT01135511|38119533|FG003|Overall Study|could not visit the clinic|0|||
16975865|NCT01135511|38119534|FG004|Overall Study|could not visit the clinic|0|||
16975866|NCT01135511|38119535|FG005|Overall Study|could not visit the clinic|0|||
16780175|NCT02613507|37719290|FG000|Overall Study|Study Drug Toxicity|15|||
16975867|NCT01135511|38119536|FG006|Overall Study|could not visit the clinic|0|||
16975868|NCT01135511|38119537|FG007|Overall Study|could not visit the clinic|0|||
16975869|NCT01135511|38119538|FG008|Overall Study|could not visit the clinic|0|||
16975870|NCT01135511|38119530|FG000|Overall Study|noncompliance with study drug taken|0|||
16975871|NCT01135511|38119531|FG001|Overall Study|noncompliance with study drug taken|0|||
16975872|NCT01135511|38119532|FG002|Overall Study|noncompliance with study drug taken|0|||
16975873|NCT01135511|38119533|FG003|Overall Study|noncompliance with study drug taken|0|||
16975874|NCT01135511|38119534|FG004|Overall Study|noncompliance with study drug taken|1|||
16975875|NCT01135511|38119535|FG005|Overall Study|noncompliance with study drug taken|0|||
16975876|NCT01135511|38119536|FG006|Overall Study|noncompliance with study drug taken|0|||
16975877|NCT01135511|38119537|FG007|Overall Study|noncompliance with study drug taken|0|||
16975878|NCT01135511|38119538|FG008|Overall Study|noncompliance with study drug taken|0|||
16975879|NCT01135511|38119530|FG000|Overall Study|Withdrawal by Subject|0|||
16975880|NCT01135511|38119531|FG001|Overall Study|Withdrawal by Subject|0|||
16975881|NCT01135511|38119532|FG002|Overall Study|Withdrawal by Subject|0|||
16975882|NCT01135511|38119533|FG003|Overall Study|Withdrawal by Subject|0|||
16975883|NCT01135511|38119534|FG004|Overall Study|Withdrawal by Subject|0|||
16975884|NCT01135511|38119535|FG005|Overall Study|Withdrawal by Subject|0|||
16975885|NCT01135511|38119536|FG006|Overall Study|Withdrawal by Subject|1|||
16975886|NCT01135511|38119537|FG007|Overall Study|Withdrawal by Subject|0|||
16975887|NCT01135511|38119538|FG008|Overall Study|Withdrawal by Subject|1|||
16975888|NCT01180790|38119574|FG000|Overall Study|Adverse Event|1|||
16975889|NCT01180790|38119575|FG001|Overall Study|Adverse Event|1|||
16975890|NCT01180790|38119576|FG002|Overall Study|Adverse Event|2|||
16975891|NCT01180790|38119577|FG003|Overall Study|Adverse Event|0|||
16975892|NCT01180790|38119578|FG004|Overall Study|Adverse Event|1|||
16975893|NCT01180790|38119579|FG005|Overall Study|Adverse Event|3|||
16975894|NCT01180790|38119580|FG006|Overall Study|Adverse Event|0|||
16975895|NCT01180790|38119574|FG000|Overall Study|Withdrawal by Subject|3|||
16975896|NCT01180790|38119575|FG001|Overall Study|Withdrawal by Subject|0|||
16975897|NCT01180790|38119576|FG002|Overall Study|Withdrawal by Subject|5|||
16975898|NCT01180790|38119577|FG003|Overall Study|Withdrawal by Subject|0|||
16975899|NCT01180790|38119578|FG004|Overall Study|Withdrawal by Subject|2|||
16975900|NCT01180790|38119579|FG005|Overall Study|Withdrawal by Subject|1|||
16975901|NCT01180790|38119580|FG006|Overall Study|Withdrawal by Subject|0|||
16975902|NCT01180790|38119574|FG000|Overall Study|Lost to Follow-up|3|||
16975903|NCT01180790|38119575|FG001|Overall Study|Lost to Follow-up|1|||
16975904|NCT01180790|38119576|FG002|Overall Study|Lost to Follow-up|0|||
16975905|NCT01180790|38119577|FG003|Overall Study|Lost to Follow-up|2|||
16975906|NCT01180790|38119578|FG004|Overall Study|Lost to Follow-up|1|||
16975907|NCT01180790|38119579|FG005|Overall Study|Lost to Follow-up|0|||
16975908|NCT01180790|38119580|FG006|Overall Study|Lost to Follow-up|1|||
16975909|NCT01180790|38119574|FG000|Overall Study|Physician Decision|1|||
16975910|NCT01180790|38119575|FG001|Overall Study|Physician Decision|0|||
16975911|NCT01180790|38119576|FG002|Overall Study|Physician Decision|0|||
16975912|NCT01180790|38119577|FG003|Overall Study|Physician Decision|1|||
16975913|NCT01180790|38119578|FG004|Overall Study|Physician Decision|0|||
16975914|NCT01180790|38119579|FG005|Overall Study|Physician Decision|0|||
16975915|NCT01180790|38119580|FG006|Overall Study|Physician Decision|0|||
16975916|NCT01180790|38119574|FG000|Overall Study|Lack of Efficacy|1|||
16975917|NCT01180790|38119575|FG001|Overall Study|Lack of Efficacy|2|||
16975918|NCT01180790|38119576|FG002|Overall Study|Lack of Efficacy|5|||
16975919|NCT01180790|38119577|FG003|Overall Study|Lack of Efficacy|6|||
16975920|NCT01180790|38119578|FG004|Overall Study|Lack of Efficacy|1|||
16975921|NCT01180790|38119579|FG005|Overall Study|Lack of Efficacy|3|||
16975922|NCT01180790|38119580|FG006|Overall Study|Lack of Efficacy|0|||
16975923|NCT01180790|38119574|FG000|Overall Study|compliance|0|||
16975924|NCT01180790|38119575|FG001|Overall Study|compliance|1|||
16975925|NCT01180790|38119576|FG002|Overall Study|compliance|0|||
16975926|NCT01180790|38119577|FG003|Overall Study|compliance|0|||
16975927|NCT01180790|38119578|FG004|Overall Study|compliance|0|||
16975928|NCT01180790|38119579|FG005|Overall Study|compliance|0|||
16975929|NCT01180790|38119580|FG006|Overall Study|compliance|0|||
16975930|NCT01180790|38119574|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
16975931|NCT01180790|38119575|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
16975932|NCT01180790|38119576|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
16975933|NCT01180790|38119577|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
16975934|NCT01180790|38119578|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
16975935|NCT01180790|38119579|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
16975936|NCT01180790|38119580|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
16975937|NCT01184846|38119624|FG000|Overall Study|Adverse Event|2|||
16975938|NCT01184846|38119624|FG000|Overall Study|Insufficient response|1|||
16975939|NCT01180400|38119632|FG000|Overall Study|Withdrawal by Subject|5|||
16975940|NCT01180400|38119633|FG001|Overall Study|Withdrawal by Subject|6|||
16975941|NCT01180400|38119632|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16975942|NCT01180400|38119633|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
16975943|NCT01180400|38119632|FG000|Overall Study|Adverse Event|12|||
16975944|NCT01180400|38119633|FG001|Overall Study|Adverse Event|10|||
16975945|NCT01180400|38119632|FG000|Overall Study|Severe non-compliance to protocol|1|||
16975946|NCT01180400|38119633|FG001|Overall Study|Severe non-compliance to protocol|2|||
16975947|NCT01180400|38119632|FG000|Overall Study|Condition under investigation worsened|2|||
16975948|NCT01180400|38119633|FG001|Overall Study|Condition under investigation worsened|1|||
16975949|NCT01180400|38119632|FG000|Overall Study|Lack of Efficacy|2|||
16975950|NCT01180400|38119633|FG001|Overall Study|Lack of Efficacy|0|||
16975951|NCT01180400|38119632|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16975952|NCT01180400|38119633|FG001|Overall Study|Study-specific withdrawal criteria|2|||
16975953|NCT01180400|38119632|FG000|Overall Study|Lost to Follow-up|2|||
16975954|NCT01180400|38119633|FG001|Overall Study|Lost to Follow-up|3|||
16975955|NCT01180400|38119632|FG000|Overall Study|Other|0|||
16975956|NCT01180400|38119633|FG001|Overall Study|Other|1|||
16975957|NCT01180244|38119641|FG000|Overall Study|Lack of Efficacy|0|||
16975958|NCT01180244|38119642|FG001|Overall Study|Lack of Efficacy|7|||
16975959|NCT01180244|38119641|FG000|Overall Study|Physician Decision|3|||
16975960|NCT01180244|38119642|FG001|Overall Study|Physician Decision|0|||
16975961|NCT01180244|38119641|FG000|Overall Study|Adverse Event|1|||
16975962|NCT01180244|38119642|FG001|Overall Study|Adverse Event|0|||
16975963|NCT01180244|38119641|FG000|Overall Study|Withdrawal by Subject|0|||
16975964|NCT01180244|38119642|FG001|Overall Study|Withdrawal by Subject|1|||
16975965|NCT01180244|38119641|FG000|Overall Study|Protocol Violation|1|||
16975966|NCT01180244|38119642|FG001|Overall Study|Protocol Violation|0|||
16975967|NCT01180244|38119641|FG000|Overall Study|Lost to Follow-up|1|||
16975968|NCT01180244|38119642|FG001|Overall Study|Lost to Follow-up|0|||
16975969|NCT01191086|38119648|FG000|Overall Study|Adverse Event|20|||
16975970|NCT01191086|38119648|FG000|Overall Study|Lack of Efficacy|10|||
16975971|NCT01191086|38119648|FG000|Overall Study|Lost to Follow-up|4|||
16975972|NCT01191086|38119648|FG000|Overall Study|Physician Decision|2|||
16975973|NCT01191086|38119648|FG000|Overall Study|Withdrawal by Subject|24|||
16975974|NCT01191086|38119648|FG000|Overall Study|Discontinuation criterion met|1|||
16975975|NCT01191086|38119648|FG000|Overall Study|Other|1|||
16975976|NCT01191008|38119652|FG000|Overall Study|Protocol Violation|7|||
16975977|NCT01191008|38119652|FG000|Overall Study|Lost to Follow-up|8|||
16975978|NCT04505722|38119658|FG000|Overall Study|Adverse Event|1|||
16975979|NCT04505722|38119659|FG001|Overall Study|Adverse Event|2|||
16975980|NCT04505722|38119658|FG000|Overall Study|Death|34|||
16975981|NCT04505722|38119659|FG001|Overall Study|Death|63|||
16975982|NCT04505722|38119658|FG000|Overall Study|Lost to Follow-up|271|||
16975983|NCT04505722|38119659|FG001|Overall Study|Lost to Follow-up|333|||
16975984|NCT04505722|38119658|FG000|Overall Study|Physician Decision|17|||
16975985|NCT04505722|38119659|FG001|Overall Study|Physician Decision|17|||
16975986|NCT04505722|38119658|FG000|Overall Study|Protocol Violation|0|||
16975987|NCT04505722|38119659|FG001|Overall Study|Protocol Violation|1|||
16975988|NCT04505722|38119658|FG000|Overall Study|Withdrawal by Subject|376|||
16975989|NCT04505722|38119659|FG001|Overall Study|Withdrawal by Subject|714|||
16975990|NCT04505722|38119658|FG000|Overall Study|Other|61|||
16975991|NCT04505722|38119659|FG001|Overall Study|Other|98|||
16975992|NCT04505722|38119658|FG000|Overall Study|Still ongoing|21138|||
16975993|NCT04505722|38119659|FG001|Overall Study|Still ongoing|20662|||
16975994|NCT04505722|38119658|FG000|Overall Study|Randomized not vaccinated|276|||
16975995|NCT04505722|38119659|FG001|Overall Study|Randomized not vaccinated|260|||
16975996|NCT01088412|38119668|FG000|Overall Study|Adverse Event|38|||
16975997|NCT01088412|38119669|FG001|Overall Study|Adverse Event|0|||
16975998|NCT01088412|38119670|FG002|Overall Study|Adverse Event|0|||
16975999|NCT01088412|38119668|FG000|Overall Study|Death|42|||
16976000|NCT01088412|38119669|FG001|Overall Study|Death|6|||
16976001|NCT01088412|38119670|FG002|Overall Study|Death|0|||
16976002|NCT01088412|38119668|FG000|Overall Study|Other Reason per Case Report Form|2089|||
16976003|NCT01088412|38119669|FG001|Overall Study|Other Reason per Case Report Form|103|||
16976004|NCT01088412|38119670|FG002|Overall Study|Other Reason per Case Report Form|9|||
16976005|NCT01088412|38119668|FG000|Overall Study|Withdrawal by Subject|1761|||
16976006|NCT01088412|38119669|FG001|Overall Study|Withdrawal by Subject|25|||
16976007|NCT01088412|38119670|FG002|Overall Study|Withdrawal by Subject|1|||
16976008|NCT01088412|38119668|FG000|Overall Study|Received Another GH Product|79|||
16976009|NCT01088412|38119669|FG001|Overall Study|Received Another GH Product|0|||
16976010|NCT01088412|38119670|FG002|Overall Study|Received Another GH Product|0|||
16976011|NCT01088412|38119668|FG000|Overall Study|Participant Moved|601|||
16976012|NCT01088412|38119669|FG001|Overall Study|Participant Moved|21|||
16976013|NCT01088412|38119670|FG002|Overall Study|Participant Moved|2|||
16976014|NCT01088412|38119668|FG000|Overall Study|Physician Decision|1041|||
16976015|NCT01088412|38119669|FG001|Overall Study|Physician Decision|8|||
16976016|NCT01088412|38119670|FG002|Overall Study|Physician Decision|4|||
16976017|NCT01088412|38119668|FG000|Overall Study|Sponsor Decision|4467|||
16976018|NCT01088412|38119669|FG001|Overall Study|Sponsor Decision|79|||
16976019|NCT01088412|38119670|FG002|Overall Study|Sponsor Decision|23|||
16976020|NCT01088412|38119668|FG000|Overall Study|Third Party Required to Change Brand|487|||
16976021|NCT01088412|38119669|FG001|Overall Study|Third Party Required to Change Brand|0|||
16976022|NCT01088412|38119670|FG002|Overall Study|Third Party Required to Change Brand|0|||
16976023|NCT01088412|38119668|FG000|Overall Study|Lost to Follow-up|3052|||
16976024|NCT01088412|38119669|FG001|Overall Study|Lost to Follow-up|130|||
16976025|NCT01088412|38119670|FG002|Overall Study|Lost to Follow-up|11|||
16976026|NCT01088412|38119668|FG000|Overall Study|Study Summary Not Completed|4360|||
16976027|NCT01088412|38119669|FG001|Overall Study|Study Summary Not Completed|64|||
16976028|NCT01088412|38119670|FG002|Overall Study|Study Summary Not Completed|22|||
16976029|NCT01076400|38119681|FG000|Overall Study|Adverse Event|2|||
16976030|NCT01076400|38119682|FG001|Overall Study|Adverse Event|0|||
16976031|NCT01076400|38119683|FG002|Overall Study|Adverse Event|0|||
16976032|NCT01076400|38119681|FG000|Overall Study|Progressive Disease|5|||
16976033|NCT01076400|38119682|FG001|Overall Study|Progressive Disease|0|||
16976034|NCT01076400|38119683|FG002|Overall Study|Progressive Disease|0|||
16976035|NCT01086384|38119689|FG000|2-week Run-in Period|Adverse Event|1|||
16976036|NCT01086384|38119690|FG001|2-week Run-in Period|Adverse Event|0|||
16976037|NCT01086384|38119691|FG002|2-week Run-in Period|Adverse Event|0|||
16976038|NCT01086384|38119689|FG000|2-week Run-in Period|Protocol Violation|1|||
16976039|NCT01086384|38119690|FG001|2-week Run-in Period|Protocol Violation|0|||
16976040|NCT01086384|38119691|FG002|2-week Run-in Period|Protocol Violation|0|||
16976041|NCT01086384|38119689|FG000|2-week Run-in Period|Lost to Follow-up|1|||
16976042|NCT01086384|38119690|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16976043|NCT01086384|38119691|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16976044|NCT01086384|38119689|FG000|2-week Run-in Period|Physician Decision|6|||
16976045|NCT01086384|38119690|FG001|2-week Run-in Period|Physician Decision|0|||
16976046|NCT01086384|38119691|FG002|2-week Run-in Period|Physician Decision|0|||
16976047|NCT01086384|38119689|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
16976048|NCT01086384|38119690|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16976049|NCT01086384|38119691|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16976050|NCT01086384|38119689|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
16976051|NCT01086384|38119690|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
16976052|NCT01086384|38119691|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
16976053|NCT01086384|38119689|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
16976054|NCT01086384|38119690|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
16976055|NCT01086384|38119691|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
16976056|NCT01086384|38119689|FG000|2-week Run-in Period|Randomized in Error|1|||
16976057|NCT01086384|38119690|FG001|2-week Run-in Period|Randomized in Error|0|||
16976058|NCT01086384|38119691|FG002|2-week Run-in Period|Randomized in Error|0|||
16976059|NCT01086384|38119689|FG000|Treatment Period|Withdrawal by Subject|0|||
16976060|NCT01086384|38119690|FG001|Treatment Period|Withdrawal by Subject|53|||
16976061|NCT01086384|38119691|FG002|Treatment Period|Withdrawal by Subject|55|||
16976062|NCT01086384|38119689|FG000|Treatment Period|Protocol Violation|0|||
16976063|NCT01086384|38119690|FG001|Treatment Period|Protocol Violation|26|||
16976064|NCT01086384|38119691|FG002|Treatment Period|Protocol Violation|17|||
16976065|NCT01086384|38119689|FG000|Treatment Period|Lack of Efficacy|0|||
16976066|NCT01086384|38119690|FG001|Treatment Period|Lack of Efficacy|22|||
16976067|NCT01086384|38119691|FG002|Treatment Period|Lack of Efficacy|13|||
16976068|NCT01086384|38119689|FG000|Treatment Period|Adverse Event|0|||
16976069|NCT01086384|38119690|FG001|Treatment Period|Adverse Event|19|||
16976070|NCT01086384|38119691|FG002|Treatment Period|Adverse Event|15|||
16976071|NCT01086384|38119689|FG000|Treatment Period|Lost to Follow-up|0|||
16780176|NCT02613507|37719291|FG001|Overall Study|Study Drug Toxicity|14|||
16780177|NCT02613507|37719290|FG000|Overall Study|Death|3|||
16976072|NCT01086384|38119690|FG001|Treatment Period|Lost to Follow-up|11|||
16976073|NCT01086384|38119691|FG002|Treatment Period|Lost to Follow-up|9|||
16976074|NCT01086384|38119689|FG000|Treatment Period|Physician Decision|0|||
16976075|NCT01086384|38119690|FG001|Treatment Period|Physician Decision|9|||
16976076|NCT01086384|38119691|FG002|Treatment Period|Physician Decision|6|||
16976077|NCT01086384|38119689|FG000|Treatment Period|Study Closed/Terminated|0|||
16976078|NCT01086384|38119690|FG001|Treatment Period|Study Closed/Terminated|7|||
16976079|NCT01086384|38119691|FG002|Treatment Period|Study Closed/Terminated|8|||
16976080|NCT01086384|38119689|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
16976081|NCT01086384|38119690|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
16976082|NCT01086384|38119691|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
16976083|NCT01086384|38119689|FG000|Treatment Period|Received Treatment in Error|0|||
16976084|NCT01086384|38119690|FG001|Treatment Period|Received Treatment in Error|1|||
16976085|NCT01086384|38119691|FG002|Treatment Period|Received Treatment in Error|0|||
16976086|NCT01127633|38119712|FG000|Overall Study|Adverse Event|74|||
16976087|NCT01127633|38119713|FG001|Overall Study|Adverse Event|73|||
16976088|NCT01127633|38119712|FG000|Overall Study|Death|40|||
16976089|NCT01127633|38119713|FG001|Overall Study|Death|43|||
16976090|NCT01127633|38119712|FG000|Overall Study|Lost to Follow-up|4|||
16976091|NCT01127633|38119713|FG001|Overall Study|Lost to Follow-up|0|||
16976092|NCT01127633|38119712|FG000|Overall Study|Parent/Caregiver Decision|246|||
16976093|NCT01127633|38119713|FG001|Overall Study|Parent/Caregiver Decision|228|||
16976094|NCT01127633|38119712|FG000|Overall Study|Physician Decision|60|||
16976095|NCT01127633|38119713|FG001|Overall Study|Physician Decision|45|||
16976096|NCT01127633|38119712|FG000|Overall Study|Withdrawal by Subject|57|||
16976097|NCT01127633|38119713|FG001|Overall Study|Withdrawal by Subject|72|||
16976098|NCT01127633|38119712|FG000|Overall Study|Sponsor Decision|163|||
16976099|NCT01127633|38119713|FG001|Overall Study|Sponsor Decision|195|||
16976100|NCT01127633|38119712|FG000|Overall Study|Protocol Violation|8|||
16976101|NCT01127633|38119713|FG001|Overall Study|Protocol Violation|16|||
16976102|NCT01127633|38119712|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
16976103|NCT01127633|38119713|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
16976104|NCT01127633|38119712|FG000|Overall Study|Not treated|1|||
16976105|NCT01127633|38119713|FG001|Overall Study|Not treated|0|||
16976106|NCT01122173|38119719|FG000|Overall Study|Lost to Follow-up|3|||
16976107|NCT01122173|38119719|FG000|Overall Study|Withdrawal by Subject|3|||
16976108|NCT01122173|38119719|FG000|Overall Study|Left study for other reasons|3|||
16976109|NCT01127165|38119726|FG000|Overall Study|Adverse Event|2|||
16976110|NCT01127165|38119727|FG001|Overall Study|Adverse Event|2|||
16976111|NCT01127165|38119726|FG000|Overall Study|Lack of Efficacy|10|||
16976112|NCT01127165|38119727|FG001|Overall Study|Lack of Efficacy|8|||
16976113|NCT01127165|38119726|FG000|Overall Study|Lost to Follow-up|3|||
16976114|NCT01127165|38119727|FG001|Overall Study|Lost to Follow-up|5|||
16976115|NCT01127165|38119726|FG000|Overall Study|Withdrawal by Subject|1|||
16976116|NCT01127165|38119727|FG001|Overall Study|Withdrawal by Subject|3|||
16976117|NCT01127165|38119726|FG000|Overall Study|Protocol Violation|0|||
16976118|NCT01127165|38119727|FG001|Overall Study|Protocol Violation|1|||
16976119|NCT01126619|38119733|FG000|Overall Study|Not eligible for the study|2|||
16976120|NCT01126619|38119733|FG000|Overall Study|Investigator decision|4|||
16976121|NCT01126619|38119733|FG000|Overall Study|Serious adverse event|1|||
16976122|NCT01126619|38119733|FG000|Overall Study|Withdrawal by Subject|9|||
16976123|NCT01126619|38119733|FG000|Overall Study|Non-compliance|1|||
16976124|NCT00941733|38119741|FG000|Overall Study|Death|24|||
16976125|NCT00941733|38119742|FG001|Overall Study|Death|10|||
16976126|NCT00941733|38119741|FG000|Overall Study|Withdrawal by Subject|14|||
16976127|NCT00941733|38119742|FG001|Overall Study|Withdrawal by Subject|6|||
16976128|NCT00941733|38119741|FG000|Overall Study|Adverse Event|20|||
16976129|NCT00941733|38119742|FG001|Overall Study|Adverse Event|4|||
16976130|NCT00941733|38119741|FG000|Overall Study|Lost to Follow-up|1|||
16976131|NCT00941733|38119742|FG001|Overall Study|Lost to Follow-up|2|||
16976132|NCT00941733|38119741|FG000|Overall Study|Protocol Violation|15|||
16976133|NCT00941733|38119742|FG001|Overall Study|Protocol Violation|6|||
16976134|NCT00941655|38119750|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
16976135|NCT00941655|38119751|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
16976136|NCT00941655|38119750|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
16976137|NCT00941655|38119751|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
16976138|NCT00941655|38119750|FG000|Overall Study|progressed while on chemo|0|||
16976139|NCT00941655|38119751|FG001|Overall Study|progressed while on chemo|2|||
16976140|NCT00941655|38119750|FG000|Overall Study|refused further treatment|0|||
16976141|NCT00941655|38119751|FG001|Overall Study|refused further treatment|1|||
16976142|NCT00941655|38119750|FG000|Overall Study|withdrew consent|0|||
16976143|NCT00941655|38119751|FG001|Overall Study|withdrew consent|1|||
16976144|NCT00941655|38119750|FG000|Overall Study|non-compliant|0|||
16976145|NCT00941655|38119751|FG001|Overall Study|non-compliant|1|||
16976146|NCT00939393|38119760|FG000|Overall Study|Withdrawal by Subject|1|||
16976147|NCT00939393|38119761|FG001|Overall Study|Withdrawal by Subject|0|||
16976148|NCT00939393|38119760|FG000|Overall Study|Lost to Follow-up|3|||
16976149|NCT00939393|38119761|FG001|Overall Study|Lost to Follow-up|0|||
16976150|NCT00936117|38119778|FG000|Overall Study|Adverse Event|7|||
16976151|NCT00936117|38119778|FG000|Overall Study|Unable to continue oral medication|3|||
16976152|NCT04088500|38119783|FG000|Overall Study|Reason unknown|1|||
16976153|NCT04088500|38119783|FG000|Overall Study|Participant withdrew consent|1|||
16976154|NCT04088500|38119783|FG000|Overall Study|Disease progression|3|||
16976155|NCT01082874|38119791|FG000|Overall Study|Lost to Follow-up|10|||
16976156|NCT01082874|38119792|FG001|Overall Study|Lost to Follow-up|10|||
16976157|NCT01082874|38119793|FG002|Overall Study|Lost to Follow-up|6|||
16976158|NCT01082874|38119794|FG003|Overall Study|Lost to Follow-up|10|||
16976159|NCT01082874|38119791|FG000|Overall Study|Withdrawal by Subject|1|||
16976160|NCT01082874|38119792|FG001|Overall Study|Withdrawal by Subject|2|||
16976161|NCT01082874|38119793|FG002|Overall Study|Withdrawal by Subject|5|||
16976162|NCT01082874|38119794|FG003|Overall Study|Withdrawal by Subject|3|||
16976163|NCT00933543|38119806|FG000|Overall Study|Adverse Event|2|||
16976164|NCT00933543|38119807|FG001|Overall Study|Adverse Event|1|||
16976165|NCT00933543|38119806|FG000|Overall Study|Lost to Follow-up|0|||
16976166|NCT00933543|38119807|FG001|Overall Study|Lost to Follow-up|1|||
16976167|NCT00933543|38119806|FG000|Overall Study|Withdrawal by Subject|0|||
16976168|NCT00933543|38119807|FG001|Overall Study|Withdrawal by Subject|1|||
16976169|NCT00933543|38119806|FG000|Overall Study|Lack of Efficacy|0|||
16976170|NCT00933543|38119807|FG001|Overall Study|Lack of Efficacy|3|||
16976171|NCT00933543|38119806|FG000|Overall Study|Other|1|||
16976172|NCT00933543|38119807|FG001|Overall Study|Other|1|||
16976173|NCT01082328|38119813|FG000|Overall Study|Adverse Event|1|||
16976174|NCT01079988|38119822|FG000|Overall Study|Lost to Follow-up|0|||
16976175|NCT01079988|38119823|FG001|Overall Study|Lost to Follow-up|0|||
16976176|NCT01079988|38119824|FG002|Overall Study|Lost to Follow-up|0|||
16976177|NCT01079988|38119825|FG003|Overall Study|Lost to Follow-up|1|||
16976178|NCT01079988|38119826|FG004|Overall Study|Lost to Follow-up|0|||
16976179|NCT01079988|38119822|FG000|Overall Study|Lack of Efficacy|1|||
16976180|NCT01079988|38119823|FG001|Overall Study|Lack of Efficacy|0|||
16976181|NCT01079988|38119824|FG002|Overall Study|Lack of Efficacy|0|||
16976182|NCT01079988|38119825|FG003|Overall Study|Lack of Efficacy|0|||
16976183|NCT01079988|38119826|FG004|Overall Study|Lack of Efficacy|0|||
16976184|NCT01079988|38119822|FG000|Overall Study|Other|0|||
16976185|NCT01079988|38119823|FG001|Overall Study|Other|0|||
16976186|NCT01079988|38119824|FG002|Overall Study|Other|0|||
16976187|NCT01079988|38119825|FG003|Overall Study|Other|2|||
16976188|NCT01079988|38119826|FG004|Overall Study|Other|1|||
16976189|NCT01074216|38119838|FG000|Overall Study|Physician Decision|1|||
16976190|NCT01074216|38119838|FG000|Overall Study|Not Treated|12|||
16976191|NCT01079832|38119842|FG000|Overall Study|Withdrawal by Subject|1|||
16976192|NCT01072344|38119848|FG000|Overall Study|Relasped-reached end point|7|||
16976193|NCT01072344|38119849|FG001|Overall Study|Relasped-reached end point|12|||
16976194|NCT01072344|38119848|FG000|Overall Study|Protocol Violation|1|||
16976195|NCT01072344|38119849|FG001|Overall Study|Protocol Violation|2|||
16976196|NCT01072344|38119848|FG000|Overall Study|Lost to Follow-up|3|||
16976197|NCT01072344|38119849|FG001|Overall Study|Lost to Follow-up|4|||
16976198|NCT01071954|38119855|FG000|Overall Study|Noncompliance|4|||
16976199|NCT01071954|38119855|FG000|Overall Study|Adverse Event|1|||
16976200|NCT01071954|38119855|FG000|Overall Study|Withdrawal by Subject|11|||
16976201|NCT01071954|38119855|FG000|Overall Study|Requirement for Alternative Therapy|5|||
16976202|NCT01071954|38119855|FG000|Overall Study|Administrative Decision|5|||
16976203|NCT01071954|38119855|FG000|Overall Study|Protocol Specified Criteria|1|||
16976204|NCT00837811|38119862|FG000|Overall Study|Adverse Event|4|||
16976205|NCT00837811|38119863|FG001|Overall Study|Adverse Event|6|||
16976206|NCT00837811|38119864|FG002|Overall Study|Adverse Event|0|||
16976207|NCT00837811|38119862|FG000|Overall Study|Death|1|||
16976208|NCT00837811|38119863|FG001|Overall Study|Death|1|||
16976209|NCT00837811|38119864|FG002|Overall Study|Death|0|||
16976210|NCT00837811|38119862|FG000|Overall Study|Lack of Efficacy|0|||
16976211|NCT00837811|38119863|FG001|Overall Study|Lack of Efficacy|11|||
16976212|NCT00837811|38119864|FG002|Overall Study|Lack of Efficacy|0|||
16976213|NCT00837811|38119862|FG000|Overall Study|Lost to Follow-up|1|||
16976214|NCT00837811|38119863|FG001|Overall Study|Lost to Follow-up|3|||
16976215|NCT00837811|38119864|FG002|Overall Study|Lost to Follow-up|0|||
16976216|NCT00837811|38119862|FG000|Overall Study|Physician Decision|0|||
16976217|NCT00837811|38119863|FG001|Overall Study|Physician Decision|2|||
16976218|NCT00837811|38119864|FG002|Overall Study|Physician Decision|1|||
16976219|NCT00837811|38119862|FG000|Overall Study|Withdrawal by Subject|1|||
16976220|NCT00837811|38119863|FG001|Overall Study|Withdrawal by Subject|9|||
16976221|NCT00837811|38119864|FG002|Overall Study|Withdrawal by Subject|0|||
16976222|NCT00837811|38119862|FG000|Overall Study|Sponsor Decision|0|||
16976223|NCT00837811|38119863|FG001|Overall Study|Sponsor Decision|2|||
16976224|NCT00837811|38119864|FG002|Overall Study|Sponsor Decision|0|||
16976225|NCT00857389|38119881|FG000|Overall Study|Did not proceed to transplant|2|||
16976226|NCT01071798|38119885|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
16976227|NCT01071798|38119885|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
16976228|NCT01071798|38119885|FG000|Participants Who Received One Cycle|Patient requirement|20|||
16976229|NCT01071798|38119885|FG000|Participants Who Received One Cycle|Death|5|||
16976230|NCT01071798|38119885|FG000|Participants Who Received One Cycle|Change of therapy|6|||
16976231|NCT01071798|38119885|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
16976232|NCT01071798|38119885|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
16976233|NCT01071798|38119885|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
16976234|NCT01071798|38119885|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
16976235|NCT01071798|38119885|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
16976236|NCT00857311|38119903|FG000|Overall Study|Lost to Follow-up|1|||
16976237|NCT00857311|38119904|FG001|Overall Study|Lost to Follow-up|0|||
16976238|NCT00857311|38119905|FG002|Overall Study|Lost to Follow-up|0|||
16976239|NCT00857311|38119906|FG003|Overall Study|Lost to Follow-up|0|||
16976240|NCT00857233|38119912|FG000|Overall Study|Adverse Event|24|||
16976241|NCT00857233|38119912|FG000|Overall Study|Lack of Efficacy|1|||
16976242|NCT00857233|38119912|FG000|Overall Study|Non-compliance|1|||
16976243|NCT00857233|38119912|FG000|Overall Study|Withdrawal of Consent|9|||
16976244|NCT00857233|38119912|FG000|Overall Study|Lost to Follow-up|4|||
16976245|NCT00857233|38119912|FG000|Overall Study|Nursing Home Placement|14|||
16976246|NCT00857233|38119912|FG000|Overall Study|Other Reasons|2|||
16976247|NCT00856999|38119916|FG000|Overall Study|Withdrawal by Subject|5|||
16976248|NCT01071252|38119926|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
16976249|NCT01071252|38119927|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
16976250|NCT01071252|38119928|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
16976251|NCT01071252|38119929|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
16976252|NCT01071252|38119930|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
16976253|NCT01071252|38119926|FG000|Overall Study|Withdrawal by Subject|8|||
16976254|NCT01071252|38119927|FG001|Overall Study|Withdrawal by Subject|2|||
16976255|NCT01071252|38119928|FG002|Overall Study|Withdrawal by Subject|1|||
16976256|NCT01071252|38119929|FG003|Overall Study|Withdrawal by Subject|2|||
16976257|NCT01071252|38119930|FG004|Overall Study|Withdrawal by Subject|3|||
16976258|NCT01071252|38119926|FG000|Overall Study|administrative problems|1|||
16976259|NCT01071252|38119927|FG001|Overall Study|administrative problems|1|||
16976260|NCT01071252|38119928|FG002|Overall Study|administrative problems|0|||
16976261|NCT01071252|38119929|FG003|Overall Study|administrative problems|2|||
16976262|NCT01071252|38119930|FG004|Overall Study|administrative problems|1|||
16976263|NCT01071252|38119926|FG000|Overall Study|Lost to Follow-up|1|||
16976264|NCT01071252|38119927|FG001|Overall Study|Lost to Follow-up|0|||
16976265|NCT01071252|38119928|FG002|Overall Study|Lost to Follow-up|1|||
16976266|NCT01071252|38119929|FG003|Overall Study|Lost to Follow-up|2|||
16976267|NCT01071252|38119930|FG004|Overall Study|Lost to Follow-up|0|||
16976268|NCT01071252|38119926|FG000|Overall Study|Adverse Event|1|||
16976269|NCT01071252|38119927|FG001|Overall Study|Adverse Event|1|||
16976270|NCT01071252|38119928|FG002|Overall Study|Adverse Event|0|||
16976271|NCT01071252|38119929|FG003|Overall Study|Adverse Event|1|||
16976272|NCT01071252|38119930|FG004|Overall Study|Adverse Event|0|||
16976273|NCT01071252|38119926|FG000|Overall Study|Death|0|||
16976274|NCT01071252|38119927|FG001|Overall Study|Death|0|||
16976275|NCT01071252|38119928|FG002|Overall Study|Death|0|||
16976276|NCT01071252|38119929|FG003|Overall Study|Death|0|||
16976277|NCT01071252|38119930|FG004|Overall Study|Death|1|||
16976278|NCT00856843|38119944|FG000|Overall Study|Withdrawal by Subject|1|||
16976279|NCT00856843|38119945|FG001|Overall Study|Withdrawal by Subject|5|||
16976280|NCT00856843|38119944|FG000|Overall Study|Lack of Efficacy|1|||
16976281|NCT00856843|38119945|FG001|Overall Study|Lack of Efficacy|0|||
16976282|NCT00856609|38119953|FG000|Overall Study|Adverse Event|1|||
16976283|NCT00856609|38119954|FG001|Overall Study|Adverse Event|0|||
16976284|NCT01071096|38119960|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
16976285|NCT01071096|38119961|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
16976286|NCT00856375|38119980|FG000|Overall Study|Other|0|||
16976287|NCT00856375|38119981|FG001|Overall Study|Other|1|||
16976288|NCT00856375|38119980|FG000|Overall Study|Death|32|||
16976289|NCT00856375|38119981|FG001|Overall Study|Death|30|||
16976290|NCT00856375|38119980|FG000|Overall Study|Sponsor Terminated Study|7|||
16976291|NCT00856375|38119981|FG001|Overall Study|Sponsor Terminated Study|7|||
16976292|NCT00856375|38119980|FG000|Overall Study|Withdrawal by Subject|2|||
16976293|NCT00856375|38119981|FG001|Overall Study|Withdrawal by Subject|1|||
16976294|NCT00856375|38119980|FG000|Overall Study|Lost to Follow-up|1|||
16976295|NCT00856375|38119981|FG001|Overall Study|Lost to Follow-up|2|||
16976296|NCT01070784|38119989|FG000|Overall Study|Withdrawal by Subject|6|||
16976297|NCT01070784|38119990|FG001|Overall Study|Withdrawal by Subject|9|||
16976298|NCT01070784|38119989|FG000|Overall Study|Adverse Event|14|||
16976299|NCT01070784|38119990|FG001|Overall Study|Adverse Event|9|||
16976300|NCT00837577|38119998|FG000|Double-blind Period|Clinical Adverse Event|1|||
16976301|NCT00837577|38119999|FG001|Double-blind Period|Clinical Adverse Event|0|||
16976302|NCT00837577|38119998|FG000|Double-blind Period|Withdrawal by Subject|1|||
16976303|NCT00837577|38119999|FG001|Double-blind Period|Withdrawal by Subject|0|||
16976304|NCT00837577|38119998|FG000|Open-label Period|Clinical Adverse Event|2|||
16976305|NCT00837577|38119999|FG001|Open-label Period|Clinical Adverse Event|2|||
16976306|NCT00837577|38119998|FG000|Open-label Period|Laboratory Adverse Event|0|||
16976307|NCT00837577|38119999|FG001|Open-label Period|Laboratory Adverse Event|1|||
16976308|NCT00837577|38119998|FG000|Open-label Period|Lack of Efficacy|4|||
16976309|NCT00837577|38119999|FG001|Open-label Period|Lack of Efficacy|3|||
16976310|NCT00837577|38119998|FG000|Open-label Period|Withdrawal by Subject|1|||
16976311|NCT00837577|38119999|FG001|Open-label Period|Withdrawal by Subject|2|||
16976312|NCT00837577|38119998|FG000|Open-label Period|Other Reason|1|||
16976313|NCT00837577|38119999|FG001|Open-label Period|Other Reason|1|||
16976314|NCT01070550|38120012|FG000|Overall Study|Adverse Event|43|||
16976315|NCT01070550|38120013|FG001|Overall Study|Adverse Event|1|||
16976316|NCT01070550|38120014|FG002|Overall Study|Adverse Event|3|||
16976317|NCT01070550|38120015|FG003|Overall Study|Adverse Event|0|||
16976318|NCT01070550|38120016|FG004|Overall Study|Adverse Event|0|||
16976319|NCT01070550|38120017|FG005|Overall Study|Adverse Event|0|||
16976320|NCT01070550|38120012|FG000|Overall Study|Death|20|||
16976321|NCT01070550|38120013|FG001|Overall Study|Death|4|||
16976322|NCT01070550|38120014|FG002|Overall Study|Death|3|||
16976323|NCT01070550|38120015|FG003|Overall Study|Death|0|||
16976324|NCT01070550|38120016|FG004|Overall Study|Death|0|||
16976325|NCT01070550|38120017|FG005|Overall Study|Death|0|||
16976326|NCT01070550|38120012|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
16976327|NCT01070550|38120013|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
16976328|NCT01070550|38120014|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
16976329|NCT01070550|38120015|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16976330|NCT01070550|38120016|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16976331|NCT01070550|38120017|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16976332|NCT01070550|38120012|FG000|Overall Study|Early termination|3|||
16976333|NCT01070550|38120013|FG001|Overall Study|Early termination|0|||
16976334|NCT01070550|38120014|FG002|Overall Study|Early termination|0|||
16976335|NCT01070550|38120015|FG003|Overall Study|Early termination|0|||
16976336|NCT01070550|38120016|FG004|Overall Study|Early termination|0|||
16976337|NCT01070550|38120017|FG005|Overall Study|Early termination|0|||
16976338|NCT01070550|38120012|FG000|Overall Study|Failed to return|450|||
16976339|NCT01070550|38120013|FG001|Overall Study|Failed to return|33|||
16976340|NCT01070550|38120014|FG002|Overall Study|Failed to return|144|||
16976341|NCT01070550|38120015|FG003|Overall Study|Failed to return|40|||
16976342|NCT01070550|38120016|FG004|Overall Study|Failed to return|1|||
16976343|NCT01070550|38120017|FG005|Overall Study|Failed to return|2|||
16976344|NCT01070550|38120012|FG000|Overall Study|Incomplete treatment|2|||
16976345|NCT01070550|38120013|FG001|Overall Study|Incomplete treatment|0|||
16976346|NCT01070550|38120014|FG002|Overall Study|Incomplete treatment|0|||
16976347|NCT01070550|38120015|FG003|Overall Study|Incomplete treatment|0|||
16976348|NCT01070550|38120016|FG004|Overall Study|Incomplete treatment|0|||
16976349|NCT01070550|38120017|FG005|Overall Study|Incomplete treatment|0|||
16976350|NCT01070550|38120012|FG000|Overall Study|Lab test not done|22|||
16976351|NCT01070550|38120013|FG001|Overall Study|Lab test not done|3|||
16976352|NCT01070550|38120014|FG002|Overall Study|Lab test not done|4|||
16976353|NCT01070550|38120015|FG003|Overall Study|Lab test not done|1|||
16976354|NCT01070550|38120016|FG004|Overall Study|Lab test not done|0|||
16976355|NCT01070550|38120017|FG005|Overall Study|Lab test not done|1|||
16976356|NCT01070550|38120012|FG000|Overall Study|Lack of Efficacy|65|||
16976357|NCT01070550|38120013|FG001|Overall Study|Lack of Efficacy|1|||
16976358|NCT01070550|38120014|FG002|Overall Study|Lack of Efficacy|5|||
16976359|NCT01070550|38120015|FG003|Overall Study|Lack of Efficacy|5|||
16976360|NCT01070550|38120016|FG004|Overall Study|Lack of Efficacy|0|||
16976361|NCT01070550|38120017|FG005|Overall Study|Lack of Efficacy|1|||
16976362|NCT01070550|38120012|FG000|Overall Study|Miscellaneous|12|||
16976363|NCT01070550|38120013|FG001|Overall Study|Miscellaneous|2|||
16976364|NCT01070550|38120014|FG002|Overall Study|Miscellaneous|3|||
16976365|NCT01070550|38120015|FG003|Overall Study|Miscellaneous|1|||
16976366|NCT01070550|38120016|FG004|Overall Study|Miscellaneous|0|||
16976367|NCT01070550|38120017|FG005|Overall Study|Miscellaneous|0|||
16976368|NCT01070550|38120012|FG000|Overall Study|New treatment started|3|||
16976369|NCT01070550|38120013|FG001|Overall Study|New treatment started|1|||
16976370|NCT01070550|38120014|FG002|Overall Study|New treatment started|0|||
16976371|NCT01070550|38120015|FG003|Overall Study|New treatment started|2|||
16976372|NCT01070550|38120016|FG004|Overall Study|New treatment started|0|||
16976373|NCT01070550|38120017|FG005|Overall Study|New treatment started|0|||
16976374|NCT01070550|38120012|FG000|Overall Study|Non-responders|493|||
16976375|NCT01070550|38120013|FG001|Overall Study|Non-responders|4|||
16976376|NCT01070550|38120014|FG002|Overall Study|Non-responders|21|||
16976377|NCT01070550|38120015|FG003|Overall Study|Non-responders|20|||
16976378|NCT01070550|38120016|FG004|Overall Study|Non-responders|0|||
16976379|NCT01070550|38120017|FG005|Overall Study|Non-responders|2|||
16976380|NCT01070550|38120012|FG000|Overall Study|Not categorized|33|||
16976381|NCT01070550|38120013|FG001|Overall Study|Not categorized|2|||
16976382|NCT01070550|38120014|FG002|Overall Study|Not categorized|6|||
16976383|NCT01070550|38120015|FG003|Overall Study|Not categorized|1|||
16976384|NCT01070550|38120016|FG004|Overall Study|Not categorized|0|||
16976385|NCT01070550|38120017|FG005|Overall Study|Not categorized|1|||
16976386|NCT01070550|38120012|FG000|Overall Study|Protocol Violation|15|||
16976387|NCT01070550|38120013|FG001|Overall Study|Protocol Violation|1|||
16976388|NCT01070550|38120014|FG002|Overall Study|Protocol Violation|1|||
16976389|NCT01070550|38120015|FG003|Overall Study|Protocol Violation|1|||
16976390|NCT01070550|38120016|FG004|Overall Study|Protocol Violation|0|||
16976391|NCT01070550|38120017|FG005|Overall Study|Protocol Violation|0|||
16976392|NCT01070550|38120012|FG000|Overall Study|Relapse|44|||
16976393|NCT01070550|38120013|FG001|Overall Study|Relapse|5|||
16976394|NCT01070550|38120014|FG002|Overall Study|Relapse|14|||
16976395|NCT01070550|38120015|FG003|Overall Study|Relapse|4|||
16976396|NCT01070550|38120016|FG004|Overall Study|Relapse|0|||
16976397|NCT01070550|38120017|FG005|Overall Study|Relapse|0|||
16976398|NCT01070550|38120012|FG000|Overall Study|Result not available|3|||
16976399|NCT01070550|38120013|FG001|Overall Study|Result not available|1|||
16976400|NCT01070550|38120014|FG002|Overall Study|Result not available|3|||
16976401|NCT01070550|38120015|FG003|Overall Study|Result not available|0|||
16976402|NCT01070550|38120016|FG004|Overall Study|Result not available|0|||
16976403|NCT01070550|38120017|FG005|Overall Study|Result not available|0|||
16976404|NCT01070550|38120012|FG000|Overall Study|Screen failure|1|||
16976405|NCT01070550|38120013|FG001|Overall Study|Screen failure|0|||
16976406|NCT01070550|38120014|FG002|Overall Study|Screen failure|0|||
16976407|NCT01070550|38120015|FG003|Overall Study|Screen failure|0|||
16976408|NCT01070550|38120016|FG004|Overall Study|Screen failure|0|||
16976409|NCT01070550|38120017|FG005|Overall Study|Screen failure|0|||
16976410|NCT01070550|38120012|FG000|Overall Study|Sponsor decision|1|||
16976411|NCT01070550|38120013|FG001|Overall Study|Sponsor decision|0|||
16976412|NCT01070550|38120014|FG002|Overall Study|Sponsor decision|0|||
16976413|NCT01070550|38120015|FG003|Overall Study|Sponsor decision|0|||
16976414|NCT01070550|38120016|FG004|Overall Study|Sponsor decision|0|||
16976415|NCT01070550|38120017|FG005|Overall Study|Sponsor decision|0|||
16976416|NCT01070550|38120012|FG000|Overall Study|Treatment duration shortened|1|||
16976417|NCT01070550|38120013|FG001|Overall Study|Treatment duration shortened|0|||
16976418|NCT01070550|38120014|FG002|Overall Study|Treatment duration shortened|0|||
16976419|NCT01070550|38120015|FG003|Overall Study|Treatment duration shortened|0|||
16976420|NCT01070550|38120016|FG004|Overall Study|Treatment duration shortened|0|||
16976421|NCT01070550|38120017|FG005|Overall Study|Treatment duration shortened|0|||
16976422|NCT01070550|38120012|FG000|Overall Study|Treatment interrupted|7|||
16976423|NCT01070550|38120013|FG001|Overall Study|Treatment interrupted|0|||
16976424|NCT01070550|38120014|FG002|Overall Study|Treatment interrupted|1|||
16976425|NCT01070550|38120015|FG003|Overall Study|Treatment interrupted|1|||
16976426|NCT01070550|38120016|FG004|Overall Study|Treatment interrupted|0|||
16976427|NCT01070550|38120017|FG005|Overall Study|Treatment interrupted|0|||
16976428|NCT01070550|38120012|FG000|Overall Study|Treatment not started|14|||
16976429|NCT01070550|38120013|FG001|Overall Study|Treatment not started|2|||
16976430|NCT01070550|38120014|FG002|Overall Study|Treatment not started|4|||
16976431|NCT01070550|38120015|FG003|Overall Study|Treatment not started|0|||
16976432|NCT01070550|38120016|FG004|Overall Study|Treatment not started|0|||
16976433|NCT01070550|38120017|FG005|Overall Study|Treatment not started|0|||
16976434|NCT01070550|38120012|FG000|Overall Study|Treatment restarted|0|||
16976435|NCT01070550|38120013|FG001|Overall Study|Treatment restarted|1|||
16976436|NCT01070550|38120014|FG002|Overall Study|Treatment restarted|0|||
16976437|NCT01070550|38120015|FG003|Overall Study|Treatment restarted|0|||
16976438|NCT01070550|38120016|FG004|Overall Study|Treatment restarted|0|||
16976439|NCT01070550|38120017|FG005|Overall Study|Treatment restarted|0|||
16976440|NCT01070550|38120012|FG000|Overall Study|Treatment stopped|3|||
16976441|NCT01070550|38120013|FG001|Overall Study|Treatment stopped|0|||
16976442|NCT01070550|38120014|FG002|Overall Study|Treatment stopped|0|||
16976443|NCT01070550|38120015|FG003|Overall Study|Treatment stopped|0|||
16976444|NCT01070550|38120016|FG004|Overall Study|Treatment stopped|0|||
16976445|NCT01070550|38120017|FG005|Overall Study|Treatment stopped|0|||
16976446|NCT01070550|38120012|FG000|Overall Study|Treatment unavailable|1|||
16976447|NCT01070550|38120013|FG001|Overall Study|Treatment unavailable|0|||
16976448|NCT01070550|38120014|FG002|Overall Study|Treatment unavailable|0|||
16976449|NCT01070550|38120015|FG003|Overall Study|Treatment unavailable|0|||
16976450|NCT01070550|38120016|FG004|Overall Study|Treatment unavailable|0|||
16976451|NCT01070550|38120017|FG005|Overall Study|Treatment unavailable|0|||
16976452|NCT01070550|38120012|FG000|Overall Study|Treatment was stopped early|7|||
16976453|NCT01070550|38120013|FG001|Overall Study|Treatment was stopped early|0|||
16976454|NCT01070550|38120014|FG002|Overall Study|Treatment was stopped early|0|||
16976455|NCT01070550|38120015|FG003|Overall Study|Treatment was stopped early|0|||
16976456|NCT01070550|38120016|FG004|Overall Study|Treatment was stopped early|0|||
16976457|NCT01070550|38120017|FG005|Overall Study|Treatment was stopped early|0|||
16976458|NCT01070550|38120012|FG000|Overall Study|Other|5|||
16976459|NCT01070550|38120013|FG001|Overall Study|Other|0|||
16976460|NCT01070550|38120014|FG002|Overall Study|Other|0|||
16976461|NCT01070550|38120015|FG003|Overall Study|Other|1|||
16976462|NCT01070550|38120016|FG004|Overall Study|Other|0|||
16976463|NCT01070550|38120017|FG005|Overall Study|Other|0|||
16976464|NCT01070550|38120012|FG000|Overall Study|Withdrawal by Subject|35|||
16976465|NCT01070550|38120013|FG001|Overall Study|Withdrawal by Subject|0|||
16976466|NCT01070550|38120014|FG002|Overall Study|Withdrawal by Subject|3|||
16976467|NCT01070550|38120015|FG003|Overall Study|Withdrawal by Subject|0|||
16976468|NCT01070550|38120016|FG004|Overall Study|Withdrawal by Subject|0|||
16976469|NCT01070550|38120017|FG005|Overall Study|Withdrawal by Subject|0|||
16976470|NCT00848107|38120032|FG000|Overall Study|Lost to Follow-up|2|||
16976471|NCT00848107|38120032|FG000|Overall Study|Withdrawal by Subject|8|||
16976472|NCT00848107|38120032|FG000|Overall Study|Adverse Event|9|||
16976473|NCT00848107|38120032|FG000|Overall Study|Death|1|||
16976474|NCT00848107|38120032|FG000|Overall Study|Pregnancy|1|||
16976475|NCT00856297|38120041|FG000|Overall Study|Unable to classify|2|||
16976476|NCT00856297|38120042|FG001|Overall Study|Unable to classify|0|||
16976477|NCT00856297|38120043|FG002|Overall Study|Unable to classify|0|||
16976478|NCT00856297|38120044|FG003|Overall Study|Unable to classify|0|||
16976479|NCT00856297|38120045|FG004|Overall Study|Unable to classify|0|||
16976480|NCT01046136|38120064|FG000|Overall Study|Withdrawal by Subject|0|||
16976481|NCT01046136|38120065|FG001|Overall Study|Withdrawal by Subject|4|||
16976482|NCT01046136|38120064|FG000|Overall Study|Physician Decision|1|||
16976483|NCT01046136|38120065|FG001|Overall Study|Physician Decision|1|||
16976484|NCT01046136|38120064|FG000|Overall Study|Lost to Follow-up|3|||
16976485|NCT01046136|38120065|FG001|Overall Study|Lost to Follow-up|3|||
16976486|NCT01070394|38120073|FG000|Overall Study|Adverse Event|6|||
16976487|NCT01070394|38120073|FG000|Overall Study|Withdrawal by Subject|1|||
16976488|NCT00836953|38120079|FG000|Overall Study|Withdrawal by Subject|1|||
16976489|NCT00836953|38120079|FG000|Overall Study|Lost to Follow-up|1|||
16976490|NCT01070316|38120083|FG000|Extension Phase|Lack of Efficacy|3|||
16976491|NCT01070316|38120083|FG000|Extension Phase|Withdrawal by Subject|1|||
16976492|NCT01126541|38120090|FG000|Overall Study|Adverse Event|0|||
16976493|NCT01126541|38120091|FG001|Overall Study|Adverse Event|2|||
16976494|NCT01126541|38120092|FG002|Overall Study|Adverse Event|4|||
16976495|NCT01126541|38120090|FG000|Overall Study|Death|0|||
16976496|NCT01126541|38120091|FG001|Overall Study|Death|1|||
16976497|NCT01126541|38120092|FG002|Overall Study|Death|0|||
16976498|NCT01126541|38120090|FG000|Overall Study|Lack of Efficacy|6|||
16976499|NCT01126541|38120091|FG001|Overall Study|Lack of Efficacy|1|||
16976500|NCT01126541|38120092|FG002|Overall Study|Lack of Efficacy|11|||
16976501|NCT01126541|38120090|FG000|Overall Study|Lost to Follow-up|1|||
16976502|NCT01126541|38120091|FG001|Overall Study|Lost to Follow-up|2|||
16976503|NCT01126541|38120092|FG002|Overall Study|Lost to Follow-up|2|||
16976504|NCT01126541|38120090|FG000|Overall Study|Withdrawal by Subject|2|||
16976505|NCT01126541|38120091|FG001|Overall Study|Withdrawal by Subject|5|||
16976506|NCT01126541|38120092|FG002|Overall Study|Withdrawal by Subject|6|||
16976507|NCT01126541|38120090|FG000|Overall Study|Protocol Violation|0|||
16976508|NCT01126541|38120091|FG001|Overall Study|Protocol Violation|0|||
16976509|NCT01126541|38120092|FG002|Overall Study|Protocol Violation|1|||
16976510|NCT01126541|38120090|FG000|Overall Study|Administrative reason or other|1|||
16976511|NCT01126541|38120091|FG001|Overall Study|Administrative reason or other|1|||
16976512|NCT01126541|38120092|FG002|Overall Study|Administrative reason or other|2|||
16976513|NCT00836875|38120104|FG000|Overall Study|Death|3|||
16976514|NCT00836875|38120105|FG001|Overall Study|Death|2|||
16976515|NCT00836875|38120104|FG000|Overall Study|Withdrawal by Subject|0|||
16976516|NCT00836875|38120105|FG001|Overall Study|Withdrawal by Subject|1|||
16976517|NCT01125917|38120111|FG000|Overall Study|Adverse Event|43|||
16976518|NCT01125917|38120111|FG000|Overall Study|Lost to Follow-up|23|||
16976519|NCT01125917|38120111|FG000|Overall Study|Withdrawal by Subject|31|||
16976520|NCT01125917|38120111|FG000|Overall Study|Administrative|223|||
16976521|NCT01125917|38120111|FG000|Overall Study|Lack of Efficacy|19|||
16976522|NCT00847561|38120117|FG000|Overall Study|Withdrawal by Subject|4|||
16976523|NCT00847561|38120118|FG001|Overall Study|Withdrawal by Subject|3|||
16976524|NCT00847561|38120117|FG000|Overall Study|Unable to schedule|9|||
16976525|NCT00847561|38120118|FG001|Overall Study|Unable to schedule|1|||
16976526|NCT01121549|38120124|FG000|Overall Study|Adverse Event|10|||
16976527|NCT01121549|38120124|FG000|Overall Study|Lack of Efficacy|11|||
16976528|NCT01121549|38120124|FG000|Overall Study|Lost to Follow-up|12|||
16976529|NCT01121549|38120124|FG000|Overall Study|Did not meet entrance criteria|9|||
16976530|NCT01121549|38120124|FG000|Overall Study|Study terminated by sponsor|197|||
16976531|NCT01121549|38120124|FG000|Overall Study|Pregnancy|1|||
16976532|NCT01121549|38120124|FG000|Overall Study|Protocol Violation|33|||
16976533|NCT01121549|38120124|FG000|Overall Study|Withdrawal by Subject|16|||
16976534|NCT01121549|38120124|FG000|Overall Study|Other|58|||
16976535|NCT00847405|38120130|FG000|First Intervention|Adverse Event|0|||
16976536|NCT00847405|38120131|FG001|First Intervention|Adverse Event|1|||
16976537|NCT00847405|38120130|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16976538|NCT00847405|38120131|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16976539|NCT00836095|38120137|FG000|Overall Study|Physician Decision|0|||
16976540|NCT00836095|38120138|FG001|Overall Study|Physician Decision|3|||
16976541|NCT00835237|38120155|FG000|Overall Study|Lost to Follow-up|4|||
16976542|NCT00835237|38120156|FG001|Overall Study|Lost to Follow-up|0|||
16976543|NCT00835237|38120155|FG000|Overall Study|Withdrawal by Subject|2|||
16976544|NCT00835237|38120156|FG001|Overall Study|Withdrawal by Subject|0|||
16976545|NCT01072500|38120164|FG000|Overall Study|Death|2|||
16976546|NCT01072500|38120165|FG001|Overall Study|Death|2|||
16976547|NCT01072500|38120164|FG000|Overall Study|Lost to Follow-up|5|||
16976548|NCT01072500|38120165|FG001|Overall Study|Lost to Follow-up|2|||
16976549|NCT01072500|38120164|FG000|Overall Study|Withdrawal by Subject|17|||
16976550|NCT01072500|38120165|FG001|Overall Study|Withdrawal by Subject|10|||
16976551|NCT00847015|38120173|FG000|Overall Study|Withdrawal by Subject|1|||
16976552|NCT00847015|38120173|FG000|Overall Study|declined any surgery|1|||
16976553|NCT00847015|38120173|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
16976554|NCT00855595|38120179|FG000|Overall Study|Withdrawal by Subject|1|||
16976555|NCT00855595|38120180|FG001|Overall Study|Withdrawal by Subject|2|||
16976556|NCT00855595|38120179|FG000|Overall Study|Lost to Follow-up|3|||
16976557|NCT00855595|38120180|FG001|Overall Study|Lost to Follow-up|3|||
16976558|NCT00855595|38120179|FG000|Overall Study|Adverse Event|1|||
16976559|NCT00855595|38120180|FG001|Overall Study|Adverse Event|1|||
16976560|NCT00855595|38120179|FG000|Overall Study|patient moved out of state|1|||
16976561|NCT00855595|38120180|FG001|Overall Study|patient moved out of state|0|||
16976562|NCT00855595|38120179|FG000|Overall Study|patient left country|0|||
16976563|NCT00855595|38120180|FG001|Overall Study|patient left country|1|||
16976564|NCT00855439|38120188|FG000|Overall Study|Withdrawal by Subject|2|||
16976565|NCT00855439|38120189|FG001|Overall Study|Withdrawal by Subject|0|||
16976566|NCT00855439|38120188|FG000|Overall Study|Pregnancy|1|||
16976567|NCT00855439|38120189|FG001|Overall Study|Pregnancy|0|||
16976568|NCT01064856|38120197|FG000|Double-blind (DB) Period|Adverse Event|1|||
16976569|NCT01064856|38120198|FG001|Double-blind (DB) Period|Adverse Event|0|||
16976570|NCT01064856|38120199|FG002|Double-blind (DB) Period|Adverse Event|0|||
16976571|NCT01064856|38120200|FG003|Double-blind (DB) Period|Adverse Event|0|||
16976572|NCT01064856|38120197|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
16976573|NCT01064856|38120198|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
16976574|NCT01064856|38120199|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
16976575|NCT01064856|38120200|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
16976576|NCT01064856|38120197|FG000|Open-label (OL) Period|Adverse Event|0|||
16976577|NCT01064856|38120198|FG001|Open-label (OL) Period|Adverse Event|0|||
16976578|NCT01064856|38120199|FG002|Open-label (OL) Period|Adverse Event|12|||
16976579|NCT01064856|38120200|FG003|Open-label (OL) Period|Adverse Event|6|||
16976580|NCT01064856|38120197|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
16976581|NCT01064856|38120198|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
16976582|NCT01064856|38120199|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
16976583|NCT01064856|38120200|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
16976584|NCT01064856|38120197|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
16976585|NCT01064856|38120198|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
16976586|NCT01064856|38120199|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
16976587|NCT01064856|38120200|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
16976588|NCT01064856|38120197|FG000|Open-label (OL) Period|Other|0|||
16976589|NCT01064856|38120198|FG001|Open-label (OL) Period|Other|0|||
16976590|NCT01064856|38120199|FG002|Open-label (OL) Period|Other|7|||
16976591|NCT01064856|38120200|FG003|Open-label (OL) Period|Other|7|||
16976592|NCT00846391|38120210|FG000|Overall Study|Physician Decision|0|||
16976593|NCT00846391|38120211|FG001|Overall Study|Physician Decision|0|||
16976594|NCT00846391|38120212|FG002|Overall Study|Physician Decision|1|||
16976595|NCT00846391|38120210|FG000|Overall Study|Study Terminated by Sponsor|1|||
16976596|NCT00846391|38120211|FG001|Overall Study|Study Terminated by Sponsor|2|||
16976597|NCT00846391|38120212|FG002|Overall Study|Study Terminated by Sponsor|2|||
16976598|NCT01042392|38120222|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
16976599|NCT01042392|38120223|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
16976600|NCT01042392|38120224|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
16976601|NCT01042392|38120225|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
16976602|NCT01042392|38120222|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
16976603|NCT01042392|38120223|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
16976604|NCT01042392|38120224|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
16976605|NCT01042392|38120225|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
16976606|NCT01042392|38120222|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
16976607|NCT01042392|38120223|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
16976608|NCT01042392|38120224|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
16976609|NCT01042392|38120225|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
16976610|NCT01042392|38120222|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
16976611|NCT01042392|38120223|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
16976612|NCT01042392|38120224|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
16976613|NCT01042392|38120225|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
16976614|NCT01042392|38120222|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
16976615|NCT01042392|38120223|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
16976616|NCT01042392|38120224|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
16976617|NCT01042392|38120225|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
16976618|NCT01042392|38120222|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
16976619|NCT01042392|38120223|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
16976620|NCT01042392|38120224|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
16976621|NCT01042392|38120225|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
16976622|NCT01042392|38120222|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
16976623|NCT01042392|38120223|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
16976624|NCT01042392|38120224|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
16976625|NCT01042392|38120225|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
16976626|NCT01042392|38120222|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
16976627|NCT01042392|38120223|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
16976628|NCT01042392|38120224|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
16976629|NCT01042392|38120225|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
16976630|NCT01042392|38120222|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
16976631|NCT01042392|38120223|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
16976632|NCT01042392|38120224|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
16976633|NCT01042392|38120225|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
16976634|NCT01064310|38120239|FG000|Period 1|Adverse Event|7|||
16976635|NCT01064310|38120240|FG001|Period 1|Adverse Event|10|||
16976636|NCT01064310|38120241|FG002|Period 1|Adverse Event|0|||
16976637|NCT01064310|38120239|FG000|Period 1|Physician Decision|1|||
16976638|NCT01064310|38120240|FG001|Period 1|Physician Decision|0|||
16976639|NCT01064310|38120241|FG002|Period 1|Physician Decision|0|||
16976640|NCT01064310|38120239|FG000|Period 1|Withdrawal by Subject|2|||
16976641|NCT01064310|38120240|FG001|Period 1|Withdrawal by Subject|2|||
16976642|NCT01064310|38120241|FG002|Period 1|Withdrawal by Subject|0|||
16976643|NCT01064310|38120239|FG000|Period 1|Lack of Efficacy|3|||
16976644|NCT01064310|38120240|FG001|Period 1|Lack of Efficacy|5|||
16976645|NCT01064310|38120241|FG002|Period 1|Lack of Efficacy|0|||
16976646|NCT01064310|38120239|FG000|Period 1|Entered Open-label Period|1|||
16976647|NCT01064310|38120240|FG001|Period 1|Entered Open-label Period|1|||
16976648|NCT01064310|38120241|FG002|Period 1|Entered Open-label Period|0|||
16976649|NCT01064310|38120239|FG000|Period 2|Adverse Event|2|||
16976650|NCT01064310|38120240|FG001|Period 2|Adverse Event|1|||
16976651|NCT01064310|38120241|FG002|Period 2|Adverse Event|0|||
16976652|NCT01064310|38120239|FG000|Period 2|Physician Decision|0|||
16976653|NCT01064310|38120240|FG001|Period 2|Physician Decision|1|||
16976654|NCT01064310|38120241|FG002|Period 2|Physician Decision|0|||
16976655|NCT01064310|38120239|FG000|Period 2|Entered Open-label Period|1|||
16976656|NCT01064310|38120240|FG001|Period 2|Entered Open-label Period|0|||
16976657|NCT01064310|38120241|FG002|Period 2|Entered Open-label Period|0|||
16976658|NCT01064310|38120239|FG000|Period 2|Lack of Efficacy|1|||
16976659|NCT01064310|38120240|FG001|Period 2|Lack of Efficacy|4|||
16976660|NCT01064310|38120241|FG002|Period 2|Lack of Efficacy|0|||
16976661|NCT01064310|38120239|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
16976662|NCT01064310|38120240|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
16976663|NCT01064310|38120241|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
16976664|NCT01064310|38120239|FG000|Open Label Pazopinib|Adverse Event|0|||
16976665|NCT01064310|38120240|FG001|Open Label Pazopinib|Adverse Event|0|||
16976666|NCT01064310|38120241|FG002|Open Label Pazopinib|Adverse Event|12|||
16976667|NCT01064310|38120239|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
16976668|NCT01064310|38120240|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
16976669|NCT01064310|38120241|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
16976670|NCT01064310|38120239|FG000|Open Label Pazopinib|Physician Decision|0|||
16976671|NCT01064310|38120240|FG001|Open Label Pazopinib|Physician Decision|0|||
16976672|NCT01064310|38120241|FG002|Open Label Pazopinib|Physician Decision|20|||
16976673|NCT01037244|38120254|FG000|Overall Study|Adverse Event|3|||
16976674|NCT01037244|38120255|FG001|Overall Study|Adverse Event|2|||
16976675|NCT01037244|38120256|FG002|Overall Study|Adverse Event|6|||
16976676|NCT01037244|38120257|FG003|Overall Study|Adverse Event|3|||
16976677|NCT01037244|38120254|FG000|Overall Study|Lack of Efficacy|1|||
16976678|NCT01037244|38120255|FG001|Overall Study|Lack of Efficacy|1|||
16976679|NCT01037244|38120256|FG002|Overall Study|Lack of Efficacy|0|||
16976680|NCT01037244|38120257|FG003|Overall Study|Lack of Efficacy|1|||
16976681|NCT01037244|38120254|FG000|Overall Study|Lost to Follow-up|3|||
16976682|NCT01037244|38120255|FG001|Overall Study|Lost to Follow-up|3|||
16976683|NCT01037244|38120256|FG002|Overall Study|Lost to Follow-up|4|||
16976684|NCT01037244|38120257|FG003|Overall Study|Lost to Follow-up|4|||
16976685|NCT01037244|38120254|FG000|Overall Study|Withdrawal by Subject|1|||
16976686|NCT01037244|38120255|FG001|Overall Study|Withdrawal by Subject|5|||
16976687|NCT01037244|38120256|FG002|Overall Study|Withdrawal by Subject|3|||
16976688|NCT01037244|38120257|FG003|Overall Study|Withdrawal by Subject|5|||
16976689|NCT01037244|38120254|FG000|Overall Study|Partner Withdrew Consent|2|||
16976690|NCT01037244|38120255|FG001|Overall Study|Partner Withdrew Consent|1|||
16976691|NCT01037244|38120256|FG002|Overall Study|Partner Withdrew Consent|0|||
16976692|NCT01037244|38120257|FG003|Overall Study|Partner Withdrew Consent|0|||
16976693|NCT01037244|38120254|FG000|Overall Study|Various|3|||
16976694|NCT01037244|38120255|FG001|Overall Study|Various|2|||
16976695|NCT01037244|38120256|FG002|Overall Study|Various|1|||
16976696|NCT01037244|38120257|FG003|Overall Study|Various|1|||
16976697|NCT00833989|38120271|FG000|Overall Study|Physician Decision|0|||
16976698|NCT00833989|38120272|FG001|Overall Study|Physician Decision|0|||
16976699|NCT00833989|38120273|FG002|Overall Study|Physician Decision|0|||
16976700|NCT00833989|38120274|FG003|Overall Study|Physician Decision|1|||
16976701|NCT00833989|38120271|FG000|Overall Study|Withdrawal by Subject|3|||
16976702|NCT00833989|38120272|FG001|Overall Study|Withdrawal by Subject|0|||
16976703|NCT00833989|38120273|FG002|Overall Study|Withdrawal by Subject|1|||
16976704|NCT00833989|38120274|FG003|Overall Study|Withdrawal by Subject|1|||
16976705|NCT01037088|38120287|FG000|Overall Study|Withdrawal by Subject|3|||
16976706|NCT01042236|38120296|FG000|Treatment Period 1|Adverse Event|0|||
16976707|NCT01042236|38120297|FG001|Treatment Period 1|Adverse Event|1|||
16976708|NCT01042236|38120298|FG002|Treatment Period 1|Adverse Event|0|||
16976709|NCT01042236|38120299|FG003|Treatment Period 1|Adverse Event|0|||
16976710|NCT01042236|38120300|FG004|Treatment Period 1|Adverse Event|1|||
16976711|NCT01042236|38120301|FG005|Treatment Period 1|Adverse Event|0|||
16976712|NCT01042236|38120296|FG000|Treatment Period 3|Adverse Event|0|||
16976713|NCT01042236|38120297|FG001|Treatment Period 3|Adverse Event|0|||
16976714|NCT01042236|38120298|FG002|Treatment Period 3|Adverse Event|0|||
16976715|NCT01042236|38120299|FG003|Treatment Period 3|Adverse Event|1|||
16976716|NCT01042236|38120300|FG004|Treatment Period 3|Adverse Event|0|||
16976717|NCT01042236|38120301|FG005|Treatment Period 3|Adverse Event|0|||
16976718|NCT01042236|38120296|FG000|Treatment Period 3|Protocol Violation|0|||
16976719|NCT01042236|38120297|FG001|Treatment Period 3|Protocol Violation|0|||
16976720|NCT01042236|38120298|FG002|Treatment Period 3|Protocol Violation|0|||
16976721|NCT01042236|38120299|FG003|Treatment Period 3|Protocol Violation|1|||
16976722|NCT01042236|38120300|FG004|Treatment Period 3|Protocol Violation|0|||
16976723|NCT01042236|38120301|FG005|Treatment Period 3|Protocol Violation|0|||
16976724|NCT00592501|38120309|FG000|Overall Study|Withdrawal by Subject|1|||
16976725|NCT00592501|38120309|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
16976726|NCT01040832|38120315|FG000|Overall Study|Adverse Event|4|||
16976727|NCT01040832|38120316|FG001|Overall Study|Adverse Event|5|||
16976728|NCT01040832|38120315|FG000|Overall Study|Death|4|||
16976729|NCT01040832|38120316|FG001|Overall Study|Death|6|||
16976730|NCT01040832|38120315|FG000|Overall Study|Withdrawal by Subject|2|||
16976731|NCT01040832|38120316|FG001|Overall Study|Withdrawal by Subject|3|||
16976732|NCT01040832|38120315|FG000|Overall Study|Progressive disease|32|||
16976733|NCT01040832|38120316|FG001|Overall Study|Progressive disease|17|||
16976734|NCT01040832|38120315|FG000|Overall Study|Symptomatic deterioration|2|||
16976735|NCT01040832|38120316|FG001|Overall Study|Symptomatic deterioration|5|||
16976736|NCT01040832|38120315|FG000|Overall Study|Other|2|||
16976737|NCT01040832|38120316|FG001|Overall Study|Other|1|||
16976738|NCT00854581|38120322|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
16976739|NCT00854581|38120322|FG000|Induction (Up to Day 21)|Death|1|||
16976740|NCT00854581|38120322|FG000|Induction (Up to Day 21)|Physician Decision|1|||
16976741|NCT00854581|38120322|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
16976742|NCT00833911|38120331|FG000|Titration|Adverse Event|18|||
16976743|NCT00833911|38120331|FG000|Titration|Withdrawal by Subject|3|||
16976744|NCT00833911|38120331|FG000|Maintenance Phase I|Adverse Event|73|||
16976745|NCT00833911|38120331|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
16976746|NCT00833911|38120331|FG000|Maintenance Phase I|Physician Decision|10|||
16976747|NCT00833911|38120331|FG000|Maintenance Phase I|Lack of Efficacy|4|||
16976748|NCT00833911|38120331|FG000|Maintenance Phase II|Adverse Event|6|||
16976749|NCT00833911|38120331|FG000|Maintenance Phase II|Physician Decision|2|||
16976750|NCT00833911|38120331|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
16976751|NCT00833911|38120331|FG000|Maintenance Phase II|Lack of Efficacy|1|||
16976752|NCT01125293|38120345|FG000|Overall Study|Disease Progression|1|||
16976753|NCT01125293|38120346|FG001|Overall Study|Disease Progression|3|||
16976754|NCT01125293|38120347|FG002|Overall Study|Disease Progression|4|||
16976755|NCT01125293|38120348|FG003|Overall Study|Disease Progression|3|||
16976756|NCT01125293|38120349|FG004|Overall Study|Disease Progression|5|||
16976757|NCT01125293|38120350|FG005|Overall Study|Disease Progression|12|||
16976758|NCT01125293|38120345|FG000|Overall Study|Adverse Event|1|||
16976759|NCT01125293|38120346|FG001|Overall Study|Adverse Event|0|||
16976760|NCT01125293|38120347|FG002|Overall Study|Adverse Event|0|||
16976761|NCT01125293|38120348|FG003|Overall Study|Adverse Event|0|||
16976762|NCT01125293|38120349|FG004|Overall Study|Adverse Event|2|||
16976763|NCT01125293|38120350|FG005|Overall Study|Adverse Event|8|||
16976764|NCT01125293|38120345|FG000|Overall Study|Symptomatic Deterioration|1|||
16976765|NCT01125293|38120346|FG001|Overall Study|Symptomatic Deterioration|0|||
16976766|NCT01125293|38120347|FG002|Overall Study|Symptomatic Deterioration|0|||
16976767|NCT01125293|38120348|FG003|Overall Study|Symptomatic Deterioration|0|||
16976768|NCT01125293|38120349|FG004|Overall Study|Symptomatic Deterioration|0|||
16976769|NCT01125293|38120350|FG005|Overall Study|Symptomatic Deterioration|0|||
16976770|NCT01125293|38120345|FG000|Overall Study|Death|0|||
16976771|NCT01125293|38120346|FG001|Overall Study|Death|0|||
16976772|NCT01125293|38120347|FG002|Overall Study|Death|0|||
16976773|NCT01125293|38120348|FG003|Overall Study|Death|0|||
16976774|NCT01125293|38120349|FG004|Overall Study|Death|1|||
16976775|NCT01125293|38120350|FG005|Overall Study|Death|0|||
16976776|NCT01125293|38120345|FG000|Overall Study|Withdrawal by Subject|0|||
16976777|NCT01125293|38120346|FG001|Overall Study|Withdrawal by Subject|0|||
16976778|NCT01125293|38120347|FG002|Overall Study|Withdrawal by Subject|0|||
16976779|NCT01125293|38120348|FG003|Overall Study|Withdrawal by Subject|0|||
16976780|NCT01125293|38120349|FG004|Overall Study|Withdrawal by Subject|2|||
16976781|NCT01125293|38120350|FG005|Overall Study|Withdrawal by Subject|1|||
16976782|NCT01125293|38120345|FG000|Overall Study|Physician Decision|0|||
16976783|NCT01125293|38120346|FG001|Overall Study|Physician Decision|0|||
16976784|NCT01125293|38120347|FG002|Overall Study|Physician Decision|0|||
16976785|NCT01125293|38120348|FG003|Overall Study|Physician Decision|0|||
16976786|NCT01125293|38120349|FG004|Overall Study|Physician Decision|0|||
16976787|NCT01125293|38120350|FG005|Overall Study|Physician Decision|2|||
16976788|NCT01121393|38120369|FG000|Overall Study|Progressive disease|201|||
16976789|NCT01121393|38120370|FG001|Overall Study|Progressive disease|20|||
16976790|NCT01121393|38120369|FG000|Overall Study|Other Adverse events|24|||
16976791|NCT01121393|38120370|FG001|Overall Study|Other Adverse events|45|||
16976792|NCT01121393|38120369|FG000|Overall Study|Non-compliant with protocol|0|||
16976793|NCT01121393|38120370|FG001|Overall Study|Non-compliant with protocol|3|||
16976794|NCT01121393|38120369|FG000|Overall Study|Lost to Follow-up|1|||
16976795|NCT01121393|38120370|FG001|Overall Study|Lost to Follow-up|0|||
16976796|NCT01121393|38120369|FG000|Overall Study|Refused cont. medication|7|||
16976797|NCT01121393|38120370|FG001|Overall Study|Refused cont. medication|7|||
16976798|NCT01121393|38120369|FG000|Overall Study|Not treated|3|||
16976799|NCT01121393|38120370|FG001|Overall Study|Not treated|9|||
16976800|NCT01121393|38120369|FG000|Overall Study|Other than listed|6|||
16976801|NCT01121393|38120370|FG001|Overall Study|Other than listed|0|||
16976802|NCT00937521|38120408|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16976803|NCT00937521|38120409|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16976804|NCT00937521|38120410|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
16976805|NCT00937521|38120411|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16976806|NCT00937521|38120412|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16976807|NCT00937521|38120413|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16976808|NCT00937521|38120414|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
16976809|NCT00937521|38120415|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16976810|NCT00937521|38120408|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
16976811|NCT00937521|38120409|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
16976812|NCT00937521|38120410|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
16976813|NCT00937521|38120411|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
16976814|NCT00937521|38120412|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
16976815|NCT00937521|38120413|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
16976816|NCT00937521|38120414|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
16976817|NCT00937521|38120415|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
16976818|NCT00937521|38120408|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16976819|NCT00937521|38120409|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16976820|NCT00937521|38120410|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
16976821|NCT00937521|38120411|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
16976822|NCT00937521|38120412|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16976823|NCT00937521|38120413|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16976824|NCT00937521|38120414|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16976825|NCT00937521|38120415|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16976826|NCT00937521|38120408|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
16976827|NCT00937521|38120409|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
16976828|NCT00937521|38120410|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
16976829|NCT00937521|38120411|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
16976830|NCT00937521|38120412|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
16976831|NCT00937521|38120413|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
16976832|NCT00937521|38120414|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
16976833|NCT00937521|38120415|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
16976834|NCT00937521|38120408|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
16976835|NCT00937521|38120409|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16976836|NCT00937521|38120410|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16976837|NCT00937521|38120411|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16976838|NCT00937521|38120412|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16976839|NCT00937521|38120413|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16976840|NCT00937521|38120414|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
16976841|NCT00937521|38120415|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16976842|NCT00937521|38120408|FG000|Booster Phase|Adverse Event|0|||
16976843|NCT00937521|38120409|FG001|Booster Phase|Adverse Event|0|||
16976844|NCT00937521|38120410|FG002|Booster Phase|Adverse Event|0|||
16976845|NCT00937521|38120411|FG003|Booster Phase|Adverse Event|0|||
16976846|NCT00937521|38120412|FG004|Booster Phase|Adverse Event|0|||
16976847|NCT00937521|38120413|FG005|Booster Phase|Adverse Event|0|||
16976848|NCT00937521|38120414|FG006|Booster Phase|Adverse Event|1|||
16976849|NCT00937521|38120415|FG007|Booster Phase|Adverse Event|0|||
16976850|NCT00937521|38120408|FG000|Booster Phase|Withdrawal by Subject|1|||
16976851|NCT00937521|38120409|FG001|Booster Phase|Withdrawal by Subject|0|||
16976852|NCT00937521|38120410|FG002|Booster Phase|Withdrawal by Subject|0|||
16976853|NCT00937521|38120411|FG003|Booster Phase|Withdrawal by Subject|1|||
16976854|NCT00937521|38120412|FG004|Booster Phase|Withdrawal by Subject|0|||
16976855|NCT00937521|38120413|FG005|Booster Phase|Withdrawal by Subject|0|||
16976856|NCT00937521|38120414|FG006|Booster Phase|Withdrawal by Subject|0|||
16976857|NCT00937521|38120415|FG007|Booster Phase|Withdrawal by Subject|2|||
16976858|NCT00937521|38120408|FG000|Booster Phase|Lost to Follow-up|2|||
16976859|NCT00937521|38120409|FG001|Booster Phase|Lost to Follow-up|2|||
16976860|NCT00937521|38120410|FG002|Booster Phase|Lost to Follow-up|4|||
16976861|NCT00937521|38120411|FG003|Booster Phase|Lost to Follow-up|2|||
16976862|NCT00937521|38120412|FG004|Booster Phase|Lost to Follow-up|4|||
16976863|NCT00937521|38120413|FG005|Booster Phase|Lost to Follow-up|4|||
16976864|NCT00937521|38120414|FG006|Booster Phase|Lost to Follow-up|3|||
16976865|NCT00937521|38120415|FG007|Booster Phase|Lost to Follow-up|0|||
16976866|NCT00937521|38120408|FG000|Booster Phase|Administrative Reason|0|||
16976867|NCT00937521|38120409|FG001|Booster Phase|Administrative Reason|0|||
16976868|NCT00937521|38120410|FG002|Booster Phase|Administrative Reason|1|||
16976869|NCT00937521|38120411|FG003|Booster Phase|Administrative Reason|0|||
16976870|NCT00937521|38120412|FG004|Booster Phase|Administrative Reason|1|||
16976871|NCT00937521|38120413|FG005|Booster Phase|Administrative Reason|1|||
16976872|NCT00937521|38120414|FG006|Booster Phase|Administrative Reason|0|||
16976873|NCT00937521|38120415|FG007|Booster Phase|Administrative Reason|0|||
16976874|NCT00937521|38120408|FG000|Booster Phase|Protocol Deviation|0|||
16976875|NCT00937521|38120409|FG001|Booster Phase|Protocol Deviation|0|||
16976876|NCT00937521|38120410|FG002|Booster Phase|Protocol Deviation|0|||
16976877|NCT00937521|38120411|FG003|Booster Phase|Protocol Deviation|0|||
16976878|NCT00937521|38120412|FG004|Booster Phase|Protocol Deviation|0|||
16976879|NCT00937521|38120413|FG005|Booster Phase|Protocol Deviation|0|||
16976880|NCT00937521|38120414|FG006|Booster Phase|Protocol Deviation|1|||
16976881|NCT00937521|38120415|FG007|Booster Phase|Protocol Deviation|0|||
16976882|NCT00935883|38120450|FG000|Treatment Period|Physician Decision|1|||
16976883|NCT00935883|38120451|FG001|Treatment Period|Physician Decision|0|||
16976884|NCT00935883|38120450|FG000|Treatment Period|Withdrawal by Subject|0|||
16976885|NCT00935883|38120451|FG001|Treatment Period|Withdrawal by Subject|2|||
16976886|NCT00936975|38120457|FG000|Overall Study|Withdrawal by Subject|1|||
16976887|NCT00936975|38120457|FG000|Overall Study|Disease progression|3|||
16976888|NCT00936975|38120457|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
16976889|NCT00936897|38120464|FG000|Overall Study|Withdrawal by Subject|9|||
16976890|NCT00936897|38120465|FG001|Overall Study|Withdrawal by Subject|19|||
16976891|NCT00936897|38120464|FG000|Overall Study|Adverse Event|4|||
16976892|NCT00936897|38120465|FG001|Overall Study|Adverse Event|13|||
16976893|NCT00936897|38120464|FG000|Overall Study|Other|3|||
16976894|NCT00936897|38120465|FG001|Overall Study|Other|9|||
16976895|NCT00936897|38120464|FG000|Overall Study|Lost to Follow-up|1|||
16976896|NCT00936897|38120465|FG001|Overall Study|Lost to Follow-up|10|||
16976897|NCT00936897|38120464|FG000|Overall Study|Administrative Decision|1|||
16976898|NCT00936897|38120465|FG001|Overall Study|Administrative Decision|2|||
16976899|NCT00936897|38120464|FG000|Overall Study|Protocol Violation|1|||
16976900|NCT00936897|38120465|FG001|Overall Study|Protocol Violation|1|||
16976901|NCT00936897|38120464|FG000|Overall Study|Ineligibility Determined|0|||
16976902|NCT00936897|38120465|FG001|Overall Study|Ineligibility Determined|3|||
16976903|NCT00936897|38120464|FG000|Overall Study|Noncompliance|0|||
16976904|NCT00936897|38120465|FG001|Overall Study|Noncompliance|2|||
16976905|NCT00936897|38120464|FG000|Overall Study|Death|0|||
16976906|NCT00936897|38120465|FG001|Overall Study|Death|1|||
16976907|NCT01120691|38120474|FG000|Overall Study|Adverse Event|59|||
16976908|NCT01120691|38120475|FG001|Overall Study|Adverse Event|67|||
16976909|NCT01120691|38120476|FG002|Overall Study|Adverse Event|47|||
16976910|NCT01120691|38120474|FG000|Overall Study|Subject withdrew consent|33|||
16976911|NCT01120691|38120475|FG001|Overall Study|Subject withdrew consent|50|||
16976912|NCT01120691|38120476|FG002|Overall Study|Subject withdrew consent|44|||
16976913|NCT01120691|38120474|FG000|Overall Study|Death|21|||
16976914|NCT01120691|38120475|FG001|Overall Study|Death|22|||
16976915|NCT01120691|38120476|FG002|Overall Study|Death|24|||
16976916|NCT01120691|38120474|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
16976917|NCT01120691|38120475|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
16976918|NCT01120691|38120476|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
16976919|NCT01120691|38120474|FG000|Overall Study|Administrative problems|15|||
16976920|NCT01120691|38120475|FG001|Overall Study|Administrative problems|8|||
16976921|NCT01120691|38120476|FG002|Overall Study|Administrative problems|9|||
16976922|NCT01120691|38120474|FG000|Overall Study|Protocol deviation|13|||
16976923|NCT01120691|38120475|FG001|Overall Study|Protocol deviation|12|||
16976924|NCT01120691|38120476|FG002|Overall Study|Protocol deviation|12|||
16976925|NCT01120691|38120474|FG000|Overall Study|Lost to Follow-up|5|||
16976926|NCT01120691|38120475|FG001|Overall Study|Lost to Follow-up|6|||
16976927|NCT01120691|38120476|FG002|Overall Study|Lost to Follow-up|4|||
16976928|NCT01120691|38120474|FG000|Overall Study|Abnormal test procedure result(s)|3|||
16976929|NCT01120691|38120475|FG001|Overall Study|Abnormal test procedure result(s)|2|||
16976930|NCT01120691|38120476|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16976931|NCT01120691|38120474|FG000|Overall Study|Patient's inability to use the device|3|||
16976932|NCT01120691|38120475|FG001|Overall Study|Patient's inability to use the device|1|||
16976933|NCT01120691|38120476|FG002|Overall Study|Patient's inability to use the device|0|||
16976934|NCT01120691|38120474|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16976935|NCT01120691|38120475|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16976936|NCT01120691|38120476|FG002|Overall Study|Abnormal laboratory value(s)|4|||
16976937|NCT00935493|38120500|FG000|Overall Study|Lost to Follow-up|1|||
16976938|NCT00935493|38120501|FG001|Overall Study|Lost to Follow-up|1|||
16976939|NCT00935493|38120502|FG002|Overall Study|Lost to Follow-up|1|||
16976940|NCT00935493|38120500|FG000|Overall Study|Treatment Discontinued|0|||
16976941|NCT00935493|38120501|FG001|Overall Study|Treatment Discontinued|1|||
16976942|NCT00935493|38120502|FG002|Overall Study|Treatment Discontinued|0|||
16976943|NCT03856996|38120512|FG000|Overall Study|Withdrawal by Subject|1|||
16976944|NCT03856996|38120513|FG001|Overall Study|Withdrawal by Subject|0|||
16976945|NCT03856996|38120512|FG000|Overall Study|Lost to Follow-up|0|||
16976946|NCT03856996|38120513|FG001|Overall Study|Lost to Follow-up|1|||
16976947|NCT03856996|38120512|FG000|Overall Study|Adverse Event|1|||
16976948|NCT03856996|38120513|FG001|Overall Study|Adverse Event|1|||
16976949|NCT03856996|38120512|FG000|Overall Study|Other|1|||
16976950|NCT03856996|38120513|FG001|Overall Study|Other|0|||
16976951|NCT00935259|38120519|FG000|Period 1|Administrative (scheduling conflict)|1|||
16976952|NCT00935259|38120520|FG001|Period 1|Administrative (scheduling conflict)|1|||
16976953|NCT01120379|38120537|FG000|One Year Timepoint|Withdrawal by Subject|41|||
16976954|NCT01120379|38120537|FG000|One Year Timepoint|Lost to Follow-up|115|||
16976955|NCT01120379|38120537|FG000|One Year Timepoint|Death|108|||
16976956|NCT01120379|38120537|FG000|One Year Timepoint|Physician Decision|9|||
16976957|NCT01120379|38120537|FG000|One Year Timepoint|Any other reason for early termination|5|||
16976958|NCT01120379|38120537|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
16976959|NCT01120379|38120537|FG000|Two Year Timepoint|Lost to Follow-up|87|||
16976960|NCT01120379|38120537|FG000|Two Year Timepoint|Death|123|||
16976961|NCT01120379|38120537|FG000|Two Year Timepoint|Physician Decision|12|||
16976962|NCT01120379|38120537|FG000|Two Year Timepoint|Any other reason for early termination|4|||
16976963|NCT01120379|38120537|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
16976964|NCT01120379|38120537|FG000|Three Year Timepoint|Lost to Follow-up|43|||
16976965|NCT01120379|38120537|FG000|Three Year Timepoint|Death|120|||
16976966|NCT01120379|38120537|FG000|Three Year Timepoint|Physician Decision|9|||
16976967|NCT01120379|38120537|FG000|Three Year Timepoint|Any other reason for early termination|17|||
16976968|NCT01120379|38120537|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
16976969|NCT01120379|38120537|FG000|Four Year Timepoint|Lost to Follow-up|10|||
16976970|NCT01120379|38120537|FG000|Four Year Timepoint|Death|131|||
16976971|NCT01120379|38120537|FG000|Four Year Timepoint|Physician Decision|5|||
16976972|NCT01120379|38120537|FG000|Four Year Timepoint|Any other reason for early termination|217|||
16976973|NCT01120067|38120543|FG000|Overall Study|Lost to Follow-up|3|||
16976974|NCT01120067|38120544|FG001|Overall Study|Lost to Follow-up|1|||
16976975|NCT01120067|38120543|FG000|Overall Study|fail to engage >3 sessions|2|||
16976976|NCT01120067|38120544|FG001|Overall Study|fail to engage >3 sessions|0|||
16976977|NCT01124045|38120552|FG000|Overall Study|Lost to Follow-up|0|||
16976978|NCT01124045|38120553|FG001|Overall Study|Lost to Follow-up|1|||
16976979|NCT01124045|38120552|FG000|Overall Study|Physician Decision|0|||
16976980|NCT01124045|38120553|FG001|Overall Study|Physician Decision|2|||
16976981|NCT01123889|38120561|FG000|Overall Study|Lost to Follow-up|3|||
16976982|NCT01123889|38120562|FG001|Overall Study|Lost to Follow-up|1|||
16976983|NCT00934947|38120570|FG000|Overall Study|Adverse Event|0|||
16976984|NCT00934947|38120571|FG001|Overall Study|Adverse Event|2|||
16976985|NCT01123655|38120581|FG000|Overall Study|Medication for RA had to be changed|1|||
16976986|NCT01123655|38120582|FG001|Overall Study|Medication for RA had to be changed|0|||
16976987|NCT01123655|38120583|FG002|Overall Study|Medication for RA had to be changed|0|||
16976988|NCT01123655|38120581|FG000|Overall Study|new illness|0|||
16976989|NCT01123655|38120582|FG001|Overall Study|new illness|1|||
16976990|NCT01123655|38120583|FG002|Overall Study|new illness|0|||
16976991|NCT01123655|38120581|FG000|Overall Study|began prohibitive drug|0|||
16976992|NCT01123655|38120582|FG001|Overall Study|began prohibitive drug|0|||
16976993|NCT01123655|38120583|FG002|Overall Study|began prohibitive drug|1|||
16976994|NCT00934791|38120591|FG000|Overall Study|Withdrawal by Subject|1|||
16976995|NCT00934791|38120592|FG001|Overall Study|Withdrawal by Subject|0|||
16976996|NCT01119443|38120600|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
16976997|NCT01119443|38120601|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
16976998|NCT01111019|38120610|FG000|Overall Study|Withdrew Prematurely|2|||
16976999|NCT01111019|38120610|FG000|Overall Study|Other|1|||
16977000|NCT01119287|38120629|FG000|Overall Study|Patient Decision, not related to AE|0|||
16977001|NCT01119287|38120630|FG001|Overall Study|Patient Decision, not related to AE|0|||
16977002|NCT01119287|38120631|FG002|Overall Study|Patient Decision, not related to AE|2|||
16977003|NCT01119287|38120632|FG003|Overall Study|Patient Decision, not related to AE|2|||
16977004|NCT01119287|38120633|FG004|Overall Study|Patient Decision, not related to AE|1|||
16977005|NCT01119287|38120634|FG005|Overall Study|Patient Decision, not related to AE|0|||
16977006|NCT01110707|38120648|FG000|Overall Study|Protocol Violation|0|||
16977007|NCT01110707|38120649|FG001|Overall Study|Protocol Violation|3|||
16977008|NCT01119131|38120659|FG000|Overall Study|Adverse Event|1|||
16977009|NCT01119131|38120660|FG001|Overall Study|Adverse Event|1|||
16977010|NCT01119131|38120661|FG002|Overall Study|Adverse Event|1|||
16977011|NCT01119131|38120659|FG000|Overall Study|Non-Compliance|1|||
16977012|NCT01119131|38120660|FG001|Overall Study|Non-Compliance|0|||
16977013|NCT01119131|38120661|FG002|Overall Study|Non-Compliance|4|||
16977014|NCT01119131|38120659|FG000|Overall Study|Physician Decision|0|||
16977015|NCT01119131|38120660|FG001|Overall Study|Physician Decision|0|||
16977016|NCT01119131|38120661|FG002|Overall Study|Physician Decision|1|||
16977017|NCT01118975|38120671|FG000|Overall Study|Adverse Event|0|||
16977018|NCT01118975|38120672|FG001|Overall Study|Adverse Event|1|||
16977019|NCT01110239|38120682|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
16977020|NCT01110239|38120683|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
16977021|NCT01110239|38120684|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
16977022|NCT01110239|38120685|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
16977023|NCT01110239|38120682|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
16977024|NCT01110239|38120683|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
16977025|NCT01110239|38120684|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
16977026|NCT01110239|38120685|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
16977027|NCT01118663|38120698|FG000|Overall Study|Adverse Event|2|||
16977028|NCT01118663|38120699|FG001|Overall Study|Adverse Event|1|||
16977029|NCT01118663|38120698|FG000|Overall Study|Withdrawal by Subject|0|||
16977030|NCT01118663|38120699|FG001|Overall Study|Withdrawal by Subject|1|||
16977031|NCT01118351|38120705|FG000|Overall Study|Adverse Event|3|||
16977032|NCT01118351|38120705|FG000|Overall Study|Withdrawal by Subject|1|||
16977033|NCT01110005|38120711|FG000|Overall Study|ineligible|1|||
16977034|NCT01110005|38120712|FG001|Overall Study|ineligible|2|||
16977035|NCT01110005|38120711|FG000|Overall Study|missing consent|3|||
16977036|NCT01110005|38120712|FG001|Overall Study|missing consent|2|||
16977037|NCT01110005|38120711|FG000|Overall Study|Withdrawal by Subject|0|||
16977038|NCT01110005|38120712|FG001|Overall Study|Withdrawal by Subject|1|||
16977039|NCT01118117|38120735|FG000|Overall Study|Death|8|||
16977040|NCT01118117|38120736|FG001|Overall Study|Death|0|||
16977041|NCT01118117|38120735|FG000|Overall Study|Lost to Follow-up|6|||
16977042|NCT01118117|38120736|FG001|Overall Study|Lost to Follow-up|0|||
16977043|NCT01118117|38120735|FG000|Overall Study|Missed 12 Month Visit|7|||
16977044|NCT01118117|38120736|FG001|Overall Study|Missed 12 Month Visit|0|||
16977045|NCT01109849|38120744|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
16977046|NCT01109849|38120745|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
16977047|NCT01109849|38120746|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
16977048|NCT01109849|38120747|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
16977049|NCT01109849|38120748|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
16977050|NCT01109849|38120744|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
16977051|NCT01109849|38120745|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
16977052|NCT01109849|38120746|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
16977053|NCT01109849|38120747|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
16977054|NCT01109849|38120748|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
16977055|NCT01109849|38120744|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
16977056|NCT01109849|38120745|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
16977057|NCT01109849|38120746|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
16977058|NCT01109849|38120747|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
16977059|NCT01109849|38120748|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
16977060|NCT01109849|38120744|FG000|Initial Randomization: ADHD Treatment|move away|2|||
16977061|NCT01109849|38120745|FG001|Initial Randomization: ADHD Treatment|move away|7|||
16977062|NCT01109849|38120746|FG002|Initial Randomization: ADHD Treatment|move away|0|||
16977063|NCT01109849|38120747|FG003|Initial Randomization: ADHD Treatment|move away|0|||
16977064|NCT01109849|38120748|FG004|Initial Randomization: ADHD Treatment|move away|0|||
16977065|NCT01109849|38120744|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
16977066|NCT01109849|38120745|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
16977067|NCT01109849|38120746|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
16977068|NCT01109849|38120747|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
16977069|NCT01109849|38120748|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
16977070|NCT01109849|38120744|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
16977071|NCT01109849|38120745|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
16977072|NCT01109849|38120746|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
16977073|NCT01109849|38120747|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
16977074|NCT01109849|38120748|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
16977075|NCT01061736|38120778|FG000|Overall Study|Dose regimen not selected|0|||
16977076|NCT01061736|38120779|FG001|Overall Study|Dose regimen not selected|0|||
16977077|NCT01061736|38120780|FG002|Overall Study|Dose regimen not selected|0|||
16977078|NCT01061736|38120781|FG003|Overall Study|Dose regimen not selected|0|||
16977079|NCT01061736|38120782|FG004|Overall Study|Dose regimen not selected|0|||
16977080|NCT01061736|38120783|FG005|Overall Study|Dose regimen not selected|0|||
16977081|NCT01061736|38120784|FG006|Overall Study|Dose regimen not selected|79|||
16977082|NCT01061736|38120785|FG007|Overall Study|Dose regimen not selected|0|||
16977083|NCT01061736|38120786|FG008|Overall Study|Dose regimen not selected|0|||
16977084|NCT01061736|38120787|FG009|Overall Study|Dose regimen not selected|0|||
16977085|NCT01061736|38120778|FG000|Overall Study|Adverse Event|13|||
16977086|NCT01061736|38120779|FG001|Overall Study|Adverse Event|1|||
16977087|NCT01061736|38120780|FG002|Overall Study|Adverse Event|3|||
16977088|NCT01061736|38120781|FG003|Overall Study|Adverse Event|2|||
16977089|NCT01061736|38120782|FG004|Overall Study|Adverse Event|4|||
16977090|NCT01061736|38120783|FG005|Overall Study|Adverse Event|1|||
16977091|NCT01061736|38120784|FG006|Overall Study|Adverse Event|4|||
16977092|NCT01061736|38120785|FG007|Overall Study|Adverse Event|63|||
16977093|NCT01061736|38120786|FG008|Overall Study|Adverse Event|67|||
16977094|NCT01061736|38120787|FG009|Overall Study|Adverse Event|34|||
16977095|NCT01061736|38120778|FG000|Overall Study|Lack of Efficacy|0|||
16977096|NCT01061736|38120779|FG001|Overall Study|Lack of Efficacy|2|||
16977097|NCT01061736|38120780|FG002|Overall Study|Lack of Efficacy|1|||
16977098|NCT01061736|38120781|FG003|Overall Study|Lack of Efficacy|1|||
16977099|NCT01061736|38120782|FG004|Overall Study|Lack of Efficacy|1|||
16977100|NCT01061736|38120783|FG005|Overall Study|Lack of Efficacy|2|||
16977101|NCT01061736|38120784|FG006|Overall Study|Lack of Efficacy|1|||
16977102|NCT01061736|38120785|FG007|Overall Study|Lack of Efficacy|9|||
16977103|NCT01061736|38120786|FG008|Overall Study|Lack of Efficacy|9|||
16977104|NCT01061736|38120787|FG009|Overall Study|Lack of Efficacy|10|||
16977105|NCT01061736|38120778|FG000|Overall Study|Poor compliance to protocol|0|||
16977106|NCT01061736|38120779|FG001|Overall Study|Poor compliance to protocol|0|||
16977107|NCT01061736|38120780|FG002|Overall Study|Poor compliance to protocol|0|||
16977108|NCT01061736|38120781|FG003|Overall Study|Poor compliance to protocol|0|||
16977109|NCT01061736|38120782|FG004|Overall Study|Poor compliance to protocol|0|||
16977110|NCT01061736|38120783|FG005|Overall Study|Poor compliance to protocol|0|||
16977111|NCT01061736|38120784|FG006|Overall Study|Poor compliance to protocol|0|||
16977112|NCT01061736|38120785|FG007|Overall Study|Poor compliance to protocol|2|||
16977113|NCT01061736|38120786|FG008|Overall Study|Poor compliance to protocol|5|||
16977114|NCT01061736|38120787|FG009|Overall Study|Poor compliance to protocol|9|||
16977115|NCT01061736|38120778|FG000|Overall Study|Not treated|0|||
16977116|NCT01061736|38120779|FG001|Overall Study|Not treated|0|||
16977117|NCT01061736|38120780|FG002|Overall Study|Not treated|0|||
16977118|NCT01061736|38120781|FG003|Overall Study|Not treated|0|||
16977119|NCT01061736|38120782|FG004|Overall Study|Not treated|1|||
16977120|NCT01061736|38120783|FG005|Overall Study|Not treated|0|||
16977121|NCT01061736|38120784|FG006|Overall Study|Not treated|0|||
16977122|NCT01061736|38120785|FG007|Overall Study|Not treated|2|||
16977123|NCT01061736|38120786|FG008|Overall Study|Not treated|1|||
16977124|NCT01061736|38120787|FG009|Overall Study|Not treated|0|||
16977125|NCT01061736|38120778|FG000|Overall Study|Other than specified above|0|||
16977126|NCT01061736|38120779|FG001|Overall Study|Other than specified above|1|||
16977127|NCT01061736|38120780|FG002|Overall Study|Other than specified above|2|||
16977128|NCT01061736|38120781|FG003|Overall Study|Other than specified above|0|||
16977129|NCT01061736|38120782|FG004|Overall Study|Other than specified above|1|||
16977130|NCT01061736|38120783|FG005|Overall Study|Other than specified above|0|||
16977131|NCT01061736|38120784|FG006|Overall Study|Other than specified above|0|||
16977132|NCT01061736|38120785|FG007|Overall Study|Other than specified above|18|||
16977133|NCT01061736|38120786|FG008|Overall Study|Other than specified above|15|||
16977134|NCT01061736|38120787|FG009|Overall Study|Other than specified above|21|||
16977135|NCT01117337|38120814|FG000|Overall Study|Lost to Follow-up|4|||
16977136|NCT01117337|38120815|FG001|Overall Study|Lost to Follow-up|0|||
16977137|NCT01108523|38120825|FG000|Overall Study|Protocol Violation|4|||
16977138|NCT01035606|38120832|FG000|Overall Study|change in health, job demands,family|3|||
16977139|NCT01035606|38120833|FG001|Overall Study|change in health, job demands,family|3|||
16977140|NCT01035606|38120834|FG002|Overall Study|change in health, job demands,family|4|||
16977141|NCT01117181|38120844|FG000|Overall Study|Lost to Follow-up|1|||
16977142|NCT01117181|38120845|FG001|Overall Study|Lost to Follow-up|0|||
16977143|NCT01117181|38120844|FG000|Overall Study|Withdrawal by Subject|0|||
16977144|NCT01117181|38120845|FG001|Overall Study|Withdrawal by Subject|2|||
16977145|NCT01040130|38120853|FG000|Overall Study|Adverse Event|1|||
16977146|NCT01040130|38120854|FG001|Overall Study|Adverse Event|1|||
16977147|NCT01040130|38120855|FG002|Overall Study|Adverse Event|0|||
16977148|NCT01040130|38120856|FG003|Overall Study|Adverse Event|5|||
16977149|NCT01040130|38120857|FG004|Overall Study|Adverse Event|0|||
16977150|NCT01040130|38120858|FG005|Overall Study|Adverse Event|3|||
16977151|NCT01040130|38120853|FG000|Overall Study|Protocol Violation|0|||
16977152|NCT01040130|38120854|FG001|Overall Study|Protocol Violation|0|||
16977153|NCT01040130|38120855|FG002|Overall Study|Protocol Violation|2|||
16977154|NCT01040130|38120856|FG003|Overall Study|Protocol Violation|0|||
16977155|NCT01040130|38120857|FG004|Overall Study|Protocol Violation|0|||
16977156|NCT01040130|38120858|FG005|Overall Study|Protocol Violation|0|||
16977157|NCT01040130|38120853|FG000|Overall Study|Withdrawal by Subject|0|||
16977158|NCT01040130|38120854|FG001|Overall Study|Withdrawal by Subject|2|||
16977159|NCT01040130|38120855|FG002|Overall Study|Withdrawal by Subject|0|||
16977160|NCT01040130|38120856|FG003|Overall Study|Withdrawal by Subject|0|||
16977161|NCT01040130|38120857|FG004|Overall Study|Withdrawal by Subject|0|||
16977162|NCT01040130|38120858|FG005|Overall Study|Withdrawal by Subject|1|||
16977163|NCT01040130|38120853|FG000|Overall Study|Other reasons not listed above|2|||
16977164|NCT01040130|38120854|FG001|Overall Study|Other reasons not listed above|0|||
16977165|NCT01040130|38120855|FG002|Overall Study|Other reasons not listed above|0|||
16780178|NCT02613507|37719291|FG001|Overall Study|Death|0|||
16977166|NCT01040130|38120856|FG003|Overall Study|Other reasons not listed above|0|||
16977167|NCT01040130|38120857|FG004|Overall Study|Other reasons not listed above|0|||
16977168|NCT01040130|38120858|FG005|Overall Study|Other reasons not listed above|0|||
16977169|NCT00932451|38120868|FG000|Overall Study|Withdrawal by Subject|69|||
16977170|NCT00932451|38120868|FG000|Overall Study|Lost to Follow-up|22|||
16977171|NCT00932451|38120868|FG000|Overall Study|Death|726|||
16977172|NCT00932451|38120868|FG000|Overall Study|Other reasons|5|||
16977173|NCT01039584|38120879|FG000|Overall Study|Withdrawal by Subject|4|||
16977174|NCT01039584|38120880|FG001|Overall Study|Withdrawal by Subject|2|||
16977175|NCT01039584|38120881|FG002|Overall Study|Withdrawal by Subject|1|||
16977176|NCT01039584|38120879|FG000|Overall Study|Protocol Violation|10|||
16977177|NCT01039584|38120880|FG001|Overall Study|Protocol Violation|4|||
16977178|NCT01039584|38120881|FG002|Overall Study|Protocol Violation|6|||
16977179|NCT01039584|38120879|FG000|Overall Study|Lost to Follow-up|5|||
16977180|NCT01039584|38120880|FG001|Overall Study|Lost to Follow-up|3|||
16977181|NCT01039584|38120881|FG002|Overall Study|Lost to Follow-up|4|||
16977182|NCT01039584|38120879|FG000|Overall Study|Negative Baseline culture for Candida|59|||
16977183|NCT01039584|38120880|FG001|Overall Study|Negative Baseline culture for Candida|59|||
16977184|NCT01039584|38120881|FG002|Overall Study|Negative Baseline culture for Candida|24|||
16977185|NCT01039584|38120879|FG000|Overall Study|Lack of Efficacy|7|||
16977186|NCT01039584|38120880|FG001|Overall Study|Lack of Efficacy|6|||
16977187|NCT01039584|38120881|FG002|Overall Study|Lack of Efficacy|10|||
16977188|NCT01039584|38120879|FG000|Overall Study|other|1|||
16977189|NCT01039584|38120880|FG001|Overall Study|other|3|||
16977190|NCT01039584|38120881|FG002|Overall Study|other|1|||
16977191|NCT01039584|38120879|FG000|Overall Study|Pap smear with significant pathology|10|||
16977192|NCT01039584|38120880|FG001|Overall Study|Pap smear with significant pathology|10|||
16977193|NCT01039584|38120881|FG002|Overall Study|Pap smear with significant pathology|3|||
16977194|NCT01039584|38120879|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
16977195|NCT01039584|38120880|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
16977196|NCT01039584|38120881|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
16977197|NCT01108055|38120889|FG000|Overall Study|Ineligible|11|||
16977198|NCT01108055|38120889|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
16977199|NCT01107899|38120896|FG000|Overall Study|Physician Decision|5|||
16977200|NCT01107899|38120897|FG001|Overall Study|Physician Decision|0|||
16977201|NCT01107899|38120898|FG002|Overall Study|Physician Decision|3|||
16977202|NCT01107899|38120896|FG000|Overall Study|Withdrawal by Subject|0|||
16977203|NCT01107899|38120897|FG001|Overall Study|Withdrawal by Subject|0|||
16977204|NCT01107899|38120898|FG002|Overall Study|Withdrawal by Subject|1|||
16977205|NCT01115933|38120909|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
16977206|NCT01107743|38120966|FG000|Overall Study|Protocol Violation|46|||
16977207|NCT01059864|38121015|FG000|Open-Label Run-In Phase|Adverse Event|7|||
16977208|NCT01059864|38121016|FG001|Open-Label Run-In Phase|Adverse Event|0|||
16977209|NCT01059864|38121017|FG002|Open-Label Run-In Phase|Adverse Event|0|||
16977210|NCT01059864|38121015|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
16977211|NCT01059864|38121016|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
16977212|NCT01059864|38121017|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
16977213|NCT01059864|38121015|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
16977214|NCT01059864|38121016|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
16977215|NCT01059864|38121017|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
16977216|NCT01059864|38121015|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
16977217|NCT01059864|38121016|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
16977218|NCT01059864|38121017|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
16977219|NCT01059864|38121015|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
16977220|NCT01059864|38121016|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
16977221|NCT01059864|38121017|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
16977222|NCT01059864|38121015|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
16977223|NCT01059864|38121016|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
16977224|NCT01059864|38121017|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
16977225|NCT01035138|38121027|FG000|Overall Study|Adverse Event|4|||
16977226|NCT01035138|38121028|FG001|Overall Study|Adverse Event|0|||
16977227|NCT01035138|38121029|FG002|Overall Study|Adverse Event|2|||
16977228|NCT01035138|38121027|FG000|Overall Study|Caregiver Decision|2|||
16977229|NCT01035138|38121028|FG001|Overall Study|Caregiver Decision|0|||
16977230|NCT01035138|38121029|FG002|Overall Study|Caregiver Decision|1|||
16977231|NCT01035138|38121027|FG000|Overall Study|Withdrawal by Subject|1|||
16977232|NCT01035138|38121028|FG001|Overall Study|Withdrawal by Subject|0|||
16977233|NCT01035138|38121029|FG002|Overall Study|Withdrawal by Subject|0|||
16977234|NCT01035138|38121027|FG000|Overall Study|Physician Decision|0|||
16977235|NCT01035138|38121028|FG001|Overall Study|Physician Decision|0|||
16977236|NCT01035138|38121029|FG002|Overall Study|Physician Decision|1|||
16977237|NCT01035138|38121027|FG000|Overall Study|Sponsor Decision|66|||
16977238|NCT01035138|38121028|FG001|Overall Study|Sponsor Decision|60|||
16977239|NCT01035138|38121029|FG002|Overall Study|Sponsor Decision|42|||
16977240|NCT01035138|38121027|FG000|Overall Study|Lost to Follow-up|0|||
16977241|NCT01035138|38121028|FG001|Overall Study|Lost to Follow-up|0|||
16977242|NCT01035138|38121029|FG002|Overall Study|Lost to Follow-up|1|||
16977243|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
16977244|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
16977245|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
16977246|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
16977247|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16977248|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
16977249|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16977250|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
16977251|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
16977252|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
16977253|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
16977254|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
16977255|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
16977256|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
16977257|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
16977258|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
16977259|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Program Termination|3|||
16977260|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Program Termination|0|||
16977261|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Program Termination|1|||
16977262|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Program Termination|1|||
16977263|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
16977264|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
16977265|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
16977266|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
16977267|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
16977268|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
16977269|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
16977270|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
16977271|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
16977272|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
16977273|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
16977274|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
16977275|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
16977276|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
16977277|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
16977278|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
16977279|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
16977280|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
16977281|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
16977282|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
16977283|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
16977284|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
16977285|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
16977286|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
16977287|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
16977288|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
16977289|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
16977290|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
16977291|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
16977292|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
16977293|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
16977294|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
16977295|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
16977296|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
16977297|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
16977298|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
16977299|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
16977300|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
16977301|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
16977302|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
16780179|NCT02613507|37719290|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
16780180|NCT02613507|37719291|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16780181|NCT02613507|37719290|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
16780182|NCT02613507|37719291|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
16780183|NCT02613507|37719290|FG000|Overall Study|Participant Withdrew Consent|0|||
16780184|NCT02613507|37719291|FG001|Overall Study|Participant Withdrew Consent|2|||
16780185|NCT02613507|37719290|FG000|Overall Study|Lost to Follow-up|1|||
16780186|NCT02613507|37719291|FG001|Overall Study|Lost to Follow-up|0|||
16977303|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
16977304|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
16977305|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
16977306|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
16977307|NCT03739840|38121043|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
16977308|NCT03739840|38121044|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
16977309|NCT03739840|38121045|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
16977310|NCT03739840|38121046|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
16977311|NCT03739840|38121043|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
16977312|NCT03739840|38121044|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
16977313|NCT03739840|38121045|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
16977314|NCT03739840|38121046|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
16977315|NCT03739840|38121043|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
16977316|NCT03739840|38121044|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
16977317|NCT03739840|38121045|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
16977318|NCT03739840|38121046|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
16977319|NCT03739840|38121043|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
16977320|NCT03739840|38121044|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
16977321|NCT03739840|38121045|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
16977322|NCT03739840|38121046|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
16977323|NCT03739840|38121043|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
16977324|NCT03739840|38121044|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
16977325|NCT03739840|38121045|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
16977326|NCT03739840|38121046|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
16977327|NCT03739840|38121043|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
16977328|NCT03739840|38121044|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
16977329|NCT03739840|38121045|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
16977330|NCT03739840|38121046|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
16977331|NCT03739840|38121043|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
16977332|NCT03739840|38121044|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
16977333|NCT03739840|38121045|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
16977334|NCT03739840|38121046|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
16977335|NCT03739840|38121043|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
16977336|NCT03739840|38121044|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
16977337|NCT03739840|38121045|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
16977338|NCT03739840|38121046|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
16977339|NCT03739840|38121043|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
16977340|NCT03739840|38121044|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
16977341|NCT03739840|38121045|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
16977342|NCT03739840|38121046|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
16977343|NCT01035060|38121070|FG000|Overall Study|Lost to Follow-up|0|||
16977344|NCT01035060|38121071|FG001|Overall Study|Lost to Follow-up|7|||
16977345|NCT01035060|38121070|FG000|Overall Study|Did not quality after 2nd screening|14|||
16977346|NCT01035060|38121071|FG001|Overall Study|Did not quality after 2nd screening|1|||
16977347|NCT01035060|38121070|FG000|Overall Study|Withdrawal by Subject|8|||
16977348|NCT01035060|38121071|FG001|Overall Study|Withdrawal by Subject|6|||
16977349|NCT01035060|38121070|FG000|Overall Study|Physician Decision|2|||
16977350|NCT01035060|38121071|FG001|Overall Study|Physician Decision|0|||
16977351|NCT01039428|38121079|FG000|Overall Study|Protocol Violation|1|||
16977352|NCT01039428|38121080|FG001|Overall Study|Protocol Violation|0|||
16977353|NCT01039428|38121079|FG000|Overall Study|Withdrawal by Subject|1|||
16977354|NCT01039428|38121080|FG001|Overall Study|Withdrawal by Subject|0|||
16977355|NCT01034358|38121086|FG000|Overall Study|Withdrawal by Subject|1|||
16977356|NCT01034358|38121086|FG000|Overall Study|Protocol Violation|1|||
16977357|NCT01033734|38121094|FG000|Overall Study|Withdrawal by Subject|1|||
16977358|NCT01115855|38121109|FG000|Overall Study|Adverse Event|16|||
16977359|NCT01115855|38121110|FG001|Overall Study|Adverse Event|18|||
16977360|NCT01115855|38121109|FG000|Overall Study|Death|6|||
16977361|NCT01115855|38121110|FG001|Overall Study|Death|5|||
16977362|NCT01115855|38121109|FG000|Overall Study|Lab Abnormality|1|||
16977363|NCT01115855|38121110|FG001|Overall Study|Lab Abnormality|1|||
16977364|NCT01115855|38121109|FG000|Overall Study|Protocol Violation|0|||
16977365|NCT01115855|38121110|FG001|Overall Study|Protocol Violation|1|||
16977366|NCT01115855|38121109|FG000|Overall Study|Withdrawal by Subject|5|||
16977367|NCT01115855|38121110|FG001|Overall Study|Withdrawal by Subject|5|||
16977368|NCT01115855|38121109|FG000|Overall Study|Other|8|||
16977369|NCT01115855|38121110|FG001|Overall Study|Other|6|||
16977370|NCT01115309|38121120|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
16977371|NCT01115309|38121120|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
16977372|NCT01115309|38121120|FG000|Long-term Follow-up|Lost to Follow-up|6|||
16977373|NCT03638128|38121128|FG000|Overall Study|Withdrawal by Subject|1|||
16977374|NCT03638128|38121129|FG001|Overall Study|Withdrawal by Subject|7|||
16977375|NCT03638128|38121130|FG002|Overall Study|Withdrawal by Subject|6|||
16977376|NCT03638128|38121128|FG000|Overall Study|Sponsor Decision|15|||
16977377|NCT03638128|38121129|FG001|Overall Study|Sponsor Decision|12|||
16977378|NCT03638128|38121130|FG002|Overall Study|Sponsor Decision|19|||
16977379|NCT03638128|38121128|FG000|Overall Study|Lost to Follow-up|0|||
16977380|NCT03638128|38121129|FG001|Overall Study|Lost to Follow-up|0|||
16977381|NCT03638128|38121130|FG002|Overall Study|Lost to Follow-up|1|||
16977382|NCT01059630|38121143|FG000|Overall Study|Death|100|||
16977383|NCT01059630|38121144|FG001|Overall Study|Death|84|||
16977384|NCT01059630|38121143|FG000|Overall Study|Lost to Follow-up|4|||
16977385|NCT01059630|38121144|FG001|Overall Study|Lost to Follow-up|1|||
16977386|NCT01059630|38121143|FG000|Overall Study|Physician Decision|2|||
16977387|NCT01059630|38121144|FG001|Overall Study|Physician Decision|4|||
16977388|NCT01059630|38121143|FG000|Overall Study|Withdrawal by Subject|21|||
16977389|NCT01059630|38121144|FG001|Overall Study|Withdrawal by Subject|14|||
16977390|NCT00932373|38121161|FG000|Overall Study|Progressive disease|3|||
16977391|NCT00932373|38121162|FG001|Overall Study|Progressive disease|1|||
16977392|NCT00932373|38121163|FG002|Overall Study|Progressive disease|0|||
16977393|NCT00932373|38121164|FG003|Overall Study|Progressive disease|0|||
16977394|NCT00932373|38121165|FG004|Overall Study|Progressive disease|10|||
16977395|NCT00932373|38121166|FG005|Overall Study|Progressive disease|1|||
16977396|NCT00932373|38121167|FG006|Overall Study|Progressive disease|0|||
16977397|NCT00932373|38121168|FG007|Overall Study|Progressive disease|2|||
16977398|NCT00932373|38121169|FG008|Overall Study|Progressive disease|1|||
16977399|NCT00932373|38121170|FG009|Overall Study|Progressive disease|9|||
16977400|NCT00932373|38121171|FG010|Overall Study|Progressive disease|2|||
16977401|NCT00932373|38121161|FG000|Overall Study|Adverse Event|0|||
16977402|NCT00932373|38121162|FG001|Overall Study|Adverse Event|0|||
16977403|NCT00932373|38121163|FG002|Overall Study|Adverse Event|0|||
16977404|NCT00932373|38121164|FG003|Overall Study|Adverse Event|0|||
16977405|NCT00932373|38121165|FG004|Overall Study|Adverse Event|2|||
16977406|NCT00932373|38121166|FG005|Overall Study|Adverse Event|1|||
16977407|NCT00932373|38121167|FG006|Overall Study|Adverse Event|0|||
16977408|NCT00932373|38121168|FG007|Overall Study|Adverse Event|1|||
16977409|NCT00932373|38121169|FG008|Overall Study|Adverse Event|0|||
16977410|NCT00932373|38121170|FG009|Overall Study|Adverse Event|2|||
16977411|NCT00932373|38121171|FG010|Overall Study|Adverse Event|1|||
16977412|NCT00932373|38121161|FG000|Overall Study|Physician Decision|0|||
16977413|NCT00932373|38121162|FG001|Overall Study|Physician Decision|0|||
16977414|NCT00932373|38121163|FG002|Overall Study|Physician Decision|1|||
16977415|NCT00932373|38121164|FG003|Overall Study|Physician Decision|0|||
16977416|NCT00932373|38121165|FG004|Overall Study|Physician Decision|2|||
16977417|NCT00932373|38121166|FG005|Overall Study|Physician Decision|0|||
16977418|NCT00932373|38121167|FG006|Overall Study|Physician Decision|0|||
16977419|NCT00932373|38121168|FG007|Overall Study|Physician Decision|0|||
16977420|NCT00932373|38121169|FG008|Overall Study|Physician Decision|0|||
16977421|NCT00932373|38121170|FG009|Overall Study|Physician Decision|1|||
16977422|NCT00932373|38121171|FG010|Overall Study|Physician Decision|0|||
16977423|NCT00932373|38121161|FG000|Overall Study|Dose limiting toxicity|0|||
16977424|NCT00932373|38121162|FG001|Overall Study|Dose limiting toxicity|0|||
16977425|NCT00932373|38121163|FG002|Overall Study|Dose limiting toxicity|0|||
16977426|NCT00932373|38121164|FG003|Overall Study|Dose limiting toxicity|0|||
16977427|NCT00932373|38121165|FG004|Overall Study|Dose limiting toxicity|0|||
16977428|NCT00932373|38121166|FG005|Overall Study|Dose limiting toxicity|1|||
16977429|NCT00932373|38121167|FG006|Overall Study|Dose limiting toxicity|0|||
16977430|NCT00932373|38121168|FG007|Overall Study|Dose limiting toxicity|0|||
16977431|NCT00932373|38121169|FG008|Overall Study|Dose limiting toxicity|0|||
16977432|NCT00932373|38121170|FG009|Overall Study|Dose limiting toxicity|0|||
16977433|NCT00932373|38121171|FG010|Overall Study|Dose limiting toxicity|0|||
16977434|NCT00932373|38121161|FG000|Overall Study|Withdrawal by Subject|0|||
16977435|NCT00932373|38121162|FG001|Overall Study|Withdrawal by Subject|0|||
16977436|NCT00932373|38121163|FG002|Overall Study|Withdrawal by Subject|0|||
16977437|NCT00932373|38121164|FG003|Overall Study|Withdrawal by Subject|0|||
16977438|NCT00932373|38121165|FG004|Overall Study|Withdrawal by Subject|0|||
16977439|NCT00932373|38121166|FG005|Overall Study|Withdrawal by Subject|0|||
16977440|NCT00932373|38121167|FG006|Overall Study|Withdrawal by Subject|0|||
16977441|NCT00932373|38121168|FG007|Overall Study|Withdrawal by Subject|0|||
16977442|NCT00932373|38121169|FG008|Overall Study|Withdrawal by Subject|1|||
16977443|NCT00932373|38121170|FG009|Overall Study|Withdrawal by Subject|0|||
16977444|NCT00932373|38121171|FG010|Overall Study|Withdrawal by Subject|0|||
16977445|NCT00932373|38121161|FG000|Overall Study|Clinical progression|0|||
16977446|NCT00932373|38121162|FG001|Overall Study|Clinical progression|0|||
16977447|NCT00932373|38121163|FG002|Overall Study|Clinical progression|0|||
16977448|NCT00932373|38121164|FG003|Overall Study|Clinical progression|0|||
16977449|NCT00932373|38121165|FG004|Overall Study|Clinical progression|0|||
16977450|NCT00932373|38121166|FG005|Overall Study|Clinical progression|0|||
16977451|NCT00932373|38121167|FG006|Overall Study|Clinical progression|1|||
16977452|NCT00932373|38121168|FG007|Overall Study|Clinical progression|0|||
16977453|NCT00932373|38121169|FG008|Overall Study|Clinical progression|0|||
16977454|NCT00932373|38121170|FG009|Overall Study|Clinical progression|0|||
16977455|NCT00932373|38121171|FG010|Overall Study|Clinical progression|0|||
16977456|NCT00932373|38121161|FG000|Overall Study|Lack of Efficacy|0|||
16977457|NCT00932373|38121162|FG001|Overall Study|Lack of Efficacy|0|||
16977458|NCT00932373|38121163|FG002|Overall Study|Lack of Efficacy|0|||
16977459|NCT00932373|38121164|FG003|Overall Study|Lack of Efficacy|0|||
16977460|NCT00932373|38121165|FG004|Overall Study|Lack of Efficacy|0|||
16977461|NCT00932373|38121166|FG005|Overall Study|Lack of Efficacy|0|||
16977462|NCT00932373|38121167|FG006|Overall Study|Lack of Efficacy|0|||
16977463|NCT00932373|38121168|FG007|Overall Study|Lack of Efficacy|0|||
16977464|NCT00932373|38121169|FG008|Overall Study|Lack of Efficacy|0|||
16977465|NCT00932373|38121170|FG009|Overall Study|Lack of Efficacy|1|||
16977466|NCT00932373|38121171|FG010|Overall Study|Lack of Efficacy|0|||
16977467|NCT01055496|38121205|FG000|Overall Study|Withdrawal by Subject|2|||
16977468|NCT01055496|38121206|FG001|Overall Study|Withdrawal by Subject|4|||
16977469|NCT01055496|38121205|FG000|Overall Study|Death|13|||
16977470|NCT01055496|38121206|FG001|Overall Study|Death|23|||
16977471|NCT01055496|38121205|FG000|Overall Study|Lost to Follow-up|0|||
16977472|NCT01055496|38121206|FG001|Overall Study|Lost to Follow-up|2|||
16977473|NCT01055496|38121205|FG000|Overall Study|Other - Unspecified|0|||
16977474|NCT01055496|38121206|FG001|Overall Study|Other - Unspecified|1|||
16977475|NCT01055262|38121233|FG000|Overall Study|Adverse Event|5|||
16977476|NCT01055262|38121233|FG000|Overall Study|Protocol Violation|3|||
16977477|NCT01055262|38121233|FG000|Overall Study|Uncooperativeness|1|||
16977478|NCT01052844|38121239|FG000|Overall Study|Adverse Event|0|||
16977479|NCT01052844|38121240|FG001|Overall Study|Adverse Event|1|||
16977480|NCT01049412|38121248|FG000|Period I|Withdrawal by Subject|4|||
16977481|NCT01049412|38121249|FG001|Period I|Withdrawal by Subject|6|||
16977482|NCT01049412|38121248|FG000|Period I|Lost to Follow-up|2|||
16977483|NCT01049412|38121249|FG001|Period I|Lost to Follow-up|2|||
16977484|NCT01049412|38121248|FG000|Period I|Physician Decision|0|||
16977485|NCT01049412|38121249|FG001|Period I|Physician Decision|3|||
16977486|NCT01049412|38121248|FG000|Period I|Protocol Violation|1|||
16977487|NCT01049412|38121249|FG001|Period I|Protocol Violation|2|||
16977488|NCT01049412|38121248|FG000|Period I|Adverse Event|1|||
16977489|NCT01049412|38121249|FG001|Period I|Adverse Event|0|||
16977490|NCT01049412|38121248|FG000|Period II|Withdrawal by Subject|2|||
16977491|NCT01049412|38121249|FG001|Period II|Withdrawal by Subject|3|||
16977492|NCT01049412|38121248|FG000|Period II|Adverse Event|1|||
16977493|NCT01049412|38121249|FG001|Period II|Adverse Event|0|||
16977494|NCT01049412|38121248|FG000|Period II|Lost to Follow-up|1|||
16977495|NCT01049412|38121249|FG001|Period II|Lost to Follow-up|0|||
16977496|NCT00934089|38121259|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
16977497|NCT00934089|38121260|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
16977498|NCT00934089|38121259|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
16977499|NCT00934089|38121260|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
16977500|NCT01032174|38121268|FG000|Overall Study|Adverse Event|0|||
16977501|NCT01032174|38121269|FG001|Overall Study|Adverse Event|1|||
16977502|NCT00933933|38121280|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
16977503|NCT00933933|38121281|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
16977504|NCT00933933|38121282|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
16977505|NCT00933933|38121280|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
16977506|NCT00933933|38121281|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
16977507|NCT00933933|38121282|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
16977508|NCT01032018|38121300|FG000|Overall Study|Lost to Follow-up|6|||
16977509|NCT01032018|38121301|FG001|Overall Study|Lost to Follow-up|5|||
16977510|NCT01032018|38121300|FG000|Overall Study|Death|0|||
16977511|NCT01032018|38121301|FG001|Overall Study|Death|1|||
16977512|NCT01031706|38121309|FG000|Overall Study|Adverse Event|1|||
16977513|NCT01031706|38121310|FG001|Overall Study|Adverse Event|0|||
16977514|NCT01031706|38121309|FG000|Overall Study|Withdrawal by Subject|1|||
16977515|NCT01031706|38121310|FG001|Overall Study|Withdrawal by Subject|1|||
16977516|NCT00927069|38121318|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
16977517|NCT00927069|38121319|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
16977518|NCT00927069|38121320|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
16977519|NCT00927069|38121321|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
16977520|NCT00927069|38121318|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
16977521|NCT00927069|38121319|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
16977522|NCT00927069|38121320|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
16977523|NCT00927069|38121321|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
16977524|NCT00927069|38121318|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
16977525|NCT00927069|38121319|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
16977526|NCT00927069|38121320|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
16977527|NCT00927069|38121321|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
16977528|NCT00927069|38121318|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
16977529|NCT00927069|38121319|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
16977530|NCT00927069|38121320|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
16977531|NCT00927069|38121321|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
16977532|NCT00927069|38121318|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
16977533|NCT00927069|38121319|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
16977534|NCT00927069|38121320|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
16977535|NCT00927069|38121321|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
16977536|NCT01031628|38121335|FG000|Overall Study|Study terminated early|0|||
16977537|NCT01031628|38121336|FG001|Overall Study|Study terminated early|1|||
16977538|NCT01031628|38121337|FG002|Overall Study|Study terminated early|3|||
16977539|NCT01031628|38121338|FG003|Overall Study|Study terminated early|0|||
16977540|NCT01031004|38121350|FG000|Overall Study|Protocol Violation|0|||
16977541|NCT01031004|38121351|FG001|Overall Study|Protocol Violation|1|||
16977542|NCT01031004|38121350|FG000|Overall Study|Lost to Follow-up|1|||
16977543|NCT01031004|38121351|FG001|Overall Study|Lost to Follow-up|0|||
16977544|NCT00931515|38121359|FG000|Overall Study|Lost to Follow-up|2|||
16977545|NCT00931515|38121360|FG001|Overall Study|Lost to Follow-up|5|||
16977546|NCT01029366|38121368|FG000|Overall Study|Withdrawal by Subject|1|||
16977547|NCT01029366|38121369|FG001|Overall Study|Withdrawal by Subject|0|||
16977548|NCT01029366|38121368|FG000|Overall Study|Death|1|||
16977549|NCT01029366|38121369|FG001|Overall Study|Death|1|||
16977550|NCT01029366|38121368|FG000|Overall Study|disease progression|2|||
16977551|NCT01029366|38121369|FG001|Overall Study|disease progression|0|||
16977552|NCT01029366|38121368|FG000|Overall Study|manufacturing failure|0|||
16977553|NCT01029366|38121369|FG001|Overall Study|manufacturing failure|1|||
16977554|NCT01028352|38121376|FG000|Overall Study|Ineligible due to baseline average pain|5|||
16977555|NCT01028352|38121376|FG000|Overall Study|Withdrawal by Subject|1|||
16977556|NCT00929643|38121393|FG000|Overall Study|Protocol Violation|2|||
16977557|NCT00926367|38121399|FG000|Overall Study|Withdrawal by Subject|0|||
16977558|NCT00926367|38121400|FG001|Overall Study|Withdrawal by Subject|1|||
16977559|NCT00926367|38121399|FG000|Overall Study|Lost to Follow-up|1|||
16977560|NCT00926367|38121400|FG001|Overall Study|Lost to Follow-up|0|||
16977561|NCT00926367|38121399|FG000|Overall Study|Skin Irritation|1|||
16977562|NCT00926367|38121400|FG001|Overall Study|Skin Irritation|2|||
16977563|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
16977564|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
16977565|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
16977566|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
16977567|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
16977568|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
16977569|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
16977570|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
16977571|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
16977572|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
16977573|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
16977574|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
16977575|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
16977576|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
16977577|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
16977578|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
16977579|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
16977580|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
16977581|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
16977582|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
16977583|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
16977584|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
16977585|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
16977586|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
16977587|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Death|2|||
16977588|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Death|1|||
16977589|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Death|2|||
16977590|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Graft loss|0|||
16977591|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Graft loss|2|||
16977592|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Graft loss|0|||
16977593|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
16977594|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
16977595|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
16977596|NCT01114529|38121411|FG000|Completed Study Medication at Month 24|Missing|2|||
16977597|NCT01114529|38121412|FG001|Completed Study Medication at Month 24|Missing|0|||
16977598|NCT01114529|38121413|FG002|Completed Study Medication at Month 24|Missing|0|||
16977599|NCT01114529|38121411|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
16977600|NCT01114529|38121412|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
16977601|NCT01114529|38121413|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
16977602|NCT01114529|38121411|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
16977603|NCT01114529|38121412|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
16977604|NCT01114529|38121413|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
16977605|NCT01114529|38121411|FG000|Completed Study Phase at Month 24|Death|8|||
16977606|NCT01114529|38121412|FG001|Completed Study Phase at Month 24|Death|5|||
16977607|NCT01114529|38121413|FG002|Completed Study Phase at Month 24|Death|4|||
16977608|NCT01114529|38121411|FG000|Completed Study Phase at Month 24|Other|2|||
16977609|NCT01114529|38121412|FG001|Completed Study Phase at Month 24|Other|0|||
16977610|NCT01114529|38121413|FG002|Completed Study Phase at Month 24|Other|0|||
16977611|NCT01114529|38121411|FG000|Completed Study Phase at Month 24|Missing|2|||
16977612|NCT01114529|38121412|FG001|Completed Study Phase at Month 24|Missing|0|||
16977613|NCT01114529|38121413|FG002|Completed Study Phase at Month 24|Missing|0|||
16977614|NCT00926289|38121425|FG000|Overall Study|Adverse Event|9|||
16977615|NCT00926289|38121426|FG001|Overall Study|Adverse Event|11|||
16977616|NCT00926289|38121425|FG000|Overall Study|Protocol Violation|8|||
16977617|NCT00926289|38121426|FG001|Overall Study|Protocol Violation|12|||
16977618|NCT00926289|38121425|FG000|Overall Study|Lost to Follow-up|3|||
16977619|NCT00926289|38121426|FG001|Overall Study|Lost to Follow-up|6|||
16977620|NCT00926289|38121425|FG000|Overall Study|Withdrawal by Subject|4|||
16977621|NCT00926289|38121426|FG001|Overall Study|Withdrawal by Subject|4|||
16977622|NCT00926289|38121425|FG000|Overall Study|Other|1|||
16977623|NCT00926289|38121426|FG001|Overall Study|Other|3|||
16977624|NCT03208036|38121451|FG000|Baseline Assessment|Withdrawal by Subject|1|||
16977625|NCT03208036|38121452|FG001|Baseline Assessment|Withdrawal by Subject|1|||
16977626|NCT03208036|38121451|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
16977627|NCT03208036|38121452|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
16977628|NCT03208036|38121451|FG000|Intervention|Withdrawal by Subject|3|||
16977629|NCT03208036|38121452|FG001|Intervention|Withdrawal by Subject|2|||
16977630|NCT03208036|38121451|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
16977631|NCT03208036|38121452|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
16977632|NCT00926211|38121458|FG000|Overall Study|Lost to Follow-up|1|||
16977633|NCT01114373|38121463|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
16977634|NCT01114373|38121464|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
16977635|NCT01114373|38121463|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
16977636|NCT01114373|38121464|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
16977637|NCT01114373|38121463|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
16977638|NCT01114373|38121464|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
16977639|NCT01114373|38121463|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
16977640|NCT01114373|38121464|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
16977641|NCT00925899|38121476|FG000|Part 1|Death|1|||
16977642|NCT00925899|38121477|FG001|Part 1|Death|2|||
16977643|NCT00925899|38121476|FG000|Part 1|Withdrawal by Subject|10|||
16977644|NCT00925899|38121477|FG001|Part 1|Withdrawal by Subject|9|||
16977645|NCT01114217|38121486|FG000|Overall Study|Adverse Event|5|||
16977646|NCT01114217|38121487|FG001|Overall Study|Adverse Event|3|||
16977647|NCT01114217|38121486|FG000|Overall Study|Lost to Follow-up|17|||
16977648|NCT01114217|38121487|FG001|Overall Study|Lost to Follow-up|33|||
16977649|NCT01114217|38121486|FG000|Overall Study|Withdrawal by Subject|21|||
16977650|NCT01114217|38121487|FG001|Overall Study|Withdrawal by Subject|28|||
16977651|NCT01114217|38121486|FG000|Overall Study|Other-Clerical Error|3|||
16977652|NCT01114217|38121487|FG001|Overall Study|Other-Clerical Error|0|||
16977653|NCT01114217|38121486|FG000|Overall Study|Other-Early termination|6|||
16977654|NCT01114217|38121487|FG001|Overall Study|Other-Early termination|10|||
16977655|NCT01114217|38121486|FG000|Overall Study|Other-Procedure|1|||
16977656|NCT01114217|38121487|FG001|Overall Study|Other-Procedure|1|||
16977657|NCT01114217|38121486|FG000|Overall Study|Other-Pregnancy|2|||
16977658|NCT01114217|38121487|FG001|Overall Study|Other-Pregnancy|4|||
16977659|NCT01114217|38121486|FG000|Overall Study|Other-Protocol Violation|1|||
16977660|NCT01114217|38121487|FG001|Overall Study|Other-Protocol Violation|3|||
16977661|NCT01114217|38121486|FG000|Overall Study|Other-Lack of Efficacy|1|||
16977662|NCT01114217|38121487|FG001|Overall Study|Other-Lack of Efficacy|0|||
16977663|NCT01114217|38121486|FG000|Overall Study|Other-Non Compliance|2|||
16977664|NCT01114217|38121487|FG001|Overall Study|Other-Non Compliance|0|||
16977665|NCT01114217|38121486|FG000|Overall Study|Other-Physician Decision|1|||
16977666|NCT01114217|38121487|FG001|Overall Study|Other-Physician Decision|1|||
16977667|NCT01114217|38121486|FG000|Overall Study|Other-Sponsor Decision|10|||
16977668|NCT01114217|38121487|FG001|Overall Study|Other-Sponsor Decision|12|||
16977669|NCT01114217|38121486|FG000|Overall Study|Other-Study Termination|0|||
16977670|NCT01114217|38121487|FG001|Overall Study|Other-Study Termination|1|||
16977671|NCT01114217|38121486|FG000|Overall Study|Other-Study Withdrawn|1|||
16977672|NCT01114217|38121487|FG001|Overall Study|Other-Study Withdrawn|1|||
16977673|NCT01114217|38121486|FG000|Overall Study|Other-Site Stopped Communicating|2|||
16977674|NCT01114217|38121487|FG001|Overall Study|Other-Site Stopped Communicating|0|||
16977675|NCT01114217|38121486|FG000|Overall Study|Other-Lost to Follow-up|1|||
16977676|NCT01114217|38121487|FG001|Overall Study|Other-Lost to Follow-up|0|||
16977677|NCT01114217|38121486|FG000|Overall Study|Other-Withdrawal by Subject|1|||
16977678|NCT01114217|38121487|FG001|Overall Study|Other-Withdrawal by Subject|1|||
16977679|NCT01030536|38121496|FG000|Overall Study|Withdrawal by Subject|0|||
16977680|NCT01030536|38121497|FG001|Overall Study|Withdrawal by Subject|0|||
16977681|NCT01030536|38121498|FG002|Overall Study|Withdrawal by Subject|1|||
16977682|NCT01030536|38121499|FG003|Overall Study|Withdrawal by Subject|0|||
16977683|NCT01030536|38121500|FG004|Overall Study|Withdrawal by Subject|0|||
16977684|NCT01030536|38121496|FG000|Overall Study|undefined|1|||
16977685|NCT01030536|38121497|FG001|Overall Study|undefined|0|||
16977686|NCT01030536|38121498|FG002|Overall Study|undefined|1|||
16977687|NCT01030536|38121499|FG003|Overall Study|undefined|1|||
16977688|NCT01030536|38121500|FG004|Overall Study|undefined|0|||
16977689|NCT01030536|38121496|FG000|Overall Study|Adverse Event|0|||
16977690|NCT01030536|38121497|FG001|Overall Study|Adverse Event|3|||
16977691|NCT01030536|38121498|FG002|Overall Study|Adverse Event|1|||
16977692|NCT01030536|38121499|FG003|Overall Study|Adverse Event|0|||
16977693|NCT01030536|38121500|FG004|Overall Study|Adverse Event|1|||
16977694|NCT01030536|38121496|FG000|Overall Study|Progressive disease|6|||
16977695|NCT01030536|38121497|FG001|Overall Study|Progressive disease|2|||
16977696|NCT01030536|38121498|FG002|Overall Study|Progressive disease|3|||
16977697|NCT01030536|38121499|FG003|Overall Study|Progressive disease|2|||
16977698|NCT01030536|38121500|FG004|Overall Study|Progressive disease|0|||
16977699|NCT01030536|38121496|FG000|Overall Study|Death|0|||
16977700|NCT01030536|38121497|FG001|Overall Study|Death|1|||
16977701|NCT01030536|38121498|FG002|Overall Study|Death|0|||
16977702|NCT01030536|38121499|FG003|Overall Study|Death|0|||
16977703|NCT01030536|38121500|FG004|Overall Study|Death|0|||
16977704|NCT01030458|38121518|FG000|Overall Study|Lost to Follow-up|9|||
16977705|NCT01030458|38121519|FG001|Overall Study|Lost to Follow-up|10|||
16977706|NCT01030458|38121518|FG000|Overall Study|Withdrawal by Subject|2|||
16977707|NCT01030458|38121519|FG001|Overall Study|Withdrawal by Subject|3|||
16977708|NCT01030458|38121518|FG000|Overall Study|Logistical reasons|9|||
16977709|NCT01030458|38121519|FG001|Overall Study|Logistical reasons|5|||
16977710|NCT01030458|38121518|FG000|Overall Study|Moved or changed job|6|||
16977711|NCT01030458|38121519|FG001|Overall Study|Moved or changed job|13|||
16977712|NCT01030458|38121518|FG000|Overall Study|Side effect of medication|1|||
16977713|NCT01030458|38121519|FG001|Overall Study|Side effect of medication|1|||
16977714|NCT00930969|38121525|FG000|Overall Study|Death|5|||
16977715|NCT00930969|38121525|FG000|Overall Study|Lost to Follow-up|1|||
16977716|NCT00930969|38121525|FG000|Overall Study|Physician Decision|13|||
16977717|NCT00930969|38121525|FG000|Overall Study|Withdrawal by Subject|19|||
16977718|NCT01114139|38121531|FG000|Overall Study|Adverse Event|3|||
16977719|NCT01114139|38121532|FG001|Overall Study|Adverse Event|2|||
16977720|NCT01114139|38121531|FG000|Overall Study|Lost to Follow-up|15|||
16977721|NCT01114139|38121532|FG001|Overall Study|Lost to Follow-up|3|||
16977722|NCT01114139|38121531|FG000|Overall Study|Withdrawal by Subject|17|||
16977723|NCT01114139|38121532|FG001|Overall Study|Withdrawal by Subject|6|||
16977724|NCT01114139|38121531|FG000|Overall Study|Other-Missed 1 visit|1|||
16977725|NCT01114139|38121532|FG001|Overall Study|Other-Missed 1 visit|0|||
16977726|NCT01114139|38121531|FG000|Overall Study|Other-Protocol Violation|1|||
16977727|NCT01114139|38121532|FG001|Overall Study|Other-Protocol Violation|0|||
16977728|NCT01114139|38121531|FG000|Overall Study|Other-Out of window for study drug dose|1|||
16977729|NCT01114139|38121532|FG001|Overall Study|Other-Out of window for study drug dose|0|||
16977730|NCT01114139|38121531|FG000|Overall Study|Other-Participant falsified records|0|||
16977731|NCT01114139|38121532|FG001|Overall Study|Other-Participant falsified records|1|||
16977732|NCT01114139|38121531|FG000|Overall Study|Other-Participant went on hospice|0|||
16977733|NCT01114139|38121532|FG001|Overall Study|Other-Participant went on hospice|1|||
16977734|NCT01114139|38121531|FG000|Overall Study|Other-Physician changed treatment|1|||
16977735|NCT01114139|38121532|FG001|Overall Study|Other-Physician changed treatment|0|||
16977736|NCT01114139|38121531|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
16977737|NCT01114139|38121532|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
16977738|NCT01027884|38121540|FG000|Overall Study|Adverse Event|2|||
16977739|NCT01027884|38121541|FG001|Overall Study|Adverse Event|1|||
16977740|NCT01027884|38121540|FG000|Overall Study|Protocol Violation|1|||
16977741|NCT01027884|38121541|FG001|Overall Study|Protocol Violation|0|||
16977742|NCT01027884|38121540|FG000|Overall Study|Non-compliance|1|||
16977743|NCT01027884|38121541|FG001|Overall Study|Non-compliance|1|||
16977744|NCT01027884|38121540|FG000|Overall Study|Withdrawal by Subject|0|||
16977745|NCT01027884|38121541|FG001|Overall Study|Withdrawal by Subject|1|||
16977746|NCT01027884|38121540|FG000|Overall Study|Lost to Follow-up|0|||
16977747|NCT01027884|38121541|FG001|Overall Study|Lost to Follow-up|1|||
16977748|NCT01027884|38121540|FG000|Overall Study|Spinal fixation surgery|0|||
16977749|NCT01027884|38121541|FG001|Overall Study|Spinal fixation surgery|3|||
16977750|NCT03387514|38121549|FG000|Overall Study|Withdrawal by Subject|2|||
16977751|NCT03387514|38121549|FG000|Overall Study|Physician Decision|1|||
16977752|NCT03387514|38121549|FG000|Overall Study|Lost to Follow-up|2|||
16977753|NCT01113749|38121564|FG000|Overall Study|Lost to Follow-up|1|||
16977754|NCT01113749|38121565|FG001|Overall Study|Lost to Follow-up|2|||
16977755|NCT01022580|38121573|FG000|Overall Study|Death|18|||
16977756|NCT01022580|38121574|FG001|Overall Study|Death|22|||
16977757|NCT01107353|38121588|FG000|Overall Study|Positive Drug Screen|1|||
16977758|NCT01107353|38121589|FG001|Overall Study|Positive Drug Screen|0|||
16977759|NCT01107197|38121597|FG000|Overall Study|Death|12|||
16977760|NCT01107197|38121598|FG001|Overall Study|Death|10|||
16977761|NCT01107197|38121597|FG000|Overall Study|Lost to Follow-up|5|||
16977762|NCT01107197|38121598|FG001|Overall Study|Lost to Follow-up|8|||
16977763|NCT01107197|38121597|FG000|Overall Study|Withdrawal by Subject|3|||
16977764|NCT01107197|38121598|FG001|Overall Study|Withdrawal by Subject|5|||
16977765|NCT01112579|38121615|FG000|Overall Study|Missed Visit|1|||
16977766|NCT01112579|38121616|FG001|Overall Study|Missed Visit|1|||
16977767|NCT01112579|38121615|FG000|Overall Study|Death|0|||
16977768|NCT01112579|38121616|FG001|Overall Study|Death|2|||
16977769|NCT01112267|38121624|FG000|Overall Study|Adverse Event|24|||
16977770|NCT01112267|38121625|FG001|Overall Study|Adverse Event|6|||
16977771|NCT01112267|38121624|FG000|Overall Study|Withdrawal by Subject|3|||
16977772|NCT01112267|38121625|FG001|Overall Study|Withdrawal by Subject|5|||
16977773|NCT01112267|38121624|FG000|Overall Study|Protocol Violation|5|||
16977774|NCT01112267|38121625|FG001|Overall Study|Protocol Violation|3|||
16977775|NCT01112267|38121624|FG000|Overall Study|Participants not compliant|1|||
16977776|NCT01112267|38121625|FG001|Overall Study|Participants not compliant|2|||
16977777|NCT01112267|38121624|FG000|Overall Study|Participants not receive any study drug|1|||
16977778|NCT01112267|38121625|FG001|Overall Study|Participants not receive any study drug|2|||
16977779|NCT00925587|38121633|FG000|Overall Study|Protocol Specified Criteria|6|||
17134027|NCT02095132|38275296|FG003|Overall Study|Death|0|||
16977780|NCT00925587|38121634|FG001|Overall Study|Protocol Specified Criteria|6|||
16977781|NCT00925587|38121633|FG000|Overall Study|Physician Decision|4|||
16977782|NCT00925587|38121634|FG001|Overall Study|Physician Decision|1|||
16977783|NCT00925587|38121633|FG000|Overall Study|Protocol Violation|6|||
16977784|NCT00925587|38121634|FG001|Overall Study|Protocol Violation|4|||
16977785|NCT00925587|38121633|FG000|Overall Study|Withdrawal by Subject|9|||
16977786|NCT00925587|38121634|FG001|Overall Study|Withdrawal by Subject|6|||
16977787|NCT00925587|38121633|FG000|Overall Study|Death|5|||
16977788|NCT00925587|38121634|FG001|Overall Study|Death|5|||
16977789|NCT00925587|38121633|FG000|Overall Study|Adverse Event|6|||
16977790|NCT00925587|38121634|FG001|Overall Study|Adverse Event|2|||
16977791|NCT00925587|38121633|FG000|Overall Study|Lost to Follow-up|0|||
16977792|NCT00925587|38121634|FG001|Overall Study|Lost to Follow-up|1|||
16977793|NCT00928707|38121646|FG000|Overall Study|Protocol Violation|1|||
16977794|NCT00928707|38121647|FG001|Overall Study|Protocol Violation|0|||
16977795|NCT00930813|38121655|FG000|Overall Study|Death|4|||
16977796|NCT00930813|38121656|FG001|Overall Study|Death|5|||
16977797|NCT00930813|38121655|FG000|Overall Study|Withdrawal by Subject|2|||
16977798|NCT00930813|38121656|FG001|Overall Study|Withdrawal by Subject|5|||
16977799|NCT00930813|38121655|FG000|Overall Study|Lost to Follow-up|2|||
16977800|NCT00930813|38121656|FG001|Overall Study|Lost to Follow-up|4|||
16977801|NCT00930579|38121664|FG000|Overall Study|Withdrawal by Subject|1|||
16977802|NCT00930579|38121664|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
16977803|NCT03367156|38121670|FG000|Overall Study|Lack of interest|3|||
16977804|NCT03367156|38121671|FG001|Overall Study|Lack of interest|1|||
16977805|NCT03367156|38121670|FG000|Overall Study|Death|2|||
16977806|NCT03367156|38121671|FG001|Overall Study|Death|0|||
16977807|NCT03367156|38121670|FG000|Overall Study|Lost to Follow-up|2|||
16977808|NCT03367156|38121671|FG001|Overall Study|Lost to Follow-up|1|||
16977809|NCT03367156|38121670|FG000|Overall Study|Became ineligible|1|||
16977810|NCT03367156|38121671|FG001|Overall Study|Became ineligible|2|||
16977811|NCT03367156|38121670|FG000|Overall Study|Hospitalization|1|||
16977812|NCT03367156|38121671|FG001|Overall Study|Hospitalization|0|||
16977813|NCT03367156|38121670|FG000|Overall Study|Concerned about Treatment|11|||
16977814|NCT03367156|38121671|FG001|Overall Study|Concerned about Treatment|3|||
16977815|NCT03367156|38121670|FG000|Overall Study|Started new treatment|4|||
16977816|NCT03367156|38121671|FG001|Overall Study|Started new treatment|1|||
16977817|NCT00925353|38121679|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
16977818|NCT01106651|38121703|FG000|Overall Study|Adverse Event|17|||
16977819|NCT01106651|38121704|FG001|Overall Study|Adverse Event|9|||
16977820|NCT01106651|38121705|FG002|Overall Study|Adverse Event|23|||
16977821|NCT01106651|38121703|FG000|Overall Study|Lost to Follow-up|8|||
16977822|NCT01106651|38121704|FG001|Overall Study|Lost to Follow-up|2|||
16977823|NCT01106651|38121705|FG002|Overall Study|Lost to Follow-up|6|||
16977824|NCT01106651|38121703|FG000|Overall Study|Physician Decision|4|||
16977825|NCT01106651|38121704|FG001|Overall Study|Physician Decision|3|||
16977826|NCT01106651|38121705|FG002|Overall Study|Physician Decision|1|||
16977827|NCT01106651|38121703|FG000|Overall Study|Protocol Violation|1|||
16977828|NCT01106651|38121704|FG001|Overall Study|Protocol Violation|2|||
16977829|NCT01106651|38121705|FG002|Overall Study|Protocol Violation|1|||
16977830|NCT01106651|38121703|FG000|Overall Study|Withdrawal by Subject|14|||
16977831|NCT01106651|38121704|FG001|Overall Study|Withdrawal by Subject|7|||
16977832|NCT01106651|38121705|FG002|Overall Study|Withdrawal by Subject|4|||
16977833|NCT01106651|38121703|FG000|Overall Study|Noncompliance with study drug|1|||
16977834|NCT01106651|38121704|FG001|Overall Study|Noncompliance with study drug|0|||
16977835|NCT01106651|38121705|FG002|Overall Study|Noncompliance with study drug|2|||
16977836|NCT01106651|38121703|FG000|Overall Study|Other|34|||
16977837|NCT01106651|38121704|FG001|Overall Study|Other|31|||
16977838|NCT01106651|38121705|FG002|Overall Study|Other|21|||
16977839|NCT01106651|38121703|FG000|Overall Study|Death|0|||
16977840|NCT01106651|38121704|FG001|Overall Study|Death|3|||
16977841|NCT01106651|38121705|FG002|Overall Study|Death|0|||
16977842|NCT01027650|38121724|FG000|Overall Study|Personal Reasons|0|||
16977843|NCT01027650|38121725|FG001|Overall Study|Personal Reasons|0|||
16977844|NCT01027650|38121726|FG002|Overall Study|Personal Reasons|0|||
16977845|NCT01027650|38121727|FG003|Overall Study|Personal Reasons|0|||
16977846|NCT01027650|38121728|FG004|Overall Study|Personal Reasons|2|||
16977847|NCT01027650|38121729|FG005|Overall Study|Personal Reasons|1|||
16977848|NCT01027650|38121730|FG006|Overall Study|Personal Reasons|0|||
16977849|NCT01027650|38121731|FG007|Overall Study|Personal Reasons|0|||
16977850|NCT01027650|38121724|FG000|Overall Study|Lost to Follow-up|0|||
16977851|NCT01027650|38121725|FG001|Overall Study|Lost to Follow-up|0|||
16977852|NCT01027650|38121726|FG002|Overall Study|Lost to Follow-up|0|||
16977853|NCT01027650|38121727|FG003|Overall Study|Lost to Follow-up|0|||
16977854|NCT01027650|38121728|FG004|Overall Study|Lost to Follow-up|0|||
16977855|NCT01027650|38121729|FG005|Overall Study|Lost to Follow-up|0|||
16977856|NCT01027650|38121730|FG006|Overall Study|Lost to Follow-up|1|||
16977857|NCT01027650|38121731|FG007|Overall Study|Lost to Follow-up|0|||
16977858|NCT01027650|38121724|FG000|Overall Study|Lack of Efficacy|0|||
16977859|NCT01027650|38121725|FG001|Overall Study|Lack of Efficacy|0|||
16977860|NCT01027650|38121726|FG002|Overall Study|Lack of Efficacy|0|||
16977861|NCT01027650|38121727|FG003|Overall Study|Lack of Efficacy|0|||
16977862|NCT01027650|38121728|FG004|Overall Study|Lack of Efficacy|0|||
16977863|NCT01027650|38121729|FG005|Overall Study|Lack of Efficacy|1|||
16977864|NCT01027650|38121730|FG006|Overall Study|Lack of Efficacy|0|||
16977865|NCT01027650|38121731|FG007|Overall Study|Lack of Efficacy|0|||
16977866|NCT01106027|38121749|FG000|Overall Study|Lost graft early, discontinued|1|||
16977867|NCT00927927|38121768|FG000|Overall Study|Withdrawal by Subject|0|||
16977868|NCT00927927|38121769|FG001|Overall Study|Withdrawal by Subject|0|||
16977869|NCT00927927|38121770|FG002|Overall Study|Withdrawal by Subject|0|||
16977870|NCT00927927|38121771|FG003|Overall Study|Withdrawal by Subject|0|||
16977871|NCT00927927|38121772|FG004|Overall Study|Withdrawal by Subject|0|||
16977872|NCT00927927|38121773|FG005|Overall Study|Withdrawal by Subject|0|||
16977873|NCT00927927|38121774|FG006|Overall Study|Withdrawal by Subject|0|||
16977874|NCT00927927|38121775|FG007|Overall Study|Withdrawal by Subject|2|||
16977875|NCT00927927|38121776|FG008|Overall Study|Withdrawal by Subject|0|||
16977876|NCT00927927|38121777|FG009|Overall Study|Withdrawal by Subject|0|||
16977877|NCT00927927|38121778|FG010|Overall Study|Withdrawal by Subject|0|||
16977878|NCT00927927|38121779|FG011|Overall Study|Withdrawal by Subject|2|||
16977879|NCT00927927|38121780|FG012|Overall Study|Withdrawal by Subject|0|||
16977880|NCT00927927|38121781|FG013|Overall Study|Withdrawal by Subject|0|||
16977881|NCT00927927|38121782|FG014|Overall Study|Withdrawal by Subject|0|||
16977882|NCT01027416|38121816|FG000|Overall Study|Withdrawal by Subject|0|||
16977883|NCT01027416|38121817|FG001|Overall Study|Withdrawal by Subject|1|||
16977884|NCT01027416|38121816|FG000|Overall Study|Physician Decision|1|||
16977885|NCT01027416|38121817|FG001|Overall Study|Physician Decision|4|||
16977886|NCT00923559|38121825|FG000|Overall Study|Lost to Follow-up|2|||
16977887|NCT00923559|38121826|FG001|Overall Study|Lost to Follow-up|3|||
16977888|NCT01015638|38121836|FG000|Overall Study|Withdrawal by Subject|1|||
16977889|NCT01015638|38121837|FG001|Overall Study|Withdrawal by Subject|0|||
16977890|NCT01022502|38121843|FG000|Overall Study|Adverse Event|1|||
16977891|NCT01022502|38121843|FG000|Overall Study|employment related reasons|1|||
16977892|NCT01022502|38121843|FG000|Overall Study|Withdrawal by Subject|1|||
16977893|NCT01105091|38121851|FG000|Overall Study|Death|2|||
16977894|NCT01105091|38121852|FG001|Overall Study|Death|0|||
16977895|NCT00924729|38121862|FG000|Overall Study|insufficient volume for analysis|1|||
16977896|NCT00924729|38121863|FG001|Overall Study|insufficient volume for analysis|0|||
16977897|NCT00924729|38121862|FG000|Overall Study|Protocol Violation|1|||
16977898|NCT00924729|38121863|FG001|Overall Study|Protocol Violation|0|||
16977899|NCT01099709|38121871|FG000|Period 1|Withdrawal by Subject|0|||
16977900|NCT01099709|38121872|FG001|Period 1|Withdrawal by Subject|1|||
16977901|NCT01099709|38121871|FG000|Period 1|Positive cotinine test|0|||
16977902|NCT01099709|38121872|FG001|Period 1|Positive cotinine test|1|||
16977903|NCT01099709|38121871|FG000|Period 1|Adverse Event|1|||
16977904|NCT01099709|38121872|FG001|Period 1|Adverse Event|0|||
16977905|NCT01099397|38121879|FG000|Overall Study|Lost to Follow-up|4|||
16977906|NCT01099397|38121879|FG000|Overall Study|Protocol Violation|4|||
16977907|NCT01099397|38121879|FG000|Overall Study|Withdrawal by Subject|5|||
16977908|NCT01022424|38121884|FG000|Overall Study|Adverse Event|1|||
16977909|NCT01022424|38121884|FG000|Overall Study|Physician Decision|1|||
16977910|NCT01022424|38121884|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
16977911|NCT01098851|38121894|FG000|Overall Study|Equipment failure|1|||
16977912|NCT01098851|38121895|FG001|Overall Study|Equipment failure|0|||
16977913|NCT01026948|38121901|FG000|Overall Study|Physician Decision|8|||
16977914|NCT01104779|38121909|FG000|Overall Study|Protocol Violation|1|||
16977915|NCT01104779|38121910|FG001|Overall Study|Protocol Violation|2|||
16977916|NCT01104779|38121911|FG002|Overall Study|Protocol Violation|2|||
16977917|NCT01104779|38121909|FG000|Overall Study|Lack of Efficacy|26|||
16977918|NCT01104779|38121910|FG001|Overall Study|Lack of Efficacy|12|||
16977919|NCT01104779|38121911|FG002|Overall Study|Lack of Efficacy|13|||
16977920|NCT01104779|38121909|FG000|Overall Study|Adverse Event|13|||
16977921|NCT01104779|38121910|FG001|Overall Study|Adverse Event|14|||
16977922|NCT01104779|38121911|FG002|Overall Study|Adverse Event|13|||
16977923|NCT01104779|38121909|FG000|Overall Study|Did not meet inc/exc criteria|1|||
16977924|NCT01104779|38121910|FG001|Overall Study|Did not meet inc/exc criteria|1|||
16977925|NCT01104779|38121911|FG002|Overall Study|Did not meet inc/exc criteria|1|||
16977926|NCT01104779|38121909|FG000|Overall Study|Other reasons|0|||
16977927|NCT01104779|38121910|FG001|Overall Study|Other reasons|1|||
16977928|NCT01104779|38121911|FG002|Overall Study|Other reasons|0|||
16977929|NCT01104779|38121909|FG000|Overall Study|Lost to Follow-up|2|||
16977930|NCT01104779|38121910|FG001|Overall Study|Lost to Follow-up|0|||
16977931|NCT01104779|38121911|FG002|Overall Study|Lost to Follow-up|1|||
16977932|NCT01104779|38121909|FG000|Overall Study|Withdrawal by Subject|16|||
16977933|NCT01104779|38121910|FG001|Overall Study|Withdrawal by Subject|25|||
16977934|NCT01104779|38121911|FG002|Overall Study|Withdrawal by Subject|32|||
16977935|NCT00918957|38121921|FG000|Overall Study|Adverse Event|2|||
16977936|NCT00918957|38121922|FG001|Overall Study|Adverse Event|0|||
16977937|NCT00918957|38121921|FG000|Overall Study|Withdrawal by Subject|1|||
16977938|NCT00918957|38121922|FG001|Overall Study|Withdrawal by Subject|0|||
16977939|NCT01022268|38121930|FG000|Overall Study|Withdrawal by Subject|1|||
16977940|NCT01022268|38121931|FG001|Overall Study|Withdrawal by Subject|0|||
16977941|NCT01022268|38121930|FG000|Overall Study|Withdrawal by Subject|1|||
16977942|NCT01022268|38121931|FG001|Overall Study|Withdrawal by Subject|0|||
16977943|NCT01015560|38121937|FG000|Overall Study|Adverse Event|1|||
16977944|NCT01015560|38121937|FG000|Overall Study|Not protocol specified|1|||
16977945|NCT01015560|38121937|FG000|Overall Study|Withdrawal by Subject|1|||
16977946|NCT00918879|38121943|FG000|Overall Study|Withdrawal by Subject|4|||
16977947|NCT00918879|38121944|FG001|Overall Study|Withdrawal by Subject|4|||
16977948|NCT00918879|38121943|FG000|Overall Study|Lost to Follow-up|1|||
16977949|NCT00918879|38121944|FG001|Overall Study|Lost to Follow-up|1|||
16977950|NCT00918879|38121943|FG000|Overall Study|Severe non-compliance to protocol|1|||
16977951|NCT00918879|38121944|FG001|Overall Study|Severe non-compliance to protocol|1|||
16977952|NCT01026792|38121950|FG000|Overall Study|Protocol Violation|1|||
16977953|NCT01026324|38121957|FG000|Follow up/Survival|Withdrawal by Subject|1|||
16977954|NCT01026324|38121958|FG001|Follow up/Survival|Withdrawal by Subject|0|||
16977955|NCT01026324|38121959|FG002|Follow up/Survival|Withdrawal by Subject|0|||
16977956|NCT01098539|38121970|FG000|Overall Study|Adverse Event|26|||
16977957|NCT01098539|38121971|FG001|Overall Study|Adverse Event|26|||
16977958|NCT01098539|38121970|FG000|Overall Study|Protocol Violation|1|||
16977959|NCT01098539|38121971|FG001|Overall Study|Protocol Violation|4|||
16977960|NCT01098539|38121970|FG000|Overall Study|Noncompliance|3|||
16977961|NCT01098539|38121971|FG001|Overall Study|Noncompliance|5|||
16977962|NCT01098539|38121970|FG000|Overall Study|Lost to Follow-up|4|||
16977963|NCT01098539|38121971|FG001|Overall Study|Lost to Follow-up|4|||
16977964|NCT01098539|38121970|FG000|Overall Study|Withdrawal by Subject|12|||
16977965|NCT01098539|38121971|FG001|Overall Study|Withdrawal by Subject|26|||
16977966|NCT01098539|38121970|FG000|Overall Study|Physician Decision|5|||
16977967|NCT01098539|38121971|FG001|Overall Study|Physician Decision|3|||
16977968|NCT01098461|38121981|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
16977969|NCT01098461|38121982|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
16977970|NCT01098461|38121983|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
16977971|NCT01098461|38121984|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
16977972|NCT01098461|38121981|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
16977973|NCT01098461|38121982|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
16977974|NCT01098461|38121983|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
16977975|NCT01098461|38121984|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
16977976|NCT01098461|38121981|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
16977977|NCT01098461|38121982|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
16977978|NCT01098461|38121983|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
16977979|NCT01098461|38121984|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
16977980|NCT01098461|38121981|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
16977981|NCT01098461|38121982|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
16977982|NCT01098461|38121983|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
16977983|NCT01098461|38121984|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
16977984|NCT01098461|38121981|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
16977985|NCT01098461|38121982|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
16977986|NCT01098461|38121983|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
16977987|NCT01098461|38121984|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
16977988|NCT01098461|38121981|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
16977989|NCT01098461|38121982|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
16977990|NCT01098461|38121983|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
16977991|NCT01098461|38121984|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
16977992|NCT01098461|38121981|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
16977993|NCT01098461|38121982|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
16977994|NCT01098461|38121983|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
16977995|NCT01098461|38121984|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
16977996|NCT01098305|38121997|FG000|Overall Study|Lost to Follow-up|31|||
16977997|NCT01098305|38121998|FG001|Overall Study|Lost to Follow-up|33|||
16977998|NCT00833833|38122010|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
16977999|NCT00833833|38122011|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
16978000|NCT00833833|38122012|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
16978001|NCT00833833|38122013|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
16978002|NCT00833833|38122014|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
16978003|NCT00833833|38122015|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
16978004|NCT00833833|38122010|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
16978005|NCT00833833|38122011|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
16978006|NCT00833833|38122012|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
16978007|NCT00833833|38122013|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
16978008|NCT00833833|38122014|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
16978009|NCT00833833|38122015|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
16978010|NCT00833833|38122010|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
16978011|NCT00833833|38122011|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
16978012|NCT00833833|38122012|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
16978013|NCT00833833|38122013|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
16978014|NCT00833833|38122014|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
16978015|NCT00833833|38122015|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
16978016|NCT00833833|38122010|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
16978017|NCT00833833|38122011|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
16978018|NCT00833833|38122012|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
16978019|NCT00833833|38122013|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
16978020|NCT00833833|38122014|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
16978021|NCT00833833|38122015|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
16978022|NCT00833833|38122010|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
16978023|NCT00833833|38122011|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16978024|NCT00833833|38122012|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
16978025|NCT00833833|38122013|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16978026|NCT00833833|38122014|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16978027|NCT00833833|38122015|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16978028|NCT00833833|38122010|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
16978029|NCT00833833|38122011|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
16978030|NCT00833833|38122012|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
16978031|NCT00833833|38122013|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
16978032|NCT00833833|38122014|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
16978033|NCT00833833|38122015|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
16978034|NCT00833833|38122010|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
16978035|NCT00833833|38122011|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
16978036|NCT00833833|38122012|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
16978037|NCT00833833|38122013|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
16978038|NCT00833833|38122014|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
16978039|NCT00833833|38122015|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
16978040|NCT00833833|38122010|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
16978041|NCT00833833|38122011|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
16978042|NCT00833833|38122012|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
16978043|NCT00833833|38122013|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
16978044|NCT00833833|38122014|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
16978045|NCT00833833|38122015|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
16978046|NCT00833833|38122010|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
16978047|NCT00833833|38122011|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
16978048|NCT00833833|38122012|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
16978049|NCT00833833|38122013|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
16978050|NCT00833833|38122014|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
16978051|NCT00833833|38122015|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
16978052|NCT00833833|38122010|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16978053|NCT00833833|38122011|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16978054|NCT00833833|38122012|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16978055|NCT00833833|38122013|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16978056|NCT00833833|38122014|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
16978057|NCT00833833|38122015|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
16978058|NCT00833833|38122010|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
16978059|NCT00833833|38122011|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
16978060|NCT00833833|38122012|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
16978061|NCT00833833|38122013|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
16978062|NCT00833833|38122014|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
16978063|NCT00833833|38122015|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
16978064|NCT00833833|38122010|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
16978065|NCT00833833|38122011|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
16978066|NCT00833833|38122012|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
16978067|NCT00833833|38122013|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
16978068|NCT00833833|38122014|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
16978069|NCT00833833|38122015|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
16978070|NCT00833833|38122010|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16978071|NCT00833833|38122011|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16978072|NCT00833833|38122012|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16978073|NCT00833833|38122013|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16978074|NCT00833833|38122014|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16978075|NCT00833833|38122015|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
16978076|NCT01098071|38122035|FG000|Overall Study|Surgery (adenoidectomy)|2|||
16978077|NCT01098071|38122035|FG000|Overall Study|Lost to Follow-up|13|||
16978078|NCT01097057|38122039|FG000|Overall Study|Physician Decision|3|||
16978079|NCT01022112|38122048|FG000|Overall Study|Adverse Event|1|||
16978080|NCT01022112|38122049|FG001|Overall Study|Adverse Event|2|||
16978081|NCT01022112|38122050|FG002|Overall Study|Adverse Event|0|||
16978082|NCT01022112|38122051|FG003|Overall Study|Adverse Event|1|||
16978083|NCT01022112|38122052|FG004|Overall Study|Adverse Event|0|||
16978084|NCT01022112|38122048|FG000|Overall Study|Lack of Efficacy|1|||
16978085|NCT01022112|38122049|FG001|Overall Study|Lack of Efficacy|0|||
16978086|NCT01022112|38122050|FG002|Overall Study|Lack of Efficacy|0|||
16978087|NCT01022112|38122051|FG003|Overall Study|Lack of Efficacy|0|||
16978088|NCT01022112|38122052|FG004|Overall Study|Lack of Efficacy|1|||
16978089|NCT01022112|38122048|FG000|Overall Study|Physician Decision|0|||
16978090|NCT01022112|38122049|FG001|Overall Study|Physician Decision|0|||
16978091|NCT01022112|38122050|FG002|Overall Study|Physician Decision|1|||
16978092|NCT01022112|38122051|FG003|Overall Study|Physician Decision|0|||
16978093|NCT01022112|38122052|FG004|Overall Study|Physician Decision|1|||
16978094|NCT01022112|38122048|FG000|Overall Study|Withdrawal by Subject|0|||
16978095|NCT01022112|38122049|FG001|Overall Study|Withdrawal by Subject|1|||
16978096|NCT01022112|38122050|FG002|Overall Study|Withdrawal by Subject|2|||
16978097|NCT01022112|38122051|FG003|Overall Study|Withdrawal by Subject|2|||
16978098|NCT01022112|38122052|FG004|Overall Study|Withdrawal by Subject|1|||
16978099|NCT01022112|38122048|FG000|Overall Study|Fasting plasma glucose level increased|1|||
16978100|NCT01022112|38122049|FG001|Overall Study|Fasting plasma glucose level increased|0|||
16978101|NCT01022112|38122050|FG002|Overall Study|Fasting plasma glucose level increased|0|||
16978102|NCT01022112|38122051|FG003|Overall Study|Fasting plasma glucose level increased|0|||
16978103|NCT01022112|38122052|FG004|Overall Study|Fasting plasma glucose level increased|7|||
16978104|NCT01096667|38122069|FG000|Overall Study|Lost to Follow-up|1|||
16978105|NCT01096667|38122070|FG001|Overall Study|Lost to Follow-up|1|||
16978106|NCT01096667|38122071|FG002|Overall Study|Lost to Follow-up|1|||
16978107|NCT01096667|38122072|FG003|Overall Study|Lost to Follow-up|0|||
16978108|NCT01096667|38122073|FG004|Overall Study|Lost to Follow-up|0|||
16978109|NCT01096667|38122069|FG000|Overall Study|Withdrawal by Subject|1|||
16978110|NCT01096667|38122070|FG001|Overall Study|Withdrawal by Subject|0|||
16978111|NCT01096667|38122071|FG002|Overall Study|Withdrawal by Subject|0|||
16978112|NCT01096667|38122072|FG003|Overall Study|Withdrawal by Subject|1|||
16978113|NCT01096667|38122073|FG004|Overall Study|Withdrawal by Subject|0|||
16978114|NCT01096667|38122069|FG000|Overall Study|Reason not available|0|||
16978115|NCT01096667|38122070|FG001|Overall Study|Reason not available|1|||
16978116|NCT01096667|38122071|FG002|Overall Study|Reason not available|1|||
16978117|NCT01096667|38122072|FG003|Overall Study|Reason not available|1|||
16978118|NCT01096667|38122073|FG004|Overall Study|Reason not available|0|||
16978119|NCT01096667|38122069|FG000|Overall Study|Protocol Violation|0|||
16978120|NCT01096667|38122070|FG001|Overall Study|Protocol Violation|0|||
16978121|NCT01096667|38122071|FG002|Overall Study|Protocol Violation|0|||
16978122|NCT01096667|38122072|FG003|Overall Study|Protocol Violation|1|||
16978123|NCT01096667|38122073|FG004|Overall Study|Protocol Violation|0|||
16978124|NCT01096667|38122069|FG000|Overall Study|Not treated|1|||
16978125|NCT01096667|38122070|FG001|Overall Study|Not treated|0|||
16978126|NCT01096667|38122071|FG002|Overall Study|Not treated|0|||
16978127|NCT01096667|38122072|FG003|Overall Study|Not treated|0|||
16978128|NCT01096667|38122073|FG004|Overall Study|Not treated|0|||
16978129|NCT01014624|38122088|FG000|Overall Study|Adverse Event|0|||
16978130|NCT01014624|38122089|FG001|Overall Study|Adverse Event|1|||
16978131|NCT01014624|38122088|FG000|Overall Study|Protocol Violation|1|||
16978132|NCT01014624|38122089|FG001|Overall Study|Protocol Violation|0|||
16978133|NCT01014624|38122088|FG000|Overall Study|Withdrawal by Subject|1|||
17134028|NCT02095132|38275297|FG004|Overall Study|Death|0|||
17134029|NCT02095132|38275298|FG005|Overall Study|Death|0|||
17134030|NCT02095132|38275299|FG006|Overall Study|Death|1|||
17134031|NCT02095132|38275300|FG007|Overall Study|Death|0|||
16978134|NCT01014624|38122089|FG001|Overall Study|Withdrawal by Subject|0|||
16978135|NCT01021878|38122099|FG000|Overall Study|Lost to Follow-up|4|||
16978136|NCT01021878|38122100|FG001|Overall Study|Lost to Follow-up|3|||
16978137|NCT01021878|38122099|FG000|Overall Study|Death|0|||
16978138|NCT01021878|38122100|FG001|Overall Study|Death|1|||
16978139|NCT01021878|38122099|FG000|Overall Study|Adverse Event|6|||
16978140|NCT01021878|38122100|FG001|Overall Study|Adverse Event|5|||
16978141|NCT01021878|38122099|FG000|Overall Study|Transplantation|6|||
16978142|NCT01021878|38122100|FG001|Overall Study|Transplantation|1|||
16978143|NCT00854113|38122120|FG000|Overall Study|Adverse Event|0|||
16978144|NCT00854113|38122121|FG001|Overall Study|Adverse Event|0|||
16978145|NCT00854113|38122122|FG002|Overall Study|Adverse Event|0|||
17134032|NCT02095132|38275301|FG008|Overall Study|Death|0|||
16978146|NCT00854113|38122123|FG003|Overall Study|Adverse Event|0|||
16978147|NCT00854113|38122124|FG004|Overall Study|Adverse Event|0|||
16978148|NCT00854113|38122125|FG005|Overall Study|Adverse Event|0|||
16978149|NCT00854113|38122126|FG006|Overall Study|Adverse Event|0|||
16978150|NCT00854113|38122127|FG007|Overall Study|Adverse Event|2|||
16978151|NCT00854113|38122128|FG008|Overall Study|Adverse Event|0|||
16978152|NCT00854113|38122129|FG009|Overall Study|Adverse Event|0|||
16978153|NCT00854113|38122130|FG010|Overall Study|Adverse Event|0|||
16978154|NCT00854113|38122120|FG000|Overall Study|Withdrawal by Subject|0|||
16978155|NCT00854113|38122121|FG001|Overall Study|Withdrawal by Subject|0|||
16978156|NCT00854113|38122122|FG002|Overall Study|Withdrawal by Subject|0|||
17134033|NCT02095132|38275293|FG000|Overall Study|Lack of Efficacy|3|||
16978157|NCT00854113|38122123|FG003|Overall Study|Withdrawal by Subject|0|||
16978158|NCT00854113|38122124|FG004|Overall Study|Withdrawal by Subject|0|||
16978159|NCT00854113|38122125|FG005|Overall Study|Withdrawal by Subject|0|||
16978160|NCT00854113|38122126|FG006|Overall Study|Withdrawal by Subject|0|||
16978161|NCT00854113|38122127|FG007|Overall Study|Withdrawal by Subject|1|||
16978162|NCT00854113|38122128|FG008|Overall Study|Withdrawal by Subject|1|||
16978163|NCT00854113|38122129|FG009|Overall Study|Withdrawal by Subject|0|||
16978164|NCT00854113|38122130|FG010|Overall Study|Withdrawal by Subject|0|||
16978165|NCT00845845|38122156|FG000|Overall Study|Lost to Follow-up|0|||
16978166|NCT00845845|38122157|FG001|Overall Study|Lost to Follow-up|4|||
16978167|NCT01104701|38122167|FG000|Overall Study|Withdrawal by Subject|0|||
16978168|NCT01104701|38122168|FG001|Overall Study|Withdrawal by Subject|1|||
16978169|NCT01104701|38122169|FG002|Overall Study|Withdrawal by Subject|2|||
16978170|NCT01104701|38122170|FG003|Overall Study|Withdrawal by Subject|1|||
16978171|NCT01104701|38122167|FG000|Overall Study|Adverse Event|0|||
16978172|NCT01104701|38122168|FG001|Overall Study|Adverse Event|0|||
16978173|NCT01104701|38122169|FG002|Overall Study|Adverse Event|0|||
16978174|NCT01104701|38122170|FG003|Overall Study|Adverse Event|1|||
16978175|NCT01104701|38122167|FG000|Overall Study|Physician Decision|0|||
16978176|NCT01104701|38122168|FG001|Overall Study|Physician Decision|2|||
16978177|NCT01104701|38122169|FG002|Overall Study|Physician Decision|0|||
16978178|NCT01104701|38122170|FG003|Overall Study|Physician Decision|0|||
16978179|NCT00833755|38122184|FG000|Overall Study|Physician Decision|4|||
16978180|NCT00833755|38122185|FG001|Overall Study|Physician Decision|4|||
16978181|NCT00833755|38122186|FG002|Overall Study|Physician Decision|2|||
16978182|NCT00833755|38122187|FG003|Overall Study|Physician Decision|6|||
16978183|NCT00833755|38122184|FG000|Overall Study|Subject had scheduling issues|0|||
16978184|NCT00833755|38122185|FG001|Overall Study|Subject had scheduling issues|1|||
16978185|NCT00833755|38122186|FG002|Overall Study|Subject had scheduling issues|0|||
16978186|NCT00833755|38122187|FG003|Overall Study|Subject had scheduling issues|0|||
16978187|NCT01021332|38122198|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
16978188|NCT01021332|38122198|FG000|Overall Study|Adverse Event|43|||
16978189|NCT01021332|38122198|FG000|Overall Study|Lack of Efficacy|19|||
16978190|NCT01021332|38122198|FG000|Overall Study|Withdrawal of Consent|23|||
16978191|NCT01021332|38122198|FG000|Overall Study|Lost to Follow-up|4|||
16978192|NCT01021332|38122198|FG000|Overall Study|Protocol Violation|9|||
16978193|NCT01021332|38122198|FG000|Overall Study|Miscellaneous|3|||
16978194|NCT00923091|38122212|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
16978195|NCT00923091|38122213|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
16978196|NCT00923091|38122214|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
16978197|NCT00923091|38122215|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
16978198|NCT00923091|38122216|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
16978199|NCT00923091|38122217|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
16978200|NCT00923091|38122218|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
16978201|NCT00923091|38122219|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
16978202|NCT00923091|38122220|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16978203|NCT00923091|38122221|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16978204|NCT00923091|38122222|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16978205|NCT00923091|38122223|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16978206|NCT00923091|38122224|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16978207|NCT00923091|38122212|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
16978208|NCT00923091|38122213|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
16978209|NCT00923091|38122214|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
16978210|NCT00923091|38122215|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
16978211|NCT00923091|38122216|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
16978212|NCT00923091|38122217|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
16978213|NCT00923091|38122218|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
16978214|NCT00923091|38122219|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
16978215|NCT00923091|38122220|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16978216|NCT00923091|38122221|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16978217|NCT00923091|38122222|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16978218|NCT00923091|38122223|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16978219|NCT00923091|38122224|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16978220|NCT00923091|38122212|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
16978221|NCT00923091|38122213|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
16978222|NCT00923091|38122214|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
16978223|NCT00923091|38122215|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
16978224|NCT00923091|38122216|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
16978225|NCT00923091|38122217|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
16978226|NCT00923091|38122218|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
16978227|NCT00923091|38122219|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
16978228|NCT00923091|38122220|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16978229|NCT00923091|38122221|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16978230|NCT00923091|38122222|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16978231|NCT00923091|38122223|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16978232|NCT00923091|38122224|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16978233|NCT00923091|38122212|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978234|NCT00923091|38122213|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978235|NCT00923091|38122214|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978236|NCT00923091|38122215|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978237|NCT00923091|38122216|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978238|NCT00923091|38122217|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
16978239|NCT00923091|38122218|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978240|NCT00923091|38122219|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978241|NCT00923091|38122220|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978242|NCT00923091|38122221|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978243|NCT00923091|38122222|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978244|NCT00923091|38122223|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978245|NCT00923091|38122224|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16978246|NCT00923091|38122212|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978247|NCT00923091|38122213|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
16978248|NCT00923091|38122214|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978249|NCT00923091|38122215|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
16978250|NCT00923091|38122216|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978251|NCT00923091|38122217|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
16978252|NCT00923091|38122218|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978253|NCT00923091|38122219|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978254|NCT00923091|38122220|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978255|NCT00923091|38122221|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978256|NCT00923091|38122222|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978257|NCT00923091|38122223|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978258|NCT00923091|38122224|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16978259|NCT00923091|38122212|FG000|Period III (Single-Blind)|Adverse Event|5|||
16978260|NCT00923091|38122213|FG001|Period III (Single-Blind)|Adverse Event|0|||
16978261|NCT00923091|38122214|FG002|Period III (Single-Blind)|Adverse Event|0|||
16978262|NCT00923091|38122215|FG003|Period III (Single-Blind)|Adverse Event|0|||
16978263|NCT00923091|38122216|FG004|Period III (Single-Blind)|Adverse Event|0|||
16978264|NCT00923091|38122217|FG005|Period III (Single-Blind)|Adverse Event|0|||
16978265|NCT00923091|38122218|FG006|Period III (Single-Blind)|Adverse Event|0|||
17134034|NCT02095132|38275294|FG001|Overall Study|Lack of Efficacy|5|||
16978266|NCT00923091|38122219|FG007|Period III (Single-Blind)|Adverse Event|0|||
16978267|NCT00923091|38122220|FG008|Period III (Single-Blind)|Adverse Event|0|||
16978268|NCT00923091|38122221|FG009|Period III (Single-Blind)|Adverse Event|0|||
16978269|NCT00923091|38122222|FG010|Period III (Single-Blind)|Adverse Event|0|||
16978270|NCT00923091|38122223|FG011|Period III (Single-Blind)|Adverse Event|0|||
16978271|NCT00923091|38122224|FG012|Period III (Single-Blind)|Adverse Event|0|||
16978272|NCT00923091|38122212|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
16978273|NCT00923091|38122213|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978274|NCT00923091|38122214|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978275|NCT00923091|38122215|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978276|NCT00923091|38122216|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978277|NCT00923091|38122217|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978278|NCT00923091|38122218|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978279|NCT00923091|38122219|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978280|NCT00923091|38122220|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978281|NCT00923091|38122221|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978282|NCT00923091|38122222|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978283|NCT00923091|38122223|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978284|NCT00923091|38122224|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
16978285|NCT00923091|38122212|FG000|Period III (Single-Blind)|Protocol Violation|3|||
16978286|NCT00923091|38122213|FG001|Period III (Single-Blind)|Protocol Violation|0|||
16978287|NCT00923091|38122214|FG002|Period III (Single-Blind)|Protocol Violation|0|||
16978288|NCT00923091|38122215|FG003|Period III (Single-Blind)|Protocol Violation|0|||
16978289|NCT00923091|38122216|FG004|Period III (Single-Blind)|Protocol Violation|0|||
16978290|NCT00923091|38122217|FG005|Period III (Single-Blind)|Protocol Violation|0|||
16978291|NCT00923091|38122218|FG006|Period III (Single-Blind)|Protocol Violation|0|||
16978292|NCT00923091|38122219|FG007|Period III (Single-Blind)|Protocol Violation|0|||
16978293|NCT00923091|38122220|FG008|Period III (Single-Blind)|Protocol Violation|0|||
16978294|NCT00923091|38122221|FG009|Period III (Single-Blind)|Protocol Violation|0|||
16978295|NCT00923091|38122222|FG010|Period III (Single-Blind)|Protocol Violation|0|||
16978296|NCT00923091|38122223|FG011|Period III (Single-Blind)|Protocol Violation|0|||
16978297|NCT00923091|38122224|FG012|Period III (Single-Blind)|Protocol Violation|0|||
16978298|NCT00923091|38122212|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
16978299|NCT00923091|38122213|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
16978300|NCT00923091|38122214|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
16978301|NCT00923091|38122215|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
16978302|NCT00923091|38122216|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
16978303|NCT00923091|38122217|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
16978304|NCT00923091|38122218|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
16978305|NCT00923091|38122219|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
16978306|NCT00923091|38122220|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
16978307|NCT00923091|38122221|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
16978308|NCT00923091|38122222|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
16978309|NCT00923091|38122223|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
16978310|NCT00923091|38122224|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
16978311|NCT00923091|38122212|FG000|Period IV (Double-Blind)|Adverse Event|2|||
16978312|NCT00923091|38122213|FG001|Period IV (Double-Blind)|Adverse Event|0|||
16978313|NCT00923091|38122214|FG002|Period IV (Double-Blind)|Adverse Event|0|||
16978314|NCT00923091|38122215|FG003|Period IV (Double-Blind)|Adverse Event|0|||
16978315|NCT00923091|38122216|FG004|Period IV (Double-Blind)|Adverse Event|0|||
16978316|NCT00923091|38122217|FG005|Period IV (Double-Blind)|Adverse Event|0|||
16978317|NCT00923091|38122218|FG006|Period IV (Double-Blind)|Adverse Event|0|||
16978318|NCT00923091|38122219|FG007|Period IV (Double-Blind)|Adverse Event|0|||
16978319|NCT00923091|38122220|FG008|Period IV (Double-Blind)|Adverse Event|0|||
16978320|NCT00923091|38122221|FG009|Period IV (Double-Blind)|Adverse Event|0|||
16978321|NCT00923091|38122222|FG010|Period IV (Double-Blind)|Adverse Event|0|||
16978322|NCT00923091|38122223|FG011|Period IV (Double-Blind)|Adverse Event|0|||
16978323|NCT00923091|38122224|FG012|Period IV (Double-Blind)|Adverse Event|0|||
16978324|NCT00923091|38122212|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978325|NCT00923091|38122213|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
16978326|NCT00923091|38122214|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978327|NCT00923091|38122215|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978328|NCT00923091|38122216|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978329|NCT00923091|38122217|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978330|NCT00923091|38122218|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978331|NCT00923091|38122219|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978332|NCT00923091|38122220|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978333|NCT00923091|38122221|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978334|NCT00923091|38122222|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978335|NCT00923091|38122223|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978336|NCT00923091|38122224|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16978337|NCT00923091|38122212|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
16978338|NCT00923091|38122213|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
16978339|NCT00923091|38122214|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
16978340|NCT00923091|38122215|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
16978341|NCT00923091|38122216|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
16978342|NCT00923091|38122217|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
16978343|NCT00923091|38122218|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
16978344|NCT00923091|38122219|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
16978345|NCT00923091|38122220|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
16978346|NCT00923091|38122221|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
16978347|NCT00923091|38122222|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
16978348|NCT00923091|38122223|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
16978349|NCT00923091|38122224|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
16978350|NCT00923091|38122212|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978351|NCT00923091|38122213|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978352|NCT00923091|38122214|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978353|NCT00923091|38122215|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978354|NCT00923091|38122216|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978355|NCT00923091|38122217|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978356|NCT00923091|38122218|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978357|NCT00923091|38122219|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978358|NCT00923091|38122220|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
16978359|NCT00923091|38122221|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978360|NCT00923091|38122222|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978361|NCT00923091|38122223|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
16978362|NCT00923091|38122224|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
16978363|NCT00923091|38122212|FG000|Period V (Double -Blind)|Protocol Violation|0|||
16978364|NCT00923091|38122213|FG001|Period V (Double -Blind)|Protocol Violation|0|||
16978365|NCT00923091|38122214|FG002|Period V (Double -Blind)|Protocol Violation|0|||
16978366|NCT00923091|38122215|FG003|Period V (Double -Blind)|Protocol Violation|0|||
16978367|NCT00923091|38122216|FG004|Period V (Double -Blind)|Protocol Violation|0|||
16978368|NCT00923091|38122217|FG005|Period V (Double -Blind)|Protocol Violation|0|||
16978369|NCT00923091|38122218|FG006|Period V (Double -Blind)|Protocol Violation|0|||
16978370|NCT00923091|38122219|FG007|Period V (Double -Blind)|Protocol Violation|0|||
16978371|NCT00923091|38122220|FG008|Period V (Double -Blind)|Protocol Violation|0|||
16978372|NCT00923091|38122221|FG009|Period V (Double -Blind)|Protocol Violation|0|||
16978373|NCT00923091|38122222|FG010|Period V (Double -Blind)|Protocol Violation|0|||
16978374|NCT00923091|38122223|FG011|Period V (Double -Blind)|Protocol Violation|0|||
16978375|NCT00923091|38122224|FG012|Period V (Double -Blind)|Protocol Violation|1|||
16978376|NCT00923091|38122212|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
16978377|NCT00923091|38122213|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
16978378|NCT00923091|38122214|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
16978379|NCT00923091|38122215|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
16978380|NCT00923091|38122216|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
16978381|NCT00923091|38122217|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
16978382|NCT00923091|38122218|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
16978383|NCT00923091|38122219|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
16978384|NCT00923091|38122220|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
16978385|NCT00923091|38122221|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
16978386|NCT00923091|38122222|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
16978387|NCT00923091|38122223|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
16978388|NCT00923091|38122224|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
16978389|NCT00923091|38122212|FG000|Period VI (Open-Label)|Adverse Event|17|||
16978390|NCT00923091|38122213|FG001|Period VI (Open-Label)|Adverse Event|0|||
16978391|NCT00923091|38122214|FG002|Period VI (Open-Label)|Adverse Event|4|||
16978392|NCT00923091|38122215|FG003|Period VI (Open-Label)|Adverse Event|1|||
16978393|NCT00923091|38122216|FG004|Period VI (Open-Label)|Adverse Event|1|||
16978394|NCT00923091|38122217|FG005|Period VI (Open-Label)|Adverse Event|0|||
16978395|NCT00923091|38122218|FG006|Period VI (Open-Label)|Adverse Event|0|||
16978396|NCT00923091|38122219|FG007|Period VI (Open-Label)|Adverse Event|0|||
16978397|NCT00923091|38122220|FG008|Period VI (Open-Label)|Adverse Event|0|||
16978398|NCT00923091|38122221|FG009|Period VI (Open-Label)|Adverse Event|0|||
16978399|NCT00923091|38122222|FG010|Period VI (Open-Label)|Adverse Event|0|||
16978400|NCT00923091|38122223|FG011|Period VI (Open-Label)|Adverse Event|0|||
16978401|NCT00923091|38122224|FG012|Period VI (Open-Label)|Adverse Event|0|||
16978402|NCT00923091|38122212|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
16978403|NCT00923091|38122213|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
16978404|NCT00923091|38122214|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
16978405|NCT00923091|38122215|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978406|NCT00923091|38122216|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
16978407|NCT00923091|38122217|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978408|NCT00923091|38122218|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978409|NCT00923091|38122219|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978410|NCT00923091|38122220|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978411|NCT00923091|38122221|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978412|NCT00923091|38122222|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978413|NCT00923091|38122223|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978414|NCT00923091|38122224|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
16978415|NCT00923091|38122212|FG000|Period VI (Open-Label)|Protocol Violation|6|||
16978416|NCT00923091|38122213|FG001|Period VI (Open-Label)|Protocol Violation|1|||
16978417|NCT00923091|38122214|FG002|Period VI (Open-Label)|Protocol Violation|3|||
16978418|NCT00923091|38122215|FG003|Period VI (Open-Label)|Protocol Violation|1|||
16978419|NCT00923091|38122216|FG004|Period VI (Open-Label)|Protocol Violation|4|||
16978420|NCT00923091|38122217|FG005|Period VI (Open-Label)|Protocol Violation|0|||
16978421|NCT00923091|38122218|FG006|Period VI (Open-Label)|Protocol Violation|0|||
16978422|NCT00923091|38122219|FG007|Period VI (Open-Label)|Protocol Violation|0|||
16978423|NCT00923091|38122220|FG008|Period VI (Open-Label)|Protocol Violation|0|||
16978424|NCT00923091|38122221|FG009|Period VI (Open-Label)|Protocol Violation|0|||
16978425|NCT00923091|38122222|FG010|Period VI (Open-Label)|Protocol Violation|0|||
16978426|NCT00923091|38122223|FG011|Period VI (Open-Label)|Protocol Violation|0|||
16978427|NCT00923091|38122224|FG012|Period VI (Open-Label)|Protocol Violation|0|||
16978428|NCT00923091|38122212|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
16978429|NCT00923091|38122213|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
16978430|NCT00923091|38122214|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
16978431|NCT00923091|38122215|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
16978432|NCT00923091|38122216|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
16978433|NCT00923091|38122217|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
16978434|NCT00923091|38122218|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
16978435|NCT00923091|38122219|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
16978436|NCT00923091|38122220|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
16978437|NCT00923091|38122221|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
16978438|NCT00923091|38122222|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
16978439|NCT00923091|38122223|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
16978440|NCT00923091|38122224|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
16978441|NCT00923091|38122212|FG000|Period VI (Open-Label)|Other Reason|0|||
16978442|NCT00923091|38122213|FG001|Period VI (Open-Label)|Other Reason|0|||
16978443|NCT00923091|38122214|FG002|Period VI (Open-Label)|Other Reason|0|||
16978444|NCT00923091|38122215|FG003|Period VI (Open-Label)|Other Reason|1|||
16978445|NCT00923091|38122216|FG004|Period VI (Open-Label)|Other Reason|1|||
16978446|NCT00923091|38122217|FG005|Period VI (Open-Label)|Other Reason|0|||
16978447|NCT00923091|38122218|FG006|Period VI (Open-Label)|Other Reason|0|||
16978448|NCT00923091|38122219|FG007|Period VI (Open-Label)|Other Reason|0|||
16978449|NCT00923091|38122220|FG008|Period VI (Open-Label)|Other Reason|0|||
16978450|NCT00923091|38122221|FG009|Period VI (Open-Label)|Other Reason|0|||
16978451|NCT00923091|38122222|FG010|Period VI (Open-Label)|Other Reason|0|||
16978452|NCT00923091|38122223|FG011|Period VI (Open-Label)|Other Reason|0|||
16978453|NCT00923091|38122224|FG012|Period VI (Open-Label)|Other Reason|0|||
16978454|NCT00853957|38122251|FG000|Overall Study|Adverse Event|9|||
16978455|NCT00853957|38122252|FG001|Overall Study|Adverse Event|3|||
16978456|NCT00853957|38122251|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16978457|NCT00853957|38122252|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16978458|NCT00853957|38122251|FG000|Overall Study|Subject withdrew consent|4|||
16978459|NCT00853957|38122252|FG001|Overall Study|Subject withdrew consent|5|||
16978460|NCT00853957|38122251|FG000|Overall Study|Lost to Follow-up|1|||
16978461|NCT00853957|38122252|FG001|Overall Study|Lost to Follow-up|6|||
16978462|NCT00853957|38122251|FG000|Overall Study|Protocol deviation|0|||
16978463|NCT00853957|38122252|FG001|Overall Study|Protocol deviation|3|||
16978464|NCT01021020|38122258|FG000|Period I|Protocol Violation|1|||
16978465|NCT01021020|38122258|FG000|Period I|Withdrawal by Subject|1|||
16978466|NCT01021020|38122258|FG000|14 Day Washout Period A|Physician Decision|1|||
16978467|NCT00833053|38122272|FG000|Overall Study|Adverse Event|4|||
16978468|NCT00833053|38122273|FG001|Overall Study|Adverse Event|0|||
16978469|NCT00833053|38122272|FG000|Overall Study|Treatment Failure|3|||
16978470|NCT00833053|38122273|FG001|Overall Study|Treatment Failure|1|||
16978471|NCT00833053|38122272|FG000|Overall Study|Withdrawal by Subject|0|||
16978472|NCT00833053|38122273|FG001|Overall Study|Withdrawal by Subject|1|||
16978473|NCT00833053|38122272|FG000|Overall Study|Protocol Violation|2|||
16978474|NCT00833053|38122273|FG001|Overall Study|Protocol Violation|1|||
16978475|NCT00832975|38122279|FG000|Overall Study|Lost to Follow-up|7|||
16978476|NCT00832975|38122279|FG000|Overall Study|Protocol Violation|6|||
16978477|NCT00832975|38122279|FG000|Overall Study|Death|5|||
16978478|NCT00832975|38122279|FG000|Overall Study|Physician Decision|4|||
16978479|NCT00832975|38122279|FG000|Overall Study|Withdrawal by Subject|3|||
16978480|NCT00832975|38122279|FG000|Overall Study|Other reasons|14|||
16978481|NCT01020786|38122283|FG000|Induction Period|Entry Criteria Not Met|2|||
16978482|NCT01020786|38122283|FG000|Induction Period|Adverse Event|10|||
16978483|NCT01020786|38122283|FG000|Induction Period|Progressive Disease|31|||
16978484|NCT01020786|38122283|FG000|Induction Period|Investigator Decision|3|||
16978485|NCT01020786|38122283|FG000|Induction Period|Withdrawal by Subject|3|||
16978486|NCT01020786|38122283|FG000|Maintenance Period|Adverse Event|8|||
16978487|NCT01020786|38122283|FG000|Maintenance Period|Progressive Disease|43|||
16978488|NCT01020786|38122283|FG000|Maintenance Period|Withdrawal by Subject|8|||
16978489|NCT01020786|38122283|FG000|Maintenance Period|Sponsor Decision|1|||
16978490|NCT00918645|38122288|FG000|Overall Study|Withdrawal by Subject|1|||
16978491|NCT00922935|38122295|FG000|Overall Study|Protocol Violation|0|||
16978492|NCT00922935|38122296|FG001|Overall Study|Protocol Violation|3|||
16978493|NCT00922935|38122297|FG002|Overall Study|Protocol Violation|0|||
16978494|NCT00922935|38122295|FG000|Overall Study|Physician Decision|1|||
16978495|NCT00922935|38122296|FG001|Overall Study|Physician Decision|1|||
16978496|NCT00922935|38122297|FG002|Overall Study|Physician Decision|0|||
16978497|NCT00922935|38122295|FG000|Overall Study|Lost to Follow-up|0|||
16978498|NCT00922935|38122296|FG001|Overall Study|Lost to Follow-up|1|||
16978499|NCT00922935|38122297|FG002|Overall Study|Lost to Follow-up|0|||
16978500|NCT01020474|38122307|FG000|Overall Study|Adverse Event|4|||
16978501|NCT01020474|38122308|FG001|Overall Study|Adverse Event|4|||
16978502|NCT01020474|38122307|FG000|Overall Study|Protocol Violation|0|||
16978503|NCT01020474|38122308|FG001|Overall Study|Protocol Violation|2|||
16978504|NCT01020474|38122307|FG000|Overall Study|Withdrawal by Subject|5|||
16978505|NCT01020474|38122308|FG001|Overall Study|Withdrawal by Subject|7|||
16978506|NCT01020474|38122307|FG000|Overall Study|Other Reasons|1|||
16978507|NCT01020474|38122308|FG001|Overall Study|Other Reasons|1|||
16978508|NCT01020474|38122307|FG000|Overall Study|Insufficient Clinical Response|0|||
16978509|NCT01020474|38122308|FG001|Overall Study|Insufficient Clinical Response|3|||
16978510|NCT00922779|38122314|FG000|Overall Study|Adverse Event|67|||
16978511|NCT00922779|38122314|FG000|Overall Study|Pregnancy|7|||
16978512|NCT00922779|38122314|FG000|Overall Study|Withdrawal by Subject|308|||
16978513|NCT00922779|38122314|FG000|Overall Study|Lost to Follow-up|44|||
16978514|NCT00922779|38122314|FG000|Overall Study|Other|27|||
16978515|NCT00922779|38122314|FG000|Overall Study|Missing|1874|||
16978516|NCT00924651|38122320|FG000|Overall Study|Chemo started too soon|2|||
16978517|NCT00924651|38122321|FG001|Overall Study|Chemo started too soon|3|||
16978518|NCT00924651|38122320|FG000|Overall Study|No Reason|3|||
16978519|NCT00924651|38122321|FG001|Overall Study|No Reason|7|||
16978520|NCT00924651|38122320|FG000|Overall Study|Overwhelmed|6|||
16978521|NCT00924651|38122321|FG001|Overall Study|Overwhelmed|6|||
16978522|NCT00924651|38122320|FG000|Overall Study|Noncompliant|1|||
16978523|NCT00924651|38122321|FG001|Overall Study|Noncompliant|4|||
16978524|NCT00924651|38122320|FG000|Overall Study|Medical|1|||
16978525|NCT00924651|38122321|FG001|Overall Study|Medical|3|||
16978526|NCT00924651|38122320|FG000|Overall Study|Changed Mind|10|||
16978527|NCT00924651|38122321|FG001|Overall Study|Changed Mind|1|||
16978528|NCT00924651|38122320|FG000|Overall Study|Incomplete Form|2|||
16978529|NCT00924651|38122321|FG001|Overall Study|Incomplete Form|1|||
16978530|NCT00922623|38122327|FG000|Overall Study|Other|4|||
16978531|NCT00922623|38122327|FG000|Overall Study|Lost to Follow-up|1|||
16978532|NCT01025232|38122335|FG000|Overall Study|Study drug no longer available|3|||
16978533|NCT01025232|38122336|FG001|Overall Study|Study drug no longer available|6|||
16978534|NCT01025154|38122342|FG000|Overall Study|Lost to Follow-up|1|||
16978535|NCT01025154|38122342|FG000|Overall Study|Withdrawal by Subject|1|||
16978536|NCT00832819|38122349|FG000|Overall Study|Adverse Event|0|||
16978537|NCT00832819|38122350|FG001|Overall Study|Adverse Event|1|||
16978538|NCT00832819|38122351|FG002|Overall Study|Adverse Event|0|||
16978539|NCT00832819|38122349|FG000|Overall Study|Protocol Violation|0|||
16978540|NCT00832819|38122350|FG001|Overall Study|Protocol Violation|0|||
16978541|NCT00832819|38122351|FG002|Overall Study|Protocol Violation|1|||
16978542|NCT00853723|38122360|FG000|Overall Study|Adverse Event|3|||
16978543|NCT00853723|38122361|FG001|Overall Study|Adverse Event|4|||
16978544|NCT00853723|38122362|FG002|Overall Study|Adverse Event|1|||
16978545|NCT00853723|38122360|FG000|Overall Study|Withdrawal by Subject|2|||
16978546|NCT00853723|38122361|FG001|Overall Study|Withdrawal by Subject|1|||
16978547|NCT00853723|38122362|FG002|Overall Study|Withdrawal by Subject|0|||
16978548|NCT00853723|38122360|FG000|Overall Study|Protocol Violation|1|||
16978549|NCT00853723|38122361|FG001|Overall Study|Protocol Violation|2|||
16978550|NCT00853723|38122362|FG002|Overall Study|Protocol Violation|1|||
16978551|NCT01104545|38122376|FG000|Overall Study|Adverse Event|0|||
16978552|NCT01104545|38122377|FG001|Overall Study|Adverse Event|1|||
16978553|NCT01104545|38122378|FG002|Overall Study|Adverse Event|2|||
16978554|NCT00918255|38122426|FG000|Overall Study|Adverse Event|1|||
16978555|NCT00918255|38122427|FG001|Overall Study|Adverse Event|0|||
16978556|NCT00918255|38122428|FG002|Overall Study|Adverse Event|0|||
16978557|NCT00918255|38122426|FG000|Overall Study|Withdrawal by Subject|1|||
16978558|NCT00918255|38122427|FG001|Overall Study|Withdrawal by Subject|0|||
16978559|NCT00918255|38122428|FG002|Overall Study|Withdrawal by Subject|2|||
16978560|NCT00918255|38122426|FG000|Overall Study|Lack of Efficacy|1|||
16978561|NCT00918255|38122427|FG001|Overall Study|Lack of Efficacy|0|||
16978562|NCT00918255|38122428|FG002|Overall Study|Lack of Efficacy|0|||
16978563|NCT00918255|38122426|FG000|Overall Study|Lost to Follow-up|1|||
17134035|NCT02095132|38275295|FG002|Overall Study|Lack of Efficacy|2|||
17134036|NCT02095132|38275296|FG003|Overall Study|Lack of Efficacy|8|||
17134037|NCT02095132|38275297|FG004|Overall Study|Lack of Efficacy|3|||
17134038|NCT02095132|38275298|FG005|Overall Study|Lack of Efficacy|6|||
17134039|NCT02095132|38275299|FG006|Overall Study|Lack of Efficacy|10|||
16978564|NCT00918255|38122427|FG001|Overall Study|Lost to Follow-up|0|||
16978565|NCT00918255|38122428|FG002|Overall Study|Lost to Follow-up|2|||
16978566|NCT00918255|38122426|FG000|Overall Study|Exceeded allowed number of interventions|0|||
16978567|NCT00918255|38122427|FG001|Overall Study|Exceeded allowed number of interventions|0|||
16978568|NCT00918255|38122428|FG002|Overall Study|Exceeded allowed number of interventions|1|||
16978569|NCT00918255|38122426|FG000|Overall Study|Non-compliance|1|||
16978570|NCT00918255|38122427|FG001|Overall Study|Non-compliance|0|||
16978571|NCT00918255|38122428|FG002|Overall Study|Non-compliance|0|||
16978572|NCT00918255|38122426|FG000|Overall Study|Investigator discretion|1|||
16978573|NCT00918255|38122427|FG001|Overall Study|Investigator discretion|0|||
16978574|NCT00918255|38122428|FG002|Overall Study|Investigator discretion|0|||
16978575|NCT01096589|38122440|FG000|Overall Study|Adverse Event|2|||
16978576|NCT01096589|38122441|FG001|Overall Study|Adverse Event|1|||
16978577|NCT01096589|38122442|FG002|Overall Study|Adverse Event|2|||
16978578|NCT01096589|38122443|FG003|Overall Study|Adverse Event|1|||
16978579|NCT01096589|38122440|FG000|Overall Study|Withdrawal by Subject|2|||
16978580|NCT01096589|38122441|FG001|Overall Study|Withdrawal by Subject|1|||
16978581|NCT01096589|38122442|FG002|Overall Study|Withdrawal by Subject|1|||
16978582|NCT01096589|38122443|FG003|Overall Study|Withdrawal by Subject|1|||
16978583|NCT01096589|38122440|FG000|Overall Study|Compliance with protocol|0|||
16978584|NCT01096589|38122441|FG001|Overall Study|Compliance with protocol|0|||
16978585|NCT01096589|38122442|FG002|Overall Study|Compliance with protocol|1|||
16978586|NCT01096589|38122443|FG003|Overall Study|Compliance with protocol|0|||
16978587|NCT01096589|38122440|FG000|Overall Study|found treatment exhausting|0|||
16978588|NCT01096589|38122441|FG001|Overall Study|found treatment exhausting|0|||
16978589|NCT01096589|38122442|FG002|Overall Study|found treatment exhausting|0|||
16978590|NCT01096589|38122443|FG003|Overall Study|found treatment exhausting|1|||
16978591|NCT00845065|38122459|FG000|Overall Study|Adverse Event|3|||
16978592|NCT00845065|38122460|FG001|Overall Study|Adverse Event|23|||
16978593|NCT00845065|38122459|FG000|Overall Study|Lack of Efficacy|43|||
16978594|NCT00845065|38122460|FG001|Overall Study|Lack of Efficacy|21|||
16978595|NCT00845065|38122459|FG000|Overall Study|Non-Medical Reasons|1|||
16978596|NCT00845065|38122460|FG001|Overall Study|Non-Medical Reasons|11|||
16978597|NCT00832585|38122466|FG000|Overall Study|Withdrawal by Subject|1|||
16978598|NCT00832585|38122466|FG000|Overall Study|Lost to Follow-up|1|||
16978599|NCT00918567|38122472|FG000|Overall Study|Lack of Efficacy|3|||
16978600|NCT00918567|38122473|FG001|Overall Study|Lack of Efficacy|1|||
16978601|NCT00918567|38122472|FG000|Overall Study|Withdrawal by Subject|1|||
16978602|NCT00918567|38122473|FG001|Overall Study|Withdrawal by Subject|1|||
16978603|NCT00918567|38122472|FG000|Overall Study|Adverse Event|1|||
16978604|NCT00918567|38122473|FG001|Overall Study|Adverse Event|0|||
16978605|NCT01024920|38122481|FG000|Overall Study|Progressive disease|47|||
16978606|NCT01024920|38122482|FG001|Overall Study|Progressive disease|25|||
16978607|NCT01024920|38122481|FG000|Overall Study|Adverse Event|8|||
16978608|NCT01024920|38122482|FG001|Overall Study|Adverse Event|4|||
16978609|NCT01024920|38122481|FG000|Overall Study|Lost to Follow-up|0|||
16978610|NCT01024920|38122482|FG001|Overall Study|Lost to Follow-up|1|||
16978611|NCT01024920|38122481|FG000|Overall Study|Patient refusal to continue|4|||
16978612|NCT01024920|38122482|FG001|Overall Study|Patient refusal to continue|0|||
16978613|NCT01024920|38122481|FG000|Overall Study|Other than listed|5|||
16978614|NCT01024920|38122482|FG001|Overall Study|Other than listed|1|||
16978615|NCT01024920|38122481|FG000|Overall Study|Not treated|3|||
16978616|NCT01024920|38122482|FG001|Overall Study|Not treated|0|||
16978617|NCT01024920|38122481|FG000|Overall Study|Protocol Violation|0|||
16978618|NCT01024920|38122482|FG001|Overall Study|Protocol Violation|1|||
16978619|NCT00832117|38122490|FG000|Overall Study|Death|1|||
16978620|NCT00832117|38122490|FG000|Overall Study|Disease Progression|11|||
16978621|NCT01104311|38122499|FG000|Overall Study|Withdrawal by Subject|6|||
16978622|NCT01104311|38122500|FG001|Overall Study|Withdrawal by Subject|6|||
16978623|NCT01104311|38122499|FG000|Overall Study|Protocol Violation|0|||
16978624|NCT01104311|38122500|FG001|Overall Study|Protocol Violation|1|||
16978625|NCT01104311|38122499|FG000|Overall Study|Physician Decision|2|||
16978626|NCT01104311|38122500|FG001|Overall Study|Physician Decision|2|||
16978627|NCT01104311|38122499|FG000|Overall Study|low compliance|1|||
16978628|NCT01104311|38122500|FG001|Overall Study|low compliance|1|||
16978629|NCT01104311|38122499|FG000|Overall Study|Adverse Event|1|||
16978630|NCT01104311|38122500|FG001|Overall Study|Adverse Event|2|||
16978631|NCT00831493|38122510|FG000|Overall Study|Intractable nausea and vomiting|1|||
16978632|NCT00853567|38122517|FG000|Overall Study|Study prematurely terminated|71|||
16978633|NCT00853489|38122527|FG000|Overall Study|Lost to Follow-up|5|||
16978634|NCT00853489|38122528|FG001|Overall Study|Lost to Follow-up|2|||
16978635|NCT01104155|38122536|FG000|Overall Study|Adverse Event|15|||
16978636|NCT01104155|38122537|FG001|Overall Study|Adverse Event|8|||
17134040|NCT02095132|38275300|FG007|Overall Study|Lack of Efficacy|9|||
16978637|NCT01104155|38122536|FG000|Overall Study|Participant choice|6|||
16978638|NCT01104155|38122537|FG001|Overall Study|Participant choice|5|||
16978639|NCT01104155|38122536|FG000|Overall Study|Withdrawal of consent|1|||
16978640|NCT01104155|38122537|FG001|Overall Study|Withdrawal of consent|1|||
16978641|NCT01104155|38122536|FG000|Overall Study|Other|3|||
16978642|NCT01104155|38122537|FG001|Overall Study|Other|4|||
16978643|NCT01019694|38122546|FG000|Overall Study|Adverse Event|12|||
16978644|NCT01019694|38122547|FG001|Overall Study|Adverse Event|16|||
16978645|NCT01019694|38122548|FG002|Overall Study|Adverse Event|19|||
16978646|NCT01019694|38122546|FG000|Overall Study|Protocol Violation|2|||
16978647|NCT01019694|38122547|FG001|Overall Study|Protocol Violation|6|||
16978648|NCT01019694|38122548|FG002|Overall Study|Protocol Violation|4|||
16978649|NCT01019694|38122546|FG000|Overall Study|Lost to Follow-up|5|||
16978650|NCT01019694|38122547|FG001|Overall Study|Lost to Follow-up|3|||
16978651|NCT01019694|38122548|FG002|Overall Study|Lost to Follow-up|3|||
16978652|NCT01019694|38122546|FG000|Overall Study|Withdrawal by Subject|4|||
16978653|NCT01019694|38122547|FG001|Overall Study|Withdrawal by Subject|6|||
16978654|NCT01019694|38122548|FG002|Overall Study|Withdrawal by Subject|12|||
16978655|NCT01019694|38122546|FG000|Overall Study|Not treated|0|||
16978656|NCT01019694|38122547|FG001|Overall Study|Not treated|2|||
16978657|NCT01019694|38122548|FG002|Overall Study|Not treated|3|||
16978658|NCT01019694|38122546|FG000|Overall Study|Other reason (not specified)|1|||
16978659|NCT01019694|38122547|FG001|Overall Study|Other reason (not specified)|5|||
16978660|NCT01019694|38122548|FG002|Overall Study|Other reason (not specified)|6|||
16978661|NCT00831415|38122556|FG000|Overall Study|Adverse Event|14|||
16978662|NCT00831415|38122556|FG000|Overall Study|Failed to return|3|||
16978663|NCT00831415|38122556|FG000|Overall Study|Physician Decision|6|||
16978664|NCT00831415|38122556|FG000|Overall Study|Lost to Follow-up|9|||
16978665|NCT00831415|38122556|FG000|Overall Study|Protocol Violation|3|||
16978666|NCT00831415|38122556|FG000|Overall Study|Withdrawal by Subject|35|||
16978667|NCT00831415|38122556|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
16978668|NCT00831415|38122556|FG000|Overall Study|Death|1|||
16978669|NCT01095653|38122563|FG000|Overall Study|Lack of Efficacy|3|||
16978670|NCT01095653|38122564|FG001|Overall Study|Lack of Efficacy|0|||
16978671|NCT01095653|38122565|FG002|Overall Study|Lack of Efficacy|0|||
16978672|NCT01095653|38122563|FG000|Overall Study|Adverse Event|1|||
16978673|NCT01095653|38122564|FG001|Overall Study|Adverse Event|4|||
16978674|NCT01095653|38122565|FG002|Overall Study|Adverse Event|4|||
16978675|NCT01095653|38122563|FG000|Overall Study|Lost to Follow-up|1|||
16978676|NCT01095653|38122564|FG001|Overall Study|Lost to Follow-up|0|||
16978677|NCT01095653|38122565|FG002|Overall Study|Lost to Follow-up|4|||
16978678|NCT01095653|38122563|FG000|Overall Study|Withdrawal by Subject|4|||
16978679|NCT01095653|38122564|FG001|Overall Study|Withdrawal by Subject|5|||
16978680|NCT01095653|38122565|FG002|Overall Study|Withdrawal by Subject|3|||
16978681|NCT01095653|38122563|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
16978682|NCT01095653|38122564|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
16978683|NCT01095653|38122565|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
16978684|NCT00920907|38122575|FG000|Induction Period|Adverse Event|0|||
16978685|NCT00920907|38122576|FG001|Induction Period|Adverse Event|2|||
16978686|NCT00920907|38122575|FG000|Induction Period|Death|1|||
16978687|NCT00920907|38122576|FG001|Induction Period|Death|1|||
16978688|NCT00920907|38122575|FG000|Induction Period|Disease Progression|12|||
16978689|NCT00920907|38122576|FG001|Induction Period|Disease Progression|11|||
16978690|NCT00920907|38122575|FG000|Induction Period|Study Drug Toxicity|8|||
16978691|NCT00920907|38122576|FG001|Induction Period|Study Drug Toxicity|6|||
16978692|NCT00920907|38122575|FG000|Induction Period|No longer meets study criteria|0|||
16978693|NCT00920907|38122576|FG001|Induction Period|No longer meets study criteria|1|||
16978694|NCT00920907|38122575|FG000|Induction Period|Withdrawal by Subject|1|||
16978695|NCT00920907|38122576|FG001|Induction Period|Withdrawal by Subject|1|||
16978696|NCT00920907|38122575|FG000|Maintenance Period|Disease Progression|3|||
16978697|NCT00920907|38122576|FG001|Maintenance Period|Disease Progression|7|||
16978698|NCT00920907|38122575|FG000|Maintenance Period|Administrative (study closure)|7|||
16978699|NCT00920907|38122576|FG001|Maintenance Period|Administrative (study closure)|2|||
16978700|NCT00920907|38122575|FG000|Maintenance Period|Study Drug Toxicity|0|||
16978701|NCT00920907|38122576|FG001|Maintenance Period|Study Drug Toxicity|2|||
16978702|NCT00920907|38122575|FG000|Maintenance Period|Death|1|||
16978703|NCT00920907|38122576|FG001|Maintenance Period|Death|1|||
16978704|NCT00920907|38122575|FG000|Maintenance Period|Withdrawal by Subject|1|||
16978705|NCT00920907|38122576|FG001|Maintenance Period|Withdrawal by Subject|0|||
16978706|NCT00920907|38122575|FG000|Maintenance Period|Adverse Event|0|||
16978707|NCT00920907|38122576|FG001|Maintenance Period|Adverse Event|1|||
16978708|NCT01103141|38122586|FG000|Overall Study|Death|0|||
16978709|NCT01103141|38122587|FG001|Overall Study|Death|1|||
16978710|NCT01103141|38122586|FG000|Overall Study|Lost to Follow-up|2|||
16978711|NCT01103141|38122587|FG001|Overall Study|Lost to Follow-up|1|||
16978712|NCT00844831|38122593|FG000|Overall Study|Withdrawal by Subject|4|||
16978713|NCT00844831|38122593|FG000|Overall Study|Adverse Event|1|||
16978714|NCT00844831|38122593|FG000|Overall Study|Physician Decision|1|||
16978715|NCT00920829|38122605|FG000|Allocation|No post randomization data|3|||
16978716|NCT00920829|38122606|FG001|Allocation|No post randomization data|1|||
16978717|NCT00920829|38122607|FG002|Allocation|No post randomization data|0|||
16978718|NCT00920829|38122608|FG003|Allocation|No post randomization data|2|||
16978719|NCT00920829|38122605|FG000|Available for Analysis|Withdrawal by Subject|6|||
16978720|NCT00920829|38122606|FG001|Available for Analysis|Withdrawal by Subject|6|||
16978721|NCT00920829|38122607|FG002|Available for Analysis|Withdrawal by Subject|6|||
16978722|NCT00920829|38122608|FG003|Available for Analysis|Withdrawal by Subject|10|||
16780187|NCT02613507|37719290|FG000|Overall Study|Maximum Clinical Benefit|4|||
16780188|NCT02613507|37719291|FG001|Overall Study|Maximum Clinical Benefit|10|||
16780189|NCT02613507|37719290|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
16780190|NCT02613507|37719291|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
16978723|NCT00920829|38122605|FG000|Available for Analysis|Required Medical Treatment|0|||
16978724|NCT00920829|38122606|FG001|Available for Analysis|Required Medical Treatment|1|||
16978725|NCT00920829|38122607|FG002|Available for Analysis|Required Medical Treatment|2|||
16978726|NCT00920829|38122608|FG003|Available for Analysis|Required Medical Treatment|0|||
16978727|NCT00920829|38122605|FG000|Available for Analysis|Adverse Event|1|||
16978728|NCT00920829|38122606|FG001|Available for Analysis|Adverse Event|2|||
16978729|NCT00920829|38122607|FG002|Available for Analysis|Adverse Event|1|||
16978730|NCT00920829|38122608|FG003|Available for Analysis|Adverse Event|0|||
16978731|NCT00920829|38122605|FG000|Available for Analysis|Death|1|||
16978732|NCT00920829|38122606|FG001|Available for Analysis|Death|0|||
16978733|NCT00920829|38122607|FG002|Available for Analysis|Death|0|||
16978734|NCT00920829|38122608|FG003|Available for Analysis|Death|0|||
16978735|NCT00920829|38122605|FG000|Available for Analysis|Protocol Violation|0|||
16978736|NCT00920829|38122606|FG001|Available for Analysis|Protocol Violation|0|||
16978737|NCT00920829|38122607|FG002|Available for Analysis|Protocol Violation|1|||
16978738|NCT00920829|38122608|FG003|Available for Analysis|Protocol Violation|0|||
16978739|NCT00920829|38122605|FG000|Available for Analysis|Required more treatment|0|||
16978740|NCT00920829|38122606|FG001|Available for Analysis|Required more treatment|2|||
16978741|NCT00920829|38122607|FG002|Available for Analysis|Required more treatment|0|||
16978742|NCT00920829|38122608|FG003|Available for Analysis|Required more treatment|1|||
16978743|NCT00831181|38122618|FG000|Overall Study|Adverse Event|12|||
16978744|NCT01023672|38122623|FG000|Overall Study|Worsening disease|2|||
16978745|NCT01023672|38122623|FG000|Overall Study|Death|1|||
16978746|NCT01094171|38122627|FG000|Overall Study|Lost to Follow-up|2|||
16978747|NCT01094171|38122627|FG000|Overall Study|Informed consent withdrawal|4|||
16978748|NCT01094171|38122627|FG000|Overall Study|Migration from the study area|3|||
16978749|NCT01094171|38122627|FG000|Overall Study|Other|1|||
16978750|NCT01093625|38122633|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
16978751|NCT01093625|38122634|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
16978752|NCT01093625|38122633|FG000|2-Week Visit|Withdrawal by Subject|1|||
16978753|NCT01093625|38122634|FG001|2-Week Visit|Withdrawal by Subject|0|||
16978754|NCT01093625|38122633|FG000|1-Month Visit|Lost to Follow-up|2|||
16780191|NCT02613507|37719290|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
16780192|NCT02613507|37719291|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
16780193|NCT02613507|37719290|FG000|Overall Study|Randomized but not Treated|1|||
16978755|NCT01093625|38122634|FG001|1-Month Visit|Lost to Follow-up|0|||
16978756|NCT01093625|38122633|FG000|3-Month Visit|Lost to Follow-up|2|||
16780194|NCT02613507|37719291|FG001|Overall Study|Randomized but not Treated|10|||
16978757|NCT01093625|38122634|FG001|3-Month Visit|Lost to Follow-up|0|||
16978758|NCT01093625|38122633|FG000|6-Month Visit|Withdrawal by Subject|6|||
16978759|NCT01093625|38122634|FG001|6-Month Visit|Withdrawal by Subject|7|||
16978760|NCT01093625|38122633|FG000|6-Month Visit|Lost to Follow-up|2|||
16978761|NCT01093625|38122634|FG001|6-Month Visit|Lost to Follow-up|2|||
16978762|NCT01093625|38122633|FG000|1-Year Visit|Lost to Follow-up|5|||
16978763|NCT01093625|38122634|FG001|1-Year Visit|Lost to Follow-up|3|||
16978764|NCT01023516|38122642|FG000|Overall Study|Voluntary discontinuation|7|||
16978765|NCT01023516|38122643|FG001|Overall Study|Voluntary discontinuation|5|||
16978766|NCT01023516|38122642|FG000|Overall Study|Adverse Event|9|||
16978767|NCT01023516|38122643|FG001|Overall Study|Adverse Event|6|||
16978768|NCT01023516|38122642|FG000|Overall Study|Safety reason|0|||
16978769|NCT01023516|38122643|FG001|Overall Study|Safety reason|3|||
16978770|NCT01023516|38122642|FG000|Overall Study|Study-specific criteria|4|||
16978771|NCT01023516|38122643|FG001|Overall Study|Study-specific criteria|2|||
16978772|NCT01023516|38122642|FG000|Overall Study|Incorrect enrolment|4|||
16978773|NCT01023516|38122643|FG001|Overall Study|Incorrect enrolment|2|||
16978774|NCT00844753|38122653|FG000|Overall Study|Lack of Efficacy|1|||
16978775|NCT00844753|38122654|FG001|Overall Study|Lack of Efficacy|0|||
16978776|NCT00844753|38122655|FG002|Overall Study|Lack of Efficacy|2|||
16978777|NCT00844753|38122656|FG003|Overall Study|Lack of Efficacy|2|||
16978778|NCT00844753|38122653|FG000|Overall Study|Adverse Event|3|||
16978779|NCT00844753|38122654|FG001|Overall Study|Adverse Event|2|||
16978780|NCT00844753|38122655|FG002|Overall Study|Adverse Event|5|||
16978781|NCT00844753|38122656|FG003|Overall Study|Adverse Event|5|||
16978782|NCT00844753|38122653|FG000|Overall Study|Lost to Follow-up|1|||
16978783|NCT00844753|38122654|FG001|Overall Study|Lost to Follow-up|1|||
16978784|NCT00844753|38122655|FG002|Overall Study|Lost to Follow-up|0|||
16978785|NCT00844753|38122656|FG003|Overall Study|Lost to Follow-up|1|||
16978786|NCT00844753|38122653|FG000|Overall Study|could not swallow medication|2|||
16978787|NCT00844753|38122654|FG001|Overall Study|could not swallow medication|0|||
16978788|NCT00844753|38122655|FG002|Overall Study|could not swallow medication|0|||
16978789|NCT00844753|38122656|FG003|Overall Study|could not swallow medication|0|||
16978790|NCT00844753|38122653|FG000|Overall Study|Withdrawal by Subject|1|||
16978791|NCT00844753|38122654|FG001|Overall Study|Withdrawal by Subject|0|||
16978792|NCT00844753|38122655|FG002|Overall Study|Withdrawal by Subject|0|||
16978793|NCT00844753|38122656|FG003|Overall Study|Withdrawal by Subject|3|||
16978794|NCT00830947|38122666|FG000|Overall Study|Lost to Follow-up|4|||
16978795|NCT00830947|38122667|FG001|Overall Study|Lost to Follow-up|4|||
16978796|NCT01018992|38122675|FG000|Overall Study|Adverse Event|8|||
16978797|NCT01018992|38122676|FG001|Overall Study|Adverse Event|3|||
16978798|NCT01018992|38122675|FG000|Overall Study|Withdrawal by Subject|3|||
16978799|NCT01018992|38122676|FG001|Overall Study|Withdrawal by Subject|8|||
16978800|NCT01018992|38122675|FG000|Overall Study|Protocol Violation|0|||
16978801|NCT01018992|38122676|FG001|Overall Study|Protocol Violation|4|||
16978802|NCT01018992|38122675|FG000|Overall Study|Lost to Follow-up|5|||
16978803|NCT01018992|38122676|FG001|Overall Study|Lost to Follow-up|1|||
16978804|NCT00917553|38122684|FG000|Overall Study|Lost to Follow-up|2|||
16978805|NCT00917553|38122685|FG001|Overall Study|Lost to Follow-up|1|||
16978806|NCT01018680|38122693|FG000|Overall Study|Adverse Event|23|||
16978807|NCT01018680|38122694|FG001|Overall Study|Adverse Event|40|||
16978808|NCT01018680|38122693|FG000|Overall Study|Withdrawal by Subject|10|||
16978809|NCT01018680|38122694|FG001|Overall Study|Withdrawal by Subject|10|||
16978810|NCT01018680|38122693|FG000|Overall Study|Protocol Violation|5|||
16978811|NCT01018680|38122694|FG001|Overall Study|Protocol Violation|8|||
16978812|NCT01018680|38122693|FG000|Overall Study|Sponsor Decision|6|||
16978813|NCT01018680|38122694|FG001|Overall Study|Sponsor Decision|7|||
16978814|NCT01018680|38122693|FG000|Overall Study|Lack of Efficacy|8|||
16978815|NCT01018680|38122694|FG001|Overall Study|Lack of Efficacy|2|||
16978816|NCT01018680|38122693|FG000|Overall Study|Lost to Follow-up|5|||
16978817|NCT01018680|38122694|FG001|Overall Study|Lost to Follow-up|3|||
16978818|NCT01018680|38122693|FG000|Overall Study|Entry Criteria Not Met|1|||
16978819|NCT01018680|38122694|FG001|Overall Study|Entry Criteria Not Met|4|||
16978820|NCT01018680|38122693|FG000|Overall Study|Physician Decision|3|||
16978821|NCT01018680|38122694|FG001|Overall Study|Physician Decision|1|||
16978822|NCT01012440|38122700|FG000|Overall Study|Withdrawal by Subject|2|||
17134041|NCT02095132|38275301|FG008|Overall Study|Lack of Efficacy|8|||
16978823|NCT00916929|38122706|FG000|Overall Study|Lost to Follow-up|1|||
16978824|NCT00916929|38122707|FG001|Overall Study|Lost to Follow-up|3|||
16978825|NCT00916929|38122706|FG000|Overall Study|Death|5|||
16978826|NCT00916929|38122707|FG001|Overall Study|Death|10|||
16978827|NCT00916929|38122706|FG000|Overall Study|Withdrawal by Subject|1|||
16978828|NCT00916929|38122707|FG001|Overall Study|Withdrawal by Subject|5|||
16978829|NCT00916929|38122706|FG000|Overall Study|Left ventricular epicardial lead|1|||
16978830|NCT00916929|38122707|FG001|Overall Study|Left ventricular epicardial lead|2|||
16978831|NCT00916929|38122706|FG000|Overall Study|Transferred to hospice care|1|||
16978832|NCT00916929|38122707|FG001|Overall Study|Transferred to hospice care|1|||
16978833|NCT00916929|38122706|FG000|Overall Study|System explant|1|||
17134042|NCT02095132|38275293|FG000|Overall Study|Physician Decision|1|||
16978834|NCT00916929|38122707|FG001|Overall Study|System explant|0|||
16978835|NCT00916929|38122706|FG000|Overall Study|Moved to another state|0|||
16978836|NCT00916929|38122707|FG001|Overall Study|Moved to another state|1|||
16978837|NCT00916929|38122706|FG000|Overall Study|Device unable to process impedance data|0|||
16978838|NCT00916929|38122707|FG001|Overall Study|Device unable to process impedance data|7|||
16978839|NCT00844597|38122721|FG000|Overall Study|Adverse Event|0|||
16978840|NCT00844597|38122722|FG001|Overall Study|Adverse Event|0|||
16978841|NCT00844597|38122723|FG002|Overall Study|Adverse Event|0|||
16978842|NCT00844597|38122724|FG003|Overall Study|Adverse Event|1|||
16978843|NCT00844597|38122725|FG004|Overall Study|Adverse Event|0|||
16978844|NCT00844597|38122726|FG005|Overall Study|Adverse Event|0|||
16978845|NCT01017120|38122744|FG000|Overall Study|Adverse Event|9|||
16978846|NCT01017120|38122745|FG001|Overall Study|Adverse Event|0|||
16978847|NCT01017120|38122744|FG000|Overall Study|Lost to Follow-up|13|||
16978848|NCT01017120|38122745|FG001|Overall Study|Lost to Follow-up|11|||
16978849|NCT01017120|38122744|FG000|Overall Study|Lack of Efficacy|1|||
16978850|NCT01017120|38122745|FG001|Overall Study|Lack of Efficacy|0|||
16978851|NCT01017120|38122744|FG000|Overall Study|Withdrawal by Subject|39|||
16978852|NCT01017120|38122745|FG001|Overall Study|Withdrawal by Subject|21|||
16978853|NCT01017120|38122744|FG000|Overall Study|Pregnancy|1|||
16978854|NCT01017120|38122745|FG001|Overall Study|Pregnancy|1|||
16978855|NCT01017120|38122744|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
16978856|NCT01017120|38122745|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
16978857|NCT01017120|38122744|FG000|Overall Study|Relocated Out of Town|0|||
16978858|NCT01017120|38122745|FG001|Overall Study|Relocated Out of Town|2|||
16978859|NCT01017120|38122744|FG000|Overall Study|Protocol Violation|1|||
16978860|NCT01017120|38122745|FG001|Overall Study|Protocol Violation|0|||
16978861|NCT01017120|38122744|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
16978862|NCT01017120|38122745|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
16978863|NCT01016964|38122753|FG000|Overall Study|Lost to Follow-up|3|||
16978864|NCT01016964|38122754|FG001|Overall Study|Lost to Follow-up|3|||
16978865|NCT02996110|38122765|FG000|Pre-Treatment|Other Reasons|0|||
16978866|NCT02996110|38122766|FG001|Pre-Treatment|Other Reasons|1|||
16978867|NCT02996110|38122767|FG002|Pre-Treatment|Other Reasons|0|||
16978868|NCT02996110|38122768|FG003|Pre-Treatment|Other Reasons|0|||
16978869|NCT02996110|38122769|FG004|Pre-Treatment|Other Reasons|1|||
16978870|NCT02996110|38122765|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
16978871|NCT02996110|38122766|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
16978872|NCT02996110|38122767|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
16978873|NCT02996110|38122768|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
16978874|NCT02996110|38122769|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
16978875|NCT02996110|38122765|FG000|Track 1|Disease Progression|15|||
16978876|NCT02996110|38122766|FG001|Track 1|Disease Progression|17|||
16978877|NCT02996110|38122767|FG002|Track 1|Disease Progression|0|||
16978878|NCT02996110|38122768|FG003|Track 1|Disease Progression|0|||
16978879|NCT02996110|38122769|FG004|Track 1|Disease Progression|0|||
16978880|NCT02996110|38122765|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
16978881|NCT02996110|38122766|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
16978882|NCT02996110|38122767|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
16978883|NCT02996110|38122768|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
16978884|NCT02996110|38122769|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
16978885|NCT02996110|38122765|FG000|Track 1|Study Drug Toxicity|5|||
16978886|NCT02996110|38122766|FG001|Track 1|Study Drug Toxicity|3|||
16978887|NCT02996110|38122767|FG002|Track 1|Study Drug Toxicity|0|||
16978888|NCT02996110|38122768|FG003|Track 1|Study Drug Toxicity|0|||
16978889|NCT02996110|38122769|FG004|Track 1|Study Drug Toxicity|0|||
16978890|NCT02996110|38122765|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
16978891|NCT02996110|38122766|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
16978892|NCT02996110|38122767|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
16978893|NCT02996110|38122768|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
16978894|NCT02996110|38122769|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
16978895|NCT02996110|38122765|FG000|Track 1|Administrative Reason by Sponsor|0|||
16978896|NCT02996110|38122766|FG001|Track 1|Administrative Reason by Sponsor|1|||
16978897|NCT02996110|38122767|FG002|Track 1|Administrative Reason by Sponsor|0|||
16978898|NCT02996110|38122768|FG003|Track 1|Administrative Reason by Sponsor|0|||
16978899|NCT02996110|38122769|FG004|Track 1|Administrative Reason by Sponsor|0|||
16978900|NCT02996110|38122765|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
16978901|NCT02996110|38122766|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
16978902|NCT02996110|38122767|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
16978903|NCT02996110|38122768|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
16978904|NCT02996110|38122769|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
16978905|NCT02996110|38122765|FG000|Track 2|Disease Progression|33|||
16978906|NCT02996110|38122766|FG001|Track 2|Disease Progression|26|||
16978907|NCT02996110|38122767|FG002|Track 2|Disease Progression|19|||
16978908|NCT02996110|38122768|FG003|Track 2|Disease Progression|16|||
16978909|NCT02996110|38122769|FG004|Track 2|Disease Progression|15|||
16978910|NCT02996110|38122765|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
16978911|NCT02996110|38122766|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
16978912|NCT02996110|38122767|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
16978913|NCT02996110|38122768|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
16978914|NCT02996110|38122769|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
16978915|NCT02996110|38122765|FG000|Track 2|Death|0|||
16978916|NCT02996110|38122766|FG001|Track 2|Death|0|||
16978917|NCT02996110|38122767|FG002|Track 2|Death|1|||
16978918|NCT02996110|38122768|FG003|Track 2|Death|0|||
16978919|NCT02996110|38122769|FG004|Track 2|Death|1|||
16978920|NCT02996110|38122765|FG000|Track 2|Study Drug Toxicity|4|||
16978921|NCT02996110|38122766|FG001|Track 2|Study Drug Toxicity|1|||
16978922|NCT02996110|38122767|FG002|Track 2|Study Drug Toxicity|4|||
16978923|NCT02996110|38122768|FG003|Track 2|Study Drug Toxicity|1|||
16978924|NCT02996110|38122769|FG004|Track 2|Study Drug Toxicity|0|||
16978925|NCT02996110|38122765|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
16978926|NCT02996110|38122766|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
16978927|NCT02996110|38122767|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
16978928|NCT02996110|38122768|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
16978929|NCT02996110|38122769|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
16978930|NCT02996110|38122765|FG000|Track 2|Participant Withdrew Consent|1|||
16978931|NCT02996110|38122766|FG001|Track 2|Participant Withdrew Consent|2|||
16978932|NCT02996110|38122767|FG002|Track 2|Participant Withdrew Consent|3|||
16978933|NCT02996110|38122768|FG003|Track 2|Participant Withdrew Consent|1|||
16978934|NCT02996110|38122769|FG004|Track 2|Participant Withdrew Consent|1|||
16978935|NCT02996110|38122765|FG000|Track 2|Other Reasons|0|||
16978936|NCT02996110|38122766|FG001|Track 2|Other Reasons|0|||
16978937|NCT02996110|38122767|FG002|Track 2|Other Reasons|1|||
16978938|NCT02996110|38122768|FG003|Track 2|Other Reasons|0|||
16978939|NCT02996110|38122769|FG004|Track 2|Other Reasons|1|||
16978940|NCT00916617|38122787|FG000|Overall Study|Adverse Event|3|||
16978941|NCT00916617|38122788|FG001|Overall Study|Adverse Event|2|||
16978942|NCT00916617|38122789|FG002|Overall Study|Adverse Event|6|||
16978943|NCT00916617|38122790|FG003|Overall Study|Adverse Event|3|||
16978944|NCT00916617|38122787|FG000|Overall Study|Withdrawal by Subject|3|||
16978945|NCT00916617|38122788|FG001|Overall Study|Withdrawal by Subject|2|||
16978946|NCT00916617|38122789|FG002|Overall Study|Withdrawal by Subject|0|||
16780195|NCT01375049|37719297|FG000|Overall Study|Adverse Event|2|||
16978947|NCT00916617|38122790|FG003|Overall Study|Withdrawal by Subject|1|||
16978948|NCT00916617|38122787|FG000|Overall Study|Caregiver Request|3|||
16978949|NCT00916617|38122788|FG001|Overall Study|Caregiver Request|2|||
16978950|NCT00916617|38122789|FG002|Overall Study|Caregiver Request|1|||
16978951|NCT00916617|38122790|FG003|Overall Study|Caregiver Request|0|||
16978952|NCT00916617|38122787|FG000|Overall Study|Physician Decision|1|||
16978953|NCT00916617|38122788|FG001|Overall Study|Physician Decision|1|||
16978954|NCT00916617|38122789|FG002|Overall Study|Physician Decision|0|||
16978955|NCT00916617|38122790|FG003|Overall Study|Physician Decision|0|||
16978956|NCT00916617|38122787|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
16978957|NCT00916617|38122788|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
16978958|NCT00916617|38122789|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
16978959|NCT00916617|38122790|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
16978960|NCT00916617|38122787|FG000|Overall Study|Lost to Follow-up|2|||
16978961|NCT00916617|38122788|FG001|Overall Study|Lost to Follow-up|1|||
16978962|NCT00916617|38122789|FG002|Overall Study|Lost to Follow-up|0|||
16978963|NCT00916617|38122790|FG003|Overall Study|Lost to Follow-up|0|||
16978964|NCT00916617|38122787|FG000|Overall Study|Lack of Efficacy|1|||
16978965|NCT00916617|38122788|FG001|Overall Study|Lack of Efficacy|0|||
16978966|NCT00916617|38122789|FG002|Overall Study|Lack of Efficacy|0|||
16978967|NCT00916617|38122790|FG003|Overall Study|Lack of Efficacy|0|||
16978968|NCT00916617|38122787|FG000|Overall Study|Other|2|||
16978969|NCT00916617|38122788|FG001|Overall Study|Other|0|||
16978970|NCT00916617|38122789|FG002|Overall Study|Other|0|||
16978971|NCT00916617|38122790|FG003|Overall Study|Other|2|||
16978972|NCT01103063|38122802|FG000|Overall Study|Adverse Event|3|||
16978973|NCT01103063|38122803|FG001|Overall Study|Adverse Event|1|||
16978974|NCT01103063|38122802|FG000|Overall Study|Lost to Follow-up|68|||
16978975|NCT01103063|38122803|FG001|Overall Study|Lost to Follow-up|51|||
16978976|NCT01103063|38122802|FG000|Overall Study|Withdrawal by Subject|60|||
16978977|NCT01103063|38122803|FG001|Overall Study|Withdrawal by Subject|15|||
16978978|NCT01103063|38122802|FG000|Overall Study|Other|16|||
16978979|NCT01103063|38122803|FG001|Overall Study|Other|11|||
16978980|NCT01103063|38122802|FG000|Overall Study|Protocol Violation|1|||
16978981|NCT01103063|38122803|FG001|Overall Study|Protocol Violation|0|||
16978982|NCT01103063|38122802|FG000|Overall Study|Study terminated by Sponsor|326|||
16978983|NCT01103063|38122803|FG001|Overall Study|Study terminated by Sponsor|342|||
16978984|NCT01103063|38122802|FG000|Overall Study|Death|3|||
16978985|NCT01103063|38122803|FG001|Overall Study|Death|1|||
16978986|NCT01091675|38122811|FG000|Overall Study|Adverse Event|7|||
16978987|NCT01091675|38122811|FG000|Overall Study|Lack of Efficacy|27|||
16978988|NCT01091519|38122817|FG000|Overall Study|Adverse Event|12|||
16978989|NCT01091519|38122818|FG001|Overall Study|Adverse Event|16|||
16978990|NCT01091519|38122817|FG000|Overall Study|Death|1|||
16978991|NCT01091519|38122818|FG001|Overall Study|Death|0|||
16978992|NCT01091519|38122817|FG000|Overall Study|Lack of Efficacy|16|||
16978993|NCT01091519|38122818|FG001|Overall Study|Lack of Efficacy|19|||
16978994|NCT01091519|38122817|FG000|Overall Study|Lost to Follow-up|14|||
16978995|NCT01091519|38122818|FG001|Overall Study|Lost to Follow-up|24|||
16978996|NCT01091519|38122817|FG000|Overall Study|Withdrawal by Subject|2|||
16978997|NCT01091519|38122818|FG001|Overall Study|Withdrawal by Subject|2|||
16978998|NCT01091519|38122817|FG000|Overall Study|Other|6|||
16978999|NCT01091519|38122818|FG001|Overall Study|Other|8|||
16979000|NCT01091519|38122817|FG000|Overall Study|Randomized not treated|4|||
16979001|NCT01091519|38122818|FG001|Overall Study|Randomized not treated|4|||
16979002|NCT01011738|38122827|FG000|Overall Study|Death|12|||
16979003|NCT01011738|38122828|FG001|Overall Study|Death|3|||
16979004|NCT01011738|38122829|FG002|Overall Study|Death|0|||
16979005|NCT01011738|38122827|FG000|Overall Study|Unknown reasons|312|||
16979006|NCT01011738|38122828|FG001|Overall Study|Unknown reasons|291|||
16979007|NCT01011738|38122829|FG002|Overall Study|Unknown reasons|17|||
16979008|NCT00918333|38122840|FG000|Overall Study|Drug not taken per protocol|1|||
16979009|NCT00918333|38122841|FG001|Overall Study|Drug not taken per protocol|0|||
16979010|NCT00918333|38122840|FG000|Overall Study|Inadequate amount of drugs provided|1|||
16979011|NCT00918333|38122841|FG001|Overall Study|Inadequate amount of drugs provided|4|||
16979012|NCT00918333|38122840|FG000|Overall Study|Ineligible|1|||
16979013|NCT00918333|38122841|FG001|Overall Study|Ineligible|0|||
16979014|NCT00918333|38122840|FG000|Overall Study|Withdrawal by Subject|0|||
16979015|NCT00918333|38122841|FG001|Overall Study|Withdrawal by Subject|1|||
16979016|NCT01091363|38122852|FG000|Overall Study|Withdrawal by Subject|11|||
16979017|NCT01091363|38122853|FG001|Overall Study|Withdrawal by Subject|15|||
16979018|NCT01091363|38122852|FG000|Overall Study|Lost to Follow-up|2|||
16979019|NCT01091363|38122853|FG001|Overall Study|Lost to Follow-up|2|||
16979020|NCT01090973|38122859|FG000|Overall Study|Disease progression|1|||
16979021|NCT01090739|38122863|FG000|Enrollment|Withdrawal by Subject|24|||
16979022|NCT01090739|38122863|FG000|Enrollment|Protocol Violation|14|||
16979023|NCT01090739|38122863|FG000|Enrollment|Lost to Follow-up|5|||
16979024|NCT01090739|38122863|FG000|Enrollment|Physician Decision|5|||
16979025|NCT01090739|38122863|FG000|Enrollment|Sponsor termination of site|4|||
16979026|NCT01090739|38122863|FG000|Enrollment|Study implant limit reached|2|||
16979027|NCT01090739|38122863|FG000|Enrollment|Adverse Event|1|||
16979028|NCT01090739|38122863|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
16979029|NCT01090739|38122863|FG000|12 Month Follow-up|Lost to Follow-up|1|||
16979030|NCT01090739|38122863|FG000|12 Month Follow-up|Physician Decision|1|||
16979031|NCT01090739|38122863|FG000|12 Month Follow-up|Death|1|||
16979032|NCT01090739|38122863|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
16979033|NCT01090739|38122863|FG000|24 Month Follow-up|Lost to Follow-up|1|||
16979034|NCT01090739|38122863|FG000|24 Month Follow-up|Death|1|||
16979035|NCT01090739|38122863|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
16979036|NCT01090739|38122863|FG000|36 Month Follow-up|Visit still pending|17|||
16979037|NCT00916383|38122881|FG000|Overall Study|Adverse Event|1|||
16979038|NCT00916383|38122881|FG000|Overall Study|Death|1|||
16979039|NCT00916383|38122881|FG000|Overall Study|Protocol Violation|1|||
16979040|NCT00916305|38122891|FG000|Overall Study|Lost to Follow-up|21|||
16979041|NCT00916305|38122892|FG001|Overall Study|Lost to Follow-up|27|||
16979042|NCT00916305|38122891|FG000|Overall Study|Withdrawal by Subject|0|||
16979043|NCT00916305|38122892|FG001|Overall Study|Withdrawal by Subject|1|||
16979044|NCT00916149|38122901|FG000|Overall Study|Lost to Follow-up|3|||
16979045|NCT00916149|38122902|FG001|Overall Study|Lost to Follow-up|2|||
16979046|NCT00916149|38122903|FG002|Overall Study|Lost to Follow-up|0|||
16979047|NCT00916149|38122901|FG000|Overall Study|Unable to place scalp EEG leads|1|||
16979048|NCT00916149|38122902|FG001|Overall Study|Unable to place scalp EEG leads|0|||
16979049|NCT00916149|38122903|FG002|Overall Study|Unable to place scalp EEG leads|0|||
16979050|NCT01090427|38122913|FG000|After Controlled Period|Death|0|||
16979051|NCT01090427|38122914|FG001|After Controlled Period|Death|0|||
16979052|NCT01090427|38122915|FG002|After Controlled Period|Death|0|||
16979053|NCT01090427|38122916|FG003|After Controlled Period|Death|0|||
16979054|NCT01090427|38122917|FG004|After Controlled Period|Death|0|||
16979055|NCT01090427|38122918|FG005|After Controlled Period|Death|1|||
16979056|NCT01090427|38122919|FG006|After Controlled Period|Death|0|||
16979057|NCT01090427|38122913|FG000|After Controlled Period|Lack of Efficacy|0|||
16979058|NCT01090427|38122914|FG001|After Controlled Period|Lack of Efficacy|0|||
16979059|NCT01090427|38122915|FG002|After Controlled Period|Lack of Efficacy|0|||
16979060|NCT01090427|38122916|FG003|After Controlled Period|Lack of Efficacy|0|||
16979061|NCT01090427|38122917|FG004|After Controlled Period|Lack of Efficacy|0|||
16979062|NCT01090427|38122918|FG005|After Controlled Period|Lack of Efficacy|3|||
16979063|NCT01090427|38122919|FG006|After Controlled Period|Lack of Efficacy|2|||
16979064|NCT01090427|38122913|FG000|After Controlled Period|Adverse Event|0|||
16979065|NCT01090427|38122914|FG001|After Controlled Period|Adverse Event|0|||
16979066|NCT01090427|38122915|FG002|After Controlled Period|Adverse Event|0|||
16979067|NCT01090427|38122916|FG003|After Controlled Period|Adverse Event|2|||
16979068|NCT01090427|38122917|FG004|After Controlled Period|Adverse Event|0|||
16979069|NCT01090427|38122918|FG005|After Controlled Period|Adverse Event|1|||
16979070|NCT01090427|38122919|FG006|After Controlled Period|Adverse Event|0|||
16979071|NCT01016262|38122934|FG000|Double-blind Phase|Adverse Event|0|||
16979072|NCT01016262|38122935|FG001|Double-blind Phase|Adverse Event|0|||
16979073|NCT01016262|38122936|FG002|Double-blind Phase|Adverse Event|1|||
16979074|NCT01016262|38122937|FG003|Double-blind Phase|Adverse Event|0|||
16979075|NCT01016262|38122938|FG004|Double-blind Phase|Adverse Event|0|||
16979076|NCT01016262|38122939|FG005|Double-blind Phase|Adverse Event|0|||
16979077|NCT01016262|38122934|FG000|Double-blind Phase|Lack of Efficacy|1|||
16979078|NCT01016262|38122935|FG001|Double-blind Phase|Lack of Efficacy|0|||
16979079|NCT01016262|38122936|FG002|Double-blind Phase|Lack of Efficacy|5|||
16979080|NCT01016262|38122937|FG003|Double-blind Phase|Lack of Efficacy|0|||
16979081|NCT01016262|38122938|FG004|Double-blind Phase|Lack of Efficacy|0|||
16979082|NCT01016262|38122939|FG005|Double-blind Phase|Lack of Efficacy|0|||
16979083|NCT01016262|38122934|FG000|Double-blind Phase|Disease Progression|0|||
16979084|NCT01016262|38122935|FG001|Double-blind Phase|Disease Progression|1|||
16979085|NCT01016262|38122936|FG002|Double-blind Phase|Disease Progression|2|||
16979086|NCT01016262|38122937|FG003|Double-blind Phase|Disease Progression|0|||
16979087|NCT01016262|38122938|FG004|Double-blind Phase|Disease Progression|0|||
16979088|NCT01016262|38122939|FG005|Double-blind Phase|Disease Progression|0|||
16979089|NCT01016262|38122934|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
16979090|NCT01016262|38122935|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
16979091|NCT01016262|38122936|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
16979092|NCT01016262|38122937|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
16979093|NCT01016262|38122938|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
16979094|NCT01016262|38122939|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
16979095|NCT01016262|38122934|FG000|Open-Label Phase|Adverse Event|0|||
16979096|NCT01016262|38122935|FG001|Open-Label Phase|Adverse Event|0|||
16979097|NCT01016262|38122936|FG002|Open-Label Phase|Adverse Event|0|||
16979098|NCT01016262|38122937|FG003|Open-Label Phase|Adverse Event|1|||
16979099|NCT01016262|38122938|FG004|Open-Label Phase|Adverse Event|0|||
16979100|NCT01016262|38122939|FG005|Open-Label Phase|Adverse Event|0|||
16979101|NCT01016262|38122934|FG000|Open-Label Phase|Lost to Follow-up|0|||
16979102|NCT01016262|38122935|FG001|Open-Label Phase|Lost to Follow-up|0|||
16979103|NCT01016262|38122936|FG002|Open-Label Phase|Lost to Follow-up|0|||
16979104|NCT01016262|38122937|FG003|Open-Label Phase|Lost to Follow-up|0|||
16979105|NCT01016262|38122938|FG004|Open-Label Phase|Lost to Follow-up|1|||
16979106|NCT01016262|38122939|FG005|Open-Label Phase|Lost to Follow-up|0|||
16979107|NCT01016262|38122934|FG000|Open-Label Phase|Lack of Efficacy|0|||
16979108|NCT01016262|38122935|FG001|Open-Label Phase|Lack of Efficacy|0|||
16979109|NCT01016262|38122936|FG002|Open-Label Phase|Lack of Efficacy|0|||
16979110|NCT01016262|38122937|FG003|Open-Label Phase|Lack of Efficacy|1|||
16979111|NCT01016262|38122938|FG004|Open-Label Phase|Lack of Efficacy|0|||
16979112|NCT01016262|38122939|FG005|Open-Label Phase|Lack of Efficacy|0|||
16979113|NCT01016262|38122934|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
16979114|NCT01016262|38122935|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
16979115|NCT01016262|38122936|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
16979116|NCT01016262|38122937|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
16979117|NCT01016262|38122938|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
16979118|NCT01016262|38122939|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
16979119|NCT01001910|38122950|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
16979120|NCT01009554|38122956|FG000|Overall Study|Adverse Event|1|||
16979121|NCT01009554|38122957|FG001|Overall Study|Adverse Event|1|||
16979122|NCT01009554|38122956|FG000|Overall Study|Withdrawal by Subject|1|||
16979123|NCT01009554|38122957|FG001|Overall Study|Withdrawal by Subject|3|||
16979124|NCT01009554|38122956|FG000|Overall Study|Noncompliant with Study Product|0|||
16979125|NCT01009554|38122957|FG001|Overall Study|Noncompliant with Study Product|3|||
16979126|NCT01006590|38122965|FG000|Overall Study|Adverse Event|2|||
16979127|NCT01006590|38122966|FG001|Overall Study|Adverse Event|3|||
16979128|NCT01006590|38122965|FG000|Overall Study|Death|1|||
16979129|NCT01006590|38122966|FG001|Overall Study|Death|1|||
16979130|NCT01006590|38122965|FG000|Overall Study|Lost to Follow-up|1|||
16979131|NCT01006590|38122966|FG001|Overall Study|Lost to Follow-up|1|||
16979132|NCT01006590|38122965|FG000|Overall Study|Protocol Violation|1|||
16979133|NCT01006590|38122966|FG001|Overall Study|Protocol Violation|0|||
16979134|NCT01006590|38122965|FG000|Overall Study|Withdrawal by Subject|4|||
16979135|NCT01006590|38122966|FG001|Overall Study|Withdrawal by Subject|2|||
16979136|NCT01006590|38122965|FG000|Overall Study|Study specific discontinuation criteria|16|||
16979137|NCT01006590|38122966|FG001|Overall Study|Study specific discontinuation criteria|23|||
16979138|NCT01006590|38122965|FG000|Overall Study|Other|3|||
16979139|NCT01006590|38122966|FG001|Overall Study|Other|2|||
16979140|NCT01001832|38122974|FG000|Short-term Period|Adverse Event|2|||
16979141|NCT01001832|38122975|FG001|Short-term Period|Adverse Event|3|||
16979142|NCT01001832|38122974|FG000|Long-term Period|Adverse Event|2|||
16979143|NCT01001832|38122975|FG001|Long-term Period|Adverse Event|1|||
16979144|NCT01001832|38122974|FG000|Long-term Period|Withdrawal by Subject|1|||
16979145|NCT01001832|38122975|FG001|Long-term Period|Withdrawal by Subject|0|||
16979146|NCT01001832|38122974|FG000|Long-term Period|Lack of Efficacy|0|||
16979147|NCT01001832|38122975|FG001|Long-term Period|Lack of Efficacy|2|||
16979148|NCT01001832|38122974|FG000|Long-term Period|Other|1|||
16979149|NCT01001832|38122975|FG001|Long-term Period|Other|2|||
16979150|NCT01001832|38122974|FG000|Follow-up Period|Withdrawal by Subject|1|||
16979151|NCT01001832|38122975|FG001|Follow-up Period|Withdrawal by Subject|0|||
16979152|NCT01001832|38122974|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
16979153|NCT01001832|38122975|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
16979154|NCT01001832|38122974|FG000|Follow-up Period|Other|2|||
16979155|NCT01001832|38122975|FG001|Follow-up Period|Other|1|||
16979156|NCT01001598|38122984|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
16979157|NCT01001598|38122984|FG000|Overall Study|Adverse Event|1|||
16979158|NCT01006356|38122988|FG000|Overall Study|Adverse Event|6|||
16979159|NCT01006356|38122988|FG000|Overall Study|Physician Decision|1|||
16979160|NCT01006356|38122988|FG000|Overall Study|Paticipants did not cooperate|6|||
16979161|NCT01006356|38122988|FG000|Overall Study|Withdrawal by Subject|1|||
16979162|NCT01006356|38122988|FG000|Overall Study|Choice by participants|2|||
16979163|NCT01006356|38122988|FG000|Overall Study|Protocol Violation|3|||
16979164|NCT01006356|38122988|FG000|Overall Study|Other|23|||
16979165|NCT01089725|38122997|FG000|Overall Study|Adverse Event|1|||
16979166|NCT01089725|38122998|FG001|Overall Study|Adverse Event|1|||
16979167|NCT01089725|38122999|FG002|Overall Study|Adverse Event|0|||
16979168|NCT01089725|38123000|FG003|Overall Study|Adverse Event|0|||
16979169|NCT01089725|38123001|FG004|Overall Study|Adverse Event|2|||
16979170|NCT01089725|38122997|FG000|Overall Study|Lack of Efficacy|4|||
16979171|NCT01089725|38122998|FG001|Overall Study|Lack of Efficacy|3|||
16979172|NCT01089725|38122999|FG002|Overall Study|Lack of Efficacy|1|||
16979173|NCT01089725|38123000|FG003|Overall Study|Lack of Efficacy|0|||
16979174|NCT01089725|38123001|FG004|Overall Study|Lack of Efficacy|4|||
16979175|NCT01089725|38122997|FG000|Overall Study|Lost to Follow-up|2|||
16979176|NCT01089725|38122998|FG001|Overall Study|Lost to Follow-up|2|||
16979177|NCT01089725|38122999|FG002|Overall Study|Lost to Follow-up|0|||
16979178|NCT01089725|38123000|FG003|Overall Study|Lost to Follow-up|3|||
16979179|NCT01089725|38123001|FG004|Overall Study|Lost to Follow-up|0|||
16979180|NCT01089725|38122997|FG000|Overall Study|Protocol Violation|0|||
16979181|NCT01089725|38122998|FG001|Overall Study|Protocol Violation|0|||
16979182|NCT01089725|38122999|FG002|Overall Study|Protocol Violation|1|||
16979183|NCT01089725|38123000|FG003|Overall Study|Protocol Violation|1|||
16979184|NCT01089725|38123001|FG004|Overall Study|Protocol Violation|0|||
16979185|NCT01089725|38122997|FG000|Overall Study|Withdrawal by Subject|5|||
16979186|NCT01089725|38122998|FG001|Overall Study|Withdrawal by Subject|5|||
16979187|NCT01089725|38122999|FG002|Overall Study|Withdrawal by Subject|4|||
16979188|NCT01089725|38123000|FG003|Overall Study|Withdrawal by Subject|5|||
16979189|NCT01089725|38123001|FG004|Overall Study|Withdrawal by Subject|4|||
16979190|NCT01089725|38122997|FG000|Overall Study|Study Terminated by Sponsor|51|||
16979191|NCT01089725|38122998|FG001|Overall Study|Study Terminated by Sponsor|56|||
16979192|NCT01089725|38122999|FG002|Overall Study|Study Terminated by Sponsor|53|||
16979193|NCT01089725|38123000|FG003|Overall Study|Study Terminated by Sponsor|68|||
16979194|NCT01089725|38123001|FG004|Overall Study|Study Terminated by Sponsor|68|||
16979195|NCT01089725|38122997|FG000|Overall Study|Randomized, but not treated|0|||
16979196|NCT01089725|38122998|FG001|Overall Study|Randomized, but not treated|1|||
16979197|NCT01089725|38122999|FG002|Overall Study|Randomized, but not treated|2|||
16979198|NCT01089725|38123000|FG003|Overall Study|Randomized, but not treated|1|||
16979199|NCT01089725|38123001|FG004|Overall Study|Randomized, but not treated|2|||
16979200|NCT01089725|38122997|FG000|Overall Study|Other|3|||
16979201|NCT01089725|38122998|FG001|Overall Study|Other|0|||
16979202|NCT01089725|38122999|FG002|Overall Study|Other|0|||
16979203|NCT01089725|38123000|FG003|Overall Study|Other|1|||
16979204|NCT01089725|38123001|FG004|Overall Study|Other|0|||
16979205|NCT01190930|38123019|FG000|Induction|Adverse Event|17|||
16979206|NCT01190930|38123020|FG001|Induction|Adverse Event|0|||
16979207|NCT01190930|38123021|FG002|Induction|Adverse Event|0|||
16979208|NCT01190930|38123022|FG003|Induction|Adverse Event|0|||
16979209|NCT01190930|38123023|FG004|Induction|Adverse Event|0|||
16979210|NCT01190930|38123024|FG005|Induction|Adverse Event|0|||
16979211|NCT01190930|38123025|FG006|Induction|Adverse Event|0|||
16979212|NCT01190930|38123026|FG007|Induction|Adverse Event|0|||
16979213|NCT01190930|38123027|FG008|Induction|Adverse Event|0|||
16979214|NCT01190930|38123028|FG009|Induction|Adverse Event|0|||
16979215|NCT01190930|38123019|FG000|Induction|Death|34|||
16979216|NCT01190930|38123020|FG001|Induction|Death|0|||
16979217|NCT01190930|38123021|FG002|Induction|Death|0|||
16979218|NCT01190930|38123022|FG003|Induction|Death|0|||
16979219|NCT01190930|38123023|FG004|Induction|Death|0|||
16979220|NCT01190930|38123024|FG005|Induction|Death|0|||
16979221|NCT01190930|38123025|FG006|Induction|Death|0|||
16979222|NCT01190930|38123026|FG007|Induction|Death|0|||
16979223|NCT01190930|38123027|FG008|Induction|Death|0|||
16979224|NCT01190930|38123028|FG009|Induction|Death|0|||
16979225|NCT01190930|38123019|FG000|Induction|Lost to Follow-up|1|||
16979226|NCT01190930|38123020|FG001|Induction|Lost to Follow-up|0|||
16979227|NCT01190930|38123021|FG002|Induction|Lost to Follow-up|0|||
16979228|NCT01190930|38123022|FG003|Induction|Lost to Follow-up|0|||
16979229|NCT01190930|38123023|FG004|Induction|Lost to Follow-up|0|||
16979230|NCT01190930|38123024|FG005|Induction|Lost to Follow-up|0|||
16979231|NCT01190930|38123025|FG006|Induction|Lost to Follow-up|0|||
16979232|NCT01190930|38123026|FG007|Induction|Lost to Follow-up|0|||
16979233|NCT01190930|38123027|FG008|Induction|Lost to Follow-up|0|||
16979234|NCT01190930|38123028|FG009|Induction|Lost to Follow-up|0|||
16979235|NCT01190930|38123019|FG000|Induction|Physician Decision|125|||
16979236|NCT01190930|38123020|FG001|Induction|Physician Decision|3|||
16979237|NCT01190930|38123021|FG002|Induction|Physician Decision|0|||
16979238|NCT01190930|38123022|FG003|Induction|Physician Decision|0|||
16979239|NCT01190930|38123023|FG004|Induction|Physician Decision|0|||
16979240|NCT01190930|38123024|FG005|Induction|Physician Decision|0|||
16979241|NCT01190930|38123025|FG006|Induction|Physician Decision|0|||
16979242|NCT01190930|38123026|FG007|Induction|Physician Decision|0|||
16979243|NCT01190930|38123027|FG008|Induction|Physician Decision|0|||
16979244|NCT01190930|38123028|FG009|Induction|Physician Decision|0|||
16979245|NCT01190930|38123019|FG000|Induction|Withdrawal by Subject|9|||
16979246|NCT01190930|38123020|FG001|Induction|Withdrawal by Subject|0|||
16979247|NCT01190930|38123021|FG002|Induction|Withdrawal by Subject|0|||
16979248|NCT01190930|38123022|FG003|Induction|Withdrawal by Subject|0|||
16979249|NCT01190930|38123023|FG004|Induction|Withdrawal by Subject|0|||
16979250|NCT01190930|38123024|FG005|Induction|Withdrawal by Subject|0|||
16979251|NCT01190930|38123025|FG006|Induction|Withdrawal by Subject|0|||
16979252|NCT01190930|38123026|FG007|Induction|Withdrawal by Subject|0|||
16979253|NCT01190930|38123027|FG008|Induction|Withdrawal by Subject|0|||
16979254|NCT01190930|38123028|FG009|Induction|Withdrawal by Subject|0|||
16979255|NCT01190930|38123019|FG000|Induction|Refusal|235|||
16979256|NCT01190930|38123020|FG001|Induction|Refusal|0|||
16979257|NCT01190930|38123021|FG002|Induction|Refusal|0|||
16979258|NCT01190930|38123022|FG003|Induction|Refusal|0|||
16979259|NCT01190930|38123023|FG004|Induction|Refusal|0|||
16979260|NCT01190930|38123024|FG005|Induction|Refusal|0|||
16979261|NCT01190930|38123025|FG006|Induction|Refusal|0|||
16979262|NCT01190930|38123026|FG007|Induction|Refusal|0|||
16979263|NCT01190930|38123027|FG008|Induction|Refusal|0|||
16979264|NCT01190930|38123028|FG009|Induction|Refusal|0|||
16979265|NCT01190930|38123019|FG000|Induction|Inevaluable|23|||
16979266|NCT01190930|38123020|FG001|Induction|Inevaluable|1|||
16979267|NCT01190930|38123021|FG002|Induction|Inevaluable|0|||
16979268|NCT01190930|38123022|FG003|Induction|Inevaluable|0|||
16979269|NCT01190930|38123023|FG004|Induction|Inevaluable|0|||
16979270|NCT01190930|38123024|FG005|Induction|Inevaluable|0|||
16979271|NCT01190930|38123025|FG006|Induction|Inevaluable|0|||
16979272|NCT01190930|38123026|FG007|Induction|Inevaluable|0|||
16979273|NCT01190930|38123027|FG008|Induction|Inevaluable|0|||
16979274|NCT01190930|38123028|FG009|Induction|Inevaluable|0|||
16979275|NCT01190930|38123019|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
16979276|NCT01190930|38123020|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979277|NCT01190930|38123021|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979278|NCT01190930|38123022|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979279|NCT01190930|38123023|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979280|NCT01190930|38123024|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979281|NCT01190930|38123025|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979282|NCT01190930|38123026|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979283|NCT01190930|38123027|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979284|NCT01190930|38123028|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16979285|NCT01190930|38123019|FG000|Induction|High Risk Downs|80|||
16979286|NCT01190930|38123020|FG001|Induction|High Risk Downs|0|||
16979287|NCT01190930|38123021|FG002|Induction|High Risk Downs|0|||
16979288|NCT01190930|38123022|FG003|Induction|High Risk Downs|0|||
16979289|NCT01190930|38123023|FG004|Induction|High Risk Downs|0|||
16979290|NCT01190930|38123024|FG005|Induction|High Risk Downs|0|||
16979291|NCT01190930|38123025|FG006|Induction|High Risk Downs|0|||
16979292|NCT01190930|38123026|FG007|Induction|High Risk Downs|0|||
16979293|NCT01190930|38123027|FG008|Induction|High Risk Downs|0|||
16979294|NCT01190930|38123028|FG009|Induction|High Risk Downs|0|||
16979295|NCT01190930|38123019|FG000|Induction|Enrollment onto another COG Protocol|1|||
16979296|NCT01190930|38123020|FG001|Induction|Enrollment onto another COG Protocol|0|||
16979297|NCT01190930|38123021|FG002|Induction|Enrollment onto another COG Protocol|0|||
16979298|NCT01190930|38123022|FG003|Induction|Enrollment onto another COG Protocol|0|||
16979299|NCT01190930|38123023|FG004|Induction|Enrollment onto another COG Protocol|0|||
16979300|NCT01190930|38123024|FG005|Induction|Enrollment onto another COG Protocol|0|||
16979301|NCT01190930|38123025|FG006|Induction|Enrollment onto another COG Protocol|0|||
16979302|NCT01190930|38123026|FG007|Induction|Enrollment onto another COG Protocol|0|||
16979303|NCT01190930|38123027|FG008|Induction|Enrollment onto another COG Protocol|0|||
16979304|NCT01190930|38123028|FG009|Induction|Enrollment onto another COG Protocol|0|||
16979305|NCT01190930|38123019|FG000|Induction|Average Risk|1847|||
16979306|NCT01190930|38123020|FG001|Induction|Average Risk|0|||
16979307|NCT01190930|38123021|FG002|Induction|Average Risk|0|||
16979308|NCT01190930|38123022|FG003|Induction|Average Risk|0|||
16979309|NCT01190930|38123023|FG004|Induction|Average Risk|0|||
16979310|NCT01190930|38123024|FG005|Induction|Average Risk|0|||
16979311|NCT01190930|38123025|FG006|Induction|Average Risk|0|||
16979312|NCT01190930|38123026|FG007|Induction|Average Risk|0|||
16979313|NCT01190930|38123027|FG008|Induction|Average Risk|0|||
16979314|NCT01190930|38123028|FG009|Induction|Average Risk|0|||
16979315|NCT01190930|38123019|FG000|Induction|High Risk|1227|||
16979316|NCT01190930|38123020|FG001|Induction|High Risk|0|||
16979317|NCT01190930|38123021|FG002|Induction|High Risk|0|||
16979318|NCT01190930|38123022|FG003|Induction|High Risk|0|||
16979319|NCT01190930|38123023|FG004|Induction|High Risk|0|||
16979320|NCT01190930|38123024|FG005|Induction|High Risk|0|||
16979321|NCT01190930|38123025|FG006|Induction|High Risk|0|||
16979322|NCT01190930|38123026|FG007|Induction|High Risk|0|||
16979323|NCT01190930|38123027|FG008|Induction|High Risk|0|||
16979324|NCT01190930|38123028|FG009|Induction|High Risk|0|||
16979325|NCT01190930|38123019|FG000|Induction|Low Risk|443|||
16979326|NCT01190930|38123020|FG001|Induction|Low Risk|0|||
16979327|NCT01190930|38123021|FG002|Induction|Low Risk|0|||
16979328|NCT01190930|38123022|FG003|Induction|Low Risk|0|||
16979329|NCT01190930|38123023|FG004|Induction|Low Risk|0|||
16979330|NCT01190930|38123024|FG005|Induction|Low Risk|0|||
16979331|NCT01190930|38123025|FG006|Induction|Low Risk|0|||
16979332|NCT01190930|38123026|FG007|Induction|Low Risk|0|||
16979333|NCT01190930|38123027|FG008|Induction|Low Risk|0|||
16979334|NCT01190930|38123028|FG009|Induction|Low Risk|0|||
16979335|NCT01190930|38123019|FG000|Induction|Very High Risk|1012|||
16979336|NCT01190930|38123020|FG001|Induction|Very High Risk|0|||
16979337|NCT01190930|38123021|FG002|Induction|Very High Risk|0|||
16979338|NCT01190930|38123022|FG003|Induction|Very High Risk|0|||
16979339|NCT01190930|38123023|FG004|Induction|Very High Risk|0|||
16979340|NCT01190930|38123024|FG005|Induction|Very High Risk|0|||
16979341|NCT01190930|38123025|FG006|Induction|Very High Risk|0|||
16979342|NCT01190930|38123026|FG007|Induction|Very High Risk|0|||
16979343|NCT01190930|38123027|FG008|Induction|Very High Risk|0|||
16979344|NCT01190930|38123028|FG009|Induction|Very High Risk|0|||
16979345|NCT01190930|38123019|FG000|Induction|Philadelphia chromosome-positive|99|||
16979346|NCT01190930|38123020|FG001|Induction|Philadelphia chromosome-positive|0|||
16979347|NCT01190930|38123021|FG002|Induction|Philadelphia chromosome-positive|0|||
16979348|NCT01190930|38123022|FG003|Induction|Philadelphia chromosome-positive|0|||
16979349|NCT01190930|38123023|FG004|Induction|Philadelphia chromosome-positive|0|||
16979350|NCT01190930|38123024|FG005|Induction|Philadelphia chromosome-positive|0|||
16979351|NCT01190930|38123025|FG006|Induction|Philadelphia chromosome-positive|0|||
16979352|NCT01190930|38123026|FG007|Induction|Philadelphia chromosome-positive|0|||
16979353|NCT01190930|38123027|FG008|Induction|Philadelphia chromosome-positive|0|||
16979354|NCT01190930|38123028|FG009|Induction|Philadelphia chromosome-positive|0|||
16979355|NCT01190930|38123019|FG000|Induction|Incomplete Induction data|63|||
16979356|NCT01190930|38123020|FG001|Induction|Incomplete Induction data|0|||
16979357|NCT01190930|38123021|FG002|Induction|Incomplete Induction data|0|||
16979358|NCT01190930|38123022|FG003|Induction|Incomplete Induction data|0|||
16979359|NCT01190930|38123023|FG004|Induction|Incomplete Induction data|0|||
16979360|NCT01190930|38123024|FG005|Induction|Incomplete Induction data|0|||
16979361|NCT01190930|38123025|FG006|Induction|Incomplete Induction data|0|||
16979362|NCT01190930|38123026|FG007|Induction|Incomplete Induction data|0|||
16979363|NCT01190930|38123027|FG008|Induction|Incomplete Induction data|0|||
16979364|NCT01190930|38123028|FG009|Induction|Incomplete Induction data|0|||
16979365|NCT01190930|38123019|FG000|Induction|Progressive disease|0|||
16979366|NCT01190930|38123020|FG001|Induction|Progressive disease|1|||
16979367|NCT01190930|38123021|FG002|Induction|Progressive disease|0|||
16979368|NCT01190930|38123022|FG003|Induction|Progressive disease|0|||
16979369|NCT01190930|38123023|FG004|Induction|Progressive disease|0|||
16979370|NCT01190930|38123024|FG005|Induction|Progressive disease|0|||
16979371|NCT01190930|38123025|FG006|Induction|Progressive disease|0|||
16979372|NCT01190930|38123026|FG007|Induction|Progressive disease|0|||
16979373|NCT01190930|38123027|FG008|Induction|Progressive disease|0|||
16979374|NCT01190930|38123028|FG009|Induction|Progressive disease|0|||
16979375|NCT01190930|38123019|FG000|Induction|No treatment|3|||
16979376|NCT01190930|38123020|FG001|Induction|No treatment|0|||
16979377|NCT01190930|38123021|FG002|Induction|No treatment|0|||
16979378|NCT01190930|38123022|FG003|Induction|No treatment|0|||
16979379|NCT01190930|38123023|FG004|Induction|No treatment|0|||
16979380|NCT01190930|38123024|FG005|Induction|No treatment|0|||
16979381|NCT01190930|38123025|FG006|Induction|No treatment|0|||
16979382|NCT01190930|38123026|FG007|Induction|No treatment|0|||
16979383|NCT01190930|38123027|FG008|Induction|No treatment|0|||
16979384|NCT01190930|38123028|FG009|Induction|No treatment|0|||
16979385|NCT01190930|38123019|FG000|Induction|Ineligible|69|||
16979386|NCT01190930|38123020|FG001|Induction|Ineligible|4|||
16979387|NCT01190930|38123021|FG002|Induction|Ineligible|0|||
16979388|NCT01190930|38123022|FG003|Induction|Ineligible|0|||
16979389|NCT01190930|38123023|FG004|Induction|Ineligible|0|||
16979390|NCT01190930|38123024|FG005|Induction|Ineligible|0|||
16979391|NCT01190930|38123025|FG006|Induction|Ineligible|0|||
16979392|NCT01190930|38123026|FG007|Induction|Ineligible|0|||
16979393|NCT01190930|38123027|FG008|Induction|Ineligible|0|||
16979394|NCT01190930|38123028|FG009|Induction|Ineligible|0|||
16979395|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
16979396|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
16979397|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
16979398|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
16979399|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
16979400|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
16979401|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
16979402|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
16979403|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
16979404|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
16979405|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|Death|0|||
16979406|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|Death|0|||
16979407|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|Death|8|||
16979408|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|Death|4|||
16979409|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|Death|0|||
16979410|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|Death|0|||
16979411|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|Death|0|||
16979412|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|Death|0|||
16979413|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|Death|0|||
16979414|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|Death|0|||
16979415|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
16979416|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
16979417|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
16979418|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
17134043|NCT02095132|38275294|FG001|Overall Study|Physician Decision|0|||
16979419|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
16979420|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
16979421|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
16979422|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
16979423|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
16979424|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
16979425|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16979426|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
16979427|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
16979428|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
16979429|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16979430|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16979431|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16979432|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16979433|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16979434|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16979435|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|Refusal|0|||
16979436|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|Refusal|2|||
16979437|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|Refusal|694|||
16979438|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|Refusal|4|||
16979439|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|Refusal|0|||
16979440|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|Refusal|3|||
16979441|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|Refusal|0|||
16979442|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|Refusal|0|||
16979443|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|Refusal|0|||
16979444|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|Refusal|0|||
16979445|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
16979446|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
16979447|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
16979448|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
16979449|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
16979450|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
16979451|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
16979452|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
16979453|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
16979454|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
16979455|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979456|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
16979457|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979458|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979459|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979460|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979461|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979462|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979463|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979464|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16979465|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
16979466|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
16979467|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
16979468|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
16979469|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
16979470|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
16979471|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
16979472|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
16979473|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
16979474|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
16979475|NCT01190930|38123019|FG000|Post Induction Pre-Maintenance|Relapse|0|||
16979476|NCT01190930|38123020|FG001|Post Induction Pre-Maintenance|Relapse|0|||
16979477|NCT01190930|38123021|FG002|Post Induction Pre-Maintenance|Relapse|1|||
16979478|NCT01190930|38123022|FG003|Post Induction Pre-Maintenance|Relapse|0|||
16979479|NCT01190930|38123023|FG004|Post Induction Pre-Maintenance|Relapse|0|||
16979480|NCT01190930|38123024|FG005|Post Induction Pre-Maintenance|Relapse|0|||
16979481|NCT01190930|38123025|FG006|Post Induction Pre-Maintenance|Relapse|0|||
16979482|NCT01190930|38123026|FG007|Post Induction Pre-Maintenance|Relapse|0|||
16979483|NCT01190930|38123027|FG008|Post Induction Pre-Maintenance|Relapse|0|||
16979484|NCT01190930|38123028|FG009|Post Induction Pre-Maintenance|Relapse|0|||
16979485|NCT01190930|38123019|FG000|Maintenance|Adverse Event|0|||
16979486|NCT01190930|38123020|FG001|Maintenance|Adverse Event|0|||
16979487|NCT01190930|38123021|FG002|Maintenance|Adverse Event|0|||
16979488|NCT01190930|38123022|FG003|Maintenance|Adverse Event|0|||
16979489|NCT01190930|38123023|FG004|Maintenance|Adverse Event|0|||
16979490|NCT01190930|38123024|FG005|Maintenance|Adverse Event|1|||
16979491|NCT01190930|38123025|FG006|Maintenance|Adverse Event|1|||
16979492|NCT01190930|38123026|FG007|Maintenance|Adverse Event|3|||
16979493|NCT01190930|38123027|FG008|Maintenance|Adverse Event|3|||
16979494|NCT01190930|38123028|FG009|Maintenance|Adverse Event|0|||
16979495|NCT01190930|38123019|FG000|Maintenance|Death|0|||
16979496|NCT01190930|38123020|FG001|Maintenance|Death|0|||
16979497|NCT01190930|38123021|FG002|Maintenance|Death|0|||
16979498|NCT01190930|38123022|FG003|Maintenance|Death|1|||
16979499|NCT01190930|38123023|FG004|Maintenance|Death|0|||
16979500|NCT01190930|38123024|FG005|Maintenance|Death|0|||
16979501|NCT01190930|38123025|FG006|Maintenance|Death|2|||
16979502|NCT01190930|38123026|FG007|Maintenance|Death|2|||
16979503|NCT01190930|38123027|FG008|Maintenance|Death|2|||
16979504|NCT01190930|38123028|FG009|Maintenance|Death|2|||
16979505|NCT01190930|38123019|FG000|Maintenance|Lost to Follow-up|0|||
16979506|NCT01190930|38123020|FG001|Maintenance|Lost to Follow-up|0|||
16979507|NCT01190930|38123021|FG002|Maintenance|Lost to Follow-up|0|||
16979508|NCT01190930|38123022|FG003|Maintenance|Lost to Follow-up|0|||
16979509|NCT01190930|38123023|FG004|Maintenance|Lost to Follow-up|0|||
16979510|NCT01190930|38123024|FG005|Maintenance|Lost to Follow-up|0|||
16979511|NCT01190930|38123025|FG006|Maintenance|Lost to Follow-up|1|||
16979512|NCT01190930|38123026|FG007|Maintenance|Lost to Follow-up|1|||
16979513|NCT01190930|38123027|FG008|Maintenance|Lost to Follow-up|1|||
16979514|NCT01190930|38123028|FG009|Maintenance|Lost to Follow-up|0|||
16979515|NCT01190930|38123019|FG000|Maintenance|Physician Decision|0|||
16979516|NCT01190930|38123020|FG001|Maintenance|Physician Decision|1|||
16979517|NCT01190930|38123021|FG002|Maintenance|Physician Decision|0|||
16979518|NCT01190930|38123022|FG003|Maintenance|Physician Decision|5|||
16979519|NCT01190930|38123023|FG004|Maintenance|Physician Decision|9|||
16979520|NCT01190930|38123024|FG005|Maintenance|Physician Decision|4|||
16979521|NCT01190930|38123025|FG006|Maintenance|Physician Decision|8|||
16979522|NCT01190930|38123026|FG007|Maintenance|Physician Decision|8|||
16979523|NCT01190930|38123027|FG008|Maintenance|Physician Decision|10|||
16979524|NCT01190930|38123028|FG009|Maintenance|Physician Decision|17|||
16979525|NCT01190930|38123019|FG000|Maintenance|Withdrawal by Subject|0|||
16979526|NCT01190930|38123020|FG001|Maintenance|Withdrawal by Subject|0|||
16979527|NCT01190930|38123021|FG002|Maintenance|Withdrawal by Subject|0|||
16979528|NCT01190930|38123022|FG003|Maintenance|Withdrawal by Subject|0|||
16979529|NCT01190930|38123023|FG004|Maintenance|Withdrawal by Subject|0|||
16979530|NCT01190930|38123024|FG005|Maintenance|Withdrawal by Subject|0|||
16979531|NCT01190930|38123025|FG006|Maintenance|Withdrawal by Subject|2|||
16979532|NCT01190930|38123026|FG007|Maintenance|Withdrawal by Subject|1|||
16979533|NCT01190930|38123027|FG008|Maintenance|Withdrawal by Subject|4|||
16979534|NCT01190930|38123028|FG009|Maintenance|Withdrawal by Subject|1|||
16979535|NCT01190930|38123019|FG000|Maintenance|Refusal|0|||
16979536|NCT01190930|38123020|FG001|Maintenance|Refusal|1|||
16979537|NCT01190930|38123021|FG002|Maintenance|Refusal|0|||
16979538|NCT01190930|38123022|FG003|Maintenance|Refusal|2|||
16979539|NCT01190930|38123023|FG004|Maintenance|Refusal|0|||
16979540|NCT01190930|38123024|FG005|Maintenance|Refusal|4|||
16979541|NCT01190930|38123025|FG006|Maintenance|Refusal|5|||
16979542|NCT01190930|38123026|FG007|Maintenance|Refusal|17|||
16979543|NCT01190930|38123027|FG008|Maintenance|Refusal|13|||
16979544|NCT01190930|38123028|FG009|Maintenance|Refusal|6|||
16979545|NCT01190930|38123019|FG000|Maintenance|second malignant neoplasm|0|||
16979546|NCT01190930|38123020|FG001|Maintenance|second malignant neoplasm|0|||
16979547|NCT01190930|38123021|FG002|Maintenance|second malignant neoplasm|0|||
16979548|NCT01190930|38123022|FG003|Maintenance|second malignant neoplasm|1|||
16979549|NCT01190930|38123023|FG004|Maintenance|second malignant neoplasm|0|||
16979550|NCT01190930|38123024|FG005|Maintenance|second malignant neoplasm|1|||
16979551|NCT01190930|38123025|FG006|Maintenance|second malignant neoplasm|0|||
16979552|NCT01190930|38123026|FG007|Maintenance|second malignant neoplasm|0|||
16979553|NCT01190930|38123027|FG008|Maintenance|second malignant neoplasm|1|||
16979554|NCT01190930|38123028|FG009|Maintenance|second malignant neoplasm|0|||
16979555|NCT01190930|38123019|FG000|Maintenance|Inevaluable|0|||
16979556|NCT01190930|38123020|FG001|Maintenance|Inevaluable|0|||
16979557|NCT01190930|38123021|FG002|Maintenance|Inevaluable|0|||
16979558|NCT01190930|38123022|FG003|Maintenance|Inevaluable|0|||
16979559|NCT01190930|38123023|FG004|Maintenance|Inevaluable|0|||
16979560|NCT01190930|38123024|FG005|Maintenance|Inevaluable|1|||
16979561|NCT01190930|38123025|FG006|Maintenance|Inevaluable|1|||
16979562|NCT01190930|38123026|FG007|Maintenance|Inevaluable|1|||
16979563|NCT01190930|38123027|FG008|Maintenance|Inevaluable|0|||
16979564|NCT01190930|38123028|FG009|Maintenance|Inevaluable|0|||
16979565|NCT01190930|38123019|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
16979566|NCT01190930|38123020|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
16979567|NCT01190930|38123021|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
16979568|NCT01190930|38123022|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
16979569|NCT01190930|38123023|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
16979570|NCT01190930|38123024|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
16979571|NCT01190930|38123025|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
16979572|NCT01190930|38123026|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
16979573|NCT01190930|38123027|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
16979574|NCT01190930|38123028|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
16979575|NCT01190930|38123019|FG000|Maintenance|Relapse|0|||
16979576|NCT01190930|38123020|FG001|Maintenance|Relapse|0|||
16979577|NCT01190930|38123021|FG002|Maintenance|Relapse|0|||
16979578|NCT01190930|38123022|FG003|Maintenance|Relapse|2|||
16979579|NCT01190930|38123023|FG004|Maintenance|Relapse|0|||
16979580|NCT01190930|38123024|FG005|Maintenance|Relapse|1|||
16979581|NCT01190930|38123025|FG006|Maintenance|Relapse|6|||
16979582|NCT01190930|38123026|FG007|Maintenance|Relapse|13|||
16979583|NCT01190930|38123027|FG008|Maintenance|Relapse|11|||
16979584|NCT01190930|38123028|FG009|Maintenance|Relapse|11|||
16979585|NCT01190930|38123019|FG000|Maintenance|Still on therapy|0|||
16979586|NCT01190930|38123020|FG001|Maintenance|Still on therapy|8|||
16979587|NCT01190930|38123021|FG002|Maintenance|Still on therapy|0|||
16979588|NCT01190930|38123022|FG003|Maintenance|Still on therapy|29|||
16979589|NCT01190930|38123023|FG004|Maintenance|Still on therapy|0|||
16979590|NCT01190930|38123024|FG005|Maintenance|Still on therapy|0|||
16979591|NCT01190930|38123025|FG006|Maintenance|Still on therapy|0|||
16979592|NCT01190930|38123026|FG007|Maintenance|Still on therapy|0|||
16979593|NCT01190930|38123027|FG008|Maintenance|Still on therapy|0|||
16979594|NCT01190930|38123028|FG009|Maintenance|Still on therapy|0|||
16979595|NCT01101191|38123052|FG000|Period 1|Withdrawal by Subject|1|||
16979596|NCT01101191|38123053|FG001|Period 1|Withdrawal by Subject|0|||
16979597|NCT01101191|38123052|FG000|Period 1|Adverse Event|1|||
16979598|NCT01101191|38123053|FG001|Period 1|Adverse Event|2|||
16979599|NCT01178762|38123060|FG000|Overall Study|Lost to Follow-up|15|||
16979600|NCT01178294|38123064|FG000|Overall Study|Adverse Event|4|||
16979601|NCT01178294|38123064|FG000|Overall Study|Lost to Follow-up|2|||
16979602|NCT01178294|38123064|FG000|Overall Study|Lack of Efficacy|1|||
16979603|NCT01178294|38123064|FG000|Overall Study|Death|1|||
16979604|NCT01178294|38123064|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
16979605|NCT01178294|38123064|FG000|Overall Study|Subject status is terminal|1|||
16979606|NCT01178294|38123064|FG000|Overall Study|Completion status could not be verified|1|||
16979607|NCT01178138|38123068|FG000|Overall Study|Lost to Follow-up|8|||
16979608|NCT01178138|38123068|FG000|Overall Study|Withdrawal by Subject|7|||
16979609|NCT01178138|38123068|FG000|Overall Study|Physician Decision|8|||
16979610|NCT01177670|38123077|FG000|Overall Study|Study Terminated|115|||
16979611|NCT01177670|38123077|FG000|Overall Study|Physician Decision|50|||
16979612|NCT01177670|38123077|FG000|Overall Study|Withdrawal by Subject|4|||
16979613|NCT01190228|38123084|FG000|Overall Study|Protocol Violation|4|||
16979614|NCT01190228|38123085|FG001|Overall Study|Protocol Violation|0|||
16979615|NCT01190228|38123086|FG002|Overall Study|Protocol Violation|0|||
16979616|NCT01190228|38123084|FG000|Overall Study|Withdrawal by Subject|1|||
16979617|NCT01190228|38123085|FG001|Overall Study|Withdrawal by Subject|0|||
16979618|NCT01190228|38123086|FG002|Overall Study|Withdrawal by Subject|0|||
16979619|NCT01009086|38123099|FG000|Overall Study|Lack of Efficacy|16|||
16979620|NCT01009086|38123100|FG001|Overall Study|Lack of Efficacy|15|||
16979621|NCT01009086|38123101|FG002|Overall Study|Lack of Efficacy|9|||
16979622|NCT01009086|38123099|FG000|Overall Study|Lost to Follow-up|4|||
16979623|NCT01009086|38123100|FG001|Overall Study|Lost to Follow-up|5|||
16979624|NCT01009086|38123101|FG002|Overall Study|Lost to Follow-up|3|||
16979625|NCT01009086|38123099|FG000|Overall Study|Adverse Event|12|||
16979626|NCT01009086|38123100|FG001|Overall Study|Adverse Event|11|||
16979627|NCT01009086|38123101|FG002|Overall Study|Adverse Event|8|||
16979628|NCT01009086|38123099|FG000|Overall Study|Withdrawal by Subject|9|||
16979629|NCT01009086|38123100|FG001|Overall Study|Withdrawal by Subject|11|||
16979630|NCT01009086|38123101|FG002|Overall Study|Withdrawal by Subject|13|||
16979631|NCT01009086|38123099|FG000|Overall Study|Other|3|||
16979632|NCT01009086|38123100|FG001|Overall Study|Other|5|||
16979633|NCT01009086|38123101|FG002|Overall Study|Other|1|||
16979634|NCT01190150|38123116|FG000|First Treatment|Withdrawal by Subject|1|||
16979635|NCT01190150|38123117|FG001|First Treatment|Withdrawal by Subject|0|||
16979636|NCT01190150|38123116|FG000|Washout|Withdrawal by Subject|0|||
16979637|NCT01190150|38123117|FG001|Washout|Withdrawal by Subject|1|||
16979638|NCT01190150|38123116|FG000|Washout|Difficulty in adherence|0|||
16979639|NCT01190150|38123117|FG001|Washout|Difficulty in adherence|1|||
16979640|NCT01001520|38123123|FG000|Medication Period 1|Withdrawal by Subject|2|||
16979641|NCT01001520|38123124|FG001|Medication Period 1|Withdrawal by Subject|2|||
16979642|NCT01001520|38123123|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
16979643|NCT01001520|38123124|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
16979644|NCT01001520|38123123|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
16979645|NCT01001520|38123124|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
16979646|NCT01001520|38123123|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
16979647|NCT01001520|38123124|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
16979648|NCT01001520|38123123|FG000|Washout Period|Withdrawal by Subject|2|||
16979649|NCT01001520|38123124|FG001|Washout Period|Withdrawal by Subject|1|||
16979650|NCT01001520|38123123|FG000|Medication Period 2|Withdrawal by Subject|0|||
16979651|NCT01001520|38123124|FG001|Medication Period 2|Withdrawal by Subject|3|||
16979652|NCT01189604|38123148|FG000|Overall Study|Impossible to visit|0|||
16979653|NCT01189604|38123149|FG001|Overall Study|Impossible to visit|0|||
16979654|NCT01189604|38123150|FG002|Overall Study|Impossible to visit|0|||
16979655|NCT01189604|38123151|FG003|Overall Study|Impossible to visit|0|||
16979656|NCT01189604|38123152|FG004|Overall Study|Impossible to visit|0|||
16979657|NCT01189604|38123153|FG005|Overall Study|Impossible to visit|1|||
16979658|NCT01189604|38123154|FG006|Overall Study|Impossible to visit|0|||
16979659|NCT01189604|38123148|FG000|Overall Study|Adverse Event|0|||
16979660|NCT01189604|38123149|FG001|Overall Study|Adverse Event|1|||
16979661|NCT01189604|38123150|FG002|Overall Study|Adverse Event|0|||
16979662|NCT01189604|38123151|FG003|Overall Study|Adverse Event|0|||
16979663|NCT01189604|38123152|FG004|Overall Study|Adverse Event|2|||
16979664|NCT01189604|38123153|FG005|Overall Study|Adverse Event|0|||
16979665|NCT01189604|38123154|FG006|Overall Study|Adverse Event|1|||
16979666|NCT01189604|38123148|FG000|Overall Study|Withdrawal by Subject|1|||
16979667|NCT01189604|38123149|FG001|Overall Study|Withdrawal by Subject|0|||
16979668|NCT01189604|38123150|FG002|Overall Study|Withdrawal by Subject|0|||
16979669|NCT01189604|38123151|FG003|Overall Study|Withdrawal by Subject|0|||
16979670|NCT01189604|38123152|FG004|Overall Study|Withdrawal by Subject|0|||
16979671|NCT01189604|38123153|FG005|Overall Study|Withdrawal by Subject|0|||
16979672|NCT01189604|38123154|FG006|Overall Study|Withdrawal by Subject|0|||
16979673|NCT01008696|38123172|FG000|Overall Study|Participant's evasion of hospital visit|5|||
16979674|NCT01008696|38123173|FG001|Overall Study|Participant's evasion of hospital visit|4|||
16979675|NCT01008696|38123172|FG000|Overall Study|Withdrawal by Subject|2|||
16979676|NCT01008696|38123173|FG001|Overall Study|Withdrawal by Subject|4|||
16979677|NCT01008696|38123172|FG000|Overall Study|Physician Decision|5|||
16979678|NCT01008696|38123173|FG001|Overall Study|Physician Decision|1|||
16979679|NCT01008696|38123172|FG000|Overall Study|Adverse Event|1|||
16979680|NCT01008696|38123173|FG001|Overall Study|Adverse Event|0|||
16979681|NCT01008696|38123172|FG000|Overall Study|Participants' non-cooperation|2|||
16979682|NCT01008696|38123173|FG001|Overall Study|Participants' non-cooperation|3|||
16979683|NCT01008696|38123172|FG000|Overall Study|Other|2|||
16979684|NCT01008696|38123173|FG001|Overall Study|Other|3|||
16979685|NCT01008696|38123172|FG000|Overall Study|Other|0|||
16979686|NCT01008696|38123173|FG001|Overall Study|Other|2|||
16979687|NCT01176968|38123192|FG000|Overall Study|Adverse Event|10|||
16979688|NCT01176968|38123193|FG001|Overall Study|Adverse Event|11|||
16979689|NCT01176968|38123192|FG000|Overall Study|Death|2|||
16979690|NCT01176968|38123193|FG001|Overall Study|Death|3|||
16979691|NCT01176968|38123192|FG000|Overall Study|Lack of Efficacy|0|||
16979692|NCT01176968|38123193|FG001|Overall Study|Lack of Efficacy|1|||
16979693|NCT01176968|38123192|FG000|Overall Study|Lost to Follow-up|16|||
16979694|NCT01176968|38123193|FG001|Overall Study|Lost to Follow-up|14|||
16979695|NCT01176968|38123192|FG000|Overall Study|Withdrawal by Subject|48|||
16979696|NCT01176968|38123193|FG001|Overall Study|Withdrawal by Subject|48|||
16979697|NCT01176968|38123192|FG000|Overall Study|Protocol Violation|2|||
16979698|NCT01176968|38123193|FG001|Overall Study|Protocol Violation|1|||
16979699|NCT01176968|38123192|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16979700|NCT01176968|38123193|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
16979701|NCT01176968|38123192|FG000|Overall Study|Study terminated by sponsor|0|||
16979702|NCT01176968|38123193|FG001|Overall Study|Study terminated by sponsor|1|||
16979703|NCT01176968|38123192|FG000|Overall Study|Reason not defined|5|||
16979704|NCT01176968|38123193|FG001|Overall Study|Reason not defined|3|||
16979705|NCT01006122|38123204|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
16979706|NCT01006122|38123205|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
16979707|NCT01006122|38123204|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
16979708|NCT01006122|38123205|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
16979709|NCT01006122|38123204|FG000|First Double-blind Intervention Period|Pregnancy|0|||
16979710|NCT01006122|38123205|FG001|First Double-blind Intervention Period|Pregnancy|1|||
16979711|NCT01006122|38123204|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
16979712|NCT01006122|38123205|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
16979713|NCT01006122|38123204|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
16979714|NCT01006122|38123205|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
16979715|NCT01006122|38123204|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
16979716|NCT01006122|38123205|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
16979717|NCT01006122|38123204|FG000|First Double-blind Intervention Period|Other|3|||
16979718|NCT01006122|38123205|FG001|First Double-blind Intervention Period|Other|0|||
16979719|NCT01006122|38123204|FG000|First Double-blind Intervention Period|Adverse Event|0|||
16979720|NCT01006122|38123205|FG001|First Double-blind Intervention Period|Adverse Event|4|||
16979721|NCT01006122|38123204|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
16979722|NCT01006122|38123205|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
16979723|NCT01006122|38123204|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
16979724|NCT01006122|38123205|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
16979725|NCT01006122|38123204|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
16979726|NCT01006122|38123205|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
16979727|NCT01006122|38123204|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
16979728|NCT01006122|38123205|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
16979729|NCT01006122|38123204|FG000|Second Double-blind Intervention Period|Death|0|||
16979730|NCT01006122|38123205|FG001|Second Double-blind Intervention Period|Death|1|||
16979731|NCT01005966|38123211|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
16979732|NCT01005966|38123212|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
16979733|NCT01005966|38123213|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
16979734|NCT01005966|38123214|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
16979735|NCT01005966|38123215|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
16979736|NCT01005966|38123211|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
16979737|NCT01005966|38123212|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
16979738|NCT01005966|38123213|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
16979739|NCT01005966|38123214|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
16979740|NCT01005966|38123215|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
16979741|NCT01005966|38123211|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
16979742|NCT01005966|38123212|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
16979743|NCT01005966|38123213|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
16979744|NCT01005966|38123214|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
16979745|NCT01005966|38123215|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
16979746|NCT01005966|38123211|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
16979747|NCT01005966|38123212|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
16979748|NCT01005966|38123213|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
16979749|NCT01005966|38123214|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
16979750|NCT01005966|38123215|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
16979751|NCT01005966|38123211|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16979752|NCT01005966|38123212|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16979753|NCT01005966|38123213|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16979754|NCT01005966|38123214|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16979755|NCT01005966|38123215|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16979756|NCT01005966|38123211|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16979757|NCT01005966|38123212|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16979758|NCT01005966|38123213|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
16979759|NCT01005966|38123214|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16979760|NCT01005966|38123215|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16979761|NCT01005966|38123211|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
16979762|NCT01005966|38123212|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
16979763|NCT01005966|38123213|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
16979764|NCT01005966|38123214|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
16979765|NCT01005966|38123215|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
16979766|NCT01005966|38123211|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
16979767|NCT01005966|38123212|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
16979768|NCT01005966|38123213|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
16979769|NCT01005966|38123214|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
16979770|NCT01005966|38123215|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
16979771|NCT01005966|38123211|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
16979772|NCT01005966|38123212|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
16979773|NCT01005966|38123213|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
16979774|NCT01005966|38123214|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
16979775|NCT01005966|38123215|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
16979776|NCT01005732|38123241|FG000|Overall Study|Lost to Follow-up|10|||
16979777|NCT01005732|38123241|FG000|Overall Study|Death|1|||
16979778|NCT00603382|38123255|FG000|Overall Study|Adverse Event|0|||
16979779|NCT00603382|38123256|FG001|Overall Study|Adverse Event|1|||
16979780|NCT00603382|38123257|FG002|Overall Study|Adverse Event|1|||
16979781|NCT00603382|38123258|FG003|Overall Study|Adverse Event|2|||
16979782|NCT00603382|38123259|FG004|Overall Study|Adverse Event|1|||
16979783|NCT00603382|38123260|FG005|Overall Study|Adverse Event|2|||
16979784|NCT00603382|38123255|FG000|Overall Study|Lack of Efficacy|14|||
16979785|NCT00603382|38123256|FG001|Overall Study|Lack of Efficacy|9|||
16979786|NCT00603382|38123257|FG002|Overall Study|Lack of Efficacy|3|||
16979787|NCT00603382|38123258|FG003|Overall Study|Lack of Efficacy|6|||
16979788|NCT00603382|38123259|FG004|Overall Study|Lack of Efficacy|6|||
16979789|NCT00603382|38123260|FG005|Overall Study|Lack of Efficacy|11|||
16979790|NCT00603382|38123255|FG000|Overall Study|Protocol Violation|1|||
16979791|NCT00603382|38123256|FG001|Overall Study|Protocol Violation|0|||
16979792|NCT00603382|38123257|FG002|Overall Study|Protocol Violation|1|||
16979793|NCT00603382|38123258|FG003|Overall Study|Protocol Violation|2|||
16979794|NCT00603382|38123259|FG004|Overall Study|Protocol Violation|1|||
16979795|NCT00603382|38123260|FG005|Overall Study|Protocol Violation|0|||
16979796|NCT00603382|38123255|FG000|Overall Study|Lost to Follow-up|0|||
16979797|NCT00603382|38123256|FG001|Overall Study|Lost to Follow-up|1|||
16979798|NCT00603382|38123257|FG002|Overall Study|Lost to Follow-up|1|||
16979799|NCT00603382|38123258|FG003|Overall Study|Lost to Follow-up|1|||
16979800|NCT00603382|38123259|FG004|Overall Study|Lost to Follow-up|0|||
16979801|NCT00603382|38123260|FG005|Overall Study|Lost to Follow-up|1|||
16979802|NCT00603382|38123255|FG000|Overall Study|Physician Decision|0|||
16979803|NCT00603382|38123256|FG001|Overall Study|Physician Decision|0|||
16979804|NCT00603382|38123257|FG002|Overall Study|Physician Decision|2|||
16979805|NCT00603382|38123258|FG003|Overall Study|Physician Decision|0|||
16979806|NCT00603382|38123259|FG004|Overall Study|Physician Decision|1|||
16979807|NCT00603382|38123260|FG005|Overall Study|Physician Decision|3|||
16979808|NCT00603382|38123255|FG000|Overall Study|Withdrawal by Subject|3|||
16979809|NCT00603382|38123256|FG001|Overall Study|Withdrawal by Subject|3|||
16979810|NCT00603382|38123257|FG002|Overall Study|Withdrawal by Subject|1|||
16979811|NCT00603382|38123258|FG003|Overall Study|Withdrawal by Subject|1|||
16979812|NCT00603382|38123259|FG004|Overall Study|Withdrawal by Subject|0|||
16979813|NCT00603382|38123260|FG005|Overall Study|Withdrawal by Subject|1|||
16979814|NCT01176266|38123274|FG000|Overall Study|Death|6|||
16979815|NCT01176266|38123274|FG000|Overall Study|Withdrawal by Subject|3|||
16979816|NCT01182428|38123284|FG000|Overall Study|Physician Decision|1|||
16979817|NCT01182428|38123285|FG001|Overall Study|Physician Decision|0|||
16979818|NCT01182428|38123284|FG000|Overall Study|Lost to Follow-up|9|||
16979819|NCT01182428|38123285|FG001|Overall Study|Lost to Follow-up|1|||
16979820|NCT01182428|38123284|FG000|Overall Study|Withdrawal by Subject|1|||
16979821|NCT01182428|38123285|FG001|Overall Study|Withdrawal by Subject|0|||
16979822|NCT00603304|38123293|FG000|Overall Study|Lost to Follow-up|5|||
16979823|NCT00603304|38123294|FG001|Overall Study|Lost to Follow-up|7|||
16979824|NCT00603304|38123293|FG000|Overall Study|Withdrawal by Subject|8|||
16979825|NCT00603304|38123294|FG001|Overall Study|Withdrawal by Subject|5|||
16979826|NCT00603304|38123293|FG000|Overall Study|Protocol Violation|1|||
16979827|NCT00603304|38123294|FG001|Overall Study|Protocol Violation|0|||
16979828|NCT00603304|38123293|FG000|Overall Study|Adverse Event|4|||
16979829|NCT00603304|38123294|FG001|Overall Study|Adverse Event|2|||
16979830|NCT00603304|38123293|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
16979831|NCT00603304|38123294|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
16979832|NCT00603304|38123293|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
16979833|NCT00603304|38123294|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
16979834|NCT00603304|38123293|FG000|Overall Study|Exclusionary Medication|2|||
16979835|NCT00603304|38123294|FG001|Overall Study|Exclusionary Medication|3|||
16979836|NCT00603304|38123293|FG000|Overall Study|Non-Compliant|0|||
16979837|NCT00603304|38123294|FG001|Overall Study|Non-Compliant|1|||
16979838|NCT00603304|38123293|FG000|Overall Study|Moved Away|0|||
16979839|NCT00603304|38123294|FG001|Overall Study|Moved Away|2|||
16979840|NCT00603304|38123293|FG000|Overall Study|Other|2|||
16979841|NCT00603304|38123294|FG001|Overall Study|Other|0|||
16979842|NCT00603304|38123293|FG000|Overall Study|Patient Decision|2|||
16979843|NCT00603304|38123294|FG001|Overall Study|Patient Decision|0|||
16979844|NCT01176032|38123304|FG000|Overall Study|Adverse Event|1|||
16979845|NCT01176032|38123305|FG001|Overall Study|Adverse Event|0|||
16979846|NCT01176032|38123304|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16979847|NCT01176032|38123305|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16979848|NCT01176032|38123304|FG000|Overall Study|Protocol Violation|1|||
16979849|NCT01176032|38123305|FG001|Overall Study|Protocol Violation|0|||
16979850|NCT01176032|38123304|FG000|Overall Study|Informed consent withdrawn|3|||
16979851|NCT01176032|38123305|FG001|Overall Study|Informed consent withdrawn|0|||
16979852|NCT01176032|38123304|FG000|Overall Study|Other|1|||
16979853|NCT01176032|38123305|FG001|Overall Study|Other|0|||
16979854|NCT01208974|38123316|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
16979855|NCT01208974|38123317|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
16979856|NCT01208974|38123318|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
16979857|NCT01208974|38123319|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
16979858|NCT01208974|38123316|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
16979859|NCT01208974|38123317|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
16979860|NCT01208974|38123318|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
16979861|NCT01208974|38123319|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
16979862|NCT01208974|38123316|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
16979863|NCT01208974|38123317|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
16979864|NCT01208974|38123318|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
16979865|NCT01208974|38123319|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
16979866|NCT01008618|38123326|FG000|Period 1 (Titration Period)|Physician Decision|2|||
16979867|NCT01008618|38123327|FG001|Period 1 (Titration Period)|Physician Decision|0|||
16979868|NCT01008618|38123328|FG002|Period 1 (Titration Period)|Physician Decision|0|||
16979869|NCT01008618|38123326|FG000|Period 1 (Titration Period)|Adverse Event|33|||
16979870|NCT01008618|38123327|FG001|Period 1 (Titration Period)|Adverse Event|0|||
16979871|NCT01008618|38123328|FG002|Period 1 (Titration Period)|Adverse Event|0|||
16979872|NCT01008618|38123326|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
16979873|NCT01008618|38123327|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
16979874|NCT01008618|38123328|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
16979875|NCT01008618|38123326|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
16979876|NCT01008618|38123327|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
16979877|NCT01008618|38123328|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
16979878|NCT01008618|38123326|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
16979879|NCT01008618|38123327|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
16979880|NCT01008618|38123328|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
16979881|NCT01008618|38123326|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
16979882|NCT01008618|38123327|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
16979883|NCT01008618|38123328|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
16979884|NCT01008618|38123326|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
16979885|NCT01008618|38123327|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
16979886|NCT01008618|38123328|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
16979887|NCT01008618|38123326|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
16979888|NCT01008618|38123327|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
16979889|NCT01008618|38123328|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
16979890|NCT01008618|38123326|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
16979891|NCT01008618|38123327|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
16979892|NCT01008618|38123328|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
16979893|NCT01008618|38123326|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
16979894|NCT01008618|38123327|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
16979895|NCT01008618|38123328|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
16979896|NCT01008618|38123326|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
16979897|NCT01008618|38123327|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
16979898|NCT01008618|38123328|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
16979899|NCT01008618|38123326|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
16979900|NCT01008618|38123327|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
16979901|NCT01008618|38123328|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
16979902|NCT01001208|38123339|FG000|Overall Study|Adverse Event|10|||
16979903|NCT01001208|38123340|FG001|Overall Study|Adverse Event|5|||
16979904|NCT01001208|38123339|FG000|Overall Study|Lost to Follow-up|5|||
16979905|NCT01001208|38123340|FG001|Overall Study|Lost to Follow-up|9|||
16979906|NCT01001208|38123339|FG000|Overall Study|Physician Decision|1|||
16979907|NCT01001208|38123340|FG001|Overall Study|Physician Decision|0|||
16979908|NCT01001208|38123339|FG000|Overall Study|Withdrawal by Subject|4|||
16979909|NCT01001208|38123340|FG001|Overall Study|Withdrawal by Subject|5|||
16979910|NCT01001208|38123339|FG000|Overall Study|Ineligibility Determined|4|||
16979911|NCT01001208|38123340|FG001|Overall Study|Ineligibility Determined|2|||
16979912|NCT01001208|38123339|FG000|Overall Study|Noncompliance|4|||
16979913|NCT01001208|38123340|FG001|Overall Study|Noncompliance|7|||
16979914|NCT01001208|38123339|FG000|Overall Study|Disease Progression|0|||
16979915|NCT01001208|38123340|FG001|Overall Study|Disease Progression|3|||
16979916|NCT01001208|38123339|FG000|Overall Study|Other|0|||
16979917|NCT01001208|38123340|FG001|Overall Study|Other|2|||
16979918|NCT01000974|38123349|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
16979919|NCT01000974|38123350|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
16979920|NCT01000974|38123351|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
16979921|NCT01000974|38123349|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
16979922|NCT01000974|38123350|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
16979923|NCT01000974|38123351|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
16979924|NCT01000974|38123349|FG000|Primary Vaccination Phase|Protocol Violation|40|||
16979925|NCT01000974|38123350|FG001|Primary Vaccination Phase|Protocol Violation|3|||
16979926|NCT01000974|38123351|FG002|Primary Vaccination Phase|Protocol Violation|2|||
16979927|NCT01000974|38123349|FG000|Primary Vaccination Phase|Adverse Event|14|||
16979928|NCT01000974|38123350|FG001|Primary Vaccination Phase|Adverse Event|2|||
16979929|NCT01000974|38123351|FG002|Primary Vaccination Phase|Adverse Event|2|||
16979930|NCT01000974|38123349|FG000|Primary Vaccination Phase|Other|4|||
16979931|NCT01000974|38123350|FG001|Primary Vaccination Phase|Other|9|||
16979932|NCT01000974|38123351|FG002|Primary Vaccination Phase|Other|12|||
16979933|NCT01000974|38123349|FG000|Booster Vaccination Phase|Protocol Violation|0|||
16979934|NCT01000974|38123350|FG001|Booster Vaccination Phase|Protocol Violation|0|||
16979935|NCT01000974|38123351|FG002|Booster Vaccination Phase|Protocol Violation|2|||
16979936|NCT01000974|38123349|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
16979937|NCT01000974|38123350|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
16979938|NCT01000974|38123351|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
16979939|NCT01000974|38123349|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
16979940|NCT01000974|38123350|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
16979941|NCT01000974|38123351|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
16979942|NCT01000974|38123349|FG000|Booster Vaccination Phase|Other|24|||
16979943|NCT01000974|38123350|FG001|Booster Vaccination Phase|Other|6|||
16979944|NCT01000974|38123351|FG002|Booster Vaccination Phase|Other|4|||
16979945|NCT01193842|38123367|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
16979946|NCT01193842|38123368|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
16979947|NCT01193842|38123369|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
16979948|NCT01193842|38123370|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
16979949|NCT01193842|38123371|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
16979950|NCT01193842|38123367|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
16979951|NCT01193842|38123368|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
16979952|NCT01193842|38123369|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
16979953|NCT01193842|38123370|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
16979954|NCT01193842|38123371|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
16979955|NCT01193842|38123367|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
16979956|NCT01193842|38123368|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
16979957|NCT01193842|38123369|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
16979958|NCT01193842|38123370|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
16979959|NCT01193842|38123371|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
16979960|NCT01193842|38123367|FG000|Phase II: Randomized Groups|Death|0|||
16979961|NCT01193842|38123368|FG001|Phase II: Randomized Groups|Death|0|||
16979962|NCT01193842|38123369|FG002|Phase II: Randomized Groups|Death|0|||
16979963|NCT01193842|38123370|FG003|Phase II: Randomized Groups|Death|1|||
16979964|NCT01193842|38123371|FG004|Phase II: Randomized Groups|Death|1|||
16979965|NCT01193842|38123367|FG000|Phase II: Randomized Groups|Adverse Event|0|||
16979966|NCT01193842|38123368|FG001|Phase II: Randomized Groups|Adverse Event|0|||
16979967|NCT01193842|38123369|FG002|Phase II: Randomized Groups|Adverse Event|0|||
16979968|NCT01193842|38123370|FG003|Phase II: Randomized Groups|Adverse Event|5|||
16979969|NCT01193842|38123371|FG004|Phase II: Randomized Groups|Adverse Event|3|||
16979970|NCT01193842|38123367|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
16979971|NCT01193842|38123368|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
16979972|NCT01193842|38123369|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
16979973|NCT01193842|38123370|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
16979974|NCT01193842|38123371|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
16979975|NCT01193842|38123367|FG000|Phase II: Randomized Groups|Ineligible|0|||
16979976|NCT01193842|38123368|FG001|Phase II: Randomized Groups|Ineligible|0|||
16979977|NCT01193842|38123369|FG002|Phase II: Randomized Groups|Ineligible|0|||
16979978|NCT01193842|38123370|FG003|Phase II: Randomized Groups|Ineligible|0|||
16979979|NCT01193842|38123371|FG004|Phase II: Randomized Groups|Ineligible|1|||
16979980|NCT01193842|38123367|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
16979981|NCT01193842|38123368|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
16979982|NCT01193842|38123369|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
16979983|NCT01193842|38123370|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
16979984|NCT01193842|38123371|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
16979985|NCT01004406|38123390|FG000|Overall Study|Withdrawal by Subject|2|||
16979986|NCT01004406|38123391|FG001|Overall Study|Withdrawal by Subject|0|||
16979987|NCT01004406|38123390|FG000|Overall Study|Lost to Follow-up|1|||
16979988|NCT01004406|38123391|FG001|Overall Study|Lost to Follow-up|0|||
16979989|NCT01182350|38123406|FG000|Overall Study|Adverse Event|5|||
16979990|NCT01182350|38123407|FG001|Overall Study|Adverse Event|0|||
16979991|NCT01182350|38123408|FG002|Overall Study|Adverse Event|0|||
16979992|NCT01182350|38123409|FG003|Overall Study|Adverse Event|0|||
16979993|NCT01182350|38123410|FG004|Overall Study|Adverse Event|0|||
16979994|NCT01182350|38123406|FG000|Overall Study|Disease Progression|15|||
16979995|NCT01182350|38123407|FG001|Overall Study|Disease Progression|12|||
16979996|NCT01182350|38123408|FG002|Overall Study|Disease Progression|0|||
16979997|NCT01182350|38123409|FG003|Overall Study|Disease Progression|1|||
16979998|NCT01182350|38123410|FG004|Overall Study|Disease Progression|0|||
16979999|NCT01182350|38123406|FG000|Overall Study|Death|0|||
16980000|NCT01182350|38123407|FG001|Overall Study|Death|1|||
16980001|NCT01182350|38123408|FG002|Overall Study|Death|1|||
16980002|NCT01182350|38123409|FG003|Overall Study|Death|0|||
16980003|NCT01182350|38123410|FG004|Overall Study|Death|0|||
16980004|NCT01182350|38123406|FG000|Overall Study|Withdrawal by Subject|3|||
16980005|NCT01182350|38123407|FG001|Overall Study|Withdrawal by Subject|1|||
16980006|NCT01182350|38123408|FG002|Overall Study|Withdrawal by Subject|0|||
16980007|NCT01182350|38123409|FG003|Overall Study|Withdrawal by Subject|1|||
16980008|NCT01182350|38123410|FG004|Overall Study|Withdrawal by Subject|0|||
16980009|NCT01182350|38123406|FG000|Overall Study|Alternative Therapy|2|||
16980010|NCT01182350|38123407|FG001|Overall Study|Alternative Therapy|0|||
16980011|NCT01182350|38123408|FG002|Overall Study|Alternative Therapy|1|||
16980012|NCT01182350|38123409|FG003|Overall Study|Alternative Therapy|0|||
16980013|NCT01182350|38123410|FG004|Overall Study|Alternative Therapy|0|||
16980014|NCT01182350|38123406|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
16980015|NCT01182350|38123407|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
16980016|NCT01182350|38123408|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
16980017|NCT01182350|38123409|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
16980018|NCT01182350|38123410|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
16980019|NCT01182350|38123406|FG000|Overall Study|Unevaluable for Biopsy|0|||
16980020|NCT01182350|38123407|FG001|Overall Study|Unevaluable for Biopsy|0|||
16980021|NCT01182350|38123408|FG002|Overall Study|Unevaluable for Biopsy|0|||
16980022|NCT01182350|38123409|FG003|Overall Study|Unevaluable for Biopsy|0|||
16980023|NCT01182350|38123410|FG004|Overall Study|Unevaluable for Biopsy|3|||
16980024|NCT01163474|38123426|FG000|Overall Study|Withdrawal by Subject|1|||
16980025|NCT01163474|38123426|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
16980026|NCT01163474|38123426|FG000|Overall Study|Lost to Follow-up|3|||
16980027|NCT00603538|38123436|FG000|Overall Study|Adverse Event|0|||
16980028|NCT00603538|38123437|FG001|Overall Study|Adverse Event|4|||
16980029|NCT00603538|38123438|FG002|Overall Study|Adverse Event|2|||
16980030|NCT00603538|38123436|FG000|Overall Study|Objective progression or relapse|3|||
16980031|NCT00603538|38123437|FG001|Overall Study|Objective progression or relapse|0|||
16980032|NCT00603538|38123438|FG002|Overall Study|Objective progression or relapse|0|||
16980033|NCT01163318|38123449|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
16980034|NCT01163318|38123449|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
16980035|NCT01163318|38123449|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
16980036|NCT01163318|38123449|FG000|Overall Study|Participants Without Case Report Form|7|||
16980037|NCT01163318|38123449|FG000|Overall Study|Multiple Reasons Per Participant|224|||
16980038|NCT01162304|38123453|FG000|Overall Study|Beck scale to high|11|||
16980039|NCT04515394|38123459|FG000|Overall Study|Participant did not receive treatment|1|||
16980040|NCT01175018|38123465|FG000|Overall Study|Adverse Event|3|||
16980041|NCT01175018|38123466|FG001|Overall Study|Adverse Event|1|||
16980042|NCT01174784|38123474|FG000|Overall Study|Screen fails|4|||
16980043|NCT01174550|38123481|FG000|Overall Study|Death|75|||
16980044|NCT01174550|38123482|FG001|Overall Study|Death|74|||
16980045|NCT01174550|38123481|FG000|Overall Study|Lost to Follow-up|652|||
16980046|NCT01174550|38123482|FG001|Overall Study|Lost to Follow-up|510|||
16980047|NCT01174550|38123481|FG000|Overall Study|Withdrawal by Subject|543|||
16980048|NCT01174550|38123482|FG001|Overall Study|Withdrawal by Subject|289|||
16980049|NCT01008150|38123492|FG000|Overall Study|did not receive study drug|1|||
16980050|NCT01008150|38123493|FG001|Overall Study|did not receive study drug|1|||
16980051|NCT01008150|38123494|FG002|Overall Study|did not receive study drug|1|||
16980052|NCT01008150|38123495|FG003|Overall Study|did not receive study drug|0|||
16980053|NCT01007916|38123506|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
16980054|NCT01007916|38123507|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
16980055|NCT01007916|38123506|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
16980056|NCT01007916|38123507|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
16980057|NCT01007838|38123517|FG000|Overall Study|Withdrawal by Subject|1|||
16780196|NCT01375049|37719297|FG000|Overall Study|Lost to Follow-up|1|||
16980058|NCT01007838|38123518|FG001|Overall Study|Withdrawal by Subject|0|||
16980059|NCT01007838|38123519|FG002|Overall Study|Withdrawal by Subject|0|||
16980060|NCT01007838|38123520|FG003|Overall Study|Withdrawal by Subject|0|||
16980061|NCT01007838|38123517|FG000|Overall Study|Physician Decision|1|||
16980062|NCT01007838|38123518|FG001|Overall Study|Physician Decision|0|||
16980063|NCT01007838|38123519|FG002|Overall Study|Physician Decision|0|||
16980064|NCT01007838|38123520|FG003|Overall Study|Physician Decision|0|||
16980065|NCT01007838|38123517|FG000|Overall Study|Started home haemodialysis|1|||
16980066|NCT01007838|38123518|FG001|Overall Study|Started home haemodialysis|0|||
16980067|NCT01007838|38123519|FG002|Overall Study|Started home haemodialysis|0|||
16980068|NCT01007838|38123520|FG003|Overall Study|Started home haemodialysis|0|||
16980069|NCT01007448|38123532|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
16980070|NCT01007448|38123533|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
16980071|NCT01007448|38123532|FG000|Overall Study|Staph Skin Infection Flare|1|||
16980072|NCT01007448|38123533|FG001|Overall Study|Staph Skin Infection Flare|0|||
16980073|NCT01007448|38123532|FG000|Overall Study|Participant Leaving the Country|1|||
16980074|NCT01007448|38123533|FG001|Overall Study|Participant Leaving the Country|0|||
16980075|NCT01007448|38123532|FG000|Overall Study|Participant Given Prohibited Medication|1|||
16980076|NCT01007448|38123533|FG001|Overall Study|Participant Given Prohibited Medication|0|||
16980077|NCT01007448|38123532|FG000|Overall Study|Progressive Disease|1|||
16980078|NCT01007448|38123533|FG001|Overall Study|Progressive Disease|2|||
16980079|NCT01007448|38123532|FG000|Overall Study|Lack of Efficacy|2|||
16980080|NCT01007448|38123533|FG001|Overall Study|Lack of Efficacy|0|||
16980081|NCT01007448|38123532|FG000|Overall Study|Withdrawal by Subject|2|||
16980082|NCT01007448|38123533|FG001|Overall Study|Withdrawal by Subject|3|||
16980083|NCT01007448|38123532|FG000|Overall Study|Adverse Event|1|||
16980084|NCT01007448|38123533|FG001|Overall Study|Adverse Event|4|||
16980085|NCT03538756|38123539|FG000|Long-Term Follow-up|Adverse Event|0|||
16980086|NCT03538756|38123540|FG001|Long-Term Follow-up|Adverse Event|0|||
16980087|NCT03538756|38123541|FG002|Long-Term Follow-up|Adverse Event|6|||
16980088|NCT03538756|38123539|FG000|Long-Term Follow-up|Death|0|||
16980089|NCT03538756|38123540|FG001|Long-Term Follow-up|Death|0|||
16980090|NCT03538756|38123541|FG002|Long-Term Follow-up|Death|1|||
16980091|NCT03538756|38123539|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
16980092|NCT03538756|38123540|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
16980093|NCT03538756|38123541|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
16980094|NCT03538756|38123539|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
16980095|NCT03538756|38123540|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
16980096|NCT03538756|38123541|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
16980097|NCT03538756|38123539|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
16980098|NCT03538756|38123540|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
16980099|NCT03538756|38123541|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
16980100|NCT01004250|38123551|FG000|Induction Therapy Period|Adverse Event|10|||
16980101|NCT01004250|38123551|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
16980102|NCT01004250|38123551|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
16980103|NCT01004250|38123551|FG000|Induction Therapy Period|Physician Decision|2|||
16980104|NCT01004250|38123551|FG000|Maintenance Therapy Period|Adverse Event|15|||
16980105|NCT01004250|38123551|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
16980106|NCT01004250|38123551|FG000|Maintenance Therapy Period|Protocol Violation|1|||
16980107|NCT01004250|38123551|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
16980108|NCT01004250|38123551|FG000|Maintenance Therapy Period|Physician Decision|4|||
16980109|NCT01004250|38123551|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
16980110|NCT01004172|38123559|FG000|Overall Study|Progressive Disease in CNS Only|16|||
16980111|NCT01004172|38123559|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
16980112|NCT01004172|38123559|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
16980113|NCT01004172|38123559|FG000|Overall Study|Adverse Event|1|||
16980114|NCT01004172|38123559|FG000|Overall Study|Physician Decision|1|||
16980115|NCT01004172|38123559|FG000|Overall Study|Symptomatic Deterioration|2|||
16980116|NCT01161524|38123566|FG000|Core Study (23 Weeks)|Adverse Event|3|||
16980117|NCT01161524|38123567|FG001|Core Study (23 Weeks)|Adverse Event|0|||
16980118|NCT01161524|38123568|FG002|Core Study (23 Weeks)|Adverse Event|0|||
16980119|NCT01161524|38123566|FG000|Core Study (23 Weeks)|Other|1|||
16980120|NCT01161524|38123567|FG001|Core Study (23 Weeks)|Other|0|||
16980121|NCT01161524|38123568|FG002|Core Study (23 Weeks)|Other|0|||
16980122|NCT01161524|38123566|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
16980123|NCT01161524|38123567|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
16980124|NCT01161524|38123568|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
16980125|NCT01161524|38123566|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
16980126|NCT01161524|38123567|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
16980127|NCT01161524|38123568|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
16980128|NCT01161524|38123566|FG000|Core Study (23 Weeks)|Subject Choice|3|||
16980129|NCT01161524|38123567|FG001|Core Study (23 Weeks)|Subject Choice|2|||
16980130|NCT01161524|38123568|FG002|Core Study (23 Weeks)|Subject Choice|0|||
16980131|NCT01161524|38123566|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
16980132|NCT01161524|38123567|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
16980133|NCT01161524|38123568|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
16980134|NCT01161524|38123566|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
16980135|NCT01161524|38123567|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
16980136|NCT01161524|38123568|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
16980137|NCT01161524|38123566|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
16980138|NCT01161524|38123567|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
16980139|NCT01161524|38123568|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
16980140|NCT01161524|38123566|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
16980141|NCT01161524|38123567|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
16980142|NCT01161524|38123568|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
16980143|NCT01161524|38123566|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
16980144|NCT01161524|38123567|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
16980145|NCT01161524|38123568|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
16980146|NCT01000506|38123581|FG000|Overall Study|Adverse Event|6|||
16980147|NCT01000506|38123582|FG001|Overall Study|Adverse Event|5|||
16980148|NCT01000506|38123583|FG002|Overall Study|Adverse Event|8|||
16980149|NCT01000506|38123584|FG003|Overall Study|Adverse Event|9|||
16980150|NCT01000506|38123581|FG000|Overall Study|Lack of Efficacy|8|||
16980151|NCT01000506|38123582|FG001|Overall Study|Lack of Efficacy|6|||
16980152|NCT01000506|38123583|FG002|Overall Study|Lack of Efficacy|4|||
16980153|NCT01000506|38123584|FG003|Overall Study|Lack of Efficacy|4|||
16980154|NCT01000506|38123581|FG000|Overall Study|Protocol Violation|1|||
16980155|NCT01000506|38123582|FG001|Overall Study|Protocol Violation|1|||
16980156|NCT01000506|38123583|FG002|Overall Study|Protocol Violation|0|||
16980157|NCT01000506|38123584|FG003|Overall Study|Protocol Violation|0|||
16980158|NCT01000506|38123581|FG000|Overall Study|Lost to Follow-up|1|||
16980159|NCT01000506|38123582|FG001|Overall Study|Lost to Follow-up|1|||
16980160|NCT01000506|38123583|FG002|Overall Study|Lost to Follow-up|4|||
16980161|NCT01000506|38123584|FG003|Overall Study|Lost to Follow-up|0|||
16980162|NCT01000506|38123581|FG000|Overall Study|Physician Decision|1|||
16980163|NCT01000506|38123582|FG001|Overall Study|Physician Decision|3|||
16980164|NCT01000506|38123583|FG002|Overall Study|Physician Decision|3|||
16980165|NCT01000506|38123584|FG003|Overall Study|Physician Decision|3|||
16980166|NCT01000506|38123581|FG000|Overall Study|Withdrawal by Subject|11|||
16980167|NCT01000506|38123582|FG001|Overall Study|Withdrawal by Subject|8|||
16980168|NCT01000506|38123583|FG002|Overall Study|Withdrawal by Subject|2|||
16980169|NCT01000506|38123584|FG003|Overall Study|Withdrawal by Subject|7|||
16980170|NCT01174238|38123594|FG000|Overall Study|Lost to Follow-up|2|||
16980171|NCT01174160|38123603|FG000|Overall Study|Adverse Event|1|||
16980172|NCT01174160|38123604|FG001|Overall Study|Adverse Event|0|||
16980173|NCT01174160|38123603|FG000|Overall Study|Lost to Follow-up|1|||
16980174|NCT01174160|38123604|FG001|Overall Study|Lost to Follow-up|0|||
16980175|NCT01174160|38123603|FG000|Overall Study|Physician Decision|1|||
16980176|NCT01174160|38123604|FG001|Overall Study|Physician Decision|0|||
16980177|NCT01174160|38123603|FG000|Overall Study|Protocol Violation|4|||
16980178|NCT01174160|38123604|FG001|Overall Study|Protocol Violation|6|||
16980179|NCT01174160|38123603|FG000|Overall Study|Withdrawal by Subject|1|||
16980180|NCT01174160|38123604|FG001|Overall Study|Withdrawal by Subject|0|||
16980181|NCT01161446|38123612|FG000|Overall Study|Lost to Follow-up|18|||
16980182|NCT01161446|38123613|FG001|Overall Study|Lost to Follow-up|14|||
16980183|NCT01161446|38123612|FG000|Overall Study|Withdrawal by Subject|0|||
16980184|NCT01161446|38123613|FG001|Overall Study|Withdrawal by Subject|1|||
16980185|NCT01174004|38123621|FG000|Overall Study|Adverse Event|2|||
16980186|NCT01174004|38123622|FG001|Overall Study|Adverse Event|10|||
16980187|NCT01174004|38123621|FG000|Overall Study|Withdrawal by Subject|2|||
16980188|NCT01174004|38123622|FG001|Overall Study|Withdrawal by Subject|3|||
16980189|NCT01174004|38123621|FG000|Overall Study|At Discretion of Sponsor|2|||
16980190|NCT01174004|38123622|FG001|Overall Study|At Discretion of Sponsor|2|||
16980191|NCT01174004|38123621|FG000|Overall Study|Protocol Violation|0|||
16980192|NCT01174004|38123622|FG001|Overall Study|Protocol Violation|1|||
16980193|NCT01174004|38123621|FG000|Overall Study|Physician Decision|1|||
16980194|NCT01174004|38123622|FG001|Overall Study|Physician Decision|0|||
16980195|NCT01173692|38123630|FG000|Overall Study|Adverse Event|1|||
16980196|NCT01173692|38123631|FG001|Overall Study|Adverse Event|2|||
16980197|NCT01173692|38123630|FG000|Overall Study|Withdrawal by Subject|1|||
16980198|NCT01173692|38123631|FG001|Overall Study|Withdrawal by Subject|3|||
16980199|NCT01101035|38123639|FG000|Overall Study|Adverse Event|191|||
16980200|NCT01101035|38123640|FG001|Overall Study|Adverse Event|172|||
16980201|NCT01101035|38123639|FG000|Overall Study|Major Protocol Deviation|52|||
16980202|NCT01101035|38123640|FG001|Overall Study|Major Protocol Deviation|46|||
16980203|NCT01101035|38123639|FG000|Overall Study|Lost to Follow-up|226|||
16980204|NCT01101035|38123640|FG001|Overall Study|Lost to Follow-up|223|||
16980205|NCT01101035|38123639|FG000|Overall Study|Voluntary Withdrawal|595|||
16980206|NCT01101035|38123640|FG001|Overall Study|Voluntary Withdrawal|587|||
16980207|NCT01101035|38123639|FG000|Overall Study|Reason not Specified|333|||
16980208|NCT01101035|38123640|FG001|Overall Study|Reason not Specified|363|||
16980209|NCT01100567|38123648|FG000|Overall Study|Withdrawal by Subject|5|||
16980210|NCT01100567|38123649|FG001|Overall Study|Withdrawal by Subject|8|||
16980211|NCT01100567|38123648|FG000|Overall Study|Early Hospital Discharge|6|||
16980212|NCT01100567|38123649|FG001|Overall Study|Early Hospital Discharge|4|||
16980213|NCT01100567|38123648|FG000|Overall Study|Lost to Follow-up|1|||
16980214|NCT01100567|38123649|FG001|Overall Study|Lost to Follow-up|2|||
16980215|NCT01100567|38123648|FG000|Overall Study|Physician Decision|0|||
16980216|NCT01100567|38123649|FG001|Overall Study|Physician Decision|1|||
16980217|NCT01100567|38123648|FG000|Overall Study|Deemed ineligible after consent|0|||
16980218|NCT01100567|38123649|FG001|Overall Study|Deemed ineligible after consent|1|||
16980219|NCT01160822|38123662|FG000|Overall Study|Adverse Event|0|||
16980220|NCT01160822|38123663|FG001|Overall Study|Adverse Event|0|||
16980221|NCT01160822|38123664|FG002|Overall Study|Adverse Event|0|||
16980222|NCT01160822|38123665|FG003|Overall Study|Adverse Event|0|||
16980223|NCT01160822|38123666|FG004|Overall Study|Adverse Event|1|||
16980224|NCT01160822|38123667|FG005|Overall Study|Adverse Event|2|||
16980225|NCT01160822|38123668|FG006|Overall Study|Adverse Event|5|||
16980226|NCT01160822|38123662|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16980227|NCT01160822|38123663|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16980228|NCT01160822|38123664|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16980229|NCT01160822|38123665|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16980230|NCT01160822|38123666|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
16980231|NCT01160822|38123667|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
16980232|NCT01160822|38123668|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
16980233|NCT01160822|38123662|FG000|Overall Study|Withdrawal by Subject|0|||
16980234|NCT01160822|38123663|FG001|Overall Study|Withdrawal by Subject|0|||
16980235|NCT01160822|38123664|FG002|Overall Study|Withdrawal by Subject|0|||
16980236|NCT01160822|38123665|FG003|Overall Study|Withdrawal by Subject|0|||
16980237|NCT01160822|38123666|FG004|Overall Study|Withdrawal by Subject|0|||
16980238|NCT01160822|38123667|FG005|Overall Study|Withdrawal by Subject|0|||
16980239|NCT01160822|38123668|FG006|Overall Study|Withdrawal by Subject|1|||
16980240|NCT01160822|38123662|FG000|Overall Study|Lost to Follow-up|0|||
16980241|NCT01160822|38123663|FG001|Overall Study|Lost to Follow-up|0|||
16980242|NCT01160822|38123664|FG002|Overall Study|Lost to Follow-up|0|||
16980243|NCT01160822|38123665|FG003|Overall Study|Lost to Follow-up|0|||
16980244|NCT01160822|38123666|FG004|Overall Study|Lost to Follow-up|1|||
16980245|NCT01160822|38123667|FG005|Overall Study|Lost to Follow-up|0|||
16980246|NCT01160822|38123668|FG006|Overall Study|Lost to Follow-up|0|||
16980247|NCT01160822|38123662|FG000|Overall Study|Administrative problems|0|||
16980248|NCT01160822|38123663|FG001|Overall Study|Administrative problems|0|||
16980249|NCT01160822|38123664|FG002|Overall Study|Administrative problems|0|||
16980250|NCT01160822|38123665|FG003|Overall Study|Administrative problems|0|||
16980251|NCT01160822|38123666|FG004|Overall Study|Administrative problems|1|||
16980252|NCT01160822|38123667|FG005|Overall Study|Administrative problems|0|||
16980253|NCT01160822|38123668|FG006|Overall Study|Administrative problems|0|||
16980254|NCT01160822|38123662|FG000|Overall Study|Protocol deviation|0|||
16980255|NCT01160822|38123663|FG001|Overall Study|Protocol deviation|0|||
16980256|NCT01160822|38123664|FG002|Overall Study|Protocol deviation|0|||
16980257|NCT01160822|38123665|FG003|Overall Study|Protocol deviation|0|||
16980258|NCT01160822|38123666|FG004|Overall Study|Protocol deviation|2|||
16980259|NCT01160822|38123667|FG005|Overall Study|Protocol deviation|0|||
16980260|NCT01160822|38123668|FG006|Overall Study|Protocol deviation|0|||
16980261|NCT01006980|38123687|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
16980262|NCT01006980|38123688|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
16980263|NCT01006980|38123687|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
16980264|NCT01006980|38123688|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
16980265|NCT01006980|38123687|FG000|Vemurafenib and Dacarbazine|Death|13|||
16980266|NCT01006980|38123688|FG001|Vemurafenib and Dacarbazine|Death|12|||
16980267|NCT01006980|38123687|FG000|Vemurafenib and Dacarbazine|Progression|257|||
16980268|NCT01006980|38123688|FG001|Vemurafenib and Dacarbazine|Progression|218|||
16980269|NCT01006980|38123687|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
16980270|NCT01006980|38123688|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
16980271|NCT01006980|38123687|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
16980272|NCT01006980|38123688|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
16980273|NCT01006980|38123687|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
16980274|NCT01006980|38123688|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
16980275|NCT01006980|38123687|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
16980276|NCT01006980|38123688|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
16980277|NCT01006980|38123687|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
16980278|NCT01006980|38123688|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
16980279|NCT01006980|38123687|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
16980280|NCT01006980|38123688|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
16980281|NCT01006980|38123687|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
16980282|NCT01006980|38123688|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
16980283|NCT01006980|38123687|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
16980284|NCT01006980|38123688|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
16980285|NCT01006980|38123687|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
16980286|NCT01006980|38123688|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
16980287|NCT00887926|38123699|FG000|Overall Study|Withdrawal by Subject|0|||
16980288|NCT00887926|38123700|FG001|Overall Study|Withdrawal by Subject|1|||
16980289|NCT00887926|38123701|FG002|Overall Study|Withdrawal by Subject|0|||
16980290|NCT00887926|38123702|FG003|Overall Study|Withdrawal by Subject|0|||
16980291|NCT00998400|38123720|FG000|Overall Study|Lack of interest/motivation|1|||
16980292|NCT00998400|38123721|FG001|Overall Study|Lack of interest/motivation|2|||
16980293|NCT00998400|38123720|FG000|Overall Study|Logistical problems|1|||
16980294|NCT00998400|38123721|FG001|Overall Study|Logistical problems|0|||
16980295|NCT00997386|38123728|FG000|Overall Study|Death|7|||
16980296|NCT00996996|38123732|FG000|Overall Study|Progressive Disease|10|||
16980297|NCT00996996|38123732|FG000|Overall Study|Non-compliance|8|||
16980298|NCT00996996|38123732|FG000|Overall Study|Lost to Follow-up|9|||
16980299|NCT00996996|38123732|FG000|Overall Study|Death|5|||
16980300|NCT00996996|38123732|FG000|Overall Study|Did Not Receive Study Medications|1|||
16980301|NCT00996918|38123741|FG000|Overall Study|Lack of Efficacy|1|||
16980302|NCT00996918|38123742|FG001|Overall Study|Lack of Efficacy|1|||
16980303|NCT00996918|38123743|FG002|Overall Study|Lack of Efficacy|2|||
16980304|NCT00996918|38123744|FG003|Overall Study|Lack of Efficacy|2|||
16980305|NCT00996918|38123745|FG004|Overall Study|Lack of Efficacy|0|||
16980306|NCT00996918|38123741|FG000|Overall Study|Adverse Event|2|||
16980307|NCT00996918|38123742|FG001|Overall Study|Adverse Event|5|||
16980308|NCT00996918|38123743|FG002|Overall Study|Adverse Event|2|||
16980309|NCT00996918|38123744|FG003|Overall Study|Adverse Event|6|||
16980310|NCT00996918|38123745|FG004|Overall Study|Adverse Event|0|||
16980311|NCT00996918|38123741|FG000|Overall Study|Withdrawal by Subject|1|||
16980312|NCT00996918|38123742|FG001|Overall Study|Withdrawal by Subject|4|||
16980313|NCT00996918|38123743|FG002|Overall Study|Withdrawal by Subject|3|||
16980314|NCT00996918|38123744|FG003|Overall Study|Withdrawal by Subject|3|||
16980315|NCT00996918|38123745|FG004|Overall Study|Withdrawal by Subject|2|||
16980316|NCT00996918|38123741|FG000|Overall Study|Physician Decision|1|||
16980317|NCT00996918|38123742|FG001|Overall Study|Physician Decision|0|||
16980318|NCT00996918|38123743|FG002|Overall Study|Physician Decision|0|||
16980319|NCT00996918|38123744|FG003|Overall Study|Physician Decision|0|||
16980320|NCT00996918|38123745|FG004|Overall Study|Physician Decision|0|||
16980321|NCT00996918|38123741|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
16980322|NCT00996918|38123742|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
16980323|NCT00996918|38123743|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
16980324|NCT00996918|38123744|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
16980325|NCT00996918|38123745|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
16980326|NCT00996918|38123741|FG000|Overall Study|Loss of Caregiver|0|||
16980327|NCT00996918|38123742|FG001|Overall Study|Loss of Caregiver|1|||
16980328|NCT00996918|38123743|FG002|Overall Study|Loss of Caregiver|0|||
16980329|NCT00996918|38123744|FG003|Overall Study|Loss of Caregiver|0|||
16980330|NCT00996918|38123745|FG004|Overall Study|Loss of Caregiver|0|||
16980331|NCT00996918|38123741|FG000|Overall Study|Other|3|||
16980332|NCT00996918|38123742|FG001|Overall Study|Other|1|||
16980333|NCT00996918|38123743|FG002|Overall Study|Other|0|||
16980334|NCT00996918|38123744|FG003|Overall Study|Other|0|||
16980335|NCT00996918|38123745|FG004|Overall Study|Other|0|||
16980336|NCT01160744|38123761|FG000|Overall Study|Withdrawal by Subject|11|||
16980337|NCT01160744|38123762|FG001|Overall Study|Withdrawal by Subject|5|||
16980338|NCT01160744|38123763|FG002|Overall Study|Withdrawal by Subject|6|||
16980339|NCT01160744|38123764|FG003|Overall Study|Withdrawal by Subject|4|||
16980340|NCT01160744|38123761|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
16980341|NCT01160744|38123762|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
16980342|NCT01160744|38123763|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
16980343|NCT01160744|38123764|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
16980344|NCT01160354|38123779|FG000|Overall Study|Death|0|||
16980345|NCT01160354|38123780|FG001|Overall Study|Death|1|||
16980346|NCT01160354|38123781|FG002|Overall Study|Death|1|||
16980347|NCT01160198|38123792|FG000|Overall Study|Withdrawal by Subject|2|||
16980348|NCT01160198|38123793|FG001|Overall Study|Withdrawal by Subject|1|||
16980349|NCT01160198|38123794|FG002|Overall Study|Withdrawal by Subject|0|||
16980350|NCT01160198|38123792|FG000|Overall Study|Adverse Event|0|||
16980351|NCT01160198|38123793|FG001|Overall Study|Adverse Event|1|||
16980352|NCT01160198|38123794|FG002|Overall Study|Adverse Event|0|||
16980353|NCT01160198|38123792|FG000|Overall Study|Lost to Follow-up|0|||
16980354|NCT01160198|38123793|FG001|Overall Study|Lost to Follow-up|1|||
16980355|NCT01160198|38123794|FG002|Overall Study|Lost to Follow-up|0|||
16980356|NCT01160198|38123792|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
16980357|NCT01160198|38123793|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
16980358|NCT01160198|38123794|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
16980359|NCT01159574|38123802|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
16980360|NCT01159574|38123802|FG000|Treatment Phase|Adverse Event|3|||
16980361|NCT01159574|38123802|FG000|Treatment Phase|Death|6|||
16980362|NCT01159574|38123802|FG000|Treatment Phase|Physician Decision|2|||
16980363|NCT01159574|38123802|FG000|Treatment Phase|Withdrawal by Subject|7|||
16980364|NCT01159574|38123802|FG000|Treatment Phase|still on treatment|2|||
16980365|NCT01159574|38123802|FG000|Follow Up Phase|Lost to Follow-up|2|||
16980366|NCT01159574|38123802|FG000|Follow Up Phase|still being followed for overall surviva|18|||
16980367|NCT01158950|38123806|FG000|1st Intervention (1 Day)|Physician Decision|1|||
16980368|NCT01158950|38123807|FG001|1st Intervention (1 Day)|Physician Decision|2|||
16980369|NCT01172288|38123814|FG000|Overall Study|Adverse Event|1|||
16980370|NCT01172288|38123815|FG001|Overall Study|Adverse Event|0|||
16980371|NCT01172288|38123814|FG000|Overall Study|Protocol Violation|0|||
16980372|NCT01172288|38123815|FG001|Overall Study|Protocol Violation|1|||
16980373|NCT00996840|38123826|FG000|Overall Study|Adverse Event|0|||
16980374|NCT00996840|38123827|FG001|Overall Study|Adverse Event|1|||
16980375|NCT00996840|38123828|FG002|Overall Study|Adverse Event|0|||
16980376|NCT00996840|38123829|FG003|Overall Study|Adverse Event|0|||
16980377|NCT00996840|38123830|FG004|Overall Study|Adverse Event|0|||
16980378|NCT00996840|38123826|FG000|Overall Study|Physician Decision|0|||
16980379|NCT00996840|38123827|FG001|Overall Study|Physician Decision|0|||
16980380|NCT00996840|38123828|FG002|Overall Study|Physician Decision|1|||
16980381|NCT00996840|38123829|FG003|Overall Study|Physician Decision|1|||
16980382|NCT00996840|38123830|FG004|Overall Study|Physician Decision|2|||
16980383|NCT00996840|38123826|FG000|Overall Study|Withdrawal by Subject|1|||
16980384|NCT00996840|38123827|FG001|Overall Study|Withdrawal by Subject|1|||
16980385|NCT00996840|38123828|FG002|Overall Study|Withdrawal by Subject|0|||
16980386|NCT00996840|38123829|FG003|Overall Study|Withdrawal by Subject|0|||
16980387|NCT00996840|38123830|FG004|Overall Study|Withdrawal by Subject|0|||
16980388|NCT00998946|38123846|FG000|Overall Study|Lost to Follow-up|1|||
16980389|NCT00998946|38123846|FG000|Overall Study|Withdrawal by Subject|1|||
16980390|NCT00998946|38123846|FG000|Overall Study|Death|2|||
16980391|NCT00998946|38123846|FG000|Overall Study|Reason Unspecified|3|||
16980392|NCT00998946|38123846|FG000|Overall Study|Enrolled but not Dosed|2|||
16980393|NCT01158404|38123858|FG000|Overall Study|Withdrawal by Subject|0|||
16980394|NCT01158404|38123859|FG001|Overall Study|Withdrawal by Subject|1|||
16980395|NCT01158404|38123860|FG002|Overall Study|Withdrawal by Subject|0|||
16980396|NCT01158404|38123861|FG003|Overall Study|Withdrawal by Subject|0|||
16980397|NCT01158404|38123862|FG004|Overall Study|Withdrawal by Subject|3|||
16980398|NCT01158404|38123863|FG005|Overall Study|Withdrawal by Subject|1|||
16980399|NCT01158404|38123864|FG006|Overall Study|Withdrawal by Subject|0|||
16980400|NCT01158404|38123865|FG007|Overall Study|Withdrawal by Subject|1|||
16980401|NCT01158404|38123858|FG000|Overall Study|Physician Decision|0|||
16980402|NCT01158404|38123859|FG001|Overall Study|Physician Decision|0|||
16980403|NCT01158404|38123860|FG002|Overall Study|Physician Decision|0|||
16980404|NCT01158404|38123861|FG003|Overall Study|Physician Decision|0|||
16980405|NCT01158404|38123862|FG004|Overall Study|Physician Decision|0|||
16980406|NCT01158404|38123863|FG005|Overall Study|Physician Decision|0|||
16980407|NCT01158404|38123864|FG006|Overall Study|Physician Decision|0|||
16980408|NCT01158404|38123865|FG007|Overall Study|Physician Decision|1|||
16980409|NCT01158404|38123858|FG000|Overall Study|Progressive Disease|0|||
16980410|NCT01158404|38123859|FG001|Overall Study|Progressive Disease|0|||
16980411|NCT01158404|38123860|FG002|Overall Study|Progressive Disease|0|||
16980412|NCT01158404|38123861|FG003|Overall Study|Progressive Disease|0|||
16980413|NCT01158404|38123862|FG004|Overall Study|Progressive Disease|0|||
16980414|NCT01158404|38123863|FG005|Overall Study|Progressive Disease|0|||
16980415|NCT01158404|38123864|FG006|Overall Study|Progressive Disease|1|||
16980416|NCT01158404|38123865|FG007|Overall Study|Progressive Disease|0|||
16980417|NCT00998790|38123885|FG000|Overall Study|Withdrawal by Subject|21|||
16980418|NCT01001988|38123889|FG000|Overall Study|Protocol Violation|84|||
16980419|NCT01001988|38123889|FG000|Overall Study|Withdrawal by Subject|18|||
16980420|NCT01001988|38123889|FG000|Overall Study|Lost to Follow-up|15|||
16980421|NCT00996606|38123893|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
16980422|NCT00996606|38123893|FG000|Overall Study|Insufficient Therapeutic Response|2|||
16980423|NCT00996606|38123893|FG000|Overall Study|Protocol Violation|1|||
16980424|NCT00996606|38123893|FG000|Overall Study|Withdrawal by Subject|3|||
16980425|NCT00995436|38123900|FG000|Overall Study|Withdrawal by Subject|2|||
16980426|NCT00995436|38123901|FG001|Overall Study|Withdrawal by Subject|5|||
16980427|NCT00995436|38123902|FG002|Overall Study|Withdrawal by Subject|0|||
16980428|NCT00994890|38123913|FG000|Overall Study|Adverse Event|13|||
16980429|NCT00994890|38123914|FG001|Overall Study|Adverse Event|9|||
16980430|NCT00994890|38123915|FG002|Overall Study|Adverse Event|11|||
16980431|NCT00994890|38123913|FG000|Overall Study|Lack of Efficacy|0|||
16980432|NCT00994890|38123914|FG001|Overall Study|Lack of Efficacy|0|||
16980433|NCT00994890|38123915|FG002|Overall Study|Lack of Efficacy|1|||
16980434|NCT00994890|38123913|FG000|Overall Study|Lost to Follow-up|6|||
16980435|NCT00994890|38123914|FG001|Overall Study|Lost to Follow-up|1|||
16980436|NCT00994890|38123915|FG002|Overall Study|Lost to Follow-up|3|||
16980437|NCT00994890|38123913|FG000|Overall Study|No longer willing to participate|8|||
16980438|NCT00994890|38123914|FG001|Overall Study|No longer willing to participate|5|||
16980439|NCT00994890|38123915|FG002|Overall Study|No longer willing to participate|13|||
16980440|NCT00994890|38123913|FG000|Overall Study|Protocol Violation|2|||
16980441|NCT00994890|38123914|FG001|Overall Study|Protocol Violation|4|||
16980442|NCT00994890|38123915|FG002|Overall Study|Protocol Violation|0|||
16980443|NCT00994890|38123913|FG000|Overall Study|Study terminated by sponsor|199|||
16980444|NCT00994890|38123914|FG001|Overall Study|Study terminated by sponsor|201|||
16980445|NCT00994890|38123915|FG002|Overall Study|Study terminated by sponsor|197|||
16980446|NCT00994890|38123913|FG000|Overall Study|Randomized, but not treated|1|||
16980447|NCT00994890|38123914|FG001|Overall Study|Randomized, but not treated|0|||
16980448|NCT00994890|38123915|FG002|Overall Study|Randomized, but not treated|0|||
16980449|NCT00994890|38123913|FG000|Overall Study|Other|2|||
16980450|NCT00994890|38123914|FG001|Overall Study|Other|2|||
16980451|NCT00994890|38123915|FG002|Overall Study|Other|1|||
16980452|NCT00994422|38123925|FG000|Overall Study|Lost to Follow-up|7|||
16980453|NCT00994422|38123926|FG001|Overall Study|Lost to Follow-up|1|||
16980454|NCT01171976|38123937|FG000|Overall Study|Protocol Violation|0|||
16980455|NCT01171976|38123938|FG001|Overall Study|Protocol Violation|0|||
16980456|NCT01171976|38123939|FG002|Overall Study|Protocol Violation|1|||
16980457|NCT01171976|38123937|FG000|Overall Study|Death|2|||
16980458|NCT01171976|38123938|FG001|Overall Study|Death|4|||
16980459|NCT01171976|38123939|FG002|Overall Study|Death|1|||
16980460|NCT01171976|38123937|FG000|Overall Study|Lost to Follow-up|4|||
16980461|NCT01171976|38123938|FG001|Overall Study|Lost to Follow-up|0|||
16980462|NCT01171976|38123939|FG002|Overall Study|Lost to Follow-up|2|||
16980463|NCT01171976|38123937|FG000|Overall Study|Withdrawal by Subject|1|||
16980464|NCT01171976|38123938|FG001|Overall Study|Withdrawal by Subject|5|||
16980465|NCT01171976|38123939|FG002|Overall Study|Withdrawal by Subject|6|||
16980466|NCT01171976|38123937|FG000|Overall Study|Abnormal test result|1|||
16980467|NCT01171976|38123938|FG001|Overall Study|Abnormal test result|0|||
16980468|NCT01171976|38123939|FG002|Overall Study|Abnormal test result|0|||
16980469|NCT01171976|38123937|FG000|Overall Study|Adverse Event|6|||
16980470|NCT01171976|38123938|FG001|Overall Study|Adverse Event|2|||
16980471|NCT01171976|38123939|FG002|Overall Study|Adverse Event|5|||
16980472|NCT00996216|38123947|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
16980473|NCT00996216|38123947|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
16980474|NCT00996216|38123947|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
16980475|NCT00830869|38123964|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
16980476|NCT00830869|38123965|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
16980477|NCT00830869|38123966|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
16980478|NCT00830869|38123967|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
16980479|NCT00830869|38123968|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
16980480|NCT00830869|38123969|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
16980481|NCT00830869|38123970|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
16980482|NCT00830869|38123971|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
16980483|NCT00830869|38123972|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
16980484|NCT00830869|38123973|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
16980485|NCT00830869|38123974|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
16980486|NCT00830869|38123975|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
16980487|NCT00830869|38123964|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
16980488|NCT00830869|38123965|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
16980489|NCT00830869|38123966|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
16980490|NCT00830869|38123967|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
16980491|NCT00830869|38123968|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
16980492|NCT00830869|38123969|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
16980493|NCT00830869|38123970|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
16980494|NCT00830869|38123971|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
16980495|NCT00830869|38123972|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
16980496|NCT00830869|38123973|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
16980497|NCT00830869|38123974|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
16980498|NCT00830869|38123975|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
16980499|NCT00830869|38123964|FG000|Period 1: Part 1|Adverse Event|0|||
16780197|NCT01375049|37719297|FG000|Overall Study|Withdrawal by Subject|2|||
16980500|NCT00830869|38123965|FG001|Period 1: Part 1|Adverse Event|0|||
16980501|NCT00830869|38123966|FG002|Period 1: Part 1|Adverse Event|0|||
16980502|NCT00830869|38123967|FG003|Period 1: Part 1|Adverse Event|0|||
16980503|NCT00830869|38123968|FG004|Period 1: Part 1|Adverse Event|0|||
16980504|NCT00830869|38123969|FG005|Period 1: Part 1|Adverse Event|1|||
16980505|NCT00830869|38123970|FG006|Period 1: Part 1|Adverse Event|1|||
16980506|NCT00830869|38123971|FG007|Period 1: Part 1|Adverse Event|0|||
16980507|NCT00830869|38123972|FG008|Period 1: Part 1|Adverse Event|0|||
16980508|NCT00830869|38123973|FG009|Period 1: Part 1|Adverse Event|0|||
16980509|NCT00830869|38123974|FG010|Period 1: Part 1|Adverse Event|0|||
16980510|NCT00830869|38123975|FG011|Period 1: Part 1|Adverse Event|0|||
16980511|NCT00830869|38123964|FG000|Period 1: Part 1|Progressive disease|1|||
16980512|NCT00830869|38123965|FG001|Period 1: Part 1|Progressive disease|0|||
16980513|NCT00830869|38123966|FG002|Period 1: Part 1|Progressive disease|1|||
16980514|NCT00830869|38123967|FG003|Period 1: Part 1|Progressive disease|6|||
16980515|NCT00830869|38123968|FG004|Period 1: Part 1|Progressive disease|4|||
16980516|NCT00830869|38123969|FG005|Period 1: Part 1|Progressive disease|4|||
16980517|NCT00830869|38123970|FG006|Period 1: Part 1|Progressive disease|1|||
16980518|NCT00830869|38123971|FG007|Period 1: Part 1|Progressive disease|0|||
16980519|NCT00830869|38123972|FG008|Period 1: Part 1|Progressive disease|0|||
16980520|NCT00830869|38123973|FG009|Period 1: Part 1|Progressive disease|0|||
16980521|NCT00830869|38123974|FG010|Period 1: Part 1|Progressive disease|0|||
16980522|NCT00830869|38123975|FG011|Period 1: Part 1|Progressive disease|0|||
16980523|NCT00830869|38123964|FG000|Period 2: Part 2|Protocol Violation|0|||
16980524|NCT00830869|38123965|FG001|Period 2: Part 2|Protocol Violation|0|||
16980525|NCT00830869|38123966|FG002|Period 2: Part 2|Protocol Violation|0|||
16980526|NCT00830869|38123967|FG003|Period 2: Part 2|Protocol Violation|0|||
16980527|NCT00830869|38123968|FG004|Period 2: Part 2|Protocol Violation|0|||
16980528|NCT00830869|38123969|FG005|Period 2: Part 2|Protocol Violation|0|||
16980529|NCT00830869|38123970|FG006|Period 2: Part 2|Protocol Violation|0|||
16980530|NCT00830869|38123971|FG007|Period 2: Part 2|Protocol Violation|1|||
16980531|NCT00830869|38123972|FG008|Period 2: Part 2|Protocol Violation|0|||
16980532|NCT00830869|38123973|FG009|Period 2: Part 2|Protocol Violation|1|||
16980533|NCT00830869|38123974|FG010|Period 2: Part 2|Protocol Violation|0|||
16980534|NCT00830869|38123975|FG011|Period 2: Part 2|Protocol Violation|0|||
16980535|NCT00830869|38123964|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
16980536|NCT00830869|38123965|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
16980537|NCT00830869|38123966|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
16980538|NCT00830869|38123967|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
16980539|NCT00830869|38123968|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
16980540|NCT00830869|38123969|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
16980541|NCT00830869|38123970|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
16980542|NCT00830869|38123971|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
16980543|NCT00830869|38123972|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
16980544|NCT00830869|38123973|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
16980545|NCT00830869|38123974|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
16980546|NCT00830869|38123975|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
16980547|NCT00830869|38123964|FG000|Period 2: Part 2|Adverse Event|0|||
16980548|NCT00830869|38123965|FG001|Period 2: Part 2|Adverse Event|0|||
16980549|NCT00830869|38123966|FG002|Period 2: Part 2|Adverse Event|0|||
16980550|NCT00830869|38123967|FG003|Period 2: Part 2|Adverse Event|0|||
16980551|NCT00830869|38123968|FG004|Period 2: Part 2|Adverse Event|0|||
16980552|NCT00830869|38123969|FG005|Period 2: Part 2|Adverse Event|0|||
16980553|NCT00830869|38123970|FG006|Period 2: Part 2|Adverse Event|0|||
16980554|NCT00830869|38123971|FG007|Period 2: Part 2|Adverse Event|4|||
16980555|NCT00830869|38123972|FG008|Period 2: Part 2|Adverse Event|3|||
16980556|NCT00830869|38123973|FG009|Period 2: Part 2|Adverse Event|2|||
16980557|NCT00830869|38123974|FG010|Period 2: Part 2|Adverse Event|2|||
16980558|NCT00830869|38123975|FG011|Period 2: Part 2|Adverse Event|0|||
16980559|NCT00830869|38123964|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
16980560|NCT00830869|38123965|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
16980561|NCT00830869|38123966|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
16980562|NCT00830869|38123967|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
16980563|NCT00830869|38123968|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
16980564|NCT00830869|38123969|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
16980565|NCT00830869|38123970|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
16980566|NCT00830869|38123971|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
16980567|NCT00830869|38123972|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
16980568|NCT00830869|38123973|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
16980569|NCT00830869|38123974|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
16980570|NCT00830869|38123975|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
16980571|NCT00830869|38123964|FG000|Period 2: Part 2|Progressive disease|0|||
16980572|NCT00830869|38123965|FG001|Period 2: Part 2|Progressive disease|0|||
16980573|NCT00830869|38123966|FG002|Period 2: Part 2|Progressive disease|0|||
16980574|NCT00830869|38123967|FG003|Period 2: Part 2|Progressive disease|0|||
16980575|NCT00830869|38123968|FG004|Period 2: Part 2|Progressive disease|0|||
16980576|NCT00830869|38123969|FG005|Period 2: Part 2|Progressive disease|0|||
16980577|NCT00830869|38123970|FG006|Period 2: Part 2|Progressive disease|0|||
16980578|NCT00830869|38123971|FG007|Period 2: Part 2|Progressive disease|14|||
16980579|NCT00830869|38123972|FG008|Period 2: Part 2|Progressive disease|11|||
16980580|NCT00830869|38123973|FG009|Period 2: Part 2|Progressive disease|12|||
16980581|NCT00830869|38123974|FG010|Period 2: Part 2|Progressive disease|8|||
16980582|NCT00830869|38123975|FG011|Period 2: Part 2|Progressive disease|15|||
16980583|NCT00830869|38123964|FG000|Period 2: Part 2|Other|0|||
16980584|NCT00830869|38123965|FG001|Period 2: Part 2|Other|0|||
16980585|NCT00830869|38123966|FG002|Period 2: Part 2|Other|0|||
16980586|NCT00830869|38123967|FG003|Period 2: Part 2|Other|0|||
16980587|NCT00830869|38123968|FG004|Period 2: Part 2|Other|0|||
16980588|NCT00830869|38123969|FG005|Period 2: Part 2|Other|0|||
16980589|NCT00830869|38123970|FG006|Period 2: Part 2|Other|0|||
16980590|NCT00830869|38123971|FG007|Period 2: Part 2|Other|0|||
16980591|NCT00830869|38123972|FG008|Period 2: Part 2|Other|0|||
16980592|NCT00830869|38123973|FG009|Period 2: Part 2|Other|1|||
16980593|NCT00830869|38123974|FG010|Period 2: Part 2|Other|0|||
16980594|NCT00830869|38123975|FG011|Period 2: Part 2|Other|0|||
16980595|NCT00844519|38124004|FG000|Overall Study|Withdrawal by Subject|1|||
16980596|NCT00844519|38124005|FG001|Overall Study|Withdrawal by Subject|1|||
16980597|NCT00844519|38124004|FG000|Overall Study|Adverse Event|1|||
16980598|NCT00844519|38124005|FG001|Overall Study|Adverse Event|0|||
16980599|NCT01171820|38124013|FG000|Overall Study|Death|3|||
16980600|NCT01171820|38124014|FG001|Overall Study|Death|3|||
16980601|NCT01171820|38124013|FG000|Overall Study|Lost to Follow-up|0|||
16980602|NCT01171820|38124014|FG001|Overall Study|Lost to Follow-up|1|||
16980603|NCT01171820|38124013|FG000|Overall Study|Withdrawal by Subject|2|||
16980604|NCT01171820|38124014|FG001|Overall Study|Withdrawal by Subject|0|||
16980605|NCT01171820|38124013|FG000|Overall Study|Physician Decision|0|||
16980606|NCT01171820|38124014|FG001|Overall Study|Physician Decision|1|||
16980607|NCT01171820|38124013|FG000|Overall Study|1-Year Missed Visit|1|||
16980608|NCT01171820|38124014|FG001|Overall Study|1-Year Missed Visit|1|||
16980609|NCT00994110|38124022|FG000|Overall Study|Withdrawal by Subject|9|||
16980610|NCT00994110|38124023|FG001|Overall Study|Withdrawal by Subject|9|||
16980611|NCT00994110|38124022|FG000|Overall Study|Not Treated|4|||
16980612|NCT00994110|38124023|FG001|Overall Study|Not Treated|8|||
16980613|NCT00994110|38124022|FG000|Overall Study|Adverse Event|1|||
16980614|NCT00994110|38124023|FG001|Overall Study|Adverse Event|0|||
16980615|NCT00994110|38124022|FG000|Overall Study|Patient not resected|41|||
16980616|NCT00994110|38124023|FG001|Overall Study|Patient not resected|52|||
16980617|NCT00994110|38124022|FG000|Overall Study|Pt not eligible|10|||
16980618|NCT00994110|38124023|FG001|Overall Study|Pt not eligible|5|||
16980619|NCT00993954|38124031|FG000|Overall Study|Protocol Violation|21|||
16980620|NCT00993954|38124032|FG001|Overall Study|Protocol Violation|2|||
16980621|NCT01157234|38124040|FG000|Overall Study|Withdrawal by Subject|1|||
16980622|NCT01157234|38124041|FG001|Overall Study|Withdrawal by Subject|0|||
16980623|NCT00991302|38124056|FG000|Overall Study|Death|0|||
16980624|NCT00991302|38124057|FG001|Overall Study|Death|1|||
16980625|NCT00991302|38124056|FG000|Overall Study|Lost to Follow-up|14|||
16980626|NCT00991302|38124057|FG001|Overall Study|Lost to Follow-up|12|||
16980627|NCT00995670|38124066|FG000|Overall Study|Failed arterial cannulation|1|||
16980628|NCT00995670|38124067|FG001|Overall Study|Failed arterial cannulation|0|||
16980629|NCT00995670|38124068|FG002|Overall Study|Failed arterial cannulation|3|||
16980630|NCT00601354|38124078|FG000|Overall Study|Lost to Follow-up|4|||
16980631|NCT00601354|38124079|FG001|Overall Study|Lost to Follow-up|5|||
16980632|NCT00853099|38124088|FG000|Double-blind Period|Adverse Event|7|||
16980633|NCT00853099|38124089|FG001|Double-blind Period|Adverse Event|9|||
16980634|NCT00853099|38124090|FG002|Double-blind Period|Adverse Event|13|||
16980635|NCT00853099|38124091|FG003|Double-blind Period|Adverse Event|0|||
16980636|NCT00853099|38124088|FG000|Double-blind Period|Withdrawal by Subject|2|||
16980637|NCT00853099|38124089|FG001|Double-blind Period|Withdrawal by Subject|3|||
16980638|NCT00853099|38124090|FG002|Double-blind Period|Withdrawal by Subject|0|||
16980639|NCT00853099|38124091|FG003|Double-blind Period|Withdrawal by Subject|0|||
16980640|NCT00853099|38124088|FG000|Double-blind Period|Lack of Efficacy|14|||
16980641|NCT00853099|38124089|FG001|Double-blind Period|Lack of Efficacy|17|||
16980642|NCT00853099|38124090|FG002|Double-blind Period|Lack of Efficacy|16|||
16980643|NCT00853099|38124091|FG003|Double-blind Period|Lack of Efficacy|0|||
16980644|NCT00853099|38124088|FG000|Double-blind Period|Other|0|||
16980645|NCT00853099|38124089|FG001|Double-blind Period|Other|0|||
16980646|NCT00853099|38124090|FG002|Double-blind Period|Other|1|||
16980647|NCT00853099|38124091|FG003|Double-blind Period|Other|0|||
16980648|NCT00853099|38124088|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
16980649|NCT00853099|38124089|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
16980650|NCT00853099|38124090|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
16980651|NCT00853099|38124091|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
16980652|NCT00853099|38124088|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
16980653|NCT00853099|38124089|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
16980654|NCT00853099|38124090|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
16980655|NCT00853099|38124091|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
16980656|NCT00853099|38124088|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
16980657|NCT00853099|38124089|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
16980658|NCT00853099|38124090|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
16980659|NCT00853099|38124091|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
16980660|NCT00853099|38124088|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
16980661|NCT00853099|38124089|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
16980662|NCT00853099|38124090|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
16980663|NCT00853099|38124091|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
16980664|NCT00853099|38124088|FG000|Double-blind + Open-label Periods|Other|0|||
16980665|NCT00853099|38124089|FG001|Double-blind + Open-label Periods|Other|0|||
16980666|NCT00853099|38124090|FG002|Double-blind + Open-label Periods|Other|0|||
16980667|NCT00853099|38124091|FG003|Double-blind + Open-label Periods|Other|6|||
16980668|NCT00992784|38124104|FG000|Overall Study|Adverse Event|2|||
16980669|NCT00992784|38124105|FG001|Overall Study|Adverse Event|1|||
16980670|NCT00992784|38124106|FG002|Overall Study|Adverse Event|0|||
16980671|NCT00992784|38124104|FG000|Overall Study|Withdrawal by Subject|1|||
16980672|NCT00992784|38124105|FG001|Overall Study|Withdrawal by Subject|1|||
16980673|NCT00992784|38124106|FG002|Overall Study|Withdrawal by Subject|1|||
16980674|NCT00830167|38124116|FG000|Overall Study|Lack of Efficacy|26|||
16980675|NCT00830167|38124117|FG001|Overall Study|Lack of Efficacy|10|||
16980676|NCT00830167|38124116|FG000|Overall Study|Adverse Event|8|||
16980677|NCT00830167|38124117|FG001|Overall Study|Adverse Event|24|||
16980678|NCT00830167|38124116|FG000|Overall Study|Not meeting entrance criteria|2|||
16980679|NCT00830167|38124117|FG001|Overall Study|Not meeting entrance criteria|5|||
16980680|NCT00830167|38124116|FG000|Overall Study|Withdrawal by Subject|2|||
16980681|NCT00830167|38124117|FG001|Overall Study|Withdrawal by Subject|0|||
16980682|NCT00830167|38124116|FG000|Overall Study|Lost to Follow-up|0|||
16980683|NCT00830167|38124117|FG001|Overall Study|Lost to Follow-up|1|||
16980684|NCT00830167|38124116|FG000|Overall Study|Protocol Violation|0|||
16980685|NCT00830167|38124117|FG001|Overall Study|Protocol Violation|1|||
16980686|NCT00830167|38124116|FG000|Overall Study|Other|2|||
16980687|NCT00830167|38124117|FG001|Overall Study|Other|2|||
16980688|NCT00992394|38124125|FG000|Overall Study|Lack of Efficacy|6|||
16980689|NCT00992394|38124126|FG001|Overall Study|Lack of Efficacy|3|||
16980690|NCT00992394|38124125|FG000|Overall Study|Adverse Event|4|||
16980691|NCT00992394|38124126|FG001|Overall Study|Adverse Event|5|||
16980692|NCT00992394|38124125|FG000|Overall Study|Withdrawal by Subject|8|||
16980693|NCT00992394|38124126|FG001|Overall Study|Withdrawal by Subject|2|||
16980694|NCT00992394|38124125|FG000|Overall Study|Physician Decision|1|||
16980695|NCT00992394|38124126|FG001|Overall Study|Physician Decision|0|||
16980696|NCT00992394|38124125|FG000|Overall Study|Protocol Violation|2|||
16980697|NCT00992394|38124126|FG001|Overall Study|Protocol Violation|4|||
16980698|NCT00992394|38124125|FG000|Overall Study|Lost to Follow-up|2|||
16980699|NCT00992394|38124126|FG001|Overall Study|Lost to Follow-up|0|||
16980700|NCT00992394|38124125|FG000|Overall Study|Other event|1|||
16980701|NCT00992394|38124126|FG001|Overall Study|Other event|0|||
16980702|NCT00829933|38124136|FG000|Overall Study|Adverse Event|2|||
16780198|NCT01375049|37719297|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
16780199|NCT01594749|37719307|FG000|Overall Study|Adverse Event|2|||
16780200|NCT01594749|37719308|FG001|Overall Study|Adverse Event|1|||
16780201|NCT01594749|37719307|FG000|Overall Study|Withdrawal by Subject|2|||
16780202|NCT01594749|37719308|FG001|Overall Study|Withdrawal by Subject|2|||
16780203|NCT01594749|37719307|FG000|Overall Study|Protocol Violation|2|||
16780204|NCT01594749|37719308|FG001|Overall Study|Protocol Violation|0|||
16780205|NCT01594749|37719307|FG000|Overall Study|Physician Decision|1|||
16780206|NCT01594749|37719308|FG001|Overall Study|Physician Decision|1|||
16980703|NCT00829933|38124137|FG001|Overall Study|Adverse Event|3|||
16980704|NCT00829933|38124138|FG002|Overall Study|Adverse Event|2|||
16980705|NCT00829933|38124139|FG003|Overall Study|Adverse Event|1|||
16980706|NCT00829933|38124136|FG000|Overall Study|Death|0|||
16980707|NCT00829933|38124137|FG001|Overall Study|Death|0|||
16980708|NCT00829933|38124138|FG002|Overall Study|Death|1|||
16980709|NCT00829933|38124139|FG003|Overall Study|Death|1|||
16980710|NCT00829933|38124136|FG000|Overall Study|Lack of Efficacy|0|||
16980711|NCT00829933|38124137|FG001|Overall Study|Lack of Efficacy|1|||
16980712|NCT00829933|38124138|FG002|Overall Study|Lack of Efficacy|0|||
16980713|NCT00829933|38124139|FG003|Overall Study|Lack of Efficacy|0|||
16980714|NCT00829933|38124136|FG000|Overall Study|Physician Decision|5|||
16980715|NCT00829933|38124137|FG001|Overall Study|Physician Decision|7|||
16980716|NCT00829933|38124138|FG002|Overall Study|Physician Decision|8|||
16980717|NCT00829933|38124139|FG003|Overall Study|Physician Decision|1|||
16980718|NCT00829933|38124136|FG000|Overall Study|Pregnancy|0|||
16980719|NCT00829933|38124137|FG001|Overall Study|Pregnancy|0|||
16980720|NCT00829933|38124138|FG002|Overall Study|Pregnancy|0|||
16980721|NCT00829933|38124139|FG003|Overall Study|Pregnancy|2|||
16980722|NCT00829933|38124136|FG000|Overall Study|Protocol Violation|2|||
16980723|NCT00829933|38124137|FG001|Overall Study|Protocol Violation|1|||
16980724|NCT00829933|38124138|FG002|Overall Study|Protocol Violation|0|||
16980725|NCT00829933|38124139|FG003|Overall Study|Protocol Violation|0|||
16980726|NCT00829933|38124136|FG000|Overall Study|withdrew before treatment started|5|||
16980727|NCT00829933|38124137|FG001|Overall Study|withdrew before treatment started|1|||
16980728|NCT00829933|38124138|FG002|Overall Study|withdrew before treatment started|2|||
16980729|NCT00829933|38124139|FG003|Overall Study|withdrew before treatment started|9|||
16980730|NCT01170962|38124152|FG000|Treatment Period|Lack of Efficacy|96|||
16980731|NCT01170962|38124153|FG001|Treatment Period|Lack of Efficacy|91|||
16980732|NCT01170962|38124154|FG002|Treatment Period|Lack of Efficacy|7|||
16980733|NCT01170962|38124152|FG000|Treatment Period|Adverse Event|11|||
16980734|NCT01170962|38124153|FG001|Treatment Period|Adverse Event|12|||
16980735|NCT01170962|38124154|FG002|Treatment Period|Adverse Event|3|||
16980736|NCT01170962|38124152|FG000|Treatment Period|Withdrawal by Subject|2|||
16980737|NCT01170962|38124153|FG001|Treatment Period|Withdrawal by Subject|1|||
16980738|NCT01170962|38124154|FG002|Treatment Period|Withdrawal by Subject|0|||
16980739|NCT01170962|38124152|FG000|Treatment Period|Lost to Follow-up|1|||
16980740|NCT01170962|38124153|FG001|Treatment Period|Lost to Follow-up|1|||
16980741|NCT01170962|38124154|FG002|Treatment Period|Lost to Follow-up|1|||
16980742|NCT01170962|38124152|FG000|Treatment Period|Participant no longer meets criteria|0|||
16980743|NCT01170962|38124153|FG001|Treatment Period|Participant no longer meets criteria|1|||
16980744|NCT01170962|38124154|FG002|Treatment Period|Participant no longer meets criteria|0|||
16980745|NCT01170962|38124152|FG000|Treatment Period|Request to discontinue treatment|7|||
16980746|NCT01170962|38124153|FG001|Treatment Period|Request to discontinue treatment|3|||
16980747|NCT01170962|38124154|FG002|Treatment Period|Request to discontinue treatment|1|||
16980748|NCT01170962|38124152|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
16980749|NCT01170962|38124153|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
16980750|NCT01170962|38124154|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
16980751|NCT01170962|38124152|FG000|Follow up Period|Withdrawal by Subject|14|||
16980752|NCT01170962|38124153|FG001|Follow up Period|Withdrawal by Subject|10|||
16980753|NCT01170962|38124154|FG002|Follow up Period|Withdrawal by Subject|2|||
16980754|NCT01170962|38124152|FG000|Follow up Period|Lost to Follow-up|13|||
16980755|NCT01170962|38124153|FG001|Follow up Period|Lost to Follow-up|8|||
16980756|NCT01170962|38124154|FG002|Follow up Period|Lost to Follow-up|1|||
16980757|NCT01170962|38124152|FG000|Follow up Period|Death|2|||
16980758|NCT01170962|38124153|FG001|Follow up Period|Death|2|||
16980759|NCT01170962|38124154|FG002|Follow up Period|Death|0|||
16980760|NCT01170962|38124152|FG000|Follow up Period|Others|10|||
16980761|NCT01170962|38124153|FG001|Follow up Period|Others|7|||
16980762|NCT01170962|38124154|FG002|Follow up Period|Others|3|||
16980763|NCT00843193|38124173|FG000|Overall Study|Adverse Event|2|||
16980764|NCT00843193|38124174|FG001|Overall Study|Adverse Event|4|||
16980765|NCT00843193|38124173|FG000|Overall Study|Lack of Efficacy|1|||
16980766|NCT00843193|38124174|FG001|Overall Study|Lack of Efficacy|1|||
16980767|NCT00843193|38124173|FG000|Overall Study|Protocol Violation|1|||
16980768|NCT00843193|38124174|FG001|Overall Study|Protocol Violation|2|||
16980769|NCT00843193|38124173|FG000|Overall Study|Lost to Follow-up|1|||
16980770|NCT00843193|38124174|FG001|Overall Study|Lost to Follow-up|0|||
16980771|NCT00843193|38124173|FG000|Overall Study|Physician Decision|0|||
16980772|NCT00843193|38124174|FG001|Overall Study|Physician Decision|1|||
16980773|NCT00843193|38124173|FG000|Overall Study|Withdrawal by Subject|3|||
16980774|NCT00843193|38124174|FG001|Overall Study|Withdrawal by Subject|3|||
16980775|NCT00829621|38124183|FG000|Overall Study|Death|1|||
16980776|NCT00829621|38124184|FG001|Overall Study|Death|0|||
16980777|NCT00829621|38124183|FG000|Overall Study|Lost to Follow-up|3|||
16980778|NCT00829621|38124184|FG001|Overall Study|Lost to Follow-up|4|||
16980779|NCT01157078|38124192|FG000|Overall Study|Withdrawal by Subject|12|||
16980780|NCT01157078|38124193|FG001|Overall Study|Withdrawal by Subject|14|||
17134044|NCT02095132|38275295|FG002|Overall Study|Physician Decision|0|||
16980781|NCT01157078|38124192|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16980782|NCT01157078|38124193|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16980783|NCT01157078|38124192|FG000|Overall Study|Adverse Event|6|||
16980784|NCT01157078|38124193|FG001|Overall Study|Adverse Event|6|||
16980785|NCT01157078|38124192|FG000|Overall Study|Severe non-compliance to protocol|2|||
16980786|NCT01157078|38124193|FG001|Overall Study|Severe non-compliance to protocol|4|||
16980787|NCT01157078|38124192|FG000|Overall Study|Condition under investigation worsened|0|||
16980788|NCT01157078|38124193|FG001|Overall Study|Condition under investigation worsened|1|||
16980789|NCT01157078|38124192|FG000|Overall Study|Lack of Efficacy|2|||
16980790|NCT01157078|38124193|FG001|Overall Study|Lack of Efficacy|0|||
16980791|NCT01157078|38124192|FG000|Overall Study|Study-specific withdrawal criteria|2|||
16980792|NCT01157078|38124193|FG001|Overall Study|Study-specific withdrawal criteria|2|||
16980793|NCT01157078|38124192|FG000|Overall Study|Lost to Follow-up|7|||
16980794|NCT01157078|38124193|FG001|Overall Study|Lost to Follow-up|5|||
16980795|NCT01157078|38124192|FG000|Overall Study|Other|2|||
16980796|NCT01157078|38124193|FG001|Overall Study|Other|4|||
16980797|NCT00591721|38124201|FG000|Overall Study|Withdrawal by Subject|10|||
16980798|NCT00591721|38124202|FG001|Overall Study|Withdrawal by Subject|10|||
16980799|NCT00591721|38124201|FG000|Overall Study|Lost to Follow-up|1|||
16980800|NCT00591721|38124202|FG001|Overall Study|Lost to Follow-up|4|||
16980801|NCT00591721|38124201|FG000|Overall Study|Intervention not received|10|||
16980802|NCT00591721|38124202|FG001|Overall Study|Intervention not received|8|||
16980803|NCT01156844|38124212|FG000|Overall Study|Adverse Event|0|||
16980804|NCT01156844|38124213|FG001|Overall Study|Adverse Event|0|||
16980805|NCT01156844|38124214|FG002|Overall Study|Adverse Event|1|||
16980806|NCT01156844|38124215|FG003|Overall Study|Adverse Event|1|||
16980807|NCT01156844|38124212|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16980808|NCT01156844|38124213|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16980809|NCT01156844|38124214|FG002|Overall Study|Abnormal test procedure result(s)|2|||
16980810|NCT01156844|38124215|FG003|Overall Study|Abnormal test procedure result(s)|2|||
16980811|NCT01156844|38124212|FG000|Overall Study|Withdrawal by Subject|0|||
16980812|NCT01156844|38124213|FG001|Overall Study|Withdrawal by Subject|0|||
16980813|NCT01156844|38124214|FG002|Overall Study|Withdrawal by Subject|2|||
16980814|NCT01156844|38124215|FG003|Overall Study|Withdrawal by Subject|2|||
16980815|NCT01156844|38124212|FG000|Overall Study|Lost to Follow-up|0|||
16980816|NCT01156844|38124213|FG001|Overall Study|Lost to Follow-up|0|||
16980817|NCT01156844|38124214|FG002|Overall Study|Lost to Follow-up|1|||
16980818|NCT01156844|38124215|FG003|Overall Study|Lost to Follow-up|0|||
16980819|NCT01156844|38124212|FG000|Overall Study|Administrative problems|0|||
16980820|NCT01156844|38124213|FG001|Overall Study|Administrative problems|1|||
16980821|NCT01156844|38124214|FG002|Overall Study|Administrative problems|0|||
16980822|NCT01156844|38124215|FG003|Overall Study|Administrative problems|1|||
16980823|NCT01156844|38124212|FG000|Overall Study|Protocol deviation|2|||
16980824|NCT01156844|38124213|FG001|Overall Study|Protocol deviation|0|||
16980825|NCT01156844|38124214|FG002|Overall Study|Protocol deviation|0|||
16980826|NCT01156844|38124215|FG003|Overall Study|Protocol deviation|0|||
16980827|NCT00853021|38124228|FG000|Overall Study|Adverse Event|2|||
16980828|NCT00853021|38124228|FG000|Overall Study|Withdrawal by Subject|2|||
16980829|NCT00853021|38124228|FG000|Overall Study|Death|1|||
16980830|NCT01156532|38124232|FG000|Overall Study|Family Reasons|1|||
16980831|NCT01156532|38124232|FG000|Overall Study|Lost to Follow-up|1|||
16980832|NCT00843115|38124236|FG000|Overall Study|Death|4|||
16980833|NCT00843115|38124236|FG000|Overall Study|Adverse Event|30|||
16980834|NCT00843115|38124236|FG000|Overall Study|Lost to Follow-up|4|||
16980835|NCT00843115|38124236|FG000|Overall Study|Withdrawal by Subject|17|||
16980836|NCT00843115|38124236|FG000|Overall Study|Family wanted meds stopped|1|||
16980837|NCT00843115|38124236|FG000|Overall Study|Family does not want continuation|1|||
16980838|NCT00843115|38124236|FG000|Overall Study|Patient forgot to take meds|1|||
16980839|NCT00843115|38124236|FG000|Overall Study|Does not meet entrance criteria|1|||
16980840|NCT00843115|38124236|FG000|Overall Study|Physician Decision|1|||
16980841|NCT00843115|38124236|FG000|Overall Study|Family discontinued meds|1|||
16980842|NCT00843115|38124236|FG000|Overall Study|patient took for 2 days then stopped|1|||
16980843|NCT00843115|38124236|FG000|Overall Study|patient never took the medication|1|||
16980844|NCT00843115|38124236|FG000|Overall Study|hospitalized due to deterioration|1|||
16980845|NCT00843115|38124236|FG000|Overall Study|week 12 not done|1|||
16980846|NCT00843115|38124236|FG000|Overall Study|Syndrome De Glissement|1|||
16980847|NCT01156376|38124243|FG000|Overall Study|Adverse Event|1|||
16980848|NCT01156376|38124244|FG001|Overall Study|Adverse Event|0|||
16980849|NCT01156376|38124245|FG002|Overall Study|Adverse Event|1|||
16980850|NCT01156376|38124243|FG000|Overall Study|Withdrawal by Subject|0|||
16980851|NCT01156376|38124244|FG001|Overall Study|Withdrawal by Subject|0|||
16980852|NCT01156376|38124245|FG002|Overall Study|Withdrawal by Subject|3|||
16980853|NCT00829387|38124255|FG000|Overall Study|Withdrawal by Subject|2|||
16980854|NCT00829387|38124256|FG001|Overall Study|Withdrawal by Subject|3|||
16980855|NCT00829387|38124255|FG000|Overall Study|Disqualified by PI|1|||
16980856|NCT00829387|38124256|FG001|Overall Study|Disqualified by PI|0|||
16980857|NCT01156142|38124264|FG000|Overall Study|Withdrawal by Subject|8|||
16980858|NCT01156142|38124265|FG001|Overall Study|Withdrawal by Subject|6|||
16980859|NCT01156142|38124264|FG000|Overall Study|Ineligible|0|||
16980860|NCT01156142|38124265|FG001|Overall Study|Ineligible|1|||
16980861|NCT00842257|38124271|FG000|Overall Study|Adverse Event|1|||
16980862|NCT00852475|38124277|FG000|Overall Study|Lost to Follow-up|3|||
16980863|NCT00852475|38124278|FG001|Overall Study|Lost to Follow-up|4|||
16980864|NCT01155284|38124288|FG000|Overall Study|Withdrawal by Subject|4|||
16980865|NCT01155284|38124289|FG001|Overall Study|Withdrawal by Subject|3|||
16980866|NCT01155284|38124288|FG000|Overall Study|Lost to Follow-up|1|||
16980867|NCT01155284|38124289|FG001|Overall Study|Lost to Follow-up|2|||
16980868|NCT01155284|38124288|FG000|Overall Study|Physician Decision|1|||
16980869|NCT01155284|38124289|FG001|Overall Study|Physician Decision|0|||
16980870|NCT01155284|38124288|FG000|Overall Study|Adverse Event|1|||
16980871|NCT01155284|38124289|FG001|Overall Study|Adverse Event|0|||
16980872|NCT00852397|38124300|FG000|Overall Study|Adverse Event|4|||
16980873|NCT00852397|38124301|FG001|Overall Study|Adverse Event|6|||
16980874|NCT00852397|38124302|FG002|Overall Study|Adverse Event|4|||
16980875|NCT00852397|38124300|FG000|Overall Study|Death|0|||
16980876|NCT00852397|38124301|FG001|Overall Study|Death|0|||
16980877|NCT00852397|38124302|FG002|Overall Study|Death|1|||
16980878|NCT00852397|38124300|FG000|Overall Study|Withdrawal by Subject|4|||
16980879|NCT00852397|38124301|FG001|Overall Study|Withdrawal by Subject|1|||
16980880|NCT00852397|38124302|FG002|Overall Study|Withdrawal by Subject|2|||
16980881|NCT00852397|38124300|FG000|Overall Study|Study terminated by sponsor|2|||
16980882|NCT00852397|38124301|FG001|Overall Study|Study terminated by sponsor|1|||
16980883|NCT00852397|38124302|FG002|Overall Study|Study terminated by sponsor|6|||
16980884|NCT00852397|38124300|FG000|Overall Study|Difficulty in study site visit|1|||
16980885|NCT00852397|38124301|FG001|Overall Study|Difficulty in study site visit|0|||
16980886|NCT00852397|38124302|FG002|Overall Study|Difficulty in study site visit|0|||
16980887|NCT00852397|38124300|FG000|Overall Study|Protocol Violation|0|||
16980888|NCT00852397|38124301|FG001|Overall Study|Protocol Violation|0|||
16980889|NCT00852397|38124302|FG002|Overall Study|Protocol Violation|1|||
16980890|NCT00841321|38124312|FG000|Overall Study|Lost to Follow-up|1|||
16980891|NCT00841321|38124313|FG001|Overall Study|Lost to Follow-up|1|||
16980892|NCT00841321|38124312|FG000|Overall Study|Adverse Event|0|||
16980893|NCT00841321|38124313|FG001|Overall Study|Adverse Event|2|||
16980894|NCT00986232|38124325|FG000|Overall Study|Adverse Event|1|||
16980895|NCT00986232|38124326|FG001|Overall Study|Adverse Event|2|||
16980896|NCT00986232|38124327|FG002|Overall Study|Adverse Event|3|||
16980897|NCT00986232|38124328|FG003|Overall Study|Adverse Event|0|||
16980898|NCT00986232|38124325|FG000|Overall Study|Lost to Follow-up|19|||
16980899|NCT00986232|38124326|FG001|Overall Study|Lost to Follow-up|12|||
16980900|NCT00986232|38124327|FG002|Overall Study|Lost to Follow-up|12|||
16980901|NCT00986232|38124328|FG003|Overall Study|Lost to Follow-up|7|||
16980902|NCT00986232|38124325|FG000|Overall Study|Protocol Violation|2|||
16980903|NCT00986232|38124326|FG001|Overall Study|Protocol Violation|3|||
16980904|NCT00986232|38124327|FG002|Overall Study|Protocol Violation|0|||
16980905|NCT00986232|38124328|FG003|Overall Study|Protocol Violation|1|||
16980906|NCT00986232|38124325|FG000|Overall Study|Withdrawal by Subject|13|||
16980907|NCT00986232|38124326|FG001|Overall Study|Withdrawal by Subject|16|||
16980908|NCT00986232|38124327|FG002|Overall Study|Withdrawal by Subject|12|||
16980909|NCT00986232|38124328|FG003|Overall Study|Withdrawal by Subject|3|||
16980910|NCT00986232|38124325|FG000|Overall Study|Missed one or more bleeds|13|||
16980911|NCT00986232|38124326|FG001|Overall Study|Missed one or more bleeds|10|||
16980912|NCT00986232|38124327|FG002|Overall Study|Missed one or more bleeds|6|||
16980913|NCT00986232|38124328|FG003|Overall Study|Missed one or more bleeds|7|||
16980914|NCT00986232|38124325|FG000|Overall Study|Incomplete safety follow-up|3|||
16980915|NCT00986232|38124326|FG001|Overall Study|Incomplete safety follow-up|7|||
16980916|NCT00986232|38124327|FG002|Overall Study|Incomplete safety follow-up|2|||
16980917|NCT00986232|38124328|FG003|Overall Study|Incomplete safety follow-up|2|||
16980918|NCT00852241|38124344|FG000|Overall Study|Physician Decision|18|||
16980919|NCT01169636|38124353|FG000|Overall Study|Adverse Event|0|||
16980920|NCT01169636|38124354|FG001|Overall Study|Adverse Event|0|||
16980921|NCT01169636|38124355|FG002|Overall Study|Adverse Event|1|||
16980922|NCT01169636|38124356|FG003|Overall Study|Adverse Event|1|||
16980923|NCT01169636|38124357|FG004|Overall Study|Adverse Event|0|||
16980924|NCT01169636|38124353|FG000|Overall Study|Screen failure|0|||
16980925|NCT01169636|38124354|FG001|Overall Study|Screen failure|0|||
16980926|NCT01169636|38124355|FG002|Overall Study|Screen failure|2|||
16980927|NCT01169636|38124356|FG003|Overall Study|Screen failure|0|||
16980928|NCT01169636|38124357|FG004|Overall Study|Screen failure|0|||
16980929|NCT01169636|38124353|FG000|Overall Study|Withdrawal by Subject|0|||
16980930|NCT01169636|38124354|FG001|Overall Study|Withdrawal by Subject|0|||
16980931|NCT01169636|38124355|FG002|Overall Study|Withdrawal by Subject|0|||
16980932|NCT01169636|38124356|FG003|Overall Study|Withdrawal by Subject|0|||
16980933|NCT01169636|38124357|FG004|Overall Study|Withdrawal by Subject|3|||
16980934|NCT01169558|38124367|FG000|Overall Study|Disease progression|98|||
16980935|NCT01169558|38124367|FG000|Overall Study|Adverse Event|25|||
16980936|NCT01169558|38124367|FG000|Overall Study|Withdrawal of Consent|8|||
16980937|NCT01169558|38124367|FG000|Overall Study|Medical Decision|7|||
16980938|NCT01169558|38124367|FG000|Overall Study|Stable Disease|4|||
16980939|NCT01169558|38124367|FG000|Overall Study|Lost to Follow-up|4|||
16980940|NCT01169558|38124367|FG000|Overall Study|Need for Surgery|4|||
16980941|NCT01169558|38124367|FG000|Overall Study|Non-compliance|2|||
16980942|NCT01169558|38124367|FG000|Overall Study|Protocol Violation|2|||
16980943|NCT01169558|38124367|FG000|Overall Study|Partial response|2|||
16980944|NCT00840463|38124373|FG000|Overall Study|Adverse Event|1|||
16980945|NCT00840463|38124374|FG001|Overall Study|Adverse Event|0|||
16980946|NCT01155050|38124384|FG000|Overall Study|Lost to Follow-up|15|||
16980947|NCT01155050|38124385|FG001|Overall Study|Lost to Follow-up|20|||
16980948|NCT01155050|38124386|FG002|Overall Study|Lost to Follow-up|19|||
16980949|NCT01155050|38124387|FG003|Overall Study|Lost to Follow-up|22|||
16980950|NCT01168856|38124399|FG000|Overall Study|Lost to Follow-up|4|||
16980951|NCT01168856|38124400|FG001|Overall Study|Lost to Follow-up|34|||
16980952|NCT01168856|38124399|FG000|Overall Study|Withdrawal by Subject|6|||
16980953|NCT01168856|38124400|FG001|Overall Study|Withdrawal by Subject|8|||
16980954|NCT01168856|38124399|FG000|Overall Study|Physician Decision|2|||
16980955|NCT01168856|38124400|FG001|Overall Study|Physician Decision|1|||
16980956|NCT01168856|38124399|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
16980957|NCT01168856|38124400|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
16980958|NCT01168856|38124399|FG000|Overall Study|Participant received anti-HCV treatment|1|||
16980959|NCT01168856|38124400|FG001|Overall Study|Participant received anti-HCV treatment|0|||
16980960|NCT01168856|38124399|FG000|Overall Study|Death|0|||
16980961|NCT01168856|38124400|FG001|Overall Study|Death|2|||
16980962|NCT01168856|38124399|FG000|Overall Study|Other|1|||
16980963|NCT01168856|38124400|FG001|Overall Study|Other|291|||
16980964|NCT01168856|38124399|FG000|Overall Study|Protocol Violation|4|||
16980965|NCT01168856|38124400|FG001|Overall Study|Protocol Violation|6|||
16980966|NCT00828451|38124411|FG000|Overall Study|Death|2|||
16980967|NCT00828451|38124411|FG000|Overall Study|Lack of intravenous line|7|||
16980968|NCT00828451|38124411|FG000|Overall Study|Withdrawal by Subject|1|||
16980969|NCT00828451|38124411|FG000|Overall Study|Deterioration in clinical status|1|||
16980970|NCT00839917|38124417|FG000|Overall Study|Lost to Follow-up|1|||
16980971|NCT00839917|38124418|FG001|Overall Study|Lost to Follow-up|0|||
16980972|NCT00839917|38124417|FG000|Overall Study|Did not receive vaccine|0|||
16980973|NCT00839917|38124418|FG001|Overall Study|Did not receive vaccine|1|||
16980974|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
16980975|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
16980976|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
16980977|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
16980978|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
16980979|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
16980980|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
16980981|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
16980982|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
16980983|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
16980984|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
16980985|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
16980986|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
16980987|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
16980988|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
16980989|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
16980990|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
16980991|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
16980992|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
16980993|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
16980994|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
16980995|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
16980996|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
16980997|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
16980998|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
16980999|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
16981000|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
16981001|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
16981002|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
16981003|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
16981004|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
16981005|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
16981006|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
16981007|NCT00839527|38124427|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
16981008|NCT00839527|38124428|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
16981009|NCT00839527|38124429|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
16981010|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
16981011|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
16981012|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
16981013|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
16981014|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
16981015|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
16981016|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
16981017|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
16981018|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
16981019|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
16981020|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
16981021|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
16981022|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
16981023|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
16981024|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
16981025|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
16981026|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
16981027|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
16981028|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
16981029|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
16981030|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
16981031|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
16981032|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
16981033|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
16981034|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
16981035|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
16981036|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
16981037|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
16981038|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
16981039|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
16981040|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
16981041|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
16981042|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
16981043|NCT00839527|38124427|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
16981044|NCT00839527|38124428|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
16981045|NCT00839527|38124429|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
16981046|NCT00600886|38124441|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
16981047|NCT00600886|38124442|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
16981048|NCT00600886|38124441|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
16981049|NCT00600886|38124442|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
16981050|NCT00600886|38124441|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
16981051|NCT00600886|38124442|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
16981052|NCT00600886|38124441|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
16981053|NCT00600886|38124442|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
16981054|NCT00600886|38124441|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
16981055|NCT00600886|38124442|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
16981056|NCT00600886|38124441|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
16981057|NCT00600886|38124442|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
16981058|NCT00600886|38124441|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
16981059|NCT00600886|38124442|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
16981060|NCT00600886|38124441|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
16981061|NCT00600886|38124442|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
16981062|NCT00600886|38124441|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
16981063|NCT00600886|38124442|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
16981064|NCT00600886|38124441|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
16981065|NCT00600886|38124442|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
16981066|NCT00600886|38124441|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
16981067|NCT00600886|38124442|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
16981068|NCT00600886|38124441|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
16981069|NCT00600886|38124442|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
16981070|NCT00600886|38124441|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
16981071|NCT00600886|38124442|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
16981072|NCT00600886|38124441|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
16981073|NCT00600886|38124442|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
16981074|NCT00600886|38124441|FG000|Extension - Same Treatment (FAS)|Death|1|||
16981075|NCT00600886|38124442|FG001|Extension - Same Treatment (FAS)|Death|1|||
16981076|NCT00600886|38124441|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
16981077|NCT00600886|38124442|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
16981078|NCT00600886|38124441|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
16981079|NCT00600886|38124442|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
16981080|NCT00600886|38124441|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
16981081|NCT00600886|38124442|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
16981082|NCT00600886|38124441|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
16981083|NCT00600886|38124442|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
16981084|NCT00600886|38124441|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
16981085|NCT00600886|38124442|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
16981086|NCT00600886|38124441|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
16981087|NCT00600886|38124442|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
16981088|NCT00600886|38124441|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
16981089|NCT00600886|38124442|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
16981090|NCT00600886|38124441|FG000|Extension - After Crossover (CAS)|Death|1|||
16981091|NCT00600886|38124442|FG001|Extension - After Crossover (CAS)|Death|0|||
16981092|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
16981093|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
16981094|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
16981095|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
16981096|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
16981097|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
16981098|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
16981099|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
16981100|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
16981101|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
16981102|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
16981103|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
16981104|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
16981105|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
16981106|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
16981107|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
16981108|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
16981109|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
16981110|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
16981111|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
16981112|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
16981113|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
16981114|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
16981115|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
16981116|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
16981117|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
16981118|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
16981119|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
16981120|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
16981121|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
16981122|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
16981123|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
16981124|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
16981125|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
16981126|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
16981127|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
16981128|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
16981129|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
16981130|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
16981131|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
16981132|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
16981133|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
16981134|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
16981135|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
16981136|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
16981137|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
16981138|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
16981139|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
16981140|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
16981141|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
16981142|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
16981143|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
16981144|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Site closed|0|||
16981145|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Site closed|0|||
16981146|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Site closed|1|||
16981147|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Site closed|0|||
16981148|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
16981149|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
16981150|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
16981151|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
16981152|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
16981153|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
16981154|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
16981155|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
16981156|NCT00838903|38124466|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
16981157|NCT00838903|38124467|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
16981158|NCT00838903|38124468|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
16981159|NCT00838903|38124469|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
16981160|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
16981161|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
16981162|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
16981163|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
16981164|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
16981165|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
16981166|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
16981167|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
16981168|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
16981169|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
16981170|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
16981171|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
16981172|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
16981173|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
16981174|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
16981175|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
16981176|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
17134045|NCT02095132|38275296|FG003|Overall Study|Physician Decision|0|||
16981177|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
16981178|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
16981179|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
16981180|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
16981181|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
16981182|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
16981183|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
16981184|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
16981185|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
16981186|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
16981187|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
16981188|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
16981189|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
16981190|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
16981191|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
16981192|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
16981193|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
16981194|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
16981195|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
16981196|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
16981197|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
16981198|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
16981199|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
16981200|NCT00838903|38124466|FG000|Follow-up Period (8 Weeks)|Missing|1|||
16981201|NCT00838903|38124467|FG001|Follow-up Period (8 Weeks)|Missing|2|||
16981202|NCT00838903|38124468|FG002|Follow-up Period (8 Weeks)|Missing|1|||
16981203|NCT00838903|38124469|FG003|Follow-up Period (8 Weeks)|Missing|1|||
16981204|NCT00828139|38124483|FG000|Overall Study|Adverse Event|8|||
16981205|NCT00828139|38124484|FG001|Overall Study|Adverse Event|1|||
16981206|NCT00828139|38124485|FG002|Overall Study|Adverse Event|10|||
16981207|NCT00828139|38124486|FG003|Overall Study|Adverse Event|5|||
16981208|NCT00828139|38124483|FG000|Overall Study|Death|2|||
16981209|NCT00828139|38124484|FG001|Overall Study|Death|1|||
16981210|NCT00828139|38124485|FG002|Overall Study|Death|0|||
16981211|NCT00828139|38124486|FG003|Overall Study|Death|2|||
16981212|NCT00828139|38124483|FG000|Overall Study|Refusal unrelated to toxicity|3|||
16981213|NCT00828139|38124484|FG001|Overall Study|Refusal unrelated to toxicity|4|||
16981214|NCT00828139|38124485|FG002|Overall Study|Refusal unrelated to toxicity|5|||
16981215|NCT00828139|38124486|FG003|Overall Study|Refusal unrelated to toxicity|3|||
16981216|NCT00828139|38124483|FG000|Overall Study|Disease Progression|24|||
16981217|NCT00828139|38124484|FG001|Overall Study|Disease Progression|33|||
16981218|NCT00828139|38124485|FG002|Overall Study|Disease Progression|35|||
16981219|NCT00828139|38124486|FG003|Overall Study|Disease Progression|39|||
16981220|NCT00828139|38124483|FG000|Overall Study|Other|4|||
16981221|NCT00828139|38124484|FG001|Overall Study|Other|2|||
16981222|NCT00828139|38124485|FG002|Overall Study|Other|5|||
16981223|NCT00828139|38124486|FG003|Overall Study|Other|2|||
16981224|NCT00838513|38124496|FG000|Screening Period|Screen Failure|3|||
16981225|NCT00838513|38124496|FG000|Extension Treatment Period|Death|1|||
16981226|NCT00838513|38124496|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
16981227|NCT00600106|38124502|FG000|Overall Study|Withdrawal by Subject|1|||
16981228|NCT00600106|38124503|FG001|Overall Study|Withdrawal by Subject|1|||
16981229|NCT00850993|38124513|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
16981230|NCT00850993|38124514|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
16981231|NCT00850993|38124515|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
16981232|NCT00850993|38124516|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
16981233|NCT00818779|38124528|FG000|Overall Study|Protocol Violation|1|||
16981234|NCT00818779|38124529|FG001|Overall Study|Protocol Violation|0|||
16981235|NCT00818779|38124528|FG000|Overall Study|Lost to Follow-up|1|||
16981236|NCT00818779|38124529|FG001|Overall Study|Lost to Follow-up|0|||
16981237|NCT00818779|38124528|FG000|Overall Study|Adverse Event|4|||
16981238|NCT00818779|38124529|FG001|Overall Study|Adverse Event|1|||
16981239|NCT00850759|38124539|FG000|Overall Study|Lost to Follow-up|7|||
16981240|NCT00850759|38124540|FG001|Overall Study|Lost to Follow-up|5|||
16981241|NCT00850759|38124541|FG002|Overall Study|Lost to Follow-up|5|||
16981242|NCT00850759|38124542|FG003|Overall Study|Lost to Follow-up|3|||
16981243|NCT00827827|38124554|FG000|Overall Study|Lost to Follow-up|3|||
16981244|NCT00827827|38124555|FG001|Overall Study|Lost to Follow-up|0|||
16981245|NCT00827827|38124554|FG000|Overall Study|Fall at home- hospitalization|1|||
16981246|NCT00827827|38124555|FG001|Overall Study|Fall at home- hospitalization|0|||
16981247|NCT00827827|38124554|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
16981248|NCT00827827|38124555|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
16981249|NCT00827827|38124554|FG000|Overall Study|Gout|1|||
16981250|NCT00827827|38124555|FG001|Overall Study|Gout|0|||
16981251|NCT00827827|38124554|FG000|Overall Study|Transportation issues|1|||
16981252|NCT00827827|38124555|FG001|Overall Study|Transportation issues|0|||
16981253|NCT00827827|38124554|FG000|Overall Study|Burned with water at home|1|||
16981254|NCT00827827|38124555|FG001|Overall Study|Burned with water at home|0|||
16981255|NCT00600028|38124564|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16981256|NCT00600028|38124565|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
16981257|NCT00600028|38124564|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
16981258|NCT00600028|38124565|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
16981259|NCT00600028|38124564|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
16981260|NCT00600028|38124565|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
16981261|NCT03542266|38124574|FG000|Treatment Phase|Withdrawal by Subject|1|||
16981262|NCT03542266|38124574|FG000|Treatment Phase|Adverse Event|1|||
16981263|NCT03542266|38124574|FG000|Treatment Phase|PD|1|||
16981264|NCT03201250|38124581|FG000|Overall Study|screen failures|3|||
16981265|NCT03201250|38124582|FG001|Overall Study|screen failures|0|||
16981266|NCT03201250|38124583|FG002|Overall Study|screen failures|0|||
16981267|NCT00818623|38124600|FG000|Overall Study|Adverse Event|1|||
16981268|NCT00818623|38124601|FG001|Overall Study|Adverse Event|0|||
16981269|NCT00818623|38124602|FG002|Overall Study|Adverse Event|1|||
16981270|NCT00818623|38124603|FG003|Overall Study|Adverse Event|0|||
16981271|NCT00818623|38124604|FG004|Overall Study|Adverse Event|0|||
16981272|NCT00818623|38124605|FG005|Overall Study|Adverse Event|1|||
16981273|NCT00818623|38124606|FG006|Overall Study|Adverse Event|0|||
16981274|NCT00818623|38124607|FG007|Overall Study|Adverse Event|0|||
16981275|NCT00818623|38124600|FG000|Overall Study|Bad prostate specific antigen response|0|||
16981276|NCT00818623|38124601|FG001|Overall Study|Bad prostate specific antigen response|3|||
16981277|NCT00818623|38124602|FG002|Overall Study|Bad prostate specific antigen response|2|||
16981278|NCT00818623|38124603|FG003|Overall Study|Bad prostate specific antigen response|5|||
16981279|NCT00818623|38124604|FG004|Overall Study|Bad prostate specific antigen response|0|||
16981280|NCT00818623|38124605|FG005|Overall Study|Bad prostate specific antigen response|1|||
16981281|NCT00818623|38124606|FG006|Overall Study|Bad prostate specific antigen response|0|||
16981282|NCT00818623|38124607|FG007|Overall Study|Bad prostate specific antigen response|0|||
16981283|NCT00818623|38124600|FG000|Overall Study|Withdrawal by Subject|0|||
16981284|NCT00818623|38124601|FG001|Overall Study|Withdrawal by Subject|1|||
16981285|NCT00818623|38124602|FG002|Overall Study|Withdrawal by Subject|1|||
16981286|NCT00818623|38124603|FG003|Overall Study|Withdrawal by Subject|0|||
16981287|NCT00818623|38124604|FG004|Overall Study|Withdrawal by Subject|0|||
16981288|NCT00818623|38124605|FG005|Overall Study|Withdrawal by Subject|1|||
16981289|NCT00818623|38124606|FG006|Overall Study|Withdrawal by Subject|1|||
16981290|NCT00818623|38124607|FG007|Overall Study|Withdrawal by Subject|1|||
16981291|NCT00818623|38124600|FG000|Overall Study|Protocol Violation|1|||
16981292|NCT00818623|38124601|FG001|Overall Study|Protocol Violation|0|||
16981293|NCT00818623|38124602|FG002|Overall Study|Protocol Violation|0|||
16981294|NCT00818623|38124603|FG003|Overall Study|Protocol Violation|0|||
16981295|NCT00818623|38124604|FG004|Overall Study|Protocol Violation|1|||
16981296|NCT00818623|38124605|FG005|Overall Study|Protocol Violation|0|||
16981297|NCT00818623|38124606|FG006|Overall Study|Protocol Violation|1|||
16981298|NCT00818623|38124607|FG007|Overall Study|Protocol Violation|0|||
16981299|NCT00818623|38124600|FG000|Overall Study|Need of additional treatment|0|||
16981300|NCT00818623|38124601|FG001|Overall Study|Need of additional treatment|0|||
16981301|NCT00818623|38124602|FG002|Overall Study|Need of additional treatment|0|||
16981302|NCT00818623|38124603|FG003|Overall Study|Need of additional treatment|0|||
16981303|NCT00818623|38124604|FG004|Overall Study|Need of additional treatment|1|||
16981304|NCT00818623|38124605|FG005|Overall Study|Need of additional treatment|0|||
16981305|NCT00818623|38124606|FG006|Overall Study|Need of additional treatment|0|||
16981306|NCT00818623|38124607|FG007|Overall Study|Need of additional treatment|0|||
16981307|NCT00818623|38124600|FG000|Overall Study|Lack of trial drug at site|0|||
16981308|NCT00818623|38124601|FG001|Overall Study|Lack of trial drug at site|0|||
16981309|NCT00818623|38124602|FG002|Overall Study|Lack of trial drug at site|0|||
16981310|NCT00818623|38124603|FG003|Overall Study|Lack of trial drug at site|0|||
16981311|NCT00818623|38124604|FG004|Overall Study|Lack of trial drug at site|2|||
16981312|NCT00818623|38124605|FG005|Overall Study|Lack of trial drug at site|0|||
16981313|NCT00818623|38124606|FG006|Overall Study|Lack of trial drug at site|1|||
16981314|NCT00818623|38124607|FG007|Overall Study|Lack of trial drug at site|0|||
16981315|NCT00818623|38124600|FG000|Overall Study|Disease progression|0|||
16981316|NCT00818623|38124601|FG001|Overall Study|Disease progression|0|||
16981317|NCT00818623|38124602|FG002|Overall Study|Disease progression|0|||
16981318|NCT00818623|38124603|FG003|Overall Study|Disease progression|0|||
16981319|NCT00818623|38124604|FG004|Overall Study|Disease progression|0|||
16981320|NCT00818623|38124605|FG005|Overall Study|Disease progression|0|||
16981321|NCT00818623|38124606|FG006|Overall Study|Disease progression|1|||
16981322|NCT00818623|38124607|FG007|Overall Study|Disease progression|0|||
16981323|NCT00827359|38124625|FG000|Overall Study|Progressive Diseas|19|||
16981324|NCT00827359|38124625|FG000|Overall Study|Unacceptable Toxicity|5|||
16981325|NCT00827359|38124625|FG000|Overall Study|Ineligible|1|||
16981326|NCT00818389|38124631|FG000|Overall Study|Death|1|||
16981327|NCT00818389|38124632|FG001|Overall Study|Death|3|||
16981328|NCT00818389|38124631|FG000|Overall Study|ALS Disease Progression|1|||
16981329|NCT00818389|38124632|FG001|Overall Study|ALS Disease Progression|0|||
16981330|NCT00818389|38124631|FG000|Overall Study|Withdrawal by Subject|2|||
16981331|NCT00818389|38124632|FG001|Overall Study|Withdrawal by Subject|2|||
16981332|NCT00818389|38124631|FG000|Overall Study|Adverse Event|0|||
16981333|NCT00818389|38124632|FG001|Overall Study|Adverse Event|1|||
16981334|NCT00850135|38124638|FG000|Overall Study|Physician Decision|1|||
16981335|NCT01154816|38124656|FG000|Overall Study|Withdrawal by Subject|1|||
16981336|NCT01154816|38124657|FG001|Overall Study|Withdrawal by Subject|0|||
16981337|NCT01154816|38124658|FG002|Overall Study|Withdrawal by Subject|0|||
16981338|NCT01154816|38124659|FG003|Overall Study|Withdrawal by Subject|1|||
16981339|NCT01154816|38124660|FG004|Overall Study|Withdrawal by Subject|0|||
16981340|NCT01154816|38124661|FG005|Overall Study|Withdrawal by Subject|0|||
16981341|NCT01154816|38124662|FG006|Overall Study|Withdrawal by Subject|0|||
16981342|NCT01154816|38124663|FG007|Overall Study|Withdrawal by Subject|0|||
16981343|NCT01154816|38124664|FG008|Overall Study|Withdrawal by Subject|1|||
16981344|NCT01154816|38124665|FG009|Overall Study|Withdrawal by Subject|3|||
16981345|NCT01154816|38124666|FG010|Overall Study|Withdrawal by Subject|0|||
16981346|NCT01154816|38124667|FG011|Overall Study|Withdrawal by Subject|0|||
16981347|NCT01154816|38124656|FG000|Overall Study|Progressive Disease|13|||
16981348|NCT01154816|38124657|FG001|Overall Study|Progressive Disease|8|||
16981349|NCT01154816|38124658|FG002|Overall Study|Progressive Disease|9|||
16981350|NCT01154816|38124659|FG003|Overall Study|Progressive Disease|9|||
16981351|NCT01154816|38124660|FG004|Overall Study|Progressive Disease|8|||
16981352|NCT01154816|38124661|FG005|Overall Study|Progressive Disease|8|||
16981353|NCT01154816|38124662|FG006|Overall Study|Progressive Disease|5|||
16981354|NCT01154816|38124663|FG007|Overall Study|Progressive Disease|6|||
16981355|NCT01154816|38124664|FG008|Overall Study|Progressive Disease|8|||
16981356|NCT01154816|38124665|FG009|Overall Study|Progressive Disease|6|||
16981357|NCT01154816|38124666|FG010|Overall Study|Progressive Disease|10|||
16981358|NCT01154816|38124667|FG011|Overall Study|Progressive Disease|3|||
16981359|NCT01154816|38124656|FG000|Overall Study|Physician Decision|1|||
16981360|NCT01154816|38124657|FG001|Overall Study|Physician Decision|0|||
16981361|NCT01154816|38124658|FG002|Overall Study|Physician Decision|1|||
16981362|NCT01154816|38124659|FG003|Overall Study|Physician Decision|0|||
16981363|NCT01154816|38124660|FG004|Overall Study|Physician Decision|2|||
16981364|NCT01154816|38124661|FG005|Overall Study|Physician Decision|0|||
16981365|NCT01154816|38124662|FG006|Overall Study|Physician Decision|0|||
16981366|NCT01154816|38124663|FG007|Overall Study|Physician Decision|0|||
16981367|NCT01154816|38124664|FG008|Overall Study|Physician Decision|0|||
16981368|NCT01154816|38124665|FG009|Overall Study|Physician Decision|1|||
16981369|NCT01154816|38124666|FG010|Overall Study|Physician Decision|1|||
16981370|NCT01154816|38124667|FG011|Overall Study|Physician Decision|1|||
16981371|NCT01154816|38124656|FG000|Overall Study|Adverse Event|5|||
16981372|NCT01154816|38124657|FG001|Overall Study|Adverse Event|2|||
16981373|NCT01154816|38124658|FG002|Overall Study|Adverse Event|0|||
16981374|NCT01154816|38124659|FG003|Overall Study|Adverse Event|0|||
16981375|NCT01154816|38124660|FG004|Overall Study|Adverse Event|0|||
16981376|NCT01154816|38124661|FG005|Overall Study|Adverse Event|0|||
16981377|NCT01154816|38124662|FG006|Overall Study|Adverse Event|1|||
16981378|NCT01154816|38124663|FG007|Overall Study|Adverse Event|1|||
16981379|NCT01154816|38124664|FG008|Overall Study|Adverse Event|0|||
16981380|NCT01154816|38124665|FG009|Overall Study|Adverse Event|0|||
16981381|NCT01154816|38124666|FG010|Overall Study|Adverse Event|0|||
16981382|NCT01154816|38124667|FG011|Overall Study|Adverse Event|0|||
16981383|NCT00849901|38124713|FG000|Acute Treatment Phase|Adverse Event|9|||
16981384|NCT00849901|38124714|FG001|Acute Treatment Phase|Adverse Event|1|||
16981385|NCT00849901|38124715|FG002|Acute Treatment Phase|Adverse Event|3|||
16981386|NCT00849901|38124713|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
16981387|NCT00849901|38124714|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
16981388|NCT00849901|38124715|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
16981389|NCT00849901|38124713|FG000|Acute Treatment Phase|Protocol Violation|0|||
16981390|NCT00849901|38124714|FG001|Acute Treatment Phase|Protocol Violation|2|||
16981391|NCT00849901|38124715|FG002|Acute Treatment Phase|Protocol Violation|1|||
16981392|NCT00849901|38124713|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
16981393|NCT00849901|38124714|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
16981394|NCT00849901|38124715|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
16981395|NCT00849901|38124713|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
16981396|NCT00849901|38124714|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
16981397|NCT00849901|38124715|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
16981398|NCT00849901|38124713|FG000|Acute Treatment Phase|Physician Decision|1|||
16981399|NCT00849901|38124714|FG001|Acute Treatment Phase|Physician Decision|1|||
16981400|NCT00849901|38124715|FG002|Acute Treatment Phase|Physician Decision|1|||
16981401|NCT00849901|38124713|FG000|Acute Treatment Phase|Sponsor Decision|1|||
16981402|NCT00849901|38124714|FG001|Acute Treatment Phase|Sponsor Decision|0|||
16981403|NCT00849901|38124715|FG002|Acute Treatment Phase|Sponsor Decision|0|||
16981404|NCT00849901|38124713|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
16981405|NCT00849901|38124714|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
16981406|NCT00849901|38124715|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
16981407|NCT00849901|38124713|FG000|Extension Phase|Adverse Event|2|||
16981408|NCT00849901|38124714|FG001|Extension Phase|Adverse Event|8|||
16981409|NCT00849901|38124715|FG002|Extension Phase|Adverse Event|4|||
16981410|NCT00849901|38124713|FG000|Extension Phase|Lost to Follow-up|3|||
16981411|NCT00849901|38124714|FG001|Extension Phase|Lost to Follow-up|0|||
16981412|NCT00849901|38124715|FG002|Extension Phase|Lost to Follow-up|1|||
16981413|NCT00849901|38124713|FG000|Extension Phase|Protocol Violation|2|||
16981414|NCT00849901|38124714|FG001|Extension Phase|Protocol Violation|2|||
16981415|NCT00849901|38124715|FG002|Extension Phase|Protocol Violation|4|||
16981416|NCT00849901|38124713|FG000|Extension Phase|Withdrawal by Subject|7|||
16981417|NCT00849901|38124714|FG001|Extension Phase|Withdrawal by Subject|6|||
16981418|NCT00849901|38124715|FG002|Extension Phase|Withdrawal by Subject|3|||
16981419|NCT00849901|38124713|FG000|Extension Phase|Parent or Caregiver Decision|10|||
16981420|NCT00849901|38124714|FG001|Extension Phase|Parent or Caregiver Decision|4|||
16981421|NCT00849901|38124715|FG002|Extension Phase|Parent or Caregiver Decision|4|||
16981422|NCT00849901|38124713|FG000|Extension Phase|Physician Decision|1|||
16981423|NCT00849901|38124714|FG001|Extension Phase|Physician Decision|2|||
16981424|NCT00849901|38124715|FG002|Extension Phase|Physician Decision|0|||
16981425|NCT00849901|38124713|FG000|Extension Phase|Lack of Efficacy|2|||
16981426|NCT00849901|38124714|FG001|Extension Phase|Lack of Efficacy|4|||
16981427|NCT00849901|38124715|FG002|Extension Phase|Lack of Efficacy|1|||
16981428|NCT01168232|38124729|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
16981429|NCT01168232|38124729|FG000|Overall Study|Ineligible- Wrong cell type|6|||
16981430|NCT01168232|38124729|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
16981431|NCT00817531|38124733|FG000|Overall Study|Adverse Event|1|||
16981432|NCT00817531|38124733|FG000|Overall Study|Lack of Efficacy|1|||
16981433|NCT00817063|38124739|FG000|Overall Study|Adverse Event|32|||
16981434|NCT00817063|38124740|FG001|Overall Study|Adverse Event|13|||
16981435|NCT00817063|38124739|FG000|Overall Study|Death|1|||
16981436|NCT00817063|38124740|FG001|Overall Study|Death|1|||
16981437|NCT00817063|38124739|FG000|Overall Study|Lack of Efficacy|33|||
16981438|NCT00817063|38124740|FG001|Overall Study|Lack of Efficacy|86|||
16981439|NCT00817063|38124739|FG000|Overall Study|Failure to Return|13|||
16981440|NCT00817063|38124740|FG001|Overall Study|Failure to Return|12|||
16981441|NCT00817063|38124739|FG000|Overall Study|Violation of Selection at Entry|7|||
16981442|NCT00817063|38124740|FG001|Overall Study|Violation of Selection at Entry|4|||
16981443|NCT00817063|38124739|FG000|Overall Study|Protocol Violation|3|||
16981444|NCT00817063|38124740|FG001|Overall Study|Protocol Violation|8|||
16981445|NCT00817063|38124739|FG000|Overall Study|Withdrawal by Subject|17|||
16981446|NCT00817063|38124740|FG001|Overall Study|Withdrawal by Subject|37|||
16981447|NCT00817063|38124739|FG000|Overall Study|Early Improvement|19|||
16981448|NCT00817063|38124740|FG001|Overall Study|Early Improvement|4|||
16981449|NCT00817063|38124739|FG000|Overall Study|Administrative|10|||
16981450|NCT00817063|38124740|FG001|Overall Study|Administrative|4|||
16981451|NCT00817063|38124739|FG000|Overall Study|Abnormality of Laboratory Test|2|||
16981452|NCT00817063|38124740|FG001|Overall Study|Abnormality of Laboratory Test|1|||
16981453|NCT01167140|38124746|FG000|Overall Study|Withdrawal by Subject|1|||
16981454|NCT01166750|38124752|FG000|Overall Study|Lost to Follow-up|1|||
16981455|NCT01166750|38124753|FG001|Overall Study|Lost to Follow-up|0|||
16981456|NCT00826267|38124762|FG000|Overall Study|Other Adverse Event|1|||
16981457|NCT00826267|38124763|FG001|Overall Study|Other Adverse Event|0|||
16981458|NCT00826267|38124764|FG002|Overall Study|Other Adverse Event|0|||
16981459|NCT00986154|38124775|FG000|Overall Study|Death|136|||
16981460|NCT00986154|38124776|FG001|Overall Study|Death|127|||
16981461|NCT00986154|38124775|FG000|Overall Study|Lost to Follow-up|7|||
16981462|NCT00986154|38124776|FG001|Overall Study|Lost to Follow-up|4|||
16981463|NCT00986154|38124775|FG000|Overall Study|Withdrawal by Subject|32|||
16981464|NCT00986154|38124776|FG001|Overall Study|Withdrawal by Subject|33|||
16981465|NCT00986154|38124775|FG000|Overall Study|investigator/subject decide not continue|6|||
16981466|NCT00986154|38124776|FG001|Overall Study|investigator/subject decide not continue|3|||
16981467|NCT00986154|38124775|FG000|Overall Study|never received study drug|25|||
16981468|NCT00986154|38124776|FG001|Overall Study|never received study drug|27|||
16981469|NCT00848965|38124782|FG000|Overall Study|Adverse Event|1|||
16981470|NCT00848965|38124782|FG000|Overall Study|Withdrawal by Subject|1|||
16981471|NCT01154036|38124801|FG000|Phase I|Physician Decision|0|||
16981472|NCT01154036|38124802|FG001|Phase I|Physician Decision|1|||
16981473|NCT01154036|38124803|FG002|Phase I|Physician Decision|0|||
16981474|NCT01154036|38124804|FG003|Phase I|Physician Decision|0|||
16981475|NCT01154036|38124805|FG004|Phase I|Physician Decision|0|||
16981476|NCT01154036|38124806|FG005|Phase I|Physician Decision|0|||
16981477|NCT01154036|38124807|FG006|Phase I|Physician Decision|0|||
16981478|NCT01154036|38124808|FG007|Phase I|Physician Decision|0|||
16981479|NCT01154036|38124801|FG000|Phase I|Lost to Follow-up|0|||
16981480|NCT01154036|38124802|FG001|Phase I|Lost to Follow-up|3|||
16981481|NCT01154036|38124803|FG002|Phase I|Lost to Follow-up|6|||
16981482|NCT01154036|38124804|FG003|Phase I|Lost to Follow-up|0|||
16981483|NCT01154036|38124805|FG004|Phase I|Lost to Follow-up|0|||
16981484|NCT01154036|38124806|FG005|Phase I|Lost to Follow-up|0|||
16981485|NCT01154036|38124807|FG006|Phase I|Lost to Follow-up|0|||
16981486|NCT01154036|38124808|FG007|Phase I|Lost to Follow-up|0|||
16981487|NCT01154036|38124801|FG000|Phase I|Protocol Violation|0|||
16981488|NCT01154036|38124802|FG001|Phase I|Protocol Violation|3|||
16981489|NCT01154036|38124803|FG002|Phase I|Protocol Violation|9|||
16981490|NCT01154036|38124804|FG003|Phase I|Protocol Violation|0|||
16981491|NCT01154036|38124805|FG004|Phase I|Protocol Violation|0|||
16981492|NCT01154036|38124806|FG005|Phase I|Protocol Violation|0|||
16981493|NCT01154036|38124807|FG006|Phase I|Protocol Violation|0|||
16981494|NCT01154036|38124808|FG007|Phase I|Protocol Violation|0|||
16981495|NCT01154036|38124801|FG000|Phase I|Withdrawal by Subject|2|||
16981496|NCT01154036|38124802|FG001|Phase I|Withdrawal by Subject|10|||
16981497|NCT01154036|38124803|FG002|Phase I|Withdrawal by Subject|29|||
16981498|NCT01154036|38124804|FG003|Phase I|Withdrawal by Subject|0|||
16981499|NCT01154036|38124805|FG004|Phase I|Withdrawal by Subject|0|||
16981500|NCT01154036|38124806|FG005|Phase I|Withdrawal by Subject|0|||
16981501|NCT01154036|38124807|FG006|Phase I|Withdrawal by Subject|0|||
16981502|NCT01154036|38124808|FG007|Phase I|Withdrawal by Subject|0|||
16981503|NCT01154036|38124801|FG000|Phase I|Adverse Event|1|||
16981504|NCT01154036|38124802|FG001|Phase I|Adverse Event|11|||
16981505|NCT01154036|38124803|FG002|Phase I|Adverse Event|12|||
16981506|NCT01154036|38124804|FG003|Phase I|Adverse Event|0|||
16981507|NCT01154036|38124805|FG004|Phase I|Adverse Event|0|||
16981508|NCT01154036|38124806|FG005|Phase I|Adverse Event|0|||
16981509|NCT01154036|38124807|FG006|Phase I|Adverse Event|0|||
16981510|NCT01154036|38124808|FG007|Phase I|Adverse Event|0|||
16981511|NCT01154036|38124801|FG000|Phase II|Adverse Event|0|||
16981512|NCT01154036|38124802|FG001|Phase II|Adverse Event|0|||
16981513|NCT01154036|38124803|FG002|Phase II|Adverse Event|0|||
16981514|NCT01154036|38124804|FG003|Phase II|Adverse Event|0|||
16981515|NCT01154036|38124805|FG004|Phase II|Adverse Event|1|||
16981516|NCT01154036|38124806|FG005|Phase II|Adverse Event|1|||
16981517|NCT01154036|38124807|FG006|Phase II|Adverse Event|1|||
16981518|NCT01154036|38124808|FG007|Phase II|Adverse Event|1|||
16981519|NCT01154036|38124801|FG000|Phase II|Physician Decision|0|||
16981520|NCT01154036|38124802|FG001|Phase II|Physician Decision|0|||
16981521|NCT01154036|38124803|FG002|Phase II|Physician Decision|0|||
16981522|NCT01154036|38124804|FG003|Phase II|Physician Decision|0|||
16981523|NCT01154036|38124805|FG004|Phase II|Physician Decision|0|||
16981524|NCT01154036|38124806|FG005|Phase II|Physician Decision|0|||
16981525|NCT01154036|38124807|FG006|Phase II|Physician Decision|1|||
16981526|NCT01154036|38124808|FG007|Phase II|Physician Decision|0|||
16780207|NCT01594749|37719307|FG000|Overall Study|Non-compliance with Protocol|0|||
16780208|NCT01594749|37719308|FG001|Overall Study|Non-compliance with Protocol|1|||
16780209|NCT01594749|37719307|FG000|Overall Study|Lost to Follow-up|1|||
16981527|NCT01154036|38124801|FG000|Phase II|Lost to Follow-up|0|||
16981528|NCT01154036|38124802|FG001|Phase II|Lost to Follow-up|0|||
16981529|NCT01154036|38124803|FG002|Phase II|Lost to Follow-up|0|||
16981530|NCT01154036|38124804|FG003|Phase II|Lost to Follow-up|1|||
16981531|NCT01154036|38124805|FG004|Phase II|Lost to Follow-up|2|||
16981532|NCT01154036|38124806|FG005|Phase II|Lost to Follow-up|0|||
16981533|NCT01154036|38124807|FG006|Phase II|Lost to Follow-up|2|||
16981534|NCT01154036|38124808|FG007|Phase II|Lost to Follow-up|1|||
16981535|NCT01154036|38124801|FG000|Phase II|Protocol Violation|0|||
16981536|NCT01154036|38124802|FG001|Phase II|Protocol Violation|0|||
16981537|NCT01154036|38124803|FG002|Phase II|Protocol Violation|0|||
16981538|NCT01154036|38124804|FG003|Phase II|Protocol Violation|0|||
16981539|NCT01154036|38124805|FG004|Phase II|Protocol Violation|1|||
16981540|NCT01154036|38124806|FG005|Phase II|Protocol Violation|2|||
16981541|NCT01154036|38124807|FG006|Phase II|Protocol Violation|0|||
16981542|NCT01154036|38124808|FG007|Phase II|Protocol Violation|0|||
16981543|NCT01154036|38124801|FG000|Phase II|Withdrawal by Subject|0|||
16981544|NCT01154036|38124802|FG001|Phase II|Withdrawal by Subject|0|||
16981545|NCT01154036|38124803|FG002|Phase II|Withdrawal by Subject|0|||
16981546|NCT01154036|38124804|FG003|Phase II|Withdrawal by Subject|0|||
16981547|NCT01154036|38124805|FG004|Phase II|Withdrawal by Subject|4|||
16981548|NCT01154036|38124806|FG005|Phase II|Withdrawal by Subject|2|||
16981549|NCT01154036|38124807|FG006|Phase II|Withdrawal by Subject|5|||
16981550|NCT01154036|38124808|FG007|Phase II|Withdrawal by Subject|4|||
16981551|NCT00816595|38124830|FG000|Overall Study|Withdrawal by Subject|2|||
16981552|NCT00816595|38124831|FG001|Overall Study|Withdrawal by Subject|0|||
16981553|NCT01166438|38124841|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
16981554|NCT01166438|38124842|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
16981555|NCT01166438|38124841|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
16981556|NCT01166438|38124842|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
16981557|NCT01166438|38124841|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
16981558|NCT01166438|38124842|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
16981559|NCT01166438|38124841|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
16981560|NCT01166438|38124842|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
16981561|NCT01166438|38124841|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
16981562|NCT01166438|38124842|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
16981563|NCT01166438|38124841|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
16981564|NCT01166438|38124842|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
16981565|NCT01153958|38124851|FG000|Overall Study|Study Terminated|36|||
16981566|NCT01153958|38124852|FG001|Overall Study|Study Terminated|32|||
16981567|NCT00599638|38124862|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
16981568|NCT00599638|38124863|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
16981569|NCT00599638|38124864|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
16981570|NCT00599638|38124865|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
16981571|NCT00599638|38124862|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
16981572|NCT00599638|38124863|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
16981573|NCT00599638|38124864|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
16981574|NCT00599638|38124865|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
16981575|NCT00599638|38124862|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
16981576|NCT00599638|38124863|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
16981577|NCT00599638|38124864|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
16981578|NCT00599638|38124865|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
16981579|NCT00599638|38124862|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
16981580|NCT00599638|38124863|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
16981581|NCT00599638|38124864|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
16981582|NCT00599638|38124865|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
16981583|NCT00599638|38124862|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
16981584|NCT00599638|38124863|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
16981585|NCT00599638|38124864|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
16981586|NCT00599638|38124865|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
16981587|NCT00599638|38124862|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
16981588|NCT00599638|38124863|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
16981589|NCT00599638|38124864|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
16981590|NCT00599638|38124865|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
16981591|NCT00599638|38124862|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
16981592|NCT00599638|38124863|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
16981593|NCT00599638|38124864|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
16981594|NCT00599638|38124865|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
16981595|NCT00599638|38124862|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
16981596|NCT00599638|38124863|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
16981597|NCT00599638|38124864|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
17134046|NCT02095132|38275297|FG004|Overall Study|Physician Decision|0|||
16981598|NCT00599638|38124865|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
16981599|NCT00599638|38124862|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
16981600|NCT00599638|38124863|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
16981601|NCT00599638|38124864|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
16981602|NCT00599638|38124865|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
16981603|NCT01166282|38124875|FG000|Open-label Period|Adverse Event|0|||
16981604|NCT01166282|38124876|FG001|Open-label Period|Adverse Event|0|||
16981605|NCT01166282|38124877|FG002|Open-label Period|Adverse Event|6|||
16981606|NCT01166282|38124875|FG000|Open-label Period|Withdrawal by Subject|0|||
16981607|NCT01166282|38124876|FG001|Open-label Period|Withdrawal by Subject|0|||
16981608|NCT01166282|38124877|FG002|Open-label Period|Withdrawal by Subject|4|||
16981609|NCT01166282|38124875|FG000|Open-label Period|Lack of Efficacy|0|||
16981610|NCT01166282|38124876|FG001|Open-label Period|Lack of Efficacy|0|||
16981611|NCT01166282|38124877|FG002|Open-label Period|Lack of Efficacy|2|||
16981612|NCT01166282|38124875|FG000|Open-label Period|Remission|0|||
16981613|NCT01166282|38124876|FG001|Open-label Period|Remission|0|||
16981614|NCT01166282|38124877|FG002|Open-label Period|Remission|4|||
16981615|NCT01166282|38124875|FG000|Open-label Period|Irregular Compliance|0|||
16981616|NCT01166282|38124876|FG001|Open-label Period|Irregular Compliance|0|||
16981617|NCT01166282|38124877|FG002|Open-label Period|Irregular Compliance|1|||
16981618|NCT01153724|38124885|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16981619|NCT01153724|38124885|FG000|Treatment Period 2|Adverse Event|1|||
16981620|NCT01153724|38124885|FG000|Treatment Period 2|Other reason not defined above|1|||
16981621|NCT01152788|38124893|FG000|Overall Study|Withdrawal by Subject|0|||
16981622|NCT01152788|38124894|FG001|Overall Study|Withdrawal by Subject|3|||
16981623|NCT01152788|38124893|FG000|Overall Study|No treatment|0|||
16981624|NCT01152788|38124894|FG001|Overall Study|No treatment|1|||
16981625|NCT01165424|38124900|FG000|Overall Study|Clinical adverse experiences|1|||
16981626|NCT01165424|38124900|FG000|Overall Study|Laboratory adverse experiences|1|||
16981627|NCT01165424|38124900|FG000|Overall Study|Did not meet entry criteria|1|||
16981628|NCT01165424|38124900|FG000|Overall Study|Participant moved (relocated)|1|||
16981629|NCT01152554|38124906|FG000|Overall Study|Withdrawal by Subject|73|||
16981630|NCT01152554|38124907|FG001|Overall Study|Withdrawal by Subject|28|||
16981631|NCT01152554|38124906|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
16981632|NCT01152554|38124907|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
16981633|NCT01152554|38124906|FG000|Overall Study|Adverse Event|67|||
16981634|NCT01152554|38124907|FG001|Overall Study|Adverse Event|14|||
16981635|NCT01152554|38124906|FG000|Overall Study|Severe non-compliance to protocol|36|||
16981636|NCT01152554|38124907|FG001|Overall Study|Severe non-compliance to protocol|14|||
16981637|NCT01152554|38124906|FG000|Overall Study|Condition under investigation worsened|5|||
16981638|NCT01152554|38124907|FG001|Overall Study|Condition under investigation worsened|2|||
16981639|NCT01152554|38124906|FG000|Overall Study|Lack of Efficacy|20|||
16981640|NCT01152554|38124907|FG001|Overall Study|Lack of Efficacy|3|||
16981641|NCT01152554|38124906|FG000|Overall Study|Study-specific withdrawal criteria|17|||
16981642|NCT01152554|38124907|FG001|Overall Study|Study-specific withdrawal criteria|8|||
16981643|NCT01152554|38124906|FG000|Overall Study|Lost to Follow-up|87|||
16981644|NCT01152554|38124907|FG001|Overall Study|Lost to Follow-up|32|||
16981645|NCT01152554|38124906|FG000|Overall Study|Other|28|||
16981646|NCT01152554|38124907|FG001|Overall Study|Other|8|||
16981647|NCT01152554|38124906|FG000|Overall Study|Death|1|||
16981648|NCT01152554|38124907|FG001|Overall Study|Death|1|||
16981649|NCT00598702|38124921|FG000|Overall Study|Other|0|||
16981650|NCT00598702|38124922|FG001|Overall Study|Other|2|||
16981651|NCT00598702|38124923|FG002|Overall Study|Other|0|||
16981652|NCT00598702|38124924|FG003|Overall Study|Other|0|||
16981653|NCT00598702|38124925|FG004|Overall Study|Other|0|||
16981654|NCT00598702|38124926|FG005|Overall Study|Other|1|||
16981655|NCT00598702|38124927|FG006|Overall Study|Other|0|||
16981656|NCT00598702|38124928|FG007|Overall Study|Other|0|||
16981657|NCT00598702|38124921|FG000|Overall Study|Early discharge from hospital|0|||
16981658|NCT00598702|38124922|FG001|Overall Study|Early discharge from hospital|0|||
16981659|NCT00598702|38124923|FG002|Overall Study|Early discharge from hospital|2|||
16981660|NCT00598702|38124924|FG003|Overall Study|Early discharge from hospital|5|||
16981661|NCT00598702|38124925|FG004|Overall Study|Early discharge from hospital|0|||
16981662|NCT00598702|38124926|FG005|Overall Study|Early discharge from hospital|10|||
16981663|NCT00598702|38124927|FG006|Overall Study|Early discharge from hospital|1|||
16981664|NCT00598702|38124928|FG007|Overall Study|Early discharge from hospital|0|||
16981665|NCT00598702|38124921|FG000|Overall Study|Adverse Event|0|||
16981666|NCT00598702|38124922|FG001|Overall Study|Adverse Event|0|||
16981667|NCT00598702|38124923|FG002|Overall Study|Adverse Event|0|||
16981668|NCT00598702|38124924|FG003|Overall Study|Adverse Event|1|||
16981669|NCT00598702|38124925|FG004|Overall Study|Adverse Event|0|||
16981670|NCT00598702|38124926|FG005|Overall Study|Adverse Event|0|||
16981671|NCT00598702|38124927|FG006|Overall Study|Adverse Event|0|||
16981672|NCT00598702|38124928|FG007|Overall Study|Adverse Event|0|||
16981673|NCT00598702|38124921|FG000|Overall Study|Withdrawal by Subject|0|||
16981674|NCT00598702|38124922|FG001|Overall Study|Withdrawal by Subject|0|||
16981675|NCT00598702|38124923|FG002|Overall Study|Withdrawal by Subject|0|||
16981676|NCT00598702|38124924|FG003|Overall Study|Withdrawal by Subject|1|||
16981677|NCT00598702|38124925|FG004|Overall Study|Withdrawal by Subject|1|||
16981678|NCT00598702|38124926|FG005|Overall Study|Withdrawal by Subject|0|||
16981679|NCT00598702|38124927|FG006|Overall Study|Withdrawal by Subject|0|||
16981680|NCT00598702|38124928|FG007|Overall Study|Withdrawal by Subject|0|||
16981681|NCT00598702|38124921|FG000|Overall Study|Physician Decision|0|||
16981682|NCT00598702|38124922|FG001|Overall Study|Physician Decision|0|||
16981683|NCT00598702|38124923|FG002|Overall Study|Physician Decision|0|||
16981684|NCT00598702|38124924|FG003|Overall Study|Physician Decision|0|||
16981685|NCT00598702|38124925|FG004|Overall Study|Physician Decision|1|||
16981686|NCT00598702|38124926|FG005|Overall Study|Physician Decision|0|||
16981687|NCT00598702|38124927|FG006|Overall Study|Physician Decision|0|||
16981688|NCT00598702|38124928|FG007|Overall Study|Physician Decision|0|||
16981689|NCT00598702|38124921|FG000|Overall Study|Dose limiting toxicity|0|||
16981690|NCT00598702|38124922|FG001|Overall Study|Dose limiting toxicity|0|||
16981691|NCT00598702|38124923|FG002|Overall Study|Dose limiting toxicity|0|||
16981692|NCT00598702|38124924|FG003|Overall Study|Dose limiting toxicity|1|||
16981693|NCT00598702|38124925|FG004|Overall Study|Dose limiting toxicity|1|||
16981694|NCT00598702|38124926|FG005|Overall Study|Dose limiting toxicity|1|||
16981695|NCT00598702|38124927|FG006|Overall Study|Dose limiting toxicity|0|||
16981696|NCT00598702|38124928|FG007|Overall Study|Dose limiting toxicity|0|||
16981697|NCT01148810|38124948|FG000|Overall Study|Adverse Event|0|||
16981698|NCT01148810|38124949|FG001|Overall Study|Adverse Event|2|||
16981699|NCT01148810|38124948|FG000|Overall Study|Lack of Efficacy|0|||
16981700|NCT01148810|38124949|FG001|Overall Study|Lack of Efficacy|1|||
16981701|NCT01148810|38124948|FG000|Overall Study|Withdrawal by Subject|0|||
16981702|NCT01148810|38124949|FG001|Overall Study|Withdrawal by Subject|2|||
16981703|NCT01148810|38124948|FG000|Overall Study|Protocol Violation|1|||
16981704|NCT01148810|38124949|FG001|Overall Study|Protocol Violation|0|||
16981705|NCT01151618|38124956|FG000|Overall Study|Adverse Event|2|||
16981706|NCT01151618|38124956|FG000|Overall Study|Withdrawal by Subject|7|||
16981707|NCT01164956|38124960|FG000|Overall Study|Side Effects|1|||
16981708|NCT01164956|38124961|FG001|Overall Study|Side Effects|0|||
16981709|NCT01164956|38124962|FG002|Overall Study|Side Effects|1|||
16981710|NCT01164722|38124972|FG000|Overall Study|Adverse Event|0|||
16981711|NCT01164722|38124973|FG001|Overall Study|Adverse Event|1|||
16981712|NCT01164722|38124972|FG000|Overall Study|Withdrawal by Subject|3|||
16981713|NCT01164722|38124973|FG001|Overall Study|Withdrawal by Subject|4|||
16981714|NCT01164722|38124972|FG000|Overall Study|Lost to Follow-up|3|||
16981715|NCT01164722|38124973|FG001|Overall Study|Lost to Follow-up|6|||
16981716|NCT01164722|38124972|FG000|Overall Study|met protocol criteria for non-treatment|11|||
16981717|NCT01164722|38124973|FG001|Overall Study|met protocol criteria for non-treatment|1|||
16981718|NCT01164722|38124972|FG000|Overall Study|enrolled on other study, concomitant med|1|||
16981719|NCT01164722|38124973|FG001|Overall Study|enrolled on other study, concomitant med|3|||
16981720|NCT01151540|38124979|FG000|Overall Study|Other|2|||
16981721|NCT01151540|38124979|FG000|Overall Study|Adverse event, non-fatal|4|||
16981722|NCT01151540|38124979|FG000|Overall Study|Withdrawal by Subject|7|||
16981723|NCT01163786|38124983|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
16981724|NCT01163786|38124983|FG000|Treatment With Bortezomib|Adverse Event|2|||
16981725|NCT01163786|38124983|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
16981726|NCT00984282|38124989|FG000|Double Blind Treatment|Adverse Event|40|||
16981727|NCT00984282|38124990|FG001|Double Blind Treatment|Adverse Event|6|||
16981728|NCT00984282|38124989|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
16981729|NCT00984282|38124990|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
16981730|NCT00984282|38124989|FG000|Double Blind Treatment|Physician Decision|1|||
16981731|NCT00984282|38124990|FG001|Double Blind Treatment|Physician Decision|2|||
16981732|NCT00984282|38124989|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
16981733|NCT00984282|38124990|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
16981734|NCT00984282|38124989|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
16981735|NCT00984282|38124990|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
16981736|NCT00984282|38124989|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
16981737|NCT00984282|38124990|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
16981738|NCT00984282|38124989|FG000|Double Blind Treatment|Lost to Follow-up|3|||
16981739|NCT00984282|38124990|FG001|Double Blind Treatment|Lost to Follow-up|0|||
16981740|NCT00984282|38124989|FG000|Double Blind Treatment|Death|8|||
16981741|NCT00984282|38124990|FG001|Double Blind Treatment|Death|4|||
16981742|NCT00984282|38124989|FG000|Double Blind Treatment|Not treated|0|||
16981743|NCT00984282|38124990|FG001|Double Blind Treatment|Not treated|1|||
16981744|NCT00984282|38124989|FG000|Double Blind Treatment|Switched to commercial drug|6|||
16981745|NCT00984282|38124990|FG001|Double Blind Treatment|Switched to commercial drug|1|||
16981746|NCT00984282|38124989|FG000|Double Blind Treatment|protocol driven decision point|1|||
16981747|NCT00984282|38124990|FG001|Double Blind Treatment|protocol driven decision point|1|||
16981748|NCT00984282|38124989|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
16981749|NCT00984282|38124990|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
16981750|NCT00984282|38124989|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
16981751|NCT00984282|38124990|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
16981752|NCT00984282|38124989|FG000|Open-label Treatment|Adverse Event|20|||
16981753|NCT00984282|38124990|FG001|Open-label Treatment|Adverse Event|30|||
16981754|NCT00984282|38124989|FG000|Open-label Treatment|Withdrawal by Subject|6|||
16981755|NCT00984282|38124990|FG001|Open-label Treatment|Withdrawal by Subject|21|||
16981756|NCT00984282|38124989|FG000|Open-label Treatment|Death|7|||
16981757|NCT00984282|38124990|FG001|Open-label Treatment|Death|15|||
16981758|NCT00984282|38124989|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
16981759|NCT00984282|38124990|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
16981760|NCT00984282|38124989|FG000|Open-label Treatment|Lost to Follow-up|1|||
16981761|NCT00984282|38124990|FG001|Open-label Treatment|Lost to Follow-up|1|||
16981762|NCT00984282|38124989|FG000|Open-label Treatment|Patient convenience|1|||
16981763|NCT00984282|38124990|FG001|Open-label Treatment|Patient convenience|0|||
16981764|NCT00984282|38124989|FG000|Open-label Treatment|Non-compliant with study medication|1|||
16981765|NCT00984282|38124990|FG001|Open-label Treatment|Non-compliant with study medication|0|||
16981766|NCT00984282|38124989|FG000|Open-label Treatment|Target lesion removed|0|||
16981767|NCT00984282|38124990|FG001|Open-label Treatment|Target lesion removed|1|||
16981768|NCT00984282|38124989|FG000|Open-label Treatment|Protocol driven decision point|1|||
16981769|NCT00984282|38124990|FG001|Open-label Treatment|Protocol driven decision point|1|||
16981770|NCT00984282|38124989|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
16981771|NCT00984282|38124990|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
16981772|NCT00984282|38124989|FG000|Open-label Treatment|Switched to commercial drug|6|||
16981773|NCT00984282|38124990|FG001|Open-label Treatment|Switched to commercial drug|7|||
16981774|NCT00984282|38124989|FG000|Open-label Treatment|Physician Decision|1|||
16981775|NCT00984282|38124990|FG001|Open-label Treatment|Physician Decision|0|||
16981776|NCT00984282|38124989|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
16981777|NCT00984282|38124990|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
16981778|NCT00984282|38124989|FG000|Long Term Follow-up|Death|27|||
16981779|NCT00984282|38124990|FG001|Long Term Follow-up|Death|68|||
16981780|NCT00984282|38124989|FG000|Long Term Follow-up|Lost to Follow-up|3|||
16981781|NCT00984282|38124990|FG001|Long Term Follow-up|Lost to Follow-up|6|||
16981782|NCT00984282|38124989|FG000|Long Term Follow-up|Protocol driven decision point|25|||
16981783|NCT00984282|38124990|FG001|Long Term Follow-up|Protocol driven decision point|26|||
16981784|NCT00984282|38124989|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
16981785|NCT00984282|38124990|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
16981786|NCT00984282|38124989|FG000|Long Term Follow-up|Switched to commercial drug|4|||
16981787|NCT00984282|38124990|FG001|Long Term Follow-up|Switched to commercial drug|2|||
16981788|NCT00984282|38124989|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
16981789|NCT00984282|38124990|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
16981790|NCT01147874|38124998|FG000|Overall Study|Adverse Event|5|||
16981791|NCT01147874|38124998|FG000|Overall Study|Investigator's Request|1|||
16981792|NCT01147874|38124998|FG000|Overall Study|Lost to Follow-up|25|||
16981793|NCT01147874|38124998|FG000|Overall Study|Other|5|||
16981794|NCT01147874|38124998|FG000|Overall Study|Protocol Violation|5|||
16981795|NCT01147874|38124998|FG000|Overall Study|Sponsor's Decision|2|||
16981796|NCT01147874|38124998|FG000|Overall Study|Withdrawal by Subject|24|||
16981797|NCT01147640|38125004|FG000|Overall Study|Adverse Event|2|||
16981798|NCT01147640|38125005|FG001|Overall Study|Adverse Event|0|||
16981799|NCT01147640|38125004|FG000|Overall Study|Physician Decision|1|||
16981800|NCT01147640|38125005|FG001|Overall Study|Physician Decision|0|||
16981801|NCT01147640|38125004|FG000|Overall Study|Withdrawal by Subject|1|||
16981802|NCT01147640|38125005|FG001|Overall Study|Withdrawal by Subject|0|||
16981803|NCT01147640|38125004|FG000|Overall Study|Lost to Follow-up|0|||
16981804|NCT01147640|38125005|FG001|Overall Study|Lost to Follow-up|1|||
16981805|NCT01147640|38125004|FG000|Overall Study|Didn't meet eligibility criteria|1|||
16981806|NCT01147640|38125005|FG001|Overall Study|Didn't meet eligibility criteria|0|||
16981807|NCT01121900|38125011|FG000|First Intervention Period|Adverse Event|1|||
16981808|NCT01121900|38125012|FG001|First Intervention Period|Adverse Event|1|||
16981809|NCT01121900|38125011|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16981810|NCT01121900|38125012|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16981811|NCT01121666|38125020|FG000|Overall Study|Protocol Violation|29|||
16981812|NCT01121666|38125021|FG001|Overall Study|Protocol Violation|10|||
16981813|NCT00984126|38125031|FG000|Overall Study|Protocol Violation|0|||
16981814|NCT00984126|38125032|FG001|Overall Study|Protocol Violation|0|||
16981815|NCT00984126|38125033|FG002|Overall Study|Protocol Violation|1|||
16981816|NCT00984126|38125034|FG003|Overall Study|Protocol Violation|2|||
16981817|NCT00984126|38125031|FG000|Overall Study|Adverse Event|0|||
16981818|NCT00984126|38125032|FG001|Overall Study|Adverse Event|0|||
16981819|NCT00984126|38125033|FG002|Overall Study|Adverse Event|0|||
16981820|NCT00984126|38125034|FG003|Overall Study|Adverse Event|2|||
16981821|NCT00984126|38125031|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
16981822|NCT00984126|38125032|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
16981823|NCT00984126|38125033|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
16981824|NCT00984126|38125034|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
16981825|NCT00984126|38125031|FG000|Overall Study|Withdrawal criteria|0|||
16981826|NCT00984126|38125032|FG001|Overall Study|Withdrawal criteria|1|||
16981827|NCT00984126|38125033|FG002|Overall Study|Withdrawal criteria|3|||
16981828|NCT00984126|38125034|FG003|Overall Study|Withdrawal criteria|9|||
16981829|NCT00979602|38125055|FG000|Overall Study|Serious Adverse Event|5|||
16981830|NCT00979602|38125056|FG001|Overall Study|Serious Adverse Event|3|||
16981831|NCT00979602|38125055|FG000|Overall Study|Protocol Violation|3|||
16981832|NCT00979602|38125056|FG001|Overall Study|Protocol Violation|0|||
16981833|NCT00979602|38125055|FG000|Overall Study|Withdrawal by Subject|31|||
16981834|NCT00979602|38125056|FG001|Overall Study|Withdrawal by Subject|25|||
16981835|NCT00979602|38125055|FG000|Overall Study|Lost to Follow-up|100|||
16981836|NCT00979602|38125056|FG001|Overall Study|Lost to Follow-up|96|||
16981837|NCT00979602|38125055|FG000|Overall Study|Migrated/moved from study area|3|||
16981838|NCT00979602|38125056|FG001|Overall Study|Migrated/moved from study area|6|||
16981839|NCT00979602|38125055|FG000|Overall Study|Others|3|||
16981840|NCT00979602|38125056|FG001|Overall Study|Others|3|||
16981841|NCT00816361|38125081|FG000|Overall Study|Withdrawal by Subject|0|||
16981842|NCT00816361|38125082|FG001|Overall Study|Withdrawal by Subject|0|||
16981843|NCT00816361|38125083|FG002|Overall Study|Withdrawal by Subject|0|||
16981844|NCT00816361|38125084|FG003|Overall Study|Withdrawal by Subject|0|||
16981845|NCT00816361|38125085|FG004|Overall Study|Withdrawal by Subject|1|||
16981846|NCT00816361|38125086|FG005|Overall Study|Withdrawal by Subject|2|||
16981847|NCT00816361|38125087|FG006|Overall Study|Withdrawal by Subject|0|||
16981848|NCT00816361|38125088|FG007|Overall Study|Withdrawal by Subject|2|||
16981849|NCT00816361|38125089|FG008|Overall Study|Withdrawal by Subject|1|||
16981850|NCT00816361|38125081|FG000|Overall Study|Death|4|||
16981851|NCT00816361|38125082|FG001|Overall Study|Death|3|||
16981852|NCT00816361|38125083|FG002|Overall Study|Death|3|||
16981853|NCT00816361|38125084|FG003|Overall Study|Death|3|||
16981854|NCT00816361|38125085|FG004|Overall Study|Death|1|||
16981855|NCT00816361|38125086|FG005|Overall Study|Death|1|||
16981856|NCT00816361|38125087|FG006|Overall Study|Death|3|||
16981857|NCT00816361|38125088|FG007|Overall Study|Death|7|||
16981858|NCT00816361|38125089|FG008|Overall Study|Death|8|||
16981859|NCT00816361|38125081|FG000|Overall Study|Other|0|||
16981860|NCT00816361|38125082|FG001|Overall Study|Other|0|||
16981861|NCT00816361|38125083|FG002|Overall Study|Other|0|||
16981862|NCT00816361|38125084|FG003|Overall Study|Other|0|||
16981863|NCT00816361|38125085|FG004|Overall Study|Other|0|||
16981864|NCT00816361|38125086|FG005|Overall Study|Other|0|||
16981865|NCT00816361|38125087|FG006|Overall Study|Other|0|||
16981866|NCT00816361|38125088|FG007|Overall Study|Other|0|||
16981867|NCT00816361|38125089|FG008|Overall Study|Other|1|||
16981868|NCT00826111|38125112|FG000|Overall Study|Lost to Follow-up|0|||
16981869|NCT00826111|38125113|FG001|Overall Study|Lost to Follow-up|1|||
16981870|NCT00826111|38125112|FG000|Overall Study|Protocol Violation|1|||
16981871|NCT00826111|38125113|FG001|Overall Study|Protocol Violation|0|||
16981872|NCT00826111|38125112|FG000|Overall Study|Withdrawal by Subject|5|||
16981873|NCT00826111|38125113|FG001|Overall Study|Withdrawal by Subject|0|||
16981874|NCT00826111|38125112|FG000|Overall Study|Physician Decision|1|||
16981875|NCT00826111|38125113|FG001|Overall Study|Physician Decision|1|||
16981876|NCT00982644|38125124|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
16981877|NCT00982644|38125125|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
16981878|NCT00982644|38125124|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
16981879|NCT00982644|38125125|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
16981880|NCT00982644|38125124|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
16981881|NCT00982644|38125125|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
16981882|NCT00982644|38125124|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
16981883|NCT00982644|38125125|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
16981884|NCT00982644|38125124|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
16981885|NCT00982644|38125125|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
16981886|NCT00982644|38125124|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
16981887|NCT00982644|38125125|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
16981888|NCT00982644|38125124|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
16981889|NCT00982644|38125125|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
16981890|NCT00982644|38125124|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
16981891|NCT00982644|38125125|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
16981892|NCT00982644|38125124|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
16981893|NCT00982644|38125125|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
16981894|NCT00982644|38125124|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
16981895|NCT00982644|38125125|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
16981896|NCT00815659|38125131|FG000|Overall Study|Adverse Event|9|||
16981897|NCT00815659|38125131|FG000|Overall Study|Withdrawal by Subject|9|||
16981898|NCT00815659|38125131|FG000|Overall Study|Lost to Follow-up|4|||
16981899|NCT00815659|38125131|FG000|Overall Study|Protocol Violation|1|||
16981900|NCT00825175|38125137|FG000|Overall Study|Withdrawal by Subject|0|||
16981901|NCT00825175|38125138|FG001|Overall Study|Withdrawal by Subject|5|||
16981902|NCT00824473|38125146|FG000|Overall Study|Adverse Event|4|||
16981903|NCT00824473|38125147|FG001|Overall Study|Adverse Event|5|||
16981904|NCT00824473|38125146|FG000|Overall Study|Lack of Efficacy|2|||
16981905|NCT00824473|38125147|FG001|Overall Study|Lack of Efficacy|2|||
16981906|NCT00824473|38125146|FG000|Overall Study|Protocol Violation|2|||
16981907|NCT00824473|38125147|FG001|Overall Study|Protocol Violation|0|||
16981908|NCT00824473|38125146|FG000|Overall Study|Non-Compliance|4|||
16981909|NCT00824473|38125147|FG001|Overall Study|Non-Compliance|2|||
16981910|NCT00824473|38125146|FG000|Overall Study|Withdrawal by Subject|2|||
16981911|NCT00824473|38125147|FG001|Overall Study|Withdrawal by Subject|3|||
16981912|NCT00824473|38125146|FG000|Overall Study|Other|1|||
16981913|NCT00824473|38125147|FG001|Overall Study|Other|1|||
16981914|NCT00815191|38125159|FG000|Overall Study|Protocol Violation|1|||
16981915|NCT00815191|38125160|FG001|Overall Study|Protocol Violation|1|||
16981916|NCT00812929|38125166|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
16981917|NCT00812929|38125167|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
16981918|NCT00812929|38125168|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
16981919|NCT00812929|38125169|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
16981920|NCT00812929|38125170|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
16981921|NCT00812929|38125171|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
16981922|NCT00812929|38125172|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
16981923|NCT00812929|38125173|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
16981924|NCT00812929|38125174|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
16981925|NCT00812929|38125175|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
16981926|NCT00812929|38125166|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
16981927|NCT00812929|38125167|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
16981928|NCT00812929|38125168|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
16981929|NCT00812929|38125169|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
16981930|NCT00812929|38125170|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
16981931|NCT00812929|38125171|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
16981932|NCT00812929|38125172|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
16981933|NCT00812929|38125173|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
16981934|NCT00812929|38125174|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
16981935|NCT00812929|38125175|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
16981936|NCT00812929|38125166|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
16981937|NCT00812929|38125167|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
16981938|NCT00812929|38125168|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
16981939|NCT00812929|38125169|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
16981940|NCT00812929|38125170|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
16981941|NCT00812929|38125171|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
16981942|NCT00812929|38125172|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
16981943|NCT00812929|38125173|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
16981944|NCT00812929|38125174|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
16981945|NCT00812929|38125175|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
16981946|NCT00824161|38125192|FG000|Overall Study|Withdrawal by Subject|1|||
16981947|NCT00824161|38125192|FG000|Overall Study|Screen Failure|1|||
16981948|NCT00979134|38125201|FG000|Overall Study|Disease progression|18|||
16981949|NCT00979134|38125202|FG001|Overall Study|Disease progression|2|||
16981950|NCT00979134|38125203|FG002|Overall Study|Disease progression|5|||
16981951|NCT00979134|38125201|FG000|Overall Study|Adverse Event|0|||
16981952|NCT00979134|38125202|FG001|Overall Study|Adverse Event|0|||
16981953|NCT00979134|38125203|FG002|Overall Study|Adverse Event|2|||
16981954|NCT00979134|38125201|FG000|Overall Study|Withdrawal by Subject|1|||
16981955|NCT00979134|38125202|FG001|Overall Study|Withdrawal by Subject|1|||
16981956|NCT00979134|38125203|FG002|Overall Study|Withdrawal by Subject|2|||
16981957|NCT00979134|38125201|FG000|Overall Study|Lost to Follow-up|2|||
16981958|NCT00979134|38125202|FG001|Overall Study|Lost to Follow-up|2|||
16981959|NCT00979134|38125203|FG002|Overall Study|Lost to Follow-up|0|||
16981960|NCT00979134|38125201|FG000|Overall Study|Death|4|||
16981961|NCT00979134|38125202|FG001|Overall Study|Death|0|||
16981962|NCT00979134|38125203|FG002|Overall Study|Death|26|||
16981963|NCT00979134|38125201|FG000|Overall Study|Other|8|||
16981964|NCT00979134|38125202|FG001|Overall Study|Other|1|||
16981965|NCT00979134|38125203|FG002|Overall Study|Other|5|||
16981966|NCT00824005|38125218|FG000|Overall Study|Death|0|||
16981967|NCT00824005|38125219|FG001|Overall Study|Death|1|||
16981968|NCT00824005|38125218|FG000|Overall Study|Lost to Follow-up|0|||
16981969|NCT00824005|38125219|FG001|Overall Study|Lost to Follow-up|1|||
16981970|NCT00814879|38125227|FG000|By Week 24|Cancer Diagnosis|1|||
16981971|NCT00814879|38125228|FG001|By Week 24|Cancer Diagnosis|0|||
16981972|NCT00814879|38125227|FG000|By Week 24|Incarceration|0|||
16981973|NCT00814879|38125228|FG001|By Week 24|Incarceration|1|||
16981974|NCT00814879|38125227|FG000|By Week 48|Lost to Follow-up|2|||
16981975|NCT00814879|38125228|FG001|By Week 48|Lost to Follow-up|2|||
16981976|NCT00814879|38125227|FG000|By Week 48|Death|0|||
16981977|NCT00814879|38125228|FG001|By Week 48|Death|1|||
16981978|NCT03347422|38125237|FG000|Part A (26 Weeks)|Adverse Event|3|||
16981979|NCT03347422|38125238|FG001|Part A (26 Weeks)|Adverse Event|0|||
16981980|NCT03347422|38125237|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
16981981|NCT03347422|38125238|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
16981982|NCT03347422|38125237|FG000|Part B (149 Weeks)|Adverse Event|0|||
16981983|NCT03347422|38125238|FG001|Part B (149 Weeks)|Adverse Event|1|||
16981984|NCT03347422|38125237|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
16981985|NCT03347422|38125238|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
16981986|NCT03347422|38125237|FG000|Part B (149 Weeks)|Other|1|||
16981987|NCT03347422|38125238|FG001|Part B (149 Weeks)|Other|0|||
16981988|NCT00814801|38125254|FG000|Overall Study|Adverse Event|15|||
16981989|NCT00814801|38125255|FG001|Overall Study|Adverse Event|16|||
16981990|NCT00814801|38125256|FG002|Overall Study|Adverse Event|19|||
16981991|NCT00814801|38125254|FG000|Overall Study|Withdrawal by Subject|9|||
16780210|NCT01594749|37719308|FG001|Overall Study|Lost to Follow-up|0|||
16981992|NCT00814801|38125255|FG001|Overall Study|Withdrawal by Subject|11|||
16981993|NCT00814801|38125256|FG002|Overall Study|Withdrawal by Subject|14|||
16981994|NCT00814801|38125254|FG000|Overall Study|Inappropriate as a subject|1|||
16981995|NCT00814801|38125255|FG001|Overall Study|Inappropriate as a subject|1|||
16981996|NCT00814801|38125256|FG002|Overall Study|Inappropriate as a subject|1|||
16981997|NCT00814801|38125254|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
16981998|NCT00814801|38125255|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
16981999|NCT00814801|38125256|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
16982000|NCT00814801|38125254|FG000|Overall Study|Missing or change of caregiver|6|||
16982001|NCT00814801|38125255|FG001|Overall Study|Missing or change of caregiver|2|||
16982002|NCT00814801|38125256|FG002|Overall Study|Missing or change of caregiver|4|||
16982003|NCT00814801|38125254|FG000|Overall Study|Non-compliance|0|||
16982004|NCT00814801|38125255|FG001|Overall Study|Non-compliance|1|||
16982005|NCT00814801|38125256|FG002|Overall Study|Non-compliance|1|||
16982006|NCT00814801|38125254|FG000|Overall Study|Other|2|||
16982007|NCT00814801|38125255|FG001|Overall Study|Other|6|||
16982008|NCT00814801|38125256|FG002|Overall Study|Other|4|||
16982009|NCT00823615|38125264|FG000|Period 2|Lost to Follow-up|2|||
16982010|NCT00823615|38125265|FG001|Period 2|Lost to Follow-up|0|||
16982011|NCT00823615|38125264|FG000|Period 2|Time/Job Conflict|1|||
16982012|NCT00823615|38125265|FG001|Period 2|Time/Job Conflict|2|||
16982013|NCT00812461|38125273|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
16982014|NCT00812461|38125274|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
16982015|NCT00812461|38125273|FG000|All Treated Patients|Adverse Event|8|||
16982016|NCT00812461|38125274|FG001|All Treated Patients|Adverse Event|15|||
16982017|NCT00812461|38125273|FG000|All Treated Patients|Lack of Efficacy|13|||
16982018|NCT00812461|38125274|FG001|All Treated Patients|Lack of Efficacy|7|||
16982019|NCT00812461|38125273|FG000|All Treated Patients|Non-compliance|6|||
16982020|NCT00812461|38125274|FG001|All Treated Patients|Non-compliance|9|||
16982021|NCT00812461|38125273|FG000|All Treated Patients|Protocol Violation|36|||
16982022|NCT00812461|38125274|FG001|All Treated Patients|Protocol Violation|27|||
16982023|NCT00812461|38125273|FG000|All Treated Patients|Withdrawal by Subject|45|||
16982024|NCT00812461|38125274|FG001|All Treated Patients|Withdrawal by Subject|54|||
16982025|NCT00812461|38125273|FG000|All Treated Patients|Lost to Follow-up|11|||
16982026|NCT00812461|38125274|FG001|All Treated Patients|Lost to Follow-up|14|||
16982027|NCT00812461|38125273|FG000|All Treated Patients|Other Reason|13|||
16982028|NCT00812461|38125274|FG001|All Treated Patients|Other Reason|21|||
16982029|NCT00599326|38125280|FG000|Overall Study|Lost to Follow-up|1|||
16982030|NCT00599326|38125280|FG000|Overall Study|Noncompliant|1|||
16982031|NCT00978432|38125287|FG000|Overall Study|Withdrawal by Subject|0|||
16982032|NCT00978432|38125288|FG001|Overall Study|Withdrawal by Subject|0|||
16982033|NCT00978432|38125289|FG002|Overall Study|Withdrawal by Subject|1|||
16982034|NCT00978432|38125287|FG000|Overall Study|Lack of Efficacy|1|||
16982035|NCT00978432|38125288|FG001|Overall Study|Lack of Efficacy|1|||
16982036|NCT00978432|38125289|FG002|Overall Study|Lack of Efficacy|3|||
16982037|NCT00978432|38125287|FG000|Overall Study|Adverse Event|2|||
16982038|NCT00978432|38125288|FG001|Overall Study|Adverse Event|0|||
16982039|NCT00978432|38125289|FG002|Overall Study|Adverse Event|1|||
16982040|NCT00975780|38125299|FG000|Follow Up|Death|88|||
16982041|NCT00975780|38125300|FG001|Follow Up|Death|122|||
16982042|NCT00975780|38125299|FG000|Follow Up|Facility Withdrawal|7|||
16982043|NCT00975780|38125300|FG001|Follow Up|Facility Withdrawal|23|||
16982044|NCT00975780|38125299|FG000|Follow Up|Discharged from Facility|7|||
16982045|NCT00975780|38125300|FG001|Follow Up|Discharged from Facility|12|||
16982046|NCT00814489|38125309|FG000|Overall Study|Other|2|||
16982047|NCT00814489|38125310|FG001|Overall Study|Other|0|||
16982048|NCT00814489|38125311|FG002|Overall Study|Other|1|||
16982049|NCT00814333|38125323|FG000|Enrollment|Lost to Follow-up|1|||
16982050|NCT00814333|38125324|FG001|Enrollment|Lost to Follow-up|0|||
16982051|NCT01147250|38125332|FG000|Overall Study|Lost to Follow-up|14|||
16982052|NCT01147250|38125333|FG001|Overall Study|Lost to Follow-up|11|||
16982053|NCT01147250|38125332|FG000|Overall Study|Withdrawal by Subject|83|||
16982054|NCT01147250|38125333|FG001|Overall Study|Withdrawal by Subject|88|||
16982055|NCT01147250|38125332|FG000|Overall Study|Site termination by sponsor|13|||
16982056|NCT01147250|38125333|FG001|Overall Study|Site termination by sponsor|5|||
16982057|NCT01147250|38125332|FG000|Overall Study|Other than specified|0|||
16982058|NCT01147250|38125333|FG001|Overall Study|Other than specified|1|||
16982059|NCT00813943|38125342|FG000|Overall Study|Ongoing at cut-off date|5|||
16982060|NCT00813943|38125343|FG001|Overall Study|Ongoing at cut-off date|5|||
16982061|NCT00813943|38125344|FG002|Overall Study|Ongoing at cut-off date|3|||
16982062|NCT00821509|38125356|FG000|Overall Study|Withdrawal by Subject|12|||
16982063|NCT00821509|38125357|FG001|Overall Study|Withdrawal by Subject|11|||
16982064|NCT00821509|38125358|FG002|Overall Study|Withdrawal by Subject|34|||
16982065|NCT00821431|38125368|FG000|Overall Study|Adverse Event|6|||
16982066|NCT00821431|38125369|FG001|Overall Study|Adverse Event|3|||
16982067|NCT00821431|38125368|FG000|Overall Study|Withdrawal by Subject|5|||
16982068|NCT00821431|38125369|FG001|Overall Study|Withdrawal by Subject|0|||
16982069|NCT00821431|38125368|FG000|Overall Study|Lost to Follow-up|1|||
16982070|NCT00821431|38125369|FG001|Overall Study|Lost to Follow-up|0|||
16982071|NCT00821431|38125368|FG000|Overall Study|Protocol Violation|3|||
16982072|NCT00821431|38125369|FG001|Overall Study|Protocol Violation|1|||
16982073|NCT00821431|38125368|FG000|Overall Study|Physician Decision|0|||
16982074|NCT00821431|38125369|FG001|Overall Study|Physician Decision|1|||
16982075|NCT01134614|38125377|FG000|Overall Study|Still on treatment as of March 2013|21|||
16982076|NCT01134614|38125378|FG001|Overall Study|Still on treatment as of March 2013|13|||
16982077|NCT01134614|38125377|FG000|Overall Study|Progressive disease|60|||
16982078|NCT01134614|38125378|FG001|Overall Study|Progressive disease|54|||
16982079|NCT01134614|38125377|FG000|Overall Study|Adverse Event|26|||
16982080|NCT01134614|38125378|FG001|Overall Study|Adverse Event|39|||
16982081|NCT01134614|38125377|FG000|Overall Study|Death|5|||
16982082|NCT01134614|38125378|FG001|Overall Study|Death|8|||
16982083|NCT01134614|38125377|FG000|Overall Study|Withdrawal by Subject|3|||
16982084|NCT01134614|38125378|FG001|Overall Study|Withdrawal by Subject|2|||
16982085|NCT01134614|38125377|FG000|Overall Study|Alternative therapy|2|||
16982086|NCT01134614|38125378|FG001|Overall Study|Alternative therapy|0|||
16982087|NCT01134614|38125377|FG000|Overall Study|Complicating disease|2|||
16982088|NCT01134614|38125378|FG001|Overall Study|Complicating disease|1|||
16982089|NCT01134614|38125377|FG000|Overall Study|Physician's decision|0|||
16982090|NCT01134614|38125378|FG001|Overall Study|Physician's decision|1|||
16982091|NCT01134614|38125377|FG000|Overall Study|Never started treatment|4|||
16982092|NCT01134614|38125378|FG001|Overall Study|Never started treatment|1|||
16982093|NCT01134614|38125377|FG000|Overall Study|Pt received tx not allowed on study|0|||
16982094|NCT01134614|38125378|FG001|Overall Study|Pt received tx not allowed on study|1|||
16982095|NCT01134614|38125377|FG000|Overall Study|Symptomatic deterioration|0|||
16982096|NCT01134614|38125378|FG001|Overall Study|Symptomatic deterioration|1|||
16982097|NCT01134614|38125377|FG000|Overall Study|Patient in hospice care|0|||
16982098|NCT01134614|38125378|FG001|Overall Study|Patient in hospice care|1|||
16982099|NCT03982368|38125387|FG000|Overall Study|Adverse Event|6|||
16982100|NCT03982368|38125388|FG001|Overall Study|Adverse Event|4|||
16982101|NCT03982368|38125389|FG002|Overall Study|Adverse Event|3|||
16982102|NCT03982368|38125387|FG000|Overall Study|Lost to Follow-up|2|||
16982103|NCT03982368|38125388|FG001|Overall Study|Lost to Follow-up|1|||
16982104|NCT03982368|38125389|FG002|Overall Study|Lost to Follow-up|0|||
16982105|NCT03982368|38125387|FG000|Overall Study|Withdrawal by Subject|1|||
16982106|NCT03982368|38125388|FG001|Overall Study|Withdrawal by Subject|2|||
16982107|NCT03982368|38125389|FG002|Overall Study|Withdrawal by Subject|0|||
16982108|NCT03982368|38125387|FG000|Overall Study|unknow|4|||
16982109|NCT03982368|38125388|FG001|Overall Study|unknow|0|||
16982110|NCT03982368|38125389|FG002|Overall Study|unknow|2|||
16982111|NCT00813865|38125400|FG000|Overall Study|Failure to Respond|3|||
16982112|NCT00813865|38125400|FG000|Overall Study|Lost to Follow-up|3|||
16982113|NCT00813865|38125400|FG000|Overall Study|Withdrawal by Subject|1|||
16982114|NCT01147172|38125404|FG000|Overall Study|Withdrawal by Subject|2|||
16982115|NCT01147172|38125404|FG000|Overall Study|Lost to Follow-up|2|||
16982116|NCT01120964|38125412|FG000|Overall Study|Did not receive full treatment|1|||
16982117|NCT01120964|38125413|FG001|Overall Study|Did not receive full treatment|0|||
16982118|NCT01146860|38125421|FG000|Overall Study|Withdrawal by Subject|0|||
16982119|NCT01146860|38125422|FG001|Overall Study|Withdrawal by Subject|1|||
16982120|NCT00591565|38125428|FG000|Overall Study|lost follow up, withdrawn|5|||
16982121|NCT01146782|38125432|FG000|Screening Cohort|Screen Failure|187|||
16982122|NCT01146782|38125432|FG000|Screening Cohort|Lost to Follow-up|4|||
16982123|NCT01146782|38125432|FG000|Screening Cohort|Physician Decision|1|||
16982124|NCT01146782|38125432|FG000|Screening Cohort|Withdrawal by Subject|29|||
16982125|NCT01146782|38125432|FG000|Safety Cohort|Screen Failure|61|||
16982126|NCT01146782|38125432|FG000|Safety Cohort|Withdrawal by Subject|4|||
16982127|NCT01146782|38125432|FG000|Safety Cohort|Control AHI <5|4|||
16982128|NCT01146782|38125432|FG000|Safety Cohort|TST <4 hrs|14|||
16982129|NCT01146782|38125432|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
16982130|NCT01146782|38125432|FG000|Primary Endpoint Cohort|Physician Decision|1|||
16982131|NCT00978120|38125441|FG000|Overall Study|Death|0|||
16982132|NCT00978120|38125442|FG001|Overall Study|Death|0|||
16982133|NCT00978120|38125443|FG002|Overall Study|Death|0|||
16982134|NCT00978120|38125444|FG003|Overall Study|Death|1|||
16982135|NCT00978120|38125441|FG000|Overall Study|Lost to Follow-up|0|||
16982136|NCT00978120|38125442|FG001|Overall Study|Lost to Follow-up|0|||
16982137|NCT00978120|38125443|FG002|Overall Study|Lost to Follow-up|3|||
16982138|NCT00978120|38125444|FG003|Overall Study|Lost to Follow-up|0|||
16982139|NCT00978120|38125441|FG000|Overall Study|Withdrawal by Subject|2|||
16982140|NCT00978120|38125442|FG001|Overall Study|Withdrawal by Subject|0|||
16982141|NCT00978120|38125443|FG002|Overall Study|Withdrawal by Subject|0|||
16982142|NCT00978120|38125444|FG003|Overall Study|Withdrawal by Subject|0|||
16982143|NCT00978120|38125441|FG000|Overall Study|Moved out of state|0|||
16982144|NCT00978120|38125442|FG001|Overall Study|Moved out of state|0|||
16982145|NCT00978120|38125443|FG002|Overall Study|Moved out of state|0|||
16982146|NCT00978120|38125444|FG003|Overall Study|Moved out of state|1|||
16982147|NCT01133756|38125461|FG000|Overall Study|Adverse Event|1|||
16982148|NCT01133756|38125462|FG001|Overall Study|Adverse Event|2|||
16982149|NCT01133756|38125463|FG002|Overall Study|Adverse Event|1|||
16982150|NCT01133756|38125461|FG000|Overall Study|Investigator Decision|1|||
16982151|NCT01133756|38125462|FG001|Overall Study|Investigator Decision|0|||
16982152|NCT01133756|38125463|FG002|Overall Study|Investigator Decision|0|||
16982153|NCT01133756|38125461|FG000|Overall Study|Withdrawal by Subject|0|||
16982154|NCT01133756|38125462|FG001|Overall Study|Withdrawal by Subject|1|||
16982155|NCT01133756|38125463|FG002|Overall Study|Withdrawal by Subject|0|||
16982156|NCT01133756|38125461|FG000|Overall Study|Progression of Disease|0|||
16982157|NCT01133756|38125462|FG001|Overall Study|Progression of Disease|0|||
16982158|NCT01133756|38125463|FG002|Overall Study|Progression of Disease|1|||
16982159|NCT00978042|38125473|FG000|Initial Treatment Period|Treated in Error|0|||
16982160|NCT00978042|38125474|FG001|Initial Treatment Period|Treated in Error|3|||
16982161|NCT00978042|38125473|FG000|Initial Treatment Period|Ineligibility|1|||
16982162|NCT00978042|38125474|FG001|Initial Treatment Period|Ineligibility|0|||
16982163|NCT00978042|38125473|FG000|Initial Treatment Period|Lost to Follow-up|21|||
16982164|NCT00978042|38125474|FG001|Initial Treatment Period|Lost to Follow-up|3|||
16982165|NCT00978042|38125473|FG000|Initial Treatment Period|Adverse Event|2|||
16982166|NCT00978042|38125474|FG001|Initial Treatment Period|Adverse Event|0|||
16982167|NCT00978042|38125473|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
16982168|NCT00978042|38125474|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
16982169|NCT00978042|38125473|FG000|Initial Treatment Period|Consent withdrawn|22|||
16982170|NCT00978042|38125474|FG001|Initial Treatment Period|Consent withdrawn|9|||
16982171|NCT00978042|38125473|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
16982172|NCT00978042|38125474|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
16982173|NCT01133678|38125482|FG000|Overall Study|Death|1|||
16982174|NCT01133678|38125483|FG001|Overall Study|Death|1|||
16982175|NCT01133522|38125506|FG000|Overall Study|Withdrawal by Subject|0|||
16982176|NCT01133522|38125507|FG001|Overall Study|Withdrawal by Subject|1|||
16982177|NCT01133522|38125508|FG002|Overall Study|Withdrawal by Subject|0|||
16982178|NCT01133522|38125509|FG003|Overall Study|Withdrawal by Subject|1|||
16982179|NCT01133522|38125510|FG004|Overall Study|Withdrawal by Subject|0|||
16982180|NCT01133522|38125511|FG005|Overall Study|Withdrawal by Subject|0|||
16982181|NCT01133522|38125512|FG006|Overall Study|Withdrawal by Subject|0|||
16982182|NCT01133522|38125513|FG007|Overall Study|Withdrawal by Subject|0|||
16982183|NCT01133522|38125514|FG008|Overall Study|Withdrawal by Subject|0|||
16982184|NCT01133522|38125515|FG009|Overall Study|Withdrawal by Subject|0|||
16982185|NCT01133522|38125506|FG000|Overall Study|Physician Decision|0|||
16982186|NCT01133522|38125507|FG001|Overall Study|Physician Decision|0|||
16982187|NCT01133522|38125508|FG002|Overall Study|Physician Decision|0|||
16982188|NCT01133522|38125509|FG003|Overall Study|Physician Decision|0|||
16982189|NCT01133522|38125510|FG004|Overall Study|Physician Decision|1|||
16982190|NCT01133522|38125511|FG005|Overall Study|Physician Decision|0|||
16982191|NCT01133522|38125512|FG006|Overall Study|Physician Decision|0|||
16982192|NCT01133522|38125513|FG007|Overall Study|Physician Decision|0|||
16982193|NCT01133522|38125514|FG008|Overall Study|Physician Decision|0|||
16982194|NCT01133522|38125515|FG009|Overall Study|Physician Decision|0|||
16982195|NCT01133288|38125544|FG000|Eligibility Assessment|met exclusion criteria|5|||
16982196|NCT01133288|38125544|FG000|Intervention Allocation|study terminated|2|||
16982197|NCT00883090|38125552|FG000|Overall Study|Sponsor's decision|1|||
16982198|NCT00883090|38125552|FG000|Overall Study|Withdrawal by Subject|1|||
16982199|NCT01132820|38125556|FG000|Overall Study|Ineligible: wrong cell type|1|||
16982200|NCT01132820|38125556|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
16982201|NCT01132820|38125556|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
16982202|NCT01132820|38125556|FG000|Overall Study|Never treated|1|||
16982203|NCT01132820|38125556|FG000|Overall Study|Inadequate data|1|||
16982204|NCT00885352|38125575|FG000|Overall Study|Adverse Event|2|||
16982205|NCT00885352|38125576|FG001|Overall Study|Adverse Event|3|||
16982206|NCT00885352|38125575|FG000|Overall Study|Lost to Follow-up|2|||
16982207|NCT00885352|38125576|FG001|Overall Study|Lost to Follow-up|2|||
16982208|NCT00885352|38125575|FG000|Overall Study|Physician Decision|0|||
16982209|NCT00885352|38125576|FG001|Overall Study|Physician Decision|3|||
16982210|NCT00885352|38125575|FG000|Overall Study|Protocol Violation|0|||
16982211|NCT00885352|38125576|FG001|Overall Study|Protocol Violation|2|||
16982212|NCT00885352|38125575|FG000|Overall Study|Withdrawal by Subject|1|||
16982213|NCT00885352|38125576|FG001|Overall Study|Withdrawal by Subject|5|||
16982214|NCT00885352|38125575|FG000|Overall Study|Contradiction to study medication|0|||
16982215|NCT00885352|38125576|FG001|Overall Study|Contradiction to study medication|2|||
16982216|NCT00885352|38125575|FG000|Overall Study|Excluded medication|2|||
16982217|NCT00885352|38125576|FG001|Overall Study|Excluded medication|2|||
16982218|NCT00885352|38125575|FG000|Overall Study|Lab abnormalities|1|||
16982219|NCT00885352|38125576|FG001|Overall Study|Lab abnormalities|1|||
16982220|NCT00885118|38125587|FG000|Overall Study|Adverse Event|1|||
16982221|NCT00885118|38125588|FG001|Overall Study|Adverse Event|0|||
16982222|NCT00885118|38125589|FG002|Overall Study|Adverse Event|0|||
16982223|NCT00885118|38125590|FG003|Overall Study|Adverse Event|0|||
16982224|NCT00885118|38125591|FG004|Overall Study|Adverse Event|0|||
16982225|NCT00885118|38125587|FG000|Overall Study|Withdrawal by Subject|0|||
16982226|NCT00885118|38125588|FG001|Overall Study|Withdrawal by Subject|0|||
16982227|NCT00885118|38125589|FG002|Overall Study|Withdrawal by Subject|0|||
16982228|NCT00885118|38125590|FG003|Overall Study|Withdrawal by Subject|0|||
16982229|NCT00885118|38125591|FG004|Overall Study|Withdrawal by Subject|1|||
16982230|NCT00885118|38125587|FG000|Overall Study|Other reason not defined above|0|||
16982231|NCT00885118|38125588|FG001|Overall Study|Other reason not defined above|0|||
16982232|NCT00885118|38125589|FG002|Overall Study|Other reason not defined above|1|||
16982233|NCT00885118|38125590|FG003|Overall Study|Other reason not defined above|0|||
16982234|NCT00885118|38125591|FG004|Overall Study|Other reason not defined above|0|||
16982235|NCT00880906|38125609|FG000|Overall Study|Lost to Follow-up|0|||
16982236|NCT00880906|38125610|FG001|Overall Study|Lost to Follow-up|1|||
16982237|NCT00880906|38125609|FG000|Overall Study|Did not meet criteria following patholog|12|||
16982238|NCT00880906|38125610|FG001|Overall Study|Did not meet criteria following patholog|6|||
16982239|NCT00882310|38125616|FG000|Overall Study|Screen Failure|10|||
16982240|NCT00882310|38125616|FG000|Overall Study|Never received treatment|1|||
16982241|NCT00882310|38125616|FG000|Overall Study|Death|6|||
16982242|NCT00882310|38125616|FG000|Overall Study|Progression of disease|4|||
16982243|NCT00882310|38125616|FG000|Overall Study|Adverse Event|1|||
16982244|NCT00884650|38125622|FG000|Overall Study|Did not return complete pain diaries|7|||
16982245|NCT00884650|38125623|FG001|Overall Study|Did not return complete pain diaries|7|||
16982246|NCT00884650|38125622|FG000|Overall Study|Admitted Post-Op|1|||
16982247|NCT00884650|38125623|FG001|Overall Study|Admitted Post-Op|0|||
16982248|NCT00884650|38125622|FG000|Overall Study|Femoral Stress Fracture|1|||
16982249|NCT00884650|38125623|FG001|Overall Study|Femoral Stress Fracture|0|||
16982250|NCT00884650|38125622|FG000|Overall Study|Pain Pump Complication|0|||
16982251|NCT00884650|38125623|FG001|Overall Study|Pain Pump Complication|1|||
16982252|NCT00881608|38125635|FG000|Overall Study|Study prematurely terminated|11|||
16982253|NCT01088399|38125650|FG000|Overall Study|Adverse Event|211|||
16982254|NCT01088399|38125651|FG001|Overall Study|Adverse Event|16|||
16982255|NCT01088399|38125652|FG002|Overall Study|Adverse Event|0|||
16982256|NCT01088399|38125650|FG000|Overall Study|Death|204|||
16982257|NCT01088399|38125651|FG001|Overall Study|Death|45|||
16982258|NCT01088399|38125652|FG002|Overall Study|Death|0|||
16982259|NCT01088399|38125650|FG000|Overall Study|Lack of Efficacy|298|||
16982260|NCT01088399|38125651|FG001|Overall Study|Lack of Efficacy|7|||
16982261|NCT01088399|38125652|FG002|Overall Study|Lack of Efficacy|5|||
16982262|NCT01088399|38125650|FG000|Overall Study|Lost to Follow-up|1070|||
16982263|NCT01088399|38125651|FG001|Overall Study|Lost to Follow-up|278|||
16982264|NCT01088399|38125652|FG002|Overall Study|Lost to Follow-up|58|||
16982265|NCT01088399|38125650|FG000|Overall Study|Physician Decision|531|||
16982266|NCT01088399|38125651|FG001|Overall Study|Physician Decision|88|||
16982267|NCT01088399|38125652|FG002|Overall Study|Physician Decision|16|||
16982268|NCT01088399|38125650|FG000|Overall Study|Withdrawal by Subject|544|||
16982269|NCT01088399|38125651|FG001|Overall Study|Withdrawal by Subject|195|||
16982270|NCT01088399|38125652|FG002|Overall Study|Withdrawal by Subject|33|||
16982271|NCT01088399|38125650|FG000|Overall Study|Change to or start of somatropin therapy|234|||
16982272|NCT01088399|38125651|FG001|Overall Study|Change to or start of somatropin therapy|17|||
16982273|NCT01088399|38125652|FG002|Overall Study|Change to or start of somatropin therapy|12|||
16982274|NCT01088399|38125650|FG000|Overall Study|Sponsor decision|1573|||
16982275|NCT01088399|38125651|FG001|Overall Study|Sponsor decision|298|||
16982276|NCT01088399|38125652|FG002|Overall Study|Sponsor decision|7|||
16982277|NCT01088399|38125650|FG000|Overall Study|Protocol Violation|10|||
16982278|NCT01088399|38125651|FG001|Overall Study|Protocol Violation|1|||
16982279|NCT01088399|38125652|FG002|Overall Study|Protocol Violation|0|||
16982280|NCT01088399|38125650|FG000|Overall Study|Enrollment criteria not met|48|||
16982281|NCT01088399|38125651|FG001|Overall Study|Enrollment criteria not met|119|||
16982282|NCT01088399|38125652|FG002|Overall Study|Enrollment criteria not met|70|||
16982283|NCT01088399|38125650|FG000|Overall Study|Study summary visit not completed|2398|||
16982284|NCT01088399|38125651|FG001|Overall Study|Study summary visit not completed|283|||
16982285|NCT01088399|38125652|FG002|Overall Study|Study summary visit not completed|80|||
16982286|NCT00598078|38125660|FG000|Period 2 (Day 2)|Adverse Event|1|||
16982287|NCT00598078|38125661|FG001|Period 2 (Day 2)|Adverse Event|0|||
16982288|NCT01079195|38125669|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
16982289|NCT01079195|38125669|FG000|Overall Study|No Documentation Available|437|||
16982290|NCT01079195|38125669|FG000|Overall Study|Adverse Event|157|||
16982291|NCT01079195|38125669|FG000|Overall Study|Reason Unknown|39|||
16982292|NCT01079195|38125669|FG000|Overall Study|Withdrawal by Subject|18|||
16982293|NCT01079195|38125669|FG000|Overall Study|Financial Reasons|15|||
16982294|NCT01079195|38125669|FG000|Overall Study|Lack of Effectiveness|12|||
16982295|NCT01079195|38125669|FG000|Overall Study|Physician Decision|4|||
16982296|NCT01079195|38125669|FG000|Overall Study|Improved Status of Participant|4|||
16982297|NCT01079195|38125669|FG000|Overall Study|No Follow-up Documentation Available|4|||
16982298|NCT01079195|38125669|FG000|Overall Study|Non-compliance|2|||
16982299|NCT00883558|38125673|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
16982300|NCT00883558|38125674|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
16982301|NCT00883558|38125675|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
16982302|NCT00883558|38125673|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
16982303|NCT00883558|38125674|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
16982304|NCT00883558|38125675|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
16982305|NCT00883558|38125673|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
16982306|NCT00883558|38125674|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
16982307|NCT00883558|38125675|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
16982308|NCT00883558|38125673|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
16982309|NCT00883558|38125674|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
16982310|NCT00883558|38125675|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
16982311|NCT00883558|38125673|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
16982312|NCT00883558|38125674|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
16982313|NCT00883558|38125675|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
16982314|NCT00880750|38125683|FG000|First Intervention|Adverse Event|1|||
16982315|NCT00880750|38125684|FG001|First Intervention|Adverse Event|0|||
16982316|NCT00880750|38125683|FG000|First Intervention|Unable to collect urine|4|||
16982317|NCT00880750|38125684|FG001|First Intervention|Unable to collect urine|0|||
16982318|NCT00880750|38125683|FG000|First Intervention|Non-compliance with meals|0|||
16982319|NCT00880750|38125684|FG001|First Intervention|Non-compliance with meals|1|||
16982320|NCT00880750|38125683|FG000|First Intervention|Withdrawal by Subject|2|||
16982321|NCT00880750|38125684|FG001|First Intervention|Withdrawal by Subject|0|||
16982322|NCT00880750|38125683|FG000|First Intervention|Lost to Follow-up|2|||
16982323|NCT00880750|38125684|FG001|First Intervention|Lost to Follow-up|0|||
16982324|NCT00880750|38125683|FG000|Second Intervention|Withdrawal by Subject|2|||
16982325|NCT00880750|38125684|FG001|Second Intervention|Withdrawal by Subject|2|||
16982326|NCT00880750|38125683|FG000|Second Intervention|Protocol Violation|1|||
16982327|NCT00880750|38125684|FG001|Second Intervention|Protocol Violation|0|||
16982328|NCT00880750|38125683|FG000|Second Intervention|Unable to collect urine|1|||
16982329|NCT00880750|38125684|FG001|Second Intervention|Unable to collect urine|0|||
16982330|NCT00597766|38125693|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
16982331|NCT00597766|38125694|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
16982332|NCT00597766|38125695|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
16982333|NCT00597766|38125693|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
16982334|NCT00597766|38125694|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
16982335|NCT00597766|38125695|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
16982336|NCT00977574|38125706|FG000|Overall Study|Never Treated|4|||
16982337|NCT00977574|38125707|FG001|Overall Study|Never Treated|2|||
16982338|NCT00977574|38125708|FG002|Overall Study|Never Treated|4|||
16982339|NCT00979992|38125716|FG000|Overall Study|Ineligible - inadequate pathology|1|||
16982340|NCT00979992|38125716|FG000|Overall Study|Ineligible - wrong cell type|2|||
16982341|NCT00979992|38125716|FG000|Overall Study|Refused - Never Treated|2|||
16982342|NCT01079741|38125725|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
16982343|NCT01079741|38125726|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
16982344|NCT01079741|38125727|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
16982345|NCT01079741|38125728|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
16982346|NCT01079741|38125729|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
16982347|NCT01079741|38125725|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
16982348|NCT01079741|38125726|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
16982349|NCT01079741|38125727|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
16982350|NCT01079741|38125728|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
16982351|NCT01079741|38125729|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
16982352|NCT01079663|38125743|FG000|Overall Study|Adverse Event|0|||
16982353|NCT01079663|38125744|FG001|Overall Study|Adverse Event|2|||
16982354|NCT01079663|38125743|FG000|Overall Study|Protocol Violation|0|||
16982355|NCT01079663|38125744|FG001|Overall Study|Protocol Violation|2|||
16982356|NCT00879814|38125754|FG000|Overall Study|Adverse Event|0|||
16982357|NCT00879814|38125755|FG001|Overall Study|Adverse Event|1|||
16982358|NCT00879814|38125756|FG002|Overall Study|Adverse Event|0|||
16982359|NCT00879814|38125757|FG003|Overall Study|Adverse Event|0|||
16982360|NCT00879814|38125754|FG000|Overall Study|Lost to Follow-up|1|||
16982361|NCT00879814|38125755|FG001|Overall Study|Lost to Follow-up|0|||
16982362|NCT00879814|38125756|FG002|Overall Study|Lost to Follow-up|0|||
16982363|NCT00879814|38125757|FG003|Overall Study|Lost to Follow-up|2|||
16982364|NCT00879814|38125754|FG000|Overall Study|Participant Failed to Return|0|||
16982365|NCT00879814|38125755|FG001|Overall Study|Participant Failed to Return|0|||
16982366|NCT00879814|38125756|FG002|Overall Study|Participant Failed to Return|0|||
16982367|NCT00879814|38125757|FG003|Overall Study|Participant Failed to Return|1|||
16982368|NCT00879814|38125754|FG000|Overall Study|Withdrawal by Subject|3|||
16982369|NCT00879814|38125755|FG001|Overall Study|Withdrawal by Subject|1|||
16982370|NCT00879814|38125756|FG002|Overall Study|Withdrawal by Subject|1|||
16982371|NCT00879814|38125757|FG003|Overall Study|Withdrawal by Subject|2|||
16982372|NCT00879814|38125754|FG000|Overall Study|Physician Decision|0|||
16982373|NCT00879814|38125755|FG001|Overall Study|Physician Decision|0|||
16982374|NCT00879814|38125756|FG002|Overall Study|Physician Decision|1|||
16982375|NCT00879814|38125757|FG003|Overall Study|Physician Decision|0|||
16982376|NCT00879814|38125754|FG000|Overall Study|Other|0|||
16982377|NCT00879814|38125755|FG001|Overall Study|Other|0|||
16982378|NCT00879814|38125756|FG002|Overall Study|Other|1|||
16982379|NCT00879814|38125757|FG003|Overall Study|Other|0|||
16982380|NCT01132664|38125772|FG000|Phase lb|Adverse Event|0|||
16982381|NCT01132664|38125773|FG001|Phase lb|Adverse Event|1|||
16982382|NCT01132664|38125774|FG002|Phase lb|Adverse Event|0|||
16982383|NCT01132664|38125775|FG003|Phase lb|Adverse Event|0|||
16982384|NCT01132664|38125776|FG004|Phase lb|Adverse Event|0|||
16982385|NCT01132664|38125772|FG000|Phase lb|Withdrawal by Subject|1|||
16982386|NCT01132664|38125773|FG001|Phase lb|Withdrawal by Subject|2|||
16982387|NCT01132664|38125774|FG002|Phase lb|Withdrawal by Subject|0|||
16982388|NCT01132664|38125775|FG003|Phase lb|Withdrawal by Subject|0|||
16982389|NCT01132664|38125776|FG004|Phase lb|Withdrawal by Subject|0|||
16982390|NCT01132664|38125772|FG000|Phase lb|Disease Progression|4|||
16982391|NCT01132664|38125773|FG001|Phase lb|Disease Progression|9|||
16982392|NCT01132664|38125774|FG002|Phase lb|Disease Progression|0|||
16982393|NCT01132664|38125775|FG003|Phase lb|Disease Progression|0|||
16982394|NCT01132664|38125776|FG004|Phase lb|Disease Progression|0|||
16982395|NCT01132664|38125772|FG000|Phase ll|Death|0|||
16982396|NCT01132664|38125773|FG001|Phase ll|Death|0|||
16982397|NCT01132664|38125774|FG002|Phase ll|Death|2|||
16982398|NCT01132664|38125775|FG003|Phase ll|Death|0|||
16982399|NCT01132664|38125776|FG004|Phase ll|Death|0|||
16982400|NCT01132664|38125772|FG000|Phase ll|Adverse Event|0|||
16982401|NCT01132664|38125773|FG001|Phase ll|Adverse Event|0|||
16982402|NCT01132664|38125774|FG002|Phase ll|Adverse Event|10|||
16982403|NCT01132664|38125775|FG003|Phase ll|Adverse Event|0|||
16982404|NCT01132664|38125776|FG004|Phase ll|Adverse Event|0|||
16982405|NCT01132664|38125772|FG000|Phase ll|Withdrawal by Subject|0|||
16982406|NCT01132664|38125773|FG001|Phase ll|Withdrawal by Subject|0|||
16982407|NCT01132664|38125774|FG002|Phase ll|Withdrawal by Subject|3|||
16982408|NCT01132664|38125775|FG003|Phase ll|Withdrawal by Subject|0|||
16982409|NCT01132664|38125776|FG004|Phase ll|Withdrawal by Subject|0|||
16982410|NCT01132664|38125772|FG000|Phase ll|Disease progression|0|||
16982411|NCT01132664|38125773|FG001|Phase ll|Disease progression|0|||
16982412|NCT01132664|38125774|FG002|Phase ll|Disease progression|35|||
16982413|NCT01132664|38125775|FG003|Phase ll|Disease progression|0|||
16982414|NCT01132664|38125776|FG004|Phase ll|Disease progression|0|||
16982415|NCT01132664|38125772|FG000|BM Cohort|Disease progression|0|||
16982416|NCT01132664|38125773|FG001|BM Cohort|Disease progression|0|||
16982417|NCT01132664|38125774|FG002|BM Cohort|Disease progression|0|||
16982418|NCT01132664|38125775|FG003|BM Cohort|Disease progression|3|||
16982419|NCT01132664|38125776|FG004|BM Cohort|Disease progression|4|||
16982420|NCT01132664|38125772|FG000|BM Cohort|Adverse Event|0|||
16982421|NCT01132664|38125773|FG001|BM Cohort|Adverse Event|0|||
16982422|NCT01132664|38125774|FG002|BM Cohort|Adverse Event|0|||
16982423|NCT01132664|38125775|FG003|BM Cohort|Adverse Event|0|||
16982424|NCT01132664|38125776|FG004|BM Cohort|Adverse Event|1|||
16982425|NCT01132664|38125772|FG000|BM Cohort|Withdrawal by Subject|0|||
16982426|NCT01132664|38125773|FG001|BM Cohort|Withdrawal by Subject|0|||
16982427|NCT01132664|38125774|FG002|BM Cohort|Withdrawal by Subject|0|||
16982428|NCT01132664|38125775|FG003|BM Cohort|Withdrawal by Subject|0|||
16982429|NCT01132664|38125776|FG004|BM Cohort|Withdrawal by Subject|1|||
16982430|NCT00591409|38125798|FG000|Overall Study|Not Treated|0|||
16982431|NCT00591409|38125799|FG001|Overall Study|Not Treated|0|||
16982432|NCT00591409|38125800|FG002|Overall Study|Not Treated|0|||
16982433|NCT00591409|38125801|FG003|Overall Study|Not Treated|0|||
16982434|NCT00591409|38125802|FG004|Overall Study|Not Treated|1|||
16982435|NCT00591409|38125803|FG005|Overall Study|Not Treated|0|||
16982436|NCT00591409|38125804|FG006|Overall Study|Not Treated|0|||
16982437|NCT00591409|38125805|FG007|Overall Study|Not Treated|0|||
16982438|NCT00591409|38125806|FG008|Overall Study|Not Treated|0|||
16982439|NCT00591409|38125807|FG009|Overall Study|Not Treated|1|||
16982440|NCT01078805|38125829|FG000|Overall Study|Clinically significant abnormal lab|5|||
16982441|NCT01078805|38125829|FG000|Overall Study|Death|134|||
16982442|NCT01078805|38125829|FG000|Overall Study|Lost to Follow-up|676|||
16982443|NCT01078805|38125829|FG000|Overall Study|Physician Decision|169|||
16982444|NCT01078805|38125829|FG000|Overall Study|Serious adverse event|26|||
16982445|NCT01078805|38125829|FG000|Overall Study|Sponsor decision|46|||
16982446|NCT01078805|38125829|FG000|Overall Study|Withdrawal by Subject|739|||
16982447|NCT01078805|38125829|FG000|Overall Study|Other|173|||
16982448|NCT01078805|38125829|FG000|Overall Study|Didn't take study drug|82|||
16982449|NCT00820027|38125837|FG000|Overall Study|Adverse Event|15|||
16982450|NCT00820027|38125838|FG001|Overall Study|Adverse Event|8|||
16982451|NCT00820027|38125839|FG002|Overall Study|Adverse Event|10|||
16982452|NCT00820027|38125840|FG003|Overall Study|Adverse Event|5|||
16982453|NCT00820027|38125837|FG000|Overall Study|Lack of Efficacy|2|||
16982454|NCT00820027|38125838|FG001|Overall Study|Lack of Efficacy|1|||
16982455|NCT00820027|38125839|FG002|Overall Study|Lack of Efficacy|2|||
16982456|NCT00820027|38125840|FG003|Overall Study|Lack of Efficacy|2|||
16982457|NCT00820027|38125837|FG000|Overall Study|Physician Decision|0|||
16982458|NCT00820027|38125838|FG001|Overall Study|Physician Decision|1|||
16982459|NCT00820027|38125839|FG002|Overall Study|Physician Decision|1|||
16982460|NCT00820027|38125840|FG003|Overall Study|Physician Decision|0|||
16982461|NCT00820027|38125837|FG000|Overall Study|Protocol Violation|3|||
16982462|NCT00820027|38125838|FG001|Overall Study|Protocol Violation|0|||
16982463|NCT00820027|38125839|FG002|Overall Study|Protocol Violation|4|||
16982464|NCT00820027|38125840|FG003|Overall Study|Protocol Violation|0|||
16982465|NCT00820027|38125837|FG000|Overall Study|Withdrawal by Subject|6|||
16982466|NCT00820027|38125838|FG001|Overall Study|Withdrawal by Subject|4|||
16982467|NCT00820027|38125839|FG002|Overall Study|Withdrawal by Subject|4|||
16982468|NCT00820027|38125840|FG003|Overall Study|Withdrawal by Subject|6|||
16982469|NCT01076153|38125851|FG000|Overall Study|Symptoms improved/resolved|10|||
16982470|NCT01076153|38125851|FG000|Overall Study|Adverse Event|1|||
16982471|NCT01076075|38125861|FG000|Overall Study|Adverse Event|3|||
16982472|NCT01076075|38125862|FG001|Overall Study|Adverse Event|9|||
16982473|NCT01076075|38125861|FG000|Overall Study|Lack of Efficacy|5|||
16982474|NCT01076075|38125862|FG001|Overall Study|Lack of Efficacy|4|||
16982475|NCT01076075|38125861|FG000|Overall Study|Lost to Follow-up|6|||
16982476|NCT01076075|38125862|FG001|Overall Study|Lost to Follow-up|5|||
16982477|NCT01076075|38125861|FG000|Overall Study|other|19|||
16982478|NCT01076075|38125862|FG001|Overall Study|other|9|||
16982479|NCT01076075|38125861|FG000|Overall Study|Protocol Violation|0|||
16982480|NCT01076075|38125862|FG001|Overall Study|Protocol Violation|1|||
16982481|NCT01076075|38125861|FG000|Overall Study|Withdrawal by Subject|8|||
16982482|NCT01076075|38125862|FG001|Overall Study|Withdrawal by Subject|19|||
16982483|NCT01075763|38125873|FG000|Overall Study|Lost to Follow-up|2|||
16982484|NCT01075763|38125874|FG001|Overall Study|Lost to Follow-up|1|||
16982485|NCT01075763|38125873|FG000|Overall Study|Lack of Efficacy|0|||
16982486|NCT01075763|38125874|FG001|Overall Study|Lack of Efficacy|1|||
16982487|NCT01075763|38125873|FG000|Overall Study|Withdrawal by Subject|2|||
16982488|NCT01075763|38125874|FG001|Overall Study|Withdrawal by Subject|2|||
16982489|NCT00881530|38125886|FG000|Overall Study|Adverse Event|5|||
16982490|NCT00881530|38125887|FG001|Overall Study|Adverse Event|1|||
16982491|NCT00881530|38125888|FG002|Overall Study|Adverse Event|1|||
16982492|NCT00881530|38125889|FG003|Overall Study|Adverse Event|4|||
16982493|NCT00881530|38125890|FG004|Overall Study|Adverse Event|10|||
16982494|NCT00881530|38125891|FG005|Overall Study|Adverse Event|2|||
16982495|NCT00881530|38125886|FG000|Overall Study|Lack of Efficacy|1|||
16982496|NCT00881530|38125887|FG001|Overall Study|Lack of Efficacy|0|||
16982497|NCT00881530|38125888|FG002|Overall Study|Lack of Efficacy|0|||
16982498|NCT00881530|38125889|FG003|Overall Study|Lack of Efficacy|0|||
16982499|NCT00881530|38125890|FG004|Overall Study|Lack of Efficacy|1|||
16982500|NCT00881530|38125891|FG005|Overall Study|Lack of Efficacy|1|||
16982501|NCT00881530|38125886|FG000|Overall Study|Not compliant with the protocol|0|||
16982502|NCT00881530|38125887|FG001|Overall Study|Not compliant with the protocol|0|||
16982503|NCT00881530|38125888|FG002|Overall Study|Not compliant with the protocol|0|||
16982504|NCT00881530|38125889|FG003|Overall Study|Not compliant with the protocol|0|||
16982505|NCT00881530|38125890|FG004|Overall Study|Not compliant with the protocol|2|||
16982506|NCT00881530|38125891|FG005|Overall Study|Not compliant with the protocol|0|||
16982507|NCT00881530|38125886|FG000|Overall Study|Lost to Follow-up|0|||
16982508|NCT00881530|38125887|FG001|Overall Study|Lost to Follow-up|1|||
16982509|NCT00881530|38125888|FG002|Overall Study|Lost to Follow-up|1|||
16982510|NCT00881530|38125889|FG003|Overall Study|Lost to Follow-up|3|||
16982511|NCT00881530|38125890|FG004|Overall Study|Lost to Follow-up|1|||
16982512|NCT00881530|38125891|FG005|Overall Study|Lost to Follow-up|0|||
16982513|NCT00881530|38125886|FG000|Overall Study|Refused to continue medication|7|||
16982514|NCT00881530|38125887|FG001|Overall Study|Refused to continue medication|2|||
16982515|NCT00881530|38125888|FG002|Overall Study|Refused to continue medication|1|||
16982516|NCT00881530|38125889|FG003|Overall Study|Refused to continue medication|2|||
16982517|NCT00881530|38125890|FG004|Overall Study|Refused to continue medication|0|||
16982518|NCT00881530|38125891|FG005|Overall Study|Refused to continue medication|0|||
16982519|NCT00881530|38125886|FG000|Overall Study|Other reason not defined above|1|||
16982520|NCT00881530|38125887|FG001|Overall Study|Other reason not defined above|1|||
16982521|NCT00881530|38125888|FG002|Overall Study|Other reason not defined above|2|||
16982522|NCT00881530|38125889|FG003|Overall Study|Other reason not defined above|0|||
16982523|NCT00881530|38125890|FG004|Overall Study|Other reason not defined above|0|||
16982524|NCT00881530|38125891|FG005|Overall Study|Other reason not defined above|2|||
16982525|NCT01075685|38125907|FG000|Overall Study|Protocol Violation|9|||
16982526|NCT01075685|38125908|FG001|Overall Study|Protocol Violation|1|||
16982527|NCT01075685|38125907|FG000|Overall Study|Withdrawal by Subject|20|||
16982528|NCT01075685|38125908|FG001|Overall Study|Withdrawal by Subject|5|||
16982529|NCT01075685|38125907|FG000|Overall Study|Lost to Follow-up|563|||
16982530|NCT01075685|38125908|FG001|Overall Study|Lost to Follow-up|220|||
16982531|NCT01075217|38125916|FG000|Overall Study|Adverse Event|1|||
16982532|NCT01075217|38125917|FG001|Overall Study|Adverse Event|1|||
16982533|NCT01075217|38125916|FG000|Overall Study|Physician Decision|1|||
16982534|NCT01075217|38125917|FG001|Overall Study|Physician Decision|0|||
16982535|NCT01078571|38125931|FG000|Overall Study|Adverse Event|36|||
16982536|NCT01078571|38125931|FG000|Overall Study|Lack of effectiveness|36|||
16982537|NCT01078571|38125931|FG000|Overall Study|Reason not reported|21|||
16982538|NCT01078571|38125931|FG000|Overall Study|Withdrawal by Subject|12|||
16982539|NCT01078571|38125931|FG000|Overall Study|Lost to Follow-up|8|||
16982540|NCT01078571|38125931|FG000|Overall Study|Protocol Violation|2|||
16982541|NCT00977106|38125942|FG000|Overall Study|Adverse Event|5|||
16982542|NCT00977106|38125943|FG001|Overall Study|Adverse Event|6|||
16982543|NCT00977106|38125942|FG000|Overall Study|Withdrawal by Subject|2|||
16982544|NCT00977106|38125943|FG001|Overall Study|Withdrawal by Subject|2|||
16982545|NCT00977106|38125942|FG000|Overall Study|Lack of Efficacy|2|||
16982546|NCT00977106|38125943|FG001|Overall Study|Lack of Efficacy|2|||
16982547|NCT00977106|38125942|FG000|Overall Study|Protocol Violation|0|||
16982548|NCT00977106|38125943|FG001|Overall Study|Protocol Violation|1|||
16982549|NCT00977106|38125942|FG000|Overall Study|Other|1|||
16982550|NCT00977106|38125943|FG001|Overall Study|Other|0|||
16982551|NCT01077713|38125953|FG000|Overall Study|Withdrawal by Subject|1|||
16982552|NCT01077713|38125954|FG001|Overall Study|Withdrawal by Subject|2|||
16982553|NCT01077713|38125953|FG000|Overall Study|Progressive Disease (PD)|0|||
16982554|NCT01077713|38125954|FG001|Overall Study|Progressive Disease (PD)|1|||
16982555|NCT01077713|38125953|FG000|Overall Study|Death|28|||
16982556|NCT01077713|38125954|FG001|Overall Study|Death|29|||
16982557|NCT01077713|38125953|FG000|Overall Study|Lost to Follow-up|1|||
16982558|NCT01077713|38125954|FG001|Overall Study|Lost to Follow-up|1|||
16982559|NCT01077713|38125953|FG000|Overall Study|Adverse Event|2|||
16982560|NCT01077713|38125954|FG001|Overall Study|Adverse Event|1|||
16982561|NCT01077713|38125953|FG000|Overall Study|Other|4|||
16982562|NCT01077713|38125954|FG001|Overall Study|Other|2|||
16982563|NCT00813709|38125963|FG000|Double Blind Period|Adverse Event|4|||
16982564|NCT00813709|38125964|FG001|Double Blind Period|Adverse Event|1|||
16982565|NCT00813709|38125965|FG002|Double Blind Period|Adverse Event|4|||
16982566|NCT00813709|38125966|FG003|Double Blind Period|Adverse Event|0|||
16982567|NCT00813709|38125967|FG004|Double Blind Period|Adverse Event|0|||
16982568|NCT00813709|38125968|FG005|Double Blind Period|Adverse Event|0|||
16982569|NCT00813709|38125963|FG000|Double Blind Period|Lost to Follow-up|3|||
16982570|NCT00813709|38125964|FG001|Double Blind Period|Lost to Follow-up|2|||
16982571|NCT00813709|38125965|FG002|Double Blind Period|Lost to Follow-up|2|||
16982572|NCT00813709|38125966|FG003|Double Blind Period|Lost to Follow-up|0|||
16982573|NCT00813709|38125967|FG004|Double Blind Period|Lost to Follow-up|0|||
16982574|NCT00813709|38125968|FG005|Double Blind Period|Lost to Follow-up|0|||
16982575|NCT00813709|38125963|FG000|Double Blind Period|Switched to open label phase|9|||
16982576|NCT00813709|38125964|FG001|Double Blind Period|Switched to open label phase|26|||
16982577|NCT00813709|38125965|FG002|Double Blind Period|Switched to open label phase|18|||
16982578|NCT00813709|38125966|FG003|Double Blind Period|Switched to open label phase|0|||
16982579|NCT00813709|38125967|FG004|Double Blind Period|Switched to open label phase|0|||
16982580|NCT00813709|38125968|FG005|Double Blind Period|Switched to open label phase|0|||
16982581|NCT00813709|38125963|FG000|Double Blind Period|Randomized but not treated|1|||
16982582|NCT00813709|38125964|FG001|Double Blind Period|Randomized but not treated|3|||
16982583|NCT00813709|38125965|FG002|Double Blind Period|Randomized but not treated|1|||
16982584|NCT00813709|38125966|FG003|Double Blind Period|Randomized but not treated|0|||
16982585|NCT00813709|38125967|FG004|Double Blind Period|Randomized but not treated|0|||
16982586|NCT00813709|38125968|FG005|Double Blind Period|Randomized but not treated|0|||
16982587|NCT00813709|38125963|FG000|Double Blind Period|Other|14|||
16982588|NCT00813709|38125964|FG001|Double Blind Period|Other|9|||
16982589|NCT00813709|38125965|FG002|Double Blind Period|Other|6|||
16982590|NCT00813709|38125966|FG003|Double Blind Period|Other|0|||
16982591|NCT00813709|38125967|FG004|Double Blind Period|Other|0|||
16982592|NCT00813709|38125968|FG005|Double Blind Period|Other|0|||
16982593|NCT00813709|38125963|FG000|Open Label Period|Adverse Event|0|||
16982594|NCT00813709|38125964|FG001|Open Label Period|Adverse Event|0|||
16982595|NCT00813709|38125965|FG002|Open Label Period|Adverse Event|0|||
16982596|NCT00813709|38125966|FG003|Open Label Period|Adverse Event|5|||
16982597|NCT00813709|38125967|FG004|Open Label Period|Adverse Event|4|||
16982598|NCT00813709|38125968|FG005|Open Label Period|Adverse Event|3|||
16982599|NCT00813709|38125963|FG000|Open Label Period|Lack of Efficacy|0|||
16982600|NCT00813709|38125964|FG001|Open Label Period|Lack of Efficacy|0|||
16982601|NCT00813709|38125965|FG002|Open Label Period|Lack of Efficacy|0|||
16982602|NCT00813709|38125966|FG003|Open Label Period|Lack of Efficacy|3|||
16982603|NCT00813709|38125967|FG004|Open Label Period|Lack of Efficacy|1|||
16982604|NCT00813709|38125968|FG005|Open Label Period|Lack of Efficacy|1|||
16982605|NCT00813709|38125963|FG000|Open Label Period|Randomized but not treated|0|||
16982606|NCT00813709|38125964|FG001|Open Label Period|Randomized but not treated|0|||
16982607|NCT00813709|38125965|FG002|Open Label Period|Randomized but not treated|0|||
16982608|NCT00813709|38125966|FG003|Open Label Period|Randomized but not treated|1|||
16982609|NCT00813709|38125967|FG004|Open Label Period|Randomized but not treated|0|||
16982610|NCT00813709|38125968|FG005|Open Label Period|Randomized but not treated|1|||
16982611|NCT00813709|38125963|FG000|Open Label Period|Other|0|||
16982612|NCT00813709|38125964|FG001|Open Label Period|Other|0|||
16982613|NCT00813709|38125965|FG002|Open Label Period|Other|0|||
16982614|NCT00813709|38125966|FG003|Open Label Period|Other|11|||
16982615|NCT00813709|38125967|FG004|Open Label Period|Other|5|||
16982616|NCT00813709|38125968|FG005|Open Label Period|Other|6|||
16982617|NCT01077323|38126000|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
16982618|NCT01077323|38126001|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
16982619|NCT01077323|38126002|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
16982620|NCT01077323|38126000|FG000|Overall Study|Dispensing of drug in baseline period|0|||
16982621|NCT01077323|38126001|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
16982622|NCT01077323|38126002|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
16982623|NCT01077323|38126000|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
16982624|NCT01077323|38126001|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
16982625|NCT01077323|38126002|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
16982626|NCT00976950|38126010|FG000|Overall Study|Adverse Event|3|||
16982627|NCT00976950|38126010|FG000|Overall Study|Events with no relationship to Aptivus|3|||
16982628|NCT00976716|38126014|FG000|Overall Study|Adverse Event|1|||
16982629|NCT00819247|38126022|FG000|Overall Study|Adverse Event|0|||
16982630|NCT00819247|38126023|FG001|Overall Study|Adverse Event|5|||
16982631|NCT00819247|38126024|FG002|Overall Study|Adverse Event|3|||
16982632|NCT00819247|38126022|FG000|Overall Study|Insufficient testosterone response|5|||
16982633|NCT00819247|38126023|FG001|Overall Study|Insufficient testosterone response|8|||
16982634|NCT00819247|38126024|FG002|Overall Study|Insufficient testosterone response|10|||
16982635|NCT00819247|38126022|FG000|Overall Study|Withdrawal by Subject|1|||
16982636|NCT00819247|38126023|FG001|Overall Study|Withdrawal by Subject|0|||
16982637|NCT00819247|38126024|FG002|Overall Study|Withdrawal by Subject|0|||
16982638|NCT00819247|38126022|FG000|Overall Study|Protocol Violation|1|||
16982639|NCT00819247|38126023|FG001|Overall Study|Protocol Violation|0|||
16982640|NCT00819247|38126024|FG002|Overall Study|Protocol Violation|1|||
16982641|NCT00819247|38126022|FG000|Overall Study|Mistakenly withdrawn|0|||
16982642|NCT00819247|38126023|FG001|Overall Study|Mistakenly withdrawn|1|||
16982643|NCT00819247|38126024|FG002|Overall Study|Mistakenly withdrawn|0|||
16982644|NCT00819247|38126022|FG000|Overall Study|Bad prostate-specific antigen response|3|||
16982645|NCT00819247|38126023|FG001|Overall Study|Bad prostate-specific antigen response|2|||
16982646|NCT00819247|38126024|FG002|Overall Study|Bad prostate-specific antigen response|0|||
16982647|NCT00819247|38126022|FG000|Overall Study|Other|1|||
16982648|NCT00819247|38126023|FG001|Overall Study|Other|0|||
16982649|NCT00819247|38126024|FG002|Overall Study|Other|0|||
16982650|NCT00973674|38126034|FG000|Overall Study|Protocol Violation|2|||
16982651|NCT00973674|38126035|FG001|Overall Study|Protocol Violation|0|||
16982652|NCT00819091|38126044|FG000|Overall Study|Adverse Event|3|||
16982653|NCT00819091|38126045|FG001|Overall Study|Adverse Event|5|||
16982654|NCT00819091|38126044|FG000|Overall Study|Protocol Violation|0|||
16982655|NCT00819091|38126045|FG001|Overall Study|Protocol Violation|1|||
16982656|NCT00819091|38126044|FG000|Overall Study|Lost to Follow-up|2|||
16982657|NCT00819091|38126045|FG001|Overall Study|Lost to Follow-up|0|||
16982658|NCT00819091|38126044|FG000|Overall Study|Withdrawal by Subject|1|||
16982659|NCT00819091|38126045|FG001|Overall Study|Withdrawal by Subject|2|||
16982660|NCT00819091|38126044|FG000|Overall Study|Other|1|||
16982661|NCT00819091|38126045|FG001|Overall Study|Other|2|||
16982662|NCT00973362|38126053|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
16982663|NCT00973362|38126054|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
16982664|NCT00973362|38126053|FG000|Baseline Evaluation|No colposcopy visit|62|||
16982665|NCT00973362|38126054|FG001|Baseline Evaluation|No colposcopy visit|0|||
16982666|NCT00973362|38126053|FG000|Baseline Evaluation|Inevaluable|686|||
16982667|NCT00973362|38126054|FG001|Baseline Evaluation|Inevaluable|223|||
16982668|NCT00973362|38126053|FG000|3-Year Follow-up|Lost to Follow-up|17|||
16982669|NCT00973362|38126054|FG001|3-Year Follow-up|Lost to Follow-up|0|||
16982670|NCT00819013|38126067|FG000|Overall Study|Not meeting continuing study eligibility|2|||
16982671|NCT00819013|38126068|FG001|Overall Study|Not meeting continuing study eligibility|1|||
16982672|NCT00819013|38126069|FG002|Overall Study|Not meeting continuing study eligibility|2|||
16982673|NCT00819013|38126070|FG003|Overall Study|Not meeting continuing study eligibility|1|||
16982674|NCT00819013|38126067|FG000|Overall Study|Adverse Event|0|||
16982675|NCT00819013|38126068|FG001|Overall Study|Adverse Event|0|||
16982676|NCT00819013|38126069|FG002|Overall Study|Adverse Event|1|||
16982677|NCT00819013|38126070|FG003|Overall Study|Adverse Event|0|||
16982678|NCT00819013|38126067|FG000|Overall Study|Withdrawal by Subject|1|||
16982679|NCT00819013|38126068|FG001|Overall Study|Withdrawal by Subject|0|||
16982680|NCT00819013|38126069|FG002|Overall Study|Withdrawal by Subject|1|||
16982681|NCT00819013|38126070|FG003|Overall Study|Withdrawal by Subject|0|||
16982682|NCT00819013|38126067|FG000|Overall Study|Lost to Follow-up|0|||
16982683|NCT00819013|38126068|FG001|Overall Study|Lost to Follow-up|0|||
16982684|NCT00819013|38126069|FG002|Overall Study|Lost to Follow-up|1|||
16982685|NCT00819013|38126070|FG003|Overall Study|Lost to Follow-up|2|||
16982686|NCT00819013|38126067|FG000|Overall Study|Death|0|||
16982687|NCT00819013|38126068|FG001|Overall Study|Death|0|||
16982688|NCT00819013|38126069|FG002|Overall Study|Death|0|||
16982689|NCT00819013|38126070|FG003|Overall Study|Death|1|||
16982690|NCT00976560|38126082|FG000|Overall Study|Adverse Event|5|||
16982691|NCT00976560|38126083|FG001|Overall Study|Adverse Event|5|||
16982692|NCT00976560|38126082|FG000|Overall Study|Lack of Efficacy|3|||
16982693|NCT00976560|38126083|FG001|Overall Study|Lack of Efficacy|5|||
16982694|NCT00976560|38126082|FG000|Overall Study|Protocol Violation|1|||
16982695|NCT00976560|38126083|FG001|Overall Study|Protocol Violation|0|||
16982696|NCT00976560|38126082|FG000|Overall Study|Lost to Follow-up|1|||
16982697|NCT00976560|38126083|FG001|Overall Study|Lost to Follow-up|0|||
16982698|NCT00976560|38126082|FG000|Overall Study|Physician Decision|2|||
16982699|NCT00976560|38126083|FG001|Overall Study|Physician Decision|0|||
16982700|NCT00976560|38126082|FG000|Overall Study|Withdrawal by Subject|2|||
16982701|NCT00976560|38126083|FG001|Overall Study|Withdrawal by Subject|3|||
16982702|NCT00976482|38126089|FG000|Overall Study|Death|208|||
16982703|NCT00976482|38126089|FG000|Overall Study|Withdrawal by Subject|45|||
16982704|NCT00976482|38126089|FG000|Overall Study|Center terminated|1|||
16982705|NCT00976482|38126089|FG000|Overall Study|Protocol Violation|5|||
16982706|NCT00975156|38126095|FG000|Overall Study|Protocol Violation|0|||
16982707|NCT00975156|38126096|FG001|Overall Study|Protocol Violation|1|||
16982708|NCT00810043|38126108|FG000|Overall Study|Withdrawal by Subject|1|||
16982709|NCT00810043|38126109|FG001|Overall Study|Withdrawal by Subject|0|||
16982710|NCT00810043|38126110|FG002|Overall Study|Withdrawal by Subject|2|||
16982711|NCT00810043|38126108|FG000|Overall Study|Lost to Follow-up|1|||
16982712|NCT00810043|38126109|FG001|Overall Study|Lost to Follow-up|0|||
16982713|NCT00810043|38126110|FG002|Overall Study|Lost to Follow-up|0|||
16982714|NCT00810043|38126108|FG000|Overall Study|Physician Decision|0|||
16982715|NCT00810043|38126109|FG001|Overall Study|Physician Decision|0|||
16982716|NCT00810043|38126110|FG002|Overall Study|Physician Decision|2|||
16982717|NCT00810043|38126108|FG000|Overall Study|Death|2|||
16982718|NCT00810043|38126109|FG001|Overall Study|Death|0|||
16982719|NCT00810043|38126110|FG002|Overall Study|Death|0|||
16982720|NCT00810043|38126108|FG000|Overall Study|Unrelated medical problem|0|||
16982721|NCT00810043|38126109|FG001|Overall Study|Unrelated medical problem|1|||
16982722|NCT00810043|38126110|FG002|Overall Study|Unrelated medical problem|0|||
16982723|NCT00810043|38126108|FG000|Overall Study|Non-medical problem|0|||
16982724|NCT00810043|38126109|FG001|Overall Study|Non-medical problem|0|||
17134047|NCT02095132|38275298|FG005|Overall Study|Physician Decision|0|||
17134048|NCT02095132|38275299|FG006|Overall Study|Physician Decision|1|||
17134049|NCT02095132|38275300|FG007|Overall Study|Physician Decision|0|||
17134050|NCT02095132|38275301|FG008|Overall Study|Physician Decision|2|||
16982725|NCT00810043|38126110|FG002|Overall Study|Non-medical problem|1|||
16982726|NCT00810043|38126108|FG000|Overall Study|No longer met enrollment criteria|0|||
16982727|NCT00810043|38126109|FG001|Overall Study|No longer met enrollment criteria|0|||
16982728|NCT00810043|38126110|FG002|Overall Study|No longer met enrollment criteria|3|||
16982729|NCT01120184|38126122|FG000|Overall Study|Adverse Event|0|||
16982730|NCT01120184|38126123|FG001|Overall Study|Adverse Event|1|||
16982731|NCT01120184|38126124|FG002|Overall Study|Adverse Event|0|||
16982732|NCT01120184|38126122|FG000|Overall Study|Lost to Follow-up|13|||
16982733|NCT01120184|38126123|FG001|Overall Study|Lost to Follow-up|13|||
16982734|NCT01120184|38126124|FG002|Overall Study|Lost to Follow-up|11|||
16982735|NCT01120184|38126122|FG000|Overall Study|Physician Decision|9|||
16982736|NCT01120184|38126123|FG001|Overall Study|Physician Decision|1|||
16982737|NCT01120184|38126124|FG002|Overall Study|Physician Decision|3|||
16982738|NCT01120184|38126122|FG000|Overall Study|Reason not Specified|8|||
16982739|NCT01120184|38126123|FG001|Overall Study|Reason not Specified|3|||
16982740|NCT01120184|38126124|FG002|Overall Study|Reason not Specified|12|||
17134051|NCT02095132|38275293|FG000|Overall Study|Withdrawal by Subject|0|||
17134052|NCT02095132|38275294|FG001|Overall Study|Withdrawal by Subject|0|||
17134053|NCT02095132|38275295|FG002|Overall Study|Withdrawal by Subject|2|||
17134054|NCT02095132|38275296|FG003|Overall Study|Withdrawal by Subject|2|||
17134055|NCT02095132|38275297|FG004|Overall Study|Withdrawal by Subject|3|||
16982741|NCT01120184|38126122|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
16982742|NCT01120184|38126123|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
16982743|NCT01120184|38126124|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
16982744|NCT01120184|38126122|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
16982745|NCT01120184|38126123|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
16982746|NCT01120184|38126124|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
16982747|NCT01120184|38126122|FG000|Overall Study|Death|170|||
16982748|NCT01120184|38126123|FG001|Overall Study|Death|176|||
16982749|NCT01120184|38126124|FG002|Overall Study|Death|169|||
16982750|NCT01120028|38126136|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
16982751|NCT01120028|38126137|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
16982752|NCT01120028|38126138|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
16982753|NCT01120028|38126139|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
16982754|NCT01120028|38126136|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
16982755|NCT01120028|38126137|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
16982756|NCT01120028|38126138|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
16982757|NCT01120028|38126139|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
16982758|NCT00878800|38126155|FG000|Overall Study|Adverse Event|0|||
17134056|NCT02095132|38275298|FG005|Overall Study|Withdrawal by Subject|0|||
16982759|NCT00878800|38126156|FG001|Overall Study|Adverse Event|0|||
16982760|NCT00878800|38126157|FG002|Overall Study|Adverse Event|2|||
16982761|NCT00878800|38126158|FG003|Overall Study|Adverse Event|0|||
16982762|NCT00878800|38126159|FG004|Overall Study|Adverse Event|1|||
16982763|NCT00878800|38126155|FG000|Overall Study|Progressive disease|1|||
16982764|NCT00878800|38126156|FG001|Overall Study|Progressive disease|5|||
16982765|NCT00878800|38126157|FG002|Overall Study|Progressive disease|6|||
16982766|NCT00878800|38126158|FG003|Overall Study|Progressive disease|5|||
16982767|NCT00878800|38126159|FG004|Overall Study|Progressive disease|13|||
16982768|NCT00878800|38126155|FG000|Overall Study|Withdrew consent|1|||
16982769|NCT00878800|38126156|FG001|Overall Study|Withdrew consent|1|||
16982770|NCT00878800|38126157|FG002|Overall Study|Withdrew consent|0|||
16982771|NCT00878800|38126158|FG003|Overall Study|Withdrew consent|1|||
16982772|NCT00878800|38126159|FG004|Overall Study|Withdrew consent|1|||
16982773|NCT00878800|38126155|FG000|Overall Study|Death|0|||
16982774|NCT00878800|38126156|FG001|Overall Study|Death|0|||
16982775|NCT00878800|38126157|FG002|Overall Study|Death|1|||
16982776|NCT00878800|38126158|FG003|Overall Study|Death|0|||
16982777|NCT00878800|38126159|FG004|Overall Study|Death|0|||
16982778|NCT00878800|38126155|FG000|Overall Study|Other|1|||
16982779|NCT00878800|38126156|FG001|Overall Study|Other|1|||
16982780|NCT00878800|38126157|FG002|Overall Study|Other|0|||
16982781|NCT00878800|38126158|FG003|Overall Study|Other|0|||
16982782|NCT00878800|38126159|FG004|Overall Study|Other|1|||
16982783|NCT01119950|38126170|FG000|Overall Study|Adverse Event|25|||
16982784|NCT01119950|38126170|FG000|Overall Study|Withdrawal by Subject|9|||
16982785|NCT01119950|38126170|FG000|Overall Study|Protocol Violation|5|||
16982786|NCT01119950|38126170|FG000|Overall Study|Lost to Follow-up|4|||
16982787|NCT01119950|38126170|FG000|Overall Study|Administrative|2|||
16982788|NCT01119950|38126170|FG000|Overall Study|Abnormal lab value|1|||
16982789|NCT01119950|38126170|FG000|Overall Study|Death|1|||
16982790|NCT01145222|38126200|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
16982791|NCT01145222|38126201|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
16982792|NCT01145222|38126202|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
16982793|NCT01145222|38126203|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
16982794|NCT01145222|38126200|FG000|Overall Study|Poor bowel preparation|0|||
16982795|NCT01145222|38126201|FG001|Overall Study|Poor bowel preparation|0|||
16982796|NCT01145222|38126202|FG002|Overall Study|Poor bowel preparation|0|||
16982797|NCT01145222|38126203|FG003|Overall Study|Poor bowel preparation|1|||
16982798|NCT01145066|38126216|FG000|Overall Study|To resume NSAIDs|2|||
16982799|NCT01145066|38126217|FG001|Overall Study|To resume NSAIDs|2|||
16982800|NCT01145066|38126218|FG002|Overall Study|To resume NSAIDs|1|||
16982801|NCT01145066|38126216|FG000|Overall Study|Non-related surgery|0|||
16982802|NCT01145066|38126217|FG001|Overall Study|Non-related surgery|0|||
16982803|NCT01145066|38126218|FG002|Overall Study|Non-related surgery|1|||
16982804|NCT01145066|38126216|FG000|Overall Study|Withdrawal by Subject|0|||
16982805|NCT01145066|38126217|FG001|Overall Study|Withdrawal by Subject|0|||
16982806|NCT01145066|38126218|FG002|Overall Study|Withdrawal by Subject|2|||
16982807|NCT01145066|38126216|FG000|Overall Study|To start new med|1|||
16982808|NCT01145066|38126217|FG001|Overall Study|To start new med|0|||
16982809|NCT01145066|38126218|FG002|Overall Study|To start new med|0|||
16982810|NCT01145066|38126216|FG000|Overall Study|problems swallowing capsule|1|||
17134057|NCT02095132|38275299|FG006|Overall Study|Withdrawal by Subject|5|||
16982811|NCT01145066|38126217|FG001|Overall Study|problems swallowing capsule|0|||
16982812|NCT01145066|38126218|FG002|Overall Study|problems swallowing capsule|0|||
16982813|NCT01145066|38126216|FG000|Overall Study|Abdominal discomfort|0|||
16982814|NCT01145066|38126217|FG001|Overall Study|Abdominal discomfort|1|||
16982815|NCT01145066|38126218|FG002|Overall Study|Abdominal discomfort|0|||
17134058|NCT02095132|38275300|FG007|Overall Study|Withdrawal by Subject|0|||
17134059|NCT02095132|38275301|FG008|Overall Study|Withdrawal by Subject|0|||
17134060|NCT00043979|38275326|FG000|Period 1|recipient with progressive disease|7|||
17134061|NCT00043979|38275327|FG001|Period 1|recipient with progressive disease|4|||
17134062|NCT00043979|38275328|FG002|Period 1|recipient with progressive disease|3|||
17134063|NCT00039377|38275345|FG000|Initial Registration|Adverse Event|2|||
17134064|NCT00039377|38275346|FG001|Initial Registration|Adverse Event|0|||
17134065|NCT00039377|38275347|FG002|Initial Registration|Adverse Event|0|||
17134066|NCT00039377|38275348|FG003|Initial Registration|Adverse Event|0|||
17134067|NCT00039377|38275345|FG000|Initial Registration|Relapsed|6|||
17134068|NCT00039377|38275346|FG001|Initial Registration|Relapsed|0|||
17134069|NCT00039377|38275347|FG002|Initial Registration|Relapsed|0|||
17134070|NCT00039377|38275348|FG003|Initial Registration|Relapsed|0|||
17134071|NCT00039377|38275345|FG000|Initial Registration|Received non-protocol therapy|11|||
17134072|NCT00039377|38275346|FG001|Initial Registration|Received non-protocol therapy|0|||
17134073|NCT00039377|38275347|FG002|Initial Registration|Received non-protocol therapy|0|||
17134074|NCT00039377|38275348|FG003|Initial Registration|Received non-protocol therapy|0|||
17134075|NCT00039377|38275345|FG000|Initial Registration|Withdrawal by Subject|3|||
17134076|NCT00039377|38275346|FG001|Initial Registration|Withdrawal by Subject|0|||
17134077|NCT00039377|38275347|FG002|Initial Registration|Withdrawal by Subject|0|||
16982816|NCT01145066|38126216|FG000|Overall Study|Low platelet count|0|||
17134078|NCT00039377|38275348|FG003|Initial Registration|Withdrawal by Subject|0|||
17134079|NCT00154102|38275358|FG000|Overall Study|investigational study phase ongoing|7|||
17134080|NCT00154102|38275359|FG001|Overall Study|investigational study phase ongoing|2|||
17134081|NCT03687502|38275382|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
17134082|NCT03687502|38275382|FG000|Overall Study|Lumason not available|1|||
17134083|NCT00035555|38275391|FG000|Overall Study|Adverse Event|5|||
17134084|NCT00035555|38275392|FG001|Overall Study|Adverse Event|8|||
17134085|NCT00035555|38275393|FG002|Overall Study|Adverse Event|9|||
17134086|NCT00035555|38275391|FG000|Overall Study|Allograft loss|1|||
16982817|NCT01145066|38126217|FG001|Overall Study|Low platelet count|1|||
16982818|NCT01145066|38126218|FG002|Overall Study|Low platelet count|0|||
16982819|NCT01132118|38126228|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
16982820|NCT01132118|38126229|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
16982821|NCT01132118|38126228|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16982822|NCT01132118|38126229|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
16982823|NCT01132118|38126228|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
16982824|NCT01132118|38126229|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
16982825|NCT00972816|38126243|FG000|Overall Study|Adverse Event|0|||
16982826|NCT00972816|38126244|FG001|Overall Study|Adverse Event|0|||
16982827|NCT00972816|38126245|FG002|Overall Study|Adverse Event|1|||
16982828|NCT00972816|38126246|FG003|Overall Study|Adverse Event|0|||
16982829|NCT00972816|38126247|FG004|Overall Study|Adverse Event|0|||
16982830|NCT00972816|38126248|FG005|Overall Study|Adverse Event|0|||
16982831|NCT00972816|38126249|FG006|Overall Study|Adverse Event|0|||
16982832|NCT00972816|38126250|FG007|Overall Study|Adverse Event|0|||
16982833|NCT00972816|38126243|FG000|Overall Study|Withdrawal by Subject|4|||
16982834|NCT00972816|38126244|FG001|Overall Study|Withdrawal by Subject|2|||
16982835|NCT00972816|38126245|FG002|Overall Study|Withdrawal by Subject|1|||
16982836|NCT00972816|38126246|FG003|Overall Study|Withdrawal by Subject|3|||
16982837|NCT00972816|38126247|FG004|Overall Study|Withdrawal by Subject|0|||
16982838|NCT00972816|38126248|FG005|Overall Study|Withdrawal by Subject|1|||
16982839|NCT00972816|38126249|FG006|Overall Study|Withdrawal by Subject|1|||
16982840|NCT00972816|38126250|FG007|Overall Study|Withdrawal by Subject|2|||
16982841|NCT00972816|38126243|FG000|Overall Study|Lost to Follow-up|11|||
16982842|NCT00972816|38126244|FG001|Overall Study|Lost to Follow-up|9|||
16982843|NCT00972816|38126245|FG002|Overall Study|Lost to Follow-up|7|||
16982844|NCT00972816|38126246|FG003|Overall Study|Lost to Follow-up|5|||
16982845|NCT00972816|38126247|FG004|Overall Study|Lost to Follow-up|11|||
16982846|NCT00972816|38126248|FG005|Overall Study|Lost to Follow-up|10|||
16982847|NCT00972816|38126249|FG006|Overall Study|Lost to Follow-up|7|||
16982848|NCT00972816|38126250|FG007|Overall Study|Lost to Follow-up|7|||
16982849|NCT00972816|38126243|FG000|Overall Study|Inappropriate enrolment|0|||
16982850|NCT00972816|38126244|FG001|Overall Study|Inappropriate enrolment|0|||
16982851|NCT00972816|38126245|FG002|Overall Study|Inappropriate enrolment|0|||
16982852|NCT00972816|38126246|FG003|Overall Study|Inappropriate enrolment|0|||
16982853|NCT00972816|38126247|FG004|Overall Study|Inappropriate enrolment|0|||
16982854|NCT00972816|38126248|FG005|Overall Study|Inappropriate enrolment|0|||
16982855|NCT00972816|38126249|FG006|Overall Study|Inappropriate enrolment|2|||
16982856|NCT00972816|38126250|FG007|Overall Study|Inappropriate enrolment|0|||
16982857|NCT00972816|38126243|FG000|Overall Study|Unable to classify|2|||
16982858|NCT00972816|38126244|FG001|Overall Study|Unable to classify|0|||
16982859|NCT00972816|38126245|FG002|Overall Study|Unable to classify|0|||
16982860|NCT00972816|38126246|FG003|Overall Study|Unable to classify|0|||
16982861|NCT00972816|38126247|FG004|Overall Study|Unable to classify|1|||
16982862|NCT00972816|38126248|FG005|Overall Study|Unable to classify|0|||
16982863|NCT00972816|38126249|FG006|Overall Study|Unable to classify|0|||
16982864|NCT00972816|38126250|FG007|Overall Study|Unable to classify|0|||
16982865|NCT00969618|38126268|FG000|Overall Study|Adverse Event|29|||
16982866|NCT00969618|38126268|FG000|Overall Study|Entry Criteria Not Met|3|||
16982867|NCT00969618|38126268|FG000|Overall Study|Lack of Efficacy|2|||
16982868|NCT00969618|38126268|FG000|Overall Study|Lost to Follow-up|7|||
16982869|NCT00969618|38126268|FG000|Overall Study|Physician Decision|1|||
16982870|NCT00969618|38126268|FG000|Overall Study|Protocol Violation|9|||
16982871|NCT00969618|38126268|FG000|Overall Study|Withdrawal by Subject|27|||
16982872|NCT00969540|38126274|FG000|Overall Study|Lost to Follow-up|1|||
16982873|NCT00969540|38126275|FG001|Overall Study|Lost to Follow-up|1|||
16982874|NCT00975000|38126295|FG000|Overall Study|Other|1|||
16982875|NCT00975000|38126296|FG001|Overall Study|Other|0|||
16982876|NCT00975000|38126295|FG000|Overall Study|Adverse Event|1|||
16982877|NCT00975000|38126296|FG001|Overall Study|Adverse Event|1|||
16982878|NCT00975000|38126295|FG000|Overall Study|Withdrawal by Subject|2|||
16982879|NCT00975000|38126296|FG001|Overall Study|Withdrawal by Subject|2|||
16982880|NCT00975000|38126295|FG000|Overall Study|Lost to Follow-up|0|||
16982881|NCT00975000|38126296|FG001|Overall Study|Lost to Follow-up|1|||
16982882|NCT00975000|38126295|FG000|Overall Study|Protocol-specified Criteria|1|||
16982883|NCT00975000|38126296|FG001|Overall Study|Protocol-specified Criteria|0|||
16982884|NCT00975000|38126295|FG000|Overall Study|Non-compliance|0|||
16982885|NCT00975000|38126296|FG001|Overall Study|Non-compliance|1|||
16982886|NCT00974922|38126302|FG000|Overall Study|study terminated|24|||
16982887|NCT00972504|38126306|FG000|Overall Study|Adverse Event|2|||
16982888|NCT00972504|38126306|FG000|Overall Study|Investigator discretion|1|||
16982889|NCT00969228|38126318|FG000|Overall Study|Adverse Event|1|||
16982890|NCT00969228|38126319|FG001|Overall Study|Adverse Event|0|||
16982891|NCT00969228|38126318|FG000|Overall Study|Withdrawal by Subject|4|||
16982892|NCT00969228|38126319|FG001|Overall Study|Withdrawal by Subject|0|||
17134087|NCT00035555|38275392|FG001|Overall Study|Allograft loss|1|||
17134088|NCT00035555|38275393|FG002|Overall Study|Allograft loss|2|||
17134089|NCT00035555|38275391|FG000|Overall Study|Death|0|||
16982893|NCT00969228|38126318|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
16982894|NCT00969228|38126319|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
16982895|NCT00969150|38126327|FG000|Overall Study|Adverse Event|4|||
16982896|NCT00969150|38126328|FG001|Overall Study|Adverse Event|14|||
16982897|NCT00969150|38126327|FG000|Overall Study|Lack of Efficacy|1|||
16982898|NCT00969150|38126328|FG001|Overall Study|Lack of Efficacy|1|||
16982899|NCT00969150|38126327|FG000|Overall Study|Protocol Violation|9|||
16982900|NCT00969150|38126328|FG001|Overall Study|Protocol Violation|12|||
16982901|NCT00969150|38126327|FG000|Overall Study|Withdrawal by Subject|13|||
16982902|NCT00969150|38126328|FG001|Overall Study|Withdrawal by Subject|9|||
16982903|NCT00969150|38126327|FG000|Overall Study|Lost to Follow-up|5|||
16982904|NCT00969150|38126328|FG001|Overall Study|Lost to Follow-up|4|||
16982905|NCT00969150|38126327|FG000|Overall Study|Other reasons|1|||
16982906|NCT00969150|38126328|FG001|Overall Study|Other reasons|0|||
16982907|NCT00974220|38126336|FG000|Treatment Period 1|Adverse Event|2|||
16982908|NCT00974220|38126337|FG001|Treatment Period 1|Adverse Event|1|||
16982909|NCT00974220|38126336|FG000|Treatment Period 1|noncompliant subjects|0|||
16982910|NCT00974220|38126337|FG001|Treatment Period 1|noncompliant subjects|1|||
16982911|NCT00971178|38126346|FG000|Overall Study|Lost to Follow-up|2|||
16982912|NCT00971178|38126347|FG001|Overall Study|Lost to Follow-up|2|||
16982913|NCT00971178|38126348|FG002|Overall Study|Lost to Follow-up|2|||
16982914|NCT03670602|38126358|FG000|Overall Study|Lost to Follow-up|1|||
16982915|NCT03670602|38126359|FG001|Overall Study|Lost to Follow-up|0|||
16982916|NCT03670602|38126358|FG000|Overall Study|Withdrawal by Subject|0|||
17134090|NCT00035555|38275392|FG001|Overall Study|Death|0|||
16982917|NCT03670602|38126359|FG001|Overall Study|Withdrawal by Subject|3|||
16982918|NCT00968526|38126367|FG000|Overall Study|Adverse Event|2|||
16982919|NCT00968526|38126368|FG001|Overall Study|Adverse Event|0|||
16982920|NCT00968526|38126367|FG000|Overall Study|Migrated/moved from study area|1|||
16982921|NCT00968526|38126368|FG001|Overall Study|Migrated/moved from study area|0|||
16982922|NCT03664674|38126385|FG000|Overall Study|Adverse Event|1|||
16982923|NCT03664674|38126386|FG001|Overall Study|Adverse Event|1|||
16982924|NCT03664674|38126385|FG000|Overall Study|Physician Decision|0|||
16982925|NCT03664674|38126386|FG001|Overall Study|Physician Decision|1|||
17134091|NCT00035555|38275393|FG002|Overall Study|Death|2|||
17134092|NCT00035555|38275391|FG000|Overall Study|Lost to Follow-up|0|||
17134093|NCT00035555|38275392|FG001|Overall Study|Lost to Follow-up|0|||
17134094|NCT00035555|38275393|FG002|Overall Study|Lost to Follow-up|1|||
17134095|NCT00035555|38275391|FG000|Overall Study|Noncompliance|0|||
17134096|NCT00035555|38275392|FG001|Overall Study|Noncompliance|1|||
16982926|NCT03664674|38126385|FG000|Overall Study|Withdrawal by Subject|2|||
16982927|NCT03664674|38126386|FG001|Overall Study|Withdrawal by Subject|0|||
16982928|NCT00967668|38126397|FG000|Overall Study|Withdrawal by Subject|13|||
16982929|NCT00967668|38126398|FG001|Overall Study|Withdrawal by Subject|8|||
17134097|NCT00035555|38275393|FG002|Overall Study|Noncompliance|1|||
16982930|NCT00967668|38126399|FG002|Overall Study|Withdrawal by Subject|8|||
16982931|NCT00967668|38126397|FG000|Overall Study|Death|0|||
17134098|NCT00035555|38275391|FG000|Overall Study|Prohibited medication|1|||
17134099|NCT00035555|38275392|FG001|Overall Study|Prohibited medication|1|||
17134100|NCT00035555|38275393|FG002|Overall Study|Prohibited medication|0|||
17134101|NCT00035555|38275391|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
16982932|NCT00967668|38126398|FG001|Overall Study|Death|2|||
16982933|NCT00967668|38126399|FG002|Overall Study|Death|4|||
16982934|NCT00967668|38126397|FG000|Overall Study|Removed due to behavior|1|||
16982935|NCT00967668|38126398|FG001|Overall Study|Removed due to behavior|1|||
17134102|NCT00035555|38275392|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
17134103|NCT00035555|38275393|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
17134104|NCT00035555|38275391|FG000|Overall Study|Withdrawal by Subject|2|||
17134105|NCT00035555|38275392|FG001|Overall Study|Withdrawal by Subject|0|||
17134106|NCT00035555|38275393|FG002|Overall Study|Withdrawal by Subject|2|||
17134107|NCT00035555|38275391|FG000|Overall Study|Investigator deemed not a good candidate|0|||
16982936|NCT00967668|38126399|FG002|Overall Study|Removed due to behavior|2|||
16982937|NCT00967668|38126397|FG000|Overall Study|Refused Year 2|11|||
16982938|NCT00967668|38126398|FG001|Overall Study|Refused Year 2|6|||
16982939|NCT00967668|38126399|FG002|Overall Study|Refused Year 2|4|||
16982940|NCT00967668|38126397|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
16982941|NCT00967668|38126398|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
16982942|NCT00967668|38126399|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
16982943|NCT00967668|38126397|FG000|Overall Study|Lost to Follow-up|15|||
16982944|NCT00967668|38126398|FG001|Overall Study|Lost to Follow-up|9|||
16982945|NCT00967668|38126399|FG002|Overall Study|Lost to Follow-up|16|||
16982946|NCT00967668|38126397|FG000|Overall Study|Refused 12-mo assessment|3|||
16982947|NCT00967668|38126398|FG001|Overall Study|Refused 12-mo assessment|1|||
16982948|NCT00967668|38126399|FG002|Overall Study|Refused 12-mo assessment|9|||
16982949|NCT00967668|38126397|FG000|Overall Study|Pregnancy|1|||
16982950|NCT00967668|38126398|FG001|Overall Study|Pregnancy|0|||
16982951|NCT00967668|38126399|FG002|Overall Study|Pregnancy|0|||
16982952|NCT00970944|38126412|FG000|Overall Study|Death|1|||
16982953|NCT00970944|38126413|FG001|Overall Study|Death|0|||
16982954|NCT00970944|38126412|FG000|Overall Study|Physician Decision|0|||
16982955|NCT00970944|38126413|FG001|Overall Study|Physician Decision|2|||
16982956|NCT04839289|38126422|FG000|Overall Study|Withdrawal by Subject|1|||
16982957|NCT04839289|38126423|FG001|Overall Study|Withdrawal by Subject|0|||
16982958|NCT04440813|38126431|FG000|Overall Study|Lost to Follow-up|5|||
16982959|NCT04440813|38126432|FG001|Overall Study|Lost to Follow-up|5|||
16982960|NCT04233073|38126446|FG000|Overall Study|Death|5|||
16982961|NCT04152200|38126452|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
16982962|NCT04152200|38126453|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
16982963|NCT03905694|38126466|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
16982964|NCT03681184|38126472|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
16982965|NCT03681184|38126473|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
16982966|NCT03681184|38126472|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
16982967|NCT03681184|38126473|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
16982968|NCT03681184|38126472|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
16982969|NCT03681184|38126473|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
16982970|NCT03657810|38126482|FG000|Overall Study|Adverse Event|0|||
16982971|NCT03657810|38126483|FG001|Overall Study|Adverse Event|1|||
16982972|NCT03657810|38126484|FG002|Overall Study|Adverse Event|0|||
16982973|NCT03657810|38126482|FG000|Overall Study|Lack of Efficacy|4|||
16982974|NCT03657810|38126483|FG001|Overall Study|Lack of Efficacy|1|||
16982975|NCT03657810|38126484|FG002|Overall Study|Lack of Efficacy|3|||
17134108|NCT00035555|38275392|FG001|Overall Study|Investigator deemed not a good candidate|0|||
17134109|NCT00035555|38275393|FG002|Overall Study|Investigator deemed not a good candidate|1|||
16982976|NCT03657810|38126482|FG000|Overall Study|Protocol Violation|1|||
16982977|NCT03657810|38126483|FG001|Overall Study|Protocol Violation|0|||
16982978|NCT03657810|38126484|FG002|Overall Study|Protocol Violation|0|||
16982979|NCT03657810|38126482|FG000|Overall Study|Lost to Follow-up|0|||
16982980|NCT03657810|38126483|FG001|Overall Study|Lost to Follow-up|1|||
17134110|NCT00035555|38275391|FG000|Overall Study|Received cyclosporin in error|0|||
17134111|NCT00035555|38275392|FG001|Overall Study|Received cyclosporin in error|0|||
17134112|NCT00035555|38275393|FG002|Overall Study|Received cyclosporin in error|1|||
17134113|NCT03894046|38275405|FG000|Overall Study|Protocol Violation|1|||
17134114|NCT03894046|38275406|FG001|Overall Study|Protocol Violation|0|||
17134115|NCT03894046|38275407|FG002|Overall Study|Protocol Violation|0|||
17134116|NCT03894046|38275405|FG000|Overall Study|Adverse Event|0|||
17134117|NCT03894046|38275406|FG001|Overall Study|Adverse Event|1|||
17134118|NCT03894046|38275407|FG002|Overall Study|Adverse Event|0|||
17134119|NCT03894046|38275405|FG000|Overall Study|Withdrawal by Subject|2|||
17134120|NCT03894046|38275406|FG001|Overall Study|Withdrawal by Subject|3|||
17134121|NCT03894046|38275407|FG002|Overall Study|Withdrawal by Subject|1|||
17134122|NCT03894046|38275405|FG000|Overall Study|Death|15|||
17134123|NCT03894046|38275406|FG001|Overall Study|Death|21|||
17134124|NCT03894046|38275407|FG002|Overall Study|Death|4|||
17134125|NCT03894046|38275405|FG000|Overall Study|No growth of ABC|2|||
17134126|NCT03894046|38275406|FG001|Overall Study|No growth of ABC|1|||
17134127|NCT03894046|38275407|FG002|Overall Study|No growth of ABC|0|||
17134128|NCT03894046|38275405|FG000|Overall Study|Physician Decision|1|||
17134129|NCT03894046|38275406|FG001|Overall Study|Physician Decision|1|||
17134130|NCT03894046|38275407|FG002|Overall Study|Physician Decision|1|||
17134131|NCT03894046|38275405|FG000|Overall Study|Prohibited concomitant medication|1|||
17134132|NCT03894046|38275406|FG001|Overall Study|Prohibited concomitant medication|0|||
17134133|NCT03894046|38275407|FG002|Overall Study|Prohibited concomitant medication|0|||
17134134|NCT03894046|38275405|FG000|Overall Study|Transferred to other arm/group|1|||
17134135|NCT03894046|38275406|FG001|Overall Study|Transferred to other arm/group|1|||
17134136|NCT03894046|38275407|FG002|Overall Study|Transferred to other arm/group|0|||
17134137|NCT00033371|38275416|FG000|Overall Study|Adverse Event|1|||
17134138|NCT00033371|38275417|FG001|Overall Study|Adverse Event|5|||
17134139|NCT00033371|38275416|FG000|Overall Study|Lost to Follow-up|2|||
17134140|NCT00033371|38275417|FG001|Overall Study|Lost to Follow-up|1|||
17134141|NCT00033371|38275416|FG000|Overall Study|Withdrawal by Subject|3|||
17134142|NCT00033371|38275417|FG001|Overall Study|Withdrawal by Subject|3|||
17134143|NCT00033371|38275416|FG000|Overall Study|Disease Progression|0|||
17134144|NCT00033371|38275417|FG001|Overall Study|Disease Progression|1|||
17134145|NCT00081731|38275429|FG000|Overall Study|scientific integrity issue|8|||
17134146|NCT00081731|38275430|FG001|Overall Study|scientific integrity issue|8|||
17134147|NCT00079937|38275438|FG000|Overall Study|Adverse Event|2|||
17134148|NCT00079937|38275439|FG001|Overall Study|Adverse Event|1|||
17134149|NCT00079937|38275438|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17134150|NCT00079937|38275439|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
17134151|NCT00079937|38275438|FG000|Overall Study|Subject no longer requires study drug|3|||
17134152|NCT00079937|38275439|FG001|Overall Study|Subject no longer requires study drug|0|||
17134153|NCT00079937|38275438|FG000|Overall Study|Protocol Violation|8|||
17134154|NCT00079937|38275439|FG001|Overall Study|Protocol Violation|6|||
17134155|NCT00079937|38275438|FG000|Overall Study|Withdrawal by Subject|21|||
16982981|NCT03657810|38126484|FG002|Overall Study|Lost to Follow-up|0|||
16982982|NCT03657810|38126482|FG000|Overall Study|Not provided|0|||
16982983|NCT03657810|38126483|FG001|Overall Study|Not provided|1|||
16982984|NCT03657810|38126484|FG002|Overall Study|Not provided|0|||
16982985|NCT03370341|38126510|FG000|Overall Study|Lost to Follow-up|0|||
16982986|NCT03370341|38126511|FG001|Overall Study|Lost to Follow-up|1|||
16982987|NCT02927301|38126571|FG000|Overall Study|Adverse Event|7|||
16982988|NCT02927301|38126571|FG000|Overall Study|Withdrawal by Subject|1|||
16982989|NCT02927301|38126571|FG000|Overall Study|Physician Decision|2|||
16982990|NCT02614066|38126588|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
16982991|NCT02614066|38126589|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
16982992|NCT02614066|38126590|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
16982993|NCT02614066|38126591|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
16982994|NCT02614066|38126588|FG000|Overall Study|Full Consent Withdrawn|0|||
16982995|NCT02614066|38126589|FG001|Overall Study|Full Consent Withdrawn|1|||
16982996|NCT02614066|38126590|FG002|Overall Study|Full Consent Withdrawn|0|||
16982997|NCT02614066|38126591|FG003|Overall Study|Full Consent Withdrawn|3|||
16982998|NCT02614066|38126588|FG000|Overall Study|Lost to Follow-up|0|||
16982999|NCT02614066|38126589|FG001|Overall Study|Lost to Follow-up|1|||
16983000|NCT02614066|38126590|FG002|Overall Study|Lost to Follow-up|0|||
16983001|NCT02614066|38126591|FG003|Overall Study|Lost to Follow-up|0|||
17134156|NCT00079937|38275439|FG001|Overall Study|Withdrawal by Subject|7|||
17134157|NCT00079937|38275438|FG000|Overall Study|Lost to Follow-up|12|||
17134158|NCT00079937|38275439|FG001|Overall Study|Lost to Follow-up|5|||
17134159|NCT00079937|38275438|FG000|Overall Study|Administrative problems|22|||
17134160|NCT00079937|38275439|FG001|Overall Study|Administrative problems|11|||
17134161|NCT00909610|38275447|FG000|Period: First Intervention|Adverse Event|0|||
17134162|NCT00909610|38275448|FG001|Period: First Intervention|Adverse Event|1|||
17134163|NCT00909610|38275447|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
16983002|NCT02614066|38126588|FG000|Overall Study|Still on-study|1|||
16983003|NCT02614066|38126589|FG001|Overall Study|Still on-study|9|||
17134164|NCT00909610|38275448|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
17134165|NCT00909610|38275447|FG000|Period: Second Intervention|Adverse Event|1|||
16983004|NCT02614066|38126590|FG002|Overall Study|Still on-study|5|||
16983005|NCT02614066|38126591|FG003|Overall Study|Still on-study|32|||
16983006|NCT02614066|38126588|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
16983007|NCT02614066|38126589|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
16983008|NCT02614066|38126590|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
16983009|NCT02614066|38126591|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
16983010|NCT02544074|38126620|FG000|Overall Study|Withdrawal by Subject|0|||
16983011|NCT02544074|38126621|FG001|Overall Study|Withdrawal by Subject|1|||
16983012|NCT02544074|38126622|FG002|Overall Study|Withdrawal by Subject|0|||
16983013|NCT02544074|38126623|FG003|Overall Study|Withdrawal by Subject|0|||
16983014|NCT02544074|38126624|FG004|Overall Study|Withdrawal by Subject|0|||
16983015|NCT02544074|38126625|FG005|Overall Study|Withdrawal by Subject|0|||
16983016|NCT02544074|38126626|FG006|Overall Study|Withdrawal by Subject|0|||
16983017|NCT02544074|38126627|FG007|Overall Study|Withdrawal by Subject|0|||
16983018|NCT02544074|38126628|FG008|Overall Study|Withdrawal by Subject|0|||
16983019|NCT02544074|38126629|FG009|Overall Study|Withdrawal by Subject|0|||
16983020|NCT02544074|38126630|FG010|Overall Study|Withdrawal by Subject|0|||
16983021|NCT02544074|38126631|FG011|Overall Study|Withdrawal by Subject|0|||
16983022|NCT02544074|38126632|FG012|Overall Study|Withdrawal by Subject|0|||
16983023|NCT02544074|38126633|FG013|Overall Study|Withdrawal by Subject|0|||
16983024|NCT02544074|38126634|FG014|Overall Study|Withdrawal by Subject|0|||
16983025|NCT02544074|38126635|FG015|Overall Study|Withdrawal by Subject|0|||
16983026|NCT02544074|38126636|FG016|Overall Study|Withdrawal by Subject|0|||
16983027|NCT02544074|38126637|FG017|Overall Study|Withdrawal by Subject|0|||
16983028|NCT02544074|38126638|FG018|Overall Study|Withdrawal by Subject|0|||
16983029|NCT02544074|38126639|FG019|Overall Study|Withdrawal by Subject|0|||
16983030|NCT02544074|38126640|FG020|Overall Study|Withdrawal by Subject|0|||
16983031|NCT02544074|38126620|FG000|Overall Study|Tablet error|0|||
16983032|NCT02544074|38126621|FG001|Overall Study|Tablet error|0|||
16983033|NCT02544074|38126622|FG002|Overall Study|Tablet error|0|||
16983034|NCT02544074|38126623|FG003|Overall Study|Tablet error|0|||
16983035|NCT02544074|38126624|FG004|Overall Study|Tablet error|0|||
16983036|NCT02544074|38126625|FG005|Overall Study|Tablet error|1|||
16983037|NCT02544074|38126626|FG006|Overall Study|Tablet error|0|||
16983038|NCT02544074|38126627|FG007|Overall Study|Tablet error|0|||
16983039|NCT02544074|38126628|FG008|Overall Study|Tablet error|0|||
16983040|NCT02544074|38126629|FG009|Overall Study|Tablet error|1|||
16983041|NCT02544074|38126630|FG010|Overall Study|Tablet error|0|||
16983042|NCT02544074|38126631|FG011|Overall Study|Tablet error|0|||
16983043|NCT02544074|38126632|FG012|Overall Study|Tablet error|0|||
16983044|NCT02544074|38126633|FG013|Overall Study|Tablet error|0|||
16983045|NCT02544074|38126634|FG014|Overall Study|Tablet error|0|||
16983046|NCT02544074|38126635|FG015|Overall Study|Tablet error|0|||
16983047|NCT02544074|38126636|FG016|Overall Study|Tablet error|0|||
16983048|NCT02544074|38126637|FG017|Overall Study|Tablet error|0|||
16983049|NCT02544074|38126638|FG018|Overall Study|Tablet error|0|||
16983050|NCT02544074|38126639|FG019|Overall Study|Tablet error|0|||
16983051|NCT02544074|38126640|FG020|Overall Study|Tablet error|0|||
16983052|NCT02502799|38126678|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
16983053|NCT02502799|38126679|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
16983054|NCT02502799|38126680|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
16983055|NCT02502799|38126681|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
16983056|NCT02502799|38126678|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
16983057|NCT02502799|38126679|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
16983058|NCT02502799|38126680|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
16983059|NCT02502799|38126681|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
17134166|NCT00909610|38275448|FG001|Period: Second Intervention|Adverse Event|0|||
16983060|NCT02502799|38126678|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
16983061|NCT02502799|38126679|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
16983062|NCT02502799|38126680|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
16983063|NCT02502799|38126681|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
16983064|NCT02502799|38126678|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
16983065|NCT02502799|38126679|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
16983066|NCT02502799|38126680|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
16983067|NCT02502799|38126681|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
16983068|NCT02502799|38126678|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
16983069|NCT02502799|38126679|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
16983070|NCT02502799|38126680|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
17134167|NCT03126110|38275470|FG000|Phase 1|Death|2|||
17134168|NCT03126110|38275471|FG001|Phase 1|Death|2|||
17134169|NCT03126110|38275472|FG002|Phase 1|Death|4|||
17134170|NCT03126110|38275473|FG003|Phase 1|Death|3|||
17134171|NCT03126110|38275474|FG004|Phase 1|Death|4|||
17134172|NCT03126110|38275475|FG005|Phase 1|Death|4|||
17134173|NCT03126110|38275476|FG006|Phase 1|Death|3|||
17134174|NCT03126110|38275477|FG007|Phase 1|Death|4|||
17134175|NCT03126110|38275478|FG008|Phase 1|Death|5|||
17134176|NCT03126110|38275479|FG009|Phase 1|Death|2|||
17134177|NCT03126110|38275480|FG010|Phase 1|Death|6|||
17134178|NCT03126110|38275481|FG011|Phase 1|Death|0|||
17134179|NCT03126110|38275482|FG012|Phase 1|Death|0|||
17134180|NCT03126110|38275483|FG013|Phase 1|Death|0|||
17134181|NCT03126110|38275484|FG014|Phase 1|Death|0|||
17134182|NCT03126110|38275485|FG015|Phase 1|Death|0|||
16983071|NCT02502799|38126681|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
16983072|NCT02086448|38126694|FG000|Overall Study|Withdrawal by Subject|1|||
16983073|NCT02086448|38126695|FG001|Overall Study|Withdrawal by Subject|0|||
17134183|NCT03126110|38275486|FG016|Phase 1|Death|0|||
17134184|NCT03126110|38275470|FG000|Phase 1|Lost to Follow-up|0|||
17134185|NCT03126110|38275471|FG001|Phase 1|Lost to Follow-up|1|||
17134186|NCT03126110|38275472|FG002|Phase 1|Lost to Follow-up|0|||
17134187|NCT03126110|38275473|FG003|Phase 1|Lost to Follow-up|0|||
17134188|NCT03126110|38275474|FG004|Phase 1|Lost to Follow-up|0|||
17134189|NCT03126110|38275475|FG005|Phase 1|Lost to Follow-up|0|||
17134190|NCT03126110|38275476|FG006|Phase 1|Lost to Follow-up|0|||
17134191|NCT03126110|38275477|FG007|Phase 1|Lost to Follow-up|0|||
17134192|NCT03126110|38275478|FG008|Phase 1|Lost to Follow-up|1|||
17134193|NCT03126110|38275479|FG009|Phase 1|Lost to Follow-up|0|||
17134194|NCT03126110|38275480|FG010|Phase 1|Lost to Follow-up|0|||
17134195|NCT03126110|38275481|FG011|Phase 1|Lost to Follow-up|0|||
17134196|NCT03126110|38275482|FG012|Phase 1|Lost to Follow-up|0|||
17134197|NCT03126110|38275483|FG013|Phase 1|Lost to Follow-up|0|||
17134198|NCT03126110|38275484|FG014|Phase 1|Lost to Follow-up|0|||
17134199|NCT03126110|38275485|FG015|Phase 1|Lost to Follow-up|0|||
17134200|NCT03126110|38275486|FG016|Phase 1|Lost to Follow-up|0|||
17134201|NCT03126110|38275470|FG000|Phase 1|Withdrawal by Subject|1|||
17134202|NCT03126110|38275471|FG001|Phase 1|Withdrawal by Subject|0|||
17134203|NCT03126110|38275472|FG002|Phase 1|Withdrawal by Subject|0|||
17134204|NCT03126110|38275473|FG003|Phase 1|Withdrawal by Subject|1|||
17134205|NCT03126110|38275474|FG004|Phase 1|Withdrawal by Subject|1|||
17134206|NCT03126110|38275475|FG005|Phase 1|Withdrawal by Subject|0|||
16983074|NCT02086448|38126696|FG002|Overall Study|Withdrawal by Subject|0|||
16983075|NCT02086448|38126697|FG003|Overall Study|Withdrawal by Subject|2|||
16983076|NCT01993836|38126710|FG000|Overall Study|Surgery Cancelled|3|||
16983077|NCT01993836|38126711|FG001|Overall Study|Surgery Cancelled|0|||
16983078|NCT01993836|38126712|FG002|Overall Study|Surgery Cancelled|0|||
16983079|NCT01993836|38126710|FG000|Overall Study|Physician Decision|2|||
17134207|NCT03126110|38275476|FG006|Phase 1|Withdrawal by Subject|0|||
17134208|NCT03126110|38275477|FG007|Phase 1|Withdrawal by Subject|0|||
17134209|NCT03126110|38275478|FG008|Phase 1|Withdrawal by Subject|2|||
17134210|NCT03126110|38275479|FG009|Phase 1|Withdrawal by Subject|1|||
17134211|NCT03126110|38275480|FG010|Phase 1|Withdrawal by Subject|0|||
17134212|NCT03126110|38275481|FG011|Phase 1|Withdrawal by Subject|0|||
16983080|NCT01993836|38126711|FG001|Overall Study|Physician Decision|1|||
16983081|NCT01993836|38126712|FG002|Overall Study|Physician Decision|0|||
16983082|NCT01993836|38126710|FG000|Overall Study|Death|0|||
16983083|NCT01993836|38126711|FG001|Overall Study|Death|2|||
16983084|NCT01993836|38126712|FG002|Overall Study|Death|0|||
16983085|NCT01993836|38126710|FG000|Overall Study|Withdrawal by Subject|12|||
16983086|NCT01993836|38126711|FG001|Overall Study|Withdrawal by Subject|10|||
16983087|NCT01993836|38126712|FG002|Overall Study|Withdrawal by Subject|5|||
16983088|NCT01909453|38126725|FG000|Overall Study|Ongoing|118|||
16983089|NCT01909453|38126726|FG001|Overall Study|Ongoing|103|||
16983090|NCT01909453|38126727|FG002|Overall Study|Ongoing|83|||
16983091|NCT01909453|38126728|FG003|Overall Study|Ongoing|164|||
16983092|NCT01909453|38126729|FG004|Overall Study|Ongoing|50|||
16983093|NCT01909453|38126725|FG000|Overall Study|Death|69|||
16983094|NCT01909453|38126726|FG001|Overall Study|Death|74|||
16983095|NCT01909453|38126727|FG002|Overall Study|Death|88|||
16983096|NCT01909453|38126728|FG003|Overall Study|Death|86|||
16983097|NCT01909453|38126729|FG004|Overall Study|Death|29|||
16983098|NCT01909453|38126725|FG000|Overall Study|Lost to Follow-up|3|||
16983099|NCT01909453|38126726|FG001|Overall Study|Lost to Follow-up|4|||
16983100|NCT01909453|38126727|FG002|Overall Study|Lost to Follow-up|4|||
16983101|NCT01909453|38126728|FG003|Overall Study|Lost to Follow-up|3|||
17134213|NCT03126110|38275482|FG012|Phase 1|Withdrawal by Subject|0|||
16983102|NCT01909453|38126729|FG004|Overall Study|Lost to Follow-up|3|||
16983103|NCT01909453|38126725|FG000|Overall Study|Withdrawal by Subject|2|||
16983104|NCT01909453|38126726|FG001|Overall Study|Withdrawal by Subject|13|||
16983105|NCT01909453|38126727|FG002|Overall Study|Withdrawal by Subject|16|||
16983106|NCT01909453|38126728|FG003|Overall Study|Withdrawal by Subject|5|||
16983107|NCT01909453|38126729|FG004|Overall Study|Withdrawal by Subject|4|||
16983108|NCT00753545|38126754|FG000|Overall Study|Death|98|||
16983109|NCT00753545|38126755|FG001|Overall Study|Death|112|||
16983110|NCT00753545|38126754|FG000|Overall Study|Lost to Follow-up|2|||
16983111|NCT00753545|38126755|FG001|Overall Study|Lost to Follow-up|3|||
16983112|NCT00753545|38126754|FG000|Overall Study|Protocol Violation|1|||
16983113|NCT00753545|38126755|FG001|Overall Study|Protocol Violation|0|||
16983114|NCT00753545|38126754|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
16983115|NCT00753545|38126755|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
16983116|NCT00278915|38126770|FG000|Overall Study|Lack of Efficacy|1|||
16983117|NCT00970632|38126777|FG000|Overall Study|Adverse Event|2|||
16983118|NCT00970632|38126778|FG001|Overall Study|Adverse Event|2|||
16983119|NCT00970632|38126779|FG002|Overall Study|Adverse Event|1|||
16983120|NCT00970632|38126777|FG000|Overall Study|Lack of Efficacy|3|||
16983121|NCT00970632|38126778|FG001|Overall Study|Lack of Efficacy|0|||
16983122|NCT00970632|38126779|FG002|Overall Study|Lack of Efficacy|0|||
16983123|NCT00970632|38126777|FG000|Overall Study|Lost to Follow-up|3|||
16983124|NCT00970632|38126778|FG001|Overall Study|Lost to Follow-up|0|||
16983125|NCT00970632|38126779|FG002|Overall Study|Lost to Follow-up|2|||
16983126|NCT00970632|38126777|FG000|Overall Study|Protocol Violation|8|||
16983127|NCT00970632|38126778|FG001|Overall Study|Protocol Violation|5|||
16983128|NCT00970632|38126779|FG002|Overall Study|Protocol Violation|8|||
16983129|NCT00970632|38126777|FG000|Overall Study|Withdrawal by Subject|7|||
16983130|NCT00970632|38126778|FG001|Overall Study|Withdrawal by Subject|6|||
16983131|NCT00970632|38126779|FG002|Overall Study|Withdrawal by Subject|4|||
16983132|NCT00970632|38126777|FG000|Overall Study|Entry criteria not met|0|||
16983133|NCT00970632|38126778|FG001|Overall Study|Entry criteria not met|2|||
16983134|NCT00970632|38126779|FG002|Overall Study|Entry criteria not met|2|||
16983135|NCT00970632|38126777|FG000|Overall Study|Sponsor decision|1|||
16983136|NCT00970632|38126778|FG001|Overall Study|Sponsor decision|0|||
16983137|NCT00970632|38126779|FG002|Overall Study|Sponsor decision|1|||
16983138|NCT01144364|38126789|FG000|Induction Phase|Disease progression|14|||
16983139|NCT01144364|38126790|FG001|Induction Phase|Disease progression|0|||
16983140|NCT01144364|38126791|FG002|Induction Phase|Disease progression|0|||
16983141|NCT01144364|38126789|FG000|Induction Phase|Adverse Event|9|||
16983142|NCT01144364|38126790|FG001|Induction Phase|Adverse Event|0|||
16983143|NCT01144364|38126791|FG002|Induction Phase|Adverse Event|0|||
16983144|NCT01144364|38126789|FG000|Induction Phase|Death|1|||
16983145|NCT01144364|38126790|FG001|Induction Phase|Death|0|||
16983146|NCT01144364|38126791|FG002|Induction Phase|Death|0|||
16983147|NCT01144364|38126789|FG000|Induction Phase|Withdrawal by Subject|1|||
16983148|NCT01144364|38126790|FG001|Induction Phase|Withdrawal by Subject|0|||
16983149|NCT01144364|38126791|FG002|Induction Phase|Withdrawal by Subject|0|||
16983150|NCT01144364|38126789|FG000|Induction Phase|Lost to Follow-up|2|||
16983151|NCT01144364|38126790|FG001|Induction Phase|Lost to Follow-up|0|||
16983152|NCT01144364|38126791|FG002|Induction Phase|Lost to Follow-up|0|||
16983153|NCT01144364|38126789|FG000|Induction Phase|Physician Decision|1|||
16983154|NCT01144364|38126790|FG001|Induction Phase|Physician Decision|0|||
16983155|NCT01144364|38126791|FG002|Induction Phase|Physician Decision|0|||
16983156|NCT01144364|38126789|FG000|Induction Phase|Stable disease|2|||
16983157|NCT01144364|38126790|FG001|Induction Phase|Stable disease|0|||
16983158|NCT01144364|38126791|FG002|Induction Phase|Stable disease|0|||
16983159|NCT01144364|38126789|FG000|Induction Phase|Secondary neoplasia|1|||
16983160|NCT01144364|38126790|FG001|Induction Phase|Secondary neoplasia|0|||
16983161|NCT01144364|38126791|FG002|Induction Phase|Secondary neoplasia|0|||
16983162|NCT01144364|38126789|FG000|Induction Phase|Protocol Violation|1|||
16983163|NCT01144364|38126790|FG001|Induction Phase|Protocol Violation|0|||
16983164|NCT01144364|38126791|FG002|Induction Phase|Protocol Violation|0|||
16983165|NCT01144364|38126789|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
16983166|NCT01144364|38126790|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
16983167|NCT01144364|38126791|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
16983168|NCT01144364|38126789|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
16983169|NCT01144364|38126790|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
16983170|NCT01144364|38126791|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
16983171|NCT01144364|38126789|FG000|Follow-Up/Maintenance Phase|Death|0|||
16983172|NCT01144364|38126790|FG001|Follow-Up/Maintenance Phase|Death|2|||
16983173|NCT01144364|38126791|FG002|Follow-Up/Maintenance Phase|Death|0|||
16983174|NCT01144364|38126789|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
16983175|NCT01144364|38126790|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
16983176|NCT01144364|38126791|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
16983177|NCT01144364|38126789|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
16983178|NCT01144364|38126790|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
16983179|NCT01144364|38126791|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
16983180|NCT01144364|38126789|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
16983181|NCT01144364|38126790|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
16983182|NCT01144364|38126791|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
16983183|NCT01144364|38126789|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
16983184|NCT01144364|38126790|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
16983185|NCT01144364|38126791|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
16983186|NCT01119248|38126801|FG000|Overall Study|Physician Decision|5|||
16983187|NCT01131494|38126806|FG000|Overall Study|Withdrawal by Subject|2|||
16983188|NCT01131260|38126813|FG000|Overall Study|Randomization error|5|||
16983189|NCT01131260|38126814|FG001|Overall Study|Randomization error|1|||
16983190|NCT01131260|38126813|FG000|Overall Study|Declined to continue participation|8|||
16983191|NCT01131260|38126814|FG001|Overall Study|Declined to continue participation|13|||
16983192|NCT01131260|38126813|FG000|Overall Study|Physician Decision|22|||
16983193|NCT01131260|38126814|FG001|Overall Study|Physician Decision|24|||
16983194|NCT01131260|38126813|FG000|Overall Study|Technical problems|7|||
16983195|NCT01131260|38126814|FG001|Overall Study|Technical problems|6|||
16983196|NCT01131260|38126813|FG000|Overall Study|Staff error|2|||
16983197|NCT01131260|38126814|FG001|Overall Study|Staff error|1|||
16983198|NCT01131260|38126813|FG000|Overall Study|Ineligible|0|||
16983199|NCT01131260|38126814|FG001|Overall Study|Ineligible|2|||
16983200|NCT00965094|38126824|FG000|Overall Study|Adverse Event|5|||
16983201|NCT00965094|38126825|FG001|Overall Study|Adverse Event|0|||
16983202|NCT00965094|38126824|FG000|Overall Study|Lost to Follow-up|0|||
16983203|NCT00965094|38126825|FG001|Overall Study|Lost to Follow-up|1|||
16983204|NCT01131182|38126834|FG000|Overall Study|Withdrawal by Subject|1|||
16983205|NCT01131182|38126835|FG001|Overall Study|Withdrawal by Subject|1|||
16983206|NCT01131182|38126834|FG000|Overall Study|Lost to Follow-up|14|||
16983207|NCT01131182|38126835|FG001|Overall Study|Lost to Follow-up|15|||
16983208|NCT01131182|38126834|FG000|Overall Study|Other Reason|1|||
16983209|NCT01131182|38126835|FG001|Overall Study|Other Reason|0|||
16983210|NCT00964860|38126843|FG000|Overall Study|Withdrawal by Subject|0|||
16983211|NCT00964860|38126844|FG001|Overall Study|Withdrawal by Subject|1|||
16983212|NCT01131104|38126850|FG000|Overall Study|Withdrawal by Subject|3|||
16983213|NCT01131104|38126850|FG000|Overall Study|Physician Decision|4|||
16983214|NCT01131104|38126850|FG000|Overall Study|Information Not Available|5|||
16983215|NCT01131104|38126850|FG000|Overall Study|No Information on Index Date of Onset|1|||
16983216|NCT01118780|38126856|FG000|Overall Study|Adverse Event|15|||
16983217|NCT01118780|38126857|FG001|Overall Study|Adverse Event|15|||
16983218|NCT01118780|38126856|FG000|Overall Study|Death|1|||
16983219|NCT01118780|38126857|FG001|Overall Study|Death|0|||
16983220|NCT01118780|38126856|FG000|Overall Study|Lack of Efficacy|2|||
16983221|NCT01118780|38126857|FG001|Overall Study|Lack of Efficacy|6|||
16983222|NCT01118780|38126856|FG000|Overall Study|Physician Decision|2|||
16983223|NCT01118780|38126857|FG001|Overall Study|Physician Decision|0|||
16983224|NCT01118780|38126856|FG000|Overall Study|Protocol Violation|3|||
16983225|NCT01118780|38126857|FG001|Overall Study|Protocol Violation|6|||
16983226|NCT01118780|38126856|FG000|Overall Study|Withdrawal by Subject|13|||
16983227|NCT01118780|38126857|FG001|Overall Study|Withdrawal by Subject|8|||
16983228|NCT00964782|38126868|FG000|Overall Study|Lost to Follow-up|1|||
16983229|NCT00964782|38126869|FG001|Overall Study|Lost to Follow-up|0|||
16983230|NCT00966654|38126877|FG000|Overall Study|Study was terminated,PI left institution|12|||
16983231|NCT03262116|38126889|FG000|Overall Study|Physician Decision|0|||
16983232|NCT03262116|38126890|FG001|Overall Study|Physician Decision|2|||
16983233|NCT03262116|38126891|FG002|Overall Study|Physician Decision|1|||
16983234|NCT03262116|38126892|FG003|Overall Study|Physician Decision|1|||
16983235|NCT03262116|38126893|FG004|Overall Study|Physician Decision|1|||
16983236|NCT03262116|38126894|FG005|Overall Study|Physician Decision|2|||
16983237|NCT01130168|38126902|FG000|Period 1|Withdrawal by Subject|0|||
16983238|NCT01130168|38126903|FG001|Period 1|Withdrawal by Subject|1|||
16983239|NCT01130168|38126904|FG002|Period 1|Withdrawal by Subject|0|||
16983240|NCT01130168|38126905|FG003|Period 1|Withdrawal by Subject|1|||
16983241|NCT01130168|38126906|FG004|Period 1|Withdrawal by Subject|0|||
16983242|NCT01130168|38126907|FG005|Period 1|Withdrawal by Subject|0|||
16983243|NCT01130168|38126902|FG000|Period 1|Discontinued For Other Reason|0|||
16983244|NCT01130168|38126903|FG001|Period 1|Discontinued For Other Reason|0|||
16983245|NCT01130168|38126904|FG002|Period 1|Discontinued For Other Reason|1|||
16983246|NCT01130168|38126905|FG003|Period 1|Discontinued For Other Reason|1|||
16983247|NCT01130168|38126906|FG004|Period 1|Discontinued For Other Reason|0|||
16983248|NCT01130168|38126907|FG005|Period 1|Discontinued For Other Reason|0|||
16983249|NCT01130168|38126902|FG000|Period 1|Adverse Event|0|||
16983250|NCT01130168|38126903|FG001|Period 1|Adverse Event|0|||
16983251|NCT01130168|38126904|FG002|Period 1|Adverse Event|0|||
16983252|NCT01130168|38126905|FG003|Period 1|Adverse Event|1|||
16983253|NCT01130168|38126906|FG004|Period 1|Adverse Event|0|||
16983254|NCT01130168|38126907|FG005|Period 1|Adverse Event|0|||
16983255|NCT01144052|38126918|FG000|Overall Study|Withdrawal by Subject|1|||
16983256|NCT01144052|38126919|FG001|Overall Study|Withdrawal by Subject|1|||
16983257|NCT01143896|38126929|FG000|Overall Study|Did not complete Baseline Interview|5|||
16983258|NCT01143896|38126930|FG001|Overall Study|Did not complete Baseline Interview|4|||
16983259|NCT01143896|38126929|FG000|Overall Study|Lost to Follow-up|18|||
16983260|NCT01143896|38126930|FG001|Overall Study|Lost to Follow-up|13|||
16983261|NCT01143896|38126929|FG000|Overall Study|Withdrawal by Subject|13|||
16983262|NCT01143896|38126930|FG001|Overall Study|Withdrawal by Subject|5|||
16983263|NCT01143896|38126929|FG000|Overall Study|Death|6|||
16983264|NCT01143896|38126930|FG001|Overall Study|Death|3|||
16983265|NCT01118312|38126939|FG000|Overall Study|Lost to Follow-up|33|||
16983266|NCT01118312|38126940|FG001|Overall Study|Lost to Follow-up|32|||
16983267|NCT01118312|38126939|FG000|Overall Study|Withdrawal by Subject|1|||
16983268|NCT01118312|38126940|FG001|Overall Study|Withdrawal by Subject|3|||
16983269|NCT01117766|38126946|FG000|First Intervention|Adverse Event|0|||
16983270|NCT01117766|38126947|FG001|First Intervention|Adverse Event|1|||
16983271|NCT01117766|38126946|FG000|First Intervention|Protocol Violation|1|||
16983272|NCT01117766|38126947|FG001|First Intervention|Protocol Violation|0|||
16983273|NCT01117766|38126946|FG000|Washout Period|Protocol Violation|0|||
16983274|NCT01117766|38126947|FG001|Washout Period|Protocol Violation|2|||
16983275|NCT01117766|38126946|FG000|Second Intervention|Lost to Follow-up|1|||
16983276|NCT01117766|38126947|FG001|Second Intervention|Lost to Follow-up|0|||
16983277|NCT01117766|38126946|FG000|Second Intervention|Other|1|||
16983278|NCT01117766|38126947|FG001|Second Intervention|Other|2|||
16983279|NCT01117766|38126946|FG000|Second Intervention|Adverse Event|0|||
16983280|NCT01117766|38126947|FG001|Second Intervention|Adverse Event|2|||
16983281|NCT01117766|38126946|FG000|Second Intervention|Withdrawal by Subject|0|||
16983282|NCT01117766|38126947|FG001|Second Intervention|Withdrawal by Subject|1|||
16983283|NCT01117454|38126955|FG000|Overall Study|Pregnancy|0|||
16983284|NCT01117454|38126956|FG001|Overall Study|Pregnancy|1|||
16983285|NCT01116440|38126964|FG000|Treatment|Withdrawal by Subject|2|||
16983286|NCT01116440|38126965|FG001|Treatment|Withdrawal by Subject|2|||
16983287|NCT01116440|38126964|FG000|Treatment|Lost to Follow-up|1|||
16983288|NCT01116440|38126965|FG001|Treatment|Lost to Follow-up|1|||
16983289|NCT01116440|38126964|FG000|Treatment|Protocol Violation|0|||
16983290|NCT01116440|38126965|FG001|Treatment|Protocol Violation|2|||
16983291|NCT01116440|38126964|FG000|Treatment|Lack of Efficacy|0|||
16983292|NCT01116440|38126965|FG001|Treatment|Lack of Efficacy|1|||
16983293|NCT01116440|38126964|FG000|Treatment|Adverse Event|0|||
16983294|NCT01116440|38126965|FG001|Treatment|Adverse Event|1|||
16983295|NCT01116440|38126964|FG000|Withdrawal|Withdrawal by Subject|0|||
16983296|NCT01116440|38126965|FG001|Withdrawal|Withdrawal by Subject|1|||
16983297|NCT01116440|38126964|FG000|Withdrawal|Lost to Follow-up|0|||
16983298|NCT01116440|38126965|FG001|Withdrawal|Lost to Follow-up|1|||
16983299|NCT01116440|38126964|FG000|Follow-up|Lost to Follow-up|0|||
16983300|NCT01116440|38126965|FG001|Follow-up|Lost to Follow-up|1|||
16983301|NCT01116440|38126964|FG000|Follow-up|Withdrawal by Subject|0|||
16983302|NCT01116440|38126965|FG001|Follow-up|Withdrawal by Subject|1|||
16983303|NCT01129622|38126973|FG000|Overall Study|Withdrawal by Subject|2|||
16983304|NCT01128842|38126978|FG000|Overall Study|Adverse Event|1|||
16983305|NCT01128842|38126978|FG000|Overall Study|Disease Progression|6|||
16983306|NCT03624036|38126987|FG000|Overall Study|Still on Study|5|||
16983307|NCT03624036|38126988|FG001|Overall Study|Still on Study|1|||
16983308|NCT03624036|38126989|FG002|Overall Study|Still on Study|3|||
16983309|NCT03624036|38126990|FG003|Overall Study|Still on Study|3|||
16983310|NCT03624036|38126987|FG000|Overall Study|Death|1|||
16983311|NCT03624036|38126988|FG001|Overall Study|Death|2|||
16983312|NCT03624036|38126989|FG002|Overall Study|Death|0|||
16983313|NCT03624036|38126990|FG003|Overall Study|Death|0|||
16983314|NCT03624036|38126987|FG000|Overall Study|Enrolled but Never Treated|1|||
16983315|NCT03624036|38126988|FG001|Overall Study|Enrolled but Never Treated|0|||
16983316|NCT03624036|38126989|FG002|Overall Study|Enrolled but Never Treated|0|||
16983317|NCT03624036|38126990|FG003|Overall Study|Enrolled but Never Treated|0|||
16983318|NCT01143038|38127000|FG000|Overall Study|Withdrawal by Subject|4|||
16983319|NCT01143038|38127000|FG000|Overall Study|Requirement for alternative therapy|5|||
16983320|NCT01143038|38127000|FG000|Overall Study|Adverse Event|3|||
16983321|NCT01143038|38127000|FG000|Overall Study|Lost to Follow-up|2|||
16983322|NCT01143038|38127000|FG000|Overall Study|Protocol Deviation|1|||
16983323|NCT01143038|38127000|FG000|Overall Study|Death|1|||
16983324|NCT00966264|38127006|FG000|Overall Study|Lost to Follow-up|4|||
16983325|NCT00966264|38127007|FG001|Overall Study|Lost to Follow-up|3|||
16983326|NCT00915525|38127015|FG000|Overall Study|Protocol Violation|9|||
16983327|NCT00915525|38127016|FG001|Overall Study|Protocol Violation|4|||
16983328|NCT00915525|38127015|FG000|Overall Study|Withdrawal by Subject|59|||
16983329|NCT00915525|38127016|FG001|Overall Study|Withdrawal by Subject|21|||
16983330|NCT00915525|38127015|FG000|Overall Study|Lost to Follow-up|27|||
16983331|NCT00915525|38127016|FG001|Overall Study|Lost to Follow-up|16|||
16983332|NCT00915525|38127015|FG000|Overall Study|Pregnancy|2|||
16983333|NCT00915525|38127016|FG001|Overall Study|Pregnancy|0|||
16983334|NCT00915525|38127015|FG000|Overall Study|Lack of Efficacy|15|||
16983335|NCT00915525|38127016|FG001|Overall Study|Lack of Efficacy|32|||
16983336|NCT00915525|38127015|FG000|Overall Study|Adverse Event|29|||
16983337|NCT00915525|38127016|FG001|Overall Study|Adverse Event|13|||
16983338|NCT00915525|38127015|FG000|Overall Study|Missing|12|||
16983339|NCT00915525|38127016|FG001|Overall Study|Missing|1|||
16983340|NCT00915525|38127015|FG000|Overall Study|Other Reason|35|||
16983341|NCT00915525|38127016|FG001|Overall Study|Other Reason|12|||
16983342|NCT00915525|38127015|FG000|Overall Study|Site Closed|27|||
16983343|NCT00915525|38127016|FG001|Overall Study|Site Closed|9|||
16983344|NCT00915525|38127015|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
16983345|NCT00915525|38127016|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
16983346|NCT00915525|38127015|FG000|Overall Study|Study Burden|28|||
16983347|NCT00915525|38127016|FG001|Overall Study|Study Burden|12|||
16983348|NCT00915525|38127015|FG000|Overall Study|Non-Compliance|3|||
16983349|NCT00915525|38127016|FG001|Overall Study|Non-Compliance|1|||
16983350|NCT00915525|38127015|FG000|Overall Study|Patient Moved|15|||
16983351|NCT00915525|38127016|FG001|Overall Study|Patient Moved|9|||
16983352|NCT01074047|38127044|FG000|Treatment Phase|Adverse Event|89|||
16983353|NCT01074047|38127045|FG001|Treatment Phase|Adverse Event|66|||
16983354|NCT01074047|38127044|FG000|Treatment Phase|Disease Progression|16|||
16983355|NCT01074047|38127045|FG001|Treatment Phase|Disease Progression|21|||
16983356|NCT01074047|38127044|FG000|Treatment Phase|Withdrawal by Subject|27|||
16983357|NCT01074047|38127045|FG001|Treatment Phase|Withdrawal by Subject|48|||
16983358|NCT01074047|38127044|FG000|Treatment Phase|Death|53|||
16983359|NCT01074047|38127045|FG001|Treatment Phase|Death|58|||
16983360|NCT01074047|38127044|FG000|Treatment Phase|Lost to Follow-up|0|||
16983361|NCT01074047|38127045|FG001|Treatment Phase|Lost to Follow-up|1|||
16983362|NCT01074047|38127044|FG000|Treatment Phase|Protocol Violation|0|||
16983363|NCT01074047|38127045|FG001|Treatment Phase|Protocol Violation|1|||
16983364|NCT01074047|38127044|FG000|Treatment Phase|Miscellaneous|32|||
16983365|NCT01074047|38127045|FG001|Treatment Phase|Miscellaneous|39|||
16983366|NCT01074047|38127044|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
16983367|NCT01074047|38127045|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
16983368|NCT01074047|38127044|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
16983369|NCT01074047|38127045|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
16983370|NCT01074047|38127044|FG000|Survival Follow-Up Phase|Death|116|||
16983371|NCT01074047|38127045|FG001|Survival Follow-Up Phase|Death|124|||
16983372|NCT01074047|38127044|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
16983373|NCT01074047|38127045|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
16983374|NCT01074047|38127044|FG000|Extension Phase|Physician Decision|1|||
16983375|NCT01074047|38127045|FG001|Extension Phase|Physician Decision|0|||
16983376|NCT01074047|38127044|FG000|Extension Phase|Adverse Event|5|||
16983377|NCT01074047|38127045|FG001|Extension Phase|Adverse Event|0|||
16983378|NCT01074047|38127044|FG000|Extension Phase|Disease Progression|9|||
16983379|NCT01074047|38127045|FG001|Extension Phase|Disease Progression|0|||
16983380|NCT01074047|38127044|FG000|Extension Phase|Withdrawal by Subject|2|||
16983381|NCT01074047|38127045|FG001|Extension Phase|Withdrawal by Subject|0|||
16983382|NCT01074047|38127044|FG000|Extension Phase|Death|5|||
16983383|NCT01074047|38127045|FG001|Extension Phase|Death|0|||
16983384|NCT01142726|38127061|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
16983385|NCT01142726|38127062|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
16983386|NCT01142726|38127063|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
16983387|NCT01142726|38127061|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
16983388|NCT01142726|38127062|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
16780211|NCT01594749|37719307|FG000|Overall Study|Death|9|||
16780212|NCT01594749|37719308|FG001|Overall Study|Death|3|||
16983389|NCT01142726|38127063|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
16983390|NCT01142726|38127061|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
16983391|NCT01142726|38127062|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
16983392|NCT01142726|38127063|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
16983393|NCT01142726|38127061|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
16983394|NCT01142726|38127062|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
16983395|NCT01142726|38127063|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
16983396|NCT01142726|38127061|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
16983397|NCT01142726|38127062|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
16983398|NCT01142726|38127063|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
16983399|NCT01142726|38127061|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
16780213|NCT01594749|37719307|FG000|Overall Study|Not Treated|4|||
16983400|NCT01142726|38127062|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
16983401|NCT01142726|38127063|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
16983402|NCT01142726|38127061|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
16983403|NCT01142726|38127062|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
16983404|NCT01142726|38127063|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
16983405|NCT01142726|38127061|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
16983406|NCT01142726|38127062|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
16983407|NCT01142726|38127063|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
16983408|NCT01142726|38127061|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
16983409|NCT01142726|38127062|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
16983410|NCT01142726|38127063|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
16983411|NCT01142726|38127061|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
16983412|NCT01142726|38127062|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
16983413|NCT01142726|38127063|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
16983414|NCT01142726|38127061|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
16983415|NCT01142726|38127062|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
16983416|NCT01142726|38127063|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
16983417|NCT01142726|38127061|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
16983418|NCT01142726|38127062|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
16983419|NCT01142726|38127063|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
16983420|NCT01142726|38127061|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
16983421|NCT01142726|38127062|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
16983422|NCT01142726|38127063|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
16983423|NCT01142726|38127061|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
16983424|NCT01142726|38127062|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
16983425|NCT01142726|38127063|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
16983426|NCT01142726|38127061|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
16983427|NCT01142726|38127062|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
16983428|NCT01142726|38127063|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
16983429|NCT01142726|38127061|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
16983430|NCT01142726|38127062|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
16983431|NCT01142726|38127063|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
16983432|NCT01073267|38127079|FG000|Overall Study|Disease Progression|3|||
16983433|NCT01142336|38127085|FG000|Overall Study|Adverse Event|1|||
16983434|NCT01142336|38127086|FG001|Overall Study|Adverse Event|1|||
16983435|NCT01142336|38127085|FG000|Overall Study|Lost to Follow-up|0|||
16983436|NCT01142336|38127086|FG001|Overall Study|Lost to Follow-up|1|||
16983437|NCT00915681|38127095|FG000|Overall Study|Screening failures|46|||
16983438|NCT01128296|38127099|FG000|Overall Study|Physician Decision|0|||
16983439|NCT01128296|38127100|FG001|Overall Study|Physician Decision|0|||
16983440|NCT01128296|38127101|FG002|Overall Study|Physician Decision|0|||
16983441|NCT01128296|38127102|FG003|Overall Study|Physician Decision|0|||
16983442|NCT01128296|38127103|FG004|Overall Study|Physician Decision|0|||
16983443|NCT01128296|38127104|FG005|Overall Study|Physician Decision|3|||
16983444|NCT01128296|38127099|FG000|Overall Study|Withdrawal by Subject|0|||
16983445|NCT01128296|38127100|FG001|Overall Study|Withdrawal by Subject|0|||
16983446|NCT01128296|38127101|FG002|Overall Study|Withdrawal by Subject|0|||
16983447|NCT01128296|38127102|FG003|Overall Study|Withdrawal by Subject|0|||
16983448|NCT01128296|38127103|FG004|Overall Study|Withdrawal by Subject|0|||
16983449|NCT01128296|38127104|FG005|Overall Study|Withdrawal by Subject|2|||
16983450|NCT01115738|38127118|FG000|Overall Study|Death|1|||
16983451|NCT01115738|38127119|FG001|Overall Study|Death|0|||
16983452|NCT01115738|38127120|FG002|Overall Study|Death|0|||
16983453|NCT01115738|38127118|FG000|Overall Study|Lost to Follow-up|0|||
16983454|NCT01115738|38127119|FG001|Overall Study|Lost to Follow-up|0|||
16983455|NCT01115738|38127120|FG002|Overall Study|Lost to Follow-up|1|||
16983456|NCT01115738|38127118|FG000|Overall Study|Physician Decision|18|||
16983457|NCT01115738|38127119|FG001|Overall Study|Physician Decision|15|||
16983458|NCT01115738|38127120|FG002|Overall Study|Physician Decision|17|||
16983459|NCT01115738|38127118|FG000|Overall Study|Withdrawal by Subject|6|||
16983460|NCT01115738|38127119|FG001|Overall Study|Withdrawal by Subject|6|||
16983461|NCT01115738|38127120|FG002|Overall Study|Withdrawal by Subject|9|||
16983462|NCT01141478|38127138|FG000|Overall Study|Withdrawal by Subject|1|||
16983463|NCT01141478|38127139|FG001|Overall Study|Withdrawal by Subject|1|||
16983464|NCT01114880|38127147|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
16983465|NCT01114880|38127148|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
16983466|NCT01114880|38127147|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
16983467|NCT01114880|38127148|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
16983468|NCT01114880|38127147|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
16983469|NCT01114880|38127148|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
16983470|NCT01114880|38127147|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
16983471|NCT01114880|38127148|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
16983472|NCT01114880|38127147|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
16983473|NCT01114880|38127148|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
16983474|NCT01114880|38127147|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
16983475|NCT01114880|38127148|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
16983476|NCT01114724|38127156|FG000|Overall Study|Death|8|||
16983477|NCT01114724|38127156|FG000|Overall Study|Lost to Follow-up|1|||
17134214|NCT03126110|38275483|FG013|Phase 1|Withdrawal by Subject|0|||
17134215|NCT03126110|38275484|FG014|Phase 1|Withdrawal by Subject|0|||
17134216|NCT03126110|38275485|FG015|Phase 1|Withdrawal by Subject|0|||
17134217|NCT03126110|38275486|FG016|Phase 1|Withdrawal by Subject|0|||
16983478|NCT01114724|38127156|FG000|Overall Study|Withdrawal by Subject|1|||
16983479|NCT00964392|38127163|FG000|Overall Study|Withdrawal by Subject|4|||
16983480|NCT00964392|38127164|FG001|Overall Study|Withdrawal by Subject|6|||
16983481|NCT00964392|38127163|FG000|Overall Study|Lost to Follow-up|4|||
16983482|NCT00964392|38127164|FG001|Overall Study|Lost to Follow-up|10|||
16983483|NCT00964392|38127163|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
16983484|NCT00964392|38127164|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
16983485|NCT00964392|38127163|FG000|Overall Study|Not completed|44|||
16983486|NCT00964392|38127164|FG001|Overall Study|Not completed|168|||
16983487|NCT00965718|38127170|FG000|Overall Study|Withdrawal by Subject|4|||
16983488|NCT00914589|38127177|FG000|Overall Study|Adverse Event|1|||
16983489|NCT00914589|38127178|FG001|Overall Study|Adverse Event|0|||
16983490|NCT00914589|38127179|FG002|Overall Study|Adverse Event|1|||
16983491|NCT00914589|38127177|FG000|Overall Study|Protocol Violation|8|||
16983492|NCT00914589|38127178|FG001|Overall Study|Protocol Violation|6|||
16983493|NCT00914589|38127179|FG002|Overall Study|Protocol Violation|3|||
16983494|NCT00914589|38127177|FG000|Overall Study|unclassified|16|||
16983495|NCT00914589|38127178|FG001|Overall Study|unclassified|9|||
16983496|NCT00914589|38127179|FG002|Overall Study|unclassified|7|||
16983497|NCT00914589|38127177|FG000|Overall Study|Death|0|||
16983498|NCT00914589|38127178|FG001|Overall Study|Death|1|||
16983499|NCT00914589|38127179|FG002|Overall Study|Death|1|||
16983500|NCT00912405|38127187|FG000|Overall Study|Lost to Follow-up|5|||
16983501|NCT00878722|38127199|FG000|Overall Study|Progressive disease|3|||
16983502|NCT00878722|38127200|FG001|Overall Study|Progressive disease|3|||
16983503|NCT00878722|38127201|FG002|Overall Study|Progressive disease|3|||
16983504|NCT00878722|38127202|FG003|Overall Study|Progressive disease|7|||
16983505|NCT00878722|38127203|FG004|Overall Study|Progressive disease|7|||
16983506|NCT00878722|38127204|FG005|Overall Study|Progressive disease|1|||
16983507|NCT00878722|38127205|FG006|Overall Study|Progressive disease|4|||
16983508|NCT00878722|38127206|FG007|Overall Study|Progressive disease|3|||
16983509|NCT00878722|38127199|FG000|Overall Study|Death|0|||
16983510|NCT00878722|38127200|FG001|Overall Study|Death|0|||
16983511|NCT00878722|38127201|FG002|Overall Study|Death|0|||
16983512|NCT00878722|38127202|FG003|Overall Study|Death|1|||
16983513|NCT00878722|38127203|FG004|Overall Study|Death|0|||
16983514|NCT00878722|38127204|FG005|Overall Study|Death|1|||
16983515|NCT00878722|38127205|FG006|Overall Study|Death|0|||
16983516|NCT00878722|38127206|FG007|Overall Study|Death|2|||
16983517|NCT00878722|38127199|FG000|Overall Study|Adverse Event|0|||
16983518|NCT00878722|38127200|FG001|Overall Study|Adverse Event|0|||
16983519|NCT00878722|38127201|FG002|Overall Study|Adverse Event|0|||
16983520|NCT00878722|38127202|FG003|Overall Study|Adverse Event|0|||
16983521|NCT00878722|38127203|FG004|Overall Study|Adverse Event|0|||
16983522|NCT00878722|38127204|FG005|Overall Study|Adverse Event|0|||
16983523|NCT00878722|38127205|FG006|Overall Study|Adverse Event|2|||
16983524|NCT00878722|38127206|FG007|Overall Study|Adverse Event|0|||
16983525|NCT00878722|38127199|FG000|Overall Study|Withdrawal by Subject|0|||
16983526|NCT00878722|38127200|FG001|Overall Study|Withdrawal by Subject|0|||
16983527|NCT00878722|38127201|FG002|Overall Study|Withdrawal by Subject|0|||
16983528|NCT00878722|38127202|FG003|Overall Study|Withdrawal by Subject|0|||
16983529|NCT00878722|38127203|FG004|Overall Study|Withdrawal by Subject|0|||
16983530|NCT00878722|38127204|FG005|Overall Study|Withdrawal by Subject|0|||
16983531|NCT00878722|38127205|FG006|Overall Study|Withdrawal by Subject|0|||
16983532|NCT00878722|38127206|FG007|Overall Study|Withdrawal by Subject|2|||
16983533|NCT00878722|38127199|FG000|Overall Study|Relapse|0|||
16983534|NCT00878722|38127200|FG001|Overall Study|Relapse|0|||
16983535|NCT00878722|38127201|FG002|Overall Study|Relapse|0|||
16983536|NCT00878722|38127202|FG003|Overall Study|Relapse|1|||
16983537|NCT00878722|38127203|FG004|Overall Study|Relapse|0|||
17134218|NCT03126110|38275470|FG000|Phase 1|Safety follow-up no longer necessary|1|||
16983538|NCT00878722|38127204|FG005|Overall Study|Relapse|0|||
16983539|NCT00878722|38127205|FG006|Overall Study|Relapse|0|||
16983540|NCT00878722|38127206|FG007|Overall Study|Relapse|0|||
16983541|NCT00964158|38127234|FG000|Overall Study|Lost to Follow-up|0|||
16983542|NCT00964158|38127235|FG001|Overall Study|Lost to Follow-up|1|||
16983543|NCT00964158|38127236|FG002|Overall Study|Lost to Follow-up|2|||
16983544|NCT00964158|38127234|FG000|Overall Study|Withdrawal by Subject|0|||
16983545|NCT00964158|38127235|FG001|Overall Study|Withdrawal by Subject|0|||
16983546|NCT00964158|38127236|FG002|Overall Study|Withdrawal by Subject|6|||
16983547|NCT00961350|38127249|FG000|Overall Study|Adverse Event|18|||
16983548|NCT00961350|38127250|FG001|Overall Study|Adverse Event|33|||
16983549|NCT00961350|38127249|FG000|Overall Study|Withdrawal by Subject|10|||
16983550|NCT00961350|38127250|FG001|Overall Study|Withdrawal by Subject|10|||
16983551|NCT00961350|38127249|FG000|Overall Study|Lost to Follow-up|3|||
16983552|NCT00961350|38127250|FG001|Overall Study|Lost to Follow-up|3|||
16983553|NCT00961350|38127249|FG000|Overall Study|Misc|16|||
16983554|NCT00961350|38127250|FG001|Overall Study|Misc|21|||
16983555|NCT00963924|38127258|FG000|Overall Study|Adverse Event|1|||
16983556|NCT00963924|38127259|FG001|Overall Study|Adverse Event|0|||
16983557|NCT00963924|38127258|FG000|Overall Study|Withdrawal by Subject|0|||
16983558|NCT00963924|38127259|FG001|Overall Study|Withdrawal by Subject|1|||
16983559|NCT00963924|38127258|FG000|Overall Study|Changed antipsychotic|0|||
16983560|NCT00963924|38127259|FG001|Overall Study|Changed antipsychotic|1|||
16983561|NCT00963924|38127258|FG000|Overall Study|Lost to Follow-up|0|||
16983562|NCT00963924|38127259|FG001|Overall Study|Lost to Follow-up|1|||
16983563|NCT03265665|38127269|FG000|24-week Data Collection|Withdrawal by Subject|2|||
16983564|NCT03265665|38127270|FG001|24-week Data Collection|Withdrawal by Subject|2|||
16983565|NCT03265665|38127269|FG000|24-week Data Collection|Lost to Follow-up|4|||
16983566|NCT03265665|38127270|FG001|24-week Data Collection|Lost to Follow-up|5|||
16983567|NCT03265665|38127269|FG000|36-week Data Collection|Lost to Follow-up|6|||
16983568|NCT03265665|38127270|FG001|36-week Data Collection|Lost to Follow-up|8|||
16983569|NCT01126736|38127283|FG000|Overall Study|Death|2|||
16983570|NCT01126736|38127284|FG001|Overall Study|Death|2|||
16983571|NCT01126736|38127285|FG002|Overall Study|Death|1|||
16983572|NCT01126736|38127286|FG003|Overall Study|Death|19|||
16983573|NCT01126736|38127287|FG004|Overall Study|Death|19|||
16983574|NCT01126736|38127283|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
16983575|NCT01126736|38127284|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
16983576|NCT01126736|38127285|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
16983577|NCT01126736|38127286|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
16983578|NCT01126736|38127287|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
16983579|NCT01126736|38127283|FG000|Overall Study|Lost to Follow-up|0|||
16983580|NCT01126736|38127284|FG001|Overall Study|Lost to Follow-up|0|||
16983581|NCT01126736|38127285|FG002|Overall Study|Lost to Follow-up|0|||
16983582|NCT01126736|38127286|FG003|Overall Study|Lost to Follow-up|1|||
16983583|NCT01126736|38127287|FG004|Overall Study|Lost to Follow-up|1|||
16983584|NCT01126736|38127283|FG000|Overall Study|Administrative reasons|0|||
16983585|NCT01126736|38127284|FG001|Overall Study|Administrative reasons|0|||
16983586|NCT01126736|38127285|FG002|Overall Study|Administrative reasons|0|||
16983587|NCT01126736|38127286|FG003|Overall Study|Administrative reasons|0|||
16983588|NCT01126736|38127287|FG004|Overall Study|Administrative reasons|1|||
16983589|NCT01126736|38127283|FG000|Overall Study|Progressive disease|0|||
16983590|NCT01126736|38127284|FG001|Overall Study|Progressive disease|0|||
16983591|NCT01126736|38127285|FG002|Overall Study|Progressive disease|0|||
16983592|NCT01126736|38127286|FG003|Overall Study|Progressive disease|2|||
16983593|NCT01126736|38127287|FG004|Overall Study|Progressive disease|1|||
16983594|NCT01126736|38127283|FG000|Overall Study|Withdrawal by Subject|0|||
16983595|NCT01126736|38127284|FG001|Overall Study|Withdrawal by Subject|0|||
16983596|NCT01126736|38127285|FG002|Overall Study|Withdrawal by Subject|0|||
16983597|NCT01126736|38127286|FG003|Overall Study|Withdrawal by Subject|1|||
16983598|NCT01126736|38127287|FG004|Overall Study|Withdrawal by Subject|1|||
16983599|NCT01126736|38127283|FG000|Overall Study|Other|2|||
16983600|NCT01126736|38127284|FG001|Overall Study|Other|4|||
16983601|NCT01126736|38127285|FG002|Overall Study|Other|4|||
16983602|NCT01126736|38127286|FG003|Overall Study|Other|16|||
16983603|NCT01126736|38127287|FG004|Overall Study|Other|15|||
16983604|NCT01114646|38127301|FG000|Overall Study|Withdrawal by Subject|3|||
16983605|NCT01114646|38127302|FG001|Overall Study|Withdrawal by Subject|2|||
16983606|NCT00965562|38127311|FG000|Overall Study|Lost to Follow-up|1|||
16983607|NCT00965562|38127312|FG001|Overall Study|Lost to Follow-up|2|||
16983608|NCT00965562|38127313|FG002|Overall Study|Lost to Follow-up|3|||
16983609|NCT00965562|38127311|FG000|Overall Study|Withdrawal by Subject|2|||
16983610|NCT00965562|38127312|FG001|Overall Study|Withdrawal by Subject|2|||
16983611|NCT00965562|38127313|FG002|Overall Study|Withdrawal by Subject|0|||
16983612|NCT00912093|38127327|FG000|The Controlled Phase|Death|0|||
16983613|NCT00912093|38127328|FG001|The Controlled Phase|Death|1|||
16983614|NCT00912093|38127329|FG002|The Controlled Phase|Death|0|||
16983615|NCT00912093|38127330|FG003|The Controlled Phase|Death|0|||
16983616|NCT00912093|38127331|FG004|The Controlled Phase|Death|0|||
16983617|NCT00912093|38127327|FG000|The Controlled Phase|Medical Condition|0|||
16983618|NCT00912093|38127328|FG001|The Controlled Phase|Medical Condition|1|||
16983619|NCT00912093|38127329|FG002|The Controlled Phase|Medical Condition|0|||
16983620|NCT00912093|38127330|FG003|The Controlled Phase|Medical Condition|0|||
16983621|NCT00912093|38127331|FG004|The Controlled Phase|Medical Condition|0|||
16983622|NCT00912093|38127327|FG000|The Controlled Phase|Lost to Follow-up|0|||
16983623|NCT00912093|38127328|FG001|The Controlled Phase|Lost to Follow-up|0|||
16983624|NCT00912093|38127329|FG002|The Controlled Phase|Lost to Follow-up|0|||
16983625|NCT00912093|38127330|FG003|The Controlled Phase|Lost to Follow-up|0|||
16983626|NCT00912093|38127331|FG004|The Controlled Phase|Lost to Follow-up|1|||
16983627|NCT00965484|38127339|FG000|Overall Study|Protocol Violation|1|||
16983628|NCT00965484|38127339|FG000|Overall Study|Withdrawal by Subject|1|||
16983629|NCT00961116|38127343|FG000|Washout Period of 7 Days|Adverse Event|1|||
16983630|NCT00961116|38127344|FG001|Washout Period of 7 Days|Adverse Event|1|||
16983631|NCT00961116|38127343|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
16983632|NCT00961116|38127344|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16983633|NCT00961116|38127343|FG000|Washout Period of 7 Days|Protocol Violation|0|||
16983634|NCT00961116|38127344|FG001|Washout Period of 7 Days|Protocol Violation|1|||
16983635|NCT00912015|38127355|FG000|Overall Study|Lack of Efficacy|1|||
16983636|NCT00912015|38127356|FG001|Overall Study|Lack of Efficacy|0|||
16983637|NCT00912015|38127357|FG002|Overall Study|Lack of Efficacy|0|||
16983638|NCT00912015|38127358|FG003|Overall Study|Lack of Efficacy|0|||
16983639|NCT00912015|38127355|FG000|Overall Study|Withdrawal by Subject|8|||
16983640|NCT00912015|38127356|FG001|Overall Study|Withdrawal by Subject|8|||
16983641|NCT00912015|38127357|FG002|Overall Study|Withdrawal by Subject|3|||
16983642|NCT00912015|38127358|FG003|Overall Study|Withdrawal by Subject|0|||
16983643|NCT00912015|38127355|FG000|Overall Study|Protocol Violation|1|||
16983644|NCT00912015|38127356|FG001|Overall Study|Protocol Violation|0|||
16983645|NCT00912015|38127357|FG002|Overall Study|Protocol Violation|0|||
16983646|NCT00912015|38127358|FG003|Overall Study|Protocol Violation|1|||
16983647|NCT00912015|38127355|FG000|Overall Study|Adverse Event|6|||
16983648|NCT00912015|38127356|FG001|Overall Study|Adverse Event|0|||
16983649|NCT00912015|38127357|FG002|Overall Study|Adverse Event|0|||
16983650|NCT00912015|38127358|FG003|Overall Study|Adverse Event|1|||
16983651|NCT00960804|38127371|FG000|Overall Study|Adverse Event|1|||
16983652|NCT00960804|38127372|FG001|Overall Study|Adverse Event|0|||
16983653|NCT00960804|38127373|FG002|Overall Study|Adverse Event|0|||
16983654|NCT00960804|38127371|FG000|Overall Study|Withdrawal by Subject|1|||
16983655|NCT00960804|38127372|FG001|Overall Study|Withdrawal by Subject|0|||
16983656|NCT00960804|38127373|FG002|Overall Study|Withdrawal by Subject|0|||
16983657|NCT00960804|38127371|FG000|Overall Study|Study terminated by the sponsor|5|||
16983658|NCT00960804|38127372|FG001|Overall Study|Study terminated by the sponsor|4|||
16983659|NCT00960804|38127373|FG002|Overall Study|Study terminated by the sponsor|10|||
16983660|NCT01126580|38127384|FG000|Overall Study|Adverse Event|14|||
16983661|NCT01126580|38127385|FG001|Overall Study|Adverse Event|8|||
16983662|NCT01126580|38127386|FG002|Overall Study|Adverse Event|12|||
16983663|NCT01126580|38127384|FG000|Overall Study|Withdrawal by Subject|11|||
16983664|NCT01126580|38127385|FG001|Overall Study|Withdrawal by Subject|19|||
16983665|NCT01126580|38127386|FG002|Overall Study|Withdrawal by Subject|14|||
16983666|NCT01126580|38127384|FG000|Overall Study|Sponsor Decision|5|||
16983667|NCT01126580|38127385|FG001|Overall Study|Sponsor Decision|4|||
16983668|NCT01126580|38127386|FG002|Overall Study|Sponsor Decision|7|||
16983669|NCT01126580|38127384|FG000|Overall Study|Physician Decision|1|||
16983670|NCT01126580|38127385|FG001|Overall Study|Physician Decision|1|||
16983671|NCT01126580|38127386|FG002|Overall Study|Physician Decision|2|||
16983672|NCT01126580|38127384|FG000|Overall Study|Entry Criteria Not Met|1|||
16983673|NCT01126580|38127385|FG001|Overall Study|Entry Criteria Not Met|1|||
16983674|NCT01126580|38127386|FG002|Overall Study|Entry Criteria Not Met|2|||
16983675|NCT01126580|38127384|FG000|Overall Study|Lack of Efficacy|2|||
16983676|NCT01126580|38127385|FG001|Overall Study|Lack of Efficacy|3|||
16983677|NCT01126580|38127386|FG002|Overall Study|Lack of Efficacy|4|||
16983678|NCT01126580|38127384|FG000|Overall Study|Protocol Violation|0|||
16983679|NCT01126580|38127385|FG001|Overall Study|Protocol Violation|1|||
16983680|NCT01126580|38127386|FG002|Overall Study|Protocol Violation|2|||
16983681|NCT01126580|38127384|FG000|Overall Study|Lost to Follow-up|15|||
16983682|NCT01126580|38127385|FG001|Overall Study|Lost to Follow-up|13|||
16983683|NCT01126580|38127386|FG002|Overall Study|Lost to Follow-up|9|||
16983684|NCT01126580|38127384|FG000|Overall Study|Treatment Non-compliance|0|||
16983685|NCT01126580|38127385|FG001|Overall Study|Treatment Non-compliance|2|||
16983686|NCT01126580|38127386|FG002|Overall Study|Treatment Non-compliance|3|||
16983687|NCT00911157|38127397|FG000|Overall Study|Adverse Event|4|||
16983688|NCT00911157|38127398|FG001|Overall Study|Adverse Event|1|||
16983689|NCT00911157|38127397|FG000|Overall Study|Withdrawal by Subject|1|||
16983690|NCT00911157|38127398|FG001|Overall Study|Withdrawal by Subject|1|||
16983691|NCT00911157|38127397|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
16983692|NCT00911157|38127398|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
16983693|NCT00911157|38127397|FG000|Overall Study|Need to treat for lung cancer|1|||
16983694|NCT00911157|38127398|FG001|Overall Study|Need to treat for lung cancer|0|||
17134219|NCT03126110|38275471|FG001|Phase 1|Safety follow-up no longer necessary|0|||
17134220|NCT03126110|38275472|FG002|Phase 1|Safety follow-up no longer necessary|0|||
17134221|NCT03126110|38275473|FG003|Phase 1|Safety follow-up no longer necessary|0|||
16983695|NCT00960570|38127404|FG000|21 Day Washout Period|Adverse Event|1|||
16983696|NCT00960570|38127404|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
16983697|NCT00960570|38127404|FG000|1 Day Period Between Dosing|Adverse Event|2|||
16983698|NCT00960570|38127404|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
16983699|NCT01126424|38127417|FG000|Overall Study|Adverse Event|0|||
16983700|NCT01126424|38127418|FG001|Overall Study|Adverse Event|0|||
16983701|NCT01126424|38127419|FG002|Overall Study|Adverse Event|0|||
16983702|NCT01126424|38127420|FG003|Overall Study|Adverse Event|0|||
16983703|NCT01126424|38127421|FG004|Overall Study|Adverse Event|1|||
16983704|NCT01126424|38127422|FG005|Overall Study|Adverse Event|0|||
16983705|NCT01126424|38127417|FG000|Overall Study|Withdrawal by Subject|0|||
16983706|NCT01126424|38127418|FG001|Overall Study|Withdrawal by Subject|0|||
16983707|NCT01126424|38127419|FG002|Overall Study|Withdrawal by Subject|1|||
16983708|NCT01126424|38127420|FG003|Overall Study|Withdrawal by Subject|3|||
16983709|NCT01126424|38127421|FG004|Overall Study|Withdrawal by Subject|1|||
16983710|NCT01126424|38127422|FG005|Overall Study|Withdrawal by Subject|0|||
16983711|NCT01126268|38127430|FG000|Overall Study|Adverse Event|1|||
16983712|NCT00879658|38127441|FG000|Overall Study|Abnormal laboratory value(s)|3|||
16983713|NCT00879658|38127442|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16983714|NCT00879658|38127443|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16983715|NCT00879658|38127444|FG003|Overall Study|Abnormal laboratory value(s)|1|||
17134222|NCT03126110|38275474|FG004|Phase 1|Safety follow-up no longer necessary|0|||
17134223|NCT03126110|38275475|FG005|Phase 1|Safety follow-up no longer necessary|0|||
17134224|NCT03126110|38275476|FG006|Phase 1|Safety follow-up no longer necessary|0|||
17134225|NCT03126110|38275477|FG007|Phase 1|Safety follow-up no longer necessary|0|||
17134226|NCT03126110|38275478|FG008|Phase 1|Safety follow-up no longer necessary|0|||
17134227|NCT03126110|38275479|FG009|Phase 1|Safety follow-up no longer necessary|0|||
16983716|NCT00879658|38127445|FG004|Overall Study|Abnormal laboratory value(s)|0|||
16983717|NCT00879658|38127446|FG005|Overall Study|Abnormal laboratory value(s)|0|||
16983718|NCT00879658|38127447|FG006|Overall Study|Abnormal laboratory value(s)|0|||
16983719|NCT00879658|38127441|FG000|Overall Study|Administrative problems|2|||
16983720|NCT00879658|38127442|FG001|Overall Study|Administrative problems|1|||
16983721|NCT00879658|38127443|FG002|Overall Study|Administrative problems|0|||
16983722|NCT00879658|38127444|FG003|Overall Study|Administrative problems|1|||
16983723|NCT00879658|38127445|FG004|Overall Study|Administrative problems|0|||
16983724|NCT00879658|38127446|FG005|Overall Study|Administrative problems|0|||
16983725|NCT00879658|38127447|FG006|Overall Study|Administrative problems|0|||
16983726|NCT00879658|38127441|FG000|Overall Study|Adverse Event|6|||
16983727|NCT00879658|38127442|FG001|Overall Study|Adverse Event|4|||
16983728|NCT00879658|38127443|FG002|Overall Study|Adverse Event|3|||
16983729|NCT00879658|38127444|FG003|Overall Study|Adverse Event|1|||
16983730|NCT00879658|38127445|FG004|Overall Study|Adverse Event|2|||
16983731|NCT00879658|38127446|FG005|Overall Study|Adverse Event|0|||
16983732|NCT00879658|38127447|FG006|Overall Study|Adverse Event|0|||
16983733|NCT00879658|38127441|FG000|Overall Study|Protocol Violation|1|||
16983734|NCT00879658|38127442|FG001|Overall Study|Protocol Violation|0|||
16983735|NCT00879658|38127443|FG002|Overall Study|Protocol Violation|0|||
16983736|NCT00879658|38127444|FG003|Overall Study|Protocol Violation|0|||
16983737|NCT00879658|38127445|FG004|Overall Study|Protocol Violation|0|||
16983738|NCT00879658|38127446|FG005|Overall Study|Protocol Violation|0|||
16983739|NCT00879658|38127447|FG006|Overall Study|Protocol Violation|0|||
16983740|NCT00879658|38127441|FG000|Overall Study|Withdrawal by Subject|3|||
16983741|NCT00879658|38127442|FG001|Overall Study|Withdrawal by Subject|0|||
17134228|NCT03126110|38275480|FG010|Phase 1|Safety follow-up no longer necessary|0|||
17134229|NCT03126110|38275481|FG011|Phase 1|Safety follow-up no longer necessary|0|||
17134230|NCT03126110|38275482|FG012|Phase 1|Safety follow-up no longer necessary|0|||
17134231|NCT03126110|38275483|FG013|Phase 1|Safety follow-up no longer necessary|0|||
17134232|NCT03126110|38275484|FG014|Phase 1|Safety follow-up no longer necessary|0|||
17134233|NCT03126110|38275485|FG015|Phase 1|Safety follow-up no longer necessary|0|||
17134234|NCT03126110|38275486|FG016|Phase 1|Safety follow-up no longer necessary|0|||
17134235|NCT03126110|38275470|FG000|Phase 1|Survival follow-up no longer necessary|0|||
17134236|NCT03126110|38275471|FG001|Phase 1|Survival follow-up no longer necessary|0|||
17134237|NCT03126110|38275472|FG002|Phase 1|Survival follow-up no longer necessary|1|||
17134238|NCT03126110|38275473|FG003|Phase 1|Survival follow-up no longer necessary|0|||
17134239|NCT03126110|38275474|FG004|Phase 1|Survival follow-up no longer necessary|0|||
17134240|NCT03126110|38275475|FG005|Phase 1|Survival follow-up no longer necessary|0|||
17134241|NCT03126110|38275476|FG006|Phase 1|Survival follow-up no longer necessary|0|||
17134242|NCT03126110|38275477|FG007|Phase 1|Survival follow-up no longer necessary|0|||
17134243|NCT03126110|38275478|FG008|Phase 1|Survival follow-up no longer necessary|0|||
17134244|NCT03126110|38275479|FG009|Phase 1|Survival follow-up no longer necessary|0|||
17134245|NCT03126110|38275480|FG010|Phase 1|Survival follow-up no longer necessary|0|||
17134246|NCT03126110|38275481|FG011|Phase 1|Survival follow-up no longer necessary|0|||
17134247|NCT03126110|38275482|FG012|Phase 1|Survival follow-up no longer necessary|0|||
17134248|NCT03126110|38275483|FG013|Phase 1|Survival follow-up no longer necessary|0|||
17134249|NCT03126110|38275484|FG014|Phase 1|Survival follow-up no longer necessary|0|||
17134250|NCT03126110|38275485|FG015|Phase 1|Survival follow-up no longer necessary|0|||
17134251|NCT03126110|38275486|FG016|Phase 1|Survival follow-up no longer necessary|0|||
17134252|NCT03126110|38275470|FG000|Phase 2|Study terminated by the sponsor|0|||
17134253|NCT03126110|38275471|FG001|Phase 2|Study terminated by the sponsor|0|||
17134254|NCT03126110|38275472|FG002|Phase 2|Study terminated by the sponsor|0|||
17134255|NCT03126110|38275473|FG003|Phase 2|Study terminated by the sponsor|0|||
17134256|NCT03126110|38275474|FG004|Phase 2|Study terminated by the sponsor|0|||
17134257|NCT03126110|38275475|FG005|Phase 2|Study terminated by the sponsor|0|||
17134258|NCT03126110|38275476|FG006|Phase 2|Study terminated by the sponsor|0|||
17134259|NCT03126110|38275477|FG007|Phase 2|Study terminated by the sponsor|0|||
17134260|NCT03126110|38275478|FG008|Phase 2|Study terminated by the sponsor|0|||
17134261|NCT03126110|38275479|FG009|Phase 2|Study terminated by the sponsor|0|||
16983742|NCT00879658|38127443|FG002|Overall Study|Withdrawal by Subject|2|||
16983743|NCT00879658|38127444|FG003|Overall Study|Withdrawal by Subject|0|||
16983744|NCT00879658|38127445|FG004|Overall Study|Withdrawal by Subject|0|||
16983745|NCT00879658|38127446|FG005|Overall Study|Withdrawal by Subject|1|||
16983746|NCT00879658|38127447|FG006|Overall Study|Withdrawal by Subject|0|||
16983747|NCT00879658|38127441|FG000|Overall Study|Lack of Efficacy|0|||
16983748|NCT00879658|38127442|FG001|Overall Study|Lack of Efficacy|0|||
16983749|NCT00879658|38127443|FG002|Overall Study|Lack of Efficacy|2|||
16983750|NCT00879658|38127444|FG003|Overall Study|Lack of Efficacy|0|||
16983751|NCT00879658|38127445|FG004|Overall Study|Lack of Efficacy|0|||
16983752|NCT00879658|38127446|FG005|Overall Study|Lack of Efficacy|0|||
16983753|NCT00879658|38127447|FG006|Overall Study|Lack of Efficacy|0|||
16983754|NCT00879658|38127441|FG000|Overall Study|misrandomized (never received study med)|0|||
16983755|NCT00879658|38127442|FG001|Overall Study|misrandomized (never received study med)|0|||
16983756|NCT00879658|38127443|FG002|Overall Study|misrandomized (never received study med)|0|||
16983757|NCT00879658|38127444|FG003|Overall Study|misrandomized (never received study med)|1|||
16983758|NCT00879658|38127445|FG004|Overall Study|misrandomized (never received study med)|0|||
16983759|NCT00879658|38127446|FG005|Overall Study|misrandomized (never received study med)|0|||
16983760|NCT00879658|38127447|FG006|Overall Study|misrandomized (never received study med)|0|||
16983761|NCT00959946|38127477|FG000|Overall Study|Adverse Event|0|||
16983762|NCT00959946|38127478|FG001|Overall Study|Adverse Event|0|||
16983763|NCT00959946|38127479|FG002|Overall Study|Adverse Event|2|||
16983764|NCT00959946|38127480|FG003|Overall Study|Adverse Event|1|||
16983765|NCT00959946|38127481|FG004|Overall Study|Adverse Event|0|||
16983766|NCT00959946|38127482|FG005|Overall Study|Adverse Event|1|||
16983767|NCT00959946|38127483|FG006|Overall Study|Adverse Event|0|||
16983768|NCT00959946|38127484|FG007|Overall Study|Adverse Event|0|||
16983769|NCT00959946|38127477|FG000|Overall Study|Death|0|||
16983770|NCT00959946|38127478|FG001|Overall Study|Death|0|||
16983771|NCT00959946|38127479|FG002|Overall Study|Death|0|||
16983772|NCT00959946|38127480|FG003|Overall Study|Death|0|||
16983773|NCT00959946|38127481|FG004|Overall Study|Death|0|||
16983774|NCT00959946|38127482|FG005|Overall Study|Death|1|||
16983775|NCT00959946|38127483|FG006|Overall Study|Death|0|||
16983776|NCT00959946|38127484|FG007|Overall Study|Death|0|||
16983777|NCT00959946|38127477|FG000|Overall Study|Disease Progression|2|||
16983778|NCT00959946|38127478|FG001|Overall Study|Disease Progression|4|||
16983779|NCT00959946|38127479|FG002|Overall Study|Disease Progression|2|||
17134262|NCT03126110|38275480|FG010|Phase 2|Study terminated by the sponsor|0|||
17134263|NCT03126110|38275481|FG011|Phase 2|Study terminated by the sponsor|0|||
16983780|NCT00959946|38127480|FG003|Overall Study|Disease Progression|4|||
16983781|NCT00959946|38127481|FG004|Overall Study|Disease Progression|4|||
16983782|NCT00959946|38127482|FG005|Overall Study|Disease Progression|6|||
16983783|NCT00959946|38127483|FG006|Overall Study|Disease Progression|2|||
16983784|NCT00959946|38127484|FG007|Overall Study|Disease Progression|2|||
16983785|NCT00959946|38127477|FG000|Overall Study|Withdrawal by Subject|0|||
16983786|NCT00959946|38127478|FG001|Overall Study|Withdrawal by Subject|0|||
16983787|NCT00959946|38127479|FG002|Overall Study|Withdrawal by Subject|0|||
16983788|NCT00959946|38127480|FG003|Overall Study|Withdrawal by Subject|0|||
16983789|NCT00959946|38127481|FG004|Overall Study|Withdrawal by Subject|0|||
16983790|NCT00959946|38127482|FG005|Overall Study|Withdrawal by Subject|1|||
16983791|NCT00959946|38127483|FG006|Overall Study|Withdrawal by Subject|0|||
16983792|NCT00959946|38127484|FG007|Overall Study|Withdrawal by Subject|0|||
16983793|NCT00911937|38127509|FG000|Overall Study|Death|1|||
16983794|NCT00911937|38127510|FG001|Overall Study|Death|0|||
16983795|NCT00911937|38127509|FG000|Overall Study|Lost to Follow-up|8|||
16983796|NCT00911937|38127510|FG001|Overall Study|Lost to Follow-up|5|||
16983797|NCT00911937|38127509|FG000|Overall Study|Withdrawal by Subject|10|||
16983798|NCT00911937|38127510|FG001|Overall Study|Withdrawal by Subject|7|||
16983799|NCT00911937|38127509|FG000|Overall Study|Withdrawn due to pregnancy|1|||
16983800|NCT00911937|38127510|FG001|Overall Study|Withdrawn due to pregnancy|0|||
16983801|NCT00911937|38127509|FG000|Overall Study|Adverse Event|11|||
16983802|NCT00911937|38127510|FG001|Overall Study|Adverse Event|25|||
16983803|NCT00911937|38127509|FG000|Overall Study|Lack of Efficacy|11|||
16983804|NCT00911937|38127510|FG001|Overall Study|Lack of Efficacy|6|||
16983805|NCT00911937|38127509|FG000|Overall Study|Did not meet inclusion criteria|9|||
16983806|NCT00911937|38127510|FG001|Overall Study|Did not meet inclusion criteria|11|||
16983807|NCT00911937|38127509|FG000|Overall Study|Protocol Violation|14|||
16983808|NCT00911937|38127510|FG001|Overall Study|Protocol Violation|23|||
16983809|NCT00911937|38127509|FG000|Overall Study|Randomized but not treated|13|||
16983810|NCT00911937|38127510|FG001|Overall Study|Randomized but not treated|13|||
16983811|NCT00911937|38127509|FG000|Overall Study|Other|9|||
16983812|NCT00911937|38127510|FG001|Overall Study|Other|5|||
16983813|NCT00880048|38127519|FG000|Overall Study|Adverse Event|2|||
16983814|NCT00880048|38127520|FG001|Overall Study|Adverse Event|3|||
16983815|NCT00880048|38127521|FG002|Overall Study|Adverse Event|5|||
16983816|NCT00880048|38127519|FG000|Overall Study|Lack of Efficacy|1|||
16983817|NCT00880048|38127520|FG001|Overall Study|Lack of Efficacy|2|||
16983818|NCT00880048|38127521|FG002|Overall Study|Lack of Efficacy|2|||
16983819|NCT00880048|38127519|FG000|Overall Study|Protocol Violation|4|||
16983820|NCT00880048|38127520|FG001|Overall Study|Protocol Violation|6|||
16983821|NCT00880048|38127521|FG002|Overall Study|Protocol Violation|5|||
16983822|NCT00880048|38127519|FG000|Overall Study|Lost to Follow-up|6|||
16983823|NCT00880048|38127520|FG001|Overall Study|Lost to Follow-up|6|||
16983824|NCT00880048|38127521|FG002|Overall Study|Lost to Follow-up|5|||
16983825|NCT00880048|38127519|FG000|Overall Study|Physician Decision|1|||
16983826|NCT00880048|38127520|FG001|Overall Study|Physician Decision|1|||
16983827|NCT00880048|38127521|FG002|Overall Study|Physician Decision|7|||
16983828|NCT00880048|38127519|FG000|Overall Study|Withdrawal by Subject|5|||
16983829|NCT00880048|38127520|FG001|Overall Study|Withdrawal by Subject|8|||
16983830|NCT00880048|38127521|FG002|Overall Study|Withdrawal by Subject|5|||
16983831|NCT00880048|38127519|FG000|Overall Study|Study closed/terminated|9|||
16983832|NCT00880048|38127520|FG001|Overall Study|Study closed/terminated|7|||
16983833|NCT00880048|38127521|FG002|Overall Study|Study closed/terminated|6|||
16983834|NCT00962208|38127531|FG000|Overall Study|Could not achieve good vision|9|||
16983835|NCT00962208|38127532|FG001|Overall Study|Could not achieve good vision|0|||
16983836|NCT00962208|38127531|FG000|Overall Study|Contraindicated to continue study|5|||
16983837|NCT00962208|38127532|FG001|Overall Study|Contraindicated to continue study|1|||
16983838|NCT00962208|38127531|FG000|Overall Study|Lost to Follow-up|0|||
16983839|NCT00962208|38127532|FG001|Overall Study|Lost to Follow-up|9|||
16983840|NCT01076543|38127544|FG000|Overall Study|Withdrawal by Subject|2|||
17134264|NCT03126110|38275482|FG012|Phase 2|Study terminated by the sponsor|0|||
17134265|NCT03126110|38275483|FG013|Phase 2|Study terminated by the sponsor|4|||
17134266|NCT03126110|38275484|FG014|Phase 2|Study terminated by the sponsor|0|||
17134267|NCT03126110|38275485|FG015|Phase 2|Study terminated by the sponsor|0|||
17134268|NCT03126110|38275486|FG016|Phase 2|Study terminated by the sponsor|0|||
17134269|NCT03126110|38275470|FG000|Phase 2|Withdrawal by Subject|0|||
17134270|NCT03126110|38275471|FG001|Phase 2|Withdrawal by Subject|0|||
17134271|NCT03126110|38275472|FG002|Phase 2|Withdrawal by Subject|0|||
16983841|NCT01076543|38127545|FG001|Overall Study|Withdrawal by Subject|0|||
16983842|NCT01076543|38127546|FG002|Overall Study|Withdrawal by Subject|0|||
16983843|NCT01076543|38127547|FG003|Overall Study|Withdrawal by Subject|0|||
16983844|NCT01076543|38127548|FG004|Overall Study|Withdrawal by Subject|0|||
16983845|NCT01076543|38127549|FG005|Overall Study|Withdrawal by Subject|0|||
16983846|NCT01072877|38127569|FG000|Overall Study|Lost to Follow-up|1|||
16983847|NCT01072877|38127570|FG001|Overall Study|Lost to Follow-up|1|||
16983848|NCT01072877|38127571|FG002|Overall Study|Lost to Follow-up|0|||
16983849|NCT01072877|38127572|FG003|Overall Study|Lost to Follow-up|2|||
16983850|NCT01072877|38127573|FG004|Overall Study|Lost to Follow-up|0|||
16983851|NCT00961896|38127590|FG000|Overall Study|Abnormal laboratory value|0|||
16983852|NCT00961896|38127591|FG001|Overall Study|Abnormal laboratory value|0|||
16983853|NCT00961896|38127592|FG002|Overall Study|Abnormal laboratory value|1|||
16983854|NCT00957528|38127606|FG000|Overall Study|Protocol Violation|0|||
16983855|NCT00957528|38127607|FG001|Overall Study|Protocol Violation|1|||
16983856|NCT00957528|38127608|FG002|Overall Study|Protocol Violation|0|||
16983857|NCT00957528|38127606|FG000|Overall Study|Withdrawal by Subject|0|||
16983858|NCT00957528|38127607|FG001|Overall Study|Withdrawal by Subject|0|||
16983859|NCT00957528|38127608|FG002|Overall Study|Withdrawal by Subject|1|||
16983860|NCT00958776|38127618|FG000|Overall Study|Adverse Event|0|||
16983861|NCT00958776|38127619|FG001|Overall Study|Adverse Event|1|||
16983862|NCT00958776|38127618|FG000|Overall Study|Physician Decision|1|||
16983863|NCT00958776|38127619|FG001|Overall Study|Physician Decision|0|||
16983864|NCT00958776|38127618|FG000|Overall Study|Lost to Follow-up|2|||
16983865|NCT00958776|38127619|FG001|Overall Study|Lost to Follow-up|6|||
16983866|NCT00958776|38127618|FG000|Overall Study|Withdrawal by Subject|7|||
16983867|NCT00958776|38127619|FG001|Overall Study|Withdrawal by Subject|16|||
16983868|NCT00958776|38127618|FG000|Overall Study|Protocol Violation|1|||
16983869|NCT00958776|38127619|FG001|Overall Study|Protocol Violation|1|||
16983870|NCT00958776|38127618|FG000|Overall Study|Death|2|||
16983871|NCT00958776|38127619|FG001|Overall Study|Death|1|||
16983872|NCT00958776|38127618|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
16983873|NCT00958776|38127619|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
16983874|NCT00958776|38127618|FG000|Overall Study|Missing|1|||
16983875|NCT00958776|38127619|FG001|Overall Study|Missing|1|||
16983876|NCT00596830|38127628|FG000|Overall Study|Death|258|||
16983877|NCT00596830|38127629|FG001|Overall Study|Death|247|||
16983878|NCT00596830|38127628|FG000|Overall Study|Lost to Follow-up|7|||
16983879|NCT00596830|38127629|FG001|Overall Study|Lost to Follow-up|11|||
16983880|NCT00596830|38127628|FG000|Overall Study|Withdrawal by Subject|22|||
16983881|NCT00596830|38127629|FG001|Overall Study|Withdrawal by Subject|12|||
16983882|NCT00596830|38127628|FG000|Overall Study|Study terminated by sponsor|51|||
16983883|NCT00596830|38127629|FG001|Overall Study|Study terminated by sponsor|62|||
16983884|NCT00596830|38127628|FG000|Overall Study|Follow-up was discontinued|1|||
16983885|NCT00596830|38127629|FG001|Overall Study|Follow-up was discontinued|0|||
16983886|NCT00596830|38127628|FG000|Overall Study|Randomized but not treated|3|||
16983887|NCT00596830|38127629|FG001|Overall Study|Randomized but not treated|7|||
16983888|NCT00957372|38127638|FG000|PART I|Lost to Follow-up|0|||
16983889|NCT00957372|38127639|FG001|PART I|Lost to Follow-up|0|||
16983890|NCT00957372|38127640|FG002|PART I|Lost to Follow-up|1|||
16983891|NCT00957372|38127641|FG003|PART I|Lost to Follow-up|0|||
16983892|NCT00957372|38127638|FG000|PART II|Withdrawal by Subject|0|||
16983893|NCT00957372|38127639|FG001|PART II|Withdrawal by Subject|0|||
16983894|NCT00957372|38127640|FG002|PART II|Withdrawal by Subject|0|||
16983895|NCT00957372|38127641|FG003|PART II|Withdrawal by Subject|8|||
16983896|NCT00957372|38127638|FG000|PART II|Physician Decision|0|||
16983897|NCT00957372|38127639|FG001|PART II|Physician Decision|0|||
16983898|NCT00957372|38127640|FG002|PART II|Physician Decision|0|||
16983899|NCT00957372|38127641|FG003|PART II|Physician Decision|1|||
16983900|NCT00957372|38127638|FG000|PART II|Pregnancy|0|||
16983901|NCT00957372|38127639|FG001|PART II|Pregnancy|0|||
16983902|NCT00957372|38127640|FG002|PART II|Pregnancy|0|||
16983903|NCT00957372|38127641|FG003|PART II|Pregnancy|1|||
16983904|NCT00957372|38127638|FG000|PART II|Not Know|0|||
17134272|NCT03126110|38275473|FG003|Phase 2|Withdrawal by Subject|0|||
17134273|NCT03126110|38275474|FG004|Phase 2|Withdrawal by Subject|0|||
16983905|NCT00957372|38127639|FG001|PART II|Not Know|0|||
16983906|NCT00957372|38127640|FG002|PART II|Not Know|0|||
16983907|NCT00957372|38127641|FG003|PART II|Not Know|20|||
16983908|NCT00957372|38127638|FG000|PART II|Adverse Event|0|||
16983909|NCT00957372|38127639|FG001|PART II|Adverse Event|0|||
16983910|NCT00957372|38127640|FG002|PART II|Adverse Event|0|||
16983911|NCT00957372|38127641|FG003|PART II|Adverse Event|10|||
16983912|NCT00957372|38127638|FG000|PART II|Patient non-compliance|0|||
16983913|NCT00957372|38127639|FG001|PART II|Patient non-compliance|0|||
16983914|NCT00957372|38127640|FG002|PART II|Patient non-compliance|0|||
16983915|NCT00957372|38127641|FG003|PART II|Patient non-compliance|4|||
16983916|NCT00953160|38127657|FG000|Overall Study|Lost to Follow-up|23|||
16983917|NCT00953160|38127657|FG000|Overall Study|Withdrawal by Subject|4|||
16983918|NCT00952848|38127661|FG000|Overall Study|Withdrawal by Subject|4|||
16983919|NCT00952614|38127665|FG000|Overall Study|Death|3|||
16983920|NCT00952614|38127665|FG000|Overall Study|Lost to Follow-up|3|||
16983921|NCT00952614|38127665|FG000|Overall Study|other reason|1|||
16983922|NCT00911859|38127673|FG000|Treatment Period|Adverse Event|3|||
17134274|NCT03126110|38275475|FG005|Phase 2|Withdrawal by Subject|0|||
17134275|NCT03126110|38275476|FG006|Phase 2|Withdrawal by Subject|0|||
17134276|NCT03126110|38275477|FG007|Phase 2|Withdrawal by Subject|0|||
17134277|NCT03126110|38275478|FG008|Phase 2|Withdrawal by Subject|0|||
17134278|NCT03126110|38275479|FG009|Phase 2|Withdrawal by Subject|0|||
17134279|NCT03126110|38275480|FG010|Phase 2|Withdrawal by Subject|0|||
17134280|NCT03126110|38275481|FG011|Phase 2|Withdrawal by Subject|1|||
17134281|NCT03126110|38275482|FG012|Phase 2|Withdrawal by Subject|3|||
17134282|NCT03126110|38275483|FG013|Phase 2|Withdrawal by Subject|3|||
17134283|NCT03126110|38275484|FG014|Phase 2|Withdrawal by Subject|2|||
17134284|NCT03126110|38275485|FG015|Phase 2|Withdrawal by Subject|1|||
17134285|NCT03126110|38275486|FG016|Phase 2|Withdrawal by Subject|0|||
17134286|NCT03126110|38275470|FG000|Phase 2|Lost to Follow-up|0|||
16983923|NCT00911859|38127674|FG001|Treatment Period|Adverse Event|3|||
17134287|NCT03126110|38275471|FG001|Phase 2|Lost to Follow-up|0|||
17134288|NCT03126110|38275472|FG002|Phase 2|Lost to Follow-up|0|||
17134289|NCT03126110|38275473|FG003|Phase 2|Lost to Follow-up|0|||
17134290|NCT03126110|38275474|FG004|Phase 2|Lost to Follow-up|0|||
17134291|NCT03126110|38275475|FG005|Phase 2|Lost to Follow-up|0|||
17134292|NCT03126110|38275476|FG006|Phase 2|Lost to Follow-up|0|||
17134293|NCT03126110|38275477|FG007|Phase 2|Lost to Follow-up|0|||
17134294|NCT03126110|38275478|FG008|Phase 2|Lost to Follow-up|0|||
17134295|NCT03126110|38275479|FG009|Phase 2|Lost to Follow-up|0|||
17134296|NCT03126110|38275480|FG010|Phase 2|Lost to Follow-up|0|||
17134297|NCT03126110|38275481|FG011|Phase 2|Lost to Follow-up|1|||
16983924|NCT00911859|38127675|FG002|Treatment Period|Adverse Event|7|||
16983925|NCT00911859|38127673|FG000|Treatment Period|Death|1|||
16983926|NCT00911859|38127674|FG001|Treatment Period|Death|3|||
16983927|NCT00911859|38127675|FG002|Treatment Period|Death|5|||
17134298|NCT03126110|38275482|FG012|Phase 2|Lost to Follow-up|1|||
17134299|NCT03126110|38275483|FG013|Phase 2|Lost to Follow-up|1|||
17134300|NCT03126110|38275484|FG014|Phase 2|Lost to Follow-up|2|||
17134301|NCT03126110|38275485|FG015|Phase 2|Lost to Follow-up|0|||
17134302|NCT03126110|38275486|FG016|Phase 2|Lost to Follow-up|0|||
17134303|NCT03126110|38275470|FG000|Phase 2|Death|0|||
17134304|NCT03126110|38275471|FG001|Phase 2|Death|0|||
17134305|NCT03126110|38275472|FG002|Phase 2|Death|0|||
17134306|NCT03126110|38275473|FG003|Phase 2|Death|0|||
17134307|NCT03126110|38275474|FG004|Phase 2|Death|0|||
16780214|NCT01594749|37719308|FG001|Overall Study|Not Treated|10|||
16780215|NCT01594749|37719307|FG000|Overall Study|Lost Source Documentation|1|||
16983928|NCT00911859|38127673|FG000|Treatment Period|Lack of Efficacy|1|||
16983929|NCT00911859|38127674|FG001|Treatment Period|Lack of Efficacy|7|||
16983930|NCT00911859|38127675|FG002|Treatment Period|Lack of Efficacy|5|||
16983931|NCT00911859|38127673|FG000|Treatment Period|Physician Decision|3|||
16983932|NCT00911859|38127674|FG001|Treatment Period|Physician Decision|3|||
16983933|NCT00911859|38127675|FG002|Treatment Period|Physician Decision|3|||
16983934|NCT00911859|38127673|FG000|Treatment Period|Withdrawal by Subject|0|||
16983935|NCT00911859|38127674|FG001|Treatment Period|Withdrawal by Subject|4|||
16983936|NCT00911859|38127675|FG002|Treatment Period|Withdrawal by Subject|5|||
16983937|NCT00911859|38127673|FG000|Treatment Period|Did not receive study treatment|0|||
16983938|NCT00911859|38127674|FG001|Treatment Period|Did not receive study treatment|1|||
16983939|NCT00911859|38127675|FG002|Treatment Period|Did not receive study treatment|0|||
16983940|NCT00911859|38127673|FG000|Maintainance Period|Lack of Efficacy|0|||
16983941|NCT00911859|38127674|FG001|Maintainance Period|Lack of Efficacy|0|||
16983942|NCT00911859|38127675|FG002|Maintainance Period|Lack of Efficacy|9|||
16983943|NCT00911859|38127673|FG000|Maintainance Period|Physician Decision|0|||
16983944|NCT00911859|38127674|FG001|Maintainance Period|Physician Decision|0|||
17134308|NCT03126110|38275475|FG005|Phase 2|Death|0|||
17134309|NCT03126110|38275476|FG006|Phase 2|Death|0|||
16780216|NCT01594749|37719308|FG001|Overall Study|Lost Source Documentation|0|||
17134310|NCT03126110|38275477|FG007|Phase 2|Death|0|||
17134311|NCT03126110|38275478|FG008|Phase 2|Death|0|||
17134312|NCT03126110|38275479|FG009|Phase 2|Death|0|||
17134313|NCT03126110|38275480|FG010|Phase 2|Death|0|||
17134314|NCT03126110|38275481|FG011|Phase 2|Death|6|||
17134315|NCT03126110|38275482|FG012|Phase 2|Death|12|||
17134316|NCT03126110|38275483|FG013|Phase 2|Death|25|||
17134317|NCT03126110|38275484|FG014|Phase 2|Death|11|||
17134318|NCT03126110|38275485|FG015|Phase 2|Death|3|||
17134319|NCT03126110|38275486|FG016|Phase 2|Death|2|||
17134320|NCT03126110|38275470|FG000|Phase 2|Progressive Disease|0|||
17134321|NCT03126110|38275471|FG001|Phase 2|Progressive Disease|0|||
17134322|NCT03126110|38275472|FG002|Phase 2|Progressive Disease|0|||
17134323|NCT03126110|38275473|FG003|Phase 2|Progressive Disease|0|||
17134324|NCT03126110|38275474|FG004|Phase 2|Progressive Disease|0|||
17134325|NCT03126110|38275475|FG005|Phase 2|Progressive Disease|0|||
17134326|NCT03126110|38275476|FG006|Phase 2|Progressive Disease|0|||
17134327|NCT03126110|38275477|FG007|Phase 2|Progressive Disease|0|||
17134328|NCT03126110|38275478|FG008|Phase 2|Progressive Disease|0|||
17134329|NCT03126110|38275479|FG009|Phase 2|Progressive Disease|0|||
17134330|NCT03126110|38275480|FG010|Phase 2|Progressive Disease|0|||
17134331|NCT03126110|38275481|FG011|Phase 2|Progressive Disease|0|||
17134332|NCT03126110|38275482|FG012|Phase 2|Progressive Disease|0|||
17134333|NCT03126110|38275483|FG013|Phase 2|Progressive Disease|1|||
17134334|NCT03126110|38275484|FG014|Phase 2|Progressive Disease|0|||
17134335|NCT03126110|38275485|FG015|Phase 2|Progressive Disease|0|||
17134336|NCT03126110|38275486|FG016|Phase 2|Progressive Disease|0|||
17134337|NCT03126110|38275470|FG000|Phase 2|Started new treatment|0|||
17134338|NCT03126110|38275471|FG001|Phase 2|Started new treatment|0|||
17134339|NCT03126110|38275472|FG002|Phase 2|Started new treatment|0|||
17134340|NCT03126110|38275473|FG003|Phase 2|Started new treatment|0|||
17134341|NCT03126110|38275474|FG004|Phase 2|Started new treatment|0|||
17134342|NCT03126110|38275475|FG005|Phase 2|Started new treatment|0|||
17134343|NCT03126110|38275476|FG006|Phase 2|Started new treatment|0|||
17134344|NCT03126110|38275477|FG007|Phase 2|Started new treatment|0|||
17134345|NCT03126110|38275478|FG008|Phase 2|Started new treatment|0|||
17134346|NCT03126110|38275479|FG009|Phase 2|Started new treatment|0|||
16983945|NCT00911859|38127675|FG002|Maintainance Period|Physician Decision|9|||
16983946|NCT00911859|38127673|FG000|Maintainance Period|Withdrawal by Subject|0|||
16983947|NCT00911859|38127674|FG001|Maintainance Period|Withdrawal by Subject|0|||
16983948|NCT00911859|38127675|FG002|Maintainance Period|Withdrawal by Subject|3|||
16983949|NCT00911859|38127673|FG000|Follow-up Period|Death|5|||
16983950|NCT00911859|38127674|FG001|Follow-up Period|Death|8|||
16983951|NCT00911859|38127675|FG002|Follow-up Period|Death|10|||
16983952|NCT00911859|38127673|FG000|Follow-up Period|Lost to Follow-up|1|||
16983953|NCT00911859|38127674|FG001|Follow-up Period|Lost to Follow-up|1|||
16983954|NCT00911859|38127675|FG002|Follow-up Period|Lost to Follow-up|0|||
16983955|NCT00911859|38127673|FG000|Follow-up Period|Withdrawal by Subject|0|||
16983956|NCT00911859|38127674|FG001|Follow-up Period|Withdrawal by Subject|4|||
16983957|NCT00911859|38127675|FG002|Follow-up Period|Withdrawal by Subject|4|||
16983958|NCT00911859|38127673|FG000|Follow-up Period|Study terminated by sponsor|5|||
16983959|NCT00911859|38127674|FG001|Follow-up Period|Study terminated by sponsor|33|||
16983960|NCT00911859|38127675|FG002|Follow-up Period|Study terminated by sponsor|27|||
16983961|NCT00956592|38127685|FG000|Overall Study|Protocol Violation|1|||
16983962|NCT00956592|38127686|FG001|Overall Study|Protocol Violation|3|||
16983963|NCT00955968|38127696|FG000|Overall Study|Death|2|||
16983964|NCT00955968|38127697|FG001|Overall Study|Death|4|||
16983965|NCT00955968|38127696|FG000|Overall Study|Withdrawal by Subject|35|||
16983966|NCT00955968|38127697|FG001|Overall Study|Withdrawal by Subject|31|||
16983967|NCT00955968|38127696|FG000|Overall Study|Lost to Follow-up|45|||
16983968|NCT00955968|38127697|FG001|Overall Study|Lost to Follow-up|39|||
16983969|NCT00955968|38127696|FG000|Overall Study|Site closed|55|||
16983970|NCT00955968|38127697|FG001|Overall Study|Site closed|52|||
16983971|NCT02725593|38127708|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
16983972|NCT02725593|38127709|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
16983973|NCT02725593|38127708|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
16983974|NCT02725593|38127709|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
16983975|NCT02725593|38127708|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
16983976|NCT02725593|38127709|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
16983977|NCT02725593|38127708|FG000|Long Term Extension|Withdrawal by Subject|1|||
16983978|NCT02725593|38127709|FG001|Long Term Extension|Withdrawal by Subject|3|||
16983979|NCT00911625|38127717|FG000|Overall Study|Lost to Follow-up|7|||
16983980|NCT00911625|38127718|FG001|Overall Study|Lost to Follow-up|0|||
16983981|NCT00596752|38127726|FG000|Overall Study|Other Reason|44|||
16983982|NCT00596752|38127727|FG001|Overall Study|Other Reason|49|||
16983983|NCT00596752|38127726|FG000|Overall Study|Adverse Event|34|||
17134347|NCT03126110|38275480|FG010|Phase 2|Started new treatment|0|||
17134348|NCT03126110|38275481|FG011|Phase 2|Started new treatment|0|||
17134349|NCT03126110|38275482|FG012|Phase 2|Started new treatment|0|||
17134350|NCT03126110|38275483|FG013|Phase 2|Started new treatment|0|||
17134351|NCT03126110|38275484|FG014|Phase 2|Started new treatment|1|||
17134352|NCT03126110|38275485|FG015|Phase 2|Started new treatment|0|||
17134353|NCT03126110|38275486|FG016|Phase 2|Started new treatment|0|||
17134354|NCT00905164|38275536|FG000|Period 1|Protocol Violation|0|||
17134355|NCT00905164|38275537|FG001|Period 1|Protocol Violation|1|||
16983984|NCT00596752|38127727|FG001|Overall Study|Adverse Event|34|||
16983985|NCT00596752|38127726|FG000|Overall Study|Lost to Follow-up|22|||
16983986|NCT00596752|38127727|FG001|Overall Study|Lost to Follow-up|38|||
16983987|NCT00596752|38127726|FG000|Overall Study|Withdrawal by Subject|12|||
16983988|NCT00596752|38127727|FG001|Overall Study|Withdrawal by Subject|9|||
16983989|NCT00596752|38127726|FG000|Overall Study|Unsatisfactory Compliance|9|||
16983990|NCT00596752|38127727|FG001|Overall Study|Unsatisfactory Compliance|6|||
16983991|NCT00596752|38127726|FG000|Overall Study|Lack of Efficacy|4|||
16983992|NCT00596752|38127727|FG001|Overall Study|Lack of Efficacy|7|||
16983993|NCT00596752|38127726|FG000|Overall Study|Protocol Violation|1|||
16983994|NCT00596752|38127727|FG001|Overall Study|Protocol Violation|0|||
16983995|NCT00958074|38127735|FG000|Overall Study|Withdrawal by Subject|0|||
16983996|NCT00958074|38127736|FG001|Overall Study|Withdrawal by Subject|1|||
16983997|NCT00809965|38127745|FG000|Overall Study|Death|194|||
16983998|NCT00809965|38127746|FG001|Overall Study|Death|147|||
16983999|NCT00809965|38127747|FG002|Overall Study|Death|196|||
16984000|NCT00809965|38127745|FG000|Overall Study|Lost to Follow-up|17|||
16984001|NCT00809965|38127746|FG001|Overall Study|Lost to Follow-up|10|||
16984002|NCT00809965|38127747|FG002|Overall Study|Lost to Follow-up|18|||
16984003|NCT00809965|38127745|FG000|Overall Study|Withdrawal by Subject|405|||
16984004|NCT00809965|38127746|FG001|Overall Study|Withdrawal by Subject|448|||
16984005|NCT00809965|38127747|FG002|Overall Study|Withdrawal by Subject|441|||
16984006|NCT00809965|38127745|FG000|Overall Study|Other Reason|167|||
16984007|NCT00809965|38127746|FG001|Overall Study|Other Reason|170|||
16984008|NCT00809965|38127747|FG002|Overall Study|Other Reason|189|||
16984009|NCT00597376|38127757|FG000|Overall Study|Withdrawal by Subject|4|||
16984010|NCT00597376|38127758|FG001|Overall Study|Withdrawal by Subject|3|||
16984011|NCT00597376|38127757|FG000|Overall Study|Adverse Event|4|||
16984012|NCT00597376|38127758|FG001|Overall Study|Adverse Event|1|||
16984013|NCT02528643|38127766|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
16984014|NCT02528643|38127767|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
16984015|NCT02528643|38127766|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
16984016|NCT02528643|38127767|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
16984017|NCT02528643|38127766|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
16984018|NCT02528643|38127767|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
16984019|NCT02528643|38127766|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
17134356|NCT03181958|38275544|FG000|Overall Study|Lost to Follow-up|17|||
17134357|NCT03181958|38275545|FG001|Overall Study|Lost to Follow-up|21|||
17134358|NCT03181958|38275546|FG002|Overall Study|Lost to Follow-up|15|||
17134359|NCT03165110|38275554|FG000|Overall Study|Anroid phone software incompatibility|1|||
17134360|NCT00079781|38275561|FG000|Pre-implant Period|Withdrawal by Subject|2|||
17134361|NCT00079781|38275562|FG001|Pre-implant Period|Withdrawal by Subject|0|||
17134362|NCT00079781|38275563|FG002|Pre-implant Period|Withdrawal by Subject|0|||
17134363|NCT00079781|38275561|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
17134364|NCT00079781|38275562|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
17134365|NCT00079781|38275563|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
17134366|NCT00079781|38275561|FG000|Follow-up Period|Withdrawal by Subject|3|||
17134367|NCT00079781|38275562|FG001|Follow-up Period|Withdrawal by Subject|0|||
17134368|NCT00079781|38275563|FG002|Follow-up Period|Withdrawal by Subject|1|||
17134369|NCT00079781|38275561|FG000|Follow-up Period|Lost to Follow-up|1|||
17134370|NCT00079781|38275562|FG001|Follow-up Period|Lost to Follow-up|0|||
17134371|NCT00079781|38275563|FG002|Follow-up Period|Lost to Follow-up|0|||
17134372|NCT00079781|38275561|FG000|Follow-up Period|Death|0|||
17134373|NCT00079781|38275562|FG001|Follow-up Period|Death|0|||
17134374|NCT00079781|38275563|FG002|Follow-up Period|Death|1|||
17134375|NCT03176966|38275571|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
17134376|NCT03176966|38275572|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
17134377|NCT03176966|38275571|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
17134378|NCT03176966|38275572|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
17134379|NCT03176966|38275571|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
17134380|NCT03176966|38275572|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
17134381|NCT03176966|38275571|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
17134382|NCT03176966|38275572|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
17134383|NCT03176966|38275571|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
17134384|NCT03176966|38275572|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
17134385|NCT03176966|38275571|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
17134386|NCT03176966|38275572|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
17134387|NCT03176966|38275571|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
17134388|NCT03176966|38275572|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
17134389|NCT03175562|38275578|FG000|Overall Study|Adverse Event|1|||
17134390|NCT03175562|38275578|FG000|Overall Study|Lost to Follow-up|3|||
17134391|NCT03175562|38275578|FG000|Overall Study|Withdrawal by Subject|7|||
17134392|NCT03175562|38275578|FG000|Overall Study|Other (Not Specified)|5|||
17134393|NCT00079391|38275585|FG000|Overall Study|Withdrawal by Subject|1|||
17134394|NCT03209570|38275593|FG000|Overall Study|Death|1|||
16984020|NCT02528643|38127767|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
16984021|NCT02528643|38127766|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
16984022|NCT02528643|38127767|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
16984023|NCT02528643|38127766|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
16984024|NCT02528643|38127767|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
16984025|NCT02528643|38127766|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
16984026|NCT02528643|38127767|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
16984027|NCT00910689|38127805|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
16984028|NCT00910689|38127806|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
16984029|NCT00910689|38127807|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
16984030|NCT00910689|38127808|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
16984031|NCT00910689|38127805|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
16984032|NCT00910689|38127806|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
16984033|NCT00910689|38127807|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
16984034|NCT00910689|38127808|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
16984035|NCT00910689|38127805|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
16984036|NCT00910689|38127806|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
16984037|NCT00910689|38127807|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
16984038|NCT00910689|38127808|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
16984039|NCT00910689|38127805|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
16984040|NCT00910689|38127806|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
16984041|NCT00910689|38127807|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
16984042|NCT00910689|38127808|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
16984043|NCT00910689|38127805|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
16984044|NCT00910689|38127806|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
16984045|NCT00910689|38127807|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
16984046|NCT00910689|38127808|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
16984047|NCT00910689|38127805|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
16984048|NCT00910689|38127806|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
16984049|NCT00910689|38127807|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
16984050|NCT00910689|38127808|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
16984051|NCT00910689|38127805|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
16984052|NCT00910689|38127806|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
16984053|NCT00910689|38127807|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
16984054|NCT00910689|38127808|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
16984055|NCT00910689|38127805|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
16984056|NCT00910689|38127806|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
16984057|NCT00910689|38127807|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
16984058|NCT00910689|38127808|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
16984059|NCT00910689|38127805|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
16984060|NCT00910689|38127806|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
16984061|NCT00910689|38127807|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
16984062|NCT00910689|38127808|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
16984063|NCT00910689|38127805|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
16984064|NCT00910689|38127806|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
16984065|NCT00910689|38127807|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
16984066|NCT00910689|38127808|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
16984067|NCT00910689|38127805|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
16984068|NCT00910689|38127806|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
16984069|NCT00910689|38127807|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
16984070|NCT00910689|38127808|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
16984071|NCT00910689|38127805|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
16984072|NCT00910689|38127806|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
16984073|NCT00910689|38127807|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
16984074|NCT00910689|38127808|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
16984075|NCT00910689|38127805|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
16984076|NCT00910689|38127806|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
17134395|NCT03209570|38275594|FG001|Overall Study|Death|0|||
16984077|NCT00910689|38127807|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
16984078|NCT00910689|38127808|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
16984079|NCT00910689|38127805|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
16984080|NCT00910689|38127806|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
16984081|NCT00910689|38127807|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
16984082|NCT00910689|38127808|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
16984083|NCT00910689|38127805|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
17134396|NCT03209570|38275593|FG000|Overall Study|Incomplete Data|8|||
16984084|NCT00910689|38127806|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
16984085|NCT00910689|38127807|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
16984086|NCT00910689|38127808|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
16984087|NCT00910689|38127805|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
16984088|NCT00910689|38127806|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
16984089|NCT00910689|38127807|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
16984090|NCT00910689|38127808|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
16984091|NCT00910689|38127805|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
16984092|NCT00910689|38127806|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
16984093|NCT00910689|38127807|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
16984094|NCT00910689|38127808|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
16984095|NCT00910689|38127805|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
17134397|NCT03209570|38275594|FG001|Overall Study|Incomplete Data|10|||
17134398|NCT03209570|38275593|FG000|Overall Study|Protocol Violation|1|||
17134399|NCT03209570|38275594|FG001|Overall Study|Protocol Violation|0|||
17134400|NCT03209570|38275593|FG000|Overall Study|Withdrawal by Subject|0|||
17134401|NCT03209570|38275594|FG001|Overall Study|Withdrawal by Subject|3|||
17134402|NCT03209492|38275600|FG000|Overall Study|Case Report Forms Uncollected|5|||
17134403|NCT03208244|38275604|FG000|Overall Study|Death|1|||
17134404|NCT03175172|38275608|FG000|Overall Study|Death|3|||
16984096|NCT00910689|38127806|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
16984097|NCT00910689|38127807|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
16984098|NCT00910689|38127808|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
16984099|NCT00910689|38127805|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
16984100|NCT00910689|38127806|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
16984101|NCT00910689|38127807|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
17134405|NCT03175172|38275608|FG000|Overall Study|Withdrawal by Subject|3|||
17134406|NCT03175172|38275608|FG000|Overall Study|Lost to Follow-up|1|||
17134407|NCT03175172|38275608|FG000|Overall Study|Study Terminated by Sponsor|3|||
17134408|NCT03172364|38275614|FG000|Overall Study|Adverse Event|1|||
17134409|NCT03172364|38275615|FG001|Overall Study|Adverse Event|1|||
17134410|NCT03172364|38275614|FG000|Overall Study|Protocol Violation|1|||
17134411|NCT03172364|38275615|FG001|Overall Study|Protocol Violation|0|||
17134412|NCT00078767|38275623|FG000|Overall Study|Withdrawal by Subject|1|||
17134413|NCT00078767|38275624|FG001|Overall Study|Withdrawal by Subject|1|||
17134414|NCT03208088|38275630|FG000|Period 2|Withdrawal by Subject|0|||
16984102|NCT00910689|38127808|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
16984103|NCT00910689|38127805|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
16984104|NCT00910689|38127806|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
16984105|NCT00910689|38127807|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
16984106|NCT00910689|38127808|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
16984107|NCT00910689|38127805|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
16984108|NCT00910689|38127806|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
16984109|NCT00910689|38127807|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
16984110|NCT00910689|38127808|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
16984111|NCT00807001|38127823|FG000|Overall Study|Non-compliance|0|||
16984112|NCT00807001|38127824|FG001|Overall Study|Non-compliance|1|||
16984113|NCT00807001|38127825|FG002|Overall Study|Non-compliance|0|||
16984114|NCT00807001|38127826|FG003|Overall Study|Non-compliance|0|||
16984115|NCT00807001|38127827|FG004|Overall Study|Non-compliance|0|||
16984116|NCT00809341|38127841|FG000|Overall Study|Physician Decision|0|||
16984117|NCT00809341|38127842|FG001|Overall Study|Physician Decision|1|||
16984118|NCT01125800|38127853|FG000|Phase I|Protocol Violation|0|||
16984119|NCT01125800|38127854|FG001|Phase I|Protocol Violation|3|||
16984120|NCT01125800|38127855|FG002|Phase I|Protocol Violation|1|||
16984121|NCT01125800|38127856|FG003|Phase I|Protocol Violation|1|||
16984122|NCT01125800|38127857|FG004|Phase I|Protocol Violation|0|||
16984123|NCT01125800|38127853|FG000|Phase I|Adverse Event|2|||
16984124|NCT01125800|38127854|FG001|Phase I|Adverse Event|2|||
16984125|NCT01125800|38127855|FG002|Phase I|Adverse Event|1|||
16984126|NCT01125800|38127856|FG003|Phase I|Adverse Event|7|||
16984127|NCT01125800|38127857|FG004|Phase I|Adverse Event|0|||
16984128|NCT01125800|38127853|FG000|Phase I|Administrative problems|1|||
16984129|NCT01125800|38127854|FG001|Phase I|Administrative problems|0|||
16984130|NCT01125800|38127855|FG002|Phase I|Administrative problems|0|||
16984131|NCT01125800|38127856|FG003|Phase I|Administrative problems|0|||
16984132|NCT01125800|38127857|FG004|Phase I|Administrative problems|0|||
16984133|NCT01125800|38127853|FG000|Phase I|Withdrawal by Subject|0|||
16984134|NCT01125800|38127854|FG001|Phase I|Withdrawal by Subject|0|||
16984135|NCT01125800|38127855|FG002|Phase I|Withdrawal by Subject|1|||
16984136|NCT01125800|38127856|FG003|Phase I|Withdrawal by Subject|0|||
16984137|NCT01125800|38127857|FG004|Phase I|Withdrawal by Subject|0|||
17134415|NCT03208088|38275631|FG001|Period 2|Withdrawal by Subject|0|||
17134416|NCT03208088|38275632|FG002|Period 2|Withdrawal by Subject|0|||
17134417|NCT03208088|38275633|FG003|Period 2|Withdrawal by Subject|0|||
16984138|NCT01125800|38127853|FG000|Phase I|Disease progression|5|||
16984139|NCT01125800|38127854|FG001|Phase I|Disease progression|4|||
16984140|NCT01125800|38127855|FG002|Phase I|Disease progression|1|||
16984141|NCT01125800|38127856|FG003|Phase I|Disease progression|3|||
16984142|NCT01125800|38127857|FG004|Phase I|Disease progression|0|||
17134418|NCT03208088|38275634|FG004|Period 2|Withdrawal by Subject|0|||
17134419|NCT03208088|38275635|FG005|Period 2|Withdrawal by Subject|0|||
17134420|NCT03208088|38275636|FG006|Period 2|Withdrawal by Subject|0|||
17134421|NCT03208088|38275637|FG007|Period 2|Withdrawal by Subject|0|||
17134422|NCT03208088|38275638|FG008|Period 2|Withdrawal by Subject|1|||
17134423|NCT03208088|38275639|FG009|Period 2|Withdrawal by Subject|0|||
17134424|NCT03208088|38275630|FG000|Period 3|Unsatisfactory Test Article|0|||
17134425|NCT03208088|38275631|FG001|Period 3|Unsatisfactory Test Article|0|||
17134426|NCT03208088|38275632|FG002|Period 3|Unsatisfactory Test Article|0|||
17134427|NCT03208088|38275633|FG003|Period 3|Unsatisfactory Test Article|1|||
17134428|NCT03208088|38275634|FG004|Period 3|Unsatisfactory Test Article|0|||
17134429|NCT03208088|38275635|FG005|Period 3|Unsatisfactory Test Article|0|||
17134430|NCT03208088|38275636|FG006|Period 3|Unsatisfactory Test Article|0|||
17134431|NCT03208088|38275637|FG007|Period 3|Unsatisfactory Test Article|0|||
17134432|NCT03208088|38275638|FG008|Period 3|Unsatisfactory Test Article|0|||
17134433|NCT03208088|38275639|FG009|Period 3|Unsatisfactory Test Article|0|||
17134434|NCT03208088|38275630|FG000|Period 4|Unsatisfactory Test Article|0|||
17134435|NCT03208088|38275631|FG001|Period 4|Unsatisfactory Test Article|0|||
17134436|NCT03208088|38275632|FG002|Period 4|Unsatisfactory Test Article|0|||
17134437|NCT03208088|38275633|FG003|Period 4|Unsatisfactory Test Article|1|||
17134438|NCT03208088|38275634|FG004|Period 4|Unsatisfactory Test Article|0|||
17134439|NCT03208088|38275635|FG005|Period 4|Unsatisfactory Test Article|0|||
17134440|NCT03208088|38275636|FG006|Period 4|Unsatisfactory Test Article|0|||
17134441|NCT03208088|38275637|FG007|Period 4|Unsatisfactory Test Article|0|||
17134442|NCT03208088|38275638|FG008|Period 4|Unsatisfactory Test Article|0|||
17134443|NCT03208088|38275639|FG009|Period 4|Unsatisfactory Test Article|0|||
17134444|NCT00078377|38275654|FG000|Overall Study|Adverse Event|2|||
17134445|NCT00078377|38275655|FG001|Overall Study|Adverse Event|5|||
17134446|NCT00078377|38275656|FG002|Overall Study|Adverse Event|1|||
17134447|NCT00078377|38275654|FG000|Overall Study|Lack of Efficacy|2|||
17134448|NCT00078377|38275655|FG001|Overall Study|Lack of Efficacy|0|||
17134449|NCT00078377|38275656|FG002|Overall Study|Lack of Efficacy|2|||
17134450|NCT00078377|38275654|FG000|Overall Study|Lost to Follow-up|0|||
17134451|NCT00078377|38275655|FG001|Overall Study|Lost to Follow-up|1|||
17134452|NCT00078377|38275656|FG002|Overall Study|Lost to Follow-up|1|||
17134453|NCT00078377|38275654|FG000|Overall Study|Physician Decision|2|||
16984143|NCT01125800|38127853|FG000|Phase II|Protocol Violation|0|||
16984144|NCT01125800|38127854|FG001|Phase II|Protocol Violation|0|||
16984145|NCT01125800|38127855|FG002|Phase II|Protocol Violation|0|||
16984146|NCT01125800|38127856|FG003|Phase II|Protocol Violation|0|||
16984147|NCT01125800|38127857|FG004|Phase II|Protocol Violation|1|||
16984148|NCT01125800|38127853|FG000|Phase II|Adverse Event|0|||
16984149|NCT01125800|38127854|FG001|Phase II|Adverse Event|0|||
16984150|NCT01125800|38127855|FG002|Phase II|Adverse Event|0|||
16984151|NCT01125800|38127856|FG003|Phase II|Adverse Event|0|||
16984152|NCT01125800|38127857|FG004|Phase II|Adverse Event|2|||
16984153|NCT01125800|38127853|FG000|Phase II|Disease progression|0|||
16984154|NCT01125800|38127854|FG001|Phase II|Disease progression|0|||
16984155|NCT01125800|38127855|FG002|Phase II|Disease progression|0|||
16984156|NCT01125800|38127856|FG003|Phase II|Disease progression|1|||
16984157|NCT01125800|38127857|FG004|Phase II|Disease progression|8|||
17134454|NCT00078377|38275655|FG001|Overall Study|Physician Decision|0|||
17134455|NCT00078377|38275656|FG002|Overall Study|Physician Decision|0|||
17134456|NCT00078377|38275654|FG000|Overall Study|Withdrawal by Subject|3|||
17134457|NCT00078377|38275655|FG001|Overall Study|Withdrawal by Subject|4|||
17134458|NCT00078377|38275656|FG002|Overall Study|Withdrawal by Subject|4|||
17134459|NCT00078377|38275654|FG000|Overall Study|Miscellaneous|2|||
16984158|NCT01125722|38127874|FG000|Overall Study|Withdrawal by Subject|2|||
16984159|NCT01125722|38127875|FG001|Overall Study|Withdrawal by Subject|1|||
16984160|NCT01125722|38127874|FG000|Overall Study|Lost to Follow-up|1|||
16984161|NCT01125722|38127875|FG001|Overall Study|Lost to Follow-up|0|||
16984162|NCT00811135|38127881|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
16984163|NCT00811135|38127881|FG000|Overall Study|Death|3|||
16984164|NCT00811135|38127881|FG000|Overall Study|Protocol Violation|2|||
16984165|NCT00811135|38127881|FG000|Overall Study|Violation of Selection Criteria|1|||
16984166|NCT00811135|38127881|FG000|Overall Study|Refused Treatment|1|||
16984167|NCT00811135|38127881|FG000|Overall Study|Withdrawal by Subject|3|||
16984168|NCT00811135|38127881|FG000|Overall Study|Administrative/Other Unspecified|11|||
16984169|NCT00811135|38127881|FG000|Overall Study|Ongoing|59|||
16984170|NCT00811057|38127888|FG000|Overall Study|Protocol Violation|5|||
16984171|NCT00811057|38127889|FG001|Overall Study|Protocol Violation|10|||
16984172|NCT00811057|38127890|FG002|Overall Study|Protocol Violation|10|||
17134460|NCT00078377|38275655|FG001|Overall Study|Miscellaneous|6|||
16984173|NCT00879970|38127901|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
17134461|NCT00078377|38275656|FG002|Overall Study|Miscellaneous|1|||
16984174|NCT00879970|38127902|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
16984175|NCT00879970|38127903|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
16984176|NCT00879970|38127904|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
16984177|NCT00879970|38127905|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
16984178|NCT00879970|38127901|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
16984179|NCT00879970|38127902|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
16984180|NCT00879970|38127903|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
16984181|NCT00879970|38127904|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
16984182|NCT00879970|38127905|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
16984183|NCT00879970|38127901|FG000|Period 1 TZD Randomization|Death|2|||
16984184|NCT00879970|38127902|FG001|Period 1 TZD Randomization|Death|1|||
16984185|NCT00879970|38127903|FG002|Period 1 TZD Randomization|Death|0|||
16984186|NCT00879970|38127904|FG003|Period 1 TZD Randomization|Death|0|||
16984187|NCT00879970|38127905|FG004|Period 1 TZD Randomization|Death|0|||
16984188|NCT00879970|38127901|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
16984189|NCT00879970|38127902|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
16984190|NCT00879970|38127903|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
16984191|NCT00879970|38127904|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
16984192|NCT00879970|38127905|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
16984193|NCT00879970|38127901|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
16984194|NCT00879970|38127902|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
16984195|NCT00879970|38127903|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
16984196|NCT00879970|38127904|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
16984197|NCT00879970|38127905|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
16984198|NCT00879970|38127901|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
16984199|NCT00879970|38127902|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
16984200|NCT00879970|38127903|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
16984201|NCT00879970|38127904|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
16984202|NCT00879970|38127905|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
16984203|NCT00879970|38127901|FG000|Period 2 Vitamin D Randomization|Death|0|||
16984204|NCT00879970|38127902|FG001|Period 2 Vitamin D Randomization|Death|0|||
16984205|NCT00879970|38127903|FG002|Period 2 Vitamin D Randomization|Death|0|||
16984206|NCT00879970|38127904|FG003|Period 2 Vitamin D Randomization|Death|2|||
16984207|NCT00879970|38127905|FG004|Period 2 Vitamin D Randomization|Death|0|||
16984208|NCT00808639|38127923|FG000|Overall Study|Disease progression before surgery.|1|||
16984209|NCT00810901|38127929|FG000|Overall Study|Lost to Follow-up|88|||
16984210|NCT00810901|38127930|FG001|Overall Study|Lost to Follow-up|58|||
16984211|NCT00910299|38127938|FG000|Overall Study|Withdrawal by Subject|16|||
16984212|NCT00910299|38127939|FG001|Overall Study|Withdrawal by Subject|13|||
16984213|NCT00910299|38127938|FG000|Overall Study|Sponsor Decision|58|||
16984214|NCT00910299|38127939|FG001|Overall Study|Sponsor Decision|60|||
16984215|NCT00910299|38127938|FG000|Overall Study|Didn't receive any study drug|2|||
16984216|NCT00910299|38127939|FG001|Overall Study|Didn't receive any study drug|1|||
16984217|NCT00595504|38127947|FG000|Overall Study|Withdrawal by Subject|1|||
16984218|NCT00595504|38127948|FG001|Overall Study|Withdrawal by Subject|3|||
16984219|NCT00595504|38127947|FG000|Overall Study|Physician Decision|1|||
16984220|NCT00595504|38127948|FG001|Overall Study|Physician Decision|0|||
16984221|NCT00808483|38127956|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
16984222|NCT00808483|38127957|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
16984223|NCT00808483|38127956|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
16984224|NCT00808483|38127957|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
16984225|NCT00808483|38127956|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
16984226|NCT00808483|38127957|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
16984227|NCT00810511|38127972|FG000|Overall Study|Protocol Violation|0|||
16984228|NCT00810511|38127973|FG001|Overall Study|Protocol Violation|1|||
16984229|NCT00810511|38127972|FG000|Overall Study|Lack of Efficacy|9|||
16984230|NCT00810511|38127973|FG001|Overall Study|Lack of Efficacy|1|||
16984231|NCT00810511|38127972|FG000|Overall Study|death in the family|0|||
16984232|NCT00810511|38127973|FG001|Overall Study|death in the family|1|||
16984233|NCT00810511|38127972|FG000|Overall Study|Lost to Follow-up|1|||
16984234|NCT00810511|38127973|FG001|Overall Study|Lost to Follow-up|0|||
16984235|NCT00810511|38127972|FG000|Overall Study|deposits on contact lens|0|||
16984236|NCT00810511|38127973|FG001|Overall Study|deposits on contact lens|1|||
16984237|NCT00596362|38127979|FG000|Overall Study|Progressive Disease|1|||
16984238|NCT00907803|38127986|FG000|Overall Study|Withdrawal of consent - long commute|1|||
16984239|NCT00907803|38127987|FG001|Overall Study|Withdrawal of consent - long commute|0|||
16984240|NCT00907803|38127988|FG002|Overall Study|Withdrawal of consent - long commute|0|||
16984241|NCT00907803|38127986|FG000|Overall Study|Adverse Event|2|||
16984242|NCT00907803|38127987|FG001|Overall Study|Adverse Event|0|||
16984243|NCT00907803|38127988|FG002|Overall Study|Adverse Event|0|||
16984244|NCT00907803|38127986|FG000|Overall Study|Withdrawal by Subject|0|||
16984245|NCT00907803|38127987|FG001|Overall Study|Withdrawal by Subject|1|||
16984246|NCT00907803|38127988|FG002|Overall Study|Withdrawal by Subject|0|||
16984247|NCT00907803|38127986|FG000|Overall Study|Lost to Follow-up|0|||
16984248|NCT00907803|38127987|FG001|Overall Study|Lost to Follow-up|1|||
16984249|NCT00907803|38127988|FG002|Overall Study|Lost to Follow-up|0|||
16984250|NCT00907803|38127986|FG000|Overall Study|Protocol Violation|0|||
16984251|NCT00907803|38127987|FG001|Overall Study|Protocol Violation|1|||
16984252|NCT00907803|38127988|FG002|Overall Study|Protocol Violation|0|||
16984253|NCT00808249|38128000|FG000|Overall Study|Adverse Event|4|||
16984254|NCT00808249|38128001|FG001|Overall Study|Adverse Event|7|||
16984255|NCT00808249|38128002|FG002|Overall Study|Adverse Event|10|||
16984256|NCT00808249|38128003|FG003|Overall Study|Adverse Event|6|||
16984257|NCT00808249|38128000|FG000|Overall Study|Lost to Follow-up|2|||
16984258|NCT00808249|38128001|FG001|Overall Study|Lost to Follow-up|3|||
16984259|NCT00808249|38128002|FG002|Overall Study|Lost to Follow-up|3|||
16984260|NCT00808249|38128003|FG003|Overall Study|Lost to Follow-up|5|||
16984261|NCT00808249|38128000|FG000|Overall Study|Withdrawal by Subject|4|||
16984262|NCT00808249|38128001|FG001|Overall Study|Withdrawal by Subject|0|||
16984263|NCT00808249|38128002|FG002|Overall Study|Withdrawal by Subject|2|||
16984264|NCT00808249|38128003|FG003|Overall Study|Withdrawal by Subject|4|||
16984265|NCT00808249|38128000|FG000|Overall Study|Protocol Violation|3|||
16984266|NCT00808249|38128001|FG001|Overall Study|Protocol Violation|3|||
16984267|NCT00808249|38128002|FG002|Overall Study|Protocol Violation|3|||
16984268|NCT00808249|38128003|FG003|Overall Study|Protocol Violation|0|||
16984269|NCT00808249|38128000|FG000|Overall Study|Lack of Efficacy|1|||
16984270|NCT00808249|38128001|FG001|Overall Study|Lack of Efficacy|1|||
16984271|NCT00808249|38128002|FG002|Overall Study|Lack of Efficacy|0|||
16984272|NCT00808249|38128003|FG003|Overall Study|Lack of Efficacy|0|||
16984273|NCT00808249|38128000|FG000|Overall Study|study specific discontinuation criteria|1|||
16984274|NCT00808249|38128001|FG001|Overall Study|study specific discontinuation criteria|0|||
16984275|NCT00808249|38128002|FG002|Overall Study|study specific discontinuation criteria|1|||
16984276|NCT00808249|38128003|FG003|Overall Study|study specific discontinuation criteria|0|||
16984277|NCT00808249|38128000|FG000|Overall Study|All other reasons|2|||
16984278|NCT00808249|38128001|FG001|Overall Study|All other reasons|1|||
17134462|NCT00886600|38275669|FG000|Double-blind Monotherapy|Adverse Event|1|||
17134463|NCT00886600|38275670|FG001|Double-blind Monotherapy|Adverse Event|1|||
17134464|NCT00886600|38275671|FG002|Double-blind Monotherapy|Adverse Event|1|||
17134465|NCT00886600|38275672|FG003|Double-blind Monotherapy|Adverse Event|1|||
17134466|NCT00886600|38275669|FG000|Double-blind Monotherapy|Protocol Violation|0|||
17134467|NCT00886600|38275670|FG001|Double-blind Monotherapy|Protocol Violation|0|||
17134468|NCT00886600|38275671|FG002|Double-blind Monotherapy|Protocol Violation|0|||
17134469|NCT00886600|38275672|FG003|Double-blind Monotherapy|Protocol Violation|1|||
17134470|NCT00886600|38275669|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
17134471|NCT00886600|38275670|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
17134472|NCT00886600|38275671|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
17134473|NCT00886600|38275672|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
17134474|NCT00886600|38275669|FG000|Combination Therapy Period|Adverse Event|0|||
17134475|NCT00886600|38275670|FG001|Combination Therapy Period|Adverse Event|0|||
17134476|NCT00886600|38275671|FG002|Combination Therapy Period|Adverse Event|1|||
17134477|NCT00886600|38275672|FG003|Combination Therapy Period|Adverse Event|0|||
17134478|NCT00886600|38275669|FG000|Combination Therapy Period|Protocol Violation|0|||
17134479|NCT00886600|38275670|FG001|Combination Therapy Period|Protocol Violation|0|||
17134480|NCT00886600|38275671|FG002|Combination Therapy Period|Protocol Violation|1|||
17134481|NCT00886600|38275672|FG003|Combination Therapy Period|Protocol Violation|0|||
17134482|NCT03172130|38275680|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
17134483|NCT03172130|38275681|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
16984279|NCT00808249|38128002|FG002|Overall Study|All other reasons|3|||
16984280|NCT00808249|38128003|FG003|Overall Study|All other reasons|1|||
16984281|NCT00908895|38128015|FG000|Overall Study|Lost to Follow-up|1|||
16984282|NCT00908895|38128016|FG001|Overall Study|Lost to Follow-up|3|||
16984283|NCT00908895|38128015|FG000|Overall Study|algodystrophy|2|||
16984284|NCT00908895|38128016|FG001|Overall Study|algodystrophy|2|||
16984285|NCT00908895|38128015|FG000|Overall Study|Adverse Event|1|||
16984286|NCT00908895|38128016|FG001|Overall Study|Adverse Event|1|||
16984287|NCT00591253|38128025|FG000|Overall Study|Adverse Event|3|||
16984288|NCT00591253|38128026|FG001|Overall Study|Adverse Event|3|||
16984289|NCT00591253|38128027|FG002|Overall Study|Adverse Event|1|||
16984290|NCT00591253|38128025|FG000|Overall Study|Protocol Violation|2|||
16984291|NCT00591253|38128026|FG001|Overall Study|Protocol Violation|2|||
16984292|NCT00591253|38128027|FG002|Overall Study|Protocol Violation|2|||
16984293|NCT00591253|38128025|FG000|Overall Study|Lost to Follow-up|2|||
16984294|NCT00591253|38128026|FG001|Overall Study|Lost to Follow-up|4|||
16984295|NCT00591253|38128027|FG002|Overall Study|Lost to Follow-up|0|||
16984296|NCT00591253|38128025|FG000|Overall Study|Withdrawal by Subject|1|||
16984297|NCT00591253|38128026|FG001|Overall Study|Withdrawal by Subject|7|||
16984298|NCT00591253|38128027|FG002|Overall Study|Withdrawal by Subject|6|||
16984299|NCT00591253|38128025|FG000|Overall Study|Lack of Efficacy|1|||
16984300|NCT00591253|38128026|FG001|Overall Study|Lack of Efficacy|0|||
16984301|NCT00591253|38128027|FG002|Overall Study|Lack of Efficacy|3|||
16984302|NCT00591253|38128025|FG000|Overall Study|Other|5|||
16984303|NCT00591253|38128026|FG001|Overall Study|Other|5|||
16984304|NCT00591253|38128027|FG002|Overall Study|Other|3|||
16984305|NCT00908583|38128035|FG000|Phase 1|Withdrawal by Subject|1|||
16984306|NCT00908583|38128035|FG000|Phase 1|Adverse Event|4|||
16984307|NCT00908583|38128035|FG000|Phase 2|Physician Decision|1|||
16984308|NCT00908583|38128035|FG000|Phase 2|Adverse Event|1|||
16984309|NCT00908583|38128035|FG000|Phase 3|Adverse Event|2|||
17134484|NCT00870688|38275697|FG000|Overall Study|Lost to Follow-up|2|||
17134485|NCT00870688|38275697|FG000|Overall Study|Death, Unrelated|1|||
17134486|NCT00870688|38275697|FG000|Overall Study|Granules in the Stools|1|||
17134487|NCT00869128|38275700|FG000|Overall Study|lack of Compliance|6|||
17134488|NCT00869128|38275701|FG001|Overall Study|lack of Compliance|6|||
17134489|NCT00077675|38275707|FG000|Overall Study|Adverse Event|1|||
17134490|NCT00077675|38275708|FG001|Overall Study|Adverse Event|2|||
17134491|NCT00077675|38275707|FG000|Overall Study|Lost to Follow-up|6|||
17134492|NCT00077675|38275708|FG001|Overall Study|Lost to Follow-up|3|||
17134493|NCT00077675|38275707|FG000|Overall Study|Withdrawal by Subject|1|||
17134494|NCT00077675|38275708|FG001|Overall Study|Withdrawal by Subject|0|||
17134495|NCT00077675|38275707|FG000|Overall Study|Other|0|||
17134496|NCT00077675|38275708|FG001|Overall Study|Other|1|||
17134497|NCT00077675|38275707|FG000|Overall Study|Never received study treatment|3|||
17134498|NCT00077675|38275708|FG001|Overall Study|Never received study treatment|3|||
17134499|NCT02576444|38275725|FG000|Overall Study|Death|1|||
17134500|NCT02576444|38275726|FG001|Overall Study|Death|1|||
17134501|NCT02576444|38275727|FG002|Overall Study|Death|0|||
17134502|NCT02576444|38275728|FG003|Overall Study|Death|0|||
17134503|NCT02576444|38275725|FG000|Overall Study|Withdrawal by Subject|0|||
17134504|NCT02576444|38275726|FG001|Overall Study|Withdrawal by Subject|0|||
17134505|NCT02576444|38275727|FG002|Overall Study|Withdrawal by Subject|2|||
17134506|NCT02576444|38275728|FG003|Overall Study|Withdrawal by Subject|0|||
17134507|NCT02576444|38275725|FG000|Overall Study|Adverse Event|0|||
17134508|NCT02576444|38275726|FG001|Overall Study|Adverse Event|0|||
16984310|NCT00908583|38128035|FG000|Phase 4|Adverse Event|1|||
16984311|NCT00908583|38128035|FG000|Phase 4|Physician Decision|1|||
16984312|NCT00908583|38128035|FG000|Phase 5|Adverse Event|3|||
16984313|NCT00909363|38128056|FG000|Overall Study|Withdrawal by Subject|1|||
16984314|NCT00909363|38128057|FG001|Overall Study|Withdrawal by Subject|0|||
16984315|NCT00909363|38128058|FG002|Overall Study|Withdrawal by Subject|0|||
16984316|NCT00909363|38128056|FG000|Overall Study|Lack of Efficacy|1|||
16984317|NCT00909363|38128057|FG001|Overall Study|Lack of Efficacy|0|||
16984318|NCT00909363|38128058|FG002|Overall Study|Lack of Efficacy|0|||
16984319|NCT00810355|38128072|FG000|Overall Study|Lost to Follow-up|13|||
16984320|NCT00810355|38128073|FG001|Overall Study|Lost to Follow-up|17|||
16984321|NCT00810355|38128074|FG002|Overall Study|Lost to Follow-up|11|||
16984322|NCT00810355|38128072|FG000|Overall Study|Withdrawal by Subject|1|||
16984323|NCT00810355|38128073|FG001|Overall Study|Withdrawal by Subject|0|||
16984324|NCT00810355|38128074|FG002|Overall Study|Withdrawal by Subject|0|||
16984325|NCT00908349|38128082|FG000|Overall Study|Adverse Event|10|||
16984326|NCT00908349|38128082|FG000|Overall Study|Withdrawal by Subject|9|||
16984327|NCT00908349|38128082|FG000|Overall Study|Physician Decision|5|||
16984328|NCT00908349|38128082|FG000|Overall Study|Lost to Follow-up|5|||
16984329|NCT00908349|38128082|FG000|Overall Study|Various|6|||
16984330|NCT01125566|38128088|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
16984331|NCT01125566|38128089|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
16984332|NCT01125566|38128090|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
16984333|NCT01125566|38128088|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
16984334|NCT01125566|38128089|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
16984335|NCT01125566|38128090|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
16984336|NCT01125566|38128088|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
16984337|NCT01125566|38128089|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
17134509|NCT02576444|38275727|FG002|Overall Study|Adverse Event|1|||
17134510|NCT02576444|38275728|FG003|Overall Study|Adverse Event|0|||
17134511|NCT02576444|38275725|FG000|Overall Study|Physician Decision|0|||
17134512|NCT02576444|38275726|FG001|Overall Study|Physician Decision|0|||
17134513|NCT02576444|38275727|FG002|Overall Study|Physician Decision|1|||
17134514|NCT02576444|38275728|FG003|Overall Study|Physician Decision|0|||
17134515|NCT00850174|38275739|FG000|Washout: One Week|Withdrawal by Subject|0|||
17134516|NCT00850174|38275740|FG001|Washout: One Week|Withdrawal by Subject|2|||
17134517|NCT00850174|38275739|FG000|Second Intervention|Withdrawal by Subject|1|||
17134518|NCT00850174|38275740|FG001|Second Intervention|Withdrawal by Subject|0|||
17134519|NCT00077207|38275751|FG000|Overall Study|Adverse Event|5|||
17134520|NCT00077207|38275751|FG000|Overall Study|Lack of Efficacy|12|||
17134521|NCT00077207|38275751|FG000|Overall Study|Physician Decision|6|||
17134522|NCT00077207|38275751|FG000|Overall Study|Withdrawal by Subject|6|||
16984338|NCT01125566|38128090|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
16984339|NCT01125566|38128088|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
16984340|NCT01125566|38128089|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
16984341|NCT01125566|38128090|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
16984342|NCT01125566|38128088|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
16984343|NCT01125566|38128089|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
16984344|NCT01125566|38128090|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
16984345|NCT01125566|38128088|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
16984346|NCT01125566|38128089|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
16984347|NCT01125566|38128090|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
16984348|NCT01125566|38128088|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
16984349|NCT01125566|38128089|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
16984350|NCT01125566|38128090|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
16984351|NCT01125566|38128088|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
16984352|NCT01125566|38128089|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
16984353|NCT01125566|38128090|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
16984354|NCT01125566|38128088|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
16984355|NCT01125566|38128089|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
16984356|NCT01125566|38128090|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
16984357|NCT01125566|38128088|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
16984358|NCT01125566|38128089|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
16984359|NCT01125566|38128090|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
16984360|NCT01125566|38128088|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
16984361|NCT01125566|38128089|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
16984362|NCT01125566|38128090|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
16984363|NCT01125566|38128088|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
16984364|NCT01125566|38128089|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
16984365|NCT01125566|38128090|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
16984366|NCT00810277|38128097|FG000|Overall Study|Adverse Event|1|||
16984367|NCT00595582|38128101|FG000|Overall Study|Pilot study that PI terminated|2|||
16984368|NCT00595582|38128101|FG000|Overall Study|Lost to Follow-up|1|||
16984369|NCT00595582|38128101|FG000|Overall Study|Adverse Event|2|||
16984370|NCT00595582|38128101|FG000|Overall Study|Physician Decision|5|||
16984371|NCT00808015|38128105|FG000|Overall Study|Death|1|||
16984372|NCT00808015|38128105|FG000|Overall Study|Lack of Efficacy|58|||
16984373|NCT00808015|38128105|FG000|Overall Study|Lost to Follow-up|76|||
16984374|NCT00808015|38128105|FG000|Overall Study|Participants not willing to participate|158|||
16984375|NCT00808015|38128105|FG000|Overall Study|Adverse Event|22|||
16984376|NCT00808015|38128105|FG000|Overall Study|Other|25|||
16984377|NCT00808015|38128105|FG000|Overall Study|Enrolled but not treated|4|||
16984378|NCT00810199|38128111|FG000|Overall Study|Adverse Event|24|||
16984379|NCT00810199|38128112|FG001|Overall Study|Adverse Event|26|||
16984380|NCT00810199|38128111|FG000|Overall Study|Death|4|||
16984381|NCT00810199|38128112|FG001|Overall Study|Death|6|||
16984382|NCT00810199|38128111|FG000|Overall Study|Withdrew consent|9|||
16984383|NCT00810199|38128112|FG001|Overall Study|Withdrew consent|12|||
16984384|NCT00810199|38128111|FG000|Overall Study|Insufficient therapeutic response|5|||
16984385|NCT00810199|38128112|FG001|Overall Study|Insufficient therapeutic response|14|||
16984386|NCT00810199|38128111|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
16984387|NCT00810199|38128112|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
16984388|NCT00810199|38128111|FG000|Overall Study|Administrative/Other|5|||
16984389|NCT00810199|38128112|FG001|Overall Study|Administrative/Other|6|||
16984390|NCT00810199|38128111|FG000|Overall Study|Protocol Violation|2|||
16984391|NCT00810199|38128112|FG001|Overall Study|Protocol Violation|6|||
16984392|NCT00810199|38128111|FG000|Overall Study|Failure to return|1|||
16984393|NCT00810199|38128112|FG001|Overall Study|Failure to return|4|||
16984394|NCT00810199|38128111|FG000|Overall Study|Did not receive study drug|2|||
16984395|NCT00810199|38128112|FG001|Overall Study|Did not receive study drug|1|||
17134523|NCT00077207|38275751|FG000|Overall Study|Ineligible|1|||
17134524|NCT03206918|38275756|FG000|Overall Study|Death|11|||
16984396|NCT00877006|38128126|FG000|Treatment Period|Death|2|||
16984397|NCT00877006|38128127|FG001|Treatment Period|Death|1|||
16984398|NCT00877006|38128126|FG000|Treatment Period|Adverse Event|10|||
16984399|NCT00877006|38128127|FG001|Treatment Period|Adverse Event|3|||
16984400|NCT00877006|38128126|FG000|Treatment Period|Withdrawal by Subject|2|||
16984401|NCT00877006|38128127|FG001|Treatment Period|Withdrawal by Subject|3|||
16984402|NCT00877006|38128126|FG000|Treatment Period|Protocol Violation|1|||
16984403|NCT00877006|38128127|FG001|Treatment Period|Protocol Violation|0|||
16984404|NCT00877006|38128126|FG000|Treatment Period|Lost to Follow-up|0|||
16984405|NCT00877006|38128127|FG001|Treatment Period|Lost to Follow-up|1|||
16984406|NCT00877006|38128126|FG000|Treatment Period|Disease Progression|1|||
16984407|NCT00877006|38128127|FG001|Treatment Period|Disease Progression|2|||
16984408|NCT00877006|38128126|FG000|Treatment Period|Started New Treatment Regimen|2|||
16984409|NCT00877006|38128127|FG001|Treatment Period|Started New Treatment Regimen|5|||
16984410|NCT00877006|38128126|FG000|Treatment Period|Other|4|||
16984411|NCT00877006|38128127|FG001|Treatment Period|Other|4|||
16984412|NCT00877006|38128126|FG000|Treatment Period|Randomized but Not Treated|3|||
16984413|NCT00877006|38128127|FG001|Treatment Period|Randomized but Not Treated|8|||
16984414|NCT00877006|38128126|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
16984415|NCT00877006|38128127|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
16984416|NCT00877006|38128126|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
16984417|NCT00877006|38128127|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
16984418|NCT00877006|38128126|FG000|Long-Term Follow-up Period|Death|26|||
16984419|NCT00877006|38128127|FG001|Long-Term Follow-up Period|Death|18|||
16984420|NCT00877006|38128126|FG000|Long-Term Follow-up Period|Other|7|||
16984421|NCT00877006|38128127|FG001|Long-Term Follow-up Period|Other|9|||
16984422|NCT00876928|38128137|FG000|Overall Study|Lost to Follow-up|2|||
16984423|NCT00876928|38128138|FG001|Overall Study|Lost to Follow-up|5|||
16984424|NCT00876928|38128137|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
16984425|NCT00876928|38128138|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
16984426|NCT00807937|38128148|FG000|Overall Study|Adverse Event|12|||
16984427|NCT00807937|38128149|FG001|Overall Study|Adverse Event|12|||
16984428|NCT00807937|38128150|FG002|Overall Study|Adverse Event|5|||
16984429|NCT00807937|38128151|FG003|Overall Study|Adverse Event|4|||
16984430|NCT00807937|38128148|FG000|Overall Study|Protocol Violation|4|||
16984431|NCT00807937|38128149|FG001|Overall Study|Protocol Violation|5|||
16984432|NCT00807937|38128150|FG002|Overall Study|Protocol Violation|3|||
16984433|NCT00807937|38128151|FG003|Overall Study|Protocol Violation|3|||
16984434|NCT00807937|38128148|FG000|Overall Study|Withdrawal by Subject|5|||
16984435|NCT00807937|38128149|FG001|Overall Study|Withdrawal by Subject|4|||
16780217|NCT02179918|37719319|FG000|Overall Study|Death|0|||
16780218|NCT02179918|37719320|FG001|Overall Study|Death|0|||
16984436|NCT00807937|38128150|FG002|Overall Study|Withdrawal by Subject|1|||
16984437|NCT00807937|38128151|FG003|Overall Study|Withdrawal by Subject|4|||
16984438|NCT00807937|38128148|FG000|Overall Study|Lost to Follow-up|4|||
16984439|NCT00807937|38128149|FG001|Overall Study|Lost to Follow-up|0|||
16984440|NCT00807937|38128150|FG002|Overall Study|Lost to Follow-up|2|||
16984441|NCT00807937|38128151|FG003|Overall Study|Lost to Follow-up|1|||
16984442|NCT00807937|38128148|FG000|Overall Study|Lack of Efficacy|0|||
16984443|NCT00807937|38128149|FG001|Overall Study|Lack of Efficacy|0|||
16984444|NCT00807937|38128150|FG002|Overall Study|Lack of Efficacy|1|||
16984445|NCT00807937|38128151|FG003|Overall Study|Lack of Efficacy|2|||
16984446|NCT00807937|38128148|FG000|Overall Study|Intake of prohibited medicine|0|||
16984447|NCT00807937|38128149|FG001|Overall Study|Intake of prohibited medicine|0|||
16984448|NCT00807937|38128150|FG002|Overall Study|Intake of prohibited medicine|2|||
16984449|NCT00807937|38128151|FG003|Overall Study|Intake of prohibited medicine|0|||
16984450|NCT00807937|38128148|FG000|Overall Study|All other reasons (not provided)|2|||
16780219|NCT02179918|37719321|FG002|Overall Study|Death|0|||
16984451|NCT00807937|38128149|FG001|Overall Study|All other reasons (not provided)|4|||
16984452|NCT00807937|38128150|FG002|Overall Study|All other reasons (not provided)|0|||
16984453|NCT00807937|38128151|FG003|Overall Study|All other reasons (not provided)|1|||
16984454|NCT00906945|38128166|FG000|Overall Study|Found to be not eligible|0|||
16984455|NCT00906945|38128167|FG001|Overall Study|Found to be not eligible|0|||
16984456|NCT00906945|38128168|FG002|Overall Study|Found to be not eligible|0|||
16984457|NCT00906945|38128169|FG003|Overall Study|Found to be not eligible|1|||
16984458|NCT00906945|38128170|FG004|Overall Study|Found to be not eligible|1|||
16984459|NCT00906945|38128171|FG005|Overall Study|Found to be not eligible|1|||
16984460|NCT00906945|38128166|FG000|Overall Study|Physician Decision|0|||
16984461|NCT00906945|38128167|FG001|Overall Study|Physician Decision|0|||
16984462|NCT00906945|38128168|FG002|Overall Study|Physician Decision|0|||
16984463|NCT00906945|38128169|FG003|Overall Study|Physician Decision|0|||
16984464|NCT00906945|38128170|FG004|Overall Study|Physician Decision|0|||
16984465|NCT00906945|38128171|FG005|Overall Study|Physician Decision|1|||
16984466|NCT00807235|38128189|FG000|Overall Study|Adverse Event|1|||
16984467|NCT00807235|38128190|FG001|Overall Study|Adverse Event|0|||
16984468|NCT00876694|38128198|FG000|Overall Study|Adverse Event|10|||
16984469|NCT00876694|38128199|FG001|Overall Study|Adverse Event|7|||
16984470|NCT00876694|38128198|FG000|Overall Study|Subject withdrew consent|6|||
16984471|NCT00876694|38128199|FG001|Overall Study|Subject withdrew consent|4|||
16984472|NCT00876694|38128198|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16984473|NCT00876694|38128199|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16984474|NCT00876694|38128198|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16984475|NCT00876694|38128199|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16984476|NCT00876694|38128198|FG000|Overall Study|Administrative problems|1|||
16984477|NCT00876694|38128199|FG001|Overall Study|Administrative problems|1|||
16984478|NCT00876694|38128198|FG000|Overall Study|Death|1|||
16984479|NCT00876694|38128199|FG001|Overall Study|Death|0|||
16984480|NCT00805441|38128207|FG000|Overall Study|Adverse Event|5|||
16984481|NCT00805441|38128208|FG001|Overall Study|Adverse Event|2|||
16984482|NCT00805441|38128207|FG000|Overall Study|Lack of Efficacy|0|||
16984483|NCT00805441|38128208|FG001|Overall Study|Lack of Efficacy|2|||
16984484|NCT00805441|38128207|FG000|Overall Study|Protocol Violation|4|||
16984485|NCT00805441|38128208|FG001|Overall Study|Protocol Violation|8|||
16984486|NCT00805441|38128207|FG000|Overall Study|Lost to Follow-up|10|||
16984487|NCT00805441|38128208|FG001|Overall Study|Lost to Follow-up|13|||
16984488|NCT00805441|38128207|FG000|Overall Study|Withdrawal by Subject|15|||
16984489|NCT00805441|38128208|FG001|Overall Study|Withdrawal by Subject|9|||
16984490|NCT00805441|38128207|FG000|Overall Study|Physician Decision|0|||
16984491|NCT00805441|38128208|FG001|Overall Study|Physician Decision|1|||
16984492|NCT00805441|38128207|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
16984493|NCT00805441|38128208|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
16984494|NCT00590317|38128216|FG000|Overall Study|Lack of Efficacy|1|||
16984495|NCT00590317|38128217|FG001|Overall Study|Lack of Efficacy|5|||
16984496|NCT01139762|38128226|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
16984497|NCT01139762|38128227|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
16984498|NCT01139762|38128228|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
16984499|NCT01139762|38128226|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
16984500|NCT01139762|38128227|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
16984501|NCT01139762|38128228|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
16984502|NCT01139762|38128226|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
16984503|NCT01139762|38128227|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
16984504|NCT01139762|38128228|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
16984505|NCT01139762|38128226|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
16984506|NCT01139762|38128227|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
16984507|NCT01139762|38128228|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
16984508|NCT01139762|38128226|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
16984509|NCT01139762|38128227|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
16984510|NCT01139762|38128228|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
16984511|NCT01139762|38128226|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
16984512|NCT01139762|38128227|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
16984513|NCT01139762|38128228|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
16984514|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
16984515|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
16984516|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
16984517|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Death|0|||
16984518|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Death|1|||
16984519|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Death|1|||
16984520|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
16780220|NCT02179918|37719322|FG003|Overall Study|Death|1|||
16780221|NCT02179918|37719323|FG004|Overall Study|Death|0|||
16780222|NCT02179918|37719319|FG000|Overall Study|Lost to Follow-up|0|||
16984521|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
16984522|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
16984523|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
16984524|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
16984525|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
16984526|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
16984527|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
16984528|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
16984529|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
16984530|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
16984531|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
16984532|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
16984533|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
17134525|NCT03206918|38275756|FG000|Overall Study|Withdrawal by Subject|5|||
17134526|NCT03206918|38275756|FG000|Overall Study|Study terminated by sponsor|12|||
16984534|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
16984535|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
16984536|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
16984537|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
16984538|NCT01139762|38128226|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
16780223|NCT02179918|37719320|FG001|Overall Study|Lost to Follow-up|0|||
16984539|NCT01139762|38128227|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
16984540|NCT01139762|38128228|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
16984541|NCT00805285|38128235|FG000|Overall Study|Lack of Efficacy|1|||
16984542|NCT01139450|38128242|FG000|Overall Study|Withdrawal by Subject|7|||
16984543|NCT01139450|38128243|FG001|Overall Study|Withdrawal by Subject|10|||
16984544|NCT01139450|38128244|FG002|Overall Study|Withdrawal by Subject|13|||
16984545|NCT01139450|38128242|FG000|Overall Study|Lack of Efficacy|3|||
16984546|NCT01139450|38128243|FG001|Overall Study|Lack of Efficacy|1|||
16984547|NCT01139450|38128244|FG002|Overall Study|Lack of Efficacy|8|||
16984548|NCT01139450|38128242|FG000|Overall Study|Protocol Violation|6|||
16984549|NCT01139450|38128243|FG001|Overall Study|Protocol Violation|5|||
16984550|NCT01139450|38128244|FG002|Overall Study|Protocol Violation|2|||
16984551|NCT01139450|38128242|FG000|Overall Study|Lost to Follow-up|9|||
16984552|NCT01139450|38128243|FG001|Overall Study|Lost to Follow-up|7|||
16984553|NCT01139450|38128244|FG002|Overall Study|Lost to Follow-up|11|||
16984554|NCT01139450|38128242|FG000|Overall Study|Administrative|0|||
16984555|NCT01139450|38128243|FG001|Overall Study|Administrative|0|||
16984556|NCT01139450|38128244|FG002|Overall Study|Administrative|1|||
16984557|NCT01139450|38128242|FG000|Overall Study|Adverse Event|2|||
16984558|NCT01139450|38128243|FG001|Overall Study|Adverse Event|2|||
16984559|NCT01139450|38128244|FG002|Overall Study|Adverse Event|3|||
16984560|NCT00805207|38128261|FG000|Overall Study|Protocol Violation|0|||
16984561|NCT00805207|38128262|FG001|Overall Study|Protocol Violation|0|||
16984562|NCT00805207|38128263|FG002|Overall Study|Protocol Violation|1|||
16984563|NCT00805207|38128264|FG003|Overall Study|Protocol Violation|0|||
16984564|NCT00805207|38128265|FG004|Overall Study|Protocol Violation|0|||
16984565|NCT00805207|38128266|FG005|Overall Study|Protocol Violation|0|||
16984566|NCT00805207|38128267|FG006|Overall Study|Protocol Violation|0|||
16984567|NCT00805207|38128268|FG007|Overall Study|Protocol Violation|0|||
16984568|NCT00805207|38128269|FG008|Overall Study|Protocol Violation|0|||
16984569|NCT00805207|38128261|FG000|Overall Study|Physician Decision|0|||
16984570|NCT00805207|38128262|FG001|Overall Study|Physician Decision|1|||
16984571|NCT00805207|38128263|FG002|Overall Study|Physician Decision|0|||
16984572|NCT00805207|38128264|FG003|Overall Study|Physician Decision|0|||
16984573|NCT00805207|38128265|FG004|Overall Study|Physician Decision|0|||
16984574|NCT00805207|38128266|FG005|Overall Study|Physician Decision|1|||
16984575|NCT00805207|38128267|FG006|Overall Study|Physician Decision|0|||
16984576|NCT00805207|38128268|FG007|Overall Study|Physician Decision|0|||
16984577|NCT00805207|38128269|FG008|Overall Study|Physician Decision|0|||
16984578|NCT00805207|38128261|FG000|Overall Study|Withdrawal by Subject|0|||
16984579|NCT00805207|38128262|FG001|Overall Study|Withdrawal by Subject|1|||
16984580|NCT00805207|38128263|FG002|Overall Study|Withdrawal by Subject|0|||
16984581|NCT00805207|38128264|FG003|Overall Study|Withdrawal by Subject|0|||
16984582|NCT00805207|38128265|FG004|Overall Study|Withdrawal by Subject|1|||
16984583|NCT00805207|38128266|FG005|Overall Study|Withdrawal by Subject|2|||
16984584|NCT00805207|38128267|FG006|Overall Study|Withdrawal by Subject|0|||
16984585|NCT00805207|38128268|FG007|Overall Study|Withdrawal by Subject|0|||
16984586|NCT00805207|38128269|FG008|Overall Study|Withdrawal by Subject|0|||
16984587|NCT00805675|38128296|FG000|Overall Study|Adverse Event|0|||
16984588|NCT00805675|38128297|FG001|Overall Study|Adverse Event|0|||
16984589|NCT00805675|38128298|FG002|Overall Study|Adverse Event|1|||
16984590|NCT00589303|38128312|FG000|Overall Study|Withdrawal by Subject|2|||
16984591|NCT00589303|38128313|FG001|Overall Study|Withdrawal by Subject|1|||
16984592|NCT00952380|38128324|FG000|Overall Study|Other|0|||
16984593|NCT00952380|38128325|FG001|Overall Study|Other|0|||
16984594|NCT00952380|38128326|FG002|Overall Study|Other|0|||
16984595|NCT00952380|38128327|FG003|Overall Study|Other|0|||
16984596|NCT00952380|38128328|FG004|Overall Study|Other|1|||
16984597|NCT00952380|38128324|FG000|Overall Study|Withdrawal by Subject|0|||
16984598|NCT00952380|38128325|FG001|Overall Study|Withdrawal by Subject|0|||
16984599|NCT00952380|38128326|FG002|Overall Study|Withdrawal by Subject|1|||
16984600|NCT00952380|38128327|FG003|Overall Study|Withdrawal by Subject|0|||
17134527|NCT03206918|38275756|FG000|Overall Study|Lost to Follow-up|3|||
17134528|NCT03206918|38275756|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
17134529|NCT03206216|38275763|FG000|Overall Study|Withdrawal by Subject|0|||
17134530|NCT03206216|38275764|FG001|Overall Study|Withdrawal by Subject|1|||
17134531|NCT03169244|38275772|FG000|Overall Study|Lost to Follow-up|1|||
17134532|NCT03169244|38275773|FG001|Overall Study|Lost to Follow-up|2|||
17134533|NCT03169244|38275772|FG000|Overall Study|Adverse Event|1|||
17134534|NCT03169244|38275773|FG001|Overall Study|Adverse Event|0|||
17134535|NCT03169244|38275772|FG000|Overall Study|Withdrawal by Subject|2|||
17134536|NCT03169244|38275773|FG001|Overall Study|Withdrawal by Subject|2|||
17134537|NCT03169244|38275772|FG000|Overall Study|Physician Decision|1|||
16780224|NCT02179918|37719321|FG002|Overall Study|Lost to Follow-up|1|||
16780225|NCT02179918|37719322|FG003|Overall Study|Lost to Follow-up|0|||
16984601|NCT00952380|38128328|FG004|Overall Study|Withdrawal by Subject|2|||
16984602|NCT00952380|38128324|FG000|Overall Study|Adverse Event|0|||
16984603|NCT00952380|38128325|FG001|Overall Study|Adverse Event|1|||
16984604|NCT00952380|38128326|FG002|Overall Study|Adverse Event|0|||
16984605|NCT00952380|38128327|FG003|Overall Study|Adverse Event|0|||
16984606|NCT00952380|38128328|FG004|Overall Study|Adverse Event|3|||
16984607|NCT00952380|38128324|FG000|Overall Study|Physician Decision|0|||
16984608|NCT00952380|38128325|FG001|Overall Study|Physician Decision|0|||
16984609|NCT00952380|38128326|FG002|Overall Study|Physician Decision|1|||
16984610|NCT00952380|38128327|FG003|Overall Study|Physician Decision|2|||
16984611|NCT00952380|38128328|FG004|Overall Study|Physician Decision|0|||
16984612|NCT00952380|38128324|FG000|Overall Study|Non-compliant to protocol|0|||
16984613|NCT00952380|38128325|FG001|Overall Study|Non-compliant to protocol|0|||
16984614|NCT00952380|38128326|FG002|Overall Study|Non-compliant to protocol|0|||
16984615|NCT00952380|38128327|FG003|Overall Study|Non-compliant to protocol|1|||
16984616|NCT00952380|38128328|FG004|Overall Study|Non-compliant to protocol|0|||
16984617|NCT00803179|38128345|FG000|Overall Study|Lost to Follow-up|3|||
16984618|NCT00804193|38128352|FG000|Overall Study|Lack of baseline fungus|32|||
16984619|NCT00804193|38128353|FG001|Overall Study|Lack of baseline fungus|31|||
16984620|NCT00804193|38128354|FG002|Overall Study|Lack of baseline fungus|19|||
16984621|NCT00804193|38128352|FG000|Overall Study|Adverse Event|0|||
16984622|NCT00804193|38128353|FG001|Overall Study|Adverse Event|0|||
16984623|NCT00804193|38128354|FG002|Overall Study|Adverse Event|2|||
16984624|NCT00804193|38128352|FG000|Overall Study|Lack of Efficacy|1|||
16984625|NCT00804193|38128353|FG001|Overall Study|Lack of Efficacy|1|||
16984626|NCT00804193|38128354|FG002|Overall Study|Lack of Efficacy|3|||
16984627|NCT00804193|38128352|FG000|Overall Study|Protocol Violation|0|||
16984628|NCT00804193|38128353|FG001|Overall Study|Protocol Violation|8|||
16984629|NCT00804193|38128354|FG002|Overall Study|Protocol Violation|2|||
16984630|NCT00804193|38128352|FG000|Overall Study|Lost to Follow-up|3|||
16984631|NCT00804193|38128353|FG001|Overall Study|Lost to Follow-up|3|||
16984632|NCT00804193|38128354|FG002|Overall Study|Lost to Follow-up|4|||
16984633|NCT00804193|38128352|FG000|Overall Study|Withdrawal by Subject|3|||
16984634|NCT00804193|38128353|FG001|Overall Study|Withdrawal by Subject|1|||
16780226|NCT02179918|37719323|FG004|Overall Study|Lost to Follow-up|0|||
16984635|NCT00804193|38128354|FG002|Overall Study|Withdrawal by Subject|2|||
16984636|NCT00957996|38128364|FG000|Overall Study|Death|4|||
16984637|NCT00957996|38128365|FG001|Overall Study|Death|10|||
16984638|NCT00957996|38128364|FG000|Overall Study|Lost to Follow-up|4|||
16984639|NCT00957996|38128365|FG001|Overall Study|Lost to Follow-up|7|||
16984640|NCT00957996|38128364|FG000|Overall Study|Withdrawal by Subject|9|||
16984641|NCT00957996|38128365|FG001|Overall Study|Withdrawal by Subject|2|||
16984642|NCT00957996|38128364|FG000|Overall Study|Adverse Event|2|||
16984643|NCT00957996|38128365|FG001|Overall Study|Adverse Event|1|||
16984644|NCT00957996|38128364|FG000|Overall Study|Physician Decision|1|||
16984645|NCT00957996|38128365|FG001|Overall Study|Physician Decision|1|||
16984646|NCT00957996|38128364|FG000|Overall Study|Influenza-related complication|0|||
16984647|NCT00957996|38128365|FG001|Overall Study|Influenza-related complication|1|||
16984648|NCT00957996|38128364|FG000|Overall Study|Missing|1|||
16984649|NCT00957996|38128365|FG001|Overall Study|Missing|0|||
16984650|NCT00957996|38128364|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
16984651|NCT00957996|38128365|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
16984652|NCT00589693|38128375|FG000|Overall Study|randomized in error|12|||
16984653|NCT00589693|38128376|FG001|Overall Study|randomized in error|6|||
16984654|NCT00589693|38128375|FG000|Overall Study|Adverse Event|4|||
16984655|NCT00589693|38128376|FG001|Overall Study|Adverse Event|4|||
17134538|NCT03169244|38275773|FG001|Overall Study|Physician Decision|0|||
16984656|NCT00589693|38128375|FG000|Overall Study|Death|26|||
16984657|NCT00589693|38128376|FG001|Overall Study|Death|16|||
16984658|NCT00589693|38128375|FG000|Overall Study|Lack of Efficacy|0|||
16984659|NCT00589693|38128376|FG001|Overall Study|Lack of Efficacy|1|||
16984660|NCT00589693|38128375|FG000|Overall Study|Lost to Follow-up|1|||
16984661|NCT00589693|38128376|FG001|Overall Study|Lost to Follow-up|0|||
16984662|NCT00589693|38128375|FG000|Overall Study|Physician Decision|0|||
16984663|NCT00589693|38128376|FG001|Overall Study|Physician Decision|1|||
16984664|NCT00589693|38128375|FG000|Overall Study|Protocol Violation|1|||
16984665|NCT00589693|38128376|FG001|Overall Study|Protocol Violation|1|||
16984666|NCT00803101|38128384|FG000|Overall Study|Death / Serious Adverse Event|4|||
16984667|NCT00803101|38128385|FG001|Overall Study|Death / Serious Adverse Event|6|||
17134539|NCT02486042|38275781|FG000|Overall Study|Physician Decision|1|||
17134540|NCT02486042|38275782|FG001|Overall Study|Physician Decision|7|||
17134541|NCT02486042|38275781|FG000|Overall Study|Hospital transfer|2|||
17134542|NCT02486042|38275782|FG001|Overall Study|Hospital transfer|2|||
17134543|NCT02486042|38275781|FG000|Overall Study|Withdrawal by Subject|0|||
17134544|NCT02486042|38275782|FG001|Overall Study|Withdrawal by Subject|2|||
17134545|NCT00057941|38275790|FG000|Overall Study|Death|1|||
17134546|NCT00057941|38275791|FG001|Overall Study|Death|2|||
17134547|NCT00057941|38275790|FG000|Overall Study|Adverse Event|7|||
17134548|NCT00057941|38275791|FG001|Overall Study|Adverse Event|9|||
16984668|NCT00803101|38128384|FG000|Overall Study|Withdrawal by Subject|6|||
16984669|NCT00803101|38128385|FG001|Overall Study|Withdrawal by Subject|4|||
16984670|NCT00803101|38128384|FG000|Overall Study|Lost to Follow-up|2|||
16984671|NCT00803101|38128385|FG001|Overall Study|Lost to Follow-up|2|||
16984672|NCT00803101|38128384|FG000|Overall Study|Protocol Violation|1|||
16984673|NCT00803101|38128385|FG001|Overall Study|Protocol Violation|7|||
16984674|NCT00803101|38128384|FG000|Overall Study|Surgery finished outside protocol window|1|||
16984675|NCT00803101|38128385|FG001|Overall Study|Surgery finished outside protocol window|1|||
16984676|NCT00803101|38128384|FG000|Overall Study|Patient died outside SAE report period|1|||
16984677|NCT00803101|38128385|FG001|Overall Study|Patient died outside SAE report period|0|||
16984678|NCT00803101|38128384|FG000|Overall Study|Patient did not attend scheduled visit|2|||
16984679|NCT00803101|38128385|FG001|Overall Study|Patient did not attend scheduled visit|1|||
16984680|NCT00803101|38128384|FG000|Overall Study|Patient did not have surgery|1|||
16984681|NCT00803101|38128385|FG001|Overall Study|Patient did not have surgery|1|||
16984682|NCT00801229|38128393|FG000|Signed Consent|Withdrawal by Subject|2|||
16984683|NCT00801229|38128394|FG001|Signed Consent|Withdrawal by Subject|2|||
16984684|NCT00801229|38128393|FG000|Signed Consent|Found Ineligible|1|||
16984685|NCT00801229|38128394|FG001|Signed Consent|Found Ineligible|1|||
16984686|NCT00801229|38128393|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
17134549|NCT00057941|38275790|FG000|Overall Study|Lack of Efficacy|54|||
17134550|NCT00057941|38275791|FG001|Overall Study|Lack of Efficacy|53|||
17134551|NCT00057941|38275790|FG000|Overall Study|Withdrawal by Subject|6|||
17134552|NCT00057941|38275791|FG001|Overall Study|Withdrawal by Subject|1|||
17134553|NCT00057941|38275790|FG000|Overall Study|still on treatment|3|||
17134554|NCT00057941|38275791|FG001|Overall Study|still on treatment|1|||
17134555|NCT00057941|38275790|FG000|Overall Study|insurance, symptomatic deterioration|1|||
17134556|NCT00057941|38275791|FG001|Overall Study|insurance, symptomatic deterioration|3|||
17134557|NCT00057941|38275790|FG000|Overall Study|Ineligible|2|||
17134558|NCT00057941|38275791|FG001|Overall Study|Ineligible|5|||
17134559|NCT00075881|38275806|FG000|Overall Study|Lack of Efficacy|18|||
17134560|NCT00075881|38275806|FG000|Overall Study|Adverse Event|7|||
16984687|NCT00801229|38128394|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
16984688|NCT00801229|38128393|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
16984689|NCT00801229|38128394|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
16984690|NCT00801229|38128393|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
16984691|NCT00801229|38128394|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
16984692|NCT00801229|38128393|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
16984693|NCT00801229|38128394|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
16984694|NCT00801229|38128393|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
16984695|NCT00801229|38128394|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
16984696|NCT00801229|38128393|FG000|Received Study Drug/Placebo|Adverse Event|1|||
16984697|NCT00801229|38128394|FG001|Received Study Drug/Placebo|Adverse Event|1|||
16984698|NCT01964430|38128402|FG000|Overall Study|Adverse Event|71|||
16984699|NCT01964430|38128403|FG001|Overall Study|Adverse Event|37|||
16984700|NCT01964430|38128402|FG000|Overall Study|Withdrawal by Subject|36|||
16984701|NCT01964430|38128403|FG001|Overall Study|Withdrawal by Subject|27|||
16984702|NCT01964430|38128402|FG000|Overall Study|Death|1|||
16984703|NCT01964430|38128403|FG001|Overall Study|Death|3|||
16984704|NCT01964430|38128402|FG000|Overall Study|Protocol Deviation|0|||
16984705|NCT01964430|38128403|FG001|Overall Study|Protocol Deviation|1|||
17134561|NCT00075881|38275806|FG000|Overall Study|Death|1|||
17134562|NCT00075881|38275806|FG000|Overall Study|Withdrawal by Subject|2|||
17134563|NCT00075881|38275806|FG000|Overall Study|Protocol Violation|4|||
17134564|NCT00075881|38275806|FG000|Overall Study|other complicating disease|3|||
17134565|NCT00075881|38275806|FG000|Overall Study|other|4|||
16984706|NCT01964430|38128402|FG000|Overall Study|Physician Decision|5|||
16984707|NCT01964430|38128403|FG001|Overall Study|Physician Decision|4|||
16984708|NCT01964430|38128402|FG000|Overall Study|Disease Relapse|28|||
16984709|NCT01964430|38128403|FG001|Overall Study|Disease Relapse|38|||
16984710|NCT01964430|38128402|FG000|Overall Study|Miscellaneous|1|||
16984711|NCT01964430|38128403|FG001|Overall Study|Miscellaneous|3|||
16984712|NCT01964430|38128402|FG000|Overall Study|Randomized but not Treated|3|||
16984713|NCT01964430|38128403|FG001|Overall Study|Randomized but not Treated|11|||
16984714|NCT00948246|38128409|FG000|Overall Study|Lost to Follow-up|11|||
16984715|NCT00948246|38128409|FG000|Overall Study|Adverse Event|11|||
16984716|NCT00948246|38128409|FG000|Overall Study|Death|1|||
16984717|NCT00948246|38128409|FG000|Overall Study|Withdrawal by Subject|1|||
16984718|NCT00800683|38128415|FG000|Overall Study|Adverse Event|11|||
16984719|NCT00800683|38128416|FG001|Overall Study|Adverse Event|8|||
16984720|NCT00800683|38128415|FG000|Overall Study|Lost to Follow-up|3|||
16984721|NCT00800683|38128416|FG001|Overall Study|Lost to Follow-up|1|||
16984722|NCT00800683|38128415|FG000|Overall Study|Withdrawal by Subject|1|||
16984723|NCT00800683|38128416|FG001|Overall Study|Withdrawal by Subject|7|||
16984724|NCT00800683|38128415|FG000|Overall Study|Lack of Efficacy|1|||
16984725|NCT00800683|38128416|FG001|Overall Study|Lack of Efficacy|1|||
16984726|NCT00800683|38128415|FG000|Overall Study|Other|1|||
16984727|NCT00800683|38128416|FG001|Overall Study|Other|2|||
16984728|NCT01124864|38128428|FG000|Overall Study|Follow up phase competed as per protocol|18|||
16984729|NCT01124864|38128429|FG001|Overall Study|Follow up phase competed as per protocol|22|||
16984730|NCT01124864|38128430|FG002|Overall Study|Follow up phase competed as per protocol|24|||
16984731|NCT01124864|38128431|FG003|Overall Study|Follow up phase competed as per protocol|18|||
16984732|NCT01124864|38128432|FG004|Overall Study|Follow up phase competed as per protocol|26|||
16984733|NCT01124864|38128433|FG005|Overall Study|Follow up phase competed as per protocol|2|||
16984734|NCT01124864|38128428|FG000|Overall Study|Death|6|||
16984735|NCT01124864|38128429|FG001|Overall Study|Death|9|||
16984736|NCT01124864|38128430|FG002|Overall Study|Death|6|||
16984737|NCT01124864|38128431|FG003|Overall Study|Death|2|||
16984738|NCT01124864|38128432|FG004|Overall Study|Death|1|||
16984739|NCT01124864|38128433|FG005|Overall Study|Death|0|||
16984740|NCT01124864|38128428|FG000|Overall Study|Withdrawal by Subject|2|||
16984741|NCT01124864|38128429|FG001|Overall Study|Withdrawal by Subject|3|||
16984742|NCT01124864|38128430|FG002|Overall Study|Withdrawal by Subject|4|||
16984743|NCT01124864|38128431|FG003|Overall Study|Withdrawal by Subject|0|||
16984744|NCT01124864|38128432|FG004|Overall Study|Withdrawal by Subject|2|||
16984745|NCT01124864|38128433|FG005|Overall Study|Withdrawal by Subject|1|||
16984746|NCT01124864|38128428|FG000|Overall Study|Lost to Follow-up|1|||
16984747|NCT01124864|38128429|FG001|Overall Study|Lost to Follow-up|1|||
16984748|NCT01124864|38128430|FG002|Overall Study|Lost to Follow-up|0|||
16984749|NCT01124864|38128431|FG003|Overall Study|Lost to Follow-up|1|||
16984750|NCT01124864|38128432|FG004|Overall Study|Lost to Follow-up|0|||
16984751|NCT01124864|38128433|FG005|Overall Study|Lost to Follow-up|0|||
16984752|NCT01124864|38128428|FG000|Overall Study|Protocol Violation|1|||
16984753|NCT01124864|38128429|FG001|Overall Study|Protocol Violation|0|||
16984754|NCT01124864|38128430|FG002|Overall Study|Protocol Violation|0|||
16984755|NCT01124864|38128431|FG003|Overall Study|Protocol Violation|0|||
16984756|NCT01124864|38128432|FG004|Overall Study|Protocol Violation|1|||
16984757|NCT01124864|38128433|FG005|Overall Study|Protocol Violation|0|||
16984758|NCT01113710|38128449|FG000|Overall Study|Adverse Event|64|||
16984759|NCT01113710|38128449|FG000|Overall Study|Lack of Efficacy|41|||
16984760|NCT01113710|38128449|FG000|Overall Study|No Information Available|40|||
16984761|NCT01113710|38128449|FG000|Overall Study|Withdrawal by Subject|28|||
16984762|NCT01113710|38128449|FG000|Overall Study|Lost to Follow-up|20|||
16984763|NCT01113710|38128449|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
16780227|NCT02179918|37719319|FG000|Overall Study|Progressive Disease|4|||
16984764|NCT01113710|38128449|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
16984765|NCT01113710|38128449|FG000|Overall Study|Lack of Patient's Compliance|8|||
16984766|NCT01113710|38128449|FG000|Overall Study|Other|7|||
16984767|NCT01113710|38128449|FG000|Overall Study|Adverse Event/Other|5|||
16984768|NCT01113710|38128449|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
16984769|NCT01113710|38128449|FG000|Overall Study|Lack of Efficacy/Other|4|||
16984770|NCT01113710|38128449|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
16984771|NCT01113710|38128449|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
16984772|NCT01113710|38128449|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
16984773|NCT01113710|38128449|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
16984774|NCT01113710|38128449|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
16984775|NCT01113710|38128449|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
16984776|NCT01113710|38128449|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
16984777|NCT01113710|38128449|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
16984778|NCT01113710|38128449|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
16984779|NCT01113710|38128449|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
16984780|NCT01113710|38128449|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
16984781|NCT01113710|38128449|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
16984782|NCT01113710|38128449|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
16984783|NCT01124162|38128455|FG000|First Intervention|Adverse Event|2|||
16984784|NCT01124162|38128456|FG001|First Intervention|Adverse Event|0|||
16984785|NCT01124162|38128455|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
17134566|NCT00075881|38275806|FG000|Overall Study|missing data|2|||
16984786|NCT01124162|38128456|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16984787|NCT00906399|38128465|FG000|Year 1|Randomized But Not Treated|0|||
16984788|NCT00906399|38128466|FG001|Year 1|Randomized But Not Treated|1|||
16984789|NCT00906399|38128467|FG002|Year 1|Randomized But Not Treated|3|||
16984790|NCT00906399|38128468|FG003|Year 1|Randomized But Not Treated|0|||
16984791|NCT00906399|38128469|FG004|Year 1|Randomized But Not Treated|0|||
16984792|NCT00906399|38128470|FG005|Year 1|Randomized But Not Treated|0|||
16984793|NCT00906399|38128471|FG006|Year 1|Randomized But Not Treated|0|||
16984794|NCT00906399|38128465|FG000|Year 1|Adverse Event|4|||
16984795|NCT00906399|38128466|FG001|Year 1|Adverse Event|22|||
16984796|NCT00906399|38128467|FG002|Year 1|Adverse Event|24|||
16984797|NCT00906399|38128468|FG003|Year 1|Adverse Event|0|||
16984798|NCT00906399|38128469|FG004|Year 1|Adverse Event|0|||
16984799|NCT00906399|38128470|FG005|Year 1|Adverse Event|0|||
16984800|NCT00906399|38128471|FG006|Year 1|Adverse Event|0|||
16984801|NCT00906399|38128465|FG000|Year 1|Lost to Follow-up|4|||
16984802|NCT00906399|38128466|FG001|Year 1|Lost to Follow-up|4|||
16984803|NCT00906399|38128467|FG002|Year 1|Lost to Follow-up|2|||
16984804|NCT00906399|38128468|FG003|Year 1|Lost to Follow-up|0|||
16984805|NCT00906399|38128469|FG004|Year 1|Lost to Follow-up|0|||
16984806|NCT00906399|38128470|FG005|Year 1|Lost to Follow-up|0|||
16984807|NCT00906399|38128471|FG006|Year 1|Lost to Follow-up|0|||
16984808|NCT00906399|38128465|FG000|Year 1|Withdrawal by Subject|30|||
16984809|NCT00906399|38128466|FG001|Year 1|Withdrawal by Subject|32|||
16984810|NCT00906399|38128467|FG002|Year 1|Withdrawal by Subject|36|||
16984811|NCT00906399|38128468|FG003|Year 1|Withdrawal by Subject|0|||
16984812|NCT00906399|38128469|FG004|Year 1|Withdrawal by Subject|0|||
16984813|NCT00906399|38128470|FG005|Year 1|Withdrawal by Subject|0|||
16984814|NCT00906399|38128471|FG006|Year 1|Withdrawal by Subject|0|||
16984815|NCT00906399|38128465|FG000|Year 1|Physician Decision|0|||
16984816|NCT00906399|38128466|FG001|Year 1|Physician Decision|1|||
16984817|NCT00906399|38128467|FG002|Year 1|Physician Decision|3|||
16984818|NCT00906399|38128468|FG003|Year 1|Physician Decision|0|||
16984819|NCT00906399|38128469|FG004|Year 1|Physician Decision|0|||
16984820|NCT00906399|38128470|FG005|Year 1|Physician Decision|0|||
16984821|NCT00906399|38128471|FG006|Year 1|Physician Decision|0|||
16984822|NCT00906399|38128465|FG000|Year 1|Death|2|||
17134567|NCT00075881|38275806|FG000|Overall Study|Ineligible|1|||
17134568|NCT00075881|38275806|FG000|Overall Study|never start protocol therapy|1|||
16984823|NCT00906399|38128466|FG001|Year 1|Death|1|||
16984824|NCT00906399|38128467|FG002|Year 1|Death|1|||
17134569|NCT00838630|38275814|FG000|First Intervention|Adverse Event|1|||
17134570|NCT00838630|38275815|FG001|First Intervention|Adverse Event|0|||
17134571|NCT00838630|38275814|FG000|Washout: 7 Days|Protocol Violation|1|||
17134572|NCT00838630|38275815|FG001|Washout: 7 Days|Protocol Violation|0|||
17134573|NCT02996474|38275819|FG000|Overall Study|Physician Decision|5|||
17134574|NCT03667924|38275826|FG000|Baseline Completed|Lost to Follow-up|0|||
16984825|NCT00906399|38128468|FG003|Year 1|Death|0|||
16984826|NCT00906399|38128469|FG004|Year 1|Death|0|||
16984827|NCT00906399|38128470|FG005|Year 1|Death|0|||
16984828|NCT00906399|38128471|FG006|Year 1|Death|0|||
16984829|NCT00906399|38128465|FG000|Year 1|Other|4|||
16984830|NCT00906399|38128466|FG001|Year 1|Other|2|||
16984831|NCT00906399|38128467|FG002|Year 1|Other|7|||
16984832|NCT00906399|38128468|FG003|Year 1|Other|0|||
16984833|NCT00906399|38128469|FG004|Year 1|Other|0|||
16984834|NCT00906399|38128470|FG005|Year 1|Other|0|||
16984835|NCT00906399|38128471|FG006|Year 1|Other|0|||
16984836|NCT00906399|38128465|FG000|Year 2|Adverse Event|0|||
16984837|NCT00906399|38128466|FG001|Year 2|Adverse Event|0|||
16984838|NCT00906399|38128467|FG002|Year 2|Adverse Event|0|||
17134575|NCT03667924|38275827|FG001|Baseline Completed|Lost to Follow-up|2|||
16984839|NCT00906399|38128468|FG003|Year 2|Adverse Event|9|||
16984840|NCT00906399|38128469|FG004|Year 2|Adverse Event|8|||
16984841|NCT00906399|38128470|FG005|Year 2|Adverse Event|11|||
16984842|NCT00906399|38128471|FG006|Year 2|Adverse Event|6|||
16984843|NCT00906399|38128465|FG000|Year 2|Lost to Follow-up|0|||
16984844|NCT00906399|38128466|FG001|Year 2|Lost to Follow-up|0|||
16984845|NCT00906399|38128467|FG002|Year 2|Lost to Follow-up|0|||
17134576|NCT03667924|38275828|FG002|Baseline Completed|Lost to Follow-up|0|||
16984846|NCT00906399|38128468|FG003|Year 2|Lost to Follow-up|1|||
16984847|NCT00906399|38128469|FG004|Year 2|Lost to Follow-up|4|||
16984848|NCT00906399|38128470|FG005|Year 2|Lost to Follow-up|2|||
16984849|NCT00906399|38128471|FG006|Year 2|Lost to Follow-up|4|||
16984850|NCT00906399|38128465|FG000|Year 2|Withdrawal by Subject|0|||
16984851|NCT00906399|38128466|FG001|Year 2|Withdrawal by Subject|0|||
16984852|NCT00906399|38128467|FG002|Year 2|Withdrawal by Subject|0|||
16984853|NCT00906399|38128468|FG003|Year 2|Withdrawal by Subject|17|||
17134577|NCT03667924|38275826|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
17134578|NCT03667924|38275827|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
16984854|NCT00906399|38128469|FG004|Year 2|Withdrawal by Subject|18|||
16984855|NCT00906399|38128470|FG005|Year 2|Withdrawal by Subject|27|||
16984856|NCT00906399|38128471|FG006|Year 2|Withdrawal by Subject|13|||
16984857|NCT00906399|38128465|FG000|Year 2|Physician Decision|0|||
16984858|NCT00906399|38128466|FG001|Year 2|Physician Decision|0|||
16984859|NCT00906399|38128467|FG002|Year 2|Physician Decision|0|||
16984860|NCT00906399|38128468|FG003|Year 2|Physician Decision|0|||
16984861|NCT00906399|38128469|FG004|Year 2|Physician Decision|2|||
16984862|NCT00906399|38128470|FG005|Year 2|Physician Decision|6|||
16984863|NCT00906399|38128471|FG006|Year 2|Physician Decision|3|||
16984864|NCT00906399|38128465|FG000|Year 2|Death|0|||
16984865|NCT00906399|38128466|FG001|Year 2|Death|0|||
16984866|NCT00906399|38128467|FG002|Year 2|Death|0|||
16984867|NCT00906399|38128468|FG003|Year 2|Death|1|||
16984868|NCT00906399|38128469|FG004|Year 2|Death|0|||
16984869|NCT00906399|38128470|FG005|Year 2|Death|0|||
16984870|NCT00906399|38128471|FG006|Year 2|Death|3|||
16984871|NCT00906399|38128465|FG000|Year 2|Other|0|||
16984872|NCT00906399|38128466|FG001|Year 2|Other|0|||
16984873|NCT00906399|38128467|FG002|Year 2|Other|0|||
16984874|NCT00906399|38128468|FG003|Year 2|Other|2|||
16984875|NCT00906399|38128469|FG004|Year 2|Other|3|||
16984876|NCT00906399|38128470|FG005|Year 2|Other|1|||
16984877|NCT00906399|38128471|FG006|Year 2|Other|0|||
16984878|NCT01111838|38128483|FG000|Overall Study|Patient Ineligible|2|||
16984879|NCT01111838|38128483|FG000|Overall Study|Not Treated|3|||
16984880|NCT01111838|38128483|FG000|Overall Study|Clinical deterioration|1|||
16984881|NCT01111838|38128483|FG000|Overall Study|Other Complicating Disease|1|||
16984882|NCT00947856|38128489|FG000|Treatment Period|Progressive Disease|33|||
16984883|NCT00947856|38128490|FG001|Treatment Period|Progressive Disease|12|||
16984884|NCT00947856|38128489|FG000|Treatment Period|Adverse Event|15|||
16984885|NCT00947856|38128490|FG001|Treatment Period|Adverse Event|9|||
16984886|NCT00947856|38128489|FG000|Treatment Period|Physician Decision|14|||
16984887|NCT00947856|38128490|FG001|Treatment Period|Physician Decision|6|||
16984888|NCT00947856|38128489|FG000|Treatment Period|Study Stopped by Sponsor|4|||
16984889|NCT00947856|38128490|FG001|Treatment Period|Study Stopped by Sponsor|4|||
16984890|NCT00947856|38128489|FG000|Treatment Period|Withdrawal by Subject|12|||
16984891|NCT00947856|38128490|FG001|Treatment Period|Withdrawal by Subject|1|||
16984892|NCT00947856|38128489|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
16984893|NCT00947856|38128490|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
16984894|NCT00947856|38128489|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
16984895|NCT00947856|38128490|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
16984896|NCT00947856|38128489|FG000|Follow-up Period|Lost to Follow-up|7|||
16984897|NCT00947856|38128490|FG001|Follow-up Period|Lost to Follow-up|0|||
16984898|NCT00947856|38128489|FG000|Follow-up Period|Patient unavailable for site visits|1|||
16984899|NCT00947856|38128490|FG001|Follow-up Period|Patient unavailable for site visits|0|||
16984900|NCT00947856|38128489|FG000|Follow-up Period|Withdrawal by Subject|1|||
16984901|NCT00947856|38128490|FG001|Follow-up Period|Withdrawal by Subject|0|||
16984902|NCT00947544|38128505|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
16984903|NCT00947544|38128506|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
16984904|NCT00907335|38128518|FG000|Overall Study|Withdrawal by Subject|2|||
16984905|NCT00907335|38128519|FG001|Overall Study|Withdrawal by Subject|0|||
16984906|NCT00907335|38128518|FG000|Overall Study|Adverse Event|4|||
16984907|NCT00907335|38128519|FG001|Overall Study|Adverse Event|1|||
16984908|NCT00907335|38128518|FG000|Overall Study|Lost to Follow-up|2|||
16984909|NCT00907335|38128519|FG001|Overall Study|Lost to Follow-up|0|||
16984910|NCT00947154|38128525|FG000|Overall Study|Lost to Follow-up|1|||
16984911|NCT01124006|38128533|FG000|Overall Study|Withdrawal by Subject|2|||
16984912|NCT01124006|38128534|FG001|Overall Study|Withdrawal by Subject|2|||
16984913|NCT01124006|38128535|FG002|Overall Study|Withdrawal by Subject|0|||
16984914|NCT01124006|38128533|FG000|Overall Study|Lost to Follow-up|1|||
16984915|NCT01124006|38128534|FG001|Overall Study|Lost to Follow-up|0|||
16984916|NCT01124006|38128535|FG002|Overall Study|Lost to Follow-up|1|||
16984917|NCT01124006|38128533|FG000|Overall Study|Other|0|||
16984918|NCT01124006|38128534|FG001|Overall Study|Other|0|||
16984919|NCT01124006|38128535|FG002|Overall Study|Other|1|||
16984920|NCT00952068|38128543|FG000|Overall Study|Adverse Event|3|||
16984921|NCT00952068|38128543|FG000|Overall Study|Withdrawal by Subject|4|||
16984922|NCT01123850|38128547|FG000|Overall Study|Slow enrollment|45|||
16984923|NCT01123382|38128553|FG000|Overall Study|Withdrawal by Subject|1|||
17134579|NCT03667924|38275828|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
17134580|NCT03667924|38275826|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
17134581|NCT03667924|38275827|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
17134582|NCT03667924|38275828|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
17134583|NCT03667924|38275826|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
17134584|NCT03667924|38275827|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
17134585|NCT03667924|38275828|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
17134586|NCT03667924|38275826|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
17134587|NCT03667924|38275827|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
17134588|NCT03667924|38275828|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
17134589|NCT03667924|38275826|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
17134590|NCT03667924|38275827|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
17134591|NCT03667924|38275828|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
17134592|NCT03667924|38275826|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
17134593|NCT03667924|38275827|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
17134594|NCT03667924|38275828|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
17134595|NCT03205046|38275840|FG000|Overall Study|Death|10|||
16780228|NCT02179918|37719320|FG001|Overall Study|Progressive Disease|1|||
16984924|NCT01123382|38128554|FG001|Overall Study|Withdrawal by Subject|4|||
16984925|NCT01123382|38128553|FG000|Overall Study|Lost to Follow-up|1|||
16984926|NCT01123382|38128554|FG001|Overall Study|Lost to Follow-up|2|||
16984927|NCT00951912|38128563|FG000|Overall Study|Lack of Efficacy|1|||
16984928|NCT00951912|38128564|FG001|Overall Study|Lack of Efficacy|0|||
16984929|NCT00951912|38128565|FG002|Overall Study|Lack of Efficacy|0|||
16984930|NCT00951912|38128563|FG000|Overall Study|Adverse Event|0|||
16984931|NCT00951912|38128564|FG001|Overall Study|Adverse Event|1|||
16984932|NCT00951912|38128565|FG002|Overall Study|Adverse Event|1|||
16984933|NCT00951912|38128563|FG000|Overall Study|Lost to Follow-up|2|||
16984934|NCT00951912|38128564|FG001|Overall Study|Lost to Follow-up|2|||
16984935|NCT00951912|38128565|FG002|Overall Study|Lost to Follow-up|0|||
16984936|NCT00951912|38128563|FG000|Overall Study|Physician Decision|1|||
16984937|NCT00951912|38128564|FG001|Overall Study|Physician Decision|0|||
16984938|NCT00951912|38128565|FG002|Overall Study|Physician Decision|1|||
16984939|NCT00951912|38128563|FG000|Overall Study|Withdrawal by Subject|1|||
16984940|NCT00951912|38128564|FG001|Overall Study|Withdrawal by Subject|1|||
16984941|NCT00951912|38128565|FG002|Overall Study|Withdrawal by Subject|0|||
16984942|NCT00951912|38128563|FG000|Overall Study|Other:Depression|1|||
16984943|NCT00951912|38128564|FG001|Overall Study|Other:Depression|0|||
16984944|NCT00951912|38128565|FG002|Overall Study|Other:Depression|0|||
16984945|NCT00951912|38128563|FG000|Overall Study|Other: Colon cancer|1|||
16984946|NCT00951912|38128564|FG001|Overall Study|Other: Colon cancer|0|||
16984947|NCT00951912|38128565|FG002|Overall Study|Other: Colon cancer|0|||
16984948|NCT00951912|38128563|FG000|Overall Study|Other: Stroke|0|||
16984949|NCT00951912|38128564|FG001|Overall Study|Other: Stroke|1|||
16984950|NCT00951912|38128565|FG002|Overall Study|Other: Stroke|0|||
16984951|NCT01123148|38128573|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
16984952|NCT01123148|38128573|FG000|Overall Study|Didn't meet milestone criteria|1|||
16984953|NCT01123070|38128581|FG000|Part B Double Blind Period|Protocol Violation|0|||
16984954|NCT01123070|38128582|FG001|Part B Double Blind Period|Protocol Violation|0|||
16984955|NCT01123070|38128583|FG002|Part B Double Blind Period|Protocol Violation|0|||
16984956|NCT01123070|38128584|FG003|Part B Double Blind Period|Protocol Violation|1|||
16984957|NCT01123070|38128581|FG000|Part B Double Blind Period|Adverse Event|0|||
16984958|NCT01123070|38128582|FG001|Part B Double Blind Period|Adverse Event|0|||
16984959|NCT01123070|38128583|FG002|Part B Double Blind Period|Adverse Event|2|||
16984960|NCT01123070|38128584|FG003|Part B Double Blind Period|Adverse Event|0|||
16984961|NCT01123070|38128581|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
16984962|NCT01123070|38128582|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
16984963|NCT01123070|38128583|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
16984964|NCT01123070|38128584|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
16984965|NCT01122680|38128595|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
16984966|NCT01122680|38128596|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
16984967|NCT01122680|38128597|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
16984968|NCT01122680|38128598|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
16984969|NCT01122680|38128595|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
16984970|NCT01122680|38128596|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
16984971|NCT01122680|38128597|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
16984972|NCT01122680|38128598|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
16984973|NCT01122680|38128595|FG000|Period 1 (4 Weeks)|Other|1|||
16984974|NCT01122680|38128596|FG001|Period 1 (4 Weeks)|Other|1|||
16984975|NCT01122680|38128597|FG002|Period 1 (4 Weeks)|Other|0|||
16984976|NCT01122680|38128598|FG003|Period 1 (4 Weeks)|Other|0|||
16984977|NCT01122680|38128595|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
16984978|NCT01122680|38128596|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
16984979|NCT01122680|38128597|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
16984980|NCT01122680|38128598|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
16984981|NCT01122680|38128595|FG000|Period 2 (4 Weeks)|Other|1|||
16984982|NCT01122680|38128596|FG001|Period 2 (4 Weeks)|Other|0|||
16984983|NCT01122680|38128597|FG002|Period 2 (4 Weeks)|Other|0|||
16984984|NCT01122680|38128598|FG003|Period 2 (4 Weeks)|Other|0|||
16984985|NCT01122680|38128595|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
16984986|NCT01122680|38128596|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
16984987|NCT01122680|38128597|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
16984988|NCT01122680|38128598|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
16984989|NCT01122680|38128595|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16984990|NCT01122680|38128596|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
16984991|NCT01122680|38128597|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16984992|NCT01122680|38128598|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16984993|NCT00946998|38128610|FG000|Overall Study|Exited prior to first outcome assessment|5|||
16984994|NCT00946998|38128611|FG001|Overall Study|Exited prior to first outcome assessment|3|||
16984995|NCT01138826|38128617|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
16984996|NCT01138826|38128618|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
16984997|NCT01138826|38128619|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
16984998|NCT01138826|38128620|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
16984999|NCT01138826|38128621|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
16985000|NCT01138826|38128622|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
16985001|NCT00906087|38128630|FG000|Initial Washout|Withdrawal by Subject|1|||
16985002|NCT00906087|38128630|FG000|Initial Washout|Physician Decision|1|||
16985003|NCT00907257|38128639|FG000|Overall Study|Adverse Event|0|||
16985004|NCT00907257|38128640|FG001|Overall Study|Adverse Event|4|||
16985005|NCT00907257|38128639|FG000|Overall Study|Protocol Violation|1|||
17134596|NCT03205046|38275841|FG001|Overall Study|Death|6|||
17134597|NCT03205046|38275840|FG000|Overall Study|Withdrawal by Subject|1|||
17134598|NCT03205046|38275841|FG001|Overall Study|Withdrawal by Subject|2|||
17134599|NCT03205046|38275840|FG000|Overall Study|Lost to Follow-up|0|||
17134600|NCT03205046|38275841|FG001|Overall Study|Lost to Follow-up|1|||
17134601|NCT03205046|38275840|FG000|Overall Study|Study terminated by sponsor|2|||
17134602|NCT03205046|38275841|FG001|Overall Study|Study terminated by sponsor|1|||
16985006|NCT00907257|38128640|FG001|Overall Study|Protocol Violation|2|||
16985007|NCT00907257|38128639|FG000|Overall Study|Lost to Follow-up|3|||
16985008|NCT00907257|38128640|FG001|Overall Study|Lost to Follow-up|3|||
16985009|NCT00907257|38128639|FG000|Overall Study|Withdrawal by Subject|1|||
16985010|NCT00907257|38128640|FG001|Overall Study|Withdrawal by Subject|2|||
16985011|NCT00907257|38128639|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
16985012|NCT00907257|38128640|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
16985013|NCT00907257|38128639|FG000|Overall Study|Moved|1|||
16985014|NCT00907257|38128640|FG001|Overall Study|Moved|0|||
16985015|NCT00907257|38128639|FG000|Overall Study|Personal Reasons|6|||
16985016|NCT00907257|38128640|FG001|Overall Study|Personal Reasons|1|||
16985017|NCT01138046|38128646|FG000|Overall Study|Withdrawal due to death|6|||
16985018|NCT00876460|38128658|FG000|Combination Therapy Phase|Progressive disease|2|||
16985019|NCT00876460|38128659|FG001|Combination Therapy Phase|Progressive disease|3|||
16985020|NCT00876460|38128660|FG002|Combination Therapy Phase|Progressive disease|3|||
16985021|NCT00876460|38128661|FG003|Combination Therapy Phase|Progressive disease|3|||
16985022|NCT00876460|38128662|FG004|Combination Therapy Phase|Progressive disease|3|||
16985023|NCT00876460|38128663|FG005|Combination Therapy Phase|Progressive disease|1|||
16985024|NCT00876460|38128664|FG006|Combination Therapy Phase|Progressive disease|1|||
16985025|NCT00876460|38128665|FG007|Combination Therapy Phase|Progressive disease|1|||
16985026|NCT00876460|38128658|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
17134603|NCT03204812|38275847|FG000|Overall Study|Adverse Event|3|||
17134604|NCT02339090|38275853|FG000|Overall Study|Adverse Event|1|||
16868014|NCT01536145|37841034|FG001|Overall Study|Withdrawal by Subject|0|||
16985027|NCT00876460|38128659|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
16985028|NCT00876460|38128660|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
16985029|NCT00876460|38128661|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
16985030|NCT00876460|38128662|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
16985031|NCT00876460|38128663|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
16985032|NCT00876460|38128664|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
16985033|NCT00876460|38128665|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
16985034|NCT00876460|38128658|FG000|Combination Therapy Phase|Adverse Event|0|||
16985035|NCT00876460|38128659|FG001|Combination Therapy Phase|Adverse Event|2|||
16985036|NCT00876460|38128660|FG002|Combination Therapy Phase|Adverse Event|0|||
16985037|NCT00876460|38128661|FG003|Combination Therapy Phase|Adverse Event|2|||
16985038|NCT00876460|38128662|FG004|Combination Therapy Phase|Adverse Event|2|||
16985039|NCT00876460|38128663|FG005|Combination Therapy Phase|Adverse Event|0|||
16985040|NCT00876460|38128664|FG006|Combination Therapy Phase|Adverse Event|3|||
17134605|NCT02339090|38275854|FG001|Overall Study|Adverse Event|0|||
17134606|NCT02339090|38275853|FG000|Overall Study|Lost to Follow-up|0|||
16985041|NCT00876460|38128665|FG007|Combination Therapy Phase|Adverse Event|2|||
16985042|NCT00876460|38128658|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
16985043|NCT00876460|38128659|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
16985044|NCT00876460|38128660|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
16985045|NCT00876460|38128661|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
16985046|NCT00876460|38128662|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
16985047|NCT00876460|38128663|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
16985048|NCT00876460|38128664|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
16985049|NCT00876460|38128665|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
16985050|NCT00876460|38128658|FG000|Combination Therapy Phase|Other reason not defined above|0|||
16985051|NCT00876460|38128659|FG001|Combination Therapy Phase|Other reason not defined above|0|||
16985052|NCT00876460|38128660|FG002|Combination Therapy Phase|Other reason not defined above|0|||
16985053|NCT00876460|38128661|FG003|Combination Therapy Phase|Other reason not defined above|0|||
16985054|NCT00876460|38128662|FG004|Combination Therapy Phase|Other reason not defined above|0|||
16985055|NCT00876460|38128663|FG005|Combination Therapy Phase|Other reason not defined above|0|||
16985056|NCT00876460|38128664|FG006|Combination Therapy Phase|Other reason not defined above|1|||
16985057|NCT00876460|38128665|FG007|Combination Therapy Phase|Other reason not defined above|2|||
16985058|NCT00876460|38128658|FG000|Combination Therapy Phase|Not treated|0|||
16985059|NCT00876460|38128659|FG001|Combination Therapy Phase|Not treated|0|||
16985060|NCT00876460|38128660|FG002|Combination Therapy Phase|Not treated|0|||
16985061|NCT00876460|38128661|FG003|Combination Therapy Phase|Not treated|0|||
16985062|NCT00876460|38128662|FG004|Combination Therapy Phase|Not treated|0|||
16985063|NCT00876460|38128663|FG005|Combination Therapy Phase|Not treated|0|||
16985064|NCT00876460|38128664|FG006|Combination Therapy Phase|Not treated|1|||
16985065|NCT00876460|38128665|FG007|Combination Therapy Phase|Not treated|0|||
16985066|NCT00876460|38128658|FG000|Mono Therapy Phase|Progressive disease|0|||
16985067|NCT00876460|38128659|FG001|Mono Therapy Phase|Progressive disease|0|||
16985068|NCT00876460|38128660|FG002|Mono Therapy Phase|Progressive disease|0|||
16985069|NCT00876460|38128661|FG003|Mono Therapy Phase|Progressive disease|0|||
16985070|NCT00876460|38128662|FG004|Mono Therapy Phase|Progressive disease|2|||
16985071|NCT00876460|38128663|FG005|Mono Therapy Phase|Progressive disease|0|||
16985072|NCT00876460|38128664|FG006|Mono Therapy Phase|Progressive disease|1|||
16985073|NCT00876460|38128665|FG007|Mono Therapy Phase|Progressive disease|3|||
16985074|NCT00876460|38128658|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
16985075|NCT00876460|38128659|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
16985076|NCT00876460|38128660|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
16985077|NCT00876460|38128661|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
16985078|NCT00876460|38128662|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
16985079|NCT00876460|38128663|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
16985080|NCT00876460|38128664|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
16985081|NCT00876460|38128665|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
16985082|NCT00876460|38128658|FG000|Mono Therapy Phase|Adverse Event|0|||
16985083|NCT00876460|38128659|FG001|Mono Therapy Phase|Adverse Event|0|||
16985084|NCT00876460|38128660|FG002|Mono Therapy Phase|Adverse Event|0|||
16985085|NCT00876460|38128661|FG003|Mono Therapy Phase|Adverse Event|1|||
16985086|NCT00876460|38128662|FG004|Mono Therapy Phase|Adverse Event|0|||
16985087|NCT00876460|38128663|FG005|Mono Therapy Phase|Adverse Event|0|||
16985088|NCT00876460|38128664|FG006|Mono Therapy Phase|Adverse Event|0|||
16985089|NCT00876460|38128665|FG007|Mono Therapy Phase|Adverse Event|0|||
16985090|NCT00908115|38128695|FG000|Overall Study|Other|14|||
16985091|NCT01137812|38128701|FG000|Overall Study|Adverse Event|21|||
16985092|NCT01137812|38128702|FG001|Overall Study|Adverse Event|14|||
16985093|NCT01137812|38128701|FG000|Overall Study|Lost to Follow-up|6|||
16985094|NCT01137812|38128702|FG001|Overall Study|Lost to Follow-up|8|||
16985095|NCT01137812|38128701|FG000|Overall Study|Physician Decision|25|||
16985096|NCT01137812|38128702|FG001|Overall Study|Physician Decision|17|||
16985097|NCT01137812|38128701|FG000|Overall Study|Protocol Violation|5|||
16985098|NCT01137812|38128702|FG001|Overall Study|Protocol Violation|4|||
16985099|NCT01137812|38128701|FG000|Overall Study|Withdrawal by Subject|5|||
16985100|NCT01137812|38128702|FG001|Overall Study|Withdrawal by Subject|13|||
16985101|NCT01137812|38128701|FG000|Overall Study|Death|2|||
16985102|NCT01137812|38128702|FG001|Overall Study|Death|0|||
16985103|NCT01137812|38128701|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
16985104|NCT01137812|38128702|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
16985105|NCT01137812|38128701|FG000|Overall Study|Other|19|||
16985106|NCT01137812|38128702|FG001|Overall Study|Other|27|||
16985107|NCT01137578|38128708|FG000|Overall Study|Participant requested to Discontinue|3|||
16985108|NCT01137578|38128709|FG001|Overall Study|Participant requested to Discontinue|0|||
17134607|NCT02339090|38275854|FG001|Overall Study|Lost to Follow-up|1|||
17134608|NCT02339090|38275853|FG000|Overall Study|Non-compliance With Study Drug|0|||
17134609|NCT02339090|38275854|FG001|Overall Study|Non-compliance With Study Drug|1|||
17134610|NCT02339090|38275853|FG000|Overall Study|Withdrawal by Subject|2|||
17134611|NCT02339090|38275854|FG001|Overall Study|Withdrawal by Subject|1|||
17134612|NCT02339090|38275853|FG000|Overall Study|Poor Growth|3|||
17134613|NCT02339090|38275854|FG001|Overall Study|Poor Growth|0|||
17134614|NCT02339090|38275853|FG000|Overall Study|Randomized but not treated|0|||
17134615|NCT02339090|38275854|FG001|Overall Study|Randomized but not treated|2|||
17134616|NCT03524092|38275875|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
17134617|NCT03524092|38275876|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
17134618|NCT03524092|38275877|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
17134619|NCT03524092|38275878|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
17134620|NCT03524092|38275879|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
17134621|NCT03524092|38275880|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
17134622|NCT03524092|38275875|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
17134623|NCT03524092|38275876|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
17134624|NCT03524092|38275877|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
17134625|NCT03524092|38275878|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
17134626|NCT03524092|38275879|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
17134627|NCT03524092|38275880|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
17134628|NCT03524092|38275875|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
17134629|NCT03524092|38275876|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
17134630|NCT03524092|38275877|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
17134631|NCT03524092|38275878|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
17134632|NCT03524092|38275879|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
17134633|NCT03524092|38275880|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
17134634|NCT03524092|38275875|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
17134635|NCT03524092|38275876|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
17134636|NCT03524092|38275877|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
17134637|NCT03524092|38275878|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
17134638|NCT03524092|38275879|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
17134639|NCT03524092|38275880|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
17134640|NCT03524092|38275875|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
17134641|NCT03524092|38275876|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
17134642|NCT03524092|38275877|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
17134643|NCT03524092|38275878|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
17134644|NCT03524092|38275879|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
17134645|NCT03524092|38275880|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
17134646|NCT03524092|38275875|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
17134647|NCT03524092|38275876|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
17134648|NCT03524092|38275877|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
17134649|NCT03524092|38275878|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
17134650|NCT03524092|38275879|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
17134651|NCT03524092|38275880|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
17134652|NCT03524092|38275875|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
17134653|NCT03524092|38275876|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
17134654|NCT03524092|38275877|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
17134655|NCT03524092|38275878|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
17134656|NCT03524092|38275879|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
17134657|NCT03524092|38275880|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
17134658|NCT03524092|38275875|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
17134659|NCT03524092|38275876|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
17134660|NCT03524092|38275877|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
17134661|NCT03524092|38275878|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
17134662|NCT03524092|38275879|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
17134663|NCT03524092|38275880|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
17134664|NCT03524092|38275875|FG000|Loss of Response Rescue Period|Adverse Event|0|||
17134665|NCT03524092|38275876|FG001|Loss of Response Rescue Period|Adverse Event|0|||
17134666|NCT03524092|38275877|FG002|Loss of Response Rescue Period|Adverse Event|0|||
17134667|NCT03524092|38275878|FG003|Loss of Response Rescue Period|Adverse Event|2|||
17134668|NCT03524092|38275879|FG004|Loss of Response Rescue Period|Adverse Event|0|||
17134669|NCT03524092|38275880|FG005|Loss of Response Rescue Period|Adverse Event|0|||
17134670|NCT03524092|38275875|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
17134671|NCT03524092|38275876|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
17134672|NCT03524092|38275877|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
16985109|NCT01137578|38128710|FG002|Overall Study|Participant requested to Discontinue|0|||
16985110|NCT01137578|38128708|FG000|Overall Study|Withdrawal by Subject|1|||
16985111|NCT01137578|38128709|FG001|Overall Study|Withdrawal by Subject|0|||
16985112|NCT01137578|38128710|FG002|Overall Study|Withdrawal by Subject|0|||
16985113|NCT01137578|38128708|FG000|Overall Study|Other|12|||
17134673|NCT03524092|38275878|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
17134674|NCT03524092|38275879|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
16985114|NCT01137578|38128709|FG001|Overall Study|Other|2|||
16985115|NCT01137578|38128710|FG002|Overall Study|Other|6|||
16985116|NCT00946920|38128740|FG000|Overall Study|Withdrawal by Subject|28|||
16985117|NCT00946920|38128741|FG001|Overall Study|Withdrawal by Subject|15|||
16985118|NCT00946920|38128740|FG000|Overall Study|Lost to Follow-up|2|||
16985119|NCT00946920|38128741|FG001|Overall Study|Lost to Follow-up|2|||
16985120|NCT00946920|38128740|FG000|Overall Study|Physician Decision|5|||
16985121|NCT00946920|38128741|FG001|Overall Study|Physician Decision|2|||
16985122|NCT00946920|38128740|FG000|Overall Study|Adverse Event|41|||
16985123|NCT00946920|38128741|FG001|Overall Study|Adverse Event|14|||
16985124|NCT00946920|38128740|FG000|Overall Study|Protocol Violation|16|||
16985125|NCT00946920|38128741|FG001|Overall Study|Protocol Violation|8|||
16985126|NCT00946920|38128740|FG000|Overall Study|Miscellaneous reasons|18|||
16985127|NCT00946920|38128741|FG001|Overall Study|Miscellaneous reasons|3|||
16985128|NCT00946530|38128751|FG000|Overall Study|Withdrawal by Subject|0|||
16985129|NCT00946530|38128752|FG001|Overall Study|Withdrawal by Subject|3|||
16985130|NCT00946530|38128753|FG002|Overall Study|Withdrawal by Subject|0|||
16985131|NCT00946530|38128754|FG003|Overall Study|Withdrawal by Subject|3|||
16985132|NCT00946530|38128751|FG000|Overall Study|Physician Decision|1|||
16985133|NCT00946530|38128752|FG001|Overall Study|Physician Decision|1|||
16985134|NCT00946530|38128753|FG002|Overall Study|Physician Decision|1|||
16985135|NCT00946530|38128754|FG003|Overall Study|Physician Decision|1|||
16985136|NCT00946296|38128770|FG000|Overall Study|Physician Decision|3|||
16985137|NCT00946296|38128771|FG001|Overall Study|Physician Decision|0|||
16985138|NCT00945906|38128777|FG000|Overall Study|Withdrawal by Subject|1|||
16985139|NCT00945906|38128777|FG000|Overall Study|Did not want to return for last visit|2|||
16985140|NCT00945906|38128777|FG000|Overall Study|Unable to return for last visit|2|||
16985141|NCT00945906|38128777|FG000|Overall Study|Moved to another country|2|||
16985142|NCT00594646|38128781|FG000|Overall Study|Withdrawal by Subject|1|||
16985143|NCT00594646|38128781|FG000|Overall Study|Lost to Follow-up|15|||
16985144|NCT01111604|38128789|FG000|Overall Study|Lost to Follow-up|0|||
16985145|NCT01111604|38128790|FG001|Overall Study|Lost to Follow-up|0|||
16985146|NCT01111604|38128791|FG002|Overall Study|Lost to Follow-up|1|||
16985147|NCT01111604|38128789|FG000|Overall Study|Withdrew Consent|3|||
16985148|NCT01111604|38128790|FG001|Overall Study|Withdrew Consent|0|||
16985149|NCT01111604|38128791|FG002|Overall Study|Withdrew Consent|2|||
16985150|NCT01111604|38128789|FG000|Overall Study|Withdrawal by Subject|2|||
16985151|NCT01111604|38128790|FG001|Overall Study|Withdrawal by Subject|0|||
16985152|NCT01111604|38128791|FG002|Overall Study|Withdrawal by Subject|0|||
16985153|NCT01111604|38128789|FG000|Overall Study|Death|1|||
16985154|NCT01111604|38128790|FG001|Overall Study|Death|0|||
16985155|NCT01111604|38128791|FG002|Overall Study|Death|0|||
16985156|NCT01111604|38128789|FG000|Overall Study|Met Exclusion Criteria|2|||
16985157|NCT01111604|38128790|FG001|Overall Study|Met Exclusion Criteria|0|||
16985158|NCT01111604|38128791|FG002|Overall Study|Met Exclusion Criteria|0|||
16985159|NCT00950742|38128819|FG000|Overall Study|Other Adverse Event|1|||
16985160|NCT00950742|38128820|FG001|Overall Study|Other Adverse Event|0|||
16985161|NCT00950742|38128819|FG000|Overall Study|Withdrawal by Subject|3|||
16985162|NCT00950742|38128820|FG001|Overall Study|Withdrawal by Subject|0|||
16985163|NCT00950742|38128819|FG000|Overall Study|Progressive Disease|6|||
16985164|NCT00950742|38128820|FG001|Overall Study|Progressive Disease|2|||
16985165|NCT00950742|38128819|FG000|Overall Study|Dose limiting toxicity|6|||
16985166|NCT00950742|38128820|FG001|Overall Study|Dose limiting toxicity|0|||
16985167|NCT00955110|38128830|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
16985168|NCT00955110|38128830|FG000|Treatment Phase|Adverse Event|2|||
16985169|NCT00955110|38128830|FG000|Treatment Phase|Administrative reasons|2|||
16985170|NCT00955110|38128830|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
16985171|NCT00955110|38128830|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
16985172|NCT00950664|38128844|FG000|First Intervention|Lost to Follow-up|1|||
16985173|NCT00950664|38128845|FG001|First Intervention|Lost to Follow-up|3|||
16985174|NCT00950664|38128844|FG000|First Intervention|Withdrawal by Subject|2|||
16985175|NCT00950664|38128845|FG001|First Intervention|Withdrawal by Subject|2|||
16985176|NCT01111526|38128851|FG000|Overall Study|GVHD Disease Progression|0|||
16985177|NCT01111526|38128852|FG001|Overall Study|GVHD Disease Progression|1|||
16985178|NCT01111526|38128853|FG002|Overall Study|GVHD Disease Progression|2|||
16985179|NCT01111292|38128859|FG000|Treatment|Physician Decision|1|||
16985180|NCT01111292|38128860|FG001|Treatment|Physician Decision|1|||
16985181|NCT00944658|38128868|FG000|Treatment 12 Weeks|Adverse Event|0|||
16985182|NCT00944658|38128869|FG001|Treatment 12 Weeks|Adverse Event|2|||
16985183|NCT01110200|38128877|FG000|Overall Study|Adverse Event|28|||
16985184|NCT01110200|38128878|FG001|Overall Study|Adverse Event|28|||
16985185|NCT01110200|38128877|FG000|Overall Study|Withdrawal by Subject|25|||
16985186|NCT01110200|38128878|FG001|Overall Study|Withdrawal by Subject|32|||
17134675|NCT03524092|38275880|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
16985187|NCT01110200|38128877|FG000|Overall Study|Lack of Efficacy|16|||
16985188|NCT01110200|38128878|FG001|Overall Study|Lack of Efficacy|25|||
16985189|NCT01110200|38128877|FG000|Overall Study|Protocol Violation|14|||
16985190|NCT01110200|38128878|FG001|Overall Study|Protocol Violation|12|||
16985191|NCT01110200|38128877|FG000|Overall Study|Physician Decision|13|||
16985192|NCT01110200|38128878|FG001|Overall Study|Physician Decision|17|||
16985193|NCT01110200|38128877|FG000|Overall Study|Lost to Follow-up|10|||
16985194|NCT01110200|38128878|FG001|Overall Study|Lost to Follow-up|7|||
16985195|NCT01108796|38128888|FG000|Overall Study|Adverse Event|0|||
16985196|NCT01108796|38128889|FG001|Overall Study|Adverse Event|1|||
16985197|NCT01108796|38128888|FG000|Overall Study|Lost to Follow-up|7|||
16985198|NCT01108796|38128889|FG001|Overall Study|Lost to Follow-up|6|||
16985199|NCT01108718|38128899|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
16985200|NCT01108718|38128900|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
16985201|NCT01137110|38128907|FG000|Overall Study|Protocol Violation|1|||
16985202|NCT01137110|38128908|FG001|Overall Study|Protocol Violation|0|||
16985203|NCT01136954|38128916|FG000|Overall Study|Adverse Event|3|||
16985204|NCT01136954|38128917|FG001|Overall Study|Adverse Event|2|||
16985205|NCT01136954|38128916|FG000|Overall Study|Withdrawal by Subject|6|||
16985206|NCT01136954|38128917|FG001|Overall Study|Withdrawal by Subject|2|||
16985207|NCT01136954|38128916|FG000|Overall Study|Lack of Efficacy|14|||
16985208|NCT01136954|38128917|FG001|Overall Study|Lack of Efficacy|13|||
16985209|NCT01136954|38128916|FG000|Overall Study|Physician Decision|0|||
16985210|NCT01136954|38128917|FG001|Overall Study|Physician Decision|1|||
16985211|NCT01136954|38128916|FG000|Overall Study|Other|1|||
16985212|NCT01136954|38128917|FG001|Overall Study|Other|3|||
16985213|NCT01136876|38128926|FG000|Overall Study|Lost to Follow-up|0|||
16985214|NCT01136876|38128927|FG001|Overall Study|Lost to Follow-up|1|||
16985215|NCT01136876|38128926|FG000|Overall Study|Physician Decision|3|||
16985216|NCT01136876|38128927|FG001|Overall Study|Physician Decision|5|||
16985217|NCT01136876|38128926|FG000|Overall Study|Missing NGAL measurement|2|||
16985218|NCT01136876|38128927|FG001|Overall Study|Missing NGAL measurement|5|||
16985219|NCT01105130|38128938|FG000|Overall Study|Withdrawal by Subject|4|||
16985220|NCT01105130|38128939|FG001|Overall Study|Withdrawal by Subject|6|||
16985221|NCT01105130|38128940|FG002|Overall Study|Withdrawal by Subject|2|||
16985222|NCT01105130|38128938|FG000|Overall Study|Never Started|2|||
16985223|NCT01105130|38128939|FG001|Overall Study|Never Started|2|||
16985224|NCT01105130|38128940|FG002|Overall Study|Never Started|4|||
16985225|NCT01105130|38128938|FG000|Overall Study|Toxicity|1|||
16985226|NCT01105130|38128939|FG001|Overall Study|Toxicity|3|||
16985227|NCT01105130|38128940|FG002|Overall Study|Toxicity|2|||
16985228|NCT01105130|38128938|FG000|Overall Study|Multiple Reasons|3|||
16985229|NCT01105130|38128939|FG001|Overall Study|Multiple Reasons|0|||
16985230|NCT01105130|38128940|FG002|Overall Study|Multiple Reasons|2|||
16985231|NCT01108094|38128952|FG000|Overall Study|Adverse Event|2|||
16985232|NCT01108094|38128953|FG001|Overall Study|Adverse Event|0|||
16985233|NCT01108094|38128954|FG002|Overall Study|Adverse Event|0|||
16985234|NCT01108094|38128955|FG003|Overall Study|Adverse Event|0|||
16985235|NCT01108094|38128952|FG000|Overall Study|Withdrawal by Subject|1|||
16985236|NCT01108094|38128953|FG001|Overall Study|Withdrawal by Subject|0|||
16985237|NCT01108094|38128954|FG002|Overall Study|Withdrawal by Subject|0|||
16985238|NCT01108094|38128955|FG003|Overall Study|Withdrawal by Subject|0|||
16985239|NCT00954174|38128972|FG000|Overall Study|Adverse Event|28|||
16985240|NCT00954174|38128973|FG001|Overall Study|Adverse Event|23|||
16985241|NCT00954174|38128974|FG002|Overall Study|Adverse Event|4|||
16985242|NCT00954174|38128975|FG003|Overall Study|Adverse Event|9|||
16985243|NCT00954174|38128972|FG000|Overall Study|Death|4|||
16985244|NCT00954174|38128973|FG001|Overall Study|Death|2|||
16985245|NCT00954174|38128974|FG002|Overall Study|Death|0|||
16985246|NCT00954174|38128975|FG003|Overall Study|Death|0|||
16985247|NCT00954174|38128972|FG000|Overall Study|Lack of Efficacy|32|||
16985248|NCT00954174|38128973|FG001|Overall Study|Lack of Efficacy|22|||
16985249|NCT00954174|38128974|FG002|Overall Study|Lack of Efficacy|8|||
16985250|NCT00954174|38128975|FG003|Overall Study|Lack of Efficacy|6|||
16985251|NCT00954174|38128972|FG000|Overall Study|Withdrawal by Subject|14|||
16985252|NCT00954174|38128973|FG001|Overall Study|Withdrawal by Subject|10|||
16985253|NCT00954174|38128974|FG002|Overall Study|Withdrawal by Subject|4|||
16985254|NCT00954174|38128975|FG003|Overall Study|Withdrawal by Subject|3|||
16985255|NCT00954174|38128972|FG000|Overall Study|Medical Reason|4|||
16985256|NCT00954174|38128973|FG001|Overall Study|Medical Reason|2|||
16985257|NCT00954174|38128974|FG002|Overall Study|Medical Reason|1|||
16985258|NCT00954174|38128975|FG003|Overall Study|Medical Reason|0|||
16985259|NCT00954174|38128972|FG000|Overall Study|Ineligible|40|||
16985260|NCT00954174|38128973|FG001|Overall Study|Ineligible|47|||
17134676|NCT03524092|38275875|FG000|Loss of Response Rescue Period|Pregnancy|0|||
16985261|NCT00954174|38128974|FG002|Overall Study|Ineligible|7|||
16985262|NCT00954174|38128975|FG003|Overall Study|Ineligible|4|||
16985263|NCT00954174|38128972|FG000|Overall Study|Never Treated|4|||
16985264|NCT00954174|38128973|FG001|Overall Study|Never Treated|17|||
16985265|NCT00954174|38128974|FG002|Overall Study|Never Treated|0|||
16985266|NCT00954174|38128975|FG003|Overall Study|Never Treated|3|||
16997762|NCT00962390|38141771|FG000|Overall Study|Withdrawal by Subject|1|||
16997763|NCT00962390|38141772|FG001|Overall Study|Withdrawal by Subject|1|||
16997764|NCT00962390|38141773|FG002|Overall Study|Withdrawal by Subject|1|||
16985267|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
16985268|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
16985269|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
16985270|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
16985271|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Adverse Event|198|||
16985272|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Adverse Event|0|||
16985273|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Adverse Event|0|||
16985274|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Adverse Event|0|||
16985275|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Death|62|||
17134677|NCT03524092|38275876|FG001|Loss of Response Rescue Period|Pregnancy|0|||
16985276|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Death|0|||
16985277|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Death|0|||
16985278|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Death|0|||
16985279|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
16985280|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
16985281|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
16985282|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
16985283|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Complicating disease|13|||
16985284|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Complicating disease|0|||
16985285|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Complicating disease|0|||
16985286|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Complicating disease|0|||
16985287|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
16985288|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
16985289|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
16985290|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
16985291|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
16985292|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
16985293|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
16985294|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
16985295|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Non-compliance|4|||
16985296|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Non-compliance|0|||
16985297|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Non-compliance|0|||
16985298|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Non-compliance|0|||
17134678|NCT03524092|38275877|FG002|Loss of Response Rescue Period|Pregnancy|0|||
16985299|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Pain|4|||
16985300|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Pain|0|||
16985301|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Pain|0|||
16985302|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Pain|0|||
16985303|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
16985304|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
16985305|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
16985306|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
16985307|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Hospice care|1|||
16985308|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Hospice care|0|||
16985309|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Hospice care|0|||
16985310|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Hospice care|0|||
16985311|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Physician Decision|1|||
16985312|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Physician Decision|0|||
16985313|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Physician Decision|0|||
16985314|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Physician Decision|0|||
16985315|NCT01107626|38128992|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
16985316|NCT01107626|38128993|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
16985317|NCT01107626|38128994|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
16985318|NCT01107626|38128995|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
16985319|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
16985320|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
16985321|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
16985322|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
16985323|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
16985324|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
16985325|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
16985326|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
16985327|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Death|0|||
16985328|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Death|8|||
16985329|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Death|2|||
16985330|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Death|13|||
16985331|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
17134679|NCT03524092|38275878|FG003|Loss of Response Rescue Period|Pregnancy|1|||
16985332|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
16985333|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
16985334|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
17134680|NCT03524092|38275879|FG004|Loss of Response Rescue Period|Pregnancy|0|||
17134681|NCT03524092|38275880|FG005|Loss of Response Rescue Period|Pregnancy|0|||
16985335|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
16985336|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
16985337|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
16985338|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
16985339|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
16985340|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
16985341|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
16985342|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
16985343|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
16985344|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
16985345|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
16985346|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
16985347|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
16985348|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
16985349|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
16985350|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
16985351|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
16985352|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
16985353|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
16985354|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
16985355|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
16985356|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
16985357|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
16985358|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
16985359|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
16985360|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
16985361|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
16985362|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
16985363|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
16985364|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
16985365|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
17134682|NCT03524092|38275875|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
17134683|NCT03524092|38275876|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
16985366|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
16985367|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
16985368|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
16985369|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
16985370|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
16985371|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Pain|0|||
16985372|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Pain|0|||
16985373|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Pain|0|||
16985374|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Pain|1|||
16985375|NCT01107626|38128992|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
16985376|NCT01107626|38128993|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
16985377|NCT01107626|38128994|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
16985378|NCT01107626|38128995|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
16985379|NCT01136408|38129007|FG000|Overall Study|Adverse Event|4|||
16985380|NCT01136408|38129008|FG001|Overall Study|Adverse Event|8|||
16985381|NCT01136408|38129009|FG002|Overall Study|Adverse Event|4|||
16985382|NCT01136408|38129007|FG000|Overall Study|Protocol Violation|1|||
16985383|NCT01136408|38129008|FG001|Overall Study|Protocol Violation|1|||
16985384|NCT01136408|38129009|FG002|Overall Study|Protocol Violation|1|||
16985385|NCT01136174|38129025|FG000|Overall Study|Adverse Event|0|||
16985386|NCT01136174|38129026|FG001|Overall Study|Adverse Event|0|||
16985387|NCT01136174|38129027|FG002|Overall Study|Adverse Event|0|||
16985388|NCT01136174|38129028|FG003|Overall Study|Adverse Event|4|||
16985389|NCT01135394|38129047|FG000|Screening|Lost to Follow-up|2|||
16985390|NCT01135394|38129047|FG000|Screening|Withdrawal by Subject|10|||
16985391|NCT01135394|38129047|FG000|Screening|Screening failure|16|||
16985392|NCT01135394|38129047|FG000|Screening|Physician Decision|5|||
16985393|NCT01135394|38129047|FG000|Baseline Assessment|Withdrawal by Subject|9|||
16985394|NCT01135394|38129047|FG000|Baseline Assessment|Physician Decision|3|||
16985395|NCT01135394|38129047|FG000|Baseline Assessment|Lost to Follow-up|2|||
16985396|NCT01135394|38129047|FG000|Baseline Assessment|Adverse Event|1|||
16985397|NCT01135394|38129047|FG000|Study Treatment|Withdrawal by Subject|1|||
17134684|NCT03524092|38275877|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
16985398|NCT01135394|38129047|FG000|Study Treatment|Physician Decision|1|||
16985399|NCT01135394|38129047|FG000|Study Treatment|Adverse Event|2|||
16985400|NCT00949884|38129054|FG000|Overall Study|Adverse Event|14|||
16985401|NCT00949884|38129055|FG001|Overall Study|Adverse Event|3|||
16985402|NCT00949884|38129056|FG002|Overall Study|Adverse Event|12|||
16985403|NCT00949884|38129054|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
16985404|NCT00949884|38129055|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
16985405|NCT00949884|38129056|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
16985406|NCT00949884|38129054|FG000|Overall Study|Lost to Follow-up|7|||
16985407|NCT00949884|38129055|FG001|Overall Study|Lost to Follow-up|5|||
16985408|NCT00949884|38129056|FG002|Overall Study|Lost to Follow-up|5|||
16985409|NCT00949884|38129054|FG000|Overall Study|Physician Decision|5|||
16985410|NCT00949884|38129055|FG001|Overall Study|Physician Decision|0|||
16985411|NCT00949884|38129056|FG002|Overall Study|Physician Decision|6|||
16985412|NCT00949884|38129054|FG000|Overall Study|Treatment non-compliance|5|||
16985413|NCT00949884|38129055|FG001|Overall Study|Treatment non-compliance|0|||
16985414|NCT00949884|38129056|FG002|Overall Study|Treatment non-compliance|8|||
16985415|NCT00949884|38129054|FG000|Overall Study|Withdrawal by Subject|13|||
16985416|NCT00949884|38129055|FG001|Overall Study|Withdrawal by Subject|4|||
16985417|NCT00949884|38129056|FG002|Overall Study|Withdrawal by Subject|16|||
16985418|NCT00949884|38129054|FG000|Overall Study|Lack of Efficacy|4|||
16985419|NCT00949884|38129055|FG001|Overall Study|Lack of Efficacy|2|||
16985420|NCT00949884|38129056|FG002|Overall Study|Lack of Efficacy|7|||
16780229|NCT02179918|37719321|FG002|Overall Study|Progressive Disease|1|||
16780230|NCT02179918|37719322|FG003|Overall Study|Progressive Disease|2|||
16780231|NCT02179918|37719323|FG004|Overall Study|Progressive Disease|6|||
16868015|NCT01536145|37841035|FG002|Overall Study|Withdrawal by Subject|1|||
16985421|NCT00949884|38129054|FG000|Overall Study|Study terminated by sponsor|0|||
16985422|NCT00949884|38129055|FG001|Overall Study|Study terminated by sponsor|0|||
16985423|NCT00949884|38129056|FG002|Overall Study|Study terminated by sponsor|1|||
16985424|NCT00949650|38129067|FG000|Overall Study|Progressive disease|188|||
16985425|NCT00949650|38129068|FG001|Overall Study|Progressive disease|19|||
16985426|NCT00949650|38129067|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
16985427|NCT00949650|38129068|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
16985428|NCT00949650|38129067|FG000|Overall Study|Other Adverse Event (AE)|28|||
16985429|NCT00949650|38129068|FG001|Overall Study|Other Adverse Event (AE)|17|||
16985430|NCT00949650|38129067|FG000|Overall Study|Protocol Violation|1|||
16985431|NCT00949650|38129068|FG001|Overall Study|Protocol Violation|4|||
16985432|NCT00949650|38129067|FG000|Overall Study|Refusal to continue medication|7|||
16985433|NCT00949650|38129068|FG001|Overall Study|Refusal to continue medication|11|||
16985434|NCT00949650|38129067|FG000|Overall Study|Not treated|1|||
16985435|NCT00949650|38129068|FG001|Overall Study|Not treated|4|||
16985436|NCT00949650|38129067|FG000|Overall Study|Other not specified above|5|||
16985437|NCT00949650|38129068|FG001|Overall Study|Other not specified above|0|||
16985438|NCT00908037|38129085|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985439|NCT00908037|38129086|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985440|NCT00908037|38129087|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985441|NCT00908037|38129088|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985442|NCT00908037|38129089|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
16985443|NCT00908037|38129090|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985444|NCT00908037|38129091|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
16985445|NCT00908037|38129092|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985446|NCT00908037|38129093|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
16985447|NCT00908037|38129094|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985448|NCT00908037|38129095|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985449|NCT00908037|38129096|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16985450|NCT00908037|38129085|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985451|NCT00908037|38129086|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985452|NCT00908037|38129087|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985453|NCT00908037|38129088|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985454|NCT00908037|38129089|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
16985455|NCT00908037|38129090|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985456|NCT00908037|38129091|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985457|NCT00908037|38129092|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985458|NCT00908037|38129093|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
16985459|NCT00908037|38129094|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985460|NCT00908037|38129095|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985461|NCT00908037|38129096|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16985462|NCT00908037|38129085|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985463|NCT00908037|38129086|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985464|NCT00908037|38129087|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985465|NCT00908037|38129088|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
16985466|NCT00908037|38129089|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985467|NCT00908037|38129090|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985468|NCT00908037|38129091|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
16985469|NCT00908037|38129092|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985470|NCT00908037|38129093|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985471|NCT00908037|38129094|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985472|NCT00908037|38129095|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985473|NCT00908037|38129096|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16985474|NCT00908037|38129085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985475|NCT00908037|38129086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985476|NCT00908037|38129087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985477|NCT00908037|38129088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985478|NCT00908037|38129089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985479|NCT00908037|38129090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985480|NCT00908037|38129091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985481|NCT00908037|38129092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985482|NCT00908037|38129093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985483|NCT00908037|38129094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985484|NCT00908037|38129095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16985485|NCT00908037|38129096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
16985486|NCT00908037|38129085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985487|NCT00908037|38129086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985488|NCT00908037|38129087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985489|NCT00908037|38129088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985490|NCT00908037|38129089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985491|NCT00908037|38129090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985492|NCT00908037|38129091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985493|NCT00908037|38129092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985494|NCT00908037|38129093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985495|NCT00908037|38129094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
16985496|NCT00908037|38129095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16985497|NCT00908037|38129096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
16985498|NCT00908037|38129085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985499|NCT00908037|38129086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985500|NCT00908037|38129087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985501|NCT00908037|38129088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985502|NCT00908037|38129089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985503|NCT00908037|38129090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985504|NCT00908037|38129091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985505|NCT00908037|38129092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985506|NCT00908037|38129093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985507|NCT00908037|38129094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
16985508|NCT00908037|38129095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985509|NCT00908037|38129096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16985510|NCT00908037|38129085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985511|NCT00908037|38129086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985512|NCT00908037|38129087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985513|NCT00908037|38129088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985514|NCT00908037|38129089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985515|NCT00908037|38129090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
17134685|NCT03524092|38275878|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
17134686|NCT03524092|38275879|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
17134687|NCT03524092|38275880|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
17134688|NCT03524092|38275875|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
17134689|NCT03524092|38275876|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
17134690|NCT03524092|38275877|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
17134691|NCT03524092|38275878|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
17134692|NCT03524092|38275879|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
17134693|NCT03524092|38275880|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
17134694|NCT03524092|38275875|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
17134695|NCT03524092|38275876|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
17134696|NCT03524092|38275877|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
17134697|NCT03524092|38275878|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
17134698|NCT03524092|38275879|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
17134699|NCT03524092|38275880|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
17134700|NCT03524092|38275875|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
17134701|NCT03524092|38275876|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
16780232|NCT02179918|37719319|FG000|Overall Study|Other|0|||
17134702|NCT03524092|38275877|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
17134703|NCT03524092|38275878|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
17134704|NCT03524092|38275879|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
17134705|NCT03524092|38275880|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
17134706|NCT03524092|38275875|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
17134707|NCT03524092|38275876|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
17134708|NCT03524092|38275877|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
16985516|NCT00908037|38129091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985517|NCT00908037|38129092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985518|NCT00908037|38129093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985519|NCT00908037|38129094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985520|NCT00908037|38129095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
17134709|NCT03524092|38275878|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
17134710|NCT03524092|38275879|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
17134711|NCT03524092|38275880|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
16985521|NCT00908037|38129096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16985522|NCT00908037|38129085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985523|NCT00908037|38129086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985524|NCT00908037|38129087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985525|NCT00908037|38129088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985526|NCT00908037|38129089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985527|NCT00908037|38129090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985528|NCT00908037|38129091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985529|NCT00908037|38129092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
17134712|NCT03524092|38275875|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
17134713|NCT03524092|38275876|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
17134714|NCT03524092|38275877|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
17134715|NCT03524092|38275878|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
17134716|NCT03524092|38275879|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
17134717|NCT03524092|38275880|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
17134718|NCT03524092|38275875|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
17134719|NCT03524092|38275876|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
17134720|NCT03524092|38275877|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
17134721|NCT03524092|38275878|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
17134722|NCT03524092|38275879|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
17134723|NCT03524092|38275880|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
17134724|NCT03524092|38275875|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
16985530|NCT00908037|38129093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985531|NCT00908037|38129094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
16985532|NCT00908037|38129095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985533|NCT00908037|38129096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16985534|NCT00908037|38129085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985535|NCT00908037|38129086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
17134725|NCT03524092|38275876|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
17134726|NCT03524092|38275877|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
17134727|NCT03524092|38275878|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
17134728|NCT03524092|38275879|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
17134729|NCT03524092|38275880|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
17134730|NCT03524092|38275875|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
17134731|NCT03524092|38275876|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
17134732|NCT03524092|38275877|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
17134733|NCT03524092|38275878|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
17134734|NCT03524092|38275879|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
17134735|NCT03524092|38275880|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
17134736|NCT03524092|38275875|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
17134737|NCT03524092|38275876|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
17188996|NCT02505334|38341958|FG000|Main Treatment Period|Lack of Efficacy|7|||
16985536|NCT00908037|38129087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985537|NCT00908037|38129088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985538|NCT00908037|38129089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985539|NCT00908037|38129090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985540|NCT00908037|38129091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985541|NCT00908037|38129092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985542|NCT00908037|38129093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985543|NCT00908037|38129094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16985544|NCT00908037|38129095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
16985545|NCT00908037|38129096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
17134738|NCT03524092|38275877|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
17134739|NCT03524092|38275878|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
17134740|NCT03524092|38275879|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
17134741|NCT03524092|38275880|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
17134742|NCT03524092|38275875|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
17134743|NCT03524092|38275876|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
17134744|NCT03524092|38275877|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
17134745|NCT03524092|38275878|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
17134746|NCT03524092|38275879|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
17134747|NCT03524092|38275880|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
16985546|NCT00904215|38129148|FG000|Overall Study|Adverse Event|25|||
16985547|NCT00904215|38129148|FG000|Overall Study|Protocol Violation|10|||
16985548|NCT00904215|38129148|FG000|Overall Study|Lost to Follow-up|63|||
16985549|NCT00904215|38129148|FG000|Overall Study|Withdrawal by Subject|9|||
16985550|NCT00904215|38129148|FG000|Overall Study|Other|28|||
16985551|NCT00905307|38129158|FG000|Overall Study|Switched to Open Label Rescue|7|||
16985552|NCT00905307|38129159|FG001|Overall Study|Switched to Open Label Rescue|17|||
16985553|NCT00905307|38129160|FG002|Overall Study|Switched to Open Label Rescue|11|||
16985554|NCT00905307|38129161|FG003|Overall Study|Switched to Open Label Rescue|11|||
16985555|NCT00905307|38129162|FG004|Overall Study|Switched to Open Label Rescue|4|||
16985556|NCT00905307|38129163|FG005|Overall Study|Switched to Open Label Rescue|15|||
16985557|NCT00905307|38129158|FG000|Overall Study|Lost to Follow-up|0|||
16985558|NCT00905307|38129159|FG001|Overall Study|Lost to Follow-up|0|||
16985559|NCT00905307|38129160|FG002|Overall Study|Lost to Follow-up|0|||
16985560|NCT00905307|38129161|FG003|Overall Study|Lost to Follow-up|0|||
16985561|NCT00905307|38129162|FG004|Overall Study|Lost to Follow-up|1|||
16985562|NCT00905307|38129163|FG005|Overall Study|Lost to Follow-up|1|||
16985563|NCT00905307|38129158|FG000|Overall Study|Adverse Event|3|||
16985564|NCT00905307|38129159|FG001|Overall Study|Adverse Event|4|||
16985565|NCT00905307|38129160|FG002|Overall Study|Adverse Event|5|||
16985566|NCT00905307|38129161|FG003|Overall Study|Adverse Event|11|||
16985567|NCT00905307|38129162|FG004|Overall Study|Adverse Event|3|||
16985568|NCT00905307|38129163|FG005|Overall Study|Adverse Event|5|||
16985569|NCT00905307|38129158|FG000|Overall Study|Withdrawal by Subject|5|||
16985570|NCT00905307|38129159|FG001|Overall Study|Withdrawal by Subject|13|||
16985571|NCT00905307|38129160|FG002|Overall Study|Withdrawal by Subject|15|||
16985572|NCT00905307|38129161|FG003|Overall Study|Withdrawal by Subject|11|||
16985573|NCT00905307|38129162|FG004|Overall Study|Withdrawal by Subject|4|||
16985574|NCT00905307|38129163|FG005|Overall Study|Withdrawal by Subject|13|||
16985575|NCT00905307|38129158|FG000|Overall Study|Protocol Violation|1|||
16985576|NCT00905307|38129159|FG001|Overall Study|Protocol Violation|0|||
16985577|NCT00905307|38129160|FG002|Overall Study|Protocol Violation|1|||
16985578|NCT00905307|38129161|FG003|Overall Study|Protocol Violation|0|||
16985579|NCT00905307|38129162|FG004|Overall Study|Protocol Violation|0|||
16985580|NCT00905307|38129163|FG005|Overall Study|Protocol Violation|0|||
16985581|NCT00905307|38129158|FG000|Overall Study|Lack of Efficacy|6|||
16985582|NCT00905307|38129159|FG001|Overall Study|Lack of Efficacy|3|||
16985583|NCT00905307|38129160|FG002|Overall Study|Lack of Efficacy|5|||
16985584|NCT00905307|38129161|FG003|Overall Study|Lack of Efficacy|4|||
16985585|NCT00905307|38129162|FG004|Overall Study|Lack of Efficacy|4|||
16985586|NCT00905307|38129163|FG005|Overall Study|Lack of Efficacy|8|||
16985587|NCT00907881|38129190|FG000|Overall Study|Lost to Follow-up|59|||
16985588|NCT00907881|38129190|FG000|Overall Study|Noncompliance|5|||
16985589|NCT00907881|38129190|FG000|Overall Study|Withdrawal by Subject|5|||
16985590|NCT00907881|38129190|FG000|Overall Study|Protocol Violation|1|||
16985591|NCT00907881|38129190|FG000|Overall Study|Missing discontinuation information|15|||
16985592|NCT00904917|38129198|FG000|Overall Study|Lost to Follow-up|2|||
16985593|NCT00904917|38129199|FG001|Overall Study|Lost to Follow-up|2|||
16985594|NCT00904917|38129200|FG002|Overall Study|Lost to Follow-up|2|||
16985595|NCT00904917|38129201|FG003|Overall Study|Lost to Follow-up|2|||
16985596|NCT00904839|38129216|FG000|Overall Study|Adverse Event|0|||
16985597|NCT00904839|38129217|FG001|Overall Study|Adverse Event|5|||
16985598|NCT00904839|38129218|FG002|Overall Study|Adverse Event|4|||
16985599|NCT00904839|38129216|FG000|Overall Study|Protocol Violation|0|||
16985600|NCT00904839|38129217|FG001|Overall Study|Protocol Violation|1|||
16985601|NCT00904839|38129218|FG002|Overall Study|Protocol Violation|1|||
16985602|NCT00904839|38129216|FG000|Overall Study|Lost to Follow-up|0|||
16985603|NCT00904839|38129217|FG001|Overall Study|Lost to Follow-up|1|||
17134748|NCT03524092|38275875|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
17134749|NCT03524092|38275876|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
17134750|NCT03524092|38275877|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
17134751|NCT03524092|38275878|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
17134752|NCT03524092|38275879|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
17134753|NCT03524092|38275880|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
17134754|NCT03331562|38275893|FG000|Overall Study|Adverse Event|2|||
17134755|NCT03331562|38275894|FG001|Overall Study|Adverse Event|0|||
17134756|NCT03331562|38275893|FG000|Overall Study|Death|1|||
17134757|NCT03331562|38275894|FG001|Overall Study|Death|0|||
17134758|NCT02038634|38275906|FG000|Overall Study|Lost to Follow-up|0|||
17134759|NCT02038634|38275907|FG001|Overall Study|Lost to Follow-up|1|||
17134760|NCT00836056|38275915|FG000|First Intervention|Adverse Event|1|||
17134761|NCT00836056|38275916|FG001|First Intervention|Adverse Event|0|||
17134762|NCT03200912|38275923|FG000|Overall Study|Adverse Event|3|||
17134763|NCT03200912|38275924|FG001|Overall Study|Adverse Event|0|||
17134764|NCT03200912|38275925|FG002|Overall Study|Adverse Event|0|||
17134765|NCT03200912|38275923|FG000|Overall Study|Withdrawal by Subject|1|||
17134766|NCT03200912|38275924|FG001|Overall Study|Withdrawal by Subject|2|||
17134767|NCT03200912|38275925|FG002|Overall Study|Withdrawal by Subject|4|||
17134768|NCT03200912|38275923|FG000|Overall Study|Non-compliance with study drug|0|||
17134769|NCT03200912|38275924|FG001|Overall Study|Non-compliance with study drug|1|||
17134770|NCT03200912|38275925|FG002|Overall Study|Non-compliance with study drug|0|||
17134771|NCT00835666|38275935|FG000|Washout|Protocol Violation|1|||
17134772|NCT00835666|38275936|FG001|Washout|Protocol Violation|0|||
17134773|NCT00835666|38275935|FG000|Washout|Withdrawal by Subject|1|||
17134774|NCT00835666|38275936|FG001|Washout|Withdrawal by Subject|0|||
17134775|NCT03200366|38275950|FG000|Patient Navigation Intervention Given|Death|0|||
17134776|NCT03200366|38275951|FG001|Patient Navigation Intervention Given|Death|2|||
17134777|NCT03200366|38275952|FG002|Patient Navigation Intervention Given|Death|0|||
17134778|NCT03200366|38275950|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
17134779|NCT03200366|38275951|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
17134780|NCT03200366|38275952|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
17134781|NCT03200366|38275950|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
17134782|NCT03200366|38275951|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
17134783|NCT03200366|38275952|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
17134784|NCT03200366|38275950|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
17134785|NCT03200366|38275951|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
17134786|NCT03200366|38275952|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
17134787|NCT03200366|38275950|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
17134788|NCT03200366|38275951|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
17134789|NCT03200366|38275952|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
16985604|NCT00904839|38129218|FG002|Overall Study|Lost to Follow-up|2|||
16985605|NCT00904839|38129216|FG000|Overall Study|Withdrawal by Subject|0|||
16985606|NCT00904839|38129217|FG001|Overall Study|Withdrawal by Subject|2|||
16985607|NCT00904839|38129218|FG002|Overall Study|Withdrawal by Subject|0|||
16985608|NCT00904839|38129216|FG000|Overall Study|Not treated|1|||
16985609|NCT00904839|38129217|FG001|Overall Study|Not treated|0|||
16985610|NCT00904839|38129218|FG002|Overall Study|Not treated|1|||
16985611|NCT00904839|38129216|FG000|Overall Study|Other than above|0|||
16985612|NCT00904839|38129217|FG001|Overall Study|Other than above|9|||
16985613|NCT00904839|38129218|FG002|Overall Study|Other than above|7|||
16985614|NCT00903357|38129229|FG000|First Intervention|Withdrawal by Subject|5|||
16985615|NCT00903357|38129230|FG001|First Intervention|Withdrawal by Subject|3|||
16985616|NCT00903357|38129229|FG000|First Intervention|Flu|0|||
16985617|NCT00903357|38129230|FG001|First Intervention|Flu|1|||
16985618|NCT00903357|38129229|FG000|Wash Out Period of 2 Weeks|Flu|0|||
16985619|NCT00903357|38129230|FG001|Wash Out Period of 2 Weeks|Flu|1|||
16985620|NCT00903357|38129229|FG000|Second Intervention|Lost to Follow-up|1|||
16985621|NCT00903357|38129230|FG001|Second Intervention|Lost to Follow-up|0|||
16985622|NCT00904371|38129240|FG000|Overall Study|Adverse Event|2|||
16985623|NCT00904371|38129240|FG000|Overall Study|Lost to Follow-up|4|||
16985624|NCT00904371|38129240|FG000|Overall Study|Discontinued at target blood pressure|2|||
16985625|NCT00904371|38129240|FG000|Overall Study|Continued with Tritace|1|||
16985626|NCT01104662|38129252|FG000|Overall Study|Adverse Event|2|||
16985627|NCT01104662|38129253|FG001|Overall Study|Adverse Event|2|||
16985628|NCT01104662|38129254|FG002|Overall Study|Adverse Event|0|||
16985629|NCT01104662|38129255|FG003|Overall Study|Adverse Event|1|||
16985630|NCT01104662|38129256|FG004|Overall Study|Adverse Event|1|||
16985631|NCT01104662|38129257|FG005|Overall Study|Adverse Event|1|||
16985632|NCT01104662|38129258|FG006|Overall Study|Adverse Event|0|||
16985633|NCT01104662|38129259|FG007|Overall Study|Adverse Event|0|||
16985634|NCT01104662|38129252|FG000|Overall Study|Clinical Failure|1|||
16985635|NCT01104662|38129253|FG001|Overall Study|Clinical Failure|0|||
16985636|NCT01104662|38129254|FG002|Overall Study|Clinical Failure|0|||
16985637|NCT01104662|38129255|FG003|Overall Study|Clinical Failure|0|||
16985638|NCT01104662|38129256|FG004|Overall Study|Clinical Failure|0|||
16985639|NCT01104662|38129257|FG005|Overall Study|Clinical Failure|1|||
16985640|NCT01104662|38129258|FG006|Overall Study|Clinical Failure|0|||
16985641|NCT01104662|38129259|FG007|Overall Study|Clinical Failure|0|||
16985642|NCT01104662|38129252|FG000|Overall Study|Participant left investigator's care|1|||
16985643|NCT01104662|38129253|FG001|Overall Study|Participant left investigator's care|1|||
16985644|NCT01104662|38129254|FG002|Overall Study|Participant left investigator's care|0|||
16985645|NCT01104662|38129255|FG003|Overall Study|Participant left investigator's care|0|||
16985646|NCT01104662|38129256|FG004|Overall Study|Participant left investigator's care|0|||
16985647|NCT01104662|38129257|FG005|Overall Study|Participant left investigator's care|0|||
16985648|NCT01104662|38129258|FG006|Overall Study|Participant left investigator's care|0|||
16985649|NCT01104662|38129259|FG007|Overall Study|Participant left investigator's care|0|||
16985650|NCT01104662|38129252|FG000|Overall Study|Reason not specified|3|||
16985651|NCT01104662|38129253|FG001|Overall Study|Reason not specified|3|||
17134790|NCT03200366|38275950|FG000|6 Month Post-Baseline Interview|Death|1|||
17134791|NCT03200366|38275951|FG001|6 Month Post-Baseline Interview|Death|1|||
17134792|NCT03200366|38275952|FG002|6 Month Post-Baseline Interview|Death|1|||
17134793|NCT03200366|38275950|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
16985652|NCT01104662|38129254|FG002|Overall Study|Reason not specified|0|||
16985653|NCT01104662|38129255|FG003|Overall Study|Reason not specified|0|||
17134794|NCT03200366|38275951|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
17134795|NCT03200366|38275952|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
17134796|NCT03200366|38275950|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
17134797|NCT03200366|38275951|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
17134798|NCT03200366|38275952|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
17134799|NCT03200366|38275950|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
17134800|NCT03200366|38275951|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
17134801|NCT03200366|38275952|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
17134802|NCT03200366|38275950|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
17134803|NCT03200366|38275951|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
17134804|NCT03200366|38275952|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
17134805|NCT03200366|38275950|FG000|9 Month Post-Baseline Interview|Death|1|||
17134806|NCT03200366|38275951|FG001|9 Month Post-Baseline Interview|Death|1|||
17134807|NCT03200366|38275952|FG002|9 Month Post-Baseline Interview|Death|1|||
17134808|NCT03200366|38275950|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
17134809|NCT03200366|38275951|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
17134810|NCT03200366|38275952|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
17134811|NCT03200366|38275950|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
17134812|NCT03200366|38275951|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
17134813|NCT03200366|38275952|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
17134814|NCT03200366|38275950|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
17134815|NCT03200366|38275951|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
17134816|NCT03200366|38275952|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
17134817|NCT00835354|38275964|FG000|First Intervention|Adverse Event|0|||
17134818|NCT00835354|38275965|FG001|First Intervention|Adverse Event|1|||
17134819|NCT00835042|38276009|FG000|First Intervention|Withdrawal by Subject|3|||
17134820|NCT00835042|38276010|FG001|First Intervention|Withdrawal by Subject|0|||
17134821|NCT00835042|38276009|FG000|First Intervention|Adverse Event|1|||
17134822|NCT00835042|38276010|FG001|First Intervention|Adverse Event|2|||
17134823|NCT00835042|38276009|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
17134824|NCT00835042|38276010|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
17134825|NCT00834418|38276047|FG000|Overall Study|Adverse Event|0|||
16985654|NCT01104662|38129256|FG004|Overall Study|Reason not specified|0|||
16985655|NCT01104662|38129257|FG005|Overall Study|Reason not specified|1|||
17134826|NCT00834418|38276048|FG001|Overall Study|Adverse Event|2|||
17134827|NCT00834340|38276054|FG000|Washout|Adverse Event|1|||
17134828|NCT00834340|38276055|FG001|Washout|Adverse Event|0|||
17134829|NCT00834340|38276054|FG000|Washout|Withdrawal by Subject|1|||
17134830|NCT00834340|38276055|FG001|Washout|Withdrawal by Subject|0|||
16985656|NCT01104662|38129258|FG006|Overall Study|Reason not specified|0|||
16985657|NCT01104662|38129259|FG007|Overall Study|Reason not specified|0|||
16985658|NCT01104662|38129252|FG000|Overall Study|Randomized but not treated|3|||
16985659|NCT01104662|38129253|FG001|Overall Study|Randomized but not treated|4|||
16985660|NCT01104662|38129254|FG002|Overall Study|Randomized but not treated|1|||
16985661|NCT01104662|38129255|FG003|Overall Study|Randomized but not treated|0|||
16985662|NCT01104662|38129256|FG004|Overall Study|Randomized but not treated|0|||
16985663|NCT01104662|38129257|FG005|Overall Study|Randomized but not treated|1|||
16985664|NCT01104662|38129258|FG006|Overall Study|Randomized but not treated|0|||
16985665|NCT01104662|38129259|FG007|Overall Study|Randomized but not treated|0|||
16985666|NCT01104584|38129278|FG000|Overall Study|Study drug never administered|21|||
16985667|NCT01104584|38129278|FG000|Overall Study|Study prematurely discontinued|2|||
16985668|NCT01103960|38129302|FG000|Overall Study|Adverse Event|2|||
17134831|NCT00151996|38276061|FG000|Overall Study|Adverse Event|3|||
17134832|NCT00151996|38276062|FG001|Overall Study|Adverse Event|2|||
17134833|NCT00151996|38276061|FG000|Overall Study|Withdrawal by Subject|1|||
17134834|NCT00151996|38276062|FG001|Overall Study|Withdrawal by Subject|1|||
17134835|NCT00151996|38276061|FG000|Overall Study|Protocol Violation|1|||
17134836|NCT00151996|38276062|FG001|Overall Study|Protocol Violation|2|||
17134837|NCT00151996|38276061|FG000|Overall Study|Sponsor's decision|0|||
17134838|NCT00151996|38276062|FG001|Overall Study|Sponsor's decision|2|||
17134839|NCT00830206|38276070|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
17134840|NCT00830206|38276071|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
17134841|NCT00829504|38276077|FG000|First Intervention|Adverse Event|1|||
17134842|NCT00829504|38276078|FG001|First Intervention|Adverse Event|0|||
17134843|NCT00829504|38276077|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
17134844|NCT00829504|38276078|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
17134845|NCT00829504|38276077|FG000|Second Intervention|Physician Decision|1|||
17134846|NCT00829504|38276078|FG001|Second Intervention|Physician Decision|0|||
17134847|NCT00829426|38276084|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
17134848|NCT00829426|38276085|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
17134849|NCT00152464|38276091|FG000|Overall Study|Adverse Event|3|||
17134850|NCT00152464|38276092|FG001|Overall Study|Adverse Event|6|||
17134851|NCT00152464|38276091|FG000|Overall Study|Lost to Follow-up|8|||
17134852|NCT00152464|38276092|FG001|Overall Study|Lost to Follow-up|4|||
17134853|NCT00152464|38276091|FG000|Overall Study|Protocol Violation|3|||
17134854|NCT00152464|38276092|FG001|Overall Study|Protocol Violation|1|||
17134855|NCT00152464|38276091|FG000|Overall Study|Withdrawal by Subject|21|||
17134856|NCT00152464|38276092|FG001|Overall Study|Withdrawal by Subject|22|||
17134857|NCT00152464|38276091|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
17134858|NCT00152464|38276092|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
17134859|NCT00152464|38276091|FG000|Overall Study|Eczema deterioration|0|||
17134860|NCT00152464|38276092|FG001|Overall Study|Eczema deterioration|1|||
17134861|NCT00152464|38276091|FG000|Overall Study|Parent decision|1|||
17134862|NCT00152464|38276092|FG001|Overall Study|Parent decision|1|||
17134863|NCT00152464|38276091|FG000|Overall Study|Investigator decision|1|||
17134864|NCT00152464|38276092|FG001|Overall Study|Investigator decision|0|||
17134865|NCT00152464|38276091|FG000|Overall Study|Lack of Efficacy|1|||
17134866|NCT00152464|38276092|FG001|Overall Study|Lack of Efficacy|0|||
17134867|NCT00152464|38276091|FG000|Overall Study|Eczema poorly controlled|1|||
17134868|NCT00152464|38276092|FG001|Overall Study|Eczema poorly controlled|0|||
17134869|NCT00152464|38276091|FG000|Overall Study|Patient relocated|1|||
17134870|NCT00152464|38276092|FG001|Overall Study|Patient relocated|0|||
17134871|NCT00674440|38276098|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
17134872|NCT00674440|38276098|FG000|Overall Study|did not have surgery, so unevaluable|7|||
17134873|NCT00674440|38276098|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
17134874|NCT02742766|38276122|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16780233|NCT02179918|37719320|FG001|Overall Study|Other|1|||
16985669|NCT01103960|38129303|FG001|Overall Study|Adverse Event|1|||
16985670|NCT01103960|38129302|FG000|Overall Study|Withdrawal by Subject|2|||
16985671|NCT01103960|38129303|FG001|Overall Study|Withdrawal by Subject|1|||
16985672|NCT01103960|38129302|FG000|Overall Study|Other|1|||
16985673|NCT01103960|38129303|FG001|Overall Study|Other|0|||
16985674|NCT01107392|38129311|FG000|Overall Study|Adverse Event|2|||
16985675|NCT01107392|38129312|FG001|Overall Study|Adverse Event|0|||
16985676|NCT01107392|38129311|FG000|Overall Study|Personal Reasons|2|||
16985677|NCT01107392|38129312|FG001|Overall Study|Personal Reasons|3|||
16985678|NCT01107392|38129311|FG000|Overall Study|Administrative decision|1|||
16985679|NCT01107392|38129312|FG001|Overall Study|Administrative decision|0|||
16985680|NCT01106846|38129320|FG000|Overall Study|Change in surgical procedure|0|||
16985681|NCT01106846|38129321|FG001|Overall Study|Change in surgical procedure|1|||
16985682|NCT00902577|38129327|FG000|Overall Study|Withdrawal by Subject|6|||
16985683|NCT00902577|38129327|FG000|Overall Study|FMISO production failure|2|||
16985684|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
17134875|NCT02742766|38276123|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134876|NCT02742766|38276124|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134877|NCT02742766|38276125|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16985685|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
16985686|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
16985687|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
16985688|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
16985689|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
16985690|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
16985691|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
16985692|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
16985693|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
16985694|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
16985695|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
16985696|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
16985697|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
16985698|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
16985699|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16985700|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16985701|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16985702|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
16985703|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16985704|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16985705|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
16985706|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16985707|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16985708|NCT01106690|38129362|FG000|Core Period: Baseline to Week 26|Other|10|||
16985709|NCT01106690|38129363|FG001|Core Period: Baseline to Week 26|Other|2|||
16985710|NCT01106690|38129364|FG002|Core Period: Baseline to Week 26|Other|6|||
16985711|NCT01106690|38129362|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16985712|NCT01106690|38129363|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16985713|NCT01106690|38129364|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16985714|NCT01106690|38129362|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16985715|NCT01106690|38129363|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16985716|NCT01106690|38129364|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16985717|NCT01106690|38129362|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16985718|NCT01106690|38129363|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16985719|NCT01106690|38129364|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16985720|NCT01106690|38129362|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
16985721|NCT01106690|38129363|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
16985722|NCT01106690|38129364|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
16985723|NCT01106690|38129362|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16985724|NCT01106690|38129363|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16985725|NCT01106690|38129364|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16985726|NCT01106690|38129362|FG000|Extension Period: Week 26 to Week 52|Other|8|||
16985727|NCT01106690|38129363|FG001|Extension Period: Week 26 to Week 52|Other|3|||
16985728|NCT01106690|38129364|FG002|Extension Period: Week 26 to Week 52|Other|4|||
16985729|NCT01106690|38129362|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
17134878|NCT02742766|38276126|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134879|NCT02742766|38276127|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16985730|NCT01106690|38129363|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16985731|NCT01106690|38129364|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16985732|NCT01103180|38129394|FG000|Overall Study|Withdrawal by Subject|8|||
16985733|NCT01103180|38129395|FG001|Overall Study|Withdrawal by Subject|13|||
16985734|NCT01103180|38129394|FG000|Overall Study|Lost to Follow-up|13|||
16985735|NCT01103180|38129395|FG001|Overall Study|Lost to Follow-up|7|||
16985736|NCT01103180|38129394|FG000|Overall Study|Physician Decision|1|||
16985737|NCT01103180|38129395|FG001|Overall Study|Physician Decision|0|||
16985738|NCT01103180|38129394|FG000|Overall Study|Protocol Violation|0|||
16985739|NCT01103180|38129395|FG001|Overall Study|Protocol Violation|1|||
16985740|NCT00944034|38129413|FG000|Overall Study|Inappropriate enrollment|0|||
16985741|NCT00944034|38129414|FG001|Overall Study|Inappropriate enrollment|1|||
16985742|NCT00944034|38129415|FG002|Overall Study|Inappropriate enrollment|0|||
16985743|NCT00944034|38129416|FG003|Overall Study|Inappropriate enrollment|1|||
16985744|NCT00944034|38129417|FG004|Overall Study|Inappropriate enrollment|2|||
16985745|NCT00944034|38129418|FG005|Overall Study|Inappropriate enrollment|1|||
16985746|NCT00944034|38129419|FG006|Overall Study|Inappropriate enrollment|0|||
17134880|NCT02742766|38276128|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134881|NCT02742766|38276129|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134882|NCT02742766|38276130|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134883|NCT02742766|38276131|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16985747|NCT00944034|38129420|FG007|Overall Study|Inappropriate enrollment|0|||
16985748|NCT00944034|38129421|FG008|Overall Study|Inappropriate enrollment|1|||
16985749|NCT00944034|38129422|FG009|Overall Study|Inappropriate enrollment|1|||
16985750|NCT00944034|38129423|FG010|Overall Study|Inappropriate enrollment|0|||
16985751|NCT00944034|38129424|FG011|Overall Study|Inappropriate enrollment|0|||
16985752|NCT00944034|38129413|FG000|Overall Study|Withdrawal by Subject|3|||
16985753|NCT00944034|38129414|FG001|Overall Study|Withdrawal by Subject|2|||
16985754|NCT00944034|38129415|FG002|Overall Study|Withdrawal by Subject|6|||
16985755|NCT00944034|38129416|FG003|Overall Study|Withdrawal by Subject|2|||
16985756|NCT00944034|38129417|FG004|Overall Study|Withdrawal by Subject|5|||
16985757|NCT00944034|38129418|FG005|Overall Study|Withdrawal by Subject|8|||
16985758|NCT00944034|38129419|FG006|Overall Study|Withdrawal by Subject|2|||
17134884|NCT02742766|38276132|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134885|NCT02742766|38276133|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16985759|NCT00944034|38129420|FG007|Overall Study|Withdrawal by Subject|2|||
17134886|NCT02742766|38276134|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134887|NCT02742766|38276135|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
16780234|NCT02179918|37719321|FG002|Overall Study|Other|0|||
16985760|NCT00944034|38129421|FG008|Overall Study|Withdrawal by Subject|3|||
16985761|NCT00944034|38129422|FG009|Overall Study|Withdrawal by Subject|4|||
16985762|NCT00944034|38129423|FG010|Overall Study|Withdrawal by Subject|0|||
16985763|NCT00944034|38129424|FG011|Overall Study|Withdrawal by Subject|4|||
16985764|NCT00944034|38129413|FG000|Overall Study|Lost to Follow-up|0|||
16985765|NCT00944034|38129414|FG001|Overall Study|Lost to Follow-up|4|||
16985766|NCT00944034|38129415|FG002|Overall Study|Lost to Follow-up|2|||
16985767|NCT00944034|38129416|FG003|Overall Study|Lost to Follow-up|0|||
16985768|NCT00944034|38129417|FG004|Overall Study|Lost to Follow-up|5|||
16985769|NCT00944034|38129418|FG005|Overall Study|Lost to Follow-up|7|||
16985770|NCT00944034|38129419|FG006|Overall Study|Lost to Follow-up|0|||
16985771|NCT00944034|38129420|FG007|Overall Study|Lost to Follow-up|1|||
16985772|NCT00944034|38129421|FG008|Overall Study|Lost to Follow-up|5|||
16985773|NCT00944034|38129422|FG009|Overall Study|Lost to Follow-up|1|||
17134888|NCT02742766|38276136|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134889|NCT02742766|38276137|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16780235|NCT02179918|37719322|FG003|Overall Study|Other|0|||
16780236|NCT02179918|37719323|FG004|Overall Study|Other|1|||
16780237|NCT02179918|37719319|FG000|Overall Study|Subject refused further follow-up|0|||
16780238|NCT02179918|37719320|FG001|Overall Study|Subject refused further follow-up|1|||
16780239|NCT02179918|37719321|FG002|Overall Study|Subject refused further follow-up|0|||
16780240|NCT02179918|37719322|FG003|Overall Study|Subject refused further follow-up|0|||
16780241|NCT02179918|37719323|FG004|Overall Study|Subject refused further follow-up|1|||
16780242|NCT02611479|37719336|FG000|Baseline Enrollment|Exited study|13|||
16780243|NCT02611479|37719336|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
16780244|NCT02611479|37719336|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
16780245|NCT02611479|37719336|FG000|Data Cleaning|No baseline function or pain metrics|2|||
16985774|NCT00944034|38129423|FG010|Overall Study|Lost to Follow-up|1|||
17134890|NCT02742766|38276138|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16985775|NCT00944034|38129424|FG011|Overall Study|Lost to Follow-up|0|||
16985776|NCT00944034|38129413|FG000|Overall Study|Death|0|||
16985777|NCT00944034|38129414|FG001|Overall Study|Death|0|||
16985778|NCT00944034|38129415|FG002|Overall Study|Death|1|||
16985779|NCT00944034|38129416|FG003|Overall Study|Death|0|||
16985780|NCT00944034|38129417|FG004|Overall Study|Death|0|||
16985781|NCT00944034|38129418|FG005|Overall Study|Death|0|||
16985782|NCT00944034|38129419|FG006|Overall Study|Death|0|||
16985783|NCT00944034|38129420|FG007|Overall Study|Death|0|||
16985784|NCT00944034|38129421|FG008|Overall Study|Death|0|||
16985785|NCT00944034|38129422|FG009|Overall Study|Death|0|||
16985786|NCT00944034|38129423|FG010|Overall Study|Death|0|||
16985787|NCT00944034|38129424|FG011|Overall Study|Death|0|||
16985788|NCT00944034|38129413|FG000|Overall Study|Protocol Violation|2|||
16985789|NCT00944034|38129414|FG001|Overall Study|Protocol Violation|0|||
16985790|NCT00944034|38129415|FG002|Overall Study|Protocol Violation|0|||
16985791|NCT00944034|38129416|FG003|Overall Study|Protocol Violation|1|||
16985792|NCT00944034|38129417|FG004|Overall Study|Protocol Violation|2|||
16985793|NCT00944034|38129418|FG005|Overall Study|Protocol Violation|3|||
16985794|NCT00944034|38129419|FG006|Overall Study|Protocol Violation|0|||
16985795|NCT00944034|38129420|FG007|Overall Study|Protocol Violation|1|||
16985796|NCT00944034|38129421|FG008|Overall Study|Protocol Violation|1|||
16985797|NCT00944034|38129422|FG009|Overall Study|Protocol Violation|4|||
16985798|NCT00944034|38129423|FG010|Overall Study|Protocol Violation|0|||
16985799|NCT00944034|38129424|FG011|Overall Study|Protocol Violation|0|||
16985800|NCT00944034|38129413|FG000|Overall Study|Unable to classify|0|||
16985801|NCT00944034|38129414|FG001|Overall Study|Unable to classify|0|||
16985802|NCT00944034|38129415|FG002|Overall Study|Unable to classify|0|||
16985803|NCT00944034|38129416|FG003|Overall Study|Unable to classify|0|||
16985804|NCT00944034|38129417|FG004|Overall Study|Unable to classify|0|||
16780246|NCT02153788|37719342|FG000|Overall Study|Physician Decision|2|||
16780247|NCT02153788|37719343|FG001|Overall Study|Physician Decision|1|||
16780248|NCT02153398|37719354|FG000|Overall Study|Withdrawal by Subject|1|||
16780249|NCT02153398|37719355|FG001|Overall Study|Withdrawal by Subject|0|||
16780250|NCT02153398|37719356|FG002|Overall Study|Withdrawal by Subject|0|||
16780251|NCT02153398|37719357|FG003|Overall Study|Withdrawal by Subject|0|||
16780252|NCT02153398|37719358|FG004|Overall Study|Withdrawal by Subject|0|||
16780253|NCT02153398|37719354|FG000|Overall Study|Adverse Event|0|||
16780254|NCT02153398|37719355|FG001|Overall Study|Adverse Event|0|||
16985805|NCT00944034|38129418|FG005|Overall Study|Unable to classify|1|||
16985806|NCT00944034|38129419|FG006|Overall Study|Unable to classify|1|||
16985807|NCT00944034|38129420|FG007|Overall Study|Unable to classify|1|||
16985808|NCT00944034|38129421|FG008|Overall Study|Unable to classify|0|||
16985809|NCT00944034|38129422|FG009|Overall Study|Unable to classify|0|||
16985810|NCT00944034|38129423|FG010|Overall Study|Unable to classify|0|||
16985811|NCT00944034|38129424|FG011|Overall Study|Unable to classify|0|||
16985812|NCT00944034|38129413|FG000|Overall Study|Administrative reason|0|||
16780255|NCT02153398|37719356|FG002|Overall Study|Adverse Event|1|||
16780256|NCT02153398|37719357|FG003|Overall Study|Adverse Event|1|||
16780257|NCT02153398|37719358|FG004|Overall Study|Adverse Event|0|||
16780258|NCT02118766|37719372|FG000|Overall Study|Adverse Event|7|||
16780259|NCT02118766|37719373|FG001|Overall Study|Adverse Event|2|||
16780260|NCT02118766|37719372|FG000|Overall Study|Withdrawal by Subject|3|||
16780261|NCT02118766|37719373|FG001|Overall Study|Withdrawal by Subject|6|||
16780262|NCT02118766|37719372|FG000|Overall Study|Lost to Follow-up|5|||
16780263|NCT02118766|37719373|FG001|Overall Study|Lost to Follow-up|4|||
16780264|NCT02118766|37719372|FG000|Overall Study|Withdrawal by parent/guardian|12|||
16780265|NCT02118766|37719373|FG001|Overall Study|Withdrawal by parent/guardian|18|||
16780266|NCT02118766|37719372|FG000|Overall Study|Other|3|||
16780267|NCT02118766|37719373|FG001|Overall Study|Other|1|||
16780268|NCT02614287|37719381|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
16780269|NCT02614287|37719382|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
16780270|NCT02614287|37719381|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
16780271|NCT02614287|37719382|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
16780272|NCT02614287|37719381|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
16780273|NCT02614287|37719382|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
16780274|NCT02614287|37719381|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
16780275|NCT02614287|37719382|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
16780276|NCT02614287|37719381|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
16780277|NCT02614287|37719382|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
16780278|NCT02614287|37719381|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
16780279|NCT02614287|37719382|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
16780280|NCT02614287|37719381|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
16780281|NCT02614287|37719382|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
16780282|NCT02614287|37719381|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
16780283|NCT02614287|37719382|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
16985813|NCT00944034|38129414|FG001|Overall Study|Administrative reason|0|||
16985814|NCT00944034|38129415|FG002|Overall Study|Administrative reason|0|||
16985815|NCT00944034|38129416|FG003|Overall Study|Administrative reason|0|||
16985816|NCT00944034|38129417|FG004|Overall Study|Administrative reason|0|||
16985817|NCT00944034|38129418|FG005|Overall Study|Administrative reason|0|||
17134891|NCT02742766|38276139|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134892|NCT02742766|38276140|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
17134893|NCT02742766|38276122|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134894|NCT02742766|38276123|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134895|NCT02742766|38276124|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134896|NCT02742766|38276125|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134897|NCT02742766|38276126|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134898|NCT02742766|38276127|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134899|NCT02742766|38276128|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134900|NCT02742766|38276129|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134901|NCT02742766|38276130|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134902|NCT02742766|38276131|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134903|NCT02742766|38276132|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134904|NCT02742766|38276133|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134905|NCT02742766|38276134|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
17134906|NCT02742766|38276135|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
16985818|NCT00944034|38129419|FG006|Overall Study|Administrative reason|1|||
16985819|NCT00944034|38129420|FG007|Overall Study|Administrative reason|0|||
16985820|NCT00944034|38129421|FG008|Overall Study|Administrative reason|0|||
16985821|NCT00944034|38129422|FG009|Overall Study|Administrative reason|0|||
16985822|NCT00944034|38129423|FG010|Overall Study|Administrative reason|0|||
16985823|NCT00944034|38129424|FG011|Overall Study|Administrative reason|0|||
17028538|NCT00799487|38172898|FG002|Dose Adjustment Period|Adverse Event|0|||
17028539|NCT00799487|38172896|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
17028540|NCT00799487|38172897|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
17028541|NCT00799487|38172898|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
17028542|NCT00799487|38172896|FG000|Dose Adjustment Period|Investigator Discretion|2|||
17028543|NCT00799487|38172897|FG001|Dose Adjustment Period|Investigator Discretion|0|||
17028544|NCT00799487|38172898|FG002|Dose Adjustment Period|Investigator Discretion|0|||
17028545|NCT00799487|38172896|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
17028546|NCT00799487|38172897|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
17028547|NCT00799487|38172898|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
16985824|NCT01106534|38129467|FG000|Overall Study|Withdrawal by Subject|18|||
16985825|NCT01106534|38129467|FG000|Overall Study|Lost to Follow-up|2|||
17028548|NCT00799487|38172896|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
17028549|NCT00799487|38172897|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
17028550|NCT00799487|38172898|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
17028551|NCT00799487|38172896|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
17028552|NCT00799487|38172897|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
16985826|NCT01106534|38129467|FG000|Overall Study|Death|16|||
16985827|NCT01106534|38129467|FG000|Overall Study|Physician Decision|1|||
16985828|NCT00941304|38129477|FG000|Overall Study|Lost to Follow-up|1|||
16985829|NCT00941304|38129478|FG001|Overall Study|Lost to Follow-up|0|||
16985830|NCT00941304|38129479|FG002|Overall Study|Lost to Follow-up|0|||
16985831|NCT00941304|38129480|FG003|Overall Study|Lost to Follow-up|0|||
16985832|NCT00941304|38129481|FG004|Overall Study|Lost to Follow-up|0|||
16985833|NCT00941070|38129493|FG000|Overall Study|Patient non-compliant|1|||
16985834|NCT01098812|38129502|FG000|Overall Study|Death|2|||
16985835|NCT01098812|38129503|FG001|Overall Study|Death|0|||
16985836|NCT01098812|38129504|FG002|Overall Study|Death|1|||
17028553|NCT00799487|38172898|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
17028554|NCT00799487|38172896|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
17028555|NCT00799487|38172897|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
17028556|NCT00799487|38172898|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
17028557|NCT00799487|38172896|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
17028558|NCT00799487|38172897|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
17028559|NCT00799487|38172898|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
17028560|NCT00799487|38172896|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
17028561|NCT00799487|38172897|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
17028562|NCT00799487|38172898|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
17028563|NCT00799487|38172896|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
17028564|NCT00799487|38172897|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
17028565|NCT00799487|38172898|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
17134907|NCT02742766|38276136|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
16985837|NCT01098812|38129502|FG000|Overall Study|Lost to Follow-up|0|||
16985838|NCT01098812|38129503|FG001|Overall Study|Lost to Follow-up|1|||
16985839|NCT01098812|38129504|FG002|Overall Study|Lost to Follow-up|0|||
16985840|NCT00903201|38129514|FG000|Overall Study|Adverse Event|1|||
16985841|NCT00903201|38129515|FG001|Overall Study|Adverse Event|4|||
16985842|NCT00903201|38129516|FG002|Overall Study|Adverse Event|0|||
16985843|NCT00903201|38129514|FG000|Overall Study|Protocol Violation|2|||
16985844|NCT00903201|38129515|FG001|Overall Study|Protocol Violation|1|||
16985845|NCT00903201|38129516|FG002|Overall Study|Protocol Violation|0|||
16985846|NCT00903201|38129514|FG000|Overall Study|Lost to Follow-up|0|||
16985847|NCT00903201|38129515|FG001|Overall Study|Lost to Follow-up|1|||
16985848|NCT00903201|38129516|FG002|Overall Study|Lost to Follow-up|0|||
16985849|NCT00903201|38129514|FG000|Overall Study|Physician Decision|1|||
16985850|NCT00903201|38129515|FG001|Overall Study|Physician Decision|0|||
16985851|NCT00903201|38129516|FG002|Overall Study|Physician Decision|1|||
16985852|NCT00903201|38129514|FG000|Overall Study|Withdrawal by Subject|1|||
16985853|NCT00903201|38129515|FG001|Overall Study|Withdrawal by Subject|0|||
16985854|NCT00903201|38129516|FG002|Overall Study|Withdrawal by Subject|1|||
16985855|NCT00902265|38129526|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
16985856|NCT00902265|38129526|FG000|Overall Study|Adverse Event|2|||
16985857|NCT00902265|38129526|FG000|Overall Study|Lack of Efficacy|2|||
16985858|NCT00902265|38129526|FG000|Overall Study|Protocol Violation|1|||
16985859|NCT00943722|38129544|FG000|Base Study|Adverse Event|0|||
16985860|NCT00943722|38129545|FG001|Base Study|Adverse Event|0|||
16985861|NCT00943722|38129546|FG002|Base Study|Adverse Event|0|||
16985862|NCT00943722|38129547|FG003|Base Study|Adverse Event|1|||
16985863|NCT00943722|38129548|FG004|Base Study|Adverse Event|0|||
16985864|NCT00943722|38129549|FG005|Base Study|Adverse Event|0|||
17134908|NCT02742766|38276137|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
17134909|NCT02742766|38276138|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134910|NCT02742766|38276139|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134911|NCT02742766|38276140|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
17134912|NCT01468922|38276218|FG000|Overall Study|Screening failure|0|||
17134913|NCT01468922|38276219|FG001|Overall Study|Screening failure|0|||
17134914|NCT01468922|38276220|FG002|Overall Study|Screening failure|0|||
17134915|NCT01468922|38276221|FG003|Overall Study|Screening failure|0|||
17134916|NCT01468922|38276222|FG004|Overall Study|Screening failure|0|||
17134917|NCT01468922|38276223|FG005|Overall Study|Screening failure|0|||
17134918|NCT01468922|38276224|FG006|Overall Study|Screening failure|0|||
17134919|NCT01468922|38276225|FG007|Overall Study|Screening failure|0|||
17134920|NCT01468922|38276226|FG008|Overall Study|Screening failure|1|||
17134921|NCT01468922|38276218|FG000|Overall Study|Per patient choice|1|||
17134922|NCT01468922|38276219|FG001|Overall Study|Per patient choice|0|||
17134923|NCT01468922|38276220|FG002|Overall Study|Per patient choice|0|||
17134924|NCT01468922|38276221|FG003|Overall Study|Per patient choice|0|||
17134925|NCT01468922|38276222|FG004|Overall Study|Per patient choice|0|||
17134926|NCT01468922|38276223|FG005|Overall Study|Per patient choice|0|||
16985865|NCT00943722|38129550|FG006|Base Study|Adverse Event|0|||
16985866|NCT00943722|38129544|FG000|Base Study|Lost to Follow-up|12|||
16985867|NCT00943722|38129545|FG001|Base Study|Lost to Follow-up|8|||
16985868|NCT00943722|38129546|FG002|Base Study|Lost to Follow-up|10|||
16985869|NCT00943722|38129547|FG003|Base Study|Lost to Follow-up|8|||
16985870|NCT00943722|38129548|FG004|Base Study|Lost to Follow-up|11|||
17134927|NCT01468922|38276224|FG006|Overall Study|Per patient choice|0|||
17134928|NCT01468922|38276225|FG007|Overall Study|Per patient choice|0|||
16985871|NCT00943722|38129549|FG005|Base Study|Lost to Follow-up|0|||
16985872|NCT00943722|38129550|FG006|Base Study|Lost to Follow-up|0|||
16985873|NCT00943722|38129544|FG000|Base Study|Physician Decision|1|||
16985874|NCT00943722|38129545|FG001|Base Study|Physician Decision|0|||
16985875|NCT00943722|38129546|FG002|Base Study|Physician Decision|0|||
16985876|NCT00943722|38129547|FG003|Base Study|Physician Decision|0|||
17134929|NCT01468922|38276226|FG008|Overall Study|Per patient choice|0|||
16985877|NCT00943722|38129548|FG004|Base Study|Physician Decision|1|||
16985878|NCT00943722|38129549|FG005|Base Study|Physician Decision|0|||
16985879|NCT00943722|38129550|FG006|Base Study|Physician Decision|0|||
16985880|NCT00943722|38129544|FG000|Base Study|Pregnancy|0|||
16985881|NCT00943722|38129545|FG001|Base Study|Pregnancy|0|||
16985882|NCT00943722|38129546|FG002|Base Study|Pregnancy|1|||
16985883|NCT00943722|38129547|FG003|Base Study|Pregnancy|0|||
16985884|NCT00943722|38129548|FG004|Base Study|Pregnancy|2|||
16985885|NCT00943722|38129549|FG005|Base Study|Pregnancy|0|||
16985886|NCT00943722|38129550|FG006|Base Study|Pregnancy|0|||
16985887|NCT00943722|38129544|FG000|Base Study|Protocol Violation|0|||
16985888|NCT00943722|38129545|FG001|Base Study|Protocol Violation|1|||
16985889|NCT00943722|38129546|FG002|Base Study|Protocol Violation|0|||
16985890|NCT00943722|38129547|FG003|Base Study|Protocol Violation|0|||
16985891|NCT00943722|38129548|FG004|Base Study|Protocol Violation|2|||
16985892|NCT00943722|38129549|FG005|Base Study|Protocol Violation|0|||
16985893|NCT00943722|38129550|FG006|Base Study|Protocol Violation|0|||
16985894|NCT00943722|38129544|FG000|Base Study|Withdrawal by Subject|12|||
16985895|NCT00943722|38129545|FG001|Base Study|Withdrawal by Subject|13|||
16985896|NCT00943722|38129546|FG002|Base Study|Withdrawal by Subject|2|||
16985897|NCT00943722|38129547|FG003|Base Study|Withdrawal by Subject|13|||
16985898|NCT00943722|38129548|FG004|Base Study|Withdrawal by Subject|8|||
16985899|NCT00943722|38129549|FG005|Base Study|Withdrawal by Subject|0|||
16985900|NCT00943722|38129550|FG006|Base Study|Withdrawal by Subject|0|||
16985901|NCT00943722|38129544|FG000|Base Study|Month 12 visit not completed|0|||
16985902|NCT00943722|38129545|FG001|Base Study|Month 12 visit not completed|0|||
16985903|NCT00943722|38129546|FG002|Base Study|Month 12 visit not completed|0|||
16985904|NCT00943722|38129547|FG003|Base Study|Month 12 visit not completed|0|||
16985905|NCT00943722|38129548|FG004|Base Study|Month 12 visit not completed|2|||
16985906|NCT00943722|38129549|FG005|Base Study|Month 12 visit not completed|0|||
16985907|NCT00943722|38129550|FG006|Base Study|Month 12 visit not completed|0|||
16985908|NCT00943722|38129544|FG000|First Extension Study: EXT 1|Adverse Event|0|||
16985909|NCT00943722|38129545|FG001|First Extension Study: EXT 1|Adverse Event|0|||
16985910|NCT00943722|38129546|FG002|First Extension Study: EXT 1|Adverse Event|0|||
16985911|NCT00943722|38129547|FG003|First Extension Study: EXT 1|Adverse Event|0|||
16985912|NCT00943722|38129548|FG004|First Extension Study: EXT 1|Adverse Event|0|||
16985913|NCT00943722|38129549|FG005|First Extension Study: EXT 1|Adverse Event|1|||
16985914|NCT00943722|38129550|FG006|First Extension Study: EXT 1|Adverse Event|0|||
16985915|NCT00943722|38129544|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
16985916|NCT00943722|38129545|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
16985917|NCT00943722|38129546|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
16985918|NCT00943722|38129547|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
16985919|NCT00943722|38129548|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
16985920|NCT00943722|38129549|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
16985921|NCT00943722|38129550|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
16985922|NCT00943722|38129544|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16985923|NCT00943722|38129545|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16985924|NCT00943722|38129546|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16985925|NCT00943722|38129547|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16985926|NCT00943722|38129548|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16985927|NCT00943722|38129549|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
16985928|NCT00943722|38129550|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
16985929|NCT00943722|38129544|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
16985930|NCT00943722|38129545|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
16985931|NCT00943722|38129546|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
16985932|NCT00943722|38129547|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
16985933|NCT00943722|38129548|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
16985934|NCT00943722|38129549|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
16985935|NCT00943722|38129550|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
16985936|NCT00943722|38129544|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
16985937|NCT00943722|38129545|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
16985938|NCT00943722|38129546|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
16985939|NCT00943722|38129547|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
16985940|NCT00943722|38129548|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
16985941|NCT00943722|38129549|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
16985942|NCT00943722|38129550|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
16985943|NCT00943722|38129544|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16985944|NCT00943722|38129545|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16985945|NCT00943722|38129546|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16985946|NCT00943722|38129547|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16985947|NCT00943722|38129548|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16985948|NCT00943722|38129549|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
16985949|NCT00943722|38129550|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
16985950|NCT00943722|38129544|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
16985951|NCT00943722|38129545|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
16985952|NCT00943722|38129546|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
16985953|NCT00943722|38129547|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
16985954|NCT00943722|38129548|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
16985955|NCT00943722|38129549|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
16985956|NCT00943722|38129550|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
16985957|NCT00943722|38129544|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
16985958|NCT00943722|38129545|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
16985959|NCT00943722|38129546|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
16985960|NCT00943722|38129547|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
16985961|NCT00943722|38129548|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
16985962|NCT00943722|38129549|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
16985963|NCT00943722|38129550|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
16985964|NCT00943722|38129544|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16985965|NCT00943722|38129545|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16985966|NCT00943722|38129546|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16985967|NCT00943722|38129547|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16985968|NCT00943722|38129548|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16985969|NCT00943722|38129549|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
16985970|NCT00943722|38129550|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
16985971|NCT00901485|38129573|FG000|Overall Study|Lack of Efficacy|0|||
16985972|NCT00901485|38129574|FG001|Overall Study|Lack of Efficacy|2|||
16985973|NCT00901485|38129573|FG000|Overall Study|Withdrawal by Subject|1|||
16985974|NCT00901485|38129574|FG001|Overall Study|Withdrawal by Subject|2|||
16985975|NCT00896337|38129580|FG000|Overall Study|Death|7|||
16985976|NCT00896337|38129580|FG000|Overall Study|Withdrawal by Subject|7|||
16985977|NCT00896337|38129580|FG000|Overall Study|Lost to Follow-up|11|||
16985978|NCT00953706|38129600|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
16985979|NCT00953706|38129601|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
16985980|NCT00953706|38129602|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
16985981|NCT00953706|38129603|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
16985982|NCT00953706|38129600|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
16985983|NCT00953706|38129601|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
16985984|NCT00953706|38129602|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
16985985|NCT00953706|38129603|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
16985986|NCT00953706|38129600|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
16985987|NCT00953706|38129601|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
16985988|NCT00953706|38129602|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
16985989|NCT00953706|38129603|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
16985990|NCT00953706|38129600|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
16985991|NCT00953706|38129601|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
16985992|NCT00953706|38129602|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
16985993|NCT00953706|38129603|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
16985994|NCT00953706|38129600|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
16985995|NCT00953706|38129601|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
16985996|NCT00953706|38129602|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
16985997|NCT00953706|38129603|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
16985998|NCT00953706|38129600|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
16985999|NCT00953706|38129601|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
16986000|NCT00953706|38129602|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
16986001|NCT00953706|38129603|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
16986002|NCT00953706|38129600|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
16986003|NCT00953706|38129601|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
16986004|NCT00953706|38129602|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
16986005|NCT00953706|38129603|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
16986006|NCT00953706|38129600|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
16986007|NCT00953706|38129601|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
16986008|NCT00953706|38129602|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
16986009|NCT00953706|38129603|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
16986010|NCT00953706|38129600|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
16986011|NCT00953706|38129601|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
16986012|NCT00953706|38129602|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
16986013|NCT00953706|38129603|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
16986014|NCT00953706|38129600|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
17028566|NCT00799487|38172896|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
16986015|NCT00953706|38129601|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
16986016|NCT00953706|38129602|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
16986017|NCT00953706|38129603|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
16986018|NCT00953706|38129600|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
16986019|NCT00953706|38129601|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
16986020|NCT00953706|38129602|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
16986021|NCT00953706|38129603|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
16986022|NCT00940992|38129616|FG000|Overall Study|Adverse Event|2|||
16986023|NCT00940992|38129617|FG001|Overall Study|Adverse Event|0|||
16986024|NCT00940992|38129618|FG002|Overall Study|Adverse Event|1|||
16986025|NCT00940992|38129616|FG000|Overall Study|subject request|2|||
16986026|NCT00940992|38129617|FG001|Overall Study|subject request|1|||
16986027|NCT00940992|38129618|FG002|Overall Study|subject request|0|||
16986028|NCT00940992|38129616|FG000|Overall Study|Lost to Follow-up|0|||
16986029|NCT00940992|38129617|FG001|Overall Study|Lost to Follow-up|1|||
16986030|NCT00940992|38129618|FG002|Overall Study|Lost to Follow-up|1|||
16986031|NCT00938964|38129628|FG000|Overall Study|Death|3|||
16986032|NCT00938964|38129629|FG001|Overall Study|Death|3|||
16986033|NCT00938964|38129628|FG000|Overall Study|Lost to Follow-up|2|||
16986034|NCT00938964|38129629|FG001|Overall Study|Lost to Follow-up|3|||
16986035|NCT00938964|38129628|FG000|Overall Study|Withdrawal by Subject|22|||
16986036|NCT00938964|38129629|FG001|Overall Study|Withdrawal by Subject|18|||
16986037|NCT00938964|38129628|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
16986038|NCT00938964|38129629|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
16986039|NCT00938886|38129637|FG000|Overall Study|Death|0|||
16986040|NCT00938886|38129638|FG001|Overall Study|Death|1|||
16986041|NCT00938886|38129637|FG000|Overall Study|Withdrawal by Subject|4|||
16986042|NCT00938886|38129638|FG001|Overall Study|Withdrawal by Subject|7|||
16986043|NCT00938886|38129637|FG000|Overall Study|Lost to Follow-up|3|||
16986044|NCT00938886|38129638|FG001|Overall Study|Lost to Follow-up|2|||
16986045|NCT00938340|38129644|FG000|Overall Study|Withdrawal by Subject|3|||
16986046|NCT00938340|38129644|FG000|Overall Study|Protocol Violation|1|||
16986047|NCT00938340|38129644|FG000|Overall Study|Adverse Event|1|||
16986048|NCT00942708|38129690|FG000|Overall Study|Withdrawal by Subject|1|||
16986049|NCT00937950|38129695|FG000|Overall Study|Withdrawal by Subject|23|||
16986050|NCT00937950|38129695|FG000|Overall Study|Migrated/moved from study area|27|||
16986051|NCT00937950|38129695|FG000|Overall Study|Lost to Follow-up|144|||
16986052|NCT00937950|38129695|FG000|Overall Study|Missing confirmed|4|||
16986053|NCT00937950|38129695|FG000|Overall Study|Other|18|||
16986054|NCT00942162|38129702|FG000|Overall Study|Death|45|||
17028567|NCT00799487|38172897|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
16986055|NCT00942162|38129703|FG001|Overall Study|Death|35|||
16986056|NCT00942162|38129704|FG002|Overall Study|Death|0|||
16986057|NCT00942162|38129702|FG000|Overall Study|Withdrawal by Subject|7|||
16986058|NCT00942162|38129703|FG001|Overall Study|Withdrawal by Subject|2|||
16986059|NCT00942162|38129704|FG002|Overall Study|Withdrawal by Subject|0|||
16986060|NCT00942162|38129702|FG000|Overall Study|Lost to Follow-up|4|||
16986061|NCT00942162|38129703|FG001|Overall Study|Lost to Follow-up|0|||
16986062|NCT00942162|38129704|FG002|Overall Study|Lost to Follow-up|0|||
16986063|NCT00942162|38129702|FG000|Overall Study|Other|14|||
16986064|NCT00942162|38129703|FG001|Overall Study|Other|13|||
16986065|NCT00942162|38129704|FG002|Overall Study|Other|2|||
16986066|NCT00942084|38129714|FG000|Overall Study|Death|2|||
16986067|NCT00941928|38129718|FG000|Overall Study|Withdrawal by Subject|1|||
16986068|NCT00941928|38129718|FG000|Overall Study|Disease Progression|1|||
16986069|NCT00937560|38129722|FG000|Initial Treatment|Death|6|||
16986070|NCT00937560|38129722|FG000|Initial Treatment|Withdraw consent|3|||
16986071|NCT00937560|38129722|FG000|Initial Treatment|Adverse Event|1|||
16986072|NCT00937560|38129722|FG000|Initial Treatment|Lost to Follow-up|1|||
16986073|NCT00937560|38129722|FG000|Initial Treatment|No end of study page|10|||
16986074|NCT00937560|38129722|FG000|Maintenance Treatment|Death|12|||
16986075|NCT00937560|38129722|FG000|Maintenance Treatment|Withdraw consent|5|||
16986076|NCT00937560|38129722|FG000|Maintenance Treatment|According to protocol|1|||
16986077|NCT00594568|38129729|FG000|Initial Treatment|Adverse Event|51|||
16986078|NCT00594568|38129730|FG001|Initial Treatment|Adverse Event|121|||
16986079|NCT00594568|38129731|FG002|Initial Treatment|Adverse Event|144|||
16986080|NCT00594568|38129729|FG000|Initial Treatment|Death|6|||
16986081|NCT00594568|38129730|FG001|Initial Treatment|Death|11|||
16986082|NCT00594568|38129731|FG002|Initial Treatment|Death|15|||
16986083|NCT00594568|38129729|FG000|Initial Treatment|Lost to Follow-up|4|||
16986084|NCT00594568|38129730|FG001|Initial Treatment|Lost to Follow-up|1|||
16986085|NCT00594568|38129731|FG002|Initial Treatment|Lost to Follow-up|4|||
16986086|NCT00594568|38129729|FG000|Initial Treatment|Physician Decision|3|||
16986087|NCT00594568|38129730|FG001|Initial Treatment|Physician Decision|2|||
16986088|NCT00594568|38129731|FG002|Initial Treatment|Physician Decision|4|||
16986089|NCT00594568|38129729|FG000|Initial Treatment|Protocol Violation|2|||
16986090|NCT00594568|38129730|FG001|Initial Treatment|Protocol Violation|2|||
16986091|NCT00594568|38129731|FG002|Initial Treatment|Protocol Violation|5|||
16986092|NCT00594568|38129729|FG000|Initial Treatment|Withdrawal by Subject|25|||
16986093|NCT00594568|38129730|FG001|Initial Treatment|Withdrawal by Subject|31|||
16986094|NCT00594568|38129731|FG002|Initial Treatment|Withdrawal by Subject|46|||
16986095|NCT00594568|38129729|FG000|Initial Treatment|Sponsor decision|193|||
16986096|NCT00594568|38129730|FG001|Initial Treatment|Sponsor decision|142|||
16986097|NCT00594568|38129731|FG002|Initial Treatment|Sponsor decision|147|||
16986098|NCT00594568|38129729|FG000|Initial Treatment|Caregiver decision|21|||
16986099|NCT00594568|38129730|FG001|Initial Treatment|Caregiver decision|36|||
16986100|NCT00594568|38129731|FG002|Initial Treatment|Caregiver decision|36|||
16986101|NCT00594568|38129729|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
16986102|NCT00594568|38129730|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
16986103|NCT00594568|38129731|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
16986104|NCT00594568|38129729|FG000|Initial Treatment|Entry criteria exclusion|0|||
16986105|NCT00594568|38129730|FG001|Initial Treatment|Entry criteria exclusion|1|||
16986106|NCT00594568|38129731|FG002|Initial Treatment|Entry criteria exclusion|1|||
16986107|NCT00594568|38129729|FG000|Delayed Start|Death|0|||
16986108|NCT00594568|38129730|FG001|Delayed Start|Death|0|||
16986109|NCT00594568|38129731|FG002|Delayed Start|Death|1|||
16986110|NCT00594568|38129729|FG000|Delayed Start|Adverse Event|12|||
16986111|NCT00594568|38129730|FG001|Delayed Start|Adverse Event|2|||
16986112|NCT00594568|38129731|FG002|Delayed Start|Adverse Event|2|||
16986113|NCT00594568|38129729|FG000|Delayed Start|Withdrawal by Subject|4|||
16986114|NCT00594568|38129730|FG001|Delayed Start|Withdrawal by Subject|3|||
16986115|NCT00594568|38129731|FG002|Delayed Start|Withdrawal by Subject|0|||
16986116|NCT00594568|38129729|FG000|Delayed Start|Physician Decision|0|||
16986117|NCT00594568|38129730|FG001|Delayed Start|Physician Decision|0|||
16986118|NCT00594568|38129731|FG002|Delayed Start|Physician Decision|1|||
16986119|NCT00594568|38129729|FG000|Delayed Start|Lost to Follow-up|0|||
16986120|NCT00594568|38129730|FG001|Delayed Start|Lost to Follow-up|0|||
16986121|NCT00594568|38129731|FG002|Delayed Start|Lost to Follow-up|1|||
16986122|NCT00594568|38129729|FG000|Delayed Start|Caregiver Decision|5|||
16986123|NCT00594568|38129730|FG001|Delayed Start|Caregiver Decision|6|||
16986124|NCT00594568|38129731|FG002|Delayed Start|Caregiver Decision|2|||
16986125|NCT00594568|38129729|FG000|Delayed Start|Sponsor Decision|77|||
16986126|NCT00594568|38129730|FG001|Delayed Start|Sponsor Decision|66|||
16986127|NCT00594568|38129731|FG002|Delayed Start|Sponsor Decision|59|||
16986128|NCT00594568|38129729|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
16986129|NCT00594568|38129730|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
16986130|NCT00594568|38129731|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
16986131|NCT00594568|38129729|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
16986132|NCT00594568|38129730|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
16986133|NCT00594568|38129731|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
16986134|NCT00594568|38129729|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
16986135|NCT00594568|38129730|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
16986136|NCT00594568|38129731|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
16986137|NCT00594568|38129729|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
16986138|NCT00594568|38129730|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
16986139|NCT00594568|38129731|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
16986140|NCT00594568|38129729|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
16986141|NCT00594568|38129730|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
16986142|NCT00594568|38129731|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
16986143|NCT00594568|38129729|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
16986144|NCT00594568|38129730|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
16986145|NCT00594568|38129731|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
16986146|NCT00875056|38129759|FG000|Overall Study|Adverse Event|6|||
16986147|NCT00875056|38129760|FG001|Overall Study|Adverse Event|1|||
16986148|NCT00875056|38129761|FG002|Overall Study|Adverse Event|2|||
16986149|NCT00875056|38129759|FG000|Overall Study|Progressive Disease|14|||
16986150|NCT00875056|38129760|FG001|Overall Study|Progressive Disease|8|||
16986151|NCT00875056|38129761|FG002|Overall Study|Progressive Disease|3|||
16986152|NCT00875056|38129759|FG000|Overall Study|Withdrawal by Subject|3|||
16986153|NCT00875056|38129760|FG001|Overall Study|Withdrawal by Subject|0|||
16986154|NCT00875056|38129761|FG002|Overall Study|Withdrawal by Subject|1|||
16986155|NCT00940602|38129771|FG000|Overall Study|Administrative problems|1|||
16986156|NCT00940602|38129772|FG001|Overall Study|Administrative problems|1|||
16986157|NCT00940602|38129771|FG000|Overall Study|Patient/guardian decision|13|||
16986158|NCT00940602|38129772|FG001|Overall Study|Patient/guardian decision|28|||
16986159|NCT00940602|38129771|FG000|Overall Study|Physician Decision|8|||
16986160|NCT00940602|38129772|FG001|Overall Study|Physician Decision|5|||
16986161|NCT00940602|38129771|FG000|Overall Study|Pregnancy|1|||
16986162|NCT00940602|38129772|FG001|Overall Study|Pregnancy|0|||
16986163|NCT00940602|38129771|FG000|Overall Study|Protocol Deviation (untreated)|1|||
16986164|NCT00940602|38129772|FG001|Overall Study|Protocol Deviation (untreated)|0|||
16986165|NCT00940602|38129771|FG000|Overall Study|Disease progression|8|||
16986166|NCT00940602|38129772|FG001|Overall Study|Disease progression|2|||
16986167|NCT00940602|38129771|FG000|Overall Study|Death|38|||
16986168|NCT00940602|38129772|FG001|Overall Study|Death|19|||
16986169|NCT00940602|38129771|FG000|Overall Study|Lost to Follow-up|3|||
16986170|NCT00940602|38129772|FG001|Overall Study|Lost to Follow-up|1|||
16986171|NCT00940602|38129771|FG000|Overall Study|Patient withdrew consent|26|||
16986172|NCT00940602|38129772|FG001|Overall Study|Patient withdrew consent|13|||
16986173|NCT00940602|38129771|FG000|Overall Study|Adverse Event|7|||
16986174|NCT00940602|38129772|FG001|Overall Study|Adverse Event|2|||
16986175|NCT00940602|38129771|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
16986176|NCT00940602|38129772|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
16986177|NCT00874822|38129779|FG000|Overall Study|excluded by criteria|8|||
16986178|NCT00875524|38129785|FG000|Overall Study|Serious adverse event|0|||
16986179|NCT00875524|38129786|FG001|Overall Study|Serious adverse event|1|||
16986180|NCT00875524|38129785|FG000|Overall Study|Protocol Violation|4|||
16986181|NCT00875524|38129786|FG001|Overall Study|Protocol Violation|0|||
16986182|NCT00875524|38129785|FG000|Overall Study|Lost to Follow-up|1|||
16986183|NCT00875524|38129786|FG001|Overall Study|Lost to Follow-up|0|||
16986184|NCT00875524|38129785|FG000|Overall Study|Withdrawal by Subject|3|||
16986185|NCT00875524|38129786|FG001|Overall Study|Withdrawal by Subject|5|||
16986186|NCT01094288|38129800|FG000|Overall Study|Adverse Event|0|||
16986187|NCT01094288|38129801|FG001|Overall Study|Adverse Event|3|||
16986188|NCT01094288|38129802|FG002|Overall Study|Adverse Event|1|||
16986189|NCT01094288|38129803|FG003|Overall Study|Adverse Event|1|||
16986190|NCT01094288|38129804|FG004|Overall Study|Adverse Event|0|||
16986191|NCT01094288|38129805|FG005|Overall Study|Adverse Event|0|||
16986192|NCT01094288|38129806|FG006|Overall Study|Adverse Event|0|||
16986193|NCT01094288|38129807|FG007|Overall Study|Adverse Event|0|||
16986194|NCT01094288|38129800|FG000|Overall Study|Withdrawal by Subject|0|||
16986195|NCT01094288|38129801|FG001|Overall Study|Withdrawal by Subject|1|||
16986196|NCT01094288|38129802|FG002|Overall Study|Withdrawal by Subject|2|||
16986197|NCT01094288|38129803|FG003|Overall Study|Withdrawal by Subject|0|||
16986198|NCT01094288|38129804|FG004|Overall Study|Withdrawal by Subject|0|||
16986199|NCT01094288|38129805|FG005|Overall Study|Withdrawal by Subject|0|||
16986200|NCT01094288|38129806|FG006|Overall Study|Withdrawal by Subject|0|||
16986201|NCT01094288|38129807|FG007|Overall Study|Withdrawal by Subject|2|||
16986202|NCT01094288|38129800|FG000|Overall Study|Initiation of Alternative Therapy|0|||
16986203|NCT01094288|38129801|FG001|Overall Study|Initiation of Alternative Therapy|0|||
16986204|NCT01094288|38129802|FG002|Overall Study|Initiation of Alternative Therapy|1|||
16986205|NCT01094288|38129803|FG003|Overall Study|Initiation of Alternative Therapy|0|||
16986206|NCT01094288|38129804|FG004|Overall Study|Initiation of Alternative Therapy|0|||
16986207|NCT01094288|38129805|FG005|Overall Study|Initiation of Alternative Therapy|0|||
16986208|NCT01094288|38129806|FG006|Overall Study|Initiation of Alternative Therapy|0|||
16986209|NCT01094288|38129807|FG007|Overall Study|Initiation of Alternative Therapy|0|||
16986210|NCT01094288|38129800|FG000|Overall Study|Reason not Specified|2|||
16986211|NCT01094288|38129801|FG001|Overall Study|Reason not Specified|3|||
16986212|NCT01094288|38129802|FG002|Overall Study|Reason not Specified|0|||
16986213|NCT01094288|38129803|FG003|Overall Study|Reason not Specified|1|||
16986214|NCT01094288|38129804|FG004|Overall Study|Reason not Specified|0|||
16986215|NCT01094288|38129805|FG005|Overall Study|Reason not Specified|0|||
16986216|NCT01094288|38129806|FG006|Overall Study|Reason not Specified|0|||
16986217|NCT01094288|38129807|FG007|Overall Study|Reason not Specified|0|||
16986218|NCT01094288|38129800|FG000|Overall Study|Ongoing Participants|0|||
16986219|NCT01094288|38129801|FG001|Overall Study|Ongoing Participants|3|||
16986220|NCT01094288|38129802|FG002|Overall Study|Ongoing Participants|0|||
16986221|NCT01094288|38129803|FG003|Overall Study|Ongoing Participants|0|||
16986222|NCT01094288|38129804|FG004|Overall Study|Ongoing Participants|0|||
16986223|NCT01094288|38129805|FG005|Overall Study|Ongoing Participants|0|||
16986224|NCT01094288|38129806|FG006|Overall Study|Ongoing Participants|0|||
16986225|NCT01094288|38129807|FG007|Overall Study|Ongoing Participants|0|||
16986226|NCT00874120|38129831|FG000|First Intervention|Adverse Event|0|||
16986227|NCT00874120|38129832|FG001|First Intervention|Adverse Event|1|||
16986228|NCT00874120|38129831|FG000|First Intervention|Withdrawal by Subject|2|||
16986229|NCT00874120|38129832|FG001|First Intervention|Withdrawal by Subject|0|||
16986230|NCT00874120|38129831|FG000|First Intervention|Lost to Follow-up|0|||
16986231|NCT00874120|38129832|FG001|First Intervention|Lost to Follow-up|1|||
16986232|NCT00874120|38129831|FG000|First Intervention|Protocol Violation|3|||
16986233|NCT00874120|38129832|FG001|First Intervention|Protocol Violation|0|||
16986234|NCT00874120|38129831|FG000|First Intervention|positive drug test|1|||
16986235|NCT00874120|38129832|FG001|First Intervention|positive drug test|0|||
16986236|NCT00874120|38129831|FG000|Second Intervention|Withdrawal by Subject|1|||
16986237|NCT00874120|38129832|FG001|Second Intervention|Withdrawal by Subject|0|||
16986238|NCT00874120|38129831|FG000|Second Intervention|Protocol Violation|1|||
16986239|NCT00874120|38129832|FG001|Second Intervention|Protocol Violation|0|||
16986240|NCT00939822|38129840|FG000|Overall Study|Lost to Follow-up|1|||
17134930|NCT01468922|38276218|FG000|Overall Study|Switched to alternative treatment|1|||
17134931|NCT01468922|38276219|FG001|Overall Study|Switched to alternative treatment|0|||
17134932|NCT01468922|38276220|FG002|Overall Study|Switched to alternative treatment|0|||
17134933|NCT01468922|38276221|FG003|Overall Study|Switched to alternative treatment|0|||
17134934|NCT01468922|38276222|FG004|Overall Study|Switched to alternative treatment|1|||
17134935|NCT01468922|38276223|FG005|Overall Study|Switched to alternative treatment|0|||
17134936|NCT01468922|38276224|FG006|Overall Study|Switched to alternative treatment|0|||
16986241|NCT00939822|38129841|FG001|Overall Study|Lost to Follow-up|0|||
16986242|NCT00939822|38129840|FG000|Overall Study|withdrew from study due to busy schedule|1|||
16986243|NCT00939822|38129841|FG001|Overall Study|withdrew from study due to busy schedule|1|||
16986244|NCT00939822|38129840|FG000|Overall Study|Mental health issues|0|||
16986245|NCT00939822|38129841|FG001|Overall Study|Mental health issues|2|||
16986246|NCT00939510|38129847|FG000|Overall Study|Withdrawal by Subject|1|||
16986247|NCT01098266|38129853|FG000|Overall Study|Physician Decision|1|||
16986248|NCT01098266|38129854|FG001|Overall Study|Physician Decision|0|||
16986249|NCT01098266|38129853|FG000|Overall Study|Death|3|||
16986250|NCT01098266|38129854|FG001|Overall Study|Death|2|||
16986251|NCT01098266|38129853|FG000|Overall Study|Withdrawal by Subject|3|||
16986252|NCT01098266|38129854|FG001|Overall Study|Withdrawal by Subject|5|||
16986253|NCT00935532|38129862|FG000|Overall Study|Adverse Event|11|||
16986254|NCT00935532|38129863|FG001|Overall Study|Adverse Event|6|||
16986255|NCT00935532|38129862|FG000|Overall Study|Death|1|||
16986256|NCT00935532|38129863|FG001|Overall Study|Death|0|||
16986257|NCT00935532|38129862|FG000|Overall Study|Lost to Follow-up|1|||
16986258|NCT00935532|38129863|FG001|Overall Study|Lost to Follow-up|0|||
16986259|NCT00935532|38129862|FG000|Overall Study|Physician Decision|1|||
16986260|NCT00935532|38129863|FG001|Overall Study|Physician Decision|2|||
16986261|NCT00935532|38129862|FG000|Overall Study|Protocol Violation|2|||
16986262|NCT00935532|38129863|FG001|Overall Study|Protocol Violation|1|||
16986263|NCT00935532|38129862|FG000|Overall Study|Subject Decision|2|||
16986264|NCT00935532|38129863|FG001|Overall Study|Subject Decision|1|||
17134937|NCT01468922|38276225|FG007|Overall Study|Switched to alternative treatment|0|||
17134938|NCT01468922|38276226|FG008|Overall Study|Switched to alternative treatment|0|||
17134939|NCT01468922|38276218|FG000|Overall Study|Enrolled on new protocol|0|||
17134940|NCT01468922|38276219|FG001|Overall Study|Enrolled on new protocol|0|||
17134941|NCT01468922|38276220|FG002|Overall Study|Enrolled on new protocol|0|||
17134942|NCT01468922|38276221|FG003|Overall Study|Enrolled on new protocol|0|||
17134943|NCT01468922|38276222|FG004|Overall Study|Enrolled on new protocol|1|||
17134944|NCT01468922|38276223|FG005|Overall Study|Enrolled on new protocol|0|||
17134945|NCT01468922|38276224|FG006|Overall Study|Enrolled on new protocol|0|||
17134946|NCT01468922|38276225|FG007|Overall Study|Enrolled on new protocol|0|||
17134947|NCT01468922|38276226|FG008|Overall Study|Enrolled on new protocol|0|||
17134948|NCT01468922|38276218|FG000|Overall Study|Adverse Event|0|||
17134949|NCT01468922|38276219|FG001|Overall Study|Adverse Event|0|||
17134950|NCT01468922|38276220|FG002|Overall Study|Adverse Event|0|||
17134951|NCT01468922|38276221|FG003|Overall Study|Adverse Event|0|||
16986265|NCT00935532|38129862|FG000|Overall Study|Sponsor Decision|0|||
16986266|NCT00935532|38129863|FG001|Overall Study|Sponsor Decision|1|||
16986267|NCT00935532|38129862|FG000|Overall Study|Loss Glucose Control|4|||
16986268|NCT00935532|38129863|FG001|Overall Study|Loss Glucose Control|0|||
16986269|NCT01093586|38129869|FG000|Overall Study|Failed to engraft|3|||
16986270|NCT00937404|38129873|FG000|Overall Study|Protocol Violation|1|||
16986271|NCT00937404|38129873|FG000|Overall Study|Withdrawal by Subject|1|||
16986272|NCT01098110|38129880|FG000|Overall Study|Withdrawal by Subject|14|||
16986273|NCT01098110|38129881|FG001|Overall Study|Withdrawal by Subject|24|||
16986274|NCT01098110|38129882|FG002|Overall Study|Withdrawal by Subject|19|||
17134952|NCT01468922|38276222|FG004|Overall Study|Adverse Event|0|||
16986275|NCT01098110|38129880|FG000|Overall Study|Adverse Event|30|||
16986276|NCT01098110|38129881|FG001|Overall Study|Adverse Event|32|||
16986277|NCT01098110|38129882|FG002|Overall Study|Adverse Event|43|||
16986278|NCT01098110|38129880|FG000|Overall Study|Lack of Efficacy|13|||
16986279|NCT01098110|38129881|FG001|Overall Study|Lack of Efficacy|9|||
16986280|NCT01098110|38129882|FG002|Overall Study|Lack of Efficacy|27|||
16986281|NCT01098110|38129880|FG000|Overall Study|Other|4|||
16986282|NCT01098110|38129881|FG001|Overall Study|Other|7|||
16986283|NCT01098110|38129882|FG002|Overall Study|Other|5|||
16986284|NCT01098110|38129880|FG000|Overall Study|Untreated|1|||
16986285|NCT01098110|38129881|FG001|Overall Study|Untreated|1|||
16986286|NCT01098110|38129882|FG002|Overall Study|Untreated|0|||
16986287|NCT01092728|38129892|FG000|Overall Study|Withdrawal by Subject|2|||
16986288|NCT01092728|38129893|FG001|Overall Study|Withdrawal by Subject|0|||
16986289|NCT01092728|38129892|FG000|Overall Study|Adverse Event|0|||
16986290|NCT01092728|38129893|FG001|Overall Study|Adverse Event|1|||
16986291|NCT01092728|38129892|FG000|Overall Study|Disease Progression|1|||
16986292|NCT01092728|38129893|FG001|Overall Study|Disease Progression|13|||
16986293|NCT01092728|38129892|FG000|Overall Study|Prohibited Concomitant Medications|1|||
16986294|NCT01092728|38129893|FG001|Overall Study|Prohibited Concomitant Medications|0|||
16986295|NCT01096550|38129901|FG000|Overall Study|discontinued site|10|||
16780284|NCT01374971|37719393|FG000|Overall Study|Withdrawal by Subject|1|||
16780285|NCT02178592|37719399|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
16780286|NCT02178592|37719400|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
16780287|NCT02178592|37719399|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
16780288|NCT02178592|37719400|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
16780289|NCT02178592|37719399|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
16986296|NCT01096550|38129902|FG001|Overall Study|discontinued site|11|||
16780290|NCT02178592|37719400|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
16986297|NCT01096550|38129901|FG000|Overall Study|non-regular treatment track at clinic|1|||
16986298|NCT01096550|38129902|FG001|Overall Study|non-regular treatment track at clinic|1|||
16986299|NCT01096550|38129901|FG000|Overall Study|clinic readmission|1|||
16986300|NCT01096550|38129902|FG001|Overall Study|clinic readmission|1|||
17028568|NCT00799487|38172898|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
16986301|NCT01096550|38129901|FG000|Overall Study|Withdrawal by Subject|0|||
16986302|NCT01096550|38129902|FG001|Overall Study|Withdrawal by Subject|1|||
16986303|NCT01096550|38129901|FG000|Overall Study|non-African American participant|13|||
16986304|NCT01096550|38129902|FG001|Overall Study|non-African American participant|6|||
16986305|NCT01096550|38129901|FG000|Overall Study|Lost to Follow-up|12|||
16986306|NCT01096550|38129902|FG001|Overall Study|Lost to Follow-up|9|||
16986307|NCT01101542|38129908|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
16986308|NCT01101542|38129908|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
16986309|NCT01101542|38129908|FG000|Year 4 Surveillance Period|Other|287|||
16986310|NCT01101542|38129908|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
16986311|NCT01101542|38129908|FG000|Year 5 Surveillance Period|Pregnancy|1|||
16986312|NCT01101542|38129908|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
16986313|NCT01101542|38129908|FG000|Year 6 Surveillance Period|Pregnancy|1|||
16986314|NCT01101542|38129908|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
16986315|NCT00937326|38129917|FG000|Overall Study|Adverse Event|0|||
16986316|NCT00937326|38129918|FG001|Overall Study|Adverse Event|3|||
16986317|NCT00937326|38129919|FG002|Overall Study|Adverse Event|1|||
16986318|NCT00937326|38129920|FG003|Overall Study|Adverse Event|1|||
16986319|NCT00937326|38129921|FG004|Overall Study|Adverse Event|2|||
16986320|NCT00937326|38129917|FG000|Overall Study|Death|0|||
16986321|NCT00937326|38129918|FG001|Overall Study|Death|0|||
16986322|NCT00937326|38129919|FG002|Overall Study|Death|1|||
16986323|NCT00937326|38129920|FG003|Overall Study|Death|0|||
16986324|NCT00937326|38129921|FG004|Overall Study|Death|0|||
16986325|NCT00937326|38129917|FG000|Overall Study|Withdrawal by Subject|3|||
16986326|NCT00937326|38129918|FG001|Overall Study|Withdrawal by Subject|4|||
16986327|NCT00937326|38129919|FG002|Overall Study|Withdrawal by Subject|1|||
16986328|NCT00937326|38129920|FG003|Overall Study|Withdrawal by Subject|4|||
16780291|NCT02178592|37719399|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
16986329|NCT00937326|38129921|FG004|Overall Study|Withdrawal by Subject|3|||
16986330|NCT00937326|38129917|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
16986331|NCT00937326|38129918|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
16986332|NCT00937326|38129919|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
16986333|NCT00937326|38129920|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
16986334|NCT00937326|38129921|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
16986335|NCT00873730|38129940|FG000|Overall Study|Protocol Deviation|5|||
16986336|NCT00873730|38129941|FG001|Overall Study|Protocol Deviation|2|||
16986337|NCT00873730|38129940|FG000|Overall Study|Adverse Event|0|||
16986338|NCT00873730|38129941|FG001|Overall Study|Adverse Event|2|||
16986339|NCT00873730|38129940|FG000|Overall Study|Withdrawal by Subject|0|||
16986340|NCT00873730|38129941|FG001|Overall Study|Withdrawal by Subject|1|||
16986341|NCT00873730|38129940|FG000|Overall Study|Sponsor decision|1|||
16986342|NCT00873730|38129941|FG001|Overall Study|Sponsor decision|0|||
16986343|NCT01092416|38129947|FG000|Enrollment|Atherectomy device not inserted|3|||
16986344|NCT01092416|38129947|FG000|30-Day Follow-up|Death|2|||
16986345|NCT01092416|38129947|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
16986346|NCT01092416|38129947|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
16986347|NCT01092416|38129947|FG000|12-Month Follow-up|Death|16|||
16986348|NCT01092416|38129947|FG000|12-Month Follow-up|Lost to Follow-up|4|||
16986349|NCT01092416|38129947|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
16986350|NCT01092416|38129947|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
16986351|NCT01092416|38129947|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
16986352|NCT00874432|38129958|FG000|Overall Study|Withdrawal by Subject|1|||
16986353|NCT00874432|38129959|FG001|Overall Study|Withdrawal by Subject|0|||
16986354|NCT00874432|38129960|FG002|Overall Study|Withdrawal by Subject|0|||
16986355|NCT00874432|38129961|FG003|Overall Study|Withdrawal by Subject|0|||
16986356|NCT00874432|38129958|FG000|Overall Study|Physician Decision|1|||
16986357|NCT00874432|38129959|FG001|Overall Study|Physician Decision|0|||
16986358|NCT00874432|38129960|FG002|Overall Study|Physician Decision|0|||
16986359|NCT00874432|38129961|FG003|Overall Study|Physician Decision|0|||
16986360|NCT00874432|38129958|FG000|Overall Study|Other|1|||
16986361|NCT00874432|38129959|FG001|Overall Study|Other|2|||
16986362|NCT00874432|38129960|FG002|Overall Study|Other|8|||
16986363|NCT00874432|38129961|FG003|Overall Study|Other|3|||
16986364|NCT00935220|38129973|FG000|Overall Study|Adverse Event|1|||
16986365|NCT00935220|38129973|FG000|Overall Study|Other reason (not specified)|1|||
16986366|NCT00874276|38129979|FG000|Overall Study|Withdrawal by Subject|1|||
16986367|NCT00874276|38129980|FG001|Overall Study|Withdrawal by Subject|1|||
16986368|NCT00594958|38129991|FG000|Overall Study|Withdrawal by Subject|1|||
16986369|NCT00594958|38129992|FG001|Overall Study|Withdrawal by Subject|0|||
16986370|NCT00594958|38129993|FG002|Overall Study|Withdrawal by Subject|1|||
16986371|NCT00594958|38129991|FG000|Overall Study|Adverse Event|4|||
16986372|NCT00594958|38129992|FG001|Overall Study|Adverse Event|1|||
16986373|NCT00594958|38129993|FG002|Overall Study|Adverse Event|2|||
16986374|NCT00594958|38129991|FG000|Overall Study|Pregnancy|0|||
16986375|NCT00594958|38129992|FG001|Overall Study|Pregnancy|2|||
16986376|NCT00594958|38129993|FG002|Overall Study|Pregnancy|0|||
16986377|NCT00594958|38129991|FG000|Overall Study|Protocol Violation|1|||
16986378|NCT00594958|38129992|FG001|Overall Study|Protocol Violation|0|||
16986379|NCT00594958|38129993|FG002|Overall Study|Protocol Violation|2|||
16986380|NCT00594958|38129991|FG000|Overall Study|Lost to Follow-up|5|||
16986381|NCT00594958|38129992|FG001|Overall Study|Lost to Follow-up|0|||
16986382|NCT00594958|38129993|FG002|Overall Study|Lost to Follow-up|3|||
16986383|NCT00594958|38129991|FG000|Overall Study|administrative|3|||
16986384|NCT00594958|38129992|FG001|Overall Study|administrative|0|||
16986385|NCT00594958|38129993|FG002|Overall Study|administrative|2|||
16986386|NCT00594880|38130003|FG000|Overall Study|Withdrawal by Subject|1|||
16986387|NCT00594880|38130004|FG001|Overall Study|Withdrawal by Subject|1|||
16986388|NCT00594880|38130003|FG000|Overall Study|Lost to Follow-up|1|||
16986389|NCT00594880|38130004|FG001|Overall Study|Lost to Follow-up|0|||
16986390|NCT00871858|38130016|FG000|Overall Study|Protocol Violation|3|||
16986391|NCT00871858|38130017|FG001|Overall Study|Protocol Violation|4|||
16986392|NCT00871858|38130016|FG000|Overall Study|Adverse Event|1|||
16986393|NCT00871858|38130017|FG001|Overall Study|Adverse Event|1|||
16986394|NCT00871858|38130016|FG000|Overall Study|Withdrawal by Subject|1|||
16986395|NCT00871858|38130017|FG001|Overall Study|Withdrawal by Subject|1|||
16986396|NCT00871858|38130016|FG000|Overall Study|Lost to Follow-up|0|||
16986397|NCT00871858|38130017|FG001|Overall Study|Lost to Follow-up|1|||
16986398|NCT00871780|38130023|FG000|Overall Study|Enrolled But Not Treated|6|||
16986399|NCT00871780|38130023|FG000|Overall Study|Withdrawal by Subject|9|||
16986400|NCT00871780|38130023|FG000|Overall Study|Adverse Event|6|||
16986401|NCT00871780|38130023|FG000|Overall Study|Voluntary Discontinuation|4|||
16986402|NCT00871780|38130023|FG000|Overall Study|Death|1|||
16986403|NCT00871780|38130023|FG000|Overall Study|Physician Decision|1|||
16986404|NCT00594178|38130030|FG000|Overall Study|Physician Decision|5|||
16986405|NCT00933270|38130034|FG000|Overall Study|Withdrawal by Subject|26|||
16986406|NCT00933270|38130034|FG000|Overall Study|Insufficient Follow-up|10|||
16986407|NCT00933270|38130034|FG000|Overall Study|Lost to Follow-up|14|||
16986408|NCT00933270|38130034|FG000|Overall Study|Adverse Event|1|||
16986409|NCT00933270|38130034|FG000|Overall Study|Missed Visit|2|||
16986410|NCT00933270|38130034|FG000|Overall Study|Death|24|||
16986411|NCT00933270|38130034|FG000|Overall Study|Moved or would not return|10|||
16986412|NCT00936858|38130039|FG000|Overall Study|Death|3|||
16986413|NCT00936858|38130039|FG000|Overall Study|Progression|29|||
16986414|NCT00936858|38130039|FG000|Overall Study|Withdrawal by Subject|5|||
16986415|NCT00936858|38130039|FG000|Overall Study|Adverse Event|1|||
16986416|NCT00936858|38130039|FG000|Overall Study|Physician Decision|7|||
16986417|NCT00936858|38130039|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
16986418|NCT00936858|38130039|FG000|Overall Study|Lost to Follow-up|1|||
16986419|NCT00872170|38130046|FG000|Overall Study|Adverse Event|1|||
16986420|NCT00872170|38130047|FG001|Overall Study|Adverse Event|0|||
16986421|NCT00936702|38130052|FG000|Overall Study|Disease progression|34|||
16986422|NCT00936702|38130052|FG000|Overall Study|Adverse Event|8|||
16986423|NCT00936702|38130052|FG000|Overall Study|Withdrawal by Subject|2|||
16986424|NCT00936702|38130052|FG000|Overall Study|Alternative Treatment|1|||
16986425|NCT00936702|38130052|FG000|Overall Study|Other|1|||
16986426|NCT00594100|38130056|FG000|Procedure|Technical Failure|9|||
16986427|NCT00594100|38130056|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
16986428|NCT00594100|38130056|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
16986429|NCT00594100|38130056|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
16986430|NCT01092182|38130063|FG000|Overall Study|Death|0|||
16986431|NCT01092182|38130064|FG001|Overall Study|Death|5|||
16986432|NCT01092182|38130065|FG002|Overall Study|Death|3|||
16986433|NCT01092182|38130063|FG000|Overall Study|participant safety|1|||
16986434|NCT01092182|38130064|FG001|Overall Study|participant safety|2|||
16986435|NCT01092182|38130065|FG002|Overall Study|participant safety|0|||
16986436|NCT01092182|38130063|FG000|Overall Study|Physician Decision|0|||
16986437|NCT01092182|38130064|FG001|Overall Study|Physician Decision|6|||
16986438|NCT01092182|38130065|FG002|Overall Study|Physician Decision|0|||
16986439|NCT01092182|38130063|FG000|Overall Study|Did not meet criteria|0|||
16986440|NCT01092182|38130064|FG001|Overall Study|Did not meet criteria|0|||
16986441|NCT01092182|38130065|FG002|Overall Study|Did not meet criteria|25|||
16986442|NCT01092182|38130063|FG000|Overall Study|Non-compliance|0|||
16986443|NCT01092182|38130064|FG001|Overall Study|Non-compliance|3|||
16986444|NCT01092182|38130065|FG002|Overall Study|Non-compliance|0|||
16986445|NCT01092182|38130063|FG000|Overall Study|Participant refused follow-up|0|||
16986446|NCT01092182|38130064|FG001|Overall Study|Participant refused follow-up|2|||
16986447|NCT01092182|38130065|FG002|Overall Study|Participant refused follow-up|0|||
16986448|NCT00932646|38130073|FG000|Overall Study|Adverse Event|2|||
16986449|NCT00932646|38130074|FG001|Overall Study|Adverse Event|1|||
16986450|NCT00932646|38130075|FG002|Overall Study|Adverse Event|1|||
16986451|NCT00932646|38130076|FG003|Overall Study|Adverse Event|1|||
16986452|NCT00932646|38130073|FG000|Overall Study|Lost to Follow-up|2|||
16986453|NCT00932646|38130074|FG001|Overall Study|Lost to Follow-up|1|||
16986454|NCT00932646|38130075|FG002|Overall Study|Lost to Follow-up|0|||
16986455|NCT00932646|38130076|FG003|Overall Study|Lost to Follow-up|0|||
16986456|NCT00932646|38130073|FG000|Overall Study|Withdrawal by Subject|1|||
16986457|NCT00932646|38130074|FG001|Overall Study|Withdrawal by Subject|1|||
16986458|NCT00932646|38130075|FG002|Overall Study|Withdrawal by Subject|3|||
16986459|NCT00932646|38130076|FG003|Overall Study|Withdrawal by Subject|0|||
16986460|NCT00871234|38130090|FG000|Overall Study|Adverse Event|2|||
16986461|NCT00871234|38130090|FG000|Overall Study|Lost to Follow-up|3|||
16986462|NCT01091246|38130097|FG000|Overall Study|Lost to Follow-up|23|||
16986463|NCT01091246|38130098|FG001|Overall Study|Lost to Follow-up|11|||
16986464|NCT01091246|38130099|FG002|Overall Study|Lost to Follow-up|7|||
16986465|NCT01091246|38130097|FG000|Overall Study|Adverse Event|1|||
16986466|NCT01091246|38130098|FG001|Overall Study|Adverse Event|0|||
16986467|NCT01091246|38130099|FG002|Overall Study|Adverse Event|1|||
16986468|NCT01091246|38130097|FG000|Overall Study|Withdrawal by Subject|9|||
16986469|NCT01091246|38130098|FG001|Overall Study|Withdrawal by Subject|5|||
16986470|NCT01091246|38130099|FG002|Overall Study|Withdrawal by Subject|4|||
16986471|NCT01091246|38130097|FG000|Overall Study|Subject not dosed|2|||
16986472|NCT01091246|38130098|FG001|Overall Study|Subject not dosed|0|||
16986473|NCT01091246|38130099|FG002|Overall Study|Subject not dosed|1|||
16986474|NCT01097330|38130111|FG000|Overall Study|Study terminated early|7|||
16986475|NCT01097330|38130112|FG001|Overall Study|Study terminated early|5|||
16986476|NCT00934440|38130118|FG000|Overall Study|Lost to Follow-up|1|||
16986477|NCT00934362|38130125|FG000|Overall Study|Adverse Event|1|||
16986478|NCT00934362|38130126|FG001|Overall Study|Adverse Event|0|||
16986479|NCT00934128|38130134|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
16986480|NCT00934128|38130135|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
16986481|NCT00934128|38130134|FG000|First Intervention (2 Hours)|Adverse Event|4|||
16986482|NCT00934128|38130135|FG001|First Intervention (2 Hours)|Adverse Event|1|||
16986483|NCT00934128|38130134|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
16986484|NCT00934128|38130135|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
16986485|NCT00934128|38130134|FG000|Washout Period (1 Hour)|Patient preference|1|||
16986486|NCT00934128|38130135|FG001|Washout Period (1 Hour)|Patient preference|3|||
16986487|NCT00934128|38130134|FG000|Washout Period (1 Hour)|Pain|1|||
16986488|NCT00934128|38130135|FG001|Washout Period (1 Hour)|Pain|0|||
16986489|NCT00934128|38130134|FG000|Washout Period (1 Hour)|Too tired|1|||
16986490|NCT00934128|38130135|FG001|Washout Period (1 Hour)|Too tired|0|||
16986491|NCT00934128|38130134|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
16986492|NCT00934128|38130135|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
16986493|NCT00934128|38130134|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
16986494|NCT00934128|38130135|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
16986495|NCT00871000|38130143|FG000|Overall Study|Withdrawal by Subject|1|||
16986496|NCT00871000|38130144|FG001|Overall Study|Withdrawal by Subject|0|||
16986497|NCT01096784|38130152|FG000|Overall Study|Withdrawal by Subject|2|||
16986498|NCT01096784|38130153|FG001|Overall Study|Withdrawal by Subject|1|||
16986499|NCT01096784|38130152|FG000|Overall Study|Adverse Event|11|||
16986500|NCT01096784|38130153|FG001|Overall Study|Adverse Event|9|||
16986501|NCT01096784|38130152|FG000|Overall Study|Protocol Deviation|2|||
16986502|NCT01096784|38130153|FG001|Overall Study|Protocol Deviation|2|||
16986503|NCT01096784|38130152|FG000|Overall Study|Administrative Decision|0|||
16986504|NCT01096784|38130153|FG001|Overall Study|Administrative Decision|1|||
16986505|NCT01096784|38130152|FG000|Overall Study|Other Unspecified|0|||
16986506|NCT01096784|38130153|FG001|Overall Study|Other Unspecified|1|||
16986507|NCT00934050|38130167|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
16986508|NCT00934050|38130168|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
16986509|NCT00934050|38130169|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
16986510|NCT00934050|38130170|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
16986511|NCT00934050|38130171|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
16986512|NCT00934050|38130172|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
16986513|NCT00934050|38130167|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
16986514|NCT00934050|38130168|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
16986515|NCT00934050|38130169|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
16986516|NCT00934050|38130170|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
16986517|NCT00934050|38130171|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
16986518|NCT00934050|38130172|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
16986519|NCT00934050|38130167|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16986520|NCT00934050|38130168|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16986521|NCT00934050|38130169|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
16986522|NCT00934050|38130170|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16986523|NCT00934050|38130171|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16986524|NCT00934050|38130172|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16986525|NCT00934050|38130167|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
16986526|NCT00934050|38130168|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
16986527|NCT00934050|38130169|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
16986528|NCT00934050|38130170|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
16986529|NCT00934050|38130171|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
16986530|NCT00934050|38130172|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
16986531|NCT00934050|38130167|FG000|Enrolled After 15 Dec 2009|Death|0|||
16986532|NCT00934050|38130168|FG001|Enrolled After 15 Dec 2009|Death|0|||
16986533|NCT00934050|38130169|FG002|Enrolled After 15 Dec 2009|Death|0|||
16986534|NCT00934050|38130170|FG003|Enrolled After 15 Dec 2009|Death|0|||
16986535|NCT00934050|38130171|FG004|Enrolled After 15 Dec 2009|Death|0|||
16986536|NCT00934050|38130172|FG005|Enrolled After 15 Dec 2009|Death|1|||
16986537|NCT00934050|38130167|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16986538|NCT00934050|38130168|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16986539|NCT00934050|38130169|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16986540|NCT00934050|38130170|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16986541|NCT00934050|38130171|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16986542|NCT00934050|38130172|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
16986543|NCT00934050|38130167|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
16986544|NCT00934050|38130168|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
16986545|NCT00934050|38130169|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
16986546|NCT00934050|38130170|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
16986547|NCT00934050|38130171|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
16986548|NCT00934050|38130172|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
16986549|NCT01091168|38130184|FG000|Overall Study|Progressive disease|250|||
16986550|NCT01091168|38130185|FG001|Overall Study|Progressive disease|234|||
16986551|NCT01091168|38130184|FG000|Overall Study|Adverse Event|21|||
16986552|NCT01091168|38130185|FG001|Overall Study|Adverse Event|24|||
16986553|NCT01091168|38130184|FG000|Overall Study|Lost to Follow-up|0|||
16986554|NCT01091168|38130185|FG001|Overall Study|Lost to Follow-up|1|||
16986555|NCT01091168|38130184|FG000|Overall Study|Physician, patient's decision, other|27|||
16986556|NCT01091168|38130185|FG001|Overall Study|Physician, patient's decision, other|37|||
16986557|NCT00864916|38130193|FG000|Overall Study|Lost to Follow-up|4|||
16986558|NCT00864916|38130194|FG001|Overall Study|Lost to Follow-up|4|||
16986559|NCT00864916|38130193|FG000|Overall Study|Protocol Violation|1|||
16986560|NCT00864916|38130194|FG001|Overall Study|Protocol Violation|0|||
16986561|NCT00864916|38130193|FG000|Overall Study|Withdrawal by Subject|1|||
16986562|NCT00864916|38130194|FG001|Overall Study|Withdrawal by Subject|0|||
16986563|NCT00864682|38130203|FG000|Overall Study|Protocol Violation|2|||
16986564|NCT00864682|38130204|FG001|Overall Study|Protocol Violation|1|||
16986565|NCT00864682|38130205|FG002|Overall Study|Protocol Violation|2|||
16986566|NCT00931944|38130213|FG000|Overall Study|Adverse Event|4|||
16986567|NCT00931944|38130213|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
16986568|NCT00931944|38130213|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
16986569|NCT00931944|38130213|FG000|Overall Study|Death|28|||
16986570|NCT00931944|38130213|FG000|Overall Study|Other|2|||
17134953|NCT01468922|38276223|FG005|Overall Study|Adverse Event|0|||
17134954|NCT01468922|38276224|FG006|Overall Study|Adverse Event|0|||
17134955|NCT01468922|38276225|FG007|Overall Study|Adverse Event|1|||
16986571|NCT00929994|38130217|FG000|Overall Study|Withdrawal by Subject|1|||
16986572|NCT00929994|38130217|FG000|Overall Study|medical issue unrelated to intervention|4|||
16986573|NCT00929994|38130217|FG000|Overall Study|employment|1|||
16986574|NCT01090310|38130228|FG000|Core Study|Adverse Event|2|||
16986575|NCT01090310|38130229|FG001|Core Study|Adverse Event|2|||
16986576|NCT01090310|38130230|FG002|Core Study|Adverse Event|1|||
16986577|NCT01090310|38130231|FG003|Core Study|Adverse Event|1|||
16986578|NCT01090310|38130228|FG000|Core Study|Subject withdrew consent|0|||
16986579|NCT01090310|38130229|FG001|Core Study|Subject withdrew consent|3|||
16986580|NCT01090310|38130230|FG002|Core Study|Subject withdrew consent|1|||
16986581|NCT01090310|38130231|FG003|Core Study|Subject withdrew consent|1|||
16986582|NCT01090310|38130228|FG000|Core Study|Abnormal test procedure result|0|||
16986583|NCT01090310|38130229|FG001|Core Study|Abnormal test procedure result|0|||
16986584|NCT01090310|38130230|FG002|Core Study|Abnormal test procedure result|1|||
16986585|NCT01090310|38130231|FG003|Core Study|Abnormal test procedure result|0|||
16986586|NCT01090310|38130228|FG000|Core Study|Administrative reasons|5|||
16986587|NCT01090310|38130229|FG001|Core Study|Administrative reasons|6|||
16986588|NCT01090310|38130230|FG002|Core Study|Administrative reasons|4|||
16986589|NCT01090310|38130231|FG003|Core Study|Administrative reasons|4|||
16986590|NCT01090310|38130228|FG000|Core Study|Protocol deviation|1|||
16986591|NCT01090310|38130229|FG001|Core Study|Protocol deviation|0|||
16986592|NCT01090310|38130230|FG002|Core Study|Protocol deviation|0|||
16986593|NCT01090310|38130231|FG003|Core Study|Protocol deviation|1|||
16986594|NCT01090310|38130228|FG000|Extension Study|Aministrative problems|13|||
16986595|NCT01090310|38130229|FG001|Extension Study|Aministrative problems|15|||
16986596|NCT01090310|38130230|FG002|Extension Study|Aministrative problems|14|||
16986597|NCT01090310|38130231|FG003|Extension Study|Aministrative problems|18|||
16986598|NCT01090310|38130228|FG000|Extension Study|Adverse Event|0|||
16986599|NCT01090310|38130229|FG001|Extension Study|Adverse Event|0|||
16986600|NCT01090310|38130230|FG002|Extension Study|Adverse Event|0|||
16986601|NCT01090310|38130231|FG003|Extension Study|Adverse Event|1|||
16986602|NCT01090310|38130228|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
17134956|NCT01468922|38276226|FG008|Overall Study|Adverse Event|0|||
17134957|NCT01468922|38276218|FG000|Overall Study|Infection of blood|0|||
17134958|NCT01468922|38276219|FG001|Overall Study|Infection of blood|0|||
17134959|NCT01468922|38276220|FG002|Overall Study|Infection of blood|0|||
17134960|NCT01468922|38276221|FG003|Overall Study|Infection of blood|0|||
17134961|NCT01468922|38276222|FG004|Overall Study|Infection of blood|0|||
17134962|NCT01468922|38276223|FG005|Overall Study|Infection of blood|0|||
17134963|NCT01468922|38276224|FG006|Overall Study|Infection of blood|0|||
17134964|NCT01468922|38276225|FG007|Overall Study|Infection of blood|1|||
17134965|NCT01468922|38276226|FG008|Overall Study|Infection of blood|0|||
16986603|NCT01090310|38130229|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
16986604|NCT01090310|38130230|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
16986605|NCT01090310|38130231|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
16986606|NCT01090310|38130228|FG000|Extension Study|Subject withdrew consent|0|||
16986607|NCT01090310|38130229|FG001|Extension Study|Subject withdrew consent|1|||
16986608|NCT01090310|38130230|FG002|Extension Study|Subject withdrew consent|0|||
16986609|NCT01090310|38130231|FG003|Extension Study|Subject withdrew consent|0|||
16986610|NCT01090076|38130243|FG000|Overall Study|Death|1|||
17134966|NCT01468922|38276218|FG000|Overall Study|Patient choice - surgery|0|||
17134967|NCT01468922|38276219|FG001|Overall Study|Patient choice - surgery|0|||
17134968|NCT01468922|38276220|FG002|Overall Study|Patient choice - surgery|0|||
17134969|NCT01468922|38276221|FG003|Overall Study|Patient choice - surgery|0|||
17134970|NCT01468922|38276222|FG004|Overall Study|Patient choice - surgery|0|||
17134971|NCT01468922|38276223|FG005|Overall Study|Patient choice - surgery|0|||
17134972|NCT01468922|38276224|FG006|Overall Study|Patient choice - surgery|0|||
17134973|NCT01468922|38276225|FG007|Overall Study|Patient choice - surgery|1|||
17134974|NCT01468922|38276226|FG008|Overall Study|Patient choice - surgery|0|||
17134975|NCT01468922|38276218|FG000|Overall Study|Refused further treatment|0|||
17134976|NCT01468922|38276219|FG001|Overall Study|Refused further treatment|0|||
17134977|NCT01468922|38276220|FG002|Overall Study|Refused further treatment|0|||
17134978|NCT01468922|38276221|FG003|Overall Study|Refused further treatment|0|||
17134979|NCT01468922|38276222|FG004|Overall Study|Refused further treatment|0|||
17134980|NCT01468922|38276223|FG005|Overall Study|Refused further treatment|0|||
17134981|NCT01468922|38276224|FG006|Overall Study|Refused further treatment|0|||
17134982|NCT01468922|38276225|FG007|Overall Study|Refused further treatment|1|||
17134983|NCT01468922|38276226|FG008|Overall Study|Refused further treatment|0|||
17134984|NCT01381094|38276249|FG000|Overall Study|Adverse Event|1|||
17134985|NCT01381094|38276250|FG001|Overall Study|Adverse Event|2|||
17134986|NCT01381094|38276251|FG002|Overall Study|Adverse Event|0|||
17134987|NCT01381094|38276252|FG003|Overall Study|Adverse Event|1|||
17134988|NCT01381094|38276253|FG004|Overall Study|Adverse Event|0|||
17134989|NCT01381094|38276249|FG000|Overall Study|Lost to Follow-up|0|||
17134990|NCT01381094|38276250|FG001|Overall Study|Lost to Follow-up|0|||
16986611|NCT01090076|38130244|FG001|Overall Study|Death|1|||
17134991|NCT01381094|38276251|FG002|Overall Study|Lost to Follow-up|0|||
17134992|NCT01381094|38276252|FG003|Overall Study|Lost to Follow-up|0|||
17134993|NCT01381094|38276253|FG004|Overall Study|Lost to Follow-up|1|||
17134994|NCT01381094|38276249|FG000|Overall Study|Withdrawal of informed consent|0|||
17134995|NCT01381094|38276250|FG001|Overall Study|Withdrawal of informed consent|1|||
17134996|NCT01381094|38276251|FG002|Overall Study|Withdrawal of informed consent|0|||
17134997|NCT01381094|38276252|FG003|Overall Study|Withdrawal of informed consent|0|||
17134998|NCT01381094|38276253|FG004|Overall Study|Withdrawal of informed consent|0|||
17134999|NCT01381094|38276249|FG000|Overall Study|Participant given Aranesp injection|1|||
17135000|NCT01381094|38276250|FG001|Overall Study|Participant given Aranesp injection|0|||
17135001|NCT01381094|38276251|FG002|Overall Study|Participant given Aranesp injection|0|||
17135002|NCT01381094|38276252|FG003|Overall Study|Participant given Aranesp injection|0|||
16986612|NCT01090076|38130243|FG000|Overall Study|Withdrawal by Subject|0|||
16986613|NCT01090076|38130244|FG001|Overall Study|Withdrawal by Subject|1|||
16986614|NCT00869050|38130252|FG000|Overall Study|Screen Failure|3|||
16986615|NCT00927186|38130258|FG000|12 Months Primary Study|Adverse Event|5|||
16986616|NCT00927186|38130259|FG001|12 Months Primary Study|Adverse Event|2|||
16986617|NCT00927186|38130258|FG000|12 Months Primary Study|Lost to Follow-up|1|||
16986618|NCT00927186|38130259|FG001|12 Months Primary Study|Lost to Follow-up|0|||
17135003|NCT01381094|38276253|FG004|Overall Study|Participant given Aranesp injection|0|||
16986619|NCT00927186|38130258|FG000|12 Months Primary Study|Protocol Violation|0|||
16986620|NCT00927186|38130259|FG001|12 Months Primary Study|Protocol Violation|1|||
16986621|NCT00927186|38130258|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
16986622|NCT00927186|38130259|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
16986623|NCT00593554|38130270|FG000|Overall Study|Death|1|||
16986624|NCT00593554|38130271|FG001|Overall Study|Death|2|||
16986625|NCT00593554|38130270|FG000|Overall Study|Physician Decision|0|||
16986626|NCT00593554|38130271|FG001|Overall Study|Physician Decision|1|||
16986627|NCT00593554|38130270|FG000|Overall Study|Withdrawal by Subject|1|||
16986628|NCT00593554|38130271|FG001|Overall Study|Withdrawal by Subject|0|||
16986629|NCT00593554|38130270|FG000|Overall Study|Disease Progression|1|||
16986630|NCT00593554|38130271|FG001|Overall Study|Disease Progression|2|||
16986631|NCT01101308|38130277|FG000|Period 1|Adverse Event|2|||
16986632|NCT01101308|38130278|FG001|Period 1|Adverse Event|1|||
16986633|NCT01101308|38130277|FG000|Period 1|Positive for cotinine|1|||
16986634|NCT01101308|38130278|FG001|Period 1|Positive for cotinine|0|||
16986635|NCT00926796|38130287|FG000|Overall Study|Did not receive randomized treatment|4|||
16986636|NCT00926796|38130288|FG001|Overall Study|Did not receive randomized treatment|7|||
16986637|NCT00926796|38130287|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
16986638|NCT00926796|38130288|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
16986639|NCT00926796|38130287|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
16986640|NCT00926796|38130288|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
16986641|NCT00926796|38130287|FG000|Overall Study|Adverse Event|7|||
16986642|NCT00926796|38130288|FG001|Overall Study|Adverse Event|14|||
16986643|NCT00926796|38130287|FG000|Overall Study|Lost to Follow-up|22|||
16986644|NCT00926796|38130288|FG001|Overall Study|Lost to Follow-up|13|||
16986645|NCT00926796|38130287|FG000|Overall Study|Protocol Violation|15|||
16986646|NCT00926796|38130288|FG001|Overall Study|Protocol Violation|11|||
16986647|NCT00926796|38130287|FG000|Overall Study|Withdrawal by Subject|1|||
16986648|NCT00926796|38130288|FG001|Overall Study|Withdrawal by Subject|0|||
16986649|NCT01087736|38130298|FG000|Overall Study|Lost to Follow-up|1|||
16986650|NCT01087736|38130299|FG001|Overall Study|Lost to Follow-up|0|||
16986651|NCT01087736|38130298|FG000|Overall Study|Death|0|||
16986652|NCT01087736|38130299|FG001|Overall Study|Death|1|||
16986653|NCT01087736|38130298|FG000|Overall Study|Withdrawal by Subject|0|||
16986654|NCT01087736|38130299|FG001|Overall Study|Withdrawal by Subject|1|||
16986655|NCT01079936|38130309|FG000|Phase I: MTD|First Remission Status|2|||
16986656|NCT01079936|38130310|FG001|Phase I: MTD|First Remission Status|0|||
16986657|NCT01079936|38130311|FG002|Phase I: MTD|First Remission Status|0|||
16986658|NCT01079936|38130312|FG003|Phase I: MTD|First Remission Status|0|||
16986659|NCT01079936|38130313|FG004|Phase I: MTD|First Remission Status|0|||
16986660|NCT01079936|38130309|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
16986661|NCT01079936|38130310|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
16986662|NCT01079936|38130311|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
16986663|NCT01079936|38130312|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
16986664|NCT01079936|38130313|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
16986665|NCT01079936|38130309|FG000|Phase II|Adverse Event|0|||
16986666|NCT01079936|38130310|FG001|Phase II|Adverse Event|0|||
16986667|NCT01079936|38130311|FG002|Phase II|Adverse Event|1|||
16986668|NCT01079936|38130312|FG003|Phase II|Adverse Event|0|||
16986669|NCT01079936|38130313|FG004|Phase II|Adverse Event|0|||
16986670|NCT01079936|38130309|FG000|Phase II|Insurance Issue|0|||
16986671|NCT01079936|38130310|FG001|Phase II|Insurance Issue|0|||
16986672|NCT01079936|38130311|FG002|Phase II|Insurance Issue|0|||
16986673|NCT01079936|38130312|FG003|Phase II|Insurance Issue|0|||
16986674|NCT01079936|38130313|FG004|Phase II|Insurance Issue|1|||
16986675|NCT00931710|38130326|FG000|Overall Study|Adverse Event|16|||
16986676|NCT00931710|38130327|FG001|Overall Study|Adverse Event|10|||
17135004|NCT03197558|38276265|FG000|Overall Study|Tubes not placed|1|||
16986677|NCT00931710|38130326|FG000|Overall Study|Abnormal test procedure results|2|||
16986678|NCT00931710|38130327|FG001|Overall Study|Abnormal test procedure results|0|||
16986679|NCT00931710|38130326|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
16986680|NCT00931710|38130327|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
16780292|NCT02178592|37719400|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
16780293|NCT02178592|37719399|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
16780294|NCT02178592|37719400|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
16780295|NCT02178592|37719399|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
16780296|NCT02178592|37719400|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
16986681|NCT00931710|38130326|FG000|Overall Study|Patient withdrew consent|4|||
16986682|NCT00931710|38130327|FG001|Overall Study|Patient withdrew consent|9|||
16986683|NCT00931710|38130326|FG000|Overall Study|Lost to Follow-up|6|||
16986684|NCT00931710|38130327|FG001|Overall Study|Lost to Follow-up|5|||
16986685|NCT00931710|38130326|FG000|Overall Study|Protocol deviation|1|||
16986686|NCT00931710|38130327|FG001|Overall Study|Protocol deviation|2|||
16986687|NCT01100528|38130333|FG000|Overall Study|Death|1|||
16986688|NCT01100528|38130333|FG000|Overall Study|Withdrawal by Subject|2|||
16780297|NCT02178592|37719399|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
16986689|NCT01079234|38130340|FG000|Main: Week 0 to 26|Adverse Event|5|||
16986690|NCT01079234|38130341|FG001|Main: Week 0 to 26|Adverse Event|4|||
16986691|NCT01079234|38130342|FG002|Main: Week 0 to 26|Adverse Event|1|||
16986692|NCT01079234|38130343|FG003|Main: Week 0 to 26|Adverse Event|0|||
16986693|NCT01079234|38130340|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
16986694|NCT01079234|38130341|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
16986695|NCT01079234|38130342|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
16986696|NCT01079234|38130343|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
16986697|NCT01079234|38130340|FG000|Main: Week 0 to 26|Protocol Violation|6|||
16986698|NCT01079234|38130341|FG001|Main: Week 0 to 26|Protocol Violation|2|||
16986699|NCT01079234|38130342|FG002|Main: Week 0 to 26|Protocol Violation|4|||
16986700|NCT01079234|38130343|FG003|Main: Week 0 to 26|Protocol Violation|0|||
16986701|NCT01079234|38130340|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
16986702|NCT01079234|38130341|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
16986703|NCT01079234|38130342|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
16986704|NCT01079234|38130343|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
16986705|NCT01079234|38130340|FG000|Main: Week 0 to 26|Unclassified|7|||
16986706|NCT01079234|38130341|FG001|Main: Week 0 to 26|Unclassified|13|||
16986707|NCT01079234|38130342|FG002|Main: Week 0 to 26|Unclassified|4|||
16986708|NCT01079234|38130343|FG003|Main: Week 0 to 26|Unclassified|0|||
16986709|NCT01079234|38130340|FG000|Extension: Week 27 to 52|Adverse Event|0|||
16986710|NCT01079234|38130341|FG001|Extension: Week 27 to 52|Adverse Event|0|||
16986711|NCT01079234|38130342|FG002|Extension: Week 27 to 52|Adverse Event|1|||
16986712|NCT01079234|38130343|FG003|Extension: Week 27 to 52|Adverse Event|0|||
16986713|NCT01079234|38130340|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
16986714|NCT01079234|38130341|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
16986715|NCT01079234|38130342|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
16986716|NCT01079234|38130343|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
16986717|NCT01079234|38130340|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
16986718|NCT01079234|38130341|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
16986719|NCT01079234|38130342|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
16986720|NCT01079234|38130343|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
16986721|NCT01079234|38130340|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
16986722|NCT01079234|38130341|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
16986723|NCT01079234|38130342|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
16986724|NCT01079234|38130343|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
16986725|NCT01079234|38130340|FG000|Extension: Week 27 to 52|Unclassified|0|||
16986726|NCT01079234|38130341|FG001|Extension: Week 27 to 52|Unclassified|0|||
16986727|NCT01079234|38130342|FG002|Extension: Week 27 to 52|Unclassified|4|||
16986728|NCT01079234|38130343|FG003|Extension: Week 27 to 52|Unclassified|7|||
16986729|NCT00931632|38130354|FG000|Overall Study|Withdrawal by Subject|2|||
16986730|NCT00931632|38130355|FG001|Overall Study|Withdrawal by Subject|3|||
16986731|NCT00931632|38130354|FG000|Overall Study|Adverse Event|19|||
16986732|NCT00931632|38130355|FG001|Overall Study|Adverse Event|15|||
16986733|NCT01078922|38130361|FG000|Overall Study|Adverse Event|1|||
16986734|NCT00863746|38130368|FG000|Treatment|Not treated|4|||
16986735|NCT00863746|38130369|FG001|Treatment|Not treated|2|||
16986736|NCT00863746|38130368|FG000|Treatment|Adverse Event|41|||
16986737|NCT00863746|38130369|FG001|Treatment|Adverse Event|16|||
16986738|NCT00863746|38130368|FG000|Treatment|non-compliant with study medication|4|||
16986739|NCT00863746|38130369|FG001|Treatment|non-compliant with study medication|0|||
16986740|NCT00863746|38130368|FG000|Treatment|Consent withdrawn|15|||
16986741|NCT00863746|38130369|FG001|Treatment|Consent withdrawn|14|||
16986742|NCT00863746|38130368|FG000|Treatment|Lost to Follow-up|1|||
16986743|NCT00863746|38130369|FG001|Treatment|Lost to Follow-up|0|||
16986744|NCT00863746|38130368|FG000|Treatment|Protocol Violation|5|||
16986745|NCT00863746|38130369|FG001|Treatment|Protocol Violation|3|||
16986746|NCT00863746|38130368|FG000|Treatment|Other|1|||
16986747|NCT00863746|38130369|FG001|Treatment|Other|0|||
16986748|NCT00863746|38130368|FG000|Survival Follow up|Death|244|||
16986749|NCT00863746|38130369|FG001|Survival Follow up|Death|271|||
16986750|NCT00863746|38130368|FG000|Survival Follow up|Lost to Follow-up|2|||
16986751|NCT00863746|38130369|FG001|Survival Follow up|Lost to Follow-up|1|||
16986752|NCT00863746|38130368|FG000|Survival Follow up|Consent Withdrawn|7|||
16986753|NCT00863746|38130369|FG001|Survival Follow up|Consent Withdrawn|8|||
16986754|NCT00926328|38130377|FG000|Overall Study|Lost to Follow-up|12|||
16986755|NCT00926328|38130378|FG001|Overall Study|Lost to Follow-up|14|||
16986756|NCT00863512|38130386|FG000|Overall Study|Adverse Event|2|||
16986757|NCT00863512|38130387|FG001|Overall Study|Adverse Event|0|||
16986758|NCT00863512|38130386|FG000|Overall Study|Withdrawal by Subject|11|||
16986759|NCT00863512|38130387|FG001|Overall Study|Withdrawal by Subject|0|||
16986760|NCT00863512|38130386|FG000|Overall Study|Physician Decision|1|||
16986761|NCT00863512|38130387|FG001|Overall Study|Physician Decision|0|||
16986762|NCT00868192|38130393|FG000|Overall Study|Ineligible|4|||
16986763|NCT00867568|38130397|FG000|Overall Study|Lack of Efficacy|10|||
16986764|NCT00867568|38130397|FG000|Overall Study|Adverse Event|4|||
16986765|NCT00867568|38130397|FG000|Overall Study|Withdrawal by Subject|1|||
16986766|NCT00930930|38130403|FG000|Overall Study|Death|1|||
16986767|NCT00930930|38130404|FG001|Overall Study|Death|0|||
16986768|NCT00930930|38130403|FG000|Overall Study|Physician Decision|1|||
16986769|NCT00930930|38130404|FG001|Overall Study|Physician Decision|0|||
16986770|NCT00930930|38130403|FG000|Overall Study|Adverse Event|13|||
16986771|NCT00930930|38130404|FG001|Overall Study|Adverse Event|3|||
16986772|NCT00930930|38130403|FG000|Overall Study|Withdrawal by Subject|3|||
16986773|NCT00930930|38130404|FG001|Overall Study|Withdrawal by Subject|1|||
16986774|NCT00930930|38130403|FG000|Overall Study|Disease progression|2|||
16986775|NCT00930930|38130404|FG001|Overall Study|Disease progression|3|||
16986776|NCT00930930|38130403|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
16986777|NCT00930930|38130404|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
16986778|NCT00930930|38130403|FG000|Overall Study|patients not compliant|1|||
16986779|NCT00930930|38130404|FG001|Overall Study|patients not compliant|1|||
16986780|NCT00862654|38130414|FG000|Overall Study|Lack of Efficacy|1|||
16986781|NCT00862654|38130415|FG001|Overall Study|Lack of Efficacy|0|||
16986782|NCT00862654|38130416|FG002|Overall Study|Lack of Efficacy|1|||
16986783|NCT00862654|38130417|FG003|Overall Study|Lack of Efficacy|0|||
16986784|NCT00862654|38130414|FG000|Overall Study|Lost to Follow-up|1|||
16986785|NCT00862654|38130415|FG001|Overall Study|Lost to Follow-up|2|||
16986786|NCT00862654|38130416|FG002|Overall Study|Lost to Follow-up|1|||
16986787|NCT00862654|38130417|FG003|Overall Study|Lost to Follow-up|3|||
16986788|NCT00862654|38130414|FG000|Overall Study|Adverse Event|0|||
16986789|NCT00862654|38130415|FG001|Overall Study|Adverse Event|1|||
16986790|NCT00862654|38130416|FG002|Overall Study|Adverse Event|1|||
16986791|NCT00862654|38130417|FG003|Overall Study|Adverse Event|0|||
16986792|NCT00862654|38130414|FG000|Overall Study|Pregnancy|1|||
16986793|NCT00862654|38130415|FG001|Overall Study|Pregnancy|1|||
16986794|NCT00862654|38130416|FG002|Overall Study|Pregnancy|0|||
16986795|NCT00862654|38130417|FG003|Overall Study|Pregnancy|0|||
16986796|NCT00862654|38130414|FG000|Overall Study|Withdrawal by Subject|2|||
16986797|NCT00862654|38130415|FG001|Overall Study|Withdrawal by Subject|2|||
16986798|NCT00862654|38130416|FG002|Overall Study|Withdrawal by Subject|2|||
16986799|NCT00862654|38130417|FG003|Overall Study|Withdrawal by Subject|3|||
16986800|NCT00862654|38130414|FG000|Overall Study|Subject mistake|0|||
16986801|NCT00862654|38130415|FG001|Overall Study|Subject mistake|1|||
16986802|NCT00862654|38130416|FG002|Overall Study|Subject mistake|0|||
16986803|NCT00862654|38130417|FG003|Overall Study|Subject mistake|0|||
16986804|NCT00862654|38130414|FG000|Overall Study|Familly constraint|0|||
16986805|NCT00862654|38130415|FG001|Overall Study|Familly constraint|1|||
16986806|NCT00862654|38130416|FG002|Overall Study|Familly constraint|0|||
16986807|NCT00862654|38130417|FG003|Overall Study|Familly constraint|0|||
16986808|NCT00862654|38130414|FG000|Overall Study|Never used study drugs|1|||
16986809|NCT00862654|38130415|FG001|Overall Study|Never used study drugs|0|||
16986810|NCT00862654|38130416|FG002|Overall Study|Never used study drugs|0|||
16986811|NCT00862654|38130417|FG003|Overall Study|Never used study drugs|0|||
16986812|NCT00862654|38130414|FG000|Overall Study|Included after end of inclusions|0|||
16986813|NCT00862654|38130415|FG001|Overall Study|Included after end of inclusions|0|||
16986814|NCT00862654|38130416|FG002|Overall Study|Included after end of inclusions|1|||
16986815|NCT00862654|38130417|FG003|Overall Study|Included after end of inclusions|0|||
16986816|NCT00867490|38130427|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
16986817|NCT00867490|38130427|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
16986818|NCT00867490|38130427|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
16986819|NCT00867490|38130427|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
16986820|NCT00867490|38130427|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
16986821|NCT00930774|38130438|FG000|Overall Study|Withdrawal by Subject|1|||
16986822|NCT00930774|38130439|FG001|Overall Study|Withdrawal by Subject|9|||
16986823|NCT00930774|38130440|FG002|Overall Study|Withdrawal by Subject|2|||
16986824|NCT00930774|38130441|FG003|Overall Study|Withdrawal by Subject|0|||
16986825|NCT00867334|38130454|FG000|Overall Study|Withdrawal by Subject|0|||
16986826|NCT00867334|38130455|FG001|Overall Study|Withdrawal by Subject|1|||
16986827|NCT00867334|38130454|FG000|Overall Study|Withdrawal by Subject|1|||
16986828|NCT00867334|38130455|FG001|Overall Study|Withdrawal by Subject|0|||
16986829|NCT00867334|38130454|FG000|Overall Study|Withdrawal by Subject|1|||
16986830|NCT00867334|38130455|FG001|Overall Study|Withdrawal by Subject|0|||
16986831|NCT00925704|38130467|FG000|First Intervention|Withdrew consent|0|||
16986832|NCT00925704|38130468|FG001|First Intervention|Withdrew consent|0|||
16986833|NCT00925704|38130469|FG002|First Intervention|Withdrew consent|0|||
16986834|NCT00925704|38130470|FG003|First Intervention|Withdrew consent|1|||
16986835|NCT00925704|38130471|FG004|First Intervention|Withdrew consent|1|||
16986836|NCT00925704|38130472|FG005|First Intervention|Withdrew consent|0|||
16986837|NCT00925704|38130467|FG000|Second Intervention|Withdrawal by Subject|1|||
16986838|NCT00925704|38130468|FG001|Second Intervention|Withdrawal by Subject|0|||
16986839|NCT00925704|38130469|FG002|Second Intervention|Withdrawal by Subject|0|||
16986840|NCT00925704|38130470|FG003|Second Intervention|Withdrawal by Subject|0|||
16986841|NCT00925704|38130471|FG004|Second Intervention|Withdrawal by Subject|1|||
16986842|NCT00925704|38130472|FG005|Second Intervention|Withdrawal by Subject|0|||
16986843|NCT00925704|38130467|FG000|Third Intervention|Withdrew consent|0|||
16986844|NCT00925704|38130468|FG001|Third Intervention|Withdrew consent|0|||
16986845|NCT00925704|38130469|FG002|Third Intervention|Withdrew consent|0|||
16986846|NCT00925704|38130470|FG003|Third Intervention|Withdrew consent|0|||
16986847|NCT00925704|38130471|FG004|Third Intervention|Withdrew consent|0|||
17135005|NCT03197324|38276271|FG000|Overall Study|Adverse Event|0|||
16986848|NCT00925704|38130472|FG005|Third Intervention|Withdrew consent|1|||
16986849|NCT01076192|38130483|FG000|Overall Study|Other|197|||
16986850|NCT01076036|38130488|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
16986851|NCT01075958|38130492|FG000|Overall Study|Blood sample could not be obtained|44|||
16986852|NCT01096316|38130498|FG000|Overall Study|Lost to Follow-up|15|||
16986853|NCT01096316|38130499|FG001|Overall Study|Lost to Follow-up|9|||
17135006|NCT03197324|38276272|FG001|Overall Study|Adverse Event|1|||
17135007|NCT03162614|38276284|FG000|Overall Study|Lost to Follow-up|2|||
17135008|NCT03162614|38276285|FG001|Overall Study|Lost to Follow-up|1|||
17135009|NCT03162614|38276286|FG002|Overall Study|Lost to Follow-up|1|||
17135010|NCT03162614|38276287|FG003|Overall Study|Lost to Follow-up|1|||
17135011|NCT03162614|38276288|FG004|Overall Study|Lost to Follow-up|2|||
16986854|NCT00925548|38130507|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
16986855|NCT00925548|38130508|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
16986856|NCT00866788|38130519|FG000|Overall Study|Adverse Event|0|||
16986857|NCT00866788|38130520|FG001|Overall Study|Adverse Event|2|||
16986858|NCT00866788|38130521|FG002|Overall Study|Adverse Event|0|||
16986859|NCT00866788|38130522|FG003|Overall Study|Adverse Event|1|||
16986860|NCT00866788|38130519|FG000|Overall Study|Lost to Follow-up|1|||
16986861|NCT00866788|38130520|FG001|Overall Study|Lost to Follow-up|1|||
16986862|NCT00866788|38130521|FG002|Overall Study|Lost to Follow-up|0|||
16986863|NCT00866788|38130522|FG003|Overall Study|Lost to Follow-up|2|||
16986864|NCT00866788|38130519|FG000|Overall Study|Withdrawal by Subject|2|||
16986865|NCT00866788|38130520|FG001|Overall Study|Withdrawal by Subject|1|||
16986866|NCT00866788|38130521|FG002|Overall Study|Withdrawal by Subject|0|||
16986867|NCT00866788|38130522|FG003|Overall Study|Withdrawal by Subject|1|||
17135012|NCT03162614|38276289|FG005|Overall Study|Lost to Follow-up|0|||
17135013|NCT03162614|38276284|FG000|Overall Study|Protocol Violation|0|||
16986868|NCT00866788|38130519|FG000|Overall Study|Pregnancy|0|||
16986869|NCT00866788|38130520|FG001|Overall Study|Pregnancy|1|||
16986870|NCT00866788|38130521|FG002|Overall Study|Pregnancy|0|||
16986871|NCT00866788|38130522|FG003|Overall Study|Pregnancy|0|||
16986872|NCT00866788|38130519|FG000|Overall Study|Disease progression|3|||
16986873|NCT00866788|38130520|FG001|Overall Study|Disease progression|1|||
17135014|NCT03162614|38276285|FG001|Overall Study|Protocol Violation|1|||
17135015|NCT03162614|38276286|FG002|Overall Study|Protocol Violation|0|||
17135016|NCT03162614|38276287|FG003|Overall Study|Protocol Violation|1|||
17135017|NCT03162614|38276288|FG004|Overall Study|Protocol Violation|0|||
17135018|NCT03162614|38276289|FG005|Overall Study|Protocol Violation|0|||
17135019|NCT03162614|38276284|FG000|Overall Study|Withdrawal by Subject|2|||
16780298|NCT02178592|37719400|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
17135020|NCT03162614|38276285|FG001|Overall Study|Withdrawal by Subject|1|||
17135021|NCT03162614|38276286|FG002|Overall Study|Withdrawal by Subject|1|||
17135022|NCT03162614|38276287|FG003|Overall Study|Withdrawal by Subject|1|||
17135023|NCT03162614|38276288|FG004|Overall Study|Withdrawal by Subject|0|||
17135024|NCT03162614|38276289|FG005|Overall Study|Withdrawal by Subject|0|||
17135025|NCT03162614|38276284|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
17135026|NCT03162614|38276285|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
17135027|NCT03162614|38276286|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
17135028|NCT03162614|38276287|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
17135029|NCT03162614|38276288|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
17135030|NCT03162614|38276289|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
17135031|NCT03160898|38276307|FG000|Overall Study|Adverse Event|4|||
16986874|NCT00866788|38130521|FG002|Overall Study|Disease progression|1|||
16986875|NCT00866788|38130522|FG003|Overall Study|Disease progression|0|||
16986876|NCT00866788|38130519|FG000|Overall Study|Physician Decision|0|||
16986877|NCT00866788|38130520|FG001|Overall Study|Physician Decision|0|||
16986878|NCT00866788|38130521|FG002|Overall Study|Physician Decision|1|||
16986879|NCT00866788|38130522|FG003|Overall Study|Physician Decision|1|||
16986880|NCT00860470|38130537|FG000|Overall Study|Death|6|||
16986881|NCT00860470|38130538|FG001|Overall Study|Death|10|||
16986882|NCT00860470|38130537|FG000|Overall Study|Moved away|8|||
16986883|NCT00860470|38130538|FG001|Overall Study|Moved away|10|||
16986884|NCT00860470|38130537|FG000|Overall Study|Lost to Follow-up|34|||
16986885|NCT00860470|38130538|FG001|Overall Study|Lost to Follow-up|39|||
16986886|NCT00923364|38130544|FG000|Overall Study|Death|3|||
16986887|NCT00923364|38130545|FG001|Overall Study|Death|0|||
16986888|NCT00923364|38130544|FG000|Overall Study|Did not go to transplant|1|||
16986889|NCT00923364|38130545|FG001|Overall Study|Did not go to transplant|0|||
16780299|NCT02178592|37719399|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
16986890|NCT01096160|38130560|FG000|Overall Study|Adverse Event|0|||
16986891|NCT01096160|38130561|FG001|Overall Study|Adverse Event|0|||
16986892|NCT01096160|38130562|FG002|Overall Study|Adverse Event|1|||
16986893|NCT01096160|38130563|FG003|Overall Study|Adverse Event|0|||
16986894|NCT01096160|38130564|FG004|Overall Study|Adverse Event|0|||
16986895|NCT01096160|38130565|FG005|Overall Study|Adverse Event|0|||
16986896|NCT01096160|38130566|FG006|Overall Study|Adverse Event|0|||
16986897|NCT01096160|38130567|FG007|Overall Study|Adverse Event|0|||
16986898|NCT01096160|38130568|FG008|Overall Study|Adverse Event|0|||
16986899|NCT01096160|38130569|FG009|Overall Study|Adverse Event|1|||
16986900|NCT01096160|38130560|FG000|Overall Study|Met stopping criteria per protocol|0|||
16986901|NCT01096160|38130561|FG001|Overall Study|Met stopping criteria per protocol|0|||
16986902|NCT01096160|38130562|FG002|Overall Study|Met stopping criteria per protocol|0|||
16986903|NCT01096160|38130563|FG003|Overall Study|Met stopping criteria per protocol|0|||
16986904|NCT01096160|38130564|FG004|Overall Study|Met stopping criteria per protocol|1|||
16986905|NCT01096160|38130565|FG005|Overall Study|Met stopping criteria per protocol|0|||
16986906|NCT01096160|38130566|FG006|Overall Study|Met stopping criteria per protocol|2|||
16986907|NCT01096160|38130567|FG007|Overall Study|Met stopping criteria per protocol|0|||
16986908|NCT01096160|38130568|FG008|Overall Study|Met stopping criteria per protocol|2|||
16986909|NCT01096160|38130569|FG009|Overall Study|Met stopping criteria per protocol|0|||
16986910|NCT00860158|38130604|FG000|Overall Study|Study Terminated|1|||
16986911|NCT00929526|38130610|FG000|Overall Study|Withdrawal by Subject|1|||
16986912|NCT00929526|38130611|FG001|Overall Study|Withdrawal by Subject|11|||
16986913|NCT00929526|38130610|FG000|Overall Study|Lost to Follow-up|8|||
16986914|NCT00929526|38130611|FG001|Overall Study|Lost to Follow-up|12|||
16986915|NCT00929526|38130610|FG000|Overall Study|Other|8|||
16986916|NCT00929526|38130611|FG001|Overall Study|Other|6|||
16986917|NCT00859456|38130617|FG000|Overall Study|Adverse Event|3|||
16986918|NCT00859456|38130617|FG000|Overall Study|Progressive disease|2|||
16986919|NCT00859456|38130617|FG000|Overall Study|Non-compliance|3|||
16986920|NCT01075646|38130625|FG000|Overall Study|Lost to Follow-up|4|||
16986921|NCT01075646|38130626|FG001|Overall Study|Lost to Follow-up|3|||
16986922|NCT01075646|38130627|FG002|Overall Study|Lost to Follow-up|1|||
16986923|NCT01075646|38130628|FG003|Overall Study|Lost to Follow-up|2|||
16986924|NCT01075412|38130640|FG000|Overall Study|Withdrawal by Subject|0|||
16986925|NCT01075412|38130641|FG001|Overall Study|Withdrawal by Subject|1|||
16986926|NCT00799903|38130648|FG000|Overall Study|Investigator Site Closed|25|||
16986927|NCT00799903|38130649|FG001|Overall Study|Investigator Site Closed|23|||
16986928|NCT00799903|38130648|FG000|Overall Study|Withdrawal by Subject|179|||
16986929|NCT00799903|38130649|FG001|Overall Study|Withdrawal by Subject|175|||
16986930|NCT00799903|38130648|FG000|Overall Study|Lost to Follow-up|69|||
16986931|NCT00799903|38130649|FG001|Overall Study|Lost to Follow-up|80|||
16986932|NCT01075256|38130658|FG000|Overall Study|Withdrawal by Subject|1|||
16986933|NCT01075256|38130659|FG001|Overall Study|Withdrawal by Subject|0|||
16986934|NCT01075256|38130660|FG002|Overall Study|Withdrawal by Subject|0|||
16986935|NCT00923130|38130673|FG000|Overall Study|Stopped treatment due to progression|17|||
16986936|NCT00923130|38130673|FG000|Overall Study|Death|1|||
16986937|NCT00923130|38130673|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
16986938|NCT00923130|38130673|FG000|Overall Study|Switched to alternative treatment|2|||
16986939|NCT00923130|38130673|FG000|Overall Study|Refused further treatment|2|||
16986940|NCT03253627|38130679|FG000|Overall Study|Lost to Follow-up|1|||
16986941|NCT03253627|38130680|FG001|Overall Study|Lost to Follow-up|2|||
16986942|NCT03253627|38130679|FG000|Overall Study|Withdrawal by Subject|0|||
16986943|NCT03253627|38130680|FG001|Overall Study|Withdrawal by Subject|2|||
16986944|NCT03253627|38130679|FG000|Overall Study|Inability to complete MRI|1|||
16986945|NCT03253627|38130680|FG001|Overall Study|Inability to complete MRI|0|||
16986946|NCT01075178|38130688|FG000|Subject Matching|eligible but not matched|130|||
16986947|NCT01075178|38130689|FG001|Subject Matching|eligible but not matched|403|||
16986948|NCT01075178|38130688|FG000|Subject Chart Review|died before chart review period|0|||
16986949|NCT01075178|38130689|FG001|Subject Chart Review|died before chart review period|2|||
16986950|NCT01075178|38130688|FG000|Subject Chart Review|no data collected due to site closure|3|||
16986951|NCT01075178|38130689|FG001|Subject Chart Review|no data collected due to site closure|4|||
16986952|NCT01075178|38130688|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
16986953|NCT01075178|38130689|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
16986954|NCT00799825|38130695|FG000|Overall Study|Adverse Event|1|||
16986955|NCT00799825|38130695|FG000|Overall Study|Withdrawal by Subject|6|||
16986956|NCT00799825|38130695|FG000|Overall Study|Lost to Follow-up|38|||
16986957|NCT00799825|38130695|FG000|Overall Study|Pregnancy|3|||
16986958|NCT00799591|38130699|FG000|Overall Study|De-escalation of doses|20|||
16986959|NCT00799591|38130699|FG000|Overall Study|Death|14|||
16986960|NCT00799591|38130699|FG000|Overall Study|Technical failure|12|||
16986961|NCT00799591|38130699|FG000|Overall Study|Resistant germ|11|||
16986962|NCT00799591|38130699|FG000|Overall Study|New infection|4|||
16986963|NCT00799591|38130699|FG000|Overall Study|Resistance germ and technical failure|2|||
16986964|NCT00799591|38130699|FG000|Overall Study|Persistance of fever undetermined origin|1|||
16986965|NCT00799591|38130699|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
16986966|NCT00799591|38130699|FG000|Overall Study|Infectious origin not probable|1|||
16986967|NCT01075100|38130705|FG000|Overall Study|Adverse Event|15|||
16986968|NCT01075100|38130706|FG001|Overall Study|Adverse Event|18|||
16986969|NCT01075100|38130705|FG000|Overall Study|Patient Request|4|||
16986970|NCT01075100|38130706|FG001|Overall Study|Patient Request|4|||
16986971|NCT01075100|38130705|FG000|Overall Study|Investigator Request|2|||
16986972|NCT01075100|38130706|FG001|Overall Study|Investigator Request|1|||
16986973|NCT01075100|38130705|FG000|Overall Study|Disease Progression|25|||
16986974|NCT01075100|38130706|FG001|Overall Study|Disease Progression|29|||
16986975|NCT01075100|38130705|FG000|Overall Study|Other|3|||
16986976|NCT01075100|38130706|FG001|Overall Study|Other|1|||
16986977|NCT00803023|38130718|FG000|Overall Study|Adverse Event|5|||
16986978|NCT00803023|38130719|FG001|Overall Study|Adverse Event|4|||
16986979|NCT00803023|38130720|FG002|Overall Study|Adverse Event|8|||
16986980|NCT00803023|38130721|FG003|Overall Study|Adverse Event|6|||
16986981|NCT00803023|38130718|FG000|Overall Study|Withdrawal by Subject|0|||
16986982|NCT00803023|38130719|FG001|Overall Study|Withdrawal by Subject|2|||
16986983|NCT00803023|38130720|FG002|Overall Study|Withdrawal by Subject|0|||
16986984|NCT00803023|38130721|FG003|Overall Study|Withdrawal by Subject|0|||
16986985|NCT00803023|38130718|FG000|Overall Study|Lost to Follow-up|0|||
16986986|NCT00803023|38130719|FG001|Overall Study|Lost to Follow-up|1|||
16986987|NCT00803023|38130720|FG002|Overall Study|Lost to Follow-up|2|||
16986988|NCT00803023|38130721|FG003|Overall Study|Lost to Follow-up|1|||
16986989|NCT00803023|38130718|FG000|Overall Study|Lack of Efficacy|0|||
16986990|NCT00803023|38130719|FG001|Overall Study|Lack of Efficacy|1|||
17135032|NCT03160898|38276308|FG001|Overall Study|Adverse Event|8|||
17135033|NCT03160898|38276309|FG002|Overall Study|Adverse Event|7|||
17135034|NCT03160898|38276310|FG003|Overall Study|Adverse Event|10|||
17135035|NCT03160898|38276307|FG000|Overall Study|Death|1|||
17135036|NCT03160898|38276308|FG001|Overall Study|Death|0|||
17135037|NCT03160898|38276309|FG002|Overall Study|Death|0|||
17135038|NCT03160898|38276310|FG003|Overall Study|Death|1|||
17135039|NCT03160898|38276307|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
17135040|NCT03160898|38276308|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
17135041|NCT03160898|38276309|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
17135042|NCT03160898|38276310|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
17135043|NCT03160898|38276307|FG000|Overall Study|Lost to Follow-up|1|||
17135044|NCT03160898|38276308|FG001|Overall Study|Lost to Follow-up|1|||
17135045|NCT03160898|38276309|FG002|Overall Study|Lost to Follow-up|1|||
17135046|NCT03160898|38276310|FG003|Overall Study|Lost to Follow-up|2|||
16986991|NCT00803023|38130720|FG002|Overall Study|Lack of Efficacy|1|||
16986992|NCT00803023|38130721|FG003|Overall Study|Lack of Efficacy|1|||
16986993|NCT00859222|38130734|FG000|Overall Study|Adverse Event|2|||
16986994|NCT00859222|38130735|FG001|Overall Study|Adverse Event|3|||
16986995|NCT00859222|38130736|FG002|Overall Study|Adverse Event|6|||
16986996|NCT00859222|38130737|FG003|Overall Study|Adverse Event|24|||
16986997|NCT00859222|38130738|FG004|Overall Study|Adverse Event|15|||
16986998|NCT00859222|38130734|FG000|Overall Study|DLT|1|||
16986999|NCT00859222|38130735|FG001|Overall Study|DLT|0|||
16987000|NCT00859222|38130736|FG002|Overall Study|DLT|0|||
16987001|NCT00859222|38130737|FG003|Overall Study|DLT|0|||
16987002|NCT00859222|38130738|FG004|Overall Study|DLT|0|||
16987003|NCT01072448|38130755|FG000|Overall Study|Adverse Event|9|||
16987004|NCT01072448|38130756|FG001|Overall Study|Adverse Event|10|||
17135047|NCT03160898|38276307|FG000|Overall Study|Physician Decision|1|||
16987005|NCT01072448|38130755|FG000|Overall Study|Subject withdrew consent|4|||
16987006|NCT01072448|38130756|FG001|Overall Study|Subject withdrew consent|9|||
16987007|NCT01072448|38130755|FG000|Overall Study|Protocol deviation|3|||
16987008|NCT01072448|38130756|FG001|Overall Study|Protocol deviation|4|||
16987009|NCT01072448|38130755|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16987010|NCT01072448|38130756|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16987011|NCT01072448|38130755|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16987012|NCT01072448|38130756|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16987013|NCT01072448|38130755|FG000|Overall Study|Lost to Follow-up|1|||
16987014|NCT01072448|38130756|FG001|Overall Study|Lost to Follow-up|1|||
16987015|NCT01072448|38130755|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16987016|NCT01072448|38130756|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16987017|NCT01072448|38130755|FG000|Overall Study|Death|0|||
16987018|NCT01072448|38130756|FG001|Overall Study|Death|2|||
16987019|NCT00922974|38130765|FG000|Phase II Component|Protocol Violation|2|||
16987020|NCT00922974|38130766|FG001|Phase II Component|Protocol Violation|0|||
16987021|NCT00922974|38130765|FG000|Phase II Component|Not evaluable for treatment review|5|||
16987022|NCT00922974|38130766|FG001|Phase II Component|Not evaluable for treatment review|0|||
16987023|NCT00922974|38130765|FG000|Phase III Component|Protocol Violation|8|||
16987024|NCT00922974|38130766|FG001|Phase III Component|Protocol Violation|6|||
16987025|NCT00858988|38130776|FG000|Analysis|Lactulose unable to be detected in urine|2|||
16987026|NCT00858988|38130777|FG001|Analysis|Lactulose unable to be detected in urine|1|||
16987027|NCT00858832|38130785|FG000|Overall Study|became ineligible: delivered vaginally|1|||
16987028|NCT00858832|38130786|FG001|Overall Study|became ineligible: delivered vaginally|0|||
16987029|NCT00858832|38130785|FG000|Overall Study|Adverse Event|0|||
16987030|NCT00858832|38130786|FG001|Overall Study|Adverse Event|1|||
16987031|NCT01071512|38130792|FG000|Overall Study|Adverse Event|1|||
16987032|NCT01071512|38130792|FG000|Overall Study|Development of antibodies to drug|2|||
16987033|NCT01071512|38130792|FG000|Overall Study|positive anti-JC virus antibody test|2|||
16987034|NCT00858442|38130798|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
16987035|NCT00858442|38130799|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
16987036|NCT01071278|38130806|FG000|Overall Study|Premature Discontinuation|254|||
16987037|NCT01071278|38130806|FG000|Overall Study|Completion Status Unknown|459|||
16987038|NCT00858208|38130812|FG000|Overall Study|Adverse Event|3|||
16987039|NCT00858208|38130812|FG000|Overall Study|Lost to Follow-up|26|||
16987040|NCT00858208|38130812|FG000|Overall Study|Participant refused|40|||
16987041|NCT00858208|38130812|FG000|Overall Study|Other|10|||
16987042|NCT01071200|38130818|FG000|Overall Study|Lack of ovarian response|1|||
16987043|NCT01071200|38130819|FG001|Overall Study|Lack of ovarian response|1|||
16987044|NCT01071200|38130818|FG000|Overall Study|No fertilization|4|||
16987045|NCT01071200|38130819|FG001|Overall Study|No fertilization|0|||
16987046|NCT01071200|38130818|FG000|Overall Study|No oocytes retrieved|1|||
16987047|NCT01071200|38130819|FG001|Overall Study|No oocytes retrieved|1|||
16987048|NCT01071200|38130818|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
16987049|NCT01071200|38130819|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
16987050|NCT01071200|38130818|FG000|Overall Study|No viable embryos|0|||
16987051|NCT01071200|38130819|FG001|Overall Study|No viable embryos|1|||
16987052|NCT02207569|38130825|FG000|1-Month|Death|6|||
16987053|NCT02207569|38130825|FG000|1-Month|Withdrawal by Subject|2|||
16987054|NCT02207569|38130825|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
16987055|NCT02207569|38130825|FG000|6-Month|Death|8|||
16987056|NCT02207569|38130825|FG000|6-Month|Withdrawal by Subject|2|||
16987057|NCT02207569|38130825|FG000|12-Month|Death|14|||
16987058|NCT02207569|38130825|FG000|12-Month|Withdrawal by Subject|2|||
17135048|NCT03160898|38276308|FG001|Overall Study|Physician Decision|0|||
17135049|NCT03160898|38276309|FG002|Overall Study|Physician Decision|0|||
17135050|NCT03160898|38276310|FG003|Overall Study|Physician Decision|1|||
17135051|NCT03160898|38276307|FG000|Overall Study|Progressive Disease|4|||
17135052|NCT03160898|38276308|FG001|Overall Study|Progressive Disease|1|||
17135053|NCT03160898|38276309|FG002|Overall Study|Progressive Disease|2|||
16987059|NCT02207569|38130825|FG000|24-Month|Death|23|||
16987060|NCT02207569|38130825|FG000|24-Month|Withdrawal by Subject|3|||
16987061|NCT02207569|38130825|FG000|36-Month|Death|23|||
16987062|NCT02207569|38130825|FG000|36-Month|Withdrawal by Subject|4|||
16987063|NCT02207569|38130825|FG000|48-Month|Death|25|||
16987064|NCT02207569|38130825|FG000|48-Month|Withdrawal by Subject|2|||
16987065|NCT02207569|38130825|FG000|48-Month|Lost to Follow-up|4|||
16987066|NCT02207569|38130825|FG000|60-Month|Death|1|||
16987067|NCT02207569|38130825|FG000|60-Month|Lost to Follow-up|1|||
16987068|NCT02207569|38130825|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
16987069|NCT02207569|38130825|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
16987070|NCT01070966|38130829|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
16987071|NCT01070966|38130829|FG000|Participants for Safety Evaluation|Off-label use|9|||
16987072|NCT01070966|38130829|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
16987073|NCT01070966|38130829|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
17135054|NCT03160898|38276310|FG003|Overall Study|Progressive Disease|1|||
17135055|NCT03160898|38276307|FG000|Overall Study|Protocol Violation|1|||
17135056|NCT03160898|38276308|FG001|Overall Study|Protocol Violation|0|||
17135057|NCT03160898|38276309|FG002|Overall Study|Protocol Violation|2|||
17135058|NCT03160898|38276310|FG003|Overall Study|Protocol Violation|0|||
17135059|NCT03160898|38276307|FG000|Overall Study|Sponsor Discretion|2|||
17135060|NCT03160898|38276308|FG001|Overall Study|Sponsor Discretion|0|||
17135061|NCT03160898|38276309|FG002|Overall Study|Sponsor Discretion|0|||
17135062|NCT03160898|38276310|FG003|Overall Study|Sponsor Discretion|0|||
16987074|NCT01070966|38130829|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
16987075|NCT01070966|38130829|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
16987076|NCT01070966|38130829|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
16987077|NCT01070966|38130829|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
16987078|NCT01070888|38130842|FG000|First Intervention (14 Days)|Adverse Event|0|||
16987079|NCT01070888|38130843|FG001|First Intervention (14 Days)|Adverse Event|1|||
16987080|NCT01070888|38130842|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
16987081|NCT01070888|38130843|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
16987082|NCT01070888|38130842|FG000|Washout (14 Days)|Physician Decision|1|||
16987083|NCT01070888|38130843|FG001|Washout (14 Days)|Physician Decision|0|||
16987084|NCT00857896|38130849|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
16987085|NCT00857818|38130856|FG000|Overall Study|Lack of Efficacy|1|||
16987086|NCT00857818|38130857|FG001|Overall Study|Lack of Efficacy|0|||
16987087|NCT00857818|38130856|FG000|Overall Study|Adverse Event|3|||
16987088|NCT00857818|38130857|FG001|Overall Study|Adverse Event|0|||
16987089|NCT00857818|38130856|FG000|Overall Study|Withdrawal by Subject|0|||
16987090|NCT00857818|38130857|FG001|Overall Study|Withdrawal by Subject|4|||
16987091|NCT00857818|38130856|FG000|Overall Study|Sponsor terminated study|6|||
16987092|NCT00857818|38130857|FG001|Overall Study|Sponsor terminated study|4|||
16987093|NCT00857818|38130856|FG000|Overall Study|Investigator decision|1|||
16987094|NCT00857818|38130857|FG001|Overall Study|Investigator decision|0|||
16987095|NCT01074944|38130863|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
16987096|NCT01074944|38130864|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
16987097|NCT01074944|38130865|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
16987098|NCT01074944|38130866|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
16987099|NCT01074944|38130867|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
16987100|NCT01074944|38130863|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
16987101|NCT01074944|38130864|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
16987102|NCT01074944|38130865|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
16987103|NCT01074944|38130866|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
16987104|NCT01074944|38130867|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
16987105|NCT01074944|38130863|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
16987106|NCT01074944|38130864|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
16987107|NCT01074944|38130865|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
16987108|NCT01074944|38130866|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
16987109|NCT01074944|38130867|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
16987110|NCT01074944|38130863|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
16987111|NCT01074944|38130864|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
16987112|NCT01074944|38130865|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
16987113|NCT01074944|38130866|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
16987114|NCT01074944|38130867|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
16987115|NCT01074944|38130863|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
16987116|NCT01074944|38130864|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
16987117|NCT01074944|38130865|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
16987118|NCT01074944|38130866|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
16987119|NCT01074944|38130867|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
16987120|NCT01074944|38130863|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
16987121|NCT01074944|38130864|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
16987122|NCT01074944|38130865|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
16987123|NCT01074944|38130866|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
16987124|NCT01074944|38130867|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
16987125|NCT01074944|38130863|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
16987126|NCT01074944|38130864|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
16987127|NCT01074944|38130865|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
16987128|NCT01074944|38130866|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
16987129|NCT01074944|38130867|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
16987130|NCT01074944|38130863|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
16987131|NCT01074944|38130864|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
16987132|NCT01074944|38130865|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
16987133|NCT01074944|38130866|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
17135063|NCT03160898|38276307|FG000|Overall Study|Withdrawal by Subject|1|||
16987134|NCT01074944|38130867|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
16987135|NCT01074944|38130863|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
16987136|NCT01074944|38130864|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
16987137|NCT01074944|38130865|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
16987138|NCT01074944|38130866|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
16987139|NCT01074944|38130867|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
16987140|NCT01074944|38130863|FG000|Long Term Treatment|Adverse Event|0|||
16987141|NCT01074944|38130864|FG001|Long Term Treatment|Adverse Event|0|||
16987142|NCT01074944|38130865|FG002|Long Term Treatment|Adverse Event|0|||
16987143|NCT01074944|38130866|FG003|Long Term Treatment|Adverse Event|3|||
16987144|NCT01074944|38130867|FG004|Long Term Treatment|Adverse Event|0|||
16987145|NCT01074944|38130863|FG000|Long Term Treatment|Lost to Follow-up|0|||
16987146|NCT01074944|38130864|FG001|Long Term Treatment|Lost to Follow-up|0|||
16987147|NCT01074944|38130865|FG002|Long Term Treatment|Lost to Follow-up|0|||
16987148|NCT01074944|38130866|FG003|Long Term Treatment|Lost to Follow-up|2|||
16987149|NCT01074944|38130867|FG004|Long Term Treatment|Lost to Follow-up|0|||
16987150|NCT01074944|38130863|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
16987151|NCT01074944|38130864|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
16987152|NCT01074944|38130865|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
16987153|NCT01074944|38130866|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
16987154|NCT01074944|38130867|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
16987155|NCT01074944|38130863|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
16987156|NCT01074944|38130864|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
16987157|NCT01074944|38130865|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
16987158|NCT01074944|38130866|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
16987159|NCT01074944|38130867|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
16987160|NCT01074944|38130863|FG000|Long Term Treatment|Withdrawal by Subject|0|||
16987161|NCT01074944|38130864|FG001|Long Term Treatment|Withdrawal by Subject|0|||
16987162|NCT01074944|38130865|FG002|Long Term Treatment|Withdrawal by Subject|0|||
16987163|NCT01074944|38130866|FG003|Long Term Treatment|Withdrawal by Subject|2|||
16987164|NCT01074944|38130867|FG004|Long Term Treatment|Withdrawal by Subject|0|||
16987165|NCT01074944|38130863|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
16987166|NCT01074944|38130864|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
16987167|NCT01074944|38130865|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
16987168|NCT01074944|38130866|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
16987169|NCT01074944|38130867|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
16987170|NCT01074944|38130863|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
16987171|NCT01074944|38130864|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
16987172|NCT01074944|38130865|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
16987173|NCT01074944|38130866|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
16987174|NCT01074944|38130867|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
16987175|NCT00802945|38130877|FG000|Overall Study|Death|27|||
16987176|NCT00802945|38130878|FG001|Overall Study|Death|23|||
16987177|NCT00802945|38130877|FG000|Overall Study|Terminated by sponsor|8|||
16987178|NCT00802945|38130878|FG001|Overall Study|Terminated by sponsor|12|||
16987179|NCT01074554|38130888|FG000|Overall Study|Adverse Event|3|||
16987180|NCT01074554|38130889|FG001|Overall Study|Adverse Event|3|||
16987181|NCT01074554|38130888|FG000|Overall Study|Lost to Follow-up|0|||
16987182|NCT01074554|38130889|FG001|Overall Study|Lost to Follow-up|1|||
16987183|NCT00857584|38130897|FG000|Overall Study|Lack of Efficacy|1|||
16987184|NCT00857584|38130898|FG001|Overall Study|Lack of Efficacy|2|||
16987185|NCT00857584|38130897|FG000|Overall Study|Adverse Event|2|||
16987186|NCT00857584|38130898|FG001|Overall Study|Adverse Event|2|||
16987187|NCT00857584|38130897|FG000|Overall Study|Physician Decision|1|||
16987188|NCT00857584|38130898|FG001|Overall Study|Physician Decision|1|||
16987189|NCT00798967|38130906|FG000|Overall Study|Adverse Event|2|||
16987190|NCT00798967|38130907|FG001|Overall Study|Adverse Event|3|||
16987191|NCT00798967|38130906|FG000|Overall Study|Withdrawal by Subject|0|||
16987192|NCT00798967|38130907|FG001|Overall Study|Withdrawal by Subject|1|||
16987193|NCT00798967|38130906|FG000|Overall Study|Physician Decision|1|||
16987194|NCT00798967|38130907|FG001|Overall Study|Physician Decision|0|||
16987195|NCT00798967|38130906|FG000|Overall Study|Randomized in error by site|1|||
16987196|NCT00798967|38130907|FG001|Overall Study|Randomized in error by site|0|||
16987197|NCT01074242|38130914|FG000|Overall Study|Case report before date of contract|40|||
16987198|NCT01074242|38130914|FG000|Overall Study|Lost to Follow-up|1|||
16987199|NCT01074242|38130914|FG000|Overall Study|Case report unclear|6|||
16987200|NCT01074242|38130914|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
16987201|NCT01074242|38130914|FG000|Overall Study|Duplicate Case Report Form|5|||
16987202|NCT00798889|38130918|FG000|Overall Study|Adverse Event|53|||
16987203|NCT00798889|38130918|FG000|Overall Study|Protocol Violation|2|||
16987204|NCT00798889|38130918|FG000|Overall Study|Withdrawal by Subject|31|||
16987205|NCT00798889|38130918|FG000|Overall Study|Lost to Follow-up|1|||
16987206|NCT00798889|38130918|FG000|Overall Study|Lack of Efficacy|213|||
16987207|NCT00798889|38130918|FG000|Overall Study|Decision of Sponsor|11|||
16987208|NCT00798889|38130918|FG000|Overall Study|Enrolled, Not treated|3|||
16987209|NCT00796861|38130922|FG000|Overall Study|Withdrawal by Subject|2|||
16987210|NCT00796861|38130922|FG000|Overall Study|Death|2|||
16987211|NCT00802867|38130926|FG000|Overall Study|Lost to Follow-up|6|||
16987212|NCT00802867|38130926|FG000|Overall Study|Protocol Violation|6|||
16987213|NCT00802867|38130926|FG000|Overall Study|Withdrawal by Subject|1|||
16987214|NCT00798655|38130930|FG000|Overall Study|Did not receive at least one dose of pan|2|||
16987215|NCT00796549|38130934|FG000|Overall Study|Adverse Event|11|||
16987216|NCT00796549|38130934|FG000|Overall Study|not entered|149|||
16987217|NCT00796549|38130934|FG000|Overall Study|Other|2|||
16987218|NCT00796549|38130934|FG000|Overall Study|Progressive disease|56|||
16987219|NCT00856492|38130943|FG000|Overall Study|Ineligible or withdrew consent|1|||
16987220|NCT00856492|38130944|FG001|Overall Study|Ineligible or withdrew consent|1|||
16987221|NCT00856492|38130945|FG002|Overall Study|Ineligible or withdrew consent|2|||
16987222|NCT00856180|38130956|FG000|Overall Study|Adverse Event|4|||
16987223|NCT00856180|38130956|FG000|Overall Study|Progressive Disease|16|||
16987224|NCT00900627|38130968|FG000|Overall Study|Condition under investigation worsened|4|||
16987225|NCT00900627|38130969|FG001|Overall Study|Condition under investigation worsened|0|||
16987226|NCT00900627|38130970|FG002|Overall Study|Condition under investigation worsened|5|||
16987227|NCT00900627|38130971|FG003|Overall Study|Condition under investigation worsened|3|||
16987228|NCT00900627|38130972|FG004|Overall Study|Condition under investigation worsened|0|||
16987229|NCT00900627|38130973|FG005|Overall Study|Condition under investigation worsened|0|||
16987230|NCT00900627|38130968|FG000|Overall Study|Withdrawal by Subject|1|||
16987231|NCT00900627|38130969|FG001|Overall Study|Withdrawal by Subject|0|||
16987232|NCT00900627|38130970|FG002|Overall Study|Withdrawal by Subject|1|||
16987233|NCT00900627|38130971|FG003|Overall Study|Withdrawal by Subject|0|||
17135064|NCT03160898|38276308|FG001|Overall Study|Withdrawal by Subject|3|||
17135065|NCT03160898|38276309|FG002|Overall Study|Withdrawal by Subject|2|||
17135066|NCT03160898|38276310|FG003|Overall Study|Withdrawal by Subject|1|||
17135067|NCT03160898|38276307|FG000|Overall Study|Other|2|||
17135068|NCT03160898|38276308|FG001|Overall Study|Other|0|||
17135069|NCT03160898|38276309|FG002|Overall Study|Other|2|||
17135070|NCT03160898|38276310|FG003|Overall Study|Other|2|||
17135071|NCT03193736|38276321|FG000|Overall Study|Death|2|||
16987234|NCT00900627|38130972|FG004|Overall Study|Withdrawal by Subject|1|||
16987235|NCT00900627|38130973|FG005|Overall Study|Withdrawal by Subject|2|||
16987236|NCT00900627|38130968|FG000|Overall Study|Adverse Event|1|||
16987237|NCT00900627|38130969|FG001|Overall Study|Adverse Event|2|||
16987238|NCT00900627|38130970|FG002|Overall Study|Adverse Event|0|||
16987239|NCT00900627|38130971|FG003|Overall Study|Adverse Event|3|||
16987240|NCT00900627|38130972|FG004|Overall Study|Adverse Event|0|||
16987241|NCT00900627|38130973|FG005|Overall Study|Adverse Event|0|||
16987242|NCT00900627|38130968|FG000|Overall Study|Death|0|||
16987243|NCT00900627|38130969|FG001|Overall Study|Death|0|||
16987244|NCT00900627|38130970|FG002|Overall Study|Death|0|||
16987245|NCT00900627|38130971|FG003|Overall Study|Death|0|||
16987246|NCT00900627|38130972|FG004|Overall Study|Death|28|||
16987247|NCT00900627|38130973|FG005|Overall Study|Death|24|||
16987248|NCT00866320|38130987|FG000|Overall Study|Withdrawal by Subject|4|||
16987249|NCT00866320|38130987|FG000|Overall Study|Death|2|||
16987250|NCT00869518|38130995|FG000|Overall Study|Lost to Follow-up|1|||
16987251|NCT00869518|38130996|FG001|Overall Study|Lost to Follow-up|1|||
16987252|NCT00797563|38131002|FG000|Overall Study|Adverse Event|1|||
16987253|NCT00869440|38131010|FG000|Overall Study|Withdrawal by Subject|1|||
16987254|NCT00869440|38131011|FG001|Overall Study|Withdrawal by Subject|0|||
16987255|NCT00869440|38131012|FG002|Overall Study|Withdrawal by Subject|0|||
16987256|NCT00869440|38131013|FG003|Overall Study|Withdrawal by Subject|0|||
16987257|NCT00869440|38131010|FG000|Overall Study|Physician Decision|1|||
16987258|NCT00869440|38131011|FG001|Overall Study|Physician Decision|1|||
16987259|NCT00869440|38131012|FG002|Overall Study|Physician Decision|0|||
16987260|NCT00869440|38131013|FG003|Overall Study|Physician Decision|0|||
17135072|NCT03193736|38276321|FG000|Overall Study|Withdrawal by Subject|1|||
16987261|NCT00895947|38131025|FG000|Overall Study|Adverse Event|3|||
16987262|NCT00895947|38131026|FG001|Overall Study|Adverse Event|4|||
16987263|NCT00895947|38131025|FG000|Overall Study|Lost to Follow-up|3|||
16987264|NCT00895947|38131026|FG001|Overall Study|Lost to Follow-up|4|||
16987265|NCT00895947|38131025|FG000|Overall Study|Protocol Violation|4|||
16987266|NCT00895947|38131026|FG001|Overall Study|Protocol Violation|2|||
16987267|NCT00895947|38131025|FG000|Overall Study|Withdrawal by Subject|2|||
16987268|NCT00895947|38131026|FG001|Overall Study|Withdrawal by Subject|0|||
16987269|NCT00869362|38131034|FG000|Overall Study|Death|0|||
16987270|NCT00869362|38131035|FG001|Overall Study|Death|2|||
16987271|NCT00869362|38131034|FG000|Overall Study|Lost to Follow-up|1|||
16987272|NCT00869362|38131035|FG001|Overall Study|Lost to Follow-up|3|||
16987273|NCT00588445|38131042|FG000|Overall Study|Protocol Violation|1|||
16987274|NCT00588445|38131042|FG000|Overall Study|Withdrawal by Subject|3|||
16987275|NCT00588445|38131042|FG000|Overall Study|Disease Progression|1|||
16987276|NCT00588445|38131042|FG000|Overall Study|Not Treated|10|||
16987277|NCT00796315|38131048|FG000|Overall Study|Protocol Violation|0|||
16987278|NCT00796315|38131049|FG001|Overall Study|Protocol Violation|1|||
16987279|NCT00796315|38131050|FG002|Overall Study|Protocol Violation|0|||
16987280|NCT00855166|38131063|FG000|Overall Study|Adverse Event|0|||
16987281|NCT00855166|38131064|FG001|Overall Study|Adverse Event|2|||
16987282|NCT00855166|38131063|FG000|Overall Study|Death|0|||
16987283|NCT00855166|38131064|FG001|Overall Study|Death|1|||
16987284|NCT00855166|38131063|FG000|Overall Study|Withdrawal by Subject|1|||
16987285|NCT00855166|38131064|FG001|Overall Study|Withdrawal by Subject|4|||
16987286|NCT00855166|38131063|FG000|Overall Study|Poor/non-compliance|2|||
16987287|NCT00855166|38131064|FG001|Overall Study|Poor/non-compliance|0|||
16987288|NCT00855166|38131063|FG000|Overall Study|Administrative reasons by sponsor|1|||
16987289|NCT00855166|38131064|FG001|Overall Study|Administrative reasons by sponsor|0|||
16987290|NCT00855166|38131063|FG000|Overall Study|Subject no longer meets study criteria|1|||
16987291|NCT00855166|38131064|FG001|Overall Study|Subject no longer meets study criteria|1|||
16987292|NCT00587587|38131074|FG000|Overall Study|Lost to Follow-up|6|||
16987293|NCT00587587|38131075|FG001|Overall Study|Lost to Follow-up|1|||
16987294|NCT00854620|38131083|FG000|Overall Study|Adverse Event|1|||
16987295|NCT00793585|38131089|FG000|Overall Study|Adverse Event|1|||
16987296|NCT00793585|38131090|FG001|Overall Study|Adverse Event|1|||
16987297|NCT00793585|38131089|FG000|Overall Study|Protocol Violation|1|||
16987298|NCT00793585|38131090|FG001|Overall Study|Protocol Violation|2|||
16987299|NCT00898443|38131098|FG000|Overall Study|Withdrawal by Subject|1|||
16987300|NCT00898443|38131099|FG001|Overall Study|Withdrawal by Subject|0|||
16987301|NCT00900159|38131107|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
16987302|NCT00900159|38131108|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
16987303|NCT00854308|38131127|FG000|Overall Study|Disease progression|42|||
16987304|NCT00854308|38131128|FG001|Overall Study|Disease progression|50|||
16987305|NCT00854308|38131127|FG000|Overall Study|Adverse Event|8|||
16987306|NCT00854308|38131128|FG001|Overall Study|Adverse Event|3|||
16987307|NCT00854308|38131127|FG000|Overall Study|Death|2|||
16987308|NCT00854308|38131128|FG001|Overall Study|Death|5|||
16987309|NCT00854308|38131127|FG000|Overall Study|Physician Decision|6|||
16987310|NCT00854308|38131128|FG001|Overall Study|Physician Decision|6|||
16987311|NCT00854308|38131127|FG000|Overall Study|Withdrawal by Subject|4|||
16987312|NCT00854308|38131128|FG001|Overall Study|Withdrawal by Subject|2|||
16987313|NCT00854308|38131127|FG000|Overall Study|Sponsor's decision to terminate study|0|||
16987314|NCT00854308|38131128|FG001|Overall Study|Sponsor's decision to terminate study|1|||
16987315|NCT00592852|38131134|FG000|Overall Study|Non-compliance|1|||
16987316|NCT00592852|38131134|FG000|Overall Study|Adverse Event|3|||
16987317|NCT00592852|38131134|FG000|Overall Study|Found ineligible|1|||
16987318|NCT00592852|38131134|FG000|Overall Study|Withdrawal by Subject|1|||
16987319|NCT00895245|38131138|FG000|Overall Study|Lack of Efficacy|6|||
16987320|NCT00865306|38131144|FG000|Controlled Trial|Lost to Follow-up|1|||
16987321|NCT00865306|38131145|FG001|Controlled Trial|Lost to Follow-up|1|||
16987322|NCT00865306|38131144|FG000|Controlled Trial|Difficulty commuting|2|||
16987323|NCT00865306|38131145|FG001|Controlled Trial|Difficulty commuting|0|||
16987324|NCT00865306|38131144|FG000|Controlled Trial|Improved btw baseline and first session|1|||
16987325|NCT00865306|38131145|FG001|Controlled Trial|Improved btw baseline and first session|0|||
16987326|NCT00865306|38131144|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
16987327|NCT00865306|38131145|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
16987328|NCT00865306|38131144|FG000|Controlled Trial|Withdrawal by Subject|0|||
16987329|NCT00865306|38131145|FG001|Controlled Trial|Withdrawal by Subject|1|||
16987330|NCT00896649|38131151|FG000|Overall Study|Physician Decision|1|||
16987331|NCT00896649|38131151|FG000|Overall Study|Pregnancy|1|||
16987332|NCT00896649|38131151|FG000|Overall Study|missing documentation|1|||
16987333|NCT00896649|38131151|FG000|Overall Study|technical difficulties|2|||
16987334|NCT00796003|38131158|FG000|Overall Study|Disease Progression|2|||
16987335|NCT00796003|38131159|FG001|Overall Study|Disease Progression|13|||
16987336|NCT00796003|38131158|FG000|Overall Study|Adverse Event|1|||
16987337|NCT00796003|38131159|FG001|Overall Study|Adverse Event|7|||
16987338|NCT00796003|38131158|FG000|Overall Study|Specified organ function not met|0|||
16987339|NCT00796003|38131159|FG001|Overall Study|Specified organ function not met|1|||
16987340|NCT00796003|38131158|FG000|Overall Study|Physician Decision|0|||
16987341|NCT00796003|38131159|FG001|Overall Study|Physician Decision|4|||
16987342|NCT00796003|38131158|FG000|Overall Study|Withdrawal by Subject|0|||
16987343|NCT00796003|38131159|FG001|Overall Study|Withdrawal by Subject|1|||
16987344|NCT00796003|38131158|FG000|Overall Study|Other|0|||
16987345|NCT00796003|38131159|FG001|Overall Study|Other|1|||
16987346|NCT00796003|38131158|FG000|Overall Study|Participants Not treated|0|||
16987347|NCT00796003|38131159|FG001|Overall Study|Participants Not treated|2|||
16987348|NCT00895011|38131171|FG000|Overall Study|Withdrawal by Subject|14|||
16987349|NCT00895011|38131172|FG001|Overall Study|Withdrawal by Subject|7|||
16987350|NCT00895011|38131173|FG002|Overall Study|Withdrawal by Subject|2|||
16987351|NCT00895011|38131171|FG000|Overall Study|Lost to Follow-up|5|||
16987352|NCT00895011|38131172|FG001|Overall Study|Lost to Follow-up|4|||
16987353|NCT00895011|38131173|FG002|Overall Study|Lost to Follow-up|1|||
16987354|NCT00895011|38131171|FG000|Overall Study|Protocol Violation|3|||
16987355|NCT00895011|38131172|FG001|Overall Study|Protocol Violation|1|||
16987356|NCT00895011|38131173|FG002|Overall Study|Protocol Violation|3|||
16987357|NCT00895011|38131171|FG000|Overall Study|Adverse Event|1|||
16987358|NCT00895011|38131172|FG001|Overall Study|Adverse Event|2|||
16987359|NCT00895011|38131173|FG002|Overall Study|Adverse Event|2|||
16987360|NCT00895011|38131171|FG000|Overall Study|schedule conflict|1|||
16987361|NCT00895011|38131172|FG001|Overall Study|schedule conflict|0|||
16987362|NCT00895011|38131173|FG002|Overall Study|schedule conflict|0|||
16987363|NCT00899847|38131182|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
16987364|NCT00795535|38131188|FG000|Overall Study|incomplete data and technical problems|20|||
16987365|NCT00853762|38131196|FG000|Overall Study|Premature Termination|16|||
16987366|NCT00853762|38131197|FG001|Overall Study|Premature Termination|15|||
16987367|NCT00853762|38131198|FG002|Overall Study|Premature Termination|14|||
16987368|NCT00853762|38131199|FG003|Overall Study|Premature Termination|21|||
16987369|NCT00853762|38131196|FG000|Overall Study|Protocol Violation|0|||
16987370|NCT00853762|38131197|FG001|Overall Study|Protocol Violation|0|||
16987371|NCT00853762|38131198|FG002|Overall Study|Protocol Violation|0|||
17135073|NCT03193736|38276321|FG000|Overall Study|Lost to Follow-up|1|||
17135074|NCT03193736|38276321|FG000|Overall Study|implant not received|1|||
17135075|NCT03192488|38276338|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
17135076|NCT03192488|38276339|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
17135077|NCT03192488|38276340|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
16987372|NCT00853762|38131199|FG003|Overall Study|Protocol Violation|1|||
16987373|NCT00853762|38131196|FG000|Overall Study|Withdrawal by Subject|0|||
16987374|NCT00853762|38131197|FG001|Overall Study|Withdrawal by Subject|0|||
16987375|NCT00853762|38131198|FG002|Overall Study|Withdrawal by Subject|1|||
16987376|NCT00853762|38131199|FG003|Overall Study|Withdrawal by Subject|0|||
16987377|NCT00853762|38131196|FG000|Overall Study|Other|0|||
16987378|NCT00853762|38131197|FG001|Overall Study|Other|2|||
16987379|NCT00853762|38131198|FG002|Overall Study|Other|0|||
16987380|NCT00853762|38131199|FG003|Overall Study|Other|0|||
16987381|NCT00853762|38131196|FG000|Overall Study|Randomised but not Treated|0|||
16987382|NCT00853762|38131197|FG001|Overall Study|Randomised but not Treated|2|||
16987383|NCT00853762|38131198|FG002|Overall Study|Randomised but not Treated|2|||
16987384|NCT00853762|38131199|FG003|Overall Study|Randomised but not Treated|0|||
16987385|NCT00789529|38131211|FG000|Overall Study|Withdrawal by Subject|0|||
16987386|NCT00789529|38131212|FG001|Overall Study|Withdrawal by Subject|1|||
16987387|NCT00789529|38131211|FG000|Overall Study|Other Reason|1|||
16987388|NCT00789529|38131212|FG001|Overall Study|Other Reason|0|||
16987389|NCT00894933|38131218|FG000|Overall Study|Lost to Follow-up|2|||
16987390|NCT00894933|38131218|FG000|Overall Study|Cancelled Procedure|1|||
16987391|NCT00894933|38131218|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
16987392|NCT00792805|38131225|FG000|Overall Study|Adverse Event|12|||
16987393|NCT00792805|38131226|FG001|Overall Study|Adverse Event|10|||
16987394|NCT00792805|38131227|FG002|Overall Study|Adverse Event|10|||
16987395|NCT00792805|38131225|FG000|Overall Study|Subject withdrew consent|5|||
16987396|NCT00792805|38131226|FG001|Overall Study|Subject withdrew consent|6|||
16987397|NCT00792805|38131227|FG002|Overall Study|Subject withdrew consent|5|||
16987398|NCT00792805|38131225|FG000|Overall Study|Administrative problems|2|||
16987399|NCT00792805|38131226|FG001|Overall Study|Administrative problems|0|||
16987400|NCT00792805|38131227|FG002|Overall Study|Administrative problems|4|||
16987401|NCT00792805|38131225|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16987402|NCT00792805|38131226|FG001|Overall Study|Abnormal test procedure result(s)|2|||
16987403|NCT00792805|38131227|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16987404|NCT00792805|38131225|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16987405|NCT00792805|38131226|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
16987406|NCT00792805|38131227|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
16987407|NCT00792805|38131225|FG000|Overall Study|Lost to Follow-up|1|||
16987408|NCT00792805|38131226|FG001|Overall Study|Lost to Follow-up|1|||
16987409|NCT00792805|38131227|FG002|Overall Study|Lost to Follow-up|6|||
16987410|NCT00792805|38131225|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16987411|NCT00792805|38131226|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16987412|NCT00792805|38131227|FG002|Overall Study|Abnormal laboratory value(s)|1|||
16987413|NCT00792805|38131225|FG000|Overall Study|Protocol deviation|0|||
16987414|NCT00792805|38131226|FG001|Overall Study|Protocol deviation|1|||
16987415|NCT00792805|38131227|FG002|Overall Study|Protocol deviation|1|||
16987416|NCT00925002|38131238|FG000|Overall Study|Other|1|||
16987417|NCT00925002|38131239|FG001|Overall Study|Other|4|||
16987418|NCT00925002|38131240|FG002|Overall Study|Other|0|||
16987419|NCT00925002|38131238|FG000|Overall Study|Death|1|||
16987420|NCT00925002|38131239|FG001|Overall Study|Death|1|||
16987421|NCT00925002|38131240|FG002|Overall Study|Death|5|||
16987422|NCT00925002|38131238|FG000|Overall Study|Adverse Event|3|||
16987423|NCT00925002|38131239|FG001|Overall Study|Adverse Event|1|||
16987424|NCT00925002|38131240|FG002|Overall Study|Adverse Event|2|||
16987425|NCT00925002|38131238|FG000|Overall Study|Participant withdrew consent|1|||
16987426|NCT00925002|38131239|FG001|Overall Study|Participant withdrew consent|3|||
16987427|NCT00925002|38131240|FG002|Overall Study|Participant withdrew consent|3|||
16987428|NCT00928746|38131249|FG000|Overall Study|Adverse Event|2|||
16987429|NCT00928746|38131249|FG000|Overall Study|Protocol Violation|1|||
16987430|NCT00928746|38131249|FG000|Overall Study|Withdrawal by Subject|1|||
16987431|NCT00928746|38131249|FG000|Overall Study|Other|2|||
16987432|NCT00922428|38131255|FG000|Overall Study|retrospective/extremely implausible data|2|||
16987433|NCT00922428|38131255|FG000|Overall Study|no medication use or questionable use|13|||
16987434|NCT00894543|38131267|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
16987435|NCT00894543|38131268|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
16987436|NCT00894543|38131267|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
16987437|NCT00894543|38131268|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
16987438|NCT00922272|38131274|FG000|Open-label Phase|Adverse Event|5|||
16987439|NCT00922272|38131275|FG001|Open-label Phase|Adverse Event|0|||
16987440|NCT00922272|38131274|FG000|Open-label Phase|Protocol Violation|1|||
16987441|NCT00922272|38131275|FG001|Open-label Phase|Protocol Violation|0|||
16987442|NCT00922272|38131274|FG000|Open-label Phase|Withdrawal by Subject|11|||
16987443|NCT00922272|38131275|FG001|Open-label Phase|Withdrawal by Subject|0|||
16987444|NCT00922272|38131274|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
16987445|NCT00922272|38131275|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
16987446|NCT00922272|38131274|FG000|Open-label Phase|Withdrawal criteria met|5|||
17135078|NCT03192488|38276341|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
17135079|NCT03192488|38276342|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
16987447|NCT00922272|38131275|FG001|Open-label Phase|Withdrawal criteria met|0|||
16987448|NCT00922272|38131274|FG000|Double-blind Phase|Adverse Event|1|||
16987449|NCT00922272|38131275|FG001|Double-blind Phase|Adverse Event|1|||
16987450|NCT00922272|38131274|FG000|Double-blind Phase|Withdrawal by Subject|1|||
16987451|NCT00922272|38131275|FG001|Double-blind Phase|Withdrawal by Subject|1|||
16987452|NCT00922272|38131274|FG000|Double-blind Phase|Lost to Follow-up|2|||
16987453|NCT00922272|38131275|FG001|Double-blind Phase|Lost to Follow-up|1|||
17135080|NCT03192488|38276343|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
17135081|NCT03192488|38276338|FG000|Third Intervention (d1)|Adverse Event|0|||
17135082|NCT03192488|38276339|FG001|Third Intervention (d1)|Adverse Event|0|||
16987454|NCT00922272|38131274|FG000|Double-blind Phase|Withdrawal criteria met|1|||
16987455|NCT00922272|38131275|FG001|Double-blind Phase|Withdrawal criteria met|1|||
16987456|NCT00922272|38131274|FG000|Double-blind Phase|Noncompliance|1|||
16987457|NCT00922272|38131275|FG001|Double-blind Phase|Noncompliance|1|||
16987458|NCT00922272|38131274|FG000|Double-blind Phase|Positive urine drug screen|1|||
16987459|NCT00922272|38131275|FG001|Double-blind Phase|Positive urine drug screen|1|||
16987460|NCT00853372|38131285|FG000|Overall Study|Death|30|||
16987461|NCT00853372|38131286|FG001|Overall Study|Death|26|||
16987462|NCT00853372|38131285|FG000|Overall Study|Lost to Follow-up|1|||
16987463|NCT00853372|38131286|FG001|Overall Study|Lost to Follow-up|2|||
17135083|NCT03192488|38276340|FG002|Third Intervention (d1)|Adverse Event|0|||
17135084|NCT03192488|38276341|FG003|Third Intervention (d1)|Adverse Event|0|||
17135085|NCT03192488|38276342|FG004|Third Intervention (d1)|Adverse Event|1|||
17135086|NCT03192488|38276343|FG005|Third Intervention (d1)|Adverse Event|0|||
17135087|NCT03192176|38276365|FG000|Overall Study|Adverse Event|1|||
17135088|NCT03192176|38276366|FG001|Overall Study|Adverse Event|0|||
17135089|NCT03192176|38276367|FG002|Overall Study|Adverse Event|4|||
17135090|NCT03192176|38276368|FG003|Overall Study|Adverse Event|5|||
17135091|NCT03192176|38276369|FG004|Overall Study|Adverse Event|3|||
17135092|NCT03192176|38276370|FG005|Overall Study|Adverse Event|2|||
17135093|NCT03192176|38276371|FG006|Overall Study|Adverse Event|3|||
17135094|NCT03192176|38276372|FG007|Overall Study|Adverse Event|3|||
17135095|NCT03192176|38276365|FG000|Overall Study|Lost to Follow-up|0|||
17135096|NCT03192176|38276366|FG001|Overall Study|Lost to Follow-up|0|||
17135097|NCT03192176|38276367|FG002|Overall Study|Lost to Follow-up|1|||
17135098|NCT03192176|38276368|FG003|Overall Study|Lost to Follow-up|2|||
17135099|NCT03192176|38276369|FG004|Overall Study|Lost to Follow-up|3|||
16987464|NCT00853372|38131285|FG000|Overall Study|Full Consent Withdrawn|1|||
16987465|NCT00853372|38131286|FG001|Overall Study|Full Consent Withdrawn|1|||
16987466|NCT00848536|38131294|FG000|Overall Study|Adverse Event|2|||
16987467|NCT00848536|38131295|FG001|Overall Study|Adverse Event|2|||
16987468|NCT00848536|38131294|FG000|Overall Study|Withdrawal by Subject|0|||
16987469|NCT00848536|38131295|FG001|Overall Study|Withdrawal by Subject|1|||
16987470|NCT00848536|38131294|FG000|Overall Study|Protocol Violation|0|||
16987471|NCT00848536|38131295|FG001|Overall Study|Protocol Violation|1|||
17135100|NCT03192176|38276370|FG005|Overall Study|Lost to Follow-up|1|||
17135101|NCT03192176|38276371|FG006|Overall Study|Lost to Follow-up|1|||
17135102|NCT03192176|38276372|FG007|Overall Study|Lost to Follow-up|1|||
17135103|NCT03192176|38276365|FG000|Overall Study|Physician Decision|1|||
17135104|NCT03192176|38276366|FG001|Overall Study|Physician Decision|0|||
17135105|NCT03192176|38276367|FG002|Overall Study|Physician Decision|0|||
16987472|NCT00848536|38131294|FG000|Overall Study|Noncompliance|1|||
16987473|NCT00848536|38131295|FG001|Overall Study|Noncompliance|0|||
16987474|NCT00848536|38131294|FG000|Overall Study|Inadequate Control of IOP|1|||
16987475|NCT00848536|38131295|FG001|Overall Study|Inadequate Control of IOP|1|||
16987476|NCT00848536|38131294|FG000|Overall Study|Patient Moved|0|||
16987477|NCT00848536|38131295|FG001|Overall Study|Patient Moved|2|||
16987478|NCT00922116|38131301|FG000|Overall Study|Adverse Event|4|||
16987479|NCT00922116|38131301|FG000|Overall Study|Death|1|||
16987480|NCT00922116|38131301|FG000|Overall Study|Lost to Follow-up|1|||
16987481|NCT00922116|38131301|FG000|Overall Study|Withdrawal by Subject|4|||
16987482|NCT00922116|38131301|FG000|Overall Study|Other|5|||
16987483|NCT00921024|38131307|FG000|Overall Study|Lost to Follow-up|2|||
16987484|NCT00921024|38131308|FG001|Overall Study|Lost to Follow-up|0|||
16987485|NCT00921024|38131307|FG000|Overall Study|Received concomittant therapy|2|||
16987486|NCT00921024|38131308|FG001|Overall Study|Received concomittant therapy|0|||
16987487|NCT00921024|38131307|FG000|Overall Study|Withdrawal by Subject|0|||
16987488|NCT00921024|38131308|FG001|Overall Study|Withdrawal by Subject|3|||
16987489|NCT00928668|38131314|FG000|Overall Study|Adverse Event|1|||
16987490|NCT00928668|38131315|FG001|Overall Study|Adverse Event|0|||
16987491|NCT00928668|38131316|FG002|Overall Study|Adverse Event|0|||
16987492|NCT00928668|38131317|FG003|Overall Study|Adverse Event|0|||
16987493|NCT00928668|38131318|FG004|Overall Study|Adverse Event|0|||
16987494|NCT00928668|38131314|FG000|Overall Study|Protocol Violation|0|||
17135106|NCT03192176|38276368|FG003|Overall Study|Physician Decision|0|||
17135107|NCT03192176|38276369|FG004|Overall Study|Physician Decision|0|||
17135108|NCT03192176|38276370|FG005|Overall Study|Physician Decision|2|||
17135109|NCT03192176|38276371|FG006|Overall Study|Physician Decision|1|||
17135110|NCT03192176|38276372|FG007|Overall Study|Physician Decision|0|||
17135111|NCT03192176|38276365|FG000|Overall Study|Protocol Deviation|1|||
17135112|NCT03192176|38276366|FG001|Overall Study|Protocol Deviation|1|||
16987495|NCT00928668|38131315|FG001|Overall Study|Protocol Violation|0|||
16987496|NCT00928668|38131316|FG002|Overall Study|Protocol Violation|0|||
16987497|NCT00928668|38131317|FG003|Overall Study|Protocol Violation|0|||
16987498|NCT00928668|38131318|FG004|Overall Study|Protocol Violation|1|||
16987499|NCT00928668|38131314|FG000|Overall Study|Withdrawal by Subject|0|||
16987500|NCT00928668|38131315|FG001|Overall Study|Withdrawal by Subject|1|||
17135113|NCT03192176|38276367|FG002|Overall Study|Protocol Deviation|0|||
17135114|NCT03192176|38276368|FG003|Overall Study|Protocol Deviation|0|||
17135115|NCT03192176|38276369|FG004|Overall Study|Protocol Deviation|2|||
17135116|NCT03192176|38276370|FG005|Overall Study|Protocol Deviation|0|||
17135117|NCT03192176|38276371|FG006|Overall Study|Protocol Deviation|0|||
17135118|NCT03192176|38276372|FG007|Overall Study|Protocol Deviation|0|||
17135119|NCT03192176|38276365|FG000|Overall Study|Withdrawal by Subject|3|||
17135120|NCT03192176|38276366|FG001|Overall Study|Withdrawal by Subject|4|||
17135121|NCT03192176|38276367|FG002|Overall Study|Withdrawal by Subject|0|||
17135122|NCT03192176|38276368|FG003|Overall Study|Withdrawal by Subject|4|||
17135123|NCT03192176|38276369|FG004|Overall Study|Withdrawal by Subject|3|||
16987501|NCT00928668|38131316|FG002|Overall Study|Withdrawal by Subject|1|||
16987502|NCT00928668|38131317|FG003|Overall Study|Withdrawal by Subject|0|||
16987503|NCT00928668|38131318|FG004|Overall Study|Withdrawal by Subject|0|||
16987504|NCT00928668|38131314|FG000|Overall Study|Other reasons not listed above|0|||
16987505|NCT00928668|38131315|FG001|Overall Study|Other reasons not listed above|0|||
16987506|NCT00928668|38131316|FG002|Overall Study|Other reasons not listed above|0|||
16987507|NCT00928668|38131317|FG003|Overall Study|Other reasons not listed above|1|||
16987508|NCT00928668|38131318|FG004|Overall Study|Other reasons not listed above|0|||
16987509|NCT00592774|38131340|FG000|Overall Study|Adverse Event|5|||
16987510|NCT00592774|38131341|FG001|Overall Study|Adverse Event|19|||
16987511|NCT00592774|38131342|FG002|Overall Study|Adverse Event|2|||
16987512|NCT00592774|38131343|FG003|Overall Study|Adverse Event|14|||
16987513|NCT00592774|38131344|FG004|Overall Study|Adverse Event|8|||
16987514|NCT00592774|38131340|FG000|Overall Study|Protocol Violation|0|||
16987515|NCT00592774|38131341|FG001|Overall Study|Protocol Violation|1|||
16987516|NCT00592774|38131342|FG002|Overall Study|Protocol Violation|0|||
16987517|NCT00592774|38131343|FG003|Overall Study|Protocol Violation|0|||
16987518|NCT00592774|38131344|FG004|Overall Study|Protocol Violation|1|||
16987519|NCT00592774|38131340|FG000|Overall Study|Withdrawal by Subject|3|||
16987520|NCT00592774|38131341|FG001|Overall Study|Withdrawal by Subject|7|||
16987521|NCT00592774|38131342|FG002|Overall Study|Withdrawal by Subject|0|||
16987522|NCT00592774|38131343|FG003|Overall Study|Withdrawal by Subject|0|||
16987523|NCT00592774|38131344|FG004|Overall Study|Withdrawal by Subject|0|||
16987524|NCT00592774|38131340|FG000|Overall Study|Lack of Efficacy|3|||
16987525|NCT00592774|38131341|FG001|Overall Study|Lack of Efficacy|3|||
16987526|NCT00592774|38131342|FG002|Overall Study|Lack of Efficacy|0|||
16987527|NCT00592774|38131343|FG003|Overall Study|Lack of Efficacy|0|||
16987528|NCT00592774|38131344|FG004|Overall Study|Lack of Efficacy|2|||
17135124|NCT03192176|38276370|FG005|Overall Study|Withdrawal by Subject|4|||
17135125|NCT03192176|38276371|FG006|Overall Study|Withdrawal by Subject|4|||
17135126|NCT03192176|38276372|FG007|Overall Study|Withdrawal by Subject|2|||
16987529|NCT00592774|38131340|FG000|Overall Study|Physician Decision|0|||
16987530|NCT00592774|38131341|FG001|Overall Study|Physician Decision|1|||
16987531|NCT00592774|38131342|FG002|Overall Study|Physician Decision|1|||
16987532|NCT00592774|38131343|FG003|Overall Study|Physician Decision|0|||
16987533|NCT00592774|38131344|FG004|Overall Study|Physician Decision|1|||
16987534|NCT00592774|38131340|FG000|Overall Study|Other|0|||
16987535|NCT00592774|38131341|FG001|Overall Study|Other|1|||
16987536|NCT00592774|38131342|FG002|Overall Study|Other|1|||
16987537|NCT00592774|38131343|FG003|Overall Study|Other|0|||
16987538|NCT00592774|38131344|FG004|Overall Study|Other|2|||
16987539|NCT00837694|38131362|FG000|Overall Study|Lost to Follow-up|2|||
16987540|NCT00837694|38131363|FG001|Overall Study|Lost to Follow-up|0|||
16987541|NCT00837694|38131364|FG002|Overall Study|Lost to Follow-up|2|||
16987542|NCT00837694|38131365|FG003|Overall Study|Lost to Follow-up|1|||
16987543|NCT00837694|38131366|FG004|Overall Study|Lost to Follow-up|1|||
16987544|NCT00837694|38131367|FG005|Overall Study|Lost to Follow-up|1|||
16987545|NCT00852202|38131384|FG000|Overall Study|Adverse Event|2|||
16987546|NCT00852202|38131385|FG001|Overall Study|Adverse Event|3|||
16987547|NCT00852202|38131386|FG002|Overall Study|Adverse Event|7|||
16987548|NCT00852202|38131384|FG000|Overall Study|Lack of Efficacy|4|||
16987549|NCT00852202|38131385|FG001|Overall Study|Lack of Efficacy|1|||
16987550|NCT00852202|38131386|FG002|Overall Study|Lack of Efficacy|2|||
16987551|NCT00852202|38131384|FG000|Overall Study|Protocol Violation|2|||
16987552|NCT00852202|38131385|FG001|Overall Study|Protocol Violation|2|||
16987553|NCT00852202|38131386|FG002|Overall Study|Protocol Violation|7|||
16987554|NCT00852202|38131384|FG000|Overall Study|Withdrawal by Subject|3|||
16987555|NCT00852202|38131385|FG001|Overall Study|Withdrawal by Subject|1|||
16987556|NCT00852202|38131386|FG002|Overall Study|Withdrawal by Subject|2|||
16987557|NCT00852202|38131384|FG000|Overall Study|Lost to Follow-up|5|||
16987558|NCT00852202|38131385|FG001|Overall Study|Lost to Follow-up|5|||
16987559|NCT00852202|38131386|FG002|Overall Study|Lost to Follow-up|6|||
16987560|NCT00852202|38131384|FG000|Overall Study|pregnancy,moving away and surgery|1|||
16987561|NCT00852202|38131385|FG001|Overall Study|pregnancy,moving away and surgery|0|||
16987562|NCT00852202|38131386|FG002|Overall Study|pregnancy,moving away and surgery|2|||
16987563|NCT01074008|38131404|FG000|Overall Study|Adverse Event|0|||
16987564|NCT01074008|38131405|FG001|Overall Study|Adverse Event|1|||
17135127|NCT03192176|38276365|FG000|Overall Study|Miscellaneous|1|||
17135128|NCT03192176|38276366|FG001|Overall Study|Miscellaneous|0|||
17135129|NCT03192176|38276367|FG002|Overall Study|Miscellaneous|1|||
17135130|NCT03192176|38276368|FG003|Overall Study|Miscellaneous|1|||
17135131|NCT03192176|38276369|FG004|Overall Study|Miscellaneous|1|||
16987565|NCT01074008|38131406|FG002|Overall Study|Adverse Event|0|||
16987566|NCT01074008|38131407|FG003|Overall Study|Adverse Event|0|||
16987567|NCT01074008|38131408|FG004|Overall Study|Adverse Event|0|||
16987568|NCT01074008|38131409|FG005|Overall Study|Adverse Event|0|||
16987569|NCT01074008|38131410|FG006|Overall Study|Adverse Event|0|||
16987570|NCT01074008|38131411|FG007|Overall Study|Adverse Event|0|||
16987571|NCT01074008|38131412|FG008|Overall Study|Adverse Event|0|||
16987572|NCT01074008|38131404|FG000|Overall Study|Withdrawal by Subject|1|||
16987573|NCT01074008|38131405|FG001|Overall Study|Withdrawal by Subject|1|||
16987574|NCT01074008|38131406|FG002|Overall Study|Withdrawal by Subject|1|||
16987575|NCT01074008|38131407|FG003|Overall Study|Withdrawal by Subject|0|||
16987576|NCT01074008|38131408|FG004|Overall Study|Withdrawal by Subject|1|||
16987577|NCT01074008|38131409|FG005|Overall Study|Withdrawal by Subject|0|||
16987578|NCT01074008|38131410|FG006|Overall Study|Withdrawal by Subject|0|||
16987579|NCT01074008|38131411|FG007|Overall Study|Withdrawal by Subject|0|||
16987580|NCT01074008|38131412|FG008|Overall Study|Withdrawal by Subject|0|||
16987581|NCT01074008|38131404|FG000|Overall Study|Lost to Follow-up|0|||
16987582|NCT01074008|38131405|FG001|Overall Study|Lost to Follow-up|1|||
16987583|NCT01074008|38131406|FG002|Overall Study|Lost to Follow-up|1|||
16987584|NCT01074008|38131407|FG003|Overall Study|Lost to Follow-up|1|||
16987585|NCT01074008|38131408|FG004|Overall Study|Lost to Follow-up|1|||
16987586|NCT01074008|38131409|FG005|Overall Study|Lost to Follow-up|0|||
17135132|NCT03192176|38276370|FG005|Overall Study|Miscellaneous|2|||
17135133|NCT03192176|38276371|FG006|Overall Study|Miscellaneous|0|||
17135134|NCT03192176|38276372|FG007|Overall Study|Miscellaneous|1|||
17135135|NCT01642004|38276393|FG000|Randomization|Adverse Event unrelated to study drug|1|||
17135136|NCT01642004|38276394|FG001|Randomization|Adverse Event unrelated to study drug|0|||
16987587|NCT01074008|38131410|FG006|Overall Study|Lost to Follow-up|1|||
16987588|NCT01074008|38131411|FG007|Overall Study|Lost to Follow-up|0|||
16987589|NCT01074008|38131412|FG008|Overall Study|Lost to Follow-up|4|||
16987590|NCT01073930|38131443|FG000|Overall Study|Withdrawal by Subject|3|||
16987591|NCT01073930|38131444|FG001|Overall Study|Withdrawal by Subject|2|||
16987592|NCT01073930|38131443|FG000|Overall Study|Lost to Follow-up|0|||
16987593|NCT01073930|38131444|FG001|Overall Study|Lost to Follow-up|1|||
16987594|NCT01073930|38131443|FG000|Overall Study|Adverse Event|0|||
16987595|NCT01073930|38131444|FG001|Overall Study|Adverse Event|1|||
16987596|NCT01073930|38131443|FG000|Overall Study|Noncompliance with study drug|0|||
16987597|NCT01073930|38131444|FG001|Overall Study|Noncompliance with study drug|1|||
16987598|NCT01073930|38131443|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
16987599|NCT01073930|38131444|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
16987600|NCT01073618|38131450|FG000|Overall Study|Death|208|||
16987601|NCT01073618|38131450|FG000|Overall Study|Adverse Event|19|||
16987602|NCT01073618|38131450|FG000|Overall Study|Other|80|||
16987603|NCT01073462|38131454|FG000|Overall Study|Death|14|||
16987604|NCT01073462|38131454|FG000|Overall Study|Kidney transplant|10|||
16987605|NCT01073462|38131454|FG000|Overall Study|Low parathyroid hormone levels|8|||
16987606|NCT01073462|38131454|FG000|Overall Study|Serious adverse event|2|||
16987607|NCT01073462|38131454|FG000|Overall Study|Lost to Follow-up|7|||
16987608|NCT00789373|38131458|FG000|Induction|Adverse Event|64|||
16987609|NCT00789373|38131459|FG001|Induction|Adverse Event|0|||
16987610|NCT00789373|38131460|FG002|Induction|Adverse Event|0|||
16987611|NCT00789373|38131458|FG000|Induction|Death Due to study disease|24|||
16987612|NCT00789373|38131459|FG001|Induction|Death Due to study disease|0|||
16987613|NCT00789373|38131460|FG002|Induction|Death Due to study disease|0|||
16987614|NCT00789373|38131458|FG000|Induction|Death due to adverse event|19|||
16987615|NCT00789373|38131459|FG001|Induction|Death due to adverse event|0|||
16987616|NCT00789373|38131460|FG002|Induction|Death due to adverse event|0|||
16987617|NCT00789373|38131458|FG000|Induction|Death due to toxicity|11|||
16987618|NCT00789373|38131459|FG001|Induction|Death due to toxicity|0|||
16987619|NCT00789373|38131460|FG002|Induction|Death due to toxicity|0|||
16987620|NCT00789373|38131458|FG000|Induction|Death due to procedure|1|||
16987621|NCT00789373|38131459|FG001|Induction|Death due to procedure|0|||
16987622|NCT00789373|38131460|FG002|Induction|Death due to procedure|0|||
16987623|NCT00789373|38131458|FG000|Induction|Investigator decision|7|||
16987624|NCT00789373|38131459|FG001|Induction|Investigator decision|0|||
16987625|NCT00789373|38131460|FG002|Induction|Investigator decision|0|||
16987626|NCT00789373|38131458|FG000|Induction|Protocol entry criteria not met|9|||
16987627|NCT00789373|38131459|FG001|Induction|Protocol entry criteria not met|0|||
16987628|NCT00789373|38131460|FG002|Induction|Protocol entry criteria not met|0|||
16987629|NCT00789373|38131458|FG000|Induction|Lost to Follow-up|6|||
16987630|NCT00789373|38131459|FG001|Induction|Lost to Follow-up|0|||
16987631|NCT00789373|38131460|FG002|Induction|Lost to Follow-up|0|||
16987632|NCT00789373|38131458|FG000|Induction|Protocol Violation|1|||
16987633|NCT00789373|38131459|FG001|Induction|Protocol Violation|0|||
16987634|NCT00789373|38131460|FG002|Induction|Protocol Violation|0|||
16987635|NCT00789373|38131458|FG000|Induction|Progressive Disease|220|||
16987636|NCT00789373|38131459|FG001|Induction|Progressive Disease|0|||
16987637|NCT00789373|38131460|FG002|Induction|Progressive Disease|0|||
16987638|NCT00789373|38131458|FG000|Induction|Withdrawal by Subject|37|||
16987639|NCT00789373|38131459|FG001|Induction|Withdrawal by Subject|0|||
16987640|NCT00789373|38131460|FG002|Induction|Withdrawal by Subject|0|||
16987641|NCT00789373|38131458|FG000|Maintenance|Adverse Event|0|||
16987642|NCT00789373|38131459|FG001|Maintenance|Adverse Event|65|||
16987643|NCT00789373|38131460|FG002|Maintenance|Adverse Event|12|||
16987644|NCT00789373|38131458|FG000|Maintenance|Death due to study disease|0|||
16987645|NCT00789373|38131459|FG001|Maintenance|Death due to study disease|3|||
16987646|NCT00789373|38131460|FG002|Maintenance|Death due to study disease|1|||
16987647|NCT00789373|38131458|FG000|Maintenance|Death due to adverse event|0|||
16987648|NCT00789373|38131459|FG001|Maintenance|Death due to adverse event|4|||
16987649|NCT00789373|38131460|FG002|Maintenance|Death due to adverse event|1|||
16987650|NCT00789373|38131458|FG000|Maintenance|Death due to toxicity|0|||
16987651|NCT00789373|38131459|FG001|Maintenance|Death due to toxicity|1|||
16987652|NCT00789373|38131460|FG002|Maintenance|Death due to toxicity|2|||
16987653|NCT00789373|38131458|FG000|Maintenance|Investigator Decision|0|||
16987654|NCT00789373|38131459|FG001|Maintenance|Investigator Decision|4|||
16987655|NCT00789373|38131460|FG002|Maintenance|Investigator Decision|2|||
16987656|NCT00789373|38131458|FG000|Maintenance|Protocol entry criteria not met|0|||
16987657|NCT00789373|38131459|FG001|Maintenance|Protocol entry criteria not met|2|||
16987658|NCT00789373|38131460|FG002|Maintenance|Protocol entry criteria not met|0|||
16987659|NCT00789373|38131458|FG000|Maintenance|Lost to Follow-up|0|||
16987660|NCT00789373|38131459|FG001|Maintenance|Lost to Follow-up|2|||
16987661|NCT00789373|38131460|FG002|Maintenance|Lost to Follow-up|0|||
16987662|NCT00789373|38131458|FG000|Maintenance|Progressive Disease|0|||
16987663|NCT00789373|38131459|FG001|Maintenance|Progressive Disease|253|||
16987664|NCT00789373|38131460|FG002|Maintenance|Progressive Disease|152|||
16987665|NCT00789373|38131458|FG000|Maintenance|Withdrawal by Subject|0|||
16987666|NCT00789373|38131459|FG001|Maintenance|Withdrawal by Subject|21|||
16987667|NCT00789373|38131460|FG002|Maintenance|Withdrawal by Subject|8|||
16987668|NCT00789373|38131458|FG000|Maintenance|Sponsor Decision|0|||
16987669|NCT00789373|38131459|FG001|Maintenance|Sponsor Decision|0|||
16987670|NCT00789373|38131460|FG002|Maintenance|Sponsor Decision|2|||
16987671|NCT00789373|38131458|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
16987672|NCT00789373|38131459|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
16987673|NCT00789373|38131460|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
16987674|NCT00851890|38131475|FG000|Overall Study|Lost to Follow-up|0|||
16987675|NCT00851890|38131476|FG001|Overall Study|Lost to Follow-up|1|||
16987676|NCT00851890|38131477|FG002|Overall Study|Lost to Follow-up|0|||
16987677|NCT00851890|38131478|FG003|Overall Study|Lost to Follow-up|1|||
16987678|NCT00837616|38131490|FG000|Overall Study|Withdrawal by Subject|0|||
16987679|NCT00837616|38131491|FG001|Overall Study|Withdrawal by Subject|1|||
16987680|NCT00788827|38131497|FG000|Overall Study|Lack of Efficacy|2|||
16987681|NCT00592072|38131503|FG000|Wash Out Period|Lost to Follow-up|1|||
16987682|NCT00592072|38131504|FG001|Wash Out Period|Lost to Follow-up|1|||
16987683|NCT00792571|38131510|FG000|Overall Study|Death|1|||
16987684|NCT00792571|38131510|FG000|Overall Study|Adverse Event|4|||
16987685|NCT00792571|38131510|FG000|Overall Study|Withdrawal by Subject|1|||
16987686|NCT00792571|38131510|FG000|Overall Study|Other|4|||
16987687|NCT01069484|38131516|FG000|Overall Study|Death-in-near-family|1|||
16987688|NCT01069484|38131517|FG001|Overall Study|Death-in-near-family|0|||
16987689|NCT01069484|38131516|FG000|Overall Study|No specific reason|8|||
16987690|NCT01069484|38131517|FG001|Overall Study|No specific reason|2|||
16987691|NCT01069484|38131516|FG000|Overall Study|Illness mother or child|3|||
16987692|NCT01069484|38131517|FG001|Overall Study|Illness mother or child|1|||
16987693|NCT00794365|38131524|FG000|Overall Study|Lost to Follow-up|38|||
16987694|NCT00794365|38131524|FG000|Overall Study|Other|17|||
16987695|NCT00794365|38131524|FG000|Overall Study|Poor Compliance|11|||
17135137|NCT01642004|38276393|FG000|Randomization|Participant withdrew consent|1|||
17135138|NCT01642004|38276394|FG001|Randomization|Participant withdrew consent|6|||
17135139|NCT01642004|38276393|FG000|Randomization|No longer meets study criteria|2|||
17135140|NCT01642004|38276394|FG001|Randomization|No longer meets study criteria|2|||
17135141|NCT01642004|38276393|FG000|Treatment|Disease progression|95|||
17135142|NCT01642004|38276394|FG001|Treatment|Disease progression|79|||
17135143|NCT01642004|38276393|FG000|Treatment|Study drug toxicity|10|||
17135144|NCT01642004|38276394|FG001|Treatment|Study drug toxicity|13|||
17135145|NCT01642004|38276393|FG000|Treatment|Death|1|||
17135146|NCT01642004|38276394|FG001|Treatment|Death|1|||
16987696|NCT00794365|38131524|FG000|Overall Study|Adverse Event|10|||
16987697|NCT00794365|38131524|FG000|Overall Study|Lack of Efficacy|3|||
16987698|NCT01067144|38131530|FG000|Treatment|Did not receive allocated intervention|4|||
16987699|NCT01067144|38131531|FG001|Treatment|Did not receive allocated intervention|7|||
16987700|NCT01067144|38131530|FG000|Follow-up|Lost to Follow-up|22|||
16987701|NCT01067144|38131531|FG001|Follow-up|Lost to Follow-up|12|||
16987702|NCT01067144|38131530|FG000|Follow-up|Censored owing to second surgery|19|||
16987703|NCT01067144|38131531|FG001|Follow-up|Censored owing to second surgery|28|||
16987704|NCT01067144|38131530|FG000|Follow-up|Withdrawal by Subject|18|||
16987705|NCT01067144|38131531|FG001|Follow-up|Withdrawal by Subject|14|||
16987706|NCT01067144|38131530|FG000|Follow-up|Surgery cancelled|0|||
16987707|NCT01067144|38131531|FG001|Follow-up|Surgery cancelled|1|||
16987708|NCT01067144|38131530|FG000|Follow-up|Death|0|||
17028569|NCT00584727|38172909|FG000|First Intervention|Discontinuation|0|||
16987709|NCT01067144|38131531|FG001|Follow-up|Death|1|||
17135147|NCT01642004|38276393|FG000|Treatment|Adverse event unrelated to study drug|9|||
16987710|NCT01078298|38131539|FG000|Overall Study|Lost to Follow-up|12|||
16987711|NCT01078298|38131540|FG001|Overall Study|Lost to Follow-up|13|||
16987712|NCT01078298|38131539|FG000|Overall Study|Withdrawal by Subject|31|||
16987713|NCT01078298|38131540|FG001|Overall Study|Withdrawal by Subject|33|||
17135148|NCT01642004|38276394|FG001|Treatment|Adverse event unrelated to study drug|13|||
17135149|NCT01642004|38276393|FG000|Treatment|Maximum clinical benefit|1|||
16987714|NCT01078298|38131539|FG000|Overall Study|Protocol Violation|6|||
16987715|NCT01078298|38131540|FG001|Overall Study|Protocol Violation|6|||
16987716|NCT01078298|38131539|FG000|Overall Study|Adverse Event|6|||
16987717|NCT01078298|38131540|FG001|Overall Study|Adverse Event|5|||
16987718|NCT01078298|38131539|FG000|Overall Study|Death|2|||
16987719|NCT01078298|38131540|FG001|Overall Study|Death|0|||
16987720|NCT01078298|38131539|FG000|Overall Study|Did not meet entrance criteria|0|||
16987721|NCT01078298|38131540|FG001|Overall Study|Did not meet entrance criteria|1|||
16987722|NCT01078298|38131539|FG000|Overall Study|Other|24|||
16987723|NCT01078298|38131540|FG001|Overall Study|Other|32|||
16987724|NCT00788593|38131546|FG000|Placebo Run-in Phase|Adverse Event|2|||
16987725|NCT00788593|38131547|FG001|Placebo Run-in Phase|Adverse Event|0|||
16987726|NCT00788593|38131548|FG002|Placebo Run-in Phase|Adverse Event|0|||
16987727|NCT00788593|38131546|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
16987728|NCT00788593|38131547|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
16987729|NCT00788593|38131548|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
16987730|NCT00788593|38131546|FG000|Placebo Run-in Phase|Protocol Violation|2|||
16987731|NCT00788593|38131547|FG001|Placebo Run-in Phase|Protocol Violation|0|||
16987732|NCT00788593|38131548|FG002|Placebo Run-in Phase|Protocol Violation|0|||
16987733|NCT00788593|38131546|FG000|First Intervention Period|Adverse Event|0|||
16987734|NCT00788593|38131547|FG001|First Intervention Period|Adverse Event|1|||
16987735|NCT00788593|38131548|FG002|First Intervention Period|Adverse Event|0|||
16987736|NCT00788593|38131546|FG000|Second Intervention Period|Lost to Follow-up|0|||
16987737|NCT00788593|38131547|FG001|Second Intervention Period|Lost to Follow-up|1|||
16987738|NCT00788593|38131548|FG002|Second Intervention Period|Lost to Follow-up|0|||
16987739|NCT00788593|38131546|FG000|Second Intervention Period|Other|0|||
16987740|NCT00788593|38131547|FG001|Second Intervention Period|Other|0|||
16987741|NCT00788593|38131548|FG002|Second Intervention Period|Other|1|||
16987742|NCT00793819|38131560|FG000|Overall Study|Adverse Event|8|||
16987743|NCT00793819|38131561|FG001|Overall Study|Adverse Event|4|||
16987744|NCT00793819|38131560|FG000|Overall Study|Lack of Efficacy|1|||
16987745|NCT00793819|38131561|FG001|Overall Study|Lack of Efficacy|1|||
16987746|NCT00793819|38131560|FG000|Overall Study|Withdrawal by Subject|4|||
16987747|NCT00793819|38131561|FG001|Overall Study|Withdrawal by Subject|3|||
16987748|NCT00793819|38131560|FG000|Overall Study|Lost to Follow-up|1|||
16987749|NCT00793819|38131561|FG001|Overall Study|Lost to Follow-up|1|||
16987750|NCT00792259|38131570|FG000|Overall Study|Poor Quality Scans|1|||
16987751|NCT00792259|38131571|FG001|Overall Study|Poor Quality Scans|0|||
16987752|NCT00792259|38131572|FG002|Overall Study|Poor Quality Scans|0|||
16987753|NCT00894387|38131582|FG000|Overall Study|Adverse Event|44|||
16987754|NCT00894387|38131583|FG001|Overall Study|Adverse Event|45|||
16987755|NCT00894387|38131582|FG000|Overall Study|Abnormal Laboratory values|2|||
16987756|NCT00894387|38131583|FG001|Overall Study|Abnormal Laboratory values|2|||
16987757|NCT00894387|38131582|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16987758|NCT00894387|38131583|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16987759|NCT00894387|38131582|FG000|Overall Study|Lost to Follow-up|3|||
16987760|NCT00894387|38131583|FG001|Overall Study|Lost to Follow-up|5|||
16987761|NCT00894387|38131582|FG000|Overall Study|Administrative problems|2|||
16987762|NCT00894387|38131583|FG001|Overall Study|Administrative problems|2|||
16987763|NCT00894387|38131582|FG000|Overall Study|Death|77|||
16987764|NCT00894387|38131583|FG001|Overall Study|Death|76|||
16987765|NCT00894387|38131582|FG000|Overall Study|Protocol Deviation|4|||
16987766|NCT00894387|38131583|FG001|Overall Study|Protocol Deviation|0|||
16987767|NCT00894387|38131582|FG000|Overall Study|Patient's request|25|||
16987768|NCT00894387|38131583|FG001|Overall Study|Patient's request|30|||
16987769|NCT00894387|38131582|FG000|Overall Study|Other (Missing)|5|||
16987770|NCT00894387|38131583|FG001|Overall Study|Other (Missing)|3|||
16987771|NCT00894387|38131582|FG000|Overall Study|Mis-randomized|13|||
16987772|NCT00894387|38131583|FG001|Overall Study|Mis-randomized|9|||
16987773|NCT00894387|38131582|FG000|Overall Study|GCP non-compliance|0|||
16987774|NCT00894387|38131583|FG001|Overall Study|GCP non-compliance|2|||
16987775|NCT00928512|38131594|FG000|Overall Study|Adverse Event|4|||
16987776|NCT00928512|38131595|FG001|Overall Study|Adverse Event|3|||
16987777|NCT00928512|38131596|FG002|Overall Study|Adverse Event|2|||
16987778|NCT00928512|38131597|FG003|Overall Study|Adverse Event|8|||
16987779|NCT00928512|38131598|FG004|Overall Study|Adverse Event|6|||
16987780|NCT00928512|38131594|FG000|Overall Study|Lack of Efficacy|2|||
16987781|NCT00928512|38131595|FG001|Overall Study|Lack of Efficacy|0|||
16987782|NCT00928512|38131596|FG002|Overall Study|Lack of Efficacy|4|||
16987783|NCT00928512|38131597|FG003|Overall Study|Lack of Efficacy|7|||
16987784|NCT00928512|38131598|FG004|Overall Study|Lack of Efficacy|3|||
16987785|NCT00928512|38131594|FG000|Overall Study|Protocol Violation|0|||
16987786|NCT00928512|38131595|FG001|Overall Study|Protocol Violation|1|||
16987787|NCT00928512|38131596|FG002|Overall Study|Protocol Violation|0|||
16987788|NCT00928512|38131597|FG003|Overall Study|Protocol Violation|1|||
16987789|NCT00928512|38131598|FG004|Overall Study|Protocol Violation|3|||
16987790|NCT00928512|38131594|FG000|Overall Study|Withdrawal by Subject|3|||
16987791|NCT00928512|38131595|FG001|Overall Study|Withdrawal by Subject|0|||
16987792|NCT00928512|38131596|FG002|Overall Study|Withdrawal by Subject|3|||
16987793|NCT00928512|38131597|FG003|Overall Study|Withdrawal by Subject|4|||
16987794|NCT00928512|38131598|FG004|Overall Study|Withdrawal by Subject|0|||
16987795|NCT00928512|38131594|FG000|Overall Study|Lost to Follow-up|1|||
16987796|NCT00928512|38131595|FG001|Overall Study|Lost to Follow-up|1|||
16987797|NCT00928512|38131596|FG002|Overall Study|Lost to Follow-up|2|||
16987798|NCT00928512|38131597|FG003|Overall Study|Lost to Follow-up|1|||
16987799|NCT00928512|38131598|FG004|Overall Study|Lost to Follow-up|3|||
16987800|NCT00928512|38131594|FG000|Overall Study|Administrative Problems|0|||
16987801|NCT00928512|38131595|FG001|Overall Study|Administrative Problems|1|||
16987802|NCT00928512|38131596|FG002|Overall Study|Administrative Problems|0|||
16987803|NCT00928512|38131597|FG003|Overall Study|Administrative Problems|0|||
16987804|NCT00928512|38131598|FG004|Overall Study|Administrative Problems|0|||
16987805|NCT00787891|38131616|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
16987806|NCT00787891|38131617|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
16987807|NCT00787891|38131616|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
16987808|NCT00787891|38131617|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
16987809|NCT00787891|38131616|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
16987810|NCT00787891|38131617|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
16987811|NCT00787891|38131616|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
16987812|NCT00787891|38131617|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
16987813|NCT00787891|38131616|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
16987814|NCT00787891|38131617|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
16987815|NCT00787891|38131616|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
16987816|NCT00787891|38131617|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
16987817|NCT00787891|38131616|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
16987818|NCT00787891|38131617|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
16987819|NCT00787891|38131616|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
16987820|NCT00787891|38131617|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
16987821|NCT00787891|38131616|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
16987822|NCT00787891|38131617|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
16987823|NCT00787891|38131616|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
16987824|NCT00787891|38131617|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
16987825|NCT00892437|38131627|FG000|Randomized Phase|Randomized but not treated|6|||
16987826|NCT00892437|38131628|FG001|Randomized Phase|Randomized but not treated|0|||
16987827|NCT00892437|38131627|FG000|Randomized Phase|Adverse Event|2|||
16987828|NCT00892437|38131628|FG001|Randomized Phase|Adverse Event|2|||
16987829|NCT00892437|38131627|FG000|Randomized Phase|Lost to Follow-up|1|||
16987830|NCT00892437|38131628|FG001|Randomized Phase|Lost to Follow-up|3|||
16987831|NCT00892437|38131627|FG000|Randomized Phase|Investigator's Discretion|1|||
16987832|NCT00892437|38131628|FG001|Randomized Phase|Investigator's Discretion|0|||
16987833|NCT00892437|38131627|FG000|Randomized Phase|Withdrew Consent|1|||
16987834|NCT00892437|38131628|FG001|Randomized Phase|Withdrew Consent|0|||
16987835|NCT00892437|38131627|FG000|Open-Label Extension Phase|Adverse Event|4|||
16987836|NCT00892437|38131628|FG001|Open-Label Extension Phase|Adverse Event|2|||
16987837|NCT00892437|38131627|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
16987838|NCT00892437|38131628|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
16987839|NCT00892437|38131627|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
16987840|NCT00892437|38131628|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
16987841|NCT00892437|38131627|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
16987842|NCT00892437|38131628|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
16987843|NCT00892437|38131627|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
16987844|NCT00892437|38131628|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
16987845|NCT00792103|38131635|FG000|Overall Study|Enrolled, not treated|15|||
16987846|NCT00792103|38131635|FG000|Overall Study|Lost to Follow-up|17|||
16987847|NCT00792103|38131635|FG000|Overall Study|Adverse Event|25|||
16987848|NCT00792103|38131635|FG000|Overall Study|Withdrawal by Subject|52|||
16987849|NCT00792103|38131635|FG000|Overall Study|Protocol Violation|10|||
16987850|NCT00792103|38131635|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
16987851|NCT00892281|38131641|FG000|Overall Study|Adverse Event|65|||
16987852|NCT00892281|38131642|FG001|Overall Study|Adverse Event|8|||
16987853|NCT00892281|38131641|FG000|Overall Study|Lost to Follow-up|81|||
16987854|NCT00892281|38131642|FG001|Overall Study|Lost to Follow-up|8|||
16987855|NCT00892281|38131641|FG000|Overall Study|Pregnancy|1|||
16987856|NCT00892281|38131642|FG001|Overall Study|Pregnancy|0|||
17135150|NCT01642004|38276394|FG001|Treatment|Maximum clinical benefit|9|||
17135151|NCT01642004|38276393|FG000|Treatment|Poor/non-compliance|1|||
16987857|NCT00892281|38131641|FG000|Overall Study|Protocol Violation|7|||
16987858|NCT00892281|38131642|FG001|Overall Study|Protocol Violation|2|||
16987859|NCT00892281|38131641|FG000|Overall Study|Withdrawal by Subject|86|||
16987860|NCT00892281|38131642|FG001|Overall Study|Withdrawal by Subject|14|||
16987861|NCT00892281|38131641|FG000|Overall Study|Subject failed to return for final visit|2|||
16987862|NCT00892281|38131642|FG001|Overall Study|Subject failed to return for final visit|0|||
16987863|NCT00892281|38131641|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
16987864|NCT00892281|38131642|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
16987865|NCT00892281|38131641|FG000|Overall Study|Final visit completed 4 weeks late|0|||
16987866|NCT00892281|38131642|FG001|Overall Study|Final visit completed 4 weeks late|1|||
16987867|NCT00892281|38131641|FG000|Overall Study|Subject completed day after study closed|1|||
16987868|NCT00892281|38131642|FG001|Overall Study|Subject completed day after study closed|0|||
16987869|NCT00892281|38131641|FG000|Overall Study|Family emergency|1|||
16987870|NCT00892281|38131642|FG001|Overall Study|Family emergency|0|||
16987871|NCT00892281|38131641|FG000|Overall Study|Last visit not done - death in family|1|||
16987872|NCT00892281|38131642|FG001|Overall Study|Last visit not done - death in family|0|||
16987873|NCT00892281|38131641|FG000|Overall Study|Did not meet incl/excl criteria|1|||
16987874|NCT00892281|38131642|FG001|Overall Study|Did not meet incl/excl criteria|0|||
16987875|NCT00892281|38131641|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
16987876|NCT00892281|38131642|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
16987877|NCT00892281|38131641|FG000|Overall Study|Unable to redeem the drug voucher|1|||
16987878|NCT00892281|38131642|FG001|Overall Study|Unable to redeem the drug voucher|0|||
16987879|NCT00892281|38131641|FG000|Overall Study|Subject not good candidate for study|1|||
16987880|NCT00892281|38131642|FG001|Overall Study|Subject not good candidate for study|0|||
16987881|NCT00892281|38131641|FG000|Overall Study|Subject did not return for any visits|1|||
16987882|NCT00892281|38131642|FG001|Overall Study|Subject did not return for any visits|0|||
16987883|NCT00892281|38131641|FG000|Overall Study|Subject missed several visits/lost meds|1|||
16987884|NCT00892281|38131642|FG001|Overall Study|Subject missed several visits/lost meds|0|||
16987885|NCT00892281|38131641|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
16987886|NCT00892281|38131642|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
16987887|NCT00892281|38131641|FG000|Overall Study|Scheduled for knee replacement|0|||
16987888|NCT00892281|38131642|FG001|Overall Study|Scheduled for knee replacement|1|||
16987889|NCT00892281|38131641|FG000|Overall Study|PI complained of inadequate compensation|3|||
16987890|NCT00892281|38131642|FG001|Overall Study|PI complained of inadequate compensation|0|||
16987891|NCT00892281|38131641|FG000|Overall Study|Subject lost interest in program|0|||
16987892|NCT00892281|38131642|FG001|Overall Study|Subject lost interest in program|1|||
16987893|NCT00892281|38131641|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
16987894|NCT00892281|38131642|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
16987895|NCT00892281|38131641|FG000|Overall Study|Death in family|1|||
16987896|NCT00892281|38131642|FG001|Overall Study|Death in family|0|||
16987897|NCT00892281|38131641|FG000|Overall Study|Lack of efficacy of study product|2|||
16987898|NCT00892281|38131642|FG001|Overall Study|Lack of efficacy of study product|0|||
16987899|NCT00892281|38131641|FG000|Overall Study|Subject not seen by PI at final visit|1|||
16780300|NCT02178592|37719400|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
16987900|NCT00892281|38131642|FG001|Overall Study|Subject not seen by PI at final visit|0|||
16987901|NCT00892281|38131641|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
16987902|NCT00892281|38131642|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
16987903|NCT00892281|38131641|FG000|Overall Study|Missed multiple visits|1|||
16987904|NCT00892281|38131642|FG001|Overall Study|Missed multiple visits|0|||
16987905|NCT00892281|38131641|FG000|Overall Study|Missed visits rescheduled out of window|1|||
16987906|NCT00892281|38131642|FG001|Overall Study|Missed visits rescheduled out of window|0|||
16987907|NCT00892281|38131641|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
16987908|NCT00892281|38131642|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
16987909|NCT00892281|38131641|FG000|Overall Study|Subject had history of drug abuse|1|||
16987910|NCT00892281|38131642|FG001|Overall Study|Subject had history of drug abuse|0|||
16987911|NCT00892281|38131641|FG000|Overall Study|Rash on hand|1|||
16987912|NCT00892281|38131642|FG001|Overall Study|Rash on hand|0|||
16987913|NCT00892281|38131641|FG000|Overall Study|Visit 4 date out of window|1|||
16987914|NCT00892281|38131642|FG001|Overall Study|Visit 4 date out of window|0|||
16987915|NCT00784693|38131650|FG000|Overall Study|Lost to Follow-up|0|||
16987916|NCT00784693|38131651|FG001|Overall Study|Lost to Follow-up|1|||
16987917|NCT00784693|38131650|FG000|Overall Study|Lack of Efficacy|1|||
16987918|NCT00784693|38131651|FG001|Overall Study|Lack of Efficacy|1|||
16987919|NCT00784693|38131650|FG000|Overall Study|Withdrawal by Subject|0|||
16987920|NCT00784693|38131651|FG001|Overall Study|Withdrawal by Subject|4|||
16987921|NCT00784693|38131650|FG000|Overall Study|Randomized but not Treated|1|||
16987922|NCT00784693|38131651|FG001|Overall Study|Randomized but not Treated|0|||
16987923|NCT00784693|38131650|FG000|Overall Study|Other|1|||
16987924|NCT00784693|38131651|FG001|Overall Study|Other|0|||
16987925|NCT00893763|38131659|FG000|Overall Study|extubated|110|||
16987926|NCT00893763|38131660|FG001|Overall Study|extubated|110|||
16987927|NCT00892047|38131670|FG000|Overall Study|Adverse Event|2|||
16987928|NCT00892047|38131671|FG001|Overall Study|Adverse Event|2|||
16987929|NCT00892047|38131670|FG000|Overall Study|subject burden|2|||
16987930|NCT00892047|38131671|FG001|Overall Study|subject burden|3|||
16987931|NCT00892047|38131670|FG000|Overall Study|Lack of Efficacy|0|||
16987932|NCT00892047|38131671|FG001|Overall Study|Lack of Efficacy|2|||
16987933|NCT00787267|38131679|FG000|Overall Study|Screen failure/Ineligible|10|||
16987934|NCT00787267|38131679|FG000|Overall Study|No Reason Provided|1|||
16987935|NCT00787267|38131679|FG000|Overall Study|Withdrawal by Subject|1|||
16987936|NCT00928434|38131686|FG000|Overall Study|Adverse Event|14|||
16987937|NCT00928434|38131687|FG001|Overall Study|Adverse Event|5|||
16987938|NCT00928434|38131688|FG002|Overall Study|Adverse Event|18|||
16987939|NCT00928434|38131686|FG000|Overall Study|Protocol Violation|5|||
16987940|NCT00928434|38131687|FG001|Overall Study|Protocol Violation|0|||
16987941|NCT00928434|38131688|FG002|Overall Study|Protocol Violation|8|||
16987942|NCT00928434|38131686|FG000|Overall Study|Physician Decision|2|||
16987943|NCT00928434|38131687|FG001|Overall Study|Physician Decision|0|||
16987944|NCT00928434|38131688|FG002|Overall Study|Physician Decision|3|||
16987945|NCT00928434|38131686|FG000|Overall Study|Lost to Follow-up|1|||
16987946|NCT00928434|38131687|FG001|Overall Study|Lost to Follow-up|0|||
16987947|NCT00928434|38131688|FG002|Overall Study|Lost to Follow-up|3|||
16987948|NCT00928434|38131686|FG000|Overall Study|Withdrawal by Subject|5|||
16987949|NCT00928434|38131687|FG001|Overall Study|Withdrawal by Subject|3|||
16987950|NCT00928434|38131688|FG002|Overall Study|Withdrawal by Subject|2|||
16987951|NCT00928434|38131686|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
16987952|NCT00928434|38131687|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
16987953|NCT00928434|38131688|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
16987954|NCT00928434|38131686|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
16987955|NCT00928434|38131687|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
16987956|NCT00928434|38131688|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
16987957|NCT00928434|38131686|FG000|Overall Study|Other (not meeting above criteria)|5|||
16987958|NCT00928434|38131687|FG001|Overall Study|Other (not meeting above criteria)|1|||
16987959|NCT00928434|38131688|FG002|Overall Study|Other (not meeting above criteria)|2|||
16987960|NCT00787189|38131706|FG000|Overall Study|Lost to Follow-up|2|||
16987961|NCT00787189|38131707|FG001|Overall Study|Lost to Follow-up|2|||
16987962|NCT00784459|38131715|FG000|Overall Study|Adverse Event|0|||
16987963|NCT00784459|38131716|FG001|Overall Study|Adverse Event|2|||
16987964|NCT00786799|38131724|FG000|Overall Study|Lost to Follow-up|1|||
16987965|NCT00786799|38131725|FG001|Overall Study|Lost to Follow-up|1|||
16987966|NCT00786565|38131736|FG000|Enrollment Prior to Surgery|Site Closed|3|||
16987967|NCT00786565|38131736|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
16987968|NCT00786565|38131736|FG000|Post Surgery|Abnormal macular pucker|1|||
16987969|NCT00786565|38131736|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
16987970|NCT00784147|38131744|FG000|Overall Study|Lost to Follow-up|2|||
16987971|NCT00784147|38131745|FG001|Overall Study|Lost to Follow-up|4|||
16987972|NCT00784147|38131744|FG000|Overall Study|Withdrawal by Subject|1|||
16987973|NCT00784147|38131745|FG001|Overall Study|Withdrawal by Subject|3|||
16987974|NCT00784147|38131744|FG000|Overall Study|Physician Decision|2|||
16987975|NCT00784147|38131745|FG001|Overall Study|Physician Decision|1|||
16987976|NCT00784147|38131744|FG000|Overall Study|Protocol Violation|1|||
16987977|NCT00784147|38131745|FG001|Overall Study|Protocol Violation|1|||
16987978|NCT00784147|38131744|FG000|Overall Study|Death|2|||
16987979|NCT00784147|38131745|FG001|Overall Study|Death|0|||
16987980|NCT00891813|38131751|FG000|Overall Study|Adverse Event|3|||
16987981|NCT00891813|38131751|FG000|Overall Study|Withdrawal by Subject|1|||
16987982|NCT00891813|38131751|FG000|Overall Study|Patient Noncompliance|6|||
16987983|NCT00891813|38131751|FG000|Overall Study|Protocol Violation|2|||
16987984|NCT00783835|38131755|FG000|Overall Study|Adverse Event|3|||
16987985|NCT00783835|38131755|FG000|Overall Study|Medical Criteria|1|||
16987986|NCT00783835|38131755|FG000|Overall Study|Withdrawal by Subject|2|||
16987987|NCT00783835|38131755|FG000|Overall Study|Lost to Follow-up|1|||
17135152|NCT01642004|38276394|FG001|Treatment|Poor/non-compliance|0|||
16987988|NCT00783835|38131755|FG000|Overall Study|Participant not Adherent|3|||
16987989|NCT00783289|38131763|FG000|Overall Study|Protocol Violation|0|||
16987990|NCT00783289|38131764|FG001|Overall Study|Protocol Violation|1|||
16987991|NCT00783289|38131765|FG002|Overall Study|Protocol Violation|0|||
16987992|NCT00783289|38131766|FG003|Overall Study|Protocol Violation|0|||
16987993|NCT00847912|38131781|FG000|Overall Study|Protocol Violation|6|||
16987994|NCT00847912|38131782|FG001|Overall Study|Protocol Violation|7|||
16987995|NCT00847912|38131781|FG000|Overall Study|Withdrawal by Subject|3|||
16987996|NCT00847912|38131782|FG001|Overall Study|Withdrawal by Subject|6|||
16987997|NCT00850564|38131789|FG000|Overall Study|Withdrawal by Subject|2|||
16987998|NCT00837148|38131793|FG000|Overall Study|Adverse Event|1|||
16987999|NCT00837148|38131793|FG000|Overall Study|Death|1|||
16988000|NCT00849940|38131797|FG000|Overall Study|Physician Decision|4|||
16988001|NCT00849472|38131801|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
16988002|NCT00849472|38131801|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
16988003|NCT00849472|38131801|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
16988004|NCT00849472|38131801|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
16988005|NCT00849472|38131801|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
16988006|NCT00849472|38131801|FG000|Weekly Paclitaxel|Disease Progression|1|||
16988007|NCT00849472|38131801|FG000|Weekly Paclitaxel|Adverse Event|11|||
16988008|NCT00849472|38131801|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
16988009|NCT00849472|38131801|FG000|Weekly Paclitaxel|Physician Decision|3|||
16988010|NCT00849472|38131801|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
16988011|NCT00849472|38131801|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
16988012|NCT00849472|38131801|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
16988013|NCT00849472|38131801|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
16988014|NCT00849472|38131801|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
16988015|NCT00849472|38131801|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
16988016|NCT00849472|38131801|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
16988017|NCT00849472|38131801|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
16988018|NCT00782509|38131809|FG000|Overall Study|Adverse Event|20|||
16988019|NCT00782509|38131810|FG001|Overall Study|Adverse Event|10|||
16988020|NCT00782509|38131811|FG002|Overall Study|Adverse Event|20|||
16988021|NCT00782509|38131809|FG000|Overall Study|Lost to Follow-up|1|||
16988022|NCT00782509|38131810|FG001|Overall Study|Lost to Follow-up|2|||
16988023|NCT00782509|38131811|FG002|Overall Study|Lost to Follow-up|3|||
16988024|NCT00782509|38131809|FG000|Overall Study|Withdrawal by Subject|3|||
16988025|NCT00782509|38131810|FG001|Overall Study|Withdrawal by Subject|5|||
16988026|NCT00782509|38131811|FG002|Overall Study|Withdrawal by Subject|8|||
16988027|NCT00782509|38131809|FG000|Overall Study|Non compliance with protocol|2|||
16988028|NCT00782509|38131810|FG001|Overall Study|Non compliance with protocol|0|||
16988029|NCT00782509|38131811|FG002|Overall Study|Non compliance with protocol|0|||
16988030|NCT00782509|38131809|FG000|Overall Study|Other reasons not stated above|5|||
16988031|NCT00782509|38131810|FG001|Overall Study|Other reasons not stated above|2|||
16988032|NCT00782509|38131811|FG002|Overall Study|Other reasons not stated above|3|||
16988033|NCT00782509|38131809|FG000|Overall Study|Lack of Efficacy|10|||
16988034|NCT00782509|38131810|FG001|Overall Study|Lack of Efficacy|5|||
16988035|NCT00782509|38131811|FG002|Overall Study|Lack of Efficacy|2|||
16988036|NCT00927810|38131830|FG000|Overall Study|Withdrawal by Subject|0|||
16988037|NCT00927810|38131831|FG001|Overall Study|Withdrawal by Subject|3|||
16988038|NCT00927810|38131832|FG002|Overall Study|Withdrawal by Subject|0|||
16988039|NCT00927810|38131833|FG003|Overall Study|Withdrawal by Subject|1|||
16988040|NCT00927810|38131830|FG000|Overall Study|Lost to Follow-up|0|||
16988041|NCT00927810|38131831|FG001|Overall Study|Lost to Follow-up|2|||
16988042|NCT00927810|38131832|FG002|Overall Study|Lost to Follow-up|1|||
16988043|NCT00927810|38131833|FG003|Overall Study|Lost to Follow-up|1|||
16988044|NCT00927810|38131830|FG000|Overall Study|Death|0|||
16988045|NCT00927810|38131831|FG001|Overall Study|Death|2|||
16988046|NCT00927810|38131832|FG002|Overall Study|Death|0|||
16988047|NCT00927810|38131833|FG003|Overall Study|Death|0|||
16988048|NCT00927810|38131830|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16988049|NCT00927810|38131831|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16988050|NCT00927810|38131832|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16988051|NCT00927810|38131833|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16988052|NCT00848926|38131851|FG000|Treatment Period|Progressive disease|45|||
16988053|NCT00848926|38131851|FG000|Treatment Period|Adverse Event|20|||
16988054|NCT00848926|38131851|FG000|Treatment Period|Physician Decision|12|||
16988055|NCT00848926|38131851|FG000|Treatment Period|Withdrawal by Subject|7|||
16988056|NCT00848926|38131851|FG000|Follow-up Period|Lost to Follow-up|7|||
16988057|NCT00848926|38131851|FG000|Follow-up Period|Withdrawal by Subject|3|||
16988058|NCT00848926|38131851|FG000|Follow-up Period|Other|2|||
16988059|NCT00847132|38131857|FG000|Overall Study|Death|1|||
16988060|NCT00847132|38131858|FG001|Overall Study|Death|1|||
16780301|NCT02178592|37719399|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
16780302|NCT02178592|37719400|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
16780303|NCT02178592|37719399|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
16780304|NCT02178592|37719400|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
16780305|NCT02178592|37719399|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
16780306|NCT02178592|37719400|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
16780307|NCT02178592|37719399|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
16780308|NCT02178592|37719400|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
16780309|NCT02610777|37719411|FG000|Overall Study|Lost to Follow-up|1|||
16780310|NCT02610777|37719412|FG001|Overall Study|Lost to Follow-up|0|||
16780311|NCT02610777|37719411|FG000|Overall Study|Site Terminated by Sponsor|9|||
16780312|NCT02610777|37719412|FG001|Overall Study|Site Terminated by Sponsor|8|||
16780313|NCT02610777|37719411|FG000|Overall Study|Withdrawal by Subject|2|||
16780314|NCT02610777|37719412|FG001|Overall Study|Withdrawal by Subject|2|||
16780315|NCT02610777|37719411|FG000|Overall Study|Reason not Specified|0|||
16780316|NCT02610777|37719412|FG001|Overall Study|Reason not Specified|1|||
16780317|NCT02610777|37719411|FG000|Overall Study|Death|50|||
16780318|NCT02610777|37719412|FG001|Overall Study|Death|47|||
16780319|NCT01628692|37719426|FG000|Overall Study|Lack of Efficacy|4|||
16780320|NCT01628692|37719427|FG001|Overall Study|Lack of Efficacy|4|||
16988061|NCT00918138|38131866|FG000|Overall Study|Subject withdrew consent|1|||
16988062|NCT00918138|38131867|FG001|Overall Study|Subject withdrew consent|1|||
16988063|NCT00918138|38131866|FG000|Overall Study|Death|1|||
16988064|NCT00918138|38131867|FG001|Overall Study|Death|0|||
16780321|NCT01628692|37719428|FG002|Overall Study|Lack of Efficacy|5|||
16780322|NCT01628692|37719429|FG003|Overall Study|Lack of Efficacy|1|||
16780323|NCT01628692|37719430|FG004|Overall Study|Lack of Efficacy|4|||
16780324|NCT01628692|37719431|FG005|Overall Study|Lack of Efficacy|7|||
16780325|NCT01628692|37719426|FG000|Overall Study|Adverse Event|2|||
16780326|NCT01628692|37719427|FG001|Overall Study|Adverse Event|0|||
16780327|NCT01628692|37719428|FG002|Overall Study|Adverse Event|2|||
16780328|NCT01628692|37719429|FG003|Overall Study|Adverse Event|0|||
16780329|NCT01628692|37719430|FG004|Overall Study|Adverse Event|0|||
16780330|NCT01628692|37719431|FG005|Overall Study|Adverse Event|0|||
16780331|NCT01628692|37719426|FG000|Overall Study|Withdrawal by Subject|0|||
16780332|NCT01628692|37719427|FG001|Overall Study|Withdrawal by Subject|1|||
16780333|NCT01628692|37719428|FG002|Overall Study|Withdrawal by Subject|1|||
16780334|NCT01628692|37719429|FG003|Overall Study|Withdrawal by Subject|0|||
16780335|NCT01628692|37719430|FG004|Overall Study|Withdrawal by Subject|0|||
16780336|NCT01628692|37719431|FG005|Overall Study|Withdrawal by Subject|0|||
16780337|NCT01628692|37719426|FG000|Overall Study|Death|0|||
16780338|NCT01628692|37719427|FG001|Overall Study|Death|1|||
16780339|NCT01628692|37719428|FG002|Overall Study|Death|0|||
16780340|NCT01628692|37719429|FG003|Overall Study|Death|0|||
16780341|NCT01628692|37719430|FG004|Overall Study|Death|0|||
16780342|NCT01628692|37719431|FG005|Overall Study|Death|0|||
16780343|NCT01628692|37719426|FG000|Overall Study|Poor compliance/noncompliance|1|||
16780344|NCT01628692|37719427|FG001|Overall Study|Poor compliance/noncompliance|0|||
16780345|NCT01628692|37719428|FG002|Overall Study|Poor compliance/noncompliance|0|||
16780346|NCT01628692|37719429|FG003|Overall Study|Poor compliance/noncompliance|0|||
16988065|NCT00782275|38131873|FG000|Overall Study|Adverse Event|11|||
16780347|NCT01628692|37719430|FG004|Overall Study|Poor compliance/noncompliance|0|||
16780348|NCT01628692|37719431|FG005|Overall Study|Poor compliance/noncompliance|0|||
16780349|NCT01628692|37719426|FG000|Overall Study|Administrative reason by sponsor|0|||
16988066|NCT00782275|38131873|FG000|Overall Study|Withdrawal by Subject|1|||
16988067|NCT00782275|38131873|FG000|Overall Study|Progressive Disease|21|||
16988068|NCT00782275|38131873|FG000|Overall Study|Physician Decision|4|||
16988069|NCT00782275|38131873|FG000|Overall Study|Not started treatment|1|||
16988070|NCT00782275|38131873|FG000|Overall Study|Other|3|||
16988071|NCT00791557|38131877|FG000|Overall Study|Adverse Event|1|||
16988072|NCT00920790|38131881|FG000|Overall Study|aggravation of general condition|14|||
16988073|NCT00781963|38131887|FG000|Overall Study|Death|3|||
16988074|NCT00781963|38131888|FG001|Overall Study|Death|0|||
16988075|NCT00781963|38131887|FG000|Overall Study|Lost to Follow-up|2|||
16988076|NCT00781963|38131888|FG001|Overall Study|Lost to Follow-up|1|||
16988077|NCT00781963|38131887|FG000|Overall Study|Withdrawal by Subject|3|||
16988078|NCT00781963|38131888|FG001|Overall Study|Withdrawal by Subject|1|||
16988079|NCT00781963|38131887|FG000|Overall Study|Refused follow-up|9|||
16988080|NCT00781963|38131888|FG001|Overall Study|Refused follow-up|0|||
16988081|NCT00920556|38131894|FG000|Overall Study|Adverse Event|16|||
16988082|NCT00920556|38131894|FG000|Overall Study|Physician Decision|7|||
16988083|NCT00920556|38131894|FG000|Overall Study|Withdrawal by Subject|1|||
16988084|NCT00781885|38131902|FG000|Overall Study|Physician Decision|1|||
16988085|NCT00918684|38131906|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
16988086|NCT00918684|38131906|FG000|Treatment Phase|Lack of Efficacy|6|||
16988087|NCT00918684|38131906|FG000|Treatment Phase|Lost to Follow-up|2|||
16988088|NCT00918684|38131906|FG000|Treatment Phase|Physician Decision|8|||
16988089|NCT00918684|38131906|FG000|Treatment Phase|Protocol Violation|1|||
16988090|NCT00918684|38131906|FG000|Treatment Phase|Withdrawal by Subject|8|||
16988091|NCT00786409|38131910|FG000|Overall Study|Withdrawal by Subject|2|||
16988092|NCT00786409|38131910|FG000|Overall Study|Adverse Event|2|||
16988093|NCT00786409|38131910|FG000|Overall Study|Pregnancy|2|||
16988094|NCT00786409|38131910|FG000|Overall Study|Lost to Follow-up|1|||
16988095|NCT00919854|38131914|FG000|Overall Study|Adverse Event|1|||
16988096|NCT00891735|38131922|FG000|Overall Study|Adverse Event|2|||
16988097|NCT00891735|38131923|FG001|Overall Study|Adverse Event|0|||
16988098|NCT00891735|38131924|FG002|Overall Study|Adverse Event|2|||
16988099|NCT00891735|38131925|FG003|Overall Study|Adverse Event|0|||
16988100|NCT00891735|38131922|FG000|Overall Study|Death|8|||
16988101|NCT00891735|38131923|FG001|Overall Study|Death|5|||
16988102|NCT00891735|38131924|FG002|Overall Study|Death|4|||
16988103|NCT00891735|38131925|FG003|Overall Study|Death|5|||
17135153|NCT01642004|38276393|FG000|Treatment|No longer meets study criteria|1|||
17135154|NCT01642004|38276394|FG001|Treatment|No longer meets study criteria|2|||
17135155|NCT01642004|38276393|FG000|Treatment|Other reasons|2|||
17135156|NCT01642004|38276394|FG001|Treatment|Other reasons|0|||
17135157|NCT01642004|38276393|FG000|Treatment|Not reported|0|||
17135158|NCT01642004|38276394|FG001|Treatment|Not reported|3|||
17135159|NCT01642004|38276393|FG000|Treatment|Participant request to discontinue study treatment|6|||
17135160|NCT01642004|38276394|FG001|Treatment|Participant request to discontinue study treatment|4|||
17135161|NCT01642004|38276393|FG000|Treatment|Participant withdrew consent|5|||
17135162|NCT01642004|38276394|FG001|Treatment|Participant withdrew consent|5|||
17135163|NCT00042289|38276450|FG000|Overall Study|Lost to Follow-up|3|||
17135164|NCT00042289|38276451|FG001|Overall Study|Lost to Follow-up|0|||
17135165|NCT00042289|38276452|FG002|Overall Study|Lost to Follow-up|0|||
17135166|NCT00042289|38276453|FG003|Overall Study|Lost to Follow-up|1|||
17135167|NCT00042289|38276454|FG004|Overall Study|Lost to Follow-up|3|||
17135168|NCT00042289|38276455|FG005|Overall Study|Lost to Follow-up|3|||
17135169|NCT00042289|38276456|FG006|Overall Study|Lost to Follow-up|6|||
17135170|NCT00042289|38276457|FG007|Overall Study|Lost to Follow-up|1|||
17135171|NCT00042289|38276458|FG008|Overall Study|Lost to Follow-up|1|||
17135172|NCT00042289|38276459|FG009|Overall Study|Lost to Follow-up|0|||
17135173|NCT00042289|38276460|FG010|Overall Study|Lost to Follow-up|0|||
17135174|NCT00042289|38276461|FG011|Overall Study|Lost to Follow-up|0|||
17135175|NCT00042289|38276462|FG012|Overall Study|Lost to Follow-up|0|||
17135176|NCT00042289|38276463|FG013|Overall Study|Lost to Follow-up|0|||
17135177|NCT00042289|38276464|FG014|Overall Study|Lost to Follow-up|0|||
17135178|NCT00042289|38276465|FG015|Overall Study|Lost to Follow-up|1|||
16988104|NCT00891735|38131922|FG000|Overall Study|Lost to Follow-up|2|||
16988105|NCT00891735|38131923|FG001|Overall Study|Lost to Follow-up|2|||
16988106|NCT00891735|38131924|FG002|Overall Study|Lost to Follow-up|2|||
16988107|NCT00891735|38131925|FG003|Overall Study|Lost to Follow-up|2|||
16988108|NCT00891735|38131922|FG000|Overall Study|Physician's decision to withdraw patient|1|||
16988109|NCT00891735|38131923|FG001|Overall Study|Physician's decision to withdraw patient|0|||
16988110|NCT00891735|38131924|FG002|Overall Study|Physician's decision to withdraw patient|0|||
16988111|NCT00891735|38131925|FG003|Overall Study|Physician's decision to withdraw patient|0|||
16988112|NCT00891735|38131922|FG000|Overall Study|Patient's decision to withdraw|4|||
16988113|NCT00891735|38131923|FG001|Overall Study|Patient's decision to withdraw|9|||
17135179|NCT00042289|38276466|FG016|Overall Study|Lost to Follow-up|1|||
17135180|NCT00042289|38276467|FG017|Overall Study|Lost to Follow-up|0|||
17135181|NCT00042289|38276468|FG018|Overall Study|Lost to Follow-up|3|||
17135182|NCT00042289|38276469|FG019|Overall Study|Lost to Follow-up|2|||
17135183|NCT00042289|38276470|FG020|Overall Study|Lost to Follow-up|0|||
17135184|NCT00042289|38276471|FG021|Overall Study|Lost to Follow-up|0|||
16988114|NCT00891735|38131924|FG002|Overall Study|Patient's decision to withdraw|4|||
16988115|NCT00891735|38131925|FG003|Overall Study|Patient's decision to withdraw|8|||
16988116|NCT00891657|38131937|FG000|Overall Study|Withdrawal by Subject|1|||
16988117|NCT00891657|38131938|FG001|Overall Study|Withdrawal by Subject|1|||
16988118|NCT00917124|38131946|FG000|Overall Study|Protocol Violation|4|||
16988119|NCT00917124|38131947|FG001|Overall Study|Protocol Violation|6|||
16988120|NCT00889863|38131953|FG000|Part I: Open Label|Death|1|||
16988121|NCT00889863|38131954|FG001|Part I: Open Label|Death|0|||
16988122|NCT00889863|38131953|FG000|Part I: Open Label|Adverse Event|4|||
16988123|NCT00889863|38131954|FG001|Part I: Open Label|Adverse Event|0|||
16988124|NCT00889863|38131953|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
16988125|NCT00889863|38131954|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
16988126|NCT00889863|38131953|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
16988127|NCT00889863|38131954|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
16988128|NCT00889863|38131953|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
16988129|NCT00889863|38131954|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
16988130|NCT00889863|38131953|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
16988131|NCT00889863|38131954|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
17135185|NCT00042289|38276472|FG022|Overall Study|Lost to Follow-up|0|||
17135186|NCT00042289|38276473|FG023|Overall Study|Lost to Follow-up|0|||
17135187|NCT00042289|38276474|FG024|Overall Study|Lost to Follow-up|0|||
17135188|NCT00042289|38276475|FG025|Overall Study|Lost to Follow-up|0|||
16988132|NCT00889863|38131953|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
16988133|NCT00889863|38131954|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
16988134|NCT00915018|38131964|FG000|Overall Study|Death|75|||
16988135|NCT00915018|38131965|FG001|Overall Study|Death|70|||
16988136|NCT00915018|38131964|FG000|Overall Study|Lost to Follow-up|10|||
16988137|NCT00915018|38131965|FG001|Overall Study|Lost to Follow-up|5|||
16988138|NCT00915018|38131964|FG000|Overall Study|Withdrawal by Subject|38|||
16988139|NCT00915018|38131965|FG001|Overall Study|Withdrawal by Subject|27|||
16988140|NCT00915018|38131964|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
16988141|NCT00915018|38131965|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
16988142|NCT00916578|38131971|FG000|Overall Study|Physician Decision|2|||
16988143|NCT00916578|38131971|FG000|Overall Study|Withdrawal by Subject|3|||
16988144|NCT00916578|38131971|FG000|Overall Study|Insurance Denial|2|||
16988145|NCT00889707|38131977|FG000|Overall Study|Adverse Event|1|||
16988146|NCT00889707|38131978|FG001|Overall Study|Adverse Event|0|||
16988147|NCT00889707|38131977|FG000|Overall Study|Withdrawal by Subject|4|||
16988148|NCT00889707|38131978|FG001|Overall Study|Withdrawal by Subject|3|||
17135189|NCT00042289|38276476|FG026|Overall Study|Lost to Follow-up|2|||
17135190|NCT00042289|38276477|FG027|Overall Study|Lost to Follow-up|2|||
16988149|NCT00889707|38131977|FG000|Overall Study|Lost to Follow-up|0|||
16988150|NCT00889707|38131978|FG001|Overall Study|Lost to Follow-up|2|||
16988151|NCT00889707|38131977|FG000|Overall Study|Lack of Efficacy|2|||
16988152|NCT00889707|38131978|FG001|Overall Study|Lack of Efficacy|5|||
17135191|NCT00042289|38276478|FG028|Overall Study|Lost to Follow-up|2|||
17135192|NCT00042289|38276479|FG029|Overall Study|Lost to Follow-up|0|||
17135193|NCT00042289|38276480|FG030|Overall Study|Lost to Follow-up|0|||
17135194|NCT00042289|38276481|FG031|Overall Study|Lost to Follow-up|2|||
17135195|NCT00042289|38276482|FG032|Overall Study|Lost to Follow-up|1|||
17135196|NCT00042289|38276483|FG033|Overall Study|Lost to Follow-up|1|||
17135197|NCT00042289|38276484|FG034|Overall Study|Lost to Follow-up|1|||
17135198|NCT00042289|38276485|FG035|Overall Study|Lost to Follow-up|2|||
17135199|NCT00042289|38276486|FG036|Overall Study|Lost to Follow-up|1|||
17135200|NCT00042289|38276487|FG037|Overall Study|Lost to Follow-up|1|||
17135201|NCT00042289|38276488|FG038|Overall Study|Lost to Follow-up|0|||
17135202|NCT00042289|38276489|FG039|Overall Study|Lost to Follow-up|5|||
17135203|NCT00042289|38276490|FG040|Overall Study|Lost to Follow-up|0|||
17135204|NCT00042289|38276491|FG041|Overall Study|Lost to Follow-up|2|||
17135205|NCT00042289|38276492|FG042|Overall Study|Lost to Follow-up|2|||
17135206|NCT00042289|38276493|FG043|Overall Study|Lost to Follow-up|0|||
17135207|NCT00042289|38276494|FG044|Overall Study|Lost to Follow-up|0|||
17135208|NCT00042289|38276495|FG045|Overall Study|Lost to Follow-up|1|||
17135209|NCT00042289|38276496|FG046|Overall Study|Lost to Follow-up|0|||
17135210|NCT00042289|38276450|FG000|Overall Study|Other reason|0|||
17135211|NCT00042289|38276451|FG001|Overall Study|Other reason|0|||
17135212|NCT00042289|38276452|FG002|Overall Study|Other reason|0|||
17135213|NCT00042289|38276453|FG003|Overall Study|Other reason|2|||
17135214|NCT00042289|38276454|FG004|Overall Study|Other reason|0|||
17135215|NCT00042289|38276455|FG005|Overall Study|Other reason|0|||
17135216|NCT00042289|38276456|FG006|Overall Study|Other reason|0|||
17135217|NCT00042289|38276457|FG007|Overall Study|Other reason|0|||
17135218|NCT00042289|38276458|FG008|Overall Study|Other reason|0|||
17135219|NCT00042289|38276459|FG009|Overall Study|Other reason|0|||
17135220|NCT00042289|38276460|FG010|Overall Study|Other reason|0|||
17135221|NCT00042289|38276461|FG011|Overall Study|Other reason|0|||
17135222|NCT00042289|38276462|FG012|Overall Study|Other reason|0|||
16988153|NCT00914940|38131984|FG000|D0 to D100 Post-transplant|Death|2|||
16988154|NCT00914940|38131984|FG000|D101 to 2 Years Post-transplant|Death|8|||
16988155|NCT00914940|38131984|FG000|2 Years to 5 Years Post-transplant|Death|3|||
16988156|NCT00835978|38131992|FG000|Overall Study|Death|33|||
16988157|NCT00835978|38131993|FG001|Overall Study|Death|40|||
16988158|NCT00835978|38131994|FG002|Overall Study|Death|49|||
16988159|NCT00835978|38131995|FG003|Overall Study|Death|4|||
16988160|NCT00835978|38131992|FG000|Overall Study|Lost to Follow-up|3|||
16988161|NCT00835978|38131993|FG001|Overall Study|Lost to Follow-up|4|||
16988162|NCT00835978|38131994|FG002|Overall Study|Lost to Follow-up|2|||
16988163|NCT00835978|38131995|FG003|Overall Study|Lost to Follow-up|1|||
16988164|NCT00835978|38131992|FG000|Overall Study|Other|5|||
16988165|NCT00835978|38131993|FG001|Overall Study|Other|1|||
16988166|NCT00835978|38131994|FG002|Overall Study|Other|8|||
16988167|NCT00835978|38131995|FG003|Overall Study|Other|0|||
16988168|NCT00835978|38131992|FG000|Overall Study|Objective progression or relapse|2|||
16988169|NCT00835978|38131993|FG001|Overall Study|Objective progression or relapse|0|||
16988170|NCT00835978|38131994|FG002|Overall Study|Objective progression or relapse|1|||
16988171|NCT00835978|38131995|FG003|Overall Study|Objective progression or relapse|0|||
17135223|NCT00042289|38276463|FG013|Overall Study|Other reason|0|||
16988172|NCT00835978|38131992|FG000|Overall Study|Adverse Event|1|||
16988173|NCT00835978|38131993|FG001|Overall Study|Adverse Event|0|||
16988174|NCT00835978|38131994|FG002|Overall Study|Adverse Event|1|||
16988175|NCT00835978|38131995|FG003|Overall Study|Adverse Event|0|||
16988176|NCT00835978|38131992|FG000|Overall Study|Withdrawal by Subject|0|||
16988177|NCT00835978|38131993|FG001|Overall Study|Withdrawal by Subject|3|||
16988178|NCT00835978|38131994|FG002|Overall Study|Withdrawal by Subject|0|||
16988179|NCT00835978|38131995|FG003|Overall Study|Withdrawal by Subject|5|||
16988180|NCT00835978|38131992|FG000|Overall Study|Study terminated by sponsor|12|||
16988181|NCT00835978|38131993|FG001|Overall Study|Study terminated by sponsor|8|||
16988182|NCT00835978|38131994|FG002|Overall Study|Study terminated by sponsor|30|||
16988183|NCT00835978|38131995|FG003|Overall Study|Study terminated by sponsor|0|||
16988184|NCT00914628|38132012|FG000|Overall Study|Death|35|||
16988185|NCT00914628|38132013|FG001|Overall Study|Death|17|||
16988186|NCT00914628|38132012|FG000|Overall Study|Medical decision|4|||
16988187|NCT00914628|38132013|FG001|Overall Study|Medical decision|0|||
16988188|NCT00914628|38132012|FG000|Overall Study|Protocol Violation|1|||
16988189|NCT00914628|38132013|FG001|Overall Study|Protocol Violation|0|||
16988190|NCT00914628|38132012|FG000|Overall Study|Lack of Efficacy|1|||
16988191|NCT00914628|38132013|FG001|Overall Study|Lack of Efficacy|0|||
16988192|NCT00914628|38132012|FG000|Overall Study|non-randomized|1|||
16988193|NCT00914628|38132013|FG001|Overall Study|non-randomized|0|||
16988194|NCT00914628|38132012|FG000|Overall Study|Relapse|1|||
16988195|NCT00914628|38132013|FG001|Overall Study|Relapse|2|||
16988196|NCT00914628|38132012|FG000|Overall Study|Study terminated by Sponsor|14|||
16988197|NCT00914628|38132013|FG001|Overall Study|Study terminated by Sponsor|8|||
16988198|NCT00914628|38132012|FG000|Overall Study|Patients who did not receive a single dose|7|||
16988199|NCT00914628|38132013|FG001|Overall Study|Patients who did not receive a single dose|1|||
16988200|NCT01077518|38132025|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
16988201|NCT01077518|38132026|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
17135224|NCT00042289|38276464|FG014|Overall Study|Other reason|0|||
16988202|NCT01077518|38132027|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
16988203|NCT01077518|38132025|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
16988204|NCT01077518|38132026|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
16988205|NCT01077518|38132027|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
16988206|NCT01077518|38132025|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
16988207|NCT01077518|38132026|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
16988208|NCT01077518|38132027|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
16988209|NCT01077518|38132025|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
16988210|NCT01077518|38132026|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
16988211|NCT01077518|38132027|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
16988212|NCT01077518|38132025|FG000|Optional Ofa Phase|Physician Decision|0|||
16988213|NCT01077518|38132026|FG001|Optional Ofa Phase|Physician Decision|0|||
16988214|NCT01077518|38132027|FG002|Optional Ofa Phase|Physician Decision|1|||
16988215|NCT01077518|38132025|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
16988216|NCT01077518|38132026|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
16988217|NCT01077518|38132027|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
16988218|NCT01077518|38132025|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
16988219|NCT01077518|38132026|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
16988220|NCT01077518|38132027|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
16988221|NCT00835120|38132036|FG000|Overall Study|Lack of Efficacy|1|||
16988222|NCT00835120|38132036|FG000|Overall Study|Lost to Follow-up|3|||
16988223|NCT00835120|38132036|FG000|Overall Study|Adverse Event|2|||
16988224|NCT00835120|38132036|FG000|Overall Study|Withdrawal by Subject|2|||
16988225|NCT00914316|38132044|FG000|Phase 1|Physician Decision|4|||
16988226|NCT00914316|38132045|FG001|Phase 1|Physician Decision|0|||
16988227|NCT00914316|38132046|FG002|Phase 1|Physician Decision|1|||
16988228|NCT00914316|38132047|FG003|Phase 1|Physician Decision|2|||
16988229|NCT00914316|38132044|FG000|Phase 1|Withdrawal by Subject|0|||
16988230|NCT00914316|38132045|FG001|Phase 1|Withdrawal by Subject|2|||
16988231|NCT00914316|38132046|FG002|Phase 1|Withdrawal by Subject|4|||
16988232|NCT00914316|38132047|FG003|Phase 1|Withdrawal by Subject|0|||
16988233|NCT00914316|38132044|FG000|Phase 1|Adverse Event|1|||
16988234|NCT00914316|38132045|FG001|Phase 1|Adverse Event|0|||
16988235|NCT00914316|38132046|FG002|Phase 1|Adverse Event|0|||
16988236|NCT00914316|38132047|FG003|Phase 1|Adverse Event|0|||
16988237|NCT00914316|38132044|FG000|Phase 2|Withdrawal by Subject|1|||
16988238|NCT00914316|38132045|FG001|Phase 2|Withdrawal by Subject|0|||
17135225|NCT00042289|38276465|FG015|Overall Study|Other reason|0|||
17135226|NCT00042289|38276466|FG016|Overall Study|Other reason|0|||
17135227|NCT00042289|38276467|FG017|Overall Study|Other reason|0|||
17135228|NCT00042289|38276468|FG018|Overall Study|Other reason|1|||
17135229|NCT00042289|38276469|FG019|Overall Study|Other reason|0|||
17135230|NCT00042289|38276470|FG020|Overall Study|Other reason|0|||
17135231|NCT00042289|38276471|FG021|Overall Study|Other reason|0|||
17135232|NCT00042289|38276472|FG022|Overall Study|Other reason|0|||
16988239|NCT00914316|38132046|FG002|Phase 2|Withdrawal by Subject|1|||
16988240|NCT00914316|38132047|FG003|Phase 2|Withdrawal by Subject|0|||
16988241|NCT00827632|38132059|FG000|Overall Study|Lost to Follow-up|8|||
16988242|NCT00827632|38132060|FG001|Overall Study|Lost to Follow-up|12|||
16988243|NCT00827632|38132059|FG000|Overall Study|Early withdrawal|14|||
16988244|NCT00827632|38132060|FG001|Overall Study|Early withdrawal|11|||
16988245|NCT00846742|38132066|FG000|Overall Study|Withdrawal by Subject|1|||
16988246|NCT00827242|38132073|FG000|Overall Study|Withdrawal by Subject|2|||
16988247|NCT00827242|38132074|FG001|Overall Study|Withdrawal by Subject|4|||
16988248|NCT00827242|38132073|FG000|Overall Study|Protocol Violation|1|||
16988249|NCT00827242|38132074|FG001|Overall Study|Protocol Violation|3|||
16988250|NCT00827242|38132073|FG000|Overall Study|Lost to Follow-up|0|||
17135233|NCT00042289|38276473|FG023|Overall Study|Other reason|1|||
17135234|NCT00042289|38276474|FG024|Overall Study|Other reason|0|||
17135235|NCT00042289|38276475|FG025|Overall Study|Other reason|0|||
17135236|NCT00042289|38276476|FG026|Overall Study|Other reason|1|||
17135237|NCT00042289|38276477|FG027|Overall Study|Other reason|0|||
17135238|NCT00042289|38276478|FG028|Overall Study|Other reason|3|||
16780350|NCT01628692|37719427|FG001|Overall Study|Administrative reason by sponsor|0|||
16780351|NCT01628692|37719428|FG002|Overall Study|Administrative reason by sponsor|0|||
16780352|NCT01628692|37719429|FG003|Overall Study|Administrative reason by sponsor|0|||
16988251|NCT00827242|38132074|FG001|Overall Study|Lost to Follow-up|3|||
16988252|NCT00827242|38132073|FG000|Overall Study|Adverse Event Excluding Death|2|||
16988253|NCT00827242|38132074|FG001|Overall Study|Adverse Event Excluding Death|1|||
16988254|NCT00827242|38132073|FG000|Overall Study|Entry Criteria Not Met|4|||
16988255|NCT00827242|38132074|FG001|Overall Study|Entry Criteria Not Met|1|||
16988256|NCT00827242|38132073|FG000|Overall Study|Physician Decision|2|||
16988257|NCT00827242|38132074|FG001|Overall Study|Physician Decision|0|||
16988258|NCT00827242|38132073|FG000|Overall Study|Death|1|||
16988259|NCT00827242|38132074|FG001|Overall Study|Death|0|||
16988260|NCT00827242|38132073|FG000|Overall Study|Lack of Efficacy|1|||
16988261|NCT00827242|38132074|FG001|Overall Study|Lack of Efficacy|0|||
16988262|NCT01077362|38132083|FG000|Overall Study|Lack of Efficacy|13|||
16988263|NCT01077362|38132084|FG001|Overall Study|Lack of Efficacy|8|||
16988264|NCT01077362|38132085|FG002|Overall Study|Lack of Efficacy|10|||
16988265|NCT01077362|38132083|FG000|Overall Study|Lost to Follow-up|1|||
16988266|NCT01077362|38132084|FG001|Overall Study|Lost to Follow-up|0|||
16988267|NCT01077362|38132085|FG002|Overall Study|Lost to Follow-up|3|||
16988268|NCT01077362|38132083|FG000|Overall Study|Adverse Event|12|||
16988269|NCT01077362|38132084|FG001|Overall Study|Adverse Event|7|||
17135239|NCT00042289|38276479|FG029|Overall Study|Other reason|0|||
17135240|NCT00042289|38276480|FG030|Overall Study|Other reason|0|||
17135241|NCT00042289|38276481|FG031|Overall Study|Other reason|1|||
17135242|NCT00042289|38276482|FG032|Overall Study|Other reason|0|||
17135243|NCT00042289|38276483|FG033|Overall Study|Other reason|1|||
17135244|NCT00042289|38276484|FG034|Overall Study|Other reason|0|||
17135245|NCT00042289|38276485|FG035|Overall Study|Other reason|2|||
17135246|NCT00042289|38276486|FG036|Overall Study|Other reason|0|||
17135247|NCT00042289|38276487|FG037|Overall Study|Other reason|0|||
17135248|NCT00042289|38276488|FG038|Overall Study|Other reason|0|||
17135249|NCT00042289|38276489|FG039|Overall Study|Other reason|0|||
17135250|NCT00042289|38276490|FG040|Overall Study|Other reason|0|||
17135251|NCT00042289|38276491|FG041|Overall Study|Other reason|0|||
17135252|NCT00042289|38276492|FG042|Overall Study|Other reason|0|||
17135253|NCT00042289|38276493|FG043|Overall Study|Other reason|1|||
17135254|NCT00042289|38276494|FG044|Overall Study|Other reason|0|||
17135255|NCT00042289|38276495|FG045|Overall Study|Other reason|0|||
17135256|NCT00042289|38276496|FG046|Overall Study|Other reason|0|||
17135257|NCT00042289|38276450|FG000|Overall Study|Severe debilitation, unable to continue|0|||
17135258|NCT00042289|38276451|FG001|Overall Study|Severe debilitation, unable to continue|0|||
16988270|NCT01077362|38132085|FG002|Overall Study|Adverse Event|4|||
16988271|NCT01077362|38132083|FG000|Overall Study|Withdrawal by Subject|5|||
16988272|NCT01077362|38132084|FG001|Overall Study|Withdrawal by Subject|3|||
16988273|NCT01077362|38132085|FG002|Overall Study|Withdrawal by Subject|5|||
16988274|NCT01077362|38132083|FG000|Overall Study|Other|0|||
16988275|NCT01077362|38132084|FG001|Overall Study|Other|1|||
16988276|NCT01077362|38132085|FG002|Overall Study|Other|2|||
16988277|NCT00846586|38132100|FG000|Overall Study|Adverse Event|20|||
16988278|NCT00846586|38132101|FG001|Overall Study|Adverse Event|10|||
16988279|NCT00846586|38132100|FG000|Overall Study|Subject withdrew consent|8|||
16988280|NCT00846586|38132101|FG001|Overall Study|Subject withdrew consent|10|||
16988281|NCT00846586|38132100|FG000|Overall Study|Administrative problems|5|||
16988282|NCT00846586|38132101|FG001|Overall Study|Administrative problems|4|||
16988283|NCT00846586|38132100|FG000|Overall Study|Death|2|||
16988284|NCT00846586|38132101|FG001|Overall Study|Death|0|||
16988285|NCT00846586|38132100|FG000|Overall Study|Protocol deviation|2|||
16988286|NCT00846586|38132101|FG001|Overall Study|Protocol deviation|6|||
16988287|NCT00846586|38132100|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16988288|NCT00846586|38132101|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16988289|NCT00846586|38132100|FG000|Overall Study|Lost to Follow-up|1|||
16988290|NCT00846586|38132101|FG001|Overall Study|Lost to Follow-up|4|||
16988291|NCT00846586|38132100|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16988292|NCT00846586|38132101|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16988293|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
16988294|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
16988295|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Adverse Event|31|||
16988296|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Adverse Event|21|||
16988297|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
16988298|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
16988299|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
16988300|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
16988301|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
16988302|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
16988303|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
16988304|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
16988305|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Administrative problems|3|||
16988306|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Administrative problems|3|||
16988307|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Death|5|||
16988308|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Death|8|||
16988309|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Disease progression|139|||
16988310|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Disease progression|119|||
16988311|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
16988312|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
16988313|NCT00785785|38132109|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
16988314|NCT00785785|38132110|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
16988315|NCT00785785|38132109|FG000|Optional Extension Phase|Adverse Event|4|||
16988316|NCT00785785|38132110|FG001|Optional Extension Phase|Adverse Event|5|||
16988317|NCT00785785|38132109|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
16988318|NCT00785785|38132110|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
16988319|NCT00785785|38132109|FG000|Optional Extension Phase|Lost to Follow-up|1|||
16988320|NCT00785785|38132110|FG001|Optional Extension Phase|Lost to Follow-up|0|||
16988321|NCT00785785|38132109|FG000|Optional Extension Phase|Administrative problems|2|||
16988322|NCT00785785|38132110|FG001|Optional Extension Phase|Administrative problems|0|||
16988323|NCT00785785|38132109|FG000|Optional Extension Phase|Death|1|||
16988324|NCT00785785|38132110|FG001|Optional Extension Phase|Death|5|||
16988325|NCT00785785|38132109|FG000|Optional Extension Phase|Disease progression|22|||
17135259|NCT00042289|38276452|FG002|Overall Study|Severe debilitation, unable to continue|0|||
17135260|NCT00042289|38276453|FG003|Overall Study|Severe debilitation, unable to continue|0|||
17135261|NCT00042289|38276454|FG004|Overall Study|Severe debilitation, unable to continue|0|||
17135262|NCT00042289|38276455|FG005|Overall Study|Severe debilitation, unable to continue|0|||
17135263|NCT00042289|38276456|FG006|Overall Study|Severe debilitation, unable to continue|0|||
17135264|NCT00042289|38276457|FG007|Overall Study|Severe debilitation, unable to continue|0|||
17135265|NCT00042289|38276458|FG008|Overall Study|Severe debilitation, unable to continue|0|||
17135266|NCT00042289|38276459|FG009|Overall Study|Severe debilitation, unable to continue|0|||
17135267|NCT00042289|38276460|FG010|Overall Study|Severe debilitation, unable to continue|0|||
17135268|NCT00042289|38276461|FG011|Overall Study|Severe debilitation, unable to continue|0|||
17135269|NCT00042289|38276462|FG012|Overall Study|Severe debilitation, unable to continue|0|||
17135270|NCT00042289|38276463|FG013|Overall Study|Severe debilitation, unable to continue|0|||
17135271|NCT00042289|38276464|FG014|Overall Study|Severe debilitation, unable to continue|0|||
17135272|NCT00042289|38276465|FG015|Overall Study|Severe debilitation, unable to continue|0|||
17135273|NCT00042289|38276466|FG016|Overall Study|Severe debilitation, unable to continue|0|||
16988326|NCT00785785|38132110|FG001|Optional Extension Phase|Disease progression|70|||
16988327|NCT00785785|38132109|FG000|Optional Extension Phase|Protocol deviation|0|||
16988328|NCT00785785|38132110|FG001|Optional Extension Phase|Protocol deviation|2|||
16988329|NCT00785785|38132109|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
17135274|NCT00042289|38276467|FG017|Overall Study|Severe debilitation, unable to continue|0|||
17135275|NCT00042289|38276468|FG018|Overall Study|Severe debilitation, unable to continue|0|||
17135276|NCT00042289|38276469|FG019|Overall Study|Severe debilitation, unable to continue|0|||
17135277|NCT00042289|38276470|FG020|Overall Study|Severe debilitation, unable to continue|0|||
17135278|NCT00042289|38276471|FG021|Overall Study|Severe debilitation, unable to continue|1|||
17135279|NCT00042289|38276472|FG022|Overall Study|Severe debilitation, unable to continue|0|||
17135280|NCT00042289|38276473|FG023|Overall Study|Severe debilitation, unable to continue|1|||
17135281|NCT00042289|38276474|FG024|Overall Study|Severe debilitation, unable to continue|0|||
17135282|NCT00042289|38276475|FG025|Overall Study|Severe debilitation, unable to continue|0|||
17135283|NCT00042289|38276476|FG026|Overall Study|Severe debilitation, unable to continue|0|||
17135284|NCT00042289|38276477|FG027|Overall Study|Severe debilitation, unable to continue|1|||
17135285|NCT00042289|38276478|FG028|Overall Study|Severe debilitation, unable to continue|0|||
17135286|NCT00042289|38276479|FG029|Overall Study|Severe debilitation, unable to continue|0|||
17135287|NCT00042289|38276480|FG030|Overall Study|Severe debilitation, unable to continue|0|||
17135288|NCT00042289|38276481|FG031|Overall Study|Severe debilitation, unable to continue|1|||
17135289|NCT00042289|38276482|FG032|Overall Study|Severe debilitation, unable to continue|1|||
17135290|NCT00042289|38276483|FG033|Overall Study|Severe debilitation, unable to continue|0|||
17135291|NCT00042289|38276484|FG034|Overall Study|Severe debilitation, unable to continue|0|||
17135292|NCT00042289|38276485|FG035|Overall Study|Severe debilitation, unable to continue|0|||
17135293|NCT00042289|38276486|FG036|Overall Study|Severe debilitation, unable to continue|0|||
17135294|NCT00042289|38276487|FG037|Overall Study|Severe debilitation, unable to continue|0|||
17135295|NCT00042289|38276488|FG038|Overall Study|Severe debilitation, unable to continue|0|||
17135296|NCT00042289|38276489|FG039|Overall Study|Severe debilitation, unable to continue|0|||
17135297|NCT00042289|38276490|FG040|Overall Study|Severe debilitation, unable to continue|0|||
17135298|NCT00042289|38276491|FG041|Overall Study|Severe debilitation, unable to continue|0|||
17135299|NCT00042289|38276492|FG042|Overall Study|Severe debilitation, unable to continue|0|||
16988330|NCT00785785|38132110|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
16988331|NCT01077284|38132121|FG000|Overall Study|Adverse Event|2|||
16988332|NCT01077284|38132122|FG001|Overall Study|Adverse Event|0|||
16988333|NCT01077284|38132123|FG002|Overall Study|Adverse Event|1|||
16988334|NCT01077284|38132121|FG000|Overall Study|Lost to Follow-up|1|||
16988335|NCT01077284|38132122|FG001|Overall Study|Lost to Follow-up|2|||
16988336|NCT01077284|38132123|FG002|Overall Study|Lost to Follow-up|0|||
16988337|NCT01077284|38132121|FG000|Overall Study|Withdrawal by Subject|2|||
16988338|NCT01077284|38132122|FG001|Overall Study|Withdrawal by Subject|3|||
16988339|NCT01077284|38132123|FG002|Overall Study|Withdrawal by Subject|1|||
16988340|NCT01077284|38132121|FG000|Overall Study|Other|0|||
16988341|NCT01077284|38132122|FG001|Overall Study|Other|0|||
16988342|NCT01077284|38132123|FG002|Overall Study|Other|1|||
16988343|NCT00826618|38132131|FG000|Overall Study|Withdrawal by Subject|1|||
16988344|NCT01077128|38132135|FG000|Overall Study|Adverse Event|8|||
16988345|NCT01077128|38132135|FG000|Overall Study|Lack of Efficacy|1|||
16988346|NCT01077128|38132135|FG000|Overall Study|Disease exacerbation|1|||
16988347|NCT01077128|38132135|FG000|Overall Study|Adverse event and consent withdrawal|1|||
16988348|NCT01077128|38132135|FG000|Overall Study|Adverse event and disease exacerbation|1|||
16988349|NCT01077128|38132135|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
16988350|NCT01077128|38132135|FG000|Overall Study|Other|54|||
16988351|NCT00826540|38132189|FG000|Overall Study|ineligible|3|||
16988352|NCT00826540|38132189|FG000|Overall Study|Withdrawal by Subject|1|||
16988353|NCT01077050|38132193|FG000|Overall Study|Subjects signed ICF could not be located|1|||
16988354|NCT01077050|38132193|FG000|Overall Study|Screen failure|8|||
16988355|NCT00592384|38132199|FG000|Overall Study|Withdrawal by Subject|5|||
16988356|NCT00592384|38132200|FG001|Overall Study|Withdrawal by Subject|6|||
16988357|NCT00846040|38132209|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
16988358|NCT00846040|38132210|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
16988359|NCT00846040|38132211|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
16988360|NCT00846040|38132209|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
16988361|NCT00846040|38132210|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
16988362|NCT00846040|38132211|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
16988363|NCT00826228|38132220|FG000|Overall Study|Withdrawal by Subject|1|||
16988364|NCT00825994|38132225|FG000|Overall Study|Withdrawal by Subject|2|||
16988365|NCT00825994|38132225|FG000|Overall Study|Lost to Follow-up|1|||
16988366|NCT00825994|38132225|FG000|Overall Study|Protocol Violation|1|||
16988367|NCT00825994|38132225|FG000|Overall Study|Placebo Responder at V2|1|||
16988368|NCT00825916|38132232|FG000|Overall Study|Lost to Follow-up|4|||
16988369|NCT00825916|38132233|FG001|Overall Study|Lost to Follow-up|2|||
16988370|NCT00825916|38132234|FG002|Overall Study|Lost to Follow-up|1|||
16988371|NCT00791479|38132281|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16988372|NCT00791479|38132282|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16988373|NCT00791479|38132283|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16988374|NCT00791479|38132284|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16988375|NCT00791479|38132285|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
16988376|NCT00791479|38132286|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16988377|NCT00791479|38132281|FG000|Overall Study|Adverse Event|0|||
16988378|NCT00791479|38132282|FG001|Overall Study|Adverse Event|1|||
16988379|NCT00791479|38132283|FG002|Overall Study|Adverse Event|0|||
16988380|NCT00791479|38132284|FG003|Overall Study|Adverse Event|2|||
17135300|NCT00042289|38276493|FG043|Overall Study|Severe debilitation, unable to continue|0|||
16988381|NCT00791479|38132285|FG004|Overall Study|Adverse Event|0|||
16988382|NCT00791479|38132286|FG005|Overall Study|Adverse Event|1|||
16988383|NCT00791479|38132281|FG000|Overall Study|Lost to Follow-up|0|||
16988384|NCT00791479|38132282|FG001|Overall Study|Lost to Follow-up|1|||
16988385|NCT00791479|38132283|FG002|Overall Study|Lost to Follow-up|0|||
16988386|NCT00791479|38132284|FG003|Overall Study|Lost to Follow-up|0|||
16988387|NCT00791479|38132285|FG004|Overall Study|Lost to Follow-up|0|||
16988388|NCT00791479|38132286|FG005|Overall Study|Lost to Follow-up|1|||
16988389|NCT00791479|38132281|FG000|Overall Study|Protocol Violation|2|||
16988390|NCT00791479|38132282|FG001|Overall Study|Protocol Violation|1|||
16988391|NCT00791479|38132283|FG002|Overall Study|Protocol Violation|0|||
16988392|NCT00791479|38132284|FG003|Overall Study|Protocol Violation|1|||
16988393|NCT00791479|38132285|FG004|Overall Study|Protocol Violation|0|||
16988394|NCT00791479|38132286|FG005|Overall Study|Protocol Violation|0|||
16988395|NCT00791479|38132281|FG000|Overall Study|Withdrawal by Subject|0|||
16988396|NCT00791479|38132282|FG001|Overall Study|Withdrawal by Subject|0|||
16988397|NCT00791479|38132283|FG002|Overall Study|Withdrawal by Subject|0|||
16988398|NCT00791479|38132284|FG003|Overall Study|Withdrawal by Subject|1|||
16988399|NCT00791479|38132285|FG004|Overall Study|Withdrawal by Subject|0|||
16988400|NCT00791479|38132286|FG005|Overall Study|Withdrawal by Subject|1|||
16988401|NCT00890097|38132310|FG000|Overall Study|Adverse Event|21|||
16988402|NCT00890097|38132311|FG001|Overall Study|Adverse Event|32|||
16988403|NCT00890097|38132312|FG002|Overall Study|Adverse Event|28|||
16988404|NCT00890097|38132310|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
16988405|NCT00890097|38132311|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
16988406|NCT00890097|38132312|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
16988407|NCT00890097|38132310|FG000|Overall Study|Withdrew Consent|9|||
16988408|NCT00890097|38132311|FG001|Overall Study|Withdrew Consent|6|||
16988409|NCT00890097|38132312|FG002|Overall Study|Withdrew Consent|9|||
16988410|NCT00890097|38132310|FG000|Overall Study|Lost to Follow-up|5|||
16988411|NCT00890097|38132311|FG001|Overall Study|Lost to Follow-up|5|||
16988412|NCT00890097|38132312|FG002|Overall Study|Lost to Follow-up|5|||
16988413|NCT00890097|38132310|FG000|Overall Study|Noncompliance|0|||
16988414|NCT00890097|38132311|FG001|Overall Study|Noncompliance|4|||
16988415|NCT00890097|38132312|FG002|Overall Study|Noncompliance|4|||
16988416|NCT00890097|38132310|FG000|Overall Study|Sponsor Decision|7|||
16988417|NCT00890097|38132311|FG001|Overall Study|Sponsor Decision|11|||
16988418|NCT00890097|38132312|FG002|Overall Study|Sponsor Decision|7|||
16988419|NCT00890097|38132310|FG000|Overall Study|Did not attend final visit|2|||
16988420|NCT00890097|38132311|FG001|Overall Study|Did not attend final visit|3|||
16988421|NCT00890097|38132312|FG002|Overall Study|Did not attend final visit|0|||
16988422|NCT00890097|38132310|FG000|Overall Study|Subject Decision|3|||
16988423|NCT00890097|38132311|FG001|Overall Study|Subject Decision|2|||
16988424|NCT00890097|38132312|FG002|Overall Study|Subject Decision|6|||
16988425|NCT00890097|38132310|FG000|Overall Study|Randomization Error|2|||
16988426|NCT00890097|38132311|FG001|Overall Study|Randomization Error|0|||
16988427|NCT00890097|38132312|FG002|Overall Study|Randomization Error|0|||
16988428|NCT00890097|38132310|FG000|Overall Study|Failed inclusion criteria|3|||
16988429|NCT00890097|38132311|FG001|Overall Study|Failed inclusion criteria|4|||
16988430|NCT00890097|38132312|FG002|Overall Study|Failed inclusion criteria|0|||
16988431|NCT00890097|38132310|FG000|Overall Study|Transportation|0|||
16988432|NCT00890097|38132311|FG001|Overall Study|Transportation|2|||
16988433|NCT00890097|38132312|FG002|Overall Study|Transportation|0|||
16988434|NCT00890097|38132310|FG000|Overall Study|Subject Moved|0|||
16988435|NCT00890097|38132311|FG001|Overall Study|Subject Moved|4|||
16988436|NCT00890097|38132312|FG002|Overall Study|Subject Moved|0|||
16988437|NCT00890097|38132310|FG000|Overall Study|Protocol Deviation|1|||
16988438|NCT00890097|38132311|FG001|Overall Study|Protocol Deviation|1|||
16988439|NCT00890097|38132312|FG002|Overall Study|Protocol Deviation|1|||
16988440|NCT00913458|38132320|FG000|Phase 1|Non-Responder|54|||
16988441|NCT00913458|38132321|FG001|Phase 1|Non-Responder|0|||
16988442|NCT00913458|38132322|FG002|Phase 1|Non-Responder|0|||
16988443|NCT00913458|38132323|FG003|Phase 1|Non-Responder|0|||
16988444|NCT00913458|38132324|FG004|Phase 1|Non-Responder|0|||
17135301|NCT00042289|38276494|FG044|Overall Study|Severe debilitation, unable to continue|0|||
17135302|NCT00042289|38276495|FG045|Overall Study|Severe debilitation, unable to continue|0|||
17135303|NCT00042289|38276496|FG046|Overall Study|Severe debilitation, unable to continue|0|||
17135304|NCT00042289|38276450|FG000|Overall Study|Site closed|0|||
16988445|NCT00913458|38132325|FG005|Phase 1|Non-Responder|0|||
16988446|NCT00913458|38132326|FG006|Phase 1|Non-Responder|0|||
16988447|NCT00913458|38132320|FG000|Phase 1|Subject Request|17|||
16988448|NCT00913458|38132321|FG001|Phase 1|Subject Request|0|||
16988449|NCT00913458|38132322|FG002|Phase 1|Subject Request|0|||
16988450|NCT00913458|38132323|FG003|Phase 1|Subject Request|0|||
16988451|NCT00913458|38132324|FG004|Phase 1|Subject Request|0|||
16988452|NCT00913458|38132325|FG005|Phase 1|Subject Request|0|||
16988453|NCT00913458|38132326|FG006|Phase 1|Subject Request|0|||
16988454|NCT00913458|38132320|FG000|Phase 1|Adverse Event|20|||
16988455|NCT00913458|38132321|FG001|Phase 1|Adverse Event|0|||
16988456|NCT00913458|38132322|FG002|Phase 1|Adverse Event|0|||
16988457|NCT00913458|38132323|FG003|Phase 1|Adverse Event|0|||
16988458|NCT00913458|38132324|FG004|Phase 1|Adverse Event|0|||
16988459|NCT00913458|38132325|FG005|Phase 1|Adverse Event|0|||
16988460|NCT00913458|38132326|FG006|Phase 1|Adverse Event|0|||
16988461|NCT00913458|38132320|FG000|Phase 1|Lost to Follow-up|2|||
16988462|NCT00913458|38132321|FG001|Phase 1|Lost to Follow-up|0|||
16988463|NCT00913458|38132322|FG002|Phase 1|Lost to Follow-up|0|||
16988464|NCT00913458|38132323|FG003|Phase 1|Lost to Follow-up|0|||
16988465|NCT00913458|38132324|FG004|Phase 1|Lost to Follow-up|0|||
16988466|NCT00913458|38132325|FG005|Phase 1|Lost to Follow-up|0|||
17135305|NCT00042289|38276451|FG001|Overall Study|Site closed|0|||
17135306|NCT00042289|38276452|FG002|Overall Study|Site closed|0|||
17135307|NCT00042289|38276453|FG003|Overall Study|Site closed|0|||
17135308|NCT00042289|38276454|FG004|Overall Study|Site closed|0|||
17135309|NCT00042289|38276455|FG005|Overall Study|Site closed|0|||
17135310|NCT00042289|38276456|FG006|Overall Study|Site closed|0|||
17135311|NCT00042289|38276457|FG007|Overall Study|Site closed|0|||
17135312|NCT00042289|38276458|FG008|Overall Study|Site closed|0|||
17135313|NCT00042289|38276459|FG009|Overall Study|Site closed|0|||
17135314|NCT00042289|38276460|FG010|Overall Study|Site closed|0|||
17135315|NCT00042289|38276461|FG011|Overall Study|Site closed|0|||
17135316|NCT00042289|38276462|FG012|Overall Study|Site closed|0|||
16988467|NCT00913458|38132326|FG006|Phase 1|Lost to Follow-up|0|||
17135317|NCT00042289|38276463|FG013|Overall Study|Site closed|0|||
17135318|NCT00042289|38276464|FG014|Overall Study|Site closed|0|||
16988468|NCT00913458|38132320|FG000|Phase 1|Protocol Violation|10|||
16988469|NCT00913458|38132321|FG001|Phase 1|Protocol Violation|0|||
16988470|NCT00913458|38132322|FG002|Phase 1|Protocol Violation|0|||
16988471|NCT00913458|38132323|FG003|Phase 1|Protocol Violation|0|||
16988472|NCT00913458|38132324|FG004|Phase 1|Protocol Violation|0|||
16988473|NCT00913458|38132325|FG005|Phase 1|Protocol Violation|0|||
16988474|NCT00913458|38132326|FG006|Phase 1|Protocol Violation|0|||
16988475|NCT00913458|38132320|FG000|Phase 1|Sponsor|2|||
16988476|NCT00913458|38132321|FG001|Phase 1|Sponsor|0|||
16988477|NCT00913458|38132322|FG002|Phase 1|Sponsor|0|||
16988478|NCT00913458|38132323|FG003|Phase 1|Sponsor|0|||
16988479|NCT00913458|38132324|FG004|Phase 1|Sponsor|0|||
17135319|NCT00042289|38276465|FG015|Overall Study|Site closed|0|||
17135320|NCT00042289|38276466|FG016|Overall Study|Site closed|0|||
16988480|NCT00913458|38132325|FG005|Phase 1|Sponsor|0|||
16988481|NCT00913458|38132326|FG006|Phase 1|Sponsor|0|||
16988482|NCT00913458|38132320|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
16988483|NCT00913458|38132321|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
16988484|NCT00913458|38132322|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
16988485|NCT00913458|38132323|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
16988486|NCT00913458|38132324|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
16988487|NCT00913458|38132325|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
16988488|NCT00913458|38132326|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
16988489|NCT00913458|38132320|FG000|Phase 2|Non-Responder|0|||
16988490|NCT00913458|38132321|FG001|Phase 2|Non-Responder|5|||
16988491|NCT00913458|38132322|FG002|Phase 2|Non-Responder|7|||
16988492|NCT00913458|38132323|FG003|Phase 2|Non-Responder|12|||
16988493|NCT00913458|38132324|FG004|Phase 2|Non-Responder|0|||
16988494|NCT00913458|38132325|FG005|Phase 2|Non-Responder|0|||
16988495|NCT00913458|38132326|FG006|Phase 2|Non-Responder|0|||
16988496|NCT00913458|38132320|FG000|Phase 2|Subject Request|0|||
16988497|NCT00913458|38132321|FG001|Phase 2|Subject Request|0|||
16988498|NCT00913458|38132322|FG002|Phase 2|Subject Request|1|||
16988499|NCT00913458|38132323|FG003|Phase 2|Subject Request|2|||
16988500|NCT00913458|38132324|FG004|Phase 2|Subject Request|0|||
16988501|NCT00913458|38132325|FG005|Phase 2|Subject Request|0|||
16988502|NCT00913458|38132326|FG006|Phase 2|Subject Request|0|||
16988503|NCT00913458|38132320|FG000|Phase 2|Adverse Event|0|||
16988504|NCT00913458|38132321|FG001|Phase 2|Adverse Event|3|||
16988505|NCT00913458|38132322|FG002|Phase 2|Adverse Event|0|||
16988506|NCT00913458|38132323|FG003|Phase 2|Adverse Event|1|||
16988507|NCT00913458|38132324|FG004|Phase 2|Adverse Event|0|||
16988508|NCT00913458|38132325|FG005|Phase 2|Adverse Event|0|||
16988509|NCT00913458|38132326|FG006|Phase 2|Adverse Event|0|||
16988510|NCT00913458|38132320|FG000|Phase 2|Lost to Follow-up|0|||
16988511|NCT00913458|38132321|FG001|Phase 2|Lost to Follow-up|0|||
16988512|NCT00913458|38132322|FG002|Phase 2|Lost to Follow-up|0|||
16988513|NCT00913458|38132323|FG003|Phase 2|Lost to Follow-up|1|||
16988514|NCT00913458|38132324|FG004|Phase 2|Lost to Follow-up|0|||
16988515|NCT00913458|38132325|FG005|Phase 2|Lost to Follow-up|0|||
16988516|NCT00913458|38132326|FG006|Phase 2|Lost to Follow-up|0|||
16988517|NCT00913458|38132320|FG000|Phase 2|Protocol Violation|0|||
16988518|NCT00913458|38132321|FG001|Phase 2|Protocol Violation|2|||
16988519|NCT00913458|38132322|FG002|Phase 2|Protocol Violation|0|||
16988520|NCT00913458|38132323|FG003|Phase 2|Protocol Violation|0|||
16988521|NCT00913458|38132324|FG004|Phase 2|Protocol Violation|0|||
16988522|NCT00913458|38132325|FG005|Phase 2|Protocol Violation|0|||
16988523|NCT00913458|38132326|FG006|Phase 2|Protocol Violation|0|||
16988524|NCT00913458|38132320|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
16988525|NCT00913458|38132321|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
16988526|NCT00913458|38132322|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
16988527|NCT00913458|38132323|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
16988528|NCT00913458|38132324|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
16988529|NCT00913458|38132325|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
16988530|NCT00913458|38132326|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
16988531|NCT00913458|38132320|FG000|Phase 3|Adverse Event|0|||
16988532|NCT00913458|38132321|FG001|Phase 3|Adverse Event|0|||
16988533|NCT00913458|38132322|FG002|Phase 3|Adverse Event|0|||
16988534|NCT00913458|38132323|FG003|Phase 3|Adverse Event|0|||
16988535|NCT00913458|38132324|FG004|Phase 3|Adverse Event|5|||
16988536|NCT00913458|38132325|FG005|Phase 3|Adverse Event|4|||
16988537|NCT00913458|38132326|FG006|Phase 3|Adverse Event|1|||
16988538|NCT00913458|38132320|FG000|Phase 3|Lost to Follow-up|0|||
16988539|NCT00913458|38132321|FG001|Phase 3|Lost to Follow-up|0|||
17135321|NCT00042289|38276467|FG017|Overall Study|Site closed|0|||
17135322|NCT00042289|38276468|FG018|Overall Study|Site closed|0|||
16988540|NCT00913458|38132322|FG002|Phase 3|Lost to Follow-up|0|||
16988541|NCT00913458|38132323|FG003|Phase 3|Lost to Follow-up|0|||
16988542|NCT00913458|38132324|FG004|Phase 3|Lost to Follow-up|2|||
16988543|NCT00913458|38132325|FG005|Phase 3|Lost to Follow-up|0|||
16988544|NCT00913458|38132326|FG006|Phase 3|Lost to Follow-up|0|||
16988545|NCT00913458|38132320|FG000|Phase 3|Non-Responder|0|||
16988546|NCT00913458|38132321|FG001|Phase 3|Non-Responder|0|||
16988547|NCT00913458|38132322|FG002|Phase 3|Non-Responder|0|||
16988548|NCT00913458|38132323|FG003|Phase 3|Non-Responder|0|||
16988549|NCT00913458|38132324|FG004|Phase 3|Non-Responder|0|||
16988550|NCT00913458|38132325|FG005|Phase 3|Non-Responder|1|||
17135323|NCT00042289|38276469|FG019|Overall Study|Site closed|0|||
16988551|NCT00913458|38132326|FG006|Phase 3|Non-Responder|3|||
16988552|NCT00913458|38132320|FG000|Phase 3|Withdrawal by Subject|0|||
16988553|NCT00913458|38132321|FG001|Phase 3|Withdrawal by Subject|0|||
16988554|NCT00913458|38132322|FG002|Phase 3|Withdrawal by Subject|0|||
16988555|NCT00913458|38132323|FG003|Phase 3|Withdrawal by Subject|0|||
16988556|NCT00913458|38132324|FG004|Phase 3|Withdrawal by Subject|1|||
16988557|NCT00913458|38132325|FG005|Phase 3|Withdrawal by Subject|2|||
16988558|NCT00913458|38132326|FG006|Phase 3|Withdrawal by Subject|0|||
16988559|NCT00913458|38132320|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
16988560|NCT00913458|38132321|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
17135324|NCT00042289|38276470|FG020|Overall Study|Site closed|0|||
17135325|NCT00042289|38276471|FG021|Overall Study|Site closed|0|||
17135326|NCT00042289|38276472|FG022|Overall Study|Site closed|0|||
17135327|NCT00042289|38276473|FG023|Overall Study|Site closed|0|||
17135328|NCT00042289|38276474|FG024|Overall Study|Site closed|0|||
17135329|NCT00042289|38276475|FG025|Overall Study|Site closed|0|||
17135330|NCT00042289|38276476|FG026|Overall Study|Site closed|0|||
16988561|NCT00913458|38132322|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
16988562|NCT00913458|38132323|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
16988563|NCT00913458|38132324|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
16988564|NCT00913458|38132325|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
16988565|NCT00913458|38132326|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
16988566|NCT00785707|38132343|FG000|Overall Study|Lost to Follow-up|7|||
16988567|NCT00913380|38132349|FG000|Clinical Outcomes|Lost to Follow-up|6|||
16988568|NCT00913380|38132350|FG001|Clinical Outcomes|Lost to Follow-up|6|||
16988569|NCT00785629|38132360|FG000|Overall Study|Adverse Event|2|||
16988570|NCT00785629|38132361|FG001|Overall Study|Adverse Event|1|||
16988571|NCT00785629|38132362|FG002|Overall Study|Adverse Event|1|||
16988572|NCT00785629|38132363|FG003|Overall Study|Adverse Event|5|||
16988573|NCT00785629|38132360|FG000|Overall Study|Protocol Violation|1|||
16988574|NCT00785629|38132361|FG001|Overall Study|Protocol Violation|2|||
16988575|NCT00785629|38132362|FG002|Overall Study|Protocol Violation|4|||
16988576|NCT00785629|38132363|FG003|Overall Study|Protocol Violation|5|||
16988577|NCT00785629|38132360|FG000|Overall Study|administrative decision|5|||
16988578|NCT00785629|38132361|FG001|Overall Study|administrative decision|1|||
16988579|NCT00785629|38132362|FG002|Overall Study|administrative decision|3|||
16988580|NCT00785629|38132363|FG003|Overall Study|administrative decision|4|||
16988581|NCT00785629|38132360|FG000|Overall Study|Withdrawal by Subject|0|||
16988582|NCT00785629|38132361|FG001|Overall Study|Withdrawal by Subject|1|||
16988583|NCT00785629|38132362|FG002|Overall Study|Withdrawal by Subject|2|||
16988584|NCT00785629|38132363|FG003|Overall Study|Withdrawal by Subject|2|||
16988585|NCT00916344|38132371|FG000|Overall Study|Death|2|||
16988586|NCT00916344|38132371|FG000|Overall Study|ICD upgrade|1|||
16988587|NCT00916344|38132371|FG000|Overall Study|Drop-out|5|||
16988588|NCT00913770|38132378|FG000|Overall Study|Unable to contact|24|||
16988589|NCT00913770|38132379|FG001|Overall Study|Unable to contact|19|||
16988590|NCT00913770|38132380|FG002|Overall Study|Unable to contact|13|||
16988591|NCT00913770|38132378|FG000|Overall Study|Refused|11|||
16988592|NCT00913770|38132379|FG001|Overall Study|Refused|10|||
16988593|NCT00913770|38132380|FG002|Overall Study|Refused|8|||
16988594|NCT00780559|38132390|FG000|Overall Study|Lost to Follow-up|2|||
16988595|NCT00780559|38132391|FG001|Overall Study|Lost to Follow-up|7|||
16988596|NCT00780559|38132390|FG000|Overall Study|Death|1|||
16988597|NCT00780559|38132391|FG001|Overall Study|Death|0|||
16988598|NCT00912912|38132399|FG000|Overall Study|Withdrawal by Subject|1|||
16988599|NCT00912912|38132399|FG000|Overall Study|Disease Progression|3|||
16988600|NCT00889005|38132405|FG000|Overall Study|Lost to Follow-up|4|||
16988601|NCT00889005|38132406|FG001|Overall Study|Lost to Follow-up|2|||
16988602|NCT00889005|38132405|FG000|Overall Study|Withdrawal by Subject|4|||
16988603|NCT00889005|38132406|FG001|Overall Study|Withdrawal by Subject|0|||
16988604|NCT00779857|38132412|FG000|Overall Study|Death|1|||
16988605|NCT00779857|38132412|FG000|Overall Study|Withdrawal by Subject|3|||
16988606|NCT00779857|38132412|FG000|Overall Study|Missed Visit|2|||
16988607|NCT00913692|38132416|FG000|Screening (4 Months)|Physician Decision|3|||
16988608|NCT00913692|38132416|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
16988609|NCT00913692|38132416|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
16988610|NCT00784927|38132423|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
16988611|NCT00784927|38132423|FG000|Overall Study|Protocol Violation|1|||
16988612|NCT00784927|38132423|FG000|Overall Study|Ineligible|1|||
16988613|NCT00779779|38132428|FG000|Overall Study|Adverse Event|1|||
16988614|NCT00779779|38132428|FG000|Overall Study|Protocol Violation|14|||
16988615|NCT00779779|38132428|FG000|Overall Study|Withdrawal by Subject|4|||
16988616|NCT00779779|38132428|FG000|Overall Study|Lost to Follow-up|5|||
16988617|NCT00845728|38132434|FG000|Overall Study|Abnormal laboratory value (s)|2|||
16988618|NCT00845728|38132435|FG001|Overall Study|Abnormal laboratory value (s)|2|||
16988619|NCT00845728|38132434|FG000|Overall Study|Patient's inability to use the device|4|||
17135331|NCT00042289|38276477|FG027|Overall Study|Site closed|0|||
17135332|NCT00042289|38276478|FG028|Overall Study|Site closed|0|||
17135333|NCT00042289|38276479|FG029|Overall Study|Site closed|0|||
16988620|NCT00845728|38132435|FG001|Overall Study|Patient's inability to use the device|6|||
16988621|NCT00845728|38132434|FG000|Overall Study|Abnormal test procedure result (s)|7|||
16988622|NCT00845728|38132435|FG001|Overall Study|Abnormal test procedure result (s)|2|||
16988623|NCT00845728|38132434|FG000|Overall Study|Lost to Follow-up|22|||
16988624|NCT00845728|38132435|FG001|Overall Study|Lost to Follow-up|13|||
16988625|NCT00845728|38132434|FG000|Overall Study|Death|24|||
16988626|NCT00845728|38132435|FG001|Overall Study|Death|26|||
16988627|NCT00845728|38132434|FG000|Overall Study|Administrative Problems|34|||
16988628|NCT00845728|38132435|FG001|Overall Study|Administrative Problems|26|||
16988629|NCT00845728|38132434|FG000|Overall Study|Protocol Violation|36|||
16988630|NCT00845728|38132435|FG001|Overall Study|Protocol Violation|24|||
16988631|NCT00845728|38132434|FG000|Overall Study|Lack of Efficacy|51|||
16988632|NCT00845728|38132435|FG001|Overall Study|Lack of Efficacy|39|||
16988633|NCT00845728|38132434|FG000|Overall Study|Adverse Event|101|||
16988634|NCT00845728|38132435|FG001|Overall Study|Adverse Event|96|||
16988635|NCT00845728|38132434|FG000|Overall Study|Withdrawal by Subject|105|||
16988636|NCT00845728|38132435|FG001|Overall Study|Withdrawal by Subject|108|||
16988637|NCT00779467|38132445|FG000|Overall Study|Lack of Efficacy|11|||
16988638|NCT00779467|38132446|FG001|Overall Study|Lack of Efficacy|2|||
16988639|NCT00779467|38132447|FG002|Overall Study|Lack of Efficacy|6|||
16988640|NCT00779467|38132448|FG003|Overall Study|Lack of Efficacy|11|||
16988641|NCT00779467|38132445|FG000|Overall Study|failed inclusion criteria|3|||
16988642|NCT00779467|38132446|FG001|Overall Study|failed inclusion criteria|3|||
16988643|NCT00779467|38132447|FG002|Overall Study|failed inclusion criteria|1|||
16988644|NCT00779467|38132448|FG003|Overall Study|failed inclusion criteria|2|||
16988645|NCT00779467|38132445|FG000|Overall Study|missing data|1|||
16988646|NCT00779467|38132446|FG001|Overall Study|missing data|0|||
16988647|NCT00779467|38132447|FG002|Overall Study|missing data|1|||
16988648|NCT00779467|38132448|FG003|Overall Study|missing data|4|||
16988649|NCT00779467|38132445|FG000|Overall Study|technical issue|0|||
16988650|NCT00779467|38132446|FG001|Overall Study|technical issue|0|||
16988651|NCT00779467|38132447|FG002|Overall Study|technical issue|2|||
16988652|NCT00779467|38132448|FG003|Overall Study|technical issue|1|||
16988653|NCT00779467|38132445|FG000|Overall Study|unavailable research staff|0|||
16988654|NCT00779467|38132446|FG001|Overall Study|unavailable research staff|0|||
16988655|NCT00779467|38132447|FG002|Overall Study|unavailable research staff|0|||
16988656|NCT00779467|38132448|FG003|Overall Study|unavailable research staff|1|||
16988657|NCT00778921|38132461|FG000|Overall Study|Adverse Event|9|||
16988658|NCT00778921|38132462|FG001|Overall Study|Adverse Event|10|||
16988659|NCT00778921|38132463|FG002|Overall Study|Adverse Event|14|||
16988660|NCT00778921|38132461|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
16988661|NCT00778921|38132462|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
16988662|NCT00778921|38132463|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
16988663|NCT00778921|38132461|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
17135334|NCT00042289|38276480|FG030|Overall Study|Site closed|0|||
17135335|NCT00042289|38276481|FG031|Overall Study|Site closed|3|||
17135336|NCT00042289|38276482|FG032|Overall Study|Site closed|0|||
17135337|NCT00042289|38276483|FG033|Overall Study|Site closed|0|||
17135338|NCT00042289|38276484|FG034|Overall Study|Site closed|0|||
17135339|NCT00042289|38276485|FG035|Overall Study|Site closed|0|||
17135340|NCT00042289|38276486|FG036|Overall Study|Site closed|1|||
16988664|NCT00778921|38132462|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
16988665|NCT00778921|38132463|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
16988666|NCT00778921|38132461|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
16988667|NCT00778921|38132462|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
16988668|NCT00778921|38132463|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
16988669|NCT00778921|38132461|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
16988670|NCT00778921|38132462|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
16988671|NCT00778921|38132463|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
16988672|NCT00778921|38132461|FG000|Overall Study|Patient withdrew request|3|||
16988673|NCT00778921|38132462|FG001|Overall Study|Patient withdrew request|1|||
16988674|NCT00778921|38132463|FG002|Overall Study|Patient withdrew request|6|||
16988675|NCT00778921|38132461|FG000|Overall Study|Lost to Follow-up|0|||
16988676|NCT00778921|38132462|FG001|Overall Study|Lost to Follow-up|2|||
16988677|NCT00778921|38132463|FG002|Overall Study|Lost to Follow-up|1|||
16988678|NCT00778921|38132461|FG000|Overall Study|Administrative Problems|1|||
16988679|NCT00778921|38132462|FG001|Overall Study|Administrative Problems|2|||
16988680|NCT00778921|38132463|FG002|Overall Study|Administrative Problems|0|||
16988681|NCT00778921|38132461|FG000|Overall Study|Protocol Violation|3|||
16988682|NCT00778921|38132462|FG001|Overall Study|Protocol Violation|0|||
16988683|NCT00778921|38132463|FG002|Overall Study|Protocol Violation|2|||
16988684|NCT00778921|38132461|FG000|Overall Study|Not treated|0|||
16988685|NCT00778921|38132462|FG001|Overall Study|Not treated|2|||
16988686|NCT00778921|38132463|FG002|Overall Study|Not treated|2|||
17135341|NCT00042289|38276487|FG037|Overall Study|Site closed|0|||
17135342|NCT00042289|38276488|FG038|Overall Study|Site closed|0|||
16988687|NCT00915876|38132473|FG000|Overall Study|Adverse Event|0|||
16988688|NCT00915876|38132474|FG001|Overall Study|Adverse Event|1|||
16988689|NCT00587431|38132482|FG000|Overall Study|Adverse Event|1|||
16988690|NCT00587431|38132483|FG001|Overall Study|Adverse Event|0|||
16988691|NCT00587431|38132482|FG000|Overall Study|Withdrawal by Subject|0|||
16988692|NCT00587431|38132483|FG001|Overall Study|Withdrawal by Subject|1|||
16988693|NCT00776659|38132492|FG000|Overall Study|Lost to Follow-up|15|||
16988694|NCT00776659|38132492|FG000|Overall Study|Withdrawal by Subject|10|||
16988695|NCT00776659|38132492|FG000|Overall Study|Study Terminated by Sponsor|1|||
16988696|NCT00825682|38132498|FG000|Overall Study|personal reasons/ inconvenience|13|||
16988697|NCT00825682|38132499|FG001|Overall Study|personal reasons/ inconvenience|5|||
16988698|NCT00833794|38132508|FG000|Open-label Phase|Adverse Event|225|||
16988699|NCT00833794|38132509|FG001|Open-label Phase|Adverse Event|0|||
16988700|NCT00833794|38132508|FG000|Open-label Phase|Lack of Efficacy|28|||
16988701|NCT00833794|38132509|FG001|Open-label Phase|Lack of Efficacy|0|||
16988702|NCT00833794|38132508|FG000|Open-label Phase|Withdrawal by Subject|48|||
16988703|NCT00833794|38132509|FG001|Open-label Phase|Withdrawal by Subject|0|||
16988704|NCT00833794|38132508|FG000|Open-label Phase|Physician Decision|20|||
16988705|NCT00833794|38132509|FG001|Open-label Phase|Physician Decision|0|||
16988706|NCT00833794|38132508|FG000|Open-label Phase|Administrative reason|1|||
16988707|NCT00833794|38132509|FG001|Open-label Phase|Administrative reason|0|||
16988708|NCT00833794|38132508|FG000|Open-label Phase|Protocol Violation|47|||
16988709|NCT00833794|38132509|FG001|Open-label Phase|Protocol Violation|0|||
16988710|NCT00833794|38132508|FG000|Open-label Phase|Did not complete wash-out period|12|||
16988711|NCT00833794|38132509|FG001|Open-label Phase|Did not complete wash-out period|0|||
16988712|NCT00833794|38132508|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
16988713|NCT00833794|38132509|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
16988714|NCT00833794|38132508|FG000|Double-blind Phase|Adverse Event|44|||
16988715|NCT00833794|38132509|FG001|Double-blind Phase|Adverse Event|11|||
16988716|NCT00833794|38132508|FG000|Double-blind Phase|Lack of Efficacy|34|||
16988717|NCT00833794|38132509|FG001|Double-blind Phase|Lack of Efficacy|22|||
16988718|NCT00833794|38132508|FG000|Double-blind Phase|Withdrawal by Subject|23|||
16988719|NCT00833794|38132509|FG001|Double-blind Phase|Withdrawal by Subject|6|||
16988720|NCT00833794|38132508|FG000|Double-blind Phase|Physician Decision|4|||
16988721|NCT00833794|38132509|FG001|Double-blind Phase|Physician Decision|7|||
16988722|NCT00833794|38132508|FG000|Double-blind Phase|Administrative reason|1|||
16988723|NCT00833794|38132509|FG001|Double-blind Phase|Administrative reason|3|||
16988724|NCT00912288|38132519|FG000|Overall Study|Death|0|||
16988725|NCT00912288|38132520|FG001|Overall Study|Death|1|||
16988726|NCT00912288|38132519|FG000|Overall Study|Adverse Event|1|||
16988727|NCT00912288|38132520|FG001|Overall Study|Adverse Event|1|||
16988728|NCT00912288|38132519|FG000|Overall Study|Lost to Follow-up|1|||
16988729|NCT00912288|38132520|FG001|Overall Study|Lost to Follow-up|0|||
16988730|NCT00912288|38132519|FG000|Overall Study|Protocol Violation|1|||
16988731|NCT00912288|38132520|FG001|Overall Study|Protocol Violation|0|||
16988732|NCT00912288|38132519|FG000|Overall Study|Withdrawal by Subject|3|||
16988733|NCT00912288|38132520|FG001|Overall Study|Withdrawal by Subject|3|||
16988734|NCT00912288|38132519|FG000|Overall Study|Study terminated by sponsor|34|||
16988735|NCT00912288|38132520|FG001|Overall Study|Study terminated by sponsor|35|||
16988736|NCT00912288|38132519|FG000|Overall Study|Other|1|||
16988737|NCT00912288|38132520|FG001|Overall Study|Other|0|||
16988738|NCT00778375|38132526|FG000|Overall Study|Ineligible|3|||
17135343|NCT00042289|38276489|FG039|Overall Study|Site closed|0|||
17135344|NCT00042289|38276490|FG040|Overall Study|Site closed|0|||
16988739|NCT00777829|38132532|FG000|Overall Study|Withdrawal by Subject|0|||
16988740|NCT00777829|38132533|FG001|Overall Study|Withdrawal by Subject|2|||
16988741|NCT00775021|38132541|FG000|First Intervention|Lost to Follow-up|1|||
16988742|NCT00775021|38132542|FG001|First Intervention|Lost to Follow-up|0|||
16988743|NCT00775021|38132541|FG000|Second Intervention|Adverse Event|0|||
16988744|NCT00775021|38132542|FG001|Second Intervention|Adverse Event|1|||
16988745|NCT00777205|38132550|FG000|Overall Study|Lost to Follow-up|25|||
16988746|NCT00777205|38132551|FG001|Overall Study|Lost to Follow-up|9|||
16988747|NCT00777205|38132550|FG000|Overall Study|Withdrawal by Subject|6|||
16988748|NCT00777205|38132551|FG001|Overall Study|Withdrawal by Subject|4|||
16988749|NCT00777205|38132550|FG000|Overall Study|Death|0|||
16988750|NCT00777205|38132551|FG001|Overall Study|Death|2|||
16988751|NCT00777205|38132550|FG000|Overall Study|Protocol Violation|0|||
16988752|NCT00777205|38132551|FG001|Overall Study|Protocol Violation|56|||
16988753|NCT00833638|38132562|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
16988754|NCT00833638|38132563|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
16988755|NCT00833638|38132564|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
16988756|NCT00833638|38132562|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
16988757|NCT00833638|38132563|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
16988758|NCT00833638|38132564|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
16988759|NCT00833638|38132562|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
16988760|NCT00833638|38132563|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
16988761|NCT00833638|38132564|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
16988762|NCT00833638|38132562|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
16988763|NCT00833638|38132563|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
16988764|NCT00833638|38132564|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
16988765|NCT00833638|38132562|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
16988766|NCT00833638|38132563|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
16988767|NCT00833638|38132564|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
16988768|NCT00833638|38132562|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
16988769|NCT00833638|38132563|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
16988770|NCT00833638|38132564|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
16988771|NCT00833638|38132562|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
17135345|NCT00042289|38276491|FG041|Overall Study|Site closed|0|||
17135346|NCT00042289|38276492|FG042|Overall Study|Site closed|1|||
17135347|NCT00042289|38276493|FG043|Overall Study|Site closed|0|||
17135348|NCT00042289|38276494|FG044|Overall Study|Site closed|0|||
16988772|NCT00833638|38132563|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
16988773|NCT00833638|38132564|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
16988774|NCT00833638|38132562|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
16988775|NCT00833638|38132563|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
16988776|NCT00833638|38132564|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
16988777|NCT00833638|38132562|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
16988778|NCT00833638|38132563|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
16988779|NCT00833638|38132564|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
16988780|NCT01041404|38132582|FG000|Overall Study|Adverse Event|45|||
16988781|NCT01041404|38132583|FG001|Overall Study|Adverse Event|35|||
16988782|NCT01041404|38132582|FG000|Overall Study|Lack of Efficacy|200|||
16988783|NCT01041404|38132583|FG001|Overall Study|Lack of Efficacy|210|||
16988784|NCT01041404|38132582|FG000|Overall Study|Violation of Selection Criteria|0|||
16988785|NCT01041404|38132583|FG001|Overall Study|Violation of Selection Criteria|1|||
16988786|NCT01041404|38132582|FG000|Overall Study|Protocol Violation|4|||
16988787|NCT01041404|38132583|FG001|Overall Study|Protocol Violation|0|||
16988788|NCT01041404|38132582|FG000|Overall Study|Withdrawal by Subject|29|||
16988789|NCT01041404|38132583|FG001|Overall Study|Withdrawal by Subject|23|||
16988790|NCT01041404|38132582|FG000|Overall Study|Failure to Return|1|||
16988791|NCT01041404|38132583|FG001|Overall Study|Failure to Return|2|||
16988792|NCT01041404|38132582|FG000|Overall Study|Other|11|||
16988793|NCT01041404|38132583|FG001|Overall Study|Other|23|||
16988794|NCT00777049|38132594|FG000|Overall Study|Withdrawal by Subject|1|||
16988795|NCT00777049|38132595|FG001|Overall Study|Withdrawal by Subject|0|||
16988796|NCT00777049|38132594|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
16988797|NCT00777049|38132595|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
16988798|NCT00774787|38132601|FG000|Overall Study|Lost to Follow-up|1|||
16988799|NCT00888927|38132609|FG000|Overall Study|Adverse Event|0|||
16988800|NCT00888927|38132610|FG001|Overall Study|Adverse Event|0|||
16988801|NCT00888927|38132611|FG002|Overall Study|Adverse Event|0|||
16988802|NCT00888927|38132612|FG003|Overall Study|Adverse Event|1|||
16988803|NCT00888927|38132609|FG000|Overall Study|Withdrawal of consent|0|||
16988804|NCT00888927|38132610|FG001|Overall Study|Withdrawal of consent|0|||
16988805|NCT00888927|38132611|FG002|Overall Study|Withdrawal of consent|0|||
16988806|NCT00888927|38132612|FG003|Overall Study|Withdrawal of consent|1|||
16988807|NCT01040780|38132624|FG000|Overall Study|Protocol Violation|1|||
16988808|NCT01040780|38132625|FG001|Overall Study|Protocol Violation|3|||
16988809|NCT00888849|38132636|FG000|Overall Study|Death|4|||
16988810|NCT00888849|38132637|FG001|Overall Study|Death|7|||
16988811|NCT00888849|38132636|FG000|Overall Study|Lost to Follow-up|1|||
16988812|NCT00888849|38132637|FG001|Overall Study|Lost to Follow-up|2|||
16988813|NCT01059812|38132645|FG000|Overall Study|Adverse Event|9|||
16988814|NCT01059812|38132646|FG001|Overall Study|Adverse Event|5|||
16988815|NCT01059812|38132645|FG000|Overall Study|Lack of Efficacy|2|||
16988816|NCT01059812|38132646|FG001|Overall Study|Lack of Efficacy|2|||
16988817|NCT01059812|38132645|FG000|Overall Study|Protocol Violation|3|||
17135349|NCT00042289|38276495|FG045|Overall Study|Site closed|0|||
16988818|NCT01059812|38132646|FG001|Overall Study|Protocol Violation|1|||
16988819|NCT01059812|38132645|FG000|Overall Study|Withdrawal Criteria|9|||
16988820|NCT01059812|38132646|FG001|Overall Study|Withdrawal Criteria|4|||
16988821|NCT01059812|38132645|FG000|Overall Study|Unclassified|14|||
17135350|NCT00042289|38276496|FG046|Overall Study|Site closed|0|||
16988822|NCT01059812|38132646|FG001|Overall Study|Unclassified|4|||
16988823|NCT00888615|38132652|FG000|Overall Study|No treatment|2|||
16988824|NCT00845650|38132662|FG000|Overall Study|Withdrawal by Subject|0|||
16988825|NCT00845650|38132663|FG001|Overall Study|Withdrawal by Subject|0|||
16988826|NCT00845650|38132664|FG002|Overall Study|Withdrawal by Subject|0|||
16988827|NCT00845650|38132665|FG003|Overall Study|Withdrawal by Subject|0|||
16988828|NCT00845650|38132666|FG004|Overall Study|Withdrawal by Subject|2|||
16988829|NCT00845650|38132667|FG005|Overall Study|Withdrawal by Subject|0|||
16988830|NCT00845650|38132662|FG000|Overall Study|Lost to Follow-up|0|||
16988831|NCT00845650|38132663|FG001|Overall Study|Lost to Follow-up|0|||
16988832|NCT00845650|38132664|FG002|Overall Study|Lost to Follow-up|3|||
16988833|NCT00845650|38132665|FG003|Overall Study|Lost to Follow-up|1|||
16988834|NCT00845650|38132666|FG004|Overall Study|Lost to Follow-up|0|||
16988835|NCT00845650|38132667|FG005|Overall Study|Lost to Follow-up|1|||
16988836|NCT00845650|38132662|FG000|Overall Study|Sponsor hold on dosing|0|||
16988837|NCT00845650|38132663|FG001|Overall Study|Sponsor hold on dosing|0|||
16988838|NCT00845650|38132664|FG002|Overall Study|Sponsor hold on dosing|0|||
16988839|NCT00845650|38132665|FG003|Overall Study|Sponsor hold on dosing|0|||
16988840|NCT00845650|38132666|FG004|Overall Study|Sponsor hold on dosing|1|||
16988841|NCT00845650|38132667|FG005|Overall Study|Sponsor hold on dosing|1|||
16988842|NCT00845650|38132662|FG000|Overall Study|Unable to access IV line|1|||
16988843|NCT00845650|38132663|FG001|Overall Study|Unable to access IV line|0|||
16988844|NCT00845650|38132664|FG002|Overall Study|Unable to access IV line|0|||
16988845|NCT00845650|38132665|FG003|Overall Study|Unable to access IV line|0|||
16988846|NCT00845650|38132666|FG004|Overall Study|Unable to access IV line|0|||
16988847|NCT00845650|38132667|FG005|Overall Study|Unable to access IV line|0|||
16988848|NCT00888381|38132685|FG000|Overall Study|Lost to Follow-up|0|||
16988849|NCT00888381|38132686|FG001|Overall Study|Lost to Follow-up|1|||
16988850|NCT00887913|38132692|FG000|Overall Study|Withdrawal by Subject|6|||
16988851|NCT00833560|38132696|FG000|Overall Study|Toxicity|13|||
16988852|NCT00833560|38132696|FG000|Overall Study|Adverse Event|11|||
16988853|NCT00833560|38132696|FG000|Overall Study|Protocol Violation|6|||
16988854|NCT00833560|38132696|FG000|Overall Study|Lack of Efficacy|4|||
16988855|NCT00833560|38132696|FG000|Overall Study|Death|2|||
16988856|NCT00833560|38132696|FG000|Overall Study|Pregression of other disease|1|||
16988857|NCT00833560|38132696|FG000|Overall Study|Other|5|||
16988858|NCT00887679|38132700|FG000|Overall Study|Withdrawal by Subject|1|||
16988859|NCT00887679|38132700|FG000|Overall Study|Lost to Follow-up|4|||
16988860|NCT00887679|38132700|FG000|Overall Study|Physician Decision|5|||
16988861|NCT00833482|38132707|FG000|Days 11-20|Adverse Event|0|||
16988862|NCT00833482|38132708|FG001|Days 11-20|Adverse Event|2|||
16988863|NCT00833482|38132709|FG002|Days 11-20|Adverse Event|0|||
16988864|NCT00833482|38132710|FG003|Days 11-20|Adverse Event|0|||
16988865|NCT00833482|38132711|FG004|Days 11-20|Adverse Event|0|||
16988866|NCT00833482|38132712|FG005|Days 11-20|Adverse Event|0|||
16988867|NCT00833482|38132707|FG000|Days 11-20|Withdrawal by Subject|0|||
16988868|NCT00833482|38132708|FG001|Days 11-20|Withdrawal by Subject|1|||
16988869|NCT00833482|38132709|FG002|Days 11-20|Withdrawal by Subject|0|||
16988870|NCT00833482|38132710|FG003|Days 11-20|Withdrawal by Subject|0|||
16988871|NCT00833482|38132711|FG004|Days 11-20|Withdrawal by Subject|0|||
16988872|NCT00833482|38132712|FG005|Days 11-20|Withdrawal by Subject|0|||
16988873|NCT00833482|38132707|FG000|Days 21-30|Adverse Event|0|||
16988874|NCT00833482|38132708|FG001|Days 21-30|Adverse Event|0|||
16988875|NCT00833482|38132709|FG002|Days 21-30|Adverse Event|1|||
16988876|NCT00833482|38132710|FG003|Days 21-30|Adverse Event|0|||
16988877|NCT00833482|38132711|FG004|Days 21-30|Adverse Event|0|||
16988878|NCT00833482|38132712|FG005|Days 21-30|Adverse Event|0|||
16988879|NCT00833482|38132707|FG000|Days 21-30|Withdrawal by Subject|0|||
16988880|NCT00833482|38132708|FG001|Days 21-30|Withdrawal by Subject|0|||
16988881|NCT00833482|38132709|FG002|Days 21-30|Withdrawal by Subject|0|||
16988882|NCT00833482|38132710|FG003|Days 21-30|Withdrawal by Subject|0|||
16988883|NCT00833482|38132711|FG004|Days 21-30|Withdrawal by Subject|1|||
16988884|NCT00833482|38132712|FG005|Days 21-30|Withdrawal by Subject|0|||
16988885|NCT00845182|38132737|FG000|Overall Study|Lost to Follow-up|3|||
16988886|NCT00845182|38132738|FG001|Overall Study|Lost to Follow-up|3|||
16988887|NCT00845182|38132739|FG002|Overall Study|Lost to Follow-up|4|||
16988888|NCT00845182|38132737|FG000|Overall Study|Adverse Event|0|||
16988889|NCT00845182|38132738|FG001|Overall Study|Adverse Event|1|||
16988890|NCT00845182|38132739|FG002|Overall Study|Adverse Event|1|||
16988891|NCT00845182|38132737|FG000|Overall Study|Physician Decision|0|||
16988892|NCT00845182|38132738|FG001|Overall Study|Physician Decision|0|||
16988893|NCT00845182|38132739|FG002|Overall Study|Physician Decision|1|||
16988894|NCT00833248|38132753|FG000|Overall Study|Adverse Event|3|||
16988895|NCT00833248|38132754|FG001|Overall Study|Adverse Event|0|||
16988896|NCT00833248|38132753|FG000|Overall Study|Protocol Violation|1|||
16988897|NCT00833248|38132754|FG001|Overall Study|Protocol Violation|2|||
16988898|NCT00833248|38132753|FG000|Overall Study|Withdrawal by Subject|0|||
16988899|NCT00833248|38132754|FG001|Overall Study|Withdrawal by Subject|1|||
16988900|NCT00887289|38132760|FG000|Overall Study|Lack of Efficacy|14|||
16988901|NCT00887289|38132760|FG000|Overall Study|Adverse Event|27|||
16988902|NCT00887289|38132760|FG000|Overall Study|Withdrawal by Subject|26|||
16988903|NCT00887289|38132760|FG000|Overall Study|Lost to Follow-up|8|||
16988904|NCT00887289|38132760|FG000|Overall Study|Other|20|||
16988905|NCT00833092|38132766|FG000|Overall Study|Withdrawal by Subject|2|||
16988906|NCT00833092|38132767|FG001|Overall Study|Withdrawal by Subject|3|||
16988907|NCT00833092|38132766|FG000|Overall Study|Protocol Violation|2|||
16988908|NCT00833092|38132767|FG001|Overall Study|Protocol Violation|1|||
16988909|NCT00833092|38132766|FG000|Overall Study|Diarrhea|0|||
16988910|NCT00833092|38132767|FG001|Overall Study|Diarrhea|2|||
16988911|NCT00833092|38132766|FG000|Overall Study|constipation|0|||
16988912|NCT00833092|38132767|FG001|Overall Study|constipation|1|||
16988913|NCT00823264|38132775|FG000|Overall Study|Protocol Violation|2|||
16988914|NCT00823264|38132776|FG001|Overall Study|Protocol Violation|0|||
16988915|NCT00832780|38132782|FG000|Overall Study|Death|16|||
16988916|NCT00832780|38132782|FG000|Overall Study|Lost to Follow-up|4|||
16988917|NCT00832780|38132782|FG000|Overall Study|no reason given|2|||
16988918|NCT00832780|38132782|FG000|Overall Study|other complicating condition|2|||
16988919|NCT00832780|38132782|FG000|Overall Study|Physician Decision|1|||
16988920|NCT00591838|38132791|FG000|Overall Study|Withdrawal by Subject|0|||
16988921|NCT00591838|38132792|FG001|Overall Study|Withdrawal by Subject|0|||
16988922|NCT00591838|38132793|FG002|Overall Study|Withdrawal by Subject|0|||
16988923|NCT00591838|38132794|FG003|Overall Study|Withdrawal by Subject|1|||
16988924|NCT00591838|38132795|FG004|Overall Study|Withdrawal by Subject|0|||
16988925|NCT00832624|38132808|FG000|Overall Study|Study Terminated|10|||
16988926|NCT00832078|38132812|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
17135351|NCT00042289|38276450|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
17135352|NCT00042289|38276451|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
17135353|NCT00042289|38276452|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
16988927|NCT00832078|38132813|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
16988928|NCT00832078|38132812|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
16988929|NCT00832078|38132813|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
16988930|NCT00822172|38132821|FG000|Overall Study|Adverse Event|10|||
16988931|NCT00822172|38132822|FG001|Overall Study|Adverse Event|12|||
16988932|NCT00822172|38132821|FG000|Overall Study|Death|1|||
16988933|NCT00822172|38132822|FG001|Overall Study|Death|0|||
16988934|NCT00822172|38132821|FG000|Overall Study|Lost to Follow-up|3|||
16988935|NCT00822172|38132822|FG001|Overall Study|Lost to Follow-up|1|||
16988936|NCT00822172|38132821|FG000|Overall Study|Withdrawal by Subject|1|||
16988937|NCT00822172|38132822|FG001|Overall Study|Withdrawal by Subject|4|||
16988938|NCT00822172|38132821|FG000|Overall Study|site closed|0|||
16988939|NCT00822172|38132822|FG001|Overall Study|site closed|1|||
16988940|NCT00822172|38132821|FG000|Overall Study|Other|0|||
16988941|NCT00822172|38132822|FG001|Overall Study|Other|1|||
16988942|NCT00832000|38132828|FG000|Overall Study|Adverse Event|2|||
16988943|NCT00832000|38132829|FG001|Overall Study|Adverse Event|0|||
16988944|NCT00832000|38132828|FG000|Overall Study|Withdrawal by Subject|1|||
16988945|NCT00832000|38132829|FG001|Overall Study|Withdrawal by Subject|0|||
16988946|NCT00832000|38132828|FG000|Overall Study|No calls to IVR in either period|1|||
16988947|NCT00832000|38132829|FG001|Overall Study|No calls to IVR in either period|1|||
16988948|NCT00832000|38132828|FG000|Overall Study|No calls to IVR in period 2|2|||
16988949|NCT00832000|38132829|FG001|Overall Study|No calls to IVR in period 2|0|||
16988950|NCT00911508|38132866|FG000|Overall Study|Lost to Follow-up|27|||
16988951|NCT00911508|38132867|FG001|Overall Study|Lost to Follow-up|18|||
16988952|NCT00911508|38132866|FG000|Overall Study|Withdrawal by Subject|79|||
16988953|NCT00911508|38132867|FG001|Overall Study|Withdrawal by Subject|112|||
16988954|NCT00774397|38132893|FG000|Overall Study|Adverse Event|1|||
16988955|NCT00774397|38132894|FG001|Overall Study|Adverse Event|3|||
16988956|NCT00774397|38132895|FG002|Overall Study|Adverse Event|16|||
17135354|NCT00042289|38276453|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
17135355|NCT00042289|38276454|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
17135356|NCT00042289|38276455|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
17135357|NCT00042289|38276456|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
17135358|NCT00042289|38276457|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
17135359|NCT00042289|38276458|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
17135360|NCT00042289|38276459|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
17135361|NCT00042289|38276460|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
17135362|NCT00042289|38276461|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
16988957|NCT00774397|38132896|FG003|Overall Study|Adverse Event|8|||
16988958|NCT00774397|38132897|FG004|Overall Study|Adverse Event|8|||
16988959|NCT00774397|38132898|FG005|Overall Study|Adverse Event|3|||
16988960|NCT00774397|38132899|FG006|Overall Study|Adverse Event|16|||
16988961|NCT00774397|38132893|FG000|Overall Study|Lack of Efficacy|11|||
17135363|NCT00042289|38276462|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
16988962|NCT00774397|38132894|FG001|Overall Study|Lack of Efficacy|4|||
16988963|NCT00774397|38132895|FG002|Overall Study|Lack of Efficacy|5|||
16988964|NCT00774397|38132896|FG003|Overall Study|Lack of Efficacy|3|||
16988965|NCT00774397|38132897|FG004|Overall Study|Lack of Efficacy|27|||
16988966|NCT00774397|38132898|FG005|Overall Study|Lack of Efficacy|15|||
16988967|NCT00774397|38132899|FG006|Overall Study|Lack of Efficacy|9|||
16988968|NCT00774397|38132893|FG000|Overall Study|Protocol Violation|0|||
16988969|NCT00774397|38132894|FG001|Overall Study|Protocol Violation|1|||
16988970|NCT00774397|38132895|FG002|Overall Study|Protocol Violation|3|||
16988971|NCT00774397|38132896|FG003|Overall Study|Protocol Violation|1|||
16988972|NCT00774397|38132897|FG004|Overall Study|Protocol Violation|2|||
16988973|NCT00774397|38132898|FG005|Overall Study|Protocol Violation|1|||
16988974|NCT00774397|38132899|FG006|Overall Study|Protocol Violation|0|||
16988975|NCT00774397|38132893|FG000|Overall Study|Lost to Follow-up|0|||
16988976|NCT00774397|38132894|FG001|Overall Study|Lost to Follow-up|1|||
16988977|NCT00774397|38132895|FG002|Overall Study|Lost to Follow-up|1|||
16988978|NCT00774397|38132896|FG003|Overall Study|Lost to Follow-up|1|||
16988979|NCT00774397|38132897|FG004|Overall Study|Lost to Follow-up|0|||
16988980|NCT00774397|38132898|FG005|Overall Study|Lost to Follow-up|1|||
16988981|NCT00774397|38132899|FG006|Overall Study|Lost to Follow-up|0|||
16988982|NCT00774397|38132893|FG000|Overall Study|Refused to continue trial medication|1|||
16988983|NCT00774397|38132894|FG001|Overall Study|Refused to continue trial medication|3|||
16988984|NCT00774397|38132895|FG002|Overall Study|Refused to continue trial medication|2|||
16988985|NCT00774397|38132896|FG003|Overall Study|Refused to continue trial medication|2|||
16988986|NCT00774397|38132897|FG004|Overall Study|Refused to continue trial medication|6|||
16988987|NCT00774397|38132898|FG005|Overall Study|Refused to continue trial medication|2|||
16988988|NCT00774397|38132899|FG006|Overall Study|Refused to continue trial medication|3|||
16988989|NCT00774397|38132893|FG000|Overall Study|Not treated|0|||
16988990|NCT00774397|38132894|FG001|Overall Study|Not treated|0|||
16988991|NCT00774397|38132895|FG002|Overall Study|Not treated|0|||
16988992|NCT00774397|38132896|FG003|Overall Study|Not treated|0|||
16988993|NCT00774397|38132897|FG004|Overall Study|Not treated|1|||
16988994|NCT00774397|38132898|FG005|Overall Study|Not treated|0|||
16988995|NCT00774397|38132899|FG006|Overall Study|Not treated|1|||
16988996|NCT00774397|38132893|FG000|Overall Study|Other than those stated above|1|||
16988997|NCT00774397|38132894|FG001|Overall Study|Other than those stated above|1|||
16988998|NCT00774397|38132895|FG002|Overall Study|Other than those stated above|3|||
16988999|NCT00774397|38132896|FG003|Overall Study|Other than those stated above|2|||
16989000|NCT00774397|38132897|FG004|Overall Study|Other than those stated above|2|||
16989001|NCT00774397|38132898|FG005|Overall Study|Other than those stated above|0|||
16989002|NCT00774397|38132899|FG006|Overall Study|Other than those stated above|1|||
16989003|NCT00909870|38132954|FG000|Overall Study|Adverse Event|13|||
16989004|NCT00909870|38132955|FG001|Overall Study|Adverse Event|7|||
16989005|NCT00909870|38132954|FG000|Overall Study|Protocol Violation|1|||
16989006|NCT00909870|38132955|FG001|Overall Study|Protocol Violation|2|||
16989007|NCT00909870|38132954|FG000|Overall Study|Withdrawal by Subject|5|||
16989008|NCT00909870|38132955|FG001|Overall Study|Withdrawal by Subject|8|||
16989009|NCT00909870|38132954|FG000|Overall Study|Lost to Follow-up|3|||
16989010|NCT00909870|38132955|FG001|Overall Study|Lost to Follow-up|3|||
16989011|NCT00909870|38132954|FG000|Overall Study|Physician Decision|0|||
16989012|NCT00909870|38132955|FG001|Overall Study|Physician Decision|2|||
16989013|NCT00909870|38132954|FG000|Overall Study|Other|1|||
16989014|NCT00909870|38132955|FG001|Overall Study|Other|5|||
16989015|NCT00768469|38132964|FG000|Overall Study|Adverse Event|0|||
16989016|NCT00768469|38132965|FG001|Overall Study|Adverse Event|2|||
16989017|NCT00768469|38132964|FG000|Overall Study|Disease Progression|3|||
16989018|NCT00768469|38132965|FG001|Overall Study|Disease Progression|4|||
16989019|NCT00768469|38132964|FG000|Overall Study|Withdrawal by Subject|0|||
16989020|NCT00768469|38132965|FG001|Overall Study|Withdrawal by Subject|1|||
16989021|NCT00886821|38132986|FG000|Stage 2|Adverse Event|0|||
16989022|NCT00886821|38132987|FG001|Stage 2|Adverse Event|0|||
16989023|NCT00886821|38132988|FG002|Stage 2|Adverse Event|0|||
16989024|NCT00886821|38132989|FG003|Stage 2|Adverse Event|0|||
16989025|NCT00886821|38132990|FG004|Stage 2|Adverse Event|0|||
16989026|NCT00886821|38132991|FG005|Stage 2|Adverse Event|0|||
16989027|NCT00886821|38132992|FG006|Stage 2|Adverse Event|0|||
16989028|NCT00886821|38132993|FG007|Stage 2|Adverse Event|0|||
16989029|NCT00886821|38132994|FG008|Stage 2|Adverse Event|0|||
16989030|NCT00886821|38132995|FG009|Stage 2|Adverse Event|0|||
16989031|NCT00886821|38132996|FG010|Stage 2|Adverse Event|0|||
16989032|NCT00886821|38132997|FG011|Stage 2|Adverse Event|1|||
16989033|NCT00886821|38132998|FG012|Stage 2|Adverse Event|3|||
16989034|NCT00886821|38132999|FG013|Stage 2|Adverse Event|0|||
16989035|NCT00886821|38132986|FG000|Stage 2|Lost to Follow-up|0|||
16989036|NCT00886821|38132987|FG001|Stage 2|Lost to Follow-up|0|||
16989037|NCT00886821|38132988|FG002|Stage 2|Lost to Follow-up|0|||
16989038|NCT00886821|38132989|FG003|Stage 2|Lost to Follow-up|0|||
16989039|NCT00886821|38132990|FG004|Stage 2|Lost to Follow-up|0|||
16989040|NCT00886821|38132991|FG005|Stage 2|Lost to Follow-up|0|||
16989041|NCT00886821|38132992|FG006|Stage 2|Lost to Follow-up|0|||
16989042|NCT00886821|38132993|FG007|Stage 2|Lost to Follow-up|0|||
16989043|NCT00886821|38132994|FG008|Stage 2|Lost to Follow-up|0|||
16989044|NCT00886821|38132995|FG009|Stage 2|Lost to Follow-up|0|||
16989045|NCT00886821|38132996|FG010|Stage 2|Lost to Follow-up|0|||
16989046|NCT00886821|38132997|FG011|Stage 2|Lost to Follow-up|0|||
16989047|NCT00886821|38132998|FG012|Stage 2|Lost to Follow-up|2|||
17135364|NCT00042289|38276463|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
16989048|NCT00886821|38132999|FG013|Stage 2|Lost to Follow-up|1|||
16989049|NCT00886743|38133043|FG000|Overall Study|Adverse Event|3|||
16989050|NCT00886743|38133043|FG000|Overall Study|Other|1|||
17135365|NCT00042289|38276464|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
17135366|NCT00042289|38276465|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
17135367|NCT00042289|38276466|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
17135368|NCT00042289|38276467|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
17135369|NCT00042289|38276468|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
17135370|NCT00042289|38276469|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
17135371|NCT00042289|38276470|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
17135372|NCT00042289|38276471|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
17135373|NCT00042289|38276472|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
17135374|NCT00042289|38276473|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
17135375|NCT00042289|38276474|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
17135376|NCT00042289|38276475|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
17135377|NCT00042289|38276476|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
17135378|NCT00042289|38276477|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
17135379|NCT00042289|38276478|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
17135380|NCT00042289|38276479|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
17135381|NCT00042289|38276480|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
17135382|NCT00042289|38276481|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
17135383|NCT00042289|38276482|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
17135384|NCT00042289|38276483|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
17135385|NCT00042289|38276484|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
17135386|NCT00042289|38276485|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
17135387|NCT00042289|38276486|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
17135388|NCT00042289|38276487|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
17135389|NCT00042289|38276488|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
17135390|NCT00042289|38276489|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
17135391|NCT00042289|38276490|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
17135392|NCT00042289|38276491|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
17135393|NCT00042289|38276492|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
17135394|NCT00042289|38276493|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
17135395|NCT00042289|38276494|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
17135396|NCT00042289|38276495|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
16989051|NCT00886587|38133049|FG000|Overall Study|Adverse Event|2|||
16989052|NCT00886587|38133050|FG001|Overall Study|Adverse Event|1|||
16989053|NCT00886587|38133049|FG000|Overall Study|Protocol Violation|2|||
16989054|NCT00886587|38133050|FG001|Overall Study|Protocol Violation|0|||
16989055|NCT00886587|38133049|FG000|Overall Study|Withdrawal by Subject|0|||
17135397|NCT00042289|38276496|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
16989056|NCT00886587|38133050|FG001|Overall Study|Withdrawal by Subject|1|||
16989057|NCT00886119|38133056|FG000|Period 1|Did not meet inclusion criteria|1|||
16989058|NCT00886119|38133057|FG001|Period 1|Did not meet inclusion criteria|0|||
16989059|NCT00768079|38133066|FG000|Overall Study|Lost to Follow-up|2|||
16989060|NCT00768079|38133067|FG001|Overall Study|Lost to Follow-up|0|||
17135398|NCT00042289|38276450|FG000|Overall Study|Protocol Violation|0|||
16989061|NCT00768079|38133068|FG002|Overall Study|Lost to Follow-up|4|||
16989062|NCT00768079|38133066|FG000|Overall Study|Participant incarcerated|0|||
16989063|NCT00768079|38133067|FG001|Overall Study|Participant incarcerated|1|||
16989064|NCT00768079|38133068|FG002|Overall Study|Participant incarcerated|0|||
16989065|NCT00767455|38133078|FG000|Overall Study|Investigator error|19|||
16989066|NCT00766831|38133084|FG000|Overall Study|Withdrawal by Subject|4|||
16989067|NCT00766831|38133084|FG000|Overall Study|Lost to Follow-up|3|||
16989068|NCT00766831|38133084|FG000|Overall Study|Adverse Event|20|||
16989069|NCT00766831|38133084|FG000|Overall Study|Protocol Violation|15|||
16989070|NCT00766831|38133084|FG000|Overall Study|Physician Decision|5|||
16989071|NCT00766831|38133084|FG000|Overall Study|Withdrawal of consent|26|||
16989072|NCT00766831|38133084|FG000|Overall Study|Non cooperation by participants|14|||
16989073|NCT00766831|38133084|FG000|Overall Study|Other|28|||
16989074|NCT00766675|38133088|FG000|Overall Study|Adverse Event|16|||
16989075|NCT00766675|38133088|FG000|Overall Study|Lost to Follow-up|2|||
16989076|NCT00766675|38133088|FG000|Overall Study|Withdrawal by Subject|11|||
16989077|NCT00766675|38133088|FG000|Overall Study|Protocol Violation|8|||
16989078|NCT00766675|38133088|FG000|Overall Study|Participant took prohibited medication|1|||
16989079|NCT00766675|38133088|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
16989080|NCT00766675|38133088|FG000|Overall Study|Insufficient therapy|1|||
16989081|NCT00766597|38133092|FG000|Overall Study|Unexpected closure of study|4|||
16989082|NCT00766597|38133092|FG000|Overall Study|Without CCR5-tropic virus|5|||
16989083|NCT00910962|38133101|FG000|Overall Study|Adverse Event|5|||
16989084|NCT00910962|38133102|FG001|Overall Study|Adverse Event|20|||
16989085|NCT00910962|38133103|FG002|Overall Study|Adverse Event|17|||
16989086|NCT00910962|38133101|FG000|Overall Study|Protocol Violation|1|||
16989087|NCT00910962|38133102|FG001|Overall Study|Protocol Violation|3|||
16989088|NCT00910962|38133103|FG002|Overall Study|Protocol Violation|3|||
17135399|NCT00042289|38276451|FG001|Overall Study|Protocol Violation|0|||
17135400|NCT00042289|38276452|FG002|Overall Study|Protocol Violation|0|||
16989089|NCT00910962|38133101|FG000|Overall Study|Lost to Follow-up|0|||
16989090|NCT00910962|38133102|FG001|Overall Study|Lost to Follow-up|3|||
16989091|NCT00910962|38133103|FG002|Overall Study|Lost to Follow-up|1|||
16989092|NCT00910962|38133101|FG000|Overall Study|Physician Decision|0|||
16989093|NCT00910962|38133102|FG001|Overall Study|Physician Decision|6|||
16989094|NCT00910962|38133103|FG002|Overall Study|Physician Decision|6|||
16989095|NCT00910962|38133101|FG000|Overall Study|Withdrawal by Subject|25|||
16989096|NCT00910962|38133102|FG001|Overall Study|Withdrawal by Subject|32|||
16989097|NCT00910962|38133103|FG002|Overall Study|Withdrawal by Subject|32|||
16989098|NCT00910962|38133101|FG000|Overall Study|Reached defined stopping criteria|12|||
16989099|NCT00910962|38133102|FG001|Overall Study|Reached defined stopping criteria|14|||
16989100|NCT00910962|38133103|FG002|Overall Study|Reached defined stopping criteria|17|||
16989101|NCT00773461|38133115|FG000|Overall Study|Adverse Event|1|||
16989102|NCT00773461|38133116|FG001|Overall Study|Adverse Event|3|||
16989103|NCT00773461|38133115|FG000|Overall Study|Withdrawal by Subject|4|||
16989104|NCT00773461|38133116|FG001|Overall Study|Withdrawal by Subject|1|||
16989105|NCT00773383|38133123|FG000|Overall Study|Adverse Event|4|||
16989106|NCT00773383|38133123|FG000|Overall Study|Death|1|||
16989107|NCT00773383|38133123|FG000|Overall Study|Progression of Disease|23|||
16989108|NCT00773383|38133123|FG000|Overall Study|Other|2|||
16989109|NCT00773383|38133123|FG000|Overall Study|No study dose received|1|||
16989110|NCT00757003|38133131|FG000|Overall Study|Death|33|||
16989111|NCT00757003|38133131|FG000|Overall Study|Lost to Follow-up|9|||
16989112|NCT00757003|38133131|FG000|Overall Study|Withdrawal by Subject|4|||
16989113|NCT00757003|38133131|FG000|Overall Study|Surgically explanted|2|||
16989114|NCT00757003|38133131|FG000|Overall Study|Not implanted|1|||
16989115|NCT00766363|38133140|FG000|Overall Study|Withdrawal by Subject|1|||
16989116|NCT00766363|38133141|FG001|Overall Study|Withdrawal by Subject|0|||
16989117|NCT00766363|38133142|FG002|Overall Study|Withdrawal by Subject|0|||
16989118|NCT00766363|38133143|FG003|Overall Study|Withdrawal by Subject|0|||
16989119|NCT00766363|38133140|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
16989120|NCT00766363|38133141|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
16989121|NCT00766363|38133142|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
16989122|NCT00766363|38133143|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
16989123|NCT02636946|38133156|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
16989124|NCT02636946|38133157|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
16989125|NCT02636946|38133156|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
16989126|NCT02636946|38133157|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
16989127|NCT02636946|38133156|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
16989128|NCT02636946|38133157|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
16989129|NCT02636946|38133156|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
16989130|NCT02636946|38133157|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
16989131|NCT02636946|38133156|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
16989132|NCT02636946|38133157|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
16989133|NCT02636946|38133156|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
16989134|NCT02636946|38133157|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
16989135|NCT00766051|38133165|FG000|Overall Study|Withdrawal by Subject|2|||
16989136|NCT00766051|38133166|FG001|Overall Study|Withdrawal by Subject|0|||
16989137|NCT00909792|38133174|FG000|Period 1|Did not meet inclusion criteria|0|||
16989138|NCT00909792|38133175|FG001|Period 1|Did not meet inclusion criteria|1|||
17135401|NCT00042289|38276453|FG003|Overall Study|Protocol Violation|0|||
16989139|NCT00909792|38133174|FG000|Period 2|Biomicroscopy|1|||
16989140|NCT00909792|38133175|FG001|Period 2|Biomicroscopy|0|||
16989141|NCT00909792|38133174|FG000|Period 2|Lost to Follow-up|0|||
16989142|NCT00909792|38133175|FG001|Period 2|Lost to Follow-up|1|||
16989143|NCT00765817|38133183|FG000|Overall Study|Adverse Event|13|||
16989144|NCT00765817|38133184|FG001|Overall Study|Adverse Event|1|||
16989145|NCT00765817|38133183|FG000|Overall Study|Death|0|||
16989146|NCT00765817|38133184|FG001|Overall Study|Death|1|||
16989147|NCT00765817|38133183|FG000|Overall Study|Entry criteria not met|2|||
16989148|NCT00765817|38133184|FG001|Overall Study|Entry criteria not met|2|||
16989149|NCT00765817|38133183|FG000|Overall Study|Loss of glucose control|0|||
16989150|NCT00765817|38133184|FG001|Overall Study|Loss of glucose control|2|||
16989151|NCT00765817|38133183|FG000|Overall Study|Lost to Follow-up|1|||
16989152|NCT00765817|38133184|FG001|Overall Study|Lost to Follow-up|3|||
16989153|NCT00765817|38133183|FG000|Overall Study|Physician Decision|2|||
16989154|NCT00765817|38133184|FG001|Overall Study|Physician Decision|1|||
16989155|NCT00765817|38133183|FG000|Overall Study|Protocol Violation|1|||
16989156|NCT00765817|38133184|FG001|Overall Study|Protocol Violation|1|||
16989157|NCT00765817|38133183|FG000|Overall Study|Subject decision|7|||
16989158|NCT00765817|38133184|FG001|Overall Study|Subject decision|11|||
16989159|NCT00772603|38133193|FG000|Overall Study|Withdrawal by Subject|11|||
16989160|NCT00772603|38133194|FG001|Overall Study|Withdrawal by Subject|10|||
16989161|NCT00772603|38133195|FG002|Overall Study|Withdrawal by Subject|6|||
16989162|NCT00772603|38133193|FG000|Overall Study|Adverse Event|37|||
16989163|NCT00772603|38133194|FG001|Overall Study|Adverse Event|18|||
16989164|NCT00772603|38133195|FG002|Overall Study|Adverse Event|10|||
16989165|NCT00772603|38133193|FG000|Overall Study|Subject Non-compliance|1|||
16989166|NCT00772603|38133194|FG001|Overall Study|Subject Non-compliance|6|||
16989167|NCT00772603|38133195|FG002|Overall Study|Subject Non-compliance|4|||
16989168|NCT00772603|38133193|FG000|Overall Study|Protocol Violation|0|||
16989169|NCT00772603|38133194|FG001|Overall Study|Protocol Violation|1|||
16989170|NCT00772603|38133195|FG002|Overall Study|Protocol Violation|1|||
16989171|NCT00772603|38133193|FG000|Overall Study|Lost to Follow-up|1|||
16989172|NCT00772603|38133194|FG001|Overall Study|Lost to Follow-up|5|||
16989173|NCT00772603|38133195|FG002|Overall Study|Lost to Follow-up|2|||
16989174|NCT00772603|38133193|FG000|Overall Study|Physician Decision|0|||
16989175|NCT00772603|38133194|FG001|Overall Study|Physician Decision|0|||
16989176|NCT00772603|38133195|FG002|Overall Study|Physician Decision|1|||
16989177|NCT00772603|38133193|FG000|Overall Study|Other|2|||
16989178|NCT00772603|38133194|FG001|Overall Study|Other|0|||
16989179|NCT00772603|38133195|FG002|Overall Study|Other|2|||
16989180|NCT00772447|38133208|FG000|Overall Study|Withdrawal by Subject|9|||
17135402|NCT00042289|38276454|FG004|Overall Study|Protocol Violation|0|||
17135403|NCT00042289|38276455|FG005|Overall Study|Protocol Violation|1|||
17135404|NCT00042289|38276456|FG006|Overall Study|Protocol Violation|0|||
17135405|NCT00042289|38276457|FG007|Overall Study|Protocol Violation|1|||
17135406|NCT00042289|38276458|FG008|Overall Study|Protocol Violation|0|||
17135407|NCT00042289|38276459|FG009|Overall Study|Protocol Violation|0|||
17135408|NCT00042289|38276460|FG010|Overall Study|Protocol Violation|0|||
17135409|NCT00042289|38276461|FG011|Overall Study|Protocol Violation|0|||
17135410|NCT00042289|38276462|FG012|Overall Study|Protocol Violation|0|||
17135411|NCT00042289|38276463|FG013|Overall Study|Protocol Violation|0|||
17135412|NCT00042289|38276464|FG014|Overall Study|Protocol Violation|0|||
17135413|NCT00042289|38276465|FG015|Overall Study|Protocol Violation|0|||
17135414|NCT00042289|38276466|FG016|Overall Study|Protocol Violation|0|||
17135415|NCT00042289|38276467|FG017|Overall Study|Protocol Violation|0|||
17135416|NCT00042289|38276468|FG018|Overall Study|Protocol Violation|0|||
17135417|NCT00042289|38276469|FG019|Overall Study|Protocol Violation|0|||
17135418|NCT00042289|38276470|FG020|Overall Study|Protocol Violation|0|||
17135419|NCT00042289|38276471|FG021|Overall Study|Protocol Violation|0|||
17135420|NCT00042289|38276472|FG022|Overall Study|Protocol Violation|0|||
17135421|NCT00042289|38276473|FG023|Overall Study|Protocol Violation|1|||
17135422|NCT00042289|38276474|FG024|Overall Study|Protocol Violation|1|||
17135423|NCT00042289|38276475|FG025|Overall Study|Protocol Violation|0|||
17135424|NCT00042289|38276476|FG026|Overall Study|Protocol Violation|2|||
17135425|NCT00042289|38276477|FG027|Overall Study|Protocol Violation|0|||
17135426|NCT00042289|38276478|FG028|Overall Study|Protocol Violation|0|||
17135427|NCT00042289|38276479|FG029|Overall Study|Protocol Violation|0|||
17135428|NCT00042289|38276480|FG030|Overall Study|Protocol Violation|1|||
17135429|NCT00042289|38276481|FG031|Overall Study|Protocol Violation|0|||
17135430|NCT00042289|38276482|FG032|Overall Study|Protocol Violation|0|||
17135431|NCT00042289|38276483|FG033|Overall Study|Protocol Violation|0|||
17135432|NCT00042289|38276484|FG034|Overall Study|Protocol Violation|0|||
17135433|NCT00042289|38276485|FG035|Overall Study|Protocol Violation|0|||
17135434|NCT00042289|38276486|FG036|Overall Study|Protocol Violation|0|||
17135435|NCT00042289|38276487|FG037|Overall Study|Protocol Violation|0|||
17135436|NCT00042289|38276488|FG038|Overall Study|Protocol Violation|0|||
16989181|NCT00772447|38133209|FG001|Overall Study|Withdrawal by Subject|5|||
16989182|NCT00772447|38133208|FG000|Overall Study|Physician Decision|4|||
16989183|NCT00772447|38133209|FG001|Overall Study|Physician Decision|8|||
17135437|NCT00042289|38276489|FG039|Overall Study|Protocol Violation|0|||
17135438|NCT00042289|38276490|FG040|Overall Study|Protocol Violation|0|||
17135439|NCT00042289|38276491|FG041|Overall Study|Protocol Violation|1|||
17135440|NCT00042289|38276492|FG042|Overall Study|Protocol Violation|1|||
16989184|NCT00772447|38133208|FG000|Overall Study|Lost to Follow-up|2|||
17135441|NCT00042289|38276493|FG043|Overall Study|Protocol Violation|1|||
16989185|NCT00772447|38133209|FG001|Overall Study|Lost to Follow-up|4|||
17135442|NCT00042289|38276494|FG044|Overall Study|Protocol Violation|0|||
17135443|NCT00042289|38276495|FG045|Overall Study|Protocol Violation|0|||
17135444|NCT00042289|38276496|FG046|Overall Study|Protocol Violation|0|||
17135445|NCT00042289|38276450|FG000|Overall Study|Withdrawal by Subject|4|||
17135446|NCT00042289|38276451|FG001|Overall Study|Withdrawal by Subject|1|||
17135447|NCT00042289|38276452|FG002|Overall Study|Withdrawal by Subject|0|||
16989186|NCT00772447|38133208|FG000|Overall Study|incorrect enrolment|3|||
16989187|NCT00772447|38133209|FG001|Overall Study|incorrect enrolment|4|||
16989188|NCT00772447|38133208|FG000|Overall Study|Protocol Violation|0|||
16989189|NCT00772447|38133209|FG001|Overall Study|Protocol Violation|1|||
16989190|NCT00772447|38133208|FG000|Overall Study|all others|2|||
16989191|NCT00772447|38133209|FG001|Overall Study|all others|2|||
16989192|NCT00765037|38133216|FG000|Overall Study|Lost to Follow-up|5|||
16989193|NCT00765037|38133216|FG000|Overall Study|Adverse Event|1|||
16989194|NCT00831844|38133230|FG000|Overall Study|Adverse Event|2|||
16989195|NCT00831844|38133231|FG001|Overall Study|Adverse Event|0|||
16989196|NCT00831844|38133232|FG002|Overall Study|Adverse Event|0|||
16989197|NCT00831844|38133233|FG003|Overall Study|Adverse Event|0|||
16989198|NCT00831844|38133234|FG004|Overall Study|Adverse Event|1|||
16989199|NCT00831844|38133235|FG005|Overall Study|Adverse Event|1|||
16989200|NCT00831844|38133236|FG006|Overall Study|Adverse Event|2|||
17135448|NCT00042289|38276453|FG003|Overall Study|Withdrawal by Subject|2|||
17135449|NCT00042289|38276454|FG004|Overall Study|Withdrawal by Subject|0|||
17135450|NCT00042289|38276455|FG005|Overall Study|Withdrawal by Subject|2|||
17135451|NCT00042289|38276456|FG006|Overall Study|Withdrawal by Subject|0|||
17135452|NCT00042289|38276457|FG007|Overall Study|Withdrawal by Subject|0|||
17135453|NCT00042289|38276458|FG008|Overall Study|Withdrawal by Subject|0|||
17135454|NCT00042289|38276459|FG009|Overall Study|Withdrawal by Subject|1|||
17135455|NCT00042289|38276460|FG010|Overall Study|Withdrawal by Subject|0|||
17135456|NCT00042289|38276461|FG011|Overall Study|Withdrawal by Subject|0|||
17135457|NCT00042289|38276462|FG012|Overall Study|Withdrawal by Subject|2|||
17135458|NCT00042289|38276463|FG013|Overall Study|Withdrawal by Subject|0|||
17135459|NCT00042289|38276464|FG014|Overall Study|Withdrawal by Subject|0|||
17135460|NCT00042289|38276465|FG015|Overall Study|Withdrawal by Subject|0|||
17135461|NCT00042289|38276466|FG016|Overall Study|Withdrawal by Subject|0|||
17135462|NCT00042289|38276467|FG017|Overall Study|Withdrawal by Subject|0|||
17135463|NCT00042289|38276468|FG018|Overall Study|Withdrawal by Subject|0|||
17135464|NCT00042289|38276469|FG019|Overall Study|Withdrawal by Subject|0|||
17135465|NCT00042289|38276470|FG020|Overall Study|Withdrawal by Subject|0|||
17135466|NCT00042289|38276471|FG021|Overall Study|Withdrawal by Subject|1|||
17135467|NCT00042289|38276472|FG022|Overall Study|Withdrawal by Subject|1|||
16989201|NCT00831844|38133237|FG007|Overall Study|Adverse Event|0|||
16989202|NCT00831844|38133238|FG008|Overall Study|Adverse Event|0|||
16989203|NCT00831844|38133239|FG009|Overall Study|Adverse Event|0|||
16989204|NCT00831844|38133230|FG000|Overall Study|Death|0|||
16989205|NCT00831844|38133231|FG001|Overall Study|Death|0|||
16989206|NCT00831844|38133232|FG002|Overall Study|Death|0|||
16989207|NCT00831844|38133233|FG003|Overall Study|Death|1|||
16989208|NCT00831844|38133234|FG004|Overall Study|Death|0|||
16989209|NCT00831844|38133235|FG005|Overall Study|Death|0|||
16989210|NCT00831844|38133236|FG006|Overall Study|Death|0|||
16989211|NCT00831844|38133237|FG007|Overall Study|Death|0|||
16989212|NCT00831844|38133238|FG008|Overall Study|Death|0|||
16989213|NCT00831844|38133239|FG009|Overall Study|Death|0|||
16989214|NCT00831844|38133230|FG000|Overall Study|Lack of Efficacy|8|||
16989215|NCT00831844|38133231|FG001|Overall Study|Lack of Efficacy|10|||
16989216|NCT00831844|38133232|FG002|Overall Study|Lack of Efficacy|15|||
16989217|NCT00831844|38133233|FG003|Overall Study|Lack of Efficacy|8|||
16989218|NCT00831844|38133234|FG004|Overall Study|Lack of Efficacy|11|||
16989219|NCT00831844|38133235|FG005|Overall Study|Lack of Efficacy|17|||
16989220|NCT00831844|38133236|FG006|Overall Study|Lack of Efficacy|8|||
16989221|NCT00831844|38133237|FG007|Overall Study|Lack of Efficacy|9|||
16989222|NCT00831844|38133238|FG008|Overall Study|Lack of Efficacy|7|||
16989223|NCT00831844|38133239|FG009|Overall Study|Lack of Efficacy|0|||
16989224|NCT00831844|38133230|FG000|Overall Study|Physician Decision|0|||
16989225|NCT00831844|38133231|FG001|Overall Study|Physician Decision|1|||
16989226|NCT00831844|38133232|FG002|Overall Study|Physician Decision|3|||
16989227|NCT00831844|38133233|FG003|Overall Study|Physician Decision|1|||
16989228|NCT00831844|38133234|FG004|Overall Study|Physician Decision|1|||
16989229|NCT00831844|38133235|FG005|Overall Study|Physician Decision|1|||
16989230|NCT00831844|38133236|FG006|Overall Study|Physician Decision|0|||
16989231|NCT00831844|38133237|FG007|Overall Study|Physician Decision|0|||
16989232|NCT00831844|38133238|FG008|Overall Study|Physician Decision|1|||
17135468|NCT00042289|38276473|FG023|Overall Study|Withdrawal by Subject|1|||
16989233|NCT00831844|38133239|FG009|Overall Study|Physician Decision|0|||
16989234|NCT00831844|38133230|FG000|Overall Study|Withdrawal by Subject|0|||
16989235|NCT00831844|38133231|FG001|Overall Study|Withdrawal by Subject|0|||
16989236|NCT00831844|38133232|FG002|Overall Study|Withdrawal by Subject|1|||
16989237|NCT00831844|38133233|FG003|Overall Study|Withdrawal by Subject|0|||
16989238|NCT00831844|38133234|FG004|Overall Study|Withdrawal by Subject|0|||
16989239|NCT00831844|38133235|FG005|Overall Study|Withdrawal by Subject|0|||
16989240|NCT00831844|38133236|FG006|Overall Study|Withdrawal by Subject|0|||
16780353|NCT01628692|37719430|FG004|Overall Study|Administrative reason by sponsor|0|||
16780354|NCT01628692|37719431|FG005|Overall Study|Administrative reason by sponsor|1|||
16780355|NCT01628692|37719426|FG000|Overall Study|Completed 12 Week only|0|||
16780356|NCT01628692|37719427|FG001|Overall Study|Completed 12 Week only|0|||
16780357|NCT01628692|37719428|FG002|Overall Study|Completed 12 Week only|0|||
16780358|NCT01628692|37719429|FG003|Overall Study|Completed 12 Week only|0|||
16780359|NCT01628692|37719430|FG004|Overall Study|Completed 12 Week only|0|||
16780360|NCT01628692|37719431|FG005|Overall Study|Completed 12 Week only|1|||
16780361|NCT02612727|37719450|FG000|Overall Study|Parent request|4|||
16989241|NCT00831844|38133237|FG007|Overall Study|Withdrawal by Subject|1|||
16989242|NCT00831844|38133238|FG008|Overall Study|Withdrawal by Subject|1|||
16989243|NCT00831844|38133239|FG009|Overall Study|Withdrawal by Subject|0|||
16989244|NCT00831844|38133230|FG000|Overall Study|Ineligible|0|||
16989245|NCT00831844|38133231|FG001|Overall Study|Ineligible|1|||
16989246|NCT00831844|38133232|FG002|Overall Study|Ineligible|1|||
16989247|NCT00831844|38133233|FG003|Overall Study|Ineligible|0|||
16989248|NCT00831844|38133234|FG004|Overall Study|Ineligible|1|||
16989249|NCT00831844|38133235|FG005|Overall Study|Ineligible|0|||
16989250|NCT00831844|38133236|FG006|Overall Study|Ineligible|0|||
16989251|NCT00831844|38133237|FG007|Overall Study|Ineligible|0|||
16989252|NCT00831844|38133238|FG008|Overall Study|Ineligible|0|||
16989253|NCT00831844|38133239|FG009|Overall Study|Ineligible|0|||
16989254|NCT00764881|38133263|FG000|Overall Study|Adverse Event|5|||
16989255|NCT00764881|38133264|FG001|Overall Study|Adverse Event|1|||
16989256|NCT00764881|38133263|FG000|Overall Study|Withdrawal by Subject|1|||
16989257|NCT00764881|38133264|FG001|Overall Study|Withdrawal by Subject|3|||
16989258|NCT00764881|38133263|FG000|Overall Study|Protocol Violation|2|||
16989259|NCT00764881|38133264|FG001|Overall Study|Protocol Violation|2|||
16989260|NCT00764881|38133263|FG000|Overall Study|Lost to Follow-up|2|||
16989261|NCT00764881|38133264|FG001|Overall Study|Lost to Follow-up|0|||
16989262|NCT00764881|38133263|FG000|Overall Study|Noncompliant|1|||
16989263|NCT00764881|38133264|FG001|Overall Study|Noncompliant|0|||
16989264|NCT00764881|38133263|FG000|Overall Study|Accidentally discontinued study drug|1|||
16989265|NCT00764881|38133264|FG001|Overall Study|Accidentally discontinued study drug|0|||
16989266|NCT00764881|38133263|FG000|Overall Study|Wished to become pregnant|1|||
16780362|NCT02612727|37719451|FG001|Overall Study|Parent request|1|||
16989267|NCT00764881|38133264|FG001|Overall Study|Wished to become pregnant|0|||
16989268|NCT00764881|38133263|FG000|Overall Study|Carcinoma detected|1|||
16780363|NCT02612727|37719450|FG000|Overall Study|Needed treatment incompatible with PT|1|||
16989269|NCT00764881|38133264|FG001|Overall Study|Carcinoma detected|0|||
16989270|NCT00764881|38133263|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
16989271|NCT00764881|38133264|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
16989272|NCT00764881|38133263|FG000|Overall Study|no treatment or no observation|2|||
16989273|NCT00764881|38133264|FG001|Overall Study|no treatment or no observation|2|||
16989274|NCT00844558|38133272|FG000|Overall Study|Withdrawal by Subject|9|||
16989275|NCT00844558|38133273|FG001|Overall Study|Withdrawal by Subject|2|||
16989276|NCT00844558|38133272|FG000|Overall Study|Death|1|||
16989277|NCT00844558|38133273|FG001|Overall Study|Death|0|||
16989278|NCT00844558|38133272|FG000|Overall Study|Protocol Violation|1|||
16989279|NCT00844558|38133273|FG001|Overall Study|Protocol Violation|1|||
16989280|NCT00844558|38133272|FG000|Overall Study|Lost to Follow-up|0|||
16989281|NCT00844558|38133273|FG001|Overall Study|Lost to Follow-up|1|||
16989282|NCT00844558|38133272|FG000|Overall Study|Physician Decision|1|||
16989283|NCT00844558|38133273|FG001|Overall Study|Physician Decision|0|||
16989284|NCT00772369|38133284|FG000|Overall Study|Did not return record release form|1|||
16989285|NCT00821236|38133291|FG000|Overall Study|Lost to Follow-up|3|||
16989286|NCT00756457|38133301|FG000|Overall Study|Lost to Follow-up|1|||
16989287|NCT00756457|38133302|FG001|Overall Study|Lost to Follow-up|2|||
16989288|NCT00844480|38133326|FG000|Overall Study|Withdrawal by Subject|2|||
16989289|NCT00844480|38133327|FG001|Overall Study|Withdrawal by Subject|3|||
16989290|NCT00771901|38133336|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
16989291|NCT00771901|38133337|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
16989292|NCT00771901|38133338|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
16989293|NCT00843856|38133348|FG000|Overall Study|Lost to Follow-up|1|||
16989294|NCT00843856|38133349|FG001|Overall Study|Lost to Follow-up|2|||
16989295|NCT00764491|38133357|FG000|Overall Study|Lost to Follow-up|35|||
16989296|NCT00764491|38133358|FG001|Overall Study|Lost to Follow-up|17|||
16989297|NCT00843778|38133364|FG000|Overall Study|Adverse Event|15|||
16989298|NCT00843778|38133364|FG000|Overall Study|Lack of Efficacy|14|||
16989299|NCT00843778|38133364|FG000|Overall Study|Loss of efficacy|2|||
16989300|NCT00843778|38133364|FG000|Overall Study|Withdrawal by Subject|4|||
16989301|NCT00591370|38133368|FG000|Overall Study|Not Treated|2|||
16989302|NCT00910728|38133381|FG000|Overall Study|Lack of Efficacy|2|||
16989303|NCT00910728|38133382|FG001|Overall Study|Lack of Efficacy|3|||
16989304|NCT00910728|38133383|FG002|Overall Study|Lack of Efficacy|1|||
16989305|NCT00910728|38133384|FG003|Overall Study|Lack of Efficacy|2|||
16989306|NCT00910728|38133385|FG004|Overall Study|Lack of Efficacy|1|||
16989307|NCT00910728|38133386|FG005|Overall Study|Lack of Efficacy|0|||
16989308|NCT00910728|38133387|FG006|Overall Study|Lack of Efficacy|2|||
16989309|NCT00910728|38133388|FG007|Overall Study|Lack of Efficacy|2|||
16989310|NCT00910728|38133389|FG008|Overall Study|Lack of Efficacy|2|||
16989311|NCT00910728|38133381|FG000|Overall Study|Withdrawal by Subject|0|||
16989312|NCT00910728|38133382|FG001|Overall Study|Withdrawal by Subject|0|||
16989313|NCT00910728|38133383|FG002|Overall Study|Withdrawal by Subject|0|||
16989314|NCT00910728|38133384|FG003|Overall Study|Withdrawal by Subject|0|||
16989315|NCT00910728|38133385|FG004|Overall Study|Withdrawal by Subject|3|||
16989316|NCT00910728|38133386|FG005|Overall Study|Withdrawal by Subject|1|||
16989317|NCT00910728|38133387|FG006|Overall Study|Withdrawal by Subject|2|||
16989318|NCT00910728|38133388|FG007|Overall Study|Withdrawal by Subject|0|||
16989319|NCT00910728|38133389|FG008|Overall Study|Withdrawal by Subject|0|||
16989320|NCT00910728|38133381|FG000|Overall Study|(not specified)|2|||
16989321|NCT00910728|38133382|FG001|Overall Study|(not specified)|0|||
16989322|NCT00910728|38133383|FG002|Overall Study|(not specified)|1|||
16989323|NCT00910728|38133384|FG003|Overall Study|(not specified)|0|||
16989324|NCT00910728|38133385|FG004|Overall Study|(not specified)|1|||
16989325|NCT00910728|38133386|FG005|Overall Study|(not specified)|0|||
16989326|NCT00910728|38133387|FG006|Overall Study|(not specified)|0|||
16989327|NCT00910728|38133388|FG007|Overall Study|(not specified)|0|||
16989328|NCT00910728|38133389|FG008|Overall Study|(not specified)|0|||
16989329|NCT00910728|38133381|FG000|Overall Study|Adverse Event|2|||
16989330|NCT00910728|38133382|FG001|Overall Study|Adverse Event|0|||
16989331|NCT00910728|38133383|FG002|Overall Study|Adverse Event|1|||
16989332|NCT00910728|38133384|FG003|Overall Study|Adverse Event|1|||
16989333|NCT00910728|38133385|FG004|Overall Study|Adverse Event|0|||
16989334|NCT00910728|38133386|FG005|Overall Study|Adverse Event|0|||
16989335|NCT00910728|38133387|FG006|Overall Study|Adverse Event|2|||
16989336|NCT00910728|38133388|FG007|Overall Study|Adverse Event|1|||
16989337|NCT00910728|38133389|FG008|Overall Study|Adverse Event|1|||
16989338|NCT00820222|38133411|FG000|Overall Study|Lost to Follow-up|10|||
16989339|NCT00820222|38133412|FG001|Overall Study|Lost to Follow-up|9|||
16989340|NCT00820222|38133411|FG000|Overall Study|Withdrawal by Subject|19|||
16989341|NCT00820222|38133412|FG001|Overall Study|Withdrawal by Subject|21|||
16989342|NCT00820222|38133411|FG000|Overall Study|Physician Decision|93|||
16989343|NCT00820222|38133412|FG001|Overall Study|Physician Decision|88|||
16989344|NCT00820222|38133411|FG000|Overall Study|Sponsor Terminated Study|43|||
16989345|NCT00820222|38133412|FG001|Overall Study|Sponsor Terminated Study|65|||
16989346|NCT00820222|38133411|FG000|Overall Study|Unkown|11|||
16989347|NCT00820222|38133412|FG001|Overall Study|Unkown|7|||
16989348|NCT01039688|38133421|FG000|Overall Study|Adverse Event|38|||
16989349|NCT01039688|38133422|FG001|Overall Study|Adverse Event|39|||
16989350|NCT01039688|38133423|FG002|Overall Study|Adverse Event|24|||
16989351|NCT01039688|38133421|FG000|Overall Study|Lack of Efficacy|20|||
16989352|NCT01039688|38133422|FG001|Overall Study|Lack of Efficacy|11|||
16989353|NCT01039688|38133423|FG002|Overall Study|Lack of Efficacy|26|||
16989354|NCT01039688|38133421|FG000|Overall Study|Lost to Follow-up|11|||
16989355|NCT01039688|38133422|FG001|Overall Study|Lost to Follow-up|9|||
16989356|NCT01039688|38133423|FG002|Overall Study|Lost to Follow-up|5|||
16989357|NCT01039688|38133421|FG000|Overall Study|Other|13|||
16989358|NCT01039688|38133422|FG001|Overall Study|Other|25|||
16989359|NCT01039688|38133423|FG002|Overall Study|Other|12|||
16989360|NCT01039688|38133421|FG000|Overall Study|Withdrawal by Subject|23|||
16989361|NCT01039688|38133422|FG001|Overall Study|Withdrawal by Subject|27|||
16989362|NCT01039688|38133423|FG002|Overall Study|Withdrawal by Subject|13|||
16989363|NCT01039688|38133421|FG000|Overall Study|Death|2|||
16989364|NCT01039688|38133422|FG001|Overall Study|Death|0|||
16989365|NCT01039688|38133423|FG002|Overall Study|Death|0|||
16989366|NCT02237508|38133444|FG000|Overall Study|Withdrawal by Subject|0|||
16989367|NCT02237508|38133445|FG001|Overall Study|Withdrawal by Subject|2|||
16989368|NCT02237508|38133446|FG002|Overall Study|Withdrawal by Subject|0|||
16989369|NCT02237508|38133447|FG003|Overall Study|Withdrawal by Subject|1|||
16989370|NCT02237508|38133448|FG004|Overall Study|Withdrawal by Subject|0|||
16989371|NCT02237508|38133449|FG005|Overall Study|Withdrawal by Subject|1|||
16989372|NCT02237508|38133450|FG006|Overall Study|Withdrawal by Subject|1|||
16989373|NCT02237508|38133451|FG007|Overall Study|Withdrawal by Subject|0|||
16989374|NCT02237508|38133452|FG008|Overall Study|Withdrawal by Subject|1|||
16989375|NCT02237508|38133453|FG009|Overall Study|Withdrawal by Subject|0|||
16989376|NCT02237508|38133444|FG000|Overall Study|Physician Decision|0|||
16989377|NCT02237508|38133445|FG001|Overall Study|Physician Decision|1|||
16989378|NCT02237508|38133446|FG002|Overall Study|Physician Decision|0|||
16989379|NCT02237508|38133447|FG003|Overall Study|Physician Decision|0|||
16989380|NCT02237508|38133448|FG004|Overall Study|Physician Decision|0|||
16989381|NCT02237508|38133449|FG005|Overall Study|Physician Decision|0|||
16989382|NCT02237508|38133450|FG006|Overall Study|Physician Decision|0|||
16989383|NCT02237508|38133451|FG007|Overall Study|Physician Decision|0|||
16989384|NCT02237508|38133452|FG008|Overall Study|Physician Decision|0|||
16989385|NCT02237508|38133453|FG009|Overall Study|Physician Decision|0|||
16989386|NCT02237508|38133444|FG000|Overall Study|Protocol Violation|0|||
16989387|NCT02237508|38133445|FG001|Overall Study|Protocol Violation|0|||
16989388|NCT02237508|38133446|FG002|Overall Study|Protocol Violation|1|||
16989389|NCT02237508|38133447|FG003|Overall Study|Protocol Violation|0|||
16989390|NCT02237508|38133448|FG004|Overall Study|Protocol Violation|0|||
16989391|NCT02237508|38133449|FG005|Overall Study|Protocol Violation|0|||
16989392|NCT02237508|38133450|FG006|Overall Study|Protocol Violation|0|||
16989393|NCT02237508|38133451|FG007|Overall Study|Protocol Violation|0|||
16989394|NCT02237508|38133452|FG008|Overall Study|Protocol Violation|0|||
16989395|NCT02237508|38133453|FG009|Overall Study|Protocol Violation|0|||
16989396|NCT00909090|38133473|FG000|Overall Study|Lost to Follow-up|17|||
16989397|NCT00909090|38133474|FG001|Overall Study|Lost to Follow-up|17|||
16989398|NCT00909480|38133485|FG000|Overall Study|Adverse Event|5|||
16989399|NCT00909480|38133486|FG001|Overall Study|Adverse Event|3|||
16989400|NCT00909480|38133485|FG000|Overall Study|Protocol Violation|6|||
16989401|NCT00909480|38133486|FG001|Overall Study|Protocol Violation|8|||
16989402|NCT00909480|38133485|FG000|Overall Study|Withdrawal criteria|9|||
16989403|NCT00909480|38133486|FG001|Overall Study|Withdrawal criteria|11|||
16989404|NCT00909480|38133485|FG000|Overall Study|Unclassified|18|||
16989405|NCT00909480|38133486|FG001|Overall Study|Unclassified|19|||
16989406|NCT01058096|38133494|FG000|Double-blind Treatment Phase|Adverse Event|11|||
16989407|NCT01058096|38133495|FG001|Double-blind Treatment Phase|Adverse Event|15|||
16989408|NCT01058096|38133494|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
16989409|NCT01058096|38133495|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
16989410|NCT01058096|38133494|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
16989411|NCT01058096|38133495|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
16989412|NCT01058096|38133494|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
16989413|NCT01058096|38133495|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
16989414|NCT01058096|38133494|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16989415|NCT01058096|38133495|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
16989416|NCT01058096|38133494|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
16989417|NCT01058096|38133495|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
16989418|NCT01057862|38133503|FG000|Overall Study|Withdrawal by Subject|1|||
16989419|NCT01057862|38133504|FG001|Overall Study|Withdrawal by Subject|2|||
16989420|NCT01038128|38133510|FG000|Overall Study|Lack of Efficacy|1|||
16989421|NCT01038128|38133510|FG000|Overall Study|Lost to Follow-up|1|||
16989422|NCT01038128|38133510|FG000|Overall Study|Withdrawal by Subject|2|||
16989423|NCT00842530|38133531|FG000|Overall Study|Serious adverse event|0|||
16989424|NCT00842530|38133532|FG001|Overall Study|Serious adverse event|6|||
16989425|NCT00842530|38133531|FG000|Overall Study|Other adverse event|6|||
16989426|NCT00842530|38133532|FG001|Overall Study|Other adverse event|1|||
16989427|NCT00842530|38133531|FG000|Overall Study|Protocol Violation|32|||
16989428|NCT00842530|38133532|FG001|Overall Study|Protocol Violation|14|||
16989429|NCT00842530|38133531|FG000|Overall Study|Lost to Follow-up|6|||
16989430|NCT00842530|38133532|FG001|Overall Study|Lost to Follow-up|8|||
16989431|NCT00842530|38133531|FG000|Overall Study|Withdrawal by Subject|73|||
16989432|NCT00842530|38133532|FG001|Overall Study|Withdrawal by Subject|28|||
16989433|NCT00819910|38133543|FG000|Overall Study|Adverse Event|0|||
16989434|NCT00819910|38133544|FG001|Overall Study|Adverse Event|0|||
16989435|NCT00819910|38133545|FG002|Overall Study|Adverse Event|2|||
16989436|NCT00819910|38133546|FG003|Overall Study|Adverse Event|1|||
16989437|NCT00819910|38133543|FG000|Overall Study|Withdrawal by Subject|1|||
16989438|NCT00819910|38133544|FG001|Overall Study|Withdrawal by Subject|1|||
16989439|NCT00819910|38133545|FG002|Overall Study|Withdrawal by Subject|1|||
16989440|NCT00819910|38133546|FG003|Overall Study|Withdrawal by Subject|0|||
16989441|NCT00819910|38133543|FG000|Overall Study|Lost to Follow-up|1|||
16989442|NCT00819910|38133544|FG001|Overall Study|Lost to Follow-up|0|||
16989443|NCT00819910|38133545|FG002|Overall Study|Lost to Follow-up|0|||
16989444|NCT00819910|38133546|FG003|Overall Study|Lost to Follow-up|0|||
16989445|NCT00830518|38133574|FG000|Overall Study|Progressive Disease|18|||
16989446|NCT00830518|38133575|FG001|Overall Study|Progressive Disease|8|||
16989447|NCT00830518|38133574|FG000|Overall Study|Symptomatic Deterioration|4|||
16989448|NCT00830518|38133575|FG001|Overall Study|Symptomatic Deterioration|1|||
16989449|NCT00830518|38133574|FG000|Overall Study|Adverse Event|14|||
16989450|NCT00830518|38133575|FG001|Overall Study|Adverse Event|1|||
16989451|NCT00830518|38133574|FG000|Overall Study|Withdrawal by Patient|2|||
16989452|NCT00830518|38133575|FG001|Overall Study|Withdrawal by Patient|0|||
16989453|NCT00830518|38133574|FG000|Overall Study|Reason not Specified|8|||
16989454|NCT00830518|38133575|FG001|Overall Study|Reason not Specified|1|||
16989455|NCT00908544|38133584|FG000|Overall Study|Withdrawal by Subject|2|||
16989456|NCT00908544|38133585|FG001|Overall Study|Withdrawal by Subject|4|||
16989457|NCT00908544|38133584|FG000|Overall Study|Lack of Efficacy|0|||
16989458|NCT00908544|38133585|FG001|Overall Study|Lack of Efficacy|1|||
16989459|NCT00908544|38133584|FG000|Overall Study|Pregnancy|1|||
16989460|NCT00908544|38133585|FG001|Overall Study|Pregnancy|0|||
16989461|NCT00908544|38133584|FG000|Overall Study|Relocation abroad|1|||
16989462|NCT00908544|38133585|FG001|Overall Study|Relocation abroad|1|||
16989463|NCT00908544|38133584|FG000|Overall Study|Unable to visit sutdy center|1|||
16989464|NCT00908544|38133585|FG001|Overall Study|Unable to visit sutdy center|0|||
16989465|NCT00830440|38133593|FG000|Overall Study|Protocol Violation|1|||
16989466|NCT00830440|38133594|FG001|Overall Study|Protocol Violation|0|||
16989467|NCT00830440|38133593|FG000|Overall Study|Withdrawal by Subject|1|||
16989468|NCT00830440|38133594|FG001|Overall Study|Withdrawal by Subject|0|||
16989469|NCT00830440|38133593|FG000|Overall Study|unsuccessful procedure|4|||
16989470|NCT00830440|38133594|FG001|Overall Study|unsuccessful procedure|0|||
16989471|NCT00830440|38133593|FG000|Overall Study|Adverse Event|2|||
16989472|NCT00830440|38133594|FG001|Overall Study|Adverse Event|0|||
16989473|NCT00908310|38133601|FG000|Overall Study|Death|37|||
16989474|NCT00908310|38133601|FG000|Overall Study|Withdrawal by Subject|7|||
16989475|NCT00908310|38133601|FG000|Overall Study|Lost to Follow-up|7|||
16989476|NCT00908310|38133601|FG000|Overall Study|Screening failure|5|||
16989477|NCT00908310|38133601|FG000|Overall Study|Other reasons|4|||
16989478|NCT00830128|38133605|FG000|Overall Study|Adverse Event|5|||
16989479|NCT00830128|38133605|FG000|Overall Study|Lack of Efficacy|7|||
16989480|NCT00830128|38133605|FG000|Overall Study|Protocol Violation|1|||
16989481|NCT00830128|38133605|FG000|Overall Study|Withdrawal by Subject|2|||
16989482|NCT00830128|38133605|FG000|Overall Study|Family obligation|1|||
16989483|NCT00830128|38133605|FG000|Overall Study|Relocation|1|||
16989484|NCT00830128|38133605|FG000|Overall Study|Work obligation|1|||
16989485|NCT00830128|38133605|FG000|Overall Study|Operating a vehicle|1|||
16989486|NCT00841906|38133611|FG000|Overall Study|Withdrawal by Subject|2|||
16989487|NCT00841906|38133612|FG001|Overall Study|Withdrawal by Subject|0|||
16989488|NCT00771667|38133624|FG000|Induction Phase|Adverse Event|5|||
16989489|NCT00771667|38133625|FG001|Induction Phase|Adverse Event|2|||
16989490|NCT00771667|38133626|FG002|Induction Phase|Adverse Event|4|||
16989491|NCT00771667|38133627|FG003|Induction Phase|Adverse Event|1|||
16989492|NCT00771667|38133628|FG004|Induction Phase|Adverse Event|0|||
16989493|NCT00771667|38133629|FG005|Induction Phase|Adverse Event|0|||
16989494|NCT00771667|38133630|FG006|Induction Phase|Adverse Event|0|||
16989495|NCT00771667|38133631|FG007|Induction Phase|Adverse Event|0|||
16989496|NCT00771667|38133632|FG008|Induction Phase|Adverse Event|0|||
16989497|NCT00771667|38133633|FG009|Induction Phase|Adverse Event|0|||
16989498|NCT00771667|38133624|FG000|Induction Phase|Lack of Efficacy|9|||
16989499|NCT00771667|38133625|FG001|Induction Phase|Lack of Efficacy|2|||
16989500|NCT00771667|38133626|FG002|Induction Phase|Lack of Efficacy|4|||
16989501|NCT00771667|38133627|FG003|Induction Phase|Lack of Efficacy|3|||
16989502|NCT00771667|38133628|FG004|Induction Phase|Lack of Efficacy|0|||
16989503|NCT00771667|38133629|FG005|Induction Phase|Lack of Efficacy|0|||
16989504|NCT00771667|38133630|FG006|Induction Phase|Lack of Efficacy|0|||
16989505|NCT00771667|38133631|FG007|Induction Phase|Lack of Efficacy|0|||
16989506|NCT00771667|38133632|FG008|Induction Phase|Lack of Efficacy|0|||
16989507|NCT00771667|38133633|FG009|Induction Phase|Lack of Efficacy|0|||
16989508|NCT00771667|38133624|FG000|Induction Phase|Lost to Follow-up|1|||
16989509|NCT00771667|38133625|FG001|Induction Phase|Lost to Follow-up|0|||
16989510|NCT00771667|38133626|FG002|Induction Phase|Lost to Follow-up|1|||
16989511|NCT00771667|38133627|FG003|Induction Phase|Lost to Follow-up|0|||
16989512|NCT00771667|38133628|FG004|Induction Phase|Lost to Follow-up|0|||
16989513|NCT00771667|38133629|FG005|Induction Phase|Lost to Follow-up|0|||
16989514|NCT00771667|38133630|FG006|Induction Phase|Lost to Follow-up|0|||
16989515|NCT00771667|38133631|FG007|Induction Phase|Lost to Follow-up|0|||
16989516|NCT00771667|38133632|FG008|Induction Phase|Lost to Follow-up|0|||
16989517|NCT00771667|38133633|FG009|Induction Phase|Lost to Follow-up|0|||
16989518|NCT00771667|38133624|FG000|Induction Phase|Other|4|||
16989519|NCT00771667|38133625|FG001|Induction Phase|Other|6|||
16989520|NCT00771667|38133626|FG002|Induction Phase|Other|3|||
16989521|NCT00771667|38133627|FG003|Induction Phase|Other|4|||
16989522|NCT00771667|38133628|FG004|Induction Phase|Other|0|||
16989523|NCT00771667|38133629|FG005|Induction Phase|Other|0|||
16989524|NCT00771667|38133630|FG006|Induction Phase|Other|0|||
16989525|NCT00771667|38133631|FG007|Induction Phase|Other|0|||
16989526|NCT00771667|38133632|FG008|Induction Phase|Other|0|||
16989527|NCT00771667|38133633|FG009|Induction Phase|Other|0|||
16989528|NCT00771667|38133624|FG000|Maintenance Phase|Adverse Event|0|||
16989529|NCT00771667|38133625|FG001|Maintenance Phase|Adverse Event|0|||
16989530|NCT00771667|38133626|FG002|Maintenance Phase|Adverse Event|0|||
16989531|NCT00771667|38133627|FG003|Maintenance Phase|Adverse Event|0|||
16989532|NCT00771667|38133628|FG004|Maintenance Phase|Adverse Event|1|||
16989533|NCT00771667|38133629|FG005|Maintenance Phase|Adverse Event|3|||
16989534|NCT00771667|38133630|FG006|Maintenance Phase|Adverse Event|5|||
16989535|NCT00771667|38133631|FG007|Maintenance Phase|Adverse Event|1|||
16989536|NCT00771667|38133632|FG008|Maintenance Phase|Adverse Event|8|||
16989537|NCT00771667|38133633|FG009|Maintenance Phase|Adverse Event|7|||
16989538|NCT00771667|38133624|FG000|Maintenance Phase|Lack of Efficacy|0|||
16989539|NCT00771667|38133625|FG001|Maintenance Phase|Lack of Efficacy|0|||
16989540|NCT00771667|38133626|FG002|Maintenance Phase|Lack of Efficacy|0|||
16989541|NCT00771667|38133627|FG003|Maintenance Phase|Lack of Efficacy|0|||
16989542|NCT00771667|38133628|FG004|Maintenance Phase|Lack of Efficacy|1|||
16989543|NCT00771667|38133629|FG005|Maintenance Phase|Lack of Efficacy|3|||
16989544|NCT00771667|38133630|FG006|Maintenance Phase|Lack of Efficacy|3|||
16989545|NCT00771667|38133631|FG007|Maintenance Phase|Lack of Efficacy|2|||
16989546|NCT00771667|38133632|FG008|Maintenance Phase|Lack of Efficacy|11|||
16989547|NCT00771667|38133633|FG009|Maintenance Phase|Lack of Efficacy|7|||
16989548|NCT00771667|38133624|FG000|Maintenance Phase|Other|0|||
16989549|NCT00771667|38133625|FG001|Maintenance Phase|Other|0|||
16989550|NCT00771667|38133626|FG002|Maintenance Phase|Other|0|||
16989551|NCT00771667|38133627|FG003|Maintenance Phase|Other|0|||
16989552|NCT00771667|38133628|FG004|Maintenance Phase|Other|0|||
16989553|NCT00771667|38133629|FG005|Maintenance Phase|Other|1|||
16989554|NCT00771667|38133630|FG006|Maintenance Phase|Other|2|||
16989555|NCT00771667|38133631|FG007|Maintenance Phase|Other|2|||
16989556|NCT00771667|38133632|FG008|Maintenance Phase|Other|3|||
16989557|NCT00771667|38133633|FG009|Maintenance Phase|Other|3|||
16989558|NCT00770965|38133655|FG000|Safety Set|Withdrawal by Subject|0|||
16989559|NCT00770965|38133656|FG001|Safety Set|Withdrawal by Subject|0|||
16989560|NCT00770965|38133657|FG002|Safety Set|Withdrawal by Subject|0|||
16989561|NCT00770965|38133658|FG003|Safety Set|Withdrawal by Subject|1|||
16989562|NCT00770965|38133655|FG000|Safety Set|Protocol deviation|0|||
16989563|NCT00770965|38133656|FG001|Safety Set|Protocol deviation|0|||
16989564|NCT00770965|38133657|FG002|Safety Set|Protocol deviation|1|||
16989565|NCT00770965|38133658|FG003|Safety Set|Protocol deviation|0|||
16989566|NCT00770965|38133655|FG000|Excluded Set|Administrative problems|14|||
16989567|NCT00770965|38133656|FG001|Excluded Set|Administrative problems|12|||
16989568|NCT00770965|38133657|FG002|Excluded Set|Administrative problems|12|||
16989569|NCT00770965|38133658|FG003|Excluded Set|Administrative problems|10|||
16989570|NCT00770965|38133655|FG000|Excluded Set|Withdrawal by Subject|1|||
16989571|NCT00770965|38133656|FG001|Excluded Set|Withdrawal by Subject|1|||
16989572|NCT00770965|38133657|FG002|Excluded Set|Withdrawal by Subject|2|||
16989573|NCT00770965|38133658|FG003|Excluded Set|Withdrawal by Subject|3|||
16989574|NCT00763555|38133670|FG000|Overall Study|Adverse Event|2|||
16989575|NCT00763555|38133671|FG001|Overall Study|Adverse Event|1|||
16989576|NCT00763555|38133670|FG000|Overall Study|Withdrawal by Subject|2|||
16989577|NCT00763555|38133671|FG001|Overall Study|Withdrawal by Subject|6|||
16989578|NCT00763555|38133670|FG000|Overall Study|Lost to Follow-up|0|||
17028570|NCT00584727|38172910|FG001|First Intervention|Discontinuation|0|||
17028571|NCT00584727|38172911|FG002|First Intervention|Discontinuation|1|||
17028572|NCT00584727|38172912|FG003|First Intervention|Discontinuation|0|||
17028573|NCT00584727|38172913|FG004|First Intervention|Discontinuation|0|||
17028574|NCT00584727|38172914|FG005|First Intervention|Discontinuation|0|||
17028575|NCT00584727|38172909|FG000|Third Intervention|Protocol Violation|0|||
17028576|NCT00584727|38172910|FG001|Third Intervention|Protocol Violation|0|||
17028577|NCT00584727|38172911|FG002|Third Intervention|Protocol Violation|1|||
17028578|NCT00584727|38172912|FG003|Third Intervention|Protocol Violation|0|||
17028579|NCT00584727|38172913|FG004|Third Intervention|Protocol Violation|4|||
17028580|NCT00584727|38172914|FG005|Third Intervention|Protocol Violation|2|||
16989579|NCT00763555|38133671|FG001|Overall Study|Lost to Follow-up|3|||
16989580|NCT00763321|38133680|FG000|Open-label Period|Adverse Event|24|||
16989581|NCT00763321|38133681|FG001|Open-label Period|Adverse Event|0|||
16989582|NCT00763321|38133682|FG002|Open-label Period|Adverse Event|0|||
16989583|NCT00763321|38133680|FG000|Open-label Period|Lost to Follow-up|14|||
16989584|NCT00763321|38133681|FG001|Open-label Period|Lost to Follow-up|0|||
16989585|NCT00763321|38133682|FG002|Open-label Period|Lost to Follow-up|0|||
16989586|NCT00763321|38133680|FG000|Open-label Period|Withdrawal by Subject|7|||
16989587|NCT00763321|38133681|FG001|Open-label Period|Withdrawal by Subject|0|||
16989588|NCT00763321|38133682|FG002|Open-label Period|Withdrawal by Subject|0|||
16989589|NCT00763321|38133680|FG000|Open-label Period|Subject noncompliant|7|||
16989590|NCT00763321|38133681|FG001|Open-label Period|Subject noncompliant|0|||
16989591|NCT00763321|38133682|FG002|Open-label Period|Subject noncompliant|0|||
16989592|NCT00763321|38133680|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
16989593|NCT00763321|38133681|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
16989594|NCT00763321|38133682|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
16989595|NCT00763321|38133680|FG000|Open-label Period|Lack of Efficacy|2|||
16989596|NCT00763321|38133681|FG001|Open-label Period|Lack of Efficacy|0|||
16989597|NCT00763321|38133682|FG002|Open-label Period|Lack of Efficacy|0|||
16989598|NCT00763321|38133680|FG000|Open-label Period|Other|4|||
16989599|NCT00763321|38133681|FG001|Open-label Period|Other|0|||
16989600|NCT00763321|38133682|FG002|Open-label Period|Other|0|||
16989601|NCT00763321|38133680|FG000|Double-blind Period|Lack of Efficacy|0|||
16989602|NCT00763321|38133681|FG001|Double-blind Period|Lack of Efficacy|9|||
16989603|NCT00763321|38133682|FG002|Double-blind Period|Lack of Efficacy|17|||
16989604|NCT00763321|38133680|FG000|Double-blind Period|Adverse Event|0|||
16989605|NCT00763321|38133681|FG001|Double-blind Period|Adverse Event|4|||
16989606|NCT00763321|38133682|FG002|Double-blind Period|Adverse Event|4|||
16989607|NCT00763321|38133680|FG000|Double-blind Period|Lost to Follow-up|0|||
16989608|NCT00763321|38133681|FG001|Double-blind Period|Lost to Follow-up|4|||
16989609|NCT00763321|38133682|FG002|Double-blind Period|Lost to Follow-up|2|||
16989610|NCT00763321|38133680|FG000|Double-blind Period|Withdrawal by Subject|0|||
16989611|NCT00763321|38133681|FG001|Double-blind Period|Withdrawal by Subject|2|||
16989612|NCT00763321|38133682|FG002|Double-blind Period|Withdrawal by Subject|3|||
16989613|NCT00763321|38133680|FG000|Double-blind Period|Other|0|||
16989614|NCT00763321|38133681|FG001|Double-blind Period|Other|2|||
16989615|NCT00763321|38133682|FG002|Double-blind Period|Other|3|||
16989616|NCT00770653|38133691|FG000|Overall Study|Adverse Event|13|||
16989617|NCT00770653|38133692|FG001|Overall Study|Adverse Event|5|||
16989618|NCT00770653|38133691|FG000|Overall Study|Protocol Violation|8|||
16989619|NCT00770653|38133692|FG001|Overall Study|Protocol Violation|6|||
16989620|NCT00770653|38133691|FG000|Overall Study|Withdrawal by Subject|4|||
16989621|NCT00770653|38133692|FG001|Overall Study|Withdrawal by Subject|7|||
16989622|NCT00770653|38133691|FG000|Overall Study|Lack of Compliance|1|||
16989623|NCT00770653|38133692|FG001|Overall Study|Lack of Compliance|4|||
16989624|NCT00770653|38133691|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
16989625|NCT00770653|38133692|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
16989626|NCT00770653|38133691|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
16989627|NCT00770653|38133692|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
16989628|NCT00770653|38133691|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
16989629|NCT00770653|38133692|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
16989630|NCT00770653|38133691|FG000|Overall Study|Lost to Follow-up|1|||
16989631|NCT00770653|38133692|FG001|Overall Study|Lost to Follow-up|2|||
16989632|NCT00770653|38133691|FG000|Overall Study|Physician Decision|1|||
16989633|NCT00770653|38133692|FG001|Overall Study|Physician Decision|0|||
16989634|NCT00819052|38133700|FG000|Overall Study|Adverse Event|0|||
16989635|NCT00819052|38133701|FG001|Overall Study|Adverse Event|5|||
16989636|NCT00819052|38133700|FG000|Overall Study|Protocol Violation|1|||
16989637|NCT00819052|38133701|FG001|Overall Study|Protocol Violation|2|||
16989638|NCT00819052|38133700|FG000|Overall Study|Lost to Follow-up|1|||
16989639|NCT00819052|38133701|FG001|Overall Study|Lost to Follow-up|2|||
16989640|NCT00819052|38133700|FG000|Overall Study|Withdrawal by Subject|1|||
16989641|NCT00819052|38133701|FG001|Overall Study|Withdrawal by Subject|2|||
16989642|NCT00819052|38133700|FG000|Overall Study|Lack of Efficacy|1|||
16989643|NCT00819052|38133701|FG001|Overall Study|Lack of Efficacy|1|||
16989644|NCT00819052|38133700|FG000|Overall Study|Pregnancy|1|||
16989645|NCT00819052|38133701|FG001|Overall Study|Pregnancy|2|||
16989646|NCT00819052|38133700|FG000|Overall Study|Death or events leading to death|1|||
16989647|NCT00819052|38133701|FG001|Overall Study|Death or events leading to death|0|||
16989648|NCT00763009|38133710|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
16989649|NCT00841672|38133717|FG000|Overall Study|Adverse Event|7|||
16989650|NCT00841672|38133718|FG001|Overall Study|Adverse Event|16|||
16989651|NCT00841672|38133717|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16989652|NCT00841672|38133718|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16989653|NCT00841672|38133717|FG000|Overall Study|Subject withdrew consent|2|||
16989654|NCT00841672|38133718|FG001|Overall Study|Subject withdrew consent|4|||
16989655|NCT00841672|38133717|FG000|Overall Study|Lost to Follow-up|1|||
16989656|NCT00841672|38133718|FG001|Overall Study|Lost to Follow-up|1|||
16989657|NCT00841672|38133717|FG000|Overall Study|Administrative problems|9|||
16989658|NCT00841672|38133718|FG001|Overall Study|Administrative problems|9|||
16989659|NCT00841672|38133717|FG000|Overall Study|Misrandomized|1|||
16989660|NCT00841672|38133718|FG001|Overall Study|Misrandomized|0|||
16989661|NCT00841672|38133717|FG000|Overall Study|Protocol Deviation|0|||
16989662|NCT00841672|38133718|FG001|Overall Study|Protocol Deviation|1|||
16989663|NCT00908232|38133724|FG000|Cycle 1 to 4|Death|5|||
16989664|NCT00908232|38133725|FG001|Cycle 1 to 4|Death|0|||
16989665|NCT00908232|38133726|FG002|Cycle 1 to 4|Death|0|||
16989666|NCT00908232|38133727|FG003|Cycle 1 to 4|Death|0|||
16989667|NCT00908232|38133724|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
16989668|NCT00908232|38133725|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
16989669|NCT00908232|38133726|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
16989670|NCT00908232|38133727|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
16989671|NCT00908232|38133724|FG000|Cycle 1 to 4|Progressive Disease|6|||
16989672|NCT00908232|38133725|FG001|Cycle 1 to 4|Progressive Disease|0|||
16989673|NCT00908232|38133726|FG002|Cycle 1 to 4|Progressive Disease|0|||
16989674|NCT00908232|38133727|FG003|Cycle 1 to 4|Progressive Disease|0|||
16989675|NCT00908232|38133724|FG000|Cycle 1 to 4|Adverse Event|12|||
16989676|NCT00908232|38133725|FG001|Cycle 1 to 4|Adverse Event|0|||
16989677|NCT00908232|38133726|FG002|Cycle 1 to 4|Adverse Event|0|||
16989678|NCT00908232|38133727|FG003|Cycle 1 to 4|Adverse Event|0|||
16989679|NCT00908232|38133724|FG000|Cycle 1 to 4|Other|1|||
16989680|NCT00908232|38133725|FG001|Cycle 1 to 4|Other|0|||
16989681|NCT00908232|38133726|FG002|Cycle 1 to 4|Other|0|||
16989682|NCT00908232|38133727|FG003|Cycle 1 to 4|Other|0|||
16989683|NCT00908232|38133724|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
16989684|NCT00908232|38133725|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
16989685|NCT00908232|38133726|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
16989686|NCT00908232|38133727|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
16989687|NCT00908232|38133724|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
16989688|NCT00908232|38133725|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
16989689|NCT00908232|38133726|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
16989690|NCT00908232|38133727|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
16989691|NCT00908232|38133724|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
16989692|NCT00908232|38133725|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
16989693|NCT00908232|38133726|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
16989694|NCT00908232|38133727|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
16989695|NCT00908232|38133724|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
16989696|NCT00908232|38133725|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
16989697|NCT00908232|38133726|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
16989698|NCT00908232|38133727|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
16989699|NCT00908232|38133724|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
16989700|NCT00908232|38133725|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
16989701|NCT00908232|38133726|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
16989702|NCT00908232|38133727|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
16989703|NCT00908232|38133724|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
16989704|NCT00908232|38133725|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
16989705|NCT00908232|38133726|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
16989706|NCT00908232|38133727|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
16989707|NCT00908232|38133724|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
16989708|NCT00908232|38133725|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
16989709|NCT00908232|38133726|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
16989710|NCT00908232|38133727|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
16989711|NCT00908232|38133724|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
17135469|NCT00042289|38276474|FG024|Overall Study|Withdrawal by Subject|0|||
17135470|NCT00042289|38276475|FG025|Overall Study|Withdrawal by Subject|0|||
17135471|NCT00042289|38276476|FG026|Overall Study|Withdrawal by Subject|1|||
17135472|NCT00042289|38276477|FG027|Overall Study|Withdrawal by Subject|0|||
16989712|NCT00908232|38133725|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
16989713|NCT00908232|38133726|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
16989714|NCT00908232|38133727|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
17135473|NCT00042289|38276478|FG028|Overall Study|Withdrawal by Subject|2|||
17135474|NCT00042289|38276479|FG029|Overall Study|Withdrawal by Subject|0|||
17135475|NCT00042289|38276480|FG030|Overall Study|Withdrawal by Subject|0|||
17135476|NCT00042289|38276481|FG031|Overall Study|Withdrawal by Subject|1|||
17135477|NCT00042289|38276482|FG032|Overall Study|Withdrawal by Subject|2|||
17135478|NCT00042289|38276483|FG033|Overall Study|Withdrawal by Subject|1|||
17135479|NCT00042289|38276484|FG034|Overall Study|Withdrawal by Subject|0|||
17135480|NCT00042289|38276485|FG035|Overall Study|Withdrawal by Subject|0|||
16989715|NCT00770341|38133736|FG000|Overall Study|Did not meet eligibility criteria|1|||
16989716|NCT00770341|38133737|FG001|Overall Study|Did not meet eligibility criteria|0|||
16989717|NCT00770341|38133738|FG002|Overall Study|Did not meet eligibility criteria|0|||
16989718|NCT00770341|38133736|FG000|Overall Study|Withdrawal by Subject|0|||
16989719|NCT00770341|38133737|FG001|Overall Study|Withdrawal by Subject|1|||
16989720|NCT00770341|38133738|FG002|Overall Study|Withdrawal by Subject|0|||
16989721|NCT00770341|38133736|FG000|Overall Study|Clinical Adverse Event|3|||
16989722|NCT00770341|38133737|FG001|Overall Study|Clinical Adverse Event|1|||
16989723|NCT00770341|38133738|FG002|Overall Study|Clinical Adverse Event|2|||
16989724|NCT00770341|38133736|FG000|Overall Study|Laboratory adverse event|3|||
16989725|NCT00770341|38133737|FG001|Overall Study|Laboratory adverse event|3|||
16989726|NCT00770341|38133738|FG002|Overall Study|Laboratory adverse event|0|||
16989727|NCT00770341|38133736|FG000|Overall Study|Lack of Efficacy|3|||
16989728|NCT00770341|38133737|FG001|Overall Study|Lack of Efficacy|0|||
16989729|NCT00770341|38133738|FG002|Overall Study|Lack of Efficacy|1|||
16989730|NCT00770341|38133736|FG000|Overall Study|Other|1|||
16989731|NCT00770341|38133737|FG001|Overall Study|Other|0|||
17135481|NCT00042289|38276486|FG036|Overall Study|Withdrawal by Subject|0|||
16989732|NCT00770341|38133738|FG002|Overall Study|Other|0|||
16989733|NCT00770341|38133736|FG000|Overall Study|Not treated|1|||
16989734|NCT00770341|38133737|FG001|Overall Study|Not treated|0|||
16989735|NCT00770341|38133738|FG002|Overall Study|Not treated|0|||
16989736|NCT00762463|38133755|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
16989737|NCT00762463|38133756|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
16989738|NCT00762463|38133757|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
16989739|NCT00762463|38133758|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
16989740|NCT00762463|38133755|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
16989741|NCT00762463|38133756|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
16989742|NCT00762463|38133757|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
16989743|NCT00762463|38133758|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
16989744|NCT00762463|38133755|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
16989745|NCT00762463|38133756|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
16989746|NCT00762463|38133757|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
16989747|NCT00762463|38133758|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
16989748|NCT00762463|38133755|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
16989749|NCT00762463|38133756|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
16989750|NCT00762463|38133757|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
16989751|NCT00762463|38133758|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
16989752|NCT00762463|38133755|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
16989753|NCT00762463|38133756|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
16989754|NCT00762463|38133757|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
16989755|NCT00762463|38133758|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
16989756|NCT00762463|38133755|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
16989757|NCT00762463|38133756|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
16989758|NCT00762463|38133757|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
16989759|NCT00762463|38133758|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
16989760|NCT00762463|38133755|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
16989761|NCT00762463|38133756|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
16989762|NCT00762463|38133757|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
16989763|NCT00762463|38133758|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
16989764|NCT00762463|38133755|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
17135482|NCT00042289|38276487|FG037|Overall Study|Withdrawal by Subject|1|||
17135483|NCT00042289|38276488|FG038|Overall Study|Withdrawal by Subject|0|||
17135484|NCT00042289|38276489|FG039|Overall Study|Withdrawal by Subject|0|||
17135485|NCT00042289|38276490|FG040|Overall Study|Withdrawal by Subject|0|||
17135486|NCT00042289|38276491|FG041|Overall Study|Withdrawal by Subject|0|||
17135487|NCT00042289|38276492|FG042|Overall Study|Withdrawal by Subject|1|||
17135488|NCT00042289|38276493|FG043|Overall Study|Withdrawal by Subject|0|||
17135489|NCT00042289|38276494|FG044|Overall Study|Withdrawal by Subject|0|||
17135490|NCT00042289|38276495|FG045|Overall Study|Withdrawal by Subject|0|||
17135491|NCT00042289|38276496|FG046|Overall Study|Withdrawal by Subject|0|||
17135492|NCT02886728|38276668|FG000|Overall Study|Withdrew Consent|31|||
17135493|NCT02886728|38276669|FG001|Overall Study|Withdrew Consent|13|||
17135494|NCT02886728|38276670|FG002|Overall Study|Withdrew Consent|11|||
17135495|NCT02886728|38276671|FG003|Overall Study|Withdrew Consent|47|||
17135496|NCT02886728|38276668|FG000|Overall Study|Lost to Follow-up|12|||
17135497|NCT02886728|38276669|FG001|Overall Study|Lost to Follow-up|6|||
17135498|NCT02886728|38276670|FG002|Overall Study|Lost to Follow-up|13|||
17135499|NCT02886728|38276671|FG003|Overall Study|Lost to Follow-up|12|||
16989765|NCT00762463|38133756|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
16989766|NCT00762463|38133757|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
16989767|NCT00762463|38133758|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
16989768|NCT00762385|38133771|FG000|First Intervention|Lens Issue|1|||
16989769|NCT00762385|38133772|FG001|First Intervention|Lens Issue|1|||
16989770|NCT00762385|38133771|FG000|First Intervention|Lost to Follow-up|0|||
16989771|NCT00762385|38133772|FG001|First Intervention|Lost to Follow-up|2|||
16989772|NCT00762385|38133771|FG000|First Intervention|Ineligible|1|||
16989773|NCT00762385|38133772|FG001|First Intervention|Ineligible|0|||
16989774|NCT00762385|38133771|FG000|First Intervention|Protocol Violation|0|||
16989775|NCT00762385|38133772|FG001|First Intervention|Protocol Violation|1|||
16989776|NCT00762385|38133771|FG000|Second Intervention|Protocol Violation|3|||
16989777|NCT00762385|38133772|FG001|Second Intervention|Protocol Violation|3|||
16989778|NCT00906282|38133781|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
16989779|NCT00906282|38133781|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
16989780|NCT00906282|38133781|FG000|Preoperative Chemotherapy|Progressive disease|6|||
16989781|NCT00906282|38133781|FG000|Preoperative Chemotherapy|Toxicity|1|||
16989782|NCT00762229|38133788|FG000|Overall Study|Lost to Follow-up|1|||
16989783|NCT00762229|38133789|FG001|Overall Study|Lost to Follow-up|1|||
16989784|NCT00762229|38133788|FG000|Overall Study|did not recveive intervention|0|||
16989785|NCT00762229|38133789|FG001|Overall Study|did not recveive intervention|1|||
16989786|NCT00907374|38133797|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
16989787|NCT00907374|38133798|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
16989788|NCT00818662|38133808|FG000|Overall Study|Adverse Event|5|||
16989789|NCT00818662|38133809|FG001|Overall Study|Adverse Event|14|||
16989790|NCT00818662|38133810|FG002|Overall Study|Adverse Event|4|||
16989791|NCT00818662|38133811|FG003|Overall Study|Adverse Event|3|||
16989792|NCT00818662|38133808|FG000|Overall Study|Withdrawal by Subject|5|||
16989793|NCT00818662|38133809|FG001|Overall Study|Withdrawal by Subject|4|||
16989794|NCT00818662|38133810|FG002|Overall Study|Withdrawal by Subject|2|||
16989795|NCT00818662|38133811|FG003|Overall Study|Withdrawal by Subject|2|||
16989796|NCT00818662|38133808|FG000|Overall Study|Death|1|||
16989797|NCT00818662|38133809|FG001|Overall Study|Death|3|||
16989798|NCT00818662|38133810|FG002|Overall Study|Death|0|||
16989799|NCT00818662|38133811|FG003|Overall Study|Death|0|||
16989800|NCT00818662|38133808|FG000|Overall Study|Physician Decision|1|||
16989801|NCT00818662|38133809|FG001|Overall Study|Physician Decision|0|||
16989802|NCT00818662|38133810|FG002|Overall Study|Physician Decision|0|||
16989803|NCT00818662|38133811|FG003|Overall Study|Physician Decision|0|||
16989804|NCT00818662|38133808|FG000|Overall Study|Lost to Follow-up|0|||
16989805|NCT00818662|38133809|FG001|Overall Study|Lost to Follow-up|0|||
16989806|NCT00818662|38133810|FG002|Overall Study|Lost to Follow-up|0|||
16989807|NCT00818662|38133811|FG003|Overall Study|Lost to Follow-up|1|||
16989808|NCT00818662|38133808|FG000|Overall Study|Unwilling or Unable to Participate|4|||
16989809|NCT00818662|38133809|FG001|Overall Study|Unwilling or Unable to Participate|6|||
16989810|NCT00818662|38133810|FG002|Overall Study|Unwilling or Unable to Participate|2|||
16989811|NCT00818662|38133811|FG003|Overall Study|Unwilling or Unable to Participate|4|||
16989812|NCT00818662|38133808|FG000|Overall Study|Protocol Violation|1|||
16989813|NCT00818662|38133809|FG001|Overall Study|Protocol Violation|1|||
16989814|NCT00818662|38133810|FG002|Overall Study|Protocol Violation|0|||
16989815|NCT00818662|38133811|FG003|Overall Study|Protocol Violation|0|||
16989816|NCT00818662|38133808|FG000|Overall Study|Requires a Prohibited Medication|1|||
16989817|NCT00818662|38133809|FG001|Overall Study|Requires a Prohibited Medication|0|||
16989818|NCT00818662|38133810|FG002|Overall Study|Requires a Prohibited Medication|0|||
16989819|NCT00818662|38133811|FG003|Overall Study|Requires a Prohibited Medication|0|||
16989820|NCT00818662|38133808|FG000|Overall Study|Safety Risk|1|||
16989821|NCT00818662|38133809|FG001|Overall Study|Safety Risk|1|||
16989822|NCT00818662|38133810|FG002|Overall Study|Safety Risk|0|||
16989823|NCT00818662|38133811|FG003|Overall Study|Safety Risk|1|||
16989824|NCT00818662|38133808|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
16989825|NCT00818662|38133809|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
16989826|NCT00818662|38133810|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
16989827|NCT00818662|38133811|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
17135500|NCT02886728|38276668|FG000|Overall Study|Adverse Event|13|||
16989828|NCT00818662|38133808|FG000|Overall Study|Participant's health declined|0|||
16989829|NCT00818662|38133809|FG001|Overall Study|Participant's health declined|0|||
16989830|NCT00818662|38133810|FG002|Overall Study|Participant's health declined|0|||
16989831|NCT00818662|38133811|FG003|Overall Study|Participant's health declined|1|||
16989832|NCT00818662|38133808|FG000|Overall Study|Caregiver to pursue other treatment|0|||
16989833|NCT00818662|38133809|FG001|Overall Study|Caregiver to pursue other treatment|1|||
16989834|NCT00818662|38133810|FG002|Overall Study|Caregiver to pursue other treatment|0|||
16989835|NCT00818662|38133811|FG003|Overall Study|Caregiver to pursue other treatment|0|||
16989836|NCT00818662|38133808|FG000|Overall Study|Moving out of state|0|||
16989837|NCT00818662|38133809|FG001|Overall Study|Moving out of state|0|||
16989838|NCT00818662|38133810|FG002|Overall Study|Moving out of state|0|||
16989839|NCT00818662|38133811|FG003|Overall Study|Moving out of state|1|||
16989840|NCT00818662|38133808|FG000|Overall Study|Declined move to another study site|1|||
16989841|NCT00818662|38133809|FG001|Overall Study|Declined move to another study site|0|||
16989842|NCT00818662|38133810|FG002|Overall Study|Declined move to another study site|0|||
16989843|NCT00818662|38133811|FG003|Overall Study|Declined move to another study site|0|||
16989844|NCT00818662|38133808|FG000|Overall Study|Change in living situation|0|||
16989845|NCT00818662|38133809|FG001|Overall Study|Change in living situation|0|||
16989846|NCT00818662|38133810|FG002|Overall Study|Change in living situation|0|||
16989847|NCT00818662|38133811|FG003|Overall Study|Change in living situation|1|||
16989848|NCT00818662|38133808|FG000|Overall Study|Study partner decision|0|||
16989849|NCT00818662|38133809|FG001|Overall Study|Study partner decision|0|||
16989850|NCT00818662|38133810|FG002|Overall Study|Study partner decision|0|||
16989851|NCT00818662|38133811|FG003|Overall Study|Study partner decision|1|||
16989852|NCT00818662|38133808|FG000|Overall Study|Admitted to long term nursing care|0|||
16989853|NCT00818662|38133809|FG001|Overall Study|Admitted to long term nursing care|1|||
16989854|NCT00818662|38133810|FG002|Overall Study|Admitted to long term nursing care|0|||
16989855|NCT00818662|38133811|FG003|Overall Study|Admitted to long term nursing care|0|||
16989856|NCT00903786|38133822|FG000|Overall Study|Physician Decision|6|||
16989857|NCT00903786|38133822|FG000|Overall Study|Lack of Efficacy|5|||
16989858|NCT00903786|38133822|FG000|Overall Study|Reason other than lack of efficacy|4|||
16989859|NCT00762073|38133831|FG000|Overall Study|Lack of Efficacy|1|||
16989860|NCT00762073|38133832|FG001|Overall Study|Lack of Efficacy|1|||
16989861|NCT00762073|38133833|FG002|Overall Study|Lack of Efficacy|0|||
16989862|NCT00762073|38133834|FG003|Overall Study|Lack of Efficacy|0|||
16989863|NCT00762073|38133831|FG000|Overall Study|Adverse Event|1|||
16989864|NCT00762073|38133832|FG001|Overall Study|Adverse Event|0|||
16989865|NCT00762073|38133833|FG002|Overall Study|Adverse Event|1|||
16989866|NCT00762073|38133834|FG003|Overall Study|Adverse Event|1|||
16989867|NCT00762073|38133831|FG000|Overall Study|Significant Subject Noncompliance|0|||
16989868|NCT00762073|38133832|FG001|Overall Study|Significant Subject Noncompliance|1|||
16989869|NCT00762073|38133833|FG002|Overall Study|Significant Subject Noncompliance|0|||
16989870|NCT00762073|38133834|FG003|Overall Study|Significant Subject Noncompliance|1|||
16989871|NCT00762073|38133831|FG000|Overall Study|Withdrawal by Subject|1|||
16989872|NCT00762073|38133832|FG001|Overall Study|Withdrawal by Subject|2|||
16989873|NCT00762073|38133833|FG002|Overall Study|Withdrawal by Subject|1|||
16989874|NCT00762073|38133834|FG003|Overall Study|Withdrawal by Subject|1|||
16989875|NCT00762073|38133831|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
16989876|NCT00762073|38133832|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
16989877|NCT00762073|38133833|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
16989878|NCT00762073|38133834|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
16989879|NCT00761761|38133853|FG000|Overall Study|Lost to Follow-up|3|||
16989880|NCT00761761|38133854|FG001|Overall Study|Lost to Follow-up|1|||
16989881|NCT00761761|38133853|FG000|Overall Study|Withdrawal by Subject|3|||
17135501|NCT02886728|38276669|FG001|Overall Study|Adverse Event|5|||
17135502|NCT02886728|38276670|FG002|Overall Study|Adverse Event|5|||
17135503|NCT02886728|38276671|FG003|Overall Study|Adverse Event|11|||
17135504|NCT02886728|38276668|FG000|Overall Study|Investigator's Discretion|11|||
17135505|NCT02886728|38276669|FG001|Overall Study|Investigator's Discretion|7|||
17135506|NCT02886728|38276670|FG002|Overall Study|Investigator's Discretion|5|||
17135507|NCT02886728|38276671|FG003|Overall Study|Investigator's Discretion|11|||
17135508|NCT02886728|38276668|FG000|Overall Study|Death|3|||
17135509|NCT02886728|38276669|FG001|Overall Study|Death|1|||
17135510|NCT02886728|38276670|FG002|Overall Study|Death|0|||
17135511|NCT02886728|38276671|FG003|Overall Study|Death|0|||
17135512|NCT02886728|38276668|FG000|Overall Study|Protocol Violation|0|||
17135513|NCT02886728|38276669|FG001|Overall Study|Protocol Violation|0|||
17135514|NCT02886728|38276670|FG002|Overall Study|Protocol Violation|0|||
17135515|NCT02886728|38276671|FG003|Overall Study|Protocol Violation|4|||
17135516|NCT02886728|38276668|FG000|Overall Study|Non-Compliance with Study Drug|1|||
17135517|NCT02886728|38276669|FG001|Overall Study|Non-Compliance with Study Drug|0|||
17135518|NCT02886728|38276670|FG002|Overall Study|Non-Compliance with Study Drug|1|||
16989882|NCT00761761|38133854|FG001|Overall Study|Withdrawal by Subject|0|||
16989883|NCT00761605|38133862|FG000|Overall Study|Adverse Event|26|||
16989884|NCT00761605|38133862|FG000|Overall Study|Death|2|||
16989885|NCT00761605|38133862|FG000|Overall Study|Lack of Efficacy|26|||
16989886|NCT00761605|38133862|FG000|Overall Study|Lost to Follow-up|29|||
16989887|NCT00761605|38133862|FG000|Overall Study|Withdrawal by Subject|37|||
16989888|NCT00761605|38133862|FG000|Overall Study|Other|21|||
16989889|NCT00761527|38133870|FG000|Overall Study|Adverse Event|3|||
16989890|NCT00761527|38133870|FG000|Overall Study|Poor Compliance|8|||
16989891|NCT00761527|38133870|FG000|Overall Study|Lost to Follow-up|9|||
16989892|NCT00761527|38133870|FG000|Overall Study|Unknown reason|2|||
16989893|NCT00770029|38133876|FG000|Overall Study|Lost to Follow-up|2|||
16989894|NCT00770029|38133877|FG001|Overall Study|Lost to Follow-up|0|||
16989895|NCT00770029|38133876|FG000|Overall Study|Withdrawal by Subject|3|||
16989896|NCT00770029|38133877|FG001|Overall Study|Withdrawal by Subject|3|||
16989897|NCT00770029|38133876|FG000|Overall Study|Adverse Event|1|||
16989898|NCT00770029|38133877|FG001|Overall Study|Adverse Event|0|||
16989899|NCT00817414|38133888|FG000|Overall Study|Adverse Event|1|||
16989900|NCT00817414|38133889|FG001|Overall Study|Adverse Event|1|||
16989901|NCT00817414|38133890|FG002|Overall Study|Adverse Event|1|||
16989902|NCT00817414|38133891|FG003|Overall Study|Adverse Event|0|||
16989903|NCT00817414|38133892|FG004|Overall Study|Adverse Event|0|||
16989904|NCT00817414|38133888|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
16989905|NCT00817414|38133889|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
16989906|NCT00817414|38133890|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
16989907|NCT00817414|38133891|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
17135519|NCT02886728|38276671|FG003|Overall Study|Non-Compliance with Study Drug|0|||
17135520|NCT02886728|38276668|FG000|Overall Study|Pregnancy|0|||
17135521|NCT02886728|38276669|FG001|Overall Study|Pregnancy|0|||
17135522|NCT02886728|38276670|FG002|Overall Study|Pregnancy|1|||
17135523|NCT02886728|38276671|FG003|Overall Study|Pregnancy|0|||
17135524|NCT02886728|38276668|FG000|Overall Study|Randomized but Not Dosed|1|||
17135525|NCT02886728|38276669|FG001|Overall Study|Randomized but Not Dosed|0|||
16989908|NCT00817414|38133892|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
16989909|NCT00817414|38133888|FG000|Overall Study|Withdrawal by Subject|1|||
17135526|NCT02886728|38276670|FG002|Overall Study|Randomized but Not Dosed|0|||
17135527|NCT02886728|38276671|FG003|Overall Study|Randomized but Not Dosed|2|||
17135528|NCT00039871|38276681|FG000|Overall Study|Adverse Event|165|||
17135529|NCT00039871|38276681|FG000|Overall Study|Lost to Follow-up|18|||
17135530|NCT00039871|38276681|FG000|Overall Study|Protocol Violation|24|||
17135531|NCT00039871|38276681|FG000|Overall Study|Withdrawal by Subject|97|||
17135532|NCT00039871|38276681|FG000|Overall Study|Did not meet eligibility criteria|11|||
17135533|NCT00039871|38276681|FG000|Overall Study|Administrative|1|||
17135534|NCT00039871|38276681|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
17135535|NCT00039871|38276681|FG000|Overall Study|Never entered follow-up|7|||
17135536|NCT00015457|38276685|FG000|First Intervention|Adverse Event|0|||
17135537|NCT00015457|38276686|FG001|First Intervention|Adverse Event|2|||
17135538|NCT00015457|38276685|FG000|First Intervention|Lack of Efficacy|0|||
16989910|NCT00817414|38133889|FG001|Overall Study|Withdrawal by Subject|1|||
17135539|NCT00015457|38276686|FG001|First Intervention|Lack of Efficacy|1|||
17135540|NCT00015457|38276685|FG000|Second Intervention|Withdrawal by Subject|1|||
17135541|NCT00015457|38276686|FG001|Second Intervention|Withdrawal by Subject|0|||
17135542|NCT03191630|38276699|FG000|Overall Study|Lost to Follow-up|7|||
17135543|NCT03191630|38276700|FG001|Overall Study|Lost to Follow-up|7|||
17135544|NCT03191552|38276711|FG000|Overall Study|Lost to Follow-up|1|||
17135545|NCT03191552|38276712|FG001|Overall Study|Lost to Follow-up|0|||
17135546|NCT03191552|38276713|FG002|Overall Study|Lost to Follow-up|0|||
17135547|NCT03191552|38276711|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
17135548|NCT03191552|38276712|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
16780364|NCT02612727|37719451|FG001|Overall Study|Needed treatment incompatible with PT|1|||
16989911|NCT00817414|38133890|FG002|Overall Study|Withdrawal by Subject|0|||
16989912|NCT00817414|38133891|FG003|Overall Study|Withdrawal by Subject|0|||
16989913|NCT00817414|38133892|FG004|Overall Study|Withdrawal by Subject|0|||
16989914|NCT00817414|38133888|FG000|Overall Study|Lost to Follow-up|0|||
16989915|NCT00817414|38133889|FG001|Overall Study|Lost to Follow-up|0|||
16989916|NCT00817414|38133890|FG002|Overall Study|Lost to Follow-up|1|||
16989917|NCT00817414|38133891|FG003|Overall Study|Lost to Follow-up|1|||
16989918|NCT00817414|38133892|FG004|Overall Study|Lost to Follow-up|1|||
16989919|NCT00817414|38133888|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
16989920|NCT00817414|38133889|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
16989921|NCT00817414|38133890|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
16989922|NCT00817414|38133891|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
16989923|NCT00817414|38133892|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
16989924|NCT00817414|38133888|FG000|Overall Study|Protocol Violation|0|||
16989925|NCT00817414|38133889|FG001|Overall Study|Protocol Violation|0|||
16989926|NCT00817414|38133890|FG002|Overall Study|Protocol Violation|0|||
16989927|NCT00817414|38133891|FG003|Overall Study|Protocol Violation|0|||
16989928|NCT00817414|38133892|FG004|Overall Study|Protocol Violation|1|||
16989929|NCT00769561|38133911|FG000|Overall Study|Withdrawal by Subject|2|||
16989930|NCT00769561|38133912|FG001|Overall Study|Withdrawal by Subject|2|||
16989931|NCT00769561|38133911|FG000|Overall Study|Lost to Follow-up|1|||
16989932|NCT00769561|38133912|FG001|Overall Study|Lost to Follow-up|3|||
16989933|NCT00817336|38133920|FG000|Overall Study|Withdrawal by Subject|1|||
16989934|NCT00817336|38133921|FG001|Overall Study|Withdrawal by Subject|1|||
16989935|NCT00761215|38133929|FG000|Overall Study|Randomized but didn't receive drug|1|||
16989936|NCT00761215|38133930|FG001|Overall Study|Randomized but didn't receive drug|1|||
16989937|NCT00761215|38133931|FG002|Overall Study|Randomized but didn't receive drug|2|||
16989938|NCT00761215|38133929|FG000|Overall Study|Lost to Follow-up|6|||
16989939|NCT00761215|38133930|FG001|Overall Study|Lost to Follow-up|3|||
16989940|NCT00761215|38133931|FG002|Overall Study|Lost to Follow-up|6|||
16989941|NCT00761215|38133929|FG000|Overall Study|Withdrawal by Subject|1|||
16989942|NCT00761215|38133930|FG001|Overall Study|Withdrawal by Subject|0|||
16989943|NCT00761215|38133931|FG002|Overall Study|Withdrawal by Subject|0|||
16989944|NCT00761215|38133929|FG000|Overall Study|Bacteremia|1|||
16989945|NCT00761215|38133930|FG001|Overall Study|Bacteremia|0|||
16989946|NCT00761215|38133931|FG002|Overall Study|Bacteremia|0|||
16989947|NCT00816556|38133945|FG000|Overall Study|Adverse Event|1|||
16989948|NCT00816556|38133946|FG001|Overall Study|Adverse Event|1|||
16989949|NCT00816556|38133947|FG002|Overall Study|Adverse Event|1|||
16989950|NCT00816556|38133945|FG000|Overall Study|Withdrawal by Subject|1|||
16989951|NCT00816556|38133946|FG001|Overall Study|Withdrawal by Subject|1|||
16989952|NCT00816556|38133947|FG002|Overall Study|Withdrawal by Subject|1|||
16989953|NCT00816556|38133945|FG000|Overall Study|Lost to Follow-up|0|||
16989954|NCT00816556|38133946|FG001|Overall Study|Lost to Follow-up|0|||
16989955|NCT00816556|38133947|FG002|Overall Study|Lost to Follow-up|1|||
16989956|NCT00760747|38133957|FG000|Study Period II|Adverse Event|3|||
16989957|NCT00760747|38133958|FG001|Study Period II|Adverse Event|4|||
16989958|NCT00760747|38133957|FG000|Study Period II|Lack of Efficacy|0|||
16989959|NCT00760747|38133958|FG001|Study Period II|Lack of Efficacy|6|||
16989960|NCT00760747|38133957|FG000|Study Period II|Parent/Caregiver Decision|3|||
16989961|NCT00760747|38133958|FG001|Study Period II|Parent/Caregiver Decision|0|||
16989962|NCT00760747|38133957|FG000|Study Period II|Protocol Violation|6|||
16989963|NCT00760747|38133958|FG001|Study Period II|Protocol Violation|3|||
16989964|NCT00760747|38133957|FG000|Study Period II|Withdrawal by Subject|1|||
16989965|NCT00760747|38133958|FG001|Study Period II|Withdrawal by Subject|0|||
16989966|NCT00760747|38133957|FG000|Study Period II|No drug administered|0|||
16989967|NCT00760747|38133958|FG001|Study Period II|No drug administered|1|||
16989968|NCT00760747|38133957|FG000|Study Period III|Adverse Event|1|||
16989969|NCT00760747|38133958|FG001|Study Period III|Adverse Event|0|||
16989970|NCT00760747|38133957|FG000|Study Period III|Lack of Efficacy|1|||
16989971|NCT00760747|38133958|FG001|Study Period III|Lack of Efficacy|0|||
16989972|NCT00760747|38133957|FG000|Study Period III|Parent/Caregiver Decision|0|||
16989973|NCT00760747|38133958|FG001|Study Period III|Parent/Caregiver Decision|1|||
16989974|NCT00760747|38133957|FG000|Study Period III|Protocol Violation|1|||
16989975|NCT00760747|38133958|FG001|Study Period III|Protocol Violation|1|||
16989976|NCT00760747|38133957|FG000|Study Period III|Physician Decision|0|||
16989977|NCT00760747|38133958|FG001|Study Period III|Physician Decision|1|||
16989978|NCT00760669|38133964|FG000|Overall Study|Not assessed for overall improvement|18|||
16989979|NCT00760669|38133964|FG000|Overall Study|Participants missing efficacy assessment|6|||
16989980|NCT00760669|38133964|FG000|Overall Study|Participants with overlapping cases|1|||
16989981|NCT00760669|38133964|FG000|Overall Study|Took drug before entering in contract|5|||
16989982|NCT00769483|38133974|FG000|Overall Study|Withdrawal by Subject|0|||
16989983|NCT00769483|38133975|FG001|Overall Study|Withdrawal by Subject|1|||
16989984|NCT00769483|38133976|FG002|Overall Study|Withdrawal by Subject|0|||
16989985|NCT00769483|38133977|FG003|Overall Study|Withdrawal by Subject|0|||
16989986|NCT00769483|38133978|FG004|Overall Study|Withdrawal by Subject|1|||
16989987|NCT00769483|38133979|FG005|Overall Study|Withdrawal by Subject|0|||
16989988|NCT00760513|38133997|FG000|Overall Study|Withdrawal by Subject|5|||
16989989|NCT00760513|38133998|FG001|Overall Study|Withdrawal by Subject|7|||
16989990|NCT00907296|38134016|FG000|Overall Study|Ineligibility Determined|1|||
16989991|NCT00907296|38134017|FG001|Overall Study|Ineligibility Determined|0|||
16989992|NCT00907296|38134018|FG002|Overall Study|Ineligibility Determined|0|||
16989993|NCT00907296|38134019|FG003|Overall Study|Ineligibility Determined|1|||
16989994|NCT00907296|38134020|FG004|Overall Study|Ineligibility Determined|0|||
16989995|NCT00907296|38134021|FG005|Overall Study|Ineligibility Determined|0|||
16989996|NCT00907296|38134022|FG006|Overall Study|Ineligibility Determined|0|||
16989997|NCT00907296|38134023|FG007|Overall Study|Ineligibility Determined|1|||
16989998|NCT00907296|38134024|FG008|Overall Study|Ineligibility Determined|0|||
16989999|NCT00907296|38134025|FG009|Overall Study|Ineligibility Determined|0|||
16990000|NCT00907296|38134016|FG000|Overall Study|Protocol Deviation|0|||
16990001|NCT00907296|38134017|FG001|Overall Study|Protocol Deviation|1|||
16990002|NCT00907296|38134018|FG002|Overall Study|Protocol Deviation|0|||
16990003|NCT00907296|38134019|FG003|Overall Study|Protocol Deviation|0|||
16990004|NCT00907296|38134020|FG004|Overall Study|Protocol Deviation|0|||
16990005|NCT00907296|38134021|FG005|Overall Study|Protocol Deviation|0|||
16990006|NCT00907296|38134022|FG006|Overall Study|Protocol Deviation|0|||
16990007|NCT00907296|38134023|FG007|Overall Study|Protocol Deviation|0|||
16990008|NCT00907296|38134024|FG008|Overall Study|Protocol Deviation|0|||
16990009|NCT00907296|38134025|FG009|Overall Study|Protocol Deviation|0|||
16990010|NCT00907296|38134016|FG000|Overall Study|Noncompliance|1|||
16990011|NCT00907296|38134017|FG001|Overall Study|Noncompliance|1|||
16990012|NCT00907296|38134018|FG002|Overall Study|Noncompliance|1|||
16990013|NCT00907296|38134019|FG003|Overall Study|Noncompliance|0|||
16990014|NCT00907296|38134020|FG004|Overall Study|Noncompliance|0|||
16990015|NCT00907296|38134021|FG005|Overall Study|Noncompliance|1|||
16990016|NCT00907296|38134022|FG006|Overall Study|Noncompliance|0|||
16990017|NCT00907296|38134023|FG007|Overall Study|Noncompliance|2|||
16990018|NCT00907296|38134024|FG008|Overall Study|Noncompliance|0|||
16990019|NCT00907296|38134025|FG009|Overall Study|Noncompliance|0|||
16990020|NCT00907296|38134016|FG000|Overall Study|Adverse Event|2|||
16990021|NCT00907296|38134017|FG001|Overall Study|Adverse Event|0|||
16990022|NCT00907296|38134018|FG002|Overall Study|Adverse Event|0|||
16990023|NCT00907296|38134019|FG003|Overall Study|Adverse Event|0|||
16990024|NCT00907296|38134020|FG004|Overall Study|Adverse Event|0|||
16990025|NCT00907296|38134021|FG005|Overall Study|Adverse Event|0|||
16990026|NCT00907296|38134022|FG006|Overall Study|Adverse Event|1|||
16990027|NCT00907296|38134023|FG007|Overall Study|Adverse Event|0|||
16990028|NCT00907296|38134024|FG008|Overall Study|Adverse Event|0|||
16990029|NCT00907296|38134025|FG009|Overall Study|Adverse Event|1|||
16990030|NCT00907296|38134016|FG000|Overall Study|Withdrawal by Subject|7|||
16990031|NCT00907296|38134017|FG001|Overall Study|Withdrawal by Subject|2|||
16990032|NCT00907296|38134018|FG002|Overall Study|Withdrawal by Subject|1|||
16990033|NCT00907296|38134019|FG003|Overall Study|Withdrawal by Subject|1|||
16990034|NCT00907296|38134020|FG004|Overall Study|Withdrawal by Subject|1|||
16990035|NCT00907296|38134021|FG005|Overall Study|Withdrawal by Subject|5|||
16990036|NCT00907296|38134022|FG006|Overall Study|Withdrawal by Subject|3|||
16990037|NCT00907296|38134023|FG007|Overall Study|Withdrawal by Subject|2|||
16990038|NCT00907296|38134024|FG008|Overall Study|Withdrawal by Subject|4|||
16990039|NCT00907296|38134025|FG009|Overall Study|Withdrawal by Subject|2|||
16780365|NCT02612727|37719450|FG000|Overall Study|Direct hyperbilirubinemia|0|||
16990040|NCT00907296|38134016|FG000|Overall Study|Lost to Follow-up|9|||
16990041|NCT00907296|38134017|FG001|Overall Study|Lost to Follow-up|1|||
16990042|NCT00907296|38134018|FG002|Overall Study|Lost to Follow-up|0|||
16990043|NCT00907296|38134019|FG003|Overall Study|Lost to Follow-up|2|||
16990044|NCT00907296|38134020|FG004|Overall Study|Lost to Follow-up|0|||
16990045|NCT00907296|38134021|FG005|Overall Study|Lost to Follow-up|3|||
16990046|NCT00907296|38134022|FG006|Overall Study|Lost to Follow-up|2|||
16990047|NCT00907296|38134023|FG007|Overall Study|Lost to Follow-up|2|||
16990048|NCT00907296|38134024|FG008|Overall Study|Lost to Follow-up|0|||
16990049|NCT00907296|38134025|FG009|Overall Study|Lost to Follow-up|4|||
16990050|NCT00816400|38134056|FG000|Overall Study|Death|2|||
16990051|NCT00816400|38134057|FG001|Overall Study|Death|3|||
16990052|NCT00816400|38134058|FG002|Overall Study|Death|3|||
16990053|NCT00816400|38134059|FG003|Overall Study|Death|3|||
16990054|NCT00816400|38134060|FG004|Overall Study|Death|2|||
16990055|NCT00816400|38134061|FG005|Overall Study|Death|3|||
16990056|NCT00816400|38134062|FG006|Overall Study|Death|2|||
16990057|NCT00816400|38134063|FG007|Overall Study|Death|5|||
16990058|NCT00816400|38134064|FG008|Overall Study|Death|6|||
17135549|NCT03191552|38276713|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
17135550|NCT03191396|38276727|FG000|Overall Study|Lost to Follow-up|0|||
17135551|NCT03191396|38276728|FG001|Overall Study|Lost to Follow-up|3|||
17135552|NCT03191396|38276727|FG000|Overall Study|Withdrawal by Subject|3|||
16990059|NCT00816400|38134056|FG000|Overall Study|In hospice care at the end of the study|0|||
16990060|NCT00816400|38134057|FG001|Overall Study|In hospice care at the end of the study|0|||
16990061|NCT00816400|38134058|FG002|Overall Study|In hospice care at the end of the study|2|||
16990062|NCT00816400|38134059|FG003|Overall Study|In hospice care at the end of the study|0|||
16990063|NCT00816400|38134060|FG004|Overall Study|In hospice care at the end of the study|0|||
16990064|NCT00816400|38134061|FG005|Overall Study|In hospice care at the end of the study|0|||
16990065|NCT00816400|38134062|FG006|Overall Study|In hospice care at the end of the study|0|||
16990066|NCT00816400|38134063|FG007|Overall Study|In hospice care at the end of the study|0|||
16990067|NCT00816400|38134064|FG008|Overall Study|In hospice care at the end of the study|0|||
16990068|NCT00906204|38134087|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
16990069|NCT00906204|38134088|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
16990070|NCT00906204|38134087|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
16990071|NCT00906204|38134088|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
16990072|NCT00906204|38134087|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
16990073|NCT00906204|38134088|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
16990074|NCT00906204|38134087|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
16990075|NCT00906204|38134088|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
16990076|NCT00906204|38134087|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
16990077|NCT00906204|38134088|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
16990078|NCT00905424|38134129|FG000|Overall Study|Lost to Follow-up|3|||
16990079|NCT00905424|38134130|FG001|Overall Study|Lost to Follow-up|3|||
16990080|NCT00905424|38134129|FG000|Overall Study|Withdrawal by Subject|1|||
16990081|NCT00905424|38134130|FG001|Overall Study|Withdrawal by Subject|2|||
16990082|NCT00905424|38134129|FG000|Overall Study|Adverse Event|4|||
16990083|NCT00905424|38134130|FG001|Overall Study|Adverse Event|2|||
16990084|NCT00905424|38134129|FG000|Overall Study|Non-compliance with study medication|2|||
16990085|NCT00905424|38134130|FG001|Overall Study|Non-compliance with study medication|0|||
16990086|NCT00905424|38134129|FG000|Overall Study|Sponsor decision|1|||
16990087|NCT00905424|38134130|FG001|Overall Study|Sponsor decision|0|||
16990088|NCT00905424|38134129|FG000|Overall Study|Positive urine drug screen|0|||
16990089|NCT00905424|38134130|FG001|Overall Study|Positive urine drug screen|1|||
16990090|NCT00905424|38134129|FG000|Overall Study|Non-adherence to visit schedule|0|||
16990091|NCT00905424|38134130|FG001|Overall Study|Non-adherence to visit schedule|1|||
16990092|NCT00816166|38134140|FG000|Overall Study|Lost to Follow-up|6|||
16990093|NCT00816166|38134141|FG001|Overall Study|Lost to Follow-up|10|||
16990094|NCT00816166|38134140|FG000|Overall Study|Death|4|||
16990095|NCT00816166|38134141|FG001|Overall Study|Death|2|||
16990096|NCT00815308|38134151|FG000|Overall Study|Adverse Event|4|||
16990097|NCT00815308|38134151|FG000|Overall Study|Withdrawal by Subject|0|||
16990098|NCT00815308|38134151|FG000|Overall Study|Protocol Violation|6|||
16990099|NCT01039376|38134157|FG000|Overall Study|Lost to Follow-up|5|||
16990100|NCT01039376|38134158|FG001|Overall Study|Lost to Follow-up|12|||
16990101|NCT01039376|38134157|FG000|Overall Study|Physician Decision|15|||
16990102|NCT01039376|38134158|FG001|Overall Study|Physician Decision|10|||
16990103|NCT01039376|38134157|FG000|Overall Study|Withdrawal by Subject|20|||
16990104|NCT01039376|38134158|FG001|Overall Study|Withdrawal by Subject|32|||
16990105|NCT01039376|38134157|FG000|Overall Study|Study terminated by Sponsor|90|||
16990106|NCT01039376|38134158|FG001|Overall Study|Study terminated by Sponsor|72|||
16990107|NCT00905034|38134165|FG000|Overall Study|Withdrawal by Subject|1|||
16990108|NCT00828568|38134172|FG000|Randomized|Withdrawal by Subject|1|||
16990109|NCT00828568|38134173|FG001|Randomized|Withdrawal by Subject|0|||
16990110|NCT00828568|38134174|FG002|Randomized|Withdrawal by Subject|2|||
17135553|NCT03191396|38276728|FG001|Overall Study|Withdrawal by Subject|2|||
16990111|NCT00828568|38134172|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
16990112|NCT00828568|38134173|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
16990113|NCT00828568|38134174|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
16990114|NCT00828568|38134172|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
16990115|NCT00828568|38134173|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
16990116|NCT00828568|38134174|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
16990117|NCT00828568|38134172|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
16990118|NCT00828568|38134173|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
16990119|NCT00828568|38134174|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
17135554|NCT00007345|38276736|FG000|Overall Study|Refused further treatment|0|||
17135555|NCT00007345|38276737|FG001|Overall Study|Refused further treatment|7|||
17135556|NCT00007345|38276736|FG000|Overall Study|Switched to alternative treatment|0|||
17135557|NCT00007345|38276737|FG001|Overall Study|Switched to alternative treatment|3|||
17135558|NCT00007345|38276736|FG000|Overall Study|Intercurrent illness|1|||
17135559|NCT00007345|38276737|FG001|Overall Study|Intercurrent illness|0|||
16990120|NCT00828568|38134172|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
16990121|NCT00828568|38134173|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
16990122|NCT00828568|38134174|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
16990123|NCT01038752|38134185|FG000|Overall Study|Tumor Progression|2|||
16990124|NCT01038752|38134186|FG001|Overall Study|Tumor Progression|2|||
16990125|NCT01038752|38134185|FG000|Overall Study|Lost to Follow-up|3|||
16990126|NCT01038752|38134186|FG001|Overall Study|Lost to Follow-up|3|||
16990127|NCT00903630|38134195|FG000|Phase 2|Adverse Event|0|||
16990128|NCT00903630|38134196|FG001|Phase 2|Adverse Event|0|||
16990129|NCT00903630|38134197|FG002|Phase 2|Adverse Event|1|||
17135560|NCT00007345|38276736|FG000|Overall Study|Death on study|1|||
17135561|NCT00007345|38276737|FG001|Overall Study|Death on study|1|||
17135562|NCT03405662|38276745|FG000|Overall Study|COVID-19 restriction|1|||
17135563|NCT03405662|38276746|FG001|Overall Study|COVID-19 restriction|0|||
17135564|NCT03405662|38276745|FG000|Overall Study|unblinding|0|||
16990130|NCT01037114|38134207|FG000|Year 20|Others|1|||
16990131|NCT00840970|38134211|FG000|Overall Study|Adverse Event|0|||
16990132|NCT00840970|38134212|FG001|Overall Study|Adverse Event|0|||
16990133|NCT00840970|38134213|FG002|Overall Study|Adverse Event|1|||
16990134|NCT01054820|38134223|FG000|Overall Study|Withdrawal by Subject|2|||
16990135|NCT00840658|38134231|FG000|Overall Study|Death|2|||
16990136|NCT00840658|38134232|FG001|Overall Study|Death|2|||
16990137|NCT00840658|38134233|FG002|Overall Study|Death|3|||
16990138|NCT00840658|38134234|FG003|Overall Study|Death|3|||
16990139|NCT00840658|38134231|FG000|Overall Study|Lost to Follow-up|3|||
16990140|NCT00840658|38134232|FG001|Overall Study|Lost to Follow-up|1|||
16990141|NCT00840658|38134233|FG002|Overall Study|Lost to Follow-up|2|||
16990142|NCT00840658|38134234|FG003|Overall Study|Lost to Follow-up|1|||
16990143|NCT01036724|38134250|FG000|Overall Study|Adverse Event|1|||
16990144|NCT01036724|38134251|FG001|Overall Study|Adverse Event|2|||
16990145|NCT01036724|38134250|FG000|Overall Study|Lack of Efficacy|1|||
16990146|NCT01036724|38134251|FG001|Overall Study|Lack of Efficacy|1|||
16990147|NCT01036724|38134250|FG000|Overall Study|Protocol Violation|4|||
16990148|NCT01036724|38134251|FG001|Overall Study|Protocol Violation|5|||
16990149|NCT01052714|38134259|FG000|Overall Study|Adverse Event|6|||
16990150|NCT01052714|38134260|FG001|Overall Study|Adverse Event|3|||
16990151|NCT01052714|38134261|FG002|Overall Study|Adverse Event|0|||
16990152|NCT01052714|38134259|FG000|Overall Study|Death|1|||
16990153|NCT01052714|38134260|FG001|Overall Study|Death|2|||
16990154|NCT01052714|38134261|FG002|Overall Study|Death|0|||
16990155|NCT01052714|38134259|FG000|Overall Study|Lost to Follow-up|2|||
16990156|NCT01052714|38134260|FG001|Overall Study|Lost to Follow-up|3|||
16990157|NCT01052714|38134261|FG002|Overall Study|Lost to Follow-up|0|||
16990158|NCT01052714|38134259|FG000|Overall Study|Physician Decision|9|||
16990159|NCT01052714|38134260|FG001|Overall Study|Physician Decision|9|||
16990160|NCT01052714|38134261|FG002|Overall Study|Physician Decision|1|||
16990161|NCT01052714|38134259|FG000|Overall Study|Withdrawal by Subject|7|||
16990162|NCT01052714|38134260|FG001|Overall Study|Withdrawal by Subject|12|||
16990163|NCT01052714|38134261|FG002|Overall Study|Withdrawal by Subject|1|||
16990164|NCT01052480|38134278|FG000|Overall Study|Lost to Follow-up|3|||
16990165|NCT01052480|38134279|FG001|Overall Study|Lost to Follow-up|3|||
17135565|NCT03405662|38276746|FG001|Overall Study|unblinding|1|||
17135566|NCT03405662|38276745|FG000|Overall Study|placement in memory care facility|0|||
17135567|NCT03405662|38276746|FG001|Overall Study|placement in memory care facility|2|||
17135568|NCT00031447|38276754|FG000|Overall Study|Lost to Follow-up|0|||
16780366|NCT02612727|37719451|FG001|Overall Study|Direct hyperbilirubinemia|2|||
17135569|NCT00031447|38276755|FG001|Overall Study|Lost to Follow-up|1|||
17135570|NCT00031447|38276754|FG000|Overall Study|Non-compliant|1|||
17135571|NCT00031447|38276755|FG001|Overall Study|Non-compliant|1|||
17135572|NCT00031447|38276754|FG000|Overall Study|Re-activation of Disease|2|||
17135573|NCT00031447|38276755|FG001|Overall Study|Re-activation of Disease|1|||
16990166|NCT01052480|38134278|FG000|Overall Study|Protocol Violation|1|||
17135574|NCT00031447|38276754|FG000|Overall Study|Disruption of blinded study drug supply|7|||
17135575|NCT00031447|38276755|FG001|Overall Study|Disruption of blinded study drug supply|4|||
17135576|NCT00006721|38276764|FG000|Overall Study|Adverse Event|0|||
17135577|NCT00006721|38276765|FG001|Overall Study|Adverse Event|4|||
17135578|NCT00006721|38276766|FG002|Overall Study|Adverse Event|4|||
17135579|NCT00006721|38276764|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
17135580|NCT00006721|38276765|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
17135581|NCT00006721|38276766|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
17135582|NCT00006721|38276764|FG000|Overall Study|Progression/Relapse|0|||
17135583|NCT00006721|38276765|FG001|Overall Study|Progression/Relapse|1|||
17135584|NCT00006721|38276766|FG002|Overall Study|Progression/Relapse|2|||
17135585|NCT00006721|38276764|FG000|Overall Study|Death|0|||
17135586|NCT00006721|38276765|FG001|Overall Study|Death|1|||
17135587|NCT00006721|38276766|FG002|Overall Study|Death|2|||
17135588|NCT00006721|38276764|FG000|Overall Study|Other - Not Protocol Specified|0|||
17135589|NCT00006721|38276765|FG001|Overall Study|Other - Not Protocol Specified|7|||
16990167|NCT01052480|38134279|FG001|Overall Study|Protocol Violation|0|||
16990168|NCT01052480|38134278|FG000|Overall Study|Withdrawal by Subject|3|||
16990169|NCT01052480|38134279|FG001|Overall Study|Withdrawal by Subject|7|||
16990170|NCT01052480|38134278|FG000|Overall Study|Physician Decision|0|||
16990171|NCT01052480|38134279|FG001|Overall Study|Physician Decision|2|||
16990172|NCT01052480|38134278|FG000|Overall Study|Death|1|||
16990173|NCT01052480|38134279|FG001|Overall Study|Death|5|||
16990174|NCT00904722|38134285|FG000|Overall Study|Physician Decision|1|||
16990175|NCT01029782|38134291|FG000|Overall Study|Lost to Follow-up|2|||
16990176|NCT01029782|38134292|FG001|Overall Study|Lost to Follow-up|2|||
16990177|NCT01029782|38134291|FG000|Overall Study|Diagnosis changed|1|||
16990178|NCT01029782|38134292|FG001|Overall Study|Diagnosis changed|1|||
16990179|NCT01029782|38134291|FG000|Overall Study|Adverse Event|0|||
16990180|NCT01029782|38134292|FG001|Overall Study|Adverse Event|1|||
16990181|NCT01029782|38134291|FG000|Overall Study|Physician Decision|0|||
16990182|NCT01029782|38134292|FG001|Overall Study|Physician Decision|1|||
16990183|NCT01029782|38134291|FG000|Overall Study|Protocol Violation|0|||
16990184|NCT01029782|38134292|FG001|Overall Study|Protocol Violation|2|||
16990185|NCT01029782|38134291|FG000|Overall Study|Withdrawal by Subject|0|||
16990186|NCT01029782|38134292|FG001|Overall Study|Withdrawal by Subject|1|||
16990187|NCT01029704|38134307|FG000|Overall Study|Adverse Event|0|||
16990188|NCT01029704|38134308|FG001|Overall Study|Adverse Event|0|||
16990189|NCT01029704|38134309|FG002|Overall Study|Adverse Event|0|||
16990190|NCT01029704|38134310|FG003|Overall Study|Adverse Event|0|||
16990191|NCT01029704|38134311|FG004|Overall Study|Adverse Event|0|||
16990192|NCT01029704|38134312|FG005|Overall Study|Adverse Event|0|||
16990193|NCT01029704|38134313|FG006|Overall Study|Adverse Event|1|||
16990194|NCT01029704|38134314|FG007|Overall Study|Adverse Event|1|||
16990195|NCT01029704|38134315|FG008|Overall Study|Adverse Event|0|||
16990196|NCT01029704|38134307|FG000|Overall Study|Withdrawal by Subject|0|||
16990197|NCT01029704|38134308|FG001|Overall Study|Withdrawal by Subject|0|||
16990198|NCT01029704|38134309|FG002|Overall Study|Withdrawal by Subject|0|||
16990199|NCT01029704|38134310|FG003|Overall Study|Withdrawal by Subject|0|||
16990200|NCT01029704|38134311|FG004|Overall Study|Withdrawal by Subject|2|||
16990201|NCT01029704|38134312|FG005|Overall Study|Withdrawal by Subject|1|||
16990202|NCT01029704|38134313|FG006|Overall Study|Withdrawal by Subject|1|||
16990203|NCT01029704|38134314|FG007|Overall Study|Withdrawal by Subject|1|||
16990204|NCT01029704|38134315|FG008|Overall Study|Withdrawal by Subject|0|||
16990205|NCT01029704|38134307|FG000|Overall Study|Lost to Follow-up|0|||
16990206|NCT01029704|38134308|FG001|Overall Study|Lost to Follow-up|0|||
16990207|NCT01029704|38134309|FG002|Overall Study|Lost to Follow-up|0|||
16990208|NCT01029704|38134310|FG003|Overall Study|Lost to Follow-up|0|||
16990209|NCT01029704|38134311|FG004|Overall Study|Lost to Follow-up|0|||
16990210|NCT01029704|38134312|FG005|Overall Study|Lost to Follow-up|0|||
16990211|NCT01029704|38134313|FG006|Overall Study|Lost to Follow-up|1|||
16990212|NCT01029704|38134314|FG007|Overall Study|Lost to Follow-up|1|||
16990213|NCT01029704|38134315|FG008|Overall Study|Lost to Follow-up|1|||
16990214|NCT01029704|38134307|FG000|Overall Study|Lack of Efficacy|0|||
16990215|NCT01029704|38134308|FG001|Overall Study|Lack of Efficacy|0|||
16990216|NCT01029704|38134309|FG002|Overall Study|Lack of Efficacy|0|||
16990217|NCT01029704|38134310|FG003|Overall Study|Lack of Efficacy|0|||
16990218|NCT01029704|38134311|FG004|Overall Study|Lack of Efficacy|2|||
16990219|NCT01029704|38134312|FG005|Overall Study|Lack of Efficacy|3|||
16990220|NCT01029704|38134313|FG006|Overall Study|Lack of Efficacy|1|||
16990221|NCT01029704|38134314|FG007|Overall Study|Lack of Efficacy|2|||
16990222|NCT01029704|38134315|FG008|Overall Study|Lack of Efficacy|0|||
16990223|NCT01029704|38134307|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
16990224|NCT01029704|38134308|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
17135590|NCT00006721|38276766|FG002|Overall Study|Other - Not Protocol Specified|7|||
17135591|NCT00006721|38276764|FG000|Overall Study|Ineligible|2|||
16990225|NCT01029704|38134309|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
16990226|NCT01029704|38134310|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
16990227|NCT01029704|38134311|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
16990228|NCT01029704|38134312|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
16990229|NCT01029704|38134313|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
16990230|NCT01029704|38134314|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
17028581|NCT00799409|38172928|FG000|Overall Study|Withdrawal by Subject|1|||
17028582|NCT00799409|38172929|FG001|Overall Study|Withdrawal by Subject|0|||
17028583|NCT00799409|38172930|FG002|Overall Study|Withdrawal by Subject|0|||
17028584|NCT00799409|38172928|FG000|Overall Study|Lost to Follow-up|1|||
17028585|NCT00799409|38172929|FG001|Overall Study|Lost to Follow-up|0|||
17028586|NCT00799409|38172930|FG002|Overall Study|Lost to Follow-up|0|||
17028587|NCT00799409|38172928|FG000|Overall Study|Optimal Dose Not Achieved|2|||
17028588|NCT00799409|38172929|FG001|Overall Study|Optimal Dose Not Achieved|0|||
17028589|NCT00799409|38172930|FG002|Overall Study|Optimal Dose Not Achieved|0|||
17028590|NCT00799409|38172928|FG000|Overall Study|Failure to follow study protocol)|1|||
17028591|NCT00799409|38172929|FG001|Overall Study|Failure to follow study protocol)|0|||
17028592|NCT00799409|38172930|FG002|Overall Study|Failure to follow study protocol)|0|||
17028593|NCT00799409|38172928|FG000|Overall Study|Did not attend lab school day 1|1|||
17028594|NCT00799409|38172929|FG001|Overall Study|Did not attend lab school day 1|0|||
17028595|NCT00799409|38172930|FG002|Overall Study|Did not attend lab school day 1|0|||
17028596|NCT00799409|38172928|FG000|Overall Study|medication compliance|1|||
17028597|NCT00799409|38172929|FG001|Overall Study|medication compliance|0|||
17028598|NCT00799409|38172930|FG002|Overall Study|medication compliance|0|||
17028599|NCT00782210|38172941|FG000|Overall Study|Adverse Event|21|||
17028600|NCT00782210|38172942|FG001|Overall Study|Adverse Event|17|||
17028601|NCT00782210|38172943|FG002|Overall Study|Adverse Event|16|||
17028602|NCT00782210|38172941|FG000|Overall Study|Lost to Follow-up|2|||
17028603|NCT00782210|38172942|FG001|Overall Study|Lost to Follow-up|1|||
17028604|NCT00782210|38172943|FG002|Overall Study|Lost to Follow-up|2|||
17028605|NCT00782210|38172941|FG000|Overall Study|Withdrawal by Subject|11|||
17028606|NCT00782210|38172942|FG001|Overall Study|Withdrawal by Subject|8|||
17028607|NCT00782210|38172943|FG002|Overall Study|Withdrawal by Subject|11|||
17028608|NCT00782210|38172941|FG000|Overall Study|Non compliance with protocol|0|||
17028609|NCT00782210|38172942|FG001|Overall Study|Non compliance with protocol|3|||
17028610|NCT00782210|38172943|FG002|Overall Study|Non compliance with protocol|2|||
17028611|NCT00782210|38172941|FG000|Overall Study|Lack of Efficacy|13|||
17028612|NCT00782210|38172942|FG001|Overall Study|Lack of Efficacy|4|||
17028613|NCT00782210|38172943|FG002|Overall Study|Lack of Efficacy|1|||
17028614|NCT00782210|38172941|FG000|Overall Study|Other reason not described above|3|||
17028615|NCT00782210|38172942|FG001|Overall Study|Other reason not described above|2|||
17028616|NCT00782210|38172943|FG002|Overall Study|Other reason not described above|3|||
17135592|NCT00006721|38276765|FG001|Overall Study|Ineligible|12|||
17135593|NCT00006721|38276766|FG002|Overall Study|Ineligible|10|||
16990231|NCT01029704|38134315|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
16990232|NCT00840034|38134337|FG000|Acute Treatment Phase|Adverse Event|6|||
16990233|NCT00840034|38134338|FG001|Acute Treatment Phase|Adverse Event|8|||
16990234|NCT00840034|38134337|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
16990235|NCT00840034|38134338|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
16990236|NCT00840034|38134337|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
16990237|NCT00840034|38134338|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
16990238|NCT00840034|38134337|FG000|Acute Treatment Phase|Physician Decision|0|||
17028617|NCT01558115|38172960|FG000|Overall Study|Withdrawal by Subject|3|||
17135594|NCT00006721|38276764|FG000|Overall Study|Eligible but no Treatment Received|1|||
17135595|NCT00006721|38276765|FG001|Overall Study|Eligible but no Treatment Received|0|||
17028618|NCT01558115|38172960|FG000|Overall Study|Study closed due to poor enrollment|4|||
17028619|NCT00764660|38172983|FG000|Overall Study|Adverse Event|6|||
17028620|NCT00764660|38172984|FG001|Overall Study|Adverse Event|3|||
17028621|NCT00764660|38172983|FG000|Overall Study|Lost to Follow-up|3|||
17028622|NCT00764660|38172984|FG001|Overall Study|Lost to Follow-up|4|||
17028623|NCT00764660|38172983|FG000|Overall Study|Withdrawal by Subject|7|||
17028624|NCT00764660|38172984|FG001|Overall Study|Withdrawal by Subject|3|||
17028625|NCT00764660|38172983|FG000|Overall Study|Noncompliance With Protocol|5|||
17028626|NCT00764660|38172984|FG001|Overall Study|Noncompliance With Protocol|1|||
17028627|NCT00764660|38172983|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
17028628|NCT00764660|38172984|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
17028629|NCT00584415|38172990|FG000|Overall Study|Adverse Event|7|||
17028630|NCT00764504|38172998|FG000|Overall Study|Death|12|||
17028631|NCT00764504|38172999|FG001|Overall Study|Death|6|||
17135596|NCT00006721|38276766|FG002|Overall Study|Eligible but no Treatment Received|0|||
17135597|NCT00006409|38276782|FG000|Baseline|Protocol Violation|48|||
17135598|NCT00006409|38276783|FG001|Baseline|Protocol Violation|70|||
17135599|NCT00006409|38276784|FG002|Baseline|Protocol Violation|0|||
17135600|NCT00006409|38276785|FG003|Baseline|Protocol Violation|0|||
17135601|NCT00006409|38276786|FG004|Baseline|Protocol Violation|0|||
16990239|NCT00840034|38134338|FG001|Acute Treatment Phase|Physician Decision|1|||
16990240|NCT00840034|38134337|FG000|Acute Treatment Phase|Protocol Violation|2|||
16990241|NCT00840034|38134338|FG001|Acute Treatment Phase|Protocol Violation|4|||
16990242|NCT00840034|38134337|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
16990243|NCT00840034|38134338|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
16990244|NCT00840034|38134337|FG000|Taper Phase|Adverse Event|1|||
16990245|NCT00840034|38134338|FG001|Taper Phase|Adverse Event|0|||
16990246|NCT00840034|38134337|FG000|Taper Phase|Lost to Follow-up|1|||
16990247|NCT00840034|38134338|FG001|Taper Phase|Lost to Follow-up|1|||
16990248|NCT00840034|38134337|FG000|Taper Phase|Withdrawal by Subject|1|||
16990249|NCT00840034|38134338|FG001|Taper Phase|Withdrawal by Subject|1|||
16990250|NCT00813904|38134346|FG000|Overall Study|Death|1|||
16990251|NCT00839956|38134350|FG000|Overall Study|Adverse Event|2|||
16990252|NCT00839956|38134350|FG000|Overall Study|Lack of Efficacy|6|||
16990253|NCT00839956|38134350|FG000|Overall Study|Physician Decision|1|||
16990254|NCT00839956|38134350|FG000|Overall Study|Withdrawal by Subject|3|||
16990255|NCT00839800|38134356|FG000|Overall Study|Adverse Event|8|||
16990256|NCT00839800|38134357|FG001|Overall Study|Adverse Event|12|||
16990257|NCT00839800|38134356|FG000|Overall Study|Lost to Follow-up|31|||
16990258|NCT00839800|38134357|FG001|Overall Study|Lost to Follow-up|26|||
16990259|NCT00839800|38134356|FG000|Overall Study|Withdrawal by Subject|28|||
16990260|NCT00839800|38134357|FG001|Overall Study|Withdrawal by Subject|34|||
16990261|NCT00839800|38134356|FG000|Overall Study|Incorrect Enrolment|3|||
16990262|NCT00839800|38134357|FG001|Overall Study|Incorrect Enrolment|3|||
16990263|NCT00839800|38134356|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
16990264|NCT00839800|38134357|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
16990265|NCT00839800|38134356|FG000|Overall Study|Safety Reasons|2|||
16990266|NCT00839800|38134357|FG001|Overall Study|Safety Reasons|1|||
16990267|NCT00839800|38134356|FG000|Overall Study|Other|8|||
16990268|NCT00839800|38134357|FG001|Overall Study|Other|14|||
16990269|NCT00839800|38134356|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
16990270|NCT00839800|38134357|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
16990271|NCT00753415|38134391|FG000|Part A|Disease progression|1|||
16990272|NCT00753415|38134392|FG001|Part A|Disease progression|0|||
17135602|NCT00006409|38276787|FG005|Baseline|Protocol Violation|0|||
16990273|NCT00753415|38134393|FG002|Part A|Disease progression|1|||
16990274|NCT00753415|38134394|FG003|Part A|Disease progression|2|||
16990275|NCT00753415|38134395|FG004|Part A|Disease progression|0|||
17135603|NCT00006409|38276782|FG000|Post-2 Year Intervention|Protocol Violation|0|||
17135604|NCT00006409|38276783|FG001|Post-2 Year Intervention|Protocol Violation|0|||
17135605|NCT00006409|38276784|FG002|Post-2 Year Intervention|Protocol Violation|251|||
17135606|NCT00006409|38276785|FG003|Post-2 Year Intervention|Protocol Violation|168|||
17135607|NCT00006409|38276786|FG004|Post-2 Year Intervention|Protocol Violation|0|||
17135608|NCT00006409|38276787|FG005|Post-2 Year Intervention|Protocol Violation|0|||
17135609|NCT00006409|38276782|FG000|Post-3 Year Intervention|Protocol Violation|0|||
17135610|NCT00006409|38276783|FG001|Post-3 Year Intervention|Protocol Violation|0|||
17135611|NCT00006409|38276784|FG002|Post-3 Year Intervention|Protocol Violation|0|||
17135612|NCT00006409|38276785|FG003|Post-3 Year Intervention|Protocol Violation|0|||
17135613|NCT00006409|38276786|FG004|Post-3 Year Intervention|Protocol Violation|62|||
17135614|NCT00006409|38276787|FG005|Post-3 Year Intervention|Protocol Violation|62|||
17135615|NCT00006289|38276803|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
17135616|NCT00006289|38276804|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
17135617|NCT00006289|38276803|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
17135618|NCT00006289|38276804|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
17135619|NCT00005947|38276822|FG000|Overall Study|Death|54|||
17135620|NCT00005947|38276823|FG001|Overall Study|Death|40|||
17135621|NCT00005947|38276822|FG000|Overall Study|Patient Refused to Continue|2|||
17135622|NCT00005947|38276823|FG001|Overall Study|Patient Refused to Continue|1|||
17135623|NCT00005947|38276822|FG000|Overall Study|Site Closure|1|||
17135624|NCT00005947|38276823|FG001|Overall Study|Site Closure|0|||
17135625|NCT00005047|38276835|FG000|Overall Study|Withdrawal by Subject|12|||
17135626|NCT00005047|38276836|FG001|Overall Study|Withdrawal by Subject|0|||
17135627|NCT00005047|38276837|FG002|Overall Study|Withdrawal by Subject|0|||
17135628|NCT00005047|38276838|FG003|Overall Study|Withdrawal by Subject|0|||
17135629|NCT00005047|38276835|FG000|Overall Study|Adverse Event|5|||
17135630|NCT00005047|38276836|FG001|Overall Study|Adverse Event|0|||
17135631|NCT00005047|38276837|FG002|Overall Study|Adverse Event|0|||
17135632|NCT00005047|38276838|FG003|Overall Study|Adverse Event|0|||
17135633|NCT00005047|38276835|FG000|Overall Study|Lost to Follow-up|1|||
17135634|NCT00005047|38276836|FG001|Overall Study|Lost to Follow-up|0|||
17135635|NCT00005047|38276837|FG002|Overall Study|Lost to Follow-up|0|||
17135636|NCT00005047|38276838|FG003|Overall Study|Lost to Follow-up|0|||
17135637|NCT00005047|38276835|FG000|Overall Study|Lack of Efficacy|1|||
16990276|NCT00753415|38134396|FG005|Part A|Disease progression|0|||
16990277|NCT00753415|38134397|FG006|Part A|Disease progression|0|||
17135638|NCT00005047|38276836|FG001|Overall Study|Lack of Efficacy|0|||
17135639|NCT00005047|38276837|FG002|Overall Study|Lack of Efficacy|0|||
17135640|NCT00005047|38276838|FG003|Overall Study|Lack of Efficacy|0|||
17135641|NCT00003907|38276850|FG000|Overall Study|Adverse Event|2|||
16990278|NCT00753415|38134398|FG007|Part A|Disease progression|0|||
16990279|NCT00753415|38134399|FG008|Part A|Disease progression|0|||
16990280|NCT00753415|38134400|FG009|Part A|Disease progression|0|||
16990281|NCT00753415|38134391|FG000|Part A|Withdrawal by Subject|0|||
16990282|NCT00753415|38134392|FG001|Part A|Withdrawal by Subject|0|||
16990283|NCT00753415|38134393|FG002|Part A|Withdrawal by Subject|1|||
16990284|NCT00753415|38134394|FG003|Part A|Withdrawal by Subject|0|||
16990285|NCT00753415|38134395|FG004|Part A|Withdrawal by Subject|0|||
16990286|NCT00753415|38134396|FG005|Part A|Withdrawal by Subject|0|||
16990287|NCT00753415|38134397|FG006|Part A|Withdrawal by Subject|0|||
16990288|NCT00753415|38134398|FG007|Part A|Withdrawal by Subject|0|||
16990289|NCT00753415|38134399|FG008|Part A|Withdrawal by Subject|0|||
16990290|NCT00753415|38134400|FG009|Part A|Withdrawal by Subject|0|||
16990291|NCT00753415|38134391|FG000|Part B|Lost to Follow-up|0|||
16990292|NCT00753415|38134392|FG001|Part B|Lost to Follow-up|0|||
16990293|NCT00753415|38134393|FG002|Part B|Lost to Follow-up|0|||
16990294|NCT00753415|38134394|FG003|Part B|Lost to Follow-up|0|||
16990295|NCT00753415|38134395|FG004|Part B|Lost to Follow-up|0|||
16990296|NCT00753415|38134396|FG005|Part B|Lost to Follow-up|0|||
16990297|NCT00753415|38134397|FG006|Part B|Lost to Follow-up|0|||
17135642|NCT00003907|38276851|FG001|Overall Study|Adverse Event|11|||
17135643|NCT00003907|38276850|FG000|Overall Study|Death|2|||
17135644|NCT00003907|38276851|FG001|Overall Study|Death|0|||
16990298|NCT00753415|38134398|FG007|Part B|Lost to Follow-up|1|||
16990299|NCT00753415|38134399|FG008|Part B|Lost to Follow-up|1|||
16990300|NCT00753415|38134400|FG009|Part B|Lost to Follow-up|0|||
16990301|NCT00753415|38134391|FG000|Part B|Disease progression|0|||
16990302|NCT00753415|38134392|FG001|Part B|Disease progression|0|||
16990303|NCT00753415|38134393|FG002|Part B|Disease progression|0|||
16990304|NCT00753415|38134394|FG003|Part B|Disease progression|0|||
16990305|NCT00753415|38134395|FG004|Part B|Disease progression|0|||
16990306|NCT00753415|38134396|FG005|Part B|Disease progression|0|||
16990307|NCT00753415|38134397|FG006|Part B|Disease progression|0|||
16990308|NCT00753415|38134398|FG007|Part B|Disease progression|0|||
16990309|NCT00753415|38134399|FG008|Part B|Disease progression|2|||
16990310|NCT00753415|38134400|FG009|Part B|Disease progression|1|||
16990311|NCT00754741|38134427|FG000|Overall Study|Died or disenrolled|57|||
16990312|NCT00754741|38134428|FG001|Overall Study|Died or disenrolled|69|||
16990313|NCT00754741|38134429|FG002|Overall Study|Died or disenrolled|54|||
16990314|NCT00752791|38134437|FG000|Overall Study|Adverse Event|7|||
16990315|NCT00752791|38134437|FG000|Overall Study|Withdrawal by Subject|1|||
16990316|NCT00752791|38134437|FG000|Overall Study|Physician Decision|1|||
16990317|NCT00752791|38134437|FG000|Overall Study|Death|1|||
16990318|NCT00752791|38134437|FG000|Overall Study|Renal transplant|3|||
16990319|NCT00752791|38134437|FG000|Overall Study|Switched to hemodialysis|2|||
16990320|NCT00752791|38134437|FG000|Overall Study|Protocol deviation|1|||
16990321|NCT00902304|38134448|FG000|Overall Study|Adverse Event|4|||
16990322|NCT00902304|38134449|FG001|Overall Study|Adverse Event|10|||
16990323|NCT00902304|38134450|FG002|Overall Study|Adverse Event|25|||
16990324|NCT00902304|38134448|FG000|Overall Study|Investigator discretion|3|||
16990325|NCT00902304|38134449|FG001|Overall Study|Investigator discretion|5|||
16990326|NCT00902304|38134450|FG002|Overall Study|Investigator discretion|13|||
16990327|NCT00902304|38134448|FG000|Overall Study|Lost to Follow-up|7|||
16990328|NCT00902304|38134449|FG001|Overall Study|Lost to Follow-up|7|||
16990329|NCT00902304|38134450|FG002|Overall Study|Lost to Follow-up|7|||
16990330|NCT00902304|38134448|FG000|Overall Study|Protocol Violation|9|||
16990331|NCT00902304|38134449|FG001|Overall Study|Protocol Violation|18|||
16990332|NCT00902304|38134450|FG002|Overall Study|Protocol Violation|20|||
16990333|NCT00902304|38134448|FG000|Overall Study|Withdrawal by Subject|32|||
16990334|NCT00902304|38134449|FG001|Overall Study|Withdrawal by Subject|22|||
16990335|NCT00902304|38134450|FG002|Overall Study|Withdrawal by Subject|43|||
16990336|NCT00902304|38134448|FG000|Overall Study|includes pregnancy|3|||
16990337|NCT00902304|38134449|FG001|Overall Study|includes pregnancy|9|||
16990338|NCT00902304|38134450|FG002|Overall Study|includes pregnancy|2|||
16990339|NCT00759109|38134461|FG000|Overall Study|Adverse Event|17|||
16990340|NCT00759109|38134462|FG001|Overall Study|Adverse Event|12|||
16990341|NCT00759109|38134461|FG000|Overall Study|Inability to comply|1|||
16990342|NCT00759109|38134462|FG001|Overall Study|Inability to comply|1|||
16990343|NCT00759109|38134461|FG000|Overall Study|Withdrawal by Subject|9|||
16990344|NCT00759109|38134462|FG001|Overall Study|Withdrawal by Subject|5|||
16990345|NCT00759109|38134461|FG000|Overall Study|Death|4|||
16990346|NCT00759109|38134462|FG001|Overall Study|Death|3|||
16990347|NCT00759109|38134461|FG000|Overall Study|Lost to Follow-up|4|||
16990348|NCT00759109|38134462|FG001|Overall Study|Lost to Follow-up|6|||
17135645|NCT00003907|38276850|FG000|Overall Study|Withdrawal by Subject|1|||
16990349|NCT00759109|38134461|FG000|Overall Study|Started new therapy|2|||
16990350|NCT00759109|38134462|FG001|Overall Study|Started new therapy|6|||
16990351|NCT00759109|38134461|FG000|Overall Study|HCV RNA negative|1|||
16990352|NCT00759109|38134462|FG001|Overall Study|HCV RNA negative|0|||
16990353|NCT00759109|38134461|FG000|Overall Study|Participant moved to a different city|0|||
16990354|NCT00759109|38134462|FG001|Overall Study|Participant moved to a different city|1|||
16990355|NCT00759109|38134461|FG000|Overall Study|Participant had a liver transplant|0|||
16990356|NCT00759109|38134462|FG001|Overall Study|Participant had a liver transplant|1|||
16990357|NCT00759109|38134461|FG000|Overall Study|Lost during study|1|||
16990358|NCT00759109|38134462|FG001|Overall Study|Lost during study|0|||
16990359|NCT00759031|38134470|FG000|First Intervention (1 Day)|Physician Decision|1|||
16990360|NCT00759031|38134471|FG001|First Intervention (1 Day)|Physician Decision|0|||
16990361|NCT00759031|38134470|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
16990362|NCT00759031|38134471|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
16990363|NCT00759031|38134470|FG000|First Intervention (1 Day)|Screening failure|1|||
16990364|NCT00759031|38134471|FG001|First Intervention (1 Day)|Screening failure|0|||
16990365|NCT00758485|38134479|FG000|Overall Study|Lost to Follow-up|0|||
16990366|NCT00758485|38134480|FG001|Overall Study|Lost to Follow-up|1|||
16990367|NCT00758485|38134479|FG000|Overall Study|Not Treated|1|||
16990368|NCT00758485|38134480|FG001|Overall Study|Not Treated|2|||
16990369|NCT00757783|38134489|FG000|Overall Study|Adverse Event|0|||
16990370|NCT00757783|38134490|FG001|Overall Study|Adverse Event|2|||
16990371|NCT00757783|38134489|FG000|Overall Study|Lost to Follow-up|1|||
16990372|NCT00757783|38134490|FG001|Overall Study|Lost to Follow-up|1|||
16990373|NCT00757783|38134489|FG000|Overall Study|Protocol Violation|1|||
16990374|NCT00757783|38134490|FG001|Overall Study|Protocol Violation|0|||
16990375|NCT00757783|38134489|FG000|Overall Study|Withdrawal by Subject|2|||
16990376|NCT00757783|38134490|FG001|Overall Study|Withdrawal by Subject|1|||
16990377|NCT00757783|38134489|FG000|Overall Study|Other|1|||
16990378|NCT00757783|38134490|FG001|Overall Study|Other|2|||
16990379|NCT00757705|38134496|FG000|Overall Study|Adverse Event|19|||
16990380|NCT00757705|38134496|FG000|Overall Study|Lost to Follow-up|16|||
16990381|NCT00757705|38134496|FG000|Overall Study|Withdrawal by Subject|25|||
16990382|NCT00757705|38134496|FG000|Overall Study|Insufficient Response|26|||
16990383|NCT00757705|38134496|FG000|Overall Study|Ineligible to continue|8|||
16990384|NCT00757705|38134496|FG000|Overall Study|Non-compliant|9|||
16990385|NCT00757705|38134496|FG000|Overall Study|Other|18|||
16990386|NCT00757627|38134500|FG000|Overall Study|Adverse Event|15|||
16990387|NCT00757627|38134500|FG000|Overall Study|Lack of Efficacy|10|||
16990388|NCT00757627|38134500|FG000|Overall Study|Lost to Follow-up|28|||
16990389|NCT00757627|38134500|FG000|Overall Study|Withdrawal by Subject|27|||
16990390|NCT00757627|38134500|FG000|Overall Study|Other|1|||
16990391|NCT01023308|38134511|FG000|Overall Study|Abnormal test proceedure results|3|||
16990392|NCT01023308|38134512|FG001|Overall Study|Abnormal test proceedure results|8|||
16990393|NCT01023308|38134511|FG000|Overall Study|Administrative problems|2|||
16990394|NCT01023308|38134512|FG001|Overall Study|Administrative problems|1|||
16990395|NCT01023308|38134511|FG000|Overall Study|Adverse Event|130|||
16990396|NCT01023308|38134512|FG001|Overall Study|Adverse Event|66|||
16990397|NCT01023308|38134511|FG000|Overall Study|Death|21|||
16990398|NCT01023308|38134512|FG001|Overall Study|Death|17|||
16990399|NCT01023308|38134511|FG000|Overall Study|Disease progression|82|||
16990400|NCT01023308|38134512|FG001|Overall Study|Disease progression|153|||
16990401|NCT01023308|38134511|FG000|Overall Study|New Cancer therapy|4|||
16990402|NCT01023308|38134512|FG001|Overall Study|New Cancer therapy|7|||
16990403|NCT01023308|38134511|FG000|Overall Study|Protocol Violation|3|||
16990404|NCT01023308|38134512|FG001|Overall Study|Protocol Violation|4|||
16990405|NCT01023308|38134511|FG000|Overall Study|Untreated|5|||
16990406|NCT01023308|38134512|FG001|Overall Study|Untreated|5|||
16990407|NCT01023308|38134511|FG000|Overall Study|Lost to Follow-up|1|||
16990408|NCT01023308|38134512|FG001|Overall Study|Lost to Follow-up|0|||
16990409|NCT01023308|38134511|FG000|Overall Study|Withdrawal by Subject|34|||
16990410|NCT01023308|38134512|FG001|Overall Study|Withdrawal by Subject|18|||
16990411|NCT01022996|38134518|FG000|Overall Study|Adverse Event|14|||
16990412|NCT01022996|38134518|FG000|Overall Study|Withdrawal by Subject|3|||
16990413|NCT01022996|38134518|FG000|Overall Study|Lost to Follow-up|1|||
16990414|NCT01022996|38134518|FG000|Overall Study|Administrative problems|6|||
16990415|NCT01022996|38134518|FG000|Overall Study|Disease Progression|32|||
16990416|NCT01022996|38134518|FG000|Overall Study|Protocol Violation|1|||
16990417|NCT00757237|38134524|FG000|Overall Study|Lost to Follow-up|0|||
16990418|NCT00757237|38134525|FG001|Overall Study|Lost to Follow-up|1|||
16990419|NCT00757237|38134524|FG000|Overall Study|Protocol Violation|0|||
16990420|NCT00757237|38134525|FG001|Overall Study|Protocol Violation|2|||
16990421|NCT00757237|38134524|FG000|Overall Study|Physician Decision|2|||
16990422|NCT00757237|38134525|FG001|Overall Study|Physician Decision|3|||
16990423|NCT00757237|38134524|FG000|Overall Study|Withdrawal by Subject|8|||
16990424|NCT00757237|38134525|FG001|Overall Study|Withdrawal by Subject|12|||
16990425|NCT00757237|38134524|FG000|Overall Study|Safety or Tolerability|3|||
16990426|NCT00757237|38134525|FG001|Overall Study|Safety or Tolerability|5|||
16990427|NCT00757237|38134524|FG000|Overall Study|Other|0|||
16990428|NCT00757237|38134525|FG001|Overall Study|Other|2|||
16990429|NCT01029392|38134533|FG000|Overall Study|Withdrawal by Subject|18|||
16990430|NCT01029392|38134534|FG001|Overall Study|Withdrawal by Subject|11|||
16990431|NCT01029392|38134533|FG000|Overall Study|Physician Decision|2|||
16990432|NCT01029392|38134534|FG001|Overall Study|Physician Decision|0|||
16990433|NCT00903006|38134546|FG000|Overall Study|Withdrawal by Subject|2|||
16990434|NCT00903006|38134547|FG001|Overall Study|Withdrawal by Subject|0|||
16990435|NCT00903006|38134548|FG002|Overall Study|Withdrawal by Subject|0|||
16990436|NCT00903006|38134549|FG003|Overall Study|Withdrawal by Subject|0|||
16990437|NCT00903006|38134546|FG000|Overall Study|Progressive Disease|0|||
16990438|NCT00903006|38134547|FG001|Overall Study|Progressive Disease|3|||
16990439|NCT00903006|38134548|FG002|Overall Study|Progressive Disease|1|||
16990440|NCT00903006|38134549|FG003|Overall Study|Progressive Disease|0|||
16990441|NCT00839332|38134562|FG000|Phase 1|Disease Progression|38|||
16990442|NCT00839332|38134563|FG001|Phase 1|Disease Progression|0|||
16990443|NCT00839332|38134564|FG002|Phase 1|Disease Progression|0|||
16990444|NCT00839332|38134562|FG000|Phase 1|Adverse Event|6|||
16990445|NCT00839332|38134563|FG001|Phase 1|Adverse Event|0|||
16990446|NCT00839332|38134564|FG002|Phase 1|Adverse Event|0|||
16990447|NCT00839332|38134562|FG000|Phase 1|Withdrawal by Subject|4|||
16990448|NCT00839332|38134563|FG001|Phase 1|Withdrawal by Subject|0|||
16990449|NCT00839332|38134564|FG002|Phase 1|Withdrawal by Subject|0|||
16990450|NCT00839332|38134562|FG000|Phase 1|Physician Decision|2|||
16990451|NCT00839332|38134563|FG001|Phase 1|Physician Decision|0|||
16990452|NCT00839332|38134564|FG002|Phase 1|Physician Decision|0|||
16990453|NCT00839332|38134562|FG000|Phase 2|Protocol Violation|0|||
16990454|NCT00839332|38134563|FG001|Phase 2|Protocol Violation|1|||
16990455|NCT00839332|38134564|FG002|Phase 2|Protocol Violation|0|||
16990456|NCT00839332|38134562|FG000|Phase 2|Disease Progression|0|||
16990457|NCT00839332|38134563|FG001|Phase 2|Disease Progression|46|||
16990458|NCT00839332|38134564|FG002|Phase 2|Disease Progression|21|||
16990459|NCT00839332|38134562|FG000|Phase 2|Adverse Event|0|||
16990460|NCT00839332|38134563|FG001|Phase 2|Adverse Event|8|||
16990461|NCT00839332|38134564|FG002|Phase 2|Adverse Event|6|||
16990462|NCT00839332|38134562|FG000|Phase 2|Death|0|||
16990463|NCT00839332|38134563|FG001|Phase 2|Death|4|||
16990464|NCT00839332|38134564|FG002|Phase 2|Death|2|||
16990465|NCT00839332|38134562|FG000|Phase 2|Withdrawal by Subject|0|||
16990466|NCT00839332|38134563|FG001|Phase 2|Withdrawal by Subject|5|||
16990467|NCT00839332|38134564|FG002|Phase 2|Withdrawal by Subject|8|||
16990468|NCT00839332|38134562|FG000|Phase 2|Physician Decision|0|||
16990469|NCT00839332|38134563|FG001|Phase 2|Physician Decision|4|||
16990470|NCT00839332|38134564|FG002|Phase 2|Physician Decision|1|||
16990471|NCT00839332|38134562|FG000|Phase 2|Lost to Follow-up|0|||
16990472|NCT00839332|38134563|FG001|Phase 2|Lost to Follow-up|0|||
16990473|NCT00839332|38134564|FG002|Phase 2|Lost to Follow-up|1|||
16990474|NCT00902850|38134575|FG000|Overall Study|Physician Decision|2|||
16990475|NCT00902850|38134576|FG001|Overall Study|Physician Decision|2|||
16990476|NCT00902538|38134585|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
16990477|NCT00902538|38134586|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16990478|NCT00902538|38134587|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16990479|NCT00902538|38134588|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16990480|NCT00902538|38134589|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16990481|NCT00902538|38134590|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16990482|NCT00902538|38134585|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
16990483|NCT00902538|38134586|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16990484|NCT00902538|38134587|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16990485|NCT00902538|38134588|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16990486|NCT00902538|38134589|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16990487|NCT00902538|38134590|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16990488|NCT00902538|38134585|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
16990489|NCT00902538|38134586|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16990490|NCT00902538|38134587|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16990491|NCT00902538|38134588|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16990492|NCT00902538|38134589|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16990493|NCT00902538|38134590|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16990494|NCT00902538|38134585|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
16990495|NCT00902538|38134586|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16990496|NCT00902538|38134587|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16990497|NCT00902538|38134588|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16990498|NCT00902538|38134589|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16990499|NCT00902538|38134590|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16990500|NCT00902538|38134585|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
16990501|NCT00902538|38134586|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16990502|NCT00902538|38134587|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16990503|NCT00902538|38134588|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16990504|NCT00902538|38134589|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16990505|NCT00902538|38134590|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16990506|NCT00902538|38134585|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
16990507|NCT00902538|38134586|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
16990508|NCT00902538|38134587|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
16990509|NCT00902538|38134588|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
16990510|NCT00902538|38134589|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
16990511|NCT00902538|38134590|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
16990512|NCT00902538|38134585|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
16990513|NCT00902538|38134586|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
16990514|NCT00902538|38134587|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
16990515|NCT00902538|38134588|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
17028632|NCT00764504|38173000|FG002|Overall Study|Death|13|||
17135646|NCT00003907|38276851|FG001|Overall Study|Withdrawal by Subject|3|||
17135647|NCT00003907|38276850|FG000|Overall Study|Progressive disease|4|||
17135648|NCT00003907|38276851|FG001|Overall Study|Progressive disease|4|||
17135649|NCT00003907|38276850|FG000|Overall Study|Complicating disease|1|||
17135650|NCT00003907|38276851|FG001|Overall Study|Complicating disease|0|||
17135651|NCT00003907|38276850|FG000|Overall Study|Other|1|||
17135652|NCT00003907|38276851|FG001|Overall Study|Other|3|||
17135653|NCT00003907|38276850|FG000|Overall Study|ineligible or not treated|2|||
17135654|NCT00003907|38276851|FG001|Overall Study|ineligible or not treated|2|||
17135655|NCT00003901|38276857|FG000|Overall Study|Adverse Event|1|||
17135656|NCT00003901|38276857|FG000|Overall Study|Withdrawal by Subject|1|||
17135657|NCT00003901|38276857|FG000|Overall Study|Ineligible|6|||
17135658|NCT00003901|38276857|FG000|Overall Study|CT Scan not within protocol requirement|2|||
17135659|NCT00003901|38276857|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
17135660|NCT00003901|38276857|FG000|Overall Study|Medical problems|6|||
17135661|NCT00003895|38276866|FG000|Overall Study|Adverse Event|4|||
17135662|NCT00003895|38276867|FG001|Overall Study|Adverse Event|0|||
17135663|NCT00003895|38276866|FG000|Overall Study|Lack of Efficacy|1|||
17135664|NCT00003895|38276867|FG001|Overall Study|Lack of Efficacy|1|||
17135665|NCT00003895|38276866|FG000|Overall Study|Patient Vacation|2|||
17135666|NCT00003895|38276867|FG001|Overall Study|Patient Vacation|0|||
17135667|NCT00003895|38276866|FG000|Overall Study|Withdrawal by Subject|0|||
17135668|NCT00003895|38276867|FG001|Overall Study|Withdrawal by Subject|3|||
17135669|NCT03800173|38276878|FG000|Overall Study|Lost to Follow-up|0|||
17135670|NCT03800173|38276879|FG001|Overall Study|Lost to Follow-up|0|||
17135671|NCT03800173|38276880|FG002|Overall Study|Lost to Follow-up|0|||
17135672|NCT03800173|38276881|FG003|Overall Study|Lost to Follow-up|0|||
17135673|NCT03800173|38276882|FG004|Overall Study|Lost to Follow-up|1|||
17135674|NCT00003631|38276901|FG000|Overall Study|Patient not treated|1|||
17135675|NCT00003631|38276902|FG001|Overall Study|Patient not treated|0|||
17135676|NCT00003631|38276903|FG002|Overall Study|Patient not treated|1|||
17135677|NCT00003631|38276901|FG000|Overall Study|Protocol Violation|1|||
17135678|NCT00003631|38276902|FG001|Overall Study|Protocol Violation|0|||
17135679|NCT00003631|38276903|FG002|Overall Study|Protocol Violation|0|||
17135680|NCT00003631|38276901|FG000|Overall Study|Adverse Event|1|||
17135681|NCT00003631|38276902|FG001|Overall Study|Adverse Event|1|||
17135682|NCT00003631|38276903|FG002|Overall Study|Adverse Event|5|||
17135683|NCT00003631|38276901|FG000|Overall Study|Death|0|||
17135684|NCT00003631|38276902|FG001|Overall Study|Death|0|||
17135685|NCT00003631|38276903|FG002|Overall Study|Death|1|||
17135686|NCT00003631|38276901|FG000|Overall Study|Evaluable for toxicity only|0|||
17135687|NCT00003631|38276902|FG001|Overall Study|Evaluable for toxicity only|0|||
17135688|NCT00003631|38276903|FG002|Overall Study|Evaluable for toxicity only|2|||
17135689|NCT00003535|38276911|FG000|Overall Study|Not evaluable|5|||
17135690|NCT00003511|38276915|FG000|Overall Study|Not evaluable|4|||
17135691|NCT00003499|38276919|FG000|Overall Study|Not evaluable|8|||
17135692|NCT00003487|38276923|FG000|Overall Study|Not evaluable|2|||
17135693|NCT00003475|38276927|FG000|Overall Study|Not evaluable|13|||
17135694|NCT00003457|38276932|FG000|Overall Study|Not evaluable|9|||
17135695|NCT00030901|38276938|FG000|Initial Registration|Ineligible|167|||
17135696|NCT00030901|38276939|FG001|Initial Registration|Ineligible|0|||
17135697|NCT00030901|38276940|FG002|Initial Registration|Ineligible|0|||
17135698|NCT00030901|38276938|FG000|Randomization|Adverse Event|0|||
16990516|NCT00902538|38134589|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
17135699|NCT00030901|38276939|FG001|Randomization|Adverse Event|11|||
17135700|NCT00030901|38276940|FG002|Randomization|Adverse Event|7|||
17135701|NCT00030901|38276938|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
17135702|NCT00030901|38276939|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
17135703|NCT00030901|38276940|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
17135704|NCT00030901|38276938|FG000|Randomization|Progression/Relapse|0|||
17135705|NCT00030901|38276939|FG001|Randomization|Progression/Relapse|22|||
17135706|NCT00030901|38276940|FG002|Randomization|Progression/Relapse|21|||
16990517|NCT00902538|38134590|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
17135707|NCT00030901|38276938|FG000|Randomization|Death|0|||
17135708|NCT00030901|38276939|FG001|Randomization|Death|1|||
17135709|NCT00030901|38276940|FG002|Randomization|Death|3|||
17135710|NCT00030901|38276938|FG000|Randomization|Other|0|||
17135711|NCT00030901|38276939|FG001|Randomization|Other|36|||
17135712|NCT00030901|38276940|FG002|Randomization|Other|33|||
17135713|NCT00030901|38276938|FG000|Randomization|Ineligible|0|||
17135714|NCT00030901|38276939|FG001|Randomization|Ineligible|15|||
17135715|NCT00030901|38276940|FG002|Randomization|Ineligible|14|||
17135716|NCT00003199|38276946|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
17135717|NCT00003199|38276946|FG000|Overall Study|Lack of insurance clearance|2|||
16780367|NCT01594827|37719459|FG000|Overall Study|Adverse Event|1|||
16990518|NCT00902538|38134585|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
16990519|NCT00902538|38134586|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
16990520|NCT00902538|38134587|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
16990521|NCT00902538|38134588|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
16990522|NCT00902538|38134589|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
16990523|NCT00902538|38134590|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
16990524|NCT00902538|38134585|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
16990525|NCT00902538|38134586|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
16990526|NCT00902538|38134587|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
16990527|NCT00902538|38134588|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
16990528|NCT00902538|38134589|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
16990529|NCT00902538|38134590|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
16990530|NCT00902538|38134585|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
16990531|NCT00902538|38134586|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
16990532|NCT00902538|38134587|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
16990533|NCT00902538|38134588|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
16990534|NCT00902538|38134589|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
16990535|NCT00902538|38134590|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
16990536|NCT00902538|38134585|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
16990537|NCT00902538|38134586|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
16990538|NCT00902538|38134587|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
16990539|NCT00902538|38134588|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
16990540|NCT00902538|38134589|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
16990541|NCT00902538|38134590|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
16990542|NCT00902538|38134585|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
16990543|NCT00902538|38134586|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
16990544|NCT00902538|38134587|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
16990545|NCT00902538|38134588|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
16990546|NCT00902538|38134589|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
16990547|NCT00902538|38134590|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
16990548|NCT00902538|38134585|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16990549|NCT00902538|38134586|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
16990550|NCT00902538|38134587|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16990551|NCT00902538|38134588|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16990552|NCT00902538|38134589|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16990553|NCT00902538|38134590|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16990554|NCT00902538|38134585|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16990555|NCT00902538|38134586|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
16990556|NCT00902538|38134587|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16990557|NCT00902538|38134588|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16990558|NCT00902538|38134589|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16990559|NCT00902538|38134590|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16990560|NCT00902538|38134585|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
16990561|NCT00902538|38134586|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
16990562|NCT00902538|38134587|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
16990563|NCT00902538|38134588|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
16990564|NCT00902538|38134589|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
17135718|NCT00003199|38276946|FG000|Overall Study|Screen fail|15|||
16990565|NCT00902538|38134590|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
16990566|NCT00902538|38134585|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
16990567|NCT00902538|38134586|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
16990568|NCT00902538|38134587|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
16990569|NCT00902538|38134588|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
16990570|NCT00902538|38134589|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
16990571|NCT00902538|38134590|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
16990572|NCT00902538|38134585|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16990573|NCT00902538|38134586|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16990574|NCT00902538|38134587|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16990575|NCT00902538|38134588|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
16990576|NCT00902538|38134589|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16990577|NCT00902538|38134590|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16990578|NCT01036022|38134612|FG000|Overall Study|Adverse Event|1|||
16990579|NCT01036022|38134613|FG001|Overall Study|Adverse Event|3|||
16990580|NCT01036022|38134614|FG002|Overall Study|Adverse Event|2|||
16990581|NCT01036022|38134615|FG003|Overall Study|Adverse Event|1|||
16990582|NCT01036022|38134616|FG004|Overall Study|Adverse Event|0|||
16990583|NCT01036022|38134617|FG005|Overall Study|Adverse Event|2|||
16990584|NCT01036022|38134612|FG000|Overall Study|Lack of Efficacy|1|||
16990585|NCT01036022|38134613|FG001|Overall Study|Lack of Efficacy|1|||
16990586|NCT01036022|38134614|FG002|Overall Study|Lack of Efficacy|1|||
16990587|NCT01036022|38134615|FG003|Overall Study|Lack of Efficacy|0|||
16990588|NCT01036022|38134616|FG004|Overall Study|Lack of Efficacy|1|||
16990589|NCT01036022|38134617|FG005|Overall Study|Lack of Efficacy|1|||
16990590|NCT01036022|38134612|FG000|Overall Study|Physician Decision|0|||
16990591|NCT01036022|38134613|FG001|Overall Study|Physician Decision|0|||
16990592|NCT01036022|38134614|FG002|Overall Study|Physician Decision|1|||
16990593|NCT01036022|38134615|FG003|Overall Study|Physician Decision|0|||
16990594|NCT01036022|38134616|FG004|Overall Study|Physician Decision|0|||
16990595|NCT01036022|38134617|FG005|Overall Study|Physician Decision|0|||
16990596|NCT01036022|38134612|FG000|Overall Study|Withdrawal by Subject|0|||
16990597|NCT01036022|38134613|FG001|Overall Study|Withdrawal by Subject|0|||
16990598|NCT01036022|38134614|FG002|Overall Study|Withdrawal by Subject|0|||
16990599|NCT01036022|38134615|FG003|Overall Study|Withdrawal by Subject|1|||
16990600|NCT01036022|38134616|FG004|Overall Study|Withdrawal by Subject|2|||
16990601|NCT01036022|38134617|FG005|Overall Study|Withdrawal by Subject|0|||
16990602|NCT00752557|38134642|FG000|Overall Study|Withdrawal by Subject|4|||
16990603|NCT00752557|38134643|FG001|Overall Study|Withdrawal by Subject|3|||
16990604|NCT00752557|38134644|FG002|Overall Study|Withdrawal by Subject|3|||
16990605|NCT00752557|38134642|FG000|Overall Study|Unspecified resaons|0|||
16990606|NCT00752557|38134643|FG001|Overall Study|Unspecified resaons|2|||
16990607|NCT00752557|38134644|FG002|Overall Study|Unspecified resaons|2|||
16990608|NCT00752557|38134642|FG000|Overall Study|Lost to Follow-up|1|||
16990609|NCT00752557|38134643|FG001|Overall Study|Lost to Follow-up|0|||
16990610|NCT00752557|38134644|FG002|Overall Study|Lost to Follow-up|1|||
16990611|NCT00747643|38134656|FG000|Overall Study|Withdrawal by Subject|36|||
16990612|NCT00747643|38134657|FG001|Overall Study|Withdrawal by Subject|27|||
16990613|NCT01022762|38134665|FG000|Overall Study|Adverse Event|3|||
16990614|NCT01022762|38134666|FG001|Overall Study|Adverse Event|1|||
16990615|NCT01022762|38134665|FG000|Overall Study|Lack of Efficacy|0|||
16990616|NCT01022762|38134666|FG001|Overall Study|Lack of Efficacy|1|||
16990617|NCT01022762|38134665|FG000|Overall Study|Protocol Violation|7|||
16990618|NCT01022762|38134666|FG001|Overall Study|Protocol Violation|6|||
16990619|NCT01022762|38134665|FG000|Overall Study|Unclassified|12|||
16990620|NCT01022762|38134666|FG001|Overall Study|Unclassified|20|||
16990621|NCT01028378|38134672|FG000|Overall Study|Lost to Follow-up|12|||
16990622|NCT01028378|38134672|FG000|Overall Study|Withdrawal by Subject|1|||
16990623|NCT01028378|38134672|FG000|Overall Study|Adminstrative Reasons|4|||
16990624|NCT00747565|38134678|FG000|Overall Study|Withdrawal by Subject|10|||
16990625|NCT00747565|38134679|FG001|Overall Study|Withdrawal by Subject|6|||
16990626|NCT00747565|38134678|FG000|Overall Study|Lost to Follow-up|4|||
16990627|NCT00747565|38134679|FG001|Overall Study|Lost to Follow-up|1|||
16990628|NCT01028300|38134685|FG000|Overall Study|Study Terminated|4|||
16990629|NCT00752089|38134689|FG000|Overall Study|Adverse Event|1|||
16990630|NCT00752089|38134689|FG000|Overall Study|Protocol Deviation|2|||
16990631|NCT00752089|38134689|FG000|Overall Study|Could not attend visit 9|1|||
16990632|NCT00752089|38134689|FG000|Overall Study|Not capable of wearing partial denture|1|||
16990633|NCT00752089|38134689|FG000|Overall Study|Cannot continue the study|1|||
16990634|NCT00751933|38134700|FG000|Overall Study|Withdrawal by Subject|0|||
16990635|NCT00751933|38134701|FG001|Overall Study|Withdrawal by Subject|1|||
16990636|NCT00751933|38134702|FG002|Overall Study|Withdrawal by Subject|0|||
16990637|NCT00751933|38134703|FG003|Overall Study|Withdrawal by Subject|0|||
16990638|NCT00751933|38134700|FG000|Overall Study|Physician Decision|0|||
16990639|NCT00751933|38134701|FG001|Overall Study|Physician Decision|0|||
16990640|NCT00751933|38134702|FG002|Overall Study|Physician Decision|1|||
16990641|NCT00751933|38134703|FG003|Overall Study|Physician Decision|1|||
16990642|NCT00751621|38134707|FG000|Overall Study|Adverse Event|1|||
16990643|NCT00751621|38134707|FG000|Overall Study|Withdrawal by Subject|1|||
16990644|NCT00751621|38134707|FG000|Overall Study|Subject moved to another country|1|||
16990645|NCT00751621|38134707|FG000|Overall Study|Poor adherence to asthma treatment|1|||
16990646|NCT01028222|38134715|FG000|Overall Study|Protocol deviation|1|||
16990647|NCT01028222|38134716|FG001|Overall Study|Protocol deviation|0|||
16990648|NCT01028222|38134715|FG000|Overall Study|Disease progression|33|||
16990649|NCT01028222|38134716|FG001|Overall Study|Disease progression|9|||
16990650|NCT01028222|38134715|FG000|Overall Study|Administrative problems|1|||
16990651|NCT01028222|38134716|FG001|Overall Study|Administrative problems|1|||
16990652|NCT01028222|38134715|FG000|Overall Study|Lost to Follow-up|0|||
16990653|NCT01028222|38134716|FG001|Overall Study|Lost to Follow-up|1|||
16990654|NCT01028222|38134715|FG000|Overall Study|Withdrawal by Subject|1|||
16990655|NCT01028222|38134716|FG001|Overall Study|Withdrawal by Subject|0|||
16990656|NCT01028222|38134715|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
16990657|NCT01028222|38134716|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
16990658|NCT01028222|38134715|FG000|Overall Study|Adverse Event|2|||
16990659|NCT01028222|38134716|FG001|Overall Study|Adverse Event|0|||
16990660|NCT00586495|38134723|FG000|Treatment Period|Adverse Event|11|||
16990661|NCT00586495|38134723|FG000|Treatment Period|Death|1|||
16990662|NCT00586495|38134723|FG000|Treatment Period|Protocol Violation|1|||
16990663|NCT00586495|38134723|FG000|Treatment Period|Withdrawal by Subject|1|||
16990664|NCT00586495|38134723|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
16990665|NCT00586495|38134723|FG000|Treatment Period|Switch to commercial drug|10|||
16990666|NCT00586495|38134723|FG000|Follow-up|Death|40|||
16990667|NCT00586495|38134723|FG000|Follow-up|Lost to Follow-up|1|||
16990668|NCT00586495|38134723|FG000|Follow-up|Withdrawal by Subject|4|||
16990669|NCT00586495|38134723|FG000|Follow-up|Protocol driven decision point|37|||
16990670|NCT00586495|38134723|FG000|Follow-up|Switch to commercial drug|10|||
16990671|NCT01027754|38134729|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
16990672|NCT01027754|38134730|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
16990673|NCT01027754|38134729|FG000|Overall Study|Withdrawal by Subject|0|||
16990674|NCT01027754|38134730|FG001|Overall Study|Withdrawal by Subject|5|||
16990675|NCT01034540|38134742|FG000|Overall Study|Adverse Event|0|||
16990676|NCT01034540|38134743|FG001|Overall Study|Adverse Event|1|||
16990677|NCT00774930|38134753|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
16990678|NCT00774930|38134754|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
16990679|NCT00774930|38134753|FG000|DB Phase|Adverse Event|1|||
16990680|NCT00774930|38134754|FG001|DB Phase|Adverse Event|2|||
16990681|NCT00774930|38134753|FG000|DB Phase|Subject Decision|1|||
16990682|NCT00774930|38134754|FG001|DB Phase|Subject Decision|5|||
16990683|NCT00774930|38134753|FG000|DB Phase|Sponsor Decision|0|||
16990684|NCT00774930|38134754|FG001|DB Phase|Sponsor Decision|1|||
16990685|NCT00774930|38134753|FG000|DB Phase|Disease Progression|1|||
16990686|NCT00774930|38134754|FG001|DB Phase|Disease Progression|1|||
16990687|NCT00774930|38134753|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
16990688|NCT00774930|38134754|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
16990689|NCT00774930|38134753|FG000|IOL Phase|Adverse Event|1|||
16990690|NCT00774930|38134754|FG001|IOL Phase|Adverse Event|1|||
16990691|NCT00774930|38134753|FG000|IOL Phase|Subject Decision|4|||
16990692|NCT00774930|38134754|FG001|IOL Phase|Subject Decision|3|||
16990693|NCT00774930|38134753|FG000|IOL Phase|Physician Decision|3|||
16990694|NCT00774930|38134754|FG001|IOL Phase|Physician Decision|2|||
16990695|NCT00774930|38134753|FG000|IOL Phase|Sponsor Decision|1|||
16990696|NCT00774930|38134754|FG001|IOL Phase|Sponsor Decision|0|||
16990697|NCT00774930|38134753|FG000|IOL Phase|Disease Progression|2|||
16990698|NCT00774930|38134754|FG001|IOL Phase|Disease Progression|1|||
17135719|NCT00030823|38276950|FG000|Overall Study|Withdrawal by Subject|1|||
17135720|NCT00001849|38276954|FG000|Overall Study|Death|4|||
16990699|NCT00774930|38134753|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
16990700|NCT00774930|38134754|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
16990701|NCT00774930|38134753|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
16990702|NCT00774930|38134754|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
16990703|NCT00774930|38134753|FG000|IOL Phase|Other|1|||
16990704|NCT00774930|38134754|FG001|IOL Phase|Other|0|||
16990705|NCT00774930|38134753|FG000|IOL Phase|Brain radiation|0|||
17135721|NCT00001849|38276954|FG000|Overall Study|Lost to Follow-up|2|||
17135722|NCT00001849|38276954|FG000|Overall Study|Withdrawal by Subject|2|||
17135723|NCT00001849|38276954|FG000|Overall Study|tumor remained occult|6|||
17135724|NCT01342952|38276971|FG000|Overall Study|Adverse Event|0|||
17135725|NCT01342952|38276972|FG001|Overall Study|Adverse Event|5|||
17135726|NCT01342952|38276973|FG002|Overall Study|Adverse Event|1|||
17135727|NCT01342952|38276974|FG003|Overall Study|Adverse Event|0|||
17135728|NCT01342952|38276971|FG000|Overall Study|Lost to Follow-up|0|||
17135729|NCT01342952|38276972|FG001|Overall Study|Lost to Follow-up|2|||
16990706|NCT00774930|38134754|FG001|IOL Phase|Brain radiation|1|||
17135730|NCT01342952|38276973|FG002|Overall Study|Lost to Follow-up|0|||
17135731|NCT01342952|38276974|FG003|Overall Study|Lost to Follow-up|0|||
17135732|NCT01342952|38276971|FG000|Overall Study|Withdrawal by Subject|1|||
17135733|NCT01342952|38276972|FG001|Overall Study|Withdrawal by Subject|1|||
17135734|NCT01342952|38276973|FG002|Overall Study|Withdrawal by Subject|0|||
17135735|NCT01342952|38276974|FG003|Overall Study|Withdrawal by Subject|0|||
17135736|NCT01342952|38276971|FG000|Overall Study|Physician Decision|3|||
17135737|NCT01342952|38276972|FG001|Overall Study|Physician Decision|3|||
17135738|NCT01342952|38276973|FG002|Overall Study|Physician Decision|1|||
17135739|NCT01342952|38276974|FG003|Overall Study|Physician Decision|0|||
17135740|NCT02886884|38277001|FG000|Follow-up|Withdrawal by Subject|0|||
17135741|NCT02886884|38277002|FG001|Follow-up|Withdrawal by Subject|0|||
17135742|NCT02886884|38277003|FG002|Follow-up|Withdrawal by Subject|0|||
17135743|NCT02886884|38277004|FG003|Follow-up|Withdrawal by Subject|1|||
17135744|NCT01240694|38277023|FG000|Overall Study|Adverse Event|9|||
17135745|NCT01240694|38277023|FG000|Overall Study|Lack of Efficacy|6|||
17135746|NCT01240694|38277023|FG000|Overall Study|Withdrawal by Subject|6|||
17135747|NCT01240694|38277023|FG000|Overall Study|Protocol Violation|2|||
17135748|NCT01240694|38277023|FG000|Overall Study|Lost to Follow-up|2|||
17135749|NCT01240694|38277023|FG000|Overall Study|Other than specified|3|||
17135750|NCT01240694|38277023|FG000|Overall Study|Withdrawn due to early study termination|107|||
17135751|NCT01112306|38277027|FG000|Overall Study|Death|175|||
17135752|NCT01112306|38277027|FG000|Overall Study|Lost to Follow-up|9|||
17135753|NCT01112306|38277027|FG000|Overall Study|Withdrawal by Subject|31|||
17135754|NCT01112306|38277027|FG000|Overall Study|Other|70|||
17135755|NCT03162224|38277034|FG000|Overall Study|Death|4|||
17135756|NCT03162224|38277035|FG001|Overall Study|Death|5|||
17135757|NCT03162224|38277036|FG002|Overall Study|Death|8|||
17135758|NCT03162224|38277034|FG000|Overall Study|Withdrawal by Subject|1|||
17135759|NCT03162224|38277035|FG001|Overall Study|Withdrawal by Subject|0|||
17135760|NCT03162224|38277036|FG002|Overall Study|Withdrawal by Subject|1|||
17135761|NCT03162224|38277034|FG000|Overall Study|Lost to Follow-up|0|||
17135762|NCT03162224|38277035|FG001|Overall Study|Lost to Follow-up|1|||
17135763|NCT03162224|38277036|FG002|Overall Study|Lost to Follow-up|0|||
17135764|NCT03162224|38277034|FG000|Overall Study|Other|6|||
17135765|NCT03162224|38277035|FG001|Overall Study|Other|2|||
17135766|NCT03162224|38277036|FG002|Overall Study|Other|1|||
17135767|NCT02886338|38277075|FG000|Overall Study|Withdrawal by Subject|1|||
17135768|NCT00004124|38277081|FG000|Overall Study|Received no protocol therapy|12|||
17135769|NCT00004124|38277082|FG001|Overall Study|Received no protocol therapy|20|||
17135770|NCT00383552|38277092|FG000|Overall Study|Adverse Event|7|||
17135771|NCT00383552|38277093|FG001|Overall Study|Adverse Event|6|||
17135772|NCT00383552|38277094|FG002|Overall Study|Adverse Event|9|||
17135773|NCT00383552|38277095|FG003|Overall Study|Adverse Event|6|||
17135774|NCT00383552|38277092|FG000|Overall Study|Lack of Efficacy|4|||
17135775|NCT00383552|38277093|FG001|Overall Study|Lack of Efficacy|13|||
17135776|NCT00383552|38277094|FG002|Overall Study|Lack of Efficacy|29|||
17135777|NCT00383552|38277095|FG003|Overall Study|Lack of Efficacy|42|||
17135778|NCT00383552|38277092|FG000|Overall Study|Lost to Follow-up|0|||
17135779|NCT00383552|38277093|FG001|Overall Study|Lost to Follow-up|1|||
17135780|NCT00383552|38277094|FG002|Overall Study|Lost to Follow-up|5|||
17135781|NCT00383552|38277095|FG003|Overall Study|Lost to Follow-up|1|||
17135782|NCT00383552|38277092|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
17135783|NCT00383552|38277093|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
17135784|NCT00383552|38277094|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
17135785|NCT00383552|38277095|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
17135786|NCT00383552|38277092|FG000|Overall Study|Did not wish to continue (related)|1|||
17135787|NCT00383552|38277093|FG001|Overall Study|Did not wish to continue (related)|0|||
17135788|NCT00383552|38277094|FG002|Overall Study|Did not wish to continue (related)|2|||
17135789|NCT00383552|38277095|FG003|Overall Study|Did not wish to continue (related)|3|||
17135790|NCT00383552|38277092|FG000|Overall Study|Noncompliance with the protocol|11|||
17135791|NCT00383552|38277093|FG001|Overall Study|Noncompliance with the protocol|6|||
17135792|NCT00383552|38277094|FG002|Overall Study|Noncompliance with the protocol|8|||
17135793|NCT00383552|38277095|FG003|Overall Study|Noncompliance with the protocol|10|||
17135794|NCT00383552|38277092|FG000|Overall Study|Did not meet protocol eligibility|8|||
17135795|NCT00383552|38277093|FG001|Overall Study|Did not meet protocol eligibility|6|||
17135796|NCT00383552|38277094|FG002|Overall Study|Did not meet protocol eligibility|2|||
17135797|NCT00383552|38277095|FG003|Overall Study|Did not meet protocol eligibility|3|||
17135798|NCT00383552|38277092|FG000|Overall Study|Administrative|1|||
17135799|NCT00383552|38277093|FG001|Overall Study|Administrative|0|||
17135800|NCT00383552|38277094|FG002|Overall Study|Administrative|1|||
17135801|NCT00383552|38277095|FG003|Overall Study|Administrative|1|||
17135802|NCT03158012|38277112|FG000|Overall Study|Withdrawal by Subject|0|||
17135803|NCT03158012|38277113|FG001|Overall Study|Withdrawal by Subject|1|||
17135804|NCT01776424|38277122|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
17135805|NCT01776424|38277123|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
17135806|NCT01776424|38277124|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
17135807|NCT01776424|38277122|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
17135808|NCT01776424|38277123|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
17135809|NCT01776424|38277124|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
17135810|NCT01776424|38277122|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
17135811|NCT01776424|38277123|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
17135812|NCT01776424|38277124|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
17135813|NCT01776424|38277122|FG000|LTOLE Part (Open Label)|Refused|5|||
17135814|NCT01776424|38277123|FG001|LTOLE Part (Open Label)|Refused|2|||
17135815|NCT01776424|38277124|FG002|LTOLE Part (Open Label)|Refused|11|||
17135816|NCT01776424|38277122|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
17135817|NCT01776424|38277123|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
17135818|NCT01776424|38277124|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
17135819|NCT03799627|38277150|FG000|Overall Study|Adverse Event|1|||
17135820|NCT03799627|38277151|FG001|Overall Study|Adverse Event|2|||
17135821|NCT03799627|38277152|FG002|Overall Study|Adverse Event|0|||
17135822|NCT03799627|38277153|FG003|Overall Study|Adverse Event|0|||
17135823|NCT03799627|38277154|FG004|Overall Study|Adverse Event|2|||
17135824|NCT03799627|38277155|FG005|Overall Study|Adverse Event|5|||
17135825|NCT03799627|38277156|FG006|Overall Study|Adverse Event|0|||
17135826|NCT03799627|38277157|FG007|Overall Study|Adverse Event|2|||
17135827|NCT03799627|38277158|FG008|Overall Study|Adverse Event|0|||
17135828|NCT03799627|38277150|FG000|Overall Study|Physician Decision|2|||
17135829|NCT03799627|38277151|FG001|Overall Study|Physician Decision|2|||
17135830|NCT03799627|38277152|FG002|Overall Study|Physician Decision|0|||
17135831|NCT03799627|38277153|FG003|Overall Study|Physician Decision|0|||
17135832|NCT03799627|38277154|FG004|Overall Study|Physician Decision|2|||
17135833|NCT03799627|38277155|FG005|Overall Study|Physician Decision|2|||
17135834|NCT03799627|38277156|FG006|Overall Study|Physician Decision|0|||
17135835|NCT03799627|38277157|FG007|Overall Study|Physician Decision|0|||
17135836|NCT03799627|38277158|FG008|Overall Study|Physician Decision|0|||
17135837|NCT03799627|38277150|FG000|Overall Study|Withdrawal by Subject|1|||
17135838|NCT03799627|38277151|FG001|Overall Study|Withdrawal by Subject|1|||
17135839|NCT03799627|38277152|FG002|Overall Study|Withdrawal by Subject|0|||
17135840|NCT03799627|38277153|FG003|Overall Study|Withdrawal by Subject|2|||
17135841|NCT03799627|38277154|FG004|Overall Study|Withdrawal by Subject|0|||
17135842|NCT03799627|38277155|FG005|Overall Study|Withdrawal by Subject|3|||
17135843|NCT03799627|38277156|FG006|Overall Study|Withdrawal by Subject|0|||
17135844|NCT03799627|38277157|FG007|Overall Study|Withdrawal by Subject|0|||
17135845|NCT03799627|38277158|FG008|Overall Study|Withdrawal by Subject|0|||
17135846|NCT03799627|38277150|FG000|Overall Study|Lack of Efficacy|0|||
17135847|NCT03799627|38277151|FG001|Overall Study|Lack of Efficacy|0|||
17135848|NCT03799627|38277152|FG002|Overall Study|Lack of Efficacy|0|||
17135849|NCT03799627|38277153|FG003|Overall Study|Lack of Efficacy|1|||
17135850|NCT03799627|38277154|FG004|Overall Study|Lack of Efficacy|0|||
17135851|NCT03799627|38277155|FG005|Overall Study|Lack of Efficacy|0|||
17135852|NCT03799627|38277156|FG006|Overall Study|Lack of Efficacy|0|||
17135853|NCT03799627|38277157|FG007|Overall Study|Lack of Efficacy|0|||
17135854|NCT03799627|38277158|FG008|Overall Study|Lack of Efficacy|0|||
17135855|NCT03799627|38277150|FG000|Overall Study|Lost to Follow-up|0|||
17135856|NCT03799627|38277151|FG001|Overall Study|Lost to Follow-up|0|||
17135857|NCT03799627|38277152|FG002|Overall Study|Lost to Follow-up|0|||
17135858|NCT03799627|38277153|FG003|Overall Study|Lost to Follow-up|0|||
17135859|NCT03799627|38277154|FG004|Overall Study|Lost to Follow-up|0|||
17135860|NCT03799627|38277155|FG005|Overall Study|Lost to Follow-up|0|||
17135861|NCT03799627|38277156|FG006|Overall Study|Lost to Follow-up|1|||
17135862|NCT03799627|38277157|FG007|Overall Study|Lost to Follow-up|0|||
17135863|NCT03799627|38277158|FG008|Overall Study|Lost to Follow-up|1|||
17135864|NCT03799627|38277150|FG000|Overall Study|Death|0|||
17135865|NCT03799627|38277151|FG001|Overall Study|Death|0|||
17135866|NCT03799627|38277152|FG002|Overall Study|Death|0|||
17135867|NCT03799627|38277153|FG003|Overall Study|Death|1|||
17135868|NCT03799627|38277154|FG004|Overall Study|Death|0|||
17135869|NCT03799627|38277155|FG005|Overall Study|Death|0|||
17135870|NCT03799627|38277156|FG006|Overall Study|Death|0|||
17135871|NCT03799627|38277157|FG007|Overall Study|Death|0|||
17135872|NCT03799627|38277158|FG008|Overall Study|Death|0|||
17135873|NCT03799627|38277150|FG000|Overall Study|Study Drug Put on Hold|1|||
17135874|NCT03799627|38277151|FG001|Overall Study|Study Drug Put on Hold|0|||
17135875|NCT03799627|38277152|FG002|Overall Study|Study Drug Put on Hold|0|||
17135876|NCT03799627|38277153|FG003|Overall Study|Study Drug Put on Hold|0|||
17135877|NCT03799627|38277154|FG004|Overall Study|Study Drug Put on Hold|0|||
17135878|NCT03799627|38277155|FG005|Overall Study|Study Drug Put on Hold|0|||
17135879|NCT03799627|38277156|FG006|Overall Study|Study Drug Put on Hold|0|||
17135880|NCT03799627|38277157|FG007|Overall Study|Study Drug Put on Hold|0|||
17135881|NCT03799627|38277158|FG008|Overall Study|Study Drug Put on Hold|0|||
17135882|NCT03799627|38277150|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
17135883|NCT03799627|38277151|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
17135884|NCT03799627|38277152|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
17135885|NCT03799627|38277153|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
17135886|NCT03799627|38277154|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
17135887|NCT03799627|38277155|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
17135888|NCT03799627|38277156|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
17135889|NCT03799627|38277157|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
17135890|NCT03799627|38277158|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
17135891|NCT03799627|38277150|FG000|Overall Study|Kidney Transplantation|1|||
17135892|NCT03799627|38277151|FG001|Overall Study|Kidney Transplantation|0|||
17135893|NCT03799627|38277152|FG002|Overall Study|Kidney Transplantation|0|||
17135894|NCT03799627|38277153|FG003|Overall Study|Kidney Transplantation|1|||
17135895|NCT03799627|38277154|FG004|Overall Study|Kidney Transplantation|1|||
17135896|NCT03799627|38277155|FG005|Overall Study|Kidney Transplantation|0|||
17135897|NCT03799627|38277156|FG006|Overall Study|Kidney Transplantation|0|||
17135898|NCT03799627|38277157|FG007|Overall Study|Kidney Transplantation|0|||
17135899|NCT03799627|38277158|FG008|Overall Study|Kidney Transplantation|0|||
17135900|NCT03799627|38277150|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
17135901|NCT03799627|38277151|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
17135902|NCT03799627|38277152|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
17135903|NCT03799627|38277153|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
17135904|NCT03799627|38277154|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
17135905|NCT03799627|38277155|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
17135906|NCT03799627|38277156|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
17135907|NCT03799627|38277157|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
17135908|NCT03799627|38277158|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
17135909|NCT03799627|38277150|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
17135910|NCT03799627|38277151|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
17135911|NCT03799627|38277152|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
17135912|NCT03799627|38277153|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
17135913|NCT03799627|38277154|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
17135914|NCT03799627|38277155|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
17135915|NCT03799627|38277156|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
17135916|NCT03799627|38277157|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
17135917|NCT03799627|38277158|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
17135918|NCT03799627|38277150|FG000|Overall Study|Met Exclusion Criteria|0|||
17135919|NCT03799627|38277151|FG001|Overall Study|Met Exclusion Criteria|0|||
17135920|NCT03799627|38277152|FG002|Overall Study|Met Exclusion Criteria|0|||
17135921|NCT03799627|38277153|FG003|Overall Study|Met Exclusion Criteria|1|||
17135922|NCT03799627|38277154|FG004|Overall Study|Met Exclusion Criteria|0|||
17135923|NCT03799627|38277155|FG005|Overall Study|Met Exclusion Criteria|0|||
17135924|NCT03799627|38277156|FG006|Overall Study|Met Exclusion Criteria|0|||
16990707|NCT00774930|38134753|FG000|LTOLE Phase|Adverse Event|7|||
16990708|NCT00774930|38134754|FG001|LTOLE Phase|Adverse Event|3|||
16990709|NCT00774930|38134753|FG000|LTOLE Phase|Subject decision|0|||
16990710|NCT00774930|38134754|FG001|LTOLE Phase|Subject decision|5|||
16990711|NCT00774930|38134753|FG000|LTOLE Phase|Physician Decision|4|||
16990712|NCT00774930|38134754|FG001|LTOLE Phase|Physician Decision|1|||
16990713|NCT00774930|38134753|FG000|LTOLE Phase|Sponsor decision|2|||
16990714|NCT00774930|38134754|FG001|LTOLE Phase|Sponsor decision|1|||
16990715|NCT00774930|38134753|FG000|LTOLE Phase|Disease Progression|2|||
16990716|NCT00774930|38134754|FG001|LTOLE Phase|Disease Progression|5|||
16990717|NCT00774930|38134753|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
16990718|NCT00774930|38134754|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
16990719|NCT00774930|38134753|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
16990720|NCT00774930|38134754|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
16990721|NCT01027364|38134775|FG000|Overall Study|Adverse Event|1|||
16990722|NCT01027364|38134776|FG001|Overall Study|Adverse Event|0|||
16990723|NCT01027364|38134777|FG002|Overall Study|Adverse Event|1|||
16990724|NCT01027364|38134778|FG003|Overall Study|Adverse Event|0|||
16990725|NCT01027364|38134775|FG000|Overall Study|Lost to Follow-up|1|||
16990726|NCT01027364|38134776|FG001|Overall Study|Lost to Follow-up|0|||
16990727|NCT01027364|38134777|FG002|Overall Study|Lost to Follow-up|0|||
16990728|NCT01027364|38134778|FG003|Overall Study|Lost to Follow-up|0|||
16990729|NCT01027364|38134775|FG000|Overall Study|Protocol Violation|1|||
16990730|NCT01027364|38134776|FG001|Overall Study|Protocol Violation|0|||
16990731|NCT01027364|38134777|FG002|Overall Study|Protocol Violation|0|||
16990732|NCT01027364|38134778|FG003|Overall Study|Protocol Violation|1|||
16990733|NCT01027364|38134775|FG000|Overall Study|Withdrawal by Subject|1|||
16990734|NCT01027364|38134776|FG001|Overall Study|Withdrawal by Subject|2|||
16990735|NCT01027364|38134777|FG002|Overall Study|Withdrawal by Subject|0|||
16990736|NCT01027364|38134778|FG003|Overall Study|Withdrawal by Subject|0|||
16990737|NCT01027286|38134806|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
16990738|NCT01027286|38134807|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
16990739|NCT01027286|38134806|FG000|Overall Study|Lost to Follow-up|0|||
16990740|NCT01027286|38134807|FG001|Overall Study|Lost to Follow-up|1|||
16990741|NCT01026974|38134817|FG000|Overall Study|Withdrawal by Subject|0|||
16990742|NCT01026974|38134818|FG001|Overall Study|Withdrawal by Subject|1|||
16990743|NCT01026974|38134819|FG002|Overall Study|Withdrawal by Subject|7|||
16990744|NCT01026974|38134820|FG003|Overall Study|Withdrawal by Subject|2|||
16990745|NCT01026974|38134817|FG000|Overall Study|Lost to Follow-up|1|||
16990746|NCT01026974|38134818|FG001|Overall Study|Lost to Follow-up|1|||
16990747|NCT01026974|38134819|FG002|Overall Study|Lost to Follow-up|4|||
16990748|NCT01026974|38134820|FG003|Overall Study|Lost to Follow-up|0|||
16990749|NCT01026974|38134817|FG000|Overall Study|Adverse Event|0|||
16990750|NCT01026974|38134818|FG001|Overall Study|Adverse Event|0|||
16990751|NCT01026974|38134819|FG002|Overall Study|Adverse Event|0|||
16990752|NCT01026974|38134820|FG003|Overall Study|Adverse Event|1|||
16990753|NCT01026974|38134817|FG000|Overall Study|Inappropriate enrollment|0|||
17028633|NCT00764504|38172998|FG000|Overall Study|Revision of Device|12|||
17028634|NCT00764504|38172999|FG001|Overall Study|Revision of Device|23|||
17028635|NCT00764504|38173000|FG002|Overall Study|Revision of Device|14|||
17028636|NCT00764504|38172998|FG000|Overall Study|Physician Decision|1|||
17028637|NCT00764504|38172999|FG001|Overall Study|Physician Decision|0|||
17028638|NCT00764504|38173000|FG002|Overall Study|Physician Decision|0|||
17028639|NCT00764504|38172998|FG000|Overall Study|Withdrawal by Subject|1|||
17028640|NCT00764504|38172999|FG001|Overall Study|Withdrawal by Subject|7|||
17028641|NCT00764504|38173000|FG002|Overall Study|Withdrawal by Subject|4|||
16990754|NCT01026974|38134818|FG001|Overall Study|Inappropriate enrollment|0|||
16990755|NCT01026974|38134819|FG002|Overall Study|Inappropriate enrollment|1|||
16990756|NCT01026974|38134820|FG003|Overall Study|Inappropriate enrollment|0|||
16990757|NCT00897390|38134835|FG000|Overall Study|Adverse Event|2|||
16990758|NCT00897390|38134835|FG000|Overall Study|No Longer Met Study Criteria|1|||
16990759|NCT00897390|38134835|FG000|Overall Study|Personal Reasons|1|||
16990760|NCT00897390|38134835|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
16990761|NCT01034462|38134848|FG000|Overall Study|Adverse Event|7|||
16990762|NCT01034462|38134849|FG001|Overall Study|Adverse Event|17|||
16990763|NCT01034462|38134848|FG000|Overall Study|Lack of Efficacy|4|||
16990764|NCT01034462|38134849|FG001|Overall Study|Lack of Efficacy|4|||
16990765|NCT01034462|38134848|FG000|Overall Study|Protocol Violation|10|||
17028642|NCT00764504|38172998|FG000|Overall Study|Lost to Follow-up|40|||
17028643|NCT00764504|38172999|FG001|Overall Study|Lost to Follow-up|34|||
17028644|NCT00764504|38173000|FG002|Overall Study|Lost to Follow-up|72|||
17028645|NCT00763958|38173010|FG000|Overall Study|did not meet final criteria|4|||
17028646|NCT00763958|38173011|FG001|Overall Study|did not meet final criteria|4|||
17028647|NCT00763958|38173010|FG000|Overall Study|Lost to Follow-up|10|||
17028648|NCT00763958|38173011|FG001|Overall Study|Lost to Follow-up|2|||
17028649|NCT00763958|38173010|FG000|Overall Study|Believed they were receiving placebo|0|||
17028650|NCT00763958|38173011|FG001|Overall Study|Believed they were receiving placebo|5|||
17028651|NCT00763256|38173020|FG000|Overall Study|Didn't return for appointments|7|||
17028652|NCT00763256|38173021|FG001|Overall Study|Didn't return for appointments|10|||
17028653|NCT00762788|38173033|FG000|Overall Study|Lost to Follow-up|26|||
17028654|NCT00762788|38173034|FG001|Overall Study|Lost to Follow-up|37|||
17028655|NCT00762788|38173035|FG002|Overall Study|Lost to Follow-up|21|||
17028656|NCT00762788|38173036|FG003|Overall Study|Lost to Follow-up|26|||
17028657|NCT00762788|38173037|FG004|Overall Study|Lost to Follow-up|13|||
17028658|NCT00762788|38173038|FG005|Overall Study|Lost to Follow-up|21|||
17028659|NCT00583947|38173054|FG000|Cross-over Period|Adverse Event|2|||
17028660|NCT00583947|38173055|FG001|Cross-over Period|Adverse Event|0|||
17028661|NCT00583947|38173054|FG000|Cross-over Period|Withdrawal by Subject|2|||
17028662|NCT00583947|38173055|FG001|Cross-over Period|Withdrawal by Subject|0|||
17028663|NCT00583947|38173054|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
17028664|NCT00583947|38173055|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
17028665|NCT00583947|38173054|FG000|Cross-over Period|Other|1|||
17028666|NCT00583947|38173055|FG001|Cross-over Period|Other|1|||
17028667|NCT00772928|38173065|FG000|Overall Study|Lost to Follow-up|9|||
17028668|NCT00772928|38173066|FG001|Overall Study|Lost to Follow-up|6|||
17028669|NCT00772928|38173065|FG000|Overall Study|Protocol Violation|10|||
17028670|NCT00772928|38173066|FG001|Overall Study|Protocol Violation|12|||
17028671|NCT00772928|38173065|FG000|Overall Study|Withdrawal by Subject|25|||
17028672|NCT00772928|38173066|FG001|Overall Study|Withdrawal by Subject|22|||
17028673|NCT00772928|38173065|FG000|Overall Study|Did not receive vaccine|0|||
17028674|NCT00772928|38173066|FG001|Overall Study|Did not receive vaccine|1|||
17028675|NCT00762476|38173074|FG000|Overall Study|Adverse Event|7|||
17028676|NCT00762476|38173075|FG001|Overall Study|Adverse Event|1|||
17028677|NCT00762476|38173074|FG000|Overall Study|Lost to Follow-up|2|||
17028678|NCT00762476|38173075|FG001|Overall Study|Lost to Follow-up|0|||
17028679|NCT00762476|38173074|FG000|Overall Study|Protocol Violation|5|||
17028680|NCT00762476|38173075|FG001|Overall Study|Protocol Violation|6|||
17028681|NCT00762476|38173074|FG000|Overall Study|Physician Decision|2|||
16990766|NCT01034462|38134849|FG001|Overall Study|Protocol Violation|7|||
17028682|NCT00762476|38173075|FG001|Overall Study|Physician Decision|14|||
17028683|NCT00762476|38173074|FG000|Overall Study|Withdrawal by Subject|6|||
17028684|NCT00762476|38173075|FG001|Overall Study|Withdrawal by Subject|12|||
17028685|NCT00762476|38173074|FG000|Overall Study|antibiotic use|0|||
17028686|NCT00762476|38173075|FG001|Overall Study|antibiotic use|1|||
17028687|NCT00762476|38173074|FG000|Overall Study|non-compliance with study visits|0|||
17028688|NCT00762476|38173075|FG001|Overall Study|non-compliance with study visits|2|||
17028689|NCT00762476|38173074|FG000|Overall Study|Seasonal allergies|1|||
17028690|NCT00762476|38173075|FG001|Overall Study|Seasonal allergies|0|||
17028691|NCT00762164|38173084|FG000|Overall Study|Lost to Follow-up|1|||
17028692|NCT00762164|38173085|FG001|Overall Study|Lost to Follow-up|1|||
17028693|NCT00762164|38173084|FG000|Overall Study|Discontinued medication|2|||
17028694|NCT00762164|38173085|FG001|Overall Study|Discontinued medication|0|||
17028695|NCT00762164|38173084|FG000|Overall Study|Withdrawal by Subject|0|||
17028696|NCT00762164|38173085|FG001|Overall Study|Withdrawal by Subject|1|||
17028697|NCT00762086|38173093|FG000|Overall Study|Adverse Event|2|||
17028698|NCT00762086|38173094|FG001|Overall Study|Adverse Event|0|||
17028699|NCT00762086|38173093|FG000|Overall Study|Lost to Follow-up|0|||
17028700|NCT00762086|38173094|FG001|Overall Study|Lost to Follow-up|2|||
17028701|NCT00762086|38173093|FG000|Overall Study|Non compliance|1|||
17028702|NCT00762086|38173094|FG001|Overall Study|Non compliance|0|||
17028703|NCT00762086|38173093|FG000|Overall Study|Withdrawal by Subject|2|||
17028704|NCT00762086|38173094|FG001|Overall Study|Withdrawal by Subject|2|||
17028705|NCT00762086|38173093|FG000|Overall Study|Ineligible to participate in the study|1|||
17028706|NCT00762086|38173094|FG001|Overall Study|Ineligible to participate in the study|0|||
16990767|NCT01034462|38134848|FG000|Overall Study|Withdrawal by Subject|9|||
16990768|NCT01034462|38134849|FG001|Overall Study|Withdrawal by Subject|8|||
17028707|NCT00761774|38173100|FG000|Overall Study|Adverse Event|17|||
17028708|NCT00761774|38173100|FG000|Overall Study|Lack of Efficacy|37|||
17028709|NCT00761774|38173100|FG000|Overall Study|Lost to Follow-up|2|||
17028710|NCT00761774|38173100|FG000|Overall Study|Withdrawal by Subject|9|||
16990769|NCT01034462|38134848|FG000|Overall Study|Lost to Follow-up|14|||
17028711|NCT00761774|38173100|FG000|Overall Study|Non-compliance|4|||
17028712|NCT00761774|38173100|FG000|Overall Study|End of study|2|||
17028713|NCT00761774|38173100|FG000|Overall Study|Reclassification of seizures|1|||
17028714|NCT00761774|38173100|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
17028715|NCT00761774|38173100|FG000|Overall Study|Sponsor decision|1|||
17028716|NCT00761774|38173100|FG000|Overall Study|Investigator clinical judgement|1|||
17028717|NCT00761774|38173100|FG000|Overall Study|Patient moved out of study area|1|||
17028718|NCT00761774|38173100|FG000|Overall Study|Coordinator leaving site|1|||
17028719|NCT00761774|38173100|FG000|Overall Study|Subject IP non-compliance|1|||
17028720|NCT00761774|38173100|FG000|Overall Study|IP stopped by hospital physician|1|||
17028721|NCT00583791|38173106|FG000|Overall Study|Other|67|||
17028722|NCT00583791|38173106|FG000|Overall Study|Death|6|||
17028723|NCT00781274|38173110|FG000|Overall Study|Withdrawal by Subject|2|||
17135925|NCT03799627|38277157|FG007|Overall Study|Met Exclusion Criteria|0|||
17028724|NCT00780416|38173116|FG000|Overall Study|Physician Decision|3|||
17028725|NCT00780416|38173117|FG001|Overall Study|Physician Decision|3|||
17028726|NCT00780416|38173116|FG000|Overall Study|Protocol Violation|1|||
17028727|NCT00780416|38173117|FG001|Overall Study|Protocol Violation|0|||
17028728|NCT00780416|38173116|FG000|Overall Study|Withdrawal by Subject|8|||
17028729|NCT00780416|38173117|FG001|Overall Study|Withdrawal by Subject|6|||
17028730|NCT00761462|38173125|FG000|Treatment|Subjects never received study medication|23|||
17028731|NCT00761462|38173126|FG001|Treatment|Subjects never received study medication|12|||
17028732|NCT00761462|38173125|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
17028733|NCT00761462|38173126|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
17028734|NCT00761462|38173125|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
17028735|NCT00761462|38173126|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
17028736|NCT00761462|38173125|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
17028737|NCT00761462|38173126|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
17028738|NCT00761306|38173132|FG000|Overall Study|Adverse Event|5|||
17028739|NCT00761306|38173132|FG000|Overall Study|Lack of Efficacy|4|||
17028740|NCT00761306|38173132|FG000|Overall Study|Protocol Violation|2|||
17028741|NCT00761306|38173132|FG000|Overall Study|Withdrawal of Consent|3|||
17028742|NCT00761306|38173132|FG000|Overall Study|Lost to Follow-up|1|||
17028743|NCT00761306|38173132|FG000|Overall Study|Administrative or Other Reasons|5|||
17028744|NCT00772538|38173138|FG000|Overall Study|Adverse Event|6|||
17028745|NCT00772538|38173139|FG001|Overall Study|Adverse Event|6|||
17028746|NCT00772538|38173138|FG000|Overall Study|Protocol Violation|3|||
16990770|NCT01034462|38134849|FG001|Overall Study|Lost to Follow-up|16|||
16990771|NCT01034462|38134848|FG000|Overall Study|Other reasons|1|||
16990772|NCT01034462|38134849|FG001|Overall Study|Other reasons|2|||
16990773|NCT01033448|38134857|FG000|Overall Study|Withdrawal by Subject|4|||
16990774|NCT01033448|38134857|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
16990775|NCT01033448|38134857|FG000|Overall Study|Lost to Follow-up|3|||
16990776|NCT01033448|38134857|FG000|Overall Study|Withdrew due to other reasons|3|||
16990777|NCT01033448|38134857|FG000|Overall Study|Unknown disposition|1|||
17028747|NCT00772538|38173139|FG001|Overall Study|Protocol Violation|3|||
17028748|NCT00772538|38173138|FG000|Overall Study|Lost to Follow-up|1|||
17028749|NCT00772538|38173139|FG001|Overall Study|Lost to Follow-up|1|||
17028750|NCT00772538|38173138|FG000|Overall Study|Withdrawal by Subject|3|||
17028751|NCT00772538|38173139|FG001|Overall Study|Withdrawal by Subject|8|||
17028752|NCT00772538|38173138|FG000|Overall Study|Lack of Efficacy|0|||
17028753|NCT00772538|38173139|FG001|Overall Study|Lack of Efficacy|1|||
17028754|NCT00772538|38173138|FG000|Overall Study|Other|7|||
17028755|NCT00772538|38173139|FG001|Overall Study|Other|7|||
17028756|NCT00761150|38173148|FG000|Open-label Period|Adverse Event|36|||
17028757|NCT00761150|38173149|FG001|Open-label Period|Adverse Event|0|||
17028758|NCT00761150|38173150|FG002|Open-label Period|Adverse Event|0|||
17028759|NCT00761150|38173148|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
17028760|NCT00761150|38173149|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
17028761|NCT00761150|38173150|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
17028762|NCT00761150|38173148|FG000|Open-label Period|Lost to Follow-up|7|||
17028763|NCT00761150|38173149|FG001|Open-label Period|Lost to Follow-up|0|||
17028764|NCT00761150|38173150|FG002|Open-label Period|Lost to Follow-up|0|||
17028765|NCT00761150|38173148|FG000|Open-label Period|Lack of Efficacy|4|||
17028766|NCT00761150|38173149|FG001|Open-label Period|Lack of Efficacy|0|||
17028767|NCT00761150|38173150|FG002|Open-label Period|Lack of Efficacy|0|||
17028768|NCT00761150|38173148|FG000|Open-label Period|Withdrawal by Subject|5|||
17028769|NCT00761150|38173149|FG001|Open-label Period|Withdrawal by Subject|0|||
17028770|NCT00761150|38173150|FG002|Open-label Period|Withdrawal by Subject|0|||
17028771|NCT00761150|38173148|FG000|Open-label Period|Noncompliance|2|||
17028772|NCT00761150|38173149|FG001|Open-label Period|Noncompliance|0|||
17028773|NCT00761150|38173150|FG002|Open-label Period|Noncompliance|0|||
17028774|NCT00761150|38173148|FG000|Open-label Period|Other|5|||
17028775|NCT00761150|38173149|FG001|Open-label Period|Other|0|||
17028776|NCT00761150|38173150|FG002|Open-label Period|Other|0|||
17028777|NCT00761150|38173148|FG000|Double-blind Period|Lack of Efficacy|0|||
17028778|NCT00761150|38173149|FG001|Double-blind Period|Lack of Efficacy|2|||
17028779|NCT00761150|38173150|FG002|Double-blind Period|Lack of Efficacy|19|||
17028780|NCT00761150|38173148|FG000|Double-blind Period|Adverse Event|0|||
17028781|NCT00761150|38173149|FG001|Double-blind Period|Adverse Event|3|||
17028782|NCT00761150|38173150|FG002|Double-blind Period|Adverse Event|3|||
17028783|NCT00761150|38173148|FG000|Double-blind Period|Withdrawal by Subject|0|||
17028784|NCT00761150|38173149|FG001|Double-blind Period|Withdrawal by Subject|3|||
17028785|NCT00761150|38173150|FG002|Double-blind Period|Withdrawal by Subject|2|||
17028786|NCT00761150|38173148|FG000|Double-blind Period|Lost to Follow-up|0|||
17028787|NCT00761150|38173149|FG001|Double-blind Period|Lost to Follow-up|2|||
17028788|NCT00761150|38173150|FG002|Double-blind Period|Lost to Follow-up|1|||
17028789|NCT00761150|38173148|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
17028790|NCT00761150|38173149|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
17028791|NCT00761150|38173150|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
17028792|NCT00761150|38173148|FG000|Double-blind Period|Noncompliance|0|||
17028793|NCT00761150|38173149|FG001|Double-blind Period|Noncompliance|1|||
17028794|NCT00761150|38173150|FG002|Double-blind Period|Noncompliance|0|||
17028795|NCT00761150|38173148|FG000|Double-blind Period|Other|0|||
17028796|NCT00761150|38173149|FG001|Double-blind Period|Other|3|||
17028797|NCT00761150|38173150|FG002|Double-blind Period|Other|3|||
17028798|NCT00760994|38173160|FG000|Overall Study|Lost to Follow-up|4|||
17028799|NCT00760994|38173161|FG001|Overall Study|Lost to Follow-up|4|||
17028800|NCT00760994|38173162|FG002|Overall Study|Lost to Follow-up|3|||
17028801|NCT00583557|38173172|FG000|Overall Study|Withdrawal by Subject|18|||
17028802|NCT00583557|38173172|FG000|Overall Study|Adverse Event|9|||
17028803|NCT00583557|38173172|FG000|Overall Study|Lack of Efficacy|31|||
17028804|NCT00583557|38173172|FG000|Overall Study|Lack of Compliance|5|||
17028805|NCT00583557|38173172|FG000|Overall Study|Other|5|||
17028806|NCT00583557|38173172|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
17028807|NCT00586820|38173178|FG000|Overall Study|Unsuccessful PCI|1|||
17028808|NCT00586820|38173179|FG001|Overall Study|Unsuccessful PCI|0|||
17028809|NCT00760838|38173187|FG000|Overall Study|Adverse Event|1|||
17028810|NCT00760838|38173188|FG001|Overall Study|Adverse Event|1|||
17028811|NCT00760838|38173187|FG000|Overall Study|Lack of Efficacy|1|||
17028812|NCT00760838|38173188|FG001|Overall Study|Lack of Efficacy|0|||
17028813|NCT00760838|38173187|FG000|Overall Study|Lost to Follow-up|2|||
16780368|NCT01594827|37719460|FG001|Overall Study|Adverse Event|0|||
16990778|NCT00746941|38134867|FG000|Overall Study|Death|2|||
16990779|NCT00746941|38134868|FG001|Overall Study|Death|0|||
16990780|NCT00746941|38134869|FG002|Overall Study|Death|0|||
16990781|NCT00746941|38134870|FG003|Overall Study|Death|6|||
16990782|NCT00746941|38134867|FG000|Overall Study|Physician Decision|0|||
16990783|NCT00746941|38134868|FG001|Overall Study|Physician Decision|0|||
16990784|NCT00746941|38134869|FG002|Overall Study|Physician Decision|2|||
16990785|NCT00746941|38134870|FG003|Overall Study|Physician Decision|0|||
16990786|NCT00746941|38134867|FG000|Overall Study|Withdrawal by Subject|3|||
16990787|NCT00746941|38134868|FG001|Overall Study|Withdrawal by Subject|0|||
16990788|NCT00746941|38134869|FG002|Overall Study|Withdrawal by Subject|0|||
17028814|NCT00760838|38173188|FG001|Overall Study|Lost to Follow-up|0|||
17028815|NCT00760838|38173187|FG000|Overall Study|Withdrawal by Subject|1|||
17135926|NCT03799627|38277158|FG008|Overall Study|Met Exclusion Criteria|0|||
16990789|NCT00746941|38134870|FG003|Overall Study|Withdrawal by Subject|2|||
17028816|NCT00760838|38173188|FG001|Overall Study|Withdrawal by Subject|1|||
17028817|NCT00586664|38173197|FG000|Overall Study|Withdrawal by Subject|3|||
17028818|NCT00586664|38173198|FG001|Overall Study|Withdrawal by Subject|7|||
17028819|NCT00586664|38173199|FG002|Overall Study|Withdrawal by Subject|1|||
16990790|NCT00746941|38134867|FG000|Overall Study|Other, reason not provided|2|||
17028820|NCT00586664|38173197|FG000|Overall Study|Exclusion criteria met|2|||
17028821|NCT00586664|38173198|FG001|Overall Study|Exclusion criteria met|0|||
17028822|NCT00586664|38173199|FG002|Overall Study|Exclusion criteria met|0|||
17090037|NCT00280566|38230152|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
17090038|NCT00280566|38230153|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
17090039|NCT00280566|38230151|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
17090040|NCT00280566|38230152|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
17090041|NCT00280566|38230153|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
17090042|NCT00280566|38230151|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
17090043|NCT00280566|38230152|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
16990791|NCT00746941|38134868|FG001|Overall Study|Other, reason not provided|4|||
16990792|NCT00746941|38134869|FG002|Overall Study|Other, reason not provided|0|||
16990793|NCT00746941|38134870|FG003|Overall Study|Other, reason not provided|4|||
16990794|NCT00746941|38134867|FG000|Overall Study|Adverse Event|0|||
16990795|NCT00746941|38134868|FG001|Overall Study|Adverse Event|0|||
16990796|NCT00746941|38134869|FG002|Overall Study|Adverse Event|0|||
16990797|NCT00746941|38134870|FG003|Overall Study|Adverse Event|1|||
16990798|NCT00746785|38134882|FG000|Overall Study|Lost to Follow-up|29|||
16990799|NCT00746785|38134883|FG001|Overall Study|Lost to Follow-up|25|||
17090044|NCT00280566|38230153|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
17090045|NCT00280566|38230151|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
17090046|NCT00280566|38230152|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
17090047|NCT00280566|38230153|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
17090048|NCT00280566|38230151|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
17090049|NCT00280566|38230152|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
17090050|NCT00280566|38230153|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
17090051|NCT00280566|38230151|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
17090052|NCT00280566|38230152|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
17090053|NCT00280566|38230153|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
17090054|NCT00280566|38230151|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
17090055|NCT00280566|38230152|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
17090056|NCT00280566|38230153|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
17090057|NCT00280566|38230151|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
17090058|NCT00280566|38230152|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
17090059|NCT00280566|38230153|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
17090060|NCT00280566|38230151|FG000|Period 2 Double Blind|Adverse Event|0|||
17135927|NCT03799627|38277150|FG000|Overall Study|Investigational Product Noncompliance|0|||
17135928|NCT03799627|38277151|FG001|Overall Study|Investigational Product Noncompliance|0|||
17135929|NCT03799627|38277152|FG002|Overall Study|Investigational Product Noncompliance|0|||
17135930|NCT03799627|38277153|FG003|Overall Study|Investigational Product Noncompliance|1|||
17135931|NCT03799627|38277154|FG004|Overall Study|Investigational Product Noncompliance|0|||
17135932|NCT03799627|38277155|FG005|Overall Study|Investigational Product Noncompliance|0|||
17135933|NCT03799627|38277156|FG006|Overall Study|Investigational Product Noncompliance|0|||
17135934|NCT03799627|38277157|FG007|Overall Study|Investigational Product Noncompliance|0|||
17135935|NCT03799627|38277158|FG008|Overall Study|Investigational Product Noncompliance|0|||
17135936|NCT03799627|38277150|FG000|Overall Study|Participant Relocation|0|||
17135937|NCT03799627|38277151|FG001|Overall Study|Participant Relocation|0|||
17135938|NCT03799627|38277152|FG002|Overall Study|Participant Relocation|0|||
17135939|NCT03799627|38277153|FG003|Overall Study|Participant Relocation|1|||
17135940|NCT03799627|38277154|FG004|Overall Study|Participant Relocation|0|||
17135941|NCT03799627|38277155|FG005|Overall Study|Participant Relocation|1|||
17135942|NCT03799627|38277156|FG006|Overall Study|Participant Relocation|0|||
17135943|NCT03799627|38277157|FG007|Overall Study|Participant Relocation|0|||
17135944|NCT03799627|38277158|FG008|Overall Study|Participant Relocation|0|||
17135945|NCT03799627|38277150|FG000|Overall Study|Eurofin Issue|0|||
17135946|NCT03799627|38277151|FG001|Overall Study|Eurofin Issue|0|||
17135947|NCT03799627|38277152|FG002|Overall Study|Eurofin Issue|0|||
17135948|NCT03799627|38277153|FG003|Overall Study|Eurofin Issue|0|||
17135949|NCT03799627|38277154|FG004|Overall Study|Eurofin Issue|1|||
17135950|NCT03799627|38277155|FG005|Overall Study|Eurofin Issue|0|||
17135951|NCT03799627|38277156|FG006|Overall Study|Eurofin Issue|0|||
17135952|NCT03799627|38277157|FG007|Overall Study|Eurofin Issue|0|||
17135953|NCT03799627|38277158|FG008|Overall Study|Eurofin Issue|0|||
16990800|NCT00746785|38134884|FG002|Overall Study|Lost to Follow-up|27|||
16990801|NCT00750919|38134892|FG000|Overall Study|Adverse Event|9|||
16990802|NCT00750919|38134892|FG000|Overall Study|Withdrawal by Subject|1|||
17090061|NCT00280566|38230152|FG001|Period 2 Double Blind|Adverse Event|11|||
17090062|NCT00280566|38230153|FG002|Period 2 Double Blind|Adverse Event|15|||
17090063|NCT00280566|38230151|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
17135954|NCT03799627|38277150|FG000|Overall Study|Noncompliance with Site Instructions|0|||
17135955|NCT03799627|38277151|FG001|Overall Study|Noncompliance with Site Instructions|0|||
17135956|NCT03799627|38277152|FG002|Overall Study|Noncompliance with Site Instructions|0|||
17135957|NCT03799627|38277153|FG003|Overall Study|Noncompliance with Site Instructions|0|||
17135958|NCT03799627|38277154|FG004|Overall Study|Noncompliance with Site Instructions|1|||
17135959|NCT03799627|38277155|FG005|Overall Study|Noncompliance with Site Instructions|0|||
17135960|NCT03799627|38277156|FG006|Overall Study|Noncompliance with Site Instructions|0|||
17135961|NCT03799627|38277157|FG007|Overall Study|Noncompliance with Site Instructions|0|||
17135962|NCT03799627|38277158|FG008|Overall Study|Noncompliance with Site Instructions|0|||
17135963|NCT03799627|38277150|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
17135964|NCT03799627|38277151|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
17135965|NCT03799627|38277152|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
17135966|NCT03799627|38277153|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
17135967|NCT03799627|38277154|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
17135968|NCT03799627|38277155|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
17135969|NCT03799627|38277156|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
17135970|NCT03799627|38277157|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
17028823|NCT00437281|38173227|FG000|Overall Study|Adverse Event|0|||
17028824|NCT00437281|38173228|FG001|Overall Study|Adverse Event|0|||
17135971|NCT03799627|38277158|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
17135972|NCT03799627|38277150|FG000|Overall Study|Changes In Hemoglobin Values|1|||
17135973|NCT03799627|38277151|FG001|Overall Study|Changes In Hemoglobin Values|2|||
17135974|NCT03799627|38277152|FG002|Overall Study|Changes In Hemoglobin Values|1|||
17135975|NCT03799627|38277153|FG003|Overall Study|Changes In Hemoglobin Values|0|||
17135976|NCT03799627|38277154|FG004|Overall Study|Changes In Hemoglobin Values|0|||
17135977|NCT03799627|38277155|FG005|Overall Study|Changes In Hemoglobin Values|2|||
17135978|NCT03799627|38277156|FG006|Overall Study|Changes In Hemoglobin Values|1|||
17135979|NCT03799627|38277157|FG007|Overall Study|Changes In Hemoglobin Values|0|||
17135980|NCT03799627|38277158|FG008|Overall Study|Changes In Hemoglobin Values|1|||
17135981|NCT00756574|38277199|FG000|Overall Study|Withdrawal by Subject|9|||
17135982|NCT00756574|38277200|FG001|Overall Study|Withdrawal by Subject|7|||
17135983|NCT00756574|38277199|FG000|Overall Study|Lost to Follow-up|4|||
17135984|NCT00756574|38277200|FG001|Overall Study|Lost to Follow-up|4|||
17135985|NCT02743780|38277209|FG000|Part 3 (7 Days)|Adverse Event|0|||
17135986|NCT02743780|38277210|FG001|Part 3 (7 Days)|Adverse Event|0|||
17028825|NCT00437281|38173229|FG002|Overall Study|Adverse Event|0|||
17028826|NCT00437281|38173230|FG003|Overall Study|Adverse Event|1|||
17028827|NCT00437281|38173231|FG004|Overall Study|Adverse Event|0|||
17028828|NCT00437281|38173232|FG005|Overall Study|Adverse Event|1|||
17028829|NCT00437281|38173233|FG006|Overall Study|Adverse Event|0|||
17028830|NCT00437281|38173234|FG007|Overall Study|Adverse Event|0|||
17028831|NCT00437281|38173235|FG008|Overall Study|Adverse Event|0|||
17028832|NCT00437281|38173236|FG009|Overall Study|Adverse Event|1|||
17028833|NCT00437281|38173237|FG010|Overall Study|Adverse Event|0|||
17028834|NCT00437281|38173238|FG011|Overall Study|Adverse Event|0|||
17028835|NCT00437281|38173239|FG012|Overall Study|Adverse Event|0|||
17028836|NCT00437281|38173240|FG013|Overall Study|Adverse Event|1|||
17028837|NCT00437281|38173241|FG014|Overall Study|Adverse Event|1|||
17028838|NCT00437281|38173242|FG015|Overall Study|Adverse Event|0|||
17028839|NCT00437281|38173243|FG016|Overall Study|Adverse Event|0|||
17028840|NCT00437281|38173244|FG017|Overall Study|Adverse Event|0|||
17028841|NCT00437281|38173245|FG018|Overall Study|Adverse Event|1|||
17135987|NCT02743780|38277211|FG002|Part 3 (7 Days)|Adverse Event|1|||
17135988|NCT02743780|38277212|FG003|Part 3 (7 Days)|Adverse Event|0|||
17135989|NCT02743780|38277213|FG004|Part 3 (7 Days)|Adverse Event|0|||
16990803|NCT00750919|38134892|FG000|Overall Study|Lack of Efficacy|8|||
16990804|NCT00750919|38134892|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
16990805|NCT00750919|38134892|FG000|Overall Study|Other|36|||
16990806|NCT00746551|38134898|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
16990807|NCT00746551|38134899|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
16990808|NCT00746551|38134898|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
16990809|NCT00746551|38134899|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
16990810|NCT00746551|38134898|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
16990811|NCT00746551|38134899|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
16990812|NCT00753649|38134907|FG000|Overall Study|Migrated/moved from study area|1|||
16990813|NCT00753649|38134908|FG001|Overall Study|Migrated/moved from study area|0|||
16990814|NCT00753649|38134907|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
16990815|NCT00753649|38134908|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
17028842|NCT00437281|38173246|FG019|Overall Study|Adverse Event|0|||
17028843|NCT00437281|38173227|FG000|Overall Study|Lost to Follow-up|0|||
17028844|NCT00437281|38173228|FG001|Overall Study|Lost to Follow-up|0|||
17028845|NCT00437281|38173229|FG002|Overall Study|Lost to Follow-up|0|||
16990816|NCT00753649|38134907|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
16990817|NCT00753649|38134908|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
16990818|NCT00753649|38134907|FG000|Overall Study|Protocol Violation|2|||
16990819|NCT00753649|38134908|FG001|Overall Study|Protocol Violation|0|||
16990820|NCT00750139|38134918|FG000|Overall Study|Adverse Event|1|||
16990821|NCT00750139|38134919|FG001|Overall Study|Adverse Event|2|||
17028846|NCT00437281|38173230|FG003|Overall Study|Lost to Follow-up|0|||
17028847|NCT00437281|38173231|FG004|Overall Study|Lost to Follow-up|0|||
17028848|NCT00437281|38173232|FG005|Overall Study|Lost to Follow-up|0|||
17028849|NCT00437281|38173233|FG006|Overall Study|Lost to Follow-up|0|||
17028850|NCT00437281|38173234|FG007|Overall Study|Lost to Follow-up|0|||
17028851|NCT00437281|38173235|FG008|Overall Study|Lost to Follow-up|0|||
17028852|NCT00437281|38173236|FG009|Overall Study|Lost to Follow-up|0|||
17028853|NCT00437281|38173237|FG010|Overall Study|Lost to Follow-up|0|||
16990822|NCT00750139|38134920|FG002|Overall Study|Adverse Event|0|||
16990823|NCT00750139|38134921|FG003|Overall Study|Adverse Event|1|||
16990824|NCT00750139|38134918|FG000|Overall Study|Lost to Follow-up|17|||
16990825|NCT00750139|38134919|FG001|Overall Study|Lost to Follow-up|12|||
16990826|NCT00750139|38134920|FG002|Overall Study|Lost to Follow-up|15|||
16990827|NCT00750139|38134921|FG003|Overall Study|Lost to Follow-up|6|||
17028854|NCT00437281|38173238|FG011|Overall Study|Lost to Follow-up|0|||
17028855|NCT00437281|38173239|FG012|Overall Study|Lost to Follow-up|0|||
16990828|NCT00750139|38134918|FG000|Overall Study|Withdrawal by Subject|3|||
16990829|NCT00750139|38134919|FG001|Overall Study|Withdrawal by Subject|2|||
16990830|NCT00750139|38134920|FG002|Overall Study|Withdrawal by Subject|6|||
16990831|NCT00750139|38134921|FG003|Overall Study|Withdrawal by Subject|2|||
16990832|NCT00750139|38134918|FG000|Overall Study|Physician Decision|1|||
16990833|NCT00750139|38134919|FG001|Overall Study|Physician Decision|1|||
17028856|NCT00437281|38173240|FG013|Overall Study|Lost to Follow-up|0|||
17028857|NCT00437281|38173241|FG014|Overall Study|Lost to Follow-up|0|||
17028858|NCT00437281|38173242|FG015|Overall Study|Lost to Follow-up|0|||
17028859|NCT00437281|38173243|FG016|Overall Study|Lost to Follow-up|0|||
17028860|NCT00437281|38173244|FG017|Overall Study|Lost to Follow-up|0|||
17028861|NCT00437281|38173245|FG018|Overall Study|Lost to Follow-up|0|||
17028862|NCT00437281|38173246|FG019|Overall Study|Lost to Follow-up|1|||
17028863|NCT00741039|38173320|FG000|Overall Study|Patient non-compliance|2|||
17028864|NCT00741039|38173321|FG001|Overall Study|Patient non-compliance|0|||
17028865|NCT00772382|38173327|FG000|Overall Study|Adverse Event|19|||
17028866|NCT00772382|38173327|FG000|Overall Study|Death|6|||
17028867|NCT00772382|38173327|FG000|Overall Study|Lack of Efficacy|4|||
17028868|NCT00772382|38173327|FG000|Overall Study|Physician Decision|5|||
17028869|NCT00772382|38173327|FG000|Overall Study|Protocol Violation|1|||
16990834|NCT00750139|38134920|FG002|Overall Study|Physician Decision|0|||
16990835|NCT00750139|38134921|FG003|Overall Study|Physician Decision|0|||
16990836|NCT00750139|38134918|FG000|Overall Study|Non-compliance|1|||
16990837|NCT00750139|38134919|FG001|Overall Study|Non-compliance|0|||
17028870|NCT00772382|38173327|FG000|Overall Study|Withdrawal by Subject|10|||
17028871|NCT00772382|38173327|FG000|Overall Study|Other Reasons|10|||
17028872|NCT00798707|38173334|FG000|Overall Study|Adverse Event|6|||
17028873|NCT00798707|38173335|FG001|Overall Study|Adverse Event|8|||
17028874|NCT00798707|38173336|FG002|Overall Study|Adverse Event|8|||
17028875|NCT00798707|38173334|FG000|Overall Study|Failed to return|2|||
17028876|NCT00798707|38173335|FG001|Overall Study|Failed to return|2|||
17028877|NCT00798707|38173336|FG002|Overall Study|Failed to return|0|||
17028878|NCT00798707|38173334|FG000|Overall Study|Investigator|0|||
17028879|NCT00798707|38173335|FG001|Overall Study|Investigator|1|||
17028880|NCT00798707|38173336|FG002|Overall Study|Investigator|2|||
17028881|NCT00798707|38173334|FG000|Overall Study|Lack of Efficacy|2|||
17028882|NCT00798707|38173335|FG001|Overall Study|Lack of Efficacy|2|||
17028883|NCT00798707|38173336|FG002|Overall Study|Lack of Efficacy|1|||
17028884|NCT00798707|38173334|FG000|Overall Study|Lost to Follow-up|5|||
17028885|NCT00798707|38173335|FG001|Overall Study|Lost to Follow-up|6|||
17028886|NCT00798707|38173336|FG002|Overall Study|Lost to Follow-up|6|||
17028887|NCT00798707|38173334|FG000|Overall Study|Other|0|||
17028888|NCT00798707|38173335|FG001|Overall Study|Other|1|||
17028889|NCT00798707|38173336|FG002|Overall Study|Other|0|||
17028890|NCT00798707|38173334|FG000|Overall Study|Protocol Violation|4|||
17028891|NCT00798707|38173335|FG001|Overall Study|Protocol Violation|0|||
17028892|NCT00798707|38173336|FG002|Overall Study|Protocol Violation|2|||
17028893|NCT00798707|38173334|FG000|Overall Study|Withdrawal by Subject|3|||
17028894|NCT00798707|38173335|FG001|Overall Study|Withdrawal by Subject|8|||
17028895|NCT00798707|38173336|FG002|Overall Study|Withdrawal by Subject|2|||
17028896|NCT00798707|38173334|FG000|Overall Study|Randomized not treated|4|||
16990838|NCT00750139|38134920|FG002|Overall Study|Non-compliance|1|||
16990839|NCT00750139|38134921|FG003|Overall Study|Non-compliance|3|||
16990840|NCT00750139|38134918|FG000|Overall Study|Termination by sponsor|4|||
16990841|NCT00750139|38134919|FG001|Overall Study|Termination by sponsor|0|||
16990842|NCT00750139|38134920|FG002|Overall Study|Termination by sponsor|0|||
17028897|NCT00798707|38173335|FG001|Overall Study|Randomized not treated|5|||
17028898|NCT00798707|38173336|FG002|Overall Study|Randomized not treated|1|||
17028899|NCT00760214|38173347|FG000|Overall Study|Adverse Event|8|||
17028900|NCT00760214|38173348|FG001|Overall Study|Adverse Event|9|||
17028901|NCT00760214|38173349|FG002|Overall Study|Adverse Event|12|||
17135990|NCT02880956|38277237|FG000|Overall Study|Adverse Event|3|||
17028902|NCT00760214|38173347|FG000|Overall Study|Protocol Violation|3|||
17028903|NCT00760214|38173348|FG001|Overall Study|Protocol Violation|0|||
17028904|NCT00760214|38173349|FG002|Overall Study|Protocol Violation|3|||
17028905|NCT00760214|38173347|FG000|Overall Study|Lost to Follow-up|0|||
17028906|NCT00760214|38173348|FG001|Overall Study|Lost to Follow-up|0|||
17028907|NCT00760214|38173349|FG002|Overall Study|Lost to Follow-up|1|||
17028908|NCT00760214|38173347|FG000|Overall Study|Withdrawal by Subject|12|||
17028909|NCT00760214|38173348|FG001|Overall Study|Withdrawal by Subject|14|||
17028910|NCT00760214|38173349|FG002|Overall Study|Withdrawal by Subject|13|||
17028911|NCT00760214|38173347|FG000|Overall Study|Lack of Efficacy|3|||
17028912|NCT00760214|38173348|FG001|Overall Study|Lack of Efficacy|2|||
17028913|NCT00760214|38173349|FG002|Overall Study|Lack of Efficacy|4|||
17028914|NCT00760214|38173347|FG000|Overall Study|Pregnancy|0|||
17028915|NCT00760214|38173348|FG001|Overall Study|Pregnancy|0|||
17028916|NCT00760214|38173349|FG002|Overall Study|Pregnancy|1|||
17028917|NCT00760214|38173347|FG000|Overall Study|Physician Decision|1|||
17028918|NCT00760214|38173348|FG001|Overall Study|Physician Decision|1|||
17028919|NCT00760214|38173349|FG002|Overall Study|Physician Decision|1|||
17028920|NCT00760214|38173347|FG000|Overall Study|Other|3|||
17028921|NCT00760214|38173348|FG001|Overall Study|Other|4|||
17028922|NCT00760214|38173349|FG002|Overall Study|Other|6|||
17028923|NCT00802841|38173359|FG000|Overall Study|Administrative problems|1|||
17028924|NCT00802841|38173360|FG001|Overall Study|Administrative problems|0|||
17028925|NCT00802841|38173359|FG000|Overall Study|Lost to Follow-up|2|||
17028926|NCT00802841|38173360|FG001|Overall Study|Lost to Follow-up|1|||
17028927|NCT00802841|38173359|FG000|Overall Study|Death|1|||
17028928|NCT00802841|38173360|FG001|Overall Study|Death|2|||
17028929|NCT00802841|38173359|FG000|Overall Study|Adverse Event|8|||
17028930|NCT00802841|38173360|FG001|Overall Study|Adverse Event|2|||
17028931|NCT00802841|38173359|FG000|Overall Study|Disease progression|7|||
17028932|NCT00802841|38173360|FG001|Overall Study|Disease progression|3|||
17028933|NCT00802841|38173359|FG000|Overall Study|Withdrawal by Subject|9|||
17028934|NCT00802841|38173360|FG001|Overall Study|Withdrawal by Subject|5|||
17028935|NCT00802841|38173359|FG000|Overall Study|Protocol deviation|2|||
17028936|NCT00802841|38173360|FG001|Overall Study|Protocol deviation|6|||
17028937|NCT00802841|38173359|FG000|Overall Study|Treatment duration completed|66|||
17028938|NCT00802841|38173360|FG001|Overall Study|Treatment duration completed|76|||
17028939|NCT00772148|38173370|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
17028940|NCT00772148|38173371|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
17028941|NCT00772148|38173370|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
17028942|NCT00772148|38173371|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
17028943|NCT00772148|38173370|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
17028944|NCT00772148|38173371|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
17028945|NCT00772148|38173370|FG000|Maintenance Phase (Week 52)|Death|2|||
17028946|NCT00772148|38173371|FG001|Maintenance Phase (Week 52)|Death|2|||
17028947|NCT00772148|38173370|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
17028948|NCT00772148|38173371|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
17028949|NCT00772148|38173370|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
17028950|NCT00772148|38173371|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
17028951|NCT00772148|38173370|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
17028952|NCT00772148|38173371|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
17028953|NCT00759902|38173379|FG000|Overall Study|Adverse Event|0|||
17028954|NCT00759902|38173380|FG001|Overall Study|Adverse Event|1|||
17028955|NCT00772070|38173388|FG000|Overall Study|Lost to Follow-up|0|||
17028956|NCT00772070|38173389|FG001|Overall Study|Lost to Follow-up|8|||
17028957|NCT00772070|38173388|FG000|Overall Study|Withdrawal by Subject|0|||
17028958|NCT00772070|38173389|FG001|Overall Study|Withdrawal by Subject|2|||
17028959|NCT00772070|38173388|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
17028960|NCT00772070|38173389|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
17028961|NCT00796757|38173395|FG000|Overall Study|Withdrawal by Subject|14|||
17028962|NCT00796757|38173395|FG000|Overall Study|Death|61|||
17028963|NCT00796757|38173395|FG000|Overall Study|Protocol Violation|1|||
17028964|NCT00796757|38173395|FG000|Overall Study|Participant noncompliance|1|||
17028965|NCT00796757|38173395|FG000|Overall Study|Investigator's decision|2|||
17028966|NCT00796757|38173395|FG000|Overall Study|Other|7|||
17028967|NCT00759356|38173401|FG000|Overall Study|Adverse Event|0|||
17028968|NCT00759356|38173402|FG001|Overall Study|Adverse Event|1|||
17028969|NCT00759356|38173401|FG000|Overall Study|Withdrawal by Subject|0|||
17028970|NCT00759356|38173402|FG001|Overall Study|Withdrawal by Subject|2|||
17028971|NCT00759356|38173401|FG000|Overall Study|Subject was unable to return|1|||
17028972|NCT00759356|38173402|FG001|Overall Study|Subject was unable to return|0|||
17028973|NCT00721734|38173413|FG000|Overall Study|Progressive Disease|3|||
17028974|NCT00721734|38173414|FG001|Overall Study|Progressive Disease|10|||
17028975|NCT00721734|38173415|FG002|Overall Study|Progressive Disease|4|||
17028976|NCT00721734|38173416|FG003|Overall Study|Progressive Disease|5|||
17028977|NCT00721734|38173417|FG004|Overall Study|Progressive Disease|2|||
17028978|NCT00721734|38173413|FG000|Overall Study|Adverse Event|3|||
17028979|NCT00721734|38173414|FG001|Overall Study|Adverse Event|1|||
17028980|NCT00721734|38173415|FG002|Overall Study|Adverse Event|4|||
17028981|NCT00721734|38173416|FG003|Overall Study|Adverse Event|0|||
17028982|NCT00721734|38173417|FG004|Overall Study|Adverse Event|3|||
17028983|NCT00721734|38173413|FG000|Overall Study|Withdrawal by Subject|2|||
17028984|NCT00721734|38173414|FG001|Overall Study|Withdrawal by Subject|1|||
17028985|NCT00721734|38173415|FG002|Overall Study|Withdrawal by Subject|0|||
17028986|NCT00721734|38173416|FG003|Overall Study|Withdrawal by Subject|0|||
17028987|NCT00721734|38173417|FG004|Overall Study|Withdrawal by Subject|1|||
17028988|NCT00721734|38173413|FG000|Overall Study|Other|0|||
17028989|NCT00721734|38173414|FG001|Overall Study|Other|0|||
17028990|NCT00721734|38173415|FG002|Overall Study|Other|0|||
17028991|NCT00721734|38173416|FG003|Overall Study|Other|1|||
17028992|NCT00721734|38173417|FG004|Overall Study|Other|0|||
17028993|NCT00798317|38173431|FG000|Overall Study|Physician Decision|0|||
17028994|NCT00798317|38173432|FG001|Overall Study|Physician Decision|1|||
17028995|NCT00798317|38173431|FG000|Overall Study|Withdrawal by Subject|5|||
17028996|NCT00798317|38173432|FG001|Overall Study|Withdrawal by Subject|4|||
17028997|NCT00798317|38173431|FG000|Overall Study|Lost to Follow-up|2|||
17028998|NCT00798317|38173432|FG001|Overall Study|Lost to Follow-up|2|||
17028999|NCT00798317|38173431|FG000|Overall Study|Adverse Event|2|||
17029000|NCT00798317|38173432|FG001|Overall Study|Adverse Event|0|||
17029001|NCT00798317|38173431|FG000|Overall Study|Death|1|||
17135991|NCT02880956|38277238|FG001|Overall Study|Adverse Event|6|||
16990843|NCT00750139|38134921|FG003|Overall Study|Termination by sponsor|1|||
16990844|NCT00750139|38134918|FG000|Overall Study|Non-specific|62|||
16990845|NCT00750139|38134919|FG001|Overall Study|Non-specific|42|||
16990846|NCT00750139|38134920|FG002|Overall Study|Non-specific|79|||
16990847|NCT00750139|38134921|FG003|Overall Study|Non-specific|33|||
16990848|NCT00750061|38134935|FG000|Overall Study|Adverse Event|2|||
16990849|NCT00750061|38134936|FG001|Overall Study|Adverse Event|0|||
16990850|NCT00750061|38134935|FG000|Overall Study|Withdrawal by Subject|0|||
16990851|NCT00750061|38134936|FG001|Overall Study|Withdrawal by Subject|1|||
16990852|NCT00750061|38134935|FG000|Overall Study|Physician Decision|0|||
17029002|NCT00798317|38173432|FG001|Overall Study|Death|0|||
17029003|NCT00779402|38173440|FG000|Treatment Phase 1|Disease Progression|1|||
17029004|NCT00779402|38173441|FG001|Treatment Phase 1|Disease Progression|0|||
17029005|NCT00779402|38173440|FG000|Treatment Phase 1|Adverse Event|2|||
17029006|NCT00779402|38173441|FG001|Treatment Phase 1|Adverse Event|0|||
17029007|NCT00779402|38173440|FG000|Treatment Phase 1|Protocol Violation|1|||
17029008|NCT00779402|38173441|FG001|Treatment Phase 1|Protocol Violation|0|||
17029009|NCT00779402|38173440|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
17029010|NCT00779402|38173441|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
17029011|NCT00779402|38173440|FG000|Treatment Phase 1|Lost to Follow-up|0|||
17029012|NCT00779402|38173441|FG001|Treatment Phase 1|Lost to Follow-up|1|||
17029013|NCT00779402|38173440|FG000|Treatment Phase 1|Death|0|||
17029014|NCT00779402|38173441|FG001|Treatment Phase 1|Death|1|||
17029015|NCT00779402|38173440|FG000|Treatment Phase 1|Intercurrent Illness|1|||
17029016|NCT00779402|38173441|FG001|Treatment Phase 1|Intercurrent Illness|1|||
17029017|NCT00779402|38173440|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
17029018|NCT00779402|38173441|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
17029019|NCT00779402|38173440|FG000|Treatment Phase 1|Other|4|||
17029020|NCT00779402|38173441|FG001|Treatment Phase 1|Other|2|||
17029021|NCT00779402|38173440|FG000|Treatment Phase 1|Closure of Study|3|||
17029022|NCT00779402|38173441|FG001|Treatment Phase 1|Closure of Study|2|||
17029023|NCT00779402|38173440|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
17029024|NCT00779402|38173441|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
17029025|NCT00779402|38173440|FG000|Surveillance Phase|Protocol Violation|0|||
17029026|NCT00779402|38173441|FG001|Surveillance Phase|Protocol Violation|1|||
17029027|NCT00779402|38173440|FG000|Surveillance Phase|Patient refused to continue|22|||
17029028|NCT00779402|38173441|FG001|Surveillance Phase|Patient refused to continue|14|||
17029029|NCT00779402|38173440|FG000|Surveillance Phase|Lost to Follow-up|2|||
16990853|NCT00750061|38134936|FG001|Overall Study|Physician Decision|1|||
17029030|NCT00779402|38173441|FG001|Surveillance Phase|Lost to Follow-up|1|||
17029031|NCT00779402|38173440|FG000|Surveillance Phase|Death|0|||
17029032|NCT00779402|38173441|FG001|Surveillance Phase|Death|1|||
17029033|NCT00779402|38173440|FG000|Surveillance Phase|Intercurrent Illness|2|||
17029034|NCT00779402|38173441|FG001|Surveillance Phase|Intercurrent Illness|0|||
17029035|NCT00779402|38173440|FG000|Surveillance Phase|Other|5|||
17029036|NCT00779402|38173441|FG001|Surveillance Phase|Other|5|||
17029037|NCT00779402|38173440|FG000|Surveillance Phase|Withdrawal by Subject|4|||
17135992|NCT02880956|38277239|FG002|Overall Study|Adverse Event|5|||
17135993|NCT02880956|38277240|FG003|Overall Study|Adverse Event|4|||
17135994|NCT02880956|38277237|FG000|Overall Study|Withdrawal by Subject|9|||
17135995|NCT02880956|38277238|FG001|Overall Study|Withdrawal by Subject|4|||
17135996|NCT02880956|38277239|FG002|Overall Study|Withdrawal by Subject|6|||
17135997|NCT02880956|38277240|FG003|Overall Study|Withdrawal by Subject|11|||
17135998|NCT02880956|38277237|FG000|Overall Study|Lost to Follow-up|0|||
17135999|NCT02880956|38277238|FG001|Overall Study|Lost to Follow-up|1|||
17136000|NCT02880956|38277239|FG002|Overall Study|Lost to Follow-up|0|||
17136001|NCT02880956|38277240|FG003|Overall Study|Lost to Follow-up|0|||
17029038|NCT00779402|38173441|FG001|Surveillance Phase|Withdrawal by Subject|1|||
17029039|NCT00779402|38173440|FG000|Surveillance Phase|Closure of study|5|||
17029040|NCT00779402|38173441|FG001|Surveillance Phase|Closure of study|6|||
17029041|NCT00779402|38173440|FG000|Surveillance Phase|Completed Protocol Visits|3|||
17029042|NCT00779402|38173441|FG001|Surveillance Phase|Completed Protocol Visits|2|||
17029043|NCT00779402|38173440|FG000|Long-term Follow-up|Patient refused to continue|2|||
17029044|NCT00779402|38173441|FG001|Long-term Follow-up|Patient refused to continue|0|||
17029045|NCT00779402|38173440|FG000|Long-term Follow-up|Other|5|||
17029046|NCT00779402|38173441|FG001|Long-term Follow-up|Other|0|||
17029047|NCT00779402|38173440|FG000|Long-term Follow-up|Closure of Study|8|||
17029048|NCT00779402|38173441|FG001|Long-term Follow-up|Closure of Study|4|||
17029049|NCT00779402|38173440|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
17029050|NCT00779402|38173441|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
17029051|NCT00771914|38173451|FG000|Overall Study|Physician Decision|0|||
17029052|NCT00771914|38173452|FG001|Overall Study|Physician Decision|0|||
17029053|NCT00771914|38173453|FG002|Overall Study|Physician Decision|0|||
17029054|NCT00771914|38173454|FG003|Overall Study|Physician Decision|1|||
17029055|NCT00771914|38173451|FG000|Overall Study|Lost to Follow-up|0|||
17029056|NCT00771914|38173452|FG001|Overall Study|Lost to Follow-up|0|||
17029057|NCT00771914|38173453|FG002|Overall Study|Lost to Follow-up|0|||
17029058|NCT00771914|38173454|FG003|Overall Study|Lost to Follow-up|1|||
17029059|NCT00779324|38173466|FG000|Overall Study|Lost to Follow-up|2|||
17029060|NCT00779324|38173467|FG001|Overall Study|Lost to Follow-up|1|||
17029061|NCT00779324|38173466|FG000|Overall Study|Withdrawal by Subject|4|||
17029062|NCT00779324|38173467|FG001|Overall Study|Withdrawal by Subject|2|||
17029063|NCT00779324|38173466|FG000|Overall Study|Missed visit|1|||
17029064|NCT00779324|38173467|FG001|Overall Study|Missed visit|1|||
17136002|NCT02880956|38277237|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
17136003|NCT02880956|38277238|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
17136004|NCT02880956|38277239|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
17136005|NCT02880956|38277240|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
17136006|NCT02880956|38277237|FG000|Overall Study|Other, Not Specified|4|||
17136007|NCT02880956|38277238|FG001|Overall Study|Other, Not Specified|2|||
17136008|NCT02880956|38277239|FG002|Overall Study|Other, Not Specified|0|||
17136009|NCT02880956|38277240|FG003|Overall Study|Other, Not Specified|3|||
17136010|NCT01352416|38277257|FG000|Overall Study|Physician Decision|1|||
17136011|NCT01352416|38277258|FG001|Overall Study|Physician Decision|2|||
17136012|NCT01352416|38277259|FG002|Overall Study|Physician Decision|2|||
17136013|NCT01352416|38277260|FG003|Overall Study|Physician Decision|1|||
17136014|NCT00439738|38277272|FG000|Overall Study|Withdrawal by Subject|16|||
17136015|NCT00439738|38277273|FG001|Overall Study|Withdrawal by Subject|13|||
17136016|NCT00439738|38277272|FG000|Overall Study|Adverse Event|6|||
17136017|NCT00439738|38277273|FG001|Overall Study|Adverse Event|4|||
17029065|NCT00779246|38173475|FG000|Overall Study|Missing sufficient data for analysis|33|||
17029066|NCT00779246|38173476|FG001|Overall Study|Missing sufficient data for analysis|53|||
17029067|NCT00771758|38173485|FG000|Overall Study|Adverse Event|2|||
17029068|NCT00771758|38173486|FG001|Overall Study|Adverse Event|8|||
17029069|NCT00771758|38173487|FG002|Overall Study|Adverse Event|1|||
17029070|NCT00771758|38173485|FG000|Overall Study|Lack of Efficacy|0|||
17136018|NCT00439738|38277272|FG000|Overall Study|Lost to Follow-up|5|||
17136019|NCT00439738|38277273|FG001|Overall Study|Lost to Follow-up|6|||
17136020|NCT00439738|38277272|FG000|Overall Study|Protocol Violation|6|||
17136021|NCT00439738|38277273|FG001|Overall Study|Protocol Violation|3|||
17136022|NCT00439738|38277272|FG000|Overall Study|Lack of Efficacy|2|||
17136023|NCT00439738|38277273|FG001|Overall Study|Lack of Efficacy|2|||
17136024|NCT00439738|38277272|FG000|Overall Study|Abnormal Lab Values|1|||
17136025|NCT00439738|38277273|FG001|Overall Study|Abnormal Lab Values|0|||
17136026|NCT00338104|38277280|FG000|Overall Study|Protocol Violation|2|||
17136027|NCT00338104|38277281|FG001|Overall Study|Protocol Violation|1|||
17136028|NCT00338104|38277282|FG002|Overall Study|Protocol Violation|3|||
17136029|NCT02883452|38277293|FG000|Overall Study|Withdrawal by Subject|1|||
17136030|NCT02883452|38277294|FG001|Overall Study|Withdrawal by Subject|1|||
17136031|NCT02883452|38277295|FG002|Overall Study|Withdrawal by Subject|3|||
17029071|NCT00771758|38173486|FG001|Overall Study|Lack of Efficacy|2|||
17029072|NCT00771758|38173487|FG002|Overall Study|Lack of Efficacy|1|||
17029073|NCT00771758|38173485|FG000|Overall Study|Lost to Follow-up|1|||
17029074|NCT00771758|38173486|FG001|Overall Study|Lost to Follow-up|0|||
17029075|NCT00771758|38173487|FG002|Overall Study|Lost to Follow-up|0|||
17029076|NCT00771758|38173485|FG000|Overall Study|Protocol Violation|1|||
17029077|NCT00771758|38173486|FG001|Overall Study|Protocol Violation|0|||
17029078|NCT00771758|38173487|FG002|Overall Study|Protocol Violation|0|||
17029079|NCT00771758|38173485|FG000|Overall Study|Withdrawal by Subject|1|||
17029080|NCT00771758|38173486|FG001|Overall Study|Withdrawal by Subject|0|||
17029081|NCT00771758|38173487|FG002|Overall Study|Withdrawal by Subject|0|||
17029082|NCT00771758|38173485|FG000|Overall Study|Other|3|||
17029083|NCT00771758|38173486|FG001|Overall Study|Other|2|||
17029084|NCT00771758|38173487|FG002|Overall Study|Other|0|||
17029085|NCT00758498|38173515|FG000|Overall Study|Adverse Event|2|||
17029086|NCT00758498|38173516|FG001|Overall Study|Adverse Event|2|||
17029087|NCT00758498|38173517|FG002|Overall Study|Adverse Event|3|||
17029088|NCT00758498|38173515|FG000|Overall Study|Subject legally detained out of state|1|||
17029089|NCT00758498|38173516|FG001|Overall Study|Subject legally detained out of state|0|||
17029090|NCT00758498|38173517|FG002|Overall Study|Subject legally detained out of state|0|||
17029091|NCT00758498|38173515|FG000|Overall Study|Withdrawal by Subject|0|||
17029092|NCT00758498|38173516|FG001|Overall Study|Withdrawal by Subject|0|||
17029093|NCT00758498|38173517|FG002|Overall Study|Withdrawal by Subject|1|||
17029094|NCT00758498|38173515|FG000|Overall Study|Noncompliance to study procedures|0|||
17029095|NCT00758498|38173516|FG001|Overall Study|Noncompliance to study procedures|0|||
17029096|NCT00758498|38173517|FG002|Overall Study|Noncompliance to study procedures|1|||
17029097|NCT00798161|38173532|FG000|Overall Study|Adverse Event|3|||
17029098|NCT00798161|38173533|FG001|Overall Study|Adverse Event|4|||
17029099|NCT00798161|38173534|FG002|Overall Study|Adverse Event|6|||
17029100|NCT00798161|38173535|FG003|Overall Study|Adverse Event|6|||
17029101|NCT00798161|38173536|FG004|Overall Study|Adverse Event|5|||
17029102|NCT00798161|38173537|FG005|Overall Study|Adverse Event|2|||
17029103|NCT00798161|38173538|FG006|Overall Study|Adverse Event|4|||
17029104|NCT00798161|38173532|FG000|Overall Study|Protocol Violation|2|||
17029105|NCT00798161|38173533|FG001|Overall Study|Protocol Violation|1|||
17029106|NCT00798161|38173534|FG002|Overall Study|Protocol Violation|3|||
17029107|NCT00798161|38173535|FG003|Overall Study|Protocol Violation|3|||
17029108|NCT00798161|38173536|FG004|Overall Study|Protocol Violation|3|||
17029109|NCT00798161|38173537|FG005|Overall Study|Protocol Violation|2|||
17029110|NCT00798161|38173538|FG006|Overall Study|Protocol Violation|0|||
17029111|NCT00798161|38173532|FG000|Overall Study|Lost to Follow-up|1|||
17029112|NCT00798161|38173533|FG001|Overall Study|Lost to Follow-up|3|||
17029113|NCT00798161|38173534|FG002|Overall Study|Lost to Follow-up|4|||
17029114|NCT00798161|38173535|FG003|Overall Study|Lost to Follow-up|3|||
17029115|NCT00798161|38173536|FG004|Overall Study|Lost to Follow-up|4|||
17029116|NCT00798161|38173537|FG005|Overall Study|Lost to Follow-up|0|||
17029117|NCT00798161|38173538|FG006|Overall Study|Lost to Follow-up|0|||
17029118|NCT00798161|38173532|FG000|Overall Study|Withdrawal by Subject|5|||
17029119|NCT00798161|38173533|FG001|Overall Study|Withdrawal by Subject|4|||
17029120|NCT00798161|38173534|FG002|Overall Study|Withdrawal by Subject|5|||
17029121|NCT00798161|38173535|FG003|Overall Study|Withdrawal by Subject|4|||
17029122|NCT00798161|38173536|FG004|Overall Study|Withdrawal by Subject|2|||
17029123|NCT00798161|38173537|FG005|Overall Study|Withdrawal by Subject|3|||
17029124|NCT00798161|38173538|FG006|Overall Study|Withdrawal by Subject|1|||
17029125|NCT00798161|38173532|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
17029126|NCT00798161|38173533|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
17029127|NCT00798161|38173534|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
17029128|NCT00798161|38173535|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
17029129|NCT00798161|38173536|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
17029130|NCT00798161|38173537|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
17029131|NCT00798161|38173538|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
17029132|NCT00588341|38173554|FG000|Overall Study|Withdrawal by Subject|3|||
17029133|NCT00588341|38173554|FG000|Overall Study|Not treated due to metastatic disease|1|||
17029134|NCT00588341|38173554|FG000|Overall Study|Patient ineligible|1|||
17029135|NCT00802529|38173560|FG000|Overall Study|Lost to Follow-up|0|||
17029136|NCT00802529|38173561|FG001|Overall Study|Lost to Follow-up|1|||
17029137|NCT00758264|38173570|FG000|Active Phase|Withdrawal by Subject|0|||
17029138|NCT00758264|38173571|FG001|Active Phase|Withdrawal by Subject|0|||
17029139|NCT00758264|38173572|FG002|Active Phase|Withdrawal by Subject|1|||
17029140|NCT00758264|38173570|FG000|Active Phase|Lost to Follow-up|1|||
17029141|NCT00758264|38173571|FG001|Active Phase|Lost to Follow-up|0|||
17029142|NCT00758264|38173572|FG002|Active Phase|Lost to Follow-up|0|||
17029143|NCT00758264|38173570|FG000|Active Phase|Other|0|||
17029144|NCT00758264|38173571|FG001|Active Phase|Other|0|||
17029145|NCT00758264|38173572|FG002|Active Phase|Other|4|||
17029146|NCT00588731|38173582|FG000|Overall Study|Withdrawal by Subject|3|||
17029147|NCT00588731|38173583|FG001|Overall Study|Withdrawal by Subject|2|||
17029148|NCT00757172|38173589|FG000|Overall Study|Withdrawal by Subject|4|||
17029149|NCT00757172|38173589|FG000|Overall Study|Physician Decision|3|||
17029150|NCT00757172|38173589|FG000|Overall Study|Progression|4|||
17029151|NCT00797225|38173597|FG000|Weeks 1 to 12|Adverse Event|0|||
17029152|NCT00797225|38173598|FG001|Weeks 1 to 12|Adverse Event|0|||
17029153|NCT00797225|38173599|FG002|Weeks 1 to 12|Adverse Event|1|||
17029154|NCT00797225|38173600|FG003|Weeks 1 to 12|Adverse Event|0|||
17029155|NCT00797225|38173601|FG004|Weeks 1 to 12|Adverse Event|0|||
17029156|NCT00797225|38173602|FG005|Weeks 1 to 12|Adverse Event|0|||
17029157|NCT00797225|38173603|FG006|Weeks 1 to 12|Adverse Event|0|||
17029158|NCT00797225|38173604|FG007|Weeks 1 to 12|Adverse Event|0|||
17029159|NCT00797225|38173597|FG000|Weeks 1 to 12|Non-compliance|0|||
17029160|NCT00797225|38173598|FG001|Weeks 1 to 12|Non-compliance|1|||
17029161|NCT00797225|38173599|FG002|Weeks 1 to 12|Non-compliance|0|||
17029162|NCT00797225|38173600|FG003|Weeks 1 to 12|Non-compliance|0|||
17029163|NCT00797225|38173601|FG004|Weeks 1 to 12|Non-compliance|0|||
17029164|NCT00797225|38173602|FG005|Weeks 1 to 12|Non-compliance|0|||
17029165|NCT00797225|38173603|FG006|Weeks 1 to 12|Non-compliance|0|||
17029166|NCT00797225|38173604|FG007|Weeks 1 to 12|Non-compliance|0|||
17029167|NCT00797225|38173597|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
17029168|NCT00797225|38173598|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
17029169|NCT00797225|38173599|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
17029170|NCT00797225|38173600|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
17029171|NCT00797225|38173601|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
17029172|NCT00797225|38173602|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
17029173|NCT00797225|38173603|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
17029174|NCT00797225|38173604|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
17029175|NCT00797225|38173597|FG000|Weeks 1 to 12|Sponsor Decision|1|||
17029176|NCT00797225|38173598|FG001|Weeks 1 to 12|Sponsor Decision|0|||
17029177|NCT00797225|38173599|FG002|Weeks 1 to 12|Sponsor Decision|0|||
17029178|NCT00797225|38173600|FG003|Weeks 1 to 12|Sponsor Decision|0|||
17029179|NCT00797225|38173601|FG004|Weeks 1 to 12|Sponsor Decision|0|||
17029180|NCT00797225|38173602|FG005|Weeks 1 to 12|Sponsor Decision|0|||
17029181|NCT00797225|38173603|FG006|Weeks 1 to 12|Sponsor Decision|0|||
16780369|NCT01594827|37719459|FG000|Overall Study|Physician Decision|3|||
17029182|NCT00797225|38173604|FG007|Weeks 1 to 12|Sponsor Decision|0|||
17029183|NCT00797225|38173597|FG000|Weeks 13 to 24|Non-compliance|0|||
17136032|NCT02883452|38277296|FG003|Overall Study|Withdrawal by Subject|0|||
17136033|NCT02883452|38277297|FG004|Overall Study|Withdrawal by Subject|2|||
17136034|NCT02883452|38277298|FG005|Overall Study|Withdrawal by Subject|5|||
17136035|NCT02883452|38277293|FG000|Overall Study|Disease progression|1|||
17136036|NCT02883452|38277294|FG001|Overall Study|Disease progression|0|||
17136037|NCT02883452|38277295|FG002|Overall Study|Disease progression|0|||
17136038|NCT02883452|38277296|FG003|Overall Study|Disease progression|1|||
17136039|NCT02883452|38277297|FG004|Overall Study|Disease progression|4|||
17136040|NCT02883452|38277298|FG005|Overall Study|Disease progression|5|||
17136041|NCT02883452|38277293|FG000|Overall Study|Adverse Event|2|||
17136042|NCT02883452|38277294|FG001|Overall Study|Adverse Event|1|||
17136043|NCT02883452|38277295|FG002|Overall Study|Adverse Event|1|||
17136044|NCT02883452|38277296|FG003|Overall Study|Adverse Event|1|||
17136045|NCT02883452|38277297|FG004|Overall Study|Adverse Event|1|||
17136046|NCT02883452|38277298|FG005|Overall Study|Adverse Event|3|||
17136047|NCT02883452|38277293|FG000|Overall Study|Physician Decision|0|||
17136048|NCT02883452|38277294|FG001|Overall Study|Physician Decision|0|||
17136049|NCT02883452|38277295|FG002|Overall Study|Physician Decision|0|||
17136050|NCT02883452|38277296|FG003|Overall Study|Physician Decision|0|||
17136051|NCT02883452|38277297|FG004|Overall Study|Physician Decision|4|||
17136052|NCT02883452|38277298|FG005|Overall Study|Physician Decision|1|||
17136053|NCT02883452|38277293|FG000|Overall Study|Death|1|||
17136054|NCT02883452|38277294|FG001|Overall Study|Death|0|||
17136055|NCT02883452|38277295|FG002|Overall Study|Death|1|||
17136056|NCT02883452|38277296|FG003|Overall Study|Death|0|||
17136057|NCT02883452|38277297|FG004|Overall Study|Death|0|||
17136058|NCT02883452|38277298|FG005|Overall Study|Death|0|||
17136059|NCT02883452|38277293|FG000|Overall Study|Other|0|||
17136060|NCT02883452|38277294|FG001|Overall Study|Other|0|||
17136061|NCT02883452|38277295|FG002|Overall Study|Other|0|||
17136062|NCT02883452|38277296|FG003|Overall Study|Other|0|||
17136063|NCT02883452|38277297|FG004|Overall Study|Other|0|||
17136064|NCT02883452|38277298|FG005|Overall Study|Other|1|||
17136065|NCT00151372|38277315|FG000|Overall Study|Death|12|||
17136066|NCT00151372|38277316|FG001|Overall Study|Death|11|||
17136067|NCT00151372|38277315|FG000|Overall Study|Lost to Follow-up|5|||
17136068|NCT00151372|38277316|FG001|Overall Study|Lost to Follow-up|5|||
17136069|NCT00151372|38277315|FG000|Overall Study|Too sick medically to continue|5|||
17136070|NCT00151372|38277316|FG001|Overall Study|Too sick medically to continue|6|||
17136071|NCT00151372|38277315|FG000|Overall Study|Withdrawal by Subject|7|||
17136072|NCT00151372|38277316|FG001|Overall Study|Withdrawal by Subject|7|||
17136073|NCT02603809|38277328|FG000|Overall Study|Withdrawal by Subject|4|||
17136074|NCT02603809|38277329|FG001|Overall Study|Withdrawal by Subject|1|||
17136075|NCT02603809|38277330|FG002|Overall Study|Withdrawal by Subject|2|||
17136076|NCT02603809|38277331|FG003|Overall Study|Withdrawal by Subject|3|||
17136077|NCT02603809|38277332|FG004|Overall Study|Withdrawal by Subject|3|||
17136078|NCT02603809|38277333|FG005|Overall Study|Withdrawal by Subject|4|||
17136079|NCT02603809|38277328|FG000|Overall Study|Lost to Follow-up|2|||
17136080|NCT02603809|38277329|FG001|Overall Study|Lost to Follow-up|3|||
17136081|NCT02603809|38277330|FG002|Overall Study|Lost to Follow-up|1|||
17136082|NCT02603809|38277331|FG003|Overall Study|Lost to Follow-up|4|||
17136083|NCT02603809|38277332|FG004|Overall Study|Lost to Follow-up|2|||
17136084|NCT02603809|38277333|FG005|Overall Study|Lost to Follow-up|2|||
17136085|NCT02603809|38277328|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
17136086|NCT02603809|38277329|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
17136087|NCT02603809|38277330|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
17136088|NCT02603809|38277331|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
17136089|NCT02603809|38277332|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
17136090|NCT02603809|38277333|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
17136091|NCT02603809|38277328|FG000|Overall Study|Physician Decision|0|||
17136092|NCT02603809|38277329|FG001|Overall Study|Physician Decision|0|||
17136093|NCT02603809|38277330|FG002|Overall Study|Physician Decision|0|||
17136094|NCT02603809|38277331|FG003|Overall Study|Physician Decision|1|||
17136095|NCT02603809|38277332|FG004|Overall Study|Physician Decision|2|||
17136096|NCT02603809|38277333|FG005|Overall Study|Physician Decision|1|||
17136097|NCT02603809|38277328|FG000|Overall Study|Adverse Event|3|||
17136098|NCT02603809|38277329|FG001|Overall Study|Adverse Event|0|||
17136099|NCT02603809|38277330|FG002|Overall Study|Adverse Event|2|||
17136100|NCT02603809|38277331|FG003|Overall Study|Adverse Event|2|||
17136101|NCT02603809|38277332|FG004|Overall Study|Adverse Event|1|||
17136102|NCT02603809|38277333|FG005|Overall Study|Adverse Event|1|||
17136103|NCT02603809|38277328|FG000|Overall Study|Lack of Efficacy|0|||
17136104|NCT02603809|38277329|FG001|Overall Study|Lack of Efficacy|1|||
17136105|NCT02603809|38277330|FG002|Overall Study|Lack of Efficacy|0|||
17136106|NCT02603809|38277331|FG003|Overall Study|Lack of Efficacy|0|||
17136107|NCT02603809|38277332|FG004|Overall Study|Lack of Efficacy|0|||
17136108|NCT02603809|38277333|FG005|Overall Study|Lack of Efficacy|1|||
17136109|NCT02741596|38277351|FG000|Overall Study|Adverse Event|1|||
17136110|NCT02741596|38277352|FG001|Overall Study|Adverse Event|5|||
17136111|NCT02741596|38277351|FG000|Overall Study|Lost to Follow-up|1|||
17136112|NCT02741596|38277352|FG001|Overall Study|Lost to Follow-up|1|||
17136113|NCT02741596|38277351|FG000|Overall Study|Physician Decision|2|||
17136114|NCT02741596|38277352|FG001|Overall Study|Physician Decision|1|||
17136115|NCT02741596|38277351|FG000|Overall Study|Pregnancy|3|||
17136116|NCT02741596|38277352|FG001|Overall Study|Pregnancy|1|||
17136117|NCT02741596|38277351|FG000|Overall Study|Other (Unspecified)|0|||
17136118|NCT02741596|38277352|FG001|Overall Study|Other (Unspecified)|3|||
17136119|NCT02741596|38277351|FG000|Overall Study|Subject withdrawn-Other|17|||
17136120|NCT02741596|38277352|FG001|Overall Study|Subject withdrawn-Other|4|||
17136121|NCT02741596|38277351|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
17029184|NCT00797225|38173598|FG001|Weeks 13 to 24|Non-compliance|2|||
17029185|NCT00797225|38173599|FG002|Weeks 13 to 24|Non-compliance|0|||
17029186|NCT00797225|38173600|FG003|Weeks 13 to 24|Non-compliance|0|||
17029187|NCT00797225|38173601|FG004|Weeks 13 to 24|Non-compliance|0|||
17029188|NCT00797225|38173602|FG005|Weeks 13 to 24|Non-compliance|0|||
17029189|NCT00797225|38173603|FG006|Weeks 13 to 24|Non-compliance|0|||
17029190|NCT00797225|38173604|FG007|Weeks 13 to 24|Non-compliance|0|||
17029191|NCT00797225|38173597|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
17029192|NCT00797225|38173598|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
17029193|NCT00797225|38173599|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
17029194|NCT00797225|38173600|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
17029195|NCT00797225|38173601|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
17029196|NCT00797225|38173602|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
17029197|NCT00797225|38173603|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
17029198|NCT00797225|38173604|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
17029199|NCT00797225|38173597|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
17029200|NCT00797225|38173598|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
17029201|NCT00797225|38173599|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
17029202|NCT00797225|38173600|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
17029203|NCT00797225|38173601|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
17029204|NCT00797225|38173602|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
17029205|NCT00797225|38173603|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
17029206|NCT00797225|38173604|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
17029207|NCT00797225|38173597|FG000|Weeks 13 to 24|Adverse Event|0|||
17029208|NCT00797225|38173598|FG001|Weeks 13 to 24|Adverse Event|1|||
17029209|NCT00797225|38173599|FG002|Weeks 13 to 24|Adverse Event|0|||
17029210|NCT00797225|38173600|FG003|Weeks 13 to 24|Adverse Event|0|||
17029211|NCT00797225|38173601|FG004|Weeks 13 to 24|Adverse Event|0|||
17029212|NCT00797225|38173602|FG005|Weeks 13 to 24|Adverse Event|0|||
17029213|NCT00797225|38173603|FG006|Weeks 13 to 24|Adverse Event|1|||
17029214|NCT00797225|38173604|FG007|Weeks 13 to 24|Adverse Event|0|||
17029215|NCT00797225|38173597|FG000|Weeks 13 to 24|Sponsor Decision|0|||
17029216|NCT00797225|38173598|FG001|Weeks 13 to 24|Sponsor Decision|0|||
17029217|NCT00797225|38173599|FG002|Weeks 13 to 24|Sponsor Decision|0|||
17029218|NCT00797225|38173600|FG003|Weeks 13 to 24|Sponsor Decision|0|||
17029219|NCT00797225|38173601|FG004|Weeks 13 to 24|Sponsor Decision|0|||
17029220|NCT00797225|38173602|FG005|Weeks 13 to 24|Sponsor Decision|0|||
17029221|NCT00797225|38173603|FG006|Weeks 13 to 24|Sponsor Decision|1|||
17029222|NCT00797225|38173604|FG007|Weeks 13 to 24|Sponsor Decision|0|||
17029223|NCT00778700|38173624|FG000|Overall Study|Adverse Event|6|||
17029224|NCT00778700|38173625|FG001|Overall Study|Adverse Event|1|||
17029225|NCT00778700|38173626|FG002|Overall Study|Adverse Event|3|||
17029226|NCT00778700|38173627|FG003|Overall Study|Adverse Event|5|||
17029227|NCT00778700|38173624|FG000|Overall Study|Protocol Violation|1|||
17029228|NCT00778700|38173625|FG001|Overall Study|Protocol Violation|1|||
17029229|NCT00778700|38173626|FG002|Overall Study|Protocol Violation|0|||
17029230|NCT00778700|38173627|FG003|Overall Study|Protocol Violation|0|||
17029231|NCT00778700|38173624|FG000|Overall Study|Subject Withdrew Consent|6|||
17029232|NCT00778700|38173625|FG001|Overall Study|Subject Withdrew Consent|4|||
17029233|NCT00778700|38173626|FG002|Overall Study|Subject Withdrew Consent|1|||
17029234|NCT00778700|38173627|FG003|Overall Study|Subject Withdrew Consent|4|||
17029235|NCT00778700|38173624|FG000|Overall Study|Lost to Follow-up|3|||
17029236|NCT00778700|38173625|FG001|Overall Study|Lost to Follow-up|1|||
17029237|NCT00778700|38173626|FG002|Overall Study|Lost to Follow-up|0|||
17029238|NCT00778700|38173627|FG003|Overall Study|Lost to Follow-up|1|||
17029239|NCT00778700|38173624|FG000|Overall Study|Reason not Specified|2|||
17029240|NCT00778700|38173625|FG001|Overall Study|Reason not Specified|0|||
17029241|NCT00778700|38173626|FG002|Overall Study|Reason not Specified|1|||
17029242|NCT00778700|38173627|FG003|Overall Study|Reason not Specified|3|||
17029243|NCT00778700|38173624|FG000|Overall Study|Other|0|||
16990854|NCT00744757|38134942|FG000|Overall Study|Objective disease progression|7|||
16990855|NCT00744757|38134942|FG000|Overall Study|Physician Decision|5|||
16990856|NCT00744757|38134942|FG000|Overall Study|Withdrawal by Subject|1|||
16990857|NCT00744757|38134942|FG000|Overall Study|Death|6|||
16990858|NCT00744757|38134942|FG000|Overall Study|Adverse Event|2|||
16990859|NCT00745849|38134946|FG000|First Intervention|Withdrawal by Subject|0|||
16990860|NCT00745849|38134947|FG001|First Intervention|Withdrawal by Subject|1|||
16990861|NCT00745849|38134946|FG000|First Intervention|Lost to Follow-up|1|||
17029244|NCT00778700|38173625|FG001|Overall Study|Other|0|||
17029245|NCT00778700|38173626|FG002|Overall Study|Other|1|||
17029246|NCT00778700|38173627|FG003|Overall Study|Other|0|||
17029247|NCT00793403|38173641|FG000|Overall Study|Other|73|||
17029248|NCT00793325|38173645|FG000|Overall Study|Protocol Violation|18|||
16990862|NCT00745849|38134947|FG001|First Intervention|Lost to Follow-up|1|||
16990863|NCT00745849|38134946|FG000|Second Intervention|Lost to Follow-up|2|||
16990864|NCT00745849|38134947|FG001|Second Intervention|Lost to Follow-up|1|||
16990865|NCT00749203|38134955|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
16990866|NCT00749203|38134956|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
16990867|NCT00749203|38134955|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
16990868|NCT00749203|38134956|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
16990869|NCT00749203|38134955|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
16990870|NCT00749203|38134956|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
16990871|NCT00749203|38134955|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
16990872|NCT00749203|38134956|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
16990873|NCT00749203|38134955|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
16990874|NCT00749203|38134956|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
16990875|NCT00749203|38134955|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
16990876|NCT00749203|38134956|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
16990877|NCT00748969|38134964|FG000|Overall Study|Withdrawal by Subject|1|||
16990878|NCT00748969|38134965|FG001|Overall Study|Withdrawal by Subject|0|||
16990879|NCT00748969|38134964|FG000|Overall Study|Withdrawal by Subject|0|||
16990880|NCT00748969|38134965|FG001|Overall Study|Withdrawal by Subject|1|||
16990881|NCT00745615|38134975|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
16990882|NCT00745615|38134976|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
16990883|NCT00745615|38134977|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
16990884|NCT00745615|38134978|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
16990885|NCT00745615|38134979|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
16990886|NCT00745615|38134980|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
16990887|NCT00745615|38134975|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16990888|NCT00745615|38134976|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
17136122|NCT02741596|38277352|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
17136123|NCT03147248|38277364|FG000|Overall Study|Adverse Event|0|||
17136124|NCT03147248|38277365|FG001|Overall Study|Adverse Event|2|||
17136125|NCT03147248|38277366|FG002|Overall Study|Adverse Event|2|||
17136126|NCT03147248|38277367|FG003|Overall Study|Adverse Event|2|||
16990889|NCT00745615|38134977|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16990890|NCT00745615|38134978|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16990891|NCT00745615|38134979|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16990892|NCT00745615|38134980|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16990893|NCT00745615|38134975|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
16990894|NCT00745615|38134976|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
16990895|NCT00745615|38134977|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
16990896|NCT00745615|38134978|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
16990897|NCT00745615|38134979|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
16990898|NCT00745615|38134980|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
16990899|NCT00745615|38134975|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16990900|NCT00745615|38134976|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
16990901|NCT00745615|38134977|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16990902|NCT00745615|38134978|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16990903|NCT00745615|38134979|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16990904|NCT00745615|38134980|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16990905|NCT00745615|38134975|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16990906|NCT00745615|38134976|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
16990907|NCT00745615|38134977|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16990908|NCT00745615|38134978|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16990909|NCT00745615|38134979|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16990910|NCT00745615|38134980|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16990911|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
16990912|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
17029249|NCT00793325|38173645|FG000|Overall Study|Lost to Follow-up|1|||
17029250|NCT00778622|38173671|FG000|Overall Study|Adverse Event|5|||
17029251|NCT00778622|38173672|FG001|Overall Study|Adverse Event|4|||
17029252|NCT00778622|38173673|FG002|Overall Study|Adverse Event|7|||
17029253|NCT00778622|38173671|FG000|Overall Study|Withdrawal by Subject|4|||
17029254|NCT00778622|38173672|FG001|Overall Study|Withdrawal by Subject|5|||
17029255|NCT00778622|38173673|FG002|Overall Study|Withdrawal by Subject|5|||
17029256|NCT00778622|38173671|FG000|Overall Study|Lost to Follow-up|3|||
17029257|NCT00778622|38173672|FG001|Overall Study|Lost to Follow-up|3|||
17029258|NCT00778622|38173673|FG002|Overall Study|Lost to Follow-up|2|||
17029259|NCT00778622|38173671|FG000|Overall Study|Protocol Violation|0|||
17029260|NCT00778622|38173672|FG001|Overall Study|Protocol Violation|3|||
17029261|NCT00778622|38173673|FG002|Overall Study|Protocol Violation|0|||
17029262|NCT00778622|38173671|FG000|Overall Study|Lack of Efficacy|2|||
17029263|NCT00778622|38173672|FG001|Overall Study|Lack of Efficacy|0|||
17029264|NCT00778622|38173673|FG002|Overall Study|Lack of Efficacy|0|||
17029265|NCT00778622|38173671|FG000|Overall Study|immigration|1|||
17029266|NCT00778622|38173672|FG001|Overall Study|immigration|0|||
17029267|NCT00778622|38173673|FG002|Overall Study|immigration|0|||
17029268|NCT00778622|38173671|FG000|Overall Study|Other|1|||
17029269|NCT00778622|38173672|FG001|Overall Study|Other|0|||
17029270|NCT00778622|38173673|FG002|Overall Study|Other|1|||
17029271|NCT00777920|38173685|FG000|Overall Study|Adverse Event|39|||
17029272|NCT00777920|38173685|FG000|Overall Study|Withdrawal of Consent|4|||
17029273|NCT00777920|38173685|FG000|Overall Study|Lost to Follow-up|1|||
17029274|NCT00777920|38173685|FG000|Overall Study|Investigator's discretion|1|||
17029275|NCT00777920|38173685|FG000|Overall Study|Clinical status did not improve|1|||
17029276|NCT00777920|38173685|FG000|Overall Study|Other, not specified|4|||
17029277|NCT04236141|38173691|FG000|Overall Study|Death|18|||
17029278|NCT04236141|38173692|FG001|Overall Study|Death|10|||
17029279|NCT04236141|38173691|FG000|Overall Study|Withdrawal by Participant|1|||
17029280|NCT04236141|38173692|FG001|Overall Study|Withdrawal by Participant|0|||
17029281|NCT04236141|38173691|FG000|Overall Study|Reason not Specified|1|||
17029282|NCT04236141|38173692|FG001|Overall Study|Reason not Specified|0|||
17029283|NCT04236141|38173691|FG000|Overall Study|Study terminated by Sponsor|8|||
17029284|NCT04236141|38173692|FG001|Overall Study|Study terminated by Sponsor|4|||
17029285|NCT00796445|38173700|FG000|Overall Study|Protocol Violation|5|||
17029286|NCT00796445|38173701|FG001|Overall Study|Protocol Violation|3|||
17029287|NCT00796445|38173700|FG000|Overall Study|Adverse event, serious fatal|10|||
17029288|NCT00796445|38173701|FG001|Overall Study|Adverse event, serious fatal|5|||
17029289|NCT00796445|38173700|FG000|Overall Study|Adverse event, non-fatal|4|||
17029290|NCT00796445|38173701|FG001|Overall Study|Adverse event, non-fatal|0|||
17029291|NCT00796445|38173700|FG000|Overall Study|Disease progression/recurrence|537|||
17029292|NCT00796445|38173701|FG001|Overall Study|Disease progression/recurrence|268|||
17029293|NCT00796445|38173700|FG000|Overall Study|Other|10|||
17029294|NCT00796445|38173701|FG001|Overall Study|Other|7|||
17029295|NCT00796445|38173700|FG000|Overall Study|Withdrawal by Subject|18|||
17029296|NCT00796445|38173701|FG001|Overall Study|Withdrawal by Subject|9|||
17029297|NCT00796445|38173700|FG000|Overall Study|Invalid Informed Consent Form|1|||
17029298|NCT00796445|38173701|FG001|Overall Study|Invalid Informed Consent Form|0|||
17029299|NCT03939819|38173717|FG000|Overall Study|Death|2|||
17029300|NCT03939819|38173718|FG001|Overall Study|Death|0|||
17029301|NCT00756938|38173727|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
17029302|NCT00756938|38173728|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
17029303|NCT00756938|38173729|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
17029304|NCT00756938|38173730|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
17029305|NCT00756938|38173727|FG000|12-week Base Study|Protocol Violation|0|||
17029306|NCT00756938|38173728|FG001|12-week Base Study|Protocol Violation|0|||
17029307|NCT00756938|38173729|FG002|12-week Base Study|Protocol Violation|1|||
17029308|NCT00756938|38173730|FG003|12-week Base Study|Protocol Violation|0|||
17029309|NCT00756938|38173727|FG000|12-week Base Study|Lost to Follow-up|1|||
17029310|NCT00756938|38173728|FG001|12-week Base Study|Lost to Follow-up|0|||
17029311|NCT00756938|38173729|FG002|12-week Base Study|Lost to Follow-up|0|||
17029312|NCT00756938|38173730|FG003|12-week Base Study|Lost to Follow-up|0|||
17029313|NCT00756938|38173727|FG000|Optional Extension|Lack of Efficacy|0|||
17029314|NCT00756938|38173728|FG001|Optional Extension|Lack of Efficacy|0|||
17029315|NCT00756938|38173729|FG002|Optional Extension|Lack of Efficacy|0|||
17029316|NCT00756938|38173730|FG003|Optional Extension|Lack of Efficacy|1|||
17029317|NCT00756938|38173727|FG000|Optional Extension|End of Study|0|||
17029318|NCT00756938|38173728|FG001|Optional Extension|End of Study|0|||
17029319|NCT00756938|38173729|FG002|Optional Extension|End of Study|0|||
17029320|NCT00756938|38173730|FG003|Optional Extension|End of Study|11|||
17029321|NCT00756938|38173727|FG000|Optional Extension|Protocol-specific criteria met|0|||
17029322|NCT00756938|38173728|FG001|Optional Extension|Protocol-specific criteria met|0|||
17029323|NCT00756938|38173729|FG002|Optional Extension|Protocol-specific criteria met|0|||
17029324|NCT00756938|38173730|FG003|Optional Extension|Protocol-specific criteria met|9|||
17029325|NCT00756938|38173727|FG000|Optional Extension|Physician Decision|0|||
17029326|NCT00756938|38173728|FG001|Optional Extension|Physician Decision|0|||
17029327|NCT00756938|38173729|FG002|Optional Extension|Physician Decision|0|||
17029328|NCT00756938|38173730|FG003|Optional Extension|Physician Decision|3|||
17029329|NCT00756938|38173727|FG000|Optional Extension|Lost to Follow-up|0|||
17029330|NCT00756938|38173728|FG001|Optional Extension|Lost to Follow-up|0|||
17029331|NCT00756938|38173729|FG002|Optional Extension|Lost to Follow-up|0|||
17029332|NCT00756938|38173730|FG003|Optional Extension|Lost to Follow-up|1|||
17029333|NCT00756938|38173727|FG000|Optional Extension|Protocol Violation|0|||
17029334|NCT00756938|38173728|FG001|Optional Extension|Protocol Violation|0|||
17029335|NCT00756938|38173729|FG002|Optional Extension|Protocol Violation|0|||
17029336|NCT00756938|38173730|FG003|Optional Extension|Protocol Violation|1|||
17029337|NCT00756938|38173727|FG000|Optional Extension|Withdrawal by Subject|0|||
17029338|NCT00756938|38173728|FG001|Optional Extension|Withdrawal by Subject|0|||
17136127|NCT03147248|38277368|FG004|Overall Study|Adverse Event|6|||
17136128|NCT03147248|38277369|FG005|Overall Study|Adverse Event|11|||
17029339|NCT00756938|38173729|FG002|Optional Extension|Withdrawal by Subject|0|||
17029340|NCT00756938|38173730|FG003|Optional Extension|Withdrawal by Subject|10|||
17029341|NCT00756938|38173727|FG000|Optional Extension|Adverse Event|0|||
17029342|NCT00756938|38173728|FG001|Optional Extension|Adverse Event|0|||
17029343|NCT00756938|38173729|FG002|Optional Extension|Adverse Event|0|||
17029344|NCT00756938|38173730|FG003|Optional Extension|Adverse Event|1|||
17029345|NCT00796367|38173751|FG000|Overall Study|Adverse Event|6|||
17029346|NCT00796367|38173752|FG001|Overall Study|Adverse Event|4|||
17029347|NCT00796367|38173753|FG002|Overall Study|Adverse Event|7|||
17029348|NCT00796367|38173751|FG000|Overall Study|Lost to Follow-up|5|||
17029349|NCT00796367|38173752|FG001|Overall Study|Lost to Follow-up|4|||
17029350|NCT00796367|38173753|FG002|Overall Study|Lost to Follow-up|21|||
17029351|NCT00796367|38173751|FG000|Overall Study|Withdrawal by Subject|9|||
17029352|NCT00796367|38173752|FG001|Overall Study|Withdrawal by Subject|11|||
17029353|NCT00796367|38173753|FG002|Overall Study|Withdrawal by Subject|12|||
17029354|NCT00796367|38173751|FG000|Overall Study|Lack of Efficacy|2|||
17029355|NCT00796367|38173752|FG001|Overall Study|Lack of Efficacy|1|||
17029356|NCT00796367|38173753|FG002|Overall Study|Lack of Efficacy|0|||
17029357|NCT00796367|38173751|FG000|Overall Study|non compliance|3|||
17029358|NCT00796367|38173752|FG001|Overall Study|non compliance|1|||
17029359|NCT00796367|38173753|FG002|Overall Study|non compliance|1|||
17029360|NCT00796367|38173751|FG000|Overall Study|Pregnancy|1|||
17029361|NCT00796367|38173752|FG001|Overall Study|Pregnancy|0|||
17029362|NCT00796367|38173753|FG002|Overall Study|Pregnancy|1|||
17029363|NCT00796367|38173751|FG000|Overall Study|Requirement for restricted medication|2|||
17029364|NCT00796367|38173752|FG001|Overall Study|Requirement for restricted medication|0|||
17029365|NCT00796367|38173753|FG002|Overall Study|Requirement for restricted medication|2|||
17029366|NCT00796367|38173751|FG000|Overall Study|other|2|||
17029367|NCT00796367|38173752|FG001|Overall Study|other|4|||
17029368|NCT00796367|38173753|FG002|Overall Study|other|3|||
17029369|NCT00770588|38173763|FG000|Overall Study|Adverse Event|9|||
17029370|NCT00770588|38173764|FG001|Overall Study|Adverse Event|2|||
17029371|NCT00770588|38173763|FG000|Overall Study|Death caused by progression of disease|70|||
17029372|NCT00770588|38173764|FG001|Overall Study|Death caused by progression of disease|91|||
17029373|NCT00770588|38173763|FG000|Overall Study|Lost to Follow-up|1|||
17029374|NCT00770588|38173764|FG001|Overall Study|Lost to Follow-up|1|||
17029375|NCT00770588|38173763|FG000|Overall Study|Withdrawal by Subject|1|||
17029376|NCT00770588|38173764|FG001|Overall Study|Withdrawal by Subject|1|||
17029377|NCT00777608|38173773|FG000|Overall Study|Lost to Follow-up|1|||
17029378|NCT00777608|38173774|FG001|Overall Study|Lost to Follow-up|1|||
17029379|NCT00777608|38173773|FG000|Overall Study|Withdrawal by Subject|1|||
17029380|NCT00777608|38173774|FG001|Overall Study|Withdrawal by Subject|3|||
17029381|NCT00777608|38173773|FG000|Overall Study|Protocol Violation|1|||
17029382|NCT00777608|38173774|FG001|Overall Study|Protocol Violation|0|||
17029383|NCT00777608|38173773|FG000|Overall Study|Investigator Decision|1|||
17136129|NCT03147248|38277364|FG000|Overall Study|Disease progression|1|||
17029384|NCT00777608|38173774|FG001|Overall Study|Investigator Decision|2|||
17029385|NCT00792935|38173782|FG000|Overall Study|Adverse Event|2|||
17029386|NCT00792935|38173783|FG001|Overall Study|Adverse Event|1|||
17029387|NCT00792935|38173782|FG000|Overall Study|Lost to Follow-up|0|||
17029388|NCT00792935|38173783|FG001|Overall Study|Lost to Follow-up|1|||
17029389|NCT00792935|38173782|FG000|Overall Study|Protocol Violation|2|||
17029390|NCT00792935|38173783|FG001|Overall Study|Protocol Violation|0|||
17029391|NCT00792935|38173782|FG000|Overall Study|Withdrawal by Subject|0|||
17029392|NCT00792935|38173783|FG001|Overall Study|Withdrawal by Subject|1|||
17029393|NCT00770510|38173789|FG000|Overall Study|Lost to Follow-up|2|||
17029394|NCT00770510|38173789|FG000|Overall Study|Pregnancy|1|||
17029395|NCT00770510|38173789|FG000|Overall Study|Withdrawal by Subject|2|||
17029396|NCT00770432|38173803|FG000|Overall Study|Other|4|||
17029397|NCT00770432|38173804|FG001|Overall Study|Other|6|||
17029398|NCT00770432|38173803|FG000|Overall Study|Non-compliance|0|||
17029399|NCT00770432|38173804|FG001|Overall Study|Non-compliance|1|||
17029400|NCT00792701|38173812|FG000|Overall Study|Adverse Event|0|||
17029401|NCT00792701|38173813|FG001|Overall Study|Adverse Event|22|||
17029402|NCT00792701|38173812|FG000|Overall Study|Ineligible|1|||
17029403|NCT00792701|38173813|FG001|Overall Study|Ineligible|3|||
17029404|NCT00792701|38173812|FG000|Overall Study|Withdrawal by Subject|1|||
17029405|NCT00792701|38173813|FG001|Overall Study|Withdrawal by Subject|19|||
17029406|NCT00792701|38173812|FG000|Overall Study|Not protocol specified|17|||
17029407|NCT00792701|38173813|FG001|Overall Study|Not protocol specified|0|||
17029408|NCT00777296|38173825|FG000|Overall Study|Adverse Event|0|||
17029409|NCT00777296|38173826|FG001|Overall Study|Adverse Event|1|||
17029410|NCT00777296|38173827|FG002|Overall Study|Adverse Event|0|||
17029411|NCT00777296|38173828|FG003|Overall Study|Adverse Event|1|||
17029412|NCT00777296|38173825|FG000|Overall Study|Withdrawal by Subject|1|||
17029413|NCT00777296|38173826|FG001|Overall Study|Withdrawal by Subject|0|||
17029414|NCT00777296|38173827|FG002|Overall Study|Withdrawal by Subject|0|||
17029415|NCT00777296|38173828|FG003|Overall Study|Withdrawal by Subject|0|||
17029416|NCT00777296|38173825|FG000|Overall Study|CRF form not completed|0|||
17029417|NCT00777296|38173826|FG001|Overall Study|CRF form not completed|0|||
17029418|NCT00777296|38173827|FG002|Overall Study|CRF form not completed|2|||
17029419|NCT00777296|38173828|FG003|Overall Study|CRF form not completed|0|||
17029420|NCT00756470|38173850|FG000|Overall Study|Withdrawal by Subject|1|||
17029421|NCT00756470|38173850|FG000|Overall Study|Adverse Event|4|||
17029422|NCT00792623|38173854|FG000|Overall Study|Adverse Event|2|||
17029423|NCT00792623|38173854|FG000|Overall Study|Withdrawal by Subject|5|||
17029424|NCT00756314|38173861|FG000|Overall Study|Lost to Follow-up|2|||
17029425|NCT00756314|38173862|FG001|Overall Study|Lost to Follow-up|59|||
17029426|NCT00727506|38173874|FG000|Overall Study|Adverse Event|0|||
17029427|NCT00727506|38173875|FG001|Overall Study|Adverse Event|0|||
17029428|NCT00727506|38173876|FG002|Overall Study|Adverse Event|4|||
17029429|NCT00727506|38173877|FG003|Overall Study|Adverse Event|4|||
17029430|NCT00727506|38173878|FG004|Overall Study|Adverse Event|1|||
17029431|NCT00727506|38173879|FG005|Overall Study|Adverse Event|8|||
17029432|NCT00727506|38173874|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
17029433|NCT00727506|38173875|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17029434|NCT00727506|38173876|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
17029435|NCT00727506|38173877|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17029436|NCT00727506|38173878|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17029437|NCT00727506|38173879|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17029438|NCT00727506|38173874|FG000|Overall Study|Progressive disease|4|||
17029439|NCT00727506|38173875|FG001|Overall Study|Progressive disease|7|||
17029440|NCT00727506|38173876|FG002|Overall Study|Progressive disease|9|||
17029441|NCT00727506|38173877|FG003|Overall Study|Progressive disease|28|||
17029442|NCT00727506|38173878|FG004|Overall Study|Progressive disease|38|||
17029443|NCT00727506|38173879|FG005|Overall Study|Progressive disease|28|||
17029444|NCT00727506|38173874|FG000|Overall Study|Refused to continue medication|0|||
17029445|NCT00727506|38173875|FG001|Overall Study|Refused to continue medication|1|||
17029446|NCT00727506|38173876|FG002|Overall Study|Refused to continue medication|2|||
17029447|NCT00727506|38173877|FG003|Overall Study|Refused to continue medication|3|||
17029448|NCT00727506|38173878|FG004|Overall Study|Refused to continue medication|1|||
17029449|NCT00727506|38173879|FG005|Overall Study|Refused to continue medication|2|||
17029450|NCT00727506|38173874|FG000|Overall Study|Other reason not described above|0|||
17029451|NCT00727506|38173875|FG001|Overall Study|Other reason not described above|0|||
17029452|NCT00727506|38173876|FG002|Overall Study|Other reason not described above|1|||
17029453|NCT00727506|38173877|FG003|Overall Study|Other reason not described above|4|||
17029454|NCT00727506|38173878|FG004|Overall Study|Other reason not described above|1|||
17029455|NCT00727506|38173879|FG005|Overall Study|Other reason not described above|1|||
17029456|NCT00789815|38173901|FG000|Overall Study|Protocol Violation|6|||
17029457|NCT00789815|38173902|FG001|Overall Study|Protocol Violation|1|||
17029458|NCT00789815|38173901|FG000|Overall Study|Intubation due to massive bleeding|1|||
17029459|NCT00789815|38173902|FG001|Overall Study|Intubation due to massive bleeding|0|||
17029460|NCT00721578|38173908|FG000|Overall Study|Death|1|||
17029461|NCT00721578|38173909|FG001|Overall Study|Death|1|||
17029462|NCT00721578|38173908|FG000|Overall Study|Withdrawal by Subject|1|||
17029463|NCT00721578|38173909|FG001|Overall Study|Withdrawal by Subject|1|||
17029464|NCT00789737|38173917|FG000|Overall Study|Withdrawal by Subject|13|||
17029465|NCT00789737|38173918|FG001|Overall Study|Withdrawal by Subject|22|||
17029466|NCT00789737|38173917|FG000|Overall Study|Lost to Follow-up|10|||
17029467|NCT00789737|38173918|FG001|Overall Study|Lost to Follow-up|14|||
17029468|NCT00789737|38173917|FG000|Overall Study|Adverse Event|8|||
17029469|NCT00789737|38173918|FG001|Overall Study|Adverse Event|8|||
17029470|NCT00789737|38173917|FG000|Overall Study|Protocol Violation|3|||
17029471|NCT00789737|38173918|FG001|Overall Study|Protocol Violation|0|||
17029472|NCT00789737|38173917|FG000|Overall Study|Lack of Efficacy|3|||
17029473|NCT00789737|38173918|FG001|Overall Study|Lack of Efficacy|0|||
17029474|NCT00789737|38173917|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
17029475|NCT00789737|38173918|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
17029476|NCT00789737|38173917|FG000|Overall Study|Other|11|||
17029477|NCT00789737|38173918|FG001|Overall Study|Other|7|||
17029478|NCT00792467|38173924|FG000|Overall Study|progression of disease|17|||
17029479|NCT00792467|38173924|FG000|Overall Study|Adverse Event|1|||
17029480|NCT00792467|38173924|FG000|Overall Study|patient request|1|||
17029481|NCT00792467|38173924|FG000|Overall Study|Lost to Follow-up|1|||
17029482|NCT00792467|38173924|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
17029483|NCT00792467|38173924|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
17029484|NCT00585468|38173929|FG000|First Intervention|Withdrawal by Subject|1|||
17029485|NCT00585468|38173930|FG001|First Intervention|Withdrawal by Subject|1|||
17029486|NCT00724152|38173943|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
17029487|NCT00724152|38173944|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
17029488|NCT00724152|38173945|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
17029489|NCT00724152|38173943|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
17029490|NCT00724152|38173944|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
17029491|NCT00724152|38173945|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
17029492|NCT00721110|38173959|FG000|Overall Study|Ultram use|1|||
17029493|NCT00721110|38173960|FG001|Overall Study|Ultram use|0|||
17029494|NCT00721110|38173961|FG002|Overall Study|Ultram use|0|||
17029495|NCT00721110|38173962|FG003|Overall Study|Ultram use|0|||
17029496|NCT00721110|38173959|FG000|Overall Study|vertical incision|0|||
17029497|NCT00721110|38173960|FG001|Overall Study|vertical incision|0|||
17029498|NCT00721110|38173961|FG002|Overall Study|vertical incision|1|||
17029499|NCT00721110|38173962|FG003|Overall Study|vertical incision|0|||
17029500|NCT00791999|38173976|FG000|Overall Study|Protocol planed withdrawal|14|||
17029501|NCT00791999|38173977|FG001|Overall Study|Protocol planed withdrawal|11|||
17029502|NCT00791999|38173978|FG002|Overall Study|Protocol planed withdrawal|11|||
17029503|NCT00791999|38173979|FG003|Overall Study|Protocol planed withdrawal|45|||
17029504|NCT00791999|38173976|FG000|Overall Study|Withdrawal by Subject|0|||
17029505|NCT00791999|38173977|FG001|Overall Study|Withdrawal by Subject|1|||
17029506|NCT00791999|38173978|FG002|Overall Study|Withdrawal by Subject|0|||
17029507|NCT00791999|38173979|FG003|Overall Study|Withdrawal by Subject|2|||
17029508|NCT00791999|38173976|FG000|Overall Study|Protocol Violation|3|||
17029509|NCT00791999|38173977|FG001|Overall Study|Protocol Violation|0|||
17029510|NCT00791999|38173978|FG002|Overall Study|Protocol Violation|1|||
17029511|NCT00791999|38173979|FG003|Overall Study|Protocol Violation|0|||
17029512|NCT00791999|38173976|FG000|Overall Study|Adverse Event|3|||
17029513|NCT00791999|38173977|FG001|Overall Study|Adverse Event|3|||
17029514|NCT00791999|38173978|FG002|Overall Study|Adverse Event|7|||
17029515|NCT00791999|38173979|FG003|Overall Study|Adverse Event|3|||
17029516|NCT00791999|38173976|FG000|Overall Study|Lack of Efficacy|0|||
17029517|NCT00791999|38173977|FG001|Overall Study|Lack of Efficacy|1|||
17029518|NCT00791999|38173978|FG002|Overall Study|Lack of Efficacy|0|||
17029519|NCT00791999|38173979|FG003|Overall Study|Lack of Efficacy|2|||
17029520|NCT00791999|38173976|FG000|Overall Study|Reason other than those above|1|||
17029521|NCT00791999|38173977|FG001|Overall Study|Reason other than those above|0|||
17029522|NCT00791999|38173978|FG002|Overall Study|Reason other than those above|1|||
17029523|NCT00791999|38173979|FG003|Overall Study|Reason other than those above|0|||
17029524|NCT00585078|38173993|FG000|Overall Study|Withdrawal by Subject|4|||
17029525|NCT00585078|38173993|FG000|Overall Study|Poor performance status|1|||
17029526|NCT00585078|38173993|FG000|Overall Study|Disease Progression|24|||
17029527|NCT00585078|38173993|FG000|Overall Study|Adverse Event|10|||
17029528|NCT00585078|38173993|FG000|Overall Study|Death|1|||
17029529|NCT00720876|38173997|FG000|Overall Study|found to be ineligible after starting tx|2|||
17029530|NCT00723840|38174001|FG000|Overall Study|Lost to Follow-up|2|||
17029531|NCT00723840|38174001|FG000|Overall Study|Failure to return|18|||
17029532|NCT00723840|38174001|FG000|Overall Study|Withdrawal by Subject|55|||
17029533|NCT00723840|38174001|FG000|Overall Study|Serious Adverse Events|3|||
17029534|NCT00723840|38174001|FG000|Overall Study|Other Medical Event|2|||
17029535|NCT00723840|38174001|FG000|Overall Study|Unspecified reason|2|||
17029536|NCT00789581|38174014|FG000|AC Therapy|Adverse Event|2|||
17029537|NCT00789581|38174015|FG001|AC Therapy|Adverse Event|3|||
17029538|NCT00789581|38174014|FG000|AC Therapy|Withdrawal by Subject|4|||
17029539|NCT00789581|38174015|FG001|AC Therapy|Withdrawal by Subject|7|||
17029540|NCT00789581|38174014|FG000|AC Therapy|Disease recurrence|3|||
17029541|NCT00789581|38174015|FG001|AC Therapy|Disease recurrence|1|||
17029542|NCT00789581|38174014|FG000|AC Therapy|Intercurrent Illness|1|||
17029543|NCT00789581|38174015|FG001|AC Therapy|Intercurrent Illness|0|||
17029544|NCT00789581|38174014|FG000|AC Therapy|Never Treated|1|||
17029545|NCT00789581|38174015|FG001|AC Therapy|Never Treated|4|||
17029546|NCT00789581|38174014|FG000|AC Therapy|Other|0|||
16990913|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
16990914|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
16990915|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
16990916|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
16990917|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
16990918|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
16990919|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
16990920|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
17029547|NCT00789581|38174015|FG001|AC Therapy|Other|2|||
17029548|NCT00789581|38174014|FG000|Adjuvant Therapy|Never treated|2|||
17029549|NCT00789581|38174015|FG001|Adjuvant Therapy|Never treated|2|||
17029550|NCT00789581|38174014|FG000|Adjuvant Therapy|Adverse Event|20|||
17029551|NCT00789581|38174015|FG001|Adjuvant Therapy|Adverse Event|44|||
17029552|NCT00789581|38174014|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
17029553|NCT00789581|38174015|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
17029554|NCT00789581|38174014|FG000|Adjuvant Therapy|Disease recurrence|2|||
17029555|NCT00789581|38174015|FG001|Adjuvant Therapy|Disease recurrence|1|||
17029556|NCT00789581|38174014|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
17029557|NCT00789581|38174015|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
17029558|NCT00789581|38174014|FG000|Adjuvant Therapy|Protocol Violation|1|||
17029559|NCT00789581|38174015|FG001|Adjuvant Therapy|Protocol Violation|1|||
17029560|NCT00789581|38174014|FG000|Adjuvant Therapy|Other|0|||
17029561|NCT00789581|38174015|FG001|Adjuvant Therapy|Other|1|||
17029562|NCT00717756|38174022|FG000|Overall Study|Withdrawal by Subject|1|||
17029563|NCT00717522|38174026|FG000|Overall Study|Disease Progression|5|||
17029564|NCT00717522|38174026|FG000|Overall Study|Adverse Event|1|||
17029565|NCT00717522|38174026|FG000|Overall Study|Death|1|||
17029566|NCT00791921|38174032|FG000|Overall Study|Protocol planed|24|||
17029567|NCT00791921|38174033|FG001|Overall Study|Protocol planed|88|||
17029568|NCT00791921|38174032|FG000|Overall Study|Withdrawal by Subject|1|||
17029569|NCT00791921|38174033|FG001|Overall Study|Withdrawal by Subject|2|||
17029570|NCT00791921|38174032|FG000|Overall Study|Adverse Event|8|||
17029571|NCT00791921|38174033|FG001|Overall Study|Adverse Event|2|||
17029572|NCT00791921|38174032|FG000|Overall Study|Lack of Efficacy|0|||
17029573|NCT00791921|38174033|FG001|Overall Study|Lack of Efficacy|2|||
17029574|NCT00791921|38174032|FG000|Overall Study|Lack of study drug administration|1|||
17029575|NCT00791921|38174033|FG001|Overall Study|Lack of study drug administration|1|||
17029576|NCT00791921|38174032|FG000|Overall Study|Reason other than those above|0|||
17029577|NCT00791921|38174033|FG001|Overall Study|Reason other than those above|1|||
17029578|NCT00582933|38174039|FG000|Overall Study|Physician Decision|3|||
17029579|NCT00791765|38174045|FG000|Weeks 1 to 12|Adverse Event|0|||
17029580|NCT00791765|38174046|FG001|Weeks 1 to 12|Adverse Event|1|||
17029581|NCT00791765|38174045|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
17029582|NCT00791765|38174046|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
17029583|NCT00791765|38174045|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
17029584|NCT00791765|38174046|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
17029585|NCT00791765|38174045|FG000|Weeks 1 to 12|Physician Decision|1|||
17029586|NCT00791765|38174046|FG001|Weeks 1 to 12|Physician Decision|0|||
17029587|NCT00791765|38174045|FG000|Weeks 1 to 12|Disease progression|3|||
17029588|NCT00791765|38174046|FG001|Weeks 1 to 12|Disease progression|0|||
17029589|NCT00791765|38174045|FG000|Weeks 1 to 12|Ineligibility determined|0|||
17029590|NCT00791765|38174046|FG001|Weeks 1 to 12|Ineligibility determined|3|||
17029591|NCT00791765|38174045|FG000|Weeks 13 to 24|Protocol deviation|2|||
17029592|NCT00791765|38174046|FG001|Weeks 13 to 24|Protocol deviation|0|||
17029593|NCT00791765|38174045|FG000|Weeks 13 to 24|Adverse Event|0|||
17029594|NCT00791765|38174046|FG001|Weeks 13 to 24|Adverse Event|3|||
17029595|NCT00791765|38174045|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
17029596|NCT00791765|38174046|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
17029597|NCT00791765|38174045|FG000|Weeks 13 to 24|Disease progression|0|||
17029598|NCT00791765|38174046|FG001|Weeks 13 to 24|Disease progression|1|||
17029599|NCT00791765|38174045|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
17029600|NCT00791765|38174046|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
17029601|NCT00791765|38174045|FG000|Weeks 13 to 24|Other|0|||
17029602|NCT00791765|38174046|FG001|Weeks 13 to 24|Other|1|||
17029603|NCT00789191|38174054|FG000|Overall Study|Adverse Event|2|||
17029604|NCT00789191|38174055|FG001|Overall Study|Adverse Event|4|||
17029605|NCT00789191|38174054|FG000|Overall Study|Lack of Efficacy|0|||
17029606|NCT00789191|38174055|FG001|Overall Study|Lack of Efficacy|5|||
17029607|NCT00789191|38174054|FG000|Overall Study|Protocol Violation|5|||
17029608|NCT00789191|38174055|FG001|Overall Study|Protocol Violation|3|||
17029609|NCT00789191|38174054|FG000|Overall Study|Withdrawal Criteria|2|||
17029610|NCT00789191|38174055|FG001|Overall Study|Withdrawal Criteria|4|||
17029611|NCT00789191|38174054|FG000|Overall Study|Unclassified|5|||
17029612|NCT00789191|38174055|FG001|Overall Study|Unclassified|3|||
16990921|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
16990922|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
16990923|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
16990924|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
16990925|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
16990926|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
16990927|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
16990928|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
16990929|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
16990930|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
16990931|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
16990932|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
17136130|NCT03147248|38277365|FG001|Overall Study|Disease progression|0|||
17136131|NCT03147248|38277366|FG002|Overall Study|Disease progression|0|||
17136132|NCT03147248|38277367|FG003|Overall Study|Disease progression|0|||
17136133|NCT03147248|38277368|FG004|Overall Study|Disease progression|0|||
17136134|NCT03147248|38277369|FG005|Overall Study|Disease progression|2|||
17136135|NCT03147248|38277364|FG000|Overall Study|Withdrawal by Subject|0|||
17136136|NCT03147248|38277365|FG001|Overall Study|Withdrawal by Subject|0|||
17136137|NCT03147248|38277366|FG002|Overall Study|Withdrawal by Subject|0|||
17136138|NCT03147248|38277367|FG003|Overall Study|Withdrawal by Subject|0|||
17136139|NCT03147248|38277368|FG004|Overall Study|Withdrawal by Subject|12|||
17136140|NCT03147248|38277369|FG005|Overall Study|Withdrawal by Subject|9|||
17136141|NCT03147248|38277364|FG000|Overall Study|Protocol Violation|0|||
17136142|NCT03147248|38277365|FG001|Overall Study|Protocol Violation|0|||
17136143|NCT03147248|38277366|FG002|Overall Study|Protocol Violation|0|||
17136144|NCT03147248|38277367|FG003|Overall Study|Protocol Violation|0|||
17136145|NCT03147248|38277368|FG004|Overall Study|Protocol Violation|2|||
17136146|NCT03147248|38277369|FG005|Overall Study|Protocol Violation|0|||
17136147|NCT03147248|38277364|FG000|Overall Study|Lost to Follow-up|0|||
17136148|NCT03147248|38277365|FG001|Overall Study|Lost to Follow-up|0|||
17136149|NCT03147248|38277366|FG002|Overall Study|Lost to Follow-up|0|||
17136150|NCT03147248|38277367|FG003|Overall Study|Lost to Follow-up|0|||
17136151|NCT03147248|38277368|FG004|Overall Study|Lost to Follow-up|2|||
17136152|NCT03147248|38277369|FG005|Overall Study|Lost to Follow-up|0|||
17136153|NCT03147248|38277364|FG000|Overall Study|Pregnancy|0|||
17136154|NCT03147248|38277365|FG001|Overall Study|Pregnancy|0|||
17029613|NCT00789035|38174066|FG000|Overall Study|Adverse Event|0|||
17029614|NCT00789035|38174067|FG001|Overall Study|Adverse Event|2|||
17029615|NCT00789035|38174068|FG002|Overall Study|Adverse Event|0|||
17029616|NCT00789035|38174069|FG003|Overall Study|Adverse Event|1|||
17136155|NCT03147248|38277366|FG002|Overall Study|Pregnancy|0|||
17136156|NCT03147248|38277367|FG003|Overall Study|Pregnancy|0|||
17136157|NCT03147248|38277368|FG004|Overall Study|Pregnancy|1|||
17136158|NCT03147248|38277369|FG005|Overall Study|Pregnancy|0|||
17136159|NCT03147248|38277364|FG000|Overall Study|Death|0|||
17136160|NCT03147248|38277365|FG001|Overall Study|Death|0|||
17136161|NCT03147248|38277366|FG002|Overall Study|Death|0|||
17136162|NCT03147248|38277367|FG003|Overall Study|Death|0|||
17136163|NCT03147248|38277368|FG004|Overall Study|Death|0|||
16990933|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
16990934|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
16990935|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
16990936|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
16990937|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
16990938|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
16990939|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
17029617|NCT00789035|38174070|FG004|Overall Study|Adverse Event|3|||
17029618|NCT00789035|38174066|FG000|Overall Study|Lack of Efficacy|3|||
17029619|NCT00789035|38174067|FG001|Overall Study|Lack of Efficacy|0|||
17029620|NCT00789035|38174068|FG002|Overall Study|Lack of Efficacy|0|||
17029621|NCT00789035|38174069|FG003|Overall Study|Lack of Efficacy|0|||
17029622|NCT00789035|38174070|FG004|Overall Study|Lack of Efficacy|2|||
17136164|NCT03147248|38277369|FG005|Overall Study|Death|4|||
17136165|NCT03147248|38277364|FG000|Overall Study|Physician Decision|0|||
17029623|NCT00789035|38174066|FG000|Overall Study|Protocol Violation|1|||
17029624|NCT00789035|38174067|FG001|Overall Study|Protocol Violation|0|||
17029625|NCT00789035|38174068|FG002|Overall Study|Protocol Violation|0|||
17029626|NCT00789035|38174069|FG003|Overall Study|Protocol Violation|0|||
17029627|NCT00789035|38174070|FG004|Overall Study|Protocol Violation|0|||
17029628|NCT00789035|38174066|FG000|Overall Study|Withdrawal by Subject|0|||
17029629|NCT00789035|38174067|FG001|Overall Study|Withdrawal by Subject|2|||
17029630|NCT00789035|38174068|FG002|Overall Study|Withdrawal by Subject|0|||
17029631|NCT00789035|38174069|FG003|Overall Study|Withdrawal by Subject|0|||
17029632|NCT00789035|38174070|FG004|Overall Study|Withdrawal by Subject|0|||
17029633|NCT00789035|38174066|FG000|Overall Study|Other reason not defined above|2|||
17029634|NCT00789035|38174067|FG001|Overall Study|Other reason not defined above|3|||
17029635|NCT00789035|38174068|FG002|Overall Study|Other reason not defined above|1|||
17029636|NCT00789035|38174069|FG003|Overall Study|Other reason not defined above|0|||
17029637|NCT00789035|38174070|FG004|Overall Study|Other reason not defined above|1|||
17029638|NCT03326193|38174094|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
17029639|NCT03326193|38174094|FG000|Overall Study|Death|19|||
17029640|NCT03326193|38174094|FG000|Overall Study|Withdrawal by Subject|8|||
17029641|NCT00437203|38174117|FG000|Overall Study|Death|0|||
17029642|NCT00437203|38174118|FG001|Overall Study|Death|0|||
17029643|NCT00437203|38174119|FG002|Overall Study|Death|1|||
17029644|NCT00437203|38174120|FG003|Overall Study|Death|0|||
17029645|NCT00437203|38174121|FG004|Overall Study|Death|0|||
17029646|NCT00437203|38174122|FG005|Overall Study|Death|0|||
17029647|NCT00437203|38174123|FG006|Overall Study|Death|0|||
17029648|NCT00437203|38174124|FG007|Overall Study|Death|1|||
17029649|NCT00437203|38174125|FG008|Overall Study|Death|0|||
17029650|NCT00437203|38174126|FG009|Overall Study|Death|1|||
17029651|NCT00437203|38174117|FG000|Overall Study|Adverse Event|1|||
17029652|NCT00437203|38174118|FG001|Overall Study|Adverse Event|1|||
17029653|NCT00437203|38174119|FG002|Overall Study|Adverse Event|0|||
17029654|NCT00437203|38174120|FG003|Overall Study|Adverse Event|0|||
17029655|NCT00437203|38174121|FG004|Overall Study|Adverse Event|0|||
17029656|NCT00437203|38174122|FG005|Overall Study|Adverse Event|0|||
17029657|NCT00437203|38174123|FG006|Overall Study|Adverse Event|0|||
17029658|NCT00437203|38174124|FG007|Overall Study|Adverse Event|1|||
17029659|NCT00437203|38174125|FG008|Overall Study|Adverse Event|0|||
17029660|NCT00437203|38174126|FG009|Overall Study|Adverse Event|1|||
17029661|NCT00437203|38174117|FG000|Overall Study|Study terminated by sponsor|0|||
17029662|NCT00437203|38174118|FG001|Overall Study|Study terminated by sponsor|0|||
17029663|NCT00437203|38174119|FG002|Overall Study|Study terminated by sponsor|0|||
17029664|NCT00437203|38174120|FG003|Overall Study|Study terminated by sponsor|0|||
17029665|NCT00437203|38174121|FG004|Overall Study|Study terminated by sponsor|0|||
17029666|NCT00437203|38174122|FG005|Overall Study|Study terminated by sponsor|0|||
17136166|NCT03147248|38277365|FG001|Overall Study|Physician Decision|0|||
17136167|NCT03147248|38277366|FG002|Overall Study|Physician Decision|0|||
17136168|NCT03147248|38277367|FG003|Overall Study|Physician Decision|0|||
17136169|NCT03147248|38277368|FG004|Overall Study|Physician Decision|2|||
17136170|NCT03147248|38277369|FG005|Overall Study|Physician Decision|4|||
17136171|NCT03147248|38277364|FG000|Overall Study|Prolonged Dosing Interval|0|||
17136172|NCT03147248|38277365|FG001|Overall Study|Prolonged Dosing Interval|0|||
17136173|NCT03147248|38277366|FG002|Overall Study|Prolonged Dosing Interval|0|||
17136174|NCT03147248|38277367|FG003|Overall Study|Prolonged Dosing Interval|0|||
17136175|NCT03147248|38277368|FG004|Overall Study|Prolonged Dosing Interval|1|||
17136176|NCT03147248|38277369|FG005|Overall Study|Prolonged Dosing Interval|1|||
17136177|NCT03796039|38277385|FG000|Overall Study|Death|2|||
17136178|NCT03796039|38277386|FG001|Overall Study|Death|1|||
17136179|NCT03796039|38277385|FG000|Overall Study|Withdrawal by Subject|7|||
17136180|NCT03796039|38277386|FG001|Overall Study|Withdrawal by Subject|4|||
17136181|NCT03794089|38277394|FG000|Overall Study|Lost to Follow-up|4|||
17136182|NCT03794089|38277395|FG001|Overall Study|Lost to Follow-up|1|||
17136183|NCT03794089|38277394|FG000|Overall Study|Withdrawal by Subject|2|||
17136184|NCT03794089|38277395|FG001|Overall Study|Withdrawal by Subject|0|||
17136185|NCT03151304|38277401|FG000|Overall Study|Termination of study by Sponsor|23|||
17136186|NCT03151304|38277401|FG000|Overall Study|missing|3|||
17029667|NCT00437203|38174123|FG006|Overall Study|Study terminated by sponsor|0|||
17029668|NCT00437203|38174124|FG007|Overall Study|Study terminated by sponsor|0|||
17029669|NCT00437203|38174125|FG008|Overall Study|Study terminated by sponsor|1|||
17029670|NCT00437203|38174126|FG009|Overall Study|Study terminated by sponsor|0|||
17029671|NCT00437203|38174117|FG000|Overall Study|Objective progression or relapse|5|||
17029672|NCT00437203|38174118|FG001|Overall Study|Objective progression or relapse|6|||
17029673|NCT00437203|38174119|FG002|Overall Study|Objective progression or relapse|2|||
17029674|NCT00437203|38174120|FG003|Overall Study|Objective progression or relapse|3|||
17029675|NCT00437203|38174121|FG004|Overall Study|Objective progression or relapse|3|||
17029676|NCT00437203|38174122|FG005|Overall Study|Objective progression or relapse|3|||
17136187|NCT03151304|38277401|FG000|Overall Study|Withdrawal by Subject|8|||
17136188|NCT03151304|38277401|FG000|Overall Study|multiple reasons|30|||
17136189|NCT03152552|38277410|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
17136190|NCT03152552|38277411|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
17136191|NCT03152552|38277412|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
17136192|NCT03152552|38277413|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
17136193|NCT03152552|38277414|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
17136194|NCT03152552|38277410|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
16990940|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
16990941|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
16990942|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
16990943|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
16990944|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
16990945|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
16990946|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
16990947|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16990948|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16990949|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16990950|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16990951|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16990952|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
16990953|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
16990954|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
16990955|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
16990956|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
16990957|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
16990958|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
16990959|NCT00745615|38134975|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
16990960|NCT00745615|38134976|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
16990961|NCT00745615|38134977|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
16990962|NCT00745615|38134978|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
16990963|NCT00745615|38134979|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
16990964|NCT00745615|38134980|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
16990965|NCT00744523|38134994|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
16990966|NCT00744523|38134995|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
16990967|NCT04517253|38135006|FG000|Overall Study|Adverse Event|1|||
17029677|NCT00437203|38174123|FG006|Overall Study|Objective progression or relapse|6|||
17029678|NCT00437203|38174124|FG007|Overall Study|Objective progression or relapse|1|||
17029679|NCT00437203|38174125|FG008|Overall Study|Objective progression or relapse|2|||
17029680|NCT00437203|38174126|FG009|Overall Study|Objective progression or relapse|2|||
17029681|NCT00437203|38174117|FG000|Overall Study|Other|0|||
17029682|NCT00437203|38174118|FG001|Overall Study|Other|1|||
17029683|NCT00437203|38174119|FG002|Overall Study|Other|0|||
17029684|NCT00437203|38174120|FG003|Overall Study|Other|0|||
17029685|NCT00437203|38174121|FG004|Overall Study|Other|0|||
17029686|NCT00437203|38174122|FG005|Overall Study|Other|0|||
16990968|NCT04517253|38135007|FG001|Overall Study|Adverse Event|0|||
16990969|NCT04517253|38135008|FG002|Overall Study|Adverse Event|0|||
17029687|NCT00437203|38174123|FG006|Overall Study|Other|1|||
17029688|NCT00437203|38174124|FG007|Overall Study|Other|0|||
17029689|NCT00437203|38174125|FG008|Overall Study|Other|0|||
17029690|NCT00437203|38174126|FG009|Overall Study|Other|0|||
17029691|NCT00753272|38174159|FG000|Overall Study|Adverse Event|878|||
16990970|NCT04517253|38135006|FG000|Overall Study|Death|0|||
16990971|NCT04517253|38135007|FG001|Overall Study|Death|1|||
16990972|NCT04517253|38135008|FG002|Overall Study|Death|0|||
16990973|NCT00744991|38135018|FG000|Overall Study|Progressive Disease|11|||
16990974|NCT00744991|38135018|FG000|Overall Study|Withdrawal by Subject|8|||
16990975|NCT00744991|38135018|FG000|Overall Study|Physician Decision|3|||
16990976|NCT00744991|38135018|FG000|Overall Study|Adverse Event|2|||
16990977|NCT00744991|38135018|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
16990978|NCT00839254|38135042|FG000|Overall Study|Protocol Violation|0|||
16990979|NCT00839254|38135043|FG001|Overall Study|Protocol Violation|1|||
16990980|NCT00839254|38135044|FG002|Overall Study|Protocol Violation|1|||
16990981|NCT00839254|38135045|FG003|Overall Study|Protocol Violation|1|||
16990982|NCT00839254|38135046|FG004|Overall Study|Protocol Violation|0|||
16990983|NCT00839254|38135047|FG005|Overall Study|Protocol Violation|0|||
16990984|NCT00839254|38135048|FG006|Overall Study|Protocol Violation|1|||
16990985|NCT00839254|38135049|FG007|Overall Study|Protocol Violation|2|||
16990986|NCT00839254|38135042|FG000|Overall Study|Physician Decision|0|||
17029692|NCT00753272|38174160|FG001|Overall Study|Adverse Event|869|||
17029693|NCT00753272|38174159|FG000|Overall Study|Protocol Violation|28|||
17029694|NCT00753272|38174160|FG001|Overall Study|Protocol Violation|46|||
17029695|NCT00753272|38174159|FG000|Overall Study|Withdrawal by Subject|2481|||
17029696|NCT00753272|38174160|FG001|Overall Study|Withdrawal by Subject|2407|||
17029697|NCT00753272|38174159|FG000|Overall Study|Lost to Follow-up|491|||
17029698|NCT00753272|38174160|FG001|Overall Study|Lost to Follow-up|497|||
17029699|NCT00753272|38174159|FG000|Overall Study|Other|1104|||
17029700|NCT00753272|38174160|FG001|Overall Study|Other|1088|||
17029701|NCT00437125|38174169|FG000|Overall Study|Adverse Event|12|||
17029702|NCT00437125|38174169|FG000|Overall Study|Death|1|||
17029703|NCT00437125|38174169|FG000|Overall Study|Clinical Relapse|1|||
17029704|NCT00437125|38174169|FG000|Overall Study|Lack of Efficacy|1|||
17029705|NCT00437125|38174169|FG000|Overall Study|Lost to Follow-up|1|||
17029706|NCT00437125|38174169|FG000|Overall Study|Withdrawal by Subject|13|||
17029707|NCT00437125|38174169|FG000|Overall Study|Withdrawal by Caregiver|2|||
17029708|NCT00437125|38174169|FG000|Overall Study|Physician Decision|1|||
17029709|NCT00582309|38174185|FG000|Overall Study|Protocol Violation|0|||
17029710|NCT00582309|38174186|FG001|Overall Study|Protocol Violation|0|||
17029711|NCT00582309|38174187|FG002|Overall Study|Protocol Violation|2|||
17029712|NCT00443053|38174197|FG000|Overall Study|Adverse Event|2|||
17029713|NCT00443053|38174198|FG001|Overall Study|Adverse Event|1|||
17029714|NCT00443053|38174197|FG000|Overall Study|Withdrawal by Subject|9|||
17029715|NCT00443053|38174198|FG001|Overall Study|Withdrawal by Subject|18|||
17029716|NCT00443053|38174197|FG000|Overall Study|Lost to Follow-up|4|||
17029717|NCT00443053|38174198|FG001|Overall Study|Lost to Follow-up|5|||
17029718|NCT00443053|38174197|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
17029719|NCT00443053|38174198|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
17029720|NCT00443053|38174197|FG000|Overall Study|Noncompliance|2|||
17029721|NCT00443053|38174198|FG001|Overall Study|Noncompliance|1|||
17029722|NCT00443053|38174197|FG000|Overall Study|Other|3|||
17029723|NCT00443053|38174198|FG001|Overall Study|Other|4|||
17136195|NCT03152552|38277411|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
17136196|NCT03152552|38277412|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
17136197|NCT03152552|38277413|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
17136198|NCT03152552|38277414|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
17029724|NCT00443053|38174197|FG000|Overall Study|Physician Decision|0|||
17029725|NCT00443053|38174198|FG001|Overall Study|Physician Decision|4|||
17029726|NCT00720798|38174204|FG000|Overall Study|Adverse Event|304|||
17029727|NCT00720798|38174204|FG000|Overall Study|Death|39|||
17029728|NCT00720798|38174204|FG000|Overall Study|Insufficient Therapeutic Response|129|||
17029729|NCT00720798|38174204|FG000|Overall Study|Protocol Violation|4|||
17029730|NCT00720798|38174204|FG000|Overall Study|Refused Treatment|151|||
17029731|NCT00720798|38174204|FG000|Overall Study|Failure to Return|46|||
17029732|NCT00720798|38174204|FG000|Overall Study|Reason not Specified|83|||
17029733|NCT00756002|38174214|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
17029734|NCT00756002|38174215|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
17029735|NCT00756002|38174214|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
17029736|NCT00756002|38174215|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
17029737|NCT00756002|38174214|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
17029738|NCT00756002|38174215|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
17029739|NCT00756002|38174214|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
17029740|NCT00756002|38174215|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
17029741|NCT00756002|38174214|FG000|Double-Blind Treatment Period|Other|2|||
17029742|NCT00756002|38174215|FG001|Double-Blind Treatment Period|Other|2|||
17029743|NCT00717366|38174223|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
17029744|NCT00717366|38174224|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
17029745|NCT00717366|38174223|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
17029746|NCT00717366|38174224|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
17029747|NCT00717366|38174223|FG000|Core Study Period (20 Weeks)|Death|0|||
17029748|NCT00717366|38174224|FG001|Core Study Period (20 Weeks)|Death|1|||
17029749|NCT00717366|38174223|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
17029750|NCT00717366|38174224|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
16780370|NCT01594827|37719460|FG001|Overall Study|Physician Decision|0|||
17029751|NCT00717366|38174223|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
17029752|NCT00717366|38174224|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
17029753|NCT00717366|38174223|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
17029754|NCT00717366|38174224|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
17029755|NCT00717366|38174223|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
17029756|NCT00717366|38174224|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
17029757|NCT00723606|38174243|FG000|Overall Study|Adverse Event|2|||
17029758|NCT00723606|38174244|FG001|Overall Study|Adverse Event|5|||
17029759|NCT00723606|38174243|FG000|Overall Study|Other|2|||
17029760|NCT00723606|38174244|FG001|Overall Study|Other|0|||
17136199|NCT03152552|38277410|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
17029761|NCT00723606|38174243|FG000|Overall Study|Withdrawal by Subject|0|||
17029762|NCT00723606|38174244|FG001|Overall Study|Withdrawal by Subject|2|||
17029763|NCT00442351|38174252|FG000|Overall Study|Administrative|6|||
17029764|NCT00442351|38174253|FG001|Overall Study|Administrative|5|||
17029765|NCT00442351|38174252|FG000|Overall Study|Did not meet protocol eligibility|1|||
17029766|NCT00442351|38174253|FG001|Overall Study|Did not meet protocol eligibility|0|||
17029767|NCT00442351|38174252|FG000|Overall Study|Other|0|||
17029768|NCT00442351|38174253|FG001|Overall Study|Other|1|||
17029769|NCT00436501|38174261|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
17029770|NCT00436501|38174262|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
17029771|NCT00436501|38174261|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
17029772|NCT00436501|38174262|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
17029773|NCT00755846|38174275|FG000|Overall Study|Adverse Event|0|||
17029774|NCT00755846|38174276|FG001|Overall Study|Adverse Event|0|||
17029775|NCT00755846|38174277|FG002|Overall Study|Adverse Event|0|||
17029776|NCT00755846|38174278|FG003|Overall Study|Adverse Event|1|||
17029777|NCT00755846|38174279|FG004|Overall Study|Adverse Event|3|||
17029778|NCT00755846|38174280|FG005|Overall Study|Adverse Event|2|||
17029779|NCT00755846|38174275|FG000|Overall Study|Protocol Violation|1|||
17029780|NCT00755846|38174276|FG001|Overall Study|Protocol Violation|1|||
17029781|NCT00755846|38174277|FG002|Overall Study|Protocol Violation|1|||
17029782|NCT00755846|38174278|FG003|Overall Study|Protocol Violation|1|||
17029783|NCT00755846|38174279|FG004|Overall Study|Protocol Violation|1|||
17029784|NCT00755846|38174280|FG005|Overall Study|Protocol Violation|1|||
17029785|NCT00755846|38174275|FG000|Overall Study|Lost to Follow-up|0|||
17029786|NCT00755846|38174276|FG001|Overall Study|Lost to Follow-up|2|||
17029787|NCT00755846|38174277|FG002|Overall Study|Lost to Follow-up|1|||
17029788|NCT00755846|38174278|FG003|Overall Study|Lost to Follow-up|0|||
17029789|NCT00755846|38174279|FG004|Overall Study|Lost to Follow-up|4|||
17029790|NCT00755846|38174280|FG005|Overall Study|Lost to Follow-up|2|||
17029791|NCT00755846|38174275|FG000|Overall Study|Withdrawal by Subject|2|||
17029792|NCT00755846|38174276|FG001|Overall Study|Withdrawal by Subject|3|||
17029793|NCT00755846|38174277|FG002|Overall Study|Withdrawal by Subject|5|||
17029794|NCT00755846|38174278|FG003|Overall Study|Withdrawal by Subject|2|||
17029795|NCT00755846|38174279|FG004|Overall Study|Withdrawal by Subject|0|||
17029796|NCT00755846|38174280|FG005|Overall Study|Withdrawal by Subject|1|||
17029797|NCT00755846|38174275|FG000|Overall Study|Hyperglycemic Rescue|21|||
17029798|NCT00755846|38174276|FG001|Overall Study|Hyperglycemic Rescue|7|||
17029799|NCT00755846|38174277|FG002|Overall Study|Hyperglycemic Rescue|5|||
17029800|NCT00755846|38174278|FG003|Overall Study|Hyperglycemic Rescue|8|||
17029801|NCT00755846|38174279|FG004|Overall Study|Hyperglycemic Rescue|8|||
17029802|NCT00755846|38174280|FG005|Overall Study|Hyperglycemic Rescue|7|||
17029803|NCT00755846|38174275|FG000|Overall Study|Physician Decision|1|||
17029804|NCT00755846|38174276|FG001|Overall Study|Physician Decision|3|||
17029805|NCT00755846|38174277|FG002|Overall Study|Physician Decision|0|||
17029806|NCT00755846|38174278|FG003|Overall Study|Physician Decision|1|||
17029807|NCT00755846|38174279|FG004|Overall Study|Physician Decision|0|||
17029808|NCT00755846|38174280|FG005|Overall Study|Physician Decision|1|||
17029809|NCT00755846|38174275|FG000|Overall Study|Administrative Error|0|||
17029810|NCT00755846|38174276|FG001|Overall Study|Administrative Error|1|||
17029811|NCT00755846|38174277|FG002|Overall Study|Administrative Error|0|||
16990987|NCT00839254|38135043|FG001|Overall Study|Physician Decision|1|||
16990988|NCT00839254|38135044|FG002|Overall Study|Physician Decision|0|||
16990989|NCT00839254|38135045|FG003|Overall Study|Physician Decision|0|||
16990990|NCT00839254|38135046|FG004|Overall Study|Physician Decision|0|||
16990991|NCT00839254|38135047|FG005|Overall Study|Physician Decision|0|||
16990992|NCT00839254|38135048|FG006|Overall Study|Physician Decision|0|||
16990993|NCT00839254|38135049|FG007|Overall Study|Physician Decision|1|||
16990994|NCT00839254|38135042|FG000|Overall Study|Wrong treatment number allocation|0|||
16990995|NCT00839254|38135043|FG001|Overall Study|Wrong treatment number allocation|1|||
16990996|NCT00839254|38135044|FG002|Overall Study|Wrong treatment number allocation|0|||
16990997|NCT00839254|38135045|FG003|Overall Study|Wrong treatment number allocation|0|||
16990998|NCT00839254|38135046|FG004|Overall Study|Wrong treatment number allocation|0|||
16990999|NCT00839254|38135047|FG005|Overall Study|Wrong treatment number allocation|1|||
16991000|NCT00839254|38135048|FG006|Overall Study|Wrong treatment number allocation|0|||
16991001|NCT00839254|38135049|FG007|Overall Study|Wrong treatment number allocation|0|||
17029812|NCT00755846|38174278|FG003|Overall Study|Administrative Error|0|||
17029813|NCT00755846|38174279|FG004|Overall Study|Administrative Error|0|||
17029814|NCT00755846|38174280|FG005|Overall Study|Administrative Error|0|||
17029815|NCT00755846|38174275|FG000|Overall Study|Participant Non-compliance|0|||
17029816|NCT00755846|38174276|FG001|Overall Study|Participant Non-compliance|0|||
17029817|NCT00755846|38174277|FG002|Overall Study|Participant Non-compliance|0|||
17029818|NCT00755846|38174278|FG003|Overall Study|Participant Non-compliance|0|||
17029819|NCT00755846|38174279|FG004|Overall Study|Participant Non-compliance|1|||
17029820|NCT00755846|38174280|FG005|Overall Study|Participant Non-compliance|0|||
17029821|NCT03850093|38174297|FG000|Overall Study|Withdrawal by Subject|1|||
16991002|NCT00839254|38135042|FG000|Overall Study|Adverse Event|12|||
16991003|NCT00839254|38135043|FG001|Overall Study|Adverse Event|6|||
16991004|NCT00839254|38135044|FG002|Overall Study|Adverse Event|3|||
16991005|NCT00839254|38135045|FG003|Overall Study|Adverse Event|5|||
16991006|NCT00839254|38135046|FG004|Overall Study|Adverse Event|2|||
16991007|NCT00839254|38135047|FG005|Overall Study|Adverse Event|1|||
16991008|NCT00839254|38135048|FG006|Overall Study|Adverse Event|0|||
16991009|NCT00839254|38135049|FG007|Overall Study|Adverse Event|1|||
17029822|NCT03850093|38174298|FG001|Overall Study|Withdrawal by Subject|0|||
17029823|NCT03850093|38174299|FG002|Overall Study|Withdrawal by Subject|2|||
17029824|NCT00442117|38174309|FG000|Overall Study|Adverse Event|3|||
17029825|NCT00442117|38174310|FG001|Overall Study|Adverse Event|2|||
17029826|NCT00442117|38174309|FG000|Overall Study|Lack of Efficacy|2|||
17029827|NCT00442117|38174310|FG001|Overall Study|Lack of Efficacy|6|||
17029828|NCT00442117|38174309|FG000|Overall Study|Lost to Follow-up|1|||
17029829|NCT00442117|38174310|FG001|Overall Study|Lost to Follow-up|2|||
17029830|NCT00442117|38174309|FG000|Overall Study|Withdrawal by Subject|2|||
17029831|NCT00442117|38174310|FG001|Overall Study|Withdrawal by Subject|2|||
17029832|NCT00442117|38174309|FG000|Overall Study|Major Deviation|25|||
17029833|NCT00442117|38174310|FG001|Overall Study|Major Deviation|20|||
17029834|NCT00442117|38174309|FG000|Overall Study|Non compliance with protocol|3|||
17029835|NCT00442117|38174310|FG001|Overall Study|Non compliance with protocol|5|||
17029836|NCT00442117|38174309|FG000|Overall Study|Met Withdrawal Criteria|2|||
17029837|NCT00442117|38174310|FG001|Overall Study|Met Withdrawal Criteria|1|||
17029838|NCT00752726|38174318|FG000|Overall Study|Lost to Follow-up|2|||
17029839|NCT00752726|38174319|FG001|Overall Study|Lost to Follow-up|1|||
17029840|NCT00752726|38174318|FG000|Overall Study|Adverse Event|3|||
17029841|NCT00752726|38174319|FG001|Overall Study|Adverse Event|0|||
17029842|NCT00752726|38174318|FG000|Overall Study|Withdrawal by Subject|5|||
17029843|NCT00752726|38174319|FG001|Overall Study|Withdrawal by Subject|10|||
17029844|NCT00752726|38174318|FG000|Overall Study|Other Reason|1|||
17029845|NCT00752726|38174319|FG001|Overall Study|Other Reason|2|||
17029846|NCT00755222|38174327|FG000|Overall Study|Withdrawal by Subject|4|||
17029847|NCT00755222|38174328|FG001|Overall Study|Withdrawal by Subject|2|||
17029848|NCT00755222|38174327|FG000|Overall Study|Adverse Event|2|||
17029849|NCT00755222|38174328|FG001|Overall Study|Adverse Event|0|||
17029850|NCT00755222|38174327|FG000|Overall Study|Protocol Violation|2|||
17029851|NCT00755222|38174328|FG001|Overall Study|Protocol Violation|0|||
17029852|NCT00441727|38174337|FG000|Overall Study|Protocol Violation|19|||
17029853|NCT00441727|38174338|FG001|Overall Study|Protocol Violation|28|||
17029854|NCT00441727|38174339|FG002|Overall Study|Protocol Violation|32|||
17029855|NCT00441727|38174337|FG000|Overall Study|Adverse Event|26|||
17029856|NCT00441727|38174338|FG001|Overall Study|Adverse Event|33|||
17029857|NCT00441727|38174339|FG002|Overall Study|Adverse Event|28|||
17029858|NCT00441727|38174337|FG000|Overall Study|Lack of Efficacy|7|||
17029859|NCT00441727|38174338|FG001|Overall Study|Lack of Efficacy|8|||
17029860|NCT00441727|38174339|FG002|Overall Study|Lack of Efficacy|48|||
17029861|NCT00441727|38174337|FG000|Overall Study|Withdrawal by Subject|40|||
17029862|NCT00441727|38174338|FG001|Overall Study|Withdrawal by Subject|34|||
17029863|NCT00441727|38174339|FG002|Overall Study|Withdrawal by Subject|47|||
17029864|NCT00441727|38174337|FG000|Overall Study|Lost to Follow-up|5|||
17029865|NCT00441727|38174338|FG001|Overall Study|Lost to Follow-up|6|||
17029866|NCT00441727|38174339|FG002|Overall Study|Lost to Follow-up|5|||
17029867|NCT00441727|38174337|FG000|Overall Study|Safety Reasons|3|||
17029868|NCT00441727|38174338|FG001|Overall Study|Safety Reasons|1|||
17029869|NCT00441727|38174339|FG002|Overall Study|Safety Reasons|3|||
17029870|NCT00441727|38174337|FG000|Overall Study|Various reason specified|6|||
17029871|NCT00441727|38174338|FG001|Overall Study|Various reason specified|8|||
17029872|NCT00441727|38174339|FG002|Overall Study|Various reason specified|5|||
17029873|NCT00770120|38174361|FG000|Overall Study|Progression|31|||
17029874|NCT00770120|38174361|FG000|Overall Study|Adverse Event|11|||
17029875|NCT00770120|38174361|FG000|Overall Study|Not Protocol Specified|11|||
17029876|NCT00770120|38174361|FG000|Overall Study|Death|3|||
17029877|NCT00770120|38174361|FG000|Overall Study|Withdrawal by Subject|2|||
16991010|NCT00839254|38135042|FG000|Overall Study|Withdrawal by Subject|87|||
16991011|NCT00839254|38135043|FG001|Overall Study|Withdrawal by Subject|53|||
16991012|NCT00839254|38135044|FG002|Overall Study|Withdrawal by Subject|54|||
17029878|NCT00770120|38174361|FG000|Overall Study|Ineligible|1|||
17029879|NCT00770120|38174361|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
17029880|NCT00770120|38174361|FG000|Overall Study|Reason under Review|1|||
17029881|NCT00436345|38174368|FG000|Overall Study|ICU resident beyond follow-up period|3|||
17029882|NCT00436345|38174369|FG001|Overall Study|ICU resident beyond follow-up period|0|||
17029883|NCT00769184|38174376|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
17029884|NCT00769184|38174377|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
17029885|NCT00769184|38174376|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
17029886|NCT00769184|38174377|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
17029887|NCT00769184|38174376|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
17029888|NCT00769184|38174377|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
17029889|NCT00768560|38174391|FG000|Intervention Set 1|Adverse Event|0|||
17029890|NCT00768560|38174392|FG001|Intervention Set 1|Adverse Event|1|||
17029891|NCT00768560|38174393|FG002|Intervention Set 1|Adverse Event|0|||
17029892|NCT00768560|38174394|FG003|Intervention Set 1|Adverse Event|0|||
17029893|NCT00768560|38174395|FG004|Intervention Set 1|Adverse Event|0|||
17029894|NCT00768560|38174396|FG005|Intervention Set 1|Adverse Event|0|||
17029895|NCT00468559|38174406|FG000|Open-label Treatment Phase|Adverse Event|5|||
17029896|NCT00468559|38174407|FG001|Open-label Treatment Phase|Adverse Event|0|||
17029897|NCT00468559|38174408|FG002|Open-label Treatment Phase|Adverse Event|0|||
17029898|NCT00468559|38174406|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
17029899|NCT00468559|38174407|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
17029900|NCT00468559|38174408|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
17029901|NCT00468559|38174406|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
17029902|NCT00468559|38174407|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
17029903|NCT00468559|38174408|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
17029904|NCT00468559|38174406|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
17029905|NCT00468559|38174407|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
17029906|NCT00468559|38174408|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
17029907|NCT00468559|38174406|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
17029908|NCT00468559|38174407|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
17029909|NCT00468559|38174408|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
17029910|NCT00754442|38174418|FG000|Overall Study|Withdrawal by Subject|5|||
17029911|NCT00754442|38174419|FG001|Overall Study|Withdrawal by Subject|3|||
17029912|NCT00754052|38174428|FG000|Overall Study|Study terminated by Sponsor|5|||
17029913|NCT00754052|38174429|FG001|Overall Study|Study terminated by Sponsor|3|||
17029914|NCT00753896|38174435|FG000|Overall Study|Adverse Event|4|||
17029915|NCT00753896|38174435|FG000|Overall Study|Death|1|||
17029916|NCT00753896|38174435|FG000|Overall Study|Lost to Follow-up|2|||
17029917|NCT00753896|38174435|FG000|Overall Study|Protocol Violation|1|||
17029918|NCT00753896|38174435|FG000|Overall Study|Withdrawal by Subject|4|||
17029919|NCT00753896|38174435|FG000|Overall Study|Entry Criteria Not Met|4|||
17029920|NCT00747812|38174441|FG000|Overall Study|Research Site Staff Relocation|5|||
17029921|NCT00747812|38174442|FG001|Overall Study|Research Site Staff Relocation|3|||
17029922|NCT02927067|38174450|FG000|Overall Study|Withdrawn Consent|20|||
17029923|NCT02927067|38174451|FG001|Overall Study|Withdrawn Consent|12|||
17029924|NCT02927067|38174450|FG000|Overall Study|Death|18|||
17029925|NCT02927067|38174451|FG001|Overall Study|Death|31|||
17029926|NCT02927067|38174450|FG000|Overall Study|Adverse Event|13|||
17029927|NCT02927067|38174451|FG001|Overall Study|Adverse Event|10|||
17029928|NCT02927067|38174450|FG000|Overall Study|Noncompliance|5|||
17029929|NCT02927067|38174451|FG001|Overall Study|Noncompliance|2|||
17029930|NCT02927067|38174450|FG000|Overall Study|Reason not Specified|4|||
17029931|NCT02927067|38174451|FG001|Overall Study|Reason not Specified|6|||
17029932|NCT01771107|38174461|FG000|Overall Study|Adverse Event|1|||
17029933|NCT01771107|38174462|FG001|Overall Study|Adverse Event|3|||
17029934|NCT01771107|38174461|FG000|Overall Study|Withdrawal by Subject|0|||
17029935|NCT01771107|38174462|FG001|Overall Study|Withdrawal by Subject|2|||
17029936|NCT01771107|38174461|FG000|Overall Study|Lost to Follow-up|0|||
17136200|NCT03152552|38277411|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
17136201|NCT03152552|38277412|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
17136202|NCT03152552|38277413|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
17136203|NCT03152552|38277414|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
17136204|NCT03152552|38277410|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
17136205|NCT03152552|38277411|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
17136206|NCT03152552|38277412|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
17136207|NCT03152552|38277413|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
17136208|NCT03152552|38277414|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
17136209|NCT03152552|38277410|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
17136210|NCT03152552|38277411|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
17136211|NCT03152552|38277412|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
17136212|NCT03152552|38277413|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
17136213|NCT03152552|38277414|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
17136214|NCT03152552|38277410|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
17136215|NCT03152552|38277411|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
17136216|NCT03152552|38277412|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
17136217|NCT03152552|38277413|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
17029937|NCT01771107|38174462|FG001|Overall Study|Lost to Follow-up|1|||
17029938|NCT01771107|38174461|FG000|Overall Study|participant moved|0|||
17029939|NCT01771107|38174462|FG001|Overall Study|participant moved|1|||
17029940|NCT01771107|38174461|FG000|Overall Study|Other|0|||
17029941|NCT01771107|38174462|FG001|Overall Study|Other|1|||
17029942|NCT01751685|38174472|FG000|6-mo Followup|Missed study visit|1|||
17029943|NCT01751685|38174473|FG001|6-mo Followup|Missed study visit|0|||
17136218|NCT03152552|38277414|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
17136219|NCT03152552|38277410|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
17136220|NCT03152552|38277411|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
17136221|NCT03152552|38277412|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
17136222|NCT03152552|38277413|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
17136223|NCT03152552|38277414|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
17136224|NCT03151226|38277427|FG000|Overall Study|Withdrawal by Subject|2|||
17136225|NCT03151226|38277427|FG000|Overall Study|not wear device correctly|1|||
17136226|NCT03151148|38277433|FG000|Overall Study|Lost to Follow-up|1|||
17029944|NCT01751685|38174472|FG000|6-mo Followup|Withdrawal by Subject|2|||
17029945|NCT01751685|38174473|FG001|6-mo Followup|Withdrawal by Subject|2|||
17029946|NCT01751685|38174472|FG000|6-mo Followup|Lost to Follow-up|0|||
17029947|NCT01751685|38174473|FG001|6-mo Followup|Lost to Follow-up|1|||
17029948|NCT01751685|38174472|FG000|12-mo Followup|Lost to Follow-up|5|||
17029949|NCT01751685|38174473|FG001|12-mo Followup|Lost to Follow-up|0|||
17029950|NCT00586508|38174481|FG000|Overall Study|Progressive disease|52|||
17029951|NCT00586508|38174482|FG001|Overall Study|Progressive disease|8|||
17029952|NCT00586508|38174481|FG000|Overall Study|Death|0|||
17029953|NCT00586508|38174482|FG001|Overall Study|Death|1|||
17029954|NCT00586508|38174481|FG000|Overall Study|Adverse Event|12|||
17029955|NCT00586508|38174482|FG001|Overall Study|Adverse Event|4|||
17029956|NCT00586508|38174481|FG000|Overall Study|Withdrawal by Subject|4|||
17029957|NCT00586508|38174482|FG001|Overall Study|Withdrawal by Subject|0|||
17029958|NCT00581919|38174488|FG000|Overall Study|Adverse Event|8|||
17029959|NCT00581919|38174488|FG000|Overall Study|Death|1|||
17029960|NCT00581919|38174488|FG000|Overall Study|Disease Progression|10|||
17029961|NCT00581919|38174488|FG000|Overall Study|Physician Decision|1|||
17029962|NCT00581919|38174488|FG000|Overall Study|Other Complicating Disease|1|||
17029963|NCT00581919|38174488|FG000|Overall Study|Started Non-Protocol Therapy|2|||
17029964|NCT00581919|38174488|FG000|Overall Study|Withdrawal by Subject|1|||
17029965|NCT00723528|38174496|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
17029966|NCT00723528|38174497|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
17029967|NCT00723528|38174498|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
17029968|NCT00723528|38174499|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
16991013|NCT00839254|38135045|FG003|Overall Study|Withdrawal by Subject|32|||
16991014|NCT00839254|38135046|FG004|Overall Study|Withdrawal by Subject|27|||
16991015|NCT00839254|38135047|FG005|Overall Study|Withdrawal by Subject|15|||
16991016|NCT00839254|38135048|FG006|Overall Study|Withdrawal by Subject|22|||
16991017|NCT00839254|38135049|FG007|Overall Study|Withdrawal by Subject|9|||
16991018|NCT00839254|38135042|FG000|Overall Study|Wrong group allocation|0|||
16991019|NCT00839254|38135043|FG001|Overall Study|Wrong group allocation|0|||
16991020|NCT00839254|38135044|FG002|Overall Study|Wrong group allocation|0|||
16991021|NCT00839254|38135045|FG003|Overall Study|Wrong group allocation|0|||
16991022|NCT00839254|38135046|FG004|Overall Study|Wrong group allocation|0|||
16991023|NCT00839254|38135047|FG005|Overall Study|Wrong group allocation|0|||
16991024|NCT00839254|38135048|FG006|Overall Study|Wrong group allocation|1|||
16991025|NCT00839254|38135049|FG007|Overall Study|Wrong group allocation|0|||
16991026|NCT00839254|38135042|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
16991027|NCT00839254|38135043|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
16991028|NCT00839254|38135044|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
16991029|NCT00839254|38135045|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
16991030|NCT00839254|38135046|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
16991031|NCT00839254|38135047|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
16991032|NCT00839254|38135048|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
16991033|NCT00839254|38135049|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
16991034|NCT00839254|38135042|FG000|Overall Study|Withdrawn due to non-compliance|2|||
16991035|NCT00839254|38135043|FG001|Overall Study|Withdrawn due to non-compliance|0|||
16991036|NCT00839254|38135044|FG002|Overall Study|Withdrawn due to non-compliance|0|||
16991037|NCT00839254|38135045|FG003|Overall Study|Withdrawn due to non-compliance|0|||
16991038|NCT00839254|38135046|FG004|Overall Study|Withdrawn due to non-compliance|0|||
16991039|NCT00839254|38135047|FG005|Overall Study|Withdrawn due to non-compliance|0|||
16991040|NCT00839254|38135048|FG006|Overall Study|Withdrawn due to non-compliance|0|||
16991041|NCT00839254|38135049|FG007|Overall Study|Withdrawn due to non-compliance|0|||
16991042|NCT00839254|38135042|FG000|Overall Study|Lost to Follow-up|51|||
16991043|NCT00839254|38135043|FG001|Overall Study|Lost to Follow-up|30|||
16991044|NCT00839254|38135044|FG002|Overall Study|Lost to Follow-up|32|||
17029969|NCT00723528|38174500|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
17029970|NCT00723528|38174501|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
17029971|NCT00723528|38174502|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
17029972|NCT00723528|38174496|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
17029973|NCT00723528|38174497|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
17136227|NCT03151148|38277434|FG001|Overall Study|Lost to Follow-up|0|||
16991045|NCT00839254|38135045|FG003|Overall Study|Lost to Follow-up|24|||
16991046|NCT00839254|38135046|FG004|Overall Study|Lost to Follow-up|8|||
16991047|NCT00839254|38135047|FG005|Overall Study|Lost to Follow-up|8|||
16991048|NCT00839254|38135048|FG006|Overall Study|Lost to Follow-up|4|||
16991049|NCT00839254|38135049|FG007|Overall Study|Lost to Follow-up|2|||
16991050|NCT00586339|38135101|FG000|Overall Study|Withdrawal by Subject|1|||
16991051|NCT00586339|38135102|FG001|Overall Study|Withdrawal by Subject|3|||
16991052|NCT00586339|38135103|FG002|Overall Study|Withdrawal by Subject|1|||
16991053|NCT00586339|38135101|FG000|Overall Study|Migrated/moved from study area|3|||
16991054|NCT00586339|38135102|FG001|Overall Study|Migrated/moved from study area|2|||
17029974|NCT00723528|38174498|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
17029975|NCT00723528|38174499|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
17029976|NCT00723528|38174500|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
17029977|NCT00723528|38174501|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
17029978|NCT00723528|38174502|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
17029979|NCT00723528|38174496|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
17029980|NCT00723528|38174497|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
17029981|NCT00723528|38174498|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
17029982|NCT00723528|38174499|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
17029983|NCT00723528|38174500|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
17029984|NCT00723528|38174501|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
17029985|NCT00723528|38174502|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
17029986|NCT00723528|38174496|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
17029987|NCT00723528|38174497|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
17029988|NCT00723528|38174498|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
17029989|NCT00723528|38174499|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
17029990|NCT00723528|38174500|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
17029991|NCT00723528|38174501|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
17029992|NCT00723528|38174502|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
17029993|NCT00723528|38174496|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
17029994|NCT00723528|38174497|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
17029995|NCT00723528|38174498|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
17029996|NCT00723528|38174499|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
17029997|NCT00723528|38174500|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
17029998|NCT00723528|38174501|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
17029999|NCT00723528|38174502|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
17030000|NCT00723528|38174496|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
17030001|NCT00723528|38174497|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
17030002|NCT00723528|38174498|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
17030003|NCT00723528|38174499|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
17030004|NCT00723528|38174500|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
17030005|NCT00723528|38174501|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
17030006|NCT00723528|38174502|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
17030007|NCT00723528|38174496|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
17030008|NCT00723528|38174497|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
17030009|NCT00723528|38174498|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
17030010|NCT00723528|38174499|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
17030011|NCT00723528|38174500|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
17030012|NCT00723528|38174501|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
17030013|NCT00723528|38174502|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
17136228|NCT03151148|38277433|FG000|Overall Study|Withdrawal by Subject|1|||
17030014|NCT00723528|38174496|FG000|Period 2: After Controlled Period|Other|0|||
17030015|NCT00723528|38174497|FG001|Period 2: After Controlled Period|Other|0|||
16991055|NCT00586339|38135103|FG002|Overall Study|Migrated/moved from study area|4|||
16991056|NCT00586339|38135101|FG000|Overall Study|Lost to Follow-up|3|||
16991057|NCT00586339|38135102|FG001|Overall Study|Lost to Follow-up|2|||
16991058|NCT00586339|38135103|FG002|Overall Study|Lost to Follow-up|1|||
16991059|NCT00812968|38135111|FG000|Overall Study|Relapse after erythroid response|6|||
16991060|NCT00812968|38135111|FG000|Overall Study|Disease progression|1|||
16991061|NCT00812968|38135111|FG000|Overall Study|No further treatment required|1|||
16991062|NCT00812968|38135111|FG000|Overall Study|Study closed due to marketing approval|3|||
17030016|NCT00723528|38174498|FG002|Period 2: After Controlled Period|Other|0|||
17030017|NCT00723528|38174499|FG003|Period 2: After Controlled Period|Other|0|||
17030018|NCT00723528|38174500|FG004|Period 2: After Controlled Period|Other|1|||
17030019|NCT00723528|38174501|FG005|Period 2: After Controlled Period|Other|4|||
16991063|NCT00839098|38135120|FG000|Overall Study|Withdrawal by Subject|2|||
16991064|NCT00839098|38135121|FG001|Overall Study|Withdrawal by Subject|1|||
16991065|NCT00839098|38135122|FG002|Overall Study|Withdrawal by Subject|7|||
16991066|NCT00813748|38135132|FG000|Skin Test Substudy|Physician Decision|0|||
16991067|NCT00813748|38135133|FG001|Skin Test Substudy|Physician Decision|1|||
16991068|NCT00813592|38135141|FG000|Overall Study|Disease assessment was not completed per|2|||
16991069|NCT00813358|38135146|FG000|Overall Study|Death|32|||
16991070|NCT00813358|38135146|FG000|Overall Study|Lost to Follow-up|12|||
16991071|NCT00813358|38135146|FG000|Overall Study|other endpoints|5|||
16991072|NCT00813358|38135146|FG000|Overall Study|Withdrawal by Subject|20|||
16991073|NCT00812812|38135152|FG000|Overall Study|Adverse Event|2|||
16991074|NCT00812812|38135153|FG001|Overall Study|Adverse Event|1|||
16991075|NCT00812812|38135152|FG000|Overall Study|Lack of Efficacy|1|||
16991076|NCT00812812|38135153|FG001|Overall Study|Lack of Efficacy|0|||
16991077|NCT00812812|38135152|FG000|Overall Study|Lost to Follow-up|0|||
16991078|NCT00812812|38135153|FG001|Overall Study|Lost to Follow-up|1|||
17030020|NCT00723528|38174502|FG006|Period 2: After Controlled Period|Other|0|||
17030021|NCT00723528|38174496|FG000|Period 2: After Controlled Period|Adverse Event|0|||
16991079|NCT00812812|38135152|FG000|Overall Study|Withdrawal by Subject|0|||
16991080|NCT00812812|38135153|FG001|Overall Study|Withdrawal by Subject|2|||
16991081|NCT00810082|38135163|FG000|Overall Study|Lost to Follow-up|0|||
16991082|NCT00810082|38135164|FG001|Overall Study|Lost to Follow-up|4|||
17030022|NCT00723528|38174497|FG001|Period 2: After Controlled Period|Adverse Event|0|||
17030023|NCT00723528|38174498|FG002|Period 2: After Controlled Period|Adverse Event|0|||
17030024|NCT00723528|38174499|FG003|Period 2: After Controlled Period|Adverse Event|0|||
17030025|NCT00723528|38174500|FG004|Period 2: After Controlled Period|Adverse Event|1|||
17030026|NCT00723528|38174501|FG005|Period 2: After Controlled Period|Adverse Event|0|||
17030027|NCT00723528|38174502|FG006|Period 2: After Controlled Period|Adverse Event|1|||
17030028|NCT00723528|38174496|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
17030029|NCT00723528|38174497|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
17030030|NCT00723528|38174498|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
17030031|NCT00723528|38174499|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
17030032|NCT00723528|38174500|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
17030033|NCT00723528|38174501|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
17030034|NCT00723528|38174502|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
17030035|NCT00723528|38174496|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
17030036|NCT00723528|38174497|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
17030037|NCT00723528|38174498|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
17030038|NCT00723528|38174499|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
17030039|NCT00723528|38174500|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
17030040|NCT00723528|38174501|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
17030041|NCT00723528|38174502|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
17030042|NCT00751790|38174518|FG000|Overall Study|Lost to Follow-up|1|||
17030043|NCT00751790|38174518|FG000|Overall Study|Death|3|||
17030044|NCT00751790|38174518|FG000|Overall Study|Withdrawal by Subject|1|||
17030045|NCT00723450|38174524|FG000|Open-Label Phase|Adverse Event|26|||
17030046|NCT00723450|38174525|FG001|Open-Label Phase|Adverse Event|0|||
17030047|NCT00723450|38174526|FG002|Open-Label Phase|Adverse Event|0|||
17030048|NCT00723450|38174524|FG000|Open-Label Phase|Lack of Efficacy|18|||
17030049|NCT00723450|38174525|FG001|Open-Label Phase|Lack of Efficacy|0|||
17030050|NCT00723450|38174526|FG002|Open-Label Phase|Lack of Efficacy|0|||
17030051|NCT00723450|38174524|FG000|Open-Label Phase|Protocol Violation|35|||
17030052|NCT00723450|38174525|FG001|Open-Label Phase|Protocol Violation|0|||
17030053|NCT00723450|38174526|FG002|Open-Label Phase|Protocol Violation|0|||
17030054|NCT00723450|38174524|FG000|Open-Label Phase|Lost to Follow-up|7|||
17030055|NCT00723450|38174525|FG001|Open-Label Phase|Lost to Follow-up|0|||
17030056|NCT00723450|38174526|FG002|Open-Label Phase|Lost to Follow-up|0|||
17030057|NCT00723450|38174524|FG000|Open-Label Phase|Physician Decision|2|||
17030058|NCT00723450|38174525|FG001|Open-Label Phase|Physician Decision|0|||
17030059|NCT00723450|38174526|FG002|Open-Label Phase|Physician Decision|0|||
17030060|NCT00723450|38174524|FG000|Open-Label Phase|Withdrawal by Subject|37|||
17030061|NCT00723450|38174525|FG001|Open-Label Phase|Withdrawal by Subject|0|||
17030062|NCT00723450|38174526|FG002|Open-Label Phase|Withdrawal by Subject|0|||
17030063|NCT00723450|38174524|FG000|Randomized Phase|Adverse Event|0|||
17030064|NCT00723450|38174525|FG001|Randomized Phase|Adverse Event|26|||
17030065|NCT00723450|38174526|FG002|Randomized Phase|Adverse Event|17|||
17030066|NCT00723450|38174524|FG000|Randomized Phase|Lack of Efficacy|0|||
17030067|NCT00723450|38174525|FG001|Randomized Phase|Lack of Efficacy|11|||
17030068|NCT00723450|38174526|FG002|Randomized Phase|Lack of Efficacy|11|||
16991083|NCT00748189|38135172|FG000|Overall Study|Death|99|||
16991084|NCT00748189|38135173|FG001|Overall Study|Death|84|||
17030069|NCT00723450|38174524|FG000|Randomized Phase|Protocol Violation|0|||
17030070|NCT00723450|38174525|FG001|Randomized Phase|Protocol Violation|9|||
17030071|NCT00723450|38174526|FG002|Randomized Phase|Protocol Violation|13|||
17030072|NCT00723450|38174524|FG000|Randomized Phase|Lost to Follow-up|0|||
17030073|NCT00723450|38174525|FG001|Randomized Phase|Lost to Follow-up|2|||
17030074|NCT00723450|38174526|FG002|Randomized Phase|Lost to Follow-up|3|||
17030075|NCT00723450|38174524|FG000|Randomized Phase|Physician Decision|0|||
17030076|NCT00723450|38174525|FG001|Randomized Phase|Physician Decision|3|||
17030077|NCT00723450|38174526|FG002|Randomized Phase|Physician Decision|1|||
17030078|NCT00723450|38174524|FG000|Randomized Phase|Withdrawal by Subject|0|||
17030079|NCT00723450|38174525|FG001|Randomized Phase|Withdrawal by Subject|14|||
17030080|NCT00723450|38174526|FG002|Randomized Phase|Withdrawal by Subject|22|||
17030081|NCT00751400|38174535|FG000|Overall Study|Lost to Follow-up|10|||
17030082|NCT00585312|38174541|FG000|Overall Study|Adverse Event|3|||
17030083|NCT00585312|38174542|FG001|Overall Study|Adverse Event|0|||
17030084|NCT00585312|38174541|FG000|Overall Study|Lack of Efficacy|6|||
17030085|NCT00585312|38174542|FG001|Overall Study|Lack of Efficacy|11|||
17030086|NCT00585312|38174541|FG000|Overall Study|Lost to Follow-up|1|||
17030087|NCT00585312|38174542|FG001|Overall Study|Lost to Follow-up|1|||
17030088|NCT00585312|38174541|FG000|Overall Study|Reason not specified|2|||
17030089|NCT00585312|38174542|FG001|Overall Study|Reason not specified|0|||
17030090|NCT00585312|38174541|FG000|Overall Study|Withdrawal by Subject|5|||
17030091|NCT00585312|38174542|FG001|Overall Study|Withdrawal by Subject|1|||
17030092|NCT00585312|38174541|FG000|Overall Study|Study terminated by the sponsor|34|||
17030093|NCT00585312|38174542|FG001|Overall Study|Study terminated by the sponsor|31|||
17030094|NCT00753506|38174550|FG000|Overall Study|Withdrawal by Subject|4|||
17030095|NCT00753506|38174551|FG001|Overall Study|Withdrawal by Subject|1|||
17030096|NCT00753506|38174550|FG000|Overall Study|Lost to Follow-up|2|||
17030097|NCT00753506|38174551|FG001|Overall Study|Lost to Follow-up|0|||
17030098|NCT00753506|38174550|FG000|Overall Study|Other reason|1|||
17030099|NCT00753506|38174551|FG001|Overall Study|Other reason|1|||
17030100|NCT00720096|38174559|FG000|Overall Study|Withdrawal by Subject|0|||
17030101|NCT00720096|38174560|FG001|Overall Study|Withdrawal by Subject|2|||
17030102|NCT00723294|38174566|FG000|Overall Study|Lobular histology|2|||
17030103|NCT00723294|38174566|FG000|Overall Study|>25% intraductal component|1|||
17030104|NCT00723294|38174566|FG000|Overall Study|No MRI tumor enhancement|1|||
17030105|NCT00723294|38174566|FG000|Overall Study|1.0-Tesla MRI|1|||
17030106|NCT00723294|38174566|FG000|Overall Study|No cryoabalation|2|||
17030107|NCT00723294|38174566|FG000|Overall Study|Did not undergo surgery|1|||
17030108|NCT00723294|38174566|FG000|Overall Study|Treated prior to registration|1|||
17030109|NCT00723294|38174566|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
17030110|NCT00723294|38174566|FG000|Overall Study|Benign lesion|1|||
17030111|NCT00723294|38174566|FG000|Overall Study|Withdrawal by Subject|1|||
17030112|NCT00723294|38174566|FG000|Overall Study|No treatment due to probe failure|1|||
17030113|NCT00747344|38174572|FG000|Controlled Period|Adverse Event|3|||
17030114|NCT00747344|38174573|FG001|Controlled Period|Adverse Event|0|||
17136229|NCT03151148|38277434|FG001|Overall Study|Withdrawal by Subject|0|||
17136230|NCT02741518|38277443|FG000|Overall Study|Withdrawal by Subject|1|||
17136231|NCT02741518|38277444|FG001|Overall Study|Withdrawal by Subject|1|||
17136232|NCT03145766|38277455|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
17136233|NCT03145766|38277456|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
17136234|NCT03145766|38277457|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
17136235|NCT03145766|38277458|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
17136236|NCT03145766|38277459|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
17136237|NCT03145766|38277455|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
17136238|NCT03145766|38277456|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
17136239|NCT03145766|38277457|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
17136240|NCT03145766|38277458|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
17136241|NCT03145766|38277459|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
17136242|NCT03145766|38277455|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
17030115|NCT00747344|38174574|FG002|Controlled Period|Adverse Event|0|||
17030116|NCT00747344|38174575|FG003|Controlled Period|Adverse Event|0|||
17030117|NCT00747344|38174572|FG000|Controlled Period|Lack of Efficacy|2|||
17030118|NCT00747344|38174573|FG001|Controlled Period|Lack of Efficacy|1|||
17030119|NCT00747344|38174574|FG002|Controlled Period|Lack of Efficacy|0|||
17030120|NCT00747344|38174575|FG003|Controlled Period|Lack of Efficacy|0|||
17030121|NCT00747344|38174572|FG000|Controlled Period|Other|0|||
17030122|NCT00747344|38174573|FG001|Controlled Period|Other|3|||
17030123|NCT00747344|38174574|FG002|Controlled Period|Other|0|||
17030124|NCT00747344|38174575|FG003|Controlled Period|Other|0|||
17030125|NCT00747344|38174572|FG000|After Controlled Period|Adverse Event|0|||
17030126|NCT00747344|38174573|FG001|After Controlled Period|Adverse Event|0|||
17030127|NCT00747344|38174574|FG002|After Controlled Period|Adverse Event|0|||
17030128|NCT00747344|38174575|FG003|After Controlled Period|Adverse Event|1|||
17030129|NCT00580983|38174583|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
17030130|NCT00716976|38174589|FG000|Overall Study|Adverse Event|2|||
17030131|NCT00716976|38174590|FG001|Overall Study|Adverse Event|0|||
17030132|NCT00716976|38174589|FG000|Overall Study|Death|1|||
17030133|NCT00716976|38174590|FG001|Overall Study|Death|0|||
17030134|NCT00716976|38174589|FG000|Overall Study|Physician Decision|2|||
17030135|NCT00716976|38174590|FG001|Overall Study|Physician Decision|2|||
17030136|NCT00716976|38174589|FG000|Overall Study|Withdrawal by Subject|5|||
17030137|NCT00716976|38174590|FG001|Overall Study|Withdrawal by Subject|1|||
17030138|NCT00716976|38174589|FG000|Overall Study|Premature discontinuation cisplatin|5|||
17030139|NCT00716976|38174590|FG001|Overall Study|Premature discontinuation cisplatin|4|||
17030140|NCT00716976|38174589|FG000|Overall Study|Radiation during protocol|1|||
17030141|NCT00716976|38174590|FG001|Overall Study|Radiation during protocol|0|||
17030142|NCT00716976|38174589|FG000|Overall Study|Ineligibles|4|||
17030143|NCT00716976|38174590|FG001|Overall Study|Ineligibles|2|||
17030144|NCT00743444|38174598|FG000|First Intervention|Catheter placement problems|0|||
17030145|NCT00743444|38174599|FG001|First Intervention|Catheter placement problems|1|||
17030146|NCT00743444|38174598|FG000|Washout Period|Adverse Event|0|||
17030147|NCT00743444|38174599|FG001|Washout Period|Adverse Event|1|||
17030148|NCT00743366|38174605|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
17030149|NCT00743366|38174606|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
17030150|NCT00721968|38174614|FG000|Overall Study|Lost to Follow-up|2|||
17030151|NCT00721968|38174615|FG001|Overall Study|Lost to Follow-up|0|||
17030152|NCT00743288|38174621|FG000|Overall Study|Adverse Event|1|||
17030153|NCT00743288|38174622|FG001|Overall Study|Adverse Event|1|||
17030154|NCT00743288|38174623|FG002|Overall Study|Adverse Event|2|||
17030155|NCT00743288|38174624|FG003|Overall Study|Adverse Event|2|||
17030156|NCT00743288|38174625|FG004|Overall Study|Adverse Event|1|||
17030157|NCT00743288|38174626|FG005|Overall Study|Adverse Event|1|||
17030158|NCT00743288|38174627|FG006|Overall Study|Adverse Event|2|||
17030159|NCT00743288|38174621|FG000|Overall Study|Withdrawal by Subject|0|||
17030160|NCT00743288|38174622|FG001|Overall Study|Withdrawal by Subject|0|||
17030161|NCT00743288|38174623|FG002|Overall Study|Withdrawal by Subject|1|||
17030162|NCT00743288|38174624|FG003|Overall Study|Withdrawal by Subject|0|||
17030163|NCT00743288|38174625|FG004|Overall Study|Withdrawal by Subject|0|||
17030164|NCT00743288|38174626|FG005|Overall Study|Withdrawal by Subject|1|||
17030165|NCT00743288|38174627|FG006|Overall Study|Withdrawal by Subject|1|||
17030166|NCT00743288|38174621|FG000|Overall Study|Progressive disease (PD)|2|||
17030167|NCT00743288|38174622|FG001|Overall Study|Progressive disease (PD)|0|||
17030168|NCT00743288|38174623|FG002|Overall Study|Progressive disease (PD)|1|||
17030169|NCT00743288|38174624|FG003|Overall Study|Progressive disease (PD)|4|||
17030170|NCT00743288|38174625|FG004|Overall Study|Progressive disease (PD)|5|||
17030171|NCT00743288|38174626|FG005|Overall Study|Progressive disease (PD)|3|||
17030172|NCT00743288|38174627|FG006|Overall Study|Progressive disease (PD)|6|||
17136243|NCT03145766|38277456|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
17136244|NCT03145766|38277457|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
17030173|NCT00743288|38174621|FG000|Overall Study|Worsening of condition (Not PD)|0|||
17030174|NCT00743288|38174622|FG001|Overall Study|Worsening of condition (Not PD)|2|||
17030175|NCT00743288|38174623|FG002|Overall Study|Worsening of condition (Not PD)|1|||
17030176|NCT00743288|38174624|FG003|Overall Study|Worsening of condition (Not PD)|1|||
17030177|NCT00743288|38174625|FG004|Overall Study|Worsening of condition (Not PD)|0|||
17030178|NCT00743288|38174626|FG005|Overall Study|Worsening of condition (Not PD)|0|||
17030179|NCT00743288|38174627|FG006|Overall Study|Worsening of condition (Not PD)|0|||
17030180|NCT00750308|38174638|FG000|First Treatment|Adverse Event|0|||
17030181|NCT00750308|38174639|FG001|First Treatment|Adverse Event|1|||
17136245|NCT03145766|38277458|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
16991085|NCT00748189|38135172|FG000|Overall Study|Withdrawal by Subject|23|||
16991086|NCT00748189|38135173|FG001|Overall Study|Withdrawal by Subject|29|||
16991087|NCT00748189|38135172|FG000|Overall Study|Physician Decision|16|||
16991088|NCT00748189|38135173|FG001|Overall Study|Physician Decision|5|||
16991089|NCT00748189|38135172|FG000|Overall Study|Lost to Follow-up|8|||
16991090|NCT00748189|38135173|FG001|Overall Study|Lost to Follow-up|15|||
16991091|NCT00748189|38135172|FG000|Overall Study|Study terminated by Sponsor|70|||
16991092|NCT00748189|38135173|FG001|Overall Study|Study terminated by Sponsor|79|||
16991093|NCT00744055|38135186|FG000|Overall Study|Withdrawal by Subject|6|||
16991094|NCT00744055|38135187|FG001|Overall Study|Withdrawal by Subject|9|||
16991095|NCT00744055|38135186|FG000|Overall Study|Lack of Efficacy|0|||
16991096|NCT00744055|38135187|FG001|Overall Study|Lack of Efficacy|1|||
17030182|NCT00750308|38174640|FG002|First Treatment|Adverse Event|0|||
17030183|NCT00750308|38174641|FG003|First Treatment|Adverse Event|0|||
17030184|NCT00750308|38174642|FG004|First Treatment|Adverse Event|0|||
17030185|NCT00750308|38174643|FG005|First Treatment|Adverse Event|0|||
17030186|NCT00750308|38174644|FG006|First Treatment|Adverse Event|0|||
17030187|NCT00750308|38174645|FG007|First Treatment|Adverse Event|0|||
17030188|NCT00750308|38174646|FG008|First Treatment|Adverse Event|0|||
17030189|NCT00750308|38174647|FG009|First Treatment|Adverse Event|0|||
17030190|NCT00750308|38174648|FG010|First Treatment|Adverse Event|1|||
17030191|NCT00750308|38174649|FG011|First Treatment|Adverse Event|1|||
16991097|NCT00744055|38135186|FG000|Overall Study|Physician Decision|0|||
16991098|NCT00744055|38135187|FG001|Overall Study|Physician Decision|2|||
16991099|NCT00744055|38135186|FG000|Overall Study|Protocol Violation|1|||
16991100|NCT00744055|38135187|FG001|Overall Study|Protocol Violation|1|||
16991101|NCT00744055|38135186|FG000|Overall Study|Lost to Follow-up|0|||
16991102|NCT00744055|38135187|FG001|Overall Study|Lost to Follow-up|1|||
16991103|NCT00748033|38135195|FG000|Overall Study|Adverse Event|0|||
16991104|NCT00748033|38135196|FG001|Overall Study|Adverse Event|1|||
16991105|NCT00735553|38135213|FG000|Overall Study|Study prematurely terminated|77|||
16991106|NCT00740779|38135224|FG000|Overall Study|Adverse Event|4|||
16991107|NCT00740779|38135225|FG001|Overall Study|Adverse Event|6|||
16991108|NCT00740779|38135226|FG002|Overall Study|Adverse Event|3|||
16991109|NCT00740779|38135224|FG000|Overall Study|Protocol Violation|1|||
16991110|NCT00740779|38135225|FG001|Overall Study|Protocol Violation|1|||
16991111|NCT00740779|38135226|FG002|Overall Study|Protocol Violation|1|||
16991112|NCT00740779|38135224|FG000|Overall Study|Lack of Efficacy|0|||
16991113|NCT00740779|38135225|FG001|Overall Study|Lack of Efficacy|0|||
16991114|NCT00740779|38135226|FG002|Overall Study|Lack of Efficacy|2|||
16991115|NCT00740779|38135224|FG000|Overall Study|Withdrawal by Subject|2|||
16991116|NCT00740779|38135225|FG001|Overall Study|Withdrawal by Subject|4|||
16991117|NCT00740779|38135226|FG002|Overall Study|Withdrawal by Subject|2|||
16991118|NCT00740779|38135224|FG000|Overall Study|Lost to Follow-up|2|||
16991119|NCT00740779|38135225|FG001|Overall Study|Lost to Follow-up|3|||
16991120|NCT00740779|38135226|FG002|Overall Study|Lost to Follow-up|5|||
16991121|NCT00735475|38135236|FG000|Overall Study|Adverse Event|0|||
16991122|NCT00735475|38135237|FG001|Overall Study|Adverse Event|1|||
16991123|NCT00735475|38135236|FG000|Overall Study|Death|1|||
16991124|NCT00735475|38135237|FG001|Overall Study|Death|1|||
16991125|NCT00735475|38135236|FG000|Overall Study|Lost to Follow-up|3|||
16991126|NCT00735475|38135237|FG001|Overall Study|Lost to Follow-up|3|||
16991127|NCT00735475|38135236|FG000|Overall Study|Physician Decision|0|||
16991128|NCT00735475|38135237|FG001|Overall Study|Physician Decision|1|||
16991129|NCT00735475|38135236|FG000|Overall Study|Withdrawal by Subject|4|||
16991130|NCT00735475|38135237|FG001|Overall Study|Withdrawal by Subject|5|||
16991131|NCT01026818|38135246|FG000|Screening Period|Entry Criteria Not Met|105|||
16991132|NCT01026818|38135247|FG001|Screening Period|Entry Criteria Not Met|0|||
16991133|NCT01026818|38135248|FG002|Screening Period|Entry Criteria Not Met|0|||
16991134|NCT01026818|38135249|FG003|Screening Period|Entry Criteria Not Met|0|||
16991135|NCT01026818|38135246|FG000|Screening Period|Withdrawal by Subject|49|||
16991136|NCT01026818|38135247|FG001|Screening Period|Withdrawal by Subject|0|||
16991137|NCT01026818|38135248|FG002|Screening Period|Withdrawal by Subject|0|||
16991138|NCT01026818|38135249|FG003|Screening Period|Withdrawal by Subject|0|||
16991139|NCT01026818|38135246|FG000|Screening Period|Protocol Deviation|3|||
16991140|NCT01026818|38135247|FG001|Screening Period|Protocol Deviation|0|||
16991141|NCT01026818|38135248|FG002|Screening Period|Protocol Deviation|0|||
16991142|NCT01026818|38135249|FG003|Screening Period|Protocol Deviation|0|||
16991143|NCT01026818|38135246|FG000|Screening Period|Adverse Event|2|||
16991144|NCT01026818|38135247|FG001|Screening Period|Adverse Event|0|||
16991145|NCT01026818|38135248|FG002|Screening Period|Adverse Event|0|||
16991146|NCT01026818|38135249|FG003|Screening Period|Adverse Event|0|||
16991147|NCT01026818|38135246|FG000|Screening Period|Physician Decision|1|||
16991148|NCT01026818|38135247|FG001|Screening Period|Physician Decision|0|||
16991149|NCT01026818|38135248|FG002|Screening Period|Physician Decision|0|||
17030192|NCT00750308|38174638|FG000|First Treatment|Withdrawal by Subject|0|||
17030193|NCT00750308|38174639|FG001|First Treatment|Withdrawal by Subject|0|||
17030194|NCT00750308|38174640|FG002|First Treatment|Withdrawal by Subject|0|||
17030195|NCT00750308|38174641|FG003|First Treatment|Withdrawal by Subject|1|||
17030196|NCT00750308|38174642|FG004|First Treatment|Withdrawal by Subject|0|||
17030197|NCT00750308|38174643|FG005|First Treatment|Withdrawal by Subject|0|||
17030198|NCT00750308|38174644|FG006|First Treatment|Withdrawal by Subject|0|||
17030199|NCT00750308|38174645|FG007|First Treatment|Withdrawal by Subject|1|||
17030200|NCT00750308|38174646|FG008|First Treatment|Withdrawal by Subject|0|||
17030201|NCT00750308|38174647|FG009|First Treatment|Withdrawal by Subject|0|||
17136246|NCT03145766|38277459|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
16780371|NCT02610231|37719468|FG000|Overall Study|Withdrawal by Subject|27|||
16991150|NCT01026818|38135249|FG003|Screening Period|Physician Decision|0|||
16991151|NCT01026818|38135246|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
16991152|NCT01026818|38135247|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
16991153|NCT01026818|38135248|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
16991154|NCT01026818|38135249|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
16991155|NCT01026818|38135246|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
16991156|NCT01026818|38135247|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
16991157|NCT01026818|38135248|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
16991158|NCT01026818|38135249|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
17030202|NCT00750308|38174648|FG010|First Treatment|Withdrawal by Subject|0|||
17030203|NCT00750308|38174649|FG011|First Treatment|Withdrawal by Subject|0|||
17030204|NCT00750308|38174638|FG000|Second Treatment|Adverse Event|0|||
17030205|NCT00750308|38174639|FG001|Second Treatment|Adverse Event|0|||
17030206|NCT00750308|38174640|FG002|Second Treatment|Adverse Event|0|||
17030207|NCT00750308|38174641|FG003|Second Treatment|Adverse Event|0|||
17030208|NCT00750308|38174642|FG004|Second Treatment|Adverse Event|0|||
17030209|NCT00750308|38174643|FG005|Second Treatment|Adverse Event|1|||
17030210|NCT00750308|38174644|FG006|Second Treatment|Adverse Event|0|||
17030211|NCT00750308|38174645|FG007|Second Treatment|Adverse Event|0|||
17030212|NCT00750308|38174646|FG008|Second Treatment|Adverse Event|1|||
17030213|NCT00750308|38174647|FG009|Second Treatment|Adverse Event|0|||
17030214|NCT00750308|38174648|FG010|Second Treatment|Adverse Event|0|||
17030215|NCT00750308|38174649|FG011|Second Treatment|Adverse Event|0|||
17030216|NCT00750308|38174638|FG000|Second Treatment|Withdrawal by Subject|0|||
17030217|NCT00750308|38174639|FG001|Second Treatment|Withdrawal by Subject|0|||
17030218|NCT00750308|38174640|FG002|Second Treatment|Withdrawal by Subject|0|||
17030219|NCT00750308|38174641|FG003|Second Treatment|Withdrawal by Subject|0|||
17030220|NCT00750308|38174642|FG004|Second Treatment|Withdrawal by Subject|1|||
17030221|NCT00750308|38174643|FG005|Second Treatment|Withdrawal by Subject|0|||
17030222|NCT00750308|38174644|FG006|Second Treatment|Withdrawal by Subject|0|||
17030223|NCT00750308|38174645|FG007|Second Treatment|Withdrawal by Subject|0|||
17030224|NCT00750308|38174646|FG008|Second Treatment|Withdrawal by Subject|0|||
17030225|NCT00750308|38174647|FG009|Second Treatment|Withdrawal by Subject|0|||
17030226|NCT00750308|38174648|FG010|Second Treatment|Withdrawal by Subject|0|||
17030227|NCT00750308|38174649|FG011|Second Treatment|Withdrawal by Subject|0|||
17030228|NCT00750308|38174638|FG000|Third Treatment|Withdrawal by Subject|0|||
17030229|NCT00750308|38174639|FG001|Third Treatment|Withdrawal by Subject|1|||
17030230|NCT00750308|38174640|FG002|Third Treatment|Withdrawal by Subject|0|||
17030231|NCT00750308|38174641|FG003|Third Treatment|Withdrawal by Subject|0|||
17030232|NCT00750308|38174642|FG004|Third Treatment|Withdrawal by Subject|0|||
17030233|NCT00750308|38174643|FG005|Third Treatment|Withdrawal by Subject|0|||
17030234|NCT00750308|38174644|FG006|Third Treatment|Withdrawal by Subject|0|||
17030235|NCT00750308|38174645|FG007|Third Treatment|Withdrawal by Subject|0|||
17030236|NCT00750308|38174646|FG008|Third Treatment|Withdrawal by Subject|0|||
17030237|NCT00750308|38174647|FG009|Third Treatment|Withdrawal by Subject|0|||
17030238|NCT00750308|38174648|FG010|Third Treatment|Withdrawal by Subject|0|||
17030239|NCT00750308|38174649|FG011|Third Treatment|Withdrawal by Subject|0|||
17030240|NCT00750152|38174665|FG000|Overall Study|Adverse Event|2|||
17030241|NCT00750152|38174666|FG001|Overall Study|Adverse Event|1|||
17030242|NCT00750152|38174665|FG000|Overall Study|Lost to Follow-up|8|||
17030243|NCT00750152|38174666|FG001|Overall Study|Lost to Follow-up|13|||
17030244|NCT00750152|38174665|FG000|Overall Study|Withdrawal by Subject|3|||
17030245|NCT00750152|38174666|FG001|Overall Study|Withdrawal by Subject|3|||
17030246|NCT00750152|38174665|FG000|Overall Study|Physician Decision|1|||
17030247|NCT00750152|38174666|FG001|Overall Study|Physician Decision|1|||
17030248|NCT00750152|38174665|FG000|Overall Study|Non-compliance|0|||
17030249|NCT00750152|38174666|FG001|Overall Study|Non-compliance|1|||
17030250|NCT00750152|38174665|FG000|Overall Study|Termination by sponsor|1|||
17030251|NCT00750152|38174666|FG001|Overall Study|Termination by sponsor|0|||
17030252|NCT00750152|38174665|FG000|Overall Study|Other|7|||
17030253|NCT00750152|38174666|FG001|Overall Study|Other|8|||
17030254|NCT00334815|38174674|FG000|Overall Study|Adverse Event|3|||
17030255|NCT00334815|38174675|FG001|Overall Study|Adverse Event|2|||
17030256|NCT00334815|38174674|FG000|Overall Study|Death|0|||
17030257|NCT00334815|38174675|FG001|Overall Study|Death|2|||
17030258|NCT00334815|38174674|FG000|Overall Study|Progression|1|||
17030259|NCT00334815|38174675|FG001|Overall Study|Progression|0|||
17030260|NCT00334815|38174674|FG000|Overall Study|ineligible|1|||
17030261|NCT00334815|38174675|FG001|Overall Study|ineligible|1|||
17030262|NCT00334815|38174674|FG000|Overall Study|patient refused treatment|0|||
17030263|NCT00334815|38174675|FG001|Overall Study|patient refused treatment|1|||
17030264|NCT00334815|38174674|FG000|Overall Study|Physician Decision|2|||
17030265|NCT00334815|38174675|FG001|Overall Study|Physician Decision|4|||
17030266|NCT00749996|38174685|FG000|Overall Study|Lost to Follow-up|7|||
17030267|NCT00749996|38174686|FG001|Overall Study|Lost to Follow-up|4|||
17030268|NCT00749996|38174685|FG000|Overall Study|Withdrawal by Subject|5|||
17030269|NCT00749996|38174686|FG001|Overall Study|Withdrawal by Subject|4|||
17030270|NCT00749996|38174685|FG000|Overall Study|Protocol Violation|2|||
17030271|NCT00749996|38174686|FG001|Overall Study|Protocol Violation|3|||
17030272|NCT00749996|38174685|FG000|Overall Study|Physician Decision|2|||
16780372|NCT02610231|37719468|FG000|Overall Study|Adverse Event|20|||
17030273|NCT00749996|38174686|FG001|Overall Study|Physician Decision|0|||
16780373|NCT02610231|37719468|FG000|Overall Study|Death|5|||
17030274|NCT00749996|38174685|FG000|Overall Study|Pregnancy|0|||
17030275|NCT00749996|38174686|FG001|Overall Study|Pregnancy|2|||
17030276|NCT00749996|38174685|FG000|Overall Study|Adverse Event|1|||
17030277|NCT00749996|38174686|FG001|Overall Study|Adverse Event|0|||
17030278|NCT00749996|38174685|FG000|Overall Study|Death|1|||
17030279|NCT00749996|38174686|FG001|Overall Study|Death|0|||
17030280|NCT00749684|38174692|FG000|Overall Study|Death|1|||
17030281|NCT00749684|38174692|FG000|Overall Study|Adverse Event|27|||
17030282|NCT00749684|38174692|FG000|Overall Study|Participant's Wish|10|||
17030283|NCT00749684|38174692|FG000|Overall Study|Not Documented|1|||
17030284|NCT00749684|38174692|FG000|Overall Study|Progressive Desease|31|||
17030285|NCT00749684|38174692|FG000|Overall Study|Therapy according to protocol + AE|2|||
17030286|NCT00749684|38174692|FG000|Overall Study|AE+discontinuation on participants wish|1|||
17030287|NCT00749684|38174692|FG000|Overall Study|Missing|9|||
17030288|NCT00746798|38174700|FG000|Overall Study|Protocol Violation|0|||
17030289|NCT00746798|38174701|FG001|Overall Study|Protocol Violation|1|||
17030290|NCT00746798|38174702|FG002|Overall Study|Protocol Violation|0|||
17030291|NCT00746798|38174703|FG003|Overall Study|Protocol Violation|0|||
17030292|NCT00746798|38174700|FG000|Overall Study|Withdrawal by Subject|0|||
17030293|NCT00746798|38174701|FG001|Overall Study|Withdrawal by Subject|1|||
17030294|NCT00746798|38174702|FG002|Overall Study|Withdrawal by Subject|1|||
17030295|NCT00746798|38174703|FG003|Overall Study|Withdrawal by Subject|0|||
17030296|NCT00746798|38174700|FG000|Overall Study|Death|0|||
17030297|NCT00746798|38174701|FG001|Overall Study|Death|0|||
17030298|NCT00746798|38174702|FG002|Overall Study|Death|2|||
17030299|NCT00746798|38174703|FG003|Overall Study|Death|0|||
17030300|NCT00746798|38174700|FG000|Overall Study|Participant unable to return for visit|1|||
17030301|NCT00746798|38174701|FG001|Overall Study|Participant unable to return for visit|0|||
17030302|NCT00746798|38174702|FG002|Overall Study|Participant unable to return for visit|0|||
17030303|NCT00746798|38174703|FG003|Overall Study|Participant unable to return for visit|0|||
17030304|NCT00716274|38174716|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
17030305|NCT00716274|38174717|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
17030306|NCT00716274|38174718|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
17030307|NCT00716274|38174719|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
17030308|NCT00716274|38174720|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
17030309|NCT00716274|38174721|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
17030310|NCT00716274|38174716|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
17030311|NCT00716274|38174717|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
17030312|NCT00716274|38174718|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
17030313|NCT00716274|38174719|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
17030314|NCT00716274|38174720|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
17030315|NCT00716274|38174721|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
17030316|NCT00716274|38174716|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
17030317|NCT00716274|38174717|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
17030318|NCT00716274|38174718|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
17030319|NCT00716274|38174719|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
17030320|NCT00716274|38174720|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
17136247|NCT03145766|38277455|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
17136248|NCT03145766|38277456|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
17136249|NCT03145766|38277457|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
17136250|NCT03145766|38277458|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
16991159|NCT01026818|38135246|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
16991160|NCT01026818|38135247|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
16991161|NCT01026818|38135248|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
17030321|NCT00716274|38174721|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
17030322|NCT00716274|38174716|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
17030323|NCT00716274|38174717|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
17030324|NCT00716274|38174718|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
17030325|NCT00716274|38174719|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
17030326|NCT00716274|38174720|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
17030327|NCT00716274|38174721|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
17030328|NCT00716274|38174716|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
17030329|NCT00716274|38174717|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
17030330|NCT00716274|38174718|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
17030331|NCT00716274|38174719|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
17030332|NCT00716274|38174720|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
17030333|NCT00716274|38174721|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
17030334|NCT00716274|38174716|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
17030335|NCT00716274|38174717|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
17030336|NCT00716274|38174718|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
16991162|NCT01026818|38135249|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
16991163|NCT01026818|38135246|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
16991164|NCT01026818|38135247|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
16991165|NCT01026818|38135248|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
16991166|NCT01026818|38135249|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
16991167|NCT01026818|38135246|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
16991168|NCT01026818|38135247|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
16991169|NCT01026818|38135248|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
17030337|NCT00716274|38174719|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
17030338|NCT00716274|38174720|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
17030339|NCT00716274|38174721|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
17030340|NCT00716274|38174716|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
17030341|NCT00716274|38174717|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
17030342|NCT00716274|38174718|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
17030343|NCT00716274|38174719|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
17136251|NCT03145766|38277459|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
17136252|NCT03145766|38277455|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
17136253|NCT03145766|38277456|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
17136254|NCT03145766|38277457|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
17136255|NCT03145766|38277458|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
17136256|NCT03145766|38277459|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
17136257|NCT03145766|38277455|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
17136258|NCT03145766|38277456|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
17136259|NCT03145766|38277457|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
17136260|NCT03145766|38277458|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
17136261|NCT03145766|38277459|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
17136262|NCT03145766|38277455|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
17136263|NCT03145766|38277456|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
17136264|NCT03145766|38277457|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
17136265|NCT03145766|38277458|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
17136266|NCT03145766|38277459|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
17136267|NCT03145064|38277472|FG000|Overall Study|Death|24|||
17136268|NCT03145064|38277472|FG000|Overall Study|Lost to Follow-up|3|||
17136269|NCT03145064|38277472|FG000|Overall Study|Withdrawal by Subject|6|||
17136270|NCT03145064|38277472|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
17136271|NCT03145064|38277472|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
17136272|NCT03144674|38277490|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
17136273|NCT03144674|38277491|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
17136274|NCT03144674|38277492|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
17136275|NCT03144674|38277493|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
17136276|NCT03144674|38277490|FG000|Overall Study|Death|3|||
17136277|NCT03144674|38277491|FG001|Overall Study|Death|1|||
17136278|NCT03144674|38277492|FG002|Overall Study|Death|1|||
17136279|NCT03144674|38277493|FG003|Overall Study|Death|10|||
17136280|NCT03144674|38277490|FG000|Overall Study|Lost to Follow-up|0|||
17136281|NCT03144674|38277491|FG001|Overall Study|Lost to Follow-up|1|||
17136282|NCT03144674|38277492|FG002|Overall Study|Lost to Follow-up|1|||
17136283|NCT03144674|38277493|FG003|Overall Study|Lost to Follow-up|1|||
17136284|NCT03144674|38277490|FG000|Overall Study|Withdrawal by Participant|0|||
17136285|NCT03144674|38277491|FG001|Overall Study|Withdrawal by Participant|0|||
17136286|NCT03144674|38277492|FG002|Overall Study|Withdrawal by Participant|0|||
17136287|NCT03144674|38277493|FG003|Overall Study|Withdrawal by Participant|3|||
17136288|NCT03144674|38277490|FG000|Overall Study|Reason not Specified|0|||
17136289|NCT03144674|38277491|FG001|Overall Study|Reason not Specified|0|||
17136290|NCT03144674|38277492|FG002|Overall Study|Reason not Specified|2|||
17136291|NCT03144674|38277493|FG003|Overall Study|Reason not Specified|4|||
17136292|NCT03787615|38277519|FG000|Overall Study|Withdrawal by Subject|2|||
17136293|NCT03787615|38277519|FG000|Overall Study|Lost to Follow-up|2|||
17136294|NCT03784963|38277528|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
17136295|NCT03784963|38277529|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
17136296|NCT03784963|38277530|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
17136297|NCT03784963|38277531|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
17136298|NCT03787303|38277541|FG000|Overall Study|Death|1|||
17136299|NCT03787303|38277541|FG000|Overall Study|Premature Termination of Study|1|||
17136300|NCT04170296|38277547|FG000|Overall Study|Adverse Event|1|||
17136301|NCT04170296|38277548|FG001|Overall Study|Adverse Event|0|||
17136302|NCT04170296|38277547|FG000|Overall Study|Withdrawal by Subject|3|||
17136303|NCT04170296|38277548|FG001|Overall Study|Withdrawal by Subject|2|||
17136304|NCT04170296|38277547|FG000|Overall Study|Lost to Follow-up|4|||
17136305|NCT04170296|38277548|FG001|Overall Study|Lost to Follow-up|2|||
17136306|NCT03141788|38277575|FG000|Overall Study|Lost to Follow-up|1|||
17136307|NCT03141788|38277575|FG000|Overall Study|Protocol Violation|3|||
16780374|NCT02610231|37719468|FG000|Overall Study|Surgery|2|||
17136308|NCT03141788|38277575|FG000|Overall Study|Withdrawal by Subject|4|||
17136309|NCT03781375|38277584|FG000|Double-blind Phase|Adverse Event|0|||
16780375|NCT02610231|37719468|FG000|Overall Study|Physician Decision|1|||
17030344|NCT00716274|38174720|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
17030345|NCT00716274|38174721|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
17030346|NCT00716274|38174716|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
17030347|NCT00716274|38174717|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
17030348|NCT00716274|38174718|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
17030349|NCT00716274|38174719|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
17030350|NCT00716274|38174720|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
17030351|NCT00716274|38174721|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
17030352|NCT00716274|38174716|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
17030353|NCT00716274|38174717|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
17030354|NCT00716274|38174718|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
17030355|NCT00716274|38174719|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
17030356|NCT00716274|38174720|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
17030357|NCT00716274|38174721|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
17030358|NCT00716274|38174716|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
17030359|NCT00716274|38174717|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
17136310|NCT03781375|38277585|FG001|Double-blind Phase|Adverse Event|1|||
17136311|NCT03781375|38277584|FG000|Double-blind Phase|Lack of Response|6|||
17136312|NCT03781375|38277585|FG001|Double-blind Phase|Lack of Response|2|||
17136313|NCT03781375|38277584|FG000|Double-blind Phase|Other|1|||
17136314|NCT03781375|38277585|FG001|Double-blind Phase|Other|3|||
17136315|NCT03781375|38277584|FG000|Open-label Phase|Protocol Issues|0|||
17136316|NCT03781375|38277585|FG001|Open-label Phase|Protocol Issues|1|||
17136317|NCT03781375|38277584|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
17136318|NCT03781375|38277585|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
17136319|NCT03781375|38277584|FG000|Open-label Phase|Other|2|||
17136320|NCT03781375|38277585|FG001|Open-label Phase|Other|2|||
17136321|NCT03779503|38277592|FG000|First Intervention|Adverse Event|0|||
17136322|NCT03779503|38277593|FG001|First Intervention|Adverse Event|1|||
17136323|NCT03779503|38277592|FG000|First Intervention|Withdrawal by Subject|1|||
17136324|NCT03779503|38277593|FG001|First Intervention|Withdrawal by Subject|0|||
17136325|NCT03150056|38277605|FG000|Overall Study|Withdrawal by Subject|0|||
17136326|NCT03150056|38277606|FG001|Overall Study|Withdrawal by Subject|0|||
17136327|NCT03150056|38277607|FG002|Overall Study|Withdrawal by Subject|0|||
17136328|NCT03150056|38277608|FG003|Overall Study|Withdrawal by Subject|0|||
17136329|NCT03150056|38277609|FG004|Overall Study|Withdrawal by Subject|0|||
17136330|NCT03150056|38277610|FG005|Overall Study|Withdrawal by Subject|2|||
17136331|NCT03150056|38277605|FG000|Overall Study|Study terminated by Sponsor|1|||
17136332|NCT03150056|38277606|FG001|Overall Study|Study terminated by Sponsor|3|||
17136333|NCT03150056|38277607|FG002|Overall Study|Study terminated by Sponsor|1|||
17136334|NCT03150056|38277608|FG003|Overall Study|Study terminated by Sponsor|1|||
16991170|NCT01026818|38135249|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
16991171|NCT01026818|38135246|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
16991172|NCT01026818|38135247|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
16991173|NCT01026818|38135248|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
17030360|NCT00716274|38174718|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
17136335|NCT03150056|38277609|FG004|Overall Study|Study terminated by Sponsor|5|||
17136336|NCT03150056|38277610|FG005|Overall Study|Study terminated by Sponsor|6|||
17136337|NCT03150056|38277605|FG000|Overall Study|Death|9|||
17136338|NCT03150056|38277606|FG001|Overall Study|Death|2|||
17136339|NCT03150056|38277607|FG002|Overall Study|Death|2|||
17136340|NCT03150056|38277608|FG003|Overall Study|Death|7|||
17136341|NCT03150056|38277609|FG004|Overall Study|Death|8|||
17136342|NCT03150056|38277610|FG005|Overall Study|Death|10|||
17136343|NCT02640664|38277630|FG000|Epoch 1|Withdrawal of informed consent|1|||
17136344|NCT02640664|38277631|FG001|Epoch 1|Withdrawal of informed consent|0|||
17136345|NCT02640664|38277632|FG002|Epoch 1|Withdrawal of informed consent|0|||
17136346|NCT02640664|38277630|FG000|Epoch 1|Death|0|||
17136347|NCT02640664|38277631|FG001|Epoch 1|Death|0|||
17136348|NCT02640664|38277632|FG002|Epoch 1|Death|1|||
17136349|NCT02640664|38277630|FG000|Epoch 2|Withdrawal of informed consent|3|||
17136350|NCT02640664|38277631|FG001|Epoch 2|Withdrawal of informed consent|4|||
17136351|NCT02640664|38277632|FG002|Epoch 2|Withdrawal of informed consent|2|||
16780376|NCT02610231|37719468|FG000|Overall Study|Non Compliance|2|||
16991174|NCT01026818|38135249|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
16991175|NCT01026818|38135246|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
16991176|NCT01026818|38135247|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
16991177|NCT01026818|38135248|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
16991178|NCT01026818|38135249|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
16991179|NCT01026818|38135246|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
16991180|NCT01026818|38135247|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
16991181|NCT01026818|38135248|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
16991182|NCT01026818|38135249|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
16991183|NCT01026818|38135246|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
17030361|NCT00716274|38174719|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
17030362|NCT00716274|38174720|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
17030363|NCT00716274|38174721|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
17030364|NCT00746564|38174738|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
17030365|NCT01298193|38174744|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
17030366|NCT01298193|38174744|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
17030367|NCT01298193|38174744|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
17030368|NCT01298193|38174744|FG000|Efficacy Phase (Second Cycle)|Death|1|||
17030369|NCT00719862|38174753|FG000|Overall Study|Adverse Event|1|||
17030370|NCT00719862|38174754|FG001|Overall Study|Adverse Event|2|||
17030371|NCT00719862|38174753|FG000|Overall Study|Lack of Efficacy|3|||
17136352|NCT02640664|38277630|FG000|Epoch 2|Subject/guardian decision|0|||
17136353|NCT02640664|38277631|FG001|Epoch 2|Subject/guardian decision|2|||
17136354|NCT02640664|38277632|FG002|Epoch 2|Subject/guardian decision|2|||
17136355|NCT02640664|38277630|FG000|Epoch 2|Lost to Follow-up|3|||
17136356|NCT02640664|38277631|FG001|Epoch 2|Lost to Follow-up|4|||
17136357|NCT02640664|38277632|FG002|Epoch 2|Lost to Follow-up|1|||
17136358|NCT02640664|38277630|FG000|Epoch 2|Death|0|||
17136359|NCT02640664|38277631|FG001|Epoch 2|Death|0|||
16991184|NCT01026818|38135247|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
16991185|NCT01026818|38135248|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
16991186|NCT01026818|38135249|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
16991187|NCT01026818|38135246|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
16991188|NCT01026818|38135247|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
16991189|NCT01026818|38135248|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
16991190|NCT01026818|38135249|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
16991191|NCT01026818|38135246|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
16991192|NCT01026818|38135247|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
17030372|NCT00719862|38174754|FG001|Overall Study|Lack of Efficacy|0|||
17030373|NCT00719862|38174753|FG000|Overall Study|Non-Compliance|1|||
17030374|NCT00719862|38174754|FG001|Overall Study|Non-Compliance|0|||
17030375|NCT00719862|38174753|FG000|Overall Study|Withdrawal by Subject|1|||
17030376|NCT00719862|38174754|FG001|Overall Study|Withdrawal by Subject|0|||
17030377|NCT00719862|38174753|FG000|Overall Study|Lost to Follow-up|0|||
17030378|NCT00719862|38174754|FG001|Overall Study|Lost to Follow-up|1|||
17030379|NCT00719862|38174753|FG000|Overall Study|Other|2|||
17030380|NCT00719862|38174754|FG001|Overall Study|Other|3|||
17030381|NCT00742508|38174762|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
17030382|NCT00742508|38174763|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
17030383|NCT00742508|38174762|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
17030384|NCT00742508|38174763|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
17136360|NCT02640664|38277632|FG002|Epoch 2|Death|1|||
17136361|NCT00812006|38277644|FG000|Overall Study|Lost to Follow-up|0|||
17136362|NCT00812006|38277645|FG001|Overall Study|Lost to Follow-up|0|||
17136363|NCT00812006|38277646|FG002|Overall Study|Lost to Follow-up|2|||
17136364|NCT00812006|38277644|FG000|Overall Study|Physician Decision|0|||
17136365|NCT00812006|38277645|FG001|Overall Study|Physician Decision|0|||
17136366|NCT00812006|38277646|FG002|Overall Study|Physician Decision|1|||
17136367|NCT00812006|38277644|FG000|Overall Study|Withdrawal by Subject|2|||
17136368|NCT00812006|38277645|FG001|Overall Study|Withdrawal by Subject|1|||
17030385|NCT00742508|38174762|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
17030386|NCT00742508|38174763|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
17030387|NCT00742508|38174762|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
17030388|NCT00742508|38174763|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
17030389|NCT00742508|38174762|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
17030390|NCT00742508|38174763|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
17030391|NCT00719706|38174771|FG000|Overall Study|Adverse Event|5|||
17030392|NCT00719706|38174772|FG001|Overall Study|Adverse Event|4|||
17030393|NCT00719706|38174771|FG000|Overall Study|Withdrawal by Subject|1|||
17030394|NCT00719706|38174772|FG001|Overall Study|Withdrawal by Subject|2|||
17030395|NCT00719706|38174771|FG000|Overall Study|Protocol Violation|3|||
17030396|NCT00719706|38174772|FG001|Overall Study|Protocol Violation|0|||
17030397|NCT00742274|38174780|FG000|Overall Study|Death|1|||
17030398|NCT00742274|38174781|FG001|Overall Study|Death|0|||
17030399|NCT00742274|38174780|FG000|Overall Study|Withdrawal by Subject|1|||
17030400|NCT00742274|38174781|FG001|Overall Study|Withdrawal by Subject|2|||
17030401|NCT00742274|38174780|FG000|Overall Study|Removed for medical reasons|1|||
17030402|NCT00742274|38174781|FG001|Overall Study|Removed for medical reasons|1|||
17030403|NCT00719472|38174787|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
17030404|NCT00719472|38174787|FG000|Enrolled in Study|Subject decision to withdraw|8|||
17030405|NCT00719472|38174787|FG000|Enrolled in Study|Various Reasons|17|||
17030406|NCT00719472|38174787|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
17136369|NCT00812006|38277646|FG002|Overall Study|Withdrawal by Subject|1|||
17136370|NCT00812006|38277644|FG000|Overall Study|Lack of Qualifying Event|4|||
17030407|NCT00719472|38174787|FG000|Received Cycle 1 Treatment|Death|5|||
17030408|NCT00719472|38174787|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
17030409|NCT00719472|38174787|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
17030410|NCT00719472|38174787|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
17030411|NCT00719472|38174787|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
17030412|NCT00719472|38174787|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
17030413|NCT00719472|38174787|FG000|Received Cycle 2 Treatment|Death|6|||
16991193|NCT01026818|38135248|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
16991194|NCT01026818|38135249|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
16991195|NCT01026818|38135246|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
16991196|NCT01026818|38135247|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
16991197|NCT01026818|38135248|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
16991198|NCT01026818|38135249|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
17030414|NCT00719472|38174787|FG000|Received Cycle 2 Treatment|Disease progression|3|||
17030415|NCT00719472|38174787|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
17030416|NCT00719472|38174787|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
17030417|NCT00719472|38174787|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
16991199|NCT01026818|38135246|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
16991200|NCT01026818|38135247|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
16991201|NCT01026818|38135248|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
16991202|NCT01026818|38135249|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
16991203|NCT01026818|38135246|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
16991204|NCT01026818|38135247|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
17030418|NCT00719472|38174787|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
17030419|NCT00579501|38174791|FG000|Overall Study|Death|1|||
17030420|NCT00579501|38174791|FG000|Overall Study|End of neoadjuvant therapy|25|||
17030421|NCT00579501|38174791|FG000|Overall Study|toxicity|1|||
17030422|NCT00579501|38174791|FG000|Overall Study|Secondary lesion|1|||
17030423|NCT00579501|38174791|FG000|Overall Study|Radiation therapy before surgery|1|||
17030424|NCT00741338|38174797|FG000|Overall Study|Adverse Event|0|||
17030425|NCT00741338|38174798|FG001|Overall Study|Adverse Event|1|||
17030426|NCT00746330|38174808|FG000|Period 1|Abnormal test procedure result|0|||
17030427|NCT00746330|38174809|FG001|Period 1|Abnormal test procedure result|0|||
17030428|NCT00746330|38174810|FG002|Period 1|Abnormal test procedure result|1|||
17030429|NCT00746330|38174811|FG003|Period 1|Abnormal test procedure result|0|||
17030430|NCT00746252|38174824|FG000|Overall Study|weight gain >7.5 %|1|||
17030431|NCT00746252|38174825|FG001|Overall Study|weight gain >7.5 %|2|||
17030432|NCT00718770|38174831|FG000|Overall Study|Adverse Event|1|||
17030433|NCT00718770|38174831|FG000|Overall Study|Lack of Efficacy|1|||
17030434|NCT00718770|38174831|FG000|Overall Study|Lack of Efficacy|1|||
17030435|NCT00718770|38174831|FG000|Overall Study|Adverse Event|1|||
17030436|NCT00718770|38174831|FG000|Overall Study|Lack of Efficacy|1|||
17030437|NCT00718770|38174831|FG000|Overall Study|Adverse Event|1|||
16991205|NCT01026818|38135248|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
16991206|NCT01026818|38135249|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
16991207|NCT01026818|38135246|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
16991208|NCT01026818|38135247|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
16991209|NCT01026818|38135248|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
16991210|NCT01026818|38135249|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
16991211|NCT01026818|38135246|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
16991212|NCT01026818|38135247|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
16991213|NCT01026818|38135248|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
16991214|NCT01026818|38135249|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
16991215|NCT01026818|38135246|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
16991216|NCT01026818|38135247|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
16991217|NCT01026818|38135248|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
16991218|NCT01026818|38135249|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
16991219|NCT01026818|38135246|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
16991220|NCT01026818|38135247|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
16991221|NCT01026818|38135248|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
16991222|NCT01026818|38135249|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
16991223|NCT01026818|38135246|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
16991224|NCT01026818|38135247|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
16991225|NCT01026818|38135248|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
16991226|NCT01026818|38135249|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
16991227|NCT00735397|38135261|FG000|Overall Study|Adverse Event|194|||
16991228|NCT00735397|38135261|FG000|Overall Study|Lost to Follow-up|33|||
16991229|NCT00735397|38135261|FG000|Overall Study|Participant choice|252|||
16991230|NCT00735397|38135261|FG000|Overall Study|Inadequate therapeutic effect|202|||
17030438|NCT00718770|38174831|FG000|Overall Study|Lack of Efficacy|1|||
17136371|NCT00812006|38277645|FG001|Overall Study|Lack of Qualifying Event|2|||
16991231|NCT00735397|38135261|FG000|Overall Study|Administrative/Other|502|||
17030439|NCT00718770|38174831|FG000|Overall Study|Adverse Event|1|||
17030440|NCT00746096|38174837|FG000|Overall Study|Adverse Event|1|||
17030441|NCT00746096|38174838|FG001|Overall Study|Adverse Event|0|||
17030442|NCT00746096|38174837|FG000|Overall Study|Withdrawal by Subject|5|||
17030443|NCT00746096|38174838|FG001|Overall Study|Withdrawal by Subject|1|||
17030444|NCT00746096|38174837|FG000|Overall Study|Lost to Follow-up|2|||
17030445|NCT00746096|38174838|FG001|Overall Study|Lost to Follow-up|1|||
17030446|NCT00746096|38174837|FG000|Overall Study|Protocol Violation|1|||
17030447|NCT00746096|38174838|FG001|Overall Study|Protocol Violation|0|||
16991232|NCT00735007|38135268|FG000|Overall Study|Adverse Event|4|||
16991233|NCT00735007|38135268|FG000|Overall Study|Protocol Violation|1|||
16991234|NCT00743509|38135272|FG000|Overall Study|Withdrawal by Subject|2|||
16991235|NCT00734929|38135278|FG000|Overall Study|Lost to Follow-up|1|||
16991236|NCT00734929|38135279|FG001|Overall Study|Lost to Follow-up|2|||
16991237|NCT00734929|38135278|FG000|Overall Study|No intervention/ screen fail|5|||
16991238|NCT00734929|38135279|FG001|Overall Study|No intervention/ screen fail|3|||
17030448|NCT00746096|38174837|FG000|Overall Study|No study drug treatment|1|||
17030449|NCT00746096|38174838|FG001|Overall Study|No study drug treatment|1|||
17030450|NCT00715026|38174844|FG000|Overall Study|Withdrawal by Subject|5|||
17030451|NCT00715026|38174844|FG000|Overall Study|Lost to Follow-up|3|||
17030452|NCT00715026|38174844|FG000|Overall Study|Protocol Violation|1|||
17030453|NCT00715026|38174844|FG000|Overall Study|Surgery done on non-study consented hip|1|||
17030454|NCT00714948|38174848|FG000|Overall Study|Adverse Event|2|||
17030455|NCT00714870|38174854|FG000|Overall Study|Lost to Follow-up|22|||
17030456|NCT00714870|38174855|FG001|Overall Study|Lost to Follow-up|5|||
17030457|NCT00714870|38174854|FG000|Overall Study|patient unable to come b/c back pain|1|||
17030458|NCT00714870|38174855|FG001|Overall Study|patient unable to come b/c back pain|0|||
17030459|NCT00714870|38174854|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
17030460|NCT00714870|38174855|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
17030461|NCT00714714|38174861|FG000|Overall Study|Adverse Event|1|||
17030462|NCT00441337|38174871|FG000|Overall Study|Disease Progression|6|||
17030463|NCT00441337|38174872|FG001|Overall Study|Disease Progression|6|||
17030464|NCT00441337|38174873|FG002|Overall Study|Disease Progression|4|||
17030465|NCT00441337|38174874|FG003|Overall Study|Disease Progression|18|||
17030466|NCT00441337|38174871|FG000|Overall Study|Lost to Follow-up|0|||
17030467|NCT00441337|38174872|FG001|Overall Study|Lost to Follow-up|0|||
17030468|NCT00441337|38174873|FG002|Overall Study|Lost to Follow-up|0|||
17030469|NCT00441337|38174874|FG003|Overall Study|Lost to Follow-up|1|||
17030470|NCT00441337|38174871|FG000|Overall Study|Sponsor Decision|0|||
17030471|NCT00441337|38174872|FG001|Overall Study|Sponsor Decision|0|||
17030472|NCT00441337|38174873|FG002|Overall Study|Sponsor Decision|1|||
17030473|NCT00441337|38174874|FG003|Overall Study|Sponsor Decision|2|||
17030474|NCT00441337|38174871|FG000|Overall Study|Did not meet inclusion criteria|0|||
17030475|NCT00441337|38174872|FG001|Overall Study|Did not meet inclusion criteria|0|||
17030476|NCT00441337|38174873|FG002|Overall Study|Did not meet inclusion criteria|1|||
17030477|NCT00441337|38174874|FG003|Overall Study|Did not meet inclusion criteria|0|||
17030478|NCT00578877|38174894|FG000|Overall Study|Lost to Follow-up|8|||
17030479|NCT00578877|38174895|FG001|Overall Study|Lost to Follow-up|10|||
17030480|NCT00578877|38174894|FG000|Overall Study|early discontinue|61|||
17030481|NCT00578877|38174895|FG001|Overall Study|early discontinue|101|||
17030482|NCT00578877|38174894|FG000|Overall Study|did not provide follow-up data|12|||
17030483|NCT00578877|38174895|FG001|Overall Study|did not provide follow-up data|17|||
17030484|NCT00468481|38174903|FG000|Overall Study|Adverse Event|13|||
17030485|NCT00468481|38174904|FG001|Overall Study|Adverse Event|3|||
17030486|NCT00468481|38174903|FG000|Overall Study|Lost to Follow-up|25|||
17030487|NCT00468481|38174904|FG001|Overall Study|Lost to Follow-up|8|||
17030488|NCT00468481|38174903|FG000|Overall Study|Pregnancy|2|||
17030489|NCT00468481|38174904|FG001|Overall Study|Pregnancy|0|||
17030490|NCT00468481|38174903|FG000|Overall Study|Protocol Violation|18|||
17030491|NCT00468481|38174904|FG001|Overall Study|Protocol Violation|8|||
17030492|NCT00468481|38174903|FG000|Overall Study|Withdrawal by Subject|12|||
17030493|NCT00468481|38174904|FG001|Overall Study|Withdrawal by Subject|3|||
17030494|NCT00468481|38174903|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
17030495|NCT00468481|38174904|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
17030496|NCT00468481|38174903|FG000|Overall Study|Prohibited Medication|1|||
17030497|NCT00468481|38174904|FG001|Overall Study|Prohibited Medication|1|||
17030498|NCT00468481|38174903|FG000|Overall Study|Egg Donor|1|||
17030499|NCT00468481|38174904|FG001|Overall Study|Egg Donor|0|||
17030500|NCT00468481|38174903|FG000|Overall Study|Moved out of area|4|||
17030501|NCT00468481|38174904|FG001|Overall Study|Moved out of area|1|||
16991239|NCT00734851|38135287|FG000|Overall Study|Withdrawal by Subject|2|||
16991240|NCT00734851|38135287|FG000|Overall Study|Lost to Follow-up|1|||
16991241|NCT00734851|38135287|FG000|Overall Study|Physician Decision|18|||
16991242|NCT00734617|38135293|FG000|Overall Study|Adverse Event|4|||
16991243|NCT00734617|38135294|FG001|Overall Study|Adverse Event|7|||
16991244|NCT00734617|38135293|FG000|Overall Study|Withdrawal by Subject|103|||
17030502|NCT00468481|38174903|FG000|Overall Study|Non-Compliance|5|||
17030503|NCT00468481|38174904|FG001|Overall Study|Non-Compliance|0|||
17030504|NCT00468481|38174903|FG000|Overall Study|Other|6|||
17030505|NCT00468481|38174904|FG001|Overall Study|Other|0|||
17030506|NCT00714168|38174912|FG000|Overall Study|Pregnancy|5|||
17030507|NCT00714168|38174913|FG001|Overall Study|Pregnancy|4|||
17030508|NCT00714168|38174912|FG000|Overall Study|Lost to Follow-up|32|||
17030509|NCT00714168|38174913|FG001|Overall Study|Lost to Follow-up|50|||
17030510|NCT00714168|38174912|FG000|Overall Study|Relocation|4|||
17030511|NCT00714168|38174913|FG001|Overall Study|Relocation|3|||
17030512|NCT00714168|38174912|FG000|Overall Study|Non-study medical condition|3|||
17030513|NCT00714168|38174913|FG001|Overall Study|Non-study medical condition|2|||
17030514|NCT00713700|38174919|FG000|Overall Study|Lost to Follow-up|3|||
17030515|NCT00713700|38174919|FG000|Overall Study|Withdrawal by Subject|1|||
17030516|NCT00468169|38174925|FG000|Overall Study|Withdrawal by Subject|1|||
17030517|NCT00468169|38174926|FG001|Overall Study|Withdrawal by Subject|0|||
17030518|NCT00435487|38174936|FG000|Overall Study|Death|3|||
17030519|NCT00435487|38174937|FG001|Overall Study|Death|4|||
17030520|NCT00435487|38174936|FG000|Overall Study|Adverse Event|0|||
17030521|NCT00435487|38174937|FG001|Overall Study|Adverse Event|3|||
17136372|NCT00812006|38277646|FG002|Overall Study|Lack of Qualifying Event|2|||
17136373|NCT03772327|38277661|FG000|Overall Study|Lost to Follow-up|3|||
17136374|NCT03772327|38277662|FG001|Overall Study|Lost to Follow-up|4|||
16991245|NCT00734617|38135294|FG001|Overall Study|Withdrawal by Subject|95|||
16991246|NCT00743431|38135300|FG000|Overall Study|Toxicity|6|||
16991247|NCT00743431|38135300|FG000|Overall Study|Tumor progression|56|||
16991248|NCT00743431|38135300|FG000|Overall Study|Withdrawal by Subject|13|||
17136375|NCT03772327|38277661|FG000|Overall Study|Withdrawal by Subject|2|||
17136376|NCT03772327|38277662|FG001|Overall Study|Withdrawal by Subject|3|||
17136377|NCT04562090|38277692|FG000|Overall Study|Withdrawal by Subject|3|||
17136378|NCT04562090|38277693|FG001|Overall Study|Withdrawal by Subject|4|||
17136379|NCT04562090|38277692|FG000|Overall Study|Protocol Violation|2|||
17136380|NCT04562090|38277693|FG001|Overall Study|Protocol Violation|0|||
17136381|NCT04562090|38277692|FG000|Overall Study|Lack of Efficacy|0|||
17136382|NCT04562090|38277693|FG001|Overall Study|Lack of Efficacy|1|||
17136383|NCT04562090|38277692|FG000|Overall Study|Adverse Event|1|||
17136384|NCT04562090|38277693|FG001|Overall Study|Adverse Event|4|||
17136385|NCT04562090|38277692|FG000|Overall Study|Miscellaneous|0|||
17136386|NCT04562090|38277693|FG001|Overall Study|Miscellaneous|3|||
17136387|NCT04364763|38277717|FG000|Overall Study|Death|1|||
17136388|NCT04364763|38277718|FG001|Overall Study|Death|2|||
17136389|NCT04364763|38277717|FG000|Overall Study|Lost to Follow-up|1|||
17136390|NCT04364763|38277718|FG001|Overall Study|Lost to Follow-up|0|||
17136391|NCT04247815|38277735|FG000|Overall Study|Adverse Event|1|||
17136392|NCT04247815|38277736|FG001|Overall Study|Adverse Event|0|||
16780377|NCT02610231|37719468|FG000|Overall Study|Other|3|||
16780378|NCT02178358|37719478|FG000|Overall Study|Withdrawal by Subject|0|||
16780379|NCT02178358|37719479|FG001|Overall Study|Withdrawal by Subject|2|||
16780380|NCT02178358|37719480|FG002|Overall Study|Withdrawal by Subject|2|||
16991249|NCT00743431|38135300|FG000|Overall Study|Death|9|||
16991250|NCT00743431|38135300|FG000|Overall Study|Reason for discontinuation not specified|29|||
16991251|NCT00743431|38135300|FG000|Overall Study|No documentation available|13|||
16991252|NCT03593655|38135306|FG000|First Product Use Period|Withdrawal by Subject|1|||
16991253|NCT03593655|38135307|FG001|First Product Use Period|Withdrawal by Subject|1|||
16991254|NCT03593655|38135306|FG000|First Product Use Period|Lost to Follow-up|1|||
16991255|NCT03593655|38135307|FG001|First Product Use Period|Lost to Follow-up|3|||
17030522|NCT00435487|38174936|FG000|Overall Study|Lost to Follow-up|2|||
17030523|NCT00435487|38174937|FG001|Overall Study|Lost to Follow-up|2|||
17030524|NCT00435487|38174936|FG000|Overall Study|Other|5|||
17136393|NCT04247815|38277735|FG000|Overall Study|Withdrawal by Subject|1|||
17136394|NCT04247815|38277736|FG001|Overall Study|Withdrawal by Subject|0|||
17136395|NCT04247815|38277735|FG000|Overall Study|Protocol Violation|0|||
17030525|NCT00435487|38174937|FG001|Overall Study|Other|2|||
17030526|NCT00435487|38174936|FG000|Overall Study|Withdrawal by Subject|2|||
17030527|NCT00435487|38174937|FG001|Overall Study|Withdrawal by Subject|1|||
17030528|NCT00435487|38174936|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
16991256|NCT03593655|38135306|FG000|Second Product Use Period|Withdrawal by Subject|1|||
16991257|NCT03593655|38135307|FG001|Second Product Use Period|Withdrawal by Subject|1|||
16991258|NCT03593655|38135306|FG000|Second Product Use Period|Lost to Follow-up|1|||
16991259|NCT03593655|38135307|FG001|Second Product Use Period|Lost to Follow-up|0|||
16991260|NCT03593655|38135306|FG000|Third Product Use Period|Lost to Follow-up|1|||
16991261|NCT03593655|38135307|FG001|Third Product Use Period|Lost to Follow-up|2|||
16991262|NCT03593655|38135306|FG000|Third Product Use Period|Physician Decision|0|||
16991263|NCT03593655|38135307|FG001|Third Product Use Period|Physician Decision|1|||
16991264|NCT03593655|38135306|FG000|Third Product Use Period|Withdrawal by Subject|0|||
17030529|NCT00435487|38174937|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
17030530|NCT00435487|38174936|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
17030531|NCT00435487|38174937|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
17030532|NCT00579345|38174951|FG000|Overall Study|Withdrawal by Subject|2|||
17030533|NCT00579345|38174952|FG001|Overall Study|Withdrawal by Subject|0|||
17030534|NCT00579345|38174953|FG002|Overall Study|Withdrawal by Subject|0|||
17030535|NCT00579345|38174954|FG003|Overall Study|Withdrawal by Subject|0|||
17030536|NCT00579345|38174955|FG004|Overall Study|Withdrawal by Subject|0|||
17030537|NCT00579345|38174956|FG005|Overall Study|Withdrawal by Subject|0|||
17030538|NCT00579345|38174957|FG006|Overall Study|Withdrawal by Subject|0|||
17030539|NCT00579345|38174958|FG007|Overall Study|Withdrawal by Subject|1|||
17030540|NCT00579345|38174951|FG000|Overall Study|Lost to Follow-up|1|||
17030541|NCT00579345|38174952|FG001|Overall Study|Lost to Follow-up|0|||
17030542|NCT00579345|38174953|FG002|Overall Study|Lost to Follow-up|0|||
17030543|NCT00579345|38174954|FG003|Overall Study|Lost to Follow-up|0|||
17136396|NCT04247815|38277736|FG001|Overall Study|Protocol Violation|1|||
17136397|NCT03432819|38277771|FG000|Overall Study|Lost to Follow-up|2|||
17136398|NCT03432819|38277772|FG001|Overall Study|Lost to Follow-up|2|||
16991265|NCT03593655|38135307|FG001|Third Product Use Period|Withdrawal by Subject|1|||
16991266|NCT00734539|38135318|FG000|Main Study|Death|33|||
16991267|NCT00734539|38135319|FG001|Main Study|Death|32|||
17030544|NCT00579345|38174955|FG004|Overall Study|Lost to Follow-up|0|||
17030545|NCT00579345|38174956|FG005|Overall Study|Lost to Follow-up|0|||
17030546|NCT00579345|38174957|FG006|Overall Study|Lost to Follow-up|0|||
17030547|NCT00579345|38174958|FG007|Overall Study|Lost to Follow-up|0|||
17030548|NCT00579345|38174951|FG000|Overall Study|Adverse Event|0|||
17030549|NCT00579345|38174952|FG001|Overall Study|Adverse Event|0|||
17030550|NCT00579345|38174953|FG002|Overall Study|Adverse Event|1|||
17030551|NCT00579345|38174954|FG003|Overall Study|Adverse Event|0|||
17030552|NCT00579345|38174955|FG004|Overall Study|Adverse Event|0|||
17030553|NCT00579345|38174956|FG005|Overall Study|Adverse Event|0|||
17030554|NCT00579345|38174957|FG006|Overall Study|Adverse Event|0|||
17030555|NCT00579345|38174958|FG007|Overall Study|Adverse Event|0|||
17030556|NCT00579345|38174951|FG000|Overall Study|Protocol Violation|1|||
17030557|NCT00579345|38174952|FG001|Overall Study|Protocol Violation|0|||
17030558|NCT00579345|38174953|FG002|Overall Study|Protocol Violation|0|||
17030559|NCT00579345|38174954|FG003|Overall Study|Protocol Violation|0|||
17030560|NCT00579345|38174955|FG004|Overall Study|Protocol Violation|0|||
17030561|NCT00579345|38174956|FG005|Overall Study|Protocol Violation|0|||
17030562|NCT00579345|38174957|FG006|Overall Study|Protocol Violation|0|||
17030563|NCT00579345|38174958|FG007|Overall Study|Protocol Violation|1|||
17030564|NCT00579345|38174951|FG000|Overall Study|Death|1|||
17030565|NCT00579345|38174952|FG001|Overall Study|Death|1|||
17030566|NCT00579345|38174953|FG002|Overall Study|Death|1|||
17030567|NCT00579345|38174954|FG003|Overall Study|Death|1|||
17030568|NCT00579345|38174955|FG004|Overall Study|Death|0|||
17030569|NCT00579345|38174956|FG005|Overall Study|Death|0|||
17030570|NCT00579345|38174957|FG006|Overall Study|Death|0|||
17030571|NCT00579345|38174958|FG007|Overall Study|Death|0|||
17030572|NCT00795821|38175006|FG000|Acute Treatment Phase|Adverse Event|23|||
17030573|NCT00795821|38175007|FG001|Acute Treatment Phase|Adverse Event|4|||
17030574|NCT00795821|38175006|FG000|Acute Treatment Phase|Death|1|||
17030575|NCT00795821|38175007|FG001|Acute Treatment Phase|Death|0|||
17030576|NCT00795821|38175006|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
17030577|NCT00795821|38175007|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
17030578|NCT00795821|38175006|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
17030579|NCT00795821|38175007|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
17030580|NCT00795821|38175006|FG000|Acute Treatment Phase|Physician Decision|1|||
17030581|NCT00795821|38175007|FG001|Acute Treatment Phase|Physician Decision|1|||
17030582|NCT00795821|38175006|FG000|Acute Treatment Phase|Protocol Violation|1|||
16780381|NCT02178358|37719478|FG000|Overall Study|Lost to Follow-up|1|||
17030583|NCT00795821|38175007|FG001|Acute Treatment Phase|Protocol Violation|2|||
17030584|NCT00795821|38175006|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
17030585|NCT00795821|38175007|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
17030586|NCT00795821|38175006|FG000|Long-term Extension Phase|Adverse Event|25|||
17030587|NCT00795821|38175007|FG001|Long-term Extension Phase|Adverse Event|32|||
17030588|NCT00795821|38175006|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
17030589|NCT00795821|38175007|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
17030590|NCT00795821|38175006|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
16991268|NCT00734539|38135318|FG000|Main Study|Physician Decision|2|||
16991269|NCT00734539|38135319|FG001|Main Study|Physician Decision|0|||
16991270|NCT00734539|38135318|FG000|Main Study|Withdrawal by Subject|1|||
16991271|NCT00734539|38135319|FG001|Main Study|Withdrawal by Subject|3|||
16991272|NCT00734539|38135318|FG000|Main Study|Enrolled in error; ineligible|1|||
16991273|NCT00734539|38135319|FG001|Main Study|Enrolled in error; ineligible|0|||
16991274|NCT00743275|38135330|FG000|Overall Study|Protocol Violation|0|||
16991275|NCT00743275|38135331|FG001|Overall Study|Protocol Violation|1|||
16991276|NCT00734149|38135337|FG000|Overall Study|Withdrawal by Subject|1|||
16991277|NCT00743197|38135345|FG000|Overall Study|Study terminated due to departure of PI.|1|||
17030591|NCT00795821|38175007|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
16991278|NCT00743197|38135346|FG001|Overall Study|Study terminated due to departure of PI.|2|||
16991279|NCT00734071|38135354|FG000|Overall Study|Adverse Event|4|||
16991280|NCT00734071|38135355|FG001|Overall Study|Adverse Event|3|||
16991281|NCT00734071|38135354|FG000|Overall Study|Lack of Efficacy|3|||
17030592|NCT00795821|38175006|FG000|Long-term Extension Phase|Physician Decision|1|||
17030593|NCT00795821|38175007|FG001|Long-term Extension Phase|Physician Decision|2|||
17030594|NCT00795821|38175006|FG000|Long-term Extension Phase|Protocol Violation|3|||
17030595|NCT00795821|38175007|FG001|Long-term Extension Phase|Protocol Violation|5|||
17030596|NCT00795821|38175006|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
17030597|NCT00795821|38175007|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
17030598|NCT00795821|38175006|FG000|Taper Phase|Adverse Event|2|||
17030599|NCT00795821|38175007|FG001|Taper Phase|Adverse Event|0|||
17030600|NCT00795821|38175006|FG000|Taper Phase|Lost to Follow-up|1|||
17030601|NCT00795821|38175007|FG001|Taper Phase|Lost to Follow-up|0|||
17030602|NCT00795821|38175006|FG000|Taper Phase|Physician Decision|2|||
17030603|NCT00795821|38175007|FG001|Taper Phase|Physician Decision|0|||
17030604|NCT00795821|38175006|FG000|Taper Phase|Withdrawal by Subject|4|||
17030605|NCT00795821|38175007|FG001|Taper Phase|Withdrawal by Subject|0|||
17030606|NCT00578643|38175023|FG000|Overall Study|Death|1|||
17030607|NCT00578643|38175023|FG000|Overall Study|Lost to Follow-up|1|||
17030608|NCT00578565|38175027|FG000|Overall Study|Adverse Event|3|||
17030609|NCT00741260|38175039|FG000|Overall Study|Disease Progression|3|||
17030610|NCT00741260|38175040|FG001|Overall Study|Disease Progression|5|||
17030611|NCT00741260|38175041|FG002|Overall Study|Disease Progression|3|||
17030612|NCT00741260|38175042|FG003|Overall Study|Disease Progression|3|||
17030613|NCT00741260|38175043|FG004|Overall Study|Disease Progression|5|||
17030614|NCT00741260|38175044|FG005|Overall Study|Disease Progression|37|||
17030615|NCT00741260|38175045|FG006|Overall Study|Disease Progression|4|||
17030616|NCT00741260|38175039|FG000|Overall Study|Death|0|||
17030617|NCT00741260|38175040|FG001|Overall Study|Death|1|||
17030618|NCT00741260|38175041|FG002|Overall Study|Death|0|||
17030619|NCT00741260|38175042|FG003|Overall Study|Death|1|||
17030620|NCT00741260|38175043|FG004|Overall Study|Death|2|||
17030621|NCT00741260|38175044|FG005|Overall Study|Death|2|||
17030622|NCT00741260|38175045|FG006|Overall Study|Death|1|||
17030623|NCT00741260|38175039|FG000|Overall Study|Withdrawal by Subject|0|||
17030624|NCT00741260|38175040|FG001|Overall Study|Withdrawal by Subject|0|||
17030625|NCT00741260|38175041|FG002|Overall Study|Withdrawal by Subject|0|||
17030626|NCT00741260|38175042|FG003|Overall Study|Withdrawal by Subject|0|||
17030627|NCT00741260|38175043|FG004|Overall Study|Withdrawal by Subject|1|||
17030628|NCT00741260|38175044|FG005|Overall Study|Withdrawal by Subject|3|||
17030629|NCT00741260|38175045|FG006|Overall Study|Withdrawal by Subject|1|||
17136399|NCT03432819|38277771|FG000|Overall Study|Withdrawal by Subject|5|||
17136400|NCT03432819|38277772|FG001|Overall Study|Withdrawal by Subject|3|||
17136401|NCT03272347|38277791|FG000|Overall Study|Death|0|||
17136402|NCT03272347|38277792|FG001|Overall Study|Death|0|||
17136403|NCT03272347|38277793|FG002|Overall Study|Death|0|||
17136404|NCT03272347|38277794|FG003|Overall Study|Death|1|||
17136405|NCT03272347|38277791|FG000|Overall Study|Lost to Follow-up|1|||
17136406|NCT03272347|38277792|FG001|Overall Study|Lost to Follow-up|3|||
17136407|NCT03272347|38277793|FG002|Overall Study|Lost to Follow-up|5|||
17136408|NCT03272347|38277794|FG003|Overall Study|Lost to Follow-up|1|||
17136409|NCT03272347|38277791|FG000|Overall Study|Physician Decision|4|||
17136410|NCT03272347|38277792|FG001|Overall Study|Physician Decision|2|||
17136411|NCT03272347|38277793|FG002|Overall Study|Physician Decision|5|||
17136412|NCT03272347|38277794|FG003|Overall Study|Physician Decision|4|||
17136413|NCT03272347|38277791|FG000|Overall Study|Screen Failure|1|||
16991282|NCT00734071|38135355|FG001|Overall Study|Lack of Efficacy|1|||
17030630|NCT00741260|38175039|FG000|Overall Study|Physician Decision|1|||
17030631|NCT00741260|38175040|FG001|Overall Study|Physician Decision|1|||
17030632|NCT00741260|38175041|FG002|Overall Study|Physician Decision|0|||
17136414|NCT03272347|38277792|FG001|Overall Study|Screen Failure|0|||
17136415|NCT03272347|38277793|FG002|Overall Study|Screen Failure|0|||
17030633|NCT00741260|38175042|FG003|Overall Study|Physician Decision|0|||
17030634|NCT00741260|38175043|FG004|Overall Study|Physician Decision|0|||
17030635|NCT00741260|38175044|FG005|Overall Study|Physician Decision|0|||
17030636|NCT00741260|38175045|FG006|Overall Study|Physician Decision|0|||
17030637|NCT00741260|38175039|FG000|Overall Study|Other|2|||
17030638|NCT00741260|38175040|FG001|Overall Study|Other|1|||
17030639|NCT00741260|38175041|FG002|Overall Study|Other|1|||
17030640|NCT00741260|38175042|FG003|Overall Study|Other|2|||
17030641|NCT00741260|38175043|FG004|Overall Study|Other|1|||
17030642|NCT00741260|38175044|FG005|Overall Study|Other|3|||
17030643|NCT00741260|38175045|FG006|Overall Study|Other|1|||
17030644|NCT00740870|38175066|FG000|Overall Study|Not Catheterized|4|||
17030645|NCT00740870|38175066|FG000|Overall Study|Further testing contraindicated implant|17|||
17030646|NCT00740792|38175077|FG000|Overall Study|Adverse Event|3|||
17030647|NCT00740792|38175078|FG001|Overall Study|Adverse Event|1|||
17030648|NCT00740792|38175079|FG002|Overall Study|Adverse Event|1|||
17030649|NCT00740792|38175080|FG003|Overall Study|Adverse Event|3|||
17030650|NCT00740792|38175077|FG000|Overall Study|Lack of Efficacy|1|||
17030651|NCT00740792|38175078|FG001|Overall Study|Lack of Efficacy|1|||
17030652|NCT00740792|38175079|FG002|Overall Study|Lack of Efficacy|0|||
17030653|NCT00740792|38175080|FG003|Overall Study|Lack of Efficacy|3|||
17030654|NCT00740792|38175077|FG000|Overall Study|Lost to Follow-up|2|||
17030655|NCT00740792|38175078|FG001|Overall Study|Lost to Follow-up|1|||
17030656|NCT00740792|38175079|FG002|Overall Study|Lost to Follow-up|0|||
17030657|NCT00740792|38175080|FG003|Overall Study|Lost to Follow-up|0|||
17030658|NCT00740792|38175077|FG000|Overall Study|Protocol Violation|0|||
17030659|NCT00740792|38175078|FG001|Overall Study|Protocol Violation|1|||
17030660|NCT00740792|38175079|FG002|Overall Study|Protocol Violation|0|||
17030661|NCT00740792|38175080|FG003|Overall Study|Protocol Violation|2|||
17030662|NCT00740792|38175077|FG000|Overall Study|Withdrawal by Subject|1|||
17030663|NCT00740792|38175078|FG001|Overall Study|Withdrawal by Subject|1|||
17030664|NCT00740792|38175079|FG002|Overall Study|Withdrawal by Subject|0|||
17030665|NCT00740792|38175080|FG003|Overall Study|Withdrawal by Subject|0|||
17030666|NCT00740792|38175077|FG000|Overall Study|administrative|3|||
17030667|NCT00740792|38175078|FG001|Overall Study|administrative|3|||
17030668|NCT00740792|38175079|FG002|Overall Study|administrative|8|||
17030669|NCT00740792|38175080|FG003|Overall Study|administrative|2|||
17030670|NCT00740714|38175093|FG000|Overall Study|Withdrawal by Subject|17|||
17030671|NCT00740714|38175094|FG001|Overall Study|Withdrawal by Subject|19|||
17030672|NCT00740714|38175095|FG002|Overall Study|Withdrawal by Subject|29|||
17030673|NCT00788957|38175107|FG000|Part 1|Death|8|||
17030674|NCT00788957|38175108|FG001|Part 1|Death|0|||
17030675|NCT00788957|38175109|FG002|Part 1|Death|0|||
17030676|NCT00788957|38175110|FG003|Part 1|Death|0|||
17030677|NCT00788957|38175111|FG004|Part 1|Death|0|||
17030678|NCT00788957|38175112|FG005|Part 1|Death|0|||
17030679|NCT00788957|38175107|FG000|Part 1|Lost to Follow-up|1|||
17030680|NCT00788957|38175108|FG001|Part 1|Lost to Follow-up|0|||
17030681|NCT00788957|38175109|FG002|Part 1|Lost to Follow-up|0|||
17030682|NCT00788957|38175110|FG003|Part 1|Lost to Follow-up|0|||
17030683|NCT00788957|38175111|FG004|Part 1|Lost to Follow-up|0|||
17030684|NCT00788957|38175112|FG005|Part 1|Lost to Follow-up|0|||
17030685|NCT00788957|38175107|FG000|Part 2|Withdrawal by Subject|0|||
17030686|NCT00788957|38175108|FG001|Part 2|Withdrawal by Subject|9|||
17030687|NCT00788957|38175109|FG002|Part 2|Withdrawal by Subject|5|||
17030688|NCT00788957|38175110|FG003|Part 2|Withdrawal by Subject|3|||
17030689|NCT00788957|38175111|FG004|Part 2|Withdrawal by Subject|0|||
17030690|NCT00788957|38175112|FG005|Part 2|Withdrawal by Subject|0|||
17030691|NCT00788957|38175107|FG000|Part 2|Death|0|||
17030692|NCT00788957|38175108|FG001|Part 2|Death|32|||
17030693|NCT00788957|38175109|FG002|Part 2|Death|35|||
17030694|NCT00788957|38175110|FG003|Part 2|Death|37|||
17030695|NCT00788957|38175111|FG004|Part 2|Death|0|||
17030696|NCT00788957|38175112|FG005|Part 2|Death|0|||
17030697|NCT00788957|38175107|FG000|Part 2|Lost to Follow-up|0|||
17030698|NCT00788957|38175108|FG001|Part 2|Lost to Follow-up|0|||
17030699|NCT00788957|38175109|FG002|Part 2|Lost to Follow-up|3|||
17030700|NCT00788957|38175110|FG003|Part 2|Lost to Follow-up|0|||
17030701|NCT00788957|38175111|FG004|Part 2|Lost to Follow-up|0|||
17030702|NCT00788957|38175112|FG005|Part 2|Lost to Follow-up|0|||
17030703|NCT00788957|38175107|FG000|Part 2|On-study at time of data cut-off|0|||
17030704|NCT00788957|38175108|FG001|Part 2|On-study at time of data cut-off|1|||
17030705|NCT00788957|38175109|FG002|Part 2|On-study at time of data cut-off|1|||
17030706|NCT00788957|38175110|FG003|Part 2|On-study at time of data cut-off|1|||
17030707|NCT00788957|38175111|FG004|Part 2|On-study at time of data cut-off|0|||
17030708|NCT00788957|38175112|FG005|Part 2|On-study at time of data cut-off|0|||
17030709|NCT00788957|38175107|FG000|Part 3|Withdrawal by Subject|0|||
16780382|NCT02178358|37719479|FG001|Overall Study|Lost to Follow-up|0|||
17030710|NCT00788957|38175108|FG001|Part 3|Withdrawal by Subject|0|||
17030711|NCT00788957|38175109|FG002|Part 3|Withdrawal by Subject|0|||
17030712|NCT00788957|38175110|FG003|Part 3|Withdrawal by Subject|0|||
17030713|NCT00788957|38175111|FG004|Part 3|Withdrawal by Subject|0|||
17030714|NCT00788957|38175112|FG005|Part 3|Withdrawal by Subject|2|||
17030715|NCT00788957|38175107|FG000|Part 3|Death|0|||
17030716|NCT00788957|38175108|FG001|Part 3|Death|0|||
17030717|NCT00788957|38175109|FG002|Part 3|Death|0|||
17030718|NCT00788957|38175110|FG003|Part 3|Death|0|||
17030719|NCT00788957|38175111|FG004|Part 3|Death|8|||
17030720|NCT00788957|38175112|FG005|Part 3|Death|9|||
17030721|NCT00788957|38175107|FG000|Part 3|On-study at time of data cut-off|0|||
17030722|NCT00788957|38175108|FG001|Part 3|On-study at time of data cut-off|0|||
17030723|NCT00788957|38175109|FG002|Part 3|On-study at time of data cut-off|0|||
17030724|NCT00788957|38175110|FG003|Part 3|On-study at time of data cut-off|0|||
17030725|NCT00788957|38175111|FG004|Part 3|On-study at time of data cut-off|1|||
17030726|NCT00788957|38175112|FG005|Part 3|On-study at time of data cut-off|0|||
17030727|NCT00740636|38175131|FG000|Overall Study|Adverse Event|0|||
17030728|NCT00740636|38175132|FG001|Overall Study|Adverse Event|2|||
17030729|NCT00740636|38175131|FG000|Overall Study|Patient Ineligible|0|||
17030730|NCT00740636|38175132|FG001|Overall Study|Patient Ineligible|1|||
17030731|NCT00740636|38175131|FG000|Overall Study|Patient Not Treated|0|||
17030732|NCT00740636|38175132|FG001|Overall Study|Patient Not Treated|1|||
17030733|NCT00740636|38175131|FG000|Overall Study|Progressive Disease|1|||
17030734|NCT00740636|38175132|FG001|Overall Study|Progressive Disease|0|||
17030735|NCT00740636|38175131|FG000|Overall Study|Death|1|||
17030736|NCT00740636|38175132|FG001|Overall Study|Death|0|||
17030737|NCT00735254|38175142|FG000|Overall Study|Protocol Violation|1|||
17030738|NCT00735254|38175143|FG001|Overall Study|Protocol Violation|1|||
17030739|NCT00735254|38175144|FG002|Overall Study|Protocol Violation|1|||
17030740|NCT00735254|38175145|FG003|Overall Study|Protocol Violation|0|||
17030741|NCT00795509|38175155|FG000|Overall Study|Protocol Violation|31|||
17030742|NCT00787787|38175159|FG000|Overall Study|Lack of Efficacy|4|||
17030743|NCT00787787|38175159|FG000|Overall Study|Adverse Event|3|||
17030744|NCT00787319|38175163|FG000|Overall Study|Lost to Follow-up|2|||
17030745|NCT00787319|38175163|FG000|Overall Study|Withdrawal by Subject|15|||
17030746|NCT00787319|38175163|FG000|Overall Study|Adverse Event|3|||
17030747|NCT00787319|38175163|FG000|Overall Study|Objective progression or relapse|30|||
17030748|NCT00787319|38175163|FG000|Overall Study|Lack of Efficacy|1|||
17030749|NCT00787319|38175163|FG000|Overall Study|Budget exhausted/exceeded|1|||
17030750|NCT00787319|38175163|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
17030751|NCT00787319|38175163|FG000|Overall Study|No health insurance reimbursement|2|||
17030752|NCT00787319|38175163|FG000|Overall Study|Stabilized disease findings|3|||
17030753|NCT00787319|38175163|FG000|Overall Study|Inactive disease|5|||
17030754|NCT00794963|38175169|FG000|Overall Study|Withdrawal by Subject|1|||
17030755|NCT00794963|38175170|FG001|Overall Study|Withdrawal by Subject|4|||
17030756|NCT00794573|38175178|FG000|Overall Study|Death|3|||
17030757|NCT00794573|38175179|FG001|Overall Study|Death|0|||
17030758|NCT00794573|38175178|FG000|Overall Study|Withdrawal by Subject|9|||
17030759|NCT00794573|38175179|FG001|Overall Study|Withdrawal by Subject|12|||
17030760|NCT00794573|38175178|FG000|Overall Study|Lost to Follow-up|26|||
17030761|NCT00794573|38175179|FG001|Overall Study|Lost to Follow-up|33|||
17030762|NCT00584844|38175185|FG000|Overall Study|Withdrawal by Subject|59|||
17030763|NCT00584844|38175185|FG000|Overall Study|Screen Failure|20|||
17030764|NCT00739934|38175193|FG000|Voriconazole IV|Adverse Event|6|||
17030765|NCT00739934|38175193|FG000|Voriconazole Oral|Other|3|||
17030766|NCT00739310|38175202|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
17030767|NCT00739310|38175202|FG000|Overall Study|Withdrawal by Subject|1|||
17030768|NCT00739310|38175202|FG000|Overall Study|Lost to Follow-up|2|||
17030769|NCT00734630|38175209|FG000|Overall Study|Lack of Efficacy|4|||
17030770|NCT00734630|38175210|FG001|Overall Study|Lack of Efficacy|4|||
17030771|NCT00734630|38175209|FG000|Overall Study|Withdrawal by Subject|7|||
17030772|NCT00734630|38175210|FG001|Overall Study|Withdrawal by Subject|9|||
17030773|NCT00734630|38175209|FG000|Overall Study|Lost to Follow-up|13|||
17030774|NCT00734630|38175210|FG001|Overall Study|Lost to Follow-up|7|||
17030775|NCT00734630|38175209|FG000|Overall Study|Protocol Violation|0|||
17030776|NCT00734630|38175210|FG001|Overall Study|Protocol Violation|3|||
17030777|NCT00734630|38175209|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
17030778|NCT00734630|38175210|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
17030779|NCT00734630|38175209|FG000|Overall Study|Adverse Event|3|||
17030780|NCT00734630|38175210|FG001|Overall Study|Adverse Event|6|||
17030781|NCT00734630|38175209|FG000|Overall Study|Randomized in Error|0|||
17030782|NCT00734630|38175210|FG001|Overall Study|Randomized in Error|1|||
17030783|NCT00734630|38175209|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
17030784|NCT00734630|38175210|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
17030785|NCT00734630|38175209|FG000|Overall Study|Poor Compliance|1|||
17030786|NCT00734630|38175210|FG001|Overall Study|Poor Compliance|1|||
17030787|NCT00584454|38175216|FG000|Overall Study|Adverse Event|1|||
17030788|NCT00584454|38175216|FG000|Overall Study|Relocation|1|||
17030789|NCT00584454|38175216|FG000|Overall Study|Clinical Hold|2|||
17030790|NCT00578175|38175223|FG000|Overall Study|Adverse Event|0|||
17030791|NCT00578175|38175224|FG001|Overall Study|Adverse Event|1|||
17030792|NCT00578175|38175225|FG002|Overall Study|Adverse Event|1|||
17030793|NCT00578175|38175223|FG000|Overall Study|Other reasons|70|||
17030794|NCT00578175|38175224|FG001|Overall Study|Other reasons|42|||
17030795|NCT00578175|38175225|FG002|Overall Study|Other reasons|23|||
17030796|NCT00435409|38175237|FG000|Overall Study|Protocol Violation|1|||
17030797|NCT00435409|38175238|FG001|Overall Study|Protocol Violation|2|||
17030798|NCT00435409|38175239|FG002|Overall Study|Protocol Violation|0|||
17030799|NCT00435409|38175237|FG000|Overall Study|Lost to Follow-up|1|||
17030800|NCT00435409|38175238|FG001|Overall Study|Lost to Follow-up|2|||
17030801|NCT00435409|38175239|FG002|Overall Study|Lost to Follow-up|0|||
17136416|NCT03272347|38277794|FG003|Overall Study|Screen Failure|0|||
17136417|NCT03272347|38277791|FG000|Overall Study|Withdrawal by Subject|5|||
17136418|NCT03272347|38277792|FG001|Overall Study|Withdrawal by Subject|1|||
17136419|NCT03272347|38277793|FG002|Overall Study|Withdrawal by Subject|2|||
17136420|NCT03272347|38277794|FG003|Overall Study|Withdrawal by Subject|1|||
17136421|NCT03259568|38277816|FG000|Overall Study|Participant performance was low|3|||
17136422|NCT03239470|38277826|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
17136423|NCT03239470|38277827|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
17136424|NCT03167723|38277833|FG000|Overall Study|Protocol Violation|4|||
17136425|NCT03167723|38277834|FG001|Overall Study|Protocol Violation|6|||
17136426|NCT03103152|38277846|FG000|Overall Study|Physician Decision|5|||
17136427|NCT03103152|38277847|FG001|Overall Study|Physician Decision|2|||
17136428|NCT03103152|38277848|FG002|Overall Study|Physician Decision|6|||
17136429|NCT03103152|38277849|FG003|Overall Study|Physician Decision|3|||
17136430|NCT03103152|38277850|FG004|Overall Study|Physician Decision|3|||
17136431|NCT03103152|38277851|FG005|Overall Study|Physician Decision|1|||
17136432|NCT03103152|38277846|FG000|Overall Study|Protocol Violation|2|||
17136433|NCT03103152|38277847|FG001|Overall Study|Protocol Violation|2|||
17136434|NCT03103152|38277848|FG002|Overall Study|Protocol Violation|1|||
17136435|NCT03103152|38277849|FG003|Overall Study|Protocol Violation|2|||
17136436|NCT03103152|38277850|FG004|Overall Study|Protocol Violation|1|||
17136437|NCT03103152|38277851|FG005|Overall Study|Protocol Violation|1|||
17136438|NCT03103152|38277846|FG000|Overall Study|Inter-current illness|0|||
17136439|NCT03103152|38277847|FG001|Overall Study|Inter-current illness|0|||
17136440|NCT03103152|38277848|FG002|Overall Study|Inter-current illness|1|||
17136441|NCT03103152|38277849|FG003|Overall Study|Inter-current illness|0|||
17136442|NCT03103152|38277850|FG004|Overall Study|Inter-current illness|0|||
17136443|NCT03103152|38277851|FG005|Overall Study|Inter-current illness|0|||
17136444|NCT03103152|38277846|FG000|Overall Study|Death|0|||
17136445|NCT03103152|38277847|FG001|Overall Study|Death|1|||
16780383|NCT02178358|37719480|FG002|Overall Study|Lost to Follow-up|0|||
17030802|NCT00435409|38175237|FG000|Overall Study|Death|8|||
17030803|NCT00435409|38175238|FG001|Overall Study|Death|6|||
17030804|NCT00435409|38175239|FG002|Overall Study|Death|6|||
17030805|NCT00435409|38175237|FG000|Overall Study|Objective progression or relapse|158|||
17030806|NCT00435409|38175238|FG001|Overall Study|Objective progression or relapse|93|||
17030807|NCT00435409|38175239|FG002|Overall Study|Objective progression or relapse|58|||
17030808|NCT00435409|38175237|FG000|Overall Study|Global deterioration of health status|0|||
17030809|NCT00435409|38175238|FG001|Overall Study|Global deterioration of health status|0|||
17030810|NCT00435409|38175239|FG002|Overall Study|Global deterioration of health status|4|||
17030811|NCT00435409|38175237|FG000|Overall Study|Withdrawal by Subject|8|||
17030812|NCT00435409|38175238|FG001|Overall Study|Withdrawal by Subject|7|||
17030813|NCT00435409|38175239|FG002|Overall Study|Withdrawal by Subject|1|||
17030814|NCT00435409|38175237|FG000|Overall Study|Other|45|||
17030815|NCT00435409|38175238|FG001|Overall Study|Other|30|||
17030816|NCT00435409|38175239|FG002|Overall Study|Other|1|||
17030817|NCT00435409|38175237|FG000|Overall Study|Adverse Event|0|||
17030818|NCT00435409|38175238|FG001|Overall Study|Adverse Event|0|||
17030819|NCT00435409|38175239|FG002|Overall Study|Adverse Event|8|||
17030820|NCT00435409|38175237|FG000|Overall Study|Sponsor decision|0|||
17030821|NCT00435409|38175238|FG001|Overall Study|Sponsor decision|3|||
17030822|NCT00435409|38175239|FG002|Overall Study|Sponsor decision|0|||
17030823|NCT00467857|38175256|FG000|Overall Study|Adverse Event|1|||
17030824|NCT00467857|38175257|FG001|Overall Study|Adverse Event|0|||
17030825|NCT00467857|38175256|FG000|Overall Study|Withdrew consent|2|||
17030826|NCT00467857|38175257|FG001|Overall Study|Withdrew consent|0|||
17030827|NCT00467857|38175256|FG000|Overall Study|Death|0|||
17030828|NCT00467857|38175257|FG001|Overall Study|Death|1|||
17030829|NCT00467857|38175256|FG000|Overall Study|Discharged from court service|0|||
17030830|NCT00467857|38175257|FG001|Overall Study|Discharged from court service|1|||
17030831|NCT00467857|38175256|FG000|Overall Study|Emergency care required|0|||
17030832|NCT00467857|38175257|FG001|Overall Study|Emergency care required|1|||
17136446|NCT03103152|38277848|FG002|Overall Study|Death|0|||
17136447|NCT03103152|38277849|FG003|Overall Study|Death|0|||
17136448|NCT03103152|38277850|FG004|Overall Study|Death|0|||
17136449|NCT03103152|38277851|FG005|Overall Study|Death|0|||
17136450|NCT03103152|38277846|FG000|Overall Study|Adverse Event|0|||
17136451|NCT03103152|38277847|FG001|Overall Study|Adverse Event|0|||
17030833|NCT00467857|38175256|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
17030834|NCT00467857|38175257|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
17030835|NCT00467857|38175256|FG000|Overall Study|Discontinuation reason missing|0|||
17030836|NCT00467857|38175257|FG001|Overall Study|Discontinuation reason missing|3|||
17030837|NCT00435019|38175265|FG000|Overall Study|Adverse Event|1|||
17030838|NCT00435019|38175266|FG001|Overall Study|Adverse Event|0|||
17030839|NCT00435019|38175265|FG000|Overall Study|Lack of Efficacy|1|||
17030840|NCT00435019|38175266|FG001|Overall Study|Lack of Efficacy|2|||
17030841|NCT00435019|38175265|FG000|Overall Study|Protocol Violation|3|||
17030842|NCT00435019|38175266|FG001|Overall Study|Protocol Violation|1|||
17030843|NCT00435019|38175265|FG000|Overall Study|Personal reasons for withdrawal|8|||
17030844|NCT00435019|38175266|FG001|Overall Study|Personal reasons for withdrawal|7|||
17030845|NCT00577863|38175274|FG000|Overall Study|Adverse Event|4|||
17030846|NCT00577863|38175275|FG001|Overall Study|Adverse Event|2|||
17030847|NCT00577863|38175274|FG000|Overall Study|Death|1|||
17030848|NCT00577863|38175275|FG001|Overall Study|Death|0|||
17030849|NCT00577863|38175274|FG000|Overall Study|Lost to Follow-up|2|||
17030850|NCT00577863|38175275|FG001|Overall Study|Lost to Follow-up|2|||
17136452|NCT03103152|38277848|FG002|Overall Study|Adverse Event|1|||
17136453|NCT03103152|38277849|FG003|Overall Study|Adverse Event|0|||
17136454|NCT03103152|38277850|FG004|Overall Study|Adverse Event|0|||
17136455|NCT03103152|38277851|FG005|Overall Study|Adverse Event|1|||
17136456|NCT03103152|38277846|FG000|Overall Study|Withdrawal by Subject|1|||
17136457|NCT03103152|38277847|FG001|Overall Study|Withdrawal by Subject|0|||
17136458|NCT03103152|38277848|FG002|Overall Study|Withdrawal by Subject|1|||
17136459|NCT03103152|38277849|FG003|Overall Study|Withdrawal by Subject|1|||
17030851|NCT00577863|38175274|FG000|Overall Study|Entry Criteria Exclusion|1|||
17030852|NCT00577863|38175275|FG001|Overall Study|Entry Criteria Exclusion|0|||
17030853|NCT00577863|38175274|FG000|Overall Study|Withdrawal by Subject|0|||
17030854|NCT00577863|38175275|FG001|Overall Study|Withdrawal by Subject|2|||
17030855|NCT00577863|38175274|FG000|Overall Study|Sponsor Decision|2|||
17030856|NCT00577863|38175275|FG001|Overall Study|Sponsor Decision|7|||
17030857|NCT00577863|38175274|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
17030858|NCT00577863|38175275|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
17030859|NCT00794417|38175285|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
17030860|NCT00794417|38175286|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
17030861|NCT00794417|38175287|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
17030862|NCT00794417|38175288|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
17030863|NCT00794417|38175285|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
17030864|NCT00794417|38175286|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
17030865|NCT00794417|38175287|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
17030866|NCT00794417|38175288|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
17030867|NCT00794417|38175285|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
17030868|NCT00794417|38175286|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
17030869|NCT00794417|38175287|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
17030870|NCT00794417|38175288|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
17030871|NCT00794417|38175285|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
17030872|NCT00794417|38175286|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
17030873|NCT00794417|38175287|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
17030874|NCT00794417|38175288|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
17030875|NCT00794417|38175285|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
17030876|NCT00794417|38175286|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
17030877|NCT00794417|38175287|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
17030878|NCT00794417|38175288|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
17030879|NCT00794417|38175285|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
17030880|NCT00794417|38175286|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
17030881|NCT00794417|38175287|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
17030882|NCT00794417|38175288|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
17030883|NCT00794339|38175300|FG000|Overall Study|Withdrawal by Subject|3|||
17030884|NCT00794339|38175300|FG000|Overall Study|Ineligible|4|||
17030885|NCT00794339|38175300|FG000|Overall Study|Tx prior to ATSM|3|||
17030886|NCT00794339|38175300|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
17030887|NCT00794339|38175300|FG000|Overall Study|Tx not per protocol|1|||
17030888|NCT00790907|38175324|FG000|Overall Study|Adverse Event|9|||
17030889|NCT00790907|38175325|FG001|Overall Study|Adverse Event|7|||
17030890|NCT00790907|38175326|FG002|Overall Study|Adverse Event|6|||
17030891|NCT00790907|38175324|FG000|Overall Study|Physician Decision|304|||
17030892|NCT00790907|38175325|FG001|Overall Study|Physician Decision|271|||
17030893|NCT00790907|38175326|FG002|Overall Study|Physician Decision|255|||
17030894|NCT00790907|38175324|FG000|Overall Study|Withdrawal by Subject|1|||
17030895|NCT00790907|38175325|FG001|Overall Study|Withdrawal by Subject|7|||
17136460|NCT03103152|38277850|FG004|Overall Study|Withdrawal by Subject|1|||
17136461|NCT03103152|38277851|FG005|Overall Study|Withdrawal by Subject|1|||
17030896|NCT00790907|38175326|FG002|Overall Study|Withdrawal by Subject|5|||
17030897|NCT00790907|38175324|FG000|Overall Study|Bleeding Event|11|||
17030898|NCT00790907|38175325|FG001|Overall Study|Bleeding Event|16|||
17030899|NCT00790907|38175326|FG002|Overall Study|Bleeding Event|21|||
17030900|NCT00790907|38175324|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
17030901|NCT00790907|38175325|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
17030902|NCT00790907|38175326|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
17030903|NCT00790907|38175324|FG000|Overall Study|Qualifying Condition Not Present|29|||
17030904|NCT00790907|38175325|FG001|Overall Study|Qualifying Condition Not Present|14|||
16991283|NCT00734071|38135354|FG000|Overall Study|Noncompliance|2|||
16991284|NCT00734071|38135355|FG001|Overall Study|Noncompliance|2|||
16991285|NCT00734071|38135354|FG000|Overall Study|Protocol Deviations|3|||
16991286|NCT00734071|38135355|FG001|Overall Study|Protocol Deviations|4|||
16991287|NCT00734071|38135354|FG000|Overall Study|Voluntary Withdrawal|9|||
16991288|NCT00734071|38135355|FG001|Overall Study|Voluntary Withdrawal|7|||
16991289|NCT00734071|38135354|FG000|Overall Study|Lost to Follow-up|16|||
16991290|NCT00734071|38135355|FG001|Overall Study|Lost to Follow-up|8|||
16991291|NCT00734071|38135354|FG000|Overall Study|Other|1|||
16991292|NCT00734071|38135355|FG001|Overall Study|Other|2|||
16991293|NCT00739297|38135361|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
16991294|NCT00739297|38135362|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
17030905|NCT00790907|38175326|FG002|Overall Study|Qualifying Condition Not Present|16|||
17030906|NCT00790907|38175324|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
17030907|NCT00790907|38175325|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
17030908|NCT00790907|38175326|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
17136462|NCT03103152|38277846|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
16991295|NCT00739297|38135363|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
16991296|NCT00739297|38135364|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
16991297|NCT00739297|38135365|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
16991298|NCT00739297|38135366|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
16991299|NCT00739297|38135367|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
16991300|NCT00739297|38135361|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16991301|NCT00739297|38135362|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16991302|NCT00739297|38135363|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16991303|NCT00739297|38135364|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16991304|NCT00739297|38135365|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16991305|NCT00739297|38135366|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
16991306|NCT00739297|38135367|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
16991307|NCT00739063|38135383|FG000|Overall Study|Screen failures|8|||
16991308|NCT01026194|38135389|FG000|Period 1：Double Blind Period|Adverse Event|2|||
16991309|NCT01026194|38135390|FG001|Period 1：Double Blind Period|Adverse Event|1|||
16991310|NCT01026194|38135389|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
16991311|NCT01026194|38135390|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
16991312|NCT01026194|38135389|FG000|Period 1：Double Blind Period|Physician Decision|0|||
16991313|NCT01026194|38135390|FG001|Period 1：Double Blind Period|Physician Decision|4|||
16991314|NCT01026194|38135389|FG000|Period 2：Open-label Period|Adverse Event|4|||
16991315|NCT01026194|38135390|FG001|Period 2：Open-label Period|Adverse Event|5|||
16991316|NCT01026194|38135389|FG000|Period 2：Open-label Period|Physician Decision|3|||
16991317|NCT01026194|38135390|FG001|Period 2：Open-label Period|Physician Decision|1|||
16991318|NCT01026194|38135389|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
16991319|NCT01026194|38135390|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
16991320|NCT01033136|38135400|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
16991321|NCT01033136|38135401|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
16991322|NCT00738673|38135411|FG000|Overall Study|Adverse Event|1|||
16991323|NCT00738673|38135412|FG001|Overall Study|Adverse Event|0|||
16991324|NCT00738673|38135411|FG000|Overall Study|Lack of Efficacy|19|||
16991325|NCT00738673|38135412|FG001|Overall Study|Lack of Efficacy|8|||
16991326|NCT00738673|38135411|FG000|Overall Study|Protocol Violation|1|||
16991327|NCT00738673|38135412|FG001|Overall Study|Protocol Violation|2|||
16991328|NCT00738673|38135411|FG000|Overall Study|Withdrawal by Subject|3|||
16991329|NCT00738673|38135412|FG001|Overall Study|Withdrawal by Subject|1|||
16991330|NCT00811954|38135421|FG000|Overall Study|Death|10|||
16991331|NCT00811954|38135422|FG001|Overall Study|Death|6|||
16991332|NCT00811954|38135423|FG002|Overall Study|Death|13|||
16991333|NCT00811954|38135421|FG000|Overall Study|Lost to Follow-up|29|||
16991334|NCT00811954|38135422|FG001|Overall Study|Lost to Follow-up|23|||
16991335|NCT00811954|38135423|FG002|Overall Study|Lost to Follow-up|34|||
16991336|NCT00811954|38135421|FG000|Overall Study|Not able to get to clinic|28|||
16991337|NCT00811954|38135422|FG001|Overall Study|Not able to get to clinic|35|||
16991338|NCT00811954|38135423|FG002|Overall Study|Not able to get to clinic|30|||
17030909|NCT00790907|38175324|FG000|Overall Study|Did Not Receive Study Drug|10|||
17030910|NCT00790907|38175325|FG001|Overall Study|Did Not Receive Study Drug|0|||
16991339|NCT00811954|38135421|FG000|Overall Study|Not willing to adhere to requirements|12|||
16991340|NCT00811954|38135422|FG001|Overall Study|Not willing to adhere to requirements|2|||
16991341|NCT00811954|38135423|FG002|Overall Study|Not willing to adhere to requirements|16|||
16991342|NCT00811954|38135421|FG000|Overall Study|Withdraw consent prior study completion|4|||
16991343|NCT00811954|38135422|FG001|Overall Study|Withdraw consent prior study completion|6|||
16991344|NCT00811954|38135423|FG002|Overall Study|Withdraw consent prior study completion|5|||
16991345|NCT00811954|38135421|FG000|Overall Study|Site Closure|4|||
16991346|NCT00811954|38135422|FG001|Overall Study|Site Closure|0|||
16991347|NCT00811954|38135423|FG002|Overall Study|Site Closure|1|||
16991348|NCT00811954|38135421|FG000|Overall Study|Severe Debilitation|2|||
16991349|NCT00811954|38135422|FG001|Overall Study|Severe Debilitation|0|||
17030911|NCT00790907|38175326|FG002|Overall Study|Did Not Receive Study Drug|0|||
17030912|NCT00793871|38175333|FG000|Overall Study|Death|50|||
17030913|NCT00793871|38175333|FG000|Overall Study|Lost to Follow-up|3|||
17030914|NCT00793871|38175333|FG000|Overall Study|Study terminated by the Sponsor|7|||
17030915|NCT00577707|38175341|FG000|Overall Study|Withdrawal by Subject|3|||
17030916|NCT00713349|38175345|FG000|Overall Study|Protocol Violation|1|||
17030917|NCT00712959|38175353|FG000|Overall Study|Protocol Violation|3|||
17030918|NCT00712959|38175354|FG001|Overall Study|Protocol Violation|1|||
17030919|NCT00712959|38175353|FG000|Overall Study|Lost to Follow-up|13|||
17030920|NCT00712959|38175354|FG001|Overall Study|Lost to Follow-up|2|||
17030921|NCT00712959|38175353|FG000|Overall Study|Withdrawal by Subject|3|||
17030922|NCT00712959|38175354|FG001|Overall Study|Withdrawal by Subject|0|||
17030923|NCT00712725|38175368|FG000|Overall Study|Adverse Event|1|||
17030924|NCT00712725|38175369|FG001|Overall Study|Adverse Event|0|||
17030925|NCT00712725|38175370|FG002|Overall Study|Adverse Event|0|||
17030926|NCT00712725|38175371|FG003|Overall Study|Adverse Event|1|||
17030927|NCT00712725|38175372|FG004|Overall Study|Adverse Event|0|||
17030928|NCT00712725|38175373|FG005|Overall Study|Adverse Event|0|||
17030929|NCT00712725|38175374|FG006|Overall Study|Adverse Event|0|||
17030930|NCT00712725|38175375|FG007|Overall Study|Adverse Event|0|||
17136463|NCT03103152|38277847|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
17136464|NCT03103152|38277848|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
17136465|NCT03103152|38277849|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
16991350|NCT00811954|38135423|FG002|Overall Study|Severe Debilitation|1|||
16991351|NCT00811954|38135421|FG000|Overall Study|Complete Protocol: No follow-up|0|||
17136466|NCT03103152|38277850|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
17136467|NCT03103152|38277851|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
17136468|NCT03103152|38277846|FG000|Overall Study|Unacceptable side effects|0|||
16991352|NCT00811954|38135422|FG001|Overall Study|Complete Protocol: No follow-up|0|||
16991353|NCT00811954|38135423|FG002|Overall Study|Complete Protocol: No follow-up|1|||
17030931|NCT00712725|38175368|FG000|Overall Study|Lost to Follow-up|3|||
17030932|NCT00712725|38175369|FG001|Overall Study|Lost to Follow-up|2|||
17030933|NCT00712725|38175370|FG002|Overall Study|Lost to Follow-up|1|||
17030934|NCT00712725|38175371|FG003|Overall Study|Lost to Follow-up|1|||
17030935|NCT00712725|38175372|FG004|Overall Study|Lost to Follow-up|2|||
17030936|NCT00712725|38175373|FG005|Overall Study|Lost to Follow-up|2|||
17030937|NCT00712725|38175374|FG006|Overall Study|Lost to Follow-up|3|||
17030938|NCT00712725|38175375|FG007|Overall Study|Lost to Follow-up|1|||
17030939|NCT00712725|38175368|FG000|Overall Study|Physician Decision|2|||
17030940|NCT00712725|38175369|FG001|Overall Study|Physician Decision|0|||
17030941|NCT00712725|38175370|FG002|Overall Study|Physician Decision|0|||
17030942|NCT00712725|38175371|FG003|Overall Study|Physician Decision|0|||
17030943|NCT00712725|38175372|FG004|Overall Study|Physician Decision|1|||
17030944|NCT00712725|38175373|FG005|Overall Study|Physician Decision|0|||
17030945|NCT00712725|38175374|FG006|Overall Study|Physician Decision|2|||
17030946|NCT00712725|38175375|FG007|Overall Study|Physician Decision|0|||
17030947|NCT00712725|38175368|FG000|Overall Study|Pregnancy|0|||
17030948|NCT00712725|38175369|FG001|Overall Study|Pregnancy|1|||
17030949|NCT00712725|38175370|FG002|Overall Study|Pregnancy|0|||
17030950|NCT00712725|38175371|FG003|Overall Study|Pregnancy|0|||
17030951|NCT00712725|38175372|FG004|Overall Study|Pregnancy|1|||
17030952|NCT00712725|38175373|FG005|Overall Study|Pregnancy|0|||
17030953|NCT00712725|38175374|FG006|Overall Study|Pregnancy|2|||
17030954|NCT00712725|38175375|FG007|Overall Study|Pregnancy|0|||
17030955|NCT00712725|38175368|FG000|Overall Study|Protocol Violation|2|||
17030956|NCT00712725|38175369|FG001|Overall Study|Protocol Violation|0|||
17030957|NCT00712725|38175370|FG002|Overall Study|Protocol Violation|1|||
17030958|NCT00712725|38175371|FG003|Overall Study|Protocol Violation|3|||
17030959|NCT00712725|38175372|FG004|Overall Study|Protocol Violation|2|||
16991354|NCT01032200|38135433|FG000|Overall Study|Death|1|||
16991355|NCT01032200|38135434|FG001|Overall Study|Death|1|||
17030960|NCT00712725|38175373|FG005|Overall Study|Protocol Violation|0|||
17030961|NCT00712725|38175374|FG006|Overall Study|Protocol Violation|1|||
17030962|NCT00712725|38175375|FG007|Overall Study|Protocol Violation|1|||
17030963|NCT00712725|38175368|FG000|Overall Study|Withdrawal by Subject|2|||
17136469|NCT03103152|38277847|FG001|Overall Study|Unacceptable side effects|0|||
17136470|NCT03103152|38277848|FG002|Overall Study|Unacceptable side effects|0|||
17136471|NCT03103152|38277849|FG003|Overall Study|Unacceptable side effects|0|||
17136472|NCT03103152|38277850|FG004|Overall Study|Unacceptable side effects|0|||
17136473|NCT03103152|38277851|FG005|Overall Study|Unacceptable side effects|1|||
17136474|NCT03103152|38277846|FG000|Overall Study|Lost to Follow-up|0|||
17136475|NCT03103152|38277847|FG001|Overall Study|Lost to Follow-up|1|||
17136476|NCT03103152|38277848|FG002|Overall Study|Lost to Follow-up|0|||
17136477|NCT03103152|38277849|FG003|Overall Study|Lost to Follow-up|1|||
17136478|NCT03103152|38277850|FG004|Overall Study|Lost to Follow-up|0|||
17136479|NCT03103152|38277851|FG005|Overall Study|Lost to Follow-up|1|||
17136480|NCT03103152|38277846|FG000|Overall Study|Testicular pain|0|||
17136481|NCT03103152|38277847|FG001|Overall Study|Testicular pain|0|||
17136482|NCT03103152|38277848|FG002|Overall Study|Testicular pain|0|||
17136483|NCT03103152|38277849|FG003|Overall Study|Testicular pain|1|||
17136484|NCT03103152|38277850|FG004|Overall Study|Testicular pain|0|||
17136485|NCT03103152|38277851|FG005|Overall Study|Testicular pain|0|||
17136486|NCT03033901|38277865|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
17136487|NCT03033901|38277865|FG000|Overall Study|Refused PSG|23|||
17136488|NCT03033901|38277865|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
17136489|NCT03033901|38277865|FG000|Overall Study|Missing Oximetry Data|3|||
17136490|NCT02867813|38277901|FG000|Overall Study|Withdrawal by Subject|57|||
17136491|NCT02867813|38277902|FG001|Overall Study|Withdrawal by Subject|56|||
17136492|NCT02867813|38277901|FG000|Overall Study|Decision by Sponsor|7|||
17136493|NCT02867813|38277902|FG001|Overall Study|Decision by Sponsor|7|||
17136494|NCT02867813|38277901|FG000|Overall Study|Lost to Follow-up|91|||
17136495|NCT02867813|38277902|FG001|Overall Study|Lost to Follow-up|78|||
17136496|NCT02867813|38277901|FG000|Overall Study|Missing|2|||
17136497|NCT02867813|38277902|FG001|Overall Study|Missing|1|||
17136498|NCT02867813|38277901|FG000|Overall Study|Death|294|||
17136499|NCT02867813|38277902|FG001|Overall Study|Death|268|||
17136500|NCT02652949|38277917|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
17136501|NCT02652949|38277917|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
17136502|NCT02652949|38277917|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
17136503|NCT02652949|38277917|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
17136504|NCT02652949|38277917|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
17136505|NCT02652949|38277917|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
17136506|NCT02652949|38277917|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
16991356|NCT01032200|38135433|FG000|Overall Study|Withdrawal by Subject|1|||
16991357|NCT01032200|38135434|FG001|Overall Study|Withdrawal by Subject|3|||
16991358|NCT01032200|38135433|FG000|Overall Study|Toxicity|0|||
16991359|NCT01032200|38135434|FG001|Overall Study|Toxicity|2|||
16991360|NCT01032200|38135433|FG000|Overall Study|Progression|1|||
16991361|NCT01032200|38135434|FG001|Overall Study|Progression|0|||
17030964|NCT00712725|38175369|FG001|Overall Study|Withdrawal by Subject|1|||
17030965|NCT00712725|38175370|FG002|Overall Study|Withdrawal by Subject|1|||
17030966|NCT00712725|38175371|FG003|Overall Study|Withdrawal by Subject|2|||
17030967|NCT00712725|38175372|FG004|Overall Study|Withdrawal by Subject|1|||
17030968|NCT00712725|38175373|FG005|Overall Study|Withdrawal by Subject|1|||
17030969|NCT00712725|38175374|FG006|Overall Study|Withdrawal by Subject|1|||
17030970|NCT00712725|38175375|FG007|Overall Study|Withdrawal by Subject|2|||
17030971|NCT00712725|38175368|FG000|Overall Study|Lack of Qualifying Event|16|||
16991362|NCT01032200|38135433|FG000|Overall Study|Multiple|1|||
16991363|NCT01032200|38135434|FG001|Overall Study|Multiple|1|||
16991364|NCT00738283|38135440|FG000|Overall Study|Death|1|||
16991365|NCT00738283|38135440|FG000|Overall Study|Transfer to another facility|2|||
16991366|NCT00738283|38135440|FG000|Overall Study|Discharge home prior to end of study|1|||
16991367|NCT00586105|38135453|FG000|Overall Study|Adverse Event|4|||
17030972|NCT00712725|38175369|FG001|Overall Study|Lack of Qualifying Event|2|||
17030973|NCT00712725|38175370|FG002|Overall Study|Lack of Qualifying Event|6|||
17030974|NCT00712725|38175371|FG003|Overall Study|Lack of Qualifying Event|8|||
17030975|NCT00712725|38175372|FG004|Overall Study|Lack of Qualifying Event|11|||
17030976|NCT00712725|38175373|FG005|Overall Study|Lack of Qualifying Event|13|||
17030977|NCT00712725|38175374|FG006|Overall Study|Lack of Qualifying Event|11|||
17030978|NCT00712725|38175375|FG007|Overall Study|Lack of Qualifying Event|6|||
17136507|NCT02652949|38277917|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
16991368|NCT00586105|38135453|FG000|Overall Study|Death|2|||
16991369|NCT00586105|38135453|FG000|Overall Study|Protocol Violation|1|||
16991370|NCT00586105|38135453|FG000|Overall Study|Withdrawal by Subject|3|||
17136508|NCT02652949|38277917|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
17136509|NCT02652949|38277917|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
17136510|NCT02652949|38277917|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
17136511|NCT02652949|38277917|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
17136512|NCT02652949|38277917|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
17136513|NCT02652949|38277917|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
17136514|NCT02652949|38277917|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
17136515|NCT02625324|38277928|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
16991371|NCT00586105|38135453|FG000|Overall Study|Disease progression|19|||
16991372|NCT00586105|38135453|FG000|Overall Study|Switched to commercial drug|9|||
17030979|NCT00712725|38175368|FG000|Overall Study|Protocol Specified Criteria|3|||
17030980|NCT00712725|38175369|FG001|Overall Study|Protocol Specified Criteria|0|||
17030981|NCT00712725|38175370|FG002|Overall Study|Protocol Specified Criteria|1|||
17136516|NCT02625324|38277928|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
17136517|NCT02625324|38277928|FG000|6-Month Follow-up Subject Accountability|Death|5|||
17136518|NCT02625324|38277928|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
17136519|NCT02625324|38277928|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
17136520|NCT02625324|38277928|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
17136521|NCT02625324|38277928|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
17136522|NCT02625324|38277928|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
17136523|NCT02625324|38277928|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
17136524|NCT02625324|38277928|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
17136525|NCT02625324|38277928|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
17030982|NCT00712725|38175371|FG003|Overall Study|Protocol Specified Criteria|2|||
17030983|NCT00712725|38175372|FG004|Overall Study|Protocol Specified Criteria|1|||
17030984|NCT00712725|38175373|FG005|Overall Study|Protocol Specified Criteria|0|||
17030985|NCT00712725|38175374|FG006|Overall Study|Protocol Specified Criteria|2|||
17030986|NCT00712725|38175375|FG007|Overall Study|Protocol Specified Criteria|1|||
17030987|NCT00712335|38175398|FG000|Overall Study|Withdrawal by Subject|0|||
17030988|NCT00712335|38175399|FG001|Overall Study|Withdrawal by Subject|7|||
17030989|NCT00712335|38175400|FG002|Overall Study|Withdrawal by Subject|2|||
17030990|NCT00712335|38175401|FG003|Overall Study|Withdrawal by Subject|3|||
17030991|NCT00712335|38175402|FG004|Overall Study|Withdrawal by Subject|0|||
17030992|NCT00712335|38175398|FG000|Overall Study|Lost to Follow-up|2|||
17030993|NCT00712335|38175399|FG001|Overall Study|Lost to Follow-up|5|||
17030994|NCT00712335|38175400|FG002|Overall Study|Lost to Follow-up|0|||
17030995|NCT00712335|38175401|FG003|Overall Study|Lost to Follow-up|1|||
17030996|NCT00712335|38175402|FG004|Overall Study|Lost to Follow-up|0|||
17030997|NCT00712335|38175398|FG000|Overall Study|Protocol Violation|1|||
17030998|NCT00712335|38175399|FG001|Overall Study|Protocol Violation|2|||
17136526|NCT02625324|38277928|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
17136527|NCT02625324|38277928|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
17136528|NCT02625324|38277928|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
17136529|NCT02625324|38277928|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
17136530|NCT02603887|38277940|FG000|Stage 1|Adverse Event|4|||
17136531|NCT02603887|38277940|FG000|Stage 1|Disease progression|1|||
17136532|NCT02603887|38277940|FG000|Stage 2|FDA guidance|1|||
17136533|NCT02475681|38277956|FG000|Overall Study|Death|16|||
17136534|NCT02475681|38277957|FG001|Overall Study|Death|6|||
17136535|NCT02475681|38277958|FG002|Overall Study|Death|9|||
17136536|NCT02475681|38277956|FG000|Overall Study|Physician Decision|0|||
17136537|NCT02475681|38277957|FG001|Overall Study|Physician Decision|3|||
17136538|NCT02475681|38277958|FG002|Overall Study|Physician Decision|1|||
17136539|NCT02475681|38277956|FG000|Overall Study|Withdrawal by Subject|12|||
17136540|NCT02475681|38277957|FG001|Overall Study|Withdrawal by Subject|6|||
17136541|NCT02475681|38277958|FG002|Overall Study|Withdrawal by Subject|9|||
17136542|NCT02475681|38277956|FG000|Overall Study|Lost to Follow-up|2|||
17136543|NCT02475681|38277957|FG001|Overall Study|Lost to Follow-up|1|||
17136544|NCT02475681|38277958|FG002|Overall Study|Lost to Follow-up|3|||
17136545|NCT02475681|38277956|FG000|Overall Study|Ongoing in Study|0|||
17136546|NCT02475681|38277957|FG001|Overall Study|Ongoing in Study|163|||
17136547|NCT02475681|38277958|FG002|Overall Study|Ongoing in Study|157|||
17136548|NCT02475681|38277956|FG000|Overall Study|Reasons other than above listed|2|||
16991373|NCT00586105|38135453|FG000|Overall Study|Reason not reported|1|||
16991374|NCT00743119|38135457|FG000|Overall Study|unreliable|3|||
16991375|NCT00743119|38135457|FG000|Overall Study|Withdrawal by Subject|1|||
16991376|NCT00733369|38135471|FG000|Overall Study|Lost to Follow-up|2|||
16991377|NCT00733369|38135472|FG001|Overall Study|Lost to Follow-up|1|||
16991378|NCT00733369|38135471|FG000|Overall Study|Adverse Event|4|||
16991379|NCT00733369|38135472|FG001|Overall Study|Adverse Event|4|||
16991380|NCT00733369|38135471|FG000|Overall Study|Protocol Violation|4|||
16991381|NCT00733369|38135472|FG001|Overall Study|Protocol Violation|4|||
16991382|NCT00813124|38135478|FG000|Overall Study|Death|2|||
16991383|NCT00813124|38135478|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
16991384|NCT00813124|38135478|FG000|Overall Study|Withdrawal by Subject|1|||
16991385|NCT00733291|38135484|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
16991386|NCT00733291|38135485|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
16991387|NCT00733291|38135486|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
16997765|NCT00962390|38141774|FG003|Overall Study|Withdrawal by Subject|0|||
17136549|NCT02475681|38277957|FG001|Overall Study|Reasons other than above listed|0|||
17136550|NCT02475681|38277958|FG002|Overall Study|Reasons other than above listed|0|||
17136551|NCT02315196|38277968|FG000|Overall Study|Withdrew consent|9|||
17030999|NCT00712335|38175400|FG002|Overall Study|Protocol Violation|1|||
17031000|NCT00712335|38175401|FG003|Overall Study|Protocol Violation|0|||
17031001|NCT00712335|38175402|FG004|Overall Study|Protocol Violation|0|||
17031002|NCT00712335|38175398|FG000|Overall Study|Lack of Efficacy|0|||
17031003|NCT00712335|38175399|FG001|Overall Study|Lack of Efficacy|0|||
17031004|NCT00712335|38175400|FG002|Overall Study|Lack of Efficacy|1|||
17031005|NCT00712335|38175401|FG003|Overall Study|Lack of Efficacy|1|||
17031006|NCT00712335|38175402|FG004|Overall Study|Lack of Efficacy|0|||
17031007|NCT00712335|38175398|FG000|Overall Study|Other Reason|0|||
17031008|NCT00712335|38175399|FG001|Overall Study|Other Reason|3|||
17031009|NCT00712335|38175400|FG002|Overall Study|Other Reason|1|||
17031010|NCT00712335|38175401|FG003|Overall Study|Other Reason|0|||
17031011|NCT00712335|38175402|FG004|Overall Study|Other Reason|0|||
17031012|NCT00577629|38175414|FG000|Treatment Period|Death|1|||
17136552|NCT02133573|38277974|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
17136553|NCT02133573|38277975|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
17136554|NCT02133573|38277974|FG000|Overall Study|Child Deaths|3|||
17136555|NCT02133573|38277975|FG001|Overall Study|Child Deaths|5|||
17136556|NCT02133573|38277974|FG000|Overall Study|Child Declined Follow Ups|2|||
17136557|NCT02133573|38277975|FG001|Overall Study|Child Declined Follow Ups|1|||
17136558|NCT02133573|38277974|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
17136559|NCT02133573|38277975|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
17136560|NCT02059005|38277987|FG000|Overall Study|Death|1|||
17136561|NCT02059005|38277988|FG001|Overall Study|Death|3|||
17136562|NCT02059005|38277987|FG000|Overall Study|Lost to Follow-up|19|||
17136563|NCT02059005|38277988|FG001|Overall Study|Lost to Follow-up|19|||
17136564|NCT02059005|38277987|FG000|Overall Study|Incarceration|0|||
17136565|NCT02059005|38277988|FG001|Overall Study|Incarceration|1|||
17136566|NCT02059005|38277987|FG000|Overall Study|Inpatient|0|||
17136567|NCT02059005|38277988|FG001|Overall Study|Inpatient|1|||
17136568|NCT01393821|38277998|FG000|Overall Study|Cancel|1|||
17136569|NCT01393821|38277999|FG001|Overall Study|Cancel|1|||
17136570|NCT01393821|38277998|FG000|Overall Study|not evaluable for primary endpoint|4|||
17136571|NCT01393821|38277999|FG001|Overall Study|not evaluable for primary endpoint|2|||
17136572|NCT01199575|38278005|FG000|Overall Study|Withdrawal by Subject|5|||
17136573|NCT00496873|38278016|FG000|Overall Study|Ineligible|2|||
17136574|NCT00496873|38278016|FG000|Overall Study|Death|2|||
17136575|NCT00496873|38278016|FG000|Overall Study|Withdrawal by Subject|3|||
17136576|NCT00492778|38278022|FG000|Overall Study|Ineligible by Pathology Review|8|||
17136577|NCT00492778|38278023|FG001|Overall Study|Ineligible by Pathology Review|1|||
17188997|NCT02505334|38341959|FG001|Main Treatment Period|Lack of Efficacy|17|||
17188998|NCT02505334|38341958|FG000|Main Treatment Period|Protocol Violation|0|||
17188999|NCT02505334|38341959|FG001|Main Treatment Period|Protocol Violation|1|||
17189000|NCT02505334|38341958|FG000|Main Treatment Period|Withdrawal by Subject|1|||
17189001|NCT02505334|38341959|FG001|Main Treatment Period|Withdrawal by Subject|8|||
17189002|NCT02505334|38341958|FG000|Main Treatment Period|Unclassified|4|||
17189003|NCT02505334|38341959|FG001|Main Treatment Period|Unclassified|10|||
17189004|NCT02505334|38341958|FG000|Extension Treatment Period|Adverse Event|5|||
17031013|NCT00577629|38175414|FG000|Long Term Follow-Up|Death|15|||
17031014|NCT00577629|38175414|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
17031015|NCT00577629|38175414|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
17031016|NCT00577629|38175414|FG000|Long Term Follow-Up|Physician Decision|1|||
17031017|NCT00710385|38175420|FG000|Overall Study|Did not qualify|1|||
17031018|NCT00710385|38175420|FG000|Overall Study|Withdrawal by Subject|1|||
17031019|NCT00710385|38175420|FG000|Overall Study|Undisclosed back pain|1|||
17031020|NCT00710385|38175420|FG000|Overall Study|Physician Decision|1|||
17031021|NCT00710385|38175420|FG000|Overall Study|Undisclosed excessive methadone use|1|||
17031022|NCT00701415|38175432|FG000|Overall Study|Adverse Event|0|||
17031023|NCT00701415|38175433|FG001|Overall Study|Adverse Event|1|||
17031024|NCT00701415|38175432|FG000|Overall Study|Social/family issues and needle phobia|1|||
17031025|NCT00701415|38175433|FG001|Overall Study|Social/family issues and needle phobia|0|||
17031026|NCT00700011|38175441|FG000|Overall Study|Death|0|||
17031027|NCT00700011|38175442|FG001|Overall Study|Death|1|||
17031028|NCT00707031|38175450|FG000|Overall Study|Adverse Event|45|||
17031029|NCT00707031|38175451|FG001|Overall Study|Adverse Event|45|||
17031030|NCT00707031|38175450|FG000|Overall Study|Lack of Efficacy|19|||
17031031|NCT00707031|38175451|FG001|Overall Study|Lack of Efficacy|6|||
17031032|NCT00707031|38175450|FG000|Overall Study|Lost to Follow-up|2|||
17031033|NCT00707031|38175451|FG001|Overall Study|Lost to Follow-up|1|||
17189005|NCT02505334|38341959|FG001|Extension Treatment Period|Adverse Event|0|||
17189006|NCT02505334|38341958|FG000|Extension Treatment Period|Lack of Efficacy|4|||
17189007|NCT02505334|38341959|FG001|Extension Treatment Period|Lack of Efficacy|0|||
17189008|NCT02505334|38341958|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
17189009|NCT02505334|38341959|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
17189010|NCT02505334|38341958|FG000|Extension Treatment Period|Unclassified|3|||
17189011|NCT02505334|38341959|FG001|Extension Treatment Period|Unclassified|0|||
17031034|NCT00707031|38175450|FG000|Overall Study|Protocol Violation|1|||
17031035|NCT00707031|38175451|FG001|Overall Study|Protocol Violation|0|||
17031036|NCT00707031|38175450|FG000|Overall Study|Withdrawal by Subject|7|||
17031037|NCT00707031|38175451|FG001|Overall Study|Withdrawal by Subject|8|||
17031038|NCT00707031|38175450|FG000|Overall Study|Poor Compliance to Protocol|7|||
17031039|NCT00707031|38175451|FG001|Overall Study|Poor Compliance to Protocol|13|||
17031040|NCT00707031|38175450|FG000|Overall Study|Familial or Personal Reasons|12|||
17031041|NCT00707031|38175451|FG001|Overall Study|Familial or Personal Reasons|15|||
17031042|NCT00707031|38175450|FG000|Overall Study|Serious Noncompliance|2|||
17031043|NCT00707031|38175451|FG001|Overall Study|Serious Noncompliance|3|||
17031044|NCT00707031|38175450|FG000|Overall Study|Sponsor Decision|9|||
17031045|NCT00707031|38175451|FG001|Overall Study|Sponsor Decision|8|||
17031046|NCT00711477|38175460|FG000|Overall Study|Adverse Event|3|||
17031047|NCT00711477|38175461|FG001|Overall Study|Adverse Event|1|||
17031048|NCT00711477|38175460|FG000|Overall Study|Lost to Follow-up|0|||
17031049|NCT00711477|38175461|FG001|Overall Study|Lost to Follow-up|1|||
17031050|NCT00711477|38175460|FG000|Overall Study|Noncompliance|0|||
17031051|NCT00711477|38175461|FG001|Overall Study|Noncompliance|1|||
17031052|NCT00699699|38175469|FG000|Overall Study|Adverse Event|36|||
17031053|NCT00699699|38175469|FG000|Overall Study|Individual different reasons|21|||
17031054|NCT00734474|38175482|FG000|Overall Study|Entry Criteria Not Met|0|||
17031055|NCT00734474|38175483|FG001|Overall Study|Entry Criteria Not Met|0|||
17031056|NCT00734474|38175484|FG002|Overall Study|Entry Criteria Not Met|5|||
17031057|NCT00734474|38175485|FG003|Overall Study|Entry Criteria Not Met|0|||
17031058|NCT00734474|38175486|FG004|Overall Study|Entry Criteria Not Met|3|||
17031059|NCT00734474|38175487|FG005|Overall Study|Entry Criteria Not Met|1|||
17031060|NCT00734474|38175488|FG006|Overall Study|Entry Criteria Not Met|0|||
17031061|NCT00734474|38175489|FG007|Overall Study|Entry Criteria Not Met|1|||
17031062|NCT00734474|38175490|FG008|Overall Study|Entry Criteria Not Met|1|||
17031063|NCT00734474|38175482|FG000|Overall Study|Lost to Follow-up|1|||
17031064|NCT00734474|38175483|FG001|Overall Study|Lost to Follow-up|0|||
17031065|NCT00734474|38175484|FG002|Overall Study|Lost to Follow-up|13|||
17031066|NCT00734474|38175485|FG003|Overall Study|Lost to Follow-up|0|||
17031067|NCT00734474|38175486|FG004|Overall Study|Lost to Follow-up|11|||
17031068|NCT00734474|38175487|FG005|Overall Study|Lost to Follow-up|1|||
17031069|NCT00734474|38175488|FG006|Overall Study|Lost to Follow-up|0|||
17031070|NCT00734474|38175489|FG007|Overall Study|Lost to Follow-up|9|||
17031071|NCT00734474|38175490|FG008|Overall Study|Lost to Follow-up|4|||
17031072|NCT00734474|38175482|FG000|Overall Study|Withdrawal by Subject|2|||
17031073|NCT00734474|38175483|FG001|Overall Study|Withdrawal by Subject|1|||
17031074|NCT00734474|38175484|FG002|Overall Study|Withdrawal by Subject|18|||
17031075|NCT00734474|38175485|FG003|Overall Study|Withdrawal by Subject|0|||
17031076|NCT00734474|38175486|FG004|Overall Study|Withdrawal by Subject|24|||
17031077|NCT00734474|38175487|FG005|Overall Study|Withdrawal by Subject|2|||
17031078|NCT00734474|38175488|FG006|Overall Study|Withdrawal by Subject|0|||
17031079|NCT00734474|38175489|FG007|Overall Study|Withdrawal by Subject|36|||
17031080|NCT00734474|38175490|FG008|Overall Study|Withdrawal by Subject|21|||
17031081|NCT00734474|38175482|FG000|Overall Study|Physician Decision|0|||
17031082|NCT00734474|38175483|FG001|Overall Study|Physician Decision|0|||
17031083|NCT00734474|38175484|FG002|Overall Study|Physician Decision|4|||
17031084|NCT00734474|38175485|FG003|Overall Study|Physician Decision|1|||
17031085|NCT00734474|38175486|FG004|Overall Study|Physician Decision|11|||
17031086|NCT00734474|38175487|FG005|Overall Study|Physician Decision|0|||
17031087|NCT00734474|38175488|FG006|Overall Study|Physician Decision|0|||
17031088|NCT00734474|38175489|FG007|Overall Study|Physician Decision|9|||
17031089|NCT00734474|38175490|FG008|Overall Study|Physician Decision|9|||
17031090|NCT00734474|38175482|FG000|Overall Study|Adverse Event|4|||
17031091|NCT00734474|38175483|FG001|Overall Study|Adverse Event|4|||
17031092|NCT00734474|38175484|FG002|Overall Study|Adverse Event|63|||
17031093|NCT00734474|38175485|FG003|Overall Study|Adverse Event|1|||
17031094|NCT00734474|38175486|FG004|Overall Study|Adverse Event|64|||
17031095|NCT00734474|38175487|FG005|Overall Study|Adverse Event|0|||
17031096|NCT00734474|38175488|FG006|Overall Study|Adverse Event|1|||
17031097|NCT00734474|38175489|FG007|Overall Study|Adverse Event|65|||
17031098|NCT00734474|38175490|FG008|Overall Study|Adverse Event|39|||
17031099|NCT00734474|38175482|FG000|Overall Study|Protocol Violation|0|||
17031100|NCT00734474|38175483|FG001|Overall Study|Protocol Violation|0|||
17031101|NCT00734474|38175484|FG002|Overall Study|Protocol Violation|4|||
17031102|NCT00734474|38175485|FG003|Overall Study|Protocol Violation|0|||
17031103|NCT00734474|38175486|FG004|Overall Study|Protocol Violation|3|||
17031104|NCT00734474|38175487|FG005|Overall Study|Protocol Violation|0|||
17031105|NCT00734474|38175488|FG006|Overall Study|Protocol Violation|0|||
17031106|NCT00734474|38175489|FG007|Overall Study|Protocol Violation|3|||
17031107|NCT00734474|38175490|FG008|Overall Study|Protocol Violation|1|||
17031108|NCT00734474|38175482|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
17031109|NCT00734474|38175483|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
17031110|NCT00734474|38175484|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
17031111|NCT00734474|38175485|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
17031112|NCT00734474|38175486|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
17031113|NCT00734474|38175487|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
17031114|NCT00734474|38175488|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
17031115|NCT00734474|38175489|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
17031116|NCT00734474|38175490|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
17031117|NCT00734474|38175482|FG000|Overall Study|Sponsor Decision|0|||
17031118|NCT00734474|38175483|FG001|Overall Study|Sponsor Decision|0|||
17136578|NCT03775681|38278057|FG000|Overall Study|Physician Decision|3|||
17136579|NCT03774823|38278063|FG000|Overall Study|Withdrawal by Subject|1|||
17136580|NCT03774823|38278064|FG001|Overall Study|Withdrawal by Subject|1|||
17136581|NCT03149042|38278070|FG000|Overall Study|Invasive FFR not performed|21|||
17136582|NCT03149042|38278070|FG000|Overall Study|Poor CT Image Quality|1|||
17136583|NCT03149042|38278070|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
17136584|NCT03774433|38278075|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
17136585|NCT02785952|38278081|FG000|Overall Study|Adverse Event|31|||
16991388|NCT00733291|38135487|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
16991389|NCT00732199|38135500|FG000|Overall Study|Withdrawal by Subject|25|||
16991390|NCT00732199|38135501|FG001|Overall Study|Withdrawal by Subject|18|||
16991391|NCT00732199|38135500|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
16991392|NCT00732199|38135501|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
16991393|NCT00807040|38135512|FG000|Overall Study|Death|24|||
16991394|NCT00807040|38135513|FG001|Overall Study|Death|29|||
16991395|NCT00807040|38135512|FG000|Overall Study|Withdrawal by Subject|8|||
17031119|NCT00734474|38175484|FG002|Overall Study|Sponsor Decision|0|||
17031120|NCT00734474|38175485|FG003|Overall Study|Sponsor Decision|0|||
17031121|NCT00734474|38175486|FG004|Overall Study|Sponsor Decision|2|||
17031122|NCT00734474|38175487|FG005|Overall Study|Sponsor Decision|0|||
17031123|NCT00734474|38175488|FG006|Overall Study|Sponsor Decision|0|||
17031124|NCT00734474|38175489|FG007|Overall Study|Sponsor Decision|0|||
17031125|NCT00734474|38175490|FG008|Overall Study|Sponsor Decision|0|||
17031126|NCT00734474|38175482|FG000|Overall Study|Death|0|||
17031127|NCT00734474|38175483|FG001|Overall Study|Death|0|||
17031128|NCT00734474|38175484|FG002|Overall Study|Death|1|||
17031129|NCT00734474|38175485|FG003|Overall Study|Death|0|||
17031130|NCT00734474|38175486|FG004|Overall Study|Death|0|||
17031131|NCT00734474|38175487|FG005|Overall Study|Death|0|||
17031132|NCT00734474|38175488|FG006|Overall Study|Death|0|||
17031133|NCT00734474|38175489|FG007|Overall Study|Death|2|||
17031134|NCT00734474|38175490|FG008|Overall Study|Death|1|||
17031135|NCT00734474|38175482|FG000|Overall Study|Lack of Efficacy|0|||
17031136|NCT00734474|38175483|FG001|Overall Study|Lack of Efficacy|0|||
17031137|NCT00734474|38175484|FG002|Overall Study|Lack of Efficacy|4|||
16991396|NCT00807040|38135513|FG001|Overall Study|Withdrawal by Subject|6|||
16991397|NCT00807040|38135512|FG000|Overall Study|Lost to Follow-up|4|||
16991398|NCT00807040|38135513|FG001|Overall Study|Lost to Follow-up|6|||
16991399|NCT00811720|38135521|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
16991400|NCT00811720|38135522|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
16991401|NCT00811720|38135521|FG000|All Treated Patients|Adverse Event|20|||
16991402|NCT00811720|38135522|FG001|All Treated Patients|Adverse Event|62|||
16991403|NCT00811720|38135521|FG000|All Treated Patients|Lack of Efficacy|22|||
16991404|NCT00811720|38135522|FG001|All Treated Patients|Lack of Efficacy|18|||
16991405|NCT00811720|38135521|FG000|All Treated Patients|Non-compliance|0|||
16991406|NCT00811720|38135522|FG001|All Treated Patients|Non-compliance|14|||
16991407|NCT00811720|38135521|FG000|All Treated Patients|Protocol Violation|9|||
16991408|NCT00811720|38135522|FG001|All Treated Patients|Protocol Violation|16|||
16991409|NCT00811720|38135521|FG000|All Treated Patients|Withdrawal by Subject|28|||
16991410|NCT00811720|38135522|FG001|All Treated Patients|Withdrawal by Subject|34|||
16991411|NCT00811720|38135521|FG000|All Treated Patients|Lost to Follow-up|10|||
16991412|NCT00811720|38135522|FG001|All Treated Patients|Lost to Follow-up|16|||
17031138|NCT00734474|38175485|FG003|Overall Study|Lack of Efficacy|0|||
17031139|NCT00734474|38175486|FG004|Overall Study|Lack of Efficacy|0|||
17031140|NCT00734474|38175487|FG005|Overall Study|Lack of Efficacy|0|||
17136586|NCT02785952|38278082|FG001|Overall Study|Adverse Event|19|||
16991413|NCT00811720|38135521|FG000|All Treated Patients|Other Reason|7|||
17031141|NCT00734474|38175488|FG006|Overall Study|Lack of Efficacy|0|||
17031142|NCT00734474|38175489|FG007|Overall Study|Lack of Efficacy|4|||
17031143|NCT00734474|38175490|FG008|Overall Study|Lack of Efficacy|6|||
17031144|NCT00583362|38175516|FG000|Overall Study|Adverse Event|44|||
17031145|NCT00583362|38175516|FG000|Overall Study|Lack of Efficacy|22|||
17031146|NCT00583362|38175516|FG000|Overall Study|Lost to Follow-up|4|||
17031147|NCT00583362|38175516|FG000|Overall Study|Non-compliance with study drug|28|||
17031148|NCT00583362|38175516|FG000|Overall Study|Pregnancy|7|||
17136587|NCT02785952|38278081|FG000|Overall Study|Refusal unrelated to adverse events|10|||
17031149|NCT00583362|38175516|FG000|Overall Study|Miscommunication of visit window|5|||
17031150|NCT00583362|38175516|FG000|Overall Study|Current site closed|7|||
17031151|NCT00583362|38175516|FG000|Overall Study|Subject not dosed in LBSL99|1|||
17031152|NCT00583362|38175516|FG000|Overall Study|Subject moved out of the country/state|2|||
17031153|NCT00583362|38175516|FG000|Overall Study|Missed visits due to staff changes|1|||
17031154|NCT00583362|38175516|FG000|Overall Study|Misunderstanding of protocol|1|||
17031155|NCT00583362|38175516|FG000|Overall Study|Behavioral problems and non-compliance|1|||
17031156|NCT00583362|38175516|FG000|Overall Study|Sponsor request due to missed doses|1|||
17031157|NCT00583362|38175516|FG000|Overall Study|Physician Decision|19|||
17031158|NCT00583362|38175516|FG000|Overall Study|Protocol Violation|2|||
17031159|NCT00583362|38175516|FG000|Overall Study|Withdrawal by Subject|57|||
17031160|NCT00577473|38175522|FG000|Overall Study|Protocol Violation|1|||
17031161|NCT00577473|38175523|FG001|Overall Study|Protocol Violation|4|||
17031162|NCT00577473|38175522|FG000|Overall Study|Adverse Event|8|||
17031163|NCT00577473|38175523|FG001|Overall Study|Adverse Event|5|||
16991414|NCT00811720|38135522|FG001|All Treated Patients|Other Reason|4|||
16991415|NCT04202679|38135530|FG000|Overall Study|Adverse Event|2|||
16991416|NCT04202679|38135531|FG001|Overall Study|Adverse Event|0|||
16991417|NCT04202679|38135530|FG000|Overall Study|Poor compliance to protocol|1|||
16991418|NCT04202679|38135531|FG001|Overall Study|Poor compliance to protocol|0|||
16991419|NCT04202679|38135530|FG000|Overall Study|Withdrawal by Subject|23|||
17031164|NCT00577473|38175522|FG000|Overall Study|Withdrawal by Subject|2|||
17031165|NCT00577473|38175523|FG001|Overall Study|Withdrawal by Subject|6|||
17031166|NCT00577473|38175522|FG000|Overall Study|Physician Decision|2|||
17031167|NCT00577473|38175523|FG001|Overall Study|Physician Decision|2|||
16991420|NCT04202679|38135531|FG001|Overall Study|Withdrawal by Subject|6|||
16991421|NCT00811642|38135538|FG000|Overall Study|Adverse Event|3|||
16991422|NCT00811642|38135538|FG000|Overall Study|Protocol Violation|1|||
16991423|NCT00811642|38135538|FG000|Overall Study|Death|2|||
16991424|NCT00811642|38135538|FG000|Overall Study|Withdrawal by Subject|7|||
16991425|NCT00811642|38135538|FG000|Overall Study|Cumulative use of antifungal agent|2|||
17031168|NCT00577473|38175522|FG000|Overall Study|Lack of Efficacy|8|||
17031169|NCT00577473|38175523|FG001|Overall Study|Lack of Efficacy|7|||
17031170|NCT00785291|38175532|FG000|Overall Study|Never began treatment|8|||
17031171|NCT00785291|38175533|FG001|Overall Study|Never began treatment|4|||
17031172|NCT00785291|38175534|FG002|Overall Study|Never began treatment|4|||
17031173|NCT00785291|38175532|FG000|Overall Study|Adverse Event|39|||
17031174|NCT00785291|38175533|FG001|Overall Study|Adverse Event|70|||
17031175|NCT00785291|38175534|FG002|Overall Study|Adverse Event|56|||
17031176|NCT00785291|38175532|FG000|Overall Study|Death|7|||
17031177|NCT00785291|38175533|FG001|Overall Study|Death|4|||
17031178|NCT00785291|38175534|FG002|Overall Study|Death|3|||
17136588|NCT02785952|38278082|FG001|Overall Study|Refusal unrelated to adverse events|5|||
17136589|NCT02785952|38278081|FG000|Overall Study|Disease progression/relapse|61|||
17136590|NCT02785952|38278082|FG001|Overall Study|Disease progression/relapse|89|||
17136591|NCT02785952|38278081|FG000|Overall Study|Death|11|||
17136592|NCT02785952|38278082|FG001|Overall Study|Death|7|||
17136593|NCT02785952|38278081|FG000|Overall Study|Other- not protocol specified|6|||
17136594|NCT02785952|38278082|FG001|Overall Study|Other- not protocol specified|4|||
17136595|NCT02785952|38278081|FG000|Overall Study|On protocol treatment|6|||
17136596|NCT02785952|38278082|FG001|Overall Study|On protocol treatment|3|||
17136597|NCT03136484|38278092|FG000|Overall Study|Withdrawal by Subject|19|||
17136598|NCT03136484|38278093|FG001|Overall Study|Withdrawal by Subject|14|||
17136599|NCT03136484|38278092|FG000|Overall Study|Lost to Follow-up|7|||
17136600|NCT03136484|38278093|FG001|Overall Study|Lost to Follow-up|8|||
17136601|NCT03136484|38278092|FG000|Overall Study|Death|1|||
17136602|NCT03136484|38278093|FG001|Overall Study|Death|0|||
17136603|NCT03922711|38278102|FG000|Overall Study|Adverse Event|3|||
17136604|NCT03922711|38278103|FG001|Overall Study|Adverse Event|2|||
17136605|NCT03922711|38278104|FG002|Overall Study|Adverse Event|2|||
17136606|NCT03922711|38278102|FG000|Overall Study|Protocol Violation|1|||
17136607|NCT03922711|38278103|FG001|Overall Study|Protocol Violation|0|||
17136608|NCT03922711|38278104|FG002|Overall Study|Protocol Violation|0|||
17136609|NCT03922711|38278102|FG000|Overall Study|Withdrawal by Subject|0|||
17136610|NCT03922711|38278103|FG001|Overall Study|Withdrawal by Subject|3|||
17136611|NCT03922711|38278104|FG002|Overall Study|Withdrawal by Subject|1|||
17136612|NCT03922711|38278102|FG000|Overall Study|Not further specified|0|||
17136613|NCT03922711|38278103|FG001|Overall Study|Not further specified|0|||
17136614|NCT03922711|38278104|FG002|Overall Study|Not further specified|1|||
17136615|NCT02877680|38278113|FG000|Overall Study|Lost to Follow-up|1|||
17136616|NCT02877680|38278114|FG001|Overall Study|Lost to Follow-up|1|||
17136617|NCT03141086|38278126|FG000|Overall Study|Study Terminated By Sponsor|1|||
17136618|NCT03141086|38278127|FG001|Overall Study|Study Terminated By Sponsor|1|||
16991426|NCT00809926|38135544|FG000|Overall Study|Adverse Event|18|||
17031179|NCT00785291|38175532|FG000|Overall Study|Withdrawal by Subject|35|||
17031180|NCT00785291|38175533|FG001|Overall Study|Withdrawal by Subject|36|||
17031181|NCT00785291|38175534|FG002|Overall Study|Withdrawal by Subject|17|||
17031182|NCT00785291|38175532|FG000|Overall Study|Alternative Therapy|12|||
17136619|NCT03141086|38278126|FG000|Overall Study|Withdrawal by Subject|0|||
17136620|NCT03141086|38278127|FG001|Overall Study|Withdrawal by Subject|1|||
17136621|NCT03141086|38278126|FG000|Overall Study|Protocol Violation|0|||
17136622|NCT03141086|38278127|FG001|Overall Study|Protocol Violation|1|||
17136623|NCT03141086|38278126|FG000|Overall Study|Adverse Event|0|||
17136624|NCT03141086|38278127|FG001|Overall Study|Adverse Event|2|||
17136625|NCT03135548|38278136|FG000|Overall Study|Lost to Follow-up|3|||
17136626|NCT03135548|38278137|FG001|Overall Study|Lost to Follow-up|0|||
17136627|NCT03135548|38278138|FG002|Overall Study|Lost to Follow-up|0|||
17136628|NCT03135548|38278136|FG000|Overall Study|Withdrawal by Subject|2|||
17136629|NCT03135548|38278137|FG001|Overall Study|Withdrawal by Subject|2|||
17136630|NCT03135548|38278138|FG002|Overall Study|Withdrawal by Subject|1|||
17136631|NCT03135548|38278136|FG000|Overall Study|Other than listed|0|||
17136632|NCT03135548|38278137|FG001|Overall Study|Other than listed|2|||
17136633|NCT03135548|38278138|FG002|Overall Study|Other than listed|2|||
17136634|NCT03134222|38278149|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
17136635|NCT03134222|38278150|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
17136636|NCT03134222|38278151|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
17136637|NCT03134222|38278152|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
17136638|NCT03134222|38278153|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
17136639|NCT03134222|38278149|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
17136640|NCT03134222|38278150|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
17136641|NCT03134222|38278151|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
17136642|NCT03134222|38278152|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
17136643|NCT03134222|38278153|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
17136644|NCT03134222|38278149|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
17136645|NCT03134222|38278150|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
17136646|NCT03134222|38278151|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
17136647|NCT03134222|38278152|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
17136648|NCT03134222|38278153|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
17136649|NCT03134222|38278149|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
17136650|NCT03134222|38278150|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
17136651|NCT03134222|38278151|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
17136652|NCT03134222|38278152|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
17136653|NCT03134222|38278153|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
17136654|NCT03134222|38278149|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
17136655|NCT03134222|38278150|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
17136656|NCT03134222|38278151|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
17136657|NCT03134222|38278152|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
17136658|NCT03134222|38278153|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
17136659|NCT03134222|38278149|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
17136660|NCT03134222|38278150|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
17136661|NCT03134222|38278151|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
17136662|NCT03134222|38278152|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
17136663|NCT03134222|38278153|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
17136664|NCT03134222|38278149|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
17136665|NCT03134222|38278150|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
17136666|NCT03134222|38278151|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
17136667|NCT03134222|38278152|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
17136668|NCT03134222|38278153|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
17136669|NCT03134222|38278149|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
16780384|NCT01598896|37719491|FG000|Overall Study|Withdrawal by Subject|0|||
16780385|NCT01598896|37719492|FG001|Overall Study|Withdrawal by Subject|1|||
16780386|NCT01598896|37719491|FG000|Overall Study|Lack of Efficacy|0|||
16780387|NCT01598896|37719492|FG001|Overall Study|Lack of Efficacy|1|||
16780388|NCT01598662|37719500|FG000|Overall Study|Lost to Follow-up|10|||
16780389|NCT01598662|37719501|FG001|Overall Study|Lost to Follow-up|17|||
16780390|NCT01598662|37719500|FG000|Overall Study|Physician Decision|1|||
16780391|NCT01598662|37719501|FG001|Overall Study|Physician Decision|2|||
16780392|NCT01598662|37719500|FG000|Overall Study|IUD expelled before month 6|0|||
16780393|NCT01598662|37719501|FG001|Overall Study|IUD expelled before month 6|2|||
16780394|NCT01629706|37719507|FG000|Phase 1 PureVision|Screen Failure|4|||
16780395|NCT01629706|37719507|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
16780396|NCT01629706|37719507|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
16991427|NCT00809926|38135545|FG001|Overall Study|Adverse Event|10|||
16780397|NCT01629706|37719507|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
16780398|NCT01629706|37719507|FG000|Phase 2 Habitual|Screen Failure|6|||
16780399|NCT01629706|37719507|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
16780400|NCT01629706|37719507|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
16780401|NCT01629706|37719507|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
16780402|NCT01629706|37719507|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
16780403|NCT02153086|37719515|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
17136670|NCT03134222|38278150|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
17136671|NCT03134222|38278151|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
17136672|NCT03134222|38278152|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
17136673|NCT03134222|38278153|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
17136674|NCT03769753|38278163|FG000|Overall Study|Not Treated|6|||
17136675|NCT03769753|38278163|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
17136676|NCT03263923|38278169|FG000|Overall Study|Withdrawal by Subject|10|||
17136677|NCT03263923|38278170|FG001|Overall Study|Withdrawal by Subject|8|||
17136678|NCT03263923|38278169|FG000|Overall Study|Lost to Follow-up|15|||
17136679|NCT03263923|38278170|FG001|Overall Study|Lost to Follow-up|13|||
17136680|NCT03139604|38278180|FG000|Overall Study|Other|7|||
17136681|NCT03139604|38278181|FG001|Overall Study|Other|3|||
17136682|NCT03139604|38278180|FG000|Overall Study|Withdrawal by Subject|16|||
17136683|NCT03139604|38278181|FG001|Overall Study|Withdrawal by Subject|17|||
17136684|NCT03139604|38278180|FG000|Overall Study|Physician Decision|1|||
17136685|NCT03139604|38278181|FG001|Overall Study|Physician Decision|2|||
17136686|NCT03139604|38278180|FG000|Overall Study|Lost to Follow-up|3|||
17136687|NCT03139604|38278181|FG001|Overall Study|Lost to Follow-up|1|||
17136688|NCT03139604|38278180|FG000|Overall Study|Death|65|||
17136689|NCT03139604|38278181|FG001|Overall Study|Death|67|||
17136690|NCT03139604|38278180|FG000|Overall Study|Study Terminated by Sponsor|122|||
17136691|NCT03139604|38278181|FG001|Overall Study|Study Terminated by Sponsor|127|||
17136692|NCT03139604|38278180|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
17136693|NCT03139604|38278181|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
17136694|NCT03139448|38278190|FG000|Overall Study|Lack of Efficacy|6|||
17136695|NCT03139448|38278191|FG001|Overall Study|Lack of Efficacy|7|||
17136696|NCT03139448|38278190|FG000|Overall Study|Location of procedure changed|2|||
17136697|NCT03139448|38278191|FG001|Overall Study|Location of procedure changed|8|||
17136698|NCT03139448|38278190|FG000|Overall Study|Withdrawal by Subject|3|||
17136699|NCT03139448|38278191|FG001|Overall Study|Withdrawal by Subject|6|||
17136700|NCT03139448|38278190|FG000|Overall Study|Screen fail|1|||
17136701|NCT03139448|38278191|FG001|Overall Study|Screen fail|3|||
17136702|NCT03139448|38278190|FG000|Overall Study|Physician Decision|0|||
17136703|NCT03139448|38278191|FG001|Overall Study|Physician Decision|2|||
17136704|NCT02875340|38278197|FG000|Overall Study|Death|2|||
17136705|NCT02875340|38278197|FG000|Overall Study|Withdrawal by Subject|2|||
17136706|NCT02875340|38278197|FG000|Overall Study|Physician Decision|3|||
17136707|NCT02875340|38278197|FG000|Overall Study|Adverse Event|1|||
17136708|NCT03237325|38278209|FG000|Overall Study|Lost to Follow-up|3|||
17136709|NCT03237325|38278210|FG001|Overall Study|Lost to Follow-up|5|||
17136710|NCT03237325|38278209|FG000|Overall Study|Physician Decision|2|||
17136711|NCT03237325|38278210|FG001|Overall Study|Physician Decision|4|||
17136712|NCT03237325|38278209|FG000|Overall Study|Withdrawal by Subject|9|||
17136713|NCT03237325|38278210|FG001|Overall Study|Withdrawal by Subject|12|||
17136714|NCT03237325|38278209|FG000|Overall Study|Noncompliance with Study Procedures|1|||
17136715|NCT03237325|38278210|FG001|Overall Study|Noncompliance with Study Procedures|1|||
17136716|NCT03237325|38278209|FG000|Overall Study|Termination by Sponsor|0|||
17136717|NCT03237325|38278210|FG001|Overall Study|Termination by Sponsor|1|||
17136718|NCT03237325|38278209|FG000|Overall Study|Reason other than described|0|||
17136719|NCT03237325|38278210|FG001|Overall Study|Reason other than described|2|||
17136720|NCT03113383|38278216|FG000|Overall Study|Death|4|||
17136721|NCT03113383|38278217|FG001|Overall Study|Death|0|||
17136722|NCT03762265|38278238|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
17136723|NCT03762265|38278239|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
17136724|NCT03762265|38278238|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
17136725|NCT03762265|38278239|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
17136726|NCT03762265|38278238|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
17136727|NCT03762265|38278239|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
17136728|NCT03762265|38278238|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
17136729|NCT03762265|38278239|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
17136730|NCT03762265|38278238|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
16780404|NCT02153086|37719515|FG000|Overall Study|Other|2|||
16991428|NCT00809926|38135544|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
17136731|NCT03762265|38278239|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
17136732|NCT03762265|38278238|FG000|BT Period: Weeks 1 to 37|Other|0|||
17136733|NCT03762265|38278239|FG001|BT Period: Weeks 1 to 37|Other|1|||
17136734|NCT03762265|38278238|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
17136735|NCT03762265|38278239|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
17136736|NCT03762265|38278238|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
17136737|NCT03762265|38278239|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
17136738|NCT03762265|38278238|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
17136739|NCT03762265|38278239|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
17136740|NCT03762265|38278238|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
17136741|NCT03762265|38278239|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
17136742|NCT03762265|38278238|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
17136743|NCT03762265|38278239|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
17136744|NCT03762265|38278238|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
17136745|NCT03762265|38278239|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
17136746|NCT03762265|38278238|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
17136747|NCT03762265|38278239|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
17136748|NCT03762265|38278238|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
17136749|NCT03762265|38278239|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
17136750|NCT03762265|38278238|FG000|LTE Period: Weeks 61 to 109|Other|1|||
17136751|NCT03762265|38278239|FG001|LTE Period: Weeks 61 to 109|Other|0|||
17136752|NCT03131960|38278263|FG000|Overall Study|Adverse Event|0|||
17136753|NCT03131960|38278264|FG001|Overall Study|Adverse Event|1|||
17136754|NCT03225170|38278273|FG000|Overall Study|Lost to Follow-up|4|||
17136755|NCT03225170|38278274|FG001|Overall Study|Lost to Follow-up|4|||
17136756|NCT03225170|38278275|FG002|Overall Study|Lost to Follow-up|0|||
17136757|NCT03225170|38278273|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
17136758|NCT03225170|38278274|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
17136759|NCT03225170|38278275|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
17136760|NCT02115139|38278281|FG000|Overall Study|Protocol Violation|1|||
17136761|NCT02115139|38278281|FG000|Overall Study|treatment discontinuation|6|||
17136762|NCT01763827|38278329|FG000|Overall Study|Withdrawal by Subject|1|||
17136763|NCT01763827|38278330|FG001|Overall Study|Withdrawal by Subject|0|||
17136764|NCT01763827|38278331|FG002|Overall Study|Withdrawal by Subject|0|||
17136765|NCT01763827|38278332|FG003|Overall Study|Withdrawal by Subject|0|||
17136766|NCT01763827|38278333|FG004|Overall Study|Withdrawal by Subject|2|||
17136767|NCT01763827|38278334|FG005|Overall Study|Withdrawal by Subject|0|||
17136768|NCT01763827|38278329|FG000|Overall Study|Decision by sponsor|2|||
17136769|NCT01763827|38278330|FG001|Overall Study|Decision by sponsor|0|||
17136770|NCT01763827|38278331|FG002|Overall Study|Decision by sponsor|3|||
17136771|NCT01763827|38278332|FG003|Overall Study|Decision by sponsor|0|||
17136772|NCT01763827|38278333|FG004|Overall Study|Decision by sponsor|2|||
17136773|NCT01763827|38278334|FG005|Overall Study|Decision by sponsor|1|||
17136774|NCT01763827|38278329|FG000|Overall Study|Lost to Follow-up|0|||
17136775|NCT01763827|38278330|FG001|Overall Study|Lost to Follow-up|1|||
17136776|NCT01763827|38278331|FG002|Overall Study|Lost to Follow-up|1|||
17136777|NCT01763827|38278332|FG003|Overall Study|Lost to Follow-up|1|||
17136778|NCT01763827|38278333|FG004|Overall Study|Lost to Follow-up|2|||
17136779|NCT01763827|38278334|FG005|Overall Study|Lost to Follow-up|1|||
17136780|NCT01732783|38278387|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
17136781|NCT01732783|38278388|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
17136782|NCT01732783|38278389|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
17136783|NCT01732783|38278387|FG000|Overall Study|Death|13|||
17136784|NCT01732783|38278388|FG001|Overall Study|Death|4|||
17136785|NCT01732783|38278389|FG002|Overall Study|Death|1|||
17136786|NCT01732783|38278387|FG000|Overall Study|Lost to Follow-up|7|||
17136787|NCT01732783|38278388|FG001|Overall Study|Lost to Follow-up|1|||
17136788|NCT01732783|38278389|FG002|Overall Study|Lost to Follow-up|1|||
17136789|NCT01732783|38278387|FG000|Overall Study|Administrative Decision|8|||
17136790|NCT01732783|38278388|FG001|Overall Study|Administrative Decision|2|||
17136791|NCT01732783|38278389|FG002|Overall Study|Administrative Decision|1|||
17136792|NCT01732783|38278387|FG000|Overall Study|Withdrawal by Subject|1|||
17136793|NCT01732783|38278388|FG001|Overall Study|Withdrawal by Subject|0|||
17136794|NCT01732783|38278389|FG002|Overall Study|Withdrawal by Subject|0|||
17136795|NCT02787850|38278416|FG000|Overall Study|Withdrawal by Subject|0|||
17136796|NCT02787850|38278417|FG001|Overall Study|Withdrawal by Subject|1|||
17136797|NCT01375777|38278441|FG000|Overall Study|Withdrawal by Subject|0|||
17136798|NCT01375777|38278442|FG001|Overall Study|Withdrawal by Subject|2|||
17136799|NCT01375777|38278443|FG002|Overall Study|Withdrawal by Subject|1|||
17136800|NCT01375777|38278444|FG003|Overall Study|Withdrawal by Subject|0|||
17136801|NCT01375777|38278445|FG004|Overall Study|Withdrawal by Subject|1|||
17136802|NCT01375777|38278446|FG005|Overall Study|Withdrawal by Subject|1|||
17136803|NCT01375777|38278447|FG006|Overall Study|Withdrawal by Subject|1|||
17136804|NCT01375777|38278448|FG007|Overall Study|Withdrawal by Subject|2|||
17136805|NCT01375777|38278449|FG008|Overall Study|Withdrawal by Subject|1|||
17136806|NCT01375777|38278441|FG000|Overall Study|Lost to Follow-up|1|||
17136807|NCT01375777|38278442|FG001|Overall Study|Lost to Follow-up|0|||
17136808|NCT01375777|38278443|FG002|Overall Study|Lost to Follow-up|0|||
17136809|NCT01375777|38278444|FG003|Overall Study|Lost to Follow-up|0|||
17136810|NCT01375777|38278445|FG004|Overall Study|Lost to Follow-up|0|||
17136811|NCT01375777|38278446|FG005|Overall Study|Lost to Follow-up|0|||
17136812|NCT01375777|38278447|FG006|Overall Study|Lost to Follow-up|1|||
17136813|NCT01375777|38278448|FG007|Overall Study|Lost to Follow-up|0|||
17136814|NCT01375777|38278449|FG008|Overall Study|Lost to Follow-up|0|||
17136815|NCT01375777|38278441|FG000|Overall Study|Other|1|||
16991429|NCT00809926|38135545|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16991430|NCT00809926|38135544|FG000|Overall Study|Patient withdrew consent|8|||
16991431|NCT00809926|38135545|FG001|Overall Study|Patient withdrew consent|6|||
17031183|NCT00785291|38175533|FG001|Overall Study|Alternative Therapy|6|||
17031184|NCT00785291|38175534|FG002|Overall Study|Alternative Therapy|7|||
17031185|NCT00785291|38175532|FG000|Overall Study|Complicating illness|6|||
17031186|NCT00785291|38175533|FG001|Overall Study|Complicating illness|4|||
17031187|NCT00785291|38175534|FG002|Overall Study|Complicating illness|4|||
17031188|NCT00785291|38175532|FG000|Overall Study|Other Medical Reasons|29|||
17031189|NCT00785291|38175533|FG001|Overall Study|Other Medical Reasons|25|||
17031190|NCT00785291|38175534|FG002|Overall Study|Other Medical Reasons|15|||
17031191|NCT00705939|38175545|FG000|Overall Study|Protocol Violation|0|||
17031192|NCT00705939|38175546|FG001|Overall Study|Protocol Violation|0|||
17031193|NCT00705939|38175547|FG002|Overall Study|Protocol Violation|1|||
16991432|NCT00809926|38135544|FG000|Overall Study|Lost to Follow-up|2|||
16991433|NCT00809926|38135545|FG001|Overall Study|Lost to Follow-up|1|||
16991434|NCT00809926|38135544|FG000|Overall Study|Administrative Problems|0|||
16991435|NCT00809926|38135545|FG001|Overall Study|Administrative Problems|1|||
16991436|NCT00809926|38135544|FG000|Overall Study|Protocol deviation|0|||
16991437|NCT00809926|38135545|FG001|Overall Study|Protocol deviation|2|||
17136816|NCT01375777|38278442|FG001|Overall Study|Other|1|||
17031194|NCT00705939|38175545|FG000|Overall Study|Withdrawal by Subject|0|||
17031195|NCT00705939|38175546|FG001|Overall Study|Withdrawal by Subject|1|||
17031196|NCT00705939|38175547|FG002|Overall Study|Withdrawal by Subject|3|||
17031197|NCT00705939|38175545|FG000|Overall Study|Physician Decision|0|||
17031198|NCT00705939|38175546|FG001|Overall Study|Physician Decision|1|||
17031199|NCT00705939|38175547|FG002|Overall Study|Physician Decision|0|||
17031200|NCT00583596|38175556|FG000|Overall Study|Lost to Follow-up|110|||
17031201|NCT00583596|38175556|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
17031202|NCT00583596|38175556|FG000|Overall Study|Death|2|||
17031203|NCT00583596|38175556|FG000|Overall Study|Withdrawal by Subject|6|||
17031204|NCT00583596|38175556|FG000|Overall Study|Lost to Follow-up|94|||
17031205|NCT00583596|38175556|FG000|Overall Study|Data not complete|1|||
17031206|NCT00583596|38175556|FG000|Overall Study|Not consented|15|||
17031207|NCT00583596|38175556|FG000|Overall Study|Outside f-up window|26|||
17031208|NCT00785213|38175561|FG000|Quinine Sulfate Alone|Adverse Event|4|||
17031209|NCT00785213|38175561|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
17031210|NCT00577317|38175570|FG000|Overall Study|Study Terminated|0|||
17031211|NCT00577317|38175571|FG001|Overall Study|Study Terminated|2|||
17031212|NCT00734162|38175581|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
17031213|NCT00734162|38175582|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
17031214|NCT00734162|38175583|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
17031215|NCT00734162|38175584|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
17031216|NCT00734162|38175581|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
17031217|NCT00734162|38175582|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
17031218|NCT00734162|38175583|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
17031219|NCT00734162|38175584|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
17031220|NCT00734162|38175581|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
17031221|NCT00734162|38175582|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
17031222|NCT00734162|38175583|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
17031223|NCT00734162|38175584|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
17031224|NCT00734162|38175581|FG000|Open-Label Phase|Withdrew Consent|1|||
17031225|NCT00734162|38175582|FG001|Open-Label Phase|Withdrew Consent|0|||
17031226|NCT00734162|38175583|FG002|Open-Label Phase|Withdrew Consent|1|||
17031227|NCT00734162|38175584|FG003|Open-Label Phase|Withdrew Consent|1|||
17031228|NCT00734162|38175581|FG000|Open-Label Phase|Lost to Follow-up|1|||
17031229|NCT00734162|38175582|FG001|Open-Label Phase|Lost to Follow-up|2|||
17031230|NCT00734162|38175583|FG002|Open-Label Phase|Lost to Follow-up|0|||
17136817|NCT01375777|38278443|FG002|Overall Study|Other|0|||
17136818|NCT01375777|38278444|FG003|Overall Study|Other|0|||
17136819|NCT01375777|38278445|FG004|Overall Study|Other|0|||
17136820|NCT01375777|38278446|FG005|Overall Study|Other|0|||
17136821|NCT01375777|38278447|FG006|Overall Study|Other|0|||
17136822|NCT01375777|38278448|FG007|Overall Study|Other|0|||
16991438|NCT00590980|38135551|FG000|Overall Study|Did not meet all inclusion criteria|10|||
17031231|NCT00734162|38175584|FG003|Open-Label Phase|Lost to Follow-up|1|||
17031232|NCT00734162|38175581|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
17031233|NCT00734162|38175582|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
17031234|NCT00734162|38175583|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
17136823|NCT01375777|38278449|FG008|Overall Study|Other|1|||
17136824|NCT02431702|38278469|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
17136825|NCT02431702|38278470|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
17136826|NCT02431702|38278471|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
17136827|NCT02431702|38278472|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
17136828|NCT02431702|38278473|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
17136829|NCT02431702|38278474|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
17136830|NCT02431702|38278475|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
17136831|NCT02431702|38278469|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
17136832|NCT02431702|38278470|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
17136833|NCT02431702|38278471|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
17136834|NCT02431702|38278472|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
17136835|NCT02431702|38278473|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
17136836|NCT02431702|38278474|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
17136837|NCT02431702|38278475|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
17136838|NCT02431702|38278469|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
17136839|NCT02431702|38278470|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
17136840|NCT02431702|38278471|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
17136841|NCT02431702|38278472|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
17136842|NCT02431702|38278473|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
17136843|NCT02431702|38278474|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
17136844|NCT02431702|38278475|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
17136845|NCT02431702|38278469|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
17136846|NCT02431702|38278470|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
17136847|NCT02431702|38278471|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
17136848|NCT02431702|38278472|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
17136849|NCT02431702|38278473|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
17136850|NCT02431702|38278474|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
17136851|NCT02431702|38278475|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
17136852|NCT02431702|38278469|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
17136853|NCT02431702|38278470|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
17136854|NCT02431702|38278471|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
17136855|NCT02431702|38278472|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
17136856|NCT02431702|38278473|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
17136857|NCT02431702|38278474|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
17136858|NCT02431702|38278475|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
17136859|NCT02431702|38278469|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
17136860|NCT02431702|38278470|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
17136861|NCT02431702|38278471|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
17136862|NCT02431702|38278472|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
17136863|NCT02431702|38278473|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
17136864|NCT02431702|38278474|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
17136865|NCT02431702|38278475|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
17136866|NCT02431702|38278469|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
17136867|NCT02431702|38278470|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
17136868|NCT02431702|38278471|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
17136869|NCT02431702|38278472|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
17136870|NCT02431702|38278473|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
17136871|NCT02431702|38278474|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
17136872|NCT02431702|38278475|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
17136873|NCT02431702|38278469|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
17136874|NCT02431702|38278470|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
17136875|NCT02431702|38278471|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
17136876|NCT02431702|38278472|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
17136877|NCT02431702|38278473|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
17136878|NCT02431702|38278474|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
17136879|NCT02431702|38278475|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
17136880|NCT02431702|38278469|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
17136881|NCT02431702|38278470|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
17136882|NCT02431702|38278471|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
17136883|NCT02431702|38278472|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
17136884|NCT02431702|38278473|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
17136885|NCT02431702|38278474|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
17136886|NCT02431702|38278475|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
17136887|NCT02431702|38278469|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
16991439|NCT00590902|38135555|FG000|Overall Study|Death|1|||
17136888|NCT02431702|38278470|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
17136889|NCT02431702|38278471|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
17136890|NCT02431702|38278472|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
17136891|NCT02431702|38278473|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
17136892|NCT02431702|38278474|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
17136893|NCT02431702|38278475|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
17136894|NCT02431702|38278469|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
17136895|NCT02431702|38278470|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
16991440|NCT00590824|38135563|FG000|Overall Study|Disease could not be resected|0|||
16991441|NCT00590824|38135564|FG001|Overall Study|Disease could not be resected|2|||
16991442|NCT00590824|38135565|FG002|Overall Study|Disease could not be resected|1|||
16991443|NCT00590824|38135566|FG003|Overall Study|Disease could not be resected|0|||
16991444|NCT00590824|38135563|FG000|Overall Study|Adverse Event|0|||
16991445|NCT00590824|38135564|FG001|Overall Study|Adverse Event|0|||
16991446|NCT00590824|38135565|FG002|Overall Study|Adverse Event|0|||
17136896|NCT02431702|38278471|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
17136897|NCT02431702|38278472|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
17136898|NCT02431702|38278473|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
16991447|NCT00590824|38135566|FG003|Overall Study|Adverse Event|1|||
16991448|NCT00590590|38135579|FG000|Overall Study|Lack of Efficacy|1|||
16991449|NCT00590590|38135580|FG001|Overall Study|Lack of Efficacy|2|||
16991450|NCT00590590|38135581|FG002|Overall Study|Lack of Efficacy|0|||
16991451|NCT00590590|38135579|FG000|Overall Study|Adverse Event|1|||
16991452|NCT00590590|38135580|FG001|Overall Study|Adverse Event|0|||
16991453|NCT00590590|38135581|FG002|Overall Study|Adverse Event|0|||
16991454|NCT00590590|38135579|FG000|Overall Study|Protocol Violation|0|||
16991455|NCT00590590|38135580|FG001|Overall Study|Protocol Violation|0|||
16991456|NCT00590590|38135581|FG002|Overall Study|Protocol Violation|2|||
16991457|NCT00590590|38135579|FG000|Overall Study|Lost to Follow-up|4|||
16991458|NCT00590590|38135580|FG001|Overall Study|Lost to Follow-up|1|||
16991459|NCT00590590|38135581|FG002|Overall Study|Lost to Follow-up|2|||
16991460|NCT00590590|38135579|FG000|Overall Study|Withdrawal by Subject|0|||
16991461|NCT00590590|38135580|FG001|Overall Study|Withdrawal by Subject|1|||
16991462|NCT00590590|38135581|FG002|Overall Study|Withdrawal by Subject|1|||
16991463|NCT00590590|38135579|FG000|Overall Study|Did not complete due to study closure|1|||
16991464|NCT00590590|38135580|FG001|Overall Study|Did not complete due to study closure|1|||
16991465|NCT00590590|38135581|FG002|Overall Study|Did not complete due to study closure|1|||
16991466|NCT00590590|38135579|FG000|Overall Study|Did not complete study|0|||
16991467|NCT00590590|38135580|FG001|Overall Study|Did not complete study|1|||
16991468|NCT00590590|38135581|FG002|Overall Study|Did not complete study|0|||
16991469|NCT00809614|38135591|FG000|Overall Study|Lack of Efficacy|2|||
16991470|NCT00809614|38135592|FG001|Overall Study|Lack of Efficacy|3|||
16991471|NCT00809614|38135591|FG000|Overall Study|Withdrawal by Subject|1|||
16991472|NCT00809614|38135592|FG001|Overall Study|Withdrawal by Subject|1|||
16991473|NCT00731731|38135601|FG000|Overall Study|Protocol Violation|0|||
16991474|NCT00731731|38135602|FG001|Overall Study|Protocol Violation|0|||
16991475|NCT00731731|38135603|FG002|Overall Study|Protocol Violation|1|||
16991476|NCT00731731|38135601|FG000|Overall Study|Cancel prior to treatment|0|||
16991477|NCT00731731|38135602|FG001|Overall Study|Cancel prior to treatment|0|||
16991478|NCT00731731|38135603|FG002|Overall Study|Cancel prior to treatment|2|||
16991479|NCT00806494|38135616|FG000|Overall Study|Adverse Event|29|||
16991480|NCT00806494|38135616|FG000|Overall Study|Lack of Efficacy|6|||
16991481|NCT00806494|38135616|FG000|Overall Study|Lost to Follow-up|10|||
16991482|NCT00806494|38135616|FG000|Overall Study|Other|30|||
16991483|NCT00806494|38135616|FG000|Overall Study|Withdrawal by Subject|5|||
16991484|NCT00806416|38135623|FG000|Period 1 - Part I|Adverse Event|0|||
16991485|NCT00806416|38135624|FG001|Period 1 - Part I|Adverse Event|1|||
16991486|NCT00806416|38135625|FG002|Period 1 - Part I|Adverse Event|0|||
16991487|NCT00806416|38135626|FG003|Period 1 - Part I|Adverse Event|0|||
16991488|NCT00806416|38135623|FG000|Period 1 - Part I|Lost to Follow-up|0|||
16991489|NCT00806416|38135624|FG001|Period 1 - Part I|Lost to Follow-up|2|||
16991490|NCT00806416|38135625|FG002|Period 1 - Part I|Lost to Follow-up|0|||
16991491|NCT00806416|38135626|FG003|Period 1 - Part I|Lost to Follow-up|0|||
16991492|NCT00806416|38135623|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
16991493|NCT00806416|38135624|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
16991494|NCT00806416|38135625|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
16991495|NCT00806416|38135626|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
16991496|NCT00806416|38135623|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
16991497|NCT00806416|38135624|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
16991498|NCT00806416|38135625|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
16991499|NCT00806416|38135626|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
16991500|NCT02724969|38135636|FG000|Overall Study|Lost to Follow-up|12|||
16991501|NCT02724969|38135637|FG001|Overall Study|Lost to Follow-up|6|||
16991502|NCT02724969|38135636|FG000|Overall Study|Withdrawal by Subject|3|||
16991503|NCT02724969|38135637|FG001|Overall Study|Withdrawal by Subject|3|||
17031235|NCT00734162|38175584|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
17031236|NCT00790751|38175602|FG000|Overall Study|Protocol non-compliance|16|||
17031237|NCT00790751|38175603|FG001|Overall Study|Protocol non-compliance|16|||
17031238|NCT00790751|38175604|FG002|Overall Study|Protocol non-compliance|10|||
17031239|NCT00790751|38175605|FG003|Overall Study|Protocol non-compliance|11|||
17031240|NCT00790751|38175602|FG000|Overall Study|Lost to Follow-up|4|||
17031241|NCT00790751|38175603|FG001|Overall Study|Lost to Follow-up|9|||
17031242|NCT00790751|38175604|FG002|Overall Study|Lost to Follow-up|4|||
17031243|NCT00790751|38175605|FG003|Overall Study|Lost to Follow-up|5|||
17031244|NCT00790751|38175602|FG000|Overall Study|Adverse Event|5|||
17031245|NCT00790751|38175603|FG001|Overall Study|Adverse Event|3|||
17031246|NCT00790751|38175604|FG002|Overall Study|Adverse Event|5|||
17031247|NCT00790751|38175605|FG003|Overall Study|Adverse Event|4|||
17031248|NCT00790751|38175602|FG000|Overall Study|Requirement for restricted medication|0|||
17031249|NCT00790751|38175603|FG001|Overall Study|Requirement for restricted medication|2|||
17031250|NCT00790751|38175604|FG002|Overall Study|Requirement for restricted medication|0|||
17031251|NCT00790751|38175605|FG003|Overall Study|Requirement for restricted medication|0|||
17031252|NCT00790751|38175602|FG000|Overall Study|Death|0|||
17031253|NCT00790751|38175603|FG001|Overall Study|Death|0|||
17031254|NCT00790751|38175604|FG002|Overall Study|Death|1|||
17031255|NCT00790751|38175605|FG003|Overall Study|Death|0|||
17031256|NCT00790751|38175602|FG000|Overall Study|Physician Decision|0|||
17031257|NCT00790751|38175603|FG001|Overall Study|Physician Decision|0|||
17031258|NCT00790751|38175604|FG002|Overall Study|Physician Decision|0|||
17031259|NCT00790751|38175605|FG003|Overall Study|Physician Decision|1|||
17031260|NCT00784979|38175615|FG000|Overall Study|incomplete data|6|||
17031261|NCT00738920|38175622|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
17031262|NCT00738920|38175623|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
17031263|NCT00738920|38175624|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
17031264|NCT00738920|38175622|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
17031265|NCT00738920|38175623|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
17031266|NCT00738920|38175624|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
17031267|NCT00738920|38175622|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
17031268|NCT00738920|38175623|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
17031269|NCT00738920|38175624|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
17031270|NCT00738920|38175622|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
17031271|NCT00738920|38175623|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
17031272|NCT00738920|38175624|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
17031273|NCT00738920|38175622|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
17031274|NCT00738920|38175623|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
17031275|NCT00738920|38175624|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
17031276|NCT00738920|38175622|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
17031277|NCT00738920|38175623|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
17031278|NCT00738920|38175624|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
17031279|NCT00738920|38175622|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
17031280|NCT00738920|38175623|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
17031281|NCT00738920|38175624|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
17031282|NCT00738920|38175622|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
17031283|NCT00738920|38175623|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
17031284|NCT00738920|38175624|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
17031285|NCT00738920|38175622|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
17031286|NCT00738920|38175623|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
17031287|NCT00738920|38175624|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
17031288|NCT00738920|38175622|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
17031289|NCT00738920|38175623|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
17031290|NCT00738920|38175624|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
17031291|NCT00582972|38175632|FG000|Overall Study|Protocol Violation|2|||
17031292|NCT04319718|38175639|FG000|Overall Study|Adverse Event|0|||
17031293|NCT04319718|38175640|FG001|Overall Study|Adverse Event|2|||
17031294|NCT04319718|38175639|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
17031295|NCT04319718|38175640|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
17031296|NCT04372602|38175648|FG000|Overall Study|Withdrawal by Subject|1|||
17031297|NCT04372602|38175649|FG001|Overall Study|Withdrawal by Subject|1|||
17031298|NCT04372602|38175648|FG000|Overall Study|Adverse Event|0|||
17031299|NCT04372602|38175649|FG001|Overall Study|Adverse Event|1|||
17031300|NCT04372602|38175648|FG000|Overall Study|Transitioned to comfort care|0|||
17031301|NCT04372602|38175649|FG001|Overall Study|Transitioned to comfort care|1|||
17031302|NCT00733304|38175658|FG000|Overall Study|Adverse Event|3|||
17136899|NCT02431702|38278474|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
17189012|NCT01062061|38341965|FG000|Overall Study|Enrolled more than once|2|||
17031303|NCT00733304|38175659|FG001|Overall Study|Adverse Event|0|||
17031304|NCT00733304|38175660|FG002|Overall Study|Adverse Event|0|||
17031305|NCT00733304|38175658|FG000|Overall Study|Lack of Efficacy|0|||
17031306|NCT00733304|38175659|FG001|Overall Study|Lack of Efficacy|0|||
17031307|NCT00733304|38175660|FG002|Overall Study|Lack of Efficacy|2|||
17031308|NCT00733304|38175658|FG000|Overall Study|Lost to Follow-up|0|||
17031309|NCT00733304|38175659|FG001|Overall Study|Lost to Follow-up|1|||
17031310|NCT00733304|38175660|FG002|Overall Study|Lost to Follow-up|0|||
17031311|NCT00733304|38175658|FG000|Overall Study|Physician Decision|3|||
17031312|NCT00733304|38175659|FG001|Overall Study|Physician Decision|1|||
17031313|NCT00733304|38175660|FG002|Overall Study|Physician Decision|3|||
17031314|NCT00733304|38175658|FG000|Overall Study|Withdrawal by Subject|1|||
17031315|NCT00733304|38175659|FG001|Overall Study|Withdrawal by Subject|1|||
17031316|NCT00733304|38175660|FG002|Overall Study|Withdrawal by Subject|0|||
17031317|NCT00711243|38175674|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
17031318|NCT00711243|38175675|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
17031319|NCT00711243|38175676|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
17031320|NCT00711243|38175677|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
17031321|NCT00711243|38175678|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
17031322|NCT00711243|38175679|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
17031323|NCT00711243|38175674|FG000|Reached First Response/4 Cycles|Death|0|||
17031324|NCT00711243|38175675|FG001|Reached First Response/4 Cycles|Death|0|||
17031325|NCT00711243|38175676|FG002|Reached First Response/4 Cycles|Death|0|||
17031326|NCT00711243|38175677|FG003|Reached First Response/4 Cycles|Death|0|||
17031327|NCT00711243|38175678|FG004|Reached First Response/4 Cycles|Death|0|||
17031328|NCT00711243|38175679|FG005|Reached First Response/4 Cycles|Death|2|||
17031329|NCT00711243|38175674|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
17031330|NCT00711243|38175675|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
17031331|NCT00711243|38175676|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
17031332|NCT00711243|38175677|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
17031333|NCT00711243|38175678|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
17031334|NCT00711243|38175679|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
17031335|NCT00711243|38175674|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
17031336|NCT00711243|38175675|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
17031337|NCT00711243|38175676|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
17031338|NCT00711243|38175677|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
17031339|NCT00711243|38175678|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
17031340|NCT00711243|38175679|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
17031341|NCT00711243|38175674|FG000|Treated Cycle 5 After First Response|Death|0|||
17031342|NCT00711243|38175675|FG001|Treated Cycle 5 After First Response|Death|0|||
17031343|NCT00711243|38175676|FG002|Treated Cycle 5 After First Response|Death|0|||
17031344|NCT00711243|38175677|FG003|Treated Cycle 5 After First Response|Death|0|||
17031345|NCT00711243|38175678|FG004|Treated Cycle 5 After First Response|Death|0|||
17031346|NCT00711243|38175679|FG005|Treated Cycle 5 After First Response|Death|2|||
17031347|NCT00711243|38175674|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
17031348|NCT00711243|38175675|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
17031349|NCT00711243|38175676|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
17031350|NCT00711243|38175677|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
17031351|NCT00711243|38175678|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
17031352|NCT00711243|38175679|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
17031353|NCT00711243|38175674|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
17031354|NCT00711243|38175675|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
17031355|NCT00711243|38175676|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
17031356|NCT00711243|38175677|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
17031357|NCT00711243|38175678|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
17031358|NCT00711243|38175679|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
17031359|NCT00733226|38175697|FG000|Overall Study|Withdrawal by Subject|1|||
17031360|NCT00733226|38175698|FG001|Overall Study|Withdrawal by Subject|0|||
17031361|NCT00733226|38175697|FG000|Overall Study|Lost to Follow-up|2|||
17031362|NCT00733226|38175698|FG001|Overall Study|Lost to Follow-up|0|||
17031363|NCT00733226|38175697|FG000|Overall Study|moved to another place|2|||
17031364|NCT00733226|38175698|FG001|Overall Study|moved to another place|0|||
17031365|NCT00732992|38175706|FG000|Overall Study|Adverse Event|1|||
17031366|NCT00732992|38175707|FG001|Overall Study|Adverse Event|1|||
17031367|NCT00732992|38175706|FG000|Overall Study|Objective Progression or Relapse|3|||
17031368|NCT00732992|38175707|FG001|Overall Study|Objective Progression or Relapse|5|||
17031369|NCT00732992|38175706|FG000|Overall Study|Global Deterioration of Health Status|1|||
17031370|NCT00732992|38175707|FG001|Overall Study|Global Deterioration of Health Status|0|||
17136900|NCT02431702|38278475|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
17136901|NCT02431702|38278469|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
17031371|NCT00732992|38175706|FG000|Overall Study|Withdrawal by Subject|1|||
17031372|NCT00732992|38175707|FG001|Overall Study|Withdrawal by Subject|0|||
17031373|NCT00732758|38175716|FG000|Overall Study|Lost to Follow-up|8|||
17031374|NCT00732758|38175717|FG001|Overall Study|Lost to Follow-up|16|||
17031375|NCT00699153|38175725|FG000|Overall Study|Lost to Follow-up|1|||
17031376|NCT00699153|38175726|FG001|Overall Study|Lost to Follow-up|0|||
17031377|NCT00699153|38175725|FG000|Overall Study|Adverse Event|0|||
17031378|NCT00699153|38175726|FG001|Overall Study|Adverse Event|2|||
17031379|NCT00699153|38175725|FG000|Overall Study|Protocol Violation|1|||
17031380|NCT00699153|38175726|FG001|Overall Study|Protocol Violation|0|||
17031381|NCT00699153|38175725|FG000|Overall Study|Travel Problem|1|||
17031382|NCT00699153|38175726|FG001|Overall Study|Travel Problem|0|||
17031383|NCT00698997|38175734|FG000|Overall Study|Lost to Follow-up|3|||
17031384|NCT00698997|38175735|FG001|Overall Study|Lost to Follow-up|0|||
17031385|NCT00698997|38175734|FG000|Overall Study|Withdrawal by Subject|7|||
17031386|NCT00698997|38175735|FG001|Overall Study|Withdrawal by Subject|27|||
17031387|NCT00711087|38175744|FG000|Overall Study|Lost to Follow-up|1|||
17031388|NCT00711087|38175745|FG001|Overall Study|Lost to Follow-up|0|||
17031389|NCT00738530|38175753|FG000|Overall Study|Death|220|||
17031390|NCT00738530|38175754|FG001|Overall Study|Death|224|||
17031391|NCT00738530|38175753|FG000|Overall Study|Lost to Follow-up|8|||
17031392|NCT00738530|38175754|FG001|Overall Study|Lost to Follow-up|6|||
17031393|NCT00738530|38175753|FG000|Overall Study|Withdrawal by Subject|6|||
17031394|NCT00738530|38175754|FG001|Overall Study|Withdrawal by Subject|8|||
17031395|NCT00711009|38175762|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
17031396|NCT00711009|38175763|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
17031397|NCT00711009|38175762|FG000|Overall Study|Withdrawal by Subject|4|||
17031398|NCT00711009|38175763|FG001|Overall Study|Withdrawal by Subject|2|||
17031399|NCT00711009|38175762|FG000|Overall Study|Lost to Follow-up|3|||
17031400|NCT00711009|38175763|FG001|Overall Study|Lost to Follow-up|9|||
17031401|NCT00711009|38175762|FG000|Overall Study|Participant Noncompliant|0|||
17031402|NCT00711009|38175763|FG001|Overall Study|Participant Noncompliant|1|||
17031403|NCT00711009|38175762|FG000|Overall Study|Virologic Failure|2|||
17031404|NCT00711009|38175763|FG001|Overall Study|Virologic Failure|1|||
17031405|NCT00711009|38175762|FG000|Overall Study|Pregnancy|1|||
17031406|NCT00711009|38175763|FG001|Overall Study|Pregnancy|0|||
17031407|NCT00711009|38175762|FG000|Overall Study|Site closing|0|||
17031408|NCT00711009|38175763|FG001|Overall Study|Site closing|1|||
17031409|NCT00711009|38175762|FG000|Overall Study|Dose adjustment|1|||
17031410|NCT00711009|38175763|FG001|Overall Study|Dose adjustment|0|||
17031411|NCT00577005|38175771|FG000|Overall Study|Lost to Follow-up|3|||
17031412|NCT00577005|38175772|FG001|Overall Study|Lost to Follow-up|2|||
17031413|NCT00577005|38175771|FG000|Overall Study|Withdrawal by Subject|2|||
17031414|NCT00577005|38175772|FG001|Overall Study|Withdrawal by Subject|1|||
17031415|NCT00576927|38175783|FG000|Clinical Assessment|Lack of Efficacy|24|||
17031416|NCT00576927|38175783|FG000|Clinical Assessment|Death|1|||
17031417|NCT00576927|38175783|FG000|Clinical Assessment|Withdrawal by Subject|10|||
17031418|NCT00576927|38175783|FG000|Clinical Assessment|Physician Decision|1|||
17031419|NCT00576927|38175783|FG000|Baseline|Physician Decision|9|||
17031420|NCT00576927|38175783|FG000|Baseline|Medication Change by PCP of subject|1|||
17031421|NCT00576927|38175783|FG000|Baseline|Withdrawal by Subject|3|||
17031422|NCT00576927|38175783|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
17031423|NCT00576927|38175783|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
17031424|NCT00576927|38175783|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
17031425|NCT00576927|38175783|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
17031426|NCT00576927|38175783|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
17031427|NCT00698841|38175789|FG000|Overall Study|Withdrawal by Subject|2|||
17031428|NCT00698841|38175789|FG000|Overall Study|Adverse Event|3|||
17031429|NCT00698841|38175789|FG000|Overall Study|Disease progression|7|||
17031430|NCT00698841|38175789|FG000|Overall Study|Failure to meet eligibility criteria|2|||
17031431|NCT00698841|38175789|FG000|Overall Study|Study drug toxicity|2|||
17031432|NCT00698841|38175789|FG000|Overall Study|Other|2|||
17031433|NCT00577395|38175795|FG000|Overall Study|Study was terminated early by Sponsor|7|||
17031434|NCT00577395|38175796|FG001|Overall Study|Study was terminated early by Sponsor|6|||
17031435|NCT00738374|38175805|FG000|Induction Treatment Phase|Adverse Event|14|||
17031436|NCT00738374|38175806|FG001|Induction Treatment Phase|Adverse Event|0|||
17031437|NCT00738374|38175807|FG002|Induction Treatment Phase|Adverse Event|0|||
17031438|NCT00738374|38175808|FG003|Induction Treatment Phase|Adverse Event|0|||
17031439|NCT00738374|38175805|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
17031440|NCT00738374|38175806|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
17031441|NCT00738374|38175807|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
17031442|NCT00738374|38175808|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
17031443|NCT00738374|38175805|FG000|Induction Treatment Phase|Physician Decision|2|||
17031444|NCT00738374|38175806|FG001|Induction Treatment Phase|Physician Decision|0|||
17031445|NCT00738374|38175807|FG002|Induction Treatment Phase|Physician Decision|0|||
17031446|NCT00738374|38175808|FG003|Induction Treatment Phase|Physician Decision|0|||
17031447|NCT00738374|38175805|FG000|Induction Treatment Phase|Protocol Violation|2|||
17031448|NCT00738374|38175806|FG001|Induction Treatment Phase|Protocol Violation|0|||
17031449|NCT00738374|38175807|FG002|Induction Treatment Phase|Protocol Violation|0|||
17031450|NCT00738374|38175808|FG003|Induction Treatment Phase|Protocol Violation|0|||
17031451|NCT00738374|38175805|FG000|Induction Treatment Phase|Non-compliance|1|||
17031452|NCT00738374|38175806|FG001|Induction Treatment Phase|Non-compliance|0|||
17031453|NCT00738374|38175807|FG002|Induction Treatment Phase|Non-compliance|0|||
17031454|NCT00738374|38175808|FG003|Induction Treatment Phase|Non-compliance|0|||
17031455|NCT00738374|38175805|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
17031456|NCT00738374|38175806|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
17031457|NCT00738374|38175807|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
17031458|NCT00738374|38175808|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
17031459|NCT00738374|38175805|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
17031460|NCT00738374|38175806|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
17031461|NCT00738374|38175807|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
17031462|NCT00738374|38175808|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
17031463|NCT00738374|38175805|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
17031464|NCT00738374|38175806|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
17031465|NCT00738374|38175807|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
17031466|NCT00738374|38175808|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
17031467|NCT00738374|38175805|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
17031468|NCT00738374|38175806|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
17031469|NCT00738374|38175807|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
17031470|NCT00738374|38175808|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
17031471|NCT00738374|38175805|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
17031472|NCT00738374|38175806|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
17031473|NCT00738374|38175807|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
17031474|NCT00738374|38175808|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
17031475|NCT00738374|38175805|FG000|Maintenance Treatment/Observation Phase|Other|0|||
17031476|NCT00738374|38175806|FG001|Maintenance Treatment/Observation Phase|Other|1|||
17031477|NCT00738374|38175807|FG002|Maintenance Treatment/Observation Phase|Other|0|||
17031478|NCT00738374|38175808|FG003|Maintenance Treatment/Observation Phase|Other|0|||
17031479|NCT00697593|38175817|FG000|Overall Study|Adverse Event|3|||
17031480|NCT00697593|38175817|FG000|Overall Study|Protocol Violation|1|||
17031481|NCT00697593|38175817|FG000|Overall Study|Lack of Efficacy|3|||
17031482|NCT00697593|38175817|FG000|Overall Study|Suspension of the study by sponsor|12|||
17031483|NCT00697515|38175821|FG000|Dose Optimization Period|Adverse Event|4|||
17031484|NCT00697515|38175822|FG001|Dose Optimization Period|Adverse Event|0|||
17031485|NCT00697515|38175821|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
17031486|NCT00697515|38175822|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
17031487|NCT00697515|38175821|FG000|Dose Optimization Period|Lost to Follow-up|2|||
17031488|NCT00697515|38175822|FG001|Dose Optimization Period|Lost to Follow-up|0|||
17031489|NCT00697515|38175821|FG000|Dose Optimization Period|sponsor request|2|||
17031490|NCT00697515|38175822|FG001|Dose Optimization Period|sponsor request|0|||
17031491|NCT00697515|38175821|FG000|Dose Optimization Period|called to active duty|1|||
17031492|NCT00697515|38175822|FG001|Dose Optimization Period|called to active duty|0|||
17031493|NCT00697515|38175821|FG000|Dose Optimization Period|elevated QTc|1|||
17031494|NCT00697515|38175822|FG001|Dose Optimization Period|elevated QTc|0|||
17031495|NCT00697515|38175821|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
17031496|NCT00697515|38175822|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
17031497|NCT00697515|38175821|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
17031498|NCT00697515|38175822|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
17031499|NCT00697515|38175821|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
17031500|NCT00697515|38175822|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
17031501|NCT00697515|38175821|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
16780405|NCT02117050|37719519|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
17031502|NCT00697515|38175822|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
17031503|NCT00738062|38175831|FG000|Open Label Treatment|Lack of Efficacy|5|||
17031504|NCT00738062|38175832|FG001|Open Label Treatment|Lack of Efficacy|0|||
17031505|NCT00738062|38175833|FG002|Open Label Treatment|Lack of Efficacy|0|||
17031506|NCT00738062|38175831|FG000|Open Label Treatment|Adverse Event|11|||
17031507|NCT00738062|38175832|FG001|Open Label Treatment|Adverse Event|0|||
17031508|NCT00738062|38175833|FG002|Open Label Treatment|Adverse Event|0|||
17031509|NCT00738062|38175831|FG000|Open Label Treatment|Protocol Violation|2|||
16780406|NCT02728895|37719526|FG000|Overall Study|Other|1|||
17031510|NCT00738062|38175832|FG001|Open Label Treatment|Protocol Violation|0|||
17031511|NCT00738062|38175833|FG002|Open Label Treatment|Protocol Violation|0|||
17031512|NCT00738062|38175831|FG000|Open Label Treatment|Withdrawal by Subject|9|||
17031513|NCT00738062|38175832|FG001|Open Label Treatment|Withdrawal by Subject|0|||
17031514|NCT00738062|38175833|FG002|Open Label Treatment|Withdrawal by Subject|0|||
17031515|NCT00738062|38175831|FG000|Open Label Treatment|Investigator Decision|1|||
17031516|NCT00738062|38175832|FG001|Open Label Treatment|Investigator Decision|0|||
17031517|NCT00738062|38175833|FG002|Open Label Treatment|Investigator Decision|0|||
17031518|NCT00738062|38175831|FG000|Open-Label Extension|Adverse Event|5|||
17031519|NCT00738062|38175832|FG001|Open-Label Extension|Adverse Event|0|||
17031520|NCT00738062|38175833|FG002|Open-Label Extension|Adverse Event|0|||
17031521|NCT00738062|38175831|FG000|Open-Label Extension|Physician Decision|1|||
17031522|NCT00738062|38175832|FG001|Open-Label Extension|Physician Decision|0|||
17031523|NCT00738062|38175833|FG002|Open-Label Extension|Physician Decision|0|||
17031524|NCT00738062|38175831|FG000|Open-Label Extension|Lack of Efficacy|2|||
17031525|NCT00738062|38175832|FG001|Open-Label Extension|Lack of Efficacy|0|||
17031526|NCT00738062|38175833|FG002|Open-Label Extension|Lack of Efficacy|0|||
17031527|NCT00738062|38175831|FG000|Open-Label Extension|Withdrawal by Subject|6|||
17031528|NCT00738062|38175832|FG001|Open-Label Extension|Withdrawal by Subject|0|||
17031529|NCT00738062|38175833|FG002|Open-Label Extension|Withdrawal by Subject|0|||
17031530|NCT00738062|38175831|FG000|Open-Label Extension|Protocol Violation|1|||
17031531|NCT00738062|38175832|FG001|Open-Label Extension|Protocol Violation|0|||
17031532|NCT00738062|38175833|FG002|Open-Label Extension|Protocol Violation|0|||
17031533|NCT00738062|38175831|FG000|Open-Label Extension|Study Terminated|2|||
17031534|NCT00738062|38175832|FG001|Open-Label Extension|Study Terminated|0|||
17031535|NCT00738062|38175833|FG002|Open-Label Extension|Study Terminated|0|||
17031536|NCT04245345|38175842|FG000|Overall Study|Death|1|||
17031537|NCT04245345|38175842|FG000|Overall Study|Exited prior to implant|5|||
17031538|NCT04245345|38175842|FG000|Overall Study|Exited prior to 1-month|9|||
17031539|NCT04245345|38175842|FG000|Overall Study|Missed 1-month visit|3|||
17031540|NCT04245345|38175842|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
17031541|NCT04245345|38175842|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
17031542|NCT00698685|38175848|FG000|Overall Study|Sister withdrew as donor|1|||
17031543|NCT00698685|38175848|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
17031544|NCT00737672|38175854|FG000|Overall Study|Graft Abandonment|48|||
17031545|NCT00737672|38175855|FG001|Overall Study|Graft Abandonment|56|||
17031546|NCT00737672|38175854|FG000|Overall Study|Death|23|||
17031547|NCT00737672|38175855|FG001|Overall Study|Death|22|||
17031548|NCT00737672|38175854|FG000|Overall Study|Withdrawal by Subject|1|||
17031549|NCT00737672|38175855|FG001|Overall Study|Withdrawal by Subject|2|||
17031550|NCT00737672|38175854|FG000|Overall Study|Lost to Follow-up|1|||
17031551|NCT00737672|38175855|FG001|Overall Study|Lost to Follow-up|0|||
17031552|NCT00737672|38175854|FG000|Overall Study|Miscellaneous|7|||
17031553|NCT00737672|38175855|FG001|Overall Study|Miscellaneous|1|||
17031554|NCT00737672|38175854|FG000|Overall Study|Physician Decision|0|||
17031555|NCT00737672|38175855|FG001|Overall Study|Physician Decision|2|||
17031556|NCT00737438|38175861|FG000|Overall Study|Withdrawal by Subject|2|||
17031557|NCT00737438|38175861|FG000|Overall Study|Patient ineligible|1|||
17031558|NCT00737282|38175867|FG000|Overall Study|Study prematurely terminated|175|||
17031559|NCT03884478|38175876|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
17031560|NCT03884478|38175877|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
17031561|NCT03884478|38175878|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
17031562|NCT03884478|38175876|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
17031563|NCT03884478|38175877|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
17031564|NCT03884478|38175878|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
17031565|NCT03884478|38175876|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
17031566|NCT03884478|38175877|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
17031567|NCT03884478|38175878|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
17031568|NCT03884478|38175876|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
17031569|NCT03884478|38175877|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
17031570|NCT03884478|38175878|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
17031571|NCT00582816|38175899|FG000|Overall Study|Engraftment Failure|3|||
17031572|NCT00737048|38175906|FG000|Overall Study|Physician Decision|0|||
17031573|NCT00737048|38175907|FG001|Overall Study|Physician Decision|0|||
17031574|NCT00737048|38175908|FG002|Overall Study|Physician Decision|1|||
17031575|NCT00737048|38175906|FG000|Overall Study|Adverse Event|0|||
17031576|NCT00737048|38175907|FG001|Overall Study|Adverse Event|1|||
17031577|NCT00737048|38175908|FG002|Overall Study|Adverse Event|0|||
17031578|NCT00737048|38175906|FG000|Overall Study|Worsening of the symptoms|3|||
17031579|NCT00737048|38175907|FG001|Overall Study|Worsening of the symptoms|5|||
17031580|NCT00737048|38175908|FG002|Overall Study|Worsening of the symptoms|3|||
17031581|NCT00731822|38175918|FG000|Overall Study|Adverse Event|2|||
17031582|NCT00731822|38175919|FG001|Overall Study|Adverse Event|1|||
17031583|NCT00731822|38175918|FG000|Overall Study|Protocol Violation|1|||
17031584|NCT00731822|38175919|FG001|Overall Study|Protocol Violation|0|||
17031585|NCT00731822|38175918|FG000|Overall Study|Lost to Follow-up|1|||
17031586|NCT00731822|38175919|FG001|Overall Study|Lost to Follow-up|0|||
17031587|NCT00731666|38175925|FG000|Overall Study|Adverse Event|2|||
17031588|NCT00731666|38175925|FG000|Overall Study|Lost to Follow-up|8|||
17031589|NCT00731666|38175925|FG000|Overall Study|Withdrawal by Subject|2|||
17031590|NCT00731120|38175932|FG000|Overall Study|Adverse Event|7|||
17031591|NCT00731120|38175933|FG001|Overall Study|Adverse Event|6|||
17031592|NCT00731120|38175934|FG002|Overall Study|Adverse Event|8|||
17031593|NCT00731120|38175932|FG000|Overall Study|Lack of Efficacy|4|||
17031594|NCT00731120|38175933|FG001|Overall Study|Lack of Efficacy|5|||
17031595|NCT00731120|38175934|FG002|Overall Study|Lack of Efficacy|4|||
17031596|NCT00731120|38175932|FG000|Overall Study|Noncompliance with Study Drug|3|||
17031597|NCT00731120|38175933|FG001|Overall Study|Noncompliance with Study Drug|3|||
17031598|NCT00731120|38175934|FG002|Overall Study|Noncompliance with Study Drug|1|||
17031599|NCT00731120|38175932|FG000|Overall Study|Protocol Deviations|1|||
17031600|NCT00731120|38175933|FG001|Overall Study|Protocol Deviations|6|||
17031601|NCT00731120|38175934|FG002|Overall Study|Protocol Deviations|1|||
17031602|NCT00731120|38175932|FG000|Overall Study|Withdrawal of Consent|13|||
17031603|NCT00731120|38175933|FG001|Overall Study|Withdrawal of Consent|8|||
17031604|NCT00731120|38175934|FG002|Overall Study|Withdrawal of Consent|4|||
17031605|NCT00731120|38175932|FG000|Overall Study|Lost to Follow-up|10|||
17031606|NCT00731120|38175933|FG001|Overall Study|Lost to Follow-up|15|||
17031607|NCT00731120|38175934|FG002|Overall Study|Lost to Follow-up|17|||
17031608|NCT00731120|38175932|FG000|Overall Study|Other|4|||
17031609|NCT00731120|38175933|FG001|Overall Study|Other|0|||
17031610|NCT00731120|38175934|FG002|Overall Study|Other|1|||
17031611|NCT00731042|38175944|FG000|Second Intervention|Did not meet inclusion criteria|0|||
17031612|NCT00731042|38175945|FG001|Second Intervention|Did not meet inclusion criteria|2|||
17031613|NCT00726986|38175951|FG000|Induction Phase|Adverse Event|4|||
17031614|NCT00726986|38175951|FG000|Induction Phase|Withdrawal by Subject|2|||
17031615|NCT00726986|38175951|FG000|Induction Phase|Death|2|||
17031616|NCT00726986|38175951|FG000|Induction Phase|Lack of Efficacy|5|||
17031617|NCT00726986|38175951|FG000|Induction Phase|Secondary Disease|2|||
17031618|NCT00726986|38175951|FG000|Maintenance Phase|Adverse Event|1|||
17031619|NCT00726986|38175951|FG000|Maintenance Phase|Lack of Efficacy|2|||
17031620|NCT00696657|38175964|FG000|Overall Study|Protocol Violation|0|||
17031621|NCT00696657|38175965|FG001|Overall Study|Protocol Violation|0|||
17031622|NCT00696657|38175966|FG002|Overall Study|Protocol Violation|0|||
17031623|NCT00696657|38175967|FG003|Overall Study|Protocol Violation|0|||
17031624|NCT00696657|38175968|FG004|Overall Study|Protocol Violation|0|||
17031625|NCT00696657|38175969|FG005|Overall Study|Protocol Violation|1|||
17031626|NCT00696657|38175970|FG006|Overall Study|Protocol Violation|0|||
17031627|NCT00696657|38175971|FG007|Overall Study|Protocol Violation|0|||
17031628|NCT00696657|38175972|FG008|Overall Study|Protocol Violation|1|||
17031629|NCT00696657|38175964|FG000|Overall Study|Lack of Efficacy|0|||
17031630|NCT00696657|38175965|FG001|Overall Study|Lack of Efficacy|1|||
17031631|NCT00696657|38175966|FG002|Overall Study|Lack of Efficacy|0|||
17031632|NCT00696657|38175967|FG003|Overall Study|Lack of Efficacy|0|||
17031633|NCT00696657|38175968|FG004|Overall Study|Lack of Efficacy|0|||
17031634|NCT00696657|38175969|FG005|Overall Study|Lack of Efficacy|0|||
17031635|NCT00696657|38175970|FG006|Overall Study|Lack of Efficacy|0|||
17031636|NCT00696657|38175971|FG007|Overall Study|Lack of Efficacy|0|||
17031637|NCT00696657|38175972|FG008|Overall Study|Lack of Efficacy|0|||
17031638|NCT00696657|38175964|FG000|Overall Study|Withdrawal criteria|1|||
17031639|NCT00696657|38175965|FG001|Overall Study|Withdrawal criteria|3|||
17031640|NCT00696657|38175966|FG002|Overall Study|Withdrawal criteria|2|||
17031641|NCT00696657|38175967|FG003|Overall Study|Withdrawal criteria|2|||
17031642|NCT00696657|38175968|FG004|Overall Study|Withdrawal criteria|0|||
17031643|NCT00696657|38175969|FG005|Overall Study|Withdrawal criteria|0|||
17031644|NCT00696657|38175970|FG006|Overall Study|Withdrawal criteria|1|||
17031645|NCT00696657|38175971|FG007|Overall Study|Withdrawal criteria|1|||
17031646|NCT00696657|38175972|FG008|Overall Study|Withdrawal criteria|2|||
17031647|NCT00696657|38175964|FG000|Overall Study|Unclassified|0|||
17031648|NCT00696657|38175965|FG001|Overall Study|Unclassified|1|||
17031649|NCT00696657|38175966|FG002|Overall Study|Unclassified|3|||
17031650|NCT00696657|38175967|FG003|Overall Study|Unclassified|2|||
17031651|NCT00696657|38175968|FG004|Overall Study|Unclassified|4|||
17031652|NCT00696657|38175969|FG005|Overall Study|Unclassified|2|||
17031653|NCT00696657|38175970|FG006|Overall Study|Unclassified|0|||
17031654|NCT00696657|38175971|FG007|Overall Study|Unclassified|0|||
17031655|NCT00696657|38175972|FG008|Overall Study|Unclassified|1|||
17031656|NCT00696657|38175964|FG000|Overall Study|Adverse Event|0|||
17031657|NCT00696657|38175965|FG001|Overall Study|Adverse Event|0|||
17031658|NCT00696657|38175966|FG002|Overall Study|Adverse Event|3|||
17031659|NCT00696657|38175967|FG003|Overall Study|Adverse Event|7|||
17031660|NCT00696657|38175968|FG004|Overall Study|Adverse Event|6|||
17031661|NCT00696657|38175969|FG005|Overall Study|Adverse Event|9|||
17031662|NCT00696657|38175970|FG006|Overall Study|Adverse Event|14|||
17031663|NCT00696657|38175971|FG007|Overall Study|Adverse Event|2|||
17031664|NCT00696657|38175972|FG008|Overall Study|Adverse Event|5|||
17031665|NCT00730886|38175994|FG000|Overall Study|Lost to Follow-up|1|||
17031666|NCT00730886|38175995|FG001|Overall Study|Lost to Follow-up|0|||
17031667|NCT00730886|38175994|FG000|Overall Study|Physician Decision|1|||
17031668|NCT00730886|38175995|FG001|Overall Study|Physician Decision|0|||
17031669|NCT00726752|38176001|FG000|Overall Study|Lack of Efficacy|6|||
17031670|NCT00730028|38176019|FG000|Overall Study|Adverse Event|23|||
17031671|NCT00730028|38176020|FG001|Overall Study|Adverse Event|26|||
17031672|NCT00730028|38176021|FG002|Overall Study|Adverse Event|16|||
17031673|NCT00730028|38176022|FG003|Overall Study|Adverse Event|20|||
17031674|NCT00730028|38176023|FG004|Overall Study|Adverse Event|43|||
17031675|NCT00730028|38176019|FG000|Overall Study|Lost to Follow-up|13|||
17031676|NCT00730028|38176020|FG001|Overall Study|Lost to Follow-up|26|||
17031677|NCT00730028|38176021|FG002|Overall Study|Lost to Follow-up|22|||
17031678|NCT00730028|38176022|FG003|Overall Study|Lost to Follow-up|26|||
17031679|NCT00730028|38176023|FG004|Overall Study|Lost to Follow-up|25|||
17031680|NCT00730028|38176019|FG000|Overall Study|Protocol Violation|6|||
17031681|NCT00730028|38176020|FG001|Overall Study|Protocol Violation|1|||
17031682|NCT00730028|38176021|FG002|Overall Study|Protocol Violation|1|||
17031683|NCT00730028|38176022|FG003|Overall Study|Protocol Violation|2|||
17031684|NCT00730028|38176023|FG004|Overall Study|Protocol Violation|0|||
17031685|NCT00730028|38176019|FG000|Overall Study|Withdrawal by Subject|9|||
17031686|NCT00730028|38176020|FG001|Overall Study|Withdrawal by Subject|5|||
17031687|NCT00730028|38176021|FG002|Overall Study|Withdrawal by Subject|4|||
17031688|NCT00730028|38176022|FG003|Overall Study|Withdrawal by Subject|5|||
17031689|NCT00730028|38176023|FG004|Overall Study|Withdrawal by Subject|9|||
17031690|NCT00730028|38176019|FG000|Overall Study|Physician Decision|3|||
17031691|NCT00730028|38176020|FG001|Overall Study|Physician Decision|3|||
17031692|NCT00730028|38176021|FG002|Overall Study|Physician Decision|2|||
17031693|NCT00730028|38176022|FG003|Overall Study|Physician Decision|3|||
17031694|NCT00730028|38176023|FG004|Overall Study|Physician Decision|2|||
17031695|NCT00730028|38176019|FG000|Overall Study|Treatment Failure|5|||
17031696|NCT00730028|38176020|FG001|Overall Study|Treatment Failure|5|||
17031697|NCT00730028|38176021|FG002|Overall Study|Treatment Failure|0|||
17136902|NCT02431702|38278470|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
17136903|NCT02431702|38278471|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
17136904|NCT02431702|38278472|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
17136905|NCT02431702|38278473|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
17136906|NCT02431702|38278474|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
16991504|NCT02724969|38135636|FG000|Overall Study|Infant demise|0|||
16991505|NCT02724969|38135637|FG001|Overall Study|Infant demise|2|||
16991506|NCT00811252|38135646|FG000|Overall Study|Adverse Event|6|||
16991507|NCT00811252|38135647|FG001|Overall Study|Adverse Event|10|||
16991508|NCT00811252|38135648|FG002|Overall Study|Adverse Event|15|||
16991509|NCT00811252|38135646|FG000|Overall Study|Lack of Efficacy|7|||
16991510|NCT00811252|38135647|FG001|Overall Study|Lack of Efficacy|2|||
16991511|NCT00811252|38135648|FG002|Overall Study|Lack of Efficacy|0|||
16991512|NCT00811252|38135646|FG000|Overall Study|Protocol Violation|3|||
16991513|NCT00811252|38135647|FG001|Overall Study|Protocol Violation|3|||
16991514|NCT00811252|38135648|FG002|Overall Study|Protocol Violation|2|||
16991515|NCT00811252|38135646|FG000|Overall Study|Withdrawal of Consent|1|||
16991516|NCT00811252|38135647|FG001|Overall Study|Withdrawal of Consent|2|||
16991517|NCT00811252|38135648|FG002|Overall Study|Withdrawal of Consent|2|||
16991518|NCT00811252|38135646|FG000|Overall Study|Lost to Follow-up|0|||
16991519|NCT00811252|38135647|FG001|Overall Study|Lost to Follow-up|0|||
16991520|NCT00811252|38135648|FG002|Overall Study|Lost to Follow-up|2|||
16991521|NCT00811252|38135646|FG000|Overall Study|Administrative or Other Reasons|0|||
16991522|NCT00811252|38135647|FG001|Overall Study|Administrative or Other Reasons|3|||
16991523|NCT00811252|38135648|FG002|Overall Study|Administrative or Other Reasons|2|||
16991524|NCT00736957|38135665|FG000|Overall Study|Adverse Event|43|||
16991525|NCT00736957|38135665|FG000|Overall Study|Withdrawal by Subject|49|||
16991526|NCT00736957|38135665|FG000|Overall Study|violation of eligibility criteria|2|||
17031698|NCT00730028|38176022|FG003|Overall Study|Treatment Failure|0|||
17031699|NCT00730028|38176023|FG004|Overall Study|Treatment Failure|1|||
17031700|NCT00730028|38176019|FG000|Overall Study|Randomization Error|1|||
17031701|NCT00730028|38176020|FG001|Overall Study|Randomization Error|0|||
17031702|NCT00730028|38176021|FG002|Overall Study|Randomization Error|0|||
17031703|NCT00730028|38176022|FG003|Overall Study|Randomization Error|0|||
17031704|NCT00730028|38176023|FG004|Overall Study|Randomization Error|2|||
17031705|NCT00736502|38176035|FG000|Overall Study|Adverse Event|22|||
17031706|NCT00736502|38176035|FG000|Overall Study|Lack of Efficacy|16|||
17031707|NCT00736502|38176035|FG000|Overall Study|Lost to Follow-up|27|||
17031708|NCT00729560|38176039|FG000|Overall Study|Withdrawal by Subject|3|||
17031709|NCT00736190|38176043|FG000|Overall Study|Pregnancy|1|||
17031710|NCT00736190|38176043|FG000|Overall Study|Withdrawal by Subject|1|||
17031711|NCT00736190|38176043|FG000|Overall Study|Adverse Event|1|||
17031712|NCT00729326|38176049|FG000|Overall Study|Lost to Follow-up|2|||
17031713|NCT00729326|38176050|FG001|Overall Study|Lost to Follow-up|0|||
17031714|NCT00729326|38176049|FG000|Overall Study|Physician Decision|0|||
17031715|NCT00729326|38176050|FG001|Overall Study|Physician Decision|1|||
17031716|NCT00729326|38176049|FG000|Overall Study|Protocol Violation|3|||
17031717|NCT00729326|38176050|FG001|Overall Study|Protocol Violation|2|||
17031718|NCT00729326|38176049|FG000|Overall Study|Subject Decision|4|||
17031719|NCT00729326|38176050|FG001|Overall Study|Subject Decision|4|||
17031720|NCT00729326|38176049|FG000|Overall Study|Sponsor Decision|1|||
17031721|NCT00729326|38176050|FG001|Overall Study|Sponsor Decision|2|||
17031722|NCT00729248|38176056|FG000|Overall Study|Physician Decision|2|||
17031723|NCT00696423|38176063|FG000|Overall Study|Lost to Follow-up|0|||
17031724|NCT00696423|38176064|FG001|Overall Study|Lost to Follow-up|5|||
17031725|NCT00736034|38176070|FG000|Overall Study|Adverse Event|2|||
17031726|NCT00576693|38176076|FG000|Overall Study|Lost to Follow-up|7|||
17031727|NCT00576693|38176077|FG001|Overall Study|Lost to Follow-up|11|||
17031728|NCT00576693|38176076|FG000|Overall Study|Withdrawal by Subject|3|||
17031729|NCT00576693|38176077|FG001|Overall Study|Withdrawal by Subject|13|||
17031730|NCT00698451|38176083|FG000|Overall Study|Adverse Event|22|||
17031731|NCT00698451|38176083|FG000|Overall Study|Physician Decision|2|||
17031732|NCT00698451|38176083|FG000|Overall Study|Protocol Violation|6|||
17031733|NCT00698451|38176083|FG000|Overall Study|Withdrawal by Subject|6|||
17031734|NCT00698451|38176083|FG000|Overall Study|Disease progression|3|||
17031735|NCT00697827|38176089|FG000|Overall Study|enrolled but not treated|2|||
17031736|NCT00697827|38176090|FG001|Overall Study|enrolled but not treated|1|||
17031737|NCT00728936|38176103|FG000|Overall Study|Withdrawal by Subject|0|||
17031738|NCT00728936|38176104|FG001|Overall Study|Withdrawal by Subject|0|||
17031739|NCT00728936|38176105|FG002|Overall Study|Withdrawal by Subject|0|||
17031740|NCT00728936|38176106|FG003|Overall Study|Withdrawal by Subject|0|||
17031741|NCT00728936|38176107|FG004|Overall Study|Withdrawal by Subject|0|||
17031742|NCT00728936|38176108|FG005|Overall Study|Withdrawal by Subject|1|||
17031743|NCT00728936|38176109|FG006|Overall Study|Withdrawal by Subject|0|||
17031744|NCT00693693|38176128|FG000|Overall Study|Lost to Follow-up|1|||
17031745|NCT00693693|38176129|FG001|Overall Study|Lost to Follow-up|1|||
17031746|NCT00693693|38176130|FG002|Overall Study|Lost to Follow-up|2|||
17031747|NCT00728468|38176138|FG000|Overall Study|Enrolled but not treated|1|||
17031748|NCT00728468|38176138|FG000|Overall Study|Death|1|||
17031749|NCT00728468|38176138|FG000|Overall Study|Protocol Violation|4|||
17031750|NCT00728468|38176138|FG000|Overall Study|Objective progression or relapse|9|||
17031751|NCT00728468|38176138|FG000|Overall Study|Study terminated by sponsor|1|||
17031752|NCT00727844|38176144|FG000|Initial Randomization|Physician Decision|2|||
17031753|NCT00727844|38176145|FG001|Initial Randomization|Physician Decision|0|||
17031754|NCT00727844|38176146|FG002|Initial Randomization|Physician Decision|0|||
17031755|NCT00727844|38176147|FG003|Initial Randomization|Physician Decision|0|||
17031756|NCT00735878|38176155|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
17031757|NCT00735878|38176156|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
17031758|NCT00735878|38176157|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
17031759|NCT00695955|38176168|FG000|Cohort 1|Adverse Event|26|||
17031760|NCT00695955|38176168|FG000|Cohort 1|Protocol Violation|2|||
17031761|NCT00695955|38176168|FG000|Cohort 1|Lost to Follow-up|30|||
17031762|NCT00695955|38176168|FG000|Cohort 1|Withdrawal by Subject|25|||
17031763|NCT00695955|38176168|FG000|Cohort 1|Lack of Efficacy|3|||
17031764|NCT00695955|38176168|FG000|Cohort 1|Other|16|||
17031765|NCT00695955|38176168|FG000|Cohort 2|Adverse Event|24|||
17031766|NCT00695955|38176168|FG000|Cohort 2|Protocol Violation|5|||
17031767|NCT00695955|38176168|FG000|Cohort 2|Lost to Follow-up|38|||
17031768|NCT00695955|38176168|FG000|Cohort 2|Withdrawal by Subject|28|||
17031769|NCT00695955|38176168|FG000|Cohort 2|Lack of Efficacy|4|||
17031770|NCT00695955|38176168|FG000|Cohort 2|Other|5|||
17031771|NCT00693225|38176176|FG000|Overall Study|Lost to Follow-up|1|||
17031772|NCT00693225|38176177|FG001|Overall Study|Lost to Follow-up|2|||
17031773|NCT00693225|38176176|FG000|Overall Study|Adverse Event|1|||
17031774|NCT00693225|38176177|FG001|Overall Study|Adverse Event|3|||
17031775|NCT00735644|38176188|FG000|Overall Study|Did not receive study vaccine|0|||
17031776|NCT00735644|38176189|FG001|Overall Study|Did not receive study vaccine|1|||
17031777|NCT00735644|38176190|FG002|Overall Study|Did not receive study vaccine|0|||
17031778|NCT00735644|38176191|FG003|Overall Study|Did not receive study vaccine|0|||
17031779|NCT00735644|38176192|FG004|Overall Study|Did not receive study vaccine|0|||
17031780|NCT00735644|38176188|FG000|Overall Study|Withdrawal by Subject|0|||
17031781|NCT00735644|38176189|FG001|Overall Study|Withdrawal by Subject|1|||
17031782|NCT00735644|38176190|FG002|Overall Study|Withdrawal by Subject|1|||
17031783|NCT00735644|38176191|FG003|Overall Study|Withdrawal by Subject|1|||
17031784|NCT00735644|38176192|FG004|Overall Study|Withdrawal by Subject|0|||
17031785|NCT03718299|38176211|FG000|Overall Study|Adverse Event|1|||
17031786|NCT03718299|38176211|FG000|Overall Study|Withdrawal by Subject|6|||
17031787|NCT03718299|38176211|FG000|Overall Study|Physician Decision|2|||
17031788|NCT03718299|38176211|FG000|Overall Study|Lost to Follow-up|1|||
17136907|NCT02431702|38278475|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
17136908|NCT02431702|38278469|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
17136909|NCT02431702|38278470|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
17136910|NCT02431702|38278471|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
17136911|NCT02431702|38278472|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
17136912|NCT02431702|38278473|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
17136913|NCT02431702|38278474|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
17136914|NCT02431702|38278475|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
17136915|NCT02431702|38278469|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
17031789|NCT00724958|38176215|FG000|Overall Study|Adverse Event|28|||
17031790|NCT00724958|38176215|FG000|Overall Study|Loss of Response|40|||
17031791|NCT00724958|38176215|FG000|Overall Study|No Response|18|||
17031792|NCT00724958|38176215|FG000|Overall Study|Remission|7|||
17031793|NCT00724958|38176215|FG000|Overall Study|Other Reason|76|||
17031794|NCT00724958|38176215|FG000|Overall Study|No documentation for end of therapy|13|||
17031795|NCT00695565|38176221|FG000|Overall Study|Lost to Follow-up|4|||
17031796|NCT00695565|38176222|FG001|Overall Study|Lost to Follow-up|4|||
17031797|NCT00695565|38176221|FG000|Overall Study|Adverse Event|3|||
17031798|NCT00695565|38176222|FG001|Overall Study|Adverse Event|1|||
17031799|NCT00695565|38176221|FG000|Overall Study|Protocol Violation|3|||
17031800|NCT00695565|38176222|FG001|Overall Study|Protocol Violation|1|||
17031801|NCT00695565|38176221|FG000|Overall Study|Withdrawal by Subject|1|||
17031802|NCT00695565|38176222|FG001|Overall Study|Withdrawal by Subject|1|||
17031803|NCT00695565|38176221|FG000|Overall Study|Lack of Efficacy|1|||
17031804|NCT00695565|38176222|FG001|Overall Study|Lack of Efficacy|1|||
17031805|NCT00695565|38176221|FG000|Overall Study|Subject did not follow instructions|1|||
17031806|NCT00695565|38176222|FG001|Overall Study|Subject did not follow instructions|1|||
17031807|NCT00727532|38176228|FG000|Overall Study|Adverse Event|1|||
17031808|NCT00727532|38176228|FG000|Overall Study|Withdrawal by Subject|1|||
17031809|NCT00721214|38176232|FG000|Overall Study|Chose another center for transplant|1|||
17031810|NCT00721214|38176232|FG000|Overall Study|Death|3|||
17031811|NCT00720902|38176238|FG000|Overall Study|Withdrawal by Subject|1|||
17031812|NCT00720902|38176239|FG001|Overall Study|Withdrawal by Subject|0|||
17031813|NCT00720902|38176238|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
17031814|NCT00720902|38176239|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
17031815|NCT00695019|38176248|FG000|Overall Study|Withdrawal by Subject|8|||
17031816|NCT00695019|38176249|FG001|Overall Study|Withdrawal by Subject|6|||
17031817|NCT00695019|38176250|FG002|Overall Study|Withdrawal by Subject|4|||
17031818|NCT00695019|38176248|FG000|Overall Study|Protocol Violation|1|||
17031819|NCT00695019|38176249|FG001|Overall Study|Protocol Violation|3|||
17031820|NCT00695019|38176250|FG002|Overall Study|Protocol Violation|1|||
17031821|NCT00695019|38176248|FG000|Overall Study|Lack of Efficacy|0|||
17031822|NCT00695019|38176249|FG001|Overall Study|Lack of Efficacy|0|||
17031823|NCT00695019|38176250|FG002|Overall Study|Lack of Efficacy|1|||
17031824|NCT00695019|38176248|FG000|Overall Study|Various|4|||
17031825|NCT00695019|38176249|FG001|Overall Study|Various|5|||
17031826|NCT00695019|38176250|FG002|Overall Study|Various|4|||
17031827|NCT00694707|38176263|FG000|Overall Study|Did Not Receive Treatment|0|||
17031828|NCT00694707|38176264|FG001|Overall Study|Did Not Receive Treatment|0|||
17031829|NCT00694707|38176265|FG002|Overall Study|Did Not Receive Treatment|1|||
17031830|NCT00694707|38176266|FG003|Overall Study|Did Not Receive Treatment|1|||
17031831|NCT00694707|38176267|FG004|Overall Study|Did Not Receive Treatment|1|||
17031832|NCT00694707|38176263|FG000|Overall Study|Adverse Event|22|||
17031833|NCT00694707|38176264|FG001|Overall Study|Adverse Event|14|||
17031834|NCT00694707|38176265|FG002|Overall Study|Adverse Event|8|||
17031835|NCT00694707|38176266|FG003|Overall Study|Adverse Event|12|||
17031836|NCT00694707|38176267|FG004|Overall Study|Adverse Event|13|||
17031837|NCT00694707|38176263|FG000|Overall Study|Insufficient Therapeutic Response|33|||
17031838|NCT00694707|38176264|FG001|Overall Study|Insufficient Therapeutic Response|18|||
17031839|NCT00694707|38176265|FG002|Overall Study|Insufficient Therapeutic Response|17|||
17031840|NCT00694707|38176266|FG003|Overall Study|Insufficient Therapeutic Response|15|||
17031841|NCT00694707|38176267|FG004|Overall Study|Insufficient Therapeutic Response|10|||
17031842|NCT00694707|38176263|FG000|Overall Study|Protocol Violation|1|||
17031843|NCT00694707|38176264|FG001|Overall Study|Protocol Violation|2|||
17031844|NCT00694707|38176265|FG002|Overall Study|Protocol Violation|1|||
17031845|NCT00694707|38176266|FG003|Overall Study|Protocol Violation|3|||
17031846|NCT00694707|38176267|FG004|Overall Study|Protocol Violation|1|||
17031847|NCT00694707|38176263|FG000|Overall Study|Withdrawal of Consent|14|||
17031848|NCT00694707|38176264|FG001|Overall Study|Withdrawal of Consent|18|||
17031849|NCT00694707|38176265|FG002|Overall Study|Withdrawal of Consent|22|||
16991527|NCT00736957|38135665|FG000|Overall Study|did not attend hospital appointments|1|||
16991528|NCT00736957|38135665|FG000|Overall Study|not eligible for Treatment Period I|22|||
16991529|NCT00736957|38135665|FG000|Overall Study|Physician Decision|5|||
16991530|NCT00736879|38135673|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
16991531|NCT00736879|38135674|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
16991532|NCT00736879|38135675|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
16991533|NCT00736879|38135676|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
16991534|NCT00736879|38135673|FG000|Double Blind Treatment Period|Adverse Event|0|||
17031850|NCT00694707|38176266|FG003|Overall Study|Withdrawal of Consent|16|||
16991535|NCT00736879|38135674|FG001|Double Blind Treatment Period|Adverse Event|1|||
16991536|NCT00736879|38135675|FG002|Double Blind Treatment Period|Adverse Event|1|||
16991537|NCT00736879|38135676|FG003|Double Blind Treatment Period|Adverse Event|0|||
16991538|NCT00736879|38135673|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
16991539|NCT00736879|38135674|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
16991540|NCT00736879|38135675|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
16991541|NCT00736879|38135676|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
16991542|NCT00736879|38135673|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
16991543|NCT00736879|38135674|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
16991544|NCT00736879|38135675|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
17136916|NCT02431702|38278470|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
17136917|NCT02431702|38278471|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
17136918|NCT02431702|38278472|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
17136919|NCT02431702|38278473|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
17136920|NCT02431702|38278474|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
17136921|NCT02431702|38278475|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
17136922|NCT02431702|38278469|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
17136923|NCT02431702|38278470|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
17136924|NCT02431702|38278471|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
17136925|NCT02431702|38278472|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
17031851|NCT00694707|38176267|FG004|Overall Study|Withdrawal of Consent|15|||
17031852|NCT00694707|38176263|FG000|Overall Study|Lost to Follow-up|0|||
17031853|NCT00694707|38176264|FG001|Overall Study|Lost to Follow-up|1|||
17031854|NCT00694707|38176265|FG002|Overall Study|Lost to Follow-up|2|||
17031855|NCT00694707|38176266|FG003|Overall Study|Lost to Follow-up|0|||
17031856|NCT00694707|38176267|FG004|Overall Study|Lost to Follow-up|0|||
17031857|NCT00694707|38176263|FG000|Overall Study|Jeopardizing Parole Status|1|||
17031858|NCT00694707|38176264|FG001|Overall Study|Jeopardizing Parole Status|0|||
17031859|NCT00694707|38176265|FG002|Overall Study|Jeopardizing Parole Status|0|||
17031860|NCT00694707|38176266|FG003|Overall Study|Jeopardizing Parole Status|0|||
17031861|NCT00694707|38176267|FG004|Overall Study|Jeopardizing Parole Status|0|||
17031862|NCT00694707|38176263|FG000|Overall Study|Death in the Family|1|||
17031863|NCT00694707|38176264|FG001|Overall Study|Death in the Family|0|||
17031864|NCT00694707|38176265|FG002|Overall Study|Death in the Family|0|||
17031865|NCT00694707|38176266|FG003|Overall Study|Death in the Family|0|||
17031866|NCT00694707|38176267|FG004|Overall Study|Death in the Family|0|||
17031867|NCT00694707|38176263|FG000|Overall Study|Arrest by Police|0|||
17031868|NCT00694707|38176264|FG001|Overall Study|Arrest by Police|1|||
17031869|NCT00694707|38176265|FG002|Overall Study|Arrest by Police|0|||
17031870|NCT00694707|38176266|FG003|Overall Study|Arrest by Police|0|||
17031871|NCT00694707|38176267|FG004|Overall Study|Arrest by Police|0|||
17031872|NCT00694707|38176263|FG000|Overall Study|Administrative Reasons|0|||
17031873|NCT00694707|38176264|FG001|Overall Study|Administrative Reasons|1|||
17031874|NCT00694707|38176265|FG002|Overall Study|Administrative Reasons|0|||
17031875|NCT00694707|38176266|FG003|Overall Study|Administrative Reasons|2|||
17031876|NCT00694707|38176267|FG004|Overall Study|Administrative Reasons|0|||
17031877|NCT00694707|38176263|FG000|Overall Study|Notification of Past Head Injury|0|||
17031878|NCT00694707|38176264|FG001|Overall Study|Notification of Past Head Injury|0|||
17031879|NCT00694707|38176265|FG002|Overall Study|Notification of Past Head Injury|0|||
17031880|NCT00694707|38176266|FG003|Overall Study|Notification of Past Head Injury|1|||
17031881|NCT00694707|38176267|FG004|Overall Study|Notification of Past Head Injury|0|||
17031882|NCT00692913|38176281|FG000|Overall Study|Adverse Event|8|||
17031883|NCT00692913|38176282|FG001|Overall Study|Adverse Event|4|||
17031884|NCT00692913|38176281|FG000|Overall Study|Lost to Follow-up|3|||
17031885|NCT00692913|38176282|FG001|Overall Study|Lost to Follow-up|5|||
17031886|NCT00692913|38176281|FG000|Overall Study|Physician Decision|2|||
17031887|NCT00692913|38176282|FG001|Overall Study|Physician Decision|0|||
17031888|NCT00692913|38176281|FG000|Overall Study|Protocol Violation|1|||
17031889|NCT00692913|38176282|FG001|Overall Study|Protocol Violation|1|||
17031890|NCT00692913|38176281|FG000|Overall Study|Withdrawal by Subject|15|||
17031891|NCT00692913|38176282|FG001|Overall Study|Withdrawal by Subject|20|||
17031892|NCT00694551|38176291|FG000|Overall Study|Disease Progression|1|||
17031893|NCT00694551|38176292|FG001|Overall Study|Disease Progression|0|||
17031894|NCT00694551|38176293|FG002|Overall Study|Disease Progression|1|||
17031895|NCT00689871|38176306|FG000|Overall Study|Lost to Follow-up|123|||
17136926|NCT02431702|38278473|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
17136927|NCT02431702|38278474|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
17136928|NCT02431702|38278475|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
16991545|NCT00736879|38135676|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
17031896|NCT00689871|38176307|FG001|Overall Study|Lost to Follow-up|13|||
17031897|NCT00689871|38176308|FG002|Overall Study|Lost to Follow-up|37|||
17031898|NCT00689871|38176309|FG003|Overall Study|Lost to Follow-up|1|||
17031899|NCT00689871|38176306|FG000|Overall Study|Explanted of All Study Devices|36|||
17031900|NCT00689871|38176307|FG001|Overall Study|Explanted of All Study Devices|25|||
17136929|NCT02086552|38278508|FG000|Overall Study|Withdrawal by Subject|1|||
17031901|NCT00689871|38176308|FG002|Overall Study|Explanted of All Study Devices|29|||
17031902|NCT00689871|38176309|FG003|Overall Study|Explanted of All Study Devices|3|||
17031903|NCT00689871|38176306|FG000|Overall Study|Withdrawal by Subject|13|||
17031904|NCT00689871|38176307|FG001|Overall Study|Withdrawal by Subject|3|||
17031905|NCT00689871|38176308|FG002|Overall Study|Withdrawal by Subject|4|||
17031906|NCT00689871|38176309|FG003|Overall Study|Withdrawal by Subject|1|||
17031907|NCT00689871|38176306|FG000|Overall Study|Death|1|||
17031908|NCT00689871|38176307|FG001|Overall Study|Death|10|||
17031909|NCT00689871|38176308|FG002|Overall Study|Death|2|||
17031910|NCT00689871|38176309|FG003|Overall Study|Death|2|||
17031911|NCT00689871|38176306|FG000|Overall Study|Physician Decision|2|||
17031912|NCT00689871|38176307|FG001|Overall Study|Physician Decision|1|||
17031913|NCT00689871|38176308|FG002|Overall Study|Physician Decision|1|||
17031914|NCT00689871|38176309|FG003|Overall Study|Physician Decision|0|||
17136930|NCT03131570|38278553|FG000|Overall Study|Adverse Event|1|||
17136931|NCT03131570|38278554|FG001|Overall Study|Adverse Event|0|||
17136932|NCT02930018|38278564|FG000|Overall Study|Lost to Follow-up|1|||
17136933|NCT02930018|38278565|FG001|Overall Study|Lost to Follow-up|1|||
17136934|NCT02930018|38278564|FG000|Overall Study|Withdrawal by Subject|5|||
17136935|NCT02930018|38278565|FG001|Overall Study|Withdrawal by Subject|2|||
17136936|NCT02875028|38278573|FG000|Washout Period|Withdrawal by Subject|0|||
17136937|NCT02875028|38278574|FG001|Washout Period|Withdrawal by Subject|1|||
17031915|NCT00793793|38176331|FG000|Overall Study|Adverse Event|0|||
17031916|NCT00793793|38176332|FG001|Overall Study|Adverse Event|0|||
17031917|NCT00793793|38176333|FG002|Overall Study|Adverse Event|1|||
17031918|NCT00793793|38176334|FG003|Overall Study|Adverse Event|1|||
17031919|NCT00793793|38176335|FG004|Overall Study|Adverse Event|0|||
17031920|NCT00793793|38176336|FG005|Overall Study|Adverse Event|1|||
17031921|NCT00793793|38176337|FG006|Overall Study|Adverse Event|2|||
17031922|NCT00793793|38176338|FG007|Overall Study|Adverse Event|0|||
17031923|NCT00793793|38176339|FG008|Overall Study|Adverse Event|0|||
17031924|NCT00793793|38176340|FG009|Overall Study|Adverse Event|0|||
17031925|NCT00793793|38176341|FG010|Overall Study|Adverse Event|0|||
16991546|NCT00736879|38135673|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
16991547|NCT00736879|38135674|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
16991548|NCT00736879|38135675|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
17031926|NCT00793793|38176342|FG011|Overall Study|Adverse Event|2|||
17031927|NCT00793793|38176331|FG000|Overall Study|Protocol Violation|0|||
17031928|NCT00793793|38176332|FG001|Overall Study|Protocol Violation|0|||
17031929|NCT00793793|38176333|FG002|Overall Study|Protocol Violation|0|||
17031930|NCT00793793|38176334|FG003|Overall Study|Protocol Violation|1|||
17031931|NCT00793793|38176335|FG004|Overall Study|Protocol Violation|0|||
17031932|NCT00793793|38176336|FG005|Overall Study|Protocol Violation|0|||
17031933|NCT00793793|38176337|FG006|Overall Study|Protocol Violation|0|||
17031934|NCT00793793|38176338|FG007|Overall Study|Protocol Violation|0|||
17031935|NCT00793793|38176339|FG008|Overall Study|Protocol Violation|0|||
17031936|NCT00793793|38176340|FG009|Overall Study|Protocol Violation|0|||
17031937|NCT00793793|38176341|FG010|Overall Study|Protocol Violation|0|||
17031938|NCT00793793|38176342|FG011|Overall Study|Protocol Violation|0|||
17031939|NCT00793793|38176331|FG000|Overall Study|Lost to Follow-up|0|||
17031940|NCT00793793|38176332|FG001|Overall Study|Lost to Follow-up|0|||
17031941|NCT00793793|38176333|FG002|Overall Study|Lost to Follow-up|1|||
17031942|NCT00793793|38176334|FG003|Overall Study|Lost to Follow-up|0|||
17031943|NCT00793793|38176335|FG004|Overall Study|Lost to Follow-up|0|||
17031944|NCT00793793|38176336|FG005|Overall Study|Lost to Follow-up|0|||
17031945|NCT00793793|38176337|FG006|Overall Study|Lost to Follow-up|0|||
17031946|NCT00793793|38176338|FG007|Overall Study|Lost to Follow-up|0|||
17031947|NCT00793793|38176339|FG008|Overall Study|Lost to Follow-up|1|||
17031948|NCT00793793|38176340|FG009|Overall Study|Lost to Follow-up|3|||
17031949|NCT00793793|38176341|FG010|Overall Study|Lost to Follow-up|1|||
17031950|NCT00793793|38176342|FG011|Overall Study|Lost to Follow-up|0|||
17031951|NCT00793793|38176331|FG000|Overall Study|Withdrawal by Subject|0|||
17031952|NCT00793793|38176332|FG001|Overall Study|Withdrawal by Subject|0|||
17031953|NCT00793793|38176333|FG002|Overall Study|Withdrawal by Subject|0|||
17031954|NCT00793793|38176334|FG003|Overall Study|Withdrawal by Subject|0|||
17136938|NCT00943618|38278585|FG000|Overall Study|Lost to Follow-up|38|||
17136939|NCT00943618|38278586|FG001|Overall Study|Lost to Follow-up|48|||
16991549|NCT00736879|38135676|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
16991550|NCT00736879|38135673|FG000|Double Blind Treatment Period|No longer met criteria|0|||
16991551|NCT00736879|38135674|FG001|Double Blind Treatment Period|No longer met criteria|1|||
16991552|NCT00736879|38135675|FG002|Double Blind Treatment Period|No longer met criteria|0|||
16997766|NCT00732472|38141788|FG000|Overall Study|Adverse Event|0|||
17031955|NCT00793793|38176335|FG004|Overall Study|Withdrawal by Subject|1|||
17031956|NCT00793793|38176336|FG005|Overall Study|Withdrawal by Subject|0|||
17031957|NCT00793793|38176337|FG006|Overall Study|Withdrawal by Subject|0|||
17031958|NCT00793793|38176338|FG007|Overall Study|Withdrawal by Subject|0|||
17031959|NCT00793793|38176339|FG008|Overall Study|Withdrawal by Subject|1|||
17031960|NCT00793793|38176340|FG009|Overall Study|Withdrawal by Subject|0|||
17031961|NCT00793793|38176341|FG010|Overall Study|Withdrawal by Subject|0|||
17031962|NCT00793793|38176342|FG011|Overall Study|Withdrawal by Subject|0|||
17031963|NCT00793793|38176331|FG000|Overall Study|reason not specified|0|||
17031964|NCT00793793|38176332|FG001|Overall Study|reason not specified|1|||
17031965|NCT00793793|38176333|FG002|Overall Study|reason not specified|0|||
17031966|NCT00793793|38176334|FG003|Overall Study|reason not specified|1|||
17031967|NCT00793793|38176335|FG004|Overall Study|reason not specified|1|||
17031968|NCT00793793|38176336|FG005|Overall Study|reason not specified|1|||
17031969|NCT00793793|38176337|FG006|Overall Study|reason not specified|2|||
17031970|NCT00793793|38176338|FG007|Overall Study|reason not specified|0|||
17031971|NCT00793793|38176339|FG008|Overall Study|reason not specified|7|||
17031972|NCT00793793|38176340|FG009|Overall Study|reason not specified|6|||
17031973|NCT00793793|38176341|FG010|Overall Study|reason not specified|2|||
17031974|NCT00793793|38176342|FG011|Overall Study|reason not specified|4|||
17031975|NCT00776789|38176390|FG000|Overall Study|Consent refusal|2|||
17031976|NCT00776789|38176391|FG001|Overall Study|Consent refusal|2|||
17031977|NCT00776789|38176390|FG000|Overall Study|Poor quality video|1|||
17031978|NCT00776789|38176391|FG001|Overall Study|Poor quality video|1|||
17031979|NCT00776555|38176401|FG000|Overall Study|Study terminated|3|||
17031980|NCT00776555|38176402|FG001|Overall Study|Study terminated|0|||
17031981|NCT00720434|38176412|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
17031982|NCT00720434|38176413|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
17031983|NCT00720434|38176414|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
17031984|NCT00720434|38176415|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
17031985|NCT00720434|38176412|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
17031986|NCT00720434|38176413|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
17031987|NCT00720434|38176414|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
17031988|NCT00720434|38176415|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
16991553|NCT00736879|38135676|FG003|Double Blind Treatment Period|No longer met criteria|0|||
16991554|NCT00736879|38135673|FG000|Double Blind Treatment Period|non-specified|0|||
16991555|NCT00736879|38135674|FG001|Double Blind Treatment Period|non-specified|1|||
16991556|NCT00736879|38135675|FG002|Double Blind Treatment Period|non-specified|0|||
16991557|NCT00736879|38135676|FG003|Double Blind Treatment Period|non-specified|0|||
16991558|NCT00736879|38135673|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
16991559|NCT00736879|38135674|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
16991560|NCT00736879|38135675|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
17031989|NCT00720434|38176412|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
16991561|NCT00736879|38135676|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
17031990|NCT00720434|38176413|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
16991562|NCT00736879|38135673|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
16991563|NCT00736879|38135674|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
16991564|NCT00736879|38135675|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
16991565|NCT00736879|38135676|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
16991566|NCT00806260|38135695|FG000|Period 1 (1 Day)|Adverse Event|0|||
16991567|NCT00806260|38135696|FG001|Period 1 (1 Day)|Adverse Event|0|||
16991568|NCT00806260|38135697|FG002|Period 1 (1 Day)|Adverse Event|0|||
16991569|NCT00806260|38135698|FG003|Period 1 (1 Day)|Adverse Event|0|||
16991570|NCT00806260|38135699|FG004|Period 1 (1 Day)|Adverse Event|3|||
16991571|NCT00806260|38135700|FG005|Period 1 (1 Day)|Adverse Event|0|||
17031991|NCT00720434|38176414|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
17031992|NCT00720434|38176415|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
17031993|NCT00720434|38176412|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
17031994|NCT00720434|38176413|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
17031995|NCT00720434|38176414|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
16991572|NCT00806260|38135695|FG000|Period 2|Adverse Event|0|||
16991573|NCT00806260|38135696|FG001|Period 2|Adverse Event|0|||
16991574|NCT00806260|38135697|FG002|Period 2|Adverse Event|0|||
16991575|NCT00806260|38135698|FG003|Period 2|Adverse Event|1|||
16991576|NCT00806260|38135699|FG004|Period 2|Adverse Event|0|||
16991577|NCT00806260|38135700|FG005|Period 2|Adverse Event|0|||
16991578|NCT00806260|38135695|FG000|Period 2|Protocol Violation|1|||
16991579|NCT00806260|38135696|FG001|Period 2|Protocol Violation|0|||
17031996|NCT00720434|38176415|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
17031997|NCT00720434|38176412|FG000|Open-Label Period (Week 5-72)|Other|4|||
17031998|NCT00720434|38176413|FG001|Open-Label Period (Week 5-72)|Other|3|||
17031999|NCT00720434|38176414|FG002|Open-Label Period (Week 5-72)|Other|3|||
17032000|NCT00720434|38176415|FG003|Open-Label Period (Week 5-72)|Other|2|||
17032001|NCT00776009|38176431|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
17032002|NCT00776009|38176432|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
17032003|NCT00776009|38176433|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
17032004|NCT00776009|38176434|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
17136940|NCT00943618|38278587|FG002|Overall Study|Lost to Follow-up|20|||
17136941|NCT00943618|38278585|FG000|Overall Study|Discontinued Medication|17|||
17136942|NCT00943618|38278586|FG001|Overall Study|Discontinued Medication|29|||
17136943|NCT00943618|38278587|FG002|Overall Study|Discontinued Medication|11|||
16991580|NCT00806260|38135697|FG002|Period 2|Protocol Violation|1|||
16991581|NCT00806260|38135698|FG003|Period 2|Protocol Violation|0|||
16991582|NCT00806260|38135699|FG004|Period 2|Protocol Violation|0|||
16991583|NCT00806260|38135700|FG005|Period 2|Protocol Violation|0|||
16991584|NCT00806260|38135695|FG000|Period 2|Need to take concomitant medication|1|||
16991585|NCT00806260|38135696|FG001|Period 2|Need to take concomitant medication|0|||
16991586|NCT00806260|38135697|FG002|Period 2|Need to take concomitant medication|0|||
16991587|NCT00806260|38135698|FG003|Period 2|Need to take concomitant medication|0|||
16991588|NCT00806260|38135699|FG004|Period 2|Need to take concomitant medication|0|||
16991589|NCT00806260|38135700|FG005|Period 2|Need to take concomitant medication|0|||
16991590|NCT00806260|38135695|FG000|Period 2|sponsor request|0|||
16991591|NCT00806260|38135696|FG001|Period 2|sponsor request|0|||
16991592|NCT00806260|38135697|FG002|Period 2|sponsor request|1|||
16991593|NCT00806260|38135698|FG003|Period 2|sponsor request|1|||
16991594|NCT00806260|38135699|FG004|Period 2|sponsor request|0|||
16991595|NCT00806260|38135700|FG005|Period 2|sponsor request|0|||
16991596|NCT00806260|38135695|FG000|Period 3|Protocol Violation|0|||
16991597|NCT00806260|38135696|FG001|Period 3|Protocol Violation|1|||
16991598|NCT00806260|38135697|FG002|Period 3|Protocol Violation|1|||
16991599|NCT00806260|38135698|FG003|Period 3|Protocol Violation|0|||
16991600|NCT00806260|38135699|FG004|Period 3|Protocol Violation|0|||
16991601|NCT00806260|38135700|FG005|Period 3|Protocol Violation|0|||
16991602|NCT00806260|38135695|FG000|Period 3|Pregnancy|1|||
16991603|NCT00806260|38135696|FG001|Period 3|Pregnancy|0|||
16991604|NCT00806260|38135697|FG002|Period 3|Pregnancy|0|||
16991605|NCT00806260|38135698|FG003|Period 3|Pregnancy|0|||
16991606|NCT00806260|38135699|FG004|Period 3|Pregnancy|0|||
16991607|NCT00806260|38135700|FG005|Period 3|Pregnancy|0|||
16991608|NCT00742885|38135714|FG000|Overall Study|Lost to Follow-up|1|||
16991609|NCT00742885|38135715|FG001|Overall Study|Lost to Follow-up|0|||
16991610|NCT00811174|38135724|FG000|Overall Study|Protocol Violation|2|||
16991611|NCT00811174|38135724|FG000|Overall Study|Sponsors Decision|1|||
16991612|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
16991613|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
16991614|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
16991615|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
16991616|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
16991617|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
16991618|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
16991619|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
16991620|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
16991621|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
16991622|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
16991623|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
16991624|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
16991625|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
16991626|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
16991627|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
16991628|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
16991629|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
16991630|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
16991631|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
16991632|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
16991633|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
16991634|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
16991635|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
16991636|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
16991637|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
16991638|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
16991639|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
16991640|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
16991641|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
16991642|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
16991643|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
16991644|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
16991645|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
16991646|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
16991647|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
16991648|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
16991649|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
16991650|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
16991651|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
16991652|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
16991653|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
16991654|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
16991655|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
16991656|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
16991657|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
16991658|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
16991659|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
16991660|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
16991661|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
16991662|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
16991663|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
16991664|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
16991665|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
16991666|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
16991667|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
16991668|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
16991669|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
16991670|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
16991671|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
16991672|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
16991673|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
16991674|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
16991675|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
16991676|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
16991677|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
16991678|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
16991679|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
16991680|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
16991681|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
16991682|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Change of location|0|||
16991683|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Change of location|0|||
16991684|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Change of location|0|||
16991685|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Change of location|1|||
16991686|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Change of location|0|||
16991687|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
16991688|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
16991689|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
16991690|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
16991691|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
16991692|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
16991693|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
16991694|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
16991695|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
16997767|NCT00732472|38141789|FG001|Overall Study|Adverse Event|1|||
17032005|NCT00776009|38176435|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
17032006|NCT00776009|38176436|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
17032007|NCT00776009|38176431|FG000|Period 1: First Intervention|Protocol Violation|0|||
17032008|NCT00776009|38176432|FG001|Period 1: First Intervention|Protocol Violation|1|||
17032009|NCT00776009|38176433|FG002|Period 1: First Intervention|Protocol Violation|0|||
17032010|NCT00776009|38176434|FG003|Period 1: First Intervention|Protocol Violation|0|||
17032011|NCT00776009|38176435|FG004|Period 1: First Intervention|Protocol Violation|1|||
17032012|NCT00776009|38176436|FG005|Period 1: First Intervention|Protocol Violation|0|||
17032013|NCT00776009|38176431|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
17032014|NCT00776009|38176432|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
17032015|NCT00776009|38176433|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
17032016|NCT00776009|38176434|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
17136944|NCT02710084|38278610|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
17136945|NCT02710084|38278611|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
17032017|NCT00776009|38176435|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
16780407|NCT02728895|37719527|FG001|Overall Study|Other|2|||
17032018|NCT00776009|38176436|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
17032019|NCT00776009|38176431|FG000|Period 2: Second Intervention|Protocol Violation|1|||
17032020|NCT00776009|38176432|FG001|Period 2: Second Intervention|Protocol Violation|0|||
17032021|NCT00776009|38176433|FG002|Period 2: Second Intervention|Protocol Violation|1|||
17032022|NCT00776009|38176434|FG003|Period 2: Second Intervention|Protocol Violation|0|||
17032023|NCT00776009|38176435|FG004|Period 2: Second Intervention|Protocol Violation|0|||
17032024|NCT00776009|38176436|FG005|Period 2: Second Intervention|Protocol Violation|0|||
17032025|NCT00776009|38176431|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
17032026|NCT00776009|38176432|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
17032027|NCT00776009|38176433|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
17032028|NCT00776009|38176434|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
16991696|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
16991697|NCT00730405|38135733|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
16991698|NCT00730405|38135734|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
16991699|NCT00730405|38135735|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
16991700|NCT00730405|38135736|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
16991701|NCT00730405|38135737|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
16991702|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
16991703|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
16991704|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
16991705|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
16991706|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
16991707|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
16991708|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
17032029|NCT00776009|38176435|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
17032030|NCT00776009|38176436|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
17032031|NCT00694161|38176444|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
17032032|NCT00694161|38176444|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
17032033|NCT00694161|38176444|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
17032034|NCT00720356|38176448|FG000|Registration to Study|Determined to have methylated MGMT|67|||
17032035|NCT00720356|38176448|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
17032036|NCT00720356|38176448|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
17032037|NCT00720356|38176448|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
17032038|NCT00720356|38176448|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
17032039|NCT00720356|38176448|FG000|Follow up Until Death|Withdrawal by Subject|1|||
17032040|NCT00720356|38176448|FG000|Follow up Until Death|Alive at last data collection|4|||
17032041|NCT00720278|38176455|FG000|Overall Study|Adverse Event|5|||
17032042|NCT00720278|38176456|FG001|Overall Study|Adverse Event|3|||
17032043|NCT00720278|38176457|FG002|Overall Study|Adverse Event|4|||
17032044|NCT00720278|38176455|FG000|Overall Study|Withdrawal by Subject|0|||
17032045|NCT00720278|38176456|FG001|Overall Study|Withdrawal by Subject|1|||
17032046|NCT00720278|38176457|FG002|Overall Study|Withdrawal by Subject|0|||
17032047|NCT00720278|38176455|FG000|Overall Study|Lost to Follow-up|0|||
17032048|NCT00720278|38176456|FG001|Overall Study|Lost to Follow-up|0|||
17032049|NCT00720278|38176457|FG002|Overall Study|Lost to Follow-up|1|||
17032050|NCT00720278|38176455|FG000|Overall Study|Non-compliance|1|||
17032051|NCT00720278|38176456|FG001|Overall Study|Non-compliance|0|||
17032052|NCT00720278|38176457|FG002|Overall Study|Non-compliance|0|||
17032053|NCT00720278|38176455|FG000|Overall Study|eligibility criteria violation|1|||
17032054|NCT00720278|38176456|FG001|Overall Study|eligibility criteria violation|0|||
17032055|NCT00720278|38176457|FG002|Overall Study|eligibility criteria violation|1|||
17032056|NCT00720122|38176465|FG000|Overall Study|Lost to Follow-up|1|||
17032057|NCT00720122|38176465|FG000|Overall Study|Physician Decision|1|||
17032058|NCT00720122|38176465|FG000|Overall Study|Withdrawal by Subject|7|||
17032059|NCT00717860|38176471|FG000|Overall Study|Clinical adverse experience|5|||
17032060|NCT00717860|38176472|FG001|Overall Study|Clinical adverse experience|9|||
17032061|NCT00717860|38176471|FG000|Overall Study|Laboratory adverse experience|2|||
17032062|NCT00717860|38176472|FG001|Overall Study|Laboratory adverse experience|2|||
17032063|NCT00717860|38176471|FG000|Overall Study|Lack of Efficacy|7|||
17032064|NCT00717860|38176472|FG001|Overall Study|Lack of Efficacy|13|||
17032065|NCT00717860|38176471|FG000|Overall Study|Discontinued for other reason|6|||
17032066|NCT00717860|38176472|FG001|Overall Study|Discontinued for other reason|1|||
17032067|NCT00717860|38176471|FG000|Overall Study|Withdrew consent|7|||
17032068|NCT00717860|38176472|FG001|Overall Study|Withdrew consent|3|||
17032069|NCT00717314|38176480|FG000|Overall Study|Adverse Event|3|||
17032070|NCT00717314|38176481|FG001|Overall Study|Adverse Event|2|||
17032071|NCT00717314|38176480|FG000|Overall Study|Protocol Violation|1|||
17032072|NCT00717314|38176481|FG001|Overall Study|Protocol Violation|0|||
17032073|NCT00717314|38176480|FG000|Overall Study|Lost to Follow-up|1|||
17032074|NCT00717314|38176481|FG001|Overall Study|Lost to Follow-up|5|||
17032075|NCT00717314|38176480|FG000|Overall Study|Withdrawal by Subject|1|||
17032076|NCT00717314|38176481|FG001|Overall Study|Withdrawal by Subject|3|||
17032077|NCT00689793|38176489|FG000|Overall Study|Lost to Follow-up|4|||
17032078|NCT00689793|38176490|FG001|Overall Study|Lost to Follow-up|5|||
17032079|NCT00723944|38176500|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
17032080|NCT00723944|38176501|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
17032081|NCT00723944|38176500|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
17032082|NCT00723944|38176501|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
17032083|NCT00723944|38176500|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
17032084|NCT00723944|38176501|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
17032085|NCT00689481|38176509|FG000|Overall Study|Adverse Event|7|||
17032086|NCT00689481|38176510|FG001|Overall Study|Adverse Event|1|||
17032087|NCT00689481|38176509|FG000|Overall Study|Lost to Follow-up|4|||
17032088|NCT00689481|38176510|FG001|Overall Study|Lost to Follow-up|3|||
17032089|NCT00689481|38176509|FG000|Overall Study|Lack of Efficacy|4|||
17032090|NCT00689481|38176510|FG001|Overall Study|Lack of Efficacy|3|||
17032091|NCT00689481|38176509|FG000|Overall Study|Non-compliance with study treatment|1|||
17032092|NCT00689481|38176510|FG001|Overall Study|Non-compliance with study treatment|1|||
17032093|NCT00689481|38176509|FG000|Overall Study|Withdrawal by Subject|8|||
17032094|NCT00689481|38176510|FG001|Overall Study|Withdrawal by Subject|4|||
17032095|NCT00689481|38176509|FG000|Overall Study|Excluded medication started during study|0|||
17032096|NCT00689481|38176510|FG001|Overall Study|Excluded medication started during study|1|||
17032097|NCT00689481|38176509|FG000|Overall Study|Subject early term, left on vacation|0|||
17032098|NCT00689481|38176510|FG001|Overall Study|Subject early term, left on vacation|1|||
17032099|NCT00688701|38176519|FG000|Overall Study|Adverse Event|1|||
17032100|NCT00688701|38176520|FG001|Overall Study|Adverse Event|0|||
17032101|NCT00688701|38176521|FG002|Overall Study|Adverse Event|5|||
17032102|NCT00688701|38176522|FG003|Overall Study|Adverse Event|3|||
17032103|NCT00688701|38176519|FG000|Overall Study|Lack of Efficacy|0|||
17032104|NCT00688701|38176520|FG001|Overall Study|Lack of Efficacy|1|||
17032105|NCT00688701|38176521|FG002|Overall Study|Lack of Efficacy|0|||
17032106|NCT00688701|38176522|FG003|Overall Study|Lack of Efficacy|0|||
17032107|NCT00688701|38176519|FG000|Overall Study|Withdrawal by Subject|3|||
17032108|NCT00688701|38176520|FG001|Overall Study|Withdrawal by Subject|3|||
17032109|NCT00688701|38176521|FG002|Overall Study|Withdrawal by Subject|4|||
17032110|NCT00688701|38176522|FG003|Overall Study|Withdrawal by Subject|8|||
17032111|NCT00688701|38176519|FG000|Overall Study|Poor compliance to protocol|0|||
17032112|NCT00688701|38176520|FG001|Overall Study|Poor compliance to protocol|1|||
17032113|NCT00688701|38176521|FG002|Overall Study|Poor compliance to protocol|1|||
17032114|NCT00688701|38176522|FG003|Overall Study|Poor compliance to protocol|0|||
17032115|NCT00688623|38176542|FG000|Overall Study|Adverse Event|22|||
17032116|NCT00688623|38176542|FG000|Overall Study|abnormal lab value|1|||
17032117|NCT00688623|38176542|FG000|Overall Study|Withdrawal by Subject|4|||
17032118|NCT00688623|38176542|FG000|Overall Study|Death|3|||
17032119|NCT00688623|38176542|FG000|Overall Study|disease progression|23|||
17032120|NCT00688623|38176542|FG000|Overall Study|Protocol Violation|2|||
17032121|NCT00717236|38176548|FG000|Double-Blind Period|Adverse Event|33|||
17032122|NCT00717236|38176549|FG001|Double-Blind Period|Adverse Event|6|||
17032123|NCT00717236|38176548|FG000|Double-Blind Period|Lack of Efficacy|6|||
17032124|NCT00717236|38176549|FG001|Double-Blind Period|Lack of Efficacy|6|||
17032125|NCT00717236|38176548|FG000|Double-Blind Period|Lost to Follow-up|3|||
17032126|NCT00717236|38176549|FG001|Double-Blind Period|Lost to Follow-up|5|||
17032127|NCT00717236|38176548|FG000|Double-Blind Period|Withdrawal by Subject|10|||
17032128|NCT00717236|38176549|FG001|Double-Blind Period|Withdrawal by Subject|2|||
17032129|NCT00717236|38176548|FG000|Double-Blind Period|Loss of efficacy|3|||
17032130|NCT00717236|38176549|FG001|Double-Blind Period|Loss of efficacy|0|||
17032131|NCT00717236|38176548|FG000|Double-Blind Period|Other: Death|1|||
17032132|NCT00717236|38176549|FG001|Double-Blind Period|Other: Death|0|||
17032133|NCT00717236|38176548|FG000|Double-Blind Period|Other: Pregnancy|1|||
17032134|NCT00717236|38176549|FG001|Double-Blind Period|Other: Pregnancy|0|||
17032135|NCT00717236|38176548|FG000|Double-Blind Period|Other: Protocol Violation|2|||
17032136|NCT00717236|38176549|FG001|Double-Blind Period|Other: Protocol Violation|0|||
17032137|NCT00717236|38176548|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
17032138|NCT00717236|38176549|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
17032139|NCT00717236|38176548|FG000|Double-Blind Period|Other: Site withdrew|2|||
17032140|NCT00717236|38176549|FG001|Double-Blind Period|Other: Site withdrew|0|||
17032141|NCT00717236|38176548|FG000|Double-Blind Period|Other: Screening failure|1|||
17032142|NCT00717236|38176549|FG001|Double-Blind Period|Other: Screening failure|0|||
17032143|NCT00717236|38176548|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
17032144|NCT00717236|38176549|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
17032145|NCT00717236|38176548|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
17032146|NCT00717236|38176549|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
17032147|NCT00717236|38176548|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
17032148|NCT00717236|38176549|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
17032149|NCT00717236|38176548|FG000|Double-Blind Period|Other: History of cancer|1|||
17032150|NCT00717236|38176549|FG001|Double-Blind Period|Other: History of cancer|0|||
17032151|NCT00717236|38176548|FG000|Double-Blind Period|Other: Sponsor request|1|||
17032152|NCT00717236|38176549|FG001|Double-Blind Period|Other: Sponsor request|0|||
17136946|NCT02849990|38278618|FG000|Overall Study|Adverse Event|1|||
17136947|NCT02849990|38278618|FG000|Overall Study|Withdrawal by Subject|1|||
17136948|NCT02017964|38278622|FG000|Overall Study|Patient deemed ineligible|1|||
17032153|NCT00717236|38176548|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
17032154|NCT00717236|38176549|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
17032155|NCT00717236|38176548|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
17032156|NCT00717236|38176549|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
17032157|NCT00717236|38176548|FG000|Double-Blind Period|Other: Subject moved|1|||
17032158|NCT00717236|38176549|FG001|Double-Blind Period|Other: Subject moved|1|||
17032159|NCT00717236|38176548|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
17032160|NCT00717236|38176549|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
17032161|NCT00717236|38176548|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
17032162|NCT00717236|38176549|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
17032163|NCT00717236|38176548|FG000|Double-Blind Period|Other: Transportation problems|0|||
17032164|NCT00717236|38176549|FG001|Double-Blind Period|Other: Transportation problems|1|||
17032165|NCT00717236|38176548|FG000|Double-Blind Period|Other: Investigator Decision|0|||
17032166|NCT00717236|38176549|FG001|Double-Blind Period|Other: Investigator Decision|1|||
17032167|NCT00717236|38176548|FG000|Open-Label Period|Adverse Event|29|||
17032168|NCT00717236|38176549|FG001|Open-Label Period|Adverse Event|4|||
17032169|NCT00717236|38176548|FG000|Open-Label Period|Lack of Efficacy|30|||
17032170|NCT00717236|38176549|FG001|Open-Label Period|Lack of Efficacy|8|||
17032171|NCT00717236|38176548|FG000|Open-Label Period|Lost to Follow-up|28|||
17032172|NCT00717236|38176549|FG001|Open-Label Period|Lost to Follow-up|4|||
17032173|NCT00717236|38176548|FG000|Open-Label Period|Withdrawal by Subject|20|||
17032174|NCT00717236|38176549|FG001|Open-Label Period|Withdrawal by Subject|2|||
17032175|NCT00717236|38176548|FG000|Open-Label Period|Loss of Efficacy|6|||
17032176|NCT00717236|38176549|FG001|Open-Label Period|Loss of Efficacy|1|||
17032177|NCT00717236|38176548|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
17032178|NCT00717236|38176549|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
17032179|NCT00717236|38176548|FG000|Open-Label Period|Other: Lack of Compliance|1|||
17032180|NCT00717236|38176549|FG001|Open-Label Period|Other: Lack of Compliance|1|||
17032181|NCT00717236|38176548|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
17032182|NCT00717236|38176549|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
17032183|NCT00717236|38176548|FG000|Open-Label Period|Other: Moved|1|||
17032184|NCT00717236|38176549|FG001|Open-Label Period|Other: Moved|0|||
17032185|NCT00717236|38176548|FG000|Open-Label Period|Other: Investigator Decision|1|||
17032186|NCT00717236|38176549|FG001|Open-Label Period|Other: Investigator Decision|0|||
17032187|NCT00717236|38176548|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
17032188|NCT00717236|38176549|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
17032189|NCT00717236|38176548|FG000|Open-Label Period|Other: Sponsor Request|3|||
17032190|NCT00717236|38176549|FG001|Open-Label Period|Other: Sponsor Request|0|||
17032191|NCT00717236|38176548|FG000|Open-Label Period|Other: Cataract Surgery|1|||
17032192|NCT00717236|38176549|FG001|Open-Label Period|Other: Cataract Surgery|0|||
17032193|NCT00717236|38176548|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
17032194|NCT00717236|38176549|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
17136949|NCT01956110|38278628|FG000|Overall Study|Protocol Violation|25|||
17136950|NCT01956110|38278629|FG001|Overall Study|Protocol Violation|11|||
17136951|NCT01956110|38278628|FG000|Overall Study|Adverse Event|9|||
17136952|NCT01956110|38278629|FG001|Overall Study|Adverse Event|10|||
17136953|NCT01956110|38278628|FG000|Overall Study|Personal reasons|1|||
17136954|NCT01956110|38278629|FG001|Overall Study|Personal reasons|1|||
17136955|NCT03116828|38278651|FG000|Overall Study|Adverse Event|1|||
17136956|NCT03116828|38278652|FG001|Overall Study|Adverse Event|10|||
17136957|NCT03116828|38278651|FG000|Overall Study|Withdrawal by Subject|4|||
17136958|NCT03116828|38278652|FG001|Overall Study|Withdrawal by Subject|8|||
17136959|NCT03116828|38278651|FG000|Overall Study|OTHER|3|||
17136960|NCT03116828|38278652|FG001|Overall Study|OTHER|3|||
17136961|NCT03938272|38278660|FG000|Overall Study|Withdrawal by Subject|1|||
17136962|NCT03938272|38278661|FG001|Overall Study|Withdrawal by Subject|0|||
17136963|NCT03938272|38278660|FG000|Overall Study|Physician Decision|0|||
17136964|NCT03938272|38278661|FG001|Overall Study|Physician Decision|2|||
17136965|NCT03938272|38278660|FG000|Overall Study|Study termination by sponsor|10|||
17136966|NCT03938272|38278661|FG001|Overall Study|Study termination by sponsor|8|||
17032195|NCT00717236|38176548|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
17032196|NCT00717236|38176549|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
17032197|NCT00717236|38176548|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
17136967|NCT02565914|38278667|FG000|Overall Study|Adverse Event|17|||
17136968|NCT02565914|38278667|FG000|Overall Study|Withdrawal of consent (not due to AE)|25|||
17136969|NCT02565914|38278667|FG000|Overall Study|Lost to Follow-up|12|||
17136970|NCT02565914|38278667|FG000|Overall Study|Death (not treatment emergent)|1|||
17136971|NCT02565914|38278667|FG000|Overall Study|Other noncompliance|6|||
17032198|NCT00717236|38176549|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
17032199|NCT00719810|38176560|FG000|Overall Study|Adverse Event|0|||
17032200|NCT00719810|38176561|FG001|Overall Study|Adverse Event|2|||
17032201|NCT00719810|38176562|FG002|Overall Study|Adverse Event|3|||
17032202|NCT00719810|38176560|FG000|Overall Study|Lost to Follow-up|2|||
17032203|NCT00719810|38176561|FG001|Overall Study|Lost to Follow-up|0|||
17032204|NCT00719810|38176562|FG002|Overall Study|Lost to Follow-up|3|||
17032205|NCT00719810|38176560|FG000|Overall Study|Physician Decision|0|||
17032206|NCT00719810|38176561|FG001|Overall Study|Physician Decision|1|||
17032207|NCT00719810|38176562|FG002|Overall Study|Physician Decision|0|||
17032208|NCT00719810|38176560|FG000|Overall Study|Withdrawal by Subject|1|||
17032209|NCT00719810|38176561|FG001|Overall Study|Withdrawal by Subject|1|||
17032210|NCT00719810|38176562|FG002|Overall Study|Withdrawal by Subject|2|||
17032211|NCT00719732|38176570|FG000|Overall Study|Lost to Follow-up|20|||
17032212|NCT00719732|38176570|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
17032213|NCT00719732|38176570|FG000|Overall Study|Illness not associated with device|1|||
17032214|NCT00723710|38176574|FG000|Overall Study|Disease progression|48|||
17032215|NCT00723710|38176574|FG000|Overall Study|Adverse Event|88|||
17032216|NCT00723710|38176574|FG000|Overall Study|Withdrawal by Subject|36|||
17032217|NCT00723710|38176574|FG000|Overall Study|Physician Decision|2|||
17032218|NCT00688545|38176580|FG000|Overall Study|Lost to Follow-up|1|||
17032219|NCT00688545|38176581|FG001|Overall Study|Lost to Follow-up|4|||
17032220|NCT00688545|38176580|FG000|Overall Study|Insurance/cost of drug|0|||
17032221|NCT00688545|38176581|FG001|Overall Study|Insurance/cost of drug|1|||
17032222|NCT00688545|38176580|FG000|Overall Study|Withdrawal by Subject|2|||
17032223|NCT00688545|38176581|FG001|Overall Study|Withdrawal by Subject|3|||
17032224|NCT00688545|38176580|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
17032225|NCT00688545|38176581|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
17032226|NCT00688467|38176591|FG000|Treatment Period 1|Adverse Event|2|||
17032227|NCT00688467|38176592|FG001|Treatment Period 1|Adverse Event|1|||
17032228|NCT00688467|38176591|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
17032229|NCT00688467|38176592|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
17032230|NCT00688467|38176591|FG000|Treatment Period 2|Protocol Violation|0|||
17032231|NCT00688467|38176592|FG001|Treatment Period 2|Protocol Violation|1|||
17032232|NCT00688467|38176591|FG000|Treatment Period 2|Adverse Event|0|||
17032233|NCT00688467|38176592|FG001|Treatment Period 2|Adverse Event|1|||
17032234|NCT00688155|38176602|FG000|Overall Study|Withdrawal by Subject|2|||
17032235|NCT00688155|38176603|FG001|Overall Study|Withdrawal by Subject|2|||
17032236|NCT00688155|38176604|FG002|Overall Study|Withdrawal by Subject|1|||
17032237|NCT00688155|38176605|FG003|Overall Study|Withdrawal by Subject|1|||
17136972|NCT02565914|38278667|FG000|Overall Study|Physician Decision|6|||
17032238|NCT00690573|38176615|FG000|Overall Study|Lack of Efficacy|8|||
17032239|NCT00690573|38176615|FG000|Overall Study|Withdrawal by Subject|1|||
17032240|NCT00719264|38176621|FG000|Overall Study|Adverse Event|41|||
17032241|NCT00719264|38176622|FG001|Overall Study|Adverse Event|49|||
17032242|NCT00719264|38176621|FG000|Overall Study|Death|13|||
17032243|NCT00719264|38176622|FG001|Overall Study|Death|10|||
17032244|NCT00719264|38176621|FG000|Overall Study|Administrative Problems|6|||
17136973|NCT02565914|38278667|FG000|Overall Study|Parent study termination by sponsor|1|||
17136974|NCT02565914|38278667|FG000|Overall Study|Commercial drug available|5|||
17136975|NCT02565914|38278667|FG000|Overall Study|Other|18|||
17136976|NCT02565914|38278667|FG000|Overall Study|Enrolled, but did not receive study drug|2|||
17136977|NCT03126344|38278691|FG000|Overall Study|Lost to Follow-up|0|||
17136978|NCT03126344|38278692|FG001|Overall Study|Lost to Follow-up|0|||
17136979|NCT03126344|38278693|FG002|Overall Study|Lost to Follow-up|5|||
17136980|NCT03115112|38278714|FG000|Overall Study|Adverse Event|5|||
17136981|NCT03115112|38278715|FG001|Overall Study|Adverse Event|1|||
17136982|NCT03115112|38278714|FG000|Overall Study|Withdrawal by Subject|4|||
17136983|NCT03115112|38278715|FG001|Overall Study|Withdrawal by Subject|2|||
17136984|NCT03115112|38278714|FG000|Overall Study|Lost to Follow-up|0|||
17136985|NCT03115112|38278715|FG001|Overall Study|Lost to Follow-up|1|||
17136986|NCT03115112|38278714|FG000|Overall Study|Death|1|||
17136987|NCT03115112|38278715|FG001|Overall Study|Death|0|||
17136988|NCT03115112|38278714|FG000|Overall Study|Pregnancy|1|||
17032245|NCT00719264|38176622|FG001|Overall Study|Administrative Problems|4|||
17032246|NCT00719264|38176621|FG000|Overall Study|Lost to Follow-up|1|||
17032247|NCT00719264|38176622|FG001|Overall Study|Lost to Follow-up|1|||
17032248|NCT00719264|38176621|FG000|Overall Study|Withdrawal by Subject|12|||
17032249|NCT00719264|38176622|FG001|Overall Study|Withdrawal by Subject|7|||
17032250|NCT00719264|38176621|FG000|Overall Study|Protocol Deviation|1|||
17032251|NCT00719264|38176622|FG001|Overall Study|Protocol Deviation|3|||
17032252|NCT00719264|38176621|FG000|Overall Study|New Cancer Therapy|4|||
17032253|NCT00719264|38176622|FG001|Overall Study|New Cancer Therapy|2|||
17032254|NCT00719264|38176621|FG000|Overall Study|Disease Progression|104|||
17032255|NCT00719264|38176622|FG001|Overall Study|Disease Progression|107|||
17032256|NCT00687609|38176628|FG000|Overall Study|Physician Decision|1|||
17032257|NCT00687609|38176628|FG000|Overall Study|Withdrawal by Subject|2|||
17136989|NCT03115112|38278715|FG001|Overall Study|Pregnancy|0|||
17032258|NCT00723554|38176632|FG000|Overall Study|Adverse Event|12|||
17032259|NCT00723554|38176632|FG000|Overall Study|Investigator's judgement|5|||
17032260|NCT00723554|38176632|FG000|Overall Study|Inhaled medication other than iloprost|4|||
17136990|NCT03115112|38278714|FG000|Overall Study|Site closure|1|||
17136991|NCT03115112|38278715|FG001|Overall Study|Site closure|1|||
17136992|NCT03556358|38278734|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
17136993|NCT03556358|38278735|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
17136994|NCT03556358|38278734|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
17136995|NCT03556358|38278735|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
17136996|NCT03556358|38278734|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
17136997|NCT03556358|38278735|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
17136998|NCT03556358|38278734|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
17136999|NCT03556358|38278735|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
17137000|NCT03556358|38278734|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
17137001|NCT03556358|38278735|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
17137002|NCT03556358|38278734|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
17137003|NCT03556358|38278735|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
17032261|NCT00723554|38176632|FG000|Overall Study|Withdrawal of consent|3|||
17032262|NCT00723554|38176632|FG000|Overall Study|Other|3|||
17032263|NCT00723554|38176632|FG000|Overall Study|Lost to Follow-up|1|||
17032264|NCT00723554|38176632|FG000|Overall Study|Non-compliance|1|||
17032265|NCT00687219|38176638|FG000|Overall Study|Adverse Event|8|||
17032266|NCT00687219|38176638|FG000|Overall Study|Discontinuance criteria met|7|||
17032267|NCT00687219|38176638|FG000|Overall Study|HCV-RNA positive conversion|34|||
17032268|NCT00687219|38176638|FG000|Overall Study|Withdrawal by Subject|1|||
17032269|NCT00687219|38176638|FG000|Overall Study|Lack of Efficacy|1|||
17032270|NCT00723398|38176647|FG000|Overall Study|Withdrawal by Subject|2|||
17032271|NCT00723398|38176648|FG001|Overall Study|Withdrawal by Subject|6|||
17032272|NCT00723398|38176649|FG002|Overall Study|Withdrawal by Subject|4|||
17137004|NCT03556358|38278734|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
17137005|NCT03556358|38278735|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
17137006|NCT03228680|38278743|FG000|Overall Study|Adverse Event|13|||
17137007|NCT03228680|38278744|FG001|Overall Study|Adverse Event|18|||
17032273|NCT00723398|38176650|FG003|Overall Study|Withdrawal by Subject|4|||
17032274|NCT00723398|38176651|FG004|Overall Study|Withdrawal by Subject|4|||
17032275|NCT00723398|38176647|FG000|Overall Study|Protocol Violation|2|||
17032276|NCT00723398|38176648|FG001|Overall Study|Protocol Violation|1|||
17032277|NCT00723398|38176649|FG002|Overall Study|Protocol Violation|5|||
17032278|NCT00723398|38176650|FG003|Overall Study|Protocol Violation|0|||
16991709|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
16991710|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
16991711|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
16991712|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
16991713|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
16991714|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
17032279|NCT00723398|38176651|FG004|Overall Study|Protocol Violation|0|||
17032280|NCT00723398|38176647|FG000|Overall Study|Physician Decision|2|||
17032281|NCT00723398|38176648|FG001|Overall Study|Physician Decision|2|||
16991715|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
16991716|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
16991717|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Death|0|||
16991718|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Death|1|||
16991719|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Death|0|||
16991720|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Death|1|||
16991721|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Death|0|||
16991722|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Change of location|1|||
16991723|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Change of location|1|||
16991724|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Change of location|0|||
16991725|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Change of location|1|||
16991726|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Change of location|0|||
16991727|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
16991728|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
16991729|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
16991730|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
16997768|NCT00732472|38141790|FG002|Overall Study|Adverse Event|1|||
17032282|NCT00723398|38176649|FG002|Overall Study|Physician Decision|5|||
17032283|NCT00723398|38176650|FG003|Overall Study|Physician Decision|0|||
17032284|NCT00723398|38176651|FG004|Overall Study|Physician Decision|1|||
17032285|NCT00723398|38176647|FG000|Overall Study|Adverse Event|0|||
17032286|NCT00723398|38176648|FG001|Overall Study|Adverse Event|5|||
17032287|NCT00723398|38176649|FG002|Overall Study|Adverse Event|3|||
16991731|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
16991732|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
16991733|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
16991734|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
16991735|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
16991736|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
16991737|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
16991738|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
16991739|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
16991740|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
16991741|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
16991742|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
16991743|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
16991744|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
17032288|NCT00723398|38176650|FG003|Overall Study|Adverse Event|1|||
17032289|NCT00723398|38176651|FG004|Overall Study|Adverse Event|4|||
17032290|NCT00723398|38176647|FG000|Overall Study|Lost to Follow-up|0|||
17032291|NCT00723398|38176648|FG001|Overall Study|Lost to Follow-up|1|||
17032292|NCT00723398|38176649|FG002|Overall Study|Lost to Follow-up|0|||
17032293|NCT00723398|38176650|FG003|Overall Study|Lost to Follow-up|0|||
17032294|NCT00723398|38176651|FG004|Overall Study|Lost to Follow-up|0|||
17032295|NCT00716456|38176666|FG000|Overall Study|Adverse Event|0|||
17032296|NCT00716456|38176667|FG001|Overall Study|Adverse Event|2|||
17032297|NCT00716456|38176668|FG002|Overall Study|Adverse Event|0|||
17032298|NCT00684645|38176676|FG000|Overall Study|Death|2|||
17032299|NCT00684645|38176676|FG000|Overall Study|Progressive disease|67|||
17032300|NCT00684645|38176676|FG000|Overall Study|Adverse Event|27|||
17032301|NCT00684645|38176676|FG000|Overall Study|Lost to Follow-up|3|||
17032302|NCT00684645|38176676|FG000|Overall Study|Other|15|||
17032303|NCT00716144|38176684|FG000|Overall Study|Withdrawal by Subject|4|||
17032304|NCT00716144|38176685|FG001|Overall Study|Withdrawal by Subject|2|||
17032305|NCT00716144|38176686|FG002|Overall Study|Withdrawal by Subject|6|||
17032306|NCT00716144|38176687|FG003|Overall Study|Withdrawal by Subject|6|||
17032307|NCT00716144|38176684|FG000|Overall Study|Lost to Follow-up|2|||
17032308|NCT00716144|38176685|FG001|Overall Study|Lost to Follow-up|2|||
17032309|NCT00716144|38176686|FG002|Overall Study|Lost to Follow-up|1|||
17032310|NCT00716144|38176687|FG003|Overall Study|Lost to Follow-up|2|||
17032311|NCT00716144|38176684|FG000|Overall Study|Adverse Event|0|||
17032312|NCT00716144|38176685|FG001|Overall Study|Adverse Event|0|||
17032313|NCT00716144|38176686|FG002|Overall Study|Adverse Event|0|||
17032314|NCT00716144|38176687|FG003|Overall Study|Adverse Event|2|||
17032315|NCT00716144|38176684|FG000|Overall Study|Non-compliance|1|||
17032316|NCT00716144|38176685|FG001|Overall Study|Non-compliance|0|||
17032317|NCT00716144|38176686|FG002|Overall Study|Non-compliance|0|||
17032318|NCT00716144|38176687|FG003|Overall Study|Non-compliance|0|||
17032319|NCT00716144|38176684|FG000|Overall Study|Protocol Violation|2|||
17032320|NCT00716144|38176685|FG001|Overall Study|Protocol Violation|0|||
17032321|NCT00716144|38176686|FG002|Overall Study|Protocol Violation|1|||
17032322|NCT00716144|38176687|FG003|Overall Study|Protocol Violation|0|||
17032323|NCT00716144|38176684|FG000|Overall Study|Physician Decision|0|||
17032324|NCT00716144|38176685|FG001|Overall Study|Physician Decision|1|||
17032325|NCT00716144|38176686|FG002|Overall Study|Physician Decision|2|||
17032326|NCT00716144|38176687|FG003|Overall Study|Physician Decision|2|||
17032327|NCT00716144|38176684|FG000|Overall Study|Intercurrent illness|0|||
17032328|NCT00716144|38176685|FG001|Overall Study|Intercurrent illness|0|||
17032329|NCT00716144|38176686|FG002|Overall Study|Intercurrent illness|1|||
17032330|NCT00716144|38176687|FG003|Overall Study|Intercurrent illness|0|||
17032331|NCT00716144|38176684|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
17032332|NCT00716144|38176685|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
17032333|NCT00716144|38176686|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
17032334|NCT00716144|38176687|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
17032335|NCT00716144|38176684|FG000|Overall Study|Adverse event: left foot pain|0|||
17032336|NCT00716144|38176685|FG001|Overall Study|Adverse event: left foot pain|1|||
17032337|NCT00716144|38176686|FG002|Overall Study|Adverse event: left foot pain|0|||
17032338|NCT00716144|38176687|FG003|Overall Study|Adverse event: left foot pain|0|||
17032339|NCT00716144|38176684|FG000|Overall Study|Clinical Depression|0|||
17032340|NCT00716144|38176685|FG001|Overall Study|Clinical Depression|1|||
17032341|NCT00716144|38176686|FG002|Overall Study|Clinical Depression|0|||
17032342|NCT00716144|38176687|FG003|Overall Study|Clinical Depression|0|||
17032343|NCT00576381|38176697|FG000|Overall Study|Reoperation|3|||
17032344|NCT00576381|38176697|FG000|Overall Study|Adverse Event|4|||
17032345|NCT00684567|38176701|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
16991745|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
16991746|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
16991747|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
16991748|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
16991749|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
16991750|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
17032346|NCT00684567|38176701|FG000|Monotherapy Period|Adverse Event|2|||
17032347|NCT00684567|38176701|FG000|Monotherapy Period|Death|1|||
17032348|NCT00684567|38176701|FG000|Monotherapy Period|Progression of primary disease|11|||
17032349|NCT00684411|38176705|FG000|Overall Study|New Primary Cancer|1|||
17032350|NCT00684411|38176705|FG000|Overall Study|Disease Progression|10|||
17032351|NCT00684411|38176705|FG000|Overall Study|Adverse Event|1|||
17032352|NCT00686829|38176709|FG000|Overall Study|Adverse Event|5|||
17032353|NCT00686829|38176709|FG000|Overall Study|Lack of Efficacy|6|||
17032354|NCT00686829|38176709|FG000|Overall Study|Lost to Follow-up|4|||
17032355|NCT00686829|38176709|FG000|Overall Study|Withdrawal by Subject|14|||
17032356|NCT00686829|38176709|FG000|Overall Study|Protocol Violation|3|||
17032357|NCT00686829|38176709|FG000|Overall Study|Sponsor discontinued VCV|47|||
17032358|NCT00687297|38176715|FG000|Randomization|Withdrawal by Subject|2|||
17032359|NCT00687297|38176716|FG001|Randomization|Withdrawal by Subject|0|||
17032360|NCT00687297|38176715|FG000|Randomization|Withdrew before treatment, ineligible|1|||
17032361|NCT00687297|38176716|FG001|Randomization|Withdrew before treatment, ineligible|1|||
17032362|NCT00687297|38176715|FG000|Induction|Withdrawal by Subject|4|||
17032363|NCT00687297|38176716|FG001|Induction|Withdrawal by Subject|4|||
17032364|NCT00687297|38176715|FG000|Induction|Adverse Event|16|||
17032365|NCT00687297|38176716|FG001|Induction|Adverse Event|15|||
17032366|NCT00687297|38176715|FG000|Induction|Death|7|||
17032367|NCT00687297|38176716|FG001|Induction|Death|11|||
17032368|NCT00687297|38176715|FG000|Induction|Lack of Efficacy|17|||
17032369|NCT00687297|38176716|FG001|Induction|Lack of Efficacy|21|||
17032370|NCT00687297|38176715|FG000|Induction|Ineligible|0|||
17032371|NCT00687297|38176716|FG001|Induction|Ineligible|1|||
17032372|NCT00687297|38176715|FG000|Induction|Patient Noncompliance|1|||
17032373|NCT00687297|38176716|FG001|Induction|Patient Noncompliance|0|||
17137008|NCT03228680|38278743|FG000|Overall Study|Randomization failure|0|||
17137009|NCT03228680|38278744|FG001|Overall Study|Randomization failure|1|||
17137010|NCT03228680|38278743|FG000|Overall Study|Withdrawal by Subject|1|||
17137011|NCT03228680|38278744|FG001|Overall Study|Withdrawal by Subject|0|||
17137012|NCT03228680|38278743|FG000|Overall Study|Other|9|||
17137013|NCT03228680|38278744|FG001|Overall Study|Other|16|||
17032374|NCT00687297|38176715|FG000|Induction|Physician Decision|0|||
17032375|NCT00687297|38176716|FG001|Induction|Physician Decision|2|||
17032376|NCT00687297|38176715|FG000|Induction|Other|0|||
17189013|NCT01062061|38341965|FG000|Overall Study|Investigated before study start|13|||
17189014|NCT01062061|38341965|FG000|Overall Study|Outside chief indications|10|||
17189015|NCT01062061|38341965|FG000|Overall Study|Failed to meet inclusion criteria|2|||
17189016|NCT02504320|38341977|FG000|Treatment Period 1|Positive Drug Screen|0|||
17189017|NCT02504320|38341978|FG001|Treatment Period 1|Positive Drug Screen|0|||
17189018|NCT02504320|38341979|FG002|Treatment Period 1|Positive Drug Screen|1|||
17189019|NCT02504320|38341980|FG003|Treatment Period 1|Positive Drug Screen|0|||
17189020|NCT02504320|38341977|FG000|Treatment Period 2|Positive Drug Screen|0|||
17189021|NCT02504320|38341978|FG001|Treatment Period 2|Positive Drug Screen|1|||
17189022|NCT02504320|38341979|FG002|Treatment Period 2|Positive Drug Screen|0|||
17189023|NCT02504320|38341980|FG003|Treatment Period 2|Positive Drug Screen|0|||
17189024|NCT02504320|38341977|FG000|Treatment Period 3|Positive Drug Screen|0|||
17189025|NCT02504320|38341978|FG001|Treatment Period 3|Positive Drug Screen|0|||
16991751|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
16991752|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
16991753|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
16991754|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
16991755|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
16991756|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
17032377|NCT00687297|38176716|FG001|Induction|Other|1|||
17032378|NCT00684177|38176726|FG000|Overall Study|Adverse Event|4|||
17137014|NCT03118934|38278772|FG000|Overall Study|Adverse Event|0|||
17137015|NCT03118934|38278773|FG001|Overall Study|Adverse Event|0|||
17137016|NCT03118934|38278774|FG002|Overall Study|Adverse Event|0|||
17137017|NCT03118934|38278775|FG003|Overall Study|Adverse Event|0|||
17137018|NCT03118934|38278776|FG004|Overall Study|Adverse Event|0|||
17137019|NCT03118934|38278777|FG005|Overall Study|Adverse Event|1|||
17137020|NCT03118934|38278772|FG000|Overall Study|Physician Decision|0|||
17137021|NCT03118934|38278773|FG001|Overall Study|Physician Decision|0|||
17137022|NCT03118934|38278774|FG002|Overall Study|Physician Decision|0|||
17137023|NCT03118934|38278775|FG003|Overall Study|Physician Decision|0|||
17137024|NCT03118934|38278776|FG004|Overall Study|Physician Decision|0|||
17137025|NCT03118934|38278777|FG005|Overall Study|Physician Decision|1|||
17137026|NCT03118934|38278772|FG000|Overall Study|Discontinued prior to exposure|0|||
17137027|NCT03118934|38278773|FG001|Overall Study|Discontinued prior to exposure|1|||
17137028|NCT03118934|38278774|FG002|Overall Study|Discontinued prior to exposure|1|||
17137029|NCT03118934|38278775|FG003|Overall Study|Discontinued prior to exposure|1|||
17137030|NCT03118934|38278776|FG004|Overall Study|Discontinued prior to exposure|2|||
17137031|NCT03118934|38278777|FG005|Overall Study|Discontinued prior to exposure|0|||
17137032|NCT03114488|38278787|FG000|Time Period 2|Withdrawal by Subject|1|||
17137033|NCT03114488|38278788|FG001|Time Period 2|Withdrawal by Subject|3|||
17137034|NCT03135262|38278807|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
17137035|NCT03135262|38278808|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
17137036|NCT03135262|38278809|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
17137037|NCT03135262|38278810|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
17137038|NCT03135262|38278811|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
17137039|NCT03135262|38278807|FG000|Overall Study|Progression of disease|0|||
17137040|NCT03135262|38278808|FG001|Overall Study|Progression of disease|0|||
17137041|NCT03135262|38278809|FG002|Overall Study|Progression of disease|0|||
17137042|NCT03135262|38278810|FG003|Overall Study|Progression of disease|1|||
17137043|NCT03135262|38278811|FG004|Overall Study|Progression of disease|0|||
17137044|NCT03135262|38278807|FG000|Overall Study|Death|6|||
17137045|NCT03135262|38278808|FG001|Overall Study|Death|2|||
17137046|NCT03135262|38278809|FG002|Overall Study|Death|2|||
17137047|NCT03135262|38278810|FG003|Overall Study|Death|2|||
17137048|NCT03135262|38278811|FG004|Overall Study|Death|0|||
17137049|NCT03135262|38278807|FG000|Overall Study|Withdrawal by Subject|0|||
17137050|NCT03135262|38278808|FG001|Overall Study|Withdrawal by Subject|0|||
17137051|NCT03135262|38278809|FG002|Overall Study|Withdrawal by Subject|1|||
17137052|NCT03135262|38278810|FG003|Overall Study|Withdrawal by Subject|0|||
17137053|NCT03135262|38278811|FG004|Overall Study|Withdrawal by Subject|1|||
17137054|NCT03135262|38278807|FG000|Overall Study|Study terminated by sponsor|2|||
17137055|NCT03135262|38278808|FG001|Overall Study|Study terminated by sponsor|4|||
17137056|NCT03135262|38278809|FG002|Overall Study|Study terminated by sponsor|4|||
17137057|NCT03135262|38278810|FG003|Overall Study|Study terminated by sponsor|3|||
17137058|NCT03135262|38278811|FG004|Overall Study|Study terminated by sponsor|0|||
17137059|NCT03535194|38278846|FG000|Induction Period|Adverse Event|2|||
17137060|NCT03535194|38278847|FG001|Induction Period|Adverse Event|2|||
17137061|NCT03535194|38278848|FG002|Induction Period|Adverse Event|1|||
17137062|NCT03535194|38278849|FG003|Induction Period|Adverse Event|3|||
17137063|NCT03535194|38278850|FG004|Induction Period|Adverse Event|0|||
17137064|NCT03535194|38278846|FG000|Induction Period|Death|0|||
17137065|NCT03535194|38278847|FG001|Induction Period|Death|1|||
17137066|NCT03535194|38278848|FG002|Induction Period|Death|0|||
17137067|NCT03535194|38278849|FG003|Induction Period|Death|0|||
17137068|NCT03535194|38278850|FG004|Induction Period|Death|0|||
17137069|NCT03535194|38278846|FG000|Induction Period|Lack of Efficacy|1|||
17137070|NCT03535194|38278847|FG001|Induction Period|Lack of Efficacy|3|||
17137071|NCT03535194|38278848|FG002|Induction Period|Lack of Efficacy|2|||
17137072|NCT03535194|38278849|FG003|Induction Period|Lack of Efficacy|2|||
17137073|NCT03535194|38278850|FG004|Induction Period|Lack of Efficacy|0|||
17137074|NCT03535194|38278846|FG000|Induction Period|Lost to Follow-up|3|||
17137075|NCT03535194|38278847|FG001|Induction Period|Lost to Follow-up|5|||
17137076|NCT03535194|38278848|FG002|Induction Period|Lost to Follow-up|2|||
17137077|NCT03535194|38278849|FG003|Induction Period|Lost to Follow-up|3|||
17137078|NCT03535194|38278850|FG004|Induction Period|Lost to Follow-up|0|||
17137079|NCT03535194|38278846|FG000|Induction Period|Physician Decision|1|||
17137080|NCT03535194|38278847|FG001|Induction Period|Physician Decision|1|||
17137081|NCT03535194|38278848|FG002|Induction Period|Physician Decision|0|||
17137082|NCT03535194|38278849|FG003|Induction Period|Physician Decision|0|||
17137083|NCT03535194|38278850|FG004|Induction Period|Physician Decision|0|||
17137084|NCT03535194|38278846|FG000|Induction Period|Protocol Violation|1|||
17137085|NCT03535194|38278847|FG001|Induction Period|Protocol Violation|0|||
17137086|NCT03535194|38278848|FG002|Induction Period|Protocol Violation|0|||
17137087|NCT03535194|38278849|FG003|Induction Period|Protocol Violation|1|||
17137088|NCT03535194|38278850|FG004|Induction Period|Protocol Violation|0|||
17137089|NCT03535194|38278846|FG000|Induction Period|Screen Failure|0|||
17137090|NCT03535194|38278847|FG001|Induction Period|Screen Failure|1|||
17137091|NCT03535194|38278848|FG002|Induction Period|Screen Failure|0|||
17137092|NCT03535194|38278849|FG003|Induction Period|Screen Failure|0|||
17137093|NCT03535194|38278850|FG004|Induction Period|Screen Failure|0|||
17137094|NCT03535194|38278846|FG000|Induction Period|Withdrawal by Subject|3|||
17137095|NCT03535194|38278847|FG001|Induction Period|Withdrawal by Subject|4|||
17137096|NCT03535194|38278848|FG002|Induction Period|Withdrawal by Subject|3|||
17137097|NCT03535194|38278849|FG003|Induction Period|Withdrawal by Subject|2|||
17137098|NCT03535194|38278850|FG004|Induction Period|Withdrawal by Subject|0|||
17137099|NCT03535194|38278846|FG000|Maintenance Period|Adverse Event|6|||
17137100|NCT03535194|38278847|FG001|Maintenance Period|Adverse Event|5|||
17137101|NCT03535194|38278848|FG002|Maintenance Period|Adverse Event|1|||
17137102|NCT03535194|38278849|FG003|Maintenance Period|Adverse Event|11|||
17137103|NCT03535194|38278850|FG004|Maintenance Period|Adverse Event|4|||
17137104|NCT03535194|38278846|FG000|Maintenance Period|Lack of Efficacy|3|||
17137105|NCT03535194|38278847|FG001|Maintenance Period|Lack of Efficacy|2|||
17137106|NCT03535194|38278848|FG002|Maintenance Period|Lack of Efficacy|5|||
17137107|NCT03535194|38278849|FG003|Maintenance Period|Lack of Efficacy|9|||
17137108|NCT03535194|38278850|FG004|Maintenance Period|Lack of Efficacy|0|||
17137109|NCT03535194|38278846|FG000|Maintenance Period|Lost to Follow-up|4|||
17137110|NCT03535194|38278847|FG001|Maintenance Period|Lost to Follow-up|2|||
17137111|NCT03535194|38278848|FG002|Maintenance Period|Lost to Follow-up|1|||
17137112|NCT03535194|38278849|FG003|Maintenance Period|Lost to Follow-up|5|||
17137113|NCT03535194|38278850|FG004|Maintenance Period|Lost to Follow-up|2|||
17137114|NCT03535194|38278846|FG000|Maintenance Period|Other|1|||
17137115|NCT03535194|38278847|FG001|Maintenance Period|Other|2|||
17137116|NCT03535194|38278848|FG002|Maintenance Period|Other|0|||
17137117|NCT03535194|38278849|FG003|Maintenance Period|Other|0|||
17137118|NCT03535194|38278850|FG004|Maintenance Period|Other|0|||
17137119|NCT03535194|38278846|FG000|Maintenance Period|Physician Decision|1|||
17137120|NCT03535194|38278847|FG001|Maintenance Period|Physician Decision|2|||
17137121|NCT03535194|38278848|FG002|Maintenance Period|Physician Decision|0|||
17137122|NCT03535194|38278849|FG003|Maintenance Period|Physician Decision|2|||
17137123|NCT03535194|38278850|FG004|Maintenance Period|Physician Decision|0|||
17137124|NCT03535194|38278846|FG000|Maintenance Period|Pregnancy|0|||
17032379|NCT00684177|38176727|FG001|Overall Study|Adverse Event|3|||
17032380|NCT00684177|38176726|FG000|Overall Study|Lack of Efficacy|10|||
17137125|NCT03535194|38278847|FG001|Maintenance Period|Pregnancy|0|||
17137126|NCT03535194|38278848|FG002|Maintenance Period|Pregnancy|0|||
17137127|NCT03535194|38278849|FG003|Maintenance Period|Pregnancy|2|||
17137128|NCT03535194|38278850|FG004|Maintenance Period|Pregnancy|0|||
17137129|NCT03535194|38278846|FG000|Maintenance Period|Protocol Violation|0|||
17137130|NCT03535194|38278847|FG001|Maintenance Period|Protocol Violation|1|||
17137131|NCT03535194|38278848|FG002|Maintenance Period|Protocol Violation|0|||
17137132|NCT03535194|38278849|FG003|Maintenance Period|Protocol Violation|0|||
17137133|NCT03535194|38278850|FG004|Maintenance Period|Protocol Violation|0|||
17137134|NCT03535194|38278846|FG000|Maintenance Period|Withdrawal by Subject|7|||
17137135|NCT03535194|38278847|FG001|Maintenance Period|Withdrawal by Subject|2|||
17137136|NCT03535194|38278848|FG002|Maintenance Period|Withdrawal by Subject|1|||
17137137|NCT03535194|38278849|FG003|Maintenance Period|Withdrawal by Subject|8|||
17137138|NCT03535194|38278850|FG004|Maintenance Period|Withdrawal by Subject|0|||
17032381|NCT00684177|38176727|FG001|Overall Study|Lack of Efficacy|15|||
17032382|NCT00684177|38176726|FG000|Overall Study|Protocol Violation|1|||
17032383|NCT00684177|38176727|FG001|Overall Study|Protocol Violation|0|||
17032384|NCT00684177|38176726|FG000|Overall Study|Lost to Follow-up|2|||
17032385|NCT00684177|38176727|FG001|Overall Study|Lost to Follow-up|1|||
17032386|NCT00684177|38176726|FG000|Overall Study|Physician Decision|2|||
17032387|NCT00684177|38176727|FG001|Overall Study|Physician Decision|0|||
17137139|NCT03535194|38278846|FG000|Post-Treatment Followup Period|Adverse Event|4|||
17137140|NCT03535194|38278847|FG001|Post-Treatment Followup Period|Adverse Event|5|||
17137141|NCT03535194|38278848|FG002|Post-Treatment Followup Period|Adverse Event|1|||
17137142|NCT03535194|38278849|FG003|Post-Treatment Followup Period|Adverse Event|8|||
17137143|NCT03535194|38278850|FG004|Post-Treatment Followup Period|Adverse Event|0|||
17137144|NCT03535194|38278846|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
17137145|NCT03535194|38278847|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
17137146|NCT03535194|38278848|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
17137147|NCT03535194|38278849|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
17137148|NCT03535194|38278850|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
17137149|NCT03535194|38278846|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
17137150|NCT03535194|38278847|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
17137151|NCT03535194|38278848|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
17137152|NCT03535194|38278849|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
17137153|NCT03535194|38278850|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
17137154|NCT03535194|38278846|FG000|Post-Treatment Followup Period|Other|1|||
17032388|NCT00684177|38176726|FG000|Overall Study|Withdrawal by Subject|1|||
17032389|NCT00684177|38176727|FG001|Overall Study|Withdrawal by Subject|2|||
17137155|NCT03535194|38278847|FG001|Post-Treatment Followup Period|Other|0|||
17137156|NCT03535194|38278848|FG002|Post-Treatment Followup Period|Other|0|||
17137157|NCT03535194|38278849|FG003|Post-Treatment Followup Period|Other|5|||
17137158|NCT03535194|38278850|FG004|Post-Treatment Followup Period|Other|0|||
17137159|NCT03535194|38278846|FG000|Post-Treatment Followup Period|Physician Decision|0|||
17137160|NCT03535194|38278847|FG001|Post-Treatment Followup Period|Physician Decision|2|||
17137161|NCT03535194|38278848|FG002|Post-Treatment Followup Period|Physician Decision|1|||
17137162|NCT03535194|38278849|FG003|Post-Treatment Followup Period|Physician Decision|1|||
17137163|NCT03535194|38278850|FG004|Post-Treatment Followup Period|Physician Decision|0|||
17137164|NCT03535194|38278846|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
17137165|NCT03535194|38278847|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
17137166|NCT03535194|38278848|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
17137167|NCT03535194|38278849|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
17137168|NCT03535194|38278850|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17137169|NCT03559530|38278874|FG000|Overall Study|non-location of medical records|44|||
17137170|NCT03559530|38278875|FG001|Overall Study|non-location of medical records|0|||
17137171|NCT03559530|38278874|FG000|Overall Study|culture results not considered for treat|29|||
17137172|NCT03559530|38278875|FG001|Overall Study|culture results not considered for treat|0|||
17137173|NCT03559530|38278874|FG000|Overall Study|duplicate cases|8|||
17137174|NCT03559530|38278875|FG001|Overall Study|duplicate cases|0|||
17137175|NCT03559530|38278874|FG000|Overall Study|other species of Acinetobacte|7|||
17137176|NCT03559530|38278875|FG001|Overall Study|other species of Acinetobacte|0|||
17137177|NCT03559530|38278874|FG000|Overall Study|contamination / colonization|3|||
17137178|NCT03559530|38278875|FG001|Overall Study|contamination / colonization|0|||
17137179|NCT01898650|38278903|FG000|Overall Study|the subject would not lie still for imaging|1|||
17137180|NCT03124784|38278907|FG000|Overall Study|Adverse Event|1|||
17137181|NCT03124784|38278907|FG000|Overall Study|Computer/Equip Malfunction|1|||
17137182|NCT03531840|38278915|FG000|Overall Study|Death on study|3|||
17137183|NCT03531840|38278916|FG001|Overall Study|Death on study|2|||
17137184|NCT03531840|38278917|FG002|Overall Study|Death on study|1|||
17137185|NCT03531840|38278918|FG003|Overall Study|Death on study|2|||
17137186|NCT03531840|38278915|FG000|Overall Study|Death during follow up|2|||
17137187|NCT03531840|38278916|FG001|Overall Study|Death during follow up|3|||
17137188|NCT03531840|38278917|FG002|Overall Study|Death during follow up|4|||
17137189|NCT03531840|38278918|FG003|Overall Study|Death during follow up|1|||
17137190|NCT03110900|38278935|FG000|Overall Study|Sponsor withdrew|1|||
17137191|NCT03110900|38278936|FG001|Overall Study|Sponsor withdrew|1|||
17137192|NCT03867734|38278942|FG000|Overall Study|Lost to Follow-up|2|||
17137193|NCT03446456|38278952|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
17137194|NCT03446456|38278953|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
17137195|NCT03446456|38278952|FG000|Overall Study|Lost to Follow-up|1|||
17032390|NCT00684177|38176726|FG000|Overall Study|Other|1|||
17032391|NCT00684177|38176727|FG001|Overall Study|Other|2|||
17032392|NCT00684021|38176737|FG000|Overall Study|MRI Contraindicated|1|||
17032393|NCT00684021|38176738|FG001|Overall Study|MRI Contraindicated|1|||
17032394|NCT00684021|38176739|FG002|Overall Study|MRI Contraindicated|1|||
17032395|NCT00684021|38176740|FG003|Overall Study|MRI Contraindicated|0|||
17032396|NCT00684021|38176737|FG000|Overall Study|MRI not performed|0|||
17137196|NCT03446456|38278953|FG001|Overall Study|Lost to Follow-up|3|||
17137197|NCT03446456|38278952|FG000|Overall Study|Participant failed the toxicology test|1|||
17137198|NCT03446456|38278953|FG001|Overall Study|Participant failed the toxicology test|0|||
17137199|NCT03446456|38278952|FG000|Overall Study|Break down of the experimental equipment|1|||
17137200|NCT03446456|38278953|FG001|Overall Study|Break down of the experimental equipment|0|||
17137201|NCT03495102|38278962|FG000|Overall Study|Adverse Event|5|||
17137202|NCT03495102|38278963|FG001|Overall Study|Adverse Event|7|||
17137203|NCT03495102|38278964|FG002|Overall Study|Adverse Event|10|||
17137204|NCT03495102|38278962|FG000|Overall Study|Death|3|||
17137205|NCT03495102|38278963|FG001|Overall Study|Death|4|||
17137206|NCT03495102|38278964|FG002|Overall Study|Death|4|||
17137207|NCT03495102|38278962|FG000|Overall Study|Lost to Follow-up|15|||
17032397|NCT00684021|38176738|FG001|Overall Study|MRI not performed|1|||
17137208|NCT03495102|38278963|FG001|Overall Study|Lost to Follow-up|16|||
17137209|NCT03495102|38278964|FG002|Overall Study|Lost to Follow-up|17|||
17137210|NCT03495102|38278962|FG000|Overall Study|Physician Decision|2|||
17137211|NCT03495102|38278963|FG001|Overall Study|Physician Decision|0|||
17032398|NCT00684021|38176739|FG002|Overall Study|MRI not performed|1|||
17137212|NCT03495102|38278964|FG002|Overall Study|Physician Decision|2|||
17137213|NCT03495102|38278962|FG000|Overall Study|Withdrawal by Subject|25|||
17137214|NCT03495102|38278963|FG001|Overall Study|Withdrawal by Subject|36|||
17137215|NCT03495102|38278964|FG002|Overall Study|Withdrawal by Subject|18|||
17137216|NCT03495102|38278962|FG000|Overall Study|Protocol Violation|1|||
17137217|NCT03495102|38278963|FG001|Overall Study|Protocol Violation|1|||
17137218|NCT03495102|38278964|FG002|Overall Study|Protocol Violation|0|||
17137219|NCT03495102|38278962|FG000|Overall Study|Site Closure|3|||
17137220|NCT03495102|38278963|FG001|Overall Study|Site Closure|1|||
17137221|NCT03495102|38278964|FG002|Overall Study|Site Closure|2|||
17137222|NCT03495102|38278962|FG000|Overall Study|Non-compliance|1|||
17137223|NCT03495102|38278963|FG001|Overall Study|Non-compliance|0|||
17137224|NCT03495102|38278964|FG002|Overall Study|Non-compliance|0|||
17137225|NCT03495102|38278962|FG000|Overall Study|Participant Duplicated at Another Site|0|||
17137226|NCT03495102|38278963|FG001|Overall Study|Participant Duplicated at Another Site|0|||
17137227|NCT03495102|38278964|FG002|Overall Study|Participant Duplicated at Another Site|1|||
17137228|NCT03495102|38278962|FG000|Overall Study|Primary Care Physician Recommendation|0|||
17137229|NCT03495102|38278963|FG001|Overall Study|Primary Care Physician Recommendation|1|||
17137230|NCT03495102|38278964|FG002|Overall Study|Primary Care Physician Recommendation|0|||
17137231|NCT03495102|38278962|FG000|Overall Study|Relocated to Another Country|0|||
17137232|NCT03495102|38278963|FG001|Overall Study|Relocated to Another Country|1|||
17137233|NCT03495102|38278964|FG002|Overall Study|Relocated to Another Country|0|||
17137234|NCT03495102|38278962|FG000|Overall Study|Participant was in Rehabilitation|1|||
17137235|NCT03495102|38278963|FG001|Overall Study|Participant was in Rehabilitation|0|||
17137236|NCT03495102|38278964|FG002|Overall Study|Participant was in Rehabilitation|0|||
17137237|NCT03105362|38278972|FG000|Overall Study|Withdrawal by Subject|1|||
17137238|NCT03105362|38278972|FG000|Overall Study|Lost to Follow-up|1|||
17137239|NCT03559218|38278981|FG000|Overall Study|Withdrawal by Subject|1|||
17137240|NCT03559218|38278982|FG001|Overall Study|Withdrawal by Subject|0|||
17137241|NCT03104816|38278991|FG000|Overall Study|Lack of Efficacy|0|||
17137242|NCT03104816|38278992|FG001|Overall Study|Lack of Efficacy|2|||
17137243|NCT03104816|38278993|FG002|Overall Study|Lack of Efficacy|0|||
17137244|NCT03104816|38278991|FG000|Overall Study|Protocol Violation|2|||
17137245|NCT03104816|38278992|FG001|Overall Study|Protocol Violation|0|||
17137246|NCT03104816|38278993|FG002|Overall Study|Protocol Violation|2|||
17137247|NCT03559062|38279004|FG000|Overall Study|Other|0|||
17137248|NCT03559062|38279005|FG001|Overall Study|Other|1|||
17137249|NCT03559062|38279006|FG002|Overall Study|Other|0|||
16991757|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
16991758|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
16991759|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
16991760|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
16991761|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
16991762|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
16991763|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
16991764|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
16991765|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
16991766|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
17032399|NCT00684021|38176740|FG003|Overall Study|MRI not performed|2|||
17032400|NCT00684021|38176737|FG000|Overall Study|Death|1|||
17032401|NCT00684021|38176738|FG001|Overall Study|Death|0|||
17137250|NCT00089791|38279017|FG000|Overall Study|Physician Decision|6|||
17137251|NCT00089791|38279018|FG001|Overall Study|Physician Decision|3|||
17137252|NCT00089791|38279017|FG000|Overall Study|Adverse Event|81|||
17137253|NCT00089791|38279018|FG001|Overall Study|Adverse Event|93|||
17137254|NCT00089791|38279017|FG000|Overall Study|Withdrawal by Subject|403|||
17137255|NCT00089791|38279018|FG001|Overall Study|Withdrawal by Subject|344|||
17137256|NCT00089791|38279017|FG000|Overall Study|Death|78|||
17137257|NCT00089791|38279018|FG001|Overall Study|Death|62|||
17137258|NCT00089791|38279017|FG000|Overall Study|Disease progression|7|||
16991767|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
17032402|NCT00684021|38176739|FG002|Overall Study|Death|0|||
17032403|NCT00684021|38176740|FG003|Overall Study|Death|0|||
17032404|NCT00686595|38176750|FG000|Overall Study|Adverse Event|3|||
17032405|NCT00686595|38176750|FG000|Overall Study|Protocol Violation|1|||
16991768|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
16991769|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
16991770|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
16991771|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
17032406|NCT00686595|38176750|FG000|Overall Study|Lost to Follow-up|1|||
17032407|NCT00686595|38176750|FG000|Overall Study|Lack of Efficacy|1|||
17032408|NCT00686595|38176750|FG000|Overall Study|Poor Compliance|1|||
17137259|NCT00089791|38279018|FG001|Overall Study|Disease progression|3|||
17137260|NCT00089791|38279017|FG000|Overall Study|Ineligibility determined|12|||
17137261|NCT00089791|38279018|FG001|Overall Study|Ineligibility determined|9|||
16991772|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
16991773|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
16991774|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
16991775|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
16991776|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
16991777|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Missing|0|||
16991778|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Missing|0|||
16991779|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Missing|2|||
16991780|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Missing|0|||
16991781|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Missing|0|||
16991782|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
16991783|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
16991784|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
16991785|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
16991786|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
16991787|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
16991788|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
16991789|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
16991790|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
16991791|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
16991792|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
16991793|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
17032409|NCT00576303|38176754|FG000|Dose Titration Period|Early withdrawal|17|||
17032410|NCT00576303|38176754|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
17032411|NCT00576303|38176754|FG000|Long Term Safety Period|Early withdrawal|16|||
17032412|NCT00686517|38176761|FG000|Treatment|Serious Adverse Event|1|||
17032413|NCT00686517|38176762|FG001|Treatment|Serious Adverse Event|2|||
17137262|NCT00089791|38279017|FG000|Overall Study|Lost to Follow-up|57|||
17137263|NCT00089791|38279018|FG001|Overall Study|Lost to Follow-up|57|||
17137264|NCT00089791|38279017|FG000|Overall Study|Noncompliance|17|||
17137265|NCT00089791|38279018|FG001|Overall Study|Noncompliance|13|||
17137266|NCT00089791|38279017|FG000|Overall Study|Other|20|||
17137267|NCT00089791|38279018|FG001|Overall Study|Other|32|||
17137268|NCT00089791|38279017|FG000|Overall Study|Protocol deviation|12|||
17137269|NCT00089791|38279018|FG001|Overall Study|Protocol deviation|10|||
17137270|NCT00089791|38279017|FG000|Overall Study|Requirement for alternative therapy|7|||
17137271|NCT00089791|38279018|FG001|Overall Study|Requirement for alternative therapy|4|||
17137272|NCT03558672|38279024|FG000|Overall Study|Study Early Termination|10|||
17137273|NCT03558516|38279030|FG000|Overall Study|Protocol Violation|2|||
17032414|NCT00686517|38176763|FG002|Treatment|Serious Adverse Event|1|||
17032415|NCT00686517|38176761|FG000|Treatment|Adverse Event|2|||
17032416|NCT00686517|38176762|FG001|Treatment|Adverse Event|0|||
17032417|NCT00686517|38176763|FG002|Treatment|Adverse Event|0|||
17032418|NCT00686517|38176761|FG000|Treatment|Poor Protocol Compliance|1|||
17032419|NCT00686517|38176762|FG001|Treatment|Poor Protocol Compliance|0|||
17032420|NCT00686517|38176763|FG002|Treatment|Poor Protocol Compliance|0|||
17032421|NCT00686517|38176761|FG000|Treatment|Protocol Violation|2|||
17032422|NCT00686517|38176762|FG001|Treatment|Protocol Violation|1|||
17032423|NCT00686517|38176763|FG002|Treatment|Protocol Violation|0|||
17032424|NCT00686205|38176773|FG000|Overall Study|Protocol Violation|127|||
17032425|NCT00686205|38176774|FG001|Overall Study|Protocol Violation|0|||
17032426|NCT00686205|38176773|FG000|Overall Study|Withdrawal by Subject|2|||
17032427|NCT00686205|38176774|FG001|Overall Study|Withdrawal by Subject|0|||
17032428|NCT00686205|38176773|FG000|Overall Study|Specimen handling procedure altered|5878|||
17032429|NCT00686205|38176774|FG001|Overall Study|Specimen handling procedure altered|0|||
17032430|NCT00686205|38176773|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
17032431|NCT00686205|38176774|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
17032432|NCT00571701|38176782|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
17032433|NCT00571701|38176783|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
17032434|NCT00571701|38176782|FG000|First Intervention 12 Months|Death|1|||
17032435|NCT00571701|38176783|FG001|First Intervention 12 Months|Death|0|||
17032436|NCT00571701|38176782|FG000|Second Intervention 12 Months|Adverse Event|0|||
17032437|NCT00571701|38176783|FG001|Second Intervention 12 Months|Adverse Event|1|||
17032438|NCT00571701|38176782|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
17032439|NCT00571701|38176783|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
17032440|NCT00686127|38176809|FG000|Overall Study|Withdrawal by Subject|14|||
17032441|NCT00686127|38176810|FG001|Overall Study|Withdrawal by Subject|6|||
17032442|NCT00718718|38176823|FG000|Prior to Week 12|Adverse Event|0|||
17032443|NCT00718718|38176824|FG001|Prior to Week 12|Adverse Event|0|||
17032444|NCT00718718|38176825|FG002|Prior to Week 12|Adverse Event|0|||
17032445|NCT00718718|38176826|FG003|Prior to Week 12|Adverse Event|0|||
17137274|NCT03558516|38279031|FG001|Overall Study|Protocol Violation|2|||
17137275|NCT03557970|38279039|FG000|Overall Study|Study closure|1|||
17032446|NCT00718718|38176827|FG004|Prior to Week 12|Adverse Event|0|||
17032447|NCT00718718|38176828|FG005|Prior to Week 12|Adverse Event|0|||
17032448|NCT00718718|38176829|FG006|Prior to Week 12|Adverse Event|0|||
17032449|NCT00718718|38176830|FG007|Prior to Week 12|Adverse Event|1|||
17032450|NCT00718718|38176831|FG008|Prior to Week 12|Adverse Event|1|||
17032451|NCT00718718|38176832|FG009|Prior to Week 12|Adverse Event|0|||
17032452|NCT00718718|38176823|FG000|Prior to Week 12|Withdrawal by Subject|0|||
17032453|NCT00718718|38176824|FG001|Prior to Week 12|Withdrawal by Subject|0|||
17032454|NCT00718718|38176825|FG002|Prior to Week 12|Withdrawal by Subject|0|||
17032455|NCT00718718|38176826|FG003|Prior to Week 12|Withdrawal by Subject|0|||
17032456|NCT00718718|38176827|FG004|Prior to Week 12|Withdrawal by Subject|3|||
17032457|NCT00718718|38176828|FG005|Prior to Week 12|Withdrawal by Subject|0|||
17032458|NCT00718718|38176829|FG006|Prior to Week 12|Withdrawal by Subject|1|||
17032459|NCT00718718|38176830|FG007|Prior to Week 12|Withdrawal by Subject|1|||
17032460|NCT00718718|38176831|FG008|Prior to Week 12|Withdrawal by Subject|1|||
17032461|NCT00718718|38176832|FG009|Prior to Week 12|Withdrawal by Subject|0|||
17032462|NCT00718718|38176823|FG000|Prior to Week 12|Other|1|||
17032463|NCT00718718|38176824|FG001|Prior to Week 12|Other|0|||
17032464|NCT00718718|38176825|FG002|Prior to Week 12|Other|1|||
17032465|NCT00718718|38176826|FG003|Prior to Week 12|Other|0|||
17032466|NCT00718718|38176827|FG004|Prior to Week 12|Other|0|||
17032467|NCT00718718|38176828|FG005|Prior to Week 12|Other|0|||
17032468|NCT00718718|38176829|FG006|Prior to Week 12|Other|0|||
17032469|NCT00718718|38176830|FG007|Prior to Week 12|Other|0|||
17032470|NCT00718718|38176831|FG008|Prior to Week 12|Other|0|||
17032471|NCT00718718|38176832|FG009|Prior to Week 12|Other|0|||
17032472|NCT00718718|38176823|FG000|Week 12 to End of Study|Adverse Event|0|||
17032473|NCT00718718|38176824|FG001|Week 12 to End of Study|Adverse Event|0|||
17032474|NCT00718718|38176825|FG002|Week 12 to End of Study|Adverse Event|0|||
17032475|NCT00718718|38176826|FG003|Week 12 to End of Study|Adverse Event|0|||
17032476|NCT00718718|38176827|FG004|Week 12 to End of Study|Adverse Event|0|||
17032477|NCT00718718|38176828|FG005|Week 12 to End of Study|Adverse Event|0|||
17032478|NCT00718718|38176829|FG006|Week 12 to End of Study|Adverse Event|0|||
17032479|NCT00718718|38176830|FG007|Week 12 to End of Study|Adverse Event|1|||
17032480|NCT00718718|38176831|FG008|Week 12 to End of Study|Adverse Event|0|||
17032481|NCT00718718|38176832|FG009|Week 12 to End of Study|Adverse Event|0|||
17032482|NCT00718718|38176823|FG000|Week 12 to End of Study|Death|0|||
17032483|NCT00718718|38176824|FG001|Week 12 to End of Study|Death|0|||
17032484|NCT00718718|38176825|FG002|Week 12 to End of Study|Death|0|||
17032485|NCT00718718|38176826|FG003|Week 12 to End of Study|Death|0|||
17032486|NCT00718718|38176827|FG004|Week 12 to End of Study|Death|0|||
17032487|NCT00718718|38176828|FG005|Week 12 to End of Study|Death|1|||
17032488|NCT00718718|38176829|FG006|Week 12 to End of Study|Death|0|||
17032489|NCT00718718|38176830|FG007|Week 12 to End of Study|Death|0|||
16997769|NCT00732472|38141791|FG003|Overall Study|Adverse Event|1|||
16997770|NCT00732472|38141788|FG000|Overall Study|Protocol Violation|0|||
16997771|NCT00732472|38141789|FG001|Overall Study|Protocol Violation|0|||
16997772|NCT00732472|38141790|FG002|Overall Study|Protocol Violation|0|||
16997773|NCT00732472|38141791|FG003|Overall Study|Protocol Violation|1|||
16997774|NCT00732472|38141788|FG000|Overall Study|Withdrawal by Subject|0|||
16997775|NCT00732472|38141789|FG001|Overall Study|Withdrawal by Subject|2|||
16997776|NCT00732472|38141790|FG002|Overall Study|Withdrawal by Subject|0|||
16997777|NCT00732472|38141791|FG003|Overall Study|Withdrawal by Subject|1|||
16997778|NCT00960986|38141806|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
16997779|NCT00960986|38141807|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
16997780|NCT00960986|38141808|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
16997781|NCT00960986|38141809|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
16997782|NCT00960986|38141806|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
16997783|NCT00960986|38141807|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
16997784|NCT00960986|38141808|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
16997785|NCT00960986|38141809|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
16997786|NCT00960986|38141806|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
16997787|NCT00960986|38141807|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
16997788|NCT00960986|38141808|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
16997789|NCT00960986|38141809|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
16997790|NCT00960986|38141806|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
16997791|NCT00960986|38141807|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
16997792|NCT00960986|38141808|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
16997793|NCT00960986|38141809|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
16997794|NCT00960986|38141806|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
16997795|NCT00960986|38141807|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
16997796|NCT00960986|38141808|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
16997797|NCT00960986|38141809|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
16997798|NCT00960986|38141806|FG000|Period 3 (7-week Therapy Period)|Death|0|||
16997799|NCT00960986|38141807|FG001|Period 3 (7-week Therapy Period)|Death|0|||
17032490|NCT00718718|38176831|FG008|Week 12 to End of Study|Death|0|||
17032491|NCT00718718|38176832|FG009|Week 12 to End of Study|Death|0|||
17032492|NCT00718718|38176823|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
17032493|NCT00718718|38176824|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
17032494|NCT00718718|38176825|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
17137276|NCT03557970|38279040|FG001|Overall Study|Study closure|0|||
17137277|NCT03557970|38279039|FG000|Overall Study|Physician Decision|0|||
17032495|NCT00718718|38176826|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
17032496|NCT00718718|38176827|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
17032497|NCT00718718|38176828|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
17032498|NCT00718718|38176829|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
17032499|NCT00718718|38176830|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
17032500|NCT00718718|38176831|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
17032501|NCT00718718|38176832|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
17032502|NCT00718718|38176823|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
17137278|NCT03557970|38279040|FG001|Overall Study|Physician Decision|1|||
17137279|NCT03557970|38279039|FG000|Overall Study|Death|0|||
17137280|NCT03557970|38279040|FG001|Overall Study|Death|1|||
17137281|NCT02815280|38279048|FG000|Double-Blind Phase|Adverse Event|1|||
17032503|NCT00718718|38176824|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
17032504|NCT00718718|38176825|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
17032505|NCT00718718|38176826|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
17032506|NCT00718718|38176827|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
17137282|NCT02815280|38279049|FG001|Double-Blind Phase|Adverse Event|1|||
17137283|NCT02815280|38279048|FG000|Double-Blind Phase|Lost to Follow-up|10|||
17137284|NCT02815280|38279049|FG001|Double-Blind Phase|Lost to Follow-up|9|||
17137285|NCT02815280|38279048|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
17137286|NCT02815280|38279049|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
17137287|NCT02815280|38279048|FG000|Double-Blind Phase|Protocol Violation|2|||
17032507|NCT00718718|38176828|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
17032508|NCT00718718|38176829|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
17032509|NCT00718718|38176830|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
17032510|NCT00718718|38176831|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
17032511|NCT00718718|38176832|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
17137288|NCT02815280|38279049|FG001|Double-Blind Phase|Protocol Violation|2|||
17137289|NCT02815280|38279048|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
17137290|NCT02815280|38279049|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
17137291|NCT02815280|38279048|FG000|Open-Label Phase|Adverse Event|2|||
17137292|NCT02815280|38279049|FG001|Open-Label Phase|Adverse Event|3|||
17137293|NCT02815280|38279048|FG000|Open-Label Phase|Lost to Follow-up|18|||
17137294|NCT02815280|38279049|FG001|Open-Label Phase|Lost to Follow-up|9|||
17137295|NCT02815280|38279048|FG000|Open-Label Phase|Withdrawal by Subject|33|||
17137296|NCT02815280|38279049|FG001|Open-Label Phase|Withdrawal by Subject|18|||
17137297|NCT02815280|38279048|FG000|Open-Label Phase|Protocol Violation|3|||
17137298|NCT02815280|38279049|FG001|Open-Label Phase|Protocol Violation|0|||
17137299|NCT02815280|38279048|FG000|Open-Label Phase|Administrative|26|||
17032512|NCT00718718|38176823|FG000|Week 12 to End of Study|Other|0|||
17032513|NCT00718718|38176824|FG001|Week 12 to End of Study|Other|1|||
17137300|NCT02815280|38279049|FG001|Open-Label Phase|Administrative|12|||
17137301|NCT02815280|38279048|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
17137302|NCT02815280|38279049|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
17137303|NCT02737930|38279061|FG000|Overall Study|Withdrawal by Subject|0|||
17137304|NCT02737930|38279062|FG001|Overall Study|Withdrawal by Subject|1|||
17137305|NCT03493698|38279068|FG000|Treatment Period C|Adverse Event|1|||
17137306|NCT03493698|38279068|FG000|Treatment Period C|Withdrawal by Subject|1|||
17137307|NCT02737852|38279082|FG000|Overall Study|Withdrawal by Subject|2|||
17137308|NCT03528174|38279086|FG000|Overall Study|Adverse Event|1|||
17137309|NCT03528174|38279086|FG000|Overall Study|sensors dislodged|1|||
17137310|NCT03109184|38279096|FG000|Overall Study|Lost to Follow-up|6|||
17137311|NCT03109184|38279097|FG001|Overall Study|Lost to Follow-up|6|||
17032514|NCT00718718|38176825|FG002|Week 12 to End of Study|Other|0|||
17032515|NCT00718718|38176826|FG003|Week 12 to End of Study|Other|1|||
17032516|NCT00718718|38176827|FG004|Week 12 to End of Study|Other|0|||
17032517|NCT00718718|38176828|FG005|Week 12 to End of Study|Other|0|||
17032518|NCT00718718|38176829|FG006|Week 12 to End of Study|Other|1|||
17032519|NCT00718718|38176830|FG007|Week 12 to End of Study|Other|0|||
17032520|NCT00718718|38176831|FG008|Week 12 to End of Study|Other|0|||
17032521|NCT00718718|38176832|FG009|Week 12 to End of Study|Other|0|||
17032522|NCT00683787|38176861|FG000|Overall Study|Progression|3|||
17032523|NCT00683787|38176862|FG001|Overall Study|Progression|3|||
17032524|NCT00683787|38176863|FG002|Overall Study|Progression|0|||
17032525|NCT00683787|38176861|FG000|Overall Study|Adverse Event|0|||
17032526|NCT00683787|38176862|FG001|Overall Study|Adverse Event|0|||
17032527|NCT00683787|38176863|FG002|Overall Study|Adverse Event|2|||
17032528|NCT00723008|38176873|FG000|Enrollment|Lost to Follow-up|1|||
17032529|NCT00723008|38176874|FG001|Enrollment|Lost to Follow-up|0|||
17032530|NCT00723008|38176873|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
17032531|NCT00723008|38176874|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
17032532|NCT00723008|38176873|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
17032533|NCT00723008|38176874|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
17032534|NCT00723008|38176873|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
17032535|NCT00723008|38176874|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
17032536|NCT00723008|38176873|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
17032537|NCT00723008|38176874|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
17032538|NCT00723008|38176873|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
17032539|NCT00723008|38176874|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
17032540|NCT00718640|38176888|FG000|Overall Study|Adverse Event|4|||
17032541|NCT00718640|38176888|FG000|Overall Study|Death|1|||
17032542|NCT00718640|38176888|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
17032543|NCT00715910|38176896|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
17032544|NCT00715910|38176897|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
17032545|NCT00715910|38176898|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
17032546|NCT00715910|38176899|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
17032547|NCT00715910|38176900|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
17032548|NCT00715910|38176901|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
17032549|NCT00715910|38176896|FG000|Booster and ESFU Phase|Other|0|||
17032550|NCT00715910|38176897|FG001|Booster and ESFU Phase|Other|0|||
17032551|NCT00715910|38176898|FG002|Booster and ESFU Phase|Other|0|||
17032552|NCT00715910|38176899|FG003|Booster and ESFU Phase|Other|5|||
17032553|NCT00715910|38176900|FG004|Booster and ESFU Phase|Other|1|||
17032554|NCT00715910|38176901|FG005|Booster and ESFU Phase|Other|0|||
17032555|NCT00715676|38176920|FG000|Overall Study|Adverse Event|3|||
17032556|NCT00715676|38176921|FG001|Overall Study|Adverse Event|5|||
17032557|NCT00715676|38176922|FG002|Overall Study|Adverse Event|21|||
17032558|NCT00715676|38176920|FG000|Overall Study|Withdrawal by Subject|1|||
17032559|NCT00715676|38176921|FG001|Overall Study|Withdrawal by Subject|3|||
17032560|NCT00715676|38176922|FG002|Overall Study|Withdrawal by Subject|8|||
17032561|NCT00715676|38176920|FG000|Overall Study|Lost to Follow-up|1|||
17032562|NCT00715676|38176921|FG001|Overall Study|Lost to Follow-up|2|||
17032563|NCT00715676|38176922|FG002|Overall Study|Lost to Follow-up|1|||
17032564|NCT00715676|38176920|FG000|Overall Study|Terminated by Sponsor|1|||
17032565|NCT00715676|38176921|FG001|Overall Study|Terminated by Sponsor|0|||
17032566|NCT00715676|38176922|FG002|Overall Study|Terminated by Sponsor|0|||
17032567|NCT00715676|38176920|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
17032568|NCT00715676|38176921|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
17032569|NCT00715676|38176922|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
17032570|NCT00715676|38176920|FG000|Overall Study|Use of Exclusionary Medication|0|||
17032571|NCT00715676|38176921|FG001|Overall Study|Use of Exclusionary Medication|0|||
17032572|NCT00715676|38176922|FG002|Overall Study|Use of Exclusionary Medication|1|||
17032573|NCT00715676|38176920|FG000|Overall Study|Elevated Blood Glucose|0|||
17032574|NCT00715676|38176921|FG001|Overall Study|Elevated Blood Glucose|1|||
17032575|NCT00715676|38176922|FG002|Overall Study|Elevated Blood Glucose|0|||
17032576|NCT00718328|38176932|FG000|Overall Study|Lost to Follow-up|1|||
17032577|NCT00718328|38176933|FG001|Overall Study|Lost to Follow-up|0|||
17032578|NCT00715520|38176942|FG000|Overall Study|Screen failure|8|||
17032579|NCT00715520|38176943|FG001|Overall Study|Screen failure|1|||
17032580|NCT00715520|38176944|FG002|Overall Study|Screen failure|1|||
17032581|NCT00715520|38176942|FG000|Overall Study|Withdrawal by Subject|2|||
17032582|NCT00715520|38176943|FG001|Overall Study|Withdrawal by Subject|0|||
17032583|NCT00715520|38176944|FG002|Overall Study|Withdrawal by Subject|1|||
17032584|NCT00680901|38176954|FG000|Overall Study|Lost to Follow-up|8|||
17032585|NCT00680901|38176955|FG001|Overall Study|Lost to Follow-up|8|||
17032586|NCT00680901|38176954|FG000|Overall Study|Withdrawal by Subject|4|||
17032587|NCT00680901|38176955|FG001|Overall Study|Withdrawal by Subject|13|||
17032588|NCT00680901|38176954|FG000|Overall Study|Physician Decision|0|||
17032589|NCT00680901|38176955|FG001|Overall Study|Physician Decision|1|||
17032590|NCT00680901|38176954|FG000|Overall Study|Ongoing: On Study Treatment|16|||
17032591|NCT00680901|38176955|FG001|Overall Study|Ongoing: On Study Treatment|13|||
17032592|NCT00680901|38176954|FG000|Overall Study|Ongoing: In Follow Up|45|||
17032593|NCT00680901|38176955|FG001|Overall Study|Ongoing: In Follow Up|41|||
17032594|NCT00790205|38176963|FG000|Overall Study|Lost to Follow-up|61|||
17032595|NCT00790205|38176964|FG001|Overall Study|Lost to Follow-up|71|||
17032596|NCT00790205|38176963|FG000|Overall Study|Withdrawal by Subject|299|||
17032597|NCT00790205|38176964|FG001|Overall Study|Withdrawal by Subject|363|||
17032598|NCT00715208|38176972|FG000|Overall Study|Withdrawal by Subject|1|||
17032599|NCT00715208|38176973|FG001|Overall Study|Withdrawal by Subject|1|||
17032600|NCT00715208|38176972|FG000|Overall Study|Adverse Event|0|||
17032601|NCT00715208|38176973|FG001|Overall Study|Adverse Event|6|||
17032602|NCT00715208|38176972|FG000|Overall Study|Lack of Efficacy|0|||
17032603|NCT00715208|38176973|FG001|Overall Study|Lack of Efficacy|2|||
17032604|NCT00775463|38176981|FG000|Overall Study|Withdrawal by Subject|0|||
17032605|NCT00775463|38176982|FG001|Overall Study|Withdrawal by Subject|1|||
17032606|NCT00775463|38176981|FG000|Overall Study|Adverse Event|7|||
17032607|NCT00775463|38176982|FG001|Overall Study|Adverse Event|9|||
17032608|NCT00775463|38176981|FG000|Overall Study|Protocol Violation|2|||
17032609|NCT00775463|38176982|FG001|Overall Study|Protocol Violation|2|||
17032610|NCT00775463|38176981|FG000|Overall Study|Lost to Follow-up|1|||
17032611|NCT00775463|38176982|FG001|Overall Study|Lost to Follow-up|0|||
17032612|NCT00775463|38176981|FG000|Overall Study|Lack of Efficacy|1|||
17032613|NCT00775463|38176982|FG001|Overall Study|Lack of Efficacy|1|||
17032614|NCT00587795|38176997|FG000|Overall Study|Withdrawal by Subject|1|||
17032615|NCT00587795|38176998|FG001|Overall Study|Withdrawal by Subject|0|||
17032616|NCT00587639|38177004|FG000|Overall Study|Withdrawal by Subject|1|||
17032617|NCT00774995|38177012|FG000|Overall Study|Protocol Violation|0|||
17032618|NCT00774995|38177013|FG001|Overall Study|Protocol Violation|0|||
17032619|NCT00774995|38177014|FG002|Overall Study|Protocol Violation|1|||
17032620|NCT00774995|38177015|FG003|Overall Study|Protocol Violation|0|||
17032621|NCT00713648|38177025|FG000|Overall Study|Adverse Event|1|||
17032622|NCT00713648|38177025|FG000|Overall Study|Unclassified|2|||
17032623|NCT00713648|38177025|FG000|Overall Study|According to Protocol|2|||
17032624|NCT00713648|38177025|FG000|Overall Study|Development of antibodies|3|||
17032625|NCT00768053|38177029|FG000|Overall Study|Adverse Event|10|||
17032626|NCT00768053|38177029|FG000|Overall Study|Lost to Follow-up|1|||
17032627|NCT00683475|38177035|FG000|Overall Study|Withdrawal by Subject|1|||
17032628|NCT00683475|38177036|FG001|Overall Study|Withdrawal by Subject|0|||
17032629|NCT00683475|38177035|FG000|Overall Study|Never Treated: Adverse Event|2|||
17032630|NCT00683475|38177036|FG001|Overall Study|Never Treated: Adverse Event|3|||
17032631|NCT00683475|38177035|FG000|Overall Study|Never Treated: Progressive Disease|1|||
17032632|NCT00683475|38177036|FG001|Overall Study|Never Treated: Progressive Disease|0|||
17032633|NCT00685035|38177043|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
17032634|NCT00685035|38177044|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
17032635|NCT00773747|38177070|FG000|Overall Study|Lack of Efficacy|112|||
17032636|NCT00773747|38177071|FG001|Overall Study|Lack of Efficacy|144|||
17032637|NCT00773747|38177070|FG000|Overall Study|Physician Decision|26|||
17032638|NCT00773747|38177071|FG001|Overall Study|Physician Decision|18|||
17032639|NCT00773747|38177070|FG000|Overall Study|Lost to Follow-up|0|||
17032640|NCT00773747|38177071|FG001|Overall Study|Lost to Follow-up|1|||
17032641|NCT00773747|38177070|FG000|Overall Study|Protocol Violation|2|||
17032642|NCT00773747|38177071|FG001|Overall Study|Protocol Violation|2|||
17032643|NCT00773747|38177070|FG000|Overall Study|Withdrawal by Subject|89|||
17032644|NCT00773747|38177071|FG001|Overall Study|Withdrawal by Subject|61|||
17032645|NCT00773747|38177070|FG000|Overall Study|Adverse Event|61|||
17032646|NCT00773747|38177071|FG001|Overall Study|Adverse Event|62|||
17032647|NCT00773747|38177070|FG000|Overall Study|Death|5|||
17032648|NCT00773747|38177071|FG001|Overall Study|Death|8|||
17032649|NCT00773747|38177070|FG000|Overall Study|Not Treated|2|||
17032650|NCT00773747|38177071|FG001|Overall Study|Not Treated|0|||
17032651|NCT00784277|38177081|FG000|IR Treatment|Adverse Event|4|||
17137312|NCT03109184|38279096|FG000|Overall Study|Withdrawal by Subject|1|||
17032652|NCT00784277|38177082|FG001|IR Treatment|Adverse Event|8|||
17032653|NCT00784277|38177083|FG002|IR Treatment|Adverse Event|19|||
17032654|NCT00784277|38177084|FG003|IR Treatment|Adverse Event|35|||
17032655|NCT00784277|38177085|FG004|IR Treatment|Adverse Event|0|||
17032656|NCT00784277|38177086|FG005|IR Treatment|Adverse Event|0|||
17032657|NCT00784277|38177087|FG006|IR Treatment|Adverse Event|0|||
17032658|NCT00784277|38177081|FG000|IR Treatment|Lack of Efficacy|4|||
17032659|NCT00784277|38177082|FG001|IR Treatment|Lack of Efficacy|4|||
17032660|NCT00784277|38177083|FG002|IR Treatment|Lack of Efficacy|1|||
17032661|NCT00784277|38177084|FG003|IR Treatment|Lack of Efficacy|0|||
17032662|NCT00784277|38177085|FG004|IR Treatment|Lack of Efficacy|0|||
17032663|NCT00784277|38177086|FG005|IR Treatment|Lack of Efficacy|0|||
17032664|NCT00784277|38177087|FG006|IR Treatment|Lack of Efficacy|0|||
17032665|NCT00784277|38177081|FG000|IR Treatment|Lost to Follow-up|1|||
17032666|NCT00784277|38177082|FG001|IR Treatment|Lost to Follow-up|0|||
17032667|NCT00784277|38177083|FG002|IR Treatment|Lost to Follow-up|1|||
17032668|NCT00784277|38177084|FG003|IR Treatment|Lost to Follow-up|0|||
17032669|NCT00784277|38177085|FG004|IR Treatment|Lost to Follow-up|0|||
17032670|NCT00784277|38177086|FG005|IR Treatment|Lost to Follow-up|0|||
17032671|NCT00784277|38177087|FG006|IR Treatment|Lost to Follow-up|0|||
17032672|NCT00784277|38177081|FG000|IR Treatment|Withdrawal by Subject|5|||
17032673|NCT00784277|38177082|FG001|IR Treatment|Withdrawal by Subject|1|||
17032674|NCT00784277|38177083|FG002|IR Treatment|Withdrawal by Subject|4|||
17032675|NCT00784277|38177084|FG003|IR Treatment|Withdrawal by Subject|6|||
17032676|NCT00784277|38177085|FG004|IR Treatment|Withdrawal by Subject|0|||
17032677|NCT00784277|38177086|FG005|IR Treatment|Withdrawal by Subject|0|||
17032678|NCT00784277|38177087|FG006|IR Treatment|Withdrawal by Subject|0|||
17032679|NCT00784277|38177081|FG000|IR Treatment|Resolution Of Pain|0|||
17032680|NCT00784277|38177082|FG001|IR Treatment|Resolution Of Pain|1|||
17032681|NCT00784277|38177083|FG002|IR Treatment|Resolution Of Pain|0|||
17032682|NCT00784277|38177084|FG003|IR Treatment|Resolution Of Pain|0|||
17032683|NCT00784277|38177085|FG004|IR Treatment|Resolution Of Pain|0|||
17032684|NCT00784277|38177086|FG005|IR Treatment|Resolution Of Pain|0|||
17032685|NCT00784277|38177087|FG006|IR Treatment|Resolution Of Pain|0|||
17032686|NCT00784277|38177081|FG000|IR Treatment|Other|2|||
17032687|NCT00784277|38177082|FG001|IR Treatment|Other|3|||
17032688|NCT00784277|38177083|FG002|IR Treatment|Other|3|||
17032689|NCT00784277|38177084|FG003|IR Treatment|Other|2|||
17032690|NCT00784277|38177085|FG004|IR Treatment|Other|0|||
17032691|NCT00784277|38177086|FG005|IR Treatment|Other|0|||
17032692|NCT00784277|38177087|FG006|IR Treatment|Other|0|||
17032693|NCT00784277|38177081|FG000|ER Treatment|Adverse Event|0|||
17032694|NCT00784277|38177082|FG001|ER Treatment|Adverse Event|0|||
17032695|NCT00784277|38177083|FG002|ER Treatment|Adverse Event|0|||
17032696|NCT00784277|38177084|FG003|ER Treatment|Adverse Event|0|||
17032697|NCT00784277|38177085|FG004|ER Treatment|Adverse Event|1|||
17032698|NCT00784277|38177086|FG005|ER Treatment|Adverse Event|7|||
17032699|NCT00784277|38177087|FG006|ER Treatment|Adverse Event|7|||
17032700|NCT00784277|38177081|FG000|ER Treatment|Lack of Efficacy|0|||
17032701|NCT00784277|38177082|FG001|ER Treatment|Lack of Efficacy|0|||
17032702|NCT00784277|38177083|FG002|ER Treatment|Lack of Efficacy|0|||
17032703|NCT00784277|38177084|FG003|ER Treatment|Lack of Efficacy|0|||
17032704|NCT00784277|38177085|FG004|ER Treatment|Lack of Efficacy|3|||
17032705|NCT00784277|38177086|FG005|ER Treatment|Lack of Efficacy|4|||
17032706|NCT00784277|38177087|FG006|ER Treatment|Lack of Efficacy|0|||
17032707|NCT00784277|38177081|FG000|ER Treatment|Lost to Follow-up|0|||
17032708|NCT00784277|38177082|FG001|ER Treatment|Lost to Follow-up|0|||
17032709|NCT00784277|38177083|FG002|ER Treatment|Lost to Follow-up|0|||
17032710|NCT00784277|38177084|FG003|ER Treatment|Lost to Follow-up|0|||
17032711|NCT00784277|38177085|FG004|ER Treatment|Lost to Follow-up|0|||
17032712|NCT00784277|38177086|FG005|ER Treatment|Lost to Follow-up|2|||
17032713|NCT00784277|38177087|FG006|ER Treatment|Lost to Follow-up|0|||
17032714|NCT00784277|38177081|FG000|ER Treatment|Withdrawal by Subject|0|||
17032715|NCT00784277|38177082|FG001|ER Treatment|Withdrawal by Subject|0|||
17032716|NCT00784277|38177083|FG002|ER Treatment|Withdrawal by Subject|0|||
17032717|NCT00784277|38177084|FG003|ER Treatment|Withdrawal by Subject|0|||
17032718|NCT00784277|38177085|FG004|ER Treatment|Withdrawal by Subject|2|||
17032719|NCT00784277|38177086|FG005|ER Treatment|Withdrawal by Subject|5|||
17032720|NCT00784277|38177087|FG006|ER Treatment|Withdrawal by Subject|3|||
17032721|NCT00784277|38177081|FG000|ER Treatment|Study Medication Non-Compliant|0|||
17032722|NCT00784277|38177082|FG001|ER Treatment|Study Medication Non-Compliant|0|||
17032723|NCT00784277|38177083|FG002|ER Treatment|Study Medication Non-Compliant|0|||
17032724|NCT00784277|38177084|FG003|ER Treatment|Study Medication Non-Compliant|0|||
17032725|NCT00784277|38177085|FG004|ER Treatment|Study Medication Non-Compliant|2|||
17032726|NCT00784277|38177086|FG005|ER Treatment|Study Medication Non-Compliant|3|||
17032727|NCT00784277|38177087|FG006|ER Treatment|Study Medication Non-Compliant|3|||
17032728|NCT00784277|38177081|FG000|ER Treatment|Other|0|||
17032729|NCT00784277|38177082|FG001|ER Treatment|Other|0|||
17032730|NCT00784277|38177083|FG002|ER Treatment|Other|0|||
17032731|NCT00784277|38177084|FG003|ER Treatment|Other|0|||
17032732|NCT00784277|38177085|FG004|ER Treatment|Other|1|||
17032733|NCT00784277|38177086|FG005|ER Treatment|Other|3|||
17032734|NCT00784277|38177087|FG006|ER Treatment|Other|2|||
17032735|NCT00682929|38177103|FG000|Overall Study|Adverse Event|4|||
17032736|NCT00682929|38177104|FG001|Overall Study|Adverse Event|1|||
17032737|NCT00682929|38177105|FG002|Overall Study|Adverse Event|1|||
17032738|NCT00682929|38177103|FG000|Overall Study|Withdrawal by Subject|1|||
17032739|NCT00682929|38177104|FG001|Overall Study|Withdrawal by Subject|2|||
17032740|NCT00682929|38177105|FG002|Overall Study|Withdrawal by Subject|1|||
17032741|NCT00682929|38177103|FG000|Overall Study|dosing compliance < 80%|0|||
17032742|NCT00682929|38177104|FG001|Overall Study|dosing compliance < 80%|2|||
17032743|NCT00682929|38177105|FG002|Overall Study|dosing compliance < 80%|0|||
17032744|NCT00682929|38177103|FG000|Overall Study|lag in DEA renewal|1|||
17032745|NCT00682929|38177104|FG001|Overall Study|lag in DEA renewal|0|||
17032746|NCT00682929|38177105|FG002|Overall Study|lag in DEA renewal|0|||
17032747|NCT00680745|38177117|FG000|Overall Study|Withdrawal by Subject|8|||
17032748|NCT00680745|38177118|FG001|Overall Study|Withdrawal by Subject|3|||
17032749|NCT00680745|38177119|FG002|Overall Study|Withdrawal by Subject|2|||
17032750|NCT00680745|38177120|FG003|Overall Study|Withdrawal by Subject|8|||
17032751|NCT00680745|38177117|FG000|Overall Study|Lost to Follow-up|0|||
17032752|NCT00680745|38177118|FG001|Overall Study|Lost to Follow-up|1|||
17032753|NCT00680745|38177119|FG002|Overall Study|Lost to Follow-up|1|||
17032754|NCT00680745|38177120|FG003|Overall Study|Lost to Follow-up|0|||
17032755|NCT00680745|38177117|FG000|Overall Study|Death|1|||
17032756|NCT00680745|38177118|FG001|Overall Study|Death|0|||
17032757|NCT00680745|38177119|FG002|Overall Study|Death|1|||
17032758|NCT00680745|38177120|FG003|Overall Study|Death|0|||
17032759|NCT00680745|38177117|FG000|Overall Study|Adverse Event|5|||
17032760|NCT00680745|38177118|FG001|Overall Study|Adverse Event|3|||
17032761|NCT00680745|38177119|FG002|Overall Study|Adverse Event|3|||
17032762|NCT00680745|38177120|FG003|Overall Study|Adverse Event|3|||
17032763|NCT00680745|38177117|FG000|Overall Study|Poor/Non-compliance|0|||
17032764|NCT00680745|38177118|FG001|Overall Study|Poor/Non-compliance|3|||
17032765|NCT00680745|38177119|FG002|Overall Study|Poor/Non-compliance|0|||
17032766|NCT00680745|38177120|FG003|Overall Study|Poor/Non-compliance|0|||
17032767|NCT00680745|38177117|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
17032768|NCT00680745|38177118|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
17032769|NCT00680745|38177119|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
17032770|NCT00680745|38177120|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
17032771|NCT00680745|38177117|FG000|Overall Study|False Treatment|0|||
17032772|NCT00680745|38177118|FG001|Overall Study|False Treatment|1|||
17032773|NCT00680745|38177119|FG002|Overall Study|False Treatment|3|||
17032774|NCT00680745|38177120|FG003|Overall Study|False Treatment|0|||
17032775|NCT00680121|38177133|FG000|Overall Study|Lost to Follow-up|27|||
17032776|NCT00680121|38177134|FG001|Overall Study|Lost to Follow-up|23|||
17032777|NCT00767819|38177143|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
17032778|NCT00767819|38177144|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
17032779|NCT00767819|38177145|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
17032780|NCT00767819|38177143|FG000|Overall Study|Withdrawal by Subject|1|||
17032781|NCT00767819|38177144|FG001|Overall Study|Withdrawal by Subject|1|||
17032782|NCT00767819|38177145|FG002|Overall Study|Withdrawal by Subject|0|||
17032783|NCT00767819|38177143|FG000|Overall Study|Administrative problems|0|||
17032784|NCT00767819|38177144|FG001|Overall Study|Administrative problems|1|||
17032785|NCT00767819|38177145|FG002|Overall Study|Administrative problems|0|||
17032786|NCT00767819|38177143|FG000|Overall Study|Death|2|||
17032787|NCT00767819|38177144|FG001|Overall Study|Death|3|||
17032788|NCT00767819|38177145|FG002|Overall Study|Death|0|||
17032789|NCT00767819|38177143|FG000|Overall Study|Adverse Event|2|||
17032790|NCT00767819|38177144|FG001|Overall Study|Adverse Event|0|||
17032791|NCT00767819|38177145|FG002|Overall Study|Adverse Event|0|||
17032792|NCT00767819|38177143|FG000|Overall Study|Abnormal lab values|1|||
17032793|NCT00767819|38177144|FG001|Overall Study|Abnormal lab values|0|||
17032794|NCT00767819|38177145|FG002|Overall Study|Abnormal lab values|0|||
17032795|NCT00767819|38177143|FG000|Overall Study|Lost to Follow-up|1|||
17032796|NCT00767819|38177144|FG001|Overall Study|Lost to Follow-up|0|||
17032797|NCT00767819|38177145|FG002|Overall Study|Lost to Follow-up|0|||
17032798|NCT00584870|38177156|FG000|Overall Study|Adverse Event|4|||
17032799|NCT00584870|38177157|FG001|Overall Study|Adverse Event|3|||
17032800|NCT00584870|38177158|FG002|Overall Study|Adverse Event|2|||
17032801|NCT00584870|38177156|FG000|Overall Study|Lost to Follow-up|4|||
17032802|NCT00584870|38177157|FG001|Overall Study|Lost to Follow-up|1|||
17032803|NCT00584870|38177158|FG002|Overall Study|Lost to Follow-up|1|||
17032804|NCT00584870|38177156|FG000|Overall Study|Lack of Efficacy|7|||
17032805|NCT00584870|38177157|FG001|Overall Study|Lack of Efficacy|14|||
17032806|NCT00584870|38177158|FG002|Overall Study|Lack of Efficacy|8|||
17032807|NCT00584870|38177156|FG000|Overall Study|Withdrawal by Subject|10|||
17032808|NCT00584870|38177157|FG001|Overall Study|Withdrawal by Subject|5|||
17032809|NCT00584870|38177158|FG002|Overall Study|Withdrawal by Subject|3|||
17032810|NCT00584870|38177156|FG000|Overall Study|Protocol Violation|1|||
17137313|NCT03109184|38279097|FG001|Overall Study|Withdrawal by Subject|1|||
17032811|NCT00584870|38177157|FG001|Overall Study|Protocol Violation|1|||
17032812|NCT00584870|38177158|FG002|Overall Study|Protocol Violation|2|||
17032813|NCT00584870|38177156|FG000|Overall Study|Did not met entrance criteria|1|||
17032814|NCT00584870|38177157|FG001|Overall Study|Did not met entrance criteria|0|||
17032815|NCT00584870|38177158|FG002|Overall Study|Did not met entrance criteria|0|||
17032816|NCT00584870|38177156|FG000|Overall Study|Other|2|||
17032817|NCT00584870|38177157|FG001|Overall Study|Other|0|||
17032818|NCT00584870|38177158|FG002|Overall Study|Other|0|||
17032819|NCT00584870|38177156|FG000|Overall Study|Randomized but not treated|0|||
17032820|NCT00584870|38177157|FG001|Overall Study|Randomized but not treated|1|||
17032821|NCT00584870|38177158|FG002|Overall Study|Randomized but not treated|2|||
17032822|NCT00679341|38177168|FG000|Overall Study|Disease progression|42|||
17032823|NCT00679341|38177169|FG001|Overall Study|Disease progression|36|||
17032824|NCT00679341|38177168|FG000|Overall Study|Adverse Event|5|||
17032825|NCT00679341|38177169|FG001|Overall Study|Adverse Event|6|||
17032826|NCT00679341|38177168|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
17032827|NCT00679341|38177169|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
17032828|NCT00679341|38177168|FG000|Overall Study|Death|1|||
17032829|NCT00679341|38177169|FG001|Overall Study|Death|1|||
17032830|NCT00679341|38177168|FG000|Overall Study|Other|1|||
17032831|NCT00679341|38177169|FG001|Overall Study|Other|0|||
17032832|NCT00679341|38177168|FG000|Overall Study|Physician Decision|1|||
17032833|NCT00679341|38177169|FG001|Overall Study|Physician Decision|0|||
17032834|NCT00679341|38177168|FG000|Overall Study|Not treated|0|||
17032835|NCT00679341|38177169|FG001|Overall Study|Not treated|2|||
17032836|NCT00679341|38177168|FG000|Overall Study|Physician/patient decision to withdraw|0|||
17032837|NCT00679341|38177169|FG001|Overall Study|Physician/patient decision to withdraw|6|||
17032838|NCT00679263|38177179|FG000|Visit 2/Dose 1|Adverse Event|1|||
17032839|NCT00679263|38177180|FG001|Visit 2/Dose 1|Adverse Event|0|||
17032840|NCT00679263|38177181|FG002|Visit 2/Dose 1|Adverse Event|0|||
17032841|NCT00679263|38177179|FG000|Visit 2/Dose 1|subject not compliance|1|||
17032842|NCT00679263|38177180|FG001|Visit 2/Dose 1|subject not compliance|1|||
17032843|NCT00679263|38177181|FG002|Visit 2/Dose 1|subject not compliance|0|||
17032844|NCT00680043|38177192|FG000|Overall Study|Withdrawal by Subject|1|||
17032845|NCT00680043|38177193|FG001|Overall Study|Withdrawal by Subject|0|||
17032846|NCT00680043|38177194|FG002|Overall Study|Withdrawal by Subject|0|||
17032847|NCT00680043|38177192|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
17032848|NCT00680043|38177193|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
17032849|NCT00680043|38177194|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
17032850|NCT00680043|38177192|FG000|Overall Study|Renal Transplant|1|||
17032851|NCT00680043|38177193|FG001|Overall Study|Renal Transplant|0|||
17032852|NCT00680043|38177194|FG002|Overall Study|Renal Transplant|4|||
17032853|NCT00682539|38177205|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
17032854|NCT00682539|38177206|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
17032855|NCT00682539|38177207|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
17032856|NCT00682539|38177205|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
17032857|NCT00682539|38177206|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
17032858|NCT00682539|38177207|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
17032859|NCT00682461|38177217|FG000|Overall Study|Adverse Event|5|||
17032860|NCT00682461|38177218|FG001|Overall Study|Adverse Event|7|||
17032861|NCT00682461|38177217|FG000|Overall Study|Lost to Follow-up|8|||
17032862|NCT00682461|38177218|FG001|Overall Study|Lost to Follow-up|5|||
17032863|NCT00682461|38177217|FG000|Overall Study|Withdrawal by Subject|12|||
17032864|NCT00682461|38177218|FG001|Overall Study|Withdrawal by Subject|19|||
17032865|NCT00679029|38177225|FG000|Overall Study|Adverse Event|3|||
17032866|NCT00679029|38177225|FG000|Overall Study|Withdrawal by Subject|1|||
17032867|NCT00679029|38177225|FG000|Overall Study|Lost to Follow-up|1|||
17032868|NCT00677235|38177231|FG000|Overall Study|Withdrawal by Subject|1|||
17032869|NCT00677235|38177232|FG001|Overall Study|Withdrawal by Subject|1|||
17032870|NCT00677235|38177231|FG000|Overall Study|Lost to Follow-up|2|||
17032871|NCT00677235|38177232|FG001|Overall Study|Lost to Follow-up|1|||
17032872|NCT00677235|38177231|FG000|Overall Study|Death|37|||
17032873|NCT00677235|38177232|FG001|Overall Study|Death|36|||
17032874|NCT00677235|38177231|FG000|Overall Study|Adverse Experience|1|||
17032875|NCT00677235|38177232|FG001|Overall Study|Adverse Experience|0|||
17032876|NCT00676689|38177238|FG000|Overall Study|Screen Failure|2|||
17032877|NCT00676689|38177238|FG000|Overall Study|Death|2|||
17032878|NCT00676689|38177238|FG000|Overall Study|Lost to Follow-up|4|||
17032879|NCT00676689|38177238|FG000|Overall Study|Physician Decision|1|||
17032880|NCT00676689|38177238|FG000|Overall Study|Withdrawal by Subject|3|||
17032881|NCT00676689|38177238|FG000|Overall Study|Continuing FU|49|||
17032882|NCT00678795|38177244|FG000|Overall Study|Adverse Event|7|||
17032883|NCT00678795|38177245|FG001|Overall Study|Adverse Event|3|||
17032884|NCT00678795|38177244|FG000|Overall Study|Withdrawal by Subject|3|||
17032885|NCT00678795|38177245|FG001|Overall Study|Withdrawal by Subject|0|||
17032886|NCT00678795|38177244|FG000|Overall Study|Protocol Violation|0|||
17032887|NCT00678795|38177245|FG001|Overall Study|Protocol Violation|1|||
17032888|NCT00678795|38177244|FG000|Overall Study|Lost to Follow-up|0|||
17032889|NCT00678795|38177245|FG001|Overall Study|Lost to Follow-up|1|||
17032890|NCT00678795|38177244|FG000|Overall Study|Lack of Efficacy|1|||
17032891|NCT00678795|38177245|FG001|Overall Study|Lack of Efficacy|1|||
17032892|NCT00678639|38177253|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
17032893|NCT00678639|38177254|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
17032894|NCT00678561|38177304|FG000|Overall Study|Adverse Event|0|||
17032895|NCT00678561|38177305|FG001|Overall Study|Adverse Event|1|||
17032896|NCT00678561|38177306|FG002|Overall Study|Adverse Event|1|||
17032897|NCT00678561|38177307|FG003|Overall Study|Adverse Event|0|||
17032898|NCT00678561|38177308|FG004|Overall Study|Adverse Event|1|||
17032899|NCT00678561|38177309|FG005|Overall Study|Adverse Event|0|||
17032900|NCT00678561|38177310|FG006|Overall Study|Adverse Event|0|||
17032901|NCT00678561|38177311|FG007|Overall Study|Adverse Event|0|||
17032902|NCT00678561|38177304|FG000|Overall Study|Protocol Violation|0|||
17032903|NCT00678561|38177305|FG001|Overall Study|Protocol Violation|0|||
17032904|NCT00678561|38177306|FG002|Overall Study|Protocol Violation|0|||
17032905|NCT00678561|38177307|FG003|Overall Study|Protocol Violation|0|||
17032906|NCT00678561|38177308|FG004|Overall Study|Protocol Violation|1|||
17032907|NCT00678561|38177309|FG005|Overall Study|Protocol Violation|1|||
17032908|NCT00678561|38177310|FG006|Overall Study|Protocol Violation|0|||
17032909|NCT00678561|38177311|FG007|Overall Study|Protocol Violation|0|||
17032910|NCT00678561|38177304|FG000|Overall Study|Withdrawal by Subject|0|||
17032911|NCT00678561|38177305|FG001|Overall Study|Withdrawal by Subject|0|||
17032912|NCT00678561|38177306|FG002|Overall Study|Withdrawal by Subject|0|||
17032913|NCT00678561|38177307|FG003|Overall Study|Withdrawal by Subject|0|||
17032914|NCT00678561|38177308|FG004|Overall Study|Withdrawal by Subject|0|||
17032915|NCT00678561|38177309|FG005|Overall Study|Withdrawal by Subject|0|||
17032916|NCT00678561|38177310|FG006|Overall Study|Withdrawal by Subject|0|||
17032917|NCT00678561|38177311|FG007|Overall Study|Withdrawal by Subject|1|||
17032918|NCT00676143|38177338|FG000|Overall Study|Adverse Event|34|||
17032919|NCT00676143|38177339|FG001|Overall Study|Adverse Event|60|||
17032920|NCT00676143|38177338|FG000|Overall Study|Death|4|||
17032921|NCT00676143|38177339|FG001|Overall Study|Death|4|||
17032922|NCT00676143|38177338|FG000|Overall Study|Lack of Efficacy|0|||
17032923|NCT00676143|38177339|FG001|Overall Study|Lack of Efficacy|6|||
17032924|NCT00676143|38177338|FG000|Overall Study|Lost to Follow-up|0|||
17032925|NCT00676143|38177339|FG001|Overall Study|Lost to Follow-up|13|||
17032926|NCT00676143|38177338|FG000|Overall Study|Physician Decision|5|||
17032927|NCT00676143|38177339|FG001|Overall Study|Physician Decision|8|||
17032928|NCT00676143|38177338|FG000|Overall Study|Protocol Violation|4|||
17032929|NCT00676143|38177339|FG001|Overall Study|Protocol Violation|8|||
17032930|NCT00676143|38177338|FG000|Overall Study|Withdrawal by Subject|24|||
17032931|NCT00676143|38177339|FG001|Overall Study|Withdrawal by Subject|42|||
17032932|NCT00676143|38177338|FG000|Overall Study|Discontinuation of study by sponsor|65|||
17032933|NCT00676143|38177339|FG001|Overall Study|Discontinuation of study by sponsor|88|||
17032934|NCT00676143|38177338|FG000|Overall Study|Failed to return|2|||
17032935|NCT00676143|38177339|FG001|Overall Study|Failed to return|1|||
17032936|NCT00676143|38177338|FG000|Overall Study|Loss of caregiver|5|||
17032937|NCT00676143|38177339|FG001|Overall Study|Loss of caregiver|3|||
17032938|NCT00676143|38177338|FG000|Overall Study|Other|11|||
17032939|NCT00676143|38177339|FG001|Overall Study|Other|20|||
17032940|NCT00676143|38177338|FG000|Overall Study|Participant participation unknown|1|||
17032941|NCT00676143|38177339|FG001|Overall Study|Participant participation unknown|4|||
17032942|NCT00676143|38177338|FG000|Overall Study|Vasogenic edema recurrence|1|||
17032943|NCT00676143|38177339|FG001|Overall Study|Vasogenic edema recurrence|3|||
17032944|NCT00675597|38177364|FG000|Overall Study|Withdrawal by Subject|3|||
17137314|NCT03493542|38279115|FG000|Overall Study|Ongoing|2|||
17032945|NCT00675441|38177372|FG000|Overall Study|Withdrawal by Subject|2|||
17032946|NCT00675441|38177372|FG000|Overall Study|Death|1|||
17032947|NCT00674973|38177387|FG000|Overall Study|Insufficient Therapeutic Response|77|||
17032948|NCT00674973|38177388|FG001|Overall Study|Insufficient Therapeutic Response|72|||
17032949|NCT00674973|38177387|FG000|Overall Study|Refused Treatment|1|||
17032950|NCT00674973|38177388|FG001|Overall Study|Refused Treatment|5|||
17032951|NCT00674973|38177387|FG000|Overall Study|Failure to Return|1|||
17032952|NCT00674973|38177388|FG001|Overall Study|Failure to Return|0|||
17032953|NCT00674973|38177387|FG000|Overall Study|Adverse Event|2|||
17032954|NCT00674973|38177388|FG001|Overall Study|Adverse Event|9|||
17032955|NCT00674973|38177387|FG000|Overall Study|Death|19|||
17032956|NCT00674973|38177388|FG001|Overall Study|Death|15|||
17032957|NCT00674973|38177387|FG000|Overall Study|Protocol Violation|0|||
17032958|NCT00674973|38177388|FG001|Overall Study|Protocol Violation|1|||
17032959|NCT00673179|38177396|FG000|Overall Study|Toxicity/Complications|3|||
17032960|NCT00673179|38177397|FG001|Overall Study|Toxicity/Complications|0|||
17032961|NCT00584012|38177403|FG000|Overall Study|Withdrawal by Subject|1|||
17032962|NCT00674817|38177407|FG000|Period 1|Withdrawal by Subject|2|||
17032963|NCT00674817|38177407|FG000|Period 1|Protocol Violation|1|||
17032964|NCT00674817|38177407|FG000|Period 3|Adverse Event|1|||
17032965|NCT00674817|38177407|FG000|Period 3|Protocol Violation|1|||
17032966|NCT00674817|38177407|FG000|Period 4|Adverse Event|1|||
17032967|NCT00672633|38177423|FG000|Overall Study|Withdrawal by Subject|0|||
17032968|NCT00672633|38177424|FG001|Overall Study|Withdrawal by Subject|1|||
17032969|NCT00672555|38177430|FG000|Overall Study|Lost to Follow-up|4|||
17032970|NCT00672555|38177430|FG000|Overall Study|Did not want to answer questionnaire|2|||
17032971|NCT00672477|38177436|FG000|Overall Study|Adverse Event|10|||
17032972|NCT00672477|38177437|FG001|Overall Study|Adverse Event|7|||
17032973|NCT00672477|38177436|FG000|Overall Study|Death|7|||
17032974|NCT00672477|38177437|FG001|Overall Study|Death|11|||
17032975|NCT00672477|38177436|FG000|Overall Study|Physician Decision|2|||
17032976|NCT00672477|38177437|FG001|Overall Study|Physician Decision|0|||
17032977|NCT00672477|38177436|FG000|Overall Study|Protocol Violation|1|||
17032978|NCT00672477|38177437|FG001|Overall Study|Protocol Violation|1|||
17032979|NCT00672477|38177436|FG000|Overall Study|Withdrawal by Subject|5|||
17032980|NCT00672477|38177437|FG001|Overall Study|Withdrawal by Subject|3|||
17032981|NCT00672477|38177436|FG000|Overall Study|Lack of Efficacy|1|||
17032982|NCT00672477|38177437|FG001|Overall Study|Lack of Efficacy|1|||
17032983|NCT00672477|38177436|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
17032984|NCT00672477|38177437|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
17032985|NCT00674661|38177445|FG000|Overall Study|Other|5|||
17032986|NCT00674661|38177446|FG001|Overall Study|Other|7|||
17032987|NCT00674661|38177445|FG000|Overall Study|Lost to Follow-up|6|||
17032988|NCT00674661|38177446|FG001|Overall Study|Lost to Follow-up|3|||
17032989|NCT00674661|38177445|FG000|Overall Study|Withdrawal by Subject|0|||
17032990|NCT00674661|38177446|FG001|Overall Study|Withdrawal by Subject|5|||
17137315|NCT03493542|38279116|FG001|Overall Study|Ongoing|3|||
17137316|NCT03493542|38279115|FG000|Overall Study|Withdrawal by parent or guardian|3|||
17137317|NCT03493542|38279116|FG001|Overall Study|Withdrawal by parent or guardian|0|||
17137318|NCT03493542|38279115|FG000|Overall Study|Withdrawal by Subject|2|||
17137319|NCT03493542|38279116|FG001|Overall Study|Withdrawal by Subject|6|||
17032991|NCT00671931|38177461|FG000|Overall Study|Physician Decision|1|||
17032992|NCT00671931|38177462|FG001|Overall Study|Physician Decision|0|||
17032993|NCT00671931|38177463|FG002|Overall Study|Physician Decision|0|||
17032994|NCT00671931|38177464|FG003|Overall Study|Physician Decision|2|||
17032995|NCT00671931|38177465|FG004|Overall Study|Physician Decision|1|||
17032996|NCT00673881|38177481|FG000|Overall Study|Withdrawal by Subject|1|||
17032997|NCT00671853|38177487|FG000|Overall Study|Lack of Efficacy|3|||
17032998|NCT00671853|38177488|FG001|Overall Study|Lack of Efficacy|7|||
17032999|NCT00671853|38177487|FG000|Overall Study|Adverse Event|7|||
17033000|NCT00671853|38177488|FG001|Overall Study|Adverse Event|1|||
17033001|NCT00671853|38177487|FG000|Overall Study|Withdrawal by Subject|1|||
17033002|NCT00671853|38177488|FG001|Overall Study|Withdrawal by Subject|5|||
17033003|NCT00671853|38177487|FG000|Overall Study|Lost to Follow-up|8|||
17033004|NCT00671853|38177488|FG001|Overall Study|Lost to Follow-up|8|||
17033005|NCT00671853|38177487|FG000|Overall Study|Physician Decision|0|||
17033006|NCT00671853|38177488|FG001|Overall Study|Physician Decision|2|||
17033007|NCT00671853|38177487|FG000|Overall Study|Non-adherence with study procedures|1|||
17033008|NCT00671853|38177488|FG001|Overall Study|Non-adherence with study procedures|4|||
17033009|NCT00570921|38177496|FG000|Overall Study|Protocol Violation|1|||
17033010|NCT00570921|38177496|FG000|Overall Study|Physician Decision|1|||
17033011|NCT00670449|38177504|FG000|Overall Study|Adverse Event|6|||
17033012|NCT00670449|38177505|FG001|Overall Study|Adverse Event|2|||
17033013|NCT00670449|38177506|FG002|Overall Study|Adverse Event|8|||
17033014|NCT00670449|38177507|FG003|Overall Study|Adverse Event|5|||
17033015|NCT00670449|38177504|FG000|Overall Study|Protocol Deviation|1|||
17033016|NCT00670449|38177505|FG001|Overall Study|Protocol Deviation|2|||
17033017|NCT00670449|38177506|FG002|Overall Study|Protocol Deviation|0|||
17137320|NCT03493386|38279124|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17137321|NCT03493386|38279125|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
17137322|NCT03493386|38279126|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17137323|NCT03493386|38279127|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17137324|NCT03478644|38279146|FG000|Phase 2|Withdrawal by Subject|2|||
17137325|NCT03478644|38279147|FG001|Phase 2|Withdrawal by Subject|1|||
17137326|NCT03478644|38279146|FG000|Phase 2|Lost to Follow-up|1|||
17137327|NCT03478644|38279147|FG001|Phase 2|Lost to Follow-up|0|||
17137328|NCT03527550|38279155|FG000|Overall Study|Lost to Follow-up|4|||
17137329|NCT03527550|38279156|FG001|Overall Study|Lost to Follow-up|2|||
17137330|NCT03527550|38279155|FG000|Overall Study|Withdrawal by Subject|4|||
17137331|NCT03527550|38279156|FG001|Overall Study|Withdrawal by Subject|1|||
17137332|NCT03527550|38279155|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
17137333|NCT03527550|38279156|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
17137334|NCT03475056|38279166|FG000|Overall Study|Lost to Follow-up|0|||
17137335|NCT03475056|38279167|FG001|Overall Study|Lost to Follow-up|1|||
17137336|NCT03475056|38279166|FG000|Overall Study|Moved from Area|0|||
17137337|NCT03475056|38279167|FG001|Overall Study|Moved from Area|2|||
17137338|NCT00938912|38279174|FG000|Overall Study|Withdrawal by Subject|28|||
17137339|NCT00938912|38279174|FG000|Overall Study|Lost to Follow-up|4|||
17137340|NCT00938912|38279174|FG000|Overall Study|Lack of Efficacy|43|||
17137341|NCT00938912|38279174|FG000|Overall Study|Adverse event, non-fatal|24|||
17137342|NCT00938912|38279174|FG000|Overall Study|Adverse event, fatal|1|||
17137343|NCT00938912|38279174|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
17137344|NCT00938912|38279174|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
17137345|NCT00938912|38279174|FG000|Overall Study|Participant needed prohibit medication|1|||
17137346|NCT00938912|38279174|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
17137347|NCT00938912|38279174|FG000|Overall Study|Did not meet Eligibility criteria|1|||
17137348|NCT00938912|38279174|FG000|Overall Study|Participant relocated not related to AE|1|||
17137349|NCT00938912|38279174|FG000|Overall Study|Participant moved to another city|1|||
17137350|NCT00938912|38279174|FG000|Overall Study|Participant experienced break through seizures|1|||
17137351|NCT00938912|38279174|FG000|Overall Study|No longer wished to participate in the study|1|||
17137352|NCT00938912|38279174|FG000|Overall Study|Protocol Deviation|2|||
17137353|NCT03473808|38279181|FG000|Overall Study|Withdrawal by Subject|1|||
17137354|NCT03473340|38279187|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
17137355|NCT03473340|38279188|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
17137356|NCT03473340|38279187|FG000|Overall Study|Withdrawal by Subject|1|||
17137357|NCT03473340|38279188|FG001|Overall Study|Withdrawal by Subject|0|||
17137358|NCT03473340|38279187|FG000|Overall Study|Lost to Follow-up|1|||
17137359|NCT03473340|38279188|FG001|Overall Study|Lost to Follow-up|2|||
17137360|NCT03490032|38279197|FG000|Overall Study|family issue (child custody)|1|||
17137361|NCT03490032|38279198|FG001|Overall Study|family issue (child custody)|0|||
17137362|NCT03490032|38279199|FG002|Overall Study|family issue (child custody)|0|||
17137363|NCT03489720|38279210|FG000|Overall Study|Withdrawal by Subject|2|||
17137364|NCT03489720|38279211|FG001|Overall Study|Withdrawal by Subject|0|||
17137365|NCT03527160|38279223|FG000|Overall Study|No urine collected|13|||
17137366|NCT03527160|38279223|FG000|Overall Study|No clinical serum creatinine collected|6|||
17137367|NCT03527160|38279223|FG000|Overall Study|Did not meet inclusion|2|||
17137368|NCT03739138|38279233|FG000|Overall Study|Death|0|||
17137369|NCT03739138|38279234|FG001|Overall Study|Death|7|||
17137370|NCT03739138|38279235|FG002|Overall Study|Death|4|||
17137371|NCT03739138|38279236|FG003|Overall Study|Death|13|||
17137372|NCT03739138|38279237|FG004|Overall Study|Death|0|||
17137373|NCT03739138|38279233|FG000|Overall Study|Lost to Follow-up|0|||
17137374|NCT03739138|38279234|FG001|Overall Study|Lost to Follow-up|0|||
17137375|NCT03739138|38279235|FG002|Overall Study|Lost to Follow-up|1|||
17137376|NCT03739138|38279236|FG003|Overall Study|Lost to Follow-up|0|||
17137377|NCT03739138|38279237|FG004|Overall Study|Lost to Follow-up|0|||
17137378|NCT03739138|38279233|FG000|Overall Study|Study Terminated By Sponsor|0|||
17137379|NCT03739138|38279234|FG001|Overall Study|Study Terminated By Sponsor|0|||
17137380|NCT03739138|38279235|FG002|Overall Study|Study Terminated By Sponsor|0|||
17137381|NCT03739138|38279236|FG003|Overall Study|Study Terminated By Sponsor|4|||
17137382|NCT03739138|38279237|FG004|Overall Study|Study Terminated By Sponsor|0|||
17137383|NCT03739138|38279233|FG000|Overall Study|Withdrawal by Subject|0|||
17137384|NCT03739138|38279234|FG001|Overall Study|Withdrawal by Subject|0|||
17137385|NCT03739138|38279235|FG002|Overall Study|Withdrawal by Subject|0|||
17137386|NCT03739138|38279236|FG003|Overall Study|Withdrawal by Subject|1|||
17137387|NCT03739138|38279237|FG004|Overall Study|Withdrawal by Subject|0|||
17137388|NCT03472326|38279247|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
17137389|NCT03472326|38279248|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
17137390|NCT03472326|38279249|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
17137391|NCT03472326|38279250|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
17137392|NCT03472326|38279247|FG000|Part 2: Combination Therapy|Pregnancy|0|||
17137393|NCT03472326|38279248|FG001|Part 2: Combination Therapy|Pregnancy|0|||
17137394|NCT03472326|38279249|FG002|Part 2: Combination Therapy|Pregnancy|0|||
17137395|NCT03472326|38279250|FG003|Part 2: Combination Therapy|Pregnancy|1|||
17137396|NCT02737618|38279259|FG000|Overall Study|Withdrawal by Subject|9|||
17137397|NCT03472014|38279263|FG000|Overall Study|Lost to Follow-up|4|||
17137398|NCT03471078|38279269|FG000|Overall Study|Withdrawal by Subject|9|||
17137399|NCT03471078|38279270|FG001|Overall Study|Withdrawal by Subject|1|||
17137400|NCT03471078|38279269|FG000|Overall Study|Adverse Event|4|||
17137401|NCT03471078|38279270|FG001|Overall Study|Adverse Event|1|||
17137402|NCT03471078|38279269|FG000|Overall Study|Physician Decision|3|||
17137403|NCT03471078|38279270|FG001|Overall Study|Physician Decision|2|||
17033018|NCT00670449|38177507|FG003|Overall Study|Protocol Deviation|1|||
17033019|NCT00670449|38177504|FG000|Overall Study|Administrative Problems|0|||
17033020|NCT00670449|38177505|FG001|Overall Study|Administrative Problems|2|||
17033021|NCT00670449|38177506|FG002|Overall Study|Administrative Problems|0|||
17033022|NCT00670449|38177507|FG003|Overall Study|Administrative Problems|1|||
17033023|NCT00670449|38177504|FG000|Overall Study|Subject Withdrew Consent|0|||
17033024|NCT00670449|38177505|FG001|Overall Study|Subject Withdrew Consent|2|||
17033025|NCT00670449|38177506|FG002|Overall Study|Subject Withdrew Consent|0|||
17033026|NCT00670449|38177507|FG003|Overall Study|Subject Withdrew Consent|1|||
17033027|NCT00670449|38177504|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
17033028|NCT00670449|38177505|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17033029|NCT00670449|38177506|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
17033030|NCT00670449|38177507|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17033031|NCT00670449|38177504|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
17033032|NCT00670449|38177505|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
17033033|NCT00670449|38177506|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
17033034|NCT00670449|38177507|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
17033035|NCT04349072|38177518|FG000|Randomization Period|Found ineligible post enrollment|0|||
17033036|NCT04349072|38177519|FG001|Randomization Period|Found ineligible post enrollment|1|||
17033037|NCT04349072|38177518|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
17033038|NCT04349072|38177519|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
17033039|NCT04349072|38177518|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
17033040|NCT04349072|38177519|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
17033041|NCT04349072|38177518|FG000|Treatment Period|Physician Decision|0|||
17033042|NCT04349072|38177519|FG001|Treatment Period|Physician Decision|1|||
17033043|NCT04349072|38177518|FG000|Treatment Period|Protocol Violation|0|||
17033044|NCT04349072|38177519|FG001|Treatment Period|Protocol Violation|1|||
17033045|NCT04349072|38177518|FG000|Treatment Period|Withdrawal by Subject|1|||
17033046|NCT04349072|38177519|FG001|Treatment Period|Withdrawal by Subject|1|||
17033047|NCT00668733|38177527|FG000|Overall Study|Lost to Follow-up|2|||
17033048|NCT00668733|38177528|FG001|Overall Study|Lost to Follow-up|3|||
17033049|NCT00668733|38177527|FG000|Overall Study|Withdrawal by Subject|0|||
17033050|NCT00668733|38177528|FG001|Overall Study|Withdrawal by Subject|4|||
17033051|NCT00673257|38177534|FG000|Overall Study|Withdrawal by Subject|4|||
17033052|NCT00673257|38177534|FG000|Overall Study|Unable to obtain specimen|1|||
17033053|NCT00667875|38177541|FG000|Overall Study|Adverse Event|0|||
17033054|NCT00667875|38177542|FG001|Overall Study|Adverse Event|2|||
17033055|NCT00667875|38177543|FG002|Overall Study|Adverse Event|6|||
17033056|NCT00667875|38177541|FG000|Overall Study|Withdrawal by Subject|10|||
17033057|NCT00667875|38177542|FG001|Overall Study|Withdrawal by Subject|9|||
17137404|NCT03471078|38279269|FG000|Overall Study|Death|2|||
17137405|NCT03471078|38279270|FG001|Overall Study|Death|0|||
17137406|NCT03471078|38279269|FG000|Overall Study|Other|3|||
17137407|NCT03471078|38279270|FG001|Overall Study|Other|2|||
17137408|NCT03526458|38279278|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
17137409|NCT03526458|38279279|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
17137410|NCT03526458|38279278|FG000|Overall Study|Stone passed, surgery cancelled|2|||
17137411|NCT03526458|38279279|FG001|Overall Study|Stone passed, surgery cancelled|1|||
17137412|NCT03526458|38279278|FG000|Overall Study|Withdrawal by Subject|1|||
17137413|NCT03526458|38279279|FG001|Overall Study|Withdrawal by Subject|0|||
17137414|NCT03526458|38279278|FG000|Overall Study|Physician Decision|2|||
17137415|NCT03526458|38279279|FG001|Overall Study|Physician Decision|1|||
17137416|NCT03526458|38279278|FG000|Overall Study|Lack of equipment|1|||
17137417|NCT03526458|38279279|FG001|Overall Study|Lack of equipment|1|||
17137418|NCT03488238|38279285|FG000|Overall Study|Equipment malfunction|1|||
17137419|NCT03488238|38279285|FG000|Overall Study|Adverse Event|1|||
17137420|NCT03525834|38279289|FG000|Overall Study|Progressive disease|1|||
17137421|NCT03525444|38279331|FG000|Overall Study|Adverse Event|0|||
17137422|NCT03525444|38279332|FG001|Overall Study|Adverse Event|1|||
17137423|NCT03525444|38279331|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
17137424|NCT03525444|38279332|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
17137425|NCT03525444|38279331|FG000|Overall Study|Other|0|||
17137426|NCT03525444|38279332|FG001|Overall Study|Other|1|||
17033058|NCT00667875|38177543|FG002|Overall Study|Withdrawal by Subject|7|||
17033059|NCT03468998|38177563|FG000|Overall Study|Withdrawal by Subject|1|||
17033060|NCT03468998|38177564|FG001|Overall Study|Withdrawal by Subject|1|||
17033061|NCT03468998|38177565|FG002|Overall Study|Withdrawal by Subject|0|||
17033062|NCT03468998|38177566|FG003|Overall Study|Withdrawal by Subject|4|||
17033063|NCT03468998|38177567|FG004|Overall Study|Withdrawal by Subject|1|||
17033064|NCT03468998|38177568|FG005|Overall Study|Withdrawal by Subject|0|||
17033065|NCT00667251|38177582|FG000|Overall Study|Adverse Event|13|||
17033066|NCT00667251|38177583|FG001|Overall Study|Adverse Event|4|||
17033067|NCT00667251|38177582|FG000|Overall Study|Withdrawal by Subject|6|||
17033068|NCT00667251|38177583|FG001|Overall Study|Withdrawal by Subject|2|||
17033069|NCT00667251|38177582|FG000|Overall Study|Other/missing|46|||
17033070|NCT00667251|38177583|FG001|Overall Study|Other/missing|84|||
17033071|NCT00667251|38177582|FG000|Overall Study|Intercurrent Illness|4|||
17033072|NCT00667251|38177583|FG001|Overall Study|Intercurrent Illness|3|||
17033073|NCT00667251|38177582|FG000|Overall Study|Symptomatic progression|1|||
17033074|NCT00667251|38177583|FG001|Overall Study|Symptomatic progression|2|||
17033075|NCT00669903|38177601|FG000|Overall Study|Adverse Event|0|||
17033076|NCT00669903|38177602|FG001|Overall Study|Adverse Event|1|||
17033077|NCT00669903|38177603|FG002|Overall Study|Adverse Event|3|||
17033078|NCT00669903|38177604|FG003|Overall Study|Adverse Event|1|||
17033079|NCT00669903|38177601|FG000|Overall Study|Withdrawal by Subject|0|||
17033080|NCT00669903|38177602|FG001|Overall Study|Withdrawal by Subject|2|||
17033081|NCT00669903|38177603|FG002|Overall Study|Withdrawal by Subject|2|||
17033082|NCT00669903|38177604|FG003|Overall Study|Withdrawal by Subject|2|||
17033083|NCT00669903|38177601|FG000|Overall Study|Lost to Follow-up|1|||
17033084|NCT00669903|38177602|FG001|Overall Study|Lost to Follow-up|1|||
17033085|NCT00669903|38177603|FG002|Overall Study|Lost to Follow-up|0|||
17033086|NCT00669903|38177604|FG003|Overall Study|Lost to Follow-up|1|||
17033087|NCT00669903|38177601|FG000|Overall Study|Protocol Violation|0|||
17033088|NCT00669903|38177602|FG001|Overall Study|Protocol Violation|1|||
17033089|NCT00669903|38177603|FG002|Overall Study|Protocol Violation|0|||
17033090|NCT00669903|38177604|FG003|Overall Study|Protocol Violation|0|||
17033091|NCT03759392|38177616|FG000|Overall Study|Adverse Event|12|||
17033092|NCT03759392|38177617|FG001|Overall Study|Adverse Event|4|||
17033093|NCT03759392|38177616|FG000|Overall Study|Death|2|||
17033094|NCT03759392|38177617|FG001|Overall Study|Death|1|||
17033095|NCT03759392|38177616|FG000|Overall Study|Withdrawal by Subject|2|||
17033096|NCT03759392|38177617|FG001|Overall Study|Withdrawal by Subject|0|||
17033097|NCT03759392|38177616|FG000|Overall Study|Protocol Violation|2|||
17033098|NCT03759392|38177617|FG001|Overall Study|Protocol Violation|0|||
17033099|NCT03759392|38177616|FG000|Overall Study|Physician Decision|0|||
17033100|NCT03759392|38177617|FG001|Overall Study|Physician Decision|1|||
17033101|NCT03759392|38177616|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
17033102|NCT03759392|38177617|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
17033103|NCT03759392|38177616|FG000|Overall Study|No longer able to take medicines|1|||
17033104|NCT03759392|38177617|FG001|Overall Study|No longer able to take medicines|0|||
17033105|NCT03759392|38177616|FG000|Overall Study|Stopped taking study drug|1|||
17033106|NCT03759392|38177617|FG001|Overall Study|Stopped taking study drug|0|||
17033107|NCT00667719|38177623|FG000|Overall Study|Adverse Event|39|||
17033108|NCT00667719|38177623|FG000|Overall Study|Abnormal Test Procedure|1|||
17033109|NCT00667719|38177623|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
17033110|NCT00667719|38177623|FG000|Overall Study|Protocol Violation|3|||
17033111|NCT00667719|38177623|FG000|Overall Study|Withdrawal by Subject|17|||
17033112|NCT00667719|38177623|FG000|Overall Study|Lost to Follow-up|8|||
17033113|NCT00669669|38177632|FG000|Overall Study|To late to start treatment|1|||
17033114|NCT00467779|38177651|FG000|Stage 1|Adverse Event|1|||
17033115|NCT00467779|38177652|FG001|Stage 1|Adverse Event|0|||
17033116|NCT00467779|38177653|FG002|Stage 1|Adverse Event|0|||
17033117|NCT00467779|38177654|FG003|Stage 1|Adverse Event|0|||
17033118|NCT00467779|38177655|FG004|Stage 1|Adverse Event|0|||
17033119|NCT00467779|38177656|FG005|Stage 1|Adverse Event|1|||
17137427|NCT03921424|38279341|FG000|Overall Study|Lost to Follow-up|0|||
17033120|NCT00467779|38177657|FG006|Stage 1|Adverse Event|2|||
17033121|NCT00467779|38177658|FG007|Stage 1|Adverse Event|1|||
17033122|NCT00467779|38177659|FG008|Stage 1|Adverse Event|0|||
17033123|NCT00467779|38177660|FG009|Stage 1|Adverse Event|0|||
17033124|NCT00467779|38177661|FG010|Stage 1|Adverse Event|0|||
17033125|NCT00467779|38177662|FG011|Stage 1|Adverse Event|0|||
17033126|NCT00467779|38177663|FG012|Stage 1|Adverse Event|0|||
17033127|NCT00467779|38177664|FG013|Stage 1|Adverse Event|0|||
17033128|NCT00467779|38177665|FG014|Stage 1|Adverse Event|0|||
17033129|NCT00467779|38177651|FG000|Stage 1|Disease Progression|2|||
17033130|NCT00467779|38177652|FG001|Stage 1|Disease Progression|2|||
17033131|NCT00467779|38177653|FG002|Stage 1|Disease Progression|2|||
17033132|NCT00467779|38177654|FG003|Stage 1|Disease Progression|3|||
17033133|NCT00467779|38177655|FG004|Stage 1|Disease Progression|2|||
17033134|NCT00467779|38177656|FG005|Stage 1|Disease Progression|2|||
17033135|NCT00467779|38177657|FG006|Stage 1|Disease Progression|4|||
17033136|NCT00467779|38177658|FG007|Stage 1|Disease Progression|5|||
17033137|NCT00467779|38177659|FG008|Stage 1|Disease Progression|0|||
17033138|NCT00467779|38177660|FG009|Stage 1|Disease Progression|0|||
17033139|NCT00467779|38177661|FG010|Stage 1|Disease Progression|0|||
17033140|NCT00467779|38177662|FG011|Stage 1|Disease Progression|0|||
17033141|NCT00467779|38177663|FG012|Stage 1|Disease Progression|0|||
17033142|NCT00467779|38177664|FG013|Stage 1|Disease Progression|0|||
17033143|NCT00467779|38177665|FG014|Stage 1|Disease Progression|0|||
17033144|NCT00467779|38177651|FG000|Stage 1|Unspecified Reason|1|||
17033145|NCT00467779|38177652|FG001|Stage 1|Unspecified Reason|0|||
17033146|NCT00467779|38177653|FG002|Stage 1|Unspecified Reason|1|||
17033147|NCT00467779|38177654|FG003|Stage 1|Unspecified Reason|0|||
17033148|NCT00467779|38177655|FG004|Stage 1|Unspecified Reason|1|||
17033149|NCT00467779|38177656|FG005|Stage 1|Unspecified Reason|2|||
17033150|NCT00467779|38177657|FG006|Stage 1|Unspecified Reason|0|||
17033151|NCT00467779|38177658|FG007|Stage 1|Unspecified Reason|0|||
17033152|NCT00467779|38177659|FG008|Stage 1|Unspecified Reason|0|||
17033153|NCT00467779|38177660|FG009|Stage 1|Unspecified Reason|0|||
17137428|NCT03921424|38279342|FG001|Overall Study|Lost to Follow-up|1|||
17137429|NCT03921424|38279341|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
17137430|NCT03921424|38279342|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
17137431|NCT03487848|38279350|FG000|Overall Study|Lost to Follow-up|1|||
17137432|NCT03524664|38279356|FG000|Overall Study|Withdrawal by Subject|1|||
17137433|NCT03524664|38279357|FG001|Overall Study|Withdrawal by Subject|2|||
17033154|NCT00467779|38177661|FG010|Stage 1|Unspecified Reason|0|||
17033155|NCT00467779|38177662|FG011|Stage 1|Unspecified Reason|0|||
17033156|NCT00467779|38177663|FG012|Stage 1|Unspecified Reason|0|||
17033157|NCT00467779|38177664|FG013|Stage 1|Unspecified Reason|0|||
17033158|NCT00467779|38177665|FG014|Stage 1|Unspecified Reason|0|||
17033159|NCT00467779|38177651|FG000|Stage 1|Physician Decision|0|||
17033160|NCT00467779|38177652|FG001|Stage 1|Physician Decision|1|||
17033161|NCT00467779|38177653|FG002|Stage 1|Physician Decision|0|||
17033162|NCT00467779|38177654|FG003|Stage 1|Physician Decision|0|||
17033163|NCT00467779|38177655|FG004|Stage 1|Physician Decision|0|||
17033164|NCT00467779|38177656|FG005|Stage 1|Physician Decision|0|||
17033165|NCT00467779|38177657|FG006|Stage 1|Physician Decision|0|||
17033166|NCT00467779|38177658|FG007|Stage 1|Physician Decision|0|||
17033167|NCT00467779|38177659|FG008|Stage 1|Physician Decision|0|||
17033168|NCT00467779|38177660|FG009|Stage 1|Physician Decision|0|||
17033169|NCT00467779|38177661|FG010|Stage 1|Physician Decision|0|||
17033170|NCT00467779|38177662|FG011|Stage 1|Physician Decision|0|||
17033171|NCT00467779|38177663|FG012|Stage 1|Physician Decision|0|||
17033172|NCT00467779|38177664|FG013|Stage 1|Physician Decision|0|||
17033173|NCT00467779|38177665|FG014|Stage 1|Physician Decision|0|||
17033174|NCT00467779|38177651|FG000|Stage 1|Withdrawal by Subject|0|||
17033175|NCT00467779|38177652|FG001|Stage 1|Withdrawal by Subject|0|||
17033176|NCT00467779|38177653|FG002|Stage 1|Withdrawal by Subject|0|||
17033177|NCT00467779|38177654|FG003|Stage 1|Withdrawal by Subject|0|||
17033178|NCT00467779|38177655|FG004|Stage 1|Withdrawal by Subject|0|||
17033179|NCT00467779|38177656|FG005|Stage 1|Withdrawal by Subject|0|||
17033180|NCT00467779|38177657|FG006|Stage 1|Withdrawal by Subject|1|||
17033181|NCT00467779|38177658|FG007|Stage 1|Withdrawal by Subject|1|||
17033182|NCT00467779|38177659|FG008|Stage 1|Withdrawal by Subject|0|||
17033183|NCT00467779|38177660|FG009|Stage 1|Withdrawal by Subject|0|||
17033184|NCT00467779|38177661|FG010|Stage 1|Withdrawal by Subject|0|||
17033185|NCT00467779|38177662|FG011|Stage 1|Withdrawal by Subject|0|||
17033186|NCT00467779|38177663|FG012|Stage 1|Withdrawal by Subject|0|||
17033187|NCT00467779|38177664|FG013|Stage 1|Withdrawal by Subject|0|||
17033188|NCT00467779|38177665|FG014|Stage 1|Withdrawal by Subject|0|||
17033189|NCT00467779|38177651|FG000|Stage 1A|Adverse Event|0|||
17033190|NCT00467779|38177652|FG001|Stage 1A|Adverse Event|0|||
17033191|NCT00467779|38177653|FG002|Stage 1A|Adverse Event|0|||
17033192|NCT00467779|38177654|FG003|Stage 1A|Adverse Event|0|||
17033193|NCT00467779|38177655|FG004|Stage 1A|Adverse Event|0|||
17033194|NCT00467779|38177656|FG005|Stage 1A|Adverse Event|0|||
17033195|NCT00467779|38177657|FG006|Stage 1A|Adverse Event|0|||
17033196|NCT00467779|38177658|FG007|Stage 1A|Adverse Event|0|||
17033197|NCT00467779|38177659|FG008|Stage 1A|Adverse Event|0|||
17033198|NCT00467779|38177660|FG009|Stage 1A|Adverse Event|0|||
17033199|NCT00467779|38177661|FG010|Stage 1A|Adverse Event|0|||
17033200|NCT00467779|38177662|FG011|Stage 1A|Adverse Event|0|||
17033201|NCT00467779|38177663|FG012|Stage 1A|Adverse Event|1|||
17033202|NCT00467779|38177664|FG013|Stage 1A|Adverse Event|0|||
17033203|NCT00467779|38177665|FG014|Stage 1A|Adverse Event|0|||
17033204|NCT00467779|38177651|FG000|Stage 1A|Death|0|||
17033205|NCT00467779|38177652|FG001|Stage 1A|Death|0|||
17033206|NCT00467779|38177653|FG002|Stage 1A|Death|0|||
17033207|NCT00467779|38177654|FG003|Stage 1A|Death|0|||
17033208|NCT00467779|38177655|FG004|Stage 1A|Death|0|||
17033209|NCT00467779|38177656|FG005|Stage 1A|Death|0|||
17033210|NCT00467779|38177657|FG006|Stage 1A|Death|0|||
17033211|NCT00467779|38177658|FG007|Stage 1A|Death|0|||
17033212|NCT00467779|38177659|FG008|Stage 1A|Death|0|||
17033213|NCT00467779|38177660|FG009|Stage 1A|Death|0|||
17033214|NCT00467779|38177661|FG010|Stage 1A|Death|0|||
17033215|NCT00467779|38177662|FG011|Stage 1A|Death|1|||
17033216|NCT00467779|38177663|FG012|Stage 1A|Death|1|||
17033217|NCT00467779|38177664|FG013|Stage 1A|Death|0|||
17033218|NCT00467779|38177665|FG014|Stage 1A|Death|0|||
17033219|NCT00467779|38177651|FG000|Stage 1A|Disease Progression|0|||
17033220|NCT00467779|38177652|FG001|Stage 1A|Disease Progression|0|||
17033221|NCT00467779|38177653|FG002|Stage 1A|Disease Progression|0|||
17033222|NCT00467779|38177654|FG003|Stage 1A|Disease Progression|0|||
17033223|NCT00467779|38177655|FG004|Stage 1A|Disease Progression|0|||
17033224|NCT00467779|38177656|FG005|Stage 1A|Disease Progression|0|||
17033225|NCT00467779|38177657|FG006|Stage 1A|Disease Progression|0|||
17033226|NCT00467779|38177658|FG007|Stage 1A|Disease Progression|0|||
17033227|NCT00467779|38177659|FG008|Stage 1A|Disease Progression|0|||
17033228|NCT00467779|38177660|FG009|Stage 1A|Disease Progression|2|||
17033229|NCT00467779|38177661|FG010|Stage 1A|Disease Progression|2|||
17033230|NCT00467779|38177662|FG011|Stage 1A|Disease Progression|5|||
17033231|NCT00467779|38177663|FG012|Stage 1A|Disease Progression|2|||
17033232|NCT00467779|38177664|FG013|Stage 1A|Disease Progression|0|||
17033233|NCT00467779|38177665|FG014|Stage 1A|Disease Progression|0|||
17033234|NCT00467779|38177651|FG000|Stage 1A|Physician Decision|0|||
17033235|NCT00467779|38177652|FG001|Stage 1A|Physician Decision|0|||
17033236|NCT00467779|38177653|FG002|Stage 1A|Physician Decision|0|||
17033237|NCT00467779|38177654|FG003|Stage 1A|Physician Decision|0|||
17033238|NCT00467779|38177655|FG004|Stage 1A|Physician Decision|0|||
17033239|NCT00467779|38177656|FG005|Stage 1A|Physician Decision|0|||
17033240|NCT00467779|38177657|FG006|Stage 1A|Physician Decision|0|||
17033241|NCT00467779|38177658|FG007|Stage 1A|Physician Decision|0|||
17033242|NCT00467779|38177659|FG008|Stage 1A|Physician Decision|0|||
17033243|NCT00467779|38177660|FG009|Stage 1A|Physician Decision|1|||
17033244|NCT00467779|38177661|FG010|Stage 1A|Physician Decision|0|||
17033245|NCT00467779|38177662|FG011|Stage 1A|Physician Decision|0|||
17033246|NCT00467779|38177663|FG012|Stage 1A|Physician Decision|0|||
17033247|NCT00467779|38177664|FG013|Stage 1A|Physician Decision|0|||
17033248|NCT00467779|38177665|FG014|Stage 1A|Physician Decision|0|||
17033249|NCT00467779|38177651|FG000|Stage 1A|Withdrawal by Subject|0|||
17033250|NCT00467779|38177652|FG001|Stage 1A|Withdrawal by Subject|0|||
17033251|NCT00467779|38177653|FG002|Stage 1A|Withdrawal by Subject|0|||
17033252|NCT00467779|38177654|FG003|Stage 1A|Withdrawal by Subject|0|||
17033253|NCT00467779|38177655|FG004|Stage 1A|Withdrawal by Subject|0|||
17137434|NCT03524664|38279356|FG000|Overall Study|Lost to Follow-up|4|||
17033254|NCT00467779|38177656|FG005|Stage 1A|Withdrawal by Subject|0|||
17033255|NCT00467779|38177657|FG006|Stage 1A|Withdrawal by Subject|0|||
17033256|NCT00467779|38177658|FG007|Stage 1A|Withdrawal by Subject|0|||
17033257|NCT00467779|38177659|FG008|Stage 1A|Withdrawal by Subject|0|||
17033258|NCT00467779|38177660|FG009|Stage 1A|Withdrawal by Subject|0|||
17033259|NCT00467779|38177661|FG010|Stage 1A|Withdrawal by Subject|1|||
17033260|NCT00467779|38177662|FG011|Stage 1A|Withdrawal by Subject|1|||
17033261|NCT00467779|38177663|FG012|Stage 1A|Withdrawal by Subject|1|||
17033262|NCT00467779|38177664|FG013|Stage 1A|Withdrawal by Subject|0|||
17033263|NCT00467779|38177665|FG014|Stage 1A|Withdrawal by Subject|0|||
17033264|NCT00467779|38177651|FG000|Stage 1A|Unspecified Reason|0|||
17033265|NCT00467779|38177652|FG001|Stage 1A|Unspecified Reason|0|||
17033266|NCT00467779|38177653|FG002|Stage 1A|Unspecified Reason|0|||
17033267|NCT00467779|38177654|FG003|Stage 1A|Unspecified Reason|0|||
17033268|NCT00467779|38177655|FG004|Stage 1A|Unspecified Reason|0|||
17033269|NCT00467779|38177656|FG005|Stage 1A|Unspecified Reason|0|||
17033270|NCT00467779|38177657|FG006|Stage 1A|Unspecified Reason|0|||
17033271|NCT00467779|38177658|FG007|Stage 1A|Unspecified Reason|0|||
17033272|NCT00467779|38177659|FG008|Stage 1A|Unspecified Reason|0|||
17137435|NCT03524664|38279357|FG001|Overall Study|Lost to Follow-up|13|||
17137436|NCT04377620|38279366|FG000|Overall Study|Death|42|||
17137437|NCT04377620|38279367|FG001|Overall Study|Death|48|||
17137438|NCT04377620|38279368|FG002|Overall Study|Death|36|||
17137439|NCT04377620|38279366|FG000|Overall Study|Withdrawal by Subject|0|||
17137440|NCT04377620|38279367|FG001|Overall Study|Withdrawal by Subject|2|||
17137441|NCT04377620|38279368|FG002|Overall Study|Withdrawal by Subject|0|||
17137442|NCT03486834|38279380|FG000|Overall Study|Withdrawal by Subject|46|||
17137443|NCT03486834|38279381|FG001|Overall Study|Withdrawal by Subject|46|||
17137444|NCT03486834|38279382|FG002|Overall Study|Withdrawal by Subject|52|||
17033273|NCT00467779|38177660|FG009|Stage 1A|Unspecified Reason|0|||
17033274|NCT00467779|38177661|FG010|Stage 1A|Unspecified Reason|0|||
17033275|NCT00467779|38177662|FG011|Stage 1A|Unspecified Reason|1|||
17033276|NCT00467779|38177663|FG012|Stage 1A|Unspecified Reason|1|||
17033277|NCT00467779|38177664|FG013|Stage 1A|Unspecified Reason|0|||
17033278|NCT00467779|38177665|FG014|Stage 1A|Unspecified Reason|0|||
17033279|NCT00467779|38177651|FG000|Stage 2|Adverse Event|0|||
17033280|NCT00467779|38177652|FG001|Stage 2|Adverse Event|0|||
17033281|NCT00467779|38177653|FG002|Stage 2|Adverse Event|0|||
17033282|NCT00467779|38177654|FG003|Stage 2|Adverse Event|0|||
17033283|NCT00467779|38177655|FG004|Stage 2|Adverse Event|0|||
17033284|NCT00467779|38177656|FG005|Stage 2|Adverse Event|0|||
17033285|NCT00467779|38177657|FG006|Stage 2|Adverse Event|0|||
17033286|NCT00467779|38177658|FG007|Stage 2|Adverse Event|0|||
17033287|NCT00467779|38177659|FG008|Stage 2|Adverse Event|1|||
17033288|NCT00467779|38177660|FG009|Stage 2|Adverse Event|0|||
17033289|NCT00467779|38177661|FG010|Stage 2|Adverse Event|0|||
17033290|NCT00467779|38177662|FG011|Stage 2|Adverse Event|0|||
17033291|NCT00467779|38177663|FG012|Stage 2|Adverse Event|0|||
17033292|NCT00467779|38177664|FG013|Stage 2|Adverse Event|0|||
17033293|NCT00467779|38177665|FG014|Stage 2|Adverse Event|0|||
17033294|NCT00467779|38177651|FG000|Stage 2|Death|0|||
17033295|NCT00467779|38177652|FG001|Stage 2|Death|0|||
17033296|NCT00467779|38177653|FG002|Stage 2|Death|0|||
17033297|NCT00467779|38177654|FG003|Stage 2|Death|0|||
17033298|NCT00467779|38177655|FG004|Stage 2|Death|0|||
17033299|NCT00467779|38177656|FG005|Stage 2|Death|0|||
17033300|NCT00467779|38177657|FG006|Stage 2|Death|0|||
17033301|NCT00467779|38177658|FG007|Stage 2|Death|0|||
17033302|NCT00467779|38177659|FG008|Stage 2|Death|1|||
17033303|NCT00467779|38177660|FG009|Stage 2|Death|0|||
17033304|NCT00467779|38177661|FG010|Stage 2|Death|0|||
17033305|NCT00467779|38177662|FG011|Stage 2|Death|0|||
17033306|NCT00467779|38177663|FG012|Stage 2|Death|0|||
17033307|NCT00467779|38177664|FG013|Stage 2|Death|0|||
17033308|NCT00467779|38177665|FG014|Stage 2|Death|0|||
17033309|NCT00467779|38177651|FG000|Stage 2|Disease Progression|0|||
17033310|NCT00467779|38177652|FG001|Stage 2|Disease Progression|0|||
17033311|NCT00467779|38177653|FG002|Stage 2|Disease Progression|0|||
17033312|NCT00467779|38177654|FG003|Stage 2|Disease Progression|0|||
17033313|NCT00467779|38177655|FG004|Stage 2|Disease Progression|0|||
17033314|NCT00467779|38177656|FG005|Stage 2|Disease Progression|0|||
17033315|NCT00467779|38177657|FG006|Stage 2|Disease Progression|0|||
17033316|NCT00467779|38177658|FG007|Stage 2|Disease Progression|0|||
17137445|NCT03486834|38279380|FG000|Overall Study|Adverse Event|8|||
17137446|NCT03486834|38279381|FG001|Overall Study|Adverse Event|7|||
17033317|NCT00467779|38177659|FG008|Stage 2|Disease Progression|16|||
17033318|NCT00467779|38177660|FG009|Stage 2|Disease Progression|0|||
17033319|NCT00467779|38177661|FG010|Stage 2|Disease Progression|0|||
17033320|NCT00467779|38177662|FG011|Stage 2|Disease Progression|0|||
17033321|NCT00467779|38177663|FG012|Stage 2|Disease Progression|0|||
17033322|NCT00467779|38177664|FG013|Stage 2|Disease Progression|0|||
17033323|NCT00467779|38177665|FG014|Stage 2|Disease Progression|0|||
17033324|NCT00467779|38177651|FG000|Stage 2|Unspecified Reason|0|||
17033325|NCT00467779|38177652|FG001|Stage 2|Unspecified Reason|0|||
17033326|NCT00467779|38177653|FG002|Stage 2|Unspecified Reason|0|||
17033327|NCT00467779|38177654|FG003|Stage 2|Unspecified Reason|0|||
17033328|NCT00467779|38177655|FG004|Stage 2|Unspecified Reason|0|||
17033329|NCT00467779|38177656|FG005|Stage 2|Unspecified Reason|0|||
17033330|NCT00467779|38177657|FG006|Stage 2|Unspecified Reason|0|||
17033331|NCT00467779|38177658|FG007|Stage 2|Unspecified Reason|0|||
17033332|NCT00467779|38177659|FG008|Stage 2|Unspecified Reason|3|||
17033333|NCT00467779|38177660|FG009|Stage 2|Unspecified Reason|0|||
17033334|NCT00467779|38177661|FG010|Stage 2|Unspecified Reason|0|||
17033335|NCT00467779|38177662|FG011|Stage 2|Unspecified Reason|0|||
17033336|NCT00467779|38177663|FG012|Stage 2|Unspecified Reason|0|||
17137447|NCT03486834|38279382|FG002|Overall Study|Adverse Event|0|||
17137448|NCT03486834|38279380|FG000|Overall Study|Lost to Follow-up|41|||
17137449|NCT03486834|38279381|FG001|Overall Study|Lost to Follow-up|24|||
17137450|NCT03486834|38279382|FG002|Overall Study|Lost to Follow-up|39|||
17033337|NCT00467779|38177664|FG013|Stage 2|Unspecified Reason|0|||
17033338|NCT00467779|38177665|FG014|Stage 2|Unspecified Reason|0|||
17033339|NCT00467779|38177651|FG000|Stage 2A|Adverse Event|0|||
17033340|NCT00467779|38177652|FG001|Stage 2A|Adverse Event|0|||
17033341|NCT00467779|38177653|FG002|Stage 2A|Adverse Event|0|||
17033342|NCT00467779|38177654|FG003|Stage 2A|Adverse Event|0|||
17033343|NCT00467779|38177655|FG004|Stage 2A|Adverse Event|0|||
17033344|NCT00467779|38177656|FG005|Stage 2A|Adverse Event|0|||
17033345|NCT00467779|38177657|FG006|Stage 2A|Adverse Event|0|||
17033346|NCT00467779|38177658|FG007|Stage 2A|Adverse Event|0|||
17033347|NCT00467779|38177659|FG008|Stage 2A|Adverse Event|0|||
17033348|NCT00467779|38177660|FG009|Stage 2A|Adverse Event|0|||
17033349|NCT00467779|38177661|FG010|Stage 2A|Adverse Event|0|||
17033350|NCT00467779|38177662|FG011|Stage 2A|Adverse Event|0|||
17033351|NCT00467779|38177663|FG012|Stage 2A|Adverse Event|0|||
17033352|NCT00467779|38177664|FG013|Stage 2A|Adverse Event|2|||
17033353|NCT00467779|38177665|FG014|Stage 2A|Adverse Event|0|||
17033354|NCT00467779|38177651|FG000|Stage 2A|Death|0|||
17033355|NCT00467779|38177652|FG001|Stage 2A|Death|0|||
17033356|NCT00467779|38177653|FG002|Stage 2A|Death|0|||
17033357|NCT00467779|38177654|FG003|Stage 2A|Death|0|||
17033358|NCT00467779|38177655|FG004|Stage 2A|Death|0|||
17033359|NCT00467779|38177656|FG005|Stage 2A|Death|0|||
17033360|NCT00467779|38177657|FG006|Stage 2A|Death|0|||
17033361|NCT00467779|38177658|FG007|Stage 2A|Death|0|||
17033362|NCT00467779|38177659|FG008|Stage 2A|Death|0|||
17033363|NCT00467779|38177660|FG009|Stage 2A|Death|0|||
17033364|NCT00467779|38177661|FG010|Stage 2A|Death|0|||
17033365|NCT00467779|38177662|FG011|Stage 2A|Death|0|||
17033366|NCT00467779|38177663|FG012|Stage 2A|Death|0|||
17033367|NCT00467779|38177664|FG013|Stage 2A|Death|1|||
17033368|NCT00467779|38177665|FG014|Stage 2A|Death|0|||
17033369|NCT00467779|38177651|FG000|Stage 2A|Disease Progression|0|||
17033370|NCT00467779|38177652|FG001|Stage 2A|Disease Progression|0|||
17033371|NCT00467779|38177653|FG002|Stage 2A|Disease Progression|0|||
17033372|NCT00467779|38177654|FG003|Stage 2A|Disease Progression|0|||
17033373|NCT00467779|38177655|FG004|Stage 2A|Disease Progression|0|||
17033374|NCT00467779|38177656|FG005|Stage 2A|Disease Progression|0|||
17033375|NCT00467779|38177657|FG006|Stage 2A|Disease Progression|0|||
17033376|NCT00467779|38177658|FG007|Stage 2A|Disease Progression|0|||
17033377|NCT00467779|38177659|FG008|Stage 2A|Disease Progression|0|||
17033378|NCT00467779|38177660|FG009|Stage 2A|Disease Progression|0|||
17033379|NCT00467779|38177661|FG010|Stage 2A|Disease Progression|0|||
17033380|NCT00467779|38177662|FG011|Stage 2A|Disease Progression|0|||
17033381|NCT00467779|38177663|FG012|Stage 2A|Disease Progression|0|||
17033382|NCT00467779|38177664|FG013|Stage 2A|Disease Progression|10|||
17033383|NCT00467779|38177665|FG014|Stage 2A|Disease Progression|0|||
17033384|NCT00467779|38177651|FG000|Stage 2A|Unspecified Reason|0|||
17033385|NCT00467779|38177652|FG001|Stage 2A|Unspecified Reason|0|||
17033386|NCT00467779|38177653|FG002|Stage 2A|Unspecified Reason|0|||
17033387|NCT00467779|38177654|FG003|Stage 2A|Unspecified Reason|0|||
17033388|NCT00467779|38177655|FG004|Stage 2A|Unspecified Reason|0|||
17033389|NCT00467779|38177656|FG005|Stage 2A|Unspecified Reason|0|||
17033390|NCT00467779|38177657|FG006|Stage 2A|Unspecified Reason|0|||
17033391|NCT00467779|38177658|FG007|Stage 2A|Unspecified Reason|0|||
17033392|NCT00467779|38177659|FG008|Stage 2A|Unspecified Reason|0|||
17033393|NCT00467779|38177660|FG009|Stage 2A|Unspecified Reason|0|||
17033394|NCT00467779|38177661|FG010|Stage 2A|Unspecified Reason|0|||
17033395|NCT00467779|38177662|FG011|Stage 2A|Unspecified Reason|0|||
17033396|NCT00467779|38177663|FG012|Stage 2A|Unspecified Reason|0|||
17033397|NCT00467779|38177664|FG013|Stage 2A|Unspecified Reason|7|||
17033398|NCT00467779|38177665|FG014|Stage 2A|Unspecified Reason|0|||
17137451|NCT03486834|38279380|FG000|Overall Study|Non-compliance with Study Drug|2|||
17033399|NCT00467779|38177651|FG000|Stage 2A|Withdrawal by Subject|0|||
17033400|NCT00467779|38177652|FG001|Stage 2A|Withdrawal by Subject|0|||
17033401|NCT00467779|38177653|FG002|Stage 2A|Withdrawal by Subject|0|||
17033402|NCT00467779|38177654|FG003|Stage 2A|Withdrawal by Subject|0|||
17033403|NCT00467779|38177655|FG004|Stage 2A|Withdrawal by Subject|0|||
17033404|NCT00467779|38177656|FG005|Stage 2A|Withdrawal by Subject|0|||
17033405|NCT00467779|38177657|FG006|Stage 2A|Withdrawal by Subject|0|||
17033406|NCT00467779|38177658|FG007|Stage 2A|Withdrawal by Subject|0|||
17033407|NCT00467779|38177659|FG008|Stage 2A|Withdrawal by Subject|0|||
17033408|NCT00467779|38177660|FG009|Stage 2A|Withdrawal by Subject|0|||
17033409|NCT00467779|38177661|FG010|Stage 2A|Withdrawal by Subject|0|||
17033410|NCT00467779|38177662|FG011|Stage 2A|Withdrawal by Subject|0|||
17033411|NCT00467779|38177663|FG012|Stage 2A|Withdrawal by Subject|0|||
17033412|NCT00467779|38177664|FG013|Stage 2A|Withdrawal by Subject|1|||
17033413|NCT00467779|38177665|FG014|Stage 2A|Withdrawal by Subject|0|||
17033414|NCT00467779|38177651|FG000|Stage 3|Adverse Event|0|||
17033415|NCT00467779|38177652|FG001|Stage 3|Adverse Event|0|||
17033416|NCT00467779|38177653|FG002|Stage 3|Adverse Event|0|||
17033417|NCT00467779|38177654|FG003|Stage 3|Adverse Event|0|||
17033418|NCT00467779|38177655|FG004|Stage 3|Adverse Event|0|||
17033419|NCT00467779|38177656|FG005|Stage 3|Adverse Event|0|||
17033420|NCT00467779|38177657|FG006|Stage 3|Adverse Event|0|||
17033421|NCT00467779|38177658|FG007|Stage 3|Adverse Event|0|||
17033422|NCT00467779|38177659|FG008|Stage 3|Adverse Event|0|||
17033423|NCT00467779|38177660|FG009|Stage 3|Adverse Event|0|||
17033424|NCT00467779|38177661|FG010|Stage 3|Adverse Event|0|||
17033425|NCT00467779|38177662|FG011|Stage 3|Adverse Event|0|||
17033426|NCT00467779|38177663|FG012|Stage 3|Adverse Event|0|||
17033427|NCT00467779|38177664|FG013|Stage 3|Adverse Event|0|||
17033428|NCT00467779|38177665|FG014|Stage 3|Adverse Event|2|||
17033429|NCT00467779|38177651|FG000|Stage 3|Death|0|||
17033430|NCT00467779|38177652|FG001|Stage 3|Death|0|||
17033431|NCT00467779|38177653|FG002|Stage 3|Death|0|||
17033432|NCT00467779|38177654|FG003|Stage 3|Death|0|||
17033433|NCT00467779|38177655|FG004|Stage 3|Death|0|||
17033434|NCT00467779|38177656|FG005|Stage 3|Death|0|||
17033435|NCT00467779|38177657|FG006|Stage 3|Death|0|||
17033436|NCT00467779|38177658|FG007|Stage 3|Death|0|||
17033437|NCT00467779|38177659|FG008|Stage 3|Death|0|||
17033438|NCT00467779|38177660|FG009|Stage 3|Death|0|||
17033439|NCT00467779|38177661|FG010|Stage 3|Death|0|||
17033440|NCT00467779|38177662|FG011|Stage 3|Death|0|||
17033441|NCT00467779|38177663|FG012|Stage 3|Death|0|||
17033442|NCT00467779|38177664|FG013|Stage 3|Death|0|||
17033443|NCT00467779|38177665|FG014|Stage 3|Death|1|||
17033444|NCT00467779|38177651|FG000|Stage 3|Disease Progression|0|||
17033445|NCT00467779|38177652|FG001|Stage 3|Disease Progression|0|||
17033446|NCT00467779|38177653|FG002|Stage 3|Disease Progression|0|||
17033447|NCT00467779|38177654|FG003|Stage 3|Disease Progression|0|||
17033448|NCT00467779|38177655|FG004|Stage 3|Disease Progression|0|||
17033449|NCT00467779|38177656|FG005|Stage 3|Disease Progression|0|||
17033450|NCT00467779|38177657|FG006|Stage 3|Disease Progression|0|||
17137452|NCT03486834|38279381|FG001|Overall Study|Non-compliance with Study Drug|2|||
17033451|NCT00467779|38177658|FG007|Stage 3|Disease Progression|0|||
17033452|NCT00467779|38177659|FG008|Stage 3|Disease Progression|0|||
17033453|NCT00467779|38177660|FG009|Stage 3|Disease Progression|0|||
17033454|NCT00467779|38177661|FG010|Stage 3|Disease Progression|0|||
17033455|NCT00467779|38177662|FG011|Stage 3|Disease Progression|0|||
17033456|NCT00467779|38177663|FG012|Stage 3|Disease Progression|0|||
17033457|NCT00467779|38177664|FG013|Stage 3|Disease Progression|0|||
17033458|NCT00467779|38177665|FG014|Stage 3|Disease Progression|9|||
17033459|NCT00467779|38177651|FG000|Stage 3|Unspecified Reason|0|||
17137453|NCT03486834|38279382|FG002|Overall Study|Non-compliance with Study Drug|0|||
17137454|NCT03486834|38279380|FG000|Overall Study|Physician Decision|5|||
17033460|NCT00467779|38177652|FG001|Stage 3|Unspecified Reason|0|||
17033461|NCT00467779|38177653|FG002|Stage 3|Unspecified Reason|0|||
17033462|NCT00467779|38177654|FG003|Stage 3|Unspecified Reason|0|||
17033463|NCT00467779|38177655|FG004|Stage 3|Unspecified Reason|0|||
17137455|NCT03486834|38279381|FG001|Overall Study|Physician Decision|2|||
17137456|NCT03486834|38279382|FG002|Overall Study|Physician Decision|3|||
17137457|NCT03486834|38279380|FG000|Overall Study|Pregnancy|10|||
17137458|NCT03486834|38279381|FG001|Overall Study|Pregnancy|12|||
17137459|NCT03486834|38279382|FG002|Overall Study|Pregnancy|12|||
17137460|NCT03486834|38279380|FG000|Overall Study|Protocol Deviation|2|||
17137461|NCT03486834|38279381|FG001|Overall Study|Protocol Deviation|3|||
17137462|NCT03486834|38279382|FG002|Overall Study|Protocol Deviation|3|||
17137463|NCT03486834|38279380|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
17137464|NCT03486834|38279381|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
17137465|NCT03486834|38279382|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
17137466|NCT03486834|38279380|FG000|Overall Study|Randomized but not treated|4|||
17033464|NCT00467779|38177656|FG005|Stage 3|Unspecified Reason|0|||
17033465|NCT00467779|38177657|FG006|Stage 3|Unspecified Reason|0|||
17033466|NCT00467779|38177658|FG007|Stage 3|Unspecified Reason|0|||
17033467|NCT00467779|38177659|FG008|Stage 3|Unspecified Reason|0|||
17033468|NCT00467779|38177660|FG009|Stage 3|Unspecified Reason|0|||
17033469|NCT00467779|38177661|FG010|Stage 3|Unspecified Reason|0|||
17033470|NCT00467779|38177662|FG011|Stage 3|Unspecified Reason|0|||
17033471|NCT00467779|38177663|FG012|Stage 3|Unspecified Reason|0|||
17033472|NCT00467779|38177664|FG013|Stage 3|Unspecified Reason|0|||
17033473|NCT00467779|38177665|FG014|Stage 3|Unspecified Reason|5|||
17033474|NCT00570687|38177705|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033475|NCT00570687|38177706|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033476|NCT00570687|38177707|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033477|NCT00570687|38177708|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033478|NCT00570687|38177709|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
17033479|NCT00570687|38177710|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
17033480|NCT00570687|38177711|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
17033481|NCT00570687|38177712|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
17033482|NCT00570687|38177713|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
17033483|NCT00570687|38177714|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
17033484|NCT00570687|38177705|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033485|NCT00570687|38177706|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033486|NCT00570687|38177707|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033487|NCT00570687|38177708|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033488|NCT00570687|38177709|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033489|NCT00570687|38177710|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033490|NCT00570687|38177711|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033491|NCT00570687|38177712|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033492|NCT00570687|38177713|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
17033493|NCT00570687|38177714|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033494|NCT00570687|38177705|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033495|NCT00570687|38177706|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033496|NCT00570687|38177707|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033497|NCT00570687|38177708|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033498|NCT00570687|38177709|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033499|NCT00570687|38177710|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033500|NCT00570687|38177711|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
17033501|NCT00570687|38177712|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033502|NCT00570687|38177713|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033503|NCT00570687|38177714|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
17033504|NCT03836677|38177728|FG000|Period 1|Adverse Event|0|||
17033505|NCT03836677|38177729|FG001|Period 1|Adverse Event|1|||
17033506|NCT03836677|38177728|FG000|Period 2|Severe non-compliance to protocol|1|||
17033507|NCT03836677|38177729|FG001|Period 2|Severe non-compliance to protocol|0|||
17033508|NCT00434161|38177760|FG000|Overall Study|Adverse Event|5|||
17033509|NCT00434161|38177761|FG001|Overall Study|Adverse Event|1|||
17033510|NCT00434161|38177762|FG002|Overall Study|Adverse Event|4|||
17033511|NCT00434161|38177760|FG000|Overall Study|Lost to Follow-up|0|||
17033512|NCT00434161|38177761|FG001|Overall Study|Lost to Follow-up|1|||
17033513|NCT00434161|38177762|FG002|Overall Study|Lost to Follow-up|0|||
17033514|NCT00434161|38177760|FG000|Overall Study|Death|1|||
17033515|NCT00434161|38177761|FG001|Overall Study|Death|0|||
17033516|NCT00434161|38177762|FG002|Overall Study|Death|1|||
17033517|NCT00434161|38177760|FG000|Overall Study|Non-Compliance|1|||
17033518|NCT00434161|38177761|FG001|Overall Study|Non-Compliance|1|||
17033519|NCT00434161|38177762|FG002|Overall Study|Non-Compliance|0|||
17033520|NCT00434161|38177760|FG000|Overall Study|Withdrawal by Subject|2|||
17033521|NCT00434161|38177761|FG001|Overall Study|Withdrawal by Subject|0|||
17033522|NCT00434161|38177762|FG002|Overall Study|Withdrawal by Subject|3|||
17033523|NCT00434161|38177760|FG000|Overall Study|Logistical error study assessments|1|||
17033524|NCT00434161|38177761|FG001|Overall Study|Logistical error study assessments|0|||
17033525|NCT00434161|38177762|FG002|Overall Study|Logistical error study assessments|3|||
17033526|NCT00441103|38177779|FG000|Overall Study|Adverse Event|2|||
17033527|NCT00441103|38177780|FG001|Overall Study|Adverse Event|1|||
17033528|NCT00441103|38177779|FG000|Overall Study|Death|1|||
17033529|NCT00441103|38177780|FG001|Overall Study|Death|0|||
17033530|NCT00441103|38177779|FG000|Overall Study|Disease Progression|2|||
17033531|NCT00441103|38177780|FG001|Overall Study|Disease Progression|0|||
17033532|NCT00441103|38177779|FG000|Overall Study|Lost to Follow-up|1|||
17137467|NCT03486834|38279381|FG001|Overall Study|Randomized but not treated|4|||
17033533|NCT00441103|38177780|FG001|Overall Study|Lost to Follow-up|0|||
17033534|NCT00441103|38177779|FG000|Overall Study|Protocol Violation|1|||
17033535|NCT00441103|38177780|FG001|Overall Study|Protocol Violation|0|||
17033536|NCT00441103|38177779|FG000|Overall Study|Participant unable to use Rebiject II|1|||
17033537|NCT00441103|38177780|FG001|Overall Study|Participant unable to use Rebiject II|0|||
17033538|NCT00441103|38177779|FG000|Overall Study|Participant refused MRI|1|||
17033539|NCT00441103|38177780|FG001|Overall Study|Participant refused MRI|0|||
17033540|NCT00441103|38177779|FG000|Overall Study|Inclusion criteria absent|1|||
17033541|NCT00441103|38177780|FG001|Overall Study|Inclusion criteria absent|0|||
17033542|NCT00441103|38177779|FG000|Overall Study|Non-compliant|0|||
17033543|NCT00441103|38177780|FG001|Overall Study|Non-compliant|1|||
17033544|NCT00441103|38177779|FG000|Overall Study|Participant decided to withdraw|1|||
17033545|NCT00441103|38177780|FG001|Overall Study|Participant decided to withdraw|0|||
17033546|NCT00441103|38177779|FG000|Overall Study|Participant's reason|0|||
17033547|NCT00441103|38177780|FG001|Overall Study|Participant's reason|1|||
17033548|NCT00441103|38177779|FG000|Overall Study|Participant decided to stop|0|||
17033549|NCT00441103|38177780|FG001|Overall Study|Participant decided to stop|1|||
17033550|NCT00433771|38177787|FG000|Overall Study|screen fail|14|||
17033551|NCT00433771|38177787|FG000|Overall Study|Treated and later found to be ineligible|2|||
17033552|NCT00433771|38177787|FG000|Overall Study|Death|2|||
17033553|NCT00433771|38177787|FG000|Overall Study|Failure to deploy stent|1|||
17033554|NCT00433537|38177791|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
17033555|NCT00433537|38177792|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
17033556|NCT00433537|38177793|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
17033557|NCT00433537|38177791|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
17033558|NCT00433537|38177792|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
17033559|NCT00433537|38177793|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
17033560|NCT00433537|38177791|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
17033561|NCT00433537|38177792|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
17033562|NCT00433537|38177793|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
17033563|NCT00433537|38177791|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
17033564|NCT00433537|38177792|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
17033565|NCT00433537|38177793|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
17033566|NCT00433537|38177791|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
17033567|NCT00433537|38177792|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
17033568|NCT00433537|38177793|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
17033569|NCT00433537|38177791|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
17033570|NCT00433537|38177792|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
17033571|NCT00433537|38177793|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
17033572|NCT00433537|38177791|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
17033573|NCT00433537|38177792|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
17033574|NCT00433537|38177793|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
17033575|NCT00433537|38177791|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
17033576|NCT00433537|38177792|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
17033577|NCT00433537|38177793|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
17033578|NCT00433537|38177791|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
17033579|NCT00433537|38177792|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
17137468|NCT03486834|38279382|FG002|Overall Study|Randomized but not treated|1|||
17033580|NCT00433537|38177793|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
17033581|NCT00570765|38177803|FG000|DB Phase|Withdrawal by Subject|1|||
17033582|NCT00570765|38177804|FG001|DB Phase|Withdrawal by Subject|0|||
17033583|NCT00570765|38177805|FG002|DB Phase|Withdrawal by Subject|0|||
17033584|NCT00570765|38177806|FG003|DB Phase|Withdrawal by Subject|0|||
17033585|NCT00570765|38177803|FG000|DB Phase|Protocol Violation|0|||
17033586|NCT00570765|38177804|FG001|DB Phase|Protocol Violation|1|||
17033587|NCT00570765|38177805|FG002|DB Phase|Protocol Violation|0|||
17033588|NCT00570765|38177806|FG003|DB Phase|Protocol Violation|0|||
17033589|NCT00570765|38177803|FG000|DB Phase|Adverse Event|3|||
17033590|NCT00570765|38177804|FG001|DB Phase|Adverse Event|6|||
17033591|NCT00570765|38177805|FG002|DB Phase|Adverse Event|0|||
17033592|NCT00570765|38177806|FG003|DB Phase|Adverse Event|0|||
17033593|NCT00570765|38177803|FG000|DB Phase|Did Not Receive Study Drug|0|||
17033594|NCT00570765|38177804|FG001|DB Phase|Did Not Receive Study Drug|0|||
17033595|NCT00570765|38177805|FG002|DB Phase|Did Not Receive Study Drug|1|||
17033596|NCT00570765|38177806|FG003|DB Phase|Did Not Receive Study Drug|0|||
17033597|NCT00570765|38177803|FG000|LTSE Phase|Withdrawal by Subject|0|||
17033598|NCT00570765|38177804|FG001|LTSE Phase|Withdrawal by Subject|0|||
17033599|NCT00570765|38177805|FG002|LTSE Phase|Withdrawal by Subject|0|||
17033600|NCT00570765|38177806|FG003|LTSE Phase|Withdrawal by Subject|1|||
17033601|NCT00570765|38177803|FG000|LTSE Phase|Adverse Event|0|||
17033602|NCT00570765|38177804|FG001|LTSE Phase|Adverse Event|0|||
17033603|NCT00570765|38177805|FG002|LTSE Phase|Adverse Event|0|||
17033604|NCT00570765|38177806|FG003|LTSE Phase|Adverse Event|7|||
17033605|NCT00570765|38177803|FG000|LTSE Phase|Physician Decision|0|||
17033606|NCT00570765|38177804|FG001|LTSE Phase|Physician Decision|0|||
17033607|NCT00570765|38177805|FG002|LTSE Phase|Physician Decision|0|||
17033608|NCT00570765|38177806|FG003|LTSE Phase|Physician Decision|4|||
17033609|NCT00667563|38177817|FG000|Overall Study|Protocol Violation|24|||
17033610|NCT00667095|38177823|FG000|Overall Study|Withdrawal by Subject|0|||
17033611|NCT00667095|38177824|FG001|Overall Study|Withdrawal by Subject|1|||
17033612|NCT00433381|38177832|FG000|Overall Study|Ineligible / no protocol treatment|3|||
17033613|NCT00433381|38177833|FG001|Overall Study|Ineligible / no protocol treatment|3|||
17033614|NCT00667017|38177847|FG000|Overall Study|Withdrawal by Subject|1|||
17033615|NCT00666705|38177851|FG000|Overall Study|Withdrawal by Subject|1|||
17033616|NCT00433147|38177864|FG000|Overall Study|Adverse Event|0|||
17033617|NCT00433147|38177865|FG001|Overall Study|Adverse Event|1|||
17033618|NCT00433147|38177866|FG002|Overall Study|Adverse Event|0|||
17033619|NCT00433147|38177867|FG003|Overall Study|Adverse Event|0|||
17033620|NCT00666237|38177879|FG000|Overall Study|Death|5|||
17033621|NCT00666237|38177880|FG001|Overall Study|Death|5|||
17033622|NCT00666237|38177879|FG000|Overall Study|Lost to Follow-up|29|||
17033623|NCT00666237|38177880|FG001|Overall Study|Lost to Follow-up|25|||
17033624|NCT00662025|38177886|FG000|Overall Study|Objective progression or relapse|51|||
17033625|NCT00662025|38177886|FG000|Overall Study|Adverse Event|7|||
17033626|NCT00662025|38177886|FG000|Overall Study|Withdrawal by Subject|1|||
17033627|NCT00662025|38177886|FG000|Overall Study|Results of other clinical study|2|||
17033628|NCT00662025|38177886|FG000|Overall Study|Target lesion cannot be evaluated|1|||
17033629|NCT00662025|38177886|FG000|Overall Study|Domestic circumstances|1|||
17033630|NCT00440947|38177890|FG000|36-Week Induction Phase|Adverse Event|16|||
17033631|NCT00440947|38177891|FG001|36-Week Induction Phase|Adverse Event|0|||
17033632|NCT00440947|38177892|FG002|36-Week Induction Phase|Adverse Event|0|||
17033633|NCT00440947|38177893|FG003|36-Week Induction Phase|Adverse Event|0|||
17033634|NCT00440947|38177894|FG004|36-Week Induction Phase|Adverse Event|0|||
17033635|NCT00440947|38177890|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
17033636|NCT00440947|38177891|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
17033637|NCT00440947|38177892|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
17033638|NCT00440947|38177893|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
17033639|NCT00440947|38177894|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
17033640|NCT00440947|38177890|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
17033641|NCT00440947|38177891|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
17033642|NCT00440947|38177892|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
17033643|NCT00440947|38177893|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
17033644|NCT00440947|38177894|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
17033645|NCT00440947|38177890|FG000|36-Week Induction Phase|Non-compliance|10|||
17033646|NCT00440947|38177891|FG001|36-Week Induction Phase|Non-compliance|0|||
17033647|NCT00440947|38177892|FG002|36-Week Induction Phase|Non-compliance|0|||
17033648|NCT00440947|38177893|FG003|36-Week Induction Phase|Non-compliance|0|||
17033649|NCT00440947|38177894|FG004|36-Week Induction Phase|Non-compliance|0|||
17033650|NCT00440947|38177890|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
17033651|NCT00440947|38177891|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
17033652|NCT00440947|38177892|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
17033653|NCT00440947|38177893|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
17033654|NCT00440947|38177894|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
17033655|NCT00440947|38177890|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
17033656|NCT00440947|38177891|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
17033657|NCT00440947|38177892|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
17033658|NCT00440947|38177893|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
17033659|NCT00440947|38177894|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
17137469|NCT03522948|38279392|FG000|Overall Study|Lost to Follow-up|1|||
17033660|NCT00440947|38177890|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
17033661|NCT00440947|38177891|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
17033662|NCT00440947|38177892|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
17033663|NCT00440947|38177893|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
17033664|NCT00440947|38177894|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
17033665|NCT00440947|38177890|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
17033666|NCT00440947|38177891|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
17033667|NCT00440947|38177892|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
17033668|NCT00440947|38177893|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
17033669|NCT00440947|38177894|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
17033670|NCT00440947|38177890|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
17033671|NCT00440947|38177891|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
17033672|NCT00440947|38177892|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
17033673|NCT00440947|38177893|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
17033674|NCT00440947|38177894|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
17033675|NCT00440947|38177890|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
17033676|NCT00440947|38177891|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
17033677|NCT00440947|38177892|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
17033678|NCT00440947|38177893|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
17033679|NCT00440947|38177894|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
17033680|NCT00440947|38177890|FG000|36-Week Induction Phase|Incarceration|3|||
17033681|NCT00440947|38177891|FG001|36-Week Induction Phase|Incarceration|0|||
17033682|NCT00440947|38177892|FG002|36-Week Induction Phase|Incarceration|0|||
17033683|NCT00440947|38177893|FG003|36-Week Induction Phase|Incarceration|0|||
17033684|NCT00440947|38177894|FG004|36-Week Induction Phase|Incarceration|0|||
17033685|NCT00440947|38177890|FG000|36-Week Induction Phase|Pregnancy|1|||
17033686|NCT00440947|38177891|FG001|36-Week Induction Phase|Pregnancy|0|||
17033687|NCT00440947|38177892|FG002|36-Week Induction Phase|Pregnancy|0|||
17033688|NCT00440947|38177893|FG003|36-Week Induction Phase|Pregnancy|0|||
17033689|NCT00440947|38177894|FG004|36-Week Induction Phase|Pregnancy|0|||
17033690|NCT00440947|38177890|FG000|48-Week Randomization Phase|Adverse Event|0|||
17033691|NCT00440947|38177891|FG001|48-Week Randomization Phase|Adverse Event|2|||
17033692|NCT00440947|38177892|FG002|48-Week Randomization Phase|Adverse Event|5|||
16991794|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
16991795|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
16991796|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
16991797|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
16991798|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
16991799|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
16991800|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
16991801|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
16991802|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
16991803|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
16991804|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
16991805|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
16991806|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
16991807|NCT00730405|38135733|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
16991808|NCT00730405|38135734|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
16991809|NCT00730405|38135735|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
16991810|NCT00730405|38135736|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
16991811|NCT00730405|38135737|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
16991812|NCT00736723|38135753|FG000|Overall Study|Withdrawal by Subject|4|||
16991813|NCT00736723|38135754|FG001|Overall Study|Withdrawal by Subject|3|||
16991814|NCT00736645|38135764|FG000|Overall Study|Adverse Event|0|||
16991815|NCT00736645|38135765|FG001|Overall Study|Adverse Event|2|||
16991816|NCT00736645|38135766|FG002|Overall Study|Adverse Event|0|||
16991817|NCT00736645|38135767|FG003|Overall Study|Adverse Event|0|||
16991818|NCT00736489|38135777|FG000|Period 1|Lost to Follow-up|1|||
16991819|NCT00736489|38135778|FG001|Period 1|Lost to Follow-up|0|||
16991820|NCT00736489|38135779|FG002|Period 1|Lost to Follow-up|0|||
16991821|NCT00736489|38135780|FG003|Period 1|Lost to Follow-up|0|||
16991822|NCT00736489|38135781|FG004|Period 1|Lost to Follow-up|0|||
16991823|NCT00736489|38135782|FG005|Period 1|Lost to Follow-up|0|||
16991824|NCT00736489|38135777|FG000|Period 1|Withdrawal by Subject|0|||
16991825|NCT00736489|38135778|FG001|Period 1|Withdrawal by Subject|0|||
16991826|NCT00736489|38135779|FG002|Period 1|Withdrawal by Subject|0|||
16991827|NCT00736489|38135780|FG003|Period 1|Withdrawal by Subject|0|||
16991828|NCT00736489|38135781|FG004|Period 1|Withdrawal by Subject|0|||
16991829|NCT00736489|38135782|FG005|Period 1|Withdrawal by Subject|1|||
17137470|NCT03406078|38279398|FG000|Overall Study|Death|1|||
17033693|NCT00440947|38177893|FG003|48-Week Randomization Phase|Adverse Event|0|||
17033694|NCT00440947|38177894|FG004|48-Week Randomization Phase|Adverse Event|0|||
17033695|NCT00440947|38177890|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
17033696|NCT00440947|38177891|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
17033697|NCT00440947|38177892|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
17033698|NCT00440947|38177893|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
17033699|NCT00440947|38177894|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
17033700|NCT00440947|38177890|FG000|48-Week Randomization Phase|Non-compliance|0|||
17033701|NCT00440947|38177891|FG001|48-Week Randomization Phase|Non-compliance|3|||
17033702|NCT00440947|38177892|FG002|48-Week Randomization Phase|Non-compliance|4|||
17033703|NCT00440947|38177893|FG003|48-Week Randomization Phase|Non-compliance|0|||
17033704|NCT00440947|38177894|FG004|48-Week Randomization Phase|Non-compliance|0|||
17033705|NCT00440947|38177890|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
17033706|NCT00440947|38177891|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
17033707|NCT00440947|38177892|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
17033708|NCT00440947|38177893|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
17033709|NCT00440947|38177894|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
17033710|NCT00440947|38177890|FG000|48-Week Randomization Phase|Protocol Violation|0|||
17033711|NCT00440947|38177891|FG001|48-Week Randomization Phase|Protocol Violation|0|||
17033712|NCT00440947|38177892|FG002|48-Week Randomization Phase|Protocol Violation|1|||
17033713|NCT00440947|38177893|FG003|48-Week Randomization Phase|Protocol Violation|0|||
17033714|NCT00440947|38177894|FG004|48-Week Randomization Phase|Protocol Violation|0|||
17033715|NCT00440947|38177890|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
17033716|NCT00440947|38177891|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
17033717|NCT00440947|38177892|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
17033718|NCT00440947|38177893|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
17033719|NCT00440947|38177894|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
17033720|NCT00440947|38177890|FG000|48-Week Randomization Phase|Pregnancy|0|||
17033721|NCT00440947|38177891|FG001|48-Week Randomization Phase|Pregnancy|0|||
17033722|NCT00440947|38177892|FG002|48-Week Randomization Phase|Pregnancy|1|||
17033723|NCT00440947|38177893|FG003|48-Week Randomization Phase|Pregnancy|0|||
17033724|NCT00440947|38177894|FG004|48-Week Randomization Phase|Pregnancy|0|||
17033725|NCT00440947|38177890|FG000|48-Week Randomization Phase|Incarceration|0|||
17033726|NCT00440947|38177891|FG001|48-Week Randomization Phase|Incarceration|3|||
17033727|NCT00440947|38177892|FG002|48-Week Randomization Phase|Incarceration|0|||
17033728|NCT00440947|38177893|FG003|48-Week Randomization Phase|Incarceration|0|||
17033729|NCT00440947|38177894|FG004|48-Week Randomization Phase|Incarceration|0|||
17033730|NCT00440947|38177890|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
17033731|NCT00440947|38177891|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
17033732|NCT00440947|38177892|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
17033733|NCT00440947|38177893|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
17033734|NCT00440947|38177894|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
17033735|NCT00440947|38177890|FG000|48-Week Randomization Phase|Physician Decision|0|||
17033736|NCT00440947|38177891|FG001|48-Week Randomization Phase|Physician Decision|2|||
17033737|NCT00440947|38177892|FG002|48-Week Randomization Phase|Physician Decision|0|||
17033738|NCT00440947|38177893|FG003|48-Week Randomization Phase|Physician Decision|0|||
17033739|NCT00440947|38177894|FG004|48-Week Randomization Phase|Physician Decision|0|||
17033740|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
17033741|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
17033742|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
17033743|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
17033744|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
17033745|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
17033746|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
17137471|NCT03406078|38279399|FG001|Overall Study|Death|0|||
17137472|NCT03406078|38279398|FG000|Overall Study|Lost to Follow-up|0|||
17137473|NCT03406078|38279399|FG001|Overall Study|Lost to Follow-up|1|||
17137474|NCT03406078|38279398|FG000|Overall Study|Withdrawal by Subject|5|||
17033747|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
17033748|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
17033749|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
17033750|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
17033751|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
17033752|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
17033753|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
17033754|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
17033755|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
17033756|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
17033757|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
17033758|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
17033759|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
17033760|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
17033761|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
17033762|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
17033763|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
17137475|NCT03406078|38279399|FG001|Overall Study|Withdrawal by Subject|2|||
17137476|NCT03634033|38279412|FG000|Overall Study|Did not have a post-assessment|384|||
17137477|NCT03634033|38279413|FG001|Overall Study|Did not have a post-assessment|291|||
17137478|NCT03634033|38279414|FG002|Overall Study|Did not have a post-assessment|114|||
17137479|NCT03634033|38279415|FG003|Overall Study|Did not have a post-assessment|161|||
17137480|NCT03634033|38279416|FG004|Overall Study|Did not have a post-assessment|5|||
17137481|NCT03634033|38279417|FG005|Overall Study|Did not have a post-assessment|0|||
17137482|NCT03634033|38279418|FG006|Overall Study|Did not have a post-assessment|0|||
17137483|NCT03634033|38279412|FG000|Overall Study|Death|0|||
17137484|NCT03634033|38279413|FG001|Overall Study|Death|0|||
17137485|NCT03634033|38279414|FG002|Overall Study|Death|0|||
17137486|NCT03634033|38279415|FG003|Overall Study|Death|0|||
17137487|NCT03634033|38279416|FG004|Overall Study|Death|0|||
17137488|NCT03634033|38279417|FG005|Overall Study|Death|7|||
17137489|NCT03634033|38279418|FG006|Overall Study|Death|7|||
17137490|NCT03634033|38279412|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
17137491|NCT03634033|38279413|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
17137492|NCT03634033|38279414|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
17137493|NCT03634033|38279415|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
17137494|NCT03634033|38279416|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
17137495|NCT03634033|38279417|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
17137496|NCT03634033|38279418|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
17137497|NCT03634033|38279412|FG000|Overall Study|Lost to Follow-up|0|||
17137498|NCT03634033|38279413|FG001|Overall Study|Lost to Follow-up|0|||
17137499|NCT03634033|38279414|FG002|Overall Study|Lost to Follow-up|0|||
17137500|NCT03634033|38279415|FG003|Overall Study|Lost to Follow-up|0|||
17137501|NCT03634033|38279416|FG004|Overall Study|Lost to Follow-up|0|||
17137502|NCT03634033|38279417|FG005|Overall Study|Lost to Follow-up|1|||
17137503|NCT03634033|38279418|FG006|Overall Study|Lost to Follow-up|2|||
17137504|NCT03634033|38279412|FG000|Overall Study|Withdrawal by Subject|0|||
17137505|NCT03634033|38279413|FG001|Overall Study|Withdrawal by Subject|0|||
17137506|NCT03634033|38279414|FG002|Overall Study|Withdrawal by Subject|0|||
17137507|NCT03634033|38279415|FG003|Overall Study|Withdrawal by Subject|0|||
17137508|NCT03634033|38279416|FG004|Overall Study|Withdrawal by Subject|0|||
17137509|NCT03634033|38279417|FG005|Overall Study|Withdrawal by Subject|0|||
17137510|NCT03634033|38279418|FG006|Overall Study|Withdrawal by Subject|1|||
17137511|NCT03103100|38279452|FG000|Overall Study|Adverse Event|1|||
17137512|NCT03103100|38279453|FG001|Overall Study|Adverse Event|0|||
17137513|NCT03103100|38279454|FG002|Overall Study|Adverse Event|0|||
17137514|NCT03103100|38279452|FG000|Overall Study|Physician Decision|1|||
17137515|NCT03103100|38279453|FG001|Overall Study|Physician Decision|0|||
17137516|NCT03103100|38279454|FG002|Overall Study|Physician Decision|2|||
17137517|NCT03438006|38279462|FG000|Overall Study|Adverse Event|1|||
17137518|NCT03438006|38279462|FG000|Overall Study|Lost to Follow-up|67|||
17137519|NCT03438006|38279462|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
17137520|NCT03438006|38279462|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
17137521|NCT04206020|38279468|FG000|Overall Study|Adverse Event|1|||
17137522|NCT04206020|38279469|FG001|Overall Study|Adverse Event|4|||
17137523|NCT04206020|38279468|FG000|Overall Study|Protocol Violation|2|||
17137524|NCT04206020|38279469|FG001|Overall Study|Protocol Violation|0|||
17137525|NCT04206020|38279468|FG000|Overall Study|Withdrawal by Subject|2|||
17137526|NCT04206020|38279469|FG001|Overall Study|Withdrawal by Subject|0|||
17033764|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
17033765|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
17033766|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
17033767|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
17033768|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
17137527|NCT04206020|38279468|FG000|Overall Study|Lost to Follow-up|2|||
17137528|NCT04206020|38279469|FG001|Overall Study|Lost to Follow-up|0|||
17137529|NCT04206020|38279468|FG000|Overall Study|Pregnancy|0|||
17137530|NCT04206020|38279469|FG001|Overall Study|Pregnancy|1|||
17137531|NCT04206020|38279468|FG000|Overall Study|Unable to attend visits|1|||
17137532|NCT04206020|38279469|FG001|Overall Study|Unable to attend visits|2|||
17137533|NCT03466086|38279475|FG000|Period 1|Sponsor decision due to study timeline|1|||
17137534|NCT03466086|38279476|FG001|Period 1|Sponsor decision due to study timeline|0|||
17137535|NCT03466086|38279475|FG000|Period 1|Withdrawal by Subject|1|||
17137536|NCT03466086|38279476|FG001|Period 1|Withdrawal by Subject|0|||
17137537|NCT03101462|38279484|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
17137538|NCT03101462|38279485|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
17033769|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
17033770|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
17137539|NCT02873936|38279494|FG000|Overall Study|Withdrew Consent|4|||
17137540|NCT02873936|38279495|FG001|Overall Study|Withdrew Consent|11|||
17137541|NCT02873936|38279496|FG002|Overall Study|Withdrew Consent|20|||
17137542|NCT02873936|38279494|FG000|Overall Study|Investigator's Discretion|3|||
17137543|NCT02873936|38279495|FG001|Overall Study|Investigator's Discretion|5|||
17137544|NCT02873936|38279496|FG002|Overall Study|Investigator's Discretion|4|||
17137545|NCT02873936|38279494|FG000|Overall Study|Adverse Event|3|||
17137546|NCT02873936|38279495|FG001|Overall Study|Adverse Event|5|||
17137547|NCT02873936|38279496|FG002|Overall Study|Adverse Event|3|||
17137548|NCT02873936|38279494|FG000|Overall Study|Protocol Violation|0|||
17137549|NCT02873936|38279495|FG001|Overall Study|Protocol Violation|1|||
17137550|NCT02873936|38279496|FG002|Overall Study|Protocol Violation|3|||
17137551|NCT02873936|38279494|FG000|Overall Study|Lost to Follow-up|1|||
17137552|NCT02873936|38279495|FG001|Overall Study|Lost to Follow-up|1|||
17137553|NCT02873936|38279496|FG002|Overall Study|Lost to Follow-up|1|||
17033771|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
17033772|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
17033773|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
17033774|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
17033775|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
17033776|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
17033777|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
17033778|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
17033779|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
17033780|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
17033781|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
17033782|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
17033783|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
17033784|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
17033785|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
17033786|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
17033787|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
17033788|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
17033789|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
17033790|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
17033791|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
17033792|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
17033793|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
17033794|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
17137554|NCT02873936|38279494|FG000|Overall Study|Non-compliance With Study Drug|1|||
17137555|NCT02873936|38279495|FG001|Overall Study|Non-compliance With Study Drug|0|||
17137556|NCT02873936|38279496|FG002|Overall Study|Non-compliance With Study Drug|1|||
17137557|NCT02873936|38279494|FG000|Overall Study|Randomized but not Dosed|1|||
17033795|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Other|0|||
17033796|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Other|0|||
17033797|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Other|0|||
17033798|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Other|1|||
17033799|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Other|0|||
17033800|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
17033801|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
17033802|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
17033803|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
17033804|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
17033805|NCT00440947|38177890|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
17033806|NCT00440947|38177891|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
17033807|NCT00440947|38177892|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
17033808|NCT00440947|38177893|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
17033809|NCT00440947|38177894|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
17033810|NCT02799602|38177917|FG000|Overall Study|Protocol Violation|1|||
17033811|NCT02799602|38177918|FG001|Overall Study|Protocol Violation|0|||
17033812|NCT02799602|38177917|FG000|Overall Study|Physician Decision|3|||
17033813|NCT02799602|38177918|FG001|Overall Study|Physician Decision|7|||
17033814|NCT02799602|38177917|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
17033815|NCT02799602|38177918|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
17033816|NCT02799602|38177917|FG000|Overall Study|Lost to Follow-up|4|||
17137558|NCT02873936|38279495|FG001|Overall Study|Randomized but not Dosed|0|||
17033817|NCT02799602|38177918|FG001|Overall Study|Lost to Follow-up|1|||
17033818|NCT02799602|38177917|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
17033819|NCT02799602|38177918|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
17033820|NCT02799602|38177917|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
17033821|NCT02799602|38177918|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
17033822|NCT02799602|38177917|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
17033823|NCT02799602|38177918|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
17033824|NCT02799602|38177917|FG000|Overall Study|Withdrawal by Subject|25|||
17033825|NCT02799602|38177918|FG001|Overall Study|Withdrawal by Subject|37|||
17033826|NCT02799602|38177917|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
17033827|NCT02799602|38177918|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
17033828|NCT02799602|38177917|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
17033829|NCT02799602|38177918|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
17033830|NCT02799602|38177917|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
17033831|NCT02799602|38177918|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
17033832|NCT02799602|38177917|FG000|Overall Study|Death|8|||
17033833|NCT02799602|38177918|FG001|Overall Study|Death|5|||
17033834|NCT02799602|38177917|FG000|Overall Study|Other|3|||
17033835|NCT02799602|38177918|FG001|Overall Study|Other|3|||
17033836|NCT02799602|38177917|FG000|Overall Study|GCP violation|1|||
17033837|NCT02799602|38177918|FG001|Overall Study|GCP violation|0|||
17033838|NCT00664521|38177926|FG000|Overall Study|Adverse Event|4|||
17033839|NCT00664521|38177927|FG001|Overall Study|Adverse Event|1|||
17033840|NCT00664521|38177926|FG000|Overall Study|Lost to Follow-up|1|||
17033841|NCT00664521|38177927|FG001|Overall Study|Lost to Follow-up|0|||
17033842|NCT00664521|38177926|FG000|Overall Study|Other|1|||
17033843|NCT00664521|38177927|FG001|Overall Study|Other|0|||
17033844|NCT00664209|38177933|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
17033845|NCT00664209|38177933|FG000|Study Treatment Period|Physician Decision|4|||
17033846|NCT00664209|38177933|FG000|Study Treatment Period|Withdrawal by Subject|2|||
17033847|NCT00440557|38177941|FG000|Overall Study|Withdrawal by Subject|10|||
17033848|NCT00440557|38177942|FG001|Overall Study|Withdrawal by Subject|5|||
17033849|NCT00440557|38177943|FG002|Overall Study|Withdrawal by Subject|11|||
17033850|NCT00440557|38177941|FG000|Overall Study|Lost to Follow-up|1|||
17033851|NCT00440557|38177942|FG001|Overall Study|Lost to Follow-up|2|||
17033852|NCT00440557|38177943|FG002|Overall Study|Lost to Follow-up|6|||
17033853|NCT00440557|38177941|FG000|Overall Study|Adverse Event|3|||
17033854|NCT00440557|38177942|FG001|Overall Study|Adverse Event|3|||
17033855|NCT00440557|38177943|FG002|Overall Study|Adverse Event|5|||
17033856|NCT00440557|38177941|FG000|Overall Study|Death|2|||
17033857|NCT00440557|38177942|FG001|Overall Study|Death|6|||
17033858|NCT00440557|38177943|FG002|Overall Study|Death|3|||
17033859|NCT00440557|38177941|FG000|Overall Study|Began Dialysis|4|||
17033860|NCT00440557|38177942|FG001|Overall Study|Began Dialysis|1|||
17033861|NCT00440557|38177943|FG002|Overall Study|Began Dialysis|4|||
17033862|NCT00440557|38177941|FG000|Overall Study|Principal Investigator decision|0|||
17033863|NCT00440557|38177942|FG001|Overall Study|Principal Investigator decision|3|||
17033864|NCT00440557|38177943|FG002|Overall Study|Principal Investigator decision|1|||
17033865|NCT00440557|38177941|FG000|Overall Study|Patient moved|1|||
17033866|NCT00440557|38177942|FG001|Overall Study|Patient moved|2|||
17033867|NCT00440557|38177943|FG002|Overall Study|Patient moved|1|||
17033868|NCT00440557|38177941|FG000|Overall Study|Principal Investigator's office closed|3|||
17033869|NCT00440557|38177942|FG001|Overall Study|Principal Investigator's office closed|6|||
17033870|NCT00440557|38177943|FG002|Overall Study|Principal Investigator's office closed|4|||
17033871|NCT00440557|38177941|FG000|Overall Study|Patient transferred to nursing home|0|||
17033872|NCT00440557|38177942|FG001|Overall Study|Patient transferred to nursing home|1|||
17033873|NCT00440557|38177943|FG002|Overall Study|Patient transferred to nursing home|0|||
17033874|NCT00440557|38177941|FG000|Overall Study|Patient had surgery|1|||
17033875|NCT00440557|38177942|FG001|Overall Study|Patient had surgery|0|||
17033876|NCT00440557|38177943|FG002|Overall Study|Patient had surgery|0|||
17033877|NCT00582608|38178003|FG000|Overall Study|Not Treated|7|||
17033878|NCT00582608|38178003|FG000|Overall Study|Patient Ineligible|1|||
17033879|NCT00582608|38178003|FG000|Overall Study|Lack of accrual|4|||
17033880|NCT03014570|38178009|FG000|Overall Study|COVID-19 Restrictions|38|||
17033881|NCT03014570|38178010|FG001|Overall Study|COVID-19 Restrictions|24|||
17033882|NCT03014570|38178009|FG000|Overall Study|Death|70|||
17137559|NCT02873936|38279496|FG002|Overall Study|Randomized but not Dosed|0|||
17137560|NCT02874794|38279506|FG000|Overall Study|Physician Decision|3|||
17137561|NCT02874794|38279507|FG001|Overall Study|Physician Decision|2|||
17137562|NCT02874794|38279506|FG000|Overall Study|Withdrawal by Subject|2|||
17137563|NCT02874794|38279507|FG001|Overall Study|Withdrawal by Subject|8|||
17033883|NCT03014570|38178010|FG001|Overall Study|Death|79|||
17033884|NCT03014570|38178009|FG000|Overall Study|Transfer from facility|11|||
17033885|NCT03014570|38178010|FG001|Overall Study|Transfer from facility|14|||
17033886|NCT03014570|38178009|FG000|Overall Study|Hospitalized|5|||
17137564|NCT02874794|38279506|FG000|Overall Study|Death|2|||
17137565|NCT02874794|38279507|FG001|Overall Study|Death|1|||
17137566|NCT03102710|38279519|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
17137567|NCT03102710|38279520|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
17137568|NCT03102710|38279521|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
17137569|NCT03102710|38279519|FG000|Overall Study|Technical issues during final MRI scan|0|||
17033887|NCT03014570|38178010|FG001|Overall Study|Hospitalized|3|||
17033888|NCT03014570|38178009|FG000|Overall Study|Transfer within facility|1|||
17033889|NCT03014570|38178010|FG001|Overall Study|Transfer within facility|0|||
17033890|NCT03014570|38178009|FG000|Overall Study|Site refusal|0|||
17033891|NCT03014570|38178010|FG001|Overall Study|Site refusal|11|||
17033892|NCT00427999|38178017|FG000|Overall Study|Adverse Event|6|||
17033893|NCT00427999|38178017|FG000|Overall Study|Abnormal laboratory values|1|||
17033894|NCT00427999|38178017|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
17033895|NCT00427999|38178017|FG000|Overall Study|Protocol Violation|2|||
17033896|NCT00427999|38178017|FG000|Overall Study|Withdrawal by Subject|9|||
17033897|NCT00427999|38178017|FG000|Overall Study|Death|1|||
17033898|NCT00661713|38178030|FG000|Overall Study|Death|1|||
17033899|NCT00661713|38178031|FG001|Overall Study|Death|0|||
17033900|NCT00661713|38178032|FG002|Overall Study|Death|0|||
17033901|NCT00661713|38178033|FG003|Overall Study|Death|0|||
17033902|NCT00661713|38178034|FG004|Overall Study|Death|1|||
17033903|NCT00661713|38178035|FG005|Overall Study|Death|0|||
17033904|NCT00661713|38178036|FG006|Overall Study|Death|0|||
17033905|NCT00661713|38178037|FG007|Overall Study|Death|0|||
17033906|NCT00661713|38178030|FG000|Overall Study|Unable to Classify|1|||
17033907|NCT00661713|38178031|FG001|Overall Study|Unable to Classify|0|||
17033908|NCT00661713|38178032|FG002|Overall Study|Unable to Classify|0|||
17033909|NCT00661713|38178033|FG003|Overall Study|Unable to Classify|0|||
17033910|NCT00661713|38178034|FG004|Overall Study|Unable to Classify|0|||
17033911|NCT00661713|38178035|FG005|Overall Study|Unable to Classify|0|||
17033912|NCT00661713|38178036|FG006|Overall Study|Unable to Classify|0|||
17033913|NCT00661713|38178037|FG007|Overall Study|Unable to Classify|0|||
17033914|NCT00661713|38178030|FG000|Overall Study|Protocol Violation|1|||
17033915|NCT00661713|38178031|FG001|Overall Study|Protocol Violation|6|||
17033916|NCT00661713|38178032|FG002|Overall Study|Protocol Violation|3|||
17033917|NCT00661713|38178033|FG003|Overall Study|Protocol Violation|3|||
17033918|NCT00661713|38178034|FG004|Overall Study|Protocol Violation|0|||
17033919|NCT00661713|38178035|FG005|Overall Study|Protocol Violation|2|||
17033920|NCT00661713|38178036|FG006|Overall Study|Protocol Violation|2|||
17033921|NCT00661713|38178037|FG007|Overall Study|Protocol Violation|1|||
17033922|NCT00661713|38178030|FG000|Overall Study|Withdrawal by Subject|11|||
17033923|NCT00661713|38178031|FG001|Overall Study|Withdrawal by Subject|25|||
17033924|NCT00661713|38178032|FG002|Overall Study|Withdrawal by Subject|12|||
17033925|NCT00661713|38178033|FG003|Overall Study|Withdrawal by Subject|21|||
17033926|NCT00661713|38178034|FG004|Overall Study|Withdrawal by Subject|12|||
17033927|NCT00661713|38178035|FG005|Overall Study|Withdrawal by Subject|26|||
17033928|NCT00661713|38178036|FG006|Overall Study|Withdrawal by Subject|45|||
17033929|NCT00661713|38178037|FG007|Overall Study|Withdrawal by Subject|9|||
17033930|NCT00661713|38178030|FG000|Overall Study|Lost to Follow-up|2|||
17033931|NCT00661713|38178031|FG001|Overall Study|Lost to Follow-up|7|||
17033932|NCT00661713|38178032|FG002|Overall Study|Lost to Follow-up|2|||
17033933|NCT00661713|38178033|FG003|Overall Study|Lost to Follow-up|2|||
17033934|NCT00661713|38178034|FG004|Overall Study|Lost to Follow-up|5|||
17033935|NCT00661713|38178035|FG005|Overall Study|Lost to Follow-up|7|||
17033936|NCT00661713|38178036|FG006|Overall Study|Lost to Follow-up|14|||
17033937|NCT00661713|38178037|FG007|Overall Study|Lost to Follow-up|1|||
17033938|NCT00661713|38178030|FG000|Overall Study|Administrative Reason|0|||
17033939|NCT00661713|38178031|FG001|Overall Study|Administrative Reason|1|||
17033940|NCT00661713|38178032|FG002|Overall Study|Administrative Reason|0|||
17033941|NCT00661713|38178033|FG003|Overall Study|Administrative Reason|2|||
17033942|NCT00661713|38178034|FG004|Overall Study|Administrative Reason|2|||
17033943|NCT00661713|38178035|FG005|Overall Study|Administrative Reason|2|||
17033944|NCT00661713|38178036|FG006|Overall Study|Administrative Reason|1|||
17033945|NCT00661713|38178037|FG007|Overall Study|Administrative Reason|0|||
17033946|NCT00661713|38178030|FG000|Overall Study|Adverse Event|0|||
17033947|NCT00661713|38178031|FG001|Overall Study|Adverse Event|0|||
17033948|NCT00661713|38178032|FG002|Overall Study|Adverse Event|0|||
17033949|NCT00661713|38178033|FG003|Overall Study|Adverse Event|0|||
17033950|NCT00661713|38178034|FG004|Overall Study|Adverse Event|0|||
17033951|NCT00661713|38178035|FG005|Overall Study|Adverse Event|0|||
17033952|NCT00661713|38178036|FG006|Overall Study|Adverse Event|1|||
17033953|NCT00661713|38178037|FG007|Overall Study|Adverse Event|0|||
17033954|NCT00661713|38178030|FG000|Overall Study|Inappropriate Enrollment|0|||
17033955|NCT00661713|38178031|FG001|Overall Study|Inappropriate Enrollment|0|||
17033956|NCT00661713|38178032|FG002|Overall Study|Inappropriate Enrollment|0|||
17033957|NCT00661713|38178033|FG003|Overall Study|Inappropriate Enrollment|0|||
17033958|NCT00661713|38178034|FG004|Overall Study|Inappropriate Enrollment|0|||
17033959|NCT00661713|38178035|FG005|Overall Study|Inappropriate Enrollment|0|||
17033960|NCT00661713|38178036|FG006|Overall Study|Inappropriate Enrollment|1|||
17033961|NCT00661713|38178037|FG007|Overall Study|Inappropriate Enrollment|0|||
17033962|NCT03835975|38178062|FG000|Overall Study|Lost to Follow-up|1|||
17033963|NCT03835975|38178063|FG001|Overall Study|Lost to Follow-up|1|||
17033964|NCT03835975|38178064|FG002|Overall Study|Lost to Follow-up|0|||
17033965|NCT03835975|38178065|FG003|Overall Study|Lost to Follow-up|0|||
17033966|NCT03835975|38178066|FG004|Overall Study|Lost to Follow-up|0|||
17033967|NCT03835975|38178062|FG000|Overall Study|No longer met eligibility criteria|0|||
17033968|NCT03835975|38178063|FG001|Overall Study|No longer met eligibility criteria|1|||
17033969|NCT03835975|38178064|FG002|Overall Study|No longer met eligibility criteria|0|||
17033970|NCT03835975|38178065|FG003|Overall Study|No longer met eligibility criteria|0|||
17033971|NCT03835975|38178066|FG004|Overall Study|No longer met eligibility criteria|0|||
17033972|NCT03835975|38178062|FG000|Overall Study|Protocol Violation|1|||
17033973|NCT03835975|38178063|FG001|Overall Study|Protocol Violation|1|||
17033974|NCT03835975|38178064|FG002|Overall Study|Protocol Violation|2|||
17033975|NCT03835975|38178065|FG003|Overall Study|Protocol Violation|0|||
17033976|NCT03835975|38178066|FG004|Overall Study|Protocol Violation|0|||
17033977|NCT03835975|38178062|FG000|Overall Study|Withdrawal by Subject|1|||
17033978|NCT03835975|38178063|FG001|Overall Study|Withdrawal by Subject|0|||
17033979|NCT03835975|38178064|FG002|Overall Study|Withdrawal by Subject|1|||
17033980|NCT03835975|38178065|FG003|Overall Study|Withdrawal by Subject|1|||
17033981|NCT03835975|38178066|FG004|Overall Study|Withdrawal by Subject|0|||
17033982|NCT00427921|38178080|FG000|Overall Study|Adverse Event|26|||
17033983|NCT00427921|38178080|FG000|Overall Study|Withdrawal by Subject|4|||
17033984|NCT00427921|38178080|FG000|Overall Study|Lost to Follow-up|2|||
17033985|NCT00427921|38178080|FG000|Overall Study|Other reason not specified|10|||
17033986|NCT00427921|38178080|FG000|Overall Study|Adverse Event + Hospitalization|1|||
17033987|NCT00427921|38178080|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
17033988|NCT00427921|38178080|FG000|Overall Study|Adverse Event + No Response|1|||
17033989|NCT00427921|38178080|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
17033990|NCT00427921|38178080|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
17033991|NCT00427921|38178080|FG000|Overall Study|Adverse Event + Lost Response|1|||
17033992|NCT00427921|38178080|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
17033993|NCT00427921|38178080|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
17033994|NCT00432991|38178086|FG000|Overall Study|Protocol Violation|7|||
17033995|NCT00432991|38178087|FG001|Overall Study|Protocol Violation|12|||
17033996|NCT00432835|38178095|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
17033997|NCT00432835|38178096|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
17033998|NCT00580970|38178104|FG000|Pre-treatment|Non-compliance|1|||
17033999|NCT00580970|38178104|FG000|Treatment (Lovastatin)|Non-compliance|6|||
17034000|NCT00580970|38178104|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
17034001|NCT00580970|38178104|FG000|Treatment (Lovastatin)|Physician Decision|4|||
17034002|NCT00580970|38178104|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
17034003|NCT00580970|38178104|FG000|Treatment (Lovastatin)|Death|1|||
17034004|NCT00665925|38178112|FG000|Overall Study|Lack of Efficacy|10|||
17034005|NCT00665925|38178113|FG001|Overall Study|Lack of Efficacy|8|||
17034006|NCT00665925|38178114|FG002|Overall Study|Lack of Efficacy|9|||
17034007|NCT00665925|38178115|FG003|Overall Study|Lack of Efficacy|8|||
17034008|NCT00665925|38178112|FG000|Overall Study|Lost to Follow-up|1|||
17034009|NCT00665925|38178113|FG001|Overall Study|Lost to Follow-up|2|||
17034010|NCT00665925|38178114|FG002|Overall Study|Lost to Follow-up|2|||
17034011|NCT00665925|38178115|FG003|Overall Study|Lost to Follow-up|2|||
17034012|NCT00665925|38178112|FG000|Overall Study|Withdrawal by Subject|2|||
17034013|NCT00665925|38178113|FG001|Overall Study|Withdrawal by Subject|2|||
17034014|NCT00665925|38178114|FG002|Overall Study|Withdrawal by Subject|3|||
17034015|NCT00665925|38178115|FG003|Overall Study|Withdrawal by Subject|2|||
17034016|NCT00665925|38178112|FG000|Overall Study|Physician Decision|0|||
17034017|NCT00665925|38178113|FG001|Overall Study|Physician Decision|0|||
17034018|NCT00665925|38178114|FG002|Overall Study|Physician Decision|1|||
17034019|NCT00665925|38178115|FG003|Overall Study|Physician Decision|2|||
17034020|NCT00665925|38178112|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
17034021|NCT00665925|38178113|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
17034022|NCT00665925|38178114|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
17034023|NCT00665925|38178115|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
17034024|NCT00665925|38178112|FG000|Overall Study|Adverse Event|1|||
17034025|NCT00665925|38178113|FG001|Overall Study|Adverse Event|5|||
17034026|NCT00665925|38178114|FG002|Overall Study|Adverse Event|10|||
17034027|NCT00665925|38178115|FG003|Overall Study|Adverse Event|5|||
17034028|NCT00665925|38178112|FG000|Overall Study|Enrolled by mistake|0|||
17034029|NCT00665925|38178113|FG001|Overall Study|Enrolled by mistake|0|||
17034030|NCT00665925|38178114|FG002|Overall Study|Enrolled by mistake|0|||
17034031|NCT00665925|38178115|FG003|Overall Study|Enrolled by mistake|1|||
17034032|NCT00665925|38178112|FG000|Overall Study|Due to exclusion criteria|1|||
17034033|NCT00665925|38178113|FG001|Overall Study|Due to exclusion criteria|0|||
17034034|NCT00665925|38178114|FG002|Overall Study|Due to exclusion criteria|0|||
17034035|NCT00665925|38178115|FG003|Overall Study|Due to exclusion criteria|0|||
17034036|NCT00426751|38178128|FG000|Overall Study|Adverse Event|8|||
17034037|NCT00426751|38178129|FG001|Overall Study|Adverse Event|1|||
17034038|NCT00426751|38178128|FG000|Overall Study|Lost to Follow-up|7|||
17034039|NCT00426751|38178129|FG001|Overall Study|Lost to Follow-up|6|||
17034040|NCT00426751|38178128|FG000|Overall Study|Consent Withdrawn|0|||
17034041|NCT00426751|38178129|FG001|Overall Study|Consent Withdrawn|1|||
17034042|NCT00426751|38178128|FG000|Overall Study|Other Reasons|7|||
17034043|NCT00426751|38178129|FG001|Overall Study|Other Reasons|12|||
17034044|NCT00440401|38178137|FG000|Overall Study|Adverse Event|2|||
17034045|NCT00440401|38178138|FG001|Overall Study|Adverse Event|1|||
17034046|NCT00440401|38178137|FG000|Overall Study|Other|2|||
17034047|NCT00440401|38178138|FG001|Overall Study|Other|5|||
17034048|NCT02598960|38178157|FG000|Treatment Period|Disease Progression|4|||
17034049|NCT02598960|38178158|FG001|Treatment Period|Disease Progression|4|||
17034050|NCT02598960|38178159|FG002|Treatment Period|Disease Progression|4|||
17034051|NCT02598960|38178160|FG003|Treatment Period|Disease Progression|6|||
17034052|NCT02598960|38178161|FG004|Treatment Period|Disease Progression|8|||
17034053|NCT02598960|38178162|FG005|Treatment Period|Disease Progression|2|||
17034054|NCT02598960|38178163|FG006|Treatment Period|Disease Progression|2|||
17034055|NCT02598960|38178164|FG007|Treatment Period|Disease Progression|3|||
17034056|NCT02598960|38178165|FG008|Treatment Period|Disease Progression|7|||
17034057|NCT02598960|38178166|FG009|Treatment Period|Disease Progression|9|||
17034058|NCT02598960|38178167|FG010|Treatment Period|Disease Progression|7|||
17034059|NCT02598960|38178168|FG011|Treatment Period|Disease Progression|143|||
17034060|NCT02598960|38178169|FG012|Treatment Period|Disease Progression|23|||
17034061|NCT02598960|38178157|FG000|Treatment Period|Study drug toxicity|0|||
17034062|NCT02598960|38178158|FG001|Treatment Period|Study drug toxicity|0|||
17034063|NCT02598960|38178159|FG002|Treatment Period|Study drug toxicity|0|||
17034064|NCT02598960|38178160|FG003|Treatment Period|Study drug toxicity|0|||
17137570|NCT03102710|38279520|FG001|Overall Study|Technical issues during final MRI scan|1|||
17137571|NCT03102710|38279521|FG002|Overall Study|Technical issues during final MRI scan|0|||
17137572|NCT03102710|38279519|FG000|Overall Study|Nausea during MRI scan|0|||
17137573|NCT03102710|38279520|FG001|Overall Study|Nausea during MRI scan|1|||
17137574|NCT03102710|38279521|FG002|Overall Study|Nausea during MRI scan|0|||
17137575|NCT03102710|38279519|FG000|Overall Study|Subject unable to attend final session|0|||
17137576|NCT03102710|38279520|FG001|Overall Study|Subject unable to attend final session|1|||
17137577|NCT03102710|38279521|FG002|Overall Study|Subject unable to attend final session|0|||
17137578|NCT03101150|38279531|FG000|Overall Study|Lost to Follow-up|2|||
17034065|NCT02598960|38178161|FG004|Treatment Period|Study drug toxicity|0|||
17034066|NCT02598960|38178162|FG005|Treatment Period|Study drug toxicity|0|||
17034067|NCT02598960|38178163|FG006|Treatment Period|Study drug toxicity|0|||
17034068|NCT02598960|38178164|FG007|Treatment Period|Study drug toxicity|0|||
17034069|NCT02598960|38178165|FG008|Treatment Period|Study drug toxicity|0|||
17034070|NCT02598960|38178166|FG009|Treatment Period|Study drug toxicity|1|||
17034071|NCT02598960|38178167|FG010|Treatment Period|Study drug toxicity|0|||
17034072|NCT02598960|38178168|FG011|Treatment Period|Study drug toxicity|3|||
17034073|NCT02598960|38178169|FG012|Treatment Period|Study drug toxicity|0|||
17034074|NCT02598960|38178157|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
17034075|NCT02598960|38178158|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
17034076|NCT02598960|38178159|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
17034077|NCT02598960|38178160|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
17034078|NCT02598960|38178161|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
17034079|NCT02598960|38178162|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
17034080|NCT02598960|38178163|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
17034081|NCT02598960|38178164|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
17034082|NCT02598960|38178165|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
17034083|NCT02598960|38178166|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
17034084|NCT02598960|38178167|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
17034085|NCT02598960|38178168|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
17034086|NCT02598960|38178169|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
17034087|NCT02598960|38178157|FG000|Treatment Period|participant request to discontinue|0|||
17034088|NCT02598960|38178158|FG001|Treatment Period|participant request to discontinue|1|||
17034089|NCT02598960|38178159|FG002|Treatment Period|participant request to discontinue|0|||
17034090|NCT02598960|38178160|FG003|Treatment Period|participant request to discontinue|0|||
17034091|NCT02598960|38178161|FG004|Treatment Period|participant request to discontinue|1|||
17034092|NCT02598960|38178162|FG005|Treatment Period|participant request to discontinue|0|||
17034093|NCT02598960|38178163|FG006|Treatment Period|participant request to discontinue|0|||
17034094|NCT02598960|38178164|FG007|Treatment Period|participant request to discontinue|0|||
17034095|NCT02598960|38178165|FG008|Treatment Period|participant request to discontinue|0|||
17034096|NCT02598960|38178166|FG009|Treatment Period|participant request to discontinue|0|||
17034097|NCT02598960|38178167|FG010|Treatment Period|participant request to discontinue|1|||
17034098|NCT02598960|38178168|FG011|Treatment Period|participant request to discontinue|4|||
17034099|NCT02598960|38178169|FG012|Treatment Period|participant request to discontinue|0|||
17034100|NCT02598960|38178157|FG000|Treatment Period|participant withdrew consent|0|||
17034101|NCT02598960|38178158|FG001|Treatment Period|participant withdrew consent|0|||
17034102|NCT02598960|38178159|FG002|Treatment Period|participant withdrew consent|0|||
17034103|NCT02598960|38178160|FG003|Treatment Period|participant withdrew consent|0|||
17034104|NCT02598960|38178161|FG004|Treatment Period|participant withdrew consent|0|||
17034105|NCT02598960|38178162|FG005|Treatment Period|participant withdrew consent|0|||
17034106|NCT02598960|38178163|FG006|Treatment Period|participant withdrew consent|0|||
17034107|NCT02598960|38178164|FG007|Treatment Period|participant withdrew consent|0|||
17034108|NCT02598960|38178165|FG008|Treatment Period|participant withdrew consent|0|||
17034109|NCT02598960|38178166|FG009|Treatment Period|participant withdrew consent|0|||
17034110|NCT02598960|38178167|FG010|Treatment Period|participant withdrew consent|0|||
17034111|NCT02598960|38178168|FG011|Treatment Period|participant withdrew consent|3|||
17034112|NCT02598960|38178169|FG012|Treatment Period|participant withdrew consent|0|||
17034113|NCT02598960|38178157|FG000|Treatment Period|No longer meets study criteria|0|||
17034114|NCT02598960|38178158|FG001|Treatment Period|No longer meets study criteria|0|||
17034115|NCT02598960|38178159|FG002|Treatment Period|No longer meets study criteria|0|||
17034116|NCT02598960|38178160|FG003|Treatment Period|No longer meets study criteria|0|||
17034117|NCT02598960|38178161|FG004|Treatment Period|No longer meets study criteria|0|||
17034118|NCT02598960|38178162|FG005|Treatment Period|No longer meets study criteria|0|||
17034119|NCT02598960|38178163|FG006|Treatment Period|No longer meets study criteria|0|||
17034120|NCT02598960|38178164|FG007|Treatment Period|No longer meets study criteria|0|||
17034121|NCT02598960|38178165|FG008|Treatment Period|No longer meets study criteria|0|||
17034122|NCT02598960|38178166|FG009|Treatment Period|No longer meets study criteria|0|||
17034123|NCT02598960|38178167|FG010|Treatment Period|No longer meets study criteria|0|||
17034124|NCT02598960|38178168|FG011|Treatment Period|No longer meets study criteria|1|||
17034125|NCT02598960|38178169|FG012|Treatment Period|No longer meets study criteria|0|||
17034126|NCT02598960|38178157|FG000|Treatment Period|Other Reasons|0|||
17034127|NCT02598960|38178158|FG001|Treatment Period|Other Reasons|0|||
17034128|NCT02598960|38178159|FG002|Treatment Period|Other Reasons|0|||
17034129|NCT02598960|38178160|FG003|Treatment Period|Other Reasons|0|||
17034130|NCT02598960|38178161|FG004|Treatment Period|Other Reasons|0|||
17034131|NCT02598960|38178162|FG005|Treatment Period|Other Reasons|0|||
17034132|NCT02598960|38178163|FG006|Treatment Period|Other Reasons|0|||
17034133|NCT02598960|38178164|FG007|Treatment Period|Other Reasons|0|||
17034134|NCT02598960|38178165|FG008|Treatment Period|Other Reasons|0|||
17034135|NCT02598960|38178166|FG009|Treatment Period|Other Reasons|0|||
17034136|NCT02598960|38178167|FG010|Treatment Period|Other Reasons|0|||
17034137|NCT02598960|38178168|FG011|Treatment Period|Other Reasons|0|||
17034138|NCT02598960|38178169|FG012|Treatment Period|Other Reasons|1|||
17034139|NCT02598960|38178157|FG000|Participants Entering Follow Up Period|Death|1|||
17034140|NCT02598960|38178158|FG001|Participants Entering Follow Up Period|Death|0|||
17034141|NCT02598960|38178159|FG002|Participants Entering Follow Up Period|Death|0|||
17034142|NCT02598960|38178160|FG003|Participants Entering Follow Up Period|Death|0|||
17034143|NCT02598960|38178161|FG004|Participants Entering Follow Up Period|Death|0|||
17034144|NCT02598960|38178162|FG005|Participants Entering Follow Up Period|Death|0|||
17034145|NCT02598960|38178163|FG006|Participants Entering Follow Up Period|Death|0|||
17034146|NCT02598960|38178164|FG007|Participants Entering Follow Up Period|Death|0|||
17034147|NCT02598960|38178165|FG008|Participants Entering Follow Up Period|Death|0|||
17034148|NCT02598960|38178166|FG009|Participants Entering Follow Up Period|Death|1|||
17034149|NCT02598960|38178167|FG010|Participants Entering Follow Up Period|Death|0|||
17034150|NCT02598960|38178168|FG011|Participants Entering Follow Up Period|Death|11|||
17034151|NCT02598960|38178169|FG012|Participants Entering Follow Up Period|Death|2|||
17034152|NCT02598960|38178157|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034153|NCT02598960|38178158|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034154|NCT02598960|38178159|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034155|NCT02598960|38178160|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034156|NCT02598960|38178161|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034157|NCT02598960|38178162|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034158|NCT02598960|38178163|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034159|NCT02598960|38178164|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034160|NCT02598960|38178165|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034161|NCT02598960|38178166|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034162|NCT02598960|38178167|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034163|NCT02598960|38178168|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
17034164|NCT02598960|38178169|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
17034165|NCT02598960|38178157|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
17034166|NCT02598960|38178158|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
17034167|NCT02598960|38178159|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
17034168|NCT02598960|38178160|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
17034169|NCT02598960|38178161|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
17034170|NCT02598960|38178162|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
17034171|NCT02598960|38178163|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
17034172|NCT02598960|38178164|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
17034173|NCT02598960|38178165|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
17034174|NCT02598960|38178166|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
17034175|NCT02598960|38178167|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
17034176|NCT02598960|38178168|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
17034177|NCT02598960|38178169|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
17034178|NCT02598960|38178157|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034179|NCT02598960|38178158|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034180|NCT02598960|38178159|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034181|NCT02598960|38178160|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034182|NCT02598960|38178161|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034183|NCT02598960|38178162|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034184|NCT02598960|38178163|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034185|NCT02598960|38178164|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034186|NCT02598960|38178165|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034187|NCT02598960|38178166|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034188|NCT02598960|38178167|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034189|NCT02598960|38178168|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
17034190|NCT02598960|38178169|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
17034191|NCT02598960|38178157|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
17034192|NCT02598960|38178158|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
17034193|NCT02598960|38178159|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
17034194|NCT02598960|38178160|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
17034195|NCT02598960|38178161|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
17034196|NCT02598960|38178162|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
17034197|NCT02598960|38178163|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
17034198|NCT02598960|38178164|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
17034199|NCT02598960|38178165|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
17034200|NCT02598960|38178166|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
17034201|NCT02598960|38178167|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
17034202|NCT02598960|38178168|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
17034203|NCT02598960|38178169|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
17034204|NCT00426361|38178200|FG000|Overall Study|Lost to Follow-up|3|||
17034205|NCT00426361|38178201|FG001|Overall Study|Lost to Follow-up|2|||
17034206|NCT00426361|38178202|FG002|Overall Study|Lost to Follow-up|5|||
17034207|NCT00426361|38178200|FG000|Overall Study|Withdrawal by Subject|1|||
17034208|NCT00426361|38178201|FG001|Overall Study|Withdrawal by Subject|3|||
17034209|NCT00426361|38178202|FG002|Overall Study|Withdrawal by Subject|0|||
17034210|NCT00665847|38178210|FG000|Overall Study|Adverse Event|8|||
17034211|NCT00665847|38178210|FG000|Overall Study|Withdrawal by Subject|2|||
17034212|NCT00665847|38178210|FG000|Overall Study|Subject non-compliant|8|||
17034213|NCT00665847|38178210|FG000|Overall Study|Subject reached a virologic endpoint|4|||
17034214|NCT00665847|38178210|FG000|Overall Study|Resistance to TMC125|1|||
17034215|NCT00665847|38178210|FG000|Overall Study|Subject ineligible to continue the trial|1|||
17034216|NCT00665847|38178210|FG000|Overall Study|Switch to Commercial Medication|1|||
17034217|NCT00426127|38178214|FG000|Overall Study|Adverse Event|1|||
17034218|NCT00426127|38178214|FG000|Overall Study|Removed due to disease progression|1|||
17034219|NCT00425503|38178218|FG000|Overall Study|Adverse Event|2|||
17034220|NCT00425503|38178218|FG000|Overall Study|Protocol Violation|1|||
17034221|NCT00425269|38178224|FG000|Overall Study|Pregnancy|5|||
17034222|NCT00425269|38178225|FG001|Overall Study|Pregnancy|7|||
17034223|NCT00425269|38178224|FG000|Overall Study|Lost to Follow-up|9|||
17034224|NCT00425269|38178225|FG001|Overall Study|Lost to Follow-up|9|||
17034225|NCT00425269|38178224|FG000|Overall Study|moved or medical reason|5|||
17034226|NCT00425269|38178225|FG001|Overall Study|moved or medical reason|4|||
17034227|NCT00430573|38178231|FG000|Overall Study|Withdrawal by Subject|5|||
17034228|NCT02075840|38178255|FG000|Overall Study|Withdrawal by Subject|13|||
17034229|NCT02075840|38178256|FG001|Overall Study|Withdrawal by Subject|22|||
17034230|NCT02075840|38178255|FG000|Overall Study|Reason not specified|1|||
17034231|NCT02075840|38178256|FG001|Overall Study|Reason not specified|0|||
17034232|NCT02075840|38178255|FG000|Overall Study|Adverse Event|0|||
17034233|NCT02075840|38178256|FG001|Overall Study|Adverse Event|2|||
17034234|NCT02075840|38178255|FG000|Overall Study|Death|35|||
17034235|NCT02075840|38178256|FG001|Overall Study|Death|40|||
17034236|NCT02075840|38178255|FG000|Overall Study|Lost to Follow-up|3|||
17034237|NCT02075840|38178256|FG001|Overall Study|Lost to Follow-up|2|||
17034238|NCT02075840|38178255|FG000|Overall Study|Physician Decision|1|||
17034239|NCT02075840|38178256|FG001|Overall Study|Physician Decision|3|||
17034240|NCT02075840|38178255|FG000|Overall Study|Ongoing at CCOD|99|||
17034241|NCT02075840|38178256|FG001|Overall Study|Ongoing at CCOD|82|||
17034242|NCT00430495|38178266|FG000|Overall Study|Adverse Event|2|||
17137579|NCT03101150|38279532|FG001|Overall Study|Lost to Follow-up|4|||
17137580|NCT03101150|38279531|FG000|Overall Study|Miscarriage|3|||
17034243|NCT00430495|38178267|FG001|Overall Study|Adverse Event|3|||
17034244|NCT00430495|38178268|FG002|Overall Study|Adverse Event|2|||
17034245|NCT00430495|38178269|FG003|Overall Study|Adverse Event|0|||
17034246|NCT00430495|38178266|FG000|Overall Study|Death|0|||
17034247|NCT00430495|38178267|FG001|Overall Study|Death|0|||
17034248|NCT00430495|38178268|FG002|Overall Study|Death|1|||
17034249|NCT00430495|38178269|FG003|Overall Study|Death|0|||
17034250|NCT00430495|38178266|FG000|Overall Study|Lost to Follow-up|0|||
17137581|NCT03101150|38279532|FG001|Overall Study|Miscarriage|6|||
17137582|NCT03101930|38279541|FG000|Overall Study|Withdrawal by Subject|2|||
17137583|NCT03101930|38279542|FG001|Overall Study|Withdrawal by Subject|1|||
17034251|NCT00430495|38178267|FG001|Overall Study|Lost to Follow-up|1|||
17034252|NCT00430495|38178268|FG002|Overall Study|Lost to Follow-up|4|||
17034253|NCT00430495|38178269|FG003|Overall Study|Lost to Follow-up|0|||
17137584|NCT03101930|38279543|FG002|Overall Study|Withdrawal by Subject|2|||
17034254|NCT00430495|38178266|FG000|Overall Study|Protocol Violation|1|||
17034255|NCT00430495|38178267|FG001|Overall Study|Protocol Violation|0|||
17034256|NCT00430495|38178268|FG002|Overall Study|Protocol Violation|1|||
17034257|NCT00430495|38178269|FG003|Overall Study|Protocol Violation|0|||
17034258|NCT00430495|38178266|FG000|Overall Study|Disease Progression|1|||
17137585|NCT02928848|38279553|FG000|Arm 2|Withdrawal by Subject|1|||
17034259|NCT00430495|38178267|FG001|Overall Study|Disease Progression|1|||
17034260|NCT00430495|38178268|FG002|Overall Study|Disease Progression|0|||
17034261|NCT00430495|38178269|FG003|Overall Study|Disease Progression|0|||
17034262|NCT00430495|38178266|FG000|Overall Study|Other|8|||
17034263|NCT00430495|38178267|FG001|Overall Study|Other|2|||
17034264|NCT00430495|38178268|FG002|Overall Study|Other|5|||
17034265|NCT00430495|38178269|FG003|Overall Study|Other|4|||
17034266|NCT00430495|38178266|FG000|Overall Study|Randomized but not Treated|2|||
17034267|NCT00430495|38178267|FG001|Overall Study|Randomized but not Treated|0|||
17034268|NCT00430495|38178268|FG002|Overall Study|Randomized but not Treated|0|||
17034269|NCT00430495|38178269|FG003|Overall Study|Randomized but not Treated|0|||
17034270|NCT00425113|38178281|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
17034271|NCT00425113|38178282|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
17034272|NCT00425113|38178281|FG000|Overall Study|diagnosis of abdominal TB|0|||
17034273|NCT00425113|38178282|FG001|Overall Study|diagnosis of abdominal TB|1|||
17034274|NCT00425113|38178281|FG000|Overall Study|missing study drug more than 14 days|0|||
17034275|NCT00425113|38178282|FG001|Overall Study|missing study drug more than 14 days|1|||
17034276|NCT00425113|38178281|FG000|Overall Study|Withdrawal by Subject|1|||
17034277|NCT00425113|38178282|FG001|Overall Study|Withdrawal by Subject|0|||
17034278|NCT00440011|38178291|FG000|Overall Study|Adverse Event|2|||
17034279|NCT00440011|38178292|FG001|Overall Study|Adverse Event|0|||
17034280|NCT00440011|38178291|FG000|Overall Study|Lost to Follow-up|0|||
17034281|NCT00440011|38178292|FG001|Overall Study|Lost to Follow-up|2|||
17137586|NCT02928848|38279554|FG001|Arm 2|Withdrawal by Subject|0|||
17137587|NCT02928770|38279562|FG000|Overall Study|Withdrawal by Subject|2|||
17034282|NCT00440011|38178291|FG000|Overall Study|Protocol Violation|1|||
17034283|NCT00440011|38178292|FG001|Overall Study|Protocol Violation|1|||
17034284|NCT00440011|38178291|FG000|Overall Study|Withdrawal by Subject|1|||
17034285|NCT00440011|38178292|FG001|Overall Study|Withdrawal by Subject|0|||
17034286|NCT00663117|38178329|FG000|Overall Study|Lack of Efficacy|1|||
17034287|NCT00663117|38178330|FG001|Overall Study|Lack of Efficacy|0|||
17137588|NCT03464136|38279568|FG000|Overall Study|Lost to Follow-up|5|||
17137589|NCT03464136|38279569|FG001|Overall Study|Lost to Follow-up|8|||
17137590|NCT03464136|38279568|FG000|Overall Study|Withdrawal by Subject|16|||
17137591|NCT03464136|38279569|FG001|Overall Study|Withdrawal by Subject|13|||
17137592|NCT03464136|38279568|FG000|Overall Study|Death|1|||
17137593|NCT03464136|38279569|FG001|Overall Study|Death|0|||
17137594|NCT03464136|38279568|FG000|Overall Study|Other|8|||
17137595|NCT03464136|38279569|FG001|Overall Study|Other|4|||
17137596|NCT03100838|38279575|FG000|Overall Study|Adverse Event|1|||
17137597|NCT03100838|38279576|FG001|Overall Study|Adverse Event|0|||
17137598|NCT03100838|38279577|FG002|Overall Study|Adverse Event|0|||
17137599|NCT03100838|38279578|FG003|Overall Study|Adverse Event|0|||
17137600|NCT03100838|38279575|FG000|Overall Study|Physician Decision|1|||
17137601|NCT03100838|38279576|FG001|Overall Study|Physician Decision|1|||
17137602|NCT03100838|38279577|FG002|Overall Study|Physician Decision|1|||
17137603|NCT03100838|38279578|FG003|Overall Study|Physician Decision|1|||
17137604|NCT03100838|38279575|FG000|Overall Study|Pregnancy|0|||
17137605|NCT03100838|38279576|FG001|Overall Study|Pregnancy|1|||
17137606|NCT03100838|38279577|FG002|Overall Study|Pregnancy|0|||
17137607|NCT03100838|38279578|FG003|Overall Study|Pregnancy|0|||
17137608|NCT03100838|38279575|FG000|Overall Study|Lost to Follow-up|0|||
17137609|NCT03100838|38279576|FG001|Overall Study|Lost to Follow-up|0|||
17137610|NCT03100838|38279577|FG002|Overall Study|Lost to Follow-up|1|||
17137611|NCT03100838|38279578|FG003|Overall Study|Lost to Follow-up|0|||
17137612|NCT03480750|38279594|FG000|Overall Study|Withdrawal by Subject|0|||
17137613|NCT03480750|38279595|FG001|Overall Study|Withdrawal by Subject|1|||
17137614|NCT03480750|38279596|FG002|Overall Study|Withdrawal by Subject|0|||
17137615|NCT03480750|38279597|FG003|Overall Study|Withdrawal by Subject|0|||
16991830|NCT00730327|38135814|FG000|Overall Study|Lost to Follow-up|14|||
17034288|NCT02410902|38178353|FG000|Overall Study|Adverse Event|2|||
17034289|NCT02410902|38178354|FG001|Overall Study|Adverse Event|3|||
17034290|NCT02410902|38178353|FG000|Overall Study|Lost to Follow-up|4|||
17034291|NCT02410902|38178354|FG001|Overall Study|Lost to Follow-up|1|||
17034292|NCT02410902|38178353|FG000|Overall Study|Protocol Violation|1|||
17034293|NCT02410902|38178354|FG001|Overall Study|Protocol Violation|4|||
17034294|NCT02410902|38178353|FG000|Overall Study|Withdrawal by Subject|6|||
17034295|NCT02410902|38178354|FG001|Overall Study|Withdrawal by Subject|8|||
17034296|NCT02410902|38178353|FG000|Overall Study|Non-Compliance|8|||
17034297|NCT02410902|38178354|FG001|Overall Study|Non-Compliance|2|||
17034298|NCT00570141|38178362|FG000|Overall Study|Adverse Event|1|||
17034299|NCT00570141|38178362|FG000|Overall Study|Missed visits|1|||
17137616|NCT03480750|38279598|FG004|Overall Study|Withdrawal by Subject|0|||
17137617|NCT03480750|38279599|FG005|Overall Study|Withdrawal by Subject|0|||
17137618|NCT03480750|38279594|FG000|Overall Study|The interruption in Trientine shippment|0|||
17137619|NCT03480750|38279595|FG001|Overall Study|The interruption in Trientine shippment|0|||
17034300|NCT00570141|38178362|FG000|Overall Study|Lost to Follow-up|1|||
17034301|NCT00579254|38178366|FG000|Overall Study|Lost to Follow-up|39|||
17137620|NCT03480750|38279596|FG002|Overall Study|The interruption in Trientine shippment|0|||
17034302|NCT00579254|38178366|FG000|Overall Study|Discontinued when study terminated|73|||
17034303|NCT00661089|38178372|FG000|Overall Study|1 subject withdrawal|0|||
17034304|NCT00661089|38178373|FG001|Overall Study|1 subject withdrawal|1|||
17034305|NCT00661089|38178372|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
17034306|NCT00661089|38178373|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
17034307|NCT00582426|38178382|FG000|Overall Study|Lost to Follow-up|0|||
17034308|NCT00582426|38178383|FG001|Overall Study|Lost to Follow-up|2|||
17034309|NCT00582426|38178382|FG000|Overall Study|Adverse Event|4|||
17034310|NCT00582426|38178383|FG001|Overall Study|Adverse Event|2|||
17034311|NCT00582426|38178382|FG000|Overall Study|Protocol Violation|6|||
17034312|NCT00582426|38178383|FG001|Overall Study|Protocol Violation|2|||
17034313|NCT00582426|38178382|FG000|Overall Study|Death|4|||
17137621|NCT03480750|38279597|FG003|Overall Study|The interruption in Trientine shippment|0|||
17137622|NCT03480750|38279598|FG004|Overall Study|The interruption in Trientine shippment|0|||
17137623|NCT03480750|38279599|FG005|Overall Study|The interruption in Trientine shippment|1|||
17137624|NCT03462030|38279624|FG000|Overall Study|Withdrawal by Subject|1|||
17137625|NCT03462030|38279625|FG001|Overall Study|Withdrawal by Subject|1|||
17137626|NCT03412734|38279633|FG000|Overall Study|Incorrect labeling of samples|2|||
17137627|NCT03412734|38279634|FG001|Overall Study|Incorrect labeling of samples|0|||
17137628|NCT03412734|38279633|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
17137629|NCT03412734|38279634|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
17137630|NCT02374814|38279646|FG000|Overall Study|Lost to Follow-up|1|||
17137631|NCT02374814|38279647|FG001|Overall Study|Lost to Follow-up|1|||
17137632|NCT02374814|38279648|FG002|Overall Study|Lost to Follow-up|0|||
17137633|NCT02374814|38279649|FG003|Overall Study|Lost to Follow-up|1|||
17137634|NCT02374814|38279650|FG004|Overall Study|Lost to Follow-up|0|||
17137635|NCT02374814|38279651|FG005|Overall Study|Lost to Follow-up|0|||
17137636|NCT02374814|38279646|FG000|Overall Study|Withdrawal by Subject|0|||
17137637|NCT02374814|38279647|FG001|Overall Study|Withdrawal by Subject|0|||
17137638|NCT02374814|38279648|FG002|Overall Study|Withdrawal by Subject|1|||
17137639|NCT02374814|38279649|FG003|Overall Study|Withdrawal by Subject|1|||
17137640|NCT02374814|38279650|FG004|Overall Study|Withdrawal by Subject|0|||
17137641|NCT02374814|38279651|FG005|Overall Study|Withdrawal by Subject|0|||
17137642|NCT04608344|38279675|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
17137643|NCT04608344|38279676|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
17137644|NCT04608344|38279675|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
17137645|NCT04608344|38279676|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
17137646|NCT03433482|38279694|FG000|Overall Study|Lost to Follow-up|1|||
17137647|NCT03433482|38279695|FG001|Overall Study|Lost to Follow-up|0|||
17137648|NCT03433482|38279696|FG002|Overall Study|Lost to Follow-up|1|||
17137649|NCT03433482|38279697|FG003|Overall Study|Lost to Follow-up|1|||
17137650|NCT03433482|38279694|FG000|Overall Study|Withdrawal by Subject|0|||
17137651|NCT03433482|38279695|FG001|Overall Study|Withdrawal by Subject|0|||
17137652|NCT03433482|38279696|FG002|Overall Study|Withdrawal by Subject|1|||
17137653|NCT03433482|38279697|FG003|Overall Study|Withdrawal by Subject|0|||
17137654|NCT03433482|38279694|FG000|Overall Study|Unknown reason|0|||
17137655|NCT03433482|38279695|FG001|Overall Study|Unknown reason|0|||
17137656|NCT03433482|38279696|FG002|Overall Study|Unknown reason|2|||
17137657|NCT03433482|38279697|FG003|Overall Study|Unknown reason|0|||
17137658|NCT03432858|38279710|FG000|Overall Study|Protocol Violation|2|||
17137659|NCT03432858|38279711|FG001|Overall Study|Protocol Violation|1|||
17137660|NCT03432858|38279712|FG002|Overall Study|Protocol Violation|9|||
17137661|NCT03432858|38279710|FG000|Overall Study|Withdrawal by Subject|0|||
17137662|NCT03432858|38279711|FG001|Overall Study|Withdrawal by Subject|1|||
17137663|NCT03432858|38279712|FG002|Overall Study|Withdrawal by Subject|1|||
17137664|NCT03432858|38279710|FG000|Overall Study|Procedure canceled/rescheduled|0|||
17137665|NCT03432858|38279711|FG001|Overall Study|Procedure canceled/rescheduled|9|||
17137666|NCT03432858|38279712|FG002|Overall Study|Procedure canceled/rescheduled|6|||
17137667|NCT03432858|38279710|FG000|Overall Study|Required postop mobilization with splinting|0|||
17137668|NCT03432858|38279711|FG001|Overall Study|Required postop mobilization with splinting|0|||
17137669|NCT03432858|38279712|FG002|Overall Study|Required postop mobilization with splinting|1|||
17137670|NCT03432390|38279722|FG000|Apnea Period|Protocol Violation|2|||
17137671|NCT03432390|38279723|FG001|Apnea Period|Protocol Violation|2|||
17137672|NCT03456960|38279735|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
17137673|NCT03456960|38279736|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
17137674|NCT03456960|38279737|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
17137675|NCT03456960|38279738|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
17137676|NCT03456960|38279739|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
17137677|NCT03456960|38279740|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
17137678|NCT03456960|38279735|FG000|Period 2 (1 Day)|Adverse Event|1|||
17034314|NCT00582426|38178383|FG001|Overall Study|Death|3|||
17034315|NCT00582426|38178382|FG000|Overall Study|Withdrawal by Subject|3|||
17034316|NCT00582426|38178383|FG001|Overall Study|Withdrawal by Subject|2|||
17034317|NCT00582426|38178382|FG000|Overall Study|Disease Progression|2|||
17034318|NCT00582426|38178383|FG001|Overall Study|Disease Progression|2|||
17034319|NCT00582426|38178382|FG000|Overall Study|Use of illicit drugs|1|||
17034320|NCT00582426|38178383|FG001|Overall Study|Use of illicit drugs|0|||
17034321|NCT02387970|38178391|FG000|Overall Study|Did not complete 1-year follow up|1|||
17034322|NCT02387970|38178392|FG001|Overall Study|Did not complete 1-year follow up|2|||
17034323|NCT00580034|38178398|FG000|Overall Study|Toxicity|10|||
17034324|NCT00580034|38178399|FG001|Overall Study|Toxicity|0|||
17034325|NCT00773513|38178405|FG000|Overall Study|Renal Transplant|254|||
17034326|NCT00773513|38178406|FG001|Overall Study|Renal Transplant|263|||
17034327|NCT00773513|38178405|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
17034328|NCT00773513|38178406|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
17034329|NCT00773513|38178405|FG000|Overall Study|Withdrew Consent|68|||
17034330|NCT00773513|38178406|FG001|Overall Study|Withdrew Consent|69|||
17034331|NCT00773513|38178405|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
17034332|NCT00773513|38178406|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
17034333|NCT00773513|38178405|FG000|Overall Study|Failure to Return|22|||
17034334|NCT00773513|38178406|FG001|Overall Study|Failure to Return|8|||
17034335|NCT00773513|38178405|FG000|Overall Study|Insufficient Therapeutic Response|1|||
17034336|NCT00773513|38178406|FG001|Overall Study|Insufficient Therapeutic Response|18|||
17034337|NCT00773513|38178405|FG000|Overall Study|Reason Not Specified|159|||
17034338|NCT00773513|38178406|FG001|Overall Study|Reason Not Specified|126|||
17034339|NCT00773513|38178405|FG000|Overall Study|Death|531|||
17137679|NCT03456960|38279736|FG001|Period 2 (1 Day)|Adverse Event|0|||
17137680|NCT03456960|38279737|FG002|Period 2 (1 Day)|Adverse Event|0|||
17137681|NCT03456960|38279738|FG003|Period 2 (1 Day)|Adverse Event|1|||
17137682|NCT03456960|38279739|FG004|Period 2 (1 Day)|Adverse Event|0|||
17137683|NCT03456960|38279740|FG005|Period 2 (1 Day)|Adverse Event|0|||
17137684|NCT03430986|38279758|FG000|24-week Control Period|Adverse Event|1|||
17137685|NCT03430986|38279759|FG001|24-week Control Period|Adverse Event|0|||
17137686|NCT03430986|38279758|FG000|24-week Control Period|Lost to Follow-up|2|||
17137687|NCT03430986|38279759|FG001|24-week Control Period|Lost to Follow-up|2|||
17137688|NCT03430986|38279758|FG000|24-week Control Period|Withdrawal by Participant|5|||
17137689|NCT03430986|38279759|FG001|24-week Control Period|Withdrawal by Participant|0|||
17137690|NCT03430986|38279758|FG000|24-week Control Period|Protocol Deviation|0|||
17034340|NCT00773513|38178406|FG001|Overall Study|Death|545|||
17034341|NCT00581828|38178412|FG000|Overall Study|Protocol Violation|1|||
17034342|NCT00767039|38178418|FG000|Overall Study|Death|5|||
17034343|NCT00767039|38178419|FG001|Overall Study|Death|2|||
17034344|NCT00662649|38178429|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
17034345|NCT00662649|38178430|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
17034346|NCT00662649|38178431|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
17034347|NCT00662649|38178432|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
17034348|NCT00662649|38178433|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
17034349|NCT00662649|38178429|FG000|Core Study (24 Months)|Adverse Event|22|||
17034350|NCT00662649|38178430|FG001|Core Study (24 Months)|Adverse Event|13|||
17034351|NCT00662649|38178431|FG002|Core Study (24 Months)|Adverse Event|18|||
17034352|NCT00662649|38178432|FG003|Core Study (24 Months)|Adverse Event|0|||
17034353|NCT00662649|38178433|FG004|Core Study (24 Months)|Adverse Event|0|||
17034354|NCT00662649|38178429|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
17034355|NCT00662649|38178430|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
17034356|NCT00662649|38178431|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
17034357|NCT00662649|38178432|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
17034358|NCT00662649|38178433|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
17034359|NCT00662649|38178429|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
17034360|NCT00662649|38178430|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
17034361|NCT00662649|38178431|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
17034362|NCT00662649|38178432|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
17034363|NCT00662649|38178433|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
17034364|NCT00662649|38178429|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
17137691|NCT03430986|38279759|FG001|24-week Control Period|Protocol Deviation|2|||
17137692|NCT03430986|38279758|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
17137693|NCT03430986|38279759|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
17137694|NCT03430986|38279758|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
17137695|NCT03430986|38279759|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
17137696|NCT03448536|38279770|FG000|Overall Study|Protocol Violation|2|||
17034365|NCT00662649|38178430|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
17034366|NCT00662649|38178431|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
17034367|NCT00662649|38178432|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
17034368|NCT00662649|38178433|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
17034369|NCT00662649|38178429|FG000|Core Study (24 Months)|Protocol Violation|5|||
17034370|NCT00662649|38178430|FG001|Core Study (24 Months)|Protocol Violation|5|||
17034371|NCT00662649|38178431|FG002|Core Study (24 Months)|Protocol Violation|4|||
17034372|NCT00662649|38178432|FG003|Core Study (24 Months)|Protocol Violation|0|||
17034373|NCT00662649|38178433|FG004|Core Study (24 Months)|Protocol Violation|0|||
17034374|NCT00662649|38178429|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
17034375|NCT00662649|38178430|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
17034376|NCT00662649|38178431|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
17034377|NCT00662649|38178432|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
17034378|NCT00662649|38178433|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
17034379|NCT00662649|38178429|FG000|Core Study (24 Months)|Death|1|||
17034380|NCT00662649|38178430|FG001|Core Study (24 Months)|Death|0|||
17034381|NCT00662649|38178431|FG002|Core Study (24 Months)|Death|2|||
17034382|NCT00662649|38178432|FG003|Core Study (24 Months)|Death|0|||
17034383|NCT00662649|38178433|FG004|Core Study (24 Months)|Death|0|||
17034384|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
17034385|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
17034386|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
17034387|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
17034388|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
17034389|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
17034390|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
17034391|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
17034392|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
17034393|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
17034394|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
17137697|NCT03448536|38279771|FG001|Overall Study|Protocol Violation|0|||
17137698|NCT03448536|38279770|FG000|Overall Study|Pregnancy|1|||
17034395|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
17034396|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
17034397|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
17034398|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
17034399|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
17034400|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
17034401|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
17034402|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
17034403|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
17034404|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
17034405|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
17034406|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
17034407|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
17034408|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
17137699|NCT03448536|38279771|FG001|Overall Study|Pregnancy|0|||
17137700|NCT03448536|38279770|FG000|Overall Study|Withdrawal by Subject|1|||
17137701|NCT03448536|38279771|FG001|Overall Study|Withdrawal by Subject|2|||
17137702|NCT03448536|38279770|FG000|Overall Study|Lost to Follow-up|3|||
17137703|NCT03448536|38279771|FG001|Overall Study|Lost to Follow-up|2|||
17137704|NCT03448536|38279770|FG000|Overall Study|Inadequate pain reporter|1|||
17137705|NCT03448536|38279771|FG001|Overall Study|Inadequate pain reporter|0|||
17137706|NCT03448536|38279770|FG000|Overall Study|Other|3|||
17137707|NCT03448536|38279771|FG001|Overall Study|Other|0|||
17137708|NCT03448536|38279770|FG000|Overall Study|Physician Decision|1|||
17137709|NCT03448536|38279771|FG001|Overall Study|Physician Decision|0|||
17137710|NCT03448224|38279779|FG000|Overall Study|Provided same answer to every question|1|||
17137711|NCT03448224|38279780|FG001|Overall Study|Provided same answer to every question|0|||
17137712|NCT03424044|38279786|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
17137713|NCT03424044|38279787|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
17137714|NCT03424044|38279788|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
17137715|NCT03424044|38279789|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
17137716|NCT03424044|38279790|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
17137717|NCT03424044|38279791|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
17137718|NCT03424044|38279792|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
17137719|NCT03424044|38279793|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
17137720|NCT03424044|38279794|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
17137721|NCT03424044|38279786|FG000|First Intervention (76 Hours)|Adverse Event|0|||
17034409|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
17034410|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
17034411|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
17034412|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
17034413|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
17034414|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
17034415|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
17034416|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
17034417|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
17034418|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
17034419|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
17034420|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
17034421|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
17034422|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
17034423|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
17034424|NCT00662649|38178429|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
17034425|NCT00662649|38178430|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
17034426|NCT00662649|38178431|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
17034427|NCT00662649|38178432|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
17034428|NCT00662649|38178433|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
17034429|NCT00766493|38178447|FG000|30 Days Post-Procedure|Discontinued|7|||
17034430|NCT00766493|38178447|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
17034431|NCT00766493|38178447|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
17034432|NCT03070392|38178453|FG000|Overall Study|Not Treated|7|||
17034433|NCT03070392|38178454|FG001|Overall Study|Not Treated|0|||
17034434|NCT03070392|38178455|FG002|Overall Study|Not Treated|3|||
17034435|NCT03070392|38178456|FG003|Overall Study|Not Treated|12|||
17034436|NCT03070392|38178453|FG000|Overall Study|Death|3|||
17034437|NCT03070392|38178454|FG001|Overall Study|Death|0|||
17034438|NCT03070392|38178455|FG002|Overall Study|Death|0|||
17034439|NCT03070392|38178456|FG003|Overall Study|Death|1|||
17034440|NCT03070392|38178453|FG000|Overall Study|Withdrawal by Subject|7|||
17034441|NCT03070392|38178454|FG001|Overall Study|Withdrawal by Subject|0|||
17034442|NCT03070392|38178455|FG002|Overall Study|Withdrawal by Subject|0|||
17034443|NCT03070392|38178456|FG003|Overall Study|Withdrawal by Subject|3|||
17034444|NCT03070392|38178453|FG000|Overall Study|Physician Decision|1|||
17034445|NCT03070392|38178454|FG001|Overall Study|Physician Decision|0|||
17034446|NCT03070392|38178455|FG002|Overall Study|Physician Decision|0|||
17034447|NCT03070392|38178456|FG003|Overall Study|Physician Decision|2|||
17034448|NCT03070392|38178453|FG000|Overall Study|Progressive Disease|154|||
17034449|NCT03070392|38178454|FG001|Overall Study|Progressive Disease|6|||
17034450|NCT03070392|38178455|FG002|Overall Study|Progressive Disease|2|||
17034451|NCT03070392|38178456|FG003|Overall Study|Progressive Disease|70|||
17034452|NCT03070392|38178453|FG000|Overall Study|Adverse Event|6|||
17034453|NCT03070392|38178454|FG001|Overall Study|Adverse Event|1|||
17034454|NCT03070392|38178455|FG002|Overall Study|Adverse Event|1|||
17034455|NCT03070392|38178456|FG003|Overall Study|Adverse Event|3|||
17034456|NCT03070392|38178453|FG000|Overall Study|Alternate anticancer treatment|1|||
17034457|NCT03070392|38178454|FG001|Overall Study|Alternate anticancer treatment|0|||
17034458|NCT03070392|38178455|FG002|Overall Study|Alternate anticancer treatment|0|||
17034459|NCT03070392|38178456|FG003|Overall Study|Alternate anticancer treatment|1|||
17034460|NCT03070392|38178453|FG000|Overall Study|Ongoing|73|||
17034461|NCT03070392|38178454|FG001|Overall Study|Ongoing|0|||
17034462|NCT03070392|38178455|FG002|Overall Study|Ongoing|0|||
17034463|NCT03070392|38178456|FG003|Overall Study|Ongoing|11|||
17034464|NCT00784043|38178464|FG000|Overall Study|Withdrawal by Subject|8|||
17034465|NCT00784043|38178465|FG001|Overall Study|Withdrawal by Subject|5|||
17034466|NCT00784043|38178464|FG000|Overall Study|Protocol Terminated|23|||
17034467|NCT00784043|38178465|FG001|Overall Study|Protocol Terminated|1|||
17034468|NCT00773279|38178471|FG000|Period 1|Adverse Event|2|||
17034469|NCT00773279|38178472|FG001|Period 1|Adverse Event|1|||
17034470|NCT00773279|38178471|FG000|Period 1|Lack of Efficacy|0|||
17034471|NCT00773279|38178472|FG001|Period 1|Lack of Efficacy|2|||
17034472|NCT00773279|38178471|FG000|Period 1|Unclassified|5|||
17034473|NCT00773279|38178472|FG001|Period 1|Unclassified|1|||
17034474|NCT00773279|38178471|FG000|Period 2|Adverse Event|0|||
17034475|NCT00773279|38178472|FG001|Period 2|Adverse Event|1|||
17034476|NCT00773279|38178471|FG000|Period 2|Lack of Efficacy|1|||
17034477|NCT00773279|38178472|FG001|Period 2|Lack of Efficacy|0|||
17034478|NCT00773279|38178471|FG000|Period 2|Protocol Violation|0|||
17034479|NCT00773279|38178472|FG001|Period 2|Protocol Violation|3|||
17034480|NCT00773279|38178471|FG000|Period 2|Unclassified|2|||
17034481|NCT00773279|38178472|FG001|Period 2|Unclassified|2|||
17034482|NCT00766415|38178481|FG000|Overall Study|Withdrawal by Subject|0|||
17034483|NCT00766415|38178482|FG001|Overall Study|Withdrawal by Subject|1|||
17034484|NCT00772967|38178488|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
17034485|NCT00772967|38178489|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
17034486|NCT00772967|38178490|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
17034487|NCT00772967|38178491|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
17034488|NCT00772967|38178492|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
17034489|NCT00772967|38178493|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
17034490|NCT00772967|38178488|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
17034491|NCT00772967|38178489|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
17034492|NCT00772967|38178490|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
17034493|NCT00772967|38178491|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
17034494|NCT00772967|38178492|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
17034495|NCT00772967|38178493|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
17034496|NCT00772967|38178488|FG000|Crossover Treatment 3|Adverse Event|0|||
17034497|NCT00772967|38178489|FG001|Crossover Treatment 3|Adverse Event|0|||
17034498|NCT00772967|38178490|FG002|Crossover Treatment 3|Adverse Event|0|||
17034499|NCT00772967|38178491|FG003|Crossover Treatment 3|Adverse Event|0|||
17034500|NCT00772967|38178492|FG004|Crossover Treatment 3|Adverse Event|1|||
17034501|NCT00772967|38178493|FG005|Crossover Treatment 3|Adverse Event|0|||
17034502|NCT00662259|38178516|FG000|Overall Study|Adverse Event|2|||
17034503|NCT00662259|38178517|FG001|Overall Study|Adverse Event|0|||
17034504|NCT00660699|38178523|FG000|Overall Study|Withdrawal by Subject|2|||
17034505|NCT00582114|38178529|FG000|Overall Study|Death|4|||
17034506|NCT00582114|38178530|FG001|Overall Study|Death|4|||
17034507|NCT00582114|38178529|FG000|Overall Study|Kidney Transplant|3|||
17034508|NCT00582114|38178530|FG001|Overall Study|Kidney Transplant|1|||
17034509|NCT00582114|38178529|FG000|Overall Study|Lost to Follow-up|7|||
17034510|NCT00582114|38178530|FG001|Overall Study|Lost to Follow-up|6|||
17034511|NCT00582114|38178529|FG000|Overall Study|Withdrawal by Subject|8|||
17034512|NCT00582114|38178530|FG001|Overall Study|Withdrawal by Subject|16|||
17034513|NCT00582114|38178529|FG000|Overall Study|Adverse Event|1|||
17034514|NCT00582114|38178530|FG001|Overall Study|Adverse Event|1|||
17034515|NCT00582114|38178529|FG000|Overall Study|Physician Decision|0|||
17034516|NCT00582114|38178530|FG001|Overall Study|Physician Decision|6|||
17034517|NCT00582114|38178529|FG000|Overall Study|Stopped by data safety monitoring board|19|||
17034518|NCT00582114|38178530|FG001|Overall Study|Stopped by data safety monitoring board|20|||
17034519|NCT00582036|38178538|FG000|Overall Study|Withdrawal by Subject|0|||
17034520|NCT00582036|38178539|FG001|Overall Study|Withdrawal by Subject|1|||
17034521|NCT00581360|38178545|FG000|Overall Study|Withdrawal by Subject|1|||
17034522|NCT00660387|38178551|FG000|Overall Study|Adverse Event|1|||
17034523|NCT00660387|38178552|FG001|Overall Study|Adverse Event|2|||
17034524|NCT00660387|38178551|FG000|Overall Study|Lack of Efficacy|0|||
17034525|NCT00660387|38178552|FG001|Overall Study|Lack of Efficacy|1|||
17034526|NCT00660387|38178551|FG000|Overall Study|Protocol Violation|1|||
17034527|NCT00660387|38178552|FG001|Overall Study|Protocol Violation|0|||
17034528|NCT00582738|38178560|FG000|Overall Study|Administrative Problems|7|||
17034529|NCT00582738|38178561|FG001|Overall Study|Administrative Problems|8|||
17034530|NCT00582738|38178560|FG000|Overall Study|Adverse Event|0|||
17034531|NCT00582738|38178561|FG001|Overall Study|Adverse Event|5|||
17034532|NCT00582738|38178560|FG000|Overall Study|Graft Lost|0|||
17034533|NCT00582738|38178561|FG001|Overall Study|Graft Lost|1|||
17034534|NCT00582738|38178560|FG000|Overall Study|Other|1|||
17034535|NCT00582738|38178561|FG001|Overall Study|Other|0|||
17034536|NCT00582738|38178560|FG000|Overall Study|Protocol Violation|1|||
17034537|NCT00582738|38178561|FG001|Overall Study|Protocol Violation|1|||
17034538|NCT00582738|38178560|FG000|Overall Study|Withdrawal by Subject|0|||
17034539|NCT00582738|38178561|FG001|Overall Study|Withdrawal by Subject|3|||
17034540|NCT00772889|38178576|FG000|Overall Study|Adverse Event|7|||
17034541|NCT00772889|38178577|FG001|Overall Study|Adverse Event|4|||
17034542|NCT00772889|38178578|FG002|Overall Study|Adverse Event|0|||
17034543|NCT00772889|38178576|FG000|Overall Study|Withdrawal by Subject|9|||
17034544|NCT00772889|38178577|FG001|Overall Study|Withdrawal by Subject|8|||
17034545|NCT00772889|38178578|FG002|Overall Study|Withdrawal by Subject|9|||
17034546|NCT00772889|38178576|FG000|Overall Study|Lost to Follow-up|6|||
17034547|NCT00772889|38178577|FG001|Overall Study|Lost to Follow-up|6|||
17034548|NCT00772889|38178578|FG002|Overall Study|Lost to Follow-up|7|||
17034549|NCT01247324|38178588|FG000|Overall Study|Death|1|||
17034550|NCT01247324|38178589|FG001|Overall Study|Death|0|||
17034551|NCT01247324|38178588|FG000|Overall Study|Physician Decision|0|||
17034552|NCT01247324|38178589|FG001|Overall Study|Physician Decision|1|||
17034553|NCT01247324|38178588|FG000|Overall Study|Non-compliance with study drug|3|||
17034554|NCT01247324|38178589|FG001|Overall Study|Non-compliance with study drug|0|||
17034555|NCT01247324|38178588|FG000|Overall Study|Lack of Efficacy|12|||
17034556|NCT01247324|38178589|FG001|Overall Study|Lack of Efficacy|8|||
17034557|NCT01247324|38178588|FG000|Overall Study|Non-compliance|2|||
17034558|NCT01247324|38178589|FG001|Overall Study|Non-compliance|0|||
17034559|NCT01247324|38178588|FG000|Overall Study|Pregnancy|2|||
17034560|NCT01247324|38178589|FG001|Overall Study|Pregnancy|3|||
17034561|NCT01247324|38178588|FG000|Overall Study|Protocol Violation|1|||
17034562|NCT01247324|38178589|FG001|Overall Study|Protocol Violation|2|||
17034563|NCT01247324|38178588|FG000|Overall Study|Reason not specified|11|||
17034564|NCT01247324|38178589|FG001|Overall Study|Reason not specified|8|||
17034565|NCT01247324|38178588|FG000|Overall Study|Consent withdrawn by participant|13|||
17034566|NCT01247324|38178589|FG001|Overall Study|Consent withdrawn by participant|8|||
17034567|NCT01247324|38178588|FG000|Overall Study|Adverse Event|25|||
17034568|NCT01247324|38178589|FG001|Overall Study|Adverse Event|13|||
17034569|NCT01247324|38178588|FG000|Overall Study|Lost to Follow-up|1|||
17034570|NCT01247324|38178589|FG001|Overall Study|Lost to Follow-up|1|||
17034571|NCT00772577|38178598|FG000|Overall Study|Adverse Event|6|||
17034572|NCT00772577|38178599|FG001|Overall Study|Adverse Event|3|||
17034573|NCT00772577|38178598|FG000|Overall Study|Abnormal laboratory values|0|||
17034574|NCT00772577|38178599|FG001|Overall Study|Abnormal laboratory values|1|||
17034575|NCT00772577|38178598|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
17034576|NCT00772577|38178599|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
17034577|NCT00772577|38178598|FG000|Overall Study|Patient withdrew consent|8|||
17034578|NCT00772577|38178599|FG001|Overall Study|Patient withdrew consent|5|||
17034579|NCT00772577|38178598|FG000|Overall Study|Lost to Follow-up|4|||
17034580|NCT00772577|38178599|FG001|Overall Study|Lost to Follow-up|3|||
17034581|NCT00772577|38178598|FG000|Overall Study|Administrative problems|2|||
17034582|NCT00772577|38178599|FG001|Overall Study|Administrative problems|1|||
17034583|NCT00772577|38178598|FG000|Overall Study|Protocol Deviation|3|||
17034584|NCT00772577|38178599|FG001|Overall Study|Protocol Deviation|2|||
17034585|NCT02345850|38178608|FG000|Overall Study|Not transplanted|10|||
17034586|NCT02345850|38178609|FG001|Overall Study|Not transplanted|5|||
17034587|NCT02345850|38178610|FG002|Overall Study|Not transplanted|4|||
17034588|NCT02345850|38178608|FG000|Overall Study|Lost to Follow-up|2|||
17034589|NCT02345850|38178609|FG001|Overall Study|Lost to Follow-up|3|||
17034590|NCT02345850|38178610|FG002|Overall Study|Lost to Follow-up|2|||
17034591|NCT02345850|38178608|FG000|Overall Study|Withdrawal by Subject|1|||
17034592|NCT02345850|38178609|FG001|Overall Study|Withdrawal by Subject|0|||
17034593|NCT02345850|38178610|FG002|Overall Study|Withdrawal by Subject|0|||
17034594|NCT00659607|38178618|FG000|Overall Study|No blood pressure recorded|147|||
17034595|NCT00659607|38178618|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
17034596|NCT00659607|38178618|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
17034597|NCT00659607|38178618|FG000|Overall Study|No recorded efficacy data|15|||
17034598|NCT00659607|38178618|FG000|Overall Study|Inconsistent BP measuring date|2|||
17034599|NCT02848092|38178626|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
17034600|NCT02848092|38178627|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
17034601|NCT02848092|38178626|FG000|1-month Post-training Follow-up|Adverse Event|2|||
17034602|NCT02848092|38178627|FG001|1-month Post-training Follow-up|Adverse Event|1|||
17034603|NCT02848092|38178626|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
17034604|NCT02848092|38178627|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
17137722|NCT03424044|38279787|FG001|First Intervention (76 Hours)|Adverse Event|0|||
17137723|NCT03424044|38279788|FG002|First Intervention (76 Hours)|Adverse Event|0|||
17137724|NCT03424044|38279789|FG003|First Intervention (76 Hours)|Adverse Event|0|||
17137725|NCT03424044|38279790|FG004|First Intervention (76 Hours)|Adverse Event|1|||
17137726|NCT03424044|38279791|FG005|First Intervention (76 Hours)|Adverse Event|0|||
17137727|NCT03424044|38279792|FG006|First Intervention (76 Hours)|Adverse Event|0|||
17137728|NCT03424044|38279793|FG007|First Intervention (76 Hours)|Adverse Event|0|||
17137729|NCT03424044|38279794|FG008|First Intervention (76 Hours)|Adverse Event|0|||
17137730|NCT03424044|38279786|FG000|First Intervention (76 Hours)|device issues|0|||
17137731|NCT03424044|38279787|FG001|First Intervention (76 Hours)|device issues|0|||
17137732|NCT03424044|38279788|FG002|First Intervention (76 Hours)|device issues|0|||
17137733|NCT03424044|38279789|FG003|First Intervention (76 Hours)|device issues|0|||
17137734|NCT03424044|38279790|FG004|First Intervention (76 Hours)|device issues|0|||
17137735|NCT03424044|38279791|FG005|First Intervention (76 Hours)|device issues|0|||
17137736|NCT03424044|38279792|FG006|First Intervention (76 Hours)|device issues|1|||
17137737|NCT03424044|38279793|FG007|First Intervention (76 Hours)|device issues|1|||
17034605|NCT02848092|38178626|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
17034606|NCT02848092|38178627|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
17034607|NCT02848092|38178626|FG000|1-month Post-training Follow-up|fatigue|0|||
17034608|NCT02848092|38178627|FG001|1-month Post-training Follow-up|fatigue|1|||
17034609|NCT02848092|38178626|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
17034610|NCT02848092|38178627|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
17034611|NCT02848092|38178626|FG000|6-month Post-training Follow-up|Adverse Event|1|||
17137738|NCT03424044|38279794|FG008|First Intervention (76 Hours)|device issues|1|||
17137739|NCT03424044|38279786|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
17137740|NCT03424044|38279787|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
17137741|NCT03424044|38279788|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
17034612|NCT02848092|38178627|FG001|6-month Post-training Follow-up|Adverse Event|1|||
17034613|NCT02848092|38178626|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
17034614|NCT02848092|38178627|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
17034615|NCT02848092|38178626|FG000|6-month Post-training Follow-up|frustrated with task|1|||
17034616|NCT02848092|38178627|FG001|6-month Post-training Follow-up|frustrated with task|0|||
17034617|NCT02848092|38178626|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
17137742|NCT03424044|38279789|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
17137743|NCT03424044|38279790|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
17137744|NCT03424044|38279791|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
17137745|NCT03424044|38279792|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
17137746|NCT03424044|38279793|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
17137747|NCT03424044|38279794|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
17137748|NCT03424044|38279786|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
17137749|NCT03424044|38279787|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
17137750|NCT03424044|38279788|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
17137751|NCT03424044|38279789|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
17137752|NCT03424044|38279790|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
17137753|NCT03424044|38279791|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
17137754|NCT03424044|38279792|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
17137755|NCT03424044|38279793|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
17137756|NCT03424044|38279794|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
17137757|NCT03422250|38279808|FG000|Intervention|Adverse Event|0|||
17137758|NCT03422250|38279809|FG001|Intervention|Adverse Event|1|||
17137759|NCT03422250|38279810|FG002|Intervention|Adverse Event|0|||
17137760|NCT03422250|38279811|FG003|Intervention|Adverse Event|1|||
17137761|NCT03422250|38279808|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
17137762|NCT03422250|38279809|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
17137763|NCT03422250|38279810|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
17137764|NCT03422250|38279811|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
16991831|NCT00730327|38135815|FG001|Overall Study|Lost to Follow-up|16|||
16991832|NCT00730327|38135814|FG000|Overall Study|Adverse Event|8|||
16991833|NCT00730327|38135815|FG001|Overall Study|Adverse Event|1|||
16991834|NCT00730327|38135814|FG000|Overall Study|Withdrawal by Subject|3|||
16991835|NCT00730327|38135815|FG001|Overall Study|Withdrawal by Subject|13|||
16991836|NCT00730327|38135814|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
16991837|NCT00730327|38135815|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
16991838|NCT00742417|38135830|FG000|Randomized|Withdrawal by legal representative|0|||
16991839|NCT00742417|38135831|FG001|Randomized|Withdrawal by legal representative|1|||
16991840|NCT00742417|38135830|FG000|Randomized|Withdrawal by Subject|1|||
16991841|NCT00742417|38135831|FG001|Randomized|Withdrawal by Subject|0|||
16991842|NCT00742417|38135830|FG000|Randomized|Physician Decision|1|||
16991843|NCT00742417|38135831|FG001|Randomized|Physician Decision|0|||
16991844|NCT00742417|38135830|FG000|Intensive Period|Withdrawal by Subject|1|||
16991845|NCT00742417|38135831|FG001|Intensive Period|Withdrawal by Subject|1|||
16991846|NCT00742417|38135830|FG000|Intensive Period|Adverse Event|2|||
16991847|NCT00742417|38135831|FG001|Intensive Period|Adverse Event|0|||
16991848|NCT00811018|38135839|FG000|Overall Study|Additional Chronic Treatment|31|||
16991849|NCT00811018|38135839|FG000|Overall Study|Adverse Event|79|||
16991850|NCT00811018|38135839|FG000|Overall Study|Death|147|||
16991851|NCT00811018|38135839|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
16991852|NCT00811018|38135839|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
16991853|NCT00811018|38135839|FG000|Overall Study|Investigator Decision|57|||
16991854|NCT00811018|38135839|FG000|Overall Study|Lost to Follow-up|19|||
16991855|NCT00811018|38135839|FG000|Overall Study|Pregnancy|6|||
16991856|NCT00811018|38135839|FG000|Overall Study|Sponsor Decision|450|||
16991857|NCT00811018|38135839|FG000|Overall Study|Withdrawal by Subject|70|||
16991858|NCT00811018|38135839|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
16991859|NCT00811018|38135839|FG000|Overall Study|Other|26|||
16991860|NCT00730171|38135848|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
16991861|NCT00730171|38135848|FG000|Overall Study|Adverse Event|193|||
16991862|NCT00730171|38135848|FG000|Overall Study|Protocol Violation|48|||
16991863|NCT00730171|38135848|FG000|Overall Study|Withdrawal by Subject|202|||
16991864|NCT00730171|38135848|FG000|Overall Study|Lost to Follow-up|121|||
16991865|NCT00730171|38135848|FG000|Overall Study|Insufficient Therapeutic Response|141|||
16991866|NCT00730171|38135848|FG000|Overall Study|Other|61|||
16991867|NCT00730015|38135859|FG000|Overall Study|Adverse Event|11|||
16991868|NCT00730015|38135860|FG001|Overall Study|Adverse Event|10|||
16991869|NCT00730015|38135861|FG002|Overall Study|Adverse Event|8|||
16991870|NCT00730015|38135859|FG000|Overall Study|Protocol Violation|2|||
16991871|NCT00730015|38135860|FG001|Overall Study|Protocol Violation|6|||
16991872|NCT00730015|38135861|FG002|Overall Study|Protocol Violation|4|||
16991873|NCT00730015|38135859|FG000|Overall Study|Withdrawal by Subject|12|||
16991874|NCT00730015|38135860|FG001|Overall Study|Withdrawal by Subject|12|||
16991875|NCT00730015|38135861|FG002|Overall Study|Withdrawal by Subject|8|||
16991876|NCT00730015|38135859|FG000|Overall Study|Lost to Follow-up|4|||
16991877|NCT00730015|38135860|FG001|Overall Study|Lost to Follow-up|10|||
16991878|NCT00730015|38135861|FG002|Overall Study|Lost to Follow-up|3|||
16991879|NCT00730015|38135859|FG000|Overall Study|Lack of Efficacy|1|||
16991880|NCT00730015|38135860|FG001|Overall Study|Lack of Efficacy|2|||
16991881|NCT00730015|38135861|FG002|Overall Study|Lack of Efficacy|8|||
17034618|NCT02848092|38178627|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
17034619|NCT02848092|38178626|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
17034620|NCT02848092|38178627|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
17034621|NCT00660309|38178635|FG000|Overall Study|Adverse Event|2|||
17034622|NCT00660309|38178636|FG001|Overall Study|Adverse Event|0|||
17034623|NCT00660309|38178635|FG000|Overall Study|Withdrawal by Subject|0|||
17034624|NCT00660309|38178636|FG001|Overall Study|Withdrawal by Subject|3|||
17034625|NCT00581100|38178645|FG000|Overall Study|Death|1|||
17034626|NCT00581100|38178646|FG001|Overall Study|Death|0|||
17034627|NCT00581100|38178645|FG000|Overall Study|Adverse Event|2|||
17034628|NCT00581100|38178646|FG001|Overall Study|Adverse Event|1|||
17034629|NCT00581100|38178645|FG000|Overall Study|Withdrawal by Subject|1|||
17034630|NCT00581100|38178646|FG001|Overall Study|Withdrawal by Subject|4|||
17034631|NCT00581100|38178645|FG000|Overall Study|Other|3|||
17034632|NCT00581100|38178646|FG001|Overall Study|Other|0|||
17034633|NCT00579098|38178654|FG000|Overall Study|Lost to Follow-up|2|||
17034634|NCT00579098|38178655|FG001|Overall Study|Lost to Follow-up|0|||
17034635|NCT00579098|38178654|FG000|Overall Study|Adverse Event|2|||
17034636|NCT00579098|38178655|FG001|Overall Study|Adverse Event|3|||
17034637|NCT00579098|38178654|FG000|Overall Study|Withdrawal by Subject|2|||
17034638|NCT00579098|38178655|FG001|Overall Study|Withdrawal by Subject|3|||
17034639|NCT00579098|38178654|FG000|Overall Study|AF returned after ablation|3|||
17034640|NCT00579098|38178655|FG001|Overall Study|AF returned after ablation|2|||
17034641|NCT00772109|38178665|FG000|Overall Study|Serious adverse event|1|||
17034642|NCT00772109|38178666|FG001|Overall Study|Serious adverse event|0|||
17034643|NCT00772109|38178667|FG002|Overall Study|Serious adverse event|1|||
17034644|NCT00772109|38178668|FG003|Overall Study|Serious adverse event|0|||
17034645|NCT00772109|38178665|FG000|Overall Study|Protocol Violation|5|||
17034646|NCT00772109|38178666|FG001|Overall Study|Protocol Violation|8|||
17034647|NCT00772109|38178667|FG002|Overall Study|Protocol Violation|7|||
17034648|NCT00772109|38178668|FG003|Overall Study|Protocol Violation|6|||
17034649|NCT00772109|38178665|FG000|Overall Study|Lost to Follow-up|7|||
17034650|NCT00772109|38178666|FG001|Overall Study|Lost to Follow-up|3|||
16780408|NCT02728895|37719526|FG000|Overall Study|Withdrawal by Subject|0|||
16780409|NCT02728895|37719527|FG001|Overall Study|Withdrawal by Subject|3|||
17034651|NCT00772109|38178667|FG002|Overall Study|Lost to Follow-up|5|||
17034652|NCT00772109|38178668|FG003|Overall Study|Lost to Follow-up|9|||
17034653|NCT00772109|38178665|FG000|Overall Study|Withdrawal by Subject|8|||
17034654|NCT00772109|38178666|FG001|Overall Study|Withdrawal by Subject|8|||
17034655|NCT00772109|38178667|FG002|Overall Study|Withdrawal by Subject|6|||
17034656|NCT00772109|38178668|FG003|Overall Study|Withdrawal by Subject|16|||
17034657|NCT00772031|38178680|FG000|Overall Study|Early termination of trial|12|||
17034658|NCT00772031|38178681|FG001|Overall Study|Early termination of trial|10|||
17034659|NCT00772031|38178680|FG000|Overall Study|Lost to Follow-up|20|||
17034660|NCT00772031|38178681|FG001|Overall Study|Lost to Follow-up|33|||
17034661|NCT00580866|38178695|FG000|Overall Study|Lost to Follow-up|2|||
17034662|NCT00580866|38178696|FG001|Overall Study|Lost to Follow-up|2|||
17034663|NCT00771953|38178704|FG000|Overall Study|Adverse Event|5|||
17034664|NCT00771953|38178705|FG001|Overall Study|Adverse Event|3|||
17034665|NCT00771953|38178704|FG000|Overall Study|Death|2|||
17034666|NCT00771953|38178705|FG001|Overall Study|Death|2|||
17034667|NCT00771953|38178704|FG000|Overall Study|Progression before active Tx|1|||
17034668|NCT00771953|38178705|FG001|Overall Study|Progression before active Tx|2|||
17137765|NCT03422250|38279808|FG000|Follow-up|Withdrawal by Subject|0|||
17137766|NCT03422250|38279809|FG001|Follow-up|Withdrawal by Subject|0|||
17137767|NCT03422250|38279810|FG002|Follow-up|Withdrawal by Subject|0|||
17137768|NCT03422250|38279811|FG003|Follow-up|Withdrawal by Subject|1|||
17137769|NCT03422250|38279808|FG000|Follow-up|Adverse Event|0|||
17034669|NCT00771953|38178704|FG000|Overall Study|Sponsor decision|1|||
17034670|NCT00771953|38178705|FG001|Overall Study|Sponsor decision|0|||
17034671|NCT00771953|38178704|FG000|Overall Study|Other complicating disease|1|||
17034672|NCT00771953|38178705|FG001|Overall Study|Other complicating disease|0|||
17034673|NCT00771953|38178704|FG000|Overall Study|Withdrawal by Subject|0|||
17034674|NCT00771953|38178705|FG001|Overall Study|Withdrawal by Subject|3|||
17034675|NCT00621244|38178717|FG000|Overall Study|Withdrawal by Subject|7|||
17034676|NCT00621244|38178718|FG001|Overall Study|Withdrawal by Subject|3|||
17034677|NCT00621244|38178719|FG002|Overall Study|Withdrawal by Subject|3|||
17034678|NCT00621244|38178720|FG003|Overall Study|Withdrawal by Subject|3|||
17034679|NCT00621244|38178717|FG000|Overall Study|Disease progression|44|||
17034680|NCT00621244|38178718|FG001|Overall Study|Disease progression|20|||
17034681|NCT00621244|38178719|FG002|Overall Study|Disease progression|20|||
17034682|NCT00621244|38178720|FG003|Overall Study|Disease progression|15|||
17034683|NCT00621244|38178717|FG000|Overall Study|Death|3|||
17034684|NCT00621244|38178718|FG001|Overall Study|Death|3|||
17034685|NCT00621244|38178719|FG002|Overall Study|Death|1|||
17034686|NCT00621244|38178720|FG003|Overall Study|Death|1|||
17034687|NCT00621244|38178717|FG000|Overall Study|Adverse Event|27|||
17034688|NCT00621244|38178718|FG001|Overall Study|Adverse Event|7|||
17034689|NCT00621244|38178719|FG002|Overall Study|Adverse Event|9|||
17034690|NCT00621244|38178720|FG003|Overall Study|Adverse Event|2|||
17034691|NCT00621244|38178717|FG000|Overall Study|Administrative problems|5|||
17034692|NCT00621244|38178718|FG001|Overall Study|Administrative problems|1|||
17034693|NCT00621244|38178719|FG002|Overall Study|Administrative problems|0|||
17034694|NCT00621244|38178720|FG003|Overall Study|Administrative problems|2|||
17034695|NCT00659529|38178794|FG000|Overall Study|Withdrawal by Subject|4|||
17034696|NCT00659529|38178794|FG000|Overall Study|Protocol Violation|3|||
17034697|NCT00659529|38178794|FG000|Overall Study|Screen failure|9|||
17034698|NCT00578942|38178798|FG000|Overall Study|Lost to Follow-up|1|||
17034699|NCT00765245|38178804|FG000|Overall Study|disease progression|3|||
17034700|NCT00765245|38178805|FG001|Overall Study|disease progression|2|||
17034701|NCT00765245|38178804|FG000|Overall Study|Withdrawal by Subject|3|||
17034702|NCT00765245|38178805|FG001|Overall Study|Withdrawal by Subject|0|||
17034703|NCT00765245|38178804|FG000|Overall Study|Adverse Event|5|||
17034704|NCT00765245|38178805|FG001|Overall Study|Adverse Event|0|||
17034705|NCT00765245|38178804|FG000|Overall Study|Physician Decision|1|||
17034706|NCT00765245|38178805|FG001|Overall Study|Physician Decision|0|||
17034707|NCT00765245|38178804|FG000|Overall Study|Death|1|||
17034708|NCT00765245|38178805|FG001|Overall Study|Death|0|||
17034709|NCT00782795|38178813|FG000|Overall Study|Withdrawal by Subject|1|||
17034710|NCT00782795|38178814|FG001|Overall Study|Withdrawal by Subject|2|||
17034711|NCT00656799|38178820|FG000|Overall Study|Death|2|||
17034712|NCT00764699|38178824|FG000|Overall Study|PI left and study terminated|3|||
17034713|NCT00782717|38178830|FG000|Overall Study|Adverse Event|2|||
17034714|NCT00782717|38178831|FG001|Overall Study|Adverse Event|5|||
17034715|NCT00782717|38178830|FG000|Overall Study|Patient decision unrelated to AE|6|||
17034716|NCT00782717|38178831|FG001|Overall Study|Patient decision unrelated to AE|3|||
17034717|NCT00782717|38178830|FG000|Overall Study|Noncompliance|2|||
17034718|NCT00782717|38178831|FG001|Overall Study|Noncompliance|1|||
17034719|NCT00782717|38178830|FG000|Overall Study|Treatment failure|3|||
17034720|NCT00782717|38178831|FG001|Overall Study|Treatment failure|14|||
17034721|NCT00782717|38178830|FG000|Overall Study|Enrollment close prior to surgery|1|||
17034722|NCT00782717|38178831|FG001|Overall Study|Enrollment close prior to surgery|0|||
17034723|NCT00782717|38178830|FG000|Overall Study|Did not meet entrance criteria|1|||
17034724|NCT00782717|38178831|FG001|Overall Study|Did not meet entrance criteria|3|||
17034725|NCT00782717|38178830|FG000|Overall Study|Exited in error|0|||
17034726|NCT00782717|38178831|FG001|Overall Study|Exited in error|2|||
17034727|NCT00656175|38178839|FG000|Overall Study|Adverse Event|1|||
17034728|NCT00656175|38178840|FG001|Overall Study|Adverse Event|0|||
17137770|NCT03422250|38279809|FG001|Follow-up|Adverse Event|0|||
17034729|NCT00656175|38178839|FG000|Overall Study|Transportation issues|0|||
17034730|NCT00656175|38178840|FG001|Overall Study|Transportation issues|1|||
17034731|NCT00620776|38178848|FG000|Overall Study|Did not receive treatment|3|||
17034732|NCT00620776|38178849|FG001|Overall Study|Did not receive treatment|5|||
17034733|NCT00620776|38178848|FG000|Overall Study|Adverse Event|2|||
16780410|NCT02606877|37719535|FG000|Overall Study|Adverse Event|3|||
16780411|NCT02606877|37719536|FG001|Overall Study|Adverse Event|0|||
16780412|NCT02606877|37719535|FG000|Overall Study|Non-compliance with protocol|0|||
16780413|NCT02606877|37719536|FG001|Overall Study|Non-compliance with protocol|1|||
16780414|NCT02606877|37719535|FG000|Overall Study|Other than listed above|1|||
16780415|NCT02606877|37719536|FG001|Overall Study|Other than listed above|0|||
16780416|NCT02606643|37719546|FG000|Overall Study|did not meet inclusion criteria|1|||
16780417|NCT02606643|37719547|FG001|Overall Study|did not meet inclusion criteria|3|||
16780418|NCT02609607|37719578|FG000|Overall Study|Lost to Follow-up|0|||
16780419|NCT02609607|37719579|FG001|Overall Study|Lost to Follow-up|1|||
16780420|NCT02606253|37719588|FG000|Overall Study|Adverse Event|2|||
16780421|NCT02606253|37719589|FG001|Overall Study|Adverse Event|0|||
16780422|NCT02606253|37719590|FG002|Overall Study|Adverse Event|0|||
17034734|NCT00620776|38178849|FG001|Overall Study|Adverse Event|3|||
17034735|NCT00620776|38178848|FG000|Overall Study|Lack of Efficacy|2|||
17034736|NCT00620776|38178849|FG001|Overall Study|Lack of Efficacy|1|||
17034737|NCT00620776|38178848|FG000|Overall Study|Lost to Follow-up|2|||
17034738|NCT00620776|38178849|FG001|Overall Study|Lost to Follow-up|5|||
17034739|NCT00620776|38178848|FG000|Overall Study|Withdrawal by Subject|3|||
17034740|NCT00620776|38178849|FG001|Overall Study|Withdrawal by Subject|2|||
17034741|NCT00656019|38178859|FG000|Overall Study|Not Eligible|10|||
17034742|NCT00656019|38178860|FG001|Overall Study|Not Eligible|0|||
17034743|NCT00656019|38178861|FG002|Overall Study|Not Eligible|0|||
17034744|NCT00656019|38178862|FG003|Overall Study|Not Eligible|0|||
17034745|NCT00656019|38178859|FG000|Overall Study|Withdrawal by Subject|2|||
17034746|NCT00656019|38178860|FG001|Overall Study|Withdrawal by Subject|0|||
17034747|NCT00656019|38178861|FG002|Overall Study|Withdrawal by Subject|0|||
17034748|NCT00656019|38178862|FG003|Overall Study|Withdrawal by Subject|0|||
17034749|NCT00656019|38178859|FG000|Overall Study|Lost to Follow-up|2|||
17034750|NCT00656019|38178860|FG001|Overall Study|Lost to Follow-up|1|||
17034751|NCT00656019|38178861|FG002|Overall Study|Lost to Follow-up|0|||
17137771|NCT03422250|38279810|FG002|Follow-up|Adverse Event|0|||
17137772|NCT03422250|38279811|FG003|Follow-up|Adverse Event|1|||
17137773|NCT01266031|38279826|FG000|Overall Study|Not treated|0|||
17137774|NCT01266031|38279827|FG001|Overall Study|Not treated|3|||
17137775|NCT01266031|38279828|FG002|Overall Study|Not treated|2|||
17137776|NCT00075725|38279859|FG000|Overall Study|Adverse Event|6|||
17137777|NCT00075725|38279860|FG001|Overall Study|Adverse Event|6|||
17137778|NCT00075725|38279861|FG002|Overall Study|Adverse Event|20|||
17034752|NCT00656019|38178862|FG003|Overall Study|Lost to Follow-up|0|||
17034753|NCT00782483|38178872|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
17034754|NCT00782171|38178878|FG000|Overall Study|Lost to Follow-up|2|||
17034755|NCT00782171|38178879|FG001|Overall Study|Lost to Follow-up|2|||
17034756|NCT00782171|38178878|FG000|Overall Study|Withdrawal by Subject|2|||
17034757|NCT00782171|38178879|FG001|Overall Study|Withdrawal by Subject|1|||
17034758|NCT00782171|38178878|FG000|Overall Study|complications|3|||
17034759|NCT00782171|38178879|FG001|Overall Study|complications|1|||
17034760|NCT00782171|38178878|FG000|Overall Study|others|7|||
17034761|NCT00782171|38178879|FG001|Overall Study|others|9|||
17034762|NCT00782171|38178878|FG000|Overall Study|not eligible|8|||
17034763|NCT00782171|38178879|FG001|Overall Study|not eligible|6|||
17034764|NCT00764465|38178891|FG000|Overall Study|Adverse Event|2|||
17034765|NCT00764465|38178892|FG001|Overall Study|Adverse Event|0|||
17034766|NCT00764465|38178893|FG002|Overall Study|Adverse Event|0|||
17034767|NCT00764465|38178894|FG003|Overall Study|Adverse Event|1|||
17034768|NCT00764465|38178895|FG004|Overall Study|Adverse Event|1|||
17034769|NCT00764465|38178896|FG005|Overall Study|Adverse Event|1|||
17034770|NCT00764465|38178891|FG000|Overall Study|Withdrawal by Subject|0|||
17034771|NCT00764465|38178892|FG001|Overall Study|Withdrawal by Subject|1|||
17034772|NCT00764465|38178893|FG002|Overall Study|Withdrawal by Subject|1|||
17034773|NCT00764465|38178894|FG003|Overall Study|Withdrawal by Subject|0|||
17034774|NCT00764465|38178895|FG004|Overall Study|Withdrawal by Subject|0|||
17034775|NCT00764465|38178896|FG005|Overall Study|Withdrawal by Subject|0|||
17034776|NCT00655863|38178916|FG000|Overall Study|Lost to Follow-up|0|||
17034777|NCT00655863|38178917|FG001|Overall Study|Lost to Follow-up|0|||
17034778|NCT00655863|38178918|FG002|Overall Study|Lost to Follow-up|1|||
17034779|NCT00781937|38178928|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
17034780|NCT00781937|38178929|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
17034781|NCT00781937|38178928|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
17034782|NCT00781937|38178929|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
17034783|NCT00781937|38178928|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
16780423|NCT02606253|37719588|FG000|Overall Study|Protocol Violation|2|||
17137779|NCT00075725|38279862|FG003|Overall Study|Adverse Event|8|||
17034784|NCT00781937|38178929|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
17034785|NCT00781937|38178928|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
17034786|NCT00781937|38178929|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
17034787|NCT00781937|38178928|FG000|Main Trial Period Through Week 56|Unclassified|10|||
17034788|NCT00781937|38178929|FG001|Main Trial Period Through Week 56|Unclassified|15|||
17034789|NCT00781937|38178928|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
17034790|NCT00781937|38178929|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
17034791|NCT00781937|38178928|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
17034792|NCT00781937|38178929|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
17034793|NCT00659373|38178937|FG000|Overall Study|Withdrawal by Subject|3|||
17034794|NCT00659373|38178938|FG001|Overall Study|Withdrawal by Subject|5|||
17034795|NCT00659373|38178937|FG000|Overall Study|Assessment Missed|2|||
17034796|NCT00659373|38178938|FG001|Overall Study|Assessment Missed|2|||
17034797|NCT00439777|38178946|FG000|Treatment Period|Death|29|||
17034798|NCT00439777|38178947|FG001|Treatment Period|Death|21|||
17034799|NCT00439777|38178946|FG000|Treatment Period|Study terminated by sponsor|125|||
17034800|NCT00439777|38178947|FG001|Treatment Period|Study terminated by sponsor|132|||
17034801|NCT00439777|38178946|FG000|Treatment Period|Site closed by investigator|0|||
17034802|NCT00439777|38178947|FG001|Treatment Period|Site closed by investigator|1|||
17034803|NCT00439777|38178946|FG000|Treatment Period|Did not take study treatment|7|||
17034804|NCT00439777|38178947|FG001|Treatment Period|Did not take study treatment|8|||
17034805|NCT00439777|38178946|FG000|Treatment Period|Adverse Event|111|||
17034806|NCT00439777|38178947|FG001|Treatment Period|Adverse Event|92|||
17034807|NCT00439777|38178946|FG000|Treatment Period|Protocol Violation|23|||
17034808|NCT00439777|38178947|FG001|Treatment Period|Protocol Violation|30|||
17034809|NCT00439777|38178946|FG000|Treatment Period|Withdrawal by Subject|66|||
17034810|NCT00439777|38178947|FG001|Treatment Period|Withdrawal by Subject|118|||
17034811|NCT00439777|38178946|FG000|Treatment Period|Lack of Efficacy|1|||
17034812|NCT00439777|38178947|FG001|Treatment Period|Lack of Efficacy|4|||
17034813|NCT00439777|38178946|FG000|Treatment Period|Lost to Follow-up|8|||
17034814|NCT00439777|38178947|FG001|Treatment Period|Lost to Follow-up|10|||
17034815|NCT00439777|38178946|FG000|Treatment Period|Protocol driven decision point|1|||
17034816|NCT00439777|38178947|FG001|Treatment Period|Protocol driven decision point|3|||
17034817|NCT00439777|38178946|FG000|Treatment Period|Physician Decision|7|||
17034818|NCT00439777|38178947|FG001|Treatment Period|Physician Decision|18|||
17034819|NCT00439777|38178946|FG000|Treatment Period|Clinical endpoint reached|26|||
17034820|NCT00439777|38178947|FG001|Treatment Period|Clinical endpoint reached|13|||
17034821|NCT00439777|38178946|FG000|Treatment Period|Technical problems|3|||
17034822|NCT00439777|38178947|FG001|Treatment Period|Technical problems|1|||
17034823|NCT00439777|38178946|FG000|Treatment Period|Participant convenience|12|||
17034824|NCT00439777|38178947|FG001|Treatment Period|Participant convenience|8|||
17034825|NCT00439777|38178946|FG000|Observational Period|Protocol Violation|0|||
17034826|NCT00439777|38178947|FG001|Observational Period|Protocol Violation|2|||
17034827|NCT00439777|38178946|FG000|Observational Period|Withdrawal by Subject|9|||
17034828|NCT00439777|38178947|FG001|Observational Period|Withdrawal by Subject|5|||
17034829|NCT00439777|38178946|FG000|Observational Period|Lost to Follow-up|1|||
17034830|NCT00439777|38178947|FG001|Observational Period|Lost to Follow-up|11|||
17137780|NCT00075725|38279863|FG004|Overall Study|Adverse Event|4|||
17137781|NCT00075725|38279864|FG005|Overall Study|Adverse Event|38|||
17137782|NCT00075725|38279865|FG006|Overall Study|Adverse Event|3|||
17137783|NCT00075725|38279866|FG007|Overall Study|Adverse Event|51|||
17137784|NCT00075725|38279867|FG008|Overall Study|Adverse Event|15|||
17137785|NCT00075725|38279868|FG009|Overall Study|Adverse Event|4|||
17034831|NCT00439777|38178946|FG000|Observational Period|Death|27|||
17034832|NCT00439777|38178947|FG001|Observational Period|Death|20|||
17034833|NCT00439777|38178946|FG000|Observational Period|Study terminated by sponsor|3|||
17034834|NCT00439777|38178947|FG001|Observational Period|Study terminated by sponsor|1|||
17034835|NCT00439777|38178946|FG000|Observational Period|Protocol driven decision point|0|||
17034836|NCT00439777|38178947|FG001|Observational Period|Protocol driven decision point|1|||
17034837|NCT00439777|38178946|FG000|Observational Period|Lack of Efficacy|1|||
17034838|NCT00439777|38178947|FG001|Observational Period|Lack of Efficacy|0|||
17034839|NCT00439777|38178946|FG000|Observational Period|Technical problems|0|||
17034840|NCT00439777|38178947|FG001|Observational Period|Technical problems|1|||
17034841|NCT00620854|38178959|FG000|Washout 1|Withdrawal by Subject|0|||
17034842|NCT00620854|38178960|FG001|Washout 1|Withdrawal by Subject|0|||
17034843|NCT00620854|38178961|FG002|Washout 1|Withdrawal by Subject|1|||
17034844|NCT00620854|38178962|FG003|Washout 1|Withdrawal by Subject|1|||
17034845|NCT00620854|38178963|FG004|Washout 1|Withdrawal by Subject|0|||
17034846|NCT00620854|38178964|FG005|Washout 1|Withdrawal by Subject|0|||
17034847|NCT00430027|38178975|FG000|Overall Study|Study terminated|8|||
17137786|NCT00075725|38279869|FG010|Overall Study|Adverse Event|2|||
17034848|NCT00792948|38178979|FG000|Overall Study|Adverse Event|6|||
17034849|NCT00792948|38178979|FG000|Overall Study|Death|4|||
17034850|NCT00792948|38178979|FG000|Overall Study|Withdrawal by Subject|3|||
17034851|NCT00792948|38178979|FG000|Overall Study|Ineligible|2|||
17034852|NCT00792948|38178979|FG000|Overall Study|Insurance denial - not treated|1|||
17034853|NCT00792948|38178979|FG000|Overall Study|Physician Decision|11|||
17034854|NCT00792948|38178979|FG000|Overall Study|Protocol Violation|1|||
17034855|NCT00429793|38178986|FG000|Overall Study|Improper pre-protocol treatment|3|||
17034856|NCT00429793|38178986|FG000|Overall Study|Required test not done|1|||
17034857|NCT00429793|38178986|FG000|Overall Study|Never treated|1|||
17034858|NCT00429793|38178986|FG000|Overall Study|Non-measurable|1|||
17034859|NCT00424645|38178997|FG000|Overall Study|Death|1|||
17034860|NCT00424645|38178998|FG001|Overall Study|Death|0|||
17034861|NCT00763451|38179008|FG000|Overall Study|Adverse Event|4|||
17034862|NCT00763451|38179009|FG001|Overall Study|Adverse Event|6|||
17034863|NCT00763451|38179010|FG002|Overall Study|Adverse Event|19|||
17034864|NCT00763451|38179011|FG003|Overall Study|Adverse Event|14|||
17034865|NCT00763451|38179008|FG000|Overall Study|Lack of Efficacy|1|||
17034866|NCT00763451|38179009|FG001|Overall Study|Lack of Efficacy|4|||
17034867|NCT00763451|38179010|FG002|Overall Study|Lack of Efficacy|3|||
17034868|NCT00763451|38179011|FG003|Overall Study|Lack of Efficacy|2|||
17034869|NCT00763451|38179008|FG000|Overall Study|Withdrawal by Subject|1|||
17034870|NCT00763451|38179009|FG001|Overall Study|Withdrawal by Subject|6|||
17034871|NCT00763451|38179010|FG002|Overall Study|Withdrawal by Subject|9|||
17034872|NCT00763451|38179011|FG003|Overall Study|Withdrawal by Subject|7|||
17034873|NCT00763451|38179008|FG000|Overall Study|Protocol Violation|0|||
17034874|NCT00763451|38179009|FG001|Overall Study|Protocol Violation|0|||
17034875|NCT00763451|38179010|FG002|Overall Study|Protocol Violation|1|||
17034876|NCT00763451|38179011|FG003|Overall Study|Protocol Violation|0|||
17034877|NCT00763451|38179008|FG000|Overall Study|Poor Compliance to Protocol|1|||
17034878|NCT00763451|38179009|FG001|Overall Study|Poor Compliance to Protocol|1|||
17034879|NCT00763451|38179010|FG002|Overall Study|Poor Compliance to Protocol|2|||
17034880|NCT00763451|38179011|FG003|Overall Study|Poor Compliance to Protocol|2|||
17034881|NCT00763451|38179008|FG000|Overall Study|Familial and Personal Reasons|5|||
17034882|NCT00763451|38179009|FG001|Overall Study|Familial and Personal Reasons|3|||
17034883|NCT00763451|38179010|FG002|Overall Study|Familial and Personal Reasons|5|||
17034884|NCT00763451|38179011|FG003|Overall Study|Familial and Personal Reasons|4|||
17034885|NCT00763451|38179008|FG000|Overall Study|Randomized but not Treated|1|||
17034886|NCT00763451|38179009|FG001|Overall Study|Randomized but not Treated|1|||
17034887|NCT00763451|38179010|FG002|Overall Study|Randomized but not Treated|0|||
17034888|NCT00763451|38179011|FG003|Overall Study|Randomized but not Treated|0|||
17034889|NCT00763451|38179008|FG000|Overall Study|Study Site Reason|0|||
17034890|NCT00763451|38179009|FG001|Overall Study|Study Site Reason|1|||
17034891|NCT00763451|38179010|FG002|Overall Study|Study Site Reason|1|||
17034892|NCT00763451|38179011|FG003|Overall Study|Study Site Reason|1|||
17034893|NCT00762762|38179024|FG000|Overall Study|Did not return for appointments|6|||
17034894|NCT00762762|38179025|FG001|Overall Study|Did not return for appointments|8|||
17034895|NCT00424489|38179033|FG000|Overall Study|Death|3|||
17034896|NCT00578864|38179039|FG000|Overall Study|Death|1|||
17034897|NCT00578864|38179040|FG001|Overall Study|Death|0|||
17034898|NCT00770315|38179063|FG000|Overall Study|Adverse Event|11|||
17034899|NCT00770315|38179064|FG001|Overall Study|Adverse Event|17|||
17034900|NCT00770315|38179065|FG002|Overall Study|Adverse Event|16|||
17034901|NCT00770315|38179066|FG003|Overall Study|Adverse Event|6|||
17034902|NCT00770315|38179063|FG000|Overall Study|Lost to Follow-up|9|||
17034903|NCT00770315|38179064|FG001|Overall Study|Lost to Follow-up|5|||
17034904|NCT00770315|38179065|FG002|Overall Study|Lost to Follow-up|10|||
17034905|NCT00770315|38179066|FG003|Overall Study|Lost to Follow-up|3|||
17034906|NCT00770315|38179063|FG000|Overall Study|Withdrawal by Subject|13|||
17034907|NCT00770315|38179064|FG001|Overall Study|Withdrawal by Subject|17|||
17034908|NCT00770315|38179065|FG002|Overall Study|Withdrawal by Subject|24|||
17034909|NCT00770315|38179066|FG003|Overall Study|Withdrawal by Subject|20|||
17034910|NCT00770315|38179063|FG000|Overall Study|Noncompliance with Protocol|7|||
17034911|NCT00770315|38179064|FG001|Overall Study|Noncompliance with Protocol|4|||
17034912|NCT00770315|38179065|FG002|Overall Study|Noncompliance with Protocol|7|||
17034913|NCT00770315|38179066|FG003|Overall Study|Noncompliance with Protocol|9|||
17034914|NCT00587171|38179078|FG000|Overall Study|Lost to Follow-up|1|||
17034915|NCT00587171|38179079|FG001|Overall Study|Lost to Follow-up|1|||
17034916|NCT00763139|38179085|FG000|Overall Study|Adverse Event|4|||
17034917|NCT00763139|38179086|FG001|Overall Study|Adverse Event|2|||
17034918|NCT00763139|38179085|FG000|Overall Study|Withdrawal by Subject|0|||
17034919|NCT00763139|38179086|FG001|Overall Study|Withdrawal by Subject|1|||
17034920|NCT00763139|38179085|FG000|Overall Study|med change not allowed by protocol|1|||
17034921|NCT00763139|38179086|FG001|Overall Study|med change not allowed by protocol|0|||
17034922|NCT01366092|38179097|FG000|Overall Study|Progressive cGVHD|2|||
17034923|NCT01366092|38179097|FG000|Overall Study|Physician Decision|1|||
17034924|NCT01366092|38179097|FG000|Overall Study|Withdrawal by Subject|1|||
17034925|NCT00781859|38179103|FG000|Overall Study|Adverse Event|2|||
17034926|NCT00781859|38179104|FG001|Overall Study|Adverse Event|2|||
17034927|NCT00781859|38179103|FG000|Overall Study|Withdrawal by Subject|8|||
17034928|NCT00781859|38179104|FG001|Overall Study|Withdrawal by Subject|4|||
17034929|NCT00781859|38179103|FG000|Overall Study|Lost to Follow-up|6|||
17034930|NCT00781859|38179104|FG001|Overall Study|Lost to Follow-up|3|||
17034931|NCT00781859|38179103|FG000|Overall Study|Death|3|||
17034932|NCT00781859|38179104|FG001|Overall Study|Death|0|||
17034933|NCT00580788|38179114|FG000|Overall Study|Adverse Event|0|||
17034934|NCT00580788|38179115|FG001|Overall Study|Adverse Event|0|||
17034935|NCT00580788|38179116|FG002|Overall Study|Adverse Event|0|||
17034936|NCT00580788|38179117|FG003|Overall Study|Adverse Event|1|||
17034937|NCT00417079|38179136|FG000|Overall Study|Disease progression|267|||
17034938|NCT00417079|38179137|FG001|Overall Study|Disease progression|180|||
17034939|NCT00417079|38179136|FG000|Overall Study|Adverse Event|32|||
17034940|NCT00417079|38179137|FG001|Overall Study|Adverse Event|67|||
17034941|NCT00417079|38179136|FG000|Overall Study|Non-compliance to protocol|0|||
17034942|NCT00417079|38179137|FG001|Overall Study|Non-compliance to protocol|1|||
17034943|NCT00417079|38179136|FG000|Overall Study|Lost to Follow-up|2|||
17034944|NCT00417079|38179137|FG001|Overall Study|Lost to Follow-up|0|||
17034945|NCT00417079|38179136|FG000|Overall Study|Withdrawal by Subject|17|||
17034946|NCT00417079|38179137|FG001|Overall Study|Withdrawal by Subject|8|||
17034947|NCT00417079|38179136|FG000|Overall Study|Not treated|6|||
17034948|NCT00417079|38179137|FG001|Overall Study|Not treated|7|||
17034949|NCT00417079|38179136|FG000|Overall Study|Screened failure|2|||
17034950|NCT00417079|38179137|FG001|Overall Study|Screened failure|1|||
17034951|NCT00417079|38179136|FG000|Overall Study|Investigator's decision|1|||
17034952|NCT00417079|38179137|FG001|Overall Study|Investigator's decision|4|||
17034953|NCT00417079|38179136|FG000|Overall Study|Non-confirmed Disease progression|1|||
17034954|NCT00417079|38179137|FG001|Overall Study|Non-confirmed Disease progression|1|||
17034955|NCT00417079|38179136|FG000|Overall Study|Clinical deterioration|1|||
17034956|NCT00417079|38179137|FG001|Overall Study|Clinical deterioration|0|||
17034957|NCT00417079|38179136|FG000|Overall Study|Screening error|2|||
17034958|NCT00417079|38179137|FG001|Overall Study|Screening error|1|||
17034959|NCT00417079|38179136|FG000|Overall Study|Withdrawal by subject's family|0|||
17034960|NCT00417079|38179137|FG001|Overall Study|Withdrawal by subject's family|1|||
17034961|NCT00417079|38179136|FG000|Overall Study|Patient unable to come to the clinic|0|||
17034962|NCT00417079|38179137|FG001|Overall Study|Patient unable to come to the clinic|1|||
17034963|NCT00417079|38179136|FG000|Overall Study|abnormal liver function tests|0|||
17034964|NCT00417079|38179137|FG001|Overall Study|abnormal liver function tests|1|||
17034965|NCT00429169|38179145|FG000|Overall Study|Lost to Follow-up|0|||
17034966|NCT00429169|38179146|FG001|Overall Study|Lost to Follow-up|1|||
17034967|NCT00429169|38179145|FG000|Overall Study|Ineligibility discovered after entry|2|||
17034968|NCT00429169|38179146|FG001|Overall Study|Ineligibility discovered after entry|1|||
17034969|NCT00416455|38179156|FG000|Overall Study|PET / CT not done|3|||
17034970|NCT00416455|38179157|FG001|Overall Study|PET / CT not done|5|||
17034971|NCT00416455|38179156|FG000|Overall Study|PET / CT poor quality|2|||
17034972|NCT00416455|38179157|FG001|Overall Study|PET / CT poor quality|1|||
17034973|NCT00416455|38179156|FG000|Overall Study|Inadequate pathology|11|||
17034974|NCT00416455|38179157|FG001|Overall Study|Inadequate pathology|2|||
17034975|NCT00415909|38179174|FG000|Overall Study|Withdrawal by Subject|2|||
17034976|NCT00415909|38179174|FG000|Overall Study|Death|1|||
17034977|NCT00415597|38179178|FG000|Enrollment|Withdrawal by Subject|1|||
17034978|NCT00415597|38179178|FG000|Enrollment|Protocol Violation|1|||
17034979|NCT00415597|38179178|FG000|Treatment|Adverse Event|110|||
17034980|NCT00415597|38179178|FG000|Treatment|Lack of Efficacy|39|||
17034981|NCT00415597|38179178|FG000|Treatment|Protocol Violation|67|||
17034982|NCT00415597|38179178|FG000|Treatment|Physician Decision|3|||
17034983|NCT00415597|38179178|FG000|Treatment|Withdrawal by Subject|51|||
17034984|NCT00415597|38179178|FG000|Treatment|Lost to Follow-up|28|||
17034985|NCT00415597|38179178|FG000|Treatment|Drug Screen|2|||
17034986|NCT00415597|38179178|FG000|Treatment|Administrative|3|||
17034987|NCT00415597|38179178|FG000|Treatment|Sponsor Decision|1|||
17034988|NCT00415597|38179178|FG000|Treatment|Multiple Reasons|1|||
17034989|NCT00620542|38179184|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
17034990|NCT00620542|38179185|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
17034991|NCT00620542|38179186|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
17034992|NCT00620542|38179187|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
17034993|NCT00620542|38179184|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
17034994|NCT00620542|38179185|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
17034995|NCT00620542|38179186|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
17034996|NCT00620542|38179187|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
17034997|NCT00620542|38179184|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
17034998|NCT00620542|38179185|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
17034999|NCT00620542|38179186|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
17035000|NCT00620542|38179187|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
17035001|NCT00620542|38179184|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
17035002|NCT00620542|38179185|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
17035003|NCT00620542|38179186|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
17035004|NCT00620542|38179187|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
17035005|NCT00620542|38179184|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
17035006|NCT00620542|38179185|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
17035007|NCT00620542|38179186|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
17035008|NCT00620542|38179187|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
17035009|NCT00620542|38179184|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
17035010|NCT00620542|38179185|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
17035011|NCT00620542|38179186|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
17035012|NCT00620542|38179187|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
17035013|NCT00620542|38179184|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
17035014|NCT00620542|38179185|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
17035015|NCT00620542|38179186|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
17035016|NCT00620542|38179187|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
17035017|NCT00620542|38179184|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
17035018|NCT00620542|38179185|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
17035019|NCT00620542|38179186|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
17035020|NCT00620542|38179187|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
17035021|NCT00620542|38179184|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
17137787|NCT00075725|38279870|FG011|Overall Study|Adverse Event|2|||
17137788|NCT00075725|38279859|FG000|Overall Study|Death|3|||
17137789|NCT00075725|38279860|FG001|Overall Study|Death|5|||
17137790|NCT00075725|38279861|FG002|Overall Study|Death|10|||
17137791|NCT00075725|38279862|FG003|Overall Study|Death|2|||
17137792|NCT00075725|38279863|FG004|Overall Study|Death|3|||
17137793|NCT00075725|38279864|FG005|Overall Study|Death|25|||
17137794|NCT00075725|38279865|FG006|Overall Study|Death|4|||
17137795|NCT00075725|38279866|FG007|Overall Study|Death|22|||
17137796|NCT00075725|38279867|FG008|Overall Study|Death|14|||
17137797|NCT00075725|38279868|FG009|Overall Study|Death|4|||
17137798|NCT00075725|38279869|FG010|Overall Study|Death|3|||
17137799|NCT00075725|38279870|FG011|Overall Study|Death|0|||
17137800|NCT00075725|38279859|FG000|Overall Study|Lost to Follow-up|1|||
17137801|NCT00075725|38279860|FG001|Overall Study|Lost to Follow-up|1|||
17137802|NCT00075725|38279861|FG002|Overall Study|Lost to Follow-up|4|||
17137803|NCT00075725|38279862|FG003|Overall Study|Lost to Follow-up|1|||
17137804|NCT00075725|38279863|FG004|Overall Study|Lost to Follow-up|0|||
17137805|NCT00075725|38279864|FG005|Overall Study|Lost to Follow-up|13|||
17137806|NCT00075725|38279865|FG006|Overall Study|Lost to Follow-up|2|||
17137807|NCT00075725|38279866|FG007|Overall Study|Lost to Follow-up|4|||
17137808|NCT00075725|38279867|FG008|Overall Study|Lost to Follow-up|1|||
17137809|NCT00075725|38279868|FG009|Overall Study|Lost to Follow-up|0|||
17137810|NCT00075725|38279869|FG010|Overall Study|Lost to Follow-up|0|||
17137811|NCT00075725|38279870|FG011|Overall Study|Lost to Follow-up|0|||
17137812|NCT00075725|38279859|FG000|Overall Study|Physician Decision|2|||
17137813|NCT00075725|38279860|FG001|Overall Study|Physician Decision|6|||
17137814|NCT00075725|38279861|FG002|Overall Study|Physician Decision|5|||
17137815|NCT00075725|38279862|FG003|Overall Study|Physician Decision|8|||
17137816|NCT00075725|38279863|FG004|Overall Study|Physician Decision|4|||
17137817|NCT00075725|38279864|FG005|Overall Study|Physician Decision|19|||
17137818|NCT00075725|38279865|FG006|Overall Study|Physician Decision|3|||
17137819|NCT00075725|38279866|FG007|Overall Study|Physician Decision|17|||
17137820|NCT00075725|38279867|FG008|Overall Study|Physician Decision|5|||
17137821|NCT00075725|38279868|FG009|Overall Study|Physician Decision|0|||
17137822|NCT00075725|38279869|FG010|Overall Study|Physician Decision|1|||
17137823|NCT00075725|38279870|FG011|Overall Study|Physician Decision|0|||
17137824|NCT00075725|38279859|FG000|Overall Study|Pregnancy|0|||
17137825|NCT00075725|38279860|FG001|Overall Study|Pregnancy|0|||
17137826|NCT00075725|38279861|FG002|Overall Study|Pregnancy|0|||
17137827|NCT00075725|38279862|FG003|Overall Study|Pregnancy|0|||
17137828|NCT00075725|38279863|FG004|Overall Study|Pregnancy|0|||
17137829|NCT00075725|38279864|FG005|Overall Study|Pregnancy|1|||
17137830|NCT00075725|38279865|FG006|Overall Study|Pregnancy|0|||
17035022|NCT00620542|38179185|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
17035023|NCT00620542|38179186|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
17137831|NCT00075725|38279866|FG007|Overall Study|Pregnancy|1|||
17137832|NCT00075725|38279867|FG008|Overall Study|Pregnancy|0|||
17137833|NCT00075725|38279868|FG009|Overall Study|Pregnancy|0|||
17137834|NCT00075725|38279869|FG010|Overall Study|Pregnancy|0|||
17137835|NCT00075725|38279870|FG011|Overall Study|Pregnancy|0|||
17137836|NCT00075725|38279859|FG000|Overall Study|Protocol Violation|1|||
17035024|NCT00620542|38179187|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
17035025|NCT00620542|38179184|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
17035026|NCT00620542|38179185|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
17035027|NCT00620542|38179186|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
17035028|NCT00620542|38179187|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
17035029|NCT00620542|38179184|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
17035030|NCT00620542|38179185|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
17035031|NCT00620542|38179186|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
17035032|NCT00620542|38179187|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
17035033|NCT00620542|38179184|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
17035034|NCT00620542|38179185|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
17035035|NCT00620542|38179186|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
17035036|NCT00620542|38179187|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
17035037|NCT00620542|38179184|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
17035038|NCT00620542|38179185|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
17035039|NCT00620542|38179186|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
17035040|NCT00620542|38179187|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
17035041|NCT00620542|38179184|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
17035042|NCT00620542|38179185|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
17035043|NCT00620542|38179186|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
17035044|NCT00620542|38179187|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
17035045|NCT00620542|38179184|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
17035046|NCT00620542|38179185|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
17035047|NCT00620542|38179186|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
17035048|NCT00620542|38179187|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
17035049|NCT00618982|38179195|FG000|Overall Study|Adverse Event|23|||
17035050|NCT00618982|38179195|FG000|Overall Study|Withdrawal by Subject|1|||
17035051|NCT00618982|38179195|FG000|Overall Study|Protocol Violation|1|||
17035052|NCT00618982|38179195|FG000|Overall Study|ongoing, still treated with study med.|25|||
17035053|NCT00578786|38179205|FG000|Overall Study|Adverse Event|27|||
17035054|NCT00578786|38179206|FG001|Overall Study|Adverse Event|37|||
17035055|NCT00578786|38179207|FG002|Overall Study|Adverse Event|17|||
17035056|NCT00578786|38179205|FG000|Overall Study|Lack of Efficacy|2|||
17035057|NCT00578786|38179206|FG001|Overall Study|Lack of Efficacy|5|||
17035058|NCT00578786|38179207|FG002|Overall Study|Lack of Efficacy|2|||
17035059|NCT00578786|38179205|FG000|Overall Study|Early Escape from Prior Study|2|||
17035060|NCT00578786|38179206|FG001|Overall Study|Early Escape from Prior Study|1|||
17035061|NCT00578786|38179207|FG002|Overall Study|Early Escape from Prior Study|2|||
17035062|NCT00578786|38179205|FG000|Overall Study|Withdrawal by Subject|7|||
17035063|NCT00578786|38179206|FG001|Overall Study|Withdrawal by Subject|8|||
17035064|NCT00578786|38179207|FG002|Overall Study|Withdrawal by Subject|5|||
17035065|NCT00578786|38179205|FG000|Overall Study|Protocol Violation|0|||
17035066|NCT00578786|38179206|FG001|Overall Study|Protocol Violation|3|||
17035067|NCT00578786|38179207|FG002|Overall Study|Protocol Violation|1|||
17035068|NCT00578786|38179205|FG000|Overall Study|Physician Decision|1|||
17035069|NCT00578786|38179206|FG001|Overall Study|Physician Decision|0|||
17035070|NCT00578786|38179207|FG002|Overall Study|Physician Decision|1|||
17035071|NCT00578786|38179205|FG000|Overall Study|Sponsor Decision|0|||
17035072|NCT00578786|38179206|FG001|Overall Study|Sponsor Decision|0|||
17035073|NCT00578786|38179207|FG002|Overall Study|Sponsor Decision|1|||
17035074|NCT00578786|38179205|FG000|Overall Study|Lost to Follow-up|0|||
17035075|NCT00578786|38179206|FG001|Overall Study|Lost to Follow-up|4|||
17035076|NCT00578786|38179207|FG002|Overall Study|Lost to Follow-up|0|||
17035077|NCT00578786|38179205|FG000|Overall Study|Pregnancy|0|||
17035078|NCT00578786|38179206|FG001|Overall Study|Pregnancy|1|||
17035079|NCT00578786|38179207|FG002|Overall Study|Pregnancy|0|||
17035080|NCT00578786|38179205|FG000|Overall Study|Not Otherwise Specified|0|||
17035081|NCT00578786|38179206|FG001|Overall Study|Not Otherwise Specified|4|||
17035082|NCT00578786|38179207|FG002|Overall Study|Not Otherwise Specified|1|||
17035083|NCT00578786|38179205|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
17035084|NCT00578786|38179206|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
17035085|NCT00578786|38179207|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
17035086|NCT00424255|38179227|FG000|Overall Study|Death|115|||
17035087|NCT00424255|38179228|FG001|Overall Study|Death|111|||
17035088|NCT00424255|38179227|FG000|Overall Study|Lost to Follow-up|26|||
17035089|NCT00424255|38179228|FG001|Overall Study|Lost to Follow-up|20|||
17035090|NCT00424255|38179227|FG000|Overall Study|Protocol Violation|0|||
17035091|NCT00424255|38179228|FG001|Overall Study|Protocol Violation|1|||
17035092|NCT00424255|38179227|FG000|Overall Study|Withdrawal by Subject|34|||
17035093|NCT00424255|38179228|FG001|Overall Study|Withdrawal by Subject|38|||
17035094|NCT00424255|38179227|FG000|Overall Study|Physician Decision|3|||
17035095|NCT00424255|38179228|FG001|Overall Study|Physician Decision|7|||
17035096|NCT00424255|38179227|FG000|Overall Study|Cognitive Disturbance|1|||
17035097|NCT00424255|38179228|FG001|Overall Study|Cognitive Disturbance|0|||
17137837|NCT00075725|38279860|FG001|Overall Study|Protocol Violation|1|||
17035098|NCT00424255|38179227|FG000|Overall Study|Non-compliance by Participants|1|||
17035099|NCT00424255|38179228|FG001|Overall Study|Non-compliance by Participants|0|||
17035100|NCT00424255|38179227|FG000|Overall Study|Fatigue|1|||
17035101|NCT00424255|38179228|FG001|Overall Study|Fatigue|0|||
17035102|NCT00424255|38179227|FG000|Overall Study|Disease Progression|0|||
17035103|NCT00424255|38179228|FG001|Overall Study|Disease Progression|2|||
17035104|NCT00424255|38179227|FG000|Overall Study|Sponsor Terminated Study|161|||
17035105|NCT00424255|38179228|FG001|Overall Study|Sponsor Terminated Study|167|||
17035106|NCT00620074|38179234|FG000|Overall Study|Adverse Event|1|||
17035107|NCT00424177|38179238|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
17035108|NCT00424177|38179238|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
17035109|NCT00424177|38179238|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
17035110|NCT00424177|38179238|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
17035111|NCT00424177|38179238|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
17035112|NCT00424177|38179238|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
17035113|NCT00424177|38179238|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
17035114|NCT00424177|38179238|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
17035115|NCT00424177|38179238|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
17035116|NCT00424177|38179238|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
17035117|NCT00618826|38179250|FG000|Overall Study|Adverse Event|1|||
17137838|NCT00075725|38279861|FG002|Overall Study|Protocol Violation|0|||
17137839|NCT00075725|38279862|FG003|Overall Study|Protocol Violation|3|||
17137840|NCT00075725|38279863|FG004|Overall Study|Protocol Violation|3|||
17137841|NCT00075725|38279864|FG005|Overall Study|Protocol Violation|2|||
17137842|NCT00075725|38279865|FG006|Overall Study|Protocol Violation|1|||
17137843|NCT00075725|38279866|FG007|Overall Study|Protocol Violation|2|||
17137844|NCT00075725|38279867|FG008|Overall Study|Protocol Violation|3|||
17137845|NCT00075725|38279868|FG009|Overall Study|Protocol Violation|0|||
17137846|NCT00075725|38279869|FG010|Overall Study|Protocol Violation|0|||
17137847|NCT00075725|38279870|FG011|Overall Study|Protocol Violation|1|||
17137848|NCT00075725|38279859|FG000|Overall Study|Withdrawal by Subject|12|||
17137849|NCT00075725|38279860|FG001|Overall Study|Withdrawal by Subject|3|||
17137850|NCT00075725|38279861|FG002|Overall Study|Withdrawal by Subject|6|||
17137851|NCT00075725|38279862|FG003|Overall Study|Withdrawal by Subject|10|||
17137852|NCT00075725|38279863|FG004|Overall Study|Withdrawal by Subject|6|||
17035118|NCT00578448|38179255|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
17035119|NCT00578448|38179255|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
17035120|NCT00578448|38179255|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
17035121|NCT00578448|38179255|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
17035122|NCT00578318|38179263|FG000|Overall Study|Lost to Follow-up|2|||
17035123|NCT00578318|38179264|FG001|Overall Study|Lost to Follow-up|0|||
17035124|NCT00578318|38179263|FG000|Overall Study|Physician Decision|1|||
17035125|NCT00578318|38179264|FG001|Overall Study|Physician Decision|0|||
17035126|NCT00618748|38179273|FG000|Overall Study|Adverse Event|4|||
17035127|NCT00618748|38179274|FG001|Overall Study|Adverse Event|3|||
17035128|NCT00618748|38179275|FG002|Overall Study|Adverse Event|8|||
17035129|NCT00618748|38179273|FG000|Overall Study|Physician Decision|3|||
17137853|NCT00075725|38279864|FG005|Overall Study|Withdrawal by Subject|27|||
17137854|NCT00075725|38279865|FG006|Overall Study|Withdrawal by Subject|7|||
17137855|NCT00075725|38279866|FG007|Overall Study|Withdrawal by Subject|31|||
17137856|NCT00075725|38279867|FG008|Overall Study|Withdrawal by Subject|10|||
17137857|NCT00075725|38279868|FG009|Overall Study|Withdrawal by Subject|2|||
17137858|NCT00075725|38279869|FG010|Overall Study|Withdrawal by Subject|0|||
17035130|NCT00618748|38179274|FG001|Overall Study|Physician Decision|1|||
17035131|NCT00618748|38179275|FG002|Overall Study|Physician Decision|1|||
17035132|NCT00618748|38179273|FG000|Overall Study|Withdrawal by Subject|4|||
17035133|NCT00618748|38179274|FG001|Overall Study|Withdrawal by Subject|1|||
17035134|NCT00618748|38179275|FG002|Overall Study|Withdrawal by Subject|5|||
17035135|NCT00658359|38179286|FG000|Overall Study|Death|3|||
17035136|NCT00658359|38179287|FG001|Overall Study|Death|1|||
17035137|NCT00658359|38179288|FG002|Overall Study|Death|2|||
17035138|NCT00658359|38179286|FG000|Overall Study|Adverse Event|13|||
17035139|NCT00658359|38179287|FG001|Overall Study|Adverse Event|6|||
17035140|NCT00658359|38179288|FG002|Overall Study|Adverse Event|9|||
17035141|NCT00658359|38179286|FG000|Overall Study|Protocol Violation|1|||
17035142|NCT00658359|38179287|FG001|Overall Study|Protocol Violation|0|||
17035143|NCT00658359|38179288|FG002|Overall Study|Protocol Violation|0|||
17035144|NCT00658359|38179286|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
17035145|NCT00658359|38179287|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
17035146|NCT00658359|38179288|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
17137859|NCT00075725|38279870|FG011|Overall Study|Withdrawal by Subject|0|||
17137860|NCT00075725|38279859|FG000|Overall Study|Disease Progression, all other reasons|17|||
17137861|NCT00075725|38279860|FG001|Overall Study|Disease Progression, all other reasons|5|||
17137862|NCT00075725|38279861|FG002|Overall Study|Disease Progression, all other reasons|33|||
17137863|NCT00075725|38279862|FG003|Overall Study|Disease Progression, all other reasons|6|||
17035147|NCT00658359|38179286|FG000|Overall Study|Withdrawal by Subject|7|||
17035148|NCT00658359|38179287|FG001|Overall Study|Withdrawal by Subject|4|||
17035149|NCT00658359|38179288|FG002|Overall Study|Withdrawal by Subject|2|||
17035150|NCT00658359|38179286|FG000|Overall Study|Lost to Follow-up|2|||
17035151|NCT00658359|38179287|FG001|Overall Study|Lost to Follow-up|2|||
17035152|NCT00658359|38179288|FG002|Overall Study|Lost to Follow-up|4|||
17035153|NCT00658359|38179286|FG000|Overall Study|Lack of Efficacy|0|||
17035154|NCT00658359|38179287|FG001|Overall Study|Lack of Efficacy|1|||
17035155|NCT00658359|38179288|FG002|Overall Study|Lack of Efficacy|0|||
17035156|NCT00619918|38179300|FG000|Overall Study|Withdrawal by Subject|4|||
17035157|NCT00619918|38179301|FG001|Overall Study|Withdrawal by Subject|3|||
17035158|NCT00619918|38179300|FG000|Overall Study|Physician Decision|8|||
17035159|NCT00619918|38179301|FG001|Overall Study|Physician Decision|8|||
17035160|NCT00619918|38179300|FG000|Overall Study|Transfer to outside facility|3|||
17035161|NCT00619918|38179301|FG001|Overall Study|Transfer to outside facility|3|||
17035162|NCT00619918|38179300|FG000|Overall Study|Left before receiving first dose|5|||
17137864|NCT00075725|38279863|FG004|Overall Study|Disease Progression, all other reasons|21|||
17137865|NCT00075725|38279864|FG005|Overall Study|Disease Progression, all other reasons|59|||
17137866|NCT00075725|38279865|FG006|Overall Study|Disease Progression, all other reasons|20|||
17137867|NCT00075725|38279866|FG007|Overall Study|Disease Progression, all other reasons|46|||
17137868|NCT00075725|38279867|FG008|Overall Study|Disease Progression, all other reasons|21|||
17137869|NCT00075725|38279868|FG009|Overall Study|Disease Progression, all other reasons|4|||
17035163|NCT00619918|38179301|FG001|Overall Study|Left before receiving first dose|8|||
17035164|NCT01005914|38179307|FG000|Overall Study|Adverse Event|4|||
17035165|NCT01005914|38179307|FG000|Overall Study|Death|4|||
17035166|NCT01005914|38179307|FG000|Overall Study|Lack of Efficacy|1|||
17035167|NCT01005914|38179307|FG000|Overall Study|Withdrawal by Subject|1|||
17035168|NCT00618514|38179318|FG000|Overall Study|Lost to Follow-up|11|||
17035169|NCT00618514|38179319|FG001|Overall Study|Lost to Follow-up|12|||
17035170|NCT00618514|38179320|FG002|Overall Study|Lost to Follow-up|4|||
17035171|NCT00578292|38179326|FG000|Overall Study|Death|1|||
17035172|NCT00578292|38179326|FG000|Overall Study|Graft failure|2|||
17035173|NCT00655629|38179332|FG000|Overall Study|Adverse Event|4|||
17035174|NCT00655629|38179333|FG001|Overall Study|Adverse Event|1|||
17035175|NCT00655629|38179332|FG000|Overall Study|Lack of Efficacy|2|||
17035176|NCT00655629|38179333|FG001|Overall Study|Lack of Efficacy|12|||
17035177|NCT00655629|38179332|FG000|Overall Study|Lost to Follow-up|4|||
17035178|NCT00655629|38179333|FG001|Overall Study|Lost to Follow-up|3|||
17035179|NCT00655629|38179332|FG000|Overall Study|Protocol Violation|5|||
17035180|NCT00655629|38179333|FG001|Overall Study|Protocol Violation|3|||
17035181|NCT00655629|38179332|FG000|Overall Study|consent withdrawn|6|||
17035182|NCT00655629|38179333|FG001|Overall Study|consent withdrawn|4|||
17035183|NCT00570063|38179341|FG000|Overall Study|Adverse Event|4|||
17035184|NCT00570063|38179342|FG001|Overall Study|Adverse Event|1|||
17035185|NCT00570063|38179341|FG000|Overall Study|Lack of Efficacy|0|||
17035186|NCT00570063|38179342|FG001|Overall Study|Lack of Efficacy|1|||
17035187|NCT00570063|38179341|FG000|Overall Study|Withdrawal by Subject|4|||
17035188|NCT00570063|38179342|FG001|Overall Study|Withdrawal by Subject|3|||
17035189|NCT00570063|38179341|FG000|Overall Study|Sponsor's Decision|7|||
17035190|NCT00570063|38179342|FG001|Overall Study|Sponsor's Decision|3|||
17035191|NCT00577772|38179359|FG000|Overall Study|Lost to Follow-up|0|||
17035192|NCT00577772|38179360|FG001|Overall Study|Lost to Follow-up|1|||
17035193|NCT00578136|38179368|FG000|Overall Study|Not given intervention|1|||
17137870|NCT00075725|38279869|FG010|Overall Study|Disease Progression, all other reasons|0|||
17137871|NCT00075725|38279870|FG011|Overall Study|Disease Progression, all other reasons|5|||
17137872|NCT00075725|38279859|FG000|Overall Study|Patient off treatment|0|||
17137873|NCT00075725|38279860|FG001|Overall Study|Patient off treatment|0|||
17137874|NCT00075725|38279861|FG002|Overall Study|Patient off treatment|1|||
17137875|NCT00075725|38279862|FG003|Overall Study|Patient off treatment|2|||
17137876|NCT00075725|38279863|FG004|Overall Study|Patient off treatment|1|||
17137877|NCT00075725|38279864|FG005|Overall Study|Patient off treatment|0|||
17137878|NCT00075725|38279865|FG006|Overall Study|Patient off treatment|0|||
17137879|NCT00075725|38279866|FG007|Overall Study|Patient off treatment|2|||
17137880|NCT00075725|38279867|FG008|Overall Study|Patient off treatment|1|||
17035194|NCT00578136|38179369|FG001|Overall Study|Not given intervention|1|||
17035195|NCT00655551|38179378|FG000|All Periods Combined|Adverse Event|0|||
17035196|NCT00655551|38179379|FG001|All Periods Combined|Adverse Event|3|||
17035197|NCT00655551|38179380|FG002|All Periods Combined|Adverse Event|4|||
17035198|NCT00655551|38179378|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
17035199|NCT00655551|38179379|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
17035200|NCT00655551|38179380|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
17035201|NCT00655551|38179378|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
17035202|NCT00655551|38179379|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
17035203|NCT00655551|38179380|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
17035204|NCT00655551|38179378|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
17137881|NCT00075725|38279868|FG009|Overall Study|Patient off treatment|0|||
17035205|NCT00655551|38179379|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
17035206|NCT00655551|38179380|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
17035207|NCT00312728|38179388|FG000|Overall Study|Progressive disease|53|||
17035208|NCT00312728|38179388|FG000|Overall Study|Adverse Event|32|||
17035209|NCT00312728|38179388|FG000|Overall Study|Withdrawal by Subject|10|||
17035210|NCT00312728|38179388|FG000|Overall Study|Required non-protocol cancer treatment|2|||
17035211|NCT00312728|38179388|FG000|Overall Study|Protocol Violation|2|||
17035212|NCT00312728|38179388|FG000|Overall Study|Other|10|||
17035213|NCT00312728|38179388|FG000|Overall Study|Other|1|||
17035214|NCT00577824|38179395|FG000|Overall Study|Adverse Event|6|||
17035215|NCT00577824|38179396|FG001|Overall Study|Adverse Event|18|||
17035216|NCT00577824|38179397|FG002|Overall Study|Adverse Event|1|||
17035217|NCT00577824|38179395|FG000|Overall Study|Patient decision|0|||
17035218|NCT00577824|38179396|FG001|Overall Study|Patient decision|1|||
17035219|NCT00577824|38179397|FG002|Overall Study|Patient decision|1|||
17035220|NCT00577824|38179395|FG000|Overall Study|Protocol Violation|1|||
17035221|NCT00577824|38179396|FG001|Overall Study|Protocol Violation|1|||
17035222|NCT00577824|38179397|FG002|Overall Study|Protocol Violation|0|||
17035223|NCT00617344|38179408|FG000|Overall Study|Serious adverse event|1|||
17035224|NCT00617344|38179409|FG001|Overall Study|Serious adverse event|0|||
17035225|NCT00617344|38179410|FG002|Overall Study|Serious adverse event|0|||
17035226|NCT00617344|38179408|FG000|Overall Study|Other Adverse Event|1|||
17035227|NCT00617344|38179409|FG001|Overall Study|Other Adverse Event|1|||
17035228|NCT00617344|38179410|FG002|Overall Study|Other Adverse Event|0|||
17035229|NCT00617344|38179408|FG000|Overall Study|Protocol Violation|10|||
17035230|NCT00617344|38179409|FG001|Overall Study|Protocol Violation|8|||
17035231|NCT00617344|38179410|FG002|Overall Study|Protocol Violation|5|||
17035232|NCT00617344|38179408|FG000|Overall Study|Lost to Follow-up|5|||
17035233|NCT00617344|38179409|FG001|Overall Study|Lost to Follow-up|4|||
17035234|NCT00617344|38179410|FG002|Overall Study|Lost to Follow-up|1|||
17035235|NCT00617344|38179408|FG000|Overall Study|Withdrawal by Subject|8|||
17035236|NCT00617344|38179409|FG001|Overall Study|Withdrawal by Subject|9|||
17035237|NCT00617344|38179410|FG002|Overall Study|Withdrawal by Subject|2|||
17035238|NCT00654381|38179478|FG000|1st Stage|Adverse Event|3|||
17035239|NCT00654381|38179479|FG001|1st Stage|Adverse Event|3|||
17035240|NCT00654381|38179480|FG002|1st Stage|Adverse Event|3|||
17035241|NCT00654381|38179481|FG003|1st Stage|Adverse Event|3|||
17035242|NCT00654381|38179482|FG004|1st Stage|Adverse Event|2|||
17035243|NCT00654381|38179483|FG005|1st Stage|Adverse Event|1|||
17035244|NCT00654381|38179478|FG000|1st Stage|Withdrawal by Subject|0|||
17035245|NCT00654381|38179479|FG001|1st Stage|Withdrawal by Subject|0|||
17035246|NCT00654381|38179480|FG002|1st Stage|Withdrawal by Subject|0|||
17035247|NCT00654381|38179481|FG003|1st Stage|Withdrawal by Subject|1|||
17035248|NCT00654381|38179482|FG004|1st Stage|Withdrawal by Subject|0|||
17035249|NCT00654381|38179483|FG005|1st Stage|Withdrawal by Subject|1|||
17035250|NCT00654381|38179478|FG000|1st Stage|Investigator's decision|0|||
17035251|NCT00654381|38179479|FG001|1st Stage|Investigator's decision|0|||
17035252|NCT00654381|38179480|FG002|1st Stage|Investigator's decision|0|||
17035253|NCT00654381|38179481|FG003|1st Stage|Investigator's decision|1|||
16780424|NCT02606253|37719589|FG001|Overall Study|Protocol Violation|1|||
17035254|NCT00654381|38179482|FG004|1st Stage|Investigator's decision|0|||
17035255|NCT00654381|38179483|FG005|1st Stage|Investigator's decision|0|||
17035256|NCT00654381|38179478|FG000|2nd Stage|Adverse Event|2|||
17035257|NCT00654381|38179479|FG001|2nd Stage|Adverse Event|0|||
17035258|NCT00654381|38179480|FG002|2nd Stage|Adverse Event|2|||
17035259|NCT00654381|38179481|FG003|2nd Stage|Adverse Event|3|||
17035260|NCT00654381|38179482|FG004|2nd Stage|Adverse Event|7|||
17035261|NCT00654381|38179483|FG005|2nd Stage|Adverse Event|2|||
17035262|NCT00654381|38179478|FG000|2nd Stage|Withdrawal by Subject|0|||
17035263|NCT00654381|38179479|FG001|2nd Stage|Withdrawal by Subject|0|||
17137882|NCT00075725|38279869|FG010|Overall Study|Patient off treatment|0|||
17137883|NCT00075725|38279870|FG011|Overall Study|Patient off treatment|0|||
17035264|NCT00654381|38179480|FG002|2nd Stage|Withdrawal by Subject|0|||
17035265|NCT00654381|38179481|FG003|2nd Stage|Withdrawal by Subject|0|||
17035266|NCT00654381|38179482|FG004|2nd Stage|Withdrawal by Subject|1|||
17035267|NCT00654381|38179483|FG005|2nd Stage|Withdrawal by Subject|1|||
17035268|NCT00654381|38179478|FG000|2nd Stage|Investigator's decision|0|||
17035269|NCT00654381|38179479|FG001|2nd Stage|Investigator's decision|0|||
17035270|NCT00654381|38179480|FG002|2nd Stage|Investigator's decision|1|||
17035271|NCT00654381|38179481|FG003|2nd Stage|Investigator's decision|1|||
17035272|NCT00654381|38179482|FG004|2nd Stage|Investigator's decision|0|||
17035273|NCT00654381|38179483|FG005|2nd Stage|Investigator's decision|0|||
17035274|NCT00654381|38179478|FG000|Extension Stage|Adverse Event|1|||
17035275|NCT00654381|38179479|FG001|Extension Stage|Adverse Event|2|||
17035276|NCT00654381|38179480|FG002|Extension Stage|Adverse Event|9|||
17035277|NCT00654381|38179481|FG003|Extension Stage|Adverse Event|7|||
17035278|NCT00654381|38179482|FG004|Extension Stage|Adverse Event|1|||
17035279|NCT00654381|38179483|FG005|Extension Stage|Adverse Event|1|||
17035280|NCT00654381|38179478|FG000|Extension Stage|Protocol Violation|0|||
17035281|NCT00654381|38179479|FG001|Extension Stage|Protocol Violation|0|||
17035282|NCT00654381|38179480|FG002|Extension Stage|Protocol Violation|0|||
17035283|NCT00654381|38179481|FG003|Extension Stage|Protocol Violation|1|||
17035284|NCT00654381|38179482|FG004|Extension Stage|Protocol Violation|0|||
17035285|NCT00654381|38179483|FG005|Extension Stage|Protocol Violation|0|||
17035286|NCT00654381|38179478|FG000|Extension Stage|Lack of Efficacy|0|||
17035287|NCT00654381|38179479|FG001|Extension Stage|Lack of Efficacy|0|||
17035288|NCT00654381|38179480|FG002|Extension Stage|Lack of Efficacy|1|||
17035289|NCT00654381|38179481|FG003|Extension Stage|Lack of Efficacy|0|||
17035290|NCT00654381|38179482|FG004|Extension Stage|Lack of Efficacy|0|||
17035291|NCT00654381|38179483|FG005|Extension Stage|Lack of Efficacy|0|||
17035292|NCT00654381|38179478|FG000|Extension Stage|Withdrawal by Subject|0|||
17035293|NCT00654381|38179479|FG001|Extension Stage|Withdrawal by Subject|0|||
17035294|NCT00654381|38179480|FG002|Extension Stage|Withdrawal by Subject|1|||
17035295|NCT00654381|38179481|FG003|Extension Stage|Withdrawal by Subject|1|||
17035296|NCT00654381|38179482|FG004|Extension Stage|Withdrawal by Subject|1|||
17035297|NCT00654381|38179483|FG005|Extension Stage|Withdrawal by Subject|1|||
17035298|NCT00654381|38179478|FG000|Extension Stage|Closure of the trial site|0|||
17035299|NCT00654381|38179479|FG001|Extension Stage|Closure of the trial site|0|||
17035300|NCT00654381|38179480|FG002|Extension Stage|Closure of the trial site|0|||
17035301|NCT00654381|38179481|FG003|Extension Stage|Closure of the trial site|0|||
17035302|NCT00654381|38179482|FG004|Extension Stage|Closure of the trial site|1|||
17035303|NCT00654381|38179483|FG005|Extension Stage|Closure of the trial site|1|||
17035304|NCT00657267|38179500|FG000|Overall Study|Progressive disease|45|||
17035305|NCT00657267|38179500|FG000|Overall Study|Adverse Event|9|||
17035306|NCT00653991|38179508|FG000|3 Month Follow-up|Participant would not respond|150|||
17035307|NCT00653991|38179509|FG001|3 Month Follow-up|Participant would not respond|157|||
17035308|NCT00653991|38179508|FG000|6 Month Follow-up|Participant would not respond|133|||
17035309|NCT00653991|38179509|FG001|6 Month Follow-up|Participant would not respond|141|||
17035310|NCT00652899|38179517|FG000|Overall Study|Death|1|||
17035311|NCT00652899|38179517|FG000|Overall Study|Treating physician decision|1|||
17035312|NCT02879448|38179544|FG000|Overall Study|No implant attempt|17|||
17035313|NCT02879448|38179545|FG001|Overall Study|No implant attempt|28|||
17035314|NCT02879448|38179544|FG000|Overall Study|Withdrawal by Subject|20|||
17035315|NCT02879448|38179545|FG001|Overall Study|Withdrawal by Subject|46|||
17035316|NCT02879448|38179544|FG000|Overall Study|Death|63|||
17035317|NCT02879448|38179545|FG001|Overall Study|Death|85|||
17035318|NCT02879448|38179544|FG000|Overall Study|Lost to Follow-up|3|||
17035319|NCT02879448|38179545|FG001|Overall Study|Lost to Follow-up|4|||
17035320|NCT02879448|38179544|FG000|Overall Study|Missing visit|34|||
17035321|NCT02879448|38179545|FG001|Overall Study|Missing visit|39|||
17137884|NCT00075725|38279859|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
17137885|NCT00075725|38279860|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
17137886|NCT00075725|38279861|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
17137887|NCT00075725|38279862|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
17137888|NCT00075725|38279863|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
17137889|NCT00075725|38279864|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
17137890|NCT00075725|38279865|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
17137891|NCT00075725|38279866|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
17035322|NCT02879448|38179544|FG000|Overall Study|Pending evaluation|1|||
17035323|NCT02879448|38179545|FG001|Overall Study|Pending evaluation|0|||
17035324|NCT00617890|38179555|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
17035325|NCT00617890|38179556|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
17035326|NCT00617890|38179557|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
17035327|NCT00617890|38179558|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
17035328|NCT00617890|38179555|FG000|Overall Study|Lack of Efficacy|23|||
17035329|NCT00617890|38179556|FG001|Overall Study|Lack of Efficacy|26|||
17035330|NCT00617890|38179557|FG002|Overall Study|Lack of Efficacy|30|||
17035331|NCT00617890|38179558|FG003|Overall Study|Lack of Efficacy|97|||
17035332|NCT00617890|38179555|FG000|Overall Study|Lost to Follow-up|0|||
17035333|NCT00617890|38179556|FG001|Overall Study|Lost to Follow-up|0|||
17035334|NCT00617890|38179557|FG002|Overall Study|Lost to Follow-up|1|||
17035335|NCT00617890|38179558|FG003|Overall Study|Lost to Follow-up|2|||
17035336|NCT00617890|38179555|FG000|Overall Study|Withdrawal by Subject|4|||
17035337|NCT00617890|38179556|FG001|Overall Study|Withdrawal by Subject|1|||
17035338|NCT00617890|38179557|FG002|Overall Study|Withdrawal by Subject|0|||
17035339|NCT00617890|38179558|FG003|Overall Study|Withdrawal by Subject|2|||
17035340|NCT00617890|38179555|FG000|Overall Study|Protocol Violation|2|||
17035341|NCT00617890|38179556|FG001|Overall Study|Protocol Violation|1|||
17035342|NCT00617890|38179557|FG002|Overall Study|Protocol Violation|0|||
17035343|NCT00617890|38179558|FG003|Overall Study|Protocol Violation|0|||
17035344|NCT00617890|38179555|FG000|Overall Study|Adverse Event|1|||
17035345|NCT00617890|38179556|FG001|Overall Study|Adverse Event|0|||
17035346|NCT00617890|38179557|FG002|Overall Study|Adverse Event|3|||
17035347|NCT00617890|38179558|FG003|Overall Study|Adverse Event|8|||
17035348|NCT00617890|38179555|FG000|Overall Study|Not treated|1|||
17035349|NCT00617890|38179556|FG001|Overall Study|Not treated|0|||
17035350|NCT00617890|38179557|FG002|Overall Study|Not treated|1|||
17035351|NCT00617890|38179558|FG003|Overall Study|Not treated|1|||
17035352|NCT00712166|38179573|FG000|Overall Study|Noncompliance|0|||
17035353|NCT00712166|38179574|FG001|Overall Study|Noncompliance|1|||
17035354|NCT00652743|38179585|FG000|Months 12-18|Lost to Follow-up|1|||
17035355|NCT00652743|38179586|FG001|Months 12-18|Lost to Follow-up|2|||
17035356|NCT00652743|38179587|FG002|Months 12-18|Lost to Follow-up|7|||
17035357|NCT00652743|38179585|FG000|Months 24-30|Other|5|||
17035358|NCT00652743|38179586|FG001|Months 24-30|Other|1|||
17035359|NCT00652743|38179587|FG002|Months 24-30|Other|11|||
17035360|NCT00652743|38179585|FG000|Months 36-42|Serious Adverse Events|0|||
17035361|NCT00652743|38179586|FG001|Months 36-42|Serious Adverse Events|1|||
17035362|NCT00652743|38179587|FG002|Months 36-42|Serious Adverse Events|1|||
17035363|NCT00652743|38179585|FG000|Months 36-42|Withdrawal by Subject|1|||
17035364|NCT00652743|38179586|FG001|Months 36-42|Withdrawal by Subject|1|||
17035365|NCT00652743|38179587|FG002|Months 36-42|Withdrawal by Subject|0|||
17035366|NCT00652743|38179585|FG000|Months 36-42|Lost to Follow-up|0|||
17035367|NCT00652743|38179586|FG001|Months 36-42|Lost to Follow-up|1|||
17035368|NCT00652743|38179587|FG002|Months 36-42|Lost to Follow-up|0|||
17035369|NCT00652743|38179585|FG000|Months 36-42|Migrated/moved from study area|1|||
17035370|NCT00652743|38179586|FG001|Months 36-42|Migrated/moved from study area|0|||
17035371|NCT00652743|38179587|FG002|Months 36-42|Migrated/moved from study area|0|||
17035372|NCT00652743|38179585|FG000|Months 36-42|Other|4|||
17035373|NCT00652743|38179586|FG001|Months 36-42|Other|2|||
17035374|NCT00652743|38179587|FG002|Months 36-42|Other|8|||
17035375|NCT00712010|38179598|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
17035376|NCT00653523|38179614|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
17035377|NCT00653523|38179614|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
17035378|NCT00653523|38179614|FG000|Overall Study|Adverse Event|7|||
17137892|NCT00075725|38279867|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
17137893|NCT00075725|38279868|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
17137894|NCT00075725|38279869|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
17137895|NCT00075725|38279870|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
17137896|NCT00075725|38279859|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
17035379|NCT00653523|38179614|FG000|Overall Study|Withdrawal by Subject|6|||
17035380|NCT00653523|38179614|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
17035381|NCT00653523|38179614|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
17035382|NCT02717442|38179620|FG000|Overall Study|Study Terminated by Sponsor|31|||
17035383|NCT02717442|38179621|FG001|Overall Study|Study Terminated by Sponsor|29|||
17035384|NCT02717442|38179620|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
17035385|NCT02717442|38179621|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
17035386|NCT02717442|38179620|FG000|Overall Study|Other - Not Specified|2|||
17035387|NCT02717442|38179621|FG001|Overall Study|Other - Not Specified|0|||
17035388|NCT00616018|38179634|FG000|Overall Study|Protocol Violation|3|||
17035389|NCT00424021|38179643|FG000|NCT00046319 Study Period|Adverse Event|1|||
17035390|NCT00424021|38179644|FG001|NCT00046319 Study Period|Adverse Event|0|||
17035391|NCT00424021|38179645|FG002|NCT00046319 Study Period|Adverse Event|1|||
17035392|NCT00424021|38179646|FG003|NCT00046319 Study Period|Adverse Event|1|||
17035393|NCT00424021|38179643|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
17035394|NCT00424021|38179644|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
17035395|NCT00424021|38179645|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
17035396|NCT00424021|38179646|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
17035397|NCT00424021|38179643|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
17035398|NCT00424021|38179644|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
17035399|NCT00424021|38179645|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
17035400|NCT00424021|38179646|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
17035401|NCT00424021|38179643|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
17035402|NCT00424021|38179644|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
17035403|NCT00424021|38179645|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
17137897|NCT00075725|38279860|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
17137898|NCT00075725|38279861|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
17137899|NCT00075725|38279862|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
17137900|NCT00075725|38279863|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
17137901|NCT00075725|38279864|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
17137902|NCT00075725|38279865|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
17137903|NCT00075725|38279866|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
17137904|NCT00075725|38279867|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
17137905|NCT00075725|38279868|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
17137906|NCT00075725|38279869|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
17137907|NCT00075725|38279870|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
17137908|NCT00075725|38279859|FG000|Overall Study|Pt non compliant with therapy|2|||
17035404|NCT00424021|38179646|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
17035405|NCT00424021|38179643|FG000|AMB-220-E Study Period|Adverse Event|1|||
17035406|NCT00424021|38179644|FG001|AMB-220-E Study Period|Adverse Event|1|||
17035407|NCT00424021|38179645|FG002|AMB-220-E Study Period|Adverse Event|3|||
17035408|NCT00424021|38179646|FG003|AMB-220-E Study Period|Adverse Event|7|||
17035409|NCT00424021|38179643|FG000|AMB-220-E Study Period|Death|0|||
17035410|NCT00424021|38179644|FG001|AMB-220-E Study Period|Death|0|||
17035411|NCT00424021|38179645|FG002|AMB-220-E Study Period|Death|1|||
17035412|NCT00424021|38179646|FG003|AMB-220-E Study Period|Death|1|||
17035413|NCT00424021|38179643|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
17035414|NCT00424021|38179644|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
17035415|NCT00424021|38179645|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
17035416|NCT00424021|38179646|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
17035417|NCT00424021|38179643|FG000|AMB-220-E Study Period|Physician Decision|0|||
17035418|NCT00424021|38179644|FG001|AMB-220-E Study Period|Physician Decision|0|||
17035419|NCT00424021|38179645|FG002|AMB-220-E Study Period|Physician Decision|0|||
17035420|NCT00424021|38179646|FG003|AMB-220-E Study Period|Physician Decision|1|||
17035421|NCT00617734|38179665|FG000|Overall Study|Withdrew Consent|2|||
17035422|NCT00617734|38179666|FG001|Overall Study|Withdrew Consent|0|||
17137909|NCT00075725|38279860|FG001|Overall Study|Pt non compliant with therapy|1|||
17137910|NCT00075725|38279861|FG002|Overall Study|Pt non compliant with therapy|1|||
17137911|NCT00075725|38279862|FG003|Overall Study|Pt non compliant with therapy|0|||
17137912|NCT00075725|38279863|FG004|Overall Study|Pt non compliant with therapy|2|||
17137913|NCT00075725|38279864|FG005|Overall Study|Pt non compliant with therapy|14|||
17137914|NCT00075725|38279865|FG006|Overall Study|Pt non compliant with therapy|2|||
17137915|NCT00075725|38279866|FG007|Overall Study|Pt non compliant with therapy|5|||
17137916|NCT00075725|38279867|FG008|Overall Study|Pt non compliant with therapy|3|||
17137917|NCT00075725|38279868|FG009|Overall Study|Pt non compliant with therapy|0|||
17137918|NCT00075725|38279869|FG010|Overall Study|Pt non compliant with therapy|0|||
17137919|NCT00075725|38279870|FG011|Overall Study|Pt non compliant with therapy|0|||
17137920|NCT00075725|38279859|FG000|Overall Study|Pt age out of range for treatment|0|||
17137921|NCT00075725|38279860|FG001|Overall Study|Pt age out of range for treatment|1|||
17137922|NCT00075725|38279861|FG002|Overall Study|Pt age out of range for treatment|0|||
17137923|NCT00075725|38279862|FG003|Overall Study|Pt age out of range for treatment|0|||
17137924|NCT00075725|38279863|FG004|Overall Study|Pt age out of range for treatment|0|||
17137925|NCT00075725|38279864|FG005|Overall Study|Pt age out of range for treatment|1|||
17035423|NCT00617734|38179665|FG000|Overall Study|Adverse Event|4|||
17035424|NCT00617734|38179666|FG001|Overall Study|Adverse Event|1|||
17035425|NCT00617734|38179665|FG000|Overall Study|Protocol Violation|1|||
17137926|NCT00075725|38279865|FG006|Overall Study|Pt age out of range for treatment|0|||
17137927|NCT00075725|38279866|FG007|Overall Study|Pt age out of range for treatment|1|||
17137928|NCT00075725|38279867|FG008|Overall Study|Pt age out of range for treatment|0|||
17137929|NCT00075725|38279868|FG009|Overall Study|Pt age out of range for treatment|0|||
16780425|NCT02606253|37719590|FG002|Overall Study|Protocol Violation|0|||
16780426|NCT02606253|37719588|FG000|Overall Study|Physician Decision|1|||
17035426|NCT00617734|38179666|FG001|Overall Study|Protocol Violation|0|||
17035427|NCT00617734|38179665|FG000|Overall Study|Found Ineligible After Randomization|1|||
17035428|NCT00617734|38179666|FG001|Overall Study|Found Ineligible After Randomization|4|||
17035429|NCT00617734|38179665|FG000|Overall Study|Lost to Follow-up|0|||
17035430|NCT00617734|38179666|FG001|Overall Study|Lost to Follow-up|1|||
17035431|NCT00577460|38179675|FG000|Overall Study|Adverse Event|11|||
17035432|NCT00577460|38179676|FG001|Overall Study|Adverse Event|7|||
17035433|NCT00577460|38179677|FG002|Overall Study|Adverse Event|14|||
17035434|NCT00577460|38179675|FG000|Overall Study|Protocol Violation|0|||
17035435|NCT00577460|38179676|FG001|Overall Study|Protocol Violation|1|||
17035436|NCT00577460|38179677|FG002|Overall Study|Protocol Violation|1|||
17035437|NCT00577460|38179675|FG000|Overall Study|Lost to Follow-up|0|||
17035438|NCT00577460|38179676|FG001|Overall Study|Lost to Follow-up|3|||
17035439|NCT00577460|38179677|FG002|Overall Study|Lost to Follow-up|4|||
17035440|NCT00577460|38179675|FG000|Overall Study|Withdrawal by Subject|5|||
17035441|NCT00577460|38179676|FG001|Overall Study|Withdrawal by Subject|5|||
17035442|NCT00577460|38179677|FG002|Overall Study|Withdrawal by Subject|6|||
17035443|NCT00577460|38179675|FG000|Overall Study|Other|0|||
17035444|NCT00577460|38179676|FG001|Overall Study|Other|3|||
17035445|NCT00577460|38179677|FG002|Overall Study|Other|2|||
17035446|NCT00415519|38179694|FG000|Overall Study|Adverse Event|1|||
17035447|NCT00415519|38179695|FG001|Overall Study|Adverse Event|0|||
17035448|NCT00415519|38179694|FG000|Overall Study|Withdrawal by Subject|2|||
17035449|NCT00415519|38179695|FG001|Overall Study|Withdrawal by Subject|0|||
17035450|NCT00415519|38179694|FG000|Overall Study|Patient's convenience|1|||
17035451|NCT00415519|38179695|FG001|Overall Study|Patient's convenience|0|||
17035452|NCT00423943|38179703|FG000|Overall Study|Withdrawal by Subject|3|||
17035453|NCT00423943|38179704|FG001|Overall Study|Withdrawal by Subject|1|||
17035454|NCT00428389|38179712|FG000|Core Phase|Adverse Event|6|||
17035455|NCT00428389|38179713|FG001|Core Phase|Adverse Event|4|||
17035456|NCT00428389|38179712|FG000|Core Phase|Lack of Efficacy|2|||
17035457|NCT00428389|38179713|FG001|Core Phase|Lack of Efficacy|0|||
17035458|NCT00428389|38179712|FG000|Core Phase|Abnormal test procedure result(s)|0|||
17137930|NCT00075725|38279869|FG010|Overall Study|Pt age out of range for treatment|0|||
17137931|NCT00075725|38279870|FG011|Overall Study|Pt age out of range for treatment|0|||
17137932|NCT00075725|38279859|FG000|Overall Study|Insurance issues|0|||
17137933|NCT00075725|38279860|FG001|Overall Study|Insurance issues|1|||
17137934|NCT00075725|38279861|FG002|Overall Study|Insurance issues|0|||
17137935|NCT00075725|38279862|FG003|Overall Study|Insurance issues|1|||
17137936|NCT00075725|38279863|FG004|Overall Study|Insurance issues|1|||
17137937|NCT00075725|38279864|FG005|Overall Study|Insurance issues|1|||
17137938|NCT00075725|38279865|FG006|Overall Study|Insurance issues|0|||
17137939|NCT00075725|38279866|FG007|Overall Study|Insurance issues|1|||
17137940|NCT00075725|38279867|FG008|Overall Study|Insurance issues|0|||
17137941|NCT00075725|38279868|FG009|Overall Study|Insurance issues|0|||
17137942|NCT00075725|38279869|FG010|Overall Study|Insurance issues|0|||
17137943|NCT00075725|38279870|FG011|Overall Study|Insurance issues|0|||
17137944|NCT00075725|38279859|FG000|Overall Study|MRD positive after extended ind|0|||
17137945|NCT00075725|38279860|FG001|Overall Study|MRD positive after extended ind|1|||
17137946|NCT00075725|38279861|FG002|Overall Study|MRD positive after extended ind|1|||
17137947|NCT00075725|38279862|FG003|Overall Study|MRD positive after extended ind|0|||
17137948|NCT00075725|38279863|FG004|Overall Study|MRD positive after extended ind|1|||
17137949|NCT00075725|38279864|FG005|Overall Study|MRD positive after extended ind|2|||
17137950|NCT00075725|38279865|FG006|Overall Study|MRD positive after extended ind|0|||
17137951|NCT00075725|38279866|FG007|Overall Study|MRD positive after extended ind|1|||
17137952|NCT00075725|38279867|FG008|Overall Study|MRD positive after extended ind|0|||
17137953|NCT00075725|38279868|FG009|Overall Study|MRD positive after extended ind|0|||
17137954|NCT00075725|38279869|FG010|Overall Study|MRD positive after extended ind|0|||
17137955|NCT00075725|38279870|FG011|Overall Study|MRD positive after extended ind|0|||
17137956|NCT00075725|38279859|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
17137957|NCT00075725|38279860|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
17137958|NCT00075725|38279861|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
17137959|NCT00075725|38279862|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
17137960|NCT00075725|38279863|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
17137961|NCT00075725|38279864|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
17137962|NCT00075725|38279865|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
17137963|NCT00075725|38279866|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
17137964|NCT00075725|38279867|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
17137965|NCT00075725|38279868|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
17137966|NCT00075725|38279869|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
17137967|NCT00075725|38279870|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
17137968|NCT00075725|38279859|FG000|Overall Study|Inevaluable|1|||
17137969|NCT00075725|38279860|FG001|Overall Study|Inevaluable|1|||
17035459|NCT00428389|38179713|FG001|Core Phase|Abnormal test procedure result(s)|1|||
17035460|NCT00428389|38179712|FG000|Core Phase|Withdrawal by Subject|3|||
17035461|NCT00428389|38179713|FG001|Core Phase|Withdrawal by Subject|4|||
17137970|NCT00075725|38279861|FG002|Overall Study|Inevaluable|4|||
17137971|NCT00075725|38279862|FG003|Overall Study|Inevaluable|2|||
17137972|NCT00075725|38279863|FG004|Overall Study|Inevaluable|2|||
17137973|NCT00075725|38279864|FG005|Overall Study|Inevaluable|9|||
17137974|NCT00075725|38279865|FG006|Overall Study|Inevaluable|1|||
17035462|NCT00428389|38179712|FG000|Core Phase|Protocol deviation|0|||
17035463|NCT00428389|38179713|FG001|Core Phase|Protocol deviation|2|||
17035464|NCT00428389|38179712|FG000|Extension Phase|Adverse Event|17|||
17035465|NCT00428389|38179713|FG001|Extension Phase|Adverse Event|11|||
17035466|NCT00428389|38179712|FG000|Extension Phase|Lack of Efficacy|4|||
17035467|NCT00428389|38179713|FG001|Extension Phase|Lack of Efficacy|3|||
17035468|NCT00428389|38179712|FG000|Extension Phase|Withdrawal by Subject|6|||
17035469|NCT00428389|38179713|FG001|Extension Phase|Withdrawal by Subject|6|||
17035470|NCT00428389|38179712|FG000|Extension Phase|Lost to Follow-up|0|||
17035471|NCT00428389|38179713|FG001|Extension Phase|Lost to Follow-up|3|||
17137975|NCT00075725|38279866|FG007|Overall Study|Inevaluable|11|||
17137976|NCT00075725|38279867|FG008|Overall Study|Inevaluable|2|||
17137977|NCT00075725|38279868|FG009|Overall Study|Inevaluable|0|||
17137978|NCT00075725|38279869|FG010|Overall Study|Inevaluable|1|||
17137979|NCT00075725|38279870|FG011|Overall Study|Inevaluable|0|||
17137980|NCT00075725|38279859|FG000|Overall Study|Other|4|||
17137981|NCT00075725|38279860|FG001|Overall Study|Other|2|||
17137982|NCT00075725|38279861|FG002|Overall Study|Other|1|||
17035472|NCT00428389|38179712|FG000|Extension Phase|Death|1|||
17035473|NCT00428389|38179713|FG001|Extension Phase|Death|0|||
17035474|NCT00428389|38179712|FG000|Extension Phase|Protocol Violation|3|||
17035475|NCT00428389|38179713|FG001|Extension Phase|Protocol Violation|2|||
17035476|NCT00428389|38179712|FG000|Extension Phase|Administrative problems|1|||
17035477|NCT00428389|38179713|FG001|Extension Phase|Administrative problems|1|||
17035478|NCT00616642|38179721|FG000|Overall Study|Withdrawal by Subject|0|||
17035479|NCT00616642|38179722|FG001|Overall Study|Withdrawal by Subject|1|||
17035480|NCT00406315|38179728|FG000|Overall Study|Death|1|||
17035481|NCT00406315|38179728|FG000|Overall Study|Adverse Event|39|||
17035482|NCT00406315|38179728|FG000|Overall Study|Laboratory Abnormality|4|||
17035483|NCT00406315|38179728|FG000|Overall Study|Lack of Efficacy|13|||
17035484|NCT00406315|38179728|FG000|Overall Study|Other|33|||
17035485|NCT00406315|38179728|FG000|Overall Study|Lost to Follow-up|21|||
17035486|NCT00406315|38179728|FG000|Overall Study|Withdrawal by Subject|30|||
17035487|NCT00711594|38179736|FG000|Overall Study|Progressive disease|2|||
17035488|NCT00711594|38179737|FG001|Overall Study|Progressive disease|2|||
17035489|NCT00711594|38179738|FG002|Overall Study|Progressive disease|6|||
17035490|NCT00711594|38179739|FG003|Overall Study|Progressive disease|44|||
17035491|NCT00711594|38179736|FG000|Overall Study|Other Adverse Event|1|||
17035492|NCT00711594|38179737|FG001|Overall Study|Other Adverse Event|0|||
17035493|NCT00711594|38179738|FG002|Overall Study|Other Adverse Event|0|||
17035494|NCT00711594|38179739|FG003|Overall Study|Other Adverse Event|16|||
17035495|NCT00711594|38179736|FG000|Overall Study|Withdrawal by Subject|0|||
17035496|NCT00711594|38179737|FG001|Overall Study|Withdrawal by Subject|1|||
17035497|NCT00711594|38179738|FG002|Overall Study|Withdrawal by Subject|0|||
17035498|NCT00711594|38179739|FG003|Overall Study|Withdrawal by Subject|2|||
17035499|NCT00710762|38179753|FG000|Overall Study|Progressive disease|27|||
17035500|NCT00710762|38179754|FG001|Overall Study|Progressive disease|30|||
17035501|NCT00710762|38179753|FG000|Overall Study|Adverse Event other disease worsening|2|||
17035502|NCT00710762|38179754|FG001|Overall Study|Adverse Event other disease worsening|1|||
17035503|NCT00710762|38179753|FG000|Overall Study|Other Adverse Event|7|||
17035504|NCT00710762|38179754|FG001|Overall Study|Other Adverse Event|7|||
17035505|NCT00710762|38179753|FG000|Overall Study|Lost to Follow-up|1|||
17035506|NCT00710762|38179754|FG001|Overall Study|Lost to Follow-up|0|||
17035507|NCT00710762|38179753|FG000|Overall Study|Reason other than listed above|2|||
17035508|NCT00710762|38179754|FG001|Overall Study|Reason other than listed above|2|||
17035509|NCT00573430|38179763|FG000|Overall Study|Incorrect enrollment of randomization|0|||
17035510|NCT00573430|38179764|FG001|Overall Study|Incorrect enrollment of randomization|4|||
17035511|NCT00573430|38179765|FG002|Overall Study|Incorrect enrollment of randomization|3|||
17035512|NCT00573430|38179763|FG000|Overall Study|Adverse Event|0|||
17035513|NCT00573430|38179764|FG001|Overall Study|Adverse Event|0|||
17035514|NCT00573430|38179765|FG002|Overall Study|Adverse Event|2|||
17035515|NCT00573430|38179763|FG000|Overall Study|Withdrawal by Subject|1|||
17035516|NCT00573430|38179764|FG001|Overall Study|Withdrawal by Subject|0|||
17035517|NCT00573430|38179765|FG002|Overall Study|Withdrawal by Subject|1|||
17035518|NCT00573430|38179763|FG000|Overall Study|Protocol Violation|0|||
17035519|NCT00573430|38179764|FG001|Overall Study|Protocol Violation|1|||
17035520|NCT00573430|38179765|FG002|Overall Study|Protocol Violation|1|||
17035521|NCT00573430|38179763|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
17035522|NCT00573430|38179764|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
17137983|NCT00075725|38279862|FG003|Overall Study|Other|1|||
17137984|NCT00075725|38279863|FG004|Overall Study|Other|1|||
17137985|NCT00075725|38279864|FG005|Overall Study|Other|4|||
17137986|NCT00075725|38279865|FG006|Overall Study|Other|2|||
17137987|NCT00075725|38279866|FG007|Overall Study|Other|9|||
17035523|NCT00573430|38179765|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
17035524|NCT00711516|38179775|FG000|Overall Study|Adverse Event|1|||
17035525|NCT00711516|38179776|FG001|Overall Study|Adverse Event|1|||
17035526|NCT00711516|38179775|FG000|Overall Study|Withdrawal by Subject|0|||
17035527|NCT00711516|38179776|FG001|Overall Study|Withdrawal by Subject|1|||
17035528|NCT00711516|38179775|FG000|Overall Study|Protocol Violation|0|||
17035529|NCT00711516|38179776|FG001|Overall Study|Protocol Violation|1|||
17035530|NCT00615550|38179784|FG000|Overall Study|Lost to Follow-up|6|||
17035531|NCT00615550|38179785|FG001|Overall Study|Lost to Follow-up|1|||
17035532|NCT00186888|38179794|FG000|Overall Study|Toxicity|0|||
17035533|NCT00186888|38179795|FG001|Overall Study|Toxicity|1|||
17035534|NCT00186888|38179796|FG002|Overall Study|Toxicity|0|||
17137988|NCT00075725|38279867|FG008|Overall Study|Other|2|||
17035535|NCT00186888|38179794|FG000|Overall Study|Relapse or progression of disease|4|||
17035536|NCT00186888|38179795|FG001|Overall Study|Relapse or progression of disease|2|||
17137989|NCT00075725|38279868|FG009|Overall Study|Other|1|||
17137990|NCT00075725|38279869|FG010|Overall Study|Other|0|||
17137991|NCT00075725|38279870|FG011|Overall Study|Other|3|||
17137992|NCT00075725|38279859|FG000|Overall Study|Pt trying to find a BM donor|0|||
17137993|NCT00075725|38279860|FG001|Overall Study|Pt trying to find a BM donor|1|||
17137994|NCT00075725|38279861|FG002|Overall Study|Pt trying to find a BM donor|0|||
17137995|NCT00075725|38279862|FG003|Overall Study|Pt trying to find a BM donor|0|||
17137996|NCT00075725|38279863|FG004|Overall Study|Pt trying to find a BM donor|0|||
17137997|NCT00075725|38279864|FG005|Overall Study|Pt trying to find a BM donor|0|||
17137998|NCT00075725|38279865|FG006|Overall Study|Pt trying to find a BM donor|0|||
17137999|NCT00075725|38279866|FG007|Overall Study|Pt trying to find a BM donor|0|||
17138000|NCT00075725|38279867|FG008|Overall Study|Pt trying to find a BM donor|0|||
17138001|NCT00075725|38279868|FG009|Overall Study|Pt trying to find a BM donor|0|||
17138002|NCT00075725|38279869|FG010|Overall Study|Pt trying to find a BM donor|0|||
17138003|NCT00075725|38279870|FG011|Overall Study|Pt trying to find a BM donor|0|||
17138004|NCT00075725|38279859|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
17138005|NCT00075725|38279860|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
17138006|NCT00075725|38279861|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
17138007|NCT00075725|38279862|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
17138008|NCT00075725|38279863|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
17138009|NCT00075725|38279864|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
17138010|NCT00075725|38279865|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
17138011|NCT00075725|38279866|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
17138012|NCT00075725|38279867|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
17138013|NCT00075725|38279868|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
17138014|NCT00075725|38279869|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
17138015|NCT00075725|38279870|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
17138016|NCT00075725|38279859|FG000|Overall Study|Unsuccessful institutional transfer|0|||
17138017|NCT00075725|38279860|FG001|Overall Study|Unsuccessful institutional transfer|0|||
17138018|NCT00075725|38279861|FG002|Overall Study|Unsuccessful institutional transfer|2|||
17138019|NCT00075725|38279862|FG003|Overall Study|Unsuccessful institutional transfer|0|||
17138020|NCT00075725|38279863|FG004|Overall Study|Unsuccessful institutional transfer|0|||
17138021|NCT00075725|38279864|FG005|Overall Study|Unsuccessful institutional transfer|0|||
17138022|NCT00075725|38279865|FG006|Overall Study|Unsuccessful institutional transfer|0|||
17138023|NCT00075725|38279866|FG007|Overall Study|Unsuccessful institutional transfer|0|||
17138024|NCT00075725|38279867|FG008|Overall Study|Unsuccessful institutional transfer|0|||
17138025|NCT00075725|38279868|FG009|Overall Study|Unsuccessful institutional transfer|1|||
17138026|NCT00075725|38279869|FG010|Overall Study|Unsuccessful institutional transfer|0|||
17138027|NCT00075725|38279870|FG011|Overall Study|Unsuccessful institutional transfer|0|||
17138028|NCT00075725|38279859|FG000|Overall Study|specimen(s) not submitted|0|||
17138029|NCT00075725|38279860|FG001|Overall Study|specimen(s) not submitted|0|||
17138030|NCT00075725|38279861|FG002|Overall Study|specimen(s) not submitted|2|||
17138031|NCT00075725|38279862|FG003|Overall Study|specimen(s) not submitted|0|||
17138032|NCT00075725|38279863|FG004|Overall Study|specimen(s) not submitted|0|||
17138033|NCT00075725|38279864|FG005|Overall Study|specimen(s) not submitted|0|||
17138034|NCT00075725|38279865|FG006|Overall Study|specimen(s) not submitted|0|||
17138035|NCT00075725|38279866|FG007|Overall Study|specimen(s) not submitted|0|||
17138036|NCT00075725|38279867|FG008|Overall Study|specimen(s) not submitted|0|||
17138037|NCT00075725|38279868|FG009|Overall Study|specimen(s) not submitted|0|||
17138038|NCT00075725|38279869|FG010|Overall Study|specimen(s) not submitted|0|||
17138039|NCT00075725|38279870|FG011|Overall Study|specimen(s) not submitted|0|||
17138040|NCT00075725|38279859|FG000|Overall Study|Pt went to transplant|0|||
17035537|NCT00186888|38179796|FG002|Overall Study|Relapse or progression of disease|0|||
17035538|NCT00577382|38179833|FG000|Overall Study|Adverse Event|0|||
17138041|NCT00075725|38279860|FG001|Overall Study|Pt went to transplant|0|||
17138042|NCT00075725|38279861|FG002|Overall Study|Pt went to transplant|0|||
17138043|NCT00075725|38279862|FG003|Overall Study|Pt went to transplant|1|||
17138044|NCT00075725|38279863|FG004|Overall Study|Pt went to transplant|0|||
17138045|NCT00075725|38279864|FG005|Overall Study|Pt went to transplant|1|||
17138046|NCT00075725|38279865|FG006|Overall Study|Pt went to transplant|0|||
17138047|NCT00075725|38279866|FG007|Overall Study|Pt went to transplant|0|||
17035539|NCT00577382|38179834|FG001|Overall Study|Adverse Event|6|||
17035540|NCT00577382|38179833|FG000|Overall Study|Withdrawal by Subject|0|||
17035541|NCT00577382|38179834|FG001|Overall Study|Withdrawal by Subject|1|||
17035542|NCT00577382|38179833|FG000|Overall Study|Progressive Disease|17|||
17035543|NCT00577382|38179834|FG001|Overall Study|Progressive Disease|19|||
17035544|NCT00577382|38179833|FG000|Overall Study|Intercurrent Illness|1|||
17035545|NCT00577382|38179834|FG001|Overall Study|Intercurrent Illness|2|||
17035546|NCT00577382|38179833|FG000|Overall Study|Death|1|||
17035547|NCT00577382|38179834|FG001|Overall Study|Death|1|||
17035548|NCT00577382|38179833|FG000|Overall Study|Lost to Follow-up|2|||
17035549|NCT00577382|38179834|FG001|Overall Study|Lost to Follow-up|2|||
17035550|NCT00614926|38179842|FG000|Overall Study|Burden of travel|1|||
17035551|NCT00614926|38179843|FG001|Overall Study|Burden of travel|0|||
17035552|NCT00614926|38179842|FG000|Overall Study|Adverse Event|3|||
17035553|NCT00614926|38179843|FG001|Overall Study|Adverse Event|0|||
17035554|NCT00423319|38179856|FG000|Overall Study|Death|2|||
17035555|NCT00423319|38179857|FG001|Overall Study|Death|0|||
17035556|NCT00423319|38179856|FG000|Overall Study|Adverse Event|93|||
17035557|NCT00423319|38179857|FG001|Overall Study|Adverse Event|112|||
17035558|NCT00423319|38179856|FG000|Overall Study|Withdrawal by Subject|86|||
17035559|NCT00423319|38179857|FG001|Overall Study|Withdrawal by Subject|99|||
17035560|NCT00423319|38179856|FG000|Overall Study|Lost to Follow-up|4|||
17035561|NCT00423319|38179857|FG001|Overall Study|Lost to Follow-up|3|||
17035562|NCT00423319|38179856|FG000|Overall Study|Poor compliance or noncompliance|1|||
17035563|NCT00423319|38179857|FG001|Overall Study|Poor compliance or noncompliance|1|||
17035564|NCT00423319|38179856|FG000|Overall Study|No longer meets study criteria|15|||
17035565|NCT00423319|38179857|FG001|Overall Study|No longer meets study criteria|15|||
17035566|NCT00423319|38179856|FG000|Overall Study|Other|23|||
17035567|NCT00423319|38179857|FG001|Overall Study|Other|22|||
17035568|NCT00710684|38179867|FG000|Overall Study|Adverse Event|11|||
17035569|NCT00710684|38179868|FG001|Overall Study|Adverse Event|19|||
17035570|NCT00710684|38179869|FG002|Overall Study|Adverse Event|16|||
17035571|NCT00710684|38179867|FG000|Overall Study|Lack of Efficacy|4|||
17035572|NCT00710684|38179868|FG001|Overall Study|Lack of Efficacy|3|||
17035573|NCT00710684|38179869|FG002|Overall Study|Lack of Efficacy|5|||
17035574|NCT00710684|38179867|FG000|Overall Study|Protocol Violation|5|||
17035575|NCT00710684|38179868|FG001|Overall Study|Protocol Violation|5|||
17035576|NCT00710684|38179869|FG002|Overall Study|Protocol Violation|5|||
17035577|NCT00710684|38179867|FG000|Overall Study|Lost to Follow-up|4|||
17035578|NCT00710684|38179868|FG001|Overall Study|Lost to Follow-up|6|||
17035579|NCT00710684|38179869|FG002|Overall Study|Lost to Follow-up|7|||
17035580|NCT00710684|38179867|FG000|Overall Study|Physician Decision|0|||
17035581|NCT00710684|38179868|FG001|Overall Study|Physician Decision|2|||
17035582|NCT00710684|38179869|FG002|Overall Study|Physician Decision|4|||
17035583|NCT00710684|38179867|FG000|Overall Study|Withdrawal by Subject|24|||
17035584|NCT00710684|38179868|FG001|Overall Study|Withdrawal by Subject|18|||
17035585|NCT00710684|38179869|FG002|Overall Study|Withdrawal by Subject|11|||
17035586|NCT00710684|38179867|FG000|Overall Study|Missing|1|||
17035587|NCT00710684|38179868|FG001|Overall Study|Missing|0|||
17035588|NCT00710684|38179869|FG002|Overall Study|Missing|0|||
17035589|NCT00710684|38179867|FG000|Overall Study|Did not continue after week 24|25|||
17035590|NCT00710684|38179868|FG001|Overall Study|Did not continue after week 24|21|||
17035591|NCT00710684|38179869|FG002|Overall Study|Did not continue after week 24|16|||
17035592|NCT00710606|38179885|FG000|Overall Study|Adverse Event|0|||
17035593|NCT00710606|38179886|FG001|Overall Study|Adverse Event|2|||
17035594|NCT00713544|38179900|FG000|Overall Study|Adverse Event|5|||
17035595|NCT00713544|38179901|FG001|Overall Study|Adverse Event|3|||
17035596|NCT00713544|38179902|FG002|Overall Study|Adverse Event|7|||
17035597|NCT00713544|38179903|FG003|Overall Study|Adverse Event|7|||
17035598|NCT00713544|38179904|FG004|Overall Study|Adverse Event|3|||
17035599|NCT00713544|38179905|FG005|Overall Study|Adverse Event|5|||
17035600|NCT00713544|38179900|FG000|Overall Study|Withdrawal by Subject|2|||
17035601|NCT00713544|38179901|FG001|Overall Study|Withdrawal by Subject|0|||
17035602|NCT00713544|38179902|FG002|Overall Study|Withdrawal by Subject|3|||
17035603|NCT00713544|38179903|FG003|Overall Study|Withdrawal by Subject|2|||
17035604|NCT00713544|38179904|FG004|Overall Study|Withdrawal by Subject|3|||
17035605|NCT00713544|38179905|FG005|Overall Study|Withdrawal by Subject|1|||
17035606|NCT00713544|38179900|FG000|Overall Study|Protocol Violation|0|||
17035607|NCT00713544|38179901|FG001|Overall Study|Protocol Violation|0|||
17035608|NCT00713544|38179902|FG002|Overall Study|Protocol Violation|0|||
17035609|NCT00713544|38179903|FG003|Overall Study|Protocol Violation|0|||
17035610|NCT00713544|38179904|FG004|Overall Study|Protocol Violation|0|||
17035611|NCT00713544|38179905|FG005|Overall Study|Protocol Violation|1|||
17035612|NCT00713544|38179900|FG000|Overall Study|Physician Decision|0|||
17035613|NCT00713544|38179901|FG001|Overall Study|Physician Decision|0|||
17035614|NCT00713544|38179902|FG002|Overall Study|Physician Decision|0|||
17035615|NCT00713544|38179903|FG003|Overall Study|Physician Decision|0|||
17035616|NCT00713544|38179904|FG004|Overall Study|Physician Decision|0|||
17035617|NCT00713544|38179905|FG005|Overall Study|Physician Decision|2|||
17035618|NCT00713544|38179900|FG000|Overall Study|Lack of Efficacy|0|||
17035619|NCT00713544|38179901|FG001|Overall Study|Lack of Efficacy|1|||
17035620|NCT00713544|38179902|FG002|Overall Study|Lack of Efficacy|0|||
17035621|NCT00713544|38179903|FG003|Overall Study|Lack of Efficacy|1|||
17035622|NCT00713544|38179904|FG004|Overall Study|Lack of Efficacy|1|||
17035623|NCT00713544|38179905|FG005|Overall Study|Lack of Efficacy|0|||
17035624|NCT00713544|38179900|FG000|Overall Study|Lost to Follow-up|0|||
17035625|NCT00713544|38179901|FG001|Overall Study|Lost to Follow-up|0|||
17035626|NCT00713544|38179902|FG002|Overall Study|Lost to Follow-up|1|||
17035627|NCT00713544|38179903|FG003|Overall Study|Lost to Follow-up|0|||
17035628|NCT00713544|38179904|FG004|Overall Study|Lost to Follow-up|0|||
17035629|NCT00713544|38179905|FG005|Overall Study|Lost to Follow-up|0|||
17035630|NCT00713544|38179900|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
17035631|NCT00713544|38179901|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
17035632|NCT00713544|38179902|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
17035633|NCT00713544|38179903|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
17035634|NCT00713544|38179904|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
17035635|NCT00713544|38179905|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
17035636|NCT00713544|38179900|FG000|Overall Study|Incorrect enrollment|0|||
17035637|NCT00713544|38179901|FG001|Overall Study|Incorrect enrollment|1|||
17035638|NCT00713544|38179902|FG002|Overall Study|Incorrect enrollment|0|||
17035639|NCT00713544|38179903|FG003|Overall Study|Incorrect enrollment|0|||
17035640|NCT00713544|38179904|FG004|Overall Study|Incorrect enrollment|0|||
17035641|NCT00713544|38179905|FG005|Overall Study|Incorrect enrollment|0|||
17035642|NCT00713544|38179900|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
17035643|NCT00713544|38179901|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
17035644|NCT00713544|38179902|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
17035645|NCT00713544|38179903|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
17035646|NCT00713544|38179904|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
17035647|NCT00713544|38179905|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
17035648|NCT00415363|38179921|FG000|Overall Study|Withdrawal by Subject|4|||
17035649|NCT00415363|38179922|FG001|Overall Study|Withdrawal by Subject|4|||
17035650|NCT00415363|38179921|FG000|Overall Study|Adverse Event|4|||
17035651|NCT00415363|38179922|FG001|Overall Study|Adverse Event|4|||
17035652|NCT00415363|38179921|FG000|Overall Study|Lost to Follow-up|2|||
17035653|NCT00415363|38179922|FG001|Overall Study|Lost to Follow-up|1|||
17035654|NCT00415363|38179921|FG000|Overall Study|Physician Decision|3|||
17035655|NCT00415363|38179922|FG001|Overall Study|Physician Decision|1|||
17035656|NCT00415363|38179921|FG000|Overall Study|Death|16|||
17035657|NCT00415363|38179922|FG001|Overall Study|Death|12|||
17035658|NCT00415363|38179921|FG000|Overall Study|Progressive disease|26|||
17035659|NCT00415363|38179922|FG001|Overall Study|Progressive disease|32|||
17035660|NCT00415051|38179929|FG000|Overall Study|Protocol Violation|1|||
17035661|NCT00713258|38179935|FG000|Overall Study|Adverse Event|2|||
17035662|NCT00713258|38179936|FG001|Overall Study|Adverse Event|4|||
17035663|NCT00713258|38179935|FG000|Overall Study|Non-Compliance|2|||
17035664|NCT00713258|38179936|FG001|Overall Study|Non-Compliance|1|||
17035665|NCT00713258|38179935|FG000|Overall Study|Other|1|||
17035666|NCT00713258|38179936|FG001|Overall Study|Other|1|||
17035667|NCT00710034|38179944|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
17035668|NCT00710034|38179945|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
17035669|NCT00710034|38179944|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
17035670|NCT00710034|38179945|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
17035671|NCT00710034|38179944|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
17035672|NCT00710034|38179945|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
17035673|NCT00710034|38179944|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
17035674|NCT00710034|38179945|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
17035675|NCT00710034|38179944|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
17138048|NCT00075725|38279867|FG008|Overall Study|Pt went to transplant|0|||
17138049|NCT00075725|38279868|FG009|Overall Study|Pt went to transplant|0|||
17138050|NCT00075725|38279869|FG010|Overall Study|Pt went to transplant|0|||
17138051|NCT00075725|38279870|FG011|Overall Study|Pt went to transplant|0|||
17138052|NCT00075725|38279859|FG000|Overall Study|Pt received additional steroids|0|||
17138053|NCT00075725|38279860|FG001|Overall Study|Pt received additional steroids|0|||
17035676|NCT00710034|38179945|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
17035677|NCT00710034|38179944|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
17035678|NCT00710034|38179945|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
17035679|NCT00710034|38179944|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
17035680|NCT00710034|38179945|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
17035681|NCT00710034|38179944|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
17035682|NCT00710034|38179945|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
17035683|NCT00710034|38179944|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
17035684|NCT00710034|38179945|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
17035685|NCT00710034|38179944|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
17035686|NCT00710034|38179945|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
17035687|NCT00710034|38179944|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
17035688|NCT00710034|38179945|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
17035689|NCT00414973|38179955|FG000|Overall Study|Withdrawal by Subject|14|||
17035690|NCT00414973|38179956|FG001|Overall Study|Withdrawal by Subject|4|||
17035691|NCT00414973|38179957|FG002|Overall Study|Withdrawal by Subject|1|||
17035692|NCT00414973|38179958|FG003|Overall Study|Withdrawal by Subject|0|||
17035693|NCT00414973|38179955|FG000|Overall Study|Adverse Event|10|||
17035694|NCT00414973|38179956|FG001|Overall Study|Adverse Event|0|||
17035695|NCT00414973|38179957|FG002|Overall Study|Adverse Event|1|||
17035696|NCT00414973|38179958|FG003|Overall Study|Adverse Event|0|||
17035697|NCT00414973|38179955|FG000|Overall Study|Protocol Violation|3|||
17035698|NCT00414973|38179956|FG001|Overall Study|Protocol Violation|4|||
17035699|NCT00414973|38179957|FG002|Overall Study|Protocol Violation|0|||
17035700|NCT00414973|38179958|FG003|Overall Study|Protocol Violation|0|||
17035701|NCT00414973|38179955|FG000|Overall Study|Lost to Follow-up|0|||
17035702|NCT00414973|38179956|FG001|Overall Study|Lost to Follow-up|2|||
17035703|NCT00414973|38179957|FG002|Overall Study|Lost to Follow-up|0|||
17035704|NCT00414973|38179958|FG003|Overall Study|Lost to Follow-up|0|||
17035705|NCT00414973|38179955|FG000|Overall Study|Sponsor Decision|1|||
17035706|NCT00414973|38179956|FG001|Overall Study|Sponsor Decision|0|||
17035707|NCT00414973|38179957|FG002|Overall Study|Sponsor Decision|0|||
17035708|NCT00414973|38179958|FG003|Overall Study|Sponsor Decision|0|||
17035709|NCT00414973|38179955|FG000|Overall Study|Death|0|||
17035710|NCT00414973|38179956|FG001|Overall Study|Death|0|||
17035711|NCT00414973|38179957|FG002|Overall Study|Death|1|||
17035712|NCT00414973|38179958|FG003|Overall Study|Death|0|||
17035713|NCT00423085|38179971|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
17035714|NCT00423085|38179972|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
17035715|NCT00423085|38179973|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
17035716|NCT00423085|38179974|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
17035717|NCT00423085|38179971|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
17035718|NCT00423085|38179972|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
17035719|NCT00423085|38179973|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
17035720|NCT00423085|38179974|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
17035721|NCT00423085|38179971|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
17035722|NCT00423085|38179972|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
17035723|NCT00423085|38179973|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
17035724|NCT00423085|38179974|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
17035725|NCT00423085|38179971|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
17035726|NCT00423085|38179972|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
17035727|NCT00423085|38179973|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
17138054|NCT00075725|38279861|FG002|Overall Study|Pt received additional steroids|0|||
17138055|NCT00075725|38279862|FG003|Overall Study|Pt received additional steroids|1|||
17138056|NCT00075725|38279863|FG004|Overall Study|Pt received additional steroids|0|||
17138057|NCT00075725|38279864|FG005|Overall Study|Pt received additional steroids|0|||
17138058|NCT00075725|38279865|FG006|Overall Study|Pt received additional steroids|0|||
17138059|NCT00075725|38279866|FG007|Overall Study|Pt received additional steroids|0|||
17138060|NCT00075725|38279867|FG008|Overall Study|Pt received additional steroids|0|||
17138061|NCT00075725|38279868|FG009|Overall Study|Pt received additional steroids|0|||
17138062|NCT00075725|38279869|FG010|Overall Study|Pt received additional steroids|0|||
17138063|NCT00075725|38279870|FG011|Overall Study|Pt received additional steroids|0|||
17138064|NCT00075725|38279859|FG000|Overall Study|Pt relocated|0|||
17138065|NCT00075725|38279860|FG001|Overall Study|Pt relocated|0|||
17138066|NCT00075725|38279861|FG002|Overall Study|Pt relocated|0|||
17138067|NCT00075725|38279862|FG003|Overall Study|Pt relocated|2|||
17138068|NCT00075725|38279863|FG004|Overall Study|Pt relocated|0|||
17138069|NCT00075725|38279864|FG005|Overall Study|Pt relocated|1|||
17138070|NCT00075725|38279865|FG006|Overall Study|Pt relocated|1|||
17138071|NCT00075725|38279866|FG007|Overall Study|Pt relocated|2|||
17138072|NCT00075725|38279867|FG008|Overall Study|Pt relocated|1|||
17138073|NCT00075725|38279868|FG009|Overall Study|Pt relocated|0|||
17138074|NCT00075725|38279869|FG010|Overall Study|Pt relocated|0|||
17035728|NCT00423085|38179974|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
17035729|NCT00423085|38179971|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
17035730|NCT00423085|38179972|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
17035731|NCT00423085|38179973|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
17035732|NCT00423085|38179974|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
17035733|NCT00423085|38179971|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
17035734|NCT00423085|38179972|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
17035735|NCT00423085|38179973|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
17035736|NCT00423085|38179974|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
17035737|NCT00423085|38179971|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
17035738|NCT00423085|38179972|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
17035739|NCT00423085|38179973|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
17035740|NCT00423085|38179974|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
17035741|NCT00423085|38179971|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
17035742|NCT00423085|38179972|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
17035743|NCT00423085|38179973|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
17035744|NCT00423085|38179974|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
17035745|NCT00423085|38179971|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
17035746|NCT00423085|38179972|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
17035747|NCT00423085|38179973|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
17035748|NCT00423085|38179974|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
17035749|NCT00423085|38179971|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
17035750|NCT00423085|38179972|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
17035751|NCT00423085|38179973|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
17035752|NCT00423085|38179974|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
17035753|NCT00423085|38179971|FG000|52-Week Open-Label Extension Phase|Death|0|||
17035754|NCT00423085|38179972|FG001|52-Week Open-Label Extension Phase|Death|0|||
17035755|NCT00423085|38179973|FG002|52-Week Open-Label Extension Phase|Death|0|||
17035756|NCT00423085|38179974|FG003|52-Week Open-Label Extension Phase|Death|2|||
17035757|NCT00414661|38179988|FG000|Overall Study|Death|2|||
17035758|NCT00414661|38179989|FG001|Overall Study|Death|5|||
17035759|NCT00414661|38179990|FG002|Overall Study|Death|0|||
17035760|NCT00414661|38179991|FG003|Overall Study|Death|0|||
17035761|NCT00414661|38179988|FG000|Overall Study|Lost to Follow-up|1|||
17035762|NCT00414661|38179989|FG001|Overall Study|Lost to Follow-up|4|||
17035763|NCT00414661|38179990|FG002|Overall Study|Lost to Follow-up|0|||
17035764|NCT00414661|38179991|FG003|Overall Study|Lost to Follow-up|1|||
17035765|NCT00414661|38179988|FG000|Overall Study|Withdrawal by Subject|5|||
17035766|NCT00414661|38179989|FG001|Overall Study|Withdrawal by Subject|2|||
17035767|NCT00414661|38179990|FG002|Overall Study|Withdrawal by Subject|2|||
17035768|NCT00414661|38179991|FG003|Overall Study|Withdrawal by Subject|2|||
17035769|NCT00414661|38179988|FG000|Overall Study|Other|6|||
17035770|NCT00414661|38179989|FG001|Overall Study|Other|3|||
17035771|NCT00414661|38179990|FG002|Overall Study|Other|0|||
17035772|NCT00414661|38179991|FG003|Overall Study|Other|0|||
17035773|NCT00405067|38180004|FG000|Overall Study|Adverse Event|4|||
17035774|NCT00405067|38180005|FG001|Overall Study|Adverse Event|9|||
17035775|NCT00405067|38180006|FG002|Overall Study|Adverse Event|4|||
17035776|NCT00405067|38180004|FG000|Overall Study|Lost to Follow-up|0|||
17035777|NCT00405067|38180005|FG001|Overall Study|Lost to Follow-up|0|||
17035778|NCT00405067|38180006|FG002|Overall Study|Lost to Follow-up|1|||
17035779|NCT00708708|38180014|FG000|Overall Study|Another therapy instead of Enbrel|141|||
17035780|NCT00708708|38180014|FG000|Overall Study|Lost to Follow-up|52|||
17035781|NCT00708708|38180014|FG000|Overall Study|Withdrawal by Subject|51|||
17035782|NCT00708708|38180014|FG000|Overall Study|Intolerance|42|||
17035783|NCT00708708|38180014|FG000|Overall Study|Another therapy along with Enbrel|15|||
17035784|NCT00708708|38180014|FG000|Overall Study|Other unspecified|11|||
17035785|NCT00708708|38180014|FG000|Overall Study|Good effectiveness|9|||
17138075|NCT00075725|38279870|FG011|Overall Study|Pt relocated|0|||
17138076|NCT00075725|38279859|FG000|Overall Study|Institution Terminated|0|||
17138077|NCT00075725|38279860|FG001|Overall Study|Institution Terminated|0|||
17138078|NCT00075725|38279861|FG002|Overall Study|Institution Terminated|0|||
17035786|NCT00708708|38180014|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
17035787|NCT00708708|38180014|FG000|Overall Study|Administrative reasons|7|||
17035788|NCT00708708|38180014|FG000|Overall Study|Lack of effectiveness|4|||
17035789|NCT00708708|38180014|FG000|Overall Study|Lack of compliance|3|||
17035790|NCT00708708|38180014|FG000|Overall Study|Pregnancy|3|||
17035791|NCT00708708|38180014|FG000|Overall Study|Adverse Event|3|||
17035792|NCT00708708|38180014|FG000|Overall Study|Missing values|392|||
17035793|NCT00404755|38180021|FG000|Phase I (Bupropion)|Adverse Event|3|||
17035794|NCT00404755|38180021|FG000|Phase I (Bupropion)|Other|1|||
17035795|NCT00404755|38180021|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
17035796|NCT00614614|38180031|FG000|Primary Vaccination Phase|Adverse Event|6|||
17035797|NCT00614614|38180032|FG001|Primary Vaccination Phase|Adverse Event|0|||
17035798|NCT00614614|38180033|FG002|Primary Vaccination Phase|Adverse Event|0|||
17035799|NCT00614614|38180034|FG003|Primary Vaccination Phase|Adverse Event|0|||
17035800|NCT00614614|38180035|FG004|Primary Vaccination Phase|Adverse Event|0|||
17035801|NCT00614614|38180031|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
17035802|NCT00614614|38180032|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
17035803|NCT00614614|38180033|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
17035804|NCT00614614|38180034|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
17035805|NCT00614614|38180035|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
17035806|NCT00614614|38180031|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
17035807|NCT00614614|38180032|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
17035808|NCT00614614|38180033|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
17035809|NCT00614614|38180034|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
17035810|NCT00614614|38180035|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
17035811|NCT00614614|38180031|FG000|Primary Vaccination Phase|Protocol Violation|9|||
17035812|NCT00614614|38180032|FG001|Primary Vaccination Phase|Protocol Violation|3|||
17035813|NCT00614614|38180033|FG002|Primary Vaccination Phase|Protocol Violation|0|||
17035814|NCT00614614|38180034|FG003|Primary Vaccination Phase|Protocol Violation|0|||
17035815|NCT00614614|38180035|FG004|Primary Vaccination Phase|Protocol Violation|0|||
17035816|NCT00614614|38180031|FG000|Primary Vaccination Phase|Other|4|||
17035817|NCT00614614|38180032|FG001|Primary Vaccination Phase|Other|0|||
17035818|NCT00614614|38180033|FG002|Primary Vaccination Phase|Other|0|||
17035819|NCT00614614|38180034|FG003|Primary Vaccination Phase|Other|0|||
17035820|NCT00614614|38180035|FG004|Primary Vaccination Phase|Other|0|||
17035821|NCT00614614|38180031|FG000|Booster Vaccination Phase|Adverse Event|0|||
17035822|NCT00614614|38180032|FG001|Booster Vaccination Phase|Adverse Event|0|||
17035823|NCT00614614|38180033|FG002|Booster Vaccination Phase|Adverse Event|1|||
17035824|NCT00614614|38180034|FG003|Booster Vaccination Phase|Adverse Event|1|||
17035825|NCT00614614|38180035|FG004|Booster Vaccination Phase|Adverse Event|0|||
17035826|NCT00614614|38180031|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
17035827|NCT00614614|38180032|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
17035828|NCT00614614|38180033|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
17035829|NCT00614614|38180034|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
17035830|NCT00614614|38180035|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
17035831|NCT00614614|38180031|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
17035832|NCT00614614|38180032|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
17035833|NCT00614614|38180033|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
17035834|NCT00614614|38180034|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
17035835|NCT00614614|38180035|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
17035836|NCT00614614|38180031|FG000|Booster Vaccination Phase|Protocol Violation|0|||
17035837|NCT00614614|38180032|FG001|Booster Vaccination Phase|Protocol Violation|0|||
17035838|NCT00614614|38180033|FG002|Booster Vaccination Phase|Protocol Violation|2|||
17035839|NCT00614614|38180034|FG003|Booster Vaccination Phase|Protocol Violation|3|||
17035840|NCT00614614|38180035|FG004|Booster Vaccination Phase|Protocol Violation|0|||
17035841|NCT00614614|38180031|FG000|Booster Vaccination Phase|Other|0|||
17035842|NCT00614614|38180032|FG001|Booster Vaccination Phase|Other|1|||
17035843|NCT00614614|38180033|FG002|Booster Vaccination Phase|Other|3|||
17035844|NCT00614614|38180034|FG003|Booster Vaccination Phase|Other|2|||
17035845|NCT00614614|38180035|FG004|Booster Vaccination Phase|Other|1|||
17035846|NCT00713310|38180052|FG000|Overall Study|Adverse Event|5|||
17035847|NCT00713310|38180053|FG001|Overall Study|Adverse Event|2|||
17035848|NCT00713310|38180052|FG000|Overall Study|Lack of Efficacy|0|||
17138079|NCT00075725|38279862|FG003|Overall Study|Institution Terminated|0|||
17138080|NCT00075725|38279863|FG004|Overall Study|Institution Terminated|1|||
17035849|NCT00713310|38180053|FG001|Overall Study|Lack of Efficacy|2|||
17035850|NCT00713310|38180052|FG000|Overall Study|Withdrawal by Subject|0|||
17035851|NCT00713310|38180053|FG001|Overall Study|Withdrawal by Subject|2|||
17035852|NCT00422461|38180063|FG000|Overall Study|Adverse Event|1|||
17035853|NCT00422461|38180064|FG001|Overall Study|Adverse Event|2|||
17035854|NCT00422461|38180065|FG002|Overall Study|Adverse Event|1|||
17035855|NCT00422461|38180066|FG003|Overall Study|Adverse Event|1|||
17035856|NCT00422461|38180063|FG000|Overall Study|Other|0|||
17035857|NCT00422461|38180064|FG001|Overall Study|Other|0|||
17035858|NCT00422461|38180065|FG002|Overall Study|Other|0|||
17035859|NCT00422461|38180066|FG003|Overall Study|Other|2|||
17035860|NCT00422461|38180063|FG000|Overall Study|Participants no longer willing to participate in study|1|||
17035861|NCT00422461|38180064|FG001|Overall Study|Participants no longer willing to participate in study|0|||
17138081|NCT00075725|38279864|FG005|Overall Study|Institution Terminated|0|||
17035862|NCT00422461|38180065|FG002|Overall Study|Participants no longer willing to participate in study|0|||
17035863|NCT00422461|38180066|FG003|Overall Study|Participants no longer willing to participate in study|0|||
17138082|NCT00075725|38279865|FG006|Overall Study|Institution Terminated|0|||
17138083|NCT00075725|38279866|FG007|Overall Study|Institution Terminated|3|||
17138084|NCT00075725|38279867|FG008|Overall Study|Institution Terminated|0|||
17138085|NCT00075725|38279868|FG009|Overall Study|Institution Terminated|0|||
17138086|NCT00075725|38279869|FG010|Overall Study|Institution Terminated|0|||
17138087|NCT00075725|38279870|FG011|Overall Study|Institution Terminated|0|||
17138088|NCT00075725|38279859|FG000|Overall Study|Study Closure|1|||
17138089|NCT00075725|38279860|FG001|Overall Study|Study Closure|0|||
17138090|NCT00075725|38279861|FG002|Overall Study|Study Closure|0|||
17138091|NCT00075725|38279862|FG003|Overall Study|Study Closure|0|||
17138092|NCT00075725|38279863|FG004|Overall Study|Study Closure|1|||
17138093|NCT00075725|38279864|FG005|Overall Study|Study Closure|3|||
17138094|NCT00075725|38279865|FG006|Overall Study|Study Closure|0|||
17138095|NCT00075725|38279866|FG007|Overall Study|Study Closure|1|||
17138096|NCT00075725|38279867|FG008|Overall Study|Study Closure|0|||
17138097|NCT00075725|38279868|FG009|Overall Study|Study Closure|0|||
17138098|NCT00075725|38279869|FG010|Overall Study|Study Closure|0|||
17138099|NCT00075725|38279870|FG011|Overall Study|Study Closure|0|||
17138100|NCT00075725|38279859|FG000|Overall Study|Other complications|0|||
17035864|NCT00422461|38180063|FG000|Overall Study|Randomized but not treated|1|||
17035865|NCT00422461|38180064|FG001|Overall Study|Randomized but not treated|1|||
17035866|NCT00422461|38180065|FG002|Overall Study|Randomized but not treated|0|||
17035867|NCT00422461|38180066|FG003|Overall Study|Randomized but not treated|0|||
17035868|NCT00712920|38180079|FG000|Overall Study|Adverse Event|3|||
17138101|NCT00075725|38279860|FG001|Overall Study|Other complications|0|||
17035869|NCT00712920|38180080|FG001|Overall Study|Adverse Event|4|||
17035870|NCT00712920|38180081|FG002|Overall Study|Adverse Event|7|||
17035871|NCT00712920|38180079|FG000|Overall Study|Withdrawal by Subject|4|||
17035872|NCT00712920|38180080|FG001|Overall Study|Withdrawal by Subject|2|||
17138102|NCT00075725|38279861|FG002|Overall Study|Other complications|0|||
17138103|NCT00075725|38279862|FG003|Overall Study|Other complications|0|||
17138104|NCT00075725|38279863|FG004|Overall Study|Other complications|0|||
17138105|NCT00075725|38279864|FG005|Overall Study|Other complications|1|||
17138106|NCT00075725|38279865|FG006|Overall Study|Other complications|0|||
17138107|NCT00075725|38279866|FG007|Overall Study|Other complications|0|||
17138108|NCT00075725|38279867|FG008|Overall Study|Other complications|0|||
17138109|NCT00075725|38279868|FG009|Overall Study|Other complications|0|||
17138110|NCT00075725|38279869|FG010|Overall Study|Other complications|0|||
17138111|NCT00075725|38279870|FG011|Overall Study|Other complications|0|||
17138112|NCT00075725|38279859|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
17138113|NCT00075725|38279860|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
17138114|NCT00075725|38279861|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
17138115|NCT00075725|38279862|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
17035873|NCT00712920|38180081|FG002|Overall Study|Withdrawal by Subject|1|||
17035874|NCT00712920|38180079|FG000|Overall Study|Lost to Follow-up|1|||
17035875|NCT00712920|38180080|FG001|Overall Study|Lost to Follow-up|4|||
17035876|NCT00712920|38180081|FG002|Overall Study|Lost to Follow-up|0|||
17138116|NCT00075725|38279863|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
17138117|NCT00075725|38279864|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
17138118|NCT00075725|38279865|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
17138119|NCT00075725|38279866|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
17138120|NCT00075725|38279867|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
17138121|NCT00075725|38279868|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
17035877|NCT00712920|38180079|FG000|Overall Study|Lack of Efficacy|1|||
17035878|NCT00712920|38180080|FG001|Overall Study|Lack of Efficacy|0|||
17035879|NCT00712920|38180081|FG002|Overall Study|Lack of Efficacy|1|||
17035880|NCT00712920|38180079|FG000|Overall Study|Other|5|||
17035881|NCT00712920|38180080|FG001|Overall Study|Other|7|||
17035882|NCT00712920|38180081|FG002|Overall Study|Other|3|||
17035883|NCT00712920|38180079|FG000|Overall Study|Non-compliance|3|||
17035884|NCT00712920|38180080|FG001|Overall Study|Non-compliance|0|||
17035885|NCT00712920|38180081|FG002|Overall Study|Non-compliance|0|||
17035886|NCT00710424|38180100|FG000|Overall Study|Adverse Event|30|||
17035887|NCT00710424|38180101|FG001|Overall Study|Adverse Event|12|||
17035888|NCT00710424|38180100|FG000|Overall Study|Lack of Efficacy|4|||
17035889|NCT00710424|38180101|FG001|Overall Study|Lack of Efficacy|5|||
17035890|NCT00710424|38180100|FG000|Overall Study|Withdrawal by Subject|5|||
17035891|NCT00710424|38180101|FG001|Overall Study|Withdrawal by Subject|3|||
17035892|NCT00710424|38180100|FG000|Overall Study|Lost to Follow-up|0|||
17035893|NCT00710424|38180101|FG001|Overall Study|Lost to Follow-up|1|||
17035894|NCT00710424|38180100|FG000|Overall Study|Refused medication, no side effects|1|||
17035895|NCT00710424|38180101|FG001|Overall Study|Refused medication, no side effects|0|||
17035896|NCT00710424|38180100|FG000|Overall Study|Non-compliance with stable analgesia|1|||
17035897|NCT00710424|38180101|FG001|Overall Study|Non-compliance with stable analgesia|0|||
17035898|NCT00710424|38180100|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
17035899|NCT00710424|38180101|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
17035900|NCT00710424|38180100|FG000|Overall Study|Subject thought medication changed|1|||
17035901|NCT00710424|38180101|FG001|Overall Study|Subject thought medication changed|0|||
17035902|NCT00710424|38180100|FG000|Overall Study|Ceased treatment due to travel|1|||
17035903|NCT00710424|38180101|FG001|Overall Study|Ceased treatment due to travel|0|||
17035904|NCT00710424|38180100|FG000|Overall Study|Subject preferred paracetamol|0|||
17035905|NCT00710424|38180101|FG001|Overall Study|Subject preferred paracetamol|1|||
17035906|NCT00710424|38180100|FG000|Overall Study|Felt good so stopped treatment|0|||
17035907|NCT00710424|38180101|FG001|Overall Study|Felt good so stopped treatment|1|||
17035908|NCT00612586|38180109|FG000|Overall Study|Adverse Event|6|||
17035909|NCT00612586|38180110|FG001|Overall Study|Adverse Event|2|||
17035910|NCT00612586|38180109|FG000|Overall Study|Death|1|||
17035911|NCT00612586|38180110|FG001|Overall Study|Death|0|||
17035912|NCT00612586|38180109|FG000|Overall Study|Entry Criteria Not Met|0|||
17035913|NCT00612586|38180110|FG001|Overall Study|Entry Criteria Not Met|2|||
17035914|NCT00612586|38180109|FG000|Overall Study|Withdrawal by Subject|7|||
17035915|NCT00612586|38180110|FG001|Overall Study|Withdrawal by Subject|9|||
17035916|NCT00612586|38180109|FG000|Overall Study|Physician Decision|1|||
17035917|NCT00612586|38180110|FG001|Overall Study|Physician Decision|2|||
17035918|NCT00612586|38180109|FG000|Overall Study|Sponsor Decision|1|||
17035919|NCT00612586|38180110|FG001|Overall Study|Sponsor Decision|1|||
17138122|NCT00075725|38279869|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
17138123|NCT00075725|38279870|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
17035920|NCT00612586|38180109|FG000|Overall Study|Progressive Disease|26|||
17035921|NCT00612586|38180110|FG001|Overall Study|Progressive Disease|24|||
17138124|NCT00075725|38279859|FG000|Overall Study|Pt incarcerated|0|||
17138125|NCT00075725|38279860|FG001|Overall Study|Pt incarcerated|0|||
17138126|NCT00075725|38279861|FG002|Overall Study|Pt incarcerated|0|||
17035922|NCT00612586|38180109|FG000|Overall Study|Randomized and Not Treated|1|||
17138127|NCT00075725|38279862|FG003|Overall Study|Pt incarcerated|0|||
17138128|NCT00075725|38279863|FG004|Overall Study|Pt incarcerated|0|||
17138129|NCT00075725|38279864|FG005|Overall Study|Pt incarcerated|0|||
17138130|NCT00075725|38279865|FG006|Overall Study|Pt incarcerated|0|||
17138131|NCT00075725|38279866|FG007|Overall Study|Pt incarcerated|1|||
17138132|NCT00075725|38279867|FG008|Overall Study|Pt incarcerated|0|||
17138133|NCT00075725|38279868|FG009|Overall Study|Pt incarcerated|0|||
17138134|NCT00075725|38279869|FG010|Overall Study|Pt incarcerated|0|||
17138135|NCT00075725|38279870|FG011|Overall Study|Pt incarcerated|0|||
17138136|NCT02953782|38279909|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
17138137|NCT02953782|38279910|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
17138138|NCT02953782|38279911|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
17138139|NCT02953782|38279912|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
17138140|NCT02953782|38279913|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
17138141|NCT02953782|38279914|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
17138142|NCT02953782|38279915|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
17138143|NCT02953782|38279916|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
17138144|NCT02953782|38279909|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
17138145|NCT02953782|38279910|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
17138146|NCT02953782|38279911|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
17035923|NCT00612586|38180110|FG001|Overall Study|Randomized and Not Treated|1|||
17035924|NCT00614380|38180121|FG000|Overall Study|Adverse Event|14|||
17035925|NCT00614380|38180122|FG001|Overall Study|Adverse Event|4|||
17035926|NCT00614380|38180123|FG002|Overall Study|Adverse Event|0|||
17138147|NCT02953782|38279912|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
17138148|NCT02953782|38279913|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
17138149|NCT02953782|38279914|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
17138150|NCT02953782|38279915|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
17035927|NCT00614380|38180124|FG003|Overall Study|Adverse Event|0|||
17035928|NCT00614380|38180121|FG000|Overall Study|Lost to Follow-up|6|||
17035929|NCT00614380|38180122|FG001|Overall Study|Lost to Follow-up|1|||
17035930|NCT00614380|38180123|FG002|Overall Study|Lost to Follow-up|0|||
17035931|NCT00614380|38180124|FG003|Overall Study|Lost to Follow-up|0|||
17035932|NCT00614380|38180121|FG000|Overall Study|Non compliant with the protocol|12|||
17035933|NCT00614380|38180122|FG001|Overall Study|Non compliant with the protocol|2|||
17035934|NCT00614380|38180123|FG002|Overall Study|Non compliant with the protocol|1|||
17035935|NCT00614380|38180124|FG003|Overall Study|Non compliant with the protocol|2|||
17035936|NCT00614380|38180121|FG000|Overall Study|Consent withdrawn|3|||
17035937|NCT00614380|38180122|FG001|Overall Study|Consent withdrawn|1|||
17035938|NCT00614380|38180123|FG002|Overall Study|Consent withdrawn|0|||
17035939|NCT00614380|38180124|FG003|Overall Study|Consent withdrawn|0|||
17035940|NCT00612508|38180141|FG000|Overall Study|Withdrawal by Subject|3|||
17035941|NCT00612508|38180142|FG001|Overall Study|Withdrawal by Subject|4|||
17035942|NCT00613834|38180152|FG000|Overall Study|Withdrawal by Subject|0|||
17035943|NCT00613834|38180153|FG001|Overall Study|Withdrawal by Subject|3|||
17035944|NCT00613366|38180167|FG000|Overall Study|Withdrawal by Subject|3|||
17035945|NCT00613366|38180168|FG001|Overall Study|Withdrawal by Subject|2|||
17035946|NCT00612352|38180176|FG000|Overall Study|Adverse Event|1|||
17035947|NCT00612352|38180177|FG001|Overall Study|Adverse Event|0|||
17035948|NCT00612352|38180176|FG000|Overall Study|Withdrawal by Subject|3|||
17035949|NCT00612352|38180177|FG001|Overall Study|Withdrawal by Subject|5|||
17035950|NCT00612352|38180176|FG000|Overall Study|moved out of state|1|||
17035951|NCT00612352|38180177|FG001|Overall Study|moved out of state|0|||
17035952|NCT00612352|38180176|FG000|Overall Study|didn't return calls/show up on test date|4|||
17035953|NCT00612352|38180177|FG001|Overall Study|didn't return calls/show up on test date|1|||
17035954|NCT00704730|38180185|FG000|Overall Study|Adverse Event|35|||
17035955|NCT00704730|38180186|FG001|Overall Study|Adverse Event|9|||
17035956|NCT00704730|38180185|FG000|Overall Study|Death|11|||
17035957|NCT00704730|38180186|FG001|Overall Study|Death|5|||
17035958|NCT00704730|38180185|FG000|Overall Study|Physician Decision|2|||
17035959|NCT00704730|38180186|FG001|Overall Study|Physician Decision|0|||
17035960|NCT00704730|38180185|FG000|Overall Study|Did not receive drug|5|||
17035961|NCT00704730|38180186|FG001|Overall Study|Did not receive drug|2|||
17035962|NCT00704730|38180185|FG000|Overall Study|Disease progression per PI|58|||
17035963|NCT00704730|38180186|FG001|Overall Study|Disease progression per PI|67|||
17035964|NCT00704730|38180185|FG000|Overall Study|data unavailable|1|||
17138151|NCT02953782|38279916|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
17035965|NCT00704730|38180186|FG001|Overall Study|data unavailable|0|||
17138152|NCT02953782|38279909|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
17138153|NCT02953782|38279910|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
17035966|NCT00704730|38180185|FG000|Overall Study|Withdrawal by Subject|9|||
17035967|NCT00704730|38180186|FG001|Overall Study|Withdrawal by Subject|13|||
17035968|NCT00651261|38180195|FG000|Overall Study|Adverse Event|32|||
17035969|NCT00651261|38180196|FG001|Overall Study|Adverse Event|22|||
17035970|NCT00651261|38180195|FG000|Overall Study|Death|18|||
17035971|NCT00651261|38180196|FG001|Overall Study|Death|18|||
17035972|NCT00651261|38180195|FG000|Overall Study|Withdrawal by Subject|22|||
17035973|NCT00651261|38180196|FG001|Overall Study|Withdrawal by Subject|40|||
17035974|NCT00651261|38180195|FG000|Overall Study|Induction failure|24|||
17035975|NCT00651261|38180196|FG001|Overall Study|Induction failure|35|||
17035976|NCT00651261|38180195|FG000|Overall Study|Disease progression|58|||
17035977|NCT00651261|38180196|FG001|Overall Study|Disease progression|58|||
17035978|NCT00651261|38180195|FG000|Overall Study|Alternative therapy|109|||
17035979|NCT00651261|38180196|FG001|Overall Study|Alternative therapy|107|||
17035980|NCT00651261|38180195|FG000|Overall Study|Other disease or participant decisions|23|||
17035981|NCT00651261|38180196|FG001|Overall Study|Other disease or participant decisions|23|||
17035982|NCT00651261|38180195|FG000|Overall Study|Never treated|5|||
17035983|NCT00651261|38180196|FG001|Overall Study|Never treated|3|||
17035984|NCT00651183|38180204|FG000|Overall Study|Lack of Efficacy|1|||
17035985|NCT00651183|38180205|FG001|Overall Study|Lack of Efficacy|0|||
17035986|NCT00651183|38180204|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
17035987|NCT00651183|38180205|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
17035988|NCT00651183|38180204|FG000|Overall Study|Tolerability insufficient|5|||
17035989|NCT00651183|38180205|FG001|Overall Study|Tolerability insufficient|2|||
17035990|NCT00651183|38180204|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
17035991|NCT00651183|38180205|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
17035992|NCT00651183|38180204|FG000|Overall Study|Withdrawal by Subject|6|||
17035993|NCT00651183|38180205|FG001|Overall Study|Withdrawal by Subject|3|||
17035994|NCT00651183|38180204|FG000|Overall Study|Lost to Follow-up|3|||
17035995|NCT00651183|38180205|FG001|Overall Study|Lost to Follow-up|1|||
17035996|NCT00651183|38180204|FG000|Overall Study|Other reasons|4|||
17035997|NCT00651183|38180205|FG001|Overall Study|Other reasons|2|||
17035998|NCT00651183|38180204|FG000|Overall Study|missing|1|||
17035999|NCT00651183|38180205|FG001|Overall Study|missing|0|||
17036000|NCT00699972|38180214|FG000|Overall Study|Adverse Event|7|||
17036001|NCT00699972|38180215|FG001|Overall Study|Adverse Event|9|||
17036002|NCT00699972|38180216|FG002|Overall Study|Adverse Event|24|||
17036003|NCT00699972|38180214|FG000|Overall Study|Lost to Follow-up|0|||
17036004|NCT00699972|38180215|FG001|Overall Study|Lost to Follow-up|2|||
17036005|NCT00699972|38180216|FG002|Overall Study|Lost to Follow-up|0|||
17036006|NCT00699972|38180214|FG000|Overall Study|Withdrawal by Subject|3|||
17036007|NCT00699972|38180215|FG001|Overall Study|Withdrawal by Subject|7|||
17036008|NCT00699972|38180216|FG002|Overall Study|Withdrawal by Subject|4|||
17036009|NCT00699972|38180214|FG000|Overall Study|Lack of Efficacy|2|||
17036010|NCT00699972|38180215|FG001|Overall Study|Lack of Efficacy|0|||
17036011|NCT00699972|38180216|FG002|Overall Study|Lack of Efficacy|2|||
17036012|NCT00699972|38180214|FG000|Overall Study|Administrative/Other|3|||
17036013|NCT00699972|38180215|FG001|Overall Study|Administrative/Other|1|||
17036014|NCT00699972|38180216|FG002|Overall Study|Administrative/Other|4|||
17036015|NCT00699972|38180214|FG000|Overall Study|Randomized, Not Treated|1|||
17036016|NCT00699972|38180215|FG001|Overall Study|Randomized, Not Treated|0|||
17036017|NCT00699972|38180216|FG002|Overall Study|Randomized, Not Treated|1|||
17036018|NCT00642759|38180224|FG000|Overall Study|Protocol Violation|1|||
17036019|NCT00611026|38180232|FG000|Randomized to Double-blind Treatment|Not treated|2|||
17036020|NCT00611026|38180233|FG001|Randomized to Double-blind Treatment|Not treated|1|||
17036021|NCT00611026|38180234|FG002|Randomized to Double-blind Treatment|Not treated|3|||
17036022|NCT00611026|38180232|FG000|Double-blind Treatment Period|Death|1|||
17036023|NCT00611026|38180233|FG001|Double-blind Treatment Period|Death|0|||
17036024|NCT00611026|38180234|FG002|Double-blind Treatment Period|Death|0|||
17036025|NCT00611026|38180232|FG000|Double-blind Treatment Period|Adverse Event|9|||
17036026|NCT00611026|38180233|FG001|Double-blind Treatment Period|Adverse Event|28|||
17036027|NCT00611026|38180234|FG002|Double-blind Treatment Period|Adverse Event|46|||
17036028|NCT00611026|38180232|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
17138154|NCT02953782|38279911|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
17138155|NCT02953782|38279912|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
17138156|NCT02953782|38279913|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
17138157|NCT02953782|38279914|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
17138158|NCT02953782|38279915|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
17036029|NCT00611026|38180233|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
17036030|NCT00611026|38180234|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
17036031|NCT00611026|38180232|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
17036032|NCT00611026|38180233|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
17036033|NCT00611026|38180234|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
17036034|NCT00611026|38180232|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
17036035|NCT00611026|38180233|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
17036036|NCT00611026|38180234|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
17036037|NCT00611026|38180232|FG000|Double-blind Treatment Period|Other|13|||
17036038|NCT00611026|38180233|FG001|Double-blind Treatment Period|Other|20|||
16991882|NCT00730015|38135859|FG000|Overall Study|Other Reason|1|||
16991883|NCT00730015|38135860|FG001|Overall Study|Other Reason|0|||
16991884|NCT00730015|38135861|FG002|Overall Study|Other Reason|1|||
16991885|NCT00806026|38135880|FG000|Overall Study|Death|0|||
17036039|NCT00611026|38180234|FG002|Double-blind Treatment Period|Other|18|||
17036040|NCT00646113|38180244|FG000|Overall Study|Lost to Follow-up|5|||
17036041|NCT00646113|38180244|FG000|Overall Study|Adverse Event|3|||
16991886|NCT00806026|38135881|FG001|Overall Study|Death|0|||
17036042|NCT00422383|38180253|FG000|Overall Study|Adverse Event|5|||
17036043|NCT00422383|38180254|FG001|Overall Study|Adverse Event|3|||
17036044|NCT00422383|38180255|FG002|Overall Study|Adverse Event|1|||
17036045|NCT00422383|38180256|FG003|Overall Study|Adverse Event|1|||
17036046|NCT00422383|38180257|FG004|Overall Study|Adverse Event|0|||
17036047|NCT00422383|38180253|FG000|Overall Study|Lack of Efficacy|4|||
17036048|NCT00422383|38180254|FG001|Overall Study|Lack of Efficacy|4|||
17036049|NCT00422383|38180255|FG002|Overall Study|Lack of Efficacy|2|||
17036050|NCT00422383|38180256|FG003|Overall Study|Lack of Efficacy|1|||
17036051|NCT00422383|38180257|FG004|Overall Study|Lack of Efficacy|1|||
17036052|NCT00422383|38180253|FG000|Overall Study|Lost to Follow-up|0|||
17036053|NCT00422383|38180254|FG001|Overall Study|Lost to Follow-up|1|||
17036054|NCT00422383|38180255|FG002|Overall Study|Lost to Follow-up|0|||
17036055|NCT00422383|38180256|FG003|Overall Study|Lost to Follow-up|0|||
17036056|NCT00422383|38180257|FG004|Overall Study|Lost to Follow-up|1|||
17036057|NCT00422383|38180253|FG000|Overall Study|Protocol Violation|1|||
17036058|NCT00422383|38180254|FG001|Overall Study|Protocol Violation|1|||
17036059|NCT00422383|38180255|FG002|Overall Study|Protocol Violation|1|||
17036060|NCT00422383|38180256|FG003|Overall Study|Protocol Violation|0|||
17036061|NCT00422383|38180257|FG004|Overall Study|Protocol Violation|0|||
17036062|NCT00422383|38180253|FG000|Overall Study|Withdrawal by Subject|5|||
17036063|NCT00422383|38180254|FG001|Overall Study|Withdrawal by Subject|5|||
17036064|NCT00422383|38180255|FG002|Overall Study|Withdrawal by Subject|0|||
17036065|NCT00422383|38180256|FG003|Overall Study|Withdrawal by Subject|0|||
17036066|NCT00422383|38180257|FG004|Overall Study|Withdrawal by Subject|1|||
17036067|NCT00612040|38180278|FG000|Overall Study|Adverse Event|0|||
17036068|NCT00612040|38180279|FG001|Overall Study|Adverse Event|2|||
17036069|NCT00612040|38180280|FG002|Overall Study|Adverse Event|1|||
17036070|NCT00612040|38180278|FG000|Overall Study|Protocol Violation|1|||
17036071|NCT00612040|38180279|FG001|Overall Study|Protocol Violation|2|||
17036072|NCT00612040|38180280|FG002|Overall Study|Protocol Violation|1|||
17036073|NCT00612040|38180278|FG000|Overall Study|Lack of Efficacy|2|||
17036074|NCT00612040|38180279|FG001|Overall Study|Lack of Efficacy|1|||
17036075|NCT00612040|38180280|FG002|Overall Study|Lack of Efficacy|0|||
17036076|NCT00612040|38180278|FG000|Overall Study|Unclassified|2|||
16991887|NCT00806026|38135882|FG002|Overall Study|Death|0|||
16991888|NCT00806026|38135883|FG003|Overall Study|Death|1|||
16991889|NCT00806026|38135884|FG004|Overall Study|Death|0|||
16991890|NCT00806026|38135885|FG005|Overall Study|Death|0|||
16991891|NCT00806026|38135880|FG000|Overall Study|Did not meet entrance criteria|4|||
16991892|NCT00806026|38135881|FG001|Overall Study|Did not meet entrance criteria|1|||
16991893|NCT00806026|38135882|FG002|Overall Study|Did not meet entrance criteria|2|||
17036077|NCT00612040|38180279|FG001|Overall Study|Unclassified|2|||
17036078|NCT00612040|38180280|FG002|Overall Study|Unclassified|5|||
17036079|NCT00422227|38180290|FG000|Overall Study|Adverse Event|3|||
17036080|NCT00422227|38180291|FG001|Overall Study|Adverse Event|8|||
17036081|NCT00422227|38180290|FG000|Overall Study|Lost to Follow-up|1|||
16780427|NCT02606253|37719589|FG001|Overall Study|Physician Decision|1|||
17036082|NCT00422227|38180291|FG001|Overall Study|Lost to Follow-up|3|||
17036083|NCT00422227|38180290|FG000|Overall Study|Withdrawal by Subject|0|||
16991894|NCT00806026|38135883|FG003|Overall Study|Did not meet entrance criteria|1|||
17036084|NCT00422227|38180291|FG001|Overall Study|Withdrawal by Subject|4|||
17036085|NCT00421993|38180301|FG000|Overall Study|Withdrawal by Subject|22|||
17036086|NCT00421993|38180302|FG001|Overall Study|Withdrawal by Subject|23|||
17036087|NCT00421993|38180303|FG002|Overall Study|Withdrawal by Subject|23|||
17036088|NCT00421993|38180304|FG003|Overall Study|Withdrawal by Subject|24|||
17036089|NCT00421993|38180301|FG000|Overall Study|Lost to Follow-up|18|||
17036090|NCT00421993|38180302|FG001|Overall Study|Lost to Follow-up|19|||
17036091|NCT00421993|38180303|FG002|Overall Study|Lost to Follow-up|22|||
17036092|NCT00421993|38180304|FG003|Overall Study|Lost to Follow-up|20|||
17036093|NCT00421993|38180301|FG000|Overall Study|Adverse Event|11|||
17036094|NCT00421993|38180302|FG001|Overall Study|Adverse Event|1|||
17036095|NCT00421993|38180303|FG002|Overall Study|Adverse Event|6|||
17036096|NCT00421993|38180304|FG003|Overall Study|Adverse Event|4|||
17036097|NCT00421993|38180301|FG000|Overall Study|Protocol Violation|2|||
17036098|NCT00421993|38180302|FG001|Overall Study|Protocol Violation|2|||
17036099|NCT00421993|38180303|FG002|Overall Study|Protocol Violation|0|||
17036100|NCT00421993|38180304|FG003|Overall Study|Protocol Violation|1|||
17036101|NCT00421993|38180301|FG000|Overall Study|Lack of Efficacy|0|||
17036102|NCT00421993|38180302|FG001|Overall Study|Lack of Efficacy|3|||
17036103|NCT00421993|38180303|FG002|Overall Study|Lack of Efficacy|0|||
17036104|NCT00421993|38180304|FG003|Overall Study|Lack of Efficacy|5|||
17036105|NCT00421993|38180301|FG000|Overall Study|Pregnancy|0|||
17036106|NCT00421993|38180302|FG001|Overall Study|Pregnancy|1|||
17036107|NCT00421993|38180303|FG002|Overall Study|Pregnancy|1|||
17036108|NCT00421993|38180304|FG003|Overall Study|Pregnancy|2|||
17036109|NCT00421993|38180301|FG000|Overall Study|Subject transportation issues|0|||
17036110|NCT00421993|38180302|FG001|Overall Study|Subject transportation issues|0|||
17036111|NCT00421993|38180303|FG002|Overall Study|Subject transportation issues|0|||
17036112|NCT00421993|38180304|FG003|Overall Study|Subject transportation issues|1|||
17036113|NCT00413959|38180314|FG000|Overall Study|Pt had only one cycle.|1|||
17036114|NCT00645567|38180318|FG000|Overall Study|Adverse Event|1|||
17036115|NCT00611884|38180330|FG000|Overall Study|Adverse Event|1|||
17036116|NCT00611884|38180331|FG001|Overall Study|Adverse Event|0|||
17036117|NCT00611884|38180332|FG002|Overall Study|Adverse Event|0|||
17036118|NCT00611884|38180333|FG003|Overall Study|Adverse Event|1|||
17036119|NCT00611884|38180330|FG000|Overall Study|Non-Compliance|1|||
17036120|NCT00611884|38180331|FG001|Overall Study|Non-Compliance|4|||
17036121|NCT00611884|38180332|FG002|Overall Study|Non-Compliance|2|||
17036122|NCT00611884|38180333|FG003|Overall Study|Non-Compliance|2|||
17036123|NCT00611884|38180330|FG000|Overall Study|Lack of Efficacy|0|||
17036124|NCT00611884|38180331|FG001|Overall Study|Lack of Efficacy|1|||
17036125|NCT00611884|38180332|FG002|Overall Study|Lack of Efficacy|0|||
17036126|NCT00611884|38180333|FG003|Overall Study|Lack of Efficacy|0|||
17036127|NCT00611884|38180330|FG000|Overall Study|Unclassified|7|||
17036128|NCT00611884|38180331|FG001|Overall Study|Unclassified|4|||
17036129|NCT00611884|38180332|FG002|Overall Study|Unclassified|2|||
17036130|NCT00611884|38180333|FG003|Overall Study|Unclassified|3|||
17036131|NCT00420745|38180345|FG000|Overall Study|Adverse Event|2|||
17036132|NCT00420745|38180346|FG001|Overall Study|Adverse Event|2|||
17036133|NCT00420745|38180345|FG000|Overall Study|Lost to Follow-up|10|||
17036134|NCT00420745|38180346|FG001|Overall Study|Lost to Follow-up|2|||
17036135|NCT00420745|38180345|FG000|Overall Study|Protocol Violation|1|||
17036136|NCT00420745|38180346|FG001|Overall Study|Protocol Violation|0|||
17036137|NCT00420745|38180345|FG000|Overall Study|Physician Decision|1|||
17036138|NCT00420745|38180346|FG001|Overall Study|Physician Decision|1|||
17036139|NCT00420745|38180345|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
17036140|NCT00420745|38180346|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
17036141|NCT00420745|38180345|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
17036142|NCT00420745|38180346|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
17036143|NCT00611806|38180354|FG000|Overall Study|Withdrawal by Subject|8|||
17036144|NCT00611806|38180355|FG001|Overall Study|Withdrawal by Subject|2|||
17036145|NCT00611806|38180354|FG000|Overall Study|Adverse Event|2|||
17036146|NCT00611806|38180355|FG001|Overall Study|Adverse Event|1|||
17036147|NCT00611806|38180354|FG000|Overall Study|Lost to Follow-up|6|||
17036148|NCT00611806|38180355|FG001|Overall Study|Lost to Follow-up|0|||
17036149|NCT00413413|38180364|FG000|Single-Blind|Adverse Event|0|||
17036150|NCT00413413|38180365|FG001|Single-Blind|Adverse Event|9|||
17036151|NCT00413413|38180366|FG002|Single-Blind|Adverse Event|0|||
17036152|NCT00413413|38180364|FG000|Single-Blind|Lack of Efficacy|0|||
17036153|NCT00413413|38180365|FG001|Single-Blind|Lack of Efficacy|5|||
17036154|NCT00413413|38180366|FG002|Single-Blind|Lack of Efficacy|0|||
17036155|NCT00413413|38180364|FG000|Single-Blind|Subject no longer requires study drug|0|||
17036156|NCT00413413|38180365|FG001|Single-Blind|Subject no longer requires study drug|151|||
17036157|NCT00413413|38180366|FG002|Single-Blind|Subject no longer requires study drug|0|||
17036158|NCT00413413|38180364|FG000|Single-Blind|Protocol Violation|0|||
17036159|NCT00413413|38180365|FG001|Single-Blind|Protocol Violation|16|||
17036160|NCT00413413|38180366|FG002|Single-Blind|Protocol Violation|0|||
17036161|NCT00413413|38180364|FG000|Single-Blind|Withdrawal by Subject|0|||
17036162|NCT00413413|38180365|FG001|Single-Blind|Withdrawal by Subject|27|||
17036163|NCT00413413|38180366|FG002|Single-Blind|Withdrawal by Subject|0|||
17036164|NCT00413413|38180364|FG000|Single-Blind|Lost to Follow-up|0|||
17036165|NCT00413413|38180365|FG001|Single-Blind|Lost to Follow-up|8|||
17036166|NCT00413413|38180366|FG002|Single-Blind|Lost to Follow-up|0|||
17036167|NCT00413413|38180364|FG000|Double-Blind|Adverse Event|6|||
17036168|NCT00413413|38180365|FG001|Double-Blind|Adverse Event|0|||
17036169|NCT00413413|38180366|FG002|Double-Blind|Adverse Event|5|||
17036170|NCT00413413|38180364|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
17036171|NCT00413413|38180365|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
17036172|NCT00413413|38180366|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
17036173|NCT00413413|38180364|FG000|Double-Blind|Protocol deviation|1|||
17036174|NCT00413413|38180365|FG001|Double-Blind|Protocol deviation|2|||
17036175|NCT00413413|38180366|FG002|Double-Blind|Protocol deviation|1|||
17036176|NCT00413413|38180364|FG000|Double-Blind|Subject withdrew consent|4|||
17036177|NCT00413413|38180365|FG001|Double-Blind|Subject withdrew consent|6|||
17036178|NCT00413413|38180366|FG002|Double-Blind|Subject withdrew consent|9|||
17036179|NCT00413413|38180364|FG000|Double-Blind|Lost to Follow-up|3|||
17036180|NCT00413413|38180365|FG001|Double-Blind|Lost to Follow-up|4|||
17036181|NCT00413413|38180366|FG002|Double-Blind|Lost to Follow-up|2|||
17036182|NCT00610714|38180376|FG000|Overall Study|Adverse Event|3|||
17036183|NCT00610714|38180377|FG001|Overall Study|Adverse Event|1|||
17036184|NCT00610714|38180376|FG000|Overall Study|Death|12|||
17036185|NCT00610714|38180377|FG001|Overall Study|Death|18|||
17036186|NCT00610714|38180376|FG000|Overall Study|Withdrawal by Subject|9|||
17036187|NCT00610714|38180377|FG001|Overall Study|Withdrawal by Subject|3|||
17036188|NCT00610714|38180376|FG000|Overall Study|Study completion at 120 PFS events|2|||
17036189|NCT00610714|38180377|FG001|Overall Study|Study completion at 120 PFS events|2|||
17036190|NCT00403585|38180383|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
17036191|NCT00403585|38180383|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
17036192|NCT00403585|38180383|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
17036193|NCT00645411|38180391|FG000|Overall Study|Adverse Event|0|||
17036194|NCT00645411|38180392|FG001|Overall Study|Adverse Event|0|||
17036195|NCT00645411|38180393|FG002|Overall Study|Adverse Event|0|||
17138159|NCT02953782|38279916|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
17138160|NCT02953782|38279909|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
17138161|NCT02953782|38279910|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
17138162|NCT02953782|38279911|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
17138163|NCT02953782|38279912|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
17138164|NCT02953782|38279913|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
17138165|NCT02953782|38279914|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
17138166|NCT02953782|38279915|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
17138167|NCT02953782|38279916|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
17138168|NCT02953782|38279909|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
17138169|NCT02953782|38279910|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
17138170|NCT02953782|38279911|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
17036196|NCT00645411|38180394|FG003|Overall Study|Adverse Event|2|||
17036197|NCT00645411|38180391|FG000|Overall Study|Withdrawal by Subject|2|||
17036198|NCT00645411|38180392|FG001|Overall Study|Withdrawal by Subject|1|||
17036199|NCT00645411|38180393|FG002|Overall Study|Withdrawal by Subject|19|||
17036200|NCT00645411|38180394|FG003|Overall Study|Withdrawal by Subject|21|||
17036201|NCT00645411|38180391|FG000|Overall Study|Lost to Follow-up|10|||
17036202|NCT00645411|38180392|FG001|Overall Study|Lost to Follow-up|5|||
17036203|NCT00645411|38180393|FG002|Overall Study|Lost to Follow-up|124|||
17036204|NCT00645411|38180394|FG003|Overall Study|Lost to Follow-up|75|||
17036205|NCT00645411|38180391|FG000|Overall Study|Protocol Violation|1|||
17036206|NCT00645411|38180392|FG001|Overall Study|Protocol Violation|0|||
17036207|NCT00645411|38180393|FG002|Overall Study|Protocol Violation|1|||
17036208|NCT00645411|38180394|FG003|Overall Study|Protocol Violation|0|||
17036209|NCT00645411|38180391|FG000|Overall Study|Inappropriate enrollment|0|||
17036210|NCT00645411|38180392|FG001|Overall Study|Inappropriate enrollment|0|||
17036211|NCT00645411|38180393|FG002|Overall Study|Inappropriate enrollment|4|||
17036212|NCT00645411|38180394|FG003|Overall Study|Inappropriate enrollment|1|||
17036213|NCT00645411|38180391|FG000|Overall Study|Unable to classify|0|||
17036214|NCT00645411|38180392|FG001|Overall Study|Unable to classify|0|||
17036215|NCT00645411|38180393|FG002|Overall Study|Unable to classify|3|||
17036216|NCT00645411|38180394|FG003|Overall Study|Unable to classify|4|||
17036217|NCT00403273|38180413|FG000|Overall Study|Lost to Follow-up|3|||
17036218|NCT00403273|38180414|FG001|Overall Study|Lost to Follow-up|2|||
17036219|NCT00403273|38180413|FG000|Overall Study|Physician Decision|0|||
17036220|NCT00403273|38180414|FG001|Overall Study|Physician Decision|1|||
17036221|NCT00403273|38180413|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
17036222|NCT00403273|38180414|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
17036223|NCT00402727|38180437|FG000|Overall Study|Adverse Event|10|||
17036224|NCT00402727|38180438|FG001|Overall Study|Adverse Event|6|||
17036225|NCT00402727|38180437|FG000|Overall Study|Death|1|||
17138171|NCT02953782|38279912|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
17138172|NCT02953782|38279913|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
17138173|NCT02953782|38279914|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
17138174|NCT02953782|38279915|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
17036226|NCT00402727|38180438|FG001|Overall Study|Death|0|||
17036227|NCT00402727|38180437|FG000|Overall Study|Lack of Efficacy|1|||
17036228|NCT00402727|38180438|FG001|Overall Study|Lack of Efficacy|3|||
17036229|NCT00402727|38180437|FG000|Overall Study|Lost to Follow-up|24|||
17036230|NCT00402727|38180438|FG001|Overall Study|Lost to Follow-up|11|||
17036231|NCT00402727|38180437|FG000|Overall Study|Physician Decision|1|||
17036232|NCT00402727|38180438|FG001|Overall Study|Physician Decision|1|||
17036233|NCT00402727|38180437|FG000|Overall Study|Protocol Violation|0|||
17036234|NCT00402727|38180438|FG001|Overall Study|Protocol Violation|4|||
17036235|NCT00402727|38180437|FG000|Overall Study|Withdrawal by Subject|3|||
17036236|NCT00402727|38180438|FG001|Overall Study|Withdrawal by Subject|7|||
17036237|NCT00402727|38180437|FG000|Overall Study|supply problems|2|||
17036238|NCT00402727|38180438|FG001|Overall Study|supply problems|1|||
17036239|NCT00402727|38180437|FG000|Overall Study|non-compliance|0|||
17036240|NCT00402727|38180438|FG001|Overall Study|non-compliance|1|||
17036241|NCT00402649|38180444|FG000|Overall Study|Lost to Follow-up|1|||
17036242|NCT00402649|38180444|FG000|Overall Study|Withdrawal by Subject|1|||
17036243|NCT00402337|38180453|FG000|Overall Study|Adverse Event|0|||
17036244|NCT00402337|38180454|FG001|Overall Study|Adverse Event|2|||
17036245|NCT00402337|38180455|FG002|Overall Study|Adverse Event|2|||
17036246|NCT00402337|38180456|FG003|Overall Study|Adverse Event|3|||
17036247|NCT00402337|38180457|FG004|Overall Study|Adverse Event|2|||
17036248|NCT00402337|38180453|FG000|Overall Study|Noncompliance|0|||
17036249|NCT00402337|38180454|FG001|Overall Study|Noncompliance|0|||
17036250|NCT00402337|38180455|FG002|Overall Study|Noncompliance|0|||
17036251|NCT00402337|38180456|FG003|Overall Study|Noncompliance|0|||
17036252|NCT00402337|38180457|FG004|Overall Study|Noncompliance|2|||
17036253|NCT00402337|38180453|FG000|Overall Study|Withdrawal by Subject|5|||
17036254|NCT00402337|38180454|FG001|Overall Study|Withdrawal by Subject|3|||
17036255|NCT00402337|38180455|FG002|Overall Study|Withdrawal by Subject|1|||
17036256|NCT00402337|38180456|FG003|Overall Study|Withdrawal by Subject|6|||
17036257|NCT00402337|38180457|FG004|Overall Study|Withdrawal by Subject|4|||
17036258|NCT00402337|38180453|FG000|Overall Study|Lost to Follow-up|0|||
17036259|NCT00402337|38180454|FG001|Overall Study|Lost to Follow-up|0|||
17036260|NCT00402337|38180455|FG002|Overall Study|Lost to Follow-up|1|||
17036261|NCT00402337|38180456|FG003|Overall Study|Lost to Follow-up|2|||
17036262|NCT00402337|38180457|FG004|Overall Study|Lost to Follow-up|0|||
17138175|NCT02953782|38279916|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
17138176|NCT02953782|38279909|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
17138177|NCT02953782|38279910|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
17138178|NCT02953782|38279911|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
17138179|NCT02953782|38279912|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
17036263|NCT00402337|38180453|FG000|Overall Study|Physician Decision|0|||
17036264|NCT00402337|38180454|FG001|Overall Study|Physician Decision|0|||
17036265|NCT00402337|38180455|FG002|Overall Study|Physician Decision|0|||
17036266|NCT00402337|38180456|FG003|Overall Study|Physician Decision|1|||
17036267|NCT00402337|38180457|FG004|Overall Study|Physician Decision|0|||
17036268|NCT00402337|38180453|FG000|Overall Study|Other Reason|0|||
17036269|NCT00402337|38180454|FG001|Overall Study|Other Reason|1|||
17036270|NCT00402337|38180455|FG002|Overall Study|Other Reason|0|||
17036271|NCT00402337|38180456|FG003|Overall Study|Other Reason|0|||
17036272|NCT00402337|38180457|FG004|Overall Study|Other Reason|0|||
17036273|NCT00650091|38180471|FG000|Amended Study Design|Withdrawal by Subject|12|||
17036274|NCT00650091|38180472|FG001|Amended Study Design|Withdrawal by Subject|11|||
17036275|NCT00650091|38180473|FG002|Amended Study Design|Withdrawal by Subject|0|||
17036276|NCT00650091|38180471|FG000|Amended Study Design|Physician Decision|5|||
17036277|NCT00650091|38180472|FG001|Amended Study Design|Physician Decision|0|||
17036278|NCT00650091|38180473|FG002|Amended Study Design|Physician Decision|0|||
17036279|NCT00650091|38180471|FG000|Amended Study Design|Adverse Event|1|||
17036280|NCT00650091|38180472|FG001|Amended Study Design|Adverse Event|4|||
17036281|NCT00650091|38180473|FG002|Amended Study Design|Adverse Event|0|||
17036282|NCT00650091|38180471|FG000|Amended Study Design|Lung transplantation|4|||
17036283|NCT00650091|38180472|FG001|Amended Study Design|Lung transplantation|2|||
17036284|NCT00650091|38180473|FG002|Amended Study Design|Lung transplantation|0|||
17036285|NCT00650091|38180471|FG000|Amended Study Design|Other|1|||
17036286|NCT00650091|38180472|FG001|Amended Study Design|Other|3|||
17036287|NCT00650091|38180473|FG002|Amended Study Design|Other|0|||
17036288|NCT00642369|38180483|FG000|Overall Study|Adverse Event|2|||
17036289|NCT00642369|38180484|FG001|Overall Study|Adverse Event|3|||
17036290|NCT00642369|38180483|FG000|Overall Study|Withdrawal by Subject|1|||
17036291|NCT00642369|38180484|FG001|Overall Study|Withdrawal by Subject|0|||
17036292|NCT00642369|38180483|FG000|Overall Study|misdiagnosis|0|||
17036293|NCT00642369|38180484|FG001|Overall Study|misdiagnosis|1|||
17036294|NCT00642369|38180483|FG000|Overall Study|Lack of Efficacy|2|||
17036295|NCT00642369|38180484|FG001|Overall Study|Lack of Efficacy|2|||
17036296|NCT00645099|38180509|FG000|Overall Study|Lack of Efficacy|15|||
17036297|NCT00645099|38180510|FG001|Overall Study|Lack of Efficacy|6|||
17036298|NCT00645099|38180509|FG000|Overall Study|Withdrawal by Subject|30|||
17036299|NCT00645099|38180510|FG001|Overall Study|Withdrawal by Subject|22|||
17036300|NCT00645099|38180509|FG000|Overall Study|Lost to Follow-up|6|||
17036301|NCT00645099|38180510|FG001|Overall Study|Lost to Follow-up|4|||
17036302|NCT00645099|38180509|FG000|Overall Study|Adverse Event|11|||
17036303|NCT00645099|38180510|FG001|Overall Study|Adverse Event|5|||
17036304|NCT00645099|38180509|FG000|Overall Study|Other|9|||
17036305|NCT00645099|38180510|FG001|Overall Study|Other|5|||
17036306|NCT00420511|38180518|FG000|Overall Study|Adverse Event|1|||
17036307|NCT00420511|38180519|FG001|Overall Study|Adverse Event|1|||
17036308|NCT00420511|38180518|FG000|Overall Study|Lost to Follow-up|1|||
17036309|NCT00420511|38180519|FG001|Overall Study|Lost to Follow-up|0|||
17036310|NCT00420199|38180529|FG000|Overall Study|Participant no longer met study criteria|1|||
17036311|NCT00420199|38180530|FG001|Overall Study|Participant no longer met study criteria|0|||
17036312|NCT00649389|38180545|FG000|Overall Study|Adverse Event|22|||
17036313|NCT00649389|38180546|FG001|Overall Study|Adverse Event|46|||
17036314|NCT00649389|38180547|FG002|Overall Study|Adverse Event|38|||
17036315|NCT00649389|38180548|FG003|Overall Study|Adverse Event|48|||
17036316|NCT00649389|38180545|FG000|Overall Study|Lost to Follow-up|15|||
17036317|NCT00649389|38180546|FG001|Overall Study|Lost to Follow-up|17|||
17036318|NCT00649389|38180547|FG002|Overall Study|Lost to Follow-up|21|||
17036319|NCT00649389|38180548|FG003|Overall Study|Lost to Follow-up|26|||
17036320|NCT00649389|38180545|FG000|Overall Study|Protocol Violation|11|||
17036321|NCT00649389|38180546|FG001|Overall Study|Protocol Violation|13|||
17036322|NCT00649389|38180547|FG002|Overall Study|Protocol Violation|9|||
17036323|NCT00649389|38180548|FG003|Overall Study|Protocol Violation|8|||
17036324|NCT00649389|38180545|FG000|Overall Study|Withdrawal by Subject|20|||
17036325|NCT00649389|38180546|FG001|Overall Study|Withdrawal by Subject|21|||
17036326|NCT00649389|38180547|FG002|Overall Study|Withdrawal by Subject|19|||
17036327|NCT00649389|38180548|FG003|Overall Study|Withdrawal by Subject|23|||
17036328|NCT00649389|38180545|FG000|Overall Study|Other|3|||
17036329|NCT00649389|38180546|FG001|Overall Study|Other|9|||
17036330|NCT00649389|38180547|FG002|Overall Study|Other|1|||
17036331|NCT00649389|38180548|FG003|Overall Study|Other|6|||
17036332|NCT00402103|38180560|FG000|Overall Study|Adverse Event|60|||
17036333|NCT00402103|38180561|FG001|Overall Study|Adverse Event|7|||
17036334|NCT00402103|38180560|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17036335|NCT00402103|38180561|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
17036336|NCT00402103|38180560|FG000|Overall Study|Condition no longer requires study drug|2|||
17036337|NCT00402103|38180561|FG001|Overall Study|Condition no longer requires study drug|0|||
17036338|NCT00402103|38180560|FG000|Overall Study|Protocol Deviation|8|||
17036339|NCT00402103|38180561|FG001|Overall Study|Protocol Deviation|0|||
17036340|NCT00402103|38180560|FG000|Overall Study|Patient withdrew consent|12|||
17036341|NCT00402103|38180561|FG001|Overall Study|Patient withdrew consent|1|||
17036342|NCT00402103|38180560|FG000|Overall Study|Lost to Follow-up|6|||
17036343|NCT00402103|38180561|FG001|Overall Study|Lost to Follow-up|3|||
17036344|NCT00402103|38180560|FG000|Overall Study|Administrative problems|2|||
17036345|NCT00402103|38180561|FG001|Overall Study|Administrative problems|0|||
17036346|NCT00641667|38180571|FG000|Overall Study|Withdrawal by Subject|1|||
17036347|NCT00641667|38180571|FG000|Overall Study|Adverse Event|1|||
17036348|NCT00641667|38180571|FG000|Overall Study|Physician Decision|1|||
17036349|NCT00641667|38180571|FG000|Overall Study|Worsening of underlying disease|3|||
17036350|NCT00704184|38180580|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
17036351|NCT00704184|38180581|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
17036352|NCT00704184|38180582|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
17036353|NCT00704184|38180583|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
17036354|NCT00704184|38180584|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
17036355|NCT00704184|38180580|FG000|Open-Label Treatment|Adverse Event|0|||
17036356|NCT00704184|38180581|FG001|Open-Label Treatment|Adverse Event|0|||
17036357|NCT00704184|38180582|FG002|Open-Label Treatment|Adverse Event|2|||
17036358|NCT00704184|38180583|FG003|Open-Label Treatment|Adverse Event|0|||
17036359|NCT00704184|38180584|FG004|Open-Label Treatment|Adverse Event|1|||
17036360|NCT00704184|38180580|FG000|Open-Label Treatment|Lack of Efficacy|0|||
17036361|NCT00704184|38180581|FG001|Open-Label Treatment|Lack of Efficacy|2|||
17036362|NCT00704184|38180582|FG002|Open-Label Treatment|Lack of Efficacy|2|||
17036363|NCT00704184|38180583|FG003|Open-Label Treatment|Lack of Efficacy|2|||
17036364|NCT00704184|38180584|FG004|Open-Label Treatment|Lack of Efficacy|1|||
17036365|NCT00704184|38180580|FG000|Open-Label Treatment|Physician Decision|0|||
17036366|NCT00704184|38180581|FG001|Open-Label Treatment|Physician Decision|0|||
17036367|NCT00704184|38180582|FG002|Open-Label Treatment|Physician Decision|0|||
17036368|NCT00704184|38180583|FG003|Open-Label Treatment|Physician Decision|0|||
17036369|NCT00704184|38180584|FG004|Open-Label Treatment|Physician Decision|1|||
17036370|NCT00704184|38180580|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
17036371|NCT00704184|38180581|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
17036372|NCT00704184|38180582|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
17036373|NCT00704184|38180583|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
17036374|NCT00704184|38180584|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
17036375|NCT00641043|38180598|FG000|Overall Study|Adverse Event|6|||
17036376|NCT00641043|38180599|FG001|Overall Study|Adverse Event|4|||
17036377|NCT00641043|38180598|FG000|Overall Study|Protocol Violation|2|||
17036378|NCT00641043|38180599|FG001|Overall Study|Protocol Violation|3|||
17036379|NCT00641043|38180598|FG000|Overall Study|Lost to Follow-up|3|||
17036380|NCT00641043|38180599|FG001|Overall Study|Lost to Follow-up|2|||
17036381|NCT00641043|38180598|FG000|Overall Study|Withdrawal by Subject|4|||
17036382|NCT00641043|38180599|FG001|Overall Study|Withdrawal by Subject|4|||
17036383|NCT00641043|38180598|FG000|Overall Study|Other incl. lack of efficacy|4|||
17036384|NCT00641043|38180599|FG001|Overall Study|Other incl. lack of efficacy|2|||
17036385|NCT00402025|38180608|FG000|Overall Study|Adverse Event|0|||
17036386|NCT00402025|38180609|FG001|Overall Study|Adverse Event|0|||
17036387|NCT00402025|38180610|FG002|Overall Study|Adverse Event|2|||
17036388|NCT00402025|38180608|FG000|Overall Study|Death|0|||
17036389|NCT00402025|38180609|FG001|Overall Study|Death|1|||
17036390|NCT00402025|38180610|FG002|Overall Study|Death|5|||
17036391|NCT00402025|38180608|FG000|Overall Study|Disease Progression|1|||
17036392|NCT00402025|38180609|FG001|Overall Study|Disease Progression|1|||
17036393|NCT00402025|38180610|FG002|Overall Study|Disease Progression|2|||
17036394|NCT00402025|38180608|FG000|Overall Study|Physician Decision|1|||
17036395|NCT00402025|38180609|FG001|Overall Study|Physician Decision|1|||
17036396|NCT00402025|38180610|FG002|Overall Study|Physician Decision|0|||
17036397|NCT00402025|38180608|FG000|Overall Study|Participant Decision|0|||
17036398|NCT00402025|38180609|FG001|Overall Study|Participant Decision|0|||
17036399|NCT00402025|38180610|FG002|Overall Study|Participant Decision|1|||
17036400|NCT00609622|38180620|FG000|Overall Study|Adverse Event|14|||
17036401|NCT00609622|38180621|FG001|Overall Study|Adverse Event|10|||
17036402|NCT00609622|38180620|FG000|Overall Study|Withdrawal by Subject|4|||
17036403|NCT00609622|38180621|FG001|Overall Study|Withdrawal by Subject|20|||
17036404|NCT00609622|38180620|FG000|Overall Study|Death|1|||
17036405|NCT00609622|38180621|FG001|Overall Study|Death|4|||
17036406|NCT00609622|38180620|FG000|Overall Study|Protocol Violation|1|||
17138180|NCT02953782|38279913|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
17138181|NCT02953782|38279914|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
17138182|NCT02953782|38279915|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
17138183|NCT02953782|38279916|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
17138184|NCT02953782|38279909|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
17138185|NCT02953782|38279910|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
17138186|NCT02953782|38279911|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
17138187|NCT02953782|38279912|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
17138188|NCT02953782|38279913|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
17138189|NCT02953782|38279914|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
17138190|NCT02953782|38279915|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
17138191|NCT02953782|38279916|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
17036407|NCT00609622|38180621|FG001|Overall Study|Protocol Violation|1|||
17036408|NCT00609622|38180620|FG000|Overall Study|Objective progression or relapse|47|||
17036409|NCT00609622|38180621|FG001|Overall Study|Objective progression or relapse|41|||
17036410|NCT00609622|38180620|FG000|Overall Study|Study terminated by sponsor|16|||
17036411|NCT00609622|38180621|FG001|Overall Study|Study terminated by sponsor|3|||
17036412|NCT00609622|38180620|FG000|Overall Study|Other|7|||
17138192|NCT02953782|38279909|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
17138193|NCT02953782|38279910|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
17138194|NCT02953782|38279911|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
17138195|NCT02953782|38279912|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
17138196|NCT02953782|38279913|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
17138197|NCT02953782|38279914|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
17138198|NCT02953782|38279915|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
17138199|NCT02953782|38279916|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
17138200|NCT03760081|38279939|FG000|Overall Study|Miscellaneous|0|||
17138201|NCT03760081|38279940|FG001|Overall Study|Miscellaneous|1|||
17138202|NCT03760081|38279939|FG000|Overall Study|Progressive Disease|5|||
17138203|NCT03760081|38279940|FG001|Overall Study|Progressive Disease|10|||
17036413|NCT00609622|38180621|FG001|Overall Study|Other|14|||
17036414|NCT00609622|38180620|FG000|Overall Study|Global deterioration of health status|6|||
17036415|NCT00609622|38180621|FG001|Overall Study|Global deterioration of health status|2|||
17036416|NCT00699816|38180629|FG000|Overall Study|Protocol Violation|1|||
17036417|NCT00699816|38180630|FG001|Overall Study|Protocol Violation|3|||
17036418|NCT00699660|38180638|FG000|Overall Study|Lost to Follow-up|4|||
17036419|NCT00699660|38180639|FG001|Overall Study|Lost to Follow-up|2|||
17036420|NCT00699660|38180638|FG000|Overall Study|missing reports and recording failures|10|||
17036421|NCT00699660|38180639|FG001|Overall Study|missing reports and recording failures|6|||
17036422|NCT00627705|38180647|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
17036423|NCT00627705|38180648|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
17036424|NCT00627705|38180647|FG000|Overall Study|Adverse Event|1|||
17036425|NCT00627705|38180648|FG001|Overall Study|Adverse Event|0|||
17036426|NCT00627705|38180647|FG000|Overall Study|Withdrawal by Subject|0|||
17036427|NCT00627705|38180648|FG001|Overall Study|Withdrawal by Subject|2|||
17036428|NCT00627705|38180647|FG000|Overall Study|Lost to Follow-up|0|||
17036429|NCT00627705|38180648|FG001|Overall Study|Lost to Follow-up|1|||
17036430|NCT00610168|38180656|FG000|Overall Study|Withdrawal by Subject|2|||
17036431|NCT00610168|38180657|FG001|Overall Study|Withdrawal by Subject|0|||
17036432|NCT00644787|38180663|FG000|Period 1: Titration Phase|Adverse Event|11|||
17036433|NCT00644787|38180664|FG001|Period 1: Titration Phase|Adverse Event|0|||
17036434|NCT00644787|38180665|FG002|Period 1: Titration Phase|Adverse Event|0|||
17036435|NCT00644787|38180663|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
17036436|NCT00644787|38180664|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
17036437|NCT00644787|38180665|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
17036438|NCT00644787|38180663|FG000|Period 1: Titration Phase|Physician Decision|1|||
17036439|NCT00644787|38180664|FG001|Period 1: Titration Phase|Physician Decision|0|||
17036440|NCT00644787|38180665|FG002|Period 1: Titration Phase|Physician Decision|0|||
17036441|NCT00644787|38180663|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
17036442|NCT00644787|38180664|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
17036443|NCT00644787|38180665|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
17036444|NCT00644787|38180663|FG000|Period 1: Titration Phase|Worsening of complications|1|||
17036445|NCT00644787|38180664|FG001|Period 1: Titration Phase|Worsening of complications|0|||
17036446|NCT00644787|38180665|FG002|Period 1: Titration Phase|Worsening of complications|0|||
17036447|NCT00644787|38180663|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
17036448|NCT00644787|38180664|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
17036449|NCT00644787|38180665|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
17036450|NCT00644787|38180663|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
17036451|NCT00644787|38180664|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
17036452|NCT00644787|38180665|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
17138204|NCT03760081|38279939|FG000|Overall Study|Death|1|||
17138205|NCT03760081|38279940|FG001|Overall Study|Death|1|||
17138206|NCT03422172|38279948|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
17138207|NCT03422172|38279948|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
17138208|NCT03422172|38279948|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
17138209|NCT00057863|38279957|FG000|Overall Study|Death|1|||
17138210|NCT00057863|38279957|FG000|Overall Study|Withdrawal by Subject|2|||
17036453|NCT00644787|38180663|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
17036454|NCT00644787|38180664|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
17036455|NCT00644787|38180665|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
17036456|NCT00644787|38180663|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
17036457|NCT00644787|38180664|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
17036458|NCT00644787|38180665|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
17036459|NCT00644787|38180663|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
17036460|NCT00644787|38180664|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
17036461|NCT00644787|38180665|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
17036462|NCT00644787|38180663|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
17036463|NCT00644787|38180664|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
17036464|NCT00644787|38180665|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
17036465|NCT00644787|38180663|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
17036466|NCT00644787|38180664|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
17036467|NCT00644787|38180665|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
17036468|NCT00699582|38180676|FG000|Overall Study|Adverse Event|4|||
17036469|NCT00699582|38180677|FG001|Overall Study|Adverse Event|11|||
17036470|NCT00699582|38180678|FG002|Overall Study|Adverse Event|23|||
17036471|NCT00699582|38180676|FG000|Overall Study|Withdrawal by Subject|6|||
17036472|NCT00699582|38180677|FG001|Overall Study|Withdrawal by Subject|7|||
17036473|NCT00699582|38180678|FG002|Overall Study|Withdrawal by Subject|4|||
17036474|NCT00699582|38180676|FG000|Overall Study|Lack of Efficacy|1|||
17036475|NCT00699582|38180677|FG001|Overall Study|Lack of Efficacy|0|||
17036476|NCT00699582|38180678|FG002|Overall Study|Lack of Efficacy|1|||
17036477|NCT00699582|38180676|FG000|Overall Study|Progressive Disease|1|||
17036478|NCT00699582|38180677|FG001|Overall Study|Progressive Disease|0|||
17036479|NCT00699582|38180678|FG002|Overall Study|Progressive Disease|0|||
17036480|NCT00699582|38180676|FG000|Overall Study|Administrative/Other|4|||
17036481|NCT00699582|38180677|FG001|Overall Study|Administrative/Other|3|||
17036482|NCT00699582|38180678|FG002|Overall Study|Administrative/Other|0|||
17036483|NCT00699582|38180676|FG000|Overall Study|Randomized, Not Treated|2|||
17036484|NCT00699582|38180677|FG001|Overall Study|Randomized, Not Treated|1|||
17036485|NCT00699582|38180678|FG002|Overall Study|Randomized, Not Treated|0|||
17036486|NCT00640341|38180689|FG000|Overall Study|Adverse Event|0|||
17036487|NCT00640341|38180690|FG001|Overall Study|Adverse Event|0|||
17036488|NCT00640341|38180691|FG002|Overall Study|Adverse Event|1|||
17036489|NCT00640341|38180689|FG000|Overall Study|Positive Slit Lamp Findings|0|||
17036490|NCT00640341|38180690|FG001|Overall Study|Positive Slit Lamp Findings|0|||
17036491|NCT00640341|38180691|FG002|Overall Study|Positive Slit Lamp Findings|1|||
17036492|NCT00640341|38180689|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
17036493|NCT00640341|38180690|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
17036494|NCT00640341|38180691|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
17036495|NCT00640341|38180689|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
17036496|NCT00640341|38180690|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
17036497|NCT00640341|38180691|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
17036498|NCT00640341|38180689|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
17036499|NCT00640341|38180690|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
17036500|NCT00640341|38180691|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
17036501|NCT00640341|38180689|FG000|Overall Study|Lost to Follow-up|2|||
17036502|NCT00640341|38180690|FG001|Overall Study|Lost to Follow-up|0|||
17036503|NCT00640341|38180691|FG002|Overall Study|Lost to Follow-up|0|||
17036504|NCT00640341|38180689|FG000|Overall Study|Withdrawal by Subject|4|||
17036505|NCT00640341|38180690|FG001|Overall Study|Withdrawal by Subject|0|||
17036506|NCT00640341|38180691|FG002|Overall Study|Withdrawal by Subject|1|||
17036507|NCT00640341|38180689|FG000|Overall Study|Unacceptable Lens Movement|1|||
17036508|NCT00640341|38180690|FG001|Overall Study|Unacceptable Lens Movement|0|||
17036509|NCT00640341|38180691|FG002|Overall Study|Unacceptable Lens Movement|0|||
17036510|NCT00640341|38180689|FG000|Overall Study|Poor fit/Uncomfortable|4|||
17036511|NCT00640341|38180690|FG001|Overall Study|Poor fit/Uncomfortable|0|||
17036512|NCT00640341|38180691|FG002|Overall Study|Poor fit/Uncomfortable|0|||
17036513|NCT00640341|38180689|FG000|Overall Study|Ineligable at Baseline|5|||
17036514|NCT00640341|38180690|FG001|Overall Study|Ineligable at Baseline|3|||
17036515|NCT00640341|38180691|FG002|Overall Study|Ineligable at Baseline|2|||
17036516|NCT00640341|38180689|FG000|Overall Study|Adverse event and positive slit lamp|1|||
17036517|NCT00640341|38180690|FG001|Overall Study|Adverse event and positive slit lamp|0|||
17036518|NCT00640341|38180691|FG002|Overall Study|Adverse event and positive slit lamp|0|||
17036519|NCT00699348|38180699|FG000|Overall Study|Death|6|||
17036520|NCT00699348|38180699|FG000|Overall Study|Adverse Event|15|||
17036521|NCT00699348|38180699|FG000|Overall Study|Withdrawal by Subject|11|||
17036522|NCT00699348|38180699|FG000|Overall Study|Protocol Violation|10|||
17036523|NCT00699348|38180699|FG000|Overall Study|Lack of Efficacy|8|||
17036524|NCT00699348|38180699|FG000|Overall Study|Failure to return|1|||
17036525|NCT00699348|38180699|FG000|Overall Study|Blood transfusion|24|||
17138211|NCT00075023|38279963|FG000|Pilot Study|Physician Decision|1|||
17138212|NCT00075023|38279964|FG001|Pilot Study|Physician Decision|2|||
17138213|NCT00075023|38279963|FG000|Pilot Study|Withdrawal by Subject|1|||
17138214|NCT00075023|38279964|FG001|Pilot Study|Withdrawal by Subject|0|||
17138215|NCT00074711|38279973|FG000|Overall Study|Withdrawal by Subject|1|||
17036526|NCT00699348|38180699|FG000|Overall Study|Renal transplantation|10|||
17036527|NCT00699348|38180699|FG000|Overall Study|Other|5|||
17036528|NCT00643851|38180706|FG000|Overall Study|Death|0|||
17036529|NCT00643851|38180707|FG001|Overall Study|Death|1|||
17138216|NCT00074711|38279974|FG001|Overall Study|Withdrawal by Subject|1|||
17036530|NCT00643851|38180708|FG002|Overall Study|Death|0|||
17036531|NCT00643851|38180706|FG000|Overall Study|Lack of Efficacy|0|||
17036532|NCT00643851|38180707|FG001|Overall Study|Lack of Efficacy|1|||
17036533|NCT00643851|38180708|FG002|Overall Study|Lack of Efficacy|0|||
17036534|NCT00643851|38180706|FG000|Overall Study|Adverse Event|2|||
17036535|NCT00643851|38180707|FG001|Overall Study|Adverse Event|6|||
17036536|NCT00643851|38180708|FG002|Overall Study|Adverse Event|6|||
17036537|NCT00643851|38180706|FG000|Overall Study|Lost to Follow-up|4|||
17036538|NCT00643851|38180707|FG001|Overall Study|Lost to Follow-up|6|||
17036539|NCT00643851|38180708|FG002|Overall Study|Lost to Follow-up|9|||
17036540|NCT00643851|38180706|FG000|Overall Study|Withdrawal by Subject|8|||
17036541|NCT00643851|38180707|FG001|Overall Study|Withdrawal by Subject|15|||
17036542|NCT00643851|38180708|FG002|Overall Study|Withdrawal by Subject|9|||
17036543|NCT00643851|38180706|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
17036544|NCT00643851|38180707|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
17036545|NCT00643851|38180708|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
17138217|NCT00074711|38279973|FG000|Overall Study|Lost to Follow-up|10|||
17036546|NCT03667690|38180718|FG000|Overall Study|Adverse Event|0|||
17036547|NCT03667690|38180719|FG001|Overall Study|Adverse Event|3|||
17036548|NCT03667690|38180718|FG000|Overall Study|Death|22|||
17036549|NCT03667690|38180719|FG001|Overall Study|Death|21|||
17036550|NCT03667690|38180718|FG000|Overall Study|Lost to Follow-up|4|||
17036551|NCT03667690|38180719|FG001|Overall Study|Lost to Follow-up|5|||
17036552|NCT03667690|38180718|FG000|Overall Study|Withdrawal by Subject|7|||
17036553|NCT03667690|38180719|FG001|Overall Study|Withdrawal by Subject|8|||
17036554|NCT03667690|38180718|FG000|Overall Study|Subject could not return for additional investigational product|1|||
17036555|NCT03667690|38180719|FG001|Overall Study|Subject could not return for additional investigational product|0|||
17036556|NCT03667690|38180718|FG000|Overall Study|Subject discharged to hospice care|2|||
17036557|NCT03667690|38180719|FG001|Overall Study|Subject discharged to hospice care|0|||
17036558|NCT03667690|38180718|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
17036559|NCT03667690|38180719|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
17036560|NCT03667690|38180718|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
17036561|NCT03667690|38180719|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
17036562|NCT03667690|38180718|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
17036563|NCT03667690|38180719|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
17036564|NCT03667690|38180718|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
17036565|NCT03667690|38180719|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
17036566|NCT03667690|38180718|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
17036567|NCT03667690|38180719|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
17036568|NCT00627393|38180727|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
17036569|NCT00627393|38180728|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
17036570|NCT00627393|38180727|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
17036571|NCT00627393|38180728|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
17036572|NCT00627393|38180727|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
17036573|NCT00627393|38180728|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
17036574|NCT00627393|38180727|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
17036575|NCT00627393|38180728|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
17036576|NCT00577122|38180738|FG000|Overall Study|Adverse Event|0|||
17036577|NCT00577122|38180739|FG001|Overall Study|Adverse Event|2|||
17036578|NCT00577122|38180738|FG000|Overall Study|Progression, relapse during active trt|6|||
17036579|NCT00577122|38180739|FG001|Overall Study|Progression, relapse during active trt|8|||
17036580|NCT00577122|38180738|FG000|Overall Study|Prog, refract disease during active trt|8|||
17036581|NCT00577122|38180739|FG001|Overall Study|Prog, refract disease during active trt|5|||
17036582|NCT00577122|38180738|FG000|Overall Study|Alternative Therapy|0|||
17036583|NCT00577122|38180739|FG001|Overall Study|Alternative Therapy|1|||
17036584|NCT00696774|38180749|FG000|Period II|Adverse Event|0|||
17036585|NCT00696774|38180750|FG001|Period II|Adverse Event|0|||
17036586|NCT00696774|38180751|FG002|Period II|Adverse Event|15|||
17036587|NCT00696774|38180749|FG000|Period II|Lost to Follow-up|0|||
17036588|NCT00696774|38180750|FG001|Period II|Lost to Follow-up|0|||
17036589|NCT00696774|38180751|FG002|Period II|Lost to Follow-up|4|||
17036590|NCT00696774|38180749|FG000|Period II|Protocol Violation|0|||
17036591|NCT00696774|38180750|FG001|Period II|Protocol Violation|0|||
17036592|NCT00696774|38180751|FG002|Period II|Protocol Violation|11|||
17036593|NCT00696774|38180749|FG000|Period II|Withdrawal by Subject|0|||
17036594|NCT00696774|38180750|FG001|Period II|Withdrawal by Subject|0|||
17036595|NCT00696774|38180751|FG002|Period II|Withdrawal by Subject|4|||
17036596|NCT00696774|38180749|FG000|Period II|Sponsor Decision|0|||
17036597|NCT00696774|38180750|FG001|Period II|Sponsor Decision|0|||
17036598|NCT00696774|38180751|FG002|Period II|Sponsor Decision|0|||
17036599|NCT00696774|38180749|FG000|Period II|Lack of Efficacy|0|||
17036600|NCT00696774|38180750|FG001|Period II|Lack of Efficacy|0|||
17036601|NCT00696774|38180751|FG002|Period II|Lack of Efficacy|2|||
17036602|NCT00696774|38180749|FG000|Period III|Adverse Event|1|||
17036603|NCT00696774|38180750|FG001|Period III|Adverse Event|1|||
17138218|NCT00074711|38279974|FG001|Overall Study|Lost to Follow-up|8|||
17138219|NCT00074711|38279973|FG000|Overall Study|Participant stopped study drug|4|||
17138220|NCT00074711|38279974|FG001|Overall Study|Participant stopped study drug|6|||
17138221|NCT03420300|38279980|FG000|Overall Study|Death|2|||
17138222|NCT03419598|38279984|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
17138223|NCT03407430|38279992|FG000|Washout|Protocol Violation|1|||
17138224|NCT03407430|38279993|FG001|Washout|Protocol Violation|0|||
17138225|NCT03407118|38280006|FG000|Period 2|Withdrawal by Subject|1|||
17138226|NCT03407118|38280007|FG001|Period 2|Withdrawal by Subject|0|||
17036604|NCT00696774|38180751|FG002|Period III|Adverse Event|0|||
17138227|NCT03406962|38280013|FG000|Overall Study|Death|2|||
17138228|NCT03406962|38280013|FG000|Overall Study|Adverse Event|1|||
17036605|NCT00696774|38180749|FG000|Period III|Lost to Follow-up|2|||
17036606|NCT00696774|38180750|FG001|Period III|Lost to Follow-up|1|||
17036607|NCT00696774|38180751|FG002|Period III|Lost to Follow-up|0|||
17036608|NCT00696774|38180749|FG000|Period III|Protocol Violation|1|||
17036609|NCT00696774|38180750|FG001|Period III|Protocol Violation|1|||
17036610|NCT00696774|38180751|FG002|Period III|Protocol Violation|0|||
17036611|NCT00696774|38180749|FG000|Period III|Withdrawal by Subject|1|||
17036612|NCT00696774|38180750|FG001|Period III|Withdrawal by Subject|2|||
17036613|NCT00696774|38180751|FG002|Period III|Withdrawal by Subject|0|||
17036614|NCT00696774|38180749|FG000|Period III|Sponsor Decision|2|||
17036615|NCT00696774|38180750|FG001|Period III|Sponsor Decision|0|||
17036616|NCT00696774|38180751|FG002|Period III|Sponsor Decision|0|||
17036617|NCT00696774|38180749|FG000|Period III|Lack of Efficacy|0|||
17036618|NCT00696774|38180750|FG001|Period III|Lack of Efficacy|2|||
17036619|NCT00696774|38180751|FG002|Period III|Lack of Efficacy|0|||
17036620|NCT00608842|38180763|FG000|Overall Study|Participant's Request|0|||
17036621|NCT00608842|38180764|FG001|Overall Study|Participant's Request|1|||
17036622|NCT00608842|38180765|FG002|Overall Study|Participant's Request|2|||
17036623|NCT00608842|38180766|FG003|Overall Study|Participant's Request|1|||
17036624|NCT00608842|38180763|FG000|Overall Study|Lost to Follow-up|1|||
17036625|NCT00608842|38180764|FG001|Overall Study|Lost to Follow-up|0|||
17036626|NCT00608842|38180765|FG002|Overall Study|Lost to Follow-up|0|||
17036627|NCT00608842|38180766|FG003|Overall Study|Lost to Follow-up|0|||
17036628|NCT00626925|38180778|FG000|Overall Study|Lost to Follow-up|1|||
17036629|NCT00626925|38180779|FG001|Overall Study|Lost to Follow-up|2|||
17036630|NCT00626925|38180778|FG000|Overall Study|relapse|1|||
17036631|NCT00626925|38180779|FG001|Overall Study|relapse|0|||
17036632|NCT00626925|38180778|FG000|Overall Study|Adverse effect|6|||
17036633|NCT00626925|38180779|FG001|Overall Study|Adverse effect|2|||
17036634|NCT00626925|38180778|FG000|Overall Study|Lack of Efficacy|1|||
17036635|NCT00626925|38180779|FG001|Overall Study|Lack of Efficacy|4|||
17036636|NCT00626925|38180778|FG000|Overall Study|Time constraints|3|||
17036637|NCT00626925|38180779|FG001|Overall Study|Time constraints|1|||
17036638|NCT00698646|38180802|FG000|Overall Study|Adverse Event|8|||
17036639|NCT00698646|38180803|FG001|Overall Study|Adverse Event|7|||
17036640|NCT00698646|38180804|FG002|Overall Study|Adverse Event|8|||
17036641|NCT00698646|38180802|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
17036642|NCT00698646|38180803|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
17036643|NCT00698646|38180804|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
17036644|NCT00698646|38180802|FG000|Overall Study|Protocol Deviation|6|||
17036645|NCT00698646|38180803|FG001|Overall Study|Protocol Deviation|2|||
17036646|NCT00698646|38180804|FG002|Overall Study|Protocol Deviation|3|||
17036647|NCT00698646|38180802|FG000|Overall Study|Withdrawal by Subject|10|||
17036648|NCT00698646|38180803|FG001|Overall Study|Withdrawal by Subject|11|||
17036649|NCT00698646|38180804|FG002|Overall Study|Withdrawal by Subject|8|||
17036650|NCT00698646|38180802|FG000|Overall Study|Lost to Follow-up|0|||
17036651|NCT00698646|38180803|FG001|Overall Study|Lost to Follow-up|0|||
17036652|NCT00698646|38180804|FG002|Overall Study|Lost to Follow-up|2|||
17036653|NCT00698646|38180802|FG000|Overall Study|Administrative problems|1|||
17138229|NCT03406260|38280024|FG000|Period 1|Adverse Event|0|||
17138230|NCT03406260|38280025|FG001|Period 1|Adverse Event|0|||
17138231|NCT03406260|38280026|FG002|Period 1|Adverse Event|0|||
17138232|NCT03406260|38280027|FG003|Period 1|Adverse Event|0|||
17138233|NCT03406260|38280028|FG004|Period 1|Adverse Event|1|||
17138234|NCT03406260|38280029|FG005|Period 1|Adverse Event|0|||
17138235|NCT03419364|38280042|FG000|Overall Study|Delivery due to maternal condition|2|||
17138236|NCT03419364|38280043|FG001|Overall Study|Delivery due to maternal condition|0|||
17138237|NCT03419364|38280044|FG002|Overall Study|Delivery due to maternal condition|0|||
17138238|NCT02954172|38280054|FG000|Overall Study|Protocol Violation|3|||
17138239|NCT02954172|38280055|FG001|Overall Study|Protocol Violation|0|||
17138240|NCT02954172|38280054|FG000|Overall Study|allergic reaction|2|||
17138241|NCT02954172|38280055|FG001|Overall Study|allergic reaction|1|||
17138242|NCT02954172|38280054|FG000|Overall Study|non-measurable lesions at baseline|1|||
17138243|NCT02954172|38280055|FG001|Overall Study|non-measurable lesions at baseline|2|||
17138244|NCT02953938|38280064|FG000|Overall Study|Adverse Event|0|||
17138245|NCT02953938|38280065|FG001|Overall Study|Adverse Event|1|||
17138246|NCT02953938|38280064|FG000|Overall Study|Withdrawal by Subject|1|||
17138247|NCT02953938|38280065|FG001|Overall Study|Withdrawal by Subject|1|||
17138248|NCT03758443|38280076|FG000|Induction Period|Adverse Event|2|||
17138249|NCT03758443|38280077|FG001|Induction Period|Adverse Event|4|||
17036654|NCT00698646|38180803|FG001|Overall Study|Administrative problems|0|||
17036655|NCT00698646|38180804|FG002|Overall Study|Administrative problems|1|||
17036656|NCT00609466|38180815|FG000|Overall Study|Withdrawal by Subject|0|||
17138250|NCT03758443|38280078|FG002|Induction Period|Adverse Event|2|||
17138251|NCT03758443|38280079|FG003|Induction Period|Adverse Event|3|||
17138252|NCT03758443|38280076|FG000|Induction Period|Physician Decision|1|||
17138253|NCT03758443|38280077|FG001|Induction Period|Physician Decision|1|||
17138254|NCT03758443|38280078|FG002|Induction Period|Physician Decision|3|||
17138255|NCT03758443|38280079|FG003|Induction Period|Physician Decision|0|||
17138256|NCT03758443|38280076|FG000|Induction Period|Protocol Violation|0|||
17138257|NCT03758443|38280077|FG001|Induction Period|Protocol Violation|0|||
17138258|NCT03758443|38280078|FG002|Induction Period|Protocol Violation|0|||
17138259|NCT03758443|38280079|FG003|Induction Period|Protocol Violation|1|||
17138260|NCT03758443|38280076|FG000|Induction Period|Withdrawal by Subject|3|||
17138261|NCT03758443|38280077|FG001|Induction Period|Withdrawal by Subject|2|||
17138262|NCT03758443|38280078|FG002|Induction Period|Withdrawal by Subject|2|||
17138263|NCT03758443|38280079|FG003|Induction Period|Withdrawal by Subject|4|||
17138264|NCT03758443|38280076|FG000|Extended Induction Period|Adverse Event|1|||
17138265|NCT03758443|38280077|FG001|Extended Induction Period|Adverse Event|1|||
17138266|NCT03758443|38280078|FG002|Extended Induction Period|Adverse Event|0|||
17138267|NCT03758443|38280079|FG003|Extended Induction Period|Adverse Event|1|||
17138268|NCT03758443|38280076|FG000|Extended Induction Period|Lost to Follow-up|1|||
17138269|NCT03758443|38280077|FG001|Extended Induction Period|Lost to Follow-up|0|||
17036657|NCT00609466|38180816|FG001|Overall Study|Withdrawal by Subject|1|||
17036658|NCT00609466|38180817|FG002|Overall Study|Withdrawal by Subject|1|||
17036659|NCT00609466|38180815|FG000|Overall Study|Adverse Event|2|||
17036660|NCT00609466|38180816|FG001|Overall Study|Adverse Event|3|||
17036661|NCT00609466|38180817|FG002|Overall Study|Adverse Event|1|||
17036662|NCT00609466|38180815|FG000|Overall Study|Lack of Efficacy|0|||
17036663|NCT00609466|38180816|FG001|Overall Study|Lack of Efficacy|2|||
17036664|NCT00609466|38180817|FG002|Overall Study|Lack of Efficacy|2|||
17036665|NCT00608530|38180829|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
17138270|NCT03758443|38280078|FG002|Extended Induction Period|Lost to Follow-up|0|||
17138271|NCT03758443|38280079|FG003|Extended Induction Period|Lost to Follow-up|0|||
17138272|NCT03758443|38280076|FG000|Extended Induction Period|Physician Decision|2|||
17138273|NCT03758443|38280077|FG001|Extended Induction Period|Physician Decision|1|||
17036666|NCT00608530|38180830|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
17036667|NCT00608530|38180831|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
17036668|NCT00608530|38180832|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
17036669|NCT00608530|38180829|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
17036670|NCT00608530|38180830|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
17036671|NCT00608530|38180831|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
17138274|NCT03758443|38280078|FG002|Extended Induction Period|Physician Decision|2|||
17138275|NCT03758443|38280079|FG003|Extended Induction Period|Physician Decision|2|||
17138276|NCT03758443|38280076|FG000|Extended Induction Period|Protocol Violation|0|||
17138277|NCT03758443|38280077|FG001|Extended Induction Period|Protocol Violation|0|||
17138278|NCT03758443|38280078|FG002|Extended Induction Period|Protocol Violation|0|||
17138279|NCT03758443|38280079|FG003|Extended Induction Period|Protocol Violation|1|||
17036672|NCT00608530|38180832|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
17036673|NCT00608530|38180829|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
17036674|NCT00608530|38180830|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
17036675|NCT00608530|38180831|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
17036676|NCT00608530|38180832|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
17036677|NCT00608530|38180829|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
17036678|NCT00608530|38180830|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
17036679|NCT00608530|38180831|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
17036680|NCT00608530|38180832|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
17036681|NCT00608530|38180829|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
17036682|NCT00608530|38180830|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
17036683|NCT00608530|38180831|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
17036684|NCT00608530|38180832|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
17036685|NCT00608530|38180829|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
17036686|NCT00608530|38180830|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
17036687|NCT00608530|38180831|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
17036688|NCT00608530|38180832|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
17138280|NCT03758443|38280076|FG000|Extended Induction Period|Withdrawal by Subject|8|||
17138281|NCT03758443|38280077|FG001|Extended Induction Period|Withdrawal by Subject|1|||
17138282|NCT03758443|38280078|FG002|Extended Induction Period|Withdrawal by Subject|7|||
17138283|NCT03758443|38280079|FG003|Extended Induction Period|Withdrawal by Subject|3|||
17138284|NCT03758443|38280076|FG000|Extended Induction Period|Miscellaneous|1|||
17138285|NCT03758443|38280077|FG001|Extended Induction Period|Miscellaneous|0|||
17138286|NCT03758443|38280078|FG002|Extended Induction Period|Miscellaneous|0|||
17138287|NCT03758443|38280079|FG003|Extended Induction Period|Miscellaneous|0|||
17138288|NCT03758443|38280076|FG000|Maintenance Period|Adverse Event|1|||
17138289|NCT03758443|38280077|FG001|Maintenance Period|Adverse Event|2|||
17138290|NCT03758443|38280078|FG002|Maintenance Period|Adverse Event|0|||
17138291|NCT03758443|38280079|FG003|Maintenance Period|Adverse Event|0|||
17138292|NCT03758443|38280076|FG000|Maintenance Period|Lost to Follow-up|0|||
17138293|NCT03758443|38280077|FG001|Maintenance Period|Lost to Follow-up|0|||
17138294|NCT03758443|38280078|FG002|Maintenance Period|Lost to Follow-up|0|||
17138295|NCT03758443|38280079|FG003|Maintenance Period|Lost to Follow-up|1|||
17138296|NCT03758443|38280076|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
17138297|NCT03758443|38280077|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
17138298|NCT03758443|38280078|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
17138299|NCT03758443|38280079|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
17138300|NCT03758443|38280076|FG000|Maintenance Period|Protocol Violation|0|||
17138301|NCT03758443|38280077|FG001|Maintenance Period|Protocol Violation|1|||
17138302|NCT03758443|38280078|FG002|Maintenance Period|Protocol Violation|0|||
17138303|NCT03758443|38280079|FG003|Maintenance Period|Protocol Violation|0|||
17138304|NCT03758443|38280076|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
17138305|NCT03758443|38280077|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
17138306|NCT03758443|38280078|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
17138307|NCT03758443|38280079|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
17138308|NCT03758443|38280076|FG000|Maintenance Period|Withdrawal by Subject|1|||
17138309|NCT03758443|38280077|FG001|Maintenance Period|Withdrawal by Subject|0|||
17138310|NCT03758443|38280078|FG002|Maintenance Period|Withdrawal by Subject|1|||
17138311|NCT03758443|38280079|FG003|Maintenance Period|Withdrawal by Subject|1|||
17138312|NCT03758443|38280076|FG000|Maintenance Period|Miscellaneous|0|||
17138313|NCT03758443|38280077|FG001|Maintenance Period|Miscellaneous|0|||
17138314|NCT03758443|38280078|FG002|Maintenance Period|Miscellaneous|1|||
17138315|NCT03758443|38280079|FG003|Maintenance Period|Miscellaneous|0|||
17138316|NCT03442764|38280101|FG000|Overall Study|Adverse Event|1|||
17138317|NCT03442764|38280102|FG001|Overall Study|Adverse Event|0|||
17138318|NCT03442764|38280103|FG002|Overall Study|Adverse Event|0|||
17138319|NCT03442296|38280114|FG000|3 Month Follow-up|Death|3|||
17138320|NCT03442296|38280115|FG001|3 Month Follow-up|Death|1|||
17138321|NCT03442296|38280114|FG000|3 Month Follow-up|Lost to Follow-up|1|||
17138322|NCT03442296|38280115|FG001|3 Month Follow-up|Lost to Follow-up|1|||
17138323|NCT03442296|38280114|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
17138324|NCT03442296|38280115|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
17138325|NCT03442296|38280114|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
17138326|NCT03442296|38280115|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
17138327|NCT03442296|38280114|FG000|12 Month Follow-up|Incomplete measurement|1|||
17138328|NCT03442296|38280115|FG001|12 Month Follow-up|Incomplete measurement|1|||
17138329|NCT03441984|38280123|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17036689|NCT00642993|38180849|FG000|Overall Study|Adverse Event|85|||
17036690|NCT00642993|38180850|FG001|Overall Study|Adverse Event|4|||
17036691|NCT00642993|38180849|FG000|Overall Study|Lost to Follow-up|8|||
17036692|NCT00642993|38180850|FG001|Overall Study|Lost to Follow-up|4|||
17036693|NCT00642993|38180849|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
17036694|NCT00642993|38180850|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
17036695|NCT00642993|38180849|FG000|Overall Study|Protocol Violation|1|||
17036696|NCT00642993|38180850|FG001|Overall Study|Protocol Violation|4|||
17036697|NCT00642993|38180849|FG000|Overall Study|Did not meet protocol eligibility|0|||
17036698|NCT00642993|38180850|FG001|Overall Study|Did not meet protocol eligibility|1|||
17036699|NCT00642993|38180849|FG000|Overall Study|Administrative|1|||
17036700|NCT00642993|38180850|FG001|Overall Study|Administrative|0|||
17036701|NCT00696696|38180856|FG000|Overall Study|Adverse Event|5|||
17036702|NCT00696696|38180856|FG000|Overall Study|Withdrawal by Subject|8|||
17036703|NCT00696696|38180856|FG000|Overall Study|Physician Decision|2|||
17036704|NCT00696696|38180856|FG000|Overall Study|Death|3|||
17036705|NCT00699192|38180863|FG000|Overall Study|Missing|1|||
17036706|NCT00699192|38180864|FG001|Overall Study|Missing|1|||
17036707|NCT00699192|38180865|FG002|Overall Study|Missing|1|||
17036708|NCT00699192|38180863|FG000|Overall Study|Adverse Event|9|||
17036709|NCT00699192|38180864|FG001|Overall Study|Adverse Event|4|||
17036710|NCT00699192|38180865|FG002|Overall Study|Adverse Event|3|||
17036711|NCT00699192|38180863|FG000|Overall Study|Abnormal test procedure result(s)|0|||
17036712|NCT00699192|38180864|FG001|Overall Study|Abnormal test procedure result(s)|0|||
17036713|NCT00699192|38180865|FG002|Overall Study|Abnormal test procedure result(s)|1|||
17036714|NCT00699192|38180863|FG000|Overall Study|Lack of Efficacy|0|||
17036715|NCT00699192|38180864|FG001|Overall Study|Lack of Efficacy|0|||
17036716|NCT00699192|38180865|FG002|Overall Study|Lack of Efficacy|1|||
17036717|NCT00699192|38180863|FG000|Overall Study|Withdrawal by Subject|3|||
17036718|NCT00699192|38180864|FG001|Overall Study|Withdrawal by Subject|2|||
17036719|NCT00699192|38180865|FG002|Overall Study|Withdrawal by Subject|4|||
17036720|NCT00699192|38180863|FG000|Overall Study|Administrative problems|1|||
17036721|NCT00699192|38180864|FG001|Overall Study|Administrative problems|3|||
17036722|NCT00699192|38180865|FG002|Overall Study|Administrative problems|1|||
17036723|NCT00699192|38180863|FG000|Overall Study|Protocol Violation|2|||
17036724|NCT00699192|38180864|FG001|Overall Study|Protocol Violation|2|||
17138330|NCT03441984|38280124|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17138331|NCT03441984|38280125|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
17036725|NCT00699192|38180865|FG002|Overall Study|Protocol Violation|0|||
17036726|NCT00401245|38180881|FG000|Double Blind Titration Phase|Adverse Event|3|||
17036727|NCT00401245|38180882|FG001|Double Blind Titration Phase|Adverse Event|2|||
17036728|NCT00401245|38180883|FG002|Double Blind Titration Phase|Adverse Event|5|||
17036729|NCT00401245|38180884|FG003|Double Blind Titration Phase|Adverse Event|12|||
17036730|NCT00401245|38180885|FG004|Double Blind Titration Phase|Adverse Event|0|||
17036731|NCT00401245|38180886|FG005|Double Blind Titration Phase|Adverse Event|0|||
17036732|NCT00401245|38180887|FG006|Double Blind Titration Phase|Adverse Event|0|||
17036733|NCT00401245|38180888|FG007|Double Blind Titration Phase|Adverse Event|0|||
17036734|NCT00401245|38180881|FG000|Double Blind Titration Phase|Other|0|||
17036735|NCT00401245|38180882|FG001|Double Blind Titration Phase|Other|0|||
17036736|NCT00401245|38180883|FG002|Double Blind Titration Phase|Other|1|||
17036737|NCT00401245|38180884|FG003|Double Blind Titration Phase|Other|0|||
17036738|NCT00401245|38180885|FG004|Double Blind Titration Phase|Other|0|||
17036739|NCT00401245|38180886|FG005|Double Blind Titration Phase|Other|0|||
17036740|NCT00401245|38180887|FG006|Double Blind Titration Phase|Other|0|||
17036741|NCT00401245|38180888|FG007|Double Blind Titration Phase|Other|0|||
17036742|NCT00401245|38180881|FG000|Double Blind Titration Phase|Protocol Violation|0|||
17036743|NCT00401245|38180882|FG001|Double Blind Titration Phase|Protocol Violation|0|||
17036744|NCT00401245|38180883|FG002|Double Blind Titration Phase|Protocol Violation|0|||
17036745|NCT00401245|38180884|FG003|Double Blind Titration Phase|Protocol Violation|1|||
17036746|NCT00401245|38180885|FG004|Double Blind Titration Phase|Protocol Violation|0|||
17036747|NCT00401245|38180886|FG005|Double Blind Titration Phase|Protocol Violation|0|||
17036748|NCT00401245|38180887|FG006|Double Blind Titration Phase|Protocol Violation|0|||
17036749|NCT00401245|38180888|FG007|Double Blind Titration Phase|Protocol Violation|0|||
17036750|NCT00401245|38180881|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
17138332|NCT03441984|38280126|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17138333|NCT03441984|38280127|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17138334|NCT03441984|38280128|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17036751|NCT00401245|38180882|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
17036752|NCT00401245|38180883|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
17036753|NCT00401245|38180884|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
17036754|NCT00401245|38180885|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
17036755|NCT00401245|38180886|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
17036756|NCT00401245|38180887|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
17036757|NCT00401245|38180888|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
17036758|NCT00401245|38180881|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
17138335|NCT03441984|38280129|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17138336|NCT03441984|38280130|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17138337|NCT03441984|38280131|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17138338|NCT03441984|38280132|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17036759|NCT00401245|38180882|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
17036760|NCT00401245|38180883|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
17036761|NCT00401245|38180884|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
17036762|NCT00401245|38180885|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
17036763|NCT00401245|38180886|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
17036764|NCT00401245|38180887|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
17036765|NCT00401245|38180888|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
17036766|NCT00401245|38180881|FG000|Open Label Phase|Adverse Event|5|||
17036767|NCT00401245|38180882|FG001|Open Label Phase|Adverse Event|14|||
17036768|NCT00401245|38180883|FG002|Open Label Phase|Adverse Event|6|||
17036769|NCT00401245|38180884|FG003|Open Label Phase|Adverse Event|7|||
17036770|NCT00401245|38180885|FG004|Open Label Phase|Adverse Event|0|||
17036771|NCT00401245|38180886|FG005|Open Label Phase|Adverse Event|0|||
17036772|NCT00401245|38180887|FG006|Open Label Phase|Adverse Event|0|||
17036773|NCT00401245|38180888|FG007|Open Label Phase|Adverse Event|0|||
17036774|NCT00401245|38180881|FG000|Open Label Phase|Lost to Follow-up|5|||
17036775|NCT00401245|38180882|FG001|Open Label Phase|Lost to Follow-up|7|||
17036776|NCT00401245|38180883|FG002|Open Label Phase|Lost to Follow-up|5|||
17138339|NCT03441984|38280133|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17036777|NCT00401245|38180884|FG003|Open Label Phase|Lost to Follow-up|4|||
17036778|NCT00401245|38180885|FG004|Open Label Phase|Lost to Follow-up|0|||
17036779|NCT00401245|38180886|FG005|Open Label Phase|Lost to Follow-up|0|||
17036780|NCT00401245|38180887|FG006|Open Label Phase|Lost to Follow-up|0|||
17036781|NCT00401245|38180888|FG007|Open Label Phase|Lost to Follow-up|0|||
17036782|NCT00401245|38180881|FG000|Open Label Phase|Other|4|||
17036783|NCT00401245|38180882|FG001|Open Label Phase|Other|8|||
17036784|NCT00401245|38180883|FG002|Open Label Phase|Other|7|||
17036785|NCT00401245|38180884|FG003|Open Label Phase|Other|8|||
17036786|NCT00401245|38180885|FG004|Open Label Phase|Other|0|||
17036787|NCT00401245|38180886|FG005|Open Label Phase|Other|0|||
17036788|NCT00401245|38180887|FG006|Open Label Phase|Other|0|||
17138340|NCT03441984|38280134|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
17138341|NCT03441360|38280152|FG000|Overall Study|Radiological disease progression|5|||
17138342|NCT03441360|38280153|FG001|Overall Study|Radiological disease progression|6|||
17138343|NCT03441360|38280154|FG002|Overall Study|Radiological disease progression|4|||
17138344|NCT03441360|38280152|FG000|Overall Study|Clinical disease progression|2|||
17138345|NCT03441360|38280153|FG001|Overall Study|Clinical disease progression|2|||
17138346|NCT03441360|38280154|FG002|Overall Study|Clinical disease progression|0|||
17138347|NCT03441360|38280152|FG000|Overall Study|Adverse Event|1|||
17138348|NCT03441360|38280153|FG001|Overall Study|Adverse Event|0|||
17138349|NCT03441360|38280154|FG002|Overall Study|Adverse Event|1|||
17138350|NCT01347840|38280162|FG000|Overall Study|Withdrawal by Subject|1|||
17138351|NCT01347762|38280170|FG000|Overall Study|Lost to Follow-up|0|||
17138352|NCT01347762|38280171|FG001|Overall Study|Lost to Follow-up|1|||
17138353|NCT01347762|38280172|FG002|Overall Study|Lost to Follow-up|6|||
17138354|NCT01347762|38280173|FG003|Overall Study|Lost to Follow-up|5|||
17138355|NCT01347762|38280170|FG000|Overall Study|Withdrawal by Subject|4|||
17138356|NCT01347762|38280171|FG001|Overall Study|Withdrawal by Subject|1|||
17036789|NCT00401245|38180888|FG007|Open Label Phase|Other|0|||
17036790|NCT00401245|38180881|FG000|Open Label Phase|Protocol Violation|0|||
17036791|NCT00401245|38180882|FG001|Open Label Phase|Protocol Violation|1|||
17036792|NCT00401245|38180883|FG002|Open Label Phase|Protocol Violation|0|||
17036793|NCT00401245|38180884|FG003|Open Label Phase|Protocol Violation|1|||
17036794|NCT00401245|38180885|FG004|Open Label Phase|Protocol Violation|0|||
17036795|NCT00401245|38180886|FG005|Open Label Phase|Protocol Violation|0|||
17036796|NCT00401245|38180887|FG006|Open Label Phase|Protocol Violation|0|||
17036797|NCT00401245|38180888|FG007|Open Label Phase|Protocol Violation|0|||
17036798|NCT00401245|38180881|FG000|Open Label Phase|Withdrawal by Subject|3|||
17036799|NCT00401245|38180882|FG001|Open Label Phase|Withdrawal by Subject|3|||
17036800|NCT00401245|38180883|FG002|Open Label Phase|Withdrawal by Subject|2|||
17036801|NCT00401245|38180884|FG003|Open Label Phase|Withdrawal by Subject|1|||
17036802|NCT00401245|38180885|FG004|Open Label Phase|Withdrawal by Subject|0|||
17036803|NCT00401245|38180886|FG005|Open Label Phase|Withdrawal by Subject|0|||
17036804|NCT00401245|38180887|FG006|Open Label Phase|Withdrawal by Subject|0|||
17036805|NCT00401245|38180888|FG007|Open Label Phase|Withdrawal by Subject|0|||
17036806|NCT00401245|38180881|FG000|Open Label Phase|Lack of Efficacy|4|||
17036807|NCT00401245|38180882|FG001|Open Label Phase|Lack of Efficacy|2|||
17036808|NCT00401245|38180883|FG002|Open Label Phase|Lack of Efficacy|3|||
17036809|NCT00401245|38180884|FG003|Open Label Phase|Lack of Efficacy|0|||
17036810|NCT00401245|38180885|FG004|Open Label Phase|Lack of Efficacy|0|||
17036811|NCT00401245|38180886|FG005|Open Label Phase|Lack of Efficacy|0|||
17036812|NCT00401245|38180887|FG006|Open Label Phase|Lack of Efficacy|0|||
17036813|NCT00401245|38180888|FG007|Open Label Phase|Lack of Efficacy|0|||
17036814|NCT00401245|38180881|FG000|Double Blind Tapering Phase|Adverse Event|0|||
17036815|NCT00401245|38180882|FG001|Double Blind Tapering Phase|Adverse Event|0|||
17036816|NCT00401245|38180883|FG002|Double Blind Tapering Phase|Adverse Event|0|||
17036817|NCT00401245|38180884|FG003|Double Blind Tapering Phase|Adverse Event|0|||
17036818|NCT00401245|38180885|FG004|Double Blind Tapering Phase|Adverse Event|1|||
17036819|NCT00401245|38180886|FG005|Double Blind Tapering Phase|Adverse Event|1|||
17036820|NCT00401245|38180887|FG006|Double Blind Tapering Phase|Adverse Event|2|||
17036821|NCT00401245|38180888|FG007|Double Blind Tapering Phase|Adverse Event|4|||
17036822|NCT00401245|38180881|FG000|Double Blind Tapering Phase|Investigator request|0|||
17036823|NCT00401245|38180882|FG001|Double Blind Tapering Phase|Investigator request|0|||
17138357|NCT01347762|38280172|FG002|Overall Study|Withdrawal by Subject|3|||
17138358|NCT01347762|38280173|FG003|Overall Study|Withdrawal by Subject|3|||
17138359|NCT03438396|38280183|FG000|Overall Study|Ongoing on study treatment|4|||
17138360|NCT03438396|38280183|FG000|Overall Study|Ongoing in survival follow-up|33|||
17036824|NCT00401245|38180883|FG002|Double Blind Tapering Phase|Investigator request|0|||
17036825|NCT00401245|38180884|FG003|Double Blind Tapering Phase|Investigator request|0|||
17036826|NCT00401245|38180885|FG004|Double Blind Tapering Phase|Investigator request|0|||
17036827|NCT00401245|38180886|FG005|Double Blind Tapering Phase|Investigator request|0|||
17036828|NCT00401245|38180887|FG006|Double Blind Tapering Phase|Investigator request|0|||
17036829|NCT00401245|38180888|FG007|Double Blind Tapering Phase|Investigator request|1|||
17036830|NCT00401245|38180881|FG000|Double Blind Tapering Phase|Other|0|||
17036831|NCT00401245|38180882|FG001|Double Blind Tapering Phase|Other|0|||
17036832|NCT00401245|38180883|FG002|Double Blind Tapering Phase|Other|0|||
17036833|NCT00401245|38180884|FG003|Double Blind Tapering Phase|Other|0|||
17036834|NCT00401245|38180885|FG004|Double Blind Tapering Phase|Other|1|||
17036835|NCT00401245|38180886|FG005|Double Blind Tapering Phase|Other|0|||
17036836|NCT00401245|38180887|FG006|Double Blind Tapering Phase|Other|2|||
17036837|NCT00401245|38180888|FG007|Double Blind Tapering Phase|Other|2|||
17036838|NCT00401245|38180881|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
17036839|NCT00401245|38180882|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
17036840|NCT00401245|38180883|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
17036841|NCT00401245|38180884|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
17036842|NCT00401245|38180885|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
17036843|NCT00401245|38180886|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
17036844|NCT00401245|38180887|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
17036845|NCT00401245|38180888|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
17036846|NCT00401245|38180881|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
17036847|NCT00401245|38180882|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
17036848|NCT00401245|38180883|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
17036849|NCT00401245|38180884|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
17036850|NCT00401245|38180885|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
17036851|NCT00401245|38180886|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
17036852|NCT00401245|38180887|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
17036853|NCT00401245|38180888|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
17036854|NCT00696384|38180908|FG000|Open Label Phase|Adverse Event|27|||
17036855|NCT00696384|38180909|FG001|Open Label Phase|Adverse Event|0|||
17036856|NCT00696384|38180910|FG002|Open Label Phase|Adverse Event|0|||
17036857|NCT00696384|38180908|FG000|Open Label Phase|Protocol Violation|18|||
17036858|NCT00696384|38180909|FG001|Open Label Phase|Protocol Violation|0|||
17036859|NCT00696384|38180910|FG002|Open Label Phase|Protocol Violation|0|||
17036860|NCT00696384|38180908|FG000|Open Label Phase|Lost to Follow-up|24|||
17036861|NCT00696384|38180909|FG001|Open Label Phase|Lost to Follow-up|0|||
17036862|NCT00696384|38180910|FG002|Open Label Phase|Lost to Follow-up|0|||
17036863|NCT00696384|38180908|FG000|Open Label Phase|Withdrawal by Subject|37|||
17036864|NCT00696384|38180909|FG001|Open Label Phase|Withdrawal by Subject|0|||
17036865|NCT00696384|38180910|FG002|Open Label Phase|Withdrawal by Subject|0|||
17036866|NCT00696384|38180908|FG000|Open Label Phase|Other|6|||
17036867|NCT00696384|38180909|FG001|Open Label Phase|Other|0|||
17036868|NCT00696384|38180910|FG002|Open Label Phase|Other|0|||
17036869|NCT00696384|38180908|FG000|Open Label Phase|Lack of Efficacy|3|||
17036870|NCT00696384|38180909|FG001|Open Label Phase|Lack of Efficacy|0|||
17036871|NCT00696384|38180910|FG002|Open Label Phase|Lack of Efficacy|0|||
17036872|NCT00696384|38180908|FG000|Open Label Phase|Physician Decision|4|||
17036873|NCT00696384|38180909|FG001|Open Label Phase|Physician Decision|0|||
17036874|NCT00696384|38180910|FG002|Open Label Phase|Physician Decision|0|||
17036875|NCT00696384|38180908|FG000|Double Blind Phase|Adverse Event|0|||
17036876|NCT00696384|38180909|FG001|Double Blind Phase|Adverse Event|2|||
17036877|NCT00696384|38180910|FG002|Double Blind Phase|Adverse Event|2|||
17036878|NCT00696384|38180908|FG000|Double Blind Phase|Lost to Follow-up|0|||
17036879|NCT00696384|38180909|FG001|Double Blind Phase|Lost to Follow-up|2|||
17036880|NCT00696384|38180910|FG002|Double Blind Phase|Lost to Follow-up|1|||
17036881|NCT00696384|38180908|FG000|Double Blind Phase|Withdrawal by Subject|0|||
17036882|NCT00696384|38180909|FG001|Double Blind Phase|Withdrawal by Subject|4|||
17036883|NCT00696384|38180910|FG002|Double Blind Phase|Withdrawal by Subject|3|||
17036884|NCT00696384|38180908|FG000|Double Blind Phase|Lack of Efficacy|0|||
17036885|NCT00696384|38180909|FG001|Double Blind Phase|Lack of Efficacy|1|||
17036886|NCT00696384|38180910|FG002|Double Blind Phase|Lack of Efficacy|0|||
17036887|NCT00696384|38180908|FG000|Double Blind Phase|Physician Decision|0|||
17036888|NCT00696384|38180909|FG001|Double Blind Phase|Physician Decision|2|||
17036889|NCT00696384|38180910|FG002|Double Blind Phase|Physician Decision|0|||
17036890|NCT00569127|38180921|FG000|Overall Study|Adverse Event|57|||
17036891|NCT00569127|38180922|FG001|Overall Study|Adverse Event|47|||
17036892|NCT00569127|38180921|FG000|Overall Study|Withdrawal by Subject|13|||
17036893|NCT00569127|38180922|FG001|Overall Study|Withdrawal by Subject|27|||
17036894|NCT00569127|38180921|FG000|Overall Study|Progression|99|||
17036895|NCT00569127|38180922|FG001|Overall Study|Progression|100|||
17036896|NCT00569127|38180921|FG000|Overall Study|Death|4|||
17036897|NCT00569127|38180922|FG001|Overall Study|Death|3|||
17036898|NCT00569127|38180921|FG000|Overall Study|Other|20|||
17036899|NCT00569127|38180922|FG001|Overall Study|Other|19|||
17036900|NCT00569127|38180921|FG000|Overall Study|Lost to Follow-up|0|||
17036901|NCT00569127|38180922|FG001|Overall Study|Lost to Follow-up|3|||
17036902|NCT00569127|38180921|FG000|Overall Study|Not Eligible|14|||
17036903|NCT00569127|38180922|FG001|Overall Study|Not Eligible|11|||
17036904|NCT00569127|38180921|FG000|Overall Study|Still on Treatment|7|||
17036905|NCT00569127|38180922|FG001|Overall Study|Still on Treatment|3|||
17036906|NCT00636675|38180930|FG000|Overall Study|Lost to Follow-up|121|||
17036907|NCT00636675|38180931|FG001|Overall Study|Lost to Follow-up|31|||
17036908|NCT00636675|38180930|FG000|Overall Study|Withdrawal by Subject|19|||
17036909|NCT00636675|38180931|FG001|Overall Study|Withdrawal by Subject|10|||
17036910|NCT00699998|38180941|FG000|Overall Study|Withdrawal by Subject|194|||
17036911|NCT00699998|38180942|FG001|Overall Study|Withdrawal by Subject|83|||
17036912|NCT00699998|38180943|FG002|Overall Study|Withdrawal by Subject|202|||
17036913|NCT00699998|38180944|FG003|Overall Study|Withdrawal by Subject|80|||
17036914|NCT00699998|38180941|FG000|Overall Study|Physician Decision|3|||
17036915|NCT00699998|38180942|FG001|Overall Study|Physician Decision|2|||
17036916|NCT00699998|38180943|FG002|Overall Study|Physician Decision|1|||
17036917|NCT00699998|38180944|FG003|Overall Study|Physician Decision|1|||
17036918|NCT00699998|38180941|FG000|Overall Study|Lost to Follow-up|2|||
17036919|NCT00699998|38180942|FG001|Overall Study|Lost to Follow-up|1|||
17036920|NCT00699998|38180943|FG002|Overall Study|Lost to Follow-up|3|||
17036921|NCT00699998|38180944|FG003|Overall Study|Lost to Follow-up|1|||
17036922|NCT00696072|38180961|FG000|Overall Study|continuing active treatment|10|||
17036923|NCT00696072|38180962|FG001|Overall Study|continuing active treatment|13|||
17036924|NCT00696072|38180961|FG000|Overall Study|Adverse Event|10|||
17036925|NCT00696072|38180962|FG001|Overall Study|Adverse Event|6|||
17036926|NCT00696072|38180961|FG000|Overall Study|Patient Request|3|||
17036927|NCT00696072|38180962|FG001|Overall Study|Patient Request|7|||
17036928|NCT00696072|38180961|FG000|Overall Study|Investigator Request|1|||
17036929|NCT00696072|38180962|FG001|Overall Study|Investigator Request|4|||
17036930|NCT00696072|38180961|FG000|Overall Study|Sponsor Request|0|||
17036931|NCT00696072|38180962|FG001|Overall Study|Sponsor Request|1|||
17036932|NCT00696072|38180961|FG000|Overall Study|Disease Progression|32|||
17036933|NCT00696072|38180962|FG001|Overall Study|Disease Progression|30|||
17036934|NCT00696072|38180961|FG000|Overall Study|Non-specified|1|||
17036935|NCT00696072|38180962|FG001|Overall Study|Non-specified|2|||
17036936|NCT00634647|38180969|FG000|Overall Study|death on study|3|||
17036937|NCT00634647|38180969|FG000|Overall Study|refused further treatment|3|||
17036938|NCT00634647|38180969|FG000|Overall Study|declined to participate before treatment|1|||
17036939|NCT00576732|38180976|FG000|DOUBLE BLIND|Adverse Event|0|||
17036940|NCT00576732|38180977|FG001|DOUBLE BLIND|Adverse Event|0|||
17036941|NCT00576732|38180978|FG002|DOUBLE BLIND|Adverse Event|1|||
17036942|NCT00576732|38180979|FG003|DOUBLE BLIND|Adverse Event|0|||
17036943|NCT00576732|38180980|FG004|DOUBLE BLIND|Adverse Event|0|||
17036944|NCT00576732|38180981|FG005|DOUBLE BLIND|Adverse Event|0|||
17036945|NCT00576732|38180976|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
17036946|NCT00576732|38180977|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
17036947|NCT00576732|38180978|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
17036948|NCT00576732|38180979|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
17036949|NCT00576732|38180980|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
17036950|NCT00576732|38180981|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
17036951|NCT00576732|38180976|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
17036952|NCT00576732|38180977|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
17036953|NCT00576732|38180978|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
17036954|NCT00576732|38180979|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
17036955|NCT00576732|38180980|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
17036956|NCT00576732|38180981|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
17036957|NCT00576732|38180976|FG000|DOUBLE BLIND|OTHER|0|||
17036958|NCT00576732|38180977|FG001|DOUBLE BLIND|OTHER|2|||
17036959|NCT00576732|38180978|FG002|DOUBLE BLIND|OTHER|1|||
17036960|NCT00576732|38180979|FG003|DOUBLE BLIND|OTHER|0|||
17036961|NCT00576732|38180980|FG004|DOUBLE BLIND|OTHER|0|||
17036962|NCT00576732|38180981|FG005|DOUBLE BLIND|OTHER|0|||
17036963|NCT00576732|38180976|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
17036964|NCT00576732|38180977|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
17036965|NCT00576732|38180978|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
17036966|NCT00576732|38180979|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
17036967|NCT00576732|38180980|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
17138361|NCT03438396|38280183|FG000|Overall Study|Withdrawal by Subject|4|||
17036968|NCT00576732|38180981|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
17036969|NCT00576732|38180976|FG000|DOUBLE BLIND|Protocol Violation|1|||
17036970|NCT00576732|38180977|FG001|DOUBLE BLIND|Protocol Violation|0|||
17138362|NCT03438396|38280183|FG000|Overall Study|Lost to Follow-up|2|||
17138363|NCT03438396|38280183|FG000|Overall Study|Death|58|||
17138364|NCT03438396|38280183|FG000|Overall Study|Not treated|1|||
17138365|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
17138366|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
17138367|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
17138368|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
17138369|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
17138370|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
17138371|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
17138372|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
17138373|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
17138374|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
17138375|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
17138376|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
17138377|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
17138378|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
17138379|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
17138380|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
17138381|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
17138382|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
17138383|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
17138384|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
17138385|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
17138386|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
17138387|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
17138388|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
17138389|NCT00073307|38280189|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
17138390|NCT00073307|38280190|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
17138391|NCT00073307|38280191|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
17036971|NCT00576732|38180978|FG002|DOUBLE BLIND|Protocol Violation|0|||
17036972|NCT00576732|38180979|FG003|DOUBLE BLIND|Protocol Violation|0|||
17036973|NCT00576732|38180980|FG004|DOUBLE BLIND|Protocol Violation|0|||
17036974|NCT00576732|38180981|FG005|DOUBLE BLIND|Protocol Violation|0|||
17036975|NCT00576732|38180976|FG000|OPEN LABEL|Adverse Event|0|||
17036976|NCT00576732|38180977|FG001|OPEN LABEL|Adverse Event|0|||
17036977|NCT00576732|38180978|FG002|OPEN LABEL|Adverse Event|0|||
17036978|NCT00576732|38180979|FG003|OPEN LABEL|Adverse Event|4|||
17036979|NCT00576732|38180980|FG004|OPEN LABEL|Adverse Event|0|||
17036980|NCT00576732|38180981|FG005|OPEN LABEL|Adverse Event|1|||
17036981|NCT00576732|38180976|FG000|OPEN LABEL|Lost to Follow-up|0|||
17036982|NCT00576732|38180977|FG001|OPEN LABEL|Lost to Follow-up|0|||
17036983|NCT00576732|38180978|FG002|OPEN LABEL|Lost to Follow-up|0|||
17036984|NCT00576732|38180979|FG003|OPEN LABEL|Lost to Follow-up|2|||
17036985|NCT00576732|38180980|FG004|OPEN LABEL|Lost to Follow-up|1|||
17036986|NCT00576732|38180981|FG005|OPEN LABEL|Lost to Follow-up|1|||
17036987|NCT00576732|38180976|FG000|OPEN LABEL|Withdrawal by Subject|0|||
17036988|NCT00576732|38180977|FG001|OPEN LABEL|Withdrawal by Subject|0|||
17036989|NCT00576732|38180978|FG002|OPEN LABEL|Withdrawal by Subject|0|||
17036990|NCT00576732|38180979|FG003|OPEN LABEL|Withdrawal by Subject|1|||
17036991|NCT00576732|38180980|FG004|OPEN LABEL|Withdrawal by Subject|0|||
17036992|NCT00576732|38180981|FG005|OPEN LABEL|Withdrawal by Subject|1|||
17036993|NCT00576732|38180976|FG000|OPEN LABEL|OTHER|0|||
17036994|NCT00576732|38180977|FG001|OPEN LABEL|OTHER|0|||
17036995|NCT00576732|38180978|FG002|OPEN LABEL|OTHER|0|||
17036996|NCT00576732|38180979|FG003|OPEN LABEL|OTHER|0|||
17036997|NCT00576732|38180980|FG004|OPEN LABEL|OTHER|0|||
17036998|NCT00576732|38180981|FG005|OPEN LABEL|OTHER|2|||
17036999|NCT00576732|38180976|FG000|OPEN LABEL|Lack of Efficacy|0|||
17037000|NCT00576732|38180977|FG001|OPEN LABEL|Lack of Efficacy|0|||
17037001|NCT00576732|38180978|FG002|OPEN LABEL|Lack of Efficacy|0|||
17037002|NCT00576732|38180979|FG003|OPEN LABEL|Lack of Efficacy|2|||
17037003|NCT00576732|38180980|FG004|OPEN LABEL|Lack of Efficacy|2|||
17037004|NCT00576732|38180981|FG005|OPEN LABEL|Lack of Efficacy|3|||
17037005|NCT00576732|38180976|FG000|OPEN LABEL|Protocol Violation|0|||
17037006|NCT00576732|38180977|FG001|OPEN LABEL|Protocol Violation|0|||
17037007|NCT00576732|38180978|FG002|OPEN LABEL|Protocol Violation|0|||
17037008|NCT00576732|38180979|FG003|OPEN LABEL|Protocol Violation|2|||
17037009|NCT00576732|38180980|FG004|OPEN LABEL|Protocol Violation|1|||
17037010|NCT00576732|38180981|FG005|OPEN LABEL|Protocol Violation|0|||
17037011|NCT00697788|38180993|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
17037012|NCT00697788|38180994|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
17037013|NCT00697788|38180995|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
17037014|NCT00697788|38180996|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
17037015|NCT00697788|38180997|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
17037016|NCT00697788|38180998|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
17037017|NCT00697788|38180999|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
17037018|NCT00697788|38181000|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
17037019|NCT00697788|38180993|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
17037020|NCT00697788|38180994|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
17037021|NCT00697788|38180995|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
17037022|NCT00697788|38180996|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
17037023|NCT00697788|38180997|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
17037024|NCT00697788|38180998|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
17037025|NCT00697788|38180999|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
17037026|NCT00697788|38181000|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
17037027|NCT00400153|38181030|FG000|Overall Study|AE due to study disease worsening|14|||
17037028|NCT00400153|38181031|FG001|Overall Study|AE due to study disease worsening|19|||
17037029|NCT00400153|38181032|FG002|Overall Study|AE due to study disease worsening|20|||
17037030|NCT00400153|38181030|FG000|Overall Study|AE due to other disease worsening|2|||
17037031|NCT00400153|38181031|FG001|Overall Study|AE due to other disease worsening|1|||
17037032|NCT00400153|38181032|FG002|Overall Study|AE due to other disease worsening|0|||
17037033|NCT00400153|38181030|FG000|Overall Study|AE due to other condition|3|||
17037034|NCT00400153|38181031|FG001|Overall Study|AE due to other condition|14|||
17037035|NCT00400153|38181032|FG002|Overall Study|AE due to other condition|15|||
17037036|NCT00400153|38181030|FG000|Overall Study|Protocol Violation|7|||
17037037|NCT00400153|38181031|FG001|Overall Study|Protocol Violation|4|||
17037038|NCT00400153|38181032|FG002|Overall Study|Protocol Violation|9|||
17037039|NCT00400153|38181030|FG000|Overall Study|Lost to Follow-up|2|||
17138392|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
17138393|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
17138394|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
17138395|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
17037040|NCT00400153|38181031|FG001|Overall Study|Lost to Follow-up|1|||
17037041|NCT00400153|38181032|FG002|Overall Study|Lost to Follow-up|4|||
17037042|NCT00400153|38181030|FG000|Overall Study|Withdrawal by Subject|12|||
17037043|NCT00400153|38181031|FG001|Overall Study|Withdrawal by Subject|11|||
17037044|NCT00400153|38181032|FG002|Overall Study|Withdrawal by Subject|10|||
17037045|NCT00400153|38181030|FG000|Overall Study|Other reasons - not mentioned above|8|||
17037046|NCT00400153|38181031|FG001|Overall Study|Other reasons - not mentioned above|5|||
17037047|NCT00400153|38181032|FG002|Overall Study|Other reasons - not mentioned above|3|||
17037048|NCT00631917|38181047|FG000|Overall Study|Adverse Event|34|||
17037049|NCT00631917|38181048|FG001|Overall Study|Adverse Event|45|||
17037050|NCT00631917|38181047|FG000|Overall Study|Abnormal laboratory value(s)|2|||
17037051|NCT00631917|38181048|FG001|Overall Study|Abnormal laboratory value(s)|1|||
17037052|NCT00631917|38181047|FG000|Overall Study|Abnormal test procedure result(s)|3|||
17037053|NCT00631917|38181048|FG001|Overall Study|Abnormal test procedure result(s)|2|||
17037054|NCT00631917|38181047|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
17037055|NCT00631917|38181048|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
17037056|NCT00631917|38181047|FG000|Overall Study|No longer required study drug|0|||
17037057|NCT00631917|38181048|FG001|Overall Study|No longer required study drug|1|||
17037058|NCT00631917|38181047|FG000|Overall Study|Protocol deviation|6|||
17037059|NCT00631917|38181048|FG001|Overall Study|Protocol deviation|5|||
17037060|NCT00631917|38181047|FG000|Overall Study|Subject withdrew consent|25|||
17037061|NCT00631917|38181048|FG001|Overall Study|Subject withdrew consent|33|||
17037062|NCT00631917|38181047|FG000|Overall Study|Lost to Follow-up|7|||
17037063|NCT00631917|38181048|FG001|Overall Study|Lost to Follow-up|7|||
17037064|NCT00631917|38181047|FG000|Overall Study|Administrative problems|2|||
17037065|NCT00631917|38181048|FG001|Overall Study|Administrative problems|0|||
17037066|NCT00631917|38181047|FG000|Overall Study|Death|1|||
17037067|NCT00631917|38181048|FG001|Overall Study|Death|0|||
17037068|NCT00419341|38181065|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
17037069|NCT00419341|38181065|FG000|Wash in/Wash Out Period|Adverse Event|2|||
17037070|NCT00419341|38181065|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
17037071|NCT00419341|38181065|FG000|Efficacy Period|Withdrawal by Subject|6|||
17037072|NCT00419341|38181065|FG000|Efficacy Period|Protocol Violation|1|||
17037073|NCT00419341|38181065|FG000|Efficacy Period|Lost to Follow-up|1|||
17037074|NCT00419341|38181065|FG000|Efficacy Period|Non-compliance|1|||
17138396|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
17138397|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
17037075|NCT00419341|38181065|FG000|Efficacy Period|Termination of study site|1|||
17037076|NCT00694122|38181071|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
17037077|NCT00694122|38181072|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
17037078|NCT00694122|38181071|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
17037079|NCT00694122|38181072|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
17037080|NCT00694122|38181071|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
17037081|NCT00694122|38181072|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
17037082|NCT03922620|38181085|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
17037083|NCT03922620|38181086|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
17037084|NCT00419263|38181095|FG000|Overall Study|Lost to Follow-up|2|||
17037085|NCT00419263|38181096|FG001|Overall Study|Lost to Follow-up|1|||
17037086|NCT00419263|38181097|FG002|Overall Study|Lost to Follow-up|1|||
17037087|NCT00419263|38181095|FG000|Overall Study|Randomized in Error, Not Treated|1|||
17138398|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
17138399|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
17138400|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
17138401|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
17138402|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
17138403|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
17138404|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
17138405|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
17138406|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
17138407|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
17138408|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
17138409|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
17138410|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
17138411|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
17138412|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
17138413|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
17138414|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
17138415|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
17138416|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
17138417|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
17138418|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
17138419|NCT00073307|38280189|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
17138420|NCT00073307|38280190|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
17138421|NCT00073307|38280191|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
17138422|NCT03388164|38280202|FG000|Overall Study|Withdrawal by Subject|3|||
17138423|NCT03388164|38280203|FG001|Overall Study|Withdrawal by Subject|1|||
17138424|NCT03403374|38280209|FG000|Overall Study|Lost to Follow-up|1|||
17138425|NCT03387462|38280213|FG000|Overall Study|Lost to Follow-up|1|||
17138426|NCT03756883|38280220|FG000|Overall Study|Adverse Event|2|||
17138427|NCT03756883|38280221|FG001|Overall Study|Adverse Event|2|||
17138428|NCT03756883|38280222|FG002|Overall Study|Adverse Event|2|||
17138429|NCT03756883|38280220|FG000|Overall Study|Lack of Efficacy|0|||
17138430|NCT03756883|38280221|FG001|Overall Study|Lack of Efficacy|1|||
17037088|NCT00419263|38181096|FG001|Overall Study|Randomized in Error, Not Treated|1|||
17037089|NCT00419263|38181097|FG002|Overall Study|Randomized in Error, Not Treated|0|||
17037090|NCT00419263|38181095|FG000|Overall Study|Adverse Event|0|||
17037091|NCT00419263|38181096|FG001|Overall Study|Adverse Event|0|||
17037092|NCT00419263|38181097|FG002|Overall Study|Adverse Event|1|||
17037093|NCT00419263|38181095|FG000|Overall Study|Withdrawal by Subject|0|||
17037094|NCT00419263|38181096|FG001|Overall Study|Withdrawal by Subject|0|||
17037095|NCT00419263|38181097|FG002|Overall Study|Withdrawal by Subject|1|||
17037096|NCT00399763|38181108|FG000|Overall Study|Lost to Follow-up|2|||
17037097|NCT00399763|38181109|FG001|Overall Study|Lost to Follow-up|3|||
17037098|NCT00699842|38181118|FG000|Overall Study|Death|0|||
17037099|NCT00699842|38181119|FG001|Overall Study|Death|1|||
17037100|NCT00699842|38181120|FG002|Overall Study|Death|0|||
17037101|NCT00399529|38181128|FG000|Overall Study|Off Study Prior to Treatment|2|||
17037102|NCT00712712|38181133|FG000|Overall Study|Protocol Violation|11|||
17037103|NCT00712712|38181133|FG000|Overall Study|Radiofrequency not done|3|||
17037104|NCT00712712|38181133|FG000|Overall Study|Death|8|||
17037105|NCT00712712|38181133|FG000|Overall Study|Withdrawal by Subject|1|||
17037106|NCT00411151|38181137|FG000|Overall Study|Death|38|||
17037107|NCT00411151|38181137|FG000|Overall Study|Withdrawal by Subject|2|||
17037108|NCT00411151|38181137|FG000|Overall Study|Lost to Follow-up|2|||
17037109|NCT00411151|38181137|FG000|Overall Study|Protocol Violation|1|||
17037110|NCT00411151|38181137|FG000|Overall Study|Trial prematurely closed|4|||
17037111|NCT00607048|38181143|FG000|Overall Study|Adverse Event|0|||
17037112|NCT00607048|38181144|FG001|Overall Study|Adverse Event|1|||
17037113|NCT00607048|38181145|FG002|Overall Study|Adverse Event|0|||
17138431|NCT03756883|38280222|FG002|Overall Study|Lack of Efficacy|2|||
17138432|NCT03756883|38280220|FG000|Overall Study|Lost to Follow-up|3|||
17138433|NCT03756883|38280221|FG001|Overall Study|Lost to Follow-up|3|||
17138434|NCT03756883|38280222|FG002|Overall Study|Lost to Follow-up|0|||
17037114|NCT00607048|38181146|FG003|Overall Study|Adverse Event|0|||
17037115|NCT00607048|38181147|FG004|Overall Study|Adverse Event|4|||
17037116|NCT00607048|38181148|FG005|Overall Study|Adverse Event|0|||
17037117|NCT00607048|38181143|FG000|Overall Study|Global deterioration of health|1|||
17037118|NCT00607048|38181144|FG001|Overall Study|Global deterioration of health|0|||
17037119|NCT00607048|38181145|FG002|Overall Study|Global deterioration of health|0|||
17037120|NCT00607048|38181146|FG003|Overall Study|Global deterioration of health|0|||
17037121|NCT00607048|38181147|FG004|Overall Study|Global deterioration of health|0|||
17037122|NCT00607048|38181148|FG005|Overall Study|Global deterioration of health|0|||
17037123|NCT00607048|38181143|FG000|Overall Study|Objective disease progression - relapse|1|||
17037124|NCT00607048|38181144|FG001|Overall Study|Objective disease progression - relapse|2|||
17037125|NCT00607048|38181145|FG002|Overall Study|Objective disease progression - relapse|4|||
17037126|NCT00607048|38181146|FG003|Overall Study|Objective disease progression - relapse|2|||
17037127|NCT00607048|38181147|FG004|Overall Study|Objective disease progression - relapse|2|||
17037128|NCT00607048|38181148|FG005|Overall Study|Objective disease progression - relapse|2|||
17037129|NCT00607048|38181143|FG000|Overall Study|Withdrawal by Subject|0|||
17037130|NCT00607048|38181144|FG001|Overall Study|Withdrawal by Subject|0|||
17037131|NCT00607048|38181145|FG002|Overall Study|Withdrawal by Subject|0|||
17037132|NCT00607048|38181146|FG003|Overall Study|Withdrawal by Subject|1|||
17037133|NCT00607048|38181147|FG004|Overall Study|Withdrawal by Subject|0|||
17037134|NCT00607048|38181148|FG005|Overall Study|Withdrawal by Subject|2|||
17037135|NCT00607048|38181143|FG000|Overall Study|Other|1|||
17037136|NCT00607048|38181144|FG001|Overall Study|Other|1|||
17037137|NCT00607048|38181145|FG002|Overall Study|Other|0|||
17037138|NCT00607048|38181146|FG003|Overall Study|Other|0|||
17037139|NCT00607048|38181147|FG004|Overall Study|Other|0|||
17037140|NCT00607048|38181148|FG005|Overall Study|Other|1|||
17037141|NCT00699608|38181164|FG000|First Intervention|Withdrawal by Subject|0|||
17037142|NCT00699608|38181165|FG001|First Intervention|Withdrawal by Subject|0|||
17037143|NCT00699608|38181166|FG002|First Intervention|Withdrawal by Subject|1|||
17037144|NCT00699608|38181167|FG003|First Intervention|Withdrawal by Subject|0|||
17037145|NCT00699608|38181168|FG004|First Intervention|Withdrawal by Subject|0|||
17037146|NCT00699608|38181169|FG005|First Intervention|Withdrawal by Subject|0|||
17037147|NCT00699608|38181164|FG000|First Intervention|Protocol Violation|0|||
17037148|NCT00699608|38181165|FG001|First Intervention|Protocol Violation|0|||
17037149|NCT00699608|38181166|FG002|First Intervention|Protocol Violation|0|||
17037150|NCT00699608|38181167|FG003|First Intervention|Protocol Violation|0|||
17037151|NCT00699608|38181168|FG004|First Intervention|Protocol Violation|1|||
17037152|NCT00699608|38181169|FG005|First Intervention|Protocol Violation|0|||
17037153|NCT00699608|38181164|FG000|Second Intervention|Adverse Event|0|||
17037154|NCT00699608|38181165|FG001|Second Intervention|Adverse Event|0|||
17037155|NCT00699608|38181166|FG002|Second Intervention|Adverse Event|1|||
17037156|NCT00699608|38181167|FG003|Second Intervention|Adverse Event|0|||
17037157|NCT00699608|38181168|FG004|Second Intervention|Adverse Event|0|||
17037158|NCT00699608|38181169|FG005|Second Intervention|Adverse Event|0|||
17037159|NCT00699608|38181164|FG000|Second Intervention|Withdrawal by Subject|0|||
17037160|NCT00699608|38181165|FG001|Second Intervention|Withdrawal by Subject|0|||
17037161|NCT00699608|38181166|FG002|Second Intervention|Withdrawal by Subject|0|||
17037162|NCT00699608|38181167|FG003|Second Intervention|Withdrawal by Subject|1|||
17037163|NCT00699608|38181168|FG004|Second Intervention|Withdrawal by Subject|0|||
17037164|NCT00699608|38181169|FG005|Second Intervention|Withdrawal by Subject|0|||
17037165|NCT03823404|38181180|FG000|Overall Study|Lost to Follow-up|1|||
17037166|NCT03823404|38181181|FG001|Overall Study|Lost to Follow-up|2|||
17037167|NCT03823404|38181182|FG002|Overall Study|Lost to Follow-up|3|||
17037168|NCT03823404|38181180|FG000|Overall Study|Protocol Violation|2|||
17037169|NCT03823404|38181181|FG001|Overall Study|Protocol Violation|0|||
17037170|NCT03823404|38181182|FG002|Overall Study|Protocol Violation|2|||
17037171|NCT03823404|38181180|FG000|Overall Study|Adverse Event|35|||
17037172|NCT03823404|38181181|FG001|Overall Study|Adverse Event|38|||
17037173|NCT03823404|38181182|FG002|Overall Study|Adverse Event|8|||
17037174|NCT03823404|38181180|FG000|Overall Study|Withdrawal by Subject|38|||
17037175|NCT03823404|38181181|FG001|Overall Study|Withdrawal by Subject|40|||
17037176|NCT03823404|38181182|FG002|Overall Study|Withdrawal by Subject|35|||
17037177|NCT03823404|38181180|FG000|Overall Study|Death|4|||
17037178|NCT03823404|38181181|FG001|Overall Study|Death|0|||
17037179|NCT03823404|38181182|FG002|Overall Study|Death|0|||
17037180|NCT03823404|38181180|FG000|Overall Study|Other: Various reasons provided|5|||
17037181|NCT03823404|38181181|FG001|Overall Study|Other: Various reasons provided|5|||
17037182|NCT03823404|38181182|FG002|Overall Study|Other: Various reasons provided|6|||
17037183|NCT00706706|38181190|FG000|Overall Study|Death|53|||
17037184|NCT00706706|38181190|FG000|Overall Study|Lost to Follow-up|7|||
17037185|NCT00706706|38181190|FG000|Overall Study|Study endpoint had reached|45|||
17037186|NCT00410761|38181196|FG000|Overall Study|Adverse Event|29|||
17037187|NCT00410761|38181197|FG001|Overall Study|Adverse Event|3|||
17138435|NCT03756883|38280220|FG000|Overall Study|Protocol Violation|2|||
17037188|NCT00410761|38181196|FG000|Overall Study|objective disease progression|71|||
17138436|NCT03756883|38280221|FG001|Overall Study|Protocol Violation|0|||
17138437|NCT03756883|38280222|FG002|Overall Study|Protocol Violation|1|||
17138438|NCT03756883|38280220|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
17138439|NCT03756883|38280221|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
17138440|NCT03756883|38280222|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
17138441|NCT03756883|38280220|FG000|Overall Study|Withdrawal by Subject|4|||
17138442|NCT03756883|38280221|FG001|Overall Study|Withdrawal by Subject|1|||
17138443|NCT03756883|38280222|FG002|Overall Study|Withdrawal by Subject|0|||
17138444|NCT03756883|38280220|FG000|Overall Study|Other Reasons|2|||
17138445|NCT03756883|38280221|FG001|Overall Study|Other Reasons|4|||
17138446|NCT03756883|38280222|FG002|Overall Study|Other Reasons|0|||
17138447|NCT03386994|38280233|FG000|Overall Study|Lung transplant|1|||
17138448|NCT03386994|38280233|FG000|Overall Study|Adverse Event|14|||
17138449|NCT03386994|38280233|FG000|Overall Study|Lost to Follow-up|4|||
17138450|NCT03386994|38280233|FG000|Overall Study|Withdrawal by Subject|3|||
17138451|NCT03386994|38280233|FG000|Overall Study|Death|16|||
17138452|NCT03756571|38280250|FG000|Overall Study|Lost to Follow-up|1|||
17138453|NCT03756571|38280251|FG001|Overall Study|Lost to Follow-up|1|||
17138454|NCT03386448|38280259|FG000|Overall Study|Adverse Event|0|||
17138455|NCT03386448|38280260|FG001|Overall Study|Adverse Event|2|||
17138456|NCT02951988|38280269|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
17138457|NCT02951988|38280270|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
17138458|NCT02951988|38280271|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
17138459|NCT02951988|38280272|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
17138460|NCT02951988|38280269|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
17138461|NCT02951988|38280270|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
17138462|NCT02951988|38280271|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
17138463|NCT02951988|38280272|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
17138464|NCT02951988|38280269|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
17138465|NCT02951988|38280270|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
17138466|NCT02951988|38280271|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
17138467|NCT02951988|38280272|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
17138468|NCT02951988|38280269|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
17138469|NCT02951988|38280270|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
17138470|NCT02951988|38280271|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
17138471|NCT02951988|38280272|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
17138472|NCT02951988|38280269|FG000|Open-Label Treatment Period|Protocol Violation|22|||
17138473|NCT02951988|38280270|FG001|Open-Label Treatment Period|Protocol Violation|0|||
17138474|NCT02951988|38280271|FG002|Open-Label Treatment Period|Protocol Violation|0|||
17138475|NCT02951988|38280272|FG003|Open-Label Treatment Period|Protocol Violation|0|||
17138476|NCT02951988|38280269|FG000|Open-Label Treatment Period|Pregnancy|2|||
17138477|NCT02951988|38280270|FG001|Open-Label Treatment Period|Pregnancy|0|||
17138478|NCT02951988|38280271|FG002|Open-Label Treatment Period|Pregnancy|0|||
17138479|NCT02951988|38280272|FG003|Open-Label Treatment Period|Pregnancy|0|||
17138480|NCT02951988|38280269|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
17138481|NCT02951988|38280270|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
17138482|NCT02951988|38280271|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
17138483|NCT02951988|38280272|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
17138484|NCT02951988|38280269|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
17138485|NCT02951988|38280270|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
17138486|NCT02951988|38280271|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
17138487|NCT02951988|38280272|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
17138488|NCT02951988|38280269|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
17138489|NCT02951988|38280270|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
17138490|NCT02951988|38280271|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
17138491|NCT02951988|38280272|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
17138492|NCT02951988|38280269|FG000|Open-Label Treatment Period|Adverse Event|45|||
17138493|NCT02951988|38280270|FG001|Open-Label Treatment Period|Adverse Event|0|||
17138494|NCT02951988|38280271|FG002|Open-Label Treatment Period|Adverse Event|0|||
17138495|NCT02951988|38280272|FG003|Open-Label Treatment Period|Adverse Event|0|||
17138496|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
17138497|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
17138498|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
17138499|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
17138500|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
17138501|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
17138502|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
17138503|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
17138504|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
17138505|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
17138506|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
17138507|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
17138508|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
17138509|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
17138510|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
17138511|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
17138512|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Pregnancy|0|||
17138513|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Pregnancy|1|||
17138514|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Pregnancy|1|||
17138515|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Pregnancy|0|||
17138516|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
17138517|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
17138518|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
17138519|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
17138520|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
17138521|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
17138522|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
17138523|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
17138524|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Adverse Event|0|||
17138525|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Adverse Event|8|||
17138526|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Adverse Event|3|||
17138527|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Adverse Event|6|||
17138528|NCT02951988|38280269|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
17138529|NCT02951988|38280270|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
17138530|NCT02951988|38280271|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
17138531|NCT02951988|38280272|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
17138532|NCT00009737|38280284|FG000|Overall Study|Adverse Event|112|||
17138533|NCT00009737|38280285|FG001|Overall Study|Adverse Event|75|||
17138534|NCT00009737|38280284|FG000|Overall Study|Death|4|||
17138535|NCT00009737|38280285|FG001|Overall Study|Death|6|||
17138536|NCT00009737|38280284|FG000|Overall Study|Lack of Efficacy|17|||
17138537|NCT00009737|38280285|FG001|Overall Study|Lack of Efficacy|15|||
17138538|NCT00009737|38280284|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
17138539|NCT00009737|38280285|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
17138540|NCT00009737|38280284|FG000|Overall Study|Other Protocol Violation|1|||
17037189|NCT00410761|38181197|FG001|Overall Study|objective disease progression|55|||
17037190|NCT00410761|38181196|FG000|Overall Study|Withdrawal by Subject|8|||
17037191|NCT00410761|38181197|FG001|Overall Study|Withdrawal by Subject|4|||
17037192|NCT00410761|38181196|FG000|Overall Study|Other|12|||
17037193|NCT00410761|38181197|FG001|Overall Study|Other|9|||
17037194|NCT00410761|38181196|FG000|Overall Study|Never received randomised treatment|0|||
17037195|NCT00410761|38181197|FG001|Overall Study|Never received randomised treatment|1|||
17037196|NCT00410605|38181203|FG000|Overall Study|Adverse Event|12|||
17037197|NCT00410605|38181203|FG000|Overall Study|Physician Decision|3|||
17037198|NCT00410605|38181203|FG000|Overall Study|Withdrawal by Subject|5|||
17037199|NCT00410605|38181203|FG000|Overall Study|Started Non-Protocol Therapy|3|||
17037200|NCT00410605|38181203|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
17037201|NCT00410605|38181203|FG000|Overall Study|Transferred to another Institution|1|||
17037202|NCT00418717|38181207|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
17037203|NCT00418717|38181207|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
17037204|NCT00572572|38181213|FG000|Overall Study|Withdrawal by Subject|3|||
17037205|NCT00572572|38181214|FG001|Overall Study|Withdrawal by Subject|6|||
17037206|NCT00418561|38181223|FG000|Overall Study|Participant's (guardian's) decision|0|||
17037207|NCT00418561|38181224|FG001|Overall Study|Participant's (guardian's) decision|1|||
17037208|NCT00418561|38181225|FG002|Overall Study|Participant's (guardian's) decision|0|||
17037209|NCT00398047|38181233|FG000|Overall Study|all patient progressed before completion|3|||
17037210|NCT00631371|38181240|FG000|Overall Study|Lost to Follow-up|24|||
17037211|NCT00631371|38181241|FG001|Overall Study|Lost to Follow-up|19|||
17037212|NCT00631371|38181240|FG000|Overall Study|Other reason|5|||
17037213|NCT00631371|38181241|FG001|Overall Study|Other reason|12|||
17037214|NCT00631371|38181240|FG000|Overall Study|subject request|38|||
17037215|NCT00631371|38181241|FG001|Overall Study|subject request|45|||
17037216|NCT00631371|38181240|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
17037217|NCT00631371|38181241|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
17037218|NCT00631371|38181240|FG000|Overall Study|Death|263|||
17037219|NCT00631371|38181241|FG001|Overall Study|Death|239|||
17037220|NCT00409747|38181247|FG000|Overall Study|Withdrawal by Subject|1|||
17037221|NCT00630747|38181251|FG000|Overall Study|Death|1|||
17037222|NCT00630747|38181251|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
17037223|NCT00630747|38181251|FG000|Overall Study|Returned to country of origin|1|||
17037224|NCT00397891|38181260|FG000|Overall Study|Withdrawal by Subject|1|||
17037225|NCT00397891|38181261|FG001|Overall Study|Withdrawal by Subject|0|||
17037226|NCT00397891|38181262|FG002|Overall Study|Withdrawal by Subject|0|||
17037227|NCT00397891|38181263|FG003|Overall Study|Withdrawal by Subject|0|||
17037228|NCT00397891|38181264|FG004|Overall Study|Withdrawal by Subject|1|||
17037229|NCT00397189|38181278|FG000|3 Weeks Period|Lost to Follow-up|5|||
17037230|NCT00397189|38181279|FG001|3 Weeks Period|Lost to Follow-up|4|||
17037231|NCT00397189|38181278|FG000|3 Weeks Period|Adverse Event|3|||
17037232|NCT00397189|38181279|FG001|3 Weeks Period|Adverse Event|2|||
17037233|NCT00397189|38181278|FG000|3 Weeks Period|Withdrawal by Subject|13|||
17138541|NCT00009737|38280285|FG001|Overall Study|Other Protocol Violation|0|||
17138542|NCT00009737|38280284|FG000|Overall Study|Refused Treatment|15|||
17138543|NCT00009737|38280285|FG001|Overall Study|Refused Treatment|16|||
17138544|NCT00009737|38280284|FG000|Overall Study|Lost to Follow-up|1|||
17138545|NCT00009737|38280285|FG001|Overall Study|Lost to Follow-up|1|||
17138546|NCT00009737|38280284|FG000|Overall Study|Administrative/Other Reasons|7|||
17138547|NCT00009737|38280285|FG001|Overall Study|Administrative/Other Reasons|1|||
17138548|NCT03417102|38280293|FG000|Overall Study|Adverse Event|0|||
17138549|NCT03417102|38280294|FG001|Overall Study|Adverse Event|1|||
17138550|NCT03417102|38280293|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
17138551|NCT03417102|38280294|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
17138552|NCT03417102|38280293|FG000|Overall Study|Other|0|||
17138553|NCT03417102|38280294|FG001|Overall Study|Other|1|||
17138554|NCT03417024|38280300|FG000|Overall Study|Study Termination prior to follow-up|11|||
17138555|NCT03417024|38280300|FG000|Overall Study|Physician Decision|2|||
17138556|NCT00028769|38280304|FG000|Overall Study|Adverse Event|2|||
17138557|NCT00028769|38280304|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
17138558|NCT00028769|38280304|FG000|Overall Study|Progression or Death|31|||
17138559|NCT00028769|38280304|FG000|Overall Study|Other - Not Protocol Specified|1|||
17138560|NCT00028769|38280304|FG000|Overall Study|Ineligible|5|||
17138561|NCT00028769|38280304|FG000|Overall Study|Not Analyzable|1|||
17138562|NCT02953314|38280310|FG000|Overall Study|Adverse Event|0|||
17138563|NCT02953314|38280311|FG001|Overall Study|Adverse Event|1|||
17138564|NCT02953314|38280310|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
17138565|NCT02953314|38280311|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
17138566|NCT03402750|38280319|FG000|Overall Study|Lost to Follow-up|2|||
17138567|NCT03402750|38280320|FG001|Overall Study|Lost to Follow-up|1|||
17138568|NCT00007475|38280329|FG000|Overall Study|Withdrawal by Subject|1|||
17138569|NCT00007475|38280330|FG001|Overall Study|Withdrawal by Subject|0|||
17138570|NCT00007475|38280331|FG002|Overall Study|Withdrawal by Subject|0|||
17138571|NCT00007475|38280332|FG003|Overall Study|Withdrawal by Subject|0|||
17138572|NCT00007475|38280329|FG000|Overall Study|Adverse Event|3|||
17138573|NCT00007475|38280330|FG001|Overall Study|Adverse Event|0|||
17138574|NCT00007475|38280331|FG002|Overall Study|Adverse Event|0|||
17138575|NCT00007475|38280332|FG003|Overall Study|Adverse Event|0|||
17138576|NCT00025883|38280344|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
17138577|NCT00025883|38280344|FG000|Overall Study|no baseline data|1|||
17138578|NCT00025883|38280344|FG000|Overall Study|Death|1|||
17037234|NCT00397189|38181279|FG001|3 Weeks Period|Withdrawal by Subject|9|||
17037235|NCT00397189|38181278|FG000|3 Weeks Period|Physician Decision|0|||
17037236|NCT00397189|38181279|FG001|3 Weeks Period|Physician Decision|2|||
17037237|NCT00397189|38181278|FG000|3 Weeks Period|Protocol Violation|0|||
17037238|NCT00397189|38181279|FG001|3 Weeks Period|Protocol Violation|3|||
17037239|NCT00397189|38181278|FG000|3 Weeks Period|Other|0|||
17037240|NCT00397189|38181279|FG001|3 Weeks Period|Other|2|||
17037241|NCT00606034|38181287|FG000|Overall Study|incarceration|1|||
17037242|NCT00397033|38181296|FG000|Overall Study|Adverse Event|7|||
17037243|NCT00397033|38181297|FG001|Overall Study|Adverse Event|10|||
17037244|NCT00397033|38181298|FG002|Overall Study|Adverse Event|4|||
17037245|NCT00397033|38181296|FG000|Overall Study|Lack of Efficacy|22|||
17037246|NCT00397033|38181297|FG001|Overall Study|Lack of Efficacy|12|||
17037247|NCT00397033|38181298|FG002|Overall Study|Lack of Efficacy|9|||
17037248|NCT00397033|38181296|FG000|Overall Study|Lost to Follow-up|3|||
17037249|NCT00397033|38181297|FG001|Overall Study|Lost to Follow-up|3|||
17037250|NCT00397033|38181298|FG002|Overall Study|Lost to Follow-up|3|||
17037251|NCT00397033|38181296|FG000|Overall Study|Withdrawal by Subject|12|||
17037252|NCT00397033|38181297|FG001|Overall Study|Withdrawal by Subject|7|||
17037253|NCT00397033|38181298|FG002|Overall Study|Withdrawal by Subject|5|||
17037254|NCT00397033|38181296|FG000|Overall Study|Other|0|||
17037255|NCT00397033|38181297|FG001|Overall Study|Other|5|||
17037256|NCT00397033|38181298|FG002|Overall Study|Other|2|||
17037257|NCT00572728|38181306|FG000|Overall Study|Withdrawal by Subject|10|||
17037258|NCT00572728|38181306|FG000|Overall Study|Ineligible|3|||
17037259|NCT00572728|38181306|FG000|Overall Study|Enrolled under Amendment 4|5|||
17138579|NCT00025883|38280344|FG000|Overall Study|Adverse Event|1|||
17138580|NCT00025883|38280344|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
17138581|NCT00072293|38280351|FG000|Overall Study|Lost to Follow-up|1|||
17138582|NCT00072293|38280352|FG001|Overall Study|Lost to Follow-up|1|||
17037260|NCT00572728|38181306|FG000|Overall Study|Offstudy due to complicating disease|1|||
17037261|NCT00572728|38181306|FG000|Overall Study|FLT1 not completed|4|||
17037262|NCT00572728|38181306|FG000|Overall Study|First Chemotherapy not initiated|2|||
17037263|NCT00572728|38181306|FG000|Overall Study|FLT2 not completed|5|||
17037264|NCT00572728|38181306|FG000|Overall Study|Second chemotherapy not initiated|1|||
17037265|NCT00572728|38181306|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
17037266|NCT00572728|38181306|FG000|Overall Study|Pathology missing|1|||
17037267|NCT00699374|38181314|FG000|Overall Study|Death|93|||
17037268|NCT00699374|38181315|FG001|Overall Study|Death|83|||
17037269|NCT00699374|38181314|FG000|Overall Study|Adverse Event|70|||
17037270|NCT00699374|38181315|FG001|Overall Study|Adverse Event|67|||
17037271|NCT00699374|38181314|FG000|Overall Study|Global deterioration of health status|7|||
17037272|NCT00699374|38181315|FG001|Overall Study|Global deterioration of health status|8|||
17037273|NCT00699374|38181314|FG000|Overall Study|Lost to Follow-up|3|||
17037274|NCT00699374|38181315|FG001|Overall Study|Lost to Follow-up|5|||
17037275|NCT00699374|38181314|FG000|Overall Study|Withdrawal by Subject|34|||
17037276|NCT00699374|38181315|FG001|Overall Study|Withdrawal by Subject|44|||
17037277|NCT00699374|38181314|FG000|Overall Study|Objective progression or relapse|281|||
17037278|NCT00699374|38181315|FG001|Overall Study|Objective progression or relapse|277|||
17037279|NCT00699374|38181314|FG000|Overall Study|Other|18|||
17037280|NCT00699374|38181315|FG001|Overall Study|Other|15|||
17037281|NCT00699374|38181314|FG000|Overall Study|Protocol Violation|2|||
17037282|NCT00699374|38181315|FG001|Overall Study|Protocol Violation|6|||
17037283|NCT00699374|38181314|FG000|Overall Study|Study terminated by sponsor|13|||
17037284|NCT00699374|38181315|FG001|Overall Study|Study terminated by sponsor|28|||
17138583|NCT00072293|38280351|FG000|Overall Study|Withdrawal by Subject|0|||
17138584|NCT00072293|38280352|FG001|Overall Study|Withdrawal by Subject|1|||
17138585|NCT03753763|38280360|FG000|Overall Study|Adverse Event|2|||
17138586|NCT03753763|38280361|FG001|Overall Study|Adverse Event|0|||
17138587|NCT03753763|38280360|FG000|Overall Study|Withdrawal by Subject|3|||
17138588|NCT03753763|38280361|FG001|Overall Study|Withdrawal by Subject|1|||
17138589|NCT03753763|38280360|FG000|Overall Study|clinical deterioration|1|||
17138590|NCT03753763|38280361|FG001|Overall Study|clinical deterioration|0|||
17138591|NCT03384966|38280370|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
17138592|NCT03384966|38280371|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
16991895|NCT00806026|38135884|FG004|Overall Study|Did not meet entrance criteria|0|||
16991896|NCT00806026|38135885|FG005|Overall Study|Did not meet entrance criteria|0|||
16991897|NCT00806026|38135880|FG000|Overall Study|Lack of Efficacy|5|||
16991898|NCT00806026|38135881|FG001|Overall Study|Lack of Efficacy|18|||
16991899|NCT00806026|38135882|FG002|Overall Study|Lack of Efficacy|13|||
16991900|NCT00806026|38135883|FG003|Overall Study|Lack of Efficacy|4|||
16991901|NCT00806026|38135884|FG004|Overall Study|Lack of Efficacy|8|||
16991902|NCT00806026|38135885|FG005|Overall Study|Lack of Efficacy|7|||
16991903|NCT00806026|38135880|FG000|Overall Study|Lost to Follow-up|8|||
16991904|NCT00806026|38135881|FG001|Overall Study|Lost to Follow-up|15|||
17138593|NCT03384966|38280372|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
17138594|NCT03384966|38280370|FG000|Follow-up Period|Adverse Event|1|||
16991905|NCT00806026|38135882|FG002|Overall Study|Lost to Follow-up|8|||
17037285|NCT00699374|38181314|FG000|Overall Study|Randomized but not treated|4|||
17037286|NCT00699374|38181315|FG001|Overall Study|Randomized but not treated|2|||
17037287|NCT00699374|38181314|FG000|Overall Study|Died 28 days after last dose|5|||
17138595|NCT03384966|38280371|FG001|Follow-up Period|Adverse Event|0|||
17138596|NCT03384966|38280372|FG002|Follow-up Period|Adverse Event|0|||
17138597|NCT03402126|38280389|FG000|Overall Study|Lost to Follow-up|6|||
17037288|NCT00699374|38181315|FG001|Overall Study|Died 28 days after last dose|9|||
17037289|NCT00606892|38181321|FG000|First Intervention|Protocol Violation|1|||
17037290|NCT00606892|38181322|FG001|First Intervention|Protocol Violation|4|||
17037291|NCT00625443|38181357|FG000|Overall Study|Adverse Event|1|||
17037292|NCT00625443|38181358|FG001|Overall Study|Adverse Event|4|||
17037293|NCT00625443|38181359|FG002|Overall Study|Adverse Event|0|||
17037294|NCT00625443|38181357|FG000|Overall Study|Non-compliance with protocol|0|||
17037295|NCT00625443|38181358|FG001|Overall Study|Non-compliance with protocol|1|||
17037296|NCT00625443|38181359|FG002|Overall Study|Non-compliance with protocol|0|||
17037297|NCT00625443|38181357|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
17037298|NCT00625443|38181358|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
17037299|NCT00625443|38181359|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
17037300|NCT00625443|38181357|FG000|Overall Study|Withdrawal by Subject|0|||
17037301|NCT00625443|38181358|FG001|Overall Study|Withdrawal by Subject|1|||
17037302|NCT00625443|38181359|FG002|Overall Study|Withdrawal by Subject|2|||
17037303|NCT00625443|38181357|FG000|Overall Study|Physician Decision|0|||
17037304|NCT00625443|38181358|FG001|Overall Study|Physician Decision|4|||
17037305|NCT00625443|38181359|FG002|Overall Study|Physician Decision|2|||
17138598|NCT03402126|38280389|FG000|Overall Study|Protocol Violation|10|||
17037306|NCT00625443|38181357|FG000|Overall Study|Other|0|||
17037307|NCT00625443|38181358|FG001|Overall Study|Other|1|||
17037308|NCT00625443|38181359|FG002|Overall Study|Other|1|||
17037309|NCT00625365|38181370|FG000|Overall Study|Withdrawal by Subject|1|||
17037310|NCT00625365|38181370|FG000|Overall Study|No IV access|5|||
17037311|NCT00625365|38181370|FG000|Overall Study|VSD|1|||
17037312|NCT00606580|38181377|FG000|Overall Study|Lost to Follow-up|1|||
17037313|NCT00606580|38181378|FG001|Overall Study|Lost to Follow-up|1|||
17037314|NCT00606580|38181379|FG002|Overall Study|Lost to Follow-up|4|||
17037315|NCT00606580|38181377|FG000|Overall Study|Clinical failures|1|||
17037316|NCT00606580|38181378|FG001|Overall Study|Clinical failures|0|||
17037317|NCT00606580|38181379|FG002|Overall Study|Clinical failures|12|||
17037318|NCT00606580|38181377|FG000|Overall Study|Withdrawal by investigator|0|||
17037319|NCT00606580|38181378|FG001|Overall Study|Withdrawal by investigator|1|||
17138599|NCT03402126|38280389|FG000|Overall Study|Sponsor request/Study termination|29|||
17138600|NCT03402126|38280389|FG000|Overall Study|Study product no longer in use|1|||
17138601|NCT03402126|38280389|FG000|Overall Study|Technical problems|1|||
17138602|NCT03402126|38280389|FG000|Overall Study|Withdrawal by Subject|6|||
17138603|NCT03402126|38280389|FG000|Overall Study|Physician Decision|2|||
17138604|NCT03402126|38280389|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
17138605|NCT03402126|38280389|FG000|Overall Study|Death|4|||
17138606|NCT03355326|38280395|FG000|Overall Study|Protocol Violation|3|||
17138607|NCT03355326|38280396|FG001|Overall Study|Protocol Violation|3|||
17138608|NCT03353220|38280402|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
17138609|NCT03353220|38280403|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
17138610|NCT03751657|38280411|FG000|Overall Study|Physician Decision|0|||
17138611|NCT03751657|38280412|FG001|Overall Study|Physician Decision|1|||
17037320|NCT00606580|38181379|FG002|Overall Study|Withdrawal by investigator|6|||
17138612|NCT03751657|38280411|FG000|Overall Study|Withdrawal by Subject|1|||
17138613|NCT03751657|38280412|FG001|Overall Study|Withdrawal by Subject|1|||
17138614|NCT03751657|38280411|FG000|Overall Study|Lost to Follow-up|2|||
17138615|NCT03751657|38280412|FG001|Overall Study|Lost to Follow-up|1|||
17138616|NCT00025259|38280425|FG000|Overall Study|Death|1|||
17138617|NCT00025259|38280426|FG001|Overall Study|Death|3|||
17138618|NCT00025259|38280427|FG002|Overall Study|Death|0|||
17138619|NCT00025259|38280428|FG003|Overall Study|Death|3|||
17138620|NCT00025259|38280429|FG004|Overall Study|Death|0|||
17037321|NCT00606580|38181377|FG000|Overall Study|Withdrawal by Subject|0|||
17037322|NCT00606580|38181378|FG001|Overall Study|Withdrawal by Subject|1|||
17037323|NCT00606580|38181379|FG002|Overall Study|Withdrawal by Subject|0|||
17037324|NCT00625131|38181389|FG000|Overall Study|Lost to Follow-up|3|||
17037325|NCT00625131|38181390|FG001|Overall Study|Lost to Follow-up|2|||
17037326|NCT00625131|38181391|FG002|Overall Study|Lost to Follow-up|0|||
17037327|NCT00625131|38181389|FG000|Overall Study|Withdrawal by Subject|1|||
17037328|NCT00625131|38181390|FG001|Overall Study|Withdrawal by Subject|0|||
17037329|NCT00625131|38181391|FG002|Overall Study|Withdrawal by Subject|5|||
17037330|NCT00629265|38181399|FG000|Overall Study|Lost to Follow-up|4|||
17037331|NCT00629265|38181400|FG001|Overall Study|Lost to Follow-up|5|||
17037332|NCT00629265|38181399|FG000|Overall Study|Withdrawal by Subject|11|||
17037333|NCT00629265|38181400|FG001|Overall Study|Withdrawal by Subject|8|||
17037334|NCT00629265|38181399|FG000|Overall Study|Death|1|||
17037335|NCT00629265|38181400|FG001|Overall Study|Death|0|||
17037336|NCT00629265|38181399|FG000|Overall Study|Adverse Event|2|||
17037337|NCT00629265|38181400|FG001|Overall Study|Adverse Event|0|||
17037338|NCT00629265|38181399|FG000|Overall Study|HNC Recurrence|4|||
17037339|NCT00629265|38181400|FG001|Overall Study|HNC Recurrence|0|||
17037340|NCT00629265|38181399|FG000|Overall Study|Other CA Requiring Treatment|1|||
17037341|NCT00629265|38181400|FG001|Overall Study|Other CA Requiring Treatment|3|||
17037342|NCT00629265|38181399|FG000|Overall Study|Needed Esophageal Dilation|4|||
17037343|NCT00629265|38181400|FG001|Overall Study|Needed Esophageal Dilation|1|||
17037344|NCT00629265|38181399|FG000|Overall Study|Unrelated Medical Complications|3|||
17037345|NCT00629265|38181400|FG001|Overall Study|Unrelated Medical Complications|1|||
17037346|NCT00629265|38181399|FG000|Overall Study|Unknown Reason|2|||
17037347|NCT00629265|38181400|FG001|Overall Study|Unknown Reason|2|||
17037348|NCT00606502|38181408|FG000|Randomization|Randomized but not treated|3|||
17037349|NCT00606502|38181409|FG001|Randomization|Randomized but not treated|0|||
17037350|NCT00606502|38181408|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
17037351|NCT00606502|38181409|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
17037352|NCT00605722|38181415|FG000|Overall Study|Adverse Event|6|||
17037353|NCT00605722|38181415|FG000|Overall Study|Insufficient therapeutic response|44|||
17037354|NCT00605722|38181415|FG000|Overall Study|Failure to return|1|||
17037355|NCT00605566|38181419|FG000|Overall Study|Adverse Event|1|||
17037356|NCT00605566|38181419|FG000|Overall Study|Clinical deterioration|1|||
17037357|NCT00605566|38181419|FG000|Overall Study|Poor compliance in run-in period|1|||
17037358|NCT00396877|38181425|FG000|Overall Study|Lost to Follow-up|2|||
17037359|NCT00396877|38181426|FG001|Overall Study|Lost to Follow-up|1|||
17037360|NCT00396877|38181425|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
17037361|NCT00396877|38181426|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
17037362|NCT00628251|38181435|FG000|Randomised Part|Withdrawal by Subject|0|||
17037363|NCT00628251|38181436|FG001|Randomised Part|Withdrawal by Subject|0|||
17037364|NCT00628251|38181437|FG002|Randomised Part|Withdrawal by Subject|1|||
17037365|NCT00628251|38181435|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
17037366|NCT00628251|38181436|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
17037367|NCT00628251|38181437|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
17037368|NCT00628251|38181435|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
17037369|NCT00628251|38181436|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
17037370|NCT00628251|38181437|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
17037371|NCT00628251|38181435|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
17037372|NCT00628251|38181436|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
17037373|NCT00628251|38181437|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
17037374|NCT00628251|38181435|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
17037375|NCT00628251|38181436|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
17037376|NCT00628251|38181437|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
17037377|NCT00628251|38181435|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
17037378|NCT00628251|38181436|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
17037379|NCT00628251|38181437|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
17037380|NCT00408499|38181447|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
17037381|NCT00408499|38181448|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
17037382|NCT00408499|38181449|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
17037383|NCT00408499|38181450|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
17037384|NCT00408499|38181451|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
17037385|NCT00408499|38181447|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
17037386|NCT00408499|38181448|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
17037387|NCT00408499|38181449|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
17037388|NCT00408499|38181450|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
17138621|NCT00025259|38280430|FG005|Overall Study|Death|1|||
17037389|NCT00408499|38181451|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
17037390|NCT00408499|38181447|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
17037391|NCT00408499|38181448|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
17037392|NCT00408499|38181449|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
17037393|NCT00408499|38181450|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
17037394|NCT00408499|38181451|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
17037395|NCT00408499|38181447|FG000|Phase II- MTD Expansion|Adverse Event|0|||
17037396|NCT00408499|38181448|FG001|Phase II- MTD Expansion|Adverse Event|0|||
17037397|NCT00408499|38181449|FG002|Phase II- MTD Expansion|Adverse Event|0|||
17037398|NCT00408499|38181450|FG003|Phase II- MTD Expansion|Adverse Event|0|||
17037399|NCT00408499|38181451|FG004|Phase II- MTD Expansion|Adverse Event|9|||
17037400|NCT00408499|38181447|FG000|Phase II- MTD Expansion|Death|0|||
17037401|NCT00408499|38181448|FG001|Phase II- MTD Expansion|Death|0|||
17037402|NCT00408499|38181449|FG002|Phase II- MTD Expansion|Death|0|||
17037403|NCT00408499|38181450|FG003|Phase II- MTD Expansion|Death|0|||
17037404|NCT00408499|38181451|FG004|Phase II- MTD Expansion|Death|2|||
17037405|NCT00408499|38181447|FG000|Phase II- MTD Expansion|Physician Decision|0|||
17037406|NCT00408499|38181448|FG001|Phase II- MTD Expansion|Physician Decision|0|||
17037407|NCT00408499|38181449|FG002|Phase II- MTD Expansion|Physician Decision|0|||
17037408|NCT00408499|38181450|FG003|Phase II- MTD Expansion|Physician Decision|0|||
17037409|NCT00408499|38181451|FG004|Phase II- MTD Expansion|Physician Decision|1|||
17037410|NCT00408499|38181447|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
17037411|NCT00408499|38181448|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
17037412|NCT00408499|38181449|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
17037413|NCT00408499|38181450|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
17037414|NCT00408499|38181451|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
17037415|NCT00408499|38181447|FG000|Phase II- MTD Expansion|treatment delay|0|||
17037416|NCT00408499|38181448|FG001|Phase II- MTD Expansion|treatment delay|0|||
17037417|NCT00408499|38181449|FG002|Phase II- MTD Expansion|treatment delay|0|||
17037418|NCT00408499|38181450|FG003|Phase II- MTD Expansion|treatment delay|0|||
17037419|NCT00408499|38181451|FG004|Phase II- MTD Expansion|treatment delay|3|||
17037420|NCT00621777|38181462|FG000|Open Phase|Adverse Event|20|||
17037421|NCT00621777|38181463|FG001|Open Phase|Adverse Event|0|||
17037422|NCT00621777|38181462|FG000|Open Phase|Did not abstain during open phase|56|||
17037423|NCT00621777|38181463|FG001|Open Phase|Did not abstain during open phase|0|||
17037424|NCT00621777|38181462|FG000|Open Phase|Withdrawal by Subject|17|||
17037425|NCT00621777|38181463|FG001|Open Phase|Withdrawal by Subject|0|||
17037426|NCT00621777|38181462|FG000|Open Phase|administrative|13|||
17037427|NCT00621777|38181463|FG001|Open Phase|administrative|0|||
17037428|NCT00621777|38181462|FG000|Open Phase|Lost to Follow-up|10|||
17037429|NCT00621777|38181463|FG001|Open Phase|Lost to Follow-up|0|||
17037430|NCT00621777|38181462|FG000|Randomized Phase|Adverse Event|3|||
17037431|NCT00621777|38181463|FG001|Randomized Phase|Adverse Event|3|||
17037432|NCT00621777|38181462|FG000|Randomized Phase|Lost to Follow-up|3|||
17037433|NCT00621777|38181463|FG001|Randomized Phase|Lost to Follow-up|3|||
17037434|NCT00621777|38181462|FG000|Randomized Phase|Withdrawal by Subject|1|||
17037435|NCT00621777|38181463|FG001|Randomized Phase|Withdrawal by Subject|9|||
17037436|NCT00621777|38181462|FG000|Randomized Phase|administrative|0|||
17037437|NCT00621777|38181463|FG001|Randomized Phase|administrative|3|||
17037438|NCT00621777|38181462|FG000|Randomized Phase|Death|0|||
17037439|NCT00621777|38181463|FG001|Randomized Phase|Death|1|||
17037440|NCT00408421|38181473|FG000|Treatment Initial Randomization|Adverse Event|5|||
17037441|NCT00408421|38181474|FG001|Treatment Initial Randomization|Adverse Event|9|||
17037442|NCT00408421|38181475|FG002|Treatment Initial Randomization|Adverse Event|0|||
17037443|NCT00408421|38181473|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
17037444|NCT00408421|38181474|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
17037445|NCT00408421|38181475|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
17037446|NCT00408421|38181473|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
17037447|NCT00408421|38181474|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
17037448|NCT00408421|38181475|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
17037449|NCT00408421|38181473|FG000|Treatment Initial Randomization|Physician Decision|1|||
17037450|NCT00408421|38181474|FG001|Treatment Initial Randomization|Physician Decision|0|||
17037451|NCT00408421|38181475|FG002|Treatment Initial Randomization|Physician Decision|0|||
17037452|NCT00408421|38181473|FG000|Treatment Initial Randomization|Protocol Violation|0|||
17037453|NCT00408421|38181474|FG001|Treatment Initial Randomization|Protocol Violation|1|||
17037454|NCT00408421|38181475|FG002|Treatment Initial Randomization|Protocol Violation|0|||
17037455|NCT00408421|38181473|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
17037456|NCT00408421|38181474|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
17037457|NCT00408421|38181475|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
17037458|NCT00408421|38181473|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
17037459|NCT00408421|38181474|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
17037460|NCT00408421|38181475|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
17037461|NCT00408421|38181473|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
17037462|NCT00408421|38181474|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
17037463|NCT00408421|38181475|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
17037464|NCT00408421|38181473|FG000|Treatment Re-Randomization|Adverse Event|2|||
17037465|NCT00408421|38181474|FG001|Treatment Re-Randomization|Adverse Event|2|||
17037466|NCT00408421|38181475|FG002|Treatment Re-Randomization|Adverse Event|4|||
17037467|NCT00408421|38181473|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
17037468|NCT00408421|38181474|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
17037469|NCT00408421|38181475|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
17037470|NCT00408421|38181473|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
17037471|NCT00408421|38181474|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
17037472|NCT00408421|38181475|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
17037473|NCT00408421|38181473|FG000|Treatment Re-Randomization|Physician Decision|1|||
17037474|NCT00408421|38181474|FG001|Treatment Re-Randomization|Physician Decision|3|||
17037475|NCT00408421|38181475|FG002|Treatment Re-Randomization|Physician Decision|0|||
17037476|NCT00408421|38181473|FG000|Treatment Re-Randomization|Protocol Violation|1|||
17037477|NCT00408421|38181474|FG001|Treatment Re-Randomization|Protocol Violation|1|||
17138622|NCT00025259|38280431|FG006|Overall Study|Death|2|||
17138623|NCT00025259|38280425|FG000|Overall Study|Lack of Efficacy|2|||
17138624|NCT00025259|38280426|FG001|Overall Study|Lack of Efficacy|46|||
17138625|NCT00025259|38280427|FG002|Overall Study|Lack of Efficacy|60|||
17138626|NCT00025259|38280428|FG003|Overall Study|Lack of Efficacy|78|||
17138627|NCT00025259|38280429|FG004|Overall Study|Lack of Efficacy|11|||
17138628|NCT00025259|38280430|FG005|Overall Study|Lack of Efficacy|30|||
17138629|NCT00025259|38280431|FG006|Overall Study|Lack of Efficacy|38|||
17138630|NCT00025259|38280425|FG000|Overall Study|Lost to Follow-up|2|||
17138631|NCT00025259|38280426|FG001|Overall Study|Lost to Follow-up|9|||
17138632|NCT00025259|38280427|FG002|Overall Study|Lost to Follow-up|13|||
17138633|NCT00025259|38280428|FG003|Overall Study|Lost to Follow-up|13|||
17138634|NCT00025259|38280429|FG004|Overall Study|Lost to Follow-up|1|||
17138635|NCT00025259|38280430|FG005|Overall Study|Lost to Follow-up|3|||
17138636|NCT00025259|38280431|FG006|Overall Study|Lost to Follow-up|1|||
17138637|NCT00025259|38280425|FG000|Overall Study|Physician Decision|12|||
17138638|NCT00025259|38280426|FG001|Overall Study|Physician Decision|1|||
17138639|NCT00025259|38280427|FG002|Overall Study|Physician Decision|0|||
17138640|NCT00025259|38280428|FG003|Overall Study|Physician Decision|5|||
17138641|NCT00025259|38280429|FG004|Overall Study|Physician Decision|4|||
17138642|NCT00025259|38280430|FG005|Overall Study|Physician Decision|2|||
17138643|NCT00025259|38280431|FG006|Overall Study|Physician Decision|1|||
17138644|NCT00025259|38280425|FG000|Overall Study|Protocol Violation|3|||
17037478|NCT00408421|38181475|FG002|Treatment Re-Randomization|Protocol Violation|0|||
17037479|NCT00408421|38181473|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
17037480|NCT00408421|38181474|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
17037481|NCT00408421|38181475|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
17037482|NCT00604786|38181485|FG000|Overall Study|Lost to Follow-up|2|||
17037483|NCT00604786|38181486|FG001|Overall Study|Lost to Follow-up|0|||
17037484|NCT00604708|38181494|FG000|Overall Study|Withdrawal by Subject|9|||
17037485|NCT00604708|38181495|FG001|Overall Study|Withdrawal by Subject|10|||
17037486|NCT00604708|38181494|FG000|Overall Study|Protocol Violation|2|||
17037487|NCT00604708|38181495|FG001|Overall Study|Protocol Violation|8|||
17037488|NCT00604708|38181494|FG000|Overall Study|Lost to Follow-up|5|||
17037489|NCT00604708|38181495|FG001|Overall Study|Lost to Follow-up|5|||
17037490|NCT00604708|38181494|FG000|Overall Study|administrative reasons|9|||
17037491|NCT00604708|38181495|FG001|Overall Study|administrative reasons|11|||
17037492|NCT00604708|38181494|FG000|Overall Study|Adverse Event|6|||
17037493|NCT00604708|38181495|FG001|Overall Study|Adverse Event|6|||
17037494|NCT00407797|38181501|FG000|Overall Study|Lost to Follow-up|2|||
17037495|NCT00407797|38181501|FG000|Overall Study|Adverse Event|6|||
17138645|NCT00025259|38280426|FG001|Overall Study|Protocol Violation|2|||
17138646|NCT00025259|38280427|FG002|Overall Study|Protocol Violation|2|||
17138647|NCT00025259|38280428|FG003|Overall Study|Protocol Violation|1|||
17138648|NCT00025259|38280429|FG004|Overall Study|Protocol Violation|2|||
17138649|NCT00025259|38280430|FG005|Overall Study|Protocol Violation|1|||
17138650|NCT00025259|38280431|FG006|Overall Study|Protocol Violation|3|||
17138651|NCT00025259|38280425|FG000|Overall Study|Withdrawal by Subject|9|||
17138652|NCT00025259|38280426|FG001|Overall Study|Withdrawal by Subject|27|||
17138653|NCT00025259|38280427|FG002|Overall Study|Withdrawal by Subject|6|||
17138654|NCT00025259|38280428|FG003|Overall Study|Withdrawal by Subject|14|||
17138655|NCT00025259|38280429|FG004|Overall Study|Withdrawal by Subject|11|||
17138656|NCT00025259|38280430|FG005|Overall Study|Withdrawal by Subject|8|||
17037496|NCT00407797|38181501|FG000|Overall Study|Other|7|||
17037497|NCT00407797|38181501|FG000|Overall Study|Withdrawal by Subject|3|||
17037498|NCT00568126|38181507|FG000|Overall Study|Adverse Event|3|||
17037499|NCT00568126|38181508|FG001|Overall Study|Adverse Event|0|||
17037500|NCT00568126|38181507|FG000|Overall Study|Withdrawal by Subject|2|||
17037501|NCT00568126|38181508|FG001|Overall Study|Withdrawal by Subject|3|||
17037502|NCT00568126|38181507|FG000|Overall Study|Lost to Follow-up|4|||
17037503|NCT00568126|38181508|FG001|Overall Study|Lost to Follow-up|3|||
17037504|NCT00568126|38181507|FG000|Overall Study|Lack of Efficacy|0|||
17037505|NCT00568126|38181508|FG001|Overall Study|Lack of Efficacy|1|||
17037506|NCT00568126|38181507|FG000|Overall Study|Physician Decision|2|||
17037507|NCT00568126|38181508|FG001|Overall Study|Physician Decision|2|||
17037508|NCT00407563|38181514|FG000|Overall Study|Patient continues on treatment|1|||
17037509|NCT00567892|38181520|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
17037510|NCT00567892|38181521|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
17037511|NCT00567892|38181522|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
17037512|NCT00567892|38181523|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
17037513|NCT00567892|38181520|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
17037514|NCT00567892|38181521|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
17037515|NCT00567892|38181522|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
17037516|NCT00567892|38181523|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
17037517|NCT00623103|38181537|FG000|Overall Study|Adverse Event|70|||
17037518|NCT00623103|38181538|FG001|Overall Study|Adverse Event|60|||
17037519|NCT00623103|38181537|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
17037520|NCT00623103|38181538|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
17037521|NCT00623103|38181537|FG000|Overall Study|Withdrawal by Subject|18|||
17138657|NCT00025259|38280431|FG006|Overall Study|Withdrawal by Subject|3|||
17138658|NCT00025259|38280425|FG000|Overall Study|Ineligible|14|||
17138659|NCT00025259|38280426|FG001|Overall Study|Ineligible|1|||
17138660|NCT00025259|38280427|FG002|Overall Study|Ineligible|0|||
17138661|NCT00025259|38280428|FG003|Overall Study|Ineligible|0|||
17138662|NCT00025259|38280429|FG004|Overall Study|Ineligible|6|||
17138663|NCT00025259|38280430|FG005|Overall Study|Ineligible|0|||
17138664|NCT00025259|38280431|FG006|Overall Study|Ineligible|1|||
17138665|NCT00025259|38280425|FG000|Overall Study|Randomization error|1|||
17037522|NCT00623103|38181538|FG001|Overall Study|Withdrawal by Subject|24|||
17037523|NCT00623103|38181537|FG000|Overall Study|Lost to Follow-up|4|||
17037524|NCT00623103|38181538|FG001|Overall Study|Lost to Follow-up|1|||
17138666|NCT00025259|38280426|FG001|Overall Study|Randomization error|0|||
17138667|NCT00025259|38280427|FG002|Overall Study|Randomization error|0|||
17138668|NCT00025259|38280428|FG003|Overall Study|Randomization error|0|||
17138669|NCT00025259|38280429|FG004|Overall Study|Randomization error|1|||
17037525|NCT00623103|38181537|FG000|Overall Study|Administrative problems|2|||
17037526|NCT00623103|38181538|FG001|Overall Study|Administrative problems|4|||
17037527|NCT00623103|38181537|FG000|Overall Study|Death|11|||
17037528|NCT00623103|38181538|FG001|Overall Study|Death|11|||
17037529|NCT00623103|38181537|FG000|Overall Study|Protocol deviation|2|||
17037530|NCT00623103|38181538|FG001|Overall Study|Protocol deviation|1|||
17037531|NCT00396565|38181547|FG000|Overall Study|Physician Decision|3|||
17037532|NCT00396565|38181548|FG001|Overall Study|Physician Decision|1|||
17037533|NCT00396565|38181549|FG002|Overall Study|Physician Decision|2|||
17037534|NCT00396565|38181547|FG000|Overall Study|Adverse Event|5|||
17037535|NCT00396565|38181548|FG001|Overall Study|Adverse Event|13|||
17037536|NCT00396565|38181549|FG002|Overall Study|Adverse Event|3|||
17037537|NCT00396565|38181547|FG000|Overall Study|Withdrawal by Subject|8|||
17037538|NCT00396565|38181548|FG001|Overall Study|Withdrawal by Subject|13|||
17037539|NCT00396565|38181549|FG002|Overall Study|Withdrawal by Subject|1|||
17037540|NCT00396565|38181547|FG000|Overall Study|Lack of Efficacy|32|||
17037541|NCT00396565|38181548|FG001|Overall Study|Lack of Efficacy|64|||
17037542|NCT00396565|38181549|FG002|Overall Study|Lack of Efficacy|11|||
17037543|NCT00394771|38181561|FG000|Overall Study|Did not meet protocol requirements|1|||
17037544|NCT00394771|38181562|FG001|Overall Study|Did not meet protocol requirements|0|||
17037545|NCT00394771|38181563|FG002|Overall Study|Did not meet protocol requirements|2|||
17037546|NCT00394771|38181564|FG003|Overall Study|Did not meet protocol requirements|0|||
17037547|NCT00394771|38181561|FG000|Overall Study|Protocol Violation|2|||
17037548|NCT00394771|38181562|FG001|Overall Study|Protocol Violation|4|||
17037549|NCT00394771|38181563|FG002|Overall Study|Protocol Violation|9|||
17037550|NCT00394771|38181564|FG003|Overall Study|Protocol Violation|7|||
17037551|NCT00394771|38181561|FG000|Overall Study|Withdrawal by Subject|10|||
17037552|NCT00394771|38181562|FG001|Overall Study|Withdrawal by Subject|6|||
17037553|NCT00394771|38181563|FG002|Overall Study|Withdrawal by Subject|8|||
17037554|NCT00394771|38181564|FG003|Overall Study|Withdrawal by Subject|12|||
17037555|NCT00394771|38181561|FG000|Overall Study|Adverse Event|10|||
17037556|NCT00394771|38181562|FG001|Overall Study|Adverse Event|5|||
17037557|NCT00394771|38181563|FG002|Overall Study|Adverse Event|12|||
17037558|NCT00394771|38181564|FG003|Overall Study|Adverse Event|8|||
17037559|NCT00394771|38181561|FG000|Overall Study|Participant pregnant|0|||
17037560|NCT00394771|38181562|FG001|Overall Study|Participant pregnant|1|||
17037561|NCT00394771|38181563|FG002|Overall Study|Participant pregnant|2|||
17037562|NCT00394771|38181564|FG003|Overall Study|Participant pregnant|2|||
17037563|NCT00394771|38181561|FG000|Overall Study|Lost to Follow-up|15|||
17037564|NCT00394771|38181562|FG001|Overall Study|Lost to Follow-up|15|||
17037565|NCT00394771|38181563|FG002|Overall Study|Lost to Follow-up|13|||
17037566|NCT00394771|38181564|FG003|Overall Study|Lost to Follow-up|10|||
17037567|NCT00394771|38181561|FG000|Overall Study|Other|3|||
17037568|NCT00394771|38181562|FG001|Overall Study|Other|3|||
17037569|NCT00394771|38181563|FG002|Overall Study|Other|1|||
17037570|NCT00394771|38181564|FG003|Overall Study|Other|0|||
17037571|NCT00396409|38181576|FG000|Period 1 - 2007|Adverse Event|0|||
17037572|NCT00396409|38181577|FG001|Period 1 - 2007|Adverse Event|1|||
17037573|NCT00396409|38181576|FG000|Period 1 - 2007|Lack of Efficacy|0|||
17037574|NCT00396409|38181577|FG001|Period 1 - 2007|Lack of Efficacy|1|||
17037575|NCT00396409|38181576|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
17037576|NCT00396409|38181577|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
17037577|NCT00396409|38181576|FG000|Period 1 - 2007|Lost to Follow-up|2|||
17037578|NCT00396409|38181577|FG001|Period 1 - 2007|Lost to Follow-up|3|||
17037579|NCT00396409|38181576|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
17037580|NCT00396409|38181577|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
17037581|NCT00396409|38181576|FG000|Period 2 - 2008|Protocol Violation|1|||
17037582|NCT00396409|38181577|FG001|Period 2 - 2008|Protocol Violation|0|||
17037583|NCT00396409|38181576|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
17037584|NCT00396409|38181577|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
17037585|NCT00396409|38181576|FG000|Period 2 - 2008|Lost to Follow-up|3|||
17037586|NCT00396409|38181577|FG001|Period 2 - 2008|Lost to Follow-up|1|||
17037587|NCT02924376|38181589|FG000|Overall Study|Progressive Disease|4|||
17037588|NCT02924376|38181590|FG001|Overall Study|Progressive Disease|0|||
17037589|NCT02924376|38181591|FG002|Overall Study|Progressive Disease|1|||
17037590|NCT02924376|38181592|FG003|Overall Study|Progressive Disease|0|||
17037591|NCT02924376|38181589|FG000|Overall Study|Death|73|||
17037592|NCT02924376|38181590|FG001|Overall Study|Death|18|||
17037593|NCT02924376|38181591|FG002|Overall Study|Death|15|||
17037594|NCT02924376|38181592|FG003|Overall Study|Death|2|||
17037595|NCT02924376|38181589|FG000|Overall Study|Lost to Follow-up|3|||
17037596|NCT02924376|38181590|FG001|Overall Study|Lost to Follow-up|0|||
17037597|NCT02924376|38181591|FG002|Overall Study|Lost to Follow-up|0|||
17037598|NCT02924376|38181592|FG003|Overall Study|Lost to Follow-up|0|||
17037599|NCT02924376|38181589|FG000|Overall Study|Study Terminated by Sponsor|19|||
17037600|NCT02924376|38181590|FG001|Overall Study|Study Terminated by Sponsor|0|||
17037601|NCT02924376|38181591|FG002|Overall Study|Study Terminated by Sponsor|0|||
17037602|NCT02924376|38181592|FG003|Overall Study|Study Terminated by Sponsor|0|||
17037603|NCT02924376|38181589|FG000|Overall Study|Physician Decision|1|||
17037604|NCT02924376|38181590|FG001|Overall Study|Physician Decision|0|||
17037605|NCT02924376|38181591|FG002|Overall Study|Physician Decision|0|||
17037606|NCT02924376|38181592|FG003|Overall Study|Physician Decision|0|||
17037607|NCT02924376|38181589|FG000|Overall Study|Withdrawal by Subject|7|||
17037608|NCT02924376|38181590|FG001|Overall Study|Withdrawal by Subject|2|||
17037609|NCT02924376|38181591|FG002|Overall Study|Withdrawal by Subject|1|||
17037610|NCT02924376|38181592|FG003|Overall Study|Withdrawal by Subject|0|||
17037611|NCT02924376|38181589|FG000|Overall Study|Rolled Over to Another Study|1|||
17037612|NCT02924376|38181590|FG001|Overall Study|Rolled Over to Another Study|0|||
17037613|NCT02924376|38181591|FG002|Overall Study|Rolled Over to Another Study|0|||
17037614|NCT02924376|38181592|FG003|Overall Study|Rolled Over to Another Study|0|||
17037615|NCT00567580|38181608|FG000|Overall Study|Protocol Violation|28|||
17037616|NCT00567580|38181609|FG001|Overall Study|Protocol Violation|24|||
17037617|NCT00567580|38181610|FG002|Overall Study|Protocol Violation|24|||
17037618|NCT00693420|38181623|FG000|Overall Study|Adverse Event|4|||
17037619|NCT00693420|38181624|FG001|Overall Study|Adverse Event|4|||
17037620|NCT00693420|38181623|FG000|Overall Study|Lost to Follow-up|0|||
17037621|NCT00693420|38181624|FG001|Overall Study|Lost to Follow-up|3|||
17037622|NCT00693420|38181623|FG000|Overall Study|Withdrawal by Subject|1|||
17037623|NCT00693420|38181624|FG001|Overall Study|Withdrawal by Subject|0|||
17037624|NCT00693420|38181623|FG000|Overall Study|Protocol Violation|0|||
17037625|NCT00693420|38181624|FG001|Overall Study|Protocol Violation|2|||
17037626|NCT00693420|38181623|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
17037627|NCT00693420|38181624|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
17037628|NCT00693420|38181623|FG000|Overall Study|Personal Reasons|1|||
17037629|NCT00693420|38181624|FG001|Overall Study|Personal Reasons|4|||
17037630|NCT00695136|38181630|FG000|Overall Study|Withdrawal by Subject|1|||
17037631|NCT00695136|38181630|FG000|Overall Study|unrelated adverse event|1|||
17037632|NCT00605176|38181646|FG000|Overall Study|Adverse Event|2|||
17037633|NCT00605176|38181647|FG001|Overall Study|Adverse Event|1|||
17037634|NCT00605176|38181648|FG002|Overall Study|Adverse Event|3|||
17037635|NCT00605176|38181646|FG000|Overall Study|Withdrawal by Subject|4|||
17037636|NCT00605176|38181647|FG001|Overall Study|Withdrawal by Subject|2|||
17037637|NCT00605176|38181648|FG002|Overall Study|Withdrawal by Subject|4|||
17037638|NCT00605176|38181646|FG000|Overall Study|Lost to Follow-up|2|||
16991906|NCT00806026|38135883|FG003|Overall Study|Lost to Follow-up|2|||
16991907|NCT00806026|38135884|FG004|Overall Study|Lost to Follow-up|6|||
16991908|NCT00806026|38135885|FG005|Overall Study|Lost to Follow-up|6|||
16991909|NCT00806026|38135880|FG000|Overall Study|Withdrawal by Subject|14|||
16991910|NCT00806026|38135881|FG001|Overall Study|Withdrawal by Subject|17|||
16991911|NCT00806026|38135882|FG002|Overall Study|Withdrawal by Subject|9|||
16991912|NCT00806026|38135883|FG003|Overall Study|Withdrawal by Subject|2|||
16991913|NCT00806026|38135884|FG004|Overall Study|Withdrawal by Subject|5|||
16991914|NCT00806026|38135885|FG005|Overall Study|Withdrawal by Subject|3|||
16991915|NCT00806026|38135880|FG000|Overall Study|Other|3|||
16991916|NCT00806026|38135881|FG001|Overall Study|Other|6|||
16991917|NCT00806026|38135882|FG002|Overall Study|Other|8|||
16991918|NCT00806026|38135883|FG003|Overall Study|Other|2|||
16991919|NCT00806026|38135884|FG004|Overall Study|Other|0|||
16991920|NCT00806026|38135885|FG005|Overall Study|Other|4|||
16991921|NCT00806026|38135880|FG000|Overall Study|Protocol Violation|6|||
16991922|NCT00806026|38135881|FG001|Overall Study|Protocol Violation|9|||
16991923|NCT00806026|38135882|FG002|Overall Study|Protocol Violation|9|||
16991924|NCT00806026|38135883|FG003|Overall Study|Protocol Violation|0|||
16991925|NCT00806026|38135884|FG004|Overall Study|Protocol Violation|2|||
16991926|NCT00806026|38135885|FG005|Overall Study|Protocol Violation|3|||
16991927|NCT00806026|38135880|FG000|Overall Study|Adverse Event|52|||
16991928|NCT00806026|38135881|FG001|Overall Study|Adverse Event|35|||
16991929|NCT00806026|38135882|FG002|Overall Study|Adverse Event|44|||
16991930|NCT00806026|38135883|FG003|Overall Study|Adverse Event|17|||
16991931|NCT00806026|38135884|FG004|Overall Study|Adverse Event|9|||
16991932|NCT00806026|38135885|FG005|Overall Study|Adverse Event|9|||
17037639|NCT00605176|38181647|FG001|Overall Study|Lost to Follow-up|2|||
17037640|NCT00605176|38181648|FG002|Overall Study|Lost to Follow-up|1|||
17037641|NCT00605176|38181646|FG000|Overall Study|Non-complicance with study procedures|1|||
17037642|NCT00605176|38181647|FG001|Overall Study|Non-complicance with study procedures|0|||
16991933|NCT04026165|38135900|FG000|Run-in Placebo Period|Enrollment Error|13|||
16991934|NCT04026165|38135901|FG001|Run-in Placebo Period|Enrollment Error|0|||
17037643|NCT00605176|38181648|FG002|Overall Study|Non-complicance with study procedures|0|||
17037644|NCT00605176|38181646|FG000|Overall Study|Use of concomitant therapy|1|||
17037645|NCT00605176|38181647|FG001|Overall Study|Use of concomitant therapy|0|||
17037646|NCT00605176|38181648|FG002|Overall Study|Use of concomitant therapy|1|||
17037647|NCT00605176|38181646|FG000|Overall Study|Other (not due to AE)|1|||
17037648|NCT00605176|38181647|FG001|Overall Study|Other (not due to AE)|1|||
16991935|NCT04026165|38135902|FG002|Run-in Placebo Period|Enrollment Error|0|||
16991936|NCT04026165|38135903|FG003|Run-in Placebo Period|Enrollment Error|0|||
16991937|NCT04026165|38135900|FG000|Run-in Placebo Period|Run-in Failure|4|||
16991938|NCT04026165|38135901|FG001|Run-in Placebo Period|Run-in Failure|0|||
17037649|NCT00605176|38181648|FG002|Overall Study|Other (not due to AE)|0|||
17037650|NCT00694356|38181659|FG000|Overall Study|Adverse Event|1|||
17037651|NCT00694356|38181660|FG001|Overall Study|Adverse Event|0|||
17037652|NCT00694356|38181661|FG002|Overall Study|Adverse Event|0|||
17037653|NCT00694356|38181659|FG000|Overall Study|Progressive Disease|2|||
17037654|NCT00694356|38181660|FG001|Overall Study|Progressive Disease|6|||
17037655|NCT00694356|38181661|FG002|Overall Study|Progressive Disease|6|||
17037656|NCT00692406|38181669|FG000|Overall Study|PI dropped, bad data|57|||
17037657|NCT00567502|38181686|FG000|Overall Study|Lost to Follow-up|91|||
17037658|NCT00567502|38181687|FG001|Overall Study|Lost to Follow-up|14|||
17037659|NCT00567502|38181688|FG002|Overall Study|Lost to Follow-up|351|||
17037660|NCT00567502|38181689|FG003|Overall Study|Lost to Follow-up|2|||
17037661|NCT00567502|38181686|FG000|Overall Study|Death|65|||
17037662|NCT00567502|38181687|FG001|Overall Study|Death|16|||
17037663|NCT00567502|38181688|FG002|Overall Study|Death|360|||
17037664|NCT00567502|38181689|FG003|Overall Study|Death|5|||
17037665|NCT00567502|38181686|FG000|Overall Study|Other|64|||
17037666|NCT00567502|38181687|FG001|Overall Study|Other|2|||
17037667|NCT00567502|38181688|FG002|Overall Study|Other|134|||
17037668|NCT00567502|38181689|FG003|Overall Study|Other|6|||
17037669|NCT00567502|38181686|FG000|Overall Study|Participant request|12|||
17037670|NCT00567502|38181687|FG001|Overall Study|Participant request|1|||
17037671|NCT00567502|38181688|FG002|Overall Study|Participant request|33|||
17037672|NCT00567502|38181689|FG003|Overall Study|Participant request|1|||
17037673|NCT00567502|38181686|FG000|Overall Study|Sponsor request|9|||
17037674|NCT00567502|38181687|FG001|Overall Study|Sponsor request|0|||
17037675|NCT00567502|38181688|FG002|Overall Study|Sponsor request|30|||
17037676|NCT00567502|38181689|FG003|Overall Study|Sponsor request|1|||
17037677|NCT00567502|38181686|FG000|Overall Study|Never Initiated Treatment|0|||
17037678|NCT00567502|38181687|FG001|Overall Study|Never Initiated Treatment|0|||
17037679|NCT00567502|38181688|FG002|Overall Study|Never Initiated Treatment|0|||
17037680|NCT00567502|38181689|FG003|Overall Study|Never Initiated Treatment|72|||
17037681|NCT00396331|38181714|FG000|Overall Study|Failed to mobilize - no transplant|8|||
17037682|NCT00396331|38181714|FG000|Overall Study|Did not go on to transplant|5|||
17037683|NCT00396331|38181714|FG000|Overall Study|Lost to Follow-up|3|||
17037684|NCT00396331|38181714|FG000|Overall Study|Death|16|||
17037685|NCT00396253|38181726|FG000|Overall Study|Protocol Violation|1|||
17037686|NCT00396253|38181726|FG000|Overall Study|Withdrawal by Subject|7|||
17037687|NCT00396253|38181726|FG000|Overall Study|Death|3|||
17037688|NCT00396253|38181726|FG000|Overall Study|Physician Decision|1|||
17037689|NCT00396253|38181726|FG000|Overall Study|Change in eligibility status|1|||
17037690|NCT00604162|38181730|FG000|Overall Study|Physician Decision|3|||
17037691|NCT00604162|38181730|FG000|Overall Study|Withdrawal by Subject|1|||
17037692|NCT00396097|38181739|FG000|Overall Study|Withdrawal by Subject|17|||
17037693|NCT00396097|38181740|FG001|Overall Study|Withdrawal by Subject|17|||
17138670|NCT00025259|38280430|FG005|Overall Study|Randomization error|7|||
17138671|NCT00025259|38280431|FG006|Overall Study|Randomization error|2|||
16991939|NCT04026165|38135902|FG002|Run-in Placebo Period|Run-in Failure|0|||
16991940|NCT04026165|38135903|FG003|Run-in Placebo Period|Run-in Failure|0|||
16991941|NCT04026165|38135900|FG000|Run-in Placebo Period|Protocol Violation|2|||
16991942|NCT04026165|38135901|FG001|Run-in Placebo Period|Protocol Violation|0|||
16991943|NCT04026165|38135902|FG002|Run-in Placebo Period|Protocol Violation|0|||
16991944|NCT04026165|38135903|FG003|Run-in Placebo Period|Protocol Violation|0|||
16991945|NCT04026165|38135900|FG000|Run-in Placebo Period|Withdrew Consent|2|||
16991946|NCT04026165|38135901|FG001|Run-in Placebo Period|Withdrew Consent|0|||
16991947|NCT04026165|38135902|FG002|Run-in Placebo Period|Withdrew Consent|0|||
16991948|NCT04026165|38135903|FG003|Run-in Placebo Period|Withdrew Consent|0|||
17037694|NCT00396097|38181739|FG000|Overall Study|Lost to Follow-up|4|||
17138672|NCT00025259|38280425|FG000|Overall Study|Adverse Event|1|||
17138673|NCT00025259|38280426|FG001|Overall Study|Adverse Event|0|||
17138674|NCT00025259|38280427|FG002|Overall Study|Adverse Event|0|||
17138675|NCT00025259|38280428|FG003|Overall Study|Adverse Event|0|||
17138676|NCT00025259|38280429|FG004|Overall Study|Adverse Event|0|||
17138677|NCT00025259|38280430|FG005|Overall Study|Adverse Event|0|||
17138678|NCT00025259|38280431|FG006|Overall Study|Adverse Event|0|||
17138679|NCT03351738|38280456|FG000|Overall Study|Withdrawal by Subject|0|||
17138680|NCT03351738|38280457|FG001|Overall Study|Withdrawal by Subject|1|||
17138681|NCT03351738|38280458|FG002|Overall Study|Withdrawal by Subject|0|||
17138682|NCT03351738|38280459|FG003|Overall Study|Withdrawal by Subject|1|||
17138683|NCT03351738|38280460|FG004|Overall Study|Withdrawal by Subject|0|||
17138684|NCT03351738|38280461|FG005|Overall Study|Withdrawal by Subject|0|||
17138685|NCT03351114|38280480|FG000|Overall Study|Withdrawal by Subject|1|||
17138686|NCT03350256|38280484|FG000|Overall Study|Inclusion/exclusion violation|4|||
17138687|NCT03350256|38280484|FG000|Overall Study|Recommended for other therapies|2|||
16991949|NCT04026165|38135900|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
17037695|NCT00396097|38181740|FG001|Overall Study|Lost to Follow-up|9|||
17037696|NCT00396097|38181739|FG000|Overall Study|Other|3|||
17037697|NCT00396097|38181740|FG001|Overall Study|Other|5|||
17138688|NCT03350256|38280484|FG000|Overall Study|Protocol Violation|3|||
17138689|NCT03350256|38280484|FG000|Overall Study|Non compliance|2|||
17138690|NCT03350256|38280484|FG000|Overall Study|Denial by insurance|1|||
17138691|NCT03350256|38280484|FG000|Overall Study|Adverse Event|2|||
17138692|NCT03350256|38280484|FG000|Overall Study|Trial failure|12|||
17138693|NCT03350256|38280484|FG000|Overall Study|Did not proceed to permanent implant|3|||
17138694|NCT03350256|38280484|FG000|Overall Study|Withdrawal by Subject|3|||
17138695|NCT03350256|38280484|FG000|Overall Study|Subject moving out of state|1|||
17138696|NCT03350256|38280484|FG000|Overall Study|Lost to Follow-up|1|||
17138697|NCT03350256|38280484|FG000|Overall Study|Lack of Efficacy|2|||
17138698|NCT00024167|38280491|FG000|Overall Study|Death|53|||
17138699|NCT00024167|38280492|FG001|Overall Study|Death|47|||
17138700|NCT00022763|38280501|FG000|Overall Study|Adverse Event|1|||
17138701|NCT00022763|38280502|FG001|Overall Study|Adverse Event|2|||
17138702|NCT00022763|38280501|FG000|Overall Study|Injection Site Reactions|0|||
17138703|NCT00022763|38280502|FG001|Overall Study|Injection Site Reactions|2|||
17138704|NCT00022763|38280501|FG000|Overall Study|Death|0|||
17037698|NCT00396097|38181739|FG000|Overall Study|Protocol Violation|0|||
17037699|NCT00396097|38181740|FG001|Overall Study|Protocol Violation|6|||
17037700|NCT00396097|38181739|FG000|Overall Study|Adverse Event|1|||
17037701|NCT00396097|38181740|FG001|Overall Study|Adverse Event|5|||
17037702|NCT00396097|38181739|FG000|Overall Study|Insufficient Clinical Response|1|||
17037703|NCT00396097|38181740|FG001|Overall Study|Insufficient Clinical Response|4|||
17037704|NCT00375505|38181752|FG000|Overall Study|Adverse Event|1|||
17037705|NCT00375505|38181753|FG001|Overall Study|Adverse Event|2|||
17037706|NCT00375427|38181761|FG000|Overall Study|Adverse Event|21|||
17037707|NCT00375427|38181762|FG001|Overall Study|Adverse Event|27|||
17037708|NCT00375427|38181761|FG000|Overall Study|Abnormal test procedure result(s)|0|||
17037709|NCT00375427|38181762|FG001|Overall Study|Abnormal test procedure result(s)|1|||
17037710|NCT00375427|38181761|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17037711|NCT00375427|38181762|FG001|Overall Study|Abnormal laboratory value(s)|2|||
17037712|NCT00375427|38181761|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
17037713|NCT00375427|38181762|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
17037714|NCT00375427|38181761|FG000|Overall Study|Patient no longer requires study drug|3|||
17037715|NCT00375427|38181762|FG001|Overall Study|Patient no longer requires study drug|7|||
17037716|NCT00375427|38181761|FG000|Overall Study|Protocol Violation|10|||
17037717|NCT00375427|38181762|FG001|Overall Study|Protocol Violation|8|||
17037718|NCT00375427|38181761|FG000|Overall Study|Withdrawal by Subject|9|||
17037719|NCT00375427|38181762|FG001|Overall Study|Withdrawal by Subject|13|||
17037720|NCT00375427|38181761|FG000|Overall Study|Lost to Follow-up|1|||
17037721|NCT00375427|38181762|FG001|Overall Study|Lost to Follow-up|1|||
17037722|NCT00375427|38181761|FG000|Overall Study|Administrative reasons|0|||
17037723|NCT00375427|38181762|FG001|Overall Study|Administrative reasons|1|||
17037724|NCT00375427|38181761|FG000|Overall Study|Death|11|||
17037725|NCT00375427|38181762|FG001|Overall Study|Death|10|||
17037726|NCT00393913|38181768|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
17037727|NCT00393913|38181768|FG000|Initial Assessment|Withdrawal by Subject|16|||
17037728|NCT00393913|38181768|FG000|CPAP|Withdrawal by Subject|3|||
17037729|NCT00393913|38181768|FG000|CPAP|Physician Decision|1|||
17037730|NCT00393913|38181768|FG000|CPAP|TEchnical problem with CPAP|3|||
17037731|NCT00567268|38181773|FG000|Overall Study|Protocol Violation|7|||
17037732|NCT00567268|38181773|FG000|Overall Study|Lost to Follow-up|36|||
17037733|NCT00567268|38181773|FG000|Overall Study|No Visit After First Day of Treatment|2|||
17037734|NCT00567268|38181773|FG000|Overall Study|No Drug Administration|4|||
17037735|NCT00567268|38181773|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
17037736|NCT03976648|38181814|FG000|Overall Study|Adverse Event|0|||
17037737|NCT03976648|38181815|FG001|Overall Study|Adverse Event|2|||
17037738|NCT03976648|38181814|FG000|Overall Study|Study terminated by sponsor|21|||
17037739|NCT03976648|38181815|FG001|Overall Study|Study terminated by sponsor|8|||
17037740|NCT00566254|38181823|FG000|Overall Study|Adverse Event|3|||
17037741|NCT00566254|38181824|FG001|Overall Study|Adverse Event|1|||
17037742|NCT00566254|38181823|FG000|Overall Study|Protocol Violation|1|||
17037743|NCT00566254|38181824|FG001|Overall Study|Protocol Violation|3|||
17037744|NCT00566254|38181823|FG000|Overall Study|Withdrawal by Subject|1|||
17037745|NCT00566254|38181824|FG001|Overall Study|Withdrawal by Subject|2|||
17037746|NCT00566254|38181823|FG000|Overall Study|Lack of Efficacy|5|||
17037747|NCT00566254|38181824|FG001|Overall Study|Lack of Efficacy|6|||
17037748|NCT00566254|38181823|FG000|Overall Study|Other|0|||
17037749|NCT00566254|38181824|FG001|Overall Study|Other|2|||
17138705|NCT00022763|38280502|FG001|Overall Study|Death|1|||
17138706|NCT00022763|38280501|FG000|Overall Study|Lost to Follow-up|0|||
17138707|NCT00022763|38280502|FG001|Overall Study|Lost to Follow-up|3|||
17138708|NCT00022763|38280501|FG000|Overall Study|Withdrawal by Subject|4|||
17138709|NCT00022763|38280502|FG001|Overall Study|Withdrawal by Subject|7|||
17138710|NCT00022763|38280501|FG000|Overall Study|Insufficient Therapy|1|||
17138711|NCT00022763|38280502|FG001|Overall Study|Insufficient Therapy|0|||
17138712|NCT00022763|38280501|FG000|Overall Study|Admin|3|||
17138713|NCT00022763|38280502|FG001|Overall Study|Admin|2|||
17138714|NCT00071981|38280511|FG000|Overall Study|Lack of Efficacy|37|||
17138715|NCT00071981|38280512|FG001|Overall Study|Lack of Efficacy|29|||
17138716|NCT00071981|38280513|FG002|Overall Study|Lack of Efficacy|30|||
17138717|NCT00071981|38280514|FG003|Overall Study|Lack of Efficacy|43|||
17138718|NCT00071981|38280511|FG000|Overall Study|Adverse Event|4|||
17138719|NCT00071981|38280512|FG001|Overall Study|Adverse Event|4|||
17138720|NCT00071981|38280513|FG002|Overall Study|Adverse Event|3|||
17138721|NCT00071981|38280514|FG003|Overall Study|Adverse Event|1|||
17138722|NCT00071981|38280511|FG000|Overall Study|Death|0|||
17138723|NCT00071981|38280512|FG001|Overall Study|Death|0|||
17138724|NCT00071981|38280513|FG002|Overall Study|Death|1|||
17138725|NCT00071981|38280514|FG003|Overall Study|Death|1|||
17138726|NCT00071981|38280511|FG000|Overall Study|Withdrawal by Subject|3|||
17138727|NCT00071981|38280512|FG001|Overall Study|Withdrawal by Subject|1|||
17138728|NCT00071981|38280513|FG002|Overall Study|Withdrawal by Subject|0|||
17138729|NCT00071981|38280514|FG003|Overall Study|Withdrawal by Subject|0|||
17138730|NCT00071981|38280511|FG000|Overall Study|No protocol therapy|2|||
17138731|NCT00071981|38280512|FG001|Overall Study|No protocol therapy|5|||
17138732|NCT00071981|38280513|FG002|Overall Study|No protocol therapy|1|||
17138733|NCT00071981|38280514|FG003|Overall Study|No protocol therapy|0|||
17138734|NCT00071981|38280511|FG000|Overall Study|others (not specified in the study)|0|||
17138735|NCT00071981|38280512|FG001|Overall Study|others (not specified in the study)|2|||
17138736|NCT00071981|38280513|FG002|Overall Study|others (not specified in the study)|2|||
17138737|NCT00071981|38280514|FG003|Overall Study|others (not specified in the study)|0|||
17138738|NCT00071513|38280526|FG000|Intervention Component|Withdrawal by Subject|2|||
17138739|NCT00071513|38280527|FG001|Intervention Component|Withdrawal by Subject|3|||
17138740|NCT00071513|38280526|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
17138741|NCT00071513|38280527|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
17138742|NCT00006389|38280535|FG000|Overall Study|Adverse Event|1|||
17138743|NCT00006305|38280544|FG000|Overall Study|Withdrawal by Subject|17|||
17138744|NCT00006305|38280545|FG001|Overall Study|Withdrawal by Subject|10|||
17138745|NCT00006305|38280546|FG002|Overall Study|Withdrawal by Subject|15|||
17138746|NCT00006305|38280547|FG003|Overall Study|Withdrawal by Subject|14|||
17138747|NCT03529773|38280597|FG000|Overall Study|Adverse Event|0|||
17138748|NCT03529773|38280598|FG001|Overall Study|Adverse Event|0|||
17138749|NCT03529773|38280599|FG002|Overall Study|Adverse Event|0|||
17138750|NCT03529773|38280600|FG003|Overall Study|Adverse Event|0|||
17138751|NCT03529773|38280601|FG004|Overall Study|Adverse Event|0|||
17138752|NCT03529773|38280602|FG005|Overall Study|Adverse Event|0|||
17138753|NCT03529773|38280603|FG006|Overall Study|Adverse Event|0|||
17138754|NCT03529773|38280604|FG007|Overall Study|Adverse Event|0|||
17138755|NCT03529773|38280605|FG008|Overall Study|Adverse Event|0|||
17138756|NCT03529773|38280606|FG009|Overall Study|Adverse Event|0|||
17138757|NCT03529773|38280607|FG010|Overall Study|Adverse Event|0|||
17138758|NCT03529773|38280608|FG011|Overall Study|Adverse Event|0|||
17138759|NCT03529773|38280609|FG012|Overall Study|Adverse Event|0|||
17138760|NCT03529773|38280610|FG013|Overall Study|Adverse Event|0|||
17138761|NCT03529773|38280611|FG014|Overall Study|Adverse Event|0|||
17138762|NCT03529773|38280612|FG015|Overall Study|Adverse Event|0|||
17138763|NCT03529773|38280613|FG016|Overall Study|Adverse Event|0|||
17138764|NCT03529773|38280614|FG017|Overall Study|Adverse Event|0|||
17138765|NCT03529773|38280615|FG018|Overall Study|Adverse Event|0|||
17138766|NCT03529773|38280616|FG019|Overall Study|Adverse Event|0|||
17138767|NCT03529773|38280617|FG020|Overall Study|Adverse Event|0|||
17138768|NCT03529773|38280618|FG021|Overall Study|Adverse Event|0|||
17138769|NCT03529773|38280619|FG022|Overall Study|Adverse Event|0|||
17138770|NCT03529773|38280620|FG023|Overall Study|Adverse Event|0|||
17138771|NCT03529773|38280621|FG024|Overall Study|Adverse Event|0|||
17138772|NCT03529773|38280622|FG025|Overall Study|Adverse Event|0|||
17138773|NCT03529773|38280623|FG026|Overall Study|Adverse Event|0|||
17138774|NCT03529773|38280624|FG027|Overall Study|Adverse Event|0|||
17138775|NCT03529773|38280625|FG028|Overall Study|Adverse Event|0|||
17138776|NCT03529773|38280626|FG029|Overall Study|Adverse Event|0|||
17138777|NCT03529773|38280627|FG030|Overall Study|Adverse Event|1|||
17138778|NCT03529773|38280628|FG031|Overall Study|Adverse Event|0|||
17138779|NCT03529773|38280629|FG032|Overall Study|Adverse Event|0|||
17138780|NCT03529773|38280630|FG033|Overall Study|Adverse Event|0|||
17138781|NCT03529773|38280631|FG034|Overall Study|Adverse Event|0|||
17138782|NCT03529773|38280632|FG035|Overall Study|Adverse Event|1|||
17138783|NCT03529773|38280633|FG036|Overall Study|Adverse Event|0|||
17138784|NCT03529773|38280634|FG037|Overall Study|Adverse Event|0|||
17138785|NCT03529773|38280635|FG038|Overall Study|Adverse Event|1|||
17138786|NCT03529773|38280636|FG039|Overall Study|Adverse Event|1|||
17138787|NCT03529773|38280597|FG000|Overall Study|Death|0|||
17138788|NCT03529773|38280598|FG001|Overall Study|Death|0|||
17138789|NCT03529773|38280599|FG002|Overall Study|Death|0|||
17138790|NCT03529773|38280600|FG003|Overall Study|Death|0|||
17138791|NCT03529773|38280601|FG004|Overall Study|Death|0|||
17138792|NCT03529773|38280602|FG005|Overall Study|Death|0|||
17138793|NCT03529773|38280603|FG006|Overall Study|Death|0|||
17138794|NCT03529773|38280604|FG007|Overall Study|Death|0|||
17138795|NCT03529773|38280605|FG008|Overall Study|Death|0|||
17138796|NCT03529773|38280606|FG009|Overall Study|Death|0|||
17138797|NCT03529773|38280607|FG010|Overall Study|Death|0|||
17037750|NCT00393523|38181835|FG000|Overall Study|Lost to Follow-up|0|||
17037751|NCT00393523|38181836|FG001|Overall Study|Lost to Follow-up|0|||
17037752|NCT00393523|38181837|FG002|Overall Study|Lost to Follow-up|0|||
17037753|NCT00393523|38181838|FG003|Overall Study|Lost to Follow-up|2|||
17037754|NCT00393523|38181839|FG004|Overall Study|Lost to Follow-up|1|||
17037755|NCT00393523|38181835|FG000|Overall Study|Protocol Violation|6|||
17037756|NCT00393523|38181836|FG001|Overall Study|Protocol Violation|2|||
17037757|NCT00393523|38181837|FG002|Overall Study|Protocol Violation|0|||
17037758|NCT00393523|38181838|FG003|Overall Study|Protocol Violation|1|||
17037759|NCT00393523|38181839|FG004|Overall Study|Protocol Violation|0|||
17037760|NCT00393523|38181835|FG000|Overall Study|Withdrawal by Subject|6|||
17037761|NCT00393523|38181836|FG001|Overall Study|Withdrawal by Subject|7|||
17037762|NCT00393523|38181837|FG002|Overall Study|Withdrawal by Subject|2|||
17138798|NCT03529773|38280608|FG011|Overall Study|Death|0|||
17138799|NCT03529773|38280609|FG012|Overall Study|Death|1|||
17138800|NCT03529773|38280610|FG013|Overall Study|Death|0|||
17138801|NCT03529773|38280611|FG014|Overall Study|Death|0|||
17138802|NCT03529773|38280612|FG015|Overall Study|Death|0|||
17138803|NCT03529773|38280613|FG016|Overall Study|Death|0|||
17138804|NCT03529773|38280614|FG017|Overall Study|Death|0|||
17138805|NCT03529773|38280615|FG018|Overall Study|Death|0|||
17138806|NCT03529773|38280616|FG019|Overall Study|Death|1|||
17138807|NCT03529773|38280617|FG020|Overall Study|Death|0|||
17138808|NCT03529773|38280618|FG021|Overall Study|Death|0|||
17138809|NCT03529773|38280619|FG022|Overall Study|Death|1|||
17138810|NCT03529773|38280620|FG023|Overall Study|Death|0|||
17138811|NCT03529773|38280621|FG024|Overall Study|Death|0|||
17138812|NCT03529773|38280622|FG025|Overall Study|Death|0|||
17138813|NCT03529773|38280623|FG026|Overall Study|Death|0|||
17138814|NCT03529773|38280624|FG027|Overall Study|Death|0|||
17138815|NCT03529773|38280625|FG028|Overall Study|Death|0|||
17138816|NCT03529773|38280626|FG029|Overall Study|Death|0|||
17138817|NCT03529773|38280627|FG030|Overall Study|Death|0|||
17138818|NCT03529773|38280628|FG031|Overall Study|Death|0|||
17138819|NCT03529773|38280629|FG032|Overall Study|Death|0|||
17138820|NCT03529773|38280630|FG033|Overall Study|Death|1|||
17138821|NCT03529773|38280631|FG034|Overall Study|Death|1|||
17138822|NCT03529773|38280632|FG035|Overall Study|Death|0|||
17138823|NCT03529773|38280633|FG036|Overall Study|Death|1|||
17138824|NCT03529773|38280634|FG037|Overall Study|Death|0|||
17138825|NCT03529773|38280635|FG038|Overall Study|Death|0|||
17138826|NCT03529773|38280636|FG039|Overall Study|Death|0|||
17138827|NCT03529773|38280597|FG000|Overall Study|Lost to Follow-up|0|||
17138828|NCT03529773|38280598|FG001|Overall Study|Lost to Follow-up|0|||
17138829|NCT03529773|38280599|FG002|Overall Study|Lost to Follow-up|1|||
17138830|NCT03529773|38280600|FG003|Overall Study|Lost to Follow-up|0|||
17138831|NCT03529773|38280601|FG004|Overall Study|Lost to Follow-up|1|||
17138832|NCT03529773|38280602|FG005|Overall Study|Lost to Follow-up|1|||
17138833|NCT03529773|38280603|FG006|Overall Study|Lost to Follow-up|0|||
17138834|NCT03529773|38280604|FG007|Overall Study|Lost to Follow-up|0|||
17138835|NCT03529773|38280605|FG008|Overall Study|Lost to Follow-up|0|||
17138836|NCT03529773|38280606|FG009|Overall Study|Lost to Follow-up|0|||
17138837|NCT03529773|38280607|FG010|Overall Study|Lost to Follow-up|0|||
17138838|NCT03529773|38280608|FG011|Overall Study|Lost to Follow-up|0|||
17138839|NCT03529773|38280609|FG012|Overall Study|Lost to Follow-up|0|||
17138840|NCT03529773|38280610|FG013|Overall Study|Lost to Follow-up|1|||
17138841|NCT03529773|38280611|FG014|Overall Study|Lost to Follow-up|4|||
17138842|NCT03529773|38280612|FG015|Overall Study|Lost to Follow-up|1|||
17138843|NCT03529773|38280613|FG016|Overall Study|Lost to Follow-up|1|||
17138844|NCT03529773|38280614|FG017|Overall Study|Lost to Follow-up|0|||
17138845|NCT03529773|38280615|FG018|Overall Study|Lost to Follow-up|1|||
17138846|NCT03529773|38280616|FG019|Overall Study|Lost to Follow-up|1|||
17138847|NCT03529773|38280617|FG020|Overall Study|Lost to Follow-up|2|||
17037763|NCT00393523|38181838|FG003|Overall Study|Withdrawal by Subject|3|||
17138848|NCT03529773|38280618|FG021|Overall Study|Lost to Follow-up|4|||
17138849|NCT03529773|38280619|FG022|Overall Study|Lost to Follow-up|3|||
17138850|NCT03529773|38280620|FG023|Overall Study|Lost to Follow-up|4|||
17138851|NCT03529773|38280621|FG024|Overall Study|Lost to Follow-up|3|||
17138852|NCT03529773|38280622|FG025|Overall Study|Lost to Follow-up|5|||
17138853|NCT03529773|38280623|FG026|Overall Study|Lost to Follow-up|5|||
17138854|NCT03529773|38280624|FG027|Overall Study|Lost to Follow-up|0|||
17138855|NCT03529773|38280625|FG028|Overall Study|Lost to Follow-up|0|||
17138856|NCT03529773|38280626|FG029|Overall Study|Lost to Follow-up|0|||
17138857|NCT03529773|38280627|FG030|Overall Study|Lost to Follow-up|1|||
17037764|NCT00393523|38181839|FG004|Overall Study|Withdrawal by Subject|0|||
17138858|NCT03529773|38280628|FG031|Overall Study|Lost to Follow-up|0|||
17138859|NCT03529773|38280629|FG032|Overall Study|Lost to Follow-up|0|||
17138860|NCT03529773|38280630|FG033|Overall Study|Lost to Follow-up|1|||
17138861|NCT03529773|38280631|FG034|Overall Study|Lost to Follow-up|1|||
17037765|NCT00393523|38181835|FG000|Overall Study|Difficulties in specimen collection|0|||
17037766|NCT00393523|38181836|FG001|Overall Study|Difficulties in specimen collection|0|||
17037767|NCT00393523|38181837|FG002|Overall Study|Difficulties in specimen collection|1|||
17037768|NCT00393523|38181838|FG003|Overall Study|Difficulties in specimen collection|0|||
17037769|NCT00393523|38181839|FG004|Overall Study|Difficulties in specimen collection|0|||
17037770|NCT00393523|38181835|FG000|Overall Study|Vaccine supply issue|0|||
17037771|NCT00393523|38181836|FG001|Overall Study|Vaccine supply issue|0|||
17037772|NCT00393523|38181837|FG002|Overall Study|Vaccine supply issue|1|||
17037773|NCT00393523|38181838|FG003|Overall Study|Vaccine supply issue|0|||
17037774|NCT00393523|38181839|FG004|Overall Study|Vaccine supply issue|0|||
17037775|NCT00393367|38181852|FG000|Overall Study|Protocol Violation|2|||
17037776|NCT00393367|38181853|FG001|Overall Study|Protocol Violation|5|||
17138862|NCT03529773|38280632|FG035|Overall Study|Lost to Follow-up|0|||
17138863|NCT03529773|38280633|FG036|Overall Study|Lost to Follow-up|0|||
17138864|NCT03529773|38280634|FG037|Overall Study|Lost to Follow-up|3|||
17138865|NCT03529773|38280635|FG038|Overall Study|Lost to Follow-up|1|||
17138866|NCT03529773|38280636|FG039|Overall Study|Lost to Follow-up|1|||
17138867|NCT03529773|38280597|FG000|Overall Study|No longer meets eligibility criteria|0|||
17138868|NCT03529773|38280598|FG001|Overall Study|No longer meets eligibility criteria|0|||
17138869|NCT03529773|38280599|FG002|Overall Study|No longer meets eligibility criteria|0|||
17138870|NCT03529773|38280600|FG003|Overall Study|No longer meets eligibility criteria|0|||
17138871|NCT03529773|38280601|FG004|Overall Study|No longer meets eligibility criteria|0|||
17138872|NCT03529773|38280602|FG005|Overall Study|No longer meets eligibility criteria|0|||
17138873|NCT03529773|38280603|FG006|Overall Study|No longer meets eligibility criteria|0|||
17138874|NCT03529773|38280604|FG007|Overall Study|No longer meets eligibility criteria|0|||
17138875|NCT03529773|38280605|FG008|Overall Study|No longer meets eligibility criteria|0|||
17037777|NCT00393367|38181852|FG000|Overall Study|Withdrawal by Subject|0|||
17037778|NCT00393367|38181853|FG001|Overall Study|Withdrawal by Subject|2|||
17138876|NCT03529773|38280606|FG009|Overall Study|No longer meets eligibility criteria|0|||
17138877|NCT03529773|38280607|FG010|Overall Study|No longer meets eligibility criteria|0|||
17138878|NCT03529773|38280608|FG011|Overall Study|No longer meets eligibility criteria|0|||
17138879|NCT03529773|38280609|FG012|Overall Study|No longer meets eligibility criteria|0|||
17037779|NCT00395863|38181863|FG000|Overall Study|Patients did not complete both exams|2|||
17037780|NCT00395863|38181864|FG001|Overall Study|Patients did not complete both exams|3|||
17037781|NCT00395629|38181876|FG000|Core Study|Adverse Event|0|||
17037782|NCT00395629|38181877|FG001|Core Study|Adverse Event|3|||
17037783|NCT00395629|38181878|FG002|Core Study|Adverse Event|4|||
17037784|NCT00395629|38181876|FG000|Core Study|Abnormal laboratory value(s)|0|||
17037785|NCT00395629|38181877|FG001|Core Study|Abnormal laboratory value(s)|0|||
17037786|NCT00395629|38181878|FG002|Core Study|Abnormal laboratory value(s)|1|||
17037787|NCT00395629|38181876|FG000|Core Study|Protocol Violation|1|||
17037788|NCT00395629|38181877|FG001|Core Study|Protocol Violation|0|||
17037789|NCT00395629|38181878|FG002|Core Study|Protocol Violation|0|||
17037790|NCT00395629|38181876|FG000|Core Study|Withdrawal by Subject|0|||
17037791|NCT00395629|38181877|FG001|Core Study|Withdrawal by Subject|1|||
17037792|NCT00395629|38181878|FG002|Core Study|Withdrawal by Subject|1|||
17037793|NCT00395629|38181876|FG000|Core Study|Lost to Follow-up|0|||
16780428|NCT02606253|37719590|FG002|Overall Study|Physician Decision|0|||
17138880|NCT03529773|38280610|FG013|Overall Study|No longer meets eligibility criteria|0|||
17138881|NCT03529773|38280611|FG014|Overall Study|No longer meets eligibility criteria|0|||
17138882|NCT03529773|38280612|FG015|Overall Study|No longer meets eligibility criteria|0|||
17138883|NCT03529773|38280613|FG016|Overall Study|No longer meets eligibility criteria|0|||
17138884|NCT03529773|38280614|FG017|Overall Study|No longer meets eligibility criteria|0|||
17138885|NCT03529773|38280615|FG018|Overall Study|No longer meets eligibility criteria|0|||
17138886|NCT03529773|38280616|FG019|Overall Study|No longer meets eligibility criteria|0|||
17138887|NCT03529773|38280617|FG020|Overall Study|No longer meets eligibility criteria|0|||
17138888|NCT03529773|38280618|FG021|Overall Study|No longer meets eligibility criteria|0|||
17138889|NCT03529773|38280619|FG022|Overall Study|No longer meets eligibility criteria|1|||
17138890|NCT03529773|38280620|FG023|Overall Study|No longer meets eligibility criteria|0|||
17138891|NCT03529773|38280621|FG024|Overall Study|No longer meets eligibility criteria|0|||
17138892|NCT03529773|38280622|FG025|Overall Study|No longer meets eligibility criteria|0|||
17037794|NCT00395629|38181877|FG001|Core Study|Lost to Follow-up|0|||
17037795|NCT00395629|38181878|FG002|Core Study|Lost to Follow-up|1|||
17037796|NCT00395629|38181876|FG000|Extension Study|Adverse Event|0|||
17037797|NCT00395629|38181877|FG001|Extension Study|Adverse Event|0|||
17037798|NCT00395629|38181878|FG002|Extension Study|Adverse Event|2|||
17037799|NCT00395629|38181876|FG000|Extension Study|Administrative problems|0|||
17037800|NCT00395629|38181877|FG001|Extension Study|Administrative problems|0|||
17138893|NCT03529773|38280623|FG026|Overall Study|No longer meets eligibility criteria|0|||
17138894|NCT03529773|38280624|FG027|Overall Study|No longer meets eligibility criteria|0|||
17037801|NCT00395629|38181878|FG002|Extension Study|Administrative problems|1|||
17037802|NCT00392665|38181891|FG000|Overall Study|Death|16|||
17037803|NCT00392665|38181892|FG001|Overall Study|Death|14|||
17037804|NCT00392665|38181891|FG000|Overall Study|Lost to Follow-up|1|||
17037805|NCT00392665|38181892|FG001|Overall Study|Lost to Follow-up|1|||
17037806|NCT00622869|38181901|FG000|Overall Study|Subject Withdrew Consent|13|||
17037807|NCT00622869|38181902|FG001|Overall Study|Subject Withdrew Consent|17|||
17037808|NCT00622869|38181903|FG002|Overall Study|Subject Withdrew Consent|11|||
17037809|NCT00622869|38181901|FG000|Overall Study|Administrative Problems|11|||
17037810|NCT00622869|38181902|FG001|Overall Study|Administrative Problems|17|||
17037811|NCT00622869|38181903|FG002|Overall Study|Administrative Problems|13|||
17037812|NCT00622869|38181901|FG000|Overall Study|Death|12|||
17037813|NCT00622869|38181902|FG001|Overall Study|Death|15|||
17037814|NCT00622869|38181903|FG002|Overall Study|Death|10|||
17037815|NCT00622869|38181901|FG000|Overall Study|Lost to Follow-up|2|||
17037816|NCT00622869|38181902|FG001|Overall Study|Lost to Follow-up|4|||
17037817|NCT00622869|38181903|FG002|Overall Study|Lost to Follow-up|2|||
17037818|NCT00622869|38181901|FG000|Overall Study|Graft Loss|5|||
17037819|NCT00622869|38181902|FG001|Overall Study|Graft Loss|3|||
17037820|NCT00622869|38181903|FG002|Overall Study|Graft Loss|2|||
17037821|NCT00622869|38181901|FG000|Overall Study|Missing|0|||
17037822|NCT00622869|38181902|FG001|Overall Study|Missing|1|||
17037823|NCT00622869|38181903|FG002|Overall Study|Missing|1|||
17037824|NCT00395083|38181913|FG000|Overall Study|Withdrawal by Subject|6|||
17037825|NCT00395083|38181914|FG001|Overall Study|Withdrawal by Subject|5|||
17037826|NCT00395083|38181913|FG000|Overall Study|Developed another disease|4|||
17037827|NCT00395083|38181914|FG001|Overall Study|Developed another disease|3|||
17037828|NCT00366457|38181920|FG000|Overall Study|never began study therapy|2|||
17037829|NCT00624819|38181928|FG000|Follow-up Period: Year 4|Parents decision|0|||
17037830|NCT00624819|38181929|FG001|Follow-up Period: Year 4|Parents decision|0|||
17037831|NCT00624819|38181930|FG002|Follow-up Period: Year 4|Parents decision|1|||
17037832|NCT00624819|38181931|FG003|Follow-up Period: Year 4|Parents decision|0|||
17037833|NCT00624819|38181928|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
17037834|NCT00624819|38181929|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
17037835|NCT00624819|38181930|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
17037836|NCT00624819|38181931|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
17037837|NCT03832387|38181943|FG000|Overall Study|Protocol Violation|2|||
17037838|NCT03832387|38181944|FG001|Overall Study|Protocol Violation|6|||
17037839|NCT03832387|38181943|FG000|Overall Study|EXCLUSION CRITERIA|3|||
17037840|NCT03832387|38181944|FG001|Overall Study|EXCLUSION CRITERIA|1|||
17037841|NCT00366301|38181954|FG000|Overall Study|Lost to Follow-up|4|||
17037842|NCT00366301|38181955|FG001|Overall Study|Lost to Follow-up|4|||
17037843|NCT00366301|38181956|FG002|Overall Study|Lost to Follow-up|3|||
17037844|NCT00366301|38181957|FG003|Overall Study|Lost to Follow-up|7|||
17037845|NCT00366301|38181954|FG000|Overall Study|Withdrawal by Subject|4|||
17037846|NCT00366301|38181955|FG001|Overall Study|Withdrawal by Subject|2|||
17037847|NCT00366301|38181956|FG002|Overall Study|Withdrawal by Subject|1|||
17037848|NCT00366301|38181957|FG003|Overall Study|Withdrawal by Subject|1|||
17037849|NCT00365989|38181967|FG000|Overall Study|Withdrawal by Subject|1|||
17037850|NCT00365989|38181967|FG000|Overall Study|Non-compliance|1|||
17037851|NCT00622713|38181972|FG000|Overall Study|Adverse Event|35|||
17037852|NCT00622713|38181972|FG000|Overall Study|Administrative problems|4|||
17037853|NCT00622713|38181972|FG000|Overall Study|Withdrawal by Subject|11|||
17037854|NCT00622713|38181972|FG000|Overall Study|Lost to Follow-up|5|||
17037855|NCT00622713|38181972|FG000|Overall Study|Death|2|||
17037856|NCT00622713|38181972|FG000|Overall Study|Subject no longer required study drug|1|||
17037857|NCT00622713|38181972|FG000|Overall Study|Did not meet eligibility criteria|1|||
17037858|NCT00392197|38181978|FG000|Overall Study|Adverse Event|4|||
17037859|NCT00392197|38181979|FG001|Overall Study|Adverse Event|12|||
17037860|NCT00392197|38181978|FG000|Overall Study|Lack of Efficacy|3|||
17037861|NCT00392197|38181979|FG001|Overall Study|Lack of Efficacy|4|||
17037862|NCT00392197|38181978|FG000|Overall Study|Lost to Follow-up|0|||
17037863|NCT00392197|38181979|FG001|Overall Study|Lost to Follow-up|1|||
17037864|NCT00392197|38181978|FG000|Overall Study|Physician Decision|3|||
17037865|NCT00392197|38181979|FG001|Overall Study|Physician Decision|2|||
17037866|NCT00392197|38181978|FG000|Overall Study|Protocol Violation|7|||
17037867|NCT00392197|38181979|FG001|Overall Study|Protocol Violation|5|||
17037868|NCT00392197|38181978|FG000|Overall Study|Withdrawal by Subject|4|||
17037869|NCT00392197|38181979|FG001|Overall Study|Withdrawal by Subject|6|||
17037870|NCT00391807|38181985|FG000|Overall Study|Did not receive study medication|23|||
17037871|NCT00391807|38181985|FG000|Overall Study|Adverse Event|177|||
17037872|NCT00391807|38181985|FG000|Overall Study|Pregnancy|25|||
17138895|NCT03529773|38280625|FG028|Overall Study|No longer meets eligibility criteria|0|||
17138896|NCT03529773|38280626|FG029|Overall Study|No longer meets eligibility criteria|0|||
17138897|NCT03529773|38280627|FG030|Overall Study|No longer meets eligibility criteria|0|||
17138898|NCT03529773|38280628|FG031|Overall Study|No longer meets eligibility criteria|0|||
17138899|NCT03529773|38280629|FG032|Overall Study|No longer meets eligibility criteria|0|||
17138900|NCT03529773|38280630|FG033|Overall Study|No longer meets eligibility criteria|0|||
17138901|NCT03529773|38280631|FG034|Overall Study|No longer meets eligibility criteria|0|||
17138902|NCT03529773|38280632|FG035|Overall Study|No longer meets eligibility criteria|0|||
17138903|NCT03529773|38280633|FG036|Overall Study|No longer meets eligibility criteria|0|||
17037873|NCT00391807|38181985|FG000|Overall Study|Lost to Follow-up|227|||
17037874|NCT00391807|38181985|FG000|Overall Study|Withdrawal by Subject|147|||
17037875|NCT00391807|38181985|FG000|Overall Study|Protocol Violation|20|||
17037876|NCT00391807|38181985|FG000|Overall Study|Various|96|||
17037877|NCT00624585|38181989|FG000|Overall Study|Death|3|||
17037878|NCT00624585|38181989|FG000|Overall Study|Disease Progression|6|||
17037879|NCT00624585|38181989|FG000|Overall Study|Adverse Event|3|||
17037880|NCT00622635|38181993|FG000|Treatment Period 1|Adverse Event|0|||
17037881|NCT00622635|38181994|FG001|Treatment Period 1|Adverse Event|0|||
17037882|NCT00622635|38181995|FG002|Treatment Period 1|Adverse Event|1|||
17037883|NCT00622635|38181996|FG003|Treatment Period 1|Adverse Event|0|||
17037884|NCT00622635|38181997|FG004|Treatment Period 1|Adverse Event|0|||
17037885|NCT00622635|38181998|FG005|Treatment Period 1|Adverse Event|0|||
17037886|NCT00622635|38181993|FG000|Treatment Period 1|Withdrawal by Subject|0|||
17037887|NCT00622635|38181994|FG001|Treatment Period 1|Withdrawal by Subject|1|||
17037888|NCT00622635|38181995|FG002|Treatment Period 1|Withdrawal by Subject|0|||
17037889|NCT00622635|38181996|FG003|Treatment Period 1|Withdrawal by Subject|0|||
17037890|NCT00622635|38181997|FG004|Treatment Period 1|Withdrawal by Subject|0|||
17037891|NCT00622635|38181998|FG005|Treatment Period 1|Withdrawal by Subject|0|||
17037892|NCT00622635|38181993|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
17037893|NCT00622635|38181994|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
17037894|NCT00622635|38181995|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
17037895|NCT00622635|38181996|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
17037896|NCT00622635|38181997|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
17037897|NCT00622635|38181998|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
17037898|NCT00622635|38181993|FG000|Treatment Period 2|Adverse Event|1|||
17037899|NCT00622635|38181994|FG001|Treatment Period 2|Adverse Event|0|||
17037900|NCT00622635|38181995|FG002|Treatment Period 2|Adverse Event|0|||
17037901|NCT00622635|38181996|FG003|Treatment Period 2|Adverse Event|0|||
17037902|NCT00622635|38181997|FG004|Treatment Period 2|Adverse Event|0|||
17037903|NCT00622635|38181998|FG005|Treatment Period 2|Adverse Event|0|||
17037904|NCT00622635|38181993|FG000|Treatment Period 3|Adverse Event|0|||
17037905|NCT00622635|38181994|FG001|Treatment Period 3|Adverse Event|0|||
17037906|NCT00622635|38181995|FG002|Treatment Period 3|Adverse Event|0|||
17037907|NCT00622635|38181996|FG003|Treatment Period 3|Adverse Event|2|||
17037908|NCT00622635|38181997|FG004|Treatment Period 3|Adverse Event|0|||
17037909|NCT00622635|38181998|FG005|Treatment Period 3|Adverse Event|0|||
17037910|NCT00622635|38181993|FG000|Treatment Period 3|Withdrawal by Subject|0|||
17037911|NCT00622635|38181994|FG001|Treatment Period 3|Withdrawal by Subject|0|||
17037912|NCT00622635|38181995|FG002|Treatment Period 3|Withdrawal by Subject|0|||
17037913|NCT00622635|38181996|FG003|Treatment Period 3|Withdrawal by Subject|1|||
17037914|NCT00622635|38181997|FG004|Treatment Period 3|Withdrawal by Subject|0|||
17037915|NCT00622635|38181998|FG005|Treatment Period 3|Withdrawal by Subject|0|||
17037916|NCT00391027|38182008|FG000|Overall Study|Adverse Event|8|||
17037917|NCT00391027|38182009|FG001|Overall Study|Adverse Event|8|||
17037918|NCT00391027|38182008|FG000|Overall Study|Lack of Efficacy|3|||
17037919|NCT00391027|38182009|FG001|Overall Study|Lack of Efficacy|0|||
17037920|NCT00391027|38182008|FG000|Overall Study|Withdrawal by Subject|10|||
17037921|NCT00391027|38182009|FG001|Overall Study|Withdrawal by Subject|1|||
17037922|NCT00391027|38182008|FG000|Overall Study|Other|4|||
17037923|NCT00391027|38182009|FG001|Overall Study|Other|3|||
17037924|NCT00622401|38182018|FG000|Overall Study|Disease progression prior to treatment|3|||
17037925|NCT00622401|38182019|FG001|Overall Study|Disease progression prior to treatment|2|||
17037926|NCT00622401|38182020|FG002|Overall Study|Disease progression prior to treatment|0|||
17037927|NCT00621621|38182030|FG000|Overall Study|Subjects were exited at EP study|30|||
17037928|NCT00621621|38182031|FG001|Overall Study|Subjects were exited at EP study|0|||
17037929|NCT00621543|38182039|FG000|Overall Study|Lost to Follow-up|23|||
17037930|NCT00623805|38182045|FG000|Overall Study|Adverse Event|9|||
17037931|NCT00623805|38182046|FG001|Overall Study|Adverse Event|6|||
17037932|NCT00623805|38182045|FG000|Overall Study|Death|2|||
17037933|NCT00623805|38182046|FG001|Overall Study|Death|0|||
17037934|NCT00623805|38182045|FG000|Overall Study|Lack of Efficacy|3|||
17037935|NCT00623805|38182046|FG001|Overall Study|Lack of Efficacy|7|||
17138904|NCT03529773|38280634|FG037|Overall Study|No longer meets eligibility criteria|0|||
17138905|NCT03529773|38280635|FG038|Overall Study|No longer meets eligibility criteria|1|||
17138906|NCT03529773|38280636|FG039|Overall Study|No longer meets eligibility criteria|0|||
17138907|NCT03529773|38280597|FG000|Overall Study|Other|0|||
17138908|NCT03529773|38280598|FG001|Overall Study|Other|0|||
17138909|NCT03529773|38280599|FG002|Overall Study|Other|0|||
17138910|NCT03529773|38280600|FG003|Overall Study|Other|0|||
17138911|NCT03529773|38280601|FG004|Overall Study|Other|0|||
17037936|NCT00623805|38182045|FG000|Overall Study|Lost to Follow-up|2|||
17037937|NCT00623805|38182046|FG001|Overall Study|Lost to Follow-up|2|||
17037938|NCT00623805|38182045|FG000|Overall Study|Protocol Violation|1|||
17138912|NCT03529773|38280602|FG005|Overall Study|Other|0|||
17138913|NCT03529773|38280603|FG006|Overall Study|Other|0|||
17138914|NCT03529773|38280604|FG007|Overall Study|Other|0|||
17037939|NCT00623805|38182046|FG001|Overall Study|Protocol Violation|1|||
17037940|NCT00623805|38182045|FG000|Overall Study|Reason not Specified|3|||
17037941|NCT00623805|38182046|FG001|Overall Study|Reason not Specified|6|||
17037942|NCT00621309|38182052|FG000|Overall Study|Withdrawal by Subject|2|||
17037943|NCT00621309|38182053|FG001|Overall Study|Withdrawal by Subject|0|||
17037944|NCT00621309|38182054|FG002|Overall Study|Withdrawal by Subject|1|||
17037945|NCT00621309|38182055|FG003|Overall Study|Withdrawal by Subject|1|||
17037946|NCT00621309|38182056|FG004|Overall Study|Withdrawal by Subject|1|||
17037947|NCT00621309|38182057|FG005|Overall Study|Withdrawal by Subject|1|||
17037948|NCT00567190|38182065|FG000|Overall Study|Death|235|||
17037949|NCT00567190|38182066|FG001|Overall Study|Death|280|||
17037950|NCT00567190|38182065|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
17037951|NCT00567190|38182066|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
17037952|NCT00691938|38182084|FG000|Overall Study|QTc prolongation|1|||
17037953|NCT00691938|38182085|FG001|Overall Study|QTc prolongation|0|||
17037954|NCT00691938|38182086|FG002|Overall Study|QTc prolongation|0|||
17037955|NCT00691938|38182087|FG003|Overall Study|QTc prolongation|0|||
17037956|NCT00691938|38182088|FG004|Overall Study|QTc prolongation|0|||
17037957|NCT00691938|38182089|FG005|Overall Study|QTc prolongation|0|||
17037958|NCT00691938|38182090|FG006|Overall Study|QTc prolongation|0|||
17037959|NCT00365365|38182104|FG000|Overall Study|Randomized but not treated|0|||
17037960|NCT00365365|38182105|FG001|Overall Study|Randomized but not treated|2|||
17037961|NCT00365365|38182106|FG002|Overall Study|Randomized but not treated|0|||
17037962|NCT00365365|38182104|FG000|Overall Study|Poor compliance to protocol|0|||
17037963|NCT00365365|38182105|FG001|Overall Study|Poor compliance to protocol|1|||
17037964|NCT00365365|38182106|FG002|Overall Study|Poor compliance to protocol|0|||
17037965|NCT00365365|38182104|FG000|Overall Study|Lost to Follow-up|3|||
17037966|NCT00365365|38182105|FG001|Overall Study|Lost to Follow-up|3|||
17037967|NCT00365365|38182106|FG002|Overall Study|Lost to Follow-up|3|||
17037968|NCT00365365|38182104|FG000|Overall Study|Death|1|||
17037969|NCT00365365|38182105|FG001|Overall Study|Death|3|||
17037970|NCT00365365|38182106|FG002|Overall Study|Death|0|||
17037971|NCT00365365|38182104|FG000|Overall Study|Subject's request|11|||
17037972|NCT00365365|38182105|FG001|Overall Study|Subject's request|13|||
17037973|NCT00365365|38182106|FG002|Overall Study|Subject's request|1|||
17037974|NCT00365365|38182104|FG000|Overall Study|Disease progression/relapse|9|||
17037975|NCT00365365|38182105|FG001|Overall Study|Disease progression/relapse|6|||
17037976|NCT00365365|38182106|FG002|Overall Study|Disease progression/relapse|7|||
17037977|NCT00365365|38182104|FG000|Overall Study|Adverse Event|6|||
17037978|NCT00365365|38182105|FG001|Overall Study|Adverse Event|6|||
17037979|NCT00365365|38182106|FG002|Overall Study|Adverse Event|3|||
17037980|NCT00365365|38182104|FG000|Overall Study|Moved|2|||
17037981|NCT00365365|38182105|FG001|Overall Study|Moved|0|||
17037982|NCT00365365|38182106|FG002|Overall Study|Moved|0|||
17037983|NCT00365365|38182104|FG000|Overall Study|New cancer|1|||
17037984|NCT00365365|38182105|FG001|Overall Study|New cancer|0|||
17037985|NCT00365365|38182106|FG002|Overall Study|New cancer|0|||
17037986|NCT00365365|38182104|FG000|Overall Study|Withdrew consent|1|||
17037987|NCT00365365|38182105|FG001|Overall Study|Withdrew consent|1|||
17037988|NCT00365365|38182106|FG002|Overall Study|Withdrew consent|0|||
17037989|NCT00365365|38182104|FG000|Overall Study|Second malignancy|0|||
17037990|NCT00365365|38182105|FG001|Overall Study|Second malignancy|1|||
17037991|NCT00365365|38182106|FG002|Overall Study|Second malignancy|0|||
17037992|NCT00365365|38182104|FG000|Overall Study|Patient/physician decision|0|||
17037993|NCT00365365|38182105|FG001|Overall Study|Patient/physician decision|0|||
17037994|NCT00365365|38182106|FG002|Overall Study|Patient/physician decision|1|||
17037995|NCT00623727|38182116|FG000|Double Blind (DB)|Adverse Event|1|||
17037996|NCT00623727|38182117|FG001|Double Blind (DB)|Adverse Event|3|||
17037997|NCT00623727|38182116|FG000|Double Blind (DB)|Physician Decision|0|||
17037998|NCT00623727|38182117|FG001|Double Blind (DB)|Physician Decision|1|||
17037999|NCT00623727|38182116|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
17038000|NCT00623727|38182117|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
17038001|NCT00623727|38182116|FG000|Double Blind (DB)|Lack of Efficacy|2|||
17038002|NCT00623727|38182117|FG001|Double Blind (DB)|Lack of Efficacy|2|||
17038003|NCT00623727|38182116|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
17038004|NCT00623727|38182117|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
17038005|NCT00623727|38182116|FG000|Double Blind (DB)|Lost to Follow-up|1|||
17038006|NCT00623727|38182117|FG001|Double Blind (DB)|Lost to Follow-up|1|||
17038007|NCT00623727|38182116|FG000|Double Blind (DB)|Protocol Violation|2|||
17038008|NCT00623727|38182117|FG001|Double Blind (DB)|Protocol Violation|2|||
17038009|NCT00623727|38182116|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
17038010|NCT00623727|38182117|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
17038011|NCT00623727|38182116|FG000|Open Label Follow-up|Study termination|0|||
17038012|NCT00623727|38182117|FG001|Open Label Follow-up|Study termination|6|||
17038013|NCT00623727|38182116|FG000|Open Label Follow-up|Participant convenience|0|||
17038014|NCT00623727|38182117|FG001|Open Label Follow-up|Participant convenience|1|||
17038015|NCT00372775|38182125|FG000|Overall Study|Adverse Event|8|||
17038016|NCT00372775|38182125|FG000|Overall Study|Death|15|||
17038017|NCT00372775|38182125|FG000|Overall Study|Objective progression or relapse|30|||
17038018|NCT00372775|38182125|FG000|Overall Study|Global deterioration of health status|6|||
17038019|NCT00372775|38182125|FG000|Overall Study|Withdrawal by Subject|1|||
17038020|NCT00372775|38182125|FG000|Overall Study|Other|1|||
17038021|NCT00372775|38182125|FG000|Overall Study|Not Treated|2|||
17038022|NCT00372697|38182131|FG000|Overall Study|Protocol Violation|1|||
17038023|NCT00372697|38182132|FG001|Overall Study|Protocol Violation|1|||
17038024|NCT00566098|38182138|FG000|Collection of MILs|Withdrawal by Subject|1|||
17038025|NCT00566098|38182138|FG000|Collection of MILs|Relapsed|1|||
17038026|NCT00566098|38182138|FG000|Generation of MILs Product|Relapsed|1|||
17038027|NCT00566098|38182138|FG000|Administration of ASCT+MILs|Death|10|||
17038028|NCT00566098|38182138|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
17038029|NCT00690378|38182149|FG000|Overall Study|Adverse Event|1|||
17038030|NCT00690378|38182150|FG001|Overall Study|Adverse Event|0|||
17038031|NCT00690378|38182149|FG000|Overall Study|Withdrawal by Subject|2|||
17038032|NCT00690378|38182150|FG001|Overall Study|Withdrawal by Subject|0|||
17038033|NCT00690378|38182149|FG000|Overall Study|Protocol Violation|1|||
17038034|NCT00690378|38182150|FG001|Overall Study|Protocol Violation|0|||
17038035|NCT00690378|38182149|FG000|Overall Study|Lost to Follow-up|2|||
17038036|NCT00690378|38182150|FG001|Overall Study|Lost to Follow-up|3|||
17038037|NCT00690378|38182149|FG000|Overall Study|Did not meet inc/exc criteria|13|||
17038038|NCT00690378|38182150|FG001|Overall Study|Did not meet inc/exc criteria|11|||
17038039|NCT00690378|38182149|FG000|Overall Study|Social problem|1|||
17038040|NCT00690378|38182150|FG001|Overall Study|Social problem|0|||
17038041|NCT00574275|38182158|FG000|Overall Study|Randomized but not treated|2|||
17038042|NCT00574275|38182159|FG001|Overall Study|Randomized but not treated|3|||
17038043|NCT00574275|38182158|FG000|Overall Study|Adverse Event|32|||
17038044|NCT00574275|38182159|FG001|Overall Study|Adverse Event|76|||
17038045|NCT00574275|38182158|FG000|Overall Study|Disease progression|160|||
17038046|NCT00574275|38182159|FG001|Overall Study|Disease progression|146|||
17038047|NCT00574275|38182158|FG000|Overall Study|Lost to Follow-up|2|||
17038048|NCT00574275|38182159|FG001|Overall Study|Lost to Follow-up|1|||
17038049|NCT00574275|38182158|FG000|Overall Study|Study stopped based on DMC decision|62|||
17038050|NCT00574275|38182159|FG001|Overall Study|Study stopped based on DMC decision|23|||
17038051|NCT00574275|38182158|FG000|Overall Study|Withdrawal by Subject|15|||
17038052|NCT00574275|38182159|FG001|Overall Study|Withdrawal by Subject|17|||
17038053|NCT00574275|38182158|FG000|Overall Study|Error calculating tumor measurement|1|||
17038054|NCT00574275|38182159|FG001|Overall Study|Error calculating tumor measurement|0|||
17038055|NCT00574275|38182158|FG000|Overall Study|Physician Decision|1|||
17038056|NCT00574275|38182159|FG001|Overall Study|Physician Decision|1|||
17038057|NCT00574275|38182158|FG000|Overall Study|Protocol Violation|0|||
17038058|NCT00574275|38182159|FG001|Overall Study|Protocol Violation|1|||
17038059|NCT00574275|38182158|FG000|Overall Study|Patient and Investigator decision|0|||
17038060|NCT00574275|38182159|FG001|Overall Study|Patient and Investigator decision|1|||
17038061|NCT00574275|38182158|FG000|Overall Study|Insurance change|0|||
17038062|NCT00574275|38182159|FG001|Overall Study|Insurance change|1|||
17138915|NCT03529773|38280605|FG008|Overall Study|Other|0|||
17138916|NCT03529773|38280606|FG009|Overall Study|Other|0|||
17138917|NCT03529773|38280607|FG010|Overall Study|Other|0|||
17138918|NCT03529773|38280608|FG011|Overall Study|Other|0|||
17138919|NCT03529773|38280609|FG012|Overall Study|Other|1|||
17138920|NCT03529773|38280610|FG013|Overall Study|Other|0|||
17138921|NCT03529773|38280611|FG014|Overall Study|Other|2|||
17138922|NCT03529773|38280612|FG015|Overall Study|Other|0|||
17038063|NCT00574275|38182158|FG000|Overall Study|Operation for curative intent|0|||
17038064|NCT00574275|38182159|FG001|Overall Study|Operation for curative intent|1|||
17038065|NCT00567112|38182165|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
17038066|NCT00567112|38182166|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
17038067|NCT00567112|38182167|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
17138923|NCT03529773|38280613|FG016|Overall Study|Other|0|||
17138924|NCT03529773|38280614|FG017|Overall Study|Other|3|||
17138925|NCT03529773|38280615|FG018|Overall Study|Other|0|||
17138926|NCT03529773|38280616|FG019|Overall Study|Other|0|||
17138927|NCT03529773|38280617|FG020|Overall Study|Other|1|||
17138928|NCT03529773|38280618|FG021|Overall Study|Other|0|||
17138929|NCT03529773|38280619|FG022|Overall Study|Other|1|||
17138930|NCT03529773|38280620|FG023|Overall Study|Other|0|||
17138931|NCT03529773|38280621|FG024|Overall Study|Other|3|||
17138932|NCT03529773|38280622|FG025|Overall Study|Other|2|||
17138933|NCT03529773|38280623|FG026|Overall Study|Other|2|||
17138934|NCT03529773|38280624|FG027|Overall Study|Other|0|||
17138935|NCT03529773|38280625|FG028|Overall Study|Other|0|||
17138936|NCT03529773|38280626|FG029|Overall Study|Other|0|||
17138937|NCT03529773|38280627|FG030|Overall Study|Other|0|||
17138938|NCT03529773|38280628|FG031|Overall Study|Other|0|||
17138939|NCT03529773|38280629|FG032|Overall Study|Other|0|||
17138940|NCT03529773|38280630|FG033|Overall Study|Other|0|||
17138941|NCT03529773|38280631|FG034|Overall Study|Other|1|||
17138942|NCT03529773|38280632|FG035|Overall Study|Other|1|||
17138943|NCT03529773|38280633|FG036|Overall Study|Other|0|||
17138944|NCT03529773|38280634|FG037|Overall Study|Other|0|||
17138945|NCT03529773|38280635|FG038|Overall Study|Other|0|||
17138946|NCT03529773|38280636|FG039|Overall Study|Other|0|||
17138947|NCT03529773|38280597|FG000|Overall Study|Physician Decision|0|||
17138948|NCT03529773|38280598|FG001|Overall Study|Physician Decision|0|||
17138949|NCT03529773|38280599|FG002|Overall Study|Physician Decision|0|||
17138950|NCT03529773|38280600|FG003|Overall Study|Physician Decision|0|||
17138951|NCT03529773|38280601|FG004|Overall Study|Physician Decision|0|||
17138952|NCT03529773|38280602|FG005|Overall Study|Physician Decision|0|||
17138953|NCT03529773|38280603|FG006|Overall Study|Physician Decision|0|||
17138954|NCT03529773|38280604|FG007|Overall Study|Physician Decision|0|||
17138955|NCT03529773|38280605|FG008|Overall Study|Physician Decision|0|||
17138956|NCT03529773|38280606|FG009|Overall Study|Physician Decision|0|||
17138957|NCT03529773|38280607|FG010|Overall Study|Physician Decision|0|||
17138958|NCT03529773|38280608|FG011|Overall Study|Physician Decision|0|||
17138959|NCT03529773|38280609|FG012|Overall Study|Physician Decision|0|||
17138960|NCT03529773|38280610|FG013|Overall Study|Physician Decision|0|||
17138961|NCT03529773|38280611|FG014|Overall Study|Physician Decision|0|||
17138962|NCT03529773|38280612|FG015|Overall Study|Physician Decision|0|||
17138963|NCT03529773|38280613|FG016|Overall Study|Physician Decision|0|||
17138964|NCT03529773|38280614|FG017|Overall Study|Physician Decision|0|||
17138965|NCT03529773|38280615|FG018|Overall Study|Physician Decision|0|||
17038068|NCT00567112|38182165|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
17038069|NCT00567112|38182166|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
17038070|NCT00567112|38182167|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
17038071|NCT00567112|38182165|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
17038072|NCT00567112|38182166|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
17038073|NCT00567112|38182167|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
17038074|NCT01618656|38182187|FG000|Overall Study|Withdrawal by Subject|7|||
17038075|NCT01618656|38182188|FG001|Overall Study|Withdrawal by Subject|3|||
17038076|NCT01618656|38182187|FG000|Overall Study|Physician Decision|1|||
17038077|NCT01618656|38182188|FG001|Overall Study|Physician Decision|1|||
17038078|NCT03978832|38182194|FG000|Overall Study|Adverse Event|1|||
17038079|NCT03978832|38182194|FG000|Overall Study|Lost to Follow-up|1|||
17038080|NCT03978832|38182194|FG000|Overall Study|Withdrawal by Subject|6|||
17038081|NCT03978832|38182194|FG000|Overall Study|Physician Decision|2|||
17138966|NCT03529773|38280616|FG019|Overall Study|Physician Decision|1|||
17138967|NCT03529773|38280617|FG020|Overall Study|Physician Decision|1|||
17138968|NCT03529773|38280618|FG021|Overall Study|Physician Decision|0|||
17138969|NCT03529773|38280619|FG022|Overall Study|Physician Decision|0|||
17138970|NCT03529773|38280620|FG023|Overall Study|Physician Decision|0|||
17038082|NCT03978832|38182194|FG000|Overall Study|did not pass screening criteria|44|||
17038083|NCT00566722|38182201|FG000|Overall Study|Adverse Event|0|||
17038084|NCT00566722|38182202|FG001|Overall Study|Adverse Event|1|||
17038085|NCT00566722|38182203|FG002|Overall Study|Adverse Event|0|||
17038086|NCT00566722|38182201|FG000|Overall Study|Withdrawal by Subject|0|||
17038087|NCT00566722|38182202|FG001|Overall Study|Withdrawal by Subject|0|||
17038088|NCT00566722|38182203|FG002|Overall Study|Withdrawal by Subject|1|||
17038089|NCT00566722|38182201|FG000|Overall Study|Lost to Follow-up|1|||
17038090|NCT00566722|38182202|FG001|Overall Study|Lost to Follow-up|1|||
17038091|NCT00566722|38182203|FG002|Overall Study|Lost to Follow-up|1|||
17038092|NCT00566722|38182201|FG000|Overall Study|Lack of Efficacy|1|||
17038093|NCT00566722|38182202|FG001|Overall Study|Lack of Efficacy|2|||
17038094|NCT00566722|38182203|FG002|Overall Study|Lack of Efficacy|4|||
17038095|NCT00566722|38182201|FG000|Overall Study|Did not meet exclusion criteria|0|||
17038096|NCT00566722|38182202|FG001|Overall Study|Did not meet exclusion criteria|0|||
17038097|NCT00566722|38182203|FG002|Overall Study|Did not meet exclusion criteria|2|||
17038098|NCT00566722|38182201|FG000|Overall Study|Serious adverse event|0|||
17138971|NCT03529773|38280621|FG024|Overall Study|Physician Decision|0|||
17038099|NCT00566722|38182202|FG001|Overall Study|Serious adverse event|1|||
17038100|NCT00566722|38182203|FG002|Overall Study|Serious adverse event|0|||
17038101|NCT00566722|38182201|FG000|Overall Study|Noncompliant with drug administration|0|||
17038102|NCT00566722|38182202|FG001|Overall Study|Noncompliant with drug administration|0|||
17038103|NCT00566722|38182203|FG002|Overall Study|Noncompliant with drug administration|1|||
17038104|NCT00691704|38182214|FG000|Induction Therapy|Disease Progression|1|||
17038105|NCT00691704|38182214|FG000|Induction Therapy|Active Hepatitis|1|||
17038106|NCT00691704|38182214|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
17038107|NCT00691704|38182214|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
17038108|NCT00691704|38182214|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
17038109|NCT00566020|38182218|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
17038110|NCT00566020|38182219|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
17038111|NCT00566020|38182218|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
17038112|NCT00566020|38182219|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
17038113|NCT00566020|38182218|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
17038114|NCT00566020|38182219|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
17038115|NCT00566020|38182218|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
17038116|NCT00566020|38182219|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
17138972|NCT03529773|38280622|FG025|Overall Study|Physician Decision|0|||
17138973|NCT03529773|38280623|FG026|Overall Study|Physician Decision|0|||
17138974|NCT03529773|38280624|FG027|Overall Study|Physician Decision|0|||
17138975|NCT03529773|38280625|FG028|Overall Study|Physician Decision|0|||
17138976|NCT03529773|38280626|FG029|Overall Study|Physician Decision|0|||
17038117|NCT00566020|38182218|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
17038118|NCT00566020|38182219|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
17038119|NCT00566020|38182218|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
17038120|NCT00566020|38182219|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
17038121|NCT00564070|38182226|FG000|Overall Study|Lost to Follow-up|9|||
17038122|NCT00564070|38182227|FG001|Overall Study|Lost to Follow-up|7|||
17038123|NCT00564070|38182226|FG000|Overall Study|Worsening depression, referred to care|3|||
17038124|NCT00564070|38182227|FG001|Overall Study|Worsening depression, referred to care|0|||
17038125|NCT00690612|38182233|FG000|Overall Study|Adverse Event|1|||
17038126|NCT00690612|38182233|FG000|Overall Study|Withdrawal by Subject|2|||
17038127|NCT00621153|38182239|FG000|Overall Study|Safety Reason|8|||
17038128|NCT00621153|38182240|FG001|Overall Study|Safety Reason|7|||
17038129|NCT00621153|38182239|FG000|Overall Study|Adverse Event|3|||
17038130|NCT00621153|38182240|FG001|Overall Study|Adverse Event|2|||
17038131|NCT00621153|38182239|FG000|Overall Study|Lost to Follow-up|5|||
17038132|NCT00621153|38182240|FG001|Overall Study|Lost to Follow-up|1|||
17038133|NCT00621153|38182239|FG000|Overall Study|Withdrawal by Subject|4|||
17038134|NCT00621153|38182240|FG001|Overall Study|Withdrawal by Subject|5|||
17038135|NCT00574119|38182246|FG000|Overall Study|Adverse Event|1|||
17038136|NCT00574119|38182246|FG000|Overall Study|Protocol Violation|1|||
17038137|NCT00574119|38182246|FG000|Overall Study|Withdrawal by Subject|1|||
17038138|NCT00574119|38182246|FG000|Overall Study|Physician Decision|1|||
17038139|NCT00705614|38182252|FG000|Initial Intervention|Adverse Event|40|||
17038140|NCT00705614|38182253|FG001|Initial Intervention|Adverse Event|21|||
17038141|NCT00705614|38182252|FG000|Initial Intervention|Lost to Follow-up|310|||
17038142|NCT00705614|38182253|FG001|Initial Intervention|Lost to Follow-up|191|||
17038143|NCT00705614|38182252|FG000|Initial Intervention|Withdrawal by Subject|114|||
17038144|NCT00705614|38182253|FG001|Initial Intervention|Withdrawal by Subject|71|||
17038145|NCT00705614|38182252|FG000|Initial Intervention|Administrative Reason|51|||
17038146|NCT00705614|38182253|FG001|Initial Intervention|Administrative Reason|38|||
17038147|NCT00705614|38182252|FG000|Initial Intervention|Status completion unknown|3|||
17038148|NCT00705614|38182253|FG001|Initial Intervention|Status completion unknown|0|||
17038149|NCT00705614|38182252|FG000|Switch to Remicade|Adverse Event|0|||
17038150|NCT00705614|38182253|FG001|Switch to Remicade|Adverse Event|5|||
17038151|NCT00705614|38182252|FG000|Switch to Remicade|Lost to Follow-up|0|||
17038152|NCT00705614|38182253|FG001|Switch to Remicade|Lost to Follow-up|23|||
17038153|NCT00705614|38182252|FG000|Switch to Remicade|Withdrawal by Subject|0|||
17038154|NCT00705614|38182253|FG001|Switch to Remicade|Withdrawal by Subject|12|||
17038155|NCT00705614|38182252|FG000|Switch to Remicade|Administrative Reason|0|||
17038156|NCT00705614|38182253|FG001|Switch to Remicade|Administrative Reason|9|||
17038157|NCT00620763|38182261|FG000|Period: First Intervention|Withdrawal by Subject|0|||
17038158|NCT00620763|38182262|FG001|Period: First Intervention|Withdrawal by Subject|2|||
17038159|NCT00620763|38182261|FG000|Period: First Intervention|Protocol Violation|0|||
17038160|NCT00620763|38182262|FG001|Period: First Intervention|Protocol Violation|3|||
17038161|NCT00620763|38182261|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
17038162|NCT00620763|38182262|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
17038163|NCT00562978|38182270|FG000|Overall Study|Patient had imaging dose only|1|||
17038164|NCT00562978|38182271|FG001|Overall Study|Patient had imaging dose only|11|||
17038165|NCT00620373|38182277|FG000|Overall Study|Unverified cancer status|33|||
17038166|NCT00372619|38182291|FG000|Overall Study|Ineligible|0|||
17038167|NCT00372619|38182292|FG001|Overall Study|Ineligible|0|||
17038168|NCT00372619|38182293|FG002|Overall Study|Ineligible|0|||
17038169|NCT00372619|38182294|FG003|Overall Study|Ineligible|0|||
17038170|NCT00372619|38182295|FG004|Overall Study|Ineligible|0|||
17038171|NCT00372619|38182296|FG005|Overall Study|Ineligible|2|||
17038172|NCT00372619|38182297|FG006|Overall Study|Ineligible|0|||
17038173|NCT00372619|38182291|FG000|Overall Study|Inevaluable|0|||
17038174|NCT00372619|38182292|FG001|Overall Study|Inevaluable|0|||
17038175|NCT00372619|38182293|FG002|Overall Study|Inevaluable|0|||
17038176|NCT00372619|38182294|FG003|Overall Study|Inevaluable|0|||
17038177|NCT00372619|38182295|FG004|Overall Study|Inevaluable|0|||
17038178|NCT00372619|38182296|FG005|Overall Study|Inevaluable|1|||
17038179|NCT00372619|38182297|FG006|Overall Study|Inevaluable|0|||
17038180|NCT00562588|38182315|FG000|Overall Study|Adverse Event|40|||
17038181|NCT00562588|38182316|FG001|Overall Study|Adverse Event|58|||
17038182|NCT00562588|38182315|FG000|Overall Study|Protocol Violation|30|||
17038183|NCT00562588|38182316|FG001|Overall Study|Protocol Violation|26|||
17038184|NCT00562588|38182315|FG000|Overall Study|Lost to Follow-up|12|||
17038185|NCT00562588|38182316|FG001|Overall Study|Lost to Follow-up|4|||
17038186|NCT00562588|38182315|FG000|Overall Study|Withdrawal by Subject|10|||
17038187|NCT00562588|38182316|FG001|Overall Study|Withdrawal by Subject|9|||
17038188|NCT00562588|38182315|FG000|Overall Study|Other|0|||
17038189|NCT00562588|38182316|FG001|Overall Study|Other|2|||
17038190|NCT00622167|38182322|FG000|Overall Study|Did not meet angiographic criteria|20|||
17038191|NCT00562354|38182328|FG000|Overall Study|Physician Decision|0|||
17038192|NCT00562354|38182329|FG001|Overall Study|Physician Decision|1|||
17038193|NCT00562354|38182328|FG000|Overall Study|Lost to Follow-up|0|||
17038194|NCT00562354|38182329|FG001|Overall Study|Lost to Follow-up|1|||
17038195|NCT00372385|38182341|FG000|Overall Study|Adverse Event|6|||
17038196|NCT00372385|38182342|FG001|Overall Study|Adverse Event|11|||
17038197|NCT00372385|38182343|FG002|Overall Study|Adverse Event|9|||
17038198|NCT00372385|38182344|FG003|Overall Study|Adverse Event|7|||
17038199|NCT00372385|38182341|FG000|Overall Study|Noncompliance|0|||
17038200|NCT00372385|38182342|FG001|Overall Study|Noncompliance|1|||
17038201|NCT00372385|38182343|FG002|Overall Study|Noncompliance|1|||
17038202|NCT00372385|38182344|FG003|Overall Study|Noncompliance|1|||
17038203|NCT00372385|38182341|FG000|Overall Study|Physician Decision|1|||
17038204|NCT00372385|38182342|FG001|Overall Study|Physician Decision|0|||
17038205|NCT00372385|38182343|FG002|Overall Study|Physician Decision|0|||
17038206|NCT00372385|38182344|FG003|Overall Study|Physician Decision|0|||
17038207|NCT00372385|38182341|FG000|Overall Study|Lost to Follow-up|2|||
17038208|NCT00372385|38182342|FG001|Overall Study|Lost to Follow-up|0|||
17038209|NCT00372385|38182343|FG002|Overall Study|Lost to Follow-up|0|||
17038210|NCT00372385|38182344|FG003|Overall Study|Lost to Follow-up|0|||
17038211|NCT00372385|38182341|FG000|Overall Study|Withdrawal by Subject|2|||
17038212|NCT00372385|38182342|FG001|Overall Study|Withdrawal by Subject|1|||
17138977|NCT03529773|38280627|FG030|Overall Study|Physician Decision|0|||
17038213|NCT00372385|38182343|FG002|Overall Study|Withdrawal by Subject|0|||
17038214|NCT00372385|38182344|FG003|Overall Study|Withdrawal by Subject|0|||
17038215|NCT00372385|38182341|FG000|Overall Study|Refusal of Treatment|3|||
17038216|NCT00372385|38182342|FG001|Overall Study|Refusal of Treatment|6|||
17038217|NCT00372385|38182343|FG002|Overall Study|Refusal of Treatment|0|||
17038218|NCT00372385|38182344|FG003|Overall Study|Refusal of Treatment|0|||
17038219|NCT00372385|38182341|FG000|Overall Study|No Response|1|||
17038220|NCT00372385|38182342|FG001|Overall Study|No Response|1|||
17038221|NCT00372385|38182343|FG002|Overall Study|No Response|0|||
17038222|NCT00372385|38182344|FG003|Overall Study|No Response|0|||
17038223|NCT00372385|38182341|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
17038224|NCT00372385|38182342|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
17038225|NCT00372385|38182343|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
17038226|NCT00372385|38182344|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
17038227|NCT00372385|38182341|FG000|Overall Study|Virologic Stopping Rule|17|||
17038228|NCT00372385|38182342|FG001|Overall Study|Virologic Stopping Rule|0|||
17038229|NCT00372385|38182343|FG002|Overall Study|Virologic Stopping Rule|0|||
17038230|NCT00372385|38182344|FG003|Overall Study|Virologic Stopping Rule|0|||
17038231|NCT03830281|38182357|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
17038232|NCT03830281|38182358|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
17038233|NCT03830281|38182357|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
17038234|NCT03830281|38182358|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
17038235|NCT03830281|38182357|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
17038236|NCT03830281|38182358|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
17038237|NCT03830281|38182357|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
17038238|NCT03830281|38182358|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
17038239|NCT03830281|38182357|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
17038240|NCT03830281|38182358|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
17038241|NCT03830281|38182357|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
17038242|NCT03830281|38182358|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
17038243|NCT03830281|38182357|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
17038244|NCT03830281|38182358|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
17038245|NCT03830281|38182357|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
17038246|NCT03830281|38182358|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
17038247|NCT03830281|38182357|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
17038248|NCT03830281|38182358|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
17038249|NCT00563368|38182372|FG000|Overall Study|Lost to Follow-up|14|||
17038250|NCT00563368|38182373|FG001|Overall Study|Lost to Follow-up|14|||
17038251|NCT00563368|38182374|FG002|Overall Study|Lost to Follow-up|12|||
17038252|NCT00563368|38182375|FG003|Overall Study|Lost to Follow-up|6|||
17038253|NCT00563368|38182376|FG004|Overall Study|Lost to Follow-up|9|||
17038254|NCT00563368|38182377|FG005|Overall Study|Lost to Follow-up|8|||
17038255|NCT00563368|38182378|FG006|Overall Study|Lost to Follow-up|9|||
17038256|NCT00563368|38182372|FG000|Overall Study|Adverse Event|3|||
17038257|NCT00563368|38182373|FG001|Overall Study|Adverse Event|4|||
17038258|NCT00563368|38182374|FG002|Overall Study|Adverse Event|5|||
17038259|NCT00563368|38182375|FG003|Overall Study|Adverse Event|9|||
17038260|NCT00563368|38182376|FG004|Overall Study|Adverse Event|6|||
17038261|NCT00563368|38182377|FG005|Overall Study|Adverse Event|10|||
17038262|NCT00563368|38182378|FG006|Overall Study|Adverse Event|17|||
17038263|NCT00563368|38182372|FG000|Overall Study|Withdrawal by Subject|11|||
17038264|NCT00563368|38182373|FG001|Overall Study|Withdrawal by Subject|6|||
17038265|NCT00563368|38182374|FG002|Overall Study|Withdrawal by Subject|5|||
17038266|NCT00563368|38182375|FG003|Overall Study|Withdrawal by Subject|7|||
17038267|NCT00563368|38182376|FG004|Overall Study|Withdrawal by Subject|8|||
17038268|NCT00563368|38182377|FG005|Overall Study|Withdrawal by Subject|5|||
17038269|NCT00563368|38182378|FG006|Overall Study|Withdrawal by Subject|4|||
17038270|NCT00563368|38182372|FG000|Overall Study|protocol non-compliance|1|||
17038271|NCT00563368|38182373|FG001|Overall Study|protocol non-compliance|1|||
17138978|NCT03529773|38280628|FG031|Overall Study|Physician Decision|0|||
17038272|NCT00563368|38182374|FG002|Overall Study|protocol non-compliance|2|||
17038273|NCT00563368|38182375|FG003|Overall Study|protocol non-compliance|1|||
17038274|NCT00563368|38182376|FG004|Overall Study|protocol non-compliance|0|||
17038275|NCT00563368|38182377|FG005|Overall Study|protocol non-compliance|1|||
17038276|NCT00563368|38182378|FG006|Overall Study|protocol non-compliance|3|||
17038277|NCT00563368|38182372|FG000|Overall Study|Pregnancy|1|||
17038278|NCT00563368|38182373|FG001|Overall Study|Pregnancy|0|||
17038279|NCT00563368|38182374|FG002|Overall Study|Pregnancy|1|||
17038280|NCT00563368|38182375|FG003|Overall Study|Pregnancy|2|||
17038281|NCT00563368|38182376|FG004|Overall Study|Pregnancy|1|||
17038282|NCT00563368|38182377|FG005|Overall Study|Pregnancy|2|||
17038283|NCT00563368|38182378|FG006|Overall Study|Pregnancy|0|||
17038284|NCT00563368|38182372|FG000|Overall Study|requirement for restricted medication|0|||
17038285|NCT00563368|38182373|FG001|Overall Study|requirement for restricted medication|0|||
17038286|NCT00563368|38182374|FG002|Overall Study|requirement for restricted medication|2|||
17038287|NCT00563368|38182375|FG003|Overall Study|requirement for restricted medication|0|||
17038288|NCT00563368|38182376|FG004|Overall Study|requirement for restricted medication|0|||
17038289|NCT00563368|38182377|FG005|Overall Study|requirement for restricted medication|0|||
17038290|NCT00563368|38182378|FG006|Overall Study|requirement for restricted medication|0|||
17038291|NCT00563368|38182372|FG000|Overall Study|Other|5|||
17038292|NCT00563368|38182373|FG001|Overall Study|Other|5|||
17038293|NCT00563368|38182374|FG002|Overall Study|Other|3|||
17038294|NCT00563368|38182375|FG003|Overall Study|Other|4|||
17038295|NCT00563368|38182376|FG004|Overall Study|Other|4|||
17038296|NCT00563368|38182377|FG005|Overall Study|Other|4|||
17038297|NCT00563368|38182378|FG006|Overall Study|Other|0|||
17038298|NCT00390013|38182397|FG000|Phase 1|tired|0|||
17038299|NCT00390013|38182398|FG001|Phase 1|tired|0|||
17038300|NCT00390013|38182399|FG002|Phase 1|tired|0|||
17038301|NCT00390013|38182400|FG003|Phase 1|tired|1|||
17038302|NCT00390013|38182397|FG000|Phase 2 First Treatment|tired|1|||
17038303|NCT00390013|38182398|FG001|Phase 2 First Treatment|tired|0|||
17138979|NCT03529773|38280629|FG032|Overall Study|Physician Decision|0|||
17138980|NCT03529773|38280630|FG033|Overall Study|Physician Decision|0|||
17138981|NCT03529773|38280631|FG034|Overall Study|Physician Decision|0|||
17138982|NCT03529773|38280632|FG035|Overall Study|Physician Decision|0|||
17038304|NCT00390013|38182399|FG002|Phase 2 First Treatment|tired|0|||
17038305|NCT00390013|38182400|FG003|Phase 2 First Treatment|tired|0|||
17038306|NCT00390013|38182397|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
17038307|NCT00390013|38182398|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
17038308|NCT00390013|38182399|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
17038309|NCT00390013|38182400|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
17138983|NCT03529773|38280633|FG036|Overall Study|Physician Decision|0|||
17138984|NCT03529773|38280634|FG037|Overall Study|Physician Decision|0|||
17138985|NCT03529773|38280635|FG038|Overall Study|Physician Decision|0|||
17138986|NCT03529773|38280636|FG039|Overall Study|Physician Decision|0|||
17138987|NCT03529773|38280597|FG000|Overall Study|Protocol Violation|0|||
17138988|NCT03529773|38280598|FG001|Overall Study|Protocol Violation|0|||
17138989|NCT03529773|38280599|FG002|Overall Study|Protocol Violation|0|||
17138990|NCT03529773|38280600|FG003|Overall Study|Protocol Violation|0|||
17138991|NCT03529773|38280601|FG004|Overall Study|Protocol Violation|0|||
17138992|NCT03529773|38280602|FG005|Overall Study|Protocol Violation|0|||
17138993|NCT03529773|38280603|FG006|Overall Study|Protocol Violation|0|||
17138994|NCT03529773|38280604|FG007|Overall Study|Protocol Violation|0|||
17138995|NCT03529773|38280605|FG008|Overall Study|Protocol Violation|0|||
17138996|NCT03529773|38280606|FG009|Overall Study|Protocol Violation|0|||
17138997|NCT03529773|38280607|FG010|Overall Study|Protocol Violation|0|||
17138998|NCT03529773|38280608|FG011|Overall Study|Protocol Violation|0|||
17138999|NCT03529773|38280609|FG012|Overall Study|Protocol Violation|0|||
17139000|NCT03529773|38280610|FG013|Overall Study|Protocol Violation|0|||
17139001|NCT03529773|38280611|FG014|Overall Study|Protocol Violation|0|||
17139002|NCT03529773|38280612|FG015|Overall Study|Protocol Violation|0|||
17139003|NCT03529773|38280613|FG016|Overall Study|Protocol Violation|0|||
17139004|NCT03529773|38280614|FG017|Overall Study|Protocol Violation|0|||
17139005|NCT03529773|38280615|FG018|Overall Study|Protocol Violation|0|||
17038310|NCT00561652|38182408|FG000|Overall Study|Withdrawal by Subject|0|||
17038311|NCT00561652|38182409|FG001|Overall Study|Withdrawal by Subject|1|||
17038312|NCT00697346|38182418|FG000|Overall Study|Adverse Event|4|||
17139006|NCT03529773|38280616|FG019|Overall Study|Protocol Violation|0|||
17139007|NCT03529773|38280617|FG020|Overall Study|Protocol Violation|0|||
17139008|NCT03529773|38280618|FG021|Overall Study|Protocol Violation|0|||
17139009|NCT03529773|38280619|FG022|Overall Study|Protocol Violation|0|||
17038313|NCT00697346|38182419|FG001|Overall Study|Adverse Event|5|||
17038314|NCT00697346|38182420|FG002|Overall Study|Adverse Event|0|||
17038315|NCT00697346|38182418|FG000|Overall Study|Progressive Disease|19|||
17139010|NCT03529773|38280620|FG023|Overall Study|Protocol Violation|0|||
17139011|NCT03529773|38280621|FG024|Overall Study|Protocol Violation|0|||
17139012|NCT03529773|38280622|FG025|Overall Study|Protocol Violation|0|||
17139013|NCT03529773|38280623|FG026|Overall Study|Protocol Violation|0|||
17139014|NCT03529773|38280624|FG027|Overall Study|Protocol Violation|0|||
17139015|NCT03529773|38280625|FG028|Overall Study|Protocol Violation|0|||
17139016|NCT03529773|38280626|FG029|Overall Study|Protocol Violation|0|||
17139017|NCT03529773|38280627|FG030|Overall Study|Protocol Violation|1|||
17139018|NCT03529773|38280628|FG031|Overall Study|Protocol Violation|0|||
17139019|NCT03529773|38280629|FG032|Overall Study|Protocol Violation|0|||
17139020|NCT03529773|38280630|FG033|Overall Study|Protocol Violation|0|||
17139021|NCT03529773|38280631|FG034|Overall Study|Protocol Violation|0|||
17139022|NCT03529773|38280632|FG035|Overall Study|Protocol Violation|0|||
17139023|NCT03529773|38280633|FG036|Overall Study|Protocol Violation|0|||
17139024|NCT03529773|38280634|FG037|Overall Study|Protocol Violation|0|||
17139025|NCT03529773|38280635|FG038|Overall Study|Protocol Violation|0|||
17139026|NCT03529773|38280636|FG039|Overall Study|Protocol Violation|0|||
17139027|NCT03529773|38280597|FG000|Overall Study|Withdrawal by Subject|0|||
17139028|NCT03529773|38280598|FG001|Overall Study|Withdrawal by Subject|0|||
17139029|NCT03529773|38280599|FG002|Overall Study|Withdrawal by Subject|0|||
17139030|NCT03529773|38280600|FG003|Overall Study|Withdrawal by Subject|0|||
17139031|NCT03529773|38280601|FG004|Overall Study|Withdrawal by Subject|0|||
17139032|NCT03529773|38280602|FG005|Overall Study|Withdrawal by Subject|0|||
17139033|NCT03529773|38280603|FG006|Overall Study|Withdrawal by Subject|0|||
17139034|NCT03529773|38280604|FG007|Overall Study|Withdrawal by Subject|1|||
17139035|NCT03529773|38280605|FG008|Overall Study|Withdrawal by Subject|0|||
17139036|NCT03529773|38280606|FG009|Overall Study|Withdrawal by Subject|1|||
17139037|NCT03529773|38280607|FG010|Overall Study|Withdrawal by Subject|1|||
17038316|NCT00697346|38182419|FG001|Overall Study|Progressive Disease|18|||
17038317|NCT00697346|38182420|FG002|Overall Study|Progressive Disease|0|||
17038318|NCT00697346|38182418|FG000|Overall Study|Symptomatic Deterioration|0|||
17038319|NCT00697346|38182419|FG001|Overall Study|Symptomatic Deterioration|1|||
17038320|NCT00697346|38182420|FG002|Overall Study|Symptomatic Deterioration|0|||
17038321|NCT00697346|38182418|FG000|Overall Study|Withdrawal by Subject|2|||
17038322|NCT00697346|38182419|FG001|Overall Study|Withdrawal by Subject|2|||
17038323|NCT00697346|38182420|FG002|Overall Study|Withdrawal by Subject|0|||
17038324|NCT00697346|38182418|FG000|Overall Study|Reason not Specified|3|||
17038325|NCT00697346|38182419|FG001|Overall Study|Reason not Specified|0|||
17038326|NCT00697346|38182420|FG002|Overall Study|Reason not Specified|1|||
17038327|NCT00562120|38182447|FG000|First Intervention Period|Adverse Event|1|||
17038328|NCT00562120|38182448|FG001|First Intervention Period|Adverse Event|0|||
17038329|NCT00562120|38182449|FG002|First Intervention Period|Adverse Event|0|||
17038330|NCT00562120|38182450|FG003|First Intervention Period|Adverse Event|0|||
17038331|NCT00562120|38182447|FG000|First Intervention Period|Randomized but not Treated|1|||
17038332|NCT00562120|38182448|FG001|First Intervention Period|Randomized but not Treated|0|||
17038333|NCT00562120|38182449|FG002|First Intervention Period|Randomized but not Treated|0|||
17139038|NCT03529773|38280608|FG011|Overall Study|Withdrawal by Subject|0|||
17139039|NCT03529773|38280609|FG012|Overall Study|Withdrawal by Subject|0|||
17139040|NCT03529773|38280610|FG013|Overall Study|Withdrawal by Subject|0|||
17139041|NCT03529773|38280611|FG014|Overall Study|Withdrawal by Subject|0|||
17139042|NCT03529773|38280612|FG015|Overall Study|Withdrawal by Subject|3|||
17139043|NCT03529773|38280613|FG016|Overall Study|Withdrawal by Subject|0|||
17139044|NCT03529773|38280614|FG017|Overall Study|Withdrawal by Subject|2|||
17139045|NCT03529773|38280615|FG018|Overall Study|Withdrawal by Subject|3|||
17139046|NCT03529773|38280616|FG019|Overall Study|Withdrawal by Subject|1|||
17038334|NCT00562120|38182450|FG003|First Intervention Period|Randomized but not Treated|0|||
17038335|NCT00561730|38182460|FG000|Overall Study|Adverse Event|2|||
17038336|NCT00561730|38182460|FG000|Overall Study|Handling of the drug|1|||
17038337|NCT00561730|38182460|FG000|Overall Study|Lost to Follow-up|5|||
17038338|NCT00561730|38182460|FG000|Overall Study|Not specified reasons|1|||
17038339|NCT00697112|38182466|FG000|Overall Study|Adverse Event|8|||
17139047|NCT03529773|38280617|FG020|Overall Study|Withdrawal by Subject|3|||
17139048|NCT03529773|38280618|FG021|Overall Study|Withdrawal by Subject|1|||
17139049|NCT03529773|38280619|FG022|Overall Study|Withdrawal by Subject|1|||
17139050|NCT03529773|38280620|FG023|Overall Study|Withdrawal by Subject|2|||
17139051|NCT03529773|38280621|FG024|Overall Study|Withdrawal by Subject|2|||
17139052|NCT03529773|38280622|FG025|Overall Study|Withdrawal by Subject|4|||
17139053|NCT03529773|38280623|FG026|Overall Study|Withdrawal by Subject|2|||
17139054|NCT03529773|38280624|FG027|Overall Study|Withdrawal by Subject|1|||
17139055|NCT03529773|38280625|FG028|Overall Study|Withdrawal by Subject|1|||
17139056|NCT03529773|38280626|FG029|Overall Study|Withdrawal by Subject|0|||
17139057|NCT03529773|38280627|FG030|Overall Study|Withdrawal by Subject|0|||
17139058|NCT03529773|38280628|FG031|Overall Study|Withdrawal by Subject|0|||
17139059|NCT03529773|38280629|FG032|Overall Study|Withdrawal by Subject|0|||
17139060|NCT03529773|38280630|FG033|Overall Study|Withdrawal by Subject|0|||
17139061|NCT03529773|38280631|FG034|Overall Study|Withdrawal by Subject|1|||
17139062|NCT03529773|38280632|FG035|Overall Study|Withdrawal by Subject|2|||
17038340|NCT00697112|38182466|FG000|Overall Study|Lost to Follow-up|1|||
17038341|NCT00697112|38182466|FG000|Overall Study|Did not meet inclusion criteria|1|||
17038342|NCT00621855|38182475|FG000|Overall Study|Adverse Event|32|||
17038343|NCT00621855|38182476|FG001|Overall Study|Adverse Event|31|||
17038344|NCT00621855|38182477|FG002|Overall Study|Adverse Event|48|||
17038345|NCT00621855|38182478|FG003|Overall Study|Adverse Event|34|||
17038346|NCT00621855|38182479|FG004|Overall Study|Adverse Event|31|||
17038347|NCT00621855|38182475|FG000|Overall Study|Lost to Follow-up|0|||
17038348|NCT00621855|38182476|FG001|Overall Study|Lost to Follow-up|1|||
17038349|NCT00621855|38182477|FG002|Overall Study|Lost to Follow-up|3|||
17038350|NCT00621855|38182478|FG003|Overall Study|Lost to Follow-up|4|||
17038351|NCT00621855|38182479|FG004|Overall Study|Lost to Follow-up|1|||
17038352|NCT00621855|38182475|FG000|Overall Study|Protocol Violation|16|||
17038353|NCT00621855|38182476|FG001|Overall Study|Protocol Violation|8|||
17038354|NCT00621855|38182477|FG002|Overall Study|Protocol Violation|6|||
17038355|NCT00621855|38182478|FG003|Overall Study|Protocol Violation|7|||
17038356|NCT00621855|38182479|FG004|Overall Study|Protocol Violation|8|||
17038357|NCT00621855|38182475|FG000|Overall Study|Withdrawal by Subject|16|||
17038358|NCT00621855|38182476|FG001|Overall Study|Withdrawal by Subject|11|||
17038359|NCT00621855|38182477|FG002|Overall Study|Withdrawal by Subject|13|||
17038360|NCT00621855|38182478|FG003|Overall Study|Withdrawal by Subject|13|||
17038361|NCT00621855|38182479|FG004|Overall Study|Withdrawal by Subject|9|||
17038362|NCT00621855|38182475|FG000|Overall Study|Other|9|||
17038363|NCT00621855|38182476|FG001|Overall Study|Other|7|||
17038364|NCT00621855|38182477|FG002|Overall Study|Other|6|||
17038365|NCT00621855|38182478|FG003|Overall Study|Other|5|||
17139063|NCT03529773|38280633|FG036|Overall Study|Withdrawal by Subject|0|||
17139064|NCT03529773|38280634|FG037|Overall Study|Withdrawal by Subject|2|||
17139065|NCT03529773|38280635|FG038|Overall Study|Withdrawal by Subject|1|||
17139066|NCT03529773|38280636|FG039|Overall Study|Withdrawal by Subject|1|||
17139067|NCT03529773|38280597|FG000|Overall Study|Screen Failure|0|||
17139068|NCT03529773|38280598|FG001|Overall Study|Screen Failure|0|||
17139069|NCT03529773|38280599|FG002|Overall Study|Screen Failure|0|||
17139070|NCT03529773|38280600|FG003|Overall Study|Screen Failure|0|||
17139071|NCT03529773|38280601|FG004|Overall Study|Screen Failure|0|||
17139072|NCT03529773|38280602|FG005|Overall Study|Screen Failure|0|||
17139073|NCT03529773|38280603|FG006|Overall Study|Screen Failure|0|||
17139074|NCT03529773|38280604|FG007|Overall Study|Screen Failure|0|||
17139075|NCT03529773|38280605|FG008|Overall Study|Screen Failure|0|||
17139076|NCT03529773|38280606|FG009|Overall Study|Screen Failure|0|||
17139077|NCT03529773|38280607|FG010|Overall Study|Screen Failure|0|||
17139078|NCT03529773|38280608|FG011|Overall Study|Screen Failure|0|||
17139079|NCT03529773|38280609|FG012|Overall Study|Screen Failure|0|||
17139080|NCT03529773|38280610|FG013|Overall Study|Screen Failure|0|||
17139081|NCT03529773|38280611|FG014|Overall Study|Screen Failure|0|||
17139082|NCT03529773|38280612|FG015|Overall Study|Screen Failure|0|||
17139083|NCT03529773|38280613|FG016|Overall Study|Screen Failure|0|||
17139084|NCT03529773|38280614|FG017|Overall Study|Screen Failure|0|||
17139085|NCT03529773|38280615|FG018|Overall Study|Screen Failure|0|||
17139086|NCT03529773|38280616|FG019|Overall Study|Screen Failure|0|||
17139087|NCT03529773|38280617|FG020|Overall Study|Screen Failure|0|||
17139088|NCT03529773|38280618|FG021|Overall Study|Screen Failure|0|||
17139089|NCT03529773|38280619|FG022|Overall Study|Screen Failure|0|||
17139090|NCT03529773|38280620|FG023|Overall Study|Screen Failure|0|||
17139091|NCT03529773|38280621|FG024|Overall Study|Screen Failure|0|||
17139092|NCT03529773|38280622|FG025|Overall Study|Screen Failure|0|||
17139093|NCT03529773|38280623|FG026|Overall Study|Screen Failure|0|||
17139094|NCT03529773|38280624|FG027|Overall Study|Screen Failure|0|||
17139095|NCT03529773|38280625|FG028|Overall Study|Screen Failure|0|||
17038366|NCT00621855|38182479|FG004|Overall Study|Other|4|||
17038367|NCT00621855|38182475|FG000|Overall Study|Patients did not receive study drug|3|||
17038368|NCT00621855|38182476|FG001|Overall Study|Patients did not receive study drug|3|||
17038369|NCT00621855|38182477|FG002|Overall Study|Patients did not receive study drug|5|||
17038370|NCT00621855|38182478|FG003|Overall Study|Patients did not receive study drug|4|||
17038371|NCT00621855|38182479|FG004|Overall Study|Patients did not receive study drug|2|||
17038372|NCT04222088|38182493|FG000|Overall Study|Lost to Follow-up|5|||
17038373|NCT04222088|38182494|FG001|Overall Study|Lost to Follow-up|1|||
17038374|NCT04222088|38182493|FG000|Overall Study|Withdrawal by Subject|4|||
17038375|NCT04222088|38182494|FG001|Overall Study|Withdrawal by Subject|0|||
17038376|NCT00561574|38182502|FG000|Overall Study|Adverse Event|21|||
17038377|NCT00561574|38182503|FG001|Overall Study|Adverse Event|24|||
17139096|NCT03529773|38280626|FG029|Overall Study|Screen Failure|0|||
17139097|NCT03529773|38280627|FG030|Overall Study|Screen Failure|0|||
17139098|NCT03529773|38280628|FG031|Overall Study|Screen Failure|0|||
17139099|NCT03529773|38280629|FG032|Overall Study|Screen Failure|0|||
17139100|NCT03529773|38280630|FG033|Overall Study|Screen Failure|0|||
17139101|NCT03529773|38280631|FG034|Overall Study|Screen Failure|0|||
17038378|NCT00561574|38182502|FG000|Overall Study|Lack of Efficacy|11|||
17038379|NCT00561574|38182503|FG001|Overall Study|Lack of Efficacy|21|||
17038380|NCT00561574|38182502|FG000|Overall Study|Withdrawal by Subject|4|||
17038381|NCT00561574|38182503|FG001|Overall Study|Withdrawal by Subject|4|||
17139102|NCT03529773|38280632|FG035|Overall Study|Screen Failure|0|||
17139103|NCT03529773|38280633|FG036|Overall Study|Screen Failure|1|||
17139104|NCT03529773|38280634|FG037|Overall Study|Screen Failure|1|||
17139105|NCT03529773|38280635|FG038|Overall Study|Screen Failure|0|||
17139106|NCT03529773|38280636|FG039|Overall Study|Screen Failure|1|||
17139107|NCT03529773|38280597|FG000|Overall Study|Randomized but not vaccinated|0|||
17139108|NCT03529773|38280598|FG001|Overall Study|Randomized but not vaccinated|0|||
17139109|NCT03529773|38280599|FG002|Overall Study|Randomized but not vaccinated|0|||
17038382|NCT00561574|38182502|FG000|Overall Study|Reason Unrelated to Trial|6|||
17038383|NCT00561574|38182503|FG001|Overall Study|Reason Unrelated to Trial|2|||
17038384|NCT00561574|38182502|FG000|Overall Study|Lost to Follow-up|1|||
17038385|NCT00561574|38182503|FG001|Overall Study|Lost to Follow-up|0|||
17038386|NCT00561574|38182502|FG000|Overall Study|Other|5|||
17038387|NCT00561574|38182503|FG001|Overall Study|Other|7|||
17038388|NCT00619827|38182511|FG000|Overall Study|Adverse Event|1|||
17038389|NCT00619827|38182512|FG001|Overall Study|Adverse Event|2|||
17038390|NCT00619827|38182511|FG000|Overall Study|Withdrawal by Subject|2|||
17038391|NCT00619827|38182512|FG001|Overall Study|Withdrawal by Subject|2|||
17038392|NCT00687804|38182521|FG000|Core Study|Adverse Event|5|||
17038393|NCT00687804|38182522|FG001|Core Study|Adverse Event|3|||
17038394|NCT00687804|38182523|FG002|Core Study|Adverse Event|3|||
17038395|NCT00687804|38182521|FG000|Core Study|Abnormal laboratory value(s)|1|||
17038396|NCT00687804|38182522|FG001|Core Study|Abnormal laboratory value(s)|0|||
17038397|NCT00687804|38182523|FG002|Core Study|Abnormal laboratory value(s)|0|||
17038398|NCT00687804|38182521|FG000|Core Study|Lack of Efficacy|1|||
17038399|NCT00687804|38182522|FG001|Core Study|Lack of Efficacy|1|||
17038400|NCT00687804|38182523|FG002|Core Study|Lack of Efficacy|1|||
17038401|NCT00687804|38182521|FG000|Core Study|Withdrawal by Subject|4|||
17038402|NCT00687804|38182522|FG001|Core Study|Withdrawal by Subject|7|||
17038403|NCT00687804|38182523|FG002|Core Study|Withdrawal by Subject|7|||
17038404|NCT00687804|38182521|FG000|Core Study|Lost to Follow-up|0|||
17038405|NCT00687804|38182522|FG001|Core Study|Lost to Follow-up|1|||
17038406|NCT00687804|38182523|FG002|Core Study|Lost to Follow-up|0|||
17038407|NCT00687804|38182521|FG000|Core Study|Death|2|||
17038408|NCT00687804|38182522|FG001|Core Study|Death|2|||
17038409|NCT00687804|38182523|FG002|Core Study|Death|2|||
17038410|NCT00687804|38182521|FG000|Core Study|Protocol Violation|1|||
17038411|NCT00687804|38182522|FG001|Core Study|Protocol Violation|1|||
17038412|NCT00687804|38182523|FG002|Core Study|Protocol Violation|0|||
17038413|NCT00687804|38182521|FG000|Open-Label Extension Study|Adverse Event|2|||
17038414|NCT00687804|38182522|FG001|Open-Label Extension Study|Adverse Event|2|||
17038415|NCT00687804|38182523|FG002|Open-Label Extension Study|Adverse Event|2|||
17038416|NCT00687804|38182521|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
17038417|NCT00687804|38182522|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
17038418|NCT00687804|38182523|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
17038419|NCT00687804|38182521|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
17038420|NCT00687804|38182522|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
17038421|NCT00687804|38182523|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
17038422|NCT00687804|38182521|FG000|Open-Label Extension Study|Administrative problems|1|||
17038423|NCT00687804|38182522|FG001|Open-Label Extension Study|Administrative problems|1|||
17038424|NCT00687804|38182523|FG002|Open-Label Extension Study|Administrative problems|0|||
17038425|NCT00687804|38182521|FG000|Open-Label Extension Study|Death|2|||
17038426|NCT00687804|38182522|FG001|Open-Label Extension Study|Death|3|||
17038427|NCT00687804|38182523|FG002|Open-Label Extension Study|Death|3|||
17038428|NCT00689052|38182550|FG000|Overall Study|Adverse Event|4|||
17038429|NCT00689052|38182551|FG001|Overall Study|Adverse Event|6|||
17038430|NCT00689052|38182550|FG000|Overall Study|Protocol Violation|1|||
17038431|NCT00689052|38182551|FG001|Overall Study|Protocol Violation|0|||
17038432|NCT00689052|38182550|FG000|Overall Study|Lost to Follow-up|2|||
17038433|NCT00689052|38182551|FG001|Overall Study|Lost to Follow-up|0|||
17038434|NCT00689052|38182550|FG000|Overall Study|Withdrawal by Subject|2|||
17038435|NCT00689052|38182551|FG001|Overall Study|Withdrawal by Subject|0|||
17038436|NCT00689052|38182550|FG000|Overall Study|Early termination of the trial|22|||
17038437|NCT00689052|38182551|FG001|Overall Study|Early termination of the trial|24|||
17038438|NCT00560950|38182561|FG000|Overall Study|Lost to Follow-up|1|||
17038439|NCT00560950|38182562|FG001|Overall Study|Lost to Follow-up|0|||
17038440|NCT00576758|38182572|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
17038441|NCT00576758|38182573|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
17038442|NCT00576758|38182572|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
17038443|NCT00576758|38182573|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
17038444|NCT00576758|38182572|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
17038445|NCT00576758|38182573|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
17038446|NCT00576758|38182572|FG000|Induction Treatment Period|Death|1|||
17038447|NCT00576758|38182573|FG001|Induction Treatment Period|Death|0|||
17038448|NCT00576758|38182572|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
17038449|NCT00576758|38182573|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
17038450|NCT00576758|38182572|FG000|Induction Treatment Period|Withdrew consent|1|||
17038451|NCT00576758|38182573|FG001|Induction Treatment Period|Withdrew consent|0|||
17038452|NCT00576758|38182572|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
17038453|NCT00576758|38182573|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
17038454|NCT00576758|38182572|FG000|Extension Treatment Period|Death|1|||
17038455|NCT00576758|38182573|FG001|Extension Treatment Period|Death|1|||
17038456|NCT00576758|38182572|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
17038457|NCT00576758|38182573|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
17038458|NCT00576758|38182572|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
17038459|NCT00576758|38182573|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
17038460|NCT00576758|38182572|FG000|Extension Treatment Period|Administrative/Other|3|||
17038461|NCT00576758|38182573|FG001|Extension Treatment Period|Administrative/Other|1|||
17038462|NCT00576758|38182572|FG000|Follow-up Period|Administrative/Other|6|||
17038463|NCT00576758|38182573|FG001|Follow-up Period|Administrative/Other|8|||
17038464|NCT00576758|38182572|FG000|Follow-up Period|Death|3|||
17038465|NCT00576758|38182573|FG001|Follow-up Period|Death|3|||
17038466|NCT00576758|38182572|FG000|Follow-up Period|Insufficient therapeutic response|16|||
17038467|NCT00576758|38182573|FG001|Follow-up Period|Insufficient therapeutic response|5|||
17038468|NCT00576758|38182572|FG000|Follow-up Period|Withdrew consent|2|||
17038469|NCT00576758|38182573|FG001|Follow-up Period|Withdrew consent|1|||
17038470|NCT00560794|38182580|FG000|Overall Study|Adverse Event|2|||
17038471|NCT00560794|38182580|FG000|Overall Study|Patient was not Compliant|1|||
17038472|NCT00560794|38182580|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
17038473|NCT00560794|38182580|FG000|Overall Study|Hematological Relapse|1|||
17038474|NCT00560794|38182580|FG000|Overall Study|Received Bone Marrow Transplant|6|||
17038475|NCT00619359|38182588|FG000|Overall Study|Adverse Event|32|||
17038476|NCT00619359|38182589|FG001|Overall Study|Adverse Event|36|||
17038477|NCT00619359|38182588|FG000|Overall Study|Lost to Follow-up|12|||
17038478|NCT00619359|38182589|FG001|Overall Study|Lost to Follow-up|16|||
17038479|NCT00619359|38182588|FG000|Overall Study|Physician Decision|0|||
17038480|NCT00619359|38182589|FG001|Overall Study|Physician Decision|7|||
17038481|NCT00619359|38182588|FG000|Overall Study|Protocol Violation|1|||
17038482|NCT00619359|38182589|FG001|Overall Study|Protocol Violation|1|||
17038483|NCT00619359|38182588|FG000|Overall Study|Withdrawal by Subject|19|||
17038484|NCT00619359|38182589|FG001|Overall Study|Withdrawal by Subject|20|||
17038485|NCT00619359|38182588|FG000|Overall Study|Progressive Disease|3|||
17038486|NCT00619359|38182589|FG001|Overall Study|Progressive Disease|1|||
17038487|NCT00372229|38182597|FG000|Study Phase|Graft loss|0|||
16991950|NCT04026165|38135901|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
16991951|NCT04026165|38135902|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
16991952|NCT04026165|38135903|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
16991953|NCT04026165|38135900|FG000|Run-in SEL Period|Run-in Failure|0|||
16991954|NCT04026165|38135901|FG001|Run-in SEL Period|Run-in Failure|26|||
16991955|NCT04026165|38135902|FG002|Run-in SEL Period|Run-in Failure|0|||
16991956|NCT04026165|38135903|FG003|Run-in SEL Period|Run-in Failure|0|||
17038488|NCT00372229|38182598|FG001|Study Phase|Graft loss|3|||
17038489|NCT00372229|38182597|FG000|Study Phase|Protocol Violation|3|||
17038490|NCT00372229|38182598|FG001|Study Phase|Protocol Violation|4|||
17038491|NCT00372229|38182597|FG000|Study Phase|Consent withdrawn|16|||
17038492|NCT00372229|38182598|FG001|Study Phase|Consent withdrawn|14|||
17038493|NCT00372229|38182597|FG000|Study Phase|Refused treatment/did not cooperate|3|||
17038494|NCT00372229|38182598|FG001|Study Phase|Refused treatment/did not cooperate|1|||
17038495|NCT00372229|38182597|FG000|Study Phase|Death|3|||
17038496|NCT00372229|38182598|FG001|Study Phase|Death|2|||
17038497|NCT00372229|38182597|FG000|Study Phase|Reason not specified|3|||
17038498|NCT00372229|38182598|FG001|Study Phase|Reason not specified|2|||
17038499|NCT00372229|38182597|FG000|Study Phase|Lost to Follow-up|3|||
17038500|NCT00372229|38182598|FG001|Study Phase|Lost to Follow-up|3|||
17038501|NCT00372229|38182597|FG000|Follow-Up Phase|Graft loss|8|||
17038502|NCT00372229|38182598|FG001|Follow-Up Phase|Graft loss|7|||
17038503|NCT00372229|38182597|FG000|Follow-Up Phase|Consent withdrawn|13|||
17038504|NCT00372229|38182598|FG001|Follow-Up Phase|Consent withdrawn|19|||
17038505|NCT00372229|38182597|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
17038506|NCT00372229|38182598|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
17038507|NCT00372229|38182597|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
17038508|NCT00372229|38182598|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
17038509|NCT00372229|38182597|FG000|Follow-Up Phase|Death|9|||
17038510|NCT00372229|38182598|FG001|Follow-Up Phase|Death|12|||
17038511|NCT00372229|38182597|FG000|Follow-Up Phase|Administrative|1|||
17038512|NCT00372229|38182598|FG001|Follow-Up Phase|Administrative|0|||
17038513|NCT00372229|38182597|FG000|Follow-Up Phase|Reason not specified|2|||
17038514|NCT00372229|38182598|FG001|Follow-Up Phase|Reason not specified|3|||
17038515|NCT00372229|38182597|FG000|Follow-Up Phase|Lost to Follow-up|12|||
17038516|NCT00372229|38182598|FG001|Follow-Up Phase|Lost to Follow-up|10|||
17038517|NCT00698828|38182611|FG000|Overall Study|Adverse Event|3|||
17038518|NCT00698828|38182612|FG001|Overall Study|Adverse Event|4|||
17038519|NCT00698828|38182613|FG002|Overall Study|Adverse Event|4|||
17038520|NCT00698828|38182611|FG000|Overall Study|Death|0|||
17038521|NCT00698828|38182612|FG001|Overall Study|Death|0|||
17038522|NCT00698828|38182613|FG002|Overall Study|Death|1|||
17038523|NCT00698828|38182611|FG000|Overall Study|Exacerbation of COPD|1|||
17038524|NCT00698828|38182612|FG001|Overall Study|Exacerbation of COPD|3|||
17038525|NCT00698828|38182613|FG002|Overall Study|Exacerbation of COPD|0|||
17038526|NCT00698828|38182611|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
17038527|NCT00698828|38182612|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
17038528|NCT00698828|38182613|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
17038529|NCT00698828|38182611|FG000|Overall Study|Investigator/Sponsor decision|1|||
17038530|NCT00698828|38182612|FG001|Overall Study|Investigator/Sponsor decision|0|||
17038531|NCT00698828|38182613|FG002|Overall Study|Investigator/Sponsor decision|2|||
17038532|NCT00698828|38182611|FG000|Overall Study|Lost to Follow-up|1|||
17038533|NCT00698828|38182612|FG001|Overall Study|Lost to Follow-up|1|||
17038534|NCT00698828|38182613|FG002|Overall Study|Lost to Follow-up|0|||
17038535|NCT00698828|38182611|FG000|Overall Study|Withdrew consent|0|||
17038536|NCT00698828|38182612|FG001|Overall Study|Withdrew consent|7|||
17038537|NCT00698828|38182613|FG002|Overall Study|Withdrew consent|4|||
17038538|NCT00698828|38182611|FG000|Overall Study|Withdrew consent (not treated)|2|||
17038539|NCT00698828|38182612|FG001|Overall Study|Withdrew consent (not treated)|0|||
17038540|NCT00698828|38182613|FG002|Overall Study|Withdrew consent (not treated)|0|||
17038541|NCT00619515|38182621|FG000|Overall Study|Study Termination by IRB|73|||
17038542|NCT03167606|38182627|FG000|Overall Study|Lost to Follow-up|73|||
17038543|NCT03167606|38182628|FG001|Overall Study|Lost to Follow-up|64|||
17038544|NCT03167606|38182627|FG000|Overall Study|Withdrawal by Subject|6|||
17038545|NCT03167606|38182628|FG001|Overall Study|Withdrawal by Subject|5|||
17038546|NCT03167606|38182627|FG000|Overall Study|Withdrawal by Investigator|0|||
17038547|NCT03167606|38182628|FG001|Overall Study|Withdrawal by Investigator|2|||
17038548|NCT00688740|38182636|FG000|Overall Study|Adverse Event|45|||
17038549|NCT00688740|38182637|FG001|Overall Study|Adverse Event|8|||
17038550|NCT00688740|38182636|FG000|Overall Study|Death|2|||
17038551|NCT00688740|38182637|FG001|Overall Study|Death|2|||
17038552|NCT00688740|38182636|FG000|Overall Study|Lost to Follow-up|0|||
17038553|NCT00688740|38182637|FG001|Overall Study|Lost to Follow-up|1|||
17038554|NCT00688740|38182636|FG000|Overall Study|Consent Withdrawn|17|||
17038555|NCT00688740|38182637|FG001|Overall Study|Consent Withdrawn|17|||
17038556|NCT00688740|38182636|FG000|Overall Study|Breast Cancer Relapse|1|||
17038557|NCT00688740|38182637|FG001|Overall Study|Breast Cancer Relapse|4|||
17038558|NCT00688740|38182636|FG000|Overall Study|Violation of Inclusion Criteria|1|||
17038559|NCT00688740|38182637|FG001|Overall Study|Violation of Inclusion Criteria|3|||
17038560|NCT00552760|38182645|FG000|Overall Study|Adverse Event|3|||
17038561|NCT00552760|38182646|FG001|Overall Study|Adverse Event|5|||
17038562|NCT00552760|38182645|FG000|Overall Study|Relapsed- Depressed Event|10|||
17038563|NCT00552760|38182646|FG001|Overall Study|Relapsed- Depressed Event|16|||
17038564|NCT00552760|38182645|FG000|Overall Study|Relapse- Manic Event|3|||
16991957|NCT04026165|38135900|FG000|Run-in SEL Period|Withdrew Consent|0|||
16991958|NCT04026165|38135901|FG001|Run-in SEL Period|Withdrew Consent|10|||
16991959|NCT04026165|38135902|FG002|Run-in SEL Period|Withdrew Consent|0|||
16991960|NCT04026165|38135903|FG003|Run-in SEL Period|Withdrew Consent|0|||
16991961|NCT04026165|38135900|FG000|Run-in SEL Period|Enrollment Error|0|||
16991962|NCT04026165|38135901|FG001|Run-in SEL Period|Enrollment Error|4|||
16991963|NCT04026165|38135902|FG002|Run-in SEL Period|Enrollment Error|0|||
16991964|NCT04026165|38135903|FG003|Run-in SEL Period|Enrollment Error|0|||
16991965|NCT04026165|38135900|FG000|Run-in SEL Period|Protocol Violation|0|||
16991966|NCT04026165|38135901|FG001|Run-in SEL Period|Protocol Violation|3|||
16991967|NCT04026165|38135902|FG002|Run-in SEL Period|Protocol Violation|0|||
16991968|NCT04026165|38135903|FG003|Run-in SEL Period|Protocol Violation|0|||
16991969|NCT04026165|38135900|FG000|Run-in SEL Period|Investigator's Discretion|0|||
16991970|NCT04026165|38135901|FG001|Run-in SEL Period|Investigator's Discretion|2|||
16991971|NCT04026165|38135902|FG002|Run-in SEL Period|Investigator's Discretion|0|||
16991972|NCT04026165|38135903|FG003|Run-in SEL Period|Investigator's Discretion|0|||
16991973|NCT04026165|38135900|FG000|Run-in SEL Period|Death|0|||
16991974|NCT04026165|38135901|FG001|Run-in SEL Period|Death|1|||
16991975|NCT04026165|38135902|FG002|Run-in SEL Period|Death|0|||
16991976|NCT04026165|38135903|FG003|Run-in SEL Period|Death|0|||
16991977|NCT04026165|38135900|FG000|Randomized Period|Withdrew Consent|0|||
16991978|NCT04026165|38135901|FG001|Randomized Period|Withdrew Consent|0|||
16991979|NCT04026165|38135902|FG002|Randomized Period|Withdrew Consent|5|||
16991980|NCT04026165|38135903|FG003|Randomized Period|Withdrew Consent|8|||
16991981|NCT04026165|38135900|FG000|Randomized Period|Death|0|||
16991982|NCT04026165|38135901|FG001|Randomized Period|Death|0|||
16991983|NCT04026165|38135902|FG002|Randomized Period|Death|5|||
16991984|NCT04026165|38135903|FG003|Randomized Period|Death|7|||
16991985|NCT04026165|38135900|FG000|Randomized Period|Investigator's Discretion|0|||
16991986|NCT04026165|38135901|FG001|Randomized Period|Investigator's Discretion|0|||
16991987|NCT04026165|38135902|FG002|Randomized Period|Investigator's Discretion|2|||
16991988|NCT04026165|38135903|FG003|Randomized Period|Investigator's Discretion|2|||
16991989|NCT04026165|38135900|FG000|Randomized Period|Lost to Follow-up|0|||
17038565|NCT00552760|38182646|FG001|Overall Study|Relapse- Manic Event|3|||
17038566|NCT00552760|38182645|FG000|Overall Study|Relapsed- Mixed Event|3|||
17038567|NCT00552760|38182646|FG001|Overall Study|Relapsed- Mixed Event|5|||
17038568|NCT00552760|38182645|FG000|Overall Study|Protocol Violation|0|||
16991990|NCT04026165|38135901|FG001|Randomized Period|Lost to Follow-up|0|||
16991991|NCT04026165|38135902|FG002|Randomized Period|Lost to Follow-up|2|||
17038569|NCT00552760|38182646|FG001|Overall Study|Protocol Violation|1|||
17038570|NCT00552760|38182645|FG000|Overall Study|Lost to Follow-up|1|||
17038571|NCT00552760|38182646|FG001|Overall Study|Lost to Follow-up|1|||
17038572|NCT00552760|38182645|FG000|Overall Study|Non-compliance|1|||
17038573|NCT00552760|38182646|FG001|Overall Study|Non-compliance|1|||
17038574|NCT00552760|38182645|FG000|Overall Study|Medical Condition|1|||
17038575|NCT00552760|38182646|FG001|Overall Study|Medical Condition|1|||
17038576|NCT00552760|38182645|FG000|Overall Study|Withdrawal by Subject|3|||
17038577|NCT00552760|38182646|FG001|Overall Study|Withdrawal by Subject|0|||
17038578|NCT00552760|38182645|FG000|Overall Study|Medication Change|1|||
17038579|NCT00552760|38182646|FG001|Overall Study|Medication Change|0|||
17038580|NCT00686790|38182652|FG000|Overall Study|Adverse Event|2|||
17038581|NCT00686790|38182652|FG000|Overall Study|Withdrawal by Subject|1|||
17038582|NCT00686790|38182652|FG000|Overall Study|Death|1|||
17038583|NCT00686790|38182652|FG000|Overall Study|Lost to Follow-up|12|||
17038584|NCT00686712|38182659|FG000|Overall Study|Protocol Violation|8|||
17038585|NCT00686712|38182660|FG001|Overall Study|Protocol Violation|8|||
17038586|NCT00686712|38182661|FG002|Overall Study|Protocol Violation|10|||
17038587|NCT00686712|38182659|FG000|Overall Study|Lost to Follow-up|1|||
17038588|NCT00686712|38182660|FG001|Overall Study|Lost to Follow-up|2|||
17038589|NCT00686712|38182661|FG002|Overall Study|Lost to Follow-up|3|||
17139110|NCT03529773|38280600|FG003|Overall Study|Randomized but not vaccinated|0|||
17139111|NCT03529773|38280601|FG004|Overall Study|Randomized but not vaccinated|0|||
17139112|NCT03529773|38280602|FG005|Overall Study|Randomized but not vaccinated|0|||
17139113|NCT03529773|38280603|FG006|Overall Study|Randomized but not vaccinated|0|||
17139114|NCT03529773|38280604|FG007|Overall Study|Randomized but not vaccinated|0|||
17139115|NCT03529773|38280605|FG008|Overall Study|Randomized but not vaccinated|0|||
17139116|NCT03529773|38280606|FG009|Overall Study|Randomized but not vaccinated|0|||
17139117|NCT03529773|38280607|FG010|Overall Study|Randomized but not vaccinated|0|||
17139118|NCT03529773|38280608|FG011|Overall Study|Randomized but not vaccinated|0|||
17139119|NCT03529773|38280609|FG012|Overall Study|Randomized but not vaccinated|0|||
17139120|NCT03529773|38280610|FG013|Overall Study|Randomized but not vaccinated|0|||
17139121|NCT03529773|38280611|FG014|Overall Study|Randomized but not vaccinated|0|||
17139122|NCT03529773|38280612|FG015|Overall Study|Randomized but not vaccinated|0|||
17139123|NCT03529773|38280613|FG016|Overall Study|Randomized but not vaccinated|0|||
17038590|NCT00686712|38182659|FG000|Overall Study|Adverse Event|1|||
17038591|NCT00686712|38182660|FG001|Overall Study|Adverse Event|1|||
17038592|NCT00686712|38182661|FG002|Overall Study|Adverse Event|0|||
17038593|NCT00686634|38182672|FG000|Overall Study|Protocol Violation|6|||
17038594|NCT00560404|38182679|FG000|Overall Study|Adverse Event|2|||
17038595|NCT00560404|38182680|FG001|Overall Study|Adverse Event|3|||
17038596|NCT00560404|38182679|FG000|Overall Study|Death|3|||
17038597|NCT00560404|38182680|FG001|Overall Study|Death|3|||
17038598|NCT00560404|38182679|FG000|Overall Study|Protocol Violation|12|||
17038599|NCT00560404|38182680|FG001|Overall Study|Protocol Violation|7|||
17038600|NCT00560404|38182679|FG000|Overall Study|Administrative Reasons|1|||
17038601|NCT00560404|38182680|FG001|Overall Study|Administrative Reasons|1|||
17038602|NCT00560404|38182679|FG000|Overall Study|Withdrew Consent|4|||
17038603|NCT00560404|38182680|FG001|Overall Study|Withdrew Consent|0|||
17038604|NCT00560404|38182679|FG000|Overall Study|Failure to return|1|||
17038605|NCT00560404|38182680|FG001|Overall Study|Failure to return|2|||
17038606|NCT00560404|38182679|FG000|Overall Study|Other withdrawal reason|13|||
17038607|NCT00560404|38182680|FG001|Overall Study|Other withdrawal reason|5|||
17038608|NCT03967444|38182688|FG000|Overall Study|Lost to Follow-up|1|||
17038609|NCT03967444|38182689|FG001|Overall Study|Lost to Follow-up|2|||
17038610|NCT00619983|38182699|FG000|Test Drug Alone|Withdrawal by Subject|1|||
17038611|NCT00619983|38182700|FG001|Test Drug Alone|Withdrawal by Subject|0|||
17038612|NCT00619983|38182701|FG002|Test Drug Alone|Withdrawal by Subject|0|||
17038613|NCT00619983|38182702|FG003|Test Drug Alone|Withdrawal by Subject|1|||
17038614|NCT00619983|38182699|FG000|Test Drug Alone|Failure of daily diary device|1|||
17038615|NCT00619983|38182700|FG001|Test Drug Alone|Failure of daily diary device|1|||
17038616|NCT00619983|38182701|FG002|Test Drug Alone|Failure of daily diary device|2|||
17038617|NCT00619983|38182702|FG003|Test Drug Alone|Failure of daily diary device|2|||
17038618|NCT00576420|38182715|FG000|Overall Study|Death|0|||
17038619|NCT00576420|38182716|FG001|Overall Study|Death|0|||
17038620|NCT00576420|38182717|FG002|Overall Study|Death|1|||
17038621|NCT03961204|38182766|FG000|Overall Study|Withdrawal by Subject|2|||
17038622|NCT03961204|38182766|FG000|Overall Study|Lost to Follow-up|3|||
17038623|NCT03961204|38182766|FG000|Overall Study|Other|1|||
17038624|NCT03961204|38182766|FG000|Overall Study|Missing|1|||
17038625|NCT00364351|38182772|FG000|Overall Study|Adverse Event|90|||
17038626|NCT00364351|38182773|FG001|Overall Study|Adverse Event|44|||
17038627|NCT00364351|38182772|FG000|Overall Study|Condition under investigation worsened|469|||
17038628|NCT00364351|38182773|FG001|Overall Study|Condition under investigation worsened|497|||
17038629|NCT00364351|38182772|FG000|Overall Study|Prohibited concomitant medication|0|||
17038630|NCT00364351|38182773|FG001|Overall Study|Prohibited concomitant medication|2|||
17038631|NCT00364351|38182772|FG000|Overall Study|Lost to Follow-up|1|||
17038632|NCT00364351|38182773|FG001|Overall Study|Lost to Follow-up|1|||
17038633|NCT00364351|38182772|FG000|Overall Study|Withdrawal by Subject|30|||
17038634|NCT00364351|38182773|FG001|Overall Study|Withdrawal by Subject|29|||
17038635|NCT00364351|38182772|FG000|Overall Study|Incorrect enrollment|1|||
17139124|NCT03529773|38280614|FG017|Overall Study|Randomized but not vaccinated|1|||
17139125|NCT03529773|38280615|FG018|Overall Study|Randomized but not vaccinated|0|||
17139126|NCT03529773|38280616|FG019|Overall Study|Randomized but not vaccinated|0|||
17139127|NCT03529773|38280617|FG020|Overall Study|Randomized but not vaccinated|0|||
17139128|NCT03529773|38280618|FG021|Overall Study|Randomized but not vaccinated|0|||
17038636|NCT00364351|38182773|FG001|Overall Study|Incorrect enrollment|1|||
17038637|NCT00364351|38182772|FG000|Overall Study|Sponsor decision|1|||
17038638|NCT00364351|38182773|FG001|Overall Study|Sponsor decision|0|||
17038639|NCT00364351|38182772|FG000|Overall Study|Poor treatment compliance|0|||
17038640|NCT00364351|38182773|FG001|Overall Study|Poor treatment compliance|3|||
17038641|NCT00364351|38182772|FG000|Overall Study|Investigator error|0|||
17038642|NCT00364351|38182773|FG001|Overall Study|Investigator error|2|||
17038643|NCT00364351|38182772|FG000|Overall Study|Patient could not travel to site|0|||
17038644|NCT00364351|38182773|FG001|Overall Study|Patient could not travel to site|1|||
17038645|NCT00364351|38182772|FG000|Overall Study|Randomised treatment not started|0|||
17038646|NCT00364351|38182773|FG001|Overall Study|Randomised treatment not started|3|||
17038647|NCT00388297|38182783|FG000|Overall Study|Lost to Follow-up|16|||
17038648|NCT00388297|38182784|FG001|Overall Study|Lost to Follow-up|12|||
17038649|NCT00388297|38182785|FG002|Overall Study|Lost to Follow-up|11|||
17038650|NCT00388297|38182786|FG003|Overall Study|Lost to Follow-up|8|||
17038651|NCT00686166|38182796|FG000|Overall Study|Adverse Event|7|||
17038652|NCT00686166|38182796|FG000|Overall Study|Withdrawal by Subject|1|||
17038653|NCT00686166|38182796|FG000|Overall Study|Progression/Relapse|1|||
17038654|NCT00686166|38182796|FG000|Overall Study|Death|1|||
17038655|NCT00686166|38182796|FG000|Overall Study|Not Protocol Specified|1|||
17038656|NCT00686166|38182796|FG000|Overall Study|Ineligible|5|||
17038657|NCT00686166|38182796|FG000|Overall Study|Did not begin protocol therapy|4|||
17038658|NCT00363649|38182807|FG000|Overall Study|Withdrawal by Subject|1|||
17038659|NCT00363649|38182808|FG001|Overall Study|Withdrawal by Subject|1|||
17038660|NCT00363649|38182807|FG000|Overall Study|Adverse Event|6|||
17038661|NCT00363649|38182808|FG001|Overall Study|Adverse Event|0|||
17038662|NCT00684060|38182816|FG000|Overall Study|Lost to Follow-up|1|||
17038663|NCT00684060|38182817|FG001|Overall Study|Lost to Follow-up|0|||
17038664|NCT00684060|38182816|FG000|Overall Study|New stenosis identified|1|||
17038665|NCT00684060|38182817|FG001|Overall Study|New stenosis identified|0|||
17038666|NCT00684060|38182816|FG000|Overall Study|Unable to collect MRI|1|||
17038667|NCT00684060|38182817|FG001|Overall Study|Unable to collect MRI|2|||
17038668|NCT00684060|38182816|FG000|Overall Study|Death|0|||
17038669|NCT00684060|38182817|FG001|Overall Study|Death|1|||
17038670|NCT03131648|38182825|FG000|Initial Treatment Period|Not dosed|2|||
17038671|NCT03131648|38182826|FG001|Initial Treatment Period|Not dosed|2|||
17038672|NCT03131648|38182827|FG002|Initial Treatment Period|Not dosed|0|||
17038673|NCT03131648|38182828|FG003|Initial Treatment Period|Not dosed|0|||
17038674|NCT03131648|38182829|FG004|Initial Treatment Period|Not dosed|0|||
17038675|NCT03131648|38182830|FG005|Initial Treatment Period|Not dosed|0|||
17038676|NCT03131648|38182831|FG006|Initial Treatment Period|Not dosed|0|||
17038677|NCT03131648|38182832|FG007|Initial Treatment Period|Not dosed|0|||
17038678|NCT03131648|38182825|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
17038679|NCT03131648|38182826|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
17038680|NCT03131648|38182827|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17038681|NCT03131648|38182828|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17038682|NCT03131648|38182829|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17038683|NCT03131648|38182830|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17038684|NCT03131648|38182831|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17038685|NCT03131648|38182832|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17038686|NCT03131648|38182825|FG000|Open-label Treatment|Discontinued IMP|0|||
17038687|NCT03131648|38182826|FG001|Open-label Treatment|Discontinued IMP|0|||
17038688|NCT03131648|38182827|FG002|Open-label Treatment|Discontinued IMP|0|||
17038689|NCT03131648|38182828|FG003|Open-label Treatment|Discontinued IMP|0|||
17038690|NCT03131648|38182829|FG004|Open-label Treatment|Discontinued IMP|0|||
17038691|NCT03131648|38182830|FG005|Open-label Treatment|Discontinued IMP|0|||
17038692|NCT03131648|38182831|FG006|Open-label Treatment|Discontinued IMP|112|||
17038693|NCT03131648|38182832|FG007|Open-label Treatment|Discontinued IMP|0|||
17038694|NCT03131648|38182825|FG000|Open-label Treatment|Completed Week 50|0|||
17038695|NCT03131648|38182826|FG001|Open-label Treatment|Completed Week 50|0|||
17038696|NCT03131648|38182827|FG002|Open-label Treatment|Completed Week 50|0|||
17038697|NCT03131648|38182828|FG003|Open-label Treatment|Completed Week 50|0|||
17038698|NCT03131648|38182829|FG004|Open-label Treatment|Completed Week 50|0|||
17038699|NCT03131648|38182830|FG005|Open-label Treatment|Completed Week 50|0|||
17038700|NCT03131648|38182831|FG006|Open-label Treatment|Completed Week 50|6|||
17038701|NCT03131648|38182832|FG007|Open-label Treatment|Completed Week 50|0|||
17038702|NCT03131648|38182825|FG000|Maintenance Treatment Period|Not dosed|0|||
17038703|NCT03131648|38182826|FG001|Maintenance Treatment Period|Not dosed|0|||
17038704|NCT03131648|38182827|FG002|Maintenance Treatment Period|Not dosed|3|||
17038705|NCT03131648|38182828|FG003|Maintenance Treatment Period|Not dosed|2|||
17038706|NCT03131648|38182829|FG004|Maintenance Treatment Period|Not dosed|1|||
17038707|NCT03131648|38182830|FG005|Maintenance Treatment Period|Not dosed|0|||
17038708|NCT03131648|38182831|FG006|Maintenance Treatment Period|Not dosed|0|||
17038709|NCT03131648|38182832|FG007|Maintenance Treatment Period|Not dosed|0|||
17038710|NCT03131648|38182825|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
17038711|NCT03131648|38182826|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
17139129|NCT03529773|38280619|FG022|Overall Study|Randomized but not vaccinated|0|||
17139130|NCT03529773|38280620|FG023|Overall Study|Randomized but not vaccinated|0|||
17139131|NCT03529773|38280621|FG024|Overall Study|Randomized but not vaccinated|0|||
17139132|NCT03529773|38280622|FG025|Overall Study|Randomized but not vaccinated|0|||
17139133|NCT03529773|38280623|FG026|Overall Study|Randomized but not vaccinated|0|||
17038712|NCT03131648|38182827|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
17038713|NCT03131648|38182828|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
17038714|NCT03131648|38182829|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
17139134|NCT03529773|38280624|FG027|Overall Study|Randomized but not vaccinated|1|||
17139135|NCT03529773|38280625|FG028|Overall Study|Randomized but not vaccinated|0|||
17139136|NCT03529773|38280626|FG029|Overall Study|Randomized but not vaccinated|0|||
17038715|NCT03131648|38182830|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
17038716|NCT03131648|38182831|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
17038717|NCT03131648|38182832|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
17038718|NCT03131648|38182825|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
17038719|NCT03131648|38182826|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
17038720|NCT03131648|38182827|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
17038721|NCT03131648|38182828|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
17038722|NCT03131648|38182829|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
17038723|NCT03131648|38182830|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
17038724|NCT03131648|38182831|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
17038725|NCT03131648|38182832|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
17038726|NCT03131648|38182825|FG000|Maintenance Treatment Period|Completed Week 50|0|||
17038727|NCT03131648|38182826|FG001|Maintenance Treatment Period|Completed Week 50|0|||
17038728|NCT03131648|38182827|FG002|Maintenance Treatment Period|Completed Week 50|0|||
17038729|NCT03131648|38182828|FG003|Maintenance Treatment Period|Completed Week 50|0|||
17038730|NCT03131648|38182829|FG004|Maintenance Treatment Period|Completed Week 50|1|||
17038731|NCT03131648|38182830|FG005|Maintenance Treatment Period|Completed Week 50|0|||
17038732|NCT03131648|38182831|FG006|Maintenance Treatment Period|Completed Week 50|0|||
17038733|NCT03131648|38182832|FG007|Maintenance Treatment Period|Completed Week 50|0|||
17038734|NCT03131648|38182825|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
17038735|NCT03131648|38182826|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
17038736|NCT03131648|38182827|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
17038737|NCT03131648|38182828|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
17038738|NCT03131648|38182829|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
17038739|NCT03131648|38182830|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
17038740|NCT03131648|38182831|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
17038741|NCT03131648|38182832|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
17038742|NCT00618813|38182849|FG000|Overall Study|Lack of Efficacy|1|||
17038743|NCT00618813|38182849|FG000|Overall Study|Physician Decision|2|||
17038744|NCT00618813|38182849|FG000|Overall Study|Withdrawal by Subject|1|||
17038745|NCT00554788|38182856|FG000|Overall Study|Adverse Event|0|||
17038746|NCT00554788|38182857|FG001|Overall Study|Adverse Event|1|||
17038747|NCT00554788|38182858|FG002|Overall Study|Adverse Event|2|||
17038748|NCT00554788|38182856|FG000|Overall Study|Lost to Follow-up|4|||
17038749|NCT00554788|38182857|FG001|Overall Study|Lost to Follow-up|3|||
17038750|NCT00554788|38182858|FG002|Overall Study|Lost to Follow-up|3|||
17038751|NCT00554788|38182856|FG000|Overall Study|Physician Decision|1|||
17038752|NCT00554788|38182857|FG001|Overall Study|Physician Decision|1|||
17038753|NCT00554788|38182858|FG002|Overall Study|Physician Decision|3|||
17038754|NCT00554788|38182856|FG000|Overall Study|Withdrawal by Subject|0|||
17038755|NCT00554788|38182857|FG001|Overall Study|Withdrawal by Subject|0|||
17038756|NCT00554788|38182858|FG002|Overall Study|Withdrawal by Subject|1|||
17038757|NCT00554788|38182856|FG000|Overall Study|Refusal of further protocol therapy|0|||
17038758|NCT00554788|38182857|FG001|Overall Study|Refusal of further protocol therapy|1|||
17038759|NCT00554788|38182858|FG002|Overall Study|Refusal of further protocol therapy|1|||
17038760|NCT00554788|38182856|FG000|Overall Study|Progressive disease|0|||
17038761|NCT00554788|38182857|FG001|Overall Study|Progressive disease|0|||
17038762|NCT00554788|38182858|FG002|Overall Study|Progressive disease|3|||
17038763|NCT00554788|38182856|FG000|Overall Study|Ineligible|2|||
17038764|NCT00554788|38182857|FG001|Overall Study|Ineligible|0|||
17038765|NCT00554788|38182858|FG002|Overall Study|Ineligible|1|||
17038766|NCT00685698|38182867|FG000|Overall Study|Withdrawal by Subject|1|||
17038767|NCT00685698|38182867|FG000|Overall Study|Protocol Violation|6|||
17038768|NCT00685698|38182867|FG000|Overall Study|Adverse Event|3|||
17038769|NCT00685698|38182867|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
17038770|NCT00685698|38182867|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
17038771|NCT00685698|38182867|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
17038772|NCT00549328|38182883|FG000|Overall Study|Adverse Event|2|||
17038773|NCT00549328|38182883|FG000|Overall Study|Disease Progression|10|||
17038774|NCT00549328|38182883|FG000|Overall Study|Death|1|||
17038775|NCT00549328|38182883|FG000|Overall Study|Use of Prohibited Medication|1|||
17139137|NCT03529773|38280627|FG030|Overall Study|Randomized but not vaccinated|0|||
17139138|NCT03529773|38280628|FG031|Overall Study|Randomized but not vaccinated|0|||
17038776|NCT00696410|38182889|FG000|Overall Study|Lost to Follow-up|2|||
17038777|NCT00696410|38182890|FG001|Overall Study|Lost to Follow-up|0|||
17038778|NCT00696410|38182889|FG000|Overall Study|Withdrawal by Subject|8|||
17038779|NCT00696410|38182890|FG001|Overall Study|Withdrawal by Subject|0|||
17038780|NCT00696410|38182889|FG000|Overall Study|Physician Decision|3|||
17038781|NCT00696410|38182890|FG001|Overall Study|Physician Decision|0|||
17139139|NCT03529773|38280629|FG032|Overall Study|Randomized but not vaccinated|0|||
17139140|NCT03529773|38280630|FG033|Overall Study|Randomized but not vaccinated|0|||
17139141|NCT03529773|38280631|FG034|Overall Study|Randomized but not vaccinated|0|||
17139142|NCT03529773|38280632|FG035|Overall Study|Randomized but not vaccinated|0|||
17139143|NCT03529773|38280633|FG036|Overall Study|Randomized but not vaccinated|0|||
17139144|NCT03529773|38280634|FG037|Overall Study|Randomized but not vaccinated|0|||
17038782|NCT00683904|38182903|FG000|Dose Level 1|Disease progression|2|||
17038783|NCT00683904|38182904|FG001|Dose Level 1|Disease progression|0|||
17038784|NCT00683904|38182903|FG000|Dose Level 1|Adverse Event|1|||
17038785|NCT00683904|38182904|FG001|Dose Level 1|Adverse Event|0|||
17038786|NCT00683904|38182903|FG000|Dose Level 2|Adverse Event|0|||
17038787|NCT00683904|38182904|FG001|Dose Level 2|Adverse Event|2|||
17038788|NCT00363415|38182918|FG000|Overall Study|Progressive Disease|196|||
17038789|NCT00363415|38182919|FG001|Overall Study|Progressive Disease|107|||
17038790|NCT00363415|38182918|FG000|Overall Study|Sponsor Decision|67|||
17038791|NCT00363415|38182919|FG001|Overall Study|Sponsor Decision|31|||
17038792|NCT00363415|38182918|FG000|Overall Study|Death|32|||
17038793|NCT00363415|38182919|FG001|Overall Study|Death|29|||
17139145|NCT03529773|38280635|FG038|Overall Study|Randomized but not vaccinated|0|||
17139146|NCT03529773|38280636|FG039|Overall Study|Randomized but not vaccinated|0|||
17139147|NCT03799211|38280741|FG000|Overall Study|Lost to Follow-up|2|||
17038794|NCT00363415|38182918|FG000|Overall Study|Adverse Event|24|||
17038795|NCT00363415|38182919|FG001|Overall Study|Adverse Event|15|||
17038796|NCT00363415|38182918|FG000|Overall Study|Physician Decision|18|||
17038797|NCT00363415|38182919|FG001|Overall Study|Physician Decision|35|||
17038798|NCT00363415|38182918|FG000|Overall Study|Entry Criteria Not Met|11|||
17038799|NCT00363415|38182919|FG001|Overall Study|Entry Criteria Not Met|10|||
17038800|NCT00363415|38182918|FG000|Overall Study|Withdrawal by Subject|9|||
17038801|NCT00363415|38182919|FG001|Overall Study|Withdrawal by Subject|15|||
17038802|NCT00363415|38182918|FG000|Overall Study|Lost to Follow-up|3|||
17038803|NCT00363415|38182919|FG001|Overall Study|Lost to Follow-up|3|||
17038804|NCT00363415|38182918|FG000|Overall Study|Protocol Violation|1|||
17038805|NCT00363415|38182919|FG001|Overall Study|Protocol Violation|4|||
17038806|NCT00696020|38182929|FG000|Overall Study|Adverse Event|3|||
17038807|NCT00696020|38182930|FG001|Overall Study|Adverse Event|1|||
17038808|NCT00696020|38182931|FG002|Overall Study|Adverse Event|2|||
17038809|NCT00696020|38182932|FG003|Overall Study|Adverse Event|1|||
17038810|NCT00696020|38182929|FG000|Overall Study|Lack of Efficacy|1|||
17038811|NCT00696020|38182930|FG001|Overall Study|Lack of Efficacy|0|||
17038812|NCT00696020|38182931|FG002|Overall Study|Lack of Efficacy|0|||
17038813|NCT00696020|38182932|FG003|Overall Study|Lack of Efficacy|0|||
17038814|NCT00696020|38182929|FG000|Overall Study|Protocol Violation|0|||
17038815|NCT00696020|38182930|FG001|Overall Study|Protocol Violation|0|||
17038816|NCT00696020|38182931|FG002|Overall Study|Protocol Violation|0|||
17038817|NCT00696020|38182932|FG003|Overall Study|Protocol Violation|1|||
17038818|NCT00696020|38182929|FG000|Overall Study|Withdrawal by Subject|0|||
17038819|NCT00696020|38182930|FG001|Overall Study|Withdrawal by Subject|1|||
17038820|NCT00696020|38182931|FG002|Overall Study|Withdrawal by Subject|0|||
17038821|NCT00696020|38182932|FG003|Overall Study|Withdrawal by Subject|1|||
17038822|NCT00696020|38182929|FG000|Overall Study|Other not stated above|0|||
17038823|NCT00696020|38182930|FG001|Overall Study|Other not stated above|0|||
17038824|NCT00696020|38182931|FG002|Overall Study|Other not stated above|1|||
17038825|NCT00696020|38182932|FG003|Overall Study|Other not stated above|1|||
17038826|NCT00576576|38182944|FG000|Overall Study|Lost to Follow-up|6|||
17038827|NCT00576576|38182944|FG000|Overall Study|Protocol Violation|1|||
17038828|NCT00695864|38182963|FG000|Placebo|Withdrawal by Subject|1|||
17038829|NCT00695864|38182963|FG000|Placebo|Physician Decision|4|||
17038830|NCT00684996|38182969|FG000|Overall Study|Adverse Event|1|||
17038831|NCT00684996|38182969|FG000|Overall Study|Refusal unrelated to adverse event|1|||
17038832|NCT00684996|38182969|FG000|Overall Study|Progression/relapse|2|||
17038833|NCT00684996|38182969|FG000|Overall Study|Other reasons not protocol specified|1|||
17038834|NCT00684762|38182976|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
17038835|NCT00684762|38182977|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
17038836|NCT00695786|38182987|FG000|Overall Study|Adverse Event|0|||
17038837|NCT00695786|38182988|FG001|Overall Study|Adverse Event|3|||
17038838|NCT00695786|38182989|FG002|Overall Study|Adverse Event|4|||
17038839|NCT00695786|38182990|FG003|Overall Study|Adverse Event|2|||
17038840|NCT00695786|38182987|FG000|Overall Study|Lost to Follow-up|0|||
17038841|NCT00695786|38182988|FG001|Overall Study|Lost to Follow-up|5|||
17038842|NCT00695786|38182989|FG002|Overall Study|Lost to Follow-up|1|||
17038843|NCT00695786|38182990|FG003|Overall Study|Lost to Follow-up|1|||
17038844|NCT00695786|38182987|FG000|Overall Study|Withdrawal by Subject|0|||
17038845|NCT00695786|38182988|FG001|Overall Study|Withdrawal by Subject|4|||
17038846|NCT00695786|38182989|FG002|Overall Study|Withdrawal by Subject|3|||
17038847|NCT00695786|38182990|FG003|Overall Study|Withdrawal by Subject|1|||
17038848|NCT00695786|38182987|FG000|Overall Study|Deemed Ineligible|1|||
17038849|NCT00695786|38182988|FG001|Overall Study|Deemed Ineligible|0|||
17038850|NCT00695786|38182989|FG002|Overall Study|Deemed Ineligible|0|||
17038851|NCT00695786|38182990|FG003|Overall Study|Deemed Ineligible|0|||
17038852|NCT00695786|38182987|FG000|Overall Study|Lack of Efficacy|0|||
17038853|NCT00695786|38182988|FG001|Overall Study|Lack of Efficacy|0|||
17038854|NCT00695786|38182989|FG002|Overall Study|Lack of Efficacy|0|||
17038855|NCT00695786|38182990|FG003|Overall Study|Lack of Efficacy|4|||
17038856|NCT00387127|38183002|FG000|Overall Study|Lost to Follow-up|0|||
17038857|NCT00387127|38183003|FG001|Overall Study|Lost to Follow-up|4|||
17038858|NCT00387127|38183002|FG000|Overall Study|Death|16|||
17038859|NCT00387127|38183003|FG001|Overall Study|Death|16|||
17038860|NCT00387127|38183002|FG000|Overall Study|Physician Decision|0|||
17038861|NCT00387127|38183003|FG001|Overall Study|Physician Decision|1|||
17038862|NCT00387127|38183002|FG000|Overall Study|Withdrawal by Subject|3|||
17038863|NCT00387127|38183003|FG001|Overall Study|Withdrawal by Subject|2|||
17038864|NCT00387127|38183002|FG000|Overall Study|Required by Protocol Amendment #4|12|||
17038865|NCT00387127|38183003|FG001|Overall Study|Required by Protocol Amendment #4|10|||
17038866|NCT00387127|38183002|FG000|Overall Study|Serious Adverse Event|1|||
17038867|NCT00387127|38183003|FG001|Overall Study|Serious Adverse Event|1|||
17038868|NCT00387127|38183002|FG000|Overall Study|Sponsor Unblinded|1|||
17038869|NCT00387127|38183003|FG001|Overall Study|Sponsor Unblinded|0|||
17038870|NCT00683592|38183013|FG000|Overall Study|Adverse Event|12|||
17038871|NCT00683592|38183014|FG001|Overall Study|Adverse Event|4|||
17038872|NCT00683592|38183013|FG000|Overall Study|Withdrawal by Subject|11|||
17139148|NCT03799211|38280742|FG001|Overall Study|Lost to Follow-up|13|||
17139149|NCT03799211|38280741|FG000|Overall Study|Withdrawal by Subject|2|||
17139150|NCT03799211|38280742|FG001|Overall Study|Withdrawal by Subject|0|||
17139151|NCT03349710|38280754|FG000|Treatment Period|Death|0|||
17139152|NCT03349710|38280755|FG001|Treatment Period|Death|0|||
17139153|NCT03349710|38280756|FG002|Treatment Period|Death|1|||
17139154|NCT03349710|38280757|FG003|Treatment Period|Death|0|||
17139155|NCT03349710|38280754|FG000|Treatment Period|Disease Progression|0|||
17139156|NCT03349710|38280755|FG001|Treatment Period|Disease Progression|2|||
17139157|NCT03349710|38280756|FG002|Treatment Period|Disease Progression|0|||
17139158|NCT03349710|38280757|FG003|Treatment Period|Disease Progression|1|||
17139159|NCT03349710|38280754|FG000|Treatment Period|Study Drug Toxicity|1|||
17038873|NCT00683592|38183014|FG001|Overall Study|Withdrawal by Subject|11|||
17038874|NCT00683592|38183013|FG000|Overall Study|Lost to Follow-up|17|||
17139160|NCT03349710|38280755|FG001|Treatment Period|Study Drug Toxicity|0|||
17139161|NCT03349710|38280756|FG002|Treatment Period|Study Drug Toxicity|1|||
17139162|NCT03349710|38280757|FG003|Treatment Period|Study Drug Toxicity|1|||
17038875|NCT00683592|38183014|FG001|Overall Study|Lost to Follow-up|17|||
17038876|NCT00683592|38183013|FG000|Overall Study|Lack of Efficacy|3|||
17038877|NCT00683592|38183014|FG001|Overall Study|Lack of Efficacy|7|||
17038878|NCT00683592|38183013|FG000|Overall Study|Physician Decision|0|||
17038879|NCT00683592|38183014|FG001|Overall Study|Physician Decision|1|||
17038880|NCT00683592|38183013|FG000|Overall Study|Non-compliance|3|||
17038881|NCT00683592|38183014|FG001|Overall Study|Non-compliance|5|||
17038882|NCT00683592|38183013|FG000|Overall Study|Other|1|||
17038883|NCT00683592|38183014|FG001|Overall Study|Other|1|||
17038884|NCT00695396|38183023|FG000|Overall Study|Study Closed Prematurely|5|||
17038885|NCT00695396|38183024|FG001|Overall Study|Study Closed Prematurely|6|||
17038886|NCT00695396|38183025|FG002|Overall Study|Study Closed Prematurely|8|||
17038887|NCT00695396|38183023|FG000|Overall Study|Withdrawal by Subject|2|||
17038888|NCT00695396|38183024|FG001|Overall Study|Withdrawal by Subject|2|||
17038889|NCT00695396|38183025|FG002|Overall Study|Withdrawal by Subject|0|||
17038890|NCT02656706|38183033|FG000|Overall Study|Insurance Denial|1|||
17038891|NCT00575328|38183039|FG000|Overall Study|Adverse Event|1|||
17038892|NCT00575328|38183040|FG001|Overall Study|Adverse Event|1|||
17038893|NCT00575328|38183039|FG000|Overall Study|Lost to Follow-up|2|||
17038894|NCT00575328|38183040|FG001|Overall Study|Lost to Follow-up|1|||
17038895|NCT00575094|38183046|FG000|Overall Study|Adverse Event|2|||
17038896|NCT00575094|38183046|FG000|Overall Study|Withdrawal by Subject|1|||
17038897|NCT00553696|38183054|FG000|Overall Study|Adverse Event|2|||
17038898|NCT00553696|38183055|FG001|Overall Study|Adverse Event|4|||
17038899|NCT00553696|38183056|FG002|Overall Study|Adverse Event|0|||
17139163|NCT03349710|38280754|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
17139164|NCT03349710|38280755|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
17038900|NCT00553696|38183057|FG003|Overall Study|Adverse Event|1|||
17038901|NCT00553696|38183054|FG000|Overall Study|Global deterioration of health status|0|||
17038902|NCT00553696|38183055|FG001|Overall Study|Global deterioration of health status|2|||
17038903|NCT00553696|38183056|FG002|Overall Study|Global deterioration of health status|0|||
17038904|NCT00553696|38183057|FG003|Overall Study|Global deterioration of health status|0|||
17038905|NCT00553696|38183054|FG000|Overall Study|Objective progression or relapse|2|||
17038906|NCT00553696|38183055|FG001|Overall Study|Objective progression or relapse|9|||
17038907|NCT00553696|38183056|FG002|Overall Study|Objective progression or relapse|6|||
17038908|NCT00553696|38183057|FG003|Overall Study|Objective progression or relapse|0|||
17038909|NCT00553696|38183054|FG000|Overall Study|Withdrawal by Subject|0|||
17038910|NCT00553696|38183055|FG001|Overall Study|Withdrawal by Subject|1|||
17038911|NCT00553696|38183056|FG002|Overall Study|Withdrawal by Subject|0|||
17038912|NCT00553696|38183057|FG003|Overall Study|Withdrawal by Subject|0|||
17038913|NCT00553540|38183072|FG000|Overall Study|discharged after first visit|2|||
17038914|NCT00553540|38183073|FG001|Overall Study|discharged after first visit|5|||
17038915|NCT00617409|38183082|FG000|Overall Study|Withdrawal by Subject|4|||
17038916|NCT00617409|38183083|FG001|Overall Study|Withdrawal by Subject|1|||
17038917|NCT00617409|38183084|FG002|Overall Study|Withdrawal by Subject|2|||
17038918|NCT00617409|38183082|FG000|Overall Study|Adverse Event|0|||
17038919|NCT00617409|38183083|FG001|Overall Study|Adverse Event|2|||
17038920|NCT00617409|38183084|FG002|Overall Study|Adverse Event|3|||
17038921|NCT00617409|38183082|FG000|Overall Study|Disease Progression|8|||
17038922|NCT00617409|38183083|FG001|Overall Study|Disease Progression|8|||
17038923|NCT00617409|38183084|FG002|Overall Study|Disease Progression|18|||
17038924|NCT00617409|38183082|FG000|Overall Study|Death|3|||
17038925|NCT00617409|38183083|FG001|Overall Study|Death|5|||
17038926|NCT00617409|38183084|FG002|Overall Study|Death|4|||
17038927|NCT00617409|38183082|FG000|Overall Study|Alternative Therapy|1|||
17038928|NCT00617409|38183083|FG001|Overall Study|Alternative Therapy|2|||
17038929|NCT00617409|38183084|FG002|Overall Study|Alternative Therapy|0|||
17038930|NCT00695318|38183095|FG000|Overall Study|Lost to Follow-up|1|||
17038931|NCT00695318|38183096|FG001|Overall Study|Lost to Follow-up|0|||
17038932|NCT00695318|38183095|FG000|Overall Study|Withdrawal by Subject|2|||
17038933|NCT00695318|38183096|FG001|Overall Study|Withdrawal by Subject|0|||
17038934|NCT00695318|38183095|FG000|Overall Study|Death|1|||
17038935|NCT00695318|38183096|FG001|Overall Study|Death|1|||
17038936|NCT00695318|38183095|FG000|Overall Study|Study Terminated|1|||
17038937|NCT00695318|38183096|FG001|Overall Study|Study Terminated|0|||
17038938|NCT00386425|38183110|FG000|Overall Study|Physician Decision|3|||
17038939|NCT00386425|38183111|FG001|Overall Study|Physician Decision|0|||
17038940|NCT00386425|38183112|FG002|Overall Study|Physician Decision|0|||
17038941|NCT00386425|38183110|FG000|Overall Study|Withdrawal by Subject|0|||
17038942|NCT00386425|38183111|FG001|Overall Study|Withdrawal by Subject|1|||
17038943|NCT00386425|38183112|FG002|Overall Study|Withdrawal by Subject|0|||
17038944|NCT00694304|38183124|FG000|Overall Study|Adverse Event|42|||
17038945|NCT00694304|38183124|FG000|Overall Study|Lack of Efficacy|35|||
17038946|NCT00694304|38183124|FG000|Overall Study|Non-compliance With Study Product|16|||
17038947|NCT00694304|38183124|FG000|Overall Study|Protocol Violation|6|||
17038948|NCT00694304|38183124|FG000|Overall Study|Withdrawal of Consent|61|||
17038949|NCT00694304|38183124|FG000|Overall Study|Lost to Follow-up|15|||
17038950|NCT00694304|38183124|FG000|Overall Study|Administrative or Other Reasons|32|||
17038951|NCT00371839|38183131|FG000|Overall Study|Death|4|||
17038952|NCT00371839|38183132|FG001|Overall Study|Death|0|||
17038953|NCT00371839|38183133|FG002|Overall Study|Death|0|||
17038954|NCT00371839|38183131|FG000|Overall Study|Withdrawal by Subject|7|||
17038955|NCT00371839|38183132|FG001|Overall Study|Withdrawal by Subject|4|||
17038956|NCT00371839|38183133|FG002|Overall Study|Withdrawal by Subject|0|||
17038957|NCT00371839|38183131|FG000|Overall Study|Lost to Follow-up|6|||
17038958|NCT00371839|38183132|FG001|Overall Study|Lost to Follow-up|3|||
17038959|NCT00371839|38183133|FG002|Overall Study|Lost to Follow-up|2|||
17038960|NCT00682890|38183141|FG000|Overall Study|Lost to Follow-up|1|||
17038961|NCT00682890|38183142|FG001|Overall Study|Lost to Follow-up|1|||
17038962|NCT00682890|38183141|FG000|Overall Study|subject moved away|0|||
17038963|NCT00682890|38183142|FG001|Overall Study|subject moved away|1|||
17038964|NCT00682890|38183141|FG000|Overall Study|heavy menstrual bleeding|1|||
17038965|NCT00682890|38183142|FG001|Overall Study|heavy menstrual bleeding|0|||
17038966|NCT00385723|38183151|FG000|Overall Study|Lost to Follow-up|1|||
17038967|NCT00385723|38183152|FG001|Overall Study|Lost to Follow-up|1|||
17038968|NCT00385723|38183153|FG002|Overall Study|Lost to Follow-up|0|||
17038969|NCT00385723|38183151|FG000|Overall Study|Withdrawal by Subject|1|||
17038970|NCT00385723|38183152|FG001|Overall Study|Withdrawal by Subject|0|||
17038971|NCT00385723|38183153|FG002|Overall Study|Withdrawal by Subject|2|||
17038972|NCT00698516|38183161|FG000|Overall Study|Study Termination|2|||
17038973|NCT00698516|38183161|FG000|Overall Study|Withdrawal by Subject|3|||
17038974|NCT00679302|38183171|FG000|Overall Study|Lost to Follow-up|8|||
17038975|NCT00679302|38183172|FG001|Overall Study|Lost to Follow-up|4|||
17038976|NCT00690482|38183201|FG000|Overall Study|Adverse Event|2|||
17038977|NCT00690482|38183202|FG001|Overall Study|Adverse Event|1|||
17038978|NCT00690482|38183201|FG000|Overall Study|Incorrect enrolment|0|||
17038979|NCT00690482|38183202|FG001|Overall Study|Incorrect enrolment|1|||
17038980|NCT00690482|38183201|FG000|Overall Study|Study-specific discontinuation criteria|1|||
17038981|NCT00690482|38183202|FG001|Overall Study|Study-specific discontinuation criteria|0|||
17038982|NCT00690482|38183201|FG000|Overall Study|Intake of prohibited medicine|1|||
17038983|NCT00690482|38183202|FG001|Overall Study|Intake of prohibited medicine|0|||
17038984|NCT00690482|38183201|FG000|Overall Study|withdrew consent at rand.day|0|||
17038985|NCT00690482|38183202|FG001|Overall Study|withdrew consent at rand.day|1|||
17038986|NCT00385255|38183210|FG000|Overall Study|Serious Adverse Event|1|||
17038987|NCT00385255|38183211|FG001|Overall Study|Serious Adverse Event|2|||
17038988|NCT00385255|38183210|FG000|Overall Study|Protocol Violation|0|||
17038989|NCT00385255|38183211|FG001|Overall Study|Protocol Violation|4|||
17038990|NCT00385255|38183210|FG000|Overall Study|Withdrawal by Subject|0|||
17038991|NCT00385255|38183211|FG001|Overall Study|Withdrawal by Subject|8|||
17038992|NCT00385255|38183210|FG000|Overall Study|Migrated/moved from study area|0|||
17038993|NCT00385255|38183211|FG001|Overall Study|Migrated/moved from study area|1|||
17038994|NCT00385255|38183210|FG000|Overall Study|Lost to Follow-up|20|||
17038995|NCT00385255|38183211|FG001|Overall Study|Lost to Follow-up|58|||
17038996|NCT00571662|38183221|FG000|Overall Study|Withdrawal by Subject|2|||
17038997|NCT00571662|38183221|FG000|Overall Study|psychiatric instability|1|||
17038998|NCT00571662|38183221|FG000|Overall Study|Adverse Event|5|||
17038999|NCT00698204|38183229|FG000|Overall Study|Withdrawal by Subject|1|||
17039000|NCT00698204|38183230|FG001|Overall Study|Withdrawal by Subject|0|||
17039001|NCT00549718|38183242|FG000|Overall Study|Insufficient clinical response|20|||
17039002|NCT00549718|38183243|FG001|Overall Study|Insufficient clinical response|7|||
17039003|NCT00549718|38183244|FG002|Overall Study|Insufficient clinical response|18|||
17039004|NCT00549718|38183245|FG003|Overall Study|Insufficient clinical response|32|||
17039005|NCT00549718|38183242|FG000|Overall Study|Adverse Event|6|||
17039006|NCT00549718|38183243|FG001|Overall Study|Adverse Event|8|||
17039007|NCT00549718|38183244|FG002|Overall Study|Adverse Event|7|||
17039008|NCT00549718|38183245|FG003|Overall Study|Adverse Event|3|||
17039009|NCT00549718|38183242|FG000|Overall Study|Lost to Follow-up|4|||
17039010|NCT00549718|38183243|FG001|Overall Study|Lost to Follow-up|2|||
17039011|NCT00549718|38183244|FG002|Overall Study|Lost to Follow-up|0|||
17039012|NCT00549718|38183245|FG003|Overall Study|Lost to Follow-up|6|||
17039013|NCT00549718|38183242|FG000|Overall Study|Withdrawal by Subject|9|||
17039014|NCT00549718|38183243|FG001|Overall Study|Withdrawal by Subject|18|||
17039015|NCT00549718|38183244|FG002|Overall Study|Withdrawal by Subject|12|||
17039016|NCT00549718|38183245|FG003|Overall Study|Withdrawal by Subject|13|||
17039017|NCT00549718|38183242|FG000|Overall Study|Administrative|2|||
17039018|NCT00549718|38183243|FG001|Overall Study|Administrative|2|||
17039019|NCT00549718|38183244|FG002|Overall Study|Administrative|2|||
17039020|NCT00549718|38183245|FG003|Overall Study|Administrative|1|||
17039021|NCT00371761|38183257|FG000|Overall Study|Adverse Event|1|||
17039022|NCT00371761|38183258|FG001|Overall Study|Adverse Event|1|||
17039023|NCT00371761|38183257|FG000|Overall Study|Withdrawal by Subject|1|||
17039024|NCT00371761|38183258|FG001|Overall Study|Withdrawal by Subject|3|||
17039025|NCT00371761|38183257|FG000|Overall Study|Investigator Judgment|2|||
17039026|NCT00371761|38183258|FG001|Overall Study|Investigator Judgment|3|||
17039027|NCT00371761|38183257|FG000|Overall Study|Study termination|4|||
17039028|NCT00371761|38183258|FG001|Overall Study|Study termination|3|||
17039029|NCT00549640|38183266|FG000|Overall Study|Withdrawal by Subject|6|||
17039030|NCT00549640|38183267|FG001|Overall Study|Withdrawal by Subject|12|||
17039031|NCT00549640|38183266|FG000|Overall Study|Adverse Event|5|||
17039032|NCT00549640|38183267|FG001|Overall Study|Adverse Event|0|||
17039033|NCT00549640|38183266|FG000|Overall Study|Lost to Follow-up|7|||
17039034|NCT00549640|38183267|FG001|Overall Study|Lost to Follow-up|4|||
17039035|NCT00549562|38183289|FG000|Overall Study|Adverse Event|1|||
17039036|NCT00549562|38183289|FG000|Overall Study|Lack of Efficacy|1|||
17039037|NCT00681564|38183295|FG000|Overall Study|Lost to Follow-up|6|||
17039038|NCT00681564|38183296|FG001|Overall Study|Lost to Follow-up|6|||
17039039|NCT00681564|38183295|FG000|Overall Study|Withdrawal by Subject|0|||
17039040|NCT00681564|38183296|FG001|Overall Study|Withdrawal by Subject|1|||
17039041|NCT00681564|38183295|FG000|Overall Study|Death|0|||
17039042|NCT00681564|38183296|FG001|Overall Study|Death|1|||
17039043|NCT00677352|38183304|FG000|Treatment Phase|Adverse Event|14|||
17039044|NCT00677352|38183305|FG001|Treatment Phase|Adverse Event|22|||
17039045|NCT00677352|38183304|FG000|Treatment Phase|Lack of Efficacy|2|||
17039046|NCT00677352|38183305|FG001|Treatment Phase|Lack of Efficacy|3|||
17039047|NCT00677352|38183304|FG000|Treatment Phase|Lost to Follow-up|0|||
17039048|NCT00677352|38183305|FG001|Treatment Phase|Lost to Follow-up|1|||
17039049|NCT00677352|38183304|FG000|Treatment Phase|Withdrawal by Subject|7|||
17039050|NCT00677352|38183305|FG001|Treatment Phase|Withdrawal by Subject|7|||
17039051|NCT00677352|38183304|FG000|Treatment Phase|Physician Decision|1|||
17039052|NCT00677352|38183305|FG001|Treatment Phase|Physician Decision|0|||
17039053|NCT00677352|38183304|FG000|Treatment Phase|Pregnancy|0|||
17039054|NCT00677352|38183305|FG001|Treatment Phase|Pregnancy|1|||
17039055|NCT00677352|38183304|FG000|Treatment Phase|Protocol Violation|1|||
17039056|NCT00677352|38183305|FG001|Treatment Phase|Protocol Violation|1|||
17039057|NCT00677352|38183304|FG000|Treatment Phase|Transference or work related matter|0|||
17039058|NCT00677352|38183305|FG001|Treatment Phase|Transference or work related matter|5|||
17039059|NCT00677352|38183304|FG000|Treatment Phase|Not treated|0|||
17039060|NCT00677352|38183305|FG001|Treatment Phase|Not treated|2|||
17039061|NCT00677352|38183304|FG000|Tapering Phase|Adverse Event|1|||
17039062|NCT00677352|38183305|FG001|Tapering Phase|Adverse Event|5|||
17039063|NCT00677352|38183304|FG000|Tapering Phase|Withdrawal by Subject|5|||
17039064|NCT00677352|38183305|FG001|Tapering Phase|Withdrawal by Subject|3|||
17039065|NCT00677352|38183304|FG000|Tapering Phase|Pregnancy|0|||
17039066|NCT00677352|38183305|FG001|Tapering Phase|Pregnancy|1|||
17039067|NCT00677352|38183304|FG000|Tapering Phase|Job transfer|0|||
17039068|NCT00677352|38183305|FG001|Tapering Phase|Job transfer|1|||
17039069|NCT00371683|38183318|FG000|DB Treatment Period-Randomized Patients|Death|1|||
17039070|NCT00371683|38183319|FG001|DB Treatment Period-Randomized Patients|Death|1|||
17039071|NCT00371683|38183318|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
17039072|NCT00371683|38183319|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
17039073|NCT00371683|38183318|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
17039074|NCT00371683|38183319|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
17039075|NCT00371683|38183318|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
17039076|NCT00371683|38183319|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
17039077|NCT00371683|38183318|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
17039078|NCT00371683|38183319|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
17039079|NCT00371683|38183318|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
17039080|NCT00371683|38183319|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
17039081|NCT00371683|38183318|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
17039082|NCT00371683|38183319|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
17039083|NCT00371683|38183318|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
17039084|NCT00371683|38183319|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
17039085|NCT00371683|38183318|FG000|Follow-Up Period - Randomized Patients|Death|0|||
17039086|NCT00371683|38183319|FG001|Follow-Up Period - Randomized Patients|Death|2|||
17039087|NCT00371683|38183318|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
17039088|NCT00371683|38183319|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
17039089|NCT00371683|38183318|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
17039090|NCT00371683|38183319|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
17039091|NCT03951766|38183335|FG000|Treatment Phase|Lost to Follow-up|1|||
17039092|NCT03951766|38183335|FG000|Follow-up Phase|Lost to Follow-up|10|||
17039093|NCT00371137|38183344|FG000|Overall Study|Adverse Event|20|||
17039094|NCT00371137|38183345|FG001|Overall Study|Adverse Event|35|||
17039095|NCT00371137|38183346|FG002|Overall Study|Adverse Event|42|||
17039096|NCT00371137|38183344|FG000|Overall Study|Withdrawal by Subject|11|||
17039097|NCT00371137|38183345|FG001|Overall Study|Withdrawal by Subject|10|||
17039098|NCT00371137|38183346|FG002|Overall Study|Withdrawal by Subject|15|||
17039099|NCT00371137|38183344|FG000|Overall Study|Lost to Follow-up|6|||
17039100|NCT00371137|38183345|FG001|Overall Study|Lost to Follow-up|3|||
17039101|NCT00371137|38183346|FG002|Overall Study|Lost to Follow-up|5|||
17039102|NCT00371137|38183344|FG000|Overall Study|Lack of Efficacy|30|||
17039103|NCT00371137|38183345|FG001|Overall Study|Lack of Efficacy|12|||
17039104|NCT00371137|38183346|FG002|Overall Study|Lack of Efficacy|13|||
17039105|NCT00371137|38183344|FG000|Overall Study|Sponsor Decision|2|||
17039106|NCT00371137|38183345|FG001|Overall Study|Sponsor Decision|1|||
17039107|NCT00371137|38183346|FG002|Overall Study|Sponsor Decision|2|||
17039108|NCT00371137|38183344|FG000|Overall Study|Physician Decision|1|||
17039109|NCT00371137|38183345|FG001|Overall Study|Physician Decision|1|||
17139165|NCT03349710|38280756|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
17139166|NCT03349710|38280757|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
17139167|NCT03349710|38280754|FG000|Treatment Period|admin reason by sponsor|0|||
17139168|NCT03349710|38280755|FG001|Treatment Period|admin reason by sponsor|7|||
17139169|NCT03349710|38280756|FG002|Treatment Period|admin reason by sponsor|0|||
17139170|NCT03349710|38280757|FG003|Treatment Period|admin reason by sponsor|19|||
17139171|NCT03349710|38280754|FG000|Treatment Period|Other Reason|2|||
17139172|NCT03349710|38280755|FG001|Treatment Period|Other Reason|0|||
17139173|NCT03349710|38280756|FG002|Treatment Period|Other Reason|2|||
17139174|NCT03349710|38280757|FG003|Treatment Period|Other Reason|1|||
17139175|NCT03349710|38280754|FG000|Treatment Period|completed|6|||
17139176|NCT03349710|38280755|FG001|Treatment Period|completed|0|||
17139177|NCT03349710|38280756|FG002|Treatment Period|completed|18|||
17139178|NCT03349710|38280757|FG003|Treatment Period|completed|1|||
17139179|NCT03349710|38280754|FG000|Treatment Period|participant request to discontinue|0|||
17139180|NCT03349710|38280755|FG001|Treatment Period|participant request to discontinue|0|||
17139181|NCT03349710|38280756|FG002|Treatment Period|participant request to discontinue|4|||
17139182|NCT03349710|38280757|FG003|Treatment Period|participant request to discontinue|0|||
17139183|NCT03349710|38280754|FG000|Treatment Period|participant withdrew consent|1|||
17139184|NCT03349710|38280755|FG001|Treatment Period|participant withdrew consent|0|||
17139185|NCT03349710|38280756|FG002|Treatment Period|participant withdrew consent|0|||
17139186|NCT03349710|38280757|FG003|Treatment Period|participant withdrew consent|0|||
17139187|NCT03511053|38280767|FG000|Overall Study|Withdrawal by Subject|1|||
17139188|NCT03377634|38280773|FG000|Study Period|Adverse Event|1|||
17139189|NCT03377634|38280774|FG001|Study Period|Adverse Event|0|||
17139190|NCT03377634|38280773|FG000|Study Period|Withdrawal by Subject|1|||
17139191|NCT03377634|38280774|FG001|Study Period|Withdrawal by Subject|0|||
17139192|NCT03528369|38280783|FG000|Overall Study|Withdrawal by Subject|2|||
17139193|NCT03528369|38280784|FG001|Overall Study|Withdrawal by Subject|0|||
17139194|NCT03528369|38280785|FG002|Overall Study|Withdrawal by Subject|0|||
17139195|NCT03528369|38280783|FG000|Overall Study|Lost to Follow-up|1|||
17139196|NCT03528369|38280784|FG001|Overall Study|Lost to Follow-up|0|||
17039110|NCT00371137|38183346|FG002|Overall Study|Physician Decision|1|||
17039111|NCT00371137|38183344|FG000|Overall Study|Protocol Violation|2|||
17039112|NCT00371137|38183345|FG001|Overall Study|Protocol Violation|1|||
17039113|NCT00371137|38183346|FG002|Overall Study|Protocol Violation|1|||
17039114|NCT00616239|38183354|FG000|Overall Study|Withdrawal by Subject|2|||
17039115|NCT00547534|38183358|FG000|Overall Study|Adverse Event|7|||
17039116|NCT00547534|38183358|FG000|Overall Study|Disease Progression|4|||
17039117|NCT00384397|38183366|FG000|Overall Study|Adverse Event|0|||
17039118|NCT00384397|38183367|FG001|Overall Study|Adverse Event|1|||
17039119|NCT00384397|38183368|FG002|Overall Study|Adverse Event|2|||
17039120|NCT00384397|38183366|FG000|Overall Study|Protocol Violation|7|||
17039121|NCT00384397|38183367|FG001|Overall Study|Protocol Violation|15|||
17039122|NCT00384397|38183368|FG002|Overall Study|Protocol Violation|13|||
17039123|NCT00384397|38183366|FG000|Overall Study|Lost to Follow-up|11|||
17039124|NCT00384397|38183367|FG001|Overall Study|Lost to Follow-up|13|||
17039125|NCT00384397|38183368|FG002|Overall Study|Lost to Follow-up|3|||
17039126|NCT00384397|38183366|FG000|Overall Study|Withdrawal by Subject|14|||
17039127|NCT00384397|38183367|FG001|Overall Study|Withdrawal by Subject|17|||
17039128|NCT00384397|38183368|FG002|Overall Study|Withdrawal by Subject|15|||
17039129|NCT00384085|38183379|FG000|Overall Study|Adverse Event|5|||
17039130|NCT00384085|38183380|FG001|Overall Study|Adverse Event|5|||
17039131|NCT00384085|38183381|FG002|Overall Study|Adverse Event|4|||
17039132|NCT00384085|38183379|FG000|Overall Study|Lack of Efficacy|0|||
17039133|NCT00384085|38183380|FG001|Overall Study|Lack of Efficacy|3|||
17039134|NCT00384085|38183381|FG002|Overall Study|Lack of Efficacy|2|||
17039135|NCT00384085|38183379|FG000|Overall Study|No longer Requires Study Treatment|1|||
17039136|NCT00384085|38183380|FG001|Overall Study|No longer Requires Study Treatment|0|||
17039137|NCT00384085|38183381|FG002|Overall Study|No longer Requires Study Treatment|1|||
17039138|NCT00384085|38183379|FG000|Overall Study|Protocol Violation|2|||
17039139|NCT00384085|38183380|FG001|Overall Study|Protocol Violation|2|||
17039140|NCT00384085|38183381|FG002|Overall Study|Protocol Violation|2|||
17039141|NCT00384085|38183379|FG000|Overall Study|Lost to Follow-up|9|||
17039142|NCT00384085|38183380|FG001|Overall Study|Lost to Follow-up|9|||
17039143|NCT00384085|38183381|FG002|Overall Study|Lost to Follow-up|10|||
17039144|NCT00384085|38183379|FG000|Overall Study|Progressive Disease|0|||
17039145|NCT00384085|38183380|FG001|Overall Study|Progressive Disease|1|||
17039146|NCT00384085|38183381|FG002|Overall Study|Progressive Disease|0|||
17039147|NCT00384085|38183379|FG000|Overall Study|Withdrawal by Subject|14|||
17039148|NCT00384085|38183380|FG001|Overall Study|Withdrawal by Subject|19|||
17039149|NCT00384085|38183381|FG002|Overall Study|Withdrawal by Subject|29|||
17039150|NCT00384085|38183379|FG000|Overall Study|Patient non-compliant|4|||
17039151|NCT00384085|38183380|FG001|Overall Study|Patient non-compliant|4|||
17039152|NCT00384085|38183381|FG002|Overall Study|Patient non-compliant|5|||
17039153|NCT00384085|38183379|FG000|Overall Study|Physician Decision|1|||
17039154|NCT00384085|38183380|FG001|Overall Study|Physician Decision|0|||
17039155|NCT00384085|38183381|FG002|Overall Study|Physician Decision|0|||
17039156|NCT00384085|38183379|FG000|Overall Study|Loss of site personnel|1|||
17039157|NCT00384085|38183380|FG001|Overall Study|Loss of site personnel|0|||
17039158|NCT00384085|38183381|FG002|Overall Study|Loss of site personnel|1|||
17039159|NCT00384085|38183379|FG000|Overall Study|Sponsor decision|1|||
17039160|NCT00384085|38183380|FG001|Overall Study|Sponsor decision|2|||
17039161|NCT00384085|38183381|FG002|Overall Study|Sponsor decision|1|||
17039162|NCT00384085|38183379|FG000|Overall Study|Patient moved|1|||
17039163|NCT00384085|38183380|FG001|Overall Study|Patient moved|0|||
17039164|NCT00384085|38183381|FG002|Overall Study|Patient moved|1|||
17039165|NCT00384085|38183379|FG000|Overall Study|Patient required surgery|0|||
17039166|NCT00384085|38183380|FG001|Overall Study|Patient required surgery|1|||
17039167|NCT00384085|38183381|FG002|Overall Study|Patient required surgery|0|||
17039168|NCT00361231|38183391|FG000|Overall Study|Physician Decision|3|||
17039169|NCT00361231|38183391|FG000|Overall Study|Symptomatic deterioration|5|||
17039170|NCT00361231|38183391|FG000|Overall Study|Radiographic disease progression|16|||
17039171|NCT00361231|38183391|FG000|Overall Study|Withdrawal by Subject|4|||
17039172|NCT00361231|38183391|FG000|Overall Study|Adverse Event|6|||
17039173|NCT00676650|38183397|FG000|Overall Study|Death|45|||
17039174|NCT00676650|38183398|FG001|Overall Study|Death|14|||
17039175|NCT00676650|38183397|FG000|Overall Study|Adverse Event|159|||
17039176|NCT00676650|38183398|FG001|Overall Study|Adverse Event|21|||
17039177|NCT00676650|38183397|FG000|Overall Study|Global deterioration of health status|66|||
17039178|NCT00676650|38183398|FG001|Overall Study|Global deterioration of health status|31|||
17039179|NCT00676650|38183397|FG000|Overall Study|Lost to Follow-up|0|||
17039180|NCT00676650|38183398|FG001|Overall Study|Lost to Follow-up|1|||
17139197|NCT03528369|38280785|FG002|Overall Study|Lost to Follow-up|0|||
17039181|NCT00676650|38183397|FG000|Overall Study|Objective progression or relapse|189|||
17039182|NCT00676650|38183398|FG001|Overall Study|Objective progression or relapse|140|||
17039183|NCT00676650|38183397|FG000|Overall Study|Other|14|||
17039184|NCT00676650|38183398|FG001|Overall Study|Other|10|||
17039185|NCT00676650|38183397|FG000|Overall Study|Protocol Violation|3|||
17039186|NCT00676650|38183398|FG001|Overall Study|Protocol Violation|1|||
17039187|NCT00676650|38183397|FG000|Overall Study|Study terminated by sponsor|57|||
17039188|NCT00676650|38183398|FG001|Overall Study|Study terminated by sponsor|43|||
17039189|NCT00676650|38183397|FG000|Overall Study|Withdrawal by Subject|48|||
17039190|NCT00676650|38183398|FG001|Overall Study|Withdrawal by Subject|24|||
17039191|NCT00676650|38183397|FG000|Overall Study|Randomized but not treated|3|||
17039192|NCT00676650|38183398|FG001|Overall Study|Randomized but not treated|4|||
17039193|NCT00573183|38183406|FG000|Overall Study|Lost to Follow-up|52|||
17039194|NCT00573183|38183407|FG001|Overall Study|Lost to Follow-up|50|||
17039195|NCT00573183|38183406|FG000|Overall Study|Withdrawal by Subject|8|||
17039196|NCT00573183|38183407|FG001|Overall Study|Withdrawal by Subject|2|||
17039197|NCT00573183|38183406|FG000|Overall Study|Death|0|||
17039198|NCT00573183|38183407|FG001|Overall Study|Death|1|||
17039199|NCT00573183|38183406|FG000|Overall Study|Adverse Event|2|||
17039200|NCT00573183|38183407|FG001|Overall Study|Adverse Event|0|||
17039201|NCT00573183|38183406|FG000|Overall Study|Incarceration|5|||
17039202|NCT00573183|38183407|FG001|Overall Study|Incarceration|8|||
17039203|NCT00573183|38183406|FG000|Overall Study|Other|5|||
17039204|NCT00573183|38183407|FG001|Overall Study|Other|2|||
17039205|NCT00615459|38183415|FG000|Period I|Adverse Event|2|||
17039206|NCT00615459|38183416|FG001|Period I|Adverse Event|0|||
17039207|NCT00615459|38183417|FG002|Period I|Adverse Event|1|||
17039208|NCT00615459|38183418|FG003|Period I|Adverse Event|0|||
17039209|NCT00615459|38183415|FG000|Period I|Subject withdrew consent|1|||
17039210|NCT00615459|38183416|FG001|Period I|Subject withdrew consent|0|||
17039211|NCT00615459|38183417|FG002|Period I|Subject withdrew consent|0|||
17039212|NCT00615459|38183418|FG003|Period I|Subject withdrew consent|1|||
17039213|NCT00615459|38183415|FG000|Period I|Abnormal test procedure results|1|||
17039214|NCT00615459|38183416|FG001|Period I|Abnormal test procedure results|1|||
17039215|NCT00615459|38183417|FG002|Period I|Abnormal test procedure results|1|||
17039216|NCT00615459|38183418|FG003|Period I|Abnormal test procedure results|0|||
17039217|NCT00615459|38183415|FG000|Period II|Adverse Event|1|||
17039218|NCT00615459|38183416|FG001|Period II|Adverse Event|0|||
17039219|NCT00615459|38183417|FG002|Period II|Adverse Event|0|||
17039220|NCT00615459|38183418|FG003|Period II|Adverse Event|0|||
17039221|NCT00615459|38183415|FG000|Period II|Lost to Follow-up|0|||
17039222|NCT00615459|38183416|FG001|Period II|Lost to Follow-up|0|||
17039223|NCT00615459|38183417|FG002|Period II|Lost to Follow-up|0|||
17039224|NCT00615459|38183418|FG003|Period II|Lost to Follow-up|1|||
17039225|NCT00615459|38183415|FG000|Period III|Adverse Event|0|||
17039226|NCT00615459|38183416|FG001|Period III|Adverse Event|1|||
17039227|NCT00615459|38183417|FG002|Period III|Adverse Event|0|||
17039228|NCT00615459|38183418|FG003|Period III|Adverse Event|0|||
17039229|NCT00615459|38183415|FG000|Period III|Administrative problems|0|||
17039230|NCT00615459|38183416|FG001|Period III|Administrative problems|1|||
17039231|NCT00615459|38183417|FG002|Period III|Administrative problems|1|||
17039232|NCT00615459|38183418|FG003|Period III|Administrative problems|0|||
17039233|NCT00615459|38183415|FG000|Period III|Unsatisfactory therapeutic effect|0|||
17039234|NCT00615459|38183416|FG001|Period III|Unsatisfactory therapeutic effect|1|||
17039235|NCT00615459|38183417|FG002|Period III|Unsatisfactory therapeutic effect|0|||
17039236|NCT00615459|38183418|FG003|Period III|Unsatisfactory therapeutic effect|0|||
17039237|NCT00383149|38183432|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
17039238|NCT00383149|38183432|FG000|Overall Study|Death|2|||
17039239|NCT00383149|38183432|FG000|Overall Study|Disease Progression|38|||
17039240|NCT00383149|38183432|FG000|Overall Study|Lost to Follow-up|1|||
17039241|NCT00383149|38183432|FG000|Overall Study|Other|1|||
17039242|NCT00383149|38183432|FG000|Overall Study|Study Drug Toxicity|4|||
17039243|NCT00383149|38183432|FG000|Overall Study|Request to Discontinue Treatment|4|||
17039244|NCT00383149|38183432|FG000|Overall Study|Participant Withdrew Consent|1|||
17039245|NCT00382993|38183438|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
17039246|NCT00382993|38183439|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
17039247|NCT00382993|38183438|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
17039248|NCT00382993|38183439|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
17039249|NCT00382993|38183438|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
17039250|NCT00382993|38183439|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
17039251|NCT00382993|38183438|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
17039252|NCT00382993|38183439|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
17039253|NCT00382993|38183438|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
17039254|NCT00382993|38183439|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
17039255|NCT00382993|38183438|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
17039256|NCT00382993|38183439|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
17039257|NCT00382993|38183438|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
17039258|NCT00382993|38183439|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
17039259|NCT00382993|38183438|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
17039260|NCT00382993|38183439|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
17039261|NCT00382993|38183438|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
17039262|NCT00382993|38183439|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
17039263|NCT00382993|38183438|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
17039264|NCT00382993|38183439|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
17039265|NCT00369967|38183447|FG000|Overall Study|Lost to Follow-up|23|||
17039266|NCT00369967|38183448|FG001|Overall Study|Lost to Follow-up|12|||
17039267|NCT00616629|38183463|FG000|Overall Study|Protocol Violation|1|||
17039268|NCT00616629|38183464|FG001|Overall Study|Protocol Violation|2|||
17039269|NCT00616629|38183465|FG002|Overall Study|Protocol Violation|1|||
17039270|NCT00616629|38183466|FG003|Overall Study|Protocol Violation|0|||
17039271|NCT00616629|38183467|FG004|Overall Study|Protocol Violation|0|||
17039272|NCT00616629|38183463|FG000|Overall Study|AV-block|1|||
17039273|NCT00616629|38183464|FG001|Overall Study|AV-block|0|||
17039274|NCT00616629|38183465|FG002|Overall Study|AV-block|0|||
17039275|NCT00616629|38183466|FG003|Overall Study|AV-block|0|||
17039276|NCT00616629|38183467|FG004|Overall Study|AV-block|0|||
17039277|NCT00369655|38183479|FG000|Overall Study|Refusal of further treatment|2|||
17039278|NCT00615069|38183483|FG000|Overall Study|Death|10|||
17039279|NCT00615069|38183483|FG000|Overall Study|Physician Decision|2|||
17039280|NCT00615069|38183483|FG000|Overall Study|Withdrawal by Subject|4|||
17039281|NCT00676338|38183491|FG000|Overall Study|Adverse Event|6|||
17039282|NCT00676338|38183492|FG001|Overall Study|Adverse Event|6|||
17039283|NCT00676338|38183493|FG002|Overall Study|Adverse Event|5|||
17039284|NCT00676338|38183494|FG003|Overall Study|Adverse Event|1|||
17039285|NCT00676338|38183491|FG000|Overall Study|Lost to Follow-up|4|||
17039286|NCT00676338|38183492|FG001|Overall Study|Lost to Follow-up|1|||
17039287|NCT00676338|38183493|FG002|Overall Study|Lost to Follow-up|3|||
17139198|NCT03528369|38280783|FG000|Overall Study|Adverse Event|0|||
17139199|NCT03528369|38280784|FG001|Overall Study|Adverse Event|1|||
17039288|NCT00676338|38183494|FG003|Overall Study|Lost to Follow-up|4|||
17039289|NCT00676338|38183491|FG000|Overall Study|Physician Decision|3|||
17039290|NCT00676338|38183492|FG001|Overall Study|Physician Decision|3|||
17039291|NCT00676338|38183493|FG002|Overall Study|Physician Decision|2|||
17039292|NCT00676338|38183494|FG003|Overall Study|Physician Decision|3|||
17039293|NCT00676338|38183491|FG000|Overall Study|Protocol Violation|5|||
17039294|NCT00676338|38183492|FG001|Overall Study|Protocol Violation|9|||
17039295|NCT00676338|38183493|FG002|Overall Study|Protocol Violation|2|||
17039296|NCT00676338|38183494|FG003|Overall Study|Protocol Violation|5|||
17039297|NCT00676338|38183491|FG000|Overall Study|Withdrawal by Subject|17|||
17039298|NCT00676338|38183492|FG001|Overall Study|Withdrawal by Subject|9|||
17039299|NCT00676338|38183493|FG002|Overall Study|Withdrawal by Subject|12|||
17039300|NCT00676338|38183494|FG003|Overall Study|Withdrawal by Subject|6|||
17039301|NCT00676338|38183491|FG000|Overall Study|Entry Criteria Not Met|0|||
17039302|NCT00676338|38183492|FG001|Overall Study|Entry Criteria Not Met|2|||
17039303|NCT00676338|38183493|FG002|Overall Study|Entry Criteria Not Met|1|||
17139200|NCT03528369|38280785|FG002|Overall Study|Adverse Event|0|||
17139201|NCT00006011|38280796|FG000|Overall Study|Disease progression|13|||
17139202|NCT00006011|38280797|FG001|Overall Study|Disease progression|6|||
17139203|NCT00006011|38280798|FG002|Overall Study|Disease progression|26|||
17139204|NCT00006011|38280796|FG000|Overall Study|Refused further treatment|15|||
17039304|NCT00676338|38183494|FG003|Overall Study|Entry Criteria Not Met|1|||
17039305|NCT00676338|38183491|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
17039306|NCT00676338|38183492|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
17039307|NCT00676338|38183493|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
17039308|NCT00676338|38183494|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
17039309|NCT00382291|38183507|FG000|Overall Study|Adverse Event|1|||
17039310|NCT00382291|38183508|FG001|Overall Study|Adverse Event|2|||
17039311|NCT00382291|38183509|FG002|Overall Study|Adverse Event|2|||
17039312|NCT00382291|38183507|FG000|Overall Study|Protocol Violation|1|||
17039313|NCT00382291|38183508|FG001|Overall Study|Protocol Violation|0|||
17039314|NCT00382291|38183509|FG002|Overall Study|Protocol Violation|0|||
17039315|NCT00382291|38183507|FG000|Overall Study|Temporary study suspension|2|||
17039316|NCT00382291|38183508|FG001|Overall Study|Temporary study suspension|2|||
17039317|NCT00382291|38183509|FG002|Overall Study|Temporary study suspension|5|||
17039318|NCT00382291|38183507|FG000|Overall Study|Withdrawal by Subject|0|||
17039319|NCT00382291|38183508|FG001|Overall Study|Withdrawal by Subject|2|||
17039320|NCT00382291|38183509|FG002|Overall Study|Withdrawal by Subject|0|||
17039321|NCT00382291|38183507|FG000|Overall Study|Physician Decision|0|||
17039322|NCT00382291|38183508|FG001|Overall Study|Physician Decision|1|||
17039323|NCT00382291|38183509|FG002|Overall Study|Physician Decision|0|||
17039324|NCT00382291|38183507|FG000|Overall Study|Lack of Efficacy|0|||
17039325|NCT00382291|38183508|FG001|Overall Study|Lack of Efficacy|0|||
17039326|NCT00382291|38183509|FG002|Overall Study|Lack of Efficacy|1|||
17039327|NCT00547378|38183531|FG000|Randomized Cohort|Withdrawal by Subject|7|||
17039328|NCT00547378|38183532|FG001|Randomized Cohort|Withdrawal by Subject|5|||
17039329|NCT00547378|38183533|FG002|Randomized Cohort|Withdrawal by Subject|0|||
17139205|NCT00006011|38280797|FG001|Overall Study|Refused further treatment|13|||
17039330|NCT00547378|38183531|FG000|Randomized Cohort|Death|0|||
17039331|NCT00547378|38183532|FG001|Randomized Cohort|Death|1|||
17039332|NCT00547378|38183533|FG002|Randomized Cohort|Death|0|||
17039333|NCT00547378|38183531|FG000|Randomized Cohort|Lost to Follow-up|1|||
17039334|NCT00547378|38183532|FG001|Randomized Cohort|Lost to Follow-up|0|||
17039335|NCT00547378|38183533|FG002|Randomized Cohort|Lost to Follow-up|0|||
17039336|NCT00547378|38183531|FG000|Randomized Cohort|Adverse Event|1|||
17039337|NCT00547378|38183532|FG001|Randomized Cohort|Adverse Event|0|||
17039338|NCT00547378|38183533|FG002|Randomized Cohort|Adverse Event|0|||
17039339|NCT00547378|38183531|FG000|Randomized Cohort|Other reasons|2|||
17039340|NCT00547378|38183532|FG001|Randomized Cohort|Other reasons|0|||
17039341|NCT00547378|38183533|FG002|Randomized Cohort|Other reasons|0|||
17039342|NCT00547378|38183531|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
17039343|NCT00547378|38183532|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
17039344|NCT00547378|38183533|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
17039345|NCT00547378|38183531|FG000|All Implanted Cohort|Adverse Event|4|||
17039346|NCT00547378|38183532|FG001|All Implanted Cohort|Adverse Event|10|||
17039347|NCT00547378|38183533|FG002|All Implanted Cohort|Adverse Event|17|||
17039348|NCT00547378|38183531|FG000|All Implanted Cohort|Lost to Follow-up|0|||
17039349|NCT00547378|38183532|FG001|All Implanted Cohort|Lost to Follow-up|1|||
17039350|NCT00547378|38183533|FG002|All Implanted Cohort|Lost to Follow-up|14|||
17039351|NCT00547378|38183531|FG000|All Implanted Cohort|Death|3|||
17039352|NCT00547378|38183532|FG001|All Implanted Cohort|Death|1|||
17039353|NCT00547378|38183533|FG002|All Implanted Cohort|Death|4|||
17039354|NCT00547378|38183531|FG000|All Implanted Cohort|Physician Decision|0|||
17039355|NCT00547378|38183532|FG001|All Implanted Cohort|Physician Decision|2|||
17039356|NCT00547378|38183533|FG002|All Implanted Cohort|Physician Decision|6|||
17039357|NCT00547378|38183531|FG000|All Implanted Cohort|Site closure|2|||
17039358|NCT00547378|38183532|FG001|All Implanted Cohort|Site closure|0|||
17039359|NCT00547378|38183533|FG002|All Implanted Cohort|Site closure|1|||
17039360|NCT00547378|38183531|FG000|All Implanted Cohort|Other reasons|1|||
17139206|NCT00006011|38280798|FG002|Overall Study|Refused further treatment|26|||
17139207|NCT00006011|38280796|FG000|Overall Study|Adverse Event|15|||
17139208|NCT00006011|38280797|FG001|Overall Study|Adverse Event|39|||
17139209|NCT00006011|38280798|FG002|Overall Study|Adverse Event|5|||
17139210|NCT00006011|38280796|FG000|Overall Study|Death|0|||
17139211|NCT00006011|38280797|FG001|Overall Study|Death|1|||
17039361|NCT00547378|38183532|FG001|All Implanted Cohort|Other reasons|0|||
17139212|NCT00006011|38280798|FG002|Overall Study|Death|2|||
17139213|NCT00006011|38280796|FG000|Overall Study|Other|4|||
17139214|NCT00006011|38280797|FG001|Overall Study|Other|2|||
17139215|NCT00006011|38280798|FG002|Overall Study|Other|5|||
17139216|NCT00006011|38280796|FG000|Overall Study|Ineligible|18|||
17139217|NCT00006011|38280797|FG001|Overall Study|Ineligible|16|||
17039362|NCT00547378|38183533|FG002|All Implanted Cohort|Other reasons|1|||
17039363|NCT00381043|38183543|FG000|Overall Study|Lost to Follow-up|8|||
17139218|NCT00006011|38280798|FG002|Overall Study|Ineligible|9|||
17039364|NCT00381043|38183544|FG001|Overall Study|Lost to Follow-up|6|||
17039365|NCT00381043|38183543|FG000|Overall Study|Withdrawal by Subject|3|||
17039366|NCT00381043|38183544|FG001|Overall Study|Withdrawal by Subject|1|||
17039367|NCT00381043|38183543|FG000|Overall Study|wanted more care|0|||
17039368|NCT00381043|38183544|FG001|Overall Study|wanted more care|1|||
17039369|NCT00381043|38183543|FG000|Overall Study|incarcerated|1|||
17039370|NCT00381043|38183544|FG001|Overall Study|incarcerated|0|||
17039371|NCT00614991|38183556|FG000|Overall Study|Adverse Event|3|||
17039372|NCT00614991|38183557|FG001|Overall Study|Adverse Event|3|||
17039373|NCT00614991|38183558|FG002|Overall Study|Adverse Event|0|||
17039374|NCT00614991|38183559|FG003|Overall Study|Adverse Event|0|||
17039375|NCT00614991|38183560|FG004|Overall Study|Adverse Event|1|||
17039376|NCT00614991|38183561|FG005|Overall Study|Adverse Event|0|||
17039377|NCT00360529|38183583|FG000|Overall Study|Adverse Event|10|||
17039378|NCT00360529|38183584|FG001|Overall Study|Adverse Event|23|||
17039379|NCT00360529|38183585|FG002|Overall Study|Adverse Event|33|||
17039380|NCT00360529|38183583|FG000|Overall Study|Protocol Violation|3|||
17039381|NCT00360529|38183584|FG001|Overall Study|Protocol Violation|3|||
17039382|NCT00360529|38183585|FG002|Overall Study|Protocol Violation|11|||
17039383|NCT00360529|38183583|FG000|Overall Study|Lost to Follow-up|14|||
17039384|NCT00360529|38183584|FG001|Overall Study|Lost to Follow-up|10|||
17039385|NCT00360529|38183585|FG002|Overall Study|Lost to Follow-up|13|||
17039386|NCT00360529|38183583|FG000|Overall Study|Withdrawal by Subject|22|||
17039387|NCT00360529|38183584|FG001|Overall Study|Withdrawal by Subject|14|||
17039388|NCT00360529|38183585|FG002|Overall Study|Withdrawal by Subject|18|||
17039389|NCT00360529|38183583|FG000|Overall Study|Lack of Efficacy|8|||
17039390|NCT00360529|38183584|FG001|Overall Study|Lack of Efficacy|6|||
17039391|NCT00360529|38183585|FG002|Overall Study|Lack of Efficacy|5|||
17039392|NCT00360529|38183583|FG000|Overall Study|Reason discontinued not explained above|4|||
17039393|NCT00360529|38183584|FG001|Overall Study|Reason discontinued not explained above|9|||
17039394|NCT00360529|38183585|FG002|Overall Study|Reason discontinued not explained above|11|||
17039395|NCT00369577|38183600|FG000|Overall Study|Withdrawal by Subject|0|||
17039396|NCT00369577|38183601|FG001|Overall Study|Withdrawal by Subject|0|||
17039397|NCT00369577|38183602|FG002|Overall Study|Withdrawal by Subject|1|||
17039398|NCT00678288|38183612|FG000|Overall Study|Adverse Event|0|||
17039399|NCT00678288|38183613|FG001|Overall Study|Adverse Event|2|||
17039400|NCT00678288|38183612|FG000|Overall Study|Withdrawal by Subject|1|||
17039401|NCT00678288|38183613|FG001|Overall Study|Withdrawal by Subject|1|||
17039402|NCT00678288|38183612|FG000|Overall Study|Study terminated by the sponsor|2|||
17039403|NCT00678288|38183613|FG001|Overall Study|Study terminated by the sponsor|0|||
17039404|NCT00678288|38183612|FG000|Overall Study|Not compliant with study medication|0|||
17039405|NCT00678288|38183613|FG001|Overall Study|Not compliant with study medication|1|||
17039406|NCT00678288|38183612|FG000|Overall Study|Switch to commercial drug|0|||
17039407|NCT00678288|38183613|FG001|Overall Study|Switch to commercial drug|1|||
17039408|NCT00678288|38183612|FG000|Overall Study|Reason not reported|1|||
17039409|NCT00678288|38183613|FG001|Overall Study|Reason not reported|0|||
17039410|NCT00678288|38183612|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
17039411|NCT00678288|38183613|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
17039412|NCT00369343|38183621|FG000|Double-blind Phase|Adverse Event|19|||
17039413|NCT00369343|38183622|FG001|Double-blind Phase|Adverse Event|4|||
17039414|NCT00369343|38183621|FG000|Double-blind Phase|Failed to return|2|||
17039415|NCT00369343|38183622|FG001|Double-blind Phase|Failed to return|0|||
17039416|NCT00369343|38183621|FG000|Double-blind Phase|Lost to Follow-up|9|||
17039417|NCT00369343|38183622|FG001|Double-blind Phase|Lost to Follow-up|2|||
17039418|NCT00369343|38183621|FG000|Double-blind Phase|Protocol Violation|2|||
17039419|NCT00369343|38183622|FG001|Double-blind Phase|Protocol Violation|0|||
17039420|NCT00369343|38183621|FG000|Double-blind Phase|Withdrawal by Subject|8|||
17039421|NCT00369343|38183622|FG001|Double-blind Phase|Withdrawal by Subject|6|||
17039422|NCT00369343|38183621|FG000|Double-blind Phase|Lack of Efficacy|0|||
17039423|NCT00369343|38183622|FG001|Double-blind Phase|Lack of Efficacy|4|||
17039424|NCT00369343|38183621|FG000|Double-blind Phase|Protocol deviation|4|||
17039425|NCT00369343|38183622|FG001|Double-blind Phase|Protocol deviation|0|||
17039426|NCT00369343|38183621|FG000|Open-label Phase|Adverse Event|19|||
17039427|NCT00369343|38183622|FG001|Open-label Phase|Adverse Event|7|||
17039428|NCT00369343|38183621|FG000|Open-label Phase|Failed to return|4|||
17039429|NCT00369343|38183622|FG001|Open-label Phase|Failed to return|0|||
17039430|NCT00369343|38183621|FG000|Open-label Phase|Physician Decision|2|||
17039431|NCT00369343|38183622|FG001|Open-label Phase|Physician Decision|0|||
17139219|NCT03377556|38280804|FG000|Overall Study|Adverse Event|5|||
17039432|NCT00369343|38183621|FG000|Open-label Phase|Lost to Follow-up|5|||
17039433|NCT00369343|38183622|FG001|Open-label Phase|Lost to Follow-up|3|||
17039434|NCT00369343|38183621|FG000|Open-label Phase|inadvertently reported study completers|3|||
17039435|NCT00369343|38183622|FG001|Open-label Phase|inadvertently reported study completers|2|||
17039436|NCT00369343|38183621|FG000|Open-label Phase|Protocol Violation|1|||
17039437|NCT00369343|38183622|FG001|Open-label Phase|Protocol Violation|3|||
17039438|NCT00369343|38183621|FG000|Open-label Phase|Withdrawal by Subject|15|||
17039439|NCT00369343|38183622|FG001|Open-label Phase|Withdrawal by Subject|6|||
17039440|NCT00369343|38183621|FG000|Open-label Phase|Lack of Efficacy|4|||
17039441|NCT00369343|38183622|FG001|Open-label Phase|Lack of Efficacy|3|||
17039442|NCT00369343|38183621|FG000|Open-label Phase|Lack of continuance tolerability|3|||
17039443|NCT00369343|38183622|FG001|Open-label Phase|Lack of continuance tolerability|4|||
17039444|NCT00369343|38183621|FG000|Open-label Phase|did not take study drug|1|||
17039445|NCT00369343|38183622|FG001|Open-label Phase|did not take study drug|2|||
17039446|NCT00369265|38183637|FG000|Overall Study|Study terminated|4|||
17039447|NCT00369265|38183638|FG001|Overall Study|Study terminated|7|||
17039448|NCT00368875|38183644|FG000|Overall Study|Adverse Event|0|||
17039449|NCT00368875|38183645|FG001|Overall Study|Adverse Event|12|||
17039450|NCT00368875|38183644|FG000|Overall Study|Progressive disease|3|||
17039451|NCT00368875|38183645|FG001|Overall Study|Progressive disease|27|||
17039452|NCT00368875|38183644|FG000|Overall Study|Withdrawal by Subject|2|||
17039453|NCT00368875|38183645|FG001|Overall Study|Withdrawal by Subject|6|||
17039454|NCT00368875|38183644|FG000|Overall Study|Other Reason|0|||
17039455|NCT00368875|38183645|FG001|Overall Study|Other Reason|2|||
17039456|NCT00368875|38183644|FG000|Overall Study|Alternative Therapy|1|||
17039457|NCT00368875|38183645|FG001|Overall Study|Alternative Therapy|1|||
17039458|NCT00614055|38183654|FG000|Overall Study|Adverse Event|1|||
17039459|NCT00614055|38183655|FG001|Overall Study|Adverse Event|0|||
17039460|NCT00614055|38183656|FG002|Overall Study|Adverse Event|0|||
17039461|NCT00614055|38183654|FG000|Overall Study|Protocol Violation|2|||
17039462|NCT00614055|38183655|FG001|Overall Study|Protocol Violation|2|||
17039463|NCT00614055|38183656|FG002|Overall Study|Protocol Violation|1|||
17039464|NCT00614055|38183654|FG000|Overall Study|Lack of Efficacy|0|||
17039465|NCT00614055|38183655|FG001|Overall Study|Lack of Efficacy|0|||
17039466|NCT00614055|38183656|FG002|Overall Study|Lack of Efficacy|2|||
17039467|NCT00614055|38183654|FG000|Overall Study|Unclassified|1|||
17039468|NCT00614055|38183655|FG001|Overall Study|Unclassified|4|||
17039469|NCT00614055|38183656|FG002|Overall Study|Unclassified|2|||
17039470|NCT00613821|38183669|FG000|Overall Study|Withdrawal by Subject|1|||
17039471|NCT00613821|38183670|FG001|Overall Study|Withdrawal by Subject|0|||
17039472|NCT00613821|38183669|FG000|Overall Study|Physician Decision|1|||
17039473|NCT00613821|38183670|FG001|Overall Study|Physician Decision|1|||
17039474|NCT00548548|38183678|FG000|Overall Study|Death|345|||
17039475|NCT00548548|38183679|FG001|Overall Study|Death|348|||
16991992|NCT04026165|38135903|FG003|Randomized Period|Lost to Follow-up|2|||
16991993|NCT00805792|38135911|FG000|Overall Study|Death|3|||
16991994|NCT00805792|38135911|FG000|Overall Study|Lost to Follow-up|2|||
16991995|NCT00590044|38135917|FG000|Overall Study|Withdrawal by Subject|2|||
16991996|NCT00590044|38135918|FG001|Overall Study|Withdrawal by Subject|2|||
16991997|NCT00590044|38135917|FG000|Overall Study|wrong insulin arm assigned|1|||
16991998|NCT00590044|38135918|FG001|Overall Study|wrong insulin arm assigned|0|||
16991999|NCT00590044|38135917|FG000|Overall Study|Protocol Violation|1|||
16992000|NCT00590044|38135918|FG001|Overall Study|Protocol Violation|0|||
17039476|NCT00548548|38183678|FG000|Overall Study|Lost to Follow-up|17|||
17039477|NCT00548548|38183679|FG001|Overall Study|Lost to Follow-up|18|||
16992001|NCT00805480|38135931|FG000|Overall Study|Withdrawal by Subject|13|||
17039478|NCT00613509|38183687|FG000|Cycle 1|Adverse Event|2|||
17039479|NCT00613509|38183688|FG001|Cycle 1|Adverse Event|1|||
17039480|NCT00613509|38183687|FG000|Cycle 1|Disease Progression|2|||
17039481|NCT00613509|38183688|FG001|Cycle 1|Disease Progression|6|||
17039482|NCT00613509|38183687|FG000|Cycle 1|Unacceptable Toxicity|1|||
17039483|NCT00613509|38183688|FG001|Cycle 1|Unacceptable Toxicity|0|||
17039484|NCT00613509|38183687|FG000|Cycle 1|Other administrative reason|0|||
17039485|NCT00613509|38183688|FG001|Cycle 1|Other administrative reason|1|||
17139220|NCT03377556|38280804|FG000|Overall Study|Refusal unrelated to adverse events|1|||
17139221|NCT03377556|38280804|FG000|Overall Study|Progression/relapse|38|||
17139222|NCT03377556|38280804|FG000|Overall Study|Death|3|||
17139223|NCT03750955|38280810|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
17139224|NCT03750955|38280811|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
17139225|NCT03750955|38280810|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
17039486|NCT00547300|38183713|FG000|Overall Study|Study was Administratively Terminated|25|||
17039487|NCT00547300|38183714|FG001|Overall Study|Study was Administratively Terminated|24|||
17039488|NCT00547300|38183713|FG000|Overall Study|Did not Meet Entry Criteria|0|||
17039489|NCT00547300|38183714|FG001|Overall Study|Did not Meet Entry Criteria|2|||
17039490|NCT00612807|38183722|FG000|Overall Study|Withdrawal by Subject|2|||
17039491|NCT00612807|38183723|FG001|Overall Study|Withdrawal by Subject|0|||
17039492|NCT00678210|38183733|FG000|Overall Study|Adverse Event|1|||
17039493|NCT00678210|38183734|FG001|Overall Study|Adverse Event|2|||
17039494|NCT00678210|38183735|FG002|Overall Study|Adverse Event|3|||
17039495|NCT00678210|38183736|FG003|Overall Study|Adverse Event|3|||
17039496|NCT00678210|38183733|FG000|Overall Study|Lack of Efficacy|2|||
17039497|NCT00678210|38183734|FG001|Overall Study|Lack of Efficacy|3|||
17039498|NCT00678210|38183735|FG002|Overall Study|Lack of Efficacy|1|||
17039499|NCT00678210|38183736|FG003|Overall Study|Lack of Efficacy|9|||
17039500|NCT00678210|38183733|FG000|Overall Study|Lost to Follow-up|4|||
17039501|NCT00678210|38183734|FG001|Overall Study|Lost to Follow-up|2|||
17039502|NCT00678210|38183735|FG002|Overall Study|Lost to Follow-up|0|||
17039503|NCT00678210|38183736|FG003|Overall Study|Lost to Follow-up|1|||
17039504|NCT00678210|38183733|FG000|Overall Study|Withdrawal by Subject|3|||
17039505|NCT00678210|38183734|FG001|Overall Study|Withdrawal by Subject|4|||
17039506|NCT00678210|38183735|FG002|Overall Study|Withdrawal by Subject|1|||
17039507|NCT00678210|38183736|FG003|Overall Study|Withdrawal by Subject|7|||
17039508|NCT00678210|38183733|FG000|Overall Study|Other|1|||
17039509|NCT00678210|38183734|FG001|Overall Study|Other|0|||
17039510|NCT00678210|38183735|FG002|Overall Study|Other|1|||
17039511|NCT00678210|38183736|FG003|Overall Study|Other|0|||
17039512|NCT00611715|38183748|FG000|Overall Study|Disease Progression|24|||
17039513|NCT00611715|38183749|FG001|Overall Study|Disease Progression|4|||
17039514|NCT00611715|38183748|FG000|Overall Study|Withdrawal by Subject|5|||
17039515|NCT00611715|38183749|FG001|Overall Study|Withdrawal by Subject|1|||
17039516|NCT00611715|38183748|FG000|Overall Study|Adverse Event|9|||
17039517|NCT00611715|38183749|FG001|Overall Study|Adverse Event|1|||
17039518|NCT00611715|38183748|FG000|Overall Study|Death|1|||
17039519|NCT00611715|38183749|FG001|Overall Study|Death|0|||
17039520|NCT00611715|38183748|FG000|Overall Study|two patients are still on treatment|2|||
17039521|NCT00611715|38183749|FG001|Overall Study|two patients are still on treatment|0|||
17039522|NCT00677820|38183763|FG000|Overall Study|Lost to Follow-up|1|||
17039523|NCT00677820|38183764|FG001|Overall Study|Lost to Follow-up|0|||
17039524|NCT00611559|38183773|FG000|Overall Study|Lost to Follow-up|0|||
17039525|NCT00611559|38183774|FG001|Overall Study|Lost to Follow-up|1|||
17039526|NCT00611559|38183775|FG002|Overall Study|Lost to Follow-up|0|||
17039527|NCT00611559|38183773|FG000|Overall Study|Protocol Violation|1|||
17039528|NCT00611559|38183774|FG001|Overall Study|Protocol Violation|0|||
17039529|NCT00611559|38183775|FG002|Overall Study|Protocol Violation|1|||
17039530|NCT00611247|38183785|FG000|Overall Study|Death|1|||
17039531|NCT00611247|38183786|FG001|Overall Study|Death|5|||
17039532|NCT00611247|38183785|FG000|Overall Study|Lack of Efficacy|1|||
17039533|NCT00611247|38183786|FG001|Overall Study|Lack of Efficacy|16|||
17039534|NCT00675948|38183795|FG000|Overall Study|Adverse Event|23|||
17039535|NCT00675948|38183796|FG001|Overall Study|Adverse Event|1|||
17039536|NCT00675948|38183795|FG000|Overall Study|Lack of Efficacy|3|||
17039537|NCT00675948|38183796|FG001|Overall Study|Lack of Efficacy|0|||
17039538|NCT00675948|38183795|FG000|Overall Study|Withdrawal by Subject|7|||
17039539|NCT00675948|38183796|FG001|Overall Study|Withdrawal by Subject|0|||
17039540|NCT00675948|38183795|FG000|Overall Study|Lost to Follow-up|2|||
17039541|NCT00675948|38183796|FG001|Overall Study|Lost to Follow-up|0|||
17039542|NCT00675948|38183795|FG000|Overall Study|Protocol Violation|1|||
17039543|NCT00675948|38183796|FG001|Overall Study|Protocol Violation|0|||
17039544|NCT00675948|38183795|FG000|Overall Study|Pain under control|1|||
17039545|NCT00675948|38183796|FG001|Overall Study|Pain under control|0|||
17039546|NCT00675948|38183795|FG000|Overall Study|Sponsor decision|0|||
17039547|NCT00675948|38183796|FG001|Overall Study|Sponsor decision|1|||
17039548|NCT00675948|38183795|FG000|Overall Study|Patient died|1|||
17139226|NCT03750955|38280811|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
17139227|NCT00005957|38280821|FG000|Overall Study|No treated|3|||
17139228|NCT00005957|38280822|FG001|Overall Study|No treated|9|||
17139229|NCT00005957|38280821|FG000|Overall Study|Crossover to the other arm|5|||
17139230|NCT00005957|38280822|FG001|Overall Study|Crossover to the other arm|19|||
17139231|NCT00005879|38280830|FG000|Overall Study|Withdrawal by Subject|8|||
17139232|NCT00005879|38280831|FG001|Overall Study|Withdrawal by Subject|10|||
17139233|NCT03527745|38280863|FG000|Overall Study|Lost to Follow-up|3|||
17139234|NCT03527745|38280864|FG001|Overall Study|Lost to Follow-up|6|||
17139235|NCT03527745|38280865|FG002|Overall Study|Lost to Follow-up|7|||
17139236|NCT03527745|38280866|FG003|Overall Study|Lost to Follow-up|9|||
17139237|NCT03527745|38280867|FG004|Overall Study|Lost to Follow-up|0|||
17139238|NCT03527745|38280868|FG005|Overall Study|Lost to Follow-up|2|||
17139239|NCT03527745|38280869|FG006|Overall Study|Lost to Follow-up|3|||
17139240|NCT03527745|38280870|FG007|Overall Study|Lost to Follow-up|2|||
17139241|NCT03527745|38280871|FG008|Overall Study|Lost to Follow-up|3|||
17139242|NCT03527745|38280872|FG009|Overall Study|Lost to Follow-up|2|||
17139243|NCT03527745|38280873|FG010|Overall Study|Lost to Follow-up|1|||
17139244|NCT03527745|38280874|FG011|Overall Study|Lost to Follow-up|1|||
17139245|NCT03527745|38280875|FG012|Overall Study|Lost to Follow-up|0|||
17139246|NCT03527745|38280876|FG013|Overall Study|Lost to Follow-up|0|||
17139247|NCT03527745|38280877|FG014|Overall Study|Lost to Follow-up|0|||
17139248|NCT03527745|38280878|FG015|Overall Study|Lost to Follow-up|0|||
17139249|NCT03527745|38280879|FG016|Overall Study|Lost to Follow-up|1|||
17139250|NCT03527745|38280880|FG017|Overall Study|Lost to Follow-up|0|||
17139251|NCT03527745|38280881|FG018|Overall Study|Lost to Follow-up|0|||
17139252|NCT03527745|38280882|FG019|Overall Study|Lost to Follow-up|1|||
17139253|NCT03527745|38280883|FG020|Overall Study|Lost to Follow-up|1|||
17139254|NCT03527745|38280884|FG021|Overall Study|Lost to Follow-up|5|||
17139255|NCT03527745|38280885|FG022|Overall Study|Lost to Follow-up|6|||
17139256|NCT03527745|38280886|FG023|Overall Study|Lost to Follow-up|8|||
17139257|NCT03527745|38280887|FG024|Overall Study|Lost to Follow-up|1|||
17139258|NCT03527745|38280888|FG025|Overall Study|Lost to Follow-up|3|||
17139259|NCT03583359|38280946|FG000|Overall Study|Withdrawal by Subject|15|||
17139260|NCT03583359|38280947|FG001|Overall Study|Withdrawal by Subject|6|||
17139261|NCT03583359|38280946|FG000|Overall Study|Lost to Follow-up|12|||
17139262|NCT03583359|38280947|FG001|Overall Study|Lost to Follow-up|3|||
17139263|NCT03583359|38280946|FG000|Overall Study|Adverse Event|0|||
17139264|NCT03583359|38280947|FG001|Overall Study|Adverse Event|1|||
17139265|NCT03583359|38280946|FG000|Overall Study|Protocol Violation|0|||
17139266|NCT03583359|38280947|FG001|Overall Study|Protocol Violation|1|||
17139267|NCT03583359|38280946|FG000|Overall Study|Other|2|||
17139268|NCT03583359|38280947|FG001|Overall Study|Other|1|||
17139269|NCT03510663|38280961|FG000|Overall Study|Withdrawal by Subject|0|||
17139270|NCT03510663|38280962|FG001|Overall Study|Withdrawal by Subject|1|||
17139271|NCT03510663|38280963|FG002|Overall Study|Withdrawal by Subject|0|||
17139272|NCT03510663|38280964|FG003|Overall Study|Withdrawal by Subject|0|||
17139273|NCT03510663|38280965|FG004|Overall Study|Withdrawal by Subject|0|||
17139274|NCT03510663|38280966|FG005|Overall Study|Withdrawal by Subject|0|||
17139275|NCT03510663|38280967|FG006|Overall Study|Withdrawal by Subject|0|||
17139276|NCT03510663|38280968|FG007|Overall Study|Withdrawal by Subject|0|||
17139277|NCT03510273|38280978|FG000|Overall Study|Withdrawal by Subject|2|||
17139278|NCT03510273|38280978|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
17139279|NCT03510273|38280978|FG000|Overall Study|Moved away from study area|4|||
17139280|NCT03582813|38280988|FG000|Overall Study|Lost to Follow-up|18|||
17139281|NCT03582813|38280989|FG001|Overall Study|Lost to Follow-up|21|||
17039549|NCT00675948|38183796|FG001|Overall Study|Patient died|0|||
17039550|NCT00675948|38183795|FG000|Overall Study|Patient unable to comply with diaries|1|||
17039551|NCT00675948|38183796|FG001|Overall Study|Patient unable to comply with diaries|0|||
17039552|NCT00675948|38183795|FG000|Overall Study|Patient feels unable to take medication|0|||
17139282|NCT03582813|38280988|FG000|Overall Study|Withdrawal by Subject|1|||
17139283|NCT03582813|38280989|FG001|Overall Study|Withdrawal by Subject|0|||
17139284|NCT03480009|38280999|FG000|Overall Study|Lost to Follow-up|4|||
17139285|NCT03480009|38281000|FG001|Overall Study|Lost to Follow-up|5|||
17139286|NCT03480009|38281001|FG002|Overall Study|Lost to Follow-up|4|||
17139287|NCT03480009|38281002|FG003|Overall Study|Lost to Follow-up|0|||
17139288|NCT03399786|38281017|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
17139289|NCT03399786|38281018|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
17139290|NCT03399786|38281019|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
17139291|NCT03399786|38281020|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
17139292|NCT03399786|38281017|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
17139293|NCT03399786|38281018|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
17139294|NCT03399786|38281019|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
17039553|NCT00675948|38183796|FG001|Overall Study|Patient feels unable to take medication|1|||
17039554|NCT00610935|38183805|FG000|Overall Study|Lost to Follow-up|0|||
17039555|NCT00610935|38183806|FG001|Overall Study|Lost to Follow-up|1|||
17039556|NCT00610935|38183805|FG000|Overall Study|Withdrawal by Subject|0|||
17039557|NCT00610935|38183806|FG001|Overall Study|Withdrawal by Subject|2|||
17039558|NCT00610935|38183805|FG000|Overall Study|Sponsor Discontinuation|1|||
17039559|NCT00610935|38183806|FG001|Overall Study|Sponsor Discontinuation|0|||
17039560|NCT00610857|38183821|FG000|Overall Study|Not evaluable for response|2|||
17039561|NCT00672984|38183828|FG000|First Intervention|Adverse Event|5|||
17039562|NCT00672984|38183829|FG001|First Intervention|Adverse Event|0|||
17039563|NCT00672984|38183830|FG002|First Intervention|Adverse Event|0|||
17039564|NCT00672984|38183828|FG000|First Intervention|Withdrawal by Subject|1|||
17039565|NCT00672984|38183829|FG001|First Intervention|Withdrawal by Subject|2|||
17039566|NCT00672984|38183830|FG002|First Intervention|Withdrawal by Subject|2|||
17039567|NCT00672984|38183828|FG000|First Intervention|Sponsor decision|3|||
17039568|NCT00672984|38183829|FG001|First Intervention|Sponsor decision|0|||
17039569|NCT00672984|38183830|FG002|First Intervention|Sponsor decision|0|||
17039570|NCT00672984|38183828|FG000|Second Intervention|Non-compliance with facility policies|0|||
17039571|NCT00672984|38183829|FG001|Second Intervention|Non-compliance with facility policies|2|||
17039572|NCT00672984|38183830|FG002|Second Intervention|Non-compliance with facility policies|0|||
17039573|NCT00672984|38183828|FG000|Second Intervention|Withdrawal by Subject|0|||
17039574|NCT00672984|38183829|FG001|Second Intervention|Withdrawal by Subject|3|||
17039575|NCT00672984|38183830|FG002|Second Intervention|Withdrawal by Subject|0|||
17039576|NCT00672984|38183828|FG000|Second Intervention|Protocol Violation|0|||
17039577|NCT00672984|38183829|FG001|Second Intervention|Protocol Violation|1|||
17039578|NCT00672984|38183830|FG002|Second Intervention|Protocol Violation|1|||
17039579|NCT00672984|38183828|FG000|Third Intervention|Adverse Event|1|||
17039580|NCT00672984|38183829|FG001|Third Intervention|Adverse Event|0|||
17039581|NCT00672984|38183830|FG002|Third Intervention|Adverse Event|1|||
17039582|NCT00546364|38183843|FG000|Overall Study|Disease progression|5|||
17039583|NCT00546364|38183844|FG001|Overall Study|Disease progression|11|||
17039584|NCT00546364|38183845|FG002|Overall Study|Disease progression|8|||
17039585|NCT00546364|38183843|FG000|Overall Study|Completed and off treatment|1|||
17039586|NCT00546364|38183844|FG001|Overall Study|Completed and off treatment|0|||
17039587|NCT00546364|38183845|FG002|Overall Study|Completed and off treatment|2|||
17039588|NCT00546364|38183843|FG000|Overall Study|Administrative reason by sponsor|1|||
17039589|NCT00546364|38183844|FG001|Overall Study|Administrative reason by sponsor|0|||
17039590|NCT00546364|38183845|FG002|Overall Study|Administrative reason by sponsor|0|||
17039591|NCT00546364|38183843|FG000|Overall Study|Poor compliance/noncompliance|0|||
17039592|NCT00546364|38183844|FG001|Overall Study|Poor compliance/noncompliance|0|||
17039593|NCT00546364|38183845|FG002|Overall Study|Poor compliance/noncompliance|1|||
17039594|NCT00546364|38183843|FG000|Overall Study|No longer meets study criteria|1|||
17039595|NCT00546364|38183844|FG001|Overall Study|No longer meets study criteria|1|||
17039596|NCT00546364|38183845|FG002|Overall Study|No longer meets study criteria|0|||
17039597|NCT00546364|38183843|FG000|Overall Study|Withdrawal by Subject|5|||
17039598|NCT00546364|38183844|FG001|Overall Study|Withdrawal by Subject|6|||
17039599|NCT00546364|38183845|FG002|Overall Study|Withdrawal by Subject|3|||
17039600|NCT00546364|38183843|FG000|Overall Study|Prior taxotere|1|||
17039601|NCT00546364|38183844|FG001|Overall Study|Prior taxotere|0|||
17039602|NCT00546364|38183845|FG002|Overall Study|Prior taxotere|0|||
17039603|NCT00546364|38183843|FG000|Overall Study|Mixed response|1|||
17039604|NCT00546364|38183844|FG001|Overall Study|Mixed response|0|||
17039605|NCT00546364|38183845|FG002|Overall Study|Mixed response|0|||
17039606|NCT00546364|38183843|FG000|Overall Study|Palliative treatment|1|||
17039607|NCT00546364|38183844|FG001|Overall Study|Palliative treatment|0|||
17039608|NCT00546364|38183845|FG002|Overall Study|Palliative treatment|1|||
17039609|NCT00546364|38183843|FG000|Overall Study|Target lesions resected|1|||
17039610|NCT00546364|38183844|FG001|Overall Study|Target lesions resected|0|||
17039611|NCT00546364|38183845|FG002|Overall Study|Target lesions resected|0|||
17039612|NCT00546364|38183843|FG000|Overall Study|Physician Decision|0|||
17039613|NCT00546364|38183844|FG001|Overall Study|Physician Decision|0|||
17039614|NCT00546364|38183845|FG002|Overall Study|Physician Decision|1|||
17039615|NCT00546364|38183843|FG000|Overall Study|Sponsor decision|0|||
17039616|NCT00546364|38183844|FG001|Overall Study|Sponsor decision|0|||
17039617|NCT00546364|38183845|FG002|Overall Study|Sponsor decision|1|||
17039618|NCT00612105|38183855|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
17039619|NCT00612105|38183856|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
17039620|NCT00612105|38183855|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
17039621|NCT00612105|38183856|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
17039622|NCT00612105|38183855|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
17039623|NCT00612105|38183856|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
17039624|NCT00612105|38183855|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
17039625|NCT00612105|38183856|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
17039626|NCT00612105|38183855|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
17039627|NCT00612105|38183856|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
17039628|NCT00612105|38183855|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
17039629|NCT00612105|38183856|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
17039630|NCT00612105|38183855|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
17039631|NCT00612105|38183856|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
17039632|NCT00612105|38183855|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
17039633|NCT00612105|38183856|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
17039634|NCT00612105|38183855|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
17039635|NCT00612105|38183856|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
17039636|NCT00612105|38183855|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
17039637|NCT00612105|38183856|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
17039638|NCT00612105|38183855|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
17039639|NCT00612105|38183856|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
17039640|NCT00612105|38183855|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
17039641|NCT00612105|38183856|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
17039642|NCT00546052|38183862|FG000|Overall Study|Adverse Event|47|||
17039643|NCT00546052|38183862|FG000|Overall Study|Lost to Follow-up|144|||
17039644|NCT00546052|38183862|FG000|Overall Study|Protocol Violation|9|||
17039645|NCT00546052|38183862|FG000|Overall Study|Withdrawal by Subject|20|||
17039646|NCT00546052|38183862|FG000|Overall Study|Non Compliance|7|||
17039647|NCT00673920|38183877|FG000|Baseline up to Week 48|Withdrew consent|1|||
17039648|NCT00673920|38183878|FG001|Baseline up to Week 48|Withdrew consent|0|||
17039649|NCT00673920|38183879|FG002|Baseline up to Week 48|Withdrew consent|2|||
17039650|NCT00673920|38183880|FG003|Baseline up to Week 48|Withdrew consent|0|||
17039651|NCT00673920|38183881|FG004|Baseline up to Week 48|Withdrew consent|0|||
17039652|NCT00673920|38183882|FG005|Baseline up to Week 48|Withdrew consent|0|||
17039653|NCT00673920|38183883|FG006|Baseline up to Week 48|Withdrew consent|0|||
17039654|NCT00673920|38183884|FG007|Baseline up to Week 48|Withdrew consent|0|||
17039655|NCT00673920|38183877|FG000|Baseline up to Week 48|Refused treatment|1|||
17039656|NCT00673920|38183878|FG001|Baseline up to Week 48|Refused treatment|0|||
17039657|NCT00673920|38183879|FG002|Baseline up to Week 48|Refused treatment|0|||
17039658|NCT00673920|38183880|FG003|Baseline up to Week 48|Refused treatment|0|||
17039659|NCT00673920|38183881|FG004|Baseline up to Week 48|Refused treatment|0|||
17039660|NCT00673920|38183882|FG005|Baseline up to Week 48|Refused treatment|0|||
17039661|NCT00673920|38183883|FG006|Baseline up to Week 48|Refused treatment|0|||
17039662|NCT00673920|38183884|FG007|Baseline up to Week 48|Refused treatment|0|||
17039663|NCT00673920|38183877|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
17039664|NCT00673920|38183878|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
17039665|NCT00673920|38183879|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
17039666|NCT00673920|38183880|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
17039667|NCT00673920|38183881|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
17039668|NCT00673920|38183882|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
17039669|NCT00673920|38183883|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
17039670|NCT00673920|38183884|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
17039671|NCT00673920|38183877|FG000|Baseline up to Week 48|Protocol Violation|0|||
17039672|NCT00673920|38183878|FG001|Baseline up to Week 48|Protocol Violation|0|||
17039673|NCT00673920|38183879|FG002|Baseline up to Week 48|Protocol Violation|1|||
17039674|NCT00673920|38183880|FG003|Baseline up to Week 48|Protocol Violation|0|||
17139295|NCT03399786|38281020|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
17139296|NCT03399786|38281017|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
17139297|NCT03399786|38281018|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
17139298|NCT03399786|38281019|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
17139299|NCT03399786|38281020|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
17139300|NCT03505593|38281028|FG000|Overall Study|Withdrawal by Subject|1|||
17139301|NCT03505593|38281028|FG000|Overall Study|Died before procedure|1|||
17139302|NCT03505593|38281028|FG000|Overall Study|Anatomical abnormality|1|||
17139303|NCT03505593|38281028|FG000|Overall Study|Unable to pass through esophagus|1|||
17139304|NCT03505593|38281028|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
17139305|NCT03504189|38281032|FG000|Overall Study|Withdrawal by Subject|1|||
17139306|NCT03504189|38281032|FG000|Overall Study|Screening Failure|1|||
17139307|NCT03504189|38281032|FG000|Overall Study|Device Failure|2|||
17139308|NCT03374358|38281043|FG000|Overall Study|Withdrawal by Subject|0|||
17139309|NCT03374358|38281044|FG001|Overall Study|Withdrawal by Subject|2|||
17139310|NCT03372096|38281050|FG000|Overall Study|Study Closed|8|||
17139311|NCT00004859|38281059|FG000|Overall Study|Lack of Efficacy|43|||
17139312|NCT00004859|38281060|FG001|Overall Study|Lack of Efficacy|113|||
17139313|NCT00004859|38281059|FG000|Overall Study|Adverse Event|31|||
17139314|NCT00004859|38281060|FG001|Overall Study|Adverse Event|93|||
17139315|NCT00004859|38281059|FG000|Overall Study|Death|5|||
17139316|NCT00004859|38281060|FG001|Overall Study|Death|5|||
17139317|NCT00004859|38281059|FG000|Overall Study|Withdrawal by Subject|7|||
17139318|NCT00004859|38281060|FG001|Overall Study|Withdrawal by Subject|33|||
17139319|NCT00004859|38281059|FG000|Overall Study|Protocol Violation|2|||
17139320|NCT00004859|38281060|FG001|Overall Study|Protocol Violation|2|||
17139321|NCT00004859|38281059|FG000|Overall Study|other disease|0|||
17139322|NCT00004859|38281060|FG001|Overall Study|other disease|3|||
17139323|NCT00004859|38281059|FG000|Overall Study|error|3|||
17139324|NCT00004859|38281060|FG001|Overall Study|error|1|||
17039675|NCT00673920|38183881|FG004|Baseline up to Week 48|Protocol Violation|0|||
17039676|NCT00673920|38183882|FG005|Baseline up to Week 48|Protocol Violation|0|||
17039677|NCT00673920|38183883|FG006|Baseline up to Week 48|Protocol Violation|0|||
17039678|NCT00673920|38183884|FG007|Baseline up to Week 48|Protocol Violation|0|||
17039679|NCT00673920|38183877|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
17039680|NCT00673920|38183878|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
17039681|NCT00673920|38183879|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
17039682|NCT00673920|38183880|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
17039683|NCT00673920|38183881|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
17039684|NCT00673920|38183882|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
17039685|NCT00673920|38183883|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
17039686|NCT00673920|38183884|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
17039687|NCT00673920|38183877|FG000|Baseline up to Week 48|Administrative/Other|0|||
17039688|NCT00673920|38183878|FG001|Baseline up to Week 48|Administrative/Other|1|||
17039689|NCT00673920|38183879|FG002|Baseline up to Week 48|Administrative/Other|2|||
17039690|NCT00673920|38183880|FG003|Baseline up to Week 48|Administrative/Other|0|||
17039691|NCT00673920|38183881|FG004|Baseline up to Week 48|Administrative/Other|0|||
17039692|NCT00673920|38183882|FG005|Baseline up to Week 48|Administrative/Other|0|||
17039693|NCT00673920|38183883|FG006|Baseline up to Week 48|Administrative/Other|0|||
17039694|NCT00673920|38183884|FG007|Baseline up to Week 48|Administrative/Other|0|||
17039695|NCT00673920|38183877|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
17039696|NCT00673920|38183878|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
17039697|NCT00673920|38183879|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
17039698|NCT00673920|38183880|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
17039699|NCT00673920|38183881|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
17039700|NCT00673920|38183882|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
17039701|NCT00673920|38183883|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
17039702|NCT00673920|38183884|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
17039703|NCT00673920|38183877|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
17039704|NCT00673920|38183878|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
17039705|NCT00673920|38183879|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
17039706|NCT00673920|38183880|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
17039707|NCT00673920|38183881|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
17039708|NCT00673920|38183882|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
17039709|NCT00673920|38183883|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
17039710|NCT00673920|38183884|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
17039711|NCT00673920|38183877|FG000|Week 24 to Week 48|Failure to return|0|||
17039712|NCT00673920|38183878|FG001|Week 24 to Week 48|Failure to return|0|||
17039713|NCT00673920|38183879|FG002|Week 24 to Week 48|Failure to return|0|||
17039714|NCT00673920|38183880|FG003|Week 24 to Week 48|Failure to return|0|||
17039715|NCT00673920|38183881|FG004|Week 24 to Week 48|Failure to return|0|||
17039716|NCT00673920|38183882|FG005|Week 24 to Week 48|Failure to return|1|||
17039717|NCT00673920|38183883|FG006|Week 24 to Week 48|Failure to return|0|||
17139325|NCT00004859|38281059|FG000|Overall Study|missing data|14|||
16780429|NCT02607735|37719600|FG000|Primary Study|Randomized but Never Treated|1|||
16780430|NCT02607735|37719601|FG001|Primary Study|Randomized but Never Treated|0|||
16780431|NCT02607735|37719602|FG002|Primary Study|Randomized but Never Treated|0|||
16780432|NCT02607735|37719600|FG000|Primary Study|Lost to Follow-up|4|||
16780433|NCT02607735|37719601|FG001|Primary Study|Lost to Follow-up|0|||
16780434|NCT02607735|37719602|FG002|Primary Study|Lost to Follow-up|0|||
16780435|NCT02607735|37719600|FG000|Primary Study|Withdrew Consent|2|||
16780436|NCT02607735|37719601|FG001|Primary Study|Withdrew Consent|0|||
16780437|NCT02607735|37719602|FG002|Primary Study|Withdrew Consent|0|||
16780438|NCT02607735|37719600|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
16780439|NCT02607735|37719601|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
16780440|NCT02607735|37719602|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
16780441|NCT02607735|37719600|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
16780442|NCT02607735|37719601|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
16780443|NCT02607735|37719602|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
16780444|NCT01668537|37719612|FG000|Overall Study|Request to Discontinue Prematurely|1|||
16780445|NCT01668537|37719613|FG001|Overall Study|Request to Discontinue Prematurely|1|||
16780446|NCT01668537|37719612|FG000|Overall Study|Subject unwilling/unable to comply|5|||
16780447|NCT01668537|37719613|FG001|Overall Study|Subject unwilling/unable to comply|0|||
16780448|NCT01668537|37719612|FG000|Overall Study|Reason Precludes Participation|1|||
16780449|NCT01668537|37719613|FG001|Overall Study|Reason Precludes Participation|0|||
16780450|NCT01668537|37719612|FG000|Overall Study|Lost to Follow-up|13|||
16780451|NCT01668537|37719613|FG001|Overall Study|Lost to Follow-up|6|||
16780452|NCT01668537|37719612|FG000|Overall Study|Other|2|||
16780453|NCT01668537|37719613|FG001|Overall Study|Other|3|||
16780454|NCT01668147|37719619|FG000|Overall Study|Withdrawal by Subject|6|||
16780455|NCT02600559|37719627|FG000|Overall Study|Withdrawal by Subject|3|||
16780456|NCT02600559|37719627|FG000|Overall Study|Lost to Follow-up|20|||
16780457|NCT02601573|37719636|FG000|Overall Study|Lost to Follow-up|0|||
16780458|NCT02601573|37719637|FG001|Overall Study|Lost to Follow-up|3|||
16780459|NCT02601573|37719638|FG002|Overall Study|Lost to Follow-up|1|||
16780460|NCT02601573|37719639|FG003|Overall Study|Lost to Follow-up|0|||
16780461|NCT02601573|37719640|FG004|Overall Study|Lost to Follow-up|2|||
16780462|NCT02601573|37719636|FG000|Overall Study|Withdrawal by Subject|0|||
16780463|NCT02601573|37719637|FG001|Overall Study|Withdrawal by Subject|1|||
16780464|NCT02601573|37719638|FG002|Overall Study|Withdrawal by Subject|0|||
16780465|NCT02601573|37719639|FG003|Overall Study|Withdrawal by Subject|1|||
16780466|NCT02601573|37719640|FG004|Overall Study|Withdrawal by Subject|0|||
16780467|NCT02601027|37719654|FG000|Registration to Surgery|Withdrawal by Subject|20|||
16780468|NCT02601027|37719655|FG001|Registration to Surgery|Withdrawal by Subject|10|||
16780469|NCT02600871|37719663|FG000|Overall Study|Lost to Follow-up|13|||
16780470|NCT02600871|37719664|FG001|Overall Study|Lost to Follow-up|10|||
16780471|NCT02598297|37719673|FG000|Overall Study|Study terminated by Sponsor|21|||
16780472|NCT02598297|37719674|FG001|Overall Study|Study terminated by Sponsor|23|||
16780473|NCT02598297|37719673|FG000|Overall Study|Adverse Event|1|||
16780474|NCT02598297|37719674|FG001|Overall Study|Adverse Event|1|||
16780475|NCT02598297|37719673|FG000|Overall Study|Physician Decision|1|||
16780476|NCT02598297|37719674|FG001|Overall Study|Physician Decision|0|||
16780477|NCT02598297|37719673|FG000|Overall Study|Subject/guardian decision|1|||
17039718|NCT00673920|38183884|FG007|Week 24 to Week 48|Failure to return|0|||
17039719|NCT00673920|38183877|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
17039720|NCT00673920|38183878|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
17039721|NCT00673920|38183879|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
17039722|NCT00673920|38183880|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
17039723|NCT00673920|38183881|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
17039724|NCT00673920|38183882|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
17039725|NCT00673920|38183883|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
17039726|NCT00673920|38183884|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
17039727|NCT00673920|38183877|FG000|Week 24 to Week 48|Death|0|||
17039728|NCT00673920|38183878|FG001|Week 24 to Week 48|Death|0|||
17039729|NCT00673920|38183879|FG002|Week 24 to Week 48|Death|0|||
17039730|NCT00673920|38183880|FG003|Week 24 to Week 48|Death|0|||
17039731|NCT00673920|38183881|FG004|Week 24 to Week 48|Death|0|||
17039732|NCT00673920|38183882|FG005|Week 24 to Week 48|Death|1|||
17039733|NCT00673920|38183883|FG006|Week 24 to Week 48|Death|0|||
17039734|NCT00673920|38183884|FG007|Week 24 to Week 48|Death|0|||
17039735|NCT00673920|38183877|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
17039736|NCT00673920|38183878|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
17039737|NCT00673920|38183879|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
17039738|NCT00673920|38183880|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
17039739|NCT00673920|38183881|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
17039740|NCT00673920|38183882|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
17039741|NCT00673920|38183883|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
17039742|NCT00673920|38183884|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
17039743|NCT00379795|38183911|FG000|Overall Study|Death|31|||
17039744|NCT00379795|38183912|FG001|Overall Study|Death|8|||
17039745|NCT00379795|38183913|FG002|Overall Study|Death|6|||
17039746|NCT00379795|38183914|FG003|Overall Study|Death|4|||
17039747|NCT00379795|38183915|FG004|Overall Study|Death|7|||
17039748|NCT00379795|38183911|FG000|Overall Study|Adverse Event|17|||
17039749|NCT00379795|38183912|FG001|Overall Study|Adverse Event|3|||
17039750|NCT00379795|38183913|FG002|Overall Study|Adverse Event|3|||
17039751|NCT00379795|38183914|FG003|Overall Study|Adverse Event|1|||
17039752|NCT00379795|38183915|FG004|Overall Study|Adverse Event|4|||
17039753|NCT00379795|38183911|FG000|Overall Study|Lost to Follow-up|8|||
17039754|NCT00379795|38183912|FG001|Overall Study|Lost to Follow-up|1|||
17039755|NCT00379795|38183913|FG002|Overall Study|Lost to Follow-up|2|||
17039756|NCT00379795|38183914|FG003|Overall Study|Lost to Follow-up|1|||
17039757|NCT00379795|38183915|FG004|Overall Study|Lost to Follow-up|4|||
17039758|NCT00379795|38183911|FG000|Overall Study|Physician Decision|25|||
17039759|NCT00379795|38183912|FG001|Overall Study|Physician Decision|0|||
17039760|NCT00379795|38183913|FG002|Overall Study|Physician Decision|2|||
17039761|NCT00379795|38183914|FG003|Overall Study|Physician Decision|2|||
17039762|NCT00379795|38183915|FG004|Overall Study|Physician Decision|2|||
17039763|NCT00379795|38183911|FG000|Overall Study|Withdrawal by Subject|94|||
17039764|NCT00379795|38183912|FG001|Overall Study|Withdrawal by Subject|11|||
17039765|NCT00379795|38183913|FG002|Overall Study|Withdrawal by Subject|19|||
17039766|NCT00379795|38183914|FG003|Overall Study|Withdrawal by Subject|7|||
17039767|NCT00379795|38183915|FG004|Overall Study|Withdrawal by Subject|14|||
17039768|NCT00379795|38183911|FG000|Overall Study|Subject non-compliance|7|||
17039769|NCT00379795|38183912|FG001|Overall Study|Subject non-compliance|2|||
17039770|NCT00379795|38183913|FG002|Overall Study|Subject non-compliance|0|||
17039771|NCT00379795|38183914|FG003|Overall Study|Subject non-compliance|0|||
17039772|NCT00379795|38183915|FG004|Overall Study|Subject non-compliance|1|||
16780478|NCT02598297|37719674|FG001|Overall Study|Subject/guardian decision|0|||
16780479|NCT02598297|37719673|FG000|Overall Study|Followed for survival|1|||
16780480|NCT02598297|37719674|FG001|Overall Study|Followed for survival|0|||
16780481|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
16780482|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
16782558|NCT01663623|37722164|FG001|Overall Study|Other-Study closed/terminated|1|||
17039773|NCT00379795|38183911|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
17039774|NCT00379795|38183912|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
17039775|NCT00379795|38183913|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
17039776|NCT00379795|38183914|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
17039777|NCT00379795|38183915|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
17039778|NCT00379795|38183911|FG000|Overall Study|Subjects condition mandated intervention|34|||
17039779|NCT00379795|38183912|FG001|Overall Study|Subjects condition mandated intervention|9|||
17139326|NCT00004859|38281060|FG001|Overall Study|missing data|11|||
17039780|NCT00379795|38183913|FG002|Overall Study|Subjects condition mandated intervention|7|||
17039781|NCT00379795|38183914|FG003|Overall Study|Subjects condition mandated intervention|5|||
17039782|NCT00379795|38183915|FG004|Overall Study|Subjects condition mandated intervention|7|||
17039783|NCT00379795|38183911|FG000|Overall Study|Sponsor's decision|257|||
17039784|NCT00379795|38183912|FG001|Overall Study|Sponsor's decision|17|||
17039785|NCT00379795|38183913|FG002|Overall Study|Sponsor's decision|54|||
17039786|NCT00379795|38183914|FG003|Overall Study|Sponsor's decision|47|||
17139327|NCT00004859|38281059|FG000|Overall Study|Other|13|||
17139328|NCT00004859|38281060|FG001|Overall Study|Other|21|||
17139329|NCT03500679|38281070|FG000|Overall Study|Lost to Follow-up|6|||
17139330|NCT03500679|38281071|FG001|Overall Study|Lost to Follow-up|3|||
17039787|NCT00379795|38183915|FG004|Overall Study|Sponsor's decision|10|||
17039788|NCT00610155|38183930|FG000|Period 1|Withdrawal by Subject|0|||
17039789|NCT00610155|38183931|FG001|Period 1|Withdrawal by Subject|0|||
17039790|NCT00610155|38183932|FG002|Period 1|Withdrawal by Subject|1|||
17039791|NCT00610155|38183933|FG003|Period 1|Withdrawal by Subject|0|||
17039792|NCT00610155|38183934|FG004|Period 1|Withdrawal by Subject|0|||
17039793|NCT00610155|38183935|FG005|Period 1|Withdrawal by Subject|0|||
17039794|NCT00610155|38183930|FG000|Period 3|Adverse Event|1|||
17139331|NCT03500679|38281070|FG000|Overall Study|Withdrawal by Subject|3|||
17139332|NCT03500679|38281071|FG001|Overall Study|Withdrawal by Subject|0|||
17139333|NCT03348930|38281077|FG000|Washout (1 Week)|Lost to Follow-up|1|||
17139334|NCT03348930|38281078|FG001|Washout (1 Week)|Lost to Follow-up|1|||
17139335|NCT03500211|38281086|FG000|Overall Study|Withdrawal by Subject|1|||
17039795|NCT00610155|38183931|FG001|Period 3|Adverse Event|0|||
17039796|NCT00610155|38183932|FG002|Period 3|Adverse Event|0|||
17139336|NCT03500211|38281087|FG001|Overall Study|Withdrawal by Subject|1|||
17039797|NCT00610155|38183933|FG003|Period 3|Adverse Event|0|||
17039798|NCT00610155|38183934|FG004|Period 3|Adverse Event|0|||
17039799|NCT00610155|38183935|FG005|Period 3|Adverse Event|0|||
17039800|NCT00674700|38183946|FG000|Year 1|Adverse Event|17|||
17039801|NCT00674700|38183947|FG001|Year 1|Adverse Event|20|||
17039802|NCT00674700|38183948|FG002|Year 1|Adverse Event|5|||
17039803|NCT00674700|38183946|FG000|Year 1|Withdrawal by Subject|7|||
17039804|NCT00674700|38183947|FG001|Year 1|Withdrawal by Subject|7|||
17039805|NCT00674700|38183948|FG002|Year 1|Withdrawal by Subject|6|||
17039806|NCT00674700|38183946|FG000|Year 1|Any other reason not above-mentioned|7|||
17039807|NCT00674700|38183947|FG001|Year 1|Any other reason not above-mentioned|7|||
17039808|NCT00674700|38183948|FG002|Year 1|Any other reason not above-mentioned|6|||
17039809|NCT00674700|38183946|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
17039810|NCT00674700|38183947|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
17039811|NCT00674700|38183948|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
17039812|NCT00674700|38183946|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
17039813|NCT00674700|38183947|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
17039814|NCT00674700|38183948|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
17139337|NCT03478683|38281095|FG000|Overall Study|Adverse Event|5|||
17139338|NCT03478683|38281096|FG001|Overall Study|Adverse Event|3|||
17139339|NCT03478683|38281095|FG000|Overall Study|Lost to Follow-up|0|||
17039815|NCT00674700|38183946|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
17039816|NCT00674700|38183947|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
17039817|NCT00674700|38183948|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
17039818|NCT00546910|38183958|FG000|Overall Study|Adverse Event|2|||
17039819|NCT00546910|38183959|FG001|Overall Study|Adverse Event|3|||
17039820|NCT00546910|38183958|FG000|Overall Study|Lack of Efficacy|5|||
17039821|NCT00546910|38183959|FG001|Overall Study|Lack of Efficacy|7|||
17039822|NCT00546910|38183958|FG000|Overall Study|Physician Decision|0|||
17039823|NCT00546910|38183959|FG001|Overall Study|Physician Decision|1|||
17039824|NCT00546910|38183958|FG000|Overall Study|Withdrawal by Subject|2|||
17039825|NCT00546910|38183959|FG001|Overall Study|Withdrawal by Subject|0|||
17039826|NCT00379639|38183970|FG000|Overall Study|Disease Progression|3|||
17039827|NCT00379639|38183971|FG001|Overall Study|Disease Progression|3|||
17039828|NCT00379639|38183972|FG002|Overall Study|Disease Progression|3|||
17039829|NCT00379639|38183973|FG003|Overall Study|Disease Progression|4|||
17139340|NCT03478683|38281096|FG001|Overall Study|Lost to Follow-up|5|||
17039830|NCT00379639|38183974|FG004|Overall Study|Disease Progression|4|||
17039831|NCT00379639|38183970|FG000|Overall Study|Physician Decision|0|||
17039832|NCT00379639|38183971|FG001|Overall Study|Physician Decision|2|||
17139341|NCT03478683|38281095|FG000|Overall Study|Physician Decision|1|||
17139342|NCT03478683|38281096|FG001|Overall Study|Physician Decision|3|||
17139343|NCT03478683|38281095|FG000|Overall Study|Withdrawal by Subject|7|||
17039833|NCT00379639|38183972|FG002|Overall Study|Physician Decision|1|||
17039834|NCT00379639|38183973|FG003|Overall Study|Physician Decision|1|||
17139344|NCT03478683|38281096|FG001|Overall Study|Withdrawal by Subject|7|||
17139345|NCT03478371|38281102|FG000|Overall Study|non-compliance|1|||
17139346|NCT03478371|38281102|FG000|Overall Study|Lost to Follow-up|4|||
17139347|NCT03477903|38281112|FG000|Overall Study|Study Terminated by Sponsor|1|||
17139348|NCT03475875|38281116|FG000|Period 1|Lost to Follow-up|1|||
17139349|NCT03475875|38281117|FG001|Period 1|Lost to Follow-up|0|||
17139350|NCT03475875|38281116|FG000|Period 1|Adverse Event|2|||
17139351|NCT03475875|38281117|FG001|Period 1|Adverse Event|1|||
17139352|NCT03475875|38281116|FG000|Period 2|Adverse Event|3|||
17039835|NCT00379639|38183974|FG004|Overall Study|Physician Decision|0|||
17039836|NCT00379639|38183970|FG000|Overall Study|Symptomatic Deterioration|0|||
17039837|NCT00379639|38183971|FG001|Overall Study|Symptomatic Deterioration|0|||
17039838|NCT00379639|38183972|FG002|Overall Study|Symptomatic Deterioration|1|||
17039839|NCT00379639|38183973|FG003|Overall Study|Symptomatic Deterioration|0|||
17039840|NCT00379639|38183974|FG004|Overall Study|Symptomatic Deterioration|1|||
17039841|NCT00379639|38183970|FG000|Overall Study|Adverse Event|0|||
17039842|NCT00379639|38183971|FG001|Overall Study|Adverse Event|0|||
17039843|NCT00379639|38183972|FG002|Overall Study|Adverse Event|1|||
17039844|NCT00379639|38183973|FG003|Overall Study|Adverse Event|0|||
17039845|NCT00379639|38183974|FG004|Overall Study|Adverse Event|1|||
17039846|NCT00379639|38183970|FG000|Overall Study|Lost to Follow-up|0|||
17039847|NCT00379639|38183971|FG001|Overall Study|Lost to Follow-up|0|||
17039848|NCT00379639|38183972|FG002|Overall Study|Lost to Follow-up|0|||
17039849|NCT00379639|38183973|FG003|Overall Study|Lost to Follow-up|1|||
17039850|NCT00379639|38183974|FG004|Overall Study|Lost to Follow-up|0|||
17039851|NCT00379639|38183970|FG000|Overall Study|Other|0|||
17039852|NCT00379639|38183971|FG001|Overall Study|Other|0|||
17039853|NCT00379639|38183972|FG002|Overall Study|Other|3|||
17039854|NCT00379639|38183973|FG003|Overall Study|Other|0|||
17039855|NCT00379639|38183974|FG004|Overall Study|Other|0|||
17039856|NCT03948334|38183988|FG000|Overall Study|Adverse Event|1|||
17039857|NCT03948334|38183989|FG001|Overall Study|Adverse Event|4|||
17039858|NCT03948334|38183988|FG000|Overall Study|Lack of Efficacy|2|||
17039859|NCT03948334|38183989|FG001|Overall Study|Lack of Efficacy|0|||
17039860|NCT03948334|38183988|FG000|Overall Study|Lost to Follow-up|1|||
17039861|NCT03948334|38183989|FG001|Overall Study|Lost to Follow-up|0|||
17039862|NCT03948334|38183988|FG000|Overall Study|Physician Decision|1|||
17039863|NCT03948334|38183989|FG001|Overall Study|Physician Decision|0|||
17039864|NCT03948334|38183988|FG000|Overall Study|Pregnancy|0|||
17039865|NCT03948334|38183989|FG001|Overall Study|Pregnancy|1|||
17039866|NCT03948334|38183988|FG000|Overall Study|Protocol Deviation|1|||
17039867|NCT03948334|38183989|FG001|Overall Study|Protocol Deviation|0|||
17139353|NCT03475875|38281117|FG001|Period 2|Adverse Event|0|||
17139354|NCT03475875|38281116|FG000|Period 2|Protocol Violation|0|||
17139355|NCT03475875|38281117|FG001|Period 2|Protocol Violation|1|||
17139356|NCT03474081|38281125|FG000|Overall Study|Adverse Event|6|||
17139357|NCT03474081|38281126|FG001|Overall Study|Adverse Event|3|||
17139358|NCT03474081|38281125|FG000|Overall Study|Lost to Follow-up|2|||
17139359|NCT03474081|38281126|FG001|Overall Study|Lost to Follow-up|1|||
17139360|NCT03474081|38281125|FG000|Overall Study|Physician Decision|3|||
17139361|NCT03474081|38281126|FG001|Overall Study|Physician Decision|2|||
17139362|NCT03474081|38281125|FG000|Overall Study|Withdrawal by Subject|5|||
17139363|NCT03474081|38281126|FG001|Overall Study|Withdrawal by Subject|7|||
17139364|NCT03474081|38281125|FG000|Overall Study|Investigator site closed|1|||
17139365|NCT03474081|38281126|FG001|Overall Study|Investigator site closed|0|||
17139366|NCT03346434|38281138|FG000|Overall Study|Randomized in Error|0|||
16782559|NCT01663623|37722163|FG000|Overall Study|Physician Decision|1|||
17039868|NCT03948334|38183988|FG000|Overall Study|Study terminated by Sponsor|50|||
17039869|NCT03948334|38183989|FG001|Overall Study|Study terminated by Sponsor|51|||
17039870|NCT03948334|38183988|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
17139367|NCT03346434|38281139|FG001|Overall Study|Randomized in Error|0|||
17139368|NCT03346434|38281140|FG002|Overall Study|Randomized in Error|0|||
17139369|NCT03346434|38281141|FG003|Overall Study|Randomized in Error|0|||
17139370|NCT03346434|38281142|FG004|Overall Study|Randomized in Error|1|||
17139371|NCT03346434|38281143|FG005|Overall Study|Randomized in Error|0|||
17139372|NCT03346434|38281138|FG000|Overall Study|Withdrawal by Subject|0|||
17039871|NCT03948334|38183989|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
17039872|NCT00609765|38184003|FG000|Overall Study|Study ended prior to 12 months|1|||
17039873|NCT00608829|38184007|FG000|Overall Study|Death|6|||
17039874|NCT00608829|38184007|FG000|Overall Study|Withdrawal by Subject|4|||
17039875|NCT00608829|38184007|FG000|Overall Study|Subject refuses to follow up or return.|5|||
17039876|NCT00545818|38184013|FG000|Overall Study|Protocol Violation|1|||
17039877|NCT00545818|38184014|FG001|Overall Study|Protocol Violation|0|||
17039878|NCT00545818|38184013|FG000|Overall Study|Adverse Event|1|||
17039879|NCT00545818|38184014|FG001|Overall Study|Adverse Event|1|||
17039880|NCT00545818|38184013|FG000|Overall Study|Lost to Follow-up|1|||
17039881|NCT00545818|38184014|FG001|Overall Study|Lost to Follow-up|6|||
17039882|NCT00674154|38184022|FG000|Overall Study|Withdrawal by Subject|3|||
17039883|NCT00674154|38184023|FG001|Overall Study|Withdrawal by Subject|1|||
17039884|NCT00674154|38184022|FG000|Overall Study|Did not want parathyroidectomy|0|||
17039885|NCT00674154|38184023|FG001|Overall Study|Did not want parathyroidectomy|2|||
17039886|NCT00608517|38184032|FG000|Overall Study|Death|1|||
17039887|NCT00608517|38184033|FG001|Overall Study|Death|0|||
17039888|NCT00608517|38184034|FG002|Overall Study|Death|0|||
17039889|NCT00608205|38184045|FG000|Overall Study|Adverse Event|3|||
17039890|NCT00608205|38184046|FG001|Overall Study|Adverse Event|2|||
17039891|NCT00608205|38184045|FG000|Overall Study|Patient non-compliant|0|||
17039892|NCT00608205|38184046|FG001|Overall Study|Patient non-compliant|1|||
17039893|NCT00670800|38184056|FG000|Overall Study|2 controls were insulin resistant|0|||
17039894|NCT00670800|38184057|FG001|Overall Study|2 controls were insulin resistant|2|||
17039895|NCT00607893|38184067|FG000|Overall Study|Lost to Follow-up|4|||
17039896|NCT00607893|38184068|FG001|Overall Study|Lost to Follow-up|0|||
17039897|NCT00607893|38184067|FG000|Overall Study|withdrew due to loss of interest|0|||
17039898|NCT00607893|38184068|FG001|Overall Study|withdrew due to loss of interest|1|||
17039899|NCT00607893|38184067|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
17039900|NCT00607893|38184068|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
17039901|NCT00607893|38184067|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
17039902|NCT00607893|38184068|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
17039903|NCT00607893|38184067|FG000|Overall Study|Declined to be treated|1|||
17039904|NCT00607893|38184068|FG001|Overall Study|Declined to be treated|0|||
17039905|NCT00607893|38184067|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
17039906|NCT00607893|38184068|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
17039907|NCT00571038|38184078|FG000|Overall Study|Lost to Follow-up|1|||
17039908|NCT00571038|38184079|FG001|Overall Study|Lost to Follow-up|4|||
17039909|NCT00571038|38184078|FG000|Overall Study|Death|7|||
17039910|NCT00571038|38184079|FG001|Overall Study|Death|5|||
17039911|NCT00571038|38184078|FG000|Overall Study|Withdrawal by Subject|1|||
17039912|NCT00571038|38184079|FG001|Overall Study|Withdrawal by Subject|3|||
17039913|NCT00571038|38184078|FG000|Overall Study|Moved out of state|2|||
17039914|NCT00571038|38184079|FG001|Overall Study|Moved out of state|2|||
17039915|NCT00545740|38184089|FG000|Overall Study|Lack of Efficacy|34|||
17039916|NCT00545740|38184090|FG001|Overall Study|Lack of Efficacy|35|||
17039917|NCT00545740|38184091|FG002|Overall Study|Lack of Efficacy|47|||
17039918|NCT00545740|38184092|FG003|Overall Study|Lack of Efficacy|36|||
17039919|NCT00545740|38184089|FG000|Overall Study|Withdrawal by Subject|17|||
17039920|NCT00545740|38184090|FG001|Overall Study|Withdrawal by Subject|15|||
17039921|NCT00545740|38184091|FG002|Overall Study|Withdrawal by Subject|16|||
17039922|NCT00545740|38184092|FG003|Overall Study|Withdrawal by Subject|18|||
17039923|NCT00545740|38184089|FG000|Overall Study|Adverse Event|10|||
17039924|NCT00545740|38184090|FG001|Overall Study|Adverse Event|18|||
17039925|NCT00545740|38184091|FG002|Overall Study|Adverse Event|19|||
17039926|NCT00545740|38184092|FG003|Overall Study|Adverse Event|9|||
17039927|NCT00545740|38184089|FG000|Overall Study|Lost to Follow-up|7|||
17139373|NCT03346434|38281139|FG001|Overall Study|Withdrawal by Subject|0|||
17139374|NCT03346434|38281140|FG002|Overall Study|Withdrawal by Subject|1|||
17139375|NCT03346434|38281141|FG003|Overall Study|Withdrawal by Subject|0|||
17139376|NCT03346434|38281142|FG004|Overall Study|Withdrawal by Subject|1|||
17139377|NCT03346434|38281143|FG005|Overall Study|Withdrawal by Subject|0|||
17139378|NCT03346434|38281138|FG000|Overall Study|Lost to Follow-up|0|||
17139379|NCT03346434|38281139|FG001|Overall Study|Lost to Follow-up|0|||
17139380|NCT03346434|38281140|FG002|Overall Study|Lost to Follow-up|0|||
17139381|NCT03346434|38281141|FG003|Overall Study|Lost to Follow-up|0|||
17039928|NCT00545740|38184090|FG001|Overall Study|Lost to Follow-up|5|||
17039929|NCT00545740|38184091|FG002|Overall Study|Lost to Follow-up|5|||
17039930|NCT00545740|38184092|FG003|Overall Study|Lost to Follow-up|6|||
17039931|NCT00545740|38184089|FG000|Overall Study|Protocol Violation|1|||
17139382|NCT03346434|38281142|FG004|Overall Study|Lost to Follow-up|1|||
17139383|NCT03346434|38281143|FG005|Overall Study|Lost to Follow-up|1|||
17139384|NCT03346434|38281138|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
17139385|NCT03346434|38281139|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
17039932|NCT00545740|38184090|FG001|Overall Study|Protocol Violation|3|||
17039933|NCT00545740|38184091|FG002|Overall Study|Protocol Violation|1|||
17039934|NCT00545740|38184092|FG003|Overall Study|Protocol Violation|0|||
17039935|NCT00545740|38184089|FG000|Overall Study|Non-compliance|0|||
17039936|NCT00545740|38184090|FG001|Overall Study|Non-compliance|2|||
17039937|NCT00545740|38184091|FG002|Overall Study|Non-compliance|1|||
17039938|NCT00545740|38184092|FG003|Overall Study|Non-compliance|0|||
17039939|NCT00545740|38184089|FG000|Overall Study|Moved|2|||
17039940|NCT00545740|38184090|FG001|Overall Study|Moved|0|||
17039941|NCT00545740|38184091|FG002|Overall Study|Moved|1|||
17039942|NCT00545740|38184092|FG003|Overall Study|Moved|0|||
17039943|NCT00545740|38184089|FG000|Overall Study|Diverticulitis attack|0|||
17039944|NCT00545740|38184090|FG001|Overall Study|Diverticulitis attack|0|||
17039945|NCT00545740|38184091|FG002|Overall Study|Diverticulitis attack|1|||
17039946|NCT00545740|38184092|FG003|Overall Study|Diverticulitis attack|1|||
17039947|NCT00545740|38184089|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
17039948|NCT00545740|38184090|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
17039949|NCT00545740|38184091|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
17039950|NCT00545740|38184092|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
17039951|NCT00545740|38184089|FG000|Overall Study|Site closure|1|||
17039952|NCT00545740|38184090|FG001|Overall Study|Site closure|0|||
17039953|NCT00545740|38184091|FG002|Overall Study|Site closure|0|||
17039954|NCT00545740|38184092|FG003|Overall Study|Site closure|0|||
17039955|NCT00545740|38184089|FG000|Overall Study|Missed visit|1|||
17039956|NCT00545740|38184090|FG001|Overall Study|Missed visit|0|||
17039957|NCT00545740|38184091|FG002|Overall Study|Missed visit|0|||
17039958|NCT00545740|38184092|FG003|Overall Study|Missed visit|0|||
17039959|NCT00545740|38184089|FG000|Overall Study|Physician Decision|0|||
17039960|NCT00545740|38184090|FG001|Overall Study|Physician Decision|0|||
17039961|NCT00545740|38184091|FG002|Overall Study|Physician Decision|3|||
17039962|NCT00545740|38184092|FG003|Overall Study|Physician Decision|0|||
17039963|NCT00545740|38184089|FG000|Overall Study|Accepted only monthly telephone calls|1|||
17039964|NCT00545740|38184090|FG001|Overall Study|Accepted only monthly telephone calls|0|||
17039965|NCT00545740|38184091|FG002|Overall Study|Accepted only monthly telephone calls|0|||
17039966|NCT00545740|38184092|FG003|Overall Study|Accepted only monthly telephone calls|0|||
17039967|NCT00545740|38184089|FG000|Overall Study|Sponsor decision|0|||
17039968|NCT00545740|38184090|FG001|Overall Study|Sponsor decision|1|||
17039969|NCT00545740|38184091|FG002|Overall Study|Sponsor decision|0|||
17039970|NCT00545740|38184092|FG003|Overall Study|Sponsor decision|0|||
17039971|NCT00545740|38184089|FG000|Overall Study|Lack of time|0|||
17039972|NCT00545740|38184090|FG001|Overall Study|Lack of time|1|||
17039973|NCT00545740|38184091|FG002|Overall Study|Lack of time|0|||
17039974|NCT00545740|38184092|FG003|Overall Study|Lack of time|0|||
17039975|NCT00545740|38184089|FG000|Overall Study|Non-adherence to visits|0|||
17039976|NCT00545740|38184090|FG001|Overall Study|Non-adherence to visits|1|||
17039977|NCT00545740|38184091|FG002|Overall Study|Non-adherence to visits|0|||
17039978|NCT00545740|38184092|FG003|Overall Study|Non-adherence to visits|0|||
17039979|NCT00545740|38184089|FG000|Overall Study|Patient difficulties|0|||
17039980|NCT00545740|38184090|FG001|Overall Study|Patient difficulties|1|||
17039981|NCT00545740|38184091|FG002|Overall Study|Patient difficulties|0|||
17039982|NCT00545740|38184092|FG003|Overall Study|Patient difficulties|0|||
17039983|NCT00545740|38184089|FG000|Overall Study|Husband against study|0|||
17039984|NCT00545740|38184090|FG001|Overall Study|Husband against study|0|||
17039985|NCT00545740|38184091|FG002|Overall Study|Husband against study|1|||
17039986|NCT00545740|38184092|FG003|Overall Study|Husband against study|0|||
17039987|NCT00609609|38184104|FG000|Overall Study|Withdrawal by Subject|2|||
17039988|NCT00609609|38184105|FG001|Overall Study|Withdrawal by Subject|0|||
17039989|NCT00609609|38184104|FG000|Overall Study|Progression|4|||
17039990|NCT00609609|38184105|FG001|Overall Study|Progression|2|||
17039991|NCT00673452|38184113|FG000|Acute Double-Blind Phase|Adverse Event|41|||
17039992|NCT00673452|38184114|FG001|Acute Double-Blind Phase|Adverse Event|24|||
17039993|NCT00673452|38184113|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
17039994|NCT00673452|38184114|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
17039995|NCT00673452|38184113|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
17039996|NCT00673452|38184114|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
17039997|NCT00673452|38184113|FG000|Acute Double-Blind Phase|Physician Decision|0|||
17039998|NCT00673452|38184114|FG001|Acute Double-Blind Phase|Physician Decision|6|||
17039999|NCT00673452|38184113|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
17040000|NCT00673452|38184114|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
17040001|NCT00673452|38184113|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
17040002|NCT00673452|38184114|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
17040003|NCT00673452|38184113|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
17040004|NCT00673452|38184114|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
17040005|NCT00673452|38184113|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
17040006|NCT00673452|38184114|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
17139386|NCT03346434|38281140|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
17139387|NCT03346434|38281141|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
17040007|NCT00673452|38184113|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
17040008|NCT00673452|38184114|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
17040009|NCT00673452|38184113|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
17040010|NCT00673452|38184114|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
17139388|NCT03346434|38281142|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
17139389|NCT03346434|38281143|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
17139390|NCT03393000|38281161|FG000|Overall Study|Death|11|||
17139391|NCT03393000|38281161|FG000|Overall Study|Withdrawal by Subject|2|||
17139392|NCT03393000|38281161|FG000|Overall Study|Physician Decision|1|||
17139393|NCT03370770|38281165|FG000|Overall Study|Patient was followed in another hospital center|1|||
17139394|NCT03370770|38281165|FG000|Overall Study|Progressive Disease|98|||
17139395|NCT03370770|38281165|FG000|Overall Study|Adverse Event|2|||
17139396|NCT03370770|38281165|FG000|Overall Study|Death|5|||
17139397|NCT03473301|38281172|FG000|Overall Study|Protocol Violation|4|||
17139398|NCT03473301|38281173|FG001|Overall Study|Protocol Violation|0|||
17139399|NCT03473301|38281174|FG002|Overall Study|Protocol Violation|0|||
17139400|NCT03473301|38281172|FG000|Overall Study|Withdrawal by Subject|0|||
17139401|NCT03473301|38281173|FG001|Overall Study|Withdrawal by Subject|1|||
17139402|NCT03473301|38281174|FG002|Overall Study|Withdrawal by Subject|0|||
17139403|NCT03473301|38281172|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
17139404|NCT03473301|38281173|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
17139405|NCT03473301|38281174|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
17139406|NCT03390426|38281186|FG000|Overall Study|Protocol Violation|0|||
17139407|NCT03390426|38281187|FG001|Overall Study|Protocol Violation|1|||
17139408|NCT03472521|38281195|FG000|Overall Study|Lost to Follow-up|3|||
17139409|NCT03472521|38281196|FG001|Overall Study|Lost to Follow-up|2|||
17139410|NCT03472521|38281195|FG000|Overall Study|Discontinued intervention|3|||
17139411|NCT03472521|38281196|FG001|Overall Study|Discontinued intervention|1|||
17040011|NCT00673452|38184113|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
17040012|NCT00673452|38184114|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
17040013|NCT00673452|38184113|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
17040014|NCT00673452|38184114|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
17040015|NCT00673452|38184113|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
17040016|NCT00673452|38184114|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
17040017|NCT00673452|38184113|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
17040018|NCT00673452|38184114|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
17040019|NCT00673452|38184113|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
17040020|NCT00673452|38184114|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
17040021|NCT00545584|38184123|FG000|Overall Study|Only one reason for discontinuation|62|||
17040022|NCT00545584|38184124|FG001|Overall Study|Only one reason for discontinuation|61|||
17139412|NCT02906020|38281212|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
17139413|NCT02906020|38281213|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
17040023|NCT00545584|38184125|FG002|Overall Study|Only one reason for discontinuation|48|||
17040024|NCT00545584|38184123|FG000|Overall Study|Two or more reasons for discontinuation|17|||
17040025|NCT00545584|38184124|FG001|Overall Study|Two or more reasons for discontinuation|19|||
17040026|NCT00545584|38184125|FG002|Overall Study|Two or more reasons for discontinuation|8|||
17040027|NCT00378703|38184137|FG000|Overall Study|Disease progression|59|||
17040028|NCT00378703|38184138|FG001|Overall Study|Disease progression|43|||
17040029|NCT00378703|38184139|FG002|Overall Study|Disease progression|48|||
17040030|NCT00378703|38184140|FG003|Overall Study|Disease progression|49|||
17040031|NCT00378703|38184137|FG000|Overall Study|Adverse Event|11|||
17040032|NCT00378703|38184138|FG001|Overall Study|Adverse Event|17|||
17040033|NCT00378703|38184139|FG002|Overall Study|Adverse Event|20|||
17040034|NCT00378703|38184140|FG003|Overall Study|Adverse Event|18|||
17040035|NCT00378703|38184137|FG000|Overall Study|Death|2|||
17040036|NCT00378703|38184138|FG001|Overall Study|Death|2|||
17040037|NCT00378703|38184139|FG002|Overall Study|Death|4|||
17040038|NCT00378703|38184140|FG003|Overall Study|Death|3|||
17040039|NCT00378703|38184137|FG000|Overall Study|Withdrawal by Subject|4|||
17040040|NCT00378703|38184138|FG001|Overall Study|Withdrawal by Subject|8|||
17040041|NCT00378703|38184139|FG002|Overall Study|Withdrawal by Subject|5|||
17040042|NCT00378703|38184140|FG003|Overall Study|Withdrawal by Subject|7|||
17040043|NCT00378703|38184137|FG000|Overall Study|Physician Decision|1|||
17040044|NCT00378703|38184138|FG001|Overall Study|Physician Decision|4|||
17040045|NCT00378703|38184139|FG002|Overall Study|Physician Decision|1|||
17040046|NCT00378703|38184140|FG003|Overall Study|Physician Decision|0|||
17040047|NCT00378703|38184137|FG000|Overall Study|Alternative therapy|4|||
17040048|NCT00378703|38184138|FG001|Overall Study|Alternative therapy|2|||
17040049|NCT00378703|38184139|FG002|Overall Study|Alternative therapy|0|||
17040050|NCT00378703|38184140|FG003|Overall Study|Alternative therapy|0|||
17040051|NCT00378703|38184137|FG000|Overall Study|Other complicated disease|0|||
17139414|NCT02906020|38281214|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
17139415|NCT02906020|38281215|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
17139416|NCT02906020|38281216|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
17139417|NCT02906020|38281217|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
17139418|NCT02906020|38281218|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
17139419|NCT02906020|38281219|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
17139420|NCT02906020|38281220|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
17139421|NCT02906020|38281221|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
17040052|NCT00378703|38184138|FG001|Overall Study|Other complicated disease|2|||
17040053|NCT00378703|38184139|FG002|Overall Study|Other complicated disease|2|||
17040054|NCT00378703|38184140|FG003|Overall Study|Other complicated disease|0|||
17040055|NCT00378703|38184137|FG000|Overall Study|Symptomatic deterioration|0|||
17040056|NCT00378703|38184138|FG001|Overall Study|Symptomatic deterioration|1|||
17040057|NCT00378703|38184139|FG002|Overall Study|Symptomatic deterioration|0|||
17040058|NCT00378703|38184140|FG003|Overall Study|Symptomatic deterioration|2|||
17040059|NCT00378703|38184137|FG000|Overall Study|Surgery|1|||
17040060|NCT00378703|38184138|FG001|Overall Study|Surgery|0|||
17040061|NCT00378703|38184139|FG002|Overall Study|Surgery|0|||
17040062|NCT00378703|38184140|FG003|Overall Study|Surgery|1|||
17040063|NCT00378703|38184137|FG000|Overall Study|Joint decision of physician and patient|1|||
17040064|NCT00378703|38184138|FG001|Overall Study|Joint decision of physician and patient|0|||
17040065|NCT00378703|38184139|FG002|Overall Study|Joint decision of physician and patient|0|||
17040066|NCT00378703|38184140|FG003|Overall Study|Joint decision of physician and patient|0|||
17040067|NCT00378703|38184137|FG000|Overall Study|Adverse events and progressive disease|0|||
17040068|NCT00378703|38184138|FG001|Overall Study|Adverse events and progressive disease|0|||
17139422|NCT02906020|38281222|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
17139423|NCT02906020|38281223|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
17139424|NCT02906020|38281224|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
17139425|NCT02906020|38281225|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
17139426|NCT02906020|38281226|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
17139427|NCT02906020|38281227|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
17139428|NCT02906020|38281212|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139429|NCT02906020|38281213|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17040069|NCT00378703|38184139|FG002|Overall Study|Adverse events and progressive disease|0|||
17040070|NCT00378703|38184140|FG003|Overall Study|Adverse events and progressive disease|1|||
17040071|NCT00378703|38184137|FG000|Overall Study|Relocation|0|||
17040072|NCT00378703|38184138|FG001|Overall Study|Relocation|0|||
17040073|NCT00378703|38184139|FG002|Overall Study|Relocation|1|||
17040074|NCT00378703|38184140|FG003|Overall Study|Relocation|0|||
17040075|NCT00378703|38184137|FG000|Overall Study|Ineligible|4|||
17040076|NCT00378703|38184138|FG001|Overall Study|Ineligible|7|||
17040077|NCT00378703|38184139|FG002|Overall Study|Ineligible|7|||
17040078|NCT00378703|38184140|FG003|Overall Study|Ineligible|7|||
17040079|NCT00378703|38184137|FG000|Overall Study|Never started treatment|1|||
17040080|NCT00378703|38184138|FG001|Overall Study|Never started treatment|4|||
17040081|NCT00378703|38184139|FG002|Overall Study|Never started treatment|0|||
17139430|NCT02906020|38281214|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17040082|NCT00378703|38184140|FG003|Overall Study|Never started treatment|0|||
17040083|NCT00378703|38184137|FG000|Overall Study|Other|1|||
17040084|NCT00378703|38184138|FG001|Overall Study|Other|1|||
17139431|NCT02906020|38281215|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139432|NCT02906020|38281216|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17040085|NCT00378703|38184139|FG002|Overall Study|Other|2|||
17040086|NCT00378703|38184140|FG003|Overall Study|Other|3|||
17040087|NCT00368641|38184156|FG000|Overall Study|Adverse Event|2|||
17040088|NCT00368641|38184157|FG001|Overall Study|Adverse Event|1|||
17040089|NCT00368641|38184156|FG000|Overall Study|Death|1|||
17040090|NCT00368641|38184157|FG001|Overall Study|Death|0|||
17040091|NCT00368641|38184156|FG000|Overall Study|Withdrawal by Subject|1|||
17040092|NCT00368641|38184157|FG001|Overall Study|Withdrawal by Subject|0|||
17040093|NCT00368641|38184156|FG000|Overall Study|Sponsor decision to terminate study|2|||
17040094|NCT00368641|38184157|FG001|Overall Study|Sponsor decision to terminate study|5|||
17040095|NCT00608985|38184167|FG000|Overall Study|Adverse Event|2|||
17040096|NCT00608985|38184168|FG001|Overall Study|Adverse Event|7|||
17040097|NCT00608985|38184169|FG002|Overall Study|Adverse Event|4|||
17040098|NCT00608985|38184170|FG003|Overall Study|Adverse Event|6|||
17040099|NCT00608985|38184167|FG000|Overall Study|Administrative/Other|7|||
17040100|NCT00608985|38184168|FG001|Overall Study|Administrative/Other|4|||
17040101|NCT00608985|38184169|FG002|Overall Study|Administrative/Other|1|||
17040102|NCT00608985|38184170|FG003|Overall Study|Administrative/Other|2|||
17040103|NCT00608985|38184167|FG000|Overall Study|Withdrawal of Consent|5|||
17040104|NCT00608985|38184168|FG001|Overall Study|Withdrawal of Consent|1|||
17040105|NCT00608985|38184169|FG002|Overall Study|Withdrawal of Consent|1|||
17040106|NCT00608985|38184170|FG003|Overall Study|Withdrawal of Consent|1|||
17040107|NCT00608985|38184167|FG000|Overall Study|Lost to Follow-up|2|||
17040108|NCT00608985|38184168|FG001|Overall Study|Lost to Follow-up|1|||
17040109|NCT00608985|38184169|FG002|Overall Study|Lost to Follow-up|0|||
17040110|NCT00608985|38184170|FG003|Overall Study|Lost to Follow-up|0|||
17040111|NCT00368251|38184183|FG000|Overall Study|SAE, non-fatal|1|||
17040112|NCT00368251|38184184|FG001|Overall Study|SAE, non-fatal|0|||
17040113|NCT00368251|38184185|FG002|Overall Study|SAE, non-fatal|0|||
17040114|NCT00368251|38184183|FG000|Overall Study|AE, non-serious non-fatal|0|||
17040115|NCT00368251|38184184|FG001|Overall Study|AE, non-serious non-fatal|0|||
17040116|NCT00368251|38184185|FG002|Overall Study|AE, non-serious non-fatal|1|||
17040117|NCT00378079|38184196|FG000|Overall Study|Lost to Follow-up|6|||
17040118|NCT00378079|38184197|FG001|Overall Study|Lost to Follow-up|1|||
17040119|NCT00378079|38184198|FG002|Overall Study|Lost to Follow-up|0|||
17040120|NCT03936244|38184208|FG000|Overall Study|Lost to Follow-up|5|||
17040121|NCT03936244|38184209|FG001|Overall Study|Lost to Follow-up|1|||
17040122|NCT03936244|38184208|FG000|Overall Study|Physician Decision|7|||
17040123|NCT03936244|38184209|FG001|Overall Study|Physician Decision|3|||
17040124|NCT03923530|38184216|FG000|Overall Study|Withdrawal by Subject|1|||
17040125|NCT03923530|38184216|FG000|Overall Study|screen failure|3|||
17040126|NCT00608907|38184223|FG000|Overall Study|Adverse Event|6|||
17040127|NCT00608907|38184224|FG001|Overall Study|Adverse Event|0|||
17040128|NCT00608907|38184225|FG002|Overall Study|Adverse Event|1|||
17040129|NCT00608907|38184223|FG000|Overall Study|Death|1|||
17040130|NCT00608907|38184224|FG001|Overall Study|Death|0|||
17040131|NCT00608907|38184225|FG002|Overall Study|Death|0|||
17040132|NCT00608907|38184223|FG000|Overall Study|Withdrawal by Subject|4|||
17040133|NCT00608907|38184224|FG001|Overall Study|Withdrawal by Subject|0|||
17040134|NCT00608907|38184225|FG002|Overall Study|Withdrawal by Subject|0|||
17040135|NCT00608907|38184223|FG000|Overall Study|Progressive Disease|1|||
17040136|NCT00608907|38184224|FG001|Overall Study|Progressive Disease|0|||
17040137|NCT00608907|38184225|FG002|Overall Study|Progressive Disease|0|||
17040138|NCT00377611|38184235|FG000|Overall Study|Adverse Event|2|||
17040139|NCT00377611|38184236|FG001|Overall Study|Adverse Event|9|||
17040140|NCT00377611|38184235|FG000|Overall Study|Protocol Violation|2|||
17040141|NCT00377611|38184236|FG001|Overall Study|Protocol Violation|0|||
17040142|NCT00377611|38184235|FG000|Overall Study|Withdrawal by Subject|0|||
17040143|NCT00377611|38184236|FG001|Overall Study|Withdrawal by Subject|5|||
17040144|NCT00377611|38184235|FG000|Overall Study|Lost to Follow-up|18|||
17040145|NCT00377611|38184236|FG001|Overall Study|Lost to Follow-up|16|||
17040146|NCT00377611|38184235|FG000|Overall Study|Other|0|||
17040147|NCT00377611|38184236|FG001|Overall Study|Other|3|||
17040148|NCT00545272|38184249|FG000|Overall Study|Protocol deviation|0|||
17040149|NCT00545272|38184250|FG001|Overall Study|Protocol deviation|1|||
17040150|NCT00545272|38184251|FG002|Overall Study|Protocol deviation|0|||
17040151|NCT00545272|38184252|FG003|Overall Study|Protocol deviation|1|||
17040152|NCT00545272|38184253|FG004|Overall Study|Protocol deviation|0|||
17040153|NCT00545272|38184254|FG005|Overall Study|Protocol deviation|1|||
17040154|NCT00545272|38184249|FG000|Overall Study|Adverse Event|0|||
17040155|NCT00545272|38184250|FG001|Overall Study|Adverse Event|0|||
17040156|NCT00545272|38184251|FG002|Overall Study|Adverse Event|1|||
17040157|NCT00545272|38184252|FG003|Overall Study|Adverse Event|0|||
17040158|NCT00545272|38184253|FG004|Overall Study|Adverse Event|0|||
17040159|NCT00545272|38184254|FG005|Overall Study|Adverse Event|1|||
17040160|NCT00545272|38184249|FG000|Overall Study|Abnormal laboratory value(s)|0|||
17040161|NCT00545272|38184250|FG001|Overall Study|Abnormal laboratory value(s)|0|||
17040162|NCT00545272|38184251|FG002|Overall Study|Abnormal laboratory value(s)|0|||
17040163|NCT00545272|38184252|FG003|Overall Study|Abnormal laboratory value(s)|0|||
17139433|NCT02906020|38281217|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139434|NCT02906020|38281218|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139435|NCT02906020|38281219|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139436|NCT02906020|38281220|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
17139437|NCT02906020|38281221|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
17139438|NCT02906020|38281222|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139439|NCT02906020|38281223|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139440|NCT02906020|38281224|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139441|NCT02906020|38281225|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139442|NCT02906020|38281226|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139443|NCT02906020|38281227|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
17139444|NCT02906020|38281212|FG000|Part 2: Double-blind Treatment Period|Other|0|||
17139445|NCT02906020|38281213|FG001|Part 2: Double-blind Treatment Period|Other|0|||
17139446|NCT02906020|38281214|FG002|Part 2: Double-blind Treatment Period|Other|0|||
17139447|NCT02906020|38281215|FG003|Part 2: Double-blind Treatment Period|Other|0|||
17139448|NCT02906020|38281216|FG004|Part 2: Double-blind Treatment Period|Other|0|||
17139449|NCT02906020|38281217|FG005|Part 2: Double-blind Treatment Period|Other|0|||
17139450|NCT02906020|38281218|FG006|Part 2: Double-blind Treatment Period|Other|0|||
17040164|NCT00545272|38184253|FG004|Overall Study|Abnormal laboratory value(s)|0|||
17040165|NCT00545272|38184254|FG005|Overall Study|Abnormal laboratory value(s)|1|||
17040166|NCT00545272|38184249|FG000|Overall Study|Abnormal test procedure result(s)|0|||
17040167|NCT00545272|38184250|FG001|Overall Study|Abnormal test procedure result(s)|0|||
17040168|NCT00545272|38184251|FG002|Overall Study|Abnormal test procedure result(s)|0|||
17040169|NCT00545272|38184252|FG003|Overall Study|Abnormal test procedure result(s)|0|||
17040170|NCT00545272|38184253|FG004|Overall Study|Abnormal test procedure result(s)|1|||
17139451|NCT02906020|38281219|FG007|Part 2: Double-blind Treatment Period|Other|0|||
17139452|NCT02906020|38281220|FG008|Part 2: Double-blind Treatment Period|Other|6|||
17139453|NCT02906020|38281221|FG009|Part 2: Double-blind Treatment Period|Other|10|||
17139454|NCT02906020|38281222|FG010|Part 2: Double-blind Treatment Period|Other|0|||
17040171|NCT00545272|38184254|FG005|Overall Study|Abnormal test procedure result(s)|0|||
17040172|NCT00545272|38184249|FG000|Overall Study|Lost to Follow-up|0|||
17040173|NCT00545272|38184250|FG001|Overall Study|Lost to Follow-up|0|||
17040174|NCT00545272|38184251|FG002|Overall Study|Lost to Follow-up|0|||
17040175|NCT00545272|38184252|FG003|Overall Study|Lost to Follow-up|0|||
17040176|NCT00545272|38184253|FG004|Overall Study|Lost to Follow-up|1|||
17040177|NCT00545272|38184254|FG005|Overall Study|Lost to Follow-up|0|||
17040178|NCT00377455|38184268|FG000|Overall Study|Withdrawal by Subject|1|||
17040179|NCT00377299|38184274|FG000|Overall Study|Lost to Follow-up|14|||
17040180|NCT00377299|38184275|FG001|Overall Study|Lost to Follow-up|19|||
17040181|NCT00377299|38184274|FG000|Overall Study|Adverse Event|0|||
17040182|NCT00377299|38184275|FG001|Overall Study|Adverse Event|1|||
17040183|NCT00377299|38184274|FG000|Overall Study|Withdrawal by Subject|5|||
17040184|NCT00377299|38184275|FG001|Overall Study|Withdrawal by Subject|4|||
17040185|NCT00376675|38184284|FG000|Overall Study|Withdrawal by Subject|9|||
17040186|NCT00376675|38184285|FG001|Overall Study|Withdrawal by Subject|2|||
17040187|NCT00376675|38184284|FG000|Overall Study|Adverse Event|10|||
17040188|NCT00376675|38184285|FG001|Overall Study|Adverse Event|5|||
17040189|NCT00376675|38184284|FG000|Overall Study|Other Reason|1|||
17040190|NCT00376675|38184285|FG001|Overall Study|Other Reason|7|||
17040191|NCT03931330|38184291|FG000|Overall Study|Physician Decision|1|||
17040192|NCT00367237|38184298|FG000|Overall Study|Adverse Event|7|||
17040193|NCT00367237|38184299|FG001|Overall Study|Adverse Event|2|||
17040194|NCT00367237|38184298|FG000|Overall Study|Lost to Follow-up|1|||
17040195|NCT00367237|38184299|FG001|Overall Study|Lost to Follow-up|0|||
17040196|NCT00367237|38184298|FG000|Overall Study|Withdrawal by Subject|0|||
17040197|NCT00367237|38184299|FG001|Overall Study|Withdrawal by Subject|4|||
17040198|NCT00367237|38184298|FG000|Overall Study|Protocol Violation|2|||
17040199|NCT00367237|38184299|FG001|Overall Study|Protocol Violation|5|||
17040200|NCT00544882|38184307|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
17040201|NCT00544882|38184308|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
17040202|NCT00544882|38184309|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
17040203|NCT00544882|38184307|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
17040204|NCT00544882|38184308|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
17040205|NCT00544882|38184309|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
17040206|NCT00544882|38184307|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
17040207|NCT00544882|38184308|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
17040208|NCT00544882|38184309|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
17040209|NCT00544882|38184307|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
17040210|NCT00544882|38184308|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
17040211|NCT00544882|38184309|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
17040212|NCT00544882|38184307|FG000|Cycle 3: Follow-up|Noncompliance|0|||
17040213|NCT00544882|38184308|FG001|Cycle 3: Follow-up|Noncompliance|1|||
17040214|NCT00544882|38184309|FG002|Cycle 3: Follow-up|Noncompliance|0|||
17040215|NCT00544882|38184307|FG000|Cycle 3: Follow-up|Pregnancy|0|||
17040216|NCT00544882|38184308|FG001|Cycle 3: Follow-up|Pregnancy|1|||
17040217|NCT00544882|38184309|FG002|Cycle 3: Follow-up|Pregnancy|0|||
17040218|NCT00606801|38184317|FG000|Intervention|Protocol Violation|3|||
17040219|NCT00606801|38184318|FG001|Intervention|Protocol Violation|3|||
17040220|NCT00606177|38184330|FG000|Overall Study|Adverse Event|9|||
17040221|NCT00606177|38184331|FG001|Overall Study|Adverse Event|5|||
17040222|NCT00606177|38184330|FG000|Overall Study|Lack of Efficacy|3|||
17040223|NCT00606177|38184331|FG001|Overall Study|Lack of Efficacy|7|||
17040224|NCT00606177|38184330|FG000|Overall Study|Physician Decision|1|||
17040225|NCT00606177|38184331|FG001|Overall Study|Physician Decision|0|||
17040226|NCT00606177|38184330|FG000|Overall Study|Protocol Violation|1|||
17040227|NCT00606177|38184331|FG001|Overall Study|Protocol Violation|4|||
17040228|NCT00606177|38184330|FG000|Overall Study|Withdrawal by Subject|5|||
17040229|NCT00606177|38184331|FG001|Overall Study|Withdrawal by Subject|6|||
17040230|NCT00606177|38184330|FG000|Overall Study|Progression to depressive phase|6|||
17040231|NCT00606177|38184331|FG001|Overall Study|Progression to depressive phase|1|||
17040232|NCT00606177|38184330|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
17040233|NCT00606177|38184331|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
17040234|NCT00606177|38184330|FG000|Overall Study|Change of residence or other commitments|1|||
17040235|NCT00606177|38184331|FG001|Overall Study|Change of residence or other commitments|1|||
17040236|NCT00359281|38184346|FG000|Overall Study|Adverse Event|1|||
17040237|NCT00359281|38184347|FG001|Overall Study|Adverse Event|0|||
17040238|NCT00359281|38184348|FG002|Overall Study|Adverse Event|0|||
17040239|NCT00359281|38184349|FG003|Overall Study|Adverse Event|0|||
17040240|NCT00359281|38184350|FG004|Overall Study|Adverse Event|0|||
17040241|NCT00359281|38184351|FG005|Overall Study|Adverse Event|0|||
17040242|NCT00359281|38184352|FG006|Overall Study|Adverse Event|1|||
17040243|NCT00359281|38184353|FG007|Overall Study|Adverse Event|0|||
17040244|NCT00359281|38184354|FG008|Overall Study|Adverse Event|0|||
17040245|NCT00359281|38184346|FG000|Overall Study|Withdrawal by Subject|0|||
17040246|NCT00359281|38184347|FG001|Overall Study|Withdrawal by Subject|0|||
17040247|NCT00359281|38184348|FG002|Overall Study|Withdrawal by Subject|0|||
17040248|NCT00359281|38184349|FG003|Overall Study|Withdrawal by Subject|0|||
17040249|NCT00359281|38184350|FG004|Overall Study|Withdrawal by Subject|0|||
17040250|NCT00359281|38184351|FG005|Overall Study|Withdrawal by Subject|0|||
17040251|NCT00359281|38184352|FG006|Overall Study|Withdrawal by Subject|1|||
17040252|NCT00359281|38184353|FG007|Overall Study|Withdrawal by Subject|0|||
17040253|NCT00359281|38184354|FG008|Overall Study|Withdrawal by Subject|0|||
17040254|NCT00366535|38184383|FG000|First Phase: 12 Weeks|Adverse Event|1|||
17040255|NCT00366535|38184384|FG001|First Phase: 12 Weeks|Adverse Event|3|||
17040256|NCT00366535|38184383|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
17040257|NCT00366535|38184384|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
17040258|NCT00366535|38184383|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
17040259|NCT00366535|38184384|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
17040260|NCT00366535|38184383|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
17040261|NCT00366535|38184384|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
17040262|NCT00350545|38184398|FG000|Overall Study|Withdrawal by Subject|2|||
17040263|NCT00349921|38184406|FG000|First Spinal Injection|Physician Decision|1|||
17040264|NCT00349921|38184407|FG001|First Spinal Injection|Physician Decision|0|||
17040265|NCT00349921|38184408|FG002|First Spinal Injection|Physician Decision|0|||
17040266|NCT00349921|38184409|FG003|First Spinal Injection|Physician Decision|0|||
17040267|NCT00349921|38184406|FG000|First Spinal Injection|Adverse Event|0|||
17040268|NCT00349921|38184407|FG001|First Spinal Injection|Adverse Event|0|||
17040269|NCT00349921|38184408|FG002|First Spinal Injection|Adverse Event|1|||
17040270|NCT00349921|38184409|FG003|First Spinal Injection|Adverse Event|0|||
17040271|NCT00606021|38184420|FG000|Induction Phase|Death|73|||
17040272|NCT00606021|38184421|FG001|Induction Phase|Death|0|||
17040273|NCT00606021|38184422|FG002|Induction Phase|Death|0|||
17040274|NCT00606021|38184420|FG000|Induction Phase|Physician Decision|2|||
17040275|NCT00606021|38184421|FG001|Induction Phase|Physician Decision|0|||
17040276|NCT00606021|38184422|FG002|Induction Phase|Physician Decision|0|||
17040277|NCT00606021|38184420|FG000|Induction Phase|Withdrawal by Subject|2|||
17040278|NCT00606021|38184421|FG001|Induction Phase|Withdrawal by Subject|0|||
17040279|NCT00606021|38184422|FG002|Induction Phase|Withdrawal by Subject|0|||
17040280|NCT00606021|38184420|FG000|Induction Phase|Lost to Follow-up|10|||
17040281|NCT00606021|38184421|FG001|Induction Phase|Lost to Follow-up|0|||
17040282|NCT00606021|38184422|FG002|Induction Phase|Lost to Follow-up|0|||
17040283|NCT00606021|38184420|FG000|Maintenance Phase|Death|0|||
17040284|NCT00606021|38184421|FG001|Maintenance Phase|Death|17|||
17040285|NCT00606021|38184422|FG002|Maintenance Phase|Death|15|||
17040286|NCT00606021|38184420|FG000|Maintenance Phase|Physician Decision|0|||
17040287|NCT00606021|38184421|FG001|Maintenance Phase|Physician Decision|1|||
17040288|NCT00606021|38184422|FG002|Maintenance Phase|Physician Decision|0|||
17040289|NCT00606021|38184420|FG000|Maintenance Phase|Lost to Follow-up|0|||
17040290|NCT00606021|38184421|FG001|Maintenance Phase|Lost to Follow-up|5|||
17040291|NCT00606021|38184422|FG002|Maintenance Phase|Lost to Follow-up|2|||
17040292|NCT00337675|38184433|FG000|Overall Study|Adverse Event|10|||
17040293|NCT00337675|38184434|FG001|Overall Study|Adverse Event|9|||
17040294|NCT00337675|38184435|FG002|Overall Study|Adverse Event|19|||
17040295|NCT00337675|38184433|FG000|Overall Study|Lack of Efficacy|10|||
17040296|NCT00337675|38184434|FG001|Overall Study|Lack of Efficacy|7|||
17040297|NCT00337675|38184435|FG002|Overall Study|Lack of Efficacy|9|||
17040298|NCT00337675|38184433|FG000|Overall Study|Lost to Follow-up|22|||
17040299|NCT00337675|38184434|FG001|Overall Study|Lost to Follow-up|19|||
17040300|NCT00337675|38184435|FG002|Overall Study|Lost to Follow-up|17|||
17040301|NCT00337675|38184433|FG000|Overall Study|Physician Decision|9|||
17040302|NCT00337675|38184434|FG001|Overall Study|Physician Decision|17|||
17040303|NCT00337675|38184435|FG002|Overall Study|Physician Decision|14|||
17040304|NCT00337675|38184433|FG000|Overall Study|Protocol Violation|21|||
17040305|NCT00337675|38184434|FG001|Overall Study|Protocol Violation|24|||
17040306|NCT00337675|38184435|FG002|Overall Study|Protocol Violation|19|||
17040307|NCT00337675|38184433|FG000|Overall Study|Withdrawal by Subject|25|||
17040308|NCT00337675|38184434|FG001|Overall Study|Withdrawal by Subject|25|||
17040309|NCT00337675|38184435|FG002|Overall Study|Withdrawal by Subject|19|||
17040310|NCT00337675|38184433|FG000|Overall Study|Progressive Disease|0|||
17040311|NCT00337675|38184434|FG001|Overall Study|Progressive Disease|2|||
17040312|NCT00337675|38184435|FG002|Overall Study|Progressive Disease|0|||
17040313|NCT00337675|38184433|FG000|Overall Study|Trial Terminated|0|||
17040314|NCT00337675|38184434|FG001|Overall Study|Trial Terminated|0|||
17040315|NCT00337675|38184435|FG002|Overall Study|Trial Terminated|2|||
17040316|NCT00337285|38184443|FG000|Overall Study|Withdrawal by Subject|42|||
17040317|NCT00337285|38184443|FG000|Overall Study|Lost to Follow-up|41|||
17040318|NCT00337285|38184443|FG000|Overall Study|Adverse Event|28|||
17040319|NCT00337285|38184443|FG000|Overall Study|Protocol Violation|27|||
17040320|NCT00337285|38184443|FG000|Overall Study|Lack of Efficacy|11|||
17040321|NCT00337285|38184443|FG000|Overall Study|Death|1|||
17040322|NCT00337285|38184443|FG000|Overall Study|Physician Decision|1|||
17040323|NCT00337285|38184443|FG000|Overall Study|Lack of protocol compliance|7|||
17040324|NCT00605865|38184447|FG000|Overall Study|Protocol Violation|115|||
17040325|NCT00348673|38184487|FG000|Stage 1|Randomized but not Treated|0|||
17040326|NCT00348673|38184488|FG001|Stage 1|Randomized but not Treated|0|||
17040327|NCT00348673|38184489|FG002|Stage 1|Randomized but not Treated|1|||
17040328|NCT00348673|38184490|FG003|Stage 1|Randomized but not Treated|0|||
17040329|NCT00348673|38184491|FG004|Stage 1|Randomized but not Treated|0|||
17040330|NCT00348673|38184492|FG005|Stage 1|Randomized but not Treated|0|||
17040331|NCT00348673|38184493|FG006|Stage 1|Randomized but not Treated|0|||
17040332|NCT00348673|38184494|FG007|Stage 1|Randomized but not Treated|0|||
17040333|NCT00348673|38184495|FG008|Stage 1|Randomized but not Treated|0|||
17040334|NCT00337207|38184513|FG000|Overall Study|Withdrawal by Subject|3|||
17040335|NCT00604695|38184520|FG000|Overall Study|Did not receive first bolus.|0|||
17040336|NCT00604695|38184521|FG001|Overall Study|Did not receive first bolus.|4|||
17040337|NCT00348595|38184529|FG000|Overall Study|Adverse Event|5|||
17040338|NCT00348595|38184530|FG001|Overall Study|Adverse Event|8|||
17040339|NCT00337129|38184536|FG000|Overall Study|Adverse Event|4|||
17040340|NCT00337129|38184536|FG000|Overall Study|Withdrawal by Subject|1|||
17040341|NCT00337129|38184536|FG000|Overall Study|Lack of Efficacy|32|||
17040342|NCT00337129|38184536|FG000|Overall Study|Death|2|||
17040343|NCT00337129|38184536|FG000|Overall Study|not protocol specified|1|||
17040344|NCT00605085|38184542|FG000|Overall Study|Withdrawal by Subject|8|||
17040345|NCT00605085|38184543|FG001|Overall Study|Withdrawal by Subject|5|||
17040346|NCT00605085|38184542|FG000|Overall Study|Adverse Event|9|||
17040347|NCT00605085|38184543|FG001|Overall Study|Adverse Event|5|||
17040348|NCT00605085|38184542|FG000|Overall Study|Pregnancy|2|||
17040349|NCT00605085|38184543|FG001|Overall Study|Pregnancy|0|||
17040350|NCT00605085|38184542|FG000|Overall Study|Protocol Violation|3|||
17040351|NCT00605085|38184543|FG001|Overall Study|Protocol Violation|2|||
17040352|NCT00605085|38184542|FG000|Overall Study|Lost to Follow-up|10|||
17040353|NCT00605085|38184543|FG001|Overall Study|Lost to Follow-up|5|||
17040354|NCT00605085|38184542|FG000|Overall Study|administrative reasons|18|||
17040355|NCT00605085|38184543|FG001|Overall Study|administrative reasons|8|||
17040356|NCT00348283|38184551|FG000|Induction|Adverse Event|0|||
17040357|NCT00348283|38184552|FG001|Induction|Adverse Event|2|||
17040358|NCT00348283|38184551|FG000|Induction|Protocol Violation|0|||
17040359|NCT00348283|38184552|FG001|Induction|Protocol Violation|4|||
17040360|NCT00348283|38184551|FG000|Double Blind|Adverse Event|2|||
17040361|NCT00348283|38184552|FG001|Double Blind|Adverse Event|5|||
17040362|NCT00348283|38184551|FG000|Double Blind|Withdrawal by Subject|1|||
17040363|NCT00348283|38184552|FG001|Double Blind|Withdrawal by Subject|1|||
17040364|NCT00348283|38184551|FG000|Double Blind|Protocol Violation|0|||
17040365|NCT00348283|38184552|FG001|Double Blind|Protocol Violation|1|||
17040366|NCT00348283|38184551|FG000|Double Blind|Lack of Efficacy|2|||
17040367|NCT00348283|38184552|FG001|Double Blind|Lack of Efficacy|2|||
17040368|NCT00348283|38184551|FG000|Double Blind|Pregnancy|0|||
17040369|NCT00348283|38184552|FG001|Double Blind|Pregnancy|1|||
17040370|NCT00348283|38184551|FG000|Open Label|Adverse Event|0|||
17040371|NCT00348283|38184552|FG001|Open Label|Adverse Event|8|||
17040372|NCT00348283|38184551|FG000|Open Label|Withdrawal by Subject|0|||
17040373|NCT00348283|38184552|FG001|Open Label|Withdrawal by Subject|4|||
17040374|NCT00348283|38184551|FG000|Open Label|Lost to Follow-up|0|||
17040375|NCT00348283|38184552|FG001|Open Label|Lost to Follow-up|1|||
17040376|NCT00348283|38184551|FG000|Open Label|Lack of Efficacy|0|||
16992002|NCT00805480|38135932|FG001|Overall Study|Withdrawal by Subject|5|||
16992003|NCT00805480|38135933|FG002|Overall Study|Withdrawal by Subject|11|||
16992004|NCT00805480|38135934|FG003|Overall Study|Withdrawal by Subject|5|||
16992005|NCT00805480|38135931|FG000|Overall Study|Lost to Follow-up|1|||
16992006|NCT00805480|38135932|FG001|Overall Study|Lost to Follow-up|2|||
16992007|NCT00805480|38135933|FG002|Overall Study|Lost to Follow-up|0|||
16992008|NCT00805480|38135934|FG003|Overall Study|Lost to Follow-up|0|||
16992009|NCT00805480|38135931|FG000|Overall Study|Adverse Event|0|||
16992010|NCT00805480|38135932|FG001|Overall Study|Adverse Event|0|||
16992011|NCT00805480|38135933|FG002|Overall Study|Adverse Event|1|||
16992012|NCT00805480|38135934|FG003|Overall Study|Adverse Event|0|||
16992013|NCT00729937|38135950|FG000|Overall Study|Lost to Follow-up|49|||
16992014|NCT00729937|38135951|FG001|Overall Study|Lost to Follow-up|58|||
16992015|NCT00729937|38135952|FG002|Overall Study|Lost to Follow-up|18|||
16992016|NCT00729937|38135953|FG003|Overall Study|Lost to Follow-up|33|||
16992017|NCT00729937|38135954|FG004|Overall Study|Lost to Follow-up|18|||
16992018|NCT00729937|38135955|FG005|Overall Study|Lost to Follow-up|23|||
16992019|NCT00729937|38135950|FG000|Overall Study|Physician Decision|7|||
16992020|NCT00729937|38135951|FG001|Overall Study|Physician Decision|16|||
16992021|NCT00729937|38135952|FG002|Overall Study|Physician Decision|2|||
16992022|NCT00729937|38135953|FG003|Overall Study|Physician Decision|0|||
16992023|NCT00729937|38135954|FG004|Overall Study|Physician Decision|5|||
16992024|NCT00729937|38135955|FG005|Overall Study|Physician Decision|8|||
16992025|NCT00729937|38135950|FG000|Overall Study|Death|1|||
16992026|NCT00729937|38135951|FG001|Overall Study|Death|0|||
16992027|NCT00729937|38135952|FG002|Overall Study|Death|1|||
16992028|NCT00729937|38135953|FG003|Overall Study|Death|0|||
16992029|NCT00729937|38135954|FG004|Overall Study|Death|0|||
16992030|NCT00729937|38135955|FG005|Overall Study|Death|1|||
16992031|NCT00729937|38135950|FG000|Overall Study|Withdrawal by Subject|3|||
16992032|NCT00729937|38135951|FG001|Overall Study|Withdrawal by Subject|5|||
16992033|NCT00729937|38135952|FG002|Overall Study|Withdrawal by Subject|6|||
16992034|NCT00729937|38135953|FG003|Overall Study|Withdrawal by Subject|0|||
16992035|NCT00729937|38135954|FG004|Overall Study|Withdrawal by Subject|4|||
16992036|NCT00729937|38135955|FG005|Overall Study|Withdrawal by Subject|2|||
16992037|NCT00729937|38135950|FG000|Overall Study|Randomized but not treated|12|||
16992038|NCT00729937|38135951|FG001|Overall Study|Randomized but not treated|6|||
16992039|NCT00729937|38135952|FG002|Overall Study|Randomized but not treated|1|||
16992040|NCT00729937|38135953|FG003|Overall Study|Randomized but not treated|0|||
17040377|NCT00348283|38184552|FG001|Open Label|Lack of Efficacy|13|||
17040378|NCT00348283|38184551|FG000|Open Label|Administrative reasons|0|||
17040379|NCT00348283|38184552|FG001|Open Label|Administrative reasons|5|||
17040380|NCT00348283|38184551|FG000|Open Label|Subject moved to the United States|0|||
16992041|NCT00729937|38135954|FG004|Overall Study|Randomized but not treated|1|||
17040381|NCT00348283|38184552|FG001|Open Label|Subject moved to the United States|1|||
17040382|NCT00348283|38184551|FG000|Open Label|Pregnancy|0|||
17040383|NCT00348283|38184552|FG001|Open Label|Pregnancy|1|||
17040384|NCT00348283|38184551|FG000|Open Label|Sponsor decision|0|||
17040385|NCT00348283|38184552|FG001|Open Label|Sponsor decision|1|||
17040386|NCT00336895|38184558|FG000|Overall Study|diarrhea|1|||
17040387|NCT00336895|38184558|FG000|Overall Study|nausea and upset stomach|1|||
17040388|NCT00336895|38184558|FG000|Overall Study|Physician Decision|1|||
17040389|NCT00336895|38184558|FG000|Overall Study|screen failed|1|||
17040390|NCT00336583|38184562|FG000|Overall Study|Lost to Follow-up|1|||
17040391|NCT00336583|38184562|FG000|Overall Study|Death|1|||
17040392|NCT00336505|38184568|FG000|Overall Study|Adverse Event|10|||
17040393|NCT00336505|38184569|FG001|Overall Study|Adverse Event|9|||
17040394|NCT00336505|38184568|FG000|Overall Study|Lack of Efficacy|8|||
17040395|NCT00336505|38184569|FG001|Overall Study|Lack of Efficacy|4|||
17040396|NCT00336505|38184568|FG000|Overall Study|Lost to Follow-up|7|||
17040397|NCT00336505|38184569|FG001|Overall Study|Lost to Follow-up|4|||
17040398|NCT00336505|38184568|FG000|Overall Study|Withdrawal by Subject|5|||
17040399|NCT00336505|38184569|FG001|Overall Study|Withdrawal by Subject|3|||
17040400|NCT00336505|38184568|FG000|Overall Study|Other|7|||
17040401|NCT00336505|38184569|FG001|Overall Study|Other|7|||
17040402|NCT00357877|38184577|FG000|Overall Study|Death|2|||
17040403|NCT00357877|38184578|FG001|Overall Study|Death|1|||
17040404|NCT00357877|38184577|FG000|Overall Study|Lost to Follow-up|20|||
17040405|NCT00357877|38184578|FG001|Overall Study|Lost to Follow-up|23|||
17040406|NCT00357877|38184577|FG000|Overall Study|Withdrawal by Subject|3|||
17040407|NCT00357877|38184578|FG001|Overall Study|Withdrawal by Subject|3|||
17040408|NCT00357877|38184577|FG000|Overall Study|Administrative withdrawal|1|||
17040409|NCT00357877|38184578|FG001|Overall Study|Administrative withdrawal|1|||
17040410|NCT00357877|38184577|FG000|Overall Study|Other|0|||
17040411|NCT00357877|38184578|FG001|Overall Study|Other|2|||
16992042|NCT00729937|38135955|FG005|Overall Study|Randomized but not treated|3|||
16992043|NCT00729937|38135950|FG000|Overall Study|Did not meet eligibility criteria|2|||
17040412|NCT00335959|38184586|FG000|Overall Study|Adverse Event|2|||
17040413|NCT00335959|38184586|FG000|Overall Study|Ineligible|1|||
17040414|NCT00670488|38184601|FG000|Overall Study|Adverse Event|0|||
17040415|NCT00670488|38184602|FG001|Overall Study|Adverse Event|7|||
17040416|NCT00670488|38184603|FG002|Overall Study|Adverse Event|0|||
17040417|NCT00670488|38184604|FG003|Overall Study|Adverse Event|3|||
17040418|NCT00670488|38184605|FG004|Overall Study|Adverse Event|1|||
17040419|NCT00670488|38184606|FG005|Overall Study|Adverse Event|1|||
17040420|NCT00670488|38184607|FG006|Overall Study|Adverse Event|5|||
17040421|NCT00670488|38184608|FG007|Overall Study|Adverse Event|1|||
17040422|NCT00670488|38184609|FG008|Overall Study|Adverse Event|0|||
17040423|NCT00670488|38184610|FG009|Overall Study|Adverse Event|1|||
17040424|NCT00670488|38184601|FG000|Overall Study|Physician Decision|1|||
17040425|NCT00670488|38184602|FG001|Overall Study|Physician Decision|9|||
17040426|NCT00670488|38184603|FG002|Overall Study|Physician Decision|0|||
17040427|NCT00670488|38184604|FG003|Overall Study|Physician Decision|1|||
17040428|NCT00670488|38184605|FG004|Overall Study|Physician Decision|0|||
17040429|NCT00670488|38184606|FG005|Overall Study|Physician Decision|0|||
17040430|NCT00670488|38184607|FG006|Overall Study|Physician Decision|0|||
17040431|NCT00670488|38184608|FG007|Overall Study|Physician Decision|0|||
17040432|NCT00670488|38184609|FG008|Overall Study|Physician Decision|0|||
16992044|NCT00729937|38135951|FG001|Overall Study|Did not meet eligibility criteria|1|||
16992045|NCT00729937|38135952|FG002|Overall Study|Did not meet eligibility criteria|0|||
16992046|NCT00729937|38135953|FG003|Overall Study|Did not meet eligibility criteria|0|||
16992047|NCT00729937|38135954|FG004|Overall Study|Did not meet eligibility criteria|0|||
16992048|NCT00729937|38135955|FG005|Overall Study|Did not meet eligibility criteria|0|||
16992049|NCT00729937|38135950|FG000|Overall Study|Incarcerated|0|||
16992050|NCT00729937|38135951|FG001|Overall Study|Incarcerated|2|||
16992051|NCT00729937|38135952|FG002|Overall Study|Incarcerated|1|||
16992052|NCT00729937|38135953|FG003|Overall Study|Incarcerated|1|||
17040433|NCT00670488|38184610|FG009|Overall Study|Physician Decision|0|||
17040434|NCT00670488|38184601|FG000|Overall Study|Progressive Disease|2|||
17040435|NCT00670488|38184602|FG001|Overall Study|Progressive Disease|41|||
17040436|NCT00670488|38184603|FG002|Overall Study|Progressive Disease|3|||
17040437|NCT00670488|38184604|FG003|Overall Study|Progressive Disease|2|||
17040438|NCT00670488|38184605|FG004|Overall Study|Progressive Disease|2|||
17040439|NCT00670488|38184606|FG005|Overall Study|Progressive Disease|4|||
17040440|NCT00670488|38184607|FG006|Overall Study|Progressive Disease|11|||
17040441|NCT00670488|38184608|FG007|Overall Study|Progressive Disease|2|||
17040442|NCT00670488|38184609|FG008|Overall Study|Progressive Disease|2|||
17040443|NCT00670488|38184610|FG009|Overall Study|Progressive Disease|1|||
17040444|NCT00670488|38184601|FG000|Overall Study|Withdrawal by Subject|0|||
17040445|NCT00670488|38184602|FG001|Overall Study|Withdrawal by Subject|1|||
17040446|NCT00670488|38184603|FG002|Overall Study|Withdrawal by Subject|0|||
17040447|NCT00670488|38184604|FG003|Overall Study|Withdrawal by Subject|1|||
17040448|NCT00670488|38184605|FG004|Overall Study|Withdrawal by Subject|0|||
17040449|NCT00670488|38184606|FG005|Overall Study|Withdrawal by Subject|0|||
17040450|NCT00670488|38184607|FG006|Overall Study|Withdrawal by Subject|1|||
17040451|NCT00670488|38184608|FG007|Overall Study|Withdrawal by Subject|0|||
17040452|NCT00670488|38184609|FG008|Overall Study|Withdrawal by Subject|1|||
17040453|NCT00670488|38184610|FG009|Overall Study|Withdrawal by Subject|0|||
17040454|NCT00671658|38184632|FG000|Overall Study|Physician Decision|5|||
17040455|NCT00542386|38184642|FG000|Overall Study|Adverse Event|1|||
17040456|NCT00542386|38184643|FG001|Overall Study|Adverse Event|7|||
17040457|NCT00542386|38184644|FG002|Overall Study|Adverse Event|7|||
17040458|NCT00542386|38184645|FG003|Overall Study|Adverse Event|8|||
17040459|NCT00542386|38184646|FG004|Overall Study|Adverse Event|13|||
17040460|NCT00542386|38184647|FG005|Overall Study|Adverse Event|4|||
17040461|NCT00542386|38184642|FG000|Overall Study|Death|0|||
17040462|NCT00542386|38184643|FG001|Overall Study|Death|0|||
17040463|NCT00542386|38184644|FG002|Overall Study|Death|1|||
17040464|NCT00542386|38184645|FG003|Overall Study|Death|2|||
17040465|NCT00542386|38184646|FG004|Overall Study|Death|1|||
17040466|NCT00542386|38184647|FG005|Overall Study|Death|2|||
17040467|NCT00542386|38184642|FG000|Overall Study|Lack of Efficacy|32|||
17040468|NCT00542386|38184643|FG001|Overall Study|Lack of Efficacy|12|||
17040469|NCT00542386|38184644|FG002|Overall Study|Lack of Efficacy|10|||
17040470|NCT00542386|38184645|FG003|Overall Study|Lack of Efficacy|13|||
17040471|NCT00542386|38184646|FG004|Overall Study|Lack of Efficacy|7|||
17040472|NCT00542386|38184647|FG005|Overall Study|Lack of Efficacy|31|||
17040473|NCT00542386|38184642|FG000|Overall Study|Physician Decision|1|||
17040474|NCT00542386|38184643|FG001|Overall Study|Physician Decision|0|||
17040475|NCT00542386|38184644|FG002|Overall Study|Physician Decision|0|||
17040476|NCT00542386|38184645|FG003|Overall Study|Physician Decision|1|||
17040477|NCT00542386|38184646|FG004|Overall Study|Physician Decision|0|||
17040478|NCT00542386|38184647|FG005|Overall Study|Physician Decision|0|||
17040479|NCT00542386|38184642|FG000|Overall Study|Protocol Violation|0|||
17040480|NCT00542386|38184643|FG001|Overall Study|Protocol Violation|0|||
17040481|NCT00542386|38184644|FG002|Overall Study|Protocol Violation|1|||
17040482|NCT00542386|38184645|FG003|Overall Study|Protocol Violation|0|||
17040483|NCT00542386|38184646|FG004|Overall Study|Protocol Violation|0|||
17040484|NCT00542386|38184647|FG005|Overall Study|Protocol Violation|4|||
17040485|NCT00542386|38184642|FG000|Overall Study|Withdrawal by Subject|5|||
17040486|NCT00542386|38184643|FG001|Overall Study|Withdrawal by Subject|8|||
17040487|NCT00542386|38184644|FG002|Overall Study|Withdrawal by Subject|10|||
17040488|NCT00542386|38184645|FG003|Overall Study|Withdrawal by Subject|11|||
17040489|NCT00542386|38184646|FG004|Overall Study|Withdrawal by Subject|15|||
17040490|NCT00542386|38184647|FG005|Overall Study|Withdrawal by Subject|7|||
17040491|NCT00542386|38184642|FG000|Overall Study|Other Reasons|4|||
17040492|NCT00542386|38184643|FG001|Overall Study|Other Reasons|1|||
17040493|NCT00542386|38184644|FG002|Overall Study|Other Reasons|4|||
17040494|NCT00542386|38184645|FG003|Overall Study|Other Reasons|3|||
17040495|NCT00542386|38184646|FG004|Overall Study|Other Reasons|4|||
17040496|NCT00542386|38184647|FG005|Overall Study|Other Reasons|2|||
17040497|NCT00604383|38184663|FG000|Overall Study|Withdrawal by Subject|33|||
17040498|NCT00604383|38184664|FG001|Overall Study|Withdrawal by Subject|31|||
17040499|NCT00604383|38184663|FG000|Overall Study|Lost to Follow-up|24|||
17040500|NCT00604383|38184664|FG001|Overall Study|Lost to Follow-up|19|||
17040501|NCT00604383|38184663|FG000|Overall Study|Death|14|||
17040502|NCT00604383|38184664|FG001|Overall Study|Death|22|||
17040503|NCT00604383|38184663|FG000|Overall Study|Adverse Event|16|||
17040504|NCT00604383|38184664|FG001|Overall Study|Adverse Event|9|||
17040505|NCT00604383|38184663|FG000|Overall Study|Physician Decision|0|||
17040506|NCT00604383|38184664|FG001|Overall Study|Physician Decision|3|||
17040507|NCT00333775|38184673|FG000|Overall Study|Death|144|||
17040508|NCT00333775|38184674|FG001|Overall Study|Death|149|||
17040509|NCT00333775|38184675|FG002|Overall Study|Death|143|||
17040510|NCT00333775|38184673|FG000|Overall Study|In Follow-up When Study Stopped|87|||
17040511|NCT00333775|38184674|FG001|Overall Study|In Follow-up When Study Stopped|92|||
17040512|NCT00333775|38184675|FG002|Overall Study|In Follow-up When Study Stopped|96|||
17040513|NCT00333775|38184673|FG000|Overall Study|Lost to Follow-up|10|||
17040514|NCT00333775|38184674|FG001|Overall Study|Lost to Follow-up|7|||
17040515|NCT00333775|38184675|FG002|Overall Study|Lost to Follow-up|8|||
17040516|NCT00605475|38184693|FG000|Overall Study|Abnormal Laboratory Values|0|||
17040517|NCT00605475|38184694|FG001|Overall Study|Abnormal Laboratory Values|0|||
17040518|NCT00605475|38184695|FG002|Overall Study|Abnormal Laboratory Values|0|||
17040519|NCT00605475|38184696|FG003|Overall Study|Abnormal Laboratory Values|0|||
17040520|NCT00605475|38184697|FG004|Overall Study|Abnormal Laboratory Values|0|||
17040521|NCT00605475|38184698|FG005|Overall Study|Abnormal Laboratory Values|0|||
17040522|NCT00605475|38184699|FG006|Overall Study|Abnormal Laboratory Values|0|||
17040523|NCT00605475|38184700|FG007|Overall Study|Abnormal Laboratory Values|0|||
17040524|NCT00605475|38184701|FG008|Overall Study|Abnormal Laboratory Values|1|||
17040525|NCT00605475|38184702|FG009|Overall Study|Abnormal Laboratory Values|0|||
17040526|NCT00605475|38184693|FG000|Overall Study|Administrative problems|0|||
17040527|NCT00605475|38184694|FG001|Overall Study|Administrative problems|0|||
17040528|NCT00605475|38184695|FG002|Overall Study|Administrative problems|0|||
17040529|NCT00605475|38184696|FG003|Overall Study|Administrative problems|0|||
17040530|NCT00605475|38184697|FG004|Overall Study|Administrative problems|0|||
17040531|NCT00605475|38184698|FG005|Overall Study|Administrative problems|0|||
17040532|NCT00605475|38184699|FG006|Overall Study|Administrative problems|1|||
17040533|NCT00605475|38184700|FG007|Overall Study|Administrative problems|0|||
17040534|NCT00605475|38184701|FG008|Overall Study|Administrative problems|0|||
17040535|NCT00605475|38184702|FG009|Overall Study|Administrative problems|0|||
17040536|NCT00605475|38184693|FG000|Overall Study|Lost to Follow-up|0|||
17040537|NCT00605475|38184694|FG001|Overall Study|Lost to Follow-up|0|||
17040538|NCT00605475|38184695|FG002|Overall Study|Lost to Follow-up|0|||
17040539|NCT00605475|38184696|FG003|Overall Study|Lost to Follow-up|0|||
17040540|NCT00605475|38184697|FG004|Overall Study|Lost to Follow-up|0|||
17040541|NCT00605475|38184698|FG005|Overall Study|Lost to Follow-up|0|||
17040542|NCT00605475|38184699|FG006|Overall Study|Lost to Follow-up|0|||
17040543|NCT00605475|38184700|FG007|Overall Study|Lost to Follow-up|0|||
17040544|NCT00605475|38184701|FG008|Overall Study|Lost to Follow-up|1|||
17040545|NCT00605475|38184702|FG009|Overall Study|Lost to Follow-up|1|||
17040546|NCT00605475|38184693|FG000|Overall Study|Protocol Violation|0|||
17040547|NCT00605475|38184694|FG001|Overall Study|Protocol Violation|0|||
17040548|NCT00605475|38184695|FG002|Overall Study|Protocol Violation|0|||
17040549|NCT00605475|38184696|FG003|Overall Study|Protocol Violation|0|||
17040550|NCT00605475|38184697|FG004|Overall Study|Protocol Violation|1|||
17040551|NCT00605475|38184698|FG005|Overall Study|Protocol Violation|0|||
17040552|NCT00605475|38184699|FG006|Overall Study|Protocol Violation|0|||
17040553|NCT00605475|38184700|FG007|Overall Study|Protocol Violation|0|||
17139455|NCT02906020|38281223|FG011|Part 2: Double-blind Treatment Period|Other|0|||
17139456|NCT02906020|38281224|FG012|Part 2: Double-blind Treatment Period|Other|0|||
17139457|NCT02906020|38281225|FG013|Part 2: Double-blind Treatment Period|Other|0|||
17139458|NCT02906020|38281226|FG014|Part 2: Double-blind Treatment Period|Other|0|||
17139459|NCT02906020|38281227|FG015|Part 2: Double-blind Treatment Period|Other|0|||
17139460|NCT02906020|38281212|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17040554|NCT00605475|38184701|FG008|Overall Study|Protocol Violation|0|||
17040555|NCT00605475|38184702|FG009|Overall Study|Protocol Violation|0|||
17040556|NCT00605475|38184693|FG000|Overall Study|Withdrawal by Subject|0|||
17040557|NCT00605475|38184694|FG001|Overall Study|Withdrawal by Subject|0|||
17040558|NCT00605475|38184695|FG002|Overall Study|Withdrawal by Subject|0|||
17139461|NCT02906020|38281213|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139462|NCT02906020|38281214|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139463|NCT02906020|38281215|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139464|NCT02906020|38281216|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139465|NCT02906020|38281217|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139466|NCT02906020|38281218|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139467|NCT02906020|38281219|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139468|NCT02906020|38281220|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139469|NCT02906020|38281221|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139470|NCT02906020|38281222|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139471|NCT02906020|38281223|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139472|NCT02906020|38281224|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
17139473|NCT02906020|38281225|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
17139474|NCT02906020|38281226|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139475|NCT02906020|38281227|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
17139476|NCT02906020|38281212|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139477|NCT02906020|38281213|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139478|NCT02906020|38281214|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139479|NCT02906020|38281215|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139480|NCT02906020|38281216|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139481|NCT02906020|38281217|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139482|NCT02906020|38281218|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139483|NCT02906020|38281219|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17040559|NCT00605475|38184696|FG003|Overall Study|Withdrawal by Subject|0|||
17040560|NCT00605475|38184697|FG004|Overall Study|Withdrawal by Subject|0|||
17040561|NCT00605475|38184698|FG005|Overall Study|Withdrawal by Subject|2|||
17040562|NCT00605475|38184699|FG006|Overall Study|Withdrawal by Subject|0|||
17040563|NCT00605475|38184700|FG007|Overall Study|Withdrawal by Subject|0|||
17040564|NCT00605475|38184701|FG008|Overall Study|Withdrawal by Subject|0|||
17040565|NCT00605475|38184702|FG009|Overall Study|Withdrawal by Subject|1|||
17040566|NCT00333619|38184747|FG000|Overall Study|Death|12|||
17139484|NCT02906020|38281220|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139485|NCT02906020|38281221|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139486|NCT02906020|38281222|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139487|NCT02906020|38281223|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139488|NCT02906020|38281224|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
17139489|NCT02906020|38281225|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
17139490|NCT02906020|38281226|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
17139491|NCT02906020|38281227|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
17139492|NCT02906020|38281212|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139493|NCT02906020|38281213|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139494|NCT02906020|38281214|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139495|NCT02906020|38281215|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139496|NCT02906020|38281216|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139497|NCT02906020|38281217|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139498|NCT02906020|38281218|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139499|NCT02906020|38281219|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139500|NCT02906020|38281220|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139501|NCT02906020|38281221|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139502|NCT02906020|38281222|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139503|NCT02906020|38281223|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139504|NCT02906020|38281224|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
17139505|NCT02906020|38281225|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
17139506|NCT02906020|38281226|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139507|NCT02906020|38281227|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
17139508|NCT02906020|38281212|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139509|NCT02906020|38281213|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139510|NCT02906020|38281214|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139511|NCT02906020|38281215|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139512|NCT02906020|38281216|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139513|NCT02906020|38281217|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139514|NCT02906020|38281218|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139515|NCT02906020|38281219|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139516|NCT02906020|38281220|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139517|NCT02906020|38281221|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139518|NCT02906020|38281222|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139519|NCT02906020|38281223|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139520|NCT02906020|38281224|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
17139521|NCT02906020|38281225|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
17139522|NCT02906020|38281226|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139523|NCT02906020|38281227|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
17139524|NCT02906020|38281212|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139525|NCT02906020|38281213|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139526|NCT02906020|38281214|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139527|NCT02906020|38281215|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139528|NCT02906020|38281216|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139529|NCT02906020|38281217|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139530|NCT02906020|38281218|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139531|NCT02906020|38281219|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139532|NCT02906020|38281220|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139533|NCT02906020|38281221|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139534|NCT02906020|38281222|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139535|NCT02906020|38281223|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
17139536|NCT02906020|38281224|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
17139537|NCT02906020|38281225|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
17139538|NCT02906020|38281226|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
17139539|NCT02906020|38281227|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
17139540|NCT02906020|38281212|FG000|Part 2: Long-term Follow-up Period|Other|0|||
17139541|NCT02906020|38281213|FG001|Part 2: Long-term Follow-up Period|Other|0|||
17139542|NCT02906020|38281214|FG002|Part 2: Long-term Follow-up Period|Other|0|||
17139543|NCT02906020|38281215|FG003|Part 2: Long-term Follow-up Period|Other|0|||
17139544|NCT02906020|38281216|FG004|Part 2: Long-term Follow-up Period|Other|0|||
17139545|NCT02906020|38281217|FG005|Part 2: Long-term Follow-up Period|Other|0|||
17139546|NCT02906020|38281218|FG006|Part 2: Long-term Follow-up Period|Other|0|||
17139547|NCT02906020|38281219|FG007|Part 2: Long-term Follow-up Period|Other|0|||
17139548|NCT02906020|38281220|FG008|Part 2: Long-term Follow-up Period|Other|0|||
17139549|NCT02906020|38281221|FG009|Part 2: Long-term Follow-up Period|Other|0|||
17139550|NCT02906020|38281222|FG010|Part 2: Long-term Follow-up Period|Other|0|||
17139551|NCT02906020|38281223|FG011|Part 2: Long-term Follow-up Period|Other|0|||
17139552|NCT02906020|38281224|FG012|Part 2: Long-term Follow-up Period|Other|13|||
17139553|NCT02906020|38281225|FG013|Part 2: Long-term Follow-up Period|Other|8|||
17040567|NCT00333619|38184748|FG001|Overall Study|Death|6|||
17040568|NCT00333619|38184747|FG000|Overall Study|Withdrawal by Subject|6|||
17040569|NCT00333619|38184748|FG001|Overall Study|Withdrawal by Subject|1|||
17040570|NCT00333619|38184747|FG000|Overall Study|Lost to Follow-up|3|||
17040571|NCT00333619|38184748|FG001|Overall Study|Lost to Follow-up|3|||
17040572|NCT00605319|38184756|FG000|Overall Study|Adverse Event|6|||
17040573|NCT00333229|38184768|FG000|Overall Study|Lack of Efficacy|0|||
17040574|NCT00333229|38184769|FG001|Overall Study|Lack of Efficacy|1|||
17040575|NCT00332839|38184777|FG000|Core (Months 0 - 12)|Administrative problems|1|||
17040576|NCT00332839|38184778|FG001|Core (Months 0 - 12)|Administrative problems|1|||
16992053|NCT00729937|38135954|FG004|Overall Study|Incarcerated|0|||
16992054|NCT00729937|38135955|FG005|Overall Study|Incarcerated|0|||
16992055|NCT00729859|38135972|FG000|Overall Study|Adverse Event|0|||
16992056|NCT00729859|38135973|FG001|Overall Study|Adverse Event|1|||
16992057|NCT00729859|38135974|FG002|Overall Study|Adverse Event|0|||
16992058|NCT00729859|38135972|FG000|Overall Study|Withdrawal by Subject|0|||
16992059|NCT00729859|38135973|FG001|Overall Study|Withdrawal by Subject|1|||
16992060|NCT00729859|38135974|FG002|Overall Study|Withdrawal by Subject|0|||
16992061|NCT00810394|38135990|FG000|Overall Study|Withdrawal by Subject|3|||
16992062|NCT00736333|38135994|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
16992063|NCT00736333|38135994|FG000|Overall Study|Data Missing|2|||
16992064|NCT00736333|38135994|FG000|Overall Study|Tumor Progression|75|||
16992065|NCT00736333|38135994|FG000|Overall Study|Toxicity|6|||
16992066|NCT00736333|38135994|FG000|Overall Study|Withdrawal by Subject|10|||
16992067|NCT00736333|38135994|FG000|Overall Study|Death|7|||
16992068|NCT00736333|38135994|FG000|Overall Study|Other|4|||
17040577|NCT00332839|38184777|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
17040578|NCT00332839|38184778|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
17040579|NCT00332839|38184777|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
17040580|NCT00332839|38184778|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
17040581|NCT00332839|38184777|FG000|Core (Months 0 - 12)|Adverse Event|5|||
17040582|NCT00332839|38184778|FG001|Core (Months 0 - 12)|Adverse Event|15|||
17040583|NCT00332839|38184777|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
17040584|NCT00332839|38184778|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
17040585|NCT00332839|38184777|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
17040586|NCT00332839|38184778|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
17040587|NCT00332839|38184777|FG000|Follow-up (Months 12 - 60)|Death|1|||
17040588|NCT00332839|38184778|FG001|Follow-up (Months 12 - 60)|Death|1|||
17040589|NCT00357097|38184786|FG000|Overall Study|Did not meet inclusion criteria|5|||
16992069|NCT00736255|38136000|FG000|Overall Study|Adverse Event|1|||
17040590|NCT00357097|38184787|FG001|Overall Study|Did not meet inclusion criteria|3|||
17040591|NCT00357097|38184786|FG000|Overall Study|Adverse Event|34|||
17040592|NCT00357097|38184787|FG001|Overall Study|Adverse Event|6|||
17040593|NCT00357097|38184786|FG000|Overall Study|Withdrawal by Subject|8|||
17040594|NCT00357097|38184787|FG001|Overall Study|Withdrawal by Subject|7|||
17040595|NCT00357097|38184786|FG000|Overall Study|Non-compliance|1|||
17040596|NCT00357097|38184787|FG001|Overall Study|Non-compliance|2|||
17040597|NCT00357097|38184786|FG000|Overall Study|Lack of Efficacy|2|||
17040598|NCT00357097|38184787|FG001|Overall Study|Lack of Efficacy|8|||
17040599|NCT00357097|38184786|FG000|Overall Study|Met Exclusion Criteria|3|||
17040600|NCT00357097|38184787|FG001|Overall Study|Met Exclusion Criteria|1|||
17040601|NCT00357097|38184786|FG000|Overall Study|Other|1|||
17040602|NCT00357097|38184787|FG001|Overall Study|Other|1|||
17040603|NCT00357097|38184786|FG000|Overall Study|Increase of RLS Symptoms|0|||
17040604|NCT00357097|38184787|FG001|Overall Study|Increase of RLS Symptoms|1|||
17040605|NCT00356863|38184795|FG000|Overall Study|Death|16|||
17040606|NCT00356863|38184796|FG001|Overall Study|Death|32|||
17040607|NCT00356863|38184795|FG000|Overall Study|Lost to Follow-up|76|||
17040608|NCT00356863|38184796|FG001|Overall Study|Lost to Follow-up|43|||
16992070|NCT00736255|38136001|FG001|Overall Study|Adverse Event|0|||
17040609|NCT00355615|38184819|FG000|Randomized Double Blind Period|Adverse Event|1|||
17139554|NCT02906020|38281226|FG014|Part 2: Long-term Follow-up Period|Other|3|||
17139555|NCT02906020|38281227|FG015|Part 2: Long-term Follow-up Period|Other|2|||
16992071|NCT00736255|38136000|FG000|Overall Study|Physician Decision|1|||
17040610|NCT00355615|38184820|FG001|Randomized Double Blind Period|Adverse Event|0|||
17040611|NCT00355615|38184821|FG002|Randomized Double Blind Period|Adverse Event|0|||
17040612|NCT00355615|38184822|FG003|Randomized Double Blind Period|Adverse Event|0|||
17040613|NCT00355615|38184823|FG004|Randomized Double Blind Period|Adverse Event|0|||
17040614|NCT00355615|38184819|FG000|Randomized Double Blind Period|Protocol Violation|0|||
17040615|NCT00355615|38184820|FG001|Randomized Double Blind Period|Protocol Violation|0|||
17040616|NCT00355615|38184821|FG002|Randomized Double Blind Period|Protocol Violation|1|||
17040617|NCT00355615|38184822|FG003|Randomized Double Blind Period|Protocol Violation|1|||
17040618|NCT00355615|38184823|FG004|Randomized Double Blind Period|Protocol Violation|0|||
17040619|NCT00355615|38184819|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
17040620|NCT00355615|38184820|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
17040621|NCT00355615|38184821|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
16992072|NCT00736255|38136001|FG001|Overall Study|Physician Decision|0|||
16992073|NCT00736255|38136000|FG000|Overall Study|Non-compliance|1|||
16992074|NCT00736255|38136001|FG001|Overall Study|Non-compliance|1|||
16992075|NCT03920254|38136010|FG000|Overall Study|Adverse Event|1|||
16992076|NCT03920254|38136011|FG001|Overall Study|Adverse Event|0|||
16992077|NCT03920254|38136012|FG002|Overall Study|Adverse Event|0|||
16992078|NCT03920254|38136010|FG000|Overall Study|Physician Decision|0|||
16992079|NCT03920254|38136011|FG001|Overall Study|Physician Decision|1|||
16992080|NCT03920254|38136012|FG002|Overall Study|Physician Decision|2|||
16992081|NCT03920254|38136010|FG000|Overall Study|Study Terminated By Sponsor|12|||
16992082|NCT03920254|38136011|FG001|Overall Study|Study Terminated By Sponsor|17|||
16992083|NCT03920254|38136012|FG002|Overall Study|Study Terminated By Sponsor|12|||
16992084|NCT03920254|38136010|FG000|Overall Study|Withdrawal by Subject|0|||
16992085|NCT03920254|38136011|FG001|Overall Study|Withdrawal by Subject|0|||
16992086|NCT03920254|38136012|FG002|Overall Study|Withdrawal by Subject|1|||
16992087|NCT00729469|38136022|FG000|Overall Study|Adverse Event|14|||
16992088|NCT00729469|38136023|FG001|Overall Study|Adverse Event|25|||
16992089|NCT00729469|38136022|FG000|Overall Study|Lost to Follow-up|9|||
16992090|NCT00729469|38136023|FG001|Overall Study|Lost to Follow-up|9|||
16992091|NCT00729469|38136022|FG000|Overall Study|Protocol Violation|2|||
16992092|NCT00729469|38136023|FG001|Overall Study|Protocol Violation|1|||
16992093|NCT00729469|38136022|FG000|Overall Study|Withdrawal by Subject|19|||
16992094|NCT00729469|38136023|FG001|Overall Study|Withdrawal by Subject|8|||
16992095|NCT00729469|38136022|FG000|Overall Study|Other-Not mentioned|9|||
16992096|NCT00729469|38136023|FG001|Overall Study|Other-Not mentioned|4|||
16992097|NCT00742183|38136031|FG000|Overall Study|Adverse Event|2|||
16992098|NCT00742183|38136032|FG001|Overall Study|Adverse Event|2|||
16992099|NCT00742183|38136031|FG000|Overall Study|Death|1|||
16992100|NCT00742183|38136032|FG001|Overall Study|Death|0|||
16992101|NCT00742183|38136031|FG000|Overall Study|Physician Decision|0|||
16992102|NCT00742183|38136032|FG001|Overall Study|Physician Decision|2|||
16992103|NCT00742183|38136031|FG000|Overall Study|Lost to Follow-up|4|||
16992104|NCT00742183|38136032|FG001|Overall Study|Lost to Follow-up|4|||
16992105|NCT00742183|38136031|FG000|Overall Study|Required skin-graft|1|||
16992106|NCT00742183|38136032|FG001|Overall Study|Required skin-graft|1|||
16992107|NCT00742183|38136031|FG000|Overall Study|Withdrawal by Subject|1|||
16992108|NCT00742183|38136032|FG001|Overall Study|Withdrawal by Subject|0|||
16992109|NCT00742183|38136031|FG000|Overall Study|Lack of Efficacy|0|||
16992110|NCT00742183|38136032|FG001|Overall Study|Lack of Efficacy|3|||
16992111|NCT00808444|38136040|FG000|Overall Study|Withdrawal by Subject|1|||
16992112|NCT00808444|38136041|FG001|Overall Study|Withdrawal by Subject|0|||
16992113|NCT00808444|38136040|FG000|Overall Study|Lost to Follow-up|0|||
16992114|NCT00808444|38136041|FG001|Overall Study|Lost to Follow-up|1|||
16992115|NCT00742027|38136047|FG000|Overall Study|Disease Progression|76|||
16992116|NCT00742027|38136047|FG000|Overall Study|New Cancer Therapy|19|||
16992117|NCT00742027|38136047|FG000|Overall Study|Withdrawal by Subject|18|||
16992118|NCT00742027|38136047|FG000|Overall Study|Death|7|||
16992119|NCT00742027|38136047|FG000|Overall Study|Lost to Follow-up|4|||
16992120|NCT00742027|38136047|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
16992121|NCT00742027|38136047|FG000|Overall Study|Missing|2|||
16992122|NCT00742027|38136047|FG000|Overall Study|Administrative Problems|1|||
16992123|NCT03996369|38136053|FG000|Overall Study|Protocol deviation|1|||
16992124|NCT03996369|38136054|FG001|Overall Study|Protocol deviation|1|||
16992125|NCT03996369|38136053|FG000|Overall Study|Physician Decision|4|||
16992126|NCT03996369|38136054|FG001|Overall Study|Physician Decision|2|||
16992127|NCT03996369|38136053|FG000|Overall Study|Participant decision|0|||
16992128|NCT03996369|38136054|FG001|Overall Study|Participant decision|1|||
16992129|NCT03996369|38136053|FG000|Overall Study|Lack of Efficacy|4|||
16992130|NCT03996369|38136054|FG001|Overall Study|Lack of Efficacy|0|||
16992131|NCT03996369|38136053|FG000|Overall Study|Adverse Event|9|||
16992132|NCT03996369|38136054|FG001|Overall Study|Adverse Event|0|||
16992133|NCT03996369|38136053|FG000|Overall Study|Withdrawal by Subject|6|||
16992134|NCT03996369|38136054|FG001|Overall Study|Withdrawal by Subject|8|||
16992135|NCT03996369|38136053|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
16992136|NCT03996369|38136054|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
16992137|NCT03996369|38136053|FG000|Overall Study|Lost to Follow-up|0|||
16992138|NCT03996369|38136054|FG001|Overall Study|Lost to Follow-up|1|||
16992139|NCT00808210|38136062|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
16992140|NCT00808210|38136063|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
16992141|NCT00808210|38136062|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
16992142|NCT00808210|38136063|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
17139556|NCT03499353|38281255|FG000|Treatment|Adverse Event|3|||
17040622|NCT00355615|38184822|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
17040623|NCT00355615|38184823|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
17040624|NCT00355615|38184819|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
17139557|NCT03499353|38281255|FG000|Treatment|Progressive Disease|10|||
17139558|NCT03499353|38281255|FG000|Treatment|Other|1|||
17040625|NCT00355615|38184820|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
17040626|NCT00355615|38184821|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
17040627|NCT00355615|38184822|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
17040628|NCT00355615|38184823|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
17040629|NCT00355615|38184819|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
17040630|NCT00355615|38184820|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
17040631|NCT00355615|38184821|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
17040632|NCT00355615|38184822|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
17040633|NCT00355615|38184823|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
17040634|NCT00355615|38184819|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
17040635|NCT00355615|38184820|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
17040636|NCT00355615|38184821|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
17040637|NCT00355615|38184822|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
17040638|NCT00355615|38184823|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
17040639|NCT00347269|38184836|FG000|Overall Study|Lost to Follow-up|74|||
17040640|NCT00347269|38184837|FG001|Overall Study|Lost to Follow-up|65|||
17040641|NCT00347269|38184836|FG000|Overall Study|Withdrawal by Subject|18|||
17139559|NCT03499353|38281255|FG000|Treatment|Withdrawal by Subject|2|||
17139560|NCT03499353|38281255|FG000|Long-Term Follow-up|Death|2|||
17139561|NCT03499353|38281255|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
17139562|NCT03499353|38281255|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
17139563|NCT03368664|38281259|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
17139564|NCT03368664|38281259|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
17040642|NCT00347269|38184837|FG001|Overall Study|Withdrawal by Subject|38|||
17040643|NCT00347269|38184836|FG000|Overall Study|Death|2|||
17040644|NCT00347269|38184837|FG001|Overall Study|Death|3|||
17040645|NCT00544648|38184845|FG000|Overall Study|Withdrawal by Subject|1|||
17040646|NCT00544648|38184846|FG001|Overall Study|Withdrawal by Subject|0|||
17040647|NCT00544648|38184845|FG000|Overall Study|Adverse Event|1|||
17040648|NCT00544648|38184846|FG001|Overall Study|Adverse Event|1|||
17040649|NCT00544648|38184845|FG000|Overall Study|progression of disease|1|||
17040650|NCT00544648|38184846|FG001|Overall Study|progression of disease|0|||
17040651|NCT00346333|38184856|FG000|Overall Study|Death|1|||
17040652|NCT00346333|38184857|FG001|Overall Study|Death|0|||
17040653|NCT00346333|38184856|FG000|Overall Study|unwilling or unable to continue|4|||
17040654|NCT00346333|38184857|FG001|Overall Study|unwilling or unable to continue|8|||
17040655|NCT00330967|38184867|FG000|Overall Study|Withdrawal by Subject|0|||
17040656|NCT00330967|38184868|FG001|Overall Study|Withdrawal by Subject|5|||
17040657|NCT00330967|38184867|FG000|Overall Study|Physician Decision|0|||
17040658|NCT00330967|38184868|FG001|Overall Study|Physician Decision|9|||
17040659|NCT00330343|38184874|FG000|Overall Study|Lost to Follow-up|5|||
17040660|NCT00330187|38184882|FG000|Overall Study|Lost to Follow-up|12|||
17040661|NCT00330187|38184883|FG001|Overall Study|Lost to Follow-up|13|||
17040662|NCT00330187|38184884|FG002|Overall Study|Lost to Follow-up|14|||
17040663|NCT00330187|38184885|FG003|Overall Study|Lost to Follow-up|10|||
17040664|NCT00330187|38184882|FG000|Overall Study|Withdrawal by Subject|8|||
17139565|NCT03368664|38281259|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
17139566|NCT03368664|38281259|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
17139567|NCT00004259|38281271|FG000|Overall Study|Protocol Violation|1|||
17139568|NCT00004259|38281272|FG001|Overall Study|Protocol Violation|2|||
17139569|NCT00004259|38281273|FG002|Overall Study|Protocol Violation|0|||
17139570|NCT00004259|38281274|FG003|Overall Study|Protocol Violation|0|||
17139571|NCT00004259|38281271|FG000|Overall Study|Withdrawal by Subject|0|||
17139572|NCT00004259|38281272|FG001|Overall Study|Withdrawal by Subject|2|||
17139573|NCT00004259|38281273|FG002|Overall Study|Withdrawal by Subject|0|||
17139574|NCT00004259|38281274|FG003|Overall Study|Withdrawal by Subject|0|||
17139575|NCT03365934|38281298|FG000|Overall Study|Adverse Event|1|||
17139576|NCT03365934|38281298|FG000|Overall Study|Withdrawal by Subject|1|||
17139577|NCT03468855|38281307|FG000|Overall Study|Adverse Event|2|||
17139578|NCT03468855|38281307|FG000|Overall Study|Lost to Follow-up|5|||
17139579|NCT03468855|38281307|FG000|Overall Study|Withdrawal by Subject|3|||
17139580|NCT03468855|38281307|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
17139581|NCT03738865|38281313|FG000|Overall Study|Withdrawal by Subject|3|||
17139582|NCT03738865|38281314|FG001|Overall Study|Withdrawal by Subject|3|||
17139583|NCT03738865|38281313|FG000|Overall Study|Adverse Event|2|||
17139584|NCT03738865|38281314|FG001|Overall Study|Adverse Event|0|||
17040665|NCT00330187|38184883|FG001|Overall Study|Withdrawal by Subject|5|||
17040666|NCT00330187|38184884|FG002|Overall Study|Withdrawal by Subject|4|||
17040667|NCT00330187|38184885|FG003|Overall Study|Withdrawal by Subject|4|||
17040668|NCT03914950|38184895|FG000|Overall Study|Physician Decision|54|||
17040669|NCT00329797|38184907|FG000|Overall Study|Protocol Violation|1|||
17040670|NCT00329797|38184908|FG001|Overall Study|Protocol Violation|0|||
17040671|NCT00329797|38184907|FG000|Overall Study|Withdrawal by Subject|6|||
17040672|NCT00329797|38184908|FG001|Overall Study|Withdrawal by Subject|6|||
17040673|NCT00541450|38184916|FG000|Phase A|Adverse Event|3|||
17040674|NCT00541450|38184917|FG001|Phase A|Adverse Event|0|||
17040675|NCT00541450|38184916|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
16992143|NCT00808210|38136062|FG000|Double-Blind TX Period|Adverse Event|0|||
16992144|NCT00808210|38136063|FG001|Double-Blind TX Period|Adverse Event|1|||
16992145|NCT00808210|38136062|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
16992146|NCT00808210|38136063|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
16992147|NCT00808210|38136062|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
16992148|NCT00808210|38136063|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
16992149|NCT00808210|38136062|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
16992150|NCT00808210|38136063|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
16992151|NCT00736099|38136071|FG000|Overall Study|Adverse Event|61|||
16992152|NCT00736099|38136072|FG001|Overall Study|Adverse Event|18|||
16992153|NCT00736099|38136071|FG000|Overall Study|Protocol Violation|10|||
16992154|NCT00736099|38136072|FG001|Overall Study|Protocol Violation|4|||
16992155|NCT00736099|38136071|FG000|Overall Study|Lost to Follow-up|12|||
16992156|NCT00736099|38136072|FG001|Overall Study|Lost to Follow-up|5|||
16992157|NCT00736099|38136071|FG000|Overall Study|Withdrawal by Subject|42|||
16992158|NCT00736099|38136072|FG001|Overall Study|Withdrawal by Subject|13|||
16992159|NCT00736099|38136071|FG000|Overall Study|Lack of Efficacy|15|||
16992160|NCT00736099|38136072|FG001|Overall Study|Lack of Efficacy|8|||
16992161|NCT00736099|38136071|FG000|Overall Study|Other reason|43|||
16992162|NCT00736099|38136072|FG001|Overall Study|Other reason|10|||
16992163|NCT00735943|38136078|FG000|Overall Study|Lost to Follow-up|1|||
16992164|NCT00735943|38136078|FG000|Overall Study|Adverse Event|1|||
17040676|NCT00541450|38184917|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
17040677|NCT00541450|38184916|FG000|Phase A|Hyperglycemia|0|||
17040678|NCT00541450|38184917|FG001|Phase A|Hyperglycemia|1|||
17040679|NCT00541450|38184916|FG000|Phase A|Lost to Follow-up|6|||
17040680|NCT00541450|38184917|FG001|Phase A|Lost to Follow-up|4|||
17040681|NCT00541450|38184916|FG000|Phase A|Physician Decision|2|||
17040682|NCT00541450|38184917|FG001|Phase A|Physician Decision|0|||
17040683|NCT00541450|38184916|FG000|Phase A|Protocol Violation|2|||
17040684|NCT00541450|38184917|FG001|Phase A|Protocol Violation|3|||
17040685|NCT00541450|38184916|FG000|Phase A|Withdrawal by Subject|7|||
17040686|NCT00541450|38184917|FG001|Phase A|Withdrawal by Subject|7|||
17040687|NCT00541450|38184916|FG000|Phase B|Adverse Event|6|||
17040688|NCT00541450|38184917|FG001|Phase B|Adverse Event|6|||
17040689|NCT00541450|38184916|FG000|Phase B|Hyperglycemia|10|||
17040690|NCT00541450|38184917|FG001|Phase B|Hyperglycemia|9|||
17040691|NCT00541450|38184916|FG000|Phase B|Lost to Follow-up|6|||
17040692|NCT00541450|38184917|FG001|Phase B|Lost to Follow-up|4|||
17040693|NCT00541450|38184916|FG000|Phase B|Physician Decision|4|||
17040694|NCT00541450|38184917|FG001|Phase B|Physician Decision|2|||
17040695|NCT00541450|38184916|FG000|Phase B|Pregnancy|0|||
17040696|NCT00541450|38184917|FG001|Phase B|Pregnancy|1|||
17040697|NCT00541450|38184916|FG000|Phase B|Protocol Violation|3|||
16782560|NCT01663623|37722164|FG001|Overall Study|Physician Decision|4|||
17139585|NCT03738865|38281313|FG000|Overall Study|Physician Decision|0|||
17139586|NCT03738865|38281314|FG001|Overall Study|Physician Decision|1|||
17139587|NCT03524157|38281323|FG000|Overall Study|cytology not readable|0|||
17139588|NCT03524157|38281324|FG001|Overall Study|cytology not readable|0|||
17139589|NCT03524157|38281325|FG002|Overall Study|cytology not readable|1|||
17040698|NCT00541450|38184917|FG001|Phase B|Protocol Violation|3|||
17040699|NCT00541450|38184916|FG000|Phase B|Withdrawal by Subject|8|||
17040700|NCT00541450|38184917|FG001|Phase B|Withdrawal by Subject|6|||
17040701|NCT00355147|38184929|FG000|Overall Study|Lost to Follow-up|10|||
17040702|NCT00355147|38184930|FG001|Overall Study|Lost to Follow-up|8|||
17040703|NCT00355147|38184929|FG000|Overall Study|Withdrawal by Subject|8|||
17040704|NCT00355147|38184930|FG001|Overall Study|Withdrawal by Subject|12|||
17040705|NCT03909100|38184940|FG000|Overall Study|Protocol Deviation|2|||
17040706|NCT03909100|38184940|FG000|Overall Study|Technical Problems|4|||
17040707|NCT03909100|38184940|FG000|Overall Study|Withdrawal by Subject|4|||
17040708|NCT03909100|38184940|FG000|Overall Study|Lost to Follow-up|1|||
17040709|NCT03909100|38184940|FG000|Overall Study|Reason not Specified|4|||
17040710|NCT00540124|38184950|FG000|Overall Study|Adverse Event|0|||
17040711|NCT00540124|38184951|FG001|Overall Study|Adverse Event|2|||
17040712|NCT00540124|38184952|FG002|Overall Study|Adverse Event|1|||
17040713|NCT00540124|38184950|FG000|Overall Study|Entry Criteria Not Met|2|||
17040714|NCT00540124|38184951|FG001|Overall Study|Entry Criteria Not Met|0|||
17040715|NCT00540124|38184952|FG002|Overall Study|Entry Criteria Not Met|0|||
17040716|NCT00540124|38184950|FG000|Overall Study|Lack of Efficacy|1|||
17040717|NCT00540124|38184951|FG001|Overall Study|Lack of Efficacy|0|||
17040718|NCT00540124|38184952|FG002|Overall Study|Lack of Efficacy|0|||
17040719|NCT00540124|38184950|FG000|Overall Study|Withdrawal by Subject|1|||
17040720|NCT00540124|38184951|FG001|Overall Study|Withdrawal by Subject|1|||
17040721|NCT00540124|38184952|FG002|Overall Study|Withdrawal by Subject|0|||
17040722|NCT00540046|38184962|FG000|Overall Study|Lost to Follow-up|33|||
17040723|NCT00540046|38184963|FG001|Overall Study|Lost to Follow-up|23|||
17040724|NCT00689936|38184974|FG000|Active Treatment Phase|Adverse Event|68|||
17040725|NCT00689936|38184975|FG001|Active Treatment Phase|Adverse Event|71|||
17040726|NCT00689936|38184976|FG002|Active Treatment Phase|Adverse Event|76|||
17040727|NCT00689936|38184974|FG000|Active Treatment Phase|Disease Progression|273|||
17040728|NCT00689936|38184975|FG001|Active Treatment Phase|Disease Progression|362|||
17040729|NCT00689936|38184976|FG002|Active Treatment Phase|Disease Progression|339|||
17040730|NCT00689936|38184974|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
17040731|NCT00689936|38184975|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
17040732|NCT00689936|38184976|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
17139590|NCT03437733|38281339|FG000|Overall Study|Eligibility criteria not met|0|||
17040733|NCT00689936|38184974|FG000|Active Treatment Phase|Death|60|||
17040734|NCT00689936|38184975|FG001|Active Treatment Phase|Death|28|||
17040735|NCT00689936|38184976|FG002|Active Treatment Phase|Death|37|||
17040736|NCT00689936|38184974|FG000|Active Treatment Phase|Lost to Follow-up|0|||
17040737|NCT00689936|38184975|FG001|Active Treatment Phase|Lost to Follow-up|2|||
17040738|NCT00689936|38184976|FG002|Active Treatment Phase|Lost to Follow-up|2|||
17040739|NCT00689936|38184974|FG000|Active Treatment Phase|Protocol Violation|2|||
17040740|NCT00689936|38184975|FG001|Active Treatment Phase|Protocol Violation|2|||
17040741|NCT00689936|38184976|FG002|Active Treatment Phase|Protocol Violation|4|||
17139591|NCT03437733|38281340|FG001|Overall Study|Eligibility criteria not met|3|||
17139592|NCT03468543|38281348|FG000|Overall Study|Protocol stopping rules met|3|||
17139593|NCT03467763|38281352|FG000|Overall Study|Lost to Follow-up|1|||
17139594|NCT03467763|38281352|FG000|Overall Study|Protocol Violation|2|||
17040742|NCT00689936|38184974|FG000|Active Treatment Phase|Study Close Out|64|||
17040743|NCT00689936|38184975|FG001|Active Treatment Phase|Study Close Out|26|||
17040744|NCT00689936|38184976|FG002|Active Treatment Phase|Study Close Out|21|||
17040745|NCT00689936|38184974|FG000|Active Treatment Phase|Miscellaneous|52|||
17040746|NCT00689936|38184975|FG001|Active Treatment Phase|Miscellaneous|34|||
17040747|NCT00689936|38184976|FG002|Active Treatment Phase|Miscellaneous|47|||
17040748|NCT00689936|38184974|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
17040749|NCT00689936|38184975|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
17040750|NCT00689936|38184976|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
17040751|NCT00671034|38184987|FG000|Overall Study|Adverse Event|5|||
17040752|NCT00671034|38184988|FG001|Overall Study|Adverse Event|7|||
17040753|NCT00671034|38184989|FG002|Overall Study|Adverse Event|1|||
17040754|NCT00671034|38184987|FG000|Overall Study|Death|3|||
17040755|NCT00671034|38184988|FG001|Overall Study|Death|2|||
17040756|NCT00671034|38184989|FG002|Overall Study|Death|1|||
17040757|NCT00671034|38184987|FG000|Overall Study|Physician Decision|12|||
17040758|NCT00671034|38184988|FG001|Overall Study|Physician Decision|4|||
17040759|NCT00671034|38184989|FG002|Overall Study|Physician Decision|5|||
17040760|NCT00671034|38184987|FG000|Overall Study|VHR ALL feature|8|||
17040761|NCT00671034|38184988|FG001|Overall Study|VHR ALL feature|3|||
17040762|NCT00671034|38184989|FG002|Overall Study|VHR ALL feature|5|||
17040763|NCT00671034|38184987|FG000|Overall Study|Refusal|5|||
17040764|NCT00671034|38184988|FG001|Overall Study|Refusal|3|||
17040765|NCT00671034|38184989|FG002|Overall Study|Refusal|5|||
17040766|NCT00671034|38184987|FG000|Overall Study|includes Alternative therapy, etc.|6|||
17040767|NCT00671034|38184988|FG001|Overall Study|includes Alternative therapy, etc.|1|||
17040768|NCT00671034|38184989|FG002|Overall Study|includes Alternative therapy, etc.|7|||
17040769|NCT04404478|38185000|FG000|Overall Study|Withdrawal by Subject|1|||
17040770|NCT04404478|38185001|FG001|Overall Study|Withdrawal by Subject|3|||
17040771|NCT01196390|38185011|FG000|Overall Study|Protocol Violation|4|||
17040772|NCT01196390|38185012|FG001|Overall Study|Protocol Violation|5|||
17040773|NCT00539734|38185020|FG000|Overall Study|Protocol Violation|1|||
17040774|NCT03907072|38185027|FG000|Overall Study|Study Terminated by Sponsor|2|||
17040775|NCT03907072|38185028|FG001|Overall Study|Study Terminated by Sponsor|2|||
17040776|NCT03907072|38185029|FG002|Overall Study|Study Terminated by Sponsor|2|||
17040777|NCT00329719|38185054|FG000|Overall Study|Lost to Follow-up|0|||
17040778|NCT00329719|38185055|FG001|Overall Study|Lost to Follow-up|0|||
17040779|NCT00329719|38185056|FG002|Overall Study|Lost to Follow-up|0|||
17040780|NCT00329719|38185057|FG003|Overall Study|Lost to Follow-up|1|||
17040781|NCT00329641|38185067|FG000|Overall Study|Did not start treatment|1|||
17040782|NCT00329641|38185067|FG000|Overall Study|Not eligible|1|||
17040783|NCT00329641|38185067|FG000|Overall Study|Adverse Event|3|||
17040784|NCT00329641|38185067|FG000|Overall Study|Other reason, not protocol specified|1|||
17040785|NCT00329407|38185081|FG000|Overall Study|Withdrawal by Subject|1|||
17040786|NCT00328783|38185085|FG000|Overall Study|Could not tolerate ABC|21|||
17040787|NCT00328783|38185085|FG000|Overall Study|No heart in RT field|4|||
17040788|NCT00328783|38185085|FG000|Overall Study|Withdrawal by Subject|1|||
17040789|NCT00567489|38185093|FG000|Overall Study|Adverse Event|6|||
17040790|NCT00567489|38185094|FG001|Overall Study|Adverse Event|14|||
17040791|NCT00567489|38185093|FG000|Overall Study|Physician Decision|0|||
17040792|NCT00567489|38185094|FG001|Overall Study|Physician Decision|4|||
17040793|NCT00567489|38185093|FG000|Overall Study|Withdrawal by Subject|0|||
17040794|NCT00567489|38185094|FG001|Overall Study|Withdrawal by Subject|2|||
17040795|NCT00567489|38185093|FG000|Overall Study|Renal Transplantation|0|||
17040796|NCT00567489|38185094|FG001|Overall Study|Renal Transplantation|3|||
17040797|NCT00567489|38185093|FG000|Overall Study|Other|1|||
17040798|NCT00567489|38185094|FG001|Overall Study|Other|0|||
17040799|NCT00669942|38185112|FG000|Parts 2 and 3|Adverse Event|0|||
17040800|NCT00669942|38185113|FG001|Parts 2 and 3|Adverse Event|0|||
17040801|NCT00669942|38185114|FG002|Parts 2 and 3|Adverse Event|0|||
17040802|NCT00669942|38185115|FG003|Parts 2 and 3|Adverse Event|0|||
17040803|NCT00669942|38185116|FG004|Parts 2 and 3|Adverse Event|0|||
17040804|NCT00669942|38185117|FG005|Parts 2 and 3|Adverse Event|0|||
17040805|NCT00669942|38185118|FG006|Parts 2 and 3|Adverse Event|0|||
17040806|NCT00669942|38185119|FG007|Parts 2 and 3|Adverse Event|2|||
17040807|NCT00669942|38185120|FG008|Parts 2 and 3|Adverse Event|1|||
17040808|NCT00669942|38185121|FG009|Parts 2 and 3|Adverse Event|0|||
17040809|NCT00669942|38185122|FG010|Parts 2 and 3|Adverse Event|0|||
17040810|NCT00669942|38185123|FG011|Parts 2 and 3|Adverse Event|0|||
17040811|NCT00669942|38185112|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
17040812|NCT00669942|38185113|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
17040813|NCT00669942|38185114|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
17040814|NCT00669942|38185115|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
17040815|NCT00669942|38185116|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
17040816|NCT00669942|38185117|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
17040817|NCT00669942|38185118|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
17040818|NCT00669942|38185119|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
16782561|NCT01663623|37722163|FG000|Overall Study|Withdrawal by Subject|2|||
17040819|NCT00669942|38185120|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
17040820|NCT00669942|38185121|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
17040821|NCT00669942|38185122|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
17040822|NCT00669942|38185123|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
17040823|NCT00669942|38185112|FG000|Parts 2 and 3|Protocol Violation|0|||
17040824|NCT00669942|38185113|FG001|Parts 2 and 3|Protocol Violation|0|||
17040825|NCT00669942|38185114|FG002|Parts 2 and 3|Protocol Violation|0|||
17040826|NCT00669942|38185115|FG003|Parts 2 and 3|Protocol Violation|0|||
17040827|NCT00669942|38185116|FG004|Parts 2 and 3|Protocol Violation|0|||
17040828|NCT00669942|38185117|FG005|Parts 2 and 3|Protocol Violation|1|||
17040829|NCT00669942|38185118|FG006|Parts 2 and 3|Protocol Violation|0|||
17040830|NCT00669942|38185119|FG007|Parts 2 and 3|Protocol Violation|0|||
17040831|NCT00669942|38185120|FG008|Parts 2 and 3|Protocol Violation|0|||
17040832|NCT00669942|38185121|FG009|Parts 2 and 3|Protocol Violation|0|||
17040833|NCT00669942|38185122|FG010|Parts 2 and 3|Protocol Violation|0|||
17040834|NCT00669942|38185123|FG011|Parts 2 and 3|Protocol Violation|0|||
17040835|NCT00669864|38185146|FG000|Overall Study|Lost to Follow-up|2|||
17040836|NCT00669864|38185146|FG000|Overall Study|Protocol Violation|2|||
17040837|NCT00669864|38185146|FG000|Overall Study|Withdrawal by Subject|3|||
17040838|NCT00669864|38185146|FG000|Overall Study|Other|2|||
17040839|NCT00668148|38185150|FG000|Overall Study|Adverse Event|5|||
17040840|NCT00668148|38185150|FG000|Overall Study|Subject Non-compliance|1|||
17040841|NCT00668148|38185150|FG000|Overall Study|Progressive Disease Before Treatment|2|||
17040842|NCT00668148|38185150|FG000|Overall Study|Withdrawal of Consent|2|||
17040843|NCT00667992|38185167|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
17040844|NCT00667992|38185168|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
17040845|NCT00667992|38185167|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
17040846|NCT00667992|38185168|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
17040847|NCT00667992|38185167|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
17040848|NCT00667992|38185168|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
17040849|NCT00667992|38185167|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
17040850|NCT00667992|38185168|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
17040851|NCT00667992|38185167|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
17040852|NCT00667992|38185168|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
17040853|NCT00667992|38185167|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
17040854|NCT00667992|38185168|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
17040855|NCT00667992|38185167|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
17040856|NCT00667992|38185168|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
17040857|NCT00667992|38185167|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
17040858|NCT00667992|38185168|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
17040859|NCT00667992|38185167|FG000|Wash-out|Not within one doubling dilution|4|||
17040860|NCT00667992|38185168|FG001|Wash-out|Not within one doubling dilution|3|||
17139595|NCT00004031|38281360|FG000|Overall Study|Adverse Event|5|||
17139596|NCT00004031|38281361|FG001|Overall Study|Adverse Event|0|||
17139597|NCT00004031|38281360|FG000|Overall Study|Refusal unrelated to adverse events|2|||
17139598|NCT00004031|38281361|FG001|Overall Study|Refusal unrelated to adverse events|11|||
17139599|NCT00004031|38281360|FG000|Overall Study|Progression/relapse|9|||
17139600|NCT00004031|38281361|FG001|Overall Study|Progression/relapse|4|||
17040861|NCT00667992|38185167|FG000|Wash-out|Failure to wash-out|2|||
17040862|NCT00667992|38185168|FG001|Wash-out|Failure to wash-out|2|||
17040863|NCT00667992|38185167|FG000|Wash-out|Withdrawal by Subject|1|||
17040864|NCT00667992|38185168|FG001|Wash-out|Withdrawal by Subject|0|||
17040865|NCT00667992|38185167|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
17040866|NCT00667992|38185168|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
17040867|NCT00667992|38185167|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
17040868|NCT00667992|38185168|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
17040869|NCT00669396|38185186|FG000|Overall Study|Lost to Follow-up|10|||
17040870|NCT00669396|38185187|FG001|Overall Study|Lost to Follow-up|12|||
17040871|NCT00669318|38185193|FG000|Overall Study|Withdrawal by Subject|2|||
17040872|NCT00669240|38185197|FG000|Overall Study|Lack of Efficacy|33|||
17040873|NCT00669240|38185197|FG000|Overall Study|Withdrawal by Subject|42|||
17040874|NCT00669240|38185197|FG000|Overall Study|Lost to Follow-up|34|||
17040875|NCT00669240|38185197|FG000|Overall Study|Adverse Event|21|||
17040876|NCT00669240|38185197|FG000|Overall Study|Other|19|||
17040877|NCT00669240|38185197|FG000|Overall Study|Enrolled but not treated|15|||
17040878|NCT00669240|38185197|FG000|Overall Study|Enrolled but no dosing record|1|||
17040879|NCT00669162|38185201|FG000|Overall Study|Withdrawal by Subject|1|||
17040880|NCT00400946|38185210|FG000|Overall Study|Ineligible|0|||
17040881|NCT00400946|38185211|FG001|Overall Study|Ineligible|0|||
17040882|NCT00400946|38185212|FG002|Overall Study|Ineligible|0|||
17040883|NCT00400946|38185213|FG003|Overall Study|Ineligible|5|||
17040884|NCT00400946|38185214|FG004|Overall Study|Ineligible|1|||
17040885|NCT00400946|38185210|FG000|Overall Study|Induction Failure|0|||
17040886|NCT00400946|38185211|FG001|Overall Study|Induction Failure|0|||
17040887|NCT00400946|38185212|FG002|Overall Study|Induction Failure|0|||
17040888|NCT00400946|38185213|FG003|Overall Study|Induction Failure|11|||
17139601|NCT00004031|38281360|FG000|Overall Study|Death|3|||
17040889|NCT00400946|38185214|FG004|Overall Study|Induction Failure|8|||
17040890|NCT00400946|38185210|FG000|Overall Study|Induction Death|0|||
17040891|NCT00400946|38185211|FG001|Overall Study|Induction Death|0|||
17040892|NCT00400946|38185212|FG002|Overall Study|Induction Death|0|||
17040893|NCT00400946|38185213|FG003|Overall Study|Induction Death|13|||
17040894|NCT00400946|38185214|FG004|Overall Study|Induction Death|3|||
17040895|NCT00400946|38185210|FG000|Overall Study|Lost to Follow-up|1|||
17040896|NCT00400946|38185211|FG001|Overall Study|Lost to Follow-up|1|||
17139602|NCT00004031|38281361|FG001|Overall Study|Death|1|||
17139603|NCT00004031|38281360|FG000|Overall Study|Other- not protocol specified|3|||
17139604|NCT00004031|38281361|FG001|Overall Study|Other- not protocol specified|3|||
17139605|NCT00004031|38281360|FG000|Overall Study|Reason under review|3|||
17139606|NCT00004031|38281361|FG001|Overall Study|Reason under review|2|||
17139607|NCT03467217|38281371|FG000|Overall Study|Trial stopped early|5|||
17139608|NCT03467217|38281372|FG001|Overall Study|Trial stopped early|2|||
17139609|NCT03467217|38281371|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
17139610|NCT03467217|38281372|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
17139611|NCT03467217|38281371|FG000|Overall Study|Lost to Follow-up|0|||
17139612|NCT03467217|38281372|FG001|Overall Study|Lost to Follow-up|2|||
17139613|NCT00003875|38281378|FG000|Overall Study|Screen Failed|1|||
17139614|NCT03495453|38281384|FG000|Overall Study|Withdrawal by Subject|0|||
17139615|NCT03495453|38281385|FG001|Overall Study|Withdrawal by Subject|1|||
17139616|NCT03364686|38281391|FG000|Overall Study|Physician Decision|2|||
17139617|NCT03437577|38281398|FG000|Pre-Randomization|Withdrawal by Subject|0|||
17139618|NCT03437577|38281399|FG001|Pre-Randomization|Withdrawal by Subject|0|||
17139619|NCT03437577|38281400|FG002|Pre-Randomization|Withdrawal by Subject|10|||
17139620|NCT03437577|38281398|FG000|Post-Randomization|Physician Decision|0|||
17139621|NCT03437577|38281399|FG001|Post-Randomization|Physician Decision|2|||
17139622|NCT03437577|38281400|FG002|Post-Randomization|Physician Decision|0|||
17139623|NCT03336528|38281408|FG000|Overall Study|Protocol Violation|1|||
17139624|NCT03336528|38281409|FG001|Overall Study|Protocol Violation|1|||
17139625|NCT03336528|38281408|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
17139626|NCT03336528|38281409|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
17139627|NCT03336528|38281408|FG000|Overall Study|Did not receive study medication|1|||
17139628|NCT03336528|38281409|FG001|Overall Study|Did not receive study medication|2|||
17139629|NCT03364608|38281417|FG000|Overall Study|Withdrawal by Subject|4|||
17139630|NCT03364608|38281417|FG000|Overall Study|Protocol Violation|2|||
17139631|NCT03364608|38281417|FG000|Overall Study|Lost to Follow-up|2|||
17139632|NCT00003869|38281431|FG000|Overall Study|Adverse Event|14|||
17139633|NCT00003869|38281432|FG001|Overall Study|Adverse Event|3|||
17139634|NCT00003869|38281431|FG000|Overall Study|Withdrawal by Subject|21|||
17139635|NCT00003869|38281432|FG001|Overall Study|Withdrawal by Subject|3|||
17139636|NCT00003869|38281431|FG000|Overall Study|Death|1|||
17040897|NCT00400946|38185212|FG002|Overall Study|Lost to Follow-up|0|||
17040898|NCT00400946|38185213|FG003|Overall Study|Lost to Follow-up|0|||
17040899|NCT00400946|38185214|FG004|Overall Study|Lost to Follow-up|1|||
17040900|NCT00400946|38185210|FG000|Overall Study|Remission Death|1|||
17040901|NCT00400946|38185211|FG001|Overall Study|Remission Death|1|||
17040902|NCT00400946|38185212|FG002|Overall Study|Remission Death|0|||
17139637|NCT00003869|38281432|FG001|Overall Study|Death|2|||
17139638|NCT00003869|38281431|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
17139639|NCT00003869|38281432|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
17139640|NCT03344640|38281440|FG000|Overall Study|Adverse Event|1|||
17139641|NCT03344640|38281441|FG001|Overall Study|Adverse Event|0|||
17139642|NCT03344640|38281440|FG000|Overall Study|Physician Decision|1|||
17139643|NCT03344640|38281441|FG001|Overall Study|Physician Decision|1|||
17139644|NCT03344640|38281440|FG000|Overall Study|Withdrawal by Subject|1|||
17040903|NCT00400946|38185213|FG003|Overall Study|Remission Death|0|||
17040904|NCT00400946|38185214|FG004|Overall Study|Remission Death|1|||
17040905|NCT00400946|38185210|FG000|Overall Study|Relapse|9|||
17040906|NCT00400946|38185211|FG001|Overall Study|Relapse|2|||
17040907|NCT00400946|38185212|FG002|Overall Study|Relapse|1|||
17040908|NCT00400946|38185213|FG003|Overall Study|Relapse|1|||
17040909|NCT00400946|38185214|FG004|Overall Study|Relapse|5|||
17040910|NCT00400946|38185210|FG000|Overall Study|Transplant in CR1|0|||
17040911|NCT00400946|38185211|FG001|Overall Study|Transplant in CR1|0|||
17139645|NCT03344640|38281441|FG001|Overall Study|Withdrawal by Subject|2|||
17139646|NCT03344640|38281440|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
17139647|NCT03344640|38281441|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
17139648|NCT03344562|38281449|FG000|Overall Study|Withdrawal by Subject|2|||
17139649|NCT03344562|38281450|FG001|Overall Study|Withdrawal by Subject|0|||
17139650|NCT00003659|38281456|FG000|Overall Study|Withdrawal by Subject|3|||
17139651|NCT03494985|38281464|FG000|Overall Study|Adverse Event|3|||
17139652|NCT03494985|38281465|FG001|Overall Study|Adverse Event|2|||
17040912|NCT00400946|38185212|FG002|Overall Study|Transplant in CR1|0|||
17040913|NCT00400946|38185213|FG003|Overall Study|Transplant in CR1|10|||
17040914|NCT00400946|38185214|FG004|Overall Study|Transplant in CR1|1|||
17040915|NCT00400946|38185210|FG000|Overall Study|Withdrawal by Subject|2|||
17139653|NCT03494985|38281466|FG002|Overall Study|Adverse Event|3|||
17040916|NCT00400946|38185211|FG001|Overall Study|Withdrawal by Subject|5|||
17040917|NCT00400946|38185212|FG002|Overall Study|Withdrawal by Subject|1|||
17040918|NCT00400946|38185213|FG003|Overall Study|Withdrawal by Subject|5|||
17040919|NCT00400946|38185214|FG004|Overall Study|Withdrawal by Subject|8|||
17040920|NCT00400946|38185210|FG000|Overall Study|Clinical|1|||
17040921|NCT00400946|38185211|FG001|Overall Study|Clinical|2|||
17040922|NCT00400946|38185212|FG002|Overall Study|Clinical|0|||
17040923|NCT00400946|38185213|FG003|Overall Study|Clinical|2|||
17040924|NCT00400946|38185214|FG004|Overall Study|Clinical|9|||
17040925|NCT00400946|38185210|FG000|Overall Study|Other|0|||
17040926|NCT00400946|38185211|FG001|Overall Study|Other|0|||
17040927|NCT00400946|38185212|FG002|Overall Study|Other|0|||
17040928|NCT00400946|38185213|FG003|Overall Study|Other|0|||
17040929|NCT00400946|38185214|FG004|Overall Study|Other|1|||
17040930|NCT00666588|38185245|FG000|Overall Study|ineligible|2|||
17040931|NCT00666588|38185246|FG001|Overall Study|ineligible|0|||
17040932|NCT00666588|38185247|FG002|Overall Study|ineligible|0|||
17040933|NCT00666588|38185248|FG003|Overall Study|ineligible|2|||
17040934|NCT00666588|38185245|FG000|Overall Study|inevaluable|2|||
17040935|NCT00666588|38185246|FG001|Overall Study|inevaluable|0|||
17040936|NCT00666588|38185247|FG002|Overall Study|inevaluable|0|||
17139654|NCT03494985|38281467|FG003|Overall Study|Adverse Event|0|||
17139655|NCT03494985|38281464|FG000|Overall Study|Other (Withdrawal of consent)|2|||
17139656|NCT03494985|38281465|FG001|Overall Study|Other (Withdrawal of consent)|3|||
17139657|NCT03494985|38281466|FG002|Overall Study|Other (Withdrawal of consent)|2|||
17139658|NCT03494985|38281467|FG003|Overall Study|Other (Withdrawal of consent)|5|||
17139659|NCT03494985|38281464|FG000|Overall Study|Other (Not specified)|0|||
17139660|NCT03494985|38281465|FG001|Overall Study|Other (Not specified)|1|||
17139661|NCT03494985|38281466|FG002|Overall Study|Other (Not specified)|1|||
17139662|NCT03494985|38281467|FG003|Overall Study|Other (Not specified)|0|||
17139663|NCT03437265|38281477|FG000|Overall Study|Protocol Violation|6|||
17139664|NCT00003509|38281481|FG000|Overall Study|Not evaluable|5|||
17139665|NCT03344172|38281487|FG000|Overall Study|Received <1 dose of treatment|1|||
17139666|NCT03344172|38281488|FG001|Overall Study|Received <1 dose of treatment|0|||
17139667|NCT03465891|38281496|FG000|Overall Study|Withdrawal by Subject|0|||
17139668|NCT03465891|38281497|FG001|Overall Study|Withdrawal by Subject|1|||
17139669|NCT03465891|38281496|FG000|Overall Study|Disease progression|1|||
17139670|NCT03465891|38281497|FG001|Overall Study|Disease progression|0|||
17139671|NCT03363906|38281503|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
16992165|NCT00735709|38136086|FG000|Overall Study|Adverse Event|2|||
16992166|NCT00735709|38136087|FG001|Overall Study|Adverse Event|3|||
16992167|NCT00735709|38136088|FG002|Overall Study|Adverse Event|1|||
16992168|NCT00735709|38136089|FG003|Overall Study|Adverse Event|5|||
16992169|NCT00735709|38136086|FG000|Overall Study|Lack of Efficacy|8|||
16992170|NCT00735709|38136087|FG001|Overall Study|Lack of Efficacy|4|||
16992171|NCT00735709|38136088|FG002|Overall Study|Lack of Efficacy|2|||
16992172|NCT00735709|38136089|FG003|Overall Study|Lack of Efficacy|3|||
16992173|NCT00735709|38136086|FG000|Overall Study|Noncompliance|0|||
16992174|NCT00735709|38136087|FG001|Overall Study|Noncompliance|0|||
17040937|NCT00666588|38185248|FG003|Overall Study|inevaluable|0|||
17040938|NCT00689390|38185260|FG000|Overall Study|Adverse Event|19|||
17139672|NCT03363906|38281504|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
17139673|NCT03363906|38281503|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
17139674|NCT03363906|38281504|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
16992175|NCT00735709|38136088|FG002|Overall Study|Noncompliance|1|||
17040939|NCT00689390|38185261|FG001|Overall Study|Adverse Event|0|||
17040940|NCT00689390|38185260|FG000|Overall Study|Lost to Follow-up|179|||
17040941|NCT00689390|38185261|FG001|Overall Study|Lost to Follow-up|7|||
17040942|NCT00689390|38185260|FG000|Overall Study|Withdrawal by Subject|117|||
17040943|NCT00689390|38185261|FG001|Overall Study|Withdrawal by Subject|3|||
17139675|NCT03363906|38281503|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
17139676|NCT03363906|38281504|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
17139677|NCT03363906|38281503|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
17139678|NCT03363906|38281504|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
17040944|NCT00689390|38185260|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
17040945|NCT00689390|38185261|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
17040946|NCT00689390|38185260|FG000|Overall Study|Non-Compliance With Protocol|21|||
17040947|NCT00689390|38185261|FG001|Overall Study|Non-Compliance With Protocol|0|||
17040948|NCT00689390|38185260|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
17040949|NCT00689390|38185261|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
17040950|NCT00689390|38185260|FG000|Overall Study|Administrative|37|||
17040951|NCT00689390|38185261|FG001|Overall Study|Administrative|0|||
17040952|NCT00567879|38185278|FG000|Overall Study|Adverse Event|2|||
17040953|NCT00567879|38185279|FG001|Overall Study|Adverse Event|0|||
17040954|NCT00567879|38185280|FG002|Overall Study|Adverse Event|1|||
17040955|NCT00567879|38185281|FG003|Overall Study|Adverse Event|0|||
17040956|NCT00567879|38185282|FG004|Overall Study|Adverse Event|1|||
17040957|NCT00567879|38185283|FG005|Overall Study|Adverse Event|0|||
17040958|NCT00567879|38185278|FG000|Overall Study|Abnormal test procedure(s)|0|||
17040959|NCT00567879|38185279|FG001|Overall Study|Abnormal test procedure(s)|0|||
17040960|NCT00567879|38185280|FG002|Overall Study|Abnormal test procedure(s)|1|||
17040961|NCT00567879|38185281|FG003|Overall Study|Abnormal test procedure(s)|0|||
17139679|NCT00003473|38281510|FG000|Overall Study|Three patients were not evaluable.|3|||
17139680|NCT03343626|38281522|FG000|Overall Study|Lost to Follow-up|4|||
17040962|NCT00567879|38185282|FG004|Overall Study|Abnormal test procedure(s)|0|||
17040963|NCT00567879|38185283|FG005|Overall Study|Abnormal test procedure(s)|0|||
17040964|NCT00567879|38185278|FG000|Overall Study|Withdrawal by Subject|0|||
17040965|NCT00567879|38185279|FG001|Overall Study|Withdrawal by Subject|0|||
17040966|NCT00567879|38185280|FG002|Overall Study|Withdrawal by Subject|3|||
17040967|NCT00567879|38185281|FG003|Overall Study|Withdrawal by Subject|1|||
17040968|NCT00567879|38185282|FG004|Overall Study|Withdrawal by Subject|0|||
17040969|NCT00567879|38185283|FG005|Overall Study|Withdrawal by Subject|0|||
17040970|NCT00567879|38185278|FG000|Overall Study|New cancer therapy|0|||
17040971|NCT00567879|38185279|FG001|Overall Study|New cancer therapy|0|||
17040972|NCT00567879|38185280|FG002|Overall Study|New cancer therapy|1|||
17040973|NCT00567879|38185281|FG003|Overall Study|New cancer therapy|0|||
17040974|NCT00567879|38185282|FG004|Overall Study|New cancer therapy|0|||
17040975|NCT00567879|38185283|FG005|Overall Study|New cancer therapy|0|||
17040976|NCT00567879|38185278|FG000|Overall Study|Disease progression|5|||
17040977|NCT00567879|38185279|FG001|Overall Study|Disease progression|7|||
17040978|NCT00567879|38185280|FG002|Overall Study|Disease progression|15|||
17040979|NCT00567879|38185281|FG003|Overall Study|Disease progression|5|||
17139681|NCT03343626|38281523|FG001|Overall Study|Lost to Follow-up|3|||
17139682|NCT03343626|38281524|FG002|Overall Study|Lost to Follow-up|2|||
17139683|NCT03343626|38281525|FG003|Overall Study|Lost to Follow-up|5|||
16992176|NCT00735709|38136089|FG003|Overall Study|Noncompliance|0|||
16992177|NCT00735709|38136086|FG000|Overall Study|Protocol deviations|1|||
16992178|NCT00735709|38136087|FG001|Overall Study|Protocol deviations|2|||
16992179|NCT00735709|38136088|FG002|Overall Study|Protocol deviations|1|||
16992180|NCT00735709|38136089|FG003|Overall Study|Protocol deviations|1|||
16992181|NCT00735709|38136086|FG000|Overall Study|Voluntary Withdrawal|1|||
16992182|NCT00735709|38136087|FG001|Overall Study|Voluntary Withdrawal|3|||
16992183|NCT00735709|38136088|FG002|Overall Study|Voluntary Withdrawal|5|||
16992184|NCT00735709|38136089|FG003|Overall Study|Voluntary Withdrawal|7|||
16992185|NCT00735709|38136086|FG000|Overall Study|Lost to Follow-up|0|||
16992186|NCT00735709|38136087|FG001|Overall Study|Lost to Follow-up|1|||
16992187|NCT00735709|38136088|FG002|Overall Study|Lost to Follow-up|1|||
16992188|NCT00735709|38136089|FG003|Overall Study|Lost to Follow-up|1|||
16992189|NCT00735709|38136086|FG000|Overall Study|Excluded medication|1|||
16992190|NCT00735709|38136087|FG001|Overall Study|Excluded medication|0|||
16992191|NCT00735709|38136088|FG002|Overall Study|Excluded medication|0|||
16992192|NCT00735709|38136089|FG003|Overall Study|Excluded medication|1|||
16992193|NCT00729157|38136099|FG000|Overall Study|Withdrawal by Subject|1|||
16992194|NCT00728689|38136105|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
16992195|NCT00728689|38136106|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
16992196|NCT00727909|38136114|FG000|Overall Study|Withdrawal by Subject|5|||
16992197|NCT00727909|38136115|FG001|Overall Study|Withdrawal by Subject|11|||
17040980|NCT00567879|38185282|FG004|Overall Study|Disease progression|11|||
17040981|NCT00567879|38185283|FG005|Overall Study|Disease progression|3|||
17040982|NCT00603915|38185301|FG000|Overall Study|Physician Decision|1|||
17040983|NCT00603837|38185307|FG000|Overall Study|Physician Decision|3|||
17040984|NCT00603837|38185308|FG001|Overall Study|Physician Decision|0|||
17040985|NCT00667602|38185317|FG000|Overall Study|Withdrawal by Subject|4|||
17040986|NCT00667602|38185318|FG001|Overall Study|Withdrawal by Subject|9|||
17040987|NCT00667602|38185319|FG002|Overall Study|Withdrawal by Subject|10|||
17040988|NCT00667602|38185317|FG000|Overall Study|Lost to Follow-up|4|||
17040989|NCT00667602|38185318|FG001|Overall Study|Lost to Follow-up|5|||
17040990|NCT00667602|38185319|FG002|Overall Study|Lost to Follow-up|6|||
17040991|NCT00667602|38185317|FG000|Overall Study|Administrative reason|0|||
17040992|NCT00667602|38185318|FG001|Overall Study|Administrative reason|0|||
17040993|NCT00667602|38185319|FG002|Overall Study|Administrative reason|2|||
17139684|NCT03343626|38281526|FG004|Overall Study|Lost to Follow-up|4|||
17139685|NCT03343626|38281527|FG005|Overall Study|Lost to Follow-up|4|||
17139686|NCT03343626|38281528|FG006|Overall Study|Lost to Follow-up|4|||
17139687|NCT03343626|38281529|FG007|Overall Study|Lost to Follow-up|7|||
17139688|NCT03343626|38281522|FG000|Overall Study|Withdrawal of Consent|2|||
17139689|NCT03343626|38281523|FG001|Overall Study|Withdrawal of Consent|1|||
17139690|NCT03343626|38281524|FG002|Overall Study|Withdrawal of Consent|0|||
17139691|NCT03343626|38281525|FG003|Overall Study|Withdrawal of Consent|3|||
17139692|NCT03343626|38281526|FG004|Overall Study|Withdrawal of Consent|3|||
17040994|NCT00667602|38185317|FG000|Overall Study|Protocol Violation|0|||
17040995|NCT00667602|38185318|FG001|Overall Study|Protocol Violation|1|||
17040996|NCT00667602|38185319|FG002|Overall Study|Protocol Violation|0|||
17040997|NCT00691028|38185335|FG000|Open-label Period|Adverse Event|0|||
17040998|NCT00691028|38185336|FG001|Open-label Period|Adverse Event|0|||
17040999|NCT00691028|38185337|FG002|Open-label Period|Adverse Event|0|||
17041000|NCT00691028|38185338|FG003|Open-label Period|Adverse Event|16|||
17041001|NCT00691028|38185335|FG000|Open-label Period|Withdrawal by Subject|0|||
17041002|NCT00691028|38185336|FG001|Open-label Period|Withdrawal by Subject|0|||
17041003|NCT00691028|38185337|FG002|Open-label Period|Withdrawal by Subject|0|||
17041004|NCT00691028|38185338|FG003|Open-label Period|Withdrawal by Subject|3|||
17041005|NCT00691028|38185335|FG000|Open-label Period|not come to a hospital|0|||
17041006|NCT00691028|38185336|FG001|Open-label Period|not come to a hospital|0|||
17041007|NCT00691028|38185337|FG002|Open-label Period|not come to a hospital|0|||
17041008|NCT00691028|38185338|FG003|Open-label Period|not come to a hospital|1|||
17041009|NCT00691028|38185335|FG000|Double-blind Period|Adverse Event|8|||
17041010|NCT00691028|38185336|FG001|Double-blind Period|Adverse Event|9|||
17041011|NCT00691028|38185337|FG002|Double-blind Period|Adverse Event|6|||
17041012|NCT00691028|38185338|FG003|Double-blind Period|Adverse Event|0|||
17041013|NCT00691028|38185335|FG000|Double-blind Period|Lack of Efficacy|4|||
17041014|NCT00691028|38185336|FG001|Double-blind Period|Lack of Efficacy|3|||
17041015|NCT00691028|38185337|FG002|Double-blind Period|Lack of Efficacy|2|||
17041016|NCT00691028|38185338|FG003|Double-blind Period|Lack of Efficacy|0|||
17041017|NCT00691028|38185335|FG000|Double-blind Period|Withdrawal by Subject|1|||
17041018|NCT00691028|38185336|FG001|Double-blind Period|Withdrawal by Subject|0|||
17041019|NCT00691028|38185337|FG002|Double-blind Period|Withdrawal by Subject|1|||
17041020|NCT00691028|38185338|FG003|Double-blind Period|Withdrawal by Subject|0|||
17041021|NCT00691028|38185335|FG000|Double-blind Period|not come to a hospital.|0|||
17041022|NCT00691028|38185336|FG001|Double-blind Period|not come to a hospital.|1|||
17041023|NCT00691028|38185337|FG002|Double-blind Period|not come to a hospital.|0|||
17041024|NCT00691028|38185338|FG003|Double-blind Period|not come to a hospital.|0|||
17041025|NCT00690794|38185352|FG000|Overall Study|Adverse Event|12|||
17041026|NCT00690794|38185353|FG001|Overall Study|Adverse Event|10|||
17041027|NCT00690794|38185352|FG000|Overall Study|Lost to Follow-up|1|||
17041028|NCT00690794|38185353|FG001|Overall Study|Lost to Follow-up|4|||
17041029|NCT00690794|38185352|FG000|Overall Study|Withdrawal by Subject|0|||
17041030|NCT00690794|38185353|FG001|Overall Study|Withdrawal by Subject|9|||
17041031|NCT00690794|38185352|FG000|Overall Study|Protocol Violation|6|||
17041032|NCT00690794|38185353|FG001|Overall Study|Protocol Violation|7|||
17041033|NCT00690794|38185352|FG000|Overall Study|Noncompliance|1|||
17041034|NCT00690794|38185353|FG001|Overall Study|Noncompliance|2|||
17041035|NCT00690794|38185352|FG000|Overall Study|Other not specified|1|||
17041036|NCT00690794|38185353|FG001|Overall Study|Other not specified|3|||
17041037|NCT00666276|38185359|FG000|Overall Study|Protocol Violation|34|||
17139693|NCT03343626|38281527|FG005|Overall Study|Withdrawal of Consent|1|||
17041038|NCT00567255|38185384|FG000|Overall Study|Adverse Event|241|||
17041039|NCT00567255|38185385|FG001|Overall Study|Adverse Event|68|||
17041040|NCT00567255|38185384|FG000|Overall Study|Lost to Follow-up|77|||
17041041|NCT00567255|38185385|FG001|Overall Study|Lost to Follow-up|48|||
17041042|NCT00567255|38185384|FG000|Overall Study|Withdrawal by Subject|75|||
17041043|NCT00567255|38185385|FG001|Overall Study|Withdrawal by Subject|56|||
17041044|NCT00567255|38185384|FG000|Overall Study|Lack of Efficacy|19|||
17041045|NCT00567255|38185385|FG001|Overall Study|Lack of Efficacy|33|||
17041046|NCT00567255|38185384|FG000|Overall Study|Protocol Violation|20|||
17041047|NCT00567255|38185385|FG001|Overall Study|Protocol Violation|8|||
17041048|NCT00567255|38185384|FG000|Overall Study|Pregnancy|6|||
17041049|NCT00567255|38185385|FG001|Overall Study|Pregnancy|0|||
17041050|NCT00567255|38185384|FG000|Overall Study|Drug noncompliance,moved,other|25|||
17041051|NCT00567255|38185385|FG001|Overall Study|Drug noncompliance,moved,other|15|||
17041052|NCT00667446|38185393|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
17041053|NCT00667446|38185394|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
17041054|NCT00667446|38185393|FG000|Treatment Period (36 Months)|Other|2|||
17041055|NCT00667446|38185394|FG001|Treatment Period (36 Months)|Other|2|||
17041056|NCT00667446|38185393|FG000|Treatment Period (36 Months)|Personal reasons|2|||
17041057|NCT00667446|38185394|FG001|Treatment Period (36 Months)|Personal reasons|2|||
17041058|NCT00667446|38185393|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
17041059|NCT00667446|38185394|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
17041060|NCT00667446|38185393|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
17041061|NCT00667446|38185394|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
17041062|NCT00667446|38185393|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
17041063|NCT00667446|38185394|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
17041064|NCT00667446|38185393|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
17041065|NCT00667446|38185394|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
17041066|NCT00667446|38185393|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
17041067|NCT00667446|38185394|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
17041068|NCT00667446|38185393|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
17041069|NCT00667446|38185394|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
17041070|NCT00688844|38185400|FG000|Overall Study|Lost to Follow-up|10|||
17041071|NCT00667368|38185406|FG000|Overall Study|Lost to Follow-up|176|||
17041072|NCT00667368|38185407|FG001|Overall Study|Lost to Follow-up|155|||
17041073|NCT00667368|38185406|FG000|Overall Study|Discontinued early|24|||
17041074|NCT00667368|38185407|FG001|Overall Study|Discontinued early|17|||
17041075|NCT00567567|38185416|FG000|Overall Study|Adverse Event|0|||
17041076|NCT00567567|38185417|FG001|Overall Study|Adverse Event|2|||
17041077|NCT00567567|38185418|FG002|Overall Study|Adverse Event|5|||
17041078|NCT00567567|38185416|FG000|Overall Study|Death|8|||
17041079|NCT00567567|38185417|FG001|Overall Study|Death|1|||
17041080|NCT00567567|38185418|FG002|Overall Study|Death|5|||
17041081|NCT00567567|38185416|FG000|Overall Study|Lack of Efficacy|16|||
17041082|NCT00567567|38185417|FG001|Overall Study|Lack of Efficacy|17|||
17041083|NCT00567567|38185418|FG002|Overall Study|Lack of Efficacy|48|||
17041084|NCT00567567|38185416|FG000|Overall Study|Lost to Follow-up|0|||
17041085|NCT00567567|38185417|FG001|Overall Study|Lost to Follow-up|0|||
17041086|NCT00567567|38185418|FG002|Overall Study|Lost to Follow-up|1|||
17041087|NCT00567567|38185416|FG000|Overall Study|Physician Decision|16|||
17041088|NCT00567567|38185417|FG001|Overall Study|Physician Decision|18|||
17041089|NCT00567567|38185418|FG002|Overall Study|Physician Decision|84|||
17041090|NCT00567567|38185416|FG000|Overall Study|Withdrawal by Subject|0|||
17041091|NCT00567567|38185417|FG001|Overall Study|Withdrawal by Subject|0|||
17041092|NCT00567567|38185418|FG002|Overall Study|Withdrawal by Subject|2|||
17041093|NCT00567567|38185416|FG000|Overall Study|Ineligible|4|||
17041094|NCT00567567|38185417|FG001|Overall Study|Ineligible|0|||
17041095|NCT00567567|38185418|FG002|Overall Study|Ineligible|9|||
17041096|NCT00567567|38185416|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
17041097|NCT00567567|38185417|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
17041098|NCT00567567|38185418|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
17041099|NCT00567567|38185416|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
17041100|NCT00567567|38185417|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
17139694|NCT03343626|38281528|FG006|Overall Study|Withdrawal of Consent|1|||
17139695|NCT03343626|38281529|FG007|Overall Study|Withdrawal of Consent|2|||
17041101|NCT00567567|38185418|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
17041102|NCT00567567|38185416|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
17041103|NCT00567567|38185417|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
17041104|NCT00567567|38185418|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
17041105|NCT00666198|38185428|FG000|Overall Study|Protocol Violation|10|||
17041106|NCT00666198|38185428|FG000|Overall Study|No Visit After First Day of Treatment|13|||
17041107|NCT00666198|38185428|FG000|Overall Study|Safety Not Assessable|6|||
17041108|NCT00666198|38185428|FG000|Overall Study|No Drug Administration|4|||
17041109|NCT00664560|38185435|FG000|Overall Study|Adverse Event|19|||
17041110|NCT00664560|38185436|FG001|Overall Study|Adverse Event|16|||
17041111|NCT00664560|38185437|FG002|Overall Study|Adverse Event|7|||
17041112|NCT00664560|38185435|FG000|Overall Study|Withdrawal by Subject|9|||
17041113|NCT00664560|38185436|FG001|Overall Study|Withdrawal by Subject|13|||
17041114|NCT00664560|38185437|FG002|Overall Study|Withdrawal by Subject|7|||
17041115|NCT00664560|38185435|FG000|Overall Study|Lost to Follow-up|0|||
17041116|NCT00664560|38185436|FG001|Overall Study|Lost to Follow-up|2|||
17041117|NCT00664560|38185437|FG002|Overall Study|Lost to Follow-up|0|||
17041118|NCT00664560|38185435|FG000|Overall Study|Other|11|||
17041119|NCT00664560|38185436|FG001|Overall Study|Other|4|||
17041120|NCT00664560|38185437|FG002|Overall Study|Other|5|||
17139696|NCT03343626|38281522|FG000|Overall Study|Reason not Specified|0|||
17139697|NCT03343626|38281523|FG001|Overall Study|Reason not Specified|1|||
17139698|NCT03343626|38281524|FG002|Overall Study|Reason not Specified|0|||
17139699|NCT03343626|38281525|FG003|Overall Study|Reason not Specified|0|||
17139700|NCT03343626|38281526|FG004|Overall Study|Reason not Specified|0|||
17139701|NCT03343626|38281527|FG005|Overall Study|Reason not Specified|0|||
17041121|NCT00566709|38185447|FG000|Overall Study|Protocol Violation|5|||
17041122|NCT00566709|38185448|FG001|Overall Study|Protocol Violation|0|||
17041123|NCT00688688|38185457|FG000|Overall Study|Eligibility criterion not met|7|||
17041124|NCT00688688|38185458|FG001|Overall Study|Eligibility criterion not met|7|||
17041125|NCT00688688|38185459|FG002|Overall Study|Eligibility criterion not met|10|||
17041126|NCT00688688|38185457|FG000|Overall Study|Adverse Event|52|||
17041127|NCT00688688|38185458|FG001|Overall Study|Adverse Event|51|||
17041128|NCT00688688|38185459|FG002|Overall Study|Adverse Event|50|||
17041129|NCT00688688|38185457|FG000|Overall Study|Lack of Efficacy|34|||
17041130|NCT00688688|38185458|FG001|Overall Study|Lack of Efficacy|25|||
17041131|NCT00688688|38185459|FG002|Overall Study|Lack of Efficacy|45|||
17041132|NCT00688688|38185457|FG000|Overall Study|Withdrawal by Subject|66|||
17041133|NCT00688688|38185458|FG001|Overall Study|Withdrawal by Subject|75|||
17041134|NCT00688688|38185459|FG002|Overall Study|Withdrawal by Subject|65|||
17041135|NCT00688688|38185457|FG000|Overall Study|Lost to Follow-up|14|||
17041136|NCT00688688|38185458|FG001|Overall Study|Lost to Follow-up|7|||
17041137|NCT00688688|38185459|FG002|Overall Study|Lost to Follow-up|7|||
17041138|NCT00688688|38185457|FG000|Overall Study|Protocol Violation|6|||
17041139|NCT00688688|38185458|FG001|Overall Study|Protocol Violation|9|||
17041140|NCT00688688|38185459|FG002|Overall Study|Protocol Violation|11|||
17041141|NCT00688688|38185457|FG000|Overall Study|Randomized but never received study drug|1|||
17041142|NCT00688688|38185458|FG001|Overall Study|Randomized but never received study drug|0|||
17041143|NCT00688688|38185459|FG002|Overall Study|Randomized but never received study drug|0|||
17041144|NCT00688688|38185457|FG000|Overall Study|Non-compliance with study procedures|5|||
17041145|NCT00688688|38185458|FG001|Overall Study|Non-compliance with study procedures|3|||
17139702|NCT03343626|38281528|FG006|Overall Study|Reason not Specified|0|||
17139703|NCT03343626|38281529|FG007|Overall Study|Reason not Specified|1|||
17139704|NCT03343626|38281522|FG000|Overall Study|Data Entry Error|0|||
17139705|NCT03343626|38281523|FG001|Overall Study|Data Entry Error|0|||
17041146|NCT00688688|38185459|FG002|Overall Study|Non-compliance with study procedures|4|||
17041147|NCT00688688|38185457|FG000|Overall Study|Taking exclusionary medications|1|||
17041148|NCT00688688|38185458|FG001|Overall Study|Taking exclusionary medications|0|||
17041149|NCT00688688|38185459|FG002|Overall Study|Taking exclusionary medications|0|||
17041150|NCT00688688|38185457|FG000|Overall Study|Site closure|0|||
17041151|NCT00688688|38185458|FG001|Overall Study|Site closure|1|||
17041152|NCT00688688|38185459|FG002|Overall Study|Site closure|0|||
17041153|NCT00688688|38185457|FG000|Overall Study|Violation of exclusion criterion|0|||
17041154|NCT00688688|38185458|FG001|Overall Study|Violation of exclusion criterion|1|||
17041155|NCT00688688|38185459|FG002|Overall Study|Violation of exclusion criterion|0|||
17041156|NCT00664326|38185467|FG000|Overall Study|Adverse Event|14|||
17041157|NCT00664326|38185467|FG000|Overall Study|Noncompliance with study medication|3|||
17041158|NCT00664326|38185467|FG000|Overall Study|Withdrawal by Subject|1|||
17041159|NCT00664326|38185467|FG000|Overall Study|Physician Decision|1|||
17041160|NCT00664326|38185467|FG000|Overall Study|Other Reasons|3|||
17041161|NCT00664326|38185467|FG000|Overall Study|Death|2|||
17041162|NCT00664326|38185467|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
17041163|NCT00686972|38185471|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
17041164|NCT00665652|38185475|FG000|Overall Study|Adverse Event|4|||
17041165|NCT00665652|38185475|FG000|Overall Study|Death|1|||
17041166|NCT00665652|38185475|FG000|Overall Study|No longer met inclusion criteria.|1|||
17041167|NCT00566631|38185479|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
17041168|NCT00566631|38185479|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
17041169|NCT00566631|38185479|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
17041170|NCT00566631|38185479|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
17041171|NCT00566631|38185479|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
17041172|NCT00566631|38185479|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
17041173|NCT00566631|38185479|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
17041174|NCT00566631|38185479|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
17139706|NCT03343626|38281524|FG002|Overall Study|Data Entry Error|0|||
17041175|NCT00566631|38185479|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
17041176|NCT00566631|38185479|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
17041177|NCT00566631|38185479|FG000|Part 2: Extension Phase|Adverse Event|11|||
17041178|NCT00566631|38185479|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
17041179|NCT00566631|38185479|FG000|Part 2: Extension Phase|Death|1|||
17041180|NCT00566631|38185479|FG000|Part 2: Extension Phase|Other|5|||
17041181|NCT00661830|38185485|FG000|Overall Study|Death|37|||
17041182|NCT00661830|38185486|FG001|Overall Study|Death|33|||
17041183|NCT00661830|38185485|FG000|Overall Study|Lost to Follow-up|1|||
17041184|NCT00661830|38185486|FG001|Overall Study|Lost to Follow-up|3|||
17041185|NCT00661830|38185485|FG000|Overall Study|Withdrawal by Subject|1|||
17041186|NCT00661830|38185486|FG001|Overall Study|Withdrawal by Subject|1|||
17041187|NCT00661830|38185485|FG000|Overall Study|Other reason|1|||
17041188|NCT00661830|38185486|FG001|Overall Study|Other reason|5|||
17041189|NCT00540592|38185502|FG000|Overall Study|Adverse Event|0|||
17041190|NCT00540592|38185503|FG001|Overall Study|Adverse Event|1|||
17041191|NCT00540592|38185504|FG002|Overall Study|Adverse Event|0|||
17041192|NCT00540592|38185505|FG003|Overall Study|Adverse Event|0|||
17041193|NCT00540592|38185506|FG004|Overall Study|Adverse Event|1|||
17041194|NCT00540592|38185507|FG005|Overall Study|Adverse Event|0|||
17041195|NCT00540592|38185508|FG006|Overall Study|Adverse Event|0|||
17041196|NCT00540592|38185509|FG007|Overall Study|Adverse Event|1|||
17041197|NCT00540592|38185510|FG008|Overall Study|Adverse Event|1|||
17041198|NCT00540592|38185511|FG009|Overall Study|Adverse Event|2|||
17041199|NCT00540592|38185502|FG000|Overall Study|Lost to Follow-up|2|||
17041200|NCT00540592|38185503|FG001|Overall Study|Lost to Follow-up|0|||
17041201|NCT00540592|38185504|FG002|Overall Study|Lost to Follow-up|0|||
17041202|NCT00540592|38185505|FG003|Overall Study|Lost to Follow-up|0|||
17041203|NCT00540592|38185506|FG004|Overall Study|Lost to Follow-up|0|||
17041204|NCT00540592|38185507|FG005|Overall Study|Lost to Follow-up|0|||
17041205|NCT00540592|38185508|FG006|Overall Study|Lost to Follow-up|0|||
17041206|NCT00540592|38185509|FG007|Overall Study|Lost to Follow-up|0|||
17139707|NCT03343626|38281525|FG003|Overall Study|Data Entry Error|0|||
17139708|NCT03343626|38281526|FG004|Overall Study|Data Entry Error|0|||
17041207|NCT00540592|38185510|FG008|Overall Study|Lost to Follow-up|0|||
17041208|NCT00540592|38185511|FG009|Overall Study|Lost to Follow-up|0|||
17041209|NCT00540592|38185502|FG000|Overall Study|Withdrawal by Subject|0|||
17041210|NCT00540592|38185503|FG001|Overall Study|Withdrawal by Subject|0|||
17041211|NCT00540592|38185504|FG002|Overall Study|Withdrawal by Subject|1|||
17041212|NCT00540592|38185505|FG003|Overall Study|Withdrawal by Subject|1|||
17041213|NCT00540592|38185506|FG004|Overall Study|Withdrawal by Subject|0|||
17041214|NCT00540592|38185507|FG005|Overall Study|Withdrawal by Subject|0|||
17041215|NCT00540592|38185508|FG006|Overall Study|Withdrawal by Subject|0|||
17041216|NCT00540592|38185509|FG007|Overall Study|Withdrawal by Subject|0|||
17041217|NCT00540592|38185510|FG008|Overall Study|Withdrawal by Subject|0|||
17041218|NCT00540592|38185511|FG009|Overall Study|Withdrawal by Subject|0|||
17041219|NCT03970395|38185535|FG000|Overall Study|Withdrawal by Subject|3|||
17041220|NCT03970395|38185536|FG001|Overall Study|Withdrawal by Subject|4|||
17041221|NCT03970395|38185535|FG000|Overall Study|Lost to Follow-up|4|||
17041222|NCT03970395|38185536|FG001|Overall Study|Lost to Follow-up|8|||
17041223|NCT00565773|38185546|FG000|Overall Study|Withdrawal by Subject|1|||
17041224|NCT00565773|38185546|FG000|Overall Study|Physician Decision|1|||
17041225|NCT00570492|38185552|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
17041226|NCT00570492|38185553|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
17041227|NCT00570492|38185554|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
17041228|NCT00570492|38185552|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
17041229|NCT00570492|38185553|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
17041230|NCT00570492|38185554|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
17041231|NCT00570492|38185552|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
17139709|NCT03343626|38281527|FG005|Overall Study|Data Entry Error|0|||
17139710|NCT03343626|38281528|FG006|Overall Study|Data Entry Error|0|||
17139711|NCT03343626|38281529|FG007|Overall Study|Data Entry Error|1|||
17139712|NCT03334422|38281554|FG000|Overall Study|Adverse Event|1|||
17139713|NCT03334422|38281555|FG001|Overall Study|Adverse Event|3|||
17139714|NCT03334422|38281556|FG002|Overall Study|Adverse Event|2|||
17139715|NCT03334422|38281557|FG003|Overall Study|Adverse Event|2|||
17139716|NCT03334422|38281554|FG000|Overall Study|Lack of Efficacy|10|||
17139717|NCT03334422|38281555|FG001|Overall Study|Lack of Efficacy|2|||
17139718|NCT03334422|38281556|FG002|Overall Study|Lack of Efficacy|7|||
17041232|NCT00570492|38185553|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
17041233|NCT00570492|38185554|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
17041234|NCT00570492|38185552|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
17041235|NCT00570492|38185553|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
17139719|NCT03334422|38281557|FG003|Overall Study|Lack of Efficacy|3|||
17139720|NCT03334422|38281554|FG000|Overall Study|Withdrawal by Subject|8|||
17139721|NCT03334422|38281555|FG001|Overall Study|Withdrawal by Subject|3|||
17139722|NCT03334422|38281556|FG002|Overall Study|Withdrawal by Subject|1|||
17139723|NCT03334422|38281557|FG003|Overall Study|Withdrawal by Subject|0|||
17139724|NCT03334422|38281554|FG000|Overall Study|Lost to Follow-up|0|||
17139725|NCT03334422|38281555|FG001|Overall Study|Lost to Follow-up|0|||
17139726|NCT03334422|38281556|FG002|Overall Study|Lost to Follow-up|0|||
17139727|NCT03334422|38281557|FG003|Overall Study|Lost to Follow-up|1|||
17139728|NCT03334422|38281554|FG000|Overall Study|Inability to obtain laboratory samples|0|||
17139729|NCT03334422|38281555|FG001|Overall Study|Inability to obtain laboratory samples|1|||
17139730|NCT03334422|38281556|FG002|Overall Study|Inability to obtain laboratory samples|0|||
17139731|NCT03334422|38281557|FG003|Overall Study|Inability to obtain laboratory samples|0|||
17139732|NCT03334422|38281554|FG000|Overall Study|Pregnancy|0|||
17139733|NCT03334422|38281555|FG001|Overall Study|Pregnancy|1|||
17139734|NCT03334422|38281556|FG002|Overall Study|Pregnancy|0|||
17139735|NCT03334422|38281557|FG003|Overall Study|Pregnancy|0|||
17139736|NCT00003389|38281574|FG000|Overall Study|Disease progression|6|||
17139737|NCT00003389|38281575|FG001|Overall Study|Disease progression|1|||
17139738|NCT00003389|38281574|FG000|Overall Study|Adverse Event|13|||
17139739|NCT00003389|38281575|FG001|Overall Study|Adverse Event|2|||
17139740|NCT00003389|38281574|FG000|Overall Study|Death|0|||
17139741|NCT00003389|38281575|FG001|Overall Study|Death|3|||
17139742|NCT00003389|38281574|FG000|Overall Study|Withdrawal by Subject|12|||
17139743|NCT00003389|38281575|FG001|Overall Study|Withdrawal by Subject|5|||
17139744|NCT00003389|38281574|FG000|Overall Study|Alternative therapy|2|||
17139745|NCT00003389|38281575|FG001|Overall Study|Alternative therapy|1|||
17139746|NCT00003389|38281574|FG000|Overall Study|Complicating disease|1|||
17139747|NCT00003389|38281575|FG001|Overall Study|Complicating disease|0|||
17139748|NCT00003389|38281574|FG000|Overall Study|Off-treatment reason missing|31|||
17139749|NCT00003389|38281575|FG001|Overall Study|Off-treatment reason missing|21|||
17139750|NCT00003389|38281574|FG000|Overall Study|Ineligible|33|||
17139751|NCT00003389|38281575|FG001|Overall Study|Ineligible|27|||
17139752|NCT03362190|38281585|FG000|Overall Study|Adverse Event|0|||
17139753|NCT03362190|38281586|FG001|Overall Study|Adverse Event|0|||
17139754|NCT03362190|38281587|FG002|Overall Study|Adverse Event|0|||
17139755|NCT03362190|38281588|FG003|Overall Study|Adverse Event|1|||
17139756|NCT03362190|38281585|FG000|Overall Study|Withdrawal by Subject|0|||
17139757|NCT03362190|38281586|FG001|Overall Study|Withdrawal by Subject|0|||
17139758|NCT03362190|38281587|FG002|Overall Study|Withdrawal by Subject|0|||
17139759|NCT03362190|38281588|FG003|Overall Study|Withdrawal by Subject|1|||
17139760|NCT02323126|38281604|FG000|Overall Study|Patient / guardian decision|0|||
17139761|NCT02323126|38281605|FG001|Overall Study|Patient / guardian decision|1|||
17139762|NCT02323126|38281606|FG002|Overall Study|Patient / guardian decision|2|||
17139763|NCT02323126|38281604|FG000|Overall Study|Progressive disease|14|||
17139764|NCT02323126|38281605|FG001|Overall Study|Progressive disease|8|||
17139765|NCT02323126|38281606|FG002|Overall Study|Progressive disease|14|||
17139766|NCT02323126|38281604|FG000|Overall Study|Physician Decision|0|||
17041236|NCT00570492|38185554|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
17041237|NCT00570492|38185552|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
17041238|NCT00570492|38185553|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
17041239|NCT00570492|38185554|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
17041240|NCT00570492|38185552|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
17041241|NCT00570492|38185553|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
17041242|NCT00570492|38185554|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
17041243|NCT00570492|38185552|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
17041244|NCT00570492|38185553|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
17041245|NCT00570492|38185554|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
17041246|NCT00570492|38185552|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
17041247|NCT00570492|38185553|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
17041248|NCT00570492|38185554|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
17139767|NCT02323126|38281605|FG001|Overall Study|Physician Decision|1|||
17139768|NCT02323126|38281606|FG002|Overall Study|Physician Decision|3|||
17139769|NCT02323126|38281604|FG000|Overall Study|Death|1|||
17139770|NCT02323126|38281605|FG001|Overall Study|Death|1|||
17139771|NCT02323126|38281606|FG002|Overall Study|Death|4|||
17139772|NCT02323126|38281604|FG000|Overall Study|Adverse Event|3|||
17139773|NCT02323126|38281605|FG001|Overall Study|Adverse Event|5|||
17139774|NCT02323126|38281606|FG002|Overall Study|Adverse Event|7|||
17139775|NCT03491553|38281623|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
17139776|NCT03491553|38281624|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
17139777|NCT03491553|38281625|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
17041249|NCT00570492|38185552|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
17041250|NCT00570492|38185553|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
17041251|NCT00570492|38185554|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
17041252|NCT00570492|38185552|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
17041253|NCT00570492|38185553|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
17041254|NCT00570492|38185554|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
17041255|NCT00570492|38185552|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
17041256|NCT00570492|38185553|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
17139778|NCT03491553|38281626|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
17139779|NCT03491553|38281627|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
17139780|NCT03491553|38281628|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
17139781|NCT03491553|38281623|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
17139782|NCT03491553|38281624|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
17139783|NCT03491553|38281625|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
17139784|NCT03491553|38281626|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
17139785|NCT03491553|38281627|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
17139786|NCT03491553|38281628|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
17139787|NCT00003377|38281649|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
17139788|NCT00003377|38281650|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
17139789|NCT00003377|38281651|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
17041257|NCT00570492|38185554|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
17041258|NCT00570492|38185552|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
17041259|NCT00570492|38185553|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
17041260|NCT00570492|38185554|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
17041261|NCT00570492|38185552|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
17041262|NCT00570492|38185553|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
17041263|NCT00570492|38185554|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
17041264|NCT00570492|38185552|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
17041265|NCT00570492|38185553|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
17041266|NCT00570492|38185554|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
17041287|NCT00571922|38185579|FG000|Overall Study|Completion unknown|36|||
17041288|NCT00571922|38185580|FG001|Overall Study|Completion unknown|36|||
17041289|NCT00686894|38185586|FG000|Overall Study|Relapse|2|||
17041290|NCT00686894|38185586|FG000|Overall Study|Protocol Violation|4|||
17041291|NCT00328627|38185602|FG000|Overall Study|Hyperglycemic Rescue|41|||
17041292|NCT00328627|38185603|FG001|Overall Study|Hyperglycemic Rescue|18|||
17041293|NCT00328627|38185604|FG002|Overall Study|Hyperglycemic Rescue|16|||
17041294|NCT00328627|38185605|FG003|Overall Study|Hyperglycemic Rescue|13|||
17041295|NCT00328627|38185606|FG004|Overall Study|Hyperglycemic Rescue|6|||
17041296|NCT00328627|38185607|FG005|Overall Study|Hyperglycemic Rescue|5|||
17041297|NCT00328627|38185608|FG006|Overall Study|Hyperglycemic Rescue|19|||
17041298|NCT00328627|38185609|FG007|Overall Study|Hyperglycemic Rescue|6|||
17041299|NCT00328627|38185610|FG008|Overall Study|Hyperglycemic Rescue|6|||
17041300|NCT00328627|38185611|FG009|Overall Study|Hyperglycemic Rescue|11|||
17041301|NCT00328627|38185612|FG010|Overall Study|Hyperglycemic Rescue|3|||
17041302|NCT00328627|38185613|FG011|Overall Study|Hyperglycemic Rescue|2|||
17041303|NCT00328627|38185602|FG000|Overall Study|Adverse Event|3|||
17041304|NCT00328627|38185603|FG001|Overall Study|Adverse Event|1|||
17041305|NCT00328627|38185604|FG002|Overall Study|Adverse Event|2|||
17041306|NCT00328627|38185605|FG003|Overall Study|Adverse Event|3|||
17041307|NCT00328627|38185606|FG004|Overall Study|Adverse Event|1|||
17041308|NCT00328627|38185607|FG005|Overall Study|Adverse Event|2|||
17139790|NCT00003377|38281652|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
17041309|NCT00328627|38185608|FG006|Overall Study|Adverse Event|1|||
17041310|NCT00328627|38185609|FG007|Overall Study|Adverse Event|2|||
17041311|NCT00328627|38185610|FG008|Overall Study|Adverse Event|0|||
17041312|NCT00328627|38185611|FG009|Overall Study|Adverse Event|7|||
17041313|NCT00328627|38185612|FG010|Overall Study|Adverse Event|5|||
17041314|NCT00328627|38185613|FG011|Overall Study|Adverse Event|4|||
17041315|NCT00328627|38185602|FG000|Overall Study|Protocol Violation|2|||
17041316|NCT00328627|38185603|FG001|Overall Study|Protocol Violation|2|||
17041317|NCT00328627|38185604|FG002|Overall Study|Protocol Violation|2|||
17041318|NCT00328627|38185605|FG003|Overall Study|Protocol Violation|8|||
17041319|NCT00328627|38185606|FG004|Overall Study|Protocol Violation|5|||
17041320|NCT00328627|38185607|FG005|Overall Study|Protocol Violation|5|||
17041321|NCT00328627|38185608|FG006|Overall Study|Protocol Violation|6|||
17041322|NCT00328627|38185609|FG007|Overall Study|Protocol Violation|2|||
17041323|NCT00328627|38185610|FG008|Overall Study|Protocol Violation|1|||
17041324|NCT00328627|38185611|FG009|Overall Study|Protocol Violation|4|||
17041325|NCT00328627|38185612|FG010|Overall Study|Protocol Violation|6|||
17041326|NCT00328627|38185613|FG011|Overall Study|Protocol Violation|2|||
17041327|NCT00328627|38185602|FG000|Overall Study|Lost to Follow-up|4|||
17041328|NCT00328627|38185603|FG001|Overall Study|Lost to Follow-up|2|||
17041329|NCT00328627|38185604|FG002|Overall Study|Lost to Follow-up|2|||
17041330|NCT00328627|38185605|FG003|Overall Study|Lost to Follow-up|4|||
17041331|NCT00328627|38185606|FG004|Overall Study|Lost to Follow-up|0|||
17041332|NCT00328627|38185607|FG005|Overall Study|Lost to Follow-up|2|||
17041333|NCT00328627|38185608|FG006|Overall Study|Lost to Follow-up|3|||
17041334|NCT00328627|38185609|FG007|Overall Study|Lost to Follow-up|0|||
17139791|NCT00003377|38281653|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
17139792|NCT00003377|38281649|FG000|Period II|Ureteral stent complications|0|||
17139793|NCT00003377|38281650|FG001|Period II|Ureteral stent complications|0|||
17139794|NCT00003377|38281651|FG002|Period II|Ureteral stent complications|0|||
17139795|NCT00003377|38281652|FG003|Period II|Ureteral stent complications|0|||
17139796|NCT00003377|38281653|FG004|Period II|Ureteral stent complications|1|||
17139797|NCT00651742|38281666|FG000|Overall Study|Objective Disease Progression|22|||
17139798|NCT00651742|38281666|FG000|Overall Study|Toxicity|3|||
17139799|NCT00651742|38281666|FG000|Overall Study|Investigator Judgment|1|||
17041335|NCT00328627|38185610|FG008|Overall Study|Lost to Follow-up|3|||
17041336|NCT00328627|38185611|FG009|Overall Study|Lost to Follow-up|2|||
17041337|NCT00328627|38185612|FG010|Overall Study|Lost to Follow-up|0|||
17041338|NCT00328627|38185613|FG011|Overall Study|Lost to Follow-up|1|||
17041339|NCT00328627|38185602|FG000|Overall Study|Withdrawal by Subject|5|||
17041340|NCT00328627|38185603|FG001|Overall Study|Withdrawal by Subject|4|||
17041341|NCT00328627|38185604|FG002|Overall Study|Withdrawal by Subject|5|||
17041342|NCT00328627|38185605|FG003|Overall Study|Withdrawal by Subject|6|||
17041343|NCT00328627|38185606|FG004|Overall Study|Withdrawal by Subject|2|||
17041344|NCT00328627|38185607|FG005|Overall Study|Withdrawal by Subject|5|||
17041345|NCT00328627|38185608|FG006|Overall Study|Withdrawal by Subject|4|||
17041346|NCT00328627|38185609|FG007|Overall Study|Withdrawal by Subject|4|||
17041347|NCT00328627|38185610|FG008|Overall Study|Withdrawal by Subject|4|||
17041348|NCT00328627|38185611|FG009|Overall Study|Withdrawal by Subject|5|||
17041349|NCT00328627|38185612|FG010|Overall Study|Withdrawal by Subject|2|||
17041350|NCT00328627|38185613|FG011|Overall Study|Withdrawal by Subject|7|||
17041351|NCT00328627|38185602|FG000|Overall Study|Pregnancy|0|||
17041352|NCT00328627|38185603|FG001|Overall Study|Pregnancy|1|||
17041353|NCT00328627|38185604|FG002|Overall Study|Pregnancy|0|||
17041354|NCT00328627|38185605|FG003|Overall Study|Pregnancy|0|||
17041355|NCT00328627|38185606|FG004|Overall Study|Pregnancy|0|||
17041356|NCT00328627|38185607|FG005|Overall Study|Pregnancy|0|||
17041357|NCT00328627|38185608|FG006|Overall Study|Pregnancy|0|||
17041358|NCT00328627|38185609|FG007|Overall Study|Pregnancy|0|||
17041359|NCT00328627|38185610|FG008|Overall Study|Pregnancy|0|||
17041360|NCT00328627|38185611|FG009|Overall Study|Pregnancy|0|||
17041361|NCT00328627|38185612|FG010|Overall Study|Pregnancy|0|||
17041362|NCT00328627|38185613|FG011|Overall Study|Pregnancy|0|||
17041363|NCT00328627|38185602|FG000|Overall Study|Physician Decision|4|||
17041364|NCT00328627|38185603|FG001|Overall Study|Physician Decision|3|||
17041365|NCT00328627|38185604|FG002|Overall Study|Physician Decision|1|||
17041366|NCT00328627|38185605|FG003|Overall Study|Physician Decision|2|||
17041367|NCT00328627|38185606|FG004|Overall Study|Physician Decision|1|||
17041368|NCT00328627|38185607|FG005|Overall Study|Physician Decision|1|||
17041369|NCT00328627|38185608|FG006|Overall Study|Physician Decision|1|||
17041370|NCT00328627|38185609|FG007|Overall Study|Physician Decision|0|||
17041371|NCT00328627|38185610|FG008|Overall Study|Physician Decision|3|||
17041372|NCT00328627|38185611|FG009|Overall Study|Physician Decision|2|||
17041373|NCT00328627|38185612|FG010|Overall Study|Physician Decision|1|||
17041374|NCT00328627|38185613|FG011|Overall Study|Physician Decision|0|||
17041375|NCT00328627|38185602|FG000|Overall Study|Other|0|||
17041376|NCT00328627|38185603|FG001|Overall Study|Other|0|||
17041377|NCT00328627|38185604|FG002|Overall Study|Other|0|||
17041378|NCT00328627|38185605|FG003|Overall Study|Other|1|||
17041379|NCT00328627|38185606|FG004|Overall Study|Other|0|||
17139800|NCT00651742|38281666|FG000|Overall Study|Withdrawal of Consent|1|||
17041380|NCT00328627|38185607|FG005|Overall Study|Other|0|||
17041381|NCT00328627|38185608|FG006|Overall Study|Other|1|||
17041382|NCT00328627|38185609|FG007|Overall Study|Other|0|||
17041383|NCT00328627|38185610|FG008|Overall Study|Other|0|||
17041384|NCT00328627|38185611|FG009|Overall Study|Other|1|||
17041385|NCT00328627|38185612|FG010|Overall Study|Other|1|||
17041386|NCT00328627|38185613|FG011|Overall Study|Other|0|||
17041387|NCT03977727|38185649|FG000|Second Treatment|Lost to Follow-up|0|||
17041388|NCT03977727|38185650|FG001|Second Treatment|Lost to Follow-up|3|||
17041389|NCT00663858|38185659|FG000|Overall Study|Adverse Event|9|||
17041390|NCT00663858|38185660|FG001|Overall Study|Adverse Event|1|||
17041391|NCT00663858|38185661|FG002|Overall Study|Adverse Event|6|||
17041392|NCT00663858|38185659|FG000|Overall Study|Lack of Efficacy|5|||
17041393|NCT00663858|38185660|FG001|Overall Study|Lack of Efficacy|1|||
17041394|NCT00663858|38185661|FG002|Overall Study|Lack of Efficacy|3|||
17041395|NCT00663858|38185659|FG000|Overall Study|Withdrawal by Subject|7|||
17041396|NCT00663858|38185660|FG001|Overall Study|Withdrawal by Subject|3|||
17041397|NCT00663858|38185661|FG002|Overall Study|Withdrawal by Subject|3|||
17041398|NCT00663858|38185659|FG000|Overall Study|Protocol Violation|5|||
17041399|NCT00663858|38185660|FG001|Overall Study|Protocol Violation|3|||
17041400|NCT00663858|38185661|FG002|Overall Study|Protocol Violation|4|||
17041401|NCT00663858|38185659|FG000|Overall Study|Other|8|||
17041402|NCT00663858|38185660|FG001|Overall Study|Other|2|||
17041403|NCT00663858|38185661|FG002|Overall Study|Other|4|||
17041404|NCT00659880|38185669|FG000|Overall Study|Lost to Follow-up|5|||
17041405|NCT00683774|38185676|FG000|Overall Study|Withdrawal by Subject|0|||
17041406|NCT00683774|38185677|FG001|Overall Study|Withdrawal by Subject|1|||
17041407|NCT00683774|38185676|FG000|Overall Study|Physician Decision|3|||
17041408|NCT00683774|38185677|FG001|Overall Study|Physician Decision|0|||
17041409|NCT00354679|38185683|FG000|Overall Study|Patient Not Treated|1|||
17041410|NCT00683696|38185689|FG000|Overall Study|Withdrawn due to study closure|337|||
17041411|NCT00683696|38185690|FG001|Overall Study|Withdrawn due to study closure|338|||
17041412|NCT00683696|38185689|FG000|Overall Study|Withdrawn prior to study closure|13|||
17041413|NCT00683696|38185690|FG001|Overall Study|Withdrawn prior to study closure|28|||
17041414|NCT00683696|38185689|FG000|Overall Study|Lost to Follow-up|5|||
17041415|NCT00683696|38185690|FG001|Overall Study|Lost to Follow-up|6|||
17041416|NCT00683696|38185689|FG000|Overall Study|Vital status follow-up only|3|||
17041417|NCT00683696|38185690|FG001|Overall Study|Vital status follow-up only|3|||
17041418|NCT00683696|38185689|FG000|Overall Study|Death|46|||
17041419|NCT00683696|38185690|FG001|Overall Study|Death|30|||
17041420|NCT00345631|38185700|FG000|Overall Study|Withdrawal by Subject|1|||
17041421|NCT00345631|38185701|FG001|Overall Study|Withdrawal by Subject|0|||
17041422|NCT00345631|38185702|FG002|Overall Study|Withdrawal by Subject|1|||
17041423|NCT00345631|38185700|FG000|Overall Study|Adverse Event|0|||
17041424|NCT00345631|38185701|FG001|Overall Study|Adverse Event|1|||
17041425|NCT00345631|38185702|FG002|Overall Study|Adverse Event|0|||
17041426|NCT00345631|38185700|FG000|Overall Study|Lost to Follow-up|3|||
17041427|NCT00345631|38185701|FG001|Overall Study|Lost to Follow-up|7|||
17041428|NCT00345631|38185702|FG002|Overall Study|Lost to Follow-up|4|||
17041429|NCT00345631|38185700|FG000|Overall Study|Other reasons|0|||
17041430|NCT00345631|38185701|FG001|Overall Study|Other reasons|0|||
17041431|NCT00345631|38185702|FG002|Overall Study|Other reasons|1|||
17041432|NCT00540514|38185714|FG000|Overall Study|Still on treatment|3|||
17041433|NCT00540514|38185715|FG001|Overall Study|Still on treatment|0|||
17041434|NCT00540514|38185714|FG000|Overall Study|Unacceptable Toxicity|61|||
17041435|NCT00540514|38185715|FG001|Overall Study|Unacceptable Toxicity|62|||
17041436|NCT00540514|38185714|FG000|Overall Study|Adverse Event|20|||
17041437|NCT00540514|38185715|FG001|Overall Study|Adverse Event|24|||
17041438|NCT00540514|38185714|FG000|Overall Study|Physician Decision|86|||
17041439|NCT00540514|38185715|FG001|Overall Study|Physician Decision|99|||
17041440|NCT00540514|38185714|FG000|Overall Study|Protocol Deviation|3|||
17041441|NCT00540514|38185715|FG001|Overall Study|Protocol Deviation|4|||
17041442|NCT00540514|38185714|FG000|Overall Study|Lost to Follow-up|1|||
17041443|NCT00540514|38185715|FG001|Overall Study|Lost to Follow-up|1|||
17041444|NCT00540514|38185714|FG000|Overall Study|Withdrawal by Subject|65|||
17041445|NCT00540514|38185715|FG001|Overall Study|Withdrawal by Subject|67|||
17041446|NCT00540514|38185714|FG000|Overall Study|Excluded prior to treatment|7|||
17041447|NCT00540514|38185715|FG001|Overall Study|Excluded prior to treatment|7|||
17041448|NCT00540514|38185714|FG000|Overall Study|Paclitaxel not available|0|||
17041449|NCT00540514|38185715|FG001|Overall Study|Paclitaxel not available|2|||
17041450|NCT00663702|38185724|FG000|Overall Study|Adverse Event|8|||
17041451|NCT00663702|38185725|FG001|Overall Study|Adverse Event|4|||
17041452|NCT00663702|38185724|FG000|Overall Study|Withdrawal by Subject|3|||
17041453|NCT00663702|38185725|FG001|Overall Study|Withdrawal by Subject|1|||
17041454|NCT00663702|38185724|FG000|Overall Study|Pregnancy|0|||
17041455|NCT00663702|38185725|FG001|Overall Study|Pregnancy|1|||
17041456|NCT00663702|38185724|FG000|Overall Study|Lost to Follow-up|3|||
17041457|NCT00663702|38185725|FG001|Overall Study|Lost to Follow-up|0|||
17041458|NCT00663702|38185724|FG000|Overall Study|Death|1|||
17041459|NCT00663702|38185725|FG001|Overall Study|Death|1|||
17041460|NCT00663702|38185724|FG000|Overall Study|Lack of Efficacy|3|||
17041461|NCT00663702|38185725|FG001|Overall Study|Lack of Efficacy|3|||
17041462|NCT00683618|38185734|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
17041463|NCT00683618|38185735|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
17041464|NCT00683618|38185736|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
17041465|NCT00683618|38185734|FG000|Randomised Treatment Period|Protocol Violation|0|||
17041466|NCT00683618|38185735|FG001|Randomised Treatment Period|Protocol Violation|1|||
17041467|NCT00683618|38185736|FG002|Randomised Treatment Period|Protocol Violation|0|||
17041468|NCT00683618|38185734|FG000|Randomised Treatment Period|Adverse Event|2|||
17041469|NCT00683618|38185735|FG001|Randomised Treatment Period|Adverse Event|0|||
17041470|NCT00683618|38185736|FG002|Randomised Treatment Period|Adverse Event|2|||
17041471|NCT00683618|38185734|FG000|Randomised Treatment Period|Reason not provided|0|||
17041472|NCT00683618|38185735|FG001|Randomised Treatment Period|Reason not provided|0|||
17041473|NCT00683618|38185736|FG002|Randomised Treatment Period|Reason not provided|2|||
17041474|NCT00683618|38185734|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
17041475|NCT00683618|38185735|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
17041476|NCT00683618|38185736|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
17041477|NCT00683618|38185734|FG000|Extension Treatment Period|Adverse Event|1|||
17041478|NCT00683618|38185735|FG001|Extension Treatment Period|Adverse Event|0|||
17041479|NCT00683618|38185736|FG002|Extension Treatment Period|Adverse Event|0|||
17041480|NCT00683618|38185734|FG000|Extension Treatment Period|Protocol Violation|1|||
17041481|NCT00683618|38185735|FG001|Extension Treatment Period|Protocol Violation|0|||
17041482|NCT00683618|38185736|FG002|Extension Treatment Period|Protocol Violation|0|||
17041483|NCT00688064|38185748|FG000|Overall Study|Protocol Violation|0|||
17139801|NCT00651742|38281666|FG000|Overall Study|Enrolled but not treated|1|||
17139802|NCT00002651|38281672|FG000|Induction|Adverse Event|44|||
17139803|NCT00002651|38281673|FG001|Induction|Adverse Event|0|||
17139804|NCT00002651|38281674|FG002|Induction|Adverse Event|0|||
17139805|NCT00002651|38281672|FG000|Induction|Refusal unrelated to adverse event|50|||
17139806|NCT00002651|38281673|FG001|Induction|Refusal unrelated to adverse event|0|||
17139807|NCT00002651|38281674|FG002|Induction|Refusal unrelated to adverse event|0|||
17139808|NCT00002651|38281672|FG000|Induction|Progression/relapse|274|||
17041484|NCT00688064|38185749|FG001|Overall Study|Protocol Violation|1|||
17041485|NCT00688064|38185748|FG000|Overall Study|Adverse Event|2|||
17041486|NCT00688064|38185749|FG001|Overall Study|Adverse Event|4|||
17041487|NCT00688064|38185748|FG000|Overall Study|Withdrawal by Subject|7|||
17139809|NCT00002651|38281673|FG001|Induction|Progression/relapse|0|||
17041488|NCT00688064|38185749|FG001|Overall Study|Withdrawal by Subject|7|||
17041489|NCT00688064|38185748|FG000|Overall Study|Lost to Follow-up|10|||
17041490|NCT00688064|38185749|FG001|Overall Study|Lost to Follow-up|10|||
17041491|NCT00688064|38185748|FG000|Overall Study|Lack of Efficacy|0|||
17041492|NCT00688064|38185749|FG001|Overall Study|Lack of Efficacy|1|||
17041493|NCT00688064|38185748|FG000|Overall Study|Pregnancy|1|||
17041494|NCT00688064|38185749|FG001|Overall Study|Pregnancy|0|||
17041495|NCT00688064|38185748|FG000|Overall Study|Any other reasons|1|||
17041496|NCT00688064|38185749|FG001|Overall Study|Any other reasons|3|||
17041497|NCT00663234|38185755|FG000|Overall Study|Not willing to adhere to requirements|1|||
17139810|NCT00002651|38281674|FG002|Induction|Progression/relapse|0|||
17139811|NCT00002651|38281672|FG000|Induction|Death|62|||
17139812|NCT00002651|38281673|FG001|Induction|Death|0|||
17139813|NCT00002651|38281674|FG002|Induction|Death|0|||
17139814|NCT00002651|38281672|FG000|Induction|Other|823|||
17139815|NCT00002651|38281673|FG001|Induction|Other|0|||
17139816|NCT00002651|38281674|FG002|Induction|Other|0|||
16992198|NCT00727909|38136116|FG002|Overall Study|Withdrawal by Subject|8|||
16992199|NCT00727909|38136117|FG003|Overall Study|Withdrawal by Subject|5|||
16992200|NCT00727909|38136114|FG000|Overall Study|Death|0|||
16992201|NCT00727909|38136115|FG001|Overall Study|Death|0|||
16992202|NCT00727909|38136116|FG002|Overall Study|Death|1|||
16992203|NCT00727909|38136117|FG003|Overall Study|Death|0|||
16992204|NCT00726895|38136121|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16992205|NCT00726895|38136122|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16992206|NCT00585325|38136131|FG000|Overall Study|Withdrawal by Subject|1|||
16992207|NCT00585325|38136132|FG001|Overall Study|Withdrawal by Subject|1|||
16992208|NCT00726661|38136140|FG000|Overall Study|Lost to Follow-up|36|||
16992209|NCT00726661|38136141|FG001|Overall Study|Lost to Follow-up|11|||
17041498|NCT00683384|38185763|FG000|Overall Study|Death|1|||
17041499|NCT00683384|38185763|FG000|Overall Study|Adverse Event|1|||
17041500|NCT00326911|38185769|FG000|Overall Study|Hospitalization prior to treatment|0|||
17041501|NCT00326911|38185770|FG001|Overall Study|Hospitalization prior to treatment|1|||
17041502|NCT00326911|38185769|FG000|Overall Study|Physician decision prior to treatment|1|||
17041503|NCT00326911|38185770|FG001|Overall Study|Physician decision prior to treatment|0|||
17139817|NCT00002651|38281672|FG000|Induction|not eligible|90|||
17139818|NCT00002651|38281673|FG001|Induction|not eligible|0|||
17139819|NCT00002651|38281674|FG002|Induction|not eligible|0|||
17139820|NCT00002651|38281672|FG000|Consolidation and Randomization|Adverse Event|0|||
17139821|NCT00002651|38281673|FG001|Consolidation and Randomization|Adverse Event|36|||
17139822|NCT00002651|38281674|FG002|Consolidation and Randomization|Adverse Event|14|||
17139823|NCT00002651|38281672|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
17041504|NCT00326911|38185769|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
17041505|NCT00326911|38185770|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
17041506|NCT00540436|38185776|FG000|First 12-Week Treatment Period|Adverse Event|1|||
17041507|NCT00540436|38185776|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
17041508|NCT00540436|38185776|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
17041509|NCT00540436|38185776|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
17041510|NCT00687440|38185780|FG000|Overall Study|Adverse Event|3|||
17041511|NCT00687440|38185780|FG000|Overall Study|Lost to Follow-up|3|||
17041512|NCT00687440|38185780|FG000|Overall Study|Lack of Efficacy|2|||
17041513|NCT00687440|38185780|FG000|Overall Study|Death|2|||
17041514|NCT00687440|38185780|FG000|Overall Study|Other|1|||
17139824|NCT00002651|38281673|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
17139825|NCT00002651|38281674|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
17139826|NCT00002651|38281672|FG000|Consolidation and Randomization|Progression/relapse|0|||
17139827|NCT00002651|38281673|FG001|Consolidation and Randomization|Progression/relapse|295|||
17139828|NCT00002651|38281674|FG002|Consolidation and Randomization|Progression/relapse|298|||
17139829|NCT00002651|38281672|FG000|Consolidation and Randomization|Death|0|||
17139830|NCT00002651|38281673|FG001|Consolidation and Randomization|Death|38|||
17139831|NCT00002651|38281674|FG002|Consolidation and Randomization|Death|48|||
17139832|NCT00002651|38281672|FG000|Consolidation and Randomization|Other|0|||
17139833|NCT00002651|38281673|FG001|Consolidation and Randomization|Other|314|||
17139834|NCT00002651|38281674|FG002|Consolidation and Randomization|Other|313|||
17139835|NCT00002651|38281672|FG000|Consolidation and Randomization|not eligible|0|||
17139836|NCT00002651|38281673|FG001|Consolidation and Randomization|not eligible|102|||
17139837|NCT00002651|38281674|FG002|Consolidation and Randomization|not eligible|112|||
17139838|NCT00002597|38281684|FG000|Overall Study|Protocol Violation|19|||
17139839|NCT00002597|38281685|FG001|Overall Study|Protocol Violation|17|||
17139840|NCT00002597|38281684|FG000|Overall Study|Withdrawal by Subject|7|||
17139841|NCT00002597|38281685|FG001|Overall Study|Withdrawal by Subject|6|||
17139842|NCT03435081|38281694|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
17139843|NCT03435081|38281695|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
17139844|NCT03435081|38281696|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
17139845|NCT03435081|38281694|FG000|Week 0 to Week 16|Adverse Event|2|||
17139846|NCT03435081|38281695|FG001|Week 0 to Week 16|Adverse Event|2|||
17139847|NCT03435081|38281696|FG002|Week 0 to Week 16|Adverse Event|2|||
17139848|NCT03435081|38281694|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
17139849|NCT03435081|38281695|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
17139850|NCT03435081|38281696|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
16992210|NCT00726661|38136140|FG000|Overall Study|Withdrawal by Subject|17|||
16992211|NCT00726661|38136141|FG001|Overall Study|Withdrawal by Subject|13|||
16992212|NCT00726661|38136140|FG000|Overall Study|Trial terminated by sponsor|214|||
16992213|NCT00726661|38136141|FG001|Overall Study|Trial terminated by sponsor|187|||
16992214|NCT00726661|38136140|FG000|Overall Study|Death|475|||
16992215|NCT00726661|38136141|FG001|Overall Study|Death|159|||
16992216|NCT00726661|38136140|FG000|Overall Study|Physician Decision|25|||
16992217|NCT00726661|38136141|FG001|Overall Study|Physician Decision|13|||
16992218|NCT00726661|38136140|FG000|Overall Study|Other|47|||
16992219|NCT00726661|38136141|FG001|Overall Study|Other|35|||
16992220|NCT00741091|38136157|FG000|Overall Study|Death|13|||
16992221|NCT00741091|38136157|FG000|Overall Study|Lost to Follow-up|16|||
16992222|NCT00741091|38136157|FG000|Overall Study|Withdrawal by Subject|6|||
16992223|NCT00741091|38136157|FG000|Overall Study|Missed Visit|22|||
16992224|NCT00741013|38136164|FG000|Overall Study|Adverse Event|1|||
17041515|NCT00687440|38185780|FG000|Overall Study|Missing|1|||
17041516|NCT00659490|38185787|FG000|Overall Study|Lost to Follow-up|2|||
17139851|NCT03435081|38281694|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
17139852|NCT03435081|38281695|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
17139853|NCT03435081|38281696|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
17139854|NCT03435081|38281694|FG000|Week 0 to Week 16|Pregnancy|1|||
17139855|NCT03435081|38281695|FG001|Week 0 to Week 16|Pregnancy|0|||
17139856|NCT03435081|38281696|FG002|Week 0 to Week 16|Pregnancy|0|||
17139857|NCT03435081|38281694|FG000|Week 0 to Week 16|Non-compliance|1|||
17139858|NCT03435081|38281695|FG001|Week 0 to Week 16|Non-compliance|0|||
17139859|NCT03435081|38281696|FG002|Week 0 to Week 16|Non-compliance|2|||
17139860|NCT03435081|38281694|FG000|Week 0 to Week 16|Inadequate Response|0|||
17139861|NCT03435081|38281695|FG001|Week 0 to Week 16|Inadequate Response|1|||
17139862|NCT03435081|38281696|FG002|Week 0 to Week 16|Inadequate Response|0|||
17139863|NCT03435081|38281694|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
17139864|NCT03435081|38281695|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
17139865|NCT03435081|38281696|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
17139866|NCT03435081|38281694|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
17139867|NCT03435081|38281695|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
17139868|NCT03435081|38281696|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
17139869|NCT03435081|38281694|FG000|Week 16 to Week 104|Adverse Event|1|||
17139870|NCT03435081|38281695|FG001|Week 16 to Week 104|Adverse Event|0|||
17139871|NCT03435081|38281696|FG002|Week 16 to Week 104|Adverse Event|2|||
17139872|NCT03435081|38281694|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
17139873|NCT03435081|38281695|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
17139874|NCT03435081|38281696|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
17139875|NCT03435081|38281694|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
17139876|NCT03435081|38281695|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
17139877|NCT03435081|38281696|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
17139878|NCT03435081|38281694|FG000|Week 16 to Week 104|Non--Compliance|0|||
17139879|NCT03435081|38281695|FG001|Week 16 to Week 104|Non--Compliance|0|||
17139880|NCT03435081|38281696|FG002|Week 16 to Week 104|Non--Compliance|1|||
17139881|NCT02738008|38281711|FG000|Overall Study|Study Terminated by Sponsor|1|||
17139882|NCT02738008|38281712|FG001|Overall Study|Study Terminated by Sponsor|5|||
17139883|NCT02738008|38281713|FG002|Overall Study|Study Terminated by Sponsor|3|||
17139884|NCT02738008|38281711|FG000|Overall Study|Adverse Event|0|||
17139885|NCT02738008|38281712|FG001|Overall Study|Adverse Event|1|||
17139886|NCT02738008|38281713|FG002|Overall Study|Adverse Event|2|||
17139887|NCT00002525|38281723|FG000|Overall Study|Adverse Event|36|||
17139888|NCT00002525|38281724|FG001|Overall Study|Adverse Event|0|||
17139889|NCT00002525|38281723|FG000|Overall Study|Death|5|||
17139890|NCT00002525|38281724|FG001|Overall Study|Death|0|||
17139891|NCT00002525|38281723|FG000|Overall Study|Withdrawal by Subject|11|||
17139892|NCT00002525|38281724|FG001|Overall Study|Withdrawal by Subject|0|||
17139893|NCT00002525|38281723|FG000|Overall Study|Start non-protocol therapy|1|||
17139894|NCT00002525|38281724|FG001|Overall Study|Start non-protocol therapy|0|||
17139895|NCT00002525|38281723|FG000|Overall Study|Other complicating disease|1|||
17139896|NCT00002525|38281724|FG001|Overall Study|Other complicating disease|0|||
17139897|NCT00002525|38281723|FG000|Overall Study|Duke's A, B1, D disease|92|||
17139898|NCT00002525|38281724|FG001|Overall Study|Duke's A, B1, D disease|0|||
17139899|NCT00002525|38281723|FG000|Overall Study|Error|6|||
17139900|NCT00002525|38281724|FG001|Overall Study|Error|0|||
17139901|NCT00002525|38281723|FG000|Overall Study|Other|26|||
17139902|NCT00002525|38281724|FG001|Overall Study|Other|0|||
17139903|NCT00002525|38281723|FG000|Overall Study|Never start protocol therapy|8|||
17139904|NCT00002525|38281724|FG001|Overall Study|Never start protocol therapy|0|||
17139905|NCT03489369|38281736|FG000|Overall Study|Documented Progressive Disease|3|||
17139906|NCT03489369|38281737|FG001|Overall Study|Documented Progressive Disease|2|||
17139907|NCT03489369|38281738|FG002|Overall Study|Documented Progressive Disease|3|||
17041517|NCT00659490|38185788|FG001|Overall Study|Lost to Follow-up|0|||
17041518|NCT00659490|38185789|FG002|Overall Study|Lost to Follow-up|1|||
17041519|NCT00539500|38185797|FG000|Overall Study|Disease Progression|1|||
17041520|NCT00539500|38185797|FG000|Overall Study|Lost to Follow-up|2|||
17041521|NCT00662532|38185803|FG000|Overall Study|Adverse Event|0|||
17041522|NCT00662532|38185804|FG001|Overall Study|Adverse Event|1|||
17041523|NCT00662532|38185803|FG000|Overall Study|Lost to Follow-up|0|||
17139908|NCT03489369|38281739|FG003|Overall Study|Documented Progressive Disease|6|||
17139909|NCT03489369|38281736|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
17041524|NCT00662532|38185804|FG001|Overall Study|Lost to Follow-up|1|||
17041525|NCT00686036|38185812|FG000|Overall Study|Adverse Event|3|||
17041526|NCT00686036|38185813|FG001|Overall Study|Adverse Event|0|||
17041527|NCT00686036|38185812|FG000|Overall Study|Withdrawal by Subject|3|||
17041528|NCT00686036|38185813|FG001|Overall Study|Withdrawal by Subject|1|||
17041529|NCT00686036|38185812|FG000|Overall Study|Study terminated by AstraZeneca|2|||
17041530|NCT00686036|38185813|FG001|Overall Study|Study terminated by AstraZeneca|1|||
17041531|NCT00686036|38185812|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
17041532|NCT00686036|38185813|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
17041533|NCT00686036|38185812|FG000|Overall Study|Other reasons not identified|0|||
17041534|NCT00686036|38185813|FG001|Overall Study|Other reasons not identified|4|||
17139910|NCT03489369|38281737|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
17041535|NCT00682448|38185821|FG000|Overall Study|Adverse Event|1|||
17041536|NCT00682448|38185822|FG001|Overall Study|Adverse Event|2|||
17041537|NCT00682448|38185821|FG000|Overall Study|Lack of Efficacy|1|||
17041538|NCT00682448|38185822|FG001|Overall Study|Lack of Efficacy|0|||
17041539|NCT00682448|38185821|FG000|Overall Study|Lost to Follow-up|1|||
17139911|NCT03489369|38281738|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
17139912|NCT03489369|38281739|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
17139913|NCT03257254|38281749|FG000|Overall Study|Withdrawal by Subject|7|||
17139914|NCT03257254|38281749|FG000|Overall Study|Lost to Follow-up|9|||
17139915|NCT03257254|38281749|FG000|Overall Study|Study discontinued by sponsor|5|||
17139916|NCT03738475|38281755|FG000|Overall Study|Participant Non-Compliance|1|||
17139917|NCT03738475|38281756|FG001|Overall Study|Participant Non-Compliance|0|||
17139918|NCT03084718|38281767|FG000|Overall Study|Withdrawal by Subject|4|||
17139919|NCT03084718|38281768|FG001|Overall Study|Withdrawal by Subject|3|||
17139920|NCT03084718|38281769|FG002|Overall Study|Withdrawal by Subject|4|||
17139921|NCT03084718|38281770|FG003|Overall Study|Withdrawal by Subject|0|||
17139922|NCT03084718|38281771|FG004|Overall Study|Withdrawal by Subject|0|||
17139923|NCT03084718|38281767|FG000|Overall Study|Physician Decision|1|||
17139924|NCT03084718|38281768|FG001|Overall Study|Physician Decision|0|||
17139925|NCT03084718|38281769|FG002|Overall Study|Physician Decision|0|||
17139926|NCT03084718|38281770|FG003|Overall Study|Physician Decision|0|||
17139927|NCT03084718|38281771|FG004|Overall Study|Physician Decision|0|||
17139928|NCT03084718|38281767|FG000|Overall Study|Adverse Event|3|||
17139929|NCT03084718|38281768|FG001|Overall Study|Adverse Event|5|||
17139930|NCT03084718|38281769|FG002|Overall Study|Adverse Event|5|||
17139931|NCT03084718|38281770|FG003|Overall Study|Adverse Event|8|||
17139932|NCT03084718|38281771|FG004|Overall Study|Adverse Event|2|||
17139933|NCT03084718|38281767|FG000|Overall Study|Lack of Efficacy|2|||
17139934|NCT03084718|38281768|FG001|Overall Study|Lack of Efficacy|0|||
17041540|NCT00682448|38185822|FG001|Overall Study|Lost to Follow-up|3|||
17041541|NCT00682448|38185821|FG000|Overall Study|Pregnancy|0|||
17041542|NCT00682448|38185822|FG001|Overall Study|Pregnancy|1|||
17041543|NCT00682448|38185821|FG000|Overall Study|Withdrawal by Subject|2|||
17041544|NCT00682448|38185822|FG001|Overall Study|Withdrawal by Subject|0|||
17041545|NCT00681824|38185831|FG000|Overall Study|withdrawn by investigator|0|||
17041546|NCT00681824|38185832|FG001|Overall Study|withdrawn by investigator|0|||
17139935|NCT03084718|38281769|FG002|Overall Study|Lack of Efficacy|1|||
17139936|NCT03084718|38281770|FG003|Overall Study|Lack of Efficacy|4|||
17139937|NCT03084718|38281771|FG004|Overall Study|Lack of Efficacy|0|||
17139938|NCT03084718|38281767|FG000|Overall Study|Lost to Follow-up|0|||
17139939|NCT03084718|38281768|FG001|Overall Study|Lost to Follow-up|1|||
17139940|NCT03084718|38281769|FG002|Overall Study|Lost to Follow-up|0|||
17139941|NCT03084718|38281770|FG003|Overall Study|Lost to Follow-up|0|||
17139942|NCT03084718|38281771|FG004|Overall Study|Lost to Follow-up|2|||
17139943|NCT03084718|38281767|FG000|Overall Study|Protocol Violation|0|||
17139944|NCT03084718|38281768|FG001|Overall Study|Protocol Violation|0|||
17139945|NCT03084718|38281769|FG002|Overall Study|Protocol Violation|1|||
17139946|NCT03084718|38281770|FG003|Overall Study|Protocol Violation|0|||
17139947|NCT03084718|38281771|FG004|Overall Study|Protocol Violation|0|||
17041547|NCT00681824|38185833|FG002|Overall Study|withdrawn by investigator|1|||
17041548|NCT00681824|38185831|FG000|Overall Study|scheduling conflict|1|||
17041549|NCT00681824|38185832|FG001|Overall Study|scheduling conflict|0|||
17041550|NCT00681824|38185833|FG002|Overall Study|scheduling conflict|0|||
17041551|NCT00681824|38185831|FG000|Overall Study|Death|0|||
17041552|NCT00681824|38185832|FG001|Overall Study|Death|1|||
17041553|NCT00681824|38185833|FG002|Overall Study|Death|0|||
17139948|NCT03084718|38281767|FG000|Overall Study|Death|0|||
17139949|NCT03084718|38281768|FG001|Overall Study|Death|1|||
17139950|NCT03084718|38281769|FG002|Overall Study|Death|0|||
17139951|NCT03084718|38281770|FG003|Overall Study|Death|0|||
17139952|NCT03084718|38281771|FG004|Overall Study|Death|0|||
17139953|NCT03084718|38281767|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
17139954|NCT03084718|38281768|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
17139955|NCT03084718|38281769|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
17041554|NCT00681668|38185841|FG000|Overall Study|Protocol Violation|1|||
17041555|NCT00681668|38185841|FG000|Overall Study|Withdrawal by Subject|1|||
17041556|NCT00539188|38185847|FG000|Overall Study|Withdrawal by Subject|1|||
17041557|NCT00539188|38185848|FG001|Overall Study|Withdrawal by Subject|0|||
17139956|NCT03084718|38281770|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
17189026|NCT02504320|38341979|FG002|Treatment Period 3|Positive Drug Screen|0|||
17189027|NCT02504320|38341980|FG003|Treatment Period 3|Positive Drug Screen|1|||
17139957|NCT03084718|38281771|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
17139958|NCT04321252|38281795|FG000|Overall Study|Withdrawal by Subject|0|||
17139959|NCT04321252|38281796|FG001|Overall Study|Withdrawal by Subject|0|||
17139960|NCT04321252|38281797|FG002|Overall Study|Withdrawal by Subject|0|||
17139961|NCT04321252|38281798|FG003|Overall Study|Withdrawal by Subject|0|||
17139962|NCT04321252|38281799|FG004|Overall Study|Withdrawal by Subject|0|||
17139963|NCT04321252|38281800|FG005|Overall Study|Withdrawal by Subject|1|||
17139964|NCT04321252|38281801|FG006|Overall Study|Withdrawal by Subject|0|||
17139965|NCT04321252|38281802|FG007|Overall Study|Withdrawal by Subject|0|||
17139966|NCT04321252|38281803|FG008|Overall Study|Withdrawal by Subject|0|||
17139967|NCT03433677|38281835|FG000|Period 1|Protocol Violation|1|||
17139968|NCT03433677|38281836|FG001|Period 1|Protocol Violation|0|||
17139969|NCT03433677|38281835|FG000|Period 2|Withdrawal by Subject|1|||
17139970|NCT03433677|38281836|FG001|Period 2|Withdrawal by Subject|1|||
17139971|NCT02492711|38281846|FG000|Overall Study|Adverse Event|9|||
17139972|NCT02492711|38281847|FG001|Overall Study|Adverse Event|9|||
17139973|NCT02492711|38281848|FG002|Overall Study|Adverse Event|2|||
17139974|NCT02492711|38281846|FG000|Overall Study|Death|3|||
17139975|NCT02492711|38281847|FG001|Overall Study|Death|3|||
17139976|NCT02492711|38281848|FG002|Overall Study|Death|0|||
17139977|NCT02492711|38281846|FG000|Overall Study|Withdrawal by Subject|10|||
17139978|NCT02492711|38281847|FG001|Overall Study|Withdrawal by Subject|16|||
17139979|NCT02492711|38281848|FG002|Overall Study|Withdrawal by Subject|5|||
17139980|NCT02492711|38281846|FG000|Overall Study|Physician Decision|10|||
17139981|NCT02492711|38281847|FG001|Overall Study|Physician Decision|6|||
17139982|NCT02492711|38281848|FG002|Overall Study|Physician Decision|4|||
17139983|NCT02492711|38281846|FG000|Overall Study|Lost to Follow-up|0|||
17139984|NCT02492711|38281847|FG001|Overall Study|Lost to Follow-up|0|||
17139985|NCT02492711|38281848|FG002|Overall Study|Lost to Follow-up|1|||
17139986|NCT02492711|38281846|FG000|Overall Study|study treatment delay|2|||
17139987|NCT02492711|38281847|FG001|Overall Study|study treatment delay|1|||
17139988|NCT02492711|38281848|FG002|Overall Study|study treatment delay|0|||
17139989|NCT02492711|38281846|FG000|Overall Study|change in chemotherapy|0|||
17139990|NCT02492711|38281847|FG001|Overall Study|change in chemotherapy|1|||
17139991|NCT02492711|38281848|FG002|Overall Study|change in chemotherapy|0|||
17139992|NCT02492711|38281846|FG000|Overall Study|never treated|2|||
17139993|NCT02492711|38281847|FG001|Overall Study|never treated|4|||
17139994|NCT02492711|38281848|FG002|Overall Study|never treated|0|||
17139995|NCT02492711|38281846|FG000|Overall Study|Other|0|||
17139996|NCT02492711|38281847|FG001|Overall Study|Other|0|||
17139997|NCT02492711|38281848|FG002|Overall Study|Other|1|||
17139998|NCT01147822|38281863|FG000|Overall Study|Death|66|||
17139999|NCT01147822|38281864|FG001|Overall Study|Death|59|||
17140000|NCT01147822|38281863|FG000|Overall Study|Protocol Violation|0|||
17140001|NCT01147822|38281864|FG001|Overall Study|Protocol Violation|1|||
17140002|NCT01147822|38281863|FG000|Overall Study|Lost to Follow-up|3|||
17140003|NCT01147822|38281864|FG001|Overall Study|Lost to Follow-up|2|||
16780483|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
16780484|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
16780485|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
16780486|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
16992225|NCT00741013|38136165|FG001|Overall Study|Adverse Event|0|||
16992226|NCT00741013|38136166|FG002|Overall Study|Adverse Event|0|||
16992227|NCT00741013|38136164|FG000|Overall Study|Withdrawal by Subject|0|||
16992228|NCT00741013|38136165|FG001|Overall Study|Withdrawal by Subject|0|||
16992229|NCT00741013|38136166|FG002|Overall Study|Withdrawal by Subject|1|||
16992230|NCT00741013|38136164|FG000|Overall Study|Discovered failed screen after enrolled|0|||
16992231|NCT00741013|38136165|FG001|Overall Study|Discovered failed screen after enrolled|2|||
16992232|NCT00741013|38136166|FG002|Overall Study|Discovered failed screen after enrolled|0|||
16992233|NCT00740857|38136177|FG000|Overall Study|Withdrawal by Subject|1|||
16992234|NCT00740857|38136178|FG001|Overall Study|Withdrawal by Subject|0|||
16992235|NCT00740857|38136179|FG002|Overall Study|Withdrawal by Subject|0|||
16992236|NCT00808132|38136192|FG000|Overall Study|Adverse Event|34|||
16992237|NCT00808132|38136193|FG001|Overall Study|Adverse Event|33|||
16992238|NCT00808132|38136194|FG002|Overall Study|Adverse Event|16|||
16992239|NCT00808132|38136195|FG003|Overall Study|Adverse Event|31|||
16992240|NCT00808132|38136196|FG004|Overall Study|Adverse Event|33|||
16992241|NCT00808132|38136192|FG000|Overall Study|Death|0|||
16992242|NCT00808132|38136193|FG001|Overall Study|Death|0|||
17041558|NCT00539188|38185847|FG000|Overall Study|Lost to Follow-up|2|||
17041559|NCT00539188|38185848|FG001|Overall Study|Lost to Follow-up|1|||
17041560|NCT00681590|38185856|FG000|Overall Study|Withdrawal by Subject|2|||
17041561|NCT00681590|38185857|FG001|Overall Study|Withdrawal by Subject|12|||
17041562|NCT04980456|38185865|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
17041563|NCT04980456|38185866|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
17041564|NCT04980456|38185865|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
17041565|NCT04980456|38185866|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
17041566|NCT04980456|38185865|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
17041567|NCT04980456|38185866|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
17041568|NCT04980456|38185865|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
17041569|NCT04980456|38185866|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
17041570|NCT00326599|38185879|FG000|Overall Study|Withdrawal by Subject|1|||
17041571|NCT00326599|38185880|FG001|Overall Study|Withdrawal by Subject|0|||
17041572|NCT00326599|38185881|FG002|Overall Study|Withdrawal by Subject|5|||
17041573|NCT00326599|38185882|FG003|Overall Study|Withdrawal by Subject|2|||
17041574|NCT00326599|38185879|FG000|Overall Study|Adverse Event|1|||
17041575|NCT00326599|38185880|FG001|Overall Study|Adverse Event|0|||
17041576|NCT00326599|38185881|FG002|Overall Study|Adverse Event|32|||
17041577|NCT00326599|38185882|FG003|Overall Study|Adverse Event|3|||
17140004|NCT01147822|38281863|FG000|Overall Study|Physician Decision|0|||
17140005|NCT01147822|38281864|FG001|Overall Study|Physician Decision|2|||
17140006|NCT01147822|38281863|FG000|Overall Study|Withdrawal by Subject|8|||
17140007|NCT01147822|38281864|FG001|Overall Study|Withdrawal by Subject|13|||
17140008|NCT01147822|38281863|FG000|Overall Study|Not Completed/Ongoing|111|||
17140009|NCT01147822|38281864|FG001|Overall Study|Not Completed/Ongoing|102|||
17041578|NCT00326599|38185879|FG000|Overall Study|Disease Progression|3|||
17041579|NCT00326599|38185880|FG001|Overall Study|Disease Progression|1|||
17041580|NCT00326599|38185881|FG002|Overall Study|Disease Progression|13|||
17041581|NCT00326599|38185882|FG003|Overall Study|Disease Progression|11|||
17041582|NCT00326599|38185879|FG000|Overall Study|Alternate Treatment|1|||
17041583|NCT00326599|38185880|FG001|Overall Study|Alternate Treatment|0|||
17041584|NCT00326599|38185881|FG002|Overall Study|Alternate Treatment|0|||
17041585|NCT00326599|38185882|FG003|Overall Study|Alternate Treatment|0|||
17041586|NCT00326599|38185879|FG000|Overall Study|Death|0|||
17041587|NCT00326599|38185880|FG001|Overall Study|Death|0|||
17041588|NCT00326599|38185881|FG002|Overall Study|Death|1|||
17041589|NCT00326599|38185882|FG003|Overall Study|Death|2|||
17041590|NCT00326599|38185879|FG000|Overall Study|Other Unspecified Reason|0|||
17041591|NCT00326599|38185880|FG001|Overall Study|Other Unspecified Reason|0|||
17041592|NCT00326599|38185881|FG002|Overall Study|Other Unspecified Reason|2|||
17041593|NCT00326599|38185882|FG003|Overall Study|Other Unspecified Reason|1|||
17041594|NCT00539032|38185893|FG000|Overall Study|Withdrawal by Subject|2|||
17041595|NCT00539032|38185894|FG001|Overall Study|Withdrawal by Subject|1|||
17041596|NCT00685802|38185900|FG000|Washout Period of 7 Days|Protocol Violation|2|||
17041597|NCT00685802|38185901|FG001|Washout Period of 7 Days|Protocol Violation|0|||
17041598|NCT00685802|38185900|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
17041599|NCT00685802|38185901|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
17140010|NCT03431337|38281872|FG000|Overall Study|Lost to Follow-up|21|||
17140011|NCT03431337|38281873|FG001|Overall Study|Lost to Follow-up|19|||
17140012|NCT03431337|38281872|FG000|Overall Study|Withdrawal by Subject|8|||
17140013|NCT03431337|38281873|FG001|Overall Study|Withdrawal by Subject|3|||
17140014|NCT03738241|38281893|FG000|Overall Study|Withdrawal by Subject|0|||
17140015|NCT03738241|38281894|FG001|Overall Study|Withdrawal by Subject|0|||
17140016|NCT03738241|38281895|FG002|Overall Study|Withdrawal by Subject|0|||
17140017|NCT03738241|38281896|FG003|Overall Study|Withdrawal by Subject|0|||
17140018|NCT03738241|38281897|FG004|Overall Study|Withdrawal by Subject|0|||
17140019|NCT03738241|38281898|FG005|Overall Study|Withdrawal by Subject|0|||
17140020|NCT03738241|38281899|FG006|Overall Study|Withdrawal by Subject|0|||
17140021|NCT03738241|38281900|FG007|Overall Study|Withdrawal by Subject|0|||
17140022|NCT03738241|38281901|FG008|Overall Study|Withdrawal by Subject|0|||
17140023|NCT03738241|38281902|FG009|Overall Study|Withdrawal by Subject|1|||
17140024|NCT03738241|38281893|FG000|Overall Study|Physician Decision|0|||
17041600|NCT00354601|38185907|FG000|Overall Study|Protocol Violation|1|||
17041601|NCT00354601|38185907|FG000|Overall Study|progression|1|||
17140025|NCT03738241|38281894|FG001|Overall Study|Physician Decision|0|||
17140026|NCT03738241|38281895|FG002|Overall Study|Physician Decision|0|||
17041602|NCT03827473|38185913|FG000|Overall Study|Withdrawal by Subject|1|||
17041603|NCT03827473|38185914|FG001|Overall Study|Withdrawal by Subject|0|||
17041604|NCT00345397|38185920|FG000|Overall Study|Death|1|||
17041605|NCT00326209|38185925|FG000|Overall Study|Adverse Event|28|||
17041606|NCT00326209|38185925|FG000|Overall Study|Withdrawal by Subject|22|||
17041607|NCT00326209|38185925|FG000|Overall Study|Lack of Efficacy|31|||
17041608|NCT00326209|38185925|FG000|Overall Study|Lost to Follow-up|18|||
17041609|NCT00326209|38185925|FG000|Overall Study|Participant non-compliant|6|||
17041610|NCT00326209|38185925|FG000|Overall Study|Sponsor closed study|173|||
17140027|NCT03738241|38281896|FG003|Overall Study|Physician Decision|0|||
17041611|NCT00326209|38185925|FG000|Overall Study|Prohibited medication use|1|||
17041612|NCT00326209|38185925|FG000|Overall Study|Violation of entry criteria|1|||
17041613|NCT00326209|38185925|FG000|Overall Study|Withdrawn in error|1|||
17041614|NCT00326209|38185925|FG000|Overall Study|Pregnancy|1|||
17041615|NCT00537940|38185931|FG000|Overall Study|Adverse Event|20|||
17041616|NCT00537940|38185932|FG001|Overall Study|Adverse Event|19|||
17041617|NCT00537940|38185931|FG000|Overall Study|Lack of Efficacy|8|||
17041618|NCT00537940|38185932|FG001|Overall Study|Lack of Efficacy|16|||
17041619|NCT00537940|38185931|FG000|Overall Study|Lost to Follow-up|23|||
17041620|NCT00537940|38185932|FG001|Overall Study|Lost to Follow-up|29|||
17041621|NCT00537940|38185931|FG000|Overall Study|Withdrawal by Subject|113|||
17041622|NCT00537940|38185932|FG001|Overall Study|Withdrawal by Subject|95|||
17041623|NCT00537940|38185931|FG000|Overall Study|Protocol Violation|6|||
17041624|NCT00537940|38185932|FG001|Overall Study|Protocol Violation|4|||
17041625|NCT00537940|38185931|FG000|Overall Study|Pregnancy|1|||
17041626|NCT00537940|38185932|FG001|Overall Study|Pregnancy|1|||
17041627|NCT00537940|38185931|FG000|Overall Study|Study terminated by sponsor|2|||
17041628|NCT00537940|38185932|FG001|Overall Study|Study terminated by sponsor|3|||
17041629|NCT00537940|38185931|FG000|Overall Study|Other|10|||
17041630|NCT00537940|38185932|FG001|Overall Study|Other|12|||
17041631|NCT00661362|38185940|FG000|Overall Study|Adverse Event|5|||
17041632|NCT00661362|38185941|FG001|Overall Study|Adverse Event|4|||
17140028|NCT03738241|38281897|FG004|Overall Study|Physician Decision|0|||
17140029|NCT03738241|38281898|FG005|Overall Study|Physician Decision|0|||
17041633|NCT00661362|38185940|FG000|Overall Study|Incorrect enrollment|2|||
17041634|NCT00661362|38185941|FG001|Overall Study|Incorrect enrollment|0|||
17041635|NCT00661362|38185940|FG000|Overall Study|Study specific discontinuation criteria|4|||
17041636|NCT00661362|38185941|FG001|Overall Study|Study specific discontinuation criteria|11|||
17041637|NCT00661362|38185940|FG000|Overall Study|Withdrawal by Subject|13|||
17041638|NCT00661362|38185941|FG001|Overall Study|Withdrawal by Subject|23|||
17041639|NCT00661362|38185940|FG000|Overall Study|Lost to Follow-up|3|||
17140030|NCT03738241|38281899|FG006|Overall Study|Physician Decision|0|||
17140031|NCT03738241|38281900|FG007|Overall Study|Physician Decision|0|||
17140032|NCT03738241|38281901|FG008|Overall Study|Physician Decision|1|||
17140033|NCT03738241|38281902|FG009|Overall Study|Physician Decision|0|||
17140034|NCT03738241|38281893|FG000|Overall Study|Adverse Event|1|||
17140035|NCT03738241|38281894|FG001|Overall Study|Adverse Event|0|||
17140036|NCT03738241|38281895|FG002|Overall Study|Adverse Event|0|||
17140037|NCT03738241|38281896|FG003|Overall Study|Adverse Event|0|||
17140038|NCT03738241|38281897|FG004|Overall Study|Adverse Event|0|||
17140039|NCT03738241|38281898|FG005|Overall Study|Adverse Event|0|||
17140040|NCT03738241|38281899|FG006|Overall Study|Adverse Event|0|||
17140041|NCT03738241|38281900|FG007|Overall Study|Adverse Event|0|||
17140042|NCT03738241|38281901|FG008|Overall Study|Adverse Event|0|||
17140043|NCT03738241|38281902|FG009|Overall Study|Adverse Event|0|||
17140044|NCT03430245|38281924|FG000|Overall Study|Withdrawal by Subject|6|||
17140045|NCT03430245|38281924|FG000|Overall Study|Lost to Follow-up|1|||
17140046|NCT03461289|38281928|FG000|Overall Study|Death|1|||
17140047|NCT03428997|38281932|FG000|Overall Study|Sponsor decision.|1|||
17140048|NCT03428997|38281932|FG000|Overall Study|Withdrawal by Subject|3|||
17140049|NCT03428997|38281932|FG000|Overall Study|Lost to Follow-up|4|||
17140050|NCT03452943|38281940|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
17140051|NCT03452943|38281941|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
17140052|NCT03452943|38281940|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
17140053|NCT03452943|38281941|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
17140054|NCT03452943|38281940|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
17140055|NCT03452943|38281941|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
17140056|NCT03452943|38281940|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
17140057|NCT03452943|38281941|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
17140058|NCT03452943|38281940|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
17140059|NCT03452943|38281941|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
17140060|NCT03452943|38281940|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
17140061|NCT03452943|38281941|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
17140062|NCT03481725|38281949|FG000|Overall Study|Withdrawal by Subject|1|||
17140063|NCT03481725|38281950|FG001|Overall Study|Withdrawal by Subject|0|||
17140064|NCT03480243|38281958|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
17140065|NCT03480243|38281958|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
17140066|NCT03426345|38281973|FG000|Overall Study|Adverse Event|4|||
17041640|NCT00661362|38185941|FG001|Overall Study|Lost to Follow-up|1|||
17041641|NCT00661362|38185940|FG000|Overall Study|Severe non-compliance to protocol|0|||
17041642|NCT00661362|38185941|FG001|Overall Study|Severe non-compliance to protocol|1|||
17041643|NCT00661362|38185940|FG000|Overall Study|Safety reasons|1|||
17041644|NCT00661362|38185941|FG001|Overall Study|Safety reasons|0|||
17041645|NCT00661362|38185940|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
17041646|NCT00661362|38185941|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
17041647|NCT00325897|38185949|FG000|Overall Study|Lost to Follow-up|12|||
17140067|NCT03426345|38281974|FG001|Overall Study|Adverse Event|4|||
17140068|NCT03426345|38281973|FG000|Overall Study|Lack of Efficacy|1|||
17140069|NCT03426345|38281974|FG001|Overall Study|Lack of Efficacy|0|||
17140070|NCT03426345|38281973|FG000|Overall Study|Withdrawal by Subject|5|||
17140071|NCT03426345|38281974|FG001|Overall Study|Withdrawal by Subject|6|||
17140072|NCT03426345|38281973|FG000|Overall Study|Lost to Follow-up|3|||
17140073|NCT03426345|38281974|FG001|Overall Study|Lost to Follow-up|1|||
17140074|NCT03426345|38281973|FG000|Overall Study|Protocol Deviation|3|||
17140075|NCT03426345|38281974|FG001|Overall Study|Protocol Deviation|4|||
17041648|NCT00325897|38185950|FG001|Overall Study|Lost to Follow-up|13|||
17041649|NCT00344773|38185959|FG000|Overall Study|Adverse Event|2|||
17041650|NCT00344773|38185959|FG000|Overall Study|Objective Disease Progression|16|||
17041651|NCT00344773|38185959|FG000|Overall Study|Withdrawal by Subject|1|||
17041652|NCT00344773|38185959|FG000|Overall Study|Not Eligible for the study|2|||
17041653|NCT00325819|38185965|FG000|Overall Study|Study product lost in mail|2|||
17041654|NCT00325819|38185966|FG001|Overall Study|Study product lost in mail|1|||
17041655|NCT00325819|38185965|FG000|Overall Study|Did not take a dose of study product|4|||
17041656|NCT00325819|38185966|FG001|Overall Study|Did not take a dose of study product|9|||
17041657|NCT00325819|38185965|FG000|Overall Study|Lost to Follow-up|3|||
17041658|NCT00325819|38185966|FG001|Overall Study|Lost to Follow-up|3|||
17041659|NCT00687362|38185974|FG000|Overall Study|Protocol Violation|2|||
17041660|NCT00687362|38185974|FG000|Overall Study|Withdrawal by Subject|1|||
17041661|NCT00325195|38185981|FG000|Randomized|Not dosed|5|||
17041662|NCT00325195|38185982|FG001|Randomized|Not dosed|5|||
17041663|NCT00325195|38185983|FG002|Randomized|Not dosed|3|||
17041664|NCT00325195|38185981|FG000|Received Intervention: ITT Population|Adverse Event|15|||
17041665|NCT00325195|38185982|FG001|Received Intervention: ITT Population|Adverse Event|17|||
17041666|NCT00325195|38185983|FG002|Received Intervention: ITT Population|Adverse Event|1|||
17041667|NCT00325195|38185981|FG000|Received Intervention: ITT Population|Death|3|||
17041668|NCT00325195|38185982|FG001|Received Intervention: ITT Population|Death|1|||
17041669|NCT00325195|38185983|FG002|Received Intervention: ITT Population|Death|0|||
17041670|NCT00325195|38185981|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
17041671|NCT00325195|38185982|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
17140076|NCT03426345|38281973|FG000|Overall Study|Reason Not Specified|1|||
17140077|NCT03426345|38281974|FG001|Overall Study|Reason Not Specified|2|||
17140078|NCT03426345|38281973|FG000|Overall Study|Missing Completion Status|1|||
17140079|NCT03426345|38281974|FG001|Overall Study|Missing Completion Status|0|||
17140080|NCT03426267|38281983|FG000|Overall Study|Physician Decision|1|||
17140081|NCT03426267|38281984|FG001|Overall Study|Physician Decision|4|||
17140082|NCT03426267|38281983|FG000|Overall Study|Lost to Follow-up|1|||
17140083|NCT03426267|38281984|FG001|Overall Study|Lost to Follow-up|0|||
17140084|NCT03426267|38281983|FG000|Overall Study|Withdrawal by Subject|4|||
17140085|NCT03426267|38281984|FG001|Overall Study|Withdrawal by Subject|10|||
17140086|NCT03426267|38281983|FG000|Overall Study|Protocol Violation|1|||
17140087|NCT03426267|38281984|FG001|Overall Study|Protocol Violation|3|||
17140088|NCT03426267|38281983|FG000|Overall Study|Adverse Event|9|||
17140089|NCT03426267|38281984|FG001|Overall Study|Adverse Event|27|||
17140090|NCT03426267|38281983|FG000|Overall Study|Prohibited Treatment Intake|2|||
17140091|NCT03426267|38281984|FG001|Overall Study|Prohibited Treatment Intake|3|||
17140092|NCT03426267|38281983|FG000|Overall Study|Lack of Efficacy|0|||
17140093|NCT03426267|38281984|FG001|Overall Study|Lack of Efficacy|25|||
17140094|NCT03426267|38281983|FG000|Overall Study|other|3|||
17140095|NCT03426267|38281984|FG001|Overall Study|other|0|||
17140096|NCT03412929|38281990|FG000|Overall Study|Protocol Violation|3|||
17140097|NCT03451773|38281996|FG000|Overall Study|Death on study|1|||
17140098|NCT03451773|38281997|FG001|Overall Study|Death on study|5|||
17140099|NCT03451773|38281996|FG000|Overall Study|Death during follow-up period|0|||
17140100|NCT03451773|38281997|FG001|Overall Study|Death during follow-up period|1|||
17140101|NCT03425253|38282004|FG000|Overall Study|Adverse Event|2|||
17140102|NCT03425253|38282004|FG000|Overall Study|Lost to Follow-up|3|||
17140103|NCT03425253|38282004|FG000|Overall Study|Withdrew Consent|6|||
17140104|NCT03425253|38282004|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
17140105|NCT03424239|38282009|FG000|Overall Study|Withdrawal by Subject|2|||
17140106|NCT03451071|38282013|FG000|First Vaccine|Withdrawal by Subject|1|||
17041672|NCT00325195|38185983|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
17041673|NCT00325195|38185981|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
17041674|NCT00325195|38185982|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
17041675|NCT00325195|38185983|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
17041676|NCT00325195|38185981|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
17041677|NCT00325195|38185982|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
17041678|NCT00325195|38185983|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
17041679|NCT03976401|38185997|FG000|Overall Study|Adverse Event|2|||
17041680|NCT03976401|38185998|FG001|Overall Study|Adverse Event|0|||
17041681|NCT03976401|38185999|FG002|Overall Study|Adverse Event|4|||
17041682|NCT03976401|38186000|FG003|Overall Study|Adverse Event|1|||
17140107|NCT03451071|38282013|FG000|Second Vaccine|Lost to Follow-up|19|||
17041683|NCT03976401|38186001|FG004|Overall Study|Adverse Event|1|||
17041684|NCT03976401|38186002|FG005|Overall Study|Adverse Event|0|||
17041685|NCT03976401|38185997|FG000|Overall Study|Withdrawal by Subject|0|||
17041686|NCT03976401|38185998|FG001|Overall Study|Withdrawal by Subject|1|||
17041687|NCT03976401|38185999|FG002|Overall Study|Withdrawal by Subject|0|||
17041688|NCT03976401|38186000|FG003|Overall Study|Withdrawal by Subject|0|||
17041689|NCT03976401|38186001|FG004|Overall Study|Withdrawal by Subject|0|||
17041690|NCT03976401|38186002|FG005|Overall Study|Withdrawal by Subject|1|||
17041691|NCT03976401|38185997|FG000|Overall Study|Physician Decision|0|||
17041692|NCT03976401|38185998|FG001|Overall Study|Physician Decision|0|||
17041693|NCT03976401|38185999|FG002|Overall Study|Physician Decision|1|||
17041694|NCT03976401|38186000|FG003|Overall Study|Physician Decision|0|||
17041695|NCT03976401|38186001|FG004|Overall Study|Physician Decision|0|||
17041696|NCT03976401|38186002|FG005|Overall Study|Physician Decision|0|||
17041697|NCT03976401|38185997|FG000|Overall Study|Lost to Follow-up|1|||
17041698|NCT03976401|38185998|FG001|Overall Study|Lost to Follow-up|2|||
17041699|NCT03976401|38185999|FG002|Overall Study|Lost to Follow-up|0|||
17041700|NCT03976401|38186000|FG003|Overall Study|Lost to Follow-up|0|||
17041701|NCT03976401|38186001|FG004|Overall Study|Lost to Follow-up|0|||
17041702|NCT03976401|38186002|FG005|Overall Study|Lost to Follow-up|0|||
17041703|NCT03976401|38185997|FG000|Overall Study|Protocol Violation|0|||
17041704|NCT03976401|38185998|FG001|Overall Study|Protocol Violation|1|||
17041705|NCT03976401|38185999|FG002|Overall Study|Protocol Violation|0|||
17041706|NCT03976401|38186000|FG003|Overall Study|Protocol Violation|0|||
17041707|NCT03976401|38186001|FG004|Overall Study|Protocol Violation|0|||
17041708|NCT03976401|38186002|FG005|Overall Study|Protocol Violation|0|||
17041709|NCT03976401|38185997|FG000|Overall Study|Withdrew Consent|0|||
17140108|NCT03451071|38282013|FG000|Third Vaccine|Lost to Follow-up|22|||
17140109|NCT03451071|38282013|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
17140110|NCT03449979|38282021|FG000|Overall Study|Technical difficulty|0|||
17140111|NCT03449979|38282022|FG001|Overall Study|Technical difficulty|0|||
17140112|NCT03449979|38282023|FG002|Overall Study|Technical difficulty|0|||
17140113|NCT03449979|38282024|FG003|Overall Study|Technical difficulty|1|||
17140114|NCT03449199|38282037|FG000|Overall Study|Lost to Follow-up|1|||
17140115|NCT03449199|38282038|FG001|Overall Study|Lost to Follow-up|1|||
17140116|NCT03449199|38282039|FG002|Overall Study|Lost to Follow-up|0|||
17140117|NCT03449199|38282037|FG000|Overall Study|Protocol Deviation|0|||
17140118|NCT03449199|38282038|FG001|Overall Study|Protocol Deviation|0|||
17140119|NCT03449199|38282039|FG002|Overall Study|Protocol Deviation|1|||
17140120|NCT03449199|38282037|FG000|Overall Study|Withdrawal by Subject|0|||
17140121|NCT03449199|38282038|FG001|Overall Study|Withdrawal by Subject|0|||
17041710|NCT03976401|38185998|FG001|Overall Study|Withdrew Consent|0|||
17041711|NCT03976401|38185999|FG002|Overall Study|Withdrew Consent|0|||
17041712|NCT03976401|38186000|FG003|Overall Study|Withdrew Consent|1|||
17041713|NCT03976401|38186001|FG004|Overall Study|Withdrew Consent|0|||
17041714|NCT03976401|38186002|FG005|Overall Study|Withdrew Consent|0|||
17041715|NCT00660816|38186018|FG000|Overall Study|Adverse Event|1|||
17041716|NCT00660816|38186019|FG001|Overall Study|Adverse Event|2|||
17041717|NCT00660816|38186018|FG000|Overall Study|Withdrawal by Subject|1|||
17041718|NCT00660816|38186019|FG001|Overall Study|Withdrawal by Subject|0|||
17041719|NCT00660816|38186018|FG000|Overall Study|Death|0|||
17041720|NCT00660816|38186019|FG001|Overall Study|Death|2|||
17041721|NCT00660816|38186018|FG000|Overall Study|Lack of Efficacy|1|||
17041722|NCT00660816|38186019|FG001|Overall Study|Lack of Efficacy|0|||
17041723|NCT00660816|38186018|FG000|Overall Study|Physician Decision|0|||
17041724|NCT00660816|38186019|FG001|Overall Study|Physician Decision|2|||
17041725|NCT00660816|38186018|FG000|Overall Study|Protocol Violation|1|||
17041726|NCT00660816|38186019|FG001|Overall Study|Protocol Violation|0|||
17041727|NCT00660816|38186018|FG000|Overall Study|Disease Progression|16|||
17041728|NCT00660816|38186019|FG001|Overall Study|Disease Progression|12|||
17041729|NCT00660816|38186018|FG000|Overall Study|Complicating Disease|0|||
17041730|NCT00660816|38186019|FG001|Overall Study|Complicating Disease|1|||
17041731|NCT00565617|38186025|FG000|Overall Study|Withdrawal by Subject|1|||
17041732|NCT00685334|38186031|FG000|Overall Study|Withdrawal by Subject|5|||
17140122|NCT03449199|38282039|FG002|Overall Study|Withdrawal by Subject|1|||
17140123|NCT03421431|38282053|FG000|Overall Study|Adverse Event|2|||
17140124|NCT03421431|38282054|FG001|Overall Study|Adverse Event|1|||
17041733|NCT00685334|38186032|FG001|Overall Study|Withdrawal by Subject|6|||
17041734|NCT00685334|38186031|FG000|Overall Study|Lost to Follow-up|4|||
17041735|NCT00685334|38186032|FG001|Overall Study|Lost to Follow-up|0|||
17041736|NCT00685334|38186031|FG000|Overall Study|Chose to enter hospital|1|||
17041737|NCT00685334|38186032|FG001|Overall Study|Chose to enter hospital|1|||
17041738|NCT00325039|38186040|FG000|Overall Study|Lost to Follow-up|18|||
17041739|NCT00325039|38186041|FG001|Overall Study|Lost to Follow-up|14|||
17041740|NCT00344461|38186047|FG000|Overall Study|Adverse Event|6|||
17041741|NCT00344461|38186047|FG000|Overall Study|Death|1|||
17140125|NCT03421431|38282055|FG002|Overall Study|Adverse Event|12|||
17140126|NCT03421431|38282053|FG000|Overall Study|Lost to Follow-up|1|||
17140127|NCT03421431|38282054|FG001|Overall Study|Lost to Follow-up|1|||
17140128|NCT03421431|38282055|FG002|Overall Study|Lost to Follow-up|1|||
17140129|NCT03421431|38282053|FG000|Overall Study|Withdrawal by Subject|3|||
17140130|NCT03421431|38282054|FG001|Overall Study|Withdrawal by Subject|2|||
17140131|NCT03421431|38282055|FG002|Overall Study|Withdrawal by Subject|1|||
17140132|NCT03421431|38282053|FG000|Overall Study|Protocol Violation|0|||
17140133|NCT03421431|38282054|FG001|Overall Study|Protocol Violation|1|||
17041742|NCT00344461|38186047|FG000|Overall Study|Lack of Efficacy|2|||
17041743|NCT00344461|38186047|FG000|Overall Study|Lost to Follow-up|2|||
17041744|NCT00344461|38186047|FG000|Overall Study|Physician Decision|2|||
17041745|NCT00344461|38186047|FG000|Overall Study|Protocol Violation|6|||
17041746|NCT00344461|38186047|FG000|Overall Study|Withdrawal by Subject|2|||
17041747|NCT00685178|38186056|FG000|Overall Study|Adverse Event|1|||
17041748|NCT00685178|38186057|FG001|Overall Study|Adverse Event|5|||
17041749|NCT00685178|38186058|FG002|Overall Study|Adverse Event|2|||
17041750|NCT00685178|38186059|FG003|Overall Study|Adverse Event|4|||
17041751|NCT00685178|38186056|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
17041752|NCT00685178|38186057|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
17041753|NCT00685178|38186058|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
17041754|NCT00685178|38186059|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
17041755|NCT00685178|38186056|FG000|Overall Study|voluntary study discharge|4|||
17041756|NCT00685178|38186057|FG001|Overall Study|voluntary study discharge|5|||
17041757|NCT00685178|38186058|FG002|Overall Study|voluntary study discharge|1|||
17041758|NCT00685178|38186059|FG003|Overall Study|voluntary study discharge|1|||
17041759|NCT00685178|38186056|FG000|Overall Study|incarcerated|1|||
17041760|NCT00685178|38186057|FG001|Overall Study|incarcerated|3|||
17041761|NCT00685178|38186058|FG002|Overall Study|incarcerated|7|||
17140134|NCT03421431|38282055|FG002|Overall Study|Protocol Violation|0|||
17140135|NCT03421431|38282053|FG000|Overall Study|Participant met Stopping Rules|0|||
17041762|NCT00685178|38186059|FG003|Overall Study|incarcerated|0|||
17041763|NCT00685178|38186056|FG000|Overall Study|administrative (disciplinary) discharge|0|||
17041764|NCT00685178|38186057|FG001|Overall Study|administrative (disciplinary) discharge|1|||
17041765|NCT00685178|38186058|FG002|Overall Study|administrative (disciplinary) discharge|0|||
17041766|NCT00685178|38186059|FG003|Overall Study|administrative (disciplinary) discharge|2|||
17041767|NCT00685178|38186056|FG000|Overall Study|Pregnancy|0|||
17041768|NCT00685178|38186057|FG001|Overall Study|Pregnancy|0|||
17041769|NCT00685178|38186058|FG002|Overall Study|Pregnancy|0|||
17041770|NCT00685178|38186059|FG003|Overall Study|Pregnancy|1|||
17041771|NCT00537394|38186072|FG000|First Year of Follow-up|Death|7|||
17041772|NCT00537394|38186073|FG001|First Year of Follow-up|Death|0|||
17041773|NCT00537394|38186074|FG002|First Year of Follow-up|Death|0|||
17041774|NCT00537394|38186072|FG000|First Year of Follow-up|Severe debilitation|1|||
17041775|NCT00537394|38186073|FG001|First Year of Follow-up|Severe debilitation|0|||
17041776|NCT00537394|38186074|FG002|First Year of Follow-up|Severe debilitation|1|||
17041777|NCT00537394|38186072|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
17041778|NCT00537394|38186073|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
17041779|NCT00537394|38186074|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
17041780|NCT00537394|38186072|FG000|First Year of Follow-up|Lost to Follow-up|1|||
17041781|NCT00537394|38186073|FG001|First Year of Follow-up|Lost to Follow-up|5|||
17041782|NCT00537394|38186074|FG002|First Year of Follow-up|Lost to Follow-up|1|||
17041783|NCT00537394|38186072|FG000|2nd Year of Follow-up|Death|4|||
17041784|NCT00537394|38186073|FG001|2nd Year of Follow-up|Death|1|||
17041785|NCT00537394|38186074|FG002|2nd Year of Follow-up|Death|2|||
17041786|NCT00537394|38186072|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
17041787|NCT00537394|38186073|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
17041788|NCT00537394|38186074|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
17041789|NCT00537394|38186072|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
17041790|NCT00537394|38186073|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
17041791|NCT00537394|38186074|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
17041792|NCT00537394|38186072|FG000|2nd Year of Follow-up|Clinic site closure|1|||
16992243|NCT00808132|38136194|FG002|Overall Study|Death|0|||
17041793|NCT00537394|38186073|FG001|2nd Year of Follow-up|Clinic site closure|0|||
17041794|NCT00537394|38186074|FG002|2nd Year of Follow-up|Clinic site closure|0|||
17041795|NCT00352885|38186082|FG000|Overall Study|Withdrawal by Subject|0|||
17041796|NCT00352885|38186083|FG001|Overall Study|Withdrawal by Subject|3|||
17041797|NCT00352885|38186082|FG000|Overall Study|Development of major depression|0|||
17041798|NCT00352885|38186083|FG001|Overall Study|Development of major depression|1|||
17041799|NCT00352885|38186082|FG000|Overall Study|Progression of metastatic melanoma|5|||
17041800|NCT00352885|38186083|FG001|Overall Study|Progression of metastatic melanoma|3|||
17041801|NCT00352885|38186082|FG000|Overall Study|Side effects of IL-2 administration|1|||
17140136|NCT03421431|38282054|FG001|Overall Study|Participant met Stopping Rules|1|||
17041802|NCT00352885|38186083|FG001|Overall Study|Side effects of IL-2 administration|0|||
17041803|NCT00660660|38186091|FG000|Overall Study|Adverse Event|1|||
17041804|NCT00660660|38186092|FG001|Overall Study|Adverse Event|0|||
17041805|NCT00660660|38186091|FG000|Overall Study|Lost to Follow-up|0|||
17041806|NCT00660660|38186092|FG001|Overall Study|Lost to Follow-up|6|||
17041807|NCT00660660|38186091|FG000|Overall Study|Lack of Efficacy|0|||
17041808|NCT00660660|38186092|FG001|Overall Study|Lack of Efficacy|2|||
17041809|NCT00660660|38186091|FG000|Overall Study|Withdrawal by Subject|3|||
17041810|NCT00660660|38186092|FG001|Overall Study|Withdrawal by Subject|0|||
17041811|NCT00660660|38186091|FG000|Overall Study|Incorrect enrollment and other|0|||
17041812|NCT00660660|38186092|FG001|Overall Study|Incorrect enrollment and other|1|||
17041813|NCT00660660|38186091|FG000|Overall Study|New medication after randomization|1|||
17041814|NCT00660660|38186092|FG001|Overall Study|New medication after randomization|0|||
17041815|NCT00344305|38186100|FG000|Overall Study|Lost to Follow-up|2|||
17041816|NCT00344305|38186101|FG001|Overall Study|Lost to Follow-up|0|||
17041817|NCT00344305|38186100|FG000|Overall Study|Participant was not contacted in window|0|||
17041818|NCT00344305|38186101|FG001|Overall Study|Participant was not contacted in window|1|||
17041819|NCT00576056|38186108|FG000|Overall Study|Adverse Event|1|||
17041820|NCT00576056|38186108|FG000|Overall Study|Death|1|||
17041821|NCT00576056|38186108|FG000|Overall Study|Lack of Efficacy|1|||
17041822|NCT00576056|38186108|FG000|Overall Study|Withdrawal by Subject|2|||
17041823|NCT00576056|38186108|FG000|Overall Study|did not meet eligibility criteria|8|||
17041824|NCT00576056|38186108|FG000|Overall Study|Physician Decision|1|||
17041825|NCT00575510|38186115|FG000|Overall Study|Lost to Follow-up|4|||
17041826|NCT00575510|38186116|FG001|Overall Study|Lost to Follow-up|6|||
17041827|NCT00575510|38186117|FG002|Overall Study|Lost to Follow-up|9|||
17041828|NCT00575510|38186115|FG000|Overall Study|Withdrawal by Subject|1|||
17041829|NCT00575510|38186116|FG001|Overall Study|Withdrawal by Subject|0|||
17041830|NCT00575510|38186117|FG002|Overall Study|Withdrawal by Subject|0|||
17041831|NCT00575510|38186115|FG000|Overall Study|Clinic Called Patient|7|||
17041832|NCT00575510|38186116|FG001|Overall Study|Clinic Called Patient|7|||
17041833|NCT00575510|38186117|FG002|Overall Study|Clinic Called Patient|7|||
17041834|NCT00575510|38186115|FG000|Overall Study|Pregnancy|0|||
17041835|NCT00575510|38186116|FG001|Overall Study|Pregnancy|0|||
17041836|NCT00575510|38186117|FG002|Overall Study|Pregnancy|1|||
17041837|NCT02636439|38186128|FG000|Overall Study|Adverse Event|2|||
17041838|NCT02636439|38186129|FG001|Overall Study|Adverse Event|2|||
17041839|NCT02636439|38186128|FG000|Overall Study|Lost to Follow-up|1|||
17041840|NCT02636439|38186129|FG001|Overall Study|Lost to Follow-up|0|||
17041841|NCT02636439|38186128|FG000|Overall Study|Non-compliance|1|||
17041842|NCT02636439|38186129|FG001|Overall Study|Non-compliance|1|||
17041843|NCT02636439|38186128|FG000|Overall Study|Personal reasons|2|||
17041844|NCT02636439|38186129|FG001|Overall Study|Personal reasons|0|||
17041845|NCT00343915|38186137|FG000|Primary Study|Withdrawal by Subject|1|||
17041846|NCT00343915|38186138|FG001|Primary Study|Withdrawal by Subject|0|||
17140137|NCT03421431|38282055|FG002|Overall Study|Participant met Stopping Rules|0|||
17140138|NCT03448419|38282067|FG000|Overall Study|Adverse Event|10|||
17041847|NCT00343915|38186137|FG000|Primary Study|Lost to Follow-up|2|||
17041848|NCT00343915|38186138|FG001|Primary Study|Lost to Follow-up|3|||
17041849|NCT00343915|38186137|FG000|Primary Study|Other|1|||
17041850|NCT00343915|38186138|FG001|Primary Study|Other|0|||
17041851|NCT00575666|38186149|FG000|Overall Study|Withdrawal by Subject|3|||
17041852|NCT00575666|38186150|FG001|Overall Study|Withdrawal by Subject|2|||
17041853|NCT00575666|38186149|FG000|Overall Study|Physician Decision|1|||
17041854|NCT00575666|38186150|FG001|Overall Study|Physician Decision|1|||
17041855|NCT00658632|38186158|FG000|Overall Study|Adverse Event|13|||
17041856|NCT00658632|38186159|FG001|Overall Study|Adverse Event|11|||
17041857|NCT00658632|38186158|FG000|Overall Study|Lost to Follow-up|25|||
17041858|NCT00658632|38186159|FG001|Overall Study|Lost to Follow-up|23|||
17041859|NCT00658632|38186158|FG000|Overall Study|Withdrawal by Subject|10|||
17041860|NCT00658632|38186159|FG001|Overall Study|Withdrawal by Subject|7|||
17041861|NCT00658632|38186158|FG000|Overall Study|Lack of Efficacy|0|||
17041862|NCT00658632|38186159|FG001|Overall Study|Lack of Efficacy|1|||
17041863|NCT00658632|38186158|FG000|Overall Study|Withdrawal of consent|8|||
17041864|NCT00658632|38186159|FG001|Overall Study|Withdrawal of consent|14|||
17041865|NCT00658632|38186158|FG000|Overall Study|Pregnancy|1|||
17041866|NCT00658632|38186159|FG001|Overall Study|Pregnancy|1|||
17041867|NCT00658632|38186158|FG000|Overall Study|Other|7|||
17041868|NCT00658632|38186159|FG001|Overall Study|Other|8|||
17041869|NCT00677534|38186165|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
17041870|NCT00677534|38186165|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
17041871|NCT00677534|38186165|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
17041872|NCT00660348|38186171|FG000|Overall Study|Withdrawal by Subject|1|||
17041873|NCT00660348|38186172|FG001|Overall Study|Withdrawal by Subject|0|||
17041874|NCT00660192|38186180|FG000|Overall Study|Lost to Follow-up|2|||
17041875|NCT00660192|38186181|FG001|Overall Study|Lost to Follow-up|3|||
17041876|NCT00571688|38186189|FG000|Overall Study|Lost to Follow-up|3|||
17041877|NCT00571688|38186190|FG001|Overall Study|Lost to Follow-up|6|||
17041878|NCT00571688|38186189|FG000|Overall Study|subject did not tolerate Consta|1|||
17041879|NCT00571688|38186190|FG001|Overall Study|subject did not tolerate Consta|0|||
17041880|NCT00571688|38186189|FG000|Overall Study|subject moved out of the area|1|||
17041881|NCT00571688|38186190|FG001|Overall Study|subject moved out of the area|0|||
17041882|NCT00343291|38186198|FG000|Overall Study|Adverse Event|13|||
17041883|NCT00343291|38186199|FG001|Overall Study|Adverse Event|13|||
17041884|NCT00343291|38186198|FG000|Overall Study|Death|3|||
17041885|NCT00343291|38186199|FG001|Overall Study|Death|2|||
17041886|NCT00343291|38186198|FG000|Overall Study|Progressive disease|33|||
17041887|NCT00343291|38186199|FG001|Overall Study|Progressive disease|34|||
17041888|NCT00343291|38186198|FG000|Overall Study|Withdrawal by Subject|0|||
17041889|NCT00343291|38186199|FG001|Overall Study|Withdrawal by Subject|2|||
17041890|NCT00343291|38186198|FG000|Overall Study|Other|8|||
17041891|NCT00343291|38186199|FG001|Overall Study|Other|5|||
17041892|NCT00658788|38186205|FG000|Overall Study|Adverse Event|11|||
17041893|NCT00658788|38186205|FG000|Overall Study|Withdrawal by Subject|13|||
17041894|NCT00658788|38186205|FG000|Overall Study|Lost to Follow-up|18|||
17041895|NCT00658788|38186205|FG000|Overall Study|Treatment Discontinuation|32|||
17041896|NCT04829214|38186220|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
17041897|NCT04829214|38186221|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
17041898|NCT04829214|38186220|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
17041899|NCT04829214|38186221|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
17041900|NCT00562965|38186231|FG000|Overall Study|Withdrawal by Subject|0|||
17041901|NCT00562965|38186232|FG001|Overall Study|Withdrawal by Subject|1|||
17041902|NCT00562965|38186231|FG000|Overall Study|Death|2|||
17041903|NCT00562965|38186232|FG001|Overall Study|Death|4|||
17041904|NCT00562965|38186231|FG000|Overall Study|Lost to Follow-up|1|||
17041905|NCT00562965|38186232|FG001|Overall Study|Lost to Follow-up|0|||
17041906|NCT00562965|38186231|FG000|Overall Study|Other|0|||
17041907|NCT00562965|38186232|FG001|Overall Study|Other|1|||
17041908|NCT00537082|38186241|FG000|Overall Study|Adverse Event|6|||
17041909|NCT00537082|38186242|FG001|Overall Study|Adverse Event|6|||
17041910|NCT00537082|38186243|FG002|Overall Study|Adverse Event|3|||
17041911|NCT00537082|38186241|FG000|Overall Study|Protocol Violation|0|||
17041912|NCT00537082|38186242|FG001|Overall Study|Protocol Violation|2|||
17041913|NCT00537082|38186243|FG002|Overall Study|Protocol Violation|1|||
17041914|NCT00537082|38186241|FG000|Overall Study|Lack of Efficacy|0|||
17041915|NCT00537082|38186242|FG001|Overall Study|Lack of Efficacy|0|||
17041916|NCT00537082|38186243|FG002|Overall Study|Lack of Efficacy|2|||
17041917|NCT00537082|38186241|FG000|Overall Study|Withdrawal by Subject|0|||
17041918|NCT00537082|38186242|FG001|Overall Study|Withdrawal by Subject|1|||
17041919|NCT00537082|38186243|FG002|Overall Study|Withdrawal by Subject|0|||
17041920|NCT00537082|38186241|FG000|Overall Study|Discontinued before initiating treatment|3|||
17041921|NCT00537082|38186242|FG001|Overall Study|Discontinued before initiating treatment|0|||
17041922|NCT00537082|38186243|FG002|Overall Study|Discontinued before initiating treatment|0|||
17041923|NCT03828487|38186251|FG000|Overall Study|Physician Decision|1|||
17041924|NCT00324961|38186255|FG000|Overall Study|Adverse Event|5|||
17041925|NCT00324961|38186255|FG000|Overall Study|Consent Withdrawn|11|||
17041926|NCT00324961|38186255|FG000|Overall Study|Lost to Follow-up|22|||
17041927|NCT00324961|38186255|FG000|Overall Study|Protocol Violation|3|||
17041928|NCT00324961|38186255|FG000|Overall Study|Other|2|||
17041929|NCT00324649|38186263|FG000|Overall Study|Adverse Event|1|||
17041930|NCT00324649|38186264|FG001|Overall Study|Adverse Event|4|||
17041931|NCT00324649|38186263|FG000|Overall Study|Withdrawal by Subject|0|||
17041932|NCT00324649|38186264|FG001|Overall Study|Withdrawal by Subject|1|||
17041933|NCT00324649|38186263|FG000|Overall Study|Noncompliance|1|||
17041934|NCT00324649|38186264|FG001|Overall Study|Noncompliance|0|||
17041935|NCT00656370|38186270|FG000|Overall Study|Screen Failures|7|||
17041936|NCT00656370|38186270|FG000|Overall Study|Alternates|3|||
17041937|NCT00680186|38186278|FG000|Overall Study|Adverse Event|47|||
17041938|NCT00680186|38186279|FG001|Overall Study|Adverse Event|44|||
17041939|NCT00680186|38186278|FG000|Overall Study|Protocol Violation|31|||
17041940|NCT00680186|38186279|FG001|Overall Study|Protocol Violation|26|||
17041941|NCT00680186|38186278|FG000|Overall Study|Lost to Follow-up|11|||
17041942|NCT00680186|38186279|FG001|Overall Study|Lost to Follow-up|6|||
17041943|NCT00680186|38186278|FG000|Overall Study|Withdrawal by Subject|32|||
17041944|NCT00680186|38186279|FG001|Overall Study|Withdrawal by Subject|39|||
17041945|NCT00680186|38186278|FG000|Overall Study|Other|4|||
17041946|NCT00680186|38186279|FG001|Overall Study|Other|1|||
17041947|NCT00656292|38186287|FG000|Overall Study|Withdrawal by Subject|2|||
17041948|NCT00656292|38186288|FG001|Overall Study|Withdrawal by Subject|3|||
17041949|NCT00656292|38186287|FG000|Overall Study|Screen failure|1|||
17041950|NCT00656292|38186288|FG001|Overall Study|Screen failure|2|||
17041951|NCT00352417|38186296|FG000|Overall Study|Adverse Event|1|||
17041952|NCT00352417|38186297|FG001|Overall Study|Adverse Event|0|||
17041953|NCT00352417|38186296|FG000|Overall Study|Protocol Violation|0|||
17041954|NCT00352417|38186297|FG001|Overall Study|Protocol Violation|2|||
17041955|NCT00352417|38186296|FG000|Overall Study|Withdrawal by Subject|1|||
17140139|NCT03448419|38282068|FG001|Overall Study|Adverse Event|9|||
17140140|NCT03448419|38282067|FG000|Overall Study|Lost to Follow-up|0|||
17041956|NCT00352417|38186297|FG001|Overall Study|Withdrawal by Subject|2|||
17041957|NCT00352417|38186296|FG000|Overall Study|Lost to Follow-up|1|||
17041958|NCT00352417|38186297|FG001|Overall Study|Lost to Follow-up|0|||
17041959|NCT00352417|38186296|FG000|Overall Study|Schedule Change|2|||
17041960|NCT00352417|38186297|FG001|Overall Study|Schedule Change|1|||
17041961|NCT00323869|38186303|FG000|Overall Study|Death|1|||
17041962|NCT00323557|38186309|FG000|Overall Study|Physician Decision|1|||
17041963|NCT00323557|38186310|FG001|Overall Study|Physician Decision|0|||
17041964|NCT00558363|38186319|FG000|Overall Study|Physician Decision|18|||
17041965|NCT00558363|38186320|FG001|Overall Study|Physician Decision|4|||
17041966|NCT00558363|38186319|FG000|Overall Study|Withdrawal by Subject|11|||
17041967|NCT00558363|38186320|FG001|Overall Study|Withdrawal by Subject|4|||
17041968|NCT00558363|38186319|FG000|Overall Study|Adverse Event|5|||
17041969|NCT00558363|38186320|FG001|Overall Study|Adverse Event|5|||
17041970|NCT00558363|38186319|FG000|Overall Study|Lack of Efficacy|2|||
17041971|NCT00558363|38186320|FG001|Overall Study|Lack of Efficacy|2|||
17140141|NCT03448419|38282068|FG001|Overall Study|Lost to Follow-up|2|||
17140142|NCT03448419|38282067|FG000|Overall Study|Withdrawal by Subject|3|||
17140143|NCT03448419|38282068|FG001|Overall Study|Withdrawal by Subject|1|||
17140144|NCT03448419|38282067|FG000|Overall Study|Not treated|0|||
17041972|NCT00558363|38186319|FG000|Overall Study|Protocol Violation|2|||
17041973|NCT00558363|38186320|FG001|Overall Study|Protocol Violation|1|||
17041974|NCT00558363|38186319|FG000|Overall Study|Lost to Follow-up|0|||
17041975|NCT00558363|38186320|FG001|Overall Study|Lost to Follow-up|1|||
17041976|NCT00558363|38186319|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
17041977|NCT00558363|38186320|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
17041978|NCT00558363|38186319|FG000|Overall Study|Randomized in Error|1|||
17041979|NCT00558363|38186320|FG001|Overall Study|Randomized in Error|2|||
17041980|NCT00558363|38186319|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
17041981|NCT00558363|38186320|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
17041982|NCT00323479|38186326|FG000|Overall Study|Adverse Event|2|||
17041983|NCT00323479|38186326|FG000|Overall Study|Withdrawal by Subject|2|||
17041984|NCT00323479|38186326|FG000|Overall Study|Protocol Violation|3|||
17041985|NCT00323479|38186326|FG000|Overall Study|house moving|1|||
17041986|NCT00352105|38186330|FG000|Overall Study|Death|5|||
17041987|NCT00352105|38186330|FG000|Overall Study|Withdrawal by Subject|5|||
17041988|NCT00352105|38186330|FG000|Overall Study|Lack of Efficacy|9|||
17041989|NCT00352105|38186330|FG000|Overall Study|Adverse Event|19|||
17041990|NCT00352105|38186330|FG000|Overall Study|Protocol Violation|2|||
17041991|NCT00350779|38186336|FG000|Overall Study|Adverse Event|4|||
17140145|NCT03448419|38282068|FG001|Overall Study|Not treated|1|||
17041992|NCT00350779|38186337|FG001|Overall Study|Adverse Event|2|||
17140146|NCT03448419|38282067|FG000|Overall Study|Patient did not attend all visits|0|||
17140147|NCT03448419|38282068|FG001|Overall Study|Patient did not attend all visits|2|||
17140148|NCT03448419|38282067|FG000|Overall Study|Withdrawn by Sponsor|0|||
17041993|NCT00350779|38186336|FG000|Overall Study|Lack of Efficacy|0|||
17041994|NCT00350779|38186337|FG001|Overall Study|Lack of Efficacy|4|||
17041995|NCT00350779|38186336|FG000|Overall Study|Lost to Follow-up|2|||
17041996|NCT00350779|38186337|FG001|Overall Study|Lost to Follow-up|0|||
17041997|NCT00350779|38186336|FG000|Overall Study|Physician Decision|2|||
17041998|NCT00350779|38186337|FG001|Overall Study|Physician Decision|4|||
17041999|NCT00350779|38186336|FG000|Overall Study|Protocol Violation|3|||
17042000|NCT00350779|38186337|FG001|Overall Study|Protocol Violation|1|||
17042001|NCT00350779|38186336|FG000|Overall Study|Withdrawal by Subject|9|||
17042002|NCT00350779|38186337|FG001|Overall Study|Withdrawal by Subject|8|||
17042003|NCT00350779|38186336|FG000|Overall Study|Patient Moved|2|||
17042004|NCT00350779|38186337|FG001|Overall Study|Patient Moved|1|||
17042005|NCT00350779|38186336|FG000|Overall Study|Non-compliance with study procedures|0|||
17042006|NCT00350779|38186337|FG001|Overall Study|Non-compliance with study procedures|1|||
17042007|NCT00350623|38186348|FG000|Overall Study|Lost to Follow-up|8|||
17042008|NCT00350623|38186349|FG001|Overall Study|Lost to Follow-up|3|||
17042009|NCT00350623|38186350|FG002|Overall Study|Lost to Follow-up|4|||
17042010|NCT00350623|38186348|FG000|Overall Study|Withdrawal by Subject|0|||
17042011|NCT00350623|38186349|FG001|Overall Study|Withdrawal by Subject|1|||
17042012|NCT00350623|38186350|FG002|Overall Study|Withdrawal by Subject|1|||
17042013|NCT00350623|38186348|FG000|Overall Study|patient traveling outside the country|0|||
17042014|NCT00350623|38186349|FG001|Overall Study|patient traveling outside the country|0|||
17042015|NCT00350623|38186350|FG002|Overall Study|patient traveling outside the country|1|||
17042016|NCT00656136|38186360|FG000|Overall Study|Progressive disease|177|||
17042017|NCT00656136|38186361|FG001|Overall Study|Progressive disease|322|||
17042018|NCT00656136|38186360|FG000|Overall Study|Other Adverse Event|5|||
17042019|NCT00656136|38186361|FG001|Overall Study|Other Adverse Event|51|||
17042020|NCT00656136|38186360|FG000|Overall Study|Protocol Violation|2|||
17042021|NCT00656136|38186361|FG001|Overall Study|Protocol Violation|3|||
17042022|NCT00656136|38186360|FG000|Overall Study|Patient refused to take study medication|7|||
17042023|NCT00656136|38186361|FG001|Overall Study|Patient refused to take study medication|10|||
17042024|NCT00656136|38186360|FG000|Overall Study|Unknown and others|4|||
17042025|NCT00656136|38186361|FG001|Overall Study|Unknown and others|4|||
17042026|NCT00676520|38186367|FG000|Overall Study|Withdrawal by Subject|163|||
17042027|NCT00676520|38186367|FG000|Overall Study|Lost to Follow-up|162|||
17042028|NCT00676520|38186367|FG000|Overall Study|Death|159|||
17042029|NCT00676520|38186367|FG000|Overall Study|Physician Decision|20|||
17042030|NCT00676520|38186367|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
17042031|NCT00676520|38186367|FG000|Overall Study|Other Reason|18|||
17042032|NCT00652938|38186379|FG000|Overall Study|Adverse Event|1|||
17042033|NCT00652938|38186380|FG001|Overall Study|Adverse Event|0|||
17042034|NCT00652938|38186381|FG002|Overall Study|Adverse Event|2|||
17042035|NCT00652938|38186379|FG000|Overall Study|Withdrawal by Subject|0|||
17042036|NCT00652938|38186380|FG001|Overall Study|Withdrawal by Subject|6|||
17042037|NCT00652938|38186381|FG002|Overall Study|Withdrawal by Subject|1|||
17042038|NCT00652938|38186379|FG000|Overall Study|Lost to Follow-up|0|||
17042039|NCT00652938|38186380|FG001|Overall Study|Lost to Follow-up|0|||
17042040|NCT00652938|38186381|FG002|Overall Study|Lost to Follow-up|2|||
17042041|NCT00652938|38186379|FG000|Overall Study|fear of blood sampling|0|||
17042042|NCT00652938|38186380|FG001|Overall Study|fear of blood sampling|1|||
17042043|NCT00652938|38186381|FG002|Overall Study|fear of blood sampling|0|||
17042044|NCT00322621|38186389|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
17042045|NCT00322621|38186390|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
17042046|NCT00322621|38186391|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
17042047|NCT00322621|38186389|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
17042048|NCT00322621|38186390|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
17042049|NCT00322621|38186391|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
17042050|NCT00322621|38186389|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
17042051|NCT00322621|38186390|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
17042052|NCT00322621|38186391|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
17042053|NCT00322621|38186389|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
17140149|NCT03448419|38282068|FG001|Overall Study|Withdrawn by Sponsor|1|||
17140150|NCT03419403|38282079|FG000|Overall Study|Withdrawal by Subject|5|||
17140151|NCT03419403|38282080|FG001|Overall Study|Withdrawal by Subject|2|||
17042054|NCT00322621|38186390|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
17042055|NCT00322621|38186391|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
17140152|NCT03419403|38282081|FG002|Overall Study|Withdrawal by Subject|5|||
17140153|NCT03419403|38282082|FG003|Overall Study|Withdrawal by Subject|1|||
17140154|NCT03419403|38282079|FG000|Overall Study|Progressive disease (per protocol)|0|||
17140155|NCT03419403|38282080|FG001|Overall Study|Progressive disease (per protocol)|2|||
17140156|NCT03419403|38282081|FG002|Overall Study|Progressive disease (per protocol)|2|||
17140157|NCT03419403|38282082|FG003|Overall Study|Progressive disease (per protocol)|0|||
17140158|NCT03419403|38282079|FG000|Overall Study|Other, not specified|6|||
17140159|NCT03419403|38282080|FG001|Overall Study|Other, not specified|4|||
17140160|NCT03419403|38282081|FG002|Overall Study|Other, not specified|5|||
17140161|NCT03419403|38282082|FG003|Overall Study|Other, not specified|1|||
17140162|NCT03419403|38282079|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
17140163|NCT03419403|38282080|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
17042056|NCT00322621|38186389|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
17042057|NCT00322621|38186390|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
17042058|NCT00322621|38186391|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
17042059|NCT00322621|38186389|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
17042060|NCT00322621|38186390|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
17042061|NCT00322621|38186391|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
17042062|NCT00322621|38186389|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
17042063|NCT00322621|38186390|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
17042064|NCT00322621|38186391|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
17042065|NCT00322621|38186389|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
17042066|NCT00322621|38186390|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
17042067|NCT00322621|38186391|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
17042068|NCT00322621|38186389|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
17042069|NCT00322621|38186390|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
17042070|NCT00322621|38186391|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
17042071|NCT00322621|38186389|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
17042072|NCT00322621|38186390|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
17042073|NCT00322621|38186391|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
17042074|NCT00322621|38186389|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
17042075|NCT00322621|38186390|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
17042076|NCT00322621|38186391|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
17042077|NCT00575042|38186404|FG000|Overall Study|Adverse Event|2|||
17042078|NCT00575042|38186404|FG000|Overall Study|Lost to Follow-up|1|||
17042079|NCT00676208|38186411|FG000|Overall Study|Lost to Follow-up|0|||
17140164|NCT03419403|38282081|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
17140165|NCT03419403|38282082|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
17042080|NCT00676208|38186412|FG001|Overall Study|Lost to Follow-up|2|||
17042081|NCT00676208|38186411|FG000|Overall Study|Incomplete data|2|||
17042082|NCT00676208|38186412|FG001|Overall Study|Incomplete data|4|||
17140166|NCT03447249|38282092|FG000|Overall Study|Adverse Event|1|||
17140167|NCT03447249|38282093|FG001|Overall Study|Adverse Event|0|||
17140168|NCT03447249|38282092|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
17140169|NCT03447249|38282093|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
17140170|NCT03447249|38282092|FG000|Overall Study|Other|3|||
17140171|NCT03447249|38282093|FG001|Overall Study|Other|0|||
17042083|NCT00656058|38186420|FG000|Overall Study|Withdrawal by Subject|2|||
17042084|NCT00656058|38186420|FG000|Overall Study|Withdrawal by Subject|4|||
17042085|NCT00537316|38186430|FG000|Part 1|Adverse Event|7|||
17042086|NCT00537316|38186431|FG001|Part 1|Adverse Event|11|||
17042087|NCT00537316|38186432|FG002|Part 1|Adverse Event|8|||
17042088|NCT00537316|38186433|FG003|Part 1|Adverse Event|0|||
17042089|NCT00537316|38186434|FG004|Part 1|Adverse Event|0|||
17042090|NCT00537316|38186435|FG005|Part 1|Adverse Event|0|||
17042091|NCT00537316|38186436|FG006|Part 1|Adverse Event|0|||
17042092|NCT00537316|38186430|FG000|Part 1|Protocol defined clinical event|1|||
17042093|NCT00537316|38186431|FG001|Part 1|Protocol defined clinical event|0|||
17042094|NCT00537316|38186432|FG002|Part 1|Protocol defined clinical event|0|||
17042095|NCT00537316|38186433|FG003|Part 1|Protocol defined clinical event|0|||
17140172|NCT03418545|38282103|FG000|Overall Study|Withdrawal by Participant|2|||
17140173|NCT03418545|38282104|FG001|Overall Study|Withdrawal by Participant|4|||
17140174|NCT03418545|38282103|FG000|Overall Study|Lost to Follow-up|3|||
17140175|NCT03418545|38282104|FG001|Overall Study|Lost to Follow-up|5|||
17140176|NCT03418545|38282103|FG000|Overall Study|Reason Not Specified|0|||
17140177|NCT03418545|38282104|FG001|Overall Study|Reason Not Specified|1|||
17140178|NCT03418545|38282103|FG000|Overall Study|Missing Completion Status|0|||
17140179|NCT03418545|38282104|FG001|Overall Study|Missing Completion Status|1|||
17140180|NCT03409731|38282113|FG000|Overall Study|Withdrawal by Subject|1|||
17140181|NCT03409731|38282113|FG000|Overall Study|Death|2|||
17140182|NCT03446781|38282119|FG000|Overall Study|Lost to Follow-up|11|||
17140183|NCT03446781|38282120|FG001|Overall Study|Lost to Follow-up|5|||
17140184|NCT03446781|38282119|FG000|Overall Study|Withdrawal by Subject|9|||
17140185|NCT03446781|38282120|FG001|Overall Study|Withdrawal by Subject|7|||
17140186|NCT03446781|38282119|FG000|Overall Study|Adverse Event|8|||
17140187|NCT03446781|38282120|FG001|Overall Study|Adverse Event|2|||
17140188|NCT03446781|38282119|FG000|Overall Study|Protocol Violation|0|||
17042096|NCT00537316|38186434|FG004|Part 1|Protocol defined clinical event|0|||
17042097|NCT00537316|38186435|FG005|Part 1|Protocol defined clinical event|0|||
17042098|NCT00537316|38186436|FG006|Part 1|Protocol defined clinical event|0|||
17042099|NCT00537316|38186430|FG000|Part 1|Lost to Follow-up|1|||
17042100|NCT00537316|38186431|FG001|Part 1|Lost to Follow-up|0|||
17042101|NCT00537316|38186432|FG002|Part 1|Lost to Follow-up|0|||
17042102|NCT00537316|38186433|FG003|Part 1|Lost to Follow-up|0|||
17042103|NCT00537316|38186434|FG004|Part 1|Lost to Follow-up|0|||
17140189|NCT03446781|38282120|FG001|Overall Study|Protocol Violation|3|||
17140190|NCT03445065|38282152|FG000|Overall Study|Withdrawal by Subject|3|||
17042104|NCT00537316|38186435|FG005|Part 1|Lost to Follow-up|0|||
17140191|NCT03445065|38282153|FG001|Overall Study|Withdrawal by Subject|6|||
17140192|NCT03445065|38282154|FG002|Overall Study|Withdrawal by Subject|2|||
17042105|NCT00537316|38186436|FG006|Part 1|Lost to Follow-up|0|||
17042106|NCT00537316|38186430|FG000|Part 1|Withdrawal by Subject|3|||
17042107|NCT00537316|38186431|FG001|Part 1|Withdrawal by Subject|8|||
17042108|NCT00537316|38186432|FG002|Part 1|Withdrawal by Subject|4|||
17042109|NCT00537316|38186433|FG003|Part 1|Withdrawal by Subject|0|||
17042110|NCT00537316|38186434|FG004|Part 1|Withdrawal by Subject|0|||
17042111|NCT00537316|38186435|FG005|Part 1|Withdrawal by Subject|0|||
17042112|NCT00537316|38186436|FG006|Part 1|Withdrawal by Subject|0|||
17042113|NCT00537316|38186430|FG000|Part 1|Protocol Violation|1|||
17042114|NCT00537316|38186431|FG001|Part 1|Protocol Violation|5|||
17042115|NCT00537316|38186432|FG002|Part 1|Protocol Violation|1|||
17042116|NCT00537316|38186433|FG003|Part 1|Protocol Violation|0|||
17042117|NCT00537316|38186434|FG004|Part 1|Protocol Violation|0|||
17042118|NCT00537316|38186435|FG005|Part 1|Protocol Violation|0|||
17042119|NCT00537316|38186436|FG006|Part 1|Protocol Violation|0|||
17042120|NCT00537316|38186430|FG000|Part 1|Did not meet protocol eligibility|1|||
17042121|NCT00537316|38186431|FG001|Part 1|Did not meet protocol eligibility|3|||
17042122|NCT00537316|38186432|FG002|Part 1|Did not meet protocol eligibility|2|||
17042123|NCT00537316|38186433|FG003|Part 1|Did not meet protocol eligibility|0|||
17042124|NCT00537316|38186434|FG004|Part 1|Did not meet protocol eligibility|0|||
17042125|NCT00537316|38186435|FG005|Part 1|Did not meet protocol eligibility|0|||
17042126|NCT00537316|38186436|FG006|Part 1|Did not meet protocol eligibility|0|||
17042127|NCT00537316|38186430|FG000|Part 1|Administrative|0|||
17042128|NCT00537316|38186431|FG001|Part 1|Administrative|0|||
17042129|NCT00537316|38186432|FG002|Part 1|Administrative|2|||
17042130|NCT00537316|38186433|FG003|Part 1|Administrative|0|||
17042131|NCT00537316|38186434|FG004|Part 1|Administrative|0|||
17042132|NCT00537316|38186435|FG005|Part 1|Administrative|0|||
17042133|NCT00537316|38186436|FG006|Part 1|Administrative|0|||
17042134|NCT00537316|38186430|FG000|Part 2|Never entered follow-up|0|||
17042135|NCT00537316|38186431|FG001|Part 2|Never entered follow-up|0|||
17042136|NCT00537316|38186432|FG002|Part 2|Never entered follow-up|0|||
17042137|NCT00537316|38186433|FG003|Part 2|Never entered follow-up|0|||
17042138|NCT00537316|38186434|FG004|Part 2|Never entered follow-up|0|||
17042139|NCT00537316|38186435|FG005|Part 2|Never entered follow-up|0|||
17042140|NCT00537316|38186436|FG006|Part 2|Never entered follow-up|1|||
17042141|NCT00537316|38186430|FG000|Part 2|Adverse Event|4|||
17042142|NCT00537316|38186431|FG001|Part 2|Adverse Event|0|||
17042143|NCT00537316|38186432|FG002|Part 2|Adverse Event|2|||
17042144|NCT00537316|38186433|FG003|Part 2|Adverse Event|0|||
17042145|NCT00537316|38186434|FG004|Part 2|Adverse Event|0|||
17042146|NCT00537316|38186435|FG005|Part 2|Adverse Event|0|||
17042147|NCT00537316|38186436|FG006|Part 2|Adverse Event|0|||
17042148|NCT00537316|38186430|FG000|Part 2|Lost to Follow-up|1|||
17042149|NCT00537316|38186431|FG001|Part 2|Lost to Follow-up|0|||
17042150|NCT00537316|38186432|FG002|Part 2|Lost to Follow-up|2|||
17042151|NCT00537316|38186433|FG003|Part 2|Lost to Follow-up|0|||
17042152|NCT00537316|38186434|FG004|Part 2|Lost to Follow-up|0|||
17042153|NCT00537316|38186435|FG005|Part 2|Lost to Follow-up|0|||
17042154|NCT00537316|38186436|FG006|Part 2|Lost to Follow-up|0|||
17042155|NCT00537316|38186430|FG000|Part 2|Withdrawal by Subject|5|||
17042156|NCT00537316|38186431|FG001|Part 2|Withdrawal by Subject|1|||
17042157|NCT00537316|38186432|FG002|Part 2|Withdrawal by Subject|4|||
17042158|NCT00537316|38186433|FG003|Part 2|Withdrawal by Subject|0|||
17042159|NCT00537316|38186434|FG004|Part 2|Withdrawal by Subject|0|||
17042160|NCT00537316|38186435|FG005|Part 2|Withdrawal by Subject|0|||
17042161|NCT00537316|38186436|FG006|Part 2|Withdrawal by Subject|0|||
17042162|NCT00537316|38186430|FG000|Part 2|Administrative|16|||
17042163|NCT00537316|38186431|FG001|Part 2|Administrative|8|||
17042164|NCT00537316|38186432|FG002|Part 2|Administrative|24|||
17042165|NCT00537316|38186433|FG003|Part 2|Administrative|3|||
17042166|NCT00537316|38186434|FG004|Part 2|Administrative|1|||
17042167|NCT00537316|38186435|FG005|Part 2|Administrative|4|||
17042168|NCT00537316|38186436|FG006|Part 2|Administrative|1|||
17042169|NCT03827395|38186457|FG000|Overall Study|Lost to Follow-up|1|||
17042170|NCT03827395|38186458|FG001|Overall Study|Lost to Follow-up|0|||
17042171|NCT03827395|38186457|FG000|Overall Study|Protocol Violation|1|||
17042172|NCT03827395|38186458|FG001|Overall Study|Protocol Violation|0|||
17042173|NCT03827395|38186457|FG000|Overall Study|Became ineligible after enrollment|1|||
17042174|NCT03827395|38186458|FG001|Overall Study|Became ineligible after enrollment|2|||
17042175|NCT00655980|38186467|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
17042176|NCT00655980|38186468|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
17042177|NCT00655980|38186469|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
17042178|NCT00679172|38186485|FG000|Overall Study|Non-compliance|1|||
17042179|NCT00679172|38186486|FG001|Overall Study|Non-compliance|1|||
17042180|NCT00679172|38186487|FG002|Overall Study|Non-compliance|0|||
17042181|NCT00679172|38186488|FG003|Overall Study|Non-compliance|1|||
17042182|NCT00679172|38186489|FG004|Overall Study|Non-compliance|0|||
17042183|NCT00679172|38186485|FG000|Overall Study|Other not specified|0|||
17042184|NCT00679172|38186486|FG001|Overall Study|Other not specified|0|||
17042185|NCT00679172|38186487|FG002|Overall Study|Other not specified|1|||
17042186|NCT00679172|38186488|FG003|Overall Study|Other not specified|0|||
17042187|NCT00679172|38186489|FG004|Overall Study|Other not specified|0|||
17042188|NCT00676130|38186506|FG000|Overall Study|Lost to Follow-up|0|||
17042189|NCT00676130|38186507|FG001|Overall Study|Lost to Follow-up|1|||
17042190|NCT00676130|38186506|FG000|Overall Study|Found ineligible|3|||
17042191|NCT00676130|38186507|FG001|Overall Study|Found ineligible|2|||
17042192|NCT00676130|38186506|FG000|Overall Study|Withdrawal by Subject|0|||
17042193|NCT00676130|38186507|FG001|Overall Study|Withdrawal by Subject|1|||
17042194|NCT00676052|38186519|FG000|Overall Study|Adverse Event|0|||
17042195|NCT00676052|38186520|FG001|Overall Study|Adverse Event|1|||
17042196|NCT00676052|38186521|FG002|Overall Study|Adverse Event|1|||
17042197|NCT00676052|38186522|FG003|Overall Study|Adverse Event|2|||
17042198|NCT00676052|38186523|FG004|Overall Study|Adverse Event|2|||
17042199|NCT00676052|38186524|FG005|Overall Study|Adverse Event|2|||
17042200|NCT00676052|38186519|FG000|Overall Study|Lack of Efficacy|2|||
17042201|NCT00676052|38186520|FG001|Overall Study|Lack of Efficacy|2|||
17042202|NCT00676052|38186521|FG002|Overall Study|Lack of Efficacy|1|||
17042203|NCT00676052|38186522|FG003|Overall Study|Lack of Efficacy|1|||
17042204|NCT00676052|38186523|FG004|Overall Study|Lack of Efficacy|2|||
17042205|NCT00676052|38186524|FG005|Overall Study|Lack of Efficacy|1|||
17042206|NCT00676052|38186519|FG000|Overall Study|Protocol Violation|5|||
17042207|NCT00676052|38186520|FG001|Overall Study|Protocol Violation|3|||
17042208|NCT00676052|38186521|FG002|Overall Study|Protocol Violation|2|||
17042209|NCT00676052|38186522|FG003|Overall Study|Protocol Violation|2|||
17042210|NCT00676052|38186523|FG004|Overall Study|Protocol Violation|1|||
17042211|NCT00676052|38186524|FG005|Overall Study|Protocol Violation|2|||
17042212|NCT00676052|38186519|FG000|Overall Study|Lost to Follow-up|0|||
17042213|NCT00676052|38186520|FG001|Overall Study|Lost to Follow-up|0|||
17042214|NCT00676052|38186521|FG002|Overall Study|Lost to Follow-up|0|||
17042215|NCT00676052|38186522|FG003|Overall Study|Lost to Follow-up|0|||
17042216|NCT00676052|38186523|FG004|Overall Study|Lost to Follow-up|1|||
17042217|NCT00676052|38186524|FG005|Overall Study|Lost to Follow-up|0|||
16780487|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
16780488|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
16780489|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
16780490|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
17042218|NCT00676052|38186519|FG000|Overall Study|Physician Decision|1|||
17042219|NCT00676052|38186520|FG001|Overall Study|Physician Decision|1|||
17042220|NCT00676052|38186521|FG002|Overall Study|Physician Decision|1|||
17042221|NCT00676052|38186522|FG003|Overall Study|Physician Decision|0|||
17042222|NCT00676052|38186523|FG004|Overall Study|Physician Decision|0|||
17042223|NCT00676052|38186524|FG005|Overall Study|Physician Decision|1|||
17042224|NCT00676052|38186519|FG000|Overall Study|Withdrawal by Subject|1|||
17042225|NCT00676052|38186520|FG001|Overall Study|Withdrawal by Subject|0|||
17042226|NCT00676052|38186521|FG002|Overall Study|Withdrawal by Subject|1|||
17042227|NCT00676052|38186522|FG003|Overall Study|Withdrawal by Subject|0|||
17042228|NCT00676052|38186523|FG004|Overall Study|Withdrawal by Subject|0|||
17042229|NCT00676052|38186524|FG005|Overall Study|Withdrawal by Subject|0|||
17042230|NCT00535288|38186543|FG000|Overall Study|Adverse Event|20|||
17042231|NCT00535288|38186544|FG001|Overall Study|Adverse Event|19|||
17042232|NCT00535288|38186545|FG002|Overall Study|Adverse Event|25|||
17042233|NCT00535288|38186546|FG003|Overall Study|Adverse Event|20|||
17042234|NCT00535288|38186547|FG004|Overall Study|Adverse Event|30|||
17042235|NCT00535288|38186543|FG000|Overall Study|Lost to Follow-up|0|||
17042236|NCT00535288|38186544|FG001|Overall Study|Lost to Follow-up|3|||
17042237|NCT00535288|38186545|FG002|Overall Study|Lost to Follow-up|0|||
17042238|NCT00535288|38186546|FG003|Overall Study|Lost to Follow-up|0|||
17042239|NCT00535288|38186547|FG004|Overall Study|Lost to Follow-up|0|||
17042240|NCT00535288|38186543|FG000|Overall Study|Lack of Efficacy|26|||
17042241|NCT00535288|38186544|FG001|Overall Study|Lack of Efficacy|3|||
17042242|NCT00535288|38186545|FG002|Overall Study|Lack of Efficacy|4|||
17042243|NCT00535288|38186546|FG003|Overall Study|Lack of Efficacy|4|||
17042244|NCT00535288|38186547|FG004|Overall Study|Lack of Efficacy|7|||
16780491|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
17042245|NCT00535288|38186543|FG000|Overall Study|Unwilling to cooperate|6|||
17042246|NCT00535288|38186544|FG001|Overall Study|Unwilling to cooperate|6|||
17189028|NCT02504320|38341977|FG000|Treatment Period 3|Adverse Event|0|||
17140193|NCT03445065|38282155|FG003|Overall Study|Withdrawal by Subject|2|||
17140194|NCT03445065|38282152|FG000|Overall Study|Other|4|||
17140195|NCT03445065|38282153|FG001|Overall Study|Other|3|||
17140196|NCT03445065|38282154|FG002|Overall Study|Other|3|||
17042247|NCT00535288|38186545|FG002|Overall Study|Unwilling to cooperate|3|||
17042248|NCT00535288|38186546|FG003|Overall Study|Unwilling to cooperate|3|||
17042249|NCT00535288|38186547|FG004|Overall Study|Unwilling to cooperate|4|||
17042250|NCT00535288|38186543|FG000|Overall Study|Other|2|||
17042251|NCT00535288|38186544|FG001|Overall Study|Other|1|||
17042252|NCT00535288|38186545|FG002|Overall Study|Other|1|||
17042253|NCT00535288|38186546|FG003|Overall Study|Other|2|||
17042254|NCT00535288|38186547|FG004|Overall Study|Other|1|||
17042255|NCT03904420|38186566|FG000|Overall Study|Study terminated|2|||
17042256|NCT03904420|38186567|FG001|Overall Study|Study terminated|2|||
17042257|NCT00675506|38186575|FG000|Overall Study|Lost to Follow-up|1|||
17042258|NCT00675506|38186576|FG001|Overall Study|Lost to Follow-up|5|||
17042259|NCT00675506|38186575|FG000|Overall Study|Lost interest|3|||
17042260|NCT00675506|38186576|FG001|Overall Study|Lost interest|5|||
17042261|NCT00675506|38186575|FG000|Overall Study|Elevated fasting glucose|2|||
17042262|NCT00675506|38186576|FG001|Overall Study|Elevated fasting glucose|1|||
17042263|NCT00675506|38186575|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
17042264|NCT00675506|38186576|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
17042265|NCT00675506|38186575|FG000|Overall Study|Elevated IGF-1|2|||
17042266|NCT00675506|38186576|FG001|Overall Study|Elevated IGF-1|0|||
17042267|NCT00675506|38186575|FG000|Overall Study|Hypersensitivity Reaction|1|||
17042268|NCT00675506|38186576|FG001|Overall Study|Hypersensitivity Reaction|0|||
17042269|NCT00675506|38186575|FG000|Overall Study|Disclosed history of cancer|1|||
17042270|NCT00675506|38186576|FG001|Overall Study|Disclosed history of cancer|0|||
17042271|NCT00675506|38186575|FG000|Overall Study|Declined participation|1|||
17042272|NCT00675506|38186576|FG001|Overall Study|Declined participation|0|||
17042273|NCT00675506|38186575|FG000|Overall Study|Schedule conflict|0|||
17042274|NCT00675506|38186576|FG001|Overall Study|Schedule conflict|1|||
17042275|NCT03895840|38186583|FG000|Overall Study|Withdrawal by Subject|21|||
17042276|NCT00310375|38186589|FG000|Primary Reporting Phase|Adverse Event|28|||
17042277|NCT00310375|38186590|FG001|Primary Reporting Phase|Adverse Event|22|||
17042278|NCT00310375|38186591|FG002|Primary Reporting Phase|Adverse Event|0|||
17042279|NCT00310375|38186589|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
17042280|NCT00310375|38186590|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
17042281|NCT00310375|38186591|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
17042282|NCT00310375|38186589|FG000|Primary Reporting Phase|Pregnancy|2|||
17042283|NCT00310375|38186590|FG001|Primary Reporting Phase|Pregnancy|2|||
17042284|NCT00310375|38186591|FG002|Primary Reporting Phase|Pregnancy|0|||
17042285|NCT00310375|38186589|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
17042286|NCT00310375|38186590|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
17042287|NCT00310375|38186591|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
17042288|NCT00310375|38186589|FG000|Primary Reporting Phase|Protocol Violation|8|||
17042289|NCT00310375|38186590|FG001|Primary Reporting Phase|Protocol Violation|5|||
17042290|NCT00310375|38186591|FG002|Primary Reporting Phase|Protocol Violation|0|||
17042291|NCT00310375|38186589|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
17042292|NCT00310375|38186590|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
17042293|NCT00310375|38186591|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
17042294|NCT00310375|38186589|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
17042295|NCT00310375|38186590|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
17042296|NCT00310375|38186591|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
17042297|NCT00310375|38186589|FG000|Primary Reporting Phase|Physician Decision|5|||
17042298|NCT00310375|38186590|FG001|Primary Reporting Phase|Physician Decision|3|||
17042299|NCT00310375|38186591|FG002|Primary Reporting Phase|Physician Decision|0|||
17042300|NCT00310375|38186589|FG000|Primary Reporting Phase|Request of the sponsor|2|||
17042301|NCT00310375|38186590|FG001|Primary Reporting Phase|Request of the sponsor|2|||
17140197|NCT03445065|38282155|FG003|Overall Study|Other|1|||
17140198|NCT01224106|38282180|FG000|Double-Blind Treatment Phase|Death|3|||
17140199|NCT01224106|38282181|FG001|Double-Blind Treatment Phase|Death|0|||
17140200|NCT01224106|38282182|FG002|Double-Blind Treatment Phase|Death|0|||
17140201|NCT01224106|38282183|FG003|Double-Blind Treatment Phase|Death|0|||
17140202|NCT01224106|38282184|FG004|Double-Blind Treatment Phase|Death|0|||
17140203|NCT01224106|38282180|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
17140204|NCT01224106|38282181|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
17189029|NCT02504320|38341978|FG001|Treatment Period 3|Adverse Event|0|||
17042302|NCT00310375|38186591|FG002|Primary Reporting Phase|Request of the sponsor|0|||
17042303|NCT00310375|38186589|FG000|Primary Reporting Phase|Failed to return|1|||
17042304|NCT00310375|38186590|FG001|Primary Reporting Phase|Failed to return|3|||
17042305|NCT00310375|38186591|FG002|Primary Reporting Phase|Failed to return|0|||
17042306|NCT00310375|38186589|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
17042307|NCT00310375|38186590|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
17042308|NCT00310375|38186591|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
17140205|NCT01224106|38282182|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
17140206|NCT01224106|38282183|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
17140207|NCT01224106|38282184|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
17140208|NCT01224106|38282180|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
17140209|NCT01224106|38282181|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
17140210|NCT01224106|38282182|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
17140211|NCT01224106|38282183|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
17042309|NCT00310375|38186589|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
17042310|NCT00310375|38186590|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
17042311|NCT00310375|38186591|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
17042312|NCT00310375|38186589|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
17042313|NCT00310375|38186590|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
17042314|NCT00310375|38186591|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
17042315|NCT00310375|38186589|FG000|Primary Reporting Phase|Site closure|3|||
17042316|NCT00310375|38186590|FG001|Primary Reporting Phase|Site closure|0|||
17042317|NCT00310375|38186591|FG002|Primary Reporting Phase|Site closure|0|||
17042318|NCT00310375|38186589|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
17042319|NCT00310375|38186590|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
17042320|NCT00310375|38186591|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
17042321|NCT00310375|38186589|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
17042322|NCT00310375|38186590|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
17042323|NCT00310375|38186591|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
17042324|NCT00310375|38186589|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
17042325|NCT00310375|38186590|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
17042326|NCT00310375|38186591|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
17042327|NCT00310375|38186589|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
17042328|NCT00310375|38186590|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
17042329|NCT00310375|38186591|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
17042330|NCT00309907|38186600|FG000|Overall Study|Death|4|||
17042331|NCT00309907|38186600|FG000|Overall Study|Physician Decision|1|||
17042332|NCT00309907|38186600|FG000|Overall Study|Ineligible|11|||
17042333|NCT00309907|38186600|FG000|Overall Study|Major infectious event|4|||
17042334|NCT00655824|38186605|FG000|Overall Study|Adverse Event|3|||
17042335|NCT00655824|38186605|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
17042336|NCT00655824|38186605|FG000|Overall Study|Protocol Violation|1|||
17042337|NCT00655824|38186605|FG000|Overall Study|Withdrawal by Subject|4|||
17042338|NCT00655824|38186605|FG000|Overall Study|Deterioration of Trial Disease|2|||
17140212|NCT01224106|38282184|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
17140213|NCT01224106|38282180|FG000|Double-Blind Treatment Phase|Other|0|||
17140214|NCT01224106|38282181|FG001|Double-Blind Treatment Phase|Other|0|||
17140215|NCT01224106|38282182|FG002|Double-Blind Treatment Phase|Other|1|||
17140216|NCT01224106|38282183|FG003|Double-Blind Treatment Phase|Other|0|||
17140217|NCT01224106|38282184|FG004|Double-Blind Treatment Phase|Other|0|||
17042339|NCT00575588|38186611|FG000|Overall Study|Adverse Event|11|||
17042340|NCT00575588|38186612|FG001|Overall Study|Adverse Event|13|||
17042341|NCT00575588|38186611|FG000|Overall Study|Withdrawal by Subject|27|||
17042342|NCT00575588|38186612|FG001|Overall Study|Withdrawal by Subject|31|||
17042343|NCT00575588|38186611|FG000|Overall Study|Lost to Follow-up|1|||
17042344|NCT00575588|38186612|FG001|Overall Study|Lost to Follow-up|3|||
17042345|NCT00575588|38186611|FG000|Overall Study|Death|4|||
17042346|NCT00575588|38186612|FG001|Overall Study|Death|2|||
17042347|NCT00575588|38186611|FG000|Overall Study|Incorrect enrollment|8|||
17042348|NCT00575588|38186612|FG001|Overall Study|Incorrect enrollment|4|||
17042349|NCT00575588|38186611|FG000|Overall Study|Study specific discontinuation criteria|203|||
17042350|NCT00575588|38186612|FG001|Overall Study|Study specific discontinuation criteria|218|||
17042351|NCT00575588|38186611|FG000|Overall Study|Severe non-compliance to protocol|5|||
17042352|NCT00575588|38186612|FG001|Overall Study|Severe non-compliance to protocol|7|||
17042353|NCT00575588|38186611|FG000|Overall Study|Safety reasons|2|||
17042354|NCT00575588|38186612|FG001|Overall Study|Safety reasons|1|||
17042355|NCT00575588|38186611|FG000|Overall Study|Elevated triglyceride|1|||
17042356|NCT00575588|38186612|FG001|Overall Study|Elevated triglyceride|0|||
17042357|NCT00575588|38186611|FG000|Overall Study|Patient moved|1|||
17042358|NCT00575588|38186612|FG001|Overall Study|Patient moved|3|||
17042359|NCT00575588|38186611|FG000|Overall Study|Impossible to determine HbA1c|0|||
17042360|NCT00575588|38186612|FG001|Overall Study|Impossible to determine HbA1c|1|||
17042361|NCT00675428|38186620|FG000|Overall Study|Disease Progression|2|||
17042362|NCT00675428|38186621|FG001|Overall Study|Disease Progression|2|||
17042363|NCT00675428|38186620|FG000|Overall Study|No Disease Response After Cycle 6|0|||
17042364|NCT00675428|38186621|FG001|Overall Study|No Disease Response After Cycle 6|1|||
17042365|NCT00675428|38186620|FG000|Overall Study|Physician Decision|1|||
17042366|NCT00675428|38186621|FG001|Overall Study|Physician Decision|0|||
17042367|NCT00557505|38186645|FG000|Overall Study|Death|0|||
17140218|NCT01224106|38282180|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
17140219|NCT01224106|38282181|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
17042368|NCT00557505|38186646|FG001|Overall Study|Death|0|||
17042369|NCT00557505|38186647|FG002|Overall Study|Death|0|||
17042370|NCT00557505|38186648|FG003|Overall Study|Death|0|||
17042371|NCT00557505|38186649|FG004|Overall Study|Death|0|||
17042372|NCT00557505|38186650|FG005|Overall Study|Death|0|||
17042373|NCT00557505|38186651|FG006|Overall Study|Death|0|||
17042374|NCT00557505|38186652|FG007|Overall Study|Death|0|||
17042375|NCT00557505|38186653|FG008|Overall Study|Death|1|||
17042376|NCT00557505|38186645|FG000|Overall Study|Adverse Event|0|||
17042377|NCT00557505|38186646|FG001|Overall Study|Adverse Event|0|||
17042378|NCT00557505|38186647|FG002|Overall Study|Adverse Event|1|||
17042379|NCT00557505|38186648|FG003|Overall Study|Adverse Event|0|||
17042380|NCT00557505|38186649|FG004|Overall Study|Adverse Event|0|||
17042381|NCT00557505|38186650|FG005|Overall Study|Adverse Event|0|||
17042382|NCT00557505|38186651|FG006|Overall Study|Adverse Event|1|||
17042383|NCT00557505|38186652|FG007|Overall Study|Adverse Event|0|||
17042384|NCT00557505|38186653|FG008|Overall Study|Adverse Event|0|||
17042385|NCT00557505|38186645|FG000|Overall Study|Global deterioration of health|1|||
17042386|NCT00557505|38186646|FG001|Overall Study|Global deterioration of health|0|||
17042387|NCT00557505|38186647|FG002|Overall Study|Global deterioration of health|0|||
17042388|NCT00557505|38186648|FG003|Overall Study|Global deterioration of health|0|||
17042389|NCT00557505|38186649|FG004|Overall Study|Global deterioration of health|0|||
17042390|NCT00557505|38186650|FG005|Overall Study|Global deterioration of health|0|||
17042391|NCT00557505|38186651|FG006|Overall Study|Global deterioration of health|0|||
17042392|NCT00557505|38186652|FG007|Overall Study|Global deterioration of health|0|||
17042393|NCT00557505|38186653|FG008|Overall Study|Global deterioration of health|0|||
17042394|NCT00557505|38186645|FG000|Overall Study|Objective progression or relapse|2|||
17042395|NCT00557505|38186646|FG001|Overall Study|Objective progression or relapse|3|||
17042396|NCT00557505|38186647|FG002|Overall Study|Objective progression or relapse|3|||
17042397|NCT00557505|38186648|FG003|Overall Study|Objective progression or relapse|2|||
17042398|NCT00557505|38186649|FG004|Overall Study|Objective progression or relapse|2|||
17042399|NCT00557505|38186650|FG005|Overall Study|Objective progression or relapse|3|||
17042400|NCT00557505|38186651|FG006|Overall Study|Objective progression or relapse|2|||
17042401|NCT00557505|38186652|FG007|Overall Study|Objective progression or relapse|5|||
17042402|NCT00557505|38186653|FG008|Overall Study|Objective progression or relapse|15|||
17042403|NCT00557505|38186645|FG000|Overall Study|Withdrawal by Subject|0|||
17042404|NCT00557505|38186646|FG001|Overall Study|Withdrawal by Subject|0|||
17042405|NCT00557505|38186647|FG002|Overall Study|Withdrawal by Subject|0|||
17042406|NCT00557505|38186648|FG003|Overall Study|Withdrawal by Subject|1|||
17042407|NCT00557505|38186649|FG004|Overall Study|Withdrawal by Subject|0|||
17042408|NCT00557505|38186650|FG005|Overall Study|Withdrawal by Subject|0|||
17042409|NCT00557505|38186651|FG006|Overall Study|Withdrawal by Subject|0|||
17042410|NCT00557505|38186652|FG007|Overall Study|Withdrawal by Subject|0|||
17042411|NCT00557505|38186653|FG008|Overall Study|Withdrawal by Subject|1|||
17042412|NCT00674570|38186679|FG000|Overall Study|Withdrawal by Subject|0|||
17042413|NCT00674570|38186680|FG001|Overall Study|Withdrawal by Subject|2|||
17042414|NCT00674570|38186681|FG002|Overall Study|Withdrawal by Subject|0|||
17042415|NCT00561951|38186692|FG000|Overall Study|Adverse Event|11|||
17042416|NCT00561951|38186693|FG001|Overall Study|Adverse Event|14|||
17042417|NCT00561951|38186694|FG002|Overall Study|Adverse Event|14|||
17042418|NCT00561951|38186692|FG000|Overall Study|Lack of Efficacy|5|||
17042419|NCT00561951|38186693|FG001|Overall Study|Lack of Efficacy|3|||
17042420|NCT00561951|38186694|FG002|Overall Study|Lack of Efficacy|2|||
17042421|NCT00561951|38186692|FG000|Overall Study|Lost to Follow-up|1|||
17042422|NCT00561951|38186693|FG001|Overall Study|Lost to Follow-up|1|||
17042423|NCT00561951|38186694|FG002|Overall Study|Lost to Follow-up|0|||
17042424|NCT00561951|38186692|FG000|Overall Study|Withdrawal by Subject|10|||
17042425|NCT00561951|38186693|FG001|Overall Study|Withdrawal by Subject|9|||
17042426|NCT00561951|38186694|FG002|Overall Study|Withdrawal by Subject|10|||
17042427|NCT00561951|38186692|FG000|Overall Study|Protocol Violation|4|||
17042428|NCT00561951|38186693|FG001|Overall Study|Protocol Violation|3|||
17042429|NCT00561951|38186694|FG002|Overall Study|Protocol Violation|4|||
17042430|NCT00561951|38186692|FG000|Overall Study|Physician Decision|1|||
17042431|NCT00561951|38186693|FG001|Overall Study|Physician Decision|0|||
17042432|NCT00561951|38186694|FG002|Overall Study|Physician Decision|0|||
17042433|NCT00561951|38186692|FG000|Overall Study|Pregnancy|0|||
17042434|NCT00561951|38186693|FG001|Overall Study|Pregnancy|1|||
17042435|NCT00561951|38186694|FG002|Overall Study|Pregnancy|0|||
17042436|NCT00561951|38186692|FG000|Overall Study|Meet Withdrawal Criterion|0|||
17042437|NCT00561951|38186693|FG001|Overall Study|Meet Withdrawal Criterion|1|||
17042438|NCT00561951|38186694|FG002|Overall Study|Meet Withdrawal Criterion|1|||
17042439|NCT00561951|38186692|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
17042440|NCT00561951|38186693|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
17189030|NCT02504320|38341979|FG002|Treatment Period 3|Adverse Event|1|||
17042441|NCT00561951|38186694|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
17042442|NCT00322387|38186704|FG000|Treatment Period|Adverse Event|0|||
17042443|NCT00322387|38186705|FG001|Treatment Period|Adverse Event|1|||
17042444|NCT00322387|38186704|FG000|Follow-up Period|Final assessment not done|1|||
17042445|NCT00322387|38186705|FG001|Follow-up Period|Final assessment not done|3|||
17042446|NCT00322387|38186704|FG000|Follow-up Period|Death|1|||
17042447|NCT00322387|38186705|FG001|Follow-up Period|Death|0|||
17042448|NCT00561015|38186728|FG000|Overall Study|Adverse Event|0|||
17042449|NCT00561015|38186729|FG001|Overall Study|Adverse Event|0|||
17042450|NCT00561015|38186730|FG002|Overall Study|Adverse Event|0|||
17042451|NCT00561015|38186731|FG003|Overall Study|Adverse Event|0|||
17042452|NCT00561015|38186732|FG004|Overall Study|Adverse Event|1|||
17042453|NCT00561015|38186733|FG005|Overall Study|Adverse Event|0|||
17042454|NCT00561015|38186728|FG000|Overall Study|Lost to Follow-up|2|||
17042455|NCT00561015|38186729|FG001|Overall Study|Lost to Follow-up|0|||
17042456|NCT00561015|38186730|FG002|Overall Study|Lost to Follow-up|0|||
17042457|NCT00561015|38186731|FG003|Overall Study|Lost to Follow-up|1|||
17042458|NCT00561015|38186732|FG004|Overall Study|Lost to Follow-up|0|||
17042459|NCT00561015|38186733|FG005|Overall Study|Lost to Follow-up|3|||
17042460|NCT00561015|38186728|FG000|Overall Study|Participant non-compliance|2|||
17042461|NCT00561015|38186729|FG001|Overall Study|Participant non-compliance|0|||
17042462|NCT00561015|38186730|FG002|Overall Study|Participant non-compliance|0|||
17042463|NCT00561015|38186731|FG003|Overall Study|Participant non-compliance|0|||
17042464|NCT00561015|38186732|FG004|Overall Study|Participant non-compliance|0|||
17042465|NCT00561015|38186733|FG005|Overall Study|Participant non-compliance|0|||
17042466|NCT00560937|38186753|FG000|Overall Study|Withdrawal by Subject|0|||
17042467|NCT00560937|38186754|FG001|Overall Study|Withdrawal by Subject|1|||
17042468|NCT00560937|38186753|FG000|Overall Study|Physician Decision|1|||
17042469|NCT00560937|38186754|FG001|Overall Study|Physician Decision|1|||
17042470|NCT00561795|38186762|FG000|Overall Study|Adverse Event|3|||
17042471|NCT00561795|38186763|FG001|Overall Study|Adverse Event|3|||
17042472|NCT00561795|38186764|FG002|Overall Study|Adverse Event|0|||
17042473|NCT00561795|38186765|FG003|Overall Study|Adverse Event|0|||
17042474|NCT00561795|38186762|FG000|Overall Study|Study Closed/Terminated|0|||
17042475|NCT00561795|38186763|FG001|Overall Study|Study Closed/Terminated|3|||
17042476|NCT00561795|38186764|FG002|Overall Study|Study Closed/Terminated|0|||
17042477|NCT00561795|38186765|FG003|Overall Study|Study Closed/Terminated|0|||
17042478|NCT00561795|38186762|FG000|Overall Study|Physician Decision|1|||
17042479|NCT00561795|38186763|FG001|Overall Study|Physician Decision|0|||
17042480|NCT00561795|38186764|FG002|Overall Study|Physician Decision|0|||
17042481|NCT00561795|38186765|FG003|Overall Study|Physician Decision|0|||
17042482|NCT00652626|38186780|FG000|Initial Treatment Phase|Adverse Event|0|||
17042483|NCT00652626|38186781|FG001|Initial Treatment Phase|Adverse Event|0|||
17042484|NCT00652626|38186782|FG002|Initial Treatment Phase|Adverse Event|0|||
17042485|NCT00652626|38186783|FG003|Initial Treatment Phase|Adverse Event|0|||
17042486|NCT00652626|38186784|FG004|Initial Treatment Phase|Adverse Event|1|||
17042487|NCT00652626|38186785|FG005|Initial Treatment Phase|Adverse Event|0|||
17140220|NCT01224106|38282182|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
17140221|NCT01224106|38282183|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
17140222|NCT01224106|38282184|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
17042488|NCT00652626|38186786|FG006|Initial Treatment Phase|Adverse Event|0|||
17042489|NCT00652626|38186780|FG000|Initial Treatment Phase|Protocol Violation|0|||
17042490|NCT00652626|38186781|FG001|Initial Treatment Phase|Protocol Violation|0|||
17042491|NCT00652626|38186782|FG002|Initial Treatment Phase|Protocol Violation|0|||
17042492|NCT00652626|38186783|FG003|Initial Treatment Phase|Protocol Violation|1|||
17042493|NCT00652626|38186784|FG004|Initial Treatment Phase|Protocol Violation|0|||
17042494|NCT00652626|38186785|FG005|Initial Treatment Phase|Protocol Violation|0|||
17042495|NCT00652626|38186786|FG006|Initial Treatment Phase|Protocol Violation|0|||
17042496|NCT00652626|38186780|FG000|Initial Treatment Phase|Physician Decision|0|||
17042497|NCT00652626|38186781|FG001|Initial Treatment Phase|Physician Decision|0|||
17042498|NCT00652626|38186782|FG002|Initial Treatment Phase|Physician Decision|0|||
17042499|NCT00652626|38186783|FG003|Initial Treatment Phase|Physician Decision|0|||
17042500|NCT00652626|38186784|FG004|Initial Treatment Phase|Physician Decision|1|||
17042501|NCT00652626|38186785|FG005|Initial Treatment Phase|Physician Decision|0|||
17042502|NCT00652626|38186786|FG006|Initial Treatment Phase|Physician Decision|0|||
17042503|NCT00652626|38186780|FG000|Initial Treatment Phase|Sponsor Request|0|||
17042504|NCT00652626|38186781|FG001|Initial Treatment Phase|Sponsor Request|0|||
17042505|NCT00652626|38186782|FG002|Initial Treatment Phase|Sponsor Request|1|||
17042506|NCT00652626|38186783|FG003|Initial Treatment Phase|Sponsor Request|0|||
17042507|NCT00652626|38186784|FG004|Initial Treatment Phase|Sponsor Request|0|||
17042508|NCT00652626|38186785|FG005|Initial Treatment Phase|Sponsor Request|0|||
17042509|NCT00652626|38186786|FG006|Initial Treatment Phase|Sponsor Request|0|||
17042510|NCT00652626|38186780|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
17042511|NCT00652626|38186781|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
17042512|NCT00652626|38186782|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
17042513|NCT00652626|38186783|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
17042514|NCT00652626|38186784|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
17042515|NCT00652626|38186785|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
17042516|NCT00652626|38186786|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
17042517|NCT00652626|38186780|FG000|Extension Phase|Withdrawal by Subject|0|||
17042518|NCT00652626|38186781|FG001|Extension Phase|Withdrawal by Subject|0|||
17042519|NCT00652626|38186782|FG002|Extension Phase|Withdrawal by Subject|0|||
17042520|NCT00652626|38186783|FG003|Extension Phase|Withdrawal by Subject|0|||
17042521|NCT00652626|38186784|FG004|Extension Phase|Withdrawal by Subject|0|||
17042522|NCT00652626|38186785|FG005|Extension Phase|Withdrawal by Subject|2|||
17042523|NCT00652626|38186786|FG006|Extension Phase|Withdrawal by Subject|0|||
17042524|NCT00652626|38186780|FG000|Extension Phase|Adverse Event|0|||
17042525|NCT00652626|38186781|FG001|Extension Phase|Adverse Event|0|||
17042526|NCT00652626|38186782|FG002|Extension Phase|Adverse Event|0|||
17042527|NCT00652626|38186783|FG003|Extension Phase|Adverse Event|0|||
17042528|NCT00652626|38186784|FG004|Extension Phase|Adverse Event|0|||
17042529|NCT00652626|38186785|FG005|Extension Phase|Adverse Event|2|||
17042530|NCT00652626|38186786|FG006|Extension Phase|Adverse Event|1|||
17042531|NCT00652626|38186780|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
17042532|NCT00652626|38186781|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
17042533|NCT00652626|38186782|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
17042534|NCT00652626|38186783|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
17042535|NCT00652626|38186784|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
17042536|NCT00652626|38186785|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
17042537|NCT00652626|38186786|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
17042538|NCT00652626|38186780|FG000|Extension Phase|Physician Decision|0|||
17042539|NCT00652626|38186781|FG001|Extension Phase|Physician Decision|0|||
17042540|NCT00652626|38186782|FG002|Extension Phase|Physician Decision|0|||
17042541|NCT00652626|38186783|FG003|Extension Phase|Physician Decision|0|||
17042542|NCT00652626|38186784|FG004|Extension Phase|Physician Decision|0|||
17042543|NCT00652626|38186785|FG005|Extension Phase|Physician Decision|1|||
17042544|NCT00652626|38186786|FG006|Extension Phase|Physician Decision|1|||
17042545|NCT00652626|38186780|FG000|Extension Phase|Death|0|||
17042546|NCT00652626|38186781|FG001|Extension Phase|Death|0|||
17042547|NCT00652626|38186782|FG002|Extension Phase|Death|0|||
17042548|NCT00652626|38186783|FG003|Extension Phase|Death|0|||
17042549|NCT00652626|38186784|FG004|Extension Phase|Death|0|||
17042550|NCT00652626|38186785|FG005|Extension Phase|Death|1|||
17042551|NCT00652626|38186786|FG006|Extension Phase|Death|1|||
17042552|NCT00560703|38186806|FG000|Overall Study|Adverse Event|0|||
17042553|NCT00560703|38186807|FG001|Overall Study|Adverse Event|2|||
17042554|NCT00560703|38186806|FG000|Overall Study|Protocol Violation|0|||
17042555|NCT00560703|38186807|FG001|Overall Study|Protocol Violation|2|||
17042556|NCT00560703|38186806|FG000|Overall Study|Withdrawal by Subject|0|||
17042557|NCT00560703|38186807|FG001|Overall Study|Withdrawal by Subject|1|||
17042558|NCT00560703|38186806|FG000|Overall Study|non-compliance|0|||
17042559|NCT00560703|38186807|FG001|Overall Study|non-compliance|1|||
17042560|NCT00308737|38186816|FG000|Overall Study|Adverse Event|104|||
17042561|NCT00308737|38186817|FG001|Overall Study|Adverse Event|9|||
17042562|NCT00308737|38186818|FG002|Overall Study|Adverse Event|0|||
17042563|NCT00308737|38186816|FG000|Overall Study|Death|4|||
17042564|NCT00308737|38186817|FG001|Overall Study|Death|3|||
17042565|NCT00308737|38186818|FG002|Overall Study|Death|0|||
17042566|NCT00308737|38186816|FG000|Overall Study|Lost to Follow-up|56|||
17042567|NCT00308737|38186817|FG001|Overall Study|Lost to Follow-up|80|||
17042568|NCT00308737|38186818|FG002|Overall Study|Lost to Follow-up|5|||
17042569|NCT00308737|38186816|FG000|Overall Study|Physician Decision|15|||
17042570|NCT00308737|38186817|FG001|Overall Study|Physician Decision|2|||
17042571|NCT00308737|38186818|FG002|Overall Study|Physician Decision|1|||
17042572|NCT00308737|38186816|FG000|Overall Study|Protocol Violation|34|||
17042573|NCT00308737|38186817|FG001|Overall Study|Protocol Violation|9|||
17042574|NCT00308737|38186818|FG002|Overall Study|Protocol Violation|5|||
17042575|NCT00308737|38186816|FG000|Overall Study|Withdrawal by Subject|218|||
17042576|NCT00308737|38186817|FG001|Overall Study|Withdrawal by Subject|166|||
17042577|NCT00308737|38186818|FG002|Overall Study|Withdrawal by Subject|18|||
17042578|NCT00308737|38186816|FG000|Overall Study|Various|32|||
17042579|NCT00308737|38186817|FG001|Overall Study|Various|20|||
17042580|NCT00308737|38186818|FG002|Overall Study|Various|8|||
17042581|NCT00655746|38186826|FG000|Overall Study|Withdrawal by Subject|1|||
17042582|NCT00338455|38186836|FG000|Overall Study|Death|2|||
17042583|NCT00338455|38186837|FG001|Overall Study|Death|1|||
17042584|NCT00338455|38186836|FG000|Overall Study|Physician Decision|1|||
17042585|NCT00338455|38186837|FG001|Overall Study|Physician Decision|0|||
17042586|NCT00651924|38186845|FG000|Overall Study|Withdrawal by PI|0|||
17042587|NCT00651924|38186846|FG001|Overall Study|Withdrawal by PI|2|||
17042588|NCT00651924|38186845|FG000|Overall Study|Withdrawal by Subject|0|||
17042589|NCT00651924|38186846|FG001|Overall Study|Withdrawal by Subject|5|||
17042590|NCT00678392|38186854|FG000|Overall Study|Adverse Event|0|||
17042591|NCT00678392|38186855|FG001|Overall Study|Adverse Event|6|||
17042592|NCT00678392|38186854|FG000|Overall Study|Death|280|||
17042593|NCT00678392|38186855|FG001|Overall Study|Death|269|||
17042594|NCT00678392|38186854|FG000|Overall Study|Lost to Follow-up|15|||
17042595|NCT00678392|38186855|FG001|Overall Study|Lost to Follow-up|13|||
17042596|NCT00678392|38186854|FG000|Overall Study|Objective Progression or Relapse|3|||
17042597|NCT00678392|38186855|FG001|Overall Study|Objective Progression or Relapse|8|||
17042598|NCT00678392|38186854|FG000|Overall Study|Sponsor's Decision|1|||
17042599|NCT00678392|38186855|FG001|Overall Study|Sponsor's Decision|2|||
17042600|NCT00678392|38186854|FG000|Overall Study|Withdrawal by Subject|4|||
17042601|NCT00678392|38186855|FG001|Overall Study|Withdrawal by Subject|4|||
17042602|NCT00678392|38186854|FG000|Overall Study|Randomized But Not Treated|2|||
17042603|NCT00678392|38186855|FG001|Overall Study|Randomized But Not Treated|7|||
17042604|NCT00678392|38186854|FG000|Overall Study|Other|56|||
17042605|NCT00678392|38186855|FG001|Overall Study|Other|53|||
17042606|NCT00308581|38186861|FG000|Induction Phase|Adverse Event|0|||
17042607|NCT00308581|38186862|FG001|Induction Phase|Adverse Event|0|||
17042608|NCT00308581|38186863|FG002|Induction Phase|Adverse Event|37|||
17042609|NCT00308581|38186861|FG000|Induction Phase|Lack of Efficacy|0|||
17042610|NCT00308581|38186862|FG001|Induction Phase|Lack of Efficacy|0|||
17042611|NCT00308581|38186863|FG002|Induction Phase|Lack of Efficacy|121|||
17042612|NCT00308581|38186861|FG000|Induction Phase|Withdrawal by Subject|0|||
17042613|NCT00308581|38186862|FG001|Induction Phase|Withdrawal by Subject|0|||
17042614|NCT00308581|38186863|FG002|Induction Phase|Withdrawal by Subject|5|||
17042615|NCT00308581|38186861|FG000|Induction Phase|Unknown reason|0|||
17042616|NCT00308581|38186862|FG001|Induction Phase|Unknown reason|0|||
17042617|NCT00308581|38186863|FG002|Induction Phase|Unknown reason|3|||
17042618|NCT00308581|38186861|FG000|Randomized Maintenance Phase|Adverse Event|10|||
17042619|NCT00308581|38186862|FG001|Randomized Maintenance Phase|Adverse Event|17|||
17042620|NCT00308581|38186863|FG002|Randomized Maintenance Phase|Adverse Event|0|||
17042621|NCT00308581|38186861|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
17042622|NCT00308581|38186862|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
17042623|NCT00308581|38186863|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
17042624|NCT00308581|38186861|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
17042625|NCT00308581|38186862|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
17042626|NCT00308581|38186863|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
17042627|NCT00308581|38186861|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
17042628|NCT00308581|38186862|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
16992244|NCT00808132|38136195|FG003|Overall Study|Death|0|||
16992245|NCT00808132|38136196|FG004|Overall Study|Death|1|||
16992246|NCT00808132|38136192|FG000|Overall Study|Physician Decision|0|||
16992247|NCT00808132|38136193|FG001|Overall Study|Physician Decision|1|||
16992248|NCT00808132|38136194|FG002|Overall Study|Physician Decision|0|||
16992249|NCT00808132|38136195|FG003|Overall Study|Physician Decision|0|||
16992250|NCT00808132|38136196|FG004|Overall Study|Physician Decision|0|||
16992251|NCT00808132|38136192|FG000|Overall Study|Lost to Follow-up|8|||
17042629|NCT00308581|38186863|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
17042630|NCT00308581|38186861|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
17042631|NCT00308581|38186862|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
17042632|NCT00308581|38186863|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
17042633|NCT00308581|38186861|FG000|Randomized Maintenance Phase|Unknown reason|3|||
17042634|NCT00308581|38186862|FG001|Randomized Maintenance Phase|Unknown reason|0|||
17042635|NCT00308581|38186863|FG002|Randomized Maintenance Phase|Unknown reason|0|||
17042636|NCT00678080|38186873|FG000|Overall Study|Physician Decision|2|||
17042637|NCT00678080|38186874|FG001|Overall Study|Physician Decision|0|||
17042638|NCT00678080|38186873|FG000|Overall Study|Lost to Follow-up|1|||
17042639|NCT00678080|38186874|FG001|Overall Study|Lost to Follow-up|0|||
17042640|NCT00678080|38186873|FG000|Overall Study|Withdrawal by Subject|0|||
17042641|NCT00678080|38186874|FG001|Overall Study|Withdrawal by Subject|1|||
17042642|NCT00658320|38186882|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
17042643|NCT00658320|38186883|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
17042644|NCT00658320|38186882|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
17042645|NCT00658320|38186883|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
17042646|NCT00658320|38186882|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
17042647|NCT00658320|38186883|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
17042648|NCT00658320|38186882|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
17042649|NCT00658320|38186883|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
17042650|NCT00322153|38186893|FG000|Overall Study|Adverse Event|21|||
17042651|NCT00322153|38186894|FG001|Overall Study|Adverse Event|34|||
17042652|NCT00322153|38186893|FG000|Overall Study|Protocol Violation|6|||
17042653|NCT00322153|38186894|FG001|Overall Study|Protocol Violation|14|||
17042654|NCT00322153|38186893|FG000|Overall Study|Withdrawal by Subject|18|||
17042655|NCT00322153|38186894|FG001|Overall Study|Withdrawal by Subject|10|||
17042656|NCT00322153|38186893|FG000|Overall Study|Lack of Efficacy|8|||
17042657|NCT00322153|38186894|FG001|Overall Study|Lack of Efficacy|3|||
17042658|NCT00322153|38186893|FG000|Overall Study|Lost to Follow-up|5|||
17042659|NCT00322153|38186894|FG001|Overall Study|Lost to Follow-up|4|||
17042660|NCT00322153|38186893|FG000|Overall Study|Withdrawn for other reasons|5|||
17042661|NCT00322153|38186894|FG001|Overall Study|Withdrawn for other reasons|4|||
17042662|NCT00657618|38186900|FG000|Overall Study|Adverse Event|32|||
17042663|NCT00657618|38186900|FG000|Overall Study|Withdrawal by Subject|8|||
17042664|NCT00657618|38186900|FG000|Overall Study|negative for leishmaniasis|2|||
17042665|NCT00657618|38186900|FG000|Overall Study|didn't start due to schedule conflicts|1|||
17042666|NCT00657540|38186906|FG000|Overall Study|Lost to Follow-up|1|||
17042667|NCT00657540|38186907|FG001|Overall Study|Lost to Follow-up|4|||
17042668|NCT00672620|38186917|FG000|Overall Study|Adverse Event|7|||
17042669|NCT00672620|38186918|FG001|Overall Study|Adverse Event|7|||
17042670|NCT00672620|38186919|FG002|Overall Study|Adverse Event|12|||
17042671|NCT00672620|38186920|FG003|Overall Study|Adverse Event|17|||
17042672|NCT00672620|38186917|FG000|Overall Study|Lack of Efficacy|1|||
17042673|NCT00672620|38186918|FG001|Overall Study|Lack of Efficacy|2|||
17042674|NCT00672620|38186919|FG002|Overall Study|Lack of Efficacy|2|||
17042675|NCT00672620|38186920|FG003|Overall Study|Lack of Efficacy|0|||
17042676|NCT00672620|38186917|FG000|Overall Study|Noncompliance with Study Drug|3|||
17042677|NCT00672620|38186918|FG001|Overall Study|Noncompliance with Study Drug|4|||
17042678|NCT00672620|38186919|FG002|Overall Study|Noncompliance with Study Drug|0|||
17042679|NCT00672620|38186920|FG003|Overall Study|Noncompliance with Study Drug|2|||
17042680|NCT00672620|38186917|FG000|Overall Study|Protocol Deviations|5|||
17042681|NCT00672620|38186918|FG001|Overall Study|Protocol Deviations|7|||
17042682|NCT00672620|38186919|FG002|Overall Study|Protocol Deviations|2|||
17042683|NCT00672620|38186920|FG003|Overall Study|Protocol Deviations|5|||
17042684|NCT00672620|38186917|FG000|Overall Study|Withdrawal of Consent|6|||
17042685|NCT00672620|38186918|FG001|Overall Study|Withdrawal of Consent|12|||
17042686|NCT00672620|38186919|FG002|Overall Study|Withdrawal of Consent|5|||
17042687|NCT00672620|38186920|FG003|Overall Study|Withdrawal of Consent|6|||
17042688|NCT00672620|38186917|FG000|Overall Study|Lost to Follow-up|8|||
17042689|NCT00672620|38186918|FG001|Overall Study|Lost to Follow-up|19|||
17042690|NCT00672620|38186919|FG002|Overall Study|Lost to Follow-up|8|||
17042691|NCT00672620|38186920|FG003|Overall Study|Lost to Follow-up|11|||
17042692|NCT00672620|38186917|FG000|Overall Study|Reason not Specified|3|||
17042693|NCT00672620|38186918|FG001|Overall Study|Reason not Specified|3|||
17042694|NCT00672620|38186919|FG002|Overall Study|Reason not Specified|2|||
17042695|NCT00672620|38186920|FG003|Overall Study|Reason not Specified|1|||
17042696|NCT00673790|38186933|FG000|Overall Study|Adverse Event|23|||
17042697|NCT00673790|38186934|FG001|Overall Study|Adverse Event|14|||
17042698|NCT00673790|38186935|FG002|Overall Study|Adverse Event|2|||
17042699|NCT00673790|38186933|FG000|Overall Study|Lack of Efficacy|2|||
17042700|NCT00673790|38186934|FG001|Overall Study|Lack of Efficacy|2|||
17042701|NCT00673790|38186935|FG002|Overall Study|Lack of Efficacy|2|||
17042702|NCT00673790|38186933|FG000|Overall Study|Protocol Violation|6|||
17042703|NCT00673790|38186934|FG001|Overall Study|Protocol Violation|9|||
17042704|NCT00673790|38186935|FG002|Overall Study|Protocol Violation|1|||
17042705|NCT00673790|38186933|FG000|Overall Study|Withdrawal by Subject|7|||
17042706|NCT00673790|38186934|FG001|Overall Study|Withdrawal by Subject|4|||
17042707|NCT00673790|38186935|FG002|Overall Study|Withdrawal by Subject|1|||
17042708|NCT00673790|38186933|FG000|Overall Study|Lost to Follow-up|6|||
17042709|NCT00673790|38186934|FG001|Overall Study|Lost to Follow-up|6|||
17042710|NCT00673790|38186935|FG002|Overall Study|Lost to Follow-up|5|||
17042711|NCT00673790|38186933|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
17042712|NCT00673790|38186934|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
17042713|NCT00673790|38186935|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
17042714|NCT00673790|38186933|FG000|Overall Study|Poor compliance|1|||
17140223|NCT01224106|38282180|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
17140224|NCT01224106|38282181|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
17140225|NCT01224106|38282182|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
17140226|NCT01224106|38282183|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
17140227|NCT01224106|38282184|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
17140228|NCT01224106|38282180|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
17140229|NCT01224106|38282181|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
17140230|NCT01224106|38282182|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
17140231|NCT01224106|38282183|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
17042715|NCT00673790|38186934|FG001|Overall Study|Poor compliance|0|||
17042716|NCT00673790|38186935|FG002|Overall Study|Poor compliance|0|||
17042717|NCT00673790|38186933|FG000|Overall Study|Participated in two Nebivolol studies|0|||
17042718|NCT00673790|38186934|FG001|Overall Study|Participated in two Nebivolol studies|0|||
17042719|NCT00673790|38186935|FG002|Overall Study|Participated in two Nebivolol studies|1|||
17042720|NCT00673790|38186933|FG000|Overall Study|Unconfirmed pregnancy|0|||
17042721|NCT00673790|38186934|FG001|Overall Study|Unconfirmed pregnancy|1|||
17042722|NCT00673790|38186935|FG002|Overall Study|Unconfirmed pregnancy|0|||
17042723|NCT00673790|38186933|FG000|Overall Study|Randomization criteria not met|0|||
17042724|NCT00673790|38186934|FG001|Overall Study|Randomization criteria not met|1|||
17042725|NCT00673790|38186935|FG002|Overall Study|Randomization criteria not met|0|||
17042726|NCT00657150|38186946|FG000|Overall Study|Adverse Event|19|||
17140232|NCT01224106|38282184|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
17140233|NCT01224106|38282180|FG000|Open-Label Extension (OLE) Phase|Death|0|||
17140234|NCT01224106|38282181|FG001|Open-Label Extension (OLE) Phase|Death|0|||
17140235|NCT01224106|38282182|FG002|Open-Label Extension (OLE) Phase|Death|0|||
17140236|NCT01224106|38282183|FG003|Open-Label Extension (OLE) Phase|Death|1|||
17140237|NCT01224106|38282184|FG004|Open-Label Extension (OLE) Phase|Death|3|||
17140238|NCT01224106|38282180|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
17140239|NCT01224106|38282181|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
17140240|NCT01224106|38282182|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
17140241|NCT01224106|38282183|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
17140242|NCT01224106|38282184|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
17140243|NCT01224106|38282180|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
17140244|NCT01224106|38282181|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
17140245|NCT01224106|38282182|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
17140246|NCT01224106|38282183|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
17140247|NCT01224106|38282184|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
17140248|NCT01224106|38282180|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
17140249|NCT01224106|38282181|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
17140250|NCT01224106|38282182|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
17140251|NCT01224106|38282183|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
17140252|NCT01224106|38282184|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
17140253|NCT01224106|38282180|FG000|Open-Label Extension (OLE) Phase|Other|0|||
17140254|NCT01224106|38282181|FG001|Open-Label Extension (OLE) Phase|Other|0|||
17140255|NCT01224106|38282182|FG002|Open-Label Extension (OLE) Phase|Other|0|||
17140256|NCT01224106|38282183|FG003|Open-Label Extension (OLE) Phase|Other|5|||
17140257|NCT01224106|38282184|FG004|Open-Label Extension (OLE) Phase|Other|3|||
17140258|NCT03409107|38282204|FG000|Overall Study|Withdrawal by Subject|4|||
17140259|NCT03409107|38282205|FG001|Overall Study|Withdrawal by Subject|2|||
17140260|NCT03409107|38282204|FG000|Overall Study|Physician Decision|1|||
17140261|NCT03409107|38282205|FG001|Overall Study|Physician Decision|0|||
17140262|NCT03409107|38282204|FG000|Overall Study|Lost to Follow-up|7|||
17140263|NCT03409107|38282205|FG001|Overall Study|Lost to Follow-up|2|||
17140264|NCT03409107|38282204|FG000|Overall Study|Adverse Event|5|||
17140265|NCT03409107|38282205|FG001|Overall Study|Adverse Event|3|||
17140266|NCT03408873|38282219|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
17140267|NCT03408873|38282219|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
17140268|NCT03408873|38282219|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
17140269|NCT03408873|38282219|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
17042727|NCT00657150|38186947|FG001|Overall Study|Adverse Event|10|||
17042728|NCT00657150|38186946|FG000|Overall Study|Non-compliant with protocol|5|||
17042729|NCT00657150|38186947|FG001|Overall Study|Non-compliant with protocol|9|||
17042730|NCT00657150|38186946|FG000|Overall Study|Lost to Follow-up|2|||
17042731|NCT00657150|38186947|FG001|Overall Study|Lost to Follow-up|0|||
17042732|NCT00657150|38186946|FG000|Overall Study|Withdrawal by Subject|51|||
17042733|NCT00657150|38186947|FG001|Overall Study|Withdrawal by Subject|36|||
17042734|NCT00657150|38186946|FG000|Overall Study|Other|38|||
17042735|NCT00657150|38186947|FG001|Overall Study|Other|38|||
17042736|NCT00657150|38186946|FG000|Treatment|Adverse Event|60|||
17042737|NCT00657150|38186947|FG001|Treatment|Adverse Event|53|||
17042738|NCT00657150|38186946|FG000|Treatment|Non-compliant with protocol|10|||
17042739|NCT00657150|38186947|FG001|Treatment|Non-compliant with protocol|9|||
17042740|NCT00657150|38186946|FG000|Treatment|Lost to Follow-up|1|||
17042741|NCT00657150|38186947|FG001|Treatment|Lost to Follow-up|0|||
17042742|NCT00657150|38186946|FG000|Treatment|Withdrawal by Subject|23|||
17042743|NCT00657150|38186947|FG001|Treatment|Withdrawal by Subject|20|||
17042744|NCT00657150|38186946|FG000|Treatment|Other|13|||
17042745|NCT00657150|38186947|FG001|Treatment|Other|15|||
17042746|NCT00670748|38186957|FG000|Overall Study|Death during treatment|1|||
17042747|NCT00670748|38186958|FG001|Overall Study|Death during treatment|1|||
17042748|NCT00670748|38186959|FG002|Overall Study|Death during treatment|1|||
17042749|NCT00670748|38186960|FG003|Overall Study|Death during treatment|0|||
17042750|NCT00670748|38186957|FG000|Overall Study|Not off study|2|||
17042751|NCT00670748|38186958|FG001|Overall Study|Not off study|1|||
17140270|NCT03408873|38282219|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
17140271|NCT03408873|38282219|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
17042752|NCT00670748|38186959|FG002|Overall Study|Not off study|1|||
17042753|NCT00670748|38186960|FG003|Overall Study|Not off study|1|||
17042754|NCT00646776|38186972|FG000|Overall Study|Adverse Event|1|||
17042755|NCT00646776|38186973|FG001|Overall Study|Adverse Event|9|||
17042756|NCT00646776|38186972|FG000|Overall Study|Investigator discretion|0|||
17042757|NCT00646776|38186973|FG001|Overall Study|Investigator discretion|4|||
17042758|NCT00655668|38186982|FG000|Overall Study|Adverse Event|6|||
17042759|NCT00655668|38186982|FG000|Overall Study|Death|5|||
17042760|NCT00655668|38186982|FG000|Overall Study|Disease Progression|27|||
17042761|NCT00655668|38186982|FG000|Overall Study|Study Terminated|9|||
17042762|NCT00655668|38186982|FG000|Overall Study|Other|1|||
17042763|NCT00655668|38186982|FG000|Overall Study|New Lymphoma Treatment Started|4|||
17042764|NCT00655668|38186982|FG000|Overall Study|Withdrawal by Subject|2|||
17042765|NCT00569166|38186989|FG000|Overall Study|Withdrawal by Subject|7|||
17042766|NCT00569166|38186990|FG001|Overall Study|Withdrawal by Subject|5|||
17042767|NCT00569166|38186991|FG002|Overall Study|Withdrawal by Subject|3|||
17042768|NCT00569166|38186989|FG000|Overall Study|Lost to Follow-up|2|||
17042769|NCT00569166|38186990|FG001|Overall Study|Lost to Follow-up|1|||
17042770|NCT00569166|38186991|FG002|Overall Study|Lost to Follow-up|1|||
17042771|NCT00655356|38187001|FG000|Overall Study|Withdrawal by Subject|3|||
17042772|NCT00655356|38187002|FG001|Overall Study|Withdrawal by Subject|4|||
17042773|NCT00655356|38187001|FG000|Overall Study|Sponsor Request|10|||
17042774|NCT00655356|38187002|FG001|Overall Study|Sponsor Request|4|||
17042775|NCT00655356|38187001|FG000|Overall Study|Adverse Event|1|||
17042776|NCT00655356|38187002|FG001|Overall Study|Adverse Event|1|||
17042777|NCT00655356|38187001|FG000|Overall Study|Protocol Violation|2|||
17042778|NCT00655356|38187002|FG001|Overall Study|Protocol Violation|1|||
17042779|NCT00655356|38187001|FG000|Overall Study|Other Reason|1|||
17042780|NCT00655356|38187002|FG001|Overall Study|Other Reason|0|||
17042781|NCT00571064|38187008|FG000|Overall Study|Adverse Event|13|||
17042782|NCT00571064|38187008|FG000|Overall Study|Protocol Violation|4|||
17042783|NCT00571064|38187008|FG000|Overall Study|Withdrawal by Subject|2|||
17042784|NCT00571064|38187008|FG000|Overall Study|Other|2|||
17042785|NCT03895372|38187021|FG000|Investigational Treatment Period|Adverse Event|1|||
17042786|NCT03895372|38187022|FG001|Investigational Treatment Period|Adverse Event|0|||
17042787|NCT03895372|38187023|FG002|Investigational Treatment Period|Adverse Event|0|||
17042788|NCT03895372|38187024|FG003|Investigational Treatment Period|Adverse Event|0|||
17042789|NCT03895372|38187025|FG004|Investigational Treatment Period|Adverse Event|0|||
17042790|NCT03895372|38187026|FG005|Investigational Treatment Period|Adverse Event|0|||
17042791|NCT03895372|38187027|FG006|Investigational Treatment Period|Adverse Event|4|||
17042792|NCT03895372|38187028|FG007|Investigational Treatment Period|Adverse Event|3|||
17042793|NCT03895372|38187021|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
17042794|NCT03895372|38187022|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
17140272|NCT03780959|38282226|FG000|Part 1|Adverse Event|1|||
17042795|NCT03895372|38187023|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
17042796|NCT03895372|38187024|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
17042797|NCT03895372|38187025|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
17042798|NCT03895372|38187026|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
17042799|NCT03895372|38187027|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
17042800|NCT03895372|38187028|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
17042801|NCT03895372|38187021|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
17042802|NCT03895372|38187022|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
17042803|NCT03895372|38187023|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
17042804|NCT03895372|38187024|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
17042805|NCT03895372|38187025|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
17042806|NCT03895372|38187026|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
17042807|NCT03895372|38187027|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
17042808|NCT03895372|38187028|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
17042809|NCT03895372|38187021|FG000|Investigational Treatment Period|Other|0|||
17042810|NCT03895372|38187022|FG001|Investigational Treatment Period|Other|0|||
17042811|NCT03895372|38187023|FG002|Investigational Treatment Period|Other|0|||
17042812|NCT03895372|38187024|FG003|Investigational Treatment Period|Other|0|||
17042813|NCT03895372|38187025|FG004|Investigational Treatment Period|Other|0|||
17042814|NCT03895372|38187026|FG005|Investigational Treatment Period|Other|1|||
17042815|NCT03895372|38187027|FG006|Investigational Treatment Period|Other|0|||
17042816|NCT03895372|38187028|FG007|Investigational Treatment Period|Other|2|||
17042817|NCT03895372|38187021|FG000|Investigational Treatment Period|Protocol Violation|0|||
17042818|NCT03895372|38187022|FG001|Investigational Treatment Period|Protocol Violation|0|||
17042819|NCT03895372|38187023|FG002|Investigational Treatment Period|Protocol Violation|0|||
17042820|NCT03895372|38187024|FG003|Investigational Treatment Period|Protocol Violation|1|||
17042821|NCT03895372|38187025|FG004|Investigational Treatment Period|Protocol Violation|0|||
17042822|NCT03895372|38187026|FG005|Investigational Treatment Period|Protocol Violation|0|||
17042823|NCT03895372|38187027|FG006|Investigational Treatment Period|Protocol Violation|0|||
17042824|NCT03895372|38187028|FG007|Investigational Treatment Period|Protocol Violation|0|||
17042825|NCT03895372|38187021|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
17042826|NCT03895372|38187022|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
17042827|NCT03895372|38187023|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
17042828|NCT03895372|38187024|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
17042829|NCT03895372|38187025|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
17042830|NCT03895372|38187026|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
17042831|NCT03895372|38187027|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
17042832|NCT03895372|38187028|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
17042833|NCT03895372|38187021|FG000|Extension Treatment Period|Adverse Event|0|||
17042834|NCT03895372|38187022|FG001|Extension Treatment Period|Adverse Event|1|||
17042835|NCT03895372|38187023|FG002|Extension Treatment Period|Adverse Event|0|||
17042836|NCT03895372|38187024|FG003|Extension Treatment Period|Adverse Event|1|||
17042837|NCT03895372|38187025|FG004|Extension Treatment Period|Adverse Event|0|||
17042838|NCT03895372|38187026|FG005|Extension Treatment Period|Adverse Event|0|||
17042839|NCT03895372|38187027|FG006|Extension Treatment Period|Adverse Event|3|||
17042840|NCT03895372|38187028|FG007|Extension Treatment Period|Adverse Event|3|||
17042841|NCT03895372|38187021|FG000|Extension Treatment Period|Other|1|||
17042842|NCT03895372|38187022|FG001|Extension Treatment Period|Other|3|||
17042843|NCT03895372|38187023|FG002|Extension Treatment Period|Other|0|||
17042844|NCT03895372|38187024|FG003|Extension Treatment Period|Other|0|||
17042845|NCT03895372|38187025|FG004|Extension Treatment Period|Other|1|||
17042846|NCT03895372|38187026|FG005|Extension Treatment Period|Other|0|||
17042847|NCT03895372|38187027|FG006|Extension Treatment Period|Other|0|||
17042848|NCT03895372|38187028|FG007|Extension Treatment Period|Other|2|||
17042849|NCT03895372|38187021|FG000|Extension Treatment Period|Pregnancy|0|||
17042850|NCT03895372|38187022|FG001|Extension Treatment Period|Pregnancy|0|||
17042851|NCT03895372|38187023|FG002|Extension Treatment Period|Pregnancy|0|||
17042852|NCT03895372|38187024|FG003|Extension Treatment Period|Pregnancy|0|||
17140273|NCT03780959|38282227|FG001|Part 1|Adverse Event|0|||
17140274|NCT03780959|38282228|FG002|Part 1|Adverse Event|0|||
17140275|NCT03780959|38282226|FG000|Part 1|Withdrawal by Subject|1|||
17140276|NCT03780959|38282227|FG001|Part 1|Withdrawal by Subject|0|||
17140277|NCT03780959|38282228|FG002|Part 1|Withdrawal by Subject|0|||
17140278|NCT03780959|38282226|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
17140279|NCT03780959|38282227|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
17140280|NCT03780959|38282228|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
17140281|NCT03780959|38282226|FG000|Part 1|Response Status|2|||
17140282|NCT03780959|38282227|FG001|Part 1|Response Status|0|||
17140283|NCT03780959|38282228|FG002|Part 1|Response Status|0|||
17140284|NCT03780959|38282226|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
17140285|NCT03780959|38282227|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
17140286|NCT03780959|38282228|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
17140287|NCT03780959|38282226|FG000|Part 2|Response Status|0|||
17140288|NCT03780959|38282227|FG001|Part 2|Response Status|18|||
17140289|NCT03780959|38282228|FG002|Part 2|Response Status|6|||
17140290|NCT03408639|38282240|FG000|Overall Study|Death|5|||
17140291|NCT03408639|38282241|FG001|Overall Study|Death|5|||
17140292|NCT03408639|38282240|FG000|Overall Study|Lost to Follow-up|1|||
17140293|NCT03408639|38282241|FG001|Overall Study|Lost to Follow-up|4|||
17140294|NCT03408639|38282240|FG000|Overall Study|Withdrawal by Subject|2|||
17140295|NCT03408639|38282241|FG001|Overall Study|Withdrawal by Subject|7|||
17140296|NCT03408639|38282240|FG000|Overall Study|Physician Decision|3|||
17140297|NCT03408639|38282241|FG001|Overall Study|Physician Decision|6|||
17140298|NCT03810235|38282249|FG000|Overall Study|Withdrawal by Subject|2|||
17140299|NCT03810235|38282250|FG001|Overall Study|Withdrawal by Subject|0|||
17140300|NCT03408483|38282259|FG000|Overall Study|Physician Decision|3|||
17140301|NCT03408483|38282260|FG001|Overall Study|Physician Decision|3|||
17042853|NCT03895372|38187025|FG004|Extension Treatment Period|Pregnancy|1|||
17042854|NCT03895372|38187026|FG005|Extension Treatment Period|Pregnancy|0|||
17042855|NCT03895372|38187027|FG006|Extension Treatment Period|Pregnancy|0|||
17042856|NCT03895372|38187028|FG007|Extension Treatment Period|Pregnancy|0|||
17042857|NCT03895372|38187021|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
17042858|NCT03895372|38187022|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
17042859|NCT03895372|38187023|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
17042860|NCT03895372|38187024|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
17042861|NCT03895372|38187025|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
17042862|NCT03895372|38187026|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
17042863|NCT03895372|38187027|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
17042864|NCT03895372|38187028|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
17042865|NCT00669110|38187053|FG000|Overall Study|Adverse Event|4|||
17042866|NCT00669110|38187054|FG001|Overall Study|Adverse Event|3|||
17042867|NCT00669110|38187053|FG000|Overall Study|Caregiver request|3|||
17042868|NCT00669110|38187054|FG001|Overall Study|Caregiver request|2|||
17042869|NCT00669110|38187053|FG000|Overall Study|Physician Decision|0|||
17042870|NCT00669110|38187054|FG001|Overall Study|Physician Decision|1|||
17042871|NCT00669110|38187053|FG000|Overall Study|Lost to Follow-up|1|||
17042872|NCT00669110|38187054|FG001|Overall Study|Lost to Follow-up|0|||
17042873|NCT00669110|38187053|FG000|Overall Study|Protocol Violation|0|||
17042874|NCT00669110|38187054|FG001|Overall Study|Protocol Violation|5|||
17042875|NCT00669110|38187053|FG000|Overall Study|Withdrawal by Subject|0|||
17042876|NCT00669110|38187054|FG001|Overall Study|Withdrawal by Subject|2|||
17042877|NCT00654732|38187062|FG000|Overall Study|Adverse Event|4|||
17042878|NCT00654732|38187063|FG001|Overall Study|Adverse Event|6|||
17042879|NCT00649428|38187071|FG000|Overall Study|Adverse Event|2|||
17042880|NCT00649428|38187072|FG001|Overall Study|Adverse Event|2|||
17042881|NCT00649428|38187071|FG000|Overall Study|Withdrawal by Subject|6|||
17042882|NCT00649428|38187072|FG001|Overall Study|Withdrawal by Subject|6|||
17042883|NCT00649428|38187071|FG000|Overall Study|Lost to Follow-up|1|||
17042884|NCT00649428|38187072|FG001|Overall Study|Lost to Follow-up|3|||
17042885|NCT00649428|38187071|FG000|Overall Study|Insufficient manufacturing yield|5|||
17042886|NCT00649428|38187072|FG001|Overall Study|Insufficient manufacturing yield|1|||
17042887|NCT00649428|38187071|FG000|Overall Study|Protocol Violation|6|||
17042888|NCT00649428|38187072|FG001|Overall Study|Protocol Violation|2|||
17042889|NCT00649428|38187071|FG000|Overall Study|Physician Decision|0|||
17042890|NCT00649428|38187072|FG001|Overall Study|Physician Decision|1|||
17042891|NCT00669032|38187081|FG000|Overall Study|Lost to Follow-up|6|||
17042892|NCT00669032|38187082|FG001|Overall Study|Lost to Follow-up|5|||
17042893|NCT00669032|38187081|FG000|Overall Study|Lack of Efficacy|8|||
17042894|NCT00669032|38187082|FG001|Overall Study|Lack of Efficacy|19|||
17042895|NCT00669032|38187081|FG000|Overall Study|Withdrawal by Subject|12|||
17042896|NCT00669032|38187082|FG001|Overall Study|Withdrawal by Subject|13|||
17042897|NCT00669032|38187081|FG000|Overall Study|Adverse Event|12|||
17042898|NCT00669032|38187082|FG001|Overall Study|Adverse Event|16|||
17042899|NCT00669032|38187081|FG000|Overall Study|Physician Decision|1|||
17042900|NCT00669032|38187082|FG001|Overall Study|Physician Decision|1|||
17042901|NCT00669032|38187081|FG000|Overall Study|No fulfilment of the selection criteria|5|||
17042902|NCT00669032|38187082|FG001|Overall Study|No fulfilment of the selection criteria|5|||
17042903|NCT00654498|38187090|FG000|Overall Study|Not Treated|1|||
17042904|NCT00654498|38187091|FG001|Overall Study|Not Treated|0|||
17042905|NCT00654498|38187090|FG000|Overall Study|Adverse Event|6|||
17042906|NCT00654498|38187091|FG001|Overall Study|Adverse Event|1|||
17042907|NCT00654498|38187090|FG000|Overall Study|Protocol Violation|1|||
17042908|NCT00654498|38187091|FG001|Overall Study|Protocol Violation|1|||
17042909|NCT00654498|38187090|FG000|Overall Study|Lost to Follow-up|1|||
17042910|NCT00654498|38187091|FG001|Overall Study|Lost to Follow-up|5|||
17042911|NCT00654498|38187090|FG000|Overall Study|Withdrawal by Subject|1|||
17042912|NCT00654498|38187091|FG001|Overall Study|Withdrawal by Subject|0|||
17042913|NCT00654498|38187090|FG000|Overall Study|Other reason not defined above|4|||
17042914|NCT00654498|38187091|FG001|Overall Study|Other reason not defined above|5|||
17042915|NCT00670046|38187099|FG000|Overall Study|Lost to Follow-up|1|||
17042916|NCT00670046|38187100|FG001|Overall Study|Lost to Follow-up|1|||
17042917|NCT00670046|38187099|FG000|Overall Study|Withdrawal by Subject|0|||
17042918|NCT00670046|38187100|FG001|Overall Study|Withdrawal by Subject|1|||
17042919|NCT00321919|38187108|FG000|Overall Study|Adverse Event|17|||
17042920|NCT00321919|38187109|FG001|Overall Study|Adverse Event|10|||
17042921|NCT00321919|38187108|FG000|Overall Study|Death|21|||
17042922|NCT00321919|38187109|FG001|Overall Study|Death|17|||
17042923|NCT00321919|38187108|FG000|Overall Study|Insufficient Therapeutic Response|1|||
17042924|NCT00321919|38187109|FG001|Overall Study|Insufficient Therapeutic Response|0|||
17042925|NCT00321919|38187108|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
17042926|NCT00321919|38187109|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
17042927|NCT00321919|38187108|FG000|Overall Study|Refused Treatment|23|||
17042928|NCT00321919|38187109|FG001|Overall Study|Refused Treatment|14|||
17042929|NCT00321919|38187108|FG000|Overall Study|Other Protocol Violation|2|||
17042930|NCT00321919|38187109|FG001|Overall Study|Other Protocol Violation|3|||
17042931|NCT00321919|38187108|FG000|Overall Study|Failure to Return|3|||
17042932|NCT00321919|38187109|FG001|Overall Study|Failure to Return|1|||
17042933|NCT00321919|38187108|FG000|Overall Study|Other withdrawal reason|7|||
17042934|NCT00321919|38187109|FG001|Overall Study|Other withdrawal reason|6|||
17042935|NCT00560391|38187121|FG000|Overall Study|Still on treatment|0|||
17042936|NCT00560391|38187122|FG001|Overall Study|Still on treatment|0|||
17042937|NCT00560391|38187123|FG002|Overall Study|Still on treatment|0|||
17042938|NCT00560391|38187124|FG003|Overall Study|Still on treatment|1|||
17042939|NCT00560391|38187125|FG004|Overall Study|Still on treatment|2|||
17042940|NCT00537238|38187140|FG000|Overall Study|Death|1|||
17042941|NCT00537238|38187141|FG001|Overall Study|Death|2|||
17042942|NCT00537238|38187140|FG000|Overall Study|Adverse Event|31|||
17042943|NCT00537238|38187141|FG001|Overall Study|Adverse Event|22|||
17042944|NCT00537238|38187140|FG000|Overall Study|Lack of Efficacy|20|||
17042945|NCT00537238|38187141|FG001|Overall Study|Lack of Efficacy|21|||
17042946|NCT00537238|38187140|FG000|Overall Study|Lost to Follow-up|12|||
17042947|NCT00537238|38187141|FG001|Overall Study|Lost to Follow-up|8|||
17042948|NCT00537238|38187140|FG000|Overall Study|Withdrawal by Subject|51|||
17042949|NCT00537238|38187141|FG001|Overall Study|Withdrawal by Subject|47|||
17042950|NCT00537238|38187140|FG000|Overall Study|Protocol Violation|15|||
17042951|NCT00537238|38187141|FG001|Overall Study|Protocol Violation|19|||
17042952|NCT00537238|38187140|FG000|Overall Study|Does not meet entrance criteria|0|||
17042953|NCT00537238|38187141|FG001|Overall Study|Does not meet entrance criteria|2|||
17042954|NCT00537238|38187140|FG000|Overall Study|Other|44|||
17042955|NCT00537238|38187141|FG001|Overall Study|Other|52|||
17042956|NCT03966885|38187149|FG000|Overall Study|Death|1|||
17042957|NCT03966885|38187150|FG001|Overall Study|Death|0|||
17042958|NCT03966885|38187149|FG000|Overall Study|Lost to Follow-up|1|||
17042959|NCT03966885|38187150|FG001|Overall Study|Lost to Follow-up|2|||
17042960|NCT03966885|38187149|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
17042961|NCT03966885|38187150|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
17042962|NCT03966885|38187149|FG000|Overall Study|Moved from study area.|0|||
17042963|NCT03966885|38187150|FG001|Overall Study|Moved from study area.|2|||
17042964|NCT03965403|38187157|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
17042965|NCT00552669|38187163|FG000|Overall Study|Death|3|||
17042966|NCT00552669|38187164|FG001|Overall Study|Death|7|||
17042967|NCT00552513|38187172|FG000|Overall Study|Lost to Follow-up|5|||
17042968|NCT00552513|38187173|FG001|Overall Study|Lost to Follow-up|1|||
17042969|NCT00560313|38187181|FG000|Overall Study|Adverse Events or Death|2|||
17042970|NCT00560313|38187181|FG000|Overall Study|Withdrawal by Subject|2|||
17042971|NCT00560313|38187181|FG000|Overall Study|Lost to Follow-up|1|||
17042972|NCT00560313|38187181|FG000|Overall Study|Protocol Violation|1|||
17042973|NCT00667862|38187200|FG000|Overall Study|Adverse Event|9|||
17042974|NCT00667862|38187200|FG000|Overall Study|Death|1|||
17042975|NCT00667862|38187200|FG000|Overall Study|Disease Progression|22|||
17042976|NCT00667862|38187200|FG000|Overall Study|Withdrawal by Subject|3|||
17042977|NCT00535132|38187206|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
17042978|NCT00535132|38187207|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
17042979|NCT00535132|38187206|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
17042980|NCT00535132|38187207|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
17042981|NCT00570908|38187215|FG000|Overall Study|Adverse Event|5|||
17042982|NCT00570908|38187215|FG000|Overall Study|Withdrawal by Subject|2|||
17042983|NCT00781391|38187222|FG000|Overall Study|never received study drug|24|||
17042984|NCT00781391|38187223|FG001|Overall Study|never received study drug|23|||
17042985|NCT00781391|38187224|FG002|Overall Study|never received study drug|32|||
17042986|NCT00781391|38187222|FG000|Overall Study|Protocol Violation|19|||
17042987|NCT00781391|38187223|FG001|Overall Study|Protocol Violation|17|||
17042988|NCT00781391|38187224|FG002|Overall Study|Protocol Violation|20|||
17042989|NCT00781391|38187222|FG000|Overall Study|Death|789|||
17042990|NCT00781391|38187223|FG001|Overall Study|Death|730|||
17042991|NCT00781391|38187224|FG002|Overall Study|Death|706|||
17042992|NCT00781391|38187222|FG000|Overall Study|Withdrawal by Subject|47|||
17042993|NCT00781391|38187223|FG001|Overall Study|Withdrawal by Subject|37|||
17042994|NCT00781391|38187224|FG002|Overall Study|Withdrawal by Subject|25|||
17042995|NCT00781391|38187222|FG000|Overall Study|Lost to Follow-up|0|||
17042996|NCT00781391|38187223|FG001|Overall Study|Lost to Follow-up|0|||
17042997|NCT00781391|38187224|FG002|Overall Study|Lost to Follow-up|1|||
17140302|NCT03408483|38282259|FG000|Overall Study|Lost to Follow-up|3|||
17042998|NCT00534976|38187234|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
17042999|NCT00534976|38187235|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
17043000|NCT00534976|38187234|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
17043001|NCT00534976|38187235|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
17043002|NCT00534976|38187234|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
17043003|NCT00534976|38187235|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
17043004|NCT00321763|38187245|FG000|Overall Study|Adverse Event|1|||
17043005|NCT00321763|38187246|FG001|Overall Study|Adverse Event|1|||
17043006|NCT00321763|38187247|FG002|Overall Study|Adverse Event|0|||
17043007|NCT00321763|38187248|FG003|Overall Study|Adverse Event|1|||
17043008|NCT00321763|38187245|FG000|Overall Study|Withdrawal by Subject|2|||
17043009|NCT00321763|38187246|FG001|Overall Study|Withdrawal by Subject|0|||
17043010|NCT00321763|38187247|FG002|Overall Study|Withdrawal by Subject|1|||
17043011|NCT00321763|38187248|FG003|Overall Study|Withdrawal by Subject|0|||
17043012|NCT00321763|38187245|FG000|Overall Study|Lost to Follow-up|3|||
17043013|NCT00321763|38187246|FG001|Overall Study|Lost to Follow-up|1|||
17043014|NCT00321763|38187247|FG002|Overall Study|Lost to Follow-up|5|||
17043015|NCT00321763|38187248|FG003|Overall Study|Lost to Follow-up|4|||
17043016|NCT00308113|38187264|FG000|Overall Study|Protocol closure|0|||
17043017|NCT00308113|38187265|FG001|Overall Study|Protocol closure|0|||
17043018|NCT00308113|38187266|FG002|Overall Study|Protocol closure|0|||
17043019|NCT00308113|38187267|FG003|Overall Study|Protocol closure|1|||
17043020|NCT00307801|38187283|FG000|Overall Study|Adverse Event|12|||
17043021|NCT00307801|38187284|FG001|Overall Study|Adverse Event|4|||
17043022|NCT00307801|38187283|FG000|Overall Study|Withdrawal by Subject|9|||
17043023|NCT00307801|38187284|FG001|Overall Study|Withdrawal by Subject|4|||
17043024|NCT00307801|38187283|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
17043025|NCT00307801|38187284|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
17043026|NCT00307801|38187283|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
17043027|NCT00307801|38187284|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
17043028|NCT00307801|38187283|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
17043029|NCT00307801|38187284|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
17043030|NCT00307801|38187283|FG000|Overall Study|Wrong Randomization|1|||
17043031|NCT00307801|38187284|FG001|Overall Study|Wrong Randomization|0|||
17043032|NCT00307801|38187283|FG000|Overall Study|Lack of Efficacy|0|||
17043033|NCT00307801|38187284|FG001|Overall Study|Lack of Efficacy|2|||
17043034|NCT00307801|38187283|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
17043035|NCT00307801|38187284|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
17043036|NCT00307801|38187283|FG000|Overall Study|Frustration with e-diary|1|||
17043037|NCT00307801|38187284|FG001|Overall Study|Frustration with e-diary|0|||
17043038|NCT00307801|38187283|FG000|Overall Study|Protocol Violation|3|||
17043039|NCT00307801|38187284|FG001|Overall Study|Protocol Violation|2|||
17043040|NCT00307801|38187283|FG000|Overall Study|No reason specified|2|||
17043041|NCT00307801|38187284|FG001|Overall Study|No reason specified|0|||
17043042|NCT00307801|38187283|FG000|Overall Study|Pregnancy|0|||
17043043|NCT00307801|38187284|FG001|Overall Study|Pregnancy|1|||
17043044|NCT00671060|38187293|FG000|Overall Study|Protocol Violation|1|||
17043045|NCT00671060|38187294|FG001|Overall Study|Protocol Violation|0|||
17043046|NCT00671060|38187293|FG000|Overall Study|Physician Decision|0|||
17043047|NCT00671060|38187294|FG001|Overall Study|Physician Decision|1|||
17043048|NCT00654420|38187304|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
17043049|NCT00654420|38187305|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
17043050|NCT00654420|38187306|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
17140303|NCT03408483|38282260|FG001|Overall Study|Lost to Follow-up|0|||
17140304|NCT03777917|38282268|FG000|Overall Study|Withdrawal by Subject|1|||
17043051|NCT00654420|38187307|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
17043052|NCT00654420|38187304|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
17043053|NCT00654420|38187305|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
17043054|NCT00654420|38187306|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
17043055|NCT00654420|38187307|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
17043056|NCT00654420|38187304|FG000|Phase II|Adverse Event|0|||
17043057|NCT00654420|38187305|FG001|Phase II|Adverse Event|0|||
17043058|NCT00654420|38187306|FG002|Phase II|Adverse Event|3|||
17043059|NCT00654420|38187307|FG003|Phase II|Adverse Event|3|||
17043060|NCT00654420|38187304|FG000|Phase II|Lost to Follow-up|0|||
17043061|NCT00654420|38187305|FG001|Phase II|Lost to Follow-up|0|||
17043062|NCT00654420|38187306|FG002|Phase II|Lost to Follow-up|0|||
17043063|NCT00654420|38187307|FG003|Phase II|Lost to Follow-up|1|||
17043064|NCT00654420|38187304|FG000|Phase II|Physician Decision|0|||
17043065|NCT00654420|38187305|FG001|Phase II|Physician Decision|0|||
17043066|NCT00654420|38187306|FG002|Phase II|Physician Decision|0|||
17043067|NCT00654420|38187307|FG003|Phase II|Physician Decision|4|||
17043068|NCT00654420|38187304|FG000|Phase II|Progressive Disease|0|||
17043069|NCT00654420|38187305|FG001|Phase II|Progressive Disease|0|||
17043070|NCT00654420|38187306|FG002|Phase II|Progressive Disease|29|||
17043071|NCT00654420|38187307|FG003|Phase II|Progressive Disease|29|||
17043072|NCT00654420|38187304|FG000|Phase II|Withdrawal by Subject|0|||
17043073|NCT00654420|38187305|FG001|Phase II|Withdrawal by Subject|0|||
17043074|NCT00654420|38187306|FG002|Phase II|Withdrawal by Subject|4|||
17043075|NCT00654420|38187307|FG003|Phase II|Withdrawal by Subject|1|||
17043076|NCT00654420|38187304|FG000|Phase II|Missing Disposition Record|0|||
17043077|NCT00654420|38187305|FG001|Phase II|Missing Disposition Record|0|||
17043078|NCT00654420|38187306|FG002|Phase II|Missing Disposition Record|1|||
17043079|NCT00654420|38187307|FG003|Phase II|Missing Disposition Record|0|||
17043080|NCT00307489|38187319|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
17043081|NCT00307489|38187320|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
17043082|NCT00307489|38187319|FG000|Baseline Through Week 48|Physician Decision|1|||
17043083|NCT00307489|38187320|FG001|Baseline Through Week 48|Physician Decision|0|||
17043084|NCT00307489|38187319|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
17043085|NCT00307489|38187320|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
17043086|NCT00307489|38187319|FG000|Week 48 Through Week 168|Adverse Event|1|||
17043087|NCT00307489|38187320|FG001|Week 48 Through Week 168|Adverse Event|0|||
17043088|NCT00307489|38187319|FG000|Week 48 Through Week 168|Physician Decision|1|||
17043089|NCT00307489|38187320|FG001|Week 48 Through Week 168|Physician Decision|0|||
17043090|NCT00307489|38187319|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
17043091|NCT00307489|38187320|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
17043092|NCT00307489|38187319|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
17043093|NCT00307489|38187320|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
17043094|NCT00307489|38187319|FG000|Week 48 Through Week 168|Death|0|||
17043095|NCT00307489|38187320|FG001|Week 48 Through Week 168|Death|1|||
17043096|NCT00307489|38187319|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
17043097|NCT00307489|38187320|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
17043098|NCT00307489|38187319|FG000|Week 48 Through Week 168|Seroconversion|1|||
17043099|NCT00307489|38187320|FG001|Week 48 Through Week 168|Seroconversion|0|||
17043100|NCT00667628|38187328|FG000|Overall Study|Lost to Follow-up|1|||
17043101|NCT00667628|38187329|FG001|Overall Study|Lost to Follow-up|0|||
17043102|NCT00667628|38187328|FG000|Overall Study|Death|6|||
17043103|NCT00667628|38187329|FG001|Overall Study|Death|6|||
17043104|NCT00667628|38187328|FG000|Overall Study|Investigator Considers in Best Interest|1|||
17043105|NCT00667628|38187329|FG001|Overall Study|Investigator Considers in Best Interest|0|||
17043106|NCT00667628|38187328|FG000|Overall Study|Sponsor Terminated Study|17|||
17043107|NCT00667628|38187329|FG001|Overall Study|Sponsor Terminated Study|21|||
17043108|NCT00645840|38187335|FG000|Overall Study|Protocol Violation|3|||
17043109|NCT00307333|38187341|FG000|Overall Study|Lost to Follow-up|11|||
17043110|NCT00307333|38187342|FG001|Overall Study|Lost to Follow-up|3|||
17043111|NCT00762359|38187350|FG000|Overall Study|Adverse Event|20|||
17043112|NCT00762359|38187351|FG001|Overall Study|Adverse Event|23|||
17043113|NCT00762359|38187350|FG000|Overall Study|Protocol Violation|21|||
17043114|NCT00762359|38187351|FG001|Overall Study|Protocol Violation|13|||
17043115|NCT00762359|38187350|FG000|Overall Study|Withdrawal by Subject|13|||
17043116|NCT00762359|38187351|FG001|Overall Study|Withdrawal by Subject|10|||
17043117|NCT00762359|38187350|FG000|Overall Study|Lack of Efficacy|0|||
17043118|NCT00762359|38187351|FG001|Overall Study|Lack of Efficacy|4|||
17043119|NCT00762359|38187350|FG000|Overall Study|Institution closed|2|||
17043120|NCT00762359|38187351|FG001|Overall Study|Institution closed|3|||
17043121|NCT00762359|38187350|FG000|Overall Study|Physician Decision|2|||
17043122|NCT00762359|38187351|FG001|Overall Study|Physician Decision|3|||
17043123|NCT00762359|38187350|FG000|Overall Study|Removal|0|||
17043124|NCT00762359|38187351|FG001|Overall Study|Removal|1|||
17043125|NCT00762359|38187350|FG000|Overall Study|Withdrew consent|1|||
17043126|NCT00762359|38187351|FG001|Overall Study|Withdrew consent|0|||
17043127|NCT00654186|38187357|FG000|Overall Study|Withdrawal by Subject|5|||
17043128|NCT00761969|38187363|FG000|Overall Study|Death|112|||
17043129|NCT00761969|38187364|FG001|Overall Study|Death|47|||
17043130|NCT00761969|38187363|FG000|Overall Study|Lost to Follow-up|88|||
17043131|NCT00761969|38187364|FG001|Overall Study|Lost to Follow-up|93|||
17043132|NCT00761891|38187375|FG000|Overall Study|Withdrawal by Subject|10|||
17043133|NCT00321685|38187380|FG000|Overall Study|Adverse Event|18|||
17043134|NCT00321685|38187380|FG000|Overall Study|Death|2|||
17043135|NCT00321685|38187380|FG000|Overall Study|Withdrawal by Subject|8|||
17043136|NCT00321685|38187380|FG000|Overall Study|Alternative therapy|1|||
17043137|NCT00321685|38187380|FG000|Overall Study|Complicating disese|1|||
17043138|NCT00321685|38187380|FG000|Overall Study|Other|5|||
17043139|NCT00321685|38187380|FG000|Overall Study|Not start protocol therapy|2|||
17043140|NCT00321685|38187380|FG000|Overall Study|Ineligible|2|||
17043141|NCT03902392|38187386|FG000|Overall Study|Lost to Follow-up|7|||
17043142|NCT03902392|38187387|FG001|Overall Study|Lost to Follow-up|7|||
17043143|NCT00306787|38187395|FG000|Overall Study|Discontinued without taking study drug|208|||
17043144|NCT00306787|38187396|FG001|Overall Study|Discontinued without taking study drug|215|||
17043145|NCT00306787|38187395|FG000|Overall Study|Adverse Event|1|||
17043146|NCT00306787|38187396|FG001|Overall Study|Adverse Event|1|||
17043147|NCT00306787|38187395|FG000|Overall Study|Lack of Efficacy|1|||
17043148|NCT00306787|38187396|FG001|Overall Study|Lack of Efficacy|0|||
17043149|NCT00306787|38187395|FG000|Overall Study|Protocol Violation|8|||
17043150|NCT00306787|38187396|FG001|Overall Study|Protocol Violation|10|||
17043151|NCT00306787|38187395|FG000|Overall Study|Withdrawal by Subject|2|||
17043152|NCT00306787|38187396|FG001|Overall Study|Withdrawal by Subject|9|||
17043153|NCT00306787|38187395|FG000|Overall Study|Lost to Follow-up|9|||
17043154|NCT00306787|38187396|FG001|Overall Study|Lost to Follow-up|6|||
17043155|NCT00306787|38187395|FG000|Overall Study|Administrative problems|4|||
17043156|NCT00306787|38187396|FG001|Overall Study|Administrative problems|0|||
17043157|NCT00306787|38187395|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17043158|NCT00306787|38187396|FG001|Overall Study|Abnormal laboratory value(s)|0|||
17043159|NCT00769067|38187404|FG000|Overall Study|Death|89|||
17043160|NCT00769067|38187405|FG001|Overall Study|Death|86|||
17043161|NCT00769067|38187404|FG000|Overall Study|Lost to Follow-up|3|||
17043162|NCT00769067|38187405|FG001|Overall Study|Lost to Follow-up|1|||
17043163|NCT00769067|38187404|FG000|Overall Study|Study terminated by sponsor|1|||
17043164|NCT00769067|38187405|FG001|Overall Study|Study terminated by sponsor|3|||
17043165|NCT00769067|38187404|FG000|Overall Study|Other|1|||
17043166|NCT00769067|38187405|FG001|Overall Study|Other|3|||
17043167|NCT00769067|38187404|FG000|Overall Study|Withdrawal by Subject|0|||
17043168|NCT00769067|38187405|FG001|Overall Study|Withdrawal by Subject|1|||
17043169|NCT00321373|38187415|FG000|Overall Study|Adverse Event|0|||
17043170|NCT00321373|38187416|FG001|Overall Study|Adverse Event|0|||
17043171|NCT00321373|38187417|FG002|Overall Study|Adverse Event|1|||
17043172|NCT00321373|38187415|FG000|Overall Study|Lost to Follow-up|1|||
17043173|NCT00321373|38187416|FG001|Overall Study|Lost to Follow-up|0|||
17043174|NCT00321373|38187417|FG002|Overall Study|Lost to Follow-up|1|||
17043175|NCT00321373|38187415|FG000|Overall Study|Withdrawal by Subject|1|||
17043176|NCT00321373|38187416|FG001|Overall Study|Withdrawal by Subject|0|||
17043177|NCT00321373|38187417|FG002|Overall Study|Withdrawal by Subject|0|||
17043178|NCT00321373|38187415|FG000|Overall Study|Other|0|||
17043179|NCT00321373|38187416|FG001|Overall Study|Other|0|||
17043180|NCT00321373|38187417|FG002|Overall Study|Other|1|||
17043181|NCT00667394|38187427|FG000|Overall Study|Adverse Event|3|||
17043182|NCT00667394|38187428|FG001|Overall Study|Adverse Event|0|||
17043183|NCT00667394|38187427|FG000|Overall Study|Progressive disease|1|||
17043184|NCT00667394|38187428|FG001|Overall Study|Progressive disease|0|||
17043185|NCT00761735|38187434|FG000|Overall Study|Lost to Follow-up|6|||
17043186|NCT00761735|38187434|FG000|Overall Study|Withdrawal by Subject|6|||
17043187|NCT00761735|38187434|FG000|Overall Study|Non-compliance with protocol|1|||
17043188|NCT00761735|38187434|FG000|Overall Study|Administrative|1|||
17043189|NCT00569946|38187442|FG000|Overall Study|Adverse Event|16|||
17043190|NCT00569946|38187442|FG000|Overall Study|Objective Progression or Relapse|42|||
17043191|NCT00569946|38187442|FG000|Overall Study|Global Deterioration of Health Status|1|||
17043192|NCT00645528|38187446|FG000|Overall Study|Did not show up for Visit 2|7|||
17043193|NCT00295633|38187453|FG000|Overall Study|Lack of Efficacy|19|||
17043194|NCT00295633|38187454|FG001|Overall Study|Lack of Efficacy|7|||
17043195|NCT00295633|38187455|FG002|Overall Study|Lack of Efficacy|16|||
17043196|NCT00295633|38187453|FG000|Overall Study|Withdrawal of consent by subject|16|||
17043197|NCT00295633|38187454|FG001|Overall Study|Withdrawal of consent by subject|16|||
17043198|NCT00295633|38187455|FG002|Overall Study|Withdrawal of consent by subject|26|||
17043199|NCT00295633|38187453|FG000|Overall Study|Adverse Event|9|||
17043200|NCT00295633|38187454|FG001|Overall Study|Adverse Event|17|||
17043201|NCT00295633|38187455|FG002|Overall Study|Adverse Event|9|||
17043202|NCT00295633|38187453|FG000|Overall Study|Lost to Follow-up|6|||
17043203|NCT00295633|38187454|FG001|Overall Study|Lost to Follow-up|11|||
17043204|NCT00295633|38187455|FG002|Overall Study|Lost to Follow-up|7|||
17043205|NCT00295633|38187453|FG000|Overall Study|Physician Decision|9|||
17043206|NCT00295633|38187454|FG001|Overall Study|Physician Decision|10|||
17140305|NCT03777917|38282269|FG001|Overall Study|Withdrawal by Subject|0|||
17043207|NCT00295633|38187455|FG002|Overall Study|Physician Decision|8|||
17043208|NCT00295633|38187453|FG000|Overall Study|Poor/Noncompliance|2|||
17043209|NCT00295633|38187454|FG001|Overall Study|Poor/Noncompliance|2|||
17043210|NCT00295633|38187455|FG002|Overall Study|Poor/Noncompliance|6|||
17043211|NCT00295633|38187453|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
17043212|NCT00295633|38187454|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
17043213|NCT00295633|38187455|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
17043214|NCT00295633|38187453|FG000|Overall Study|Death|1|||
17043215|NCT00295633|38187454|FG001|Overall Study|Death|1|||
17043216|NCT00295633|38187455|FG002|Overall Study|Death|0|||
17043217|NCT00295633|38187453|FG000|Overall Study|Administrative reason by sponsor|0|||
17043218|NCT00295633|38187454|FG001|Overall Study|Administrative reason by sponsor|0|||
17043219|NCT00295633|38187455|FG002|Overall Study|Administrative reason by sponsor|1|||
17043220|NCT00570674|38187463|FG000|Overall Study|Withdrawal by Subject|0|||
17043221|NCT00570674|38187464|FG001|Overall Study|Withdrawal by Subject|0|||
17043222|NCT00570674|38187465|FG002|Overall Study|Withdrawal by Subject|1|||
17043223|NCT00570674|38187466|FG003|Overall Study|Withdrawal by Subject|0|||
17043224|NCT00570674|38187467|FG004|Overall Study|Withdrawal by Subject|0|||
17043225|NCT00570674|38187468|FG005|Overall Study|Withdrawal by Subject|0|||
17043226|NCT00570674|38187469|FG006|Overall Study|Withdrawal by Subject|0|||
17043227|NCT00768989|38187482|FG000|Prior to Week 24|Withdrawal by Subject|1|||
17043228|NCT00768989|38187483|FG001|Prior to Week 24|Withdrawal by Subject|0|||
17043229|NCT00768989|38187482|FG000|Prior to Week 24|Adverse Event|3|||
17043230|NCT00768989|38187483|FG001|Prior to Week 24|Adverse Event|0|||
17043231|NCT00768989|38187482|FG000|Prior to Week 24|Lost to Follow-up|0|||
17043232|NCT00768989|38187483|FG001|Prior to Week 24|Lost to Follow-up|1|||
17043233|NCT00768989|38187482|FG000|Prior to Week 24|Protocol Violation|0|||
17043234|NCT00768989|38187483|FG001|Prior to Week 24|Protocol Violation|2|||
17043235|NCT00768989|38187482|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
17043236|NCT00768989|38187483|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
17043237|NCT00768989|38187482|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
17043238|NCT00768989|38187483|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
17043239|NCT00768989|38187482|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
17043240|NCT00768989|38187483|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
17043241|NCT00768989|38187482|FG000|On or After Week 36|Lack of Efficacy|1|||
17043242|NCT00768989|38187483|FG001|On or After Week 36|Lack of Efficacy|0|||
17043243|NCT00768989|38187482|FG000|On or After Week 36|Adverse Event|0|||
17043244|NCT00768989|38187483|FG001|On or After Week 36|Adverse Event|1|||
17043245|NCT00768989|38187482|FG000|On or After Week 36|Lost to Follow-up|1|||
17043246|NCT00768989|38187483|FG001|On or After Week 36|Lost to Follow-up|0|||
17043247|NCT00768989|38187482|FG000|On or After Week 36|Poor Compliance|1|||
17043248|NCT00768989|38187483|FG001|On or After Week 36|Poor Compliance|0|||
17043249|NCT00768989|38187482|FG000|On or After Week 36|Protocol Violation|1|||
17043250|NCT00768989|38187483|FG001|On or After Week 36|Protocol Violation|0|||
17043251|NCT00768989|38187482|FG000|On or After Week 36|Did not attend termination visit|2|||
17043252|NCT00768989|38187483|FG001|On or After Week 36|Did not attend termination visit|0|||
17043253|NCT00768989|38187482|FG000|On or After Week 36|Sponsor Termination|45|||
17043254|NCT00768989|38187483|FG001|On or After Week 36|Sponsor Termination|26|||
17043255|NCT00305773|38187493|FG000|Overall Study|Death|3|||
17043256|NCT00305773|38187494|FG001|Overall Study|Death|2|||
17043257|NCT00305773|38187493|FG000|Overall Study|Adverse Event|1|||
17043258|NCT00305773|38187494|FG001|Overall Study|Adverse Event|2|||
17043259|NCT00305773|38187493|FG000|Overall Study|Alternative Treatment|4|||
17043260|NCT00305773|38187494|FG001|Overall Study|Alternative Treatment|4|||
17043261|NCT00305773|38187493|FG000|Overall Study|Physician Decision|1|||
17043262|NCT00305773|38187494|FG001|Overall Study|Physician Decision|1|||
17043263|NCT00305773|38187493|FG000|Overall Study|Withdrawal by Subject|1|||
17043264|NCT00305773|38187494|FG001|Overall Study|Withdrawal by Subject|4|||
17043265|NCT00305773|38187493|FG000|Overall Study|Disease Progression|1|||
17043266|NCT00305773|38187494|FG001|Overall Study|Disease Progression|3|||
17043267|NCT00305773|38187493|FG000|Overall Study|All other reasons|3|||
17043268|NCT00305773|38187494|FG001|Overall Study|All other reasons|2|||
17043269|NCT00305695|38187502|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
17043270|NCT00305695|38187503|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
17043271|NCT00305695|38187502|FG000|Overall Study|Did not have baseline scan|1|||
17043272|NCT00305695|38187503|FG001|Overall Study|Did not have baseline scan|1|||
17043273|NCT00647556|38187511|FG000|Overall Study|Adverse Event|0|||
17043274|NCT00647556|38187512|FG001|Overall Study|Adverse Event|1|||
17043275|NCT00647556|38187511|FG000|Overall Study|Lost to Follow-up|1|||
17043276|NCT00647556|38187512|FG001|Overall Study|Lost to Follow-up|0|||
17043277|NCT00647556|38187511|FG000|Overall Study|Protocol Violation|0|||
17043278|NCT00647556|38187512|FG001|Overall Study|Protocol Violation|1|||
17043279|NCT00647556|38187511|FG000|Overall Study|Withdrawal by Subject|1|||
17043280|NCT00647556|38187512|FG001|Overall Study|Withdrawal by Subject|0|||
17043281|NCT00647556|38187511|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
17043282|NCT00647556|38187512|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
17043283|NCT00320593|38187520|FG000|Overall Study|Lost to Follow-up|3|||
17043284|NCT00320593|38187521|FG001|Overall Study|Lost to Follow-up|0|||
17043285|NCT00320593|38187520|FG000|Overall Study|Moved to another state|1|||
17043286|NCT00320593|38187521|FG001|Overall Study|Moved to another state|0|||
17043287|NCT00320593|38187520|FG000|Overall Study|Withdrawal by Subject|2|||
17043288|NCT00320593|38187521|FG001|Overall Study|Withdrawal by Subject|1|||
17043289|NCT00320593|38187520|FG000|Overall Study|Withdrawal by clinical center|1|||
17043290|NCT00320593|38187521|FG001|Overall Study|Withdrawal by clinical center|0|||
17043291|NCT00320515|38187527|FG000|Overall Study|Death|33|||
17043292|NCT00320515|38187527|FG000|Overall Study|Lost to Follow-up|6|||
17043293|NCT00320515|38187527|FG000|Overall Study|Physician Decision|2|||
17043294|NCT00320515|38187527|FG000|Overall Study|Withdrawal by Subject|8|||
17043295|NCT00662012|38187531|FG000|Overall Study|Lost to Follow-up|85|||
17043296|NCT00662012|38187531|FG000|Overall Study|Death|1|||
17043297|NCT00662012|38187531|FG000|Overall Study|Withdrawal by Subject|1|||
17043298|NCT00305227|38187537|FG000|Overall Study|Lost to Follow-up|7|||
17043299|NCT00305227|38187538|FG001|Overall Study|Lost to Follow-up|6|||
17043300|NCT00661778|38187544|FG000|Overall Study|Disease Progression|23|||
17043301|NCT00661778|38187544|FG000|Overall Study|Adverse Event|18|||
17043302|NCT00661778|38187544|FG000|Overall Study|Reason not Specified|6|||
17043303|NCT00661778|38187544|FG000|Overall Study|Protocol Violation|2|||
17043304|NCT00661778|38187544|FG000|Overall Study|Withdrawal of Consent|1|||
17043305|NCT00319735|38187548|FG000|Overall Study|Death|2|||
17043306|NCT00653328|38187553|FG000|Overall Study|Withdrawal by Subject|1|||
17043307|NCT00653328|38187553|FG000|Overall Study|Adverse Event|2|||
17043308|NCT00653328|38187553|FG000|Overall Study|Disease progression|10|||
17043309|NCT00653328|38187553|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
17043310|NCT00642642|38187566|FG000|Treatment & Follow Up|Adverse Event|2|||
17043311|NCT00642642|38187566|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
17043312|NCT00642642|38187566|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
17043313|NCT00534352|38187576|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
17043314|NCT00534352|38187576|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
17043315|NCT00534352|38187576|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
17043316|NCT00534352|38187576|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
17043317|NCT00534352|38187576|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
17043318|NCT00534352|38187576|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
17043319|NCT00642174|38187591|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
17043320|NCT00642174|38187592|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
17043321|NCT00665366|38187600|FG000|Overall Study|Lack of Efficacy|11|||
17043322|NCT00665366|38187601|FG001|Overall Study|Lack of Efficacy|10|||
17043323|NCT00665366|38187600|FG000|Overall Study|Adverse Event|25|||
17043324|NCT00665366|38187601|FG001|Overall Study|Adverse Event|23|||
17043325|NCT00665366|38187600|FG000|Overall Study|Withdrawal by Subject|11|||
17043326|NCT00665366|38187601|FG001|Overall Study|Withdrawal by Subject|14|||
17043327|NCT00665366|38187600|FG000|Overall Study|Lost to Follow-up|3|||
17043328|NCT00665366|38187601|FG001|Overall Study|Lost to Follow-up|5|||
17043329|NCT00665366|38187600|FG000|Overall Study|Poor compliance/noncompliance|3|||
17043330|NCT00665366|38187601|FG001|Overall Study|Poor compliance/noncompliance|5|||
17043331|NCT00665366|38187600|FG000|Overall Study|Pregnancy|1|||
17043332|NCT00665366|38187601|FG001|Overall Study|Pregnancy|0|||
17043333|NCT00665366|38187600|FG000|Overall Study|No longer meets study criteria|0|||
17043334|NCT00665366|38187601|FG001|Overall Study|No longer meets study criteria|1|||
17043335|NCT00665366|38187600|FG000|Overall Study|Other reasons|4|||
17043336|NCT00665366|38187601|FG001|Overall Study|Other reasons|1|||
17043337|NCT00642018|38187631|FG000|Overall Study|Adverse Event|11|||
17043338|NCT00642018|38187632|FG001|Overall Study|Adverse Event|36|||
17043339|NCT00642018|38187631|FG000|Overall Study|Withdrawal by Subject|4|||
17043340|NCT00642018|38187632|FG001|Overall Study|Withdrawal by Subject|10|||
17043341|NCT00642018|38187631|FG000|Overall Study|Progressive Disease|13|||
17043342|NCT00642018|38187632|FG001|Overall Study|Progressive Disease|18|||
17043343|NCT00642018|38187631|FG000|Overall Study|Physician Decision|0|||
17043344|NCT00642018|38187632|FG001|Overall Study|Physician Decision|10|||
17043345|NCT00642018|38187631|FG000|Overall Study|Protocol Violation|0|||
17043346|NCT00642018|38187632|FG001|Overall Study|Protocol Violation|1|||
17043347|NCT00642018|38187631|FG000|Overall Study|Death|0|||
17043348|NCT00642018|38187632|FG001|Overall Study|Death|3|||
17043349|NCT00642018|38187631|FG000|Overall Study|Entry Criteria Not Met|0|||
17043350|NCT00642018|38187632|FG001|Overall Study|Entry Criteria Not Met|1|||
17043351|NCT00532948|38187642|FG000|Overall Study|Protocol Violation|1|||
17043352|NCT00532948|38187643|FG001|Overall Study|Protocol Violation|0|||
17043353|NCT00532948|38187644|FG002|Overall Study|Protocol Violation|0|||
17043354|NCT00532948|38187642|FG000|Overall Study|Death|3|||
17043355|NCT00532948|38187643|FG001|Overall Study|Death|3|||
17043356|NCT00532948|38187644|FG002|Overall Study|Death|4|||
17043357|NCT00532948|38187642|FG000|Overall Study|Violation of selection criteria at entry|0|||
17043358|NCT00532948|38187643|FG001|Overall Study|Violation of selection criteria at entry|1|||
17140306|NCT03777917|38282268|FG000|Overall Study|Physician Decision|1|||
17043359|NCT00532948|38187644|FG002|Overall Study|Violation of selection criteria at entry|0|||
17043360|NCT00532948|38187642|FG000|Overall Study|Failure to return|0|||
17043361|NCT00532948|38187643|FG001|Overall Study|Failure to return|1|||
17043362|NCT00532948|38187644|FG002|Overall Study|Failure to return|0|||
17043363|NCT00641706|38187658|FG000|Overall Study|Adverse Event|2|||
17043364|NCT00641706|38187659|FG001|Overall Study|Adverse Event|1|||
17043365|NCT00641706|38187658|FG000|Overall Study|Withdrawal by Subject|6|||
17043366|NCT00641706|38187659|FG001|Overall Study|Withdrawal by Subject|1|||
17043367|NCT00641706|38187658|FG000|Overall Study|Clinical Decline|1|||
17043368|NCT00641706|38187659|FG001|Overall Study|Clinical Decline|0|||
17043369|NCT00641706|38187658|FG000|Overall Study|Lead Investigator Decision|0|||
17043370|NCT00641706|38187659|FG001|Overall Study|Lead Investigator Decision|1|||
17043371|NCT00644358|38187665|FG000|Overall Study|Adverse Event|124|||
17043372|NCT00644358|38187665|FG000|Overall Study|Lost to Follow-up|105|||
17043373|NCT00644358|38187665|FG000|Overall Study|Consent Withdrawal|64|||
17043374|NCT00644358|38187665|FG000|Overall Study|Lack of Effectiveness|39|||
17043375|NCT00644358|38187665|FG000|Overall Study|Protocol Violation|5|||
17043376|NCT00644358|38187665|FG000|Overall Study|Noncompliance|14|||
17043377|NCT00644358|38187665|FG000|Overall Study|Other Unspecified|11|||
17043378|NCT00640926|38187672|FG000|Overall Study|Adverse Event|2|||
17043379|NCT00640926|38187673|FG001|Overall Study|Adverse Event|3|||
17043380|NCT00640926|38187674|FG002|Overall Study|Adverse Event|2|||
17043381|NCT00640926|38187672|FG000|Overall Study|Lack of Efficacy|0|||
17043382|NCT00640926|38187673|FG001|Overall Study|Lack of Efficacy|2|||
17043383|NCT00640926|38187674|FG002|Overall Study|Lack of Efficacy|1|||
17043384|NCT00640926|38187672|FG000|Overall Study|Protocol Violation|2|||
17043385|NCT00640926|38187673|FG001|Overall Study|Protocol Violation|0|||
17043386|NCT00640926|38187674|FG002|Overall Study|Protocol Violation|2|||
17043387|NCT00640926|38187672|FG000|Overall Study|Lost to Follow-up|3|||
17043388|NCT00640926|38187673|FG001|Overall Study|Lost to Follow-up|1|||
17043389|NCT00640926|38187674|FG002|Overall Study|Lost to Follow-up|2|||
17043390|NCT00640926|38187672|FG000|Overall Study|Withdrawal by Subject|1|||
17043391|NCT00640926|38187673|FG001|Overall Study|Withdrawal by Subject|0|||
17043392|NCT00640926|38187674|FG002|Overall Study|Withdrawal by Subject|1|||
17043393|NCT03892564|38187682|FG000|Overall Study|Withdrawal by Subject|2|||
17140307|NCT03777917|38282269|FG001|Overall Study|Physician Decision|0|||
17140308|NCT03777917|38282268|FG000|Overall Study|Lost to Follow-up|6|||
17140309|NCT03777917|38282269|FG001|Overall Study|Lost to Follow-up|2|||
17140310|NCT03777917|38282268|FG000|Overall Study|Other|1|||
17043394|NCT03891862|38187689|FG000|Open-label Period|Adverse Event|2|||
17043395|NCT03891862|38187690|FG001|Open-label Period|Adverse Event|0|||
17043396|NCT03891862|38187691|FG002|Open-label Period|Adverse Event|0|||
17043397|NCT03891862|38187689|FG000|Open-label Period|Protocol Violation|5|||
17043398|NCT03891862|38187690|FG001|Open-label Period|Protocol Violation|0|||
17043399|NCT03891862|38187691|FG002|Open-label Period|Protocol Violation|0|||
17043400|NCT03891862|38187689|FG000|Open-label Period|Withdrawal by Subject|6|||
17043401|NCT03891862|38187690|FG001|Open-label Period|Withdrawal by Subject|0|||
17043402|NCT03891862|38187691|FG002|Open-label Period|Withdrawal by Subject|0|||
17043403|NCT03891862|38187689|FG000|Open-label Period|Death|1|||
17043404|NCT03891862|38187690|FG001|Open-label Period|Death|0|||
17043405|NCT03891862|38187691|FG002|Open-label Period|Death|0|||
17043406|NCT03891862|38187689|FG000|Open-label Period|Lost to Follow-up|2|||
17043407|NCT03891862|38187690|FG001|Open-label Period|Lost to Follow-up|0|||
17043408|NCT03891862|38187691|FG002|Open-label Period|Lost to Follow-up|0|||
17043409|NCT03891862|38187689|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
17140311|NCT03777917|38282269|FG001|Overall Study|Other|0|||
17140312|NCT03777059|38282280|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
17140313|NCT03777059|38282281|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
17043410|NCT03891862|38187690|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
17043411|NCT03891862|38187691|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
17043412|NCT03891862|38187689|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
17043413|NCT03891862|38187690|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
17043414|NCT03891862|38187691|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
17043415|NCT03891862|38187689|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
17189031|NCT02504320|38341980|FG003|Treatment Period 3|Adverse Event|0|||
17189032|NCT01061671|38341992|FG000|Overall Study|Withdrawal by Subject|16|||
17189033|NCT01061671|38341993|FG001|Overall Study|Withdrawal by Subject|20|||
17189034|NCT01061671|38341992|FG000|Overall Study|Lost to Follow-up|3|||
17189035|NCT01061671|38341993|FG001|Overall Study|Lost to Follow-up|5|||
17189036|NCT01061671|38341992|FG000|Overall Study|Death|28|||
17189037|NCT01061671|38341993|FG001|Overall Study|Death|30|||
17189038|NCT00709995|38342001|FG000|Overall Study|Adverse Event|4|||
17189039|NCT00709995|38342002|FG001|Overall Study|Adverse Event|2|||
17189040|NCT00709995|38342001|FG000|Overall Study|Withdrawal by Subject|1|||
17189041|NCT00709995|38342002|FG001|Overall Study|Withdrawal by Subject|3|||
17189042|NCT02503540|38342011|FG000|Overall Study|Death|2|||
17140314|NCT03777059|38282282|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
17140315|NCT03777059|38282283|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
17140316|NCT03777059|38282280|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
17043416|NCT03891862|38187690|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
17043417|NCT03891862|38187691|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
17043418|NCT03891862|38187689|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
17043419|NCT03891862|38187690|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
17043420|NCT03891862|38187691|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
17043421|NCT00640614|38187700|FG000|Overall Study|Lost to Follow-up|1|||
17043422|NCT00640614|38187701|FG001|Overall Study|Lost to Follow-up|0|||
17043423|NCT00761657|38187739|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
17043424|NCT00761657|38187740|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
17043425|NCT00761657|38187741|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
17043426|NCT00761657|38187742|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
17043427|NCT00761657|38187743|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
17043428|NCT00761657|38187744|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
17043429|NCT00761657|38187745|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
17043430|NCT00761657|38187746|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
17043431|NCT00761657|38187747|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
17043432|NCT00761657|38187739|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
17043433|NCT00761657|38187740|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
17043434|NCT00761657|38187741|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
17043435|NCT00761657|38187742|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
17043436|NCT00761657|38187743|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
17043437|NCT00761657|38187744|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
17043438|NCT00761657|38187745|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
17043439|NCT00761657|38187746|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
17043440|NCT00761657|38187747|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
17043441|NCT00761657|38187739|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
17043442|NCT00761657|38187740|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
17043443|NCT00761657|38187741|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
17043444|NCT00761657|38187742|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
17043445|NCT00761657|38187743|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
17043446|NCT00761657|38187744|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
17043447|NCT00761657|38187745|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
17043448|NCT00761657|38187746|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
17043449|NCT00761657|38187747|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
17043450|NCT00761657|38187739|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
17043451|NCT00761657|38187740|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
17043452|NCT00761657|38187741|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
17043453|NCT00761657|38187742|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
17043454|NCT00761657|38187743|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
17043455|NCT00761657|38187744|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
17043456|NCT00761657|38187745|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
17043457|NCT00761657|38187746|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
17043458|NCT00761657|38187747|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
17043459|NCT00319501|38187779|FG000|Double-blind Period|Withdrawal by Subject|0|||
17043460|NCT00319501|38187780|FG001|Double-blind Period|Withdrawal by Subject|3|||
17043461|NCT00319501|38187779|FG000|Double-blind Period|Sponsor Request|1|||
17043462|NCT00319501|38187780|FG001|Double-blind Period|Sponsor Request|0|||
17043463|NCT00319501|38187779|FG000|Double-blind Period|Did not receive treatment|42|||
17043464|NCT00319501|38187780|FG001|Double-blind Period|Did not receive treatment|29|||
17043465|NCT00319501|38187779|FG000|Open-label Period|Adverse Event|5|||
17043466|NCT00319501|38187780|FG001|Open-label Period|Adverse Event|0|||
17043467|NCT00319501|38187779|FG000|Open-label Period|Protocol Violation|6|||
17043468|NCT00319501|38187780|FG001|Open-label Period|Protocol Violation|0|||
17043469|NCT00319501|38187779|FG000|Open-label Period|Withdrawal by Subject|38|||
17043470|NCT00319501|38187780|FG001|Open-label Period|Withdrawal by Subject|0|||
17043471|NCT00319501|38187779|FG000|Open-label Period|Principal Investigator decision|6|||
17043472|NCT00319501|38187780|FG001|Open-label Period|Principal Investigator decision|0|||
17043473|NCT00319501|38187779|FG000|Open-label Period|Sponsor request|12|||
17043474|NCT00319501|38187780|FG001|Open-label Period|Sponsor request|0|||
17043475|NCT00319501|38187779|FG000|Open-label Period|Lost to Follow-up|5|||
17043476|NCT00319501|38187780|FG001|Open-label Period|Lost to Follow-up|0|||
17043477|NCT00319501|38187779|FG000|Open-label Period|Did not receive treatment|33|||
17043478|NCT00319501|38187780|FG001|Open-label Period|Did not receive treatment|0|||
17043479|NCT00319501|38187779|FG000|Open-label Period|Other|11|||
17043480|NCT00319501|38187780|FG001|Open-label Period|Other|0|||
17043481|NCT00319501|38187779|FG000|Open-label Extension Period|Adverse Event|2|||
17043482|NCT00319501|38187780|FG001|Open-label Extension Period|Adverse Event|0|||
17043483|NCT00319501|38187779|FG000|Open-label Extension Period|Did not receive treatment|18|||
17043484|NCT00319501|38187780|FG001|Open-label Extension Period|Did not receive treatment|0|||
17043485|NCT00319501|38187779|FG000|Open-label Extension Period|Other|1|||
17043486|NCT00319501|38187780|FG001|Open-label Extension Period|Other|0|||
17043487|NCT00319501|38187779|FG000|Open-label Extension Period|Principal investigator decision|2|||
17043488|NCT00319501|38187780|FG001|Open-label Extension Period|Principal investigator decision|0|||
17043489|NCT00319501|38187779|FG000|Open-label Extension Period|Sponsor request|26|||
17043490|NCT00319501|38187780|FG001|Open-label Extension Period|Sponsor request|0|||
17043491|NCT00319501|38187779|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
17043492|NCT00319501|38187780|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
17043493|NCT00761579|38187791|FG000|Overall Study|Adverse Event|10|||
17043494|NCT00761579|38187791|FG000|Overall Study|Death|2|||
17043495|NCT00761579|38187791|FG000|Overall Study|Lack of Efficacy|21|||
17043496|NCT00761579|38187791|FG000|Overall Study|Lost to Follow-up|16|||
17043497|NCT00761579|38187791|FG000|Overall Study|Pregnancy|1|||
17043498|NCT00761579|38187791|FG000|Overall Study|Withdrawal by Subject|34|||
17043499|NCT00761579|38187791|FG000|Overall Study|Lack of compliance|2|||
17043500|NCT00761579|38187791|FG000|Overall Study|Protocol deviation|1|||
17043501|NCT00761579|38187791|FG000|Overall Study|Drug overdose|1|||
17043502|NCT00761579|38187791|FG000|Overall Study|Aggravation of depression|1|||
17043503|NCT00761579|38187791|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
17043504|NCT00761579|38187791|FG000|Overall Study|Lost survey form|1|||
17043505|NCT00761579|38187791|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
17043506|NCT00627042|38187797|FG000|Overall Study|Withdrawal by Subject|2|||
17043507|NCT00319111|38187801|FG000|Overall Study|Adverse Event|20|||
17043508|NCT00319111|38187801|FG000|Overall Study|Withdrawal of consent|11|||
17043509|NCT00319111|38187801|FG000|Overall Study|Death|9|||
17043510|NCT00319111|38187801|FG000|Overall Study|Lack of clinical improvement|4|||
17043511|NCT00319111|38187801|FG000|Overall Study|Administrative|2|||
17043512|NCT00319111|38187801|FG000|Overall Study|Treatment failure|1|||
17043513|NCT00640224|38187809|FG000|Overall Study|Lost to Follow-up|5|||
17043514|NCT00640224|38187810|FG001|Overall Study|Lost to Follow-up|2|||
17043515|NCT00640224|38187811|FG002|Overall Study|Lost to Follow-up|0|||
17043516|NCT00640224|38187812|FG003|Overall Study|Lost to Follow-up|0|||
17043517|NCT00640224|38187809|FG000|Overall Study|Withdrawal by Subject|1|||
17043518|NCT00640224|38187810|FG001|Overall Study|Withdrawal by Subject|0|||
17043519|NCT00640224|38187811|FG002|Overall Study|Withdrawal by Subject|0|||
17043520|NCT00640224|38187812|FG003|Overall Study|Withdrawal by Subject|0|||
17043521|NCT00640224|38187809|FG000|Overall Study|Headaches|0|||
17043522|NCT00640224|38187810|FG001|Overall Study|Headaches|1|||
17043523|NCT00640224|38187811|FG002|Overall Study|Headaches|0|||
17043524|NCT00640224|38187812|FG003|Overall Study|Headaches|0|||
17043525|NCT00318643|38187827|FG000|Overall Study|Adverse Event|0|||
17043526|NCT00318643|38187828|FG001|Overall Study|Adverse Event|0|||
17043527|NCT00318643|38187829|FG002|Overall Study|Adverse Event|0|||
17043528|NCT00318643|38187830|FG003|Overall Study|Adverse Event|0|||
17043529|NCT00318643|38187831|FG004|Overall Study|Adverse Event|1|||
17043530|NCT00318643|38187827|FG000|Overall Study|Participant's Decision|0|||
17043531|NCT00318643|38187828|FG001|Overall Study|Participant's Decision|0|||
17043532|NCT00318643|38187829|FG002|Overall Study|Participant's Decision|0|||
17043533|NCT00318643|38187830|FG003|Overall Study|Participant's Decision|0|||
17043534|NCT00318643|38187831|FG004|Overall Study|Participant's Decision|1|||
17043535|NCT00318643|38187827|FG000|Overall Study|Investigator's Decision|0|||
17043536|NCT00318643|38187828|FG001|Overall Study|Investigator's Decision|0|||
17043537|NCT00318643|38187829|FG002|Overall Study|Investigator's Decision|0|||
17043538|NCT00318643|38187830|FG003|Overall Study|Investigator's Decision|0|||
17043539|NCT00318643|38187831|FG004|Overall Study|Investigator's Decision|1|||
17043540|NCT00318565|38187844|FG000|Overall Study|Excluded per protocol|24|||
17043541|NCT00304915|38187850|FG000|Overall Study|Lost to Follow-up|11|||
17043542|NCT00304915|38187851|FG001|Overall Study|Lost to Follow-up|11|||
17043543|NCT00304915|38187850|FG000|Overall Study|Death|4|||
17043544|NCT00304915|38187851|FG001|Overall Study|Death|5|||
17043545|NCT00304915|38187850|FG000|Overall Study|Withdrawal by Subject|3|||
17043546|NCT00304915|38187851|FG001|Overall Study|Withdrawal by Subject|0|||
17043547|NCT03687970|38187859|FG000|Overall Study|visit scheduling conflicts|2|||
17043548|NCT03687970|38187860|FG001|Overall Study|visit scheduling conflicts|0|||
17043549|NCT00530920|38187871|FG000|Overall Study|Randomized but not treated|0|||
17043550|NCT00530920|38187872|FG001|Overall Study|Randomized but not treated|2|||
17043551|NCT00530920|38187873|FG002|Overall Study|Randomized but not treated|0|||
17043552|NCT00530920|38187871|FG000|Overall Study|Adverse Event|0|||
17043553|NCT00530920|38187872|FG001|Overall Study|Adverse Event|0|||
17043554|NCT00530920|38187873|FG002|Overall Study|Adverse Event|3|||
17043555|NCT00530920|38187871|FG000|Overall Study|Withdrawal by Subject|0|||
17043556|NCT00530920|38187872|FG001|Overall Study|Withdrawal by Subject|0|||
17043557|NCT00530920|38187873|FG002|Overall Study|Withdrawal by Subject|1|||
17043558|NCT03878758|38187882|FG000|Overall Study|Withdrawal by Subject|1|||
17043559|NCT03878758|38187882|FG000|Overall Study|Protocol defined|2|||
17043560|NCT03878758|38187882|FG000|Overall Study|Improper consent documentation|1|||
17043561|NCT03878602|38187897|FG000|Overall Study|cord blood donation|7|||
17140317|NCT03777059|38282281|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
17043562|NCT03878602|38187898|FG001|Overall Study|cord blood donation|1|||
17043563|NCT03878602|38187897|FG000|Overall Study|incomplete data collection|2|||
17043564|NCT03878602|38187898|FG001|Overall Study|incomplete data collection|0|||
17043565|NCT00768755|38187910|FG000|Phase 1|Death|6|||
17043566|NCT00768755|38187911|FG001|Phase 1|Death|0|||
17043567|NCT00768755|38187912|FG002|Phase 1|Death|0|||
17043568|NCT00768755|38187913|FG003|Phase 1|Death|0|||
17043569|NCT00768755|38187910|FG000|Phase 1|Other|4|||
17043570|NCT00768755|38187911|FG001|Phase 1|Other|0|||
17043571|NCT00768755|38187912|FG002|Phase 1|Other|0|||
17043572|NCT00768755|38187913|FG003|Phase 1|Other|0|||
17043573|NCT00768755|38187910|FG000|Phase 2|Death|0|||
17043574|NCT00768755|38187911|FG001|Phase 2|Death|37|||
17043575|NCT00768755|38187912|FG002|Phase 2|Death|48|||
17043576|NCT00768755|38187913|FG003|Phase 2|Death|31|||
17043577|NCT00768755|38187910|FG000|Phase 2|Protocol Violation|0|||
17043578|NCT00768755|38187911|FG001|Phase 2|Protocol Violation|2|||
17043579|NCT00768755|38187912|FG002|Phase 2|Protocol Violation|0|||
17043580|NCT00768755|38187913|FG003|Phase 2|Protocol Violation|1|||
17043581|NCT00768755|38187910|FG000|Phase 2|Lost to Follow-up|0|||
17043582|NCT00768755|38187911|FG001|Phase 2|Lost to Follow-up|1|||
17043583|NCT00768755|38187912|FG002|Phase 2|Lost to Follow-up|1|||
17043584|NCT00768755|38187913|FG003|Phase 2|Lost to Follow-up|4|||
17043585|NCT00768755|38187910|FG000|Phase 2|Withdrawal by Subject|0|||
17043586|NCT00768755|38187911|FG001|Phase 2|Withdrawal by Subject|1|||
17043587|NCT00768755|38187912|FG002|Phase 2|Withdrawal by Subject|0|||
17043588|NCT00768755|38187913|FG003|Phase 2|Withdrawal by Subject|1|||
17043589|NCT00768755|38187910|FG000|Phase 2|Other|0|||
17043590|NCT00768755|38187911|FG001|Phase 2|Other|1|||
17043591|NCT00768755|38187912|FG002|Phase 2|Other|2|||
17043592|NCT00768755|38187913|FG003|Phase 2|Other|4|||
17043593|NCT00768755|38187910|FG000|Phase 2|Study Terminated by Sponsor|0|||
17043594|NCT00768755|38187911|FG001|Phase 2|Study Terminated by Sponsor|13|||
17043595|NCT00768755|38187912|FG002|Phase 2|Study Terminated by Sponsor|7|||
17043596|NCT00768755|38187913|FG003|Phase 2|Study Terminated by Sponsor|14|||
17043597|NCT00768755|38187910|FG000|Phase 2|Randomized but not treated|0|||
17043598|NCT00768755|38187911|FG001|Phase 2|Randomized but not treated|0|||
17043599|NCT00768755|38187912|FG002|Phase 2|Randomized but not treated|0|||
17043600|NCT00768755|38187913|FG003|Phase 2|Randomized but not treated|2|||
17043601|NCT00530842|38187924|FG000|Overall Study|Adverse Event|10|||
17043602|NCT00530842|38187925|FG001|Overall Study|Adverse Event|6|||
17043603|NCT00530842|38187924|FG000|Overall Study|Lack of Efficacy|2|||
17043604|NCT00530842|38187925|FG001|Overall Study|Lack of Efficacy|1|||
17043605|NCT00530842|38187924|FG000|Overall Study|Lost to Follow-up|0|||
17043606|NCT00530842|38187925|FG001|Overall Study|Lost to Follow-up|4|||
17043607|NCT00530842|38187924|FG000|Overall Study|Protocol Violation|3|||
17043608|NCT00530842|38187925|FG001|Overall Study|Protocol Violation|2|||
17043609|NCT00530842|38187924|FG000|Overall Study|Withdrawal by Subject|4|||
17043610|NCT00530842|38187925|FG001|Overall Study|Withdrawal by Subject|5|||
17043611|NCT00530842|38187924|FG000|Overall Study|Individual different reasons|4|||
17043612|NCT00530842|38187925|FG001|Overall Study|Individual different reasons|3|||
17043613|NCT00530842|38187924|FG000|Period 1|Adverse Event|7|||
17043614|NCT00530842|38187925|FG001|Period 1|Adverse Event|3|||
17043615|NCT00530842|38187924|FG000|Period 1|Lack of Efficacy|1|||
17043616|NCT00530842|38187925|FG001|Period 1|Lack of Efficacy|1|||
17043617|NCT00530842|38187924|FG000|Period 1|Protocol Violation|2|||
17043618|NCT00530842|38187925|FG001|Period 1|Protocol Violation|1|||
17043619|NCT00530842|38187924|FG000|Period 1|Withdrawal by Subject|2|||
17043620|NCT00530842|38187925|FG001|Period 1|Withdrawal by Subject|3|||
17043621|NCT00530842|38187924|FG000|Period 1|Individual different reasons|2|||
17043622|NCT00530842|38187925|FG001|Period 1|Individual different reasons|3|||
17043623|NCT00530842|38187924|FG000|Period 2|Adverse Event|3|||
17043624|NCT00530842|38187925|FG001|Period 2|Adverse Event|3|||
17043625|NCT00530842|38187924|FG000|Period 2|Lack of Efficacy|1|||
17043626|NCT00530842|38187925|FG001|Period 2|Lack of Efficacy|0|||
17043627|NCT00530842|38187924|FG000|Period 2|Lost to Follow-up|0|||
17043628|NCT00530842|38187925|FG001|Period 2|Lost to Follow-up|4|||
17043629|NCT00530842|38187924|FG000|Period 2|Protocol Violation|1|||
17043630|NCT00530842|38187925|FG001|Period 2|Protocol Violation|0|||
17043631|NCT00530842|38187924|FG000|Period 2|Withdrawal by Subject|1|||
17043632|NCT00530842|38187925|FG001|Period 2|Withdrawal by Subject|2|||
17043633|NCT00530842|38187924|FG000|Period 2|Individual different reasons|2|||
17043634|NCT00530842|38187925|FG001|Period 2|Individual different reasons|0|||
17043635|NCT03882424|38187936|FG000|Overall Study|Lost to Follow-up|3|||
17043636|NCT03882424|38187937|FG001|Overall Study|Lost to Follow-up|0|||
17043637|NCT03882424|38187938|FG002|Overall Study|Lost to Follow-up|0|||
17043638|NCT03882424|38187936|FG000|Overall Study|schedule conflict|1|||
17043639|NCT03882424|38187937|FG001|Overall Study|schedule conflict|0|||
17043640|NCT03882424|38187938|FG002|Overall Study|schedule conflict|0|||
17043641|NCT03879772|38187951|FG000|Overall Study|Adverse Event|2|||
17043642|NCT03879772|38187952|FG001|Overall Study|Adverse Event|2|||
17043643|NCT03879772|38187953|FG002|Overall Study|Adverse Event|3|||
17043644|NCT03879772|38187954|FG003|Overall Study|Adverse Event|4|||
17043645|NCT03879772|38187955|FG004|Overall Study|Adverse Event|3|||
17043646|NCT03879772|38187951|FG000|Overall Study|Treatment Failure|1|||
17043647|NCT03879772|38187952|FG001|Overall Study|Treatment Failure|0|||
17043648|NCT03879772|38187953|FG002|Overall Study|Treatment Failure|0|||
17043649|NCT03879772|38187954|FG003|Overall Study|Treatment Failure|2|||
17043650|NCT03879772|38187955|FG004|Overall Study|Treatment Failure|1|||
17043651|NCT03879772|38187951|FG000|Overall Study|Lost to Follow-up|0|||
17140318|NCT03777059|38282282|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
17140319|NCT03777059|38282283|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
17140320|NCT03777059|38282280|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
17140321|NCT03777059|38282281|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
17140322|NCT03777059|38282282|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
17140323|NCT03777059|38282283|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
17140324|NCT03777059|38282280|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
17140325|NCT03777059|38282281|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
17140326|NCT03777059|38282282|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
17140327|NCT03777059|38282283|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
17140328|NCT03777059|38282280|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
17140329|NCT03777059|38282281|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
17140330|NCT03777059|38282282|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
17140331|NCT03777059|38282283|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
17140332|NCT03777059|38282280|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
17140333|NCT03777059|38282281|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
17140334|NCT03777059|38282282|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
17140335|NCT03777059|38282283|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
17140336|NCT03777059|38282280|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
17140337|NCT03777059|38282281|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
17043652|NCT03879772|38187952|FG001|Overall Study|Lost to Follow-up|0|||
17043653|NCT03879772|38187953|FG002|Overall Study|Lost to Follow-up|0|||
17140338|NCT03777059|38282282|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
17140339|NCT03777059|38282283|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
17140340|NCT03777059|38282280|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
17140341|NCT03777059|38282281|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
17140342|NCT03777059|38282282|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
17140343|NCT03777059|38282283|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
17140344|NCT03777059|38282280|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
17140345|NCT03777059|38282281|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
17140346|NCT03777059|38282282|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
17140347|NCT03777059|38282283|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
17140348|NCT03777059|38282280|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
17140349|NCT03777059|38282281|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
17140350|NCT03777059|38282282|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
17140351|NCT03777059|38282283|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
17140352|NCT03777059|38282280|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
17140353|NCT03777059|38282281|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
17140354|NCT03777059|38282282|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
17140355|NCT03777059|38282283|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
17043654|NCT03879772|38187954|FG003|Overall Study|Lost to Follow-up|0|||
17043655|NCT03879772|38187955|FG004|Overall Study|Lost to Follow-up|1|||
17043656|NCT03879772|38187951|FG000|Overall Study|Withdrawal by Subject|0|||
17043657|NCT03879772|38187952|FG001|Overall Study|Withdrawal by Subject|1|||
17043658|NCT03879772|38187953|FG002|Overall Study|Withdrawal by Subject|3|||
17043659|NCT03879772|38187954|FG003|Overall Study|Withdrawal by Subject|1|||
17043660|NCT03879772|38187955|FG004|Overall Study|Withdrawal by Subject|1|||
17043661|NCT03879772|38187951|FG000|Overall Study|Protocol Violation|0|||
17043662|NCT03879772|38187952|FG001|Overall Study|Protocol Violation|0|||
17043663|NCT03879772|38187953|FG002|Overall Study|Protocol Violation|3|||
17043664|NCT03879772|38187954|FG003|Overall Study|Protocol Violation|1|||
17043665|NCT03879772|38187955|FG004|Overall Study|Protocol Violation|2|||
17043666|NCT03879772|38187951|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
17043667|NCT03879772|38187952|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
17043668|NCT03879772|38187953|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
17043669|NCT03879772|38187954|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
17043670|NCT03879772|38187955|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
17043671|NCT00642954|38187972|FG000|Overall Study|Progressive Disease|3|||
17043672|NCT00642954|38187973|FG001|Overall Study|Progressive Disease|3|||
17043673|NCT00642954|38187974|FG002|Overall Study|Progressive Disease|3|||
17043674|NCT00642954|38187975|FG003|Overall Study|Progressive Disease|3|||
17043675|NCT00642954|38187976|FG004|Overall Study|Progressive Disease|9|||
17043676|NCT00642954|38187972|FG000|Overall Study|Withdrawal by Subject|0|||
17043677|NCT00642954|38187973|FG001|Overall Study|Withdrawal by Subject|0|||
17043678|NCT00642954|38187974|FG002|Overall Study|Withdrawal by Subject|0|||
17043679|NCT00642954|38187975|FG003|Overall Study|Withdrawal by Subject|0|||
17043680|NCT00642954|38187976|FG004|Overall Study|Withdrawal by Subject|1|||
17043681|NCT00642954|38187972|FG000|Overall Study|Adverse Event|1|||
17043682|NCT00642954|38187973|FG001|Overall Study|Adverse Event|1|||
17043683|NCT00642954|38187974|FG002|Overall Study|Adverse Event|0|||
17043684|NCT00642954|38187975|FG003|Overall Study|Adverse Event|0|||
17043685|NCT00642954|38187976|FG004|Overall Study|Adverse Event|6|||
17043686|NCT00640146|38187990|FG000|Overall Study|Adverse Event|2|||
17043687|NCT00640146|38187991|FG001|Overall Study|Adverse Event|0|||
17043688|NCT00640146|38187990|FG000|Overall Study|Lost to Follow-up|0|||
17043689|NCT00640146|38187991|FG001|Overall Study|Lost to Follow-up|1|||
17043690|NCT00640146|38187990|FG000|Overall Study|Lack of Efficacy|0|||
17043691|NCT00640146|38187991|FG001|Overall Study|Lack of Efficacy|1|||
17043692|NCT00640146|38187990|FG000|Overall Study|Withdrawal by Subject|1|||
17043693|NCT00640146|38187991|FG001|Overall Study|Withdrawal by Subject|1|||
17043694|NCT00640146|38187990|FG000|Overall Study|Randomized but not treated|1|||
17043695|NCT00640146|38187991|FG001|Overall Study|Randomized but not treated|3|||
17140356|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
17140357|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
17140358|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
17140359|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
17140360|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
17140361|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
17140362|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
17140363|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
17140364|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
17140365|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
17140366|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
17140367|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
17140368|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
17140369|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
17140370|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
17140371|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
17140372|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
17140373|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
17140374|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
17140375|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
17140376|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
17140377|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
17140378|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
17140379|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
17140380|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
17140381|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
17140382|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140383|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
17140384|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
17140385|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140386|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140387|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
17140388|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
17140389|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140390|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140391|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140392|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140393|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140394|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
17140395|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140396|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
17140397|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
17140398|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140399|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140400|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140401|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
17140402|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140403|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
17140404|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140405|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140406|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140407|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
17140408|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140409|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140410|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140411|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
17140412|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140413|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140414|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140415|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
17140416|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140417|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140418|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140419|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140420|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
17140421|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140422|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140423|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140424|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
17140425|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140426|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140427|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
17140428|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140429|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140430|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140431|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140432|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140433|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
17140434|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140435|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
17140436|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140437|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140438|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140439|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140440|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140441|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140442|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140443|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140444|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140445|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140446|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
17140447|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
17140448|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140449|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140450|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140451|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140452|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140453|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140454|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140455|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140456|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140457|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140458|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140459|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
17140460|NCT03100058|38282302|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140461|NCT03100058|38282303|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140462|NCT03100058|38282304|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140463|NCT03100058|38282305|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140464|NCT03100058|38282306|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140465|NCT03100058|38282307|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140466|NCT03100058|38282308|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
17140467|NCT03100058|38282309|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140468|NCT03100058|38282310|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140469|NCT03100058|38282311|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140470|NCT03100058|38282312|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140471|NCT03100058|38282313|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140472|NCT03100058|38282314|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
17140473|NCT03100058|38282302|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140474|NCT03100058|38282303|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140475|NCT03100058|38282304|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140476|NCT03100058|38282305|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140477|NCT03100058|38282306|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140478|NCT03100058|38282307|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140479|NCT03100058|38282308|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140480|NCT03100058|38282309|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140481|NCT03100058|38282310|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140482|NCT03100058|38282311|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
17140483|NCT03100058|38282312|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
17140484|NCT03100058|38282313|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
17140485|NCT03100058|38282314|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
17140486|NCT03100058|38282302|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140487|NCT03100058|38282303|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140488|NCT03100058|38282304|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140489|NCT03100058|38282305|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140490|NCT03100058|38282306|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140491|NCT03100058|38282307|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140492|NCT03100058|38282308|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140493|NCT03100058|38282309|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140494|NCT03100058|38282310|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140495|NCT03100058|38282311|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140496|NCT03100058|38282312|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
17140497|NCT03100058|38282313|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
17140498|NCT03100058|38282314|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
17140499|NCT03100058|38282302|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140500|NCT03100058|38282303|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140501|NCT03100058|38282304|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140502|NCT03100058|38282305|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140503|NCT03100058|38282306|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140504|NCT03100058|38282307|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140505|NCT03100058|38282308|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140506|NCT03100058|38282309|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140507|NCT03100058|38282310|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140508|NCT03100058|38282311|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
17140509|NCT03100058|38282312|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
17140510|NCT03100058|38282313|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
17140511|NCT03100058|38282314|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
17140512|NCT03100058|38282302|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140513|NCT03100058|38282303|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140514|NCT03100058|38282304|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140515|NCT03100058|38282305|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140516|NCT03100058|38282306|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140517|NCT03100058|38282307|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140518|NCT03100058|38282308|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140519|NCT03100058|38282309|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140520|NCT03100058|38282310|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140521|NCT03100058|38282311|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140522|NCT03100058|38282312|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
17140523|NCT03100058|38282313|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140524|NCT03100058|38282314|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
17140525|NCT03100058|38282302|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140526|NCT03100058|38282303|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140527|NCT03100058|38282304|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140528|NCT03100058|38282305|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140529|NCT03100058|38282306|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140530|NCT03100058|38282307|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140531|NCT03100058|38282308|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140532|NCT03100058|38282309|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140533|NCT03100058|38282310|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140534|NCT03100058|38282311|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140535|NCT03100058|38282312|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140536|NCT03100058|38282313|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
17140537|NCT03100058|38282314|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
17140538|NCT03100058|38282302|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140539|NCT03100058|38282303|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140540|NCT03100058|38282304|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140541|NCT03100058|38282305|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140542|NCT03100058|38282306|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140543|NCT03100058|38282307|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140544|NCT03100058|38282308|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140545|NCT03100058|38282309|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140546|NCT03100058|38282310|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140547|NCT03100058|38282311|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
17140548|NCT03100058|38282312|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140549|NCT03100058|38282313|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140550|NCT03100058|38282314|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
17140551|NCT02871778|38282360|FG000|Part A: Treatment Period 1|Adverse Event|1|||
17140552|NCT02871778|38282361|FG001|Part A: Treatment Period 1|Adverse Event|1|||
17140553|NCT02871778|38282362|FG002|Part A: Treatment Period 1|Adverse Event|1|||
17140554|NCT02871778|38282363|FG003|Part A: Treatment Period 1|Adverse Event|0|||
17140555|NCT02871778|38282364|FG004|Part A: Treatment Period 1|Adverse Event|0|||
17140556|NCT02871778|38282365|FG005|Part A: Treatment Period 1|Adverse Event|0|||
17140557|NCT02871778|38282366|FG006|Part A: Treatment Period 1|Adverse Event|0|||
17140558|NCT02871778|38282367|FG007|Part A: Treatment Period 1|Adverse Event|0|||
17140559|NCT02871778|38282360|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
17140560|NCT02871778|38282361|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
17140561|NCT02871778|38282362|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
17140562|NCT02871778|38282363|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
17140563|NCT02871778|38282364|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
17140564|NCT02871778|38282365|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
17140565|NCT02871778|38282366|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
17140566|NCT02871778|38282367|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
17140567|NCT02871778|38282360|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
17140568|NCT02871778|38282361|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
17140569|NCT02871778|38282362|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
17140570|NCT02871778|38282363|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
17140571|NCT02871778|38282364|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
17140572|NCT02871778|38282365|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
17140573|NCT02871778|38282366|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
17140574|NCT02871778|38282367|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
17140575|NCT02871778|38282360|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
17140576|NCT02871778|38282361|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
17140577|NCT02871778|38282362|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
17140578|NCT02871778|38282363|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
17140579|NCT02871778|38282364|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
17140580|NCT02871778|38282365|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
17140581|NCT02871778|38282366|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
17140582|NCT02871778|38282367|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
17140583|NCT02871778|38282360|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
17140584|NCT02871778|38282361|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
17140585|NCT02871778|38282362|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
17140586|NCT02871778|38282363|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
17140587|NCT02871778|38282364|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
17140588|NCT02871778|38282365|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
17140589|NCT02871778|38282366|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
17140590|NCT02871778|38282367|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
17140591|NCT02871778|38282360|FG000|Part A: Treatment Period 2|Adverse Event|2|||
17140592|NCT02871778|38282361|FG001|Part A: Treatment Period 2|Adverse Event|2|||
17140593|NCT02871778|38282362|FG002|Part A: Treatment Period 2|Adverse Event|0|||
17140594|NCT02871778|38282363|FG003|Part A: Treatment Period 2|Adverse Event|0|||
17140595|NCT02871778|38282364|FG004|Part A: Treatment Period 2|Adverse Event|0|||
17140596|NCT02871778|38282365|FG005|Part A: Treatment Period 2|Adverse Event|0|||
17140597|NCT02871778|38282366|FG006|Part A: Treatment Period 2|Adverse Event|0|||
17140598|NCT02871778|38282367|FG007|Part A: Treatment Period 2|Adverse Event|0|||
17140599|NCT02871778|38282360|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
17140600|NCT02871778|38282361|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
17140601|NCT02871778|38282362|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
17140602|NCT02871778|38282363|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
16992252|NCT00808132|38136193|FG001|Overall Study|Lost to Follow-up|10|||
17140603|NCT02871778|38282364|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
17140604|NCT02871778|38282365|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
17140605|NCT02871778|38282366|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
17140606|NCT02871778|38282367|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
17140607|NCT02871778|38282360|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
17140608|NCT02871778|38282361|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
17140609|NCT02871778|38282362|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
17140610|NCT02871778|38282363|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
17140611|NCT02871778|38282364|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
17140612|NCT02871778|38282365|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
17140613|NCT02871778|38282366|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
17140614|NCT02871778|38282367|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
17140615|NCT02871778|38282360|FG000|Part B: Treatment Period 3|Adverse Event|0|||
17140616|NCT02871778|38282361|FG001|Part B: Treatment Period 3|Adverse Event|0|||
17140617|NCT02871778|38282362|FG002|Part B: Treatment Period 3|Adverse Event|0|||
17140618|NCT02871778|38282363|FG003|Part B: Treatment Period 3|Adverse Event|0|||
17140619|NCT02871778|38282364|FG004|Part B: Treatment Period 3|Adverse Event|1|||
17140620|NCT02871778|38282365|FG005|Part B: Treatment Period 3|Adverse Event|1|||
17140621|NCT02871778|38282366|FG006|Part B: Treatment Period 3|Adverse Event|1|||
17140622|NCT02871778|38282367|FG007|Part B: Treatment Period 3|Adverse Event|0|||
17140623|NCT01471444|38282400|FG000|Overall Study|Physician Decision|3|||
17140624|NCT01471444|38282401|FG001|Overall Study|Physician Decision|2|||
17140625|NCT01471444|38282400|FG000|Overall Study|Withdrawal by Subject|0|||
17140626|NCT01471444|38282401|FG001|Overall Study|Withdrawal by Subject|1|||
17140627|NCT03443427|38282419|FG000|Overall Study|Adverse Event|2|||
17140628|NCT03443427|38282420|FG001|Overall Study|Adverse Event|3|||
17140629|NCT03443427|38282419|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
17140630|NCT03443427|38282420|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
17140631|NCT03443427|38282419|FG000|Overall Study|Other|4|||
17140632|NCT03443427|38282420|FG001|Overall Study|Other|6|||
17140633|NCT03417219|38282428|FG000|Overall Study|Lost to Follow-up|0|||
17140634|NCT03417219|38282429|FG001|Overall Study|Lost to Follow-up|3|||
17140635|NCT02953821|38282437|FG000|Overall Study|Adverse Event|0|||
17140636|NCT02953821|38282438|FG001|Overall Study|Adverse Event|4|||
17140637|NCT02953821|38282437|FG000|Overall Study|Death|1|||
17140638|NCT02953821|38282438|FG001|Overall Study|Death|0|||
17140639|NCT02953821|38282437|FG000|Overall Study|Progressive Disease|5|||
17140640|NCT02953821|38282438|FG001|Overall Study|Progressive Disease|1|||
17140641|NCT02953821|38282437|FG000|Overall Study|Lost to Follow-up|2|||
17140642|NCT02953821|38282438|FG001|Overall Study|Lost to Follow-up|0|||
17140643|NCT02953821|38282437|FG000|Overall Study|Physician Decision|1|||
17140644|NCT02953821|38282438|FG001|Overall Study|Physician Decision|1|||
17140645|NCT02953821|38282437|FG000|Overall Study|Withdrawal by Subject|3|||
17140646|NCT02953821|38282438|FG001|Overall Study|Withdrawal by Subject|3|||
17140647|NCT02953821|38282437|FG000|Overall Study|Change of address|0|||
17140648|NCT02953821|38282438|FG001|Overall Study|Change of address|1|||
17140649|NCT02953821|38282437|FG000|Overall Study|Lack of Efficacy|1|||
17140650|NCT02953821|38282438|FG001|Overall Study|Lack of Efficacy|0|||
17140651|NCT02953821|38282437|FG000|Overall Study|Out of state for indeterminate time|0|||
17140652|NCT02953821|38282438|FG001|Overall Study|Out of state for indeterminate time|1|||
17140653|NCT02953821|38282437|FG000|Overall Study|No improvement|0|||
17140654|NCT02953821|38282438|FG001|Overall Study|No improvement|1|||
17140655|NCT02953821|38282437|FG000|Overall Study|Refused follow-up visit|2|||
17140656|NCT02953821|38282438|FG001|Overall Study|Refused follow-up visit|1|||
17140657|NCT03783923|38282448|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
17140658|NCT03783923|38282449|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
17140659|NCT03783923|38282448|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
17140660|NCT03783923|38282449|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
17140661|NCT03783923|38282448|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
17140662|NCT03783923|38282449|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
17140663|NCT03783923|38282448|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
17140664|NCT03783923|38282449|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
17140665|NCT03783923|38282448|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
17140666|NCT03783923|38282449|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
17140667|NCT03417141|38282453|FG000|Overall Study|Withdrawal by Subject|1|||
17140668|NCT03417141|38282453|FG000|Overall Study|Protocol Violation|3|||
17140669|NCT03724981|38282461|FG000|First Device|Protocol Violation|1|||
17140670|NCT03724981|38282462|FG001|First Device|Protocol Violation|1|||
17140671|NCT03442569|38282470|FG000|Overall Study|Subject was ineligible after enrollment|1|||
17140672|NCT01347879|38282476|FG000|Overall Study|Adverse Event|0|||
17140673|NCT01347879|38282477|FG001|Overall Study|Adverse Event|12|||
17140674|NCT01347879|38282476|FG000|Overall Study|Lost to Follow-up|2|||
17140675|NCT01347879|38282477|FG001|Overall Study|Lost to Follow-up|0|||
17140676|NCT01347879|38282476|FG000|Overall Study|Withdrawal by Subject|3|||
17140677|NCT01347879|38282477|FG001|Overall Study|Withdrawal by Subject|2|||
17140678|NCT01347879|38282476|FG000|Overall Study|Other|2|||
17140679|NCT01347879|38282477|FG001|Overall Study|Other|3|||
17140680|NCT03441789|38282494|FG000|Overall Study|Withdrawal by Subject|1|||
17140681|NCT03441789|38282495|FG001|Overall Study|Withdrawal by Subject|1|||
17140682|NCT03441789|38282494|FG000|Overall Study|Adverse Event|0|||
17140683|NCT03441789|38282495|FG001|Overall Study|Adverse Event|1|||
17140684|NCT03441789|38282494|FG000|Overall Study|Protocol Violation|0|||
17140685|NCT03441789|38282495|FG001|Overall Study|Protocol Violation|1|||
17140686|NCT03441789|38282494|FG000|Overall Study|Lost to Follow-up|0|||
17140687|NCT03441789|38282495|FG001|Overall Study|Lost to Follow-up|1|||
17140688|NCT03387735|38282512|FG000|Overall Study|Lost to Follow-up|4|||
17140689|NCT03387735|38282513|FG001|Overall Study|Lost to Follow-up|8|||
17140690|NCT03387735|38282512|FG000|Overall Study|Death|4|||
17140691|NCT03387735|38282513|FG001|Overall Study|Death|8|||
17140692|NCT03439137|38282521|FG000|Overall Study|Adverse Event|16|||
17140693|NCT03439137|38282522|FG001|Overall Study|Adverse Event|12|||
17140694|NCT03439137|38282521|FG000|Overall Study|Physician Decision|0|||
17140695|NCT03439137|38282522|FG001|Overall Study|Physician Decision|5|||
17140696|NCT03439137|38282521|FG000|Overall Study|Withdrawal by Subject|14|||
17140697|NCT03439137|38282522|FG001|Overall Study|Withdrawal by Subject|4|||
17140698|NCT03439137|38282521|FG000|Overall Study|Conducting rescue therapy|2|||
17140699|NCT03439137|38282522|FG001|Overall Study|Conducting rescue therapy|1|||
17140700|NCT03439137|38282521|FG000|Overall Study|Difficult to control Hb|10|||
17140701|NCT03439137|38282522|FG001|Overall Study|Difficult to control Hb|2|||
17140702|NCT03439137|38282521|FG000|Overall Study|Initiation of a renal transplant|0|||
17140703|NCT03439137|38282522|FG001|Overall Study|Initiation of a renal transplant|2|||
17140704|NCT04055090|38282530|FG000|Overall Study|screen failure|1|||
17140705|NCT04055090|38282531|FG001|Overall Study|screen failure|0|||
17140706|NCT04055090|38282530|FG000|Overall Study|Withdrawal by Subject|1|||
17140707|NCT04055090|38282531|FG001|Overall Study|Withdrawal by Subject|0|||
17140708|NCT03403413|38282554|FG000|Overall Study|Lack of Efficacy|2|||
17140709|NCT03354663|38282569|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
17140710|NCT03354663|38282569|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
17140711|NCT03354663|38282569|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
17140712|NCT03354663|38282569|FG000|Completed 30-day Visit|Missed Visit|1|||
17140713|NCT03721705|38282579|FG000|Overall Study|Adverse Event|2|||
17140714|NCT03721705|38282580|FG001|Overall Study|Adverse Event|0|||
17140715|NCT03721705|38282579|FG000|Overall Study|Withdrawal by Subject|4|||
17140716|NCT03721705|38282580|FG001|Overall Study|Withdrawal by Subject|10|||
17140717|NCT03721705|38282579|FG000|Overall Study|No Suitable Study Partner|1|||
17140718|NCT03721705|38282580|FG001|Overall Study|No Suitable Study Partner|0|||
17140719|NCT03721705|38282579|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
17140720|NCT03721705|38282580|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
17140721|NCT03721705|38282579|FG000|Overall Study|Death|0|||
17140722|NCT03721705|38282580|FG001|Overall Study|Death|1|||
17140723|NCT03720847|38282586|FG000|Washout|Physician Decision|1|||
17140724|NCT03720847|38282587|FG001|Washout|Physician Decision|2|||
17140725|NCT02631070|38282596|FG000|Overall Study|Withdrawal by Subject|35|||
17140726|NCT02631070|38282597|FG001|Overall Study|Withdrawal by Subject|13|||
17140727|NCT02631070|38282596|FG000|Overall Study|Death|45|||
17140728|NCT02631070|38282597|FG001|Overall Study|Death|24|||
17140729|NCT02631070|38282596|FG000|Overall Study|Lost to Follow-up|5|||
17140730|NCT02631070|38282597|FG001|Overall Study|Lost to Follow-up|1|||
17140731|NCT02631070|38282596|FG000|Overall Study|Transition to rollover protocol|52|||
17140732|NCT02631070|38282597|FG001|Overall Study|Transition to rollover protocol|21|||
17140733|NCT02631070|38282596|FG000|Overall Study|Other reasons|12|||
17140734|NCT02631070|38282597|FG001|Overall Study|Other reasons|5|||
17140735|NCT00741988|38282605|FG000|Overall Study|Adverse Event|2|||
17140736|NCT00741988|38282606|FG001|Overall Study|Adverse Event|4|||
17140737|NCT00741988|38282605|FG000|Overall Study|Lack of Efficacy|2|||
17140738|NCT00741988|38282606|FG001|Overall Study|Lack of Efficacy|0|||
17140739|NCT03354429|38282614|FG000|Overall Study|Withdrawal by Subject|8|||
17140740|NCT03354429|38282615|FG001|Overall Study|Withdrawal by Subject|7|||
17140741|NCT03354429|38282614|FG000|Overall Study|Lost to Follow-up|1|||
17140742|NCT03354429|38282615|FG001|Overall Study|Lost to Follow-up|0|||
17140743|NCT03352713|38282621|FG000|Overall Study|Lost to Follow-up|8|||
17140744|NCT03352713|38282621|FG000|Overall Study|Withdrawn by investigator|5|||
17140745|NCT03352713|38282621|FG000|Overall Study|Completed 0 EMAs|8|||
17140746|NCT03352713|38282621|FG000|Overall Study|Device incompatible/stolen|5|||
17140747|NCT03901144|38282625|FG000|Overall Study|Lost to Follow-up|1|||
17140748|NCT03901144|38282626|FG001|Overall Study|Lost to Follow-up|1|||
17140749|NCT03901144|38282627|FG002|Overall Study|Lost to Follow-up|1|||
17140750|NCT03901144|38282628|FG003|Overall Study|Lost to Follow-up|1|||
17140751|NCT02952261|38282640|FG000|Overall Study|Withdrawal by Subject|4|||
17140752|NCT02952261|38282641|FG001|Overall Study|Withdrawal by Subject|5|||
17140753|NCT02952261|38282640|FG000|Overall Study|Protocol Violation|1|||
17140754|NCT02952261|38282641|FG001|Overall Study|Protocol Violation|0|||
17140755|NCT03384693|38282647|FG000|Overall Study|Adverse Event|3|||
17140756|NCT03718429|38282659|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
17140757|NCT03718429|38282660|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
17140758|NCT03718429|38282661|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
17140759|NCT03718429|38282662|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
17140760|NCT01285102|38282682|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
17140761|NCT03382899|38282716|FG000|Overall Study|Ineligibility Determined|0|||
17140762|NCT03382899|38282717|FG001|Overall Study|Ineligibility Determined|1|||
17140763|NCT03382899|38282716|FG000|Overall Study|Lost to Follow-up|0|||
17140764|NCT03382899|38282717|FG001|Overall Study|Lost to Follow-up|1|||
17140765|NCT03382899|38282716|FG000|Overall Study|Sponsor's decision|31|||
17140766|NCT03382899|38282717|FG001|Overall Study|Sponsor's decision|28|||
17140767|NCT03382899|38282716|FG000|Overall Study|Withdrawal by Subject|0|||
17140768|NCT03382899|38282717|FG001|Overall Study|Withdrawal by Subject|5|||
17140769|NCT00709852|38282723|FG000|Period 1|Adverse Event|2|||
17140770|NCT00709852|38282724|FG001|Period 1|Adverse Event|0|||
17140771|NCT00709852|38282723|FG000|Period 1|Withdrawal by Subject|4|||
17140772|NCT00709852|38282724|FG001|Period 1|Withdrawal by Subject|2|||
17140773|NCT00709852|38282723|FG000|Period 1|Protocol Violation|1|||
17140774|NCT00709852|38282724|FG001|Period 1|Protocol Violation|0|||
17140775|NCT00709852|38282723|FG000|Period 1|Defective scanner|0|||
17140776|NCT00709852|38282724|FG001|Period 1|Defective scanner|1|||
17140777|NCT00709852|38282723|FG000|Period 1|Lost to Follow-up|1|||
17140778|NCT00709852|38282724|FG001|Period 1|Lost to Follow-up|0|||
17140779|NCT00709852|38282723|FG000|Period 2|Protocol Violation|4|||
17140780|NCT00709852|38282724|FG001|Period 2|Protocol Violation|1|||
17140781|NCT00709852|38282723|FG000|Period 2|Adverse Event|1|||
17140782|NCT00709852|38282724|FG001|Period 2|Adverse Event|1|||
17140783|NCT00709852|38282723|FG000|Period 2|Lost to Follow-up|1|||
17140784|NCT00709852|38282724|FG001|Period 2|Lost to Follow-up|0|||
17140785|NCT00709852|38282723|FG000|Period 2|No 72-hour follow-up|3|||
17140786|NCT00709852|38282724|FG001|Period 2|No 72-hour follow-up|0|||
17140787|NCT03382041|38282741|FG000|Overall Study|Consent Form Lost|2|||
17140788|NCT03382041|38282742|FG001|Overall Study|Consent Form Lost|1|||
17140789|NCT03382041|38282741|FG000|Overall Study|Withdrawal by Subject|1|||
17140790|NCT03382041|38282742|FG001|Overall Study|Withdrawal by Subject|4|||
17140791|NCT03382041|38282741|FG000|Overall Study|Lost to Follow-up|1|||
17140792|NCT03382041|38282742|FG001|Overall Study|Lost to Follow-up|4|||
17140793|NCT03351231|38282748|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
17140794|NCT03351231|38282748|FG000|Combination Therapy Period|Disease progression|2|||
17140795|NCT03351231|38282748|FG000|Combination Therapy Period|Study drug toxicity|1|||
17140796|NCT03351231|38282748|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
17140797|NCT03351231|38282748|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
17140798|NCT03351231|38282748|FG000|Safety Follow-Up Period|Other reason|2|||
17140799|NCT03381339|38282754|FG000|Overall Study|Protocol Violation|4|||
17140800|NCT03381339|38282755|FG001|Overall Study|Protocol Violation|3|||
17140801|NCT03381339|38282754|FG000|Overall Study|Lost to Follow-up|0|||
17140802|NCT03381339|38282755|FG001|Overall Study|Lost to Follow-up|1|||
17140803|NCT03401229|38282763|FG000|Overall Study|Lost to Follow-up|2|||
17140804|NCT03401229|38282764|FG001|Overall Study|Lost to Follow-up|1|||
17140805|NCT03401229|38282763|FG000|Overall Study|Other|1|||
17140806|NCT03401229|38282764|FG001|Overall Study|Other|3|||
17140807|NCT03401229|38282763|FG000|Overall Study|Adverse Event|8|||
17140808|NCT03401229|38282764|FG001|Overall Study|Adverse Event|6|||
17140809|NCT03401229|38282763|FG000|Overall Study|Withdrawal by Subject|29|||
17140810|NCT03401229|38282764|FG001|Overall Study|Withdrawal by Subject|26|||
17140811|NCT03401229|38282763|FG000|Overall Study|COVID-19|0|||
17140812|NCT03401229|38282764|FG001|Overall Study|COVID-19|1|||
17140813|NCT03349515|38282772|FG000|Overall Study|Lack of Efficacy|2|||
17140814|NCT03349515|38282773|FG001|Overall Study|Lack of Efficacy|0|||
17140815|NCT03349515|38282772|FG000|Overall Study|Physician Decision|3|||
17140816|NCT03349515|38282773|FG001|Overall Study|Physician Decision|1|||
17140817|NCT03349437|38282779|FG000|Screening|Screen Fail|4|||
17140818|NCT03349437|38282780|FG001|Screening|Screen Fail|0|||
17140819|NCT03349437|38282781|FG002|Screening|Screen Fail|0|||
17140820|NCT03349437|38282779|FG000|Screening|Withdrawn|1|||
17140821|NCT03349437|38282780|FG001|Screening|Withdrawn|0|||
17140822|NCT03349437|38282781|FG002|Screening|Withdrawn|0|||
17140823|NCT03380091|38282790|FG000|Overall Study|Withdrawal by Subject|2|||
17140824|NCT03380091|38282791|FG001|Overall Study|Withdrawal by Subject|1|||
17140825|NCT03379233|38282801|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
17140826|NCT03379233|38282802|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
17140827|NCT01377922|38282810|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
17140828|NCT01377922|38282811|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
17140829|NCT03372603|38282817|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
17140830|NCT03372603|38282818|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
17140831|NCT03372603|38282817|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
17140832|NCT03372603|38282818|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
17140833|NCT01377844|38282826|FG000|Overall Study|Withdrawal by Subject|25|||
17140834|NCT01377844|38282827|FG001|Overall Study|Withdrawal by Subject|28|||
17140835|NCT01377844|38282826|FG000|Overall Study|Protocol Violation|2|||
17140836|NCT01377844|38282827|FG001|Overall Study|Protocol Violation|3|||
17140837|NCT01377844|38282826|FG000|Overall Study|Adverse Event|3|||
17140838|NCT01377844|38282827|FG001|Overall Study|Adverse Event|0|||
17140839|NCT01377844|38282826|FG000|Overall Study|Physician Decision|6|||
17140840|NCT01377844|38282827|FG001|Overall Study|Physician Decision|3|||
17140841|NCT01377844|38282826|FG000|Overall Study|Study terminated by Sponsor|0|||
17140842|NCT01377844|38282827|FG001|Overall Study|Study terminated by Sponsor|1|||
17140843|NCT03372369|38282836|FG000|Qualification Period|Withdrawal by Subject|16|||
17140844|NCT03372369|38282837|FG001|Qualification Period|Withdrawal by Subject|13|||
17140845|NCT03372369|38282836|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
17140846|NCT03372369|38282837|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
17140847|NCT03372369|38282836|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
17140848|NCT03372369|38282837|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
17140849|NCT03371355|38282847|FG000|Overall Study|Investigator judgment|0|||
17140850|NCT03371355|38282848|FG001|Overall Study|Investigator judgment|0|||
17140851|NCT03371355|38282849|FG002|Overall Study|Investigator judgment|1|||
17140852|NCT03371355|38282850|FG003|Overall Study|Investigator judgment|1|||
17140853|NCT03371355|38282847|FG000|Overall Study|Voluntary withdrawal|1|||
17140854|NCT03371355|38282848|FG001|Overall Study|Voluntary withdrawal|0|||
17140855|NCT03371355|38282849|FG002|Overall Study|Voluntary withdrawal|1|||
17140856|NCT03371355|38282850|FG003|Overall Study|Voluntary withdrawal|2|||
17140857|NCT03371355|38282847|FG000|Overall Study|Adverse Event|0|||
17140858|NCT03371355|38282848|FG001|Overall Study|Adverse Event|1|||
17140859|NCT03371355|38282849|FG002|Overall Study|Adverse Event|2|||
17140860|NCT03371355|38282850|FG003|Overall Study|Adverse Event|3|||
17140861|NCT03371355|38282847|FG000|Overall Study|Reason not Specified|0|||
17140862|NCT03371355|38282848|FG001|Overall Study|Reason not Specified|1|||
17140863|NCT03371355|38282849|FG002|Overall Study|Reason not Specified|0|||
17140864|NCT03371355|38282850|FG003|Overall Study|Reason not Specified|1|||
17140865|NCT03370419|38282864|FG000|Overall Study|Lost to Follow-up|16|||
17140866|NCT03369951|38282872|FG000|Overall Study|Withdrawal by Subject|3|||
17140867|NCT03369951|38282872|FG000|Overall Study|Death|1|||
17140868|NCT03369951|38282872|FG000|Overall Study|Lost to Follow-up|1|||
17140869|NCT03369951|38282872|FG000|Overall Study|Protocol Violation|1|||
17140870|NCT04040192|38282876|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
17140871|NCT04040192|38282877|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
17140872|NCT04040192|38282878|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
17140873|NCT04040192|38282876|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
17140874|NCT04040192|38282877|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
17140875|NCT04040192|38282878|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
17140876|NCT04040192|38282876|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
17140877|NCT04040192|38282877|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
17140878|NCT04040192|38282878|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
17140879|NCT04040192|38282876|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
17140880|NCT04040192|38282877|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
17140881|NCT04040192|38282878|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
17140882|NCT04040192|38282876|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
17140883|NCT04040192|38282877|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
17140884|NCT04040192|38282878|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
17140885|NCT04040192|38282876|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
17140886|NCT04040192|38282877|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
17140887|NCT04040192|38282878|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
17140888|NCT04040192|38282876|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
17140889|NCT04040192|38282877|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
17140890|NCT04040192|38282878|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
17140891|NCT04040192|38282876|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
17140892|NCT04040192|38282877|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
17140893|NCT04040192|38282878|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
17140894|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
17140895|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
17140896|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
17140897|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
17140898|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
17140899|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
17140900|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
17140901|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
17140902|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
17140903|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
17140904|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
17140905|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
17140906|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
17140907|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
17140908|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
17140909|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
17140910|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
17140911|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
17140912|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
17140913|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
17140914|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
17140915|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
17140916|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
17140917|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
17140918|NCT04040192|38282876|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
17140919|NCT04040192|38282877|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
17140920|NCT04040192|38282878|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
17140921|NCT03368859|38282902|FG000|Overall Study|Withdrew Consent|5|||
17140922|NCT03368859|38282903|FG001|Overall Study|Withdrew Consent|4|||
17140923|NCT03368859|38282902|FG000|Overall Study|Death|12|||
17140924|NCT03368859|38282903|FG001|Overall Study|Death|6|||
17140925|NCT03368859|38282902|FG000|Overall Study|Study terminated by Sponsor|18|||
17140926|NCT03368859|38282903|FG001|Overall Study|Study terminated by Sponsor|23|||
17140927|NCT03368859|38282902|FG000|Overall Study|Other|1|||
17140928|NCT03368859|38282903|FG001|Overall Study|Other|1|||
17140929|NCT03096314|38282917|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
17140930|NCT03096314|38282918|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
17140931|NCT03335163|38282924|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
17140932|NCT03335163|38282924|FG000|Overall Study|Withdrawal by Subject|18|||
17140933|NCT03364335|38282950|FG000|Overall Study|Adverse Event|3|||
17140934|NCT03364335|38282951|FG001|Overall Study|Adverse Event|4|||
17140935|NCT03364335|38282952|FG002|Overall Study|Adverse Event|1|||
17140936|NCT03364335|38282953|FG003|Overall Study|Adverse Event|2|||
17140937|NCT03364335|38282954|FG004|Overall Study|Adverse Event|0|||
17140938|NCT03364335|38282950|FG000|Overall Study|Lost to Follow-up|7|||
17140939|NCT03364335|38282951|FG001|Overall Study|Lost to Follow-up|7|||
17140940|NCT03364335|38282952|FG002|Overall Study|Lost to Follow-up|10|||
17140941|NCT03364335|38282953|FG003|Overall Study|Lost to Follow-up|11|||
17140942|NCT03364335|38282954|FG004|Overall Study|Lost to Follow-up|11|||
17140943|NCT03334695|38282977|FG000|Overall Study|Lost to Follow-up|3|||
17140944|NCT03334695|38282978|FG001|Overall Study|Lost to Follow-up|3|||
17140945|NCT03334695|38282977|FG000|Overall Study|Physician Decision|1|||
17140946|NCT03334695|38282978|FG001|Overall Study|Physician Decision|2|||
17140947|NCT03334695|38282977|FG000|Overall Study|Protocol Violation|0|||
17140948|NCT03334695|38282978|FG001|Overall Study|Protocol Violation|1|||
17140949|NCT03364023|38282986|FG000|Overall Study|Lost to Follow-up|3|||
17140950|NCT03364023|38282986|FG000|Overall Study|Death|14|||
17140951|NCT03764813|38283010|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
17140952|NCT03764813|38283011|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
17140953|NCT03764813|38283012|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
17140954|NCT03764813|38283013|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
17140955|NCT03363321|38283034|FG000|Overall Study|Withdrawal by Subject|0|||
17140956|NCT03363321|38283035|FG001|Overall Study|Withdrawal by Subject|1|||
17140957|NCT03363321|38283036|FG002|Overall Study|Withdrawal by Subject|0|||
17140958|NCT03363321|38283037|FG003|Overall Study|Withdrawal by Subject|1|||
17140959|NCT03363321|38283038|FG004|Overall Study|Withdrawal by Subject|0|||
17140960|NCT03361605|38283051|FG000|Overall Study|Analyzable data not available|3|||
17140961|NCT03829046|38283057|FG000|Overall Study|Withdrawal by Subject|1|||
17140962|NCT03829046|38283058|FG001|Overall Study|Withdrawal by Subject|0|||
17140963|NCT03361293|38283066|FG000|Overall Study|Lost to Follow-up|0|||
17140964|NCT03361293|38283067|FG001|Overall Study|Lost to Follow-up|2|||
17140965|NCT03361293|38283066|FG000|Overall Study|Withdrawal by Subject|1|||
17140966|NCT03361293|38283067|FG001|Overall Study|Withdrawal by Subject|3|||
17140967|NCT03361137|38283078|FG000|Overall Study|Reason not specified|1|||
17140968|NCT03361137|38283079|FG001|Overall Study|Reason not specified|0|||
17140969|NCT03361137|38283080|FG002|Overall Study|Reason not specified|0|||
17140970|NCT03361137|38283081|FG003|Overall Study|Reason not specified|0|||
17140971|NCT03361137|38283082|FG004|Overall Study|Reason not specified|0|||
17140972|NCT03360747|38283096|FG000|Overall Study|Voluntary Withdrawal|1|||
17140973|NCT03359811|38283102|FG000|Overall Study|Protocol Violation|2|||
17140974|NCT03359811|38283103|FG001|Overall Study|Protocol Violation|0|||
17140975|NCT03728426|38283110|FG000|Overall Study|Death|3|||
17140976|NCT02095678|38283116|FG000|Overall Study|Withdrawal by Subject|0|||
17043696|NCT00317473|38188003|FG000|Overall Study|Withdrawal by Subject|2|||
17140977|NCT02095678|38283117|FG001|Overall Study|Withdrawal by Subject|1|||
17140978|NCT02095678|38283116|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
17140979|NCT02095678|38283117|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
17140980|NCT02095678|38283116|FG000|Overall Study|lesion impacted by previous treatment|1|||
17140981|NCT02095678|38283117|FG001|Overall Study|lesion impacted by previous treatment|1|||
17140982|NCT02095678|38283116|FG000|Overall Study|No Confirmed Diagnosis|0|||
17140983|NCT02095678|38283117|FG001|Overall Study|No Confirmed Diagnosis|3|||
17140984|NCT02095678|38283116|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
17140985|NCT02095678|38283117|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
17140986|NCT02095678|38283116|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
17140987|NCT02095678|38283117|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
17140988|NCT03763877|38283130|FG000|Overall Study|Withdrawal by Subject|3|||
17140989|NCT03763877|38283131|FG001|Overall Study|Withdrawal by Subject|1|||
17140990|NCT03763877|38283132|FG002|Overall Study|Withdrawal by Subject|3|||
17140991|NCT03763877|38283133|FG003|Overall Study|Withdrawal by Subject|4|||
17140992|NCT03763877|38283130|FG000|Overall Study|Adverse Event|1|||
17140993|NCT03763877|38283131|FG001|Overall Study|Adverse Event|1|||
17140994|NCT03763877|38283132|FG002|Overall Study|Adverse Event|3|||
17140995|NCT03763877|38283133|FG003|Overall Study|Adverse Event|1|||
17140996|NCT03763877|38283130|FG000|Overall Study|Protocol Violation|1|||
17140997|NCT03763877|38283131|FG001|Overall Study|Protocol Violation|1|||
17140998|NCT03763877|38283132|FG002|Overall Study|Protocol Violation|0|||
17140999|NCT03763877|38283133|FG003|Overall Study|Protocol Violation|0|||
17141000|NCT03763877|38283130|FG000|Overall Study|Lost to Follow-up|0|||
17141001|NCT03763877|38283131|FG001|Overall Study|Lost to Follow-up|1|||
17141002|NCT03763877|38283132|FG002|Overall Study|Lost to Follow-up|1|||
17141003|NCT03763877|38283133|FG003|Overall Study|Lost to Follow-up|0|||
17141004|NCT03358407|38283166|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17141005|NCT03358407|38283167|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17141006|NCT03358407|38283168|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
17141007|NCT03358407|38283169|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17043697|NCT00317473|38188004|FG001|Overall Study|Withdrawal by Subject|1|||
17141008|NCT03358407|38283170|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17141009|NCT03358407|38283171|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17141010|NCT03358407|38283172|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17141011|NCT03358407|38283173|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17141012|NCT03358407|38283174|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17141013|NCT03358407|38283175|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
17141014|NCT03358407|38283166|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141015|NCT03358407|38283167|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141016|NCT03358407|38283168|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141017|NCT03358407|38283169|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17043698|NCT00317473|38188005|FG002|Overall Study|Withdrawal by Subject|2|||
17141018|NCT03358407|38283170|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
17141019|NCT03358407|38283171|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17043699|NCT00317473|38188006|FG003|Overall Study|Withdrawal by Subject|1|||
17043700|NCT00317473|38188007|FG004|Overall Study|Withdrawal by Subject|3|||
17043701|NCT00317473|38188008|FG005|Overall Study|Withdrawal by Subject|1|||
17043702|NCT00317473|38188003|FG000|Overall Study|Relocation|1|||
17043703|NCT00317473|38188004|FG001|Overall Study|Relocation|0|||
17043704|NCT00317473|38188005|FG002|Overall Study|Relocation|1|||
17141020|NCT03358407|38283172|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141021|NCT03358407|38283173|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141022|NCT03358407|38283174|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141023|NCT03358407|38283175|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141024|NCT03358407|38283166|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
17141025|NCT03358407|38283167|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
17141026|NCT03358407|38283168|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
17141027|NCT03358407|38283169|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
17141028|NCT03358407|38283170|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
17141029|NCT03358407|38283171|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
17141030|NCT03358407|38283172|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
17141031|NCT03358407|38283173|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
17141032|NCT03358407|38283174|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
17141033|NCT03358407|38283175|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
17141034|NCT03358407|38283166|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
17141035|NCT03358407|38283167|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
17141036|NCT03358407|38283168|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
17141037|NCT03358407|38283169|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
17141038|NCT03358407|38283170|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
17141039|NCT03358407|38283171|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
17141040|NCT03358407|38283172|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
17141041|NCT03358407|38283173|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
17141042|NCT03358407|38283174|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
17141043|NCT03358407|38283175|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
17141044|NCT03358407|38283166|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141045|NCT03358407|38283167|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141046|NCT03358407|38283168|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141047|NCT03358407|38283169|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141048|NCT03358407|38283170|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141049|NCT03358407|38283171|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
17141050|NCT03358407|38283172|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
17141051|NCT03358407|38283173|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141052|NCT03358407|38283174|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141053|NCT03358407|38283175|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
17141054|NCT03358407|38283166|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
17141055|NCT03358407|38283167|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
17141056|NCT03358407|38283168|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
17141057|NCT03358407|38283169|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
17141058|NCT03358407|38283170|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
17141059|NCT03358407|38283171|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
17141060|NCT03358407|38283172|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
17141061|NCT03358407|38283173|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
17141062|NCT03358407|38283174|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
17141063|NCT03358407|38283175|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
17141064|NCT02950545|38283217|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
17141065|NCT02950545|38283218|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
17141066|NCT02950545|38283219|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
17141067|NCT02950545|38283220|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
17141068|NCT02950545|38283221|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
17141069|NCT02950545|38283222|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
17141070|NCT02950545|38283217|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
17141071|NCT02950545|38283218|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
17141072|NCT02950545|38283219|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
17141073|NCT02950545|38283220|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
17141074|NCT02950545|38283221|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
17141075|NCT02950545|38283222|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
17141076|NCT02950545|38283217|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
17141077|NCT02950545|38283218|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
17141078|NCT02950545|38283219|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
17141079|NCT02950545|38283220|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
17141080|NCT02950545|38283221|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
17141081|NCT02950545|38283222|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
17141082|NCT02950545|38283217|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
17141083|NCT02950545|38283218|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
17141084|NCT02950545|38283219|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
17141085|NCT02950545|38283220|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
17141086|NCT02950545|38283221|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
17141087|NCT02950545|38283222|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
17141088|NCT02950545|38283217|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
17141089|NCT02950545|38283218|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
17141090|NCT02950545|38283219|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
17141091|NCT02950545|38283220|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
17141092|NCT02950545|38283221|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
17141093|NCT02950545|38283222|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
17141094|NCT03358329|38283228|FG000|Overall Study|Lost to Follow-up|2|||
17141095|NCT03358329|38283228|FG000|Overall Study|Withdrawal by Subject|2|||
17141096|NCT03357471|38283244|FG000|Overall Study|Adverse Event|1|||
17141097|NCT03357471|38283245|FG001|Overall Study|Adverse Event|0|||
17141098|NCT03357471|38283244|FG000|Overall Study|Lost to Follow-up|1|||
17141099|NCT03357471|38283245|FG001|Overall Study|Lost to Follow-up|0|||
17141100|NCT03356145|38283253|FG000|Overall Study|Withdrawal by Subject|2|||
17141101|NCT03356145|38283254|FG001|Overall Study|Withdrawal by Subject|1|||
17043705|NCT00317473|38188006|FG003|Overall Study|Relocation|1|||
17043706|NCT00317473|38188007|FG004|Overall Study|Relocation|5|||
17043707|NCT00317473|38188008|FG005|Overall Study|Relocation|2|||
17043708|NCT00317473|38188003|FG000|Overall Study|Death|1|||
17043709|NCT00317473|38188004|FG001|Overall Study|Death|0|||
17043710|NCT00317473|38188005|FG002|Overall Study|Death|0|||
17043711|NCT00317473|38188006|FG003|Overall Study|Death|0|||
17043712|NCT00317473|38188007|FG004|Overall Study|Death|0|||
17043713|NCT00317473|38188008|FG005|Overall Study|Death|0|||
17043714|NCT00317473|38188003|FG000|Overall Study|Other|0|||
17043715|NCT00317473|38188004|FG001|Overall Study|Other|2|||
17043716|NCT00317473|38188005|FG002|Overall Study|Other|0|||
17043717|NCT00317473|38188006|FG003|Overall Study|Other|0|||
17043718|NCT00317473|38188007|FG004|Overall Study|Other|0|||
17043719|NCT00317473|38188008|FG005|Overall Study|Other|0|||
17043720|NCT00530218|38188032|FG000|Overall Study|CMV Not Detected|13|||
17043721|NCT00530218|38188032|FG000|Overall Study|Death|12|||
17043722|NCT00761267|38188042|FG000|Overall Study|Death|1|||
17043723|NCT00761267|38188043|FG001|Overall Study|Death|2|||
17043724|NCT00761267|38188044|FG002|Overall Study|Death|5|||
17043725|NCT00761267|38188042|FG000|Overall Study|Lost to Follow-up|0|||
17043726|NCT00761267|38188043|FG001|Overall Study|Lost to Follow-up|0|||
17043727|NCT00761267|38188044|FG002|Overall Study|Lost to Follow-up|1|||
17043728|NCT00761267|38188042|FG000|Overall Study|Randomized but not treated|1|||
17043729|NCT00761267|38188043|FG001|Overall Study|Randomized but not treated|1|||
17043730|NCT00761267|38188044|FG002|Overall Study|Randomized but not treated|0|||
17043731|NCT00761267|38188042|FG000|Overall Study|Withdrawal by Subject|0|||
17043732|NCT00761267|38188043|FG001|Overall Study|Withdrawal by Subject|1|||
17043733|NCT00761267|38188044|FG002|Overall Study|Withdrawal by Subject|0|||
17043734|NCT00303667|38188065|FG000|Overall Study|Death|0|||
17043735|NCT00303667|38188066|FG001|Overall Study|Death|4|||
17043736|NCT00761189|38188072|FG000|Overall Study|Adverse Event|42|||
17043737|NCT00761189|38188072|FG000|Overall Study|Lack of Efficacy|45|||
17043738|NCT00761189|38188072|FG000|Overall Study|Lost to Follow-up|36|||
17043739|NCT00761189|38188072|FG000|Overall Study|Withdrawal by Subject|49|||
17043740|NCT00761189|38188072|FG000|Overall Study|Other|13|||
17141102|NCT03356145|38283253|FG000|Overall Study|Did not meet inclusion criteria|1|||
17141103|NCT03356145|38283254|FG001|Overall Study|Did not meet inclusion criteria|0|||
17141104|NCT03342963|38283264|FG000|Overall Study|Adverse Event|1|||
17141105|NCT03342963|38283265|FG001|Overall Study|Adverse Event|2|||
17141106|NCT03342963|38283266|FG002|Overall Study|Adverse Event|0|||
17043741|NCT00529516|38188079|FG000|Overall Study|Adverse Event|2|||
17043742|NCT00529516|38188080|FG001|Overall Study|Adverse Event|1|||
17043743|NCT00529516|38188081|FG002|Overall Study|Adverse Event|0|||
17043744|NCT00529516|38188079|FG000|Overall Study|Withdrawal by Subject|1|||
17043745|NCT00529516|38188080|FG001|Overall Study|Withdrawal by Subject|1|||
17043746|NCT00529516|38188081|FG002|Overall Study|Withdrawal by Subject|0|||
17043747|NCT00529516|38188079|FG000|Overall Study|Lost to Follow-up|0|||
17043748|NCT00529516|38188080|FG001|Overall Study|Lost to Follow-up|0|||
17043749|NCT00529516|38188081|FG002|Overall Study|Lost to Follow-up|1|||
17043750|NCT00316693|38188091|FG000|Overall Study|Adverse Event|6|||
17043751|NCT00316693|38188092|FG001|Overall Study|Adverse Event|1|||
17043752|NCT00316693|38188091|FG000|Overall Study|Protocol Violation|1|||
17043753|NCT00316693|38188092|FG001|Overall Study|Protocol Violation|0|||
17043754|NCT00316693|38188091|FG000|Overall Study|Withdrawal by Subject|6|||
17043755|NCT00316693|38188092|FG001|Overall Study|Withdrawal by Subject|6|||
17043756|NCT00316693|38188091|FG000|Overall Study|Lost to Follow-up|26|||
17043757|NCT00316693|38188092|FG001|Overall Study|Lost to Follow-up|34|||
17043758|NCT00316693|38188091|FG000|Overall Study|Other|38|||
17043759|NCT00316693|38188092|FG001|Overall Study|Other|44|||
17043760|NCT00316303|38188100|FG000|Overall Study|Lost to Follow-up|11|||
17141107|NCT03342963|38283267|FG003|Overall Study|Adverse Event|0|||
17141108|NCT03342963|38283264|FG000|Overall Study|Withdrawal by Subject|1|||
17141109|NCT03342963|38283265|FG001|Overall Study|Withdrawal by Subject|0|||
17141110|NCT03342963|38283266|FG002|Overall Study|Withdrawal by Subject|0|||
17141111|NCT03342963|38283267|FG003|Overall Study|Withdrawal by Subject|0|||
17141112|NCT03361956|38283282|FG000|Overall Study|Adverse Event|1|||
17141113|NCT03361956|38283283|FG001|Overall Study|Adverse Event|0|||
17141114|NCT03361956|38283284|FG002|Overall Study|Adverse Event|1|||
17141115|NCT03361956|38283285|FG003|Overall Study|Adverse Event|1|||
17141116|NCT03361956|38283286|FG004|Overall Study|Adverse Event|0|||
17141117|NCT03361956|38283282|FG000|Overall Study|Other|0|||
17141118|NCT03361956|38283283|FG001|Overall Study|Other|0|||
17141119|NCT03361956|38283284|FG002|Overall Study|Other|0|||
17141120|NCT03361956|38283285|FG003|Overall Study|Other|1|||
17141121|NCT03361956|38283286|FG004|Overall Study|Other|0|||
17141122|NCT03361956|38283282|FG000|Overall Study|Withdrawal by Subject|2|||
17141123|NCT03361956|38283283|FG001|Overall Study|Withdrawal by Subject|2|||
17141124|NCT03361956|38283284|FG002|Overall Study|Withdrawal by Subject|2|||
17141125|NCT03361956|38283285|FG003|Overall Study|Withdrawal by Subject|0|||
17043761|NCT00316303|38188101|FG001|Overall Study|Lost to Follow-up|16|||
17043762|NCT00760877|38188112|FG000|Overall Study|Protocol Violation|1|||
17043763|NCT00760877|38188113|FG001|Overall Study|Protocol Violation|0|||
17043764|NCT00760877|38188112|FG000|Overall Study|Non-compliance with protocol treatment|2|||
17043765|NCT00760877|38188113|FG001|Overall Study|Non-compliance with protocol treatment|1|||
17043766|NCT00760877|38188112|FG000|Overall Study|Pregnancy|1|||
17043767|NCT00760877|38188113|FG001|Overall Study|Pregnancy|4|||
17043768|NCT00760877|38188112|FG000|Overall Study|Death|2|||
17043769|NCT00760877|38188113|FG001|Overall Study|Death|1|||
17043770|NCT00760877|38188112|FG000|Overall Study|Withdrawal by Subject|7|||
17043771|NCT00760877|38188113|FG001|Overall Study|Withdrawal by Subject|3|||
17043772|NCT00760877|38188112|FG000|Overall Study|Adverse Event|19|||
17043773|NCT00760877|38188113|FG001|Overall Study|Adverse Event|12|||
17043774|NCT00760877|38188112|FG000|Overall Study|Participant diagnosed with AML|0|||
17043775|NCT00760877|38188113|FG001|Overall Study|Participant diagnosed with AML|1|||
17043776|NCT00760877|38188112|FG000|Overall Study|Participant not eligible to cross-over|0|||
17043777|NCT00760877|38188113|FG001|Overall Study|Participant not eligible to cross-over|1|||
17043778|NCT00760877|38188112|FG000|Overall Study|Physician Decision|1|||
17043779|NCT00760877|38188113|FG001|Overall Study|Physician Decision|2|||
17043780|NCT00760877|38188112|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
17043781|NCT00760877|38188113|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
17043782|NCT00760877|38188112|FG000|Overall Study|Treatment failure|1|||
17043783|NCT00760877|38188113|FG001|Overall Study|Treatment failure|0|||
17043784|NCT00302731|38188124|FG000|Overall Study|Lost to Follow-up|1|||
17043785|NCT00302731|38188125|FG001|Overall Study|Lost to Follow-up|2|||
17043786|NCT00302731|38188126|FG002|Overall Study|Lost to Follow-up|0|||
17043787|NCT00302731|38188127|FG003|Overall Study|Lost to Follow-up|0|||
17043788|NCT00302731|38188124|FG000|Overall Study|Adverse Event|0|||
17043789|NCT00302731|38188125|FG001|Overall Study|Adverse Event|2|||
17043790|NCT00302731|38188126|FG002|Overall Study|Adverse Event|2|||
17043791|NCT00302731|38188127|FG003|Overall Study|Adverse Event|0|||
17043792|NCT00302731|38188124|FG000|Overall Study|Withdrawal by Subject|1|||
17043793|NCT00302731|38188125|FG001|Overall Study|Withdrawal by Subject|1|||
17043794|NCT00302731|38188126|FG002|Overall Study|Withdrawal by Subject|0|||
17043795|NCT00302731|38188127|FG003|Overall Study|Withdrawal by Subject|0|||
17043796|NCT00302731|38188124|FG000|Overall Study|Protocol Violation|1|||
17043797|NCT00302731|38188125|FG001|Overall Study|Protocol Violation|0|||
17043798|NCT00302731|38188126|FG002|Overall Study|Protocol Violation|0|||
17043799|NCT00302731|38188127|FG003|Overall Study|Protocol Violation|0|||
17043800|NCT00302731|38188124|FG000|Overall Study|cancer unrelated to study discovered|1|||
17043801|NCT00302731|38188125|FG001|Overall Study|cancer unrelated to study discovered|0|||
17043802|NCT00302731|38188126|FG002|Overall Study|cancer unrelated to study discovered|1|||
17043803|NCT00302731|38188127|FG003|Overall Study|cancer unrelated to study discovered|0|||
17043804|NCT00780143|38188137|FG000|Overall Study|Progressive disease|1|||
17141126|NCT03361956|38283286|FG004|Overall Study|Withdrawal by Subject|3|||
17141127|NCT03361956|38283282|FG000|Overall Study|Disease Relapse|0|||
17043805|NCT00780143|38188137|FG000|Overall Study|Toxicity|1|||
17043806|NCT00780143|38188137|FG000|Overall Study|Adverse Event|1|||
17043807|NCT00779909|38188145|FG000|Overall Study|Lost to Follow-up|1|||
17043808|NCT00779909|38188146|FG001|Overall Study|Lost to Follow-up|0|||
17043809|NCT00779909|38188147|FG002|Overall Study|Lost to Follow-up|0|||
17043810|NCT00779909|38188148|FG003|Overall Study|Lost to Follow-up|1|||
17043811|NCT00779909|38188145|FG000|Overall Study|Withdrawal by Subject|0|||
17043812|NCT00779909|38188146|FG001|Overall Study|Withdrawal by Subject|1|||
17043813|NCT00779909|38188147|FG002|Overall Study|Withdrawal by Subject|0|||
17043814|NCT00779909|38188148|FG003|Overall Study|Withdrawal by Subject|0|||
17043815|NCT00302107|38188167|FG000|Overall Study|Lost to Follow-up|6|||
17043816|NCT00302107|38188168|FG001|Overall Study|Lost to Follow-up|5|||
17043817|NCT00302107|38188167|FG000|Overall Study|Protocol Violation|1|||
17043818|NCT00302107|38188168|FG001|Overall Study|Protocol Violation|0|||
17043819|NCT00302107|38188167|FG000|Overall Study|Relocation|0|||
17043820|NCT00302107|38188168|FG001|Overall Study|Relocation|1|||
17043821|NCT00302107|38188167|FG000|Overall Study|Withdrawal by Subject|0|||
17043822|NCT00302107|38188168|FG001|Overall Study|Withdrawal by Subject|3|||
17043823|NCT00302107|38188167|FG000|Overall Study|Adverse Event|1|||
17043824|NCT00302107|38188168|FG001|Overall Study|Adverse Event|0|||
17043825|NCT00760487|38188174|FG000|Overall Study|Unilateral implantation|3|||
17043826|NCT00316225|38188178|FG000|Overall Study|Adverse Event|2|||
17043827|NCT00316225|38188178|FG000|Overall Study|Physician Decision|3|||
17043828|NCT00316225|38188178|FG000|Overall Study|Progressive Disease|15|||
17043829|NCT00316225|38188178|FG000|Overall Study|Withdrawal by Subject|3|||
17043830|NCT00316225|38188178|FG000|Overall Study|Death|2|||
17043831|NCT00586703|38188182|FG000|Overall Study|Death|12|||
17043832|NCT00586625|38188188|FG000|Overall Study|Adverse Event|6|||
17043833|NCT00586625|38188189|FG001|Overall Study|Adverse Event|6|||
17043834|NCT00586625|38188188|FG000|Overall Study|Protocol Violation|3|||
17043835|NCT00586625|38188189|FG001|Overall Study|Protocol Violation|0|||
17043836|NCT00586625|38188188|FG000|Overall Study|Withdrawal by Subject|32|||
17043837|NCT00586625|38188189|FG001|Overall Study|Withdrawal by Subject|10|||
17043838|NCT00586625|38188188|FG000|Overall Study|Subject non-compliance|0|||
17043839|NCT00586625|38188189|FG001|Overall Study|Subject non-compliance|1|||
17043840|NCT00586625|38188188|FG000|Overall Study|Subject unable to return for visit|2|||
17043841|NCT00586625|38188189|FG001|Overall Study|Subject unable to return for visit|0|||
17043842|NCT00636168|38188197|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
17043843|NCT00636168|38188198|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
17043844|NCT00636168|38188197|FG000|Randomized to Study Drug|Adverse Event|1|||
17043845|NCT00636168|38188198|FG001|Randomized to Study Drug|Adverse Event|0|||
17043846|NCT00636168|38188197|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
17043847|NCT00636168|38188198|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
17043848|NCT00636168|38188197|FG000|Treated With Study Drug|Recurrence of disease|135|||
17043849|NCT00636168|38188198|FG001|Treated With Study Drug|Recurrence of disease|282|||
17043850|NCT00636168|38188197|FG000|Treated With Study Drug|Adverse Event|250|||
17043851|NCT00636168|38188198|FG001|Treated With Study Drug|Adverse Event|22|||
17043852|NCT00636168|38188197|FG000|Treated With Study Drug|Participant withdrew consent|16|||
17043853|NCT00636168|38188198|FG001|Treated With Study Drug|Participant withdrew consent|21|||
17043854|NCT00636168|38188197|FG000|Treated With Study Drug|Poor/non-compliance|1|||
17043855|NCT00636168|38188198|FG001|Treated With Study Drug|Poor/non-compliance|3|||
17043856|NCT00636168|38188197|FG000|Treated With Study Drug|Death|3|||
17043857|NCT00636168|38188198|FG001|Treated With Study Drug|Death|0|||
17043858|NCT00636168|38188197|FG000|Treated With Study Drug|Pregnancy|1|||
17043859|NCT00636168|38188198|FG001|Treated With Study Drug|Pregnancy|0|||
17043860|NCT00636168|38188197|FG000|Treated With Study Drug|No longer meets study criteria|1|||
17043861|NCT00636168|38188198|FG001|Treated With Study Drug|No longer meets study criteria|0|||
17043862|NCT00636168|38188197|FG000|Treated With Study Drug|Other reason|1|||
17043863|NCT00636168|38188198|FG001|Treated With Study Drug|Other reason|3|||
17043864|NCT00636168|38188197|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
17043865|NCT00636168|38188198|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
17043866|NCT00636168|38188197|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
17043867|NCT00636168|38188198|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
17043868|NCT00636168|38188197|FG000|Long Term Follow-Up|Death|8|||
17043869|NCT00636168|38188198|FG001|Long Term Follow-Up|Death|9|||
17043870|NCT00759941|38188206|FG000|Overall Study|Use of medication|1|||
17043871|NCT00759941|38188207|FG001|Overall Study|Use of medication|0|||
17043872|NCT00759941|38188206|FG000|Overall Study|Adverse Event|1|||
17043873|NCT00759941|38188207|FG001|Overall Study|Adverse Event|0|||
17043874|NCT00759941|38188206|FG000|Overall Study|Exited in error by site|1|||
17043875|NCT00759941|38188207|FG001|Overall Study|Exited in error by site|1|||
17043876|NCT00528424|38188213|FG000|Overall Study|Lost to Follow-up|13|||
17043877|NCT00528424|38188213|FG000|Overall Study|Withdrew consent|2|||
17043878|NCT00528424|38188213|FG000|Overall Study|Administrative reason|2|||
17043879|NCT00528424|38188213|FG000|Overall Study|Other|12|||
17043880|NCT00315445|38188220|FG000|Overall Study|Adverse Event|7|||
17043881|NCT00315445|38188221|FG001|Overall Study|Adverse Event|12|||
17043882|NCT00315445|38188222|FG002|Overall Study|Adverse Event|15|||
17043883|NCT00315445|38188220|FG000|Overall Study|Lack of Efficacy|16|||
17043884|NCT00315445|38188221|FG001|Overall Study|Lack of Efficacy|1|||
17043885|NCT00315445|38188222|FG002|Overall Study|Lack of Efficacy|7|||
17043886|NCT00315445|38188220|FG000|Overall Study|Lost to Follow-up|1|||
17043887|NCT00315445|38188221|FG001|Overall Study|Lost to Follow-up|0|||
17043888|NCT00315445|38188222|FG002|Overall Study|Lost to Follow-up|1|||
17043889|NCT00315445|38188220|FG000|Overall Study|Protocol Violation|2|||
17043890|NCT00315445|38188221|FG001|Overall Study|Protocol Violation|0|||
17043891|NCT00315445|38188222|FG002|Overall Study|Protocol Violation|1|||
17043892|NCT00315445|38188220|FG000|Overall Study|Other|1|||
17043893|NCT00315445|38188221|FG001|Overall Study|Other|3|||
17043894|NCT00315445|38188222|FG002|Overall Study|Other|0|||
17043895|NCT03687736|38188230|FG000|Overall Study|Lost to Follow-up|7|||
17043896|NCT03687736|38188230|FG000|Overall Study|Withdrawal by Subject|3|||
17043897|NCT00779675|38188236|FG000|Treatment Period|Adverse Event|87|||
17043898|NCT00779675|38188236|FG000|Treatment Period|Treatment Failure|80|||
17043899|NCT00779675|38188236|FG000|Treatment Period|Transferred to Another Study|38|||
17043900|NCT00779675|38188236|FG000|Treatment Period|Lost to Follow-up|23|||
17043901|NCT00779675|38188236|FG000|Treatment Period|Withdrawal by Subject|46|||
17043902|NCT00779675|38188236|FG000|Treatment Period|Protocol Violation|54|||
17043903|NCT00779675|38188236|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
17043904|NCT00779675|38188236|FG000|Treatment Period|Administrative|3|||
17043905|NCT00779675|38188236|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
17043906|NCT00779675|38188236|FG000|Extended Treatment Period|Protocol Violation|13|||
17043907|NCT00779675|38188236|FG000|Extended Treatment Period|Adverse Event|6|||
17043908|NCT00779675|38188236|FG000|Extended Treatment Period|Treatment Failure|11|||
17043909|NCT00779675|38188236|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
17043910|NCT00779675|38188236|FG000|Extended Treatment Period|Lost to Follow-up|6|||
17043911|NCT00759863|38188246|FG000|Overall Study|Death, moved, or lost contact|20|||
17043912|NCT00759863|38188247|FG001|Overall Study|Death, moved, or lost contact|18|||
17043913|NCT00759785|38188255|FG000|Overall Study|Participant sample not evaluable|11|||
17043914|NCT00759785|38188256|FG001|Overall Study|Participant sample not evaluable|2|||
17043915|NCT00759785|38188255|FG000|Overall Study|Participant sample lost|0|||
17043916|NCT00759785|38188256|FG001|Overall Study|Participant sample lost|1|||
17043917|NCT00759785|38188255|FG000|Overall Study|Protocol Violation|1|||
17043918|NCT00759785|38188256|FG001|Overall Study|Protocol Violation|0|||
17043919|NCT00759785|38188255|FG000|Overall Study|Physician Decision|0|||
17043920|NCT00759785|38188256|FG001|Overall Study|Physician Decision|1|||
17043921|NCT00759785|38188255|FG000|Overall Study|Withdrawal by Subject|0|||
17043922|NCT00759785|38188256|FG001|Overall Study|Withdrawal by Subject|1|||
17043923|NCT00300781|38188264|FG000|Overall Study|Disease Progression|55|||
17043924|NCT00300781|38188265|FG001|Overall Study|Disease Progression|52|||
17043925|NCT00300781|38188264|FG000|Overall Study|Adverse Event|5|||
17043926|NCT00300781|38188265|FG001|Overall Study|Adverse Event|6|||
17043927|NCT00300781|38188264|FG000|Overall Study|Withdrawal by Subject|1|||
17043928|NCT00300781|38188265|FG001|Overall Study|Withdrawal by Subject|2|||
17043929|NCT00300781|38188264|FG000|Overall Study|Physician Decision|1|||
17043930|NCT00300781|38188265|FG001|Overall Study|Physician Decision|0|||
17043931|NCT00300781|38188264|FG000|Overall Study|Not Recorded|0|||
17043932|NCT00300781|38188265|FG001|Overall Study|Not Recorded|1|||
17043933|NCT00300781|38188264|FG000|Overall Study|Symptomatic Deterioration|1|||
17043934|NCT00300781|38188265|FG001|Overall Study|Symptomatic Deterioration|0|||
17043935|NCT00300781|38188264|FG000|Overall Study|Lost to Follow-up|0|||
17043936|NCT00300781|38188265|FG001|Overall Study|Lost to Follow-up|1|||
17043937|NCT00315055|38188273|FG000|Overall Study|Protocol Violation|2|||
17043938|NCT00315055|38188274|FG001|Overall Study|Protocol Violation|4|||
17043939|NCT00315055|38188273|FG000|Overall Study|Lost to Follow-up|1|||
17043940|NCT00315055|38188274|FG001|Overall Study|Lost to Follow-up|1|||
17043941|NCT00528970|38188286|FG000|Overall Study|Adverse Event|6|||
17043942|NCT00528970|38188287|FG001|Overall Study|Adverse Event|8|||
17043943|NCT00528970|38188288|FG002|Overall Study|Adverse Event|5|||
17043944|NCT00528970|38188286|FG000|Overall Study|Lost to Follow-up|0|||
17043945|NCT00528970|38188287|FG001|Overall Study|Lost to Follow-up|0|||
17043946|NCT00528970|38188288|FG002|Overall Study|Lost to Follow-up|1|||
17043947|NCT00528970|38188286|FG000|Overall Study|Other than specified|2|||
17043948|NCT00528970|38188287|FG001|Overall Study|Other than specified|3|||
17043949|NCT00528970|38188288|FG002|Overall Study|Other than specified|3|||
17043950|NCT00528970|38188286|FG000|Overall Study|Protocol Violation|2|||
17043951|NCT00528970|38188287|FG001|Overall Study|Protocol Violation|1|||
17043952|NCT00528970|38188288|FG002|Overall Study|Protocol Violation|4|||
17043953|NCT00528970|38188286|FG000|Overall Study|Lack of Efficacy|0|||
17043954|NCT00528970|38188287|FG001|Overall Study|Lack of Efficacy|0|||
17043955|NCT00528970|38188288|FG002|Overall Study|Lack of Efficacy|1|||
17043956|NCT00528970|38188286|FG000|Overall Study|Withdrawal by Subject|4|||
17043957|NCT00528970|38188287|FG001|Overall Study|Withdrawal by Subject|3|||
17043958|NCT00528970|38188288|FG002|Overall Study|Withdrawal by Subject|5|||
17043959|NCT00528970|38188286|FG000|Overall Study|Randomized but not treated|0|||
17043960|NCT00528970|38188287|FG001|Overall Study|Randomized but not treated|0|||
17043961|NCT00528970|38188288|FG002|Overall Study|Randomized but not treated|1|||
17043962|NCT00759395|38188298|FG000|Overall Study|Adverse Event|1|||
17043963|NCT00759395|38188299|FG001|Overall Study|Adverse Event|0|||
17043964|NCT00759395|38188298|FG000|Overall Study|Withdrawal by Subject|1|||
17043965|NCT00759395|38188299|FG001|Overall Study|Withdrawal by Subject|0|||
17043966|NCT00759395|38188298|FG000|Overall Study|Lack of Efficacy|0|||
17043967|NCT00759395|38188299|FG001|Overall Study|Lack of Efficacy|2|||
17043968|NCT00293293|38188307|FG000|Overall Study|Withdrawal by Subject|1|||
17043969|NCT00293293|38188308|FG001|Overall Study|Withdrawal by Subject|1|||
17043970|NCT00293293|38188307|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
17043971|NCT00293293|38188308|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
17043972|NCT00293293|38188307|FG000|Overall Study|Patient discontinued chemotherapy|0|||
17043973|NCT00293293|38188308|FG001|Overall Study|Patient discontinued chemotherapy|1|||
17043974|NCT04864639|38188315|FG000|Overall Study|Death|1|||
17043975|NCT04864639|38188315|FG000|Overall Study|Lost to Follow-up|1|||
17043976|NCT04439123|38188337|FG000|Overall Study|Adverse Event|11|||
17043977|NCT04439123|38188337|FG000|Overall Study|Death|1|||
17043978|NCT04439123|38188337|FG000|Overall Study|Disease progression|19|||
17043979|NCT04439123|38188337|FG000|Overall Study|Withdrawal by Subject|2|||
17141128|NCT03361956|38283283|FG001|Overall Study|Disease Relapse|0|||
17141129|NCT03361956|38283284|FG002|Overall Study|Disease Relapse|1|||
17141130|NCT03361956|38283285|FG003|Overall Study|Disease Relapse|0|||
17141131|NCT03361956|38283286|FG004|Overall Study|Disease Relapse|0|||
17141132|NCT03361956|38283282|FG000|Overall Study|Physician Decision|0|||
17141133|NCT03361956|38283283|FG001|Overall Study|Physician Decision|2|||
17141134|NCT03361956|38283284|FG002|Overall Study|Physician Decision|0|||
17141135|NCT03361956|38283285|FG003|Overall Study|Physician Decision|1|||
17141136|NCT03361956|38283286|FG004|Overall Study|Physician Decision|0|||
17141137|NCT03361956|38283282|FG000|Overall Study|Lost to Follow-up|0|||
17043980|NCT04439123|38188337|FG000|Overall Study|Still on treatment|2|||
17043981|NCT04439110|38188341|FG000|Overall Study|Ineligible|2|||
17043982|NCT04439110|38188341|FG000|Overall Study|Adverse Event|4|||
17141138|NCT03361956|38283283|FG001|Overall Study|Lost to Follow-up|0|||
17141139|NCT03361956|38283284|FG002|Overall Study|Lost to Follow-up|1|||
17141140|NCT03361956|38283285|FG003|Overall Study|Lost to Follow-up|1|||
17141141|NCT03361956|38283286|FG004|Overall Study|Lost to Follow-up|2|||
17141142|NCT03361176|38283357|FG000|Overall Study|Lost to Follow-up|1|||
17141143|NCT03361176|38283358|FG001|Overall Study|Lost to Follow-up|2|||
17141144|NCT03361176|38283357|FG000|Overall Study|Adverse Event|0|||
17141145|NCT03361176|38283358|FG001|Overall Study|Adverse Event|2|||
17141146|NCT03361176|38283357|FG000|Overall Study|Withdrawal by Subject|0|||
17141147|NCT03361176|38283358|FG001|Overall Study|Withdrawal by Subject|1|||
17141148|NCT05283499|38283366|FG000|Overall Study|Did not receive intervention|1|||
17141149|NCT05283499|38283367|FG001|Overall Study|Did not receive intervention|2|||
17141150|NCT05271175|38283376|FG000|One Week Follow up|Lost to Follow-up|10|||
17141151|NCT05271175|38283377|FG001|One Week Follow up|Lost to Follow-up|7|||
17141152|NCT05271175|38283378|FG002|One Week Follow up|Lost to Follow-up|5|||
17141153|NCT05271175|38283376|FG000|One Month Follow up|Lost to Follow-up|12|||
17141154|NCT05271175|38283377|FG001|One Month Follow up|Lost to Follow-up|7|||
17141155|NCT05271175|38283378|FG002|One Month Follow up|Lost to Follow-up|9|||
17141156|NCT05271175|38283376|FG000|Six Months Follow up|Lost to Follow-up|8|||
17141157|NCT05271175|38283377|FG001|Six Months Follow up|Lost to Follow-up|2|||
17141158|NCT05271175|38283378|FG002|Six Months Follow up|Lost to Follow-up|2|||
17141159|NCT03098030|38283390|FG000|Overall Study|Death|10|||
17141160|NCT03098030|38283391|FG001|Overall Study|Death|156|||
17141161|NCT03098030|38283392|FG002|Overall Study|Death|156|||
17141162|NCT03098030|38283393|FG003|Overall Study|Death|82|||
17141163|NCT03098030|38283390|FG000|Overall Study|Withdrawal by Subject|0|||
17141164|NCT03098030|38283391|FG001|Overall Study|Withdrawal by Subject|7|||
17141165|NCT03098030|38283392|FG002|Overall Study|Withdrawal by Subject|8|||
17141166|NCT03098030|38283393|FG003|Overall Study|Withdrawal by Subject|2|||
17141167|NCT03098030|38283390|FG000|Overall Study|Lost to Follow-up|0|||
17141168|NCT03098030|38283391|FG001|Overall Study|Lost to Follow-up|0|||
17141169|NCT03098030|38283392|FG002|Overall Study|Lost to Follow-up|2|||
17141170|NCT03098030|38283393|FG003|Overall Study|Lost to Follow-up|1|||
17141171|NCT03341637|38283404|FG000|Overall Study|Lost to Follow-up|1|||
17141172|NCT03341637|38283405|FG001|Overall Study|Lost to Follow-up|0|||
17043983|NCT04439110|38188341|FG000|Overall Study|Death|2|||
17043984|NCT04439110|38188341|FG000|Overall Study|Disease proression|25|||
17043985|NCT04439110|38188341|FG000|Overall Study|Withdrawal by Subject|1|||
17043986|NCT04439110|38188341|FG000|Overall Study|Alternative therapy|1|||
17043987|NCT04439110|38188341|FG000|Overall Study|Other complicating disease|1|||
17043988|NCT04439110|38188341|FG000|Overall Study|Personal reasons|1|||
17043989|NCT04439110|38188341|FG000|Overall Study|Still on treatment|1|||
17043990|NCT04245449|38188349|FG000|Overall Study|COVID shutdown|7|||
17043991|NCT03887221|38188359|FG000|Overall Study|Protocol Violation|1|||
17043992|NCT03887221|38188360|FG001|Overall Study|Protocol Violation|0|||
17043993|NCT03164616|38188381|FG000|Overall Study|Death|250|||
17141173|NCT03341637|38283404|FG000|Overall Study|Withdrawal by Subject|3|||
17141174|NCT03341637|38283405|FG001|Overall Study|Withdrawal by Subject|3|||
17141175|NCT03341637|38283404|FG000|Overall Study|Reason not Specified|1|||
17141176|NCT03341637|38283405|FG001|Overall Study|Reason not Specified|1|||
17141177|NCT01378858|38283413|FG000|Overall Study|Withdrawal by Subject|4|||
17141178|NCT01378858|38283414|FG001|Overall Study|Withdrawal by Subject|4|||
17141179|NCT02891850|38283422|FG000|Overall Study|Adverse Event|3|||
17141180|NCT02891850|38283423|FG001|Overall Study|Adverse Event|0|||
17141181|NCT02891850|38283422|FG000|Overall Study|Death|0|||
17141182|NCT02891850|38283423|FG001|Overall Study|Death|4|||
17141183|NCT02891850|38283422|FG000|Overall Study|Physician Decision|1|||
17141184|NCT02891850|38283423|FG001|Overall Study|Physician Decision|0|||
17141185|NCT02891850|38283422|FG000|Overall Study|Pregnancy|1|||
17141186|NCT02891850|38283423|FG001|Overall Study|Pregnancy|0|||
17141187|NCT02891850|38283422|FG000|Overall Study|Withdrawal by Subject|2|||
17141188|NCT02891850|38283423|FG001|Overall Study|Withdrawal by Subject|3|||
17141189|NCT02949219|38283429|FG000|Overall Study|Withdrawal by Subject|1|||
17141190|NCT05594173|38283433|FG000|Overall Study|Adverse Event|1|||
17141191|NCT05594173|38283433|FG000|Overall Study|COVID-19 Pandemic|2|||
17141192|NCT03339999|38283446|FG000|Overall Study|Adverse Event|1|||
17141193|NCT03339999|38283447|FG001|Overall Study|Adverse Event|2|||
17141194|NCT03339999|38283448|FG002|Overall Study|Adverse Event|2|||
17141195|NCT03339999|38283449|FG003|Overall Study|Adverse Event|1|||
17141196|NCT03339999|38283446|FG000|Overall Study|Lack of Efficacy|0|||
17141197|NCT03339999|38283447|FG001|Overall Study|Lack of Efficacy|1|||
17141198|NCT03339999|38283448|FG002|Overall Study|Lack of Efficacy|0|||
17141199|NCT03339999|38283449|FG003|Overall Study|Lack of Efficacy|0|||
17141200|NCT03339999|38283446|FG000|Overall Study|Lost to Follow-up|0|||
17141201|NCT03339999|38283447|FG001|Overall Study|Lost to Follow-up|0|||
17141202|NCT03339999|38283448|FG002|Overall Study|Lost to Follow-up|0|||
17141203|NCT03339999|38283449|FG003|Overall Study|Lost to Follow-up|1|||
17141204|NCT03339999|38283446|FG000|Overall Study|Study Terminated by Sponsor|6|||
17043994|NCT03164616|38188382|FG001|Overall Study|Death|264|||
17141205|NCT03339999|38283447|FG001|Overall Study|Study Terminated by Sponsor|3|||
17141206|NCT03339999|38283448|FG002|Overall Study|Study Terminated by Sponsor|4|||
17141207|NCT03339999|38283449|FG003|Overall Study|Study Terminated by Sponsor|3|||
17141208|NCT03097328|38283462|FG000|Overall Study|Still on Therapy|2|||
17141209|NCT03097328|38283462|FG000|Overall Study|Progressive Disease|29|||
17141210|NCT03097328|38283462|FG000|Overall Study|Adverse Event|4|||
17141211|NCT03097328|38283462|FG000|Overall Study|Withdrawal by Subject|1|||
17141212|NCT03097328|38283462|FG000|Overall Study|Physician Decision|1|||
17141213|NCT03097328|38283462|FG000|Overall Study|Patient Decision|1|||
17141214|NCT03097328|38283462|FG000|Overall Study|Ineligible for Study Drug|1|||
17141215|NCT03339453|38283466|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
17141216|NCT03339453|38283467|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
17141217|NCT03761056|38283492|FG000|Overall Study|Still on Study|34|||
17141218|NCT03761056|38283492|FG000|Overall Study|Death|6|||
17141219|NCT03761056|38283492|FG000|Overall Study|Investigator Decision|1|||
17141220|NCT03761056|38283492|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
17141221|NCT03359850|38283517|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
17141222|NCT03359850|38283518|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
17141223|NCT03359850|38283517|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
17141224|NCT03359850|38283518|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
17043995|NCT03164616|38188383|FG002|Overall Study|Death|279|||
17043996|NCT03164616|38188381|FG000|Overall Study|Lost to Follow-up|2|||
17043997|NCT03164616|38188382|FG001|Overall Study|Lost to Follow-up|2|||
17043998|NCT03164616|38188383|FG002|Overall Study|Lost to Follow-up|2|||
17043999|NCT03164616|38188381|FG000|Overall Study|Withdrawal by Subject|6|||
17044000|NCT03164616|38188382|FG001|Overall Study|Withdrawal by Subject|7|||
17044001|NCT03164616|38188383|FG002|Overall Study|Withdrawal by Subject|16|||
17044002|NCT02782741|38188395|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
17044003|NCT02782741|38188396|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
17044004|NCT02782741|38188395|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
17044005|NCT02782741|38188396|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
17044006|NCT02782741|38188395|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
17044007|NCT02782741|38188396|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
17044008|NCT02782741|38188395|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
17044009|NCT02782741|38188396|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
17044010|NCT02782741|38188395|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
17044011|NCT02782741|38188396|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
17044012|NCT02771626|38188412|FG000|Overall Study|Adverse Event|1|||
17044013|NCT02771626|38188413|FG001|Overall Study|Adverse Event|5|||
17044014|NCT02771626|38188414|FG002|Overall Study|Adverse Event|3|||
17044015|NCT02771626|38188415|FG003|Overall Study|Adverse Event|0|||
17044016|NCT02771626|38188416|FG004|Overall Study|Adverse Event|1|||
17044017|NCT02771626|38188417|FG005|Overall Study|Adverse Event|1|||
17044018|NCT02771626|38188412|FG000|Overall Study|Radiologic Disease Progression|6|||
17044019|NCT02771626|38188413|FG001|Overall Study|Radiologic Disease Progression|13|||
17044020|NCT02771626|38188414|FG002|Overall Study|Radiologic Disease Progression|10|||
17044021|NCT02771626|38188415|FG003|Overall Study|Radiologic Disease Progression|7|||
17044022|NCT02771626|38188416|FG004|Overall Study|Radiologic Disease Progression|28|||
17044023|NCT02771626|38188417|FG005|Overall Study|Radiologic Disease Progression|15|||
17044024|NCT02771626|38188412|FG000|Overall Study|Symptomatic Deterioration|0|||
17044025|NCT02771626|38188413|FG001|Overall Study|Symptomatic Deterioration|4|||
17044026|NCT02771626|38188414|FG002|Overall Study|Symptomatic Deterioration|2|||
17044027|NCT02771626|38188415|FG003|Overall Study|Symptomatic Deterioration|0|||
17044028|NCT02771626|38188416|FG004|Overall Study|Symptomatic Deterioration|5|||
17044029|NCT02771626|38188417|FG005|Overall Study|Symptomatic Deterioration|2|||
17044030|NCT02771626|38188412|FG000|Overall Study|Participant Request|0|||
17044031|NCT02771626|38188413|FG001|Overall Study|Participant Request|1|||
17044032|NCT02771626|38188414|FG002|Overall Study|Participant Request|0|||
17044033|NCT02771626|38188415|FG003|Overall Study|Participant Request|2|||
17044034|NCT02771626|38188416|FG004|Overall Study|Participant Request|0|||
17044035|NCT02771626|38188417|FG005|Overall Study|Participant Request|1|||
17044036|NCT02771626|38188412|FG000|Overall Study|Investigator Decision|0|||
17044037|NCT02771626|38188413|FG001|Overall Study|Investigator Decision|1|||
17044038|NCT02771626|38188414|FG002|Overall Study|Investigator Decision|0|||
17044039|NCT02771626|38188415|FG003|Overall Study|Investigator Decision|0|||
17044040|NCT02771626|38188416|FG004|Overall Study|Investigator Decision|1|||
17044041|NCT02771626|38188417|FG005|Overall Study|Investigator Decision|0|||
17044042|NCT02771626|38188412|FG000|Overall Study|Study Termination by Sponsor|0|||
17044043|NCT02771626|38188413|FG001|Overall Study|Study Termination by Sponsor|2|||
17141225|NCT03359850|38283517|FG000|Extension Phase (Up to 28 Months)|Death|2|||
17141226|NCT03359850|38283518|FG001|Extension Phase (Up to 28 Months)|Death|4|||
17044044|NCT02771626|38188414|FG002|Overall Study|Study Termination by Sponsor|1|||
17044045|NCT02771626|38188415|FG003|Overall Study|Study Termination by Sponsor|0|||
17044046|NCT02771626|38188416|FG004|Overall Study|Study Termination by Sponsor|1|||
17141227|NCT03359850|38283517|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
17044047|NCT02771626|38188417|FG005|Overall Study|Study Termination by Sponsor|0|||
17044048|NCT02771626|38188412|FG000|Overall Study|Informed Consent Withdrawn|0|||
17044049|NCT02771626|38188413|FG001|Overall Study|Informed Consent Withdrawn|0|||
17044050|NCT02771626|38188414|FG002|Overall Study|Informed Consent Withdrawn|1|||
17044051|NCT02771626|38188415|FG003|Overall Study|Informed Consent Withdrawn|0|||
17044052|NCT02771626|38188416|FG004|Overall Study|Informed Consent Withdrawn|1|||
17044053|NCT02771626|38188417|FG005|Overall Study|Informed Consent Withdrawn|1|||
17044054|NCT02771626|38188412|FG000|Overall Study|Other, Not Specified|1|||
17044055|NCT02771626|38188413|FG001|Overall Study|Other, Not Specified|0|||
17044056|NCT02771626|38188414|FG002|Overall Study|Other, Not Specified|0|||
17044057|NCT02771626|38188415|FG003|Overall Study|Other, Not Specified|0|||
17044058|NCT02771626|38188416|FG004|Overall Study|Other, Not Specified|0|||
17044059|NCT02771626|38188417|FG005|Overall Study|Other, Not Specified|1|||
17044060|NCT02677896|38188433|FG000|Double Blind Period (up to 35 Months)|Death|113|||
17044061|NCT02677896|38188434|FG001|Double Blind Period (up to 35 Months)|Death|189|||
17044062|NCT02677896|38188433|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
17044063|NCT02677896|38188434|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
17044064|NCT02677896|38188433|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
17044065|NCT02677896|38188434|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
17044066|NCT02677896|38188433|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
17044067|NCT02677896|38188434|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
17044068|NCT02677896|38188433|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
17044069|NCT02677896|38188434|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
17044070|NCT02677896|38188433|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
17044071|NCT02677896|38188434|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
17044072|NCT02677896|38188433|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
17044073|NCT02677896|38188434|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
17044074|NCT02677896|38188433|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
17044075|NCT02677896|38188434|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
17044076|NCT02677896|38188433|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
17044077|NCT02677896|38188434|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
17044078|NCT02677896|38188433|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
17044079|NCT02677896|38188434|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
17044080|NCT02677896|38188433|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
17044081|NCT02677896|38188434|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
17044082|NCT02677896|38188433|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
17044083|NCT02677896|38188434|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
17044084|NCT02677896|38188433|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
17044085|NCT02677896|38188434|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
17044086|NCT02677896|38188433|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
17044087|NCT02677896|38188434|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
17044088|NCT02272790|38188447|FG000|Overall Study|Physician Decision|0|||
17044089|NCT02272790|38188448|FG001|Overall Study|Physician Decision|1|||
17044090|NCT02272790|38188449|FG002|Overall Study|Physician Decision|0|||
17044091|NCT02272790|38188450|FG003|Overall Study|Physician Decision|0|||
17044092|NCT02272790|38188451|FG004|Overall Study|Physician Decision|0|||
17044093|NCT02272790|38188452|FG005|Overall Study|Physician Decision|0|||
17044094|NCT01566695|38188474|FG000|Overall Study|Lack of Efficacy|18|||
17044095|NCT01566695|38188475|FG001|Overall Study|Lack of Efficacy|45|||
17044096|NCT01566695|38188474|FG000|Overall Study|Adverse Event|28|||
17044097|NCT01566695|38188475|FG001|Overall Study|Adverse Event|27|||
17044098|NCT01566695|38188474|FG000|Overall Study|Death|20|||
17044099|NCT01566695|38188475|FG001|Overall Study|Death|8|||
17044100|NCT01566695|38188474|FG000|Overall Study|Withdrawal by Subject|14|||
17044101|NCT01566695|38188475|FG001|Overall Study|Withdrawal by Subject|7|||
17044102|NCT01566695|38188474|FG000|Overall Study|Progressive Disease|11|||
17044103|NCT01566695|38188475|FG001|Overall Study|Progressive Disease|6|||
17044104|NCT01566695|38188474|FG000|Overall Study|Miscellaneous|4|||
17044105|NCT01566695|38188475|FG001|Overall Study|Miscellaneous|6|||
17044106|NCT01557751|38188481|FG000|Overall Study|Physician Decision|3|||
17044107|NCT01464164|38188492|FG000|Overall Study|Screen failure|0|||
17044108|NCT01464164|38188493|FG001|Overall Study|Screen failure|1|||
17044109|NCT01464164|38188494|FG002|Overall Study|Screen failure|2|||
17044110|NCT01464164|38188495|FG003|Overall Study|Screen failure|0|||
17044111|NCT01464164|38188496|FG004|Overall Study|Screen failure|0|||
17044112|NCT01464164|38188497|FG005|Overall Study|Screen failure|0|||
17044113|NCT01464164|38188498|FG006|Overall Study|Screen failure|0|||
17044114|NCT01464164|38188492|FG000|Overall Study|Physician Decision|0|||
17044115|NCT01464164|38188493|FG001|Overall Study|Physician Decision|1|||
17044116|NCT01464164|38188494|FG002|Overall Study|Physician Decision|0|||
17044117|NCT01464164|38188495|FG003|Overall Study|Physician Decision|0|||
17044118|NCT01464164|38188496|FG004|Overall Study|Physician Decision|0|||
17044119|NCT01464164|38188497|FG005|Overall Study|Physician Decision|0|||
17044120|NCT01464164|38188498|FG006|Overall Study|Physician Decision|2|||
17044121|NCT01377389|38188514|FG000|Overall Study|Withdrawal by Subject|1|||
17044122|NCT01377389|38188514|FG000|Overall Study|Screen failure|2|||
17044123|NCT01194271|38188518|FG000|Overall Study|Withdrawal by Subject|1|||
17044124|NCT01194271|38188518|FG000|Overall Study|Ineligible, Screen Failure|1|||
17044125|NCT01194271|38188518|FG000|Overall Study|Death|1|||
17044126|NCT01119508|38188522|FG000|Overall Study|Adverse Event|56|||
17044127|NCT01119508|38188522|FG000|Overall Study|Withdrawal by Subject|2|||
17044128|NCT01119508|38188522|FG000|Overall Study|Died before tumor response evaluation|1|||
17044129|NCT00769379|38188528|FG000|Overall Study|No follow up data mapped to Other.|3|||
17044130|NCT00769379|38188529|FG001|Overall Study|No follow up data mapped to Other.|13|||
17044131|NCT00568776|38188562|FG000|Overall Study|Adverse Event|8|||
17044132|NCT00568776|38188563|FG001|Overall Study|Adverse Event|8|||
17044133|NCT00568776|38188564|FG002|Overall Study|Adverse Event|10|||
17044134|NCT00568776|38188565|FG003|Overall Study|Adverse Event|8|||
17044135|NCT00568776|38188562|FG000|Overall Study|Death|0|||
17044136|NCT00568776|38188563|FG001|Overall Study|Death|1|||
17044137|NCT00568776|38188564|FG002|Overall Study|Death|4|||
17044138|NCT00568776|38188565|FG003|Overall Study|Death|3|||
17044139|NCT00568776|38188562|FG000|Overall Study|Physician Decision|0|||
17044140|NCT00568776|38188563|FG001|Overall Study|Physician Decision|2|||
17044141|NCT00568776|38188564|FG002|Overall Study|Physician Decision|0|||
17044142|NCT00568776|38188565|FG003|Overall Study|Physician Decision|0|||
17044143|NCT00568776|38188562|FG000|Overall Study|Lack of Efficacy|2|||
17044144|NCT00568776|38188563|FG001|Overall Study|Lack of Efficacy|2|||
17141228|NCT03359850|38283518|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
17044145|NCT00568776|38188564|FG002|Overall Study|Lack of Efficacy|2|||
17044146|NCT00568776|38188565|FG003|Overall Study|Lack of Efficacy|4|||
17044147|NCT00568776|38188562|FG000|Overall Study|Lost to Follow-up|1|||
17044148|NCT00568776|38188563|FG001|Overall Study|Lost to Follow-up|1|||
17044149|NCT00568776|38188564|FG002|Overall Study|Lost to Follow-up|1|||
17044150|NCT00568776|38188565|FG003|Overall Study|Lost to Follow-up|1|||
17044151|NCT00568776|38188562|FG000|Overall Study|Protocol Violation|1|||
17044152|NCT00568776|38188563|FG001|Overall Study|Protocol Violation|0|||
17044153|NCT00568776|38188564|FG002|Overall Study|Protocol Violation|1|||
17044154|NCT00568776|38188565|FG003|Overall Study|Protocol Violation|1|||
17044155|NCT00568776|38188562|FG000|Overall Study|Withdrawal by Subject|13|||
17044156|NCT00568776|38188563|FG001|Overall Study|Withdrawal by Subject|15|||
17044157|NCT00568776|38188564|FG002|Overall Study|Withdrawal by Subject|13|||
17044158|NCT00568776|38188565|FG003|Overall Study|Withdrawal by Subject|7|||
17044159|NCT00568776|38188562|FG000|Overall Study|Loss of Caregiver|0|||
17044160|NCT00568776|38188563|FG001|Overall Study|Loss of Caregiver|2|||
17044161|NCT00568776|38188564|FG002|Overall Study|Loss of Caregiver|1|||
17044162|NCT00568776|38188565|FG003|Overall Study|Loss of Caregiver|2|||
17044163|NCT00568776|38188562|FG000|Overall Study|Sponsor Decision|2|||
17044164|NCT00568776|38188563|FG001|Overall Study|Sponsor Decision|2|||
17044165|NCT00568776|38188564|FG002|Overall Study|Sponsor Decision|41|||
17044166|NCT00568776|38188565|FG003|Overall Study|Sponsor Decision|42|||
17044167|NCT00568776|38188562|FG000|Overall Study|Miscellaeneous|3|||
17044168|NCT00568776|38188563|FG001|Overall Study|Miscellaeneous|3|||
17044169|NCT00568776|38188564|FG002|Overall Study|Miscellaeneous|1|||
17044170|NCT00568776|38188565|FG003|Overall Study|Miscellaeneous|4|||
17044171|NCT00758771|38188577|FG000|Overall Study|Withdrawal by Subject|1|||
17044172|NCT00758771|38188578|FG001|Overall Study|Withdrawal by Subject|1|||
17044173|NCT00758771|38188577|FG000|Overall Study|Did not meet eligibility criteria|2|||
17044174|NCT00758771|38188578|FG001|Overall Study|Did not meet eligibility criteria|4|||
17044175|NCT00635154|38188584|FG000|Overall Study|Alternative Treatment|8|||
17044176|NCT00635154|38188584|FG000|Overall Study|Other|4|||
17044177|NCT00635154|38188584|FG000|Overall Study|Still on treatment|21|||
17044178|NCT00778895|38188593|FG000|Active Phase|Adverse Event|3|||
17044179|NCT00778895|38188594|FG001|Active Phase|Adverse Event|1|||
17044180|NCT00778895|38188595|FG002|Active Phase|Adverse Event|0|||
17044181|NCT00778895|38188593|FG000|Active Phase|Withdrawal by Subject|1|||
17044182|NCT00778895|38188594|FG001|Active Phase|Withdrawal by Subject|4|||
17044183|NCT00778895|38188595|FG002|Active Phase|Withdrawal by Subject|0|||
17044184|NCT00778895|38188593|FG000|Active Phase|Lost to Follow-up|1|||
17044185|NCT00778895|38188594|FG001|Active Phase|Lost to Follow-up|1|||
17044186|NCT00778895|38188595|FG002|Active Phase|Lost to Follow-up|0|||
17044187|NCT00778895|38188593|FG000|Active Phase|Other|2|||
17044188|NCT00778895|38188594|FG001|Active Phase|Other|0|||
17044189|NCT00778895|38188595|FG002|Active Phase|Other|0|||
17044190|NCT00778895|38188593|FG000|ESFU Phase|Adverse Event|2|||
17044191|NCT00778895|38188594|FG001|ESFU Phase|Adverse Event|1|||
17044192|NCT00778895|38188595|FG002|ESFU Phase|Adverse Event|0|||
17044193|NCT00778895|38188593|FG000|ESFU Phase|Withdrawal by Subject|1|||
17044194|NCT00778895|38188594|FG001|ESFU Phase|Withdrawal by Subject|4|||
17044195|NCT00778895|38188595|FG002|ESFU Phase|Withdrawal by Subject|0|||
17044196|NCT00778895|38188593|FG000|ESFU Phase|Lost to Follow-up|6|||
17044197|NCT00778895|38188594|FG001|ESFU Phase|Lost to Follow-up|7|||
17044198|NCT00778895|38188595|FG002|ESFU Phase|Lost to Follow-up|2|||
17044199|NCT00778895|38188593|FG000|ESFU Phase|Other|2|||
17044200|NCT00778895|38188594|FG001|ESFU Phase|Other|0|||
17044201|NCT00778895|38188595|FG002|ESFU Phase|Other|0|||
17044202|NCT00293215|38188606|FG000|Overall Study|Progressive disease|3|||
17044203|NCT00293215|38188607|FG001|Overall Study|Progressive disease|1|||
17044204|NCT00293215|38188606|FG000|Overall Study|Adverse Event|2|||
17044205|NCT00293215|38188607|FG001|Overall Study|Adverse Event|2|||
17044206|NCT00778817|38188613|FG000|Overall Study|Adverse Event|2|||
17044207|NCT00778817|38188613|FG000|Overall Study|Withdrawal by Subject|2|||
17044208|NCT00293059|38188619|FG000|Overall Study|Adverse Event|12|||
17044209|NCT00293059|38188620|FG001|Overall Study|Adverse Event|4|||
17044210|NCT00293059|38188619|FG000|Overall Study|Lack of Efficacy|2|||
17044211|NCT00293059|38188620|FG001|Overall Study|Lack of Efficacy|0|||
17044212|NCT00293059|38188619|FG000|Overall Study|Lost to Follow-up|2|||
17044213|NCT00293059|38188620|FG001|Overall Study|Lost to Follow-up|3|||
17044214|NCT00293059|38188619|FG000|Overall Study|Pregnancy|1|||
17044215|NCT00293059|38188620|FG001|Overall Study|Pregnancy|1|||
17141229|NCT03359850|38283517|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
17044216|NCT00293059|38188619|FG000|Overall Study|Protocol Violation|2|||
17044217|NCT00293059|38188620|FG001|Overall Study|Protocol Violation|0|||
17044218|NCT00293059|38188619|FG000|Overall Study|Withdrawal by Subject|11|||
17044219|NCT00293059|38188620|FG001|Overall Study|Withdrawal by Subject|5|||
17044220|NCT00293059|38188619|FG000|Overall Study|Participant moved out of state|1|||
17044221|NCT00293059|38188620|FG001|Overall Study|Participant moved out of state|0|||
17044222|NCT00293059|38188619|FG000|Overall Study|Participant stopped study drug|1|||
17044223|NCT00293059|38188620|FG001|Overall Study|Participant stopped study drug|0|||
17044224|NCT00293059|38188619|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
17044225|NCT00293059|38188620|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
17044226|NCT00293059|38188619|FG000|Overall Study|missing|3|||
17044227|NCT00293059|38188620|FG001|Overall Study|missing|5|||
17044228|NCT00756275|38188628|FG000|Overall Study|Lost to Follow-up|25|||
17044229|NCT00756275|38188629|FG001|Overall Study|Lost to Follow-up|21|||
17044230|NCT00756275|38188628|FG000|Overall Study|Withdrawal by Subject|4|||
17044231|NCT00756275|38188629|FG001|Overall Study|Withdrawal by Subject|7|||
17044232|NCT00758459|38188637|FG000|Overall Study|Adverse Event|3|||
17044233|NCT00758459|38188638|FG001|Overall Study|Adverse Event|2|||
17044234|NCT00758459|38188637|FG000|Overall Study|Protocol Violation|0|||
17141230|NCT03359850|38283518|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
17141231|NCT00114140|38283537|FG000|Overall Study|Protocol Violation|7|||
17141232|NCT03342690|38283548|FG000|Overall Study|Missing Information|9|||
17141233|NCT03342690|38283548|FG000|Overall Study|Protocol Violation|16|||
17141234|NCT03712345|38283555|FG000|Overall Study|Failure to meet randomization criteria|0|||
17141235|NCT03712345|38283556|FG001|Overall Study|Failure to meet randomization criteria|0|||
17141236|NCT03712345|38283557|FG002|Overall Study|Failure to meet randomization criteria|1|||
17141237|NCT03358290|38283570|FG000|Overall Study|Study discontinued by Sponsor|0|||
17044235|NCT00758459|38188638|FG001|Overall Study|Protocol Violation|1|||
17044236|NCT00758459|38188637|FG000|Overall Study|Withdrawal by Subject|0|||
17044237|NCT00758459|38188638|FG001|Overall Study|Withdrawal by Subject|1|||
17044238|NCT00298831|38188644|FG000|Overall Study|Adverse Event|1|||
17044239|NCT00298831|38188644|FG000|Overall Study|Lost to Follow-up|3|||
17044240|NCT00298831|38188644|FG000|Overall Study|Withdrawal by Subject|1|||
17044241|NCT00298831|38188644|FG000|Overall Study|Participants did not receive treatment|27|||
17044242|NCT00758069|38188651|FG000|Overall Study|Lack of Efficacy|0|||
17044243|NCT00758069|38188652|FG001|Overall Study|Lack of Efficacy|0|||
17044244|NCT00758069|38188653|FG002|Overall Study|Lack of Efficacy|1|||
17044245|NCT00758069|38188651|FG000|Overall Study|Incorrect Study Drug|1|||
17044246|NCT00758069|38188652|FG001|Overall Study|Incorrect Study Drug|0|||
17044247|NCT00758069|38188653|FG002|Overall Study|Incorrect Study Drug|0|||
17044248|NCT00311623|38188664|FG000|Overall Study|Physician Decision|0|||
17044249|NCT00311623|38188665|FG001|Overall Study|Physician Decision|0|||
17044250|NCT00311623|38188666|FG002|Overall Study|Physician Decision|2|||
17044251|NCT00528112|38188677|FG000|Treatment up to 3 Years|Adverse Event|313|||
17044252|NCT00528112|38188678|FG001|Treatment up to 3 Years|Adverse Event|278|||
17044253|NCT00528112|38188677|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
17044254|NCT00528112|38188678|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
17044255|NCT00528112|38188677|FG000|Treatment up to 3 Years|Protocol Violation|16|||
17044256|NCT00528112|38188678|FG001|Treatment up to 3 Years|Protocol Violation|16|||
17044257|NCT00528112|38188677|FG000|Treatment up to 3 Years|Death|0|||
17044258|NCT00528112|38188678|FG001|Treatment up to 3 Years|Death|1|||
17044259|NCT00528112|38188677|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
17044260|NCT00528112|38188678|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
17044261|NCT00528112|38188677|FG000|Treatment up to 3 Years|Pregnancy|9|||
17044262|NCT00528112|38188678|FG001|Treatment up to 3 Years|Pregnancy|10|||
17044263|NCT00528112|38188677|FG000|Treatment up to 3 Years|Other reasons|186|||
17044264|NCT00528112|38188678|FG001|Treatment up to 3 Years|Other reasons|186|||
17044265|NCT00528112|38188677|FG000|Extension Phase|Withdrawal by Subject|0|||
17044266|NCT00528112|38188678|FG001|Extension Phase|Withdrawal by Subject|3|||
17044267|NCT00528112|38188677|FG000|Extension Phase|Other reasons|0|||
17044268|NCT00528112|38188678|FG001|Extension Phase|Other reasons|100|||
17044269|NCT00528112|38188677|FG000|Extension Phase|Pregnancy|0|||
17044270|NCT00528112|38188678|FG001|Extension Phase|Pregnancy|3|||
17044271|NCT00528112|38188677|FG000|Extension Phase|Lost to Follow-up|0|||
17044272|NCT00528112|38188678|FG001|Extension Phase|Lost to Follow-up|12|||
17044273|NCT00528112|38188677|FG000|Extension Phase|Death|0|||
17044274|NCT00528112|38188678|FG001|Extension Phase|Death|1|||
17044275|NCT00528112|38188677|FG000|Extension Phase|Adverse Event|0|||
17044276|NCT00528112|38188678|FG001|Extension Phase|Adverse Event|36|||
17044277|NCT00528112|38188677|FG000|Extension Phase|Protocol Violation|0|||
17044278|NCT00528112|38188678|FG001|Extension Phase|Protocol Violation|2|||
17044279|NCT00633594|38188689|FG000|Overall Study|Adverse Event|0|||
17044280|NCT00633594|38188690|FG001|Overall Study|Adverse Event|4|||
17044281|NCT00633594|38188691|FG002|Overall Study|Adverse Event|7|||
17044282|NCT00633594|38188689|FG000|Overall Study|Death|0|||
17044283|NCT00633594|38188690|FG001|Overall Study|Death|1|||
17044284|NCT00633594|38188691|FG002|Overall Study|Death|2|||
17044285|NCT00633594|38188689|FG000|Overall Study|Disease Progression|0|||
17044286|NCT00633594|38188690|FG001|Overall Study|Disease Progression|0|||
17044287|NCT00633594|38188691|FG002|Overall Study|Disease Progression|1|||
17044288|NCT00755807|38188704|FG000|Acute Phase|Adverse Event|16|||
17044289|NCT00755807|38188705|FG001|Acute Phase|Adverse Event|5|||
17044290|NCT00755807|38188704|FG000|Acute Phase|Protocol Violation|1|||
17044291|NCT00755807|38188705|FG001|Acute Phase|Protocol Violation|3|||
17044292|NCT00755807|38188704|FG000|Acute Phase|Withdrawal by Subject|1|||
17044293|NCT00755807|38188705|FG001|Acute Phase|Withdrawal by Subject|2|||
17044294|NCT00755807|38188704|FG000|Acute Phase|Lack of Efficacy|0|||
17044295|NCT00755807|38188705|FG001|Acute Phase|Lack of Efficacy|1|||
17044296|NCT00755807|38188704|FG000|Acute Phase|Physician Decision|0|||
17141238|NCT03358290|38283571|FG001|Overall Study|Study discontinued by Sponsor|1|||
17141239|NCT03358290|38283572|FG002|Overall Study|Study discontinued by Sponsor|1|||
17044297|NCT00755807|38188705|FG001|Acute Phase|Physician Decision|1|||
17044298|NCT00755807|38188704|FG000|Open-label Extension Phase|Adverse Event|7|||
17044299|NCT00755807|38188705|FG001|Open-label Extension Phase|Adverse Event|7|||
17044300|NCT00755807|38188704|FG000|Open-label Extension Phase|Protocol Violation|5|||
17044301|NCT00755807|38188705|FG001|Open-label Extension Phase|Protocol Violation|2|||
17044302|NCT00755807|38188704|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
17044303|NCT00755807|38188705|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
17044304|NCT00755807|38188704|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
17044305|NCT00755807|38188705|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
17044306|NCT00755807|38188704|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
17044307|NCT00755807|38188705|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
17044308|NCT00755807|38188704|FG000|Open-label Extension Phase|Sponsor Decision|0|||
17044309|NCT00755807|38188705|FG001|Open-label Extension Phase|Sponsor Decision|1|||
17044310|NCT00631410|38188717|FG000|Overall Study|Adverse Event|1|||
17044311|NCT00631410|38188718|FG001|Overall Study|Adverse Event|3|||
17044312|NCT00631410|38188717|FG000|Overall Study|Objective Progression or Relapse|4|||
17044313|NCT00631410|38188718|FG001|Overall Study|Objective Progression or Relapse|3|||
17044314|NCT00631410|38188717|FG000|Overall Study|Surgery|1|||
17044315|NCT00631410|38188718|FG001|Overall Study|Surgery|0|||
17044316|NCT03686176|38188730|FG000|Overall Study|Procedure cancelled|1|||
17044317|NCT03686176|38188731|FG001|Overall Study|Procedure cancelled|0|||
17044318|NCT03686176|38188732|FG002|Overall Study|Procedure cancelled|0|||
17044319|NCT03686176|38188730|FG000|Overall Study|VR Malfunction|1|||
17044320|NCT03686176|38188731|FG001|Overall Study|VR Malfunction|0|||
17044321|NCT03686176|38188732|FG002|Overall Study|VR Malfunction|0|||
17044322|NCT00755417|38188743|FG000|Overall Study|Adverse Event|28|||
17044323|NCT00755417|38188744|FG001|Overall Study|Adverse Event|20|||
17044324|NCT00755417|38188745|FG002|Overall Study|Adverse Event|7|||
17044325|NCT00755417|38188743|FG000|Overall Study|Lack of Efficacy|8|||
17044326|NCT00755417|38188744|FG001|Overall Study|Lack of Efficacy|4|||
17044327|NCT00755417|38188745|FG002|Overall Study|Lack of Efficacy|9|||
17044328|NCT00755417|38188743|FG000|Overall Study|Protocol Violation|2|||
17044329|NCT00755417|38188744|FG001|Overall Study|Protocol Violation|1|||
17044330|NCT00755417|38188745|FG002|Overall Study|Protocol Violation|1|||
17044331|NCT00755417|38188743|FG000|Overall Study|Lost to Follow-up|3|||
17044332|NCT00755417|38188744|FG001|Overall Study|Lost to Follow-up|0|||
17044333|NCT00755417|38188745|FG002|Overall Study|Lost to Follow-up|1|||
17044334|NCT00755417|38188743|FG000|Overall Study|Withdrawal by Subject|12|||
17044335|NCT00755417|38188744|FG001|Overall Study|Withdrawal by Subject|12|||
17044336|NCT00755417|38188745|FG002|Overall Study|Withdrawal by Subject|12|||
17044337|NCT00755417|38188743|FG000|Overall Study|Not specified or missing data|9|||
17044338|NCT00755417|38188744|FG001|Overall Study|Not specified or missing data|18|||
17044339|NCT00755417|38188745|FG002|Overall Study|Not specified or missing data|12|||
17044340|NCT03685708|38188756|FG000|Overall Study|Withdrawal by Subject|0|||
17044341|NCT03685708|38188757|FG001|Overall Study|Withdrawal by Subject|0|||
17044342|NCT03685708|38188758|FG002|Overall Study|Withdrawal by Subject|1|||
17044343|NCT03685708|38188756|FG000|Overall Study|Screen Fail|0|||
17044344|NCT03685708|38188757|FG001|Overall Study|Screen Fail|1|||
17044345|NCT03685708|38188758|FG002|Overall Study|Screen Fail|1|||
17044346|NCT03685708|38188756|FG000|Overall Study|COVID 19 Pandemic|1|||
17044347|NCT03685708|38188757|FG001|Overall Study|COVID 19 Pandemic|1|||
17044348|NCT03685708|38188758|FG002|Overall Study|COVID 19 Pandemic|6|||
17044349|NCT03685708|38188756|FG000|Overall Study|Disease Progression|0|||
17044350|NCT03685708|38188757|FG001|Overall Study|Disease Progression|0|||
17044351|NCT03685708|38188758|FG002|Overall Study|Disease Progression|1|||
17044352|NCT03684928|38188766|FG000|First Intervention|Lost to Follow-up|0|||
17044353|NCT03684928|38188767|FG001|First Intervention|Lost to Follow-up|1|||
17044354|NCT03684928|38188766|FG000|First Intervention|Withdrawal by Subject|0|||
17044355|NCT03684928|38188767|FG001|First Intervention|Withdrawal by Subject|2|||
17044356|NCT03684928|38188766|FG000|Second Intervention|Soft Tissue Injury|1|||
17044357|NCT03684928|38188767|FG001|Second Intervention|Soft Tissue Injury|0|||
17044358|NCT00777803|38188775|FG000|Overall Study|Lost to Follow-up|12|||
17044359|NCT00777803|38188776|FG001|Overall Study|Lost to Follow-up|5|||
17044360|NCT00777803|38188775|FG000|Overall Study|Adverse Event|1|||
17044361|NCT00777803|38188776|FG001|Overall Study|Adverse Event|0|||
17044362|NCT00777803|38188775|FG000|Overall Study|Non-compliance|2|||
17044363|NCT00777803|38188776|FG001|Overall Study|Non-compliance|2|||
17044364|NCT00527488|38188786|FG000|Overall Study|Withdrawn prior to dosing|0|||
17044365|NCT00527488|38188787|FG001|Overall Study|Withdrawn prior to dosing|1|||
17044366|NCT00527488|38188788|FG002|Overall Study|Withdrawn prior to dosing|1|||
17044367|NCT00527488|38188789|FG003|Overall Study|Withdrawn prior to dosing|0|||
17044368|NCT00527332|38188801|FG000|Overall Study|Protocol Violation|4|||
17044369|NCT00527332|38188802|FG001|Overall Study|Protocol Violation|8|||
17044370|NCT00527332|38188801|FG000|Overall Study|Withdrew consent|5|||
17044371|NCT00527332|38188802|FG001|Overall Study|Withdrew consent|1|||
17044372|NCT00752609|38188810|FG000|Overall Study|Adverse Event|2|||
17044373|NCT00752609|38188811|FG001|Overall Study|Adverse Event|2|||
17044374|NCT00752609|38188810|FG000|Overall Study|Withdrawal by Subject|3|||
17044375|NCT00752609|38188811|FG001|Overall Study|Withdrawal by Subject|0|||
17044376|NCT00752609|38188810|FG000|Overall Study|Physician Decision|1|||
17044377|NCT00752609|38188811|FG001|Overall Study|Physician Decision|0|||
17044378|NCT00752609|38188810|FG000|Overall Study|Death|1|||
17044379|NCT00752609|38188811|FG001|Overall Study|Death|0|||
17044380|NCT00752609|38188810|FG000|Overall Study|Met exclusion criteria|1|||
17044381|NCT00752609|38188811|FG001|Overall Study|Met exclusion criteria|0|||
17044382|NCT00752609|38188810|FG000|Overall Study|Received Aranesp in error|1|||
17044383|NCT00752609|38188811|FG001|Overall Study|Received Aranesp in error|0|||
17044384|NCT03684304|38188822|FG000|Overall Study|Lost to Follow-up|19|||
17044385|NCT03684304|38188823|FG001|Overall Study|Lost to Follow-up|17|||
17044386|NCT00629772|38188831|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
17044387|NCT00629772|38188832|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
17044388|NCT00629772|38188831|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
17044389|NCT00629772|38188832|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
17044390|NCT00526630|38188839|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
17044391|NCT00526630|38188840|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
17044392|NCT00526630|38188839|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
17044393|NCT00526630|38188840|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
17044394|NCT00755183|38188850|FG000|Overall Study|Adverse Event|5|||
17044395|NCT00755183|38188851|FG001|Overall Study|Adverse Event|2|||
17044396|NCT00755183|38188850|FG000|Overall Study|Protocol Violation|0|||
17044397|NCT00755183|38188851|FG001|Overall Study|Protocol Violation|1|||
17141240|NCT03358290|38283573|FG003|Overall Study|Study discontinued by Sponsor|0|||
17141241|NCT03358290|38283574|FG004|Overall Study|Study discontinued by Sponsor|0|||
17141242|NCT03358290|38283570|FG000|Overall Study|Adverse Event|0|||
17141243|NCT03358290|38283571|FG001|Overall Study|Adverse Event|0|||
17141244|NCT03358290|38283572|FG002|Overall Study|Adverse Event|1|||
17141245|NCT03358290|38283573|FG003|Overall Study|Adverse Event|2|||
17141246|NCT03358290|38283574|FG004|Overall Study|Adverse Event|0|||
17141247|NCT03358290|38283570|FG000|Overall Study|Withdrawal by Subject|0|||
17141248|NCT03358290|38283571|FG001|Overall Study|Withdrawal by Subject|0|||
17141249|NCT03358290|38283572|FG002|Overall Study|Withdrawal by Subject|0|||
17141250|NCT03358290|38283573|FG003|Overall Study|Withdrawal by Subject|0|||
17044398|NCT00755183|38188850|FG000|Overall Study|Withdrawal by Subject|0|||
17044399|NCT00755183|38188851|FG001|Overall Study|Withdrawal by Subject|2|||
17044400|NCT00755183|38188850|FG000|Overall Study|Administrative|2|||
17044401|NCT00755183|38188851|FG001|Overall Study|Administrative|1|||
17044402|NCT00755105|38188862|FG000|Overall Study|Withdrawal by Subject|9|||
17044403|NCT00755105|38188863|FG001|Overall Study|Withdrawal by Subject|11|||
17044404|NCT00755105|38188864|FG002|Overall Study|Withdrawal by Subject|4|||
17141251|NCT03358290|38283574|FG004|Overall Study|Withdrawal by Subject|1|||
17141252|NCT03089216|38283590|FG000|Overall Study|Adverse Event|0|||
17141253|NCT03089216|38283591|FG001|Overall Study|Adverse Event|0|||
17141254|NCT03089216|38283592|FG002|Overall Study|Adverse Event|0|||
17141255|NCT03089216|38283593|FG003|Overall Study|Adverse Event|1|||
17141256|NCT03339726|38283610|FG000|Overall Study|Withdrawal by Subject|1|||
17141257|NCT03339726|38283611|FG001|Overall Study|Withdrawal by Subject|0|||
17141258|NCT03339726|38283612|FG002|Overall Study|Withdrawal by Subject|0|||
16780492|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
16780493|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
16780494|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
16780495|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
16780496|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
16780497|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
16780498|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
16780499|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
16780500|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
16780501|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
16780502|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
16780503|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
16780504|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
16780505|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
16780506|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
17141259|NCT03339726|38283610|FG000|Overall Study|Lost to Follow-up|0|||
16780507|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
17044405|NCT00526162|38188872|FG000|Overall Study|Device not implanted|3|||
17044406|NCT03875482|38188882|FG000|Overall Study|Adverse Event|0|||
17044407|NCT03875482|38188883|FG001|Overall Study|Adverse Event|1|||
17044408|NCT03875482|38188882|FG000|Overall Study|Withdrew consent|5|||
17044409|NCT03875482|38188883|FG001|Overall Study|Withdrew consent|6|||
17044410|NCT03875482|38188882|FG000|Overall Study|Lost to Follow-up|8|||
17044411|NCT03875482|38188883|FG001|Overall Study|Lost to Follow-up|2|||
17044412|NCT03875482|38188882|FG000|Overall Study|Lack of Efficacy|0|||
17044413|NCT03875482|38188883|FG001|Overall Study|Lack of Efficacy|11|||
17044414|NCT00754793|38188891|FG000|Overall Study|voluntary withdrawn from study|0|||
17044415|NCT00754793|38188892|FG001|Overall Study|voluntary withdrawn from study|1|||
17044416|NCT00586469|38188900|FG000|Overall Study|Adverse Event|0|||
17044417|NCT00586469|38188901|FG001|Overall Study|Adverse Event|1|||
17044418|NCT00626028|38188909|FG000|Overall Study|Adverse Event|1|||
17044419|NCT00626028|38188910|FG001|Overall Study|Adverse Event|1|||
17044420|NCT00626028|38188909|FG000|Overall Study|Device Failure|0|||
17044421|NCT00626028|38188910|FG001|Overall Study|Device Failure|1|||
17044422|NCT00626028|38188909|FG000|Overall Study|Physician Decision|2|||
17044423|NCT00626028|38188910|FG001|Overall Study|Physician Decision|1|||
17044424|NCT00626028|38188909|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
17044425|NCT00626028|38188910|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
17044426|NCT00777257|38188919|FG000|Overall Study|Adverse Event|3|||
17044427|NCT00777257|38188920|FG001|Overall Study|Adverse Event|1|||
17044428|NCT00777257|38188921|FG002|Overall Study|Adverse Event|0|||
17044429|NCT00777257|38188919|FG000|Overall Study|Lost to Follow-up|3|||
17044430|NCT00777257|38188920|FG001|Overall Study|Lost to Follow-up|3|||
17044431|NCT00777257|38188921|FG002|Overall Study|Lost to Follow-up|2|||
17044432|NCT00777257|38188919|FG000|Overall Study|Protocol Violation|2|||
17044433|NCT00777257|38188920|FG001|Overall Study|Protocol Violation|2|||
17044434|NCT00777257|38188921|FG002|Overall Study|Protocol Violation|2|||
17044435|NCT00777257|38188919|FG000|Overall Study|Withdrawal by Subject|3|||
17044436|NCT00777257|38188920|FG001|Overall Study|Withdrawal by Subject|6|||
17044437|NCT00777257|38188921|FG002|Overall Study|Withdrawal by Subject|5|||
17044438|NCT00628758|38188931|FG000|Overall Study|Adverse Event|2|||
17044439|NCT00628758|38188932|FG001|Overall Study|Adverse Event|3|||
17044440|NCT00628758|38188931|FG000|Overall Study|Withdrawal by Subject|6|||
17044441|NCT00628758|38188932|FG001|Overall Study|Withdrawal by Subject|3|||
17044442|NCT00628758|38188931|FG000|Overall Study|Death|1|||
17044443|NCT00628758|38188932|FG001|Overall Study|Death|0|||
17044444|NCT00628758|38188931|FG000|Overall Study|Protocol Violation|5|||
17044445|NCT00628758|38188932|FG001|Overall Study|Protocol Violation|1|||
17044446|NCT00628758|38188931|FG000|Overall Study|Lost to Follow-up|25|||
17044447|NCT00628758|38188932|FG001|Overall Study|Lost to Follow-up|31|||
17044448|NCT00628758|38188931|FG000|Overall Study|Pregnancy|2|||
17044449|NCT00628758|38188932|FG001|Overall Study|Pregnancy|2|||
17044450|NCT00628758|38188931|FG000|Overall Study|Investigator Moved|3|||
17044451|NCT00628758|38188932|FG001|Overall Study|Investigator Moved|0|||
17044452|NCT00628758|38188931|FG000|Overall Study|Treatment Failure|0|||
17044453|NCT00628758|38188932|FG001|Overall Study|Treatment Failure|2|||
17044454|NCT04491604|38188940|FG000|Overall Study|Withdrawal by Subject|3|||
17044455|NCT00628446|38188945|FG000|Overall Study|Lost to Follow-up|3|||
17044456|NCT00628446|38188945|FG000|Overall Study|Withdrawal by Subject|1|||
17044457|NCT00628446|38188945|FG000|Overall Study|Protocol Violation|3|||
17044458|NCT00754559|38188950|FG000|Overall Study|Adverse Event|15|||
17044459|NCT00754559|38188950|FG000|Overall Study|Protocol Violation|11|||
17044460|NCT00754559|38188950|FG000|Overall Study|Lack of Efficacy|10|||
17044461|NCT00754559|38188950|FG000|Overall Study|Lost to Follow-up|2|||
17044462|NCT00754559|38188950|FG000|Overall Study|Administrative reason|1|||
17044463|NCT00754559|38188950|FG000|Overall Study|Other|5|||
17044464|NCT00754559|38188950|FG000|Overall Study|Withdrawal by Subject|3|||
17044465|NCT00525148|38188961|FG000|Overall Study|Other Adverse Event|3|||
17044466|NCT00525148|38188962|FG001|Overall Study|Other Adverse Event|5|||
17044467|NCT00525148|38188963|FG002|Overall Study|Other Adverse Event|1|||
17044468|NCT00525148|38188964|FG003|Overall Study|Other Adverse Event|8|||
17044469|NCT00525148|38188961|FG000|Overall Study|Progressive disease|18|||
17044470|NCT00525148|38188962|FG001|Overall Study|Progressive disease|30|||
17044471|NCT00525148|38188963|FG002|Overall Study|Progressive disease|6|||
17044472|NCT00525148|38188964|FG003|Overall Study|Progressive disease|49|||
17044473|NCT00525148|38188961|FG000|Overall Study|Refused continuation of study medication|0|||
17044474|NCT00525148|38188962|FG001|Overall Study|Refused continuation of study medication|2|||
17044475|NCT00525148|38188963|FG002|Overall Study|Refused continuation of study medication|0|||
17044476|NCT00525148|38188964|FG003|Overall Study|Refused continuation of study medication|1|||
17044477|NCT00525148|38188961|FG000|Overall Study|Other than stated|2|||
17044478|NCT00525148|38188962|FG001|Overall Study|Other than stated|1|||
17044479|NCT00525148|38188963|FG002|Overall Study|Other than stated|0|||
17044480|NCT00525148|38188964|FG003|Overall Study|Other than stated|3|||
17044481|NCT00754325|38188976|FG000|Initial Treatment|Continuing Active Treatment|4|||
17044482|NCT00754325|38188977|FG001|Initial Treatment|Continuing Active Treatment|5|||
17044483|NCT00754325|38188976|FG000|Initial Treatment|Adverse Event|7|||
17044484|NCT00754325|38188977|FG001|Initial Treatment|Adverse Event|6|||
17044485|NCT00754325|38188976|FG000|Initial Treatment|Withdrawal by Subject|2|||
17044486|NCT00754325|38188977|FG001|Initial Treatment|Withdrawal by Subject|2|||
17044487|NCT00754325|38188976|FG000|Initial Treatment|Physician Decision|2|||
17044488|NCT00754325|38188977|FG001|Initial Treatment|Physician Decision|0|||
17044489|NCT00754325|38188976|FG000|Initial Treatment|Sponsor Request|0|||
17044490|NCT00754325|38188977|FG001|Initial Treatment|Sponsor Request|1|||
17044491|NCT00754325|38188976|FG000|Initial Treatment|Disease Progression|35|||
17044492|NCT00754325|38188977|FG001|Initial Treatment|Disease Progression|35|||
17044493|NCT00524680|38188988|FG000|Overall Study|progression|0|||
17044494|NCT00524680|38188989|FG001|Overall Study|progression|0|||
17044495|NCT00524680|38188990|FG002|Overall Study|progression|0|||
17044496|NCT00524680|38188991|FG003|Overall Study|progression|1|||
17044497|NCT00524680|38188988|FG000|Overall Study|Adverse Event|2|||
17044498|NCT00524680|38188989|FG001|Overall Study|Adverse Event|0|||
17044499|NCT00524680|38188990|FG002|Overall Study|Adverse Event|0|||
17044500|NCT00524680|38188991|FG003|Overall Study|Adverse Event|1|||
17044501|NCT00524680|38188988|FG000|Overall Study|Other|0|||
17044502|NCT00524680|38188989|FG001|Overall Study|Other|1|||
17044503|NCT00524680|38188990|FG002|Overall Study|Other|2|||
17044504|NCT00524680|38188991|FG003|Overall Study|Other|3|||
17141260|NCT03339726|38283611|FG001|Overall Study|Lost to Follow-up|1|||
17141261|NCT03339726|38283612|FG002|Overall Study|Lost to Follow-up|0|||
17044505|NCT00524680|38188988|FG000|Overall Study|Withdrawal by Subject|1|||
17044506|NCT00524680|38188989|FG001|Overall Study|Withdrawal by Subject|0|||
17044507|NCT00524680|38188990|FG002|Overall Study|Withdrawal by Subject|1|||
17044508|NCT00524680|38188991|FG003|Overall Study|Withdrawal by Subject|1|||
17044509|NCT00628212|38189005|FG000|Overall Study|Adverse Event|2|||
17044510|NCT00628212|38189006|FG001|Overall Study|Adverse Event|0|||
17044511|NCT00628212|38189007|FG002|Overall Study|Adverse Event|1|||
17044512|NCT00628212|38189008|FG003|Overall Study|Adverse Event|2|||
17044513|NCT00628212|38189005|FG000|Overall Study|Physician Decision|1|||
17044514|NCT00628212|38189006|FG001|Overall Study|Physician Decision|1|||
17044515|NCT00628212|38189007|FG002|Overall Study|Physician Decision|2|||
17044516|NCT00628212|38189008|FG003|Overall Study|Physician Decision|3|||
17044517|NCT00298363|38189021|FG000|Overall Study|Lost to Follow-up|0|||
17044518|NCT00298363|38189022|FG001|Overall Study|Lost to Follow-up|0|||
17044519|NCT00298363|38189023|FG002|Overall Study|Lost to Follow-up|1|||
17044520|NCT00298363|38189021|FG000|Overall Study|Physician Decision|4|||
17044521|NCT00298363|38189022|FG001|Overall Study|Physician Decision|1|||
17044522|NCT00298363|38189023|FG002|Overall Study|Physician Decision|0|||
17044523|NCT00298363|38189021|FG000|Overall Study|Protocol Violation|1|||
17044524|NCT00298363|38189022|FG001|Overall Study|Protocol Violation|1|||
17044525|NCT00298363|38189023|FG002|Overall Study|Protocol Violation|0|||
17044526|NCT00298363|38189021|FG000|Overall Study|Withdrawal by Subject|5|||
17044527|NCT00298363|38189022|FG001|Overall Study|Withdrawal by Subject|1|||
17044528|NCT00298363|38189023|FG002|Overall Study|Withdrawal by Subject|3|||
17044529|NCT00298363|38189021|FG000|Overall Study|Adverse Event|5|||
17044530|NCT00298363|38189022|FG001|Overall Study|Adverse Event|2|||
17044531|NCT00298363|38189023|FG002|Overall Study|Adverse Event|2|||
17044532|NCT00298363|38189021|FG000|Overall Study|Lack of Efficacy|2|||
17044533|NCT00298363|38189022|FG001|Overall Study|Lack of Efficacy|3|||
17044534|NCT00298363|38189023|FG002|Overall Study|Lack of Efficacy|0|||
17044535|NCT00524368|38189039|FG000|Overall Study|Adverse Event|10|||
17044536|NCT00524368|38189040|FG001|Overall Study|Adverse Event|12|||
17044537|NCT00524368|38189039|FG000|Overall Study|Lost to Follow-up|9|||
17044538|NCT00524368|38189040|FG001|Overall Study|Lost to Follow-up|13|||
17044539|NCT00524368|38189039|FG000|Overall Study|Withdrawal by Subject|4|||
17044540|NCT00524368|38189040|FG001|Overall Study|Withdrawal by Subject|5|||
17044541|NCT00524368|38189039|FG000|Overall Study|Non-compliant|8|||
17044542|NCT00524368|38189040|FG001|Overall Study|Non-compliant|9|||
17044543|NCT00524368|38189039|FG000|Overall Study|Reached a Virologic Endpoint|3|||
17044544|NCT00524368|38189040|FG001|Overall Study|Reached a Virologic Endpoint|2|||
17044545|NCT00524368|38189039|FG000|Overall Study|Sponsor's Decision|2|||
17044546|NCT00524368|38189040|FG001|Overall Study|Sponsor's Decision|0|||
17044547|NCT00524368|38189039|FG000|Overall Study|Ineligible to Continue the study|2|||
17044548|NCT00524368|38189040|FG001|Overall Study|Ineligible to Continue the study|5|||
17044549|NCT00524368|38189039|FG000|Overall Study|Other|3|||
17044550|NCT00524368|38189040|FG001|Overall Study|Other|2|||
17044551|NCT00777101|38189048|FG000|Overall Study|Death|48|||
17044552|NCT00777101|38189049|FG001|Overall Study|Death|43|||
17044553|NCT00777101|38189048|FG000|Overall Study|Withdrawal by Subject|11|||
17044554|NCT00777101|38189049|FG001|Overall Study|Withdrawal by Subject|6|||
17044555|NCT00777101|38189048|FG000|Overall Study|Lost to Follow-up|2|||
17044556|NCT00777101|38189049|FG001|Overall Study|Lost to Follow-up|1|||
17044557|NCT00777101|38189048|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
17044558|NCT00777101|38189049|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
17044559|NCT00777101|38189048|FG000|Overall Study|Failed to Return|0|||
17044560|NCT00777101|38189049|FG001|Overall Study|Failed to Return|1|||
17044561|NCT00297427|38189058|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
17044562|NCT00297427|38189059|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
17044563|NCT00297427|38189058|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
17044564|NCT00297427|38189059|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
17044565|NCT00297427|38189058|FG000|Phase 1: Initial Intervention|Death|0|||
17044566|NCT00297427|38189059|FG001|Phase 1: Initial Intervention|Death|1|||
17044567|NCT00297427|38189058|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
17044568|NCT00297427|38189059|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
17044569|NCT00297427|38189058|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
17044570|NCT00297427|38189059|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
17044571|NCT00297427|38189058|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
17044572|NCT00297427|38189059|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
17141262|NCT03339297|38283622|FG000|Overall Study|Relapse of Hematologic Disease|1|||
17141263|NCT03339297|38283623|FG001|Overall Study|Relapse of Hematologic Disease|0|||
17141264|NCT03339297|38283622|FG000|Overall Study|Death|10|||
17141265|NCT03339297|38283623|FG001|Overall Study|Death|7|||
17044573|NCT00297427|38189058|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
17044574|NCT00297427|38189059|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
17044575|NCT00297427|38189058|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
17044576|NCT00297427|38189059|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
17044577|NCT00524134|38189073|FG000|Overall Study|Withdrawal by Subject|1|||
17044578|NCT00524134|38189073|FG000|Overall Study|Physician Decision|1|||
17044579|NCT00777023|38189080|FG000|Overall Study|Adverse Event|15|||
17044580|NCT00777023|38189081|FG001|Overall Study|Adverse Event|21|||
17044581|NCT00777023|38189082|FG002|Overall Study|Adverse Event|8|||
17044582|NCT00777023|38189080|FG000|Overall Study|Lack of Efficacy|1|||
17044583|NCT00777023|38189081|FG001|Overall Study|Lack of Efficacy|0|||
17044584|NCT00777023|38189082|FG002|Overall Study|Lack of Efficacy|14|||
17044585|NCT00777023|38189080|FG000|Overall Study|Protocol Violation|2|||
17044586|NCT00777023|38189081|FG001|Overall Study|Protocol Violation|1|||
17044587|NCT00777023|38189082|FG002|Overall Study|Protocol Violation|1|||
17044588|NCT00777023|38189080|FG000|Overall Study|Lost to Follow-up|2|||
17044589|NCT00777023|38189081|FG001|Overall Study|Lost to Follow-up|3|||
17044590|NCT00777023|38189082|FG002|Overall Study|Lost to Follow-up|3|||
17044591|NCT00777023|38189080|FG000|Overall Study|Death|0|||
17044592|NCT00777023|38189081|FG001|Overall Study|Death|1|||
17044593|NCT00777023|38189082|FG002|Overall Study|Death|0|||
17044594|NCT00777023|38189080|FG000|Overall Study|Withdrawal by Subject|7|||
17044595|NCT00777023|38189081|FG001|Overall Study|Withdrawal by Subject|7|||
17044596|NCT00777023|38189082|FG002|Overall Study|Withdrawal by Subject|8|||
17044597|NCT00777023|38189080|FG000|Overall Study|Missing data|1|||
17044598|NCT00777023|38189081|FG001|Overall Study|Missing data|1|||
17044599|NCT00777023|38189082|FG002|Overall Study|Missing data|0|||
17044600|NCT00777023|38189080|FG000|Overall Study|Reasons not specified|4|||
17044601|NCT00777023|38189081|FG001|Overall Study|Reasons not specified|4|||
17044602|NCT00777023|38189082|FG002|Overall Study|Reasons not specified|2|||
17044603|NCT00777023|38189080|FG000|Overall Study|Last dose date unknown|3|||
17044604|NCT00777023|38189081|FG001|Overall Study|Last dose date unknown|3|||
17044605|NCT00777023|38189082|FG002|Overall Study|Last dose date unknown|1|||
17044606|NCT00297037|38189092|FG000|Overall Study|Withdrawal by Subject|2|||
17044607|NCT00297037|38189093|FG001|Overall Study|Withdrawal by Subject|0|||
17044608|NCT00292981|38189101|FG000|Overall Study|Adverse Event|1|||
17044609|NCT00292981|38189101|FG000|Overall Study|Lost to Follow-up|13|||
17044610|NCT00292981|38189101|FG000|Overall Study|Withdrawal by Subject|22|||
17044611|NCT00292981|38189101|FG000|Overall Study|Other|3|||
17044612|NCT00296725|38189105|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
17044613|NCT00296725|38189105|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
17044614|NCT00296725|38189105|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
17044615|NCT00625872|38189113|FG000|Overall Study|Withdrawal by Subject|1|||
17044616|NCT00625872|38189114|FG001|Overall Study|Withdrawal by Subject|0|||
17044617|NCT00625872|38189113|FG000|Overall Study|Does not meet inclusion criteria|1|||
17044618|NCT00625872|38189114|FG001|Overall Study|Does not meet inclusion criteria|0|||
17044619|NCT00625872|38189113|FG000|Overall Study|Terminated by sponsor|2|||
17044620|NCT00625872|38189114|FG001|Overall Study|Terminated by sponsor|5|||
17044621|NCT00625872|38189113|FG000|Overall Study|Randomized but not treated|0|||
17044622|NCT00625872|38189114|FG001|Overall Study|Randomized but not treated|1|||
17044623|NCT00523978|38189122|FG000|Overall Study|Withdrawal by Subject|3|||
17044624|NCT00523978|38189123|FG001|Overall Study|Withdrawal by Subject|7|||
17044625|NCT00523978|38189122|FG000|Overall Study|Screen Failures|5|||
17044626|NCT00523978|38189123|FG001|Overall Study|Screen Failures|1|||
17044627|NCT00523978|38189122|FG000|Overall Study|Death|1|||
17044628|NCT00523978|38189123|FG001|Overall Study|Death|0|||
17044629|NCT00296647|38189135|FG000|Overall Study|Death|4|||
17044630|NCT00296647|38189136|FG001|Overall Study|Death|1|||
17044631|NCT00296647|38189137|FG002|Overall Study|Death|2|||
17044632|NCT00296647|38189138|FG003|Overall Study|Death|1|||
17044633|NCT00296647|38189139|FG004|Overall Study|Death|1|||
17044634|NCT00296647|38189135|FG000|Overall Study|Withdrawal by Subject|28|||
17044635|NCT00296647|38189136|FG001|Overall Study|Withdrawal by Subject|27|||
17044636|NCT00296647|38189137|FG002|Overall Study|Withdrawal by Subject|32|||
17044637|NCT00296647|38189138|FG003|Overall Study|Withdrawal by Subject|16|||
17044638|NCT00296647|38189139|FG004|Overall Study|Withdrawal by Subject|19|||
17044639|NCT00754013|38189153|FG000|Overall Study|Lost to Follow-up|1|||
17044640|NCT00754013|38189154|FG001|Overall Study|Lost to Follow-up|1|||
17044641|NCT00754013|38189153|FG000|Overall Study|didn't return after study termed|3|||
17044642|NCT00754013|38189154|FG001|Overall Study|didn't return after study termed|4|||
17044643|NCT00523744|38189160|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
17044644|NCT00523744|38189160|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
17044645|NCT00523744|38189160|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
17044646|NCT00523744|38189160|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
17044647|NCT00523744|38189160|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
17044648|NCT00523744|38189160|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
17044649|NCT00752219|38189178|FG000|Overall Study|Clinical failure|0|||
17044650|NCT00752219|38189179|FG001|Overall Study|Clinical failure|1|||
17044651|NCT00752219|38189178|FG000|Overall Study|Adverse Event|5|||
17044652|NCT00752219|38189179|FG001|Overall Study|Adverse Event|3|||
17044653|NCT00752219|38189178|FG000|Overall Study|Protocol deviation|1|||
17044654|NCT00752219|38189179|FG001|Overall Study|Protocol deviation|0|||
17044655|NCT00752219|38189178|FG000|Overall Study|Lost to Follow-up|1|||
17044656|NCT00752219|38189179|FG001|Overall Study|Lost to Follow-up|2|||
17044657|NCT00752219|38189178|FG000|Overall Study|Randomized but not treated|1|||
17044658|NCT00752219|38189179|FG001|Overall Study|Randomized but not treated|0|||
17044659|NCT00752219|38189178|FG000|Overall Study|Other|3|||
17044660|NCT00752219|38189179|FG001|Overall Study|Other|0|||
17044661|NCT00622908|38189187|FG000|Overall Study|Protocol Violation|1|||
17044662|NCT00622908|38189188|FG001|Overall Study|Protocol Violation|0|||
17044663|NCT00622908|38189187|FG000|Overall Study|Adverse Event|0|||
17044664|NCT00622908|38189188|FG001|Overall Study|Adverse Event|1|||
17044665|NCT00622908|38189187|FG000|Overall Study|Lack of Efficacy|1|||
17044666|NCT00622908|38189188|FG001|Overall Study|Lack of Efficacy|7|||
17044667|NCT00622908|38189187|FG000|Overall Study|Lost to Follow-up|1|||
17044668|NCT00622908|38189188|FG001|Overall Study|Lost to Follow-up|0|||
17044669|NCT00622908|38189187|FG000|Overall Study|Refusal|0|||
17044670|NCT00622908|38189188|FG001|Overall Study|Refusal|1|||
17044671|NCT00622908|38189187|FG000|Overall Study|Termination by study sponser|0|||
17141266|NCT03339297|38283622|FG000|Overall Study|Hepatic Candidosis|1|||
17141267|NCT03339297|38283623|FG001|Overall Study|Hepatic Candidosis|0|||
17141268|NCT03339297|38283622|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
17141269|NCT03339297|38283623|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
17141270|NCT03339297|38283622|FG000|Overall Study|Consent Withdrawn by Participant|3|||
17141271|NCT03339297|38283623|FG001|Overall Study|Consent Withdrawn by Participant|3|||
17044672|NCT00622908|38189188|FG001|Overall Study|Termination by study sponser|1|||
17044673|NCT00296491|38189198|FG000|Overall Study|Low Pollen Counts|18|||
17044674|NCT00296491|38189199|FG001|Overall Study|Low Pollen Counts|26|||
17044675|NCT00296491|38189200|FG002|Overall Study|Low Pollen Counts|25|||
17044676|NCT00296491|38189201|FG003|Overall Study|Low Pollen Counts|16|||
17044677|NCT00296491|38189198|FG000|Overall Study|Protocol Violation|4|||
17044678|NCT00296491|38189199|FG001|Overall Study|Protocol Violation|6|||
17044679|NCT00296491|38189200|FG002|Overall Study|Protocol Violation|2|||
17044680|NCT00296491|38189201|FG003|Overall Study|Protocol Violation|3|||
17044681|NCT00296491|38189198|FG000|Overall Study|Adverse Event|1|||
17141272|NCT03339297|38283622|FG000|Overall Study|Disease Relapse|2|||
17141273|NCT03339297|38283623|FG001|Overall Study|Disease Relapse|0|||
17141274|NCT03339297|38283622|FG000|Overall Study|Physician Decision|1|||
17141275|NCT03339297|38283623|FG001|Overall Study|Physician Decision|1|||
17141276|NCT03339297|38283622|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
17044682|NCT00296491|38189199|FG001|Overall Study|Adverse Event|3|||
17044683|NCT00296491|38189200|FG002|Overall Study|Adverse Event|1|||
17044684|NCT00296491|38189201|FG003|Overall Study|Adverse Event|4|||
17044685|NCT00296491|38189198|FG000|Overall Study|Withdrawn due to Asthma|0|||
17044686|NCT00296491|38189199|FG001|Overall Study|Withdrawn due to Asthma|0|||
17044687|NCT00296491|38189200|FG002|Overall Study|Withdrawn due to Asthma|0|||
17044688|NCT00296491|38189201|FG003|Overall Study|Withdrawn due to Asthma|4|||
17044689|NCT00296491|38189198|FG000|Overall Study|Withdrawal by Subject|7|||
17044690|NCT00296491|38189199|FG001|Overall Study|Withdrawal by Subject|3|||
17044691|NCT00296491|38189200|FG002|Overall Study|Withdrawal by Subject|3|||
17044692|NCT00296491|38189201|FG003|Overall Study|Withdrawal by Subject|2|||
17044693|NCT00296491|38189198|FG000|Overall Study|Non-Compliance|12|||
17044694|NCT00296491|38189199|FG001|Overall Study|Non-Compliance|13|||
17044695|NCT00296491|38189200|FG002|Overall Study|Non-Compliance|10|||
17044696|NCT00296491|38189201|FG003|Overall Study|Non-Compliance|14|||
17044697|NCT00296491|38189198|FG000|Overall Study|Lost to Follow-up|0|||
17044698|NCT00296491|38189199|FG001|Overall Study|Lost to Follow-up|2|||
17044699|NCT00296491|38189200|FG002|Overall Study|Lost to Follow-up|2|||
17044700|NCT00296491|38189201|FG003|Overall Study|Lost to Follow-up|0|||
17044701|NCT00747617|38189220|FG000|Overall Study|Lost to Follow-up|3|||
17044702|NCT00747617|38189221|FG001|Overall Study|Lost to Follow-up|1|||
17044703|NCT00296335|38189229|FG000|Overall Study|Recurrence|3|||
17044704|NCT00296335|38189230|FG001|Overall Study|Recurrence|51|||
17044705|NCT00296335|38189229|FG000|Overall Study|Adverse Event|17|||
17044706|NCT00296335|38189230|FG001|Overall Study|Adverse Event|27|||
17044707|NCT00296335|38189229|FG000|Overall Study|Lost to Follow-up|7|||
17044708|NCT00296335|38189230|FG001|Overall Study|Lost to Follow-up|33|||
17044709|NCT00296335|38189229|FG000|Overall Study|Physician Decision|3|||
17044710|NCT00296335|38189230|FG001|Overall Study|Physician Decision|11|||
17044711|NCT00747461|38189238|FG000|Overall Study|study terminated by sponsor|5|||
17044712|NCT03683758|38189245|FG000|Overall Study|Non-study commitment conflict|1|||
17141277|NCT03339297|38283623|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
17044713|NCT03683758|38189246|FG001|Overall Study|Non-study commitment conflict|3|||
17044714|NCT03683758|38189245|FG000|Overall Study|Illness preventing participation|1|||
17044715|NCT03683758|38189246|FG001|Overall Study|Illness preventing participation|0|||
17044716|NCT03683758|38189245|FG000|Overall Study|Adverse Event|1|||
17044717|NCT03683758|38189246|FG001|Overall Study|Adverse Event|0|||
17044718|NCT00522418|38189254|FG000|Overall Study|Local IRB Consent Violation|5|||
17044719|NCT00522418|38189255|FG001|Overall Study|Local IRB Consent Violation|5|||
17044720|NCT00522418|38189254|FG000|Overall Study|Early Study Termination|46|||
17044721|NCT00522418|38189255|FG001|Overall Study|Early Study Termination|47|||
17044722|NCT00522418|38189254|FG000|Overall Study|Noncompliance|2|||
17044723|NCT00522418|38189255|FG001|Overall Study|Noncompliance|2|||
17044724|NCT00522418|38189254|FG000|Overall Study|Reason Not Specified|3|||
17044725|NCT00522418|38189255|FG001|Overall Study|Reason Not Specified|1|||
17044726|NCT00522418|38189254|FG000|Overall Study|Consent Withdraw|1|||
17044727|NCT00522418|38189255|FG001|Overall Study|Consent Withdraw|2|||
17044728|NCT00522418|38189254|FG000|Overall Study|Lack of Efficacy|0|||
17044729|NCT00522418|38189255|FG001|Overall Study|Lack of Efficacy|1|||
17044730|NCT00624780|38189269|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
17044731|NCT00624780|38189270|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
17044732|NCT00624780|38189271|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
17044733|NCT00624780|38189272|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
17044734|NCT00624780|38189273|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
17044735|NCT00624780|38189274|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
17044736|NCT00624780|38189269|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
17044737|NCT00624780|38189270|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
17044738|NCT00624780|38189271|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
17044739|NCT00624780|38189272|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
17044740|NCT00624780|38189273|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
17044741|NCT00624780|38189274|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
17141278|NCT03339297|38283622|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
17141279|NCT03339297|38283623|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
17141280|NCT03339297|38283622|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
17141281|NCT03339297|38283623|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
17141282|NCT03339297|38283622|FG000|Overall Study|Adverse Event, Non-fatal|1|||
17141283|NCT03339297|38283623|FG001|Overall Study|Adverse Event, Non-fatal|0|||
17141284|NCT03339297|38283622|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
17141285|NCT03339297|38283623|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
17141286|NCT03339297|38283622|FG000|Overall Study|Patient Was Not Eligible|1|||
17141287|NCT03339297|38283623|FG001|Overall Study|Patient Was Not Eligible|0|||
17141288|NCT03713281|38283649|FG000|Overall Study|Lens handling difficuluties|2|||
17141289|NCT03713281|38283649|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
17141290|NCT03339219|38283653|FG000|Overall Study|Death|12|||
17141291|NCT03339219|38283653|FG000|Overall Study|Site Terminated by Sponsor|22|||
17141292|NCT03339219|38283653|FG000|Overall Study|Withdrawal by Subject|1|||
17141293|NCT03338673|38283659|FG000|Overall Study|Lost to Follow-up|1|||
17141294|NCT03338673|38283660|FG001|Overall Study|Lost to Follow-up|1|||
17141295|NCT02949024|38283668|FG000|Overall Study|Withdrawal by Subject|0|||
17141296|NCT02949024|38283669|FG001|Overall Study|Withdrawal by Subject|1|||
17141297|NCT03093428|38283679|FG000|Overall Study|Not eligible for treatment|2|||
17141298|NCT03093428|38283680|FG001|Overall Study|Not eligible for treatment|1|||
17141299|NCT03093428|38283679|FG000|Overall Study|Progression|14|||
17141300|NCT03093428|38283680|FG001|Overall Study|Progression|4|||
16992253|NCT00808132|38136194|FG002|Overall Study|Lost to Follow-up|11|||
17044742|NCT00624780|38189269|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
17044743|NCT00624780|38189270|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
17044744|NCT00624780|38189271|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
17044745|NCT00624780|38189272|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
17044746|NCT00624780|38189273|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
17044747|NCT00624780|38189274|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
17044748|NCT00624780|38189269|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
16992254|NCT00808132|38136195|FG003|Overall Study|Lost to Follow-up|8|||
16992255|NCT00808132|38136196|FG004|Overall Study|Lost to Follow-up|9|||
16992256|NCT00808132|38136192|FG000|Overall Study|Protocol Violation|8|||
16992257|NCT00808132|38136193|FG001|Overall Study|Protocol Violation|9|||
16992258|NCT00808132|38136194|FG002|Overall Study|Protocol Violation|4|||
16992259|NCT00808132|38136195|FG003|Overall Study|Protocol Violation|9|||
16992260|NCT00808132|38136196|FG004|Overall Study|Protocol Violation|5|||
16992261|NCT00808132|38136192|FG000|Overall Study|Withdrawal by Subject|27|||
16992262|NCT00808132|38136193|FG001|Overall Study|Withdrawal by Subject|18|||
16992263|NCT00808132|38136194|FG002|Overall Study|Withdrawal by Subject|2|||
16992264|NCT00808132|38136195|FG003|Overall Study|Withdrawal by Subject|7|||
17044749|NCT00624780|38189270|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
17044750|NCT00624780|38189271|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
17044751|NCT00624780|38189272|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
17044752|NCT00624780|38189273|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
17044753|NCT00624780|38189274|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
17044754|NCT00624780|38189269|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
17044755|NCT00624780|38189270|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
17044756|NCT00624780|38189271|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
17044757|NCT00624780|38189272|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
17044758|NCT00624780|38189273|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
17044759|NCT00624780|38189274|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
17044760|NCT00624780|38189269|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
17044761|NCT00624780|38189270|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
17044762|NCT00624780|38189271|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
17044763|NCT00624780|38189272|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
17044764|NCT00624780|38189273|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
17044765|NCT00624780|38189274|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
17044766|NCT00624780|38189269|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
17044767|NCT00624780|38189270|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
17044768|NCT00624780|38189271|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
17044769|NCT00624780|38189272|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
17044770|NCT00624780|38189273|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
17044771|NCT00624780|38189274|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
17044772|NCT00624780|38189269|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
17044773|NCT00624780|38189270|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
17044774|NCT00624780|38189271|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
17044775|NCT00624780|38189272|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
17044776|NCT00624780|38189273|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
17044777|NCT00624780|38189274|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
17044778|NCT00624780|38189269|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
17044779|NCT00624780|38189270|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
17044780|NCT00624780|38189271|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
17044781|NCT00624780|38189272|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
17044782|NCT00624780|38189273|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
17044783|NCT00624780|38189274|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
17044784|NCT00624780|38189269|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
17044785|NCT00624780|38189270|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
17044786|NCT00624780|38189271|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
17044787|NCT00624780|38189272|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
17044788|NCT00624780|38189273|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
17044789|NCT00624780|38189274|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
17044790|NCT00624780|38189269|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
17044791|NCT00624780|38189270|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
17044792|NCT00624780|38189271|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
17044793|NCT00624780|38189272|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
17044794|NCT00624780|38189273|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
17044795|NCT00624780|38189274|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
17044796|NCT00624780|38189269|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
17044797|NCT00624780|38189270|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
17044798|NCT00624780|38189271|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
17044799|NCT00624780|38189272|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
17044800|NCT00624780|38189273|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
17044801|NCT00624780|38189274|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
17044802|NCT00624780|38189269|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
17044803|NCT00624780|38189270|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
17044804|NCT00624780|38189271|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
17044805|NCT00624780|38189272|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
17044806|NCT00624780|38189273|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
17044807|NCT00624780|38189274|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
17044808|NCT00624780|38189269|FG000|Follow-up (Week 26)|Death|0|||
17044809|NCT00624780|38189270|FG001|Follow-up (Week 26)|Death|0|||
17044810|NCT00624780|38189271|FG002|Follow-up (Week 26)|Death|1|||
17044811|NCT00624780|38189272|FG003|Follow-up (Week 26)|Death|0|||
17044812|NCT00624780|38189273|FG004|Follow-up (Week 26)|Death|0|||
17044813|NCT00624780|38189274|FG005|Follow-up (Week 26)|Death|0|||
17044814|NCT00624780|38189269|FG000|Follow-up (Week 26)|Adverse Event|0|||
17044815|NCT00624780|38189270|FG001|Follow-up (Week 26)|Adverse Event|0|||
17044816|NCT00624780|38189271|FG002|Follow-up (Week 26)|Adverse Event|0|||
17044817|NCT00624780|38189272|FG003|Follow-up (Week 26)|Adverse Event|0|||
17044818|NCT00624780|38189273|FG004|Follow-up (Week 26)|Adverse Event|1|||
17044819|NCT00624780|38189274|FG005|Follow-up (Week 26)|Adverse Event|0|||
17044820|NCT00624780|38189269|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
17044821|NCT00624780|38189270|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
17044822|NCT00624780|38189271|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
17044823|NCT00624780|38189272|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
17044824|NCT00624780|38189273|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
17044825|NCT00624780|38189274|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
17044826|NCT00624780|38189269|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
17044827|NCT00624780|38189270|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
17044828|NCT00624780|38189271|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
17044829|NCT00624780|38189272|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
17044830|NCT00624780|38189273|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
17044831|NCT00624780|38189274|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
17044832|NCT00624780|38189269|FG000|Follow-up (Week 26)|Other|1|||
17044833|NCT00624780|38189270|FG001|Follow-up (Week 26)|Other|1|||
17044834|NCT00624780|38189271|FG002|Follow-up (Week 26)|Other|0|||
17044835|NCT00624780|38189272|FG003|Follow-up (Week 26)|Other|0|||
17044836|NCT00624780|38189273|FG004|Follow-up (Week 26)|Other|0|||
17044837|NCT00624780|38189274|FG005|Follow-up (Week 26)|Other|0|||
17044838|NCT00750893|38189291|FG000|Overall Study|Adverse Event|5|||
17044839|NCT00750893|38189291|FG000|Overall Study|Withdrawal by Subject|10|||
17044840|NCT00750893|38189291|FG000|Overall Study|Lost to Follow-up|510|||
17044841|NCT00750893|38189291|FG000|Overall Study|Other|17|||
17044842|NCT00753623|38189297|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
17044843|NCT00753623|38189298|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
17044844|NCT00753623|38189297|FG000|Phase I (14 Days)|Physician Decision|1|||
17044845|NCT00753623|38189298|FG001|Phase I (14 Days)|Physician Decision|2|||
17044846|NCT00753623|38189297|FG000|Phase I (14 Days)|Adverse Event|0|||
17044847|NCT00753623|38189298|FG001|Phase I (14 Days)|Adverse Event|1|||
17044848|NCT00753623|38189297|FG000|Washout (7 Days)|Physician Decision|1|||
17044849|NCT00753623|38189298|FG001|Washout (7 Days)|Physician Decision|0|||
17044850|NCT00753623|38189297|FG000|Phase II (14 Days)|Physician Decision|0|||
17044851|NCT00753623|38189298|FG001|Phase II (14 Days)|Physician Decision|1|||
17044852|NCT00750737|38189306|FG000|Overall Study|Withdrawal by Subject|3|||
16992265|NCT00808132|38136196|FG004|Overall Study|Withdrawal by Subject|16|||
16992266|NCT00808132|38136192|FG000|Overall Study|Other|6|||
16992267|NCT00808132|38136193|FG001|Overall Study|Other|4|||
16992268|NCT00808132|38136194|FG002|Overall Study|Other|6|||
16992269|NCT00808132|38136195|FG003|Overall Study|Other|2|||
16992270|NCT00808132|38136196|FG004|Overall Study|Other|15|||
16992271|NCT00808132|38136192|FG000|Overall Study|Randomized, but not treated|10|||
16992272|NCT00808132|38136193|FG001|Overall Study|Randomized, but not treated|7|||
16992273|NCT00808132|38136194|FG002|Overall Study|Randomized, but not treated|9|||
16992274|NCT00808132|38136195|FG003|Overall Study|Randomized, but not treated|8|||
16992275|NCT00808132|38136196|FG004|Overall Study|Randomized, but not treated|9|||
16992276|NCT00808132|38136192|FG000|Overall Study|Unsatisfactory response|5|||
16992277|NCT00808132|38136193|FG001|Overall Study|Unsatisfactory response|6|||
16992278|NCT00808132|38136194|FG002|Overall Study|Unsatisfactory response|6|||
16992279|NCT00808132|38136195|FG003|Overall Study|Unsatisfactory response|4|||
16992280|NCT00808132|38136196|FG004|Overall Study|Unsatisfactory response|12|||
16992281|NCT00727441|38136211|FG000|Overall Study|Disease Progression|11|||
16992282|NCT00727441|38136212|FG001|Overall Study|Disease Progression|14|||
16992283|NCT00727441|38136213|FG002|Overall Study|Disease Progression|17|||
16992284|NCT00727441|38136211|FG000|Overall Study|Eligibility|7|||
16992285|NCT00727441|38136212|FG001|Overall Study|Eligibility|5|||
16992286|NCT00727441|38136213|FG002|Overall Study|Eligibility|7|||
16992287|NCT00727441|38136211|FG000|Overall Study|Death|0|||
16992288|NCT00727441|38136212|FG001|Overall Study|Death|1|||
16992289|NCT00727441|38136213|FG002|Overall Study|Death|1|||
16992290|NCT00727441|38136211|FG000|Overall Study|Physician Decision|0|||
16992291|NCT00727441|38136212|FG001|Overall Study|Physician Decision|1|||
16992292|NCT00727441|38136213|FG002|Overall Study|Physician Decision|0|||
16992293|NCT00727441|38136211|FG000|Overall Study|Withdrawal by Subject|0|||
16992294|NCT00727441|38136212|FG001|Overall Study|Withdrawal by Subject|1|||
16992295|NCT00727441|38136213|FG002|Overall Study|Withdrawal by Subject|0|||
16992296|NCT00717769|38136227|FG000|Overall Study|Adverse Event|9|||
16992297|NCT00717769|38136228|FG001|Overall Study|Adverse Event|6|||
16992298|NCT00717769|38136229|FG002|Overall Study|Adverse Event|1|||
16992299|NCT00717769|38136227|FG000|Overall Study|Lack of compliance|0|||
16992300|NCT00717769|38136228|FG001|Overall Study|Lack of compliance|2|||
16992301|NCT00717769|38136229|FG002|Overall Study|Lack of compliance|0|||
16992302|NCT00717769|38136227|FG000|Overall Study|Lost to Follow-up|3|||
16992303|NCT00717769|38136228|FG001|Overall Study|Lost to Follow-up|4|||
16992304|NCT00717769|38136229|FG002|Overall Study|Lost to Follow-up|0|||
16992305|NCT00717769|38136227|FG000|Overall Study|Lack of Efficacy|1|||
16992306|NCT00717769|38136228|FG001|Overall Study|Lack of Efficacy|2|||
16992307|NCT00717769|38136229|FG002|Overall Study|Lack of Efficacy|0|||
16992308|NCT00717769|38136227|FG000|Overall Study|Protocol Violation|0|||
16992309|NCT00717769|38136228|FG001|Overall Study|Protocol Violation|2|||
16992310|NCT00717769|38136229|FG002|Overall Study|Protocol Violation|0|||
17044853|NCT00750737|38189307|FG001|Overall Study|Withdrawal by Subject|3|||
17044854|NCT00622440|38189315|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
17044855|NCT00622440|38189316|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
17044856|NCT00622440|38189315|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
17044857|NCT00622440|38189316|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
17044858|NCT00622440|38189315|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
17044859|NCT00622440|38189316|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
17044860|NCT00622440|38189315|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
17044861|NCT00622440|38189316|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
17044862|NCT00744653|38189322|FG000|Overall Study|antineoplastic treatment|11|||
17044863|NCT00744653|38189322|FG000|Overall Study|Death|1|||
17044864|NCT00744653|38189322|FG000|Overall Study|Lost to Follow-up|1|||
17044865|NCT00744653|38189322|FG000|Overall Study|Physician Decision|3|||
17044866|NCT00311311|38189329|FG000|Overall Study|Adverse Event|3|||
17044867|NCT00311311|38189330|FG001|Overall Study|Adverse Event|2|||
17044868|NCT00311311|38189329|FG000|Overall Study|Withdrawal by Subject|1|||
17044869|NCT00311311|38189330|FG001|Overall Study|Withdrawal by Subject|1|||
17044870|NCT00311311|38189329|FG000|Overall Study|Noncompliance|0|||
17044871|NCT00311311|38189330|FG001|Overall Study|Noncompliance|1|||
17044872|NCT00311311|38189329|FG000|Overall Study|Study Termination by Sponsor|3|||
17044873|NCT00311311|38189330|FG001|Overall Study|Study Termination by Sponsor|4|||
17044874|NCT00311311|38189329|FG000|Overall Study|Death|1|||
17044875|NCT00311311|38189330|FG001|Overall Study|Death|0|||
17044876|NCT00311311|38189329|FG000|Overall Study|Lack of ancillary assistance|0|||
17044877|NCT00311311|38189330|FG001|Overall Study|Lack of ancillary assistance|1|||
17044878|NCT00521404|38189336|FG000|Overall Study|Adverse Event|13|||
17044879|NCT00521404|38189336|FG000|Overall Study|Disease Progression|33|||
17044880|NCT00521404|38189336|FG000|Overall Study|Investigator decision|5|||
17044881|NCT00521404|38189336|FG000|Overall Study|Withdrawal of consent|3|||
17044882|NCT00521404|38189336|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
17044883|NCT00521404|38189336|FG000|Overall Study|Other|7|||
17044884|NCT00311155|38189340|FG000|Overall Study|Adverse Event|21|||
17044885|NCT00311155|38189340|FG000|Overall Study|Withdrawal by Subject|17|||
17044886|NCT00311155|38189340|FG000|Overall Study|Did not meet entry criteria|55|||
17044887|NCT00292045|38189344|FG000|Core Study (Through Week 13)|Adverse Event|1|||
17044888|NCT00292045|38189344|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
17044889|NCT00274651|38189350|FG000|Overall Study|Adverse Event|6|||
17044890|NCT00274651|38189351|FG001|Overall Study|Adverse Event|3|||
17044891|NCT00274651|38189350|FG000|Overall Study|Lack of Efficacy|13|||
17044892|NCT00274651|38189351|FG001|Overall Study|Lack of Efficacy|6|||
17044893|NCT00274651|38189350|FG000|Overall Study|Death|1|||
17044894|NCT00274651|38189351|FG001|Overall Study|Death|3|||
17044895|NCT00274651|38189350|FG000|Overall Study|Withdrawal by Subject|0|||
17044896|NCT00274651|38189351|FG001|Overall Study|Withdrawal by Subject|1|||
17044897|NCT00274651|38189350|FG000|Overall Study|Physician Decision|8|||
17044898|NCT00274651|38189351|FG001|Overall Study|Physician Decision|7|||
17044899|NCT00274261|38189360|FG000|Overall Study|Adverse Event|19|||
16780508|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
16780509|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
16780510|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
16992311|NCT00717769|38136227|FG000|Overall Study|Sponsor decision|1|||
16992312|NCT00717769|38136228|FG001|Overall Study|Sponsor decision|0|||
16992313|NCT00717769|38136229|FG002|Overall Study|Sponsor decision|10|||
16992314|NCT00717769|38136227|FG000|Overall Study|Withdrew consent|2|||
16992315|NCT00717769|38136228|FG001|Overall Study|Withdrew consent|2|||
16992316|NCT00717769|38136229|FG002|Overall Study|Withdrew consent|0|||
16992317|NCT04153929|38136247|FG000|Overall Study|Other than listed|2|||
16992318|NCT04153929|38136248|FG001|Overall Study|Other than listed|2|||
16992319|NCT04153929|38136249|FG002|Overall Study|Other than listed|0|||
16992320|NCT04153929|38136250|FG003|Overall Study|Other than listed|1|||
16992321|NCT04153929|38136251|FG004|Overall Study|Other than listed|0|||
16992322|NCT04153929|38136252|FG005|Overall Study|Other than listed|2|||
16992323|NCT04153929|38136253|FG006|Overall Study|Other than listed|2|||
16992324|NCT04153929|38136254|FG007|Overall Study|Other than listed|1|||
16992325|NCT04153929|38136247|FG000|Overall Study|Lost to Follow-up|2|||
16992326|NCT04153929|38136248|FG001|Overall Study|Lost to Follow-up|1|||
16992327|NCT04153929|38136249|FG002|Overall Study|Lost to Follow-up|0|||
16992328|NCT04153929|38136250|FG003|Overall Study|Lost to Follow-up|1|||
16992329|NCT04153929|38136251|FG004|Overall Study|Lost to Follow-up|1|||
16992330|NCT04153929|38136252|FG005|Overall Study|Lost to Follow-up|0|||
16992331|NCT04153929|38136253|FG006|Overall Study|Lost to Follow-up|0|||
16992332|NCT04153929|38136254|FG007|Overall Study|Lost to Follow-up|0|||
16992333|NCT04153929|38136247|FG000|Overall Study|Withdrawal by Subject|3|||
16992334|NCT04153929|38136248|FG001|Overall Study|Withdrawal by Subject|1|||
17044900|NCT00274261|38189361|FG001|Overall Study|Adverse Event|11|||
17044901|NCT00274261|38189360|FG000|Overall Study|Pregnancy|114|||
17044902|NCT00274261|38189361|FG001|Overall Study|Pregnancy|83|||
17141301|NCT03093428|38283679|FG000|Overall Study|Death|1|||
17141302|NCT03093428|38283680|FG001|Overall Study|Death|0|||
17141303|NCT03093428|38283679|FG000|Overall Study|Adverse Event|1|||
17141304|NCT03093428|38283680|FG001|Overall Study|Adverse Event|0|||
17141305|NCT03093428|38283679|FG000|Overall Study|Withdrawal by Subject|1|||
17141306|NCT03093428|38283680|FG001|Overall Study|Withdrawal by Subject|1|||
17141307|NCT02735980|38283689|FG000|Overall Study|Adverse Event|0|||
17141308|NCT02735980|38283690|FG001|Overall Study|Adverse Event|4|||
17141309|NCT02735980|38283691|FG002|Overall Study|Adverse Event|1|||
17141310|NCT02735980|38283689|FG000|Overall Study|Death|5|||
17141311|NCT02735980|38283690|FG001|Overall Study|Death|4|||
17141312|NCT02735980|38283691|FG002|Overall Study|Death|0|||
17141313|NCT02735980|38283689|FG000|Overall Study|Physician Decision|3|||
17141314|NCT02735980|38283690|FG001|Overall Study|Physician Decision|1|||
17141315|NCT02735980|38283691|FG002|Overall Study|Physician Decision|0|||
17141316|NCT02735980|38283689|FG000|Overall Study|Screen failure|1|||
17141317|NCT02735980|38283690|FG001|Overall Study|Screen failure|0|||
17141318|NCT02735980|38283691|FG002|Overall Study|Screen failure|0|||
17044903|NCT00274261|38189360|FG000|Overall Study|Withdrawal by Subject|179|||
17044904|NCT00274261|38189361|FG001|Overall Study|Withdrawal by Subject|126|||
17044905|NCT00274261|38189360|FG000|Overall Study|Protocol Violation|71|||
17044906|NCT00274261|38189361|FG001|Overall Study|Protocol Violation|42|||
17044907|NCT00274261|38189360|FG000|Overall Study|Lost to Follow-up|106|||
17044908|NCT00274261|38189361|FG001|Overall Study|Lost to Follow-up|75|||
17044909|NCT00624468|38189371|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
17044910|NCT00624468|38189372|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
17044911|NCT00624468|38189373|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
16780511|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
16780512|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
16780513|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
16780514|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
16780515|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
16780516|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
16780517|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
16780518|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
16780519|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
16780520|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
16780521|NCT02596893|37719684|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
16780522|NCT02596893|37719685|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
16780523|NCT02596893|37719686|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
16992335|NCT04153929|38136249|FG002|Overall Study|Withdrawal by Subject|0|||
16992336|NCT04153929|38136250|FG003|Overall Study|Withdrawal by Subject|3|||
16992337|NCT04153929|38136251|FG004|Overall Study|Withdrawal by Subject|1|||
16992338|NCT04153929|38136252|FG005|Overall Study|Withdrawal by Subject|0|||
16992339|NCT04153929|38136253|FG006|Overall Study|Withdrawal by Subject|1|||
16992340|NCT04153929|38136254|FG007|Overall Study|Withdrawal by Subject|0|||
16992341|NCT04153929|38136247|FG000|Overall Study|Protocol Violation|0|||
16992342|NCT04153929|38136248|FG001|Overall Study|Protocol Violation|0|||
16992343|NCT04153929|38136249|FG002|Overall Study|Protocol Violation|0|||
16992344|NCT04153929|38136250|FG003|Overall Study|Protocol Violation|0|||
16992345|NCT04153929|38136251|FG004|Overall Study|Protocol Violation|0|||
16992346|NCT04153929|38136252|FG005|Overall Study|Protocol Violation|0|||
16992347|NCT04153929|38136253|FG006|Overall Study|Protocol Violation|1|||
16992348|NCT04153929|38136254|FG007|Overall Study|Protocol Violation|2|||
16992349|NCT04153929|38136247|FG000|Overall Study|Adverse Event|3|||
17044912|NCT00624468|38189374|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
17141319|NCT02735980|38283689|FG000|Overall Study|Withdrawal by Subject|1|||
17141320|NCT02735980|38283690|FG001|Overall Study|Withdrawal by Subject|2|||
17141321|NCT02735980|38283691|FG002|Overall Study|Withdrawal by Subject|0|||
16780524|NCT02596893|37719687|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
16780525|NCT02592447|37719703|FG000|Overall Study|Lost to Follow-up|1|||
16780526|NCT02592447|37719704|FG001|Overall Study|Lost to Follow-up|0|||
16780527|NCT02592447|37719703|FG000|Overall Study|Ineligible after randomization|1|||
16780528|NCT02592447|37719704|FG001|Overall Study|Ineligible after randomization|0|||
16780529|NCT02592447|37719703|FG000|Overall Study|Withdrawal by Subject|0|||
16780530|NCT02592447|37719704|FG001|Overall Study|Withdrawal by Subject|1|||
16780531|NCT02595723|37719713|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
17044913|NCT00624468|38189371|FG000|Double-blind Period|Withdrew Prematurely|1|||
17044914|NCT00624468|38189372|FG001|Double-blind Period|Withdrew Prematurely|1|||
17044915|NCT00624468|38189373|FG002|Double-blind Period|Withdrew Prematurely|0|||
17044916|NCT00624468|38189374|FG003|Double-blind Period|Withdrew Prematurely|0|||
17044917|NCT00624468|38189371|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
17044918|NCT00624468|38189372|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
17044919|NCT00624468|38189373|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
17044920|NCT00624468|38189374|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
17044921|NCT00624468|38189371|FG000|Safety Follow-up (SFU) Period|Other|0|||
17044922|NCT00624468|38189372|FG001|Safety Follow-up (SFU) Period|Other|0|||
17044923|NCT00624468|38189373|FG002|Safety Follow-up (SFU) Period|Other|1|||
17044924|NCT00624468|38189374|FG003|Safety Follow-up (SFU) Period|Other|1|||
17044925|NCT02367040|38189384|FG000|Overall Study|Lost to Follow-up|1|||
17044926|NCT02367040|38189385|FG001|Overall Study|Lost to Follow-up|1|||
17044927|NCT02367040|38189384|FG000|Overall Study|Lack of Efficacy|1|||
17044928|NCT02367040|38189385|FG001|Overall Study|Lack of Efficacy|0|||
17044929|NCT02367040|38189384|FG000|Overall Study|Additional primary malignancy|0|||
17044930|NCT02367040|38189385|FG001|Overall Study|Additional primary malignancy|1|||
17044931|NCT02367040|38189384|FG000|Overall Study|AE not associated with clinical disease progression|104|||
17044932|NCT02367040|38189385|FG001|Overall Study|AE not associated with clinical disease progression|9|||
17044933|NCT02367040|38189384|FG000|Overall Study|AE associated with clinical disease progression|1|||
17044934|NCT02367040|38189385|FG001|Overall Study|AE associated with clinical disease progression|3|||
17044935|NCT02367040|38189384|FG000|Overall Study|Physician Decision|2|||
17044936|NCT02367040|38189385|FG001|Overall Study|Physician Decision|8|||
17044937|NCT02367040|38189384|FG000|Overall Study|Non-compliance with study drug|1|||
17044938|NCT02367040|38189385|FG001|Overall Study|Non-compliance with study drug|0|||
17044939|NCT02367040|38189384|FG000|Overall Study|Failure to meet continuation criteria|1|||
17044940|NCT02367040|38189385|FG001|Overall Study|Failure to meet continuation criteria|0|||
17044941|NCT02367040|38189384|FG000|Overall Study|Switching to other therapy|2|||
17044942|NCT02367040|38189385|FG001|Overall Study|Switching to other therapy|0|||
17044943|NCT02367040|38189384|FG000|Overall Study|Withdrawal by Subject|41|||
17044944|NCT02367040|38189385|FG001|Overall Study|Withdrawal by Subject|14|||
17044945|NCT02367040|38189384|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
17044946|NCT02367040|38189385|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
17044947|NCT02367040|38189384|FG000|Overall Study|Patient decision|35|||
17044948|NCT02367040|38189385|FG001|Overall Study|Patient decision|11|||
17044949|NCT02367040|38189384|FG000|Overall Study|Required procedure failed|1|||
17044950|NCT02367040|38189385|FG001|Overall Study|Required procedure failed|0|||
17044951|NCT02367040|38189384|FG000|Overall Study|Randomized by mistake with study treatment|1|||
17044952|NCT02367040|38189385|FG001|Overall Study|Randomized by mistake with study treatment|0|||
17044953|NCT02367040|38189384|FG000|Overall Study|Protocol Violation|1|||
17044954|NCT02367040|38189385|FG001|Overall Study|Protocol Violation|0|||
17044955|NCT02367040|38189384|FG000|Overall Study|Progressive disease - radiological progression|39|||
17044956|NCT02367040|38189385|FG001|Overall Study|Progressive disease - radiological progression|67|||
17044957|NCT02367040|38189384|FG000|Overall Study|Progressive disease - clinical progression|2|||
17044958|NCT02367040|38189385|FG001|Overall Study|Progressive disease - clinical progression|6|||
17044959|NCT02367040|38189384|FG000|Overall Study|Drug not administered|3|||
17044960|NCT02367040|38189385|FG001|Overall Study|Drug not administered|2|||
17044961|NCT00521014|38189391|FG000|Overall Study|Inevaluable, not treated|1|||
17044962|NCT00560235|38189398|FG000|Phase 1|Discontinued|8|||
17044963|NCT00560235|38189399|FG001|Phase 1|Discontinued|0|||
17044964|NCT00560235|38189400|FG002|Phase 1|Discontinued|0|||
17044965|NCT00560235|38189398|FG000|Phase 1B|Discontinued|0|||
17044966|NCT00560235|38189399|FG001|Phase 1B|Discontinued|19|||
17044967|NCT00560235|38189400|FG002|Phase 1B|Discontinued|0|||
17044968|NCT00560235|38189398|FG000|Phase 2|Discontinued|0|||
17044969|NCT00560235|38189399|FG001|Phase 2|Discontinued|0|||
17044970|NCT00560235|38189400|FG002|Phase 2|Discontinued|96|||
17044971|NCT00560235|38189398|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
17044972|NCT00560235|38189399|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
17044973|NCT00560235|38189400|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
17044974|NCT00291577|38189418|FG000|Overall Study|Adverse Event|1|||
17044975|NCT00291577|38189418|FG000|Overall Study|Other|4|||
17044976|NCT00291577|38189418|FG000|Overall Study|Withdrawal by Subject|2|||
17044977|NCT00291577|38189418|FG000|Overall Study|Lack of Efficacy|14|||
16780532|NCT02595723|37719714|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
17044978|NCT00520936|38189430|FG000|Overall Study|Physician Decision|0|||
17044979|NCT00520936|38189431|FG001|Overall Study|Physician Decision|2|||
17044980|NCT00520936|38189432|FG002|Overall Study|Physician Decision|1|||
17044981|NCT00520936|38189433|FG003|Overall Study|Physician Decision|0|||
17044982|NCT00520936|38189434|FG004|Overall Study|Physician Decision|0|||
17044983|NCT00520936|38189435|FG005|Overall Study|Physician Decision|0|||
17044984|NCT00520936|38189436|FG006|Overall Study|Physician Decision|0|||
17044985|NCT00520936|38189437|FG007|Overall Study|Physician Decision|0|||
17044986|NCT00520936|38189430|FG000|Overall Study|Withdrawal by Subject|0|||
17044987|NCT00520936|38189431|FG001|Overall Study|Withdrawal by Subject|0|||
17044988|NCT00520936|38189432|FG002|Overall Study|Withdrawal by Subject|0|||
17044989|NCT00520936|38189433|FG003|Overall Study|Withdrawal by Subject|0|||
17044990|NCT00520936|38189434|FG004|Overall Study|Withdrawal by Subject|0|||
16992350|NCT04153929|38136248|FG001|Overall Study|Adverse Event|5|||
16992351|NCT04153929|38136249|FG002|Overall Study|Adverse Event|5|||
17044991|NCT00520936|38189435|FG005|Overall Study|Withdrawal by Subject|0|||
17044992|NCT00520936|38189436|FG006|Overall Study|Withdrawal by Subject|0|||
17044993|NCT00520936|38189437|FG007|Overall Study|Withdrawal by Subject|1|||
17044994|NCT00520936|38189430|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
17044995|NCT00520936|38189431|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
17044996|NCT00520936|38189432|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
17044997|NCT00520936|38189433|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
17044998|NCT00520936|38189434|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
17044999|NCT00520936|38189435|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
17045000|NCT00520936|38189436|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
17045001|NCT00520936|38189437|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
17045002|NCT00520936|38189430|FG000|Overall Study|Death|0|||
17045003|NCT00520936|38189431|FG001|Overall Study|Death|0|||
17045004|NCT00520936|38189432|FG002|Overall Study|Death|0|||
17045005|NCT00520936|38189433|FG003|Overall Study|Death|0|||
17045006|NCT00520936|38189434|FG004|Overall Study|Death|0|||
17045007|NCT00520936|38189435|FG005|Overall Study|Death|0|||
17045008|NCT00520936|38189436|FG006|Overall Study|Death|1|||
16992352|NCT04153929|38136250|FG003|Overall Study|Adverse Event|11|||
16992353|NCT04153929|38136251|FG004|Overall Study|Adverse Event|15|||
16992354|NCT04153929|38136252|FG005|Overall Study|Adverse Event|4|||
16992355|NCT04153929|38136253|FG006|Overall Study|Adverse Event|8|||
16992356|NCT04153929|38136254|FG007|Overall Study|Adverse Event|2|||
16992357|NCT04153929|38136247|FG000|Overall Study|Not treated|1|||
16992358|NCT04153929|38136248|FG001|Overall Study|Not treated|0|||
16992359|NCT04153929|38136249|FG002|Overall Study|Not treated|0|||
16992360|NCT04153929|38136250|FG003|Overall Study|Not treated|0|||
16992361|NCT04153929|38136251|FG004|Overall Study|Not treated|0|||
17045009|NCT00520936|38189437|FG007|Overall Study|Death|0|||
17045010|NCT00520936|38189430|FG000|Overall Study|Protocol Violation|0|||
17045011|NCT00520936|38189431|FG001|Overall Study|Protocol Violation|1|||
17045012|NCT00520936|38189432|FG002|Overall Study|Protocol Violation|1|||
17045013|NCT00520936|38189433|FG003|Overall Study|Protocol Violation|0|||
17045014|NCT00520936|38189434|FG004|Overall Study|Protocol Violation|1|||
17045015|NCT00520936|38189435|FG005|Overall Study|Protocol Violation|0|||
17045016|NCT00520936|38189436|FG006|Overall Study|Protocol Violation|1|||
17045017|NCT00520936|38189437|FG007|Overall Study|Protocol Violation|0|||
17045018|NCT03867760|38189450|FG000|Overall Study|Lost to Follow-up|2|||
17045019|NCT03867760|38189451|FG001|Overall Study|Lost to Follow-up|3|||
17045020|NCT03867760|38189450|FG000|Overall Study|Withdrawal by Subject|1|||
17045021|NCT03867760|38189451|FG001|Overall Study|Withdrawal by Subject|2|||
17045022|NCT03867760|38189450|FG000|Overall Study|subject could not meet study logistics|3|||
17045023|NCT03867760|38189451|FG001|Overall Study|subject could not meet study logistics|3|||
17045024|NCT03865732|38189461|FG000|Overall Study|Adverse Event|0|||
17045025|NCT03865732|38189462|FG001|Overall Study|Adverse Event|1|||
17045026|NCT00520546|38189469|FG000|Overall Study|Withdrawal by Subject|1|||
17045027|NCT00520546|38189469|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
17045028|NCT00555009|38189480|FG000|Overall Study|Withdrawal by Subject|0|||
17045029|NCT00555009|38189481|FG001|Overall Study|Withdrawal by Subject|1|||
17045030|NCT00555009|38189480|FG000|Overall Study|Terminated by Sponsor|2|||
17045031|NCT00555009|38189481|FG001|Overall Study|Terminated by Sponsor|5|||
17045032|NCT00623766|38189489|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
17045033|NCT00623766|38189490|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
17045034|NCT00623766|38189489|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
17045035|NCT00623766|38189490|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
17045036|NCT00623766|38189489|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
17045037|NCT00623766|38189490|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
17045038|NCT00623766|38189489|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
17045039|NCT00623766|38189490|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
17045040|NCT00623766|38189489|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
17045041|NCT00623766|38189490|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
17045042|NCT00550407|38189502|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
17045043|NCT00550407|38189503|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
17045044|NCT00550407|38189504|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
17045045|NCT00550407|38189502|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
17045046|NCT00550407|38189503|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
17045047|NCT00550407|38189504|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
17045048|NCT00550407|38189502|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
17045049|NCT00550407|38189503|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
17045050|NCT00550407|38189504|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
17045051|NCT00550407|38189502|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
17045052|NCT00550407|38189503|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
17045053|NCT00550407|38189504|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
17045054|NCT00550407|38189502|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
17045055|NCT00550407|38189503|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
17045056|NCT00550407|38189504|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
17045057|NCT00550407|38189502|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
17045058|NCT00550407|38189503|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
17045059|NCT00550407|38189504|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
17045060|NCT00550407|38189502|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
17045061|NCT00550407|38189503|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
17045062|NCT00550407|38189504|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
17045063|NCT00550407|38189502|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
17045064|NCT00550407|38189503|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
17045065|NCT00550407|38189504|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
17045066|NCT00550407|38189502|FG000|26-Week Randomized Phase|Adverse Event|0|||
17045067|NCT00550407|38189503|FG001|26-Week Randomized Phase|Adverse Event|5|||
17045068|NCT00550407|38189504|FG002|26-Week Randomized Phase|Adverse Event|2|||
17045069|NCT00550407|38189502|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
17045070|NCT00550407|38189503|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
17045071|NCT00550407|38189504|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
17045072|NCT00550407|38189502|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
17045073|NCT00550407|38189503|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
17045074|NCT00550407|38189504|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
17045075|NCT00550407|38189502|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
17045076|NCT00550407|38189503|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
17045077|NCT00550407|38189504|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
17045078|NCT00531934|38189514|FG000|Overall Study|Adverse Event|4|||
17045079|NCT00531934|38189515|FG001|Overall Study|Adverse Event|8|||
17045080|NCT00531934|38189514|FG000|Overall Study|Progression|52|||
17045081|NCT00531934|38189515|FG001|Overall Study|Progression|42|||
17045082|NCT00531934|38189514|FG000|Overall Study|Death|7|||
17045083|NCT00531934|38189515|FG001|Overall Study|Death|10|||
17045084|NCT00531934|38189514|FG000|Overall Study|Withdrawal by Subject|1|||
17045085|NCT00531934|38189515|FG001|Overall Study|Withdrawal by Subject|1|||
17045086|NCT00531934|38189514|FG000|Overall Study|Other|2|||
17045087|NCT00531934|38189515|FG001|Overall Study|Other|2|||
17045088|NCT00549939|38189524|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
17045089|NCT00549939|38189525|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
17045090|NCT00549939|38189526|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
17045091|NCT00549939|38189524|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
17045092|NCT00549939|38189525|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
17045093|NCT00549939|38189526|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
17045094|NCT00549939|38189524|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
17045095|NCT00549939|38189525|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
17045096|NCT00549939|38189526|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
17045097|NCT00549939|38189524|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
17045098|NCT00549939|38189525|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
17045099|NCT00549939|38189526|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
17045100|NCT00549939|38189524|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
17045101|NCT00549939|38189525|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
17045102|NCT00549939|38189526|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
17045103|NCT00549939|38189524|FG000|40-week Open Label Treatment Period|Other|0|||
17045104|NCT00549939|38189525|FG001|40-week Open Label Treatment Period|Other|1|||
17045105|NCT00549939|38189526|FG002|40-week Open Label Treatment Period|Other|4|||
17045106|NCT00272779|38189538|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
17045107|NCT00272779|38189539|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
17045108|NCT00272779|38189538|FG000|Baseline Through Week 48|Death before Week 48|4|||
17045109|NCT00272779|38189539|FG001|Baseline Through Week 48|Death before Week 48|4|||
17045110|NCT00272779|38189538|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
17045111|NCT00272779|38189539|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
17045112|NCT00272779|38189538|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
17045113|NCT00272779|38189539|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
17045114|NCT00272779|38189538|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
17045115|NCT00272779|38189539|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
17045116|NCT00272779|38189538|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
17045117|NCT00272779|38189539|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
17045118|NCT00272779|38189538|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
17045119|NCT00272779|38189539|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
17045120|NCT00272779|38189538|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
17045121|NCT00272779|38189539|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
17045122|NCT00272779|38189538|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
17045123|NCT00272779|38189539|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
17045124|NCT00272779|38189538|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
17045125|NCT00272779|38189539|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
17045126|NCT00272779|38189538|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
17045127|NCT00272779|38189539|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
17045128|NCT00272779|38189538|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
17045129|NCT00272779|38189539|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
17045130|NCT00272779|38189538|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
17045131|NCT00272779|38189539|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
17045132|NCT00272779|38189538|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
17045133|NCT00272779|38189539|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
17045134|NCT00272779|38189538|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
17045135|NCT00272779|38189539|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
17045136|NCT00272779|38189538|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
17045137|NCT00272779|38189539|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
17045138|NCT00272779|38189538|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
17045139|NCT00272779|38189539|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
17045140|NCT00272779|38189538|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
17045141|NCT00272779|38189539|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
17045142|NCT00272779|38189538|FG000|Baseline Through Week 48|Continuing treatment|385|||
17045143|NCT00272779|38189539|FG001|Baseline Through Week 48|Continuing treatment|368|||
17141322|NCT03338400|38283706|FG000|Overall Study|Lost to Follow-up|1|||
17141323|NCT03338400|38283707|FG001|Overall Study|Lost to Follow-up|2|||
17141324|NCT03337113|38283725|FG000|Overall Study|Adverse Event|1|||
17141325|NCT03337113|38283726|FG001|Overall Study|Adverse Event|1|||
17141326|NCT03337113|38283727|FG002|Overall Study|Adverse Event|0|||
17045144|NCT00272779|38189538|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
17045145|NCT00272779|38189539|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
17045146|NCT00272779|38189538|FG000|Baseline Through Week 48|Never treated|2|||
17045147|NCT00272779|38189539|FG001|Baseline Through Week 48|Never treated|3|||
17045148|NCT00272779|38189538|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
17045149|NCT00272779|38189539|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
17045150|NCT00272779|38189538|FG000|Baseline Through Week 96|Death before Week 96|6|||
17045151|NCT00272779|38189539|FG001|Baseline Through Week 96|Death before Week 96|5|||
17045152|NCT00272779|38189538|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
17045153|NCT00272779|38189539|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
17045154|NCT00272779|38189538|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
17045155|NCT00272779|38189539|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
17045156|NCT00272779|38189538|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
17045157|NCT00272779|38189539|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
17045158|NCT00272779|38189538|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
17045159|NCT00272779|38189539|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
17045160|NCT00272779|38189538|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
17045161|NCT00272779|38189539|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
17045162|NCT00272779|38189538|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
17045163|NCT00272779|38189539|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
17045164|NCT00272779|38189538|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
17045165|NCT00272779|38189539|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
17045166|NCT00272779|38189538|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
17045167|NCT00272779|38189539|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
17045168|NCT00272779|38189538|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
17045169|NCT00272779|38189539|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
17045170|NCT00272779|38189538|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
17045171|NCT00272779|38189539|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
17045172|NCT00272779|38189538|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
17045173|NCT00272779|38189539|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
17045174|NCT00272779|38189538|FG000|Baseline Through Week 96|Never treated|2|||
17045175|NCT00272779|38189539|FG001|Baseline Through Week 96|Never treated|3|||
17045176|NCT00272779|38189538|FG000|Baseline Through Week 96|Continuing on treatment|61|||
17045177|NCT00272779|38189539|FG001|Baseline Through Week 96|Continuing on treatment|38|||
17045178|NCT00511810|38189548|FG000|Overall Study|Lost to Follow-up|1|||
17045179|NCT00511810|38189549|FG001|Overall Study|Lost to Follow-up|2|||
17045180|NCT00511810|38189548|FG000|Overall Study|Lack of Efficacy|0|||
17045181|NCT00511810|38189549|FG001|Overall Study|Lack of Efficacy|2|||
17045182|NCT00511810|38189548|FG000|Overall Study|Refused second scn|0|||
17045183|NCT00511810|38189549|FG001|Overall Study|Refused second scn|1|||
17045184|NCT00291499|38189557|FG000|Overall Study|Adverse Event|3|||
17045185|NCT00291499|38189558|FG001|Overall Study|Adverse Event|8|||
17045186|NCT00291499|38189557|FG000|Overall Study|Change to other therapy|2|||
17045187|NCT00291499|38189558|FG001|Overall Study|Change to other therapy|1|||
17045188|NCT00291499|38189557|FG000|Overall Study|Intercurrent illness|1|||
17045189|NCT00291499|38189558|FG001|Overall Study|Intercurrent illness|0|||
17045190|NCT00291499|38189557|FG000|Overall Study|Protocol Violation|2|||
17045191|NCT00291499|38189558|FG001|Overall Study|Protocol Violation|2|||
17045192|NCT00291499|38189557|FG000|Overall Study|Other reasons|1|||
17045193|NCT00291499|38189558|FG001|Overall Study|Other reasons|4|||
17045194|NCT00553605|38189566|FG000|Overall Study|Did not meet entrance criteria|1|||
17045195|NCT00553605|38189567|FG001|Overall Study|Did not meet entrance criteria|3|||
17045196|NCT00553605|38189566|FG000|Overall Study|Did not receive full dose|1|||
17045197|NCT00553605|38189567|FG001|Overall Study|Did not receive full dose|0|||
17045198|NCT00553605|38189566|FG000|Overall Study|Randomized but not treated|2|||
17045199|NCT00553605|38189567|FG001|Overall Study|Randomized but not treated|0|||
17045200|NCT00621582|38189573|FG000|Overall Study|Adverse Event|7|||
17045201|NCT00621582|38189573|FG000|Overall Study|Protocol Violation|57|||
17045202|NCT00621582|38189573|FG000|Overall Study|Lost to Follow-up|24|||
17045203|NCT00621582|38189573|FG000|Overall Study|issues not identified by investigators|18|||
17045204|NCT00744497|38189579|FG000|Overall Study|Withdrawal by Subject|21|||
17045205|NCT00744497|38189580|FG001|Overall Study|Withdrawal by Subject|18|||
17045206|NCT00744497|38189579|FG000|Overall Study|Death|11|||
17045207|NCT00744497|38189580|FG001|Overall Study|Death|9|||
17045208|NCT00744497|38189579|FG000|Overall Study|Lost to Follow-up|4|||
17045209|NCT00744497|38189580|FG001|Overall Study|Lost to Follow-up|2|||
17045210|NCT00744497|38189579|FG000|Overall Study|Poor compliance/noncompliance|9|||
17045211|NCT00744497|38189580|FG001|Overall Study|Poor compliance/noncompliance|5|||
17045212|NCT00744497|38189579|FG000|Overall Study|No longer meets study criteria|7|||
17045213|NCT00744497|38189580|FG001|Overall Study|No longer meets study criteria|3|||
17045214|NCT00744497|38189579|FG000|Overall Study|Administrative Reason By Sponsor|25|||
17045215|NCT00744497|38189580|FG001|Overall Study|Administrative Reason By Sponsor|8|||
17045216|NCT00744497|38189579|FG000|Overall Study|Disease progression|312|||
17045217|NCT00744497|38189580|FG001|Overall Study|Disease progression|219|||
17045218|NCT00744497|38189579|FG000|Overall Study|Study drug toxicity|68|||
17045219|NCT00744497|38189580|FG001|Overall Study|Study drug toxicity|141|||
17045220|NCT00744497|38189579|FG000|Overall Study|Adverse event unrelated to study drug|78|||
17045221|NCT00744497|38189580|FG001|Overall Study|Adverse event unrelated to study drug|122|||
17045222|NCT00744497|38189579|FG000|Overall Study|Patient requested to stop study drug|65|||
17045223|NCT00744497|38189580|FG001|Overall Study|Patient requested to stop study drug|80|||
17045224|NCT00744497|38189579|FG000|Overall Study|Maximum clinical benefit|141|||
17045225|NCT00744497|38189580|FG001|Overall Study|Maximum clinical benefit|142|||
17045226|NCT00744497|38189579|FG000|Overall Study|Not defined|19|||
17045227|NCT00744497|38189580|FG001|Overall Study|Not defined|13|||
17045228|NCT00747227|38189588|FG000|Overall Study|Death|3|||
17045229|NCT00747227|38189589|FG001|Overall Study|Death|1|||
17045230|NCT00747227|38189588|FG000|Overall Study|Withdrawal by Subject|1|||
17045231|NCT00747227|38189589|FG001|Overall Study|Withdrawal by Subject|0|||
17045232|NCT00747227|38189588|FG000|Overall Study|Lost to Follow-up|1|||
17045233|NCT00747227|38189589|FG001|Overall Study|Lost to Follow-up|2|||
17045234|NCT00747227|38189588|FG000|Overall Study|Illness|1|||
17045235|NCT00747227|38189589|FG001|Overall Study|Illness|1|||
17045236|NCT00747149|38189597|FG000|Overall Study|Adverse Event|0|||
17045237|NCT00747149|38189598|FG001|Overall Study|Adverse Event|15|||
17045238|NCT00747149|38189597|FG000|Overall Study|Lost to Follow-up|0|||
17045239|NCT00747149|38189598|FG001|Overall Study|Lost to Follow-up|10|||
17045240|NCT00747149|38189597|FG000|Overall Study|Withdrawal by Subject|0|||
17045241|NCT00747149|38189598|FG001|Overall Study|Withdrawal by Subject|6|||
17045242|NCT00747149|38189597|FG000|Overall Study|Did not receive treatment|0|||
17045243|NCT00747149|38189598|FG001|Overall Study|Did not receive treatment|1|||
17045244|NCT00747149|38189597|FG000|Overall Study|Incorrect enrollment|0|||
17045245|NCT00747149|38189598|FG001|Overall Study|Incorrect enrollment|6|||
17045246|NCT00747149|38189597|FG000|Overall Study|Severe non-compliance to protocol|0|||
17045247|NCT00747149|38189598|FG001|Overall Study|Severe non-compliance to protocol|1|||
17045248|NCT00747149|38189597|FG000|Overall Study|Not reported|1|||
17045249|NCT00747149|38189598|FG001|Overall Study|Not reported|4|||
17045250|NCT00271609|38189612|FG000|Overall Study|Adverse Event|11|||
17045251|NCT00271609|38189613|FG001|Overall Study|Adverse Event|3|||
17045252|NCT00271609|38189612|FG000|Overall Study|Withdrawal by Subject|2|||
17045253|NCT00271609|38189613|FG001|Overall Study|Withdrawal by Subject|0|||
17045254|NCT00548847|38189619|FG000|Overall Study|Disease progression|7|||
17045255|NCT00290407|38189623|FG000|Overall Study|Physician Decision|2|||
17045256|NCT00749411|38189629|FG000|Overall Study|Adverse Event|0|||
17045257|NCT00749411|38189630|FG001|Overall Study|Adverse Event|2|||
17045258|NCT00749411|38189629|FG000|Overall Study|Lack of Efficacy|0|||
17045259|NCT00749411|38189630|FG001|Overall Study|Lack of Efficacy|1|||
17045260|NCT00749411|38189629|FG000|Overall Study|Protocol Violation|1|||
17045261|NCT00749411|38189630|FG001|Overall Study|Protocol Violation|1|||
17045262|NCT00749411|38189629|FG000|Overall Study|Protocol-defined stopping criteria|0|||
17045263|NCT00749411|38189630|FG001|Overall Study|Protocol-defined stopping criteria|1|||
17045264|NCT03958149|38189638|FG000|Overall Study|Withdrawal by Subject|0|||
17045265|NCT03958149|38189639|FG001|Overall Study|Withdrawal by Subject|1|||
17045266|NCT00549549|38189653|FG000|Overall Study|Adverse Event|5|||
17045267|NCT00549549|38189654|FG001|Overall Study|Adverse Event|3|||
17045268|NCT00549549|38189655|FG002|Overall Study|Adverse Event|1|||
17045269|NCT00549549|38189656|FG003|Overall Study|Adverse Event|9|||
17045270|NCT00549549|38189653|FG000|Overall Study|Lack of Efficacy|9|||
17045271|NCT00549549|38189654|FG001|Overall Study|Lack of Efficacy|6|||
17045272|NCT00549549|38189655|FG002|Overall Study|Lack of Efficacy|4|||
17045273|NCT00549549|38189656|FG003|Overall Study|Lack of Efficacy|2|||
17045274|NCT00549549|38189653|FG000|Overall Study|Lost to Follow-up|1|||
17045275|NCT00549549|38189654|FG001|Overall Study|Lost to Follow-up|0|||
17045276|NCT00549549|38189655|FG002|Overall Study|Lost to Follow-up|1|||
17045277|NCT00549549|38189656|FG003|Overall Study|Lost to Follow-up|2|||
17045278|NCT00549549|38189653|FG000|Overall Study|Withdrawal by Subject|0|||
17045279|NCT00549549|38189654|FG001|Overall Study|Withdrawal by Subject|4|||
17045280|NCT00549549|38189655|FG002|Overall Study|Withdrawal by Subject|1|||
17045281|NCT00549549|38189656|FG003|Overall Study|Withdrawal by Subject|0|||
17045282|NCT00549549|38189653|FG000|Overall Study|Other|9|||
16992362|NCT04153929|38136252|FG005|Overall Study|Not treated|0|||
16992363|NCT04153929|38136253|FG006|Overall Study|Not treated|1|||
16992364|NCT04153929|38136254|FG007|Overall Study|Not treated|0|||
16992365|NCT00591214|38136272|FG000|Overall Study|Physician Decision|7|||
16992366|NCT00591214|38136272|FG000|Overall Study|Withdrawal by Subject|1|||
16992367|NCT00725725|38136279|FG000|Overall Study|Adverse Event|1|||
16992368|NCT00725725|38136280|FG001|Overall Study|Adverse Event|3|||
16992369|NCT00725725|38136281|FG002|Overall Study|Adverse Event|2|||
16992370|NCT00725725|38136279|FG000|Overall Study|Lost to Follow-up|2|||
16992371|NCT00725725|38136280|FG001|Overall Study|Lost to Follow-up|0|||
16992372|NCT00725725|38136281|FG002|Overall Study|Lost to Follow-up|2|||
16992373|NCT00725725|38136279|FG000|Overall Study|Withdrawal by Subject|1|||
16992374|NCT00725725|38136280|FG001|Overall Study|Withdrawal by Subject|0|||
16992375|NCT00725725|38136281|FG002|Overall Study|Withdrawal by Subject|1|||
16992376|NCT00725725|38136279|FG000|Overall Study|Protocol Violation|0|||
16992377|NCT00725725|38136280|FG001|Overall Study|Protocol Violation|1|||
16992378|NCT00725725|38136281|FG002|Overall Study|Protocol Violation|0|||
17045283|NCT00549549|38189654|FG001|Overall Study|Other|9|||
17045284|NCT00549549|38189655|FG002|Overall Study|Other|9|||
17045285|NCT00549549|38189656|FG003|Overall Study|Other|11|||
17045286|NCT00549549|38189653|FG000|Overall Study|Randomized but not treated|0|||
17045287|NCT00549549|38189654|FG001|Overall Study|Randomized but not treated|0|||
17045288|NCT00549549|38189655|FG002|Overall Study|Randomized but not treated|1|||
17045289|NCT00549549|38189656|FG003|Overall Study|Randomized but not treated|1|||
17045290|NCT00270205|38189670|FG000|Overall Study|Lost to Follow-up|1|||
17045291|NCT00270205|38189671|FG001|Overall Study|Lost to Follow-up|0|||
17045292|NCT00270205|38189672|FG002|Overall Study|Lost to Follow-up|0|||
17045293|NCT00270205|38189673|FG003|Overall Study|Lost to Follow-up|1|||
17045294|NCT00622284|38189685|FG000|Overall Study|Lack of Efficacy|45|||
17045295|NCT00622284|38189686|FG001|Overall Study|Lack of Efficacy|15|||
17045296|NCT00622284|38189685|FG000|Overall Study|Adverse Event|61|||
17045297|NCT00622284|38189686|FG001|Overall Study|Adverse Event|90|||
17045298|NCT00622284|38189685|FG000|Overall Study|Protocol Violation|12|||
17045299|NCT00622284|38189686|FG001|Overall Study|Protocol Violation|5|||
17045300|NCT00622284|38189685|FG000|Overall Study|Lost to Follow-up|11|||
17045301|NCT00622284|38189686|FG001|Overall Study|Lost to Follow-up|13|||
17045302|NCT00622284|38189685|FG000|Overall Study|Withdrawal by Subject|27|||
16992379|NCT00725101|38136289|FG000|Overall Study|Death|3|||
16992380|NCT00725101|38136289|FG000|Overall Study|Lost to Follow-up|353|||
16992381|NCT00725101|38136289|FG000|Overall Study|Protocol Violation|1|||
16992382|NCT00725101|38136289|FG000|Overall Study|Withdrawal by Subject|127|||
17045303|NCT00622284|38189686|FG001|Overall Study|Withdrawal by Subject|24|||
17045304|NCT00622284|38189685|FG000|Overall Study|Other reason (not specified)|33|||
17141327|NCT03337113|38283728|FG003|Overall Study|Adverse Event|1|||
17045305|NCT00622284|38189686|FG001|Overall Study|Other reason (not specified)|24|||
17045306|NCT00269113|38189694|FG000|Overall Study|Adverse Event|14|||
17045307|NCT00269113|38189695|FG001|Overall Study|Adverse Event|7|||
17045308|NCT00269113|38189694|FG000|Overall Study|Lack of Efficacy|35|||
17045309|NCT00269113|38189695|FG001|Overall Study|Lack of Efficacy|18|||
17045310|NCT00269113|38189694|FG000|Overall Study|Early Improvement|2|||
17045311|NCT00269113|38189695|FG001|Overall Study|Early Improvement|0|||
17045312|NCT00269113|38189694|FG000|Overall Study|Withdrawal by Subject|0|||
17045313|NCT00269113|38189695|FG001|Overall Study|Withdrawal by Subject|2|||
17045314|NCT00269113|38189694|FG000|Overall Study|Death|6|||
17045315|NCT00269113|38189695|FG001|Overall Study|Death|2|||
17045316|NCT00269113|38189694|FG000|Overall Study|Lost to Follow-up|2|||
17045317|NCT00269113|38189695|FG001|Overall Study|Lost to Follow-up|1|||
17045318|NCT00269113|38189694|FG000|Overall Study|Protocol Violation|15|||
17045319|NCT00269113|38189695|FG001|Overall Study|Protocol Violation|5|||
17045320|NCT00269113|38189694|FG000|Overall Study|Other|0|||
17045321|NCT00269113|38189695|FG001|Overall Study|Other|2|||
17045322|NCT00291187|38189705|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
17045323|NCT00291187|38189706|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
17045324|NCT00291187|38189707|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
17045325|NCT00291187|38189708|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
17045326|NCT00546819|38189724|FG000|Overall Study|Adverse Event|2|||
17045327|NCT00546819|38189725|FG001|Overall Study|Adverse Event|3|||
17045328|NCT00546819|38189724|FG000|Overall Study|Lost to Follow-up|2|||
17045329|NCT00546819|38189725|FG001|Overall Study|Lost to Follow-up|1|||
17045330|NCT00546819|38189724|FG000|Overall Study|Withdrawal by Subject|4|||
17045331|NCT00546819|38189725|FG001|Overall Study|Withdrawal by Subject|2|||
17045332|NCT00621504|38189733|FG000|Overall Study|Adverse Event|1|||
17045333|NCT00621504|38189734|FG001|Overall Study|Adverse Event|3|||
17045334|NCT00621504|38189733|FG000|Overall Study|At the request of sponsor/investigator|1|||
17045335|NCT00621504|38189734|FG001|Overall Study|At the request of sponsor/investigator|0|||
17045336|NCT00621504|38189733|FG000|Overall Study|Withdrew consent|9|||
17045337|NCT00621504|38189734|FG001|Overall Study|Withdrew consent|6|||
17045338|NCT00621504|38189733|FG000|Overall Study|Lost to Follow-up|8|||
17045339|NCT00621504|38189734|FG001|Overall Study|Lost to Follow-up|10|||
17045340|NCT00621504|38189733|FG000|Overall Study|Other|1|||
17045341|NCT00621504|38189734|FG001|Overall Study|Other|0|||
17045342|NCT00621504|38189733|FG000|Overall Study|Death|6|||
17045343|NCT00621504|38189734|FG001|Overall Study|Death|6|||
17045344|NCT00548145|38189742|FG000|Overall Study|Death|0|||
17045345|NCT00548145|38189743|FG001|Overall Study|Death|1|||
17045346|NCT00548145|38189742|FG000|Overall Study|Withdrawal by Subject|0|||
17045347|NCT00548145|38189743|FG001|Overall Study|Withdrawal by Subject|2|||
17045348|NCT00548145|38189742|FG000|Overall Study|Physician Decision|1|||
17045349|NCT00548145|38189743|FG001|Overall Study|Physician Decision|1|||
17045350|NCT00547911|38189753|FG000|Overall Study|Adverse Event|0|||
17045351|NCT00547911|38189754|FG001|Overall Study|Adverse Event|0|||
17045352|NCT00547911|38189755|FG002|Overall Study|Adverse Event|0|||
17045353|NCT00547911|38189756|FG003|Overall Study|Adverse Event|1|||
17045354|NCT00547911|38189757|FG004|Overall Study|Adverse Event|0|||
17045355|NCT00547911|38189758|FG005|Overall Study|Adverse Event|0|||
17045356|NCT00289783|38189773|FG000|Primary Phase|Adverse Event|10|||
17045357|NCT00289783|38189774|FG001|Primary Phase|Adverse Event|1|||
17045358|NCT00289783|38189773|FG000|Primary Phase|Protocol Violation|27|||
17045359|NCT00289783|38189774|FG001|Primary Phase|Protocol Violation|6|||
17045360|NCT00289783|38189773|FG000|Primary Phase|Withdrawal by Subject|93|||
17045361|NCT00289783|38189774|FG001|Primary Phase|Withdrawal by Subject|40|||
17045362|NCT00289783|38189773|FG000|Primary Phase|Lost to Follow-up|60|||
17045363|NCT00289783|38189774|FG001|Primary Phase|Lost to Follow-up|14|||
17045364|NCT00289783|38189773|FG000|Primary Phase|Migration from the study area|26|||
17045365|NCT00289783|38189774|FG001|Primary Phase|Migration from the study area|10|||
17045366|NCT00289783|38189773|FG000|Primary Phase|Other|32|||
17045367|NCT00289783|38189774|FG001|Primary Phase|Other|12|||
17045368|NCT00289783|38189773|FG000|Fourth Dose Phase|Adverse Event|1|||
17045369|NCT00289783|38189774|FG001|Fourth Dose Phase|Adverse Event|0|||
17045370|NCT00289783|38189773|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
17045371|NCT00289783|38189774|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
17045372|NCT00289783|38189773|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
17045373|NCT00289783|38189774|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
17045374|NCT00289783|38189773|FG000|Fourth Dose Phase|Migration from the study area|1|||
17045375|NCT00289783|38189774|FG001|Fourth Dose Phase|Migration from the study area|1|||
17045376|NCT00289783|38189773|FG000|Fourth Dose Phase|Other|22|||
17045377|NCT00289783|38189774|FG001|Fourth Dose Phase|Other|10|||
17045378|NCT00574080|38189790|FG000|Overall Study|Death|10|||
17045379|NCT00574080|38189791|FG001|Overall Study|Death|10|||
17045380|NCT00546351|38189797|FG000|Overall Study|Adverse Event|76|||
17045381|NCT00546351|38189797|FG000|Overall Study|Lack of Efficacy|15|||
17045382|NCT00546351|38189797|FG000|Overall Study|Withdrawal by Subject|109|||
17045383|NCT00546351|38189797|FG000|Overall Study|Lost to Follow-up|9|||
17045384|NCT00546351|38189797|FG000|Overall Study|Protocol Deviation|1|||
17045385|NCT00546351|38189797|FG000|Overall Study|Unsatisfactory compliance|9|||
17045386|NCT00546351|38189797|FG000|Overall Study|Other reasons for premature termination|17|||
17045387|NCT00267865|38189801|FG000|Induction Treatment|Died before completing.|2|||
17045388|NCT00267865|38189801|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
17045389|NCT00546117|38189807|FG000|Overall Study|Withdrawal by Subject|3|||
17045390|NCT00546117|38189808|FG001|Overall Study|Withdrawal by Subject|0|||
17045391|NCT00546117|38189807|FG000|Overall Study|Inability to schedule follow-up visit|1|||
17045392|NCT00546117|38189808|FG001|Overall Study|Inability to schedule follow-up visit|0|||
17045393|NCT00251719|38189819|FG000|Overall Study|Adverse Event|14|||
17045394|NCT00251719|38189820|FG001|Overall Study|Adverse Event|8|||
17045395|NCT00251719|38189821|FG002|Overall Study|Adverse Event|7|||
17045396|NCT00251719|38189819|FG000|Overall Study|Protocol Violation|1|||
17045397|NCT00251719|38189820|FG001|Overall Study|Protocol Violation|1|||
17045398|NCT00251719|38189821|FG002|Overall Study|Protocol Violation|1|||
17045399|NCT00251719|38189819|FG000|Overall Study|Lost to Follow-up|5|||
17045400|NCT00251719|38189820|FG001|Overall Study|Lost to Follow-up|11|||
17045401|NCT00251719|38189821|FG002|Overall Study|Lost to Follow-up|8|||
17045402|NCT00251719|38189819|FG000|Overall Study|Withdrawal by Subject|14|||
17045403|NCT00251719|38189820|FG001|Overall Study|Withdrawal by Subject|12|||
17045404|NCT00251719|38189821|FG002|Overall Study|Withdrawal by Subject|11|||
17045405|NCT00251719|38189819|FG000|Overall Study|Lack of Efficacy|2|||
17045406|NCT00251719|38189820|FG001|Overall Study|Lack of Efficacy|1|||
17045407|NCT00251719|38189821|FG002|Overall Study|Lack of Efficacy|0|||
17045408|NCT00251719|38189819|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
17045409|NCT00251719|38189820|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
17045410|NCT00251719|38189821|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
17045411|NCT00251719|38189819|FG000|Overall Study|Investigator decision|1|||
17045412|NCT00251719|38189820|FG001|Overall Study|Investigator decision|1|||
17045413|NCT00251719|38189821|FG002|Overall Study|Investigator decision|0|||
17045414|NCT00251719|38189819|FG000|Overall Study|Noncompliance|2|||
17045415|NCT00251719|38189820|FG001|Overall Study|Noncompliance|3|||
17045416|NCT00251719|38189821|FG002|Overall Study|Noncompliance|1|||
17045417|NCT00251719|38189819|FG000|Overall Study|Barrett's esophagus|2|||
17045418|NCT00251719|38189820|FG001|Overall Study|Barrett's esophagus|2|||
17045419|NCT00251719|38189821|FG002|Overall Study|Barrett's esophagus|0|||
17045420|NCT03952143|38189831|FG000|Lead-In Period|Adverse Event|2|||
17045421|NCT03952143|38189832|FG001|Lead-In Period|Adverse Event|0|||
17045422|NCT03952143|38189833|FG002|Lead-In Period|Adverse Event|0|||
17045423|NCT03952143|38189831|FG000|Lead-In Period|Lack of Efficacy|2|||
17045424|NCT03952143|38189832|FG001|Lead-In Period|Lack of Efficacy|0|||
17045425|NCT03952143|38189833|FG002|Lead-In Period|Lack of Efficacy|0|||
17045426|NCT03952143|38189831|FG000|Lead-In Period|Physician Decision|5|||
17045427|NCT03952143|38189832|FG001|Lead-In Period|Physician Decision|0|||
17045428|NCT03952143|38189833|FG002|Lead-In Period|Physician Decision|0|||
17045429|NCT03952143|38189831|FG000|Lead-In Period|Protocol Violation|5|||
17045430|NCT03952143|38189832|FG001|Lead-In Period|Protocol Violation|0|||
17045431|NCT03952143|38189833|FG002|Lead-In Period|Protocol Violation|0|||
17045432|NCT03952143|38189831|FG000|Lead-In Period|Withdrawal by Subject|19|||
17045433|NCT03952143|38189832|FG001|Lead-In Period|Withdrawal by Subject|0|||
17045434|NCT03952143|38189833|FG002|Lead-In Period|Withdrawal by Subject|0|||
17045435|NCT03952143|38189831|FG000|Treatment Period|Adverse Event|0|||
17045436|NCT03952143|38189832|FG001|Treatment Period|Adverse Event|0|||
17045437|NCT03952143|38189833|FG002|Treatment Period|Adverse Event|1|||
17045438|NCT03952143|38189831|FG000|Treatment Period|Lost to Follow-up|0|||
17045439|NCT03952143|38189832|FG001|Treatment Period|Lost to Follow-up|2|||
17045440|NCT03952143|38189833|FG002|Treatment Period|Lost to Follow-up|0|||
17045441|NCT03952143|38189831|FG000|Treatment Period|Physician Decision|0|||
17045442|NCT03952143|38189832|FG001|Treatment Period|Physician Decision|0|||
17045443|NCT03952143|38189833|FG002|Treatment Period|Physician Decision|2|||
17045444|NCT03952143|38189831|FG000|Treatment Period|Protocol Violation|0|||
17045445|NCT03952143|38189832|FG001|Treatment Period|Protocol Violation|0|||
17045446|NCT03952143|38189833|FG002|Treatment Period|Protocol Violation|1|||
17045447|NCT03952143|38189831|FG000|Treatment Period|Withdrawal by Subject|0|||
17045448|NCT03952143|38189832|FG001|Treatment Period|Withdrawal by Subject|5|||
17045449|NCT03952143|38189833|FG002|Treatment Period|Withdrawal by Subject|26|||
17045450|NCT03952143|38189831|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
17045451|NCT03952143|38189832|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
17045452|NCT03952143|38189833|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
17045453|NCT03952143|38189831|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
17045454|NCT03952143|38189832|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
17045455|NCT03952143|38189833|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
17045456|NCT00621192|38189844|FG000|Overall Study|Withdrawal by Subject|0|||
17045457|NCT00621192|38189845|FG001|Overall Study|Withdrawal by Subject|0|||
17045458|NCT00621192|38189846|FG002|Overall Study|Withdrawal by Subject|2|||
17045459|NCT00621192|38189847|FG003|Overall Study|Withdrawal by Subject|0|||
17045460|NCT00621192|38189844|FG000|Overall Study|Physician Decision|1|||
17045461|NCT00621192|38189845|FG001|Overall Study|Physician Decision|3|||
17045462|NCT00621192|38189846|FG002|Overall Study|Physician Decision|0|||
17045463|NCT00621192|38189847|FG003|Overall Study|Physician Decision|0|||
17045464|NCT00621192|38189844|FG000|Overall Study|Protocol Violation|1|||
17045465|NCT00621192|38189845|FG001|Overall Study|Protocol Violation|0|||
17045466|NCT00621192|38189846|FG002|Overall Study|Protocol Violation|0|||
17045467|NCT00621192|38189847|FG003|Overall Study|Protocol Violation|1|||
17045468|NCT00621192|38189844|FG000|Overall Study|Adverse Event|0|||
17045469|NCT00621192|38189845|FG001|Overall Study|Adverse Event|1|||
17045470|NCT00621192|38189846|FG002|Overall Study|Adverse Event|0|||
17045471|NCT00621192|38189847|FG003|Overall Study|Adverse Event|1|||
17045472|NCT00621192|38189844|FG000|Overall Study|Death|2|||
17045473|NCT00621192|38189845|FG001|Overall Study|Death|5|||
17045474|NCT00621192|38189846|FG002|Overall Study|Death|0|||
17045475|NCT00621192|38189847|FG003|Overall Study|Death|0|||
17045476|NCT00621192|38189844|FG000|Overall Study|Final Assessments not Completed|0|||
17045477|NCT00621192|38189845|FG001|Overall Study|Final Assessments not Completed|0|||
17045478|NCT00621192|38189846|FG002|Overall Study|Final Assessments not Completed|3|||
17045479|NCT00621192|38189847|FG003|Overall Study|Final Assessments not Completed|1|||
17045480|NCT00267007|38189859|FG000|Overall Study|Withdrawal by Subject|6|||
17045481|NCT00267007|38189860|FG001|Overall Study|Withdrawal by Subject|0|||
17045482|NCT00267007|38189859|FG000|Overall Study|Lost to Follow-up|1|||
17045483|NCT00267007|38189860|FG001|Overall Study|Lost to Follow-up|0|||
17045484|NCT00267007|38189859|FG000|Overall Study|Non-compliance|0|||
17045485|NCT00267007|38189860|FG001|Overall Study|Non-compliance|1|||
17045486|NCT00267007|38189859|FG000|Overall Study|Adverse Event|1|||
17045487|NCT00267007|38189860|FG001|Overall Study|Adverse Event|0|||
17045488|NCT03943095|38189868|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
17045489|NCT03943095|38189869|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
17045490|NCT03943095|38189868|FG000|Overall Study|Withdrawal by Subject|1|||
17045491|NCT03943095|38189869|FG001|Overall Study|Withdrawal by Subject|0|||
17045492|NCT00251641|38189878|FG000|Overall Study|Adverse Event|80|||
17045493|NCT00251641|38189879|FG001|Overall Study|Adverse Event|8|||
17045494|NCT00251641|38189878|FG000|Overall Study|Lack of Efficacy|2|||
17045495|NCT00251641|38189879|FG001|Overall Study|Lack of Efficacy|1|||
17045496|NCT00251641|38189878|FG000|Overall Study|Progression of Disease|0|||
17045497|NCT00251641|38189879|FG001|Overall Study|Progression of Disease|2|||
17045498|NCT00251641|38189878|FG000|Overall Study|Lost to Follow-up|3|||
17045499|NCT00251641|38189879|FG001|Overall Study|Lost to Follow-up|3|||
17045500|NCT00251641|38189878|FG000|Overall Study|Withdrawal by Subject|6|||
17045501|NCT00251641|38189879|FG001|Overall Study|Withdrawal by Subject|8|||
17045502|NCT00251641|38189878|FG000|Overall Study|Protocol Violation|10|||
17045503|NCT00251641|38189879|FG001|Overall Study|Protocol Violation|2|||
17045504|NCT00251641|38189878|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
17045505|NCT00251641|38189879|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
17045506|NCT00251641|38189878|FG000|Overall Study|Switched Treatment|9|||
17045507|NCT00251641|38189879|FG001|Overall Study|Switched Treatment|63|||
17045508|NCT00250705|38189887|FG000|Overall Study|Lack of Efficacy|2|||
17045509|NCT00266695|38189893|FG000|Overall Study|Adverse Event|1|||
17045510|NCT00266695|38189893|FG000|Overall Study|Death|9|||
17045511|NCT00266695|38189893|FG000|Overall Study|Physician Decision|1|||
17045512|NCT00266695|38189893|FG000|Overall Study|Lost to Follow-up|3|||
17045513|NCT00266695|38189893|FG000|Overall Study|Withdrawal by Subject|15|||
17045514|NCT00620022|38189897|FG000|Treatment Period 1|Adverse Event|4|||
17045515|NCT00620022|38189898|FG001|Treatment Period 1|Adverse Event|6|||
17045516|NCT00620022|38189897|FG000|Treatment Period 1|Subject withdrew consent|1|||
17045517|NCT00620022|38189898|FG001|Treatment Period 1|Subject withdrew consent|0|||
17045518|NCT00620022|38189897|FG000|Treatment Period 2|Adverse Event|2|||
17141328|NCT03337113|38283725|FG000|Overall Study|Physician Decision|0|||
17141329|NCT03337113|38283726|FG001|Overall Study|Physician Decision|2|||
17141330|NCT03337113|38283727|FG002|Overall Study|Physician Decision|0|||
17045519|NCT00620022|38189898|FG001|Treatment Period 2|Adverse Event|2|||
17045520|NCT00547521|38189906|FG000|Short Term Study (4 Months)|Adverse Event|1|||
17045521|NCT00547521|38189907|FG001|Short Term Study (4 Months)|Adverse Event|0|||
17045522|NCT00547521|38189906|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
17045523|NCT00547521|38189907|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
17045524|NCT00547521|38189906|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
17045525|NCT00547521|38189907|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
17045526|NCT00547521|38189906|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
17045527|NCT00547521|38189907|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
17045528|NCT00547521|38189906|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
17045529|NCT00547521|38189907|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
17045530|NCT00547521|38189906|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
17045531|NCT00547521|38189907|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
17141331|NCT03337113|38283728|FG003|Overall Study|Physician Decision|1|||
17141332|NCT03337113|38283725|FG000|Overall Study|Withdrawal by Subject|0|||
17141333|NCT03337113|38283726|FG001|Overall Study|Withdrawal by Subject|0|||
17141334|NCT03337113|38283727|FG002|Overall Study|Withdrawal by Subject|1|||
17141335|NCT03337113|38283728|FG003|Overall Study|Withdrawal by Subject|0|||
17141336|NCT03092726|38283740|FG000|Overall Study|Adverse Event|3|||
17141337|NCT03092726|38283741|FG001|Overall Study|Adverse Event|10|||
17141338|NCT03092726|38283740|FG000|Overall Study|Lack of Efficacy|0|||
17141339|NCT03092726|38283741|FG001|Overall Study|Lack of Efficacy|1|||
17141340|NCT03092726|38283740|FG000|Overall Study|Lost to Follow-up|1|||
17141341|NCT03092726|38283741|FG001|Overall Study|Lost to Follow-up|0|||
17141342|NCT03092726|38283740|FG000|Overall Study|Withdrawal by Subject|5|||
17141343|NCT03092726|38283741|FG001|Overall Study|Withdrawal by Subject|3|||
17141344|NCT03338010|38283749|FG000|Overall Study|Withdrawal by Subject|14|||
17141345|NCT03338010|38283750|FG001|Overall Study|Withdrawal by Subject|8|||
17141346|NCT03338010|38283749|FG000|Overall Study|Lost to Follow-up|4|||
17141347|NCT03338010|38283750|FG001|Overall Study|Lost to Follow-up|2|||
17141348|NCT03338010|38283749|FG000|Overall Study|Adverse Event|3|||
17141349|NCT03338010|38283750|FG001|Overall Study|Adverse Event|2|||
17141350|NCT03338010|38283749|FG000|Overall Study|Physician Decision|2|||
17141351|NCT03338010|38283750|FG001|Overall Study|Physician Decision|2|||
17141352|NCT03338010|38283749|FG000|Overall Study|Non-Compliance with Study Drug|0|||
17141353|NCT03338010|38283750|FG001|Overall Study|Non-Compliance with Study Drug|3|||
17141354|NCT03338010|38283749|FG000|Overall Study|Protocol Violation|0|||
17141355|NCT03338010|38283750|FG001|Overall Study|Protocol Violation|1|||
17141356|NCT03337542|38283756|FG000|Overall Study|Withdrew Consent|17|||
17141357|NCT03337542|38283756|FG000|Overall Study|Allergic Adverse Event|1|||
17141358|NCT03337542|38283756|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
17141359|NCT03337542|38283756|FG000|Overall Study|Lost to Follow-up|1|||
17141360|NCT03337542|38283756|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
17141361|NCT01328548|38283763|FG000|Overall Study|Death|3|||
17141362|NCT01328548|38283764|FG001|Overall Study|Death|0|||
17141363|NCT01328548|38283763|FG000|Overall Study|Protocol Violation|1|||
17141364|NCT01328548|38283764|FG001|Overall Study|Protocol Violation|0|||
17141365|NCT03337308|38283802|FG000|Overall Study|Adverse Event|2|||
17141366|NCT03337308|38283803|FG001|Overall Study|Adverse Event|3|||
17141367|NCT03337308|38283804|FG002|Overall Study|Adverse Event|3|||
17141368|NCT03337308|38283805|FG003|Overall Study|Adverse Event|1|||
17141369|NCT03337308|38283802|FG000|Overall Study|Lost to Follow-up|1|||
17141370|NCT03337308|38283803|FG001|Overall Study|Lost to Follow-up|2|||
17141371|NCT03337308|38283804|FG002|Overall Study|Lost to Follow-up|0|||
17141372|NCT03337308|38283805|FG003|Overall Study|Lost to Follow-up|0|||
17141373|NCT03337308|38283802|FG000|Overall Study|Withdrawal by Subject|2|||
17141374|NCT03337308|38283803|FG001|Overall Study|Withdrawal by Subject|1|||
17141375|NCT03337308|38283804|FG002|Overall Study|Withdrawal by Subject|2|||
17141376|NCT03337308|38283805|FG003|Overall Study|Withdrawal by Subject|1|||
17141377|NCT03337308|38283802|FG000|Overall Study|Protocol Violation|0|||
17141378|NCT03337308|38283803|FG001|Overall Study|Protocol Violation|1|||
17141379|NCT03337308|38283804|FG002|Overall Study|Protocol Violation|0|||
17141380|NCT03337308|38283805|FG003|Overall Study|Protocol Violation|0|||
17141381|NCT02948829|38283815|FG000|Overall Study|Lost to Follow-up|2|||
17141382|NCT02948829|38283815|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
17141383|NCT02948829|38283815|FG000|Overall Study|Pregnancy|1|||
17141384|NCT02948829|38283815|FG000|Overall Study|Other: Reason not Specified|8|||
17141385|NCT03337152|38283836|FG000|Overall Study|Physician Decision|1|||
17141386|NCT03337152|38283837|FG001|Overall Study|Physician Decision|0|||
17141387|NCT03337152|38283836|FG000|Overall Study|Lost to Follow-up|1|||
17141388|NCT03337152|38283837|FG001|Overall Study|Lost to Follow-up|3|||
17141389|NCT03337152|38283836|FG000|Overall Study|Adverse Event|3|||
17141390|NCT03337152|38283837|FG001|Overall Study|Adverse Event|1|||
17141391|NCT03337152|38283836|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
17141392|NCT03337152|38283837|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
17141393|NCT03710161|38283851|FG000|Overall Study|Study halted due to COVID pandemic|3|||
17141394|NCT03710161|38283852|FG001|Overall Study|Study halted due to COVID pandemic|2|||
17141395|NCT03091400|38283860|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
17141396|NCT03091400|38283861|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
17141397|NCT01318993|38283867|FG000|Overall Study|Adverse Event|53|||
17141398|NCT01318993|38283867|FG000|Overall Study|Lack of Efficacy|121|||
17141399|NCT01318993|38283867|FG000|Overall Study|Protocol Violation|3|||
17141400|NCT01318993|38283867|FG000|Overall Study|Protocol based stopping criteria|6|||
17141401|NCT01318993|38283867|FG000|Overall Study|Study closed or terminated|174|||
17141402|NCT01318993|38283867|FG000|Overall Study|Lost to Follow-up|4|||
17141403|NCT01318993|38283867|FG000|Overall Study|Physician Decision|13|||
17141404|NCT01318993|38283867|FG000|Overall Study|Withdrawal by Subject|24|||
17141405|NCT03090152|38283874|FG000|Overall Study|Withdrawal by Subject|0|||
17141406|NCT03090152|38283875|FG001|Overall Study|Withdrawal by Subject|2|||
17141407|NCT03090152|38283876|FG002|Overall Study|Withdrawal by Subject|1|||
17141408|NCT03090152|38283874|FG000|Overall Study|Surgery Canceled|1|||
17141409|NCT03090152|38283875|FG001|Overall Study|Surgery Canceled|0|||
17141410|NCT03090152|38283876|FG002|Overall Study|Surgery Canceled|0|||
17141411|NCT03090152|38283874|FG000|Overall Study|Epidural catheter could not be placed|0|||
17141412|NCT03090152|38283875|FG001|Overall Study|Epidural catheter could not be placed|2|||
17141413|NCT03090152|38283876|FG002|Overall Study|Epidural catheter could not be placed|0|||
17141414|NCT04252287|38283886|FG000|Overall Study|Death|5|||
17141415|NCT04252287|38283887|FG001|Overall Study|Death|3|||
17141416|NCT04252287|38283886|FG000|Overall Study|Lost to Follow-up|4|||
17141417|NCT04252287|38283887|FG001|Overall Study|Lost to Follow-up|6|||
17141418|NCT04252287|38283886|FG000|Overall Study|Withdrawal by Subject|19|||
17141419|NCT04252287|38283887|FG001|Overall Study|Withdrawal by Subject|16|||
17141420|NCT04252287|38283886|FG000|Overall Study|Protocol Violation|3|||
17141421|NCT04252287|38283887|FG001|Overall Study|Protocol Violation|4|||
17141422|NCT02735200|38283899|FG000|Overall Study|Lost to Follow-up|0|||
17141423|NCT02735200|38283900|FG001|Overall Study|Lost to Follow-up|5|||
17141424|NCT02735200|38283899|FG000|Overall Study|Withdrawal by Subject|8|||
17141425|NCT02735200|38283900|FG001|Overall Study|Withdrawal by Subject|0|||
17141426|NCT02946918|38283908|FG000|Overall Study|Patient unblinded himself|1|||
17141427|NCT02946918|38283909|FG001|Overall Study|Patient unblinded himself|0|||
17141428|NCT02946918|38283908|FG000|Overall Study|Physician Decision|0|||
17141429|NCT02946918|38283909|FG001|Overall Study|Physician Decision|2|||
17141430|NCT02946918|38283908|FG000|Overall Study|Ran out of study medication|0|||
17141431|NCT02946918|38283909|FG001|Overall Study|Ran out of study medication|1|||
17141432|NCT02734810|38283930|FG000|Overall Study|Adverse Event|1|||
17141433|NCT02734810|38283931|FG001|Overall Study|Adverse Event|0|||
17141434|NCT02734810|38283930|FG000|Overall Study|Lack of Efficacy|1|||
17141435|NCT02734810|38283931|FG001|Overall Study|Lack of Efficacy|0|||
17141436|NCT03656068|38283956|FG000|Overall Study|Withdrawal by Subject|4|||
17141437|NCT03656068|38283956|FG000|Overall Study|Adverse Event|1|||
17141438|NCT02944383|38283963|FG000|Overall Study|Lost to Follow-up|0|||
17141439|NCT02944383|38283964|FG001|Overall Study|Lost to Follow-up|0|||
17141440|NCT02944383|38283965|FG002|Overall Study|Lost to Follow-up|1|||
17141441|NCT02944383|38283963|FG000|Overall Study|Withdrawal by Subject|1|||
17141442|NCT02944383|38283964|FG001|Overall Study|Withdrawal by Subject|0|||
17141443|NCT02944383|38283965|FG002|Overall Study|Withdrawal by Subject|0|||
17141444|NCT02096588|38283977|FG000|Overall Study|Lack of Efficacy|2|||
17141445|NCT02096588|38283978|FG001|Overall Study|Lack of Efficacy|0|||
17141446|NCT02096588|38283977|FG000|Overall Study|Withdrawal by Subject|0|||
17141447|NCT02096588|38283978|FG001|Overall Study|Withdrawal by Subject|1|||
17141448|NCT03768089|38284002|FG000|Part A|Lost to Follow-up|0|||
17141449|NCT03768089|38284003|FG001|Part A|Lost to Follow-up|0|||
17141450|NCT03768089|38284004|FG002|Part A|Lost to Follow-up|0|||
17141451|NCT03768089|38284005|FG003|Part A|Lost to Follow-up|0|||
17141452|NCT03768089|38284006|FG004|Part A|Lost to Follow-up|1|||
17141453|NCT03768089|38284007|FG005|Part A|Lost to Follow-up|0|||
17141454|NCT03768089|38284008|FG006|Part A|Lost to Follow-up|0|||
17141455|NCT03768089|38284009|FG007|Part A|Lost to Follow-up|0|||
17141456|NCT03768089|38284010|FG008|Part A|Lost to Follow-up|0|||
17141457|NCT03768089|38284011|FG009|Part A|Lost to Follow-up|0|||
17141458|NCT03768089|38284012|FG010|Part A|Lost to Follow-up|0|||
17141459|NCT03768089|38284013|FG011|Part A|Lost to Follow-up|0|||
17141460|NCT03768089|38284014|FG012|Part A|Lost to Follow-up|0|||
17141461|NCT03768089|38284015|FG013|Part A|Lost to Follow-up|0|||
17141462|NCT03768089|38284016|FG014|Part A|Lost to Follow-up|0|||
17141463|NCT03768089|38284017|FG015|Part A|Lost to Follow-up|0|||
17141464|NCT03768089|38284018|FG016|Part A|Lost to Follow-up|0|||
17141465|NCT03768089|38284019|FG017|Part A|Lost to Follow-up|0|||
17141466|NCT03768089|38284002|FG000|Part C|Randomized, Never Dosed|0|||
17141467|NCT03768089|38284003|FG001|Part C|Randomized, Never Dosed|0|||
17141468|NCT03768089|38284004|FG002|Part C|Randomized, Never Dosed|0|||
17141469|NCT03768089|38284005|FG003|Part C|Randomized, Never Dosed|0|||
17141470|NCT03768089|38284006|FG004|Part C|Randomized, Never Dosed|0|||
17141471|NCT03768089|38284007|FG005|Part C|Randomized, Never Dosed|0|||
17141472|NCT03768089|38284008|FG006|Part C|Randomized, Never Dosed|0|||
17141473|NCT03768089|38284009|FG007|Part C|Randomized, Never Dosed|0|||
17141474|NCT03768089|38284010|FG008|Part C|Randomized, Never Dosed|0|||
17141475|NCT03768089|38284011|FG009|Part C|Randomized, Never Dosed|0|||
17141476|NCT03768089|38284012|FG010|Part C|Randomized, Never Dosed|0|||
17141477|NCT03768089|38284013|FG011|Part C|Randomized, Never Dosed|0|||
17141478|NCT03768089|38284014|FG012|Part C|Randomized, Never Dosed|0|||
17141479|NCT03768089|38284015|FG013|Part C|Randomized, Never Dosed|0|||
17141480|NCT03768089|38284016|FG014|Part C|Randomized, Never Dosed|1|||
17141481|NCT03768089|38284017|FG015|Part C|Randomized, Never Dosed|0|||
17141482|NCT03768089|38284018|FG016|Part C|Randomized, Never Dosed|0|||
17141483|NCT03768089|38284019|FG017|Part C|Randomized, Never Dosed|0|||
17141484|NCT03086330|38284080|FG000|Overall Study|Withdrawal by Subject|3|||
17141485|NCT03086330|38284081|FG001|Overall Study|Withdrawal by Subject|2|||
17141486|NCT03086330|38284080|FG000|Overall Study|Lost to Follow-up|1|||
17141487|NCT03086330|38284081|FG001|Overall Study|Lost to Follow-up|2|||
17141488|NCT02943993|38284113|FG000|Overall Study|Withdrawal by Subject|52|||
17141489|NCT02943993|38284113|FG000|Overall Study|Transfer to another institution|6|||
17141490|NCT02943993|38284113|FG000|Overall Study|Lost to Follow-up|135|||
17141491|NCT02943993|38284113|FG000|Overall Study|Death|98|||
17141492|NCT02943993|38284113|FG000|Overall Study|Other reason for premature termination|32|||
17141493|NCT02943993|38284113|FG000|Overall Study|Missing reason for termination|7|||
17141494|NCT02943447|38284137|FG000|Blinded Study Phase|Withdrew Consent|1|||
17141495|NCT02943447|38284138|FG001|Blinded Study Phase|Withdrew Consent|2|||
17141496|NCT02943447|38284139|FG002|Blinded Study Phase|Withdrew Consent|1|||
17141497|NCT02943447|38284137|FG000|Blinded Study Phase|Adverse Event|3|||
17141498|NCT02943447|38284138|FG001|Blinded Study Phase|Adverse Event|0|||
17141499|NCT02943447|38284139|FG002|Blinded Study Phase|Adverse Event|0|||
17141500|NCT02943447|38284137|FG000|Blinded Study Phase|Investigator's discretion|1|||
17141501|NCT02943447|38284138|FG001|Blinded Study Phase|Investigator's discretion|0|||
17141502|NCT02943447|38284139|FG002|Blinded Study Phase|Investigator's discretion|0|||
17141503|NCT02943447|38284137|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
17141504|NCT02943447|38284138|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
17141505|NCT02943447|38284139|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
17141506|NCT02943447|38284137|FG000|Open-Label Extension Phase|Adverse Event|4|||
17141507|NCT02943447|38284138|FG001|Open-Label Extension Phase|Adverse Event|7|||
17141508|NCT02943447|38284139|FG002|Open-Label Extension Phase|Adverse Event|3|||
17141509|NCT02943447|38284137|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
17141510|NCT02943447|38284138|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
17141511|NCT02943447|38284139|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
17141512|NCT02943447|38284137|FG000|Open-Label Extension Phase|Withdrew consent|1|||
17141513|NCT02943447|38284138|FG001|Open-Label Extension Phase|Withdrew consent|1|||
17141514|NCT02943447|38284139|FG002|Open-Label Extension Phase|Withdrew consent|1|||
17141515|NCT02943447|38284137|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
17141516|NCT02943447|38284138|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
17141517|NCT02943447|38284139|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
17141518|NCT02844777|38284168|FG000|Overall Study|Withdrawal by Subject|2|||
17141519|NCT02844777|38284169|FG001|Overall Study|Withdrawal by Subject|0|||
17141520|NCT02844777|38284170|FG002|Overall Study|Withdrawal by Subject|0|||
17141521|NCT04003142|38284181|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
17141522|NCT04003142|38284182|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
17141523|NCT04003142|38284183|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
17141524|NCT04003142|38284184|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
17141525|NCT04003142|38284185|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
17141526|NCT04003142|38284181|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
17141527|NCT04003142|38284182|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
17141528|NCT04003142|38284183|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
17141529|NCT04003142|38284184|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
17141530|NCT04003142|38284185|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
17141531|NCT04003142|38284181|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
17141532|NCT04003142|38284182|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
17141533|NCT04003142|38284183|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
17141534|NCT04003142|38284184|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
17141535|NCT04003142|38284185|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
17141536|NCT04003142|38284181|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
17141537|NCT04003142|38284182|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
17141538|NCT04003142|38284183|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
17141539|NCT04003142|38284184|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
17141540|NCT04003142|38284185|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
17141541|NCT04003142|38284181|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
17141542|NCT04003142|38284182|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
17141543|NCT04003142|38284183|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
17141544|NCT04003142|38284184|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
17141545|NCT04003142|38284185|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
17141546|NCT04003142|38284181|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
17141547|NCT04003142|38284182|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
17141548|NCT04003142|38284183|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
17141549|NCT04003142|38284184|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
17141550|NCT04003142|38284185|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
17141551|NCT04003142|38284181|FG000|Extension Period (40 Weeks)|Death|0|||
17141552|NCT04003142|38284182|FG001|Extension Period (40 Weeks)|Death|0|||
17141553|NCT04003142|38284183|FG002|Extension Period (40 Weeks)|Death|0|||
17141554|NCT04003142|38284184|FG003|Extension Period (40 Weeks)|Death|0|||
17141555|NCT04003142|38284185|FG004|Extension Period (40 Weeks)|Death|1|||
17141556|NCT04003142|38284181|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
17141557|NCT04003142|38284182|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
17141558|NCT04003142|38284183|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
17141559|NCT04003142|38284184|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
17141560|NCT04003142|38284185|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
17141561|NCT04003142|38284181|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
17141562|NCT04003142|38284182|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
17141563|NCT04003142|38284183|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
17141564|NCT04003142|38284184|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
17141565|NCT04003142|38284185|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
17141566|NCT04003142|38284181|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
17141567|NCT04003142|38284182|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
17141568|NCT04003142|38284183|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
17141569|NCT04003142|38284184|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
17141570|NCT04003142|38284185|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
17141571|NCT04003142|38284181|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
17141572|NCT04003142|38284182|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
17141573|NCT04003142|38284183|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
17141574|NCT04003142|38284184|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
17141575|NCT04003142|38284185|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
17141576|NCT02612337|38284205|FG000|Overall Study|Lack of Efficacy|1|||
17141577|NCT02612337|38284206|FG001|Overall Study|Lack of Efficacy|0|||
17141578|NCT02612337|38284205|FG000|Overall Study|Withdrawal by Subject|2|||
17141579|NCT02612337|38284206|FG001|Overall Study|Withdrawal by Subject|2|||
17141580|NCT02612337|38284205|FG000|Overall Study|Did not receive study drug|0|||
17141581|NCT02612337|38284206|FG001|Overall Study|Did not receive study drug|1|||
17141582|NCT03532451|38284220|FG000|Overall Study|Withdrawal by Subject|0|||
17141583|NCT03532451|38284221|FG001|Overall Study|Withdrawal by Subject|1|||
17141584|NCT03532451|38284220|FG000|Overall Study|Progression prior to the surgery|1|||
17141585|NCT03532451|38284221|FG001|Overall Study|Progression prior to the surgery|0|||
17141586|NCT03562767|38284230|FG000|Overall Study|Physician Decision|2|||
17141587|NCT03562767|38284231|FG001|Overall Study|Physician Decision|0|||
17141588|NCT03562767|38284232|FG002|Overall Study|Physician Decision|0|||
17141589|NCT03562767|38284230|FG000|Overall Study|Logistic Reason|1|||
17141590|NCT03562767|38284231|FG001|Overall Study|Logistic Reason|3|||
17141591|NCT03562767|38284232|FG002|Overall Study|Logistic Reason|0|||
17141592|NCT03085238|38284244|FG000|Overall Study|Adverse Event|2|||
17141593|NCT03085238|38284244|FG000|Overall Study|Death|2|||
17141594|NCT03383666|38284257|FG000|Overall Study|Withdrawal by Subject|2|||
17141595|NCT03383666|38284257|FG000|Overall Study|Lost to Follow-up|2|||
17141596|NCT03086018|38284261|FG000|Final Testing for End of Trial|Adverse Event|1|||
17141597|NCT03086018|38284261|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
17141598|NCT03319953|38284271|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
17141599|NCT03319953|38284272|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
17141600|NCT03319953|38284273|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
17141601|NCT03319953|38284274|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
17141602|NCT03319953|38284271|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
17141603|NCT03319953|38284272|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
17141604|NCT03319953|38284273|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
17141605|NCT03319953|38284274|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
17141606|NCT02927834|38284285|FG000|Overall Study|Lost to Follow-up|1|||
17141607|NCT02927834|38284286|FG001|Overall Study|Lost to Follow-up|2|||
17141608|NCT02927834|38284287|FG002|Overall Study|Lost to Follow-up|2|||
17141609|NCT01964547|38284301|FG000|Overall Study|Adverse Event|8|||
17141610|NCT01964547|38284302|FG001|Overall Study|Adverse Event|2|||
17141611|NCT01964547|38284301|FG000|Overall Study|Withdrawal by Subject|4|||
17141612|NCT01964547|38284302|FG001|Overall Study|Withdrawal by Subject|7|||
17141613|NCT01964547|38284301|FG000|Overall Study|Lost to Follow-up|0|||
17141614|NCT01964547|38284302|FG001|Overall Study|Lost to Follow-up|1|||
17141615|NCT01964547|38284301|FG000|Overall Study|Withdrawal by Investigator|0|||
17141616|NCT01964547|38284302|FG001|Overall Study|Withdrawal by Investigator|1|||
17141617|NCT03319719|38284308|FG000|Overall Study|Lost to Follow-up|1|||
17141618|NCT03318783|38284316|FG000|Overall Study|Withdrawal by Subject|0|||
17141619|NCT03318783|38284317|FG001|Overall Study|Withdrawal by Subject|1|||
17141620|NCT03318783|38284316|FG000|Overall Study|Death|0|||
17141621|NCT03318783|38284317|FG001|Overall Study|Death|1|||
17141622|NCT01313689|38284328|FG000|24-Week Randomization 1|Adverse Event|10|||
17141623|NCT01313689|38284329|FG001|24-Week Randomization 1|Adverse Event|5|||
17141624|NCT01313689|38284330|FG002|24-Week Randomization 1|Adverse Event|0|||
17141625|NCT01313689|38284331|FG003|24-Week Randomization 1|Adverse Event|0|||
17141626|NCT01313689|38284332|FG004|24-Week Randomization 1|Adverse Event|0|||
17141627|NCT01313689|38284328|FG000|24-Week Randomization 1|Physician Decision|4|||
17141628|NCT01313689|38284329|FG001|24-Week Randomization 1|Physician Decision|5|||
17141629|NCT01313689|38284330|FG002|24-Week Randomization 1|Physician Decision|0|||
17141630|NCT01313689|38284331|FG003|24-Week Randomization 1|Physician Decision|0|||
17141631|NCT01313689|38284332|FG004|24-Week Randomization 1|Physician Decision|0|||
17141632|NCT01313689|38284328|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
17141633|NCT01313689|38284329|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
17141634|NCT01313689|38284330|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
17141635|NCT01313689|38284331|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
17141636|NCT01313689|38284332|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
17141637|NCT01313689|38284328|FG000|24-Week Randomization 2|Adverse Event|0|||
17141638|NCT01313689|38284329|FG001|24-Week Randomization 2|Adverse Event|0|||
17141639|NCT01313689|38284330|FG002|24-Week Randomization 2|Adverse Event|2|||
17141640|NCT01313689|38284331|FG003|24-Week Randomization 2|Adverse Event|0|||
17141641|NCT01313689|38284332|FG004|24-Week Randomization 2|Adverse Event|8|||
17141642|NCT01313689|38284328|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
17141643|NCT01313689|38284329|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
17141644|NCT01313689|38284330|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
17141645|NCT01313689|38284331|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
17141646|NCT01313689|38284332|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
17141647|NCT01313689|38284328|FG000|24-Week Randomization 2|Physician Decision|0|||
17141648|NCT01313689|38284329|FG001|24-Week Randomization 2|Physician Decision|0|||
17141649|NCT01313689|38284330|FG002|24-Week Randomization 2|Physician Decision|0|||
17141650|NCT01313689|38284331|FG003|24-Week Randomization 2|Physician Decision|0|||
17141651|NCT01313689|38284332|FG004|24-Week Randomization 2|Physician Decision|4|||
17141652|NCT03318315|38284354|FG000|Overall Study|Lost to Follow-up|3|||
17141653|NCT03318315|38284355|FG001|Overall Study|Lost to Follow-up|2|||
17141654|NCT03318315|38284356|FG002|Overall Study|Lost to Follow-up|1|||
17141655|NCT03318315|38284354|FG000|Overall Study|Protocol Violation|1|||
17141656|NCT03318315|38284355|FG001|Overall Study|Protocol Violation|1|||
17141657|NCT03318315|38284356|FG002|Overall Study|Protocol Violation|1|||
17141658|NCT03318315|38284354|FG000|Overall Study|Withdrawal by Subject|0|||
17141659|NCT03318315|38284355|FG001|Overall Study|Withdrawal by Subject|0|||
17141660|NCT03318315|38284356|FG002|Overall Study|Withdrawal by Subject|2|||
17141661|NCT04460183|38284367|FG000|Overall Study|Lost to Follow-up|3|||
17141662|NCT04460183|38284368|FG001|Overall Study|Lost to Follow-up|1|||
17141663|NCT04460183|38284367|FG000|Overall Study|Withdrawal by Subject|1|||
17141664|NCT04460183|38284368|FG001|Overall Study|Withdrawal by Subject|0|||
17141665|NCT03710083|38284374|FG000|Overall Study|Withdrawal by Subject|2|||
17141666|NCT03710083|38284374|FG000|Overall Study|Unsuccessful Procedure|1|||
17141667|NCT03318003|38284380|FG000|Overall Study|Withdrawal by Subject|1|||
17141668|NCT03318003|38284381|FG001|Overall Study|Withdrawal by Subject|1|||
17141669|NCT03318003|38284380|FG000|Overall Study|fetal loss|0|||
17141670|NCT03318003|38284381|FG001|Overall Study|fetal loss|1|||
17141671|NCT03317379|38284390|FG000|Overall Study|Lost to Follow-up|0|||
17141672|NCT03317379|38284391|FG001|Overall Study|Lost to Follow-up|3|||
17141673|NCT03317379|38284392|FG002|Overall Study|Lost to Follow-up|2|||
17141674|NCT03316911|38284402|FG000|Overall Study|Lost to Follow-up|33|||
17141675|NCT03316911|38284403|FG001|Overall Study|Lost to Follow-up|29|||
17141676|NCT01106391|38284409|FG000|Overall Study|Death|12|||
17141677|NCT01106391|38284409|FG000|Overall Study|Withdrawal by Subject|7|||
17141678|NCT03316131|38284413|FG000|Treatment Period 2|Protocol deviation|1|||
17141679|NCT03316131|38284414|FG001|Treatment Period 2|Protocol deviation|0|||
17141680|NCT03301415|38284430|FG000|Overall Study|Lost to Follow-up|2|||
17141681|NCT03301415|38284430|FG000|Overall Study|Unable to comply with visit schedule|2|||
17141682|NCT02732938|38284436|FG000|Overall Study|Death|0|||
17141683|NCT02732938|38284437|FG001|Overall Study|Death|11|||
17141684|NCT02732938|38284438|FG002|Overall Study|Death|0|||
17141685|NCT02732938|38284436|FG000|Overall Study|Randomized but did not receive treatment|0|||
17141686|NCT02732938|38284437|FG001|Overall Study|Randomized but did not receive treatment|1|||
17141687|NCT02732938|38284438|FG002|Overall Study|Randomized but did not receive treatment|0|||
17141688|NCT02732938|38284436|FG000|Overall Study|Refused further follow-up|1|||
17141689|NCT02732938|38284437|FG001|Overall Study|Refused further follow-up|0|||
17141690|NCT02732938|38284438|FG002|Overall Study|Refused further follow-up|0|||
17141691|NCT02732938|38284436|FG000|Overall Study|Study terminated by sponsor|3|||
17141692|NCT02732938|38284437|FG001|Overall Study|Study terminated by sponsor|6|||
17141693|NCT02732938|38284438|FG002|Overall Study|Study terminated by sponsor|0|||
17141694|NCT04647721|38284446|FG000|Overall Study|Withdrawal by Subject|0|||
17141695|NCT04647721|38284447|FG001|Overall Study|Withdrawal by Subject|2|||
17141696|NCT04647721|38284446|FG000|Overall Study|Lost to Follow-up|2|||
17141697|NCT04647721|38284447|FG001|Overall Study|Lost to Follow-up|0|||
17141698|NCT05159362|38284462|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
17141699|NCT05159362|38284463|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
17141700|NCT05159362|38284464|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
17141701|NCT03718000|38284480|FG000|Overall Study|Relocation|2|||
17141702|NCT03718000|38284481|FG001|Overall Study|Relocation|4|||
17141703|NCT03718000|38284480|FG000|Overall Study|Pregnancy|0|||
17141704|NCT03718000|38284481|FG001|Overall Study|Pregnancy|1|||
17141705|NCT03063203|38284488|FG000|Overall Study|Chose alternative therapy|3|||
17141706|NCT03063203|38284488|FG000|Overall Study|Death|2|||
17141707|NCT03063203|38284488|FG000|Overall Study|Disease progression|4|||
17141708|NCT03063203|38284488|FG000|Overall Study|Physician Decision|5|||
17141709|NCT02891226|38284503|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
17141710|NCT02891226|38284504|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
17141711|NCT02891226|38284505|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
17141712|NCT02891226|38284506|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141713|NCT02891226|38284507|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141714|NCT02891226|38284508|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141715|NCT02891226|38284509|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141716|NCT02891226|38284510|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141717|NCT02891226|38284511|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141718|NCT02891226|38284512|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141719|NCT02891226|38284513|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141720|NCT02891226|38284514|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141721|NCT02891226|38284515|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141722|NCT02891226|38284516|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141723|NCT02891226|38284517|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141724|NCT02891226|38284518|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
17141725|NCT02891226|38284503|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
17141726|NCT02891226|38284504|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
17141727|NCT02891226|38284505|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141728|NCT02891226|38284506|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141729|NCT02891226|38284507|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141730|NCT02891226|38284508|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141731|NCT02891226|38284509|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141732|NCT02891226|38284510|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141733|NCT02891226|38284511|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141734|NCT02891226|38284512|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141735|NCT02891226|38284513|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141736|NCT02891226|38284514|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141737|NCT02891226|38284515|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141738|NCT02891226|38284516|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141739|NCT02891226|38284517|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141740|NCT02891226|38284518|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
17141741|NCT02891226|38284503|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141742|NCT02891226|38284504|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141743|NCT02891226|38284505|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141744|NCT02891226|38284506|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
17141745|NCT02891226|38284507|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141746|NCT02891226|38284508|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141747|NCT02891226|38284509|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141748|NCT02891226|38284510|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141749|NCT02891226|38284511|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141750|NCT02891226|38284512|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141751|NCT02891226|38284513|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141752|NCT02891226|38284514|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141753|NCT02891226|38284515|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141754|NCT02891226|38284516|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141755|NCT02891226|38284517|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141756|NCT02891226|38284518|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
17141757|NCT02891226|38284503|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141758|NCT02891226|38284504|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141759|NCT02891226|38284505|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
17141760|NCT02891226|38284506|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141761|NCT02891226|38284507|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141762|NCT02891226|38284508|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141763|NCT02891226|38284509|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141764|NCT02891226|38284510|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141765|NCT02891226|38284511|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141766|NCT02891226|38284512|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141767|NCT02891226|38284513|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16992383|NCT00725101|38136289|FG000|Overall Study|not specified/no reason given|11|||
16992384|NCT00585169|38136293|FG000|Overall Study|Withdrawal by Subject|1|||
16992385|NCT00807742|38136301|FG000|Overall Study|Death|9|||
16992386|NCT00807742|38136302|FG001|Overall Study|Death|2|||
16992387|NCT00807742|38136301|FG000|Overall Study|Withdrawal by Subject|2|||
16992388|NCT00807742|38136302|FG001|Overall Study|Withdrawal by Subject|1|||
16992389|NCT00807742|38136301|FG000|Overall Study|Lost to Follow-up|35|||
16992390|NCT00807742|38136302|FG001|Overall Study|Lost to Follow-up|51|||
16992391|NCT00724945|38136308|FG000|Period 1|non-compliance|1|||
16992392|NCT00724945|38136309|FG001|Period 1|non-compliance|0|||
17141768|NCT02891226|38284514|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141769|NCT02891226|38284515|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16992393|NCT00724945|38136308|FG000|Period 1|Adverse Event|1|||
16992394|NCT00724945|38136309|FG001|Period 1|Adverse Event|1|||
16992395|NCT00724945|38136308|FG000|Period 1|Lost to Follow-up|1|||
17141770|NCT02891226|38284516|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141771|NCT02891226|38284517|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141772|NCT02891226|38284518|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
17141773|NCT02891226|38284503|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16780533|NCT02595723|37719715|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
16780534|NCT02595723|37719713|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
16780535|NCT02595723|37719714|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
16780536|NCT02595723|37719715|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
16780537|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
16992396|NCT00724945|38136309|FG001|Period 1|Lost to Follow-up|0|||
17141774|NCT02891226|38284504|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141775|NCT02891226|38284505|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141776|NCT02891226|38284506|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
17141777|NCT02891226|38284507|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141778|NCT02891226|38284508|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141779|NCT02891226|38284509|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141780|NCT02891226|38284510|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141781|NCT02891226|38284511|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141782|NCT02891226|38284512|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141783|NCT02891226|38284513|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141784|NCT02891226|38284514|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141785|NCT02891226|38284515|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141786|NCT02891226|38284516|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141787|NCT02891226|38284517|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141788|NCT02891226|38284518|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
17141789|NCT02891226|38284503|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141790|NCT02891226|38284504|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141791|NCT02891226|38284505|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141792|NCT02891226|38284506|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
17045532|NCT00547521|38189906|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
17045533|NCT00547521|38189907|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
17045534|NCT00547521|38189906|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
17045535|NCT00547521|38189907|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
17045536|NCT00547521|38189906|FG000|Long Term Extension (LTE) Study|Other|0|||
17045537|NCT00547521|38189907|FG001|Long Term Extension (LTE) Study|Other|2|||
17045538|NCT00547521|38189906|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
17045539|NCT00547521|38189907|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
17045540|NCT00266227|38189922|FG000|Initial Treatment|Adverse Event|0|||
17045541|NCT00266227|38189923|FG001|Initial Treatment|Adverse Event|0|||
17045542|NCT00266227|38189924|FG002|Initial Treatment|Adverse Event|13|||
17045543|NCT00266227|38189922|FG000|Initial Treatment|Lost to Follow-up|0|||
17045544|NCT00266227|38189923|FG001|Initial Treatment|Lost to Follow-up|0|||
17045545|NCT00266227|38189924|FG002|Initial Treatment|Lost to Follow-up|6|||
17045546|NCT00266227|38189922|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
17045547|NCT00266227|38189923|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
17045548|NCT00266227|38189924|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
17045549|NCT00266227|38189922|FG000|Initial Treatment|Physician decision to withdraw|0|||
17045550|NCT00266227|38189923|FG001|Initial Treatment|Physician decision to withdraw|0|||
17045551|NCT00266227|38189924|FG002|Initial Treatment|Physician decision to withdraw|12|||
17045552|NCT00266227|38189922|FG000|Initial Treatment|Pregnancy|0|||
17045553|NCT00266227|38189923|FG001|Initial Treatment|Pregnancy|0|||
17045554|NCT00266227|38189924|FG002|Initial Treatment|Pregnancy|1|||
17045555|NCT00266227|38189922|FG000|Retreatment: Up to Week 48|Death|1|||
17045556|NCT00266227|38189923|FG001|Retreatment: Up to Week 48|Death|0|||
17045557|NCT00266227|38189924|FG002|Retreatment: Up to Week 48|Death|0|||
17045558|NCT00266227|38189922|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
17045559|NCT00266227|38189923|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
17045560|NCT00266227|38189924|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
17045561|NCT00266227|38189922|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
17045562|NCT00266227|38189923|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
17045563|NCT00266227|38189924|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
17141793|NCT02891226|38284507|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141794|NCT02891226|38284508|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16992397|NCT00724945|38136308|FG000|Period 2|lens comfort issue|3|||
16992398|NCT00724945|38136309|FG001|Period 2|lens comfort issue|0|||
16992399|NCT00724945|38136308|FG000|Period 2|lens physiology issue|1|||
16992400|NCT00724945|38136309|FG001|Period 2|lens physiology issue|0|||
16992401|NCT00803452|38136317|FG000|Overall Study|Adverse Event|0|||
16992402|NCT00803452|38136318|FG001|Overall Study|Adverse Event|2|||
16992403|NCT00803452|38136317|FG000|Overall Study|Lost to Follow-up|0|||
16992404|NCT00803452|38136318|FG001|Overall Study|Lost to Follow-up|3|||
16992405|NCT00589108|38136327|FG000|Overall Study|Lost to Follow-up|1|||
16992406|NCT00589108|38136328|FG001|Overall Study|Lost to Follow-up|1|||
16992407|NCT00589108|38136329|FG002|Overall Study|Lost to Follow-up|1|||
16992408|NCT00589108|38136327|FG000|Overall Study|Death|3|||
16992409|NCT00589108|38136328|FG001|Overall Study|Death|3|||
16992410|NCT00589108|38136329|FG002|Overall Study|Death|4|||
16992411|NCT00717067|38136342|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
17045564|NCT00266227|38189922|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
17045565|NCT00266227|38189923|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
17045566|NCT00266227|38189924|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
17045567|NCT00266227|38189922|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
17045568|NCT00266227|38189923|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
17045569|NCT00266227|38189924|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
17045570|NCT00266227|38189922|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
17045571|NCT00266227|38189923|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
17045572|NCT00266227|38189924|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
17045573|NCT00266227|38189922|FG000|Retreatment: Week 48 to Week 72|Death|1|||
17045574|NCT00266227|38189923|FG001|Retreatment: Week 48 to Week 72|Death|1|||
17045575|NCT00266227|38189924|FG002|Retreatment: Week 48 to Week 72|Death|0|||
17045576|NCT00266227|38189922|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
17045577|NCT00266227|38189923|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
17045578|NCT00266227|38189924|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
17045579|NCT00266227|38189922|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
17045580|NCT00266227|38189923|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
17045581|NCT00266227|38189924|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
17045582|NCT00266227|38189922|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
17045583|NCT00266227|38189923|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
17045584|NCT00266227|38189924|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
17045585|NCT00266227|38189922|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
17045586|NCT00266227|38189923|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
17045587|NCT00266227|38189924|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
17045588|NCT00287365|38189933|FG000|Overall Study|sample not acquired|13|||
17045589|NCT00573768|38189941|FG000|Overall Study|Adverse Event|1|||
17045590|NCT00573768|38189942|FG001|Overall Study|Adverse Event|1|||
17045591|NCT00573768|38189943|FG002|Overall Study|Adverse Event|2|||
17045592|NCT00573768|38189941|FG000|Overall Study|Protocol Violation|1|||
17045593|NCT00573768|38189942|FG001|Overall Study|Protocol Violation|0|||
17045594|NCT00573768|38189943|FG002|Overall Study|Protocol Violation|1|||
17045595|NCT00573768|38189941|FG000|Overall Study|Withdrawal by Subject|0|||
17045596|NCT00573768|38189942|FG001|Overall Study|Withdrawal by Subject|1|||
17045597|NCT00573768|38189943|FG002|Overall Study|Withdrawal by Subject|0|||
17045598|NCT00573768|38189941|FG000|Overall Study|Lost to Follow-up|0|||
17045599|NCT00573768|38189942|FG001|Overall Study|Lost to Follow-up|0|||
17045600|NCT00573768|38189943|FG002|Overall Study|Lost to Follow-up|1|||
17045601|NCT00547365|38189951|FG000|Overall Study|Physician Decision|1|||
17045602|NCT00547365|38189951|FG000|Overall Study|Lost to Follow-up|1|||
17045603|NCT00547365|38189951|FG000|Overall Study|Protocol Violation|2|||
17045604|NCT00547365|38189951|FG000|Overall Study|death (not related to study)|4|||
17045605|NCT00619866|38189959|FG000|Weeks 1 - 12|Adverse Event|0|||
17045606|NCT00619866|38189960|FG001|Weeks 1 - 12|Adverse Event|1|||
17045607|NCT00619866|38189961|FG002|Weeks 1 - 12|Adverse Event|2|||
17045608|NCT00619866|38189962|FG003|Weeks 1 - 12|Adverse Event|0|||
17045609|NCT00619866|38189963|FG004|Weeks 1 - 12|Adverse Event|0|||
17045610|NCT00619866|38189959|FG000|Weeks 1 - 12|Non-compliance|0|||
17045611|NCT00619866|38189960|FG001|Weeks 1 - 12|Non-compliance|0|||
17045612|NCT00619866|38189961|FG002|Weeks 1 - 12|Non-compliance|1|||
17045613|NCT00619866|38189962|FG003|Weeks 1 - 12|Non-compliance|0|||
17045614|NCT00619866|38189963|FG004|Weeks 1 - 12|Non-compliance|0|||
17045615|NCT00619866|38189959|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
17045616|NCT00619866|38189960|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
17045617|NCT00619866|38189961|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
17045618|NCT00619866|38189962|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
17045619|NCT00619866|38189963|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
17045620|NCT00619866|38189959|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
17045621|NCT00619866|38189960|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
17045622|NCT00619866|38189961|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
17045623|NCT00619866|38189962|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
17045624|NCT00619866|38189963|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
17045625|NCT00619866|38189959|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
17045626|NCT00619866|38189960|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
17045627|NCT00619866|38189961|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
17045628|NCT00619866|38189962|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
17045629|NCT00619866|38189963|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
17045630|NCT00619866|38189959|FG000|Weeks 1 - 12|Sponsor Decision|0|||
17045631|NCT00619866|38189960|FG001|Weeks 1 - 12|Sponsor Decision|1|||
17045632|NCT00619866|38189961|FG002|Weeks 1 - 12|Sponsor Decision|0|||
17045633|NCT00619866|38189962|FG003|Weeks 1 - 12|Sponsor Decision|0|||
17045634|NCT00619866|38189963|FG004|Weeks 1 - 12|Sponsor Decision|0|||
17045635|NCT00619866|38189959|FG000|Weeks 13 - 24|Adverse Event|0|||
17045636|NCT00619866|38189960|FG001|Weeks 13 - 24|Adverse Event|0|||
17045637|NCT00619866|38189961|FG002|Weeks 13 - 24|Adverse Event|2|||
17045638|NCT00619866|38189962|FG003|Weeks 13 - 24|Adverse Event|1|||
17045639|NCT00619866|38189963|FG004|Weeks 13 - 24|Adverse Event|0|||
17045640|NCT00619866|38189959|FG000|Weeks 13 - 24|Protocol Deviation|0|||
17045641|NCT00619866|38189960|FG001|Weeks 13 - 24|Protocol Deviation|0|||
17045642|NCT00619866|38189961|FG002|Weeks 13 - 24|Protocol Deviation|0|||
17045643|NCT00619866|38189962|FG003|Weeks 13 - 24|Protocol Deviation|1|||
17045644|NCT00619866|38189963|FG004|Weeks 13 - 24|Protocol Deviation|0|||
17045645|NCT00619866|38189959|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
17045646|NCT00619866|38189960|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
17045647|NCT00619866|38189961|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
17045648|NCT00619866|38189962|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
17045649|NCT00619866|38189963|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
17045650|NCT00619866|38189959|FG000|Weeks 13 - 24|Non-compliance|0|||
17045651|NCT00619866|38189960|FG001|Weeks 13 - 24|Non-compliance|1|||
17045652|NCT00619866|38189961|FG002|Weeks 13 - 24|Non-compliance|1|||
17045653|NCT00619866|38189962|FG003|Weeks 13 - 24|Non-compliance|0|||
17045654|NCT00619866|38189963|FG004|Weeks 13 - 24|Non-compliance|0|||
17045655|NCT00619866|38189959|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
17045656|NCT00619866|38189960|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
17045657|NCT00619866|38189961|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
17045658|NCT00619866|38189962|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
17045659|NCT00619866|38189963|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
17045660|NCT03937479|38189991|FG000|Overall Study|Adverse Event|2|||
17045661|NCT03937479|38189992|FG001|Overall Study|Adverse Event|3|||
17045662|NCT03937479|38189993|FG002|Overall Study|Adverse Event|0|||
17045663|NCT03937479|38189994|FG003|Overall Study|Adverse Event|0|||
17045664|NCT03937479|38189995|FG004|Overall Study|Adverse Event|1|||
17045665|NCT03937479|38189991|FG000|Overall Study|Withdrawal by Subject|3|||
17045666|NCT03937479|38189992|FG001|Overall Study|Withdrawal by Subject|5|||
17045667|NCT03937479|38189993|FG002|Overall Study|Withdrawal by Subject|2|||
17045668|NCT03937479|38189994|FG003|Overall Study|Withdrawal by Subject|2|||
17045669|NCT03937479|38189995|FG004|Overall Study|Withdrawal by Subject|1|||
17045670|NCT03937479|38189991|FG000|Overall Study|Protocol Violation|5|||
17045671|NCT03937479|38189992|FG001|Overall Study|Protocol Violation|6|||
17045672|NCT03937479|38189993|FG002|Overall Study|Protocol Violation|4|||
17045673|NCT03937479|38189994|FG003|Overall Study|Protocol Violation|3|||
17045674|NCT03937479|38189995|FG004|Overall Study|Protocol Violation|2|||
17045675|NCT03937479|38189991|FG000|Overall Study|Lost to Follow-up|0|||
17045676|NCT03937479|38189992|FG001|Overall Study|Lost to Follow-up|1|||
17045677|NCT03937479|38189993|FG002|Overall Study|Lost to Follow-up|0|||
17045678|NCT03937479|38189994|FG003|Overall Study|Lost to Follow-up|1|||
17045679|NCT03937479|38189995|FG004|Overall Study|Lost to Follow-up|0|||
17045680|NCT03937479|38189991|FG000|Overall Study|Physician Decision|0|||
17045681|NCT03937479|38189992|FG001|Overall Study|Physician Decision|0|||
17045682|NCT03937479|38189993|FG002|Overall Study|Physician Decision|1|||
17045683|NCT03937479|38189994|FG003|Overall Study|Physician Decision|0|||
17045684|NCT03937479|38189995|FG004|Overall Study|Physician Decision|1|||
17045685|NCT00619476|38190011|FG000|Overall Study|Adverse Event|12|||
17045686|NCT00619476|38190012|FG001|Overall Study|Adverse Event|6|||
17045687|NCT00619476|38190013|FG002|Overall Study|Adverse Event|12|||
17045688|NCT00619476|38190014|FG003|Overall Study|Adverse Event|16|||
17045689|NCT00619476|38190011|FG000|Overall Study|Lack of Efficacy|6|||
17045690|NCT00619476|38190012|FG001|Overall Study|Lack of Efficacy|1|||
17045691|NCT00619476|38190013|FG002|Overall Study|Lack of Efficacy|1|||
17045692|NCT00619476|38190014|FG003|Overall Study|Lack of Efficacy|4|||
17045693|NCT00619476|38190011|FG000|Overall Study|Protocol Violation|5|||
17045694|NCT00619476|38190012|FG001|Overall Study|Protocol Violation|4|||
17045695|NCT00619476|38190013|FG002|Overall Study|Protocol Violation|4|||
17045696|NCT00619476|38190014|FG003|Overall Study|Protocol Violation|9|||
17045697|NCT00619476|38190011|FG000|Overall Study|Lost to Follow-up|1|||
17045698|NCT00619476|38190012|FG001|Overall Study|Lost to Follow-up|2|||
17045699|NCT00619476|38190013|FG002|Overall Study|Lost to Follow-up|0|||
17045700|NCT00619476|38190014|FG003|Overall Study|Lost to Follow-up|1|||
17045701|NCT00619476|38190011|FG000|Overall Study|Investigator Discretion|2|||
17045702|NCT00619476|38190012|FG001|Overall Study|Investigator Discretion|2|||
17045703|NCT00619476|38190013|FG002|Overall Study|Investigator Discretion|2|||
17045704|NCT00619476|38190014|FG003|Overall Study|Investigator Discretion|0|||
17045705|NCT00619476|38190011|FG000|Overall Study|Withdrawal by Subject|5|||
17045706|NCT00619476|38190012|FG001|Overall Study|Withdrawal by Subject|7|||
17045707|NCT00619476|38190013|FG002|Overall Study|Withdrawal by Subject|5|||
17045708|NCT00619476|38190014|FG003|Overall Study|Withdrawal by Subject|4|||
17045709|NCT00618072|38190027|FG000|Overall Study|Lost to Follow-up|2|||
17045710|NCT00618072|38190028|FG001|Overall Study|Lost to Follow-up|0|||
17045711|NCT00618072|38190029|FG002|Overall Study|Lost to Follow-up|3|||
17045712|NCT00618072|38190027|FG000|Overall Study|Physician Decision|0|||
17045713|NCT00618072|38190028|FG001|Overall Study|Physician Decision|1|||
17045714|NCT00618072|38190029|FG002|Overall Study|Physician Decision|1|||
17045715|NCT00666926|38190037|FG000|Overall Study|Adverse Event|0|||
17045716|NCT00666926|38190038|FG001|Overall Study|Adverse Event|0|||
17045717|NCT00666926|38190039|FG002|Overall Study|Adverse Event|0|||
17045718|NCT00666926|38190040|FG003|Overall Study|Adverse Event|0|||
17045719|NCT00666926|38190041|FG004|Overall Study|Adverse Event|0|||
17045720|NCT00666926|38190042|FG005|Overall Study|Adverse Event|0|||
17045721|NCT00666926|38190043|FG006|Overall Study|Adverse Event|0|||
17045722|NCT00666926|38190044|FG007|Overall Study|Adverse Event|0|||
17045723|NCT00666926|38190045|FG008|Overall Study|Adverse Event|0|||
17045724|NCT00666926|38190046|FG009|Overall Study|Adverse Event|2|||
17045725|NCT00666926|38190047|FG010|Overall Study|Adverse Event|2|||
17141795|NCT02891226|38284509|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141796|NCT02891226|38284510|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141797|NCT02891226|38284511|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17045726|NCT00666926|38190048|FG011|Overall Study|Adverse Event|2|||
17045727|NCT00666926|38190049|FG012|Overall Study|Adverse Event|0|||
17045728|NCT00666926|38190050|FG013|Overall Study|Adverse Event|1|||
17045729|NCT00666926|38190051|FG014|Overall Study|Adverse Event|0|||
17045730|NCT00666926|38190052|FG015|Overall Study|Adverse Event|0|||
17045731|NCT00666926|38190037|FG000|Overall Study|Laboratory abnormality|0|||
17045732|NCT00666926|38190038|FG001|Overall Study|Laboratory abnormality|0|||
17045733|NCT00666926|38190039|FG002|Overall Study|Laboratory abnormality|0|||
17045734|NCT00666926|38190040|FG003|Overall Study|Laboratory abnormality|0|||
17045735|NCT00666926|38190041|FG004|Overall Study|Laboratory abnormality|0|||
17045736|NCT00666926|38190042|FG005|Overall Study|Laboratory abnormality|0|||
17045737|NCT00666926|38190043|FG006|Overall Study|Laboratory abnormality|0|||
17045738|NCT00666926|38190044|FG007|Overall Study|Laboratory abnormality|0|||
17045739|NCT00666926|38190045|FG008|Overall Study|Laboratory abnormality|0|||
17045740|NCT00666926|38190046|FG009|Overall Study|Laboratory abnormality|0|||
17045741|NCT00666926|38190047|FG010|Overall Study|Laboratory abnormality|1|||
17045742|NCT00666926|38190048|FG011|Overall Study|Laboratory abnormality|0|||
17045743|NCT00666926|38190049|FG012|Overall Study|Laboratory abnormality|0|||
17045744|NCT00666926|38190050|FG013|Overall Study|Laboratory abnormality|0|||
17045745|NCT00666926|38190051|FG014|Overall Study|Laboratory abnormality|0|||
17045746|NCT00666926|38190052|FG015|Overall Study|Laboratory abnormality|1|||
17045747|NCT00666926|38190037|FG000|Overall Study|Lack of Efficacy|0|||
17045748|NCT00666926|38190038|FG001|Overall Study|Lack of Efficacy|0|||
17045749|NCT00666926|38190039|FG002|Overall Study|Lack of Efficacy|0|||
17045750|NCT00666926|38190040|FG003|Overall Study|Lack of Efficacy|0|||
17045751|NCT00666926|38190041|FG004|Overall Study|Lack of Efficacy|0|||
17045752|NCT00666926|38190042|FG005|Overall Study|Lack of Efficacy|1|||
17045753|NCT00666926|38190043|FG006|Overall Study|Lack of Efficacy|0|||
17045754|NCT00666926|38190044|FG007|Overall Study|Lack of Efficacy|0|||
17045755|NCT00666926|38190045|FG008|Overall Study|Lack of Efficacy|0|||
17045756|NCT00666926|38190046|FG009|Overall Study|Lack of Efficacy|0|||
17045757|NCT00666926|38190047|FG010|Overall Study|Lack of Efficacy|0|||
17045758|NCT00666926|38190048|FG011|Overall Study|Lack of Efficacy|1|||
17045759|NCT00666926|38190049|FG012|Overall Study|Lack of Efficacy|0|||
17045760|NCT00666926|38190050|FG013|Overall Study|Lack of Efficacy|0|||
17045761|NCT00666926|38190051|FG014|Overall Study|Lack of Efficacy|0|||
17045762|NCT00666926|38190052|FG015|Overall Study|Lack of Efficacy|0|||
17045763|NCT00666926|38190037|FG000|Overall Study|Lost to Follow-up|0|||
17045764|NCT00666926|38190038|FG001|Overall Study|Lost to Follow-up|0|||
17045765|NCT00666926|38190039|FG002|Overall Study|Lost to Follow-up|0|||
17045766|NCT00666926|38190040|FG003|Overall Study|Lost to Follow-up|1|||
17045767|NCT00666926|38190041|FG004|Overall Study|Lost to Follow-up|0|||
17045768|NCT00666926|38190042|FG005|Overall Study|Lost to Follow-up|0|||
17045769|NCT00666926|38190043|FG006|Overall Study|Lost to Follow-up|0|||
17045770|NCT00666926|38190044|FG007|Overall Study|Lost to Follow-up|0|||
17045771|NCT00666926|38190045|FG008|Overall Study|Lost to Follow-up|0|||
17045772|NCT00666926|38190046|FG009|Overall Study|Lost to Follow-up|0|||
17045773|NCT00666926|38190047|FG010|Overall Study|Lost to Follow-up|0|||
17045774|NCT00666926|38190048|FG011|Overall Study|Lost to Follow-up|0|||
17045775|NCT00666926|38190049|FG012|Overall Study|Lost to Follow-up|0|||
17045776|NCT00666926|38190050|FG013|Overall Study|Lost to Follow-up|0|||
17045777|NCT00666926|38190051|FG014|Overall Study|Lost to Follow-up|0|||
17045778|NCT00666926|38190052|FG015|Overall Study|Lost to Follow-up|0|||
17045779|NCT00666926|38190037|FG000|Overall Study|Other|2|||
17045780|NCT00666926|38190038|FG001|Overall Study|Other|4|||
17045781|NCT00666926|38190039|FG002|Overall Study|Other|3|||
17045782|NCT00666926|38190040|FG003|Overall Study|Other|3|||
17045783|NCT00666926|38190041|FG004|Overall Study|Other|3|||
17045784|NCT00666926|38190042|FG005|Overall Study|Other|3|||
17045785|NCT00666926|38190043|FG006|Overall Study|Other|4|||
17045786|NCT00666926|38190044|FG007|Overall Study|Other|0|||
17045787|NCT00666926|38190045|FG008|Overall Study|Other|3|||
17045788|NCT00666926|38190046|FG009|Overall Study|Other|5|||
17045789|NCT00666926|38190047|FG010|Overall Study|Other|3|||
17045790|NCT00666926|38190048|FG011|Overall Study|Other|26|||
17045791|NCT00666926|38190049|FG012|Overall Study|Other|3|||
17045792|NCT00666926|38190050|FG013|Overall Study|Other|2|||
17045793|NCT00666926|38190051|FG014|Overall Study|Other|4|||
17045794|NCT00666926|38190052|FG015|Overall Study|Other|4|||
17045795|NCT00666926|38190037|FG000|Overall Study|Withdrawal by Subject|0|||
17045796|NCT00666926|38190038|FG001|Overall Study|Withdrawal by Subject|0|||
17045797|NCT00666926|38190039|FG002|Overall Study|Withdrawal by Subject|0|||
17045798|NCT00666926|38190040|FG003|Overall Study|Withdrawal by Subject|0|||
17045799|NCT00666926|38190041|FG004|Overall Study|Withdrawal by Subject|0|||
17045800|NCT00666926|38190042|FG005|Overall Study|Withdrawal by Subject|0|||
17045801|NCT00666926|38190043|FG006|Overall Study|Withdrawal by Subject|0|||
17045802|NCT00666926|38190044|FG007|Overall Study|Withdrawal by Subject|1|||
17045803|NCT00666926|38190045|FG008|Overall Study|Withdrawal by Subject|0|||
17045804|NCT00666926|38190046|FG009|Overall Study|Withdrawal by Subject|3|||
17045805|NCT00666926|38190047|FG010|Overall Study|Withdrawal by Subject|0|||
17045806|NCT00666926|38190048|FG011|Overall Study|Withdrawal by Subject|3|||
17045807|NCT00666926|38190049|FG012|Overall Study|Withdrawal by Subject|0|||
17045808|NCT00666926|38190050|FG013|Overall Study|Withdrawal by Subject|1|||
17045809|NCT00666926|38190051|FG014|Overall Study|Withdrawal by Subject|3|||
17045810|NCT00666926|38190052|FG015|Overall Study|Withdrawal by Subject|3|||
17045811|NCT00666926|38190037|FG000|Overall Study|Death|0|||
17045812|NCT00666926|38190038|FG001|Overall Study|Death|0|||
17045813|NCT00666926|38190039|FG002|Overall Study|Death|0|||
17045814|NCT00666926|38190040|FG003|Overall Study|Death|0|||
17045815|NCT00666926|38190041|FG004|Overall Study|Death|0|||
17045816|NCT00666926|38190042|FG005|Overall Study|Death|0|||
17045817|NCT00666926|38190043|FG006|Overall Study|Death|0|||
17045818|NCT00666926|38190044|FG007|Overall Study|Death|0|||
17045819|NCT00666926|38190045|FG008|Overall Study|Death|0|||
17045820|NCT00666926|38190046|FG009|Overall Study|Death|0|||
16780538|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
16780539|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
17045821|NCT00666926|38190047|FG010|Overall Study|Death|0|||
17045822|NCT00666926|38190048|FG011|Overall Study|Death|1|||
17045823|NCT00666926|38190049|FG012|Overall Study|Death|0|||
17045824|NCT00666926|38190050|FG013|Overall Study|Death|0|||
17045825|NCT00666926|38190051|FG014|Overall Study|Death|0|||
17045826|NCT00666926|38190052|FG015|Overall Study|Death|0|||
17045827|NCT03861052|38190107|FG000|Overall Study|Adverse Event|1|||
17045828|NCT03861052|38190108|FG001|Overall Study|Adverse Event|1|||
17045829|NCT03861052|38190109|FG002|Overall Study|Adverse Event|2|||
17045830|NCT03861052|38190110|FG003|Overall Study|Adverse Event|4|||
17045831|NCT03861052|38190107|FG000|Overall Study|Lost to Follow-up|0|||
17045832|NCT03861052|38190108|FG001|Overall Study|Lost to Follow-up|0|||
17045833|NCT03861052|38190109|FG002|Overall Study|Lost to Follow-up|0|||
17045834|NCT03861052|38190110|FG003|Overall Study|Lost to Follow-up|1|||
17045835|NCT03861052|38190107|FG000|Overall Study|Physician Decision|0|||
17045836|NCT03861052|38190108|FG001|Overall Study|Physician Decision|1|||
17045837|NCT03861052|38190109|FG002|Overall Study|Physician Decision|0|||
17045838|NCT03861052|38190110|FG003|Overall Study|Physician Decision|0|||
17045839|NCT03861052|38190107|FG000|Overall Study|Withdrawal by Subject|2|||
17045840|NCT03861052|38190108|FG001|Overall Study|Withdrawal by Subject|5|||
17045841|NCT03861052|38190109|FG002|Overall Study|Withdrawal by Subject|3|||
17045842|NCT03861052|38190110|FG003|Overall Study|Withdrawal by Subject|0|||
17045843|NCT03861052|38190107|FG000|Overall Study|Relocation to other city|1|||
17045844|NCT03861052|38190108|FG001|Overall Study|Relocation to other city|0|||
17045845|NCT03861052|38190109|FG002|Overall Study|Relocation to other city|0|||
17045846|NCT03861052|38190110|FG003|Overall Study|Relocation to other city|0|||
17045847|NCT00664742|38190125|FG000|Overall Study|Withdrawn due to adverse events|3|||
17045848|NCT00664742|38190125|FG000|Overall Study|Withdrawal by Subject|31|||
17045849|NCT00664742|38190125|FG000|Overall Study|Lost to Follow-up|92|||
17045850|NCT00511342|38190131|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
17045851|NCT00511342|38190132|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
17045852|NCT00511342|38190131|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
17045853|NCT00511342|38190132|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
17045854|NCT00511342|38190131|FG000|Overall Study|Pregnancy|0|||
17045855|NCT00511342|38190132|FG001|Overall Study|Pregnancy|1|||
17045856|NCT00511342|38190131|FG000|Overall Study|Pregnancy wish|0|||
17045857|NCT00511342|38190132|FG001|Overall Study|Pregnancy wish|1|||
17045858|NCT00511342|38190131|FG000|Overall Study|Lost to Follow-up|1|||
17045859|NCT00511342|38190132|FG001|Overall Study|Lost to Follow-up|5|||
17045860|NCT00511342|38190131|FG000|Overall Study|Other Reason|2|||
17045861|NCT00511342|38190132|FG001|Overall Study|Other Reason|2|||
16780540|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
16780541|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
16780542|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
16780543|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
17045862|NCT03931785|38190142|FG000|Overall Study|Lost to Follow-up|4|||
17045863|NCT03931785|38190143|FG001|Overall Study|Lost to Follow-up|1|||
17045864|NCT03931785|38190144|FG002|Overall Study|Lost to Follow-up|4|||
17045865|NCT03931785|38190145|FG003|Overall Study|Lost to Follow-up|3|||
17045866|NCT03931785|38190142|FG000|Overall Study|Adverse Event|1|||
17045867|NCT03931785|38190143|FG001|Overall Study|Adverse Event|0|||
16780544|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
17045868|NCT03931785|38190144|FG002|Overall Study|Adverse Event|3|||
17045869|NCT03931785|38190145|FG003|Overall Study|Adverse Event|4|||
17045870|NCT03931785|38190142|FG000|Overall Study|Protocol Violation|0|||
17045871|NCT03931785|38190143|FG001|Overall Study|Protocol Violation|1|||
17045872|NCT03931785|38190144|FG002|Overall Study|Protocol Violation|0|||
17045873|NCT03931785|38190145|FG003|Overall Study|Protocol Violation|0|||
17045874|NCT03931785|38190142|FG000|Overall Study|Noncompliance With Study drug|0|||
17045875|NCT03931785|38190143|FG001|Overall Study|Noncompliance With Study drug|1|||
17045876|NCT03931785|38190144|FG002|Overall Study|Noncompliance With Study drug|0|||
17045877|NCT03931785|38190145|FG003|Overall Study|Noncompliance With Study drug|0|||
17045878|NCT03931785|38190142|FG000|Overall Study|Other Not specified|0|||
17045879|NCT03931785|38190143|FG001|Overall Study|Other Not specified|2|||
17045880|NCT03931785|38190144|FG002|Overall Study|Other Not specified|2|||
17045881|NCT03931785|38190145|FG003|Overall Study|Other Not specified|2|||
17045882|NCT03931785|38190142|FG000|Overall Study|Withdrawal by Subject|0|||
17045883|NCT03931785|38190143|FG001|Overall Study|Withdrawal by Subject|2|||
17045884|NCT03931785|38190144|FG002|Overall Study|Withdrawal by Subject|4|||
17045885|NCT03931785|38190145|FG003|Overall Study|Withdrawal by Subject|1|||
17045886|NCT03931785|38190142|FG000|Overall Study|Pregnancy|0|||
17045887|NCT03931785|38190143|FG001|Overall Study|Pregnancy|0|||
17045888|NCT03931785|38190144|FG002|Overall Study|Pregnancy|0|||
17045889|NCT03931785|38190145|FG003|Overall Study|Pregnancy|1|||
17045890|NCT00666536|38190157|FG000|Overall Study|Adverse Event|9|||
17045891|NCT00666536|38190158|FG001|Overall Study|Adverse Event|19|||
17045892|NCT00666536|38190157|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16780545|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
16780546|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
16780547|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
16780548|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
16780549|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
16780550|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
16780551|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
16780552|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
16780553|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
16780554|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
16780555|NCT01667679|37719725|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
16780556|NCT01667679|37719726|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
17045893|NCT00666536|38190158|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17045894|NCT00666536|38190157|FG000|Overall Study|Protocol deviation(s)|8|||
17045895|NCT00666536|38190158|FG001|Overall Study|Protocol deviation(s)|6|||
17045896|NCT00666536|38190157|FG000|Overall Study|Withdrawal by Subject|10|||
17045897|NCT00666536|38190158|FG001|Overall Study|Withdrawal by Subject|9|||
17045898|NCT00666536|38190157|FG000|Overall Study|Lost to Follow-up|4|||
17045899|NCT00666536|38190158|FG001|Overall Study|Lost to Follow-up|3|||
17045900|NCT00519532|38190164|FG000|Overall Study|Adverse Event|11|||
17045901|NCT00519532|38190164|FG000|Overall Study|Withdrawal by Subject|5|||
17045902|NCT00519532|38190164|FG000|Overall Study|Lost to Follow-up|2|||
17045903|NCT00666458|38190170|FG000|Overall Study|Adverse Event|8|||
17045904|NCT00666458|38190171|FG001|Overall Study|Adverse Event|7|||
17045905|NCT00666458|38190170|FG000|Overall Study|Withdrawal by Subject|5|||
17045906|NCT00666458|38190171|FG001|Overall Study|Withdrawal by Subject|4|||
17045907|NCT00666458|38190170|FG000|Overall Study|Lost to Follow-up|0|||
17045908|NCT00666458|38190171|FG001|Overall Study|Lost to Follow-up|3|||
17045909|NCT00666458|38190170|FG000|Overall Study|Administrative reason by sponsor|1|||
17045910|NCT00666458|38190171|FG001|Overall Study|Administrative reason by sponsor|1|||
17045911|NCT00666458|38190170|FG000|Overall Study|Incorrect enrollment|7|||
17045912|NCT00666458|38190171|FG001|Overall Study|Incorrect enrollment|1|||
17045913|NCT00666458|38190170|FG000|Overall Study|Study specific discontinuation criteria|14|||
17045914|NCT00666458|38190171|FG001|Overall Study|Study specific discontinuation criteria|7|||
17045915|NCT00666458|38190170|FG000|Overall Study|Severe non-compliance to the protocol|1|||
17045916|NCT00666458|38190171|FG001|Overall Study|Severe non-compliance to the protocol|1|||
17045917|NCT00666458|38190170|FG000|Overall Study|Safety reasons|1|||
17045918|NCT00666458|38190171|FG001|Overall Study|Safety reasons|0|||
17045919|NCT00666458|38190170|FG000|Overall Study|Medical history of anemia|1|||
17045920|NCT00666458|38190171|FG001|Overall Study|Medical history of anemia|0|||
17045921|NCT00511108|38190181|FG000|Overall Study|Adverse Event|2|||
17045922|NCT00511108|38190182|FG001|Overall Study|Adverse Event|0|||
17045923|NCT00511108|38190183|FG002|Overall Study|Adverse Event|1|||
17045924|NCT00511108|38190184|FG003|Overall Study|Adverse Event|2|||
17045925|NCT00511108|38190181|FG000|Overall Study|Lost to Follow-up|0|||
17045926|NCT00511108|38190182|FG001|Overall Study|Lost to Follow-up|2|||
17045927|NCT00511108|38190183|FG002|Overall Study|Lost to Follow-up|1|||
17045928|NCT00511108|38190184|FG003|Overall Study|Lost to Follow-up|0|||
17045929|NCT00511108|38190181|FG000|Overall Study|Physician Decision|0|||
17045930|NCT00511108|38190182|FG001|Overall Study|Physician Decision|0|||
16780557|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
17045931|NCT00511108|38190183|FG002|Overall Study|Physician Decision|0|||
17045932|NCT00511108|38190184|FG003|Overall Study|Physician Decision|1|||
17045933|NCT00511108|38190181|FG000|Overall Study|Withdrawal by Subject|4|||
17045934|NCT00511108|38190182|FG001|Overall Study|Withdrawal by Subject|0|||
17045935|NCT00511108|38190183|FG002|Overall Study|Withdrawal by Subject|3|||
17045936|NCT00511108|38190184|FG003|Overall Study|Withdrawal by Subject|2|||
17045937|NCT00510952|38190196|FG000|Overall Study|Adverse Event|1|||
17045938|NCT00510952|38190197|FG001|Overall Study|Adverse Event|0|||
17045939|NCT00510952|38190196|FG000|Overall Study|Entry Criteria Not Met|3|||
17045940|NCT00510952|38190197|FG001|Overall Study|Entry Criteria Not Met|1|||
17045941|NCT00510952|38190196|FG000|Overall Study|Lost to Follow-up|5|||
17045942|NCT00510952|38190197|FG001|Overall Study|Lost to Follow-up|3|||
17045943|NCT00510952|38190196|FG000|Overall Study|Physician Decision|1|||
17045944|NCT00510952|38190197|FG001|Overall Study|Physician Decision|1|||
17045945|NCT00510952|38190196|FG000|Overall Study|Protocol Violation|7|||
17045946|NCT00510952|38190197|FG001|Overall Study|Protocol Violation|4|||
17045947|NCT00510952|38190196|FG000|Overall Study|Sponsor Decision|1|||
17045948|NCT00510952|38190197|FG001|Overall Study|Sponsor Decision|0|||
17045949|NCT00510952|38190196|FG000|Overall Study|Withdrawal by Subject|6|||
17045950|NCT00510952|38190197|FG001|Overall Study|Withdrawal by Subject|7|||
17045951|NCT00510952|38190196|FG000|Overall Study|Did Not Receive Study Drug|2|||
17045952|NCT00510952|38190197|FG001|Overall Study|Did Not Receive Study Drug|0|||
17045953|NCT00617604|38190205|FG000|Overall Study|Death|2|||
17045954|NCT00617604|38190206|FG001|Overall Study|Death|1|||
17045955|NCT00617604|38190205|FG000|Overall Study|Lost to Follow-up|1|||
17045956|NCT00617604|38190206|FG001|Overall Study|Lost to Follow-up|0|||
17045957|NCT00617604|38190205|FG000|Overall Study|Miscellaneous Reasons|8|||
17045958|NCT00617604|38190206|FG001|Overall Study|Miscellaneous Reasons|10|||
17045959|NCT00617604|38190205|FG000|Overall Study|Withdrawal by Subject|4|||
17045960|NCT00617604|38190206|FG001|Overall Study|Withdrawal by Subject|6|||
17045961|NCT00617604|38190205|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
17045962|NCT00617604|38190206|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
17045963|NCT00661622|38190214|FG000|Overall Study|Protocol Violation|1|||
17045964|NCT00661622|38190215|FG001|Overall Study|Protocol Violation|0|||
17045965|NCT04093752|38190226|FG000|Overall Study|Adverse Event|7|||
17045966|NCT04093752|38190227|FG001|Overall Study|Adverse Event|19|||
17045967|NCT04093752|38190228|FG002|Overall Study|Adverse Event|18|||
17045968|NCT04093752|38190229|FG003|Overall Study|Adverse Event|4|||
17045969|NCT04093752|38190226|FG000|Overall Study|Withdrawal by Subject|6|||
17045970|NCT04093752|38190227|FG001|Overall Study|Withdrawal by Subject|6|||
17045971|NCT04093752|38190228|FG002|Overall Study|Withdrawal by Subject|8|||
17045972|NCT04093752|38190229|FG003|Overall Study|Withdrawal by Subject|20|||
17045973|NCT04093752|38190226|FG000|Overall Study|Lost to Follow-up|2|||
17045974|NCT04093752|38190227|FG001|Overall Study|Lost to Follow-up|1|||
17045975|NCT04093752|38190228|FG002|Overall Study|Lost to Follow-up|1|||
17045976|NCT04093752|38190229|FG003|Overall Study|Lost to Follow-up|1|||
17045977|NCT04093752|38190226|FG000|Overall Study|Death|0|||
17045978|NCT04093752|38190227|FG001|Overall Study|Death|0|||
17045979|NCT04093752|38190228|FG002|Overall Study|Death|1|||
17045980|NCT04093752|38190229|FG003|Overall Study|Death|2|||
17045981|NCT04093752|38190226|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
17045982|NCT04093752|38190227|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
17045983|NCT04093752|38190228|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
17045984|NCT04093752|38190229|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
17045985|NCT04093752|38190226|FG000|Overall Study|Covid 19|0|||
17045986|NCT04093752|38190227|FG001|Overall Study|Covid 19|0|||
17045987|NCT04093752|38190228|FG002|Overall Study|Covid 19|0|||
17045988|NCT04093752|38190229|FG003|Overall Study|Covid 19|1|||
17045989|NCT04093752|38190226|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
17045990|NCT04093752|38190227|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
17045991|NCT04093752|38190228|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
17045992|NCT04093752|38190229|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
17045993|NCT04093752|38190226|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
17045994|NCT04093752|38190227|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
17045995|NCT04093752|38190228|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
17045996|NCT04093752|38190229|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
17045997|NCT04093752|38190226|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
17045998|NCT04093752|38190227|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
17045999|NCT04093752|38190228|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
17046000|NCT04093752|38190229|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
17046001|NCT03928821|38190247|FG000|Overall Study|Death|0|||
17046002|NCT03928821|38190248|FG001|Overall Study|Death|1|||
17046003|NCT03928821|38190249|FG002|Overall Study|Death|0|||
17046004|NCT03928821|38190250|FG003|Overall Study|Death|0|||
17046005|NCT03928821|38190247|FG000|Overall Study|Lost to Follow-up|0|||
17046006|NCT03928821|38190248|FG001|Overall Study|Lost to Follow-up|2|||
17046007|NCT03928821|38190249|FG002|Overall Study|Lost to Follow-up|3|||
17046008|NCT03928821|38190250|FG003|Overall Study|Lost to Follow-up|0|||
17046009|NCT03928821|38190247|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
17046010|NCT03928821|38190248|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
17046011|NCT03928821|38190249|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
17046012|NCT03928821|38190250|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
17046013|NCT00666224|38190262|FG000|Double-Blind|Adverse Event|15|||
17046014|NCT00666224|38190263|FG001|Double-Blind|Adverse Event|5|||
17046015|NCT00666224|38190262|FG000|Double-Blind|Lost to Follow-up|2|||
17046016|NCT00666224|38190263|FG001|Double-Blind|Lost to Follow-up|2|||
17046017|NCT00666224|38190262|FG000|Double-Blind|Withdrawal by Subject|18|||
17141798|NCT02891226|38284512|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141799|NCT02891226|38284513|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141800|NCT02891226|38284514|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141801|NCT02891226|38284515|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17046018|NCT00666224|38190263|FG001|Double-Blind|Withdrawal by Subject|14|||
17046019|NCT00666224|38190262|FG000|Double-Blind|Physician Decision|0|||
17046020|NCT00666224|38190263|FG001|Double-Blind|Physician Decision|3|||
17046021|NCT00666224|38190262|FG000|Double-Blind|Sponsor decision|1|||
17046022|NCT00666224|38190263|FG001|Double-Blind|Sponsor decision|0|||
17046023|NCT00666224|38190262|FG000|Double-Blind|Pregnancy|3|||
17046024|NCT00666224|38190263|FG001|Double-Blind|Pregnancy|2|||
17046025|NCT00666224|38190262|FG000|Double-Blind|Noncompliance|1|||
17046026|NCT00666224|38190263|FG001|Double-Blind|Noncompliance|0|||
17046027|NCT00666224|38190262|FG000|Double-Blind|Death|1|||
17046028|NCT00666224|38190263|FG001|Double-Blind|Death|0|||
17046029|NCT00666224|38190262|FG000|Double-Blind|Undefined/Unknown|4|||
17046030|NCT00666224|38190263|FG001|Double-Blind|Undefined/Unknown|1|||
17046031|NCT00666224|38190262|FG000|Open-Label|Adverse Event|8|||
17046032|NCT00666224|38190263|FG001|Open-Label|Adverse Event|43|||
17046033|NCT00666224|38190262|FG000|Open-Label|Lost to Follow-up|4|||
17046034|NCT00666224|38190263|FG001|Open-Label|Lost to Follow-up|5|||
17046035|NCT00666224|38190262|FG000|Open-Label|Withdrawal by Subject|12|||
17046036|NCT00666224|38190263|FG001|Open-Label|Withdrawal by Subject|25|||
17046037|NCT00666224|38190262|FG000|Open-Label|Physician Decision|7|||
17046038|NCT00666224|38190263|FG001|Open-Label|Physician Decision|5|||
17046039|NCT00666224|38190262|FG000|Open-Label|Pregnancy|1|||
17046040|NCT00666224|38190263|FG001|Open-Label|Pregnancy|5|||
17046041|NCT00666224|38190262|FG000|Open-Label|Noncompliance|2|||
17046042|NCT00666224|38190263|FG001|Open-Label|Noncompliance|1|||
17046043|NCT00666224|38190262|FG000|Open-Label|Undefined/Unknown|1|||
17046044|NCT00666224|38190263|FG001|Open-Label|Undefined/Unknown|1|||
17046045|NCT00663962|38190272|FG000|Overall Study|somnolence|1|||
17046046|NCT00663962|38190273|FG001|Overall Study|somnolence|0|||
17046047|NCT00265759|38190285|FG000|Overall Study|Withdrawal by Subject|0|||
17046048|NCT00265759|38190286|FG001|Overall Study|Withdrawal by Subject|1|||
17046049|NCT00265759|38190287|FG002|Overall Study|Withdrawal by Subject|2|||
17046050|NCT00265759|38190288|FG003|Overall Study|Withdrawal by Subject|2|||
17046051|NCT00265759|38190285|FG000|Overall Study|Cancel|0|||
17046052|NCT00265759|38190286|FG001|Overall Study|Cancel|0|||
17046053|NCT00265759|38190287|FG002|Overall Study|Cancel|0|||
17046054|NCT00265759|38190288|FG003|Overall Study|Cancel|3|||
17046055|NCT00265759|38190285|FG000|Overall Study|Ineligible|0|||
17046056|NCT00265759|38190286|FG001|Overall Study|Ineligible|0|||
17046057|NCT00265759|38190287|FG002|Overall Study|Ineligible|0|||
17046058|NCT00265759|38190288|FG003|Overall Study|Ineligible|1|||
17046059|NCT00265759|38190285|FG000|Overall Study|Bilateral disease|0|||
17046060|NCT00265759|38190286|FG001|Overall Study|Bilateral disease|0|||
17046061|NCT00265759|38190287|FG002|Overall Study|Bilateral disease|0|||
17046062|NCT00265759|38190288|FG003|Overall Study|Bilateral disease|2|||
17046063|NCT00265759|38190285|FG000|Overall Study|Discontinued due to intolerability|0|||
17046064|NCT00265759|38190286|FG001|Overall Study|Discontinued due to intolerability|0|||
17046065|NCT00265759|38190287|FG002|Overall Study|Discontinued due to intolerability|0|||
17046066|NCT00265759|38190288|FG003|Overall Study|Discontinued due to intolerability|1|||
17046067|NCT00744263|38190301|FG000|Overall Study|Death|3006|||
17046068|NCT00744263|38190302|FG001|Overall Study|Death|3005|||
17046069|NCT00744263|38190301|FG000|Overall Study|Lost to Follow-up|2038|||
17046070|NCT00744263|38190302|FG001|Overall Study|Lost to Follow-up|2135|||
17046071|NCT00744263|38190301|FG000|Overall Study|Withdrawal by Subject|166|||
17046072|NCT00744263|38190302|FG001|Overall Study|Withdrawal by Subject|150|||
17046073|NCT00744263|38190301|FG000|Overall Study|Physician Decision|20|||
17046074|NCT00744263|38190302|FG001|Overall Study|Physician Decision|23|||
17046075|NCT00744263|38190301|FG000|Overall Study|Protocol Violation|3|||
17046076|NCT00744263|38190302|FG001|Overall Study|Protocol Violation|5|||
17046077|NCT00744263|38190301|FG000|Overall Study|Adverse Event|1|||
17046078|NCT00744263|38190302|FG001|Overall Study|Adverse Event|0|||
17046079|NCT00744263|38190301|FG000|Overall Study|Other|2|||
17046080|NCT00744263|38190302|FG001|Overall Study|Other|2|||
17046081|NCT00618774|38190312|FG000|Overall Study|Adverse Event|5|||
17046082|NCT00618774|38190313|FG001|Overall Study|Adverse Event|3|||
17046083|NCT00618774|38190312|FG000|Overall Study|Withdrawal by Subject|1|||
17046084|NCT00618774|38190313|FG001|Overall Study|Withdrawal by Subject|0|||
17046085|NCT00545571|38190319|FG000|Overall Study|Administrative Reasons|1|||
17046086|NCT00545571|38190319|FG000|Overall Study|Adverse Event|2|||
17046087|NCT00545571|38190319|FG000|Overall Study|Death|5|||
17046088|NCT00545571|38190319|FG000|Overall Study|Lack of Efficacy|1|||
17046089|NCT00545571|38190319|FG000|Overall Study|Protocol Violation|2|||
17046090|NCT00545571|38190319|FG000|Overall Study|Refused Treatment|1|||
17046091|NCT00545571|38190319|FG000|Overall Study|Screen Failure|16|||
17046092|NCT00545571|38190319|FG000|Overall Study|Transfusion|12|||
17046093|NCT00545571|38190319|FG000|Overall Study|Early Termination of Study|24|||
17046094|NCT00545571|38190319|FG000|Overall Study|Kidney Transplantation|3|||
17046095|NCT00748709|38190323|FG000|Overall Study|Progressive disease|15|||
17046096|NCT00748709|38190323|FG000|Overall Study|Drug reducing Toxity|2|||
17046097|NCT00748709|38190323|FG000|Overall Study|Other Adverse Event|1|||
17046098|NCT00748709|38190323|FG000|Overall Study|Withdrawal by Subject|1|||
17046099|NCT00748709|38190323|FG000|Overall Study|Other Reasons|1|||
17046100|NCT00263887|38190329|FG000|Overall Study|Withdrawal by Subject|1|||
17046101|NCT00263887|38190330|FG001|Overall Study|Withdrawal by Subject|1|||
17046102|NCT00263887|38190329|FG000|Overall Study|Lung transplantation|1|||
17046103|NCT00263887|38190330|FG001|Overall Study|Lung transplantation|2|||
17046104|NCT00263887|38190329|FG000|Overall Study|Too ill to attend visit|1|||
17046105|NCT00263887|38190330|FG001|Overall Study|Too ill to attend visit|0|||
17046106|NCT00263887|38190329|FG000|Overall Study|Adverse Event|0|||
17046107|NCT00263887|38190330|FG001|Overall Study|Adverse Event|2|||
17046108|NCT00263887|38190329|FG000|Overall Study|Disease progression|0|||
17046109|NCT00263887|38190330|FG001|Overall Study|Disease progression|1|||
17046110|NCT00263887|38190329|FG000|Overall Study|Lack of Efficacy|0|||
17046111|NCT00263887|38190330|FG001|Overall Study|Lack of Efficacy|1|||
17046112|NCT00748553|38190338|FG000|Overall Study|Adverse Event|0|||
17046113|NCT00748553|38190339|FG001|Overall Study|Adverse Event|1|||
17046114|NCT00748553|38190338|FG000|Overall Study|disease progression|2|||
17046115|NCT00748553|38190339|FG001|Overall Study|disease progression|0|||
17046116|NCT00748553|38190338|FG000|Overall Study|noncompliance|1|||
17046117|NCT00748553|38190339|FG001|Overall Study|noncompliance|0|||
17046118|NCT00661388|38190344|FG000|Overall Study|Adverse Event|14|||
17046119|NCT00661388|38190344|FG000|Overall Study|Protocol Violation|7|||
17046120|NCT00661388|38190344|FG000|Overall Study|Renal transplantation|1|||
17046121|NCT00661388|38190344|FG000|Overall Study|Dialysis initiation|1|||
17046122|NCT00661388|38190344|FG000|Overall Study|Administrative reasons|1|||
17046123|NCT00743483|38190348|FG000|Baseline Period|Physician Decision|1|||
17046124|NCT00743483|38190348|FG000|Treatment Period|Adverse Event|1|||
17046125|NCT00263575|38190352|FG000|Titration Period|Adverse Event|14|||
17046126|NCT00263575|38190352|FG000|Titration Period|Withdrawal by Subject|10|||
17046127|NCT00263575|38190352|FG000|Titration Period|Protocol Violation|9|||
17046128|NCT00263575|38190352|FG000|Titration Period|Sponsor Decision|2|||
17046129|NCT00263575|38190352|FG000|Titration Period|Other|2|||
17046130|NCT00263575|38190352|FG000|Titration Period|Lack of Efficacy|6|||
17046131|NCT00263575|38190352|FG000|Maintence Period|Adverse Event|23|||
17046132|NCT00263575|38190352|FG000|Maintence Period|Withdrawal by Subject|8|||
17046133|NCT00263575|38190352|FG000|Maintence Period|Protocol Violation|4|||
17046134|NCT00263575|38190352|FG000|Maintence Period|Lack of Efficacy|4|||
17046135|NCT00263575|38190352|FG000|Maintence Period|Physician Decision|6|||
17046136|NCT00263575|38190352|FG000|Maintence Period|Lost to Follow-up|1|||
17046137|NCT00263575|38190352|FG000|Maintence Period|Sponsor Decision|24|||
17046138|NCT00263575|38190352|FG000|Maintence Period|Other|7|||
17046139|NCT00748241|38190358|FG000|Overall Study|Implant failure|1|||
17046140|NCT00748241|38190358|FG000|Overall Study|Lost to Follow-up|5|||
17046141|NCT00748241|38190358|FG000|Overall Study|Death|2|||
17046142|NCT00570128|38190364|FG000|Overall Study|Adverse Event|1|||
17046143|NCT00570128|38190365|FG001|Overall Study|Adverse Event|0|||
17046144|NCT00570128|38190364|FG000|Overall Study|Lost to Follow-up|1|||
17046145|NCT00570128|38190365|FG001|Overall Study|Lost to Follow-up|0|||
17046146|NCT00570128|38190364|FG000|Overall Study|Withdrawal by Subject|2|||
17046147|NCT00570128|38190365|FG001|Overall Study|Withdrawal by Subject|0|||
17046148|NCT00743249|38190373|FG000|Overall Study|Adverse Event|0|||
17046149|NCT00743249|38190374|FG001|Overall Study|Adverse Event|4|||
17046150|NCT00743249|38190373|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
17046151|NCT00743249|38190374|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
17046152|NCT00743249|38190373|FG000|Overall Study|Unsuccessful insertion of stent|2|||
17046153|NCT00743249|38190374|FG001|Overall Study|Unsuccessful insertion of stent|1|||
17046154|NCT00262951|38190380|FG000|Overall Study|Progressive disease/relapse|3|||
17046155|NCT00262951|38190380|FG000|Overall Study|Adverse Event|7|||
17046156|NCT00262951|38190380|FG000|Overall Study|Death|1|||
17046157|NCT00262951|38190380|FG000|Overall Study|Withdrawal by Subject|1|||
17046158|NCT00262951|38190380|FG000|Overall Study|Alternative treatment|3|||
17046159|NCT00262951|38190380|FG000|Overall Study|Off treatment for other disease|1|||
17046160|NCT00262873|38190384|FG000|Overall Study|Adverse Event|3|||
17046161|NCT00262873|38190384|FG000|Overall Study|Withdrawal by Subject|5|||
17046162|NCT00573534|38190388|FG000|Overall Study|oppositional behavior|3|||
17046163|NCT00260533|38190395|FG000|Overall Study|Other|3|||
17046164|NCT00260533|38190396|FG001|Overall Study|Other|3|||
17046165|NCT03945981|38190402|FG000|Overall Study|Lost to Follow-up|12|||
17046166|NCT03945981|38190402|FG000|Overall Study|Physician Decision|4|||
17141802|NCT02891226|38284516|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141803|NCT02891226|38284517|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17141804|NCT02891226|38284518|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
17046167|NCT03945981|38190402|FG000|Overall Study|Withdrawal by Subject|6|||
17046168|NCT03945981|38190402|FG000|Overall Study|Protocol Violation|1|||
17046169|NCT00745901|38190429|FG000|Overall Study|Adverse Event|3|||
17046170|NCT00745901|38190430|FG001|Overall Study|Adverse Event|4|||
17141805|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141806|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141807|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141808|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17046171|NCT00745901|38190429|FG000|Overall Study|Protocol Violation|0|||
17046172|NCT00745901|38190430|FG001|Overall Study|Protocol Violation|1|||
17046173|NCT00745901|38190429|FG000|Overall Study|Withdrawal by Subject|1|||
17046174|NCT00745901|38190430|FG001|Overall Study|Withdrawal by Subject|0|||
17046175|NCT00745901|38190429|FG000|Overall Study|Lost to Follow-up|7|||
17046176|NCT00745901|38190430|FG001|Overall Study|Lost to Follow-up|4|||
17046177|NCT00745901|38190429|FG000|Overall Study|Pregnancy|2|||
17046178|NCT00745901|38190430|FG001|Overall Study|Pregnancy|4|||
17046179|NCT00745901|38190429|FG000|Overall Study|Lack of compliance|2|||
17046180|NCT00745901|38190430|FG001|Overall Study|Lack of compliance|2|||
17046181|NCT00745901|38190429|FG000|Overall Study|Patient's next menses did not start with|1|||
17046182|NCT00745901|38190430|FG001|Overall Study|Patient's next menses did not start with|0|||
17046183|NCT00745901|38190429|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
17046184|NCT00745901|38190430|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
17046185|NCT00745901|38190429|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
17046186|NCT00745901|38190430|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
17046187|NCT00745901|38190429|FG000|Overall Study|Patient didn't take any study medication|7|||
17046188|NCT00745901|38190430|FG001|Overall Study|Patient didn't take any study medication|3|||
17046189|NCT00286429|38190439|FG000|Overall Study|Adverse Event|4|||
17046190|NCT00286429|38190440|FG001|Overall Study|Adverse Event|1|||
17046191|NCT00286429|38190441|FG002|Overall Study|Adverse Event|6|||
17046192|NCT00286429|38190439|FG000|Overall Study|Lack of Efficacy|52|||
17046193|NCT00286429|38190440|FG001|Overall Study|Lack of Efficacy|27|||
17046194|NCT00286429|38190441|FG002|Overall Study|Lack of Efficacy|25|||
17046195|NCT00286429|38190439|FG000|Overall Study|Lost to Follow-up|2|||
17046196|NCT00286429|38190440|FG001|Overall Study|Lost to Follow-up|4|||
17046197|NCT00286429|38190441|FG002|Overall Study|Lost to Follow-up|3|||
17046198|NCT00286429|38190439|FG000|Overall Study|Physician Decision|10|||
17046199|NCT00286429|38190440|FG001|Overall Study|Physician Decision|7|||
17046200|NCT00286429|38190441|FG002|Overall Study|Physician Decision|7|||
17046201|NCT00286429|38190439|FG000|Overall Study|Protocol Violation|3|||
17046202|NCT00286429|38190440|FG001|Overall Study|Protocol Violation|5|||
17046203|NCT00286429|38190441|FG002|Overall Study|Protocol Violation|4|||
17046204|NCT00286429|38190439|FG000|Overall Study|Withdrawal by Subject|3|||
16780558|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
17046205|NCT00286429|38190440|FG001|Overall Study|Withdrawal by Subject|2|||
16780559|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
16780560|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
16780561|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
16780562|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
16780563|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
16780564|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
16780565|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
16780566|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
16780567|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
16780568|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
17046206|NCT00286429|38190441|FG002|Overall Study|Withdrawal by Subject|6|||
17046207|NCT00286429|38190439|FG000|Overall Study|Administrative Error|1|||
17046208|NCT00286429|38190440|FG001|Overall Study|Administrative Error|1|||
17046209|NCT00286429|38190441|FG002|Overall Study|Administrative Error|1|||
17046210|NCT00286429|38190439|FG000|Overall Study|Administrative Decision|0|||
17046211|NCT00286429|38190440|FG001|Overall Study|Administrative Decision|1|||
16780569|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
16780570|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
16780571|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
16780572|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
16780573|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
16780574|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
16780575|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
16780576|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
16780577|NCT01667679|37719725|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
16780578|NCT01667679|37719726|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
16780579|NCT02597049|37719737|FG000|Overall Study|Lost to Follow-up|0|||
17046212|NCT00286429|38190441|FG002|Overall Study|Administrative Decision|0|||
17046213|NCT00665444|38190449|FG000|Overall Study|Physician Decision|1|||
17046214|NCT00665444|38190449|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
17046215|NCT03926169|38190456|FG000|Period A|Adverse Event|2|||
17046216|NCT03926169|38190457|FG001|Period A|Adverse Event|2|||
17046217|NCT03926169|38190458|FG002|Period A|Adverse Event|1|||
17046218|NCT03926169|38190456|FG000|Period A|Withdrawal by Subject|2|||
17046219|NCT03926169|38190457|FG001|Period A|Withdrawal by Subject|2|||
17046220|NCT03926169|38190458|FG002|Period A|Withdrawal by Subject|2|||
17046221|NCT03926169|38190456|FG000|Period A|Lost to Follow-up|3|||
17046222|NCT03926169|38190457|FG001|Period A|Lost to Follow-up|1|||
17046223|NCT03926169|38190458|FG002|Period A|Lost to Follow-up|0|||
17046224|NCT03926169|38190456|FG000|Period A|Lack of Efficacy|0|||
17046225|NCT03926169|38190457|FG001|Period A|Lack of Efficacy|2|||
17046226|NCT03926169|38190458|FG002|Period A|Lack of Efficacy|2|||
17046227|NCT03926169|38190456|FG000|Period A|COVID-19 Infection|0|||
17046228|NCT03926169|38190457|FG001|Period A|COVID-19 Infection|1|||
17046229|NCT03926169|38190458|FG002|Period A|COVID-19 Infection|0|||
17046230|NCT03926169|38190456|FG000|Period A|COVID-19 Logistical Restrictions|0|||
17046231|NCT03926169|38190457|FG001|Period A|COVID-19 Logistical Restrictions|2|||
17046232|NCT03926169|38190458|FG002|Period A|COVID-19 Logistical Restrictions|1|||
17046233|NCT03926169|38190456|FG000|Period A|Other, Not Specified|1|||
17046234|NCT03926169|38190457|FG001|Period A|Other, Not Specified|0|||
17046235|NCT03926169|38190458|FG002|Period A|Other, Not Specified|0|||
17046236|NCT03926169|38190456|FG000|Period B|Adverse Event|3|||
17046237|NCT03926169|38190457|FG001|Period B|Adverse Event|1|||
17046238|NCT03926169|38190458|FG002|Period B|Adverse Event|1|||
17046239|NCT03926169|38190456|FG000|Period B|Withdrawal by Subject|1|||
17046240|NCT03926169|38190457|FG001|Period B|Withdrawal by Subject|3|||
17046241|NCT03926169|38190458|FG002|Period B|Withdrawal by Subject|0|||
17046242|NCT03926169|38190456|FG000|Period B|Lack of Efficacy|3|||
17046243|NCT03926169|38190457|FG001|Period B|Lack of Efficacy|1|||
17046244|NCT03926169|38190458|FG002|Period B|Lack of Efficacy|1|||
17046245|NCT03926169|38190456|FG000|Period B|Lost to Follow-up|1|||
17046246|NCT03926169|38190457|FG001|Period B|Lost to Follow-up|1|||
17046247|NCT03926169|38190458|FG002|Period B|Lost to Follow-up|4|||
17046248|NCT03926169|38190456|FG000|Period B|Other, Not Specified|62|||
17046249|NCT03926169|38190457|FG001|Period B|Other, Not Specified|57|||
17046250|NCT03926169|38190458|FG002|Period B|Other, Not Specified|65|||
17046251|NCT00285649|38190472|FG000|Overall Study|Lost to Follow-up|6|||
17046252|NCT00285649|38190473|FG001|Overall Study|Lost to Follow-up|4|||
17046253|NCT00285649|38190474|FG002|Overall Study|Lost to Follow-up|4|||
17046254|NCT00285649|38190472|FG000|Overall Study|Withdrawal by Subject|3|||
17046255|NCT00285649|38190473|FG001|Overall Study|Withdrawal by Subject|2|||
17046256|NCT00285649|38190474|FG002|Overall Study|Withdrawal by Subject|2|||
17046257|NCT00745823|38190484|FG000|Overall Study|Adverse Event|5|||
17046258|NCT00745823|38190485|FG001|Overall Study|Adverse Event|3|||
17046259|NCT00745823|38190484|FG000|Overall Study|Lack of Efficacy|20|||
17046260|NCT00745823|38190485|FG001|Overall Study|Lack of Efficacy|6|||
17046261|NCT00745823|38190484|FG000|Overall Study|Lost to Follow-up|10|||
17046262|NCT00745823|38190485|FG001|Overall Study|Lost to Follow-up|11|||
17046263|NCT00745823|38190484|FG000|Overall Study|Physician Decision|10|||
17046264|NCT00745823|38190485|FG001|Overall Study|Physician Decision|5|||
17046265|NCT00745823|38190484|FG000|Overall Study|Pregnancy|0|||
17046266|NCT00745823|38190485|FG001|Overall Study|Pregnancy|4|||
17046267|NCT00745823|38190484|FG000|Overall Study|Withdrawal by Subject|14|||
17046268|NCT00745823|38190485|FG001|Overall Study|Withdrawal by Subject|8|||
17046269|NCT00745823|38190484|FG000|Overall Study|Study Terminated by Sponsor|326|||
17046270|NCT00745823|38190485|FG001|Overall Study|Study Terminated by Sponsor|349|||
17046271|NCT00663260|38190496|FG000|Overall Study|Lack of Efficacy|2|||
17046272|NCT00663260|38190497|FG001|Overall Study|Lack of Efficacy|0|||
17046273|NCT00663260|38190498|FG002|Overall Study|Lack of Efficacy|0|||
16780580|NCT02597049|37719738|FG001|Overall Study|Lost to Follow-up|3|||
17046274|NCT00663260|38190496|FG000|Overall Study|Adverse Event|12|||
17046275|NCT00663260|38190497|FG001|Overall Study|Adverse Event|7|||
17046276|NCT00663260|38190498|FG002|Overall Study|Adverse Event|6|||
17046277|NCT00663260|38190496|FG000|Overall Study|Withdrawal by Subject|3|||
17046278|NCT00663260|38190497|FG001|Overall Study|Withdrawal by Subject|1|||
17046279|NCT00663260|38190498|FG002|Overall Study|Withdrawal by Subject|6|||
17046280|NCT00663260|38190496|FG000|Overall Study|Death|1|||
17046281|NCT00663260|38190497|FG001|Overall Study|Death|0|||
17046282|NCT00663260|38190498|FG002|Overall Study|Death|1|||
17046283|NCT00663260|38190496|FG000|Overall Study|Lost to Follow-up|0|||
17046284|NCT00663260|38190497|FG001|Overall Study|Lost to Follow-up|1|||
17046285|NCT00663260|38190498|FG002|Overall Study|Lost to Follow-up|0|||
17046286|NCT00663260|38190496|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
17046287|NCT00663260|38190497|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
17046288|NCT00663260|38190498|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
17141809|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141810|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141811|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
17141812|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
17141813|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
17141814|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
17046289|NCT00740597|38190506|FG000|Overall Study|insurance would not cover treatment|1|||
17046290|NCT00284089|38190514|FG000|Multiple Dose Phase|Adverse Event|1|||
17046291|NCT00284089|38190515|FG001|Multiple Dose Phase|Adverse Event|0|||
17046292|NCT00284089|38190516|FG002|Multiple Dose Phase|Adverse Event|1|||
17046293|NCT00284089|38190517|FG003|Multiple Dose Phase|Adverse Event|1|||
17046294|NCT00284089|38190514|FG000|Multiple Dose Phase|Protocol Violation|0|||
17046295|NCT00284089|38190515|FG001|Multiple Dose Phase|Protocol Violation|0|||
17046296|NCT00284089|38190516|FG002|Multiple Dose Phase|Protocol Violation|1|||
17046297|NCT00284089|38190517|FG003|Multiple Dose Phase|Protocol Violation|0|||
17046298|NCT00284089|38190514|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
17046299|NCT00284089|38190515|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
17046300|NCT00284089|38190516|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
17046301|NCT00284089|38190517|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
17046302|NCT00284089|38190514|FG000|Multiple Dose Phase|Death|0|||
17046303|NCT00284089|38190515|FG001|Multiple Dose Phase|Death|0|||
17046304|NCT00284089|38190516|FG002|Multiple Dose Phase|Death|1|||
17046305|NCT00284089|38190517|FG003|Multiple Dose Phase|Death|1|||
17046306|NCT00284089|38190514|FG000|Extension Phase|Adverse Event|0|||
17046307|NCT00284089|38190515|FG001|Extension Phase|Adverse Event|0|||
17046308|NCT00284089|38190516|FG002|Extension Phase|Adverse Event|2|||
17046309|NCT00284089|38190517|FG003|Extension Phase|Adverse Event|2|||
17046310|NCT00284089|38190514|FG000|Extension Phase|condition no longer requires study drug|2|||
17046311|NCT00284089|38190515|FG001|Extension Phase|condition no longer requires study drug|0|||
17046312|NCT00284089|38190516|FG002|Extension Phase|condition no longer requires study drug|2|||
17046313|NCT00284089|38190517|FG003|Extension Phase|condition no longer requires study drug|7|||
17046314|NCT00284089|38190514|FG000|Extension Phase|Protocol Violation|0|||
17046315|NCT00284089|38190515|FG001|Extension Phase|Protocol Violation|0|||
17046316|NCT00284089|38190516|FG002|Extension Phase|Protocol Violation|1|||
17046317|NCT00284089|38190517|FG003|Extension Phase|Protocol Violation|0|||
17046318|NCT00284089|38190514|FG000|Extension Phase|Withdrawal by Subject|0|||
17046319|NCT00284089|38190515|FG001|Extension Phase|Withdrawal by Subject|0|||
17046320|NCT00284089|38190516|FG002|Extension Phase|Withdrawal by Subject|1|||
17046321|NCT00284089|38190517|FG003|Extension Phase|Withdrawal by Subject|3|||
17046322|NCT00659984|38190527|FG000|Overall Study|Adverse Event|1|||
17141815|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17046323|NCT00283387|38190541|FG000|First Intervention|Subject non-compliant|1|||
17046324|NCT00283387|38190542|FG001|First Intervention|Subject non-compliant|1|||
17046325|NCT00283387|38190541|FG000|First Intervention|Withdrawal by Subject|0|||
17046326|NCT00283387|38190542|FG001|First Intervention|Withdrawal by Subject|1|||
17046327|NCT00282919|38190548|FG000|Overall Study|Lack of Efficacy|4|||
17046328|NCT00282919|38190548|FG000|Overall Study|Withdrawal by Subject|1|||
17046329|NCT00282919|38190548|FG000|Overall Study|Asymptomatic Parasitemia|2|||
17046330|NCT00742859|38190556|FG000|Overall Study|Adverse Event|5|||
17046331|NCT00742859|38190557|FG001|Overall Study|Adverse Event|6|||
17046332|NCT00742859|38190558|FG002|Overall Study|Adverse Event|3|||
17046333|NCT00742859|38190559|FG003|Overall Study|Adverse Event|1|||
17046334|NCT00742859|38190556|FG000|Overall Study|Death|1|||
17046335|NCT00742859|38190557|FG001|Overall Study|Death|0|||
17046336|NCT00742859|38190558|FG002|Overall Study|Death|0|||
17046337|NCT00742859|38190559|FG003|Overall Study|Death|1|||
17046338|NCT00742859|38190556|FG000|Overall Study|Physician Decision|1|||
17046339|NCT00742859|38190557|FG001|Overall Study|Physician Decision|2|||
17046340|NCT00742859|38190558|FG002|Overall Study|Physician Decision|0|||
17046341|NCT00742859|38190559|FG003|Overall Study|Physician Decision|0|||
17046342|NCT00742859|38190556|FG000|Overall Study|Withdrawal by Subject|4|||
17046343|NCT00742859|38190557|FG001|Overall Study|Withdrawal by Subject|2|||
17046344|NCT00742859|38190558|FG002|Overall Study|Withdrawal by Subject|4|||
17046345|NCT00742859|38190559|FG003|Overall Study|Withdrawal by Subject|1|||
17046346|NCT00742859|38190556|FG000|Overall Study|Endpoint|0|||
17046347|NCT00742859|38190557|FG001|Overall Study|Endpoint|1|||
17046348|NCT00742859|38190558|FG002|Overall Study|Endpoint|1|||
17046349|NCT00742859|38190559|FG003|Overall Study|Endpoint|2|||
17046350|NCT00742859|38190556|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
17046351|NCT00742859|38190557|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
17046352|NCT00742859|38190558|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
17046353|NCT00742859|38190559|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
17046354|NCT00742859|38190556|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
17046355|NCT00742859|38190557|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
17046356|NCT00742859|38190558|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
17046357|NCT00742859|38190559|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
17046358|NCT00742859|38190556|FG000|Overall Study|Sponsor request patient out of town|0|||
17046359|NCT00742859|38190557|FG001|Overall Study|Sponsor request patient out of town|0|||
17046360|NCT00742859|38190558|FG002|Overall Study|Sponsor request patient out of town|1|||
17046361|NCT00742859|38190559|FG003|Overall Study|Sponsor request patient out of town|1|||
17046362|NCT00742859|38190556|FG000|Overall Study|Site error|0|||
17046363|NCT00742859|38190557|FG001|Overall Study|Site error|0|||
17046364|NCT00742859|38190558|FG002|Overall Study|Site error|1|||
17046365|NCT00742859|38190559|FG003|Overall Study|Site error|1|||
17046366|NCT00282295|38190572|FG000|Overall Study|Adverse Event|0|||
17046367|NCT00282295|38190573|FG001|Overall Study|Adverse Event|1|||
17046368|NCT00282295|38190574|FG002|Overall Study|Adverse Event|0|||
17046369|NCT00282295|38190572|FG000|Overall Study|Serious Adverse Events|0|||
17046370|NCT00282295|38190573|FG001|Overall Study|Serious Adverse Events|0|||
17046371|NCT00282295|38190574|FG002|Overall Study|Serious Adverse Events|1|||
17046372|NCT00282295|38190572|FG000|Overall Study|Protocol Violation|0|||
17046373|NCT00282295|38190573|FG001|Overall Study|Protocol Violation|2|||
17046374|NCT00282295|38190574|FG002|Overall Study|Protocol Violation|1|||
17046375|NCT00282295|38190572|FG000|Overall Study|Withdrawal by Subject|2|||
17046376|NCT00282295|38190573|FG001|Overall Study|Withdrawal by Subject|6|||
17046377|NCT00282295|38190574|FG002|Overall Study|Withdrawal by Subject|4|||
17141816|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141817|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141818|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141819|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141820|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
17141821|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141822|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141823|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141824|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141825|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141826|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
17141827|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141828|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141829|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141830|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
17141831|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141832|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141833|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141834|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141835|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141836|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
17141837|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141838|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141839|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141840|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141841|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141842|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141843|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
17141844|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
17141845|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
17141846|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
17141847|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141848|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141849|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141850|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141851|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141852|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
17141853|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141854|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141855|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141856|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141857|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
17141858|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141859|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141860|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141861|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141862|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17046378|NCT00282295|38190572|FG000|Overall Study|Lost to Follow-up|1|||
17046379|NCT00282295|38190573|FG001|Overall Study|Lost to Follow-up|7|||
17046380|NCT00282295|38190574|FG002|Overall Study|Lost to Follow-up|2|||
17046381|NCT00282295|38190572|FG000|Overall Study|Other|0|||
17046382|NCT00282295|38190573|FG001|Overall Study|Other|1|||
17046383|NCT00282295|38190574|FG002|Overall Study|Other|0|||
17046384|NCT00742781|38190587|FG000|Overall Study|Withdrawal by Subject|3|||
17046385|NCT00663026|38190595|FG000|Overall Study|Lost to Follow-up|1|||
17046386|NCT00663026|38190596|FG001|Overall Study|Lost to Follow-up|0|||
17046387|NCT00663026|38190597|FG002|Overall Study|Lost to Follow-up|0|||
17046388|NCT00663026|38190595|FG000|Overall Study|Other|1|||
17046389|NCT00663026|38190596|FG001|Overall Study|Other|2|||
17046390|NCT00663026|38190597|FG002|Overall Study|Other|0|||
17046391|NCT00663026|38190595|FG000|Overall Study|Adverse Event|0|||
17046392|NCT00663026|38190596|FG001|Overall Study|Adverse Event|2|||
17046393|NCT00663026|38190597|FG002|Overall Study|Adverse Event|3|||
17046394|NCT00663026|38190595|FG000|Overall Study|Caregiver Request|0|||
17046395|NCT00663026|38190596|FG001|Overall Study|Caregiver Request|2|||
17046396|NCT00663026|38190597|FG002|Overall Study|Caregiver Request|0|||
17046397|NCT00663026|38190595|FG000|Overall Study|Withdrawal by Subject|0|||
17046398|NCT00663026|38190596|FG001|Overall Study|Withdrawal by Subject|0|||
17046399|NCT00663026|38190597|FG002|Overall Study|Withdrawal by Subject|1|||
17046400|NCT00280735|38190607|FG000|Overall Study|Adverse Event|5|||
17046401|NCT00280735|38190607|FG000|Overall Study|Lack of Efficacy|3|||
17046402|NCT00280735|38190607|FG000|Overall Study|Withdrawal by Subject|8|||
17046403|NCT00280735|38190607|FG000|Overall Study|Intercurrent Illness|2|||
17046404|NCT00260065|38190615|FG000|Overall Study|Progressive Disease|22|||
17046405|NCT00260065|38190615|FG000|Overall Study|Adverse Event|17|||
17046406|NCT00260065|38190615|FG000|Overall Study|Death|13|||
17046407|NCT00260065|38190615|FG000|Overall Study|Withdrawal by Subject|13|||
17046408|NCT00260065|38190615|FG000|Overall Study|Physician Decision|19|||
17046409|NCT00260065|38190615|FG000|Overall Study|Not otherwise specified|8|||
17046410|NCT00260065|38190615|FG000|Overall Study|Medication Noncompliance|1|||
17046411|NCT00506350|38190628|FG000|Overall Study|Serious Adverse Event|1|||
17046412|NCT00506350|38190629|FG001|Overall Study|Serious Adverse Event|0|||
17046413|NCT00506350|38190630|FG002|Overall Study|Serious Adverse Event|0|||
17046414|NCT00506350|38190631|FG003|Overall Study|Serious Adverse Event|0|||
17046415|NCT00506350|38190632|FG004|Overall Study|Serious Adverse Event|0|||
17046416|NCT00506350|38190633|FG005|Overall Study|Serious Adverse Event|0|||
17046417|NCT00506350|38190634|FG006|Overall Study|Serious Adverse Event|0|||
17046418|NCT00506350|38190635|FG007|Overall Study|Serious Adverse Event|0|||
17046419|NCT00506350|38190636|FG008|Overall Study|Serious Adverse Event|0|||
17046420|NCT00506350|38190628|FG000|Overall Study|Adverse Event|0|||
17046421|NCT00506350|38190629|FG001|Overall Study|Adverse Event|0|||
17046422|NCT00506350|38190630|FG002|Overall Study|Adverse Event|0|||
17046423|NCT00506350|38190631|FG003|Overall Study|Adverse Event|0|||
17046424|NCT00506350|38190632|FG004|Overall Study|Adverse Event|0|||
17046425|NCT00506350|38190633|FG005|Overall Study|Adverse Event|0|||
17141863|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141864|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141865|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17046426|NCT00506350|38190634|FG006|Overall Study|Adverse Event|0|||
17046427|NCT00506350|38190635|FG007|Overall Study|Adverse Event|1|||
17046428|NCT00506350|38190636|FG008|Overall Study|Adverse Event|1|||
17046429|NCT00506350|38190628|FG000|Overall Study|Protocol Violation|0|||
17046430|NCT00506350|38190629|FG001|Overall Study|Protocol Violation|0|||
17046431|NCT00506350|38190630|FG002|Overall Study|Protocol Violation|1|||
17046432|NCT00506350|38190631|FG003|Overall Study|Protocol Violation|0|||
17046433|NCT00506350|38190632|FG004|Overall Study|Protocol Violation|0|||
17046434|NCT00506350|38190633|FG005|Overall Study|Protocol Violation|0|||
17046435|NCT00506350|38190634|FG006|Overall Study|Protocol Violation|1|||
17046436|NCT00506350|38190635|FG007|Overall Study|Protocol Violation|0|||
17046437|NCT00506350|38190636|FG008|Overall Study|Protocol Violation|0|||
17046438|NCT00506350|38190628|FG000|Overall Study|Withdrawal by Subject|0|||
17046439|NCT00506350|38190629|FG001|Overall Study|Withdrawal by Subject|1|||
17046440|NCT00506350|38190630|FG002|Overall Study|Withdrawal by Subject|1|||
17046441|NCT00506350|38190631|FG003|Overall Study|Withdrawal by Subject|1|||
17046442|NCT00506350|38190632|FG004|Overall Study|Withdrawal by Subject|4|||
17046443|NCT00506350|38190633|FG005|Overall Study|Withdrawal by Subject|1|||
17046444|NCT00506350|38190634|FG006|Overall Study|Withdrawal by Subject|1|||
17046445|NCT00506350|38190635|FG007|Overall Study|Withdrawal by Subject|2|||
17046446|NCT00506350|38190636|FG008|Overall Study|Withdrawal by Subject|0|||
17046447|NCT00506350|38190628|FG000|Overall Study|Lost to Follow-up|1|||
17046448|NCT00506350|38190629|FG001|Overall Study|Lost to Follow-up|1|||
17046449|NCT00506350|38190630|FG002|Overall Study|Lost to Follow-up|1|||
17046450|NCT00506350|38190631|FG003|Overall Study|Lost to Follow-up|1|||
17046451|NCT00506350|38190632|FG004|Overall Study|Lost to Follow-up|2|||
17046452|NCT00506350|38190633|FG005|Overall Study|Lost to Follow-up|1|||
17046453|NCT00506350|38190634|FG006|Overall Study|Lost to Follow-up|0|||
17046454|NCT00506350|38190635|FG007|Overall Study|Lost to Follow-up|0|||
17046455|NCT00506350|38190636|FG008|Overall Study|Lost to Follow-up|2|||
17046456|NCT00506350|38190628|FG000|Overall Study|Medical Reason|0|||
17046457|NCT00506350|38190629|FG001|Overall Study|Medical Reason|0|||
17046458|NCT00506350|38190630|FG002|Overall Study|Medical Reason|0|||
17046459|NCT00506350|38190631|FG003|Overall Study|Medical Reason|0|||
17046460|NCT00506350|38190632|FG004|Overall Study|Medical Reason|1|||
17046461|NCT00506350|38190633|FG005|Overall Study|Medical Reason|0|||
17046462|NCT00506350|38190634|FG006|Overall Study|Medical Reason|0|||
17046463|NCT00506350|38190635|FG007|Overall Study|Medical Reason|0|||
17046464|NCT00506350|38190636|FG008|Overall Study|Medical Reason|0|||
17046465|NCT00506350|38190628|FG000|Overall Study|Other|1|||
17046466|NCT00506350|38190629|FG001|Overall Study|Other|1|||
17046467|NCT00506350|38190630|FG002|Overall Study|Other|3|||
17046468|NCT00506350|38190631|FG003|Overall Study|Other|0|||
17046469|NCT00506350|38190632|FG004|Overall Study|Other|3|||
17046470|NCT00506350|38190633|FG005|Overall Study|Other|0|||
17046471|NCT00506350|38190634|FG006|Overall Study|Other|0|||
17046472|NCT00506350|38190635|FG007|Overall Study|Other|2|||
17046473|NCT00506350|38190636|FG008|Overall Study|Other|2|||
17046474|NCT00258895|38190665|FG000|Overall Study|Lost to Follow-up|3|||
17046475|NCT00258895|38190666|FG001|Overall Study|Lost to Follow-up|1|||
17046476|NCT00258895|38190665|FG000|Overall Study|Protocol Violation|6|||
17046477|NCT00258895|38190666|FG001|Overall Study|Protocol Violation|2|||
17046478|NCT00258895|38190665|FG000|Overall Study|Withdrawal by Subject|1|||
17046479|NCT00258895|38190666|FG001|Overall Study|Withdrawal by Subject|0|||
17046480|NCT00742625|38190672|FG000|Remission Induction|Progression|6|||
17046481|NCT00742625|38190672|FG000|Remission Induction|Failed induction|8|||
17046482|NCT00742625|38190672|FG000|Remission Induction|Adverse Event|3|||
17046483|NCT00742625|38190672|FG000|Remission Induction|Death|10|||
17046484|NCT00742625|38190672|FG000|Remission Induction|Refusal|5|||
17046485|NCT00742625|38190672|FG000|Remission Induction|Non protocol treatment|17|||
17046486|NCT00742625|38190672|FG000|Remission Induction|Other, not specified|5|||
17046487|NCT00742625|38190672|FG000|Consolidation|Progression|5|||
17046488|NCT00742625|38190672|FG000|Consolidation|Adverse Event|1|||
17046489|NCT00742625|38190672|FG000|Consolidation|Death|1|||
16780581|NCT02597049|37719739|FG002|Overall Study|Lost to Follow-up|2|||
16780582|NCT02597049|37719737|FG000|Overall Study|Withdrawal by Subject|2|||
16780583|NCT02597049|37719738|FG001|Overall Study|Withdrawal by Subject|2|||
16780584|NCT02597049|37719739|FG002|Overall Study|Withdrawal by Subject|1|||
16780585|NCT02597049|37719737|FG000|Overall Study|Adverse Event|2|||
16780586|NCT02597049|37719738|FG001|Overall Study|Adverse Event|0|||
16780587|NCT02597049|37719739|FG002|Overall Study|Adverse Event|0|||
16780588|NCT02597049|37719737|FG000|Overall Study|Death|2|||
17046490|NCT00742625|38190672|FG000|Consolidation|Refused|1|||
17046491|NCT00742625|38190672|FG000|Consolidation|Non protocol therapy|13|||
17046492|NCT00618618|38190683|FG000|Overall Study|Patient Request|0|||
17046493|NCT00618618|38190684|FG001|Overall Study|Patient Request|0|||
17046494|NCT00618618|38190685|FG002|Overall Study|Patient Request|2|||
16780589|NCT02597049|37719738|FG001|Overall Study|Death|0|||
16780590|NCT02597049|37719739|FG002|Overall Study|Death|0|||
17046495|NCT00618618|38190686|FG003|Overall Study|Patient Request|0|||
17046496|NCT00618618|38190683|FG000|Overall Study|Inability to Complete Study Procedures|0|||
16780591|NCT02597049|37719737|FG000|Overall Study|Noncompliant with Study Visits|1|||
16780592|NCT02597049|37719738|FG001|Overall Study|Noncompliant with Study Visits|0|||
16780593|NCT02597049|37719739|FG002|Overall Study|Noncompliant with Study Visits|0|||
16780594|NCT02594163|37719749|FG000|Treatment Period|Progressive disease|2|||
16780595|NCT02594163|37719750|FG001|Treatment Period|Progressive disease|3|||
16780596|NCT02594163|37719749|FG000|Treatment Period|Adverse Event|1|||
16780597|NCT02594163|37719750|FG001|Treatment Period|Adverse Event|5|||
16780598|NCT02594163|37719749|FG000|Treatment Period|Physician Decision|1|||
16780599|NCT02594163|37719750|FG001|Treatment Period|Physician Decision|3|||
16780600|NCT02594163|37719749|FG000|Treatment Period|Study termination by sponsor|2|||
16780601|NCT02594163|37719750|FG001|Treatment Period|Study termination by sponsor|1|||
16780602|NCT02594163|37719749|FG000|Treatment Period|Other, Non-AE|1|||
16780603|NCT02594163|37719750|FG001|Treatment Period|Other, Non-AE|0|||
16780604|NCT02594163|37719749|FG000|Follow-up Period|Withdrawal by Subject|0|||
16780605|NCT02594163|37719750|FG001|Follow-up Period|Withdrawal by Subject|1|||
16780606|NCT02594163|37719749|FG000|Follow-up Period|Study Termination by Sponsor|6|||
16780607|NCT02594163|37719750|FG001|Follow-up Period|Study Termination by Sponsor|4|||
16780608|NCT02594163|37719749|FG000|Follow-up Period|Lost to Follow-up|1|||
16780609|NCT02594163|37719750|FG001|Follow-up Period|Lost to Follow-up|0|||
16780610|NCT02594163|37719749|FG000|Follow-up Period|Death|2|||
16780611|NCT02594163|37719750|FG001|Follow-up Period|Death|5|||
16780612|NCT02594163|37719749|FG000|Follow-up Period|Adverse Event|0|||
16780613|NCT02594163|37719750|FG001|Follow-up Period|Adverse Event|1|||
16780614|NCT02594163|37719749|FG000|Follow-up Period|Progressive Disease|2|||
16780615|NCT02594163|37719750|FG001|Follow-up Period|Progressive Disease|0|||
16780616|NCT02594163|37719749|FG000|Follow-up Period|Physician Decision|0|||
16780617|NCT02594163|37719750|FG001|Follow-up Period|Physician Decision|1|||
16780618|NCT02712983|37719765|FG000|Treatment Phase|Adverse Event|3|||
16780619|NCT02712983|37719766|FG001|Treatment Phase|Adverse Event|1|||
16780620|NCT02712983|37719767|FG002|Treatment Phase|Adverse Event|1|||
16780621|NCT02712983|37719768|FG003|Treatment Phase|Adverse Event|4|||
16780622|NCT02712983|37719769|FG004|Treatment Phase|Adverse Event|3|||
16780623|NCT02712983|37719770|FG005|Treatment Phase|Adverse Event|0|||
16780624|NCT02712983|37719771|FG006|Treatment Phase|Adverse Event|6|||
16780625|NCT02712983|37719772|FG007|Treatment Phase|Adverse Event|6|||
16780626|NCT02712983|37719773|FG008|Treatment Phase|Adverse Event|1|||
16780627|NCT02712983|37719765|FG000|Treatment Phase|Protocol Deviation|0|||
16780628|NCT02712983|37719766|FG001|Treatment Phase|Protocol Deviation|0|||
16780629|NCT02712983|37719767|FG002|Treatment Phase|Protocol Deviation|0|||
16780630|NCT02712983|37719768|FG003|Treatment Phase|Protocol Deviation|2|||
16780631|NCT02712983|37719769|FG004|Treatment Phase|Protocol Deviation|0|||
16780632|NCT02712983|37719770|FG005|Treatment Phase|Protocol Deviation|0|||
16780633|NCT02712983|37719771|FG006|Treatment Phase|Protocol Deviation|1|||
16780634|NCT02712983|37719772|FG007|Treatment Phase|Protocol Deviation|0|||
16780635|NCT02712983|37719773|FG008|Treatment Phase|Protocol Deviation|0|||
16780636|NCT02712983|37719765|FG000|Treatment Phase|Technical Problems|0|||
16780637|NCT02712983|37719766|FG001|Treatment Phase|Technical Problems|0|||
16780638|NCT02712983|37719767|FG002|Treatment Phase|Technical Problems|0|||
16780639|NCT02712983|37719768|FG003|Treatment Phase|Technical Problems|0|||
16780640|NCT02712983|37719769|FG004|Treatment Phase|Technical Problems|0|||
16780641|NCT02712983|37719770|FG005|Treatment Phase|Technical Problems|0|||
16780642|NCT02712983|37719771|FG006|Treatment Phase|Technical Problems|1|||
16780643|NCT02712983|37719772|FG007|Treatment Phase|Technical Problems|0|||
16780644|NCT02712983|37719773|FG008|Treatment Phase|Technical Problems|0|||
16780645|NCT02712983|37719765|FG000|Treatment Phase|Physician Decision|0|||
16780646|NCT02712983|37719766|FG001|Treatment Phase|Physician Decision|0|||
16780647|NCT02712983|37719767|FG002|Treatment Phase|Physician Decision|0|||
16780648|NCT02712983|37719768|FG003|Treatment Phase|Physician Decision|0|||
16780649|NCT02712983|37719769|FG004|Treatment Phase|Physician Decision|0|||
16780650|NCT02712983|37719770|FG005|Treatment Phase|Physician Decision|0|||
16780651|NCT02712983|37719771|FG006|Treatment Phase|Physician Decision|0|||
16780652|NCT02712983|37719772|FG007|Treatment Phase|Physician Decision|1|||
16780653|NCT02712983|37719773|FG008|Treatment Phase|Physician Decision|1|||
16780654|NCT02712983|37719765|FG000|Treatment Phase|Subject Decision|2|||
16780655|NCT02712983|37719766|FG001|Treatment Phase|Subject Decision|0|||
16780656|NCT02712983|37719767|FG002|Treatment Phase|Subject Decision|0|||
16780657|NCT02712983|37719768|FG003|Treatment Phase|Subject Decision|2|||
16780658|NCT02712983|37719769|FG004|Treatment Phase|Subject Decision|1|||
16780659|NCT02712983|37719770|FG005|Treatment Phase|Subject Decision|0|||
16780660|NCT02712983|37719771|FG006|Treatment Phase|Subject Decision|1|||
16780661|NCT02712983|37719772|FG007|Treatment Phase|Subject Decision|2|||
16780662|NCT02712983|37719773|FG008|Treatment Phase|Subject Decision|0|||
16780663|NCT02712983|37719765|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16780664|NCT02712983|37719766|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
16780665|NCT02712983|37719767|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16780666|NCT02712983|37719768|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16780667|NCT02712983|37719769|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16780668|NCT02712983|37719770|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16780669|NCT02712983|37719771|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
16780670|NCT02712983|37719772|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
16780671|NCT02712983|37719773|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16780672|NCT02712983|37719765|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16780673|NCT02712983|37719766|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16780674|NCT02712983|37719767|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16780675|NCT02712983|37719768|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
16780676|NCT02712983|37719769|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16780677|NCT02712983|37719770|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16780678|NCT02712983|37719771|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16780679|NCT02712983|37719772|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16780680|NCT02712983|37719773|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16780681|NCT02712983|37719765|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16780682|NCT02712983|37719766|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16780683|NCT02712983|37719767|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16780684|NCT02712983|37719768|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16780685|NCT02712983|37719769|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
16780686|NCT02712983|37719770|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
16780687|NCT02712983|37719771|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
16780688|NCT02712983|37719772|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
16780689|NCT02712983|37719773|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16780690|NCT02596971|37719796|FG000|Overall Study|Death|5|||
16780691|NCT02596971|37719797|FG001|Overall Study|Death|1|||
16780692|NCT02596971|37719798|FG002|Overall Study|Death|5|||
16780693|NCT02596971|37719796|FG000|Overall Study|Withdrawal by Subject|5|||
16780694|NCT02596971|37719797|FG001|Overall Study|Withdrawal by Subject|1|||
16780695|NCT02596971|37719798|FG002|Overall Study|Withdrawal by Subject|4|||
16780696|NCT02593773|37719809|FG000|Overall Study|Voluntary Withdrawal|3|||
16780697|NCT02593773|37719809|FG000|Overall Study|Study Terminated by Sponsor|31|||
16780698|NCT02593773|37719809|FG000|Overall Study|Death|1|||
16780699|NCT02593539|37719813|FG000|Overall Study|Adverse Event|1|||
16780700|NCT00919763|37719822|FG000|Overall Study|Adverse Event|7|||
16780701|NCT00919763|37719823|FG001|Overall Study|Adverse Event|1|||
16780702|NCT00919763|37719822|FG000|Overall Study|Lost to Follow-up|1|||
16780703|NCT00919763|37719823|FG001|Overall Study|Lost to Follow-up|0|||
16780704|NCT00919763|37719822|FG000|Overall Study|Protocol Violation|1|||
16780705|NCT00919763|37719823|FG001|Overall Study|Protocol Violation|1|||
16780706|NCT00919763|37719822|FG000|Overall Study|Withdrawal by Subject|3|||
16780707|NCT00919763|37719823|FG001|Overall Study|Withdrawal by Subject|1|||
16780708|NCT00919763|37719822|FG000|Overall Study|Non-compliance|0|||
16780709|NCT00919763|37719823|FG001|Overall Study|Non-compliance|1|||
16780710|NCT02593305|37719841|FG000|Post 1|Comparison only group. No intervention.|0|||
16780711|NCT02593305|37719842|FG001|Post 1|Comparison only group. No intervention.|0|||
16780712|NCT02593305|37719843|FG002|Post 1|Comparison only group. No intervention.|10|||
16780713|NCT02593149|37719854|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
16780714|NCT02593149|37719855|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
16780715|NCT02593149|37719854|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
16780716|NCT02593149|37719855|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
16780717|NCT02177812|37719870|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16780718|NCT02177812|37719871|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16780719|NCT02177812|37719872|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16780720|NCT02177812|37719873|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16780721|NCT02177812|37719874|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16780722|NCT02177812|37719875|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
16780723|NCT02177812|37719876|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
16780724|NCT02177812|37719877|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
16780725|NCT02177812|37719878|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16780726|NCT02177812|37719870|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16780727|NCT02177812|37719871|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16780728|NCT02177812|37719872|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16780729|NCT02177812|37719873|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16780730|NCT02177812|37719874|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16780731|NCT02177812|37719875|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
16780732|NCT02177812|37719876|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
16780733|NCT02177812|37719877|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16780734|NCT02177812|37719878|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16780735|NCT02177812|37719870|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
16780736|NCT02177812|37719871|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
16780737|NCT02177812|37719872|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
16780738|NCT02177812|37719873|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
16780739|NCT02177812|37719874|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
16780740|NCT02177812|37719875|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
16780741|NCT02177812|37719876|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
16780742|NCT02177812|37719877|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
16780743|NCT02177812|37719878|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
16780744|NCT01626352|37719922|FG000|Overall Study|Disease Progression|3|||
16780745|NCT01626352|37719922|FG000|Overall Study|Intercurrent Illness|2|||
16780746|NCT01626352|37719922|FG000|Overall Study|Death|2|||
16780747|NCT01626352|37719922|FG000|Overall Study|Withdrawal by Subject|1|||
16780748|NCT01626352|37719922|FG000|Overall Study|Non-Compliance|1|||
16780749|NCT01626352|37719922|FG000|Overall Study|Never Treated|1|||
16780750|NCT01626118|37719933|FG000|Overall Study|Lack of Efficacy|1|||
16780751|NCT01626118|37719934|FG001|Overall Study|Lack of Efficacy|0|||
16780752|NCT01626118|37719935|FG002|Overall Study|Lack of Efficacy|1|||
16780753|NCT01626118|37719936|FG003|Overall Study|Lack of Efficacy|3|||
16780754|NCT01626118|37719933|FG000|Overall Study|Lost to Follow-up|1|||
16780755|NCT01626118|37719934|FG001|Overall Study|Lost to Follow-up|0|||
16780756|NCT01626118|37719935|FG002|Overall Study|Lost to Follow-up|0|||
16780757|NCT01626118|37719936|FG003|Overall Study|Lost to Follow-up|0|||
16780758|NCT01626118|37719933|FG000|Overall Study|Adverse Event|0|||
16780759|NCT01626118|37719934|FG001|Overall Study|Adverse Event|1|||
16780760|NCT01626118|37719935|FG002|Overall Study|Adverse Event|1|||
16780761|NCT01626118|37719936|FG003|Overall Study|Adverse Event|0|||
16780762|NCT01626118|37719933|FG000|Overall Study|Investigator Decision|0|||
16780763|NCT01626118|37719934|FG001|Overall Study|Investigator Decision|1|||
16780764|NCT01626118|37719935|FG002|Overall Study|Investigator Decision|0|||
16780765|NCT01626118|37719936|FG003|Overall Study|Investigator Decision|0|||
16780766|NCT02152384|37719946|FG000|Period 1|Withdrawal by Subject|0|||
16780767|NCT02152384|37719947|FG001|Period 1|Withdrawal by Subject|1|||
16780768|NCT02152384|37719946|FG000|Period 1|Adverse Event|1|||
16780769|NCT02152384|37719947|FG001|Period 1|Adverse Event|1|||
16780770|NCT02177266|37719959|FG000|Overall Study|Adverse Event|0|||
16780771|NCT02177266|37719960|FG001|Overall Study|Adverse Event|1|||
16780772|NCT02177266|37719959|FG000|Overall Study|Withdrawal by Subject|1|||
17046497|NCT00618618|38190684|FG001|Overall Study|Inability to Complete Study Procedures|1|||
16780773|NCT02177266|37719960|FG001|Overall Study|Withdrawal by Subject|0|||
16780774|NCT02177032|37719970|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
16780775|NCT02177032|37719971|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
16780776|NCT02177032|37719972|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
16780777|NCT02177032|37719973|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
16780778|NCT02177032|37719970|FG000|Overall Study|Lost to Follow-up|0|||
17046498|NCT00618618|38190685|FG002|Overall Study|Inability to Complete Study Procedures|0|||
17046499|NCT00618618|38190686|FG003|Overall Study|Inability to Complete Study Procedures|0|||
16780779|NCT02177032|37719971|FG001|Overall Study|Lost to Follow-up|2|||
16780780|NCT02177032|37719972|FG002|Overall Study|Lost to Follow-up|0|||
16780781|NCT02177032|37719973|FG003|Overall Study|Lost to Follow-up|0|||
16780782|NCT02177032|37719970|FG000|Overall Study|OTHER|2|||
16780783|NCT02177032|37719971|FG001|Overall Study|OTHER|0|||
16780784|NCT02177032|37719972|FG002|Overall Study|OTHER|1|||
16780785|NCT02177032|37719973|FG003|Overall Study|OTHER|0|||
16780786|NCT02177032|37719970|FG000|Overall Study|Withdrawal by Subject|1|||
16780787|NCT02177032|37719971|FG001|Overall Study|Withdrawal by Subject|0|||
16780788|NCT02177032|37719972|FG002|Overall Study|Withdrawal by Subject|1|||
16780789|NCT02177032|37719973|FG003|Overall Study|Withdrawal by Subject|0|||
16780790|NCT02116972|37719997|FG000|Overall Study|Adverse Event|4|||
16780791|NCT02116972|37719998|FG001|Overall Study|Adverse Event|4|||
16780792|NCT02116972|37719999|FG002|Overall Study|Adverse Event|1|||
16780793|NCT02116972|37719997|FG000|Overall Study|Withdrawal by Subject|1|||
16780794|NCT02116972|37719998|FG001|Overall Study|Withdrawal by Subject|1|||
16780795|NCT02116972|37719999|FG002|Overall Study|Withdrawal by Subject|5|||
16780796|NCT02116972|37719997|FG000|Overall Study|Protocol Violation|1|||
16780797|NCT02116972|37719998|FG001|Overall Study|Protocol Violation|0|||
16780798|NCT02116972|37719999|FG002|Overall Study|Protocol Violation|1|||
16780799|NCT02116972|37719997|FG000|Overall Study|Lost to Follow-up|4|||
16780800|NCT02116972|37719998|FG001|Overall Study|Lost to Follow-up|3|||
16780801|NCT02116972|37719999|FG002|Overall Study|Lost to Follow-up|1|||
16780802|NCT02116972|37719997|FG000|Overall Study|Lack of Efficacy|6|||
16780803|NCT02116972|37719998|FG001|Overall Study|Lack of Efficacy|6|||
16780804|NCT02116972|37719999|FG002|Overall Study|Lack of Efficacy|5|||
16780805|NCT02116972|37719997|FG000|Overall Study|scheduling conflicts and relocation|3|||
16780806|NCT02116972|37719998|FG001|Overall Study|scheduling conflicts and relocation|3|||
16780807|NCT02116972|37719999|FG002|Overall Study|scheduling conflicts and relocation|6|||
16780808|NCT02176642|37720011|FG000|Overall Study|Withdrawal by Subject|0|||
16780809|NCT02176642|37720012|FG001|Overall Study|Withdrawal by Subject|1|||
16780810|NCT02116660|37720020|FG000|Overall Study|Deteriorating renal function|0|||
16780811|NCT02116660|37720021|FG001|Overall Study|Deteriorating renal function|1|||
16780812|NCT02116660|37720020|FG000|Overall Study|Adverse Event|1|||
16780813|NCT02116660|37720021|FG001|Overall Study|Adverse Event|1|||
16780814|NCT02116660|37720020|FG000|Overall Study|Withdrawal by Subject|0|||
16780815|NCT02116660|37720021|FG001|Overall Study|Withdrawal by Subject|2|||
16780816|NCT02116660|37720020|FG000|Overall Study|Organization reason|1|||
16780817|NCT02116660|37720021|FG001|Overall Study|Organization reason|0|||
16780818|NCT02589405|37720029|FG000|Overall Study|Adverse Event|3|||
16780819|NCT02589405|37720029|FG000|Overall Study|Withdrawal by Subject|1|||
16780820|NCT02176018|37720035|FG000|Overall Study|Adverse Event|0|||
16780821|NCT02176018|37720036|FG001|Overall Study|Adverse Event|2|||
16780822|NCT02176018|37720035|FG000|Overall Study|Lost to Follow-up|3|||
16780823|NCT02176018|37720036|FG001|Overall Study|Lost to Follow-up|1|||
16780824|NCT02176018|37720035|FG000|Overall Study|Protocol Violation|1|||
16780825|NCT02176018|37720036|FG001|Overall Study|Protocol Violation|1|||
16780826|NCT02176018|37720035|FG000|Overall Study|Withdrawal by Subject|1|||
16780827|NCT02176018|37720036|FG001|Overall Study|Withdrawal by Subject|2|||
16780828|NCT02116582|37720042|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
16780829|NCT02116582|37720042|FG000|Overall Study|Adverse Event|22|||
16780830|NCT02116582|37720042|FG000|Overall Study|Death|9|||
16780831|NCT02116582|37720042|FG000|Overall Study|Progressive Disease|148|||
16780832|NCT02116582|37720042|FG000|Overall Study|Protocol Violation|3|||
16780833|NCT02116582|37720042|FG000|Overall Study|Withdrawal by Subject|8|||
16780834|NCT02116582|37720042|FG000|Overall Study|Other: Miscellaneous|11|||
16780835|NCT02116582|37720042|FG000|Overall Study|Lost to Follow-up|1|||
16780836|NCT02116582|37720042|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
16780837|NCT02589639|37720049|FG000|Overall Study|Lost to Follow-up|1|||
16780838|NCT02589639|37720050|FG001|Overall Study|Lost to Follow-up|0|||
16780839|NCT02589639|37720051|FG002|Overall Study|Lost to Follow-up|0|||
16780840|NCT02589639|37720049|FG000|Overall Study|Protocol Violation|1|||
16780841|NCT02589639|37720050|FG001|Overall Study|Protocol Violation|0|||
16780842|NCT02589639|37720051|FG002|Overall Study|Protocol Violation|0|||
16780843|NCT02589639|37720049|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
16780844|NCT02589639|37720050|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
16780845|NCT02589639|37720051|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
16780846|NCT02589639|37720049|FG000|Overall Study|Adverse Event|4|||
16780847|NCT02589639|37720050|FG001|Overall Study|Adverse Event|5|||
16780848|NCT02589639|37720051|FG002|Overall Study|Adverse Event|3|||
16780849|NCT02589639|37720049|FG000|Overall Study|Other reason than specified above|1|||
16780850|NCT02589639|37720050|FG001|Overall Study|Other reason than specified above|2|||
16780851|NCT02589639|37720051|FG002|Overall Study|Other reason than specified above|1|||
16780852|NCT02589639|37720049|FG000|Overall Study|Not Treated|0|||
16780853|NCT02589639|37720050|FG001|Overall Study|Not Treated|3|||
16780854|NCT02589639|37720051|FG002|Overall Study|Not Treated|0|||
16780855|NCT02151682|37720061|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16780856|NCT02151682|37720062|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
16780857|NCT02151682|37720063|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16780858|NCT02151682|37720064|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16780859|NCT02151682|37720065|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16780860|NCT02151682|37720066|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16780861|NCT02151682|37720061|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16780862|NCT02151682|37720062|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
16780863|NCT02151682|37720063|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16780864|NCT02151682|37720064|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16780865|NCT02151682|37720065|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16780866|NCT02151682|37720066|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16780867|NCT02151682|37720061|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16780868|NCT02151682|37720062|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
16780869|NCT02151682|37720063|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16780870|NCT02151682|37720064|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16780871|NCT02151682|37720065|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16780872|NCT02151682|37720066|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16780873|NCT02151682|37720061|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
16780874|NCT02151682|37720062|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
16780875|NCT02151682|37720063|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
16780876|NCT02151682|37720064|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
16780877|NCT02151682|37720065|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
16780878|NCT02151682|37720066|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
17046500|NCT00618618|38190683|FG000|Overall Study|Lost to Follow-up|3|||
16780879|NCT02151682|37720061|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
16780880|NCT02151682|37720062|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16780881|NCT02151682|37720063|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16780882|NCT02151682|37720064|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16780883|NCT02151682|37720065|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16780884|NCT02151682|37720066|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16780885|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16780886|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16780887|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
16780888|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16780889|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16780890|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16780891|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
16780892|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
16780893|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
16780894|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
16780895|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
16780896|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
16780897|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
16780898|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
16780899|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
16780900|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
16780901|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
16780902|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
16780903|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16780904|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16780905|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
16780906|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16780907|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16780908|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16992412|NCT00717067|38136343|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
16992413|NCT00717067|38136344|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
16992414|NCT00717067|38136345|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
16992415|NCT00717067|38136346|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
17046501|NCT00618618|38190684|FG001|Overall Study|Lost to Follow-up|0|||
17046502|NCT00618618|38190685|FG002|Overall Study|Lost to Follow-up|0|||
17046503|NCT00618618|38190686|FG003|Overall Study|Lost to Follow-up|1|||
17046504|NCT00618618|38190683|FG000|Overall Study|Non-compliance|1|||
17046505|NCT00618618|38190684|FG001|Overall Study|Non-compliance|1|||
17046506|NCT00618618|38190685|FG002|Overall Study|Non-compliance|0|||
17046507|NCT00618618|38190686|FG003|Overall Study|Non-compliance|0|||
17046508|NCT00618618|38190683|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
17046509|NCT00618618|38190684|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
17046510|NCT00618618|38190685|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
16992416|NCT00802438|38136368|FG000|Overall Study|Screen Failure|20|||
16992417|NCT00802438|38136368|FG000|Overall Study|Withdrawal by Subject|7|||
16992418|NCT00802438|38136368|FG000|Overall Study|Physician Decision|1|||
16992419|NCT00588952|38136378|FG000|Overall Study|Adverse Event|0|||
16992420|NCT00588952|38136379|FG001|Overall Study|Adverse Event|2|||
16992421|NCT00588952|38136378|FG000|Overall Study|Withdrawal by Subject|3|||
16992422|NCT00588952|38136379|FG001|Overall Study|Withdrawal by Subject|5|||
16992423|NCT01021748|38136394|FG000|Overall Study|Adverse Event|2|||
16992424|NCT01021748|38136395|FG001|Overall Study|Adverse Event|1|||
16992425|NCT01021748|38136396|FG002|Overall Study|Adverse Event|2|||
16992426|NCT01021748|38136397|FG003|Overall Study|Adverse Event|0|||
16992427|NCT01021748|38136398|FG004|Overall Study|Adverse Event|2|||
16992428|NCT01021748|38136399|FG005|Overall Study|Adverse Event|0|||
16992429|NCT01021748|38136400|FG006|Overall Study|Adverse Event|1|||
16992430|NCT01021748|38136401|FG007|Overall Study|Adverse Event|0|||
16992431|NCT01021748|38136402|FG008|Overall Study|Adverse Event|7|||
16992432|NCT01021748|38136394|FG000|Overall Study|Physician Decision|1|||
16992433|NCT01021748|38136395|FG001|Overall Study|Physician Decision|0|||
16992434|NCT01021748|38136396|FG002|Overall Study|Physician Decision|1|||
16992435|NCT01021748|38136397|FG003|Overall Study|Physician Decision|1|||
16992436|NCT01021748|38136398|FG004|Overall Study|Physician Decision|0|||
16992437|NCT01021748|38136399|FG005|Overall Study|Physician Decision|0|||
16992438|NCT01021748|38136400|FG006|Overall Study|Physician Decision|1|||
16992439|NCT01021748|38136401|FG007|Overall Study|Physician Decision|1|||
16992440|NCT01021748|38136402|FG008|Overall Study|Physician Decision|2|||
16992441|NCT01021748|38136394|FG000|Overall Study|Progressive Disease|3|||
16992442|NCT01021748|38136395|FG001|Overall Study|Progressive Disease|3|||
16992443|NCT01021748|38136396|FG002|Overall Study|Progressive Disease|4|||
16992444|NCT01021748|38136397|FG003|Overall Study|Progressive Disease|6|||
17046511|NCT00618618|38190686|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
17046512|NCT00618618|38190683|FG000|Overall Study|Death|0|||
17046513|NCT00618618|38190684|FG001|Overall Study|Death|1|||
17046514|NCT00618618|38190685|FG002|Overall Study|Death|0|||
17046515|NCT00618618|38190686|FG003|Overall Study|Death|0|||
17046516|NCT00246805|38190699|FG000|Phase 1|Lost to Follow-up|1|||
17046517|NCT00246805|38190700|FG001|Phase 1|Lost to Follow-up|0|||
17046518|NCT00519376|38190706|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046519|NCT00519376|38190707|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046520|NCT00519376|38190708|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046521|NCT00519376|38190709|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046522|NCT00519376|38190710|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046523|NCT00519376|38190711|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046524|NCT00519376|38190712|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046525|NCT00519376|38190713|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046526|NCT00519376|38190714|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046527|NCT00519376|38190715|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046528|NCT00519376|38190716|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046529|NCT00519376|38190717|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046530|NCT00519376|38190718|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
17046531|NCT00519376|38190719|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046532|NCT00519376|38190720|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046533|NCT00519376|38190721|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
17046534|NCT00519376|38190706|FG000|Treatment Period 4|Lost to Follow-up|0|||
17046535|NCT00519376|38190707|FG001|Treatment Period 4|Lost to Follow-up|0|||
17046536|NCT00519376|38190708|FG002|Treatment Period 4|Lost to Follow-up|1|||
17141866|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141867|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17141868|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
17046537|NCT00519376|38190709|FG003|Treatment Period 4|Lost to Follow-up|0|||
17046538|NCT00519376|38190710|FG004|Treatment Period 4|Lost to Follow-up|0|||
17046539|NCT00519376|38190711|FG005|Treatment Period 4|Lost to Follow-up|0|||
17046540|NCT00519376|38190712|FG006|Treatment Period 4|Lost to Follow-up|0|||
17046541|NCT00519376|38190713|FG007|Treatment Period 4|Lost to Follow-up|0|||
17046542|NCT00519376|38190714|FG008|Treatment Period 4|Lost to Follow-up|0|||
17046543|NCT00519376|38190715|FG009|Treatment Period 4|Lost to Follow-up|0|||
17046544|NCT00519376|38190716|FG010|Treatment Period 4|Lost to Follow-up|0|||
17046545|NCT00519376|38190717|FG011|Treatment Period 4|Lost to Follow-up|0|||
17046546|NCT00519376|38190718|FG012|Treatment Period 4|Lost to Follow-up|0|||
17046547|NCT00519376|38190719|FG013|Treatment Period 4|Lost to Follow-up|0|||
17046548|NCT00519376|38190720|FG014|Treatment Period 4|Lost to Follow-up|0|||
17046549|NCT00519376|38190721|FG015|Treatment Period 4|Lost to Follow-up|0|||
17046550|NCT00745121|38190735|FG000|Overall Study|Death|3|||
17046551|NCT00745121|38190736|FG001|Overall Study|Death|0|||
17046552|NCT00745121|38190735|FG000|Overall Study|Adverse Event|1|||
17046553|NCT00745121|38190736|FG001|Overall Study|Adverse Event|0|||
17046554|NCT00745121|38190735|FG000|Overall Study|Lost to Follow-up|1|||
17046555|NCT00745121|38190736|FG001|Overall Study|Lost to Follow-up|0|||
17046556|NCT00745121|38190735|FG000|Overall Study|Withdrawal by Subject|4|||
17046557|NCT00745121|38190736|FG001|Overall Study|Withdrawal by Subject|2|||
17046558|NCT00740051|38190744|FG000|Overall Study|Lack of Efficacy|2|||
17046559|NCT00740051|38190745|FG001|Overall Study|Lack of Efficacy|5|||
17046560|NCT00740051|38190744|FG000|Overall Study|Adverse Event|1|||
17046561|NCT00740051|38190745|FG001|Overall Study|Adverse Event|4|||
17046562|NCT00740051|38190744|FG000|Overall Study|Protocol Violation|2|||
17046563|NCT00740051|38190745|FG001|Overall Study|Protocol Violation|6|||
17046564|NCT00740051|38190744|FG000|Overall Study|Lost to Follow-up|3|||
17046565|NCT00740051|38190745|FG001|Overall Study|Lost to Follow-up|8|||
17046566|NCT00740051|38190744|FG000|Overall Study|Withdrawal by Subject|6|||
17046567|NCT00740051|38190745|FG001|Overall Study|Withdrawal by Subject|8|||
17046568|NCT00740051|38190744|FG000|Overall Study|Other reason (not specified)|4|||
17046569|NCT00740051|38190745|FG001|Overall Study|Other reason (not specified)|1|||
17046570|NCT00518986|38190754|FG000|Overall Study|Adverse Event|12|||
17046571|NCT00518986|38190755|FG001|Overall Study|Adverse Event|7|||
17046572|NCT00518986|38190754|FG000|Overall Study|Lack of Efficacy|0|||
17046573|NCT00518986|38190755|FG001|Overall Study|Lack of Efficacy|2|||
17046574|NCT00518986|38190754|FG000|Overall Study|Lost to Follow-up|3|||
17046575|NCT00518986|38190755|FG001|Overall Study|Lost to Follow-up|2|||
17046576|NCT00518986|38190754|FG000|Overall Study|Physician Decision|0|||
17046577|NCT00518986|38190755|FG001|Overall Study|Physician Decision|3|||
17046578|NCT00518986|38190754|FG000|Overall Study|Protocol Violation|5|||
17046579|NCT00518986|38190755|FG001|Overall Study|Protocol Violation|7|||
17046580|NCT00518986|38190754|FG000|Overall Study|Withdrawal by Subject|4|||
17046581|NCT00518986|38190755|FG001|Overall Study|Withdrawal by Subject|4|||
17046582|NCT00518986|38190754|FG000|Overall Study|Non-Specific|2|||
17046583|NCT00518986|38190755|FG001|Overall Study|Non-Specific|1|||
17046584|NCT00742391|38190763|FG000|Overall Study|Adverse Event|2|||
17046585|NCT00742391|38190764|FG001|Overall Study|Adverse Event|1|||
17046586|NCT00742391|38190763|FG000|Overall Study|Lost to Follow-up|1|||
17046587|NCT00742391|38190764|FG001|Overall Study|Lost to Follow-up|0|||
17046588|NCT00742391|38190763|FG000|Overall Study|Protocol Violation|1|||
17046589|NCT00742391|38190764|FG001|Overall Study|Protocol Violation|0|||
17046590|NCT00742235|38190772|FG000|Overall Study|Lost to Follow-up|0|||
17046591|NCT00742235|38190773|FG001|Overall Study|Lost to Follow-up|31|||
17046592|NCT00742079|38190781|FG000|Overall Study|Lost to Follow-up|0|||
17046593|NCT00742079|38190782|FG001|Overall Study|Lost to Follow-up|1|||
17046594|NCT00662792|38190788|FG000|Period 1|Personal Reasons|0|||
17046595|NCT00662792|38190789|FG001|Period 1|Personal Reasons|0|||
17046596|NCT00662792|38190790|FG002|Period 1|Personal Reasons|1|||
17046597|NCT00662792|38190791|FG003|Period 1|Personal Reasons|0|||
17046598|NCT00662792|38190788|FG000|Period 1|Refused continuing medication|0|||
17046599|NCT00662792|38190789|FG001|Period 1|Refused continuing medication|1|||
17046600|NCT00662792|38190790|FG002|Period 1|Refused continuing medication|1|||
17046601|NCT00662792|38190791|FG003|Period 1|Refused continuing medication|0|||
17046602|NCT00662792|38190788|FG000|Period 1|Lost to Follow-up|1|||
17046603|NCT00662792|38190789|FG001|Period 1|Lost to Follow-up|0|||
17046604|NCT00662792|38190790|FG002|Period 1|Lost to Follow-up|0|||
17046605|NCT00662792|38190791|FG003|Period 1|Lost to Follow-up|0|||
17046606|NCT00662792|38190788|FG000|Period 1|Other adverse event (AE)|0|||
17046607|NCT00662792|38190789|FG001|Period 1|Other adverse event (AE)|2|||
17046608|NCT00662792|38190790|FG002|Period 1|Other adverse event (AE)|0|||
17046609|NCT00662792|38190791|FG003|Period 1|Other adverse event (AE)|0|||
17046610|NCT00662792|38190788|FG000|Period 1|Worsening of disease under study (AE)|1|||
17046611|NCT00662792|38190789|FG001|Period 1|Worsening of disease under study (AE)|3|||
17046612|NCT00662792|38190790|FG002|Period 1|Worsening of disease under study (AE)|2|||
17046613|NCT00662792|38190791|FG003|Period 1|Worsening of disease under study (AE)|0|||
17046614|NCT00662792|38190788|FG000|Period 1|Not treated|0|||
17141869|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141870|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17046615|NCT00662792|38190789|FG001|Period 1|Not treated|1|||
17046616|NCT00662792|38190790|FG002|Period 1|Not treated|0|||
17046617|NCT00662792|38190791|FG003|Period 1|Not treated|0|||
17046618|NCT00662792|38190788|FG000|Period 2|Worsening of disease under study|1|||
17046619|NCT00662792|38190789|FG001|Period 2|Worsening of disease under study|0|||
17046620|NCT00662792|38190790|FG002|Period 2|Worsening of disease under study|0|||
17046621|NCT00662792|38190791|FG003|Period 2|Worsening of disease under study|3|||
17046622|NCT00662792|38190788|FG000|Period 3|Refused continuing medication|1|||
17046623|NCT00662792|38190789|FG001|Period 3|Refused continuing medication|0|||
17046624|NCT00662792|38190790|FG002|Period 3|Refused continuing medication|1|||
17046625|NCT00662792|38190791|FG003|Period 3|Refused continuing medication|0|||
17046626|NCT00662792|38190788|FG000|Period 3|Other adverse event (AE)|0|||
17046627|NCT00662792|38190789|FG001|Period 3|Other adverse event (AE)|0|||
17046628|NCT00662792|38190790|FG002|Period 3|Other adverse event (AE)|1|||
17046629|NCT00662792|38190791|FG003|Period 3|Other adverse event (AE)|1|||
17046630|NCT00662792|38190788|FG000|Period 4|Refused continuing medication|0|||
17046631|NCT00662792|38190789|FG001|Period 4|Refused continuing medication|1|||
17046632|NCT00662792|38190790|FG002|Period 4|Refused continuing medication|0|||
17046633|NCT00662792|38190791|FG003|Period 4|Refused continuing medication|0|||
17046634|NCT00662792|38190788|FG000|Period 4|Other adverse event (AE)|1|||
17046635|NCT00662792|38190789|FG001|Period 4|Other adverse event (AE)|0|||
17046636|NCT00662792|38190790|FG002|Period 4|Other adverse event (AE)|0|||
17046637|NCT00662792|38190791|FG003|Period 4|Other adverse event (AE)|0|||
17046638|NCT00662792|38190788|FG000|Period 4|Worsening of disease under study (AE)|0|||
17046639|NCT00662792|38190789|FG001|Period 4|Worsening of disease under study (AE)|0|||
17046640|NCT00662792|38190790|FG002|Period 4|Worsening of disease under study (AE)|0|||
17046641|NCT00662792|38190791|FG003|Period 4|Worsening of disease under study (AE)|1|||
17046642|NCT00742001|38190806|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
17046643|NCT00742001|38190807|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
17046644|NCT00742001|38190808|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
17046645|NCT00616902|38190821|FG000|Overall Study|Termination of study|6|||
17046646|NCT00616902|38190822|FG001|Overall Study|Termination of study|6|||
17046647|NCT00741611|38190831|FG000|Overall Study|Death|0|||
17046648|NCT00741611|38190832|FG001|Overall Study|Death|0|||
17046649|NCT00741611|38190833|FG002|Overall Study|Death|1|||
17046650|NCT00741611|38190831|FG000|Overall Study|Withdrawal by Subject|0|||
17046651|NCT00741611|38190832|FG001|Overall Study|Withdrawal by Subject|2|||
17046652|NCT00741611|38190833|FG002|Overall Study|Withdrawal by Subject|2|||
17046653|NCT00662558|38190844|FG000|Overall Study|Adverse Event|21|||
17046654|NCT00662558|38190845|FG001|Overall Study|Adverse Event|59|||
17046655|NCT00662558|38190844|FG000|Overall Study|Lack of Efficacy|4|||
17046656|NCT00662558|38190845|FG001|Overall Study|Lack of Efficacy|7|||
17046657|NCT00662558|38190844|FG000|Overall Study|Lost to Follow-up|13|||
17046658|NCT00662558|38190845|FG001|Overall Study|Lost to Follow-up|10|||
17046659|NCT00662558|38190844|FG000|Overall Study|Other|9|||
17046660|NCT00662558|38190845|FG001|Overall Study|Other|14|||
17046661|NCT00662558|38190844|FG000|Overall Study|Withdrawal by Subject|7|||
17046662|NCT00662558|38190845|FG001|Overall Study|Withdrawal by Subject|12|||
17141871|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141872|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141873|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141874|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17046663|NCT00662558|38190844|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
17046664|NCT00662558|38190845|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
17046665|NCT00739973|38190860|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
17046666|NCT00739973|38190861|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
17046667|NCT00739973|38190862|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
17046668|NCT00739973|38190863|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
17141875|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
17141876|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141877|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141878|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17189043|NCT02503540|38342011|FG000|Overall Study|Withdrawal by Subject|1|||
17046669|NCT00739973|38190864|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
17046670|NCT00739973|38190865|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
17046671|NCT00739973|38190866|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
17046672|NCT00739973|38190867|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
17046673|NCT00739973|38190868|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
17046674|NCT00739973|38190860|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
17046675|NCT00739973|38190861|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
17046676|NCT00739973|38190862|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
17046677|NCT00739973|38190863|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
17046678|NCT00739973|38190864|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
17046679|NCT00739973|38190865|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
17046680|NCT00739973|38190866|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
17046681|NCT00739973|38190867|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
17046682|NCT00739973|38190868|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
17046683|NCT00739973|38190860|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
17046684|NCT00739973|38190861|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
17046685|NCT00739973|38190862|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
17046686|NCT00739973|38190863|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
17046687|NCT00739973|38190864|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
17046688|NCT00739973|38190865|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
17046689|NCT00739973|38190866|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
17046690|NCT00739973|38190867|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
17046691|NCT00739973|38190868|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
17046692|NCT00739973|38190860|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
17046693|NCT00739973|38190861|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
17046694|NCT00739973|38190862|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
17046695|NCT00739973|38190863|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
17046696|NCT00739973|38190864|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
17046697|NCT00739973|38190865|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
17046698|NCT00739973|38190866|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
17046699|NCT00739973|38190867|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
17046700|NCT00739973|38190868|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
17046701|NCT00739973|38190860|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
17046702|NCT00739973|38190861|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
17046703|NCT00739973|38190862|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
17046704|NCT00739973|38190863|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
17046705|NCT00739973|38190864|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
17046706|NCT00739973|38190865|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
17046707|NCT00739973|38190866|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
17046708|NCT00739973|38190867|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
17046709|NCT00739973|38190868|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
17046710|NCT00739973|38190860|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
17046711|NCT00739973|38190861|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
17046712|NCT00739973|38190862|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
17046713|NCT00739973|38190863|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
17046714|NCT00739973|38190864|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
17046715|NCT00739973|38190865|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
17046716|NCT00739973|38190866|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
17046717|NCT00739973|38190867|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
17046718|NCT00739973|38190868|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
17046719|NCT00739973|38190860|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
17046720|NCT00739973|38190861|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
17046721|NCT00739973|38190862|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
17046722|NCT00739973|38190863|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
17046723|NCT00739973|38190864|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
17046724|NCT00739973|38190865|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
17046725|NCT00739973|38190866|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
17046726|NCT00739973|38190867|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
17046727|NCT00739973|38190868|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
17046728|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
17046729|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
17046730|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
17046731|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
17046732|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
17046733|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
17046734|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
17046735|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
17046736|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
17046737|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
17046738|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
17046739|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
17046740|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
17046741|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
17046742|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
17046743|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
17046744|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
17046745|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
17141879|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141880|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141881|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141882|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141883|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141884|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
17141885|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141886|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141887|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141888|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141889|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141890|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141891|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141892|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
17141893|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
17141894|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
17046746|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
17046747|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
17046748|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
17046749|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
17046750|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
17046751|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
17046752|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
17141895|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141896|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141897|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141898|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141899|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141900|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
17141901|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141902|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141903|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141904|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141905|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141906|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141907|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141908|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
17141909|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141910|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141911|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141912|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141913|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141914|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141915|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141916|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
17141917|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141918|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141919|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141920|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141921|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141922|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141923|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141924|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17046753|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
17046754|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
17046755|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
17046756|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
17046757|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
17046758|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
16992445|NCT01021748|38136398|FG004|Overall Study|Progressive Disease|7|||
16992446|NCT01021748|38136399|FG005|Overall Study|Progressive Disease|3|||
16992447|NCT01021748|38136400|FG006|Overall Study|Progressive Disease|0|||
16992448|NCT01021748|38136401|FG007|Overall Study|Progressive Disease|5|||
16992449|NCT01021748|38136402|FG008|Overall Study|Progressive Disease|6|||
16992450|NCT01021748|38136394|FG000|Overall Study|Withdrawal by Subject|0|||
16992451|NCT01021748|38136395|FG001|Overall Study|Withdrawal by Subject|0|||
17046759|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
17046760|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
17141925|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
17141926|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141927|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141928|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141929|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141930|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141931|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141932|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
17141933|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141934|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141935|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141936|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141937|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141938|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141939|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141940|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141941|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141942|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
17141943|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16992452|NCT01021748|38136396|FG002|Overall Study|Withdrawal by Subject|0|||
16992453|NCT01021748|38136397|FG003|Overall Study|Withdrawal by Subject|0|||
16992454|NCT01021748|38136398|FG004|Overall Study|Withdrawal by Subject|0|||
16992455|NCT01021748|38136399|FG005|Overall Study|Withdrawal by Subject|0|||
17141944|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141945|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141946|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141947|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141948|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
17141949|NCT02891226|38284503|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141950|NCT02891226|38284504|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141951|NCT02891226|38284505|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141952|NCT02891226|38284506|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141953|NCT02891226|38284507|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141954|NCT02891226|38284508|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141955|NCT02891226|38284509|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141956|NCT02891226|38284510|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141957|NCT02891226|38284511|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141958|NCT02891226|38284512|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
17141959|NCT02891226|38284513|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141960|NCT02891226|38284514|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141961|NCT02891226|38284515|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141962|NCT02891226|38284516|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141963|NCT02891226|38284517|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141964|NCT02891226|38284518|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
17141965|NCT02891226|38284503|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141966|NCT02891226|38284504|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141967|NCT02891226|38284505|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141968|NCT02891226|38284506|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141969|NCT02891226|38284507|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141970|NCT02891226|38284508|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141971|NCT02891226|38284509|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141972|NCT02891226|38284510|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141973|NCT02891226|38284511|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141974|NCT02891226|38284512|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141975|NCT02891226|38284513|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
17141976|NCT02891226|38284514|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141977|NCT02891226|38284515|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141978|NCT02891226|38284516|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141979|NCT02891226|38284517|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141980|NCT02891226|38284518|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
17141981|NCT02891226|38284503|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141982|NCT02891226|38284504|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141983|NCT02891226|38284505|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141984|NCT02891226|38284506|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141985|NCT02891226|38284507|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141986|NCT02891226|38284508|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141987|NCT02891226|38284509|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141988|NCT02891226|38284510|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141989|NCT02891226|38284511|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141990|NCT02891226|38284512|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141991|NCT02891226|38284513|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
17141992|NCT02891226|38284514|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141993|NCT02891226|38284515|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141994|NCT02891226|38284516|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141995|NCT02891226|38284517|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141996|NCT02891226|38284518|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
17141997|NCT02891226|38284503|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17141998|NCT02891226|38284504|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17141999|NCT02891226|38284505|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142000|NCT02891226|38284506|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142001|NCT02891226|38284507|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142002|NCT02891226|38284508|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142003|NCT02891226|38284509|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142004|NCT02891226|38284510|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17046761|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
17046762|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
17046763|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
17046764|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
17046765|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
17046766|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
17142005|NCT02891226|38284511|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17046767|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
17046768|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
17046769|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
17046770|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
17046771|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
17046772|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
17046773|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
17046774|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
17046775|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
17046776|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
17046777|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
17046778|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
17046779|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
17046780|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
17046781|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
17046782|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
17046783|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
17046784|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
17046785|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
17046786|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
17046787|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
17046788|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
17046789|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
17046790|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
17046791|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
17046792|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
17046793|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
17046794|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
17046795|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
17046796|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
17046797|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
17046798|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
17046799|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
17046800|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
17046801|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
17046802|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
17046803|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
17046804|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
17046805|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
17046806|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
17046807|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
17046808|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
17046809|NCT00739973|38190860|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
17046810|NCT00739973|38190861|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
17046811|NCT00739973|38190862|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
17046812|NCT00739973|38190863|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
17046813|NCT00739973|38190864|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
17046814|NCT00739973|38190865|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
17046815|NCT00739973|38190866|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
17142006|NCT02891226|38284512|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142007|NCT02891226|38284513|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
17142008|NCT02891226|38284514|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16992456|NCT01021748|38136400|FG006|Overall Study|Withdrawal by Subject|1|||
16992457|NCT01021748|38136401|FG007|Overall Study|Withdrawal by Subject|0|||
16992458|NCT01021748|38136402|FG008|Overall Study|Withdrawal by Subject|1|||
16992459|NCT01021748|38136394|FG000|Overall Study|Not Treated|0|||
16992460|NCT01021748|38136395|FG001|Overall Study|Not Treated|1|||
16992461|NCT01021748|38136396|FG002|Overall Study|Not Treated|0|||
16992462|NCT01021748|38136397|FG003|Overall Study|Not Treated|0|||
16992463|NCT01021748|38136398|FG004|Overall Study|Not Treated|0|||
16992464|NCT01021748|38136399|FG005|Overall Study|Not Treated|0|||
16992465|NCT01021748|38136400|FG006|Overall Study|Not Treated|0|||
16992466|NCT01021748|38136401|FG007|Overall Study|Not Treated|0|||
17046816|NCT00739973|38190867|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
17046817|NCT00739973|38190868|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
17046818|NCT00510874|38190903|FG000|Overall Study|Withdrawal by Subject|1|||
17046819|NCT00510874|38190904|FG001|Overall Study|Withdrawal by Subject|1|||
17046820|NCT00510874|38190905|FG002|Overall Study|Withdrawal by Subject|0|||
17046821|NCT00510874|38190906|FG003|Overall Study|Withdrawal by Subject|0|||
17046822|NCT00510874|38190907|FG004|Overall Study|Withdrawal by Subject|3|||
17046823|NCT00510874|38190908|FG005|Overall Study|Withdrawal by Subject|0|||
17046824|NCT00510874|38190909|FG006|Overall Study|Withdrawal by Subject|0|||
17046825|NCT00510874|38190903|FG000|Overall Study|Lost to Follow-up|2|||
17046826|NCT00510874|38190904|FG001|Overall Study|Lost to Follow-up|3|||
17046827|NCT00510874|38190905|FG002|Overall Study|Lost to Follow-up|1|||
17046828|NCT00510874|38190906|FG003|Overall Study|Lost to Follow-up|3|||
17046829|NCT00510874|38190907|FG004|Overall Study|Lost to Follow-up|4|||
17046830|NCT00510874|38190908|FG005|Overall Study|Lost to Follow-up|0|||
17046831|NCT00510874|38190909|FG006|Overall Study|Lost to Follow-up|1|||
17046832|NCT00739661|38190928|FG000|Overall Study|Adverse Event|2|||
17046833|NCT00739661|38190929|FG001|Overall Study|Adverse Event|0|||
17046834|NCT00739661|38190928|FG000|Overall Study|Physician decision to withdraw patient|1|||
17046835|NCT00739661|38190929|FG001|Overall Study|Physician decision to withdraw patient|0|||
17046836|NCT00739661|38190928|FG000|Overall Study|Patient decision to withdraw|9|||
17046837|NCT00739661|38190929|FG001|Overall Study|Patient decision to withdraw|4|||
17046838|NCT00739661|38190928|FG000|Overall Study|Disease progression, radiographic|33|||
17046839|NCT00739661|38190929|FG001|Overall Study|Disease progression, radiographic|37|||
17046840|NCT00739661|38190928|FG000|Overall Study|Reason for discontinuation not available|1|||
17046841|NCT00739661|38190929|FG001|Overall Study|Reason for discontinuation not available|1|||
17046842|NCT00615030|38190935|FG000|Period I|Administrative problem|0|||
17046843|NCT00615030|38190936|FG001|Period I|Administrative problem|0|||
17046844|NCT00615030|38190937|FG002|Period I|Administrative problem|0|||
17046845|NCT00615030|38190938|FG003|Period I|Administrative problem|0|||
17046846|NCT00615030|38190939|FG004|Period I|Administrative problem|1|||
17046847|NCT00615030|38190940|FG005|Period I|Administrative problem|0|||
17046848|NCT00615030|38190941|FG006|Period I|Administrative problem|0|||
17046849|NCT00615030|38190942|FG007|Period I|Administrative problem|0|||
17046850|NCT00615030|38190943|FG008|Period I|Administrative problem|0|||
17046851|NCT00615030|38190944|FG009|Period I|Administrative problem|0|||
17046852|NCT00615030|38190945|FG010|Period I|Administrative problem|0|||
17046853|NCT00615030|38190946|FG011|Period I|Administrative problem|0|||
17046854|NCT00615030|38190935|FG000|Period I|Protocol deviation|1|||
17046855|NCT00615030|38190936|FG001|Period I|Protocol deviation|0|||
17046856|NCT00615030|38190937|FG002|Period I|Protocol deviation|0|||
17142009|NCT02891226|38284515|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142010|NCT02891226|38284516|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142011|NCT02891226|38284517|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17142012|NCT02891226|38284518|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
17046857|NCT00615030|38190938|FG003|Period I|Protocol deviation|0|||
17142013|NCT02891226|38284503|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16992467|NCT01021748|38136402|FG008|Overall Study|Not Treated|0|||
16992468|NCT00802360|38136426|FG000|Overall Study|Stimulation failure|4|||
16992469|NCT00802360|38136427|FG001|Overall Study|Stimulation failure|0|||
16992470|NCT00802360|38136428|FG002|Overall Study|Stimulation failure|3|||
16992471|NCT00802360|38136429|FG003|Overall Study|Stimulation failure|3|||
16992472|NCT00802360|38136426|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
16992473|NCT00802360|38136427|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
16992474|NCT00802360|38136428|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
16992475|NCT00802360|38136429|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
16992476|NCT00802360|38136426|FG000|Overall Study|Cycle cancelled|0|||
17046858|NCT00615030|38190939|FG004|Period I|Protocol deviation|0|||
17046859|NCT00615030|38190940|FG005|Period I|Protocol deviation|0|||
17046860|NCT00615030|38190941|FG006|Period I|Protocol deviation|0|||
17046861|NCT00615030|38190942|FG007|Period I|Protocol deviation|0|||
17046862|NCT00615030|38190943|FG008|Period I|Protocol deviation|0|||
17046863|NCT00615030|38190944|FG009|Period I|Protocol deviation|0|||
17046864|NCT00615030|38190945|FG010|Period I|Protocol deviation|0|||
17046865|NCT00615030|38190946|FG011|Period I|Protocol deviation|0|||
17046866|NCT00615030|38190935|FG000|Period I|Subject withdrew consent|0|||
17046867|NCT00615030|38190936|FG001|Period I|Subject withdrew consent|0|||
17046868|NCT00615030|38190937|FG002|Period I|Subject withdrew consent|0|||
17046869|NCT00615030|38190938|FG003|Period I|Subject withdrew consent|0|||
17046870|NCT00615030|38190939|FG004|Period I|Subject withdrew consent|0|||
17046871|NCT00615030|38190940|FG005|Period I|Subject withdrew consent|0|||
17046872|NCT00615030|38190941|FG006|Period I|Subject withdrew consent|0|||
17046873|NCT00615030|38190942|FG007|Period I|Subject withdrew consent|0|||
17046874|NCT00615030|38190943|FG008|Period I|Subject withdrew consent|1|||
17046875|NCT00615030|38190944|FG009|Period I|Subject withdrew consent|0|||
17046876|NCT00615030|38190945|FG010|Period I|Subject withdrew consent|1|||
17046877|NCT00615030|38190946|FG011|Period I|Subject withdrew consent|1|||
17046878|NCT00615030|38190935|FG000|Period I|Abnormal laboratory value(s)|0|||
17046879|NCT00615030|38190936|FG001|Period I|Abnormal laboratory value(s)|0|||
17046880|NCT00615030|38190937|FG002|Period I|Abnormal laboratory value(s)|0|||
17046881|NCT00615030|38190938|FG003|Period I|Abnormal laboratory value(s)|0|||
17046882|NCT00615030|38190939|FG004|Period I|Abnormal laboratory value(s)|0|||
17046883|NCT00615030|38190940|FG005|Period I|Abnormal laboratory value(s)|1|||
17046884|NCT00615030|38190941|FG006|Period I|Abnormal laboratory value(s)|0|||
17046885|NCT00615030|38190942|FG007|Period I|Abnormal laboratory value(s)|0|||
17046886|NCT00615030|38190943|FG008|Period I|Abnormal laboratory value(s)|0|||
17046887|NCT00615030|38190944|FG009|Period I|Abnormal laboratory value(s)|0|||
17046888|NCT00615030|38190945|FG010|Period I|Abnormal laboratory value(s)|0|||
17046889|NCT00615030|38190946|FG011|Period I|Abnormal laboratory value(s)|0|||
17046890|NCT00615030|38190935|FG000|Period II|Adverse Event|0|||
17046891|NCT00615030|38190936|FG001|Period II|Adverse Event|0|||
17046892|NCT00615030|38190937|FG002|Period II|Adverse Event|1|||
17046893|NCT00615030|38190938|FG003|Period II|Adverse Event|0|||
17046894|NCT00615030|38190939|FG004|Period II|Adverse Event|0|||
17046895|NCT00615030|38190940|FG005|Period II|Adverse Event|0|||
17046896|NCT00615030|38190941|FG006|Period II|Adverse Event|0|||
17046897|NCT00615030|38190942|FG007|Period II|Adverse Event|0|||
17046898|NCT00615030|38190943|FG008|Period II|Adverse Event|1|||
17046899|NCT00615030|38190944|FG009|Period II|Adverse Event|0|||
17046900|NCT00615030|38190945|FG010|Period II|Adverse Event|0|||
17142014|NCT02891226|38284504|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17046901|NCT00615030|38190946|FG011|Period II|Adverse Event|0|||
17046902|NCT00615030|38190935|FG000|Period II|Subject withdrew consent|0|||
17046903|NCT00615030|38190936|FG001|Period II|Subject withdrew consent|0|||
17046904|NCT00615030|38190937|FG002|Period II|Subject withdrew consent|0|||
17046905|NCT00615030|38190938|FG003|Period II|Subject withdrew consent|1|||
17046906|NCT00615030|38190939|FG004|Period II|Subject withdrew consent|0|||
17046907|NCT00615030|38190940|FG005|Period II|Subject withdrew consent|0|||
17046908|NCT00615030|38190941|FG006|Period II|Subject withdrew consent|1|||
17046909|NCT00615030|38190942|FG007|Period II|Subject withdrew consent|0|||
17046910|NCT00615030|38190943|FG008|Period II|Subject withdrew consent|0|||
17046911|NCT00615030|38190944|FG009|Period II|Subject withdrew consent|0|||
17046912|NCT00615030|38190945|FG010|Period II|Subject withdrew consent|0|||
17046913|NCT00615030|38190946|FG011|Period II|Subject withdrew consent|0|||
17046914|NCT00615030|38190935|FG000|Period III|Administrative problems|1|||
17046915|NCT00615030|38190936|FG001|Period III|Administrative problems|0|||
17046916|NCT00615030|38190937|FG002|Period III|Administrative problems|0|||
17046917|NCT00615030|38190938|FG003|Period III|Administrative problems|1|||
17046918|NCT00615030|38190939|FG004|Period III|Administrative problems|0|||
17046919|NCT00615030|38190940|FG005|Period III|Administrative problems|0|||
17046920|NCT00615030|38190941|FG006|Period III|Administrative problems|0|||
17046921|NCT00615030|38190942|FG007|Period III|Administrative problems|0|||
17046922|NCT00615030|38190943|FG008|Period III|Administrative problems|0|||
17046923|NCT00615030|38190944|FG009|Period III|Administrative problems|0|||
17046924|NCT00615030|38190945|FG010|Period III|Administrative problems|0|||
17046925|NCT00615030|38190946|FG011|Period III|Administrative problems|0|||
17046926|NCT00518284|38190964|FG000|Overall Study|Adverse Event|0|||
17046927|NCT00518284|38190965|FG001|Overall Study|Adverse Event|1|||
17046928|NCT00518284|38190966|FG002|Overall Study|Adverse Event|0|||
17046929|NCT00518284|38190967|FG003|Overall Study|Adverse Event|0|||
17046930|NCT00518284|38190964|FG000|Overall Study|Study Termination|0|||
17046931|NCT00518284|38190965|FG001|Overall Study|Study Termination|2|||
17046932|NCT00518284|38190966|FG002|Overall Study|Study Termination|1|||
17046933|NCT00518284|38190967|FG003|Overall Study|Study Termination|2|||
17046934|NCT00614874|38190977|FG000|Overall Study|Protocol Violation|1|||
17046935|NCT00614874|38190977|FG000|Overall Study|Withdrawal by Subject|1|||
17046936|NCT00727415|38190981|FG000|Phase I|Dose Limiting Toxicity|2|||
17046937|NCT00544557|38190985|FG000|Overall Study|Adverse Event|140|||
17046938|NCT00544557|38190985|FG000|Overall Study|Lack of Efficacy|196|||
17046939|NCT00544557|38190985|FG000|Overall Study|Other|98|||
17046940|NCT00727259|38190989|FG000|Overall Study|Not all questionnaires completed|1055|||
17046941|NCT00735371|38190998|FG000|Overall Study|Adverse Event|3|||
17046942|NCT00735371|38190999|FG001|Overall Study|Adverse Event|3|||
17046943|NCT00735371|38191000|FG002|Overall Study|Adverse Event|4|||
17046944|NCT00735371|38191001|FG003|Overall Study|Adverse Event|1|||
17046945|NCT00735371|38190998|FG000|Overall Study|Protocol Violation|2|||
17046946|NCT00735371|38190999|FG001|Overall Study|Protocol Violation|2|||
17046947|NCT00735371|38191000|FG002|Overall Study|Protocol Violation|0|||
17046948|NCT00735371|38191001|FG003|Overall Study|Protocol Violation|3|||
17046949|NCT00735371|38190998|FG000|Overall Study|Withdrawal by Subject|0|||
17046950|NCT00735371|38190999|FG001|Overall Study|Withdrawal by Subject|2|||
17142015|NCT02891226|38284505|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142016|NCT02891226|38284506|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142017|NCT02891226|38284507|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142018|NCT02891226|38284508|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17046951|NCT00735371|38191000|FG002|Overall Study|Withdrawal by Subject|2|||
17046952|NCT00735371|38191001|FG003|Overall Study|Withdrawal by Subject|0|||
17046953|NCT00735371|38190998|FG000|Overall Study|Lost to Follow-up|1|||
17046954|NCT00735371|38190999|FG001|Overall Study|Lost to Follow-up|1|||
17046955|NCT00735371|38191000|FG002|Overall Study|Lost to Follow-up|3|||
17046956|NCT00735371|38191001|FG003|Overall Study|Lost to Follow-up|1|||
17046957|NCT00735371|38190998|FG000|Overall Study|Lack of Efficacy|4|||
17046958|NCT00735371|38190999|FG001|Overall Study|Lack of Efficacy|2|||
17142019|NCT02891226|38284509|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142020|NCT02891226|38284510|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142021|NCT02891226|38284511|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142022|NCT02891226|38284512|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142023|NCT02891226|38284513|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
17142024|NCT02891226|38284514|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142025|NCT02891226|38284515|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142026|NCT02891226|38284516|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142027|NCT02891226|38284517|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142028|NCT02891226|38284518|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
17142029|NCT02891226|38284503|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142030|NCT02891226|38284504|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142031|NCT02891226|38284505|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142032|NCT02891226|38284506|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142033|NCT02891226|38284507|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17046959|NCT00735371|38191000|FG002|Overall Study|Lack of Efficacy|0|||
17046960|NCT00735371|38191001|FG003|Overall Study|Lack of Efficacy|4|||
17046961|NCT00735371|38190998|FG000|Overall Study|Sponsor Decision|3|||
17046962|NCT00735371|38190999|FG001|Overall Study|Sponsor Decision|1|||
17046963|NCT00735371|38191000|FG002|Overall Study|Sponsor Decision|0|||
17046964|NCT00735371|38191001|FG003|Overall Study|Sponsor Decision|1|||
17046965|NCT00735371|38190998|FG000|Overall Study|Protocol Violation|0|||
17046966|NCT00735371|38190999|FG001|Overall Study|Protocol Violation|1|||
17046967|NCT00735371|38191000|FG002|Overall Study|Protocol Violation|2|||
17046968|NCT00735371|38191001|FG003|Overall Study|Protocol Violation|0|||
17046969|NCT00735371|38190998|FG000|Overall Study|Prior Vyvanse Exposure|1|||
17046970|NCT00735371|38190999|FG001|Overall Study|Prior Vyvanse Exposure|1|||
17046971|NCT00735371|38191000|FG002|Overall Study|Prior Vyvanse Exposure|0|||
17142034|NCT02891226|38284508|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17189044|NCT02502526|38342018|FG000|Overall Study|Lost to Follow-up|2|||
17046972|NCT00735371|38191001|FG003|Overall Study|Prior Vyvanse Exposure|0|||
17046973|NCT00735371|38190998|FG000|Overall Study|Exclusion criteria|1|||
17046974|NCT00735371|38190999|FG001|Overall Study|Exclusion criteria|0|||
17046975|NCT00735371|38191000|FG002|Overall Study|Exclusion criteria|0|||
17046976|NCT00735371|38191001|FG003|Overall Study|Exclusion criteria|0|||
17046977|NCT00518206|38191013|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
17046978|NCT00518206|38191014|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
17046979|NCT00518206|38191013|FG000|Overall Study|Withdrawal by Subject|2|||
17046980|NCT00518206|38191014|FG001|Overall Study|Withdrawal by Subject|0|||
17046981|NCT00518206|38191013|FG000|Overall Study|Drug Supply Issue|1|||
17046982|NCT00518206|38191014|FG001|Overall Study|Drug Supply Issue|0|||
17046983|NCT00518206|38191013|FG000|Overall Study|Reason Unknown|1|||
17046984|NCT00518206|38191014|FG001|Overall Study|Reason Unknown|0|||
17046985|NCT00518206|38191013|FG000|Overall Study|Completion Status Unknown|1|||
17046986|NCT00518206|38191014|FG001|Overall Study|Completion Status Unknown|0|||
17046987|NCT00586313|38191020|FG000|Overall Study|Lack of Efficacy|2|||
17046988|NCT00727025|38191024|FG000|Overall Study|Physician Decision|23|||
17046989|NCT00734747|38191032|FG000|SRS Procedure|No staples placed|3|||
17046990|NCT00734747|38191032|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
17046991|NCT00726557|38191036|FG000|Overall Study|Screening failure|4|||
17046992|NCT00726557|38191036|FG000|Overall Study|No end of treatment documentation|37|||
17046993|NCT00726557|38191036|FG000|Overall Study|No follow-up documentation available|55|||
17046994|NCT00726557|38191036|FG000|Overall Study|Treatment less than 3 months|17|||
17046995|NCT00726557|38191036|FG000|Overall Study|Inclusion criteria not met|15|||
17046996|NCT00738881|38191043|FG000|Overall Study|Withdrawal by Subject|0|||
17046997|NCT00738881|38191044|FG001|Overall Study|Withdrawal by Subject|2|||
17046998|NCT00657020|38191050|FG000|PERIOD 1|Adverse Event|0|||
17046999|NCT00657020|38191051|FG001|PERIOD 1|Adverse Event|1|||
17047000|NCT03921723|38191063|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
17047001|NCT03921723|38191063|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
17047002|NCT00544167|38191071|FG000|Overall Study|Adverse Event|21|||
17047003|NCT00544167|38191071|FG000|Overall Study|Physician Decision|8|||
17047004|NCT00659438|38191077|FG000|Overall Study|Withdrawal by Subject|2|||
17047005|NCT00659438|38191078|FG001|Overall Study|Withdrawal by Subject|2|||
17047006|NCT00659438|38191077|FG000|Overall Study|Death|11|||
17142035|NCT02891226|38284509|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142036|NCT02891226|38284510|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142037|NCT02891226|38284511|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142038|NCT02891226|38284512|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142039|NCT02891226|38284513|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
17142040|NCT02891226|38284514|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142041|NCT02891226|38284515|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142042|NCT02891226|38284516|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142043|NCT02891226|38284517|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142044|NCT02891226|38284518|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
17142045|NCT02891226|38284503|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142046|NCT02891226|38284504|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17047007|NCT00659438|38191078|FG001|Overall Study|Death|6|||
17047008|NCT00659438|38191077|FG000|Overall Study|Lost to Follow-up|1|||
17047009|NCT00659438|38191078|FG001|Overall Study|Lost to Follow-up|0|||
17047010|NCT00543855|38191088|FG000|Overall Study|Adverse Event|3|||
17047011|NCT00543855|38191089|FG001|Overall Study|Adverse Event|1|||
17047012|NCT00543855|38191090|FG002|Overall Study|Adverse Event|3|||
17047013|NCT00543855|38191091|FG003|Overall Study|Adverse Event|4|||
17047014|NCT00543855|38191088|FG000|Overall Study|Lost to Follow-up|0|||
17047015|NCT00543855|38191089|FG001|Overall Study|Lost to Follow-up|0|||
17047016|NCT00543855|38191090|FG002|Overall Study|Lost to Follow-up|1|||
17047017|NCT00543855|38191091|FG003|Overall Study|Lost to Follow-up|0|||
17047018|NCT00543855|38191088|FG000|Overall Study|Withdrawal by Subject|0|||
17047019|NCT00543855|38191089|FG001|Overall Study|Withdrawal by Subject|1|||
17047020|NCT00543855|38191090|FG002|Overall Study|Withdrawal by Subject|2|||
17047021|NCT00543855|38191091|FG003|Overall Study|Withdrawal by Subject|0|||
17047022|NCT00543855|38191088|FG000|Overall Study|Protocol Violation|1|||
17047023|NCT00543855|38191089|FG001|Overall Study|Protocol Violation|0|||
17047024|NCT00543855|38191090|FG002|Overall Study|Protocol Violation|0|||
17047025|NCT00543855|38191091|FG003|Overall Study|Protocol Violation|0|||
17047026|NCT00656474|38191101|FG000|Overall Study|Other Reason|1|||
17047027|NCT00656084|38191106|FG000|Overall Study|Adverse Event|4|||
17047028|NCT00656084|38191106|FG000|Overall Study|Withdrawal by Subject|1|||
17047029|NCT00656084|38191106|FG000|Overall Study|Patient Request|1|||
17047030|NCT00656084|38191106|FG000|Overall Study|Investigator Request|1|||
17047031|NCT00613938|38191114|FG000|Overall Study|Withdrawal by Subject|2|||
17047032|NCT00613938|38191115|FG001|Overall Study|Withdrawal by Subject|4|||
17047033|NCT00613938|38191116|FG002|Overall Study|Withdrawal by Subject|9|||
17047034|NCT00613938|38191117|FG003|Overall Study|Withdrawal by Subject|9|||
17047035|NCT00613938|38191114|FG000|Overall Study|Adverse Event|1|||
17047036|NCT00613938|38191115|FG001|Overall Study|Adverse Event|4|||
17047037|NCT00613938|38191116|FG002|Overall Study|Adverse Event|8|||
17047038|NCT00613938|38191117|FG003|Overall Study|Adverse Event|5|||
17047039|NCT00613938|38191114|FG000|Overall Study|Lack of Efficacy|16|||
17047040|NCT00613938|38191115|FG001|Overall Study|Lack of Efficacy|18|||
17047041|NCT00613938|38191116|FG002|Overall Study|Lack of Efficacy|5|||
17047042|NCT00613938|38191117|FG003|Overall Study|Lack of Efficacy|9|||
17047043|NCT00613938|38191114|FG000|Overall Study|Other|1|||
17047044|NCT00613938|38191115|FG001|Overall Study|Other|2|||
17047045|NCT00613938|38191116|FG002|Overall Study|Other|1|||
17047046|NCT00613938|38191117|FG003|Overall Study|Other|3|||
17047047|NCT00655928|38191129|FG000|Overall Study|Withdrawal by Subject|2|||
17047048|NCT00655928|38191130|FG001|Overall Study|Withdrawal by Subject|1|||
17047049|NCT00655928|38191129|FG000|Overall Study|Physician Decision|1|||
17047050|NCT00655928|38191130|FG001|Overall Study|Physician Decision|1|||
17047051|NCT00655850|38191136|FG000|Overall Study|Death|2|||
17047052|NCT00655850|38191136|FG000|Overall Study|Withdrawal by Subject|1|||
17047053|NCT00726323|38191144|FG000|Overall Study|Withdrawal by Subject|3|||
17047054|NCT00726323|38191145|FG001|Overall Study|Withdrawal by Subject|1|||
17047055|NCT00726323|38191144|FG000|Overall Study|Physician Decision|1|||
17047056|NCT00726323|38191145|FG001|Overall Study|Physician Decision|0|||
17047057|NCT00726323|38191144|FG000|Overall Study|Progressive disease|23|||
17047058|NCT00726323|38191145|FG001|Overall Study|Progressive disease|16|||
17047059|NCT00726323|38191144|FG000|Overall Study|Clinical progression|0|||
17047060|NCT00726323|38191145|FG001|Overall Study|Clinical progression|3|||
17047061|NCT00726323|38191144|FG000|Overall Study|Adverse Event|9|||
17047062|NCT00726323|38191145|FG001|Overall Study|Adverse Event|9|||
17047063|NCT00726323|38191144|FG000|Overall Study|Death|1|||
17047064|NCT00726323|38191145|FG001|Overall Study|Death|0|||
17047065|NCT00726323|38191144|FG000|Overall Study|Participant wished to discontinue|0|||
17047066|NCT00726323|38191145|FG001|Overall Study|Participant wished to discontinue|1|||
17047067|NCT00726323|38191144|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
17047068|NCT00726323|38191145|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
17047069|NCT00246571|38191153|FG000|Overall Study|Adverse Event|7|||
17047070|NCT00246571|38191154|FG001|Overall Study|Adverse Event|0|||
17047071|NCT00246571|38191153|FG000|Overall Study|Protocol Violation|0|||
17047072|NCT00246571|38191154|FG001|Overall Study|Protocol Violation|1|||
17047073|NCT00246571|38191153|FG000|Overall Study|Withdrawal by Subject|2|||
17047074|NCT00246571|38191154|FG001|Overall Study|Withdrawal by Subject|3|||
17047075|NCT00246571|38191153|FG000|Overall Study|Lack of Efficacy|84|||
17047076|NCT00246571|38191154|FG001|Overall Study|Lack of Efficacy|21|||
17047077|NCT00246571|38191153|FG000|Overall Study|Death|17|||
17047078|NCT00246571|38191154|FG001|Overall Study|Death|3|||
17047079|NCT00246571|38191153|FG000|Overall Study|Sponsor|0|||
17047080|NCT00246571|38191154|FG001|Overall Study|Sponsor|1|||
17047081|NCT00246571|38191153|FG000|Overall Study|Did not meet entrance criteria|2|||
17047082|NCT00246571|38191154|FG001|Overall Study|Did not meet entrance criteria|1|||
17047083|NCT00246571|38191153|FG000|Overall Study|Laboratory abnormalities|1|||
17047084|NCT00246571|38191154|FG001|Overall Study|Laboratory abnormalities|0|||
17047085|NCT00246571|38191153|FG000|Overall Study|Crossover participants|0|||
17142047|NCT02891226|38284505|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142048|NCT02891226|38284506|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142049|NCT02891226|38284507|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17047086|NCT00246571|38191154|FG001|Overall Study|Crossover participants|74|||
17047087|NCT00734591|38191162|FG000|Screening for Prospective Period|Site did not participate|1604|||
17047088|NCT00734591|38191163|FG001|Screening for Prospective Period|Site did not participate|1488|||
17047089|NCT00734591|38191162|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
17047090|NCT00734591|38191163|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
17047091|NCT00734591|38191162|FG000|Prospective Period|Withdrawal by Subject|11|||
17047092|NCT00734591|38191163|FG001|Prospective Period|Withdrawal by Subject|9|||
17047093|NCT00734591|38191162|FG000|Prospective Period|Lost to Follow-up|37|||
17047094|NCT00734591|38191163|FG001|Prospective Period|Lost to Follow-up|33|||
17047095|NCT00734591|38191162|FG000|Prospective Period|Study Terminated|1|||
17047096|NCT00734591|38191163|FG001|Prospective Period|Study Terminated|0|||
17047097|NCT00734591|38191162|FG000|Prospective Period|Other|2|||
17047098|NCT00734591|38191163|FG001|Prospective Period|Other|2|||
17047099|NCT00569270|38191169|FG000|Period: First Intervention|Protocol Violation|0|||
17047100|NCT00569270|38191170|FG001|Period: First Intervention|Protocol Violation|1|||
17047101|NCT00545103|38191189|FG000|Overall Study|Lack of Efficacy|48|||
17047102|NCT00545103|38191190|FG001|Overall Study|Lack of Efficacy|45|||
17047103|NCT00545103|38191191|FG002|Overall Study|Lack of Efficacy|31|||
17047104|NCT00545103|38191192|FG003|Overall Study|Lack of Efficacy|27|||
17047105|NCT00545103|38191189|FG000|Overall Study|Withdrawal by Subject|6|||
17047106|NCT00545103|38191190|FG001|Overall Study|Withdrawal by Subject|10|||
17047107|NCT00545103|38191191|FG002|Overall Study|Withdrawal by Subject|18|||
17047108|NCT00545103|38191192|FG003|Overall Study|Withdrawal by Subject|22|||
17047109|NCT00545103|38191189|FG000|Overall Study|Adverse Event|11|||
17047110|NCT00545103|38191190|FG001|Overall Study|Adverse Event|12|||
17047111|NCT00545103|38191191|FG002|Overall Study|Adverse Event|17|||
17047112|NCT00545103|38191192|FG003|Overall Study|Adverse Event|10|||
17047113|NCT00545103|38191189|FG000|Overall Study|Lost to Follow-up|4|||
17047114|NCT00545103|38191190|FG001|Overall Study|Lost to Follow-up|6|||
17047115|NCT00545103|38191191|FG002|Overall Study|Lost to Follow-up|3|||
17047116|NCT00545103|38191192|FG003|Overall Study|Lost to Follow-up|4|||
17047117|NCT00545103|38191189|FG000|Overall Study|Protocol Violation|1|||
17047118|NCT00545103|38191190|FG001|Overall Study|Protocol Violation|2|||
17047119|NCT00545103|38191191|FG002|Overall Study|Protocol Violation|3|||
17047120|NCT00545103|38191192|FG003|Overall Study|Protocol Violation|0|||
17047121|NCT00545103|38191189|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
17047122|NCT00545103|38191190|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
17047123|NCT00545103|38191191|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
17047124|NCT00545103|38191192|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
17047125|NCT00545103|38191189|FG000|Overall Study|Difficult to open package|0|||
17047126|NCT00545103|38191190|FG001|Overall Study|Difficult to open package|0|||
17047127|NCT00545103|38191191|FG002|Overall Study|Difficult to open package|0|||
17047128|NCT00545103|38191192|FG003|Overall Study|Difficult to open package|1|||
17047129|NCT00545103|38191189|FG000|Overall Study|Investigational product not taken|1|||
17047130|NCT00545103|38191190|FG001|Overall Study|Investigational product not taken|0|||
17047131|NCT00545103|38191191|FG002|Overall Study|Investigational product not taken|0|||
17047132|NCT00545103|38191192|FG003|Overall Study|Investigational product not taken|1|||
17047133|NCT00545103|38191189|FG000|Overall Study|Wish to start a family|0|||
17047134|NCT00545103|38191190|FG001|Overall Study|Wish to start a family|0|||
17047135|NCT00545103|38191191|FG002|Overall Study|Wish to start a family|0|||
17047136|NCT00545103|38191192|FG003|Overall Study|Wish to start a family|1|||
17047137|NCT00545103|38191189|FG000|Overall Study|Diverticulitis crisis|0|||
17047138|NCT00545103|38191190|FG001|Overall Study|Diverticulitis crisis|0|||
17047139|NCT00545103|38191191|FG002|Overall Study|Diverticulitis crisis|0|||
17047140|NCT00545103|38191192|FG003|Overall Study|Diverticulitis crisis|1|||
17047141|NCT00545103|38191189|FG000|Overall Study|Personal reasons|1|||
17142050|NCT02891226|38284508|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142051|NCT02891226|38284509|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142052|NCT02891226|38284510|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142053|NCT02891226|38284511|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142054|NCT02891226|38284512|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142055|NCT02891226|38284513|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
17142056|NCT02891226|38284514|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142057|NCT02891226|38284515|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17047142|NCT00545103|38191190|FG001|Overall Study|Personal reasons|0|||
17047143|NCT00545103|38191191|FG002|Overall Study|Personal reasons|0|||
17047144|NCT00545103|38191192|FG003|Overall Study|Personal reasons|0|||
17047145|NCT00545103|38191189|FG000|Overall Study|Subject's decision|1|||
17047146|NCT00545103|38191190|FG001|Overall Study|Subject's decision|0|||
17047147|NCT00545103|38191191|FG002|Overall Study|Subject's decision|0|||
17047148|NCT00545103|38191192|FG003|Overall Study|Subject's decision|0|||
17047149|NCT00545103|38191189|FG000|Overall Study|Noncompliance|0|||
17047150|NCT00545103|38191190|FG001|Overall Study|Noncompliance|1|||
17047151|NCT00545103|38191191|FG002|Overall Study|Noncompliance|0|||
17047152|NCT00545103|38191192|FG003|Overall Study|Noncompliance|0|||
17047153|NCT00545103|38191189|FG000|Overall Study|Investigator decision|0|||
17047154|NCT00545103|38191190|FG001|Overall Study|Investigator decision|0|||
17047155|NCT00545103|38191191|FG002|Overall Study|Investigator decision|1|||
17047156|NCT00545103|38191192|FG003|Overall Study|Investigator decision|0|||
17047157|NCT00545103|38191189|FG000|Overall Study|Subject moved|0|||
17047158|NCT00545103|38191190|FG001|Overall Study|Subject moved|1|||
17047159|NCT00545103|38191191|FG002|Overall Study|Subject moved|0|||
17047160|NCT00545103|38191192|FG003|Overall Study|Subject moved|0|||
17047161|NCT00545103|38191189|FG000|Overall Study|Use of prohibited medication|0|||
17047162|NCT00545103|38191190|FG001|Overall Study|Use of prohibited medication|0|||
17047163|NCT00545103|38191191|FG002|Overall Study|Use of prohibited medication|1|||
17047164|NCT00545103|38191192|FG003|Overall Study|Use of prohibited medication|0|||
17047165|NCT00545103|38191189|FG000|Overall Study|Does not want to take study drug anymore|1|||
17047166|NCT00545103|38191190|FG001|Overall Study|Does not want to take study drug anymore|0|||
17047167|NCT00545103|38191191|FG002|Overall Study|Does not want to take study drug anymore|1|||
17047168|NCT00545103|38191192|FG003|Overall Study|Does not want to take study drug anymore|0|||
17047169|NCT00545103|38191189|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
17047170|NCT00545103|38191190|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
17047171|NCT00545103|38191191|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
17047172|NCT00545103|38191192|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
17047173|NCT00545103|38191189|FG000|Overall Study|Death|0|||
17047174|NCT00545103|38191190|FG001|Overall Study|Death|1|||
17047175|NCT00545103|38191191|FG002|Overall Study|Death|0|||
17047176|NCT00545103|38191192|FG003|Overall Study|Death|0|||
17047177|NCT00586157|38191202|FG000|First Intervention|Worsening behavior|1|||
17047178|NCT00586157|38191203|FG001|First Intervention|Worsening behavior|0|||
17047179|NCT00586157|38191202|FG000|Second Intervention|Withdrawal by Subject|1|||
17047180|NCT00586157|38191203|FG001|Second Intervention|Withdrawal by Subject|0|||
17047181|NCT00586157|38191202|FG000|Second Intervention|Worsening behavior|1|||
17047182|NCT00586157|38191203|FG001|Second Intervention|Worsening behavior|0|||
17047183|NCT00586157|38191202|FG000|Second Intervention|Adverse Event|0|||
17047184|NCT00586157|38191203|FG001|Second Intervention|Adverse Event|1|||
17047185|NCT00246337|38191218|FG000|Overall Study|Lost to Follow-up|3|||
17047186|NCT00246337|38191219|FG001|Overall Study|Lost to Follow-up|0|||
17047187|NCT00246337|38191220|FG002|Overall Study|Lost to Follow-up|0|||
17047188|NCT00246337|38191221|FG003|Overall Study|Lost to Follow-up|0|||
17047189|NCT00246337|38191222|FG004|Overall Study|Lost to Follow-up|2|||
17047190|NCT00246337|38191223|FG005|Overall Study|Lost to Follow-up|2|||
17047191|NCT00246337|38191224|FG006|Overall Study|Lost to Follow-up|1|||
17047192|NCT00246337|38191225|FG007|Overall Study|Lost to Follow-up|2|||
17047193|NCT00246337|38191226|FG008|Overall Study|Lost to Follow-up|0|||
17047194|NCT00246337|38191218|FG000|Overall Study|Protocol Violation|1|||
17047195|NCT00246337|38191219|FG001|Overall Study|Protocol Violation|0|||
17047196|NCT00246337|38191220|FG002|Overall Study|Protocol Violation|0|||
17047197|NCT00246337|38191221|FG003|Overall Study|Protocol Violation|0|||
17047198|NCT00246337|38191222|FG004|Overall Study|Protocol Violation|1|||
17047199|NCT00246337|38191223|FG005|Overall Study|Protocol Violation|0|||
17047200|NCT00246337|38191224|FG006|Overall Study|Protocol Violation|1|||
17047201|NCT00246337|38191225|FG007|Overall Study|Protocol Violation|1|||
17047202|NCT00246337|38191226|FG008|Overall Study|Protocol Violation|0|||
17047203|NCT00246337|38191218|FG000|Overall Study|Withdrawal by Subject|2|||
17047204|NCT00246337|38191219|FG001|Overall Study|Withdrawal by Subject|0|||
17047205|NCT00246337|38191220|FG002|Overall Study|Withdrawal by Subject|0|||
17047206|NCT00246337|38191221|FG003|Overall Study|Withdrawal by Subject|0|||
17047207|NCT00246337|38191222|FG004|Overall Study|Withdrawal by Subject|0|||
17047208|NCT00246337|38191223|FG005|Overall Study|Withdrawal by Subject|0|||
17047209|NCT00246337|38191224|FG006|Overall Study|Withdrawal by Subject|1|||
17047210|NCT00246337|38191225|FG007|Overall Study|Withdrawal by Subject|1|||
17047211|NCT00246337|38191226|FG008|Overall Study|Withdrawal by Subject|0|||
17047212|NCT00246337|38191218|FG000|Overall Study|Lack of Qualifying Event|8|||
17047213|NCT00246337|38191219|FG001|Overall Study|Lack of Qualifying Event|2|||
17047214|NCT00246337|38191220|FG002|Overall Study|Lack of Qualifying Event|1|||
17047215|NCT00246337|38191221|FG003|Overall Study|Lack of Qualifying Event|1|||
17047216|NCT00246337|38191222|FG004|Overall Study|Lack of Qualifying Event|1|||
17047217|NCT00246337|38191223|FG005|Overall Study|Lack of Qualifying Event|3|||
17047218|NCT00246337|38191224|FG006|Overall Study|Lack of Qualifying Event|3|||
17047219|NCT00246337|38191225|FG007|Overall Study|Lack of Qualifying Event|2|||
17047220|NCT00246337|38191226|FG008|Overall Study|Lack of Qualifying Event|5|||
17047221|NCT00246337|38191218|FG000|Overall Study|Site Terminated|10|||
17047222|NCT00246337|38191219|FG001|Overall Study|Site Terminated|0|||
17047223|NCT00246337|38191220|FG002|Overall Study|Site Terminated|0|||
17047224|NCT00246337|38191221|FG003|Overall Study|Site Terminated|0|||
17047225|NCT00246337|38191222|FG004|Overall Study|Site Terminated|0|||
17047226|NCT00246337|38191223|FG005|Overall Study|Site Terminated|7|||
17047227|NCT00246337|38191224|FG006|Overall Study|Site Terminated|1|||
17047228|NCT00246337|38191225|FG007|Overall Study|Site Terminated|6|||
17047229|NCT00246337|38191226|FG008|Overall Study|Site Terminated|2|||
17047230|NCT00246337|38191218|FG000|Overall Study|Abnormal baseline lab values|7|||
17189045|NCT02502526|38342019|FG001|Overall Study|Lost to Follow-up|2|||
17047231|NCT00246337|38191219|FG001|Overall Study|Abnormal baseline lab values|0|||
17047232|NCT00246337|38191220|FG002|Overall Study|Abnormal baseline lab values|2|||
17047233|NCT00246337|38191221|FG003|Overall Study|Abnormal baseline lab values|0|||
17047234|NCT00246337|38191222|FG004|Overall Study|Abnormal baseline lab values|0|||
17047235|NCT00246337|38191223|FG005|Overall Study|Abnormal baseline lab values|2|||
17047236|NCT00246337|38191224|FG006|Overall Study|Abnormal baseline lab values|2|||
17047237|NCT00246337|38191225|FG007|Overall Study|Abnormal baseline lab values|0|||
17047238|NCT00246337|38191226|FG008|Overall Study|Abnormal baseline lab values|4|||
17047239|NCT00246337|38191218|FG000|Overall Study|Overwhelmed|0|||
17047240|NCT00246337|38191219|FG001|Overall Study|Overwhelmed|0|||
17047241|NCT00246337|38191220|FG002|Overall Study|Overwhelmed|0|||
17047242|NCT00246337|38191221|FG003|Overall Study|Overwhelmed|0|||
17047243|NCT00246337|38191222|FG004|Overall Study|Overwhelmed|0|||
17047244|NCT00246337|38191223|FG005|Overall Study|Overwhelmed|1|||
17047245|NCT00246337|38191224|FG006|Overall Study|Overwhelmed|0|||
17047246|NCT00246337|38191225|FG007|Overall Study|Overwhelmed|0|||
17047247|NCT00246337|38191226|FG008|Overall Study|Overwhelmed|0|||
17047248|NCT00246337|38191218|FG000|Overall Study|Protocol Violator|1|||
17047249|NCT00246337|38191219|FG001|Overall Study|Protocol Violator|0|||
17047250|NCT00246337|38191220|FG002|Overall Study|Protocol Violator|0|||
17047251|NCT00246337|38191221|FG003|Overall Study|Protocol Violator|0|||
17047252|NCT00246337|38191222|FG004|Overall Study|Protocol Violator|0|||
17047253|NCT00246337|38191223|FG005|Overall Study|Protocol Violator|0|||
17047254|NCT00246337|38191224|FG006|Overall Study|Protocol Violator|0|||
17047255|NCT00246337|38191225|FG007|Overall Study|Protocol Violator|0|||
17047256|NCT00246337|38191226|FG008|Overall Study|Protocol Violator|0|||
17047257|NCT00246337|38191218|FG000|Overall Study|Reported as completing trial in error|0|||
17047258|NCT00246337|38191219|FG001|Overall Study|Reported as completing trial in error|0|||
17047259|NCT00246337|38191220|FG002|Overall Study|Reported as completing trial in error|0|||
17047260|NCT00246337|38191221|FG003|Overall Study|Reported as completing trial in error|0|||
17047261|NCT00246337|38191222|FG004|Overall Study|Reported as completing trial in error|0|||
17047262|NCT00246337|38191223|FG005|Overall Study|Reported as completing trial in error|0|||
17047263|NCT00246337|38191224|FG006|Overall Study|Reported as completing trial in error|0|||
17047264|NCT00246337|38191225|FG007|Overall Study|Reported as completing trial in error|1|||
17047265|NCT00246337|38191226|FG008|Overall Study|Reported as completing trial in error|0|||
17047266|NCT00243919|38191249|FG000|Overall Study|Death|3|||
17047267|NCT00243919|38191250|FG001|Overall Study|Death|4|||
17047268|NCT00243919|38191251|FG002|Overall Study|Death|6|||
17047269|NCT00243919|38191249|FG000|Overall Study|Withdrawal by Subject|6|||
17047270|NCT00243919|38191250|FG001|Overall Study|Withdrawal by Subject|6|||
17047271|NCT00243919|38191251|FG002|Overall Study|Withdrawal by Subject|2|||
17047272|NCT00243919|38191249|FG000|Overall Study|Lost to Follow-up|6|||
17047273|NCT00243919|38191250|FG001|Overall Study|Lost to Follow-up|7|||
17047274|NCT00243919|38191251|FG002|Overall Study|Lost to Follow-up|3|||
17047275|NCT00243919|38191249|FG000|Overall Study|Administrative Error|1|||
17047276|NCT00243919|38191250|FG001|Overall Study|Administrative Error|0|||
17047277|NCT00243919|38191251|FG002|Overall Study|Administrative Error|0|||
17047278|NCT00243919|38191249|FG000|Overall Study|Physician Decision|1|||
17047279|NCT00243919|38191250|FG001|Overall Study|Physician Decision|1|||
17047280|NCT00243919|38191251|FG002|Overall Study|Physician Decision|0|||
17047281|NCT00725621|38191259|FG000|Overall Study|Adverse Event|25|||
17047282|NCT00725621|38191259|FG000|Overall Study|Lack of Efficacy|46|||
17047283|NCT00725621|38191259|FG000|Overall Study|Withdrawal by Subject|57|||
17047284|NCT00725621|38191259|FG000|Overall Study|Physician Decision|19|||
17047285|NCT00725621|38191259|FG000|Overall Study|Lost to Follow-up|52|||
17047286|NCT00725621|38191259|FG000|Overall Study|Non-compliance|8|||
17047287|NCT00725621|38191259|FG000|Overall Study|Continued treatment by other physician|6|||
17047288|NCT00725621|38191259|FG000|Overall Study|Switched to other study|1|||
17047289|NCT00725621|38191259|FG000|Overall Study|Switched to other drug|1|||
17047290|NCT00725621|38191259|FG000|Overall Study|Prepared for elective surgery|1|||
17047291|NCT00725621|38191259|FG000|Overall Study|Reason not specified|55|||
17047292|NCT00613626|38191270|FG000|Overall Study|Ineligible|0|||
17047293|NCT00613626|38191271|FG001|Overall Study|Ineligible|1|||
17047294|NCT00613626|38191272|FG002|Overall Study|Ineligible|0|||
17047295|NCT00725543|38191279|FG000|Overall Study|Adverse Event|10|||
17047296|NCT00725543|38191279|FG000|Overall Study|Lack of Efficacy|3|||
17142058|NCT02891226|38284516|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142059|NCT02891226|38284517|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142060|NCT02891226|38284518|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
17142061|NCT02891226|38284503|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142062|NCT02891226|38284504|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142063|NCT02891226|38284505|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142064|NCT02891226|38284506|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142065|NCT02891226|38284507|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142066|NCT02891226|38284508|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142067|NCT02891226|38284509|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142068|NCT02891226|38284510|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142069|NCT02891226|38284511|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142070|NCT02891226|38284512|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142071|NCT02891226|38284513|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
17142072|NCT02891226|38284514|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142073|NCT02891226|38284515|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142074|NCT02891226|38284516|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142075|NCT02891226|38284517|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17047297|NCT00725543|38191279|FG000|Overall Study|Withdrawal by Subject|10|||
17047298|NCT00725543|38191279|FG000|Overall Study|Physician Decision|5|||
17047299|NCT00725543|38191279|FG000|Overall Study|Lost to Follow-up|4|||
17047300|NCT00725543|38191279|FG000|Overall Study|Non-compliance|2|||
17047301|NCT00725543|38191279|FG000|Overall Study|Other|119|||
17047302|NCT00239005|38191285|FG000|Overall Study|Adverse Event|6|||
17047303|NCT00239005|38191286|FG001|Overall Study|Adverse Event|6|||
17047304|NCT00239005|38191285|FG000|Overall Study|Withdrawal by Subject|3|||
17047305|NCT00239005|38191286|FG001|Overall Study|Withdrawal by Subject|4|||
17047306|NCT00239005|38191285|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
17047307|NCT00239005|38191286|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
17047308|NCT00239005|38191285|FG000|Overall Study|Protocol Violation|1|||
17047309|NCT00239005|38191286|FG001|Overall Study|Protocol Violation|0|||
17047310|NCT00239005|38191285|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
17047311|NCT00239005|38191286|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
17142076|NCT02891226|38284518|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
17142077|NCT02891226|38284503|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142078|NCT02891226|38284504|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142079|NCT02891226|38284505|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142080|NCT02891226|38284506|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142081|NCT02891226|38284507|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142082|NCT02891226|38284508|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142083|NCT02891226|38284509|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142084|NCT02891226|38284510|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17047312|NCT00239005|38191285|FG000|Overall Study|Lost to Follow-up|0|||
17047313|NCT00239005|38191286|FG001|Overall Study|Lost to Follow-up|1|||
17047314|NCT00616434|38191294|FG000|Overall Study|Adverse Event|5|||
17047315|NCT00616434|38191295|FG001|Overall Study|Adverse Event|2|||
17047316|NCT00616434|38191294|FG000|Overall Study|Physician Decision|0|||
17047317|NCT00616434|38191295|FG001|Overall Study|Physician Decision|4|||
17047318|NCT00616434|38191294|FG000|Overall Study|Withdrawal by Subject|1|||
17047319|NCT00616434|38191295|FG001|Overall Study|Withdrawal by Subject|1|||
17047320|NCT00616434|38191294|FG000|Overall Study|Protocol deviation|0|||
17047321|NCT00616434|38191295|FG001|Overall Study|Protocol deviation|1|||
17047322|NCT00652340|38191303|FG000|Overall Study|Had not progressed.|4|||
17047323|NCT00652340|38191304|FG001|Overall Study|Had not progressed.|3|||
17047324|NCT00613314|38191310|FG000|Overall Study|Adverse Event|5|||
17047325|NCT00613314|38191310|FG000|Overall Study|Protocol Violation|14|||
17047326|NCT00613314|38191310|FG000|Overall Study|Lost to Follow-up|46|||
17047327|NCT00613314|38191310|FG000|Overall Study|Other reason not defined above|90|||
17047328|NCT00257725|38191314|FG000|Overall Study|Adverse Event|3|||
17047329|NCT00544869|38191322|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
17047330|NCT00544869|38191323|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
17047331|NCT00544869|38191324|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
17047332|NCT00544869|38191322|FG000|Overall Study|Adverse Event|6|||
17047333|NCT00544869|38191323|FG001|Overall Study|Adverse Event|1|||
17047334|NCT00544869|38191324|FG002|Overall Study|Adverse Event|0|||
17047335|NCT00544869|38191322|FG000|Overall Study|Lack of Efficacy|1|||
17047336|NCT00544869|38191323|FG001|Overall Study|Lack of Efficacy|1|||
17047337|NCT00544869|38191324|FG002|Overall Study|Lack of Efficacy|0|||
17047338|NCT00544869|38191322|FG000|Overall Study|Physician Decision|2|||
17047339|NCT00544869|38191323|FG001|Overall Study|Physician Decision|0|||
17047340|NCT00544869|38191324|FG002|Overall Study|Physician Decision|0|||
17047341|NCT00725075|38191335|FG000|Overall Study|Use of Excluded Medication|0|||
17047342|NCT00725075|38191336|FG001|Overall Study|Use of Excluded Medication|1|||
17047343|NCT00725075|38191337|FG002|Overall Study|Use of Excluded Medication|0|||
17047344|NCT00725075|38191335|FG000|Overall Study|Protocol Violation|0|||
17047345|NCT00725075|38191336|FG001|Overall Study|Protocol Violation|0|||
17047346|NCT00725075|38191337|FG002|Overall Study|Protocol Violation|1|||
17047347|NCT00725075|38191335|FG000|Overall Study|Lost to Follow-up|1|||
17047348|NCT00725075|38191336|FG001|Overall Study|Lost to Follow-up|0|||
17047349|NCT00725075|38191337|FG002|Overall Study|Lost to Follow-up|0|||
17047350|NCT00725075|38191335|FG000|Overall Study|Withdrawal by Subject|4|||
17047351|NCT00725075|38191336|FG001|Overall Study|Withdrawal by Subject|5|||
17047352|NCT00725075|38191337|FG002|Overall Study|Withdrawal by Subject|4|||
17047353|NCT00725075|38191335|FG000|Overall Study|Adverse Event|2|||
17047354|NCT00725075|38191336|FG001|Overall Study|Adverse Event|1|||
17047355|NCT00725075|38191337|FG002|Overall Study|Adverse Event|1|||
17047356|NCT00725075|38191335|FG000|Overall Study|Worsening of Disease|2|||
17047357|NCT00725075|38191336|FG001|Overall Study|Worsening of Disease|1|||
17047358|NCT00725075|38191337|FG002|Overall Study|Worsening of Disease|2|||
17047359|NCT00725075|38191335|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
17047360|NCT00725075|38191336|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
17047361|NCT00725075|38191337|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
17047362|NCT00725075|38191335|FG000|Overall Study|Other|1|||
17047363|NCT00725075|38191336|FG001|Overall Study|Other|0|||
17047364|NCT00725075|38191337|FG002|Overall Study|Other|0|||
17047365|NCT00733499|38191347|FG000|Pre-operative|Protocol Violation|0|||
17047366|NCT00733499|38191348|FG001|Pre-operative|Protocol Violation|1|||
17047367|NCT00733499|38191347|FG000|3 Months Follow-up|Death|1|||
17047368|NCT00733499|38191348|FG001|3 Months Follow-up|Death|2|||
17047369|NCT00733499|38191347|FG000|6 Months Follow-up|Death|0|||
17047370|NCT00733499|38191348|FG001|6 Months Follow-up|Death|2|||
17047371|NCT00733499|38191347|FG000|6 Months Follow-up|Adverse Event|0|||
17047372|NCT00733499|38191348|FG001|6 Months Follow-up|Adverse Event|1|||
17047373|NCT00733499|38191347|FG000|12 Months Follow-up|Death|2|||
17047374|NCT00733499|38191348|FG001|12 Months Follow-up|Death|1|||
17047375|NCT00733499|38191347|FG000|24 Months Follow-up|Death|0|||
17047376|NCT00733499|38191348|FG001|24 Months Follow-up|Death|1|||
17047377|NCT00733499|38191347|FG000|5 Year Followup|Adverse Event|2|||
17142085|NCT02891226|38284511|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142086|NCT02891226|38284512|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17047378|NCT00733499|38191348|FG001|5 Year Followup|Adverse Event|2|||
17047379|NCT00733499|38191347|FG000|5 Year Followup|Non device related AE|0|||
17047380|NCT00733499|38191348|FG001|5 Year Followup|Non device related AE|1|||
17047381|NCT00733499|38191347|FG000|5 Year Followup|Revision of Study Implant|0|||
17047382|NCT00733499|38191348|FG001|5 Year Followup|Revision of Study Implant|1|||
17047383|NCT00733499|38191347|FG000|5 Year Followup|Lost to Follow-up|2|||
17047384|NCT00733499|38191348|FG001|5 Year Followup|Lost to Follow-up|0|||
17047385|NCT00733499|38191347|FG000|5 Year Followup|Death|13|||
17047386|NCT00733499|38191348|FG001|5 Year Followup|Death|19|||
17047387|NCT00733499|38191347|FG000|5 Year Followup|missing, unable to locate|0|||
17047388|NCT00733499|38191348|FG001|5 Year Followup|missing, unable to locate|1|||
17047389|NCT00733499|38191347|FG000|5 Year Followup|Withdrawal by Subject|4|||
17047390|NCT00733499|38191348|FG001|5 Year Followup|Withdrawal by Subject|1|||
17047391|NCT00733499|38191347|FG000|10 Year Followup|Death|9|||
17047392|NCT00733499|38191348|FG001|10 Year Followup|Death|7|||
17047393|NCT00733499|38191347|FG000|10 Year Followup|Adverse Event|3|||
17047394|NCT00733499|38191348|FG001|10 Year Followup|Adverse Event|3|||
17047395|NCT00733499|38191347|FG000|10 Year Followup|Lost to Follow-up|3|||
17047396|NCT00733499|38191348|FG001|10 Year Followup|Lost to Follow-up|2|||
17047397|NCT00733499|38191347|FG000|10 Year Followup|Withdrawal by Subject|5|||
17047398|NCT00733499|38191348|FG001|10 Year Followup|Withdrawal by Subject|5|||
17047399|NCT00733499|38191347|FG000|10 Year Followup|missing, unable to locate|0|||
17047400|NCT00733499|38191348|FG001|10 Year Followup|missing, unable to locate|2|||
17047401|NCT00652028|38191358|FG000|Overall Study|Adverse Event|1|||
17047402|NCT00652028|38191359|FG001|Overall Study|Adverse Event|0|||
17047403|NCT00652028|38191360|FG002|Overall Study|Adverse Event|0|||
17047404|NCT00652028|38191361|FG003|Overall Study|Adverse Event|0|||
17047405|NCT00652028|38191358|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
17047406|NCT00652028|38191359|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
17047407|NCT00652028|38191360|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
17142087|NCT02891226|38284513|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
17142088|NCT02891226|38284514|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142089|NCT02891226|38284515|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142090|NCT02891226|38284516|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142091|NCT02891226|38284517|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142092|NCT02891226|38284518|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
17142093|NCT02891226|38284503|FG000|Follow-up Period|Withdrawal by Subject|0|||
17142094|NCT02891226|38284504|FG001|Follow-up Period|Withdrawal by Subject|0|||
17142095|NCT02891226|38284505|FG002|Follow-up Period|Withdrawal by Subject|0|||
17142096|NCT02891226|38284506|FG003|Follow-up Period|Withdrawal by Subject|0|||
17142097|NCT02891226|38284507|FG004|Follow-up Period|Withdrawal by Subject|0|||
17142098|NCT02891226|38284508|FG005|Follow-up Period|Withdrawal by Subject|0|||
17142099|NCT02891226|38284509|FG006|Follow-up Period|Withdrawal by Subject|0|||
17142100|NCT02891226|38284510|FG007|Follow-up Period|Withdrawal by Subject|0|||
17142101|NCT02891226|38284511|FG008|Follow-up Period|Withdrawal by Subject|0|||
17142102|NCT02891226|38284512|FG009|Follow-up Period|Withdrawal by Subject|0|||
17142103|NCT02891226|38284513|FG010|Follow-up Period|Withdrawal by Subject|0|||
17142104|NCT02891226|38284514|FG011|Follow-up Period|Withdrawal by Subject|1|||
17142105|NCT02891226|38284515|FG012|Follow-up Period|Withdrawal by Subject|0|||
17142106|NCT02891226|38284516|FG013|Follow-up Period|Withdrawal by Subject|0|||
17142107|NCT02891226|38284517|FG014|Follow-up Period|Withdrawal by Subject|1|||
17142108|NCT02891226|38284518|FG015|Follow-up Period|Withdrawal by Subject|1|||
17142109|NCT03612856|38284545|FG000|Pre-dose Period|Physician Decision|0|||
17142110|NCT03612856|38284546|FG001|Pre-dose Period|Physician Decision|1|||
17142111|NCT03612856|38284547|FG002|Pre-dose Period|Physician Decision|1|||
17142112|NCT03612856|38284545|FG000|Pre-dose Period|Withdrawal by Subject|0|||
17047408|NCT00652028|38191361|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
17047409|NCT00652028|38191358|FG000|Overall Study|Physician Decision|0|||
17047410|NCT00652028|38191359|FG001|Overall Study|Physician Decision|0|||
17142113|NCT03612856|38284546|FG001|Pre-dose Period|Withdrawal by Subject|1|||
17142114|NCT03612856|38284547|FG002|Pre-dose Period|Withdrawal by Subject|0|||
17142115|NCT03333837|38284560|FG000|Overall Study|Adverse Event|2|||
17142116|NCT03333837|38284561|FG001|Overall Study|Adverse Event|1|||
17142117|NCT03333837|38284562|FG002|Overall Study|Adverse Event|1|||
17047411|NCT00652028|38191360|FG002|Overall Study|Physician Decision|1|||
17047412|NCT00652028|38191361|FG003|Overall Study|Physician Decision|0|||
17142118|NCT03333837|38284563|FG003|Overall Study|Adverse Event|1|||
17142119|NCT03333837|38284564|FG004|Overall Study|Adverse Event|0|||
17142120|NCT03333837|38284560|FG000|Overall Study|Caregiver withdrew|0|||
17142121|NCT03333837|38284561|FG001|Overall Study|Caregiver withdrew|2|||
17142122|NCT03333837|38284562|FG002|Overall Study|Caregiver withdrew|1|||
17142123|NCT03333837|38284563|FG003|Overall Study|Caregiver withdrew|0|||
17142124|NCT03333837|38284564|FG004|Overall Study|Caregiver withdrew|0|||
17142125|NCT03333837|38284560|FG000|Overall Study|Withdrawal by Subject|0|||
17142126|NCT03333837|38284561|FG001|Overall Study|Withdrawal by Subject|0|||
17142127|NCT03333837|38284562|FG002|Overall Study|Withdrawal by Subject|1|||
17142128|NCT03333837|38284563|FG003|Overall Study|Withdrawal by Subject|1|||
17047413|NCT00738101|38191371|FG000|Overall Study|Physician Decision|5|||
17047414|NCT00738101|38191371|FG000|Overall Study|Death|1|||
17142129|NCT03333837|38284564|FG004|Overall Study|Withdrawal by Subject|3|||
17142130|NCT03333837|38284560|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
17142131|NCT03333837|38284561|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
17142132|NCT03333837|38284562|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
17142133|NCT03333837|38284563|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
17142134|NCT03333837|38284564|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
17142135|NCT03708211|38284582|FG000|Overall Study|Progressive Disease|10|||
17142136|NCT03708211|38284583|FG001|Overall Study|Progressive Disease|7|||
17142137|NCT03708211|38284582|FG000|Overall Study|Withdrawal by Subject|0|||
17142138|NCT03708211|38284583|FG001|Overall Study|Withdrawal by Subject|1|||
17142139|NCT03708211|38284582|FG000|Overall Study|Other|2|||
17142140|NCT03708211|38284583|FG001|Overall Study|Other|0|||
17047415|NCT00738101|38191371|FG000|Overall Study|Repeat enrollment|1|||
17047416|NCT00733421|38191377|FG000|Overall Study|Withdrawal by Subject|1|||
17047417|NCT00733421|38191378|FG001|Overall Study|Withdrawal by Subject|1|||
17047418|NCT00613080|38191384|FG000|Overall Study|Ineligible / no protocol treatment|11|||
17047419|NCT00732875|38191388|FG000|Overall Study|Adverse Event|16|||
17047420|NCT00732875|38191388|FG000|Overall Study|Withdrawal by Subject|6|||
17047421|NCT00732875|38191388|FG000|Overall Study|Lack of Efficacy|13|||
17047422|NCT00615264|38191398|FG000|Overall Study|Withdrawal by Subject|17|||
17047423|NCT00615264|38191399|FG001|Overall Study|Withdrawal by Subject|19|||
17047424|NCT00615264|38191398|FG000|Overall Study|Lost to Follow-up|6|||
17047425|NCT00615264|38191399|FG001|Overall Study|Lost to Follow-up|13|||
17047426|NCT00615264|38191398|FG000|Overall Study|Adverse Event|8|||
17047427|NCT00615264|38191399|FG001|Overall Study|Adverse Event|5|||
17047428|NCT00615264|38191398|FG000|Overall Study|Death|1|||
17047429|NCT00615264|38191399|FG001|Overall Study|Death|1|||
17047430|NCT00615264|38191398|FG000|Overall Study|Protocol Violation|11|||
17047431|NCT00615264|38191399|FG001|Overall Study|Protocol Violation|7|||
17047432|NCT00615264|38191398|FG000|Overall Study|Not defined|7|||
17047433|NCT00615264|38191399|FG001|Overall Study|Not defined|4|||
17047434|NCT00615264|38191398|FG000|Overall Study|Dermal Hypersensitivity|0|||
17047435|NCT00615264|38191399|FG001|Overall Study|Dermal Hypersensitivity|3|||
17047436|NCT00732641|38191407|FG000|Overall Study|Relapse or Progressive Disease|65|||
17047437|NCT00732641|38191408|FG001|Overall Study|Relapse or Progressive Disease|101|||
17047438|NCT00732641|38191407|FG000|Overall Study|Serious Adverse Events|12|||
17047439|NCT00732641|38191408|FG001|Overall Study|Serious Adverse Events|3|||
17047440|NCT00732641|38191407|FG000|Overall Study|Physician Decision|6|||
17047441|NCT00732641|38191408|FG001|Overall Study|Physician Decision|0|||
17047442|NCT00732641|38191407|FG000|Overall Study|Withdrawal by Subject|4|||
17047443|NCT00732641|38191408|FG001|Overall Study|Withdrawal by Subject|2|||
17047444|NCT00732641|38191407|FG000|Overall Study|Unable to Complete|1|||
17047445|NCT00732641|38191408|FG001|Overall Study|Unable to Complete|1|||
17047446|NCT00732641|38191407|FG000|Overall Study|Other|18|||
17047447|NCT00732641|38191408|FG001|Overall Study|Other|5|||
17047448|NCT00737711|38191414|FG000|Overall Study|Adverse Event|2|||
17047449|NCT00737711|38191414|FG000|Overall Study|Death|8|||
17047450|NCT00737711|38191414|FG000|Overall Study|Failure to return|4|||
17047451|NCT00737711|38191414|FG000|Overall Study|Protocol Violation|1|||
17047452|NCT00737711|38191414|FG000|Overall Study|Withdrawal by Subject|5|||
17047453|NCT00737711|38191414|FG000|Overall Study|Blood transfusion|6|||
17047454|NCT00737711|38191414|FG000|Overall Study|Other|5|||
17047455|NCT00615108|38191418|FG000|Overall Study|Adverse Event|122|||
17047456|NCT00615108|38191418|FG000|Overall Study|Other|370|||
17142141|NCT02948634|38284593|FG000|Overall Study|Lack of efficacy and study suspended|10|||
17142142|NCT02948634|38284594|FG001|Overall Study|Lack of efficacy and study suspended|2|||
17142143|NCT02945046|38284603|FG000|Overall Study|Adverse Event|1|||
17047457|NCT00615108|38191418|FG000|Overall Study|Lost to Follow-up|15|||
17047458|NCT00238303|38191427|FG000|Overall Study|Withdrawal by Subject|11|||
17047459|NCT00238303|38191428|FG001|Overall Study|Withdrawal by Subject|1|||
17047460|NCT00238303|38191429|FG002|Overall Study|Withdrawal by Subject|2|||
17047461|NCT00238303|38191427|FG000|Overall Study|Death|1|||
17047462|NCT00238303|38191428|FG001|Overall Study|Death|0|||
17047463|NCT00238303|38191429|FG002|Overall Study|Death|1|||
17047464|NCT00238303|38191427|FG000|Overall Study|Other Medical Problems|2|||
17047465|NCT00238303|38191428|FG001|Overall Study|Other Medical Problems|0|||
17047466|NCT00238303|38191429|FG002|Overall Study|Other Medical Problems|2|||
17047467|NCT00238303|38191427|FG000|Overall Study|Poor tolerance of study treatment|1|||
17047468|NCT00238303|38191428|FG001|Overall Study|Poor tolerance of study treatment|0|||
17047469|NCT00238303|38191429|FG002|Overall Study|Poor tolerance of study treatment|1|||
17142144|NCT02945046|38284604|FG001|Overall Study|Adverse Event|0|||
17142145|NCT02945046|38284605|FG002|Overall Study|Adverse Event|2|||
17142146|NCT02945046|38284603|FG000|Overall Study|Withdrawal by Subject|3|||
17142147|NCT02945046|38284604|FG001|Overall Study|Withdrawal by Subject|3|||
17142148|NCT02945046|38284605|FG002|Overall Study|Withdrawal by Subject|3|||
17142149|NCT02945046|38284603|FG000|Overall Study|Protocol Violation|2|||
17047470|NCT00238303|38191427|FG000|Overall Study|Adverse Event|0|||
17047471|NCT00238303|38191428|FG001|Overall Study|Adverse Event|1|||
17047472|NCT00238303|38191429|FG002|Overall Study|Adverse Event|3|||
17047473|NCT00737633|38191440|FG000|Overall Study|Study terminated by sponsor|44|||
17047474|NCT00737633|38191441|FG001|Overall Study|Study terminated by sponsor|55|||
17047475|NCT00737633|38191440|FG000|Overall Study|Lost to Follow-up|0|||
17047476|NCT00737633|38191441|FG001|Overall Study|Lost to Follow-up|1|||
17047477|NCT00737633|38191440|FG000|Overall Study|protocol non-compliance|0|||
17047478|NCT00737633|38191441|FG001|Overall Study|protocol non-compliance|1|||
17047479|NCT00732251|38191447|FG000|Overall Study|Lost to Follow-up|3|||
17047480|NCT00732251|38191447|FG000|Overall Study|Withdrawal by Subject|3|||
17047481|NCT00732251|38191447|FG000|Overall Study|Early Term due to Site Closure|1|||
17047482|NCT00737477|38191451|FG000|Overall Study|Adverse Event|9|||
17047483|NCT00737477|38191451|FG000|Overall Study|Death|9|||
17047484|NCT00737477|38191451|FG000|Overall Study|Treatment Refusal|1|||
17047485|NCT00737477|38191451|FG000|Overall Study|Withdrawal by Subject|1|||
17047486|NCT00737477|38191451|FG000|Overall Study|Renal Transplantation|10|||
17047487|NCT00737477|38191451|FG000|Overall Study|Other|4|||
17047488|NCT00256867|38191463|FG000|Overall Study|Adverse Event|0|||
17047489|NCT00256867|38191464|FG001|Overall Study|Adverse Event|1|||
17047490|NCT00256867|38191465|FG002|Overall Study|Adverse Event|1|||
17047491|NCT00256867|38191466|FG003|Overall Study|Adverse Event|1|||
17047492|NCT00256867|38191467|FG004|Overall Study|Adverse Event|2|||
17047493|NCT00256867|38191468|FG005|Overall Study|Adverse Event|2|||
17142150|NCT02945046|38284604|FG001|Overall Study|Protocol Violation|3|||
17142151|NCT02945046|38284605|FG002|Overall Study|Protocol Violation|2|||
17142152|NCT02945046|38284603|FG000|Overall Study|Lost to Follow-up|1|||
17142153|NCT02945046|38284604|FG001|Overall Study|Lost to Follow-up|1|||
17142154|NCT02945046|38284605|FG002|Overall Study|Lost to Follow-up|0|||
17142155|NCT02945046|38284603|FG000|Overall Study|Lack of Efficacy|1|||
17142156|NCT02945046|38284604|FG001|Overall Study|Lack of Efficacy|2|||
17142157|NCT02945046|38284605|FG002|Overall Study|Lack of Efficacy|1|||
17142158|NCT02945046|38284603|FG000|Overall Study|Other than specified|5|||
17142159|NCT02945046|38284604|FG001|Overall Study|Other than specified|4|||
17142160|NCT02945046|38284605|FG002|Overall Study|Other than specified|7|||
17047494|NCT00256867|38191469|FG006|Overall Study|Adverse Event|1|||
17047495|NCT00256867|38191470|FG007|Overall Study|Adverse Event|4|||
17047496|NCT00256867|38191463|FG000|Overall Study|Lost to Follow-up|2|||
17047497|NCT00256867|38191464|FG001|Overall Study|Lost to Follow-up|2|||
17047498|NCT00256867|38191465|FG002|Overall Study|Lost to Follow-up|2|||
17047499|NCT00256867|38191466|FG003|Overall Study|Lost to Follow-up|3|||
17047500|NCT00256867|38191467|FG004|Overall Study|Lost to Follow-up|2|||
17047501|NCT00256867|38191468|FG005|Overall Study|Lost to Follow-up|0|||
17047502|NCT00256867|38191469|FG006|Overall Study|Lost to Follow-up|1|||
17047503|NCT00256867|38191470|FG007|Overall Study|Lost to Follow-up|2|||
17047504|NCT00256867|38191463|FG000|Overall Study|Protocol Violation|0|||
17047505|NCT00256867|38191464|FG001|Overall Study|Protocol Violation|0|||
17047506|NCT00256867|38191465|FG002|Overall Study|Protocol Violation|0|||
17047507|NCT00256867|38191466|FG003|Overall Study|Protocol Violation|1|||
17047508|NCT00256867|38191467|FG004|Overall Study|Protocol Violation|0|||
17047509|NCT00256867|38191468|FG005|Overall Study|Protocol Violation|1|||
17047510|NCT00256867|38191469|FG006|Overall Study|Protocol Violation|0|||
17047511|NCT00256867|38191470|FG007|Overall Study|Protocol Violation|1|||
17047512|NCT00256867|38191463|FG000|Overall Study|Withdrawal by Subject|0|||
17047513|NCT00256867|38191464|FG001|Overall Study|Withdrawal by Subject|0|||
17047514|NCT00256867|38191465|FG002|Overall Study|Withdrawal by Subject|1|||
17047515|NCT00256867|38191466|FG003|Overall Study|Withdrawal by Subject|1|||
17047516|NCT00256867|38191467|FG004|Overall Study|Withdrawal by Subject|2|||
17047517|NCT00256867|38191468|FG005|Overall Study|Withdrawal by Subject|2|||
17047518|NCT00256867|38191469|FG006|Overall Study|Withdrawal by Subject|3|||
17047519|NCT00256867|38191470|FG007|Overall Study|Withdrawal by Subject|2|||
17047520|NCT00256867|38191463|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
17142161|NCT03705793|38284615|FG000|Overall Study|Lost to Follow-up|3|||
17047521|NCT00256867|38191464|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
17142162|NCT03705793|38284616|FG001|Overall Study|Lost to Follow-up|4|||
17142163|NCT03705793|38284615|FG000|Overall Study|Withdrawal by Subject|2|||
17047522|NCT00256867|38191465|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
17047523|NCT00256867|38191466|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
17047524|NCT00256867|38191467|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
17047525|NCT00256867|38191468|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
17047526|NCT00256867|38191469|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
17047527|NCT00256867|38191470|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
17142164|NCT03705793|38284616|FG001|Overall Study|Withdrawal by Subject|1|||
17142165|NCT02944968|38284635|FG000|Overall Study|Subject excluded before study procedure|1|||
17142166|NCT02944968|38284635|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
17142167|NCT03761797|38284639|FG000|Overall Study|Changing hospital|11|||
17142168|NCT03761797|38284639|FG000|Overall Study|Improvement/remission|6|||
17142169|NCT03761797|38284639|FG000|Overall Study|Withdrawal by Subject|19|||
17142170|NCT03761797|38284639|FG000|Overall Study|Lost to Follow-up|33|||
17142171|NCT03761797|38284639|FG000|Overall Study|Adverse Event|37|||
17142172|NCT03761797|38284639|FG000|Overall Study|Case report form (CRF) not collected|5|||
17142173|NCT03761797|38284639|FG000|Overall Study|No patient visit after entry|13|||
17142174|NCT03761797|38284639|FG000|Overall Study|Switch to other diabetes medication|10|||
17142175|NCT03761797|38284639|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
16992477|NCT00802360|38136427|FG001|Overall Study|Cycle cancelled|1|||
16992478|NCT00802360|38136428|FG002|Overall Study|Cycle cancelled|1|||
16992479|NCT00802360|38136429|FG003|Overall Study|Cycle cancelled|1|||
16992480|NCT00802360|38136426|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
16992481|NCT00802360|38136427|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
16992482|NCT00802360|38136428|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
16992483|NCT00802360|38136429|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
16992484|NCT00802360|38136426|FG000|Overall Study|No positive serum pregnancy|17|||
16992485|NCT00802360|38136427|FG001|Overall Study|No positive serum pregnancy|20|||
16992486|NCT00802360|38136428|FG002|Overall Study|No positive serum pregnancy|14|||
16992487|NCT00802360|38136429|FG003|Overall Study|No positive serum pregnancy|10|||
16992488|NCT00802360|38136426|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
16992489|NCT00802360|38136427|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
16992490|NCT00802360|38136428|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
16992491|NCT00802360|38136429|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
16992492|NCT00802360|38136426|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
16992493|NCT00802360|38136427|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
16992494|NCT00802360|38136428|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
16992495|NCT00802360|38136429|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
16992496|NCT00802360|38136426|FG000|Overall Study|Other|2|||
16992497|NCT00802360|38136427|FG001|Overall Study|Other|3|||
16992498|NCT00802360|38136428|FG002|Overall Study|Other|6|||
16992499|NCT00802360|38136429|FG003|Overall Study|Other|3|||
16992500|NCT01026038|38136444|FG000|Overall Study|Lost to Follow-up|1|||
16992501|NCT01026038|38136445|FG001|Overall Study|Lost to Follow-up|1|||
16992502|NCT01026038|38136446|FG002|Overall Study|Lost to Follow-up|0|||
16992503|NCT00801892|38136465|FG000|Main Study Period|Withdrawal by Subject|0|||
16992504|NCT00801892|38136466|FG001|Main Study Period|Withdrawal by Subject|1|||
16992505|NCT00801892|38136465|FG000|Sham Crossover Period|Lost to Follow-up|0|||
16992506|NCT00801892|38136466|FG001|Sham Crossover Period|Lost to Follow-up|2|||
16992507|NCT02680587|38136480|FG000|Overall Study|Withdrawal by Subject|1|||
17047528|NCT00256867|38191463|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
17047529|NCT00256867|38191464|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
17047530|NCT00256867|38191465|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
17047531|NCT00256867|38191466|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
17047532|NCT00256867|38191467|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
17047533|NCT00256867|38191468|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
17047534|NCT00256867|38191469|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
17047535|NCT00256867|38191470|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
17047536|NCT00256867|38191463|FG000|Overall Study|Investigator's Decision|0|||
17047537|NCT00256867|38191464|FG001|Overall Study|Investigator's Decision|0|||
17047538|NCT00256867|38191465|FG002|Overall Study|Investigator's Decision|0|||
17047539|NCT00256867|38191466|FG003|Overall Study|Investigator's Decision|0|||
17047540|NCT00256867|38191467|FG004|Overall Study|Investigator's Decision|1|||
17047541|NCT00256867|38191468|FG005|Overall Study|Investigator's Decision|0|||
17047542|NCT00256867|38191469|FG006|Overall Study|Investigator's Decision|0|||
17047543|NCT00256867|38191470|FG007|Overall Study|Investigator's Decision|0|||
17047544|NCT00256867|38191463|FG000|Overall Study|Non-compliance with study medication|0|||
17047545|NCT00256867|38191464|FG001|Overall Study|Non-compliance with study medication|0|||
17047546|NCT00256867|38191465|FG002|Overall Study|Non-compliance with study medication|0|||
17047547|NCT00256867|38191466|FG003|Overall Study|Non-compliance with study medication|0|||
17047548|NCT00256867|38191467|FG004|Overall Study|Non-compliance with study medication|0|||
17047549|NCT00256867|38191468|FG005|Overall Study|Non-compliance with study medication|0|||
17047550|NCT00256867|38191469|FG006|Overall Study|Non-compliance with study medication|0|||
17047551|NCT00256867|38191470|FG007|Overall Study|Non-compliance with study medication|1|||
17047552|NCT00256867|38191463|FG000|Overall Study|Participant travelled Overseas|0|||
17047553|NCT00256867|38191464|FG001|Overall Study|Participant travelled Overseas|1|||
17047554|NCT00256867|38191465|FG002|Overall Study|Participant travelled Overseas|0|||
17047555|NCT00256867|38191466|FG003|Overall Study|Participant travelled Overseas|0|||
17047556|NCT00256867|38191467|FG004|Overall Study|Participant travelled Overseas|0|||
17047557|NCT00256867|38191468|FG005|Overall Study|Participant travelled Overseas|0|||
17047558|NCT00256867|38191469|FG006|Overall Study|Participant travelled Overseas|0|||
17047559|NCT00256867|38191470|FG007|Overall Study|Participant travelled Overseas|0|||
17047560|NCT00256867|38191463|FG000|Overall Study|Participant out of assessment window|0|||
17047561|NCT00256867|38191464|FG001|Overall Study|Participant out of assessment window|0|||
17047562|NCT00256867|38191465|FG002|Overall Study|Participant out of assessment window|1|||
17047563|NCT00256867|38191466|FG003|Overall Study|Participant out of assessment window|0|||
17047564|NCT00256867|38191467|FG004|Overall Study|Participant out of assessment window|0|||
17047565|NCT00256867|38191468|FG005|Overall Study|Participant out of assessment window|0|||
17047566|NCT00256867|38191469|FG006|Overall Study|Participant out of assessment window|0|||
17142176|NCT03761797|38284639|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
17142177|NCT03761797|38284639|FG000|Overall Study|Insufficient effectives|2|||
17047567|NCT00256867|38191470|FG007|Overall Study|Participant out of assessment window|0|||
17047568|NCT00256867|38191463|FG000|Overall Study|Withdrawal by participant|0|||
17047569|NCT00256867|38191464|FG001|Overall Study|Withdrawal by participant|0|||
17047570|NCT00256867|38191465|FG002|Overall Study|Withdrawal by participant|0|||
17047571|NCT00256867|38191466|FG003|Overall Study|Withdrawal by participant|0|||
17047572|NCT00256867|38191467|FG004|Overall Study|Withdrawal by participant|0|||
17047573|NCT00256867|38191468|FG005|Overall Study|Withdrawal by participant|1|||
17047574|NCT00256867|38191469|FG006|Overall Study|Withdrawal by participant|0|||
17047575|NCT00256867|38191470|FG007|Overall Study|Withdrawal by participant|0|||
17047576|NCT00731939|38191493|FG000|Overall Study|Adverse Event|6|||
17047577|NCT00731939|38191493|FG000|Overall Study|Lost to Follow-up|15|||
17047578|NCT00731939|38191493|FG000|Overall Study|Not implanted with study device|9|||
17047579|NCT00731939|38191493|FG000|Overall Study|Withdrawal by Subject|2|||
17047580|NCT00731939|38191493|FG000|Overall Study|Did not meet enrollment criteria|2|||
17047581|NCT00731783|38191499|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
17047582|NCT00731783|38191500|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
17047583|NCT00731783|38191499|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
17047584|NCT00731783|38191500|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
17047585|NCT00731783|38191499|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
17047586|NCT00731783|38191500|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
17047587|NCT00731783|38191499|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
17047588|NCT00731783|38191500|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
17047589|NCT00724451|38191506|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
17047590|NCT00724451|38191506|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
17047591|NCT00724451|38191506|FG000|Overall Study|Not Eligible for Treatment|431|||
17047592|NCT00724451|38191506|FG000|Overall Study|Participant Refused Treatment|89|||
17047593|NCT00724451|38191506|FG000|Overall Study|Never Started Treatment|89|||
17047594|NCT00724451|38191506|FG000|Overall Study|Unknown; No Data Sources Available|9|||
17142178|NCT03761797|38284639|FG000|Overall Study|Excessive alcohol intake|1|||
17047595|NCT00724451|38191506|FG000|Overall Study|Physician Decision|116|||
17142179|NCT02944656|38284645|FG000|Overall Study|No longer eligible|3|||
17142180|NCT02944656|38284646|FG001|Overall Study|No longer eligible|0|||
17142181|NCT02944656|38284645|FG000|Overall Study|Lost to Follow-up|7|||
17142182|NCT02944656|38284646|FG001|Overall Study|Lost to Follow-up|10|||
17142183|NCT02713529|38284659|FG000|Overall Study|Withdrawal by Subject|3|||
17142184|NCT02713529|38284660|FG001|Overall Study|Withdrawal by Subject|1|||
17142185|NCT02713529|38284661|FG002|Overall Study|Withdrawal by Subject|4|||
17142186|NCT02713529|38284662|FG003|Overall Study|Withdrawal by Subject|2|||
17142187|NCT02713529|38284663|FG004|Overall Study|Withdrawal by Subject|0|||
17142188|NCT02713529|38284664|FG005|Overall Study|Withdrawal by Subject|1|||
17142189|NCT02713529|38284665|FG006|Overall Study|Withdrawal by Subject|1|||
17142190|NCT02713529|38284659|FG000|Overall Study|Lost to Follow-up|1|||
17142191|NCT02713529|38284660|FG001|Overall Study|Lost to Follow-up|0|||
17142192|NCT02713529|38284661|FG002|Overall Study|Lost to Follow-up|1|||
17142193|NCT02713529|38284662|FG003|Overall Study|Lost to Follow-up|0|||
17142194|NCT02713529|38284663|FG004|Overall Study|Lost to Follow-up|0|||
17142195|NCT02713529|38284664|FG005|Overall Study|Lost to Follow-up|0|||
17142196|NCT02713529|38284665|FG006|Overall Study|Lost to Follow-up|0|||
17142197|NCT02713529|38284659|FG000|Overall Study|Death|3|||
17142198|NCT02713529|38284660|FG001|Overall Study|Death|3|||
17142199|NCT02713529|38284661|FG002|Overall Study|Death|26|||
17142200|NCT02713529|38284662|FG003|Overall Study|Death|27|||
17142201|NCT02713529|38284663|FG004|Overall Study|Death|3|||
17142202|NCT02713529|38284664|FG005|Overall Study|Death|13|||
17142203|NCT02713529|38284665|FG006|Overall Study|Death|3|||
17142204|NCT03707821|38284691|FG000|Overall Study|Protocol Violation|0|||
17142205|NCT03707821|38284692|FG001|Overall Study|Protocol Violation|1|||
17142206|NCT03707821|38284691|FG000|Overall Study|Unsatisfactory Visual Response|1|||
17142207|NCT03707821|38284692|FG001|Overall Study|Unsatisfactory Visual Response|0|||
17142208|NCT03707821|38284691|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
17142209|NCT03707821|38284692|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
17142210|NCT04546581|38284700|FG000|Overall Study|Adverse Event|9|||
17142211|NCT04546581|38284701|FG001|Overall Study|Adverse Event|3|||
17142212|NCT04546581|38284700|FG000|Overall Study|Physician Decision|0|||
17142213|NCT04546581|38284701|FG001|Overall Study|Physician Decision|1|||
17142214|NCT04546581|38284700|FG000|Overall Study|Protocol Violation|1|||
17142215|NCT04546581|38284701|FG001|Overall Study|Protocol Violation|2|||
17142216|NCT04546581|38284700|FG000|Overall Study|Withdrawal by Subject|3|||
17142217|NCT04546581|38284701|FG001|Overall Study|Withdrawal by Subject|7|||
17142218|NCT03707587|38284709|FG000|Overall Study|Death|0|||
17142219|NCT03707587|38284710|FG001|Overall Study|Death|1|||
17142220|NCT03312933|38284716|FG000|Overall Study|Protocol Violation|15|||
17142221|NCT03312933|38284716|FG000|Overall Study|Lost to Follow-up|36|||
17142222|NCT03312933|38284716|FG000|Overall Study|Withdrawal by Subject|3|||
17142223|NCT02561273|38284722|FG000|Overall Study|Protocol Violation|1|||
17142224|NCT02561273|38284723|FG001|Overall Study|Protocol Violation|0|||
17142225|NCT03312543|38284733|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
17142226|NCT03312543|38284734|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
17142227|NCT03312543|38284733|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
17142228|NCT03312543|38284734|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
17142229|NCT03312543|38284733|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
17142230|NCT03312543|38284734|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
17142231|NCT03312543|38284733|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
17142232|NCT03312543|38284734|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
17142233|NCT03312543|38284733|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
17142234|NCT03312543|38284734|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
17142235|NCT03312543|38284733|FG000|Regression (Week 12 to Week 24)|Death|0|||
17142236|NCT03312543|38284734|FG001|Regression (Week 12 to Week 24)|Death|1|||
17142237|NCT02392559|38284742|FG000|Overall Study|Withdrawal by Subject|0|||
17142238|NCT02392559|38284743|FG001|Overall Study|Withdrawal by Subject|1|||
17142239|NCT03332589|38284757|FG000|Overall Study|Lack of Efficacy|2|||
17142240|NCT03332589|38284758|FG001|Overall Study|Lack of Efficacy|0|||
17142241|NCT03332589|38284759|FG002|Overall Study|Lack of Efficacy|0|||
17142242|NCT03332589|38284757|FG000|Overall Study|Adverse Event|1|||
17142243|NCT03332589|38284758|FG001|Overall Study|Adverse Event|0|||
17142244|NCT03332589|38284759|FG002|Overall Study|Adverse Event|0|||
17142245|NCT03332589|38284757|FG000|Overall Study|Death|1|||
17142246|NCT03332589|38284758|FG001|Overall Study|Death|0|||
17142247|NCT03332589|38284759|FG002|Overall Study|Death|0|||
17142248|NCT00458003|38284769|FG000|Overall Study|Non protocol spinal anesthesia|1|||
17142249|NCT00458003|38284770|FG001|Overall Study|Non protocol spinal anesthesia|1|||
17142250|NCT02061293|38284780|FG000|Overall Study|Elevated Blood Pressure|1|||
17142251|NCT02061293|38284781|FG001|Overall Study|Elevated Blood Pressure|1|||
17142252|NCT02913612|38284791|FG000|Overall Study|Lost to Follow-up|6|||
17142253|NCT02913612|38284792|FG001|Overall Study|Lost to Follow-up|5|||
17142254|NCT02913612|38284793|FG002|Overall Study|Lost to Follow-up|2|||
17142255|NCT02913612|38284794|FG003|Overall Study|Lost to Follow-up|0|||
17047596|NCT00724451|38191506|FG000|Overall Study|Withdrawal by Subject|45|||
17047597|NCT00724451|38191506|FG000|Overall Study|Investigator + Participant Decision|13|||
17047598|NCT00724373|38191510|FG000|Overall Study|Adverse Event|41|||
17047599|NCT00724373|38191510|FG000|Overall Study|Lack of Efficacy|82|||
17047600|NCT00724373|38191510|FG000|Overall Study|Lost to Follow-up|7|||
17047601|NCT00724373|38191510|FG000|Overall Study|Non-compliance|2|||
17047602|NCT00724373|38191510|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
17047603|NCT00724373|38191510|FG000|Overall Study|Participant moved away|1|||
17047604|NCT00724373|38191510|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
17047605|NCT00724373|38191510|FG000|Overall Study|Only to have 24 week regimen|1|||
17047606|NCT00724373|38191510|FG000|Overall Study|Viral Relapse|1|||
17047607|NCT00724373|38191510|FG000|Overall Study|Acute HCV infection|1|||
17047608|NCT00724373|38191510|FG000|Overall Study|Drug Relapse|1|||
17047609|NCT00724373|38191510|FG000|Overall Study|Tolerability|23|||
17047610|NCT00724061|38191514|FG000|Dose Escalation Phase|Adverse Event|2|||
17047611|NCT00724061|38191514|FG000|Dose Escalation Phase|Disease Progression|3|||
17047612|NCT00731549|38191518|FG000|Overall Study|Lost to Follow-up|19|||
17047613|NCT00731549|38191518|FG000|Overall Study|Met withdrawal criteria|24|||
17047614|NCT00731549|38191518|FG000|Overall Study|Physician Decision|16|||
17047615|NCT00731549|38191518|FG000|Overall Study|Withdrawal by Subject|89|||
17047616|NCT00731549|38191518|FG000|Overall Study|Protocol deviation|1|||
17047617|NCT00731549|38191518|FG000|Overall Study|Adverse Event|31|||
17047618|NCT00731549|38191518|FG000|Overall Study|Lack of efficacy with AE|37|||
17047619|NCT00731549|38191518|FG000|Overall Study|Lack of efficacy without AE|6|||
17047620|NCT00730925|38191563|FG000|Overall Study|Progressive Disease|21|||
17047621|NCT00730925|38191563|FG000|Overall Study|Dose reducing Event|2|||
17047622|NCT00730925|38191563|FG000|Overall Study|Other Averse Event|7|||
17047623|NCT00730925|38191563|FG000|Overall Study|Protocol Violation|1|||
17047624|NCT00730925|38191563|FG000|Overall Study|Withdrawal by Subject|1|||
17047625|NCT00730925|38191563|FG000|Overall Study|Switch to combination therapy|8|||
17047626|NCT00730925|38191563|FG000|Overall Study|Other|1|||
17047627|NCT00236899|38191571|FG000|Overall Study|Adverse Event (Study Related)|1|||
17047628|NCT00236899|38191572|FG001|Overall Study|Adverse Event (Study Related)|1|||
17047629|NCT00236899|38191573|FG002|Overall Study|Adverse Event (Study Related)|2|||
17047630|NCT00236899|38191574|FG003|Overall Study|Adverse Event (Study Related)|1|||
17047631|NCT00236899|38191571|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
17047632|NCT00236899|38191572|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
17047633|NCT00236899|38191573|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
17047634|NCT00236899|38191574|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
17047635|NCT00236899|38191571|FG000|Overall Study|Death (Study Disease)|1|||
17047636|NCT00236899|38191572|FG001|Overall Study|Death (Study Disease)|4|||
17047637|NCT00236899|38191573|FG002|Overall Study|Death (Study Disease)|0|||
17047638|NCT00236899|38191574|FG003|Overall Study|Death (Study Disease)|0|||
17047639|NCT00236899|38191571|FG000|Overall Study|Death (Not Study Related)|2|||
17047640|NCT00236899|38191572|FG001|Overall Study|Death (Not Study Related)|0|||
17047641|NCT00236899|38191573|FG002|Overall Study|Death (Not Study Related)|0|||
17047642|NCT00236899|38191574|FG003|Overall Study|Death (Not Study Related)|0|||
17047643|NCT00236899|38191571|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
17047644|NCT00236899|38191572|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
17047645|NCT00236899|38191573|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
17047646|NCT00236899|38191574|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
17047647|NCT00236899|38191571|FG000|Overall Study|Lost to Follow-up|0|||
17047648|NCT00236899|38191572|FG001|Overall Study|Lost to Follow-up|1|||
17047649|NCT00236899|38191573|FG002|Overall Study|Lost to Follow-up|0|||
17047650|NCT00236899|38191574|FG003|Overall Study|Lost to Follow-up|0|||
17047651|NCT00236899|38191571|FG000|Overall Study|Entry Criteria Exclusion|0|||
17047652|NCT00236899|38191572|FG001|Overall Study|Entry Criteria Exclusion|1|||
17047653|NCT00236899|38191573|FG002|Overall Study|Entry Criteria Exclusion|1|||
17047654|NCT00236899|38191574|FG003|Overall Study|Entry Criteria Exclusion|0|||
17047655|NCT00236899|38191571|FG000|Overall Study|Protocol Violation|1|||
17047656|NCT00236899|38191572|FG001|Overall Study|Protocol Violation|0|||
17047657|NCT00236899|38191573|FG002|Overall Study|Protocol Violation|0|||
17047658|NCT00236899|38191574|FG003|Overall Study|Protocol Violation|0|||
17047659|NCT00236899|38191571|FG000|Overall Study|Withdrawal by Subject|6|||
17047660|NCT00236899|38191572|FG001|Overall Study|Withdrawal by Subject|4|||
17047661|NCT00236899|38191573|FG002|Overall Study|Withdrawal by Subject|5|||
17047662|NCT00236899|38191574|FG003|Overall Study|Withdrawal by Subject|2|||
17047663|NCT00236899|38191571|FG000|Overall Study|Physician Decision|7|||
17047664|NCT00236899|38191572|FG001|Overall Study|Physician Decision|8|||
17047665|NCT00236899|38191573|FG002|Overall Study|Physician Decision|7|||
17047666|NCT00236899|38191574|FG003|Overall Study|Physician Decision|6|||
17047667|NCT00236899|38191571|FG000|Overall Study|Satisfactory Response|2|||
17047668|NCT00236899|38191572|FG001|Overall Study|Satisfactory Response|0|||
17047669|NCT00236899|38191573|FG002|Overall Study|Satisfactory Response|0|||
17047670|NCT00236899|38191574|FG003|Overall Study|Satisfactory Response|1|||
17047671|NCT00236899|38191571|FG000|Overall Study|Lack of Efficacy|18|||
17047672|NCT00236899|38191572|FG001|Overall Study|Lack of Efficacy|18|||
17047673|NCT00236899|38191573|FG002|Overall Study|Lack of Efficacy|25|||
17047674|NCT00236899|38191574|FG003|Overall Study|Lack of Efficacy|23|||
17047675|NCT00611130|38191593|FG000|Overall Study|Lost to Follow-up|25|||
17047676|NCT00611130|38191594|FG001|Overall Study|Lost to Follow-up|29|||
17047677|NCT00611130|38191593|FG000|Overall Study|Protocol noncompliance|7|||
17047678|NCT00611130|38191594|FG001|Overall Study|Protocol noncompliance|6|||
17047679|NCT00611130|38191593|FG000|Overall Study|Withdrawal by Subject|6|||
17047680|NCT00611130|38191594|FG001|Overall Study|Withdrawal by Subject|5|||
17047681|NCT00611130|38191593|FG000|Overall Study|Other|5|||
17047682|NCT00611130|38191594|FG001|Overall Study|Other|4|||
17047683|NCT00611130|38191593|FG000|Overall Study|Incarceration|3|||
17047684|NCT00611130|38191594|FG001|Overall Study|Incarceration|2|||
17047685|NCT00611130|38191593|FG000|Overall Study|Administrative|1|||
17047686|NCT00611130|38191594|FG001|Overall Study|Administrative|1|||
17047687|NCT00611130|38191593|FG000|Overall Study|Adverse Event|1|||
17047688|NCT00611130|38191594|FG001|Overall Study|Adverse Event|0|||
17047689|NCT00611130|38191593|FG000|Overall Study|Death|1|||
17047690|NCT00611130|38191594|FG001|Overall Study|Death|0|||
17047691|NCT00256243|38191601|FG000|Overall Study|Lost to Follow-up|2|||
17047692|NCT00256243|38191601|FG000|Overall Study|Death|7|||
17142256|NCT02913612|38284791|FG000|Overall Study|Physician Decision|1|||
17142257|NCT02913612|38284792|FG001|Overall Study|Physician Decision|4|||
17047693|NCT00256243|38191601|FG000|Overall Study|Not treated|1|||
17047694|NCT00236197|38191608|FG000|Overall Study|Withdrawal by Subject|3|||
17047695|NCT00236197|38191609|FG001|Overall Study|Withdrawal by Subject|2|||
17047696|NCT00236197|38191608|FG000|Overall Study|Lost to Follow-up|1|||
17047697|NCT00236197|38191609|FG001|Overall Study|Lost to Follow-up|5|||
17047698|NCT00236197|38191608|FG000|Overall Study|Protocol Violation|0|||
17047699|NCT00236197|38191609|FG001|Overall Study|Protocol Violation|3|||
17047700|NCT00236197|38191608|FG000|Overall Study|Medication non-compliance|1|||
17047701|NCT00236197|38191609|FG001|Overall Study|Medication non-compliance|2|||
17047702|NCT00236197|38191608|FG000|Overall Study|Other|0|||
17047703|NCT00236197|38191609|FG001|Overall Study|Other|2|||
17047704|NCT00278629|38191615|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
17047705|NCT00612690|38191622|FG000|Overall Study|Lost to Follow-up|72|||
17047706|NCT00612690|38191623|FG001|Overall Study|Lost to Follow-up|98|||
17047707|NCT00612690|38191622|FG000|Overall Study|Withdrawal by Subject|32|||
17047708|NCT00612690|38191623|FG001|Overall Study|Withdrawal by Subject|20|||
17047709|NCT00612690|38191622|FG000|Overall Study|Withdrawal by Site|11|||
17047710|NCT00612690|38191623|FG001|Overall Study|Withdrawal by Site|0|||
17047711|NCT00278473|38191633|FG000|Overall Study|drop out|4|||
17047712|NCT00278473|38191634|FG001|Overall Study|drop out|3|||
17047713|NCT00278395|38191640|FG000|Overall Study|Adverse Event|2|||
17047714|NCT00278395|38191640|FG000|Overall Study|Nonevaluable|1|||
17047715|NCT00612534|38191651|FG000|Overall Study|Adverse Event|0|||
17047716|NCT00612534|38191652|FG001|Overall Study|Adverse Event|4|||
17047717|NCT00612534|38191653|FG002|Overall Study|Adverse Event|2|||
17047718|NCT00612534|38191654|FG003|Overall Study|Adverse Event|1|||
17047719|NCT00612534|38191651|FG000|Overall Study|Lack of Efficacy|13|||
17047720|NCT00612534|38191652|FG001|Overall Study|Lack of Efficacy|12|||
17047721|NCT00612534|38191653|FG002|Overall Study|Lack of Efficacy|5|||
17047722|NCT00612534|38191654|FG003|Overall Study|Lack of Efficacy|16|||
17047723|NCT00612534|38191651|FG000|Overall Study|Other Reason|0|||
17047724|NCT00612534|38191652|FG001|Overall Study|Other Reason|1|||
17047725|NCT00612534|38191653|FG002|Overall Study|Other Reason|0|||
17047726|NCT00612534|38191654|FG003|Overall Study|Other Reason|0|||
17047727|NCT00736853|38191664|FG000|Open-Label Period|Physician Decision|2|||
17142258|NCT02913612|38284793|FG002|Overall Study|Physician Decision|1|||
17047728|NCT00736853|38191665|FG001|Open-Label Period|Physician Decision|0|||
17142259|NCT02913612|38284794|FG003|Overall Study|Physician Decision|0|||
17142260|NCT02913612|38284791|FG000|Overall Study|Withdrawal by Subject|2|||
17142261|NCT02913612|38284792|FG001|Overall Study|Withdrawal by Subject|4|||
17142262|NCT02913612|38284793|FG002|Overall Study|Withdrawal by Subject|0|||
17142263|NCT02913612|38284794|FG003|Overall Study|Withdrawal by Subject|0|||
17142264|NCT02913612|38284791|FG000|Overall Study|Hemangioma resolved|1|||
17142265|NCT02913612|38284792|FG001|Overall Study|Hemangioma resolved|0|||
17142266|NCT02913612|38284793|FG002|Overall Study|Hemangioma resolved|0|||
17047729|NCT00736853|38191666|FG002|Open-Label Period|Physician Decision|0|||
17047730|NCT00736853|38191664|FG000|Open-Label Period|Adverse Event|31|||
17047731|NCT00736853|38191665|FG001|Open-Label Period|Adverse Event|0|||
17047732|NCT00736853|38191666|FG002|Open-Label Period|Adverse Event|0|||
17047733|NCT00736853|38191664|FG000|Open-Label Period|Withdrawal by Subject|16|||
17047734|NCT00736853|38191665|FG001|Open-Label Period|Withdrawal by Subject|0|||
17047735|NCT00736853|38191666|FG002|Open-Label Period|Withdrawal by Subject|0|||
17047736|NCT00736853|38191664|FG000|Open-Label Period|Started but not treated|42|||
17047737|NCT00736853|38191665|FG001|Open-Label Period|Started but not treated|0|||
17047738|NCT00736853|38191666|FG002|Open-Label Period|Started but not treated|0|||
17047739|NCT00736853|38191664|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
17047740|NCT00736853|38191665|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
17047741|NCT00736853|38191666|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
17047742|NCT00736853|38191664|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
17047743|NCT00736853|38191665|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
17047744|NCT00736853|38191666|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
17047745|NCT00736853|38191664|FG000|Double-Blind Period|Lack of Efficacy|0|||
17047746|NCT00736853|38191665|FG001|Double-Blind Period|Lack of Efficacy|19|||
17047747|NCT00736853|38191666|FG002|Double-Blind Period|Lack of Efficacy|42|||
17047748|NCT00736853|38191664|FG000|Double-Blind Period|Adverse Event|0|||
17047749|NCT00736853|38191665|FG001|Double-Blind Period|Adverse Event|3|||
17047750|NCT00736853|38191666|FG002|Double-Blind Period|Adverse Event|2|||
17047751|NCT00736853|38191664|FG000|Double-Blind Period|Withdrawal by Subject|0|||
17047752|NCT00736853|38191665|FG001|Double-Blind Period|Withdrawal by Subject|1|||
17047753|NCT00736853|38191666|FG002|Double-Blind Period|Withdrawal by Subject|4|||
17047754|NCT00736853|38191664|FG000|Double-Blind Period|Ineligible to participate the study|0|||
17047755|NCT00736853|38191665|FG001|Double-Blind Period|Ineligible to participate the study|1|||
17047756|NCT00736853|38191666|FG002|Double-Blind Period|Ineligible to participate the study|0|||
17047757|NCT00730847|38191675|FG000|Overall Study|Adverse Event|1|||
17047758|NCT00730847|38191675|FG000|Overall Study|Protocol Violation|2|||
17047759|NCT00730847|38191675|FG000|Overall Study|Withdrawal by Subject|16|||
17047760|NCT00730847|38191675|FG000|Overall Study|Lost to Follow-up|67|||
17047761|NCT00730847|38191675|FG000|Overall Study|Unknown completion status|21|||
17047762|NCT00730847|38191675|FG000|Overall Study|Other|24|||
17047763|NCT00573066|38191679|FG000|Overall Study|Exclusion criteria|18|||
17047764|NCT00573066|38191679|FG000|Overall Study|IV malfunction|1|||
17047765|NCT00573066|38191679|FG000|Overall Study|Postoperative bleeding|1|||
17047766|NCT00612456|38191686|FG000|Overall Study|Adverse Event|1|||
17047767|NCT00612456|38191687|FG001|Overall Study|Adverse Event|0|||
17047768|NCT00612456|38191688|FG002|Overall Study|Adverse Event|0|||
17047769|NCT00612456|38191686|FG000|Overall Study|Lack of Efficacy|1|||
17047770|NCT00612456|38191687|FG001|Overall Study|Lack of Efficacy|1|||
17047771|NCT00612456|38191688|FG002|Overall Study|Lack of Efficacy|0|||
17047772|NCT00612456|38191686|FG000|Overall Study|Withdrawal by Subject|0|||
17047773|NCT00612456|38191687|FG001|Overall Study|Withdrawal by Subject|1|||
17047774|NCT00612456|38191688|FG002|Overall Study|Withdrawal by Subject|0|||
17047775|NCT00730691|38191703|FG000|Overall Study|Adverse Event|4|||
17047776|NCT00730691|38191704|FG001|Overall Study|Adverse Event|8|||
17047777|NCT00730691|38191705|FG002|Overall Study|Adverse Event|11|||
17142267|NCT02913612|38284794|FG003|Overall Study|Hemangioma resolved|0|||
17142268|NCT02913612|38284791|FG000|Overall Study|Local IRB decision|1|||
17142269|NCT02913612|38284792|FG001|Overall Study|Local IRB decision|0|||
17142270|NCT02913612|38284793|FG002|Overall Study|Local IRB decision|0|||
17142271|NCT02913612|38284794|FG003|Overall Study|Local IRB decision|0|||
17142272|NCT02913612|38284791|FG000|Overall Study|Study drug non-compliance|1|||
17142273|NCT02913612|38284792|FG001|Overall Study|Study drug non-compliance|1|||
17047778|NCT00730691|38191706|FG003|Overall Study|Adverse Event|11|||
17142274|NCT02913612|38284793|FG002|Overall Study|Study drug non-compliance|0|||
17142275|NCT02913612|38284794|FG003|Overall Study|Study drug non-compliance|0|||
17047779|NCT00730691|38191707|FG004|Overall Study|Adverse Event|23|||
17047780|NCT00730691|38191703|FG000|Overall Study|Lack of Efficacy|4|||
17047781|NCT00730691|38191704|FG001|Overall Study|Lack of Efficacy|4|||
17047782|NCT00730691|38191705|FG002|Overall Study|Lack of Efficacy|2|||
17047783|NCT00730691|38191706|FG003|Overall Study|Lack of Efficacy|1|||
17142276|NCT02913612|38284791|FG000|Overall Study|Insurance issues|0|||
17142277|NCT02913612|38284792|FG001|Overall Study|Insurance issues|1|||
17142278|NCT02913612|38284793|FG002|Overall Study|Insurance issues|0|||
17142279|NCT02913612|38284794|FG003|Overall Study|Insurance issues|0|||
17047784|NCT00730691|38191707|FG004|Overall Study|Lack of Efficacy|1|||
17047785|NCT00730691|38191703|FG000|Overall Study|Non-compliance with Study Drug|6|||
17047786|NCT00730691|38191704|FG001|Overall Study|Non-compliance with Study Drug|1|||
17047787|NCT00730691|38191705|FG002|Overall Study|Non-compliance with Study Drug|6|||
17047788|NCT00730691|38191706|FG003|Overall Study|Non-compliance with Study Drug|3|||
17047789|NCT00730691|38191707|FG004|Overall Study|Non-compliance with Study Drug|3|||
17047790|NCT00730691|38191703|FG000|Overall Study|Protocol Deviations|3|||
17047791|NCT00730691|38191704|FG001|Overall Study|Protocol Deviations|5|||
17047792|NCT00730691|38191705|FG002|Overall Study|Protocol Deviations|3|||
17047793|NCT00730691|38191706|FG003|Overall Study|Protocol Deviations|7|||
17047794|NCT00730691|38191707|FG004|Overall Study|Protocol Deviations|5|||
17047795|NCT00730691|38191703|FG000|Overall Study|Withdrawal of Consent|7|||
17047796|NCT00730691|38191704|FG001|Overall Study|Withdrawal of Consent|9|||
17047797|NCT00730691|38191705|FG002|Overall Study|Withdrawal of Consent|3|||
17047798|NCT00730691|38191706|FG003|Overall Study|Withdrawal of Consent|6|||
17047799|NCT00730691|38191707|FG004|Overall Study|Withdrawal of Consent|3|||
17047800|NCT00730691|38191703|FG000|Overall Study|Lost to Follow-up|11|||
17047801|NCT00730691|38191704|FG001|Overall Study|Lost to Follow-up|8|||
17047802|NCT00730691|38191705|FG002|Overall Study|Lost to Follow-up|13|||
17047803|NCT00730691|38191706|FG003|Overall Study|Lost to Follow-up|15|||
17047804|NCT00730691|38191707|FG004|Overall Study|Lost to Follow-up|13|||
17047805|NCT00730691|38191703|FG000|Overall Study|Other|1|||
17047806|NCT00730691|38191704|FG001|Overall Study|Other|1|||
17047807|NCT00730691|38191705|FG002|Overall Study|Other|1|||
17047808|NCT00730691|38191706|FG003|Overall Study|Other|2|||
17047809|NCT00730691|38191707|FG004|Overall Study|Other|2|||
17047810|NCT00235495|38191721|FG000|Overall Study|Death|52|||
17047811|NCT00235495|38191722|FG001|Overall Study|Death|42|||
17142280|NCT02913612|38284791|FG000|Overall Study|Needed to treat second hemangioma|0|||
17142281|NCT02913612|38284792|FG001|Overall Study|Needed to treat second hemangioma|1|||
17142282|NCT02913612|38284793|FG002|Overall Study|Needed to treat second hemangioma|0|||
17142283|NCT02913612|38284794|FG003|Overall Study|Needed to treat second hemangioma|0|||
17142284|NCT02913612|38284791|FG000|Overall Study|Study completion criteria not met|0|||
17142285|NCT02913612|38284792|FG001|Overall Study|Study completion criteria not met|1|||
17142286|NCT02913612|38284793|FG002|Overall Study|Study completion criteria not met|0|||
17142287|NCT02913612|38284794|FG003|Overall Study|Study completion criteria not met|0|||
17142288|NCT02913612|38284791|FG000|Overall Study|Ineligible|0|||
17142289|NCT02913612|38284792|FG001|Overall Study|Ineligible|1|||
17142290|NCT02913612|38284793|FG002|Overall Study|Ineligible|0|||
17142291|NCT02913612|38284794|FG003|Overall Study|Ineligible|0|||
17142292|NCT03312231|38284808|FG000|Overall Study|Lost to Follow-up|2|||
17142293|NCT03312231|38284809|FG001|Overall Study|Lost to Follow-up|6|||
17142294|NCT03312231|38284810|FG002|Overall Study|Lost to Follow-up|1|||
17142295|NCT03312231|38284811|FG003|Overall Study|Lost to Follow-up|3|||
17142296|NCT03312231|38284812|FG004|Overall Study|Lost to Follow-up|1|||
17142297|NCT03312231|38284808|FG000|Overall Study|Withdrawal by Subject|0|||
17047812|NCT00235495|38191721|FG000|Overall Study|Withdrawal by Subject|5|||
17047813|NCT00235495|38191722|FG001|Overall Study|Withdrawal by Subject|3|||
17047814|NCT00235495|38191721|FG000|Overall Study|Lost to Follow-up|11|||
17047815|NCT00235495|38191722|FG001|Overall Study|Lost to Follow-up|13|||
17047816|NCT00235495|38191721|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
17047817|NCT00235495|38191722|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
17047818|NCT00278161|38191728|FG000|Overall Study|Death|11|||
17047819|NCT00255151|38191735|FG000|Overall Study|Adverse Event|10|||
17047820|NCT00255151|38191736|FG001|Overall Study|Adverse Event|6|||
17047821|NCT00255151|38191737|FG002|Overall Study|Adverse Event|9|||
17047822|NCT00255151|38191735|FG000|Overall Study|Lost to Follow-up|4|||
17047823|NCT00255151|38191736|FG001|Overall Study|Lost to Follow-up|3|||
17047824|NCT00255151|38191737|FG002|Overall Study|Lost to Follow-up|4|||
17047825|NCT00255151|38191735|FG000|Overall Study|Withdrawal by Subject|18|||
17047826|NCT00255151|38191736|FG001|Overall Study|Withdrawal by Subject|17|||
17047827|NCT00255151|38191737|FG002|Overall Study|Withdrawal by Subject|8|||
17047828|NCT00255151|38191735|FG000|Overall Study|Noncompliance|0|||
17047829|NCT00255151|38191736|FG001|Overall Study|Noncompliance|1|||
17047830|NCT00255151|38191737|FG002|Overall Study|Noncompliance|2|||
17047831|NCT00255151|38191735|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
17047832|NCT00255151|38191736|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
17047833|NCT00255151|38191737|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
17047834|NCT00255151|38191735|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
17047835|NCT00255151|38191736|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
17047836|NCT00255151|38191737|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
17047837|NCT00255151|38191735|FG000|Overall Study|Possible Barrett's Esophagus|1|||
17047838|NCT00255151|38191736|FG001|Overall Study|Possible Barrett's Esophagus|3|||
17142298|NCT03312231|38284809|FG001|Overall Study|Withdrawal by Subject|3|||
17047839|NCT00255151|38191737|FG002|Overall Study|Possible Barrett's Esophagus|8|||
17047840|NCT00255151|38191735|FG000|Overall Study|Esophageal Stricture|0|||
17047841|NCT00255151|38191736|FG001|Overall Study|Esophageal Stricture|0|||
17047842|NCT00255151|38191737|FG002|Overall Study|Esophageal Stricture|1|||
17142299|NCT03312231|38284810|FG002|Overall Study|Withdrawal by Subject|1|||
17142300|NCT03312231|38284811|FG003|Overall Study|Withdrawal by Subject|0|||
17142301|NCT03312231|38284812|FG004|Overall Study|Withdrawal by Subject|0|||
17142302|NCT03312231|38284808|FG000|Overall Study|Death|0|||
17142303|NCT03312231|38284809|FG001|Overall Study|Death|1|||
17142304|NCT03312231|38284810|FG002|Overall Study|Death|1|||
17142305|NCT03312231|38284811|FG003|Overall Study|Death|0|||
17142306|NCT03312231|38284812|FG004|Overall Study|Death|0|||
17142307|NCT03312231|38284808|FG000|Overall Study|Study Vaccination not Received|1|||
17142308|NCT03312231|38284809|FG001|Overall Study|Study Vaccination not Received|1|||
17142309|NCT03312231|38284810|FG002|Overall Study|Study Vaccination not Received|1|||
17142310|NCT03312231|38284811|FG003|Overall Study|Study Vaccination not Received|0|||
17142311|NCT03312231|38284812|FG004|Overall Study|Study Vaccination not Received|0|||
17142312|NCT03323736|38284827|FG000|Overall Study|Screen Failure|14|||
17142313|NCT03323736|38284828|FG001|Overall Study|Screen Failure|9|||
17142314|NCT03323736|38284829|FG002|Overall Study|Screen Failure|1|||
17142315|NCT03323736|38284827|FG000|Overall Study|Withdrawal Before Treatment|3|||
17142316|NCT03323736|38284828|FG001|Overall Study|Withdrawal Before Treatment|1|||
17142317|NCT03323736|38284829|FG002|Overall Study|Withdrawal Before Treatment|1|||
17142318|NCT03323736|38284827|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
17142319|NCT03323736|38284828|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
17142320|NCT03323736|38284829|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
17142321|NCT03311841|38284844|FG000|14-day Wash-out|Adverse Event|0|||
17142322|NCT03311841|38284845|FG001|14-day Wash-out|Adverse Event|1|||
17142323|NCT03311841|38284846|FG002|14-day Wash-out|Adverse Event|0|||
17047843|NCT00255151|38191735|FG000|Overall Study|Therapeutic Failure|11|||
17047844|NCT00255151|38191736|FG001|Overall Study|Therapeutic Failure|2|||
17047845|NCT00255151|38191737|FG002|Overall Study|Therapeutic Failure|3|||
17047846|NCT00658658|38191750|FG000|Overall Study|Withdrawal by Subject|0|||
17047847|NCT00658658|38191751|FG001|Overall Study|Withdrawal by Subject|1|||
17047848|NCT00658658|38191752|FG002|Overall Study|Withdrawal by Subject|0|||
17047849|NCT00658658|38191753|FG003|Overall Study|Withdrawal by Subject|0|||
17047850|NCT00658658|38191754|FG004|Overall Study|Withdrawal by Subject|0|||
17047851|NCT00658658|38191750|FG000|Overall Study|Death|4|||
17047852|NCT00658658|38191751|FG001|Overall Study|Death|0|||
17047853|NCT00658658|38191752|FG002|Overall Study|Death|0|||
17047854|NCT00658658|38191753|FG003|Overall Study|Death|1|||
17047855|NCT00658658|38191754|FG004|Overall Study|Death|1|||
17047856|NCT00658658|38191750|FG000|Overall Study|Disease Progression|0|||
17047857|NCT00658658|38191751|FG001|Overall Study|Disease Progression|1|||
17047858|NCT00658658|38191752|FG002|Overall Study|Disease Progression|0|||
17047859|NCT00658658|38191753|FG003|Overall Study|Disease Progression|1|||
17047860|NCT00658658|38191754|FG004|Overall Study|Disease Progression|3|||
17047861|NCT00658658|38191750|FG000|Overall Study|Protocol-specified Criteria|1|||
17047862|NCT00658658|38191751|FG001|Overall Study|Protocol-specified Criteria|0|||
17047863|NCT00658658|38191752|FG002|Overall Study|Protocol-specified Criteria|0|||
17047864|NCT00658658|38191753|FG003|Overall Study|Protocol-specified Criteria|0|||
17047865|NCT00658658|38191754|FG004|Overall Study|Protocol-specified Criteria|0|||
17047866|NCT00658658|38191750|FG000|Overall Study|Other|0|||
17047867|NCT00658658|38191751|FG001|Overall Study|Other|0|||
17047868|NCT00658658|38191752|FG002|Overall Study|Other|0|||
17047869|NCT00658658|38191753|FG003|Overall Study|Other|0|||
17047870|NCT00658658|38191754|FG004|Overall Study|Other|1|||
17047871|NCT00723203|38191766|FG000|Overall Study|Withdrawal by Subject|3|||
17047872|NCT00233389|38191772|FG000|Overall Study|Adverse Event|5|||
17047873|NCT00233389|38191773|FG001|Overall Study|Adverse Event|5|||
17047874|NCT00233389|38191772|FG000|Overall Study|Lack of Efficacy|11|||
17047875|NCT00233389|38191773|FG001|Overall Study|Lack of Efficacy|8|||
17047876|NCT00233389|38191772|FG000|Overall Study|Lost to Follow-up|1|||
17047877|NCT00233389|38191773|FG001|Overall Study|Lost to Follow-up|1|||
17047878|NCT00233389|38191772|FG000|Overall Study|Physician Decision|1|||
17047879|NCT00233389|38191773|FG001|Overall Study|Physician Decision|0|||
17047880|NCT00233389|38191772|FG000|Overall Study|Protocol Violation|0|||
17047881|NCT00233389|38191773|FG001|Overall Study|Protocol Violation|1|||
17047882|NCT00233389|38191772|FG000|Overall Study|Withdrawal by Subject|0|||
17047883|NCT00233389|38191773|FG001|Overall Study|Withdrawal by Subject|1|||
17047884|NCT00543543|38191783|FG000|Base Study|Adverse Event|1|||
17047885|NCT00543543|38191784|FG001|Base Study|Adverse Event|11|||
17047886|NCT00543543|38191785|FG002|Base Study|Adverse Event|0|||
17047887|NCT00543543|38191786|FG003|Base Study|Adverse Event|5|||
17047888|NCT00543543|38191783|FG000|Base Study|Lost to Follow-up|12|||
17142324|NCT03311841|38284847|FG003|14-day Wash-out|Adverse Event|0|||
17142325|NCT03311841|38284848|FG004|14-day Wash-out|Adverse Event|0|||
17142326|NCT03311841|38284844|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
17142327|NCT03311841|38284845|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
17047889|NCT00543543|38191784|FG001|Base Study|Lost to Follow-up|749|||
17047890|NCT00543543|38191785|FG002|Base Study|Lost to Follow-up|9|||
17047891|NCT00543543|38191786|FG003|Base Study|Lost to Follow-up|701|||
17047892|NCT00543543|38191783|FG000|Base Study|Physician Decision|0|||
17047893|NCT00543543|38191784|FG001|Base Study|Physician Decision|4|||
17047894|NCT00543543|38191785|FG002|Base Study|Physician Decision|0|||
17047895|NCT00543543|38191786|FG003|Base Study|Physician Decision|7|||
17047896|NCT00543543|38191783|FG000|Base Study|Protocol Violation|0|||
17047897|NCT00543543|38191784|FG001|Base Study|Protocol Violation|6|||
17047898|NCT00543543|38191785|FG002|Base Study|Protocol Violation|0|||
17047899|NCT00543543|38191786|FG003|Base Study|Protocol Violation|6|||
17047900|NCT00543543|38191783|FG000|Base Study|Withdrawal by Subject|7|||
17047901|NCT00543543|38191784|FG001|Base Study|Withdrawal by Subject|482|||
17047902|NCT00543543|38191785|FG002|Base Study|Withdrawal by Subject|5|||
17047903|NCT00543543|38191786|FG003|Base Study|Withdrawal by Subject|503|||
17047904|NCT00543543|38191783|FG000|Extension Study|Adverse Event|0|||
17047905|NCT00543543|38191784|FG001|Extension Study|Adverse Event|0|||
17047906|NCT00543543|38191785|FG002|Extension Study|Adverse Event|0|||
17047907|NCT00543543|38191786|FG003|Extension Study|Adverse Event|5|||
17047908|NCT00543543|38191783|FG000|Extension Study|Lost to Follow-up|0|||
17047909|NCT00543543|38191784|FG001|Extension Study|Lost to Follow-up|0|||
17047910|NCT00543543|38191785|FG002|Extension Study|Lost to Follow-up|0|||
17047911|NCT00543543|38191786|FG003|Extension Study|Lost to Follow-up|77|||
17047912|NCT00543543|38191783|FG000|Extension Study|Physician Decision|0|||
17047913|NCT00543543|38191784|FG001|Extension Study|Physician Decision|0|||
17047914|NCT00543543|38191785|FG002|Extension Study|Physician Decision|0|||
17047915|NCT00543543|38191786|FG003|Extension Study|Physician Decision|7|||
17047916|NCT00543543|38191783|FG000|Extension Study|Pregnancy|0|||
17047917|NCT00543543|38191784|FG001|Extension Study|Pregnancy|0|||
17047918|NCT00543543|38191785|FG002|Extension Study|Pregnancy|0|||
17047919|NCT00543543|38191786|FG003|Extension Study|Pregnancy|6|||
17047920|NCT00543543|38191783|FG000|Extension Study|Protocol Violation|0|||
17047921|NCT00543543|38191784|FG001|Extension Study|Protocol Violation|0|||
17047922|NCT00543543|38191785|FG002|Extension Study|Protocol Violation|0|||
17047923|NCT00543543|38191786|FG003|Extension Study|Protocol Violation|11|||
17047924|NCT00543543|38191783|FG000|Extension Study|Withdrawal by Subject|0|||
17047925|NCT00543543|38191784|FG001|Extension Study|Withdrawal by Subject|0|||
17047926|NCT00543543|38191785|FG002|Extension Study|Withdrawal by Subject|0|||
17047927|NCT00543543|38191786|FG003|Extension Study|Withdrawal by Subject|120|||
17047928|NCT00649220|38191801|FG000|Overall Study|Adverse Event|2|||
17047929|NCT00649220|38191801|FG000|Overall Study|Withdrawal by Subject|1|||
17047930|NCT00654368|38191808|FG000|Overall Study|Ineligibility determined|6|||
17047931|NCT00654368|38191809|FG001|Overall Study|Ineligibility determined|0|||
17047932|NCT00654368|38191810|FG002|Overall Study|Ineligibility determined|0|||
17047933|NCT00654368|38191808|FG000|Overall Study|Protocol deviation|3|||
17047934|NCT00654368|38191809|FG001|Overall Study|Protocol deviation|2|||
17047935|NCT00654368|38191810|FG002|Overall Study|Protocol deviation|1|||
17047936|NCT00654368|38191808|FG000|Overall Study|Non-compliance|2|||
17047937|NCT00654368|38191809|FG001|Overall Study|Non-compliance|1|||
17047938|NCT00654368|38191810|FG002|Overall Study|Non-compliance|2|||
17047939|NCT00654368|38191808|FG000|Overall Study|Withdrawal by Subject|5|||
17047940|NCT00654368|38191809|FG001|Overall Study|Withdrawal by Subject|2|||
17047941|NCT00654368|38191810|FG002|Overall Study|Withdrawal by Subject|2|||
17047942|NCT00654368|38191808|FG000|Overall Study|Disease progression|21|||
17047943|NCT00654368|38191809|FG001|Overall Study|Disease progression|31|||
17047944|NCT00654368|38191810|FG002|Overall Study|Disease progression|13|||
17047945|NCT00654368|38191808|FG000|Overall Study|Requirement for alternative therapy|1|||
17047946|NCT00654368|38191809|FG001|Overall Study|Requirement for alternative therapy|1|||
17047947|NCT00654368|38191810|FG002|Overall Study|Requirement for alternative therapy|1|||
17047948|NCT00654368|38191808|FG000|Overall Study|Physician Decision|0|||
17047949|NCT00654368|38191809|FG001|Overall Study|Physician Decision|0|||
17047950|NCT00654368|38191810|FG002|Overall Study|Physician Decision|2|||
17047951|NCT00654368|38191808|FG000|Overall Study|Death|1|||
17047952|NCT00654368|38191809|FG001|Overall Study|Death|0|||
17047953|NCT00654368|38191810|FG002|Overall Study|Death|0|||
17047954|NCT00654368|38191808|FG000|Overall Study|Pregnancy|0|||
17047955|NCT00654368|38191809|FG001|Overall Study|Pregnancy|0|||
17047956|NCT00654368|38191810|FG002|Overall Study|Pregnancy|2|||
17047957|NCT00654368|38191808|FG000|Overall Study|Other|0|||
17047958|NCT00654368|38191809|FG001|Overall Study|Other|2|||
17047959|NCT00654368|38191810|FG002|Overall Study|Other|3|||
17047960|NCT00654368|38191808|FG000|Overall Study|Adverse Event|14|||
17047961|NCT00654368|38191809|FG001|Overall Study|Adverse Event|9|||
17047962|NCT00654368|38191810|FG002|Overall Study|Adverse Event|6|||
17047963|NCT00647426|38191817|FG000|Overall Study|Withdrawal by Subject|2|||
17047964|NCT00647348|38191824|FG000|Overall Study|Lost to Follow-up|3|||
17047965|NCT00647348|38191825|FG001|Overall Study|Lost to Follow-up|6|||
17047966|NCT00647270|38191834|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
17047967|NCT00647270|38191835|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
17047968|NCT00647270|38191836|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
17047969|NCT00647270|38191834|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
17047970|NCT00647270|38191835|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
17047971|NCT00647270|38191836|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
17047972|NCT00647270|38191834|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
17047973|NCT00647270|38191835|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
17047974|NCT00647270|38191836|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
17047975|NCT00647270|38191834|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
17047976|NCT00647270|38191835|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
17047977|NCT00647270|38191836|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
17047978|NCT00647270|38191834|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
17047979|NCT00647270|38191835|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
17047980|NCT00647270|38191836|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
17047981|NCT00647270|38191834|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
17047982|NCT00647270|38191835|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
17047983|NCT00647270|38191836|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
17047984|NCT00647270|38191834|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
17047985|NCT00647270|38191835|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
17047986|NCT00647270|38191836|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
17047987|NCT00645944|38191849|FG000|Randomized|Withdrawal by Subject|1|||
17047988|NCT00645944|38191850|FG001|Randomized|Withdrawal by Subject|2|||
17047989|NCT00645944|38191849|FG000|Received Medication|Adverse Event|2|||
17047990|NCT00645944|38191850|FG001|Received Medication|Adverse Event|1|||
17047991|NCT00645944|38191849|FG000|Received Medication|Withdrawal by Subject|1|||
17047992|NCT00645944|38191850|FG001|Received Medication|Withdrawal by Subject|1|||
17047993|NCT00645944|38191849|FG000|Received Medication|Lost to Follow-up|1|||
17047994|NCT00645944|38191850|FG001|Received Medication|Lost to Follow-up|0|||
17047995|NCT00645944|38191849|FG000|Received Medication|Protocol Violation|2|||
17047996|NCT00645944|38191850|FG001|Received Medication|Protocol Violation|1|||
17047997|NCT00646958|38191859|FG000|Overall Study|Lack of Efficacy|1|||
17047998|NCT00646958|38191860|FG001|Overall Study|Lack of Efficacy|0|||
17047999|NCT00646958|38191861|FG002|Overall Study|Lack of Efficacy|0|||
17048000|NCT00646958|38191859|FG000|Overall Study|Adverse Event|4|||
17048001|NCT00646958|38191860|FG001|Overall Study|Adverse Event|0|||
17048002|NCT00646958|38191861|FG002|Overall Study|Adverse Event|0|||
17048003|NCT00646958|38191859|FG000|Overall Study|Lost to Follow-up|1|||
17048004|NCT00646958|38191860|FG001|Overall Study|Lost to Follow-up|5|||
17048005|NCT00646958|38191861|FG002|Overall Study|Lost to Follow-up|7|||
17048006|NCT00646958|38191859|FG000|Overall Study|Protocol Violation|1|||
17048007|NCT00646958|38191860|FG001|Overall Study|Protocol Violation|1|||
17048008|NCT00646958|38191861|FG002|Overall Study|Protocol Violation|0|||
17048009|NCT00646958|38191859|FG000|Overall Study|Abnormal screening lab tests|1|||
17048010|NCT00646958|38191860|FG001|Overall Study|Abnormal screening lab tests|1|||
17048011|NCT00646958|38191861|FG002|Overall Study|Abnormal screening lab tests|0|||
17048012|NCT00646958|38191859|FG000|Overall Study|Withdrawal by Subject|1|||
17048013|NCT00646958|38191860|FG001|Overall Study|Withdrawal by Subject|2|||
17048014|NCT00646958|38191861|FG002|Overall Study|Withdrawal by Subject|0|||
17048015|NCT00646958|38191859|FG000|Overall Study|Did not receive study drug|2|||
17048016|NCT00646958|38191860|FG001|Overall Study|Did not receive study drug|0|||
17048017|NCT00646958|38191861|FG002|Overall Study|Did not receive study drug|2|||
17048018|NCT00642746|38191871|FG000|Overall Study|Patient unevaluable|1|||
16992508|NCT02680587|38136481|FG001|Overall Study|Withdrawal by Subject|0|||
16992509|NCT00589420|38136491|FG000|Overall Study|screen failure|1|||
16992510|NCT01025336|38136500|FG000|Overall Study|Protocol Violation|0|||
16992511|NCT01025336|38136501|FG001|Overall Study|Protocol Violation|0|||
16992512|NCT01025336|38136502|FG002|Overall Study|Protocol Violation|0|||
16992513|NCT01025336|38136503|FG003|Overall Study|Protocol Violation|2|||
16992514|NCT01025336|38136504|FG004|Overall Study|Protocol Violation|0|||
16992515|NCT00796978|38136538|FG000|Overall Study|Cardiac adverse event|5|||
16992516|NCT00796978|38136538|FG000|Overall Study|Adverse Event|4|||
16992517|NCT00796978|38136538|FG000|Overall Study|Withdrawal by Subject|3|||
16992518|NCT00796822|38136544|FG000|Overall Study|Lost to Follow-up|2|||
16992519|NCT00796822|38136545|FG001|Overall Study|Lost to Follow-up|0|||
16992520|NCT00796822|38136544|FG000|Overall Study|Adverse Event|1|||
16992521|NCT00796822|38136545|FG001|Overall Study|Adverse Event|0|||
16992522|NCT01020812|38136551|FG000|Overall Study|Physician Decision|1|||
16992523|NCT01020812|38136551|FG000|Overall Study|Withdrawal by Subject|1|||
16992524|NCT01020812|38136551|FG000|Overall Study|Protocol Violation|1|||
16992525|NCT01032044|38136557|FG000|Overall Study|Protocol Violation|14|||
17048019|NCT00642746|38191872|FG001|Overall Study|Patient unevaluable|0|||
17048020|NCT00642668|38191878|FG000|Overall Study|Lost to Follow-up|1|||
17048021|NCT00642668|38191878|FG000|Overall Study|Adverse Event|2|||
17048022|NCT00642668|38191878|FG000|Overall Study|Death|2|||
17048023|NCT00642668|38191878|FG000|Overall Study|Insufficient Therapeutic Response|1|||
17048024|NCT00642668|38191878|FG000|Overall Study|Failure to Return|1|||
17048025|NCT00642668|38191878|FG000|Overall Study|Dialysis Initiation|5|||
17048026|NCT00642668|38191878|FG000|Overall Study|Blood Transfusion|2|||
17048027|NCT00729833|38191882|FG000|Overall Study|Death|5|||
17048028|NCT00729833|38191883|FG001|Overall Study|Death|1|||
17048029|NCT00729833|38191884|FG002|Overall Study|Death|3|||
17048030|NCT00729833|38191885|FG003|Overall Study|Death|5|||
17048031|NCT00729833|38191882|FG000|Overall Study|Study Terminated by Sponsor|0|||
17048032|NCT00729833|38191883|FG001|Overall Study|Study Terminated by Sponsor|0|||
17048033|NCT00729833|38191884|FG002|Overall Study|Study Terminated by Sponsor|1|||
17048034|NCT00729833|38191885|FG003|Overall Study|Study Terminated by Sponsor|0|||
17048035|NCT00729833|38191882|FG000|Overall Study|Lost to Follow-up|1|||
17048036|NCT00729833|38191883|FG001|Overall Study|Lost to Follow-up|0|||
17048037|NCT00729833|38191884|FG002|Overall Study|Lost to Follow-up|0|||
17048038|NCT00729833|38191885|FG003|Overall Study|Lost to Follow-up|0|||
17048039|NCT00729833|38191882|FG000|Overall Study|Withdrawal by Subject|3|||
17048040|NCT00729833|38191883|FG001|Overall Study|Withdrawal by Subject|1|||
17048041|NCT00729833|38191884|FG002|Overall Study|Withdrawal by Subject|3|||
17048042|NCT00729833|38191885|FG003|Overall Study|Withdrawal by Subject|0|||
17048043|NCT00729833|38191882|FG000|Overall Study|Unspecified Reasons|11|||
17048044|NCT00729833|38191883|FG001|Overall Study|Unspecified Reasons|5|||
17048045|NCT00729833|38191884|FG002|Overall Study|Unspecified Reasons|5|||
17048046|NCT00729833|38191885|FG003|Overall Study|Unspecified Reasons|1|||
17048047|NCT00645788|38191900|FG000|Overall Study|Did not receive study drug|1|||
17048048|NCT00645788|38191901|FG001|Overall Study|Did not receive study drug|1|||
17048049|NCT00645788|38191902|FG002|Overall Study|Did not receive study drug|0|||
17048050|NCT00645788|38191903|FG003|Overall Study|Did not receive study drug|0|||
17048051|NCT00645788|38191900|FG000|Overall Study|Adverse Event|4|||
17048052|NCT00645788|38191901|FG001|Overall Study|Adverse Event|9|||
17048053|NCT00645788|38191902|FG002|Overall Study|Adverse Event|5|||
17048054|NCT00645788|38191903|FG003|Overall Study|Adverse Event|3|||
17048055|NCT00645788|38191900|FG000|Overall Study|Lost to Follow-up|1|||
17048056|NCT00645788|38191901|FG001|Overall Study|Lost to Follow-up|0|||
17048057|NCT00645788|38191902|FG002|Overall Study|Lost to Follow-up|0|||
17048058|NCT00645788|38191903|FG003|Overall Study|Lost to Follow-up|0|||
17048059|NCT00645788|38191900|FG000|Overall Study|Protocol Violation|1|||
17048060|NCT00645788|38191901|FG001|Overall Study|Protocol Violation|0|||
17048061|NCT00645788|38191902|FG002|Overall Study|Protocol Violation|2|||
17048062|NCT00645788|38191903|FG003|Overall Study|Protocol Violation|0|||
17048063|NCT00645788|38191900|FG000|Overall Study|Withdrawal by Subject|0|||
17048064|NCT00645788|38191901|FG001|Overall Study|Withdrawal by Subject|1|||
17048065|NCT00645788|38191902|FG002|Overall Study|Withdrawal by Subject|0|||
17048066|NCT00645788|38191903|FG003|Overall Study|Withdrawal by Subject|2|||
17048067|NCT00645788|38191900|FG000|Overall Study|Pulmonary exacerbation|13|||
17048068|NCT00645788|38191901|FG001|Overall Study|Pulmonary exacerbation|16|||
17048069|NCT00645788|38191902|FG002|Overall Study|Pulmonary exacerbation|11|||
17048070|NCT00645788|38191903|FG003|Overall Study|Pulmonary exacerbation|9|||
17048071|NCT00642356|38191915|FG000|Overall Study|Adverse Event|1|||
17048072|NCT00642356|38191916|FG001|Overall Study|Adverse Event|0|||
17048073|NCT00642356|38191915|FG000|Overall Study|Protocol Violation|0|||
17048074|NCT00642356|38191916|FG001|Overall Study|Protocol Violation|3|||
17048075|NCT00642356|38191915|FG000|Overall Study|Lack of Efficacy|1|||
17048076|NCT00642356|38191916|FG001|Overall Study|Lack of Efficacy|0|||
17048077|NCT00642278|38191929|FG000|Overall Study|Adverse Event|2|||
17048078|NCT00642278|38191930|FG001|Overall Study|Adverse Event|1|||
17048079|NCT00642278|38191931|FG002|Overall Study|Adverse Event|3|||
17048080|NCT00642278|38191932|FG003|Overall Study|Adverse Event|1|||
17048081|NCT00642278|38191933|FG004|Overall Study|Adverse Event|2|||
17048082|NCT00642278|38191934|FG005|Overall Study|Adverse Event|2|||
17048083|NCT00642278|38191935|FG006|Overall Study|Adverse Event|0|||
17048084|NCT00642278|38191929|FG000|Overall Study|Lack of Efficacy|0|||
17048085|NCT00642278|38191930|FG001|Overall Study|Lack of Efficacy|1|||
17048086|NCT00642278|38191931|FG002|Overall Study|Lack of Efficacy|0|||
17048087|NCT00642278|38191932|FG003|Overall Study|Lack of Efficacy|0|||
17048088|NCT00642278|38191933|FG004|Overall Study|Lack of Efficacy|0|||
17048089|NCT00642278|38191934|FG005|Overall Study|Lack of Efficacy|0|||
17048090|NCT00642278|38191935|FG006|Overall Study|Lack of Efficacy|0|||
17189046|NCT02502526|38342020|FG002|Overall Study|Lost to Follow-up|3|||
17048091|NCT00642278|38191929|FG000|Overall Study|Lost to Follow-up|5|||
17048092|NCT00642278|38191930|FG001|Overall Study|Lost to Follow-up|1|||
17048093|NCT00642278|38191931|FG002|Overall Study|Lost to Follow-up|0|||
17048094|NCT00642278|38191932|FG003|Overall Study|Lost to Follow-up|1|||
17048095|NCT00642278|38191933|FG004|Overall Study|Lost to Follow-up|0|||
17048096|NCT00642278|38191934|FG005|Overall Study|Lost to Follow-up|1|||
17048097|NCT00642278|38191935|FG006|Overall Study|Lost to Follow-up|1|||
17048098|NCT00642278|38191929|FG000|Overall Study|Physician Decision|0|||
17048099|NCT00642278|38191930|FG001|Overall Study|Physician Decision|0|||
17048100|NCT00642278|38191931|FG002|Overall Study|Physician Decision|0|||
17048101|NCT00642278|38191932|FG003|Overall Study|Physician Decision|1|||
17048102|NCT00642278|38191933|FG004|Overall Study|Physician Decision|0|||
17048103|NCT00642278|38191934|FG005|Overall Study|Physician Decision|0|||
17048104|NCT00642278|38191935|FG006|Overall Study|Physician Decision|0|||
17048105|NCT00642278|38191929|FG000|Overall Study|Protocol Violation|0|||
17048106|NCT00642278|38191930|FG001|Overall Study|Protocol Violation|0|||
17048107|NCT00642278|38191931|FG002|Overall Study|Protocol Violation|1|||
17048108|NCT00642278|38191932|FG003|Overall Study|Protocol Violation|1|||
17048109|NCT00642278|38191933|FG004|Overall Study|Protocol Violation|0|||
17048110|NCT00642278|38191934|FG005|Overall Study|Protocol Violation|1|||
17048111|NCT00642278|38191935|FG006|Overall Study|Protocol Violation|2|||
17048112|NCT00642278|38191929|FG000|Overall Study|Withdrawal by Subject|1|||
17048113|NCT00642278|38191930|FG001|Overall Study|Withdrawal by Subject|1|||
17048114|NCT00642278|38191931|FG002|Overall Study|Withdrawal by Subject|1|||
17048115|NCT00642278|38191932|FG003|Overall Study|Withdrawal by Subject|3|||
17048116|NCT00642278|38191933|FG004|Overall Study|Withdrawal by Subject|6|||
17048117|NCT00642278|38191934|FG005|Overall Study|Withdrawal by Subject|2|||
17048118|NCT00642278|38191935|FG006|Overall Study|Withdrawal by Subject|2|||
17048119|NCT00642278|38191929|FG000|Overall Study|Noncompliance with study drug regimen|0|||
17048120|NCT00642278|38191930|FG001|Overall Study|Noncompliance with study drug regimen|0|||
17048121|NCT00642278|38191931|FG002|Overall Study|Noncompliance with study drug regimen|0|||
17048122|NCT00642278|38191932|FG003|Overall Study|Noncompliance with study drug regimen|1|||
17048123|NCT00642278|38191933|FG004|Overall Study|Noncompliance with study drug regimen|0|||
17048124|NCT00642278|38191934|FG005|Overall Study|Noncompliance with study drug regimen|0|||
17048125|NCT00642278|38191935|FG006|Overall Study|Noncompliance with study drug regimen|0|||
17048126|NCT00642278|38191929|FG000|Overall Study|Other|2|||
17048127|NCT00642278|38191930|FG001|Overall Study|Other|1|||
17048128|NCT00642278|38191931|FG002|Overall Study|Other|0|||
17048129|NCT00642278|38191932|FG003|Overall Study|Other|1|||
17048130|NCT00642278|38191933|FG004|Overall Study|Other|0|||
17048131|NCT00642278|38191934|FG005|Overall Study|Other|1|||
17048132|NCT00642278|38191935|FG006|Overall Study|Other|0|||
17048133|NCT00645164|38191951|FG000|Overall Study|Lost to Follow-up|2|||
17048134|NCT00645164|38191951|FG000|Overall Study|Withdrawal by Subject|4|||
17048135|NCT00645164|38191951|FG000|Overall Study|Protocol Violation|1|||
17048136|NCT00723125|38191957|FG000|Overall Study|Met Dx|1|||
17048137|NCT00723125|38191958|FG001|Overall Study|Met Dx|0|||
16992526|NCT01032044|38136558|FG001|Overall Study|Protocol Violation|8|||
16992527|NCT01032044|38136557|FG000|Overall Study|Adverse Event|0|||
16992528|NCT01032044|38136558|FG001|Overall Study|Adverse Event|1|||
16992529|NCT01032044|38136557|FG000|Overall Study|Lost to Follow-up|11|||
17048138|NCT00723125|38191957|FG000|Overall Study|Withdrawal by Subject|15|||
17048139|NCT00723125|38191958|FG001|Overall Study|Withdrawal by Subject|6|||
17048140|NCT00723125|38191957|FG000|Overall Study|Adverse Event|2|||
17048141|NCT00723125|38191958|FG001|Overall Study|Adverse Event|0|||
17048142|NCT00722423|38191972|FG000|Overall Study|Protocol Violation|0|||
17048143|NCT00722423|38191973|FG001|Overall Study|Protocol Violation|1|||
17048144|NCT00640562|38191983|FG000|Overall Study|Adverse Event|8|||
17048145|NCT00640562|38191984|FG001|Overall Study|Adverse Event|5|||
17048146|NCT00640562|38191983|FG000|Overall Study|Lack of Efficacy|1|||
17048147|NCT00640562|38191984|FG001|Overall Study|Lack of Efficacy|4|||
17048148|NCT00640562|38191983|FG000|Overall Study|Protocol Violation|2|||
17048149|NCT00640562|38191984|FG001|Overall Study|Protocol Violation|4|||
17048150|NCT00640562|38191983|FG000|Overall Study|Withdrawal by Subject|6|||
17048151|NCT00640562|38191984|FG001|Overall Study|Withdrawal by Subject|10|||
17048152|NCT00640562|38191983|FG000|Overall Study|Known risperidone intolerance|0|||
17048153|NCT00640562|38191984|FG001|Overall Study|Known risperidone intolerance|1|||
17048154|NCT00640562|38191983|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
17048155|NCT00640562|38191984|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
17048156|NCT00640562|38191983|FG000|Overall Study|Low study drug dose|0|||
17048157|NCT00640562|38191984|FG001|Overall Study|Low study drug dose|1|||
17048158|NCT00640562|38191983|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
17048159|NCT00640562|38191984|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
17048160|NCT00585923|38191992|FG000|Overall Study|Physician decided not to continue|31|||
17048161|NCT00585923|38191993|FG001|Overall Study|Physician decided not to continue|33|||
17048162|NCT00721955|38192002|FG000|Overall Study|Adverse Event|0|||
17048163|NCT00721955|38192003|FG001|Overall Study|Adverse Event|0|||
17048164|NCT00721955|38192004|FG002|Overall Study|Adverse Event|2|||
17048165|NCT00585689|38192012|FG000|Overall Study|Received different ABI-007 schedule|3|||
17048166|NCT00585689|38192012|FG000|Overall Study|Adverse Event|1|||
17048167|NCT00585689|38192012|FG000|Overall Study|Patient Declined Surgery|1|||
17048168|NCT00585689|38192012|FG000|Overall Study|Patient had unresectable disease|1|||
17048169|NCT00585689|38192012|FG000|Overall Study|Death|1|||
17048170|NCT00721799|38192016|FG000|Overall Study|Withdrawal by Subject|7|||
17048171|NCT00721799|38192016|FG000|Overall Study|withdraw by subject after scan 1|1|||
17048172|NCT00653432|38192022|FG000|Overall Study|Adverse Event|4|||
17048173|NCT00653432|38192023|FG001|Overall Study|Adverse Event|1|||
17048174|NCT00653432|38192022|FG000|Overall Study|Withdrawal by Subject|4|||
17048175|NCT00653432|38192023|FG001|Overall Study|Withdrawal by Subject|5|||
17048176|NCT00653432|38192022|FG000|Overall Study|Lost to Follow-up|7|||
17048177|NCT00653432|38192023|FG001|Overall Study|Lost to Follow-up|6|||
17048178|NCT00653432|38192022|FG000|Overall Study|Use/Need of Con Therapy|2|||
17048179|NCT00653432|38192023|FG001|Overall Study|Use/Need of Con Therapy|1|||
17048180|NCT00653432|38192022|FG000|Overall Study|Other - Reason Not Provided|5|||
17048181|NCT00653432|38192023|FG001|Overall Study|Other - Reason Not Provided|3|||
17048182|NCT00729365|38192032|FG000|Overall Study|Physician Decision|33|||
17048183|NCT00729365|38192033|FG001|Overall Study|Physician Decision|6|||
17048184|NCT00729365|38192034|FG002|Overall Study|Physician Decision|7|||
17048185|NCT00254293|38192050|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
17048186|NCT00254293|38192051|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
17048187|NCT00254293|38192052|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
17048188|NCT00254293|38192053|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
17048189|NCT00254293|38192054|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
17048190|NCT00254293|38192055|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
17048191|NCT00254293|38192056|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
17142328|NCT03311841|38284846|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
17048192|NCT00254293|38192050|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
17048193|NCT00254293|38192051|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
17048194|NCT00254293|38192052|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
17048195|NCT00254293|38192053|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
17048196|NCT00254293|38192054|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
17048197|NCT00254293|38192055|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
17048198|NCT00254293|38192056|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
17048199|NCT00254293|38192050|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
17048200|NCT00254293|38192051|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
17048201|NCT00254293|38192052|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
17048202|NCT00254293|38192053|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
17048203|NCT00254293|38192054|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
17048204|NCT00254293|38192055|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
17048205|NCT00254293|38192056|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
17048206|NCT00254293|38192050|FG000|LTE Open Label Variable SC Dosing|Death|0|||
17048207|NCT00254293|38192051|FG001|LTE Open Label Variable SC Dosing|Death|0|||
17048208|NCT00254293|38192052|FG002|LTE Open Label Variable SC Dosing|Death|1|||
17048209|NCT00254293|38192053|FG003|LTE Open Label Variable SC Dosing|Death|0|||
17048210|NCT00254293|38192054|FG004|LTE Open Label Variable SC Dosing|Death|0|||
17048211|NCT00254293|38192055|FG005|LTE Open Label Variable SC Dosing|Death|0|||
17048212|NCT00254293|38192056|FG006|LTE Open Label Variable SC Dosing|Death|0|||
17048213|NCT00254293|38192050|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
17048214|NCT00254293|38192051|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
17048215|NCT00254293|38192052|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
17048216|NCT00254293|38192053|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
17048217|NCT00254293|38192054|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
17048218|NCT00254293|38192055|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
17048219|NCT00254293|38192056|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
17048220|NCT00254293|38192050|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
17048221|NCT00254293|38192051|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
17048222|NCT00254293|38192052|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
17048223|NCT00254293|38192053|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
17048224|NCT00254293|38192054|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
17048225|NCT00254293|38192055|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
17048226|NCT00254293|38192056|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
17048227|NCT00254293|38192050|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
17048228|NCT00254293|38192051|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
17048229|NCT00254293|38192052|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
17048230|NCT00254293|38192053|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
17048231|NCT00254293|38192054|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
17048232|NCT00254293|38192055|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
17048233|NCT00254293|38192056|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
17048234|NCT00254293|38192050|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
17048235|NCT00254293|38192051|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
17048236|NCT00254293|38192052|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
17048237|NCT00254293|38192053|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
17048238|NCT00254293|38192054|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
17048239|NCT00254293|38192055|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
17048240|NCT00254293|38192056|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
17048241|NCT00254293|38192050|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
17048242|NCT00254293|38192051|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
17048243|NCT00254293|38192052|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
17048244|NCT00254293|38192053|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
17048245|NCT00254293|38192054|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
17048246|NCT00254293|38192055|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
17048247|NCT00254293|38192056|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
17048248|NCT00254293|38192050|FG000|LTE Open Label Variable SC Dosing|Other|0|||
17048249|NCT00254293|38192051|FG001|LTE Open Label Variable SC Dosing|Other|0|||
17048250|NCT00254293|38192052|FG002|LTE Open Label Variable SC Dosing|Other|2|||
17048251|NCT00254293|38192053|FG003|LTE Open Label Variable SC Dosing|Other|0|||
17048252|NCT00254293|38192054|FG004|LTE Open Label Variable SC Dosing|Other|0|||
17048253|NCT00254293|38192055|FG005|LTE Open Label Variable SC Dosing|Other|0|||
17048254|NCT00254293|38192056|FG006|LTE Open Label Variable SC Dosing|Other|0|||
17048255|NCT00254293|38192050|FG000|LTE Open Label Fixed Dosing|Death|0|||
17048256|NCT00254293|38192051|FG001|LTE Open Label Fixed Dosing|Death|0|||
17048257|NCT00254293|38192052|FG002|LTE Open Label Fixed Dosing|Death|0|||
17048258|NCT00254293|38192053|FG003|LTE Open Label Fixed Dosing|Death|0|||
17048259|NCT00254293|38192054|FG004|LTE Open Label Fixed Dosing|Death|0|||
17048260|NCT00254293|38192055|FG005|LTE Open Label Fixed Dosing|Death|0|||
17048261|NCT00254293|38192056|FG006|LTE Open Label Fixed Dosing|Death|3|||
17048262|NCT00254293|38192050|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
17048263|NCT00254293|38192051|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
17048264|NCT00254293|38192052|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
17048265|NCT00254293|38192053|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
17048266|NCT00254293|38192054|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
17048267|NCT00254293|38192055|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
17048268|NCT00254293|38192056|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
17048269|NCT00254293|38192050|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
17048270|NCT00254293|38192051|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
17048271|NCT00254293|38192052|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
17048272|NCT00254293|38192053|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
17048273|NCT00254293|38192054|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
17048274|NCT00254293|38192055|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
17048275|NCT00254293|38192056|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
17048276|NCT00254293|38192050|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
17048277|NCT00254293|38192051|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
17048278|NCT00254293|38192052|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
17048279|NCT00254293|38192053|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
17048280|NCT00254293|38192054|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
17048281|NCT00254293|38192055|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
17048282|NCT00254293|38192056|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
17048283|NCT00254293|38192050|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
17048284|NCT00254293|38192051|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
17048285|NCT00254293|38192052|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
17048286|NCT00254293|38192053|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
17048287|NCT00254293|38192054|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
17048288|NCT00254293|38192055|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
17048289|NCT00254293|38192056|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
17048290|NCT00254293|38192050|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
17048291|NCT00254293|38192051|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
17048292|NCT00254293|38192052|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
17048293|NCT00254293|38192053|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
17048294|NCT00254293|38192054|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
17048295|NCT00254293|38192055|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
17048296|NCT00254293|38192056|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
17048297|NCT00254293|38192050|FG000|LTE Open Label Fixed Dosing|Other|0|||
17048298|NCT00254293|38192051|FG001|LTE Open Label Fixed Dosing|Other|0|||
17048299|NCT00254293|38192052|FG002|LTE Open Label Fixed Dosing|Other|0|||
17048300|NCT00254293|38192053|FG003|LTE Open Label Fixed Dosing|Other|0|||
17048301|NCT00254293|38192054|FG004|LTE Open Label Fixed Dosing|Other|0|||
17048302|NCT00254293|38192055|FG005|LTE Open Label Fixed Dosing|Other|0|||
17048303|NCT00254293|38192056|FG006|LTE Open Label Fixed Dosing|Other|1|||
17048304|NCT00736385|38192101|FG000|Overall Study|Withdrawal by Subject|2|||
17048305|NCT00736385|38192102|FG001|Overall Study|Withdrawal by Subject|2|||
17048306|NCT00736385|38192101|FG000|Overall Study|Adverse Event|0|||
17048307|NCT00736385|38192102|FG001|Overall Study|Adverse Event|1|||
17048308|NCT00585221|38192108|FG000|Overall Study|Protocol Violation|8|||
17048309|NCT00253747|38192114|FG000|Overall Study|Lost to Follow-up|13|||
17048310|NCT00253747|38192115|FG001|Overall Study|Lost to Follow-up|14|||
17048311|NCT00253747|38192114|FG000|Overall Study|Withdrawal by Subject|10|||
17048312|NCT00253747|38192115|FG001|Overall Study|Withdrawal by Subject|11|||
17048313|NCT00253747|38192114|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
17048314|NCT00253747|38192115|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
17048315|NCT00252733|38192133|FG000|Overall Study|Withdrawal by Subject|73|||
17048316|NCT00252733|38192134|FG001|Overall Study|Withdrawal by Subject|67|||
17048317|NCT00252733|38192133|FG000|Overall Study|Death|7|||
17048318|NCT00252733|38192134|FG001|Overall Study|Death|5|||
17048319|NCT00252733|38192133|FG000|Overall Study|Lost to Follow-up|12|||
17048320|NCT00252733|38192134|FG001|Overall Study|Lost to Follow-up|6|||
17048321|NCT00252733|38192133|FG000|Overall Study|Multiple Reasons|14|||
17048322|NCT00252733|38192134|FG001|Overall Study|Multiple Reasons|14|||
17048323|NCT00275821|38192143|FG000|Overall Study|Adverse Event|4|||
17048324|NCT00275821|38192144|FG001|Overall Study|Adverse Event|12|||
17048325|NCT00275821|38192145|FG002|Overall Study|Adverse Event|5|||
17048326|NCT00275821|38192143|FG000|Overall Study|Administrative problems|3|||
17048327|NCT00275821|38192144|FG001|Overall Study|Administrative problems|4|||
17048328|NCT00275821|38192145|FG002|Overall Study|Administrative problems|4|||
17048329|NCT00275821|38192143|FG000|Overall Study|Withdrawal by Subject|0|||
17048330|NCT00275821|38192144|FG001|Overall Study|Withdrawal by Subject|2|||
17048331|NCT00275821|38192145|FG002|Overall Study|Withdrawal by Subject|1|||
17048332|NCT00275821|38192143|FG000|Overall Study|Lost to Follow-up|0|||
17048333|NCT00275821|38192144|FG001|Overall Study|Lost to Follow-up|1|||
17048334|NCT00275821|38192145|FG002|Overall Study|Lost to Follow-up|1|||
17048335|NCT00275821|38192143|FG000|Overall Study|Death|0|||
17048336|NCT00275821|38192144|FG001|Overall Study|Death|2|||
17048337|NCT00275821|38192145|FG002|Overall Study|Death|1|||
17048338|NCT00275821|38192143|FG000|Overall Study|Lack of Efficacy|2|||
17048339|NCT00275821|38192144|FG001|Overall Study|Lack of Efficacy|1|||
17048340|NCT00275821|38192145|FG002|Overall Study|Lack of Efficacy|0|||
17048341|NCT00275821|38192143|FG000|Overall Study|Protocol Violation|5|||
17048342|NCT00275821|38192144|FG001|Overall Study|Protocol Violation|1|||
17048343|NCT00275821|38192145|FG002|Overall Study|Protocol Violation|0|||
17048344|NCT00275509|38192155|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
17048345|NCT00275509|38192156|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
17048346|NCT00252577|38192162|FG000|Overall Study|Lost to Follow-up|20|||
17048347|NCT00252499|38192169|FG000|Overall Study|Lost to Follow-up|1|||
17048348|NCT00252499|38192170|FG001|Overall Study|Lost to Follow-up|0|||
17048349|NCT00252499|38192171|FG002|Overall Study|Lost to Follow-up|0|||
17048350|NCT00252187|38192181|FG000|Overall Study|Adverse Event|3|||
17048351|NCT00252187|38192182|FG001|Overall Study|Adverse Event|1|||
17048352|NCT00252187|38192181|FG000|Overall Study|Withdrawal by Subject|1|||
17048353|NCT00252187|38192182|FG001|Overall Study|Withdrawal by Subject|0|||
17048354|NCT00572910|38192194|FG000|Overall Study|Adverse Event|1|||
17048355|NCT00572910|38192195|FG001|Overall Study|Adverse Event|2|||
17048356|NCT00572910|38192196|FG002|Overall Study|Adverse Event|0|||
17048357|NCT00572910|38192197|FG003|Overall Study|Adverse Event|2|||
17048358|NCT00572910|38192198|FG004|Overall Study|Adverse Event|0|||
17048359|NCT00572910|38192199|FG005|Overall Study|Adverse Event|0|||
17048360|NCT00572910|38192200|FG006|Overall Study|Adverse Event|4|||
17048361|NCT00572910|38192201|FG007|Overall Study|Adverse Event|2|||
17048362|NCT00572910|38192202|FG008|Overall Study|Adverse Event|1|||
17048363|NCT00572910|38192203|FG009|Overall Study|Adverse Event|3|||
17048364|NCT00572910|38192204|FG010|Overall Study|Adverse Event|2|||
17048365|NCT00572910|38192194|FG000|Overall Study|Lost to Follow-up|0|||
17048366|NCT00572910|38192195|FG001|Overall Study|Lost to Follow-up|1|||
17048367|NCT00572910|38192196|FG002|Overall Study|Lost to Follow-up|1|||
17048368|NCT00572910|38192197|FG003|Overall Study|Lost to Follow-up|2|||
17048369|NCT00572910|38192198|FG004|Overall Study|Lost to Follow-up|1|||
17048370|NCT00572910|38192199|FG005|Overall Study|Lost to Follow-up|0|||
17048371|NCT00572910|38192200|FG006|Overall Study|Lost to Follow-up|0|||
17048372|NCT00572910|38192201|FG007|Overall Study|Lost to Follow-up|0|||
17048373|NCT00572910|38192202|FG008|Overall Study|Lost to Follow-up|0|||
17048374|NCT00572910|38192203|FG009|Overall Study|Lost to Follow-up|1|||
17048375|NCT00572910|38192204|FG010|Overall Study|Lost to Follow-up|0|||
17048376|NCT00572910|38192194|FG000|Overall Study|Withdrawal by Subject|3|||
17048377|NCT00572910|38192195|FG001|Overall Study|Withdrawal by Subject|0|||
17048378|NCT00572910|38192196|FG002|Overall Study|Withdrawal by Subject|1|||
17048379|NCT00572910|38192197|FG003|Overall Study|Withdrawal by Subject|0|||
17048380|NCT00572910|38192198|FG004|Overall Study|Withdrawal by Subject|1|||
17048381|NCT00572910|38192199|FG005|Overall Study|Withdrawal by Subject|3|||
17048382|NCT00572910|38192200|FG006|Overall Study|Withdrawal by Subject|0|||
17048383|NCT00572910|38192201|FG007|Overall Study|Withdrawal by Subject|2|||
17048384|NCT00572910|38192202|FG008|Overall Study|Withdrawal by Subject|2|||
17048385|NCT00572910|38192203|FG009|Overall Study|Withdrawal by Subject|2|||
17048386|NCT00572910|38192204|FG010|Overall Study|Withdrawal by Subject|1|||
17048387|NCT00163657|38192242|FG000|Overall Study|Death|12|||
17048388|NCT00163657|38192243|FG001|Overall Study|Death|14|||
17048389|NCT00163657|38192244|FG002|Overall Study|Death|19|||
17048390|NCT00163657|38192242|FG000|Overall Study|graft loss|4|||
17048391|NCT00163657|38192243|FG001|Overall Study|graft loss|1|||
17048392|NCT00163657|38192244|FG002|Overall Study|graft loss|2|||
17048393|NCT00163657|38192242|FG000|Overall Study|Withdrawal by Subject|2|||
17048394|NCT00163657|38192243|FG001|Overall Study|Withdrawal by Subject|3|||
17048395|NCT00163657|38192244|FG002|Overall Study|Withdrawal by Subject|2|||
17048396|NCT00163657|38192242|FG000|Overall Study|Physician Decision|0|||
17048397|NCT00163657|38192243|FG001|Overall Study|Physician Decision|1|||
17048398|NCT00163657|38192244|FG002|Overall Study|Physician Decision|1|||
17048399|NCT00163657|38192242|FG000|Overall Study|Non Compliance|1|||
17048400|NCT00163657|38192243|FG001|Overall Study|Non Compliance|0|||
16992530|NCT01032044|38136558|FG001|Overall Study|Lost to Follow-up|11|||
17142329|NCT03311841|38284847|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
17142330|NCT03311841|38284848|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
17142331|NCT03311373|38284869|FG000|Overall Study|Adverse Event|1|||
17142332|NCT03311373|38284869|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
17142333|NCT03311373|38284869|FG000|Overall Study|Lost to Follow-up|1|||
17142334|NCT03311373|38284869|FG000|Overall Study|Physician Decision|1|||
17142335|NCT03311373|38284869|FG000|Overall Study|Withdrawal by Subject|3|||
17142336|NCT01155375|38284881|FG000|Overall Study|Adverse Event|1|||
17142337|NCT01155375|38284882|FG001|Overall Study|Adverse Event|0|||
17142338|NCT00628095|38284891|FG000|Overall Study|Adverse Event|5|||
17142339|NCT00628095|38284892|FG001|Overall Study|Adverse Event|3|||
17142340|NCT00628095|38284891|FG000|Overall Study|Lack of Efficacy|0|||
17142341|NCT00628095|38284892|FG001|Overall Study|Lack of Efficacy|3|||
17142342|NCT00628095|38284891|FG000|Overall Study|Withdrawal by Subject|2|||
17142343|NCT00628095|38284892|FG001|Overall Study|Withdrawal by Subject|0|||
17142344|NCT00628095|38284891|FG000|Overall Study|Other|0|||
17142345|NCT00628095|38284892|FG001|Overall Study|Other|1|||
17142346|NCT02889861|38284900|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
17142347|NCT03325881|38284911|FG000|Overall Study|Protocol Violation|0|||
17142348|NCT03325881|38284912|FG001|Overall Study|Protocol Violation|1|||
17142349|NCT03325881|38284911|FG000|Overall Study|Withdrawal by Subject|0|||
17142350|NCT03325881|38284912|FG001|Overall Study|Withdrawal by Subject|2|||
17142351|NCT03325881|38284911|FG000|Overall Study|Lack of Efficacy|2|||
17142352|NCT03325881|38284912|FG001|Overall Study|Lack of Efficacy|0|||
16992531|NCT01024946|38136564|FG000|Overall Study|Screen Failure|3|||
16992532|NCT01024946|38136564|FG000|Overall Study|Withdrawal by Subject|1|||
17142353|NCT03325881|38284911|FG000|Overall Study|Not treated|1|||
17142354|NCT03325881|38284912|FG001|Overall Study|Not treated|0|||
17142355|NCT02887989|38284922|FG000|Overall Study|Withdrawal by Subject|8|||
17142356|NCT02887989|38284923|FG001|Overall Study|Withdrawal by Subject|11|||
17142357|NCT02887989|38284922|FG000|Overall Study|Death|1|||
17142358|NCT02887989|38284923|FG001|Overall Study|Death|0|||
17142359|NCT02887521|38284931|FG000|Overall Study|Withdrawal by Subject|0|||
17142360|NCT02887521|38284932|FG001|Overall Study|Withdrawal by Subject|3|||
17142361|NCT03305055|38284940|FG000|Overall Study|Withdrawal by Subject|0|||
17142362|NCT03305055|38284941|FG001|Overall Study|Withdrawal by Subject|1|||
17142363|NCT03305055|38284940|FG000|Overall Study|Adverse Event|1|||
17142364|NCT03305055|38284941|FG001|Overall Study|Adverse Event|1|||
17142365|NCT02763189|38284949|FG000|Overall Study|Device failure|0|||
17142366|NCT02763189|38284950|FG001|Overall Study|Device failure|2|||
17142367|NCT03273387|38284958|FG000|Overall Study|Death|2|||
17142368|NCT03273387|38284959|FG001|Overall Study|Death|2|||
17142369|NCT03273387|38284958|FG000|Overall Study|Withdrawal by Subject|1|||
17142370|NCT03273387|38284959|FG001|Overall Study|Withdrawal by Subject|1|||
17142371|NCT01328080|38284965|FG000|Overall Study|Lost to Follow-up|5|||
16992533|NCT01024946|38136564|FG000|Overall Study|Adverse Event|1|||
16992534|NCT00724867|38136568|FG000|Overall Study|Adverse Event|25|||
16992535|NCT00724867|38136568|FG000|Overall Study|Lack of Efficacy|14|||
16992536|NCT00724867|38136568|FG000|Overall Study|Lost to Follow-up|12|||
16992537|NCT00724867|38136568|FG000|Overall Study|Non-compliance with study drug|6|||
17142372|NCT02649946|38284984|FG000|Overall Study|Withdrawal by Subject|1|||
16992538|NCT00724867|38136568|FG000|Overall Study|Physician Decision|17|||
16992539|NCT00724867|38136568|FG000|Overall Study|Protocol Violation|1|||
17142373|NCT02649946|38284985|FG001|Overall Study|Withdrawal by Subject|1|||
17142374|NCT02649946|38284984|FG000|Overall Study|Death|7|||
17142375|NCT02649946|38284985|FG001|Overall Study|Death|9|||
17142376|NCT02649946|38284984|FG000|Overall Study|Physician Decision|1|||
17142377|NCT02649946|38284985|FG001|Overall Study|Physician Decision|0|||
17142378|NCT02649946|38284984|FG000|Overall Study|Lost to Follow-up|2|||
17142379|NCT02649946|38284985|FG001|Overall Study|Lost to Follow-up|1|||
17142380|NCT02649946|38284984|FG000|Overall Study|Erroneously enrolled|1|||
17142381|NCT02649946|38284985|FG001|Overall Study|Erroneously enrolled|0|||
17142382|NCT02649946|38284984|FG000|Overall Study|Missed 6-month follow-up visit|0|||
17142383|NCT02649946|38284985|FG001|Overall Study|Missed 6-month follow-up visit|4|||
17142384|NCT03273153|38284993|FG000|Overall Study|Adverse Event|1|||
17142385|NCT03273153|38284994|FG001|Overall Study|Adverse Event|2|||
17142386|NCT03273153|38284993|FG000|Overall Study|Missing|0|||
17142387|NCT03273153|38284994|FG001|Overall Study|Missing|2|||
17142388|NCT03273153|38284993|FG000|Overall Study|Other|3|||
17142389|NCT03273153|38284994|FG001|Overall Study|Other|2|||
17142390|NCT03273153|38284993|FG000|Overall Study|Symptomatic Deterioration|0|||
17142391|NCT03273153|38284994|FG001|Overall Study|Symptomatic Deterioration|1|||
17142392|NCT03273153|38284993|FG000|Overall Study|Progressive Disease|6|||
17142393|NCT03273153|38284994|FG001|Overall Study|Progressive Disease|5|||
17142394|NCT03273153|38284993|FG000|Overall Study|Physician Decision|1|||
17142395|NCT03273153|38284994|FG001|Overall Study|Physician Decision|3|||
17142396|NCT03273153|38284993|FG000|Overall Study|Study Terminated by Sponsor|112|||
17142397|NCT03273153|38284994|FG001|Overall Study|Study Terminated by Sponsor|102|||
17142398|NCT03273153|38284993|FG000|Overall Study|Withdrawal by Subject|26|||
17142399|NCT03273153|38284994|FG001|Overall Study|Withdrawal by Subject|25|||
17142400|NCT03273153|38284993|FG000|Overall Study|Protocol Deviation|3|||
17142401|NCT03273153|38284994|FG001|Overall Study|Protocol Deviation|0|||
17142402|NCT03273153|38284993|FG000|Overall Study|Lost to Follow-up|6|||
17048401|NCT00163657|38192244|FG002|Overall Study|Non Compliance|0|||
17048402|NCT00163657|38192242|FG000|Overall Study|Lost to Follow-up|1|||
17142403|NCT03273153|38284994|FG001|Overall Study|Lost to Follow-up|11|||
17142404|NCT03273153|38284993|FG000|Overall Study|Death|66|||
17142405|NCT03273153|38284994|FG001|Overall Study|Death|69|||
17142406|NCT03323034|38285006|FG000|Overall Study|Lack of Efficacy|5|||
17142407|NCT03323034|38285007|FG001|Overall Study|Lack of Efficacy|5|||
17142408|NCT03323034|38285008|FG002|Overall Study|Lack of Efficacy|6|||
17142409|NCT03323034|38285009|FG003|Overall Study|Lack of Efficacy|5|||
17142410|NCT03323034|38285010|FG004|Overall Study|Lack of Efficacy|5|||
17142411|NCT03323034|38285006|FG000|Overall Study|Physician Decision|0|||
17142412|NCT03323034|38285007|FG001|Overall Study|Physician Decision|0|||
17142413|NCT03323034|38285008|FG002|Overall Study|Physician Decision|0|||
17048403|NCT00163657|38192243|FG001|Overall Study|Lost to Follow-up|3|||
17048404|NCT00163657|38192244|FG002|Overall Study|Lost to Follow-up|10|||
17048405|NCT00163657|38192242|FG000|Overall Study|Other reason|0|||
17048406|NCT00163657|38192243|FG001|Overall Study|Other reason|1|||
17048407|NCT00163657|38192244|FG002|Overall Study|Other reason|3|||
17048408|NCT00609492|38192255|FG000|Overall Study|Withdrawal by Subject|0|||
17048409|NCT00609492|38192256|FG001|Overall Study|Withdrawal by Subject|2|||
17048410|NCT00609492|38192257|FG002|Overall Study|Withdrawal by Subject|3|||
17048411|NCT00609492|38192255|FG000|Overall Study|Lost to Follow-up|1|||
17048412|NCT00609492|38192256|FG001|Overall Study|Lost to Follow-up|1|||
17048413|NCT00609492|38192257|FG002|Overall Study|Lost to Follow-up|4|||
17048414|NCT00230971|38192269|FG000|Randomization|No study drug administered|3|||
17048415|NCT00230971|38192270|FG001|Randomization|No study drug administered|3|||
17048416|NCT00230971|38192269|FG000|Baseline Participants|Lost to Follow-up|5|||
17048417|NCT00230971|38192270|FG001|Baseline Participants|Lost to Follow-up|12|||
17048418|NCT00230971|38192269|FG000|Baseline Participants|Death|6|||
17048419|NCT00230971|38192270|FG001|Baseline Participants|Death|5|||
17048420|NCT00230971|38192269|FG000|Baseline Participants|Withdrawal by Subject|7|||
17048421|NCT00230971|38192270|FG001|Baseline Participants|Withdrawal by Subject|1|||
17048422|NCT00230971|38192269|FG000|Baseline Participants|Adverse Event|1|||
17048423|NCT00230971|38192270|FG001|Baseline Participants|Adverse Event|0|||
17048424|NCT00230971|38192269|FG000|Baseline Participants|No bacteria observed|1|||
17048425|NCT00230971|38192270|FG001|Baseline Participants|No bacteria observed|0|||
17048426|NCT00230971|38192269|FG000|Baseline Participants|Failure to return|1|||
17048427|NCT00230971|38192270|FG001|Baseline Participants|Failure to return|1|||
17048428|NCT00230971|38192269|FG000|Baseline Participants|Reintervention|1|||
17048429|NCT00230971|38192270|FG001|Baseline Participants|Reintervention|0|||
17048430|NCT00211081|38192276|FG000|Overall Study|Withdrawal by Subject|2|||
17048431|NCT00609336|38192280|FG000|Overall Study|Protocol Violation|3|||
17048432|NCT00609336|38192280|FG000|Overall Study|Death|1|||
17048433|NCT00609336|38192280|FG000|Overall Study|LA or Met at Surgery|9|||
17048434|NCT00612066|38192285|FG000|Overall Study|Adverse Event|1|||
17048435|NCT00573144|38192291|FG000|Overall Study|Withdrawal by Subject|2|||
17048436|NCT00573144|38192292|FG001|Overall Study|Withdrawal by Subject|3|||
17142414|NCT03323034|38285009|FG003|Overall Study|Physician Decision|0|||
17048437|NCT00640328|38192304|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
17048438|NCT00640328|38192305|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
17048439|NCT00640328|38192306|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
17142415|NCT03323034|38285010|FG004|Overall Study|Physician Decision|1|||
17048440|NCT00640328|38192307|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
17048441|NCT00640328|38192308|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
17048442|NCT00640328|38192309|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
17048443|NCT00640328|38192304|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
17048444|NCT00640328|38192305|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
17048445|NCT00640328|38192306|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
17048446|NCT00640328|38192307|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
17048447|NCT00640328|38192308|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
17048448|NCT00640328|38192309|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
17048449|NCT00640328|38192304|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
17048450|NCT00640328|38192305|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
17048451|NCT00640328|38192306|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
17048452|NCT00640328|38192307|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
17048453|NCT00640328|38192308|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
17048454|NCT00640328|38192309|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
17048455|NCT00640328|38192304|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
17048456|NCT00640328|38192305|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
17048457|NCT00640328|38192306|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
17048458|NCT00640328|38192307|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
17048459|NCT00640328|38192308|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
17048460|NCT00640328|38192309|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
17048461|NCT00163189|38192330|FG000|Overall Study|Other|6|||
17048462|NCT00163189|38192330|FG000|Overall Study|Lost to Follow-up|1|||
17048463|NCT00163189|38192330|FG000|Overall Study|Protocol Violation|2|||
17048464|NCT00163189|38192330|FG000|Overall Study|Death|3|||
17048465|NCT00163189|38192330|FG000|Overall Study|Adverse Event|6|||
17048466|NCT00163189|38192330|FG000|Overall Study|Lack of Efficacy|7|||
17048467|NCT00163189|38192330|FG000|Overall Study|Study terminated by sponsor|11|||
17048468|NCT00163189|38192330|FG000|Overall Study|Withdrawal by Subject|11|||
17048469|NCT00163189|38192330|FG000|Overall Study|Did not meet continuation criterion|16|||
17048470|NCT00162097|38192338|FG000|Overall Study|Participant no longer met study criteria|0|||
17048471|NCT00162097|38192339|FG001|Overall Study|Participant no longer met study criteria|0|||
17048472|NCT00162097|38192340|FG002|Overall Study|Participant no longer met study criteria|0|||
17048473|NCT00162097|38192341|FG003|Overall Study|Participant no longer met study criteria|1|||
17048474|NCT00640016|38192361|FG000|Overall Study|Withdrawal by Subject|0|||
17048475|NCT00640016|38192362|FG001|Overall Study|Withdrawal by Subject|1|||
17048476|NCT00640016|38192363|FG002|Overall Study|Withdrawal by Subject|0|||
17048477|NCT00640016|38192364|FG003|Overall Study|Withdrawal by Subject|0|||
17048478|NCT00640016|38192361|FG000|Overall Study|Study termination|2|||
17048479|NCT00640016|38192362|FG001|Overall Study|Study termination|1|||
17048480|NCT00640016|38192363|FG002|Overall Study|Study termination|3|||
17048481|NCT00640016|38192364|FG003|Overall Study|Study termination|2|||
17048482|NCT00640016|38192361|FG000|Overall Study|Adverse Event|0|||
17048483|NCT00640016|38192362|FG001|Overall Study|Adverse Event|0|||
17048484|NCT00640016|38192363|FG002|Overall Study|Adverse Event|0|||
17048485|NCT00640016|38192364|FG003|Overall Study|Adverse Event|1|||
17048486|NCT00608868|38192381|FG000|Overall Study|Withdrawal by Subject|7|||
17048487|NCT00608868|38192381|FG000|Overall Study|Protocol Violation|3|||
17048488|NCT00608868|38192381|FG000|Overall Study|Lost to Follow-up|2|||
17048489|NCT00608868|38192381|FG000|Overall Study|Adverse Event|1|||
17048490|NCT00608868|38192381|FG000|Overall Study|Physician Decision|2|||
17048491|NCT00608322|38192387|FG000|Overall Study|Death|2|||
17048492|NCT00608322|38192388|FG001|Overall Study|Death|1|||
17048493|NCT00606294|38192396|FG000|Overall Study|Withdrawal by Subject|36|||
17048494|NCT00606294|38192397|FG001|Overall Study|Withdrawal by Subject|0|||
17048495|NCT00608244|38192403|FG000|Overall Study|Adverse Event|1|||
17048496|NCT00608244|38192403|FG000|Overall Study|Low trough levels|1|||
17048497|NCT00605280|38192413|FG000|Year 1|Protocol Violation|0|||
17048498|NCT00605280|38192414|FG001|Year 1|Protocol Violation|0|||
17048499|NCT00605280|38192415|FG002|Year 1|Protocol Violation|0|||
17048500|NCT00605280|38192416|FG003|Year 1|Protocol Violation|1|||
17048501|NCT00605280|38192413|FG000|Year 1|Adverse Event|3|||
17048502|NCT00605280|38192414|FG001|Year 1|Adverse Event|1|||
17048503|NCT00605280|38192415|FG002|Year 1|Adverse Event|1|||
17048504|NCT00605280|38192416|FG003|Year 1|Adverse Event|5|||
17048505|NCT00605280|38192413|FG000|Year 1|Physician Decision|7|||
17048506|NCT00605280|38192414|FG001|Year 1|Physician Decision|4|||
16780909|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
17048507|NCT00605280|38192415|FG002|Year 1|Physician Decision|0|||
17048508|NCT00605280|38192416|FG003|Year 1|Physician Decision|6|||
17048509|NCT00605280|38192413|FG000|Year 1|Withdrawal by Subject|2|||
17048510|NCT00605280|38192414|FG001|Year 1|Withdrawal by Subject|4|||
17048511|NCT00605280|38192415|FG002|Year 1|Withdrawal by Subject|0|||
17048512|NCT00605280|38192416|FG003|Year 1|Withdrawal by Subject|4|||
17048513|NCT00605280|38192413|FG000|Year 1|Other|2|||
17048514|NCT00605280|38192414|FG001|Year 1|Other|1|||
17048515|NCT00605280|38192415|FG002|Year 1|Other|0|||
17048516|NCT00605280|38192416|FG003|Year 1|Other|1|||
17048517|NCT00605280|38192413|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
17048518|NCT00605280|38192414|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
17048519|NCT00605280|38192415|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
17048520|NCT00605280|38192416|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
17048521|NCT00605280|38192413|FG000|Year 2|Adverse Event|4|||
17048522|NCT00605280|38192414|FG001|Year 2|Adverse Event|0|||
17048523|NCT00605280|38192415|FG002|Year 2|Adverse Event|2|||
17048524|NCT00605280|38192416|FG003|Year 2|Adverse Event|4|||
17048525|NCT00605280|38192413|FG000|Year 2|Physician Decision|11|||
17048526|NCT00605280|38192414|FG001|Year 2|Physician Decision|6|||
17048527|NCT00605280|38192415|FG002|Year 2|Physician Decision|4|||
17048528|NCT00605280|38192416|FG003|Year 2|Physician Decision|11|||
17048529|NCT00605280|38192413|FG000|Year 2|Withdrawal by Subject|4|||
17048530|NCT00605280|38192414|FG001|Year 2|Withdrawal by Subject|0|||
17048531|NCT00605280|38192415|FG002|Year 2|Withdrawal by Subject|0|||
17048532|NCT00605280|38192416|FG003|Year 2|Withdrawal by Subject|4|||
17048533|NCT00605280|38192413|FG000|Year 2|Other|1|||
17048534|NCT00605280|38192414|FG001|Year 2|Other|0|||
17048535|NCT00605280|38192415|FG002|Year 2|Other|0|||
17048536|NCT00605280|38192416|FG003|Year 2|Other|1|||
17048537|NCT00605280|38192413|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
17048538|NCT00605280|38192414|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
17048539|NCT00605280|38192415|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
17048540|NCT00605280|38192416|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
17048541|NCT00605280|38192413|FG000|Year 3 Extension|Adverse Event|2|||
17048542|NCT00605280|38192414|FG001|Year 3 Extension|Adverse Event|0|||
17048543|NCT00605280|38192415|FG002|Year 3 Extension|Adverse Event|0|||
17048544|NCT00605280|38192416|FG003|Year 3 Extension|Adverse Event|2|||
17048545|NCT00605280|38192413|FG000|Year 3 Extension|Physician Decision|0|||
17048546|NCT00605280|38192414|FG001|Year 3 Extension|Physician Decision|0|||
17048547|NCT00605280|38192415|FG002|Year 3 Extension|Physician Decision|0|||
17048548|NCT00605280|38192416|FG003|Year 3 Extension|Physician Decision|2|||
17048549|NCT00605280|38192413|FG000|Year 3 Extension|Withdrawal by Subject|2|||
17048550|NCT00605280|38192414|FG001|Year 3 Extension|Withdrawal by Subject|0|||
17048551|NCT00605280|38192415|FG002|Year 3 Extension|Withdrawal by Subject|0|||
17048552|NCT00605280|38192416|FG003|Year 3 Extension|Withdrawal by Subject|5|||
17048553|NCT00605280|38192413|FG000|Year 3 Extension|Other|2|||
17048554|NCT00605280|38192414|FG001|Year 3 Extension|Other|0|||
17048555|NCT00605280|38192415|FG002|Year 3 Extension|Other|0|||
17048556|NCT00605280|38192416|FG003|Year 3 Extension|Other|0|||
17048557|NCT00605280|38192413|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
17048558|NCT00605280|38192414|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
17048559|NCT00605280|38192415|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
17048560|NCT00605280|38192416|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
17048561|NCT00607386|38192426|FG000|Overall Study|Physician Decision|1|||
17048562|NCT00638690|38192432|FG000|Overall Study|Death|655|||
17048563|NCT00638690|38192433|FG001|Overall Study|Death|335|||
17048564|NCT00638690|38192432|FG000|Overall Study|Withdrawal by Subject|22|||
17048565|NCT00638690|38192433|FG001|Overall Study|Withdrawal by Subject|5|||
17048566|NCT00638690|38192432|FG000|Overall Study|Lost to Follow-up|4|||
17048567|NCT00638690|38192433|FG001|Overall Study|Lost to Follow-up|2|||
17048568|NCT00543387|38192449|FG000|Panel 1 + Panel 2|Adverse Event|0|||
17048569|NCT00543387|38192450|FG001|Panel 1 + Panel 2|Adverse Event|1|||
17048570|NCT00543387|38192451|FG002|Panel 1 + Panel 2|Adverse Event|0|||
17048571|NCT00543387|38192452|FG003|Panel 1 + Panel 2|Adverse Event|0|||
17048572|NCT00543387|38192453|FG004|Panel 1 + Panel 2|Adverse Event|0|||
17048573|NCT00543387|38192454|FG005|Panel 1 + Panel 2|Adverse Event|0|||
17048574|NCT00543387|38192455|FG006|Panel 1 + Panel 2|Adverse Event|0|||
17048575|NCT00543387|38192456|FG007|Panel 1 + Panel 2|Adverse Event|1|||
17048576|NCT00543387|38192457|FG008|Panel 1 + Panel 2|Adverse Event|1|||
17048577|NCT00543387|38192458|FG009|Panel 1 + Panel 2|Adverse Event|0|||
17048578|NCT00543387|38192459|FG010|Panel 1 + Panel 2|Adverse Event|0|||
17048579|NCT00543387|38192449|FG000|Panel 1 + Panel 2|Physician Decision|0|||
17048580|NCT00543387|38192450|FG001|Panel 1 + Panel 2|Physician Decision|0|||
17048581|NCT00543387|38192451|FG002|Panel 1 + Panel 2|Physician Decision|1|||
17048582|NCT00543387|38192452|FG003|Panel 1 + Panel 2|Physician Decision|0|||
17048583|NCT00543387|38192453|FG004|Panel 1 + Panel 2|Physician Decision|0|||
17048584|NCT00543387|38192454|FG005|Panel 1 + Panel 2|Physician Decision|0|||
17048585|NCT00543387|38192455|FG006|Panel 1 + Panel 2|Physician Decision|0|||
17048586|NCT00543387|38192456|FG007|Panel 1 + Panel 2|Physician Decision|1|||
17048587|NCT00543387|38192457|FG008|Panel 1 + Panel 2|Physician Decision|0|||
17048588|NCT00543387|38192458|FG009|Panel 1 + Panel 2|Physician Decision|0|||
17048589|NCT00543387|38192459|FG010|Panel 1 + Panel 2|Physician Decision|0|||
17048590|NCT00543387|38192449|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
17048591|NCT00543387|38192450|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
17048592|NCT00543387|38192451|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
17048593|NCT00543387|38192452|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
17048594|NCT00543387|38192453|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
17048595|NCT00543387|38192454|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
17048596|NCT00543387|38192455|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
17048597|NCT00543387|38192456|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
17048598|NCT00543387|38192457|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
17048599|NCT00543387|38192458|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
17048600|NCT00543387|38192459|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
17048601|NCT00543387|38192449|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048602|NCT00543387|38192450|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048603|NCT00543387|38192451|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048604|NCT00543387|38192452|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048605|NCT00543387|38192453|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048606|NCT00543387|38192454|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048607|NCT00543387|38192455|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
17048608|NCT00543387|38192456|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048609|NCT00543387|38192457|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048610|NCT00543387|38192458|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048611|NCT00543387|38192459|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
17048612|NCT00543387|38192449|FG000|Crossover Participants|Progressive Disease|0|||
17048613|NCT00543387|38192450|FG001|Crossover Participants|Progressive Disease|0|||
17048614|NCT00543387|38192451|FG002|Crossover Participants|Progressive Disease|0|||
17048615|NCT00543387|38192452|FG003|Crossover Participants|Progressive Disease|0|||
17048616|NCT00543387|38192453|FG004|Crossover Participants|Progressive Disease|0|||
17048617|NCT00543387|38192454|FG005|Crossover Participants|Progressive Disease|0|||
17048618|NCT00543387|38192455|FG006|Crossover Participants|Progressive Disease|0|||
17048619|NCT00543387|38192456|FG007|Crossover Participants|Progressive Disease|0|||
17048620|NCT00543387|38192457|FG008|Crossover Participants|Progressive Disease|0|||
17048621|NCT00543387|38192458|FG009|Crossover Participants|Progressive Disease|1|||
17048622|NCT00543387|38192459|FG010|Crossover Participants|Progressive Disease|2|||
17048623|NCT00543387|38192449|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
17048624|NCT00543387|38192450|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
17048625|NCT00543387|38192451|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
17048626|NCT00543387|38192452|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
17048627|NCT00543387|38192453|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
17048628|NCT00543387|38192454|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
17048629|NCT00543387|38192455|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
17048630|NCT00543387|38192456|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
17048631|NCT00543387|38192457|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
17048632|NCT00543387|38192458|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
17048633|NCT00543387|38192459|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
17048634|NCT00635570|38192489|FG000|Overall Study|Lost to Follow-up|8|||
17048635|NCT00635570|38192490|FG001|Overall Study|Lost to Follow-up|8|||
17048636|NCT00635570|38192489|FG000|Overall Study|Withdrawal by Subject|1|||
17048637|NCT00635570|38192490|FG001|Overall Study|Withdrawal by Subject|1|||
17048638|NCT00635570|38192489|FG000|Overall Study|Adverse Event|2|||
17048639|NCT00635570|38192490|FG001|Overall Study|Adverse Event|0|||
17048640|NCT00635570|38192489|FG000|Overall Study|Physician Decision|1|||
17048641|NCT00635570|38192490|FG001|Overall Study|Physician Decision|0|||
17048642|NCT00635570|38192489|FG000|Overall Study|Did not complete survey|2|||
17048643|NCT00635570|38192490|FG001|Overall Study|Did not complete survey|1|||
17048644|NCT00635570|38192489|FG000|Overall Study|Early termination(No sexual activity)|1|||
17048645|NCT00635570|38192490|FG001|Overall Study|Early termination(No sexual activity)|1|||
17048646|NCT00635492|38192498|FG000|Overall Study|Death|12|||
17048647|NCT00635492|38192499|FG001|Overall Study|Death|40|||
17048648|NCT00635492|38192498|FG000|Overall Study|Lost to Follow-up|151|||
17048649|NCT00635492|38192499|FG001|Overall Study|Lost to Follow-up|172|||
17048650|NCT00635492|38192498|FG000|Overall Study|Physician Decision|32|||
17048651|NCT00635492|38192499|FG001|Overall Study|Physician Decision|22|||
17048652|NCT00635492|38192498|FG000|Overall Study|Sponsor decision|2|||
17048653|NCT00635492|38192499|FG001|Overall Study|Sponsor decision|3|||
17048654|NCT00635492|38192498|FG000|Overall Study|Withdrawal by Subject|82|||
17048655|NCT00635492|38192499|FG001|Overall Study|Withdrawal by Subject|45|||
17048656|NCT00543309|38192512|FG000|Overall Study|Physician Decision|0|||
17048657|NCT00543309|38192513|FG001|Overall Study|Physician Decision|1|||
17048658|NCT00543309|38192514|FG002|Overall Study|Physician Decision|0|||
17142416|NCT03323034|38285006|FG000|Overall Study|Withdrawal by Subject|1|||
17142417|NCT03323034|38285007|FG001|Overall Study|Withdrawal by Subject|1|||
17048659|NCT00569582|38192523|FG000|Overall Study|Withdrawal by Subject|5|||
17048660|NCT00569582|38192523|FG000|Overall Study|Death|2|||
17048661|NCT00569582|38192523|FG000|Overall Study|Adverse Event|7|||
17048662|NCT00569582|38192523|FG000|Overall Study|Subject was too ill to travel.|1|||
17048663|NCT00569582|38192523|FG000|Overall Study|Subject was non-compliant.|1|||
17048664|NCT00721409|38192530|FG000|Overall Study|Global deterioration of health status|2|||
17048665|NCT00721409|38192531|FG001|Overall Study|Global deterioration of health status|6|||
17142418|NCT03323034|38285008|FG002|Overall Study|Withdrawal by Subject|0|||
17142419|NCT03323034|38285009|FG003|Overall Study|Withdrawal by Subject|1|||
17142420|NCT03323034|38285010|FG004|Overall Study|Withdrawal by Subject|0|||
17142421|NCT03270657|38285041|FG000|Overall Study|Withdrawal by Subject|1|||
17142422|NCT03303417|38285045|FG000|Overall Study|Withdrawal by Subject|1|||
17142423|NCT03303417|38285046|FG001|Overall Study|Withdrawal by Subject|1|||
17142424|NCT02943564|38285055|FG000|Overall Study|Miscellaneous Reasons|0|||
17142425|NCT02943564|38285056|FG001|Overall Study|Miscellaneous Reasons|0|||
17142426|NCT02943564|38285057|FG002|Overall Study|Miscellaneous Reasons|3|||
17142427|NCT02943564|38285055|FG000|Overall Study|Site terminated by sponsor|0|||
17142428|NCT02943564|38285056|FG001|Overall Study|Site terminated by sponsor|1|||
17142429|NCT02943564|38285057|FG002|Overall Study|Site terminated by sponsor|0|||
17142430|NCT02943564|38285055|FG000|Overall Study|Non-compliance with study drug|0|||
17142431|NCT02943564|38285056|FG001|Overall Study|Non-compliance with study drug|1|||
17142432|NCT02943564|38285057|FG002|Overall Study|Non-compliance with study drug|0|||
17142433|NCT02943564|38285055|FG000|Overall Study|Pregnancy|0|||
17142434|NCT02943564|38285056|FG001|Overall Study|Pregnancy|1|||
17142435|NCT02943564|38285057|FG002|Overall Study|Pregnancy|1|||
17142436|NCT02943564|38285055|FG000|Overall Study|Protocol Violation|2|||
17142437|NCT02943564|38285056|FG001|Overall Study|Protocol Violation|2|||
17142438|NCT02943564|38285057|FG002|Overall Study|Protocol Violation|2|||
17142439|NCT02943564|38285055|FG000|Overall Study|Lost to Follow-up|1|||
17142440|NCT02943564|38285056|FG001|Overall Study|Lost to Follow-up|0|||
17142441|NCT02943564|38285057|FG002|Overall Study|Lost to Follow-up|0|||
17142442|NCT02943564|38285055|FG000|Overall Study|Withdrawal by Subject|6|||
17142443|NCT02943564|38285056|FG001|Overall Study|Withdrawal by Subject|5|||
17142444|NCT02943564|38285057|FG002|Overall Study|Withdrawal by Subject|2|||
17142445|NCT02943564|38285055|FG000|Overall Study|Adverse Event|1|||
17142446|NCT02943564|38285056|FG001|Overall Study|Adverse Event|2|||
17142447|NCT02943564|38285057|FG002|Overall Study|Adverse Event|1|||
17142448|NCT02943564|38285055|FG000|Overall Study|Lack of Efficacy|0|||
17142449|NCT02943564|38285056|FG001|Overall Study|Lack of Efficacy|1|||
17142450|NCT02943564|38285057|FG002|Overall Study|Lack of Efficacy|0|||
17142451|NCT03268941|38285069|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
17142452|NCT03268941|38285070|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
17142453|NCT03268941|38285071|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
17142454|NCT03268941|38285072|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
17142455|NCT03268941|38285073|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
17142456|NCT03268941|38285074|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
17142457|NCT03268941|38285075|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
17142458|NCT03268941|38285069|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
17142459|NCT03268941|38285070|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
17142460|NCT03268941|38285071|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
17142461|NCT03268941|38285072|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
17142462|NCT03268941|38285073|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
17142463|NCT03268941|38285074|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
17142464|NCT03268941|38285075|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
17142465|NCT03268941|38285069|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
17142466|NCT03268941|38285070|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
17142467|NCT03268941|38285071|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
17142468|NCT03268941|38285072|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
17142469|NCT03268941|38285073|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
17142470|NCT03268941|38285074|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
17142471|NCT03268941|38285075|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
17142472|NCT03268941|38285069|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
17142473|NCT03268941|38285070|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
17142474|NCT03268941|38285071|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
17142475|NCT03268941|38285072|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
17142476|NCT03268941|38285073|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
17142477|NCT03268941|38285074|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
17142478|NCT03268941|38285075|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
17142479|NCT03268941|38285069|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
17142480|NCT03268941|38285070|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
17142481|NCT03268941|38285071|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
17142482|NCT03268941|38285072|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
17142483|NCT03268941|38285073|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
17142484|NCT03268941|38285074|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
17142485|NCT03268941|38285075|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
17142486|NCT03245619|38285152|FG000|Part A (Up to Day 22)|Physician Decision|4|||
17142487|NCT03245619|38285153|FG001|Part A (Up to Day 22)|Physician Decision|6|||
17142488|NCT03245619|38285154|FG002|Part A (Up to Day 22)|Physician Decision|6|||
17142489|NCT03245619|38285155|FG003|Part A (Up to Day 22)|Physician Decision|0|||
17142490|NCT03245619|38285156|FG004|Part A (Up to Day 22)|Physician Decision|0|||
17142491|NCT03245619|38285157|FG005|Part A (Up to Day 22)|Physician Decision|0|||
17142492|NCT03245619|38285158|FG006|Part A (Up to Day 22)|Physician Decision|0|||
17142493|NCT03245619|38285159|FG007|Part A (Up to Day 22)|Physician Decision|0|||
17142494|NCT03245619|38285160|FG008|Part A (Up to Day 22)|Physician Decision|0|||
17142495|NCT03245619|38285161|FG009|Part A (Up to Day 22)|Physician Decision|0|||
17142496|NCT03245619|38285162|FG010|Part A (Up to Day 22)|Physician Decision|0|||
17142497|NCT03245619|38285163|FG011|Part A (Up to Day 22)|Physician Decision|0|||
17142498|NCT03245619|38285164|FG012|Part A (Up to Day 22)|Physician Decision|0|||
17142499|NCT03245619|38285165|FG013|Part A (Up to Day 22)|Physician Decision|0|||
17142500|NCT03245619|38285166|FG014|Part A (Up to Day 22)|Physician Decision|0|||
17142501|NCT03245619|38285167|FG015|Part A (Up to Day 22)|Physician Decision|0|||
17142502|NCT03245619|38285168|FG016|Part A (Up to Day 22)|Physician Decision|0|||
17048666|NCT00721409|38192532|FG002|Overall Study|Global deterioration of health status|3|||
17048667|NCT00721409|38192530|FG000|Overall Study|Death|0|||
17048668|NCT00721409|38192531|FG001|Overall Study|Death|1|||
17048669|NCT00721409|38192532|FG002|Overall Study|Death|0|||
17048670|NCT00721409|38192530|FG000|Overall Study|Randomized not Treated|0|||
17048671|NCT00721409|38192531|FG001|Overall Study|Randomized not Treated|1|||
17048672|NCT00721409|38192532|FG002|Overall Study|Randomized not Treated|4|||
17048673|NCT00721409|38192530|FG000|Overall Study|Reason not specified|1|||
17048674|NCT00721409|38192531|FG001|Overall Study|Reason not specified|0|||
17048675|NCT00721409|38192532|FG002|Overall Study|Reason not specified|2|||
17048676|NCT00721409|38192530|FG000|Overall Study|Adverse Event|0|||
17048677|NCT00721409|38192531|FG001|Overall Study|Adverse Event|13|||
17048678|NCT00721409|38192532|FG002|Overall Study|Adverse Event|2|||
17048679|NCT00721409|38192530|FG000|Overall Study|Lost to Follow-up|0|||
17048680|NCT00721409|38192531|FG001|Overall Study|Lost to Follow-up|0|||
17048681|NCT00721409|38192532|FG002|Overall Study|Lost to Follow-up|1|||
17048682|NCT00721409|38192530|FG000|Overall Study|Withdrawal by Subject|1|||
17048683|NCT00721409|38192531|FG001|Overall Study|Withdrawal by Subject|6|||
17048684|NCT00721409|38192532|FG002|Overall Study|Withdrawal by Subject|5|||
17048685|NCT00721409|38192530|FG000|Overall Study|Objective progression or relapse|8|||
17048686|NCT00721409|38192531|FG001|Overall Study|Objective progression or relapse|55|||
17048687|NCT00721409|38192532|FG002|Overall Study|Objective progression or relapse|62|||
17048688|NCT00542997|38192556|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
17048689|NCT00542997|38192556|FG000|Wash in / Wash Out Period|Adverse Event|3|||
17048690|NCT00542997|38192556|FG000|Efficacy Period|Adverse Event|3|||
17048691|NCT00572832|38192565|FG000|Overall Study|Lost to Follow-up|0|||
17048692|NCT00572832|38192566|FG001|Overall Study|Lost to Follow-up|11|||
17048693|NCT00572832|38192565|FG000|Overall Study|Pregnancy|0|||
17048694|NCT00572832|38192566|FG001|Overall Study|Pregnancy|1|||
17048695|NCT03917823|38192574|FG000|Overall Study|Lost to Follow-up|1|||
17142503|NCT02388906|38285229|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
17142504|NCT02388906|38285230|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
17142505|NCT02388906|38285229|FG000|Treatment Period|Disease progression|121|||
17142506|NCT02388906|38285230|FG001|Treatment Period|Disease progression|101|||
17142507|NCT02388906|38285229|FG000|Treatment Period|Study drug toxicity|41|||
17142508|NCT02388906|38285230|FG001|Treatment Period|Study drug toxicity|208|||
17142509|NCT02388906|38285229|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
17142510|NCT02388906|38285230|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
17048696|NCT03917823|38192575|FG001|Overall Study|Lost to Follow-up|1|||
17048697|NCT03917823|38192574|FG000|Overall Study|Withdrawal by Subject|0|||
17048698|NCT03917823|38192575|FG001|Overall Study|Withdrawal by Subject|1|||
17048699|NCT00229723|38192588|FG000|Concomitant Phase|Adverse Event|4|||
17048700|NCT00229723|38192589|FG001|Concomitant Phase|Adverse Event|2|||
17048701|NCT00229723|38192590|FG002|Concomitant Phase|Adverse Event|5|||
17048702|NCT00229723|38192591|FG003|Concomitant Phase|Adverse Event|2|||
17048703|NCT00229723|38192592|FG004|Concomitant Phase|Adverse Event|0|||
17048704|NCT00229723|38192593|FG005|Concomitant Phase|Adverse Event|1|||
17048705|NCT00229723|38192594|FG006|Concomitant Phase|Adverse Event|2|||
17142511|NCT02388906|38285229|FG000|Treatment Period|Participant request to stop treatment|5|||
17142512|NCT02388906|38285230|FG001|Treatment Period|Participant request to stop treatment|9|||
17048706|NCT00229723|38192588|FG000|Concomitant Phase|Objective disease progression|0|||
17048707|NCT00229723|38192589|FG001|Concomitant Phase|Objective disease progression|0|||
17048708|NCT00229723|38192590|FG002|Concomitant Phase|Objective disease progression|0|||
17048709|NCT00229723|38192591|FG003|Concomitant Phase|Objective disease progression|0|||
17048710|NCT00229723|38192592|FG004|Concomitant Phase|Objective disease progression|0|||
17048711|NCT00229723|38192593|FG005|Concomitant Phase|Objective disease progression|0|||
17048712|NCT00229723|38192594|FG006|Concomitant Phase|Objective disease progression|0|||
17048713|NCT00229723|38192588|FG000|Concomitant Phase|Clinical progression|0|||
17048714|NCT00229723|38192589|FG001|Concomitant Phase|Clinical progression|0|||
17048715|NCT00229723|38192590|FG002|Concomitant Phase|Clinical progression|0|||
17048716|NCT00229723|38192591|FG003|Concomitant Phase|Clinical progression|0|||
17048717|NCT00229723|38192592|FG004|Concomitant Phase|Clinical progression|0|||
17048718|NCT00229723|38192593|FG005|Concomitant Phase|Clinical progression|0|||
17048719|NCT00229723|38192594|FG006|Concomitant Phase|Clinical progression|1|||
17048720|NCT00229723|38192588|FG000|Concomitant Phase|Lost to Follow-up|0|||
17048721|NCT00229723|38192589|FG001|Concomitant Phase|Lost to Follow-up|0|||
17048722|NCT00229723|38192590|FG002|Concomitant Phase|Lost to Follow-up|0|||
17048723|NCT00229723|38192591|FG003|Concomitant Phase|Lost to Follow-up|0|||
17048724|NCT00229723|38192592|FG004|Concomitant Phase|Lost to Follow-up|1|||
17048725|NCT00229723|38192593|FG005|Concomitant Phase|Lost to Follow-up|0|||
17048726|NCT00229723|38192594|FG006|Concomitant Phase|Lost to Follow-up|0|||
17048727|NCT00229723|38192588|FG000|Concomitant Phase|Informed consent withdrawn|3|||
17048728|NCT00229723|38192589|FG001|Concomitant Phase|Informed consent withdrawn|2|||
17048729|NCT00229723|38192590|FG002|Concomitant Phase|Informed consent withdrawn|0|||
17048730|NCT00229723|38192591|FG003|Concomitant Phase|Informed consent withdrawn|2|||
17048731|NCT00229723|38192592|FG004|Concomitant Phase|Informed consent withdrawn|0|||
17048732|NCT00229723|38192593|FG005|Concomitant Phase|Informed consent withdrawn|0|||
17048733|NCT00229723|38192594|FG006|Concomitant Phase|Informed consent withdrawn|0|||
17048734|NCT00229723|38192588|FG000|Concomitant Phase|Severe non-compliance|0|||
17048735|NCT00229723|38192589|FG001|Concomitant Phase|Severe non-compliance|1|||
17048736|NCT00229723|38192590|FG002|Concomitant Phase|Severe non-compliance|0|||
17048737|NCT00229723|38192591|FG003|Concomitant Phase|Severe non-compliance|0|||
17048738|NCT00229723|38192592|FG004|Concomitant Phase|Severe non-compliance|1|||
17048739|NCT00229723|38192593|FG005|Concomitant Phase|Severe non-compliance|0|||
17048740|NCT00229723|38192594|FG006|Concomitant Phase|Severe non-compliance|0|||
17048741|NCT00229723|38192588|FG000|Concomitant Phase|Other|3|||
17048742|NCT00229723|38192589|FG001|Concomitant Phase|Other|0|||
17048743|NCT00229723|38192590|FG002|Concomitant Phase|Other|1|||
17048744|NCT00229723|38192591|FG003|Concomitant Phase|Other|1|||
17142513|NCT02388906|38285229|FG000|Treatment Period|Participant withdrew consent|2|||
17142514|NCT02388906|38285230|FG001|Treatment Period|Participant withdrew consent|3|||
17048745|NCT00229723|38192592|FG004|Concomitant Phase|Other|0|||
17048746|NCT00229723|38192593|FG005|Concomitant Phase|Other|2|||
17048747|NCT00229723|38192594|FG006|Concomitant Phase|Other|0|||
17048748|NCT00229723|38192588|FG000|Maintenance Phase|Adverse Event|7|||
17048749|NCT00229723|38192589|FG001|Maintenance Phase|Adverse Event|2|||
17048750|NCT00229723|38192590|FG002|Maintenance Phase|Adverse Event|1|||
17048751|NCT00229723|38192591|FG003|Maintenance Phase|Adverse Event|4|||
17048752|NCT00229723|38192592|FG004|Maintenance Phase|Adverse Event|7|||
17048753|NCT00229723|38192593|FG005|Maintenance Phase|Adverse Event|5|||
17048754|NCT00229723|38192594|FG006|Maintenance Phase|Adverse Event|2|||
17048755|NCT00229723|38192588|FG000|Maintenance Phase|Objective disease progression|5|||
17048756|NCT00229723|38192589|FG001|Maintenance Phase|Objective disease progression|5|||
17048757|NCT00229723|38192590|FG002|Maintenance Phase|Objective disease progression|3|||
17048758|NCT00229723|38192591|FG003|Maintenance Phase|Objective disease progression|6|||
17048759|NCT00229723|38192592|FG004|Maintenance Phase|Objective disease progression|2|||
17048760|NCT00229723|38192593|FG005|Maintenance Phase|Objective disease progression|9|||
17048761|NCT00229723|38192594|FG006|Maintenance Phase|Objective disease progression|5|||
17048762|NCT00229723|38192588|FG000|Maintenance Phase|Clinical progression|4|||
17048763|NCT00229723|38192589|FG001|Maintenance Phase|Clinical progression|1|||
17048764|NCT00229723|38192590|FG002|Maintenance Phase|Clinical progression|2|||
17048765|NCT00229723|38192591|FG003|Maintenance Phase|Clinical progression|2|||
17048766|NCT00229723|38192592|FG004|Maintenance Phase|Clinical progression|1|||
17048767|NCT00229723|38192593|FG005|Maintenance Phase|Clinical progression|1|||
17048768|NCT00229723|38192594|FG006|Maintenance Phase|Clinical progression|1|||
17048769|NCT00229723|38192588|FG000|Maintenance Phase|Lost to Follow-up|0|||
17048770|NCT00229723|38192589|FG001|Maintenance Phase|Lost to Follow-up|1|||
17048771|NCT00229723|38192590|FG002|Maintenance Phase|Lost to Follow-up|2|||
17048772|NCT00229723|38192591|FG003|Maintenance Phase|Lost to Follow-up|2|||
17048773|NCT00229723|38192592|FG004|Maintenance Phase|Lost to Follow-up|0|||
17048774|NCT00229723|38192593|FG005|Maintenance Phase|Lost to Follow-up|0|||
17048775|NCT00229723|38192594|FG006|Maintenance Phase|Lost to Follow-up|1|||
17048776|NCT00229723|38192588|FG000|Maintenance Phase|Informed consent withdrawn|1|||
17048777|NCT00229723|38192589|FG001|Maintenance Phase|Informed consent withdrawn|0|||
17048778|NCT00229723|38192590|FG002|Maintenance Phase|Informed consent withdrawn|0|||
17048779|NCT00229723|38192591|FG003|Maintenance Phase|Informed consent withdrawn|1|||
17048780|NCT00229723|38192592|FG004|Maintenance Phase|Informed consent withdrawn|1|||
17048781|NCT00229723|38192593|FG005|Maintenance Phase|Informed consent withdrawn|1|||
17142515|NCT02388906|38285229|FG000|Treatment Period|Poor/non-compliance|0|||
17142516|NCT02388906|38285230|FG001|Treatment Period|Poor/non-compliance|1|||
17048782|NCT00229723|38192594|FG006|Maintenance Phase|Informed consent withdrawn|0|||
17048783|NCT00229723|38192588|FG000|Maintenance Phase|Severe non-compliance|3|||
17048784|NCT00229723|38192589|FG001|Maintenance Phase|Severe non-compliance|1|||
17142517|NCT02388906|38285229|FG000|Treatment Period|Participant no longer meets study criteria|0|||
17048785|NCT00229723|38192590|FG002|Maintenance Phase|Severe non-compliance|0|||
17048786|NCT00229723|38192591|FG003|Maintenance Phase|Severe non-compliance|0|||
17048787|NCT00229723|38192592|FG004|Maintenance Phase|Severe non-compliance|1|||
17048788|NCT00229723|38192593|FG005|Maintenance Phase|Severe non-compliance|0|||
17048789|NCT00229723|38192594|FG006|Maintenance Phase|Severe non-compliance|0|||
17048790|NCT00229723|38192588|FG000|Maintenance Phase|Other|5|||
17048791|NCT00229723|38192589|FG001|Maintenance Phase|Other|4|||
17048792|NCT00229723|38192590|FG002|Maintenance Phase|Other|1|||
17048793|NCT00229723|38192591|FG003|Maintenance Phase|Other|2|||
17048794|NCT00229723|38192592|FG004|Maintenance Phase|Other|3|||
17048795|NCT00229723|38192593|FG005|Maintenance Phase|Other|3|||
17048796|NCT00229723|38192594|FG006|Maintenance Phase|Other|1|||
17048797|NCT00606684|38192616|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
17048798|NCT00606684|38192617|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
17048799|NCT00606684|38192618|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
17048800|NCT00606684|38192619|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
17048801|NCT00606684|38192620|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
17048802|NCT00606684|38192621|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
17048803|NCT00606684|38192622|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
17048804|NCT00606684|38192616|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
17142518|NCT02388906|38285230|FG001|Treatment Period|Participant no longer meets study criteria|1|||
17142519|NCT02388906|38285229|FG000|Treatment Period|Other reasons|3|||
17142520|NCT02388906|38285230|FG001|Treatment Period|Other reasons|3|||
17048805|NCT00606684|38192617|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
17048806|NCT00606684|38192618|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
17048807|NCT00606684|38192619|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
17048808|NCT00606684|38192620|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
17048809|NCT00606684|38192621|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
17048810|NCT00606684|38192622|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
17048811|NCT00606684|38192616|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
17048812|NCT00606684|38192617|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
17048813|NCT00606684|38192618|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
17048814|NCT00606684|38192619|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
17048815|NCT00606684|38192620|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
17048816|NCT00606684|38192621|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
17048817|NCT00606684|38192622|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
17048818|NCT00606684|38192616|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
17048819|NCT00606684|38192617|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
17048820|NCT00606684|38192618|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
17048821|NCT00606684|38192619|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
17048822|NCT00606684|38192620|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
17048823|NCT00606684|38192621|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
17048824|NCT00606684|38192622|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
17048825|NCT00606684|38192616|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
17048826|NCT00606684|38192617|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
17048827|NCT00606684|38192618|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
17048828|NCT00606684|38192619|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
17048829|NCT00606684|38192620|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
17048830|NCT00606684|38192621|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
17048831|NCT00606684|38192622|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
17048832|NCT00606684|38192616|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
17048833|NCT00606684|38192617|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
17048834|NCT00606684|38192618|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
17048835|NCT00606684|38192619|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
17048836|NCT00606684|38192620|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
17048837|NCT00606684|38192621|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
17048838|NCT00606684|38192622|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
17048839|NCT00606684|38192616|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
17048840|NCT00606684|38192617|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
17048841|NCT00606684|38192618|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
17048842|NCT00606684|38192619|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
17048843|NCT00606684|38192620|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
17048844|NCT00606684|38192621|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
17048845|NCT00606684|38192622|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
17048846|NCT00606684|38192616|FG000|Double-Blind Treatment Period|Adverse Event|0|||
17048847|NCT00606684|38192617|FG001|Double-Blind Treatment Period|Adverse Event|3|||
17048848|NCT00606684|38192618|FG002|Double-Blind Treatment Period|Adverse Event|2|||
17048849|NCT00606684|38192619|FG003|Double-Blind Treatment Period|Adverse Event|4|||
17048850|NCT00606684|38192620|FG004|Double-Blind Treatment Period|Adverse Event|2|||
17048851|NCT00606684|38192621|FG005|Double-Blind Treatment Period|Adverse Event|0|||
17048852|NCT00606684|38192622|FG006|Double-Blind Treatment Period|Adverse Event|1|||
17048853|NCT00606684|38192616|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
17048854|NCT00606684|38192617|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
17048855|NCT00606684|38192618|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
17048856|NCT00606684|38192619|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
17048857|NCT00606684|38192620|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
17048858|NCT00606684|38192621|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
17048859|NCT00606684|38192622|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
17048860|NCT00606684|38192616|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
17048861|NCT00606684|38192617|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
17048862|NCT00606684|38192618|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
17142521|NCT04472650|38285238|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
17142522|NCT04472650|38285239|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
17142523|NCT02606461|38285251|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
17142524|NCT02606461|38285252|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
17142525|NCT02606461|38285253|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
17142526|NCT02606461|38285254|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
17142527|NCT02606461|38285255|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
17142528|NCT02606461|38285256|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
16780910|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16780911|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
17048863|NCT00606684|38192619|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
17048864|NCT00606684|38192620|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
17142529|NCT03321396|38285271|FG000|Overall Study|Physician Decision|1|||
17142530|NCT03244917|38285277|FG000|Overall Study|Lost to Follow-up|2|||
17142531|NCT03244917|38285278|FG001|Overall Study|Lost to Follow-up|2|||
17142532|NCT03321006|38285286|FG000|Overall Study|Death|1|||
17142533|NCT03321006|38285287|FG001|Overall Study|Death|0|||
17142534|NCT03321006|38285286|FG000|Overall Study|Lack of Efficacy|1|||
17142535|NCT03321006|38285287|FG001|Overall Study|Lack of Efficacy|0|||
17142536|NCT02593123|38285304|FG000|Overall Study|Physician Decision|2|||
17142537|NCT02593123|38285305|FG001|Overall Study|Physician Decision|1|||
17142538|NCT02593123|38285304|FG000|Overall Study|Relapse|1|||
17142539|NCT02593123|38285305|FG001|Overall Study|Relapse|1|||
17142540|NCT03302559|38285313|FG000|Overall Study|Adverse Event|2|||
17142541|NCT03302559|38285313|FG000|Overall Study|Lost to Follow-up|1|||
17142542|NCT03302559|38285313|FG000|Overall Study|Withdrew Consent|3|||
17142543|NCT03302247|38285317|FG000|Overall Study|the study has closed prematurely|2|||
17048865|NCT00606684|38192621|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
17048866|NCT00606684|38192622|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
17048867|NCT00606684|38192616|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
17142544|NCT03302247|38285317|FG000|Overall Study|Death|1|||
17142545|NCT04993339|38285323|FG000|Overall Study|Lost to Follow-up|0|||
17142546|NCT04993339|38285324|FG001|Overall Study|Lost to Follow-up|1|||
17142547|NCT04993339|38285323|FG000|Overall Study|no MRI scan|3|||
17142548|NCT04993339|38285324|FG001|Overall Study|no MRI scan|1|||
17142549|NCT04974697|38285332|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
17048868|NCT00606684|38192617|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
17048869|NCT00606684|38192618|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
17048870|NCT00606684|38192619|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
17048871|NCT00606684|38192620|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
17048872|NCT00606684|38192621|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
17048873|NCT00606684|38192622|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
17048874|NCT00606684|38192616|FG000|Double-Blind Treatment Period|Physician Decision|0|||
17048875|NCT00606684|38192617|FG001|Double-Blind Treatment Period|Physician Decision|5|||
17048876|NCT00606684|38192618|FG002|Double-Blind Treatment Period|Physician Decision|1|||
17048877|NCT00606684|38192619|FG003|Double-Blind Treatment Period|Physician Decision|0|||
17048878|NCT00606684|38192620|FG004|Double-Blind Treatment Period|Physician Decision|3|||
17048879|NCT00606684|38192621|FG005|Double-Blind Treatment Period|Physician Decision|1|||
17048880|NCT00606684|38192622|FG006|Double-Blind Treatment Period|Physician Decision|2|||
17048881|NCT00606684|38192616|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
17048882|NCT00606684|38192617|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
17048883|NCT00606684|38192618|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
17048884|NCT00606684|38192619|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
17048885|NCT00606684|38192620|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
17048886|NCT00606684|38192621|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
17048887|NCT00606684|38192622|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
17048888|NCT00627926|38192639|FG000|Overall Study|Adverse Event|26|||
17048889|NCT00627926|38192640|FG001|Overall Study|Adverse Event|37|||
17048890|NCT00627926|38192641|FG002|Overall Study|Adverse Event|36|||
17048891|NCT00627926|38192639|FG000|Overall Study|Death|1|||
17048892|NCT00627926|38192640|FG001|Overall Study|Death|0|||
17048893|NCT00627926|38192641|FG002|Overall Study|Death|0|||
17048894|NCT00627926|38192639|FG000|Overall Study|Lost to Follow-up|4|||
17048895|NCT00627926|38192640|FG001|Overall Study|Lost to Follow-up|3|||
17048896|NCT00627926|38192641|FG002|Overall Study|Lost to Follow-up|4|||
17048897|NCT00627926|38192639|FG000|Overall Study|Withdrawal by Subject|2|||
17142550|NCT04974697|38285332|FG000|Overall Study|Lens discomfort|1|||
17142551|NCT03265119|38285340|FG000|Overall Study|Adverse Event|2|||
17142552|NCT03265119|38285341|FG001|Overall Study|Adverse Event|1|||
17142553|NCT03265119|38285340|FG000|Overall Study|Lack of Efficacy|3|||
17142554|NCT03265119|38285341|FG001|Overall Study|Lack of Efficacy|0|||
17142555|NCT03265119|38285340|FG000|Overall Study|Protocol Violation|1|||
17142556|NCT03265119|38285341|FG001|Overall Study|Protocol Violation|2|||
17142557|NCT03265119|38285340|FG000|Overall Study|Withdrawal by Subject|2|||
17142558|NCT03265119|38285341|FG001|Overall Study|Withdrawal by Subject|4|||
17142559|NCT03265119|38285340|FG000|Overall Study|Lost to Follow-up|1|||
17142560|NCT03265119|38285341|FG001|Overall Study|Lost to Follow-up|0|||
17142561|NCT03265119|38285340|FG000|Overall Study|Lack of Compliance|1|||
17142562|NCT03265119|38285341|FG001|Overall Study|Lack of Compliance|0|||
17142563|NCT04952701|38285347|FG000|Control Lens|Physician Decision|4|||
17142564|NCT04952701|38285347|FG000|Test Lens|Physician Decision|1|||
17142565|NCT04723173|38285353|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
17142566|NCT04919317|38285367|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
17142567|NCT04919317|38285368|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
17142568|NCT04919317|38285367|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
17142569|NCT04919317|38285368|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
17142570|NCT04919161|38285376|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
17142571|NCT04919161|38285377|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
17142572|NCT04919161|38285376|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
17048898|NCT00627926|38192640|FG001|Overall Study|Withdrawal by Subject|1|||
17142573|NCT04919161|38285377|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
17142574|NCT04919161|38285376|FG000|Overall Study|Acute ankle sprain after session 1|0|||
17048899|NCT00627926|38192641|FG002|Overall Study|Withdrawal by Subject|0|||
17048900|NCT00627926|38192639|FG000|Overall Study|Lack of Efficacy|118|||
17048901|NCT00627926|38192640|FG001|Overall Study|Lack of Efficacy|40|||
17048902|NCT00627926|38192641|FG002|Overall Study|Lack of Efficacy|38|||
17048903|NCT00627926|38192639|FG000|Overall Study|Noncompliance/unspecified|8|||
17048904|NCT00627926|38192640|FG001|Overall Study|Noncompliance/unspecified|23|||
17048905|NCT00627926|38192641|FG002|Overall Study|Noncompliance/unspecified|17|||
17048906|NCT00228553|38192649|FG000|Overall Study|Adverse Event|112|||
17048907|NCT00228553|38192649|FG000|Overall Study|Lack of Efficacy|34|||
17048908|NCT00228553|38192649|FG000|Overall Study|Lost to Follow-up|67|||
17048909|NCT00228553|38192649|FG000|Overall Study|Physician Decision|48|||
17048910|NCT00228553|38192649|FG000|Overall Study|Protocol Violation|6|||
17048911|NCT00228553|38192649|FG000|Overall Study|Withdrawal by Subject|115|||
17048912|NCT00228553|38192649|FG000|Overall Study|Pregnancy|2|||
17048913|NCT00228553|38192649|FG000|Overall Study|Miscellaneous|46|||
17048914|NCT00643916|38192659|FG000|Overall Study|Protocol Violation|0|||
17048915|NCT00643916|38192660|FG001|Overall Study|Protocol Violation|1|||
17048916|NCT00643916|38192661|FG002|Overall Study|Protocol Violation|1|||
17048917|NCT00643916|38192662|FG003|Overall Study|Protocol Violation|1|||
17048918|NCT00643916|38192663|FG004|Overall Study|Protocol Violation|0|||
17048919|NCT00643916|38192664|FG005|Overall Study|Protocol Violation|0|||
17048920|NCT00643916|38192659|FG000|Overall Study|Lost to Follow-up|0|||
17048921|NCT00643916|38192660|FG001|Overall Study|Lost to Follow-up|1|||
17048922|NCT00643916|38192661|FG002|Overall Study|Lost to Follow-up|0|||
17048923|NCT00643916|38192662|FG003|Overall Study|Lost to Follow-up|0|||
17048924|NCT00643916|38192663|FG004|Overall Study|Lost to Follow-up|0|||
17048925|NCT00643916|38192664|FG005|Overall Study|Lost to Follow-up|0|||
17048926|NCT00643916|38192659|FG000|Overall Study|Withdrawal by Subject|2|||
17048927|NCT00643916|38192660|FG001|Overall Study|Withdrawal by Subject|2|||
17048928|NCT00643916|38192661|FG002|Overall Study|Withdrawal by Subject|2|||
17048929|NCT00643916|38192662|FG003|Overall Study|Withdrawal by Subject|1|||
17048930|NCT00643916|38192663|FG004|Overall Study|Withdrawal by Subject|0|||
17048931|NCT00643916|38192664|FG005|Overall Study|Withdrawal by Subject|1|||
17048932|NCT00643916|38192659|FG000|Overall Study|Not Vaccinated|2|||
17048933|NCT00643916|38192660|FG001|Overall Study|Not Vaccinated|2|||
17048934|NCT00643916|38192661|FG002|Overall Study|Not Vaccinated|3|||
17048935|NCT00643916|38192662|FG003|Overall Study|Not Vaccinated|0|||
17048936|NCT00643916|38192663|FG004|Overall Study|Not Vaccinated|2|||
17048937|NCT00643916|38192664|FG005|Overall Study|Not Vaccinated|0|||
17048938|NCT00160693|38192678|FG000|Overall Study|Adverse Event|97|||
17048939|NCT00160693|38192678|FG000|Overall Study|Lack of Efficacy|30|||
17048940|NCT00160693|38192678|FG000|Overall Study|Protocol Violation|24|||
17048941|NCT00160693|38192678|FG000|Overall Study|Lost to Follow-up|15|||
17048942|NCT00160693|38192678|FG000|Overall Study|Withdrawal by Subject|54|||
17048943|NCT00160693|38192678|FG000|Overall Study|Study terminated by sponsor|15|||
17048944|NCT00643760|38192687|FG000|Overall Study|Adverse Event|11|||
17048945|NCT00643760|38192688|FG001|Overall Study|Adverse Event|5|||
17048946|NCT00643760|38192689|FG002|Overall Study|Adverse Event|12|||
17048947|NCT00643760|38192690|FG003|Overall Study|Adverse Event|21|||
17048948|NCT00643760|38192691|FG004|Overall Study|Adverse Event|6|||
17048949|NCT00643760|38192687|FG000|Overall Study|Lack of Efficacy|3|||
17048950|NCT00643760|38192688|FG001|Overall Study|Lack of Efficacy|1|||
17048951|NCT00643760|38192689|FG002|Overall Study|Lack of Efficacy|0|||
17048952|NCT00643760|38192690|FG003|Overall Study|Lack of Efficacy|4|||
17048953|NCT00643760|38192691|FG004|Overall Study|Lack of Efficacy|3|||
17048954|NCT00643760|38192687|FG000|Overall Study|Protocol Violation|7|||
17048955|NCT00643760|38192688|FG001|Overall Study|Protocol Violation|6|||
17048956|NCT00643760|38192689|FG002|Overall Study|Protocol Violation|4|||
17048957|NCT00643760|38192690|FG003|Overall Study|Protocol Violation|4|||
17048958|NCT00643760|38192691|FG004|Overall Study|Protocol Violation|6|||
17048959|NCT00643760|38192687|FG000|Overall Study|Lost to Follow-up|6|||
17048960|NCT00643760|38192688|FG001|Overall Study|Lost to Follow-up|2|||
17048961|NCT00643760|38192689|FG002|Overall Study|Lost to Follow-up|1|||
17048962|NCT00643760|38192690|FG003|Overall Study|Lost to Follow-up|3|||
17048963|NCT00643760|38192691|FG004|Overall Study|Lost to Follow-up|3|||
17048964|NCT00643760|38192687|FG000|Overall Study|Investigator Discretion|0|||
17048965|NCT00643760|38192688|FG001|Overall Study|Investigator Discretion|0|||
17048966|NCT00643760|38192689|FG002|Overall Study|Investigator Discretion|0|||
17048967|NCT00643760|38192690|FG003|Overall Study|Investigator Discretion|2|||
17048968|NCT00643760|38192691|FG004|Overall Study|Investigator Discretion|0|||
17048969|NCT00643760|38192687|FG000|Overall Study|Withdrawal by Subject|3|||
17048970|NCT00643760|38192688|FG001|Overall Study|Withdrawal by Subject|1|||
17048971|NCT00643760|38192689|FG002|Overall Study|Withdrawal by Subject|2|||
17048972|NCT00643760|38192690|FG003|Overall Study|Withdrawal by Subject|4|||
17048973|NCT00643760|38192691|FG004|Overall Study|Withdrawal by Subject|1|||
17048974|NCT00643682|38192705|FG000|Overall Study|did not keep appointment|522|||
17048975|NCT00643682|38192706|FG001|Overall Study|did not keep appointment|509|||
17048976|NCT00643604|38192712|FG000|Overall Study|Death|1|||
17048977|NCT00603798|38192719|FG000|Overall Study|Adverse Event|4|||
17048978|NCT00603798|38192720|FG001|Overall Study|Adverse Event|2|||
17048979|NCT00603798|38192721|FG002|Overall Study|Adverse Event|1|||
17048980|NCT00603798|38192719|FG000|Overall Study|Withdrawal by Subject|4|||
17048981|NCT00603798|38192720|FG001|Overall Study|Withdrawal by Subject|3|||
17048982|NCT00603798|38192721|FG002|Overall Study|Withdrawal by Subject|4|||
17048983|NCT00603798|38192719|FG000|Overall Study|Lost to Follow-up|1|||
17048984|NCT00603798|38192720|FG001|Overall Study|Lost to Follow-up|0|||
17048985|NCT00603798|38192721|FG002|Overall Study|Lost to Follow-up|1|||
17048986|NCT00603798|38192719|FG000|Overall Study|Non-compliance with study procedures|0|||
17048987|NCT00603798|38192720|FG001|Overall Study|Non-compliance with study procedures|1|||
17048988|NCT00603798|38192721|FG002|Overall Study|Non-compliance with study procedures|0|||
17048989|NCT00603798|38192719|FG000|Overall Study|Not due to AE|1|||
17048990|NCT00603798|38192720|FG001|Overall Study|Not due to AE|1|||
17048991|NCT00603798|38192721|FG002|Overall Study|Not due to AE|4|||
17048992|NCT00630812|38192731|FG000|Randomisation to First Dose|Adverse Event|1|||
17048993|NCT00630812|38192732|FG001|Randomisation to First Dose|Adverse Event|1|||
17048994|NCT00630812|38192731|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
17048995|NCT00630812|38192732|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
17048996|NCT00630812|38192731|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
17048997|NCT00630812|38192732|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
17048998|NCT00630812|38192731|FG000|Randomisation to First Dose|Protocol Violation|4|||
17048999|NCT00630812|38192732|FG001|Randomisation to First Dose|Protocol Violation|1|||
17049000|NCT00630812|38192731|FG000|Double Blind Treatment Period|Adverse Event|13|||
17049001|NCT00630812|38192732|FG001|Double Blind Treatment Period|Adverse Event|5|||
17049002|NCT00630812|38192731|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
17049003|NCT00630812|38192732|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
17049004|NCT00630812|38192731|FG000|Double Blind Treatment Period|Physician Decision|2|||
17049005|NCT00630812|38192732|FG001|Double Blind Treatment Period|Physician Decision|1|||
17049006|NCT00630812|38192731|FG000|Double Blind Treatment Period|Protocol Violation|1|||
17049007|NCT00630812|38192732|FG001|Double Blind Treatment Period|Protocol Violation|0|||
17049008|NCT00630812|38192731|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
17049009|NCT00630812|38192732|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
17049010|NCT00630812|38192731|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
17049011|NCT00630812|38192732|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
17049012|NCT00630812|38192731|FG000|Double Blind Treatment Period|Non-compliance|0|||
17049013|NCT00630812|38192732|FG001|Double Blind Treatment Period|Non-compliance|1|||
17049014|NCT00629798|38192738|FG000|Overall Study|Not Treated|4|||
17049015|NCT00160615|38192744|FG000|Overall Study|Adverse Event|5|||
17049016|NCT00160615|38192745|FG001|Overall Study|Adverse Event|12|||
17049017|NCT00160615|38192744|FG000|Overall Study|Withdrawal by Subject|0|||
17049018|NCT00160615|38192745|FG001|Overall Study|Withdrawal by Subject|2|||
17049019|NCT00160615|38192744|FG000|Overall Study|Lack of Efficacy|11|||
17049020|NCT00160615|38192745|FG001|Overall Study|Lack of Efficacy|23|||
17049021|NCT00160615|38192744|FG000|Overall Study|Patient decision|1|||
17049022|NCT00160615|38192745|FG001|Overall Study|Patient decision|2|||
17142575|NCT04919161|38285377|FG001|Overall Study|Acute ankle sprain after session 1|1|||
17142576|NCT03262389|38285405|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
17142577|NCT03262389|38285405|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
17142578|NCT03262389|38285405|FG000|Overall Study|opted out of PET/MR|1|||
17049023|NCT00160615|38192744|FG000|Overall Study|Investigator decision|1|||
17049024|NCT00160615|38192745|FG001|Overall Study|Investigator decision|1|||
17049025|NCT00160615|38192744|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
17049026|NCT00160615|38192745|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
17049027|NCT00160615|38192744|FG000|Overall Study|Switch to surgical treatment|0|||
17049028|NCT00160615|38192745|FG001|Overall Study|Switch to surgical treatment|2|||
17049029|NCT00160615|38192744|FG000|Overall Study|Non-compliance was suspected|0|||
17049030|NCT00160615|38192745|FG001|Overall Study|Non-compliance was suspected|1|||
17142579|NCT03262233|38285413|FG000|Overall Study|Withdrawal by Subject|12|||
17142580|NCT03262233|38285414|FG001|Overall Study|Withdrawal by Subject|8|||
17142581|NCT03262233|38285415|FG002|Overall Study|Withdrawal by Subject|21|||
17142582|NCT03262233|38285416|FG003|Overall Study|Withdrawal by Subject|13|||
17142583|NCT03262233|38285413|FG000|Overall Study|Declined due to shock|1|||
17142584|NCT03262233|38285414|FG001|Overall Study|Declined due to shock|2|||
17049031|NCT00160615|38192744|FG000|Overall Study|Poor compliance|0|||
17049032|NCT00160615|38192745|FG001|Overall Study|Poor compliance|1|||
17142585|NCT03262233|38285415|FG002|Overall Study|Declined due to shock|2|||
17142586|NCT03262233|38285416|FG003|Overall Study|Declined due to shock|3|||
17142587|NCT03262233|38285413|FG000|Overall Study|Protocol Violation|5|||
17142588|NCT03262233|38285414|FG001|Overall Study|Protocol Violation|10|||
17142589|NCT03262233|38285415|FG002|Overall Study|Protocol Violation|2|||
17142590|NCT03262233|38285416|FG003|Overall Study|Protocol Violation|13|||
17142591|NCT03262233|38285413|FG000|Overall Study|data collection artifact|0|||
17142592|NCT03262233|38285414|FG001|Overall Study|data collection artifact|1|||
17142593|NCT03262233|38285415|FG002|Overall Study|data collection artifact|0|||
17142594|NCT03262233|38285416|FG003|Overall Study|data collection artifact|0|||
17142595|NCT03261531|38285427|FG000|Overall Study|Withdrawal by Subject|4|||
17142596|NCT04151290|38285431|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
17142597|NCT03260205|38285450|FG000|Overall Study|Adverse Event|2|||
17142598|NCT03260205|38285451|FG001|Overall Study|Adverse Event|0|||
17049033|NCT00643448|38192756|FG000|Overall Study|Lack of Efficacy|2|||
17049034|NCT00643448|38192757|FG001|Overall Study|Lack of Efficacy|0|||
17049035|NCT00643448|38192758|FG002|Overall Study|Lack of Efficacy|4|||
17049036|NCT00643448|38192756|FG000|Overall Study|Adverse Event|2|||
17049037|NCT00643448|38192757|FG001|Overall Study|Adverse Event|2|||
17049038|NCT00643448|38192758|FG002|Overall Study|Adverse Event|2|||
17049039|NCT00643448|38192756|FG000|Overall Study|QTcF>550 ms|0|||
17049040|NCT00643448|38192757|FG001|Overall Study|QTcF>550 ms|3|||
17049041|NCT00643448|38192758|FG002|Overall Study|QTcF>550 ms|0|||
17049042|NCT00604500|38192768|FG000|Overall Study|Adverse Event|2|||
17049043|NCT00604500|38192768|FG000|Overall Study|Protocol Violation|2|||
17049044|NCT00604500|38192768|FG000|Overall Study|Treatment Failure|1|||
17049045|NCT00604500|38192768|FG000|Overall Study|Withdrawal by Subject|4|||
17049046|NCT00604500|38192768|FG000|Overall Study|Administrative|1|||
17049047|NCT00604500|38192768|FG000|Overall Study|Did not meet protocol eligibility|1|||
17049048|NCT00627458|38192775|FG000|Overall Study|Migrated from study area|1|||
17049049|NCT00627458|38192776|FG001|Overall Study|Migrated from study area|0|||
17049050|NCT00627458|38192777|FG002|Overall Study|Migrated from study area|1|||
17049051|NCT00627458|38192775|FG000|Overall Study|Withdrawal by Subject|2|||
17049052|NCT00627458|38192776|FG001|Overall Study|Withdrawal by Subject|6|||
17049053|NCT00627458|38192777|FG002|Overall Study|Withdrawal by Subject|5|||
17049054|NCT00627458|38192775|FG000|Overall Study|Lost to Follow-up|1|||
17049055|NCT00627458|38192776|FG001|Overall Study|Lost to Follow-up|1|||
17049056|NCT00627458|38192777|FG002|Overall Study|Lost to Follow-up|0|||
17049057|NCT00542919|38192789|FG000|Overall Study|Adverse Event|1|||
17049058|NCT00542919|38192790|FG001|Overall Study|Adverse Event|5|||
17049059|NCT00542919|38192791|FG002|Overall Study|Adverse Event|1|||
17049060|NCT00542919|38192789|FG000|Overall Study|Withdrawal by Subject|1|||
17049061|NCT00542919|38192790|FG001|Overall Study|Withdrawal by Subject|0|||
17049062|NCT00542919|38192791|FG002|Overall Study|Withdrawal by Subject|3|||
17049063|NCT00542919|38192789|FG000|Overall Study|Physician Decision|2|||
17049064|NCT00542919|38192790|FG001|Overall Study|Physician Decision|2|||
17049065|NCT00542919|38192791|FG002|Overall Study|Physician Decision|1|||
17049066|NCT00542919|38192789|FG000|Overall Study|Sponsor Decision|1|||
17049067|NCT00542919|38192790|FG001|Overall Study|Sponsor Decision|0|||
17049068|NCT00542919|38192791|FG002|Overall Study|Sponsor Decision|0|||
17049069|NCT00542919|38192789|FG000|Overall Study|Lost to Follow-up|2|||
17049070|NCT00542919|38192790|FG001|Overall Study|Lost to Follow-up|0|||
17049071|NCT00542919|38192791|FG002|Overall Study|Lost to Follow-up|1|||
17049072|NCT00159913|38192818|FG000|Overall Study|Adverse Event|1|||
17049073|NCT00159913|38192819|FG001|Overall Study|Adverse Event|0|||
17049074|NCT00159913|38192820|FG002|Overall Study|Adverse Event|1|||
17049075|NCT00159913|38192821|FG003|Overall Study|Adverse Event|0|||
17049076|NCT00159913|38192818|FG000|Overall Study|Withdrawal by Subject|0|||
17049077|NCT00159913|38192819|FG001|Overall Study|Withdrawal by Subject|0|||
17049078|NCT00159913|38192820|FG002|Overall Study|Withdrawal by Subject|0|||
17049079|NCT00159913|38192821|FG003|Overall Study|Withdrawal by Subject|1|||
17049080|NCT00159913|38192818|FG000|Overall Study|Lost to Follow-up|0|||
17049081|NCT00159913|38192819|FG001|Overall Study|Lost to Follow-up|0|||
17049082|NCT00159913|38192820|FG002|Overall Study|Lost to Follow-up|0|||
17049083|NCT00159913|38192821|FG003|Overall Study|Lost to Follow-up|1|||
17049084|NCT00159913|38192818|FG000|Overall Study|Protocol Violation|1|||
17049085|NCT00159913|38192819|FG001|Overall Study|Protocol Violation|0|||
17049086|NCT00159913|38192820|FG002|Overall Study|Protocol Violation|1|||
17049087|NCT00159913|38192821|FG003|Overall Study|Protocol Violation|0|||
17049088|NCT00604188|38192835|FG000|Overall Study|Adverse Event|1|||
17049089|NCT00604188|38192836|FG001|Overall Study|Adverse Event|4|||
17049090|NCT00604188|38192835|FG000|Overall Study|Lost to Follow-up|17|||
17049091|NCT00604188|38192836|FG001|Overall Study|Lost to Follow-up|15|||
17049092|NCT00604188|38192835|FG000|Overall Study|Withdrawal by Subject|5|||
17049093|NCT00604188|38192836|FG001|Overall Study|Withdrawal by Subject|1|||
17049094|NCT00604188|38192835|FG000|Overall Study|Non-compliance with protocol|4|||
17049095|NCT00604188|38192836|FG001|Overall Study|Non-compliance with protocol|4|||
17049096|NCT00604188|38192835|FG000|Overall Study|Did not receive study drug|0|||
17049097|NCT00604188|38192836|FG001|Overall Study|Did not receive study drug|1|||
17049098|NCT03913377|38192844|FG000|Period 1|Test Article no longer available|0|||
17049099|NCT03913377|38192845|FG001|Period 1|Test Article no longer available|1|||
17049100|NCT03913377|38192846|FG002|Period 1|Test Article no longer available|0|||
17049101|NCT03913377|38192844|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
17049102|NCT03913377|38192845|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
17049103|NCT03913377|38192846|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
17049104|NCT00227539|38192853|FG000|Overall Study|Protocol Violation|1|||
17049105|NCT00227305|38192857|FG000|Overall Study|Adverse Event|40|||
17049106|NCT00227305|38192857|FG000|Overall Study|Withdrawal by Subject|42|||
17049107|NCT00227305|38192857|FG000|Overall Study|Lost to Follow-up|33|||
17049108|NCT00227305|38192857|FG000|Overall Study|Study specific discontinuation|13|||
17049109|NCT00227305|38192857|FG000|Overall Study|MOVED OUT OF AREA|3|||
17049110|NCT00227305|38192857|FG000|Overall Study|Lack of Efficacy|7|||
17049111|NCT00227305|38192857|FG000|Overall Study|Physician Decision|3|||
17049112|NCT00227305|38192857|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
17049113|NCT00227305|38192857|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
17049114|NCT00227305|38192857|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
17049115|NCT00720941|38192863|FG000|Overall Study|Death|334|||
17049116|NCT00720941|38192864|FG001|Overall Study|Death|335|||
17049117|NCT00720941|38192863|FG000|Overall Study|Protocol Violation|0|||
17049118|NCT00720941|38192864|FG001|Overall Study|Protocol Violation|2|||
17049119|NCT00720941|38192863|FG000|Overall Study|Lost to Follow-up|17|||
17049120|NCT00720941|38192864|FG001|Overall Study|Lost to Follow-up|15|||
17142599|NCT03260205|38285452|FG002|Overall Study|Adverse Event|2|||
17142600|NCT03260205|38285453|FG003|Overall Study|Adverse Event|2|||
17142601|NCT03260205|38285454|FG004|Overall Study|Adverse Event|4|||
17142602|NCT03260205|38285450|FG000|Overall Study|Lost to Follow-up|2|||
17142603|NCT03260205|38285451|FG001|Overall Study|Lost to Follow-up|2|||
17142604|NCT03260205|38285452|FG002|Overall Study|Lost to Follow-up|1|||
17049121|NCT00720941|38192863|FG000|Overall Study|Physician Decision|1|||
17049122|NCT00720941|38192864|FG001|Overall Study|Physician Decision|5|||
17049123|NCT00720941|38192863|FG000|Overall Study|Withdrawal by Subject|27|||
17049124|NCT00720941|38192864|FG001|Overall Study|Withdrawal by Subject|35|||
17049125|NCT00720941|38192863|FG000|Overall Study|Ongoing|34|||
17049126|NCT00720941|38192864|FG001|Overall Study|Ongoing|23|||
17049127|NCT00585533|38192870|FG000|Overall Study|objective or symptomatic progression|9|||
17049128|NCT00628862|38192877|FG000|Overall Study|Adverse Event|6|||
17049129|NCT00628862|38192878|FG001|Overall Study|Adverse Event|8|||
17049130|NCT00628862|38192879|FG002|Overall Study|Adverse Event|10|||
17049131|NCT00628862|38192877|FG000|Overall Study|Withdrawal by Subject|4|||
17049132|NCT00628862|38192878|FG001|Overall Study|Withdrawal by Subject|6|||
17049133|NCT00628862|38192879|FG002|Overall Study|Withdrawal by Subject|11|||
17049134|NCT00628862|38192877|FG000|Overall Study|Lost to Follow-up|0|||
17049135|NCT00628862|38192878|FG001|Overall Study|Lost to Follow-up|2|||
17049136|NCT00628862|38192879|FG002|Overall Study|Lost to Follow-up|1|||
17049137|NCT00628862|38192877|FG000|Overall Study|Protocol Violation|1|||
17049138|NCT00628862|38192878|FG001|Overall Study|Protocol Violation|0|||
17049139|NCT00628862|38192879|FG002|Overall Study|Protocol Violation|0|||
17049140|NCT00628862|38192877|FG000|Overall Study|COPD Exacerbation|0|||
17049141|NCT00628862|38192878|FG001|Overall Study|COPD Exacerbation|1|||
17049142|NCT00628862|38192879|FG002|Overall Study|COPD Exacerbation|0|||
17049143|NCT00584987|38192891|FG000|Overall Study|Protocol Violation|1|||
17049144|NCT00584987|38192892|FG001|Overall Study|Protocol Violation|1|||
17049145|NCT00584987|38192893|FG002|Overall Study|Protocol Violation|1|||
17049146|NCT00584987|38192894|FG003|Overall Study|Protocol Violation|0|||
17049147|NCT00584987|38192891|FG000|Overall Study|Adverse Event|0|||
17049148|NCT00584987|38192892|FG001|Overall Study|Adverse Event|0|||
17049149|NCT00584987|38192893|FG002|Overall Study|Adverse Event|0|||
17049150|NCT00584987|38192894|FG003|Overall Study|Adverse Event|1|||
17049151|NCT00727961|38192904|FG000|Overall Study|Lost to Follow-up|1|||
17049152|NCT00727961|38192904|FG000|Overall Study|Adverse Event|4|||
17049153|NCT00727961|38192904|FG000|Overall Study|Patient's refusal|2|||
17049154|NCT00727961|38192904|FG000|Overall Study|Progression|30|||
17049155|NCT00568958|38192910|FG000|Allocation|Withdrawal by Subject|7|||
17142605|NCT03260205|38285453|FG003|Overall Study|Lost to Follow-up|1|||
17142606|NCT03260205|38285454|FG004|Overall Study|Lost to Follow-up|5|||
17049156|NCT00568958|38192911|FG001|Allocation|Withdrawal by Subject|3|||
17049157|NCT00568958|38192910|FG000|Allocation|Physician Decision|2|||
17049158|NCT00568958|38192911|FG001|Allocation|Physician Decision|0|||
17049159|NCT00568958|38192910|FG000|Follow-Up|Withdrawal by Subject|6|||
17049160|NCT00568958|38192911|FG001|Follow-Up|Withdrawal by Subject|6|||
17049161|NCT00568958|38192910|FG000|Follow-Up|Physician Decision|1|||
17049162|NCT00568958|38192911|FG001|Follow-Up|Physician Decision|1|||
17049163|NCT00568958|38192910|FG000|Follow-Up|Family Emergency|1|||
17049164|NCT00568958|38192911|FG001|Follow-Up|Family Emergency|0|||
17049165|NCT00568958|38192910|FG000|Follow-Up|Adverse Event|1|||
17049166|NCT00568958|38192911|FG001|Follow-Up|Adverse Event|0|||
17049167|NCT00727649|38192919|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
17049168|NCT00727649|38192920|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
17142607|NCT03260205|38285450|FG000|Overall Study|Protocol Violation|0|||
17142608|NCT03260205|38285451|FG001|Overall Study|Protocol Violation|0|||
17142609|NCT03260205|38285452|FG002|Overall Study|Protocol Violation|2|||
17142610|NCT03260205|38285453|FG003|Overall Study|Protocol Violation|0|||
17142611|NCT03260205|38285454|FG004|Overall Study|Protocol Violation|1|||
17142612|NCT03260205|38285450|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
17142613|NCT03260205|38285451|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
17142614|NCT03260205|38285452|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
17142615|NCT03260205|38285453|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
17142616|NCT03260205|38285454|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
17049169|NCT00727649|38192919|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
17049170|NCT00727649|38192920|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
17049171|NCT00727649|38192919|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
17049172|NCT00727649|38192920|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
17049173|NCT00727649|38192919|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
17049174|NCT00727649|38192920|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
17049175|NCT00727649|38192919|FG000|Second Intervention (4-weeks)|Death|1|||
17049176|NCT00727649|38192920|FG001|Second Intervention (4-weeks)|Death|0|||
17049177|NCT00727649|38192919|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
17049178|NCT00727649|38192920|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
17049179|NCT00727649|38192919|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
17049180|NCT00727649|38192920|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
17049181|NCT00568334|38192930|FG000|Overall Study|Withdrawal by Subject|0|||
17049182|NCT00568334|38192931|FG001|Overall Study|Withdrawal by Subject|1|||
17049183|NCT00568334|38192930|FG000|Overall Study|Lost to Follow-up|1|||
17049184|NCT00568334|38192931|FG001|Overall Study|Lost to Follow-up|0|||
17049185|NCT00727571|38192941|FG000|Overall Study|Ineligibility determined|1|||
17049186|NCT00727571|38192942|FG001|Overall Study|Ineligibility determined|1|||
17049187|NCT00727571|38192943|FG002|Overall Study|Ineligibility determined|1|||
17049188|NCT00727571|38192944|FG003|Overall Study|Ineligibility determined|0|||
17049189|NCT00727571|38192941|FG000|Overall Study|Death|0|||
17049190|NCT00727571|38192942|FG001|Overall Study|Death|19|||
17049191|NCT00727571|38192943|FG002|Overall Study|Death|5|||
17049192|NCT00727571|38192944|FG003|Overall Study|Death|1|||
17049193|NCT00727571|38192941|FG000|Overall Study|Physician Decision|0|||
17049194|NCT00727571|38192942|FG001|Overall Study|Physician Decision|5|||
17049195|NCT00727571|38192943|FG002|Overall Study|Physician Decision|0|||
17049196|NCT00727571|38192944|FG003|Overall Study|Physician Decision|0|||
17049197|NCT00727571|38192941|FG000|Overall Study|Withdrawal by Subject|0|||
17049198|NCT00727571|38192942|FG001|Overall Study|Withdrawal by Subject|10|||
17049199|NCT00727571|38192943|FG002|Overall Study|Withdrawal by Subject|11|||
17049200|NCT00727571|38192944|FG003|Overall Study|Withdrawal by Subject|0|||
17049201|NCT00727571|38192941|FG000|Overall Study|Subject Non Compliance|0|||
17049202|NCT00727571|38192942|FG001|Overall Study|Subject Non Compliance|6|||
17049203|NCT00727571|38192943|FG002|Overall Study|Subject Non Compliance|0|||
17049204|NCT00727571|38192944|FG003|Overall Study|Subject Non Compliance|4|||
17049205|NCT00727571|38192941|FG000|Overall Study|Dismissed from nursing home|0|||
17049206|NCT00727571|38192942|FG001|Overall Study|Dismissed from nursing home|9|||
17049207|NCT00727571|38192943|FG002|Overall Study|Dismissed from nursing home|5|||
17049208|NCT00727571|38192944|FG003|Overall Study|Dismissed from nursing home|0|||
17049209|NCT00727571|38192941|FG000|Overall Study|Hospitalization|0|||
17049210|NCT00727571|38192942|FG001|Overall Study|Hospitalization|1|||
17049211|NCT00727571|38192943|FG002|Overall Study|Hospitalization|0|||
17049212|NCT00727571|38192944|FG003|Overall Study|Hospitalization|1|||
17049213|NCT00727571|38192941|FG000|Overall Study|AE not leading to hospitalization|0|||
17049214|NCT00727571|38192942|FG001|Overall Study|AE not leading to hospitalization|0|||
17049215|NCT00727571|38192943|FG002|Overall Study|AE not leading to hospitalization|2|||
17049216|NCT00727571|38192944|FG003|Overall Study|AE not leading to hospitalization|0|||
17049217|NCT00727571|38192941|FG000|Overall Study|Other|0|||
17049218|NCT00727571|38192942|FG001|Overall Study|Other|4|||
17049219|NCT00727571|38192943|FG002|Overall Study|Other|6|||
17049220|NCT00727571|38192944|FG003|Overall Study|Other|0|||
17049221|NCT00225277|38192956|FG000|Overall Study|Adverse Event|30|||
17049222|NCT00225277|38192957|FG001|Overall Study|Adverse Event|34|||
17049223|NCT00225277|38192956|FG000|Overall Study|Lack of Efficacy|4|||
17049224|NCT00225277|38192957|FG001|Overall Study|Lack of Efficacy|1|||
17049225|NCT00225277|38192956|FG000|Overall Study|Lost to Follow-up|4|||
17049226|NCT00225277|38192957|FG001|Overall Study|Lost to Follow-up|6|||
17049227|NCT00225277|38192956|FG000|Overall Study|Physician Decision|6|||
17049228|NCT00225277|38192957|FG001|Overall Study|Physician Decision|8|||
17049229|NCT00225277|38192956|FG000|Overall Study|Protocol Violation|6|||
17049230|NCT00225277|38192957|FG001|Overall Study|Protocol Violation|3|||
17049231|NCT00225277|38192956|FG000|Overall Study|Withdrawal by Subject|40|||
17049232|NCT00225277|38192957|FG001|Overall Study|Withdrawal by Subject|34|||
17049233|NCT00225277|38192956|FG000|Overall Study|Other|7|||
17049234|NCT00225277|38192957|FG001|Overall Study|Other|9|||
17049235|NCT00567996|38192966|FG000|Overall Study|Adverse Event|18|||
17049236|NCT00567996|38192967|FG001|Overall Study|Adverse Event|16|||
17049237|NCT00567996|38192968|FG002|Overall Study|Adverse Event|13|||
17049238|NCT00567996|38192966|FG000|Overall Study|Protocol Deviation|9|||
17049239|NCT00567996|38192967|FG001|Overall Study|Protocol Deviation|11|||
17049240|NCT00567996|38192968|FG002|Overall Study|Protocol Deviation|13|||
17049241|NCT00567996|38192966|FG000|Overall Study|Withdrawal by Subject|8|||
16780912|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16780913|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16780914|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16992540|NCT00724867|38136568|FG000|Overall Study|Withdrawal by Subject|31|||
17049242|NCT00567996|38192967|FG001|Overall Study|Withdrawal by Subject|12|||
17049243|NCT00567996|38192968|FG002|Overall Study|Withdrawal by Subject|22|||
17049244|NCT00567996|38192966|FG000|Overall Study|Abnormal Lab value(s)|2|||
17049245|NCT00567996|38192967|FG001|Overall Study|Abnormal Lab value(s)|1|||
17049246|NCT00567996|38192968|FG002|Overall Study|Abnormal Lab value(s)|2|||
17049247|NCT00567996|38192966|FG000|Overall Study|Abnormal test procedure result(s)|2|||
17049248|NCT00567996|38192967|FG001|Overall Study|Abnormal test procedure result(s)|1|||
17049249|NCT00567996|38192968|FG002|Overall Study|Abnormal test procedure result(s)|1|||
17049250|NCT00567996|38192966|FG000|Overall Study|Lost to Follow-up|2|||
17049251|NCT00567996|38192967|FG001|Overall Study|Lost to Follow-up|5|||
17049252|NCT00567996|38192968|FG002|Overall Study|Lost to Follow-up|2|||
17049253|NCT00567996|38192966|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17142617|NCT03260205|38285450|FG000|Overall Study|Other: Unspecified|0|||
17049254|NCT00567996|38192967|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
17049255|NCT00567996|38192968|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
17049256|NCT00567996|38192966|FG000|Overall Study|Administrative problems|1|||
17049257|NCT00567996|38192967|FG001|Overall Study|Administrative problems|1|||
17049258|NCT00567996|38192968|FG002|Overall Study|Administrative problems|0|||
17049259|NCT00567996|38192966|FG000|Overall Study|Death|1|||
17049260|NCT00567996|38192967|FG001|Overall Study|Death|0|||
17049261|NCT00567996|38192968|FG002|Overall Study|Death|2|||
17049262|NCT00567996|38192966|FG000|Overall Study|Patient's inability to use the device|0|||
17049263|NCT00567996|38192967|FG001|Overall Study|Patient's inability to use the device|1|||
17049264|NCT00567996|38192968|FG002|Overall Study|Patient's inability to use the device|0|||
17049265|NCT00224887|38192982|FG000|Overall Study|Pregnancy|6|||
17049266|NCT00224887|38192983|FG001|Overall Study|Pregnancy|6|||
17049267|NCT00148759|38192991|FG000|Overall Study|Withdrawal by Subject|1|||
17049268|NCT00148759|38192992|FG001|Overall Study|Withdrawal by Subject|1|||
17049269|NCT00148759|38192991|FG000|Overall Study|Lost to Follow-up|1|||
17049270|NCT00148759|38192992|FG001|Overall Study|Lost to Follow-up|0|||
17049271|NCT00717275|38192998|FG000|Overall Study|Premature study termination.|3|||
17049272|NCT00584909|38193002|FG000|Overall Study|Adverse Event|4|||
17049273|NCT00147823|38193008|FG000|Overall Study|Lost to Follow-up|6|||
17049274|NCT00147823|38193009|FG001|Overall Study|Lost to Follow-up|12|||
17049275|NCT00147823|38193008|FG000|Overall Study|Physician Decision|1|||
17049276|NCT00147823|38193009|FG001|Overall Study|Physician Decision|0|||
17049277|NCT00147823|38193008|FG000|Overall Study|Withdrawal by Subject|0|||
17049278|NCT00147823|38193009|FG001|Overall Study|Withdrawal by Subject|1|||
17049279|NCT00147823|38193008|FG000|Overall Study|Did not receive vitoss due to infection|6|||
17049280|NCT00147823|38193009|FG001|Overall Study|Did not receive vitoss due to infection|2|||
17049281|NCT00717197|38193015|FG000|Overall Study|Unable to purchase study drug|5|||
17049282|NCT00717197|38193015|FG000|Overall Study|Tumor Progression|1|||
17049283|NCT00717197|38193015|FG000|Overall Study|Physician Decision|1|||
17049284|NCT00147745|38193022|FG000|Overall Study|Withdrawal by Subject|1|||
17049285|NCT00147745|38193023|FG001|Overall Study|Withdrawal by Subject|0|||
17049286|NCT00147745|38193024|FG002|Overall Study|Withdrawal by Subject|0|||
16992541|NCT00724867|38136568|FG000|Overall Study|Sponsor decision to end study|14|||
16992542|NCT00724867|38136568|FG000|Overall Study|Subject incarcerated|1|||
16992543|NCT00724867|38136568|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
16992544|NCT00724867|38136568|FG000|Overall Study|Subject moved out of state|1|||
16992545|NCT00724867|38136568|FG000|Overall Study|Elected to exit due to site closure|2|||
16992546|NCT00724711|38136577|FG000|Overall Study|Adverse Event|7|||
16992547|NCT00724711|38136578|FG001|Overall Study|Adverse Event|3|||
16992548|NCT00724711|38136577|FG000|Overall Study|Pregnancy|0|||
16992549|NCT00724711|38136578|FG001|Overall Study|Pregnancy|1|||
16992550|NCT00724711|38136577|FG000|Overall Study|Lack of Efficacy|0|||
17049287|NCT00642902|38193036|FG000|Overall Study|Adverse Event|0|||
17049288|NCT00642902|38193037|FG001|Overall Study|Adverse Event|1|||
17049289|NCT00642902|38193038|FG002|Overall Study|Adverse Event|3|||
17049290|NCT00642902|38193039|FG003|Overall Study|Adverse Event|1|||
17049291|NCT00642902|38193036|FG000|Overall Study|Lost to Follow-up|1|||
17049292|NCT00642902|38193037|FG001|Overall Study|Lost to Follow-up|1|||
17049293|NCT00642902|38193038|FG002|Overall Study|Lost to Follow-up|0|||
17049294|NCT00642902|38193039|FG003|Overall Study|Lost to Follow-up|0|||
17049295|NCT00642902|38193036|FG000|Overall Study|Lack of Efficacy|0|||
17049296|NCT00642902|38193037|FG001|Overall Study|Lack of Efficacy|3|||
17049297|NCT00642902|38193038|FG002|Overall Study|Lack of Efficacy|3|||
17049298|NCT00642902|38193039|FG003|Overall Study|Lack of Efficacy|0|||
17049299|NCT00642902|38193036|FG000|Overall Study|Death|1|||
17049300|NCT00642902|38193037|FG001|Overall Study|Death|0|||
17049301|NCT00642902|38193038|FG002|Overall Study|Death|0|||
17049302|NCT00642902|38193039|FG003|Overall Study|Death|0|||
17049303|NCT00642902|38193036|FG000|Overall Study|Premature termination of clinical trial|37|||
17049304|NCT00642902|38193037|FG001|Overall Study|Premature termination of clinical trial|32|||
17049305|NCT00642902|38193038|FG002|Overall Study|Premature termination of clinical trial|35|||
17049306|NCT00642902|38193039|FG003|Overall Study|Premature termination of clinical trial|35|||
17049307|NCT00642902|38193036|FG000|Overall Study|Randomized, but not treated|0|||
17049308|NCT00642902|38193037|FG001|Overall Study|Randomized, but not treated|0|||
17049309|NCT00642902|38193038|FG002|Overall Study|Randomized, but not treated|1|||
17049310|NCT00642902|38193039|FG003|Overall Study|Randomized, but not treated|0|||
17049311|NCT00642902|38193036|FG000|Overall Study|Other|1|||
17049312|NCT00642902|38193037|FG001|Overall Study|Other|5|||
17049313|NCT00642902|38193038|FG002|Overall Study|Other|1|||
17049314|NCT00642902|38193039|FG003|Overall Study|Other|4|||
17049315|NCT00224107|38193051|FG000|Overall Study|Adverse Event|20|||
17142618|NCT03260205|38285451|FG001|Overall Study|Other: Unspecified|0|||
17142619|NCT03260205|38285452|FG002|Overall Study|Other: Unspecified|3|||
17142620|NCT03260205|38285453|FG003|Overall Study|Other: Unspecified|1|||
17142621|NCT03260205|38285454|FG004|Overall Study|Other: Unspecified|1|||
17142622|NCT03260205|38285450|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
17142623|NCT03260205|38285451|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
17049316|NCT00224107|38193052|FG001|Overall Study|Adverse Event|6|||
17049317|NCT00224107|38193051|FG000|Overall Study|Protocol Violation|2|||
17049318|NCT00224107|38193052|FG001|Overall Study|Protocol Violation|3|||
17049319|NCT00224107|38193051|FG000|Overall Study|Withdrawal by Subject|1|||
17049320|NCT00224107|38193052|FG001|Overall Study|Withdrawal by Subject|4|||
17049321|NCT00224107|38193051|FG000|Overall Study|Lack of Efficacy|2|||
17049322|NCT00224107|38193052|FG001|Overall Study|Lack of Efficacy|0|||
17049323|NCT00224107|38193051|FG000|Overall Study|Lost to Follow-up|4|||
17049324|NCT00224107|38193052|FG001|Overall Study|Lost to Follow-up|0|||
17049325|NCT00224107|38193051|FG000|Overall Study|Physician Decision|1|||
17049326|NCT00224107|38193052|FG001|Overall Study|Physician Decision|0|||
17049327|NCT00224107|38193051|FG000|Overall Study|Other|1|||
17049328|NCT00224107|38193052|FG001|Overall Study|Other|1|||
17049329|NCT00720083|38193060|FG000|Overall Study|Ineligible|1|||
17049330|NCT00720083|38193061|FG001|Overall Study|Ineligible|2|||
17049331|NCT00209131|38193069|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
17049332|NCT00209131|38193070|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
17049333|NCT00224029|38193076|FG000|Overall Study|Lost to Follow-up|1|||
17049334|NCT00224029|38193076|FG000|Overall Study|Withdrawal by Subject|4|||
17049335|NCT00224029|38193076|FG000|Overall Study|Other|1|||
17049336|NCT00223795|38193080|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
17049337|NCT00223795|38193081|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
17049338|NCT00223795|38193080|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
17049339|NCT00223795|38193081|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
17049340|NCT00719849|38193090|FG000|Overall Study|Death|0|||
17049341|NCT00719849|38193091|FG001|Overall Study|Death|1|||
17049342|NCT03907683|38193097|FG000|Overall Study|Pregnancy|1|||
17049343|NCT03907683|38193097|FG000|Overall Study|Withdrawal by Subject|1|||
17049344|NCT00626522|38193107|FG000|Overall Study|Protocol Violation|0|||
17049345|NCT00626522|38193108|FG001|Overall Study|Protocol Violation|0|||
17049346|NCT00626522|38193109|FG002|Overall Study|Protocol Violation|0|||
17049347|NCT00626522|38193110|FG003|Overall Study|Protocol Violation|0|||
17049348|NCT00626522|38193111|FG004|Overall Study|Protocol Violation|1|||
17049349|NCT00626522|38193112|FG005|Overall Study|Protocol Violation|0|||
17049350|NCT00626522|38193107|FG000|Overall Study|Adverse Event|2|||
17049351|NCT00626522|38193108|FG001|Overall Study|Adverse Event|1|||
17049352|NCT00626522|38193109|FG002|Overall Study|Adverse Event|2|||
17049353|NCT00626522|38193110|FG003|Overall Study|Adverse Event|0|||
17049354|NCT00626522|38193111|FG004|Overall Study|Adverse Event|1|||
17049355|NCT00626522|38193112|FG005|Overall Study|Adverse Event|1|||
17049356|NCT00626522|38193107|FG000|Overall Study|Withdrawal by Subject|2|||
17049357|NCT00626522|38193108|FG001|Overall Study|Withdrawal by Subject|5|||
17049358|NCT00626522|38193109|FG002|Overall Study|Withdrawal by Subject|5|||
17049359|NCT00626522|38193110|FG003|Overall Study|Withdrawal by Subject|0|||
17049360|NCT00626522|38193111|FG004|Overall Study|Withdrawal by Subject|4|||
17049361|NCT00626522|38193112|FG005|Overall Study|Withdrawal by Subject|1|||
17049362|NCT00626522|38193107|FG000|Overall Study|COPD exacerbation|0|||
17049363|NCT00626522|38193108|FG001|Overall Study|COPD exacerbation|0|||
17049364|NCT00626522|38193109|FG002|Overall Study|COPD exacerbation|0|||
17049365|NCT00626522|38193110|FG003|Overall Study|COPD exacerbation|1|||
17049366|NCT00626522|38193111|FG004|Overall Study|COPD exacerbation|1|||
17049367|NCT00626522|38193112|FG005|Overall Study|COPD exacerbation|0|||
17049368|NCT00626522|38193107|FG000|Overall Study|Lost to Follow-up|0|||
17049369|NCT00626522|38193108|FG001|Overall Study|Lost to Follow-up|1|||
17049370|NCT00626522|38193109|FG002|Overall Study|Lost to Follow-up|0|||
17049371|NCT00626522|38193110|FG003|Overall Study|Lost to Follow-up|0|||
17049372|NCT00626522|38193111|FG004|Overall Study|Lost to Follow-up|0|||
17049373|NCT00626522|38193112|FG005|Overall Study|Lost to Follow-up|0|||
17049374|NCT00626522|38193107|FG000|Overall Study|Inconsistent reason reported|1|||
17049375|NCT00626522|38193108|FG001|Overall Study|Inconsistent reason reported|0|||
17049376|NCT00626522|38193109|FG002|Overall Study|Inconsistent reason reported|0|||
17049377|NCT00626522|38193110|FG003|Overall Study|Inconsistent reason reported|0|||
17049378|NCT00626522|38193111|FG004|Overall Study|Inconsistent reason reported|0|||
17049379|NCT00626522|38193112|FG005|Overall Study|Inconsistent reason reported|0|||
17049380|NCT00626522|38193107|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
17049381|NCT00626522|38193108|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
17049382|NCT00626522|38193109|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
17049383|NCT00626522|38193110|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
17049384|NCT00626522|38193111|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
17049385|NCT00626522|38193112|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
17049386|NCT00540423|38193137|FG000|Double-Blind Treatment Period|Adverse Event|0|||
17049387|NCT00540423|38193138|FG001|Double-Blind Treatment Period|Adverse Event|1|||
17049388|NCT00540423|38193139|FG002|Double-Blind Treatment Period|Adverse Event|0|||
17049389|NCT00540423|38193137|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
17049390|NCT00540423|38193138|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
17049391|NCT00540423|38193139|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
17049392|NCT00566982|38193159|FG000|Overall Study|Adverse Event|6|||
17049393|NCT00566982|38193160|FG001|Overall Study|Adverse Event|48|||
17049394|NCT00566982|38193159|FG000|Overall Study|Withdrawal by Subject|1|||
17049395|NCT00566982|38193160|FG001|Overall Study|Withdrawal by Subject|14|||
17049396|NCT00566982|38193159|FG000|Overall Study|Protocol Violation|1|||
17049397|NCT00566982|38193160|FG001|Overall Study|Protocol Violation|4|||
17049398|NCT00566982|38193159|FG000|Overall Study|Lost to Follow-up|0|||
17049399|NCT00566982|38193160|FG001|Overall Study|Lost to Follow-up|1|||
17049400|NCT00566982|38193159|FG000|Overall Study|Other-family problems & doctor's request|0|||
17049401|NCT00566982|38193160|FG001|Overall Study|Other-family problems & doctor's request|2|||
17049402|NCT00624338|38193172|FG000|Overall Study|Adverse Event|14|||
17049403|NCT00624338|38193173|FG001|Overall Study|Adverse Event|14|||
17049404|NCT00624338|38193174|FG002|Overall Study|Adverse Event|18|||
17049405|NCT00624338|38193172|FG000|Overall Study|Lost to Follow-up|1|||
17049406|NCT00624338|38193173|FG001|Overall Study|Lost to Follow-up|0|||
17049407|NCT00624338|38193174|FG002|Overall Study|Lost to Follow-up|0|||
17049408|NCT00624338|38193172|FG000|Overall Study|Lack of Efficacy|11|||
17049409|NCT00624338|38193173|FG001|Overall Study|Lack of Efficacy|3|||
17049410|NCT00624338|38193174|FG002|Overall Study|Lack of Efficacy|14|||
17049411|NCT00624338|38193172|FG000|Overall Study|Protocol Violation|3|||
17049412|NCT00624338|38193173|FG001|Overall Study|Protocol Violation|3|||
17142624|NCT03260205|38285452|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
17142625|NCT03260205|38285453|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
17142626|NCT03260205|38285454|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
17142627|NCT04666441|38285479|FG000|Overall Study|Lost to Follow-up|1|||
17142628|NCT04666441|38285480|FG001|Overall Study|Lost to Follow-up|4|||
17142629|NCT04666441|38285481|FG002|Overall Study|Lost to Follow-up|1|||
17142630|NCT04666441|38285482|FG003|Overall Study|Lost to Follow-up|3|||
17142631|NCT04666441|38285483|FG004|Overall Study|Lost to Follow-up|0|||
17142632|NCT04666441|38285484|FG005|Overall Study|Lost to Follow-up|2|||
17142633|NCT04666441|38285485|FG006|Overall Study|Lost to Follow-up|2|||
17142634|NCT04666441|38285486|FG007|Overall Study|Lost to Follow-up|2|||
17142635|NCT04666441|38285479|FG000|Overall Study|Subject Decision|1|||
17142636|NCT04666441|38285480|FG001|Overall Study|Subject Decision|1|||
17142637|NCT04666441|38285481|FG002|Overall Study|Subject Decision|3|||
17142638|NCT04666441|38285482|FG003|Overall Study|Subject Decision|1|||
16992551|NCT00724711|38136578|FG001|Overall Study|Lack of Efficacy|1|||
16992552|NCT00724711|38136577|FG000|Overall Study|Physician Decision|0|||
16992553|NCT00724711|38136578|FG001|Overall Study|Physician Decision|3|||
16992554|NCT00724711|38136577|FG000|Overall Study|Withdrawal by Subject|5|||
16992555|NCT00724711|38136578|FG001|Overall Study|Withdrawal by Subject|4|||
16992556|NCT00724711|38136577|FG000|Overall Study|Lost to Follow-up|4|||
16992557|NCT00724711|38136578|FG001|Overall Study|Lost to Follow-up|5|||
16992558|NCT00724711|38136577|FG000|Overall Study|Protocol Violation|1|||
16992559|NCT00724711|38136578|FG001|Overall Study|Protocol Violation|0|||
16992560|NCT01024244|38136589|FG000|Overall Study|Adverse Event|1|||
16992561|NCT01024244|38136590|FG001|Overall Study|Adverse Event|2|||
17142639|NCT04666441|38285483|FG004|Overall Study|Subject Decision|0|||
17049413|NCT00624338|38193174|FG002|Overall Study|Protocol Violation|2|||
17049414|NCT00624338|38193172|FG000|Overall Study|Death|0|||
17049415|NCT00624338|38193173|FG001|Overall Study|Death|2|||
17049416|NCT00624338|38193174|FG002|Overall Study|Death|0|||
17049417|NCT00624338|38193172|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
17049418|NCT00624338|38193173|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
17049419|NCT00624338|38193174|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
17049420|NCT00624338|38193172|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
17049421|NCT00624338|38193173|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
17049422|NCT00624338|38193174|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
17049423|NCT00624338|38193172|FG000|Overall Study|Other|15|||
17049424|NCT00624338|38193173|FG001|Overall Study|Other|5|||
17049425|NCT00624338|38193174|FG002|Overall Study|Other|9|||
17049426|NCT00624338|38193172|FG000|Overall Study|Randomized but not treated|2|||
17142640|NCT04666441|38285484|FG005|Overall Study|Subject Decision|1|||
17142641|NCT04666441|38285485|FG006|Overall Study|Subject Decision|3|||
17142642|NCT04666441|38285486|FG007|Overall Study|Subject Decision|2|||
17142643|NCT03320850|38285523|FG000|Overall Study|Lost to Follow-up|0|||
17049427|NCT00624338|38193173|FG001|Overall Study|Randomized but not treated|1|||
17049428|NCT00624338|38193174|FG002|Overall Study|Randomized but not treated|3|||
17049429|NCT03977454|38193184|FG000|Overall Study|immediate postoperative revision|2|||
17049430|NCT03977454|38193185|FG001|Overall Study|immediate postoperative revision|2|||
17049431|NCT00538785|38193193|FG000|Overall Study|Death|9|||
17049432|NCT00538785|38193194|FG001|Overall Study|Death|10|||
17049433|NCT00538785|38193193|FG000|Overall Study|Withdrawal of consent|9|||
17049434|NCT00538785|38193194|FG001|Overall Study|Withdrawal of consent|7|||
17142644|NCT03320850|38285524|FG001|Overall Study|Lost to Follow-up|0|||
17142645|NCT03320850|38285525|FG002|Overall Study|Lost to Follow-up|0|||
17142646|NCT03320850|38285526|FG003|Overall Study|Lost to Follow-up|0|||
17142647|NCT03320850|38285527|FG004|Overall Study|Lost to Follow-up|1|||
17142648|NCT03320850|38285528|FG005|Overall Study|Lost to Follow-up|2|||
17142649|NCT03320850|38285529|FG006|Overall Study|Lost to Follow-up|2|||
17142650|NCT03320850|38285530|FG007|Overall Study|Lost to Follow-up|0|||
17142651|NCT03320850|38285531|FG008|Overall Study|Lost to Follow-up|6|||
17142652|NCT03320850|38285532|FG009|Overall Study|Lost to Follow-up|4|||
17142653|NCT03320850|38285523|FG000|Overall Study|Withdrawal by Subject|0|||
17142654|NCT03320850|38285524|FG001|Overall Study|Withdrawal by Subject|0|||
17142655|NCT03320850|38285525|FG002|Overall Study|Withdrawal by Subject|0|||
17142656|NCT03320850|38285526|FG003|Overall Study|Withdrawal by Subject|0|||
17142657|NCT03320850|38285527|FG004|Overall Study|Withdrawal by Subject|1|||
17142658|NCT03320850|38285528|FG005|Overall Study|Withdrawal by Subject|2|||
16992562|NCT01024244|38136591|FG002|Overall Study|Adverse Event|0|||
17049435|NCT00538785|38193193|FG000|Overall Study|Lost to Follow-up|1|||
17049436|NCT00538785|38193194|FG001|Overall Study|Lost to Follow-up|0|||
17049437|NCT00538629|38193200|FG000|Overall Study|At subject's request|1|||
17049438|NCT00538629|38193200|FG000|Overall Study|Adverse Event|2|||
17049439|NCT00538629|38193200|FG000|Overall Study|Lack of Efficacy|12|||
17049440|NCT00538629|38193200|FG000|Overall Study|Lost to Follow-up|6|||
17049441|NCT00538629|38193200|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
17049442|NCT00622700|38193207|FG000|Core Treatment Period|Randomized but Not Treated|0|||
17049443|NCT00622700|38193208|FG001|Core Treatment Period|Randomized but Not Treated|2|||
17049444|NCT00622700|38193209|FG002|Core Treatment Period|Randomized but Not Treated|2|||
17142659|NCT03320850|38285529|FG006|Overall Study|Withdrawal by Subject|4|||
17142660|NCT03320850|38285530|FG007|Overall Study|Withdrawal by Subject|5|||
17142661|NCT03320850|38285531|FG008|Overall Study|Withdrawal by Subject|2|||
16992563|NCT01024244|38136592|FG003|Overall Study|Adverse Event|1|||
16992564|NCT01024244|38136593|FG004|Overall Study|Adverse Event|2|||
16992565|NCT01024244|38136589|FG000|Overall Study|Entry Criteria Not Met|0|||
16992566|NCT01024244|38136590|FG001|Overall Study|Entry Criteria Not Met|1|||
16992567|NCT01024244|38136591|FG002|Overall Study|Entry Criteria Not Met|0|||
16992568|NCT01024244|38136592|FG003|Overall Study|Entry Criteria Not Met|0|||
16992569|NCT01024244|38136593|FG004|Overall Study|Entry Criteria Not Met|0|||
16992570|NCT01024244|38136589|FG000|Overall Study|Lack of Efficacy|1|||
16992571|NCT01024244|38136590|FG001|Overall Study|Lack of Efficacy|0|||
16992572|NCT01024244|38136591|FG002|Overall Study|Lack of Efficacy|0|||
16992573|NCT01024244|38136592|FG003|Overall Study|Lack of Efficacy|0|||
16992574|NCT01024244|38136593|FG004|Overall Study|Lack of Efficacy|0|||
16992575|NCT01024244|38136589|FG000|Overall Study|Protocol Violation|1|||
16992576|NCT01024244|38136590|FG001|Overall Study|Protocol Violation|0|||
16992577|NCT01024244|38136591|FG002|Overall Study|Protocol Violation|0|||
16992578|NCT01024244|38136592|FG003|Overall Study|Protocol Violation|0|||
16992579|NCT01024244|38136593|FG004|Overall Study|Protocol Violation|2|||
16992580|NCT01024244|38136589|FG000|Overall Study|Sponsor Decision|14|||
16992581|NCT01024244|38136590|FG001|Overall Study|Sponsor Decision|7|||
16992582|NCT01024244|38136591|FG002|Overall Study|Sponsor Decision|14|||
16992583|NCT01024244|38136592|FG003|Overall Study|Sponsor Decision|12|||
17049445|NCT00622700|38193210|FG003|Core Treatment Period|Randomized but Not Treated|0|||
17049446|NCT00622700|38193211|FG004|Core Treatment Period|Randomized but Not Treated|0|||
17049447|NCT00622700|38193212|FG005|Core Treatment Period|Randomized but Not Treated|0|||
17049448|NCT00622700|38193213|FG006|Core Treatment Period|Randomized but Not Treated|0|||
17049449|NCT00622700|38193207|FG000|Core Treatment Period|Adverse Event|18|||
17049450|NCT00622700|38193208|FG001|Core Treatment Period|Adverse Event|25|||
17049451|NCT00622700|38193209|FG002|Core Treatment Period|Adverse Event|18|||
17049452|NCT00622700|38193210|FG003|Core Treatment Period|Adverse Event|0|||
17049453|NCT00622700|38193211|FG004|Core Treatment Period|Adverse Event|0|||
17049454|NCT00622700|38193212|FG005|Core Treatment Period|Adverse Event|0|||
17049455|NCT00622700|38193213|FG006|Core Treatment Period|Adverse Event|0|||
17049456|NCT00622700|38193207|FG000|Core Treatment Period|Lack of Efficacy|19|||
17049457|NCT00622700|38193208|FG001|Core Treatment Period|Lack of Efficacy|6|||
17049458|NCT00622700|38193209|FG002|Core Treatment Period|Lack of Efficacy|12|||
17049459|NCT00622700|38193210|FG003|Core Treatment Period|Lack of Efficacy|0|||
17049460|NCT00622700|38193211|FG004|Core Treatment Period|Lack of Efficacy|0|||
17049461|NCT00622700|38193212|FG005|Core Treatment Period|Lack of Efficacy|0|||
17049462|NCT00622700|38193213|FG006|Core Treatment Period|Lack of Efficacy|0|||
17049463|NCT00622700|38193207|FG000|Core Treatment Period|Lost to Follow-up|1|||
17049464|NCT00622700|38193208|FG001|Core Treatment Period|Lost to Follow-up|1|||
17049465|NCT00622700|38193209|FG002|Core Treatment Period|Lost to Follow-up|1|||
17049466|NCT00622700|38193210|FG003|Core Treatment Period|Lost to Follow-up|0|||
17049467|NCT00622700|38193211|FG004|Core Treatment Period|Lost to Follow-up|0|||
17049468|NCT00622700|38193212|FG005|Core Treatment Period|Lost to Follow-up|0|||
17049469|NCT00622700|38193213|FG006|Core Treatment Period|Lost to Follow-up|0|||
17049470|NCT00622700|38193207|FG000|Core Treatment Period|Death|1|||
17049471|NCT00622700|38193208|FG001|Core Treatment Period|Death|0|||
17049472|NCT00622700|38193209|FG002|Core Treatment Period|Death|0|||
17049473|NCT00622700|38193210|FG003|Core Treatment Period|Death|0|||
17049474|NCT00622700|38193211|FG004|Core Treatment Period|Death|0|||
17049475|NCT00622700|38193212|FG005|Core Treatment Period|Death|0|||
17049476|NCT00622700|38193213|FG006|Core Treatment Period|Death|0|||
17049477|NCT00622700|38193207|FG000|Core Treatment Period|Progressive Disease|3|||
17049478|NCT00622700|38193208|FG001|Core Treatment Period|Progressive Disease|1|||
17049479|NCT00622700|38193209|FG002|Core Treatment Period|Progressive Disease|0|||
17049480|NCT00622700|38193210|FG003|Core Treatment Period|Progressive Disease|0|||
17049481|NCT00622700|38193211|FG004|Core Treatment Period|Progressive Disease|0|||
17049482|NCT00622700|38193212|FG005|Core Treatment Period|Progressive Disease|0|||
17049483|NCT00622700|38193213|FG006|Core Treatment Period|Progressive Disease|0|||
17049484|NCT00622700|38193207|FG000|Core Treatment Period|Withdrawal by Subject|12|||
17049485|NCT00622700|38193208|FG001|Core Treatment Period|Withdrawal by Subject|18|||
17049486|NCT00622700|38193209|FG002|Core Treatment Period|Withdrawal by Subject|15|||
17049487|NCT00622700|38193210|FG003|Core Treatment Period|Withdrawal by Subject|0|||
17049488|NCT00622700|38193211|FG004|Core Treatment Period|Withdrawal by Subject|0|||
17049489|NCT00622700|38193212|FG005|Core Treatment Period|Withdrawal by Subject|0|||
17049490|NCT00622700|38193213|FG006|Core Treatment Period|Withdrawal by Subject|0|||
17049491|NCT00622700|38193207|FG000|Core Treatment Period|Other than specified above|2|||
17049492|NCT00622700|38193208|FG001|Core Treatment Period|Other than specified above|2|||
17049493|NCT00622700|38193209|FG002|Core Treatment Period|Other than specified above|5|||
17049494|NCT00622700|38193210|FG003|Core Treatment Period|Other than specified above|0|||
17049495|NCT00622700|38193211|FG004|Core Treatment Period|Other than specified above|0|||
17049496|NCT00622700|38193212|FG005|Core Treatment Period|Other than specified above|0|||
17049497|NCT00622700|38193213|FG006|Core Treatment Period|Other than specified above|0|||
17049498|NCT00622700|38193207|FG000|Extension Treatment Period|Adverse Event|0|||
17049499|NCT00622700|38193208|FG001|Extension Treatment Period|Adverse Event|0|||
17049500|NCT00622700|38193209|FG002|Extension Treatment Period|Adverse Event|0|||
17049501|NCT00622700|38193210|FG003|Extension Treatment Period|Adverse Event|5|||
17049502|NCT00622700|38193211|FG004|Extension Treatment Period|Adverse Event|9|||
17049503|NCT00622700|38193212|FG005|Extension Treatment Period|Adverse Event|6|||
17049504|NCT00622700|38193213|FG006|Extension Treatment Period|Adverse Event|8|||
17049505|NCT00622700|38193207|FG000|Extension Treatment Period|Lack of Efficacy|0|||
17049506|NCT00622700|38193208|FG001|Extension Treatment Period|Lack of Efficacy|0|||
17049507|NCT00622700|38193209|FG002|Extension Treatment Period|Lack of Efficacy|0|||
17049508|NCT00622700|38193210|FG003|Extension Treatment Period|Lack of Efficacy|2|||
17049509|NCT00622700|38193211|FG004|Extension Treatment Period|Lack of Efficacy|8|||
17049510|NCT00622700|38193212|FG005|Extension Treatment Period|Lack of Efficacy|1|||
17049511|NCT00622700|38193213|FG006|Extension Treatment Period|Lack of Efficacy|9|||
17049512|NCT00622700|38193207|FG000|Extension Treatment Period|Protocol Violation|0|||
17049513|NCT00622700|38193208|FG001|Extension Treatment Period|Protocol Violation|0|||
17049514|NCT00622700|38193209|FG002|Extension Treatment Period|Protocol Violation|0|||
17049515|NCT00622700|38193210|FG003|Extension Treatment Period|Protocol Violation|0|||
17049516|NCT00622700|38193211|FG004|Extension Treatment Period|Protocol Violation|0|||
17049517|NCT00622700|38193212|FG005|Extension Treatment Period|Protocol Violation|2|||
17049518|NCT00622700|38193213|FG006|Extension Treatment Period|Protocol Violation|0|||
17049519|NCT00622700|38193207|FG000|Extension Treatment Period|Lost to Follow-up|0|||
17049520|NCT00622700|38193208|FG001|Extension Treatment Period|Lost to Follow-up|0|||
17049521|NCT00622700|38193209|FG002|Extension Treatment Period|Lost to Follow-up|0|||
17049522|NCT00622700|38193210|FG003|Extension Treatment Period|Lost to Follow-up|0|||
17049523|NCT00622700|38193211|FG004|Extension Treatment Period|Lost to Follow-up|1|||
17049524|NCT00622700|38193212|FG005|Extension Treatment Period|Lost to Follow-up|0|||
17049525|NCT00622700|38193213|FG006|Extension Treatment Period|Lost to Follow-up|0|||
17049526|NCT00622700|38193207|FG000|Extension Treatment Period|Progressive Disease|0|||
17049527|NCT00622700|38193208|FG001|Extension Treatment Period|Progressive Disease|0|||
17049528|NCT00622700|38193209|FG002|Extension Treatment Period|Progressive Disease|0|||
17049529|NCT00622700|38193210|FG003|Extension Treatment Period|Progressive Disease|1|||
17049530|NCT00622700|38193211|FG004|Extension Treatment Period|Progressive Disease|2|||
17049531|NCT00622700|38193212|FG005|Extension Treatment Period|Progressive Disease|0|||
17049532|NCT00622700|38193213|FG006|Extension Treatment Period|Progressive Disease|2|||
17049533|NCT00622700|38193207|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
17049534|NCT00622700|38193208|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
17049535|NCT00622700|38193209|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
17049536|NCT00622700|38193210|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
17049537|NCT00622700|38193211|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
17049538|NCT00622700|38193212|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
17049539|NCT00622700|38193213|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
17049540|NCT00622700|38193207|FG000|Extension Treatment Period|Missing|0|||
17049541|NCT00622700|38193208|FG001|Extension Treatment Period|Missing|0|||
17049542|NCT00622700|38193209|FG002|Extension Treatment Period|Missing|0|||
17049543|NCT00622700|38193210|FG003|Extension Treatment Period|Missing|2|||
17049544|NCT00622700|38193211|FG004|Extension Treatment Period|Missing|3|||
17049545|NCT00622700|38193212|FG005|Extension Treatment Period|Missing|1|||
17049546|NCT00622700|38193213|FG006|Extension Treatment Period|Missing|0|||
17049547|NCT00622700|38193207|FG000|Extension Treatment Period|Other than specified above|0|||
17049548|NCT00622700|38193208|FG001|Extension Treatment Period|Other than specified above|0|||
17049549|NCT00622700|38193209|FG002|Extension Treatment Period|Other than specified above|0|||
17049550|NCT00622700|38193210|FG003|Extension Treatment Period|Other than specified above|0|||
17049551|NCT00622700|38193211|FG004|Extension Treatment Period|Other than specified above|0|||
17049552|NCT00622700|38193212|FG005|Extension Treatment Period|Other than specified above|1|||
17049553|NCT00622700|38193213|FG006|Extension Treatment Period|Other than specified above|1|||
17049554|NCT00538473|38193232|FG000|Overall Study|Adverse Event|1|||
17049555|NCT00538473|38193233|FG001|Overall Study|Adverse Event|0|||
17049556|NCT00622466|38193239|FG000|Overall Study|Death|1|||
17049557|NCT00622466|38193239|FG000|Overall Study|Adverse Event|1|||
17049558|NCT00622466|38193239|FG000|Overall Study|Withdrawal by Subject|2|||
17049559|NCT00537771|38193245|FG000|Overall Study|Withdrawal by Subject|6|||
17049560|NCT00537771|38193246|FG001|Overall Study|Withdrawal by Subject|23|||
17049561|NCT00537771|38193245|FG000|Overall Study|Adverse Event|8|||
17049562|NCT00537771|38193246|FG001|Overall Study|Adverse Event|15|||
17049563|NCT00537771|38193245|FG000|Overall Study|Lost to Follow-up|9|||
17049564|NCT00537771|38193246|FG001|Overall Study|Lost to Follow-up|15|||
17049565|NCT00537771|38193245|FG000|Overall Study|Protocol Violation|2|||
17049566|NCT00537771|38193246|FG001|Overall Study|Protocol Violation|6|||
17049567|NCT00537771|38193245|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
17049568|NCT00537771|38193246|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
17049569|NCT00623480|38193254|FG000|Overall Study|Lost to Follow-up|0|||
17049570|NCT00623480|38193255|FG001|Overall Study|Lost to Follow-up|1|||
17049571|NCT00623480|38193254|FG000|Overall Study|Withdrawal by Subject|2|||
17049572|NCT00623480|38193255|FG001|Overall Study|Withdrawal by Subject|4|||
17049573|NCT00623480|38193254|FG000|Overall Study|Lack of Efficacy|1|||
17049574|NCT00623480|38193255|FG001|Overall Study|Lack of Efficacy|0|||
17049575|NCT00623480|38193254|FG000|Overall Study|Non-compliant with study medication|4|||
17049576|NCT00623480|38193255|FG001|Overall Study|Non-compliant with study medication|0|||
17049577|NCT00623480|38193254|FG000|Overall Study|Protocol Violation|0|||
17049578|NCT00623480|38193255|FG001|Overall Study|Protocol Violation|1|||
17049579|NCT00623480|38193254|FG000|Overall Study|Site closed by sponsor|0|||
17049580|NCT00623480|38193255|FG001|Overall Study|Site closed by sponsor|1|||
17049581|NCT02513667|38193263|FG000|Overall Study|Withdrawal by Subject|0|||
17049582|NCT02513667|38193264|FG001|Overall Study|Withdrawal by Subject|1|||
17049583|NCT00621764|38193274|FG000|Overall Study|Protocol Violation|0|||
17049584|NCT00621764|38193275|FG001|Overall Study|Protocol Violation|0|||
17049585|NCT00621764|38193276|FG002|Overall Study|Protocol Violation|0|||
17049586|NCT00621764|38193277|FG003|Overall Study|Protocol Violation|1|||
17049587|NCT00510718|38193295|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
17049588|NCT00510718|38193296|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
17049589|NCT00510718|38193295|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
17049590|NCT00510718|38193296|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
17049591|NCT00510718|38193295|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
17049592|NCT00510718|38193296|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
17049593|NCT00510718|38193295|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
17049594|NCT00510718|38193296|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
17049595|NCT00510718|38193295|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
17049596|NCT00510718|38193296|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
17049597|NCT00510718|38193295|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
17049598|NCT00510718|38193296|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
17049599|NCT00537381|38193317|FG000|Overall Study|Adverse Event|13|||
17049600|NCT00537381|38193318|FG001|Overall Study|Adverse Event|9|||
17049601|NCT00537381|38193317|FG000|Overall Study|Death|3|||
17049602|NCT00537381|38193318|FG001|Overall Study|Death|3|||
17049603|NCT00537381|38193317|FG000|Overall Study|Withdrawal by Subject|5|||
17049604|NCT00537381|38193318|FG001|Overall Study|Withdrawal by Subject|14|||
17049605|NCT00537381|38193317|FG000|Overall Study|Physician Decision|7|||
17049606|NCT00537381|38193318|FG001|Overall Study|Physician Decision|6|||
17049607|NCT00537381|38193317|FG000|Overall Study|Disease Progression|9|||
17049608|NCT00537381|38193318|FG001|Overall Study|Disease Progression|18|||
17049609|NCT00537381|38193317|FG000|Overall Study|Sponsor decision|14|||
17049610|NCT00537381|38193318|FG001|Overall Study|Sponsor decision|9|||
17049611|NCT00537381|38193317|FG000|Overall Study|Other|5|||
17049612|NCT00537381|38193318|FG001|Overall Study|Other|3|||
17049613|NCT03791398|38193329|FG000|Overall Study|Progression of Disease Under Study|2|||
17049614|NCT03791398|38193330|FG001|Overall Study|Progression of Disease Under Study|0|||
17049615|NCT03791398|38193331|FG002|Overall Study|Progression of Disease Under Study|0|||
17049616|NCT00517192|38193337|FG000|Overall Study|Adverse Event|1|||
17049617|NCT00517192|38193338|FG001|Overall Study|Adverse Event|1|||
17049618|NCT00517192|38193337|FG000|Overall Study|Lost to Follow-up|1|||
17049619|NCT00517192|38193338|FG001|Overall Study|Lost to Follow-up|1|||
17049620|NCT00517192|38193337|FG000|Overall Study|Withdrawal by Subject|1|||
17049621|NCT00517192|38193338|FG001|Overall Study|Withdrawal by Subject|0|||
17049622|NCT00517192|38193337|FG000|Overall Study|Early termination of the trial|16|||
17049623|NCT00517192|38193338|FG001|Overall Study|Early termination of the trial|18|||
17142662|NCT03320850|38285532|FG009|Overall Study|Withdrawal by Subject|1|||
17142663|NCT03320850|38285523|FG000|Overall Study|Lack of Efficacy|0|||
17142664|NCT03320850|38285524|FG001|Overall Study|Lack of Efficacy|0|||
17142665|NCT03320850|38285525|FG002|Overall Study|Lack of Efficacy|0|||
17142666|NCT03320850|38285526|FG003|Overall Study|Lack of Efficacy|1|||
17142667|NCT03320850|38285527|FG004|Overall Study|Lack of Efficacy|0|||
17142668|NCT03320850|38285528|FG005|Overall Study|Lack of Efficacy|1|||
17142669|NCT03320850|38285529|FG006|Overall Study|Lack of Efficacy|0|||
17142670|NCT03320850|38285530|FG007|Overall Study|Lack of Efficacy|2|||
17142671|NCT03320850|38285531|FG008|Overall Study|Lack of Efficacy|0|||
17142672|NCT03320850|38285532|FG009|Overall Study|Lack of Efficacy|3|||
17142673|NCT03320850|38285523|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
17142674|NCT03320850|38285524|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
16992584|NCT01024244|38136593|FG004|Overall Study|Sponsor Decision|10|||
16992585|NCT01024244|38136589|FG000|Overall Study|Withdrawal by Subject|0|||
16992586|NCT01024244|38136590|FG001|Overall Study|Withdrawal by Subject|1|||
16992587|NCT01024244|38136591|FG002|Overall Study|Withdrawal by Subject|0|||
16992588|NCT01024244|38136592|FG003|Overall Study|Withdrawal by Subject|0|||
16992589|NCT01024244|38136593|FG004|Overall Study|Withdrawal by Subject|0|||
16992590|NCT00721279|38136607|FG000|Overall Study|Lack of Efficacy|6|||
16992591|NCT00721279|38136608|FG001|Overall Study|Lack of Efficacy|3|||
16992592|NCT00721279|38136607|FG000|Overall Study|Tolerability insufficient|5|||
16992593|NCT00721279|38136608|FG001|Overall Study|Tolerability insufficient|2|||
16992594|NCT00721279|38136607|FG000|Overall Study|Withdrawal by Subject|13|||
16992595|NCT00721279|38136608|FG001|Overall Study|Withdrawal by Subject|3|||
17049624|NCT00625820|38193344|FG000|Overall Study|Withdrawal by Subject|1|||
17049625|NCT00145327|38193352|FG000|Overall Study|Withdrawal by Subject|77|||
17049626|NCT00145327|38193353|FG001|Overall Study|Withdrawal by Subject|72|||
17049627|NCT00145327|38193354|FG002|Overall Study|Withdrawal by Subject|164|||
17049628|NCT00145327|38193352|FG000|Overall Study|Death|26|||
17049629|NCT00145327|38193353|FG001|Overall Study|Death|18|||
17142675|NCT03320850|38285525|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
17142676|NCT03320850|38285526|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
17142677|NCT03320850|38285527|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
17142678|NCT03320850|38285528|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
17142679|NCT03320850|38285529|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
17049630|NCT00145327|38193354|FG002|Overall Study|Death|30|||
17049631|NCT00145327|38193352|FG000|Overall Study|Adverse Event|14|||
17049632|NCT00145327|38193353|FG001|Overall Study|Adverse Event|11|||
17049633|NCT00145327|38193354|FG002|Overall Study|Adverse Event|22|||
17049634|NCT00145327|38193352|FG000|Overall Study|Lost to Follow-up|9|||
17049635|NCT00145327|38193353|FG001|Overall Study|Lost to Follow-up|14|||
17049636|NCT00145327|38193354|FG002|Overall Study|Lost to Follow-up|14|||
17049637|NCT00145327|38193352|FG000|Overall Study|Administrative problems|12|||
17049638|NCT00145327|38193353|FG001|Overall Study|Administrative problems|9|||
17049639|NCT00145327|38193354|FG002|Overall Study|Administrative problems|13|||
17049640|NCT00145327|38193352|FG000|Overall Study|Protocol Violation|2|||
17049641|NCT00145327|38193353|FG001|Overall Study|Protocol Violation|0|||
17049642|NCT00145327|38193354|FG002|Overall Study|Protocol Violation|2|||
17049643|NCT00145327|38193352|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17142680|NCT03320850|38285530|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
17142681|NCT03320850|38285531|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
17049644|NCT00145327|38193353|FG001|Overall Study|Abnormal laboratory value(s)|0|||
17049645|NCT00145327|38193354|FG002|Overall Study|Abnormal laboratory value(s)|2|||
17049646|NCT00145327|38193352|FG000|Overall Study|Missing - not stated|1|||
17049647|NCT00145327|38193353|FG001|Overall Study|Missing - not stated|0|||
17049648|NCT00145327|38193354|FG002|Overall Study|Missing - not stated|1|||
17049649|NCT00510484|38193364|FG000|Wash-out Period|Adverse Event|0|||
17049650|NCT00510484|38193365|FG001|Wash-out Period|Adverse Event|1|||
17049651|NCT00622388|38193371|FG000|Overall Study|Disease Progression|47|||
17049652|NCT00622388|38193371|FG000|Overall Study|Adverse Event|6|||
17049653|NCT00622388|38193371|FG000|Overall Study|Protocol Violation|3|||
17049654|NCT00622388|38193371|FG000|Overall Study|Participant Refusal|1|||
17049655|NCT00622388|38193371|FG000|Overall Study|Death|3|||
17049656|NCT00622388|38193371|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
17049657|NCT00622388|38193371|FG000|Overall Study|Took Prohibited Medication|2|||
17049658|NCT00622388|38193371|FG000|Overall Study|Withdrew Consent|1|||
17049659|NCT00622388|38193371|FG000|Overall Study|Insurance Expired|1|||
17049660|NCT01156389|38193378|FG000|Overall Study|Elevated liver enzymes|4|||
17049661|NCT01156389|38193379|FG001|Overall Study|Elevated liver enzymes|0|||
17049662|NCT01156389|38193378|FG000|Overall Study|Vomiting|0|||
17049663|NCT01156389|38193379|FG001|Overall Study|Vomiting|1|||
17049664|NCT01105767|38193388|FG000|Overall Study|Lost to Follow-up|1160|||
17049665|NCT01105767|38193389|FG001|Overall Study|Lost to Follow-up|1614|||
17049666|NCT01105767|38193390|FG002|Overall Study|Lost to Follow-up|1184|||
17049667|NCT03693430|38193400|FG000|Overall Study|Lost to Follow-up|3|||
17049668|NCT03693430|38193401|FG001|Overall Study|Lost to Follow-up|14|||
17049669|NCT03693430|38193400|FG000|Overall Study|Death|1|||
17049670|NCT03693430|38193401|FG001|Overall Study|Death|0|||
17049671|NCT03693430|38193400|FG000|Overall Study|Withdrawal by Subject|0|||
17049672|NCT03693430|38193401|FG001|Overall Study|Withdrawal by Subject|4|||
17049673|NCT00625742|38193407|FG000|Overall Study|Disease Progression|2|||
17049674|NCT00625742|38193407|FG000|Overall Study|Withdrawal by Subject|1|||
17049675|NCT00625742|38193407|FG000|Overall Study|Adverse Event|4|||
17049676|NCT00625742|38193407|FG000|Overall Study|Lost to Follow-up|4|||
17049677|NCT00625742|38193407|FG000|Overall Study|Ineligible|1|||
17049678|NCT00621296|38193420|FG000|Overall Study|Adverse Event|2|||
17049679|NCT00621296|38193420|FG000|Overall Study|Lack of Efficacy|1|||
17049680|NCT00621296|38193420|FG000|Overall Study|Physician Decision|7|||
17049681|NCT00621296|38193420|FG000|Overall Study|Unmatch Criteria|1|||
17049682|NCT00621296|38193420|FG000|Overall Study|Stopping Criteria|3|||
17142682|NCT03320850|38285532|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
17142683|NCT03320850|38285523|FG000|Overall Study|Adverse Event|0|||
17142684|NCT03320850|38285524|FG001|Overall Study|Adverse Event|0|||
17142685|NCT03320850|38285525|FG002|Overall Study|Adverse Event|0|||
17142686|NCT03320850|38285526|FG003|Overall Study|Adverse Event|0|||
17142687|NCT03320850|38285527|FG004|Overall Study|Adverse Event|0|||
17142688|NCT03320850|38285528|FG005|Overall Study|Adverse Event|2|||
17142689|NCT03320850|38285529|FG006|Overall Study|Adverse Event|1|||
17049683|NCT00537303|38193426|FG000|Overall Study|Adverse Event|1|||
17049684|NCT00537303|38193427|FG001|Overall Study|Adverse Event|4|||
17049685|NCT00537303|38193426|FG000|Overall Study|Lack of Efficacy|6|||
17049686|NCT00537303|38193427|FG001|Overall Study|Lack of Efficacy|7|||
17049687|NCT00537303|38193426|FG000|Overall Study|Protocol Violation|8|||
17049688|NCT00537303|38193427|FG001|Overall Study|Protocol Violation|4|||
17049689|NCT00537303|38193426|FG000|Overall Study|Withdrawal criteria|3|||
17142690|NCT03320850|38285530|FG007|Overall Study|Adverse Event|0|||
17142691|NCT03320850|38285531|FG008|Overall Study|Adverse Event|2|||
17049690|NCT00537303|38193427|FG001|Overall Study|Withdrawal criteria|3|||
17049691|NCT00537303|38193426|FG000|Overall Study|Unclassified|8|||
17049692|NCT00537303|38193427|FG001|Overall Study|Unclassified|7|||
17049693|NCT00505414|38193435|FG000|Titration Phase|Adverse Event|0|||
17049694|NCT00505414|38193436|FG001|Titration Phase|Adverse Event|0|||
17049695|NCT00505414|38193437|FG002|Titration Phase|Adverse Event|0|||
17049696|NCT00505414|38193438|FG003|Titration Phase|Adverse Event|8|||
17049697|NCT00505414|38193439|FG004|Titration Phase|Adverse Event|3|||
17049698|NCT00505414|38193435|FG000|Titration Phase|Death|0|||
17049699|NCT00505414|38193436|FG001|Titration Phase|Death|0|||
17049700|NCT00505414|38193437|FG002|Titration Phase|Death|0|||
17049701|NCT00505414|38193438|FG003|Titration Phase|Death|2|||
17049702|NCT00505414|38193439|FG004|Titration Phase|Death|0|||
17049703|NCT00505414|38193435|FG000|Titration Phase|Lack of Efficacy|0|||
17049704|NCT00505414|38193436|FG001|Titration Phase|Lack of Efficacy|0|||
17049705|NCT00505414|38193437|FG002|Titration Phase|Lack of Efficacy|0|||
17049706|NCT00505414|38193438|FG003|Titration Phase|Lack of Efficacy|10|||
17049707|NCT00505414|38193439|FG004|Titration Phase|Lack of Efficacy|1|||
17049708|NCT00505414|38193435|FG000|Titration Phase|Protocol Violation|0|||
17049709|NCT00505414|38193436|FG001|Titration Phase|Protocol Violation|0|||
17049710|NCT00505414|38193437|FG002|Titration Phase|Protocol Violation|0|||
17049711|NCT00505414|38193438|FG003|Titration Phase|Protocol Violation|0|||
17049712|NCT00505414|38193439|FG004|Titration Phase|Protocol Violation|1|||
17049713|NCT00505414|38193435|FG000|Titration Phase|Withdrawal by Subject|0|||
17049714|NCT00505414|38193436|FG001|Titration Phase|Withdrawal by Subject|0|||
17142692|NCT03320850|38285532|FG009|Overall Study|Adverse Event|0|||
17142693|NCT03320850|38285523|FG000|Overall Study|Reason Not Specified|0|||
17142694|NCT03320850|38285524|FG001|Overall Study|Reason Not Specified|0|||
17142695|NCT03320850|38285525|FG002|Overall Study|Reason Not Specified|0|||
17142696|NCT03320850|38285526|FG003|Overall Study|Reason Not Specified|0|||
17142697|NCT03320850|38285527|FG004|Overall Study|Reason Not Specified|0|||
17142698|NCT03320850|38285528|FG005|Overall Study|Reason Not Specified|1|||
17142699|NCT03320850|38285529|FG006|Overall Study|Reason Not Specified|0|||
17142700|NCT03320850|38285530|FG007|Overall Study|Reason Not Specified|0|||
17142701|NCT03320850|38285531|FG008|Overall Study|Reason Not Specified|0|||
17142702|NCT03320850|38285532|FG009|Overall Study|Reason Not Specified|1|||
17142703|NCT03301623|38285561|FG000|Overall Study|Death|3|||
17142704|NCT03301623|38285562|FG001|Overall Study|Death|1|||
17142705|NCT03301623|38285561|FG000|Overall Study|Withdrawal by Subject|11|||
17142706|NCT03301623|38285562|FG001|Overall Study|Withdrawal by Subject|13|||
17142707|NCT03301623|38285561|FG000|Overall Study|Lost to Follow-up|3|||
17142708|NCT03301623|38285562|FG001|Overall Study|Lost to Follow-up|1|||
17142709|NCT03319212|38285570|FG000|Overall Study|Discontinued as moving out of local area|0|||
17142710|NCT03319212|38285571|FG001|Overall Study|Discontinued as moving out of local area|1|||
17142711|NCT03319212|38285570|FG000|Overall Study|Adverse Event|2|||
17142712|NCT03319212|38285571|FG001|Overall Study|Adverse Event|2|||
17142713|NCT03319212|38285570|FG000|Overall Study|Withdrawal by Subject|0|||
17142714|NCT03319212|38285571|FG001|Overall Study|Withdrawal by Subject|1|||
17142715|NCT03319212|38285570|FG000|Overall Study|Lost to Follow-up|0|||
17142716|NCT03319212|38285571|FG001|Overall Study|Lost to Follow-up|1|||
17142717|NCT03319212|38285570|FG000|Overall Study|Physician Decision|1|||
17142718|NCT03319212|38285571|FG001|Overall Study|Physician Decision|0|||
17142719|NCT04656691|38285576|FG000|Overall Study|Adverse Event|1|||
17142720|NCT03301155|38285582|FG000|Overall Study|Сompliance with exclusion criteria|8|||
17142721|NCT03301155|38285583|FG001|Overall Study|Сompliance with exclusion criteria|7|||
17142722|NCT01952730|38285589|FG000|Overall Study|FDA shut down core lab used by study|1|||
17142723|NCT03316170|38285595|FG000|Overall Study|Death|1|||
17142724|NCT03316170|38285596|FG001|Overall Study|Death|0|||
17142725|NCT03316170|38285595|FG000|Overall Study|Lost to Follow-up|6|||
17142726|NCT03316170|38285596|FG001|Overall Study|Lost to Follow-up|7|||
17142727|NCT03257865|38285605|FG000|Overall Study|Adverse Event|4|||
17142728|NCT03257865|38285606|FG001|Overall Study|Adverse Event|8|||
17142729|NCT03257865|38285605|FG000|Overall Study|Lack of Efficacy|1|||
17142730|NCT03257865|38285606|FG001|Overall Study|Lack of Efficacy|2|||
17142731|NCT03257865|38285605|FG000|Overall Study|Non-compliance with Study Drug|0|||
17142732|NCT03257865|38285606|FG001|Overall Study|Non-compliance with Study Drug|2|||
17049715|NCT00505414|38193437|FG002|Titration Phase|Withdrawal by Subject|0|||
17049716|NCT00505414|38193438|FG003|Titration Phase|Withdrawal by Subject|3|||
17049717|NCT00505414|38193439|FG004|Titration Phase|Withdrawal by Subject|4|||
17049718|NCT00505414|38193435|FG000|Titration Phase|Underlying disease and therapy required|0|||
17049719|NCT00505414|38193436|FG001|Titration Phase|Underlying disease and therapy required|0|||
17142733|NCT03257865|38285605|FG000|Overall Study|Withdrawal by Subject|23|||
17142734|NCT03257865|38285606|FG001|Overall Study|Withdrawal by Subject|17|||
17142735|NCT03257865|38285605|FG000|Overall Study|Physician Decision|3|||
17142736|NCT03257865|38285606|FG001|Overall Study|Physician Decision|1|||
17142737|NCT03257865|38285605|FG000|Overall Study|Other|0|||
17142738|NCT03257865|38285606|FG001|Overall Study|Other|1|||
17142739|NCT03257865|38285605|FG000|Overall Study|Lost to Follow-up|4|||
17142740|NCT03257865|38285606|FG001|Overall Study|Lost to Follow-up|4|||
17142741|NCT04617847|38285614|FG000|Overall Study|Withdrawal by Subject|1|||
17049720|NCT00505414|38193437|FG002|Titration Phase|Underlying disease and therapy required|0|||
17049721|NCT00505414|38193438|FG003|Titration Phase|Underlying disease and therapy required|7|||
17049722|NCT00505414|38193439|FG004|Titration Phase|Underlying disease and therapy required|3|||
17049723|NCT00505414|38193435|FG000|Maintenance Phase|Adverse Event|2|||
17049724|NCT00505414|38193436|FG001|Maintenance Phase|Adverse Event|2|||
17049725|NCT00505414|38193437|FG002|Maintenance Phase|Adverse Event|3|||
17049726|NCT00505414|38193438|FG003|Maintenance Phase|Adverse Event|0|||
17049727|NCT00505414|38193439|FG004|Maintenance Phase|Adverse Event|0|||
17049728|NCT00505414|38193435|FG000|Maintenance Phase|Death|2|||
17049729|NCT00505414|38193436|FG001|Maintenance Phase|Death|0|||
17049730|NCT00505414|38193437|FG002|Maintenance Phase|Death|1|||
17049731|NCT00505414|38193438|FG003|Maintenance Phase|Death|0|||
17049732|NCT00505414|38193439|FG004|Maintenance Phase|Death|0|||
17049733|NCT00505414|38193435|FG000|Maintenance Phase|Lack of Efficacy|2|||
17049734|NCT00505414|38193436|FG001|Maintenance Phase|Lack of Efficacy|1|||
17049735|NCT00505414|38193437|FG002|Maintenance Phase|Lack of Efficacy|1|||
17049736|NCT00505414|38193438|FG003|Maintenance Phase|Lack of Efficacy|0|||
17049737|NCT00505414|38193439|FG004|Maintenance Phase|Lack of Efficacy|0|||
17049738|NCT00505414|38193435|FG000|Maintenance Phase|Withdrawal by Subject|0|||
17049739|NCT00505414|38193436|FG001|Maintenance Phase|Withdrawal by Subject|0|||
17049740|NCT00505414|38193437|FG002|Maintenance Phase|Withdrawal by Subject|1|||
17049741|NCT00505414|38193438|FG003|Maintenance Phase|Withdrawal by Subject|0|||
17049742|NCT00505414|38193439|FG004|Maintenance Phase|Withdrawal by Subject|0|||
17049743|NCT00505414|38193435|FG000|Maintenance Phase|underlying disease and therapy required|0|||
17049744|NCT00505414|38193436|FG001|Maintenance Phase|underlying disease and therapy required|2|||
17049745|NCT00505414|38193437|FG002|Maintenance Phase|underlying disease and therapy required|2|||
17049746|NCT00505414|38193438|FG003|Maintenance Phase|underlying disease and therapy required|0|||
17049747|NCT00505414|38193439|FG004|Maintenance Phase|underlying disease and therapy required|0|||
17049748|NCT00625586|38193455|FG000|Overall Study|Adverse Event|1|||
17049749|NCT00144781|38193477|FG000|Overall Study|Adverse Event|0|||
17049750|NCT00144781|38193478|FG001|Overall Study|Adverse Event|1|||
17049751|NCT00144781|38193479|FG002|Overall Study|Adverse Event|0|||
17049752|NCT00144781|38193480|FG003|Overall Study|Adverse Event|0|||
17049753|NCT00144781|38193477|FG000|Overall Study|Non-compliant|0|||
17049754|NCT00144781|38193478|FG001|Overall Study|Non-compliant|1|||
17049755|NCT00144781|38193479|FG002|Overall Study|Non-compliant|0|||
17049756|NCT00144781|38193480|FG003|Overall Study|Non-compliant|0|||
17049757|NCT00621140|38193496|FG000|Overall Study|Adverse Event|4|||
17049758|NCT00621140|38193497|FG001|Overall Study|Adverse Event|5|||
17049759|NCT00621140|38193496|FG000|Overall Study|Lost to Follow-up|1|||
17049760|NCT00621140|38193497|FG001|Overall Study|Lost to Follow-up|2|||
17049761|NCT00621140|38193496|FG000|Overall Study|Withdrawal by Subject|4|||
17049762|NCT00621140|38193497|FG001|Overall Study|Withdrawal by Subject|6|||
17049763|NCT00621140|38193496|FG000|Overall Study|Other incl. lack of efficacy|6|||
17049764|NCT00621140|38193497|FG001|Overall Study|Other incl. lack of efficacy|5|||
17049765|NCT00207727|38193508|FG000|Overall Study|Withdrawal by Subject|0|||
17049766|NCT00207727|38193509|FG001|Overall Study|Withdrawal by Subject|0|||
17049767|NCT00207727|38193510|FG002|Overall Study|Withdrawal by Subject|0|||
17049768|NCT00207727|38193511|FG003|Overall Study|Withdrawal by Subject|0|||
17049769|NCT00207727|38193512|FG004|Overall Study|Withdrawal by Subject|1|||
17049770|NCT00207727|38193508|FG000|Overall Study|Lost to Follow-up|0|||
17049771|NCT00207727|38193509|FG001|Overall Study|Lost to Follow-up|1|||
17049772|NCT00207727|38193510|FG002|Overall Study|Lost to Follow-up|0|||
17049773|NCT00207727|38193511|FG003|Overall Study|Lost to Follow-up|0|||
17049774|NCT00207727|38193512|FG004|Overall Study|Lost to Follow-up|0|||
17049775|NCT00207727|38193508|FG000|Overall Study|Other|38|||
17049776|NCT00207727|38193509|FG001|Overall Study|Other|41|||
17142742|NCT04617847|38285615|FG001|Overall Study|Withdrawal by Subject|0|||
17142743|NCT04617847|38285614|FG000|Overall Study|Adverse Event|0|||
17049777|NCT00207727|38193510|FG002|Overall Study|Other|41|||
17049778|NCT00207727|38193511|FG003|Overall Study|Other|37|||
17049779|NCT00207727|38193512|FG004|Overall Study|Other|33|||
17049780|NCT00504556|38193529|FG000|Overall Study|Adverse Event|11|||
17049781|NCT00504556|38193530|FG001|Overall Study|Adverse Event|11|||
17049782|NCT00504556|38193531|FG002|Overall Study|Adverse Event|14|||
17049783|NCT00504556|38193532|FG003|Overall Study|Adverse Event|13|||
17049784|NCT00504556|38193533|FG004|Overall Study|Adverse Event|5|||
17049785|NCT00504556|38193529|FG000|Overall Study|Death|3|||
17049786|NCT00504556|38193530|FG001|Overall Study|Death|3|||
17049787|NCT00504556|38193531|FG002|Overall Study|Death|1|||
17049788|NCT00504556|38193532|FG003|Overall Study|Death|0|||
17049789|NCT00504556|38193533|FG004|Overall Study|Death|2|||
17049790|NCT00504556|38193529|FG000|Overall Study|Protocol Violation|1|||
17049791|NCT00504556|38193530|FG001|Overall Study|Protocol Violation|3|||
17049792|NCT00504556|38193531|FG002|Overall Study|Protocol Violation|2|||
17049793|NCT00504556|38193532|FG003|Overall Study|Protocol Violation|1|||
17049794|NCT00504556|38193533|FG004|Overall Study|Protocol Violation|2|||
17049795|NCT00504556|38193529|FG000|Overall Study|Lost to Follow-up|0|||
17049796|NCT00504556|38193530|FG001|Overall Study|Lost to Follow-up|0|||
17049797|NCT00504556|38193531|FG002|Overall Study|Lost to Follow-up|1|||
17049798|NCT00504556|38193532|FG003|Overall Study|Lost to Follow-up|1|||
17049799|NCT00504556|38193533|FG004|Overall Study|Lost to Follow-up|1|||
17049800|NCT00504556|38193529|FG000|Overall Study|Withdrawal by Subject|16|||
17049801|NCT00504556|38193530|FG001|Overall Study|Withdrawal by Subject|16|||
17049802|NCT00504556|38193531|FG002|Overall Study|Withdrawal by Subject|7|||
17049803|NCT00504556|38193532|FG003|Overall Study|Withdrawal by Subject|8|||
17049804|NCT00504556|38193533|FG004|Overall Study|Withdrawal by Subject|12|||
17049805|NCT00504556|38193529|FG000|Overall Study|administrative reasons|0|||
17049806|NCT00504556|38193530|FG001|Overall Study|administrative reasons|2|||
17049807|NCT00504556|38193531|FG002|Overall Study|administrative reasons|2|||
17049808|NCT00504556|38193532|FG003|Overall Study|administrative reasons|1|||
17049809|NCT00504556|38193533|FG004|Overall Study|administrative reasons|2|||
17049810|NCT00504556|38193529|FG000|Overall Study|did not meet entry criteria|2|||
17049811|NCT00504556|38193530|FG001|Overall Study|did not meet entry criteria|0|||
17049812|NCT00504556|38193531|FG002|Overall Study|did not meet entry criteria|1|||
17049813|NCT00504556|38193532|FG003|Overall Study|did not meet entry criteria|1|||
17049814|NCT00504556|38193533|FG004|Overall Study|did not meet entry criteria|0|||
17049815|NCT00504556|38193529|FG000|Overall Study|data monitor committee decision|0|||
17049816|NCT00504556|38193530|FG001|Overall Study|data monitor committee decision|0|||
17049817|NCT00504556|38193531|FG002|Overall Study|data monitor committee decision|0|||
17049818|NCT00504556|38193532|FG003|Overall Study|data monitor committee decision|100|||
17049819|NCT00504556|38193533|FG004|Overall Study|data monitor committee decision|0|||
17049820|NCT00504556|38193529|FG000|Overall Study|Other|2|||
17049821|NCT00504556|38193530|FG001|Overall Study|Other|2|||
17049822|NCT00504556|38193531|FG002|Overall Study|Other|2|||
17049823|NCT00504556|38193532|FG003|Overall Study|Other|3|||
17142744|NCT04617847|38285615|FG001|Overall Study|Adverse Event|2|||
17142745|NCT04617847|38285614|FG000|Overall Study|Death|0|||
17049824|NCT00504556|38193533|FG004|Overall Study|Other|0|||
17049825|NCT00504556|38193529|FG000|Overall Study|not in safety analysis set|0|||
17049826|NCT00504556|38193530|FG001|Overall Study|not in safety analysis set|1|||
17049827|NCT00504556|38193531|FG002|Overall Study|not in safety analysis set|1|||
17049828|NCT00504556|38193532|FG003|Overall Study|not in safety analysis set|0|||
17049829|NCT00504556|38193533|FG004|Overall Study|not in safety analysis set|1|||
17049830|NCT00206323|38193547|FG000|Overall Study|Lack of Efficacy|4|||
17049831|NCT00206323|38193548|FG001|Overall Study|Lack of Efficacy|1|||
17142746|NCT04617847|38285615|FG001|Overall Study|Death|1|||
17142747|NCT04617847|38285614|FG000|Overall Study|Termination of Study by Sponsor|2|||
17142748|NCT04617847|38285615|FG001|Overall Study|Termination of Study by Sponsor|21|||
17142749|NCT04615507|38285625|FG000|Period 1|Covid-19 exposure|2|||
17142750|NCT04615507|38285626|FG001|Period 1|Covid-19 exposure|1|||
17049832|NCT00206323|38193547|FG000|Overall Study|Adverse Event|1|||
17049833|NCT00206323|38193548|FG001|Overall Study|Adverse Event|1|||
17049834|NCT00206323|38193547|FG000|Overall Study|Lost to Follow-up|1|||
17049835|NCT00206323|38193548|FG001|Overall Study|Lost to Follow-up|1|||
17049836|NCT03903159|38193554|FG000|Overall Study|Discharged with Staff Approval|2|||
17049837|NCT03903159|38193554|FG000|Overall Study|Discharged at Staff Request|2|||
17049838|NCT03903159|38193554|FG000|Overall Study|Discharged Against Staff Advice|1|||
17049839|NCT00205855|38193558|FG000|Overall Study|Only received temporary implants|16|||
17049840|NCT00205855|38193558|FG000|Overall Study|Withdrawal by Subject|5|||
17049841|NCT00536991|38193562|FG000|Overall Study|Withdrawal by Subject|10|||
17049842|NCT00536991|38193562|FG000|Overall Study|Physician Decision|1|||
17049843|NCT00536991|38193562|FG000|Overall Study|patient ineligible|2|||
17049844|NCT03902613|38193567|FG000|Overall Study|Physician Decision|1|||
17049845|NCT00504166|38193573|FG000|Overall Study|Adverse Event|1|||
17049846|NCT00504166|38193574|FG001|Overall Study|Adverse Event|4|||
17049847|NCT00504166|38193573|FG000|Overall Study|Withdrawal by Subject|3|||
17049848|NCT00504166|38193574|FG001|Overall Study|Withdrawal by Subject|6|||
17049849|NCT00504166|38193573|FG000|Overall Study|Physician Decision|1|||
17049850|NCT00504166|38193574|FG001|Overall Study|Physician Decision|1|||
17049851|NCT00504166|38193573|FG000|Overall Study|Lost to Follow-up|1|||
17049852|NCT00504166|38193574|FG001|Overall Study|Lost to Follow-up|3|||
17049853|NCT00509236|38193582|FG000|Overall Study|Adverse Event|7|||
17049854|NCT00509236|38193583|FG001|Overall Study|Adverse Event|9|||
17049855|NCT00509236|38193582|FG000|Overall Study|Withdrawal by Subject|5|||
17049856|NCT00509236|38193583|FG001|Overall Study|Withdrawal by Subject|10|||
17049857|NCT00509236|38193582|FG000|Overall Study|Protocol Violation|3|||
17049858|NCT00509236|38193583|FG001|Overall Study|Protocol Violation|0|||
17049859|NCT00509236|38193582|FG000|Overall Study|Excluded Medication|1|||
17049860|NCT00509236|38193583|FG001|Overall Study|Excluded Medication|1|||
17142751|NCT04615507|38285625|FG000|Period 2|Covid-19 exposure|0|||
17142752|NCT04615507|38285626|FG001|Period 2|Covid-19 exposure|1|||
17142753|NCT04615507|38285625|FG000|Period 2|Protocol Violation|1|||
17142754|NCT04615507|38285626|FG001|Period 2|Protocol Violation|0|||
17142755|NCT04615507|38285625|FG000|Period 2|Withdrawal by Subject|1|||
17142756|NCT04615507|38285626|FG001|Period 2|Withdrawal by Subject|0|||
17142757|NCT04615507|38285625|FG000|Period 2|Adverse Event|0|||
17142758|NCT04615507|38285626|FG001|Period 2|Adverse Event|1|||
17049861|NCT00509236|38193582|FG000|Overall Study|Scheduled Kidney Transplant|1|||
17049862|NCT00509236|38193583|FG001|Overall Study|Scheduled Kidney Transplant|0|||
17049863|NCT03896295|38193591|FG000|Overall Study|Adverse Event|0|||
17049864|NCT03896295|38193592|FG001|Overall Study|Adverse Event|1|||
17049865|NCT03896295|38193591|FG000|Overall Study|COVID-19|7|||
17049866|NCT03896295|38193592|FG001|Overall Study|COVID-19|29|||
17049867|NCT00508924|38193607|FG000|Overall Study|Protocol Violation|0|||
17049868|NCT00508924|38193608|FG001|Overall Study|Protocol Violation|0|||
17049869|NCT00508924|38193609|FG002|Overall Study|Protocol Violation|1|||
17049870|NCT00508924|38193610|FG003|Overall Study|Protocol Violation|1|||
17142759|NCT04615507|38285625|FG000|Period 3|Covid-19 exposure|0|||
17142760|NCT04615507|38285626|FG001|Period 3|Covid-19 exposure|1|||
17142761|NCT04120233|38285638|FG000|Overall Study|Adverse Event|0|||
17142762|NCT04120233|38285639|FG001|Overall Study|Adverse Event|0|||
17142763|NCT04120233|38285640|FG002|Overall Study|Adverse Event|0|||
17142764|NCT04120233|38285641|FG003|Overall Study|Adverse Event|0|||
17142765|NCT04120233|38285642|FG004|Overall Study|Adverse Event|1|||
17049871|NCT00620750|38193620|FG000|Overall Study|Lost to Follow-up|25|||
17049872|NCT00508144|38193624|FG000|Overall Study|Not eligible|6|||
17049873|NCT00508144|38193624|FG000|Overall Study|Death|5|||
17049874|NCT00621842|38193628|FG000|Overall Study|Adverse Event|6|||
17049875|NCT00621842|38193628|FG000|Overall Study|Withdrawal by Subject|7|||
17049876|NCT00621842|38193628|FG000|Overall Study|Protocol Violation|4|||
17049877|NCT00621842|38193628|FG000|Overall Study|Lack of Efficacy|2|||
17049878|NCT00503776|38193636|FG000|Overall Study|Withdrawal by Subject|1|||
17049879|NCT00503776|38193637|FG001|Overall Study|Withdrawal by Subject|0|||
17049880|NCT00503776|38193638|FG002|Overall Study|Withdrawal by Subject|1|||
17049881|NCT00503776|38193639|FG003|Overall Study|Withdrawal by Subject|1|||
17049882|NCT00503776|38193636|FG000|Overall Study|Physician Decision|0|||
17049883|NCT00503776|38193637|FG001|Overall Study|Physician Decision|0|||
17049884|NCT00503776|38193638|FG002|Overall Study|Physician Decision|1|||
17049885|NCT00503776|38193639|FG003|Overall Study|Physician Decision|1|||
17049886|NCT00619112|38193656|FG000|Overall Study|Adverse Event|1|||
17049887|NCT00619112|38193657|FG001|Overall Study|Adverse Event|2|||
17049888|NCT00619502|38193668|FG000|Overall Study|Lost to Follow-up|8|||
17049889|NCT00619502|38193669|FG001|Overall Study|Lost to Follow-up|10|||
17049890|NCT00618956|38193679|FG000|Overall Study|Adverse Event|10|||
17049891|NCT00618956|38193680|FG001|Overall Study|Adverse Event|34|||
17049892|NCT00618956|38193679|FG000|Overall Study|Lack of Efficacy|2|||
17049893|NCT00618956|38193680|FG001|Overall Study|Lack of Efficacy|1|||
17049894|NCT00618956|38193679|FG000|Overall Study|Withdrawal by Subject|5|||
17049895|NCT00618956|38193680|FG001|Overall Study|Withdrawal by Subject|7|||
17049896|NCT00618956|38193679|FG000|Overall Study|Lost to Follow-up|4|||
17049897|NCT00618956|38193680|FG001|Overall Study|Lost to Follow-up|5|||
17049898|NCT00618956|38193679|FG000|Overall Study|Protocol Violation|2|||
17049899|NCT00618956|38193680|FG001|Overall Study|Protocol Violation|2|||
17049900|NCT00618956|38193679|FG000|Overall Study|did not meet criteria, non-compliance|2|||
17142766|NCT04120233|38285643|FG005|Overall Study|Adverse Event|0|||
17142767|NCT01610700|38285659|FG000|Overall Study|Adverse Event|3|||
17142768|NCT01610700|38285660|FG001|Overall Study|Adverse Event|1|||
17142769|NCT01610700|38285659|FG000|Overall Study|Withdrawal by Subject|0|||
17049901|NCT00618956|38193680|FG001|Overall Study|did not meet criteria, non-compliance|1|||
17049902|NCT00716417|38193702|FG000|Overall Study|Adverse Event|0|||
17049903|NCT00716417|38193703|FG001|Overall Study|Adverse Event|0|||
17049904|NCT00716417|38193704|FG002|Overall Study|Adverse Event|2|||
17049905|NCT00716417|38193705|FG003|Overall Study|Adverse Event|1|||
17049906|NCT00716417|38193706|FG004|Overall Study|Adverse Event|0|||
17049907|NCT00716417|38193707|FG005|Overall Study|Adverse Event|0|||
17049908|NCT00716417|38193708|FG006|Overall Study|Adverse Event|3|||
17049909|NCT00716417|38193709|FG007|Overall Study|Adverse Event|1|||
17049910|NCT00716417|38193710|FG008|Overall Study|Adverse Event|0|||
17049911|NCT00716417|38193711|FG009|Overall Study|Adverse Event|3|||
17049912|NCT00716417|38193702|FG000|Overall Study|Withdrawal by Subject|0|||
17049913|NCT00716417|38193703|FG001|Overall Study|Withdrawal by Subject|1|||
17049914|NCT00716417|38193704|FG002|Overall Study|Withdrawal by Subject|0|||
17049915|NCT00716417|38193705|FG003|Overall Study|Withdrawal by Subject|2|||
17049916|NCT00716417|38193706|FG004|Overall Study|Withdrawal by Subject|0|||
17049917|NCT00716417|38193707|FG005|Overall Study|Withdrawal by Subject|0|||
17049918|NCT00716417|38193708|FG006|Overall Study|Withdrawal by Subject|1|||
17049919|NCT00716417|38193709|FG007|Overall Study|Withdrawal by Subject|0|||
17049920|NCT00716417|38193710|FG008|Overall Study|Withdrawal by Subject|0|||
17049921|NCT00716417|38193711|FG009|Overall Study|Withdrawal by Subject|0|||
17049922|NCT00716417|38193702|FG000|Overall Study|Progressive disease|3|||
17049923|NCT00716417|38193703|FG001|Overall Study|Progressive disease|5|||
17049924|NCT00716417|38193704|FG002|Overall Study|Progressive disease|3|||
17049925|NCT00716417|38193705|FG003|Overall Study|Progressive disease|8|||
17049926|NCT00716417|38193706|FG004|Overall Study|Progressive disease|0|||
17049927|NCT00716417|38193707|FG005|Overall Study|Progressive disease|3|||
17049928|NCT00716417|38193708|FG006|Overall Study|Progressive disease|3|||
17049929|NCT00716417|38193709|FG007|Overall Study|Progressive disease|1|||
17049930|NCT00716417|38193710|FG008|Overall Study|Progressive disease|5|||
17049931|NCT00716417|38193711|FG009|Overall Study|Progressive disease|0|||
17049932|NCT00716417|38193702|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
17049933|NCT00716417|38193703|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
17049934|NCT00716417|38193704|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
17049935|NCT00716417|38193705|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
17049936|NCT00716417|38193706|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
17049937|NCT00716417|38193707|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
17049938|NCT00716417|38193708|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
17049939|NCT00716417|38193709|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
17142770|NCT01610700|38285660|FG001|Overall Study|Withdrawal by Subject|1|||
17142771|NCT01610700|38285659|FG000|Overall Study|subject took one dose of street cannabis|0|||
17142772|NCT01610700|38285660|FG001|Overall Study|subject took one dose of street cannabis|1|||
17142773|NCT03256851|38285669|FG000|Overall Study|Withdrawal by Subject|1|||
17049940|NCT00716417|38193710|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
17049941|NCT00716417|38193711|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
17049942|NCT00716417|38193702|FG000|Overall Study|On patient request due to toxicities|0|||
17049943|NCT00716417|38193703|FG001|Overall Study|On patient request due to toxicities|0|||
17049944|NCT00716417|38193704|FG002|Overall Study|On patient request due to toxicities|0|||
17049945|NCT00716417|38193705|FG003|Overall Study|On patient request due to toxicities|0|||
17049946|NCT00716417|38193706|FG004|Overall Study|On patient request due to toxicities|0|||
17049947|NCT00716417|38193707|FG005|Overall Study|On patient request due to toxicities|0|||
17049948|NCT00716417|38193708|FG006|Overall Study|On patient request due to toxicities|0|||
17049949|NCT00716417|38193709|FG007|Overall Study|On patient request due to toxicities|1|||
17049950|NCT00716417|38193710|FG008|Overall Study|On patient request due to toxicities|0|||
17049951|NCT00716417|38193711|FG009|Overall Study|On patient request due to toxicities|0|||
17049952|NCT00719537|38193737|FG000|Overall Study|Withdrawal by Subject|1|||
17049953|NCT00719537|38193738|FG001|Overall Study|Withdrawal by Subject|0|||
17049954|NCT00719537|38193737|FG000|Overall Study|Lost to Follow-up|0|||
17049955|NCT00719537|38193738|FG001|Overall Study|Lost to Follow-up|1|||
17049956|NCT00715949|38193744|FG000|Overall Study|could not finish first test|4|||
17049957|NCT00503698|38193750|FG000|Overall Study|Protocol Violation|5|||
17049958|NCT00503698|38193751|FG001|Overall Study|Protocol Violation|6|||
17049959|NCT00503698|38193750|FG000|Overall Study|Adverse Event|52|||
17049960|NCT00503698|38193751|FG001|Overall Study|Adverse Event|41|||
17049961|NCT00503698|38193750|FG000|Overall Study|Death|1|||
17049962|NCT00503698|38193751|FG001|Overall Study|Death|0|||
17049963|NCT00503698|38193750|FG000|Overall Study|Lack of Efficacy|3|||
17049964|NCT00503698|38193751|FG001|Overall Study|Lack of Efficacy|4|||
17049965|NCT00503698|38193750|FG000|Overall Study|Trial terminated|216|||
17049966|NCT00503698|38193751|FG001|Overall Study|Trial terminated|253|||
17049967|NCT00503698|38193750|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
17049968|NCT00503698|38193751|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
17049969|NCT00503698|38193750|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
17049970|NCT00503698|38193751|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
17049971|NCT00503698|38193750|FG000|Overall Study|Any condition in exclusion criteria|4|||
17049972|NCT00503698|38193751|FG001|Overall Study|Any condition in exclusion criteria|6|||
17049973|NCT00503698|38193750|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
17049974|NCT00503698|38193751|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
17049975|NCT00503698|38193750|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
17049976|NCT00503698|38193751|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
17049977|NCT00503698|38193750|FG000|Overall Study|Critically ill|2|||
17049978|NCT00503698|38193751|FG001|Overall Study|Critically ill|0|||
17049979|NCT00503698|38193750|FG000|Overall Study|Unclassified|48|||
17049980|NCT00503698|38193751|FG001|Overall Study|Unclassified|32|||
17049981|NCT00503698|38193750|FG000|Overall Study|Not exposed to trial drug|11|||
17049982|NCT00503698|38193751|FG001|Overall Study|Not exposed to trial drug|6|||
17049983|NCT00573794|38193766|FG000|Overall Study|Adverse Event|81|||
17049984|NCT00573794|38193766|FG000|Overall Study|Withdrew Consent|90|||
17049985|NCT00573794|38193766|FG000|Overall Study|Lost to Follow-up|13|||
17049986|NCT00573794|38193766|FG000|Overall Study|Protocol Violation|6|||
17049987|NCT00573794|38193766|FG000|Overall Study|Lack of Efficacy|94|||
17049988|NCT00573794|38193766|FG000|Overall Study|Other|46|||
17049989|NCT00715793|38193770|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
17049990|NCT00715793|38193771|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
17049991|NCT00715793|38193770|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
17049992|NCT00715793|38193771|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
17049993|NCT00718523|38193780|FG000|Overall Study|Withdrawal by Subject|5|||
17049994|NCT00718523|38193781|FG001|Overall Study|Withdrawal by Subject|7|||
17049995|NCT00718523|38193780|FG000|Overall Study|Death|13|||
17049996|NCT00718523|38193781|FG001|Overall Study|Death|17|||
17049997|NCT00715559|38193787|FG000|Overall Study|medication not tolerated - nausea|1|||
17049998|NCT00620282|38193803|FG000|Overall Study|Adverse Event|0|||
17049999|NCT00620282|38193804|FG001|Overall Study|Adverse Event|1|||
17050000|NCT00620282|38193805|FG002|Overall Study|Adverse Event|0|||
17050001|NCT00620282|38193803|FG000|Overall Study|Arterial line unable to be placed|0|||
17050002|NCT00620282|38193804|FG001|Overall Study|Arterial line unable to be placed|0|||
17050003|NCT00620282|38193805|FG002|Overall Study|Arterial line unable to be placed|1|||
17050004|NCT00620282|38193803|FG000|Overall Study|Withdrawal by Subject|0|||
17050005|NCT00620282|38193804|FG001|Overall Study|Withdrawal by Subject|1|||
17050006|NCT00620282|38193805|FG002|Overall Study|Withdrawal by Subject|0|||
17050007|NCT00515086|38193817|FG000|Overall Study|Adverse Event|1|||
17050008|NCT00515086|38193818|FG001|Overall Study|Adverse Event|1|||
17050009|NCT00515086|38193819|FG002|Overall Study|Adverse Event|2|||
17050010|NCT00515086|38193820|FG003|Overall Study|Adverse Event|3|||
17050011|NCT00515086|38193817|FG000|Overall Study|Administrative|1|||
17050012|NCT00515086|38193818|FG001|Overall Study|Administrative|1|||
17050013|NCT00515086|38193819|FG002|Overall Study|Administrative|0|||
17050014|NCT00515086|38193820|FG003|Overall Study|Administrative|0|||
17050015|NCT00515086|38193817|FG000|Overall Study|Withdrawal by Subject|1|||
17050016|NCT00515086|38193818|FG001|Overall Study|Withdrawal by Subject|0|||
17050017|NCT00515086|38193819|FG002|Overall Study|Withdrawal by Subject|0|||
17050018|NCT00515086|38193820|FG003|Overall Study|Withdrawal by Subject|1|||
17050019|NCT00515086|38193817|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
17050020|NCT00515086|38193818|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
17050021|NCT00515086|38193819|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
17050022|NCT00515086|38193820|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
17050023|NCT00515086|38193817|FG000|Overall Study|Lost to Follow-up|1|||
17050024|NCT00515086|38193818|FG001|Overall Study|Lost to Follow-up|0|||
17050025|NCT00515086|38193819|FG002|Overall Study|Lost to Follow-up|0|||
17050026|NCT00515086|38193820|FG003|Overall Study|Lost to Follow-up|0|||
17050027|NCT00515086|38193817|FG000|Overall Study|Study drug no longer required|0|||
17050028|NCT00515086|38193818|FG001|Overall Study|Study drug no longer required|1|||
17050029|NCT00515086|38193819|FG002|Overall Study|Study drug no longer required|0|||
17050030|NCT00515086|38193820|FG003|Overall Study|Study drug no longer required|0|||
17050031|NCT00515086|38193817|FG000|Overall Study|Death|2|||
17050032|NCT00515086|38193818|FG001|Overall Study|Death|0|||
17050033|NCT00515086|38193819|FG002|Overall Study|Death|0|||
17050034|NCT00515086|38193820|FG003|Overall Study|Death|0|||
17050035|NCT00618410|38193836|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
17050036|NCT00618410|38193837|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
17050037|NCT00618722|38193847|FG000|Overall Study|Refusal of Treatment|0|||
17050038|NCT00618722|38193848|FG001|Overall Study|Refusal of Treatment|0|||
17050039|NCT00618722|38193849|FG002|Overall Study|Refusal of Treatment|1|||
17050040|NCT00618722|38193850|FG003|Overall Study|Refusal of Treatment|0|||
17050041|NCT00618722|38193847|FG000|Overall Study|Patient Request|1|||
17050042|NCT00618722|38193848|FG001|Overall Study|Patient Request|1|||
17050043|NCT00618722|38193849|FG002|Overall Study|Patient Request|1|||
17050044|NCT00618722|38193850|FG003|Overall Study|Patient Request|1|||
17050045|NCT00618722|38193847|FG000|Overall Study|Inability to Complete Study Procedure|0|||
17050046|NCT00618722|38193848|FG001|Overall Study|Inability to Complete Study Procedure|1|||
17050047|NCT00618722|38193849|FG002|Overall Study|Inability to Complete Study Procedure|0|||
17050048|NCT00618722|38193850|FG003|Overall Study|Inability to Complete Study Procedure|0|||
17050049|NCT00618722|38193847|FG000|Overall Study|Lost to Follow-up|2|||
17050050|NCT00618722|38193848|FG001|Overall Study|Lost to Follow-up|0|||
17050051|NCT00618722|38193849|FG002|Overall Study|Lost to Follow-up|0|||
17050052|NCT00618722|38193850|FG003|Overall Study|Lost to Follow-up|2|||
17050053|NCT00618722|38193847|FG000|Overall Study|Miscellaneous Reasons|0|||
17050054|NCT00618722|38193848|FG001|Overall Study|Miscellaneous Reasons|0|||
17050055|NCT00618722|38193849|FG002|Overall Study|Miscellaneous Reasons|1|||
17050056|NCT00618722|38193850|FG003|Overall Study|Miscellaneous Reasons|1|||
17050057|NCT00507442|38193864|FG000|Overall Study|Adverse Event|8|||
17050058|NCT00507442|38193865|FG001|Overall Study|Adverse Event|11|||
17050059|NCT00507442|38193866|FG002|Overall Study|Adverse Event|4|||
17050060|NCT00507442|38193867|FG003|Overall Study|Adverse Event|1|||
17050061|NCT00507442|38193864|FG000|Overall Study|Protocol Violation|0|||
17050062|NCT00507442|38193865|FG001|Overall Study|Protocol Violation|1|||
17050063|NCT00507442|38193866|FG002|Overall Study|Protocol Violation|0|||
17050064|NCT00507442|38193867|FG003|Overall Study|Protocol Violation|0|||
17142774|NCT03256851|38285670|FG001|Overall Study|Withdrawal by Subject|0|||
17142775|NCT04837807|38285676|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
17142776|NCT04837807|38285677|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
17142777|NCT03256695|38285683|FG000|Overall Study|Adverse Event|8|||
17142778|NCT03256695|38285683|FG000|Overall Study|Death|2|||
17142779|NCT03256695|38285683|FG000|Overall Study|Withdrawal by Subject|14|||
17142780|NCT03256695|38285683|FG000|Overall Study|Non-compliance with study drug|1|||
17142781|NCT03256695|38285683|FG000|Overall Study|Lost to Follow-up|3|||
17142782|NCT03256695|38285683|FG000|Overall Study|Lack of Efficacy|3|||
17142783|NCT03256695|38285683|FG000|Overall Study|Protocol Violation|5|||
17142784|NCT03256695|38285683|FG000|Overall Study|Other than specified|3|||
17142785|NCT03305016|38285687|FG000|Overall Study|Withdrawal by Subject|2|||
17142786|NCT03297021|38285694|FG000|Overall Study|Incomplete/illegible data sheet|4|||
17142787|NCT03297021|38285695|FG001|Overall Study|Incomplete/illegible data sheet|2|||
17142788|NCT03297021|38285696|FG002|Overall Study|Incomplete/illegible data sheet|3|||
17142789|NCT03297021|38285694|FG000|Overall Study|Missing Post-Op Data|1|||
17142790|NCT03297021|38285695|FG001|Overall Study|Missing Post-Op Data|2|||
17142791|NCT03297021|38285696|FG002|Overall Study|Missing Post-Op Data|1|||
17142792|NCT04820491|38285715|FG000|Overall Study|Withdrawal by Subject|1|||
17142793|NCT04820491|38285716|FG001|Overall Study|Withdrawal by Subject|0|||
17050065|NCT00507442|38193864|FG000|Overall Study|Lost to Follow-up|0|||
17050066|NCT00507442|38193865|FG001|Overall Study|Lost to Follow-up|0|||
17050067|NCT00507442|38193866|FG002|Overall Study|Lost to Follow-up|1|||
17050068|NCT00507442|38193867|FG003|Overall Study|Lost to Follow-up|0|||
17050069|NCT00507442|38193864|FG000|Overall Study|Physician Decision|0|||
17050070|NCT00507442|38193865|FG001|Overall Study|Physician Decision|2|||
17050071|NCT00507442|38193866|FG002|Overall Study|Physician Decision|4|||
17142794|NCT01988571|38285724|FG000|Overall Study|Death|3|||
17142795|NCT01988571|38285725|FG001|Overall Study|Death|1|||
17142796|NCT01988571|38285724|FG000|Overall Study|Physician Decision|2|||
17142797|NCT01988571|38285725|FG001|Overall Study|Physician Decision|1|||
17142798|NCT01988571|38285724|FG000|Overall Study|Lost to Follow-up|3|||
17142799|NCT01988571|38285725|FG001|Overall Study|Lost to Follow-up|0|||
17142800|NCT01988571|38285724|FG000|Overall Study|Withdrawal by Subject|31|||
17142801|NCT01988571|38285725|FG001|Overall Study|Withdrawal by Subject|33|||
17142802|NCT04794751|38285731|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
17142803|NCT04794751|38285732|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
17142804|NCT04794751|38285731|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
17142805|NCT04794751|38285732|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
17142806|NCT04794751|38285731|FG000|Period 1|Protocol Violation|0|||
17142807|NCT04794751|38285732|FG001|Period 1|Protocol Violation|2|||
17142808|NCT04794751|38285731|FG000|Period 1|Withdrawal by Subject|0|||
17142809|NCT04794751|38285732|FG001|Period 1|Withdrawal by Subject|1|||
17142810|NCT04794751|38285731|FG000|Period 2|Withdrawal by Subject|0|||
17142811|NCT04794751|38285732|FG001|Period 2|Withdrawal by Subject|1|||
17142812|NCT04794751|38285731|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
17142813|NCT04794751|38285732|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
17142814|NCT04794751|38285731|FG000|Period 2|Protocol Violation|1|||
17142815|NCT04794751|38285732|FG001|Period 2|Protocol Violation|0|||
17142816|NCT04578457|38285747|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
17142817|NCT04578457|38285747|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
17142818|NCT04578457|38285747|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
17142819|NCT04578457|38285747|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
17142820|NCT03334188|38285757|FG000|Overall Study|Withdrawal by Subject|0|||
17142821|NCT03334188|38285758|FG001|Overall Study|Withdrawal by Subject|1|||
17142822|NCT03334188|38285757|FG000|Overall Study|Death|1|||
17142823|NCT03334188|38285758|FG001|Overall Study|Death|0|||
17142824|NCT03334188|38285757|FG000|Overall Study|Never had qualifying clinic visit|7|||
17142825|NCT03334188|38285758|FG001|Overall Study|Never had qualifying clinic visit|7|||
17050072|NCT00507442|38193867|FG003|Overall Study|Physician Decision|1|||
17050073|NCT00507442|38193864|FG000|Overall Study|Progressive Disease|2|||
17050074|NCT00507442|38193865|FG001|Overall Study|Progressive Disease|4|||
17050075|NCT00507442|38193866|FG002|Overall Study|Progressive Disease|2|||
17050076|NCT00507442|38193867|FG003|Overall Study|Progressive Disease|0|||
17050077|NCT00507442|38193864|FG000|Overall Study|Withdrawal by Subject|4|||
17050078|NCT00507442|38193865|FG001|Overall Study|Withdrawal by Subject|4|||
17050079|NCT00507442|38193866|FG002|Overall Study|Withdrawal by Subject|2|||
17050080|NCT00507442|38193867|FG003|Overall Study|Withdrawal by Subject|1|||
17050081|NCT00507442|38193864|FG000|Overall Study|Other|2|||
17050082|NCT00507442|38193865|FG001|Overall Study|Other|5|||
17050083|NCT00507442|38193866|FG002|Overall Study|Other|2|||
17050084|NCT00507442|38193867|FG003|Overall Study|Other|2|||
17050085|NCT00619892|38193883|FG000|Overall Study|Adverse Event|3|||
17050086|NCT00619892|38193884|FG001|Overall Study|Adverse Event|0|||
17050087|NCT00619892|38193883|FG000|Overall Study|Lost to Follow-up|0|||
17050088|NCT00619892|38193884|FG001|Overall Study|Lost to Follow-up|1|||
17050089|NCT00619892|38193883|FG000|Overall Study|Intercurrent illness|0|||
17050090|NCT00619892|38193884|FG001|Overall Study|Intercurrent illness|1|||
17050091|NCT00507130|38193896|FG000|Overall Study|Lost to Follow-up|0|||
17050092|NCT00507130|38193897|FG001|Overall Study|Lost to Follow-up|0|||
17050093|NCT00507130|38193898|FG002|Overall Study|Lost to Follow-up|1|||
17050094|NCT00507130|38193899|FG003|Overall Study|Lost to Follow-up|1|||
17050095|NCT00507130|38193896|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
17050096|NCT00507130|38193897|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
17050097|NCT00507130|38193898|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
17050098|NCT00507130|38193899|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
17050099|NCT00503308|38193911|FG000|Overall Study|Protocol Violation|2|||
17050100|NCT00503308|38193912|FG001|Overall Study|Protocol Violation|1|||
17050101|NCT03893565|38193923|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
17050102|NCT03893565|38193924|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
17050103|NCT03893565|38193925|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
17050104|NCT03893565|38193926|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
17050105|NCT03893565|38193927|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
17050106|NCT03893565|38193928|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
17050107|NCT03893565|38193929|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
17050108|NCT03893565|38193930|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
17050109|NCT03893565|38193931|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
17050110|NCT03893565|38193923|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
17050111|NCT03893565|38193924|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
17050112|NCT03893565|38193925|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
17142826|NCT03333876|38285767|FG000|Screening Period|Screen Failure|4|||
17142827|NCT03333876|38285767|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
17142828|NCT03333876|38285767|FG000|Mandibular Advancement|Adverse Event|2|||
17050113|NCT03893565|38193926|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
17050114|NCT03893565|38193927|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
17050115|NCT03893565|38193928|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
17050116|NCT03893565|38193929|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
17050117|NCT03893565|38193930|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
17050118|NCT03893565|38193931|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
17050119|NCT03893565|38193923|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050120|NCT03893565|38193924|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
17050121|NCT03893565|38193925|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050122|NCT03893565|38193926|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
17050123|NCT03893565|38193927|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050124|NCT03893565|38193928|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050125|NCT03893565|38193929|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050126|NCT03893565|38193930|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050127|NCT03893565|38193931|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050128|NCT03893565|38193923|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
17050129|NCT03893565|38193924|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
17050130|NCT03893565|38193925|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
17050131|NCT03893565|38193926|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
17050132|NCT03893565|38193927|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
17050133|NCT03893565|38193928|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
17050134|NCT03893565|38193929|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
17050135|NCT03893565|38193930|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
17050136|NCT03893565|38193931|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
17050137|NCT03893565|38193923|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
17050138|NCT03893565|38193924|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
17050139|NCT03893565|38193925|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
17050140|NCT03893565|38193926|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050141|NCT03893565|38193927|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
17050142|NCT03893565|38193928|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050143|NCT03893565|38193929|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050144|NCT03893565|38193930|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050145|NCT03893565|38193931|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050146|NCT03893565|38193923|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
17050147|NCT03893565|38193924|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
17050148|NCT03893565|38193925|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
17050149|NCT03893565|38193926|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
17050150|NCT03893565|38193927|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
17050151|NCT03893565|38193928|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
17050152|NCT03893565|38193929|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
17050153|NCT03893565|38193930|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
17050154|NCT03893565|38193931|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
17050155|NCT03893565|38193923|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050156|NCT03893565|38193924|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050157|NCT03893565|38193925|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050158|NCT03893565|38193926|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
17050159|NCT03893565|38193927|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050160|NCT03893565|38193928|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17142829|NCT03333876|38285767|FG000|Mandibular Advancement|Product Damage|2|||
17142830|NCT03294681|38285780|FG000|Overall Study|Withdrawal by Subject|1|||
17142831|NCT01140867|38285784|FG000|Overall Study|Adverse Event|22|||
17142832|NCT01140867|38285784|FG000|Overall Study|Lack of Efficacy|3|||
17142833|NCT01140867|38285784|FG000|Overall Study|Lost to Follow-up|2|||
17142834|NCT01140867|38285784|FG000|Overall Study|Withdrawal by Subject|1|||
17142835|NCT01140867|38285784|FG000|Overall Study|Protocol Violation|1|||
17142836|NCT01140867|38285784|FG000|Overall Study|Uncooperative patient|2|||
17142837|NCT01140867|38285784|FG000|Overall Study|Medication Noncompliance|2|||
17142838|NCT04572997|38285788|FG000|Overall Study|Adverse Event|1|||
17142839|NCT02943096|38285798|FG000|Overall Study|Lack of Efficacy|0|||
17142840|NCT02943096|38285799|FG001|Overall Study|Lack of Efficacy|1|||
17142841|NCT04571515|38285810|FG000|Overall Study|Physician Decision|0|||
17142842|NCT04571515|38285811|FG001|Overall Study|Physician Decision|0|||
17142843|NCT04571515|38285812|FG002|Overall Study|Physician Decision|0|||
17142844|NCT04571515|38285813|FG003|Overall Study|Physician Decision|0|||
17142845|NCT04571515|38285814|FG004|Overall Study|Physician Decision|1|||
17142846|NCT04571515|38285810|FG000|Overall Study|Withdrawal by Subject|0|||
17142847|NCT04571515|38285811|FG001|Overall Study|Withdrawal by Subject|0|||
17142848|NCT04571515|38285812|FG002|Overall Study|Withdrawal by Subject|0|||
17142849|NCT04571515|38285813|FG003|Overall Study|Withdrawal by Subject|0|||
17142850|NCT04571515|38285814|FG004|Overall Study|Withdrawal by Subject|1|||
17142851|NCT04571515|38285810|FG000|Overall Study|insufficient pain|1|||
17142852|NCT04571515|38285811|FG001|Overall Study|insufficient pain|0|||
17142853|NCT04571515|38285812|FG002|Overall Study|insufficient pain|0|||
17142854|NCT04571515|38285813|FG003|Overall Study|insufficient pain|0|||
17142855|NCT04571515|38285814|FG004|Overall Study|insufficient pain|1|||
17142856|NCT03292653|38285829|FG000|Overall Study|Adverse Event|0|||
17142857|NCT03292653|38285830|FG001|Overall Study|Adverse Event|0|||
17142858|NCT03292653|38285831|FG002|Overall Study|Adverse Event|1|||
17142859|NCT03292653|38285829|FG000|Overall Study|Did not Receive Treatment|1|||
17142860|NCT03292653|38285830|FG001|Overall Study|Did not Receive Treatment|0|||
17142861|NCT03292653|38285831|FG002|Overall Study|Did not Receive Treatment|0|||
17142862|NCT03858634|38285842|FG000|Overall Study|Withdrawal by Subject|1|||
17142863|NCT03858634|38285843|FG001|Overall Study|Withdrawal by Subject|0|||
17142864|NCT03858634|38285842|FG000|Overall Study|Adverse Event|1|||
17142865|NCT03858634|38285843|FG001|Overall Study|Adverse Event|0|||
17142866|NCT03858634|38285842|FG000|Overall Study|Lost to Follow-up|0|||
17142867|NCT03858634|38285843|FG001|Overall Study|Lost to Follow-up|1|||
17142868|NCT03858634|38285842|FG000|Overall Study|Other, Not Specified|1|||
17142869|NCT03858634|38285843|FG001|Overall Study|Other, Not Specified|1|||
17142870|NCT02891070|38285859|FG000|Overall Study|Adverse Event|1|||
17142871|NCT02891070|38285860|FG001|Overall Study|Adverse Event|0|||
17142872|NCT02891070|38285859|FG000|Overall Study|Physician Decision|0|||
17142873|NCT02891070|38285860|FG001|Overall Study|Physician Decision|1|||
17142874|NCT02891070|38285859|FG000|Overall Study|Lost to Follow-up|4|||
17142875|NCT02891070|38285860|FG001|Overall Study|Lost to Follow-up|4|||
17142876|NCT02891070|38285859|FG000|Overall Study|Other|1|||
17142877|NCT02891070|38285860|FG001|Overall Study|Other|0|||
17142878|NCT02891070|38285859|FG000|Overall Study|Protocol Violation|0|||
17142879|NCT02891070|38285860|FG001|Overall Study|Protocol Violation|1|||
17142880|NCT02891070|38285859|FG000|Overall Study|Withdrawal by Subject|1|||
17142881|NCT02891070|38285860|FG001|Overall Study|Withdrawal by Subject|2|||
17142882|NCT02891070|38285859|FG000|Overall Study|Death|3|||
17142883|NCT02891070|38285860|FG001|Overall Study|Death|0|||
17142884|NCT03255291|38285872|FG000|Overall Study|Determined to be ineligible|10|||
17142885|NCT03255291|38285873|FG001|Overall Study|Determined to be ineligible|12|||
17142886|NCT03255291|38285874|FG002|Overall Study|Determined to be ineligible|6|||
17142887|NCT03255291|38285875|FG003|Overall Study|Determined to be ineligible|6|||
17142888|NCT03255291|38285876|FG004|Overall Study|Determined to be ineligible|5|||
17142889|NCT03255291|38285877|FG005|Overall Study|Determined to be ineligible|10|||
17142890|NCT03255291|38285872|FG000|Overall Study|Baseline data collection issues|3|||
17142891|NCT03255291|38285873|FG001|Overall Study|Baseline data collection issues|0|||
17142892|NCT03255291|38285874|FG002|Overall Study|Baseline data collection issues|0|||
17142893|NCT03255291|38285875|FG003|Overall Study|Baseline data collection issues|0|||
17142894|NCT03255291|38285876|FG004|Overall Study|Baseline data collection issues|2|||
17142895|NCT03255291|38285877|FG005|Overall Study|Baseline data collection issues|0|||
17142896|NCT00381381|38285895|FG000|Overall Study|Adverse Event|3|||
17142897|NCT00381381|38285895|FG000|Overall Study|Lost to Follow-up|52|||
17142898|NCT00381381|38285895|FG000|Overall Study|Withdrawal by Subject|9|||
17142899|NCT02939937|38285901|FG000|Overall Study|Adverse Event|5|||
17142900|NCT02939937|38285902|FG001|Overall Study|Adverse Event|0|||
17142901|NCT02939937|38285901|FG000|Overall Study|Lost to Follow-up|1|||
17142902|NCT02939937|38285902|FG001|Overall Study|Lost to Follow-up|3|||
17142903|NCT02939079|38285910|FG000|Overall Study|Adverse Event|2|||
17142904|NCT02939079|38285911|FG001|Overall Study|Adverse Event|1|||
17142905|NCT02939079|38285910|FG000|Overall Study|Lost to Follow-up|0|||
17142906|NCT02939079|38285911|FG001|Overall Study|Lost to Follow-up|2|||
17142907|NCT02939079|38285910|FG000|Overall Study|Protocol Violation|1|||
17142908|NCT02939079|38285911|FG001|Overall Study|Protocol Violation|0|||
17050161|NCT03893565|38193929|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050162|NCT03893565|38193930|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050163|NCT03893565|38193931|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050164|NCT03893565|38193923|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
17050165|NCT03893565|38193924|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
17050166|NCT03893565|38193925|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
17050167|NCT03893565|38193926|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
17050168|NCT03893565|38193927|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
17050169|NCT03893565|38193928|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
17142909|NCT02939079|38285910|FG000|Overall Study|Withdrawal by Subject|0|||
17142910|NCT02939079|38285911|FG001|Overall Study|Withdrawal by Subject|1|||
17142911|NCT02939079|38285910|FG000|Overall Study|relapse during the study|1|||
17050170|NCT03893565|38193929|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
17050171|NCT03893565|38193930|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
17050172|NCT03893565|38193931|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
17050173|NCT03893565|38193923|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
17050174|NCT03893565|38193924|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
17050175|NCT03893565|38193925|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
17050176|NCT03893565|38193926|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
17050177|NCT03893565|38193927|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
17050178|NCT03893565|38193928|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
17050179|NCT03893565|38193929|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
17050180|NCT03893565|38193930|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
17050181|NCT03893565|38193931|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
17050182|NCT03893565|38193923|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
17050183|NCT03893565|38193924|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
17050184|NCT03893565|38193925|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
17050185|NCT03893565|38193926|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
17050186|NCT03893565|38193927|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
17050187|NCT03893565|38193928|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
17050188|NCT03893565|38193929|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
17050189|NCT03893565|38193930|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
17050190|NCT03893565|38193931|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
17050191|NCT03893565|38193923|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
17050192|NCT03893565|38193924|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
17050193|NCT03893565|38193925|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
17050194|NCT03893565|38193926|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
17050195|NCT03893565|38193927|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
17050196|NCT03893565|38193928|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
17050197|NCT03893565|38193929|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
17050198|NCT03893565|38193930|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
17050199|NCT03893565|38193931|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
17050200|NCT03893565|38193923|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
17050201|NCT03893565|38193924|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
17050202|NCT03893565|38193925|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
17050203|NCT03893565|38193926|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
17050204|NCT03893565|38193927|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
17050205|NCT03893565|38193928|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
17050206|NCT03893565|38193929|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
17050207|NCT03893565|38193930|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
17050208|NCT03893565|38193931|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
17050209|NCT03893565|38193923|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17142912|NCT02939079|38285911|FG001|Overall Study|relapse during the study|1|||
17142913|NCT04562155|38285921|FG000|Overall Study|COVID-19 pandemic|0|||
17142914|NCT04562155|38285922|FG001|Overall Study|COVID-19 pandemic|0|||
17142915|NCT04562155|38285923|FG002|Overall Study|COVID-19 pandemic|0|||
17142916|NCT04562155|38285924|FG003|Overall Study|COVID-19 pandemic|1|||
17142917|NCT04562155|38285921|FG000|Overall Study|Adverse Event|7|||
17050210|NCT03893565|38193924|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050211|NCT03893565|38193925|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050212|NCT03893565|38193926|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050213|NCT03893565|38193927|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050214|NCT03893565|38193928|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050215|NCT03893565|38193929|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050216|NCT03893565|38193930|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
17050217|NCT03893565|38193931|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
17050218|NCT03893565|38193923|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050219|NCT03893565|38193924|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050220|NCT03893565|38193925|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050221|NCT03893565|38193926|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050222|NCT03893565|38193927|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050223|NCT03893565|38193928|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050224|NCT03893565|38193929|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050225|NCT03893565|38193930|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
17142918|NCT04562155|38285922|FG001|Overall Study|Adverse Event|3|||
17050226|NCT03893565|38193931|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
17050227|NCT03893565|38193923|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050228|NCT03893565|38193924|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050229|NCT03893565|38193925|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050230|NCT03893565|38193926|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050231|NCT03893565|38193927|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050232|NCT03893565|38193928|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050233|NCT03893565|38193929|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050234|NCT03893565|38193930|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
17050235|NCT03893565|38193931|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
17050236|NCT03893565|38193923|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
17050237|NCT03893565|38193924|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
17050238|NCT03893565|38193925|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
17050239|NCT03893565|38193926|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
17050240|NCT03893565|38193927|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
17050241|NCT03893565|38193928|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
17050242|NCT03893565|38193929|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
17050243|NCT03893565|38193930|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
17050244|NCT03893565|38193931|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
17050245|NCT00502996|38193950|FG000|Overall Study|Lost to Follow-up|9|||
17050246|NCT00502996|38193950|FG000|Overall Study|Protocol Violation|2|||
17050247|NCT00502996|38193950|FG000|Overall Study|Treatment failure|25|||
17050248|NCT00502996|38193950|FG000|Overall Study|Withdrawal Informed Consent|6|||
17050249|NCT00502996|38193950|FG000|Overall Study|Adverse Event|2|||
17050250|NCT00715403|38193961|FG000|Overall Study|Progressive disease|0|||
17050251|NCT00715403|38193962|FG001|Overall Study|Progressive disease|1|||
17050252|NCT00715403|38193963|FG002|Overall Study|Progressive disease|3|||
17050253|NCT00715403|38193964|FG003|Overall Study|Progressive disease|9|||
17050254|NCT00715403|38193965|FG004|Overall Study|Progressive disease|5|||
17050255|NCT00715403|38193966|FG005|Overall Study|Progressive disease|14|||
17050256|NCT00715403|38193967|FG006|Overall Study|Progressive disease|1|||
17050257|NCT00715403|38193961|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
17050258|NCT00715403|38193962|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
17050259|NCT00715403|38193963|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
17050260|NCT00715403|38193964|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
17050261|NCT00715403|38193965|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
17050262|NCT00715403|38193966|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
17050263|NCT00715403|38193967|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
17050264|NCT00715403|38193961|FG000|Overall Study|Other Adverse Event than DLT|1|||
17050265|NCT00715403|38193962|FG001|Overall Study|Other Adverse Event than DLT|0|||
17050266|NCT00715403|38193963|FG002|Overall Study|Other Adverse Event than DLT|0|||
17050267|NCT00715403|38193964|FG003|Overall Study|Other Adverse Event than DLT|0|||
17050268|NCT00715403|38193965|FG004|Overall Study|Other Adverse Event than DLT|0|||
17050269|NCT00715403|38193966|FG005|Overall Study|Other Adverse Event than DLT|2|||
17050270|NCT00715403|38193967|FG006|Overall Study|Other Adverse Event than DLT|0|||
17050271|NCT00715403|38193961|FG000|Overall Study|Protocol Violation|0|||
17050272|NCT00715403|38193962|FG001|Overall Study|Protocol Violation|0|||
17050273|NCT00715403|38193963|FG002|Overall Study|Protocol Violation|0|||
17050274|NCT00715403|38193964|FG003|Overall Study|Protocol Violation|0|||
17050275|NCT00715403|38193965|FG004|Overall Study|Protocol Violation|0|||
17050276|NCT00715403|38193966|FG005|Overall Study|Protocol Violation|1|||
17050277|NCT00715403|38193967|FG006|Overall Study|Protocol Violation|0|||
17050278|NCT00715403|38193961|FG000|Overall Study|Other reason not defined above|0|||
17050279|NCT00715403|38193962|FG001|Overall Study|Other reason not defined above|0|||
17050280|NCT00715403|38193963|FG002|Overall Study|Other reason not defined above|1|||
17050281|NCT00715403|38193964|FG003|Overall Study|Other reason not defined above|0|||
17050282|NCT00715403|38193965|FG004|Overall Study|Other reason not defined above|1|||
17050283|NCT00715403|38193966|FG005|Overall Study|Other reason not defined above|1|||
17050284|NCT00715403|38193967|FG006|Overall Study|Other reason not defined above|0|||
17050285|NCT00502840|38193983|FG000|Overall Study|Adverse Event|5|||
17050286|NCT00502840|38193983|FG000|Overall Study|Additional or changed therapy|48|||
17050287|NCT00502840|38193983|FG000|Overall Study|Lack of Efficacy|11|||
17050288|NCT00502840|38193983|FG000|Overall Study|Protocol Violation|4|||
17050289|NCT00502840|38193983|FG000|Overall Study|Withdrawal by Subject|5|||
17050290|NCT00502840|38193983|FG000|Overall Study|Lost to Follow-up|6|||
17050291|NCT00502840|38193983|FG000|Overall Study|Administrative problems|1|||
17050292|NCT00502840|38193983|FG000|Overall Study|Other|20|||
17050293|NCT00515008|38193990|FG000|Overall Study|Lost to Follow-up|1|||
17050294|NCT00515008|38193991|FG001|Overall Study|Lost to Follow-up|0|||
17050295|NCT00515008|38193990|FG000|Overall Study|Declined|0|||
17050296|NCT00515008|38193991|FG001|Overall Study|Declined|3|||
17050297|NCT00515008|38193990|FG000|Overall Study|Left the Boston Area|1|||
17050298|NCT00515008|38193991|FG001|Overall Study|Left the Boston Area|1|||
17050299|NCT00515008|38193990|FG000|Overall Study|Scheduling conflict|1|||
17050300|NCT00515008|38193991|FG001|Overall Study|Scheduling conflict|0|||
17050301|NCT00514540|38194000|FG000|First-Line Chemo|Withdrawal by Subject|1|||
17050302|NCT00514540|38194000|FG000|First-Line Chemo|Protocol Violation|7|||
17050303|NCT00514540|38194000|FG000|Second-Line|Physician/Patient Decision|31|||
17050304|NCT00506662|38194010|FG000|Overall Study|Adverse Event|0|||
17050305|NCT00506662|38194011|FG001|Overall Study|Adverse Event|2|||
17050306|NCT00506662|38194010|FG000|Overall Study|Lack of Efficacy|1|||
17050307|NCT00506662|38194011|FG001|Overall Study|Lack of Efficacy|0|||
17050308|NCT00506662|38194010|FG000|Overall Study|Protocol Violation|2|||
17142919|NCT04562155|38285923|FG002|Overall Study|Adverse Event|8|||
17142920|NCT04562155|38285924|FG003|Overall Study|Adverse Event|1|||
17142921|NCT04562155|38285921|FG000|Overall Study|Withdrawal by Subject|3|||
17142922|NCT04562155|38285922|FG001|Overall Study|Withdrawal by Subject|6|||
17142923|NCT04562155|38285923|FG002|Overall Study|Withdrawal by Subject|3|||
17142924|NCT04562155|38285924|FG003|Overall Study|Withdrawal by Subject|3|||
17142925|NCT04562155|38285921|FG000|Overall Study|Participant personal reason|1|||
17142926|NCT04562155|38285922|FG001|Overall Study|Participant personal reason|0|||
17142927|NCT04562155|38285923|FG002|Overall Study|Participant personal reason|2|||
17142928|NCT04562155|38285924|FG003|Overall Study|Participant personal reason|1|||
17142929|NCT02896257|38285938|FG000|Providers|Without eligible patients|21|||
17142930|NCT02896257|38285939|FG001|Providers|Without eligible patients|28|||
17142931|NCT02896257|38285938|FG000|Patients|PFT entry criteria not met|43|||
17142932|NCT02896257|38285939|FG001|Patients|PFT entry criteria not met|50|||
17142933|NCT02896257|38285938|FG000|Patients|No capacity to review|8|||
17142934|NCT02896257|38285939|FG001|Patients|No capacity to review|11|||
17142935|NCT02896257|38285938|FG000|Patients|Appointment rescheduled/cancelled|5|||
17142936|NCT02896257|38285939|FG001|Patients|Appointment rescheduled/cancelled|7|||
17142937|NCT02896257|38285938|FG000|Patients|PCP not assigned a clinic|4|||
17142938|NCT02896257|38285939|FG001|Patients|PCP not assigned a clinic|0|||
17142939|NCT02896257|38285938|FG000|Patients|No history of COPD|0|||
17142940|NCT02896257|38285939|FG001|Patients|No history of COPD|1|||
17142941|NCT02896257|38285938|FG000|Patients|Deceased between review and index date|0|||
17142942|NCT02896257|38285939|FG001|Patients|Deceased between review and index date|1|||
17142943|NCT02896257|38285938|FG000|Patients|No ICS Rx upon review|1|||
17142944|NCT02896257|38285939|FG001|Patients|No ICS Rx upon review|1|||
17050309|NCT00506662|38194011|FG001|Overall Study|Protocol Violation|4|||
17050310|NCT00506662|38194010|FG000|Overall Study|Trial terminated|10|||
17050311|NCT00506662|38194011|FG001|Overall Study|Trial terminated|16|||
17050312|NCT00506662|38194010|FG000|Overall Study|Not recorded|4|||
17050313|NCT00506662|38194011|FG001|Overall Study|Not recorded|6|||
17050314|NCT00713609|38194027|FG000|Overall Study|Adverse Event|2|||
17050315|NCT00713609|38194028|FG001|Overall Study|Adverse Event|0|||
17050316|NCT00713609|38194029|FG002|Overall Study|Adverse Event|2|||
17050317|NCT00713609|38194030|FG003|Overall Study|Adverse Event|2|||
17050318|NCT00713609|38194031|FG004|Overall Study|Adverse Event|3|||
17050319|NCT00713609|38194032|FG005|Overall Study|Adverse Event|1|||
17050320|NCT00713609|38194027|FG000|Overall Study|Lost to Follow-up|5|||
17050321|NCT00713609|38194028|FG001|Overall Study|Lost to Follow-up|7|||
16780915|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16780916|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16780917|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
16780918|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16780919|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16780920|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16780921|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
16780922|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
16780923|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
16780924|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
16780925|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
16780926|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
16780927|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
16780928|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
16780929|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
16780930|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
16780931|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
16780932|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
16780933|NCT02151682|37720061|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16780934|NCT02151682|37720062|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16780935|NCT02151682|37720063|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
16780936|NCT02151682|37720064|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16780937|NCT02151682|37720065|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16780938|NCT02151682|37720066|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16780939|NCT02151682|37720061|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16780940|NCT02151682|37720062|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16780941|NCT02151682|37720063|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16780942|NCT02151682|37720064|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16780943|NCT02151682|37720065|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16780944|NCT02151682|37720066|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
16780945|NCT02151682|37720061|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16780946|NCT02151682|37720062|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16992596|NCT00721279|38136607|FG000|Overall Study|Other|12|||
16992597|NCT00721279|38136608|FG001|Overall Study|Other|16|||
16992598|NCT01030952|38136617|FG000|Overall Study|Protocol Violation|0|||
16992599|NCT01030952|38136618|FG001|Overall Study|Protocol Violation|1|||
16992600|NCT01030952|38136617|FG000|Overall Study|Informed consent withdrawal|1|||
16992601|NCT01030952|38136618|FG001|Overall Study|Informed consent withdrawal|0|||
16992602|NCT01030952|38136617|FG000|Overall Study|Lost to Follow-up|0|||
16992603|NCT01030952|38136618|FG001|Overall Study|Lost to Follow-up|1|||
16992604|NCT01030952|38136617|FG000|Overall Study|Unexplained|1|||
16992605|NCT01030952|38136618|FG001|Overall Study|Unexplained|1|||
16992606|NCT01030874|38136628|FG000|Overall Study|Withdrawal by Subject|1|||
16992607|NCT01030874|38136629|FG001|Overall Study|Withdrawal by Subject|0|||
17050322|NCT00713609|38194029|FG002|Overall Study|Lost to Follow-up|5|||
17050323|NCT00713609|38194030|FG003|Overall Study|Lost to Follow-up|5|||
17050324|NCT00713609|38194031|FG004|Overall Study|Lost to Follow-up|7|||
17050325|NCT00713609|38194032|FG005|Overall Study|Lost to Follow-up|0|||
17050326|NCT00713609|38194027|FG000|Overall Study|Lack of Efficacy|1|||
17050327|NCT00713609|38194028|FG001|Overall Study|Lack of Efficacy|3|||
17050328|NCT00713609|38194029|FG002|Overall Study|Lack of Efficacy|0|||
17050329|NCT00713609|38194030|FG003|Overall Study|Lack of Efficacy|0|||
17050330|NCT00713609|38194031|FG004|Overall Study|Lack of Efficacy|1|||
17050331|NCT00713609|38194032|FG005|Overall Study|Lack of Efficacy|0|||
17050332|NCT00713609|38194027|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
17050333|NCT00713609|38194028|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
17050334|NCT00713609|38194029|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
17050335|NCT00713609|38194030|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
17050336|NCT00713609|38194031|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
17050337|NCT00713609|38194032|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
17050338|NCT00713609|38194027|FG000|Overall Study|Withdrawal by Subject|6|||
17050339|NCT00713609|38194028|FG001|Overall Study|Withdrawal by Subject|1|||
17050340|NCT00713609|38194029|FG002|Overall Study|Withdrawal by Subject|5|||
17050341|NCT00713609|38194030|FG003|Overall Study|Withdrawal by Subject|1|||
17050342|NCT00713609|38194031|FG004|Overall Study|Withdrawal by Subject|5|||
17050343|NCT00713609|38194032|FG005|Overall Study|Withdrawal by Subject|7|||
17050344|NCT00713609|38194027|FG000|Overall Study|Protocol Violation|6|||
17050345|NCT00713609|38194028|FG001|Overall Study|Protocol Violation|3|||
17050346|NCT00713609|38194029|FG002|Overall Study|Protocol Violation|1|||
17050347|NCT00713609|38194030|FG003|Overall Study|Protocol Violation|1|||
17050348|NCT00713609|38194031|FG004|Overall Study|Protocol Violation|2|||
17050349|NCT00713609|38194032|FG005|Overall Study|Protocol Violation|0|||
17050350|NCT00513682|38194046|FG000|Washout Phase|Adverse Event|2|||
17050351|NCT00493012|38194055|FG000|Overall Study|Lost to Follow-up|18|||
17050352|NCT00493012|38194056|FG001|Overall Study|Lost to Follow-up|17|||
17050353|NCT00617708|38194070|FG000|Overall Study|Adverse Event|0|||
17050354|NCT00617708|38194071|FG001|Overall Study|Adverse Event|6|||
17050355|NCT00617708|38194072|FG002|Overall Study|Adverse Event|9|||
17050356|NCT00617708|38194070|FG000|Overall Study|Withdrawal by Subject|1|||
17050357|NCT00617708|38194071|FG001|Overall Study|Withdrawal by Subject|1|||
17050358|NCT00617708|38194072|FG002|Overall Study|Withdrawal by Subject|7|||
17050359|NCT00617708|38194070|FG000|Overall Study|Death|0|||
17050360|NCT00617708|38194071|FG001|Overall Study|Death|6|||
17050361|NCT00617708|38194072|FG002|Overall Study|Death|5|||
17050362|NCT00617708|38194070|FG000|Overall Study|Progression/Relapse|7|||
17050363|NCT00617708|38194071|FG001|Overall Study|Progression/Relapse|40|||
17050364|NCT00617708|38194072|FG002|Overall Study|Progression/Relapse|36|||
17050365|NCT00617708|38194070|FG000|Overall Study|Not protocol specified|1|||
17050366|NCT00617708|38194071|FG001|Overall Study|Not protocol specified|4|||
17050367|NCT00617708|38194072|FG002|Overall Study|Not protocol specified|2|||
17050368|NCT00617708|38194070|FG000|Overall Study|Not eligible|1|||
17050369|NCT00617708|38194071|FG001|Overall Study|Not eligible|3|||
17050370|NCT00617708|38194072|FG002|Overall Study|Not eligible|5|||
17050371|NCT03894969|38194087|FG000|Overall Study|Adverse Event|0|||
17050372|NCT03894969|38194088|FG001|Overall Study|Adverse Event|2|||
17050373|NCT03894969|38194089|FG002|Overall Study|Adverse Event|0|||
17050374|NCT03894969|38194090|FG003|Overall Study|Adverse Event|1|||
17050375|NCT03894969|38194091|FG004|Overall Study|Adverse Event|2|||
17050376|NCT03894969|38194087|FG000|Overall Study|Lost to Follow-up|3|||
17050377|NCT03894969|38194088|FG001|Overall Study|Lost to Follow-up|1|||
17050378|NCT03894969|38194089|FG002|Overall Study|Lost to Follow-up|1|||
17050379|NCT03894969|38194090|FG003|Overall Study|Lost to Follow-up|0|||
17050380|NCT03894969|38194091|FG004|Overall Study|Lost to Follow-up|0|||
17050381|NCT03894969|38194087|FG000|Overall Study|Withdrawal by Subject|2|||
17050382|NCT03894969|38194088|FG001|Overall Study|Withdrawal by Subject|1|||
17050383|NCT03894969|38194089|FG002|Overall Study|Withdrawal by Subject|3|||
17050384|NCT03894969|38194090|FG003|Overall Study|Withdrawal by Subject|4|||
17050385|NCT03894969|38194091|FG004|Overall Study|Withdrawal by Subject|8|||
17050386|NCT03894969|38194087|FG000|Overall Study|Other|0|||
17050387|NCT03894969|38194088|FG001|Overall Study|Other|0|||
17050388|NCT03894969|38194089|FG002|Overall Study|Other|0|||
17050389|NCT03894969|38194090|FG003|Overall Study|Other|0|||
17050390|NCT03894969|38194091|FG004|Overall Study|Other|3|||
17050391|NCT03894969|38194087|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
17050392|NCT03894969|38194088|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
17050393|NCT03894969|38194089|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
17050394|NCT03894969|38194090|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
17050395|NCT03894969|38194091|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
17050396|NCT03894969|38194087|FG000|Overall Study|Solicited Adverse Event|0|||
17050397|NCT03894969|38194088|FG001|Overall Study|Solicited Adverse Event|1|||
17050398|NCT03894969|38194089|FG002|Overall Study|Solicited Adverse Event|0|||
17050399|NCT03894969|38194090|FG003|Overall Study|Solicited Adverse Event|0|||
17050400|NCT03894969|38194091|FG004|Overall Study|Solicited Adverse Event|0|||
17050401|NCT03894813|38194107|FG000|Overall Study|Adverse Event|1|||
17050402|NCT03894813|38194108|FG001|Overall Study|Adverse Event|1|||
17050403|NCT03894813|38194107|FG000|Overall Study|Lack of Efficacy|3|||
17050404|NCT03894813|38194108|FG001|Overall Study|Lack of Efficacy|3|||
17050405|NCT03894813|38194107|FG000|Overall Study|Lost to Follow-up|1|||
17050406|NCT03894813|38194108|FG001|Overall Study|Lost to Follow-up|0|||
17050407|NCT03894813|38194107|FG000|Overall Study|Pregnancy|2|||
17050408|NCT03894813|38194108|FG001|Overall Study|Pregnancy|1|||
17050409|NCT03894813|38194107|FG000|Overall Study|Protocol Violation|3|||
17050410|NCT03894813|38194108|FG001|Overall Study|Protocol Violation|7|||
17050411|NCT03894813|38194107|FG000|Overall Study|Withdrawal by Subject|1|||
17050412|NCT03894813|38194108|FG001|Overall Study|Withdrawal by Subject|3|||
17050413|NCT03894813|38194107|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
17050414|NCT03894813|38194108|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
17050415|NCT00615992|38194114|FG000|Overall Study|Protocol Violation|67|||
17050416|NCT03892707|38194120|FG000|Overall Study|Screen failure|6|||
17050417|NCT03892707|38194121|FG001|Overall Study|Screen failure|0|||
17050418|NCT03892707|38194120|FG000|Overall Study|Pain resolution|0|||
17050419|NCT03892707|38194121|FG001|Overall Study|Pain resolution|4|||
17050420|NCT03892707|38194120|FG000|Overall Study|Withdrawal by Subject|0|||
17050421|NCT03892707|38194121|FG001|Overall Study|Withdrawal by Subject|1|||
17050422|NCT03892707|38194120|FG000|Overall Study|Other (long business trip)|0|||
17050423|NCT03892707|38194121|FG001|Overall Study|Other (long business trip)|1|||
17050424|NCT00615914|38194128|FG000|Overall Study|Adverse Event|274|||
17142945|NCT02896257|38285938|FG000|Patients|Protocol Violation|2|||
17142946|NCT02896257|38285939|FG001|Patients|Protocol Violation|1|||
17142947|NCT02896257|38285938|FG000|Patients|Hospice care|0|||
17142948|NCT02896257|38285939|FG001|Patients|Hospice care|1|||
17142949|NCT03313050|38285950|FG000|Stage 2: 12 Months|Adverse Event|0|||
17142950|NCT03313050|38285951|FG001|Stage 2: 12 Months|Adverse Event|0|||
17142951|NCT03313050|38285952|FG002|Stage 2: 12 Months|Adverse Event|0|||
17142952|NCT03313050|38285953|FG003|Stage 2: 12 Months|Adverse Event|1|||
17142953|NCT03313050|38285950|FG000|Stage 2: 12 Months|Death|0|||
17142954|NCT03313050|38285951|FG001|Stage 2: 12 Months|Death|0|||
17142955|NCT03313050|38285952|FG002|Stage 2: 12 Months|Death|3|||
17142956|NCT03313050|38285953|FG003|Stage 2: 12 Months|Death|0|||
17142957|NCT03313050|38285950|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
17142958|NCT03313050|38285951|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
17142959|NCT03313050|38285952|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
17142960|NCT03313050|38285953|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
17142961|NCT03313050|38285950|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
17142962|NCT03313050|38285951|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
17050425|NCT00615914|38194128|FG000|Overall Study|Death|20|||
17050426|NCT00615914|38194128|FG000|Overall Study|Lack of Efficacy|59|||
17142963|NCT03313050|38285952|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
17050427|NCT00615914|38194128|FG000|Overall Study|Lost to Follow-up|187|||
17050428|NCT00615914|38194128|FG000|Overall Study|Withdrawal by Subject|16|||
17050429|NCT00615914|38194128|FG000|Overall Study|Physician Decision|4|||
17050430|NCT00615914|38194128|FG000|Overall Study|No data was collected.|65|||
17050431|NCT00615914|38194128|FG000|Overall Study|No treatment|2|||
17050432|NCT00615914|38194128|FG000|Overall Study|Irregularly enrolled patients|10|||
17050433|NCT00513604|38194138|FG000|Overall Study|Not treated|2|||
17050434|NCT00513604|38194139|FG001|Overall Study|Not treated|0|||
17050435|NCT00513604|38194140|FG002|Overall Study|Not treated|1|||
17050436|NCT00513604|38194141|FG003|Overall Study|Not treated|0|||
17050437|NCT00513604|38194142|FG004|Overall Study|Not treated|0|||
17050438|NCT00513604|38194138|FG000|Overall Study|Death during treatment|0|||
17050439|NCT00513604|38194139|FG001|Overall Study|Death during treatment|3|||
17050440|NCT00513604|38194140|FG002|Overall Study|Death during treatment|2|||
17050441|NCT00513604|38194141|FG003|Overall Study|Death during treatment|0|||
17050442|NCT00513604|38194142|FG004|Overall Study|Death during treatment|0|||
17050443|NCT00534105|38194156|FG000|Overall Study|Lost to Follow-up|23|||
17050444|NCT00534105|38194157|FG001|Overall Study|Lost to Follow-up|39|||
17050445|NCT00573248|38194172|FG000|Overall Study|scheduling conflicts|15|||
17050446|NCT00573248|38194173|FG001|Overall Study|scheduling conflicts|11|||
17050447|NCT00532935|38194181|FG000|Overall Study|Adverse Event|11|||
17050448|NCT00532935|38194182|FG001|Overall Study|Adverse Event|12|||
17142964|NCT03313050|38285953|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
17142965|NCT03313050|38285950|FG000|Stage 2: 12 Months|Protocol deviation|0|||
17142966|NCT03313050|38285951|FG001|Stage 2: 12 Months|Protocol deviation|0|||
17142967|NCT03313050|38285952|FG002|Stage 2: 12 Months|Protocol deviation|7|||
17142968|NCT03313050|38285953|FG003|Stage 2: 12 Months|Protocol deviation|7|||
17142969|NCT03313050|38285950|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
17142970|NCT03313050|38285951|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
17142971|NCT03313050|38285952|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
17142972|NCT03313050|38285953|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
17142973|NCT03313050|38285950|FG000|Stage 2: 12 Months|Other|0|||
17142974|NCT03313050|38285951|FG001|Stage 2: 12 Months|Other|0|||
17142975|NCT03313050|38285952|FG002|Stage 2: 12 Months|Other|0|||
17142976|NCT03313050|38285953|FG003|Stage 2: 12 Months|Other|1|||
17142977|NCT04755595|38285972|FG000|Overall Study|Lost to Follow-up|1|||
17142978|NCT04749745|38285977|FG000|Overall Study|Withdrawal by Subject|1|||
17142979|NCT04749745|38285978|FG001|Overall Study|Withdrawal by Subject|0|||
17142980|NCT03257436|38285984|FG000|Overall Study|Withdrawal by Subject|76|||
17142981|NCT03257436|38285984|FG000|Overall Study|Death|19|||
17142982|NCT04748341|38285990|FG000|Overall Study|Lost to Follow-up|1|||
17142983|NCT04748341|38285991|FG001|Overall Study|Lost to Follow-up|1|||
17142984|NCT01328002|38285997|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
17142985|NCT01328002|38285998|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
17142986|NCT01328002|38285997|FG000|Open-Label Period|Adverse Event|8|||
17142987|NCT01328002|38285998|FG001|Open-Label Period|Adverse Event|0|||
17142988|NCT01328002|38285997|FG000|Open-Label Period|Lack of Efficacy|3|||
17142989|NCT01328002|38285998|FG001|Open-Label Period|Lack of Efficacy|0|||
17142990|NCT01328002|38285997|FG000|Open-Label Period|Protocol Violation|2|||
17050449|NCT00532935|38194181|FG000|Overall Study|Lack of Efficacy|0|||
17050450|NCT00532935|38194182|FG001|Overall Study|Lack of Efficacy|3|||
17050451|NCT00532935|38194181|FG000|Overall Study|Lost to Follow-up|10|||
17050452|NCT00532935|38194182|FG001|Overall Study|Lost to Follow-up|6|||
17050453|NCT00532935|38194181|FG000|Overall Study|Physician Decision|4|||
17050454|NCT00532935|38194182|FG001|Overall Study|Physician Decision|5|||
17050455|NCT00532935|38194181|FG000|Overall Study|Pregnancy|1|||
17050456|NCT00532935|38194182|FG001|Overall Study|Pregnancy|0|||
17050457|NCT00532935|38194181|FG000|Overall Study|Protocol Violation|4|||
17050458|NCT00532935|38194182|FG001|Overall Study|Protocol Violation|2|||
17050459|NCT00532935|38194181|FG000|Overall Study|Withdrawal by Subject|10|||
17050460|NCT00532935|38194182|FG001|Overall Study|Withdrawal by Subject|9|||
17050461|NCT00532935|38194181|FG000|Overall Study|Protocol Specific Criteria|11|||
17050462|NCT00532935|38194182|FG001|Overall Study|Protocol Specific Criteria|15|||
17050463|NCT03016312|38194190|FG000|Overall Study|Death|194|||
17050464|NCT03016312|38194191|FG001|Overall Study|Death|164|||
17050465|NCT03016312|38194190|FG000|Overall Study|Lost to Follow-up|11|||
17050466|NCT03016312|38194191|FG001|Overall Study|Lost to Follow-up|12|||
17050467|NCT03016312|38194190|FG000|Overall Study|Started new therapy, loss of contact|2|||
17050468|NCT03016312|38194191|FG001|Overall Study|Started new therapy, loss of contact|1|||
17050469|NCT03016312|38194190|FG000|Overall Study|Physician Decision|0|||
17050470|NCT03016312|38194191|FG001|Overall Study|Physician Decision|2|||
17050471|NCT03016312|38194190|FG000|Overall Study|Withdrawal by Subject|34|||
17050472|NCT03016312|38194191|FG001|Overall Study|Withdrawal by Subject|39|||
17050473|NCT00512902|38194197|FG000|Overall Study|Adverse Event|7|||
17050474|NCT00512902|38194197|FG000|Overall Study|Lost to Follow-up|1|||
17090064|NCT00280566|38230152|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
17090065|NCT00280566|38230153|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
17090066|NCT00280566|38230151|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
17090067|NCT00280566|38230152|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
17090068|NCT00280566|38230153|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
17090069|NCT00280566|38230151|FG000|Period 2 Double Blind|miscellaneous|0|||
17090070|NCT00280566|38230152|FG001|Period 2 Double Blind|miscellaneous|10|||
17090071|NCT00280566|38230153|FG002|Period 2 Double Blind|miscellaneous|5|||
17050475|NCT00492232|38194203|FG000|Placebo Run-in|Adverse Event|0|||
17142991|NCT01328002|38285998|FG001|Open-Label Period|Protocol Violation|0|||
17142992|NCT01328002|38285997|FG000|Open-Label Period|Withdrawal by Subject|9|||
17142993|NCT01328002|38285998|FG001|Open-Label Period|Withdrawal by Subject|0|||
17142994|NCT01328002|38285997|FG000|Open-Label Period|Lost to Follow-up|6|||
17050476|NCT00492232|38194204|FG001|Placebo Run-in|Adverse Event|2|||
17050477|NCT00492232|38194203|FG000|Placebo Run-in|Protocol Violation|0|||
17050478|NCT00492232|38194204|FG001|Placebo Run-in|Protocol Violation|3|||
17050479|NCT00492232|38194203|FG000|Placebo Run-in|Lost to Follow-up|0|||
17050480|NCT00492232|38194204|FG001|Placebo Run-in|Lost to Follow-up|3|||
17050481|NCT00492232|38194203|FG000|Placebo Run-in|Withdrawal by Subject|0|||
17050482|NCT00492232|38194204|FG001|Placebo Run-in|Withdrawal by Subject|8|||
17142995|NCT01328002|38285998|FG001|Open-Label Period|Lost to Follow-up|0|||
17142996|NCT01328002|38285997|FG000|Open-Label Period|Other Reason|2|||
17142997|NCT01328002|38285998|FG001|Open-Label Period|Other Reason|0|||
17142998|NCT01328002|38285997|FG000|Double-Blind Period|Adverse Event|1|||
17050483|NCT00492232|38194203|FG000|Placebo Run-in|Pregnancy|0|||
17050484|NCT00492232|38194204|FG001|Placebo Run-in|Pregnancy|1|||
17050485|NCT00492232|38194203|FG000|Placebo Run-in|Entrance criteria not met|0|||
17050486|NCT00492232|38194204|FG001|Placebo Run-in|Entrance criteria not met|45|||
17050487|NCT00492232|38194203|FG000|Placebo Run-in|Other|0|||
17050488|NCT00492232|38194204|FG001|Placebo Run-in|Other|6|||
17050489|NCT00492232|38194203|FG000|Placebo Run-in|Missing|0|||
17050490|NCT00492232|38194204|FG001|Placebo Run-in|Missing|2|||
17050491|NCT00492232|38194203|FG000|Double-Blind Treatment|Adverse Event|1|||
17050492|NCT00492232|38194204|FG001|Double-Blind Treatment|Adverse Event|2|||
17050493|NCT00492232|38194203|FG000|Double-Blind Treatment|Protocol Violation|3|||
17050494|NCT00492232|38194204|FG001|Double-Blind Treatment|Protocol Violation|7|||
17050495|NCT00492232|38194203|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
17050496|NCT00492232|38194204|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
17050497|NCT00492232|38194203|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
17050498|NCT00492232|38194204|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
17050499|NCT00492232|38194203|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
17050500|NCT00492232|38194204|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
17050501|NCT00492232|38194203|FG000|Double-Blind Treatment|Other|6|||
17050502|NCT00492232|38194204|FG001|Double-Blind Treatment|Other|5|||
17050503|NCT00492232|38194203|FG000|Double-Blind Treatment|Randomized not treated|1|||
17050504|NCT00492232|38194204|FG001|Double-Blind Treatment|Randomized not treated|0|||
17050505|NCT00492232|38194203|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
17050506|NCT00492232|38194204|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
17050507|NCT00491764|38194216|FG000|Overall Study|Adverse Event|1|||
17050508|NCT00491764|38194217|FG001|Overall Study|Adverse Event|2|||
17050509|NCT00491764|38194218|FG002|Overall Study|Adverse Event|4|||
17050510|NCT00491764|38194219|FG003|Overall Study|Adverse Event|4|||
17050511|NCT00491764|38194220|FG004|Overall Study|Adverse Event|0|||
17050512|NCT00491764|38194221|FG005|Overall Study|Adverse Event|1|||
17050513|NCT00491764|38194216|FG000|Overall Study|Lost to Follow-up|0|||
17050514|NCT00491764|38194217|FG001|Overall Study|Lost to Follow-up|1|||
17050515|NCT00491764|38194218|FG002|Overall Study|Lost to Follow-up|0|||
17050516|NCT00491764|38194219|FG003|Overall Study|Lost to Follow-up|1|||
17050517|NCT00491764|38194220|FG004|Overall Study|Lost to Follow-up|0|||
17050518|NCT00491764|38194221|FG005|Overall Study|Lost to Follow-up|3|||
17050519|NCT00491764|38194216|FG000|Overall Study|Withdrawal by Subject|2|||
17050520|NCT00491764|38194217|FG001|Overall Study|Withdrawal by Subject|3|||
17050521|NCT00491764|38194218|FG002|Overall Study|Withdrawal by Subject|1|||
17050522|NCT00491764|38194219|FG003|Overall Study|Withdrawal by Subject|2|||
17050523|NCT00491764|38194220|FG004|Overall Study|Withdrawal by Subject|2|||
17050524|NCT00491764|38194221|FG005|Overall Study|Withdrawal by Subject|4|||
17050525|NCT00491764|38194216|FG000|Overall Study|Non Compliance with the Protocol|1|||
17050526|NCT00491764|38194217|FG001|Overall Study|Non Compliance with the Protocol|0|||
17050527|NCT00491764|38194218|FG002|Overall Study|Non Compliance with the Protocol|0|||
17050528|NCT00491764|38194219|FG003|Overall Study|Non Compliance with the Protocol|0|||
17050529|NCT00491764|38194220|FG004|Overall Study|Non Compliance with the Protocol|0|||
17050530|NCT00491764|38194221|FG005|Overall Study|Non Compliance with the Protocol|0|||
17050531|NCT00491764|38194216|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
17050532|NCT00491764|38194217|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
17050533|NCT00491764|38194218|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
17050534|NCT00491764|38194219|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
17050535|NCT00491764|38194220|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
17050536|NCT00491764|38194221|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
17050537|NCT00491764|38194216|FG000|Overall Study|Administrative|1|||
17050538|NCT00491764|38194217|FG001|Overall Study|Administrative|0|||
17050539|NCT00491764|38194218|FG002|Overall Study|Administrative|2|||
17050540|NCT00491764|38194219|FG003|Overall Study|Administrative|1|||
17050541|NCT00491764|38194220|FG004|Overall Study|Administrative|0|||
17050542|NCT00491764|38194221|FG005|Overall Study|Administrative|0|||
17050543|NCT00491608|38194235|FG000|Overall Study|Death|2|||
17050544|NCT00491608|38194235|FG000|Overall Study|Withdrawal by Subject|1|||
17050545|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
17050546|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
17050547|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
17050548|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
17050549|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
17050550|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
17050551|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
17050552|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
17050553|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
17142999|NCT01328002|38285998|FG001|Double-Blind Period|Adverse Event|0|||
17143000|NCT01328002|38285997|FG000|Double-Blind Period|Lack of Efficacy|1|||
17143001|NCT01328002|38285998|FG001|Double-Blind Period|Lack of Efficacy|0|||
17143002|NCT02579265|38286007|FG000|Overall Study|Weaned off earlier than 28 days|44|||
17143003|NCT02579265|38286008|FG001|Overall Study|Weaned off earlier than 28 days|43|||
17143004|NCT02579265|38286007|FG000|Overall Study|Adverse Event|2|||
17143005|NCT02579265|38286008|FG001|Overall Study|Adverse Event|0|||
17143006|NCT02579265|38286007|FG000|Overall Study|Any other reason not specified|0|||
17143007|NCT02579265|38286008|FG001|Overall Study|Any other reason not specified|2|||
17143008|NCT02579265|38286007|FG000|Overall Study|Withdrawal by Subject|2|||
17143009|NCT02579265|38286008|FG001|Overall Study|Withdrawal by Subject|0|||
17143010|NCT02579265|38286007|FG000|Overall Study|Physician Decision|1|||
17143011|NCT02579265|38286008|FG001|Overall Study|Physician Decision|0|||
17143012|NCT02579265|38286007|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
17143013|NCT02579265|38286008|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
17143014|NCT03289533|38286014|FG000|Overall Study|Death|12|||
17143015|NCT03289533|38286014|FG000|Overall Study|Terminated from study by sponsor|10|||
17143016|NCT04727749|38286020|FG000|Overall Study|Lost to Follow-up|10|||
17143017|NCT04727749|38286021|FG001|Overall Study|Lost to Follow-up|3|||
17143018|NCT04547023|38286031|FG000|Overall Study|Did Not Receive Intervention|3|||
17143019|NCT04547023|38286032|FG001|Overall Study|Did Not Receive Intervention|2|||
17143020|NCT04547023|38286031|FG000|Overall Study|Lost to Follow-up|1|||
17143021|NCT04547023|38286032|FG001|Overall Study|Lost to Follow-up|1|||
17143022|NCT03697993|38286042|FG000|Overall Study|Became Ineligible after Enrollment|1|||
17143023|NCT03697993|38286043|FG001|Overall Study|Became Ineligible after Enrollment|3|||
17143024|NCT03697993|38286042|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
17143025|NCT03697993|38286043|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
17143026|NCT03697993|38286042|FG000|Overall Study|Lost to Follow-up|3|||
17143027|NCT03697993|38286043|FG001|Overall Study|Lost to Follow-up|0|||
17143028|NCT03697993|38286042|FG000|Overall Study|Physician Decision|4|||
17143029|NCT03697993|38286043|FG001|Overall Study|Physician Decision|0|||
17050554|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
17050555|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
17050556|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
17050557|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
17050558|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
17050559|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
17050560|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
17050561|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
17050562|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
17050563|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
17050564|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
17050565|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
17050566|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
17050567|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
17050568|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
17050569|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
17050570|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
17050571|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
17050572|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
17050573|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
17050574|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
17050575|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Other|10|||
17050576|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Other|7|||
17050577|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Other|8|||
17050578|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Other|8|||
17050579|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Other|0|||
17050580|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
17050581|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
16780947|NCT02151682|37720063|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
17050582|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
17050583|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
17050584|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
17050585|NCT00615836|38194243|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
17050586|NCT00615836|38194244|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
17050587|NCT00615836|38194245|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
17050588|NCT00615836|38194246|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
17050589|NCT00615836|38194247|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
17050590|NCT00491530|38194266|FG000|Overall Study|Adverse Event|6|||
17050591|NCT00491530|38194267|FG001|Overall Study|Adverse Event|1|||
17050592|NCT00491530|38194268|FG002|Overall Study|Adverse Event|2|||
17050593|NCT00491530|38194266|FG000|Overall Study|Withdrawal by Subject|3|||
17050594|NCT00491530|38194267|FG001|Overall Study|Withdrawal by Subject|0|||
17050595|NCT00491530|38194268|FG002|Overall Study|Withdrawal by Subject|0|||
17050596|NCT00491530|38194266|FG000|Overall Study|Lost to Follow-up|3|||
17050597|NCT00491530|38194267|FG001|Overall Study|Lost to Follow-up|2|||
17050598|NCT00491530|38194268|FG002|Overall Study|Lost to Follow-up|2|||
17050599|NCT00491530|38194266|FG000|Overall Study|Lack of Efficacy|0|||
17050600|NCT00491530|38194267|FG001|Overall Study|Lack of Efficacy|1|||
17050601|NCT00491530|38194268|FG002|Overall Study|Lack of Efficacy|0|||
17050602|NCT00491530|38194266|FG000|Overall Study|Investigator Discretion|0|||
17050603|NCT00491530|38194267|FG001|Overall Study|Investigator Discretion|1|||
17050604|NCT00491530|38194268|FG002|Overall Study|Investigator Discretion|0|||
17050605|NCT00491530|38194266|FG000|Overall Study|Patient Request|0|||
17050606|NCT00491530|38194267|FG001|Overall Study|Patient Request|1|||
17050607|NCT00491530|38194268|FG002|Overall Study|Patient Request|0|||
17050608|NCT00491530|38194266|FG000|Overall Study|Use of Prohibited Medication|0|||
17050609|NCT00491530|38194267|FG001|Overall Study|Use of Prohibited Medication|0|||
17050610|NCT00491530|38194268|FG002|Overall Study|Use of Prohibited Medication|1|||
17050611|NCT00617240|38194278|FG000|Overall Study|Lack of Efficacy|1|||
17050612|NCT00617240|38194279|FG001|Overall Study|Lack of Efficacy|0|||
17050613|NCT00615290|38194285|FG000|Overall Study|Adverse Event|2|||
17050614|NCT00615290|38194285|FG000|Overall Study|Lost to Follow-up|3|||
17050615|NCT00615290|38194285|FG000|Overall Study|Withdrawal by Subject|1|||
17050616|NCT00615290|38194285|FG000|Overall Study|Other|2|||
17050617|NCT00501046|38194291|FG000|Overall Study|Adverse Event|21|||
17050618|NCT00501046|38194292|FG001|Overall Study|Adverse Event|25|||
17050619|NCT00501046|38194291|FG000|Overall Study|Death|23|||
17050620|NCT00501046|38194292|FG001|Overall Study|Death|30|||
17050621|NCT00501046|38194291|FG000|Overall Study|Lost to Follow-up|14|||
17050622|NCT00501046|38194292|FG001|Overall Study|Lost to Follow-up|13|||
17050623|NCT00501046|38194291|FG000|Overall Study|Physician Decision|7|||
17050624|NCT00501046|38194292|FG001|Overall Study|Physician Decision|2|||
17050625|NCT00501046|38194291|FG000|Overall Study|Pregnancy|0|||
17050626|NCT00501046|38194292|FG001|Overall Study|Pregnancy|3|||
17050627|NCT00501046|38194291|FG000|Overall Study|Protocol Violation|2|||
17050628|NCT00501046|38194292|FG001|Overall Study|Protocol Violation|1|||
17050629|NCT00501046|38194291|FG000|Overall Study|Withdrawal by Subject|84|||
17050630|NCT00501046|38194292|FG001|Overall Study|Withdrawal by Subject|83|||
17050631|NCT00501046|38194291|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
17050632|NCT00501046|38194292|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
17050633|NCT00533949|38194302|FG000|Overall Study|Protocol Violation|12|||
17050634|NCT00533949|38194303|FG001|Overall Study|Protocol Violation|12|||
17050635|NCT00533949|38194304|FG002|Overall Study|Protocol Violation|9|||
17050636|NCT00533949|38194305|FG003|Overall Study|Protocol Violation|9|||
17050637|NCT00533949|38194302|FG000|Overall Study|Withdrawal by Subject|3|||
17143030|NCT03697993|38286042|FG000|Overall Study|Initial Urine Culture Negative|0|||
17143031|NCT03697993|38286043|FG001|Overall Study|Initial Urine Culture Negative|1|||
17143032|NCT03289455|38286053|FG000|Overall Study|Death|1|||
17143033|NCT03289455|38286054|FG001|Overall Study|Death|0|||
17143034|NCT03289455|38286055|FG002|Overall Study|Death|0|||
17143035|NCT03289455|38286053|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
17050638|NCT00533949|38194303|FG001|Overall Study|Withdrawal by Subject|2|||
17050639|NCT00533949|38194304|FG002|Overall Study|Withdrawal by Subject|1|||
17050640|NCT00533949|38194305|FG003|Overall Study|Withdrawal by Subject|1|||
17050641|NCT00485134|38194331|FG000|Overall Study|Lost to Follow-up|1|||
17050642|NCT00485134|38194332|FG001|Overall Study|Lost to Follow-up|0|||
17050643|NCT00485134|38194333|FG002|Overall Study|Lost to Follow-up|0|||
17050644|NCT00485134|38194334|FG003|Overall Study|Lost to Follow-up|0|||
17050645|NCT00485134|38194335|FG004|Overall Study|Lost to Follow-up|0|||
17050646|NCT00485134|38194336|FG005|Overall Study|Lost to Follow-up|0|||
17050647|NCT00485134|38194337|FG006|Overall Study|Lost to Follow-up|0|||
17050648|NCT00485134|38194338|FG007|Overall Study|Lost to Follow-up|0|||
17050649|NCT00485134|38194331|FG000|Overall Study|Withdrawal by Subject|0|||
17050650|NCT00485134|38194332|FG001|Overall Study|Withdrawal by Subject|1|||
17050651|NCT00485134|38194333|FG002|Overall Study|Withdrawal by Subject|0|||
17050652|NCT00485134|38194334|FG003|Overall Study|Withdrawal by Subject|0|||
17050653|NCT00485134|38194335|FG004|Overall Study|Withdrawal by Subject|0|||
17050654|NCT00485134|38194336|FG005|Overall Study|Withdrawal by Subject|0|||
17050655|NCT00485134|38194337|FG006|Overall Study|Withdrawal by Subject|0|||
17050656|NCT00485134|38194338|FG007|Overall Study|Withdrawal by Subject|0|||
17050657|NCT00485134|38194331|FG000|Overall Study|Change in health status|0|||
17050658|NCT00485134|38194332|FG001|Overall Study|Change in health status|1|||
17050659|NCT00485134|38194333|FG002|Overall Study|Change in health status|2|||
17050660|NCT00485134|38194334|FG003|Overall Study|Change in health status|1|||
17050661|NCT00485134|38194335|FG004|Overall Study|Change in health status|0|||
17050662|NCT00485134|38194336|FG005|Overall Study|Change in health status|1|||
17050663|NCT00485134|38194337|FG006|Overall Study|Change in health status|0|||
17143036|NCT03289455|38286054|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
17143037|NCT03289455|38286055|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
17050664|NCT00485134|38194338|FG007|Overall Study|Change in health status|0|||
17050665|NCT00485134|38194331|FG000|Overall Study|Withdrew for adverse event|0|||
17050666|NCT00485134|38194332|FG001|Overall Study|Withdrew for adverse event|0|||
17050667|NCT00485134|38194333|FG002|Overall Study|Withdrew for adverse event|1|||
17143038|NCT03289455|38286053|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
17143039|NCT03289455|38286054|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
17143040|NCT03289455|38286055|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
17050668|NCT00485134|38194334|FG003|Overall Study|Withdrew for adverse event|0|||
17050669|NCT00485134|38194335|FG004|Overall Study|Withdrew for adverse event|0|||
17050670|NCT00485134|38194336|FG005|Overall Study|Withdrew for adverse event|0|||
17050671|NCT00485134|38194337|FG006|Overall Study|Withdrew for adverse event|0|||
17050672|NCT00485134|38194338|FG007|Overall Study|Withdrew for adverse event|0|||
17050673|NCT00485134|38194331|FG000|Overall Study|Positive drug test|0|||
17050674|NCT00485134|38194332|FG001|Overall Study|Positive drug test|0|||
17050675|NCT00485134|38194333|FG002|Overall Study|Positive drug test|0|||
17050676|NCT00485134|38194334|FG003|Overall Study|Positive drug test|0|||
17050677|NCT00485134|38194335|FG004|Overall Study|Positive drug test|2|||
17050678|NCT00485134|38194336|FG005|Overall Study|Positive drug test|1|||
17050679|NCT00485134|38194337|FG006|Overall Study|Positive drug test|0|||
17050680|NCT00485134|38194338|FG007|Overall Study|Positive drug test|0|||
17050681|NCT00485134|38194331|FG000|Overall Study|Non-compliance|0|||
17050682|NCT00485134|38194332|FG001|Overall Study|Non-compliance|0|||
17050683|NCT00485134|38194333|FG002|Overall Study|Non-compliance|0|||
17050684|NCT00485134|38194334|FG003|Overall Study|Non-compliance|0|||
17050685|NCT00485134|38194335|FG004|Overall Study|Non-compliance|1|||
17050686|NCT00485134|38194336|FG005|Overall Study|Non-compliance|2|||
17050687|NCT00485134|38194337|FG006|Overall Study|Non-compliance|2|||
17050688|NCT00485134|38194338|FG007|Overall Study|Non-compliance|0|||
17050689|NCT00485134|38194331|FG000|Overall Study|Unable to comply with study schedule|0|||
17050690|NCT00485134|38194332|FG001|Overall Study|Unable to comply with study schedule|0|||
17050691|NCT00485134|38194333|FG002|Overall Study|Unable to comply with study schedule|0|||
17050692|NCT00485134|38194334|FG003|Overall Study|Unable to comply with study schedule|0|||
17050693|NCT00485134|38194335|FG004|Overall Study|Unable to comply with study schedule|0|||
17050694|NCT00485134|38194336|FG005|Overall Study|Unable to comply with study schedule|0|||
17050695|NCT00485134|38194337|FG006|Overall Study|Unable to comply with study schedule|0|||
17050696|NCT00485134|38194338|FG007|Overall Study|Unable to comply with study schedule|1|||
17050697|NCT00485134|38194331|FG000|Overall Study|Pregnancy|0|||
17050698|NCT00485134|38194332|FG001|Overall Study|Pregnancy|0|||
17050699|NCT00485134|38194333|FG002|Overall Study|Pregnancy|0|||
17050700|NCT00485134|38194334|FG003|Overall Study|Pregnancy|0|||
17050701|NCT00485134|38194335|FG004|Overall Study|Pregnancy|0|||
17050702|NCT00485134|38194336|FG005|Overall Study|Pregnancy|0|||
17050703|NCT00485134|38194337|FG006|Overall Study|Pregnancy|1|||
17050704|NCT00485134|38194338|FG007|Overall Study|Pregnancy|0|||
17050705|NCT03890367|38194353|FG000|Overall Study|Withdrawal by parent/guardian|1|||
17050706|NCT03890367|38194354|FG001|Overall Study|Withdrawal by parent/guardian|3|||
17050707|NCT03890367|38194355|FG002|Overall Study|Withdrawal by parent/guardian|0|||
17050708|NCT03890367|38194353|FG000|Overall Study|Protocol deviation|2|||
17050709|NCT03890367|38194354|FG001|Overall Study|Protocol deviation|2|||
17050710|NCT03890367|38194355|FG002|Overall Study|Protocol deviation|1|||
17050711|NCT03890367|38194353|FG000|Overall Study|Lost to Follow-up|1|||
17050712|NCT03890367|38194354|FG001|Overall Study|Lost to Follow-up|1|||
17050713|NCT03890367|38194355|FG002|Overall Study|Lost to Follow-up|0|||
17050714|NCT00583115|38194363|FG000|Overall Study|Death|1|||
17050715|NCT00532779|38194370|FG000|Overall Study|Adverse Event|122|||
17050716|NCT00532779|38194371|FG001|Overall Study|Adverse Event|112|||
17050717|NCT00532779|38194372|FG002|Overall Study|Adverse Event|56|||
17050718|NCT00532779|38194370|FG000|Overall Study|Lost to Follow-up|76|||
17050719|NCT00532779|38194371|FG001|Overall Study|Lost to Follow-up|65|||
17050720|NCT00532779|38194372|FG002|Overall Study|Lost to Follow-up|66|||
17050721|NCT00532779|38194370|FG000|Overall Study|Withdrawal by Subject|63|||
17050722|NCT00532779|38194371|FG001|Overall Study|Withdrawal by Subject|60|||
17050723|NCT00532779|38194372|FG002|Overall Study|Withdrawal by Subject|90|||
17050724|NCT00532779|38194370|FG000|Overall Study|Lack of Efficacy|12|||
17050725|NCT00532779|38194371|FG001|Overall Study|Lack of Efficacy|12|||
17050726|NCT00532779|38194372|FG002|Overall Study|Lack of Efficacy|40|||
17050727|NCT00532779|38194370|FG000|Overall Study|Protocol Violation|5|||
17050728|NCT00532779|38194371|FG001|Overall Study|Protocol Violation|9|||
17050729|NCT00532779|38194372|FG002|Overall Study|Protocol Violation|7|||
17050730|NCT00532779|38194370|FG000|Overall Study|Pregnancy|2|||
17050731|NCT00532779|38194371|FG001|Overall Study|Pregnancy|5|||
17050732|NCT00532779|38194372|FG002|Overall Study|Pregnancy|3|||
17050733|NCT00532779|38194370|FG000|Overall Study|Death|0|||
17050734|NCT00532779|38194371|FG001|Overall Study|Death|1|||
17050735|NCT00532779|38194372|FG002|Overall Study|Death|0|||
17050736|NCT00532779|38194370|FG000|Overall Study|Drug noncompliance, moved, other|14|||
17050737|NCT00532779|38194371|FG001|Overall Study|Drug noncompliance, moved, other|23|||
17050738|NCT00532779|38194372|FG002|Overall Study|Drug noncompliance, moved, other|29|||
17050739|NCT00500266|38194380|FG000|Overall Study|Death|3|||
17050740|NCT00500266|38194380|FG000|Overall Study|Lost to Follow-up|3|||
17050741|NCT00500266|38194380|FG000|Overall Study|Withdrawal by Subject|3|||
17050742|NCT00500266|38194380|FG000|Overall Study|Assigned, not treated|4|||
17050743|NCT00500110|38194385|FG000|Overall Study|Withdrawal by Subject|3|||
17050744|NCT00534495|38194391|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
17050745|NCT00534495|38194392|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
17050746|NCT00534495|38194393|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
17050747|NCT00534495|38194391|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
17050748|NCT00534495|38194392|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
17050749|NCT00534495|38194393|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
17050750|NCT00534495|38194391|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
17050751|NCT00534495|38194392|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
17050752|NCT00534495|38194393|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
17050753|NCT00534495|38194391|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
17050754|NCT00534495|38194392|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
17050755|NCT00534495|38194393|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
17050756|NCT00534495|38194391|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
17050757|NCT00534495|38194392|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
17050758|NCT00534495|38194393|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
17050759|NCT00534495|38194391|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
17050760|NCT00534495|38194392|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
17050761|NCT00534495|38194393|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
17050762|NCT00534495|38194391|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
17050763|NCT00534495|38194392|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
17050764|NCT00534495|38194393|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
17050765|NCT00534495|38194391|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
17050766|NCT00534495|38194392|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
17050767|NCT00534495|38194393|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
17050768|NCT00534495|38194391|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
17050769|NCT00534495|38194392|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
17050770|NCT00534495|38194393|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
17050771|NCT00484198|38194417|FG000|Overall Study|Participant Withdrew Consent|12|||
17050772|NCT00484198|38194418|FG001|Overall Study|Participant Withdrew Consent|21|||
17050773|NCT00484198|38194419|FG002|Overall Study|Participant Withdrew Consent|47|||
17050774|NCT00484198|38194420|FG003|Overall Study|Participant Withdrew Consent|59|||
17050775|NCT00484198|38194417|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
17050776|NCT00484198|38194418|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
17050777|NCT00484198|38194419|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
17050778|NCT00484198|38194420|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
17050779|NCT00484198|38194417|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
17050780|NCT00484198|38194418|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
17050781|NCT00484198|38194419|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
17050782|NCT00484198|38194420|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
17050783|NCT00484198|38194417|FG000|Overall Study|Adverse Event|3|||
17050784|NCT00484198|38194418|FG001|Overall Study|Adverse Event|11|||
17050785|NCT00484198|38194419|FG002|Overall Study|Adverse Event|32|||
17050786|NCT00484198|38194420|FG003|Overall Study|Adverse Event|31|||
17050787|NCT00484198|38194417|FG000|Overall Study|Protocol Violation|0|||
17050788|NCT00484198|38194418|FG001|Overall Study|Protocol Violation|5|||
17143041|NCT03289455|38286053|FG000|Overall Study|Progressive disease|3|||
17143042|NCT03289455|38286054|FG001|Overall Study|Progressive disease|4|||
17143043|NCT03289455|38286055|FG002|Overall Study|Progressive disease|5|||
17143044|NCT04484857|38286064|FG000|Overall Study|Adverse Event|2|||
17143045|NCT04484857|38286064|FG000|Overall Study|Death|10|||
17143046|NCT04484857|38286064|FG000|Overall Study|Withdrawal by Subject|3|||
17143047|NCT04484857|38286064|FG000|Overall Study|Transferred/Relocation|5|||
17143048|NCT04484857|38286064|FG000|Overall Study|Kidney Transplant|7|||
17143049|NCT04484857|38286064|FG000|Overall Study|Other than specified|4|||
17143050|NCT04484857|38286064|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
17143051|NCT04095793|38286068|FG000|Overall Study|Adverse Event|3|||
17143052|NCT04095793|38286068|FG000|Overall Study|Study Terminated by Sponsor|103|||
17143053|NCT04095793|38286068|FG000|Overall Study|Withdrawal by Subject|4|||
17143054|NCT04482439|38286072|FG000|Overall Study|Lost to Follow-up|1|||
17143055|NCT04482439|38286072|FG000|Overall Study|Unrelated illness|1|||
17143056|NCT04535947|38286079|FG000|Overall Study|Adverse Event|1|||
17143057|NCT04535947|38286080|FG001|Overall Study|Adverse Event|4|||
17143058|NCT04535947|38286079|FG000|Overall Study|Other reasons not specified|2|||
17050789|NCT00484198|38194419|FG002|Overall Study|Protocol Violation|6|||
17050790|NCT00484198|38194420|FG003|Overall Study|Protocol Violation|8|||
17050791|NCT00484198|38194417|FG000|Overall Study|Other|7|||
17050792|NCT00484198|38194418|FG001|Overall Study|Other|10|||
17050793|NCT00484198|38194419|FG002|Overall Study|Other|31|||
17050794|NCT00484198|38194420|FG003|Overall Study|Other|28|||
17050795|NCT00499486|38194435|FG000|Overall Study|Withdrawal by Subject|16|||
17050796|NCT00499252|38194439|FG000|Overall Study|Adverse Event|3|||
17050797|NCT00499252|38194439|FG000|Overall Study|Refused further treatment|2|||
17050798|NCT00499252|38194439|FG000|Overall Study|Ineligible|4|||
17050799|NCT00499252|38194439|FG000|Overall Study|<no further label>|3|||
17050800|NCT00499174|38194449|FG000|Overall Study|Physician Decision|78|||
17050801|NCT00499174|38194450|FG001|Overall Study|Physician Decision|9|||
17050802|NCT03775421|38194458|FG000|Overall Study|Lost to Follow-up|2|||
17050803|NCT03775421|38194458|FG000|Overall Study|Withdrawal by Subject|10|||
17050804|NCT03775421|38194458|FG000|Overall Study|Physician Decision|3|||
17050805|NCT03775421|38194458|FG000|Overall Study|Death|1|||
17050806|NCT03775421|38194458|FG000|Overall Study|Study Terminated by Sponsor|94|||
17050807|NCT00532155|38194464|FG000|Overall Study|Adverse Event|66|||
17050808|NCT00532155|38194465|FG001|Overall Study|Adverse Event|123|||
17050809|NCT00532155|38194464|FG000|Overall Study|Lack of Efficacy|332|||
17050810|NCT00532155|38194465|FG001|Overall Study|Lack of Efficacy|255|||
17050811|NCT00532155|38194464|FG000|Overall Study|Protocol Violation|1|||
17050812|NCT00532155|38194465|FG001|Overall Study|Protocol Violation|3|||
17050813|NCT00532155|38194464|FG000|Overall Study|Lost to Follow-up|2|||
17050814|NCT00532155|38194465|FG001|Overall Study|Lost to Follow-up|0|||
17050815|NCT00532155|38194464|FG000|Overall Study|Physician Decision|16|||
17050816|NCT00532155|38194465|FG001|Overall Study|Physician Decision|15|||
17050817|NCT00532155|38194464|FG000|Overall Study|Withdrawal by Subject|23|||
17050818|NCT00532155|38194465|FG001|Overall Study|Withdrawal by Subject|44|||
17050819|NCT00532155|38194464|FG000|Overall Study|Consent withdrawn|5|||
17050820|NCT00532155|38194465|FG001|Overall Study|Consent withdrawn|7|||
17050821|NCT00532155|38194464|FG000|Overall Study|Moved|1|||
17050822|NCT00532155|38194465|FG001|Overall Study|Moved|0|||
17050823|NCT00532155|38194464|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
17050824|NCT00532155|38194465|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
17050825|NCT00532155|38194464|FG000|Overall Study|Occurence of a second cancer|0|||
17050826|NCT00532155|38194465|FG001|Overall Study|Occurence of a second cancer|1|||
17050827|NCT00532155|38194464|FG000|Overall Study|Occurence of a secondary cancer|0|||
17050828|NCT00532155|38194465|FG001|Overall Study|Occurence of a secondary cancer|1|||
17050829|NCT00532155|38194464|FG000|Overall Study|Promotor ended study|1|||
17050830|NCT00532155|38194465|FG001|Overall Study|Promotor ended study|0|||
17050831|NCT00532155|38194464|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
17050832|NCT00532155|38194465|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
17050833|NCT00532155|38194464|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
17050834|NCT00532155|38194465|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
17050835|NCT00532155|38194464|FG000|Overall Study|Study stopped|1|||
17050836|NCT00532155|38194465|FG001|Overall Study|Study stopped|0|||
17143059|NCT04535947|38286080|FG001|Overall Study|Other reasons not specified|0|||
17050837|NCT00532155|38194464|FG000|Overall Study|Study terminated by sponsor|1|||
17050838|NCT00532155|38194465|FG001|Overall Study|Study terminated by sponsor|0|||
17050839|NCT00532155|38194464|FG000|Overall Study|Study termination stop further treatment|4|||
17050840|NCT00532155|38194465|FG001|Overall Study|Study termination stop further treatment|0|||
17050841|NCT00532155|38194464|FG000|Overall Study|Did not receive study medication|2|||
17050842|NCT00532155|38194465|FG001|Overall Study|Did not receive study medication|6|||
17050843|NCT00205777|38194475|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
17050844|NCT00205777|38194476|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
17050845|NCT00205777|38194477|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
17050846|NCT00205777|38194478|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
17050847|NCT00205777|38194479|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
17050848|NCT00205777|38194480|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
17050849|NCT00205777|38194475|FG000|Core Study (Up to 3 Years)|Death|9|||
17050850|NCT00205777|38194476|FG001|Core Study (Up to 3 Years)|Death|7|||
17050851|NCT00205777|38194477|FG002|Core Study (Up to 3 Years)|Death|14|||
17050852|NCT00205777|38194478|FG003|Core Study (Up to 3 Years)|Death|7|||
17050853|NCT00205777|38194479|FG004|Core Study (Up to 3 Years)|Death|0|||
17050854|NCT00205777|38194480|FG005|Core Study (Up to 3 Years)|Death|0|||
17050855|NCT00205777|38194475|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
17050856|NCT00205777|38194476|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
17050857|NCT00205777|38194477|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
17050858|NCT00205777|38194478|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
17050859|NCT00205777|38194479|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
17050860|NCT00205777|38194480|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
17050861|NCT00205777|38194475|FG000|Core Study (Up to 3 Years)|Other Event|49|||
17050862|NCT00205777|38194476|FG001|Core Study (Up to 3 Years)|Other Event|52|||
17050863|NCT00205777|38194477|FG002|Core Study (Up to 3 Years)|Other Event|41|||
17050864|NCT00205777|38194478|FG003|Core Study (Up to 3 Years)|Other Event|58|||
17050865|NCT00205777|38194479|FG004|Core Study (Up to 3 Years)|Other Event|0|||
17050866|NCT00205777|38194480|FG005|Core Study (Up to 3 Years)|Other Event|0|||
17050867|NCT00205777|38194475|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
17050868|NCT00205777|38194476|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
17050869|NCT00205777|38194477|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
17050870|NCT00205777|38194478|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
17143060|NCT04535947|38286079|FG000|Overall Study|Withdrawal by Subject|1|||
17143061|NCT04535947|38286080|FG001|Overall Study|Withdrawal by Subject|1|||
17143062|NCT04474405|38286092|FG000|Overall Study|Withdrawal by Subject|0|||
17143063|NCT04474405|38286093|FG001|Overall Study|Withdrawal by Subject|0|||
17143064|NCT04474405|38286094|FG002|Overall Study|Withdrawal by Subject|1|||
17143065|NCT04474405|38286095|FG003|Overall Study|Withdrawal by Subject|0|||
17143066|NCT04474405|38286096|FG004|Overall Study|Withdrawal by Subject|1|||
17143067|NCT04474405|38286097|FG005|Overall Study|Withdrawal by Subject|0|||
17143068|NCT04474405|38286092|FG000|Overall Study|Other|0|||
17143069|NCT04474405|38286093|FG001|Overall Study|Other|0|||
17143070|NCT04474405|38286094|FG002|Overall Study|Other|0|||
17143071|NCT04474405|38286095|FG003|Overall Study|Other|0|||
17143072|NCT04474405|38286096|FG004|Overall Study|Other|3|||
17143073|NCT04474405|38286097|FG005|Overall Study|Other|0|||
17143074|NCT04531813|38286111|FG000|Overall Study|Protocol Violation|1|||
16780948|NCT02151682|37720064|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16992608|NCT01030874|38136628|FG000|Overall Study|Discharged in first 2 weeks|17|||
16992609|NCT01030874|38136629|FG001|Overall Study|Discharged in first 2 weeks|16|||
16992610|NCT03611751|38136638|FG000|Pre-treatment|Randomized but not treated|1|||
16992611|NCT03611751|38136639|FG001|Pre-treatment|Randomized but not treated|1|||
16992612|NCT03611751|38136640|FG002|Pre-treatment|Randomized but not treated|0|||
16992613|NCT03611751|38136638|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
16992614|NCT03611751|38136639|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
16992615|NCT03611751|38136640|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
17050871|NCT00205777|38194479|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
17050872|NCT00205777|38194480|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
17050873|NCT00205777|38194475|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
17050874|NCT00205777|38194476|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
17050875|NCT00205777|38194477|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
17050876|NCT00205777|38194478|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
17050877|NCT00205777|38194479|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
17050878|NCT00205777|38194480|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
17050879|NCT00205777|38194475|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
17050880|NCT00205777|38194476|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
17050881|NCT00205777|38194477|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
17050882|NCT00205777|38194478|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
17050883|NCT00205777|38194479|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
17050884|NCT00205777|38194480|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
17050885|NCT00205777|38194475|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
17050886|NCT00205777|38194476|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
17050887|NCT00205777|38194477|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
17050888|NCT00205777|38194478|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
17050889|NCT00205777|38194479|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
17050890|NCT00205777|38194480|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
17050891|NCT00205777|38194475|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
17050892|NCT00205777|38194476|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
17050893|NCT00205777|38194477|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
17050894|NCT00205777|38194478|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
17050895|NCT00205777|38194479|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
17050896|NCT00205777|38194480|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
17050897|NCT00205777|38194475|FG000|Completed Core Study, Entered SE I|Other Event|52|||
17050898|NCT00205777|38194476|FG001|Completed Core Study, Entered SE I|Other Event|46|||
17050899|NCT00205777|38194477|FG002|Completed Core Study, Entered SE I|Other Event|47|||
17050900|NCT00205777|38194478|FG003|Completed Core Study, Entered SE I|Other Event|50|||
17050901|NCT00205777|38194479|FG004|Completed Core Study, Entered SE I|Other Event|0|||
17050902|NCT00205777|38194480|FG005|Completed Core Study, Entered SE I|Other Event|0|||
17050903|NCT00205777|38194475|FG000|Study Extension I|Adverse Event|57|||
17050904|NCT00205777|38194476|FG001|Study Extension I|Adverse Event|0|||
17050905|NCT00205777|38194477|FG002|Study Extension I|Adverse Event|0|||
17050906|NCT00205777|38194478|FG003|Study Extension I|Adverse Event|61|||
17050907|NCT00205777|38194479|FG004|Study Extension I|Adverse Event|58|||
17050908|NCT00205777|38194480|FG005|Study Extension I|Adverse Event|0|||
17050909|NCT00205777|38194475|FG000|Study Extension I|Death|5|||
17050910|NCT00205777|38194476|FG001|Study Extension I|Death|0|||
17050911|NCT00205777|38194477|FG002|Study Extension I|Death|0|||
17050912|NCT00205777|38194478|FG003|Study Extension I|Death|1|||
17050913|NCT00205777|38194479|FG004|Study Extension I|Death|2|||
16992616|NCT03611751|38136638|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
16992617|NCT03611751|38136639|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
16992618|NCT03611751|38136640|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
16992619|NCT03611751|38136638|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
16992620|NCT03611751|38136639|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
16992621|NCT03611751|38136640|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
16992622|NCT03611751|38136638|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
16992623|NCT03611751|38136639|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
16992624|NCT03611751|38136640|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
16992625|NCT03611751|38136638|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
16992626|NCT03611751|38136639|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
16992627|NCT03611751|38136640|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
16992628|NCT03611751|38136638|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
16992629|NCT03611751|38136639|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
16992630|NCT03611751|38136640|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
16992631|NCT03611751|38136638|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
16992632|NCT03611751|38136639|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
16992633|NCT03611751|38136640|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
16992634|NCT03611751|38136638|FG000|Treatment Week 0 - Week 16|Death|0|||
16992635|NCT03611751|38136639|FG001|Treatment Week 0 - Week 16|Death|0|||
16992636|NCT03611751|38136640|FG002|Treatment Week 0 - Week 16|Death|1|||
16992637|NCT03611751|38136638|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
16992638|NCT03611751|38136639|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
16992639|NCT03611751|38136640|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
16992640|NCT03611751|38136638|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
16992641|NCT03611751|38136639|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
17050914|NCT00205777|38194480|FG005|Study Extension I|Death|0|||
17050915|NCT00205777|38194475|FG000|Study Extension I|Withdrawal by Subject|99|||
17050916|NCT00205777|38194476|FG001|Study Extension I|Withdrawal by Subject|0|||
17143075|NCT04531813|38286111|FG000|Overall Study|Withdrawal by Subject|1|||
17143076|NCT03538444|38286117|FG000|Overall Study|opioid withdrawal|1|||
17143077|NCT03538444|38286118|FG001|Overall Study|opioid withdrawal|0|||
17143078|NCT01199302|38286128|FG000|Overall Study|Adverse Event|1|||
17143079|NCT01199302|38286129|FG001|Overall Study|Adverse Event|1|||
17143080|NCT01199302|38286130|FG002|Overall Study|Adverse Event|2|||
17143081|NCT01199302|38286131|FG003|Overall Study|Adverse Event|0|||
17143082|NCT01199302|38286128|FG000|Overall Study|Withdrawal by Subject|2|||
17143083|NCT01199302|38286129|FG001|Overall Study|Withdrawal by Subject|2|||
17143084|NCT01199302|38286130|FG002|Overall Study|Withdrawal by Subject|3|||
17143085|NCT01199302|38286131|FG003|Overall Study|Withdrawal by Subject|0|||
17143086|NCT01199302|38286128|FG000|Overall Study|Disease Progression|3|||
17143087|NCT01199302|38286129|FG001|Overall Study|Disease Progression|4|||
17143088|NCT01199302|38286130|FG002|Overall Study|Disease Progression|4|||
17143089|NCT01199302|38286131|FG003|Overall Study|Disease Progression|2|||
17050917|NCT00205777|38194477|FG002|Study Extension I|Withdrawal by Subject|0|||
17050918|NCT00205777|38194478|FG003|Study Extension I|Withdrawal by Subject|106|||
17050919|NCT00205777|38194479|FG004|Study Extension I|Withdrawal by Subject|89|||
17050920|NCT00205777|38194480|FG005|Study Extension I|Withdrawal by Subject|0|||
17050921|NCT00205777|38194475|FG000|Study Extension I|Protocol Violation|4|||
17050922|NCT00205777|38194476|FG001|Study Extension I|Protocol Violation|0|||
17050923|NCT00205777|38194477|FG002|Study Extension I|Protocol Violation|0|||
17050924|NCT00205777|38194478|FG003|Study Extension I|Protocol Violation|8|||
17050925|NCT00205777|38194479|FG004|Study Extension I|Protocol Violation|8|||
17050926|NCT00205777|38194480|FG005|Study Extension I|Protocol Violation|0|||
17050927|NCT00205777|38194475|FG000|Study Extension I|Lack of Efficacy|0|||
17050928|NCT00205777|38194476|FG001|Study Extension I|Lack of Efficacy|0|||
17050929|NCT00205777|38194477|FG002|Study Extension I|Lack of Efficacy|0|||
17050930|NCT00205777|38194478|FG003|Study Extension I|Lack of Efficacy|1|||
17050931|NCT00205777|38194479|FG004|Study Extension I|Lack of Efficacy|2|||
17050932|NCT00205777|38194480|FG005|Study Extension I|Lack of Efficacy|0|||
17050933|NCT00205777|38194475|FG000|Study Extension I|Failed to return|15|||
17050934|NCT00205777|38194476|FG001|Study Extension I|Failed to return|0|||
17050935|NCT00205777|38194477|FG002|Study Extension I|Failed to return|0|||
17050936|NCT00205777|38194478|FG003|Study Extension I|Failed to return|17|||
17050937|NCT00205777|38194479|FG004|Study Extension I|Failed to return|13|||
17143090|NCT01199302|38286128|FG000|Overall Study|Study Termination|13|||
17143091|NCT01199302|38286129|FG001|Overall Study|Study Termination|8|||
17143092|NCT01199302|38286130|FG002|Overall Study|Study Termination|11|||
17143093|NCT01199302|38286131|FG003|Overall Study|Study Termination|9|||
17143094|NCT01199302|38286128|FG000|Overall Study|Lost to Follow-up|0|||
17143095|NCT01199302|38286129|FG001|Overall Study|Lost to Follow-up|1|||
17143096|NCT01199302|38286130|FG002|Overall Study|Lost to Follow-up|0|||
17143097|NCT01199302|38286131|FG003|Overall Study|Lost to Follow-up|0|||
17143098|NCT01199302|38286128|FG000|Overall Study|Other|1|||
17143099|NCT01199302|38286129|FG001|Overall Study|Other|0|||
17143100|NCT01199302|38286130|FG002|Overall Study|Other|0|||
17143101|NCT01199302|38286131|FG003|Overall Study|Other|0|||
17143102|NCT03332784|38286158|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143103|NCT03332784|38286159|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
17143104|NCT03332784|38286160|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143105|NCT03332784|38286161|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143106|NCT03332784|38286162|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143107|NCT03332784|38286163|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17050938|NCT00205777|38194480|FG005|Study Extension I|Failed to return|0|||
17050939|NCT00205777|38194475|FG000|Study Extension I|Other Event|34|||
17143108|NCT03332784|38286164|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143109|NCT03332784|38286165|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17050940|NCT00205777|38194476|FG001|Study Extension I|Other Event|0|||
17050941|NCT00205777|38194477|FG002|Study Extension I|Other Event|0|||
17050942|NCT00205777|38194478|FG003|Study Extension I|Other Event|34|||
17050943|NCT00205777|38194479|FG004|Study Extension I|Other Event|29|||
17050944|NCT00205777|38194480|FG005|Study Extension I|Other Event|0|||
17050945|NCT00205777|38194475|FG000|Study Extension I|Withdrawn as per protocol|0|||
17050946|NCT00205777|38194476|FG001|Study Extension I|Withdrawn as per protocol|0|||
17050947|NCT00205777|38194477|FG002|Study Extension I|Withdrawn as per protocol|1070|||
17050948|NCT00205777|38194478|FG003|Study Extension I|Withdrawn as per protocol|0|||
17050949|NCT00205777|38194479|FG004|Study Extension I|Withdrawn as per protocol|0|||
17050950|NCT00205777|38194480|FG005|Study Extension I|Withdrawn as per protocol|0|||
17143110|NCT03332784|38286166|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17050951|NCT00205777|38194475|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
17050952|NCT00205777|38194476|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
17050953|NCT00205777|38194477|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
17050954|NCT00205777|38194478|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
17050955|NCT00205777|38194479|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
17050956|NCT00205777|38194480|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
17050957|NCT00205777|38194475|FG000|Study Extension II|Adverse Event|0|||
17050958|NCT00205777|38194476|FG001|Study Extension II|Adverse Event|0|||
17050959|NCT00205777|38194477|FG002|Study Extension II|Adverse Event|0|||
17050960|NCT00205777|38194478|FG003|Study Extension II|Adverse Event|14|||
17143111|NCT03332784|38286167|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143112|NCT03332784|38286168|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143113|NCT03332784|38286169|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143114|NCT03332784|38286170|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143115|NCT03332784|38286171|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143116|NCT03332784|38286172|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
17143117|NCT03332784|38286173|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143118|NCT03332784|38286174|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143119|NCT03332784|38286175|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143120|NCT03332784|38286176|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143121|NCT03332784|38286177|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
17143122|NCT04465357|38286241|FG000|Overall Study|Adverse Event|2|||
17143123|NCT04465357|38286241|FG000|Overall Study|Lack of Efficacy|1|||
17143124|NCT04465357|38286241|FG000|Overall Study|Lost to Follow-up|2|||
17143125|NCT04465357|38286241|FG000|Overall Study|Withdrawal by Subject|6|||
17143126|NCT04465357|38286241|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
17050961|NCT00205777|38194479|FG004|Study Extension II|Adverse Event|0|||
17050962|NCT00205777|38194480|FG005|Study Extension II|Adverse Event|30|||
17050963|NCT00205777|38194475|FG000|Study Extension II|Death|0|||
17050964|NCT00205777|38194476|FG001|Study Extension II|Death|0|||
17050965|NCT00205777|38194477|FG002|Study Extension II|Death|0|||
17050966|NCT00205777|38194478|FG003|Study Extension II|Death|2|||
17050967|NCT00205777|38194479|FG004|Study Extension II|Death|0|||
17050968|NCT00205777|38194480|FG005|Study Extension II|Death|5|||
17050969|NCT00205777|38194475|FG000|Study Extension II|Withdrawal by Subject|0|||
17050970|NCT00205777|38194476|FG001|Study Extension II|Withdrawal by Subject|0|||
17050971|NCT00205777|38194477|FG002|Study Extension II|Withdrawal by Subject|0|||
17050972|NCT00205777|38194478|FG003|Study Extension II|Withdrawal by Subject|35|||
17050973|NCT00205777|38194479|FG004|Study Extension II|Withdrawal by Subject|0|||
17050974|NCT00205777|38194480|FG005|Study Extension II|Withdrawal by Subject|59|||
17050975|NCT00205777|38194475|FG000|Study Extension II|Protocol Violation|0|||
17050976|NCT00205777|38194476|FG001|Study Extension II|Protocol Violation|0|||
17050977|NCT00205777|38194477|FG002|Study Extension II|Protocol Violation|0|||
17050978|NCT00205777|38194478|FG003|Study Extension II|Protocol Violation|1|||
17050979|NCT00205777|38194479|FG004|Study Extension II|Protocol Violation|0|||
17050980|NCT00205777|38194480|FG005|Study Extension II|Protocol Violation|10|||
17050981|NCT00205777|38194475|FG000|Study Extension II|Lack of Efficacy|0|||
17050982|NCT00205777|38194476|FG001|Study Extension II|Lack of Efficacy|0|||
17050983|NCT00205777|38194477|FG002|Study Extension II|Lack of Efficacy|0|||
17050984|NCT00205777|38194478|FG003|Study Extension II|Lack of Efficacy|0|||
17050985|NCT00205777|38194479|FG004|Study Extension II|Lack of Efficacy|0|||
17050986|NCT00205777|38194480|FG005|Study Extension II|Lack of Efficacy|1|||
17050987|NCT00205777|38194475|FG000|Study Extension II|Failed to return|0|||
17050988|NCT00205777|38194476|FG001|Study Extension II|Failed to return|0|||
17050989|NCT00205777|38194477|FG002|Study Extension II|Failed to return|0|||
17050990|NCT00205777|38194478|FG003|Study Extension II|Failed to return|14|||
17050991|NCT00205777|38194479|FG004|Study Extension II|Failed to return|0|||
17050992|NCT00205777|38194480|FG005|Study Extension II|Failed to return|26|||
17050993|NCT00205777|38194475|FG000|Study Extension II|Other Event|0|||
17050994|NCT00205777|38194476|FG001|Study Extension II|Other Event|0|||
17050995|NCT00205777|38194477|FG002|Study Extension II|Other Event|0|||
17050996|NCT00205777|38194478|FG003|Study Extension II|Other Event|12|||
17050997|NCT00205777|38194479|FG004|Study Extension II|Other Event|0|||
17050998|NCT00205777|38194480|FG005|Study Extension II|Other Event|20|||
17050999|NCT00205777|38194475|FG000|Study Extension II|Enrolled but not treated|0|||
17051000|NCT00205777|38194476|FG001|Study Extension II|Enrolled but not treated|0|||
17051001|NCT00205777|38194477|FG002|Study Extension II|Enrolled but not treated|0|||
17051002|NCT00205777|38194478|FG003|Study Extension II|Enrolled but not treated|71|||
17051003|NCT00205777|38194479|FG004|Study Extension II|Enrolled but not treated|0|||
17051004|NCT00205777|38194480|FG005|Study Extension II|Enrolled but not treated|131|||
17051005|NCT00483652|38194497|FG000|Double-blind Treatment Period|Protocol Violation|2|||
17051006|NCT00483652|38194498|FG001|Double-blind Treatment Period|Protocol Violation|1|||
17051007|NCT00483652|38194497|FG000|Double-blind Treatment Period|Adverse Event|3|||
17051008|NCT00483652|38194498|FG001|Double-blind Treatment Period|Adverse Event|4|||
17051009|NCT00483652|38194497|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
17051010|NCT00483652|38194498|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
17051011|NCT00483652|38194497|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
17051012|NCT00483652|38194498|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
17051013|NCT00483574|38194506|FG000|Overall Study|Adverse Event|6|||
17051014|NCT00483574|38194507|FG001|Overall Study|Adverse Event|0|||
17051015|NCT00483574|38194506|FG000|Overall Study|Protocol Violation|28|||
17051016|NCT00483574|38194507|FG001|Overall Study|Protocol Violation|9|||
17051017|NCT00483574|38194506|FG000|Overall Study|Lost to Follow-up|16|||
17051018|NCT00483574|38194507|FG001|Overall Study|Lost to Follow-up|4|||
17051019|NCT00483574|38194506|FG000|Overall Study|Withdrawal by Subject|52|||
17051020|NCT00483574|38194507|FG001|Overall Study|Withdrawal by Subject|0|||
17051021|NCT00483184|38194518|FG000|Overall Study|Withdrawal by Subject|2|||
17051022|NCT00483184|38194519|FG001|Overall Study|Withdrawal by Subject|2|||
17051023|NCT00483184|38194520|FG002|Overall Study|Withdrawal by Subject|0|||
17051024|NCT00483184|38194518|FG000|Overall Study|Lost to Follow-up|1|||
17051025|NCT00483184|38194519|FG001|Overall Study|Lost to Follow-up|0|||
17051026|NCT00483184|38194520|FG002|Overall Study|Lost to Follow-up|0|||
17051027|NCT00483184|38194518|FG000|Overall Study|Adverse Event|1|||
17051028|NCT00483184|38194519|FG001|Overall Study|Adverse Event|2|||
17051029|NCT00483184|38194520|FG002|Overall Study|Adverse Event|2|||
17051030|NCT00483184|38194518|FG000|Overall Study|Protocol Violation|1|||
17051031|NCT00483184|38194519|FG001|Overall Study|Protocol Violation|0|||
17051032|NCT00483184|38194520|FG002|Overall Study|Protocol Violation|1|||
17051033|NCT00482170|38194530|FG000|Overall Study|Adverse Event|5|||
17051034|NCT00482170|38194531|FG001|Overall Study|Adverse Event|14|||
17051035|NCT00482170|38194530|FG000|Overall Study|Withdrawal by Subject|6|||
17051036|NCT00482170|38194531|FG001|Overall Study|Withdrawal by Subject|1|||
17051037|NCT00482170|38194530|FG000|Overall Study|Protocol Violation|2|||
17051038|NCT00482170|38194531|FG001|Overall Study|Protocol Violation|3|||
17051039|NCT00482170|38194530|FG000|Overall Study|Lost to Follow-up|2|||
17051040|NCT00482170|38194531|FG001|Overall Study|Lost to Follow-up|0|||
17051041|NCT00482170|38194530|FG000|Overall Study|Unspecified reason|0|||
17051042|NCT00482170|38194531|FG001|Overall Study|Unspecified reason|2|||
17051043|NCT03883113|38194539|FG000|Overall Study|Physician Decision|4|||
17051044|NCT03883113|38194540|FG001|Overall Study|Physician Decision|2|||
17051045|NCT03883113|38194539|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
17051046|NCT03883113|38194540|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
17143127|NCT03332628|38286245|FG000|Overall Study|Physician Decision|2|||
17143128|NCT02761694|38286262|FG000|Overall Study|Lack of Efficacy|0|||
17143129|NCT02761694|38286263|FG001|Overall Study|Lack of Efficacy|0|||
17143130|NCT02761694|38286264|FG002|Overall Study|Lack of Efficacy|0|||
17143131|NCT02761694|38286265|FG003|Overall Study|Lack of Efficacy|0|||
17143132|NCT02761694|38286266|FG004|Overall Study|Lack of Efficacy|0|||
17143133|NCT02761694|38286267|FG005|Overall Study|Lack of Efficacy|0|||
17143134|NCT02761694|38286268|FG006|Overall Study|Lack of Efficacy|6|||
17143135|NCT02761694|38286269|FG007|Overall Study|Lack of Efficacy|0|||
17143136|NCT02761694|38286270|FG008|Overall Study|Lack of Efficacy|0|||
17143137|NCT02761694|38286271|FG009|Overall Study|Lack of Efficacy|1|||
17143138|NCT02761694|38286272|FG010|Overall Study|Lack of Efficacy|1|||
17143139|NCT02761694|38286273|FG011|Overall Study|Lack of Efficacy|4|||
17143140|NCT02761694|38286262|FG000|Overall Study|Death|0|||
17143141|NCT02761694|38286263|FG001|Overall Study|Death|0|||
17051047|NCT03883113|38194539|FG000|Overall Study|Pregnancy|1|||
17051048|NCT03883113|38194540|FG001|Overall Study|Pregnancy|0|||
17051049|NCT03883113|38194539|FG000|Overall Study|Adverse Event|0|||
17051050|NCT03883113|38194540|FG001|Overall Study|Adverse Event|1|||
17143142|NCT02761694|38286264|FG002|Overall Study|Death|0|||
17143143|NCT02761694|38286265|FG003|Overall Study|Death|0|||
17143144|NCT02761694|38286266|FG004|Overall Study|Death|0|||
17143145|NCT02761694|38286267|FG005|Overall Study|Death|0|||
17143146|NCT02761694|38286268|FG006|Overall Study|Death|2|||
17143147|NCT02761694|38286269|FG007|Overall Study|Death|0|||
17143148|NCT02761694|38286270|FG008|Overall Study|Death|2|||
17143149|NCT02761694|38286271|FG009|Overall Study|Death|2|||
17143150|NCT02761694|38286272|FG010|Overall Study|Death|1|||
17143151|NCT02761694|38286273|FG011|Overall Study|Death|0|||
17143152|NCT02761694|38286262|FG000|Overall Study|Physician Decision|0|||
17143153|NCT02761694|38286263|FG001|Overall Study|Physician Decision|0|||
17143154|NCT02761694|38286264|FG002|Overall Study|Physician Decision|0|||
17143155|NCT02761694|38286265|FG003|Overall Study|Physician Decision|0|||
17143156|NCT02761694|38286266|FG004|Overall Study|Physician Decision|0|||
17143157|NCT02761694|38286267|FG005|Overall Study|Physician Decision|0|||
17051051|NCT03883113|38194539|FG000|Overall Study|Withdrawal by Subject|1|||
17143158|NCT02761694|38286268|FG006|Overall Study|Physician Decision|1|||
17143159|NCT02761694|38286269|FG007|Overall Study|Physician Decision|0|||
17143160|NCT02761694|38286270|FG008|Overall Study|Physician Decision|0|||
17143161|NCT02761694|38286271|FG009|Overall Study|Physician Decision|0|||
17051052|NCT03883113|38194540|FG001|Overall Study|Withdrawal by Subject|2|||
17051053|NCT03883113|38194539|FG000|Overall Study|Lost to Follow-up|1|||
17051054|NCT03883113|38194540|FG001|Overall Study|Lost to Follow-up|0|||
17051055|NCT04218695|38194562|FG000|Overall Study|Adverse Event|1|||
17051056|NCT04218695|38194563|FG001|Overall Study|Adverse Event|0|||
17051057|NCT00490282|38194569|FG000|Overall Study|Withdrawal by Subject|3|||
17051058|NCT00615056|38194578|FG000|Overall Study|Death|31|||
17051059|NCT00615056|38194579|FG001|Overall Study|Death|31|||
17051060|NCT00615056|38194580|FG002|Overall Study|Death|21|||
17051061|NCT00615056|38194581|FG003|Overall Study|Death|23|||
17051062|NCT00615056|38194578|FG000|Overall Study|Lost to Follow-up|1|||
17051063|NCT00615056|38194579|FG001|Overall Study|Lost to Follow-up|2|||
17051064|NCT00615056|38194580|FG002|Overall Study|Lost to Follow-up|4|||
17051065|NCT00615056|38194581|FG003|Overall Study|Lost to Follow-up|5|||
17051066|NCT00615056|38194578|FG000|Overall Study|Other|13|||
17051067|NCT00615056|38194579|FG001|Overall Study|Other|15|||
17051068|NCT00615056|38194580|FG002|Overall Study|Other|10|||
17143162|NCT02761694|38286272|FG010|Overall Study|Physician Decision|0|||
17143163|NCT02761694|38286273|FG011|Overall Study|Physician Decision|0|||
17143164|NCT02761694|38286262|FG000|Overall Study|Withdrawal by Subject|0|||
16992642|NCT03611751|38136640|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
16992643|NCT03611751|38136638|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
16992644|NCT03611751|38136639|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
16992645|NCT03611751|38136640|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
16992646|NCT03611751|38136638|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
16992647|NCT03611751|38136639|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
16992648|NCT03611751|38136640|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
16992649|NCT03611751|38136638|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
16992650|NCT03611751|38136639|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
16992651|NCT03611751|38136640|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
16992652|NCT03611751|38136638|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
16992653|NCT03611751|38136639|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
16992654|NCT03611751|38136640|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
16992655|NCT03611751|38136638|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
17051069|NCT00615056|38194581|FG003|Overall Study|Other|7|||
17051070|NCT00615056|38194578|FG000|Overall Study|Objective progression or relapse|0|||
17051071|NCT00615056|38194579|FG001|Overall Study|Objective progression or relapse|2|||
17051072|NCT00615056|38194580|FG002|Overall Study|Objective progression or relapse|0|||
17051073|NCT00615056|38194581|FG003|Overall Study|Objective progression or relapse|0|||
17051074|NCT00615056|38194578|FG000|Overall Study|Withdrawal by Subject|0|||
17143165|NCT02761694|38286263|FG001|Overall Study|Withdrawal by Subject|0|||
17143166|NCT02761694|38286264|FG002|Overall Study|Withdrawal by Subject|0|||
17143167|NCT02761694|38286265|FG003|Overall Study|Withdrawal by Subject|1|||
17143168|NCT02761694|38286266|FG004|Overall Study|Withdrawal by Subject|0|||
17143169|NCT02761694|38286267|FG005|Overall Study|Withdrawal by Subject|0|||
17143170|NCT02761694|38286268|FG006|Overall Study|Withdrawal by Subject|4|||
17143171|NCT02761694|38286269|FG007|Overall Study|Withdrawal by Subject|0|||
17143172|NCT02761694|38286270|FG008|Overall Study|Withdrawal by Subject|2|||
17143173|NCT02761694|38286271|FG009|Overall Study|Withdrawal by Subject|1|||
17143174|NCT02761694|38286272|FG010|Overall Study|Withdrawal by Subject|0|||
17143175|NCT02761694|38286273|FG011|Overall Study|Withdrawal by Subject|0|||
17143176|NCT02761694|38286262|FG000|Overall Study|Lost to Follow-up|0|||
17143177|NCT02761694|38286263|FG001|Overall Study|Lost to Follow-up|0|||
17143178|NCT02761694|38286264|FG002|Overall Study|Lost to Follow-up|0|||
17143179|NCT02761694|38286265|FG003|Overall Study|Lost to Follow-up|0|||
17143180|NCT02761694|38286266|FG004|Overall Study|Lost to Follow-up|0|||
17143181|NCT02761694|38286267|FG005|Overall Study|Lost to Follow-up|0|||
17051075|NCT00615056|38194579|FG001|Overall Study|Withdrawal by Subject|1|||
17051076|NCT00615056|38194580|FG002|Overall Study|Withdrawal by Subject|1|||
17051077|NCT00615056|38194581|FG003|Overall Study|Withdrawal by Subject|0|||
17051078|NCT00615056|38194578|FG000|Overall Study|Discontinued by Sponsor|1|||
17051079|NCT00615056|38194579|FG001|Overall Study|Discontinued by Sponsor|0|||
17051080|NCT00615056|38194580|FG002|Overall Study|Discontinued by Sponsor|0|||
17051081|NCT00615056|38194581|FG003|Overall Study|Discontinued by Sponsor|0|||
17051082|NCT00615056|38194578|FG000|Overall Study|Randomized but not treated|3|||
17051083|NCT00615056|38194579|FG001|Overall Study|Randomized but not treated|0|||
17051084|NCT00615056|38194580|FG002|Overall Study|Randomized but not treated|0|||
17051085|NCT00615056|38194581|FG003|Overall Study|Randomized but not treated|0|||
17051086|NCT00482014|38194595|FG000|Overall Study|Withdrawal by Subject|1|||
17051087|NCT00482014|38194596|FG001|Overall Study|Withdrawal by Subject|2|||
17051088|NCT00482014|38194597|FG002|Overall Study|Withdrawal by Subject|3|||
17051089|NCT00482014|38194598|FG003|Overall Study|Withdrawal by Subject|4|||
16992656|NCT03611751|38136639|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
16992657|NCT03611751|38136640|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
16992658|NCT03611751|38136638|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
16992659|NCT03611751|38136639|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
17051090|NCT00482014|38194595|FG000|Overall Study|Adverse Event|3|||
17051091|NCT00482014|38194596|FG001|Overall Study|Adverse Event|0|||
17051092|NCT00482014|38194597|FG002|Overall Study|Adverse Event|2|||
17051093|NCT00482014|38194598|FG003|Overall Study|Adverse Event|8|||
17051094|NCT00482014|38194595|FG000|Overall Study|Death|1|||
17051095|NCT00482014|38194596|FG001|Overall Study|Death|2|||
17051096|NCT00482014|38194597|FG002|Overall Study|Death|1|||
17051097|NCT00482014|38194598|FG003|Overall Study|Death|4|||
17051098|NCT00482014|38194595|FG000|Overall Study|Lack of Efficacy|1|||
17051099|NCT00482014|38194596|FG001|Overall Study|Lack of Efficacy|0|||
17051100|NCT00482014|38194597|FG002|Overall Study|Lack of Efficacy|4|||
17051101|NCT00482014|38194598|FG003|Overall Study|Lack of Efficacy|6|||
17051102|NCT00482014|38194595|FG000|Overall Study|Sponsor Decision|1|||
17051103|NCT00482014|38194596|FG001|Overall Study|Sponsor Decision|2|||
17051104|NCT00482014|38194597|FG002|Overall Study|Sponsor Decision|1|||
17051105|NCT00482014|38194598|FG003|Overall Study|Sponsor Decision|1|||
17051106|NCT03595553|38194612|FG000|Overall Study|Withdrawal by Subject|20|||
17051107|NCT03595553|38194613|FG001|Overall Study|Withdrawal by Subject|8|||
17051108|NCT03595553|38194612|FG000|Overall Study|Physician Decision|3|||
17051109|NCT03595553|38194613|FG001|Overall Study|Physician Decision|2|||
17051110|NCT03595553|38194612|FG000|Overall Study|Adverse Event|2|||
17051111|NCT03595553|38194613|FG001|Overall Study|Adverse Event|5|||
17051112|NCT03595553|38194612|FG000|Overall Study|Death|24|||
17051113|NCT03595553|38194613|FG001|Overall Study|Death|22|||
17051114|NCT03595553|38194612|FG000|Overall Study|Lost to Follow-up|6|||
17051115|NCT03595553|38194613|FG001|Overall Study|Lost to Follow-up|7|||
17051116|NCT03595553|38194612|FG000|Overall Study|Other as indicated in CSR|3|||
17051117|NCT03595553|38194613|FG001|Overall Study|Other as indicated in CSR|3|||
17051118|NCT03595553|38194612|FG000|Overall Study|Sponsor Decision|0|||
17051119|NCT03595553|38194613|FG001|Overall Study|Sponsor Decision|1|||
17051120|NCT00614822|38194619|FG000|Overall Study|Adverse Event|3|||
17051121|NCT00529659|38194626|FG000|Overall Study|Adverse Event|8|||
17051122|NCT00529659|38194627|FG001|Overall Study|Adverse Event|7|||
17051123|NCT00529659|38194626|FG000|Overall Study|Lost to Follow-up|0|||
17051124|NCT00529659|38194627|FG001|Overall Study|Lost to Follow-up|2|||
17051125|NCT00529659|38194626|FG000|Overall Study|Physician Decision|0|||
17051126|NCT00529659|38194627|FG001|Overall Study|Physician Decision|2|||
17051127|NCT00529659|38194626|FG000|Overall Study|Protocol Violation|2|||
17051128|NCT00529659|38194627|FG001|Overall Study|Protocol Violation|6|||
17051129|NCT00529659|38194626|FG000|Overall Study|Withdrawal by Subject|1|||
17051130|NCT00529659|38194627|FG001|Overall Study|Withdrawal by Subject|6|||
17051131|NCT03569891|38194633|FG000|Lead-in|Ineligible during lead-in|8|||
17051132|NCT03569891|38194633|FG000|Lead-in|Withdrawal by Subject|3|||
17051133|NCT03569891|38194633|FG000|Lead-in|Risks related to COVID-19|2|||
17051134|NCT03569891|38194633|FG000|AMT-061|Adverse Event|1|||
17051135|NCT00143455|38194646|FG000|Cohort 1|Adverse Event|8|||
17051136|NCT00143455|38194647|FG001|Cohort 1|Adverse Event|4|||
17051137|NCT00143455|38194648|FG002|Cohort 1|Adverse Event|0|||
17051138|NCT00143455|38194649|FG003|Cohort 1|Adverse Event|0|||
17051139|NCT00143455|38194646|FG000|Cohort 1|Death|5|||
17051140|NCT00143455|38194647|FG001|Cohort 1|Death|2|||
17051141|NCT00143455|38194648|FG002|Cohort 1|Death|0|||
17051142|NCT00143455|38194649|FG003|Cohort 1|Death|0|||
17051143|NCT00143455|38194646|FG000|Cohort 1|Progressive Disease|0|||
17051144|NCT00143455|38194647|FG001|Cohort 1|Progressive Disease|6|||
17051145|NCT00143455|38194648|FG002|Cohort 1|Progressive Disease|0|||
17051146|NCT00143455|38194649|FG003|Cohort 1|Progressive Disease|0|||
17051147|NCT00143455|38194646|FG000|Cohort 1|Withdrawal by Subject|1|||
17051148|NCT00143455|38194647|FG001|Cohort 1|Withdrawal by Subject|4|||
17051149|NCT00143455|38194648|FG002|Cohort 1|Withdrawal by Subject|0|||
17051150|NCT00143455|38194649|FG003|Cohort 1|Withdrawal by Subject|0|||
17051151|NCT00143455|38194646|FG000|Cohort 1|Randomized But Not Treated|0|||
17051152|NCT00143455|38194647|FG001|Cohort 1|Randomized But Not Treated|1|||
17051153|NCT00143455|38194648|FG002|Cohort 1|Randomized But Not Treated|0|||
17051154|NCT00143455|38194649|FG003|Cohort 1|Randomized But Not Treated|0|||
17051155|NCT00143455|38194646|FG000|Cohort 2|Adverse Event|0|||
17051156|NCT00143455|38194647|FG001|Cohort 2|Adverse Event|0|||
17051157|NCT00143455|38194648|FG002|Cohort 2|Adverse Event|42|||
16992660|NCT03611751|38136640|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
16992661|NCT03611751|38136638|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
16992662|NCT03611751|38136639|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
16992663|NCT03611751|38136640|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
16992664|NCT03611751|38136638|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
16992665|NCT03611751|38136639|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
16992666|NCT03611751|38136640|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
16992667|NCT03611751|38136638|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
16992668|NCT03611751|38136639|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
16992669|NCT03611751|38136640|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
16992670|NCT03611751|38136638|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
16992671|NCT03611751|38136639|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
16992672|NCT03611751|38136640|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
16992673|NCT03611751|38136638|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
16992674|NCT03611751|38136639|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
16992675|NCT03611751|38136640|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
16992676|NCT03611751|38136638|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
16992677|NCT03611751|38136639|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
16992678|NCT03611751|38136640|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
17051158|NCT00143455|38194649|FG003|Cohort 2|Adverse Event|30|||
17051159|NCT00143455|38194646|FG000|Cohort 2|No Longer Required Study Treatment|0|||
17051160|NCT00143455|38194647|FG001|Cohort 2|No Longer Required Study Treatment|0|||
17051161|NCT00143455|38194648|FG002|Cohort 2|No Longer Required Study Treatment|1|||
17051162|NCT00143455|38194649|FG003|Cohort 2|No Longer Required Study Treatment|0|||
17051163|NCT00143455|38194646|FG000|Cohort 2|Protocol Violation|0|||
17051164|NCT00143455|38194647|FG001|Cohort 2|Protocol Violation|0|||
17051165|NCT00143455|38194648|FG002|Cohort 2|Protocol Violation|1|||
17051166|NCT00143455|38194649|FG003|Cohort 2|Protocol Violation|1|||
17051167|NCT00143455|38194646|FG000|Cohort 2|Lost to Follow-up|0|||
17051168|NCT00143455|38194647|FG001|Cohort 2|Lost to Follow-up|0|||
17051169|NCT00143455|38194648|FG002|Cohort 2|Lost to Follow-up|1|||
17051170|NCT00143455|38194649|FG003|Cohort 2|Lost to Follow-up|4|||
17051171|NCT00143455|38194646|FG000|Cohort 2|Death|0|||
17051172|NCT00143455|38194647|FG001|Cohort 2|Death|0|||
17051173|NCT00143455|38194648|FG002|Cohort 2|Death|20|||
17051174|NCT00143455|38194649|FG003|Cohort 2|Death|12|||
17051175|NCT00143455|38194646|FG000|Cohort 2|Progressive Disease|0|||
17051176|NCT00143455|38194647|FG001|Cohort 2|Progressive Disease|0|||
17051177|NCT00143455|38194648|FG002|Cohort 2|Progressive Disease|20|||
17051178|NCT00143455|38194649|FG003|Cohort 2|Progressive Disease|27|||
17051179|NCT00143455|38194646|FG000|Cohort 2|Withdrawal by Subject|0|||
17051180|NCT00143455|38194647|FG001|Cohort 2|Withdrawal by Subject|0|||
17051181|NCT00143455|38194648|FG002|Cohort 2|Withdrawal by Subject|13|||
17051182|NCT00143455|38194649|FG003|Cohort 2|Withdrawal by Subject|12|||
17051183|NCT00143455|38194646|FG000|Cohort 2|Other|0|||
17051184|NCT00143455|38194647|FG001|Cohort 2|Other|0|||
17051185|NCT00143455|38194648|FG002|Cohort 2|Other|7|||
17051186|NCT00143455|38194649|FG003|Cohort 2|Other|6|||
17051187|NCT00143455|38194646|FG000|Cohort 2|Randomized But Not Treated|0|||
17051188|NCT00143455|38194647|FG001|Cohort 2|Randomized But Not Treated|0|||
17051189|NCT00143455|38194648|FG002|Cohort 2|Randomized But Not Treated|1|||
17051190|NCT00143455|38194649|FG003|Cohort 2|Randomized But Not Treated|1|||
17051191|NCT03529955|38194661|FG000|Overall Study|Adverse Event|1|||
17051192|NCT03529955|38194661|FG000|Overall Study|Lack of Efficacy|1|||
17051193|NCT00142909|38194677|FG000|Randomization|Various Reasons|7|||
17051194|NCT00142909|38194678|FG001|Randomization|Various Reasons|10|||
17051195|NCT00142909|38194677|FG000|Medications Begin|Protocol Violation|2|||
17051196|NCT00142909|38194678|FG001|Medications Begin|Protocol Violation|0|||
17051197|NCT00142909|38194677|FG000|Medications Begin|Withdrawal by Subject|5|||
17051198|NCT00142909|38194678|FG001|Medications Begin|Withdrawal by Subject|3|||
17051199|NCT00142909|38194677|FG000|Medications Begin|Withdrawal by Subject|2|||
17051200|NCT00142909|38194678|FG001|Medications Begin|Withdrawal by Subject|0|||
17051201|NCT00205699|38194687|FG000|Overall Study|Lost to Follow-up|1|||
17051202|NCT00205699|38194688|FG001|Overall Study|Lost to Follow-up|3|||
17051203|NCT00205699|38194689|FG002|Overall Study|Lost to Follow-up|5|||
17051204|NCT00205699|38194687|FG000|Overall Study|Adverse Event|1|||
17051205|NCT00205699|38194688|FG001|Overall Study|Adverse Event|0|||
17051206|NCT00205699|38194689|FG002|Overall Study|Adverse Event|0|||
17051207|NCT00205699|38194687|FG000|Overall Study|Withdrawal by Subject|1|||
17051208|NCT00205699|38194688|FG001|Overall Study|Withdrawal by Subject|2|||
17051209|NCT00205699|38194689|FG002|Overall Study|Withdrawal by Subject|1|||
17051210|NCT00205699|38194687|FG000|Overall Study|Lack of Efficacy|0|||
17051211|NCT00205699|38194688|FG001|Overall Study|Lack of Efficacy|1|||
17051212|NCT00205699|38194689|FG002|Overall Study|Lack of Efficacy|0|||
17051213|NCT03882801|38194702|FG000|Period 1|Adverse Event|0|||
17051214|NCT03882801|38194703|FG001|Period 1|Adverse Event|1|||
17051215|NCT03882801|38194702|FG000|Period 1|Non-compliance with study drug|1|||
17051216|NCT03882801|38194703|FG001|Period 1|Non-compliance with study drug|1|||
17051217|NCT03882801|38194702|FG000|Period 1|Never treated with study drug|1|||
17051218|NCT03882801|38194703|FG001|Period 1|Never treated with study drug|0|||
17051219|NCT03882801|38194702|FG000|Washout Period|Physician Decision|0|||
17051220|NCT03882801|38194703|FG001|Washout Period|Physician Decision|1|||
17051221|NCT03882801|38194702|FG000|Period 2|Non-compliance with study drug|0|||
17051222|NCT03882801|38194703|FG001|Period 2|Non-compliance with study drug|1|||
17051223|NCT03880227|38194713|FG000|First Visit|Withdrawal by Subject|1|||
17051224|NCT03880227|38194714|FG001|First Visit|Withdrawal by Subject|0|||
17051225|NCT03880227|38194715|FG002|First Visit|Withdrawal by Subject|0|||
17051226|NCT03880227|38194716|FG003|First Visit|Withdrawal by Subject|0|||
17051227|NCT03880227|38194713|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
17051228|NCT03880227|38194714|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
17051229|NCT03880227|38194715|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
17051230|NCT03880227|38194716|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
17051231|NCT03880227|38194713|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
17051232|NCT03880227|38194714|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
17051233|NCT03880227|38194715|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
17051234|NCT03880227|38194716|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
17051235|NCT03880227|38194713|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
17051236|NCT03880227|38194714|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
17051237|NCT03880227|38194715|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
17051238|NCT03880227|38194716|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
17051239|NCT00530439|38194749|FG000|Overall Study|GDM|9|||
17051240|NCT00530439|38194750|FG001|Overall Study|GDM|3|||
17051241|NCT00530439|38194749|FG000|Overall Study|Withdraw|18|||
17051242|NCT00530439|38194750|FG001|Overall Study|Withdraw|14|||
17051243|NCT00530439|38194749|FG000|Overall Study|Missed abortion|1|||
17051244|NCT00530439|38194750|FG001|Overall Study|Missed abortion|4|||
17051245|NCT00530439|38194749|FG000|Overall Study|Misclassification|2|||
17051246|NCT00530439|38194750|FG001|Overall Study|Misclassification|0|||
17051247|NCT00530439|38194749|FG000|Overall Study|Twin pregnancy|0|||
17051248|NCT00530439|38194750|FG001|Overall Study|Twin pregnancy|2|||
17051249|NCT00530439|38194749|FG000|Overall Study|Severe malformation/abortion|0|||
17051250|NCT00530439|38194750|FG001|Overall Study|Severe malformation/abortion|3|||
17051251|NCT00497146|38194758|FG000|Treatment Period|Adverse Event|6|||
17051252|NCT00497146|38194759|FG001|Treatment Period|Adverse Event|2|||
17051253|NCT00497146|38194758|FG000|Treatment Period|Withdrawal by Subject|5|||
17051254|NCT00497146|38194759|FG001|Treatment Period|Withdrawal by Subject|9|||
17051255|NCT00497146|38194758|FG000|Treatment Period|Lost to Follow-up|1|||
17051256|NCT00497146|38194759|FG001|Treatment Period|Lost to Follow-up|3|||
17051257|NCT00497146|38194758|FG000|Treatment Period|Required dialysis|4|||
17051258|NCT00497146|38194759|FG001|Treatment Period|Required dialysis|1|||
17051259|NCT00497146|38194758|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
17051260|NCT00497146|38194759|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
17051261|NCT00497146|38194758|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
17051262|NCT00497146|38194759|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
17051263|NCT00497146|38194758|FG000|Treatment Period|Other Reason|2|||
17051264|NCT00497146|38194759|FG001|Treatment Period|Other Reason|3|||
17051265|NCT00497146|38194758|FG000|Long-term Follow-up Period|Adverse Event|2|||
17051266|NCT00497146|38194759|FG001|Long-term Follow-up Period|Adverse Event|2|||
17051267|NCT00497146|38194758|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
17051268|NCT00497146|38194759|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
17051269|NCT00497146|38194758|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
17051270|NCT00497146|38194759|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
17051271|NCT00497146|38194758|FG000|Long-term Follow-up Period|Other|0|||
17051272|NCT00497146|38194759|FG001|Long-term Follow-up Period|Other|1|||
17051273|NCT00489970|38194770|FG000|Persistence Year 9|Lost to Follow-up|2|||
17051274|NCT00489970|38194771|FG001|Persistence Year 9|Lost to Follow-up|2|||
17051275|NCT00489970|38194772|FG002|Persistence Year 9|Lost to Follow-up|3|||
17051276|NCT00489970|38194770|FG000|Persistence Year 9|Other|1|||
17051277|NCT00489970|38194771|FG001|Persistence Year 9|Other|0|||
17051278|NCT00489970|38194772|FG002|Persistence Year 9|Other|2|||
17051279|NCT02798471|38194785|FG000|Overall Study|Adverse Event|7|||
17051280|NCT02798471|38194786|FG001|Overall Study|Adverse Event|2|||
17051281|NCT02798471|38194785|FG000|Overall Study|Physician Decision|3|||
17051282|NCT02798471|38194786|FG001|Overall Study|Physician Decision|7|||
17051283|NCT02798471|38194785|FG000|Overall Study|Death|2|||
17051284|NCT02798471|38194786|FG001|Overall Study|Death|3|||
17051285|NCT02798471|38194785|FG000|Overall Study|Lost to Follow-up|0|||
17051286|NCT02798471|38194786|FG001|Overall Study|Lost to Follow-up|1|||
17051287|NCT02798471|38194785|FG000|Overall Study|Other|5|||
17051288|NCT02798471|38194786|FG001|Overall Study|Other|3|||
17051289|NCT02798471|38194785|FG000|Overall Study|Subject withdrew consent|0|||
17051290|NCT02798471|38194786|FG001|Overall Study|Subject withdrew consent|6|||
17051291|NCT02798471|38194785|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
17051292|NCT02798471|38194786|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
17143182|NCT02761694|38286268|FG006|Overall Study|Lost to Follow-up|1|||
17143183|NCT02761694|38286269|FG007|Overall Study|Lost to Follow-up|0|||
17143184|NCT02761694|38286270|FG008|Overall Study|Lost to Follow-up|0|||
17143185|NCT02761694|38286271|FG009|Overall Study|Lost to Follow-up|0|||
17143186|NCT02761694|38286272|FG010|Overall Study|Lost to Follow-up|0|||
17143187|NCT02761694|38286273|FG011|Overall Study|Lost to Follow-up|1|||
17143188|NCT02761694|38286262|FG000|Overall Study|Adverse Event|0|||
17143189|NCT02761694|38286263|FG001|Overall Study|Adverse Event|0|||
17143190|NCT02761694|38286264|FG002|Overall Study|Adverse Event|0|||
17051293|NCT02798471|38194785|FG000|Overall Study|Randomized, but not treated|0|||
17051294|NCT02798471|38194786|FG001|Overall Study|Randomized, but not treated|2|||
17143191|NCT02761694|38286265|FG003|Overall Study|Adverse Event|0|||
17143192|NCT02761694|38286266|FG004|Overall Study|Adverse Event|0|||
17143193|NCT02761694|38286267|FG005|Overall Study|Adverse Event|0|||
17143194|NCT02761694|38286268|FG006|Overall Study|Adverse Event|1|||
17143195|NCT02761694|38286269|FG007|Overall Study|Adverse Event|0|||
17143196|NCT02761694|38286270|FG008|Overall Study|Adverse Event|1|||
17143197|NCT02761694|38286271|FG009|Overall Study|Adverse Event|0|||
17143198|NCT02761694|38286272|FG010|Overall Study|Adverse Event|0|||
17143199|NCT02761694|38286273|FG011|Overall Study|Adverse Event|1|||
17143200|NCT02761694|38286262|FG000|Overall Study|Other|4|||
17143201|NCT02761694|38286263|FG001|Overall Study|Other|4|||
17143202|NCT02761694|38286264|FG002|Overall Study|Other|1|||
17143203|NCT02761694|38286265|FG003|Overall Study|Other|2|||
17143204|NCT02761694|38286266|FG004|Overall Study|Other|3|||
17143205|NCT02761694|38286267|FG005|Overall Study|Other|3|||
17143206|NCT02761694|38286268|FG006|Overall Study|Other|18|||
17143207|NCT02761694|38286269|FG007|Overall Study|Other|8|||
17143208|NCT02761694|38286270|FG008|Overall Study|Other|0|||
17051295|NCT00489736|38194794|FG000|Overall Study|Lack of Efficacy|53|||
17051296|NCT00489736|38194795|FG001|Overall Study|Lack of Efficacy|14|||
17051297|NCT00489736|38194794|FG000|Overall Study|Adverse Event|32|||
17051298|NCT00489736|38194795|FG001|Overall Study|Adverse Event|45|||
17051299|NCT00489736|38194794|FG000|Overall Study|Poor compliance|6|||
17051300|NCT00489736|38194795|FG001|Overall Study|Poor compliance|2|||
17051301|NCT00489736|38194794|FG000|Overall Study|Not coded/ Not pre-specified|5|||
17051302|NCT00489736|38194795|FG001|Overall Study|Not coded/ Not pre-specified|8|||
17051303|NCT00617084|38194803|FG000|Overall Study|Withdrawal by Subject|5|||
17051304|NCT00617084|38194804|FG001|Overall Study|Withdrawal by Subject|7|||
17051305|NCT00617084|38194803|FG000|Overall Study|Missed 12 Months visit|16|||
17051306|NCT00617084|38194804|FG001|Overall Study|Missed 12 Months visit|19|||
17051307|NCT00489424|38194813|FG000|Overall Study|Adverse Event|3|||
17051308|NCT00489424|38194814|FG001|Overall Study|Adverse Event|3|||
17051309|NCT00489424|38194815|FG002|Overall Study|Adverse Event|4|||
17051310|NCT00489424|38194813|FG000|Overall Study|Lack of Efficacy|1|||
17051311|NCT00489424|38194814|FG001|Overall Study|Lack of Efficacy|0|||
17051312|NCT00489424|38194815|FG002|Overall Study|Lack of Efficacy|0|||
17051313|NCT00489424|38194813|FG000|Overall Study|Administrative problems|0|||
17051314|NCT00489424|38194814|FG001|Overall Study|Administrative problems|2|||
17051315|NCT00489424|38194815|FG002|Overall Study|Administrative problems|1|||
17051316|NCT00614744|38194825|FG000|Overall Study|Lost to Follow-up|5|||
17051317|NCT00614744|38194826|FG001|Overall Study|Lost to Follow-up|4|||
17051318|NCT00614744|38194825|FG000|Overall Study|Incomplete for Behavior Issues|0|||
17051319|NCT00614744|38194826|FG001|Overall Study|Incomplete for Behavior Issues|2|||
17051320|NCT00565812|38194835|FG000|Overall Study|Death|2|||
17051321|NCT00565812|38194836|FG001|Overall Study|Death|1|||
17051322|NCT00565812|38194837|FG002|Overall Study|Death|3|||
17051323|NCT00565812|38194835|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
17051324|NCT00565812|38194836|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
17051325|NCT00565812|38194837|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
17051326|NCT00565812|38194835|FG000|Overall Study|Lost to Follow-up|10|||
17051327|NCT00565812|38194836|FG001|Overall Study|Lost to Follow-up|8|||
17051328|NCT00565812|38194837|FG002|Overall Study|Lost to Follow-up|8|||
17051329|NCT00565812|38194835|FG000|Overall Study|Withdrawal by Subject|58|||
17051330|NCT00565812|38194836|FG001|Overall Study|Withdrawal by Subject|47|||
17051331|NCT00565812|38194837|FG002|Overall Study|Withdrawal by Subject|48|||
17051332|NCT00565812|38194835|FG000|Overall Study|Work Schedule|5|||
17143209|NCT02761694|38286271|FG009|Overall Study|Other|1|||
17143210|NCT02761694|38286272|FG010|Overall Study|Other|1|||
17143211|NCT02761694|38286273|FG011|Overall Study|Other|0|||
17051333|NCT00565812|38194836|FG001|Overall Study|Work Schedule|3|||
17051334|NCT00565812|38194837|FG002|Overall Study|Work Schedule|1|||
17051335|NCT00565812|38194835|FG000|Overall Study|Protocol Violation|2|||
17051336|NCT00565812|38194836|FG001|Overall Study|Protocol Violation|6|||
17051337|NCT00565812|38194837|FG002|Overall Study|Protocol Violation|4|||
17051338|NCT00565812|38194835|FG000|Overall Study|Adverse Event|41|||
17051339|NCT00565812|38194836|FG001|Overall Study|Adverse Event|54|||
17143212|NCT04516759|38286302|FG000|Overall Study|Withdrawal by Subject|1|||
17143213|NCT04516759|38286303|FG001|Overall Study|Withdrawal by Subject|1|||
17051340|NCT00565812|38194837|FG002|Overall Study|Adverse Event|40|||
17051341|NCT00565812|38194835|FG000|Overall Study|Jury Duty|1|||
17051342|NCT00565812|38194836|FG001|Overall Study|Jury Duty|0|||
17051343|NCT00565812|38194837|FG002|Overall Study|Jury Duty|0|||
17051344|NCT00565812|38194835|FG000|Overall Study|Relocated Out of Area|5|||
17051345|NCT00565812|38194836|FG001|Overall Study|Relocated Out of Area|8|||
17051346|NCT00565812|38194837|FG002|Overall Study|Relocated Out of Area|9|||
17051347|NCT00565812|38194835|FG000|Overall Study|Sponsor Decision|1|||
17051348|NCT00565812|38194836|FG001|Overall Study|Sponsor Decision|5|||
17051349|NCT00565812|38194837|FG002|Overall Study|Sponsor Decision|1|||
17051350|NCT00565812|38194835|FG000|Overall Study|Domestic Reasons|7|||
17051351|NCT00565812|38194836|FG001|Overall Study|Domestic Reasons|1|||
17051352|NCT00565812|38194837|FG002|Overall Study|Domestic Reasons|3|||
17051353|NCT00565812|38194835|FG000|Overall Study|Research Site Closure|6|||
17051354|NCT00565812|38194836|FG001|Overall Study|Research Site Closure|1|||
17051355|NCT00565812|38194837|FG002|Overall Study|Research Site Closure|8|||
16992679|NCT00721123|38136657|FG000|Overall Study|Adverse Event|96|||
16992680|NCT00721123|38136657|FG000|Overall Study|Death|10|||
17051356|NCT00565812|38194835|FG000|Overall Study|Surgical Intervention|0|||
17051357|NCT00565812|38194836|FG001|Overall Study|Surgical Intervention|1|||
17051358|NCT00565812|38194837|FG002|Overall Study|Surgical Intervention|2|||
17051359|NCT00565812|38194835|FG000|Overall Study|Low Compliance|1|||
17051360|NCT00565812|38194836|FG001|Overall Study|Low Compliance|0|||
17051361|NCT00565812|38194837|FG002|Overall Study|Low Compliance|1|||
17051362|NCT00565812|38194835|FG000|Overall Study|Follow-up Visit Not Completed|2|||
17051363|NCT00565812|38194836|FG001|Overall Study|Follow-up Visit Not Completed|0|||
17051364|NCT00565812|38194837|FG002|Overall Study|Follow-up Visit Not Completed|1|||
17051365|NCT00565812|38194835|FG000|Overall Study|Physician Decision|2|||
17051366|NCT00565812|38194836|FG001|Overall Study|Physician Decision|0|||
17051367|NCT00565812|38194837|FG002|Overall Study|Physician Decision|0|||
17051368|NCT03974334|38194845|FG000|Overall Study|Lost to Follow-up|1|||
17051369|NCT03970824|38194852|FG000|Overall Study|Withdrawal by Subject|1|||
17051370|NCT03970824|38194853|FG001|Overall Study|Withdrawal by Subject|1|||
17051371|NCT03970824|38194854|FG002|Overall Study|Withdrawal by Subject|3|||
17051372|NCT03970824|38194852|FG000|Overall Study|Lost to Follow-up|0|||
17051373|NCT03970824|38194853|FG001|Overall Study|Lost to Follow-up|2|||
17051374|NCT03970824|38194854|FG002|Overall Study|Lost to Follow-up|1|||
17051375|NCT03970824|38194852|FG000|Overall Study|Adverse Event|1|||
17051376|NCT03970824|38194853|FG001|Overall Study|Adverse Event|0|||
17051377|NCT03970824|38194854|FG002|Overall Study|Adverse Event|0|||
17051378|NCT00564486|38194865|FG000|Overall Study|Adverse Event|0|||
17051379|NCT00564486|38194866|FG001|Overall Study|Adverse Event|1|||
16992681|NCT00721123|38136657|FG000|Overall Study|Insufficient Therapeutic Response|21|||
17051380|NCT00564486|38194867|FG002|Overall Study|Adverse Event|0|||
16992682|NCT00721123|38136657|FG000|Overall Study|Protocol Violation|1|||
16992683|NCT00721123|38136657|FG000|Overall Study|Refused Treatment|41|||
16992684|NCT00721123|38136657|FG000|Overall Study|Failure to Return|9|||
16992685|NCT00721123|38136657|FG000|Overall Study|Withdrawal by Subject|5|||
16992686|NCT00720499|38136677|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
16992687|NCT00720499|38136678|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16992688|NCT00720499|38136677|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
16992689|NCT00720499|38136678|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
16992690|NCT00720499|38136677|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
17051381|NCT00564486|38194868|FG003|Overall Study|Adverse Event|0|||
17051382|NCT00564486|38194865|FG000|Overall Study|Withdrawal by Subject|4|||
17051383|NCT00564486|38194866|FG001|Overall Study|Withdrawal by Subject|0|||
17051384|NCT00564486|38194867|FG002|Overall Study|Withdrawal by Subject|0|||
17051385|NCT00564486|38194868|FG003|Overall Study|Withdrawal by Subject|5|||
17051386|NCT00564486|38194865|FG000|Overall Study|Subject refused to have blood drawn|0|||
17051387|NCT00564486|38194866|FG001|Overall Study|Subject refused to have blood drawn|0|||
17051388|NCT00564486|38194867|FG002|Overall Study|Subject refused to have blood drawn|1|||
17051389|NCT00564486|38194868|FG003|Overall Study|Subject refused to have blood drawn|0|||
17143214|NCT04516759|38286302|FG000|Overall Study|Other|0|||
17143215|NCT04516759|38286303|FG001|Overall Study|Other|1|||
17143216|NCT03332160|38286311|FG000|Overall Study|Withdrawal by Subject|1|||
17143217|NCT03332160|38286312|FG001|Overall Study|Withdrawal by Subject|1|||
17143218|NCT03332160|38286311|FG000|Overall Study|Adverse Event|0|||
17143219|NCT03332160|38286312|FG001|Overall Study|Adverse Event|1|||
17143220|NCT03332160|38286311|FG000|Overall Study|Developed Exclusion Criteria|0|||
17143221|NCT03332160|38286312|FG001|Overall Study|Developed Exclusion Criteria|1|||
17143222|NCT03332160|38286311|FG000|Overall Study|Non-adherence to treatment|0|||
17143223|NCT03332160|38286312|FG001|Overall Study|Non-adherence to treatment|2|||
17143224|NCT03312114|38286319|FG000|Overall Study|All the five enrolled dropped out of the|5|||
16780949|NCT02151682|37720065|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16992691|NCT00720499|38136678|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
16992692|NCT00724243|38136685|FG000|Overall Study|Lack of Efficacy|10|||
16992693|NCT00724243|38136685|FG000|Overall Study|Adverse Event|5|||
16992694|NCT00720343|38136689|FG000|Overall Study|Physician Decision|3|||
16992695|NCT00720343|38136689|FG000|Overall Study|No data|3|||
16992696|NCT00720109|38136695|FG000|Induction Period|Did not meet eligibility criteria|3|||
16992697|NCT00720109|38136696|FG001|Induction Period|Did not meet eligibility criteria|0|||
16992698|NCT00720109|38136697|FG002|Induction Period|Did not meet eligibility criteria|0|||
16992699|NCT00720109|38136695|FG000|Induction Period|Bone Marrow Transplant|2|||
16992700|NCT00720109|38136696|FG001|Induction Period|Bone Marrow Transplant|0|||
16992701|NCT00720109|38136697|FG002|Induction Period|Bone Marrow Transplant|0|||
16992702|NCT00720109|38136695|FG000|Induction Period|Physician Decision|1|||
16992703|NCT00720109|38136696|FG001|Induction Period|Physician Decision|0|||
16992704|NCT00720109|38136697|FG002|Induction Period|Physician Decision|0|||
16992705|NCT00720109|38136695|FG000|Risk Stratification Period|Adverse Event|0|||
16992706|NCT00720109|38136696|FG001|Risk Stratification Period|Adverse Event|1|||
16992707|NCT00720109|38136697|FG002|Risk Stratification Period|Adverse Event|0|||
16992708|NCT00720109|38136695|FG000|Risk Stratification Period|Physician Decision|0|||
16992709|NCT00720109|38136696|FG001|Risk Stratification Period|Physician Decision|2|||
16992710|NCT00720109|38136697|FG002|Risk Stratification Period|Physician Decision|1|||
16992711|NCT00720109|38136695|FG000|Risk Stratification Period|Bone marrow transplant|0|||
16992712|NCT00720109|38136696|FG001|Risk Stratification Period|Bone marrow transplant|9|||
16992713|NCT00720109|38136697|FG002|Risk Stratification Period|Bone marrow transplant|7|||
16992714|NCT00720109|38136695|FG000|Risk Stratification Period|Disease progression or relapse|0|||
16992715|NCT00720109|38136696|FG001|Risk Stratification Period|Disease progression or relapse|2|||
16992716|NCT00720109|38136697|FG002|Risk Stratification Period|Disease progression or relapse|0|||
16992717|NCT00720109|38136695|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
16992718|NCT00720109|38136696|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
16992719|NCT00720109|38136697|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
16992720|NCT01705977|38136708|FG000|Overall Study|Withdrawal by Subject|128|||
16992721|NCT01705977|38136709|FG001|Overall Study|Withdrawal by Subject|128|||
16992722|NCT01705977|38136708|FG000|Overall Study|Adverse Event|57|||
16992723|NCT01705977|38136709|FG001|Overall Study|Adverse Event|49|||
16992724|NCT01705977|38136708|FG000|Overall Study|Protocol Violation|2|||
16992725|NCT01705977|38136709|FG001|Overall Study|Protocol Violation|4|||
16992726|NCT01705977|38136708|FG000|Overall Study|Site closure|3|||
16992727|NCT01705977|38136709|FG001|Overall Study|Site closure|2|||
16992728|NCT01705977|38136708|FG000|Overall Study|Lost to Follow-up|33|||
16992729|NCT01705977|38136709|FG001|Overall Study|Lost to Follow-up|37|||
16992730|NCT01705977|38136708|FG000|Overall Study|Physician Decision|48|||
16992731|NCT01705977|38136709|FG001|Overall Study|Physician Decision|38|||
16992732|NCT01705977|38136708|FG000|Overall Study|Missing study conclusion form|2|||
16992733|NCT01705977|38136709|FG001|Overall Study|Missing study conclusion form|2|||
16992734|NCT01015118|38136717|FG000|Overall Study|Protocol Violation|5|||
16992735|NCT01015118|38136718|FG001|Overall Study|Protocol Violation|6|||
16992736|NCT01015118|38136717|FG000|Overall Study|Withdrawal by Subject|103|||
16992737|NCT01015118|38136718|FG001|Overall Study|Withdrawal by Subject|27|||
16992738|NCT01015118|38136717|FG000|Overall Study|Other Adverse Event (AE)|141|||
16992739|NCT01015118|38136718|FG001|Overall Study|Other Adverse Event (AE)|33|||
16992740|NCT01015118|38136717|FG000|Overall Study|Worsening or AE of underlying disease|5|||
17051390|NCT00564486|38194865|FG000|Overall Study|Lost to Follow-up|3|||
17143225|NCT03694327|38286326|FG000|Overall Study|Lost to Follow-up|13|||
16780950|NCT02151682|37720066|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
17051391|NCT00564486|38194866|FG001|Overall Study|Lost to Follow-up|0|||
16992741|NCT01015118|38136718|FG001|Overall Study|Worsening or AE of underlying disease|4|||
16992742|NCT01015118|38136717|FG000|Overall Study|Progressive disease|364|||
16992743|NCT01015118|38136718|FG001|Overall Study|Progressive disease|229|||
16992744|NCT01015118|38136717|FG000|Overall Study|Not treated|9|||
16992745|NCT01015118|38136718|FG001|Overall Study|Not treated|5|||
16992746|NCT01015118|38136717|FG000|Overall Study|Other than stated above|42|||
17051392|NCT00564486|38194867|FG002|Overall Study|Lost to Follow-up|2|||
17051393|NCT00564486|38194868|FG003|Overall Study|Lost to Follow-up|2|||
17051394|NCT00481078|38194884|FG000|Overall Study|Progression of disease|11|||
17051395|NCT00481078|38194885|FG001|Overall Study|Progression of disease|11|||
17051396|NCT00481078|38194884|FG000|Overall Study|Adverse Event|15|||
17051397|NCT00481078|38194885|FG001|Overall Study|Adverse Event|3|||
17051398|NCT00481078|38194884|FG000|Overall Study|Death|5|||
17051399|NCT00481078|38194885|FG001|Overall Study|Death|3|||
17051400|NCT00481078|38194884|FG000|Overall Study|Intercurrent illness|1|||
17051401|NCT00481078|38194885|FG001|Overall Study|Intercurrent illness|0|||
17051402|NCT00481078|38194884|FG000|Overall Study|Withdrawal by Subject|7|||
17051403|NCT00481078|38194885|FG001|Overall Study|Withdrawal by Subject|1|||
17051404|NCT00481078|38194884|FG000|Overall Study|Information not available|1|||
17051405|NCT00481078|38194885|FG001|Overall Study|Information not available|0|||
17051406|NCT00481078|38194884|FG000|Overall Study|Received other treatment|2|||
17051407|NCT00481078|38194885|FG001|Overall Study|Received other treatment|1|||
17051408|NCT00481078|38194884|FG000|Overall Study|Brain metastasis|0|||
17051409|NCT00481078|38194885|FG001|Overall Study|Brain metastasis|1|||
17051410|NCT00480532|38194895|FG000|Overall Study|Withdrawal by Subject|2|||
17051411|NCT00480532|38194896|FG001|Overall Study|Withdrawal by Subject|4|||
17051412|NCT00480532|38194897|FG002|Overall Study|Withdrawal by Subject|3|||
17051413|NCT00480532|38194898|FG003|Overall Study|Withdrawal by Subject|1|||
17051414|NCT00480532|38194895|FG000|Overall Study|Protocol Violation|0|||
17051415|NCT00480532|38194896|FG001|Overall Study|Protocol Violation|0|||
17051416|NCT00480532|38194897|FG002|Overall Study|Protocol Violation|1|||
17051417|NCT00480532|38194898|FG003|Overall Study|Protocol Violation|0|||
17051418|NCT00496366|38194908|FG000|Overall Study|Death|1|||
17051419|NCT00488644|38194912|FG000|Overall Study|Not Eligible|1|||
17051420|NCT00488644|38194912|FG000|Overall Study|Not Evaluable|1|||
17051421|NCT00564018|38194919|FG000|Overall Study|Withdrawal by Subject|2|||
17051422|NCT00564018|38194920|FG001|Overall Study|Withdrawal by Subject|3|||
17051423|NCT00564018|38194921|FG002|Overall Study|Withdrawal by Subject|1|||
17051424|NCT03381287|38194933|FG000|Overall Study|Withdrawal by Subject|0|||
17051425|NCT03381287|38194934|FG001|Overall Study|Withdrawal by Subject|1|||
17051426|NCT03381287|38194935|FG002|Overall Study|Withdrawal by Subject|0|||
16992747|NCT01015118|38136718|FG001|Overall Study|Other than stated above|23|||
17051427|NCT03381287|38194936|FG003|Overall Study|Withdrawal by Subject|0|||
17051428|NCT03381287|38194933|FG000|Overall Study|Adverse Event|0|||
17051429|NCT03381287|38194934|FG001|Overall Study|Adverse Event|0|||
17051430|NCT03381287|38194935|FG002|Overall Study|Adverse Event|0|||
17051431|NCT03381287|38194936|FG003|Overall Study|Adverse Event|1|||
17051432|NCT03381287|38194933|FG000|Overall Study|Physician Decision|0|||
17051433|NCT03381287|38194934|FG001|Overall Study|Physician Decision|0|||
17051434|NCT03381287|38194935|FG002|Overall Study|Physician Decision|0|||
17051435|NCT03381287|38194936|FG003|Overall Study|Physician Decision|1|||
17051436|NCT00616928|38194960|FG000|Overall Study|Adverse Event|6|||
17051437|NCT00616928|38194961|FG001|Overall Study|Adverse Event|3|||
17051438|NCT00616928|38194962|FG002|Overall Study|Adverse Event|2|||
17051439|NCT00616928|38194963|FG003|Overall Study|Adverse Event|2|||
17051440|NCT00616928|38194960|FG000|Overall Study|Other|51|||
17051441|NCT00616928|38194961|FG001|Overall Study|Other|8|||
17051442|NCT00616928|38194962|FG002|Overall Study|Other|15|||
17051443|NCT00616928|38194963|FG003|Overall Study|Other|5|||
17051444|NCT00616928|38194960|FG000|Overall Study|Lost to Follow-up|5|||
16992748|NCT00800176|38136730|FG000|Overall Study|Adverse Event|2|||
16992749|NCT00800176|38136731|FG001|Overall Study|Adverse Event|1|||
16992750|NCT00800176|38136732|FG002|Overall Study|Adverse Event|0|||
16992751|NCT00800176|38136733|FG003|Overall Study|Adverse Event|2|||
16992752|NCT00800176|38136734|FG004|Overall Study|Adverse Event|1|||
16992753|NCT00800176|38136735|FG005|Overall Study|Adverse Event|1|||
16992754|NCT00800176|38136730|FG000|Overall Study|Refused treatment|3|||
16992755|NCT00800176|38136731|FG001|Overall Study|Refused treatment|2|||
16992756|NCT00800176|38136732|FG002|Overall Study|Refused treatment|0|||
16992757|NCT00800176|38136733|FG003|Overall Study|Refused treatment|0|||
16992758|NCT00800176|38136734|FG004|Overall Study|Refused treatment|1|||
16992759|NCT00800176|38136735|FG005|Overall Study|Refused treatment|4|||
16992760|NCT00800176|38136730|FG000|Overall Study|Failure to return|3|||
16992761|NCT00800176|38136731|FG001|Overall Study|Failure to return|3|||
16992762|NCT00800176|38136732|FG002|Overall Study|Failure to return|0|||
16992763|NCT00800176|38136733|FG003|Overall Study|Failure to return|2|||
16992764|NCT00800176|38136734|FG004|Overall Study|Failure to return|0|||
17051445|NCT00616928|38194961|FG001|Overall Study|Lost to Follow-up|7|||
17051446|NCT00616928|38194962|FG002|Overall Study|Lost to Follow-up|0|||
17051447|NCT00616928|38194963|FG003|Overall Study|Lost to Follow-up|0|||
17051448|NCT00563784|38194985|FG000|Overall Study|Withdrawal by Subject|2|||
17051449|NCT00563784|38194985|FG000|Overall Study|Screen Failures|20|||
17051450|NCT00203047|38195000|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
17051451|NCT00203047|38195001|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
17051452|NCT00203047|38195000|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
17051453|NCT00203047|38195001|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
17051454|NCT00203047|38195000|FG000|Overall Study|Withdrawal by Subject|13|||
17051455|NCT00203047|38195001|FG001|Overall Study|Withdrawal by Subject|47|||
17051456|NCT00203047|38195000|FG000|Overall Study|Teva requested participant withdrawal|1|||
17051457|NCT00203047|38195001|FG001|Overall Study|Teva requested participant withdrawal|1|||
17051458|NCT00203047|38195000|FG000|Overall Study|Physician Decision|8|||
17051459|NCT00203047|38195001|FG001|Overall Study|Physician Decision|7|||
17051460|NCT00203047|38195000|FG000|Overall Study|Non-compliance|4|||
17051461|NCT00203047|38195001|FG001|Overall Study|Non-compliance|8|||
17051462|NCT00203047|38195000|FG000|Overall Study|Protocol Violation|1|||
17051463|NCT00203047|38195001|FG001|Overall Study|Protocol Violation|0|||
17051464|NCT00203047|38195000|FG000|Overall Study|Lost to Follow-up|11|||
17051465|NCT00203047|38195001|FG001|Overall Study|Lost to Follow-up|5|||
17051466|NCT00203047|38195000|FG000|Overall Study|Adverse Event|8|||
17051467|NCT00203047|38195001|FG001|Overall Study|Adverse Event|18|||
17051468|NCT00203047|38195000|FG000|Overall Study|Death|1|||
17051469|NCT00203047|38195001|FG001|Overall Study|Death|2|||
17051470|NCT00203047|38195000|FG000|Overall Study|Pregnancy|3|||
17051471|NCT00203047|38195001|FG001|Overall Study|Pregnancy|0|||
16992765|NCT00800176|38136735|FG005|Overall Study|Failure to return|0|||
17051472|NCT00203047|38195000|FG000|Overall Study|Other|5|||
17051473|NCT00203047|38195001|FG001|Overall Study|Other|5|||
17051474|NCT00142519|38195009|FG000|Overall Study|Not Treated|7|||
17051475|NCT00142519|38195010|FG001|Overall Study|Not Treated|9|||
17051476|NCT00142519|38195009|FG000|Overall Study|Protocol Violation|1|||
17051477|NCT00142519|38195010|FG001|Overall Study|Protocol Violation|0|||
17051478|NCT00142519|38195009|FG000|Overall Study|Withdrawal by Subject|10|||
17051479|NCT00142519|38195010|FG001|Overall Study|Withdrawal by Subject|7|||
17051480|NCT00141817|38195029|FG000|Overall Study|Protocol Violation|0|||
17051481|NCT00141817|38195030|FG001|Overall Study|Protocol Violation|0|||
17051482|NCT00141817|38195031|FG002|Overall Study|Protocol Violation|1|||
17051483|NCT00141817|38195032|FG003|Overall Study|Protocol Violation|0|||
17051484|NCT00141817|38195029|FG000|Overall Study|Parent request|1|||
17051485|NCT00141817|38195030|FG001|Overall Study|Parent request|0|||
17051486|NCT00141817|38195031|FG002|Overall Study|Parent request|0|||
17051487|NCT00141817|38195032|FG003|Overall Study|Parent request|0|||
17051488|NCT00573170|38195042|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
17143226|NCT03694327|38286327|FG001|Overall Study|Lost to Follow-up|23|||
17143227|NCT03330288|38286335|FG000|Overall Study|Other reason|1|||
17051489|NCT00573170|38195043|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
17051490|NCT00573170|38195044|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
17051491|NCT00573170|38195045|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
17051492|NCT00573170|38195046|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
17051493|NCT00573170|38195047|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
17051494|NCT00573170|38195042|FG000|First Washout Period|Adverse Event|1|||
17051495|NCT00573170|38195043|FG001|First Washout Period|Adverse Event|1|||
16992766|NCT00800176|38136730|FG000|Overall Study|Other|1|||
16992767|NCT00800176|38136731|FG001|Overall Study|Other|0|||
16992768|NCT00800176|38136732|FG002|Overall Study|Other|0|||
16992769|NCT00800176|38136733|FG003|Overall Study|Other|0|||
16992770|NCT00800176|38136734|FG004|Overall Study|Other|2|||
16992771|NCT00800176|38136735|FG005|Overall Study|Other|0|||
16992772|NCT00715429|38136751|FG000|Overall Study|Did not complete the study diary|0|||
16992773|NCT00715429|38136752|FG001|Overall Study|Did not complete the study diary|1|||
16992774|NCT00715117|38136774|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
16992775|NCT00715117|38136775|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
16992776|NCT00723229|38136788|FG000|First Intervention|Lost to Follow-up|7|||
16992777|NCT00723229|38136789|FG001|First Intervention|Lost to Follow-up|3|||
16992778|NCT01030718|38136804|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
16992779|NCT01030718|38136805|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
16992780|NCT01030718|38136806|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
16992781|NCT01030718|38136804|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
17051496|NCT00573170|38195044|FG002|First Washout Period|Adverse Event|0|||
17051497|NCT00573170|38195045|FG003|First Washout Period|Adverse Event|0|||
17051498|NCT00573170|38195046|FG004|First Washout Period|Adverse Event|0|||
17051499|NCT00573170|38195047|FG005|First Washout Period|Adverse Event|1|||
17051500|NCT00573170|38195042|FG000|First Washout Period|Lack of Efficacy|0|||
17051501|NCT00573170|38195043|FG001|First Washout Period|Lack of Efficacy|0|||
17051502|NCT00573170|38195044|FG002|First Washout Period|Lack of Efficacy|0|||
17051503|NCT00573170|38195045|FG003|First Washout Period|Lack of Efficacy|0|||
17051504|NCT00573170|38195046|FG004|First Washout Period|Lack of Efficacy|0|||
17051505|NCT00573170|38195047|FG005|First Washout Period|Lack of Efficacy|1|||
17051506|NCT00573170|38195042|FG000|First Washout Period|Lost to Follow-up|1|||
17051507|NCT00573170|38195043|FG001|First Washout Period|Lost to Follow-up|1|||
17051508|NCT00573170|38195044|FG002|First Washout Period|Lost to Follow-up|0|||
17051509|NCT00573170|38195045|FG003|First Washout Period|Lost to Follow-up|2|||
17051510|NCT00573170|38195046|FG004|First Washout Period|Lost to Follow-up|0|||
17143228|NCT03330288|38286336|FG001|Overall Study|Other reason|1|||
17143229|NCT03330288|38286335|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
17143230|NCT03330288|38286336|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
17143231|NCT03330288|38286335|FG000|Overall Study|Adverse Event|1|||
17143232|NCT03330288|38286336|FG001|Overall Study|Adverse Event|0|||
17143233|NCT03330288|38286335|FG000|Overall Study|Withdrawal by Subject|1|||
17143234|NCT03330288|38286336|FG001|Overall Study|Withdrawal by Subject|0|||
17143235|NCT03330288|38286335|FG000|Overall Study|Lost to Follow-up|26|||
17143236|NCT03330288|38286336|FG001|Overall Study|Lost to Follow-up|7|||
17143237|NCT03084536|38286345|FG000|Overall Study|Determined to be ineligible|0|||
17051511|NCT00573170|38195047|FG005|First Washout Period|Lost to Follow-up|2|||
17051512|NCT00573170|38195042|FG000|First Washout Period|Withdrawal by Subject|2|||
17051513|NCT00573170|38195043|FG001|First Washout Period|Withdrawal by Subject|0|||
17051514|NCT00573170|38195044|FG002|First Washout Period|Withdrawal by Subject|0|||
17051515|NCT00573170|38195045|FG003|First Washout Period|Withdrawal by Subject|2|||
17051516|NCT00573170|38195046|FG004|First Washout Period|Withdrawal by Subject|3|||
17051517|NCT00573170|38195047|FG005|First Washout Period|Withdrawal by Subject|3|||
17051518|NCT00573170|38195042|FG000|First Washout Period|Other|4|||
17051519|NCT00573170|38195043|FG001|First Washout Period|Other|0|||
17051520|NCT00573170|38195044|FG002|First Washout Period|Other|1|||
17051521|NCT00573170|38195045|FG003|First Washout Period|Other|1|||
17051522|NCT00573170|38195046|FG004|First Washout Period|Other|0|||
17051523|NCT00573170|38195047|FG005|First Washout Period|Other|0|||
17051524|NCT00573170|38195042|FG000|Second Washout Period|Adverse Event|1|||
17051525|NCT00573170|38195043|FG001|Second Washout Period|Adverse Event|0|||
17051526|NCT00573170|38195044|FG002|Second Washout Period|Adverse Event|0|||
17051527|NCT00573170|38195045|FG003|Second Washout Period|Adverse Event|0|||
17051528|NCT00573170|38195046|FG004|Second Washout Period|Adverse Event|1|||
17051529|NCT00573170|38195047|FG005|Second Washout Period|Adverse Event|0|||
17051530|NCT00573170|38195042|FG000|Second Washout Period|Protocol Violation|2|||
17051531|NCT00573170|38195043|FG001|Second Washout Period|Protocol Violation|1|||
17051532|NCT00573170|38195044|FG002|Second Washout Period|Protocol Violation|1|||
17051533|NCT00573170|38195045|FG003|Second Washout Period|Protocol Violation|0|||
17051534|NCT00573170|38195046|FG004|Second Washout Period|Protocol Violation|0|||
17051535|NCT00573170|38195047|FG005|Second Washout Period|Protocol Violation|0|||
17051536|NCT00573170|38195042|FG000|Second Washout Period|Withdrawal by Subject|1|||
17051537|NCT00573170|38195043|FG001|Second Washout Period|Withdrawal by Subject|1|||
17051538|NCT00573170|38195044|FG002|Second Washout Period|Withdrawal by Subject|2|||
17051539|NCT00573170|38195045|FG003|Second Washout Period|Withdrawal by Subject|0|||
17051540|NCT00573170|38195046|FG004|Second Washout Period|Withdrawal by Subject|1|||
17051541|NCT00573170|38195047|FG005|Second Washout Period|Withdrawal by Subject|0|||
17051542|NCT00573170|38195042|FG000|Second Washout Period|Lost to Follow-up|0|||
17143238|NCT03084536|38286346|FG001|Overall Study|Determined to be ineligible|0|||
17143239|NCT03084536|38286347|FG002|Overall Study|Determined to be ineligible|16|||
17143240|NCT03084536|38286345|FG000|Overall Study|Withdrawal by Subject|0|||
17143241|NCT03084536|38286346|FG001|Overall Study|Withdrawal by Subject|0|||
17143242|NCT03084536|38286347|FG002|Overall Study|Withdrawal by Subject|4|||
17143243|NCT03084536|38286345|FG000|Overall Study|Physician Decision|0|||
17143244|NCT03084536|38286346|FG001|Overall Study|Physician Decision|0|||
17143245|NCT03084536|38286347|FG002|Overall Study|Physician Decision|3|||
17143246|NCT03084536|38286345|FG000|Overall Study|Death|0|||
17143247|NCT03084536|38286346|FG001|Overall Study|Death|0|||
17143248|NCT03084536|38286347|FG002|Overall Study|Death|1|||
17051543|NCT00573170|38195043|FG001|Second Washout Period|Lost to Follow-up|0|||
17051544|NCT00573170|38195044|FG002|Second Washout Period|Lost to Follow-up|0|||
17051545|NCT00573170|38195045|FG003|Second Washout Period|Lost to Follow-up|1|||
17051546|NCT00573170|38195046|FG004|Second Washout Period|Lost to Follow-up|0|||
17051547|NCT00573170|38195047|FG005|Second Washout Period|Lost to Follow-up|0|||
17051548|NCT00573170|38195042|FG000|Second Washout Period|Other|1|||
17051549|NCT00573170|38195043|FG001|Second Washout Period|Other|2|||
17051550|NCT00573170|38195044|FG002|Second Washout Period|Other|1|||
17051551|NCT00573170|38195045|FG003|Second Washout Period|Other|4|||
17051552|NCT00573170|38195046|FG004|Second Washout Period|Other|6|||
17051553|NCT00573170|38195047|FG005|Second Washout Period|Other|2|||
17051554|NCT00573170|38195042|FG000|Third Treatment Period|Withdrawal by Subject|1|||
17051555|NCT00573170|38195043|FG001|Third Treatment Period|Withdrawal by Subject|0|||
17051556|NCT00573170|38195044|FG002|Third Treatment Period|Withdrawal by Subject|0|||
17051557|NCT00573170|38195045|FG003|Third Treatment Period|Withdrawal by Subject|0|||
17051558|NCT00573170|38195046|FG004|Third Treatment Period|Withdrawal by Subject|0|||
17051559|NCT00573170|38195047|FG005|Third Treatment Period|Withdrawal by Subject|0|||
17051560|NCT00573170|38195042|FG000|Third Treatment Period|Lost to Follow-up|0|||
17051561|NCT00573170|38195043|FG001|Third Treatment Period|Lost to Follow-up|0|||
17051562|NCT00573170|38195044|FG002|Third Treatment Period|Lost to Follow-up|0|||
17143249|NCT03084536|38286345|FG000|Overall Study|Lost to Follow-up|0|||
17143250|NCT03084536|38286346|FG001|Overall Study|Lost to Follow-up|0|||
17143251|NCT03084536|38286347|FG002|Overall Study|Lost to Follow-up|1|||
17143252|NCT03084536|38286345|FG000|Overall Study|Protocol Violation|0|||
17143253|NCT03084536|38286346|FG001|Overall Study|Protocol Violation|0|||
17143254|NCT03084536|38286347|FG002|Overall Study|Protocol Violation|1|||
17051563|NCT00573170|38195045|FG003|Third Treatment Period|Lost to Follow-up|0|||
17051564|NCT00573170|38195046|FG004|Third Treatment Period|Lost to Follow-up|0|||
17051565|NCT00573170|38195047|FG005|Third Treatment Period|Lost to Follow-up|2|||
17051566|NCT00201643|38195066|FG000|Overall Study|Withdrawal by Subject|5|||
17051567|NCT00201643|38195067|FG001|Overall Study|Withdrawal by Subject|4|||
17051568|NCT00130039|38195075|FG000|Overall Study|Withdrawal by Subject|15|||
17051569|NCT00130039|38195076|FG001|Overall Study|Withdrawal by Subject|11|||
17051570|NCT00130039|38195075|FG000|Overall Study|Lost to Follow-up|3|||
17051571|NCT00130039|38195076|FG001|Overall Study|Lost to Follow-up|1|||
17051572|NCT00130039|38195075|FG000|Overall Study|Adverse Event|4|||
17051573|NCT00130039|38195076|FG001|Overall Study|Adverse Event|2|||
17051574|NCT00130039|38195075|FG000|Overall Study|Physician Decision|3|||
17051575|NCT00130039|38195076|FG001|Overall Study|Physician Decision|0|||
17051576|NCT00130039|38195075|FG000|Overall Study|clinical events without follow up MRI|5|||
17051577|NCT00130039|38195076|FG001|Overall Study|clinical events without follow up MRI|4|||
17051578|NCT00475852|38195084|FG000|Overall Study|Death|444|||
17051579|NCT00475852|38195085|FG001|Overall Study|Death|456|||
17051580|NCT00475852|38195084|FG000|Overall Study|Withdrawal by Subject|19|||
17051581|NCT00475852|38195085|FG001|Overall Study|Withdrawal by Subject|24|||
17051582|NCT00475852|38195084|FG000|Overall Study|Lost to Follow-up|54|||
17051583|NCT00475852|38195085|FG001|Overall Study|Lost to Follow-up|68|||
17051584|NCT00141271|38195094|FG000|Overall Study|Adverse Event|31|||
17051585|NCT00141271|38195095|FG001|Overall Study|Adverse Event|19|||
17051586|NCT00141271|38195096|FG002|Overall Study|Adverse Event|17|||
17051587|NCT00141271|38195094|FG000|Overall Study|Laboratory Abnormality|2|||
17051588|NCT00141271|38195095|FG001|Overall Study|Laboratory Abnormality|1|||
17051589|NCT00141271|38195096|FG002|Overall Study|Laboratory Abnormality|1|||
17051590|NCT00141271|38195094|FG000|Overall Study|Lack of Efficacy|7|||
17051591|NCT00141271|38195095|FG001|Overall Study|Lack of Efficacy|7|||
17051592|NCT00141271|38195096|FG002|Overall Study|Lack of Efficacy|3|||
17051593|NCT00141271|38195094|FG000|Overall Study|Lost to Follow-up|15|||
17051594|NCT00141271|38195095|FG001|Overall Study|Lost to Follow-up|15|||
17051595|NCT00141271|38195096|FG002|Overall Study|Lost to Follow-up|21|||
17051596|NCT00141271|38195094|FG000|Overall Study|Withdrawal by Subject|14|||
17051597|NCT00141271|38195095|FG001|Overall Study|Withdrawal by Subject|9|||
17051598|NCT00141271|38195096|FG002|Overall Study|Withdrawal by Subject|10|||
17051599|NCT00141271|38195094|FG000|Overall Study|Other|11|||
17051600|NCT00141271|38195095|FG001|Overall Study|Other|12|||
17051601|NCT00141271|38195096|FG002|Overall Study|Other|5|||
17051602|NCT00614120|38195108|FG000|Overall Study|Adverse Event|9|||
17051603|NCT00614120|38195109|FG001|Overall Study|Adverse Event|22|||
17051604|NCT00614120|38195110|FG002|Overall Study|Adverse Event|30|||
17051605|NCT00614120|38195111|FG003|Overall Study|Adverse Event|3|||
17051606|NCT00614120|38195108|FG000|Overall Study|Lack of Efficacy|3|||
17051607|NCT00614120|38195109|FG001|Overall Study|Lack of Efficacy|3|||
17051608|NCT00614120|38195110|FG002|Overall Study|Lack of Efficacy|2|||
17051609|NCT00614120|38195111|FG003|Overall Study|Lack of Efficacy|2|||
17051610|NCT00614120|38195108|FG000|Overall Study|Protocol Violation|2|||
17051611|NCT00614120|38195109|FG001|Overall Study|Protocol Violation|5|||
17051612|NCT00614120|38195110|FG002|Overall Study|Protocol Violation|3|||
17051613|NCT00614120|38195111|FG003|Overall Study|Protocol Violation|1|||
16780951|NCT02151682|37720061|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
16780952|NCT02151682|37720062|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
17051614|NCT00614120|38195108|FG000|Overall Study|Withdrawal criteria|1|||
17051615|NCT00614120|38195109|FG001|Overall Study|Withdrawal criteria|0|||
17051616|NCT00614120|38195110|FG002|Overall Study|Withdrawal criteria|0|||
17051617|NCT00614120|38195111|FG003|Overall Study|Withdrawal criteria|0|||
17051618|NCT00614120|38195108|FG000|Overall Study|Withdrawal by Subject|9|||
17051619|NCT00614120|38195109|FG001|Overall Study|Withdrawal by Subject|10|||
17051620|NCT00614120|38195110|FG002|Overall Study|Withdrawal by Subject|16|||
17051621|NCT00614120|38195111|FG003|Overall Study|Withdrawal by Subject|3|||
17051622|NCT00614120|38195108|FG000|Overall Study|Did not meet trial criteria|0|||
17051623|NCT00614120|38195109|FG001|Overall Study|Did not meet trial criteria|1|||
17051624|NCT00614120|38195110|FG002|Overall Study|Did not meet trial criteria|1|||
17051625|NCT00614120|38195111|FG003|Overall Study|Did not meet trial criteria|1|||
17051626|NCT00614120|38195108|FG000|Overall Study|hCG positive (not pregnant)|0|||
17051627|NCT00614120|38195109|FG001|Overall Study|hCG positive (not pregnant)|0|||
17051628|NCT00614120|38195110|FG002|Overall Study|hCG positive (not pregnant)|1|||
17051629|NCT00614120|38195111|FG003|Overall Study|hCG positive (not pregnant)|0|||
17051630|NCT00614120|38195108|FG000|Overall Study|Hypoglycaemia|0|||
17051631|NCT00614120|38195109|FG001|Overall Study|Hypoglycaemia|0|||
17051632|NCT00614120|38195110|FG002|Overall Study|Hypoglycaemia|0|||
17051633|NCT00614120|38195111|FG003|Overall Study|Hypoglycaemia|1|||
17051634|NCT00614120|38195108|FG000|Overall Study|Lack of trial product|3|||
17051635|NCT00614120|38195109|FG001|Overall Study|Lack of trial product|3|||
17051636|NCT00614120|38195110|FG002|Overall Study|Lack of trial product|2|||
17051637|NCT00614120|38195111|FG003|Overall Study|Lack of trial product|0|||
17051638|NCT00614120|38195108|FG000|Overall Study|Late syphilis, latent|1|||
17051639|NCT00614120|38195109|FG001|Overall Study|Late syphilis, latent|0|||
17051640|NCT00614120|38195110|FG002|Overall Study|Late syphilis, latent|0|||
17051641|NCT00614120|38195111|FG003|Overall Study|Late syphilis, latent|0|||
17051642|NCT00614120|38195108|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
17051643|NCT00614120|38195109|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
17051644|NCT00614120|38195110|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
17051645|NCT00614120|38195111|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
17051646|NCT00614120|38195108|FG000|Overall Study|Lost to Follow-up|1|||
17051647|NCT00614120|38195109|FG001|Overall Study|Lost to Follow-up|2|||
17051648|NCT00614120|38195110|FG002|Overall Study|Lost to Follow-up|3|||
17051649|NCT00614120|38195111|FG003|Overall Study|Lost to Follow-up|4|||
17051650|NCT00496054|38195121|FG000|Overall Study|Adverse Event|1|||
17051651|NCT00496054|38195121|FG000|Overall Study|Lost to Follow-up|7|||
17051652|NCT00495820|38195127|FG000|Overall Study|Adverse Event|1|||
17051653|NCT00495820|38195128|FG001|Overall Study|Adverse Event|1|||
17051654|NCT00495586|38195136|FG000|Overall Study|Withdrawal by Subject|4|||
16780953|NCT02151682|37720063|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
16780954|NCT02151682|37720064|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
16780955|NCT02151682|37720065|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
17051655|NCT00495586|38195137|FG001|Overall Study|Withdrawal by Subject|4|||
17051656|NCT00613730|38195145|FG000|Overall Study|Disease progression|2|||
17051657|NCT00613730|38195145|FG000|Overall Study|Administrative decision|1|||
17051658|NCT00613574|38195149|FG000|Overall Study|Adverse Event|3|||
17051659|NCT00613574|38195149|FG000|Overall Study|Lost to Follow-up|2|||
17051660|NCT00613574|38195149|FG000|Overall Study|Other|1|||
17051661|NCT00613106|38195155|FG000|Overall Study|Adverse Event|3|||
17051662|NCT00613106|38195156|FG001|Overall Study|Adverse Event|1|||
17051663|NCT00613106|38195155|FG000|Overall Study|Withdrawal by Subject|6|||
17051664|NCT00613106|38195156|FG001|Overall Study|Withdrawal by Subject|3|||
17051665|NCT00613106|38195155|FG000|Overall Study|Lost to Follow-up|7|||
17051666|NCT00613106|38195156|FG001|Overall Study|Lost to Follow-up|2|||
17143255|NCT03084536|38286345|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
17051667|NCT00613106|38195155|FG000|Overall Study|misc|4|||
17051668|NCT00613106|38195156|FG001|Overall Study|misc|3|||
17051669|NCT00141037|38195164|FG000|Overall Study|Physician Decision|1|||
17051670|NCT00141037|38195165|FG001|Overall Study|Physician Decision|2|||
17051671|NCT00141037|38195164|FG000|Overall Study|Lost to Follow-up|3|||
17051672|NCT00141037|38195165|FG001|Overall Study|Lost to Follow-up|1|||
17051673|NCT00141037|38195164|FG000|Overall Study|Protocol Violation|0|||
17051674|NCT00141037|38195165|FG001|Overall Study|Protocol Violation|2|||
17051675|NCT00141037|38195164|FG000|Overall Study|Withdrawal by Subject|2|||
17051676|NCT00141037|38195165|FG001|Overall Study|Withdrawal by Subject|1|||
17051677|NCT00141037|38195164|FG000|Overall Study|Other|0|||
17051678|NCT00141037|38195165|FG001|Overall Study|Other|1|||
17051679|NCT00141037|38195164|FG000|Overall Study|Moved from area|1|||
17051680|NCT00141037|38195165|FG001|Overall Study|Moved from area|7|||
17051681|NCT00141037|38195164|FG000|Overall Study|Graft Failure|3|||
17051682|NCT00141037|38195165|FG001|Overall Study|Graft Failure|4|||
17051683|NCT00140413|38195174|FG000|Overall Study|Lost to Follow-up|1|||
17051684|NCT00140413|38195175|FG001|Overall Study|Lost to Follow-up|0|||
17051685|NCT00140413|38195174|FG000|Overall Study|Withdrawal by Subject|2|||
17051686|NCT00140413|38195175|FG001|Overall Study|Withdrawal by Subject|0|||
17051687|NCT00139477|38195184|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
16780956|NCT02151682|37720066|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
17051688|NCT00139477|38195185|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
17051689|NCT00139477|38195184|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
17051690|NCT00139477|38195185|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
17051691|NCT00139477|38195184|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
17051692|NCT00139477|38195185|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
17051693|NCT00139477|38195184|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
17051694|NCT00139477|38195185|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
17051695|NCT00139477|38195184|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
17051696|NCT00139477|38195185|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
17051697|NCT00139477|38195184|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
17051698|NCT00139477|38195185|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
17051699|NCT00139477|38195184|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
17051700|NCT00139477|38195185|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
17143256|NCT03084536|38286346|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
17143257|NCT03084536|38286347|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
17143258|NCT03289143|38286358|FG000|Overall Study|Caregiver Unavailability|1|||
17143259|NCT03289143|38286359|FG001|Overall Study|Caregiver Unavailability|1|||
17143260|NCT03289143|38286360|FG002|Overall Study|Caregiver Unavailability|0|||
17143261|NCT03289143|38286361|FG003|Overall Study|Caregiver Unavailability|0|||
17143262|NCT03289143|38286358|FG000|Overall Study|Research Department Closure|0|||
17143263|NCT03289143|38286359|FG001|Overall Study|Research Department Closure|0|||
17143264|NCT03289143|38286360|FG002|Overall Study|Research Department Closure|1|||
17143265|NCT03289143|38286361|FG003|Overall Study|Research Department Closure|0|||
17143266|NCT03289143|38286358|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
17143267|NCT03289143|38286359|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
17143268|NCT03289143|38286360|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
17143269|NCT03289143|38286361|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
17143270|NCT03289143|38286358|FG000|Overall Study|Medical Monitor Decision|1|||
17143271|NCT03289143|38286359|FG001|Overall Study|Medical Monitor Decision|0|||
17143272|NCT03289143|38286360|FG002|Overall Study|Medical Monitor Decision|0|||
17143273|NCT03289143|38286361|FG003|Overall Study|Medical Monitor Decision|0|||
17143274|NCT03289143|38286358|FG000|Overall Study|Participant Non-Compliance|0|||
17143275|NCT03289143|38286359|FG001|Overall Study|Participant Non-Compliance|0|||
17143276|NCT03289143|38286360|FG002|Overall Study|Participant Non-Compliance|1|||
17051701|NCT00563706|38195202|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
17051702|NCT00563706|38195203|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
17051703|NCT00563706|38195204|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
17051704|NCT00563706|38195205|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
17051705|NCT00563706|38195206|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
17051706|NCT00563706|38195207|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
17051707|NCT00563706|38195208|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
17051708|NCT00563706|38195209|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
17051709|NCT00563706|38195210|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
17051710|NCT00563706|38195202|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
17051711|NCT00563706|38195203|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
17051712|NCT00563706|38195204|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
17051713|NCT00563706|38195205|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
17051714|NCT00563706|38195206|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
17051715|NCT00563706|38195207|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
17051716|NCT00563706|38195208|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
17051717|NCT00563706|38195209|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
17051718|NCT00563706|38195210|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
17051719|NCT00563706|38195202|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
17051720|NCT00563706|38195203|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
17090072|NCT00270894|38230160|FG000|Overall Study|Adverse Event|1|||
17090073|NCT00270894|38230160|FG000|Overall Study|Withdrawal by Subject|1|||
17090074|NCT00317642|38230166|FG000|Overall Study|Not Received Either Study Drug|1|||
17090075|NCT00317642|38230167|FG001|Overall Study|Not Received Either Study Drug|3|||
17090076|NCT00317642|38230166|FG000|Overall Study|Physician Decision|15|||
17090077|NCT00317642|38230167|FG001|Overall Study|Physician Decision|7|||
17090078|NCT00317642|38230166|FG000|Overall Study|Participant declined treatment|14|||
17090079|NCT00317642|38230167|FG001|Overall Study|Participant declined treatment|3|||
17090080|NCT00317642|38230166|FG000|Overall Study|Adverse Event|17|||
17090081|NCT00317642|38230167|FG001|Overall Study|Adverse Event|5|||
17090082|NCT00317642|38230166|FG000|Overall Study|Treatment Failure|56|||
17090083|NCT00317642|38230167|FG001|Overall Study|Treatment Failure|102|||
17090084|NCT00317642|38230166|FG000|Overall Study|Disease Recurrence|1|||
17143277|NCT03289143|38286361|FG003|Overall Study|Participant Non-Compliance|0|||
17143278|NCT03289143|38286358|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
17143279|NCT03289143|38286359|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
17143280|NCT03289143|38286360|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
17143281|NCT03289143|38286361|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
17143282|NCT03289143|38286358|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
17143283|NCT03289143|38286359|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
17143284|NCT03289143|38286360|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
17143285|NCT03289143|38286361|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
17143286|NCT03289143|38286358|FG000|Overall Study|Caregiver Passed Away|1|||
17143287|NCT03289143|38286359|FG001|Overall Study|Caregiver Passed Away|0|||
17143288|NCT03289143|38286360|FG002|Overall Study|Caregiver Passed Away|0|||
17143289|NCT03289143|38286361|FG003|Overall Study|Caregiver Passed Away|0|||
17143290|NCT03289143|38286358|FG000|Overall Study|Physician Decision|0|||
17143291|NCT03289143|38286359|FG001|Overall Study|Physician Decision|2|||
17143292|NCT03289143|38286360|FG002|Overall Study|Physician Decision|2|||
17143293|NCT03289143|38286361|FG003|Overall Study|Physician Decision|2|||
17143294|NCT03289143|38286358|FG000|Overall Study|Protocol Deviation|2|||
17143295|NCT03289143|38286359|FG001|Overall Study|Protocol Deviation|1|||
17143296|NCT03289143|38286360|FG002|Overall Study|Protocol Deviation|3|||
17143297|NCT03289143|38286361|FG003|Overall Study|Protocol Deviation|1|||
17143298|NCT03289143|38286358|FG000|Overall Study|Study Terminated By Sponsor|101|||
17143299|NCT03289143|38286359|FG001|Overall Study|Study Terminated By Sponsor|75|||
17143300|NCT03289143|38286360|FG002|Overall Study|Study Terminated By Sponsor|100|||
17143301|NCT03289143|38286361|FG003|Overall Study|Study Terminated By Sponsor|69|||
17143302|NCT03289143|38286358|FG000|Overall Study|Withdrawal by Subject|14|||
17143303|NCT03289143|38286359|FG001|Overall Study|Withdrawal by Subject|6|||
17143304|NCT03289143|38286360|FG002|Overall Study|Withdrawal by Subject|14|||
17143305|NCT03289143|38286361|FG003|Overall Study|Withdrawal by Subject|12|||
17143306|NCT03289143|38286358|FG000|Overall Study|Adverse Event|10|||
17143307|NCT03289143|38286359|FG001|Overall Study|Adverse Event|7|||
17143308|NCT03289143|38286360|FG002|Overall Study|Adverse Event|6|||
17143309|NCT03289143|38286361|FG003|Overall Study|Adverse Event|5|||
17143310|NCT03289143|38286358|FG000|Overall Study|Death|2|||
17143311|NCT03289143|38286359|FG001|Overall Study|Death|0|||
17143312|NCT03289143|38286360|FG002|Overall Study|Death|2|||
17143313|NCT03289143|38286361|FG003|Overall Study|Death|1|||
17143314|NCT03289143|38286358|FG000|Overall Study|Lost to Follow-up|2|||
17143315|NCT03289143|38286359|FG001|Overall Study|Lost to Follow-up|1|||
17143316|NCT03289143|38286360|FG002|Overall Study|Lost to Follow-up|1|||
17143317|NCT03289143|38286361|FG003|Overall Study|Lost to Follow-up|0|||
17143318|NCT03289143|38286358|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
17143319|NCT03289143|38286359|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
17143320|NCT03289143|38286360|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
17143321|NCT03289143|38286361|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
17143322|NCT03289143|38286358|FG000|Overall Study|Withdrawal by Caregiver|0|||
17143323|NCT03289143|38286359|FG001|Overall Study|Withdrawal by Caregiver|1|||
17143324|NCT03289143|38286360|FG002|Overall Study|Withdrawal by Caregiver|0|||
17051721|NCT00563706|38195204|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
17051722|NCT00563706|38195205|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
17051723|NCT00563706|38195206|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
17051724|NCT00563706|38195207|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
17051725|NCT00563706|38195208|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
17051726|NCT00563706|38195209|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
17051727|NCT00563706|38195210|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
17051728|NCT00563706|38195202|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
17051729|NCT00563706|38195203|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
17051730|NCT00563706|38195204|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
17051731|NCT00563706|38195205|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
17051732|NCT00563706|38195206|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
17143325|NCT03289143|38286361|FG003|Overall Study|Withdrawal by Caregiver|0|||
17143326|NCT03289143|38286358|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
17143327|NCT03289143|38286359|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
17143328|NCT03289143|38286360|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
17143329|NCT03289143|38286361|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
17143330|NCT03289143|38286358|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
17143331|NCT03289143|38286359|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
17143332|NCT03289143|38286360|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
17143333|NCT03289143|38286361|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
17143334|NCT03311724|38286380|FG000|Overall Study|Physician Decision|0|||
17143335|NCT03311724|38286381|FG001|Overall Study|Physician Decision|0|||
17143336|NCT03311724|38286382|FG002|Overall Study|Physician Decision|0|||
17143337|NCT03311724|38286383|FG003|Overall Study|Physician Decision|1|||
17143338|NCT03311724|38286380|FG000|Overall Study|Protocol Violation|1|||
17143339|NCT03311724|38286381|FG001|Overall Study|Protocol Violation|0|||
17143340|NCT03311724|38286382|FG002|Overall Study|Protocol Violation|1|||
17143341|NCT03311724|38286383|FG003|Overall Study|Protocol Violation|0|||
17143342|NCT03311724|38286380|FG000|Overall Study|Withdrawal by Subject|1|||
17143343|NCT03311724|38286381|FG001|Overall Study|Withdrawal by Subject|1|||
17143344|NCT03311724|38286382|FG002|Overall Study|Withdrawal by Subject|0|||
17143345|NCT03311724|38286383|FG003|Overall Study|Withdrawal by Subject|0|||
17143346|NCT03311724|38286380|FG000|Overall Study|Lost to Follow-up|1|||
17143347|NCT03311724|38286381|FG001|Overall Study|Lost to Follow-up|0|||
17143348|NCT03311724|38286382|FG002|Overall Study|Lost to Follow-up|0|||
17143349|NCT03311724|38286383|FG003|Overall Study|Lost to Follow-up|0|||
17143350|NCT03311724|38286380|FG000|Overall Study|Sponsor Decision|0|||
17143351|NCT03311724|38286381|FG001|Overall Study|Sponsor Decision|0|||
17143352|NCT03311724|38286382|FG002|Overall Study|Sponsor Decision|1|||
17143353|NCT03311724|38286383|FG003|Overall Study|Sponsor Decision|0|||
17143354|NCT03311646|38286405|FG000|Overall Study|Physician Decision|1|||
17143355|NCT03311646|38286405|FG000|Overall Study|Withdrawal by Subject|5|||
17143356|NCT03311646|38286405|FG000|Overall Study|Lost to Follow-up|5|||
17143357|NCT03311646|38286405|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
17143358|NCT01672892|38286412|FG000|Overall Study|Protocol Violation|7|||
17143359|NCT01672892|38286413|FG001|Overall Study|Protocol Violation|3|||
17143360|NCT03288987|38286424|FG000|Overall Study|Protocol Violation|10|||
17143361|NCT03288987|38286425|FG001|Overall Study|Protocol Violation|4|||
17143362|NCT02939781|38286431|FG000|Overall Study|Protocol Violation|8|||
17143363|NCT02939781|38286431|FG000|Overall Study|Withdrawal by Subject|1|||
17143364|NCT03083990|38286447|FG000|Overall Study|Adverse Event|1|||
17143365|NCT03083990|38286448|FG001|Overall Study|Adverse Event|0|||
17143366|NCT03252015|38286458|FG000|Overall Study|Withdrawal by Subject|0|||
17143367|NCT03252015|38286459|FG001|Overall Study|Withdrawal by Subject|1|||
17143368|NCT03252015|38286460|FG002|Overall Study|Withdrawal by Subject|1|||
17143369|NCT03252015|38286461|FG003|Overall Study|Withdrawal by Subject|0|||
17143370|NCT03252015|38286458|FG000|Overall Study|Adverse Event|1|||
17143371|NCT03252015|38286459|FG001|Overall Study|Adverse Event|0|||
17143372|NCT03252015|38286460|FG002|Overall Study|Adverse Event|0|||
17143373|NCT03252015|38286461|FG003|Overall Study|Adverse Event|1|||
17143374|NCT03083132|38286487|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
17143375|NCT03083132|38286488|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
17051733|NCT00563706|38195207|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
17051734|NCT00563706|38195208|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
17051735|NCT00563706|38195209|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
17051736|NCT00563706|38195210|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
17051737|NCT00563706|38195202|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
17051738|NCT00563706|38195203|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
17051739|NCT00563706|38195204|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
17051740|NCT00563706|38195205|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
17051741|NCT00563706|38195206|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
17051742|NCT00563706|38195207|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
17051743|NCT00563706|38195208|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
17051744|NCT00563706|38195209|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
17051745|NCT00563706|38195210|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
17051746|NCT00129961|38195232|FG000|Overall Study|Adverse Event|1|||
17051747|NCT00129961|38195233|FG001|Overall Study|Adverse Event|0|||
17051748|NCT00129961|38195232|FG000|Overall Study|Death|1|||
17051749|NCT00129961|38195233|FG001|Overall Study|Death|1|||
17051750|NCT00129961|38195232|FG000|Overall Study|Withdrawal by Sponsor|14|||
17051751|NCT00129961|38195233|FG001|Overall Study|Withdrawal by Sponsor|20|||
17051752|NCT00129961|38195232|FG000|Overall Study|Physician Decision|1|||
17051753|NCT00129961|38195233|FG001|Overall Study|Physician Decision|0|||
17051754|NCT00129961|38195232|FG000|Overall Study|Withdrawal by Subject|2|||
17051755|NCT00129961|38195233|FG001|Overall Study|Withdrawal by Subject|1|||
17051756|NCT00129961|38195232|FG000|Overall Study|Missing Record|0|||
17051757|NCT00129961|38195233|FG001|Overall Study|Missing Record|1|||
17051758|NCT00528567|38195241|FG000|Overall Study|Death|4|||
17051759|NCT00528567|38195242|FG001|Overall Study|Death|5|||
17051760|NCT00528567|38195241|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
17051761|NCT00528567|38195242|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
17051762|NCT00528567|38195241|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
17051763|NCT00528567|38195242|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
17051764|NCT00528567|38195241|FG000|Overall Study|Violation Criteria at Entry|3|||
17051765|NCT00528567|38195242|FG001|Overall Study|Violation Criteria at Entry|17|||
17051766|NCT00528567|38195241|FG000|Overall Study|Withdrew Consent|59|||
17051767|NCT00528567|38195242|FG001|Overall Study|Withdrew Consent|55|||
17051768|NCT00528567|38195241|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
17051769|NCT00528567|38195242|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
17051770|NCT00528567|38195241|FG000|Overall Study|Failure to Return|1|||
17051771|NCT00528567|38195242|FG001|Overall Study|Failure to Return|4|||
17051772|NCT00528567|38195241|FG000|Overall Study|Other Protocol Violation|5|||
17051773|NCT00528567|38195242|FG001|Overall Study|Other Protocol Violation|21|||
17051774|NCT00528567|38195241|FG000|Overall Study|Administrative/Other|22|||
17051775|NCT00528567|38195242|FG001|Overall Study|Administrative/Other|75|||
17051776|NCT00138151|38195255|FG000|Overall Study|Withdrawal by Subject|3|||
17051777|NCT00138151|38195255|FG000|Overall Study|Physician Decision|1|||
17051778|NCT00138073|38195259|FG000|Overall Study|lack of resources|55|||
17051779|NCT02581631|38195268|FG000|Overall Study|Disease progression|29|||
17051780|NCT02581631|38195269|FG001|Overall Study|Disease progression|19|||
17051781|NCT02581631|38195270|FG002|Overall Study|Disease progression|13|||
17051782|NCT02581631|38195271|FG003|Overall Study|Disease progression|5|||
17051783|NCT02581631|38195272|FG004|Overall Study|Disease progression|8|||
17051784|NCT02581631|38195268|FG000|Overall Study|Study drug toxicity|4|||
17051785|NCT02581631|38195269|FG001|Overall Study|Study drug toxicity|6|||
17051786|NCT02581631|38195270|FG002|Overall Study|Study drug toxicity|7|||
17051787|NCT02581631|38195271|FG003|Overall Study|Study drug toxicity|0|||
17051788|NCT02581631|38195272|FG004|Overall Study|Study drug toxicity|3|||
17051789|NCT02581631|38195268|FG000|Overall Study|AE unrelated to study drug|3|||
17051790|NCT02581631|38195269|FG001|Overall Study|AE unrelated to study drug|1|||
17051791|NCT02581631|38195270|FG002|Overall Study|AE unrelated to study drug|1|||
17051792|NCT02581631|38195271|FG003|Overall Study|AE unrelated to study drug|0|||
17051793|NCT02581631|38195272|FG004|Overall Study|AE unrelated to study drug|2|||
17051794|NCT02581631|38195268|FG000|Overall Study|Request to discontinue|1|||
17051795|NCT02581631|38195269|FG001|Overall Study|Request to discontinue|0|||
17051796|NCT02581631|38195270|FG002|Overall Study|Request to discontinue|3|||
17051797|NCT02581631|38195271|FG003|Overall Study|Request to discontinue|0|||
17051798|NCT02581631|38195272|FG004|Overall Study|Request to discontinue|1|||
17051799|NCT02581631|38195268|FG000|Overall Study|participant withdrew consent|3|||
17051800|NCT02581631|38195269|FG001|Overall Study|participant withdrew consent|0|||
17051801|NCT02581631|38195270|FG002|Overall Study|participant withdrew consent|1|||
17051802|NCT02581631|38195271|FG003|Overall Study|participant withdrew consent|0|||
17051803|NCT02581631|38195272|FG004|Overall Study|participant withdrew consent|0|||
17051804|NCT02581631|38195268|FG000|Overall Study|Maximum clinical benefit|1|||
17051805|NCT02581631|38195269|FG001|Overall Study|Maximum clinical benefit|7|||
17051806|NCT02581631|38195270|FG002|Overall Study|Maximum clinical benefit|1|||
17051807|NCT02581631|38195271|FG003|Overall Study|Maximum clinical benefit|3|||
17051808|NCT02581631|38195272|FG004|Overall Study|Maximum clinical benefit|13|||
17051809|NCT02581631|38195268|FG000|Overall Study|Other Reasons|1|||
17051810|NCT02581631|38195269|FG001|Overall Study|Other Reasons|0|||
17051811|NCT02581631|38195270|FG002|Overall Study|Other Reasons|2|||
17051812|NCT02581631|38195271|FG003|Overall Study|Other Reasons|2|||
17051813|NCT02581631|38195272|FG004|Overall Study|Other Reasons|3|||
17051814|NCT02581631|38195268|FG000|Overall Study|Poor/Non-Compliance|0|||
17051815|NCT02581631|38195269|FG001|Overall Study|Poor/Non-Compliance|0|||
17051816|NCT02581631|38195270|FG002|Overall Study|Poor/Non-Compliance|1|||
17051817|NCT02581631|38195271|FG003|Overall Study|Poor/Non-Compliance|0|||
17051818|NCT02581631|38195272|FG004|Overall Study|Poor/Non-Compliance|0|||
17051819|NCT00529035|38195284|FG000|Overall Study|Withdrawal by Subject|1|||
17051820|NCT00609674|38195297|FG000|Overall Study|Adverse Event|1|||
17051821|NCT00609674|38195298|FG001|Overall Study|Adverse Event|1|||
17051822|NCT00609674|38195297|FG000|Overall Study|Protocol Violation|3|||
17051823|NCT00609674|38195298|FG001|Overall Study|Protocol Violation|5|||
17051824|NCT00609674|38195297|FG000|Overall Study|Lost to Follow-up|1|||
17051825|NCT00609674|38195298|FG001|Overall Study|Lost to Follow-up|0|||
17051826|NCT00609674|38195297|FG000|Overall Study|Withdrew consent|2|||
16780957|NCT02151682|37720061|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
17051827|NCT00609674|38195298|FG001|Overall Study|Withdrew consent|1|||
17051828|NCT00137839|38195304|FG000|Overall Study|Adverse Event|7|||
17051829|NCT00137839|38195304|FG000|Overall Study|Physician Decision|7|||
17051830|NCT00137839|38195304|FG000|Overall Study|Death|8|||
17051831|NCT00137839|38195304|FG000|Overall Study|Disease Progression|60|||
17051832|NCT00137839|38195304|FG000|Overall Study|Not Start Treatment|1|||
17051833|NCT00137839|38195304|FG000|Overall Study|Prolonged Treatment Delay|1|||
17051834|NCT00563316|38195311|FG000|Overall Study|Adverse Event|2|||
17051835|NCT00563316|38195311|FG000|Overall Study|Physician Decision|1|||
17051836|NCT00563316|38195311|FG000|Overall Study|Lost to Follow-up|2|||
17051837|NCT00563316|38195311|FG000|Overall Study|Death|1|||
17051838|NCT00563316|38195311|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
17051839|NCT00563316|38195311|FG000|Overall Study|Other|1|||
17051840|NCT03178487|38195321|FG000|Period 1|Adverse Event|1|||
17051841|NCT03178487|38195322|FG001|Period 1|Adverse Event|2|||
17051842|NCT03178487|38195321|FG000|Period 1|Withdrawal by Subject|2|||
17051843|NCT03178487|38195322|FG001|Period 1|Withdrawal by Subject|1|||
17051844|NCT03178487|38195321|FG000|Period 1|Lost to Follow-up|1|||
17051845|NCT03178487|38195322|FG001|Period 1|Lost to Follow-up|0|||
17051846|NCT03178487|38195321|FG000|Period 1|Other|0|||
17051847|NCT03178487|38195322|FG001|Period 1|Other|1|||
17051848|NCT03178487|38195321|FG000|Period 2|Adverse Event|4|||
17051849|NCT03178487|38195322|FG001|Period 2|Adverse Event|4|||
17051850|NCT03178487|38195321|FG000|Period 2|Withdrawal by Subject|6|||
17051851|NCT03178487|38195322|FG001|Period 2|Withdrawal by Subject|6|||
17051852|NCT03178487|38195321|FG000|Period 2|Lost to Follow-up|2|||
17051853|NCT03178487|38195322|FG001|Period 2|Lost to Follow-up|2|||
17051854|NCT03178487|38195321|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
17143376|NCT03083132|38286487|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
17143377|NCT03083132|38286488|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
17143378|NCT03083132|38286487|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
16780958|NCT02151682|37720062|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
17051855|NCT03178487|38195322|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
17051856|NCT03178487|38195321|FG000|Period 2|Other|8|||
17051857|NCT03178487|38195322|FG001|Period 2|Other|7|||
17051858|NCT00528957|38195331|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
17051859|NCT00528957|38195332|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
17051860|NCT00528957|38195331|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
17051861|NCT00528957|38195332|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
17051862|NCT00528957|38195331|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
17051863|NCT00528957|38195332|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
17051864|NCT00528957|38195331|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
17051865|NCT00528957|38195332|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
17051866|NCT00528957|38195331|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
17051867|NCT00528957|38195332|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
17051868|NCT00528957|38195331|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
17051869|NCT00528957|38195332|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
17051870|NCT00528957|38195331|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
17051871|NCT00528957|38195332|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
17051872|NCT00528957|38195331|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
17051873|NCT00528957|38195332|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
17051874|NCT00528957|38195331|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
17051875|NCT00528957|38195332|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
17051876|NCT00528957|38195331|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
17051877|NCT00528957|38195332|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
17051878|NCT00528957|38195331|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
17051879|NCT00528957|38195332|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
17051880|NCT00528957|38195331|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
17051881|NCT00528957|38195332|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
17051882|NCT00528957|38195331|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
17051883|NCT00528957|38195332|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
17051884|NCT00528957|38195331|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
17051885|NCT00528957|38195332|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
17051886|NCT00528957|38195331|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
17051887|NCT00528957|38195332|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
17051888|NCT00528957|38195331|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
17051889|NCT00528957|38195332|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
17051890|NCT00560508|38195350|FG000|12 Week Double-blind Period|Adverse Event|3|||
17051891|NCT00560508|38195351|FG001|12 Week Double-blind Period|Adverse Event|2|||
17051892|NCT00560508|38195350|FG000|12 Week Double-blind Period|Protocol Violation|1|||
17051893|NCT00560508|38195351|FG001|12 Week Double-blind Period|Protocol Violation|0|||
17090085|NCT00317642|38230167|FG001|Overall Study|Disease Recurrence|2|||
17051894|NCT00560508|38195350|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
17051895|NCT00560508|38195351|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
17051896|NCT00560508|38195350|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
17051897|NCT00560508|38195351|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
17051898|NCT00560508|38195350|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
17051899|NCT00560508|38195351|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
17051900|NCT00560508|38195350|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
17051901|NCT00560508|38195351|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
17051902|NCT00560508|38195350|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
17051903|NCT00560508|38195351|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
17051904|NCT03962790|38195362|FG000|Period 1|Adverse Event|0|||
17051905|NCT03962790|38195363|FG001|Period 1|Adverse Event|1|||
17051906|NCT03962790|38195362|FG000|Period 1|Failed to meet all eligibility criteria|1|||
17051907|NCT03962790|38195363|FG001|Period 1|Failed to meet all eligibility criteria|1|||
17051908|NCT03962790|38195362|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
17051909|NCT03962790|38195363|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
17051910|NCT03962790|38195362|FG000|Period 1|Withdrawal by Subject|1|||
17051911|NCT03962790|38195363|FG001|Period 1|Withdrawal by Subject|0|||
17051912|NCT00609518|38195371|FG000|Overall Study|Death from Study Disease|32|||
17143379|NCT03083132|38286488|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
17143380|NCT03683823|38286496|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
17143381|NCT03683823|38286497|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
16992782|NCT01030718|38136805|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
16992783|NCT01030718|38136806|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
16992784|NCT01030718|38136804|FG000|Studies CA180-031 and -036 Combined|Death|0|||
16992785|NCT01030718|38136805|FG001|Studies CA180-031 and -036 Combined|Death|1|||
16992786|NCT01030718|38136806|FG002|Studies CA180-031 and -036 Combined|Death|0|||
16992787|NCT01030718|38136804|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
16992788|NCT01030718|38136805|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
16992789|NCT01030718|38136806|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
16992790|NCT01030718|38136804|FG000|Study CA180-036 Only|insufficient effect|1|||
16992791|NCT01030718|38136805|FG001|Study CA180-036 Only|insufficient effect|1|||
16992792|NCT01030718|38136806|FG002|Study CA180-036 Only|insufficient effect|5|||
16992793|NCT01030718|38136804|FG000|Study CA180-036 Only|Adverse Event|2|||
16992794|NCT01030718|38136805|FG001|Study CA180-036 Only|Adverse Event|3|||
16992795|NCT01030718|38136806|FG002|Study CA180-036 Only|Adverse Event|0|||
16992796|NCT01030718|38136804|FG000|Study CA180-036 Only|Death|0|||
16992797|NCT01030718|38136805|FG001|Study CA180-036 Only|Death|1|||
16992798|NCT01030718|38136806|FG002|Study CA180-036 Only|Death|0|||
16992799|NCT01030718|38136804|FG000|Study CA180-036 Only|Other Reasons|0|||
16992800|NCT01030718|38136805|FG001|Study CA180-036 Only|Other Reasons|2|||
16992801|NCT01030718|38136806|FG002|Study CA180-036 Only|Other Reasons|0|||
16992802|NCT00722761|38136826|FG000|Overall Study|Lost to Follow-up|1|||
16992803|NCT00722761|38136827|FG001|Overall Study|Lost to Follow-up|4|||
16992804|NCT00722761|38136826|FG000|Overall Study|Withdrawal by Subject|5|||
16992805|NCT00722761|38136827|FG001|Overall Study|Withdrawal by Subject|2|||
16992806|NCT00719953|38136833|FG000|Overall Study|Adverse Event|4|||
16992807|NCT01019486|38136840|FG000|Overall Study|Withdrawal by Subject|1|||
16992808|NCT01019486|38136841|FG001|Overall Study|Withdrawal by Subject|1|||
16992809|NCT01019486|38136842|FG002|Overall Study|Withdrawal by Subject|1|||
16992810|NCT00714493|38136851|FG000|Overall Study|Adverse Event|11|||
16992811|NCT00714493|38136851|FG000|Overall Study|Death|3|||
16992812|NCT00714493|38136851|FG000|Overall Study|Lack of Efficacy|10|||
16992813|NCT00714493|38136851|FG000|Overall Study|Lost to Follow-up|3|||
16992814|NCT00714493|38136851|FG000|Overall Study|Protocol Violation|12|||
16992815|NCT00714493|38136851|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
16992816|NCT00714493|38136851|FG000|Overall Study|OTHER|2|||
16992817|NCT01019252|38136857|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
16992818|NCT01019252|38136858|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
16992819|NCT01019252|38136857|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
16992820|NCT01019252|38136858|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
16992821|NCT01019252|38136857|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
16992822|NCT01019252|38136858|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
16992823|NCT01019252|38136857|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
16992824|NCT01019252|38136858|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
16992825|NCT01013870|38136866|FG000|Overall Study|Lost to Follow-up|1|||
16992826|NCT01013870|38136867|FG001|Overall Study|Lost to Follow-up|3|||
16992827|NCT01013792|38136875|FG000|Overall Study|Study suspended|2|||
16992828|NCT01013792|38136876|FG001|Overall Study|Study suspended|1|||
16992829|NCT01013792|38136875|FG000|Overall Study|Adverse Event|0|||
16992830|NCT01013792|38136876|FG001|Overall Study|Adverse Event|3|||
16992831|NCT01013792|38136875|FG000|Overall Study|Lost to Follow-up|0|||
17051913|NCT00609518|38195372|FG001|Overall Study|Death from Study Disease|32|||
17051914|NCT00609518|38195371|FG000|Overall Study|Withdrawal by Subject|5|||
17051915|NCT00609518|38195372|FG001|Overall Study|Withdrawal by Subject|3|||
17051916|NCT00609518|38195371|FG000|Overall Study|Lost to Follow-up|3|||
17051917|NCT00609518|38195372|FG001|Overall Study|Lost to Follow-up|0|||
17051918|NCT00609518|38195371|FG000|Overall Study|Physician Decision|1|||
17051919|NCT00609518|38195372|FG001|Overall Study|Physician Decision|3|||
17051920|NCT00609518|38195371|FG000|Overall Study|Death from Adverse Event|2|||
17051921|NCT00609518|38195372|FG001|Overall Study|Death from Adverse Event|2|||
17051922|NCT00609362|38195380|FG000|Overall Study|Withdrawal by Subject|2|||
17051923|NCT00609362|38195381|FG001|Overall Study|Withdrawal by Subject|1|||
17051924|NCT00609362|38195380|FG000|Overall Study|Adverse Event|1|||
17051925|NCT00609362|38195381|FG001|Overall Study|Adverse Event|0|||
17051926|NCT00611858|38195387|FG000|Overall Study|Adverse Event|2|||
17051927|NCT00611858|38195387|FG000|Overall Study|Withdrawal by Subject|2|||
17051928|NCT00137449|38195395|FG000|Overall Study|Disease Progression|8|||
17051929|NCT00137449|38195396|FG001|Overall Study|Disease Progression|13|||
17051930|NCT00137449|38195395|FG000|Overall Study|Death|4|||
17051931|NCT00137449|38195396|FG001|Overall Study|Death|3|||
17051932|NCT00137449|38195395|FG000|Overall Study|Adverse Event|3|||
17143382|NCT03683823|38286496|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
17143383|NCT03683823|38286497|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
17051933|NCT00137449|38195396|FG001|Overall Study|Adverse Event|1|||
17051934|NCT00137449|38195395|FG000|Overall Study|Withdrawal by Subject|1|||
17051935|NCT00137449|38195396|FG001|Overall Study|Withdrawal by Subject|1|||
17051936|NCT00528879|38195407|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
17051937|NCT00528879|38195408|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
17051938|NCT00528879|38195409|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
17051939|NCT00528879|38195410|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
17051940|NCT00528879|38195407|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
17051941|NCT00528879|38195408|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
17051942|NCT00528879|38195409|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
17051943|NCT00528879|38195410|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
17051944|NCT00528879|38195407|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
17051945|NCT00528879|38195408|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
17051946|NCT00528879|38195409|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
17051947|NCT00528879|38195410|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
17051948|NCT00528879|38195407|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
17051949|NCT00528879|38195408|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
17051950|NCT00528879|38195409|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
17051951|NCT00528879|38195410|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
17051952|NCT00528879|38195407|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
17051953|NCT00528879|38195408|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
17051954|NCT00528879|38195409|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
17051955|NCT00528879|38195410|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
17051956|NCT00528879|38195407|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
17051957|NCT00528879|38195408|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
17051958|NCT00528879|38195409|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
17051959|NCT00528879|38195410|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
17051960|NCT00528879|38195407|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
17051961|NCT00528879|38195408|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
17051962|NCT00528879|38195409|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
17051963|NCT00528879|38195410|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
17051964|NCT00528879|38195407|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
17051965|NCT00528879|38195408|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
17051966|NCT00528879|38195409|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
17051967|NCT00528879|38195410|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
17051968|NCT00528879|38195407|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
17051969|NCT00528879|38195408|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
17051970|NCT00528879|38195409|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
17051971|NCT00528879|38195410|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
17051972|NCT00528879|38195407|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
17051973|NCT00528879|38195408|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
17051974|NCT00528879|38195409|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
17051975|NCT00528879|38195410|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
17051976|NCT00528879|38195407|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
17143384|NCT03683823|38286496|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
17051977|NCT00528879|38195408|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
17051978|NCT00528879|38195409|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
17051979|NCT00528879|38195410|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
17051980|NCT00528879|38195407|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
17051981|NCT00528879|38195408|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
17051982|NCT00528879|38195409|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
17051983|NCT00528879|38195410|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
17051984|NCT00528879|38195407|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
17051985|NCT00528879|38195408|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
17051986|NCT00528879|38195409|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
17051987|NCT00528879|38195410|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
17051988|NCT00528879|38195407|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
17051989|NCT00528879|38195408|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
17051990|NCT00528879|38195409|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
17051991|NCT00528879|38195410|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
17051992|NCT00528879|38195407|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
17051993|NCT00528879|38195408|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
17051994|NCT00528879|38195409|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
17051995|NCT00528879|38195410|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
17051996|NCT00528879|38195407|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
17051997|NCT00528879|38195408|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
17051998|NCT00528879|38195409|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
17051999|NCT00528879|38195410|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
17052000|NCT00608894|38195422|FG000|Overall Study|Withdrawal by Subject|0|||
17052001|NCT00608894|38195423|FG001|Overall Study|Withdrawal by Subject|2|||
17052002|NCT00557856|38195431|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
17052003|NCT00557856|38195432|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
17052004|NCT00557856|38195433|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
17052005|NCT00557856|38195434|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
17052006|NCT00557856|38195435|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
17052007|NCT00557856|38195436|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
17052008|NCT00557856|38195437|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
17052009|NCT00557856|38195438|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
17052010|NCT00557856|38195439|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
17052011|NCT00557856|38195431|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
17052012|NCT00557856|38195432|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
17052013|NCT00557856|38195433|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
17052014|NCT00557856|38195434|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
17052015|NCT00557856|38195435|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
17052016|NCT00557856|38195436|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
17052017|NCT00557856|38195437|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
17052018|NCT00557856|38195438|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
17052019|NCT00557856|38195439|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
17052020|NCT00557856|38195431|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
17052021|NCT00557856|38195432|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
17052022|NCT00557856|38195433|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
17052023|NCT00557856|38195434|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
17052024|NCT00557856|38195435|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
17052025|NCT00557856|38195436|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
17052026|NCT00557856|38195437|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
17052027|NCT00557856|38195438|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
17052028|NCT00557856|38195439|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
17052029|NCT00557856|38195431|FG000|Part 1: Dose Escalation Phase|Other|0|||
17052030|NCT00557856|38195432|FG001|Part 1: Dose Escalation Phase|Other|0|||
17052031|NCT00557856|38195433|FG002|Part 1: Dose Escalation Phase|Other|1|||
17052032|NCT00557856|38195434|FG003|Part 1: Dose Escalation Phase|Other|1|||
17052033|NCT00557856|38195435|FG004|Part 1: Dose Escalation Phase|Other|0|||
17052034|NCT00557856|38195436|FG005|Part 1: Dose Escalation Phase|Other|0|||
17052035|NCT00557856|38195437|FG006|Part 1: Dose Escalation Phase|Other|0|||
17052036|NCT00557856|38195438|FG007|Part 1: Dose Escalation Phase|Other|1|||
17052037|NCT00557856|38195439|FG008|Part 1: Dose Escalation Phase|Other|0|||
17052038|NCT00557856|38195431|FG000|Part 1: Dose Escalation Phase|Death|0|||
17052039|NCT00557856|38195432|FG001|Part 1: Dose Escalation Phase|Death|0|||
17052040|NCT00557856|38195433|FG002|Part 1: Dose Escalation Phase|Death|0|||
17052041|NCT00557856|38195434|FG003|Part 1: Dose Escalation Phase|Death|0|||
17052042|NCT00557856|38195435|FG004|Part 1: Dose Escalation Phase|Death|0|||
17052043|NCT00557856|38195436|FG005|Part 1: Dose Escalation Phase|Death|1|||
17052044|NCT00557856|38195437|FG006|Part 1: Dose Escalation Phase|Death|0|||
17052045|NCT00557856|38195438|FG007|Part 1: Dose Escalation Phase|Death|0|||
17052046|NCT00557856|38195439|FG008|Part 1: Dose Escalation Phase|Death|0|||
17052047|NCT00557856|38195431|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
17052048|NCT00557856|38195432|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
17052049|NCT00557856|38195433|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
17052050|NCT00557856|38195434|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
17052051|NCT00557856|38195435|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
17052052|NCT00557856|38195436|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
17052053|NCT00557856|38195437|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
17052054|NCT00557856|38195438|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
17052055|NCT00557856|38195439|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
17052056|NCT00557856|38195431|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
17052057|NCT00557856|38195432|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
17052058|NCT00557856|38195433|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
17052059|NCT00557856|38195434|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
17052060|NCT00557856|38195435|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
17143385|NCT03683823|38286497|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
17143386|NCT03285711|38286505|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
17143387|NCT03285711|38286506|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
17143388|NCT03285711|38286507|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
17143389|NCT03285711|38286508|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
17143390|NCT03285711|38286505|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
17143391|NCT03285711|38286506|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
17143392|NCT03285711|38286507|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
17143393|NCT03285711|38286508|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
17143394|NCT03285711|38286505|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
17143395|NCT03285711|38286506|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
17143396|NCT03285711|38286507|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
17143397|NCT03285711|38286508|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
17143398|NCT03285711|38286505|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
17143399|NCT03285711|38286506|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
17143400|NCT03285711|38286507|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
17143401|NCT03285711|38286508|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
17090086|NCT00317642|38230166|FG000|Overall Study|Death|14|||
17090087|NCT00317642|38230167|FG001|Overall Study|Death|7|||
17090088|NCT00317642|38230166|FG000|Overall Study|Not Continue to Consolidation|2|||
17090089|NCT00317642|38230167|FG001|Overall Study|Not Continue to Consolidation|0|||
17090090|NCT00317642|38230166|FG000|Overall Study|Withdrawal by Subject|0|||
17090091|NCT00317642|38230167|FG001|Overall Study|Withdrawal by Subject|1|||
17090092|NCT00317642|38230166|FG000|Overall Study|Referred For Transplantation|1|||
17143402|NCT03341936|38286518|FG000|Overall Study|Ineligible|1|||
17143403|NCT03341936|38286518|FG000|Overall Study|Disease Progression|2|||
17143404|NCT03341936|38286518|FG000|Overall Study|Withdrew Consent|4|||
17143405|NCT03341936|38286518|FG000|Overall Study|Non-Compliance|1|||
17143406|NCT03341936|38286518|FG000|Overall Study|Physician Decision|1|||
17143407|NCT03341936|38286518|FG000|Overall Study|Withdrawal by Subject|1|||
17143408|NCT03341936|38286518|FG000|Overall Study|Other|1|||
17143409|NCT02927366|38286524|FG000|Overall Study|Adverse Event|1|||
17143410|NCT02927366|38286525|FG001|Overall Study|Adverse Event|0|||
17143411|NCT02927366|38286524|FG000|Overall Study|Patient schedule|1|||
17143412|NCT02927366|38286525|FG001|Overall Study|Patient schedule|0|||
17143413|NCT03249909|38286534|FG000|Overall Study|Withdrawal by Subject|3|||
17143414|NCT03249909|38286535|FG001|Overall Study|Withdrawal by Subject|0|||
17143415|NCT03249909|38286536|FG002|Overall Study|Withdrawal by Subject|0|||
17143416|NCT03249909|38286534|FG000|Overall Study|Adverse Event|3|||
17143417|NCT03249909|38286535|FG001|Overall Study|Adverse Event|0|||
17143418|NCT03249909|38286536|FG002|Overall Study|Adverse Event|0|||
17052061|NCT00557856|38195436|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
17052062|NCT00557856|38195437|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
17052063|NCT00557856|38195438|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
17052064|NCT00557856|38195439|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
17052065|NCT00557856|38195431|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
17052066|NCT00557856|38195432|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
17052067|NCT00557856|38195433|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
17052068|NCT00557856|38195434|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
17052069|NCT00557856|38195435|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
17052070|NCT00557856|38195436|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
17143419|NCT03249909|38286534|FG000|Overall Study|Lost to Follow-up|0|||
16992832|NCT01013792|38136876|FG001|Overall Study|Lost to Follow-up|1|||
16992833|NCT01018862|38136885|FG000|Overall Study|Adverse Event|2|||
17052071|NCT00557856|38195437|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
17052072|NCT00557856|38195438|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
17052073|NCT00557856|38195439|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
17052074|NCT00557856|38195431|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
17052075|NCT00557856|38195432|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
17052076|NCT00557856|38195433|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
17052077|NCT00557856|38195434|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
17052078|NCT00557856|38195435|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
17052079|NCT00557856|38195436|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
17052080|NCT00557856|38195437|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
17052081|NCT00557856|38195438|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
17052082|NCT00557856|38195439|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
17052083|NCT00557856|38195431|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
17052084|NCT00557856|38195432|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
17052085|NCT00557856|38195433|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
17052086|NCT00557856|38195434|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
17052087|NCT00557856|38195435|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
17052088|NCT00557856|38195436|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
17052089|NCT00557856|38195437|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
16992834|NCT01018862|38136886|FG001|Overall Study|Adverse Event|0|||
16992835|NCT01018862|38136887|FG002|Overall Study|Adverse Event|6|||
16992836|NCT01018862|38136885|FG000|Overall Study|Lack of Efficacy|1|||
16992837|NCT01018862|38136886|FG001|Overall Study|Lack of Efficacy|0|||
16992838|NCT01018862|38136887|FG002|Overall Study|Lack of Efficacy|2|||
16992839|NCT01018862|38136885|FG000|Overall Study|Lost to Follow-up|3|||
16992840|NCT01018862|38136886|FG001|Overall Study|Lost to Follow-up|1|||
16992841|NCT01018862|38136887|FG002|Overall Study|Lost to Follow-up|0|||
16992842|NCT01018862|38136885|FG000|Overall Study|Protocol Violation|1|||
16992843|NCT01018862|38136886|FG001|Overall Study|Protocol Violation|3|||
16992844|NCT01018862|38136887|FG002|Overall Study|Protocol Violation|3|||
16992845|NCT01018862|38136885|FG000|Overall Study|Withdrawal by Subject|1|||
16992846|NCT01018862|38136886|FG001|Overall Study|Withdrawal by Subject|2|||
16992847|NCT01018862|38136887|FG002|Overall Study|Withdrawal by Subject|1|||
16992848|NCT01018862|38136885|FG000|Overall Study|administrative problems|5|||
16992849|NCT01018862|38136886|FG001|Overall Study|administrative problems|4|||
16992850|NCT01018862|38136887|FG002|Overall Study|administrative problems|4|||
16992851|NCT01018394|38136897|FG000|Overall Study|Withdrawal by Subject|5|||
16992852|NCT01018394|38136898|FG001|Overall Study|Withdrawal by Subject|5|||
16992853|NCT01018394|38136897|FG000|Overall Study|Lost to Follow-up|4|||
16992854|NCT01018394|38136898|FG001|Overall Study|Lost to Follow-up|3|||
16992855|NCT01017146|38136906|FG000|Overall Study|Adverse Event|11|||
16992856|NCT01017146|38136907|FG001|Overall Study|Adverse Event|1|||
17143420|NCT03249909|38286535|FG001|Overall Study|Lost to Follow-up|1|||
17143421|NCT03249909|38286536|FG002|Overall Study|Lost to Follow-up|0|||
17052090|NCT00557856|38195438|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
17052091|NCT00557856|38195439|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
17052092|NCT00557856|38195431|FG000|Part 2: Exploratory Phase|Other|0|||
17052093|NCT00557856|38195432|FG001|Part 2: Exploratory Phase|Other|0|||
17052094|NCT00557856|38195433|FG002|Part 2: Exploratory Phase|Other|0|||
17052095|NCT00557856|38195434|FG003|Part 2: Exploratory Phase|Other|0|||
17052096|NCT00557856|38195435|FG004|Part 2: Exploratory Phase|Other|0|||
17052097|NCT00557856|38195436|FG005|Part 2: Exploratory Phase|Other|0|||
17052098|NCT00557856|38195437|FG006|Part 2: Exploratory Phase|Other|0|||
17052099|NCT00557856|38195438|FG007|Part 2: Exploratory Phase|Other|0|||
17052100|NCT00557856|38195439|FG008|Part 2: Exploratory Phase|Other|1|||
16992857|NCT01017146|38136906|FG000|Overall Study|Lost to Follow-up|14|||
16992858|NCT01017146|38136907|FG001|Overall Study|Lost to Follow-up|14|||
16992859|NCT01017146|38136906|FG000|Overall Study|Noncompliance with Study Product|1|||
16992860|NCT01017146|38136907|FG001|Overall Study|Noncompliance with Study Product|1|||
16992861|NCT01017146|38136906|FG000|Overall Study|Withdrawal by Subject|32|||
16992862|NCT01017146|38136907|FG001|Overall Study|Withdrawal by Subject|16|||
16992863|NCT01017146|38136906|FG000|Overall Study|Relocation|0|||
16992864|NCT01017146|38136907|FG001|Overall Study|Relocation|4|||
16992865|NCT01017146|38136906|FG000|Overall Study|Pregnancy|2|||
16992866|NCT01017146|38136907|FG001|Overall Study|Pregnancy|1|||
16992867|NCT01017146|38136906|FG000|Overall Study|Protocol Violation|2|||
16992868|NCT01017146|38136907|FG001|Overall Study|Protocol Violation|0|||
16992869|NCT01017146|38136906|FG000|Overall Study|Took Excluded Medication|2|||
16992870|NCT01017146|38136907|FG001|Overall Study|Took Excluded Medication|0|||
16992871|NCT01017146|38136906|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
16992872|NCT01017146|38136907|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
16992873|NCT01017146|38136906|FG000|Overall Study|Change in Work Situation|1|||
16992874|NCT01017146|38136907|FG001|Overall Study|Change in Work Situation|0|||
16992875|NCT01010750|38136919|FG000|Second Intervention|Adverse Event|0|||
16992876|NCT01010750|38136920|FG001|Second Intervention|Adverse Event|1|||
16992877|NCT01010750|38136921|FG002|Second Intervention|Adverse Event|0|||
16992878|NCT01010750|38136922|FG003|Second Intervention|Adverse Event|0|||
16992879|NCT01010750|38136923|FG004|Second Intervention|Adverse Event|0|||
16992880|NCT01010750|38136924|FG005|Second Intervention|Adverse Event|0|||
16992881|NCT01012622|38136932|FG000|Overall Study|Withdrawal by Subject|6|||
16992882|NCT01012622|38136932|FG000|Overall Study|Lost to Follow-up|5|||
16992883|NCT01012622|38136932|FG000|Overall Study|Adverse Event|7|||
16992884|NCT01012622|38136932|FG000|Overall Study|non-compliance with the drug|9|||
16992885|NCT01012622|38136932|FG000|Overall Study|Other|1|||
17052101|NCT00557856|38195431|FG000|Part 2: Exploratory Phase|Death|0|||
17052102|NCT00557856|38195432|FG001|Part 2: Exploratory Phase|Death|0|||
17052103|NCT00557856|38195433|FG002|Part 2: Exploratory Phase|Death|0|||
17052104|NCT00557856|38195434|FG003|Part 2: Exploratory Phase|Death|0|||
17052105|NCT00557856|38195435|FG004|Part 2: Exploratory Phase|Death|0|||
17052106|NCT00557856|38195436|FG005|Part 2: Exploratory Phase|Death|0|||
17052107|NCT00557856|38195437|FG006|Part 2: Exploratory Phase|Death|0|||
17052108|NCT00557856|38195438|FG007|Part 2: Exploratory Phase|Death|0|||
17052109|NCT00557856|38195439|FG008|Part 2: Exploratory Phase|Death|2|||
17052110|NCT00557856|38195431|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
17052111|NCT00557856|38195432|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
17052112|NCT00557856|38195433|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
17052113|NCT00557856|38195434|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
17052114|NCT00557856|38195435|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
17052115|NCT00557856|38195436|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
17052116|NCT00557856|38195437|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
17052117|NCT00557856|38195438|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
17052118|NCT00557856|38195439|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
17052119|NCT00191113|38195456|FG000|Core Study|Withdrawal by Subject|25|||
17052120|NCT00191113|38195457|FG001|Core Study|Withdrawal by Subject|9|||
17052121|NCT00191113|38195456|FG000|Core Study|Protocol Violation|6|||
17052122|NCT00191113|38195457|FG001|Core Study|Protocol Violation|2|||
17052123|NCT00191113|38195456|FG000|Core Study|Lost to Follow-up|3|||
17052124|NCT00191113|38195457|FG001|Core Study|Lost to Follow-up|0|||
17052125|NCT00191113|38195456|FG000|Core Study|Adverse Event|0|||
17052126|NCT00191113|38195457|FG001|Core Study|Adverse Event|2|||
17052127|NCT00191113|38195456|FG000|Core Study|Lack of Efficacy|0|||
17052128|NCT00191113|38195457|FG001|Core Study|Lack of Efficacy|2|||
17052129|NCT00191113|38195456|FG000|Core Study|Death|1|||
17052130|NCT00191113|38195457|FG001|Core Study|Death|0|||
17052131|NCT00608582|38195471|FG000|Overall Study|Lost to Follow-up|2|||
17052132|NCT00608582|38195472|FG001|Overall Study|Lost to Follow-up|0|||
17052133|NCT00608582|38195471|FG000|Overall Study|No Best Response in Phase 1 located|1|||
17052134|NCT00608582|38195472|FG001|Overall Study|No Best Response in Phase 1 located|1|||
17052135|NCT00608582|38195471|FG000|Overall Study|Illicit Drug Use|1|||
17052136|NCT00608582|38195472|FG001|Overall Study|Illicit Drug Use|0|||
17052137|NCT00608582|38195471|FG000|Overall Study|Early stage Design Change|0|||
17052138|NCT00608582|38195472|FG001|Overall Study|Early stage Design Change|3|||
17052139|NCT03965052|38195482|FG000|Overall Study|Protocol Violation|1|||
17052140|NCT03965052|38195483|FG001|Overall Study|Protocol Violation|0|||
17052141|NCT03964974|38195491|FG000|Overall Study|Lost to Follow-up|3|||
17052142|NCT03964974|38195492|FG001|Overall Study|Lost to Follow-up|2|||
17052143|NCT03964974|38195491|FG000|Overall Study|Withdrawal by Subject|0|||
17052144|NCT03964974|38195492|FG001|Overall Study|Withdrawal by Subject|3|||
17052145|NCT00606320|38195498|FG000|Overall Study|Adverse Event|3|||
17052146|NCT00606320|38195498|FG000|Overall Study|Lack of Efficacy|5|||
17052147|NCT00606320|38195498|FG000|Overall Study|Physician Decision|7|||
17052148|NCT00606320|38195498|FG000|Overall Study|Protocol Violation|8|||
17052149|NCT00606320|38195498|FG000|Overall Study|Withdrawal by Subject|10|||
17052150|NCT00606320|38195498|FG000|Overall Study|Progression to depressive phase|4|||
17052151|NCT00528411|38195505|FG000|Overall Study|Adverse Event|4|||
17052152|NCT00528411|38195506|FG001|Overall Study|Adverse Event|0|||
17052153|NCT00528411|38195507|FG002|Overall Study|Adverse Event|1|||
17052154|NCT00528411|38195505|FG000|Overall Study|Incorrect Enrolment|1|||
17052155|NCT00528411|38195506|FG001|Overall Study|Incorrect Enrolment|1|||
17052156|NCT00528411|38195507|FG002|Overall Study|Incorrect Enrolment|0|||
17052157|NCT00528411|38195505|FG000|Overall Study|Severe non-compliance to protocol|0|||
17052158|NCT00528411|38195506|FG001|Overall Study|Severe non-compliance to protocol|1|||
17052159|NCT00528411|38195507|FG002|Overall Study|Severe non-compliance to protocol|0|||
17052160|NCT00528411|38195505|FG000|Overall Study|Prior commitment medication|0|||
17052161|NCT00528411|38195506|FG001|Overall Study|Prior commitment medication|1|||
17052162|NCT00528411|38195507|FG002|Overall Study|Prior commitment medication|0|||
17052163|NCT00136357|38195517|FG000|Overall Study|Withdrawal by Subject|3|||
17052164|NCT00136357|38195518|FG001|Overall Study|Withdrawal by Subject|2|||
17052165|NCT00129649|38195526|FG000|Overall Study|Withdrawal by Subject|76|||
17052166|NCT00129649|38195527|FG001|Overall Study|Withdrawal by Subject|65|||
17052167|NCT00187135|38195539|FG000|Visit One|Withdrawal by Subject|1|||
17052168|NCT00187135|38195540|FG001|Visit One|Withdrawal by Subject|0|||
17052169|NCT00187135|38195541|FG002|Visit One|Withdrawal by Subject|0|||
17143422|NCT03081884|38286547|FG000|Overall Study|deferred prostate cancer treatment|1|||
17143423|NCT03081884|38286547|FG000|Overall Study|metastasis managed with systemic therapy|3|||
17143424|NCT03077438|38286554|FG000|Overall Study|Protocol Violation|3|||
17143425|NCT03077438|38286555|FG001|Overall Study|Protocol Violation|5|||
17143426|NCT03077438|38286554|FG000|Overall Study|Withdrawal by Subject|3|||
17143427|NCT03077438|38286555|FG001|Overall Study|Withdrawal by Subject|6|||
17143428|NCT03077438|38286554|FG000|Overall Study|Lost to Follow-up|6|||
17143429|NCT03077438|38286555|FG001|Overall Study|Lost to Follow-up|3|||
17143430|NCT03076970|38286565|FG000|Washout Period 2|Adverse Event|0|||
17143431|NCT03076970|38286566|FG001|Washout Period 2|Adverse Event|0|||
17143432|NCT03076970|38286567|FG002|Washout Period 2|Adverse Event|0|||
17143433|NCT03076970|38286568|FG003|Washout Period 2|Adverse Event|0|||
17143434|NCT03076970|38286569|FG004|Washout Period 2|Adverse Event|1|||
17143435|NCT03076970|38286570|FG005|Washout Period 2|Adverse Event|0|||
17143436|NCT03076970|38286565|FG000|Period 3|Withdrawal by Subject|0|||
17052170|NCT00187135|38195542|FG003|Visit One|Withdrawal by Subject|0|||
17052171|NCT00187135|38195543|FG004|Visit One|Withdrawal by Subject|0|||
17052172|NCT00187135|38195544|FG005|Visit One|Withdrawal by Subject|1|||
17052173|NCT00187135|38195539|FG000|Visit One|Physician Decision|3|||
17052174|NCT00187135|38195540|FG001|Visit One|Physician Decision|1|||
17052175|NCT00187135|38195541|FG002|Visit One|Physician Decision|0|||
17052176|NCT00187135|38195542|FG003|Visit One|Physician Decision|0|||
17052177|NCT00187135|38195543|FG004|Visit One|Physician Decision|0|||
17052178|NCT00187135|38195544|FG005|Visit One|Physician Decision|1|||
17143437|NCT03076970|38286566|FG001|Period 3|Withdrawal by Subject|0|||
17143438|NCT03076970|38286567|FG002|Period 3|Withdrawal by Subject|0|||
17143439|NCT03076970|38286568|FG003|Period 3|Withdrawal by Subject|0|||
17143440|NCT03076970|38286569|FG004|Period 3|Withdrawal by Subject|0|||
17143441|NCT03076970|38286570|FG005|Period 3|Withdrawal by Subject|1|||
17143442|NCT03076970|38286565|FG000|Period 3|Failure to meet I/E criteria|0|||
17143443|NCT03076970|38286566|FG001|Period 3|Failure to meet I/E criteria|0|||
17143444|NCT03076970|38286567|FG002|Period 3|Failure to meet I/E criteria|0|||
17143445|NCT03076970|38286568|FG003|Period 3|Failure to meet I/E criteria|0|||
17143446|NCT03076970|38286569|FG004|Period 3|Failure to meet I/E criteria|1|||
17143447|NCT03076970|38286570|FG005|Period 3|Failure to meet I/E criteria|0|||
17143448|NCT00726596|38286583|FG000|Overall Study|Adverse Event|2|||
17143449|NCT00726596|38286584|FG001|Overall Study|Adverse Event|1|||
17143450|NCT00726596|38286583|FG000|Overall Study|Withdrawal by Subject|3|||
17143451|NCT00726596|38286584|FG001|Overall Study|Withdrawal by Subject|3|||
17143452|NCT02890992|38286607|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
17143453|NCT02890992|38286608|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
17143454|NCT02890992|38286609|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
17143455|NCT02890992|38286610|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
17143456|NCT02890992|38286611|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
17143457|NCT02890992|38286612|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
17143458|NCT02890992|38286613|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
17143459|NCT02890992|38286614|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
17143460|NCT02890992|38286607|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
17052179|NCT00187135|38195539|FG000|Visit Two|Death|0|||
17052180|NCT00187135|38195540|FG001|Visit Two|Death|0|||
17052181|NCT00187135|38195541|FG002|Visit Two|Death|0|||
17052182|NCT00187135|38195542|FG003|Visit Two|Death|1|||
17052183|NCT00187135|38195543|FG004|Visit Two|Death|0|||
17052184|NCT00187135|38195544|FG005|Visit Two|Death|1|||
17052185|NCT00187135|38195539|FG000|Visit Two|Physician Decision|1|||
17052186|NCT00187135|38195540|FG001|Visit Two|Physician Decision|0|||
17052187|NCT00187135|38195541|FG002|Visit Two|Physician Decision|0|||
17052188|NCT00187135|38195542|FG003|Visit Two|Physician Decision|0|||
17052189|NCT00187135|38195543|FG004|Visit Two|Physician Decision|0|||
17052190|NCT00187135|38195544|FG005|Visit Two|Physician Decision|0|||
17052191|NCT00187135|38195539|FG000|Visit Two|Withdrawal by Subject|1|||
17052192|NCT00187135|38195540|FG001|Visit Two|Withdrawal by Subject|1|||
17052193|NCT00187135|38195541|FG002|Visit Two|Withdrawal by Subject|1|||
17052194|NCT00187135|38195542|FG003|Visit Two|Withdrawal by Subject|0|||
17052195|NCT00187135|38195543|FG004|Visit Two|Withdrawal by Subject|1|||
17052196|NCT00187135|38195544|FG005|Visit Two|Withdrawal by Subject|1|||
17052197|NCT00187135|38195539|FG000|Visit Two|Study Discontinued|3|||
17052198|NCT00187135|38195540|FG001|Visit Two|Study Discontinued|2|||
17052199|NCT00187135|38195541|FG002|Visit Two|Study Discontinued|1|||
17052200|NCT00187135|38195542|FG003|Visit Two|Study Discontinued|7|||
17052201|NCT00187135|38195543|FG004|Visit Two|Study Discontinued|5|||
17052202|NCT00187135|38195544|FG005|Visit Two|Study Discontinued|6|||
17052203|NCT00187135|38195539|FG000|Visit Three|Death|0|||
17052204|NCT00187135|38195540|FG001|Visit Three|Death|0|||
17052205|NCT00187135|38195541|FG002|Visit Three|Death|1|||
17052206|NCT00187135|38195542|FG003|Visit Three|Death|0|||
17052207|NCT00187135|38195543|FG004|Visit Three|Death|1|||
17052208|NCT00187135|38195544|FG005|Visit Three|Death|0|||
17052209|NCT00187135|38195539|FG000|Visit Three|Withdrawal by Subject|0|||
17052210|NCT00187135|38195540|FG001|Visit Three|Withdrawal by Subject|1|||
17052211|NCT00187135|38195541|FG002|Visit Three|Withdrawal by Subject|1|||
17052212|NCT00187135|38195542|FG003|Visit Three|Withdrawal by Subject|2|||
17052213|NCT00187135|38195543|FG004|Visit Three|Withdrawal by Subject|0|||
17052214|NCT00187135|38195544|FG005|Visit Three|Withdrawal by Subject|0|||
17052215|NCT00187135|38195539|FG000|Visit Three|Study Discontinued|7|||
17052216|NCT00187135|38195540|FG001|Visit Three|Study Discontinued|6|||
17052217|NCT00187135|38195541|FG002|Visit Three|Study Discontinued|7|||
17052218|NCT00187135|38195542|FG003|Visit Three|Study Discontinued|7|||
17052219|NCT00187135|38195543|FG004|Visit Three|Study Discontinued|7|||
17052220|NCT00187135|38195544|FG005|Visit Three|Study Discontinued|6|||
17052221|NCT00528021|38195560|FG000|Overall Study|Lack of Efficacy|17|||
17052222|NCT00528021|38195561|FG001|Overall Study|Lack of Efficacy|13|||
17052223|NCT00528021|38195562|FG002|Overall Study|Lack of Efficacy|7|||
17052224|NCT00528021|38195563|FG003|Overall Study|Lack of Efficacy|9|||
17052225|NCT00560352|38195576|FG000|Overall Study|Adverse event unrelated to study drug|2|||
17052226|NCT00560352|38195577|FG001|Overall Study|Adverse event unrelated to study drug|1|||
17052227|NCT00560352|38195578|FG002|Overall Study|Adverse event unrelated to study drug|1|||
17052228|NCT00560352|38195576|FG000|Overall Study|Study drug toxicity|3|||
17052229|NCT00560352|38195577|FG001|Overall Study|Study drug toxicity|0|||
17052230|NCT00560352|38195578|FG002|Overall Study|Study drug toxicity|1|||
17052231|NCT00560352|38195576|FG000|Overall Study|Disease progression|0|||
17052232|NCT00560352|38195577|FG001|Overall Study|Disease progression|1|||
17052233|NCT00560352|38195578|FG002|Overall Study|Disease progression|1|||
17052234|NCT00560352|38195576|FG000|Overall Study|Withdrawal by Subject|1|||
17143461|NCT02890992|38286608|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
17143462|NCT02890992|38286609|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
17052235|NCT00560352|38195577|FG001|Overall Study|Withdrawal by Subject|1|||
17052236|NCT00560352|38195578|FG002|Overall Study|Withdrawal by Subject|1|||
17052237|NCT00560352|38195576|FG000|Overall Study|Maximum clinical benefit|1|||
17052238|NCT00560352|38195577|FG001|Overall Study|Maximum clinical benefit|0|||
17052239|NCT00560352|38195578|FG002|Overall Study|Maximum clinical benefit|0|||
17052240|NCT00527787|38195592|FG000|Overall Study|Adverse Event|14|||
17052241|NCT00527787|38195593|FG001|Overall Study|Adverse Event|24|||
17052242|NCT00527787|38195592|FG000|Overall Study|Withdrawal by Subject|13|||
17052243|NCT00527787|38195593|FG001|Overall Study|Withdrawal by Subject|25|||
17052244|NCT00527787|38195592|FG000|Overall Study|Lost to Follow-up|5|||
17052245|NCT00527787|38195593|FG001|Overall Study|Lost to Follow-up|2|||
17052246|NCT00527787|38195592|FG000|Overall Study|Duodenal Ulcer|1|||
17052247|NCT00527787|38195593|FG001|Overall Study|Duodenal Ulcer|10|||
17052248|NCT00527787|38195592|FG000|Overall Study|misc|5|||
17052249|NCT00527787|38195593|FG001|Overall Study|misc|2|||
17052250|NCT00608426|38195601|FG000|Overall Study|Death|32|||
17052251|NCT00608426|38195602|FG001|Overall Study|Death|36|||
17052252|NCT00608426|38195601|FG000|Overall Study|Lost to Follow-up|485|||
17052253|NCT00608426|38195602|FG001|Overall Study|Lost to Follow-up|521|||
17052254|NCT00608426|38195601|FG000|Overall Study|refused, health issues, wrong address|319|||
17052255|NCT00608426|38195602|FG001|Overall Study|refused, health issues, wrong address|348|||
17052256|NCT00557076|38195610|FG000|Overall Study|Unblinding|0|||
17052257|NCT00557076|38195611|FG001|Overall Study|Unblinding|1|||
17052258|NCT00129259|38195619|FG000|Overall Study|Lost to Follow-up|1|||
17052259|NCT00129259|38195620|FG001|Overall Study|Lost to Follow-up|1|||
17052260|NCT00129259|38195619|FG000|Overall Study|Withdrawal by Subject|2|||
17052261|NCT00129259|38195620|FG001|Overall Study|Withdrawal by Subject|1|||
17052262|NCT00129259|38195619|FG000|Overall Study|Only available minimal phone assessments|0|||
17052263|NCT00129259|38195620|FG001|Overall Study|Only available minimal phone assessments|1|||
17052264|NCT00186901|38195629|FG000|Overall Study|Pregnancy|6|||
17052265|NCT00186901|38195630|FG001|Overall Study|Pregnancy|3|||
17052266|NCT00186901|38195631|FG002|Overall Study|Pregnancy|0|||
17052267|NCT00186901|38195629|FG000|Overall Study|Lost to Follow-up|6|||
17052268|NCT00186901|38195630|FG001|Overall Study|Lost to Follow-up|3|||
17052269|NCT00186901|38195631|FG002|Overall Study|Lost to Follow-up|0|||
17052270|NCT00186901|38195629|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
17052271|NCT00186901|38195630|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
17052272|NCT00186901|38195631|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
17052273|NCT00186901|38195629|FG000|Overall Study|ALL relapse or second malignancy|1|||
17052274|NCT00186901|38195630|FG001|Overall Study|ALL relapse or second malignancy|2|||
17052275|NCT00186901|38195631|FG002|Overall Study|ALL relapse or second malignancy|0|||
17052276|NCT00186901|38195629|FG000|Overall Study|Withdrawal by Subject|4|||
17052277|NCT00186901|38195630|FG001|Overall Study|Withdrawal by Subject|5|||
17052278|NCT00186901|38195631|FG002|Overall Study|Withdrawal by Subject|0|||
17143463|NCT02890992|38286610|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
17143464|NCT02890992|38286611|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
17143465|NCT02890992|38286612|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
17143466|NCT02890992|38286613|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
17143467|NCT02890992|38286614|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
17143468|NCT02890992|38286607|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
17143469|NCT02890992|38286608|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
17143470|NCT02890992|38286609|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
17143471|NCT02890992|38286610|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
17143472|NCT02890992|38286611|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
17143473|NCT02890992|38286612|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
17052279|NCT00186901|38195629|FG000|Overall Study|Open label|3|||
17052280|NCT00186901|38195630|FG001|Overall Study|Open label|2|||
17052281|NCT00186901|38195631|FG002|Overall Study|Open label|0|||
17052282|NCT00186901|38195629|FG000|Overall Study|Limited adherence to study requirements|20|||
17052283|NCT00186901|38195630|FG001|Overall Study|Limited adherence to study requirements|23|||
17052284|NCT00186901|38195631|FG002|Overall Study|Limited adherence to study requirements|0|||
17052285|NCT00186901|38195629|FG000|Overall Study|Bone Mineral Density > 0|0|||
17052286|NCT00186901|38195630|FG001|Overall Study|Bone Mineral Density > 0|0|||
17052287|NCT00186901|38195631|FG002|Overall Study|Bone Mineral Density > 0|149|||
17052288|NCT00186121|38195668|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
17052289|NCT00186121|38195668|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
17052290|NCT00186121|38195668|FG000|Overall Study|Not eligible (no treatment)|1|||
17052291|NCT00186043|38195674|FG000|Overall Study|Lack of Efficacy|1|||
17052292|NCT00186043|38195675|FG001|Overall Study|Lack of Efficacy|3|||
17052293|NCT00186043|38195674|FG000|Overall Study|Lost to Follow-up|4|||
17052294|NCT00186043|38195675|FG001|Overall Study|Lost to Follow-up|6|||
17052295|NCT00186043|38195674|FG000|Overall Study|Withdrawal by Subject|1|||
17052296|NCT00186043|38195675|FG001|Overall Study|Withdrawal by Subject|0|||
17052297|NCT00186043|38195674|FG000|Overall Study|Adverse Event|7|||
17052298|NCT00186043|38195675|FG001|Overall Study|Adverse Event|3|||
17052299|NCT00186043|38195674|FG000|Overall Study|Protocol Violation|2|||
17052300|NCT00186043|38195675|FG001|Overall Study|Protocol Violation|1|||
17052301|NCT00185965|38195683|FG000|Overall Study|Adverse Event|0|||
17052302|NCT00185965|38195684|FG001|Overall Study|Adverse Event|1|||
17052303|NCT00607880|38195692|FG000|Overall Study|Unable to place port due to occlusion|1|||
17052304|NCT00607880|38195693|FG001|Overall Study|Unable to place port due to occlusion|0|||
17052305|NCT00127933|38195701|FG000|Overall Study|Randomized but not dosed|1|||
17052306|NCT00127933|38195702|FG001|Overall Study|Randomized but not dosed|0|||
17052307|NCT03875313|38195713|FG000|Overall Study|Withdrawal by Subject|1|||
17052308|NCT03875313|38195714|FG001|Overall Study|Withdrawal by Subject|3|||
17052309|NCT03875313|38195715|FG002|Overall Study|Withdrawal by Subject|0|||
17052310|NCT03875313|38195716|FG003|Overall Study|Withdrawal by Subject|0|||
17052311|NCT03875313|38195717|FG004|Overall Study|Withdrawal by Subject|0|||
17052312|NCT03875313|38195713|FG000|Overall Study|Death|0|||
17052313|NCT03875313|38195714|FG001|Overall Study|Death|0|||
17052314|NCT03875313|38195715|FG002|Overall Study|Death|0|||
17052315|NCT03875313|38195716|FG003|Overall Study|Death|0|||
17052316|NCT03875313|38195717|FG004|Overall Study|Death|1|||
17052317|NCT03875313|38195713|FG000|Overall Study|Lost to Follow-up|0|||
17052318|NCT03875313|38195714|FG001|Overall Study|Lost to Follow-up|0|||
17052319|NCT03875313|38195715|FG002|Overall Study|Lost to Follow-up|0|||
17052320|NCT03875313|38195716|FG003|Overall Study|Lost to Follow-up|0|||
17052321|NCT03875313|38195717|FG004|Overall Study|Lost to Follow-up|1|||
17052322|NCT03875313|38195713|FG000|Overall Study|Study Termination by Sponsor|0|||
17052323|NCT03875313|38195714|FG001|Overall Study|Study Termination by Sponsor|1|||
17052324|NCT03875313|38195715|FG002|Overall Study|Study Termination by Sponsor|1|||
17052325|NCT03875313|38195716|FG003|Overall Study|Study Termination by Sponsor|0|||
17052326|NCT03875313|38195717|FG004|Overall Study|Study Termination by Sponsor|1|||
17052327|NCT03875313|38195713|FG000|Overall Study|New Anticancer Treatment|0|||
17052328|NCT03875313|38195714|FG001|Overall Study|New Anticancer Treatment|1|||
17052329|NCT03875313|38195715|FG002|Overall Study|New Anticancer Treatment|2|||
17052330|NCT03875313|38195716|FG003|Overall Study|New Anticancer Treatment|1|||
17052331|NCT03875313|38195717|FG004|Overall Study|New Anticancer Treatment|0|||
17052332|NCT03875313|38195713|FG000|Overall Study|Other, Not Specified|2|||
17052333|NCT03875313|38195714|FG001|Overall Study|Other, Not Specified|11|||
17052334|NCT03875313|38195715|FG002|Overall Study|Other, Not Specified|3|||
17052335|NCT03875313|38195716|FG003|Overall Study|Other, Not Specified|3|||
17052336|NCT03875313|38195717|FG004|Overall Study|Other, Not Specified|1|||
17052337|NCT00556998|38195729|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
17052338|NCT00556998|38195729|FG000|Voriconazole Intravenous (IV)|Other|4|||
17052339|NCT00556998|38195729|FG000|Voriconazole Oral|Adverse Event|1|||
17052340|NCT00556998|38195729|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
17052341|NCT00528801|38195739|FG000|Overall Study|Withdrawal by Subject|1|||
17052342|NCT00528801|38195740|FG001|Overall Study|Withdrawal by Subject|1|||
17052343|NCT00528801|38195739|FG000|Overall Study|Protocol Violation|11|||
17052344|NCT00528801|38195740|FG001|Overall Study|Protocol Violation|5|||
17052345|NCT00528801|38195739|FG000|Overall Study|Lost to Follow-up|15|||
17052346|NCT00528801|38195740|FG001|Overall Study|Lost to Follow-up|4|||
17052347|NCT00528801|38195739|FG000|Overall Study|Administrative Reasons|0|||
17052348|NCT00528801|38195740|FG001|Overall Study|Administrative Reasons|1|||
17052349|NCT00527397|38195746|FG000|Overall Study|Adverse Event|3|||
17052350|NCT00527397|38195746|FG000|Overall Study|Lack of Efficacy|1|||
17052351|NCT00527397|38195746|FG000|Overall Study|Protocol Violation|1|||
17052352|NCT00527397|38195746|FG000|Overall Study|Withdrawal by Subject|6|||
17052353|NCT00527397|38195746|FG000|Overall Study|Study terminated by sponsor|13|||
17052354|NCT00527319|38195756|FG000|Overall Study|Withdrawal by Subject|5|||
17052355|NCT00527319|38195757|FG001|Overall Study|Withdrawal by Subject|0|||
17052356|NCT00527319|38195758|FG002|Overall Study|Withdrawal by Subject|1|||
17052357|NCT00527319|38195756|FG000|Overall Study|Lost to Follow-up|1|||
17052358|NCT00527319|38195757|FG001|Overall Study|Lost to Follow-up|0|||
17052359|NCT00527319|38195758|FG002|Overall Study|Lost to Follow-up|0|||
17052360|NCT00527319|38195756|FG000|Overall Study|Death|0|||
17052361|NCT00527319|38195757|FG001|Overall Study|Death|3|||
17052362|NCT00527319|38195758|FG002|Overall Study|Death|1|||
17052363|NCT00527319|38195756|FG000|Overall Study|Intercurrent Medical Illness|0|||
17052364|NCT00527319|38195757|FG001|Overall Study|Intercurrent Medical Illness|1|||
17052365|NCT00527319|38195758|FG002|Overall Study|Intercurrent Medical Illness|3|||
17143474|NCT02890992|38286613|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
17143475|NCT02890992|38286614|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
17143476|NCT03076190|38286659|FG000|Overall Study|Lost to Follow-up|9|||
17143477|NCT03076190|38286660|FG001|Overall Study|Lost to Follow-up|34|||
17143478|NCT03076190|38286659|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
17143479|NCT03076190|38286660|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
17143480|NCT03329196|38286671|FG000|Overall Study|Adverse Event|10|||
17143481|NCT03329196|38286672|FG001|Overall Study|Adverse Event|5|||
17143482|NCT03329196|38286671|FG000|Overall Study|Physician Decision|2|||
17143483|NCT03329196|38286672|FG001|Overall Study|Physician Decision|2|||
17143484|NCT03329196|38286671|FG000|Overall Study|Withdrawal by Subject|11|||
17143485|NCT03329196|38286672|FG001|Overall Study|Withdrawal by Subject|3|||
17143486|NCT03329196|38286671|FG000|Overall Study|Hepatic function abnormalities|0|||
17052366|NCT00527319|38195756|FG000|Overall Study|Adverse Event|0|||
17052367|NCT00527319|38195757|FG001|Overall Study|Adverse Event|0|||
17052368|NCT00527319|38195758|FG002|Overall Study|Adverse Event|1|||
17052369|NCT00562302|38195768|FG000|Overall Study|Lost to Follow-up|3|||
17052370|NCT00562302|38195769|FG001|Overall Study|Lost to Follow-up|3|||
17052371|NCT00562302|38195768|FG000|Overall Study|Adverse Event|0|||
17052372|NCT00562302|38195769|FG001|Overall Study|Adverse Event|6|||
17052373|NCT00562302|38195768|FG000|Overall Study|Non-compliance|1|||
17143487|NCT03329196|38286672|FG001|Overall Study|Hepatic function abnormalities|1|||
17052374|NCT00562302|38195769|FG001|Overall Study|Non-compliance|2|||
17052375|NCT00562302|38195768|FG000|Overall Study|Withdrawal by Subject|7|||
17052376|NCT00562302|38195769|FG001|Overall Study|Withdrawal by Subject|8|||
17052377|NCT00562302|38195768|FG000|Overall Study|Death|1|||
17052378|NCT00562302|38195769|FG001|Overall Study|Death|2|||
17052379|NCT00562302|38195768|FG000|Overall Study|Lung resection prior to study completion|7|||
17052380|NCT00562302|38195769|FG001|Overall Study|Lung resection prior to study completion|7|||
17052381|NCT00562302|38195768|FG000|Overall Study|Not stated|1|||
17052382|NCT00562302|38195769|FG001|Overall Study|Not stated|4|||
17052383|NCT00134719|38195778|FG000|Primary Vaccination Phase|Adverse Event|4|||
17052384|NCT00134719|38195779|FG001|Primary Vaccination Phase|Adverse Event|0|||
17052385|NCT00134719|38195780|FG002|Primary Vaccination Phase|Adverse Event|0|||
17052386|NCT00134719|38195778|FG000|Primary Vaccination Phase|Protocol Violation|1|||
17052387|NCT00134719|38195779|FG001|Primary Vaccination Phase|Protocol Violation|0|||
17052388|NCT00134719|38195780|FG002|Primary Vaccination Phase|Protocol Violation|0|||
17052389|NCT00134719|38195778|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
17052390|NCT00134719|38195779|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
17052391|NCT00134719|38195780|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
17052392|NCT00134719|38195778|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
17052393|NCT00134719|38195779|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
17052394|NCT00134719|38195780|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
17052395|NCT00134719|38195778|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
17052396|NCT00134719|38195779|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
17052397|NCT00134719|38195780|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
17052398|NCT00134719|38195778|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
17052399|NCT00134719|38195779|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
17052400|NCT00134719|38195780|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
17052401|NCT00526071|38195797|FG000|Overall Study|Adverse Event|1|||
17052402|NCT00526071|38195797|FG000|Overall Study|Withdrawal by Subject|1|||
17052403|NCT00526071|38195797|FG000|Overall Study|Lack of Response to Study Drug|4|||
17052404|NCT00525915|38195807|FG000|Overall Study|Non-Compliance|0|||
17052405|NCT00525915|38195808|FG001|Overall Study|Non-Compliance|1|||
17052406|NCT00525915|38195807|FG000|Overall Study|Disease Progression|5|||
17052407|NCT00525915|38195808|FG001|Overall Study|Disease Progression|6|||
17052408|NCT00525915|38195807|FG000|Overall Study|Withdrawal by Subject|1|||
17052409|NCT00525915|38195808|FG001|Overall Study|Withdrawal by Subject|0|||
17052410|NCT00525915|38195807|FG000|Overall Study|Refused Surgery|1|||
17052411|NCT00525915|38195808|FG001|Overall Study|Refused Surgery|2|||
17052412|NCT00525915|38195807|FG000|Overall Study|Unrelated illness|1|||
17052413|NCT00525915|38195808|FG001|Overall Study|Unrelated illness|0|||
17052414|NCT03143153|38195817|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
17052415|NCT03143153|38195818|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
17052416|NCT03143153|38195819|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
17052417|NCT03143153|38195817|FG000|Pre-Treatment|Participant withdrew consent|0|||
17052418|NCT03143153|38195818|FG001|Pre-Treatment|Participant withdrew consent|1|||
17052419|NCT03143153|38195819|FG002|Pre-Treatment|Participant withdrew consent|12|||
17052420|NCT03143153|38195817|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
17052421|NCT03143153|38195818|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
17052422|NCT03143153|38195819|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
17052423|NCT03143153|38195817|FG000|Pre-Treatment|Other Reasons|1|||
17052424|NCT03143153|38195818|FG001|Pre-Treatment|Other Reasons|2|||
17052425|NCT03143153|38195819|FG002|Pre-Treatment|Other Reasons|1|||
17052426|NCT03143153|38195817|FG000|Pre-Treatment|Disease Progression|1|||
17052427|NCT03143153|38195818|FG001|Pre-Treatment|Disease Progression|1|||
17052428|NCT03143153|38195819|FG002|Pre-Treatment|Disease Progression|2|||
17052429|NCT03143153|38195817|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
17052430|NCT03143153|38195818|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
17052431|NCT03143153|38195819|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
17052432|NCT03143153|38195817|FG000|Treatment|Disease progression|174|||
17052433|NCT03143153|38195818|FG001|Treatment|Disease progression|184|||
17052434|NCT03143153|38195819|FG002|Treatment|Disease progression|193|||
17052435|NCT03143153|38195817|FG000|Treatment|Study drug toxicity|59|||
17052436|NCT03143153|38195818|FG001|Treatment|Study drug toxicity|33|||
17052437|NCT03143153|38195819|FG002|Treatment|Study drug toxicity|40|||
17052438|NCT03143153|38195817|FG000|Treatment|Death|5|||
17052439|NCT03143153|38195818|FG001|Treatment|Death|3|||
17052440|NCT03143153|38195819|FG002|Treatment|Death|4|||
17052441|NCT03143153|38195817|FG000|Treatment|Adverse event unrelated to study drug|19|||
17052442|NCT03143153|38195818|FG001|Treatment|Adverse event unrelated to study drug|28|||
17143488|NCT03329196|38286671|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
17143489|NCT03329196|38286672|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
17143490|NCT03329196|38286671|FG000|Overall Study|Difficult to control Hb|2|||
17052443|NCT03143153|38195819|FG002|Treatment|Adverse event unrelated to study drug|12|||
17052444|NCT03143153|38195817|FG000|Treatment|Participant request to discontinue study treatment|13|||
17052445|NCT03143153|38195818|FG001|Treatment|Participant request to discontinue study treatment|15|||
17052446|NCT03143153|38195819|FG002|Treatment|Participant request to discontinue study treatment|20|||
17052447|NCT03143153|38195817|FG000|Treatment|Participant withdrew consent|3|||
17052448|NCT03143153|38195818|FG001|Treatment|Participant withdrew consent|4|||
17052449|NCT03143153|38195819|FG002|Treatment|Participant withdrew consent|12|||
17052450|NCT03143153|38195817|FG000|Treatment|Pregnancy|1|||
17052451|NCT03143153|38195818|FG001|Treatment|Pregnancy|0|||
17052452|NCT03143153|38195819|FG002|Treatment|Pregnancy|0|||
17052453|NCT03143153|38195817|FG000|Treatment|Maximum clinical benefit|1|||
17052454|NCT03143153|38195818|FG001|Treatment|Maximum clinical benefit|3|||
17052455|NCT03143153|38195819|FG002|Treatment|Maximum clinical benefit|4|||
17052456|NCT03143153|38195817|FG000|Treatment|Completed treatment as per Protocol|13|||
17052457|NCT03143153|38195818|FG001|Treatment|Completed treatment as per Protocol|8|||
17052458|NCT03143153|38195819|FG002|Treatment|Completed treatment as per Protocol|0|||
17052459|NCT03143153|38195817|FG000|Treatment|Other reasons|12|||
17052460|NCT03143153|38195818|FG001|Treatment|Other reasons|7|||
17052461|NCT03143153|38195819|FG002|Treatment|Other reasons|15|||
17052462|NCT03143153|38195817|FG000|Treatment|Not reported|1|||
17052463|NCT03143153|38195818|FG001|Treatment|Not reported|0|||
17052464|NCT03143153|38195819|FG002|Treatment|Not reported|0|||
17052465|NCT00521079|38195829|FG000|Overall Study|Adverse Event|7|||
17052466|NCT00521079|38195830|FG001|Overall Study|Adverse Event|1|||
17052467|NCT00521079|38195829|FG000|Overall Study|Lost to Follow-up|2|||
17052468|NCT00521079|38195830|FG001|Overall Study|Lost to Follow-up|1|||
17052469|NCT00521079|38195829|FG000|Overall Study|Withdrawal by Subject|5|||
17052470|NCT00521079|38195830|FG001|Overall Study|Withdrawal by Subject|3|||
17052471|NCT00521001|38195836|FG000|Overall Study|Ineligible|1|||
17052472|NCT00134563|38195843|FG000|Overall Study|Not treated due to protocol violation|0|||
17052473|NCT00134563|38195844|FG001|Overall Study|Not treated due to protocol violation|1|||
17052474|NCT00134563|38195845|FG002|Overall Study|Not treated due to protocol violation|1|||
17052475|NCT00134563|38195843|FG000|Overall Study|Adverse Event|29|||
17052476|NCT00134563|38195844|FG001|Overall Study|Adverse Event|37|||
17052477|NCT00134563|38195845|FG002|Overall Study|Adverse Event|38|||
17052478|NCT00134563|38195843|FG000|Overall Study|Lack of Efficacy|24|||
17052479|NCT00134563|38195844|FG001|Overall Study|Lack of Efficacy|14|||
17052480|NCT00134563|38195845|FG002|Overall Study|Lack of Efficacy|17|||
17052481|NCT00134563|38195843|FG000|Overall Study|Protocol Violation|3|||
17052482|NCT00134563|38195844|FG001|Overall Study|Protocol Violation|2|||
17052483|NCT00134563|38195845|FG002|Overall Study|Protocol Violation|5|||
17052484|NCT00134563|38195843|FG000|Overall Study|Lost to Follow-up|4|||
17052485|NCT00134563|38195844|FG001|Overall Study|Lost to Follow-up|0|||
17052486|NCT00134563|38195845|FG002|Overall Study|Lost to Follow-up|2|||
17052487|NCT00134563|38195843|FG000|Overall Study|progressive disease|11|||
17052488|NCT00134563|38195844|FG001|Overall Study|progressive disease|4|||
17052489|NCT00134563|38195845|FG002|Overall Study|progressive disease|2|||
17052490|NCT00134563|38195843|FG000|Overall Study|did not wish to continue|33|||
17052491|NCT00134563|38195844|FG001|Overall Study|did not wish to continue|32|||
17052492|NCT00134563|38195845|FG002|Overall Study|did not wish to continue|26|||
17052493|NCT00134563|38195843|FG000|Overall Study|Reason other than above|0|||
17052494|NCT00134563|38195844|FG001|Overall Study|Reason other than above|2|||
17052495|NCT00134563|38195845|FG002|Overall Study|Reason other than above|5|||
17052496|NCT00520845|38195853|FG000|Overall Study|Death|3|||
17052497|NCT00520845|38195853|FG000|Overall Study|Adverse Event|4|||
17052498|NCT00520845|38195853|FG000|Overall Study|Disease Progression, relapse|13|||
17052499|NCT00520845|38195853|FG000|Overall Study|Withdrawal by Subject|1|||
17052500|NCT00520845|38195853|FG000|Overall Study|Alternative Therapy|1|||
17052501|NCT00185731|38195857|FG000|Overall Study|Withdrawal by Subject|1|||
17052502|NCT00185731|38195857|FG000|Overall Study|Not Eligible|1|||
17052503|NCT00582491|38195865|FG000|Overall Study|Withdrawal by Subject|1|||
17052504|NCT00582491|38195866|FG001|Overall Study|Withdrawal by Subject|0|||
17052505|NCT00520767|38195872|FG000|Overall Study|Death|2|||
17052506|NCT04679051|38195878|FG000|Overall Study|felt tired after restricted time in bed|3|||
17052507|NCT04679051|38195879|FG001|Overall Study|felt tired after restricted time in bed|0|||
17052508|NCT04679051|38195878|FG000|Overall Study|discomfort with blood pressure cuff|2|||
17052509|NCT04679051|38195879|FG001|Overall Study|discomfort with blood pressure cuff|0|||
17052510|NCT04679051|38195878|FG000|Overall Study|scheduling conflict|1|||
17052511|NCT04679051|38195879|FG001|Overall Study|scheduling conflict|1|||
17052512|NCT04679051|38195878|FG000|Overall Study|Protocol Violation|0|||
17052513|NCT04679051|38195879|FG001|Overall Study|Protocol Violation|4|||
17052514|NCT03873987|38195890|FG000|Overall Study|Adverse Event|1|||
17052515|NCT03873987|38195891|FG001|Overall Study|Adverse Event|0|||
17052516|NCT03873987|38195890|FG000|Overall Study|staff was unable to start a new IV line|1|||
17052517|NCT03873987|38195891|FG001|Overall Study|staff was unable to start a new IV line|0|||
17052518|NCT03873987|38195890|FG000|Overall Study|Lost to Follow-up|0|||
17052519|NCT03873987|38195891|FG001|Overall Study|Lost to Follow-up|1|||
17052520|NCT00474760|38195909|FG000|Overall Study|Death|0|||
17052521|NCT00474760|38195910|FG001|Overall Study|Death|0|||
17052522|NCT00474760|38195911|FG002|Overall Study|Death|0|||
17052523|NCT00474760|38195912|FG003|Overall Study|Death|0|||
17052524|NCT00474760|38195913|FG004|Overall Study|Death|2|||
17052525|NCT00474760|38195914|FG005|Overall Study|Death|0|||
17052526|NCT00474760|38195915|FG006|Overall Study|Death|0|||
17052527|NCT00474760|38195909|FG000|Overall Study|Adverse Event|0|||
17052528|NCT00474760|38195910|FG001|Overall Study|Adverse Event|0|||
17052529|NCT00474760|38195911|FG002|Overall Study|Adverse Event|0|||
17052530|NCT00474760|38195912|FG003|Overall Study|Adverse Event|0|||
17052531|NCT00474760|38195913|FG004|Overall Study|Adverse Event|1|||
17052532|NCT00474760|38195914|FG005|Overall Study|Adverse Event|7|||
17052533|NCT00474760|38195915|FG006|Overall Study|Adverse Event|0|||
17052534|NCT00474760|38195909|FG000|Overall Study|Laboratory abnormality|0|||
17052535|NCT00474760|38195910|FG001|Overall Study|Laboratory abnormality|0|||
17052536|NCT00474760|38195911|FG002|Overall Study|Laboratory abnormality|0|||
17052537|NCT00474760|38195912|FG003|Overall Study|Laboratory abnormality|0|||
16780959|NCT02151682|37720063|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
16780960|NCT02151682|37720064|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
16780961|NCT02151682|37720065|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
17052538|NCT00474760|38195913|FG004|Overall Study|Laboratory abnormality|0|||
17052539|NCT00474760|38195914|FG005|Overall Study|Laboratory abnormality|1|||
17052540|NCT00474760|38195915|FG006|Overall Study|Laboratory abnormality|0|||
17052541|NCT00474760|38195909|FG000|Overall Study|Withdrawal by Subject|0|||
17052542|NCT00474760|38195910|FG001|Overall Study|Withdrawal by Subject|0|||
17052543|NCT00474760|38195911|FG002|Overall Study|Withdrawal by Subject|0|||
17052544|NCT00474760|38195912|FG003|Overall Study|Withdrawal by Subject|1|||
17052545|NCT00474760|38195913|FG004|Overall Study|Withdrawal by Subject|0|||
17052546|NCT00474760|38195914|FG005|Overall Study|Withdrawal by Subject|1|||
17052547|NCT00474760|38195915|FG006|Overall Study|Withdrawal by Subject|1|||
17052548|NCT00474760|38195909|FG000|Overall Study|Other|0|||
17052549|NCT00474760|38195910|FG001|Overall Study|Other|1|||
17052550|NCT00474760|38195911|FG002|Overall Study|Other|0|||
17052551|NCT00474760|38195912|FG003|Overall Study|Other|0|||
17052552|NCT00474760|38195913|FG004|Overall Study|Other|1|||
17052553|NCT00474760|38195914|FG005|Overall Study|Other|0|||
17052554|NCT00474760|38195915|FG006|Overall Study|Other|0|||
17052555|NCT00474760|38195909|FG000|Overall Study|Progressive disease|3|||
17052556|NCT00474760|38195910|FG001|Overall Study|Progressive disease|2|||
17052557|NCT00474760|38195911|FG002|Overall Study|Progressive disease|3|||
17052558|NCT00474760|38195912|FG003|Overall Study|Progressive disease|2|||
17052559|NCT00474760|38195913|FG004|Overall Study|Progressive disease|8|||
17052560|NCT00474760|38195914|FG005|Overall Study|Progressive disease|20|||
17052561|NCT00474760|38195915|FG006|Overall Study|Progressive disease|7|||
17052562|NCT00474760|38195909|FG000|Overall Study|Terminated by sponsor|0|||
17052563|NCT00474760|38195910|FG001|Overall Study|Terminated by sponsor|0|||
17052564|NCT00474760|38195911|FG002|Overall Study|Terminated by sponsor|0|||
17052565|NCT00474760|38195912|FG003|Overall Study|Terminated by sponsor|0|||
17052566|NCT00474760|38195913|FG004|Overall Study|Terminated by sponsor|0|||
17052567|NCT00474760|38195914|FG005|Overall Study|Terminated by sponsor|0|||
17052568|NCT00474760|38195915|FG006|Overall Study|Terminated by sponsor|2|||
17052569|NCT00528645|38195938|FG000|Overall Study|Adverse Event|3|||
17052570|NCT00524745|38195947|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
17052571|NCT00524745|38195948|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
17052572|NCT00524745|38195949|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
17052573|NCT00524745|38195950|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
17052574|NCT00495040|38195960|FG000|Overall Study|Withdrawal by Subject|3|||
17052575|NCT00494026|38195968|FG000|Overall Study|Sponsor Decision|4|||
17052576|NCT00524589|38195972|FG000|Overall Study|Withdrawal by Subject|2|||
17052577|NCT00524589|38195972|FG000|Overall Study|Disease Progression|16|||
17052578|NCT00472030|38195978|FG000|Overall Study|Physician Decision|1|||
17052579|NCT00472030|38195979|FG001|Overall Study|Physician Decision|0|||
17052580|NCT00127855|38195994|FG000|Primary Vaccination Course|Adverse Event|0|||
17052581|NCT00127855|38195995|FG001|Primary Vaccination Course|Adverse Event|0|||
17052582|NCT00127855|38195996|FG002|Primary Vaccination Course|Adverse Event|1|||
17052583|NCT00127855|38195997|FG003|Primary Vaccination Course|Adverse Event|0|||
17052584|NCT00127855|38195998|FG004|Primary Vaccination Course|Adverse Event|0|||
17052585|NCT00127855|38195994|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
17052586|NCT00127855|38195995|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
17052587|NCT00127855|38195996|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
17052588|NCT00127855|38195997|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
17052589|NCT00127855|38195998|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
17052590|NCT00127855|38195994|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
17052591|NCT00127855|38195995|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
17052592|NCT00127855|38195996|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
17052593|NCT00127855|38195997|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
17052594|NCT00127855|38195998|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
17052595|NCT00127855|38195994|FG000|Primary Vaccination Course|Other|0|||
17052596|NCT00127855|38195995|FG001|Primary Vaccination Course|Other|0|||
17052597|NCT00127855|38195996|FG002|Primary Vaccination Course|Other|0|||
17052598|NCT00127855|38195997|FG003|Primary Vaccination Course|Other|0|||
17143491|NCT03329196|38286672|FG001|Overall Study|Difficult to control Hb|3|||
17143492|NCT03329196|38286671|FG000|Overall Study|Dialysis or renal transplant|13|||
17143493|NCT03329196|38286672|FG001|Overall Study|Dialysis or renal transplant|15|||
17143494|NCT03328182|38286678|FG000|Overall Study|Withdrawal by Subject|1|||
17143495|NCT03328182|38286678|FG000|Overall Study|Protocol Violation|2|||
16780962|NCT02151682|37720066|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
17052599|NCT00127855|38195998|FG004|Primary Vaccination Course|Other|1|||
17052600|NCT00493636|38196012|FG000|Overall Study|Withdrawal by Subject|1|||
17052601|NCT00493636|38196013|FG001|Overall Study|Withdrawal by Subject|0|||
17052602|NCT00493636|38196012|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
17052603|NCT00493636|38196013|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
17052604|NCT00493636|38196012|FG000|Overall Study|Mis-randomization|1|||
17052605|NCT00493636|38196013|FG001|Overall Study|Mis-randomization|1|||
17052606|NCT00524121|38196019|FG000|Overall Study|Disease progression|6|||
17052607|NCT00524121|38196019|FG000|Overall Study|Adverse Event|4|||
17052608|NCT00524121|38196019|FG000|Overall Study|Patient refused|2|||
17052609|NCT00524121|38196019|FG000|Overall Study|Other|1|||
17052610|NCT00524121|38196019|FG000|Overall Study|Death|1|||
17052611|NCT00524121|38196019|FG000|Overall Study|Not treated (became ineligible)|4|||
17052612|NCT00524121|38196019|FG000|Overall Study|Not treated (changed mind)|1|||
17052613|NCT00470626|38196034|FG000|Overall Study|Lost to Follow-up|10|||
17052614|NCT00470626|38196034|FG000|Overall Study|Withdrawal by Subject|7|||
17052615|NCT00133705|38196040|FG000|Overall Study|Withdrawal by Subject|2|||
17052616|NCT00133705|38196041|FG001|Overall Study|Withdrawal by Subject|3|||
17052617|NCT00132769|38196049|FG000|Overall Study|Withdrawal by Subject|1|||
17052618|NCT00132769|38196050|FG001|Overall Study|Withdrawal by Subject|3|||
17052619|NCT00132769|38196049|FG000|Overall Study|Lack of Efficacy|7|||
17052620|NCT00132769|38196050|FG001|Overall Study|Lack of Efficacy|6|||
17052621|NCT00132769|38196049|FG000|Overall Study|Adverse Event|2|||
17052622|NCT00132769|38196050|FG001|Overall Study|Adverse Event|1|||
17052623|NCT00132769|38196049|FG000|Overall Study|Protocol Violation|1|||
17052624|NCT00132769|38196050|FG001|Overall Study|Protocol Violation|1|||
17052625|NCT00520299|38196059|FG000|Overall Study|Withdrawal by Subject|0|||
17052626|NCT00520299|38196060|FG001|Overall Study|Withdrawal by Subject|0|||
17052627|NCT00520299|38196061|FG002|Overall Study|Withdrawal by Subject|2|||
17052628|NCT00520299|38196059|FG000|Overall Study|Progressive disease|0|||
17052629|NCT00520299|38196060|FG001|Overall Study|Progressive disease|3|||
17052630|NCT00520299|38196061|FG002|Overall Study|Progressive disease|4|||
17052631|NCT02478255|38196071|FG000|Overall Study|Physician Decision|6|||
17052632|NCT02478255|38196072|FG001|Overall Study|Physician Decision|0|||
17052633|NCT02478255|38196071|FG000|Overall Study|Withdrawal by Subject|2|||
17052634|NCT02478255|38196072|FG001|Overall Study|Withdrawal by Subject|0|||
17052635|NCT00132691|38196080|FG000|Overall Study|Lost to Follow-up|5|||
17052636|NCT00132691|38196081|FG001|Overall Study|Lost to Follow-up|8|||
17052637|NCT00132691|38196080|FG000|Overall Study|Missed 2-year visit|4|||
17052638|NCT00132691|38196081|FG001|Overall Study|Missed 2-year visit|4|||
17052639|NCT00132691|38196080|FG000|Overall Study|Death|2|||
17052640|NCT00132691|38196081|FG001|Overall Study|Death|0|||
17052641|NCT00125359|38196092|FG000|Overall Study|Death|4|||
17052642|NCT00125359|38196092|FG000|Overall Study|Adverse Event|5|||
17052643|NCT00125359|38196092|FG000|Overall Study|Physician Decision|14|||
17052644|NCT00524043|38196099|FG000|Overall Study|Lack of Efficacy|15|||
17052645|NCT00524043|38196100|FG001|Overall Study|Lack of Efficacy|13|||
17052646|NCT00524043|38196101|FG002|Overall Study|Lack of Efficacy|14|||
17052647|NCT00524043|38196099|FG000|Overall Study|Withdrawal by Subject|5|||
17052648|NCT00524043|38196100|FG001|Overall Study|Withdrawal by Subject|7|||
17052649|NCT00524043|38196101|FG002|Overall Study|Withdrawal by Subject|7|||
17052650|NCT00524043|38196099|FG000|Overall Study|Adverse Event|5|||
17052651|NCT00524043|38196100|FG001|Overall Study|Adverse Event|2|||
17052652|NCT00524043|38196101|FG002|Overall Study|Adverse Event|7|||
17052653|NCT00524043|38196099|FG000|Overall Study|Lost to Follow-up|3|||
17052654|NCT00524043|38196100|FG001|Overall Study|Lost to Follow-up|5|||
17052655|NCT00524043|38196101|FG002|Overall Study|Lost to Follow-up|3|||
17143496|NCT03328182|38286678|FG000|Overall Study|No Product Evaluated|1|||
17143497|NCT03327402|38286682|FG000|Overall Study|Withdrawal by Subject|1|||
17143498|NCT03327402|38286682|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
17143499|NCT03075878|38286686|FG000|Overall Study|Physician Decision|1|||
17143500|NCT03326856|38286695|FG000|Overall Study|Lost to Follow-up|1|||
17143501|NCT03326856|38286696|FG001|Overall Study|Lost to Follow-up|1|||
17143502|NCT03326856|38286697|FG002|Overall Study|Lost to Follow-up|0|||
17143503|NCT03326856|38286698|FG003|Overall Study|Lost to Follow-up|0|||
17052656|NCT00524043|38196099|FG000|Overall Study|Various (eg, incarceration)|2|||
17052657|NCT00524043|38196100|FG001|Overall Study|Various (eg, incarceration)|1|||
17052658|NCT00524043|38196101|FG002|Overall Study|Various (eg, incarceration)|0|||
17052659|NCT00523419|38196109|FG000|Overall Study|Adverse Event|1|||
17052660|NCT00523419|38196109|FG000|Overall Study|Withdrawal by Subject|1|||
17052661|NCT00523419|38196109|FG000|Overall Study|Physician Decision|2|||
17052662|NCT00523419|38196109|FG000|Overall Study|Progressive Disease|22|||
17052663|NCT00523419|38196109|FG000|Overall Study|Death due to Study Disease|4|||
17052664|NCT00523419|38196109|FG000|Overall Study|Death due to Adverse Event|2|||
17052665|NCT03868059|38196113|FG000|Overall Study|Adverse Event|3|||
17052666|NCT03868059|38196113|FG000|Overall Study|Lost to Follow-up|3|||
17052667|NCT03868059|38196113|FG000|Overall Study|Withdrawal by Subject|6|||
17143504|NCT03326856|38286699|FG004|Overall Study|Lost to Follow-up|0|||
17143505|NCT03309696|38286713|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
17143506|NCT03309696|38286714|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
17143507|NCT03309696|38286715|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
17143508|NCT03309696|38286716|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
17143509|NCT03075644|38286730|FG000|Overall Study|Withdrawal by Subject|1|||
17143510|NCT03075644|38286731|FG001|Overall Study|Withdrawal by Subject|1|||
17143511|NCT03075410|38286747|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
17143512|NCT03075410|38286748|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
17143513|NCT03075410|38286749|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
17143514|NCT03075410|38286750|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
17143515|NCT03075410|38286751|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
17143516|NCT03075410|38286752|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
17143517|NCT03075410|38286753|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
17143518|NCT03075410|38286754|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
17143519|NCT03075410|38286755|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
17143520|NCT03075410|38286747|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
17143521|NCT03075410|38286748|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
17143522|NCT03075410|38286749|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
17143523|NCT03075410|38286750|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
17052668|NCT00522951|38196117|FG000|Period 1|body motion|0|||
17052669|NCT00522951|38196118|FG001|Period 1|body motion|1|||
17052670|NCT00522951|38196117|FG000|Washout Period|Adverse Event|0|||
17052671|NCT00522951|38196118|FG001|Washout Period|Adverse Event|1|||
17052672|NCT00522951|38196117|FG000|Washout Period|Death|0|||
17052673|NCT00522951|38196118|FG001|Washout Period|Death|1|||
17052674|NCT00522951|38196117|FG000|Period 2|Withdrawal by Subject|1|||
17052675|NCT00522951|38196118|FG001|Period 2|Withdrawal by Subject|0|||
17052676|NCT00522951|38196117|FG000|Period 2|residual contrast medium|1|||
17052677|NCT00522951|38196118|FG001|Period 2|residual contrast medium|1|||
17052678|NCT03865953|38196130|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
17052679|NCT03865953|38196131|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
17052680|NCT03865953|38196130|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
17052681|NCT03865953|38196131|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
17052682|NCT03865953|38196130|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
17052683|NCT03865953|38196131|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
17052684|NCT03865407|38196139|FG000|Overall Study|Adverse Event|1|||
17052685|NCT03865407|38196140|FG001|Overall Study|Adverse Event|0|||
17052686|NCT03865407|38196139|FG000|Overall Study|Withdrawal by Subject|1|||
17052687|NCT03865407|38196140|FG001|Overall Study|Withdrawal by Subject|0|||
17052688|NCT03865407|38196139|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
17052689|NCT03865407|38196140|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
17052690|NCT00487942|38196150|FG000|Overall Study|Adverse Event|1|||
17052691|NCT00487942|38196151|FG001|Overall Study|Adverse Event|1|||
17052692|NCT00487942|38196152|FG002|Overall Study|Adverse Event|1|||
17052693|NCT00487942|38196153|FG003|Overall Study|Adverse Event|1|||
17143524|NCT03075410|38286751|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
17143525|NCT03075410|38286752|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
17143526|NCT03075410|38286753|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
17143527|NCT03075410|38286754|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
17143528|NCT03075410|38286755|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
17143529|NCT02100722|38286799|FG000|Overall Study|Withdrawal pre-procedure|4|||
17143530|NCT02100722|38286800|FG001|Overall Study|Withdrawal pre-procedure|9|||
17143531|NCT02100722|38286799|FG000|Overall Study|Withdrawal post-procedure|0|||
17143532|NCT02100722|38286800|FG001|Overall Study|Withdrawal post-procedure|3|||
17143533|NCT02100722|38286799|FG000|Overall Study|Lost to Follow-up|2|||
17143534|NCT02100722|38286800|FG001|Overall Study|Lost to Follow-up|2|||
17143535|NCT02100722|38286799|FG000|Overall Study|Continuing on study|751|||
17143536|NCT02100722|38286800|FG001|Overall Study|Continuing on study|729|||
17143537|NCT03071276|38286807|FG000|Overall Study|Adverse Event|1|||
17143538|NCT03071276|38286807|FG000|Overall Study|Lack of Efficacy|14|||
17143539|NCT03074162|38286817|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
17143540|NCT03074162|38286818|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
17143541|NCT03074162|38286819|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
17143542|NCT03074162|38286820|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
17143543|NCT03074162|38286821|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
17143544|NCT03074162|38286822|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
17143545|NCT03074162|38286817|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
17143546|NCT03074162|38286818|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
17052694|NCT00487942|38196150|FG000|Overall Study|Lost to Follow-up|1|||
17052695|NCT00487942|38196151|FG001|Overall Study|Lost to Follow-up|0|||
17052696|NCT00487942|38196152|FG002|Overall Study|Lost to Follow-up|0|||
17052697|NCT00487942|38196153|FG003|Overall Study|Lost to Follow-up|1|||
17052698|NCT00487942|38196150|FG000|Overall Study|Protocol Violation|1|||
17052699|NCT00487942|38196151|FG001|Overall Study|Protocol Violation|1|||
17143547|NCT03074162|38286819|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
17143548|NCT03074162|38286820|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
17143549|NCT03074162|38286821|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
17143550|NCT03074162|38286822|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
17143551|NCT03074162|38286817|FG000|Period 3|Withdrawal by Subject|1|||
17143552|NCT03074162|38286818|FG001|Period 3|Withdrawal by Subject|0|||
17143553|NCT03074162|38286819|FG002|Period 3|Withdrawal by Subject|0|||
17143554|NCT03074162|38286820|FG003|Period 3|Withdrawal by Subject|0|||
17143555|NCT03074162|38286821|FG004|Period 3|Withdrawal by Subject|1|||
17143556|NCT03074162|38286822|FG005|Period 3|Withdrawal by Subject|0|||
17143557|NCT03070964|38286830|FG000|Overall Study|Progressive disease|8|||
17143558|NCT03070964|38286830|FG000|Overall Study|Treatment-unrelated adverse event|2|||
17143559|NCT03070964|38286830|FG000|Overall Study|Never treated|1|||
17143560|NCT03070964|38286830|FG000|Overall Study|Physician Decision|1|||
17143561|NCT03070964|38286830|FG000|Overall Study|Withdrawal by Subject|1|||
17143562|NCT03070964|38286830|FG000|Overall Study|Adverse Event|1|||
17143563|NCT04065074|38286834|FG000|Overall Study|Adverse Event|1|||
17052700|NCT00487942|38196152|FG002|Overall Study|Protocol Violation|0|||
17052701|NCT00487942|38196153|FG003|Overall Study|Protocol Violation|0|||
17052702|NCT00487942|38196150|FG000|Overall Study|Withdrawal by Subject|0|||
17052703|NCT00487942|38196151|FG001|Overall Study|Withdrawal by Subject|1|||
17052704|NCT00487942|38196152|FG002|Overall Study|Withdrawal by Subject|2|||
17052705|NCT00487942|38196153|FG003|Overall Study|Withdrawal by Subject|0|||
17052706|NCT00132301|38196165|FG000|Overall Study|Death|7|||
17052707|NCT00132301|38196166|FG001|Overall Study|Death|6|||
17052708|NCT00132301|38196165|FG000|Overall Study|Withdrawal by Subject|5|||
17052709|NCT00132301|38196166|FG001|Overall Study|Withdrawal by Subject|2|||
17052710|NCT00132301|38196165|FG000|Overall Study|Physician Decision|1|||
17052711|NCT00132301|38196166|FG001|Overall Study|Physician Decision|1|||
17052712|NCT00132301|38196165|FG000|Overall Study|Lost to Follow-up|5|||
17052713|NCT00132301|38196166|FG001|Overall Study|Lost to Follow-up|3|||
17052714|NCT00132301|38196165|FG000|Overall Study|Other|1|||
17052715|NCT00132301|38196166|FG001|Overall Study|Other|1|||
17052716|NCT00132301|38196165|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
17052717|NCT00132301|38196166|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
17052718|NCT00522873|38196174|FG000|Overall Study|Adverse Event|41|||
17052719|NCT00522873|38196175|FG001|Overall Study|Adverse Event|26|||
17052720|NCT00522873|38196174|FG000|Overall Study|Withdrawal by Subject|20|||
17052721|NCT00522873|38196175|FG001|Overall Study|Withdrawal by Subject|9|||
17052722|NCT00522873|38196174|FG000|Overall Study|Protocol Violation|14|||
17052723|NCT00522873|38196175|FG001|Overall Study|Protocol Violation|4|||
17052724|NCT00522873|38196174|FG000|Overall Study|Lost to Follow-up|11|||
17052725|NCT00522873|38196175|FG001|Overall Study|Lost to Follow-up|3|||
17052726|NCT00522873|38196174|FG000|Overall Study|Personal Reasons|8|||
17052727|NCT00522873|38196175|FG001|Overall Study|Personal Reasons|1|||
17052728|NCT00522873|38196174|FG000|Overall Study|Medication Errors|1|||
17052729|NCT00522873|38196175|FG001|Overall Study|Medication Errors|1|||
17052730|NCT00522873|38196174|FG000|Overall Study|Never Received Medication|1|||
17052731|NCT00522873|38196175|FG001|Overall Study|Never Received Medication|0|||
17052732|NCT03684057|38196183|FG000|Overall Study|Withdrawal by Subject|4|||
17052733|NCT03684057|38196184|FG001|Overall Study|Withdrawal by Subject|5|||
17052734|NCT03864627|38196193|FG000|Overall Study|Adverse Event|0|||
17052735|NCT03864627|38196194|FG001|Overall Study|Adverse Event|1|||
17052736|NCT03864627|38196193|FG000|Overall Study|Lack of Efficacy|0|||
17052737|NCT03864627|38196194|FG001|Overall Study|Lack of Efficacy|1|||
17052738|NCT03864627|38196193|FG000|Overall Study|Lost to Follow-up|0|||
17052739|NCT03864627|38196194|FG001|Overall Study|Lost to Follow-up|1|||
17052740|NCT03864627|38196193|FG000|Overall Study|Withdrawal by Subject|4|||
17052741|NCT03864627|38196194|FG001|Overall Study|Withdrawal by Subject|8|||
17052742|NCT03864627|38196193|FG000|Overall Study|Study terminated by sponsor|0|||
17052743|NCT03864627|38196194|FG001|Overall Study|Study terminated by sponsor|1|||
17052744|NCT00519831|38196201|FG000|Overall Study|Adverse Event|3|||
17052745|NCT00131911|38196211|FG000|Overall Study|Withdrawal by Subject|1|||
17052746|NCT00131911|38196212|FG001|Overall Study|Withdrawal by Subject|0|||
17052747|NCT00184093|38196217|FG000|Overall Study|Adverse Event|3|||
17052748|NCT00184093|38196217|FG000|Overall Study|Lost to Follow-up|3|||
17052749|NCT00184093|38196217|FG000|Overall Study|Physician Decision|1|||
17143564|NCT04065074|38286834|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
17052750|NCT00184093|38196217|FG000|Overall Study|Withdrawal by Subject|2|||
17052751|NCT00183625|38196223|FG000|Overall Study|Withdrawal by Subject|18|||
17052752|NCT00183625|38196224|FG001|Overall Study|Withdrawal by Subject|18|||
17052753|NCT00183625|38196225|FG002|Overall Study|Withdrawal by Subject|19|||
17052754|NCT00183625|38196226|FG003|Overall Study|Withdrawal by Subject|14|||
17052755|NCT00511875|38196236|FG000|Overall Study|Lost to Follow-up|4|||
17052756|NCT00511875|38196237|FG001|Overall Study|Lost to Follow-up|0|||
17052757|NCT00511875|38196236|FG000|Overall Study|Missing variables|1|||
17052758|NCT00511875|38196237|FG001|Overall Study|Missing variables|0|||
17052759|NCT02286089|38196247|FG000|Overall Study|Ongoing in Study|1|||
17143565|NCT02888106|38286844|FG000|Overall Study|Withdrawal by Subject|1|||
17143566|NCT02888106|38286845|FG001|Overall Study|Withdrawal by Subject|2|||
17143567|NCT02888106|38286846|FG002|Overall Study|Withdrawal by Subject|0|||
17143568|NCT02888106|38286847|FG003|Overall Study|Withdrawal by Subject|1|||
17143569|NCT02888106|38286848|FG004|Overall Study|Withdrawal by Subject|0|||
17143570|NCT02888106|38286849|FG005|Overall Study|Withdrawal by Subject|0|||
17052760|NCT02286089|38196248|FG001|Overall Study|Ongoing in Study|1|||
17052761|NCT02286089|38196249|FG002|Overall Study|Ongoing in Study|4|||
17052762|NCT02286089|38196250|FG003|Overall Study|Ongoing in Study|10|||
17052763|NCT02286089|38196247|FG000|Overall Study|Withdrawal by Subject|0|||
17052764|NCT02286089|38196248|FG001|Overall Study|Withdrawal by Subject|0|||
17052765|NCT02286089|38196249|FG002|Overall Study|Withdrawal by Subject|2|||
17052766|NCT02286089|38196250|FG003|Overall Study|Withdrawal by Subject|2|||
17052767|NCT00183391|38196262|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
17052768|NCT00183391|38196263|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
17052769|NCT00183391|38196262|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
17143571|NCT02888106|38286844|FG000|Overall Study|Lost to Follow-up|1|||
17143572|NCT02888106|38286845|FG001|Overall Study|Lost to Follow-up|0|||
17052770|NCT00183391|38196263|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
17052771|NCT00493246|38196279|FG000|Overall Study|Withdrawal by Subject|0|||
17052772|NCT00493246|38196280|FG001|Overall Study|Withdrawal by Subject|0|||
17052773|NCT00493246|38196281|FG002|Overall Study|Withdrawal by Subject|0|||
17052774|NCT00493246|38196282|FG003|Overall Study|Withdrawal by Subject|0|||
17052775|NCT00493246|38196283|FG004|Overall Study|Withdrawal by Subject|1|||
17052776|NCT00493246|38196284|FG005|Overall Study|Withdrawal by Subject|0|||
17052777|NCT00493246|38196285|FG006|Overall Study|Withdrawal by Subject|0|||
17052778|NCT00493246|38196286|FG007|Overall Study|Withdrawal by Subject|0|||
17052779|NCT00493246|38196279|FG000|Overall Study|No access to draw blood|0|||
17052780|NCT00493246|38196280|FG001|Overall Study|No access to draw blood|0|||
17052781|NCT00493246|38196281|FG002|Overall Study|No access to draw blood|0|||
17052782|NCT00493246|38196282|FG003|Overall Study|No access to draw blood|0|||
17052783|NCT00493246|38196283|FG004|Overall Study|No access to draw blood|0|||
17052784|NCT00493246|38196284|FG005|Overall Study|No access to draw blood|1|||
17052785|NCT00493246|38196285|FG006|Overall Study|No access to draw blood|0|||
17052786|NCT00493246|38196286|FG007|Overall Study|No access to draw blood|0|||
17052787|NCT00493246|38196279|FG000|Overall Study|Lost to Follow-up|0|||
17052788|NCT00493246|38196280|FG001|Overall Study|Lost to Follow-up|0|||
17052789|NCT00493246|38196281|FG002|Overall Study|Lost to Follow-up|0|||
17052790|NCT00493246|38196282|FG003|Overall Study|Lost to Follow-up|0|||
17052791|NCT00493246|38196283|FG004|Overall Study|Lost to Follow-up|0|||
17052792|NCT00493246|38196284|FG005|Overall Study|Lost to Follow-up|0|||
17052793|NCT00493246|38196285|FG006|Overall Study|Lost to Follow-up|1|||
17052794|NCT00493246|38196286|FG007|Overall Study|Lost to Follow-up|0|||
17052795|NCT02281955|38196304|FG000|Overall Study|Death|1|||
17052796|NCT00511797|38196312|FG000|Overall Study|Adverse Event|1|||
17052797|NCT00511797|38196313|FG001|Overall Study|Adverse Event|2|||
17052798|NCT00511797|38196314|FG002|Overall Study|Adverse Event|2|||
17052799|NCT00511797|38196315|FG003|Overall Study|Adverse Event|2|||
17052800|NCT00511797|38196312|FG000|Overall Study|Lost to Follow-up|1|||
17052801|NCT00511797|38196313|FG001|Overall Study|Lost to Follow-up|0|||
17052802|NCT00511797|38196314|FG002|Overall Study|Lost to Follow-up|0|||
17052803|NCT00511797|38196315|FG003|Overall Study|Lost to Follow-up|1|||
17052804|NCT00511797|38196312|FG000|Overall Study|Pregnancy|0|||
17052805|NCT00511797|38196313|FG001|Overall Study|Pregnancy|0|||
17052806|NCT00511797|38196314|FG002|Overall Study|Pregnancy|0|||
17052807|NCT00511797|38196315|FG003|Overall Study|Pregnancy|1|||
17052808|NCT00511797|38196312|FG000|Overall Study|Protocol Violation|0|||
17052809|NCT00511797|38196313|FG001|Overall Study|Protocol Violation|2|||
17052810|NCT00511797|38196314|FG002|Overall Study|Protocol Violation|2|||
17052811|NCT00511797|38196315|FG003|Overall Study|Protocol Violation|3|||
17052812|NCT00511797|38196312|FG000|Overall Study|Withdrawal by Subject|3|||
17052813|NCT00511797|38196313|FG001|Overall Study|Withdrawal by Subject|3|||
17052814|NCT00511797|38196314|FG002|Overall Study|Withdrawal by Subject|4|||
17052815|NCT00511797|38196315|FG003|Overall Study|Withdrawal by Subject|2|||
17052816|NCT00511797|38196312|FG000|Overall Study|Never dispensed|1|||
17052817|NCT00511797|38196313|FG001|Overall Study|Never dispensed|0|||
17052818|NCT00511797|38196314|FG002|Overall Study|Never dispensed|1|||
17052819|NCT00511797|38196315|FG003|Overall Study|Never dispensed|3|||
17052820|NCT00511797|38196312|FG000|Overall Study|Study drug not taken|0|||
17052821|NCT00511797|38196313|FG001|Overall Study|Study drug not taken|1|||
17052822|NCT00511797|38196314|FG002|Overall Study|Study drug not taken|0|||
17052823|NCT00511797|38196315|FG003|Overall Study|Study drug not taken|1|||
17052824|NCT00511797|38196312|FG000|Overall Study|Partially missing diary|0|||
17052825|NCT00511797|38196313|FG001|Overall Study|Partially missing diary|0|||
17143573|NCT02888106|38286846|FG002|Overall Study|Lost to Follow-up|0|||
17143574|NCT02888106|38286847|FG003|Overall Study|Lost to Follow-up|1|||
17143575|NCT02888106|38286848|FG004|Overall Study|Lost to Follow-up|0|||
17143576|NCT02888106|38286849|FG005|Overall Study|Lost to Follow-up|1|||
17052826|NCT00511797|38196314|FG002|Overall Study|Partially missing diary|1|||
17052827|NCT00511797|38196315|FG003|Overall Study|Partially missing diary|0|||
17052828|NCT00511797|38196312|FG000|Overall Study|Other (moving etc)|1|||
17052829|NCT00511797|38196313|FG001|Overall Study|Other (moving etc)|0|||
17052830|NCT00511797|38196314|FG002|Overall Study|Other (moving etc)|1|||
17052831|NCT00511797|38196315|FG003|Overall Study|Other (moving etc)|2|||
17052832|NCT00487552|38196325|FG000|Overall Study|Unsuccessful magnet placements|3|||
17052833|NCT00487552|38196325|FG000|Overall Study|Death due to progressive malignancy|2|||
17052834|NCT00487552|38196325|FG000|Overall Study|Stent not placed|1|||
17052835|NCT00182689|38196332|FG000|Overall Study|Adverse Event|8|||
17052836|NCT00182689|38196333|FG001|Overall Study|Adverse Event|11|||
17052837|NCT00182689|38196332|FG000|Overall Study|Withdrawal by Subject|2|||
17052838|NCT00182689|38196333|FG001|Overall Study|Withdrawal by Subject|2|||
17052839|NCT00182689|38196332|FG000|Overall Study|Progression|27|||
17052840|NCT00182689|38196333|FG001|Overall Study|Progression|29|||
17143577|NCT02888106|38286844|FG000|Overall Study|Adverse Event|2|||
17052841|NCT00182689|38196332|FG000|Overall Study|Death|1|||
17052842|NCT00182689|38196333|FG001|Overall Study|Death|0|||
17052843|NCT00182689|38196332|FG000|Overall Study|not protocol specified|0|||
17052844|NCT00182689|38196333|FG001|Overall Study|not protocol specified|3|||
17052845|NCT00182689|38196332|FG000|Overall Study|Ineligible|1|||
17052846|NCT00182689|38196333|FG001|Overall Study|Ineligible|4|||
17052847|NCT00182689|38196332|FG000|Overall Study|Never received treatment|1|||
17052848|NCT00182689|38196333|FG001|Overall Study|Never received treatment|0|||
17052849|NCT03860259|38196345|FG000|Overall Study|Lost to Follow-up|5|||
17052850|NCT03860259|38196346|FG001|Overall Study|Lost to Follow-up|5|||
17052851|NCT03860259|38196345|FG000|Overall Study|Protocol Violation|1|||
17052852|NCT03860259|38196346|FG001|Overall Study|Protocol Violation|0|||
17052853|NCT00131365|38196352|FG000|Overall Study|Withdrawal by Subject|1|||
17052854|NCT00131365|38196352|FG000|Overall Study|Alternative treatment|3|||
17052855|NCT00487240|38196359|FG000|Overall Study|Withdrawal by Subject|12|||
17052856|NCT00487240|38196360|FG001|Overall Study|Withdrawal by Subject|6|||
17052857|NCT00487240|38196359|FG000|Overall Study|Lost to Follow-up|7|||
17052858|NCT00487240|38196360|FG001|Overall Study|Lost to Follow-up|6|||
17052859|NCT00487240|38196359|FG000|Overall Study|Adverse Event|0|||
17052860|NCT00487240|38196360|FG001|Overall Study|Adverse Event|4|||
17052861|NCT00487240|38196359|FG000|Overall Study|Protocol Violation|5|||
17052862|NCT00487240|38196360|FG001|Overall Study|Protocol Violation|5|||
17143578|NCT02888106|38286845|FG001|Overall Study|Adverse Event|0|||
17143579|NCT02888106|38286846|FG002|Overall Study|Adverse Event|0|||
17143580|NCT02888106|38286847|FG003|Overall Study|Adverse Event|0|||
17143581|NCT02888106|38286848|FG004|Overall Study|Adverse Event|0|||
17143582|NCT02888106|38286849|FG005|Overall Study|Adverse Event|0|||
17143583|NCT02888106|38286844|FG000|Overall Study|Withdrawal of consent|0|||
17143584|NCT02888106|38286845|FG001|Overall Study|Withdrawal of consent|0|||
17143585|NCT02888106|38286846|FG002|Overall Study|Withdrawal of consent|0|||
17143586|NCT02888106|38286847|FG003|Overall Study|Withdrawal of consent|0|||
17143587|NCT02888106|38286848|FG004|Overall Study|Withdrawal of consent|1|||
17143588|NCT02888106|38286849|FG005|Overall Study|Withdrawal of consent|0|||
17143589|NCT02888106|38286844|FG000|Overall Study|Pregnancy|1|||
17052863|NCT00487240|38196359|FG000|Overall Study|Entry Criteria Not Met|3|||
17052864|NCT00487240|38196360|FG001|Overall Study|Entry Criteria Not Met|4|||
17052865|NCT00487240|38196359|FG000|Overall Study|Sponsor Decision|2|||
17052866|NCT00487240|38196360|FG001|Overall Study|Sponsor Decision|1|||
17143590|NCT02888106|38286845|FG001|Overall Study|Pregnancy|0|||
17052867|NCT00487240|38196359|FG000|Overall Study|Physician Decision|2|||
17052868|NCT00487240|38196360|FG001|Overall Study|Physician Decision|0|||
17052869|NCT02224391|38196368|FG000|Overall Study|Lost to Follow-up|26|||
17143591|NCT02888106|38286846|FG002|Overall Study|Pregnancy|0|||
17143592|NCT02888106|38286847|FG003|Overall Study|Pregnancy|0|||
17143593|NCT02888106|38286848|FG004|Overall Study|Pregnancy|0|||
17143594|NCT02888106|38286849|FG005|Overall Study|Pregnancy|0|||
17143595|NCT03793010|38286871|FG000|Overall Study|Withdrawal by Subject|5|||
17143596|NCT03793010|38286872|FG001|Overall Study|Withdrawal by Subject|7|||
17143597|NCT03793010|38286871|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
17143598|NCT03793010|38286872|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
17143599|NCT03793010|38286871|FG000|Overall Study|Lost to Follow-up|1|||
17143600|NCT03793010|38286872|FG001|Overall Study|Lost to Follow-up|2|||
17143601|NCT03793010|38286871|FG000|Overall Study|Patient couldn't sit still for injection|1|||
17143602|NCT03793010|38286872|FG001|Overall Study|Patient couldn't sit still for injection|0|||
17143603|NCT03793010|38286871|FG000|Overall Study|Withdrew to pursue other treatment|1|||
17143604|NCT03793010|38286872|FG001|Overall Study|Withdrew to pursue other treatment|0|||
17052870|NCT02224391|38196369|FG001|Overall Study|Lost to Follow-up|19|||
17052871|NCT02224391|38196368|FG000|Overall Study|Withdrawal by Subject|6|||
17052872|NCT02224391|38196369|FG001|Overall Study|Withdrawal by Subject|5|||
17052873|NCT00487162|38196377|FG000|Overall Study|Adverse Event|0|||
16780963|NCT02174848|37720096|FG000|Overall Study|Adverse Event|2|||
17052874|NCT00487162|38196378|FG001|Overall Study|Adverse Event|1|||
17052875|NCT00487162|38196377|FG000|Overall Study|Physician Decision|0|||
17052876|NCT00487162|38196378|FG001|Overall Study|Physician Decision|1|||
17052877|NCT00487162|38196377|FG000|Overall Study|Withdrawal by Subject|2|||
17052878|NCT00487162|38196378|FG001|Overall Study|Withdrawal by Subject|3|||
17052879|NCT00487084|38196387|FG000|Overall Study|Did not receive intervention|4|||
17052880|NCT00487084|38196388|FG001|Overall Study|Did not receive intervention|3|||
17052881|NCT00487084|38196389|FG002|Overall Study|Did not receive intervention|5|||
17052882|NCT00466726|38196397|FG000|Overall Study|Not evaluable for response|14|||
17052883|NCT01721291|38196403|FG000|Overall Study|Withdrawal by Subject|1|||
17052884|NCT01721291|38196404|FG001|Overall Study|Withdrawal by Subject|0|||
17052885|NCT01721291|38196403|FG000|Overall Study|did not like the treatment|1|||
17052886|NCT01721291|38196404|FG001|Overall Study|did not like the treatment|0|||
17052887|NCT00486226|38196430|FG000|Overall Study|Death|3|||
17052888|NCT00486226|38196430|FG000|Overall Study|Adverse Event|1|||
17052889|NCT00486226|38196430|FG000|Overall Study|Withdrawal by Subject|1|||
17052890|NCT00486226|38196430|FG000|Overall Study|Lost to Follow-up|8|||
17052891|NCT00485758|38196439|FG000|Overall Study|Adverse Event|102|||
17052892|NCT00485758|38196440|FG001|Overall Study|Adverse Event|31|||
17052893|NCT00485758|38196439|FG000|Overall Study|Death|0|||
17052894|NCT00485758|38196440|FG001|Overall Study|Death|1|||
17052895|NCT00485758|38196439|FG000|Overall Study|Lost to Follow-up|5|||
17052896|NCT00485758|38196440|FG001|Overall Study|Lost to Follow-up|1|||
17052897|NCT00485758|38196439|FG000|Overall Study|Physician Decision|3|||
17052898|NCT00485758|38196440|FG001|Overall Study|Physician Decision|3|||
17052899|NCT00485758|38196439|FG000|Overall Study|Protocol Violation|11|||
17052900|NCT00485758|38196440|FG001|Overall Study|Protocol Violation|2|||
17052901|NCT00485758|38196439|FG000|Overall Study|Withdrawal by Subject|32|||
17052902|NCT00485758|38196440|FG001|Overall Study|Withdrawal by Subject|27|||
17052903|NCT00485758|38196439|FG000|Overall Study|Study Terminated by Sponsor|3|||
17052904|NCT00485758|38196440|FG001|Overall Study|Study Terminated by Sponsor|0|||
17052905|NCT03850444|38196448|FG000|Overall Study|Adverse Event|12|||
17052906|NCT03850444|38196449|FG001|Overall Study|Adverse Event|9|||
17052907|NCT03850444|38196448|FG000|Overall Study|Death|38|||
17052908|NCT03850444|38196449|FG001|Overall Study|Death|64|||
17052909|NCT03850444|38196448|FG000|Overall Study|Lost to Follow-up|0|||
17052910|NCT03850444|38196449|FG001|Overall Study|Lost to Follow-up|1|||
17052911|NCT03850444|38196448|FG000|Overall Study|Withdrawal by Subject|0|||
17052912|NCT03850444|38196449|FG001|Overall Study|Withdrawal by Subject|1|||
17052913|NCT03850444|38196448|FG000|Overall Study|Ongoing in Study|78|||
17052914|NCT03850444|38196449|FG001|Overall Study|Ongoing in Study|59|||
17052915|NCT00469612|38196457|FG000|Overall Study|Study terminated before data collected|2|||
17052916|NCT00469612|38196458|FG001|Overall Study|Study terminated before data collected|0|||
17052917|NCT00469456|38196466|FG000|Overall Study|Adverse Event|4|||
17052918|NCT00469456|38196467|FG001|Overall Study|Adverse Event|3|||
17143605|NCT03793010|38286871|FG000|Overall Study|Did not meet eligibility criteria|1|||
17143606|NCT03793010|38286872|FG001|Overall Study|Did not meet eligibility criteria|0|||
17143607|NCT03304626|38286880|FG000|Overall Study|Adverse Event|1|||
17052919|NCT00469456|38196466|FG000|Overall Study|Protocol Violation|1|||
17052920|NCT00469456|38196467|FG001|Overall Study|Protocol Violation|0|||
17052921|NCT00469456|38196466|FG000|Overall Study|Withdrawal by Subject|4|||
17052922|NCT00469456|38196467|FG001|Overall Study|Withdrawal by Subject|1|||
17052923|NCT00581555|38196475|FG000|Overall Study|Adverse Event|4|||
17052924|NCT00581555|38196476|FG001|Overall Study|Adverse Event|3|||
17052925|NCT00581555|38196475|FG000|Overall Study|Physician Decision|3|||
17052926|NCT00581555|38196476|FG001|Overall Study|Physician Decision|2|||
17052927|NCT00581555|38196475|FG000|Overall Study|Withdrawal by Subject|18|||
17052928|NCT00581555|38196476|FG001|Overall Study|Withdrawal by Subject|9|||
17052929|NCT00581555|38196475|FG000|Overall Study|Lost to Follow-up|2|||
17052930|NCT00581555|38196476|FG001|Overall Study|Lost to Follow-up|2|||
17052931|NCT00581555|38196475|FG000|Overall Study|Other reasons|16|||
17052932|NCT00581555|38196476|FG001|Overall Study|Other reasons|4|||
17052933|NCT00469144|38196484|FG000|Overall Study|Death|0|||
17052934|NCT00469144|38196485|FG001|Overall Study|Death|1|||
17052935|NCT00469144|38196484|FG000|Overall Study|No Response|5|||
17052936|NCT00469144|38196485|FG001|Overall Study|No Response|5|||
17052937|NCT00469144|38196484|FG000|Overall Study|Progressive Disease|1|||
17052938|NCT00469144|38196485|FG001|Overall Study|Progressive Disease|0|||
17052939|NCT00468910|38196497|FG000|Overall Study|Lost to Follow-up|2|||
17052940|NCT00468910|38196498|FG001|Overall Study|Lost to Follow-up|1|||
17052941|NCT00468910|38196497|FG000|Overall Study|Withdrawal by Subject|2|||
17052942|NCT00468910|38196498|FG001|Overall Study|Withdrawal by Subject|1|||
17052943|NCT00468910|38196497|FG000|Overall Study|Medical Contraindication|0|||
17052944|NCT00468910|38196498|FG001|Overall Study|Medical Contraindication|1|||
17052945|NCT01412333|38196507|FG000|Overall Study|Death|1|||
17052946|NCT01412333|38196508|FG001|Overall Study|Death|1|||
17052947|NCT01412333|38196507|FG000|Overall Study|Physician Decision|0|||
17052948|NCT01412333|38196508|FG001|Overall Study|Physician Decision|1|||
17052949|NCT01412333|38196507|FG000|Overall Study|Reason not specified|16|||
17052950|NCT01412333|38196508|FG001|Overall Study|Reason not specified|10|||
17052951|NCT01412333|38196507|FG000|Overall Study|Non-compliance with study drug|1|||
17052952|NCT01412333|38196508|FG001|Overall Study|Non-compliance with study drug|1|||
17052953|NCT01412333|38196507|FG000|Overall Study|Protocol Violation|1|||
17052954|NCT01412333|38196508|FG001|Overall Study|Protocol Violation|1|||
17052955|NCT01412333|38196507|FG000|Overall Study|Non-compliance|1|||
17052956|NCT01412333|38196508|FG001|Overall Study|Non-compliance|3|||
17052957|NCT01412333|38196507|FG000|Overall Study|Lack of Efficacy|15|||
17052958|NCT01412333|38196508|FG001|Overall Study|Lack of Efficacy|6|||
17052959|NCT01412333|38196507|FG000|Overall Study|Pregnancy|3|||
17052960|NCT01412333|38196508|FG001|Overall Study|Pregnancy|0|||
17052961|NCT01412333|38196507|FG000|Overall Study|Consent withdrawn by participant|25|||
17052962|NCT01412333|38196508|FG001|Overall Study|Consent withdrawn by participant|12|||
17052963|NCT01412333|38196507|FG000|Overall Study|Adverse Event|25|||
17052964|NCT01412333|38196508|FG001|Overall Study|Adverse Event|16|||
17052965|NCT01412333|38196507|FG000|Overall Study|Lost to Follow-up|10|||
17052966|NCT01412333|38196508|FG001|Overall Study|Lost to Follow-up|6|||
17052967|NCT00519285|38196517|FG000|Overall Study|Adverse Event|127|||
17052968|NCT00519285|38196518|FG001|Overall Study|Adverse Event|266|||
17052969|NCT00519285|38196517|FG000|Overall Study|Disease progression|334|||
17052970|NCT00519285|38196518|FG001|Overall Study|Disease progression|186|||
17052971|NCT00519285|38196517|FG000|Overall Study|Physician Decision|75|||
17052972|NCT00519285|38196518|FG001|Overall Study|Physician Decision|47|||
17052973|NCT00519285|38196517|FG000|Overall Study|Participant's request|53|||
17052974|NCT00519285|38196518|FG001|Overall Study|Participant's request|84|||
17052975|NCT00519285|38196517|FG000|Overall Study|Consent withdrawn|4|||
17052976|NCT00519285|38196518|FG001|Overall Study|Consent withdrawn|5|||
17052977|NCT00519285|38196517|FG000|Overall Study|Poor compliance to protocol|5|||
17052978|NCT00519285|38196518|FG001|Overall Study|Poor compliance to protocol|7|||
17052979|NCT00519285|38196517|FG000|Overall Study|Reason unspecified|5|||
17052980|NCT00519285|38196518|FG001|Overall Study|Reason unspecified|8|||
17052981|NCT00519285|38196517|FG000|Overall Study|Not treated|8|||
17052982|NCT00519285|38196518|FG001|Overall Study|Not treated|7|||
17052983|NCT00519285|38196517|FG000|Overall Study|Treatment ongoing|1|||
17052984|NCT00519285|38196518|FG001|Overall Study|Treatment ongoing|2|||
17052985|NCT00464620|38196524|FG000|Overall Study|Physician Decision|1|||
17052986|NCT00464620|38196525|FG001|Overall Study|Physician Decision|0|||
17052987|NCT00464620|38196526|FG002|Overall Study|Physician Decision|0|||
17052988|NCT00464620|38196524|FG000|Overall Study|Withdrawal by Subject|1|||
17052989|NCT00464620|38196525|FG001|Overall Study|Withdrawal by Subject|0|||
17052990|NCT00464620|38196526|FG002|Overall Study|Withdrawal by Subject|3|||
17052991|NCT00464620|38196524|FG000|Overall Study|Ineligible sarcoma subtype|0|||
17052992|NCT00464620|38196525|FG001|Overall Study|Ineligible sarcoma subtype|2|||
17052993|NCT00464620|38196526|FG002|Overall Study|Ineligible sarcoma subtype|2|||
17052994|NCT00464620|38196524|FG000|Overall Study|Use of prohibited concomitant medication|0|||
17052995|NCT00464620|38196525|FG001|Overall Study|Use of prohibited concomitant medication|0|||
17052996|NCT00464620|38196526|FG002|Overall Study|Use of prohibited concomitant medication|2|||
17052997|NCT00464542|38196539|FG000|Pre-treatment|Withdrawal by Subject|2|||
17052998|NCT00468676|38196545|FG000|Overall Study|Lost to Follow-up|14|||
17052999|NCT00468676|38196546|FG001|Overall Study|Lost to Follow-up|11|||
17053000|NCT00468676|38196545|FG000|Overall Study|Death|2|||
17053001|NCT00468676|38196546|FG001|Overall Study|Death|1|||
17053002|NCT00464308|38196557|FG000|Overall Study|Adverse Event|22|||
17053003|NCT00464308|38196558|FG001|Overall Study|Adverse Event|27|||
17053004|NCT00464308|38196559|FG002|Overall Study|Adverse Event|16|||
17053005|NCT00464308|38196557|FG000|Overall Study|Lost to Follow-up|29|||
17053006|NCT00464308|38196558|FG001|Overall Study|Lost to Follow-up|19|||
17053007|NCT00464308|38196559|FG002|Overall Study|Lost to Follow-up|20|||
17053008|NCT00464308|38196557|FG000|Overall Study|Patient discontinued and other reasons|17|||
17053009|NCT00464308|38196558|FG001|Overall Study|Patient discontinued and other reasons|17|||
17053010|NCT00464308|38196559|FG002|Overall Study|Patient discontinued and other reasons|23|||
17053011|NCT00464308|38196557|FG000|Overall Study|Physician Decision|1|||
17053012|NCT00464308|38196558|FG001|Overall Study|Physician Decision|0|||
17053013|NCT00464308|38196559|FG002|Overall Study|Physician Decision|0|||
17053014|NCT00468286|38196569|FG000|Overall Study|Adverse Event|1|||
17053015|NCT00468286|38196570|FG001|Overall Study|Adverse Event|6|||
17053016|NCT00468286|38196569|FG000|Overall Study|Protocol Violation|2|||
17053017|NCT00468286|38196570|FG001|Overall Study|Protocol Violation|2|||
17053018|NCT00468286|38196569|FG000|Overall Study|Withdrawal by Subject|4|||
17053019|NCT00468286|38196570|FG001|Overall Study|Withdrawal by Subject|3|||
17143608|NCT03304626|38286881|FG001|Overall Study|Adverse Event|0|||
17143609|NCT03304626|38286880|FG000|Overall Study|Lack of Efficacy|1|||
17143610|NCT03304626|38286881|FG001|Overall Study|Lack of Efficacy|1|||
17143611|NCT03274986|38286890|FG000|Overall Study|Withdrawal by Subject|0|||
17143612|NCT03274986|38286891|FG001|Overall Study|Withdrawal by Subject|1|||
17143613|NCT03274986|38286890|FG000|Overall Study|Lost to Follow-up|0|||
17143614|NCT03274986|38286891|FG001|Overall Study|Lost to Follow-up|1|||
17143615|NCT02919306|38286906|FG000|Overall Study|Withdrawal by Subject|1|||
17143616|NCT02919306|38286907|FG001|Overall Study|Withdrawal by Subject|0|||
17143617|NCT02919306|38286906|FG000|Overall Study|Protocol Violation|1|||
16780964|NCT02174848|37720097|FG001|Overall Study|Adverse Event|1|||
17053020|NCT00468286|38196569|FG000|Overall Study|Physician Decision|0|||
17053021|NCT00468286|38196570|FG001|Overall Study|Physician Decision|1|||
17053022|NCT00463840|38196576|FG000|Overall Study|Disease progression|7|||
17053023|NCT00463840|38196576|FG000|Overall Study|Withdrawal by Subject|2|||
17053024|NCT00463840|38196576|FG000|Overall Study|Adverse Event|3|||
17053025|NCT00129389|38196582|FG000|Overall Study|Adverse Event|19|||
17053026|NCT00129389|38196583|FG001|Overall Study|Adverse Event|87|||
17053027|NCT00129389|38196582|FG000|Overall Study|Death|0|||
17053028|NCT00129389|38196583|FG001|Overall Study|Death|1|||
17053029|NCT00129389|38196582|FG000|Overall Study|Lost to Follow-up|2|||
17053030|NCT00129389|38196583|FG001|Overall Study|Lost to Follow-up|1|||
17053031|NCT00129389|38196582|FG000|Overall Study|Physician Decision|0|||
17053032|NCT00129389|38196583|FG001|Overall Study|Physician Decision|4|||
17053033|NCT00129389|38196582|FG000|Overall Study|Protocol Violation|0|||
17053034|NCT00129389|38196583|FG001|Overall Study|Protocol Violation|6|||
16992886|NCT01012622|38136932|FG000|Overall Study|screening failure|1|||
17053035|NCT00129389|38196582|FG000|Overall Study|Withdrawal by Subject|9|||
17053036|NCT00129389|38196583|FG001|Overall Study|Withdrawal by Subject|23|||
17143618|NCT02919306|38286907|FG001|Overall Study|Protocol Violation|0|||
17143619|NCT03274440|38286913|FG000|Overall Study|Time commitment too great|1|||
17143620|NCT03274440|38286914|FG001|Overall Study|Time commitment too great|0|||
17143621|NCT03274440|38286915|FG002|Overall Study|Time commitment too great|0|||
17143622|NCT03274440|38286916|FG003|Overall Study|Time commitment too great|1|||
17143623|NCT03274440|38286917|FG004|Overall Study|Time commitment too great|0|||
17053037|NCT00129389|38196582|FG000|Overall Study|Relapse|1|||
17053038|NCT00129389|38196583|FG001|Overall Study|Relapse|0|||
17053039|NCT00129389|38196582|FG000|Overall Study|Not eligible|1|||
17053040|NCT00129389|38196583|FG001|Overall Study|Not eligible|2|||
17053041|NCT00129389|38196582|FG000|Overall Study|Crossed to the other arm|1|||
17143624|NCT03274440|38286918|FG005|Overall Study|Time commitment too great|0|||
17143625|NCT03268746|38286926|FG000|Overall Study|Withdrawal by Subject|1|||
17143626|NCT03268590|38286937|FG000|Overall Study|Previously unknown exclusion criteria|1|||
17143627|NCT03267576|38286946|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
17143628|NCT03267576|38286947|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
17143629|NCT03267576|38286946|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
17143630|NCT03267576|38286947|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
17143631|NCT03267264|38286957|FG000|Overall Study|Withdrawal by Subject|1|||
17143632|NCT03267264|38286958|FG001|Overall Study|Withdrawal by Subject|0|||
17143633|NCT03267264|38286959|FG002|Overall Study|Withdrawal by Subject|2|||
17053042|NCT00129389|38196583|FG001|Overall Study|Crossed to the other arm|16|||
17053043|NCT00468052|38196591|FG000|Overall Study|Protocol Violation|7|||
17053044|NCT00468052|38196592|FG001|Overall Study|Protocol Violation|8|||
17053045|NCT00453310|38196600|FG000|Overall Study|Progression of Disease|10|||
17053046|NCT00124657|38196607|FG000|Overall Study|Toxicity|0|||
17053047|NCT00124657|38196608|FG001|Overall Study|Toxicity|0|||
17053048|NCT00124657|38196609|FG002|Overall Study|Toxicity|1|||
17053049|NCT00124657|38196607|FG000|Overall Study|Non-compliance|1|||
17053050|NCT00124657|38196608|FG001|Overall Study|Non-compliance|0|||
17053051|NCT00124657|38196609|FG002|Overall Study|Non-compliance|4|||
17053052|NCT00124657|38196607|FG000|Overall Study|Progressive disease|14|||
17053053|NCT00124657|38196608|FG001|Overall Study|Progressive disease|5|||
17053054|NCT00124657|38196609|FG002|Overall Study|Progressive disease|27|||
17053055|NCT00124657|38196607|FG000|Overall Study|Intercurrent illness|1|||
17053056|NCT00124657|38196608|FG001|Overall Study|Intercurrent illness|0|||
17053057|NCT00124657|38196609|FG002|Overall Study|Intercurrent illness|0|||
16992887|NCT01012622|38136932|FG000|Overall Study|withdrawal of consent by a parent|2|||
16992888|NCT00722371|38136943|FG000|Overall Study|Adverse Event|6|||
16992889|NCT00722371|38136944|FG001|Overall Study|Adverse Event|13|||
16992890|NCT00722371|38136945|FG002|Overall Study|Adverse Event|9|||
16992891|NCT00722371|38136946|FG003|Overall Study|Adverse Event|10|||
16992892|NCT00722371|38136947|FG004|Overall Study|Adverse Event|6|||
16992893|NCT00722371|38136948|FG005|Overall Study|Adverse Event|8|||
16992894|NCT00722371|38136949|FG006|Overall Study|Adverse Event|4|||
16992895|NCT00722371|38136943|FG000|Overall Study|Contraindication|0|||
16992896|NCT00722371|38136944|FG001|Overall Study|Contraindication|0|||
16992897|NCT00722371|38136945|FG002|Overall Study|Contraindication|1|||
16992898|NCT00722371|38136946|FG003|Overall Study|Contraindication|0|||
16992899|NCT00722371|38136947|FG004|Overall Study|Contraindication|0|||
16992900|NCT00722371|38136948|FG005|Overall Study|Contraindication|0|||
16992901|NCT00722371|38136949|FG006|Overall Study|Contraindication|0|||
16992902|NCT00722371|38136943|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
16992903|NCT00722371|38136944|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
16992904|NCT00722371|38136945|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
16992905|NCT00722371|38136946|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
16992906|NCT00722371|38136947|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
17053058|NCT00581945|38196632|FG000|Overall Study|Adverse Event|4|||
17053059|NCT00581945|38196633|FG001|Overall Study|Adverse Event|4|||
17053060|NCT00581945|38196632|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
17053061|NCT00581945|38196633|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17053062|NCT00581945|38196632|FG000|Overall Study|Withdrawal by Subject|2|||
17053063|NCT00581945|38196633|FG001|Overall Study|Withdrawal by Subject|6|||
17053064|NCT00581945|38196632|FG000|Overall Study|Death|1|||
17053065|NCT00581945|38196633|FG001|Overall Study|Death|0|||
17053066|NCT00555906|38196642|FG000|Phase 1|Objective Progression or Relapse|3|||
17053067|NCT00555906|38196643|FG001|Phase 1|Objective Progression or Relapse|5|||
17053068|NCT00555906|38196644|FG002|Phase 1|Objective Progression or Relapse|3|||
17053069|NCT00555906|38196645|FG003|Phase 1|Objective Progression or Relapse|1|||
17053070|NCT00555906|38196646|FG004|Phase 1|Objective Progression or Relapse|0|||
17053071|NCT00555906|38196642|FG000|Phase 1|Global Deterioration of Health Status|0|||
17053072|NCT00555906|38196643|FG001|Phase 1|Global Deterioration of Health Status|1|||
17053073|NCT00555906|38196644|FG002|Phase 1|Global Deterioration of Health Status|1|||
17053074|NCT00555906|38196645|FG003|Phase 1|Global Deterioration of Health Status|1|||
17053075|NCT00555906|38196646|FG004|Phase 1|Global Deterioration of Health Status|0|||
17053076|NCT00555906|38196642|FG000|Phase 1|Adverse Event|0|||
17053077|NCT00555906|38196643|FG001|Phase 1|Adverse Event|0|||
17053078|NCT00555906|38196644|FG002|Phase 1|Adverse Event|3|||
17053079|NCT00555906|38196645|FG003|Phase 1|Adverse Event|2|||
17053080|NCT00555906|38196646|FG004|Phase 1|Adverse Event|0|||
17053081|NCT00555906|38196642|FG000|Phase 1|Withdrawal by Subject|0|||
17053082|NCT00555906|38196643|FG001|Phase 1|Withdrawal by Subject|0|||
17053083|NCT00555906|38196644|FG002|Phase 1|Withdrawal by Subject|0|||
17053084|NCT00555906|38196645|FG003|Phase 1|Withdrawal by Subject|1|||
17053085|NCT00555906|38196646|FG004|Phase 1|Withdrawal by Subject|0|||
17053086|NCT00555906|38196642|FG000|Phase 2|Adverse Event|0|||
17053087|NCT00555906|38196643|FG001|Phase 2|Adverse Event|0|||
17053088|NCT00555906|38196644|FG002|Phase 2|Adverse Event|0|||
17053089|NCT00555906|38196645|FG003|Phase 2|Adverse Event|0|||
17053090|NCT00555906|38196646|FG004|Phase 2|Adverse Event|4|||
17053091|NCT00555906|38196642|FG000|Phase 2|Global Deterioration of Health Status|0|||
17053092|NCT00555906|38196643|FG001|Phase 2|Global Deterioration of Health Status|0|||
17053093|NCT00555906|38196644|FG002|Phase 2|Global Deterioration of Health Status|0|||
17053094|NCT00555906|38196645|FG003|Phase 2|Global Deterioration of Health Status|0|||
17053095|NCT00555906|38196646|FG004|Phase 2|Global Deterioration of Health Status|2|||
17053096|NCT00555906|38196642|FG000|Phase 2|Objective Progression or Relapse|0|||
17053097|NCT00555906|38196643|FG001|Phase 2|Objective Progression or Relapse|0|||
17053098|NCT00555906|38196644|FG002|Phase 2|Objective Progression or Relapse|0|||
17053099|NCT00555906|38196645|FG003|Phase 2|Objective Progression or Relapse|0|||
17053100|NCT00555906|38196646|FG004|Phase 2|Objective Progression or Relapse|16|||
17053101|NCT00555906|38196642|FG000|Phase 2|Withdrawal by Subject|0|||
17053102|NCT00555906|38196643|FG001|Phase 2|Withdrawal by Subject|0|||
17053103|NCT00555906|38196644|FG002|Phase 2|Withdrawal by Subject|0|||
17053104|NCT00555906|38196645|FG003|Phase 2|Withdrawal by Subject|0|||
17053105|NCT00555906|38196646|FG004|Phase 2|Withdrawal by Subject|2|||
17053106|NCT00555906|38196642|FG000|Phase 2|Other|0|||
17053107|NCT00555906|38196643|FG001|Phase 2|Other|0|||
17053108|NCT00555906|38196644|FG002|Phase 2|Other|0|||
17053109|NCT00555906|38196645|FG003|Phase 2|Other|0|||
17053110|NCT00555906|38196646|FG004|Phase 2|Other|6|||
17053111|NCT00555906|38196642|FG000|Phase 2|Randomized but not Treated|0|||
17053112|NCT00555906|38196643|FG001|Phase 2|Randomized but not Treated|0|||
17053113|NCT00555906|38196644|FG002|Phase 2|Randomized but not Treated|0|||
17053114|NCT00555906|38196645|FG003|Phase 2|Randomized but not Treated|0|||
17053115|NCT00555906|38196646|FG004|Phase 2|Randomized but not Treated|2|||
17053116|NCT03817879|38196663|FG000|Overall Study|Drop out|5|||
17053117|NCT03817879|38196664|FG001|Overall Study|Drop out|12|||
17053118|NCT03817879|38196663|FG000|Overall Study|Withdrawal by Subject|0|||
17053119|NCT03817879|38196664|FG001|Overall Study|Withdrawal by Subject|1|||
17053120|NCT00555672|38196672|FG000|Overall Study|Death|0|||
17053121|NCT00555672|38196673|FG001|Overall Study|Death|2|||
17053122|NCT00555672|38196672|FG000|Overall Study|Adverse Event|8|||
17053123|NCT00555672|38196673|FG001|Overall Study|Adverse Event|2|||
17053124|NCT00555672|38196672|FG000|Overall Study|Objective progression or relapse|11|||
17053125|NCT00555672|38196673|FG001|Overall Study|Objective progression or relapse|5|||
17053126|NCT00555672|38196672|FG000|Overall Study|Other|3|||
17053127|NCT00555672|38196673|FG001|Overall Study|Other|1|||
17053128|NCT00555672|38196672|FG000|Overall Study|Participant refused|2|||
17053129|NCT00555672|38196673|FG001|Overall Study|Participant refused|0|||
17053130|NCT03958656|38196683|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
17053131|NCT03958656|38196684|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
17053132|NCT03958656|38196685|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
17053133|NCT03958656|38196686|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
17053134|NCT03958656|38196683|FG000|Overall Study|No longer meets eligibility criteria|0|||
17053135|NCT03958656|38196684|FG001|Overall Study|No longer meets eligibility criteria|0|||
17053136|NCT03958656|38196685|FG002|Overall Study|No longer meets eligibility criteria|1|||
17053137|NCT03958656|38196686|FG003|Overall Study|No longer meets eligibility criteria|0|||
17053138|NCT03958656|38196683|FG000|Overall Study|Started anti-cancer treatment|0|||
17053139|NCT03958656|38196684|FG001|Overall Study|Started anti-cancer treatment|0|||
17053140|NCT03958656|38196685|FG002|Overall Study|Started anti-cancer treatment|1|||
17053141|NCT03958656|38196686|FG003|Overall Study|Started anti-cancer treatment|0|||
17053142|NCT00453154|38196699|FG000|Double BIind Maintenance|Adverse Event|0|||
17053143|NCT00453154|38196700|FG001|Double BIind Maintenance|Adverse Event|0|||
17053144|NCT00453154|38196701|FG002|Double BIind Maintenance|Adverse Event|3|||
17053145|NCT00453154|38196702|FG003|Double BIind Maintenance|Adverse Event|12|||
17053146|NCT00453154|38196699|FG000|Double BIind Maintenance|Death|0|||
17053147|NCT00453154|38196700|FG001|Double BIind Maintenance|Death|0|||
17053148|NCT00453154|38196701|FG002|Double BIind Maintenance|Death|2|||
17053149|NCT00453154|38196702|FG003|Double BIind Maintenance|Death|1|||
17053150|NCT00453154|38196699|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
17053151|NCT00453154|38196700|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
17143634|NCT03267264|38286960|FG003|Overall Study|Withdrawal by Subject|4|||
17143635|NCT03244800|38286977|FG000|Overall Study|Adverse Event|0|||
17053152|NCT00453154|38196701|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
17053153|NCT00453154|38196702|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
17053154|NCT00453154|38196699|FG000|Double BIind Maintenance|Progression|0|||
17053155|NCT00453154|38196700|FG001|Double BIind Maintenance|Progression|0|||
17143636|NCT03244800|38286978|FG001|Overall Study|Adverse Event|1|||
17143637|NCT03244800|38286979|FG002|Overall Study|Adverse Event|0|||
17143638|NCT03244800|38286980|FG003|Overall Study|Adverse Event|1|||
17143639|NCT03244800|38286977|FG000|Overall Study|Withdrew treatment|0|||
17143640|NCT03244800|38286978|FG001|Overall Study|Withdrew treatment|0|||
17143641|NCT03244800|38286979|FG002|Overall Study|Withdrew treatment|0|||
17143642|NCT03244800|38286980|FG003|Overall Study|Withdrew treatment|1|||
17143643|NCT04516291|38287001|FG000|Treatment Period (24 Weeks)|Other|1|||
17143644|NCT04516291|38287002|FG001|Treatment Period (24 Weeks)|Other|0|||
17143645|NCT04516291|38287003|FG002|Treatment Period (24 Weeks)|Other|0|||
17143646|NCT04516291|38287004|FG003|Treatment Period (24 Weeks)|Other|2|||
17143647|NCT04516291|38287005|FG004|Treatment Period (24 Weeks)|Other|2|||
17143648|NCT04516291|38287006|FG005|Treatment Period (24 Weeks)|Other|4|||
17143649|NCT04516291|38287007|FG006|Treatment Period (24 Weeks)|Other|2|||
17143650|NCT04516291|38287008|FG007|Treatment Period (24 Weeks)|Other|0|||
17053156|NCT00453154|38196701|FG002|Double BIind Maintenance|Progression|29|||
17053157|NCT00453154|38196702|FG003|Double BIind Maintenance|Progression|26|||
17053158|NCT00453154|38196699|FG000|Double BIind Maintenance|Medical Issues|0|||
17053159|NCT00453154|38196700|FG001|Double BIind Maintenance|Medical Issues|0|||
17053160|NCT00453154|38196701|FG002|Double BIind Maintenance|Medical Issues|3|||
17053161|NCT00453154|38196702|FG003|Double BIind Maintenance|Medical Issues|1|||
17053162|NCT00453154|38196699|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
17053163|NCT00453154|38196700|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
17053164|NCT00453154|38196701|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
17053165|NCT00453154|38196702|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
17053166|NCT00561912|38196711|FG000|Overall Study|ineligible|1|||
17053167|NCT00561678|38196717|FG000|Overall Study|Withdrawal by Subject|4|||
17053168|NCT00561678|38196718|FG001|Overall Study|Withdrawal by Subject|3|||
17053169|NCT00561678|38196717|FG000|Overall Study|surgery cancelled|1|||
17053170|NCT00561678|38196718|FG001|Overall Study|surgery cancelled|1|||
17053171|NCT00561678|38196717|FG000|Overall Study|surgery rescheduled to different site|2|||
17053172|NCT00561678|38196718|FG001|Overall Study|surgery rescheduled to different site|2|||
17053173|NCT00561678|38196717|FG000|Overall Study|anesthesia provider refusal|1|||
17053174|NCT00561678|38196718|FG001|Overall Study|anesthesia provider refusal|0|||
17053175|NCT00463684|38196724|FG000|Overall Study|Withdrawal by Subject|1|||
17053176|NCT00463684|38196724|FG000|Overall Study|Lost to Follow-up|3|||
17053177|NCT00463606|38196731|FG000|Overall Study|Adverse Event|21|||
17053178|NCT00463606|38196732|FG001|Overall Study|Adverse Event|18|||
17143651|NCT04516291|38287001|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17143652|NCT04516291|38287002|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
17143653|NCT04516291|38287003|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
17143654|NCT04516291|38287004|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17143655|NCT04516291|38287005|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
17143656|NCT04516291|38287006|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17143657|NCT04516291|38287007|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17053179|NCT00463606|38196733|FG002|Overall Study|Adverse Event|11|||
17053180|NCT00463606|38196731|FG000|Overall Study|Withdrawal by Subject|11|||
17053181|NCT00463606|38196732|FG001|Overall Study|Withdrawal by Subject|11|||
17053182|NCT00463606|38196733|FG002|Overall Study|Withdrawal by Subject|5|||
17053183|NCT00463606|38196731|FG000|Overall Study|Lost to Follow-up|2|||
17053184|NCT00463606|38196732|FG001|Overall Study|Lost to Follow-up|2|||
17053185|NCT00463606|38196733|FG002|Overall Study|Lost to Follow-up|3|||
17143658|NCT04516291|38287008|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17053186|NCT00463606|38196731|FG000|Overall Study|Subject noncompliance|1|||
17053187|NCT00463606|38196732|FG001|Overall Study|Subject noncompliance|1|||
17053188|NCT00463606|38196733|FG002|Overall Study|Subject noncompliance|0|||
17053189|NCT00463606|38196731|FG000|Overall Study|Subject moved out of town|1|||
17053190|NCT00463606|38196732|FG001|Overall Study|Subject moved out of town|0|||
17053191|NCT00463606|38196733|FG002|Overall Study|Subject moved out of town|0|||
17053192|NCT00463606|38196731|FG000|Overall Study|Physician Decision|0|||
17053193|NCT00463606|38196732|FG001|Overall Study|Physician Decision|1|||
17053194|NCT00463606|38196733|FG002|Overall Study|Physician Decision|0|||
17053195|NCT00463606|38196731|FG000|Overall Study|Sponsor request|0|||
17053196|NCT00463606|38196732|FG001|Overall Study|Sponsor request|1|||
17053197|NCT00463606|38196733|FG002|Overall Study|Sponsor request|0|||
17053198|NCT00463606|38196731|FG000|Overall Study|Exclusion criteria violation|2|||
17053199|NCT00463606|38196732|FG001|Overall Study|Exclusion criteria violation|0|||
17053200|NCT00463606|38196733|FG002|Overall Study|Exclusion criteria violation|0|||
17053201|NCT00463606|38196731|FG000|Overall Study|Coordinator error|1|||
17053202|NCT00463606|38196732|FG001|Overall Study|Coordinator error|0|||
17053203|NCT00463606|38196733|FG002|Overall Study|Coordinator error|0|||
17053204|NCT00463606|38196731|FG000|Overall Study|Patient randomized in error|1|||
17053205|NCT00463606|38196732|FG001|Overall Study|Patient randomized in error|0|||
17053206|NCT00463606|38196733|FG002|Overall Study|Patient randomized in error|0|||
17053207|NCT00463606|38196731|FG000|Overall Study|Participation in another ABT-335 trial|1|||
17053208|NCT00463606|38196732|FG001|Overall Study|Participation in another ABT-335 trial|0|||
17053209|NCT00463606|38196733|FG002|Overall Study|Participation in another ABT-335 trial|0|||
17053210|NCT00463606|38196731|FG000|Overall Study|Protocol Violation|0|||
17053211|NCT00463606|38196732|FG001|Overall Study|Protocol Violation|0|||
17053212|NCT00463606|38196733|FG002|Overall Study|Protocol Violation|1|||
17143659|NCT04516291|38287001|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
17143660|NCT04516291|38287002|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
17053213|NCT03961308|38196743|FG000|Overall Study|Withdrawal by Subject|1|||
17053214|NCT03961308|38196744|FG001|Overall Study|Withdrawal by Subject|0|||
17053215|NCT03961308|38196743|FG000|Overall Study|Other|1|||
17053216|NCT03961308|38196744|FG001|Overall Study|Other|0|||
17053217|NCT03961308|38196743|FG000|Overall Study|Lost to Follow-up|0|||
17053218|NCT03961308|38196744|FG001|Overall Study|Lost to Follow-up|1|||
17053219|NCT03961308|38196743|FG000|Overall Study|Adverse Event|0|||
17053220|NCT03961308|38196744|FG001|Overall Study|Adverse Event|1|||
17053221|NCT00174187|38196752|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
17143661|NCT04516291|38287003|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
17143662|NCT04516291|38287004|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
17143663|NCT04516291|38287005|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
17143664|NCT04516291|38287006|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
17143665|NCT04516291|38287007|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
17143666|NCT04516291|38287008|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
17143667|NCT04516291|38287001|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17143668|NCT04516291|38287002|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
17143669|NCT04516291|38287003|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17143670|NCT04516291|38287004|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17143671|NCT04516291|38287005|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17143672|NCT04516291|38287006|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17143673|NCT04516291|38287007|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17143674|NCT04516291|38287008|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17143675|NCT04516291|38287001|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
17143676|NCT04516291|38287002|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
17143677|NCT04516291|38287003|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
17143678|NCT04516291|38287004|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
17143679|NCT04516291|38287005|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
17143680|NCT04516291|38287006|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
17143681|NCT04516291|38287007|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
17143682|NCT04516291|38287008|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
17143683|NCT04516291|38287001|FG000|Follow-up Period (12 Weeks)|Other|0|||
17143684|NCT04516291|38287002|FG001|Follow-up Period (12 Weeks)|Other|1|||
17143685|NCT04516291|38287003|FG002|Follow-up Period (12 Weeks)|Other|0|||
17143686|NCT04516291|38287004|FG003|Follow-up Period (12 Weeks)|Other|2|||
17143687|NCT04516291|38287005|FG004|Follow-up Period (12 Weeks)|Other|0|||
17143688|NCT04516291|38287006|FG005|Follow-up Period (12 Weeks)|Other|0|||
17143689|NCT04516291|38287007|FG006|Follow-up Period (12 Weeks)|Other|0|||
17143690|NCT04516291|38287008|FG007|Follow-up Period (12 Weeks)|Other|0|||
17143691|NCT04516291|38287001|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17143692|NCT04516291|38287002|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17143693|NCT04516291|38287003|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17053222|NCT00174187|38196753|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
17053223|NCT00174187|38196754|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
17053224|NCT00174187|38196752|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
17053225|NCT00174187|38196753|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
17053226|NCT00174187|38196754|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
17053227|NCT00174187|38196752|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
17053228|NCT00174187|38196753|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
17053229|NCT00174187|38196754|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
17053230|NCT00174187|38196752|FG000|Period 1 (up to 3 Years)|Other|0|||
17053231|NCT00174187|38196753|FG001|Period 1 (up to 3 Years)|Other|1|||
17053232|NCT00174187|38196754|FG002|Period 1 (up to 3 Years)|Other|0|||
17053233|NCT00174187|38196752|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
17053234|NCT00174187|38196753|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
17053235|NCT00174187|38196754|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
17053236|NCT00174187|38196752|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
17053237|NCT00174187|38196753|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
17143694|NCT04516291|38287004|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17143695|NCT04516291|38287005|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
17143696|NCT04516291|38287006|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17143697|NCT04516291|38287007|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17143698|NCT04516291|38287008|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17143699|NCT04516291|38287001|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
17143700|NCT04516291|38287002|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
17143701|NCT04516291|38287003|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
17143702|NCT04516291|38287004|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
17143703|NCT04516291|38287005|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
17143704|NCT04516291|38287006|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
17143705|NCT04516291|38287007|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
17143706|NCT04516291|38287008|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
17053238|NCT00174187|38196754|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
17053239|NCT00174187|38196752|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
17053240|NCT00174187|38196753|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
17053241|NCT00174187|38196754|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
17053242|NCT00174187|38196752|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
17053243|NCT00174187|38196753|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
17053244|NCT00174187|38196754|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
17053245|NCT00174187|38196752|FG000|Period 2 (After 3 Years)|Other|0|||
17053246|NCT00174187|38196753|FG001|Period 2 (After 3 Years)|Other|0|||
17053247|NCT00174187|38196754|FG002|Period 2 (After 3 Years)|Other|5|||
17053248|NCT01011335|38196766|FG000|Overall Study|Lost to Follow-up|0|||
17053249|NCT01011335|38196767|FG001|Overall Study|Lost to Follow-up|0|||
17053250|NCT01011335|38196768|FG002|Overall Study|Lost to Follow-up|1|||
17053251|NCT01011335|38196769|FG003|Overall Study|Lost to Follow-up|1|||
17053252|NCT01011335|38196770|FG004|Overall Study|Lost to Follow-up|1|||
17053253|NCT01011335|38196771|FG005|Overall Study|Lost to Follow-up|1|||
17053254|NCT01011335|38196772|FG006|Overall Study|Lost to Follow-up|2|||
17053255|NCT01011335|38196773|FG007|Overall Study|Lost to Follow-up|2|||
17053256|NCT01011335|38196774|FG008|Overall Study|Lost to Follow-up|1|||
17053257|NCT01011335|38196775|FG009|Overall Study|Lost to Follow-up|0|||
17053258|NCT01011335|38196776|FG010|Overall Study|Lost to Follow-up|0|||
17053259|NCT01011335|38196777|FG011|Overall Study|Lost to Follow-up|1|||
17053260|NCT01011335|38196778|FG012|Overall Study|Lost to Follow-up|2|||
17053261|NCT01011335|38196766|FG000|Overall Study|Protocol Violation|0|||
17053262|NCT01011335|38196767|FG001|Overall Study|Protocol Violation|1|||
17053263|NCT01011335|38196768|FG002|Overall Study|Protocol Violation|0|||
17053264|NCT01011335|38196769|FG003|Overall Study|Protocol Violation|0|||
17053265|NCT01011335|38196770|FG004|Overall Study|Protocol Violation|0|||
17053266|NCT01011335|38196771|FG005|Overall Study|Protocol Violation|0|||
17053267|NCT01011335|38196772|FG006|Overall Study|Protocol Violation|0|||
17053268|NCT01011335|38196773|FG007|Overall Study|Protocol Violation|0|||
17053269|NCT01011335|38196774|FG008|Overall Study|Protocol Violation|0|||
17053270|NCT01011335|38196775|FG009|Overall Study|Protocol Violation|0|||
17053271|NCT01011335|38196776|FG010|Overall Study|Protocol Violation|0|||
17053272|NCT01011335|38196777|FG011|Overall Study|Protocol Violation|0|||
17053273|NCT01011335|38196778|FG012|Overall Study|Protocol Violation|0|||
17053274|NCT01011335|38196766|FG000|Overall Study|Moved/deployed or no booster|1|||
17053275|NCT01011335|38196767|FG001|Overall Study|Moved/deployed or no booster|0|||
17053276|NCT01011335|38196768|FG002|Overall Study|Moved/deployed or no booster|0|||
17053277|NCT01011335|38196769|FG003|Overall Study|Moved/deployed or no booster|1|||
17053278|NCT01011335|38196770|FG004|Overall Study|Moved/deployed or no booster|0|||
17053279|NCT01011335|38196771|FG005|Overall Study|Moved/deployed or no booster|0|||
17053280|NCT01011335|38196772|FG006|Overall Study|Moved/deployed or no booster|1|||
17053281|NCT01011335|38196773|FG007|Overall Study|Moved/deployed or no booster|0|||
17053282|NCT01011335|38196774|FG008|Overall Study|Moved/deployed or no booster|1|||
17053283|NCT01011335|38196775|FG009|Overall Study|Moved/deployed or no booster|0|||
17053284|NCT01011335|38196776|FG010|Overall Study|Moved/deployed or no booster|2|||
17053285|NCT01011335|38196777|FG011|Overall Study|Moved/deployed or no booster|0|||
17143707|NCT03243630|38287026|FG000|Overall Study|Protocol Violation|1|||
17053286|NCT01011335|38196778|FG012|Overall Study|Moved/deployed or no booster|0|||
17053287|NCT01011335|38196766|FG000|Overall Study|Adverse Event|0|||
17053288|NCT01011335|38196767|FG001|Overall Study|Adverse Event|0|||
17053289|NCT01011335|38196768|FG002|Overall Study|Adverse Event|0|||
17053290|NCT01011335|38196769|FG003|Overall Study|Adverse Event|0|||
17053291|NCT01011335|38196770|FG004|Overall Study|Adverse Event|0|||
17053292|NCT01011335|38196771|FG005|Overall Study|Adverse Event|0|||
17053293|NCT01011335|38196772|FG006|Overall Study|Adverse Event|0|||
17053294|NCT01011335|38196773|FG007|Overall Study|Adverse Event|0|||
17053295|NCT01011335|38196774|FG008|Overall Study|Adverse Event|0|||
17053296|NCT01011335|38196775|FG009|Overall Study|Adverse Event|0|||
17053297|NCT01011335|38196776|FG010|Overall Study|Adverse Event|4|||
17053298|NCT01011335|38196777|FG011|Overall Study|Adverse Event|0|||
17053299|NCT01011335|38196778|FG012|Overall Study|Adverse Event|1|||
17053300|NCT00467896|38196815|FG000|Overall Study|Consent Withdrawal|18|||
17053301|NCT00467896|38196815|FG000|Overall Study|Adverse Event|7|||
17053302|NCT00467896|38196815|FG000|Overall Study|Serious Adverse Event|13|||
17053303|NCT00467896|38196815|FG000|Overall Study|Non-compliance|3|||
17053304|NCT00467896|38196815|FG000|Overall Study|Changed therapy|2|||
17053305|NCT00467896|38196815|FG000|Overall Study|Patient received transplant|2|||
17053306|NCT00467896|38196815|FG000|Overall Study|Patient had atrial septostomy|1|||
17053307|NCT00467896|38196815|FG000|Overall Study|Patient weaned off iloprost|1|||
17053308|NCT00467896|38196815|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
17053309|NCT00467896|38196815|FG000|Overall Study|Started intravenous prostacyclin|1|||
17053310|NCT00467896|38196815|FG000|Overall Study|Started inhaled Remodulin|1|||
17053311|NCT00467896|38196815|FG000|Overall Study|Patient had no improvement|1|||
17053312|NCT00579059|38196823|FG000|Overall Study|Study Canceled at 1 Year|21|||
17053313|NCT00579059|38196824|FG001|Overall Study|Study Canceled at 1 Year|10|||
17053314|NCT00467818|38196832|FG000|Overall Study|Adverse Event|1|||
17053315|NCT00467818|38196833|FG001|Overall Study|Adverse Event|0|||
17053316|NCT00467818|38196832|FG000|Overall Study|Lost to Follow-up|2|||
17053317|NCT00467818|38196833|FG001|Overall Study|Lost to Follow-up|2|||
17143708|NCT03243630|38287026|FG000|Overall Study|Physician Decision|1|||
17143709|NCT04450381|38287034|FG000|Overall Study|Protocol Violation|4|||
17143710|NCT04450381|38287034|FG000|Overall Study|Wrong device setting|2|||
17053318|NCT00467740|38196846|FG000|Overall Study|Adverse Event|0|||
17053319|NCT00467740|38196847|FG001|Overall Study|Adverse Event|0|||
17143711|NCT03068468|38287040|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
17143712|NCT03068468|38287041|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
17053320|NCT00467740|38196848|FG002|Overall Study|Adverse Event|1|||
17053321|NCT00467740|38196849|FG003|Overall Study|Adverse Event|0|||
17053322|NCT00467740|38196850|FG004|Overall Study|Adverse Event|0|||
17053323|NCT00467740|38196846|FG000|Overall Study|Protocol Violation|0|||
17053324|NCT00467740|38196847|FG001|Overall Study|Protocol Violation|0|||
17053325|NCT00467740|38196848|FG002|Overall Study|Protocol Violation|1|||
17053326|NCT00467740|38196849|FG003|Overall Study|Protocol Violation|0|||
17053327|NCT00467740|38196850|FG004|Overall Study|Protocol Violation|0|||
17053328|NCT00467740|38196846|FG000|Overall Study|Lost to Follow-up|0|||
17053329|NCT00467740|38196847|FG001|Overall Study|Lost to Follow-up|1|||
17053330|NCT00467740|38196848|FG002|Overall Study|Lost to Follow-up|0|||
17053331|NCT00467740|38196849|FG003|Overall Study|Lost to Follow-up|0|||
17053332|NCT00467740|38196850|FG004|Overall Study|Lost to Follow-up|0|||
17053333|NCT00467740|38196846|FG000|Overall Study|Withdrawal by Subject|1|||
17053334|NCT00467740|38196847|FG001|Overall Study|Withdrawal by Subject|1|||
17053335|NCT00467740|38196848|FG002|Overall Study|Withdrawal by Subject|0|||
17053336|NCT00467740|38196849|FG003|Overall Study|Withdrawal by Subject|1|||
17053337|NCT00467740|38196850|FG004|Overall Study|Withdrawal by Subject|0|||
17053338|NCT00467740|38196846|FG000|Overall Study|Lack of Efficacy|0|||
17053339|NCT00467740|38196847|FG001|Overall Study|Lack of Efficacy|1|||
17143713|NCT03068468|38287042|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
17143714|NCT03068468|38287043|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
17143715|NCT03068468|38287040|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
17143716|NCT03068468|38287041|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
17143717|NCT03068468|38287042|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
17143718|NCT03068468|38287043|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
17143719|NCT03068468|38287040|FG000|Placebo-Controlled Period|Adverse Event|16|||
17143720|NCT03068468|38287041|FG001|Placebo-Controlled Period|Adverse Event|21|||
17143721|NCT03068468|38287042|FG002|Placebo-Controlled Period|Adverse Event|0|||
17143722|NCT03068468|38287043|FG003|Placebo-Controlled Period|Adverse Event|0|||
17053340|NCT00467740|38196848|FG002|Overall Study|Lack of Efficacy|0|||
17053341|NCT00467740|38196849|FG003|Overall Study|Lack of Efficacy|0|||
17053342|NCT00467740|38196850|FG004|Overall Study|Lack of Efficacy|0|||
17053343|NCT00553254|38196864|FG000|Overall Study|Death|3|||
17053344|NCT00553254|38196865|FG001|Overall Study|Death|6|||
17053345|NCT00553254|38196866|FG002|Overall Study|Death|25|||
17053346|NCT00553254|38196864|FG000|Overall Study|Lost to Follow-up|0|||
17053347|NCT00553254|38196865|FG001|Overall Study|Lost to Follow-up|0|||
17053348|NCT00553254|38196866|FG002|Overall Study|Lost to Follow-up|2|||
17053349|NCT00553254|38196864|FG000|Overall Study|Withdrawal by Subject|2|||
17053350|NCT00553254|38196865|FG001|Overall Study|Withdrawal by Subject|0|||
17053351|NCT00553254|38196866|FG002|Overall Study|Withdrawal by Subject|2|||
17053352|NCT00553254|38196864|FG000|Overall Study|Study terminated by Sponsor|0|||
17053353|NCT00553254|38196865|FG001|Overall Study|Study terminated by Sponsor|0|||
17053354|NCT00553254|38196866|FG002|Overall Study|Study terminated by Sponsor|1|||
17053355|NCT00553254|38196864|FG000|Overall Study|Other|1|||
17053356|NCT00553254|38196865|FG001|Overall Study|Other|0|||
17053357|NCT00553254|38196866|FG002|Overall Study|Other|13|||
17053358|NCT00168805|38196881|FG000|Overall Study|Adverse Event|7|||
17053359|NCT00168805|38196882|FG001|Overall Study|Adverse Event|11|||
17053360|NCT00168805|38196883|FG002|Overall Study|Adverse Event|16|||
17053361|NCT00168805|38196881|FG000|Overall Study|Protocol Violation|12|||
17053362|NCT00168805|38196882|FG001|Overall Study|Protocol Violation|11|||
17053363|NCT00168805|38196883|FG002|Overall Study|Protocol Violation|8|||
17053364|NCT00168805|38196881|FG000|Overall Study|Lost to Follow-up|12|||
17053365|NCT00168805|38196882|FG001|Overall Study|Lost to Follow-up|17|||
17053366|NCT00168805|38196883|FG002|Overall Study|Lost to Follow-up|11|||
17053367|NCT00168805|38196881|FG000|Overall Study|Withdrawal by Subject|16|||
17053368|NCT00168805|38196882|FG001|Overall Study|Withdrawal by Subject|18|||
17053369|NCT00168805|38196883|FG002|Overall Study|Withdrawal by Subject|21|||
17053370|NCT00168805|38196881|FG000|Overall Study|Other|24|||
17053371|NCT00168805|38196882|FG001|Overall Study|Other|21|||
17053372|NCT00168805|38196883|FG002|Overall Study|Other|22|||
17053373|NCT00168805|38196881|FG000|Treatment|Adverse Event|25|||
17053374|NCT00168805|38196882|FG001|Treatment|Adverse Event|26|||
17053375|NCT00168805|38196883|FG002|Treatment|Adverse Event|32|||
17053376|NCT00168805|38196881|FG000|Treatment|Protocol Violation|3|||
17053377|NCT00168805|38196882|FG001|Treatment|Protocol Violation|5|||
17053378|NCT00168805|38196883|FG002|Treatment|Protocol Violation|5|||
17053379|NCT00168805|38196881|FG000|Treatment|Withdrawal by Subject|3|||
17053380|NCT00168805|38196882|FG001|Treatment|Withdrawal by Subject|7|||
17053381|NCT00168805|38196883|FG002|Treatment|Withdrawal by Subject|8|||
17053382|NCT00168805|38196881|FG000|Treatment|Other|18|||
17053383|NCT00168805|38196882|FG001|Treatment|Other|18|||
17053384|NCT00168805|38196883|FG002|Treatment|Other|17|||
17053385|NCT00467584|38196894|FG000|Overall Study|Withdrawal by Subject|4|||
17053386|NCT00467584|38196895|FG001|Overall Study|Withdrawal by Subject|5|||
17053387|NCT00467584|38196896|FG002|Overall Study|Withdrawal by Subject|1|||
17143723|NCT03068468|38287040|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
17143724|NCT03068468|38287041|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
17143725|NCT03068468|38287042|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
17143726|NCT03068468|38287043|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
17143727|NCT03068468|38287040|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
17143728|NCT03068468|38287041|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
17143729|NCT03068468|38287042|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
17143730|NCT03068468|38287043|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
17143731|NCT03068468|38287040|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
17143732|NCT03068468|38287041|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
17143733|NCT03068468|38287042|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
17053388|NCT03839212|38196904|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
17053389|NCT00168103|38196911|FG000|Overall Study|Withdrawal by Subject|1|||
17053390|NCT00168103|38196912|FG001|Overall Study|Withdrawal by Subject|2|||
17053391|NCT00168103|38196913|FG002|Overall Study|Withdrawal by Subject|1|||
17053392|NCT00168103|38196914|FG003|Overall Study|Withdrawal by Subject|0|||
17053393|NCT00168103|38196911|FG000|Overall Study|Lost to Follow-up|1|||
17053394|NCT00168103|38196912|FG001|Overall Study|Lost to Follow-up|3|||
17143734|NCT03068468|38287043|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
17143735|NCT03068468|38287040|FG000|Placebo-Controlled Period|Death|0|||
17143736|NCT03068468|38287041|FG001|Placebo-Controlled Period|Death|1|||
17143737|NCT03068468|38287042|FG002|Placebo-Controlled Period|Death|0|||
17143738|NCT03068468|38287043|FG003|Placebo-Controlled Period|Death|0|||
17143739|NCT03068468|38287040|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
17143740|NCT03068468|38287041|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
17143741|NCT03068468|38287042|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
17143742|NCT03068468|38287043|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
17143743|NCT03068468|38287040|FG000|Open-Label Extension Period|Adverse Event|0|||
17143744|NCT03068468|38287041|FG001|Open-Label Extension Period|Adverse Event|0|||
17143745|NCT03068468|38287042|FG002|Open-Label Extension Period|Adverse Event|13|||
16780965|NCT02174848|37720096|FG000|Overall Study|Withdrawal by Subject|3|||
17143746|NCT03068468|38287043|FG003|Open-Label Extension Period|Adverse Event|17|||
17143747|NCT03068468|38287040|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
17143748|NCT03068468|38287041|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
17143749|NCT03068468|38287042|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
17053395|NCT00168103|38196913|FG002|Overall Study|Lost to Follow-up|0|||
17053396|NCT00168103|38196914|FG003|Overall Study|Lost to Follow-up|0|||
17053397|NCT00463060|38196924|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
17053398|NCT00463060|38196924|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
17053399|NCT00462982|38196933|FG000|Overall Study|Adverse Event|1|||
17053400|NCT00462982|38196933|FG000|Overall Study|Patient Not Treated|2|||
17053401|NCT00462904|38196954|FG000|Overall Study|Lost to Follow-up|1|||
17053402|NCT00467272|38196958|FG000|Overall Study|Pneumonia|2|||
17053403|NCT00467272|38196958|FG000|Overall Study|Thrombophlebitis|1|||
17053404|NCT00462826|38196962|FG000|Overall Study|Ineligible - second primary|1|||
17053405|NCT00462826|38196962|FG000|Overall Study|Ineligible - wrong cell type|1|||
17053406|NCT00462826|38196962|FG000|Overall Study|Ineligible - wrong primary|2|||
17053407|NCT00462826|38196962|FG000|Overall Study|Never treated|1|||
17053408|NCT00551616|38196974|FG000|Overall Study|Lost to Follow-up|48|||
17053409|NCT00551616|38196975|FG001|Overall Study|Lost to Follow-up|40|||
17053410|NCT00452530|38196983|FG000|Overall Study|Death|1|||
17053411|NCT00452530|38196984|FG001|Overall Study|Death|0|||
17053412|NCT00452530|38196983|FG000|Overall Study|Adverse Event|40|||
17053413|NCT00452530|38196984|FG001|Overall Study|Adverse Event|44|||
17053414|NCT00452530|38196983|FG000|Overall Study|Withdrawal by Subject|68|||
17053415|NCT00452530|38196984|FG001|Overall Study|Withdrawal by Subject|57|||
17053416|NCT00452530|38196983|FG000|Overall Study|Lost to Follow-up|1|||
17053417|NCT00452530|38196984|FG001|Overall Study|Lost to Follow-up|0|||
17053418|NCT00452530|38196983|FG000|Overall Study|Poor compliance/noncompliance|1|||
17053419|NCT00452530|38196984|FG001|Overall Study|Poor compliance/noncompliance|2|||
17053420|NCT00452530|38196983|FG000|Overall Study|No longer met study criteria|18|||
17053421|NCT00452530|38196984|FG001|Overall Study|No longer met study criteria|22|||
17053422|NCT00452530|38196983|FG000|Overall Study|Other|7|||
17053423|NCT00452530|38196984|FG001|Overall Study|Other|11|||
17053424|NCT00549198|38196996|FG000|Overall Study|Adverse Event|28|||
17053425|NCT00549198|38196997|FG001|Overall Study|Adverse Event|26|||
17053426|NCT00549198|38196996|FG000|Overall Study|Insufficient Viral Load Response|4|||
17053427|NCT00549198|38196997|FG001|Overall Study|Insufficient Viral Load Response|2|||
17053428|NCT00549198|38196996|FG000|Overall Study|Protocol-defined Virological Failure|7|||
17053429|NCT00549198|38196997|FG001|Overall Study|Protocol-defined Virological Failure|0|||
17053430|NCT00549198|38196996|FG000|Overall Study|Non-compliance|2|||
17053431|NCT00549198|38196997|FG001|Overall Study|Non-compliance|4|||
17053432|NCT00549198|38196996|FG000|Overall Study|Lost to Follow-up|7|||
17053433|NCT00549198|38196997|FG001|Overall Study|Lost to Follow-up|8|||
17053434|NCT00549198|38196996|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
17053435|NCT00549198|38196997|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
17053436|NCT00549198|38196996|FG000|Overall Study|Protocol Violation|7|||
17053437|NCT00549198|38196997|FG001|Overall Study|Protocol Violation|2|||
17053438|NCT00549198|38196996|FG000|Overall Study|Investigator Decision|4|||
17053439|NCT00549198|38196997|FG001|Overall Study|Investigator Decision|3|||
16992907|NCT00722371|38136948|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
16992908|NCT00722371|38136949|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
16992909|NCT00722371|38136943|FG000|Overall Study|Excluded medication|0|||
16992910|NCT00722371|38136944|FG001|Overall Study|Excluded medication|1|||
16992911|NCT00722371|38136945|FG002|Overall Study|Excluded medication|1|||
16992912|NCT00722371|38136946|FG003|Overall Study|Excluded medication|0|||
16992913|NCT00722371|38136947|FG004|Overall Study|Excluded medication|0|||
16992914|NCT00722371|38136948|FG005|Overall Study|Excluded medication|0|||
16992915|NCT00722371|38136949|FG006|Overall Study|Excluded medication|1|||
16992916|NCT00722371|38136943|FG000|Overall Study|Hyperglycemia|2|||
16992917|NCT00722371|38136944|FG001|Overall Study|Hyperglycemia|6|||
16992918|NCT00722371|38136945|FG002|Overall Study|Hyperglycemia|4|||
16992919|NCT00722371|38136946|FG003|Overall Study|Hyperglycemia|2|||
17053440|NCT00549198|38196996|FG000|Overall Study|Withdrawal by Subject|7|||
16992920|NCT00722371|38136947|FG004|Overall Study|Hyperglycemia|5|||
16992921|NCT00722371|38136948|FG005|Overall Study|Hyperglycemia|1|||
16992922|NCT00722371|38136949|FG006|Overall Study|Hyperglycemia|1|||
16992923|NCT00722371|38136943|FG000|Overall Study|Hypoglycemia|1|||
16992924|NCT00722371|38136944|FG001|Overall Study|Hypoglycemia|0|||
17053441|NCT00549198|38196997|FG001|Overall Study|Withdrawal by Subject|7|||
17053442|NCT00549198|38196996|FG000|Overall Study|Disease Progression|1|||
17053443|NCT00549198|38196997|FG001|Overall Study|Disease Progression|0|||
16992925|NCT00722371|38136945|FG002|Overall Study|Hypoglycemia|0|||
17053444|NCT00549198|38196996|FG000|Overall Study|Participant Moved|2|||
17053445|NCT00549198|38196997|FG001|Overall Study|Participant Moved|0|||
17053446|NCT00549198|38196996|FG000|Overall Study|Participant not able to perform Week 96|1|||
17143750|NCT03068468|38287043|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
17143751|NCT03068468|38287040|FG000|Open-Label Extension Period|Death|0|||
17143752|NCT03068468|38287041|FG001|Open-Label Extension Period|Death|0|||
17143753|NCT03068468|38287042|FG002|Open-Label Extension Period|Death|0|||
17143754|NCT03068468|38287043|FG003|Open-Label Extension Period|Death|1|||
17143755|NCT03068468|38287040|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
17143756|NCT03068468|38287041|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
17143757|NCT03068468|38287042|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
17143758|NCT03068468|38287043|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
17143759|NCT03068468|38287040|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
17143760|NCT03068468|38287041|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
17143761|NCT03068468|38287042|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
17143762|NCT03068468|38287043|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
17143763|NCT03068468|38287040|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
17143764|NCT03068468|38287041|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
17143765|NCT03068468|38287042|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
17143766|NCT03068468|38287043|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
17143767|NCT03068468|38287040|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
17143768|NCT03068468|38287041|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
17143769|NCT03068468|38287042|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
17143770|NCT03068468|38287043|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
17143771|NCT03068468|38287040|FG000|Open-Label Extension Period|Reason not Specified|0|||
17143772|NCT03068468|38287041|FG001|Open-Label Extension Period|Reason not Specified|0|||
17143773|NCT03068468|38287042|FG002|Open-Label Extension Period|Reason not Specified|1|||
17143774|NCT03068468|38287043|FG003|Open-Label Extension Period|Reason not Specified|4|||
17143775|NCT04512001|38287053|FG000|Overall Study|Adverse Event|14|||
17143776|NCT04512001|38287054|FG001|Overall Study|Adverse Event|10|||
17143777|NCT04512001|38287053|FG000|Overall Study|Death|0|||
17143778|NCT04512001|38287054|FG001|Overall Study|Death|2|||
17143779|NCT04512001|38287053|FG000|Overall Study|Withdrawal by Subject|16|||
17143780|NCT04512001|38287054|FG001|Overall Study|Withdrawal by Subject|9|||
17143781|NCT04512001|38287053|FG000|Overall Study|Discontinued treatment prior to Week 24|4|||
17143782|NCT04512001|38287054|FG001|Overall Study|Discontinued treatment prior to Week 24|4|||
17143783|NCT04512001|38287053|FG000|Overall Study|Withdrawal By Sponsor's Decision|1|||
17143784|NCT04512001|38287054|FG001|Overall Study|Withdrawal By Sponsor's Decision|0|||
17143785|NCT04512001|38287053|FG000|Overall Study|Subject Did Not Meet Eligibility At Week 24|0|||
17143786|NCT04512001|38287054|FG001|Overall Study|Subject Did Not Meet Eligibility At Week 24|1|||
17143787|NCT04447417|38287062|FG000|Overall Study|Withdrawal by Subject|1|||
17143788|NCT04447417|38287063|FG001|Overall Study|Withdrawal by Subject|0|||
17143789|NCT04447417|38287062|FG000|Overall Study|Failure to meet inclusion criteria|1|||
17143790|NCT04447417|38287063|FG001|Overall Study|Failure to meet inclusion criteria|0|||
17143791|NCT04447417|38287062|FG000|Overall Study|Lost to Follow-up|1|||
17143792|NCT04447417|38287063|FG001|Overall Study|Lost to Follow-up|0|||
17143793|NCT02787044|38287071|FG000|Overall Study|Lost to Follow-up|15|||
17143794|NCT02787044|38287072|FG001|Overall Study|Lost to Follow-up|19|||
17143795|NCT01345019|38287084|FG000|Blinded Treatment Phase|Death|147|||
17143796|NCT01345019|38287085|FG001|Blinded Treatment Phase|Death|137|||
17143797|NCT01345019|38287084|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
17143798|NCT01345019|38287085|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
17143799|NCT01345019|38287084|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
17143800|NCT01345019|38287085|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
17143801|NCT01345019|38287084|FG000|Blinded Treatment Phase|Disease Progression|12|||
17143802|NCT01345019|38287085|FG001|Blinded Treatment Phase|Disease Progression|10|||
17143803|NCT01345019|38287084|FG000|Blinded Treatment Phase|Adverse Event|6|||
17143804|NCT01345019|38287085|FG001|Blinded Treatment Phase|Adverse Event|13|||
17143805|NCT01345019|38287084|FG000|Blinded Treatment Phase|Administrative Decision|10|||
17143806|NCT01345019|38287085|FG001|Blinded Treatment Phase|Administrative Decision|8|||
17143807|NCT01345019|38287084|FG000|Blinded Treatment Phase|Noncompliance|5|||
17143808|NCT01345019|38287085|FG001|Blinded Treatment Phase|Noncompliance|3|||
17143809|NCT01345019|38287084|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
17143810|NCT01345019|38287085|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
17143811|NCT01345019|38287084|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
17143812|NCT01345019|38287085|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
17143813|NCT01345019|38287084|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
17143814|NCT01345019|38287085|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
17143815|NCT01345019|38287084|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
17143816|NCT01345019|38287085|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
17143817|NCT01345019|38287084|FG000|Open Label Treatment Phase|Death|49|||
17143818|NCT01345019|38287085|FG001|Open Label Treatment Phase|Death|48|||
17143819|NCT01345019|38287084|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
17143820|NCT01345019|38287085|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
17143821|NCT01345019|38287084|FG000|Open Label Treatment Phase|Adverse Event|30|||
17143822|NCT01345019|38287085|FG001|Open Label Treatment Phase|Adverse Event|51|||
17143823|NCT01345019|38287084|FG000|Open Label Treatment Phase|Administrative Decision|30|||
17143824|NCT01345019|38287085|FG001|Open Label Treatment Phase|Administrative Decision|15|||
17143825|NCT01345019|38287084|FG000|Open Label Treatment Phase|Disease Progression|17|||
17053447|NCT00549198|38196997|FG001|Overall Study|Participant not able to perform Week 96|0|||
17053448|NCT00549198|38196996|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
17053449|NCT00549198|38196997|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
17053450|NCT00549198|38196996|FG000|Overall Study|Prohibited Medication|1|||
17053451|NCT00549198|38196997|FG001|Overall Study|Prohibited Medication|2|||
17053452|NCT00549198|38196996|FG000|Overall Study|Participant planning pregnancy|1|||
17053453|NCT00549198|38196997|FG001|Overall Study|Participant planning pregnancy|0|||
17053454|NCT00549198|38196996|FG000|Overall Study|Participant overweight, no scan possible|1|||
17053455|NCT00549198|38196997|FG001|Overall Study|Participant overweight, no scan possible|0|||
17053456|NCT00549198|38196996|FG000|Overall Study|No scan facilities|0|||
17053457|NCT00549198|38196997|FG001|Overall Study|No scan facilities|2|||
17053458|NCT00549198|38196996|FG000|Overall Study|Pregnancy|0|||
17053459|NCT00549198|38196997|FG001|Overall Study|Pregnancy|3|||
17053460|NCT00549198|38196996|FG000|Overall Study|Not Exposed to Study Drug|3|||
17053461|NCT00549198|38196997|FG001|Overall Study|Not Exposed to Study Drug|4|||
17053462|NCT00607724|38197010|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
17053463|NCT00607724|38197011|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
17053464|NCT00607724|38197012|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
17053465|NCT00607724|38197013|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
17053466|NCT00607724|38197014|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
17053467|NCT00607724|38197015|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
17053468|NCT00607724|38197016|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
17053469|NCT00607724|38197010|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
17053470|NCT00607724|38197011|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
17053471|NCT00607724|38197012|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
17053472|NCT00607724|38197013|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
17053473|NCT00607724|38197014|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
17053474|NCT00607724|38197015|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
17053475|NCT00607724|38197016|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
17053476|NCT00607724|38197010|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
17053477|NCT00607724|38197011|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
17053478|NCT00607724|38197012|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
17053479|NCT00607724|38197013|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
17053480|NCT00607724|38197014|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
17053481|NCT00607724|38197015|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
17053482|NCT00607724|38197016|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
17053483|NCT00607724|38197010|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
17053484|NCT00607724|38197011|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
17053485|NCT00607724|38197012|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
17053486|NCT00607724|38197013|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
17053487|NCT00607724|38197014|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
17053488|NCT00607724|38197015|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
17053489|NCT00607724|38197016|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
17053490|NCT00607724|38197010|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
17053491|NCT00607724|38197011|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
17053492|NCT00607724|38197012|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
17053493|NCT00607724|38197013|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
17053494|NCT00607724|38197014|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
17053495|NCT00607724|38197015|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
17053496|NCT00607724|38197016|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
17053497|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
17053498|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
17053499|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
17053500|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
17053501|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
17053502|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
17053503|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
17053504|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
17053505|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
17053506|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
17053507|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
17053508|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
17053509|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
17053510|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
17053511|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
17053512|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
17053513|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
17053514|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
17053515|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
17053516|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
17053517|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
17053518|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
17053519|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
17053520|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
17053521|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
17053522|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
17053523|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
17053524|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
17053525|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
17053526|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
17053527|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
17053528|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
17053529|NCT00506415|38197040|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
17053530|NCT00506415|38197041|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
17053531|NCT00506415|38197042|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
17053532|NCT00506415|38197043|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
17053533|NCT00506415|38197040|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
17053534|NCT00506415|38197041|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
17053535|NCT00506415|38197042|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
17053536|NCT00506415|38197043|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
17053537|NCT00506415|38197040|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
17143826|NCT01345019|38287085|FG001|Open Label Treatment Phase|Disease Progression|18|||
17143827|NCT01345019|38287084|FG000|Open Label Treatment Phase|Noncompliance|5|||
17143828|NCT01345019|38287085|FG001|Open Label Treatment Phase|Noncompliance|4|||
17143829|NCT01345019|38287084|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
17143830|NCT01345019|38287085|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
17143831|NCT01345019|38287084|FG000|Open Label Treatment Phase|Pregnancy|1|||
17143832|NCT01345019|38287085|FG001|Open Label Treatment Phase|Pregnancy|0|||
17143833|NCT01345019|38287084|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
17143834|NCT01345019|38287085|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
17143835|NCT01345019|38287084|FG000|Open Label Treatment Phase|Protocol Violation|0|||
17143836|NCT01345019|38287085|FG001|Open Label Treatment Phase|Protocol Violation|1|||
17143837|NCT04507867|38287095|FG000|Overall Study|Death|7|||
17143838|NCT04507867|38287096|FG001|Overall Study|Death|1|||
17143839|NCT03069716|38287120|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
17143840|NCT03069716|38287121|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
17143841|NCT03069716|38287122|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
17143842|NCT03069716|38287120|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
17143843|NCT03069716|38287121|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
17143844|NCT03069716|38287122|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
17143845|NCT03069716|38287120|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
17143846|NCT03069716|38287121|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
17143847|NCT03069716|38287122|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
17143848|NCT03069716|38287120|FG000|Randomized Treatment|Withdrawal by Subject|0|||
17143849|NCT03069716|38287121|FG001|Randomized Treatment|Withdrawal by Subject|2|||
17143850|NCT03069716|38287122|FG002|Randomized Treatment|Withdrawal by Subject|0|||
17143851|NCT03693625|38287135|FG000|Overall Study|Adverse Event|2|||
17053538|NCT00506415|38197041|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
17053539|NCT00506415|38197042|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
17053540|NCT00506415|38197043|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
17053541|NCT00506415|38197040|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
17053542|NCT00506415|38197041|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
17053543|NCT00506415|38197042|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
17053544|NCT00506415|38197043|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
17053545|NCT00506415|38197040|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
17053546|NCT00506415|38197041|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
17053547|NCT00506415|38197042|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
17053548|NCT00506415|38197043|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
17053549|NCT00506415|38197040|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
17053550|NCT00506415|38197041|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
17053551|NCT00506415|38197042|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
17053552|NCT00506415|38197043|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
17053553|NCT00506415|38197040|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
17053554|NCT00506415|38197041|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
17053555|NCT00506415|38197042|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
17053556|NCT00506415|38197043|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
17053557|NCT00506415|38197040|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
17053558|NCT00506415|38197041|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
17053559|NCT00506415|38197042|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
17053560|NCT00506415|38197043|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
17053561|NCT00506415|38197040|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
17053562|NCT00506415|38197041|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
17053563|NCT00506415|38197042|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
17053564|NCT00506415|38197043|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
17053565|NCT00506415|38197040|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
17053566|NCT00506415|38197041|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
17053567|NCT00506415|38197042|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
17053568|NCT00506415|38197043|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
17053569|NCT00506415|38197040|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
17053570|NCT00506415|38197041|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
17053571|NCT00506415|38197042|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
17053572|NCT00506415|38197043|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
17053573|NCT00506415|38197040|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
17053574|NCT00506415|38197041|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
17053575|NCT00506415|38197042|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
17053576|NCT00506415|38197043|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
17053577|NCT00506415|38197040|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
17053578|NCT00506415|38197041|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
17053579|NCT00506415|38197042|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
17053580|NCT00506415|38197043|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
17053581|NCT00506415|38197040|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
17053582|NCT00506415|38197041|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
17053583|NCT00506415|38197042|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
17053584|NCT00506415|38197043|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
17143852|NCT03693625|38287136|FG001|Overall Study|Adverse Event|0|||
17143853|NCT03693625|38287135|FG000|Overall Study|Study Terminated By Sponsor|20|||
16992926|NCT00722371|38136946|FG003|Overall Study|Hypoglycemia|0|||
16992927|NCT00722371|38136947|FG004|Overall Study|Hypoglycemia|0|||
16992928|NCT00722371|38136948|FG005|Overall Study|Hypoglycemia|0|||
16992929|NCT00722371|38136949|FG006|Overall Study|Hypoglycemia|0|||
16992930|NCT00722371|38136943|FG000|Overall Study|Lack of Efficacy|4|||
16992931|NCT00722371|38136944|FG001|Overall Study|Lack of Efficacy|6|||
16992932|NCT00722371|38136945|FG002|Overall Study|Lack of Efficacy|6|||
16992933|NCT00722371|38136946|FG003|Overall Study|Lack of Efficacy|6|||
16992934|NCT00722371|38136947|FG004|Overall Study|Lack of Efficacy|2|||
16992935|NCT00722371|38136948|FG005|Overall Study|Lack of Efficacy|3|||
16992936|NCT00722371|38136949|FG006|Overall Study|Lack of Efficacy|0|||
17053585|NCT00506415|38197040|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
17053586|NCT00506415|38197041|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
17053587|NCT00506415|38197042|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
17053588|NCT00506415|38197043|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
17053589|NCT00506415|38197040|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
17053590|NCT00506415|38197041|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
17053591|NCT00506415|38197042|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
17053592|NCT00506415|38197043|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
17053593|NCT00452452|38197059|FG000|Overall Study|Protocol Violation|0|||
17053594|NCT00452452|38197060|FG001|Overall Study|Protocol Violation|0|||
17053595|NCT00452452|38197061|FG002|Overall Study|Protocol Violation|1|||
17053596|NCT00452452|38197059|FG000|Overall Study|Withdrawal by Subject|1|||
17053597|NCT00452452|38197060|FG001|Overall Study|Withdrawal by Subject|0|||
17053598|NCT00452452|38197061|FG002|Overall Study|Withdrawal by Subject|0|||
17053599|NCT00452452|38197059|FG000|Overall Study|Lost to Follow-up|1|||
17053600|NCT00452452|38197060|FG001|Overall Study|Lost to Follow-up|0|||
17053601|NCT00452452|38197061|FG002|Overall Study|Lost to Follow-up|0|||
17053602|NCT00510783|38197077|FG000|Overall Study|Lost to Follow-up|29|||
17053603|NCT00510783|38197078|FG001|Overall Study|Lost to Follow-up|25|||
17053604|NCT00510783|38197077|FG000|Overall Study|Withdrawal by Subject|2|||
17053605|NCT00510783|38197078|FG001|Overall Study|Withdrawal by Subject|3|||
17053606|NCT00510783|38197077|FG000|Overall Study|Protocol Violation|0|||
17143854|NCT03693625|38287136|FG001|Overall Study|Study Terminated By Sponsor|7|||
17143855|NCT03693625|38287135|FG000|Overall Study|Withdrawal by Subject|1|||
17143856|NCT03693625|38287136|FG001|Overall Study|Withdrawal by Subject|1|||
17053607|NCT00510783|38197078|FG001|Overall Study|Protocol Violation|1|||
17053608|NCT00518973|38197086|FG000|Overall Study|Withdrawal by Subject|3|||
17053609|NCT00518973|38197087|FG001|Overall Study|Withdrawal by Subject|2|||
17053610|NCT00462670|38197095|FG000|Overall Study|Adverse Event|3|||
17053611|NCT00462670|38197096|FG001|Overall Study|Adverse Event|5|||
17053612|NCT00462670|38197095|FG000|Overall Study|Lack of Efficacy|1|||
17053613|NCT00462670|38197096|FG001|Overall Study|Lack of Efficacy|0|||
17053614|NCT00462670|38197095|FG000|Overall Study|Protocol Violation|1|||
17053615|NCT00462670|38197096|FG001|Overall Study|Protocol Violation|0|||
17053616|NCT00462670|38197095|FG000|Overall Study|Resolution of signs and symptoms|0|||
17053617|NCT00462670|38197096|FG001|Overall Study|Resolution of signs and symptoms|2|||
17053618|NCT03780543|38197105|FG000|Overall Study|Adverse Event|1|||
17053619|NCT03780543|38197106|FG001|Overall Study|Adverse Event|0|||
17053620|NCT03780543|38197107|FG002|Overall Study|Adverse Event|2|||
17053621|NCT03780543|38197105|FG000|Overall Study|Lost to Follow-up|2|||
17053622|NCT03780543|38197106|FG001|Overall Study|Lost to Follow-up|0|||
17053623|NCT03780543|38197107|FG002|Overall Study|Lost to Follow-up|1|||
17053624|NCT03780543|38197105|FG000|Overall Study|Study terminated by Sponsor|8|||
17053625|NCT03780543|38197106|FG001|Overall Study|Study terminated by Sponsor|7|||
17053626|NCT03780543|38197107|FG002|Overall Study|Study terminated by Sponsor|13|||
17053627|NCT03780543|38197105|FG000|Overall Study|Withdrawal by Subject|1|||
17053628|NCT03780543|38197106|FG001|Overall Study|Withdrawal by Subject|8|||
17053629|NCT03780543|38197107|FG002|Overall Study|Withdrawal by Subject|1|||
17053630|NCT03780543|38197105|FG000|Overall Study|Noncompliance with study drug|1|||
17053631|NCT03780543|38197106|FG001|Overall Study|Noncompliance with study drug|0|||
17053632|NCT03780543|38197107|FG002|Overall Study|Noncompliance with study drug|0|||
17053633|NCT00606086|38197119|FG000|Overall Study|Adverse Event|1|||
17053634|NCT00606086|38197120|FG001|Overall Study|Adverse Event|1|||
17053635|NCT00606086|38197119|FG000|Overall Study|Lost to Follow-up|4|||
17053636|NCT00606086|38197120|FG001|Overall Study|Lost to Follow-up|8|||
17053637|NCT00606086|38197119|FG000|Overall Study|Protocol Violation|1|||
17053638|NCT00606086|38197120|FG001|Overall Study|Protocol Violation|0|||
17053639|NCT00606086|38197119|FG000|Overall Study|Withdrawal by Subject|5|||
17053640|NCT00606086|38197120|FG001|Overall Study|Withdrawal by Subject|3|||
17053641|NCT00606086|38197119|FG000|Overall Study|Non-compliance|0|||
17053642|NCT00606086|38197120|FG001|Overall Study|Non-compliance|1|||
17053643|NCT00606086|38197119|FG000|Overall Study|Randomized, not treated|1|||
17053644|NCT00606086|38197120|FG001|Overall Study|Randomized, not treated|2|||
17053645|NCT00609986|38197128|FG000|Overall Study|Did not receive transplant or treatment|8|||
17053646|NCT00609986|38197129|FG001|Overall Study|Did not receive transplant or treatment|3|||
17053647|NCT00451906|38197135|FG000|Overall Study|Adverse Event|515|||
17053648|NCT00451906|38197135|FG000|Overall Study|Lost to Follow-up|31|||
17053649|NCT00451906|38197135|FG000|Overall Study|Withdrawal by Subject|111|||
17053650|NCT00451906|38197135|FG000|Overall Study|Protocol Violation|21|||
17053651|NCT00451906|38197135|FG000|Overall Study|Progressive disease|1328|||
17053652|NCT00451906|38197135|FG000|Overall Study|Termination of the study|108|||
17053653|NCT00451906|38197135|FG000|Overall Study|Other Reasons|121|||
17053654|NCT00451906|38197135|FG000|Overall Study|Did not complete final visit|4|||
17053655|NCT00451282|38197141|FG000|Overall Study|Lost to Follow-up|6|||
16992937|NCT00722371|38136943|FG000|Overall Study|Lost to Follow-up|11|||
16992938|NCT00722371|38136944|FG001|Overall Study|Lost to Follow-up|14|||
16992939|NCT00722371|38136945|FG002|Overall Study|Lost to Follow-up|21|||
16992940|NCT00722371|38136946|FG003|Overall Study|Lost to Follow-up|13|||
16992941|NCT00722371|38136947|FG004|Overall Study|Lost to Follow-up|8|||
16992942|NCT00722371|38136948|FG005|Overall Study|Lost to Follow-up|16|||
16992943|NCT00722371|38136949|FG006|Overall Study|Lost to Follow-up|13|||
16992944|NCT00722371|38136943|FG000|Overall Study|Physician Decision|5|||
16992945|NCT00722371|38136944|FG001|Overall Study|Physician Decision|2|||
16992946|NCT00722371|38136945|FG002|Overall Study|Physician Decision|2|||
16992947|NCT00722371|38136946|FG003|Overall Study|Physician Decision|5|||
16992948|NCT00722371|38136947|FG004|Overall Study|Physician Decision|2|||
16992949|NCT00722371|38136948|FG005|Overall Study|Physician Decision|3|||
16992950|NCT00722371|38136949|FG006|Overall Study|Physician Decision|4|||
17053656|NCT00451282|38197142|FG001|Overall Study|Lost to Follow-up|5|||
17053657|NCT03838198|38197150|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
17053658|NCT03838198|38197151|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
17053659|NCT03838198|38197152|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
17053660|NCT03838198|38197153|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
17053661|NCT03838198|38197150|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
17053662|NCT03838198|38197151|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
17053663|NCT03838198|38197152|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
17053664|NCT03838198|38197153|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
17053665|NCT00115765|38197168|FG000|Overall Study|Withdrawal by Subject|22|||
17053666|NCT00115765|38197169|FG001|Overall Study|Withdrawal by Subject|53|||
17053667|NCT00115765|38197170|FG002|Overall Study|Withdrawal by Subject|76|||
17053668|NCT00115765|38197171|FG003|Overall Study|Withdrawal by Subject|15|||
17053669|NCT00115765|38197168|FG000|Overall Study|Physician Decision|4|||
17053670|NCT00115765|38197169|FG001|Overall Study|Physician Decision|15|||
17053671|NCT00115765|38197170|FG002|Overall Study|Physician Decision|18|||
17053672|NCT00115765|38197171|FG003|Overall Study|Physician Decision|13|||
17053673|NCT00115765|38197168|FG000|Overall Study|Lost to Follow-up|3|||
17053674|NCT00115765|38197169|FG001|Overall Study|Lost to Follow-up|20|||
17053675|NCT00115765|38197170|FG002|Overall Study|Lost to Follow-up|18|||
17053676|NCT00115765|38197171|FG003|Overall Study|Lost to Follow-up|1|||
17053677|NCT00115765|38197168|FG000|Overall Study|Other|6|||
17053678|NCT00115765|38197169|FG001|Overall Study|Other|12|||
17053679|NCT00115765|38197170|FG002|Overall Study|Other|9|||
17053680|NCT00115765|38197171|FG003|Overall Study|Other|2|||
17053681|NCT00606008|38197179|FG000|Overall Study|Adverse Event|1|||
17053682|NCT00606008|38197179|FG000|Overall Study|Withdrawal by Subject|4|||
17053683|NCT00461812|38197191|FG000|Overall Study|study terminated|10|||
17143857|NCT01265537|38287144|FG000|Overall Study|Adverse Event|2|||
17143858|NCT01265537|38287145|FG001|Overall Study|Adverse Event|1|||
17053684|NCT00123955|38197198|FG000|Overall Study|Adverse Event|1|||
17053685|NCT00123955|38197199|FG001|Overall Study|Adverse Event|0|||
17053686|NCT00123955|38197198|FG000|Overall Study|Withdrawal by Subject|4|||
17053687|NCT00123955|38197199|FG001|Overall Study|Withdrawal by Subject|3|||
17053688|NCT00123955|38197198|FG000|Overall Study|Death|0|||
17053689|NCT00123955|38197199|FG001|Overall Study|Death|1|||
17053690|NCT03837028|38197209|FG000|Overall Study|Lost to Follow-up|4|||
17053691|NCT03837028|38197210|FG001|Overall Study|Lost to Follow-up|0|||
17053692|NCT03837028|38197211|FG002|Overall Study|Lost to Follow-up|2|||
17053693|NCT03837028|38197212|FG003|Overall Study|Lost to Follow-up|0|||
17053694|NCT03837028|38197209|FG000|Overall Study|Withdrawal by Subject|12|||
17053695|NCT03837028|38197210|FG001|Overall Study|Withdrawal by Subject|11|||
17053696|NCT03837028|38197211|FG002|Overall Study|Withdrawal by Subject|11|||
17053697|NCT03837028|38197212|FG003|Overall Study|Withdrawal by Subject|7|||
17053698|NCT00115063|38197224|FG000|Overall Study|Lost to Follow-up|98|||
17053699|NCT00115063|38197225|FG001|Overall Study|Lost to Follow-up|104|||
17053700|NCT00115063|38197224|FG000|Overall Study|Death|1|||
17053701|NCT00115063|38197225|FG001|Overall Study|Death|0|||
17053702|NCT00461500|38197233|FG000|Overall Study|Adverse Event|1|||
17053703|NCT00461500|38197234|FG001|Overall Study|Adverse Event|0|||
17053704|NCT00461500|38197233|FG000|Overall Study|Lack of Efficacy|0|||
16992951|NCT00722371|38136943|FG000|Overall Study|Pregnancy|1|||
16992952|NCT00722371|38136944|FG001|Overall Study|Pregnancy|1|||
17053705|NCT00461500|38197234|FG001|Overall Study|Lack of Efficacy|1|||
17053706|NCT00461500|38197233|FG000|Overall Study|Expired Drug Treatment|1|||
17053707|NCT00461500|38197234|FG001|Overall Study|Expired Drug Treatment|1|||
17053708|NCT00461500|38197233|FG000|Overall Study|Study Stopped|1|||
16992953|NCT00722371|38136945|FG002|Overall Study|Pregnancy|0|||
16992954|NCT00722371|38136946|FG003|Overall Study|Pregnancy|0|||
17053709|NCT00461500|38197234|FG001|Overall Study|Study Stopped|2|||
17053710|NCT00461500|38197233|FG000|Overall Study|Drug Treatment Misuse|1|||
17053711|NCT00461500|38197234|FG001|Overall Study|Drug Treatment Misuse|0|||
17053712|NCT00461500|38197233|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
17053713|NCT00461500|38197234|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
17053714|NCT00461500|38197233|FG000|Overall Study|Lost to Follow-up|2|||
17053715|NCT00461500|38197234|FG001|Overall Study|Lost to Follow-up|2|||
17053716|NCT00167245|38197242|FG000|Overall Study|Lost to Follow-up|20|||
17053717|NCT00167245|38197243|FG001|Overall Study|Lost to Follow-up|31|||
17053718|NCT00167245|38197242|FG000|Overall Study|Withdrawal by Subject|5|||
17053719|NCT00167245|38197243|FG001|Overall Study|Withdrawal by Subject|8|||
17053720|NCT00167245|38197242|FG000|Overall Study|Incarcerated|3|||
17053721|NCT00167245|38197243|FG001|Overall Study|Incarcerated|2|||
17053722|NCT00167245|38197242|FG000|Overall Study|Drowsy|1|||
17053723|NCT00167245|38197243|FG001|Overall Study|Drowsy|0|||
17053724|NCT00443560|38197254|FG000|Overall Study|No intrathecal dose|58|||
17053725|NCT00443560|38197255|FG001|Overall Study|No intrathecal dose|26|||
17053726|NCT00443560|38197254|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
17053727|NCT00443560|38197255|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
17053728|NCT00451204|38197263|FG000|Overall Study|Adverse Event|4|||
17053729|NCT00451204|38197264|FG001|Overall Study|Adverse Event|6|||
17053730|NCT00451204|38197263|FG000|Overall Study|Lack of Efficacy|4|||
17053731|NCT00451204|38197264|FG001|Overall Study|Lack of Efficacy|4|||
17053732|NCT00451204|38197263|FG000|Overall Study|Lost to Follow-up|4|||
17053733|NCT00451204|38197264|FG001|Overall Study|Lost to Follow-up|4|||
17053734|NCT00451204|38197263|FG000|Overall Study|Protocol Violation|1|||
17053735|NCT00451204|38197264|FG001|Overall Study|Protocol Violation|0|||
17053736|NCT00451204|38197263|FG000|Overall Study|Patient refusal|8|||
17053737|NCT00451204|38197264|FG001|Overall Study|Patient refusal|4|||
17053738|NCT00451204|38197263|FG000|Overall Study|Other|1|||
17053739|NCT00451204|38197264|FG001|Overall Study|Other|2|||
17053740|NCT00605540|38197273|FG000|Overall Study|Death|15|||
17053741|NCT00605540|38197273|FG000|Overall Study|Lost to Follow-up|23|||
17053742|NCT00605306|38197279|FG000|Overall Study|Adverse Event|0|||
17053743|NCT00605306|38197280|FG001|Overall Study|Adverse Event|1|||
17053744|NCT00607022|38197289|FG000|Overall Study|Withdrawal by Subject|1|||
17053745|NCT00607022|38197290|FG001|Overall Study|Withdrawal by Subject|0|||
17053746|NCT00607022|38197291|FG002|Overall Study|Withdrawal by Subject|0|||
17053747|NCT00606632|38197299|FG000|Overall Study|Withdrawal by Subject|13|||
17053748|NCT00606632|38197299|FG000|Overall Study|Miscellaneous reasons|9|||
17053749|NCT00450814|38197318|FG000|Overall Study|Failed to complete the initial therapy|0|||
17053750|NCT00450814|38197319|FG001|Overall Study|Failed to complete the initial therapy|0|||
17053751|NCT00450814|38197320|FG002|Overall Study|Failed to complete the initial therapy|0|||
17053752|NCT00450814|38197321|FG003|Overall Study|Failed to complete the initial therapy|1|||
17053753|NCT00450814|38197322|FG004|Overall Study|Failed to complete the initial therapy|1|||
17053754|NCT00450814|38197323|FG005|Overall Study|Failed to complete the initial therapy|1|||
17053755|NCT00450814|38197324|FG006|Overall Study|Failed to complete the initial therapy|0|||
17053756|NCT00450814|38197325|FG007|Overall Study|Failed to complete the initial therapy|0|||
17053757|NCT00450814|38197326|FG008|Overall Study|Failed to complete the initial therapy|0|||
17053758|NCT00450814|38197327|FG009|Overall Study|Failed to complete the initial therapy|0|||
17053759|NCT00450814|38197328|FG010|Overall Study|Failed to complete the initial therapy|0|||
17053760|NCT00450814|38197318|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
17053761|NCT00450814|38197319|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
17053762|NCT00450814|38197320|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
17053763|NCT00450814|38197321|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
17053764|NCT00450814|38197322|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
17053765|NCT00450814|38197323|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
17053766|NCT00450814|38197324|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
17053767|NCT00450814|38197325|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
17053768|NCT00450814|38197326|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
17053769|NCT00450814|38197327|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
17053770|NCT00450814|38197328|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
17053771|NCT00518115|38197363|FG000|Overall Study|Adverse Event|6|||
17053772|NCT00518115|38197364|FG001|Overall Study|Adverse Event|1|||
17053773|NCT00518115|38197365|FG002|Overall Study|Adverse Event|5|||
17053774|NCT00518115|38197366|FG003|Overall Study|Adverse Event|6|||
17053775|NCT00518115|38197367|FG004|Overall Study|Adverse Event|5|||
17053776|NCT00518115|38197368|FG005|Overall Study|Adverse Event|5|||
17053777|NCT00518115|38197369|FG006|Overall Study|Adverse Event|5|||
17053778|NCT00518115|38197370|FG007|Overall Study|Adverse Event|10|||
17053779|NCT00518115|38197371|FG008|Overall Study|Adverse Event|2|||
17053780|NCT00518115|38197372|FG009|Overall Study|Adverse Event|9|||
17053781|NCT00518115|38197363|FG000|Overall Study|Lost to Follow-up|0|||
17053782|NCT00518115|38197364|FG001|Overall Study|Lost to Follow-up|0|||
17053783|NCT00518115|38197365|FG002|Overall Study|Lost to Follow-up|2|||
17053784|NCT00518115|38197366|FG003|Overall Study|Lost to Follow-up|3|||
17053785|NCT00518115|38197367|FG004|Overall Study|Lost to Follow-up|1|||
17053786|NCT00518115|38197368|FG005|Overall Study|Lost to Follow-up|3|||
17053787|NCT00518115|38197369|FG006|Overall Study|Lost to Follow-up|0|||
17053788|NCT00518115|38197370|FG007|Overall Study|Lost to Follow-up|1|||
17053789|NCT00518115|38197371|FG008|Overall Study|Lost to Follow-up|1|||
17053790|NCT00518115|38197372|FG009|Overall Study|Lost to Follow-up|1|||
17053791|NCT00518115|38197363|FG000|Overall Study|Protocol Violation|1|||
17053792|NCT00518115|38197364|FG001|Overall Study|Protocol Violation|3|||
17053793|NCT00518115|38197365|FG002|Overall Study|Protocol Violation|1|||
17053794|NCT00518115|38197366|FG003|Overall Study|Protocol Violation|0|||
17053795|NCT00518115|38197367|FG004|Overall Study|Protocol Violation|0|||
17053796|NCT00518115|38197368|FG005|Overall Study|Protocol Violation|0|||
17053797|NCT00518115|38197369|FG006|Overall Study|Protocol Violation|0|||
17053798|NCT00518115|38197370|FG007|Overall Study|Protocol Violation|0|||
17053799|NCT00518115|38197371|FG008|Overall Study|Protocol Violation|0|||
17053800|NCT00518115|38197372|FG009|Overall Study|Protocol Violation|0|||
17053801|NCT00518115|38197363|FG000|Overall Study|Withdrawal by Subject|1|||
17053802|NCT00518115|38197364|FG001|Overall Study|Withdrawal by Subject|1|||
17053803|NCT00518115|38197365|FG002|Overall Study|Withdrawal by Subject|5|||
17053804|NCT00518115|38197366|FG003|Overall Study|Withdrawal by Subject|0|||
17053805|NCT00518115|38197367|FG004|Overall Study|Withdrawal by Subject|2|||
17053806|NCT00518115|38197368|FG005|Overall Study|Withdrawal by Subject|1|||
17053807|NCT00518115|38197369|FG006|Overall Study|Withdrawal by Subject|0|||
17053808|NCT00518115|38197370|FG007|Overall Study|Withdrawal by Subject|2|||
17053809|NCT00518115|38197371|FG008|Overall Study|Withdrawal by Subject|1|||
17053810|NCT00518115|38197372|FG009|Overall Study|Withdrawal by Subject|3|||
17053811|NCT00518115|38197363|FG000|Overall Study|Lack of Efficacy|1|||
17053812|NCT00518115|38197364|FG001|Overall Study|Lack of Efficacy|0|||
17053813|NCT00518115|38197365|FG002|Overall Study|Lack of Efficacy|1|||
17053814|NCT00518115|38197366|FG003|Overall Study|Lack of Efficacy|1|||
17053815|NCT00518115|38197367|FG004|Overall Study|Lack of Efficacy|0|||
17053816|NCT00518115|38197368|FG005|Overall Study|Lack of Efficacy|0|||
17053817|NCT00518115|38197369|FG006|Overall Study|Lack of Efficacy|0|||
17053818|NCT00518115|38197370|FG007|Overall Study|Lack of Efficacy|1|||
17053819|NCT00518115|38197371|FG008|Overall Study|Lack of Efficacy|0|||
17053820|NCT00518115|38197372|FG009|Overall Study|Lack of Efficacy|0|||
17053821|NCT00518115|38197363|FG000|Overall Study|Non-Compliance|1|||
17053822|NCT00518115|38197364|FG001|Overall Study|Non-Compliance|0|||
17053823|NCT00518115|38197365|FG002|Overall Study|Non-Compliance|1|||
17053824|NCT00518115|38197366|FG003|Overall Study|Non-Compliance|0|||
17053825|NCT00518115|38197367|FG004|Overall Study|Non-Compliance|1|||
17053826|NCT00518115|38197368|FG005|Overall Study|Non-Compliance|1|||
17053827|NCT00518115|38197369|FG006|Overall Study|Non-Compliance|1|||
17053828|NCT00518115|38197370|FG007|Overall Study|Non-Compliance|1|||
17053829|NCT00518115|38197371|FG008|Overall Study|Non-Compliance|0|||
17053830|NCT00518115|38197372|FG009|Overall Study|Non-Compliance|1|||
17053831|NCT00518115|38197363|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
17053832|NCT00518115|38197364|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
17053833|NCT00518115|38197365|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
17053834|NCT00518115|38197366|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
17053835|NCT00518115|38197367|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
17053836|NCT00518115|38197368|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
17053837|NCT00518115|38197369|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
17053838|NCT00518115|38197370|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
17053839|NCT00518115|38197371|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
17053840|NCT00518115|38197372|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
17053841|NCT00518115|38197363|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
17053842|NCT00518115|38197364|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053843|NCT00518115|38197365|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053844|NCT00518115|38197366|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053845|NCT00518115|38197367|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053846|NCT00518115|38197368|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053847|NCT00518115|38197369|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053848|NCT00518115|38197370|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053849|NCT00518115|38197371|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053850|NCT00518115|38197372|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
17053851|NCT00518115|38197363|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
17053852|NCT00518115|38197364|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
17053853|NCT00518115|38197365|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
17053854|NCT00518115|38197366|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
17053855|NCT00518115|38197367|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
17143859|NCT01265537|38287144|FG000|Overall Study|Physician Decision|0|||
17143860|NCT01265537|38287145|FG001|Overall Study|Physician Decision|1|||
17143861|NCT04396639|38287151|FG000|Overall Study|Withdrawal by Subject|1|||
17143862|NCT04396639|38287151|FG000|Overall Study|Other|1|||
17053856|NCT00518115|38197368|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
17053857|NCT00518115|38197369|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
17053858|NCT00518115|38197370|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
17053859|NCT00518115|38197371|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
17053860|NCT00518115|38197372|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
17053861|NCT00518115|38197363|FG000|Overall Study|Wrong Monotherapy Administered|0|||
17053862|NCT00518115|38197364|FG001|Overall Study|Wrong Monotherapy Administered|0|||
17053863|NCT00518115|38197365|FG002|Overall Study|Wrong Monotherapy Administered|1|||
17053864|NCT00518115|38197366|FG003|Overall Study|Wrong Monotherapy Administered|0|||
17053865|NCT00518115|38197367|FG004|Overall Study|Wrong Monotherapy Administered|0|||
17053866|NCT00518115|38197368|FG005|Overall Study|Wrong Monotherapy Administered|0|||
17053867|NCT00518115|38197369|FG006|Overall Study|Wrong Monotherapy Administered|1|||
17053868|NCT00518115|38197370|FG007|Overall Study|Wrong Monotherapy Administered|0|||
17053869|NCT00518115|38197371|FG008|Overall Study|Wrong Monotherapy Administered|0|||
17053870|NCT00518115|38197372|FG009|Overall Study|Wrong Monotherapy Administered|0|||
17053871|NCT00518115|38197363|FG000|Overall Study|Violation of Exclusion Criteria|0|||
17053872|NCT00518115|38197364|FG001|Overall Study|Violation of Exclusion Criteria|0|||
17053873|NCT00518115|38197365|FG002|Overall Study|Violation of Exclusion Criteria|0|||
17053874|NCT00518115|38197366|FG003|Overall Study|Violation of Exclusion Criteria|1|||
17053875|NCT00518115|38197367|FG004|Overall Study|Violation of Exclusion Criteria|0|||
17053876|NCT00518115|38197368|FG005|Overall Study|Violation of Exclusion Criteria|0|||
17053877|NCT00518115|38197369|FG006|Overall Study|Violation of Exclusion Criteria|1|||
17053878|NCT00518115|38197370|FG007|Overall Study|Violation of Exclusion Criteria|0|||
17143863|NCT04432298|38287157|FG000|Overall Study|Other than specified|1|||
17143864|NCT04432298|38287158|FG001|Overall Study|Other than specified|0|||
17143865|NCT04432298|38287157|FG000|Overall Study|Lost to Follow-up|0|||
17143866|NCT04432298|38287158|FG001|Overall Study|Lost to Follow-up|1|||
17143867|NCT04432298|38287157|FG000|Overall Study|Death|3|||
17053879|NCT00518115|38197371|FG008|Overall Study|Violation of Exclusion Criteria|0|||
17053880|NCT00518115|38197372|FG009|Overall Study|Violation of Exclusion Criteria|0|||
17053881|NCT00518115|38197363|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
17053882|NCT00518115|38197364|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
17053883|NCT00518115|38197365|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
17053884|NCT00518115|38197366|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
17053885|NCT00518115|38197367|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
17053886|NCT00518115|38197368|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
17053887|NCT00518115|38197369|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
17053888|NCT00518115|38197370|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
17053889|NCT00518115|38197371|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
17053890|NCT00518115|38197372|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
17053891|NCT00518115|38197363|FG000|Overall Study|Withdrew Consent|0|||
17053892|NCT00518115|38197364|FG001|Overall Study|Withdrew Consent|0|||
17053893|NCT00518115|38197365|FG002|Overall Study|Withdrew Consent|0|||
17053894|NCT00518115|38197366|FG003|Overall Study|Withdrew Consent|0|||
17053895|NCT00518115|38197367|FG004|Overall Study|Withdrew Consent|0|||
17053896|NCT00518115|38197368|FG005|Overall Study|Withdrew Consent|1|||
17053897|NCT00518115|38197369|FG006|Overall Study|Withdrew Consent|0|||
17053898|NCT00518115|38197370|FG007|Overall Study|Withdrew Consent|0|||
17053899|NCT00518115|38197371|FG008|Overall Study|Withdrew Consent|0|||
17053900|NCT00518115|38197372|FG009|Overall Study|Withdrew Consent|0|||
17053901|NCT00518115|38197363|FG000|Overall Study|Moved Out of State|0|||
17053902|NCT00518115|38197364|FG001|Overall Study|Moved Out of State|0|||
17053903|NCT00518115|38197365|FG002|Overall Study|Moved Out of State|0|||
17053904|NCT00518115|38197366|FG003|Overall Study|Moved Out of State|0|||
17053905|NCT00518115|38197367|FG004|Overall Study|Moved Out of State|0|||
17053906|NCT00518115|38197368|FG005|Overall Study|Moved Out of State|0|||
17053907|NCT00518115|38197369|FG006|Overall Study|Moved Out of State|0|||
17053908|NCT00518115|38197370|FG007|Overall Study|Moved Out of State|0|||
17053909|NCT00518115|38197371|FG008|Overall Study|Moved Out of State|0|||
17143868|NCT04432298|38287158|FG001|Overall Study|Death|2|||
17143869|NCT04432298|38287157|FG000|Overall Study|Withdrawal by Subject|2|||
17143870|NCT04432298|38287158|FG001|Overall Study|Withdrawal by Subject|0|||
17143871|NCT04359901|38287166|FG000|Overall Study|Withdrawal by Subject|0|||
17053910|NCT00518115|38197372|FG009|Overall Study|Moved Out of State|1|||
17053911|NCT00450658|38197397|FG000|Overall Study|Adverse Event|24|||
17053912|NCT00450658|38197398|FG001|Overall Study|Adverse Event|15|||
17053913|NCT00450658|38197397|FG000|Overall Study|Withdrawal by Subject|43|||
17053914|NCT00450658|38197398|FG001|Overall Study|Withdrawal by Subject|26|||
17053915|NCT00450658|38197397|FG000|Overall Study|Lost to Follow-up|22|||
17053916|NCT00450658|38197398|FG001|Overall Study|Lost to Follow-up|5|||
17143872|NCT04359901|38287167|FG001|Overall Study|Withdrawal by Subject|1|||
17053917|NCT00450658|38197397|FG000|Overall Study|UGI ulcer|33|||
17053918|NCT00450658|38197398|FG001|Overall Study|UGI ulcer|34|||
17053919|NCT00450658|38197397|FG000|Overall Study|misc|21|||
17053920|NCT00450658|38197398|FG001|Overall Study|misc|10|||
17053921|NCT00517881|38197404|FG000|Overall Study|Protocol Violation|2|||
17053922|NCT00517881|38197404|FG000|Overall Study|Adverse Event|1|||
17053923|NCT00517881|38197404|FG000|Overall Study|Renal transplantation|2|||
17053924|NCT00517413|38197425|FG000|Overall Study|Adverse Event|7|||
17053925|NCT00517413|38197425|FG000|Overall Study|Death|13|||
17053926|NCT00517413|38197425|FG000|Overall Study|Protocol Violation|15|||
17053927|NCT00517413|38197425|FG000|Overall Study|Withdrawal by Subject|2|||
17053928|NCT00517413|38197425|FG000|Overall Study|Failure to return|1|||
17053929|NCT00517413|38197425|FG000|Overall Study|Other-Reasons|23|||
17053930|NCT00604214|38197439|FG000|Baseline to Day 28|Death|223|||
17053931|NCT00604214|38197440|FG001|Baseline to Day 28|Death|202|||
17053932|NCT00604214|38197439|FG000|Baseline to Day 28|Lost to Follow-up|2|||
17053933|NCT00604214|38197440|FG001|Baseline to Day 28|Lost to Follow-up|4|||
17053934|NCT00604214|38197439|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
17053935|NCT00604214|38197440|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
17053936|NCT00604214|38197439|FG000|Day 29 to Day 90|Death|64|||
17053937|NCT00604214|38197440|FG001|Day 29 to Day 90|Death|67|||
17053938|NCT00604214|38197439|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
17053939|NCT00604214|38197440|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
17053940|NCT00604214|38197439|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
17053941|NCT00604214|38197440|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
17053942|NCT00604214|38197439|FG000|Day 91 to Day 180|Death|19|||
17053943|NCT00604214|38197440|FG001|Day 91 to Day 180|Death|23|||
17053944|NCT00604214|38197439|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
17053945|NCT00604214|38197440|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
17143873|NCT04359901|38287166|FG000|Overall Study|Death|6|||
17143874|NCT04359901|38287167|FG001|Overall Study|Death|2|||
17143875|NCT04167085|38287175|FG000|Baseline|Withdrawal by Subject|2|||
17143876|NCT04167085|38287176|FG001|Baseline|Withdrawal by Subject|1|||
17053946|NCT00604214|38197439|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
17053947|NCT00604214|38197440|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
17053948|NCT00450580|38197448|FG000|Overall Study|Adverse Event|5|||
17053949|NCT00450580|38197449|FG001|Overall Study|Adverse Event|7|||
17053950|NCT00450580|38197448|FG000|Overall Study|Lost to Follow-up|4|||
17053951|NCT00450580|38197449|FG001|Overall Study|Lost to Follow-up|5|||
17053952|NCT00450580|38197448|FG000|Overall Study|Withdrawal by Subject|2|||
17053953|NCT00450580|38197449|FG001|Overall Study|Withdrawal by Subject|2|||
17053954|NCT00450580|38197448|FG000|Overall Study|Protocol Violation|1|||
17053955|NCT00450580|38197449|FG001|Overall Study|Protocol Violation|1|||
17053956|NCT00450580|38197448|FG000|Overall Study|Protocol-defined virologic failure|1|||
17053957|NCT00450580|38197449|FG001|Overall Study|Protocol-defined virologic failure|0|||
17053958|NCT00450580|38197448|FG000|Overall Study|Could not comply with scheduled visits|1|||
17053959|NCT00450580|38197449|FG001|Overall Study|Could not comply with scheduled visits|0|||
17053960|NCT00450580|38197448|FG000|Overall Study|Patient went to Brazil|1|||
17053961|NCT00450580|38197449|FG001|Overall Study|Patient went to Brazil|0|||
17053962|NCT00450580|38197448|FG000|Overall Study|Patient could not swallow Norvir|1|||
17053963|NCT00450580|38197449|FG001|Overall Study|Patient could not swallow Norvir|0|||
17053964|NCT00450580|38197448|FG000|Overall Study|Withdrawal due to pregnancy|0|||
17053965|NCT00450580|38197449|FG001|Overall Study|Withdrawal due to pregnancy|1|||
17053966|NCT00123487|38197457|FG000|Randomized|Death prior to starting treatment|0|||
17053967|NCT00123487|38197458|FG001|Randomized|Death prior to starting treatment|1|||
17053968|NCT00123487|38197457|FG000|Randomized|SAE prior to starting treatment|1|||
17053969|NCT00123487|38197458|FG001|Randomized|SAE prior to starting treatment|0|||
17053970|NCT00123487|38197457|FG000|Treated With Study Drug|Adverse Event|23|||
17053971|NCT00123487|38197458|FG001|Treated With Study Drug|Adverse Event|22|||
17053972|NCT00123487|38197457|FG000|Treated With Study Drug|Disease Progression|141|||
17053973|NCT00123487|38197458|FG001|Treated With Study Drug|Disease Progression|122|||
17053974|NCT00123487|38197457|FG000|Treated With Study Drug|Physician Decision|8|||
17053975|NCT00123487|38197458|FG001|Treated With Study Drug|Physician Decision|9|||
17053976|NCT00123487|38197457|FG000|Treated With Study Drug|Other|59|||
17053977|NCT00123487|38197458|FG001|Treated With Study Drug|Other|58|||
17143877|NCT04167085|38287175|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
17143878|NCT04167085|38287176|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
17143879|NCT04162795|38287182|FG000|Overall Study|Other|16|||
17143880|NCT04162795|38287182|FG000|Overall Study|Screen failures|10|||
17143881|NCT03069482|38287188|FG000|Overall Study|Lost to Follow-up|0|||
17143882|NCT03069482|38287189|FG001|Overall Study|Lost to Follow-up|1|||
17053978|NCT00123487|38197457|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
17053979|NCT00123487|38197458|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
17053980|NCT00123487|38197457|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
17053981|NCT00123487|38197458|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
17053982|NCT00123487|38197457|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
17053983|NCT00123487|38197458|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
17053984|NCT00509925|38197465|FG000|Overall Study|Personal reasons|0|||
17053985|NCT00509925|38197466|FG001|Overall Study|Personal reasons|1|||
17053986|NCT00504777|38197474|FG000|Overall Study|Adverse Event|1|||
17053987|NCT00509769|38197478|FG000|Overall Study|Progressive disease|77|||
17053988|NCT00509769|38197478|FG000|Overall Study|Adverse Event|4|||
17053989|NCT00509769|38197478|FG000|Overall Study|Patient's decision|1|||
17053990|NCT00509769|38197478|FG000|Overall Study|Physician Decision|8|||
17053991|NCT00509769|38197478|FG000|Overall Study|Use of prohibited therapies during study|1|||
17053992|NCT00114127|38197484|FG000|Overall Study|Adverse Event|2|||
17053993|NCT00114127|38197485|FG001|Overall Study|Adverse Event|1|||
17053994|NCT00114127|38197484|FG000|Overall Study|Lost to Follow-up|1|||
17053995|NCT00114127|38197485|FG001|Overall Study|Lost to Follow-up|0|||
17053996|NCT00114127|38197484|FG000|Overall Study|Withdrawal by Subject|1|||
17053997|NCT00114127|38197485|FG001|Overall Study|Withdrawal by Subject|3|||
17053998|NCT00572624|38197493|FG000|Overall Study|Lost to Follow-up|10|||
17053999|NCT00572624|38197494|FG001|Overall Study|Lost to Follow-up|4|||
17054000|NCT00572624|38197493|FG000|Overall Study|Wanted to do a different diet program|1|||
17054001|NCT00572624|38197494|FG001|Overall Study|Wanted to do a different diet program|0|||
17054002|NCT00572624|38197493|FG000|Overall Study|Medication change|1|||
17054003|NCT00572624|38197494|FG001|Overall Study|Medication change|0|||
17054004|NCT00572624|38197493|FG000|Overall Study|Started a new job-- no time for study|1|||
17054005|NCT00572624|38197494|FG001|Overall Study|Started a new job-- no time for study|0|||
17054006|NCT00572624|38197493|FG000|Overall Study|Admitted to being a smoker|1|||
17054007|NCT00572624|38197494|FG001|Overall Study|Admitted to being a smoker|0|||
17054008|NCT00572624|38197493|FG000|Overall Study|Refused to do the stress test|1|||
17054009|NCT00572624|38197494|FG001|Overall Study|Refused to do the stress test|0|||
17054010|NCT00572624|38197493|FG000|Overall Study|Problem with vascular access|1|||
17054011|NCT00572624|38197494|FG001|Overall Study|Problem with vascular access|0|||
17054012|NCT00572624|38197493|FG000|Overall Study|Health issues unrelated to the study|1|||
17054013|NCT00572624|38197494|FG001|Overall Study|Health issues unrelated to the study|0|||
17054014|NCT00122317|38197500|FG000|Overall Study|Death|3|||
17054015|NCT00122317|38197500|FG000|Overall Study|Adverse Event|4|||
17054016|NCT00122317|38197500|FG000|Overall Study|Physician Decision|2|||
17054017|NCT00122317|38197500|FG000|Overall Study|patient non-compliance|1|||
17054018|NCT00122317|38197500|FG000|Overall Study|Withdrawal by Subject|1|||
17143883|NCT03069482|38287188|FG000|Overall Study|Physician Decision|1|||
17143884|NCT03069482|38287189|FG001|Overall Study|Physician Decision|0|||
17143885|NCT03266172|38287201|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
17143886|NCT03266172|38287202|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
17143887|NCT03266172|38287203|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
17143888|NCT03266172|38287201|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
17143889|NCT03266172|38287202|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
17143890|NCT03266172|38287203|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
17143891|NCT03266172|38287201|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
17143892|NCT03266172|38287202|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
17054019|NCT03870555|38197507|FG000|Period 3 (2 Days)|Adverse Event|1|||
17054020|NCT03870555|38197508|FG001|Period 3 (2 Days)|Adverse Event|0|||
17054021|NCT03870555|38197509|FG002|Period 3 (2 Days)|Adverse Event|0|||
17054022|NCT03870477|38197520|FG000|Overall Study|Early Study Termination|1|||
17054023|NCT00165841|38197526|FG000|Overall Study|Adverse Event|2|||
17054024|NCT00165841|38197527|FG001|Overall Study|Adverse Event|3|||
17054025|NCT00165841|38197526|FG000|Overall Study|Lack of Efficacy|6|||
17054026|NCT00165841|38197527|FG001|Overall Study|Lack of Efficacy|33|||
17143893|NCT03266172|38287203|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
17143894|NCT03266172|38287201|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
17143895|NCT03266172|38287202|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
17143896|NCT03266172|38287203|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
17143897|NCT03266172|38287201|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
17143898|NCT03266172|38287202|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
17143899|NCT03266172|38287203|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
17143900|NCT03266172|38287201|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
17143901|NCT03266172|38287202|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
17143902|NCT03266172|38287203|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
17143903|NCT04356937|38287255|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
17143904|NCT04356937|38287256|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
17143905|NCT03301740|38287268|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
17143906|NCT03301740|38287269|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
17143907|NCT03301740|38287268|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
17143908|NCT03301740|38287269|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
17143909|NCT04355767|38287277|FG000|Overall Study|Withdrawal by Subject|2|||
17143910|NCT04355767|38287278|FG001|Overall Study|Withdrawal by Subject|2|||
17143911|NCT04355767|38287277|FG000|Overall Study|Death|5|||
17143912|NCT04355767|38287278|FG001|Overall Study|Death|1|||
17143913|NCT00882050|38287287|FG000|Overall Study|Physician Decision|1|||
17143914|NCT00882050|38287288|FG001|Overall Study|Physician Decision|0|||
17143915|NCT00882050|38287289|FG002|Overall Study|Physician Decision|0|||
17143916|NCT03266094|38287297|FG000|Overall Study|Lost to Follow-up|1|||
17143917|NCT03266094|38287297|FG000|Overall Study|Withdrawal by Subject|1|||
17143918|NCT04161079|38287303|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
17143919|NCT03243084|38287313|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
17143920|NCT03243084|38287314|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
17143921|NCT04353817|38287323|FG000|Overall Study|Adverse Event|0|||
17143922|NCT04353817|38287324|FG001|Overall Study|Adverse Event|1|||
17143923|NCT00159588|38287333|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
17143924|NCT00159588|38287334|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
17143925|NCT00159588|38287335|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
17143926|NCT03265938|38287346|FG000|Overall Study|Withdrawal by Subject|1|||
17143927|NCT03265938|38287346|FG000|Overall Study|Physician Decision|1|||
17143928|NCT03265938|38287346|FG000|Overall Study|friable mass|6|||
17143929|NCT04353037|38287355|FG000|Overall Study|Lost to Follow-up|0|||
17143930|NCT04353037|38287356|FG001|Overall Study|Lost to Follow-up|1|||
17143931|NCT04353037|38287357|FG002|Overall Study|Lost to Follow-up|2|||
17143932|NCT04353037|38287358|FG003|Overall Study|Lost to Follow-up|3|||
17143933|NCT04353037|38287355|FG000|Overall Study|Withdrawal by Subject|0|||
17143934|NCT04353037|38287356|FG001|Overall Study|Withdrawal by Subject|2|||
17143935|NCT04353037|38287357|FG002|Overall Study|Withdrawal by Subject|3|||
17143936|NCT04353037|38287358|FG003|Overall Study|Withdrawal by Subject|5|||
17143937|NCT04353037|38287355|FG000|Overall Study|Adverse Event|0|||
17143938|NCT04353037|38287356|FG001|Overall Study|Adverse Event|0|||
17143939|NCT04353037|38287357|FG002|Overall Study|Adverse Event|2|||
17143940|NCT04353037|38287358|FG003|Overall Study|Adverse Event|0|||
17143941|NCT04353037|38287355|FG000|Overall Study|Exposure Change|0|||
17143942|NCT04353037|38287356|FG001|Overall Study|Exposure Change|0|||
17143943|NCT04353037|38287357|FG002|Overall Study|Exposure Change|0|||
17143944|NCT04353037|38287358|FG003|Overall Study|Exposure Change|2|||
17143945|NCT04349917|38287372|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
17143946|NCT04349917|38287373|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
17143947|NCT04349917|38287372|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
17143948|NCT04349917|38287373|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
17143949|NCT04156399|38287380|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
17143950|NCT04156399|38287380|FG000|Overall Study|study suspension due to COVID pandemic|3|||
17143951|NCT03300570|38287386|FG000|Overall Study|Adverse Event|0|||
17143952|NCT03300570|38287387|FG001|Overall Study|Adverse Event|1|||
17143953|NCT03300570|38287386|FG000|Overall Study|Withdrawal by Subject|1|||
17143954|NCT03300570|38287387|FG001|Overall Study|Withdrawal by Subject|0|||
17143955|NCT03300570|38287386|FG000|Overall Study|Inadequate bowel prep|1|||
17143956|NCT03300570|38287387|FG001|Overall Study|Inadequate bowel prep|0|||
17143957|NCT04154605|38287396|FG000|Overall Study|Procedure Canceled|1|||
17143958|NCT04154605|38287397|FG001|Overall Study|Procedure Canceled|1|||
17143959|NCT04154605|38287396|FG000|Overall Study|Missed follow up|1|||
17143960|NCT04154605|38287397|FG001|Overall Study|Missed follow up|1|||
17143961|NCT04154605|38287396|FG000|Overall Study|Withdrawal by Subject|1|||
17143962|NCT04154605|38287397|FG001|Overall Study|Withdrawal by Subject|0|||
17143963|NCT03264456|38287403|FG000|Overall Study|Withdrawal by Subject|3|||
17143964|NCT03264456|38287403|FG000|Overall Study|Lost to Follow-up|1|||
17143965|NCT03853694|38287410|FG000|Overall Study|Protocol Violation|3|||
17143966|NCT03853694|38287411|FG001|Overall Study|Protocol Violation|5|||
17143967|NCT03853694|38287412|FG002|Overall Study|Protocol Violation|3|||
17143968|NCT03853694|38287410|FG000|Overall Study|Delivered early|0|||
17143969|NCT03853694|38287411|FG001|Overall Study|Delivered early|1|||
17143970|NCT03853694|38287412|FG002|Overall Study|Delivered early|0|||
17143971|NCT03853694|38287410|FG000|Overall Study|not suitable to proceed|0|||
17143972|NCT03853694|38287411|FG001|Overall Study|not suitable to proceed|1|||
17143973|NCT03853694|38287412|FG002|Overall Study|not suitable to proceed|0|||
17143974|NCT03853694|38287410|FG000|Overall Study|difficult surgery|0|||
17143975|NCT03853694|38287411|FG001|Overall Study|difficult surgery|0|||
17143976|NCT03853694|38287412|FG002|Overall Study|difficult surgery|1|||
17143977|NCT03853694|38287410|FG000|Overall Study|Lost to Follow-up|0|||
17143978|NCT03853694|38287411|FG001|Overall Study|Lost to Follow-up|1|||
17143979|NCT03853694|38287412|FG002|Overall Study|Lost to Follow-up|0|||
17143980|NCT03853694|38287410|FG000|Overall Study|Withdrawal by Subject|0|||
17143981|NCT03853694|38287411|FG001|Overall Study|Withdrawal by Subject|1|||
17143982|NCT03853694|38287412|FG002|Overall Study|Withdrawal by Subject|0|||
17143983|NCT04154293|38287423|FG000|Overall Study|Withdrawal by Subject|2|||
17143984|NCT04154293|38287424|FG001|Overall Study|Withdrawal by Subject|3|||
17143985|NCT04154293|38287425|FG002|Overall Study|Withdrawal by Subject|1|||
17143986|NCT04154293|38287423|FG000|Overall Study|Physician Decision|0|||
17143987|NCT04154293|38287424|FG001|Overall Study|Physician Decision|0|||
17143988|NCT04154293|38287425|FG002|Overall Study|Physician Decision|1|||
17143989|NCT04342897|38287435|FG000|Overall Study|Death|7|||
17143990|NCT04342897|38287436|FG001|Overall Study|Death|4|||
17143991|NCT04342897|38287435|FG000|Overall Study|Lost to Follow-up|6|||
17143992|NCT04342897|38287436|FG001|Overall Study|Lost to Follow-up|6|||
17143993|NCT04342897|38287435|FG000|Overall Study|Withdrawal by Subject|1|||
17143994|NCT04342897|38287436|FG001|Overall Study|Withdrawal by Subject|2|||
17143995|NCT04340557|38287444|FG000|Overall Study|Transferred to ICU and/or death|1|||
17143996|NCT04340557|38287445|FG001|Overall Study|Transferred to ICU and/or death|2|||
17143997|NCT04382053|38287453|FG000|Overall Study|Death|6|||
17143998|NCT04382053|38287454|FG001|Overall Study|Death|8|||
17143999|NCT04382053|38287453|FG000|Overall Study|Lost to Follow-up|0|||
17144000|NCT04382053|38287454|FG001|Overall Study|Lost to Follow-up|2|||
17144001|NCT04382053|38287453|FG000|Overall Study|Protocol Deviation|1|||
17144002|NCT04382053|38287454|FG001|Overall Study|Protocol Deviation|2|||
17144003|NCT04382053|38287453|FG000|Overall Study|Withdrawal by Subject|2|||
17144004|NCT04382053|38287454|FG001|Overall Study|Withdrawal by Subject|1|||
17144005|NCT03066830|38287463|FG000|Overall Study|At the Participant's own Request|16|||
17144006|NCT03066830|38287464|FG001|Overall Study|At the Participant's own Request|17|||
17144007|NCT03066830|38287463|FG000|Overall Study|Other|3|||
17144008|NCT03066830|38287464|FG001|Overall Study|Other|0|||
17144009|NCT03066830|38287463|FG000|Overall Study|Poor Compliance to Protocol|1|||
17144010|NCT03066830|38287464|FG001|Overall Study|Poor Compliance to Protocol|0|||
17144011|NCT03066830|38287463|FG000|Overall Study|Adverse Event|2|||
17144012|NCT03066830|38287464|FG001|Overall Study|Adverse Event|2|||
17144013|NCT03066830|38287463|FG000|Overall Study|Lost to Follow-up|11|||
17144014|NCT03066830|38287464|FG001|Overall Study|Lost to Follow-up|3|||
17144015|NCT04380961|38287473|FG000|Overall Study|Lost to Follow-up|17|||
17144016|NCT04380961|38287474|FG001|Overall Study|Lost to Follow-up|11|||
17144017|NCT04380961|38287473|FG000|Overall Study|Withdrawal by Subject|3|||
17144018|NCT04380961|38287474|FG001|Overall Study|Withdrawal by Subject|0|||
17144019|NCT04380961|38287473|FG000|Overall Study|Death|22|||
17144020|NCT04380961|38287474|FG001|Overall Study|Death|16|||
17144021|NCT04380961|38287473|FG000|Overall Study|Other|1|||
17144022|NCT04380961|38287474|FG001|Overall Study|Other|0|||
17144023|NCT04380961|38287473|FG000|Overall Study|Randomized but Not Treated|1|||
17144024|NCT04380961|38287474|FG001|Overall Study|Randomized but Not Treated|2|||
17144025|NCT04331899|38287484|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
17144026|NCT04331899|38287485|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
17144027|NCT03063632|38287493|FG000|Overall Study|Death|3|||
17144028|NCT03063632|38287494|FG001|Overall Study|Death|6|||
17144029|NCT03063632|38287493|FG000|Overall Study|Lost to Follow-up|0|||
17144030|NCT03063632|38287494|FG001|Overall Study|Lost to Follow-up|1|||
17144031|NCT03063632|38287493|FG000|Overall Study|Withdrawal by Subject|0|||
17144032|NCT03063632|38287494|FG001|Overall Study|Withdrawal by Subject|2|||
17144033|NCT03063632|38287493|FG000|Overall Study|Physician Decision|2|||
17144034|NCT03063632|38287494|FG001|Overall Study|Physician Decision|0|||
17144035|NCT03063632|38287493|FG000|Overall Study|Other: Disease progression; starting another treatment|2|||
17054027|NCT00165841|38197526|FG000|Overall Study|Lost to Follow-up|4|||
17144036|NCT03063632|38287494|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
17144037|NCT04328467|38287503|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
17144038|NCT04328467|38287504|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
17144039|NCT04328467|38287505|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
17144040|NCT04328077|38287517|FG000|Overall Study|Lost to Follow-up|0|||
17144041|NCT04328077|38287518|FG001|Overall Study|Lost to Follow-up|1|||
17144042|NCT04328077|38287519|FG002|Overall Study|Lost to Follow-up|0|||
17144043|NCT04328077|38287520|FG003|Overall Study|Lost to Follow-up|0|||
17144044|NCT04328077|38287517|FG000|Overall Study|Withdrawal by Subject|0|||
17144045|NCT04328077|38287518|FG001|Overall Study|Withdrawal by Subject|1|||
16992955|NCT00722371|38136947|FG004|Overall Study|Pregnancy|0|||
17144046|NCT04328077|38287519|FG002|Overall Study|Withdrawal by Subject|1|||
17144047|NCT04328077|38287520|FG003|Overall Study|Withdrawal by Subject|3|||
17144048|NCT03691831|38287538|FG000|Overall Study|Lost to Follow-up|16|||
17144049|NCT03691831|38287539|FG001|Overall Study|Lost to Follow-up|12|||
17144050|NCT03691831|38287538|FG000|Overall Study|Withdrawal by Subject|9|||
17144051|NCT03691831|38287539|FG001|Overall Study|Withdrawal by Subject|17|||
17144052|NCT03691831|38287538|FG000|Overall Study|Investigator Decision|2|||
17144053|NCT03691831|38287539|FG001|Overall Study|Investigator Decision|2|||
17144054|NCT04320745|38287556|FG000|Overall Study|Adverse Event|26|||
17144055|NCT04320745|38287556|FG000|Overall Study|Withdrawal by Subject|4|||
17144056|NCT04320745|38287556|FG000|Overall Study|Lost to Follow-up|12|||
17144057|NCT04320745|38287556|FG000|Overall Study|Protocol Deviation|2|||
17144058|NCT04320745|38287556|FG000|Overall Study|Non-compliance With Study Drug|2|||
17144059|NCT04320745|38287556|FG000|Overall Study|Reason Not Specified|1|||
17144060|NCT03063086|38287560|FG000|Overall Study|technical problems|1|||
17144061|NCT03063086|38287561|FG001|Overall Study|technical problems|0|||
17144062|NCT03063086|38287562|FG002|Overall Study|technical problems|0|||
17144063|NCT03063086|38287563|FG003|Overall Study|technical problems|0|||
17144064|NCT03063086|38287564|FG004|Overall Study|technical problems|0|||
17144065|NCT03063086|38287565|FG005|Overall Study|technical problems|0|||
17144066|NCT03063086|38287560|FG000|Overall Study|Adverse Event|1|||
17144067|NCT03063086|38287561|FG001|Overall Study|Adverse Event|1|||
17144068|NCT03063086|38287562|FG002|Overall Study|Adverse Event|1|||
17144069|NCT03063086|38287563|FG003|Overall Study|Adverse Event|1|||
17144070|NCT03063086|38287564|FG004|Overall Study|Adverse Event|0|||
17144071|NCT03063086|38287565|FG005|Overall Study|Adverse Event|0|||
17144072|NCT03063086|38287560|FG000|Overall Study|subject/guardian decision|1|||
17144073|NCT03063086|38287561|FG001|Overall Study|subject/guardian decision|0|||
17144074|NCT03063086|38287562|FG002|Overall Study|subject/guardian decision|0|||
17144075|NCT03063086|38287563|FG003|Overall Study|subject/guardian decision|0|||
17144076|NCT03063086|38287564|FG004|Overall Study|subject/guardian decision|0|||
17144077|NCT03063086|38287565|FG005|Overall Study|subject/guardian decision|0|||
17144078|NCT03063086|38287560|FG000|Overall Study|Non-compliance with study treatment|0|||
17144079|NCT03063086|38287561|FG001|Overall Study|Non-compliance with study treatment|0|||
17144080|NCT03063086|38287562|FG002|Overall Study|Non-compliance with study treatment|0|||
17144081|NCT03063086|38287563|FG003|Overall Study|Non-compliance with study treatment|1|||
17144082|NCT03063086|38287564|FG004|Overall Study|Non-compliance with study treatment|0|||
17144083|NCT03063086|38287565|FG005|Overall Study|Non-compliance with study treatment|1|||
17144084|NCT03063086|38287560|FG000|Overall Study|Physician Decision|0|||
17144085|NCT03063086|38287561|FG001|Overall Study|Physician Decision|0|||
17144086|NCT03063086|38287562|FG002|Overall Study|Physician Decision|0|||
17144087|NCT03063086|38287563|FG003|Overall Study|Physician Decision|1|||
17144088|NCT03063086|38287564|FG004|Overall Study|Physician Decision|0|||
17144089|NCT03063086|38287565|FG005|Overall Study|Physician Decision|0|||
17144090|NCT04128007|38287576|FG000|Overall Study|Withdrawal by Subject|9|||
17144091|NCT04128007|38287577|FG001|Overall Study|Withdrawal by Subject|6|||
17144092|NCT04128007|38287576|FG000|Overall Study|Protocol Violation|1|||
17144093|NCT04128007|38287577|FG001|Overall Study|Protocol Violation|0|||
17144094|NCT04128007|38287576|FG000|Overall Study|Lost to Follow-up|8|||
17144095|NCT04128007|38287577|FG001|Overall Study|Lost to Follow-up|7|||
17144096|NCT04128007|38287576|FG000|Overall Study|Adverse Event|5|||
17144097|NCT04128007|38287577|FG001|Overall Study|Adverse Event|2|||
17144098|NCT04128007|38287576|FG000|Overall Study|Not reported|0|||
17144099|NCT04128007|38287577|FG001|Overall Study|Not reported|2|||
17144100|NCT04318093|38287585|FG000|Overall Study|Adverse Event|2|||
17144101|NCT04318093|38287586|FG001|Overall Study|Adverse Event|2|||
17144102|NCT04318093|38287585|FG000|Overall Study|Participant withdrew consent|1|||
17144103|NCT04318093|38287586|FG001|Overall Study|Participant withdrew consent|0|||
17144104|NCT04318093|38287585|FG000|Overall Study|Other reasons|0|||
17144105|NCT04318093|38287586|FG001|Overall Study|Other reasons|1|||
17144106|NCT04123405|38287597|FG000|Overall Study|Adverse Event|1|||
17144107|NCT04123405|38287598|FG001|Overall Study|Adverse Event|2|||
17144108|NCT04123405|38287599|FG002|Overall Study|Adverse Event|3|||
17144109|NCT04123405|38287600|FG003|Overall Study|Adverse Event|3|||
17144110|NCT04123405|38287597|FG000|Overall Study|Exclusion criteria met|1|||
17144111|NCT04123405|38287598|FG001|Overall Study|Exclusion criteria met|2|||
17144112|NCT04123405|38287599|FG002|Overall Study|Exclusion criteria met|0|||
17144113|NCT04123405|38287600|FG003|Overall Study|Exclusion criteria met|2|||
17144114|NCT04123405|38287597|FG000|Overall Study|Withdrawal by Subject|1|||
17144115|NCT04123405|38287598|FG001|Overall Study|Withdrawal by Subject|3|||
17144116|NCT04123405|38287599|FG002|Overall Study|Withdrawal by Subject|0|||
17144117|NCT04123405|38287600|FG003|Overall Study|Withdrawal by Subject|2|||
17144118|NCT04123405|38287597|FG000|Overall Study|Contact to subject lost|0|||
17144119|NCT04123405|38287598|FG001|Overall Study|Contact to subject lost|0|||
17144120|NCT04123405|38287599|FG002|Overall Study|Contact to subject lost|0|||
17144121|NCT04123405|38287600|FG003|Overall Study|Contact to subject lost|1|||
17144122|NCT04123405|38287597|FG000|Overall Study|screening failure|1|||
17144123|NCT04123405|38287598|FG001|Overall Study|screening failure|0|||
17144124|NCT04123405|38287599|FG002|Overall Study|screening failure|0|||
17144125|NCT04123405|38287600|FG003|Overall Study|screening failure|0|||
17144126|NCT04314037|38287629|FG000|Treatment Period 2|Adverse Event|1|||
17144127|NCT04314037|38287630|FG001|Treatment Period 2|Adverse Event|0|||
17144128|NCT04314037|38287629|FG000|Treatment Period 3|Protocol Violation|1|||
17144129|NCT04314037|38287630|FG001|Treatment Period 3|Protocol Violation|0|||
17144130|NCT04314037|38287629|FG000|Treatment Period 3|Adverse Event|0|||
17144131|NCT04314037|38287630|FG001|Treatment Period 3|Adverse Event|1|||
17144132|NCT03056300|38287646|FG000|Overall Study|Surgical reason per study protocol|3|||
17144133|NCT03061214|38287653|FG000|Overall Study|Withdrawal by Subject|21|||
17144134|NCT03061214|38287654|FG001|Overall Study|Withdrawal by Subject|26|||
17144135|NCT03061214|38287655|FG002|Overall Study|Withdrawal by Subject|9|||
17144136|NCT03061214|38287653|FG000|Overall Study|Lost to Follow-up|3|||
17144137|NCT03061214|38287654|FG001|Overall Study|Lost to Follow-up|1|||
17144138|NCT03061214|38287655|FG002|Overall Study|Lost to Follow-up|1|||
17144139|NCT03061214|38287653|FG000|Overall Study|Death|1|||
17144140|NCT03061214|38287654|FG001|Overall Study|Death|1|||
17144141|NCT03061214|38287655|FG002|Overall Study|Death|0|||
17144142|NCT04115839|38287666|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
17144143|NCT04115839|38287667|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
17144144|NCT04115839|38287668|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
17144145|NCT04115839|38287669|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
17144146|NCT04115839|38287670|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
17144147|NCT04115839|38287671|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
17144148|NCT04115839|38287672|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
17144149|NCT04115839|38287666|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
17144150|NCT04115839|38287667|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
17144151|NCT04115839|38287668|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
17144152|NCT04115839|38287669|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
17144153|NCT04115839|38287670|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
17144154|NCT04115839|38287671|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
17144155|NCT04115839|38287672|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
17144156|NCT04115839|38287666|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
17144157|NCT04115839|38287667|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
17144158|NCT04115839|38287668|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
17144159|NCT04115839|38287669|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
17144160|NCT04115839|38287670|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
17144161|NCT04115839|38287671|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
17144162|NCT04115839|38287672|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
17144163|NCT04115839|38287666|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
17144164|NCT04115839|38287667|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
17144165|NCT04115839|38287668|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
17144166|NCT04115839|38287669|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
17144167|NCT04115839|38287670|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
17144168|NCT04115839|38287671|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
17144169|NCT04115839|38287672|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
17144170|NCT04115839|38287666|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
17144171|NCT04115839|38287667|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
17144172|NCT04115839|38287668|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
17144173|NCT04115839|38287669|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
17144174|NCT04115839|38287670|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
17144175|NCT04115839|38287671|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
17144176|NCT04115839|38287672|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
17144177|NCT04115839|38287666|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
17144178|NCT04115839|38287667|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
17144179|NCT04115839|38287668|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
17144180|NCT04115839|38287669|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
17144181|NCT04115839|38287670|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
17144182|NCT04115839|38287671|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
17144183|NCT04115839|38287672|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
17144184|NCT01561430|38287701|FG000|Overall Study|Adverse Event|0|||
17144185|NCT01561430|38287702|FG001|Overall Study|Adverse Event|0|||
16992956|NCT00722371|38136948|FG005|Overall Study|Pregnancy|1|||
17144186|NCT01561430|38287703|FG002|Overall Study|Adverse Event|3|||
17144187|NCT01561430|38287704|FG003|Overall Study|Adverse Event|1|||
17144188|NCT01561430|38287701|FG000|Overall Study|Withdrawal by Subject|0|||
17144189|NCT01561430|38287702|FG001|Overall Study|Withdrawal by Subject|0|||
17144190|NCT01561430|38287703|FG002|Overall Study|Withdrawal by Subject|1|||
17144191|NCT01561430|38287704|FG003|Overall Study|Withdrawal by Subject|0|||
17144192|NCT01561430|38287701|FG000|Overall Study|Physician Decision|0|||
17144193|NCT01561430|38287702|FG001|Overall Study|Physician Decision|1|||
17144194|NCT01561430|38287703|FG002|Overall Study|Physician Decision|0|||
17144195|NCT01561430|38287704|FG003|Overall Study|Physician Decision|0|||
17144196|NCT01561430|38287701|FG000|Overall Study|Sponsor Decision|1|||
17144197|NCT01561430|38287702|FG001|Overall Study|Sponsor Decision|14|||
17144198|NCT01561430|38287703|FG002|Overall Study|Sponsor Decision|13|||
17144199|NCT01561430|38287704|FG003|Overall Study|Sponsor Decision|12|||
17144200|NCT03000530|38287740|FG000|Overall Study|Adverse Event|0|||
17144201|NCT03000530|38287741|FG001|Overall Study|Adverse Event|0|||
17144202|NCT03000530|38287742|FG002|Overall Study|Adverse Event|2|||
17144203|NCT03000530|38287740|FG000|Overall Study|Lost to Follow-up|0|||
17144204|NCT03000530|38287741|FG001|Overall Study|Lost to Follow-up|3|||
17144205|NCT03000530|38287742|FG002|Overall Study|Lost to Follow-up|1|||
17144206|NCT03000530|38287740|FG000|Overall Study|Withdrawal by Subject|0|||
17144207|NCT03000530|38287741|FG001|Overall Study|Withdrawal by Subject|2|||
17144208|NCT03000530|38287742|FG002|Overall Study|Withdrawal by Subject|1|||
17144209|NCT03060512|38287755|FG000|Overall Study|Adverse Event|4|||
17144210|NCT03060512|38287756|FG001|Overall Study|Adverse Event|6|||
17144211|NCT03060512|38287755|FG000|Overall Study|Lost to Follow-up|1|||
17144212|NCT03060512|38287756|FG001|Overall Study|Lost to Follow-up|1|||
17144213|NCT03060512|38287755|FG000|Overall Study|Withdrawal by Subject|1|||
17144214|NCT03060512|38287756|FG001|Overall Study|Withdrawal by Subject|0|||
17144215|NCT03060512|38287755|FG000|Overall Study|Non-compliance with study medication|1|||
17144216|NCT03060512|38287756|FG001|Overall Study|Non-compliance with study medication|2|||
17144217|NCT02539160|38287844|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
17144218|NCT02539160|38287845|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
17144219|NCT02539160|38287846|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
17144220|NCT02539160|38287847|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
17144221|NCT02539160|38287844|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
17144222|NCT02539160|38287845|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
17144223|NCT02539160|38287846|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
17144224|NCT02539160|38287847|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
17144225|NCT02539160|38287844|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
17144226|NCT02539160|38287845|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
17144227|NCT02539160|38287846|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
17144228|NCT02539160|38287847|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
17144229|NCT04292899|38287861|FG000|Overall Study|Death|21|||
17144230|NCT04292899|38287862|FG001|Overall Study|Death|28|||
17144231|NCT04292899|38287863|FG002|Overall Study|Death|188|||
17144232|NCT04292899|38287864|FG003|Overall Study|Death|371|||
17144233|NCT04292899|38287861|FG000|Overall Study|Lost to Follow-up|8|||
17144234|NCT04292899|38287862|FG001|Overall Study|Lost to Follow-up|4|||
17144235|NCT04292899|38287863|FG002|Overall Study|Lost to Follow-up|22|||
17144236|NCT04292899|38287864|FG003|Overall Study|Lost to Follow-up|235|||
17144237|NCT04292899|38287861|FG000|Overall Study|Withdrew consent|1|||
17144238|NCT04292899|38287862|FG001|Overall Study|Withdrew consent|0|||
17144239|NCT04292899|38287863|FG002|Overall Study|Withdrew consent|11|||
17144240|NCT04292899|38287864|FG003|Overall Study|Withdrew consent|32|||
17144241|NCT04292899|38287861|FG000|Overall Study|Adverse Event|2|||
17144242|NCT04292899|38287862|FG001|Overall Study|Adverse Event|1|||
17144243|NCT04292899|38287863|FG002|Overall Study|Adverse Event|2|||
17144244|NCT04292899|38287864|FG003|Overall Study|Adverse Event|2|||
17144245|NCT04292899|38287861|FG000|Overall Study|Investigator's Discretion|0|||
17144246|NCT04292899|38287862|FG001|Overall Study|Investigator's Discretion|0|||
17144247|NCT04292899|38287863|FG002|Overall Study|Investigator's Discretion|0|||
17144248|NCT04292899|38287864|FG003|Overall Study|Investigator's Discretion|3|||
17144249|NCT04292899|38287861|FG000|Overall Study|Non-compliance With Study Drug|0|||
17144250|NCT04292899|38287862|FG001|Overall Study|Non-compliance With Study Drug|0|||
17144251|NCT04292899|38287863|FG002|Overall Study|Non-compliance With Study Drug|0|||
17054028|NCT00165841|38197527|FG001|Overall Study|Lost to Follow-up|4|||
17054029|NCT00165841|38197526|FG000|Overall Study|Withdrawal by Subject|7|||
17054030|NCT00165841|38197527|FG001|Overall Study|Withdrawal by Subject|8|||
17054031|NCT00165841|38197526|FG000|Overall Study|Physician Decision|1|||
17054032|NCT00165841|38197527|FG001|Overall Study|Physician Decision|0|||
17054033|NCT00165841|38197526|FG000|Overall Study|Protocol Violation|6|||
17054034|NCT00165841|38197527|FG001|Overall Study|Protocol Violation|8|||
17054035|NCT00165841|38197526|FG000|Overall Study|Other|3|||
17054036|NCT00165841|38197527|FG001|Overall Study|Other|5|||
17054037|NCT00165841|38197526|FG000|Overall Study|Medication Noncompliance|1|||
17054038|NCT00165841|38197527|FG001|Overall Study|Medication Noncompliance|1|||
17054039|NCT00509223|38197535|FG000|Overall Study|Lost to Follow-up|1|||
17054040|NCT00509223|38197536|FG001|Overall Study|Lost to Follow-up|1|||
17054041|NCT00509223|38197535|FG000|Overall Study|Adverse Event|1|||
17144252|NCT04292899|38287864|FG003|Overall Study|Non-compliance With Study Drug|1|||
17144253|NCT04292899|38287861|FG000|Overall Study|Protocol Violation|0|||
17144254|NCT04292899|38287862|FG001|Overall Study|Protocol Violation|0|||
17144255|NCT04292899|38287863|FG002|Overall Study|Protocol Violation|0|||
17144256|NCT04292899|38287864|FG003|Overall Study|Protocol Violation|1|||
17144257|NCT03241173|38287883|FG000|Overall Study|Death|3|||
17054042|NCT00509223|38197536|FG001|Overall Study|Adverse Event|1|||
17054043|NCT00509223|38197535|FG000|Overall Study|Withdrawal by Subject|25|||
17054044|NCT00509223|38197536|FG001|Overall Study|Withdrawal by Subject|6|||
17054045|NCT00509223|38197535|FG000|Overall Study|Including: subject change of address|5|||
17054046|NCT00509223|38197536|FG001|Overall Study|Including: subject change of address|2|||
17054047|NCT00509223|38197535|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
17054048|NCT00509223|38197536|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
17054049|NCT00460798|38197542|FG000|Overall Study|Death|59|||
17054050|NCT00460798|38197542|FG000|Overall Study|Adverse Event|27|||
17054051|NCT00460798|38197542|FG000|Overall Study|Lost to Follow-up|19|||
17054052|NCT00460798|38197542|FG000|Overall Study|Progressive Disease|99|||
17054053|NCT00460798|38197542|FG000|Overall Study|Other|27|||
17054054|NCT00460798|38197542|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
17054055|NCT00460798|38197542|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
17054056|NCT00603980|38197546|FG000|Study Qualification|Protocol Violation|3|||
17054057|NCT00603980|38197546|FG000|Study Qualification|Inconsistent data reporting|13|||
17054058|NCT00603980|38197546|FG000|Main Study|14th subject completed trial|1|||
17054059|NCT00450190|38197566|FG000|Overall Study|Withdrawal by Subject|2|||
16992957|NCT00722371|38136949|FG006|Overall Study|Pregnancy|0|||
16992958|NCT00722371|38136943|FG000|Overall Study|Protocol Violation|6|||
16992959|NCT00722371|38136944|FG001|Overall Study|Protocol Violation|1|||
16992960|NCT00722371|38136945|FG002|Overall Study|Protocol Violation|0|||
17054060|NCT00450112|38197572|FG000|Overall Study|Other Treatment Required|5|||
17054061|NCT00450112|38197573|FG001|Overall Study|Other Treatment Required|1|||
17054062|NCT00450112|38197572|FG000|Overall Study|Withdrawal by Subject|4|||
17054063|NCT00450112|38197573|FG001|Overall Study|Withdrawal by Subject|1|||
17054064|NCT00450112|38197572|FG000|Overall Study|Lost to Follow-up|2|||
17054065|NCT00450112|38197573|FG001|Overall Study|Lost to Follow-up|1|||
17054066|NCT00450112|38197572|FG000|Overall Study|Others|2|||
17054067|NCT00450112|38197573|FG001|Overall Study|Others|3|||
17054068|NCT00449956|38197582|FG000|Overall Study|Adverse Event|7|||
17054069|NCT00449956|38197583|FG001|Overall Study|Adverse Event|1|||
17054070|NCT00449956|38197584|FG002|Overall Study|Adverse Event|6|||
17054071|NCT00449956|38197582|FG000|Overall Study|Lack of Efficacy|0|||
17054072|NCT00449956|38197583|FG001|Overall Study|Lack of Efficacy|0|||
17054073|NCT00449956|38197584|FG002|Overall Study|Lack of Efficacy|1|||
17054074|NCT00449956|38197582|FG000|Overall Study|Protocol Violation|1|||
17054075|NCT00449956|38197583|FG001|Overall Study|Protocol Violation|1|||
17054076|NCT00449956|38197584|FG002|Overall Study|Protocol Violation|1|||
17054077|NCT00449956|38197582|FG000|Overall Study|Withdrawal by Subject|0|||
17054078|NCT00449956|38197583|FG001|Overall Study|Withdrawal by Subject|1|||
17054079|NCT00449956|38197584|FG002|Overall Study|Withdrawal by Subject|0|||
17054080|NCT00449956|38197582|FG000|Overall Study|Physician Decision|2|||
17054081|NCT00449956|38197583|FG001|Overall Study|Physician Decision|1|||
17054082|NCT00449956|38197584|FG002|Overall Study|Physician Decision|1|||
17054083|NCT00509145|38197594|FG000|Overall Study|Death|0|||
17054084|NCT00509145|38197595|FG001|Overall Study|Death|2|||
17054085|NCT00509145|38197594|FG000|Overall Study|Adverse Event|42|||
17054086|NCT00509145|38197595|FG001|Overall Study|Adverse Event|28|||
17054087|NCT00509145|38197594|FG000|Overall Study|Withdrawal by Subject|32|||
17054088|NCT00509145|38197595|FG001|Overall Study|Withdrawal by Subject|38|||
17054089|NCT00509145|38197594|FG000|Overall Study|Physician Decision|11|||
17054090|NCT00509145|38197595|FG001|Overall Study|Physician Decision|14|||
17054091|NCT00509145|38197594|FG000|Overall Study|Protocol Violation|1|||
17054092|NCT00509145|38197595|FG001|Overall Study|Protocol Violation|6|||
17054093|NCT00509145|38197594|FG000|Overall Study|Pregnancy|3|||
17054094|NCT00509145|38197595|FG001|Overall Study|Pregnancy|8|||
17054095|NCT00509145|38197594|FG000|Overall Study|Lost to Follow-up|6|||
17054096|NCT00509145|38197595|FG001|Overall Study|Lost to Follow-up|5|||
17054097|NCT00509145|38197594|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
17054098|NCT00509145|38197595|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
17054099|NCT00509145|38197594|FG000|Overall Study|Other|6|||
17054100|NCT00509145|38197595|FG001|Overall Study|Other|6|||
17054101|NCT00509067|38197603|FG000|Overall Study|Lost to Follow-up|1|||
17054102|NCT00509067|38197604|FG001|Overall Study|Lost to Follow-up|1|||
17054103|NCT00509067|38197603|FG000|Overall Study|Adverse Event|3|||
17054104|NCT00509067|38197604|FG001|Overall Study|Adverse Event|1|||
17054105|NCT00509067|38197603|FG000|Overall Study|Protocol Violation|0|||
17054106|NCT00509067|38197604|FG001|Overall Study|Protocol Violation|3|||
17054107|NCT00504309|38197620|FG000|Overall Study|Death|0|||
17054108|NCT00504309|38197621|FG001|Overall Study|Death|0|||
17054109|NCT00504309|38197622|FG002|Overall Study|Death|0|||
17054110|NCT00504309|38197623|FG003|Overall Study|Death|0|||
17054111|NCT00504309|38197624|FG004|Overall Study|Death|1|||
16992961|NCT00722371|38136946|FG003|Overall Study|Protocol Violation|1|||
16992962|NCT00722371|38136947|FG004|Overall Study|Protocol Violation|4|||
16992963|NCT00722371|38136948|FG005|Overall Study|Protocol Violation|2|||
16992964|NCT00722371|38136949|FG006|Overall Study|Protocol Violation|1|||
16992965|NCT00722371|38136943|FG000|Overall Study|Withdrawal by Subject|18|||
16992966|NCT00722371|38136944|FG001|Overall Study|Withdrawal by Subject|27|||
17054112|NCT00504309|38197625|FG005|Overall Study|Death|0|||
17054113|NCT00504309|38197620|FG000|Overall Study|Withdrawal by Subject|0|||
17054114|NCT00504309|38197621|FG001|Overall Study|Withdrawal by Subject|0|||
17054115|NCT00504309|38197622|FG002|Overall Study|Withdrawal by Subject|1|||
17054116|NCT00504309|38197623|FG003|Overall Study|Withdrawal by Subject|0|||
17144258|NCT03241173|38287884|FG001|Overall Study|Death|2|||
17054117|NCT00504309|38197624|FG004|Overall Study|Withdrawal by Subject|0|||
17054118|NCT00504309|38197625|FG005|Overall Study|Withdrawal by Subject|0|||
17054119|NCT00508755|38197637|FG000|Overall Study|Withdrawal by Subject|1|||
17054120|NCT00504231|38197647|FG000|Overall Study|Discrepant chart documentation re route|0|||
17054121|NCT00504231|38197648|FG001|Overall Study|Discrepant chart documentation re route|0|||
17054122|NCT00504231|38197649|FG002|Overall Study|Discrepant chart documentation re route|1|||
17054123|NCT00504231|38197650|FG003|Overall Study|Discrepant chart documentation re route|0|||
17144259|NCT03241173|38287885|FG002|Overall Study|Death|4|||
17144260|NCT03241173|38287886|FG003|Overall Study|Death|4|||
17144261|NCT03241173|38287887|FG004|Overall Study|Death|2|||
17144262|NCT03241173|38287888|FG005|Overall Study|Death|2|||
17054124|NCT00568178|38197702|FG000|Double Blind Base Study|Adverse Event|0|||
17054125|NCT00568178|38197703|FG001|Double Blind Base Study|Adverse Event|2|||
17054126|NCT00568178|38197704|FG002|Double Blind Base Study|Adverse Event|1|||
17054127|NCT00568178|38197705|FG003|Double Blind Base Study|Adverse Event|2|||
17054128|NCT00568178|38197706|FG004|Double Blind Base Study|Adverse Event|0|||
17054129|NCT00568178|38197707|FG005|Double Blind Base Study|Adverse Event|0|||
17054130|NCT00568178|38197702|FG000|Double Blind Base Study|Lost to Follow-up|1|||
17054131|NCT00568178|38197703|FG001|Double Blind Base Study|Lost to Follow-up|0|||
17054132|NCT00568178|38197704|FG002|Double Blind Base Study|Lost to Follow-up|0|||
17054133|NCT00568178|38197705|FG003|Double Blind Base Study|Lost to Follow-up|1|||
17144263|NCT03241173|38287889|FG006|Overall Study|Death|3|||
17054134|NCT00568178|38197706|FG004|Double Blind Base Study|Lost to Follow-up|0|||
17054135|NCT00568178|38197707|FG005|Double Blind Base Study|Lost to Follow-up|0|||
17054136|NCT00568178|38197702|FG000|Double Blind Base Study|Physician Decision|1|||
17054137|NCT00568178|38197703|FG001|Double Blind Base Study|Physician Decision|1|||
17054138|NCT00568178|38197704|FG002|Double Blind Base Study|Physician Decision|0|||
17054139|NCT00568178|38197705|FG003|Double Blind Base Study|Physician Decision|1|||
17054140|NCT00568178|38197706|FG004|Double Blind Base Study|Physician Decision|0|||
17054141|NCT00568178|38197707|FG005|Double Blind Base Study|Physician Decision|0|||
17054142|NCT00568178|38197702|FG000|Double Blind Base Study|Protocol Violation|3|||
17054143|NCT00568178|38197703|FG001|Double Blind Base Study|Protocol Violation|2|||
17054144|NCT00568178|38197704|FG002|Double Blind Base Study|Protocol Violation|0|||
17054145|NCT00568178|38197705|FG003|Double Blind Base Study|Protocol Violation|0|||
17054146|NCT00568178|38197706|FG004|Double Blind Base Study|Protocol Violation|0|||
17054147|NCT00568178|38197707|FG005|Double Blind Base Study|Protocol Violation|0|||
17054148|NCT00568178|38197702|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
17054149|NCT00568178|38197703|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
17054150|NCT00568178|38197704|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
17054151|NCT00568178|38197705|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
17054152|NCT00568178|38197706|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
17054153|NCT00568178|38197707|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
17054154|NCT00568178|38197702|FG000|Double Blind Base Study|Progressive Disease|0|||
17054155|NCT00568178|38197703|FG001|Double Blind Base Study|Progressive Disease|0|||
17054156|NCT00568178|38197704|FG002|Double Blind Base Study|Progressive Disease|0|||
17054157|NCT00568178|38197705|FG003|Double Blind Base Study|Progressive Disease|1|||
17054158|NCT00568178|38197706|FG004|Double Blind Base Study|Progressive Disease|0|||
17054159|NCT00568178|38197707|FG005|Double Blind Base Study|Progressive Disease|0|||
17054160|NCT00568178|38197702|FG000|Open Label Extension|Adverse Event|0|||
17054161|NCT00568178|38197703|FG001|Open Label Extension|Adverse Event|0|||
17054162|NCT00568178|38197704|FG002|Open Label Extension|Adverse Event|0|||
17054163|NCT00568178|38197705|FG003|Open Label Extension|Adverse Event|0|||
17054164|NCT00568178|38197706|FG004|Open Label Extension|Adverse Event|11|||
17054165|NCT00568178|38197707|FG005|Open Label Extension|Adverse Event|8|||
17054166|NCT00568178|38197702|FG000|Open Label Extension|Protocol Violation|0|||
17054167|NCT00568178|38197703|FG001|Open Label Extension|Protocol Violation|0|||
17054168|NCT00568178|38197704|FG002|Open Label Extension|Protocol Violation|0|||
17054169|NCT00568178|38197705|FG003|Open Label Extension|Protocol Violation|0|||
17054170|NCT00568178|38197706|FG004|Open Label Extension|Protocol Violation|1|||
17054171|NCT00568178|38197707|FG005|Open Label Extension|Protocol Violation|0|||
17054172|NCT00568178|38197702|FG000|Open Label Extension|Lost to Follow-up|0|||
17054173|NCT00568178|38197703|FG001|Open Label Extension|Lost to Follow-up|0|||
17054174|NCT00568178|38197704|FG002|Open Label Extension|Lost to Follow-up|0|||
17144264|NCT03241173|38287890|FG007|Overall Study|Death|1|||
16780966|NCT02174848|37720097|FG001|Overall Study|Withdrawal by Subject|3|||
17054175|NCT00568178|38197705|FG003|Open Label Extension|Lost to Follow-up|0|||
17054176|NCT00568178|38197706|FG004|Open Label Extension|Lost to Follow-up|6|||
17144265|NCT03241173|38287891|FG008|Overall Study|Death|0|||
17054177|NCT00568178|38197707|FG005|Open Label Extension|Lost to Follow-up|11|||
17054178|NCT00568178|38197702|FG000|Open Label Extension|Physician Decision|0|||
17054179|NCT00568178|38197703|FG001|Open Label Extension|Physician Decision|0|||
17054180|NCT00568178|38197704|FG002|Open Label Extension|Physician Decision|0|||
17144266|NCT03241173|38287892|FG009|Overall Study|Death|5|||
17144267|NCT03241173|38287893|FG010|Overall Study|Death|4|||
17144268|NCT03241173|38287894|FG011|Overall Study|Death|3|||
17144269|NCT03241173|38287895|FG012|Overall Study|Death|0|||
17144270|NCT03241173|38287896|FG013|Overall Study|Death|0|||
17144271|NCT03241173|38287897|FG014|Overall Study|Death|0|||
17144272|NCT03241173|38287883|FG000|Overall Study|Withdrawal by Subject|0|||
17144273|NCT03241173|38287884|FG001|Overall Study|Withdrawal by Subject|0|||
17144274|NCT03241173|38287885|FG002|Overall Study|Withdrawal by Subject|1|||
17144275|NCT03241173|38287886|FG003|Overall Study|Withdrawal by Subject|0|||
17144276|NCT03241173|38287887|FG004|Overall Study|Withdrawal by Subject|0|||
17144277|NCT03241173|38287888|FG005|Overall Study|Withdrawal by Subject|1|||
17144278|NCT03241173|38287889|FG006|Overall Study|Withdrawal by Subject|0|||
17144279|NCT03241173|38287890|FG007|Overall Study|Withdrawal by Subject|0|||
17144280|NCT03241173|38287891|FG008|Overall Study|Withdrawal by Subject|0|||
17144281|NCT03241173|38287892|FG009|Overall Study|Withdrawal by Subject|0|||
17144282|NCT03241173|38287893|FG010|Overall Study|Withdrawal by Subject|0|||
17144283|NCT03241173|38287894|FG011|Overall Study|Withdrawal by Subject|0|||
17144284|NCT03241173|38287895|FG012|Overall Study|Withdrawal by Subject|0|||
17144285|NCT03241173|38287896|FG013|Overall Study|Withdrawal by Subject|0|||
17144286|NCT03241173|38287897|FG014|Overall Study|Withdrawal by Subject|0|||
17144287|NCT03241173|38287883|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
17144288|NCT03241173|38287884|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
17144289|NCT03241173|38287885|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
17144290|NCT03241173|38287886|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
17144291|NCT03241173|38287887|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
17144292|NCT03241173|38287888|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
17144293|NCT03241173|38287889|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
17144294|NCT03241173|38287890|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
17144295|NCT03241173|38287891|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
17144296|NCT03241173|38287892|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
17144297|NCT03241173|38287893|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
17144298|NCT03241173|38287894|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
17144299|NCT03241173|38287895|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
17144300|NCT03241173|38287896|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
17144301|NCT03241173|38287897|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
17144302|NCT03241173|38287883|FG000|Overall Study|Lost to Follow-up|0|||
17144303|NCT03241173|38287884|FG001|Overall Study|Lost to Follow-up|0|||
17144304|NCT03241173|38287885|FG002|Overall Study|Lost to Follow-up|0|||
17144305|NCT03241173|38287886|FG003|Overall Study|Lost to Follow-up|0|||
17144306|NCT03241173|38287887|FG004|Overall Study|Lost to Follow-up|1|||
17144307|NCT03241173|38287888|FG005|Overall Study|Lost to Follow-up|0|||
17144308|NCT03241173|38287889|FG006|Overall Study|Lost to Follow-up|0|||
17144309|NCT03241173|38287890|FG007|Overall Study|Lost to Follow-up|0|||
17144310|NCT03241173|38287891|FG008|Overall Study|Lost to Follow-up|0|||
17144311|NCT03241173|38287892|FG009|Overall Study|Lost to Follow-up|1|||
17144312|NCT03241173|38287893|FG010|Overall Study|Lost to Follow-up|0|||
17144313|NCT03241173|38287894|FG011|Overall Study|Lost to Follow-up|0|||
17144314|NCT03241173|38287895|FG012|Overall Study|Lost to Follow-up|0|||
17144315|NCT03241173|38287896|FG013|Overall Study|Lost to Follow-up|0|||
17144316|NCT03241173|38287897|FG014|Overall Study|Lost to Follow-up|0|||
17144317|NCT03264066|38287931|FG000|Overall Study|Adverse Event|1|||
17144318|NCT03264066|38287932|FG001|Overall Study|Adverse Event|1|||
17144319|NCT03264066|38287933|FG002|Overall Study|Adverse Event|0|||
17144320|NCT03264066|38287934|FG003|Overall Study|Adverse Event|0|||
17144321|NCT03264066|38287935|FG004|Overall Study|Adverse Event|0|||
17144322|NCT03264066|38287936|FG005|Overall Study|Adverse Event|0|||
17144323|NCT03264066|38287931|FG000|Overall Study|Death|12|||
17144324|NCT03264066|38287932|FG001|Overall Study|Death|12|||
17054181|NCT00568178|38197705|FG003|Open Label Extension|Physician Decision|0|||
17054182|NCT00568178|38197706|FG004|Open Label Extension|Physician Decision|9|||
17054183|NCT00568178|38197707|FG005|Open Label Extension|Physician Decision|8|||
17054184|NCT00568178|38197702|FG000|Open Label Extension|Pregnancy|0|||
17144325|NCT03264066|38287933|FG002|Overall Study|Death|8|||
17144326|NCT03264066|38287934|FG003|Overall Study|Death|10|||
17144327|NCT03264066|38287935|FG004|Overall Study|Death|6|||
17144328|NCT03264066|38287936|FG005|Overall Study|Death|1|||
17144329|NCT03264066|38287931|FG000|Overall Study|Lost to Follow-up|1|||
17144330|NCT03264066|38287932|FG001|Overall Study|Lost to Follow-up|0|||
17054185|NCT00568178|38197703|FG001|Open Label Extension|Pregnancy|0|||
17054186|NCT00568178|38197704|FG002|Open Label Extension|Pregnancy|0|||
17054187|NCT00568178|38197705|FG003|Open Label Extension|Pregnancy|0|||
17054188|NCT00568178|38197706|FG004|Open Label Extension|Pregnancy|0|||
17054189|NCT00568178|38197707|FG005|Open Label Extension|Pregnancy|1|||
17054190|NCT00568178|38197702|FG000|Open Label Extension|Progressive Disease|0|||
17054191|NCT00568178|38197703|FG001|Open Label Extension|Progressive Disease|0|||
17054192|NCT00568178|38197704|FG002|Open Label Extension|Progressive Disease|0|||
17054193|NCT00568178|38197705|FG003|Open Label Extension|Progressive Disease|0|||
17054194|NCT00568178|38197706|FG004|Open Label Extension|Progressive Disease|3|||
17054195|NCT00568178|38197707|FG005|Open Label Extension|Progressive Disease|1|||
17054196|NCT00568178|38197702|FG000|Open Label Extension|Termination of Trial|0|||
17054197|NCT00568178|38197703|FG001|Open Label Extension|Termination of Trial|0|||
17054198|NCT00568178|38197704|FG002|Open Label Extension|Termination of Trial|0|||
17054199|NCT00568178|38197705|FG003|Open Label Extension|Termination of Trial|0|||
17054200|NCT00568178|38197706|FG004|Open Label Extension|Termination of Trial|45|||
17054201|NCT00568178|38197707|FG005|Open Label Extension|Termination of Trial|47|||
17054202|NCT00568178|38197702|FG000|Open Label Extension|Withdrawal by Subject|0|||
17054203|NCT00568178|38197703|FG001|Open Label Extension|Withdrawal by Subject|0|||
17054204|NCT00568178|38197704|FG002|Open Label Extension|Withdrawal by Subject|0|||
17054205|NCT00568178|38197705|FG003|Open Label Extension|Withdrawal by Subject|0|||
17054206|NCT00568178|38197706|FG004|Open Label Extension|Withdrawal by Subject|4|||
17054207|NCT00568178|38197707|FG005|Open Label Extension|Withdrawal by Subject|4|||
17054208|NCT00577889|38197724|FG000|Overall Study|Withdrawal by Subject|1|||
17054209|NCT00577889|38197725|FG001|Overall Study|Withdrawal by Subject|0|||
17054210|NCT00577889|38197726|FG002|Overall Study|Withdrawal by Subject|0|||
17054211|NCT00460564|38197738|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
17054212|NCT00460564|38197739|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
17054213|NCT00460564|38197740|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17054214|NCT00460564|38197741|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17054215|NCT00460564|38197742|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17054216|NCT00460564|38197743|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17054217|NCT00460564|38197744|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17054218|NCT00460564|38197745|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17054219|NCT00460564|38197738|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
17054220|NCT00460564|38197739|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17054221|NCT00460564|38197740|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17054222|NCT00460564|38197741|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17054223|NCT00460564|38197742|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17054224|NCT00460564|38197743|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17054225|NCT00460564|38197744|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17054226|NCT00460564|38197745|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17054227|NCT00460564|38197738|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
17054228|NCT00460564|38197739|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
17054229|NCT00460564|38197740|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
17054230|NCT00460564|38197741|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
17054231|NCT00460564|38197742|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
17054232|NCT00460564|38197743|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
17054233|NCT00460564|38197744|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
17054234|NCT00460564|38197745|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
17054235|NCT00460564|38197738|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
17054236|NCT00460564|38197739|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
17054237|NCT00460564|38197740|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
17054238|NCT00460564|38197741|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
17054239|NCT00460564|38197742|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
17054240|NCT00460564|38197743|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
17054241|NCT00460564|38197744|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
17054242|NCT00460564|38197745|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
17054243|NCT00460564|38197738|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
17054244|NCT00460564|38197739|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
17054245|NCT00460564|38197740|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
17054246|NCT00460564|38197741|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
17054247|NCT00460564|38197742|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
17054248|NCT00460564|38197743|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
17054249|NCT00460564|38197744|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
17054250|NCT00460564|38197745|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
17054251|NCT00567476|38197767|FG000|Overall Study|Adverse Event|2|||
17054252|NCT00567476|38197768|FG001|Overall Study|Adverse Event|0|||
17054253|NCT00567476|38197767|FG000|Overall Study|Pregnancy|1|||
17054254|NCT00567476|38197768|FG001|Overall Study|Pregnancy|0|||
17054255|NCT00567476|38197767|FG000|Overall Study|Protocol Violation|4|||
17054256|NCT00567476|38197768|FG001|Overall Study|Protocol Violation|1|||
17054257|NCT00567476|38197767|FG000|Overall Study|Lost to Follow-up|0|||
17054258|NCT00567476|38197768|FG001|Overall Study|Lost to Follow-up|1|||
17054259|NCT00567476|38197767|FG000|Overall Study|Administrative issues|1|||
17054260|NCT00567476|38197768|FG001|Overall Study|Administrative issues|0|||
17054261|NCT00567476|38197767|FG000|Overall Study|Medical Decision|0|||
17054262|NCT00567476|38197768|FG001|Overall Study|Medical Decision|1|||
17054263|NCT00567476|38197767|FG000|Overall Study|Non-adherence to protocol|0|||
17054264|NCT00567476|38197768|FG001|Overall Study|Non-adherence to protocol|1|||
17054265|NCT00516321|38197776|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
17054266|NCT00516321|38197777|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
17054267|NCT00516321|38197778|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
17054268|NCT00516321|38197776|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
17054269|NCT00516321|38197777|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
17054270|NCT00516321|38197778|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
17054271|NCT00516321|38197776|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
17054272|NCT00516321|38197777|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
17054273|NCT00516321|38197778|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
17054274|NCT00516321|38197776|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
17054275|NCT00516321|38197777|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
17054276|NCT00516321|38197778|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
17054277|NCT00516321|38197776|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
17054278|NCT00516321|38197777|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
17054279|NCT00516321|38197778|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
17054280|NCT00516321|38197776|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
17054281|NCT00516321|38197777|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
17054282|NCT00516321|38197778|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
17054283|NCT00516321|38197776|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
17054284|NCT00516321|38197777|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
17054285|NCT00516321|38197778|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
17054286|NCT00516321|38197776|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
17054287|NCT00516321|38197777|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
17054288|NCT00516321|38197778|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
17054289|NCT00516321|38197776|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
17054290|NCT00516321|38197777|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
17054291|NCT00516321|38197778|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
17054292|NCT00516321|38197776|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
17054293|NCT00516321|38197777|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
17054294|NCT00516321|38197778|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
17054295|NCT00516321|38197776|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
17054296|NCT00516321|38197777|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
17054297|NCT00516321|38197778|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
17054298|NCT00460408|38197790|FG000|Overall Study|Adverse Event|1|||
17054299|NCT00460408|38197791|FG001|Overall Study|Adverse Event|0|||
17054300|NCT00460408|38197792|FG002|Overall Study|Adverse Event|0|||
17054301|NCT00460408|38197793|FG003|Overall Study|Adverse Event|0|||
17054302|NCT00460408|38197790|FG000|Overall Study|Death|7|||
17054303|NCT00460408|38197791|FG001|Overall Study|Death|0|||
17054304|NCT00460408|38197792|FG002|Overall Study|Death|0|||
17054305|NCT00460408|38197793|FG003|Overall Study|Death|0|||
17054306|NCT00460408|38197790|FG000|Overall Study|Lost to Follow-up|11|||
17054307|NCT00460408|38197791|FG001|Overall Study|Lost to Follow-up|0|||
17054308|NCT00460408|38197792|FG002|Overall Study|Lost to Follow-up|1|||
17054309|NCT00460408|38197793|FG003|Overall Study|Lost to Follow-up|0|||
17054310|NCT00460408|38197790|FG000|Overall Study|Withdrawal by Subject|31|||
17054311|NCT00460408|38197791|FG001|Overall Study|Withdrawal by Subject|0|||
17054312|NCT00460408|38197792|FG002|Overall Study|Withdrawal by Subject|0|||
17054313|NCT00460408|38197793|FG003|Overall Study|Withdrawal by Subject|0|||
17054314|NCT00460408|38197790|FG000|Overall Study|Insufficient clinical response|5|||
17054315|NCT00460408|38197791|FG001|Overall Study|Insufficient clinical response|1|||
17054316|NCT00460408|38197792|FG002|Overall Study|Insufficient clinical response|5|||
17054317|NCT00460408|38197793|FG003|Overall Study|Insufficient clinical response|0|||
17054318|NCT00460408|38197790|FG000|Overall Study|Other|12|||
17054319|NCT00460408|38197791|FG001|Overall Study|Other|2|||
17054320|NCT00460408|38197792|FG002|Overall Study|Other|0|||
17054321|NCT00460408|38197793|FG003|Overall Study|Other|0|||
17054322|NCT00507819|38197803|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
17054323|NCT00507819|38197804|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
17054324|NCT00442936|38197834|FG000|Overall Study|Protocol Violation|1|||
17054325|NCT00442936|38197835|FG001|Overall Study|Protocol Violation|0|||
17054326|NCT00442936|38197836|FG002|Overall Study|Protocol Violation|1|||
17054327|NCT00442936|38197837|FG003|Overall Study|Protocol Violation|1|||
17054328|NCT00577655|38197849|FG000|Overall Study|Patient Request|0|||
17054329|NCT00577655|38197850|FG001|Overall Study|Patient Request|2|||
17054330|NCT00577655|38197849|FG000|Overall Study|Protocol Violation|0|||
17054331|NCT00577655|38197850|FG001|Overall Study|Protocol Violation|1|||
17054332|NCT00577655|38197849|FG000|Overall Study|Lost to Follow-up|1|||
17054333|NCT00577655|38197850|FG001|Overall Study|Lost to Follow-up|1|||
17054334|NCT00113269|38197861|FG000|Overall Study|Not transplanted, donor issues|4|||
17054335|NCT00113269|38197862|FG001|Overall Study|Not transplanted, donor issues|0|||
17054336|NCT00113269|38197863|FG002|Overall Study|Not transplanted, donor issues|2|||
17054337|NCT00113269|38197864|FG003|Overall Study|Not transplanted, donor issues|2|||
17054338|NCT00113269|38197861|FG000|Overall Study|Not transplanted, recipient issues|2|||
17054339|NCT00113269|38197862|FG001|Overall Study|Not transplanted, recipient issues|1|||
17054340|NCT00113269|38197863|FG002|Overall Study|Not transplanted, recipient issues|7|||
17054341|NCT00113269|38197864|FG003|Overall Study|Not transplanted, recipient issues|4|||
17054342|NCT00113269|38197861|FG000|Overall Study|Early graft loss, technical|0|||
17054343|NCT00113269|38197862|FG001|Overall Study|Early graft loss, technical|0|||
17054344|NCT00113269|38197863|FG002|Overall Study|Early graft loss, technical|2|||
17054345|NCT00113269|38197864|FG003|Overall Study|Early graft loss, technical|0|||
17054346|NCT00113269|38197861|FG000|Overall Study|Death in operating room|0|||
17054347|NCT00113269|38197862|FG001|Overall Study|Death in operating room|0|||
17054348|NCT00113269|38197863|FG002|Overall Study|Death in operating room|0|||
17054349|NCT00113269|38197864|FG003|Overall Study|Death in operating room|1|||
17054350|NCT00113269|38197861|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
17054351|NCT00113269|38197862|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
17054352|NCT00113269|38197863|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
17054353|NCT00113269|38197864|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
17054354|NCT00113269|38197861|FG000|Overall Study|Adverse Event|2|||
17054355|NCT00113269|38197862|FG001|Overall Study|Adverse Event|7|||
17054356|NCT00113269|38197863|FG002|Overall Study|Adverse Event|11|||
17054357|NCT00113269|38197864|FG003|Overall Study|Adverse Event|7|||
17054358|NCT00113269|38197861|FG000|Overall Study|Withdrawal by Subject|4|||
17054359|NCT00113269|38197862|FG001|Overall Study|Withdrawal by Subject|3|||
17054360|NCT00113269|38197863|FG002|Overall Study|Withdrawal by Subject|4|||
17054361|NCT00113269|38197864|FG003|Overall Study|Withdrawal by Subject|2|||
17054362|NCT00113269|38197861|FG000|Overall Study|Graft loss|6|||
17054363|NCT00113269|38197862|FG001|Overall Study|Graft loss|6|||
17054364|NCT00113269|38197863|FG002|Overall Study|Graft loss|4|||
17054365|NCT00113269|38197864|FG003|Overall Study|Graft loss|9|||
17054366|NCT00113269|38197861|FG000|Overall Study|Protocol Violation|1|||
17054367|NCT00113269|38197862|FG001|Overall Study|Protocol Violation|0|||
17054368|NCT00113269|38197863|FG002|Overall Study|Protocol Violation|4|||
17054369|NCT00113269|38197864|FG003|Overall Study|Protocol Violation|2|||
17054370|NCT00113269|38197861|FG000|Overall Study|Lost to Follow-up|2|||
17054371|NCT00113269|38197862|FG001|Overall Study|Lost to Follow-up|3|||
17054372|NCT00113269|38197863|FG002|Overall Study|Lost to Follow-up|6|||
17144331|NCT03264066|38287933|FG002|Overall Study|Lost to Follow-up|0|||
17144332|NCT03264066|38287934|FG003|Overall Study|Lost to Follow-up|0|||
17144333|NCT03264066|38287935|FG004|Overall Study|Lost to Follow-up|0|||
17144334|NCT03264066|38287936|FG005|Overall Study|Lost to Follow-up|0|||
17144335|NCT03264066|38287931|FG000|Overall Study|Progressive Disease|0|||
17144336|NCT03264066|38287932|FG001|Overall Study|Progressive Disease|2|||
17144337|NCT03264066|38287933|FG002|Overall Study|Progressive Disease|1|||
17144338|NCT03264066|38287934|FG003|Overall Study|Progressive Disease|0|||
17144339|NCT03264066|38287935|FG004|Overall Study|Progressive Disease|0|||
17144340|NCT03264066|38287936|FG005|Overall Study|Progressive Disease|0|||
17144341|NCT03264066|38287931|FG000|Overall Study|Study Terminated by Sponsor|5|||
17144342|NCT03264066|38287932|FG001|Overall Study|Study Terminated by Sponsor|5|||
17144343|NCT03264066|38287933|FG002|Overall Study|Study Terminated by Sponsor|8|||
17144344|NCT03264066|38287934|FG003|Overall Study|Study Terminated by Sponsor|5|||
17144345|NCT03264066|38287935|FG004|Overall Study|Study Terminated by Sponsor|1|||
17144346|NCT03264066|38287936|FG005|Overall Study|Study Terminated by Sponsor|2|||
17144347|NCT03264066|38287931|FG000|Overall Study|Withdrawal by Subject|1|||
17144348|NCT03264066|38287932|FG001|Overall Study|Withdrawal by Subject|0|||
17144349|NCT03264066|38287933|FG002|Overall Study|Withdrawal by Subject|0|||
17144350|NCT03264066|38287934|FG003|Overall Study|Withdrawal by Subject|5|||
17144351|NCT03264066|38287935|FG004|Overall Study|Withdrawal by Subject|0|||
17144352|NCT03264066|38287936|FG005|Overall Study|Withdrawal by Subject|0|||
17144353|NCT03759041|38287954|FG000|Overall Study|Withdrawal by Subject|4|||
17144354|NCT03759041|38287955|FG001|Overall Study|Withdrawal by Subject|10|||
17054373|NCT00113269|38197864|FG003|Overall Study|Lost to Follow-up|3|||
17054374|NCT00113269|38197861|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
17144355|NCT03759041|38287956|FG002|Overall Study|Withdrawal by Subject|10|||
17144356|NCT03759041|38287954|FG000|Overall Study|Adverse Event|1|||
17144357|NCT03759041|38287955|FG001|Overall Study|Adverse Event|3|||
17144358|NCT03759041|38287956|FG002|Overall Study|Adverse Event|4|||
17144359|NCT03759041|38287954|FG000|Overall Study|Lack of Efficacy|0|||
17144360|NCT03759041|38287955|FG001|Overall Study|Lack of Efficacy|0|||
17144361|NCT03759041|38287956|FG002|Overall Study|Lack of Efficacy|1|||
17144362|NCT03759041|38287954|FG000|Overall Study|Study Terminated by Sponsor|15|||
17144363|NCT03759041|38287955|FG001|Overall Study|Study Terminated by Sponsor|16|||
17144364|NCT03759041|38287956|FG002|Overall Study|Study Terminated by Sponsor|10|||
17144365|NCT03759041|38287954|FG000|Overall Study|Other reason for discontinuation|0|||
17144366|NCT03759041|38287955|FG001|Overall Study|Other reason for discontinuation|2|||
17144367|NCT03759041|38287956|FG002|Overall Study|Other reason for discontinuation|1|||
17144368|NCT03759041|38287954|FG000|Overall Study|Lost to Follow-up|7|||
17144369|NCT03759041|38287955|FG001|Overall Study|Lost to Follow-up|2|||
17144370|NCT03759041|38287956|FG002|Overall Study|Lost to Follow-up|2|||
17144371|NCT03759041|38287954|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
17144372|NCT03759041|38287955|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
17144373|NCT03759041|38287956|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
17144374|NCT04110145|38287969|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
17144375|NCT04110145|38287970|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
17144376|NCT04110145|38287971|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
17144377|NCT04110145|38287972|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
17144378|NCT04110145|38287973|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
17144379|NCT02477618|38287987|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
17144380|NCT02477618|38287988|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
17144381|NCT02477618|38287987|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
17144382|NCT02477618|38287988|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
17144383|NCT02477618|38287987|FG000|Overall Study|Adverse Event|1|||
17054375|NCT00113269|38197862|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
17054376|NCT00113269|38197863|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
17054377|NCT00113269|38197864|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
17054378|NCT00113269|38197861|FG000|Overall Study|Discontinued due to rejection|0|||
17054379|NCT00113269|38197862|FG001|Overall Study|Discontinued due to rejection|0|||
17054380|NCT00113269|38197863|FG002|Overall Study|Discontinued due to rejection|1|||
17054381|NCT00113269|38197864|FG003|Overall Study|Discontinued due to rejection|0|||
17054382|NCT00113269|38197861|FG000|Overall Study|Moved|0|||
17054383|NCT00113269|38197862|FG001|Overall Study|Moved|1|||
17054384|NCT00113269|38197863|FG002|Overall Study|Moved|0|||
17054385|NCT00113269|38197864|FG003|Overall Study|Moved|3|||
17054386|NCT00113269|38197861|FG000|Overall Study|Received pancreas transplant|0|||
17054387|NCT00113269|38197862|FG001|Overall Study|Received pancreas transplant|0|||
17054388|NCT00113269|38197863|FG002|Overall Study|Received pancreas transplant|0|||
17054389|NCT00113269|38197864|FG003|Overall Study|Received pancreas transplant|2|||
17054390|NCT00113269|38197861|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
17054391|NCT00113269|38197862|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
17054392|NCT00113269|38197863|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
17054393|NCT00113269|38197864|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
17054394|NCT00113269|38197861|FG000|Overall Study|Did not meet eligibility criteria|1|||
17054395|NCT00113269|38197862|FG001|Overall Study|Did not meet eligibility criteria|0|||
17054396|NCT00113269|38197863|FG002|Overall Study|Did not meet eligibility criteria|0|||
17054397|NCT00113269|38197864|FG003|Overall Study|Did not meet eligibility criteria|1|||
17054398|NCT00113269|38197861|FG000|Overall Study|Unable to return for follow up|2|||
17054399|NCT00113269|38197862|FG001|Overall Study|Unable to return for follow up|1|||
17054400|NCT00113269|38197863|FG002|Overall Study|Unable to return for follow up|0|||
17054401|NCT00113269|38197864|FG003|Overall Study|Unable to return for follow up|0|||
17054402|NCT00515619|38197874|FG000|Overall Study|Adverse Event|34|||
17054403|NCT00515619|38197874|FG000|Overall Study|Lack of Efficacy|92|||
17054404|NCT00515619|38197874|FG000|Overall Study|Withdrawal by Subject|66|||
17054405|NCT00515619|38197874|FG000|Overall Study|Protocol Violation|3|||
17054406|NCT00515619|38197874|FG000|Overall Study|Lost to Follow-up|4|||
17054407|NCT00515619|38197874|FG000|Overall Study|Unsatisfactory compliance|6|||
17054408|NCT00515619|38197874|FG000|Overall Study|Other: Site discontinuing trials|2|||
17054409|NCT00515619|38197874|FG000|Overall Study|Other: Subject cannot attend visits|2|||
17054410|NCT00515619|38197874|FG000|Overall Study|Other: Subject required surgery|1|||
17054411|NCT00515619|38197874|FG000|Overall Study|Other: Subject moved to another country|1|||
17054412|NCT00515619|38197874|FG000|Overall Study|Other: Investigator decision|1|||
17054413|NCT00515619|38197874|FG000|Overall Study|Other: Subject became pregnant|1|||
17054414|NCT00515619|38197874|FG000|Overall Study|Other: Request from sponsor|1|||
17054415|NCT00515619|38197874|FG000|Overall Study|Other: Drug available on license|1|||
17054416|NCT00515619|38197874|FG000|Overall Study|Other: Subject interested in other AED|1|||
17054417|NCT00449644|38197882|FG000|Overall Study|Adverse Event|0|||
17054418|NCT00449644|38197883|FG001|Overall Study|Adverse Event|0|||
17054419|NCT00449644|38197884|FG002|Overall Study|Adverse Event|3|||
17054420|NCT00449644|38197885|FG003|Overall Study|Adverse Event|5|||
17054421|NCT00449644|38197882|FG000|Overall Study|Death|1|||
17054422|NCT00449644|38197883|FG001|Overall Study|Death|0|||
17054423|NCT00449644|38197884|FG002|Overall Study|Death|6|||
17054424|NCT00449644|38197885|FG003|Overall Study|Death|1|||
17054425|NCT00449644|38197882|FG000|Overall Study|Lost to Follow-up|1|||
17054426|NCT00449644|38197883|FG001|Overall Study|Lost to Follow-up|1|||
17054427|NCT00449644|38197884|FG002|Overall Study|Lost to Follow-up|5|||
17054428|NCT00449644|38197885|FG003|Overall Study|Lost to Follow-up|3|||
17054429|NCT00449644|38197882|FG000|Overall Study|Pregnancy|0|||
17054430|NCT00449644|38197883|FG001|Overall Study|Pregnancy|0|||
17054431|NCT00449644|38197884|FG002|Overall Study|Pregnancy|3|||
17054432|NCT00449644|38197885|FG003|Overall Study|Pregnancy|2|||
17054433|NCT00449644|38197882|FG000|Overall Study|Protocol Violation|4|||
17054434|NCT00449644|38197883|FG001|Overall Study|Protocol Violation|4|||
17054435|NCT00449644|38197884|FG002|Overall Study|Protocol Violation|3|||
17054436|NCT00449644|38197885|FG003|Overall Study|Protocol Violation|7|||
17054437|NCT00449644|38197882|FG000|Overall Study|Withdrawal by Subject|3|||
17054438|NCT00449644|38197883|FG001|Overall Study|Withdrawal by Subject|4|||
17054439|NCT00449644|38197884|FG002|Overall Study|Withdrawal by Subject|6|||
17054440|NCT00449644|38197885|FG003|Overall Study|Withdrawal by Subject|7|||
17054441|NCT00449644|38197882|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
17054442|NCT00449644|38197883|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
17054443|NCT00449644|38197884|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
17054444|NCT00449644|38197885|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
17054445|NCT00449644|38197882|FG000|Overall Study|Other|1|||
17054446|NCT00449644|38197883|FG001|Overall Study|Other|4|||
17054447|NCT00449644|38197884|FG002|Overall Study|Other|1|||
17054448|NCT00449644|38197885|FG003|Overall Study|Other|0|||
17054449|NCT00449644|38197882|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
17054450|NCT00449644|38197883|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
17054451|NCT00449644|38197884|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
17054452|NCT00449644|38197885|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
17054453|NCT00515541|38197902|FG000|Overall Study|Physician Decision|0|||
17054454|NCT00515541|38197903|FG001|Overall Study|Physician Decision|2|||
17054455|NCT00515541|38197904|FG002|Overall Study|Physician Decision|0|||
17054456|NCT00515541|38197905|FG003|Overall Study|Physician Decision|1|||
17054457|NCT00515541|38197902|FG000|Overall Study|No show for appointments|0|||
17054458|NCT00515541|38197903|FG001|Overall Study|No show for appointments|1|||
17054459|NCT00515541|38197904|FG002|Overall Study|No show for appointments|0|||
17054460|NCT00515541|38197905|FG003|Overall Study|No show for appointments|2|||
17054461|NCT00515541|38197902|FG000|Overall Study|Withdrawal by Subject|0|||
17054462|NCT00515541|38197903|FG001|Overall Study|Withdrawal by Subject|2|||
17054463|NCT00515541|38197904|FG002|Overall Study|Withdrawal by Subject|0|||
17054464|NCT00515541|38197905|FG003|Overall Study|Withdrawal by Subject|2|||
17054465|NCT00112489|38197915|FG000|Overall Study|Refused further treatment|8|||
17054466|NCT00112489|38197915|FG000|Overall Study|Adverse Event|12|||
17054467|NCT00112489|38197915|FG000|Overall Study|Death|2|||
17054468|NCT00112489|38197915|FG000|Overall Study|Other, Not Specified|9|||
17054469|NCT00112489|38197915|FG000|Overall Study|Patient never treated|2|||
17054470|NCT00112489|38197915|FG000|Overall Study|Ineligible|7|||
17054471|NCT00711971|38197928|FG000|Overall Study|Lost to Follow-up|3|||
17054472|NCT00711971|38197929|FG001|Overall Study|Lost to Follow-up|4|||
17054473|NCT00711971|38197930|FG002|Overall Study|Lost to Follow-up|1|||
17054474|NCT00515463|38197944|FG000|Overall Study|Physician Decision|4|||
17054475|NCT00515463|38197945|FG001|Overall Study|Physician Decision|2|||
17054476|NCT00515463|38197944|FG000|Overall Study|Adverse Event|1|||
17054477|NCT00515463|38197945|FG001|Overall Study|Adverse Event|2|||
17054478|NCT00515463|38197944|FG000|Overall Study|Withdrawal by Subject|3|||
17054479|NCT00515463|38197945|FG001|Overall Study|Withdrawal by Subject|4|||
17054480|NCT00515463|38197944|FG000|Overall Study|Lost to Follow-up|6|||
17054481|NCT00515463|38197945|FG001|Overall Study|Lost to Follow-up|5|||
17054482|NCT00515463|38197944|FG000|Overall Study|Other|0|||
17054483|NCT00515463|38197945|FG001|Overall Study|Other|1|||
17054484|NCT00507507|38197954|FG000|Treatment Period|Lost to Follow-up|0|||
17054485|NCT00507507|38197955|FG001|Treatment Period|Lost to Follow-up|2|||
17054486|NCT00507507|38197954|FG000|Treatment Period|Physician Decision|4|||
17054487|NCT00507507|38197955|FG001|Treatment Period|Physician Decision|1|||
17054488|NCT00507507|38197954|FG000|Treatment Period|Protocol Violation|1|||
17054489|NCT00507507|38197955|FG001|Treatment Period|Protocol Violation|2|||
17054490|NCT00507507|38197954|FG000|Treatment Period|Adverse Event|1|||
17054491|NCT00507507|38197955|FG001|Treatment Period|Adverse Event|1|||
17054492|NCT00507507|38197954|FG000|Treatment Period|Withdrawal by Subject|46|||
17054493|NCT00507507|38197955|FG001|Treatment Period|Withdrawal by Subject|47|||
17054494|NCT00507507|38197954|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
17054495|NCT00507507|38197955|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
17054496|NCT00507507|38197954|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
17054497|NCT00507507|38197955|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
17054498|NCT00507507|38197954|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
17054499|NCT00507507|38197955|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
17054500|NCT00459706|38197965|FG000|Overall Study|Adverse Event|19|||
17054501|NCT00459706|38197966|FG001|Overall Study|Adverse Event|13|||
17054502|NCT00459706|38197965|FG000|Overall Study|Withdrawal by Subject|1|||
17054503|NCT00459706|38197966|FG001|Overall Study|Withdrawal by Subject|6|||
17054504|NCT00459706|38197965|FG000|Overall Study|Physician Decision|2|||
17054505|NCT00459706|38197966|FG001|Overall Study|Physician Decision|0|||
17054506|NCT00459706|38197965|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
17054507|NCT00459706|38197966|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
17054508|NCT00459706|38197965|FG000|Overall Study|Protocol Violation|2|||
17054509|NCT00459706|38197966|FG001|Overall Study|Protocol Violation|1|||
17054510|NCT00459706|38197965|FG000|Overall Study|Failed to Return|1|||
17054511|NCT00459706|38197966|FG001|Overall Study|Failed to Return|0|||
17054512|NCT00459706|38197965|FG000|Overall Study|Other|0|||
17054513|NCT00459706|38197966|FG001|Overall Study|Other|1|||
17054514|NCT00507429|38197974|FG000|Treatment Phase|Disease Progression|12|||
17054515|NCT00507429|38197975|FG001|Treatment Phase|Disease Progression|5|||
17054516|NCT00507429|38197974|FG000|Treatment Phase|Adverse Event|12|||
16780967|NCT02174848|37720096|FG000|Overall Study|Lost to Follow-up|0|||
17054517|NCT00507429|38197975|FG001|Treatment Phase|Adverse Event|5|||
17054518|NCT00507429|38197974|FG000|Treatment Phase|Withdrawal by Subject|3|||
17054519|NCT00507429|38197975|FG001|Treatment Phase|Withdrawal by Subject|3|||
17144384|NCT02477618|38287988|FG001|Overall Study|Adverse Event|1|||
17054520|NCT00507429|38197974|FG000|Treatment Phase|Physician Decision|4|||
17054521|NCT00507429|38197975|FG001|Treatment Phase|Physician Decision|2|||
17054522|NCT00507429|38197974|FG000|Treatment Phase|Other|6|||
17054523|NCT00507429|38197975|FG001|Treatment Phase|Other|3|||
17054524|NCT00507429|38197974|FG000|Maintenance Phase|Progressive Disease|14|||
17054525|NCT00507429|38197975|FG001|Maintenance Phase|Progressive Disease|0|||
17054526|NCT00449176|38197986|FG000|Overall Study|Withdrawal by Subject|39|||
17054527|NCT00449176|38197987|FG001|Overall Study|Withdrawal by Subject|43|||
17054528|NCT00449176|38197988|FG002|Overall Study|Withdrawal by Subject|59|||
17054529|NCT00449176|38197986|FG000|Overall Study|Lost to Follow-up|13|||
17054530|NCT00449176|38197987|FG001|Overall Study|Lost to Follow-up|8|||
17054531|NCT00449176|38197988|FG002|Overall Study|Lost to Follow-up|12|||
17054532|NCT00449176|38197986|FG000|Overall Study|Adverse Event|51|||
17054533|NCT00449176|38197987|FG001|Overall Study|Adverse Event|107|||
17054534|NCT00449176|38197988|FG002|Overall Study|Adverse Event|15|||
17054535|NCT00449176|38197986|FG000|Overall Study|Lack of Efficacy|13|||
17054536|NCT00449176|38197987|FG001|Overall Study|Lack of Efficacy|7|||
17054537|NCT00449176|38197988|FG002|Overall Study|Lack of Efficacy|50|||
17054538|NCT00449176|38197986|FG000|Overall Study|Study drug non-compliant|14|||
17054539|NCT00449176|38197987|FG001|Overall Study|Study drug non-compliant|11|||
17054540|NCT00449176|38197988|FG002|Overall Study|Study drug non-compliant|11|||
17054541|NCT00449176|38197986|FG000|Overall Study|all other|22|||
17054542|NCT00449176|38197987|FG001|Overall Study|all other|19|||
17054543|NCT00449176|38197988|FG002|Overall Study|all other|20|||
17054544|NCT00515073|38197996|FG000|Overall Study|Withdrawal by Subject|1|||
17054545|NCT00515073|38197996|FG000|Overall Study|Physician Decision|1|||
17054546|NCT00710021|38198003|FG000|Overall Study|Lost to Follow-up|1|||
17054547|NCT00710021|38198004|FG001|Overall Study|Lost to Follow-up|0|||
17054548|NCT00710021|38198005|FG002|Overall Study|Lost to Follow-up|0|||
17054549|NCT00710021|38198003|FG000|Overall Study|Subject's Decision|0|||
17054550|NCT00710021|38198004|FG001|Overall Study|Subject's Decision|1|||
17054551|NCT00710021|38198005|FG002|Overall Study|Subject's Decision|0|||
17054552|NCT00710021|38198003|FG000|Overall Study|Subject misrandomized|0|||
17054553|NCT00710021|38198004|FG001|Overall Study|Subject misrandomized|1|||
17054554|NCT00710021|38198005|FG002|Overall Study|Subject misrandomized|1|||
17054555|NCT00710021|38198003|FG000|Overall Study|Physician Decision|0|||
17054556|NCT00710021|38198004|FG001|Overall Study|Physician Decision|1|||
17054557|NCT00710021|38198005|FG002|Overall Study|Physician Decision|0|||
17054558|NCT00504153|38198014|FG000|Overall Study|Withdrawal by Subject|1|||
17054559|NCT00504153|38198014|FG000|Overall Study|Adverse Event|4|||
17054560|NCT00504153|38198014|FG000|Overall Study|Death|1|||
17054561|NCT00442702|38198020|FG000|Titration Period|Adverse Event|2|||
17054562|NCT00442702|38198021|FG001|Titration Period|Adverse Event|0|||
17054563|NCT00442702|38198020|FG000|Titration Period|Death|3|||
17054564|NCT00442702|38198021|FG001|Titration Period|Death|2|||
17054565|NCT00442702|38198020|FG000|Titration Period|Insufficient Therapeutic Response|1|||
17054566|NCT00442702|38198021|FG001|Titration Period|Insufficient Therapeutic Response|0|||
17054567|NCT00442702|38198020|FG000|Titration Period|Refused Treatment|4|||
17054568|NCT00442702|38198021|FG001|Titration Period|Refused Treatment|1|||
17054569|NCT00442702|38198020|FG000|Titration Period|Failure to return|1|||
17054570|NCT00442702|38198021|FG001|Titration Period|Failure to return|0|||
17054571|NCT00442702|38198020|FG000|Titration Period|Hospitalized in another hospital|1|||
17054572|NCT00442702|38198021|FG001|Titration Period|Hospitalized in another hospital|0|||
17054573|NCT00442702|38198020|FG000|Evaluation Period|Adverse Event|1|||
17054574|NCT00442702|38198021|FG001|Evaluation Period|Adverse Event|0|||
17054575|NCT00442702|38198020|FG000|Evaluation Period|Death|1|||
17054576|NCT00442702|38198021|FG001|Evaluation Period|Death|1|||
17054577|NCT00442702|38198020|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
17054578|NCT00442702|38198021|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
17054579|NCT00442702|38198020|FG000|Evaluation Period|Refused treatment|1|||
17054580|NCT00442702|38198021|FG001|Evaluation Period|Refused treatment|1|||
17054581|NCT00442702|38198020|FG000|Evaluation Period|Renal transplant|0|||
17054582|NCT00442702|38198021|FG001|Evaluation Period|Renal transplant|1|||
17054583|NCT00442702|38198020|FG000|Evaluation Period|Failure to return|1|||
17054584|NCT00442702|38198021|FG001|Evaluation Period|Failure to return|0|||
17054585|NCT00442702|38198020|FG000|Evaluation Period|Site closure|0|||
17054586|NCT00442702|38198021|FG001|Evaluation Period|Site closure|1|||
17054587|NCT00514917|38198029|FG000|Overall Study|Death|4|||
17054588|NCT00514917|38198030|FG001|Overall Study|Death|10|||
17054589|NCT00514917|38198029|FG000|Overall Study|Protocol Violation|1|||
17054590|NCT00514917|38198030|FG001|Overall Study|Protocol Violation|0|||
17054591|NCT00514917|38198029|FG000|Overall Study|Lost to Follow-up|4|||
17054592|NCT00514917|38198030|FG001|Overall Study|Lost to Follow-up|3|||
17054593|NCT00514917|38198029|FG000|Overall Study|Withdrawal by Subject|18|||
17054594|NCT00514917|38198030|FG001|Overall Study|Withdrawal by Subject|16|||
17054595|NCT00514917|38198029|FG000|Overall Study|Discontinued due to study closure|88|||
17054596|NCT00514917|38198030|FG001|Overall Study|Discontinued due to study closure|81|||
17054597|NCT00514917|38198029|FG000|Overall Study|Undefined|11|||
17054598|NCT00514917|38198030|FG001|Overall Study|Undefined|5|||
17054599|NCT00711425|38198038|FG000|Overall Study|Protocol Violation|1|||
17054600|NCT00711425|38198038|FG000|Overall Study|Death|2|||
17054601|NCT00711425|38198038|FG000|Overall Study|Lost to Follow-up|1|||
17054602|NCT00504075|38198042|FG000|Overall Study|Adverse Event|1|||
17054603|NCT00504075|38198042|FG000|Overall Study|Lost to Follow-up|5|||
17054604|NCT00504075|38198042|FG000|Overall Study|Withdrawal by Subject|1|||
17054605|NCT00504075|38198042|FG000|Overall Study|Required other therapeutic intervention|1|||
17144385|NCT02477618|38287987|FG000|Overall Study|Transferred Away from Study Site|1|||
17144386|NCT02477618|38287988|FG001|Overall Study|Transferred Away from Study Site|0|||
17144387|NCT02477618|38287987|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
17144388|NCT02477618|38287988|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
17144389|NCT04102501|38287996|FG000|Overall Study|Withdrawal by Subject|7|||
17144390|NCT04102501|38287997|FG001|Overall Study|Withdrawal by Subject|9|||
17144391|NCT04102501|38287996|FG000|Overall Study|Adverse Event|1|||
17144392|NCT04102501|38287997|FG001|Overall Study|Adverse Event|3|||
17144393|NCT03285477|38288007|FG000|Treatment and Response Assessment Period|Death|1|||
17144394|NCT03285477|38288008|FG001|Treatment and Response Assessment Period|Death|0|||
17144395|NCT03285477|38288007|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
17144396|NCT03285477|38288008|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
17144397|NCT03285477|38288007|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
17144398|NCT03285477|38288008|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
17054606|NCT00503997|38198047|FG000|Overall Study|disease progression|1|||
17054607|NCT00503997|38198047|FG000|Overall Study|Adverse Event|5|||
17054608|NCT00503997|38198047|FG000|Overall Study|Death|1|||
17054609|NCT00503997|38198047|FG000|Overall Study|Withdrawal by Subject|1|||
17054610|NCT00096265|38198054|FG000|Overall Study|Ineligible|1|||
17054611|NCT00096265|38198055|FG001|Overall Study|Ineligible|0|||
17054612|NCT00096265|38198056|FG002|Overall Study|Ineligible|0|||
17054613|NCT00711191|38198068|FG000|Overall Study|Adverse Event|1|||
17054614|NCT00711191|38198069|FG001|Overall Study|Adverse Event|1|||
17054615|NCT00711191|38198070|FG002|Overall Study|Adverse Event|2|||
17054616|NCT00711191|38198068|FG000|Overall Study|Objective progression or relapse|2|||
17054617|NCT00711191|38198069|FG001|Overall Study|Objective progression or relapse|3|||
17054618|NCT00711191|38198070|FG002|Overall Study|Objective progression or relapse|7|||
17054619|NCT00711191|38198068|FG000|Overall Study|Withdrawal by Subject|0|||
17054620|NCT00711191|38198069|FG001|Overall Study|Withdrawal by Subject|1|||
17054621|NCT00711191|38198070|FG002|Overall Study|Withdrawal by Subject|3|||
17054622|NCT00706511|38198085|FG000|Overall Study|Withdrawal by Subject|1|||
17054623|NCT00706511|38198086|FG001|Overall Study|Withdrawal by Subject|0|||
17144399|NCT03285477|38288007|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
17144400|NCT03285477|38288008|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
17054624|NCT00706511|38198087|FG002|Overall Study|Withdrawal by Subject|0|||
17054625|NCT00706511|38198088|FG003|Overall Study|Withdrawal by Subject|0|||
17054626|NCT00448864|38198099|FG000|Overall Study|Death|1|||
17054627|NCT00448864|38198100|FG001|Overall Study|Death|0|||
17054628|NCT00448864|38198101|FG002|Overall Study|Death|0|||
17054629|NCT00448864|38198099|FG000|Overall Study|Lost to Follow-up|3|||
17144401|NCT03285477|38288007|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
17054630|NCT00448864|38198100|FG001|Overall Study|Lost to Follow-up|1|||
17144402|NCT03285477|38288008|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
17144403|NCT04289623|38288025|FG000|Wave 1 Emails|Email was not delivered|268|||
17144404|NCT04289623|38288026|FG001|Wave 1 Emails|Email was not delivered|257|||
17144405|NCT04289623|38288027|FG002|Wave 1 Emails|Email was not delivered|0|||
17144406|NCT04289623|38288028|FG003|Wave 1 Emails|Email was not delivered|0|||
17054631|NCT00448864|38198101|FG002|Overall Study|Lost to Follow-up|0|||
17054632|NCT00448864|38198099|FG000|Overall Study|Physician Decision|1|||
17054633|NCT00448864|38198100|FG001|Overall Study|Physician Decision|0|||
17054634|NCT00448864|38198101|FG002|Overall Study|Physician Decision|1|||
17144407|NCT04289623|38288029|FG004|Wave 1 Emails|Email was not delivered|0|||
17144408|NCT04289623|38288030|FG005|Wave 1 Emails|Email was not delivered|0|||
17144409|NCT03248037|38288046|FG000|Overall Study|Withdrawal by Subject|6|||
17144410|NCT03248037|38288047|FG001|Overall Study|Withdrawal by Subject|9|||
17144411|NCT03248037|38288046|FG000|Overall Study|Adverse Event|15|||
17144412|NCT03248037|38288047|FG001|Overall Study|Adverse Event|0|||
17144413|NCT04287517|38288062|FG000|Overall Study|Withdrawal by Subject|1|||
17144414|NCT04287517|38288063|FG001|Overall Study|Withdrawal by Subject|1|||
17144415|NCT03284229|38288069|FG000|Overall Study|Lost to Follow-up|3|||
17144416|NCT03242928|38288076|FG000|Overall Study|Adverse Event|2|||
17054635|NCT00448864|38198099|FG000|Overall Study|Withdrawal by Subject|0|||
17054636|NCT00448864|38198100|FG001|Overall Study|Withdrawal by Subject|2|||
17054637|NCT00448864|38198101|FG002|Overall Study|Withdrawal by Subject|0|||
17054638|NCT00448864|38198099|FG000|Overall Study|Protocol Violation|0|||
17054639|NCT00448864|38198100|FG001|Overall Study|Protocol Violation|2|||
17054640|NCT00448864|38198101|FG002|Overall Study|Protocol Violation|0|||
17054641|NCT00567398|38198113|FG000|Overall Study|Adverse Event|6|||
17054642|NCT00567398|38198114|FG001|Overall Study|Adverse Event|14|||
17054643|NCT00567398|38198113|FG000|Overall Study|Physician Decision|0|||
17054644|NCT00567398|38198114|FG001|Overall Study|Physician Decision|4|||
17054645|NCT00567398|38198113|FG000|Overall Study|Withdrawal by Subject|0|||
17054646|NCT00567398|38198114|FG001|Overall Study|Withdrawal by Subject|2|||
17054647|NCT00567398|38198113|FG000|Overall Study|Renal Transplantation|0|||
17054648|NCT00567398|38198114|FG001|Overall Study|Renal Transplantation|3|||
17054649|NCT00567398|38198113|FG000|Overall Study|Other|1|||
17054650|NCT00567398|38198114|FG001|Overall Study|Other|0|||
17144417|NCT03242928|38288077|FG001|Overall Study|Adverse Event|1|||
17054651|NCT00448708|38198122|FG000|Overall Study|Death|21|||
17054652|NCT00448708|38198123|FG001|Overall Study|Death|17|||
17054653|NCT00448708|38198122|FG000|Overall Study|Withdrawal by Subject|8|||
17054654|NCT00448708|38198123|FG001|Overall Study|Withdrawal by Subject|4|||
17054655|NCT00448708|38198122|FG000|Overall Study|Lost to Follow-up|6|||
17054656|NCT00448708|38198123|FG001|Overall Study|Lost to Follow-up|8|||
17054657|NCT00448708|38198122|FG000|Overall Study|not listed|0|||
17054658|NCT00448708|38198123|FG001|Overall Study|not listed|2|||
17054659|NCT00706355|38198133|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
17054660|NCT00706355|38198134|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
17054661|NCT00706355|38198135|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
17054662|NCT00706355|38198136|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
17054663|NCT00706355|38198133|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
17054664|NCT00706355|38198134|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
17054665|NCT00706355|38198135|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
17054666|NCT00706355|38198136|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
17054667|NCT00706355|38198133|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
17054668|NCT00706355|38198134|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
17054669|NCT00706355|38198135|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
17054670|NCT00706355|38198136|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
17054671|NCT00706355|38198133|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
17054672|NCT00706355|38198134|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
17054673|NCT00706355|38198135|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
17054674|NCT00706355|38198136|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
17054675|NCT00706355|38198133|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
17144418|NCT03242928|38288076|FG000|Overall Study|Lost to Follow-up|2|||
17144419|NCT03242928|38288077|FG001|Overall Study|Lost to Follow-up|0|||
17144420|NCT03242928|38288076|FG000|Overall Study|Physician Decision|0|||
17144421|NCT03242928|38288077|FG001|Overall Study|Physician Decision|1|||
17144422|NCT03242928|38288076|FG000|Overall Study|Withdrawal by Subject|5|||
17144423|NCT03242928|38288077|FG001|Overall Study|Withdrawal by Subject|3|||
17144424|NCT03300024|38288085|FG000|Overall Study|Physician Decision|4|||
17144425|NCT03300024|38288086|FG001|Overall Study|Physician Decision|6|||
17144426|NCT04276207|38288094|FG000|Period 1|Withdrawal by Subject|0|||
17144427|NCT04276207|38288095|FG001|Period 1|Withdrawal by Subject|1|||
17144428|NCT03240081|38288103|FG000|Overall Study|Withdrawal by Subject|0|||
17144429|NCT03240081|38288104|FG001|Overall Study|Withdrawal by Subject|2|||
17144430|NCT03240081|38288103|FG000|Overall Study|Lost to Follow-up|0|||
17144431|NCT03240081|38288104|FG001|Overall Study|Lost to Follow-up|1|||
17144432|NCT03282357|38288110|FG000|Overall Study|Lost to Follow-up|3|||
17144433|NCT03282357|38288110|FG000|Overall Study|Withdrawal by Subject|4|||
17144434|NCT03282357|38288110|FG000|Overall Study|Adverse Event|1|||
17144435|NCT03282357|38288110|FG000|Overall Study|Other|9|||
17144436|NCT03282123|38288115|FG000|Overall Study|Withdrawal by Subject|5|||
17144437|NCT04272775|38288122|FG000|Overall Study|Study Terminated by Sponsor|1|||
17144438|NCT04272775|38288123|FG001|Overall Study|Study Terminated by Sponsor|0|||
17144439|NCT04272775|38288122|FG000|Overall Study|Protocol Violation|0|||
17144440|NCT04272775|38288123|FG001|Overall Study|Protocol Violation|1|||
17144441|NCT04272775|38288122|FG000|Overall Study|Symptomatic Deterioration|1|||
17144442|NCT04272775|38288123|FG001|Overall Study|Symptomatic Deterioration|1|||
17144443|NCT04272775|38288122|FG000|Overall Study|Withdrawal by Subject|1|||
17144444|NCT04272775|38288123|FG001|Overall Study|Withdrawal by Subject|2|||
17144445|NCT04272775|38288122|FG000|Overall Study|Adverse Event|1|||
17144446|NCT04272775|38288123|FG001|Overall Study|Adverse Event|2|||
17144447|NCT04272775|38288122|FG000|Overall Study|Progressive Disease|3|||
17144448|NCT04272775|38288123|FG001|Overall Study|Progressive Disease|1|||
17054676|NCT00706355|38198134|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
17054677|NCT00706355|38198135|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
17054678|NCT00706355|38198136|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
17054679|NCT00706355|38198133|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
17054680|NCT00706355|38198134|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
17054681|NCT00706355|38198135|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
17054682|NCT00706355|38198136|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
17054683|NCT00706355|38198133|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
17054684|NCT00706355|38198134|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
17054685|NCT00706355|38198135|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
17054686|NCT00706355|38198136|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
17054687|NCT00706355|38198133|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
17054688|NCT00706355|38198134|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
17054689|NCT00706355|38198135|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
17054690|NCT00706355|38198136|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
17054691|NCT00706355|38198133|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
17054692|NCT00706355|38198134|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
17054693|NCT00706355|38198135|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
17054694|NCT00706355|38198136|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
17054695|NCT00711113|38198148|FG000|Overall Study|Lost to Follow-up|9|||
17054696|NCT00711113|38198148|FG000|Overall Study|Implant lost|2|||
17054697|NCT00710879|38198158|FG000|Overall Study|Lost to Follow-up|2|||
17054698|NCT00710879|38198159|FG001|Overall Study|Lost to Follow-up|1|||
17054699|NCT00710879|38198158|FG000|Overall Study|Protocol Violation|0|||
17054700|NCT00710879|38198159|FG001|Overall Study|Protocol Violation|3|||
17054701|NCT03979274|38198165|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17054702|NCT03979274|38198166|FG001|Treatment Period 2|Withdrawal by Subject|1|||
17054703|NCT00459316|38198176|FG000|Steps 1 & 2|Other eligibility failure|1|||
17054704|NCT00459316|38198177|FG001|Steps 1 & 2|Other eligibility failure|1|||
17054705|NCT00459316|38198178|FG002|Steps 1 & 2|Other eligibility failure|0|||
17054706|NCT00459316|38198176|FG000|Steps 1 & 2|Death|1|||
17054707|NCT00459316|38198177|FG001|Steps 1 & 2|Death|1|||
17054708|NCT00459316|38198178|FG002|Steps 1 & 2|Death|0|||
17054709|NCT00459316|38198176|FG000|Steps 1 & 2|Not able to get to clinic|7|||
17054710|NCT00459316|38198177|FG001|Steps 1 & 2|Not able to get to clinic|4|||
17054711|NCT00459316|38198178|FG002|Steps 1 & 2|Not able to get to clinic|0|||
17054712|NCT00459316|38198176|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
17054713|NCT00459316|38198177|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
17054714|NCT00459316|38198178|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
17054715|NCT00459316|38198176|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
17054716|NCT00459316|38198177|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
17054717|NCT00459316|38198178|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
17054718|NCT00459316|38198176|FG000|Steps 1 & 2|Lost to Follow-up|5|||
17054719|NCT00459316|38198177|FG001|Steps 1 & 2|Lost to Follow-up|0|||
17054720|NCT00459316|38198178|FG002|Steps 1 & 2|Lost to Follow-up|2|||
17054721|NCT00459316|38198176|FG000|Step 3|Withdrawal by Subject|3|||
17054722|NCT00459316|38198177|FG001|Step 3|Withdrawal by Subject|0|||
17054723|NCT00459316|38198178|FG002|Step 3|Withdrawal by Subject|1|||
17054724|NCT00567164|38198204|FG000|Overall Study|Withdrawal by Subject|171|||
17054725|NCT00567164|38198205|FG001|Overall Study|Withdrawal by Subject|21|||
17054726|NCT00567164|38198206|FG002|Overall Study|Withdrawal by Subject|17|||
17054727|NCT00567164|38198204|FG000|Overall Study|Protocol Violation|23|||
17054728|NCT00567164|38198205|FG001|Overall Study|Protocol Violation|4|||
17054729|NCT00567164|38198206|FG002|Overall Study|Protocol Violation|2|||
17054730|NCT00567164|38198204|FG000|Overall Study|Adverse Event|92|||
17054731|NCT00567164|38198205|FG001|Overall Study|Adverse Event|13|||
17054732|NCT00567164|38198206|FG002|Overall Study|Adverse Event|9|||
17054733|NCT00567164|38198204|FG000|Overall Study|Death|0|||
17054734|NCT00567164|38198205|FG001|Overall Study|Death|0|||
17054735|NCT00567164|38198206|FG002|Overall Study|Death|1|||
17054736|NCT00567164|38198204|FG000|Overall Study|Lost to Follow-up|202|||
17054737|NCT00567164|38198205|FG001|Overall Study|Lost to Follow-up|23|||
17054738|NCT00567164|38198206|FG002|Overall Study|Lost to Follow-up|21|||
17144449|NCT03232983|38288129|FG000|Period 1|Physician Decision|0|||
17144450|NCT03232983|38288130|FG001|Period 1|Physician Decision|0|||
17054739|NCT00567164|38198204|FG000|Overall Study|Pregnancy|20|||
17054740|NCT00567164|38198205|FG001|Overall Study|Pregnancy|4|||
17054741|NCT00567164|38198206|FG002|Overall Study|Pregnancy|6|||
17054742|NCT00567164|38198204|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
17054743|NCT00567164|38198205|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
17054744|NCT00567164|38198206|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
17054745|NCT00567164|38198204|FG000|Overall Study|Missing|1|||
17054746|NCT00567164|38198205|FG001|Overall Study|Missing|0|||
17054747|NCT00567164|38198206|FG002|Overall Study|Missing|0|||
17054748|NCT00713219|38198218|FG000|Overall Study|Death|1|||
17054749|NCT00713219|38198218|FG000|Overall Study|Protocol Violation|1|||
17054750|NCT00712985|38198222|FG000|Overall Study|1 withdrew prior to start of drug|1|||
17054751|NCT00712985|38198222|FG000|Overall Study|1 patient moved out of state|1|||
17054752|NCT00712985|38198222|FG000|Overall Study|Lack of Efficacy|3|||
17054753|NCT00700115|38198228|FG000|Overall Study|Withdrawal by Subject|1|||
17054754|NCT00700115|38198229|FG001|Overall Study|Withdrawal by Subject|0|||
17054755|NCT00700115|38198228|FG000|Overall Study|Lost to Follow-up|0|||
17054756|NCT00700115|38198229|FG001|Overall Study|Lost to Follow-up|1|||
17054757|NCT00566852|38198237|FG000|Overall Study|Protocol Violation|22|||
17054758|NCT00566852|38198238|FG001|Overall Study|Protocol Violation|24|||
17054759|NCT00566852|38198237|FG000|Overall Study|Death|95|||
17054760|NCT00566852|38198238|FG001|Overall Study|Death|78|||
17054761|NCT00566852|38198237|FG000|Overall Study|Withdrawal by Subject|30|||
17054762|NCT00566852|38198238|FG001|Overall Study|Withdrawal by Subject|25|||
17054763|NCT00566852|38198237|FG000|Overall Study|Patient refusal|37|||
17054764|NCT00566852|38198238|FG001|Overall Study|Patient refusal|37|||
17054765|NCT00566852|38198237|FG000|Overall Study|Not tested due to disability|6|||
17054766|NCT00566852|38198238|FG001|Overall Study|Not tested due to disability|12|||
17054767|NCT00566852|38198237|FG000|Overall Study|Missing reason not specified|1|||
17054768|NCT00566852|38198238|FG001|Overall Study|Missing reason not specified|2|||
17054769|NCT00566852|38198237|FG000|Overall Study|Missing reason not reported|16|||
17054770|NCT00566852|38198238|FG001|Overall Study|Missing reason not reported|20|||
17054771|NCT00442546|38198247|FG000|Overall Study|Adverse Event|11|||
17054772|NCT00442546|38198248|FG001|Overall Study|Adverse Event|17|||
17054773|NCT00442546|38198249|FG002|Overall Study|Adverse Event|13|||
17144451|NCT03232983|38288131|FG002|Period 1|Physician Decision|1|||
17144452|NCT03232983|38288132|FG003|Period 1|Physician Decision|0|||
17144453|NCT03232983|38288129|FG000|Washout Period 2|Physician Decision|0|||
17144454|NCT03232983|38288130|FG001|Washout Period 2|Physician Decision|0|||
17144455|NCT03232983|38288131|FG002|Washout Period 2|Physician Decision|1|||
17144456|NCT03232983|38288132|FG003|Washout Period 2|Physician Decision|0|||
17144457|NCT03232983|38288129|FG000|Washout Period 2|Withdrawal by Subject|0|||
17144458|NCT03232983|38288130|FG001|Washout Period 2|Withdrawal by Subject|0|||
17144459|NCT03232983|38288131|FG002|Washout Period 2|Withdrawal by Subject|0|||
17144460|NCT03232983|38288132|FG003|Washout Period 2|Withdrawal by Subject|1|||
17144461|NCT03232983|38288129|FG000|Period 4|Withdrawal by Subject|1|||
17144462|NCT03232983|38288130|FG001|Period 4|Withdrawal by Subject|0|||
17144463|NCT03232983|38288131|FG002|Period 4|Withdrawal by Subject|0|||
17054774|NCT00442546|38198247|FG000|Overall Study|Lost to Follow-up|1|||
17054775|NCT00442546|38198248|FG001|Overall Study|Lost to Follow-up|2|||
17054776|NCT00442546|38198249|FG002|Overall Study|Lost to Follow-up|1|||
17054777|NCT00442546|38198247|FG000|Overall Study|Other|4|||
17054778|NCT00442546|38198248|FG001|Overall Study|Other|9|||
17054779|NCT00442546|38198249|FG002|Overall Study|Other|6|||
17054780|NCT00442546|38198247|FG000|Overall Study|Withdrawal by Subject|5|||
17054781|NCT00442546|38198248|FG001|Overall Study|Withdrawal by Subject|5|||
17054782|NCT00442546|38198249|FG002|Overall Study|Withdrawal by Subject|7|||
17054783|NCT00442546|38198247|FG000|Overall Study|Randomized But Not Treated|5|||
17054784|NCT00442546|38198248|FG001|Overall Study|Randomized But Not Treated|4|||
17054785|NCT00442546|38198249|FG002|Overall Study|Randomized But Not Treated|6|||
17054786|NCT00514683|38198264|FG000|Overall Study|Not treated|2|||
17054787|NCT00514683|38198265|FG001|Overall Study|Not treated|1|||
17054788|NCT00514683|38198266|FG002|Overall Study|Not treated|0|||
17054789|NCT00514683|38198267|FG003|Overall Study|Not treated|0|||
17054790|NCT00514683|38198268|FG004|Overall Study|Not treated|1|||
17054791|NCT00514683|38198264|FG000|Overall Study|Adverse Event|21|||
17054792|NCT00514683|38198265|FG001|Overall Study|Adverse Event|20|||
17054793|NCT00514683|38198266|FG002|Overall Study|Adverse Event|15|||
17054794|NCT00514683|38198267|FG003|Overall Study|Adverse Event|13|||
17054795|NCT00514683|38198268|FG004|Overall Study|Adverse Event|27|||
17054796|NCT00514683|38198264|FG000|Overall Study|Protocol Violation|1|||
17054797|NCT00514683|38198265|FG001|Overall Study|Protocol Violation|1|||
17054798|NCT00514683|38198266|FG002|Overall Study|Protocol Violation|0|||
17054799|NCT00514683|38198267|FG003|Overall Study|Protocol Violation|1|||
17054800|NCT00514683|38198268|FG004|Overall Study|Protocol Violation|0|||
17054801|NCT00514683|38198264|FG000|Overall Study|Withdrawal by Subject|2|||
17054802|NCT00514683|38198265|FG001|Overall Study|Withdrawal by Subject|2|||
17144464|NCT03232983|38288132|FG003|Period 4|Withdrawal by Subject|0|||
17144465|NCT04102345|38288146|FG000|Overall Study|Withdrawal by Subject|1|||
17054803|NCT00514683|38198266|FG002|Overall Study|Withdrawal by Subject|1|||
17054804|NCT00514683|38198267|FG003|Overall Study|Withdrawal by Subject|0|||
17054805|NCT00514683|38198268|FG004|Overall Study|Withdrawal by Subject|4|||
17054806|NCT00514683|38198264|FG000|Overall Study|Reason other than listed above|0|||
17054807|NCT00514683|38198265|FG001|Overall Study|Reason other than listed above|1|||
17054808|NCT00514683|38198266|FG002|Overall Study|Reason other than listed above|2|||
17054809|NCT00514683|38198267|FG003|Overall Study|Reason other than listed above|0|||
17054810|NCT00514683|38198268|FG004|Overall Study|Reason other than listed above|1|||
17054811|NCT00566696|38198284|FG000|Overall Study|Met Exclusion Criteria|2|||
17054812|NCT00566696|38198284|FG000|Overall Study|Muromonab not available|1|||
17054813|NCT00566696|38198284|FG000|Overall Study|Health Status Change|1|||
17054814|NCT00566696|38198284|FG000|Overall Study|Physician Decision|1|||
17054815|NCT00566696|38198284|FG000|Overall Study|Non-Patient Donors|37|||
17054816|NCT00503841|38198288|FG000|Overall Study|All screen failures|44|||
17054817|NCT00442468|38198294|FG000|Overall Study|Adverse Event|4|||
17054818|NCT00442468|38198294|FG000|Overall Study|Withdrawal by Subject|91|||
17054819|NCT00442468|38198294|FG000|Overall Study|Did not complete all study procedures|88|||
17144466|NCT04102345|38288147|FG001|Overall Study|Withdrawal by Subject|0|||
17144467|NCT04271605|38288153|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
17144468|NCT03299244|38288159|FG000|Overall Study|Withdrawal by Subject|34|||
17144469|NCT03299244|38288160|FG001|Overall Study|Withdrawal by Subject|29|||
17144470|NCT03299244|38288159|FG000|Overall Study|Decision by Sponsor|4|||
17144471|NCT03299244|38288160|FG001|Overall Study|Decision by Sponsor|5|||
17054820|NCT00506883|38198301|FG000|Overall Study|Lost to Follow-up|1|||
17144472|NCT03299244|38288159|FG000|Overall Study|Death|9|||
17144473|NCT03299244|38288160|FG001|Overall Study|Death|4|||
17144474|NCT03757715|38288169|FG000|Overall Study|Lost to Follow-up|4|||
17144475|NCT03757715|38288170|FG001|Overall Study|Lost to Follow-up|9|||
17054821|NCT00506883|38198302|FG001|Overall Study|Lost to Follow-up|1|||
17054822|NCT00506883|38198303|FG002|Overall Study|Lost to Follow-up|1|||
17054823|NCT00506883|38198301|FG000|Overall Study|Withdrawal by Subject|1|||
17054824|NCT00506883|38198302|FG001|Overall Study|Withdrawal by Subject|0|||
17054825|NCT00506883|38198303|FG002|Overall Study|Withdrawal by Subject|1|||
17054826|NCT00506883|38198301|FG000|Overall Study|Lack of Efficacy|0|||
17144476|NCT03757715|38288169|FG000|Overall Study|Withdrawal by Subject|1|||
17144477|NCT03757715|38288170|FG001|Overall Study|Withdrawal by Subject|1|||
17144478|NCT03281577|38288180|FG000|Overall Study|Adverse Event|0|||
17144479|NCT03281577|38288181|FG001|Overall Study|Adverse Event|0|||
17144480|NCT03281577|38288182|FG002|Overall Study|Adverse Event|0|||
17144481|NCT03281577|38288183|FG003|Overall Study|Adverse Event|1|||
17144482|NCT03281577|38288180|FG000|Overall Study|Withdrawal by Subject|1|||
17144483|NCT03281577|38288181|FG001|Overall Study|Withdrawal by Subject|0|||
17144484|NCT03281577|38288182|FG002|Overall Study|Withdrawal by Subject|0|||
17144485|NCT03281577|38288183|FG003|Overall Study|Withdrawal by Subject|0|||
17144486|NCT04098367|38288199|FG000|Overall Study|Adverse Event|0|||
17144487|NCT04098367|38288200|FG001|Overall Study|Adverse Event|0|||
17054827|NCT00506883|38198302|FG001|Overall Study|Lack of Efficacy|1|||
17054828|NCT00506883|38198303|FG002|Overall Study|Lack of Efficacy|1|||
17054829|NCT00506883|38198301|FG000|Overall Study|Other|5|||
17054830|NCT00506883|38198302|FG001|Overall Study|Other|1|||
17054831|NCT00506883|38198303|FG002|Overall Study|Other|1|||
17054843|NCT00503685|38198321|FG000|Overall Study|Adverse Event|0|||
17054844|NCT00503685|38198322|FG001|Overall Study|Adverse Event|0|||
17054845|NCT00503685|38198323|FG002|Overall Study|Adverse Event|2|||
17054846|NCT00503685|38198321|FG000|Overall Study|Withdrawal by Subject|0|||
17054847|NCT00503685|38198322|FG001|Overall Study|Withdrawal by Subject|1|||
17054848|NCT00503685|38198323|FG002|Overall Study|Withdrawal by Subject|0|||
17054849|NCT00503685|38198321|FG000|Overall Study|Protocol Violation|0|||
17054850|NCT00503685|38198322|FG001|Overall Study|Protocol Violation|1|||
17054851|NCT00503685|38198323|FG002|Overall Study|Protocol Violation|0|||
17054852|NCT00503685|38198321|FG000|Overall Study|Eligibility Criteria Not Met|0|||
17054853|NCT00503685|38198322|FG001|Overall Study|Eligibility Criteria Not Met|1|||
17054854|NCT00503685|38198323|FG002|Overall Study|Eligibility Criteria Not Met|0|||
17144488|NCT04098367|38288201|FG002|Overall Study|Adverse Event|1|||
17054855|NCT00712673|38198335|FG000|Overall Study|Adverse Event|3|||
17054856|NCT00712673|38198336|FG001|Overall Study|Adverse Event|3|||
17144489|NCT04098367|38288199|FG000|Overall Study|Lost to Follow-up|1|||
17144490|NCT04098367|38288200|FG001|Overall Study|Lost to Follow-up|5|||
17054857|NCT00712673|38198337|FG002|Overall Study|Adverse Event|21|||
17054858|NCT00712673|38198338|FG003|Overall Study|Adverse Event|26|||
17054859|NCT00712673|38198335|FG000|Overall Study|Lack of Efficacy|2|||
17054860|NCT00712673|38198336|FG001|Overall Study|Lack of Efficacy|8|||
17054861|NCT00712673|38198337|FG002|Overall Study|Lack of Efficacy|8|||
17054862|NCT00712673|38198338|FG003|Overall Study|Lack of Efficacy|6|||
17054863|NCT00712673|38198335|FG000|Overall Study|Poor Compliance to Protocol|3|||
17054864|NCT00712673|38198336|FG001|Overall Study|Poor Compliance to Protocol|3|||
17054865|NCT00712673|38198337|FG002|Overall Study|Poor Compliance to Protocol|4|||
17054866|NCT00712673|38198338|FG003|Overall Study|Poor Compliance to Protocol|16|||
17054867|NCT00712673|38198335|FG000|Overall Study|Lost to Follow-up|1|||
17054868|NCT00712673|38198336|FG001|Overall Study|Lost to Follow-up|0|||
17054869|NCT00712673|38198337|FG002|Overall Study|Lost to Follow-up|2|||
17054870|NCT00712673|38198338|FG003|Overall Study|Lost to Follow-up|0|||
17054871|NCT00712673|38198335|FG000|Overall Study|Withdrawal by Subject|6|||
17144491|NCT04098367|38288201|FG002|Overall Study|Lost to Follow-up|2|||
17144492|NCT04098367|38288199|FG000|Overall Study|Withdrawal by Subject|0|||
17144493|NCT04098367|38288200|FG001|Overall Study|Withdrawal by Subject|0|||
17144494|NCT04098367|38288201|FG002|Overall Study|Withdrawal by Subject|1|||
17144495|NCT04098367|38288199|FG000|Overall Study|Sick . Could not attend visit|1|||
17144496|NCT04098367|38288200|FG001|Overall Study|Sick . Could not attend visit|0|||
17144497|NCT04098367|38288201|FG002|Overall Study|Sick . Could not attend visit|0|||
17144498|NCT03759587|38288216|FG000|Overall Study|Ongoing|19|||
17144499|NCT04091659|38288222|FG000|Overall Study|Protocol Violation|3|||
17144500|NCT04091659|38288223|FG001|Overall Study|Protocol Violation|0|||
17144501|NCT04091659|38288222|FG000|Overall Study|Lost to Follow-up|0|||
17144502|NCT04091659|38288223|FG001|Overall Study|Lost to Follow-up|1|||
17144503|NCT04256785|38288260|FG000|Overall Study|Adverse Event|8|||
17144504|NCT04256785|38288261|FG001|Overall Study|Adverse Event|6|||
17144505|NCT04256785|38288260|FG000|Overall Study|Lack of Efficacy|3|||
17054872|NCT00712673|38198336|FG001|Overall Study|Withdrawal by Subject|7|||
17054873|NCT00712673|38198337|FG002|Overall Study|Withdrawal by Subject|15|||
17054874|NCT00712673|38198338|FG003|Overall Study|Withdrawal by Subject|20|||
17054875|NCT00712673|38198335|FG000|Overall Study|Familial and Personal Reasons|5|||
17054876|NCT00712673|38198336|FG001|Overall Study|Familial and Personal Reasons|0|||
17054877|NCT00712673|38198337|FG002|Overall Study|Familial and Personal Reasons|5|||
17054878|NCT00712673|38198338|FG003|Overall Study|Familial and Personal Reasons|2|||
17054879|NCT00712673|38198335|FG000|Overall Study|Investigator's Decision|1|||
17054880|NCT00712673|38198336|FG001|Overall Study|Investigator's Decision|0|||
17054881|NCT00712673|38198337|FG002|Overall Study|Investigator's Decision|0|||
17054882|NCT00712673|38198338|FG003|Overall Study|Investigator's Decision|0|||
17054883|NCT00712673|38198335|FG000|Overall Study|Protocol Violation|0|||
17054884|NCT00712673|38198336|FG001|Overall Study|Protocol Violation|0|||
17054885|NCT00712673|38198337|FG002|Overall Study|Protocol Violation|2|||
17054886|NCT00712673|38198338|FG003|Overall Study|Protocol Violation|0|||
17054887|NCT03976466|38198359|FG000|Overall Study|Lost to Follow-up|1|||
17054888|NCT03976466|38198360|FG001|Overall Study|Lost to Follow-up|3|||
17054889|NCT02536755|38198368|FG000|Overall Study|Adverse Event|4|||
17054890|NCT03303105|38198377|FG000|Overall Study|Adverse Event|0|||
17054891|NCT03303105|38198378|FG001|Overall Study|Adverse Event|2|||
17054892|NCT03303105|38198377|FG000|Overall Study|Lack of Efficacy|1|||
17054893|NCT03303105|38198378|FG001|Overall Study|Lack of Efficacy|0|||
17054894|NCT03303105|38198377|FG000|Overall Study|Protocol Violation|1|||
17054895|NCT03303105|38198378|FG001|Overall Study|Protocol Violation|0|||
17054896|NCT03303105|38198377|FG000|Overall Study|Withdrawal by Subject|0|||
17054897|NCT03303105|38198378|FG001|Overall Study|Withdrawal by Subject|2|||
17054898|NCT00447694|38198384|FG000|Overall Study|Adverse Event|2|||
17054899|NCT00447694|38198384|FG000|Overall Study|Abnormal laboratory value|1|||
17054900|NCT00447694|38198384|FG000|Overall Study|Abnormal test procedure result|1|||
17054901|NCT00447694|38198384|FG000|Overall Study|Withdrawal by Subject|2|||
17054902|NCT00564278|38198390|FG000|Overall Study|Lost to Follow-up|35|||
17054903|NCT00564278|38198391|FG001|Overall Study|Lost to Follow-up|33|||
17054904|NCT00564278|38198390|FG000|Overall Study|Physician Decision|1|||
17054905|NCT00564278|38198391|FG001|Overall Study|Physician Decision|2|||
17054906|NCT00564278|38198390|FG000|Overall Study|Withdrawal by Subject|11|||
17054907|NCT00564278|38198391|FG001|Overall Study|Withdrawal by Subject|7|||
17054908|NCT00565604|38198397|FG000|Overall Study|Failure to treat|2|||
17054909|NCT00565604|38198397|FG000|Overall Study|Lost to Follow-up|2|||
17054910|NCT00447382|38198403|FG000|Overall Study|Adverse Event|1|||
17054911|NCT00447382|38198404|FG001|Overall Study|Adverse Event|1|||
17054912|NCT00447382|38198403|FG000|Overall Study|Lack of Efficacy|1|||
17054913|NCT00447382|38198404|FG001|Overall Study|Lack of Efficacy|0|||
17054914|NCT00447382|38198403|FG000|Overall Study|Protocol Violation|2|||
17054915|NCT00447382|38198404|FG001|Overall Study|Protocol Violation|0|||
17054916|NCT00447382|38198403|FG000|Overall Study|Unclassified|2|||
17054917|NCT00447382|38198404|FG001|Overall Study|Unclassified|5|||
17054918|NCT00447226|38198410|FG000|12-Week Open-label Phase|Adverse Event|0|||
17054919|NCT00447226|38198411|FG001|12-Week Open-label Phase|Adverse Event|3|||
17054920|NCT00447226|38198410|FG000|12-Week Open-label Phase|Protocol Violation|0|||
17054921|NCT00447226|38198411|FG001|12-Week Open-label Phase|Protocol Violation|1|||
17054922|NCT00447226|38198410|FG000|12-Week Open-label Phase|Disease Progression|0|||
17054923|NCT00447226|38198411|FG001|12-Week Open-label Phase|Disease Progression|20|||
17054924|NCT00447226|38198410|FG000|12-Week Open-label Phase|Physician Decision|0|||
17054925|NCT00447226|38198411|FG001|12-Week Open-label Phase|Physician Decision|1|||
17054926|NCT00447226|38198410|FG000|Double-blind Phase|Disease Progression|4|||
17054927|NCT00447226|38198411|FG001|Double-blind Phase|Disease Progression|3|||
17054928|NCT00446992|38198426|FG000|Overall Study|Adverse Event|11|||
17054929|NCT00446992|38198426|FG000|Overall Study|Lost to Follow-up|5|||
17054930|NCT00503139|38198430|FG000|Overall Study|Case Report Forms were not collected|4|||
17054931|NCT00503139|38198430|FG000|Overall Study|Protocol Violation|4|||
17054932|NCT00577031|38198434|FG000|Overall Study|Adverse Event|52|||
17054933|NCT00577031|38198434|FG000|Overall Study|Progression of disease|93|||
17054934|NCT00577031|38198434|FG000|Overall Study|Protocol Violation|5|||
17144506|NCT04256785|38288261|FG001|Overall Study|Lack of Efficacy|4|||
17144507|NCT04256785|38288260|FG000|Overall Study|Lost to Follow-up|7|||
17144508|NCT04256785|38288261|FG001|Overall Study|Lost to Follow-up|7|||
17144509|NCT04256785|38288260|FG000|Overall Study|Protocol Violation|1|||
17144510|NCT04256785|38288261|FG001|Overall Study|Protocol Violation|0|||
17144511|NCT04256785|38288260|FG000|Overall Study|Withdrawal by Subject|4|||
17144512|NCT04256785|38288261|FG001|Overall Study|Withdrawal by Subject|1|||
17144513|NCT04256785|38288260|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
17054935|NCT00577031|38198434|FG000|Overall Study|Participant withdrew consent|13|||
17054936|NCT00577031|38198434|FG000|Overall Study|Participant non-compliance|5|||
17054937|NCT00577031|38198434|FG000|Overall Study|Need for surgery|17|||
17054938|NCT00577031|38198434|FG000|Overall Study|Medical decision|14|||
17054939|NCT00577031|38198434|FG000|Overall Study|Death|6|||
17054940|NCT00565448|38198443|FG000|Overall Study|Adverse Event|1|||
17054941|NCT00565448|38198444|FG001|Overall Study|Adverse Event|2|||
17054942|NCT00565448|38198443|FG000|Overall Study|Disease progression|1|||
17054943|NCT00565448|38198444|FG001|Overall Study|Disease progression|0|||
17054944|NCT00565448|38198443|FG000|Overall Study|Withdrawal by Subject|1|||
17054945|NCT00565448|38198444|FG001|Overall Study|Withdrawal by Subject|0|||
17054946|NCT00446446|38198453|FG000|Overall Study|Death|10|||
17054947|NCT00446446|38198453|FG000|Overall Study|Withdrawal by Subject|6|||
17054948|NCT00446446|38198453|FG000|Overall Study|Other|4|||
17054949|NCT00446446|38198453|FG000|Overall Study|Disease Progession|2|||
17054950|NCT00446446|38198453|FG000|Overall Study|Adverse Event|1|||
17054951|NCT00446446|38198453|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
17054952|NCT00506493|38198457|FG000|Overall Study|Death|6|||
17054953|NCT00506493|38198457|FG000|Overall Study|Withdrawal by Subject|5|||
17054954|NCT00514449|38198465|FG000|Overall Study|Withdrawal by Subject|1|||
17054955|NCT00514449|38198466|FG001|Overall Study|Withdrawal by Subject|2|||
17054956|NCT00514449|38198465|FG000|Overall Study|Protocol Violation|1|||
17054957|NCT00514449|38198466|FG001|Overall Study|Protocol Violation|2|||
17054958|NCT00514449|38198465|FG000|Overall Study|Lost to Follow-up|1|||
17054959|NCT00514449|38198466|FG001|Overall Study|Lost to Follow-up|0|||
17144514|NCT04256785|38288261|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
17144515|NCT02959918|38288283|FG000|Overall Study|Adverse Event|1|||
17144516|NCT02959918|38288284|FG001|Overall Study|Adverse Event|1|||
17144517|NCT02959918|38288285|FG002|Overall Study|Adverse Event|2|||
17144518|NCT02959918|38288286|FG003|Overall Study|Adverse Event|0|||
17144519|NCT02959918|38288287|FG004|Overall Study|Adverse Event|0|||
17144520|NCT02959918|38288288|FG005|Overall Study|Adverse Event|2|||
17144521|NCT02959918|38288289|FG006|Overall Study|Adverse Event|2|||
17144522|NCT02959918|38288290|FG007|Overall Study|Adverse Event|1|||
17144523|NCT02959918|38288291|FG008|Overall Study|Adverse Event|2|||
17054960|NCT00565136|38198475|FG000|Overall Study|Lost to Follow-up|1|||
17054961|NCT00565136|38198475|FG000|Overall Study|Withdrawal by Subject|1|||
17054962|NCT00565136|38198475|FG000|Overall Study|Protocol Violation|1|||
17054963|NCT00492921|38198479|FG000|Overall Study|Death|1|||
17054964|NCT00492921|38198480|FG001|Overall Study|Death|0|||
17054965|NCT00492921|38198481|FG002|Overall Study|Death|1|||
17054966|NCT00502671|38198489|FG000|Overall Study|Disease Progression|13|||
17054967|NCT00502671|38198489|FG000|Overall Study|Personal Reasons|22|||
17054968|NCT00502671|38198489|FG000|Overall Study|Lost to Follow-up|7|||
17054969|NCT00502671|38198489|FG000|Overall Study|Protocol Violation|16|||
17054970|NCT00502671|38198489|FG000|Overall Study|Adverse Event|19|||
17144524|NCT02959918|38288292|FG009|Overall Study|Adverse Event|1|||
17054971|NCT00697463|38198493|FG000|Overall Study|Withdrawal by Subject|1|||
17054972|NCT00492531|38198499|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
17054973|NCT00492531|38198500|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
17144525|NCT02959918|38288293|FG010|Overall Study|Adverse Event|1|||
17054974|NCT00111475|38198516|FG000|Overall Study|Lost to Follow-up|0|||
17054975|NCT00111475|38198517|FG001|Overall Study|Lost to Follow-up|0|||
17054976|NCT00111475|38198518|FG002|Overall Study|Lost to Follow-up|0|||
17054977|NCT00111475|38198519|FG003|Overall Study|Lost to Follow-up|0|||
17054978|NCT00111475|38198520|FG004|Overall Study|Lost to Follow-up|0|||
17054979|NCT00111475|38198521|FG005|Overall Study|Lost to Follow-up|1|||
17054980|NCT00111475|38198522|FG006|Overall Study|Lost to Follow-up|0|||
17054981|NCT00111475|38198523|FG007|Overall Study|Lost to Follow-up|0|||
17054982|NCT00111475|38198524|FG008|Overall Study|Lost to Follow-up|0|||
17054983|NCT00111475|38198525|FG009|Overall Study|Lost to Follow-up|0|||
17054984|NCT00111241|38198554|FG000|Overall Study|Lost to Follow-up|1|||
17054985|NCT00111241|38198555|FG001|Overall Study|Lost to Follow-up|0|||
17054986|NCT00111241|38198554|FG000|Overall Study|Withdrawal by Subject|4|||
17054987|NCT00111241|38198555|FG001|Overall Study|Withdrawal by Subject|0|||
17054988|NCT00111241|38198554|FG000|Overall Study|Protocol Violation|9|||
17054989|NCT00111241|38198555|FG001|Overall Study|Protocol Violation|8|||
17144526|NCT02959918|38288294|FG011|Overall Study|Adverse Event|3|||
17144527|NCT02959918|38288295|FG012|Overall Study|Adverse Event|2|||
17144528|NCT02959918|38288296|FG013|Overall Study|Adverse Event|4|||
17144529|NCT02959918|38288283|FG000|Overall Study|Lost to Follow-up|0|||
17144530|NCT02959918|38288284|FG001|Overall Study|Lost to Follow-up|0|||
17144531|NCT02959918|38288285|FG002|Overall Study|Lost to Follow-up|0|||
17144532|NCT02959918|38288286|FG003|Overall Study|Lost to Follow-up|0|||
17144533|NCT02959918|38288287|FG004|Overall Study|Lost to Follow-up|0|||
17054990|NCT00111241|38198554|FG000|Overall Study|Adverse Event|1|||
17054991|NCT00111241|38198555|FG001|Overall Study|Adverse Event|0|||
17054992|NCT00492297|38198563|FG000|Treatment|Death|2|||
17054993|NCT00492297|38198563|FG000|Treatment|Study terminated by sponsor|3|||
17054994|NCT00492297|38198563|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
17054995|NCT00492297|38198563|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
17054996|NCT00492297|38198563|FG000|Survival Only Follow-up|Death|46|||
17054997|NCT00492297|38198563|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
17054998|NCT00492297|38198563|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
17054999|NCT00697073|38198567|FG000|Overall Study|Withdrawal by Subject|2|||
17055000|NCT00697073|38198567|FG000|Overall Study|Pregnancy|1|||
17055001|NCT00697073|38198567|FG000|Overall Study|non compliance and other|6|||
17055002|NCT00565058|38198573|FG000|Overall Study|Adverse Event|1|||
17055003|NCT00565058|38198574|FG001|Overall Study|Adverse Event|0|||
17055004|NCT00564902|38198583|FG000|Overall Study|Withdrawal by Subject|0|||
17055005|NCT00564902|38198584|FG001|Overall Study|Withdrawal by Subject|3|||
17055006|NCT00564902|38198585|FG002|Overall Study|Withdrawal by Subject|4|||
17055007|NCT00564902|38198583|FG000|Overall Study|Death|1|||
17055008|NCT00564902|38198584|FG001|Overall Study|Death|1|||
17055009|NCT00564902|38198585|FG002|Overall Study|Death|0|||
17055010|NCT00446134|38198597|FG000|Overall Study|Adverse Event|7|||
17055011|NCT00446134|38198598|FG001|Overall Study|Adverse Event|17|||
17055012|NCT00446134|38198599|FG002|Overall Study|Adverse Event|13|||
17055013|NCT00446134|38198600|FG003|Overall Study|Adverse Event|18|||
17055014|NCT00446134|38198597|FG000|Overall Study|Lack of Efficacy|19|||
17055015|NCT00446134|38198598|FG001|Overall Study|Lack of Efficacy|19|||
17055016|NCT00446134|38198599|FG002|Overall Study|Lack of Efficacy|24|||
17055017|NCT00446134|38198600|FG003|Overall Study|Lack of Efficacy|19|||
17055018|NCT00446134|38198597|FG000|Overall Study|Protocol Violation|0|||
17055019|NCT00446134|38198598|FG001|Overall Study|Protocol Violation|2|||
17055020|NCT00446134|38198599|FG002|Overall Study|Protocol Violation|1|||
17055021|NCT00446134|38198600|FG003|Overall Study|Protocol Violation|0|||
17055022|NCT00446134|38198597|FG000|Overall Study|Lost to Follow-up|1|||
17055023|NCT00446134|38198598|FG001|Overall Study|Lost to Follow-up|3|||
17055024|NCT00446134|38198599|FG002|Overall Study|Lost to Follow-up|1|||
17055025|NCT00446134|38198600|FG003|Overall Study|Lost to Follow-up|1|||
17055026|NCT00446134|38198597|FG000|Overall Study|Withdrawal by Subject|3|||
17055027|NCT00446134|38198598|FG001|Overall Study|Withdrawal by Subject|3|||
17055028|NCT00446134|38198599|FG002|Overall Study|Withdrawal by Subject|1|||
17144534|NCT02959918|38288288|FG005|Overall Study|Lost to Follow-up|0|||
17055029|NCT00446134|38198600|FG003|Overall Study|Withdrawal by Subject|3|||
17055030|NCT00446134|38198597|FG000|Overall Study|Physician Decision|0|||
17055031|NCT00446134|38198598|FG001|Overall Study|Physician Decision|0|||
17055032|NCT00446134|38198599|FG002|Overall Study|Physician Decision|0|||
17055033|NCT00446134|38198600|FG003|Overall Study|Physician Decision|2|||
17055034|NCT00446134|38198597|FG000|Overall Study|Adverse Event-Diarrhea|1|||
17055035|NCT00446134|38198598|FG001|Overall Study|Adverse Event-Diarrhea|1|||
17055036|NCT00446134|38198599|FG002|Overall Study|Adverse Event-Diarrhea|2|||
17055037|NCT00446134|38198600|FG003|Overall Study|Adverse Event-Diarrhea|0|||
17055038|NCT00446134|38198597|FG000|Overall Study|Reason Not Completed|3|||
17055039|NCT00446134|38198598|FG001|Overall Study|Reason Not Completed|0|||
17055040|NCT00446134|38198599|FG002|Overall Study|Reason Not Completed|1|||
17055041|NCT00446134|38198600|FG003|Overall Study|Reason Not Completed|2|||
17055042|NCT00563186|38198612|FG000|Overall Study|LOS<48 hours|97|||
17055043|NCT00563186|38198613|FG001|Overall Study|LOS<48 hours|74|||
17055044|NCT00563186|38198612|FG000|Overall Study|Incomplete data|1|||
17055045|NCT00563186|38198613|FG001|Overall Study|Incomplete data|1|||
17055046|NCT00699413|38198624|FG000|Overall Study|Withdrawal by Subject|0|||
17055047|NCT00699413|38198625|FG001|Overall Study|Withdrawal by Subject|2|||
17055048|NCT00699413|38198624|FG000|Overall Study|Study terminated by sponsor|4|||
17055049|NCT00699413|38198625|FG001|Overall Study|Study terminated by sponsor|2|||
17055050|NCT04808609|38198633|FG000|Overall Study|Lost to Follow-up|0|||
17055051|NCT04808609|38198634|FG001|Overall Study|Lost to Follow-up|2|||
17055052|NCT04808609|38198633|FG000|Overall Study|Administrative Withdrawal|0|||
17055053|NCT04808609|38198634|FG001|Overall Study|Administrative Withdrawal|1|||
17055054|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
17055055|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
17055056|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Death|5|||
17055057|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Death|2|||
17055058|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
17055059|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
17055060|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
17055061|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
17055062|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
17055063|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
17055064|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Relapse|1|||
17055065|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Relapse|0|||
17055066|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
17055067|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
17055068|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
17055069|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
17055070|NCT00111007|38198642|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
17055071|NCT00111007|38198643|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
17055072|NCT00111007|38198642|FG000|Active Follow-up|Adverse Event|1|||
17144535|NCT02959918|38288289|FG006|Overall Study|Lost to Follow-up|0|||
17144536|NCT02959918|38288290|FG007|Overall Study|Lost to Follow-up|0|||
17144537|NCT02959918|38288291|FG008|Overall Study|Lost to Follow-up|0|||
17055073|NCT00111007|38198643|FG001|Active Follow-up|Adverse Event|0|||
17144538|NCT02959918|38288292|FG009|Overall Study|Lost to Follow-up|1|||
17144539|NCT02959918|38288293|FG010|Overall Study|Lost to Follow-up|0|||
17144540|NCT02959918|38288294|FG011|Overall Study|Lost to Follow-up|0|||
17144541|NCT02959918|38288295|FG012|Overall Study|Lost to Follow-up|1|||
17055074|NCT00111007|38198642|FG000|Active Follow-up|Death|2|||
17055075|NCT00111007|38198643|FG001|Active Follow-up|Death|0|||
17055076|NCT00111007|38198642|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
17055077|NCT00111007|38198643|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
17055078|NCT00111007|38198642|FG000|Long Term Follow-up|Death|34|||
17055079|NCT00111007|38198643|FG001|Long Term Follow-up|Death|39|||
17055080|NCT00111007|38198642|FG000|Long Term Follow-up|Lost to Follow-up|1|||
17055081|NCT00111007|38198643|FG001|Long Term Follow-up|Lost to Follow-up|1|||
17055082|NCT00111007|38198642|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
17055083|NCT00111007|38198643|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
17055084|NCT00111007|38198642|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
17055085|NCT00111007|38198643|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
17055086|NCT00111007|38198642|FG000|Long Term Follow-up|Missing|10|||
17055087|NCT00111007|38198643|FG001|Long Term Follow-up|Missing|3|||
17055088|NCT03975920|38198651|FG000|Overall Study|Lost to Follow-up|1|||
17055089|NCT03975920|38198652|FG001|Overall Study|Lost to Follow-up|2|||
17055090|NCT03975920|38198651|FG000|Overall Study|Protocol Violation|1|||
17055091|NCT03975920|38198652|FG001|Overall Study|Protocol Violation|1|||
17055092|NCT03975920|38198651|FG000|Overall Study|Did not complete survey|2|||
17055093|NCT03975920|38198652|FG001|Overall Study|Did not complete survey|1|||
17055094|NCT00699335|38198658|FG000|Overall Study|Combination of multiple reasons|176|||
17144542|NCT02959918|38288296|FG013|Overall Study|Lost to Follow-up|0|||
17055095|NCT00699335|38198658|FG000|Overall Study|Missing data|52|||
17055096|NCT00445978|38198665|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
17055097|NCT00445978|38198665|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
17055098|NCT00445978|38198665|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
17055099|NCT00445978|38198665|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
17055100|NCT00445978|38198665|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
17055101|NCT00445978|38198665|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
17055102|NCT00445978|38198665|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
17055103|NCT00445978|38198665|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
17055104|NCT00445978|38198665|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
17055105|NCT00566228|38198678|FG000|Overall Study|Withdrawal by Subject|1|||
17055106|NCT00566228|38198679|FG001|Overall Study|Withdrawal by Subject|0|||
17055107|NCT00566228|38198678|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
17055108|NCT00566228|38198679|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
17055109|NCT00566228|38198678|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
17055110|NCT00566228|38198679|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
17055111|NCT00566228|38198678|FG000|Overall Study|progressed before infusion could occur|0|||
17055112|NCT00566228|38198679|FG001|Overall Study|progressed before infusion could occur|1|||
17055113|NCT00698009|38198685|FG000|Overall Study|Withdrawal by Subject|1|||
17055114|NCT03968978|38198691|FG000|Overall Study|Adverse Event|1|||
17055115|NCT03968978|38198692|FG001|Overall Study|Adverse Event|0|||
17055116|NCT00562718|38198698|FG000|Overall Study|Death|1|||
17055117|NCT00562718|38198698|FG000|Overall Study|Withdrawal by Subject|3|||
17055118|NCT00562718|38198698|FG000|Overall Study|Adverse Event|4|||
17055119|NCT00562718|38198698|FG000|Overall Study|Lack of Efficacy|2|||
17055120|NCT00562718|38198698|FG000|Overall Study|not stated|1|||
17055121|NCT00697619|38198704|FG000|Overall Study|Lack of Efficacy|2|||
17055122|NCT00697619|38198705|FG001|Overall Study|Lack of Efficacy|2|||
17055123|NCT00697619|38198704|FG000|Overall Study|Adverse Event|4|||
17055124|NCT00697619|38198705|FG001|Overall Study|Adverse Event|6|||
17055125|NCT00445432|38198714|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
17055126|NCT00445432|38198715|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
17144543|NCT02959918|38288283|FG000|Overall Study|Withdrawal by Subject|0|||
17144544|NCT02959918|38288284|FG001|Overall Study|Withdrawal by Subject|0|||
17055127|NCT00445432|38198716|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
17055128|NCT00445432|38198717|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
17055129|NCT00445432|38198714|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
17055130|NCT00445432|38198715|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
17055131|NCT00445432|38198716|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
17055132|NCT00445432|38198717|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
17055133|NCT00445432|38198714|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
17055134|NCT00445432|38198715|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
17144545|NCT02959918|38288285|FG002|Overall Study|Withdrawal by Subject|1|||
17144546|NCT02959918|38288286|FG003|Overall Study|Withdrawal by Subject|2|||
17144547|NCT02959918|38288287|FG004|Overall Study|Withdrawal by Subject|0|||
17144548|NCT02959918|38288288|FG005|Overall Study|Withdrawal by Subject|0|||
17144549|NCT02959918|38288289|FG006|Overall Study|Withdrawal by Subject|1|||
17144550|NCT02959918|38288290|FG007|Overall Study|Withdrawal by Subject|0|||
17144551|NCT02959918|38288291|FG008|Overall Study|Withdrawal by Subject|1|||
17144552|NCT02959918|38288292|FG009|Overall Study|Withdrawal by Subject|1|||
17144553|NCT02959918|38288293|FG010|Overall Study|Withdrawal by Subject|2|||
17144554|NCT02959918|38288294|FG011|Overall Study|Withdrawal by Subject|3|||
17144555|NCT02959918|38288295|FG012|Overall Study|Withdrawal by Subject|1|||
17144556|NCT02959918|38288296|FG013|Overall Study|Withdrawal by Subject|1|||
17144557|NCT02959918|38288283|FG000|Overall Study|Protocol Violation|0|||
17144558|NCT02959918|38288284|FG001|Overall Study|Protocol Violation|0|||
17144559|NCT02959918|38288285|FG002|Overall Study|Protocol Violation|1|||
17144560|NCT02959918|38288286|FG003|Overall Study|Protocol Violation|0|||
17144561|NCT02959918|38288287|FG004|Overall Study|Protocol Violation|0|||
17055135|NCT00445432|38198716|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
17055136|NCT00445432|38198717|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
17055137|NCT00445432|38198714|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
17055138|NCT00445432|38198715|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
17055139|NCT00445432|38198716|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
17055140|NCT00445432|38198717|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
17055141|NCT00445432|38198714|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
17055142|NCT00445432|38198715|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
17055143|NCT00445432|38198716|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
17055144|NCT00445432|38198717|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
17055145|NCT00445432|38198714|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
17055146|NCT00445432|38198715|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
17144562|NCT02959918|38288288|FG005|Overall Study|Protocol Violation|1|||
17055147|NCT00445432|38198716|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
17055148|NCT00445432|38198717|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
17055149|NCT00445432|38198714|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
17055150|NCT00445432|38198715|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
17055151|NCT00445432|38198716|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
17055152|NCT00445432|38198717|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
17055153|NCT03370133|38198731|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
17144563|NCT02959918|38288289|FG006|Overall Study|Protocol Violation|0|||
17144564|NCT02959918|38288290|FG007|Overall Study|Protocol Violation|0|||
17144565|NCT02959918|38288291|FG008|Overall Study|Protocol Violation|2|||
17144566|NCT02959918|38288292|FG009|Overall Study|Protocol Violation|1|||
17144567|NCT02959918|38288293|FG010|Overall Study|Protocol Violation|0|||
17144568|NCT02959918|38288294|FG011|Overall Study|Protocol Violation|1|||
17144569|NCT02959918|38288295|FG012|Overall Study|Protocol Violation|1|||
17144570|NCT02959918|38288296|FG013|Overall Study|Protocol Violation|0|||
17144571|NCT02959918|38288283|FG000|Overall Study|Stopping Rule Met|1|||
17144572|NCT02959918|38288284|FG001|Overall Study|Stopping Rule Met|0|||
17144573|NCT02959918|38288285|FG002|Overall Study|Stopping Rule Met|3|||
17144574|NCT02959918|38288286|FG003|Overall Study|Stopping Rule Met|4|||
17144575|NCT02959918|38288287|FG004|Overall Study|Stopping Rule Met|5|||
17144576|NCT02959918|38288288|FG005|Overall Study|Stopping Rule Met|3|||
17144577|NCT02959918|38288289|FG006|Overall Study|Stopping Rule Met|2|||
17144578|NCT02959918|38288290|FG007|Overall Study|Stopping Rule Met|4|||
17144579|NCT02959918|38288291|FG008|Overall Study|Stopping Rule Met|1|||
17144580|NCT02959918|38288292|FG009|Overall Study|Stopping Rule Met|1|||
17144581|NCT02959918|38288293|FG010|Overall Study|Stopping Rule Met|3|||
17144582|NCT02959918|38288294|FG011|Overall Study|Stopping Rule Met|5|||
17144583|NCT02959918|38288295|FG012|Overall Study|Stopping Rule Met|2|||
17144584|NCT02959918|38288296|FG013|Overall Study|Stopping Rule Met|1|||
17144585|NCT02959918|38288283|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
17144586|NCT02959918|38288284|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
17144587|NCT02959918|38288285|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
17144588|NCT02959918|38288286|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
17144589|NCT02959918|38288287|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144590|NCT02959918|38288288|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144591|NCT02959918|38288289|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144592|NCT02959918|38288290|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144593|NCT02959918|38288291|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144594|NCT02959918|38288292|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144595|NCT02959918|38288293|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144596|NCT02959918|38288294|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144597|NCT02959918|38288295|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144598|NCT02959918|38288296|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
17144599|NCT02959918|38288283|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144600|NCT02959918|38288284|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144601|NCT02959918|38288285|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144602|NCT02959918|38288286|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144603|NCT02959918|38288287|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144604|NCT02959918|38288288|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144605|NCT02959918|38288289|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144606|NCT02959918|38288290|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
17055154|NCT03370133|38198732|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
17055155|NCT03370133|38198733|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
17055156|NCT03370133|38198734|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
17055157|NCT03370133|38198735|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
17055158|NCT03370133|38198736|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
17055159|NCT03370133|38198731|FG000|Initial Treatment Period (WK 16)|Death|1|||
17055160|NCT03370133|38198732|FG001|Initial Treatment Period (WK 16)|Death|1|||
17055161|NCT03370133|38198733|FG002|Initial Treatment Period (WK 16)|Death|1|||
17055162|NCT03370133|38198734|FG003|Initial Treatment Period (WK 16)|Death|0|||
17055163|NCT03370133|38198735|FG004|Initial Treatment Period (WK 16)|Death|0|||
17055164|NCT03370133|38198736|FG005|Initial Treatment Period (WK 16)|Death|0|||
17055165|NCT03370133|38198731|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
17055166|NCT03370133|38198732|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
17055167|NCT03370133|38198733|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
17055168|NCT03370133|38198734|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
17055169|NCT03370133|38198735|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
17055170|NCT03370133|38198736|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
17055171|NCT03370133|38198731|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
17055172|NCT03370133|38198732|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
17055173|NCT03370133|38198733|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
17055174|NCT03370133|38198734|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
17055175|NCT03370133|38198735|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
17055176|NCT03370133|38198736|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
17055177|NCT03370133|38198731|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
17055178|NCT03370133|38198732|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
17055179|NCT03370133|38198733|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
17055180|NCT03370133|38198734|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
17055181|NCT03370133|38198735|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
17055182|NCT03370133|38198736|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
17055183|NCT03370133|38198731|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
17055184|NCT03370133|38198732|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
17055185|NCT03370133|38198733|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
17055186|NCT03370133|38198734|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
17055187|NCT03370133|38198735|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
17055188|NCT03370133|38198736|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
17055189|NCT03370133|38198731|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
17055190|NCT03370133|38198732|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
17055191|NCT03370133|38198733|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
17055192|NCT03370133|38198734|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
17055193|NCT03370133|38198735|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
17055194|NCT03370133|38198736|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
17055195|NCT03370133|38198731|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
17055196|NCT03370133|38198732|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
17055197|NCT03370133|38198733|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
17055198|NCT03370133|38198734|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
17055199|NCT03370133|38198735|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
17055200|NCT03370133|38198736|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
17055201|NCT03370133|38198731|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
17055202|NCT03370133|38198732|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
17055203|NCT03370133|38198733|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
17055204|NCT03370133|38198734|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
17055205|NCT03370133|38198735|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
17055206|NCT03370133|38198736|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
17055207|NCT03370133|38198731|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
17055208|NCT03370133|38198732|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
17055209|NCT03370133|38198733|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
17055210|NCT03370133|38198734|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
17055211|NCT03370133|38198735|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
17055212|NCT03370133|38198736|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
17055213|NCT03370133|38198731|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
17055214|NCT03370133|38198732|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
17055215|NCT03370133|38198733|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
17055216|NCT03370133|38198734|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
17055217|NCT03370133|38198735|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
17055218|NCT03370133|38198736|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
17055219|NCT03370133|38198731|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
17055220|NCT03370133|38198732|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
17055221|NCT03370133|38198733|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
17055222|NCT03370133|38198734|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
17055223|NCT03370133|38198735|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
17055224|NCT03370133|38198736|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
17055225|NCT03370133|38198731|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
17055226|NCT03370133|38198732|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
17055227|NCT03370133|38198733|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
17055228|NCT03370133|38198734|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
17055229|NCT03370133|38198735|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
17055230|NCT03370133|38198736|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
17055231|NCT03370133|38198731|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
17055232|NCT03370133|38198732|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
17055233|NCT03370133|38198733|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
17055234|NCT03370133|38198734|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
17055235|NCT03370133|38198735|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
17055236|NCT03370133|38198736|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
17055237|NCT03370133|38198731|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
17055238|NCT03370133|38198732|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
17055239|NCT03370133|38198733|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
16780968|NCT02174848|37720097|FG001|Overall Study|Lost to Follow-up|1|||
16992967|NCT00722371|38136945|FG002|Overall Study|Withdrawal by Subject|19|||
16992968|NCT00722371|38136946|FG003|Overall Study|Withdrawal by Subject|23|||
16992969|NCT00722371|38136947|FG004|Overall Study|Withdrawal by Subject|19|||
16992970|NCT00722371|38136948|FG005|Overall Study|Withdrawal by Subject|18|||
16992971|NCT00722371|38136949|FG006|Overall Study|Withdrawal by Subject|26|||
16992972|NCT00722137|38136967|FG000|Overall Study|Overt Disease Progression|5|||
16992973|NCT00722137|38136968|FG001|Overall Study|Overt Disease Progression|4|||
16992974|NCT00722137|38136967|FG000|Overall Study|Adverse Event|17|||
16992975|NCT00722137|38136968|FG001|Overall Study|Adverse Event|21|||
16992976|NCT00722137|38136967|FG000|Overall Study|Death|12|||
16992977|NCT00722137|38136968|FG001|Overall Study|Death|7|||
16992978|NCT00722137|38136967|FG000|Overall Study|Withdrawal by Subject|6|||
16992979|NCT00722137|38136968|FG001|Overall Study|Withdrawal by Subject|9|||
16992980|NCT00722137|38136967|FG000|Overall Study|Other Reason Unknown|3|||
16992981|NCT00722137|38136968|FG001|Overall Study|Other Reason Unknown|4|||
16992982|NCT00722137|38136967|FG000|Overall Study|Randomized But Not Treated|2|||
16992983|NCT00722137|38136968|FG001|Overall Study|Randomized But Not Treated|3|||
16992984|NCT02281084|38136978|FG000|Overall Study|Adverse Event|1|||
16992985|NCT02281084|38136979|FG001|Overall Study|Adverse Event|0|||
17055240|NCT03370133|38198734|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
17055241|NCT03370133|38198735|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
17055242|NCT03370133|38198736|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
17055243|NCT00696137|38198754|FG000|Overall Study|Withdrawal by Subject|2|||
17055244|NCT00441142|38198762|FG000|Overall Study|Adverse Event|2|||
17055245|NCT00441142|38198763|FG001|Overall Study|Adverse Event|3|||
17055246|NCT00441142|38198764|FG002|Overall Study|Adverse Event|3|||
17055247|NCT00441142|38198765|FG003|Overall Study|Adverse Event|22|||
17055248|NCT00441142|38198762|FG000|Overall Study|Lack of Efficacy|3|||
17055249|NCT00441142|38198763|FG001|Overall Study|Lack of Efficacy|3|||
17055250|NCT00441142|38198764|FG002|Overall Study|Lack of Efficacy|17|||
17055251|NCT00441142|38198765|FG003|Overall Study|Lack of Efficacy|32|||
17055252|NCT00441142|38198762|FG000|Overall Study|Withdrawal by Subject|0|||
17055253|NCT00441142|38198763|FG001|Overall Study|Withdrawal by Subject|0|||
17055254|NCT00441142|38198764|FG002|Overall Study|Withdrawal by Subject|2|||
17055255|NCT00441142|38198765|FG003|Overall Study|Withdrawal by Subject|10|||
17055256|NCT00441142|38198762|FG000|Overall Study|Patient still receiving active study tx|1|||
17055257|NCT00441142|38198763|FG001|Overall Study|Patient still receiving active study tx|0|||
17055258|NCT00441142|38198764|FG002|Overall Study|Patient still receiving active study tx|0|||
17055259|NCT00441142|38198765|FG003|Overall Study|Patient still receiving active study tx|2|||
17055260|NCT00441142|38198762|FG000|Overall Study|Physician Decision|0|||
17055261|NCT00441142|38198763|FG001|Overall Study|Physician Decision|1|||
17055262|NCT00441142|38198764|FG002|Overall Study|Physician Decision|0|||
17055263|NCT00441142|38198765|FG003|Overall Study|Physician Decision|1|||
17055264|NCT00441142|38198762|FG000|Overall Study|Death|0|||
17055265|NCT00441142|38198763|FG001|Overall Study|Death|0|||
17055266|NCT00441142|38198764|FG002|Overall Study|Death|0|||
17055267|NCT00441142|38198765|FG003|Overall Study|Death|1|||
17055268|NCT04025021|38198779|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
17055269|NCT04025021|38198780|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
17055270|NCT03848416|38198790|FG000|Overall Study|Withdrawal by Subject|1|||
17055271|NCT03848416|38198791|FG001|Overall Study|Withdrawal by Subject|0|||
17055272|NCT03848416|38198792|FG002|Overall Study|Withdrawal by Subject|0|||
17055273|NCT03848416|38198790|FG000|Overall Study|Death|0|||
17055274|NCT03848416|38198791|FG001|Overall Study|Death|0|||
17055275|NCT03848416|38198792|FG002|Overall Study|Death|1|||
17055276|NCT00458302|38198802|FG000|Overall Study|Adverse Event|4|||
17055277|NCT00458302|38198803|FG001|Overall Study|Adverse Event|14|||
17055278|NCT00458302|38198802|FG000|Overall Study|Pregnancy|2|||
17055279|NCT00458302|38198803|FG001|Overall Study|Pregnancy|1|||
17055280|NCT00458302|38198802|FG000|Overall Study|Protocol Violation|0|||
17055281|NCT00458302|38198803|FG001|Overall Study|Protocol Violation|2|||
17055282|NCT00458302|38198802|FG000|Overall Study|Withdrawal by Subject|6|||
17055283|NCT00458302|38198803|FG001|Overall Study|Withdrawal by Subject|4|||
17055284|NCT00458302|38198802|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
17055285|NCT00458302|38198803|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
17055286|NCT00458302|38198802|FG000|Overall Study|Study Termination By Sponsor|1|||
17055287|NCT00458302|38198803|FG001|Overall Study|Study Termination By Sponsor|0|||
17055288|NCT00458302|38198802|FG000|Overall Study|Lost to Follow-up|2|||
17055289|NCT00458302|38198803|FG001|Overall Study|Lost to Follow-up|0|||
17055290|NCT00458302|38198802|FG000|Overall Study|Other|4|||
17055291|NCT00458302|38198803|FG001|Overall Study|Other|2|||
17055292|NCT00444106|38198813|FG000|Overall Study|Lost to Follow-up|2|||
17055293|NCT00444106|38198814|FG001|Overall Study|Lost to Follow-up|1|||
17055294|NCT00444106|38198815|FG002|Overall Study|Lost to Follow-up|0|||
17055295|NCT00444106|38198813|FG000|Overall Study|Abnormal Test Procedure Results|0|||
17055296|NCT00444106|38198814|FG001|Overall Study|Abnormal Test Procedure Results|0|||
17055297|NCT00444106|38198815|FG002|Overall Study|Abnormal Test Procedure Results|1|||
17055298|NCT00561470|38198828|FG000|Overall Study|Adverse Event|74|||
17055299|NCT00561470|38198829|FG001|Overall Study|Adverse Event|163|||
17055300|NCT00561470|38198828|FG000|Overall Study|Disease progression|437|||
17055301|NCT00561470|38198829|FG001|Overall Study|Disease progression|305|||
17055302|NCT00561470|38198828|FG000|Overall Study|poor compliance to protocol|4|||
17055303|NCT00561470|38198829|FG001|Overall Study|poor compliance to protocol|4|||
17055304|NCT00561470|38198828|FG000|Overall Study|Lost to Follow-up|2|||
17055305|NCT00561470|38198829|FG001|Overall Study|Lost to Follow-up|0|||
17055306|NCT00561470|38198828|FG000|Overall Study|Physician Decision|21|||
17055307|NCT00561470|38198829|FG001|Overall Study|Physician Decision|20|||
17055308|NCT00561470|38198828|FG000|Overall Study|Consent Withdrawn|2|||
17055309|NCT00561470|38198829|FG001|Overall Study|Consent Withdrawn|6|||
17055310|NCT00561470|38198828|FG000|Overall Study|Subject request|43|||
17055311|NCT00561470|38198829|FG001|Overall Study|Subject request|77|||
17055312|NCT00561470|38198828|FG000|Overall Study|Metastatic surgery|10|||
17055313|NCT00561470|38198829|FG001|Overall Study|Metastatic surgery|12|||
17055314|NCT00561470|38198828|FG000|Overall Study|Unauthorized procedure|3|||
17055315|NCT00561470|38198829|FG001|Overall Study|Unauthorized procedure|1|||
17055316|NCT00561470|38198828|FG000|Overall Study|Randomized but not treated|5|||
17055317|NCT00561470|38198829|FG001|Overall Study|Randomized but not treated|5|||
17055318|NCT00561470|38198828|FG000|Overall Study|Missed visit window|1|||
17055319|NCT00561470|38198829|FG001|Overall Study|Missed visit window|4|||
17055320|NCT00561470|38198828|FG000|Overall Study|Planning surgery|1|||
17055321|NCT00561470|38198829|FG001|Overall Study|Planning surgery|1|||
17055322|NCT00561470|38198828|FG000|Overall Study|Ongoing Treatment|11|||
17055323|NCT00561470|38198829|FG001|Overall Study|Ongoing Treatment|14|||
17055324|NCT00443872|38198837|FG000|Overall Study|Protocol Violation|7|||
17055325|NCT00443872|38198837|FG000|Overall Study|Lost to Follow-up|2|||
17055326|NCT00443872|38198837|FG000|Overall Study|Adverse Event|8|||
17055327|NCT00441064|38198852|FG000|Overall Study|Adverse Event|1|||
17055328|NCT00441064|38198853|FG001|Overall Study|Adverse Event|0|||
17055329|NCT00441064|38198852|FG000|Overall Study|Abnormal laboratory values|0|||
17055330|NCT00441064|38198853|FG001|Overall Study|Abnormal laboratory values|2|||
17055331|NCT00441064|38198852|FG000|Overall Study|Abnormal test procedure results|0|||
17055332|NCT00441064|38198853|FG001|Overall Study|Abnormal test procedure results|1|||
17055333|NCT00441064|38198852|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17055334|NCT00441064|38198853|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17055335|NCT00441064|38198852|FG000|Overall Study|Protocol Deviation|3|||
17055336|NCT00441064|38198853|FG001|Overall Study|Protocol Deviation|2|||
17055337|NCT00441064|38198852|FG000|Overall Study|Patient withdrew consent|5|||
17144607|NCT02959918|38288291|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144608|NCT02959918|38288292|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144609|NCT02959918|38288293|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144610|NCT02959918|38288294|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144611|NCT02959918|38288295|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144612|NCT02959918|38288296|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
17144613|NCT02959918|38288283|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144614|NCT02959918|38288284|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144615|NCT02959918|38288285|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144616|NCT02959918|38288286|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144617|NCT02959918|38288287|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144618|NCT02959918|38288288|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144619|NCT02959918|38288289|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144620|NCT02959918|38288290|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144621|NCT02959918|38288291|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
17144622|NCT02959918|38288292|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144623|NCT02959918|38288293|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144624|NCT02959918|38288294|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144625|NCT02959918|38288295|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17055338|NCT00441064|38198853|FG001|Overall Study|Patient withdrew consent|2|||
17055339|NCT03962738|38198863|FG000|Overall Study|Protocol Deviation|3|||
17055340|NCT03962738|38198864|FG001|Overall Study|Protocol Deviation|0|||
17055341|NCT03962738|38198865|FG002|Overall Study|Protocol Deviation|1|||
17055342|NCT03962738|38198866|FG003|Overall Study|Protocol Deviation|1|||
17055343|NCT03962738|38198863|FG000|Overall Study|Withdrawal by Subject|4|||
17055344|NCT03962738|38198864|FG001|Overall Study|Withdrawal by Subject|0|||
17055345|NCT03962738|38198865|FG002|Overall Study|Withdrawal by Subject|0|||
17055346|NCT03962738|38198866|FG003|Overall Study|Withdrawal by Subject|0|||
17055347|NCT03962738|38198863|FG000|Overall Study|Lost to Follow-up|0|||
17055348|NCT03962738|38198864|FG001|Overall Study|Lost to Follow-up|0|||
17055349|NCT03962738|38198865|FG002|Overall Study|Lost to Follow-up|1|||
17055350|NCT03962738|38198866|FG003|Overall Study|Lost to Follow-up|0|||
17055351|NCT00561392|38198884|FG000|Overall Study|Adverse Event|38|||
17055352|NCT00561392|38198884|FG000|Overall Study|Lack of Efficacy|2|||
17055353|NCT00561392|38198884|FG000|Overall Study|Protocol Violation|1|||
17055354|NCT00561392|38198884|FG000|Overall Study|Withdrawal by Subject|8|||
17055355|NCT00561392|38198884|FG000|Overall Study|Administrative problems|4|||
17055356|NCT00694109|38198888|FG000|Overall Study|Physician Decision|3|||
17055357|NCT00694109|38198888|FG000|Overall Study|Adverse Event|74|||
17055358|NCT00694109|38198888|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
17055359|NCT00694109|38198888|FG000|Overall Study|Lack of Efficacy|2|||
17055360|NCT00694109|38198888|FG000|Overall Study|Withdrawal by Subject|13|||
17055361|NCT00694109|38198888|FG000|Overall Study|Pregnancy|1|||
17055362|NCT00694109|38198888|FG000|Overall Study|Enrolled but not treated|1|||
17055363|NCT00694109|38198888|FG000|Overall Study|Other|2|||
17055364|NCT00694109|38198888|FG000|Overall Study|Consented but no additional treatment|3|||
17055365|NCT00562484|38198899|FG000|Overall Study|Adverse Event|6|||
17055366|NCT00562484|38198900|FG001|Overall Study|Adverse Event|1|||
17055367|NCT00562484|38198899|FG000|Overall Study|Protocol Violation|11|||
17055368|NCT00562484|38198900|FG001|Overall Study|Protocol Violation|2|||
17055369|NCT00562484|38198899|FG000|Overall Study|Withdrawal by Subject|12|||
17055370|NCT00562484|38198900|FG001|Overall Study|Withdrawal by Subject|9|||
17055371|NCT00562484|38198899|FG000|Overall Study|Moved away from the study area|20|||
17055372|NCT00562484|38198900|FG001|Overall Study|Moved away from the study area|9|||
17055373|NCT00562484|38198899|FG000|Overall Study|Lost to Follow-up|132|||
17055374|NCT00562484|38198900|FG001|Overall Study|Lost to Follow-up|71|||
17055375|NCT00562484|38198899|FG000|Overall Study|Reason not provided or not specified|25|||
17055376|NCT00562484|38198900|FG001|Overall Study|Reason not provided or not specified|12|||
17055377|NCT00561080|38198909|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
17055378|NCT00561080|38198910|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
17055379|NCT00561080|38198911|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
17055380|NCT00561080|38198909|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
17055381|NCT00561080|38198910|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
17055382|NCT00561080|38198911|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
17055383|NCT00561080|38198909|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
17055384|NCT00561080|38198910|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
17055385|NCT00561080|38198911|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
17055386|NCT00561080|38198909|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
17055387|NCT00561080|38198910|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
17055388|NCT00561080|38198911|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
17055389|NCT00561080|38198909|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
17055390|NCT00561080|38198910|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
17055391|NCT00561080|38198911|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
17055392|NCT00561080|38198909|FG000|Vaccination Period (up to Month 4)|Other|0|||
17055393|NCT00561080|38198910|FG001|Vaccination Period (up to Month 4)|Other|2|||
17055394|NCT00561080|38198911|FG002|Vaccination Period (up to Month 4)|Other|1|||
17055395|NCT00561080|38198909|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
17055396|NCT00561080|38198910|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
17055397|NCT00561080|38198911|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
17055398|NCT00561080|38198909|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
17055399|NCT00561080|38198910|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
17055400|NCT00561080|38198911|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
17055401|NCT00561080|38198909|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
17055402|NCT00561080|38198910|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
17055403|NCT00561080|38198911|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
17055404|NCT00561080|38198909|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
17055405|NCT00561080|38198910|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
17055406|NCT00561080|38198911|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
17055407|NCT00562094|38198921|FG000|Overall Study|Lost to Follow-up|62|||
17055408|NCT03817853|38198929|FG000|Induction Phase|Adverse Event|5|||
17055409|NCT03817853|38198930|FG001|Induction Phase|Adverse Event|0|||
17055410|NCT03817853|38198931|FG002|Induction Phase|Adverse Event|0|||
17055411|NCT03817853|38198929|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
17055412|NCT03817853|38198930|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
17055413|NCT03817853|38198931|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
17055414|NCT03817853|38198929|FG000|Induction Phase|Physician Decision|2|||
17055415|NCT03817853|38198930|FG001|Induction Phase|Physician Decision|0|||
17055416|NCT03817853|38198931|FG002|Induction Phase|Physician Decision|0|||
17144626|NCT02959918|38288296|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
17144627|NCT02959918|38288283|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144628|NCT02959918|38288284|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144629|NCT02959918|38288285|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144630|NCT02959918|38288286|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144631|NCT02959918|38288287|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144632|NCT02959918|38288288|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17055417|NCT03817853|38198929|FG000|Induction Phase|Progressive Disease|4|||
17055418|NCT03817853|38198930|FG001|Induction Phase|Progressive Disease|0|||
17055419|NCT03817853|38198931|FG002|Induction Phase|Progressive Disease|0|||
17055420|NCT03817853|38198929|FG000|Induction Phase|Withdrawal by Subject|3|||
17055421|NCT03817853|38198930|FG001|Induction Phase|Withdrawal by Subject|0|||
17055422|NCT03817853|38198931|FG002|Induction Phase|Withdrawal by Subject|0|||
17055423|NCT03817853|38198929|FG000|Induction Phase|Continuing on Study|34|||
17055424|NCT03817853|38198930|FG001|Induction Phase|Continuing on Study|0|||
17055425|NCT03817853|38198931|FG002|Induction Phase|Continuing on Study|0|||
17055426|NCT03817853|38198929|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
17055427|NCT03817853|38198930|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
17055428|NCT03817853|38198931|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
17055429|NCT03817853|38198929|FG000|Maintenance/ Follow-up Phase|Death|0|||
17055430|NCT03817853|38198930|FG001|Maintenance/ Follow-up Phase|Death|1|||
17055431|NCT03817853|38198931|FG002|Maintenance/ Follow-up Phase|Death|1|||
17055432|NCT03817853|38198929|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
17144633|NCT02959918|38288289|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144634|NCT02959918|38288290|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17055433|NCT03817853|38198930|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
17055434|NCT03817853|38198931|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
17055435|NCT03817853|38198929|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
17055436|NCT03817853|38198930|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
17055437|NCT03817853|38198931|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
17055438|NCT03817853|38198929|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
17055439|NCT03817853|38198930|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
17055440|NCT03817853|38198931|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
17055441|NCT00439270|38198944|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
17055442|NCT00439270|38198945|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
17055443|NCT00439270|38198946|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
17055444|NCT00439270|38198947|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
17055445|NCT00439270|38198948|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
17055446|NCT00439270|38198944|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
17055447|NCT00439270|38198945|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
17055448|NCT00439270|38198946|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
17055449|NCT00439270|38198947|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
17055450|NCT00439270|38198948|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
17055451|NCT00439270|38198944|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
17055452|NCT00439270|38198945|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
17055453|NCT00439270|38198946|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
17055454|NCT00439270|38198947|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
17055455|NCT00439270|38198948|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
17055456|NCT00439270|38198944|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
17055457|NCT00439270|38198945|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
17055458|NCT00439270|38198946|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
17055459|NCT00439270|38198947|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
17055460|NCT00439270|38198948|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
17055461|NCT00439270|38198944|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
17055462|NCT00439270|38198945|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
17055463|NCT00439270|38198946|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
17055464|NCT00439270|38198947|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
17055465|NCT00439270|38198948|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
17055466|NCT00439270|38198944|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
17055467|NCT00439270|38198945|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
17055468|NCT00439270|38198946|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
17055469|NCT00439270|38198947|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
17055470|NCT00439270|38198948|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
17055471|NCT00439270|38198944|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
17055472|NCT00439270|38198945|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
17055473|NCT00439270|38198946|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
17055474|NCT00439270|38198947|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
17055475|NCT00439270|38198948|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
17144635|NCT02959918|38288291|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144636|NCT02959918|38288292|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
17144637|NCT02959918|38288293|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144638|NCT02959918|38288294|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144639|NCT02959918|38288295|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144640|NCT02959918|38288296|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
17144641|NCT03263442|38288331|FG000|Inpatient Phase|Death|1|||
17144642|NCT03263442|38288332|FG001|Inpatient Phase|Death|0|||
17144643|NCT03263442|38288331|FG000|Inpatient Phase|Withdrawal by Subject|1|||
17144644|NCT03263442|38288332|FG001|Inpatient Phase|Withdrawal by Subject|0|||
17144645|NCT03263442|38288331|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
17144646|NCT03263442|38288332|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
17144647|NCT03263442|38288331|FG000|1-month Follow-Up|Lost to Follow-up|1|||
17144648|NCT03263442|38288332|FG001|1-month Follow-Up|Lost to Follow-up|0|||
17144649|NCT03263442|38288331|FG000|3-month Follow-Up|Lost to Follow-up|1|||
17144650|NCT03263442|38288332|FG001|3-month Follow-Up|Lost to Follow-up|3|||
17144651|NCT03263442|38288331|FG000|6-month Follow-Up|Lost to Follow-up|2|||
17144652|NCT03263442|38288332|FG001|6-month Follow-Up|Lost to Follow-up|2|||
17144653|NCT04245709|38288340|FG000|Overall Study|Adverse Event|13|||
17144654|NCT04245709|38288340|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
17144655|NCT04091581|38288346|FG000|Overall Study|Lost to Follow-up|0|||
17055476|NCT00439270|38198944|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
17055477|NCT00439270|38198945|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
17055478|NCT00439270|38198946|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
17055479|NCT00439270|38198947|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
17055480|NCT00439270|38198948|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
17055481|NCT00439270|38198944|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
17055482|NCT00439270|38198945|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
17055483|NCT00439270|38198946|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
17055484|NCT00439270|38198947|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
17055485|NCT00439270|38198948|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
17055486|NCT00439270|38198944|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
17055487|NCT00439270|38198945|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
17055488|NCT00439270|38198946|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
17055489|NCT00439270|38198947|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
17055490|NCT00439270|38198948|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
17055491|NCT00553280|38198967|FG000|Overall Study|Adverse Event|19|||
17055492|NCT00553280|38198967|FG000|Overall Study|Lack of Efficacy|3|||
17055493|NCT00553280|38198967|FG000|Overall Study|Withdrawal by Subject|3|||
17055494|NCT00553280|38198967|FG000|Overall Study|Physician Decision|1|||
17055495|NCT00440518|38198974|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
17055496|NCT00440518|38198975|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
17055497|NCT00440518|38198976|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
17055498|NCT00440518|38198974|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
17055499|NCT00440518|38198975|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
17055500|NCT00440518|38198976|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
17055501|NCT00440518|38198974|FG000|Randomized /Titration Period|Protocol Deviation|1|||
17055502|NCT00440518|38198975|FG001|Randomized /Titration Period|Protocol Deviation|0|||
17055503|NCT00440518|38198976|FG002|Randomized /Titration Period|Protocol Deviation|0|||
17055504|NCT00440518|38198974|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
17055505|NCT00440518|38198975|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
17055506|NCT00440518|38198976|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
17055507|NCT00440518|38198974|FG000|Randomized /Titration Period|Other|1|||
17055508|NCT00440518|38198975|FG001|Randomized /Titration Period|Other|0|||
17055509|NCT00440518|38198976|FG002|Randomized /Titration Period|Other|0|||
17055510|NCT00440518|38198974|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
17055511|NCT00440518|38198975|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
17055512|NCT00440518|38198976|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
17055513|NCT00440518|38198974|FG000|Randomized /Titration Period|Adverse Event|2|||
17055514|NCT00440518|38198975|FG001|Randomized /Titration Period|Adverse Event|3|||
17055515|NCT00440518|38198976|FG002|Randomized /Titration Period|Adverse Event|0|||
17055516|NCT00440518|38198974|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
17055517|NCT00440518|38198975|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
17055518|NCT00440518|38198976|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
17055519|NCT00440518|38198974|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
17055520|NCT00440518|38198975|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
17055521|NCT00440518|38198976|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
17055522|NCT00440518|38198974|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
17055523|NCT00440518|38198975|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
17055524|NCT00440518|38198976|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
17055525|NCT00440518|38198974|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
16992986|NCT02281084|38136980|FG002|Overall Study|Adverse Event|0|||
16992987|NCT02281084|38136981|FG003|Overall Study|Adverse Event|0|||
16992988|NCT02281084|38136978|FG000|Overall Study|Withdrawal by Subject|1|||
16992989|NCT02281084|38136979|FG001|Overall Study|Withdrawal by Subject|2|||
16992990|NCT02281084|38136980|FG002|Overall Study|Withdrawal by Subject|0|||
16992991|NCT02281084|38136981|FG003|Overall Study|Withdrawal by Subject|0|||
16992992|NCT02281084|38136978|FG000|Overall Study|Death|20|||
16992993|NCT02281084|38136979|FG001|Overall Study|Death|16|||
16992994|NCT02281084|38136980|FG002|Overall Study|Death|3|||
16992995|NCT02281084|38136981|FG003|Overall Study|Death|5|||
16992996|NCT02281084|38136978|FG000|Overall Study|Physician Decision|0|||
16992997|NCT02281084|38136979|FG001|Overall Study|Physician Decision|0|||
16992998|NCT02281084|38136980|FG002|Overall Study|Physician Decision|1|||
16992999|NCT02281084|38136981|FG003|Overall Study|Physician Decision|0|||
16993000|NCT00796666|38136999|FG000|Overall Study|Death|2|||
16993001|NCT00796666|38137000|FG001|Overall Study|Death|4|||
16993002|NCT00796666|38136999|FG000|Overall Study|Withdrawal by Subject|2|||
16993003|NCT00796666|38137000|FG001|Overall Study|Withdrawal by Subject|0|||
16993004|NCT00796666|38136999|FG000|Overall Study|Adverse Event|7|||
16993005|NCT00796666|38137000|FG001|Overall Study|Adverse Event|5|||
17055526|NCT00440518|38198975|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
17055527|NCT00440518|38198976|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
17055528|NCT00440518|38198974|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
17055529|NCT00440518|38198975|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
17055530|NCT00440518|38198976|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
17055531|NCT00440518|38198974|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
17055532|NCT00440518|38198975|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
17055533|NCT00440518|38198976|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
17055534|NCT00438256|38198984|FG000|Overall Study|Ineligible for Resection|2|||
17055535|NCT00438256|38198985|FG001|Overall Study|Ineligible for Resection|1|||
17055536|NCT00438256|38198986|FG002|Overall Study|Ineligible for Resection|1|||
17055537|NCT00438256|38198987|FG003|Overall Study|Ineligible for Resection|7|||
17055538|NCT00438256|38198984|FG000|Overall Study|Excluded final Diagnosis|0|||
17055539|NCT00438256|38198985|FG001|Overall Study|Excluded final Diagnosis|0|||
17055540|NCT00438256|38198986|FG002|Overall Study|Excluded final Diagnosis|0|||
17055541|NCT00438256|38198987|FG003|Overall Study|Excluded final Diagnosis|2|||
17055542|NCT00436852|38199006|FG000|Overall Study|Death|23|||
17055543|NCT00436852|38199007|FG001|Overall Study|Death|34|||
17055544|NCT00436852|38199006|FG000|Overall Study|Lack of Efficacy|9|||
17055545|NCT00436852|38199007|FG001|Overall Study|Lack of Efficacy|7|||
17055546|NCT00436852|38199006|FG000|Overall Study|Withdrawal by Subject|2|||
17055547|NCT00436852|38199007|FG001|Overall Study|Withdrawal by Subject|4|||
17055548|NCT00436852|38199006|FG000|Overall Study|Ineligible|1|||
17055549|NCT00436852|38199007|FG001|Overall Study|Ineligible|0|||
17055550|NCT00120289|38199018|FG000|Overall Study|Death|96|||
17055551|NCT00120289|38199019|FG001|Overall Study|Death|82|||
17055552|NCT00120289|38199018|FG000|Overall Study|Lost to Follow-up|11|||
17055553|NCT00120289|38199019|FG001|Overall Study|Lost to Follow-up|14|||
17055554|NCT00120289|38199018|FG000|Overall Study|Withdrawal by Subject|14|||
17055555|NCT00120289|38199019|FG001|Overall Study|Withdrawal by Subject|13|||
17144656|NCT04091581|38288347|FG001|Overall Study|Lost to Follow-up|1|||
17144657|NCT02940522|38288355|FG000|Overall Study|Lost to Follow-up|1|||
17144658|NCT02940522|38288356|FG001|Overall Study|Lost to Follow-up|2|||
17144659|NCT02940522|38288355|FG000|Overall Study|Withdrawal by Subject|1|||
17144660|NCT02940522|38288356|FG001|Overall Study|Withdrawal by Subject|0|||
17144661|NCT03262038|38288364|FG000|Overall Study|Withdrawal by Subject|0|||
17144662|NCT03262038|38288365|FG001|Overall Study|Withdrawal by Subject|1|||
17055556|NCT00550446|38199032|FG000|Up To Week 12|Adverse Event|2|||
17055557|NCT00550446|38199033|FG001|Up To Week 12|Adverse Event|2|||
17055558|NCT00550446|38199034|FG002|Up To Week 12|Adverse Event|0|||
17055559|NCT00550446|38199035|FG003|Up To Week 12|Adverse Event|0|||
17055560|NCT00550446|38199036|FG004|Up To Week 12|Adverse Event|2|||
17055561|NCT00550446|38199037|FG005|Up To Week 12|Adverse Event|2|||
17055562|NCT00550446|38199038|FG006|Up To Week 12|Adverse Event|1|||
17055563|NCT00550446|38199039|FG007|Up To Week 12|Adverse Event|0|||
17055564|NCT00550446|38199040|FG008|Up To Week 12|Adverse Event|0|||
17055565|NCT00550446|38199041|FG009|Up To Week 12|Adverse Event|0|||
17055566|NCT00550446|38199042|FG010|Up To Week 12|Adverse Event|0|||
17055567|NCT00550446|38199032|FG000|Up To Week 12|Lack of Efficacy|3|||
17055568|NCT00550446|38199033|FG001|Up To Week 12|Lack of Efficacy|1|||
17055569|NCT00550446|38199034|FG002|Up To Week 12|Lack of Efficacy|0|||
17055570|NCT00550446|38199035|FG003|Up To Week 12|Lack of Efficacy|1|||
17055571|NCT00550446|38199036|FG004|Up To Week 12|Lack of Efficacy|0|||
17055572|NCT00550446|38199037|FG005|Up To Week 12|Lack of Efficacy|3|||
17055573|NCT00550446|38199038|FG006|Up To Week 12|Lack of Efficacy|3|||
17055574|NCT00550446|38199039|FG007|Up To Week 12|Lack of Efficacy|0|||
17055575|NCT00550446|38199040|FG008|Up To Week 12|Lack of Efficacy|0|||
17055576|NCT00550446|38199041|FG009|Up To Week 12|Lack of Efficacy|0|||
17055577|NCT00550446|38199042|FG010|Up To Week 12|Lack of Efficacy|0|||
17055578|NCT00550446|38199032|FG000|Up To Week 12|Lost to Follow-up|0|||
17055579|NCT00550446|38199033|FG001|Up To Week 12|Lost to Follow-up|1|||
17055580|NCT00550446|38199034|FG002|Up To Week 12|Lost to Follow-up|0|||
17055581|NCT00550446|38199035|FG003|Up To Week 12|Lost to Follow-up|0|||
17055582|NCT00550446|38199036|FG004|Up To Week 12|Lost to Follow-up|1|||
17055583|NCT00550446|38199037|FG005|Up To Week 12|Lost to Follow-up|1|||
17055584|NCT00550446|38199038|FG006|Up To Week 12|Lost to Follow-up|2|||
17055585|NCT00550446|38199039|FG007|Up To Week 12|Lost to Follow-up|0|||
17055586|NCT00550446|38199040|FG008|Up To Week 12|Lost to Follow-up|0|||
17055587|NCT00550446|38199041|FG009|Up To Week 12|Lost to Follow-up|0|||
17055588|NCT00550446|38199042|FG010|Up To Week 12|Lost to Follow-up|0|||
17144663|NCT02472964|38288373|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
17144664|NCT02472964|38288374|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
17055589|NCT00550446|38199032|FG000|Up To Week 12|Withdrawal by Subject|2|||
17055590|NCT00550446|38199033|FG001|Up To Week 12|Withdrawal by Subject|0|||
17055591|NCT00550446|38199034|FG002|Up To Week 12|Withdrawal by Subject|3|||
17055592|NCT00550446|38199035|FG003|Up To Week 12|Withdrawal by Subject|2|||
17055593|NCT00550446|38199036|FG004|Up To Week 12|Withdrawal by Subject|0|||
17144665|NCT02472964|38288373|FG000|Part 1 (up to Week 24)|disease progression|58|||
17144666|NCT02472964|38288374|FG001|Part 1 (up to Week 24)|disease progression|47|||
17055594|NCT00550446|38199037|FG005|Up To Week 12|Withdrawal by Subject|1|||
17055595|NCT00550446|38199038|FG006|Up To Week 12|Withdrawal by Subject|3|||
17055596|NCT00550446|38199039|FG007|Up To Week 12|Withdrawal by Subject|0|||
17055597|NCT00550446|38199040|FG008|Up To Week 12|Withdrawal by Subject|0|||
17055598|NCT00550446|38199041|FG009|Up To Week 12|Withdrawal by Subject|0|||
17055599|NCT00550446|38199042|FG010|Up To Week 12|Withdrawal by Subject|0|||
17055600|NCT00550446|38199032|FG000|Up To Week 12|Other|3|||
17055601|NCT00550446|38199033|FG001|Up To Week 12|Other|0|||
17055602|NCT00550446|38199034|FG002|Up To Week 12|Other|0|||
17055603|NCT00550446|38199035|FG003|Up To Week 12|Other|0|||
17055604|NCT00550446|38199036|FG004|Up To Week 12|Other|0|||
17055605|NCT00550446|38199037|FG005|Up To Week 12|Other|1|||
17055606|NCT00550446|38199038|FG006|Up To Week 12|Other|4|||
17055607|NCT00550446|38199039|FG007|Up To Week 12|Other|0|||
17055608|NCT00550446|38199040|FG008|Up To Week 12|Other|0|||
17055609|NCT00550446|38199041|FG009|Up To Week 12|Other|0|||
17055610|NCT00550446|38199042|FG010|Up To Week 12|Other|0|||
17055611|NCT00550446|38199032|FG000|Up To Week 12|Randomized not treated|0|||
17055612|NCT00550446|38199033|FG001|Up To Week 12|Randomized not treated|1|||
17055613|NCT00550446|38199034|FG002|Up To Week 12|Randomized not treated|1|||
17055614|NCT00550446|38199035|FG003|Up To Week 12|Randomized not treated|0|||
17055615|NCT00550446|38199036|FG004|Up To Week 12|Randomized not treated|0|||
17055616|NCT00550446|38199037|FG005|Up To Week 12|Randomized not treated|0|||
17055617|NCT00550446|38199038|FG006|Up To Week 12|Randomized not treated|0|||
17055618|NCT00550446|38199039|FG007|Up To Week 12|Randomized not treated|0|||
17055619|NCT00550446|38199040|FG008|Up To Week 12|Randomized not treated|0|||
17055620|NCT00550446|38199041|FG009|Up To Week 12|Randomized not treated|0|||
17055621|NCT00550446|38199042|FG010|Up To Week 12|Randomized not treated|0|||
17055622|NCT00550446|38199032|FG000|Post Week 12|Adverse Event|2|||
17055623|NCT00550446|38199033|FG001|Post Week 12|Adverse Event|1|||
17144667|NCT02472964|38288373|FG000|Part 1 (up to Week 24)|Death|3|||
17144668|NCT02472964|38288374|FG001|Part 1 (up to Week 24)|Death|6|||
17144669|NCT02472964|38288373|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
17144670|NCT02472964|38288374|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
17144671|NCT02472964|38288373|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
17144672|NCT02472964|38288374|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
17144673|NCT02472964|38288373|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
17144674|NCT02472964|38288374|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
17144675|NCT02472964|38288373|FG000|Part 1 (up to Week 24)|Other|2|||
17144676|NCT02472964|38288374|FG001|Part 1 (up to Week 24)|Other|1|||
17144677|NCT02472964|38288373|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
17144678|NCT02472964|38288374|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
17144679|NCT02472964|38288373|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
17144680|NCT02472964|38288374|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
17144681|NCT02472964|38288373|FG000|Part 2 (Week 24-week 48)|Death|0|||
17144682|NCT02472964|38288374|FG001|Part 2 (Week 24-week 48)|Death|1|||
17144683|NCT02472964|38288373|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
17144684|NCT02472964|38288374|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
17144685|NCT02472964|38288373|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
17144686|NCT02472964|38288374|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
17144687|NCT02472964|38288373|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
17144688|NCT02472964|38288374|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
17144689|NCT02472964|38288373|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
17144690|NCT02472964|38288374|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
17144691|NCT04223791|38288382|FG000|Overall Study|Lost to Follow-up|0|||
17144692|NCT04223791|38288383|FG001|Overall Study|Lost to Follow-up|4|||
17144693|NCT04223791|38288382|FG000|Overall Study|Physician Decision|5|||
17144694|NCT04223791|38288383|FG001|Overall Study|Physician Decision|1|||
17144695|NCT04223791|38288382|FG000|Overall Study|Protocol Violation|1|||
17144696|NCT04223791|38288383|FG001|Overall Study|Protocol Violation|1|||
17055624|NCT00550446|38199034|FG002|Post Week 12|Adverse Event|1|||
17055625|NCT00550446|38199035|FG003|Post Week 12|Adverse Event|1|||
17055626|NCT00550446|38199036|FG004|Post Week 12|Adverse Event|1|||
17055627|NCT00550446|38199037|FG005|Post Week 12|Adverse Event|1|||
17055628|NCT00550446|38199038|FG006|Post Week 12|Adverse Event|0|||
17055629|NCT00550446|38199039|FG007|Post Week 12|Adverse Event|0|||
17055630|NCT00550446|38199040|FG008|Post Week 12|Adverse Event|0|||
17055631|NCT00550446|38199041|FG009|Post Week 12|Adverse Event|4|||
17055632|NCT00550446|38199042|FG010|Post Week 12|Adverse Event|0|||
17055633|NCT00550446|38199032|FG000|Post Week 12|Lack of Efficacy|0|||
17144697|NCT04223791|38288382|FG000|Overall Study|Withdrawal by Subject|10|||
17144698|NCT04223791|38288383|FG001|Overall Study|Withdrawal by Subject|12|||
17144699|NCT04223791|38288382|FG000|Overall Study|Pregnancy|1|||
17055634|NCT00550446|38199033|FG001|Post Week 12|Lack of Efficacy|0|||
17055635|NCT00550446|38199034|FG002|Post Week 12|Lack of Efficacy|1|||
17055636|NCT00550446|38199035|FG003|Post Week 12|Lack of Efficacy|0|||
17055637|NCT00550446|38199036|FG004|Post Week 12|Lack of Efficacy|0|||
17055638|NCT00550446|38199037|FG005|Post Week 12|Lack of Efficacy|0|||
17055639|NCT00550446|38199038|FG006|Post Week 12|Lack of Efficacy|0|||
17055640|NCT00550446|38199039|FG007|Post Week 12|Lack of Efficacy|1|||
17055641|NCT00550446|38199040|FG008|Post Week 12|Lack of Efficacy|1|||
17055642|NCT00550446|38199041|FG009|Post Week 12|Lack of Efficacy|2|||
17055643|NCT00550446|38199042|FG010|Post Week 12|Lack of Efficacy|1|||
17055644|NCT00550446|38199032|FG000|Post Week 12|Lost to Follow-up|0|||
17055645|NCT00550446|38199033|FG001|Post Week 12|Lost to Follow-up|0|||
17055646|NCT00550446|38199034|FG002|Post Week 12|Lost to Follow-up|1|||
17055647|NCT00550446|38199035|FG003|Post Week 12|Lost to Follow-up|1|||
17055648|NCT00550446|38199036|FG004|Post Week 12|Lost to Follow-up|0|||
17055649|NCT00550446|38199037|FG005|Post Week 12|Lost to Follow-up|0|||
17055650|NCT00550446|38199038|FG006|Post Week 12|Lost to Follow-up|1|||
17055651|NCT00550446|38199039|FG007|Post Week 12|Lost to Follow-up|0|||
17055652|NCT00550446|38199040|FG008|Post Week 12|Lost to Follow-up|0|||
17055653|NCT00550446|38199041|FG009|Post Week 12|Lost to Follow-up|0|||
17055654|NCT00550446|38199042|FG010|Post Week 12|Lost to Follow-up|0|||
17055655|NCT00550446|38199032|FG000|Post Week 12|Withdrawal by Subject|0|||
17055656|NCT00550446|38199033|FG001|Post Week 12|Withdrawal by Subject|0|||
17055657|NCT00550446|38199034|FG002|Post Week 12|Withdrawal by Subject|0|||
17055658|NCT00550446|38199035|FG003|Post Week 12|Withdrawal by Subject|0|||
17055659|NCT00550446|38199036|FG004|Post Week 12|Withdrawal by Subject|1|||
17055660|NCT00550446|38199037|FG005|Post Week 12|Withdrawal by Subject|0|||
17055661|NCT00550446|38199038|FG006|Post Week 12|Withdrawal by Subject|0|||
17055662|NCT00550446|38199039|FG007|Post Week 12|Withdrawal by Subject|0|||
17055663|NCT00550446|38199040|FG008|Post Week 12|Withdrawal by Subject|0|||
17055664|NCT00550446|38199041|FG009|Post Week 12|Withdrawal by Subject|0|||
17055665|NCT00550446|38199042|FG010|Post Week 12|Withdrawal by Subject|0|||
17055666|NCT00550446|38199032|FG000|Post Week 12|Other|1|||
17055667|NCT00550446|38199033|FG001|Post Week 12|Other|1|||
17055668|NCT00550446|38199034|FG002|Post Week 12|Other|0|||
17055669|NCT00550446|38199035|FG003|Post Week 12|Other|1|||
17055670|NCT00550446|38199036|FG004|Post Week 12|Other|0|||
17055671|NCT00550446|38199037|FG005|Post Week 12|Other|0|||
17055672|NCT00550446|38199038|FG006|Post Week 12|Other|1|||
17055673|NCT00550446|38199039|FG007|Post Week 12|Other|0|||
17055674|NCT00550446|38199040|FG008|Post Week 12|Other|1|||
17055675|NCT00550446|38199041|FG009|Post Week 12|Other|1|||
16993006|NCT00796666|38136999|FG000|Overall Study|Protocol Violation|1|||
16993007|NCT00796666|38137000|FG001|Overall Study|Protocol Violation|0|||
16993008|NCT00796666|38136999|FG000|Overall Study|Other|1|||
16993009|NCT00796666|38137000|FG001|Overall Study|Other|0|||
16993010|NCT00796666|38136999|FG000|Overall Study|Terminated by sponsor|53|||
16993011|NCT00796666|38137000|FG001|Overall Study|Terminated by sponsor|55|||
16993012|NCT00796666|38136999|FG000|Overall Study|Randomized and not treated|1|||
16993013|NCT00796666|38137000|FG001|Overall Study|Randomized and not treated|0|||
16993014|NCT00799708|38137009|FG000|Overall Study|non-compliance|1|||
16993015|NCT00799708|38137010|FG001|Overall Study|non-compliance|0|||
16993016|NCT00799708|38137011|FG002|Overall Study|non-compliance|0|||
17055676|NCT00550446|38199042|FG010|Post Week 12|Other|0|||
17055677|NCT00436618|38199083|FG000|Overall Study|Withdrawal by Subject|5|||
17055678|NCT00436618|38199084|FG001|Overall Study|Withdrawal by Subject|8|||
17055679|NCT00436618|38199085|FG002|Overall Study|Withdrawal by Subject|11|||
17055680|NCT00436618|38199083|FG000|Overall Study|Adverse Event|8|||
17055681|NCT00436618|38199084|FG001|Overall Study|Adverse Event|8|||
17055682|NCT00436618|38199085|FG002|Overall Study|Adverse Event|9|||
17055683|NCT00436618|38199083|FG000|Overall Study|Alternate Treatment|3|||
17055684|NCT00436618|38199084|FG001|Overall Study|Alternate Treatment|4|||
17055685|NCT00436618|38199085|FG002|Overall Study|Alternate Treatment|12|||
17055686|NCT00436618|38199083|FG000|Overall Study|Other Medical Problems|3|||
17055687|NCT00436618|38199084|FG001|Overall Study|Other Medical Problems|1|||
17055688|NCT00436618|38199085|FG002|Overall Study|Other Medical Problems|7|||
17055689|NCT00436618|38199083|FG000|Overall Study|Death|4|||
16993017|NCT00796510|38137023|FG000|Overall Study|Death|1|||
16993018|NCT00796510|38137024|FG001|Overall Study|Death|0|||
16993019|NCT00796510|38137023|FG000|Overall Study|Study Terminated|2|||
16993020|NCT00796510|38137024|FG001|Overall Study|Study Terminated|0|||
16993021|NCT00588640|38137030|FG000|Overall Study|Physician Decision|1|||
17055690|NCT00436618|38199084|FG001|Overall Study|Death|2|||
17055691|NCT00436618|38199085|FG002|Overall Study|Death|3|||
17055692|NCT00436618|38199083|FG000|Overall Study|New Primary or Other Reasons|6|||
17055693|NCT00436618|38199084|FG001|Overall Study|New Primary or Other Reasons|2|||
17055694|NCT00436618|38199085|FG002|Overall Study|New Primary or Other Reasons|12|||
17055695|NCT00436618|38199083|FG000|Overall Study|Still on treatment|1|||
17055696|NCT00436618|38199084|FG001|Overall Study|Still on treatment|2|||
17055697|NCT00436618|38199085|FG002|Overall Study|Still on treatment|7|||
17055698|NCT00548808|38199122|FG000|Overall Study|Lost to Follow-up|9|||
17055699|NCT00548808|38199123|FG001|Overall Study|Lost to Follow-up|3|||
17055700|NCT00548808|38199122|FG000|Overall Study|Protocol Violation|8|||
17055701|NCT00548808|38199123|FG001|Overall Study|Protocol Violation|8|||
17055702|NCT00548808|38199122|FG000|Overall Study|Withdrawal by Subject|8|||
17055703|NCT00548808|38199123|FG001|Overall Study|Withdrawal by Subject|4|||
17055704|NCT00548808|38199122|FG000|Overall Study|Physician Decision|6|||
17055705|NCT00548808|38199123|FG001|Overall Study|Physician Decision|3|||
17055706|NCT00548808|38199122|FG000|Overall Study|Adverse Event|4|||
17055707|NCT00548808|38199123|FG001|Overall Study|Adverse Event|5|||
17055708|NCT00548808|38199122|FG000|Overall Study|Death|2|||
17055709|NCT00548808|38199123|FG001|Overall Study|Death|0|||
17055710|NCT00548808|38199122|FG000|Overall Study|Entry Criteria Not Met|2|||
17144700|NCT04223791|38288383|FG001|Overall Study|Pregnancy|1|||
17144701|NCT04223791|38288382|FG000|Overall Study|Ongoing in Study|305|||
17144702|NCT04223791|38288383|FG001|Overall Study|Ongoing in Study|302|||
17055711|NCT00548808|38199123|FG001|Overall Study|Entry Criteria Not Met|2|||
17055712|NCT00548808|38199122|FG000|Overall Study|Lack of Efficacy|2|||
17055713|NCT00548808|38199123|FG001|Overall Study|Lack of Efficacy|0|||
17055714|NCT00548808|38199122|FG000|Overall Study|Sponsor Decision|1|||
17055715|NCT00548808|38199123|FG001|Overall Study|Sponsor Decision|1|||
17055716|NCT00110617|38199131|FG000|Overall Study|Adverse Event|2|||
17055717|NCT00110617|38199132|FG001|Overall Study|Adverse Event|4|||
17055718|NCT00110617|38199131|FG000|Overall Study|Abnormal Laboratory Value|4|||
17055719|NCT00110617|38199132|FG001|Overall Study|Abnormal Laboratory Value|2|||
17055720|NCT00110617|38199131|FG000|Overall Study|Lack of Efficacy|1|||
17055721|NCT00110617|38199132|FG001|Overall Study|Lack of Efficacy|0|||
17055722|NCT00110617|38199131|FG000|Overall Study|Patient no longer requires study drug|1|||
17055723|NCT00110617|38199132|FG001|Overall Study|Patient no longer requires study drug|0|||
17055724|NCT00110617|38199131|FG000|Overall Study|Protocol Violation|5|||
17055725|NCT00110617|38199132|FG001|Overall Study|Protocol Violation|0|||
17055726|NCT00110617|38199131|FG000|Overall Study|Withdrawal by Subject|10|||
17055727|NCT00110617|38199132|FG001|Overall Study|Withdrawal by Subject|4|||
17055728|NCT00110617|38199131|FG000|Overall Study|Lost to Follow-up|9|||
17055729|NCT00110617|38199132|FG001|Overall Study|Lost to Follow-up|1|||
17055730|NCT00110617|38199131|FG000|Overall Study|Administrative problems|6|||
17055731|NCT00110617|38199132|FG001|Overall Study|Administrative problems|5|||
17055732|NCT00110617|38199131|FG000|Overall Study|Death|1|||
17055733|NCT00110617|38199132|FG001|Overall Study|Death|1|||
17055734|NCT00110617|38199131|FG000|Overall Study|Did not receive study drug|0|||
17055735|NCT00110617|38199132|FG001|Overall Study|Did not receive study drug|12|||
17055736|NCT03956862|38199142|FG000|Overall Study|Lost to Follow-up|1|||
17055737|NCT03956862|38199143|FG001|Overall Study|Lost to Follow-up|1|||
17055738|NCT03956862|38199142|FG000|Overall Study|Withdrawal by Subject|1|||
17055739|NCT03956862|38199143|FG001|Overall Study|Withdrawal by Subject|1|||
17055740|NCT00550238|38199149|FG000|Overall Study|Adverse Event|88|||
17055741|NCT00550238|38199149|FG000|Overall Study|Death|34|||
17055742|NCT00550238|38199149|FG000|Overall Study|Disease progression|46|||
17055743|NCT00550238|38199149|FG000|Overall Study|Withdrawal by Subject|167|||
17055744|NCT00550238|38199149|FG000|Overall Study|Physician Decision|31|||
17055745|NCT00550238|38199149|FG000|Overall Study|Patient noncompliance|25|||
17055746|NCT00550238|38199149|FG000|Overall Study|Lost to Follow-up|13|||
17055747|NCT00550238|38199149|FG000|Overall Study|Sponsor decision|55|||
17055748|NCT03956550|38199156|FG000|Overall Study|Sponsor decision|65|||
17055749|NCT03956550|38199157|FG001|Overall Study|Sponsor decision|66|||
17055750|NCT03956550|38199158|FG002|Overall Study|Sponsor decision|64|||
17055751|NCT03956550|38199156|FG000|Overall Study|Adverse Event|0|||
17055752|NCT03956550|38199157|FG001|Overall Study|Adverse Event|1|||
17055753|NCT03956550|38199158|FG002|Overall Study|Adverse Event|0|||
17055754|NCT03956550|38199156|FG000|Overall Study|Withdrawal by Subject|5|||
17055755|NCT03956550|38199157|FG001|Overall Study|Withdrawal by Subject|5|||
17055756|NCT03956550|38199158|FG002|Overall Study|Withdrawal by Subject|6|||
17055757|NCT00110305|38199170|FG000|Overall Study|Adverse Event|46|||
17055758|NCT00110305|38199171|FG001|Overall Study|Adverse Event|13|||
17055759|NCT00110305|38199170|FG000|Overall Study|Sponsors Decision|1|||
17055760|NCT00110305|38199171|FG001|Overall Study|Sponsors Decision|0|||
17055761|NCT00110305|38199170|FG000|Overall Study|Subject Non-Compliant|9|||
17055762|NCT00110305|38199171|FG001|Overall Study|Subject Non-Compliant|2|||
17055763|NCT00110305|38199170|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
17055764|NCT00110305|38199171|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
17055765|NCT00110305|38199170|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
17055766|NCT00110305|38199171|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
17055767|NCT00110305|38199170|FG000|Overall Study|Protocol Violation|0|||
17055768|NCT00110305|38199171|FG001|Overall Study|Protocol Violation|1|||
17055769|NCT00110305|38199170|FG000|Overall Study|Withdrawal by Subject|7|||
17055770|NCT00110305|38199171|FG001|Overall Study|Withdrawal by Subject|7|||
17055771|NCT00110305|38199170|FG000|Overall Study|Lost to Follow-up|20|||
17055772|NCT00110305|38199171|FG001|Overall Study|Lost to Follow-up|3|||
17055773|NCT00110305|38199170|FG000|Overall Study|Other|8|||
17055774|NCT00110305|38199171|FG001|Overall Study|Other|2|||
17055775|NCT00428116|38199190|FG000|Overall Study|Death|1|||
17144703|NCT04079803|38288396|FG000|Overall Study|Withdrawal by Subject|0|||
17055776|NCT00428116|38199191|FG001|Overall Study|Death|0|||
17055777|NCT00428116|38199190|FG000|Overall Study|Withdrawal by Subject|1|||
17055778|NCT00428116|38199191|FG001|Overall Study|Withdrawal by Subject|0|||
17055779|NCT00428116|38199190|FG000|Overall Study|Lost to Follow-up|1|||
17055780|NCT00428116|38199191|FG001|Overall Study|Lost to Follow-up|0|||
17055781|NCT00560066|38199200|FG000|Overall Study|Death|2|||
17055782|NCT00560066|38199201|FG001|Overall Study|Death|1|||
17055783|NCT00560066|38199200|FG000|Overall Study|Withdrawal by Subject|0|||
17055784|NCT00560066|38199201|FG001|Overall Study|Withdrawal by Subject|3|||
17055785|NCT00560066|38199200|FG000|Overall Study|Lost to Follow-up|4|||
17055786|NCT00560066|38199201|FG001|Overall Study|Lost to Follow-up|10|||
17055787|NCT00560066|38199200|FG000|Overall Study|Protocol Violation|0|||
17055788|NCT00560066|38199201|FG001|Overall Study|Protocol Violation|1|||
17144704|NCT04079803|38288397|FG001|Overall Study|Withdrawal by Subject|0|||
17144705|NCT04079803|38288398|FG002|Overall Study|Withdrawal by Subject|1|||
17144706|NCT03278613|38288426|FG000|Overall Study|Lost to Follow-up|3|||
17055789|NCT00560066|38199200|FG000|Overall Study|Administrative reason|0|||
17055790|NCT00560066|38199201|FG001|Overall Study|Administrative reason|5|||
17055791|NCT00560066|38199200|FG000|Overall Study|Missing primary reason|0|||
17055792|NCT00560066|38199201|FG001|Overall Study|Missing primary reason|2|||
17055793|NCT00549900|38199212|FG000|Overall Study|Adverse Event|1|||
17055794|NCT00435994|38199219|FG000|Overall Study|Lost to Follow-up|7|||
17055795|NCT00435994|38199220|FG001|Overall Study|Lost to Follow-up|0|||
17055796|NCT00435994|38199221|FG002|Overall Study|Lost to Follow-up|0|||
17055797|NCT00435370|38199232|FG000|Overall Study|Adverse Event|8|||
17055798|NCT00435370|38199233|FG001|Overall Study|Adverse Event|8|||
17055799|NCT00435370|38199232|FG000|Overall Study|Withdrawal by Subject|10|||
17055800|NCT00435370|38199233|FG001|Overall Study|Withdrawal by Subject|10|||
17055801|NCT00435370|38199232|FG000|Overall Study|Antipsychotic medication changed|4|||
17055802|NCT00435370|38199233|FG001|Overall Study|Antipsychotic medication changed|2|||
17055803|NCT00096031|38199239|FG000|Overall Study|Adverse Event|3|||
17055804|NCT00096031|38199239|FG000|Overall Study|Lack of Efficacy|42|||
17055805|NCT00096031|38199239|FG000|Overall Study|Death|4|||
17055806|NCT00096031|38199239|FG000|Overall Study|Withdrawal by Subject|1|||
17055807|NCT00096031|38199239|FG000|Overall Study|Ineligible|8|||
17055808|NCT00096031|38199239|FG000|Overall Study|Not protocol specified|5|||
17055809|NCT00118417|38199243|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
17055810|NCT00118417|38199244|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
17055811|NCT00118417|38199243|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
17055812|NCT00118417|38199244|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
17055813|NCT00118417|38199243|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
17055814|NCT00118417|38199244|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
17055815|NCT00118417|38199243|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
17055816|NCT00118417|38199244|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
17055817|NCT00118417|38199243|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
17055818|NCT00118417|38199244|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
17055819|NCT00549848|38199257|FG000|Overall Study|Death|1|||
17055820|NCT00549848|38199258|FG001|Overall Study|Death|4|||
17055821|NCT00549848|38199259|FG002|Overall Study|Death|13|||
17055822|NCT00549848|38199257|FG000|Overall Study|Physician Decision|0|||
17055823|NCT00549848|38199258|FG001|Overall Study|Physician Decision|0|||
17055824|NCT00549848|38199259|FG002|Overall Study|Physician Decision|4|||
17055825|NCT00549848|38199257|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
17055826|NCT00549848|38199258|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
17055827|NCT00549848|38199259|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
17055828|NCT00549848|38199257|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
17055829|NCT00549848|38199258|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
17055830|NCT00549848|38199259|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
17055831|NCT00549848|38199257|FG000|Overall Study|Participant/Family Withdraw|2|||
17055832|NCT00549848|38199258|FG001|Overall Study|Participant/Family Withdraw|3|||
17055833|NCT00549848|38199259|FG002|Overall Study|Participant/Family Withdraw|5|||
17055834|NCT00549848|38199257|FG000|Overall Study|Second Malignancy|1|||
17055835|NCT00549848|38199258|FG001|Overall Study|Second Malignancy|0|||
17055836|NCT00549848|38199259|FG002|Overall Study|Second Malignancy|0|||
17055837|NCT00549848|38199257|FG000|Overall Study|Transplant|3|||
17055838|NCT00549848|38199258|FG001|Overall Study|Transplant|3|||
17055839|NCT00549848|38199259|FG002|Overall Study|Transplant|18|||
17055840|NCT00549848|38199257|FG000|Overall Study|Unacceptable Toxicity|1|||
17055841|NCT00549848|38199258|FG001|Overall Study|Unacceptable Toxicity|6|||
17055842|NCT00549848|38199259|FG002|Overall Study|Unacceptable Toxicity|6|||
17055843|NCT00549770|38199283|FG000|Overall Study|Protocol deviation|1|||
17055844|NCT00549770|38199284|FG001|Overall Study|Protocol deviation|1|||
17055845|NCT00549770|38199285|FG002|Overall Study|Protocol deviation|1|||
17055846|NCT00549770|38199286|FG003|Overall Study|Protocol deviation|2|||
17055847|NCT00549770|38199287|FG004|Overall Study|Protocol deviation|2|||
17055848|NCT00549770|38199288|FG005|Overall Study|Protocol deviation|2|||
17055849|NCT00549770|38199289|FG006|Overall Study|Protocol deviation|1|||
17055850|NCT00549770|38199290|FG007|Overall Study|Protocol deviation|2|||
17055851|NCT00549770|38199283|FG000|Overall Study|Administrative problems|0|||
17055852|NCT00549770|38199284|FG001|Overall Study|Administrative problems|1|||
17055853|NCT00549770|38199285|FG002|Overall Study|Administrative problems|0|||
17055854|NCT00549770|38199286|FG003|Overall Study|Administrative problems|0|||
17055855|NCT00549770|38199287|FG004|Overall Study|Administrative problems|0|||
17055856|NCT00549770|38199288|FG005|Overall Study|Administrative problems|0|||
17055857|NCT00549770|38199289|FG006|Overall Study|Administrative problems|0|||
17055858|NCT00549770|38199290|FG007|Overall Study|Administrative problems|1|||
17055859|NCT00549770|38199283|FG000|Overall Study|Lost to Follow-up|0|||
17055860|NCT00549770|38199284|FG001|Overall Study|Lost to Follow-up|0|||
17055861|NCT00549770|38199285|FG002|Overall Study|Lost to Follow-up|2|||
17055862|NCT00549770|38199286|FG003|Overall Study|Lost to Follow-up|2|||
17055863|NCT00549770|38199287|FG004|Overall Study|Lost to Follow-up|3|||
17055864|NCT00549770|38199288|FG005|Overall Study|Lost to Follow-up|2|||
17055865|NCT00549770|38199289|FG006|Overall Study|Lost to Follow-up|0|||
17055866|NCT00549770|38199290|FG007|Overall Study|Lost to Follow-up|0|||
17055867|NCT00549770|38199283|FG000|Overall Study|Withdrawal by Subject|4|||
17055868|NCT00549770|38199284|FG001|Overall Study|Withdrawal by Subject|6|||
17055869|NCT00549770|38199285|FG002|Overall Study|Withdrawal by Subject|4|||
17055870|NCT00549770|38199286|FG003|Overall Study|Withdrawal by Subject|5|||
17055871|NCT00549770|38199287|FG004|Overall Study|Withdrawal by Subject|6|||
17055872|NCT00549770|38199288|FG005|Overall Study|Withdrawal by Subject|6|||
17055873|NCT00549770|38199289|FG006|Overall Study|Withdrawal by Subject|4|||
17055874|NCT00549770|38199290|FG007|Overall Study|Withdrawal by Subject|9|||
17055875|NCT00549770|38199283|FG000|Overall Study|Lack of Efficacy|1|||
17055876|NCT00549770|38199284|FG001|Overall Study|Lack of Efficacy|0|||
17055877|NCT00549770|38199285|FG002|Overall Study|Lack of Efficacy|2|||
17055878|NCT00549770|38199286|FG003|Overall Study|Lack of Efficacy|3|||
17055879|NCT00549770|38199287|FG004|Overall Study|Lack of Efficacy|5|||
17055880|NCT00549770|38199288|FG005|Overall Study|Lack of Efficacy|1|||
17055881|NCT00549770|38199289|FG006|Overall Study|Lack of Efficacy|3|||
17055882|NCT00549770|38199290|FG007|Overall Study|Lack of Efficacy|8|||
17055883|NCT00549770|38199283|FG000|Overall Study|Abnormal test procedure results|0|||
17055884|NCT00549770|38199284|FG001|Overall Study|Abnormal test procedure results|0|||
17055885|NCT00549770|38199285|FG002|Overall Study|Abnormal test procedure results|0|||
17055886|NCT00549770|38199286|FG003|Overall Study|Abnormal test procedure results|2|||
17055887|NCT00549770|38199287|FG004|Overall Study|Abnormal test procedure results|0|||
17055888|NCT00549770|38199288|FG005|Overall Study|Abnormal test procedure results|1|||
17055889|NCT00549770|38199289|FG006|Overall Study|Abnormal test procedure results|1|||
17055890|NCT00549770|38199290|FG007|Overall Study|Abnormal test procedure results|1|||
17055891|NCT00549770|38199283|FG000|Overall Study|Abnormal laboratory values|0|||
17055892|NCT00549770|38199284|FG001|Overall Study|Abnormal laboratory values|0|||
17055893|NCT00549770|38199285|FG002|Overall Study|Abnormal laboratory values|0|||
17055894|NCT00549770|38199286|FG003|Overall Study|Abnormal laboratory values|0|||
17055895|NCT00549770|38199287|FG004|Overall Study|Abnormal laboratory values|0|||
17055896|NCT00549770|38199288|FG005|Overall Study|Abnormal laboratory values|1|||
17055897|NCT00549770|38199289|FG006|Overall Study|Abnormal laboratory values|0|||
17055898|NCT00549770|38199290|FG007|Overall Study|Abnormal laboratory values|0|||
17055899|NCT00549770|38199283|FG000|Overall Study|Adverse Event|1|||
17055900|NCT00549770|38199284|FG001|Overall Study|Adverse Event|3|||
17055901|NCT00549770|38199285|FG002|Overall Study|Adverse Event|1|||
17055902|NCT00549770|38199286|FG003|Overall Study|Adverse Event|2|||
17055903|NCT00549770|38199287|FG004|Overall Study|Adverse Event|1|||
17055904|NCT00549770|38199288|FG005|Overall Study|Adverse Event|0|||
17055905|NCT00549770|38199289|FG006|Overall Study|Adverse Event|5|||
17055906|NCT00549770|38199290|FG007|Overall Study|Adverse Event|4|||
17055907|NCT00548184|38199308|FG000|Overall Study|Adverse Event|3|||
17055908|NCT00548184|38199308|FG000|Overall Study|took other drug|1|||
17055909|NCT00548184|38199308|FG000|Overall Study|Found Her2 negative|1|||
17055910|NCT00454636|38199316|FG000|Overall Study|Adverse Event|10|||
17055911|NCT00454636|38199317|FG001|Overall Study|Adverse Event|6|||
17055912|NCT00454636|38199318|FG002|Overall Study|Adverse Event|9|||
17055913|NCT00454636|38199319|FG003|Overall Study|Adverse Event|15|||
17055914|NCT00454636|38199316|FG000|Overall Study|Disease Progression|11|||
17055915|NCT00454636|38199317|FG001|Overall Study|Disease Progression|12|||
17055916|NCT00454636|38199318|FG002|Overall Study|Disease Progression|4|||
17055917|NCT00454636|38199319|FG003|Overall Study|Disease Progression|11|||
17055918|NCT00454636|38199316|FG000|Overall Study|Protocol Violation|3|||
17055919|NCT00454636|38199317|FG001|Overall Study|Protocol Violation|2|||
17055920|NCT00454636|38199318|FG002|Overall Study|Protocol Violation|3|||
17055921|NCT00454636|38199319|FG003|Overall Study|Protocol Violation|3|||
17055922|NCT00454636|38199316|FG000|Overall Study|Death|6|||
17055923|NCT00454636|38199317|FG001|Overall Study|Death|1|||
17055924|NCT00454636|38199318|FG002|Overall Study|Death|1|||
17055925|NCT00454636|38199319|FG003|Overall Study|Death|1|||
17055926|NCT00454636|38199316|FG000|Overall Study|Patient refusal|1|||
17055927|NCT00454636|38199317|FG001|Overall Study|Patient refusal|1|||
17055928|NCT00454636|38199318|FG002|Overall Study|Patient refusal|3|||
17144707|NCT03278613|38288427|FG001|Overall Study|Lost to Follow-up|1|||
17144708|NCT03761147|38288435|FG000|Overall Study|Withdrawal by Subject|6|||
17055929|NCT00454636|38199319|FG003|Overall Study|Patient refusal|2|||
17055930|NCT00454636|38199316|FG000|Overall Study|Lost to Follow-up|0|||
17055931|NCT00454636|38199317|FG001|Overall Study|Lost to Follow-up|1|||
17055932|NCT00454636|38199318|FG002|Overall Study|Lost to Follow-up|0|||
17055933|NCT00454636|38199319|FG003|Overall Study|Lost to Follow-up|0|||
17055934|NCT00427960|38199331|FG000|Overall Study|Adverse Event|2|||
17055935|NCT00427960|38199332|FG001|Overall Study|Adverse Event|0|||
17055936|NCT00427960|38199331|FG000|Overall Study|Withdrawal by Subject|0|||
17055937|NCT00427960|38199332|FG001|Overall Study|Withdrawal by Subject|3|||
17055938|NCT00427960|38199331|FG000|Overall Study|Other|0|||
17055939|NCT00427960|38199332|FG001|Overall Study|Other|1|||
17055940|NCT00548340|38199341|FG000|Overall Study|Protocol Violation|2|||
17055941|NCT00548340|38199342|FG001|Overall Study|Protocol Violation|3|||
17055942|NCT00548340|38199343|FG002|Overall Study|Protocol Violation|3|||
17055943|NCT00548340|38199341|FG000|Overall Study|Adverse Event|2|||
17055944|NCT00548340|38199342|FG001|Overall Study|Adverse Event|2|||
17055945|NCT00548340|38199343|FG002|Overall Study|Adverse Event|2|||
17055946|NCT00548340|38199341|FG000|Overall Study|Lost to Follow-up|1|||
17055947|NCT00548340|38199342|FG001|Overall Study|Lost to Follow-up|1|||
17055948|NCT00548340|38199343|FG002|Overall Study|Lost to Follow-up|0|||
17055949|NCT00548340|38199341|FG000|Overall Study|Withdrawal by Subject|2|||
17055950|NCT00548340|38199342|FG001|Overall Study|Withdrawal by Subject|4|||
17055951|NCT00548340|38199343|FG002|Overall Study|Withdrawal by Subject|3|||
17055952|NCT00548340|38199341|FG000|Overall Study|Other|1|||
17055953|NCT00548340|38199342|FG001|Overall Study|Other|1|||
17055954|NCT00548340|38199343|FG002|Overall Study|Other|1|||
17055955|NCT00454246|38199354|FG000|Overall Study|Adverse Event|2|||
17055956|NCT00454246|38199355|FG001|Overall Study|Adverse Event|2|||
17055957|NCT00454246|38199356|FG002|Overall Study|Adverse Event|0|||
17055958|NCT00454246|38199354|FG000|Overall Study|Violation of selection criteria at entry|6|||
17055959|NCT00454246|38199355|FG001|Overall Study|Violation of selection criteria at entry|0|||
17055960|NCT00454246|38199356|FG002|Overall Study|Violation of selection criteria at entry|0|||
17055961|NCT00454246|38199354|FG000|Overall Study|Protocol Violation|1|||
17055962|NCT00454246|38199355|FG001|Overall Study|Protocol Violation|0|||
17055963|NCT00454246|38199356|FG002|Overall Study|Protocol Violation|0|||
17055964|NCT00454246|38199354|FG000|Overall Study|Refused Treatment|1|||
17055965|NCT00454246|38199355|FG001|Overall Study|Refused Treatment|1|||
17055966|NCT00454246|38199356|FG002|Overall Study|Refused Treatment|0|||
17055967|NCT00454246|38199354|FG000|Overall Study|Failure to return|1|||
17055968|NCT00454246|38199355|FG001|Overall Study|Failure to return|0|||
17055969|NCT00454246|38199356|FG002|Overall Study|Failure to return|0|||
17055970|NCT00454246|38199354|FG000|Overall Study|Early termination of study|62|||
17055971|NCT00454246|38199355|FG001|Overall Study|Early termination of study|26|||
17055972|NCT00454246|38199356|FG002|Overall Study|Early termination of study|9|||
17055973|NCT00434590|38199366|FG000|Overall Study|Administrative problems|5|||
17055974|NCT00434590|38199367|FG001|Overall Study|Administrative problems|5|||
17055975|NCT02891837|38199375|FG000|Overall Study|Lost to Follow-up|2|||
17055976|NCT02891837|38199376|FG001|Overall Study|Lost to Follow-up|0|||
17055977|NCT02891837|38199375|FG000|Overall Study|Withdrawal by Subject|1|||
17055978|NCT02891837|38199376|FG001|Overall Study|Withdrawal by Subject|0|||
17055979|NCT00695903|38199400|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
17055980|NCT00695903|38199401|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
17055981|NCT00695903|38199400|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
17055982|NCT00695903|38199401|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
17055983|NCT00695903|38199400|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
17055984|NCT00695903|38199401|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
17055985|NCT00695903|38199400|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
17055986|NCT00695903|38199401|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
17055987|NCT00695903|38199400|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
17055988|NCT00695903|38199401|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
17055989|NCT00695903|38199400|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
17055990|NCT00695903|38199401|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
17055991|NCT00695903|38199400|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
17055992|NCT00695903|38199401|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
17055993|NCT00695903|38199400|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
17055994|NCT00695903|38199401|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
17055995|NCT00695903|38199400|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
17144709|NCT03761147|38288436|FG001|Overall Study|Withdrawal by Subject|1|||
17144710|NCT03761147|38288435|FG000|Overall Study|Adverse Event|1|||
17055996|NCT00695903|38199401|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
17144711|NCT03761147|38288436|FG001|Overall Study|Adverse Event|3|||
17144712|NCT04076917|38288442|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
17144713|NCT04076917|38288442|FG000|Overall Study|Study closure|13|||
17144714|NCT04076917|38288442|FG000|Overall Study|Physician Decision|3|||
17144715|NCT04076917|38288442|FG000|Overall Study|Death|1|||
17144716|NCT04076917|38288442|FG000|Overall Study|Lost to Follow-up|1|||
17144717|NCT04076917|38288442|FG000|Overall Study|Withdrawal by Subject|1|||
17144718|NCT04076917|38288442|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
17144719|NCT04222699|38288446|FG000|Overall Study|Lost to Follow-up|2|||
17144720|NCT02731690|38288459|FG000|Overall Study|Adverse Event|1|||
17144721|NCT02731690|38288459|FG000|Overall Study|Withdrawal by Subject|3|||
17144722|NCT02731690|38288459|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
17144723|NCT04075513|38288465|FG000|Overall Study|Withdrawal by Subject|2|||
17144724|NCT04075513|38288466|FG001|Overall Study|Withdrawal by Subject|2|||
17144725|NCT04075513|38288465|FG000|Overall Study|Lack of Efficacy|1|||
17144726|NCT04075513|38288466|FG001|Overall Study|Lack of Efficacy|0|||
17144727|NCT04075513|38288465|FG000|Overall Study|Lost to Follow-up|4|||
17144728|NCT04075513|38288466|FG001|Overall Study|Lost to Follow-up|2|||
17144729|NCT04075513|38288465|FG000|Overall Study|Switch to insulin pump|1|||
17144730|NCT04075513|38288466|FG001|Overall Study|Switch to insulin pump|0|||
17144731|NCT04073407|38288474|FG000|Part 1|Withdrawal by Subject|1|||
17144732|NCT04073407|38288475|FG001|Part 1|Withdrawal by Subject|0|||
17144733|NCT04073407|38288474|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
17144734|NCT04073407|38288475|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
17144735|NCT04073407|38288474|FG000|Part 2|Withdrawal by Subject|0|||
17144736|NCT04073407|38288475|FG001|Part 2|Withdrawal by Subject|1|||
17144737|NCT02778204|38288485|FG000|Overall Study|Adverse Event|1|||
17144738|NCT02778204|38288486|FG001|Overall Study|Adverse Event|0|||
17144739|NCT02778204|38288487|FG002|Overall Study|Adverse Event|0|||
17144740|NCT02778204|38288488|FG003|Overall Study|Adverse Event|0|||
17144741|NCT02778204|38288485|FG000|Overall Study|Withdrawal by Subject|0|||
17144742|NCT02778204|38288486|FG001|Overall Study|Withdrawal by Subject|0|||
17144743|NCT02778204|38288487|FG002|Overall Study|Withdrawal by Subject|1|||
17144744|NCT02778204|38288488|FG003|Overall Study|Withdrawal by Subject|2|||
17144745|NCT02778204|38288485|FG000|Overall Study|Lost to Follow-up|1|||
17055997|NCT02759861|38199407|FG000|Overall Study|Death|1|||
17055998|NCT00548262|38199412|FG000|Overall Study|Death|21|||
17055999|NCT00548262|38199412|FG000|Overall Study|Adverse Event|2|||
17056000|NCT00548262|38199412|FG000|Overall Study|Lack of Efficacy|4|||
17056001|NCT00548262|38199412|FG000|Overall Study|Lost to Follow-up|1|||
17056002|NCT00548262|38199412|FG000|Overall Study|Other|3|||
17056003|NCT00548262|38199412|FG000|Overall Study|Withdrawal by Subject|1|||
17056004|NCT00095173|38199416|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
17056005|NCT00095173|38199417|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
17056006|NCT00095173|38199418|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
17056007|NCT00095173|38199419|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
17056008|NCT00095173|38199420|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
17056009|NCT00095173|38199421|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
17056010|NCT00095173|38199416|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
17056011|NCT00095173|38199417|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
17144746|NCT02778204|38288486|FG001|Overall Study|Lost to Follow-up|0|||
17144747|NCT02778204|38288487|FG002|Overall Study|Lost to Follow-up|2|||
17144748|NCT02778204|38288488|FG003|Overall Study|Lost to Follow-up|1|||
17144749|NCT02778204|38288485|FG000|Overall Study|Protocol Violation|0|||
17144750|NCT02778204|38288486|FG001|Overall Study|Protocol Violation|0|||
16993022|NCT00588640|38137030|FG000|Overall Study|Ineligible Patient|1|||
16993023|NCT01016912|38137039|FG000|End of Treatment Period|Lack of Efficacy|0|||
16993024|NCT01016912|38137040|FG001|End of Treatment Period|Lack of Efficacy|1|||
16993025|NCT01016912|38137041|FG002|End of Treatment Period|Lack of Efficacy|0|||
16993026|NCT01016912|38137042|FG003|End of Treatment Period|Lack of Efficacy|4|||
16993027|NCT01016912|38137043|FG004|End of Treatment Period|Lack of Efficacy|4|||
16993028|NCT01016912|38137039|FG000|End of Treatment Period|Adverse Event|0|||
16993029|NCT01016912|38137040|FG001|End of Treatment Period|Adverse Event|1|||
16993030|NCT01016912|38137041|FG002|End of Treatment Period|Adverse Event|1|||
16993031|NCT01016912|38137042|FG003|End of Treatment Period|Adverse Event|0|||
16993032|NCT01016912|38137043|FG004|End of Treatment Period|Adverse Event|0|||
16993033|NCT01016912|38137039|FG000|End of Treatment Period|Completed double-blind period only|0|||
17056012|NCT00095173|38199418|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
17056013|NCT00095173|38199419|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
17056014|NCT00095173|38199420|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
17056015|NCT00095173|38199421|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
17056016|NCT00095173|38199416|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
17056017|NCT00095173|38199417|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
17056018|NCT00095173|38199418|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
17056019|NCT00095173|38199419|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
17056020|NCT00095173|38199420|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
17056021|NCT00095173|38199421|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
17056022|NCT00095173|38199416|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
17056023|NCT00095173|38199417|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
17056024|NCT00095173|38199418|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
17056025|NCT00095173|38199419|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
17056026|NCT00095173|38199420|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
17056027|NCT00095173|38199421|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
17056028|NCT00095173|38199416|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
17056029|NCT00095173|38199417|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
17056030|NCT00095173|38199418|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
17056031|NCT00095173|38199419|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
17056032|NCT00095173|38199420|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
17144751|NCT02778204|38288487|FG002|Overall Study|Protocol Violation|1|||
17144752|NCT02778204|38288488|FG003|Overall Study|Protocol Violation|0|||
17144753|NCT02778204|38288485|FG000|Overall Study|Eligibility Violation|0|||
17144754|NCT02778204|38288486|FG001|Overall Study|Eligibility Violation|0|||
17056033|NCT00095173|38199421|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
17056034|NCT00095173|38199416|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
17056035|NCT00095173|38199417|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
17056036|NCT00095173|38199418|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
17056037|NCT00095173|38199419|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
17056038|NCT00095173|38199420|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
17056039|NCT00095173|38199421|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
17056040|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|Death|0|||
17056041|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|Death|0|||
17056042|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|Death|0|||
17056043|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|Death|0|||
17056044|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|Death|0|||
17056045|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|Death|1|||
17056046|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
17056047|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
17056048|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
17144755|NCT02778204|38288487|FG002|Overall Study|Eligibility Violation|0|||
17056049|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
17056050|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
17056051|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
17056052|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
17056053|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
17056054|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
17056055|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
17056056|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
17056057|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
17056058|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
17056059|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
17056060|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
17056061|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
17056062|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
17056063|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
17056064|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
17056065|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
17056066|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
17056067|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
17056068|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
17056069|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
17056070|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
17056071|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
17056072|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
17056073|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
17056074|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
17056075|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
17056076|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
17056077|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
17056078|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
17056079|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
17056080|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
17056081|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
17056082|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
17056083|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
17056084|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
17056085|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
17056086|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
17056087|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
17056088|NCT00095173|38199416|FG000|Open-Label Extension Phase (Period C)|Other|0|||
17056089|NCT00095173|38199417|FG001|Open-Label Extension Phase (Period C)|Other|0|||
17056090|NCT00095173|38199418|FG002|Open-Label Extension Phase (Period C)|Other|0|||
17056091|NCT00095173|38199419|FG003|Open-Label Extension Phase (Period C)|Other|4|||
17056092|NCT00095173|38199420|FG004|Open-Label Extension Phase (Period C)|Other|6|||
17056093|NCT00095173|38199421|FG005|Open-Label Extension Phase (Period C)|Other|8|||
17056094|NCT00690443|38199437|FG000|Overall Study|Adverse Event|1|||
17056095|NCT00690443|38199438|FG001|Overall Study|Adverse Event|2|||
17056096|NCT03954834|38199448|FG000|Overall Study|Adverse Event|1|||
17056097|NCT03954834|38199449|FG001|Overall Study|Adverse Event|3|||
17056098|NCT03954834|38199450|FG002|Overall Study|Adverse Event|1|||
17056099|NCT03954834|38199451|FG003|Overall Study|Adverse Event|1|||
17056100|NCT03954834|38199448|FG000|Overall Study|Death|0|||
17056101|NCT03954834|38199449|FG001|Overall Study|Death|0|||
17056102|NCT03954834|38199450|FG002|Overall Study|Death|0|||
17056103|NCT03954834|38199451|FG003|Overall Study|Death|1|||
17056104|NCT03954834|38199448|FG000|Overall Study|Physician Decision|0|||
17056105|NCT03954834|38199449|FG001|Overall Study|Physician Decision|1|||
17056106|NCT03954834|38199450|FG002|Overall Study|Physician Decision|0|||
17056107|NCT03954834|38199451|FG003|Overall Study|Physician Decision|2|||
17056108|NCT03954834|38199448|FG000|Overall Study|Protocol Violation|1|||
17056109|NCT03954834|38199449|FG001|Overall Study|Protocol Violation|0|||
17056110|NCT03954834|38199450|FG002|Overall Study|Protocol Violation|0|||
17056111|NCT03954834|38199451|FG003|Overall Study|Protocol Violation|1|||
17056112|NCT03954834|38199448|FG000|Overall Study|Withdrawal by Subject|2|||
17056113|NCT03954834|38199449|FG001|Overall Study|Withdrawal by Subject|3|||
17056114|NCT03954834|38199450|FG002|Overall Study|Withdrawal by Subject|13|||
17056115|NCT03954834|38199451|FG003|Overall Study|Withdrawal by Subject|6|||
17056116|NCT03954834|38199448|FG000|Overall Study|Participant left the country|0|||
17056117|NCT03954834|38199449|FG001|Overall Study|Participant left the country|0|||
17056118|NCT03954834|38199450|FG002|Overall Study|Participant left the country|1|||
17056119|NCT03954834|38199451|FG003|Overall Study|Participant left the country|0|||
17056120|NCT03954834|38199448|FG000|Overall Study|Lost to Follow-up|3|||
17056121|NCT03954834|38199449|FG001|Overall Study|Lost to Follow-up|2|||
17056122|NCT03954834|38199450|FG002|Overall Study|Lost to Follow-up|3|||
17056123|NCT03954834|38199451|FG003|Overall Study|Lost to Follow-up|5|||
17056124|NCT00693017|38199463|FG000|Overall Study|Sponsor Decision|2|||
17056125|NCT00693017|38199464|FG001|Overall Study|Sponsor Decision|1|||
17056126|NCT00693017|38199463|FG000|Overall Study|Death|0|||
17056127|NCT00693017|38199464|FG001|Overall Study|Death|1|||
17056128|NCT00692237|38199472|FG000|Overall Study|Withdrawal by Subject|1|||
17056129|NCT00692237|38199473|FG001|Overall Study|Withdrawal by Subject|3|||
17056130|NCT00692237|38199472|FG000|Overall Study|Adverse Event|0|||
17056131|NCT00692237|38199473|FG001|Overall Study|Adverse Event|1|||
17056132|NCT00110149|38199479|FG000|Overall Study|Physician Decision|3|||
17056133|NCT03954444|38199487|FG000|Overall Study|Withdrawal by Subject|5|||
17056134|NCT03954444|38199488|FG001|Overall Study|Withdrawal by Subject|5|||
17056135|NCT03954444|38199489|FG002|Overall Study|Withdrawal by Subject|5|||
17056136|NCT03954444|38199487|FG000|Overall Study|Adverse Event|1|||
17056137|NCT03954444|38199488|FG001|Overall Study|Adverse Event|3|||
17056138|NCT03954444|38199489|FG002|Overall Study|Adverse Event|2|||
17056139|NCT03954444|38199487|FG000|Overall Study|Protocol Violation|0|||
17056140|NCT03954444|38199488|FG001|Overall Study|Protocol Violation|3|||
17056141|NCT03954444|38199489|FG002|Overall Study|Protocol Violation|5|||
17056142|NCT03954444|38199487|FG000|Overall Study|Use of prohibited therapy|1|||
17056143|NCT03954444|38199488|FG001|Overall Study|Use of prohibited therapy|1|||
17056144|NCT03954444|38199489|FG002|Overall Study|Use of prohibited therapy|2|||
17056145|NCT03954444|38199487|FG000|Overall Study|Lost to Follow-up|1|||
17056146|NCT03954444|38199488|FG001|Overall Study|Lost to Follow-up|0|||
17056147|NCT03954444|38199489|FG002|Overall Study|Lost to Follow-up|1|||
17056148|NCT03954444|38199487|FG000|Overall Study|Non-compliant with study drug application|2|||
17056149|NCT03954444|38199488|FG001|Overall Study|Non-compliant with study drug application|2|||
17056150|NCT03954444|38199489|FG002|Overall Study|Non-compliant with study drug application|0|||
17056151|NCT03954444|38199487|FG000|Overall Study|Administrative reasons|0|||
17056152|NCT03954444|38199488|FG001|Overall Study|Administrative reasons|0|||
17056153|NCT03954444|38199489|FG002|Overall Study|Administrative reasons|1|||
17056154|NCT03954444|38199487|FG000|Overall Study|Miscellaneous|3|||
17056155|NCT03954444|38199488|FG001|Overall Study|Miscellaneous|2|||
17056156|NCT03954444|38199489|FG002|Overall Study|Miscellaneous|1|||
17056157|NCT03953820|38199497|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
17056158|NCT03953820|38199498|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
17056159|NCT03953820|38199499|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
17056160|NCT03953820|38199497|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
17056161|NCT03953820|38199498|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
17056162|NCT03953820|38199499|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
17056163|NCT00117949|38199516|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
17056164|NCT00117949|38199517|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
17056165|NCT00117949|38199518|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
17056166|NCT00117949|38199519|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
17056167|NCT00117949|38199516|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
17056168|NCT00117949|38199517|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
17056169|NCT00117949|38199518|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
17056170|NCT00117949|38199519|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
17056171|NCT00117949|38199516|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
17056172|NCT00117949|38199517|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
17056173|NCT00117949|38199518|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
17056174|NCT00117949|38199519|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
17056175|NCT00117949|38199516|FG000|Overall Study|PSA increase >=10ng/mL|0|||
17056176|NCT00117949|38199517|FG001|Overall Study|PSA increase >=10ng/mL|1|||
17056177|NCT00117949|38199518|FG002|Overall Study|PSA increase >=10ng/mL|1|||
17056178|NCT00117949|38199519|FG003|Overall Study|PSA increase >=10ng/mL|0|||
17056179|NCT00117949|38199516|FG000|Overall Study|PSA reduction <=50%|0|||
17056180|NCT00117949|38199517|FG001|Overall Study|PSA reduction <=50%|2|||
17056181|NCT00117949|38199518|FG002|Overall Study|PSA reduction <=50%|2|||
17056182|NCT00117949|38199519|FG003|Overall Study|PSA reduction <=50%|4|||
17056183|NCT00117949|38199516|FG000|Overall Study|Hepatic abnormalities|0|||
17056184|NCT00117949|38199517|FG001|Overall Study|Hepatic abnormalities|1|||
17056185|NCT00117949|38199518|FG002|Overall Study|Hepatic abnormalities|0|||
17056186|NCT00117949|38199519|FG003|Overall Study|Hepatic abnormalities|1|||
17056187|NCT02611037|38199529|FG000|Overall Study|Withdrawal prior to treatment|2|||
17056188|NCT02611037|38199530|FG001|Overall Study|Withdrawal prior to treatment|0|||
17056189|NCT00117793|38199535|FG000|Overall Study|Withdrawal by Subject|12|||
17056190|NCT00695669|38199544|FG000|Overall Study|Adverse Event|0|||
17056191|NCT00695669|38199545|FG001|Overall Study|Adverse Event|0|||
17056192|NCT00695669|38199546|FG002|Overall Study|Adverse Event|2|||
17056193|NCT00695669|38199547|FG003|Overall Study|Adverse Event|0|||
17056194|NCT00695669|38199544|FG000|Overall Study|Lost to Follow-up|4|||
17056195|NCT00695669|38199545|FG001|Overall Study|Lost to Follow-up|4|||
17056196|NCT00695669|38199546|FG002|Overall Study|Lost to Follow-up|1|||
17056197|NCT00695669|38199547|FG003|Overall Study|Lost to Follow-up|4|||
17056198|NCT03671369|38199560|FG000|Overall Study|Other|1|||
17056199|NCT03671369|38199560|FG000|Overall Study|Withdrawal by Subject|289|||
17056200|NCT03671369|38199560|FG000|Overall Study|Not willing to be vaccinated|1|||
17056201|NCT00692003|38199566|FG000|Overall Study|Sponsor Decision|5|||
17056202|NCT00692003|38199567|FG001|Overall Study|Sponsor Decision|1|||
17056203|NCT00434512|38199579|FG000|Overall Study|Migrated/moved from study area|0|||
17056204|NCT00434512|38199580|FG001|Overall Study|Migrated/moved from study area|0|||
17056205|NCT00434512|38199581|FG002|Overall Study|Migrated/moved from study area|0|||
17056206|NCT00434512|38199582|FG003|Overall Study|Migrated/moved from study area|1|||
17056207|NCT00434512|38199583|FG004|Overall Study|Migrated/moved from study area|1|||
17056208|NCT00434512|38199584|FG005|Overall Study|Migrated/moved from study area|1|||
17056209|NCT00434512|38199579|FG000|Overall Study|Other|0|||
17056210|NCT00434512|38199580|FG001|Overall Study|Other|1|||
17056211|NCT00434512|38199581|FG002|Overall Study|Other|0|||
17056212|NCT00434512|38199582|FG003|Overall Study|Other|0|||
17056213|NCT00434512|38199583|FG004|Overall Study|Other|0|||
17056214|NCT00434512|38199584|FG005|Overall Study|Other|0|||
17056215|NCT00427648|38199604|FG000|Overall Study|Protocol Violation|1|||
17056216|NCT00427648|38199605|FG001|Overall Study|Protocol Violation|2|||
17056217|NCT00427648|38199604|FG000|Overall Study|Adverse Event|0|||
17056218|NCT00427648|38199605|FG001|Overall Study|Adverse Event|1|||
17056219|NCT00416884|38199613|FG000|Overall Study|Study terminated due to low accrual|1|||
17056220|NCT00434122|38199619|FG000|Overall Study|Non-compliance with protocol|0|||
17056221|NCT00434122|38199620|FG001|Overall Study|Non-compliance with protocol|1|||
17056222|NCT00434122|38199619|FG000|Overall Study|loss of subject contact|1|||
17056223|NCT00434122|38199620|FG001|Overall Study|loss of subject contact|1|||
17056224|NCT00434122|38199619|FG000|Overall Study|Personal reasons|1|||
17056225|NCT00434122|38199620|FG001|Overall Study|Personal reasons|1|||
17056226|NCT00434122|38199619|FG000|Overall Study|Large follicle size|2|||
17056227|NCT00434122|38199620|FG001|Overall Study|Large follicle size|2|||
17056228|NCT00434122|38199619|FG000|Overall Study|Low follicular response.|1|||
17056229|NCT00434122|38199620|FG001|Overall Study|Low follicular response.|2|||
17056230|NCT00434122|38199619|FG000|Overall Study|Travelling of subject.|1|||
17056231|NCT00434122|38199620|FG001|Overall Study|Travelling of subject.|0|||
17056232|NCT00555620|38199634|FG000|Overall Study|Death|0|||
17056233|NCT00555620|38199635|FG001|Overall Study|Death|1|||
17056234|NCT00555620|38199636|FG002|Overall Study|Death|0|||
17056235|NCT00555620|38199637|FG003|Overall Study|Death|0|||
17056236|NCT00555620|38199638|FG004|Overall Study|Death|0|||
17056237|NCT00555620|38199639|FG005|Overall Study|Death|1|||
17056238|NCT00555620|38199634|FG000|Overall Study|Study terminated by sponsor|0|||
17056239|NCT00555620|38199635|FG001|Overall Study|Study terminated by sponsor|0|||
17056240|NCT00555620|38199636|FG002|Overall Study|Study terminated by sponsor|1|||
17056241|NCT00555620|38199637|FG003|Overall Study|Study terminated by sponsor|0|||
17056242|NCT00555620|38199638|FG004|Overall Study|Study terminated by sponsor|0|||
17056243|NCT00555620|38199639|FG005|Overall Study|Study terminated by sponsor|0|||
17056244|NCT00555620|38199634|FG000|Overall Study|Adverse Event|0|||
17056245|NCT00555620|38199635|FG001|Overall Study|Adverse Event|0|||
17056246|NCT00555620|38199636|FG002|Overall Study|Adverse Event|1|||
17056247|NCT00555620|38199637|FG003|Overall Study|Adverse Event|5|||
17056248|NCT00555620|38199638|FG004|Overall Study|Adverse Event|0|||
17056249|NCT00555620|38199639|FG005|Overall Study|Adverse Event|1|||
17056250|NCT00555620|38199634|FG000|Overall Study|Objective progression or relapse|6|||
17056251|NCT00555620|38199635|FG001|Overall Study|Objective progression or relapse|5|||
17056252|NCT00555620|38199636|FG002|Overall Study|Objective progression or relapse|12|||
17056253|NCT00555620|38199637|FG003|Overall Study|Objective progression or relapse|17|||
17056254|NCT00555620|38199638|FG004|Overall Study|Objective progression or relapse|3|||
17056255|NCT00555620|38199639|FG005|Overall Study|Objective progression or relapse|16|||
17056256|NCT00555620|38199634|FG000|Overall Study|Participant refused treatment|0|||
17056257|NCT00555620|38199635|FG001|Overall Study|Participant refused treatment|1|||
17056258|NCT00555620|38199636|FG002|Overall Study|Participant refused treatment|1|||
17056259|NCT00555620|38199637|FG003|Overall Study|Participant refused treatment|0|||
17144756|NCT02778204|38288488|FG003|Overall Study|Eligibility Violation|1|||
17144757|NCT04072159|38288502|FG000|Overall Study|Lost to Follow-up|6|||
17144758|NCT04072159|38288503|FG001|Overall Study|Lost to Follow-up|6|||
17144759|NCT04072159|38288502|FG000|Overall Study|Withdrawal by Subject|2|||
17144760|NCT04072159|38288503|FG001|Overall Study|Withdrawal by Subject|0|||
17144761|NCT03232281|38288513|FG000|Overall Study|Adverse Event|1|||
17056260|NCT00555620|38199638|FG004|Overall Study|Participant refused treatment|0|||
17056261|NCT00555620|38199639|FG005|Overall Study|Participant refused treatment|1|||
17056262|NCT00555620|38199634|FG000|Overall Study|Other|0|||
17056263|NCT00555620|38199635|FG001|Overall Study|Other|0|||
17056264|NCT00555620|38199636|FG002|Overall Study|Other|0|||
17056265|NCT00555620|38199637|FG003|Overall Study|Other|1|||
17056266|NCT00555620|38199638|FG004|Overall Study|Other|0|||
17056267|NCT00555620|38199639|FG005|Overall Study|Other|3|||
17056268|NCT00433966|38199659|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
17056269|NCT00433966|38199660|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
17056270|NCT00433966|38199661|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
17056271|NCT00433966|38199662|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
17056272|NCT00433966|38199659|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
17056273|NCT00433966|38199660|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
17056274|NCT00433966|38199661|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
17056275|NCT00433966|38199662|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
17056276|NCT00433966|38199659|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
17056277|NCT00433966|38199660|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
17056278|NCT00433966|38199661|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
17056279|NCT00433966|38199662|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
17056280|NCT00433966|38199659|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
17056281|NCT00433966|38199660|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
17056282|NCT00433966|38199661|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
17056283|NCT00433966|38199662|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
17056284|NCT00433966|38199659|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
17144762|NCT03232281|38288514|FG001|Overall Study|Adverse Event|1|||
17144763|NCT03232281|38288513|FG000|Overall Study|Withdrawal by Subject|5|||
17144764|NCT03232281|38288514|FG001|Overall Study|Withdrawal by Subject|4|||
17144765|NCT03232281|38288513|FG000|Overall Study|Protocol Deviation|1|||
17144766|NCT03232281|38288514|FG001|Overall Study|Protocol Deviation|1|||
17144767|NCT04071301|38288520|FG000|Overall Study|Withdrawal by Subject|6|||
17144768|NCT04071301|38288520|FG000|Overall Study|Death|1|||
17144769|NCT03261336|38288524|FG000|Overall Study|Adverse Event|1|||
17144770|NCT00462748|38288531|FG000|Overall Study|Adverse Event|7|||
17144771|NCT00462748|38288532|FG001|Overall Study|Adverse Event|5|||
17144772|NCT00462748|38288533|FG002|Overall Study|Adverse Event|9|||
17144773|NCT00462748|38288531|FG000|Overall Study|Protocol Violation|0|||
17144774|NCT00462748|38288532|FG001|Overall Study|Protocol Violation|2|||
17056285|NCT00433966|38199660|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
17056286|NCT00433966|38199661|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
17056287|NCT00433966|38199662|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
17056288|NCT03952650|38199679|FG000|Overall Study|TRAVEL|0|||
17056289|NCT03952650|38199680|FG001|Overall Study|TRAVEL|4|||
17056290|NCT03952650|38199681|FG002|Overall Study|TRAVEL|0|||
17056291|NCT03952650|38199682|FG003|Overall Study|TRAVEL|4|||
17056292|NCT03952650|38199683|FG004|Overall Study|TRAVEL|0|||
17056293|NCT03952650|38199684|FG005|Overall Study|TRAVEL|3|||
17056294|NCT03952650|38199685|FG006|Overall Study|TRAVEL|2|||
17056295|NCT03952650|38199679|FG000|Overall Study|Withdrawal by Subject|0|||
17056296|NCT03952650|38199680|FG001|Overall Study|Withdrawal by Subject|2|||
17056297|NCT03952650|38199681|FG002|Overall Study|Withdrawal by Subject|0|||
17056298|NCT03952650|38199682|FG003|Overall Study|Withdrawal by Subject|3|||
17056299|NCT03952650|38199683|FG004|Overall Study|Withdrawal by Subject|0|||
17056300|NCT03952650|38199684|FG005|Overall Study|Withdrawal by Subject|1|||
17056301|NCT03952650|38199685|FG006|Overall Study|Withdrawal by Subject|1|||
17056302|NCT03952650|38199679|FG000|Overall Study|Lost to Follow-up|0|||
17056303|NCT03952650|38199680|FG001|Overall Study|Lost to Follow-up|1|||
17056304|NCT03952650|38199681|FG002|Overall Study|Lost to Follow-up|0|||
17056305|NCT03952650|38199682|FG003|Overall Study|Lost to Follow-up|0|||
17056306|NCT03952650|38199683|FG004|Overall Study|Lost to Follow-up|0|||
17056307|NCT03952650|38199684|FG005|Overall Study|Lost to Follow-up|1|||
17056308|NCT03952650|38199685|FG006|Overall Study|Lost to Follow-up|1|||
17056309|NCT03952650|38199679|FG000|Overall Study|Received wrong vaccine and travelled|0|||
17056310|NCT03952650|38199680|FG001|Overall Study|Received wrong vaccine and travelled|0|||
17056311|NCT03952650|38199681|FG002|Overall Study|Received wrong vaccine and travelled|0|||
17056312|NCT03952650|38199682|FG003|Overall Study|Received wrong vaccine and travelled|0|||
17056313|NCT03952650|38199683|FG004|Overall Study|Received wrong vaccine and travelled|0|||
17056314|NCT03952650|38199684|FG005|Overall Study|Received wrong vaccine and travelled|1|||
17056315|NCT03952650|38199685|FG006|Overall Study|Received wrong vaccine and travelled|0|||
17056316|NCT03952650|38199679|FG000|Overall Study|Unable to make study visit|0|||
17056317|NCT03952650|38199680|FG001|Overall Study|Unable to make study visit|0|||
17056318|NCT03952650|38199681|FG002|Overall Study|Unable to make study visit|0|||
17056319|NCT03952650|38199682|FG003|Overall Study|Unable to make study visit|0|||
17056320|NCT03952650|38199683|FG004|Overall Study|Unable to make study visit|0|||
17056321|NCT03952650|38199684|FG005|Overall Study|Unable to make study visit|1|||
17056322|NCT03952650|38199685|FG006|Overall Study|Unable to make study visit|0|||
17056323|NCT00691301|38199701|FG000|Overall Study|Adverse Event|10|||
17056324|NCT00691301|38199701|FG000|Overall Study|Death|2|||
17056325|NCT00691301|38199701|FG000|Overall Study|Lack of Efficacy|32|||
17056326|NCT00691301|38199701|FG000|Overall Study|Withdrawal by Subject|4|||
17056327|NCT00691301|38199701|FG000|Overall Study|Concurrent illness|2|||
17056328|NCT00691301|38199701|FG000|Overall Study|other reason|3|||
17056329|NCT00691301|38199701|FG000|Overall Study|Did not initiate study treatment|1|||
17056330|NCT00927563|38199711|FG000|Overall Study|Lost to Follow-up|1|||
17056331|NCT00927563|38199711|FG000|Overall Study|Withdrawal by Subject|1|||
17056332|NCT00653159|38199726|FG000|Overall Study|Adverse Event|4|||
17056333|NCT00653159|38199727|FG001|Overall Study|Adverse Event|1|||
17056334|NCT00653159|38199726|FG000|Overall Study|Lost to Follow-up|1|||
17056335|NCT00653159|38199727|FG001|Overall Study|Lost to Follow-up|2|||
17056336|NCT00117637|38199735|FG000|First Intervention (Period 1)|Adverse Event|11|||
17056337|NCT00117637|38199736|FG001|First Intervention (Period 1)|Adverse Event|16|||
17056338|NCT00117637|38199735|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
17056339|NCT00117637|38199736|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
17056340|NCT00117637|38199735|FG000|First Intervention (Period 1)|Protocol Violation|1|||
17056341|NCT00117637|38199736|FG001|First Intervention (Period 1)|Protocol Violation|0|||
17056342|NCT00117637|38199735|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
17056343|NCT00117637|38199736|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
17056344|NCT00117637|38199735|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
17056345|NCT00117637|38199736|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
17056346|NCT00117637|38199735|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
17056347|NCT00117637|38199736|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
17144775|NCT00462748|38288533|FG002|Overall Study|Protocol Violation|1|||
17144776|NCT00462748|38288531|FG000|Overall Study|Withdrew consent|3|||
17056348|NCT00117637|38199735|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
17056349|NCT00117637|38199736|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
17056350|NCT00117637|38199735|FG000|First Intervention (Period 1)|reason not reported|0|||
17056351|NCT00117637|38199736|FG001|First Intervention (Period 1)|reason not reported|1|||
17056352|NCT00117637|38199735|FG000|Second Intervention (Period 2)|Adverse Event|0|||
17056353|NCT00117637|38199736|FG001|Second Intervention (Period 2)|Adverse Event|9|||
17056354|NCT00117637|38199735|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
17056355|NCT00117637|38199736|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
17056356|NCT00117637|38199735|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
17056357|NCT00117637|38199736|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
17056358|NCT00117637|38199735|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
17056359|NCT00117637|38199736|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
17056360|NCT00117637|38199735|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
17056361|NCT00117637|38199736|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
17056362|NCT00117637|38199735|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
17056363|NCT00117637|38199736|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
17056364|NCT00117637|38199735|FG000|Second Intervention (Period 2)|reason not reported|1|||
17056365|NCT00117637|38199736|FG001|Second Intervention (Period 2)|reason not reported|0|||
17056366|NCT00690755|38199756|FG000|Overall Study|Physician Decision|2|||
17056367|NCT00690755|38199757|FG001|Overall Study|Physician Decision|0|||
17056368|NCT00690755|38199758|FG002|Overall Study|Physician Decision|46|||
17056369|NCT00690755|38199759|FG003|Overall Study|Physician Decision|5|||
17056370|NCT00690755|38199760|FG004|Overall Study|Physician Decision|0|||
17056371|NCT00690755|38199761|FG005|Overall Study|Physician Decision|4|||
17056372|NCT00690755|38199762|FG006|Overall Study|Physician Decision|0|||
17056373|NCT00549302|38199780|FG000|Double-Blind|Death|2|||
17056374|NCT00549302|38199781|FG001|Double-Blind|Death|9|||
17056375|NCT00549302|38199782|FG002|Double-Blind|Death|0|||
17056376|NCT00549302|38199780|FG000|Double-Blind|Adverse Event|3|||
17056377|NCT00549302|38199781|FG001|Double-Blind|Adverse Event|16|||
17056378|NCT00549302|38199782|FG002|Double-Blind|Adverse Event|0|||
17056379|NCT00549302|38199780|FG000|Double-Blind|Withdrawal by Subject|3|||
17056380|NCT00549302|38199781|FG001|Double-Blind|Withdrawal by Subject|8|||
17056381|NCT00549302|38199782|FG002|Double-Blind|Withdrawal by Subject|0|||
17056382|NCT00549302|38199780|FG000|Double-Blind|Investigator Decision|1|||
17056383|NCT00549302|38199781|FG001|Double-Blind|Investigator Decision|5|||
17056384|NCT00549302|38199782|FG002|Double-Blind|Investigator Decision|0|||
17056385|NCT00549302|38199780|FG000|Double-Blind|Sponsor Decision|0|||
17056386|NCT00549302|38199781|FG001|Double-Blind|Sponsor Decision|1|||
17056387|NCT00549302|38199782|FG002|Double-Blind|Sponsor Decision|0|||
17056388|NCT00549302|38199780|FG000|Double-Blind|Lost to Follow-up|1|||
17056389|NCT00549302|38199781|FG001|Double-Blind|Lost to Follow-up|2|||
17056390|NCT00549302|38199782|FG002|Double-Blind|Lost to Follow-up|0|||
17056391|NCT00549302|38199780|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
17056392|NCT00549302|38199781|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
17056393|NCT00549302|38199782|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
17056394|NCT00549302|38199780|FG000|Double-Blind|New condition or starts new therapy|0|||
17056395|NCT00549302|38199781|FG001|Double-Blind|New condition or starts new therapy|2|||
17056396|NCT00549302|38199782|FG002|Double-Blind|New condition or starts new therapy|0|||
17056397|NCT00549302|38199780|FG000|Open-Label|Adverse Event|0|||
17056398|NCT00549302|38199781|FG001|Open-Label|Adverse Event|0|||
17056399|NCT00549302|38199782|FG002|Open-Label|Adverse Event|11|||
17056400|NCT00549302|38199780|FG000|Open-Label|Death|0|||
17056401|NCT00549302|38199781|FG001|Open-Label|Death|0|||
17056402|NCT00549302|38199782|FG002|Open-Label|Death|40|||
17056403|NCT00549302|38199780|FG000|Open-Label|Investigator Decision|0|||
17056404|NCT00549302|38199781|FG001|Open-Label|Investigator Decision|0|||
17056405|NCT00549302|38199782|FG002|Open-Label|Investigator Decision|5|||
17056406|NCT00549302|38199780|FG000|Open-Label|Lost to Follow-up|0|||
17056407|NCT00549302|38199781|FG001|Open-Label|Lost to Follow-up|0|||
17056408|NCT00549302|38199782|FG002|Open-Label|Lost to Follow-up|2|||
17056409|NCT00549302|38199780|FG000|Open-Label|Other|0|||
17056410|NCT00549302|38199781|FG001|Open-Label|Other|0|||
17056411|NCT00549302|38199782|FG002|Open-Label|Other|3|||
17056412|NCT00549302|38199780|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
17056413|NCT00549302|38199781|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
17056414|NCT00549302|38199782|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
17056415|NCT00549302|38199780|FG000|Open-Label|Withdrawal by Subject|0|||
17144777|NCT00462748|38288532|FG001|Overall Study|Withdrew consent|3|||
17144778|NCT00462748|38288533|FG002|Overall Study|Withdrew consent|0|||
17144779|NCT00462748|38288531|FG000|Overall Study|Lost to Follow-up|1|||
17144780|NCT00462748|38288532|FG001|Overall Study|Lost to Follow-up|1|||
17144781|NCT00462748|38288533|FG002|Overall Study|Lost to Follow-up|1|||
17144782|NCT00462748|38288531|FG000|Overall Study|Discontinued after 41 days Rx|1|||
17144783|NCT00462748|38288532|FG001|Overall Study|Discontinued after 41 days Rx|0|||
17144784|NCT00462748|38288533|FG002|Overall Study|Discontinued after 41 days Rx|0|||
17056416|NCT00549302|38199781|FG001|Open-Label|Withdrawal by Subject|0|||
17056417|NCT00549302|38199782|FG002|Open-Label|Withdrawal by Subject|6|||
17056418|NCT00117325|38199792|FG000|Overall Study|Adverse Event|3|||
17056419|NCT00117325|38199793|FG001|Overall Study|Adverse Event|3|||
17056420|NCT00117325|38199792|FG000|Overall Study|Lost to Follow-up|1|||
17056421|NCT00117325|38199793|FG001|Overall Study|Lost to Follow-up|1|||
17056422|NCT00117325|38199792|FG000|Overall Study|Protocol Violation|2|||
17056423|NCT00117325|38199793|FG001|Overall Study|Protocol Violation|3|||
17056424|NCT00117325|38199792|FG000|Overall Study|Withdrawal by Subject|3|||
17056425|NCT00117325|38199793|FG001|Overall Study|Withdrawal by Subject|2|||
17056426|NCT00117325|38199792|FG000|Overall Study|Lack of Efficacy|1|||
17056427|NCT00117325|38199793|FG001|Overall Study|Lack of Efficacy|0|||
17056428|NCT00117325|38199792|FG000|Overall Study|Use of prohibited medicine|1|||
17056429|NCT00117325|38199793|FG001|Overall Study|Use of prohibited medicine|2|||
17056430|NCT00117325|38199792|FG000|Overall Study|Early termination|1|||
17056431|NCT00117325|38199793|FG001|Overall Study|Early termination|1|||
17056432|NCT00117325|38199792|FG000|Overall Study|Admisnitrative|1|||
17056433|NCT00117325|38199793|FG001|Overall Study|Admisnitrative|0|||
17056434|NCT00108433|38199802|FG000|Overall Study|Lack of Efficacy|1|||
17056435|NCT00108433|38199803|FG001|Overall Study|Lack of Efficacy|2|||
17056436|NCT00108433|38199802|FG000|Overall Study|Death|3|||
17056437|NCT00108433|38199803|FG001|Overall Study|Death|0|||
17056438|NCT00108433|38199802|FG000|Overall Study|Adverse Event|3|||
17056439|NCT00108433|38199803|FG001|Overall Study|Adverse Event|1|||
17056440|NCT00108433|38199802|FG000|Overall Study|Other|14|||
17056441|NCT00108433|38199803|FG001|Overall Study|Other|14|||
17056442|NCT00116779|38199811|FG000|Overall Study|Adverse Event|4|||
17056443|NCT00116779|38199812|FG001|Overall Study|Adverse Event|2|||
17056444|NCT00116779|38199811|FG000|Overall Study|Protocol Violation|1|||
17056445|NCT00116779|38199812|FG001|Overall Study|Protocol Violation|4|||
17056446|NCT00116779|38199811|FG000|Overall Study|Withdrawal by Subject|4|||
17056447|NCT00116779|38199812|FG001|Overall Study|Withdrawal by Subject|1|||
17056448|NCT00116779|38199811|FG000|Overall Study|Inadequate testosterone suppression|7|||
17056449|NCT00116779|38199812|FG001|Overall Study|Inadequate testosterone suppression|9|||
17056450|NCT00116779|38199811|FG000|Overall Study|Physician Decision|3|||
17056451|NCT00116779|38199812|FG001|Overall Study|Physician Decision|1|||
17056452|NCT00116779|38199811|FG000|Overall Study|Elevated PSA levels|2|||
17056453|NCT00116779|38199812|FG001|Overall Study|Elevated PSA levels|2|||
17056454|NCT03943290|38199827|FG000|Overall Study|Sponsor Terminated Study|6|||
17056455|NCT03943290|38199828|FG001|Overall Study|Sponsor Terminated Study|1|||
17056456|NCT03943290|38199829|FG002|Overall Study|Sponsor Terminated Study|11|||
17056457|NCT03943290|38199830|FG003|Overall Study|Sponsor Terminated Study|6|||
17056458|NCT03943290|38199831|FG004|Overall Study|Sponsor Terminated Study|7|||
17056459|NCT03943290|38199832|FG005|Overall Study|Sponsor Terminated Study|6|||
17056460|NCT03943290|38199833|FG006|Overall Study|Sponsor Terminated Study|6|||
17056461|NCT03943290|38199834|FG007|Overall Study|Sponsor Terminated Study|7|||
17056462|NCT03943290|38199835|FG008|Overall Study|Sponsor Terminated Study|8|||
17056463|NCT03943290|38199827|FG000|Overall Study|Lost to Follow-up|1|||
17056464|NCT03943290|38199828|FG001|Overall Study|Lost to Follow-up|0|||
17056465|NCT03943290|38199829|FG002|Overall Study|Lost to Follow-up|1|||
17056466|NCT03943290|38199830|FG003|Overall Study|Lost to Follow-up|0|||
17056467|NCT03943290|38199831|FG004|Overall Study|Lost to Follow-up|0|||
17056468|NCT03943290|38199832|FG005|Overall Study|Lost to Follow-up|0|||
17056469|NCT03943290|38199833|FG006|Overall Study|Lost to Follow-up|0|||
17056470|NCT03943290|38199834|FG007|Overall Study|Lost to Follow-up|1|||
17056471|NCT03943290|38199835|FG008|Overall Study|Lost to Follow-up|0|||
17056472|NCT03943290|38199827|FG000|Overall Study|Withdrawal by Subject|0|||
17056473|NCT03943290|38199828|FG001|Overall Study|Withdrawal by Subject|0|||
17056474|NCT03943290|38199829|FG002|Overall Study|Withdrawal by Subject|1|||
17056475|NCT03943290|38199830|FG003|Overall Study|Withdrawal by Subject|0|||
17056476|NCT03943290|38199831|FG004|Overall Study|Withdrawal by Subject|0|||
17056477|NCT03943290|38199832|FG005|Overall Study|Withdrawal by Subject|0|||
17056478|NCT03943290|38199833|FG006|Overall Study|Withdrawal by Subject|0|||
17056479|NCT03943290|38199834|FG007|Overall Study|Withdrawal by Subject|0|||
17056480|NCT03943290|38199835|FG008|Overall Study|Withdrawal by Subject|0|||
17056481|NCT00108355|38199870|FG000|Overall Study|Peritonitis at index paracentesis|1|||
17056482|NCT00108355|38199871|FG001|Overall Study|Peritonitis at index paracentesis|1|||
17056483|NCT00108355|38199870|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
17056484|NCT00108355|38199871|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
17056485|NCT00094861|38199892|FG000|Overall Study|Adverse Event|5|||
17056486|NCT00094861|38199893|FG001|Overall Study|Adverse Event|2|||
17056487|NCT00094861|38199892|FG000|Overall Study|Withdrawal by Subject|5|||
17056488|NCT00094861|38199893|FG001|Overall Study|Withdrawal by Subject|3|||
17056489|NCT00094861|38199892|FG000|Overall Study|Physician Decision|1|||
17056490|NCT00094861|38199893|FG001|Overall Study|Physician Decision|1|||
17056491|NCT00094861|38199892|FG000|Overall Study|Lost to Follow-up|0|||
17056492|NCT00094861|38199893|FG001|Overall Study|Lost to Follow-up|1|||
17056493|NCT00094861|38199892|FG000|Overall Study|Death|4|||
17056494|NCT00094861|38199893|FG001|Overall Study|Death|2|||
17056495|NCT00094861|38199892|FG000|Overall Study|Other|3|||
17056496|NCT00094861|38199893|FG001|Overall Study|Other|0|||
17056497|NCT00426556|38199903|FG000|Phase I - Core Phase|Disease Progression|0|||
17056498|NCT00426556|38199904|FG001|Phase I - Core Phase|Disease Progression|6|||
17056499|NCT00426556|38199905|FG002|Phase I - Core Phase|Disease Progression|2|||
17056500|NCT00426556|38199906|FG003|Phase I - Core Phase|Disease Progression|0|||
17056501|NCT00426556|38199903|FG000|Phase I - Core Phase|Adverse Event|1|||
17056502|NCT00426556|38199904|FG001|Phase I - Core Phase|Adverse Event|3|||
17144785|NCT04206085|38288544|FG000|Overall Study|Lost to Follow-up|0|||
17144786|NCT04206085|38288545|FG001|Overall Study|Lost to Follow-up|1|||
17144787|NCT04206085|38288546|FG002|Overall Study|Lost to Follow-up|0|||
17144788|NCT04206085|38288544|FG000|Overall Study|Lost to Follow-up|0|||
17144789|NCT04206085|38288545|FG001|Overall Study|Lost to Follow-up|0|||
17144790|NCT04206085|38288546|FG002|Overall Study|Lost to Follow-up|1|||
17144791|NCT04202497|38288554|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
17144792|NCT04202497|38288555|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
17144793|NCT04202497|38288556|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
17144794|NCT04202497|38288557|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
17144795|NCT03297294|38288573|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
17144796|NCT03297294|38288574|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
17144797|NCT03297294|38288575|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
17144798|NCT03297294|38288576|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
17144799|NCT03297294|38288577|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
17144800|NCT03297294|38288573|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
17144801|NCT03297294|38288574|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
17144802|NCT03297294|38288575|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17144803|NCT03297294|38288576|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17144804|NCT03297294|38288577|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17144805|NCT03297294|38288573|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
17144806|NCT03297294|38288574|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
17144807|NCT03297294|38288575|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
17056503|NCT00426556|38199905|FG002|Phase I - Core Phase|Adverse Event|1|||
17056504|NCT00426556|38199906|FG003|Phase I - Core Phase|Adverse Event|0|||
17056505|NCT00426556|38199903|FG000|Phase I - Core Phase|Death|0|||
17056506|NCT00426556|38199904|FG001|Phase I - Core Phase|Death|1|||
17056507|NCT00426556|38199905|FG002|Phase I - Core Phase|Death|0|||
17144808|NCT03297294|38288576|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
17056508|NCT00426556|38199906|FG003|Phase I - Core Phase|Death|0|||
17056509|NCT00426556|38199903|FG000|Phase I - Extension Phase|Adverse Event|0|||
17056510|NCT00426556|38199904|FG001|Phase I - Extension Phase|Adverse Event|1|||
17056511|NCT00426556|38199905|FG002|Phase I - Extension Phase|Adverse Event|1|||
17056512|NCT00426556|38199906|FG003|Phase I - Extension Phase|Adverse Event|0|||
17056513|NCT00426556|38199903|FG000|Phase I - Extension Phase|Disease Progression|5|||
17056514|NCT00426556|38199904|FG001|Phase I - Extension Phase|Disease Progression|5|||
17056515|NCT00426556|38199905|FG002|Phase I - Extension Phase|Disease Progression|6|||
17056516|NCT00426556|38199906|FG003|Phase I - Extension Phase|Disease Progression|0|||
17056517|NCT00426556|38199903|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
17056518|NCT00426556|38199904|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
17056519|NCT00426556|38199905|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
16993034|NCT01016912|38137040|FG001|End of Treatment Period|Completed double-blind period only|1|||
16993035|NCT01016912|38137041|FG002|End of Treatment Period|Completed double-blind period only|0|||
16993036|NCT01016912|38137042|FG003|End of Treatment Period|Completed double-blind period only|0|||
16993037|NCT01016912|38137043|FG004|End of Treatment Period|Completed double-blind period only|0|||
16993038|NCT01016912|38137039|FG000|Follow-up Period|Other reason|0|||
16993039|NCT01016912|38137040|FG001|Follow-up Period|Other reason|0|||
16993040|NCT01016912|38137041|FG002|Follow-up Period|Other reason|1|||
16993041|NCT01016912|38137042|FG003|Follow-up Period|Other reason|1|||
16993042|NCT01016912|38137043|FG004|Follow-up Period|Other reason|0|||
17056520|NCT00426556|38199906|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
17056521|NCT00426556|38199903|FG000|Phase II - Core Phase|Disease Progression|0|||
17056522|NCT00426556|38199904|FG001|Phase II - Core Phase|Disease Progression|0|||
17056523|NCT00426556|38199905|FG002|Phase II - Core Phase|Disease Progression|0|||
17056524|NCT00426556|38199906|FG003|Phase II - Core Phase|Disease Progression|16|||
17056525|NCT00426556|38199903|FG000|Phase II - Core Phase|Adverse Event|0|||
17056526|NCT00426556|38199904|FG001|Phase II - Core Phase|Adverse Event|0|||
17056527|NCT00426556|38199905|FG002|Phase II - Core Phase|Adverse Event|0|||
17056528|NCT00426556|38199906|FG003|Phase II - Core Phase|Adverse Event|8|||
17056529|NCT00426556|38199903|FG000|Phase II - Extension Phase|Disease Progression|0|||
17056530|NCT00426556|38199904|FG001|Phase II - Extension Phase|Disease Progression|0|||
17056531|NCT00426556|38199905|FG002|Phase II - Extension Phase|Disease Progression|0|||
17056532|NCT00426556|38199906|FG003|Phase II - Extension Phase|Disease Progression|21|||
17056533|NCT00426556|38199903|FG000|Phase II - Extension Phase|Adverse Event|0|||
17056534|NCT00426556|38199904|FG001|Phase II - Extension Phase|Adverse Event|0|||
17056535|NCT00426556|38199905|FG002|Phase II - Extension Phase|Adverse Event|0|||
17056536|NCT00426556|38199906|FG003|Phase II - Extension Phase|Adverse Event|2|||
17056537|NCT00107653|38199918|FG000|Overall Study|Adverse Event|24|||
17056538|NCT00107653|38199919|FG001|Overall Study|Adverse Event|43|||
17056539|NCT00107653|38199918|FG000|Overall Study|Insufficient Therapeutic Response|25|||
17056540|NCT00107653|38199919|FG001|Overall Study|Insufficient Therapeutic Response|11|||
17056541|NCT00107653|38199918|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
17056542|NCT00107653|38199919|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
17056543|NCT00107653|38199918|FG000|Overall Study|Protocol Violation|1|||
17056544|NCT00107653|38199919|FG001|Overall Study|Protocol Violation|0|||
17056545|NCT00107653|38199918|FG000|Overall Study|Withdrawal by Subject|12|||
17056546|NCT00107653|38199919|FG001|Overall Study|Withdrawal by Subject|13|||
17056547|NCT00107653|38199918|FG000|Overall Study|Lost to Follow-up|13|||
17056548|NCT00107653|38199919|FG001|Overall Study|Lost to Follow-up|5|||
17056549|NCT00107653|38199918|FG000|Overall Study|Administrative Reasons|3|||
17056550|NCT00107653|38199919|FG001|Overall Study|Administrative Reasons|3|||
17056551|NCT03950856|38199929|FG000|Overall Study|Death|1|||
17056552|NCT03950856|38199930|FG001|Overall Study|Death|2|||
17056553|NCT03950856|38199931|FG002|Overall Study|Death|0|||
17056554|NCT03950856|38199932|FG003|Overall Study|Death|0|||
17144809|NCT03297294|38288577|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
17144810|NCT03297294|38288573|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
17144811|NCT03297294|38288574|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
17056555|NCT03950856|38199929|FG000|Overall Study|Lost to Follow-up|5|||
17056556|NCT03950856|38199930|FG001|Overall Study|Lost to Follow-up|6|||
17056557|NCT03950856|38199931|FG002|Overall Study|Lost to Follow-up|8|||
17056558|NCT03950856|38199932|FG003|Overall Study|Lost to Follow-up|2|||
17056559|NCT03950856|38199929|FG000|Overall Study|Protocol Violation|2|||
17056560|NCT03950856|38199930|FG001|Overall Study|Protocol Violation|0|||
17056561|NCT03950856|38199931|FG002|Overall Study|Protocol Violation|0|||
17056562|NCT03950856|38199932|FG003|Overall Study|Protocol Violation|1|||
17056563|NCT03950856|38199929|FG000|Overall Study|Withdrawal by Subject|4|||
17056564|NCT03950856|38199930|FG001|Overall Study|Withdrawal by Subject|1|||
17056565|NCT03950856|38199931|FG002|Overall Study|Withdrawal by Subject|3|||
17056566|NCT03950856|38199932|FG003|Overall Study|Withdrawal by Subject|1|||
17056567|NCT03950856|38199929|FG000|Overall Study|Unable to phone|7|||
17056568|NCT03950856|38199930|FG001|Overall Study|Unable to phone|6|||
17056569|NCT03950856|38199931|FG002|Overall Study|Unable to phone|7|||
17056570|NCT03950856|38199932|FG003|Overall Study|Unable to phone|2|||
17056571|NCT00433654|38199946|FG000|Overall Study|Death|4|||
17056572|NCT00433654|38199947|FG001|Overall Study|Death|0|||
17056573|NCT00433654|38199946|FG000|Overall Study|Missed visit|6|||
17056574|NCT00433654|38199947|FG001|Overall Study|Missed visit|3|||
17056575|NCT00433654|38199946|FG000|Overall Study|Subject not yet due for visit|4|||
17056576|NCT00433654|38199947|FG001|Overall Study|Subject not yet due for visit|0|||
17056577|NCT00433654|38199946|FG000|Overall Study|Withdrawal by Subject|1|||
17056578|NCT00433654|38199947|FG001|Overall Study|Withdrawal by Subject|2|||
17056579|NCT00689351|38199961|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
17056580|NCT00689351|38199962|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
17056581|NCT00689351|38199961|FG000|Infant Series of Dosing|Adverse Event|1|||
17056582|NCT00689351|38199962|FG001|Infant Series of Dosing|Adverse Event|0|||
17056583|NCT00689351|38199961|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
17056584|NCT00689351|38199962|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
17056585|NCT00689351|38199961|FG000|After Infant Series|Parent/legal guardian request|1|||
17056586|NCT00689351|38199962|FG001|After Infant Series|Parent/legal guardian request|0|||
17056587|NCT03950622|38199974|FG000|Overall Study|Withdrawal by Subject|1|||
17056588|NCT03950622|38199975|FG001|Overall Study|Withdrawal by Subject|0|||
17056589|NCT03950622|38199974|FG000|Overall Study|Protocol Deviation|0|||
17056590|NCT03950622|38199975|FG001|Overall Study|Protocol Deviation|1|||
17056591|NCT03950622|38199974|FG000|Overall Study|Physician Decision|1|||
17056592|NCT03950622|38199975|FG001|Overall Study|Physician Decision|0|||
17056593|NCT03950622|38199974|FG000|Overall Study|Lost to Follow-up|5|||
17056594|NCT03950622|38199975|FG001|Overall Study|Lost to Follow-up|5|||
17056595|NCT03950622|38199974|FG000|Overall Study|Death|1|||
17056596|NCT03950622|38199975|FG001|Overall Study|Death|1|||
17056597|NCT03937908|38199981|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
17056598|NCT03937908|38199982|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
17056599|NCT00689273|38199990|FG000|Overall Study|Adverse Event|3|||
17056600|NCT00689273|38199991|FG001|Overall Study|Adverse Event|1|||
17056601|NCT00689273|38199990|FG000|Overall Study|Lack of Efficacy|3|||
17056602|NCT00689273|38199991|FG001|Overall Study|Lack of Efficacy|0|||
17056603|NCT00689273|38199990|FG000|Overall Study|Lost to Follow-up|0|||
17056604|NCT00689273|38199991|FG001|Overall Study|Lost to Follow-up|2|||
17056605|NCT00689273|38199990|FG000|Overall Study|Other|6|||
17056606|NCT00689273|38199991|FG001|Overall Study|Other|2|||
17056607|NCT00689273|38199990|FG000|Overall Study|Randomized but not Treated|1|||
17056608|NCT00689273|38199991|FG001|Overall Study|Randomized but not Treated|0|||
17056609|NCT00553358|38200000|FG000|Overall Study|Randomized but did not receive treatment|3|||
17056610|NCT00553358|38200001|FG001|Overall Study|Randomized but did not receive treatment|3|||
17056611|NCT00553358|38200002|FG002|Overall Study|Randomized but did not receive treatment|1|||
17056612|NCT00553358|38200000|FG000|Overall Study|Lost to Follow-up|22|||
17056613|NCT00553358|38200001|FG001|Overall Study|Lost to Follow-up|26|||
17056614|NCT00553358|38200002|FG002|Overall Study|Lost to Follow-up|18|||
17056615|NCT00553358|38200000|FG000|Overall Study|Withdrew completely|23|||
16993043|NCT00802672|38137078|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
17056616|NCT00553358|38200001|FG001|Overall Study|Withdrew completely|33|||
17056617|NCT00553358|38200002|FG002|Overall Study|Withdrew completely|34|||
17056618|NCT00553358|38200000|FG000|Overall Study|Died during clinical follow-up|25|||
17056619|NCT00553358|38200001|FG001|Overall Study|Died during clinical follow-up|29|||
17056620|NCT00553358|38200002|FG002|Overall Study|Died during clinical follow-up|32|||
17056621|NCT00553358|38200000|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
17056622|NCT00553358|38200001|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
17144812|NCT03297294|38288575|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17144813|NCT03297294|38288576|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17144814|NCT03297294|38288577|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17144815|NCT03297294|38288573|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
16993044|NCT00802672|38137079|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
16993045|NCT00802672|38137080|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
17056623|NCT00553358|38200002|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
17056624|NCT00553358|38200000|FG000|Overall Study|Died after clinical follow-up ended|1|||
17056625|NCT00553358|38200001|FG001|Overall Study|Died after clinical follow-up ended|2|||
17056626|NCT00553358|38200002|FG002|Overall Study|Died after clinical follow-up ended|0|||
17056627|NCT00553358|38200000|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
17056628|NCT00553358|38200001|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
17056629|NCT00553358|38200002|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
17056630|NCT00688259|38200018|FG000|Overall Study|Lost to Follow-up|2|||
17056631|NCT00688259|38200019|FG001|Overall Study|Lost to Follow-up|4|||
17056632|NCT00688259|38200018|FG000|Overall Study|Physician Decision|1|||
17056633|NCT00688259|38200019|FG001|Overall Study|Physician Decision|0|||
17056634|NCT00688259|38200018|FG000|Overall Study|Withdrawal by Subject|2|||
17056635|NCT00688259|38200019|FG001|Overall Study|Withdrawal by Subject|0|||
16993046|NCT00802672|38137078|FG000|Overall Study|Adverse Event|1|||
16993047|NCT00802672|38137079|FG001|Overall Study|Adverse Event|1|||
16993048|NCT00802672|38137080|FG002|Overall Study|Adverse Event|1|||
16993049|NCT00802672|38137078|FG000|Overall Study|Protocol Violation|2|||
16993050|NCT00802672|38137079|FG001|Overall Study|Protocol Violation|1|||
16993051|NCT00802672|38137080|FG002|Overall Study|Protocol Violation|1|||
17056636|NCT00688259|38200018|FG000|Overall Study|Declined Interview|2|||
16993052|NCT00802672|38137078|FG000|Overall Study|Lost to Follow-up|5|||
17056637|NCT00688259|38200019|FG001|Overall Study|Declined Interview|3|||
17056638|NCT00688259|38200018|FG000|Overall Study|Hospitalized at Follow-up|0|||
17056639|NCT00688259|38200019|FG001|Overall Study|Hospitalized at Follow-up|1|||
17056640|NCT00688181|38200025|FG000|Overall Study|Lost to Follow-up|17|||
17056641|NCT00688181|38200025|FG000|Overall Study|Unknown Reason|4|||
17056642|NCT00688181|38200025|FG000|Overall Study|Non-clinical Reason|2|||
17056643|NCT00689117|38200044|FG000|Overall Study|Adverse Event|6|||
17056644|NCT00689117|38200045|FG001|Overall Study|Adverse Event|0|||
17056645|NCT00689117|38200046|FG002|Overall Study|Adverse Event|5|||
17056646|NCT00689117|38200047|FG003|Overall Study|Adverse Event|0|||
17056647|NCT00689117|38200044|FG000|Overall Study|Lost to Follow-up|26|||
17056648|NCT00689117|38200045|FG001|Overall Study|Lost to Follow-up|19|||
17056649|NCT00689117|38200046|FG002|Overall Study|Lost to Follow-up|17|||
17056650|NCT00689117|38200047|FG003|Overall Study|Lost to Follow-up|11|||
17056651|NCT00689117|38200044|FG000|Overall Study|Lack of Efficacy|1|||
17056652|NCT00689117|38200045|FG001|Overall Study|Lack of Efficacy|2|||
17056653|NCT00689117|38200046|FG002|Overall Study|Lack of Efficacy|2|||
17056654|NCT00689117|38200047|FG003|Overall Study|Lack of Efficacy|2|||
17056655|NCT00689117|38200044|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
17056656|NCT00689117|38200045|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
17056657|NCT00689117|38200046|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
17056658|NCT00689117|38200047|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
17056659|NCT00689117|38200044|FG000|Overall Study|Withdrawal by Subject|19|||
17056660|NCT00689117|38200045|FG001|Overall Study|Withdrawal by Subject|18|||
17056661|NCT00689117|38200046|FG002|Overall Study|Withdrawal by Subject|26|||
17056662|NCT00689117|38200047|FG003|Overall Study|Withdrawal by Subject|13|||
17056663|NCT00689117|38200044|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
17056664|NCT00689117|38200045|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
17056665|NCT00689117|38200046|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
17056666|NCT00689117|38200047|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
17056667|NCT00689117|38200044|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
17056668|NCT00689117|38200045|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
17056669|NCT00689117|38200046|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17056670|NCT00689117|38200047|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17056671|NCT00689117|38200044|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
17056672|NCT00689117|38200045|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
17056673|NCT00689117|38200046|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
17056674|NCT00689117|38200047|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
17056675|NCT00689117|38200044|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
17056676|NCT00689117|38200045|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
17056677|NCT00689117|38200046|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
17056678|NCT00689117|38200047|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
17056679|NCT00689117|38200044|FG000|Overall Study|Use of Prohibitive Medication|2|||
17056680|NCT00689117|38200045|FG001|Overall Study|Use of Prohibitive Medication|1|||
17056681|NCT00689117|38200046|FG002|Overall Study|Use of Prohibitive Medication|3|||
17056682|NCT00689117|38200047|FG003|Overall Study|Use of Prohibitive Medication|0|||
17056683|NCT00689117|38200044|FG000|Overall Study|Pregnancy|0|||
17056684|NCT00689117|38200045|FG001|Overall Study|Pregnancy|2|||
17056685|NCT00689117|38200046|FG002|Overall Study|Pregnancy|0|||
17056686|NCT00689117|38200047|FG003|Overall Study|Pregnancy|2|||
17056687|NCT00689117|38200044|FG000|Overall Study|Incarceration|2|||
17056688|NCT00689117|38200045|FG001|Overall Study|Incarceration|0|||
17056689|NCT00689117|38200046|FG002|Overall Study|Incarceration|0|||
17056690|NCT00689117|38200047|FG003|Overall Study|Incarceration|0|||
17056691|NCT00689117|38200044|FG000|Overall Study|Fear of Birth Defects|0|||
17144816|NCT03297294|38288574|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
17144817|NCT03297294|38288575|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
17144818|NCT03297294|38288576|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
17144819|NCT03297294|38288577|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
17144820|NCT03238911|38288591|FG000|Overall Study|Withdrawal by Subject|1|||
17144821|NCT03238911|38288592|FG001|Overall Study|Withdrawal by Subject|2|||
17144822|NCT03238911|38288591|FG000|Overall Study|Lost to Follow-up|2|||
17144823|NCT03238911|38288592|FG001|Overall Study|Lost to Follow-up|1|||
17144824|NCT00418834|38288601|FG000|Overall Study|Adverse Event|16|||
17144825|NCT00418834|38288602|FG001|Overall Study|Adverse Event|9|||
17144826|NCT00418834|38288601|FG000|Overall Study|Lost to Follow-up|0|||
17144827|NCT00418834|38288602|FG001|Overall Study|Lost to Follow-up|1|||
17144828|NCT00418834|38288601|FG000|Overall Study|Protocol Violation|4|||
17144829|NCT00418834|38288602|FG001|Overall Study|Protocol Violation|3|||
17144830|NCT00418834|38288601|FG000|Overall Study|Withdrawal by Subject|3|||
17144831|NCT00418834|38288602|FG001|Overall Study|Withdrawal by Subject|7|||
17144832|NCT03276975|38288610|FG000|Overall Study|Withdrawal by Subject|1|||
17144833|NCT03276975|38288611|FG001|Overall Study|Withdrawal by Subject|0|||
17144834|NCT03297216|38288619|FG000|Overall Study|Death|0|||
17144835|NCT03297216|38288620|FG001|Overall Study|Death|1|||
17144836|NCT03297216|38288619|FG000|Overall Study|Miscarriage|0|||
17144837|NCT03297216|38288620|FG001|Overall Study|Miscarriage|2|||
17144838|NCT03297216|38288619|FG000|Overall Study|Lost to Follow-up|3|||
17144839|NCT03297216|38288620|FG001|Overall Study|Lost to Follow-up|2|||
17144840|NCT03260868|38288635|FG000|Overall Study|Poor Compliance to Protocol|0|||
17144841|NCT03260868|38288636|FG001|Overall Study|Poor Compliance to Protocol|2|||
17144842|NCT03260868|38288635|FG000|Overall Study|Study Terminated By Sponsor|2|||
17144843|NCT03260868|38288636|FG001|Overall Study|Study Terminated By Sponsor|1|||
17144844|NCT03260868|38288635|FG000|Overall Study|Other than specified above|1|||
17144845|NCT03260868|38288636|FG001|Overall Study|Other than specified above|0|||
17056692|NCT00689117|38200045|FG001|Overall Study|Fear of Birth Defects|0|||
17056693|NCT00689117|38200046|FG002|Overall Study|Fear of Birth Defects|1|||
17056694|NCT00689117|38200047|FG003|Overall Study|Fear of Birth Defects|0|||
17056695|NCT00689117|38200044|FG000|Overall Study|Transportation|1|||
17056696|NCT00689117|38200045|FG001|Overall Study|Transportation|0|||
17056697|NCT00689117|38200046|FG002|Overall Study|Transportation|0|||
17056698|NCT00689117|38200047|FG003|Overall Study|Transportation|0|||
17056699|NCT00689117|38200044|FG000|Overall Study|Patient Withdrew from Study|0|||
17056700|NCT00689117|38200045|FG001|Overall Study|Patient Withdrew from Study|0|||
17056701|NCT00689117|38200046|FG002|Overall Study|Patient Withdrew from Study|0|||
17056702|NCT00689117|38200047|FG003|Overall Study|Patient Withdrew from Study|1|||
17056703|NCT00689117|38200044|FG000|Overall Study|Personal Reason|0|||
17056704|NCT00689117|38200045|FG001|Overall Study|Personal Reason|1|||
17056705|NCT00689117|38200046|FG002|Overall Study|Personal Reason|0|||
17056706|NCT00689117|38200047|FG003|Overall Study|Personal Reason|0|||
17056707|NCT00689117|38200044|FG000|Overall Study|Dispensing Error|0|||
17056708|NCT00689117|38200045|FG001|Overall Study|Dispensing Error|1|||
17056709|NCT00689117|38200046|FG002|Overall Study|Dispensing Error|0|||
17056710|NCT00689117|38200047|FG003|Overall Study|Dispensing Error|0|||
17144846|NCT03293394|38288644|FG000|Follow-up (6 Months)|Adverse Event|4|||
17144847|NCT03293394|38288645|FG001|Follow-up (6 Months)|Adverse Event|2|||
17144848|NCT03259308|38288654|FG000|Overall Study|Adverse Event|5|||
17144849|NCT03259308|38288655|FG001|Overall Study|Adverse Event|4|||
17144850|NCT03259308|38288656|FG002|Overall Study|Adverse Event|1|||
17144851|NCT03259308|38288654|FG000|Overall Study|Withdrawal by Subject|2|||
17144852|NCT03259308|38288655|FG001|Overall Study|Withdrawal by Subject|1|||
17144853|NCT03259308|38288656|FG002|Overall Study|Withdrawal by Subject|3|||
17144854|NCT03259308|38288654|FG000|Overall Study|Lost to Follow-up|0|||
17144855|NCT03259308|38288655|FG001|Overall Study|Lost to Follow-up|0|||
17144856|NCT03259308|38288656|FG002|Overall Study|Lost to Follow-up|1|||
17144857|NCT03259308|38288654|FG000|Overall Study|Pregnancy|0|||
17144858|NCT03259308|38288655|FG001|Overall Study|Pregnancy|0|||
17144859|NCT03259308|38288656|FG002|Overall Study|Pregnancy|1|||
16993053|NCT00802672|38137079|FG001|Overall Study|Lost to Follow-up|5|||
17144860|NCT03259308|38288654|FG000|Overall Study|Protocol Deviation|0|||
17144861|NCT03259308|38288655|FG001|Overall Study|Protocol Deviation|3|||
17144862|NCT03259308|38288656|FG002|Overall Study|Protocol Deviation|0|||
17144863|NCT03259308|38288654|FG000|Overall Study|Lack of Efficacy|0|||
17144864|NCT03259308|38288655|FG001|Overall Study|Lack of Efficacy|0|||
17144865|NCT03259308|38288656|FG002|Overall Study|Lack of Efficacy|1|||
17144866|NCT03258762|38288666|FG000|Overall Study|Lost to Follow-up|0|||
17144867|NCT03258762|38288667|FG001|Overall Study|Lost to Follow-up|1|||
17144868|NCT04502589|38288676|FG000|Overall Study|Physician Decision|1|||
17144869|NCT04502589|38288677|FG001|Overall Study|Physician Decision|0|||
17144870|NCT03291288|38288683|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
17144871|NCT03291288|38288684|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
17144872|NCT03291288|38288683|FG000|Drug-drug Interaction Phase|Disease progression|1|||
17144873|NCT03291288|38288684|FG001|Drug-drug Interaction Phase|Disease progression|0|||
17144874|NCT03291288|38288683|FG000|Drug-drug Interaction Phase|Other|3|||
17144875|NCT03291288|38288684|FG001|Drug-drug Interaction Phase|Other|0|||
17144876|NCT03291288|38288683|FG000|Pexidartinib Only|Ongoing|0|||
17144877|NCT03291288|38288684|FG001|Pexidartinib Only|Ongoing|2|||
17144878|NCT04428333|38288700|FG000|Overall Study|Physician Decision|2|||
17144879|NCT04428333|38288701|FG001|Overall Study|Physician Decision|0|||
17144880|NCT04428333|38288700|FG000|Overall Study|Withdrawal by Subject|0|||
17144881|NCT04428333|38288701|FG001|Overall Study|Withdrawal by Subject|1|||
17056711|NCT00547248|38200061|FG000|Overall Study|Protocol Violation|0|||
17056712|NCT00547248|38200062|FG001|Overall Study|Protocol Violation|0|||
17056713|NCT00547248|38200063|FG002|Overall Study|Protocol Violation|1|||
17056714|NCT00547248|38200064|FG003|Overall Study|Protocol Violation|1|||
17056715|NCT00547248|38200061|FG000|Overall Study|Migrated/moved from study area|0|||
17056716|NCT00547248|38200062|FG001|Overall Study|Migrated/moved from study area|0|||
17056717|NCT00547248|38200063|FG002|Overall Study|Migrated/moved from study area|2|||
17056718|NCT00547248|38200064|FG003|Overall Study|Migrated/moved from study area|0|||
17056719|NCT00547248|38200061|FG000|Overall Study|Withdrawal by Subject|0|||
17056720|NCT00547248|38200062|FG001|Overall Study|Withdrawal by Subject|0|||
17056721|NCT00547248|38200063|FG002|Overall Study|Withdrawal by Subject|7|||
17056722|NCT00547248|38200064|FG003|Overall Study|Withdrawal by Subject|1|||
17056723|NCT00688103|38200079|FG000|Overall Study|Adverse Event|4|||
17056724|NCT00688103|38200080|FG001|Overall Study|Adverse Event|1|||
17056725|NCT00688103|38200079|FG000|Overall Study|Lack of Efficacy|11|||
17056726|NCT00688103|38200080|FG001|Overall Study|Lack of Efficacy|1|||
17056727|NCT00688103|38200079|FG000|Overall Study|Withdrawal by Subject|4|||
17056728|NCT00688103|38200080|FG001|Overall Study|Withdrawal by Subject|2|||
17056729|NCT00688103|38200079|FG000|Overall Study|complex reasons|11|||
17056730|NCT00688103|38200080|FG001|Overall Study|complex reasons|9|||
17056731|NCT00686855|38200090|FG000|Overall Study|Lost to Follow-up|1|||
17056732|NCT00686855|38200091|FG001|Overall Study|Lost to Follow-up|0|||
17056733|NCT00686855|38200090|FG000|Overall Study|Progressive GVHD|0|||
17056734|NCT00686855|38200091|FG001|Overall Study|Progressive GVHD|1|||
17056735|NCT00686777|38200097|FG000|Overall Study|Adverse Event|2|||
17056736|NCT00686777|38200097|FG000|Overall Study|Pregnancy|1|||
17056737|NCT00686777|38200097|FG000|Overall Study|Withdrawal by Subject|2|||
17056738|NCT00686777|38200097|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
17056739|NCT00686777|38200097|FG000|Overall Study|No Visit|1|||
17056740|NCT00686699|38200103|FG000|Treatment Period 1|Adverse Event|0|||
17056741|NCT00686699|38200104|FG001|Treatment Period 1|Adverse Event|2|||
17056742|NCT00106639|38200113|FG000|Overall Study|Adverse Event|3|||
17056743|NCT00106639|38200114|FG001|Overall Study|Adverse Event|4|||
17056744|NCT00106639|38200115|FG002|Overall Study|Adverse Event|1|||
17056745|NCT00106639|38200113|FG000|Overall Study|Protocol Violation|0|||
17056746|NCT00106639|38200114|FG001|Overall Study|Protocol Violation|1|||
17056747|NCT00106639|38200115|FG002|Overall Study|Protocol Violation|0|||
17056748|NCT00106639|38200113|FG000|Overall Study|Withdrawal by Subject|0|||
17056749|NCT00106639|38200114|FG001|Overall Study|Withdrawal by Subject|1|||
17056750|NCT00106639|38200115|FG002|Overall Study|Withdrawal by Subject|0|||
17056751|NCT00106639|38200113|FG000|Overall Study|Participant defaulted|0|||
17056752|NCT00106639|38200114|FG001|Overall Study|Participant defaulted|1|||
17056753|NCT00106639|38200115|FG002|Overall Study|Participant defaulted|1|||
17056754|NCT00106249|38200126|FG000|Overall Study|Lost to Follow-up|3|||
17056755|NCT00106249|38200127|FG001|Overall Study|Lost to Follow-up|2|||
17056756|NCT00105469|38200135|FG000|Overall Study|Adverse Event|9|||
17056757|NCT00105469|38200136|FG001|Overall Study|Adverse Event|8|||
17056758|NCT00105469|38200135|FG000|Overall Study|Protocol Violation|4|||
17056759|NCT00105469|38200136|FG001|Overall Study|Protocol Violation|0|||
17056760|NCT00105469|38200135|FG000|Overall Study|Withdrawal by Subject|2|||
17056761|NCT00105469|38200136|FG001|Overall Study|Withdrawal by Subject|3|||
17056762|NCT00105469|38200135|FG000|Overall Study|Lost to Follow-up|1|||
17056763|NCT00105469|38200136|FG001|Overall Study|Lost to Follow-up|0|||
17056764|NCT00105469|38200135|FG000|Overall Study|Lack of Efficacy|2|||
17056765|NCT00105469|38200136|FG001|Overall Study|Lack of Efficacy|0|||
17056766|NCT00105469|38200135|FG000|Overall Study|Other Reason|4|||
17056767|NCT00105469|38200136|FG001|Overall Study|Other Reason|0|||
17144882|NCT04428333|38288700|FG000|Overall Study|In Follow-Up|5|||
17144883|NCT04428333|38288701|FG001|Overall Study|In Follow-Up|10|||
17056768|NCT00105235|38200142|FG000|Overall Study|Death|4|||
17056769|NCT00105235|38200142|FG000|Overall Study|Physician Decision|1|||
17056770|NCT00105235|38200142|FG000|Overall Study|Withdrawal by Subject|2|||
17056771|NCT00547118|38200152|FG000|Overall Study|Did not qualify prior to starting drug|1|||
17056772|NCT00547118|38200153|FG001|Overall Study|Did not qualify prior to starting drug|1|||
17056773|NCT00547118|38200152|FG000|Overall Study|Study suspended|7|||
17056774|NCT00547118|38200153|FG001|Overall Study|Study suspended|8|||
17056775|NCT00502593|38200173|FG000|Overall Study|Withdrawn unspecified reason|1|||
17056776|NCT00502593|38200174|FG001|Overall Study|Withdrawn unspecified reason|1|||
17056777|NCT00502593|38200175|FG002|Overall Study|Withdrawn unspecified reason|3|||
17056778|NCT00502593|38200176|FG003|Overall Study|Withdrawn unspecified reason|1|||
17056779|NCT00502593|38200177|FG004|Overall Study|Withdrawn unspecified reason|2|||
17056780|NCT00502593|38200178|FG005|Overall Study|Withdrawn unspecified reason|0|||
17056781|NCT00502593|38200179|FG006|Overall Study|Withdrawn unspecified reason|2|||
17056782|NCT00502593|38200180|FG007|Overall Study|Withdrawn unspecified reason|0|||
17056783|NCT00502593|38200181|FG008|Overall Study|Withdrawn unspecified reason|0|||
17056784|NCT00502593|38200182|FG009|Overall Study|Withdrawn unspecified reason|0|||
17056785|NCT00502593|38200183|FG010|Overall Study|Withdrawn unspecified reason|0|||
17056786|NCT00502593|38200184|FG011|Overall Study|Withdrawn unspecified reason|0|||
17056787|NCT00502593|38200173|FG000|Overall Study|Withdrawal by Subject|0|||
17056788|NCT00502593|38200174|FG001|Overall Study|Withdrawal by Subject|0|||
17056789|NCT00502593|38200175|FG002|Overall Study|Withdrawal by Subject|6|||
17056790|NCT00502593|38200176|FG003|Overall Study|Withdrawal by Subject|2|||
17056791|NCT00502593|38200177|FG004|Overall Study|Withdrawal by Subject|2|||
17056792|NCT00502593|38200178|FG005|Overall Study|Withdrawal by Subject|0|||
17056793|NCT00502593|38200179|FG006|Overall Study|Withdrawal by Subject|3|||
17056794|NCT00502593|38200180|FG007|Overall Study|Withdrawal by Subject|0|||
17056795|NCT00502593|38200181|FG008|Overall Study|Withdrawal by Subject|3|||
17056796|NCT00502593|38200182|FG009|Overall Study|Withdrawal by Subject|0|||
17056797|NCT00502593|38200183|FG010|Overall Study|Withdrawal by Subject|1|||
17056798|NCT00502593|38200184|FG011|Overall Study|Withdrawal by Subject|0|||
17056799|NCT00502593|38200173|FG000|Overall Study|Lost to Follow-up|2|||
17056800|NCT00502593|38200174|FG001|Overall Study|Lost to Follow-up|1|||
17056801|NCT00502593|38200175|FG002|Overall Study|Lost to Follow-up|1|||
17056802|NCT00502593|38200176|FG003|Overall Study|Lost to Follow-up|1|||
17056803|NCT00502593|38200177|FG004|Overall Study|Lost to Follow-up|0|||
17056804|NCT00502593|38200178|FG005|Overall Study|Lost to Follow-up|0|||
17056805|NCT00502593|38200179|FG006|Overall Study|Lost to Follow-up|0|||
17056806|NCT00502593|38200180|FG007|Overall Study|Lost to Follow-up|0|||
17056807|NCT00502593|38200181|FG008|Overall Study|Lost to Follow-up|3|||
17056808|NCT00502593|38200182|FG009|Overall Study|Lost to Follow-up|0|||
17056809|NCT00502593|38200183|FG010|Overall Study|Lost to Follow-up|1|||
17056810|NCT00502593|38200184|FG011|Overall Study|Lost to Follow-up|0|||
17056811|NCT03946124|38200233|FG000|Overall Study|Withdrawal by Subject|19|||
17056812|NCT00686543|38200241|FG000|Overall Study|Adverse Event|9|||
17056813|NCT00686543|38200242|FG001|Overall Study|Adverse Event|1|||
17056814|NCT00686543|38200243|FG002|Overall Study|Adverse Event|3|||
17056815|NCT00686543|38200244|FG003|Overall Study|Adverse Event|2|||
17056816|NCT00686543|38200241|FG000|Overall Study|Withdrawal by Subject|2|||
17056817|NCT00686543|38200242|FG001|Overall Study|Withdrawal by Subject|0|||
17056818|NCT00686543|38200243|FG002|Overall Study|Withdrawal by Subject|0|||
17056819|NCT00686543|38200244|FG003|Overall Study|Withdrawal by Subject|0|||
17056820|NCT00686543|38200241|FG000|Overall Study|Protocol Violation|3|||
17056821|NCT00686543|38200242|FG001|Overall Study|Protocol Violation|0|||
17056822|NCT00686543|38200243|FG002|Overall Study|Protocol Violation|2|||
17056823|NCT00686543|38200244|FG003|Overall Study|Protocol Violation|1|||
17056824|NCT00545688|38200258|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
17056825|NCT00545688|38200259|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
17056826|NCT00545688|38200260|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
17056827|NCT00545688|38200261|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
17056828|NCT00545688|38200258|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
17056829|NCT00545688|38200259|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
17056830|NCT00545688|38200260|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
17056831|NCT00545688|38200261|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
17056832|NCT00545688|38200258|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
17056833|NCT00545688|38200259|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
17056834|NCT00545688|38200260|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
17056835|NCT00545688|38200261|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
17056836|NCT00545688|38200258|FG000|Neo-Adjuvant Treatment Period|Death|0|||
17056837|NCT00545688|38200259|FG001|Neo-Adjuvant Treatment Period|Death|1|||
17056838|NCT00545688|38200260|FG002|Neo-Adjuvant Treatment Period|Death|0|||
17056839|NCT00545688|38200261|FG003|Neo-Adjuvant Treatment Period|Death|0|||
17056840|NCT00545688|38200258|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
17056841|NCT00545688|38200259|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
17056842|NCT00545688|38200260|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
17056843|NCT00545688|38200261|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
17056844|NCT00545688|38200258|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
17056845|NCT00545688|38200259|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
17056846|NCT00545688|38200260|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
17056847|NCT00545688|38200261|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
17056848|NCT00545688|38200258|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
17056849|NCT00545688|38200259|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
17056850|NCT00545688|38200260|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
17056851|NCT00545688|38200261|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
17056852|NCT00545688|38200258|FG000|Adjuvant Treatment Period|Disease Progression|3|||
17056853|NCT00545688|38200259|FG001|Adjuvant Treatment Period|Disease Progression|3|||
17056854|NCT00545688|38200260|FG002|Adjuvant Treatment Period|Disease Progression|0|||
17056855|NCT00545688|38200261|FG003|Adjuvant Treatment Period|Disease Progression|7|||
17056856|NCT00545688|38200258|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
17056857|NCT00545688|38200259|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
17056858|NCT00545688|38200260|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
17056859|NCT00545688|38200261|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
17056860|NCT00545688|38200258|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
17056861|NCT00545688|38200259|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
17056862|NCT00545688|38200260|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
17056863|NCT00545688|38200261|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
17056864|NCT00545688|38200258|FG000|Adjuvant Treatment Period|Adverse Event|0|||
17056865|NCT00545688|38200259|FG001|Adjuvant Treatment Period|Adverse Event|3|||
17056866|NCT00545688|38200260|FG002|Adjuvant Treatment Period|Adverse Event|2|||
17056867|NCT00545688|38200261|FG003|Adjuvant Treatment Period|Adverse Event|2|||
17056868|NCT00545688|38200258|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
17056869|NCT00545688|38200259|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
17056870|NCT00545688|38200260|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
17056871|NCT00545688|38200261|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
17056872|NCT00545688|38200258|FG000|Follow-Up Period|Death|4|||
17056873|NCT00545688|38200259|FG001|Follow-Up Period|Death|2|||
17056874|NCT00545688|38200260|FG002|Follow-Up Period|Death|2|||
17056875|NCT00545688|38200261|FG003|Follow-Up Period|Death|6|||
17056876|NCT00545688|38200258|FG000|Follow-Up Period|Disease Progression|6|||
17056877|NCT00545688|38200259|FG001|Follow-Up Period|Disease Progression|5|||
17056878|NCT00545688|38200260|FG002|Follow-Up Period|Disease Progression|9|||
17056879|NCT00545688|38200261|FG003|Follow-Up Period|Disease Progression|9|||
17056880|NCT00545688|38200258|FG000|Follow-Up Period|Refused Treatment|6|||
17056881|NCT00545688|38200259|FG001|Follow-Up Period|Refused Treatment|2|||
17056882|NCT00545688|38200260|FG002|Follow-Up Period|Refused Treatment|0|||
16993054|NCT00802672|38137080|FG002|Overall Study|Lost to Follow-up|3|||
16993055|NCT00802672|38137078|FG000|Overall Study|Withdrawal by Subject|1|||
16993056|NCT00802672|38137079|FG001|Overall Study|Withdrawal by Subject|1|||
16993057|NCT00802672|38137080|FG002|Overall Study|Withdrawal by Subject|2|||
16993058|NCT00802672|38137078|FG000|Overall Study|other|3|||
16993059|NCT00802672|38137079|FG001|Overall Study|other|1|||
16993060|NCT00802672|38137080|FG002|Overall Study|other|2|||
16993061|NCT00714415|38137090|FG000|Overall Study|Lack of Efficacy|1|||
16993062|NCT00714415|38137091|FG001|Overall Study|Lack of Efficacy|0|||
16993063|NCT00714415|38137090|FG000|Overall Study|Death|1|||
16993064|NCT00714415|38137091|FG001|Overall Study|Death|0|||
16993065|NCT00714259|38137097|FG000|Overall Study|Death|2|||
16993066|NCT00796120|38137103|FG000|Overall Study|Death|3|||
16993067|NCT00796120|38137104|FG001|Overall Study|Death|0|||
16993068|NCT00796120|38137103|FG000|Overall Study|Adverse Event|11|||
16993069|NCT00796120|38137104|FG001|Overall Study|Adverse Event|6|||
16993070|NCT00796120|38137103|FG000|Overall Study|Progressive disease|22|||
16993071|NCT00796120|38137104|FG001|Overall Study|Progressive disease|13|||
16993072|NCT00796120|38137103|FG000|Overall Study|Participant refusal|3|||
16993073|NCT00796120|38137104|FG001|Overall Study|Participant refusal|4|||
16993074|NCT00796120|38137103|FG000|Overall Study|Other|6|||
16993075|NCT00796120|38137104|FG001|Overall Study|Other|17|||
16993076|NCT00796120|38137103|FG000|Overall Study|Physician Decision|16|||
16993077|NCT00796120|38137104|FG001|Overall Study|Physician Decision|17|||
16993078|NCT00796120|38137103|FG000|Overall Study|Randomized but not treated|0|||
16993079|NCT00796120|38137104|FG001|Overall Study|Randomized but not treated|3|||
16993080|NCT00795886|38137110|FG000|Overall Study|Death|10|||
16993081|NCT00719563|38137117|FG000|Overall Study|Adverse Event|16|||
16993082|NCT00719563|38137118|FG001|Overall Study|Adverse Event|13|||
16993083|NCT00719563|38137117|FG000|Overall Study|Medical condition changed|3|||
16993084|NCT00719563|38137118|FG001|Overall Study|Medical condition changed|5|||
16993085|NCT00719563|38137117|FG000|Overall Study|Lack of Efficacy|3|||
17056883|NCT00545688|38200261|FG003|Follow-Up Period|Refused Treatment|2|||
17056884|NCT00545688|38200258|FG000|Follow-Up Period|Lost to Follow-up|3|||
17056885|NCT00545688|38200259|FG001|Follow-Up Period|Lost to Follow-up|3|||
17056886|NCT00545688|38200260|FG002|Follow-Up Period|Lost to Follow-up|3|||
17056887|NCT00545688|38200261|FG003|Follow-Up Period|Lost to Follow-up|1|||
17056888|NCT00545688|38200258|FG000|Follow-Up Period|Unspecified Reason|2|||
17056889|NCT00545688|38200259|FG001|Follow-Up Period|Unspecified Reason|5|||
17056890|NCT00545688|38200260|FG002|Follow-Up Period|Unspecified Reason|6|||
17056891|NCT00545688|38200261|FG003|Follow-Up Period|Unspecified Reason|8|||
17056892|NCT00545688|38200258|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
17056893|NCT00545688|38200259|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
17056894|NCT00545688|38200260|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
17056895|NCT00545688|38200261|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
17056896|NCT00502203|38200274|FG000|Overall Study|Inevaluable|1|||
17056897|NCT00546078|38200280|FG000|Overall Study|Lost to Follow-up|1|||
17056898|NCT00546078|38200281|FG001|Overall Study|Lost to Follow-up|3|||
17056899|NCT00546078|38200280|FG000|Overall Study|Withdrawal by Subject|2|||
17056900|NCT00546078|38200281|FG001|Overall Study|Withdrawal by Subject|3|||
17056901|NCT00546078|38200280|FG000|Overall Study|Other reason|1|||
17056902|NCT00546078|38200281|FG001|Overall Study|Other reason|1|||
17056903|NCT00546000|38200287|FG000|Overall Study|Adverse Event|1|||
17056904|NCT00546000|38200287|FG000|Overall Study|Lost to Follow-up|1|||
17056905|NCT00546000|38200287|FG000|Overall Study|Baseline HPA Axis Supression|2|||
17056906|NCT00501969|38200291|FG000|Overall Study|Major Protocol Violation|4|||
17056907|NCT00501969|38200291|FG000|Overall Study|Lack of Efficacy|29|||
17056908|NCT00501969|38200291|FG000|Overall Study|Adverse Event|76|||
17056909|NCT00501969|38200291|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
17056910|NCT00501969|38200291|FG000|Overall Study|Subject withdrew consent|51|||
17056911|NCT00501969|38200291|FG000|Overall Study|Lost to Follow-up|4|||
17056912|NCT00501969|38200291|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
17056913|NCT00501969|38200291|FG000|Overall Study|Other: Sponsors Request|10|||
17056914|NCT00501969|38200291|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
17056915|NCT00501969|38200291|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
17056916|NCT00501969|38200291|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
17056917|NCT00501969|38200291|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
17056918|NCT00501969|38200291|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
17056919|NCT00501969|38200291|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
17056920|NCT00501969|38200291|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
17056921|NCT00501969|38200291|FG000|Overall Study|Other: As Required by Local EC|2|||
17056922|NCT00501969|38200291|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
17056923|NCT00501969|38200291|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
17056924|NCT03942042|38200297|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
17056925|NCT03942042|38200298|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
17056926|NCT03942042|38200297|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
17056927|NCT03942042|38200298|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
17056928|NCT00104299|38200310|FG000|Overall Study|Adverse Event|3|||
17056929|NCT00104299|38200311|FG001|Overall Study|Adverse Event|1|||
17056930|NCT00104299|38200310|FG000|Overall Study|Death|2|||
17056931|NCT00104299|38200311|FG001|Overall Study|Death|2|||
17056932|NCT00104299|38200310|FG000|Overall Study|Withdrawal by Subject|2|||
17056933|NCT00104299|38200311|FG001|Overall Study|Withdrawal by Subject|6|||
17056934|NCT00104299|38200310|FG000|Overall Study|Physician Decision|1|||
17056935|NCT00104299|38200311|FG001|Overall Study|Physician Decision|1|||
17056936|NCT00104299|38200310|FG000|Overall Study|To have renal transplant|1|||
17056937|NCT00104299|38200311|FG001|Overall Study|To have renal transplant|0|||
17056938|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
17056939|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
17056940|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
17056941|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
17056942|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
17056943|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
17056944|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
17056945|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
17056946|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
17056947|NCT03939312|38200317|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
17056948|NCT03939312|38200317|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
17056949|NCT03939312|38200317|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
17056950|NCT00082381|38200325|FG000|Overall Study|Adverse Event|27|||
17056951|NCT00082381|38200326|FG001|Overall Study|Adverse Event|2|||
17056952|NCT00082381|38200325|FG000|Overall Study|Lost to Follow-up|5|||
17056953|NCT00082381|38200326|FG001|Overall Study|Lost to Follow-up|7|||
17056954|NCT00082381|38200325|FG000|Overall Study|Patient Decision|8|||
17056955|NCT00082381|38200326|FG001|Overall Study|Patient Decision|4|||
17056956|NCT00082381|38200325|FG000|Overall Study|Physician Decision|1|||
17056957|NCT00082381|38200326|FG001|Overall Study|Physician Decision|2|||
17056958|NCT00082381|38200325|FG000|Overall Study|Protocol Violation|10|||
17056959|NCT00082381|38200326|FG001|Overall Study|Protocol Violation|11|||
17056960|NCT00082381|38200325|FG000|Overall Study|Loss of Glucose Control|4|||
17056961|NCT00082381|38200326|FG001|Overall Study|Loss of Glucose Control|0|||
17056962|NCT00545844|38200332|FG000|Overall Study|Lost to Follow-up|9|||
17056963|NCT00545844|38200332|FG000|Overall Study|Protocol Violation|1|||
17056964|NCT00545844|38200332|FG000|Overall Study|Withdrawal by Subject|2|||
17056965|NCT00492063|38200342|FG000|Overall Study|Death|0|||
17056966|NCT00492063|38200343|FG001|Overall Study|Death|0|||
17056967|NCT00492063|38200344|FG002|Overall Study|Death|1|||
17056968|NCT00492063|38200345|FG003|Overall Study|Death|2|||
17056969|NCT00492063|38200342|FG000|Overall Study|Withdrawal by Subject|4|||
17056970|NCT00492063|38200343|FG001|Overall Study|Withdrawal by Subject|3|||
17056971|NCT00492063|38200344|FG002|Overall Study|Withdrawal by Subject|5|||
17056972|NCT00492063|38200345|FG003|Overall Study|Withdrawal by Subject|4|||
17056973|NCT00492063|38200342|FG000|Overall Study|Lost to Follow-up|6|||
17056974|NCT00492063|38200343|FG001|Overall Study|Lost to Follow-up|11|||
17056975|NCT00492063|38200344|FG002|Overall Study|Lost to Follow-up|5|||
17144884|NCT04428333|38288700|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
17144885|NCT04428333|38288701|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
17144886|NCT03257358|38288718|FG000|Overall Study|Adverse Event|25|||
17144887|NCT03257358|38288719|FG001|Overall Study|Adverse Event|12|||
17144888|NCT03257358|38288718|FG000|Overall Study|Lack of Efficacy|1|||
17144889|NCT03257358|38288719|FG001|Overall Study|Lack of Efficacy|1|||
17056976|NCT00492063|38200345|FG003|Overall Study|Lost to Follow-up|3|||
17056977|NCT00492063|38200342|FG000|Overall Study|Protocol Violation|0|||
17056978|NCT00492063|38200343|FG001|Overall Study|Protocol Violation|0|||
17056979|NCT00492063|38200344|FG002|Overall Study|Protocol Violation|0|||
17056980|NCT00492063|38200345|FG003|Overall Study|Protocol Violation|1|||
17056981|NCT00093145|38200355|FG000|Overall Study|Unacceptable Toxicity Only|2|||
17056982|NCT00093145|38200355|FG000|Overall Study|Physician Decision|5|||
17056983|NCT00093145|38200355|FG000|Overall Study|Withdrawal by Subject|9|||
17056984|NCT00093145|38200355|FG000|Overall Study|Other|1|||
17056985|NCT00513357|38200361|FG000|Overall Study|did not receive allocated placebo|2|||
17056986|NCT00513357|38200362|FG001|Overall Study|did not receive allocated placebo|3|||
17056987|NCT00513357|38200361|FG000|Overall Study|Adverse Event|4|||
17056988|NCT00513357|38200362|FG001|Overall Study|Adverse Event|2|||
17056989|NCT00513357|38200361|FG000|Overall Study|Death|2|||
17056990|NCT00513357|38200362|FG001|Overall Study|Death|0|||
17056991|NCT00513357|38200361|FG000|Overall Study|Withdrawal by Subject|5|||
17056992|NCT00513357|38200362|FG001|Overall Study|Withdrawal by Subject|4|||
17056993|NCT00513357|38200361|FG000|Overall Study|Disease Progression|2|||
17056994|NCT00513357|38200362|FG001|Overall Study|Disease Progression|1|||
17056995|NCT03933462|38200368|FG000|Overall Study|Adverse Event|2|||
17056996|NCT03933462|38200369|FG001|Overall Study|Adverse Event|0|||
17056997|NCT03929562|38200377|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
17056998|NCT03929562|38200378|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
17056999|NCT03929562|38200377|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
17057000|NCT03929562|38200378|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
17057001|NCT03929562|38200377|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
17057002|NCT03929562|38200378|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
17057003|NCT00415636|38200392|FG000|Overall Study|Symptomatic deterioration|1|||
17057004|NCT00415636|38200393|FG001|Overall Study|Symptomatic deterioration|0|||
17057005|NCT00415636|38200394|FG002|Overall Study|Symptomatic deterioration|1|||
17057006|NCT00415636|38200395|FG003|Overall Study|Symptomatic deterioration|2|||
17057007|NCT00415636|38200396|FG004|Overall Study|Symptomatic deterioration|0|||
17057008|NCT00415636|38200397|FG005|Overall Study|Symptomatic deterioration|1|||
17057009|NCT00415636|38200392|FG000|Overall Study|Adverse Event|0|||
17057010|NCT00415636|38200393|FG001|Overall Study|Adverse Event|0|||
17057011|NCT00415636|38200394|FG002|Overall Study|Adverse Event|0|||
17057012|NCT00415636|38200395|FG003|Overall Study|Adverse Event|1|||
17057013|NCT00415636|38200396|FG004|Overall Study|Adverse Event|1|||
17057014|NCT00415636|38200397|FG005|Overall Study|Adverse Event|0|||
17057015|NCT00415636|38200392|FG000|Overall Study|Withdrawal by Subject|0|||
17057016|NCT00415636|38200393|FG001|Overall Study|Withdrawal by Subject|0|||
17057017|NCT00415636|38200394|FG002|Overall Study|Withdrawal by Subject|0|||
17057018|NCT00415636|38200395|FG003|Overall Study|Withdrawal by Subject|0|||
17057019|NCT00415636|38200396|FG004|Overall Study|Withdrawal by Subject|1|||
17057020|NCT00415636|38200397|FG005|Overall Study|Withdrawal by Subject|0|||
17057021|NCT00415636|38200392|FG000|Overall Study|Disease progression|0|||
17057022|NCT00415636|38200393|FG001|Overall Study|Disease progression|0|||
17057023|NCT00415636|38200394|FG002|Overall Study|Disease progression|0|||
17057024|NCT00415636|38200395|FG003|Overall Study|Disease progression|3|||
17057025|NCT00415636|38200396|FG004|Overall Study|Disease progression|0|||
17057026|NCT00415636|38200397|FG005|Overall Study|Disease progression|1|||
17057027|NCT00425854|38200421|FG000|Overall Study|Progressive Disease|19|||
17057028|NCT00425854|38200422|FG001|Overall Study|Progressive Disease|12|||
17057029|NCT00425854|38200421|FG000|Overall Study|Dose reduction toxicity AE|8|||
17057030|NCT00425854|38200422|FG001|Overall Study|Dose reduction toxicity AE|7|||
17057031|NCT00425854|38200421|FG000|Overall Study|Other Adverse Event|2|||
17057032|NCT00425854|38200422|FG001|Overall Study|Other Adverse Event|2|||
17057033|NCT00425698|38200431|FG000|Overall Study|Adverse Event|3|||
17057034|NCT00425698|38200432|FG001|Overall Study|Adverse Event|1|||
17057035|NCT00425698|38200431|FG000|Overall Study|Withdrawal by Subject|0|||
17057036|NCT00425698|38200432|FG001|Overall Study|Withdrawal by Subject|1|||
17057037|NCT00425308|38200440|FG000|Overall Study|Adverse Event|2|||
17057038|NCT00425308|38200441|FG001|Overall Study|Adverse Event|1|||
17057039|NCT00425308|38200440|FG000|Overall Study|Withdrawal by Subject|1|||
17057040|NCT00425308|38200441|FG001|Overall Study|Withdrawal by Subject|0|||
17057041|NCT00425308|38200440|FG000|Overall Study|Death|1|||
17057042|NCT00425308|38200441|FG001|Overall Study|Death|0|||
17057043|NCT00545064|38200447|FG000|Overall Study|Lost to Follow-up|3|||
17057044|NCT00545064|38200447|FG000|Overall Study|Withdrawal by Subject|2|||
17057045|NCT00545064|38200447|FG000|Overall Study|did not complete course of treatment|1|||
17057046|NCT00545064|38200447|FG000|Overall Study|cancel all appointments, no rebooking|1|||
17057047|NCT00545064|38200447|FG000|Overall Study|inclement weather|1|||
17057048|NCT00432562|38200455|FG000|Overall Study|Death|3|||
17057049|NCT00432562|38200456|FG001|Overall Study|Death|0|||
17057050|NCT00432172|38200466|FG000|Overall Study|Physician Decision|0|||
17057051|NCT00432172|38200467|FG001|Overall Study|Physician Decision|0|||
17057052|NCT00432172|38200468|FG002|Overall Study|Physician Decision|2|||
17057053|NCT00432172|38200469|FG003|Overall Study|Physician Decision|0|||
17057054|NCT00432172|38200466|FG000|Overall Study|Adverse Event|4|||
17057055|NCT00432172|38200467|FG001|Overall Study|Adverse Event|2|||
17057056|NCT00432172|38200468|FG002|Overall Study|Adverse Event|4|||
17057057|NCT00432172|38200469|FG003|Overall Study|Adverse Event|3|||
17057058|NCT00432172|38200466|FG000|Overall Study|Disease progression|0|||
17057059|NCT00432172|38200467|FG001|Overall Study|Disease progression|2|||
17057060|NCT00432172|38200468|FG002|Overall Study|Disease progression|5|||
17057061|NCT00432172|38200469|FG003|Overall Study|Disease progression|1|||
17057062|NCT00432172|38200466|FG000|Overall Study|Withdrawal by Subject|0|||
17057063|NCT00432172|38200467|FG001|Overall Study|Withdrawal by Subject|1|||
17057064|NCT00432172|38200468|FG002|Overall Study|Withdrawal by Subject|0|||
17057065|NCT00432172|38200469|FG003|Overall Study|Withdrawal by Subject|2|||
17057066|NCT00432172|38200466|FG000|Overall Study|No treatment received|2|||
17057067|NCT00432172|38200467|FG001|Overall Study|No treatment received|2|||
17057068|NCT00432172|38200468|FG002|Overall Study|No treatment received|0|||
17057069|NCT00432172|38200469|FG003|Overall Study|No treatment received|1|||
17057070|NCT00415168|38200481|FG000|Overall Study|Death|26|||
17057071|NCT00415168|38200481|FG000|Overall Study|Lost to Follow-up|3|||
17057072|NCT00415168|38200481|FG000|Overall Study|Physician Decision|13|||
17057073|NCT00415168|38200481|FG000|Overall Study|Sponsor Decision|4|||
17057074|NCT00415168|38200481|FG000|Overall Study|Withdrawal by Subject|6|||
17057075|NCT03921528|38200490|FG000|Overall Study|Withdrawal by Subject|0|||
17057076|NCT03921528|38200491|FG001|Overall Study|Withdrawal by Subject|1|||
17057077|NCT03921528|38200492|FG002|Overall Study|Withdrawal by Subject|0|||
17057078|NCT03921528|38200493|FG003|Overall Study|Withdrawal by Subject|0|||
17057079|NCT03921528|38200494|FG004|Overall Study|Withdrawal by Subject|0|||
17057080|NCT00424762|38200508|FG000|Overall Study|Withdrawal by Subject|18|||
17057081|NCT00424762|38200509|FG001|Overall Study|Withdrawal by Subject|19|||
17057082|NCT00424762|38200508|FG000|Overall Study|Lost to Follow-up|2|||
17057083|NCT00424762|38200509|FG001|Overall Study|Lost to Follow-up|3|||
17057084|NCT00424528|38200518|FG000|Overall Study|Adverse Event|2|||
17057085|NCT00424528|38200519|FG001|Overall Study|Adverse Event|1|||
17057086|NCT00424528|38200520|FG002|Overall Study|Adverse Event|2|||
17057087|NCT00424528|38200518|FG000|Overall Study|Protocol Violation|1|||
17057088|NCT00424528|38200519|FG001|Overall Study|Protocol Violation|1|||
17057089|NCT00424528|38200520|FG002|Overall Study|Protocol Violation|0|||
17057090|NCT00424528|38200518|FG000|Overall Study|Lost to Follow-up|0|||
17057091|NCT00424528|38200519|FG001|Overall Study|Lost to Follow-up|1|||
17057092|NCT00424528|38200520|FG002|Overall Study|Lost to Follow-up|0|||
17057093|NCT00424528|38200518|FG000|Overall Study|noncompliance with study requirements|2|||
17057094|NCT00424528|38200519|FG001|Overall Study|noncompliance with study requirements|1|||
17057095|NCT00424528|38200520|FG002|Overall Study|noncompliance with study requirements|2|||
17057096|NCT00414544|38200528|FG000|Overall Study|Lost to Follow-up|14|||
17057097|NCT00414466|38200538|FG000|Overall Study|Adverse Event|0|||
17057098|NCT00414466|38200539|FG001|Overall Study|Adverse Event|0|||
17057099|NCT00414466|38200540|FG002|Overall Study|Adverse Event|1|||
17057100|NCT00414466|38200541|FG003|Overall Study|Adverse Event|1|||
17057101|NCT00414466|38200538|FG000|Overall Study|Lack of Efficacy|1|||
17057102|NCT00414466|38200539|FG001|Overall Study|Lack of Efficacy|0|||
17057103|NCT00414466|38200540|FG002|Overall Study|Lack of Efficacy|0|||
17057104|NCT00414466|38200541|FG003|Overall Study|Lack of Efficacy|0|||
17057105|NCT00414466|38200538|FG000|Overall Study|Withdrawn by Sponsor|1|||
17057106|NCT00414466|38200539|FG001|Overall Study|Withdrawn by Sponsor|0|||
17057107|NCT00414466|38200540|FG002|Overall Study|Withdrawn by Sponsor|0|||
17057108|NCT00414466|38200541|FG003|Overall Study|Withdrawn by Sponsor|0|||
17057109|NCT00545532|38200556|FG000|Overall Study|Withdrawal by Subject|1|||
17057110|NCT00545532|38200557|FG001|Overall Study|Withdrawal by Subject|3|||
17057111|NCT00545532|38200556|FG000|Overall Study|Lost to Follow-up|5|||
17057112|NCT00545532|38200557|FG001|Overall Study|Lost to Follow-up|6|||
17057113|NCT00545532|38200556|FG000|Overall Study|Death|0|||
17057114|NCT00545532|38200557|FG001|Overall Study|Death|1|||
17057115|NCT00544440|38200565|FG000|Overall Study|Other|1|||
17057116|NCT00544440|38200565|FG000|Overall Study|Adverse Event|1|||
17057117|NCT00544440|38200565|FG000|Overall Study|Withdrawal by Subject|2|||
17057118|NCT00544440|38200565|FG000|Overall Study|Subject Non-compliance|1|||
17057119|NCT00544440|38200565|FG000|Overall Study|Progressive Disease|47|||
17057120|NCT00544440|38200565|FG000|Overall Study|Other|5|||
17057121|NCT03920670|38200571|FG000|Overall Study|Protocol Violation|2|||
17057122|NCT03920670|38200572|FG001|Overall Study|Protocol Violation|2|||
17057123|NCT03920670|38200571|FG000|Overall Study|Adverse Event|1|||
17057124|NCT03920670|38200572|FG001|Overall Study|Adverse Event|0|||
17057125|NCT00430300|38200582|FG000|Overall Study|Adverse Event|0|||
17057126|NCT00430300|38200583|FG001|Overall Study|Adverse Event|2|||
17057127|NCT00430300|38200584|FG002|Overall Study|Adverse Event|1|||
17057128|NCT00430300|38200585|FG003|Overall Study|Adverse Event|1|||
17144890|NCT03257358|38288718|FG000|Overall Study|Lost to Follow-up|12|||
17144891|NCT03257358|38288719|FG001|Overall Study|Lost to Follow-up|4|||
17144892|NCT03257358|38288718|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
17144893|NCT03257358|38288719|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
17144894|NCT03257358|38288718|FG000|Overall Study|Physician Decision|2|||
17144895|NCT03257358|38288719|FG001|Overall Study|Physician Decision|2|||
17144896|NCT03257358|38288718|FG000|Overall Study|Protocol Violation|5|||
17144897|NCT03257358|38288719|FG001|Overall Study|Protocol Violation|3|||
17057129|NCT00430300|38200582|FG000|Overall Study|Withdrawal by Subject|1|||
17057130|NCT00430300|38200583|FG001|Overall Study|Withdrawal by Subject|0|||
17057131|NCT00430300|38200584|FG002|Overall Study|Withdrawal by Subject|5|||
17057132|NCT00430300|38200585|FG003|Overall Study|Withdrawal by Subject|0|||
17057133|NCT00430300|38200582|FG000|Overall Study|Laboratory abnormality|1|||
17057134|NCT00430300|38200583|FG001|Overall Study|Laboratory abnormality|0|||
17057135|NCT00430300|38200584|FG002|Overall Study|Laboratory abnormality|0|||
17057136|NCT00430300|38200585|FG003|Overall Study|Laboratory abnormality|0|||
17057137|NCT00430300|38200582|FG000|Overall Study|Other|0|||
17057138|NCT00430300|38200583|FG001|Overall Study|Other|0|||
17057139|NCT00430300|38200584|FG002|Overall Study|Other|0|||
17057140|NCT00430300|38200585|FG003|Overall Study|Other|1|||
17057141|NCT03927846|38200597|FG000|Overall Study|Lost to Follow-up|10|||
17144898|NCT03257358|38288718|FG000|Overall Study|Technical problems|4|||
17144899|NCT03257358|38288719|FG001|Overall Study|Technical problems|1|||
17144900|NCT03257358|38288718|FG000|Overall Study|Withdrawal by Subject|8|||
17144901|NCT03257358|38288719|FG001|Overall Study|Withdrawal by Subject|3|||
17144902|NCT03257358|38288718|FG000|Overall Study|Withdrawal of informed consent|9|||
17144903|NCT03257358|38288719|FG001|Overall Study|Withdrawal of informed consent|5|||
17144904|NCT03257358|38288718|FG000|Overall Study|New therapy for study indication|1|||
17144905|NCT03257358|38288719|FG001|Overall Study|New therapy for study indication|0|||
17144906|NCT03257358|38288718|FG000|Overall Study|No longer requires treatment|0|||
17144907|NCT03257358|38288719|FG001|Overall Study|No longer requires treatment|1|||
17144908|NCT02936037|38288727|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
17144909|NCT02936037|38288728|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
17144910|NCT02936037|38288727|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
17144911|NCT02936037|38288728|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
17144912|NCT02936037|38288727|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
17144913|NCT02936037|38288728|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
17057142|NCT03927846|38200598|FG001|Overall Study|Lost to Follow-up|11|||
17057143|NCT03927144|38200606|FG000|Overall Study|Adverse Event|9|||
17057144|NCT03927144|38200607|FG001|Overall Study|Adverse Event|5|||
17057145|NCT03927144|38200606|FG000|Overall Study|Lost to Follow-up|3|||
17057146|NCT03927144|38200607|FG001|Overall Study|Lost to Follow-up|2|||
17144914|NCT02936037|38288727|FG000|Double-Blind Treatment Period|Death|0|||
17144915|NCT02936037|38288728|FG001|Double-Blind Treatment Period|Death|1|||
17057147|NCT03927144|38200606|FG000|Overall Study|New Therapy for Study Indication|0|||
17057148|NCT03927144|38200607|FG001|Overall Study|New Therapy for Study Indication|1|||
17057149|NCT03927144|38200606|FG000|Overall Study|No Longer Clinically Benefiting|4|||
17057150|NCT03927144|38200607|FG001|Overall Study|No Longer Clinically Benefiting|4|||
17057151|NCT03927144|38200606|FG000|Overall Study|Physician Decision|2|||
17057152|NCT03927144|38200607|FG001|Overall Study|Physician Decision|8|||
17057153|NCT03927144|38200606|FG000|Overall Study|Protocol Violation|2|||
17057154|NCT03927144|38200607|FG001|Overall Study|Protocol Violation|2|||
17057155|NCT03927144|38200606|FG000|Overall Study|Withdrawal by Subject|16|||
17057156|NCT03927144|38200607|FG001|Overall Study|Withdrawal by Subject|40|||
17057157|NCT00545298|38200616|FG000|Overall Study|Issues with Standard of Care|2|||
17057158|NCT00545298|38200617|FG001|Overall Study|Issues with Standard of Care|0|||
17057159|NCT00545298|38200618|FG002|Overall Study|Issues with Standard of Care|1|||
17057160|NCT00429364|38200631|FG000|Overall Study|Withdrawal by Subject|11|||
17057161|NCT00429364|38200632|FG001|Overall Study|Withdrawal by Subject|5|||
17057162|NCT00429364|38200631|FG000|Overall Study|Physician Decision|4|||
17057163|NCT00429364|38200632|FG001|Overall Study|Physician Decision|2|||
17057164|NCT00429364|38200631|FG000|Overall Study|Lost to Follow-up|7|||
17057165|NCT00429364|38200632|FG001|Overall Study|Lost to Follow-up|6|||
17057166|NCT00429364|38200631|FG000|Overall Study|Death|0|||
17057167|NCT00429364|38200632|FG001|Overall Study|Death|1|||
17057168|NCT00429364|38200631|FG000|Overall Study|Underwent aortic root surgery|10|||
17057169|NCT00429364|38200632|FG001|Overall Study|Underwent aortic root surgery|18|||
17057170|NCT00429364|38200631|FG000|Overall Study|Pregnancy|0|||
17057171|NCT00429364|38200632|FG001|Overall Study|Pregnancy|1|||
17057172|NCT00414388|38200638|FG000|Overall Study|Adverse Event|1|||
17057173|NCT03920280|38200645|FG000|Overall Study|Adverse Event|2|||
17057174|NCT03920280|38200646|FG001|Overall Study|Adverse Event|3|||
17057175|NCT03920280|38200645|FG000|Overall Study|Lost to Follow-up|0|||
17057176|NCT03920280|38200646|FG001|Overall Study|Lost to Follow-up|1|||
17057177|NCT03920280|38200645|FG000|Overall Study|Withdrawal by Subject|1|||
17057178|NCT03920280|38200646|FG001|Overall Study|Withdrawal by Subject|1|||
17057179|NCT03920280|38200645|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
17057180|NCT03920280|38200646|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
17057181|NCT00424372|38200655|FG000|Overall Study|Death|1|||
17057182|NCT00424372|38200655|FG000|Overall Study|Adverse Event|18|||
17057183|NCT00424372|38200655|FG000|Overall Study|Lack of Efficacy|6|||
17057184|NCT00424372|38200655|FG000|Overall Study|Withdrawal by Subject|4|||
17057185|NCT00424372|38200655|FG000|Overall Study|Protocol Violation|1|||
17057186|NCT00424372|38200655|FG000|Overall Study|Health deterioration|1|||
17057187|NCT00414310|38200661|FG000|Overall Study|Not treated|1|||
17057188|NCT00414310|38200662|FG001|Overall Study|Not treated|0|||
17057189|NCT00542880|38200672|FG000|Period 1|Eligibility criteria not fulfilled|2|||
17057190|NCT00542880|38200673|FG001|Period 1|Eligibility criteria not fulfilled|6|||
17057191|NCT00542880|38200672|FG000|Period 1|Adverse Event|2|||
17057192|NCT00542880|38200673|FG001|Period 1|Adverse Event|2|||
17057193|NCT00542880|38200672|FG000|Period 1|Development of study-specific criteria|1|||
17057194|NCT00542880|38200673|FG001|Period 1|Development of study-specific criteria|2|||
17057195|NCT00542880|38200672|FG000|Period 1|Withdrawal by Subject|1|||
17057196|NCT00542880|38200673|FG001|Period 1|Withdrawal by Subject|1|||
17057197|NCT00542880|38200672|FG000|Period 1|Protocol Violation|0|||
17057198|NCT00542880|38200673|FG001|Period 1|Protocol Violation|1|||
17057199|NCT00542880|38200672|FG000|Period 2|Adverse Event|5|||
17057200|NCT00542880|38200673|FG001|Period 2|Adverse Event|7|||
17057201|NCT00542880|38200672|FG000|Period 2|Eligibility not fulfilled|0|||
17057202|NCT00542880|38200673|FG001|Period 2|Eligibility not fulfilled|1|||
17057203|NCT00542880|38200672|FG000|Period 2|Discontinuation criteria|2|||
17057204|NCT00542880|38200673|FG001|Period 2|Discontinuation criteria|0|||
17057205|NCT00542880|38200672|FG000|Period 2|Severe non-compliance|0|||
17057206|NCT00542880|38200673|FG001|Period 2|Severe non-compliance|1|||
17057207|NCT00542880|38200672|FG000|Period 2|Other|0|||
17057208|NCT00542880|38200673|FG001|Period 2|Other|1|||
17057209|NCT00542880|38200672|FG000|Period 3|Adverse Event|0|||
17057210|NCT00542880|38200673|FG001|Period 3|Adverse Event|2|||
17057211|NCT00414076|38200682|FG000|Overall Study|Progression|1|||
17057212|NCT00414076|38200683|FG001|Overall Study|Progression|2|||
17057213|NCT00414076|38200682|FG000|Overall Study|Withdrawal by Subject|1|||
17057214|NCT00414076|38200683|FG001|Overall Study|Withdrawal by Subject|3|||
17057215|NCT00414076|38200682|FG000|Overall Study|Adverse Event|1|||
17057216|NCT00414076|38200683|FG001|Overall Study|Adverse Event|0|||
17057217|NCT00092677|38200691|FG000|Overall Study|Lost to Follow-up|0|||
17057218|NCT00092677|38200692|FG001|Overall Study|Lost to Follow-up|2|||
17057219|NCT00092677|38200691|FG000|Overall Study|Adminstrative|5|||
17057220|NCT00092677|38200692|FG001|Overall Study|Adminstrative|9|||
17057221|NCT00542178|38200704|FG000|Overall Study|did not complete year 4 follow-up|75|||
17057222|NCT00542178|38200705|FG001|Overall Study|did not complete year 4 follow-up|80|||
17057223|NCT00542178|38200706|FG002|Overall Study|did not complete year 4 follow-up|74|||
17057224|NCT00542178|38200707|FG003|Overall Study|did not complete year 4 follow-up|62|||
17057225|NCT00542178|38200708|FG004|Overall Study|did not complete year 4 follow-up|64|||
17057226|NCT00542178|38200709|FG005|Overall Study|did not complete year 4 follow-up|89|||
17057227|NCT00542178|38200710|FG006|Overall Study|did not complete year 4 follow-up|87|||
17057228|NCT00542178|38200711|FG007|Overall Study|did not complete year 4 follow-up|85|||
17057229|NCT00424294|38200727|FG000|Overall Study|Adverse Event|4|||
17057230|NCT00424294|38200728|FG001|Overall Study|Adverse Event|10|||
17057231|NCT00424294|38200727|FG000|Overall Study|Lack of Efficacy|2|||
17057232|NCT00424294|38200728|FG001|Overall Study|Lack of Efficacy|1|||
17057233|NCT00424294|38200727|FG000|Overall Study|Withdrawal by Subject|1|||
17057234|NCT00424294|38200728|FG001|Overall Study|Withdrawal by Subject|2|||
17057235|NCT00424294|38200727|FG000|Overall Study|Other|0|||
17057236|NCT00424294|38200728|FG001|Overall Study|Other|2|||
17057237|NCT00424294|38200727|FG000|Overall Study|Randomized but not Treated|1|||
17057238|NCT00424294|38200728|FG001|Overall Study|Randomized but not Treated|0|||
17057239|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
17057240|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
17057241|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
17057242|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
17057243|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
17057244|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
17057245|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
17057246|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
17057247|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
17057248|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
17057249|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
17057250|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
17057251|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
17057252|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
17057253|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
17057254|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
17057255|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
17057256|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
17057257|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
17057258|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
17057259|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
17057260|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
17057261|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
17057262|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
17057263|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
17057264|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
17057265|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
17057266|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
17057267|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
17057268|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
17057269|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
17057270|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
17057271|NCT00092521|38200737|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
17057272|NCT00092521|38200738|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
17057273|NCT00092521|38200739|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
17057274|NCT00092521|38200740|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
17057275|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
17057276|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
17057277|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
17057278|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
17057279|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
17057280|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
17057281|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
17057282|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
17057283|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
17057284|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
17057285|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
17144916|NCT02936037|38288727|FG000|Double-Blind Treatment Period|Adverse Event|11|||
17057286|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
17057287|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Death|2|||
17057288|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Death|0|||
17057289|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Death|1|||
17144917|NCT02936037|38288728|FG001|Double-Blind Treatment Period|Adverse Event|11|||
17144918|NCT02936037|38288727|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
17144919|NCT02936037|38288728|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
17144920|NCT02936037|38288727|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
17057290|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Death|0|||
17057291|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
17057292|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
17057293|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
17057294|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
17057295|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
17057296|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
17057297|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
17057298|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
17057299|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
17057300|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
17057301|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
17057302|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
17057303|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Moved|32|||
17057304|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Moved|2|||
17057305|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Moved|28|||
17057306|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Moved|0|||
17057307|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
17057308|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
17057309|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
17057310|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
17057311|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Travel|2|||
17057312|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Travel|0|||
17057313|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Travel|0|||
17057314|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Travel|0|||
17144921|NCT02936037|38288728|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
17057315|NCT00092521|38200737|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
17057316|NCT00092521|38200738|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
17057317|NCT00092521|38200739|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
17057318|NCT00092521|38200740|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
17057319|NCT00092521|38200737|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
17057320|NCT00092521|38200738|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
17057321|NCT00092521|38200739|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
17057322|NCT00092521|38200740|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
17057323|NCT00092521|38200737|FG000|Extension Study (Group 4)|Adverse Event|0|||
17057324|NCT00092521|38200738|FG001|Extension Study (Group 4)|Adverse Event|0|||
17057325|NCT00092521|38200739|FG002|Extension Study (Group 4)|Adverse Event|0|||
17057326|NCT00092521|38200740|FG003|Extension Study (Group 4)|Adverse Event|2|||
17057327|NCT00092521|38200737|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
17057328|NCT00092521|38200738|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
17057329|NCT00092521|38200739|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
17057330|NCT00092521|38200740|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
17144922|NCT02936037|38288727|FG000|Open Label Extension|Adverse Event|0|||
17144923|NCT02936037|38288728|FG001|Open Label Extension|Adverse Event|3|||
17144924|NCT02936037|38288727|FG000|Open Label Extension|Other|0|||
17144925|NCT02936037|38288728|FG001|Open Label Extension|Other|3|||
17144926|NCT02936037|38288727|FG000|Open Label Extension|Withdrawal by Subject|0|||
17144927|NCT02936037|38288728|FG001|Open Label Extension|Withdrawal by Subject|4|||
17144928|NCT03288714|38288736|FG000|Overall Study|Lost to Follow-up|2|||
17144929|NCT03288714|38288737|FG001|Overall Study|Lost to Follow-up|1|||
17144930|NCT03288714|38288736|FG000|Overall Study|Non-compliance with study schedule|2|||
17144931|NCT03288714|38288737|FG001|Overall Study|Non-compliance with study schedule|0|||
17144932|NCT03288714|38288736|FG000|Overall Study|Withdrawal by Subject|3|||
17144933|NCT03288714|38288737|FG001|Overall Study|Withdrawal by Subject|1|||
17144934|NCT03288714|38288736|FG000|Overall Study|Clinical Worsening|2|||
17144935|NCT03288714|38288737|FG001|Overall Study|Clinical Worsening|1|||
17144936|NCT03288714|38288736|FG000|Overall Study|Adverse Event|1|||
17144937|NCT03288714|38288737|FG001|Overall Study|Adverse Event|0|||
17057331|NCT00092521|38200737|FG000|Extension Study (Group 4)|Pregnancy|0|||
17057332|NCT00092521|38200738|FG001|Extension Study (Group 4)|Pregnancy|0|||
17057333|NCT00092521|38200739|FG002|Extension Study (Group 4)|Pregnancy|0|||
17057334|NCT00092521|38200740|FG003|Extension Study (Group 4)|Pregnancy|4|||
17057335|NCT00092521|38200737|FG000|Extension Study (Group 4)|Protocol Violation|0|||
17057336|NCT00092521|38200738|FG001|Extension Study (Group 4)|Protocol Violation|0|||
17144938|NCT04068181|38288749|FG000|Overall Study|Withdrawal by Subject|2|||
17057337|NCT00092521|38200739|FG002|Extension Study (Group 4)|Protocol Violation|0|||
17057338|NCT00092521|38200740|FG003|Extension Study (Group 4)|Protocol Violation|2|||
17057339|NCT00092521|38200737|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
17057340|NCT00092521|38200738|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
17057341|NCT00092521|38200739|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
17057342|NCT00092521|38200740|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
17057343|NCT00092521|38200737|FG000|Extension Study (Group 4)|Moved|0|||
17057344|NCT00092521|38200738|FG001|Extension Study (Group 4)|Moved|0|||
17057345|NCT00092521|38200739|FG002|Extension Study (Group 4)|Moved|0|||
17057346|NCT00092521|38200740|FG003|Extension Study (Group 4)|Moved|16|||
17057347|NCT00092521|38200737|FG000|Extension Study (Group 4)|Site Terminated|0|||
17057348|NCT00092521|38200738|FG001|Extension Study (Group 4)|Site Terminated|0|||
17057349|NCT00092521|38200739|FG002|Extension Study (Group 4)|Site Terminated|0|||
17057350|NCT00092521|38200740|FG003|Extension Study (Group 4)|Site Terminated|4|||
17057351|NCT00092521|38200737|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
17057352|NCT00092521|38200738|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
17057353|NCT00092521|38200739|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
17057354|NCT00092521|38200740|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
17057355|NCT03908970|38200750|FG000|Overall Study|Adverse Event|7|||
17057356|NCT03908970|38200751|FG001|Overall Study|Adverse Event|21|||
17057357|NCT03908970|38200750|FG000|Overall Study|Physician Decision|1|||
17057358|NCT03908970|38200751|FG001|Overall Study|Physician Decision|4|||
17057359|NCT03908970|38200750|FG000|Overall Study|Withdrawal by Subject|9|||
17057360|NCT03908970|38200751|FG001|Overall Study|Withdrawal by Subject|22|||
17057361|NCT00092443|38200759|FG000|Overall Study|Adverse Event|9|||
17057362|NCT00092443|38200760|FG001|Overall Study|Adverse Event|13|||
17057363|NCT00092443|38200759|FG000|Overall Study|Lost to Follow-up|7|||
17057364|NCT00092443|38200760|FG001|Overall Study|Lost to Follow-up|3|||
17057365|NCT00092443|38200759|FG000|Overall Study|Protocol Violation|11|||
17057366|NCT00092443|38200760|FG001|Overall Study|Protocol Violation|9|||
17057367|NCT00092443|38200759|FG000|Overall Study|Withdrawal by Subject|9|||
17057368|NCT00092443|38200760|FG001|Overall Study|Withdrawal by Subject|11|||
17057369|NCT00092443|38200759|FG000|Overall Study|Moved|5|||
17057370|NCT00092443|38200760|FG001|Overall Study|Moved|5|||
17057371|NCT00092443|38200759|FG000|Overall Study|Other|17|||
17057372|NCT00092443|38200760|FG001|Overall Study|Other|13|||
17057373|NCT00413920|38200778|FG000|Overall Study|Adverse Event|9|||
17057374|NCT00413920|38200779|FG001|Overall Study|Adverse Event|11|||
17057375|NCT00413920|38200778|FG000|Overall Study|Lack of Efficacy|11|||
17057376|NCT00413920|38200779|FG001|Overall Study|Lack of Efficacy|9|||
17057377|NCT00413920|38200778|FG000|Overall Study|Death|3|||
17057378|NCT00413920|38200779|FG001|Overall Study|Death|5|||
17057379|NCT00413920|38200778|FG000|Overall Study|Graft Loss|5|||
17057380|NCT00413920|38200779|FG001|Overall Study|Graft Loss|3|||
17057381|NCT00091819|38200787|FG000|Overall Study|Adverse Event|1|||
17057382|NCT00091819|38200788|FG001|Overall Study|Adverse Event|1|||
17057383|NCT00091819|38200787|FG000|Overall Study|Death|4|||
17057384|NCT00091819|38200788|FG001|Overall Study|Death|5|||
17057385|NCT00091819|38200787|FG000|Overall Study|Lost to Follow-up|26|||
17057386|NCT00091819|38200788|FG001|Overall Study|Lost to Follow-up|23|||
17057387|NCT00091819|38200787|FG000|Overall Study|Withdrawal by Subject|5|||
17057388|NCT00091819|38200788|FG001|Overall Study|Withdrawal by Subject|8|||
17057389|NCT00091819|38200787|FG000|Overall Study|Protocol Violation|1|||
17057390|NCT00091819|38200788|FG001|Overall Study|Protocol Violation|2|||
17057391|NCT00091819|38200787|FG000|Overall Study|Other|2|||
17057392|NCT00091819|38200788|FG001|Overall Study|Other|3|||
17057393|NCT00091819|38200787|FG000|Overall Study|Never received study treatment|3|||
17057394|NCT00091819|38200788|FG001|Overall Study|Never received study treatment|4|||
17057395|NCT00540228|38200799|FG000|Overall Study|Adverse Event|2|||
17057396|NCT00540228|38200800|FG001|Overall Study|Adverse Event|0|||
17057397|NCT00540228|38200801|FG002|Overall Study|Adverse Event|0|||
17057398|NCT00540228|38200802|FG003|Overall Study|Adverse Event|0|||
17057399|NCT00540228|38200803|FG004|Overall Study|Adverse Event|0|||
17057400|NCT00540228|38200799|FG000|Overall Study|Lost to Follow-up|1|||
17057401|NCT00540228|38200800|FG001|Overall Study|Lost to Follow-up|1|||
17057402|NCT00540228|38200801|FG002|Overall Study|Lost to Follow-up|0|||
17057403|NCT00540228|38200802|FG003|Overall Study|Lost to Follow-up|0|||
17057404|NCT00540228|38200803|FG004|Overall Study|Lost to Follow-up|0|||
17057405|NCT00539994|38200818|FG000|Overall Study|Lost to Follow-up|2|||
17057406|NCT00539994|38200819|FG001|Overall Study|Lost to Follow-up|1|||
17057407|NCT00539994|38200820|FG002|Overall Study|Lost to Follow-up|0|||
17057408|NCT00539994|38200818|FG000|Overall Study|Withdrawal by Subject|1|||
17057409|NCT00539994|38200819|FG001|Overall Study|Withdrawal by Subject|0|||
17057410|NCT00539994|38200820|FG002|Overall Study|Withdrawal by Subject|1|||
17057411|NCT00539994|38200818|FG000|Overall Study|Physician Decision|0|||
17057412|NCT00539994|38200819|FG001|Overall Study|Physician Decision|0|||
17057413|NCT00539994|38200820|FG002|Overall Study|Physician Decision|1|||
17057414|NCT00098839|38200837|FG000|Overall Study|Adverse Event|5|||
17057415|NCT00098839|38200838|FG001|Overall Study|Adverse Event|2|||
17057416|NCT00098839|38200837|FG000|Overall Study|Death|1|||
17057417|NCT00098839|38200838|FG001|Overall Study|Death|2|||
17057418|NCT00098839|38200837|FG000|Overall Study|Physician Decision|4|||
17057419|NCT00098839|38200838|FG001|Overall Study|Physician Decision|14|||
17057420|NCT00098839|38200837|FG000|Overall Study|Withdrawal by Subject|1|||
17057421|NCT00098839|38200838|FG001|Overall Study|Withdrawal by Subject|0|||
17057422|NCT00098839|38200837|FG000|Overall Study|Refusal of further protocol therapy|3|||
17057423|NCT00098839|38200838|FG001|Overall Study|Refusal of further protocol therapy|1|||
17057424|NCT00098839|38200837|FG000|Overall Study|Relapse|6|||
17057425|NCT00098839|38200838|FG001|Overall Study|Relapse|3|||
17057426|NCT00098839|38200837|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
17057427|NCT00098839|38200838|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
17057428|NCT00098839|38200837|FG000|Overall Study|Ineligible|2|||
17057429|NCT00098839|38200838|FG001|Overall Study|Ineligible|0|||
17057430|NCT03811093|38200847|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
17057431|NCT03811093|38200848|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
17057432|NCT03811093|38200847|FG000|Overall Study|Unable to measure body fat percentage|2|||
17057433|NCT03811093|38200848|FG001|Overall Study|Unable to measure body fat percentage|0|||
17057434|NCT00485589|38200860|FG000|Overall Study|Death|2|||
17057435|NCT00485589|38200861|FG001|Overall Study|Death|2|||
17057436|NCT00485589|38200862|FG002|Overall Study|Death|0|||
17057437|NCT00485589|38200860|FG000|Overall Study|Failure to return|6|||
17057438|NCT00485589|38200861|FG001|Overall Study|Failure to return|5|||
17057439|NCT00485589|38200862|FG002|Overall Study|Failure to return|1|||
17057440|NCT00485589|38200860|FG000|Overall Study|Protocol Violation|1|||
17057441|NCT00485589|38200861|FG001|Overall Study|Protocol Violation|0|||
17057442|NCT00485589|38200862|FG002|Overall Study|Protocol Violation|0|||
17057443|NCT00485589|38200860|FG000|Overall Study|Violation of selection criteria at entry|0|||
17057444|NCT00485589|38200861|FG001|Overall Study|Violation of selection criteria at entry|3|||
17057445|NCT00485589|38200862|FG002|Overall Study|Violation of selection criteria at entry|1|||
17057446|NCT00485589|38200860|FG000|Overall Study|Administrative/Other|1|||
17057447|NCT00485589|38200861|FG001|Overall Study|Administrative/Other|2|||
17057448|NCT00485589|38200862|FG002|Overall Study|Administrative/Other|1|||
17057449|NCT00485589|38200860|FG000|Overall Study|Insufficient therapeutic response|10|||
17057450|NCT00485589|38200861|FG001|Overall Study|Insufficient therapeutic response|3|||
17057451|NCT00485589|38200862|FG002|Overall Study|Insufficient therapeutic response|1|||
17057452|NCT00485589|38200860|FG000|Overall Study|Refused treatment/did not cooperate|1|||
17057453|NCT00485589|38200861|FG001|Overall Study|Refused treatment/did not cooperate|0|||
17057454|NCT00485589|38200862|FG002|Overall Study|Refused treatment/did not cooperate|2|||
17144939|NCT04068181|38288750|FG001|Overall Study|Withdrawal by Subject|0|||
17144940|NCT04068181|38288751|FG002|Overall Study|Withdrawal by Subject|0|||
17144941|NCT04068181|38288752|FG003|Overall Study|Withdrawal by Subject|0|||
17144942|NCT04068181|38288749|FG000|Overall Study|Lost to Follow-up|1|||
17144943|NCT04068181|38288750|FG001|Overall Study|Lost to Follow-up|0|||
17144944|NCT04068181|38288751|FG002|Overall Study|Lost to Follow-up|0|||
17144945|NCT04068181|38288752|FG003|Overall Study|Lost to Follow-up|0|||
17057455|NCT00485589|38200860|FG000|Overall Study|Withdrawal by Subject|3|||
17057456|NCT00485589|38200861|FG001|Overall Study|Withdrawal by Subject|2|||
17057457|NCT00485589|38200862|FG002|Overall Study|Withdrawal by Subject|2|||
17057458|NCT00485589|38200860|FG000|Overall Study|Adverse Event|3|||
17057459|NCT00485589|38200861|FG001|Overall Study|Adverse Event|3|||
17057460|NCT00485589|38200862|FG002|Overall Study|Adverse Event|10|||
17057461|NCT00490971|38200881|FG000|Acute/Continuation|Adverse Event|62|||
17057462|NCT00490971|38200882|FG001|Acute/Continuation|Adverse Event|13|||
17057463|NCT00490971|38200883|FG002|Acute/Continuation|Adverse Event|0|||
17057464|NCT00490971|38200884|FG003|Acute/Continuation|Adverse Event|0|||
17057465|NCT00490971|38200885|FG004|Acute/Continuation|Adverse Event|0|||
17057466|NCT00490971|38200881|FG000|Acute/Continuation|Death|2|||
17057467|NCT00490971|38200882|FG001|Acute/Continuation|Death|0|||
17057468|NCT00490971|38200883|FG002|Acute/Continuation|Death|0|||
17057469|NCT00490971|38200884|FG003|Acute/Continuation|Death|0|||
17057470|NCT00490971|38200885|FG004|Acute/Continuation|Death|0|||
17057471|NCT00490971|38200881|FG000|Acute/Continuation|Lack of Efficacy|106|||
17057472|NCT00490971|38200882|FG001|Acute/Continuation|Lack of Efficacy|12|||
17057473|NCT00490971|38200883|FG002|Acute/Continuation|Lack of Efficacy|0|||
17057474|NCT00490971|38200884|FG003|Acute/Continuation|Lack of Efficacy|0|||
17057475|NCT00490971|38200885|FG004|Acute/Continuation|Lack of Efficacy|0|||
17057476|NCT00490971|38200881|FG000|Acute/Continuation|Lost to Follow-up|23|||
17057477|NCT00490971|38200882|FG001|Acute/Continuation|Lost to Follow-up|7|||
17057478|NCT00490971|38200883|FG002|Acute/Continuation|Lost to Follow-up|0|||
17057479|NCT00490971|38200884|FG003|Acute/Continuation|Lost to Follow-up|0|||
17057480|NCT00490971|38200885|FG004|Acute/Continuation|Lost to Follow-up|0|||
17057481|NCT00490971|38200881|FG000|Acute/Continuation|Protocol Violation|10|||
17057482|NCT00490971|38200882|FG001|Acute/Continuation|Protocol Violation|2|||
17057483|NCT00490971|38200883|FG002|Acute/Continuation|Protocol Violation|0|||
17144946|NCT04068181|38288749|FG000|Overall Study|Death|8|||
17057484|NCT00490971|38200884|FG003|Acute/Continuation|Protocol Violation|0|||
17057485|NCT00490971|38200885|FG004|Acute/Continuation|Protocol Violation|0|||
17057486|NCT00490971|38200881|FG000|Acute/Continuation|Withdrawal by Subject|92|||
17057487|NCT00490971|38200882|FG001|Acute/Continuation|Withdrawal by Subject|24|||
17057488|NCT00490971|38200883|FG002|Acute/Continuation|Withdrawal by Subject|0|||
17057489|NCT00490971|38200884|FG003|Acute/Continuation|Withdrawal by Subject|0|||
17057490|NCT00490971|38200885|FG004|Acute/Continuation|Withdrawal by Subject|0|||
17057491|NCT00490971|38200881|FG000|Acute/Continuation|Other|11|||
17057492|NCT00490971|38200882|FG001|Acute/Continuation|Other|4|||
17057493|NCT00490971|38200883|FG002|Acute/Continuation|Other|0|||
17057494|NCT00490971|38200884|FG003|Acute/Continuation|Other|0|||
17057495|NCT00490971|38200885|FG004|Acute/Continuation|Other|0|||
17057496|NCT00490971|38200881|FG000|Maintenance|Adverse Event|0|||
17057497|NCT00490971|38200882|FG001|Maintenance|Adverse Event|0|||
17057498|NCT00490971|38200883|FG002|Maintenance|Adverse Event|4|||
17057499|NCT00490971|38200884|FG003|Maintenance|Adverse Event|5|||
17057500|NCT00490971|38200885|FG004|Maintenance|Adverse Event|7|||
17057501|NCT00490971|38200881|FG000|Maintenance|Death|0|||
17057502|NCT00490971|38200882|FG001|Maintenance|Death|0|||
17057503|NCT00490971|38200883|FG002|Maintenance|Death|0|||
17057504|NCT00490971|38200884|FG003|Maintenance|Death|2|||
17057505|NCT00490971|38200885|FG004|Maintenance|Death|0|||
17057506|NCT00490971|38200881|FG000|Maintenance|Lost to Follow-up|0|||
17057507|NCT00490971|38200882|FG001|Maintenance|Lost to Follow-up|0|||
17057508|NCT00490971|38200883|FG002|Maintenance|Lost to Follow-up|5|||
17057509|NCT00490971|38200884|FG003|Maintenance|Lost to Follow-up|8|||
17057510|NCT00490971|38200885|FG004|Maintenance|Lost to Follow-up|10|||
17057511|NCT00490971|38200881|FG000|Maintenance|Pregnancy|0|||
17057512|NCT00490971|38200882|FG001|Maintenance|Pregnancy|0|||
17057513|NCT00490971|38200883|FG002|Maintenance|Pregnancy|1|||
17057514|NCT00490971|38200884|FG003|Maintenance|Pregnancy|0|||
17057515|NCT00490971|38200885|FG004|Maintenance|Pregnancy|0|||
17057516|NCT00490971|38200881|FG000|Maintenance|Protocol Violation|0|||
17057517|NCT00490971|38200882|FG001|Maintenance|Protocol Violation|0|||
17057518|NCT00490971|38200883|FG002|Maintenance|Protocol Violation|4|||
17057519|NCT00490971|38200884|FG003|Maintenance|Protocol Violation|1|||
17057520|NCT00490971|38200885|FG004|Maintenance|Protocol Violation|1|||
17057521|NCT00490971|38200881|FG000|Maintenance|Withdrawal by Subject|0|||
17057522|NCT00490971|38200882|FG001|Maintenance|Withdrawal by Subject|0|||
17057523|NCT00490971|38200883|FG002|Maintenance|Withdrawal by Subject|26|||
17057524|NCT00490971|38200884|FG003|Maintenance|Withdrawal by Subject|28|||
17057525|NCT00490971|38200885|FG004|Maintenance|Withdrawal by Subject|18|||
17057526|NCT00490971|38200881|FG000|Maintenance|Other|0|||
17057527|NCT00490971|38200882|FG001|Maintenance|Other|0|||
17144947|NCT04068181|38288750|FG001|Overall Study|Death|8|||
17144948|NCT04068181|38288751|FG002|Overall Study|Death|4|||
17144949|NCT04068181|38288752|FG003|Overall Study|Death|2|||
17144950|NCT04068181|38288749|FG000|Overall Study|Continuing Study|16|||
17144951|NCT04068181|38288750|FG001|Overall Study|Continuing Study|7|||
17144952|NCT04068181|38288751|FG002|Overall Study|Continuing Study|11|||
17144953|NCT04068181|38288752|FG003|Overall Study|Continuing Study|13|||
17144954|NCT03256578|38288764|FG000|Overall Study|Excluded Post Randomization|66|||
17144955|NCT03256578|38288765|FG001|Overall Study|Excluded Post Randomization|56|||
17144956|NCT03227445|38288771|FG000|Period 1 (28 Days)|Adverse Event|1|||
17057528|NCT00490971|38200883|FG002|Maintenance|Other|11|||
17057529|NCT00490971|38200884|FG003|Maintenance|Other|9|||
17144957|NCT03227445|38288772|FG001|Period 1 (28 Days)|Adverse Event|2|||
17144958|NCT03227445|38288773|FG002|Period 1 (28 Days)|Adverse Event|0|||
17144959|NCT03227445|38288774|FG003|Period 1 (28 Days)|Adverse Event|1|||
17144960|NCT03227445|38288771|FG000|Period 1 (28 Days)|Protocol Violation|1|||
17144961|NCT03227445|38288772|FG001|Period 1 (28 Days)|Protocol Violation|0|||
17144962|NCT03227445|38288773|FG002|Period 1 (28 Days)|Protocol Violation|0|||
17144963|NCT03227445|38288774|FG003|Period 1 (28 Days)|Protocol Violation|0|||
17144964|NCT03227445|38288771|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
17144965|NCT03227445|38288772|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
17144966|NCT03227445|38288773|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
17144967|NCT03227445|38288774|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
17144968|NCT03227445|38288771|FG000|Period 2 (28 Days)|Adverse Event|1|||
17144969|NCT03227445|38288772|FG001|Period 2 (28 Days)|Adverse Event|0|||
17144970|NCT03227445|38288773|FG002|Period 2 (28 Days)|Adverse Event|2|||
17144971|NCT03227445|38288774|FG003|Period 2 (28 Days)|Adverse Event|1|||
17144972|NCT03227445|38288771|FG000|Period 2 (28 Days)|Protocol Violation|0|||
17144973|NCT03227445|38288772|FG001|Period 2 (28 Days)|Protocol Violation|0|||
17144974|NCT03227445|38288773|FG002|Period 2 (28 Days)|Protocol Violation|0|||
17144975|NCT03227445|38288774|FG003|Period 2 (28 Days)|Protocol Violation|1|||
17144976|NCT03227445|38288771|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
17144977|NCT03227445|38288772|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
17144978|NCT03227445|38288773|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
17144979|NCT03227445|38288774|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
17144980|NCT04067401|38288785|FG000|Overall Study|Withdrawal by Subject|7|||
17057530|NCT00490971|38200885|FG004|Maintenance|Other|3|||
17057531|NCT00686075|38200907|FG000|Overall Study|Withdrawal by Subject|4|||
17057532|NCT00686075|38200908|FG001|Overall Study|Withdrawal by Subject|3|||
17057533|NCT00686075|38200909|FG002|Overall Study|Withdrawal by Subject|3|||
17057534|NCT00686075|38200910|FG003|Overall Study|Withdrawal by Subject|7|||
17057535|NCT00686075|38200911|FG004|Overall Study|Withdrawal by Subject|1|||
17057536|NCT00686075|38200912|FG005|Overall Study|Withdrawal by Subject|0|||
17057537|NCT00686075|38200913|FG006|Overall Study|Withdrawal by Subject|0|||
17057538|NCT00686075|38200914|FG007|Overall Study|Withdrawal by Subject|2|||
17057539|NCT00686075|38200915|FG008|Overall Study|Withdrawal by Subject|4|||
17057540|NCT00686075|38200916|FG009|Overall Study|Withdrawal by Subject|6|||
17057541|NCT00686075|38200907|FG000|Overall Study|Lost to Follow-up|3|||
17057542|NCT00686075|38200908|FG001|Overall Study|Lost to Follow-up|6|||
17057543|NCT00686075|38200909|FG002|Overall Study|Lost to Follow-up|3|||
17057544|NCT00686075|38200910|FG003|Overall Study|Lost to Follow-up|2|||
17057545|NCT00686075|38200911|FG004|Overall Study|Lost to Follow-up|3|||
17144981|NCT04067401|38288786|FG001|Overall Study|Withdrawal by Subject|0|||
17144982|NCT04067401|38288785|FG000|Overall Study|no data provided|1|||
17144983|NCT04067401|38288786|FG001|Overall Study|no data provided|0|||
17144984|NCT04194151|38288798|FG000|Overall Study|Physician Decision|1|||
17144985|NCT04194151|38288799|FG001|Overall Study|Physician Decision|1|||
17144986|NCT04194151|38288800|FG002|Overall Study|Physician Decision|1|||
17057546|NCT00686075|38200912|FG005|Overall Study|Lost to Follow-up|3|||
17057547|NCT00686075|38200913|FG006|Overall Study|Lost to Follow-up|0|||
17057548|NCT00686075|38200914|FG007|Overall Study|Lost to Follow-up|0|||
17057549|NCT00686075|38200915|FG008|Overall Study|Lost to Follow-up|2|||
17057550|NCT00686075|38200916|FG009|Overall Study|Lost to Follow-up|3|||
17057551|NCT00686075|38200907|FG000|Overall Study|Other|1|||
17057552|NCT00686075|38200908|FG001|Overall Study|Other|1|||
17057553|NCT00686075|38200909|FG002|Overall Study|Other|0|||
17057554|NCT00686075|38200910|FG003|Overall Study|Other|0|||
17057555|NCT00686075|38200911|FG004|Overall Study|Other|0|||
17057556|NCT00686075|38200912|FG005|Overall Study|Other|0|||
17057557|NCT00686075|38200913|FG006|Overall Study|Other|0|||
17057558|NCT00686075|38200914|FG007|Overall Study|Other|0|||
17057559|NCT00686075|38200915|FG008|Overall Study|Other|0|||
17057560|NCT00686075|38200916|FG009|Overall Study|Other|1|||
17057561|NCT00685763|38200938|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
17057562|NCT00685763|38200938|FG000|Overall Study|Protocol Violation|1|||
17057563|NCT00098293|38200945|FG000|Double-blind (DB) Phase|Adverse Event|14|||
17057564|NCT00098293|38200946|FG001|Double-blind (DB) Phase|Adverse Event|27|||
17057565|NCT00098293|38200947|FG002|Double-blind (DB) Phase|Adverse Event|60|||
17057566|NCT00098293|38200948|FG003|Double-blind (DB) Phase|Adverse Event|0|||
17057567|NCT00098293|38200949|FG004|Double-blind (DB) Phase|Adverse Event|0|||
17057568|NCT00098293|38200945|FG000|Double-blind (DB) Phase|Pregnancy|0|||
17057569|NCT00098293|38200946|FG001|Double-blind (DB) Phase|Pregnancy|7|||
17057570|NCT00098293|38200947|FG002|Double-blind (DB) Phase|Pregnancy|9|||
17057571|NCT00098293|38200948|FG003|Double-blind (DB) Phase|Pregnancy|0|||
17057572|NCT00098293|38200949|FG004|Double-blind (DB) Phase|Pregnancy|0|||
17057573|NCT00098293|38200945|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
17057574|NCT00098293|38200946|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
17057575|NCT00098293|38200947|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
17057576|NCT00098293|38200948|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
17057577|NCT00098293|38200949|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
17057578|NCT00098293|38200945|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
17057579|NCT00098293|38200946|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
17057580|NCT00098293|38200947|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
17057581|NCT00098293|38200948|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
17057582|NCT00098293|38200949|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
17057583|NCT00098293|38200945|FG000|Double-blind (DB) Phase|Death|1|||
17057584|NCT00098293|38200946|FG001|Double-blind (DB) Phase|Death|2|||
17057585|NCT00098293|38200947|FG002|Double-blind (DB) Phase|Death|2|||
17057586|NCT00098293|38200948|FG003|Double-blind (DB) Phase|Death|0|||
17057587|NCT00098293|38200949|FG004|Double-blind (DB) Phase|Death|0|||
17144987|NCT04194151|38288801|FG003|Overall Study|Physician Decision|1|||
17057588|NCT00098293|38200945|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
17057589|NCT00098293|38200946|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
17057590|NCT00098293|38200947|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
17057591|NCT00098293|38200948|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
17057592|NCT00098293|38200949|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
17057593|NCT00098293|38200945|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
17057594|NCT00098293|38200946|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
17057595|NCT00098293|38200947|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
17144988|NCT04194151|38288802|FG004|Overall Study|Physician Decision|0|||
17144989|NCT04194151|38288803|FG005|Overall Study|Physician Decision|1|||
17144990|NCT04194151|38288798|FG000|Overall Study|Monitorization problem|0|||
17144991|NCT04194151|38288799|FG001|Overall Study|Monitorization problem|1|||
17057596|NCT00098293|38200948|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
17057597|NCT00098293|38200949|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
17057598|NCT00098293|38200945|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
17057599|NCT00098293|38200946|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
17057600|NCT00098293|38200947|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
17057601|NCT00098293|38200948|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
17057602|NCT00098293|38200949|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
17057603|NCT00098293|38200945|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
17057604|NCT00098293|38200946|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
17057605|NCT00098293|38200947|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
17057606|NCT00098293|38200948|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
17057607|NCT00098293|38200949|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
17057608|NCT00098293|38200945|FG000|Open-label (OL) Phase|Adverse Event|0|||
17057609|NCT00098293|38200946|FG001|Open-label (OL) Phase|Adverse Event|3|||
17057610|NCT00098293|38200947|FG002|Open-label (OL) Phase|Adverse Event|7|||
17057611|NCT00098293|38200948|FG003|Open-label (OL) Phase|Adverse Event|6|||
17057612|NCT00098293|38200949|FG004|Open-label (OL) Phase|Adverse Event|0|||
17057613|NCT00098293|38200945|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
17057614|NCT00098293|38200946|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
17057615|NCT00098293|38200947|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
17057616|NCT00098293|38200948|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
17057617|NCT00098293|38200949|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
17057618|NCT00098293|38200945|FG000|Open-label (OL) Phase|Pregnancy|0|||
17057619|NCT00098293|38200946|FG001|Open-label (OL) Phase|Pregnancy|1|||
16993086|NCT00719563|38137118|FG001|Overall Study|Lack of Efficacy|7|||
16993087|NCT00719563|38137117|FG000|Overall Study|Personal reasons|6|||
16993088|NCT00719563|38137118|FG001|Overall Study|Personal reasons|7|||
16993089|NCT00719563|38137117|FG000|Overall Study|Unknown reasons|4|||
16993090|NCT00719563|38137118|FG001|Overall Study|Unknown reasons|6|||
16993091|NCT00719563|38137117|FG000|Overall Study|Noncompliant|1|||
16993092|NCT00719563|38137118|FG001|Overall Study|Noncompliant|1|||
16993093|NCT00719563|38137117|FG000|Overall Study|Lost to Follow-up|5|||
16993094|NCT00719563|38137118|FG001|Overall Study|Lost to Follow-up|3|||
16993095|NCT00795184|38137125|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
16993096|NCT00795184|38137126|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
17057620|NCT00098293|38200947|FG002|Open-label (OL) Phase|Pregnancy|0|||
17144992|NCT04194151|38288800|FG002|Overall Study|Monitorization problem|0|||
16993097|NCT00718861|38137137|FG000|Overall Study|Withdrawal by Subject|15|||
17057621|NCT00098293|38200948|FG003|Open-label (OL) Phase|Pregnancy|3|||
17057622|NCT00098293|38200949|FG004|Open-label (OL) Phase|Pregnancy|0|||
17057623|NCT00098293|38200945|FG000|Open-label (OL) Phase|Protocol Violation|0|||
17057624|NCT00098293|38200946|FG001|Open-label (OL) Phase|Protocol Violation|6|||
17057625|NCT00098293|38200947|FG002|Open-label (OL) Phase|Protocol Violation|13|||
17057626|NCT00098293|38200948|FG003|Open-label (OL) Phase|Protocol Violation|16|||
17057627|NCT00098293|38200949|FG004|Open-label (OL) Phase|Protocol Violation|0|||
17057628|NCT00098293|38200945|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
17057629|NCT00098293|38200946|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
17057630|NCT00098293|38200947|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
17057631|NCT00098293|38200948|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
17057632|NCT00098293|38200949|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
17057633|NCT00098293|38200945|FG000|Open-label (OL) Phase|Death|0|||
17057634|NCT00098293|38200946|FG001|Open-label (OL) Phase|Death|2|||
17057635|NCT00098293|38200947|FG002|Open-label (OL) Phase|Death|3|||
17057636|NCT00098293|38200948|FG003|Open-label (OL) Phase|Death|0|||
17057637|NCT00098293|38200949|FG004|Open-label (OL) Phase|Death|0|||
17057638|NCT00098293|38200945|FG000|Supplemental Phase (SP)|Death|0|||
17057639|NCT00098293|38200946|FG001|Supplemental Phase (SP)|Death|0|||
17057640|NCT00098293|38200947|FG002|Supplemental Phase (SP)|Death|0|||
17057641|NCT00098293|38200948|FG003|Supplemental Phase (SP)|Death|0|||
17057642|NCT00098293|38200949|FG004|Supplemental Phase (SP)|Death|1|||
17057643|NCT00098293|38200945|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
17057644|NCT00098293|38200946|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
17057645|NCT00098293|38200947|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
17057646|NCT00098293|38200948|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
17057647|NCT00098293|38200949|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
17057648|NCT00098293|38200945|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
17144993|NCT04194151|38288801|FG003|Overall Study|Monitorization problem|0|||
17144994|NCT04194151|38288802|FG004|Overall Study|Monitorization problem|0|||
17144995|NCT04194151|38288803|FG005|Overall Study|Monitorization problem|0|||
17144996|NCT03820323|38288819|FG000|Overall Study|Lost to Follow-up|2|||
17144997|NCT03820323|38288820|FG001|Overall Study|Lost to Follow-up|1|||
17144998|NCT03820323|38288819|FG000|Overall Study|Missed 12-month visit|22|||
17144999|NCT03820323|38288820|FG001|Overall Study|Missed 12-month visit|14|||
17145000|NCT03820323|38288819|FG000|Overall Study|Death|2|||
17057649|NCT00098293|38200946|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
17057650|NCT00098293|38200947|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
17057651|NCT00098293|38200948|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
17057652|NCT00098293|38200949|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
17057653|NCT00098293|38200945|FG000|Supplemental Phase (SP)|Other|0|||
17057654|NCT00098293|38200946|FG001|Supplemental Phase (SP)|Other|0|||
17057655|NCT00098293|38200947|FG002|Supplemental Phase (SP)|Other|0|||
17057656|NCT00098293|38200948|FG003|Supplemental Phase (SP)|Other|0|||
17057657|NCT00098293|38200949|FG004|Supplemental Phase (SP)|Other|22|||
17057658|NCT00685685|38200960|FG000|Washout Period of 7 Days|Adverse Event|2|||
17057659|NCT00685685|38200961|FG001|Washout Period of 7 Days|Adverse Event|0|||
17057660|NCT00685685|38200960|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
17145001|NCT03820323|38288820|FG001|Overall Study|Death|1|||
17057661|NCT00685685|38200961|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
17057662|NCT00684671|38200970|FG000|Overall Study|Adverse Event|1|||
17057663|NCT00684671|38200971|FG001|Overall Study|Adverse Event|0|||
17057664|NCT00684671|38200972|FG002|Overall Study|Adverse Event|0|||
17145002|NCT03820323|38288819|FG000|Overall Study|Transferred out|13|||
17145003|NCT03820323|38288820|FG001|Overall Study|Transferred out|11|||
17145004|NCT03820323|38288819|FG000|Overall Study|Terminated|0|||
17145005|NCT03820323|38288820|FG001|Overall Study|Terminated|3|||
17145006|NCT03820323|38288819|FG000|Overall Study|Withdrawal by Subject|1|||
17145007|NCT03820323|38288820|FG001|Overall Study|Withdrawal by Subject|6|||
17145008|NCT03287622|38288835|FG000|Overall Study|Withdrawal by Subject|1|||
17145009|NCT03287622|38288836|FG001|Overall Study|Withdrawal by Subject|0|||
17145010|NCT03287622|38288835|FG000|Overall Study|Lost to Follow-up|27|||
17145011|NCT03287622|38288836|FG001|Overall Study|Lost to Follow-up|15|||
17145012|NCT03287622|38288835|FG000|Overall Study|No prescripion after surgery|28|||
17145013|NCT03287622|38288836|FG001|Overall Study|No prescripion after surgery|31|||
17145014|NCT03287622|38288835|FG000|Overall Study|prolonged Length of stay|2|||
17145015|NCT03287622|38288836|FG001|Overall Study|prolonged Length of stay|0|||
17145016|NCT03287622|38288835|FG000|Overall Study|surgery related|0|||
17145017|NCT03287622|38288836|FG001|Overall Study|surgery related|2|||
17145018|NCT04063657|38288851|FG000|Overall Study|Lost to Follow-up|1|||
17145019|NCT04063657|38288852|FG001|Overall Study|Lost to Follow-up|0|||
17145020|NCT04058353|38288869|FG000|Overall Study|Adverse Event|2|||
17145021|NCT04058353|38288870|FG001|Overall Study|Adverse Event|1|||
17145022|NCT04058353|38288869|FG000|Overall Study|Physician Decision|1|||
17145023|NCT04058353|38288870|FG001|Overall Study|Physician Decision|0|||
17057665|NCT00684671|38200970|FG000|Overall Study|Lost to Follow-up|1|||
17057666|NCT00684671|38200971|FG001|Overall Study|Lost to Follow-up|0|||
17057667|NCT00684671|38200972|FG002|Overall Study|Lost to Follow-up|0|||
17057668|NCT00684671|38200970|FG000|Overall Study|Alcoholic dependance|1|||
17057669|NCT00684671|38200971|FG001|Overall Study|Alcoholic dependance|0|||
17057670|NCT00684671|38200972|FG002|Overall Study|Alcoholic dependance|0|||
17057671|NCT03859323|38200993|FG000|Overall Study|Lost to Follow-up|0|||
17057672|NCT03859323|38200994|FG001|Overall Study|Lost to Follow-up|0|||
17057673|NCT03859323|38200995|FG002|Overall Study|Lost to Follow-up|0|||
17057674|NCT03859323|38200996|FG003|Overall Study|Lost to Follow-up|0|||
17057675|NCT03859323|38200997|FG004|Overall Study|Lost to Follow-up|0|||
17057676|NCT03859323|38200998|FG005|Overall Study|Lost to Follow-up|0|||
17057677|NCT03859323|38200999|FG006|Overall Study|Lost to Follow-up|1|||
17057678|NCT03859323|38201000|FG007|Overall Study|Lost to Follow-up|0|||
17057679|NCT03859323|38201001|FG008|Overall Study|Lost to Follow-up|0|||
17057680|NCT03859323|38201002|FG009|Overall Study|Lost to Follow-up|0|||
17057681|NCT03859323|38201003|FG010|Overall Study|Lost to Follow-up|0|||
17057682|NCT03859323|38201004|FG011|Overall Study|Lost to Follow-up|0|||
17057683|NCT03859323|38201005|FG012|Overall Study|Lost to Follow-up|0|||
17057684|NCT03859323|38200993|FG000|Overall Study|Withdrawal by Subject|0|||
17057685|NCT03859323|38200994|FG001|Overall Study|Withdrawal by Subject|0|||
17057686|NCT03859323|38200995|FG002|Overall Study|Withdrawal by Subject|1|||
17057687|NCT03859323|38200996|FG003|Overall Study|Withdrawal by Subject|0|||
17145024|NCT04058353|38288869|FG000|Overall Study|Other|1|||
17145025|NCT04058353|38288870|FG001|Overall Study|Other|0|||
17145026|NCT03226353|38288877|FG000|Overall Study|Withdrawal by Subject|1|||
17145027|NCT03226353|38288877|FG000|Overall Study|Screen Failure|5|||
17145028|NCT02730598|38288886|FG000|Overall Study|Withdrawal by Subject|3|||
17145029|NCT02730598|38288887|FG001|Overall Study|Withdrawal by Subject|3|||
17145030|NCT02730598|38288886|FG000|Overall Study|Protocol Violation|0|||
17145031|NCT02730598|38288887|FG001|Overall Study|Protocol Violation|1|||
17145032|NCT02730598|38288886|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
17145033|NCT02730598|38288887|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
17145034|NCT03226275|38288897|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
17145035|NCT03226275|38288898|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
17145036|NCT03226275|38288899|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
17145037|NCT03226275|38288900|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
17145038|NCT03226275|38288897|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
17145039|NCT03226275|38288898|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
17145040|NCT03226275|38288899|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
17145041|NCT03226275|38288900|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
17145042|NCT04189081|38288913|FG000|Overall Study|Lost to Follow-up|1|||
17145043|NCT04189081|38288914|FG001|Overall Study|Lost to Follow-up|0|||
17145044|NCT04189081|38288915|FG002|Overall Study|Lost to Follow-up|0|||
17145045|NCT04189081|38288913|FG000|Overall Study|Withdrawal by Subject|0|||
17145046|NCT04189081|38288914|FG001|Overall Study|Withdrawal by Subject|0|||
17145047|NCT04189081|38288915|FG002|Overall Study|Withdrawal by Subject|1|||
17145048|NCT04187989|38288925|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
17145049|NCT04187989|38288926|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
17145050|NCT04187989|38288925|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
17145051|NCT04187989|38288926|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
17145052|NCT01150890|38288936|FG000|Overall Study|Other|0|||
17145053|NCT01150890|38288937|FG001|Overall Study|Other|1|||
17145054|NCT01150890|38288938|FG002|Overall Study|Other|0|||
17145055|NCT01150890|38288939|FG003|Overall Study|Other|2|||
17145056|NCT01150890|38288936|FG000|Overall Study|Pregnancy|0|||
17145057|NCT01150890|38288937|FG001|Overall Study|Pregnancy|0|||
17145058|NCT01150890|38288938|FG002|Overall Study|Pregnancy|0|||
17145059|NCT01150890|38288939|FG003|Overall Study|Pregnancy|1|||
17145060|NCT01150890|38288936|FG000|Overall Study|Administrative Decision|4|||
17145061|NCT01150890|38288937|FG001|Overall Study|Administrative Decision|4|||
17145062|NCT01150890|38288938|FG002|Overall Study|Administrative Decision|5|||
17145063|NCT01150890|38288939|FG003|Overall Study|Administrative Decision|6|||
17145064|NCT01150890|38288936|FG000|Overall Study|Ineligibility determined|0|||
17145065|NCT01150890|38288937|FG001|Overall Study|Ineligibility determined|1|||
17057688|NCT03859323|38200997|FG004|Overall Study|Withdrawal by Subject|0|||
17057689|NCT03859323|38200998|FG005|Overall Study|Withdrawal by Subject|1|||
17057690|NCT03859323|38200999|FG006|Overall Study|Withdrawal by Subject|0|||
17057691|NCT03859323|38201000|FG007|Overall Study|Withdrawal by Subject|0|||
17057692|NCT03859323|38201001|FG008|Overall Study|Withdrawal by Subject|0|||
17057693|NCT03859323|38201002|FG009|Overall Study|Withdrawal by Subject|1|||
17057694|NCT03859323|38201003|FG010|Overall Study|Withdrawal by Subject|1|||
17057695|NCT03859323|38201004|FG011|Overall Study|Withdrawal by Subject|2|||
17057696|NCT03859323|38201005|FG012|Overall Study|Withdrawal by Subject|1|||
17057697|NCT03859323|38200993|FG000|Overall Study|Pregnancy|0|||
17057698|NCT03859323|38200994|FG001|Overall Study|Pregnancy|0|||
17057699|NCT03859323|38200995|FG002|Overall Study|Pregnancy|0|||
17057700|NCT03859323|38200996|FG003|Overall Study|Pregnancy|0|||
17057701|NCT03859323|38200997|FG004|Overall Study|Pregnancy|0|||
17057702|NCT03859323|38200998|FG005|Overall Study|Pregnancy|0|||
17057703|NCT03859323|38200999|FG006|Overall Study|Pregnancy|0|||
17057704|NCT03859323|38201000|FG007|Overall Study|Pregnancy|0|||
17057705|NCT03859323|38201001|FG008|Overall Study|Pregnancy|0|||
17057706|NCT03859323|38201002|FG009|Overall Study|Pregnancy|1|||
17057707|NCT03859323|38201003|FG010|Overall Study|Pregnancy|0|||
17057708|NCT03859323|38201004|FG011|Overall Study|Pregnancy|0|||
17057709|NCT03859323|38201005|FG012|Overall Study|Pregnancy|0|||
17057710|NCT03857841|38201048|FG000|Overall Study|Death|1|||
17057711|NCT03857841|38201049|FG001|Overall Study|Death|0|||
17057712|NCT03857841|38201050|FG002|Overall Study|Death|0|||
17057713|NCT03857841|38201051|FG003|Overall Study|Death|0|||
17057714|NCT03857841|38201048|FG000|Overall Study|Study Terminated by Sponsor|1|||
17057715|NCT03857841|38201049|FG001|Overall Study|Study Terminated by Sponsor|0|||
17057716|NCT03857841|38201050|FG002|Overall Study|Study Terminated by Sponsor|0|||
17057717|NCT03857841|38201051|FG003|Overall Study|Study Terminated by Sponsor|0|||
17057718|NCT00500331|38201068|FG000|Overall Study|Adverse Event|0|||
17057719|NCT00500331|38201069|FG001|Overall Study|Adverse Event|2|||
17057720|NCT00500331|38201070|FG002|Overall Study|Adverse Event|0|||
17057721|NCT00500331|38201071|FG003|Overall Study|Adverse Event|1|||
17057722|NCT00500331|38201072|FG004|Overall Study|Adverse Event|2|||
17057723|NCT00500331|38201073|FG005|Overall Study|Adverse Event|2|||
17057724|NCT00500331|38201074|FG006|Overall Study|Adverse Event|0|||
17057725|NCT00500331|38201068|FG000|Overall Study|Lost to Follow-up|1|||
17057726|NCT00500331|38201069|FG001|Overall Study|Lost to Follow-up|1|||
17057727|NCT00500331|38201070|FG002|Overall Study|Lost to Follow-up|1|||
17057728|NCT00500331|38201071|FG003|Overall Study|Lost to Follow-up|2|||
17057729|NCT00500331|38201072|FG004|Overall Study|Lost to Follow-up|1|||
17057730|NCT00500331|38201073|FG005|Overall Study|Lost to Follow-up|0|||
17057731|NCT00500331|38201074|FG006|Overall Study|Lost to Follow-up|0|||
17057732|NCT00500331|38201068|FG000|Overall Study|Protocol Violation|3|||
17057733|NCT00500331|38201069|FG001|Overall Study|Protocol Violation|1|||
17057734|NCT00500331|38201070|FG002|Overall Study|Protocol Violation|1|||
17057735|NCT00500331|38201071|FG003|Overall Study|Protocol Violation|0|||
17057736|NCT00500331|38201072|FG004|Overall Study|Protocol Violation|1|||
17057737|NCT00500331|38201073|FG005|Overall Study|Protocol Violation|1|||
17057738|NCT00500331|38201074|FG006|Overall Study|Protocol Violation|1|||
17057739|NCT00500331|38201068|FG000|Overall Study|Withdrawal by Subject|4|||
17057740|NCT00500331|38201069|FG001|Overall Study|Withdrawal by Subject|0|||
17057741|NCT00500331|38201070|FG002|Overall Study|Withdrawal by Subject|1|||
17057742|NCT00500331|38201071|FG003|Overall Study|Withdrawal by Subject|5|||
17057743|NCT00500331|38201072|FG004|Overall Study|Withdrawal by Subject|0|||
17057744|NCT00500331|38201073|FG005|Overall Study|Withdrawal by Subject|1|||
17057745|NCT00500331|38201074|FG006|Overall Study|Withdrawal by Subject|1|||
17057746|NCT00500331|38201068|FG000|Overall Study|Lack of Efficacy|3|||
17057747|NCT00500331|38201069|FG001|Overall Study|Lack of Efficacy|1|||
17057748|NCT00500331|38201070|FG002|Overall Study|Lack of Efficacy|0|||
17057749|NCT00500331|38201071|FG003|Overall Study|Lack of Efficacy|0|||
17057750|NCT00500331|38201072|FG004|Overall Study|Lack of Efficacy|0|||
17057751|NCT00500331|38201073|FG005|Overall Study|Lack of Efficacy|0|||
17057752|NCT00500331|38201074|FG006|Overall Study|Lack of Efficacy|0|||
17057753|NCT00500331|38201068|FG000|Overall Study|Liver function test abnormality|0|||
17057754|NCT00500331|38201069|FG001|Overall Study|Liver function test abnormality|0|||
17057755|NCT00500331|38201070|FG002|Overall Study|Liver function test abnormality|1|||
17057756|NCT00500331|38201071|FG003|Overall Study|Liver function test abnormality|0|||
17057757|NCT00500331|38201072|FG004|Overall Study|Liver function test abnormality|0|||
17145066|NCT01150890|38288938|FG002|Overall Study|Ineligibility determined|0|||
17145067|NCT01150890|38288939|FG003|Overall Study|Ineligibility determined|0|||
17057758|NCT00500331|38201073|FG005|Overall Study|Liver function test abnormality|0|||
17057759|NCT00500331|38201074|FG006|Overall Study|Liver function test abnormality|0|||
17057760|NCT00500331|38201068|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
17057761|NCT00500331|38201069|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
17057762|NCT00500331|38201070|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
17057763|NCT00500331|38201071|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
17057764|NCT00500331|38201072|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
17057765|NCT00500331|38201073|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
17057766|NCT00500331|38201074|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
17057767|NCT00500331|38201068|FG000|Overall Study|Didn't return for continuation of study|1|||
17057768|NCT00500331|38201069|FG001|Overall Study|Didn't return for continuation of study|0|||
17057769|NCT00500331|38201070|FG002|Overall Study|Didn't return for continuation of study|0|||
17057770|NCT00500331|38201071|FG003|Overall Study|Didn't return for continuation of study|0|||
17057771|NCT00500331|38201072|FG004|Overall Study|Didn't return for continuation of study|0|||
17057772|NCT00500331|38201073|FG005|Overall Study|Didn't return for continuation of study|0|||
17057773|NCT00500331|38201074|FG006|Overall Study|Didn't return for continuation of study|0|||
17057774|NCT00500331|38201068|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
17057775|NCT00500331|38201069|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
17057776|NCT00500331|38201070|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
17057777|NCT00500331|38201071|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
17057778|NCT00500331|38201072|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
17057779|NCT00500331|38201073|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
17057780|NCT00500331|38201074|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
17057781|NCT00500331|38201068|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
17057782|NCT00500331|38201069|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
17057783|NCT00500331|38201070|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
17057784|NCT00500331|38201071|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
17057785|NCT00500331|38201072|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
17057786|NCT00500331|38201073|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
17145068|NCT01150890|38288936|FG000|Overall Study|Adverse Event|0|||
17057787|NCT00500331|38201074|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
17057788|NCT00500331|38201068|FG000|Overall Study|Participant was randomized by mistake|1|||
17057789|NCT00500331|38201069|FG001|Overall Study|Participant was randomized by mistake|0|||
17057790|NCT00500331|38201070|FG002|Overall Study|Participant was randomized by mistake|0|||
17057791|NCT00500331|38201071|FG003|Overall Study|Participant was randomized by mistake|0|||
17057792|NCT00500331|38201072|FG004|Overall Study|Participant was randomized by mistake|0|||
17057793|NCT00500331|38201073|FG005|Overall Study|Participant was randomized by mistake|0|||
17057794|NCT00500331|38201074|FG006|Overall Study|Participant was randomized by mistake|0|||
17057795|NCT00500331|38201068|FG000|Overall Study|Diabetologist nurse in the study|0|||
17057796|NCT00500331|38201069|FG001|Overall Study|Diabetologist nurse in the study|0|||
17057797|NCT00500331|38201070|FG002|Overall Study|Diabetologist nurse in the study|1|||
17057798|NCT00500331|38201071|FG003|Overall Study|Diabetologist nurse in the study|0|||
17057799|NCT00500331|38201072|FG004|Overall Study|Diabetologist nurse in the study|0|||
17145069|NCT01150890|38288937|FG001|Overall Study|Adverse Event|0|||
17145070|NCT01150890|38288938|FG002|Overall Study|Adverse Event|2|||
17145071|NCT01150890|38288939|FG003|Overall Study|Adverse Event|0|||
17057800|NCT00500331|38201073|FG005|Overall Study|Diabetologist nurse in the study|0|||
17057801|NCT00500331|38201074|FG006|Overall Study|Diabetologist nurse in the study|0|||
17057802|NCT00500331|38201068|FG000|Overall Study|State ban of biological samples export|0|||
17057803|NCT00500331|38201069|FG001|Overall Study|State ban of biological samples export|0|||
17057804|NCT00500331|38201070|FG002|Overall Study|State ban of biological samples export|0|||
17057805|NCT00500331|38201071|FG003|Overall Study|State ban of biological samples export|1|||
17057806|NCT00500331|38201072|FG004|Overall Study|State ban of biological samples export|0|||
17057807|NCT00500331|38201073|FG005|Overall Study|State ban of biological samples export|0|||
17057808|NCT00500331|38201074|FG006|Overall Study|State ban of biological samples export|0|||
17057809|NCT00500331|38201068|FG000|Overall Study|Protocol violated|0|||
17057810|NCT00500331|38201069|FG001|Overall Study|Protocol violated|0|||
17057811|NCT00500331|38201070|FG002|Overall Study|Protocol violated|0|||
17057812|NCT00500331|38201071|FG003|Overall Study|Protocol violated|1|||
17057813|NCT00500331|38201072|FG004|Overall Study|Protocol violated|0|||
17057814|NCT00500331|38201073|FG005|Overall Study|Protocol violated|0|||
17057815|NCT00500331|38201074|FG006|Overall Study|Protocol violated|0|||
17057816|NCT00499863|38201093|FG000|Overall Study|Lack of Efficacy|21|||
17057817|NCT00499863|38201094|FG001|Overall Study|Lack of Efficacy|27|||
17057818|NCT00499863|38201093|FG000|Overall Study|Protocol Violation|12|||
17057819|NCT00499863|38201094|FG001|Overall Study|Protocol Violation|7|||
17057820|NCT00499863|38201093|FG000|Overall Study|Withdrawal by Subject|6|||
17057821|NCT00499863|38201094|FG001|Overall Study|Withdrawal by Subject|4|||
17057822|NCT00499863|38201093|FG000|Overall Study|Adverse Event|8|||
17057823|NCT00499863|38201094|FG001|Overall Study|Adverse Event|2|||
17057824|NCT00499863|38201093|FG000|Overall Study|Sponsor decision|2|||
17057825|NCT00499863|38201094|FG001|Overall Study|Sponsor decision|2|||
17057826|NCT00499863|38201093|FG000|Overall Study|Lost to Follow-up|1|||
17057827|NCT00499863|38201094|FG001|Overall Study|Lost to Follow-up|1|||
17057828|NCT00484185|38201100|FG000|Overall Study|Lost to Follow-up|44|||
17057829|NCT00484185|38201100|FG000|Overall Study|Other|20|||
17057830|NCT00484185|38201100|FG000|Overall Study|Randomized but not treated|5|||
17057831|NCT00484185|38201100|FG000|Overall Study|Death|2|||
17057832|NCT00097981|38201106|FG000|Overall Study|Adverse Event|31|||
17057833|NCT00097981|38201107|FG001|Overall Study|Adverse Event|44|||
17057834|NCT00097981|38201106|FG000|Overall Study|Withdrawal by Subject|10|||
17057835|NCT00097981|38201107|FG001|Overall Study|Withdrawal by Subject|8|||
17057836|NCT00097981|38201106|FG000|Overall Study|Protocol Violation|1|||
17057837|NCT00097981|38201107|FG001|Overall Study|Protocol Violation|1|||
17057838|NCT00097981|38201106|FG000|Overall Study|Death|2|||
17057839|NCT00097981|38201107|FG001|Overall Study|Death|4|||
17057840|NCT00097981|38201106|FG000|Overall Study|Physician Decision|7|||
17057841|NCT00097981|38201107|FG001|Overall Study|Physician Decision|1|||
17057842|NCT00097981|38201106|FG000|Overall Study|Disease Progression|8|||
17057843|NCT00097981|38201107|FG001|Overall Study|Disease Progression|2|||
17057844|NCT00097981|38201106|FG000|Overall Study|Transplant planned|28|||
17057845|NCT00097981|38201107|FG001|Overall Study|Transplant planned|27|||
17057846|NCT00097981|38201106|FG000|Overall Study|Other|19|||
17057847|NCT00097981|38201107|FG001|Overall Study|Other|13|||
17057848|NCT00499083|38201113|FG000|Overall Study|Not evaluable|3|||
17057849|NCT00572195|38201117|FG000|Overall Study|Withdrawal by Subject|50|||
17057850|NCT00572195|38201117|FG000|Overall Study|Death|9|||
17057851|NCT00572195|38201117|FG000|Overall Study|Adverse Event|4|||
17057852|NCT00572195|38201117|FG000|Overall Study|Lost to Follow-up|5|||
17057853|NCT00572039|38201123|FG000|Overall Study|Withdrawal by Subject|9|||
17057854|NCT00572039|38201124|FG001|Overall Study|Withdrawal by Subject|6|||
17057855|NCT00572039|38201123|FG000|Overall Study|Death|2|||
17057856|NCT00572039|38201124|FG001|Overall Study|Death|3|||
17057857|NCT00572039|38201123|FG000|Overall Study|Ill|5|||
17057858|NCT00572039|38201124|FG001|Overall Study|Ill|1|||
17057859|NCT00684593|38201134|FG000|Overall Study|Adverse Event|0|||
17057860|NCT00684593|38201135|FG001|Overall Study|Adverse Event|2|||
17057861|NCT00685373|38201141|FG000|Overall Study|Adverse Event|3|||
17057862|NCT00685373|38201141|FG000|Overall Study|Withdrawal by Subject|5|||
17057863|NCT00685373|38201141|FG000|Overall Study|Lack of Efficacy|3|||
17057864|NCT00685373|38201141|FG000|Overall Study|Condition no longer requires study drug|1|||
17057865|NCT00685373|38201141|FG000|Overall Study|Lost to Follow-up|2|||
17057866|NCT00685373|38201141|FG000|Overall Study|Protocol Violation|1|||
17057867|NCT00684515|38201148|FG000|Overall Study|Adverse Event|3|||
17057868|NCT00684515|38201149|FG001|Overall Study|Adverse Event|3|||
17057869|NCT00684515|38201150|FG002|Overall Study|Adverse Event|1|||
17057870|NCT00684515|38201148|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
17057871|NCT00684515|38201149|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
17057872|NCT00684515|38201150|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
17057873|NCT00490815|38201160|FG000|Overall Study|Adverse Event|2|||
17057874|NCT00490815|38201161|FG001|Overall Study|Adverse Event|3|||
17057875|NCT00490815|38201160|FG000|Overall Study|Withdrawal by Subject|4|||
17057876|NCT00490815|38201161|FG001|Overall Study|Withdrawal by Subject|0|||
17057877|NCT00490815|38201160|FG000|Overall Study|Lost to Follow-up|1|||
17057878|NCT00490815|38201161|FG001|Overall Study|Lost to Follow-up|3|||
17057879|NCT00490815|38201160|FG000|Overall Study|Death|1|||
17057880|NCT00490815|38201161|FG001|Overall Study|Death|3|||
17057881|NCT03855189|38201170|FG000|Overall Study|Adverse Event|5|||
17057882|NCT03855189|38201171|FG001|Overall Study|Adverse Event|2|||
17057883|NCT03855189|38201172|FG002|Overall Study|Adverse Event|4|||
17057884|NCT03855189|38201170|FG000|Overall Study|Treatment Failure|1|||
17057885|NCT03855189|38201171|FG001|Overall Study|Treatment Failure|1|||
17057886|NCT03855189|38201172|FG002|Overall Study|Treatment Failure|2|||
17057887|NCT03855189|38201170|FG000|Overall Study|Noncompliance with Protocol|0|||
17057888|NCT03855189|38201171|FG001|Overall Study|Noncompliance with Protocol|1|||
17057889|NCT03855189|38201172|FG002|Overall Study|Noncompliance with Protocol|0|||
17057890|NCT03855189|38201170|FG000|Overall Study|Did Not Return|4|||
17057891|NCT03855189|38201171|FG001|Overall Study|Did Not Return|3|||
17057892|NCT03855189|38201172|FG002|Overall Study|Did Not Return|0|||
17057893|NCT03853551|38201180|FG000|Overall Study|Death|2|||
17057894|NCT03853551|38201180|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
17057895|NCT00423670|38201191|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
17057896|NCT00423670|38201192|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
17057897|NCT00423670|38201193|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
17057898|NCT00423670|38201194|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
17057899|NCT00423670|38201195|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
17057900|NCT00423670|38201196|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
17057901|NCT00423670|38201197|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
17057902|NCT00423670|38201198|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
17057903|NCT00423670|38201191|FG000|Treatment Period|Adverse Event|8|||
17057904|NCT00423670|38201192|FG001|Treatment Period|Adverse Event|12|||
17057905|NCT00423670|38201193|FG002|Treatment Period|Adverse Event|15|||
17057906|NCT00423670|38201194|FG003|Treatment Period|Adverse Event|20|||
17057907|NCT00423670|38201195|FG004|Treatment Period|Adverse Event|9|||
17057908|NCT00423670|38201196|FG005|Treatment Period|Adverse Event|4|||
17057909|NCT00423670|38201197|FG006|Treatment Period|Adverse Event|7|||
17057910|NCT00423670|38201198|FG007|Treatment Period|Adverse Event|2|||
17057911|NCT00423670|38201191|FG000|Treatment Period|Protocol-defined clinical event|0|||
17057912|NCT00423670|38201192|FG001|Treatment Period|Protocol-defined clinical event|7|||
17057913|NCT00423670|38201193|FG002|Treatment Period|Protocol-defined clinical event|4|||
17057914|NCT00423670|38201194|FG003|Treatment Period|Protocol-defined clinical event|12|||
17057915|NCT00423670|38201195|FG004|Treatment Period|Protocol-defined clinical event|5|||
17057916|NCT00423670|38201196|FG005|Treatment Period|Protocol-defined clinical event|4|||
17057917|NCT00423670|38201197|FG006|Treatment Period|Protocol-defined clinical event|16|||
17057918|NCT00423670|38201198|FG007|Treatment Period|Protocol-defined clinical event|15|||
17057919|NCT00423670|38201191|FG000|Treatment Period|Lost to Follow-up|2|||
17057920|NCT00423670|38201192|FG001|Treatment Period|Lost to Follow-up|1|||
17057921|NCT00423670|38201193|FG002|Treatment Period|Lost to Follow-up|3|||
17057922|NCT00423670|38201194|FG003|Treatment Period|Lost to Follow-up|1|||
17057923|NCT00423670|38201195|FG004|Treatment Period|Lost to Follow-up|6|||
17057924|NCT00423670|38201196|FG005|Treatment Period|Lost to Follow-up|0|||
17057925|NCT00423670|38201197|FG006|Treatment Period|Lost to Follow-up|3|||
17057926|NCT00423670|38201198|FG007|Treatment Period|Lost to Follow-up|1|||
17057927|NCT00423670|38201191|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
17057928|NCT00423670|38201192|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
17057929|NCT00423670|38201193|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
17057930|NCT00423670|38201194|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
17057931|NCT00423670|38201195|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
17057932|NCT00423670|38201196|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
17057933|NCT00423670|38201197|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
17057934|NCT00423670|38201198|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
17057935|NCT00423670|38201191|FG000|Treatment Period|Investigator decision|0|||
17057936|NCT00423670|38201192|FG001|Treatment Period|Investigator decision|0|||
17057937|NCT00423670|38201193|FG002|Treatment Period|Investigator decision|0|||
17057938|NCT00423670|38201194|FG003|Treatment Period|Investigator decision|0|||
17057939|NCT00423670|38201195|FG004|Treatment Period|Investigator decision|0|||
17057940|NCT00423670|38201196|FG005|Treatment Period|Investigator decision|0|||
17057941|NCT00423670|38201197|FG006|Treatment Period|Investigator decision|0|||
17057942|NCT00423670|38201198|FG007|Treatment Period|Investigator decision|1|||
17057943|NCT00423670|38201191|FG000|Treatment Period|Non-compliance with protocol|3|||
17057944|NCT00423670|38201192|FG001|Treatment Period|Non-compliance with protocol|1|||
17057945|NCT00423670|38201193|FG002|Treatment Period|Non-compliance with protocol|1|||
17057946|NCT00423670|38201194|FG003|Treatment Period|Non-compliance with protocol|3|||
17057947|NCT00423670|38201195|FG004|Treatment Period|Non-compliance with protocol|2|||
17057948|NCT00423670|38201196|FG005|Treatment Period|Non-compliance with protocol|0|||
17057949|NCT00423670|38201197|FG006|Treatment Period|Non-compliance with protocol|2|||
17057950|NCT00423670|38201198|FG007|Treatment Period|Non-compliance with protocol|2|||
17057951|NCT00423670|38201191|FG000|Follow-up Period|Lost to Follow-up|0|||
17057952|NCT00423670|38201192|FG001|Follow-up Period|Lost to Follow-up|12|||
17057953|NCT00423670|38201193|FG002|Follow-up Period|Lost to Follow-up|8|||
17057954|NCT00423670|38201194|FG003|Follow-up Period|Lost to Follow-up|3|||
17057955|NCT00423670|38201195|FG004|Follow-up Period|Lost to Follow-up|1|||
17057956|NCT00423670|38201196|FG005|Follow-up Period|Lost to Follow-up|0|||
17057957|NCT00423670|38201197|FG006|Follow-up Period|Lost to Follow-up|5|||
17057958|NCT00423670|38201198|FG007|Follow-up Period|Lost to Follow-up|0|||
17057959|NCT00423670|38201191|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
17057960|NCT00423670|38201192|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
17057961|NCT00423670|38201193|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
17057962|NCT00423670|38201194|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
17057963|NCT00423670|38201195|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
17057964|NCT00423670|38201196|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
17057965|NCT00423670|38201197|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
17057966|NCT00423670|38201198|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
17057967|NCT00423670|38201191|FG000|Follow-up Period|Non-compliance with protocol|2|||
17057968|NCT00423670|38201192|FG001|Follow-up Period|Non-compliance with protocol|0|||
17057969|NCT00423670|38201193|FG002|Follow-up Period|Non-compliance with protocol|1|||
17057970|NCT00423670|38201194|FG003|Follow-up Period|Non-compliance with protocol|1|||
17057971|NCT00423670|38201195|FG004|Follow-up Period|Non-compliance with protocol|0|||
17057972|NCT00423670|38201196|FG005|Follow-up Period|Non-compliance with protocol|0|||
17057973|NCT00423670|38201197|FG006|Follow-up Period|Non-compliance with protocol|3|||
17057974|NCT00423670|38201198|FG007|Follow-up Period|Non-compliance with protocol|2|||
17057975|NCT00483717|38201221|FG000|Overall Study|Protocol Violation|5|||
17057976|NCT00483717|38201222|FG001|Overall Study|Protocol Violation|7|||
17057977|NCT00483717|38201221|FG000|Overall Study|Time of dosing missing|1|||
17057978|NCT00483717|38201222|FG001|Overall Study|Time of dosing missing|1|||
17057979|NCT00483717|38201221|FG000|Overall Study|No treatment for migraine|16|||
17057980|NCT00483717|38201222|FG001|Overall Study|No treatment for migraine|13|||
17057981|NCT00483717|38201221|FG000|Overall Study|Lost to Follow-up|1|||
17057982|NCT00483717|38201222|FG001|Overall Study|Lost to Follow-up|0|||
17057983|NCT00483717|38201221|FG000|Overall Study|Withdrawal by Subject|1|||
17057984|NCT00483717|38201222|FG001|Overall Study|Withdrawal by Subject|0|||
17057985|NCT00406354|38201231|FG000|All Randomized Patients|Protocol Violation|0|||
17057986|NCT00406354|38201232|FG001|All Randomized Patients|Protocol Violation|0|||
17057987|NCT00406354|38201233|FG002|All Randomized Patients|Protocol Violation|1|||
17057988|NCT00406354|38201231|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
17057989|NCT00406354|38201232|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
17057990|NCT00406354|38201233|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
17057991|NCT00406354|38201231|FG000|All Randomized and Treated Patients|Adverse Event|6|||
17057992|NCT00406354|38201232|FG001|All Randomized and Treated Patients|Adverse Event|2|||
17057993|NCT00406354|38201233|FG002|All Randomized and Treated Patients|Adverse Event|1|||
17057994|NCT00406354|38201231|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
17057995|NCT00406354|38201232|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
17057996|NCT00406354|38201233|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
17057997|NCT00406354|38201231|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
17057998|NCT00406354|38201232|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
17057999|NCT00406354|38201233|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
17058000|NCT00406354|38201231|FG000|All Randomized and Treated Patients|Physician Decision|0|||
17058001|NCT00406354|38201232|FG001|All Randomized and Treated Patients|Physician Decision|0|||
17058002|NCT00406354|38201233|FG002|All Randomized and Treated Patients|Physician Decision|1|||
17058003|NCT00483405|38201241|FG000|Overall Study|Adverse Event|8|||
17058004|NCT00483405|38201241|FG000|Overall Study|Lack of Efficacy|14|||
17058005|NCT00483405|38201241|FG000|Overall Study|Death|3|||
17058006|NCT00483405|38201241|FG000|Overall Study|Withdrawal by Subject|2|||
17058007|NCT00483405|38201241|FG000|Overall Study|Other complicating disease|1|||
17058008|NCT00483327|38201249|FG000|Overall Study|Adverse Event|1|||
17058009|NCT00483327|38201249|FG000|Overall Study|Withdrawal by Subject|3|||
17058010|NCT00483327|38201249|FG000|Overall Study|Lost to Follow-up|4|||
17058011|NCT00483327|38201249|FG000|Overall Study|Patient Non Compliance|2|||
17058012|NCT00684203|38201261|FG000|Overall Study|Adverse Event|6|||
17058013|NCT00684203|38201262|FG001|Overall Study|Adverse Event|4|||
17058014|NCT00684203|38201263|FG002|Overall Study|Adverse Event|8|||
17058015|NCT00684203|38201264|FG003|Overall Study|Adverse Event|0|||
17058016|NCT00684203|38201265|FG004|Overall Study|Adverse Event|0|||
17058017|NCT00684203|38201266|FG005|Overall Study|Adverse Event|0|||
17058018|NCT00684203|38201261|FG000|Overall Study|Protocol-defined clinical event|3|||
17058019|NCT00684203|38201262|FG001|Overall Study|Protocol-defined clinical event|1|||
17058020|NCT00684203|38201263|FG002|Overall Study|Protocol-defined clinical event|0|||
17058021|NCT00684203|38201264|FG003|Overall Study|Protocol-defined clinical event|0|||
17058022|NCT00684203|38201265|FG004|Overall Study|Protocol-defined clinical event|0|||
17058023|NCT00684203|38201266|FG005|Overall Study|Protocol-defined clinical event|0|||
17058024|NCT00684203|38201261|FG000|Overall Study|Withdrawal by Subject|0|||
17058025|NCT00684203|38201262|FG001|Overall Study|Withdrawal by Subject|2|||
17058026|NCT00684203|38201263|FG002|Overall Study|Withdrawal by Subject|1|||
17058027|NCT00684203|38201264|FG003|Overall Study|Withdrawal by Subject|0|||
17058028|NCT00684203|38201265|FG004|Overall Study|Withdrawal by Subject|0|||
17058029|NCT00684203|38201266|FG005|Overall Study|Withdrawal by Subject|0|||
17058030|NCT00684203|38201261|FG000|Overall Study|Did not meet protocol eligibility|0|||
17058031|NCT00684203|38201262|FG001|Overall Study|Did not meet protocol eligibility|1|||
17058032|NCT00684203|38201263|FG002|Overall Study|Did not meet protocol eligibility|0|||
17058033|NCT00684203|38201264|FG003|Overall Study|Did not meet protocol eligibility|0|||
17058034|NCT00684203|38201265|FG004|Overall Study|Did not meet protocol eligibility|0|||
17058035|NCT00684203|38201266|FG005|Overall Study|Did not meet protocol eligibility|0|||
17058036|NCT00423592|38201287|FG000|Overall Study|Adverse Event (through Week 12)|2|||
17058037|NCT00423592|38201287|FG000|Overall Study|Adverse Event (post Week 12)|5|||
17058038|NCT00683657|38201293|FG000|Overall Study|Adverse Event|0|||
17058039|NCT00683657|38201294|FG001|Overall Study|Adverse Event|1|||
17058040|NCT00683657|38201293|FG000|Overall Study|Subject Withdrew Consent|1|||
17058041|NCT00683657|38201294|FG001|Overall Study|Subject Withdrew Consent|0|||
17058042|NCT00680771|38201302|FG000|Overall Study|Withdrawal by Subject|1|||
17058043|NCT00680771|38201303|FG001|Overall Study|Withdrawal by Subject|0|||
17058044|NCT00680771|38201302|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
17058045|NCT00680771|38201303|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
17058046|NCT00680771|38201302|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
17058047|NCT00680771|38201303|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
17058048|NCT00482703|38201311|FG000|Overall Study|Poor compliance|1|||
17058049|NCT00482703|38201312|FG001|Overall Study|Poor compliance|0|||
17058050|NCT00482391|38201325|FG000|Overall Study|Withdrawal by Subject|1|||
17058051|NCT00482391|38201325|FG000|Overall Study|Adverse Event|1|||
17058052|NCT00482391|38201325|FG000|Overall Study|Death|1|||
17058053|NCT00423046|38201332|FG000|Overall Study|Other|340|||
17058054|NCT00423046|38201333|FG001|Overall Study|Other|345|||
17058055|NCT00496587|38201341|FG000|Overall Study|Adverse Event|2|||
17058056|NCT00496587|38201341|FG000|Overall Study|Progressive Disease|24|||
17058057|NCT00496587|38201341|FG000|Overall Study|Withdrawal by Subject|2|||
17058058|NCT00496587|38201341|FG000|Overall Study|Death|1|||
17058059|NCT00496587|38201341|FG000|Overall Study|Complications unrelated|2|||
17058060|NCT00405652|38201345|FG000|Overall Study|Adverse Event|4|||
17058061|NCT00422734|38201351|FG000|Overall Study|Physician Decision|1|||
17058062|NCT00422734|38201352|FG001|Overall Study|Physician Decision|1|||
17058063|NCT00422734|38201351|FG000|Overall Study|Protocol Violation|1|||
17058064|NCT00422734|38201352|FG001|Overall Study|Protocol Violation|6|||
17058065|NCT00422734|38201351|FG000|Overall Study|Withdrawal by Subject|12|||
17058066|NCT00422734|38201352|FG001|Overall Study|Withdrawal by Subject|8|||
17058067|NCT00422734|38201351|FG000|Overall Study|Adverse Event|0|||
17058068|NCT00422734|38201352|FG001|Overall Study|Adverse Event|3|||
17058069|NCT00422734|38201351|FG000|Overall Study|Partner Decision|0|||
17058070|NCT00422734|38201352|FG001|Overall Study|Partner Decision|3|||
17058071|NCT00422422|38201358|FG000|Overall Study|Lack of Efficacy|1|||
17058072|NCT00422422|38201358|FG000|Overall Study|Protocol Violation|1|||
17058073|NCT00422422|38201358|FG000|Overall Study|Withdrawal by Subject|2|||
17058074|NCT00422422|38201358|FG000|Overall Study|SAE, non-fatal|1|||
17058075|NCT00422422|38201358|FG000|Overall Study|AE, non-serious non-fatal|5|||
17058076|NCT00413374|38201366|FG000|Overall Study|Ineligible due to screening criteria.|3|||
17058077|NCT00413374|38201367|FG001|Overall Study|Ineligible due to screening criteria.|0|||
17058078|NCT00413374|38201366|FG000|Overall Study|Adverse Event|1|||
17058079|NCT00413374|38201367|FG001|Overall Study|Adverse Event|0|||
17058080|NCT00413374|38201366|FG000|Overall Study|Lost to Follow-up|1|||
17058081|NCT00413374|38201367|FG001|Overall Study|Lost to Follow-up|0|||
17058082|NCT00413374|38201366|FG000|Overall Study|Surgery|1|||
17058083|NCT00413374|38201367|FG001|Overall Study|Surgery|0|||
17058084|NCT00682643|38201378|FG000|Overall Study|Adverse Event|12|||
17058085|NCT00682643|38201379|FG001|Overall Study|Adverse Event|23|||
17058086|NCT00682643|38201378|FG000|Overall Study|Lack of Efficacy|2|||
17058087|NCT00682643|38201379|FG001|Overall Study|Lack of Efficacy|0|||
17058088|NCT00682643|38201378|FG000|Overall Study|Protocol Violation|38|||
17058089|NCT00682643|38201379|FG001|Overall Study|Protocol Violation|76|||
17058090|NCT00682643|38201378|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
17058091|NCT00682643|38201379|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
17058092|NCT00682643|38201378|FG000|Overall Study|Lost to Follow-up|1|||
17058093|NCT00682643|38201379|FG001|Overall Study|Lost to Follow-up|6|||
17058094|NCT00682643|38201378|FG000|Overall Study|Physician Decision|2|||
17058095|NCT00682643|38201379|FG001|Overall Study|Physician Decision|6|||
17058096|NCT00682643|38201378|FG000|Overall Study|Withdrawal by Subject|19|||
17058097|NCT00682643|38201379|FG001|Overall Study|Withdrawal by Subject|53|||
17058098|NCT00682643|38201378|FG000|Overall Study|Did Not Receive Study Drug|1|||
17058099|NCT00682643|38201379|FG001|Overall Study|Did Not Receive Study Drug|1|||
17058100|NCT00421408|38201388|FG000|Overall Study|Lost to Follow-up|30|||
17058101|NCT00421408|38201389|FG001|Overall Study|Lost to Follow-up|20|||
17058102|NCT00421408|38201388|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
17058103|NCT00421408|38201389|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
17058104|NCT00679913|38201397|FG000|Overall Study|Protocol Violation|18|||
17058105|NCT00679913|38201398|FG001|Overall Study|Protocol Violation|13|||
17058106|NCT00482001|38201415|FG000|Overall Study|Protocol Violation|1|||
17058107|NCT00482001|38201416|FG001|Overall Study|Protocol Violation|1|||
17058108|NCT00490035|38201428|FG000|Overall Study|AE, non-serious non-fatal|3|||
17058109|NCT00490035|38201429|FG001|Overall Study|AE, non-serious non-fatal|4|||
17058110|NCT00490035|38201430|FG002|Overall Study|AE, non-serious non-fatal|4|||
17058111|NCT00490035|38201431|FG003|Overall Study|AE, non-serious non-fatal|5|||
17058112|NCT00490035|38201428|FG000|Overall Study|Lost to Follow-up|2|||
17058113|NCT00490035|38201429|FG001|Overall Study|Lost to Follow-up|0|||
17058114|NCT00490035|38201430|FG002|Overall Study|Lost to Follow-up|1|||
17058115|NCT00490035|38201431|FG003|Overall Study|Lost to Follow-up|0|||
17058116|NCT00490035|38201428|FG000|Overall Study|Withdrawal by Subject|2|||
17058117|NCT00490035|38201429|FG001|Overall Study|Withdrawal by Subject|1|||
17058118|NCT00490035|38201430|FG002|Overall Study|Withdrawal by Subject|1|||
17058119|NCT00490035|38201431|FG003|Overall Study|Withdrawal by Subject|0|||
17058120|NCT00490035|38201428|FG000|Overall Study|Other reason|0|||
17058121|NCT00490035|38201429|FG001|Overall Study|Other reason|1|||
17058122|NCT00490035|38201430|FG002|Overall Study|Other reason|3|||
17058123|NCT00490035|38201431|FG003|Overall Study|Other reason|1|||
17058124|NCT00490035|38201428|FG000|Overall Study|AE, serious fatal|1|||
17058125|NCT00490035|38201429|FG001|Overall Study|AE, serious fatal|0|||
17058126|NCT00490035|38201430|FG002|Overall Study|AE, serious fatal|0|||
17058127|NCT00490035|38201431|FG003|Overall Study|AE, serious fatal|0|||
17058128|NCT00490035|38201428|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
17058129|NCT00490035|38201429|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
17058130|NCT00490035|38201430|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
17058131|NCT00490035|38201431|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
17058132|NCT00490035|38201428|FG000|Overall Study|AE of unknown type|0|||
17058133|NCT00490035|38201429|FG001|Overall Study|AE of unknown type|0|||
17058134|NCT00490035|38201430|FG002|Overall Study|AE of unknown type|2|||
17058135|NCT00490035|38201431|FG003|Overall Study|AE of unknown type|0|||
17058136|NCT00404248|38201444|FG000|Overall Study|pts declining status|0|||
17058137|NCT00404248|38201445|FG001|Overall Study|pts declining status|1|||
17058138|NCT00404248|38201446|FG002|Overall Study|pts declining status|0|||
17058139|NCT00404248|38201447|FG003|Overall Study|pts declining status|0|||
17058140|NCT00404248|38201448|FG004|Overall Study|pts declining status|0|||
17058141|NCT00404248|38201449|FG005|Overall Study|pts declining status|0|||
17058142|NCT00404248|38201450|FG006|Overall Study|pts declining status|0|||
17058143|NCT00404248|38201451|FG007|Overall Study|pts declining status|0|||
17058144|NCT00404248|38201452|FG008|Overall Study|pts declining status|0|||
17058145|NCT00421174|38201480|FG000|Overall Study|Withdrawal by Subject|0|||
17058146|NCT00421174|38201481|FG001|Overall Study|Withdrawal by Subject|1|||
17058147|NCT00421174|38201480|FG000|Overall Study|Ineligible due to infection|2|||
17058148|NCT00421174|38201481|FG001|Overall Study|Ineligible due to infection|0|||
17058149|NCT00496197|38201487|FG000|Overall Study|Discontinued study due to death|43|||
17058150|NCT00496197|38201487|FG000|Overall Study|Adverse Event|13|||
17058151|NCT00496197|38201487|FG000|Overall Study|Does not meet entrance criteria|5|||
17058152|NCT00496197|38201487|FG000|Overall Study|Insufficient clinical response|3|||
17058153|NCT00496197|38201487|FG000|Overall Study|Insufficient bacteriological response|10|||
17058154|NCT00496197|38201487|FG000|Overall Study|Lost to Follow-up|11|||
17058155|NCT00496197|38201487|FG000|Overall Study|Withdrawal by Subject|11|||
17058156|NCT00496197|38201487|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
17058157|NCT00496197|38201487|FG000|Overall Study|Other|14|||
17058158|NCT00496197|38201487|FG000|Overall Study|Protocol Violation|8|||
17058159|NCT00495495|38201491|FG000|Overall Study|Protocol Violation|99|||
17058160|NCT00404092|38201500|FG000|Overall Study|Death|1|||
17058161|NCT00404092|38201501|FG001|Overall Study|Death|0|||
17058162|NCT00404092|38201502|FG002|Overall Study|Death|0|||
17058163|NCT00404092|38201503|FG003|Overall Study|Death|0|||
17058164|NCT00404092|38201500|FG000|Overall Study|Adverse Event|0|||
17058165|NCT00404092|38201501|FG001|Overall Study|Adverse Event|0|||
17058166|NCT00404092|38201502|FG002|Overall Study|Adverse Event|1|||
17058167|NCT00404092|38201503|FG003|Overall Study|Adverse Event|0|||
17058168|NCT00481767|38201515|FG000|Overall Study|Withdrawal by Subject|16|||
17058169|NCT00481767|38201516|FG001|Overall Study|Withdrawal by Subject|11|||
17058170|NCT00481767|38201515|FG000|Overall Study|Lost to Follow-up|16|||
17058171|NCT00481767|38201516|FG001|Overall Study|Lost to Follow-up|10|||
17058172|NCT00489489|38201525|FG000|Overall Study|Not treated due to protocol violation|0|||
17058173|NCT00489489|38201526|FG001|Overall Study|Not treated due to protocol violation|1|||
17058174|NCT00489489|38201527|FG002|Overall Study|Not treated due to protocol violation|1|||
17058175|NCT00489489|38201525|FG000|Overall Study|Adverse Event|1|||
17058176|NCT00489489|38201526|FG001|Overall Study|Adverse Event|1|||
16993098|NCT00718861|38137138|FG001|Overall Study|Withdrawal by Subject|10|||
16993099|NCT00718861|38137137|FG000|Overall Study|Adverse Event|2|||
16993100|NCT00718861|38137138|FG001|Overall Study|Adverse Event|1|||
16993101|NCT00718861|38137137|FG000|Overall Study|Lost to Follow-up|2|||
16993102|NCT00718861|38137138|FG001|Overall Study|Lost to Follow-up|1|||
16993103|NCT00718861|38137137|FG000|Overall Study|Administrative Problems|1|||
16993104|NCT00718861|38137138|FG001|Overall Study|Administrative Problems|1|||
16993105|NCT00718861|38137137|FG000|Overall Study|Death|1|||
16993106|NCT00718861|38137138|FG001|Overall Study|Death|5|||
16993107|NCT01016600|38137148|FG000|Overall Study|Did not start treatment|1|||
16993108|NCT01016600|38137149|FG001|Overall Study|Did not start treatment|0|||
16993109|NCT01016600|38137150|FG002|Overall Study|Did not start treatment|0|||
16993110|NCT01016600|38137151|FG003|Overall Study|Did not start treatment|0|||
16993111|NCT01016132|38137162|FG000|Overall Study|Discomfort|1|||
16993112|NCT01015820|38137168|FG000|Overall Study|Suboptimal measurements|1|||
16993113|NCT01015820|38137169|FG001|Overall Study|Suboptimal measurements|0|||
16993114|NCT01010204|38137192|FG000|Overall Study|Lost to Follow-up|2|||
16993115|NCT01010204|38137193|FG001|Overall Study|Lost to Follow-up|2|||
16993116|NCT01010204|38137192|FG000|Overall Study|Adverse Event|1|||
16993117|NCT01010204|38137193|FG001|Overall Study|Adverse Event|3|||
16993118|NCT01010204|38137192|FG000|Overall Study|Withdrawal by Subject|2|||
16993119|NCT01010204|38137193|FG001|Overall Study|Withdrawal by Subject|3|||
16993120|NCT01010204|38137192|FG000|Overall Study|psychiatric hospitalization|2|||
16993121|NCT01010204|38137193|FG001|Overall Study|psychiatric hospitalization|1|||
16993122|NCT00718549|38137199|FG000|Induction Phase|Disease Progression|1|||
16993123|NCT00718549|38137200|FG001|Induction Phase|Disease Progression|0|||
16993124|NCT00718549|38137201|FG002|Induction Phase|Disease Progression|0|||
16993125|NCT00718549|38137199|FG000|Induction Phase|Eligibility Criteria Violation|2|||
16993126|NCT00718549|38137200|FG001|Induction Phase|Eligibility Criteria Violation|0|||
16993127|NCT00718549|38137201|FG002|Induction Phase|Eligibility Criteria Violation|0|||
17058177|NCT00489489|38201527|FG002|Overall Study|Adverse Event|1|||
17058178|NCT00489489|38201525|FG000|Overall Study|Protocol Violation|1|||
17058179|NCT00489489|38201526|FG001|Overall Study|Protocol Violation|0|||
17058180|NCT00489489|38201527|FG002|Overall Study|Protocol Violation|1|||
16993128|NCT00718549|38137199|FG000|Induction Phase|Early Termination - No Additional Info|59|||
17058181|NCT00489489|38201525|FG000|Overall Study|Progressive disease|0|||
17058182|NCT00489489|38201526|FG001|Overall Study|Progressive disease|1|||
17058183|NCT00489489|38201527|FG002|Overall Study|Progressive disease|0|||
17058184|NCT00489489|38201525|FG000|Overall Study|Participant did not wish to continue|1|||
17058185|NCT00489489|38201526|FG001|Overall Study|Participant did not wish to continue|1|||
17058186|NCT00489489|38201527|FG002|Overall Study|Participant did not wish to continue|0|||
17058187|NCT00489489|38201525|FG000|Overall Study|Other than above|0|||
17058188|NCT00489489|38201526|FG001|Overall Study|Other than above|1|||
17058189|NCT00489489|38201527|FG002|Overall Study|Other than above|0|||
17058190|NCT00489411|38201539|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
17058191|NCT00489411|38201540|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
17058192|NCT00489411|38201539|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
17058193|NCT00489411|38201540|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
17058194|NCT00489411|38201539|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
17058195|NCT00489411|38201540|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
16993129|NCT00718549|38137200|FG001|Induction Phase|Early Termination - No Additional Info|0|||
16993130|NCT00718549|38137201|FG002|Induction Phase|Early Termination - No Additional Info|0|||
16993131|NCT00718549|38137199|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
17058196|NCT00489411|38201539|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
17058197|NCT00489411|38201540|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
17058198|NCT00489411|38201539|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
17058199|NCT00489411|38201540|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
17058200|NCT00420784|38201550|FG000|Overall Study|Adverse Event|11|||
17058201|NCT00420784|38201551|FG001|Overall Study|Adverse Event|29|||
17058202|NCT00420784|38201552|FG002|Overall Study|Adverse Event|10|||
17058203|NCT00420784|38201553|FG003|Overall Study|Adverse Event|5|||
17058204|NCT00420784|38201550|FG000|Overall Study|Withdrawal by Subject|0|||
17058205|NCT00420784|38201551|FG001|Overall Study|Withdrawal by Subject|1|||
17058206|NCT00420784|38201552|FG002|Overall Study|Withdrawal by Subject|0|||
17058207|NCT00420784|38201553|FG003|Overall Study|Withdrawal by Subject|0|||
17058208|NCT00420784|38201550|FG000|Overall Study|Lost to Follow-up|0|||
17058209|NCT00420784|38201551|FG001|Overall Study|Lost to Follow-up|0|||
17058210|NCT00420784|38201552|FG002|Overall Study|Lost to Follow-up|2|||
17058211|NCT00420784|38201553|FG003|Overall Study|Lost to Follow-up|1|||
17058212|NCT00420784|38201550|FG000|Overall Study|Virologic Stopping Rule|17|||
17058213|NCT00420784|38201551|FG001|Overall Study|Virologic Stopping Rule|26|||
17058214|NCT00420784|38201552|FG002|Overall Study|Virologic Stopping Rule|41|||
17058215|NCT00420784|38201553|FG003|Overall Study|Virologic Stopping Rule|67|||
17058216|NCT00420784|38201550|FG000|Overall Study|Other|1|||
17058217|NCT00420784|38201551|FG001|Overall Study|Other|2|||
17058218|NCT00420784|38201552|FG002|Overall Study|Other|0|||
17058219|NCT00420784|38201553|FG003|Overall Study|Other|5|||
17058220|NCT00420628|38201566|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
17058221|NCT00420628|38201567|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
17058222|NCT00420628|38201566|FG000|Overall Study|Lost to Follow-up|3|||
17058223|NCT00420628|38201567|FG001|Overall Study|Lost to Follow-up|2|||
17058224|NCT00420628|38201566|FG000|Overall Study|Adverse Event|1|||
17058225|NCT00420628|38201567|FG001|Overall Study|Adverse Event|0|||
17058226|NCT00489255|38201575|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
17058227|NCT00489255|38201576|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
17058228|NCT00489255|38201575|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
17058229|NCT00489255|38201576|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
17058230|NCT00489255|38201575|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
17058231|NCT00489255|38201576|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
17058232|NCT00489255|38201575|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
17058233|NCT00489255|38201576|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
17058234|NCT00489255|38201575|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
17058235|NCT00489255|38201576|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
17058236|NCT00489255|38201575|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
17058237|NCT00489255|38201576|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
17058238|NCT00489255|38201575|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
17058239|NCT00489255|38201576|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
17058240|NCT00489255|38201575|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
17058241|NCT00489255|38201576|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
17058242|NCT00489255|38201575|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
17058243|NCT00489255|38201576|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
17058244|NCT00489255|38201575|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
17058245|NCT00489255|38201576|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
17058246|NCT00413218|38201584|FG000|Overall Study|Randomized but didn't receive study drug|2|||
17058247|NCT00413218|38201585|FG001|Overall Study|Randomized but didn't receive study drug|8|||
17058248|NCT00413218|38201584|FG000|Overall Study|Death|57|||
17058249|NCT00413218|38201585|FG001|Overall Study|Death|56|||
17058250|NCT00413218|38201584|FG000|Overall Study|Lost to Follow-up|14|||
17058251|NCT00413218|38201585|FG001|Overall Study|Lost to Follow-up|17|||
17058252|NCT00413218|38201584|FG000|Overall Study|Admin|20|||
17058253|NCT00413218|38201585|FG001|Overall Study|Admin|14|||
17058254|NCT00413218|38201584|FG000|Overall Study|Missing|1|||
17058255|NCT00413218|38201585|FG001|Overall Study|Missing|0|||
17058256|NCT00413218|38201584|FG000|Overall Study|Withdrawal by Subject|9|||
17058257|NCT00413218|38201585|FG001|Overall Study|Withdrawal by Subject|1|||
17058258|NCT00420316|38201594|FG000|Overall Study|Withdrawal by Subject|0|||
17058259|NCT00420316|38201595|FG001|Overall Study|Withdrawal by Subject|1|||
17058260|NCT00420316|38201594|FG000|Overall Study|Lost to Follow-up|12|||
17058261|NCT00420316|38201595|FG001|Overall Study|Lost to Follow-up|8|||
17058262|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
17058263|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
17058264|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
17058265|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
17058266|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Death|8|||
17058267|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Death|3|||
17058268|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
17058269|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
17058270|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
17058271|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
17058272|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
17058273|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
17058274|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
17058275|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
17058276|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
17058277|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
17058278|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
17058279|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
17058280|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
17058281|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
17058282|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
17058283|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
17058284|NCT00494871|38201603|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
17058285|NCT00494871|38201604|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
17058286|NCT00494871|38201603|FG000|Follow-up (FU) Period|Adverse Event|1|||
17058287|NCT00494871|38201604|FG001|Follow-up (FU) Period|Adverse Event|1|||
17058288|NCT00494871|38201603|FG000|Follow-up (FU) Period|Death|13|||
17058289|NCT00494871|38201604|FG001|Follow-up (FU) Period|Death|12|||
17058290|NCT00494871|38201603|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
17058291|NCT00494871|38201604|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
17058292|NCT00494871|38201603|FG000|Follow-up (FU) Period|Physician Decision|0|||
17058293|NCT00494871|38201604|FG001|Follow-up (FU) Period|Physician Decision|1|||
17058294|NCT00494871|38201603|FG000|Follow-up (FU) Period|Protocol Violation|1|||
17058295|NCT00494871|38201604|FG001|Follow-up (FU) Period|Protocol Violation|0|||
17058296|NCT00494871|38201603|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
17058297|NCT00494871|38201604|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
17058298|NCT00494871|38201603|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
17058299|NCT00494871|38201604|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
17058300|NCT00420238|38201614|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
17058301|NCT00420238|38201615|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
17058302|NCT00420238|38201614|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
17058303|NCT00420238|38201615|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
17058304|NCT00420238|38201614|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
17058305|NCT00420238|38201615|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
17058306|NCT00420238|38201614|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
17058307|NCT00420238|38201615|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
17058308|NCT00420238|38201614|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
17058309|NCT00420238|38201615|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
17058310|NCT00420238|38201614|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
17058311|NCT00420238|38201615|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
17058312|NCT00420004|38201630|FG000|Overall Study|Adverse Event|4|||
17058313|NCT00420004|38201631|FG001|Overall Study|Adverse Event|1|||
17058314|NCT00420004|38201632|FG002|Overall Study|Adverse Event|1|||
17058315|NCT00420004|38201630|FG000|Overall Study|Lack of Efficacy|5|||
17058316|NCT00420004|38201631|FG001|Overall Study|Lack of Efficacy|4|||
17058317|NCT00420004|38201632|FG002|Overall Study|Lack of Efficacy|1|||
17058318|NCT00420004|38201630|FG000|Overall Study|Lost to Follow-up|31|||
17058319|NCT00420004|38201631|FG001|Overall Study|Lost to Follow-up|12|||
17058320|NCT00420004|38201632|FG002|Overall Study|Lost to Follow-up|10|||
17058321|NCT00420004|38201630|FG000|Overall Study|Entry Criteria Not Met|0|||
17058322|NCT00420004|38201631|FG001|Overall Study|Entry Criteria Not Met|1|||
17058323|NCT00420004|38201632|FG002|Overall Study|Entry Criteria Not Met|0|||
17058324|NCT00420004|38201630|FG000|Overall Study|Physician Decision|14|||
17058325|NCT00420004|38201631|FG001|Overall Study|Physician Decision|4|||
17058326|NCT00420004|38201632|FG002|Overall Study|Physician Decision|2|||
17058327|NCT00420004|38201630|FG000|Overall Study|Protocol Violation|5|||
17058328|NCT00420004|38201631|FG001|Overall Study|Protocol Violation|4|||
17058329|NCT00420004|38201632|FG002|Overall Study|Protocol Violation|3|||
17058330|NCT00420004|38201630|FG000|Overall Study|Withdrawal by Subject|67|||
17058331|NCT00420004|38201631|FG001|Overall Study|Withdrawal by Subject|42|||
17058332|NCT00420004|38201632|FG002|Overall Study|Withdrawal by Subject|14|||
17058333|NCT00420004|38201630|FG000|Overall Study|Sponsor Decision|3|||
17058334|NCT00420004|38201631|FG001|Overall Study|Sponsor Decision|3|||
17058335|NCT00420004|38201632|FG002|Overall Study|Sponsor Decision|1|||
17058336|NCT00494481|38201646|FG000|Overall Study|Condition under investigation worsened|11|||
17058337|NCT00494481|38201647|FG001|Overall Study|Condition under investigation worsened|13|||
17058338|NCT00494481|38201646|FG000|Overall Study|Adverse Event|15|||
17058339|NCT00494481|38201647|FG001|Overall Study|Adverse Event|11|||
17058340|NCT00494481|38201646|FG000|Overall Study|Other|1|||
17145072|NCT01150890|38288936|FG000|Overall Study|Withdrawal by Subject|0|||
17145073|NCT01150890|38288937|FG001|Overall Study|Withdrawal by Subject|0|||
17145074|NCT01150890|38288938|FG002|Overall Study|Withdrawal by Subject|2|||
17145075|NCT01150890|38288939|FG003|Overall Study|Withdrawal by Subject|1|||
17145076|NCT01150890|38288936|FG000|Overall Study|Disease progression|0|||
17145077|NCT01150890|38288937|FG001|Overall Study|Disease progression|7|||
17145078|NCT01150890|38288938|FG002|Overall Study|Disease progression|3|||
17145079|NCT01150890|38288939|FG003|Overall Study|Disease progression|7|||
17145080|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Adverse Event|2|||
17145081|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Adverse Event|0|||
17145082|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Adverse Event|0|||
17145083|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Adverse Event|0|||
17145084|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
17145085|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
17145086|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
17145087|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
17145088|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
17145089|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
17145090|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
17145091|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
17145092|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Physician Decision|1|||
17145093|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Physician Decision|0|||
17145094|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Physician Decision|0|||
17145095|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Physician Decision|0|||
17058341|NCT00494481|38201647|FG001|Overall Study|Other|0|||
17145096|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Pregnancy|1|||
17058342|NCT00494481|38201646|FG000|Overall Study|Never received IP|2|||
17058343|NCT00494481|38201647|FG001|Overall Study|Never received IP|0|||
17058344|NCT00097591|38201655|FG000|Overall Study|Withdrawal of consent|342|||
16993132|NCT00718549|38137200|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
16993133|NCT00718549|38137201|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
16993134|NCT00718549|38137199|FG000|Maintenance/ Observation Phase|Death|0|||
16993135|NCT00718549|38137200|FG001|Maintenance/ Observation Phase|Death|1|||
16993136|NCT00718549|38137201|FG002|Maintenance/ Observation Phase|Death|2|||
16993137|NCT00718549|38137199|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
16993138|NCT00718549|38137200|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
16993139|NCT00718549|38137201|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
16993140|NCT00718549|38137199|FG000|Maintenance/ Observation Phase|Progression|0|||
16993141|NCT00718549|38137200|FG001|Maintenance/ Observation Phase|Progression|5|||
16993142|NCT00718549|38137201|FG002|Maintenance/ Observation Phase|Progression|14|||
16993143|NCT00718549|38137199|FG000|Maintenance/ Observation Phase|Relapse|0|||
16993144|NCT00718549|38137200|FG001|Maintenance/ Observation Phase|Relapse|3|||
16993145|NCT00718549|38137201|FG002|Maintenance/ Observation Phase|Relapse|2|||
16993146|NCT00793624|38137218|FG000|Overall Study|Adverse Event|18|||
16993147|NCT00793624|38137219|FG001|Overall Study|Adverse Event|16|||
16993148|NCT00793624|38137220|FG002|Overall Study|Adverse Event|15|||
16993149|NCT00793624|38137221|FG003|Overall Study|Adverse Event|20|||
16993150|NCT00793624|38137218|FG000|Overall Study|Lost to Follow-up|2|||
16993151|NCT00793624|38137219|FG001|Overall Study|Lost to Follow-up|2|||
16993152|NCT00793624|38137220|FG002|Overall Study|Lost to Follow-up|4|||
16993153|NCT00793624|38137221|FG003|Overall Study|Lost to Follow-up|0|||
16993154|NCT00793624|38137218|FG000|Overall Study|Withdrawal by Subject|20|||
16993155|NCT00793624|38137219|FG001|Overall Study|Withdrawal by Subject|9|||
16993156|NCT00793624|38137220|FG002|Overall Study|Withdrawal by Subject|11|||
16993157|NCT00793624|38137221|FG003|Overall Study|Withdrawal by Subject|14|||
16993158|NCT00793624|38137218|FG000|Overall Study|Lack of Efficacy|9|||
16993159|NCT00793624|38137219|FG001|Overall Study|Lack of Efficacy|2|||
16993160|NCT00793624|38137220|FG002|Overall Study|Lack of Efficacy|1|||
16993161|NCT00793624|38137221|FG003|Overall Study|Lack of Efficacy|3|||
16993162|NCT00793624|38137218|FG000|Overall Study|Non compliance with protocol|2|||
16993163|NCT00793624|38137219|FG001|Overall Study|Non compliance with protocol|3|||
16993164|NCT00793624|38137220|FG002|Overall Study|Non compliance with protocol|2|||
16993165|NCT00793624|38137221|FG003|Overall Study|Non compliance with protocol|3|||
16993166|NCT00793624|38137218|FG000|Overall Study|Other reason not described above|6|||
16993167|NCT00793624|38137219|FG001|Overall Study|Other reason not described above|4|||
17058345|NCT00097591|38201656|FG001|Overall Study|Withdrawal of consent|323|||
17058346|NCT00097591|38201655|FG000|Overall Study|Less than 6 months on study drug|9|||
17058347|NCT00097591|38201656|FG001|Overall Study|Less than 6 months on study drug|7|||
17058348|NCT00097591|38201655|FG000|Overall Study|Unable to attend termination visit|53|||
17058349|NCT00097591|38201656|FG001|Overall Study|Unable to attend termination visit|51|||
17145097|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Pregnancy|0|||
17058350|NCT00097591|38201655|FG000|Overall Study|Lost to follow up|6|||
17058351|NCT00097591|38201656|FG001|Overall Study|Lost to follow up|10|||
17058352|NCT00097591|38201655|FG000|Overall Study|Other|0|||
17058353|NCT00097591|38201656|FG001|Overall Study|Other|3|||
17058354|NCT00419926|38201664|FG000|Overall Study|Withdrawal by Subject|7|||
17058355|NCT00419926|38201665|FG001|Overall Study|Withdrawal by Subject|3|||
17058356|NCT00419926|38201664|FG000|Overall Study|Administrative Problem|4|||
17058357|NCT00419926|38201665|FG001|Overall Study|Administrative Problem|4|||
17058358|NCT00419926|38201664|FG000|Overall Study|Lost to Follow-up|1|||
17058359|NCT00419926|38201665|FG001|Overall Study|Lost to Follow-up|2|||
17145098|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Pregnancy|0|||
17145099|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Pregnancy|0|||
17145100|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
17145101|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
17145102|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
17058360|NCT00419926|38201664|FG000|Overall Study|Death|2|||
17058361|NCT00419926|38201665|FG001|Overall Study|Death|1|||
17058362|NCT00419770|38201673|FG000|Overall Study|Withdrawal by Subject|5|||
17058363|NCT00419770|38201674|FG001|Overall Study|Withdrawal by Subject|1|||
17058364|NCT00080119|38201684|FG000|Overall Study|Discontinued because of study closure|0|||
17058365|NCT00080119|38201685|FG001|Overall Study|Discontinued because of study closure|0|||
17145103|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
17145104|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
17145105|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
17145106|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
17145107|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
17145108|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
17145109|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
17145110|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
17145111|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
17145112|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
17058366|NCT00080119|38201686|FG002|Overall Study|Discontinued because of study closure|130|||
17058367|NCT00080119|38201687|FG003|Overall Study|Discontinued because of study closure|141|||
17058368|NCT00080119|38201684|FG000|Overall Study|Unable to get to clinic|24|||
17058369|NCT00080119|38201685|FG001|Overall Study|Unable to get to clinic|24|||
17058370|NCT00080119|38201686|FG002|Overall Study|Unable to get to clinic|7|||
17058371|NCT00080119|38201687|FG003|Overall Study|Unable to get to clinic|1|||
17058372|NCT00080119|38201684|FG000|Overall Study|Consent withdrawn|13|||
17058373|NCT00080119|38201685|FG001|Overall Study|Consent withdrawn|17|||
17058374|NCT00080119|38201686|FG002|Overall Study|Consent withdrawn|4|||
17058375|NCT00080119|38201687|FG003|Overall Study|Consent withdrawn|6|||
17058376|NCT00080119|38201684|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
17058377|NCT00080119|38201685|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
17058378|NCT00080119|38201686|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
17058379|NCT00080119|38201687|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
17058380|NCT00080119|38201684|FG000|Overall Study|Lost to Follow-up|16|||
17058381|NCT00080119|38201685|FG001|Overall Study|Lost to Follow-up|19|||
17058382|NCT00080119|38201686|FG002|Overall Study|Lost to Follow-up|19|||
17058383|NCT00080119|38201687|FG003|Overall Study|Lost to Follow-up|14|||
17058384|NCT00419380|38201701|FG000|Overall Study|Lack of Efficacy|1|||
17058385|NCT00419380|38201702|FG001|Overall Study|Lack of Efficacy|7|||
17145113|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
17058386|NCT00419380|38201701|FG000|Overall Study|Physician Decision|0|||
17058387|NCT00419380|38201702|FG001|Overall Study|Physician Decision|1|||
17058388|NCT00419380|38201701|FG000|Overall Study|Lost to Follow-up|0|||
17058389|NCT00419380|38201702|FG001|Overall Study|Lost to Follow-up|1|||
17058390|NCT00419380|38201701|FG000|Overall Study|Withdrawal by Subject|0|||
17058391|NCT00419380|38201702|FG001|Overall Study|Withdrawal by Subject|1|||
17058392|NCT00413062|38201710|FG000|Overall Study|Adverse event/serious adverse event|289|||
17058393|NCT00413062|38201711|FG001|Overall Study|Adverse event/serious adverse event|56|||
17058394|NCT00413062|38201710|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
17058395|NCT00413062|38201711|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
17058396|NCT00413062|38201710|FG000|Overall Study|Withdrawal of informed consent|111|||
17058397|NCT00413062|38201711|FG001|Overall Study|Withdrawal of informed consent|36|||
17058398|NCT00413062|38201710|FG000|Overall Study|Pregnancy|15|||
17058399|NCT00413062|38201711|FG001|Overall Study|Pregnancy|5|||
17058400|NCT00413062|38201710|FG000|Overall Study|Pregnancy wish|17|||
17058401|NCT00413062|38201711|FG001|Overall Study|Pregnancy wish|6|||
17058402|NCT00413062|38201710|FG000|Overall Study|Lost to Follow-up|175|||
17058403|NCT00413062|38201711|FG001|Overall Study|Lost to Follow-up|73|||
17058404|NCT00413062|38201710|FG000|Overall Study|Other reason|70|||
17058405|NCT00413062|38201711|FG001|Overall Study|Other reason|34|||
17058406|NCT00494091|38201721|FG000|Overall Study|Death|5|||
17058407|NCT00494091|38201722|FG001|Overall Study|Death|54|||
17058408|NCT00494091|38201721|FG000|Overall Study|Lost to Follow-up|0|||
17058409|NCT00494091|38201722|FG001|Overall Study|Lost to Follow-up|4|||
17058410|NCT00494091|38201721|FG000|Overall Study|Other|1|||
17058411|NCT00494091|38201722|FG001|Overall Study|Other|11|||
17058412|NCT00494091|38201721|FG000|Overall Study|Withdrawal by Subject|0|||
17058413|NCT00494091|38201722|FG001|Overall Study|Withdrawal by Subject|7|||
17058414|NCT00494013|38201731|FG000|Overall Study|Adverse Event|0|||
17058415|NCT00494013|38201732|FG001|Overall Study|Adverse Event|1|||
17058416|NCT00494013|38201731|FG000|Overall Study|Entry Criteria Not Met|1|||
17058417|NCT00494013|38201732|FG001|Overall Study|Entry Criteria Not Met|4|||
17058418|NCT00494013|38201731|FG000|Overall Study|Lost to Follow-up|5|||
17058419|NCT00494013|38201732|FG001|Overall Study|Lost to Follow-up|6|||
17058420|NCT00494013|38201731|FG000|Overall Study|Physician Decision|3|||
17058421|NCT00494013|38201732|FG001|Overall Study|Physician Decision|5|||
17058422|NCT00494013|38201731|FG000|Overall Study|Protocol Violation|8|||
17058423|NCT00494013|38201732|FG001|Overall Study|Protocol Violation|5|||
17058424|NCT00494013|38201731|FG000|Overall Study|Withdrawal by Subject|13|||
17058425|NCT00494013|38201732|FG001|Overall Study|Withdrawal by Subject|14|||
17058426|NCT00494013|38201731|FG000|Overall Study|Sponsor Decision|0|||
17058427|NCT00494013|38201732|FG001|Overall Study|Sponsor Decision|1|||
17058428|NCT00079339|38201741|FG000|Overall Study|Adverse Event|1|||
17058429|NCT00079339|38201742|FG001|Overall Study|Adverse Event|7|||
17058430|NCT00079339|38201743|FG002|Overall Study|Adverse Event|2|||
17058431|NCT00079339|38201741|FG000|Overall Study|Death|1|||
17058432|NCT00079339|38201742|FG001|Overall Study|Death|0|||
17058433|NCT00079339|38201743|FG002|Overall Study|Death|0|||
17058434|NCT00079339|38201741|FG000|Overall Study|Non-compliance|0|||
17058435|NCT00079339|38201742|FG001|Overall Study|Non-compliance|0|||
17058436|NCT00079339|38201743|FG002|Overall Study|Non-compliance|1|||
17058437|NCT00079339|38201741|FG000|Overall Study|Withdrawal by Subject|0|||
17058438|NCT00079339|38201742|FG001|Overall Study|Withdrawal by Subject|4|||
17058439|NCT00079339|38201743|FG002|Overall Study|Withdrawal by Subject|1|||
17058440|NCT00079339|38201741|FG000|Overall Study|Disease progression|3|||
17058441|NCT00079339|38201742|FG001|Overall Study|Disease progression|28|||
17058442|NCT00079339|38201743|FG002|Overall Study|Disease progression|2|||
17058443|NCT00493779|38201756|FG000|Overall Study|Logistical issue at site|1|||
17058444|NCT00541866|38201766|FG000|Overall Study|Adverse Event|3|||
17058445|NCT00541866|38201767|FG001|Overall Study|Adverse Event|0|||
17058446|NCT00541866|38201768|FG002|Overall Study|Adverse Event|0|||
17058447|NCT00541866|38201769|FG003|Overall Study|Adverse Event|0|||
17058448|NCT00541866|38201770|FG004|Overall Study|Adverse Event|0|||
17058449|NCT00541866|38201766|FG000|Overall Study|Death|1|||
17058450|NCT00541866|38201767|FG001|Overall Study|Death|0|||
17058451|NCT00541866|38201768|FG002|Overall Study|Death|0|||
17058452|NCT00541866|38201769|FG003|Overall Study|Death|0|||
17058453|NCT00541866|38201770|FG004|Overall Study|Death|0|||
17058454|NCT00541866|38201766|FG000|Overall Study|Lack of Efficacy|19|||
17058455|NCT00541866|38201767|FG001|Overall Study|Lack of Efficacy|15|||
17058456|NCT00541866|38201768|FG002|Overall Study|Lack of Efficacy|10|||
17058457|NCT00541866|38201769|FG003|Overall Study|Lack of Efficacy|12|||
17058458|NCT00541866|38201770|FG004|Overall Study|Lack of Efficacy|14|||
17058459|NCT00541866|38201766|FG000|Overall Study|Not Reported or Other|11|||
17058460|NCT00541866|38201767|FG001|Overall Study|Not Reported or Other|3|||
17058461|NCT00541866|38201768|FG002|Overall Study|Not Reported or Other|3|||
17058462|NCT00541866|38201769|FG003|Overall Study|Not Reported or Other|3|||
17058463|NCT00541866|38201770|FG004|Overall Study|Not Reported or Other|1|||
17058464|NCT00541866|38201766|FG000|Overall Study|Physician Decision|0|||
17058465|NCT00541866|38201767|FG001|Overall Study|Physician Decision|0|||
17058466|NCT00541866|38201768|FG002|Overall Study|Physician Decision|2|||
17058467|NCT00541866|38201769|FG003|Overall Study|Physician Decision|1|||
17058468|NCT00541866|38201770|FG004|Overall Study|Physician Decision|0|||
17058469|NCT00493467|38201798|FG000|Overall Study|Death|1|||
17058470|NCT00090493|38201802|FG000|Overall Study|Physician Decision|2|||
17058471|NCT04329702|38201809|FG000|Overall Study|illness|3|||
17058472|NCT04329702|38201810|FG001|Overall Study|illness|4|||
17058473|NCT04329702|38201811|FG002|Overall Study|illness|0|||
17058474|NCT04329702|38201809|FG000|Overall Study|Lost to Follow-up|0|||
17058475|NCT04329702|38201810|FG001|Overall Study|Lost to Follow-up|0|||
17058476|NCT04329702|38201811|FG002|Overall Study|Lost to Follow-up|2|||
17058477|NCT04329702|38201809|FG000|Overall Study|Death|0|||
17058478|NCT04329702|38201810|FG001|Overall Study|Death|2|||
17058479|NCT04329702|38201811|FG002|Overall Study|Death|0|||
17058480|NCT00481065|38201832|FG000|Overall Study|Adverse event or death|1|||
17058481|NCT00481065|38201833|FG001|Overall Study|Adverse event or death|1|||
17058482|NCT00481065|38201834|FG002|Overall Study|Adverse event or death|3|||
17058483|NCT00481065|38201835|FG003|Overall Study|Adverse event or death|0|||
17058484|NCT00481065|38201836|FG004|Overall Study|Adverse event or death|2|||
17058485|NCT00481065|38201837|FG005|Overall Study|Adverse event or death|0|||
17058486|NCT00481065|38201838|FG006|Overall Study|Adverse event or death|1|||
17058487|NCT00481065|38201839|FG007|Overall Study|Adverse event or death|1|||
17058488|NCT00481065|38201832|FG000|Overall Study|Withdrawal by Subject|11|||
17058489|NCT00481065|38201833|FG001|Overall Study|Withdrawal by Subject|12|||
17058490|NCT00481065|38201834|FG002|Overall Study|Withdrawal by Subject|7|||
17058491|NCT00481065|38201835|FG003|Overall Study|Withdrawal by Subject|11|||
17058492|NCT00481065|38201836|FG004|Overall Study|Withdrawal by Subject|13|||
17058493|NCT00481065|38201837|FG005|Overall Study|Withdrawal by Subject|12|||
17058494|NCT00481065|38201838|FG006|Overall Study|Withdrawal by Subject|9|||
17058495|NCT00481065|38201839|FG007|Overall Study|Withdrawal by Subject|10|||
17058496|NCT00481065|38201832|FG000|Overall Study|Lost to Follow-up|4|||
17058497|NCT00481065|38201833|FG001|Overall Study|Lost to Follow-up|2|||
17058498|NCT00481065|38201834|FG002|Overall Study|Lost to Follow-up|4|||
17058499|NCT00481065|38201835|FG003|Overall Study|Lost to Follow-up|3|||
17058500|NCT00481065|38201836|FG004|Overall Study|Lost to Follow-up|3|||
17058501|NCT00481065|38201837|FG005|Overall Study|Lost to Follow-up|3|||
17058502|NCT00481065|38201838|FG006|Overall Study|Lost to Follow-up|2|||
17145114|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
17058503|NCT00481065|38201839|FG007|Overall Study|Lost to Follow-up|5|||
17058504|NCT00481065|38201832|FG000|Overall Study|Inappropriate enrollment|4|||
17058505|NCT00481065|38201833|FG001|Overall Study|Inappropriate enrollment|0|||
17058506|NCT00481065|38201834|FG002|Overall Study|Inappropriate enrollment|2|||
17145115|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
17145116|NCT04057573|38288954|FG000|24-Week Double-Blind Period|Not Treated|1|||
17145117|NCT04057573|38288955|FG001|24-Week Double-Blind Period|Not Treated|0|||
17145118|NCT04057573|38288956|FG002|24-Week Double-Blind Period|Not Treated|0|||
17145119|NCT04057573|38288957|FG003|24-Week Double-Blind Period|Not Treated|0|||
17145120|NCT04057573|38288954|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
17145121|NCT04057573|38288955|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
17145122|NCT04057573|38288956|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
17145123|NCT04057573|38288957|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
17145124|NCT04057573|38288954|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
17145125|NCT04057573|38288955|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
17145126|NCT04057573|38288956|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
17145127|NCT04057573|38288957|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
17145128|NCT04057573|38288954|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
17145129|NCT04057573|38288955|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
17145130|NCT04057573|38288956|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
17145131|NCT04057573|38288957|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
17058507|NCT00481065|38201835|FG003|Overall Study|Inappropriate enrollment|0|||
17058508|NCT00481065|38201836|FG004|Overall Study|Inappropriate enrollment|2|||
17058509|NCT00481065|38201837|FG005|Overall Study|Inappropriate enrollment|1|||
17058510|NCT00481065|38201838|FG006|Overall Study|Inappropriate enrollment|0|||
17058511|NCT00481065|38201839|FG007|Overall Study|Inappropriate enrollment|1|||
17058512|NCT00481065|38201832|FG000|Overall Study|Administrative reason|0|||
17058513|NCT00481065|38201833|FG001|Overall Study|Administrative reason|0|||
17058514|NCT00481065|38201834|FG002|Overall Study|Administrative reason|0|||
17058515|NCT00481065|38201835|FG003|Overall Study|Administrative reason|0|||
17058516|NCT00481065|38201836|FG004|Overall Study|Administrative reason|0|||
17058517|NCT00481065|38201837|FG005|Overall Study|Administrative reason|2|||
17058518|NCT00481065|38201838|FG006|Overall Study|Administrative reason|1|||
17058519|NCT00481065|38201839|FG007|Overall Study|Administrative reason|0|||
17058520|NCT00481065|38201832|FG000|Overall Study|Protocol Violation|2|||
17058521|NCT00481065|38201833|FG001|Overall Study|Protocol Violation|1|||
17058522|NCT00481065|38201834|FG002|Overall Study|Protocol Violation|1|||
17058523|NCT00481065|38201835|FG003|Overall Study|Protocol Violation|1|||
17058524|NCT00481065|38201836|FG004|Overall Study|Protocol Violation|2|||
17058525|NCT00481065|38201837|FG005|Overall Study|Protocol Violation|6|||
17058526|NCT00481065|38201838|FG006|Overall Study|Protocol Violation|3|||
17058527|NCT00481065|38201839|FG007|Overall Study|Protocol Violation|2|||
17058528|NCT00481065|38201832|FG000|Overall Study|Unable to classify|0|||
17058529|NCT00481065|38201833|FG001|Overall Study|Unable to classify|1|||
17058530|NCT00481065|38201834|FG002|Overall Study|Unable to classify|2|||
17058531|NCT00481065|38201835|FG003|Overall Study|Unable to classify|0|||
17058532|NCT00481065|38201836|FG004|Overall Study|Unable to classify|1|||
17058533|NCT00481065|38201837|FG005|Overall Study|Unable to classify|0|||
17058534|NCT00481065|38201838|FG006|Overall Study|Unable to classify|0|||
17058535|NCT00481065|38201839|FG007|Overall Study|Unable to classify|0|||
17058536|NCT00493311|38201861|FG000|Overall Study|Need for rescue medication|2|||
17058537|NCT00493311|38201862|FG001|Overall Study|Need for rescue medication|2|||
17058538|NCT00571649|38201870|FG000|Treatment Period|Adverse Event|438|||
17058539|NCT00571649|38201871|FG001|Treatment Period|Adverse Event|385|||
17058540|NCT00571649|38201870|FG000|Treatment Period|Clinical endpoint reached|50|||
17058541|NCT00571649|38201871|FG001|Treatment Period|Clinical endpoint reached|56|||
17058542|NCT00571649|38201870|FG000|Treatment Period|Withdrawal by Subject|285|||
17058543|NCT00571649|38201871|FG001|Treatment Period|Withdrawal by Subject|255|||
17058544|NCT00571649|38201870|FG000|Treatment Period|Death|76|||
17058545|NCT00571649|38201871|FG001|Treatment Period|Death|59|||
17058546|NCT00571649|38201870|FG000|Treatment Period|Physician Decision|8|||
17058547|NCT00571649|38201871|FG001|Treatment Period|Physician Decision|9|||
17058548|NCT00571649|38201870|FG000|Treatment Period|Lost to Follow-up|43|||
17058549|NCT00571649|38201871|FG001|Treatment Period|Lost to Follow-up|41|||
17058550|NCT00571649|38201870|FG000|Treatment Period|Non-compliant with study medication|88|||
17058551|NCT00571649|38201871|FG001|Treatment Period|Non-compliant with study medication|89|||
17058552|NCT00571649|38201870|FG000|Treatment Period|Patient convenience|11|||
17058553|NCT00571649|38201871|FG001|Treatment Period|Patient convenience|13|||
17058554|NCT00571649|38201870|FG000|Treatment Period|Protocol Violation|90|||
17058555|NCT00571649|38201871|FG001|Treatment Period|Protocol Violation|92|||
17058556|NCT00571649|38201870|FG000|Treatment Period|Technical problems|3|||
17058557|NCT00571649|38201871|FG001|Treatment Period|Technical problems|5|||
17058558|NCT00571649|38201870|FG000|Follow-up Period|Adverse Event|46|||
17058559|NCT00571649|38201871|FG001|Follow-up Period|Adverse Event|40|||
17058560|NCT00571649|38201870|FG000|Follow-up Period|Clinical endpoint reached|5|||
17058561|NCT00571649|38201871|FG001|Follow-up Period|Clinical endpoint reached|2|||
17058562|NCT00571649|38201870|FG000|Follow-up Period|Withdrawal by Subject|119|||
17058563|NCT00571649|38201871|FG001|Follow-up Period|Withdrawal by Subject|115|||
17058564|NCT00571649|38201870|FG000|Follow-up Period|Death|132|||
17058565|NCT00571649|38201871|FG001|Follow-up Period|Death|133|||
17058566|NCT00571649|38201870|FG000|Follow-up Period|Physician Decision|7|||
17058567|NCT00571649|38201871|FG001|Follow-up Period|Physician Decision|13|||
17058568|NCT00571649|38201870|FG000|Follow-up Period|Lost to Follow-up|95|||
17058569|NCT00571649|38201871|FG001|Follow-up Period|Lost to Follow-up|92|||
17058570|NCT00571649|38201870|FG000|Follow-up Period|Patient convenience|136|||
17058571|NCT00571649|38201871|FG001|Follow-up Period|Patient convenience|121|||
17058572|NCT00571649|38201870|FG000|Follow-up Period|Protocol Violation|5|||
17058573|NCT00571649|38201871|FG001|Follow-up Period|Protocol Violation|12|||
17058574|NCT00546572|38201879|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
17058575|NCT00546572|38201880|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
17058576|NCT00546572|38201879|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
17058577|NCT00546572|38201880|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
17058578|NCT00546572|38201879|FG000|Vax 1 / Year 0|Protocol Violation|3|||
17058579|NCT00546572|38201880|FG001|Vax 1 / Year 0|Protocol Violation|4|||
17058580|NCT00546572|38201879|FG000|Vax 1 / Year 0|Death|2|||
17058581|NCT00546572|38201880|FG001|Vax 1 / Year 0|Death|2|||
17058582|NCT00546572|38201879|FG000|Vax 1 / Year 0|Adverse Event|0|||
17058583|NCT00546572|38201880|FG001|Vax 1 / Year 0|Adverse Event|1|||
17058584|NCT00546572|38201879|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
17058585|NCT00546572|38201880|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
17058586|NCT00546572|38201879|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
17058587|NCT00546572|38201880|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
17058588|NCT00546572|38201879|FG000|Vax 2 / Year 1|Other|1|||
17058589|NCT00546572|38201880|FG001|Vax 2 / Year 1|Other|1|||
17058590|NCT00546572|38201879|FG000|Vax 2 / Year 1|Adverse Event|1|||
17058591|NCT00546572|38201880|FG001|Vax 2 / Year 1|Adverse Event|0|||
17058592|NCT00546572|38201879|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
17058593|NCT00546572|38201880|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
17058594|NCT03917472|38201899|FG000|Overall Study|Physician Decision|4|||
17058595|NCT03917472|38201900|FG001|Overall Study|Physician Decision|0|||
17058596|NCT03917472|38201899|FG000|Overall Study|Adverse Event|3|||
17058597|NCT03917472|38201900|FG001|Overall Study|Adverse Event|1|||
17058598|NCT03917472|38201899|FG000|Overall Study|Death|7|||
17058599|NCT03917472|38201900|FG001|Overall Study|Death|5|||
17058600|NCT03917472|38201899|FG000|Overall Study|Withdrawal by Subject|11|||
17058601|NCT03917472|38201900|FG001|Overall Study|Withdrawal by Subject|4|||
17058602|NCT03917472|38201899|FG000|Overall Study|Lost to Follow-up|10|||
17058603|NCT03917472|38201900|FG001|Overall Study|Lost to Follow-up|5|||
17058604|NCT00681863|38201907|FG000|Overall Study|Adverse Event|1|||
17058605|NCT00681863|38201907|FG000|Overall Study|Lost to Follow-up|2|||
17058606|NCT00681863|38201907|FG000|Overall Study|Lack of Efficacy|2|||
17058607|NCT00681863|38201907|FG000|Overall Study|Other|18|||
17058608|NCT00681629|38201913|FG000|Overall Study|Study termination|4|||
17058609|NCT00681629|38201914|FG001|Overall Study|Study termination|2|||
17058610|NCT00681629|38201913|FG000|Overall Study|Adverse Event|1|||
17058611|NCT00681629|38201914|FG001|Overall Study|Adverse Event|0|||
17058612|NCT00546260|38201922|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
17058613|NCT00546260|38201923|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
17058614|NCT00679367|38201929|FG000|Overall Study|Adverse Event|7|||
17058615|NCT00679367|38201929|FG000|Overall Study|inability to swallow oral drugs|1|||
17058616|NCT00679367|38201929|FG000|Overall Study|Lack of Efficacy|3|||
17058617|NCT00679367|38201929|FG000|Overall Study|Withdrawal by Subject|1|||
17058618|NCT03937778|38201934|FG000|Overall Study|Withdrawal by Subject|1|||
17058619|NCT03937778|38201934|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
17058620|NCT03935126|38201938|FG000|Overall Study|Study termination by sponsor|3|||
17058621|NCT00545714|38201942|FG000|Induction Phase (6 Months)|Physician Decision|3|||
17058622|NCT00545714|38201942|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
17058623|NCT00545714|38201942|FG000|Induction Phase (6 Months)|Disease Progression|1|||
17058624|NCT00545714|38201942|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
17058625|NCT00545714|38201942|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
17058626|NCT00545714|38201942|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
17058627|NCT00545714|38201942|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
17058628|NCT00545714|38201942|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
17058629|NCT00545714|38201942|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
17058630|NCT00545714|38201942|FG000|Maintenance Phase (36 Months)|Death|2|||
17058631|NCT00539838|38201949|FG000|Overall Study|Fail to return|2|||
17058632|NCT00539838|38201950|FG001|Overall Study|Fail to return|0|||
17058633|NCT00539838|38201951|FG002|Overall Study|Fail to return|0|||
17058634|NCT00539838|38201949|FG000|Overall Study|Withdrawal by Subject|0|||
17058635|NCT00539838|38201950|FG001|Overall Study|Withdrawal by Subject|4|||
17058636|NCT00539838|38201951|FG002|Overall Study|Withdrawal by Subject|0|||
17058637|NCT00539838|38201949|FG000|Overall Study|Death|0|||
17058638|NCT00539838|38201950|FG001|Overall Study|Death|2|||
17058639|NCT00539838|38201951|FG002|Overall Study|Death|0|||
17058640|NCT00539838|38201949|FG000|Overall Study|Did not cooperate|1|||
17058641|NCT00539838|38201950|FG001|Overall Study|Did not cooperate|0|||
17058642|NCT00539838|38201951|FG002|Overall Study|Did not cooperate|1|||
17058643|NCT00539838|38201949|FG000|Overall Study|Administrative|4|||
17058644|NCT00539838|38201950|FG001|Overall Study|Administrative|0|||
17058645|NCT00539838|38201951|FG002|Overall Study|Administrative|8|||
17058646|NCT00679289|38201964|FG000|Overall Study|Progressive disease|4|||
17058647|NCT00679289|38201965|FG001|Overall Study|Progressive disease|5|||
17058648|NCT00679289|38201966|FG002|Overall Study|Progressive disease|18|||
17058649|NCT00679289|38201964|FG000|Overall Study|Withdrawal by Subject|0|||
17058650|NCT00679289|38201965|FG001|Overall Study|Withdrawal by Subject|1|||
17058651|NCT00679289|38201966|FG002|Overall Study|Withdrawal by Subject|1|||
17058652|NCT00679289|38201964|FG000|Overall Study|Adverse Event|0|||
17058653|NCT00679289|38201965|FG001|Overall Study|Adverse Event|0|||
17058654|NCT00679289|38201966|FG002|Overall Study|Adverse Event|3|||
17058655|NCT00679289|38201964|FG000|Overall Study|Physician Decision|1|||
17058656|NCT00679289|38201965|FG001|Overall Study|Physician Decision|0|||
17058657|NCT00679289|38201966|FG002|Overall Study|Physician Decision|1|||
17058658|NCT00679211|38201976|FG000|Overall Study|Progressive disease|82|||
17058659|NCT00679211|38201976|FG000|Overall Study|Adverse Event|7|||
17058660|NCT00679211|38201976|FG000|Overall Study|Withdrawal by Subject|2|||
17058661|NCT00679211|38201976|FG000|Overall Study|Physician Decision|5|||
17058662|NCT00679211|38201976|FG000|Overall Study|Refused to undergo protocol procedures|1|||
17058663|NCT00679211|38201976|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
17058664|NCT00679211|38201976|FG000|Overall Study|Other|1|||
17058665|NCT00545948|38201985|FG000|Overall Study|Not Treated|1|||
17058666|NCT00545948|38201986|FG001|Overall Study|Not Treated|1|||
17058667|NCT00545948|38201987|FG002|Overall Study|Not Treated|7|||
17058668|NCT00679055|38201998|FG000|Overall Study|Adverse Event|0|||
17058669|NCT00679055|38201999|FG001|Overall Study|Adverse Event|1|||
17058670|NCT00679055|38201998|FG000|Overall Study|Other|0|||
17058671|NCT00679055|38201999|FG001|Overall Study|Other|3|||
17058672|NCT00679055|38201998|FG000|Overall Study|Study Terminated|2|||
17058673|NCT00679055|38201999|FG001|Overall Study|Study Terminated|1|||
17058674|NCT03927950|38202005|FG000|Overall Study|Adverse Event|9|||
17058675|NCT00678899|38202010|FG000|Overall Study|Adverse Event|1|||
17058676|NCT00678587|38202017|FG000|Overall Study|Adverse Event|3|||
17058677|NCT00678587|38202018|FG001|Overall Study|Adverse Event|3|||
17058678|NCT00678587|38202017|FG000|Overall Study|Lack of Efficacy|1|||
17058679|NCT00678587|38202018|FG001|Overall Study|Lack of Efficacy|0|||
17058680|NCT00678587|38202017|FG000|Overall Study|Protocol Violation|2|||
17058681|NCT00678587|38202018|FG001|Overall Study|Protocol Violation|1|||
17058682|NCT00678587|38202017|FG000|Overall Study|Study Closed/Terminated|1|||
17058683|NCT00678587|38202018|FG001|Overall Study|Study Closed/Terminated|0|||
17058684|NCT00678587|38202017|FG000|Overall Study|Lost to Follow-up|3|||
17058685|NCT00678587|38202018|FG001|Overall Study|Lost to Follow-up|5|||
17058686|NCT00678587|38202017|FG000|Overall Study|Investigator Discretion|2|||
17058687|NCT00678587|38202018|FG001|Overall Study|Investigator Discretion|6|||
17058688|NCT00678587|38202017|FG000|Overall Study|Withdrew Consent|8|||
17058689|NCT00678587|38202018|FG001|Overall Study|Withdrew Consent|3|||
17058690|NCT03523728|38202030|FG000|Stage 1 (24 Months)|Adverse Event|2|||
17058691|NCT03523728|38202031|FG001|Stage 1 (24 Months)|Adverse Event|2|||
17058692|NCT03523728|38202032|FG002|Stage 1 (24 Months)|Adverse Event|4|||
17058693|NCT03523728|38202033|FG003|Stage 1 (24 Months)|Adverse Event|0|||
17058694|NCT03523728|38202034|FG004|Stage 1 (24 Months)|Adverse Event|0|||
17145132|NCT04057573|38288954|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
17145133|NCT04057573|38288955|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
17145134|NCT04057573|38288956|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
17058695|NCT03523728|38202030|FG000|Stage 1 (24 Months)|Progressive disease|0|||
17058696|NCT03523728|38202031|FG001|Stage 1 (24 Months)|Progressive disease|0|||
17058697|NCT03523728|38202032|FG002|Stage 1 (24 Months)|Progressive disease|1|||
17058698|NCT03523728|38202033|FG003|Stage 1 (24 Months)|Progressive disease|0|||
17058699|NCT03523728|38202034|FG004|Stage 1 (24 Months)|Progressive disease|0|||
17058700|NCT03523728|38202030|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
17058701|NCT03523728|38202031|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
17058702|NCT03523728|38202032|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
17058703|NCT03523728|38202033|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
17058704|NCT03523728|38202034|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
17058705|NCT03523728|38202030|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
17058706|NCT03523728|38202031|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
17058707|NCT03523728|38202032|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
17058708|NCT03523728|38202033|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
17058709|NCT03523728|38202034|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
17058710|NCT03523728|38202030|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
17058711|NCT03523728|38202031|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
17058712|NCT03523728|38202032|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
17058713|NCT03523728|38202033|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
17058714|NCT03523728|38202034|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
17058715|NCT03523728|38202030|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
17058716|NCT03523728|38202031|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
17058717|NCT03523728|38202032|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
17058718|NCT03523728|38202033|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
17058719|NCT03523728|38202034|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
17058720|NCT03523728|38202030|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
17058721|NCT03523728|38202031|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
17058722|NCT03523728|38202032|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
17058723|NCT03523728|38202033|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
17058724|NCT03523728|38202034|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
17058725|NCT03523728|38202030|FG000|Stage 2 (24 Months)|Adverse Event|0|||
17058726|NCT03523728|38202031|FG001|Stage 2 (24 Months)|Adverse Event|0|||
17058727|NCT03523728|38202032|FG002|Stage 2 (24 Months)|Adverse Event|0|||
17058728|NCT03523728|38202033|FG003|Stage 2 (24 Months)|Adverse Event|1|||
17058729|NCT03523728|38202034|FG004|Stage 2 (24 Months)|Adverse Event|2|||
17058730|NCT03523728|38202030|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
17058731|NCT03523728|38202031|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
17058732|NCT03523728|38202032|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
17058733|NCT03523728|38202033|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
17058734|NCT03523728|38202034|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
17058735|NCT03523728|38202030|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
17058736|NCT03523728|38202031|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
17058737|NCT03523728|38202032|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
17058738|NCT03523728|38202033|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
17058739|NCT03523728|38202034|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
17058740|NCT03523728|38202030|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
17058741|NCT03523728|38202031|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
17058742|NCT03523728|38202032|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
17058743|NCT03523728|38202033|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
17058744|NCT03523728|38202034|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
17058745|NCT03523728|38202030|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
17058746|NCT03523728|38202031|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
17058747|NCT03523728|38202032|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
17058748|NCT03523728|38202033|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
17058749|NCT03523728|38202034|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
17058750|NCT00538590|38202053|FG000|Overall Study|Death|1|||
17058751|NCT00538590|38202054|FG001|Overall Study|Death|0|||
17058752|NCT00466947|38202062|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
17058753|NCT00466947|38202063|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
17058754|NCT00466947|38202062|FG000|Study End Analysis Period|Adverse Event|35|||
17058755|NCT00466947|38202063|FG001|Study End Analysis Period|Adverse Event|43|||
17058756|NCT00466947|38202062|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
17058757|NCT00466947|38202063|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
17058758|NCT00466947|38202062|FG000|Study End Analysis Period|Physician Decision|29|||
17058759|NCT00466947|38202063|FG001|Study End Analysis Period|Physician Decision|29|||
17058760|NCT00466947|38202062|FG000|Study End Analysis Period|Protocol Violation|9|||
17058761|NCT00466947|38202063|FG001|Study End Analysis Period|Protocol Violation|17|||
17058762|NCT00466947|38202062|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
17058763|NCT00466947|38202063|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
17058764|NCT00466947|38202062|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
17058765|NCT00466947|38202063|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
17058766|NCT00466947|38202062|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
17058767|NCT00466947|38202063|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
17058768|NCT00466947|38202062|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
17058769|NCT00466947|38202063|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
17058770|NCT00537810|38202074|FG000|Overall Study|Withdrawal by Subject|4|||
17058771|NCT00537810|38202075|FG001|Overall Study|Withdrawal by Subject|11|||
17058772|NCT00537810|38202076|FG002|Overall Study|Withdrawal by Subject|4|||
17058773|NCT00537810|38202077|FG003|Overall Study|Withdrawal by Subject|3|||
17058774|NCT00537810|38202074|FG000|Overall Study|Medically withdrawn|2|||
17058775|NCT00537810|38202075|FG001|Overall Study|Medically withdrawn|2|||
17058776|NCT00537810|38202076|FG002|Overall Study|Medically withdrawn|0|||
17058777|NCT00537810|38202077|FG003|Overall Study|Medically withdrawn|1|||
17058778|NCT01287936|38202090|FG000|Overall Study|Lost to Follow-up|0|||
17058779|NCT01287936|38202091|FG001|Overall Study|Lost to Follow-up|1|||
17058780|NCT01287936|38202092|FG002|Overall Study|Lost to Follow-up|1|||
17058781|NCT00090259|38202102|FG000|Overall Study|Lost to Follow-up|30|||
17058782|NCT00090259|38202103|FG001|Overall Study|Lost to Follow-up|26|||
17058783|NCT00090259|38202102|FG000|Overall Study|Withdrawal by Subject|21|||
17058784|NCT00090259|38202103|FG001|Overall Study|Withdrawal by Subject|15|||
17058785|NCT00090259|38202102|FG000|Overall Study|Investigator site closed|11|||
17058786|NCT00090259|38202103|FG001|Overall Study|Investigator site closed|7|||
17058787|NCT00079183|38202109|FG000|Overall Study|Withdrawal by Subject|4|||
17058788|NCT00079183|38202109|FG000|Overall Study|Study medication non-compliance|2|||
17058789|NCT00079183|38202109|FG000|Overall Study|Specimen collection non-compliance|1|||
17058790|NCT00676403|38202120|FG000|Overall Study|Adverse Event|1|||
17058791|NCT00676403|38202121|FG001|Overall Study|Adverse Event|2|||
17058792|NCT00676403|38202122|FG002|Overall Study|Adverse Event|0|||
17058793|NCT00676403|38202123|FG003|Overall Study|Adverse Event|5|||
17058794|NCT00676403|38202124|FG004|Overall Study|Adverse Event|1|||
17058795|NCT00676403|38202125|FG005|Overall Study|Adverse Event|2|||
17058796|NCT00676403|38202120|FG000|Overall Study|Lost to Follow-up|0|||
17058797|NCT00676403|38202121|FG001|Overall Study|Lost to Follow-up|0|||
17058798|NCT00676403|38202122|FG002|Overall Study|Lost to Follow-up|0|||
17058799|NCT00676403|38202123|FG003|Overall Study|Lost to Follow-up|0|||
17058800|NCT00676403|38202124|FG004|Overall Study|Lost to Follow-up|0|||
17058801|NCT00676403|38202125|FG005|Overall Study|Lost to Follow-up|1|||
17058802|NCT00676403|38202120|FG000|Overall Study|Reason Unspecified|1|||
17058803|NCT00676403|38202121|FG001|Overall Study|Reason Unspecified|0|||
17058804|NCT00676403|38202122|FG002|Overall Study|Reason Unspecified|1|||
17058805|NCT00676403|38202123|FG003|Overall Study|Reason Unspecified|0|||
17058806|NCT00676403|38202124|FG004|Overall Study|Reason Unspecified|0|||
17058807|NCT00676403|38202125|FG005|Overall Study|Reason Unspecified|1|||
17058808|NCT00676403|38202120|FG000|Overall Study|Withdrawal by Subject|0|||
17058809|NCT00676403|38202121|FG001|Overall Study|Withdrawal by Subject|0|||
17058810|NCT00676403|38202122|FG002|Overall Study|Withdrawal by Subject|0|||
17058811|NCT00676403|38202123|FG003|Overall Study|Withdrawal by Subject|0|||
17058812|NCT00676403|38202124|FG004|Overall Study|Withdrawal by Subject|0|||
17058813|NCT00676403|38202125|FG005|Overall Study|Withdrawal by Subject|1|||
17058814|NCT00078949|38202149|FG000|Overall Study|No treated|4|||
17058815|NCT00078949|38202150|FG001|Overall Study|No treated|5|||
17058816|NCT00078949|38202151|FG002|Overall Study|No treated|3|||
17058817|NCT00078949|38202152|FG003|Overall Study|No treated|3|||
17058818|NCT00078325|38202167|FG000|Overall Study|Adverse Event|15|||
17058819|NCT00078325|38202168|FG001|Overall Study|Adverse Event|10|||
17058820|NCT00078325|38202169|FG002|Overall Study|Adverse Event|5|||
17058821|NCT00078325|38202167|FG000|Overall Study|Protocol Violation|2|||
17058822|NCT00078325|38202168|FG001|Overall Study|Protocol Violation|2|||
17058823|NCT00078325|38202169|FG002|Overall Study|Protocol Violation|0|||
17058824|NCT00078325|38202167|FG000|Overall Study|Withdrawal by Subject|1|||
17058825|NCT00078325|38202168|FG001|Overall Study|Withdrawal by Subject|5|||
17058826|NCT00078325|38202169|FG002|Overall Study|Withdrawal by Subject|3|||
17058827|NCT00078325|38202167|FG000|Overall Study|Lost to Follow-up|0|||
17058828|NCT00078325|38202168|FG001|Overall Study|Lost to Follow-up|1|||
17058829|NCT00078325|38202169|FG002|Overall Study|Lost to Follow-up|1|||
17058830|NCT00078325|38202167|FG000|Overall Study|Physician Decision|2|||
17058831|NCT00078325|38202168|FG001|Overall Study|Physician Decision|0|||
17058832|NCT00078325|38202169|FG002|Overall Study|Physician Decision|1|||
17058833|NCT00078325|38202167|FG000|Overall Study|Miscellaneous|1|||
17058834|NCT00078325|38202168|FG001|Overall Study|Miscellaneous|1|||
17058835|NCT00078325|38202169|FG002|Overall Study|Miscellaneous|1|||
17058836|NCT00077857|38202179|FG000|Overall Study|Adverse Event|30|||
17058837|NCT00077857|38202180|FG001|Overall Study|Adverse Event|32|||
17058838|NCT00077857|38202179|FG000|Overall Study|Death|7|||
17058839|NCT00077857|38202180|FG001|Overall Study|Death|3|||
17058840|NCT00077857|38202179|FG000|Overall Study|Insufficient therapeutic response|112|||
17058841|NCT00077857|38202180|FG001|Overall Study|Insufficient therapeutic response|128|||
17058842|NCT00077857|38202179|FG000|Overall Study|Violation of selection criteria at entry|3|||
17058843|NCT00077857|38202180|FG001|Overall Study|Violation of selection criteria at entry|1|||
17058844|NCT00077857|38202179|FG000|Overall Study|Other protocol violation|0|||
17058845|NCT00077857|38202180|FG001|Overall Study|Other protocol violation|1|||
17058846|NCT00077857|38202179|FG000|Overall Study|Refused treatment|29|||
17058847|NCT00077857|38202180|FG001|Overall Study|Refused treatment|21|||
17058848|NCT00077857|38202179|FG000|Overall Study|Failure to return|5|||
17058849|NCT00077857|38202180|FG001|Overall Study|Failure to return|5|||
17058850|NCT00077857|38202179|FG000|Overall Study|Other|15|||
17058851|NCT00077857|38202180|FG001|Overall Study|Other|13|||
17058852|NCT00545402|38202188|FG000|Overall Study|Discontinuation of treatment|17|||
17058853|NCT00545402|38202189|FG001|Overall Study|Discontinuation of treatment|9|||
17058854|NCT00545402|38202188|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
17058855|NCT00545402|38202189|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
17058856|NCT00545402|38202188|FG000|Overall Study|Death|5|||
17058857|NCT00545402|38202189|FG001|Overall Study|Death|7|||
17058858|NCT00545402|38202188|FG000|Overall Study|Graft loss|2|||
17058859|NCT00545402|38202189|FG001|Overall Study|Graft loss|4|||
17058860|NCT00545402|38202188|FG000|Overall Study|Withdrawal by Subject|0|||
17058861|NCT00545402|38202189|FG001|Overall Study|Withdrawal by Subject|1|||
17058862|NCT00545402|38202188|FG000|Overall Study|Protocol Violation|1|||
17058863|NCT00545402|38202189|FG001|Overall Study|Protocol Violation|0|||
17058864|NCT00545402|38202188|FG000|Overall Study|Reason not specified|1|||
17058865|NCT00545402|38202189|FG001|Overall Study|Reason not specified|1|||
17058866|NCT00545792|38202195|FG000|Overall Study|Withdrawal by Subject|1|||
17058867|NCT00545168|38202202|FG000|Overall Study|Lost to Follow-up|5|||
17058868|NCT00545168|38202203|FG001|Overall Study|Lost to Follow-up|5|||
17058869|NCT00545168|38202204|FG002|Overall Study|Lost to Follow-up|5|||
16993168|NCT00793624|38137220|FG002|Overall Study|Other reason not described above|6|||
16993169|NCT00793624|38137221|FG003|Overall Study|Other reason not described above|3|||
16993170|NCT00794950|38137239|FG000|BCG Induction|Withdrawal by Subject|2|||
16993171|NCT00794950|38137239|FG000|BCG Induction|ineligible|3|||
16993172|NCT00794950|38137239|FG000|BCG Induction|noncompliant w. BCG|1|||
16993173|NCT00794950|38137239|FG000|BCG Induction|Adverse Event|1|||
16993174|NCT00794950|38137239|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
16993175|NCT00794950|38137239|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
16993176|NCT00794950|38137239|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
16993177|NCT00794950|38137239|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
16993178|NCT00793546|38137246|FG000|Overall Study|Death|3|||
16993179|NCT00793546|38137247|FG001|Overall Study|Death|0|||
17058870|NCT00545168|38202202|FG000|Overall Study|Withdrawal by Subject|9|||
17058871|NCT00545168|38202203|FG001|Overall Study|Withdrawal by Subject|0|||
17058872|NCT00545168|38202204|FG002|Overall Study|Withdrawal by Subject|13|||
17058873|NCT00545168|38202202|FG000|Overall Study|Protocol Violation|1|||
17058874|NCT00545168|38202203|FG001|Overall Study|Protocol Violation|0|||
17058875|NCT00545168|38202204|FG002|Overall Study|Protocol Violation|1|||
17058876|NCT00545168|38202202|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
17058877|NCT00545168|38202203|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
17058878|NCT00545168|38202204|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
17058879|NCT00544544|38202213|FG000|Overall Study|Withdrawal by Subject|1|||
17058880|NCT00544544|38202213|FG000|Overall Study|Adverse Event|1|||
17058881|NCT00544544|38202213|FG000|Overall Study|Lost to Follow-up|1|||
17058882|NCT00541346|38202217|FG000|Follow-up|Adverse Event|1|||
17058883|NCT00077623|38202224|FG000|Overall Study|Adverse Event|1|||
17058884|NCT00077623|38202225|FG001|Overall Study|Adverse Event|0|||
17058885|NCT00077623|38202226|FG002|Overall Study|Adverse Event|1|||
17058886|NCT00077623|38202224|FG000|Overall Study|Withdrawal by Subject|2|||
17058887|NCT00077623|38202225|FG001|Overall Study|Withdrawal by Subject|10|||
17058888|NCT00077623|38202226|FG002|Overall Study|Withdrawal by Subject|1|||
17058889|NCT00077623|38202224|FG000|Overall Study|Other-Non safety reason|18|||
17058890|NCT00077623|38202225|FG001|Overall Study|Other-Non safety reason|15|||
17058891|NCT00077623|38202226|FG002|Overall Study|Other-Non safety reason|19|||
17058892|NCT00077623|38202224|FG000|Overall Study|Insufficient therapeutic response|2|||
17058893|NCT00077623|38202225|FG001|Overall Study|Insufficient therapeutic response|0|||
17058894|NCT00077623|38202226|FG002|Overall Study|Insufficient therapeutic response|0|||
17058895|NCT00077623|38202224|FG000|Overall Study|Death|12|||
17058896|NCT00077623|38202225|FG001|Overall Study|Death|18|||
17058897|NCT00077623|38202226|FG002|Overall Study|Death|11|||
17058898|NCT00077623|38202224|FG000|Overall Study|Failure to return|1|||
17058899|NCT00077623|38202225|FG001|Overall Study|Failure to return|0|||
17058900|NCT00077623|38202226|FG002|Overall Study|Failure to return|0|||
17058901|NCT00541034|38202234|FG000|Overall Study|Non-Compliance|3|||
17058902|NCT00540644|38202240|FG000|Overall Study|Adverse Event|3|||
17058903|NCT00540644|38202241|FG001|Overall Study|Adverse Event|1|||
17058904|NCT00540644|38202240|FG000|Overall Study|Disease Progression|3|||
17058905|NCT00540644|38202241|FG001|Overall Study|Disease Progression|1|||
17058906|NCT00540644|38202240|FG000|Overall Study|Physician Decision|0|||
17058907|NCT00540644|38202241|FG001|Overall Study|Physician Decision|5|||
17058908|NCT00540644|38202240|FG000|Overall Study|Withdrawal by Subject|2|||
17058909|NCT00540644|38202241|FG001|Overall Study|Withdrawal by Subject|2|||
17058910|NCT00540644|38202240|FG000|Overall Study|Noncomplilance|1|||
17058911|NCT00540644|38202241|FG001|Overall Study|Noncomplilance|0|||
17058912|NCT00543296|38202247|FG000|Overall Study|Physician Decision|7|||
17058913|NCT00543140|38202251|FG000|Overall Study|Lost to Follow-up|33|||
17058914|NCT00543140|38202251|FG000|Overall Study|Withdrawal by Subject|13|||
17058915|NCT00543140|38202251|FG000|Overall Study|Protocol Violation|10|||
17058916|NCT00543140|38202251|FG000|Overall Study|Insufficient weight loss|10|||
17058917|NCT00543140|38202251|FG000|Overall Study|SAE leading to explant of SAGB|3|||
17058918|NCT00543140|38202251|FG000|Overall Study|Death|1|||
17058919|NCT00543140|38202251|FG000|Overall Study|Subject moved|1|||
17058920|NCT00543140|38202251|FG000|Overall Study|Conversion to different procedure|1|||
17058921|NCT00543062|38202255|FG000|Overall Study|Withdrawal by Subject|1|||
17058922|NCT00543062|38202256|FG001|Overall Study|Withdrawal by Subject|0|||
17058923|NCT00543062|38202257|FG002|Overall Study|Withdrawal by Subject|2|||
17058924|NCT00543062|38202258|FG003|Overall Study|Withdrawal by Subject|0|||
17058925|NCT00543062|38202255|FG000|Overall Study|Adverse Event|0|||
17058926|NCT00543062|38202256|FG001|Overall Study|Adverse Event|1|||
17058927|NCT00543062|38202257|FG002|Overall Study|Adverse Event|1|||
17058928|NCT00543062|38202258|FG003|Overall Study|Adverse Event|1|||
17058929|NCT00543062|38202255|FG000|Overall Study|Protocol Violation|1|||
17058930|NCT00543062|38202256|FG001|Overall Study|Protocol Violation|0|||
17058931|NCT00543062|38202257|FG002|Overall Study|Protocol Violation|0|||
17058932|NCT00543062|38202258|FG003|Overall Study|Protocol Violation|0|||
16993180|NCT00793546|38137246|FG000|Overall Study|Lost to Follow-up|1|||
16993181|NCT00793546|38137247|FG001|Overall Study|Lost to Follow-up|0|||
16993182|NCT00793546|38137246|FG000|Overall Study|Withdrawal by Subject|1|||
16993183|NCT00793546|38137247|FG001|Overall Study|Withdrawal by Subject|1|||
16993184|NCT00793546|38137246|FG000|Overall Study|Study Terminated by Sponsor|8|||
16993185|NCT00793546|38137247|FG001|Overall Study|Study Terminated by Sponsor|27|||
16993186|NCT00793546|38137246|FG000|Overall Study|Other|1|||
16993187|NCT00793546|38137247|FG001|Overall Study|Other|0|||
16993188|NCT00798694|38137257|FG000|Overall Study|Lost to Follow-up|1|||
16993189|NCT00798694|38137258|FG001|Overall Study|Lost to Follow-up|1|||
16993190|NCT00798694|38137257|FG000|Overall Study|Physician Decision|1|||
16993191|NCT00798694|38137258|FG001|Overall Study|Physician Decision|0|||
16993192|NCT00718315|38137273|FG000|Overall Study|Adverse Event|1|||
17058933|NCT03911960|38202278|FG000|Overall Study|Lost to Follow-up|5|||
17058934|NCT03911960|38202279|FG001|Overall Study|Lost to Follow-up|3|||
17058935|NCT00676091|38202288|FG000|Infant Series|Parent or legal guardian request|10|||
17058936|NCT00676091|38202289|FG001|Infant Series|Parent or legal guardian request|8|||
17058937|NCT00676091|38202288|FG000|Infant Series|Protocol Violation|6|||
17058938|NCT00676091|38202289|FG001|Infant Series|Protocol Violation|3|||
17058939|NCT00676091|38202288|FG000|Infant Series|Adverse Event|2|||
17058940|NCT00676091|38202289|FG001|Infant Series|Adverse Event|3|||
17058941|NCT00676091|38202288|FG000|Infant Series|Failed to return|1|||
17058942|NCT00676091|38202289|FG001|Infant Series|Failed to return|3|||
17058943|NCT00676091|38202288|FG000|Infant Series|Lost to Follow-up|1|||
17058944|NCT00676091|38202289|FG001|Infant Series|Lost to Follow-up|0|||
17058945|NCT00676091|38202288|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
17058946|NCT00676091|38202289|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
17058947|NCT00676091|38202288|FG000|After Infant Series|Adverse Event|0|||
17145135|NCT04057573|38288957|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
17145136|NCT04057573|38288954|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
17145137|NCT04057573|38288955|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
17145138|NCT04057573|38288956|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
17145139|NCT04057573|38288957|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
17145140|NCT04054765|38288970|FG000|Baseline|Withdrawal by Subject|5|||
17145141|NCT04054765|38288971|FG001|Baseline|Withdrawal by Subject|3|||
17058948|NCT00676091|38202289|FG001|After Infant Series|Adverse Event|1|||
17058949|NCT00676091|38202288|FG000|After Infant Series|Protocol Violation|0|||
17058950|NCT00676091|38202289|FG001|After Infant Series|Protocol Violation|1|||
17058951|NCT00676091|38202288|FG000|After Infant Series|Failed to return|1|||
17058952|NCT00676091|38202289|FG001|After Infant Series|Failed to return|1|||
17058953|NCT00676091|38202288|FG000|Toddler Dose|Failed to return|2|||
17058954|NCT00676091|38202289|FG001|Toddler Dose|Failed to return|0|||
17058955|NCT00676091|38202288|FG000|Toddler Dose|Parent or legal guardian request|1|||
17058956|NCT00676091|38202289|FG001|Toddler Dose|Parent or legal guardian request|0|||
17058957|NCT00678041|38202301|FG000|Overall Study|Physician Decision|5|||
17058958|NCT00678041|38202302|FG001|Overall Study|Physician Decision|5|||
17058959|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
17058960|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
17058961|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
17058962|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
17058963|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
17058964|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
17058965|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
17058966|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
17058967|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
17058968|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
17058969|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
17058970|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
17058971|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
17058972|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
17058973|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
17058974|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
17058975|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
17058976|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
17058977|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
17058978|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
17058979|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
17058980|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
17058981|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
17058982|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
17058983|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
17058984|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
17058985|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
17058986|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
17058987|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
17058988|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
17058989|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
17058990|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
17058991|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
17058992|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
17058993|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
17058994|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
17058995|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
17058996|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
17058997|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
17058998|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
17058999|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
17059000|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
17059001|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
17059002|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
17059003|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
17059004|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
17059005|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
17059006|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
17059007|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
17059008|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
17059009|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
17059010|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
17059011|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
17059012|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
17059013|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
17059014|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
17059015|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
17059016|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
17145142|NCT04054765|38288970|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
17145143|NCT04054765|38288971|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
17145144|NCT04054765|38288970|FG000|3-month Follow up|Withdrawal by Subject|0|||
17145145|NCT04054765|38288971|FG001|3-month Follow up|Withdrawal by Subject|3|||
17145146|NCT04054765|38288970|FG000|6-month Follow up|Lost to Follow-up|32|||
17145147|NCT04054765|38288971|FG001|6-month Follow up|Lost to Follow-up|32|||
17145148|NCT04179721|38288979|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
17145149|NCT04179721|38288980|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
17145150|NCT04179721|38288979|FG000|Overall Study|Lost to Follow-up|0|||
17145151|NCT04179721|38288980|FG001|Overall Study|Lost to Follow-up|1|||
17145152|NCT03286218|38288986|FG000|Qualification Phase Period 1|Adverse Event|1|||
17145153|NCT03286218|38288987|FG001|Qualification Phase Period 1|Adverse Event|0|||
17145154|NCT03286218|38288988|FG002|Qualification Phase Period 1|Adverse Event|0|||
17145155|NCT03286218|38288989|FG003|Qualification Phase Period 1|Adverse Event|0|||
17145156|NCT03286218|38288990|FG004|Qualification Phase Period 1|Adverse Event|0|||
17145157|NCT03286218|38288991|FG005|Qualification Phase Period 1|Adverse Event|0|||
17145158|NCT03286218|38288992|FG006|Qualification Phase Period 1|Adverse Event|0|||
17145159|NCT03286218|38288993|FG007|Qualification Phase Period 1|Adverse Event|0|||
17145160|NCT03286218|38288994|FG008|Qualification Phase Period 1|Adverse Event|0|||
17145161|NCT03286218|38288995|FG009|Qualification Phase Period 1|Adverse Event|0|||
17145162|NCT03286218|38288996|FG010|Qualification Phase Period 1|Adverse Event|0|||
17145163|NCT03286218|38288997|FG011|Qualification Phase Period 1|Adverse Event|0|||
17145164|NCT03286218|38288986|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145165|NCT03286218|38288987|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
17059017|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
17059018|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
17145166|NCT03286218|38288988|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145167|NCT03286218|38288989|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
17059019|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
17059020|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
17059021|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
17059022|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
17059023|NCT03903822|38202317|FG000|Treatment Phase (6 Weeks)|Other|2|||
17059024|NCT03903822|38202318|FG001|Treatment Phase (6 Weeks)|Other|1|||
17059025|NCT03903822|38202319|FG002|Treatment Phase (6 Weeks)|Other|0|||
17059026|NCT03903822|38202320|FG003|Treatment Phase (6 Weeks)|Other|0|||
17059027|NCT03903822|38202321|FG004|Treatment Phase (6 Weeks)|Other|1|||
17059028|NCT03903822|38202322|FG005|Treatment Phase (6 Weeks)|Other|1|||
17059029|NCT03903822|38202323|FG006|Treatment Phase (6 Weeks)|Other|0|||
17059030|NCT03903822|38202324|FG007|Treatment Phase (6 Weeks)|Other|0|||
17059031|NCT03903822|38202317|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
17059032|NCT03903822|38202318|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
17059033|NCT03903822|38202319|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
17059034|NCT03903822|38202320|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
17059035|NCT03903822|38202321|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
17059036|NCT03903822|38202322|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
17059037|NCT03903822|38202323|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
17059038|NCT03903822|38202324|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
17059039|NCT03903822|38202317|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
17059040|NCT03903822|38202318|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
17059041|NCT03903822|38202319|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
17059042|NCT03903822|38202320|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
16993193|NCT00718315|38137274|FG001|Overall Study|Adverse Event|2|||
16993194|NCT00718315|38137275|FG002|Overall Study|Adverse Event|3|||
16993195|NCT00718315|38137273|FG000|Overall Study|Death|6|||
16993196|NCT00718315|38137274|FG001|Overall Study|Death|6|||
16993197|NCT00718315|38137275|FG002|Overall Study|Death|5|||
17059043|NCT03903822|38202321|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
17059044|NCT03903822|38202322|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
17059045|NCT03903822|38202323|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
17059046|NCT03903822|38202324|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
17059047|NCT03903822|38202317|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
17059048|NCT03903822|38202318|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
17059049|NCT03903822|38202319|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
17059050|NCT03903822|38202320|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
17059051|NCT03903822|38202321|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
17059052|NCT03903822|38202322|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
17059053|NCT03903822|38202323|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
17059054|NCT03903822|38202324|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
17059055|NCT03903822|38202317|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
17059056|NCT03903822|38202318|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
17059057|NCT03903822|38202319|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
17059058|NCT03903822|38202320|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
17059059|NCT03903822|38202321|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
17059060|NCT03903822|38202322|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
17059061|NCT03903822|38202323|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
17059062|NCT03903822|38202324|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
17059063|NCT03903822|38202317|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
17059064|NCT03903822|38202318|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
17059065|NCT03903822|38202319|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
17059066|NCT03903822|38202320|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
17059067|NCT03903822|38202321|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
17059068|NCT03903822|38202322|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
17059069|NCT03903822|38202323|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
17059070|NCT03903822|38202324|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
17059071|NCT03903822|38202317|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
17059072|NCT03903822|38202318|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
17059073|NCT03903822|38202319|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
17059074|NCT03903822|38202320|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
17059075|NCT03903822|38202321|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
17059076|NCT03903822|38202322|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
17059077|NCT03903822|38202323|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
17059078|NCT03903822|38202324|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
16993198|NCT00718315|38137273|FG000|Overall Study|Lost to Follow-up|2|||
16993199|NCT00718315|38137274|FG001|Overall Study|Lost to Follow-up|3|||
16993200|NCT00718315|38137275|FG002|Overall Study|Lost to Follow-up|4|||
16993201|NCT00718315|38137273|FG000|Overall Study|Protocol Violation|5|||
16993202|NCT00718315|38137274|FG001|Overall Study|Protocol Violation|5|||
16993203|NCT00718315|38137275|FG002|Overall Study|Protocol Violation|3|||
16993204|NCT00718315|38137273|FG000|Overall Study|Erlotinib dose decreased|4|||
16993205|NCT00718315|38137274|FG001|Overall Study|Erlotinib dose decreased|3|||
16993206|NCT00718315|38137275|FG002|Overall Study|Erlotinib dose decreased|1|||
16993207|NCT00718315|38137273|FG000|Overall Study|Use of Minocyclin|1|||
16993208|NCT00718315|38137274|FG001|Overall Study|Use of Minocyclin|1|||
16993209|NCT00718315|38137275|FG002|Overall Study|Use of Minocyclin|1|||
16993210|NCT00718315|38137273|FG000|Overall Study|Disease progression|0|||
16993211|NCT00718315|38137274|FG001|Overall Study|Disease progression|1|||
16993212|NCT00718315|38137275|FG002|Overall Study|Disease progression|1|||
16993213|NCT00718315|38137273|FG000|Overall Study|Other|0|||
16993214|NCT00718315|38137274|FG001|Overall Study|Other|0|||
16993215|NCT00718315|38137275|FG002|Overall Study|Other|1|||
16993216|NCT00718315|38137273|FG000|Overall Study|Use of ATB and Corticoids|0|||
16993217|NCT00718315|38137274|FG001|Overall Study|Use of ATB and Corticoids|1|||
17059079|NCT03903822|38202317|FG000|Follow up Phase (4 Weeks)|Other|1|||
17059080|NCT03903822|38202318|FG001|Follow up Phase (4 Weeks)|Other|1|||
17059081|NCT03903822|38202319|FG002|Follow up Phase (4 Weeks)|Other|0|||
17059082|NCT03903822|38202320|FG003|Follow up Phase (4 Weeks)|Other|0|||
17059083|NCT03903822|38202321|FG004|Follow up Phase (4 Weeks)|Other|0|||
17059084|NCT03903822|38202322|FG005|Follow up Phase (4 Weeks)|Other|0|||
17059085|NCT03903822|38202323|FG006|Follow up Phase (4 Weeks)|Other|0|||
17059086|NCT03903822|38202324|FG007|Follow up Phase (4 Weeks)|Other|0|||
17059087|NCT00677807|38202345|FG000|Overall Study|Adverse Event|4|||
17059088|NCT00677807|38202346|FG001|Overall Study|Adverse Event|1|||
17059089|NCT00677807|38202347|FG002|Overall Study|Adverse Event|6|||
17059090|NCT00677807|38202345|FG000|Overall Study|Lack of Efficacy|0|||
17059091|NCT00677807|38202346|FG001|Overall Study|Lack of Efficacy|0|||
16993218|NCT00718315|38137275|FG002|Overall Study|Use of ATB and Corticoids|2|||
16993219|NCT00798304|38137286|FG000|Overall Study|Adverse Event|0|||
16993220|NCT00798304|38137287|FG001|Overall Study|Adverse Event|1|||
16993221|NCT00798304|38137288|FG002|Overall Study|Adverse Event|1|||
16993222|NCT00798304|38137286|FG000|Overall Study|Discontinuation by Sponsor|14|||
16993223|NCT00798304|38137287|FG001|Overall Study|Discontinuation by Sponsor|21|||
16993224|NCT00798304|38137288|FG002|Overall Study|Discontinuation by Sponsor|9|||
16993225|NCT00718237|38137298|FG000|Overall Study|Adverse Event|1|||
16993226|NCT00718237|38137299|FG001|Overall Study|Adverse Event|3|||
16993227|NCT00718237|38137298|FG000|Overall Study|Lost to Follow-up|2|||
16993228|NCT00718237|38137299|FG001|Overall Study|Lost to Follow-up|2|||
16993229|NCT00718237|38137298|FG000|Overall Study|Physician Decision|1|||
16993230|NCT00718237|38137299|FG001|Overall Study|Physician Decision|0|||
16993231|NCT00718237|38137298|FG000|Overall Study|Withdrawal by Subject|9|||
16993232|NCT00718237|38137299|FG001|Overall Study|Withdrawal by Subject|10|||
16993233|NCT00793780|38137309|FG000|Overall Study|Withdrawal by Subject|2|||
16993234|NCT00793780|38137310|FG001|Overall Study|Withdrawal by Subject|1|||
16993235|NCT02643303|38137325|FG000|Overall Study|Progressive Disease|4|||
16993236|NCT02643303|38137326|FG001|Overall Study|Progressive Disease|4|||
16993237|NCT02643303|38137327|FG002|Overall Study|Progressive Disease|1|||
16993238|NCT02643303|38137328|FG003|Overall Study|Progressive Disease|12|||
16993239|NCT02643303|38137329|FG004|Overall Study|Progressive Disease|6|||
16993240|NCT02643303|38137330|FG005|Overall Study|Progressive Disease|4|||
16993241|NCT02643303|38137331|FG006|Overall Study|Progressive Disease|8|||
16993242|NCT02643303|38137332|FG007|Overall Study|Progressive Disease|2|||
16993243|NCT02643303|38137333|FG008|Overall Study|Progressive Disease|6|||
16993244|NCT02643303|38137325|FG000|Overall Study|Adverse Event|0|||
16993245|NCT02643303|38137326|FG001|Overall Study|Adverse Event|1|||
16993246|NCT02643303|38137327|FG002|Overall Study|Adverse Event|0|||
16993247|NCT02643303|38137328|FG003|Overall Study|Adverse Event|0|||
16993248|NCT02643303|38137329|FG004|Overall Study|Adverse Event|1|||
16993249|NCT02643303|38137330|FG005|Overall Study|Adverse Event|0|||
16993250|NCT02643303|38137331|FG006|Overall Study|Adverse Event|0|||
16993251|NCT02643303|38137332|FG007|Overall Study|Adverse Event|0|||
16993252|NCT02643303|38137333|FG008|Overall Study|Adverse Event|0|||
16993253|NCT02643303|38137325|FG000|Overall Study|Withdrawal by Subject|0|||
16993254|NCT02643303|38137326|FG001|Overall Study|Withdrawal by Subject|0|||
16993255|NCT02643303|38137327|FG002|Overall Study|Withdrawal by Subject|0|||
16993256|NCT02643303|38137328|FG003|Overall Study|Withdrawal by Subject|1|||
16993257|NCT02643303|38137329|FG004|Overall Study|Withdrawal by Subject|0|||
16993258|NCT02643303|38137330|FG005|Overall Study|Withdrawal by Subject|0|||
17059092|NCT00677807|38202347|FG002|Overall Study|Lack of Efficacy|2|||
17059093|NCT00677807|38202345|FG000|Overall Study|Participant no longer needs study drug|0|||
17059094|NCT00677807|38202346|FG001|Overall Study|Participant no longer needs study drug|0|||
17059095|NCT00677807|38202347|FG002|Overall Study|Participant no longer needs study drug|1|||
17059096|NCT00677807|38202345|FG000|Overall Study|Withdrawal by Subject|10|||
17059097|NCT00677807|38202346|FG001|Overall Study|Withdrawal by Subject|3|||
17059098|NCT00677807|38202347|FG002|Overall Study|Withdrawal by Subject|6|||
17145168|NCT03286218|38288990|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145169|NCT03286218|38288991|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145170|NCT03286218|38288992|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145171|NCT03286218|38288993|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145172|NCT03286218|38288994|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145173|NCT03286218|38288995|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145174|NCT03286218|38288996|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145175|NCT03286218|38288997|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
17145176|NCT03286218|38288986|FG000|Qualification Phase Period 2|Adverse Event|0|||
17145177|NCT03286218|38288987|FG001|Qualification Phase Period 2|Adverse Event|1|||
17145178|NCT03286218|38288988|FG002|Qualification Phase Period 2|Adverse Event|0|||
17145179|NCT03286218|38288989|FG003|Qualification Phase Period 2|Adverse Event|0|||
17145180|NCT03286218|38288990|FG004|Qualification Phase Period 2|Adverse Event|0|||
17145181|NCT03286218|38288991|FG005|Qualification Phase Period 2|Adverse Event|0|||
17145182|NCT03286218|38288992|FG006|Qualification Phase Period 2|Adverse Event|0|||
17059099|NCT00677807|38202345|FG000|Overall Study|Lost to Follow-up|2|||
17059100|NCT00677807|38202346|FG001|Overall Study|Lost to Follow-up|2|||
17059101|NCT00677807|38202347|FG002|Overall Study|Lost to Follow-up|2|||
17059102|NCT00677807|38202345|FG000|Overall Study|Administrative problems|1|||
17059103|NCT00677807|38202346|FG001|Overall Study|Administrative problems|1|||
17059104|NCT00677807|38202347|FG002|Overall Study|Administrative problems|2|||
17059105|NCT00677807|38202345|FG000|Overall Study|Death|0|||
17059106|NCT00677807|38202346|FG001|Overall Study|Death|1|||
17059107|NCT00677807|38202347|FG002|Overall Study|Death|1|||
17059108|NCT00677807|38202345|FG000|Overall Study|Protocol Deviation|1|||
17059109|NCT00677807|38202346|FG001|Overall Study|Protocol Deviation|3|||
17059110|NCT00677807|38202347|FG002|Overall Study|Protocol Deviation|0|||
17059111|NCT00687401|38202355|FG000|Overall Study|Protocol Violation|7|||
17059112|NCT00687401|38202355|FG000|Overall Study|Adverse Event|6|||
17059113|NCT00687401|38202355|FG000|Overall Study|Lack of Efficacy|6|||
17059114|NCT00687401|38202355|FG000|Overall Study|Withdrawal by Subject|4|||
17059115|NCT00687401|38202355|FG000|Overall Study|Did not return for visit|3|||
17059116|NCT00687401|38202355|FG000|Overall Study|For reasons different from those above|4|||
17059117|NCT00538902|38202375|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
17059118|NCT00538902|38202376|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
17059119|NCT00538902|38202377|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
17059120|NCT00538902|38202375|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
17059121|NCT00538902|38202376|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
17059122|NCT00538902|38202377|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
17059123|NCT00538902|38202375|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
17059124|NCT00538902|38202376|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
17059125|NCT00538902|38202377|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
17059126|NCT00538902|38202375|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
17059127|NCT00538902|38202376|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
17059128|NCT00538902|38202377|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
17059129|NCT00538902|38202375|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
17059130|NCT00538902|38202376|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
17059131|NCT00538902|38202377|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
17059132|NCT00538902|38202375|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
17059133|NCT00538902|38202376|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
17059134|NCT00538902|38202377|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
17059135|NCT00538902|38202375|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
17059136|NCT00538902|38202376|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
17059137|NCT00538902|38202377|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
17059138|NCT00538902|38202375|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
17059139|NCT00538902|38202376|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
17059140|NCT00538902|38202377|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
17059141|NCT00541970|38202391|FG000|Month 7|Protocol Violation|9|||
17059142|NCT00541970|38202392|FG001|Month 7|Protocol Violation|13|||
17059143|NCT00541970|38202393|FG002|Month 7|Protocol Violation|11|||
17059144|NCT00541970|38202394|FG003|Month 7|Protocol Violation|5|||
17059145|NCT00541970|38202391|FG000|Month 12|Adverse Event|0|||
17059146|NCT00541970|38202392|FG001|Month 12|Adverse Event|1|||
17059147|NCT00541970|38202393|FG002|Month 12|Adverse Event|1|||
17059148|NCT00541970|38202394|FG003|Month 12|Adverse Event|1|||
17059149|NCT00541970|38202391|FG000|Month 12|Protocol Violation|12|||
17059150|NCT00541970|38202392|FG001|Month 12|Protocol Violation|21|||
17059151|NCT00541970|38202393|FG002|Month 12|Protocol Violation|20|||
17059152|NCT00541970|38202394|FG003|Month 12|Protocol Violation|15|||
17059153|NCT00541970|38202391|FG000|Month 18|Adverse Event|0|||
17059154|NCT00541970|38202392|FG001|Month 18|Adverse Event|1|||
17059155|NCT00541970|38202393|FG002|Month 18|Adverse Event|1|||
17059156|NCT00541970|38202394|FG003|Month 18|Adverse Event|1|||
17059157|NCT00541970|38202391|FG000|Month 18|Protocol Violation|14|||
17059158|NCT00541970|38202392|FG001|Month 18|Protocol Violation|23|||
17059159|NCT00541970|38202393|FG002|Month 18|Protocol Violation|24|||
17059160|NCT00541970|38202394|FG003|Month 18|Protocol Violation|16|||
17059161|NCT00541970|38202391|FG000|Month 24|Adverse Event|0|||
17059162|NCT00541970|38202392|FG001|Month 24|Adverse Event|1|||
17059163|NCT00541970|38202393|FG002|Month 24|Adverse Event|1|||
17059164|NCT00541970|38202394|FG003|Month 24|Adverse Event|1|||
17059165|NCT00541970|38202391|FG000|Month 24|Protocol Violation|29|||
17059166|NCT00541970|38202392|FG001|Month 24|Protocol Violation|31|||
17059167|NCT00541970|38202393|FG002|Month 24|Protocol Violation|31|||
17059168|NCT00541970|38202394|FG003|Month 24|Protocol Violation|21|||
17059169|NCT00541970|38202391|FG000|Month 36|Protocol Violation|61|||
17059170|NCT00541970|38202392|FG001|Month 36|Protocol Violation|66|||
17059171|NCT00541970|38202393|FG002|Month 36|Protocol Violation|66|||
17059172|NCT00541970|38202394|FG003|Month 36|Protocol Violation|60|||
17059173|NCT00541970|38202391|FG000|Month 48|Withdrawal by Subject|2|||
17059174|NCT00541970|38202392|FG001|Month 48|Withdrawal by Subject|4|||
17059175|NCT00541970|38202393|FG002|Month 48|Withdrawal by Subject|4|||
17059176|NCT00541970|38202394|FG003|Month 48|Withdrawal by Subject|2|||
17059177|NCT00541970|38202391|FG000|Month 48|Other|3|||
17059178|NCT00541970|38202392|FG001|Month 48|Other|1|||
17059179|NCT00541970|38202393|FG002|Month 48|Other|1|||
17059180|NCT00541970|38202394|FG003|Month 48|Other|0|||
17059181|NCT00541970|38202391|FG000|Month 48|Lost to Follow-up|66|||
17059182|NCT00541970|38202392|FG001|Month 48|Lost to Follow-up|68|||
17059183|NCT00541970|38202393|FG002|Month 48|Lost to Follow-up|68|||
17059184|NCT00541970|38202394|FG003|Month 48|Lost to Follow-up|73|||
17059185|NCT00541970|38202391|FG000|Month 60|Protocol Violation|78|||
17059186|NCT00541970|38202392|FG001|Month 60|Protocol Violation|77|||
17059187|NCT00541970|38202393|FG002|Month 60|Protocol Violation|82|||
17059188|NCT00541970|38202394|FG003|Month 60|Protocol Violation|72|||
17059189|NCT00687323|38202404|FG000|Overall Study|Death|25|||
17059190|NCT00687323|38202404|FG000|Overall Study|Withdrawal by Subject|1|||
17059191|NCT00687323|38202404|FG000|Overall Study|Excluded from efficacy evaluations|6|||
17059192|NCT00687323|38202404|FG000|Overall Study|Screen failure|148|||
17059193|NCT03899064|38202421|FG000|Overall Study|Lost to Follow-up|1|||
17059194|NCT03899064|38202421|FG000|Overall Study|Protocol Violation|2|||
17059195|NCT03899064|38202421|FG000|Overall Study|Withdrawal by Subject|2|||
17059196|NCT03899064|38202421|FG000|Overall Study|Other|2|||
17059197|NCT03902574|38202428|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
17059198|NCT03902574|38202429|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
17059199|NCT03902574|38202430|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
17059200|NCT00542828|38202442|FG000|Overall Study|Physician Decision|1|||
17059201|NCT00542828|38202442|FG000|Overall Study|Need for Prohibited Treatment|3|||
17059202|NCT00542828|38202442|FG000|Overall Study|Study Prematurely Discontinued|7|||
17059203|NCT00542828|38202442|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
17145183|NCT03286218|38288993|FG007|Qualification Phase Period 2|Adverse Event|0|||
17059204|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
17059205|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
17059206|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
17059207|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
17059208|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
17059209|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
17059210|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
17059211|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
17059212|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
17059213|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
17059214|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
17059215|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
17059216|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
16993259|NCT02643303|38137331|FG006|Overall Study|Withdrawal by Subject|1|||
16993260|NCT02643303|38137332|FG007|Overall Study|Withdrawal by Subject|1|||
16993261|NCT02643303|38137333|FG008|Overall Study|Withdrawal by Subject|1|||
17059217|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
17059218|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
17059219|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
17059220|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
17059221|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
17059222|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
17059223|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
17059224|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
17059225|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
17059226|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
17059227|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
17145184|NCT03286218|38288994|FG008|Qualification Phase Period 2|Adverse Event|0|||
17145185|NCT03286218|38288995|FG009|Qualification Phase Period 2|Adverse Event|0|||
17145186|NCT03286218|38288996|FG010|Qualification Phase Period 2|Adverse Event|0|||
17059228|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
17059229|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
17059230|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
17059231|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
17059232|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
17059233|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
17059234|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
17059235|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
17059236|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
17059237|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
17059238|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
17059239|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
16993262|NCT00790036|38137359|FG000|Overall Study|Abnormal lab values|3|||
17059240|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
17059241|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
17059242|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
17059243|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
17059244|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
17059245|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
17059246|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
17059247|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
16993263|NCT00790036|38137360|FG001|Overall Study|Abnormal lab values|2|||
16993264|NCT00790036|38137359|FG000|Overall Study|Administrative problems|5|||
16993265|NCT00790036|38137360|FG001|Overall Study|Administrative problems|9|||
16993266|NCT00790036|38137359|FG000|Overall Study|Adverse Event|113|||
16993267|NCT00790036|38137360|FG001|Overall Study|Adverse Event|44|||
17059248|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
17059249|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
17059250|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
17059251|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
17059252|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
17059253|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
17059254|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
17059255|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
17059256|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
17059257|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
17059258|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
17059259|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
17059260|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
17059261|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
17059262|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
17059263|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
17059264|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
17059265|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
16993268|NCT00790036|38137359|FG000|Overall Study|Death|1|||
16993269|NCT00790036|38137360|FG001|Overall Study|Death|0|||
16993270|NCT00790036|38137359|FG000|Overall Study|Disease progression|24|||
16993271|NCT00790036|38137360|FG001|Overall Study|Disease progression|48|||
16993272|NCT00790036|38137359|FG000|Overall Study|Lost to Follow-up|1|||
16993273|NCT00790036|38137360|FG001|Overall Study|Lost to Follow-up|2|||
16993274|NCT00790036|38137359|FG000|Overall Study|Protocol Violation|10|||
16993275|NCT00790036|38137360|FG001|Overall Study|Protocol Violation|2|||
16993276|NCT00790036|38137359|FG000|Overall Study|Withdrawal by Subject|18|||
16993277|NCT00790036|38137360|FG001|Overall Study|Withdrawal by Subject|7|||
16993278|NCT00790036|38137359|FG000|Overall Study|Subject/guardian decision|20|||
16993279|NCT00790036|38137360|FG001|Overall Study|Subject/guardian decision|7|||
16993280|NCT00789958|38137367|FG000|Overall Study|Adverse Event|3|||
16993281|NCT00789958|38137367|FG000|Overall Study|Withdrawal by Subject|4|||
16993282|NCT00789958|38137367|FG000|Overall Study|Progression|3|||
16993283|NCT00789958|38137367|FG000|Overall Study|not protocol specified|1|||
16993284|NCT00789958|38137367|FG000|Overall Study|Not eligible/not analyzable|26|||
16993285|NCT00789880|38137379|FG000|Overall Study|Adverse Event|0|||
16993286|NCT00789880|38137380|FG001|Overall Study|Adverse Event|0|||
16993287|NCT00789880|38137381|FG002|Overall Study|Adverse Event|0|||
16993288|NCT00789880|38137382|FG003|Overall Study|Adverse Event|0|||
16993289|NCT00789880|38137383|FG004|Overall Study|Adverse Event|1|||
16993290|NCT00789880|38137384|FG005|Overall Study|Adverse Event|0|||
16993291|NCT00789880|38137379|FG000|Overall Study|Protocol Violation|0|||
16993292|NCT00789880|38137380|FG001|Overall Study|Protocol Violation|1|||
16993293|NCT00789880|38137381|FG002|Overall Study|Protocol Violation|0|||
16993294|NCT00789880|38137382|FG003|Overall Study|Protocol Violation|1|||
16993295|NCT00789880|38137383|FG004|Overall Study|Protocol Violation|0|||
16993296|NCT00789880|38137384|FG005|Overall Study|Protocol Violation|0|||
16993297|NCT00789880|38137379|FG000|Overall Study|Withdrawal by Subject|1|||
16993298|NCT00789880|38137380|FG001|Overall Study|Withdrawal by Subject|0|||
16993299|NCT00789880|38137381|FG002|Overall Study|Withdrawal by Subject|0|||
16993300|NCT00789880|38137382|FG003|Overall Study|Withdrawal by Subject|0|||
16993301|NCT00789880|38137383|FG004|Overall Study|Withdrawal by Subject|2|||
16993302|NCT00789880|38137384|FG005|Overall Study|Withdrawal by Subject|0|||
16993303|NCT00792298|38137398|FG000|Treatment Period 1|Adverse Event|0|||
16993304|NCT00792298|38137399|FG001|Treatment Period 1|Adverse Event|1|||
16993305|NCT00792298|38137400|FG002|Treatment Period 1|Adverse Event|0|||
16993306|NCT00792298|38137401|FG003|Treatment Period 1|Adverse Event|1|||
16993307|NCT00792298|38137402|FG004|Treatment Period 1|Adverse Event|0|||
16993308|NCT00792298|38137403|FG005|Treatment Period 1|Adverse Event|1|||
16993309|NCT00792298|38137404|FG006|Treatment Period 1|Adverse Event|1|||
16993310|NCT00792298|38137405|FG007|Treatment Period 1|Adverse Event|0|||
16993311|NCT00792298|38137398|FG000|Treatment Period 1|Lack of Efficacy|0|||
16993312|NCT00792298|38137399|FG001|Treatment Period 1|Lack of Efficacy|0|||
16993313|NCT00792298|38137400|FG002|Treatment Period 1|Lack of Efficacy|1|||
16993314|NCT00792298|38137401|FG003|Treatment Period 1|Lack of Efficacy|0|||
16993315|NCT00792298|38137402|FG004|Treatment Period 1|Lack of Efficacy|0|||
16993316|NCT00792298|38137403|FG005|Treatment Period 1|Lack of Efficacy|0|||
16993317|NCT00792298|38137404|FG006|Treatment Period 1|Lack of Efficacy|0|||
16993318|NCT00792298|38137405|FG007|Treatment Period 1|Lack of Efficacy|0|||
16993319|NCT00792298|38137398|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16993320|NCT00792298|38137399|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16993321|NCT00792298|38137400|FG002|Treatment Period 1|Withdrawal by Subject|1|||
16993322|NCT00792298|38137401|FG003|Treatment Period 1|Withdrawal by Subject|2|||
16993323|NCT00792298|38137402|FG004|Treatment Period 1|Withdrawal by Subject|0|||
17059266|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
17059267|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
17059268|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
17059269|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
17059270|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
17059271|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
17059272|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
17059273|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
17059274|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
17059275|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
17059276|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
17059277|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
17059278|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
17059279|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
17059280|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
17059281|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
17059282|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
17059283|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
17059284|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
17059285|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
17059286|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
17059287|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
17059288|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
17059289|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
17059290|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
17059291|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
17059292|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
17059293|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
17059294|NCT00090103|38202449|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
17059295|NCT00090103|38202450|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
17059296|NCT00090103|38202451|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
17059297|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
17059298|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
17059299|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
17059300|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
17059301|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
17059302|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
17059303|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
17059304|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
17059305|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
17059306|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
17059307|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
17059308|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
17059309|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
17059310|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
17059311|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
17059312|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
17059313|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
17059314|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
17059315|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
17059316|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
17059317|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
17059318|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
17059319|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
17145187|NCT03286218|38288997|FG011|Qualification Phase Period 2|Adverse Event|0|||
17145188|NCT03286218|38288986|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
17145189|NCT03286218|38288987|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
17059320|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
17059321|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
17059322|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
17059323|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
17059324|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
17059325|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
17059326|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
17059327|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
17059328|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
17059329|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
17059330|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
17059331|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
17059332|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
17059333|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
17059334|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
17059335|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
17059336|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
17059337|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
17059338|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
17059339|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
17059340|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
17059341|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
17059342|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
17059343|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
17059344|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
17059345|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Death|1|||
16780969|NCT02174848|37720096|FG000|Overall Study|Worsening of disease|1|||
16780970|NCT02174848|37720097|FG001|Overall Study|Worsening of disease|1|||
16780971|NCT02174848|37720096|FG000|Overall Study|Unable to comply with study requirements|1|||
16780972|NCT02174848|37720097|FG001|Overall Study|Unable to comply with study requirements|0|||
16780973|NCT02151058|37720111|FG000|Overall Study|Withdrawal by Subject|1|||
16780974|NCT02151058|37720112|FG001|Overall Study|Withdrawal by Subject|1|||
16780975|NCT02151058|37720113|FG002|Overall Study|Withdrawal by Subject|3|||
16780976|NCT02151058|37720111|FG000|Overall Study|Lost to Follow-up|1|||
16780977|NCT02151058|37720112|FG001|Overall Study|Lost to Follow-up|0|||
16780978|NCT02151058|37720113|FG002|Overall Study|Lost to Follow-up|2|||
16780979|NCT02149810|37720123|FG000|Overall Study|Physician Decision|1|||
16780980|NCT02149810|37720124|FG001|Overall Study|Physician Decision|2|||
16780981|NCT02149810|37720123|FG000|Overall Study|Lost to Follow-up|2|||
16780982|NCT02149810|37720124|FG001|Overall Study|Lost to Follow-up|1|||
17059346|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Death|0|||
17059347|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Death|1|||
17059348|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
17059349|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
17059350|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
17059351|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
17059352|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
17059353|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
17059354|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
17059355|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
17059356|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
17059357|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
17059358|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
17059359|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
17059360|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
17059361|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
17059362|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
17059363|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
17059364|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
17059365|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
17059366|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
17059367|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
17059368|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
17059369|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Depression|0|||
17059370|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Depression|1|||
17059371|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Depression|0|||
17059372|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
17059373|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
17059374|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
17059375|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Jailed|0|||
17059376|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Jailed|1|||
17059377|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Jailed|0|||
17059378|NCT00090103|38202449|FG000|16-Week Safety Follow-up Period|Other|0|||
17059379|NCT00090103|38202450|FG001|16-Week Safety Follow-up Period|Other|1|||
17059380|NCT00090103|38202451|FG002|16-Week Safety Follow-up Period|Other|0|||
17059381|NCT00087607|38202461|FG000|Overall Study|Adverse Event|14|||
16780983|NCT02149810|37720123|FG000|Overall Study|Withdrawal by Subject|5|||
16780984|NCT02149810|37720124|FG001|Overall Study|Withdrawal by Subject|1|||
16780985|NCT02149420|37720133|FG000|Core Study|Administrative problems|0|||
16780986|NCT02149420|37720134|FG001|Core Study|Administrative problems|1|||
17059382|NCT00087607|38202462|FG001|Overall Study|Adverse Event|24|||
17059383|NCT00087607|38202461|FG000|Overall Study|Death|0|||
17059384|NCT00087607|38202462|FG001|Overall Study|Death|1|||
17059385|NCT00087607|38202461|FG000|Overall Study|Insufficient Therapeutic Response|53|||
17059386|NCT00087607|38202462|FG001|Overall Study|Insufficient Therapeutic Response|42|||
17059387|NCT00087607|38202461|FG000|Overall Study|Failure to return|21|||
17059388|NCT00087607|38202462|FG001|Overall Study|Failure to return|17|||
17059389|NCT00087607|38202461|FG000|Overall Study|Withdrew Consent|12|||
17059390|NCT00087607|38202462|FG001|Overall Study|Withdrew Consent|16|||
17059391|NCT00087607|38202461|FG000|Overall Study|Administrative|12|||
17145190|NCT03286218|38288988|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145191|NCT03286218|38288989|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145192|NCT03286218|38288990|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145193|NCT03286218|38288991|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145194|NCT03286218|38288992|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145195|NCT03286218|38288993|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145196|NCT03286218|38288994|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145197|NCT03286218|38288995|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145198|NCT03286218|38288996|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
17145199|NCT03286218|38288997|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16993324|NCT00792298|38137403|FG005|Treatment Period 1|Withdrawal by Subject|2|||
16993325|NCT00792298|38137404|FG006|Treatment Period 1|Withdrawal by Subject|1|||
16993326|NCT00792298|38137405|FG007|Treatment Period 1|Withdrawal by Subject|0|||
16993327|NCT00792298|38137398|FG000|Treatment Period 1|Lost to Follow-up|0|||
17145200|NCT03286218|38288986|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
17145201|NCT03286218|38288987|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
17145202|NCT03286218|38288988|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
17145203|NCT03286218|38288989|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
17145204|NCT03286218|38288990|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
17145205|NCT03286218|38288991|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
17145206|NCT03286218|38288992|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
17145207|NCT03286218|38288993|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
17145208|NCT03286218|38288994|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
17145209|NCT03286218|38288995|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
17145210|NCT03286218|38288996|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
17145211|NCT03286218|38288997|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
17145212|NCT03286218|38288986|FG000|Qualification Phase Period 2|Protocol Violation|2|||
17145213|NCT03286218|38288987|FG001|Qualification Phase Period 2|Protocol Violation|0|||
16993328|NCT00792298|38137399|FG001|Treatment Period 1|Lost to Follow-up|0|||
16993329|NCT00792298|38137400|FG002|Treatment Period 1|Lost to Follow-up|0|||
16993330|NCT00792298|38137401|FG003|Treatment Period 1|Lost to Follow-up|0|||
17145214|NCT03286218|38288988|FG002|Qualification Phase Period 2|Protocol Violation|0|||
17145215|NCT03286218|38288989|FG003|Qualification Phase Period 2|Protocol Violation|0|||
17145216|NCT03286218|38288990|FG004|Qualification Phase Period 2|Protocol Violation|0|||
17145217|NCT03286218|38288991|FG005|Qualification Phase Period 2|Protocol Violation|0|||
17145218|NCT03286218|38288992|FG006|Qualification Phase Period 2|Protocol Violation|0|||
17145219|NCT03286218|38288993|FG007|Qualification Phase Period 2|Protocol Violation|0|||
17145220|NCT03286218|38288994|FG008|Qualification Phase Period 2|Protocol Violation|0|||
17145221|NCT03286218|38288995|FG009|Qualification Phase Period 2|Protocol Violation|0|||
17145222|NCT03286218|38288996|FG010|Qualification Phase Period 2|Protocol Violation|0|||
17145223|NCT03286218|38288997|FG011|Qualification Phase Period 2|Protocol Violation|0|||
17145224|NCT03286218|38288986|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
17145225|NCT03286218|38288987|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
17145226|NCT03286218|38288988|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
17145227|NCT03286218|38288989|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
17145228|NCT03286218|38288990|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
17145229|NCT03286218|38288991|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
16993331|NCT00792298|38137402|FG004|Treatment Period 1|Lost to Follow-up|0|||
17059392|NCT00087607|38202462|FG001|Overall Study|Administrative|12|||
17145230|NCT03286218|38288992|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
17145231|NCT03286218|38288993|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
17145232|NCT03286218|38288994|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
17145233|NCT03286218|38288995|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
17059393|NCT00087607|38202461|FG000|Overall Study|Refused Treatment|5|||
17145234|NCT03286218|38288996|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
17145235|NCT03286218|38288997|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
17145236|NCT03286218|38288986|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
17145237|NCT03286218|38288987|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
17145238|NCT03286218|38288988|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
17145239|NCT03286218|38288989|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
17145240|NCT03286218|38288990|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
17145241|NCT03286218|38288991|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
17145242|NCT03286218|38288992|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
17145243|NCT03286218|38288993|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
17145244|NCT03286218|38288994|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
17145245|NCT03286218|38288995|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
17145246|NCT03286218|38288996|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
17145247|NCT03286218|38288997|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
17145248|NCT03286218|38288986|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145249|NCT03286218|38288987|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145250|NCT03286218|38288988|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145251|NCT03286218|38288989|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145252|NCT03286218|38288990|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145253|NCT03286218|38288991|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145254|NCT03286218|38288992|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145255|NCT03286218|38288993|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145256|NCT03286218|38288994|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145257|NCT03286218|38288995|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145258|NCT03286218|38288996|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
17145259|NCT03286218|38288997|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
17145260|NCT03224325|38289031|FG000|Overall Study|Adverse Event|1|||
17145261|NCT03224325|38289032|FG001|Overall Study|Adverse Event|0|||
17145262|NCT03224325|38289033|FG002|Overall Study|Adverse Event|0|||
17145263|NCT03224325|38289034|FG003|Overall Study|Adverse Event|0|||
17145264|NCT03224325|38289035|FG004|Overall Study|Adverse Event|0|||
17145265|NCT03224325|38289036|FG005|Overall Study|Adverse Event|0|||
17145266|NCT03224325|38289037|FG006|Overall Study|Adverse Event|1|||
17145267|NCT03224325|38289031|FG000|Overall Study|Withdrawal by Subject|0|||
17145268|NCT03224325|38289032|FG001|Overall Study|Withdrawal by Subject|0|||
17145269|NCT03224325|38289033|FG002|Overall Study|Withdrawal by Subject|0|||
17145270|NCT03224325|38289034|FG003|Overall Study|Withdrawal by Subject|1|||
17145271|NCT03224325|38289035|FG004|Overall Study|Withdrawal by Subject|0|||
17145272|NCT03224325|38289036|FG005|Overall Study|Withdrawal by Subject|0|||
17145273|NCT03224325|38289037|FG006|Overall Study|Withdrawal by Subject|0|||
17145274|NCT04016779|38289061|FG000|Overall Study|Adverse Event|9|||
17145275|NCT04016779|38289062|FG001|Overall Study|Adverse Event|17|||
17145276|NCT04016779|38289061|FG000|Overall Study|Lack of Efficacy|4|||
17145277|NCT04016779|38289062|FG001|Overall Study|Lack of Efficacy|1|||
17145278|NCT04016779|38289061|FG000|Overall Study|Lost to Follow-up|5|||
17145279|NCT04016779|38289062|FG001|Overall Study|Lost to Follow-up|14|||
17145280|NCT04016779|38289061|FG000|Overall Study|Physician Decision|1|||
17145281|NCT04016779|38289062|FG001|Overall Study|Physician Decision|3|||
17145282|NCT04016779|38289061|FG000|Overall Study|Withdrawal by Subject|6|||
17145283|NCT04016779|38289062|FG001|Overall Study|Withdrawal by Subject|8|||
17145284|NCT04016779|38289061|FG000|Overall Study|Non-compliance with Study Drug|2|||
17145285|NCT04016779|38289062|FG001|Overall Study|Non-compliance with Study Drug|3|||
17145286|NCT04016779|38289061|FG000|Overall Study|Other, Multiple categories|17|||
17145287|NCT04016779|38289062|FG001|Overall Study|Other, Multiple categories|17|||
17145288|NCT02857426|38289072|FG000|Overall Study|Disease progression|34|||
17145289|NCT02857426|38289073|FG001|Overall Study|Disease progression|13|||
17145290|NCT02857426|38289072|FG000|Overall Study|Study drug toxicity|4|||
17145291|NCT02857426|38289073|FG001|Overall Study|Study drug toxicity|1|||
17145292|NCT02857426|38289072|FG000|Overall Study|Death|1|||
17145293|NCT02857426|38289073|FG001|Overall Study|Death|0|||
17145294|NCT02857426|38289072|FG000|Overall Study|Adverse event unrelated to study drug|6|||
17145295|NCT02857426|38289073|FG001|Overall Study|Adverse event unrelated to study drug|2|||
17145296|NCT02857426|38289072|FG000|Overall Study|Participant withdrew consent|1|||
17145297|NCT02857426|38289073|FG001|Overall Study|Participant withdrew consent|1|||
17145298|NCT02857426|38289072|FG000|Overall Study|Maximum clinical benefit|1|||
17145299|NCT02857426|38289073|FG001|Overall Study|Maximum clinical benefit|0|||
17145300|NCT02857426|38289072|FG000|Overall Study|Completed treatment|0|||
17145301|NCT02857426|38289073|FG001|Overall Study|Completed treatment|2|||
17145302|NCT01127256|38289081|FG000|Overall Study|Adverse Event|13|||
17145303|NCT01127256|38289082|FG001|Overall Study|Adverse Event|13|||
17145304|NCT01127256|38289081|FG000|Overall Study|Lack of Efficacy|4|||
17145305|NCT01127256|38289082|FG001|Overall Study|Lack of Efficacy|0|||
17145306|NCT01127256|38289081|FG000|Overall Study|Lost to Follow-up|16|||
17145307|NCT01127256|38289082|FG001|Overall Study|Lost to Follow-up|17|||
17145308|NCT01127256|38289081|FG000|Overall Study|Withdrawal by Subject|5|||
17145309|NCT01127256|38289082|FG001|Overall Study|Withdrawal by Subject|9|||
17145310|NCT01127256|38289081|FG000|Overall Study|Protocol Violation|1|||
17145311|NCT01127256|38289082|FG001|Overall Study|Protocol Violation|0|||
17145312|NCT03668613|38289090|FG000|Overall Study|Adverse Event|0|||
17145313|NCT03668613|38289091|FG001|Overall Study|Adverse Event|2|||
17145314|NCT03668613|38289090|FG000|Overall Study|Lack of Efficacy|0|||
17145315|NCT03668613|38289091|FG001|Overall Study|Lack of Efficacy|1|||
17145316|NCT04016311|38289100|FG000|Overall Study|Withdrawal by Subject|1|||
17145317|NCT04016311|38289101|FG001|Overall Study|Withdrawal by Subject|0|||
17145318|NCT04052425|38289111|FG000|24-Week Double-blind Period|Adverse Event|0|||
17145319|NCT04052425|38289112|FG001|24-Week Double-blind Period|Adverse Event|1|||
17145320|NCT04052425|38289113|FG002|24-Week Double-blind Period|Adverse Event|0|||
16780987|NCT02149420|37720135|FG002|Core Study|Administrative problems|2|||
16780988|NCT02149420|37720133|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
16780989|NCT02149420|37720134|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
16780990|NCT02149420|37720135|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
16780991|NCT02149264|37720148|FG000|Overall Study|Withdrawal by Subject|9|||
16780992|NCT02149264|37720148|FG000|Overall Study|Adverse Event|7|||
16780993|NCT02149264|37720148|FG000|Overall Study|Physician Decision|3|||
16780994|NCT02149264|37720148|FG000|Overall Study|Protocol Violation|1|||
16780995|NCT02115256|37720154|FG000|Overall Study|Withdrawal by Subject|0|||
16780996|NCT02115256|37720155|FG001|Overall Study|Withdrawal by Subject|1|||
16780997|NCT02173054|37720164|FG000|Overall Study|lack of compliance|1|||
16780998|NCT02173054|37720165|FG001|Overall Study|lack of compliance|0|||
16780999|NCT02173054|37720166|FG002|Overall Study|lack of compliance|0|||
16781000|NCT02173054|37720164|FG000|Overall Study|Withdrawal by Subject|0|||
16781001|NCT02173054|37720165|FG001|Overall Study|Withdrawal by Subject|0|||
16781002|NCT02173054|37720166|FG002|Overall Study|Withdrawal by Subject|1|||
16781003|NCT02149108|37720195|FG000|Overall Study|Not treated|1|||
16781004|NCT02149108|37720196|FG001|Overall Study|Not treated|2|||
16781005|NCT02149108|37720195|FG000|Overall Study|Progressive Disease (PD)|324|||
16781006|NCT02149108|37720196|FG001|Overall Study|Progressive Disease (PD)|318|||
16781007|NCT02149108|37720195|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
16781008|NCT02149108|37720196|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
16781009|NCT02149108|37720195|FG000|Overall Study|Other Adverse Event (AE)|8|||
16781010|NCT02149108|37720196|FG001|Overall Study|Other Adverse Event (AE)|18|||
16781011|NCT02149108|37720195|FG000|Overall Study|Other not defined above|0|||
16781012|NCT02149108|37720196|FG001|Overall Study|Other not defined above|2|||
16781013|NCT02149108|37720195|FG000|Overall Study|Refusal to continue trial medication|15|||
16781014|NCT02149108|37720196|FG001|Overall Study|Refusal to continue trial medication|11|||
16781015|NCT02149108|37720195|FG000|Overall Study|Lost to Follow-up|1|||
16781016|NCT02149108|37720196|FG001|Overall Study|Lost to Follow-up|0|||
16781017|NCT02148952|37720204|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
16781018|NCT02148952|37720205|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
16781019|NCT02148952|37720204|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
16781020|NCT02148952|37720205|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
16781021|NCT02148952|37720204|FG000|Follow-Up|Lost to Follow-up|219|||
16781022|NCT02148952|37720205|FG001|Follow-Up|Lost to Follow-up|231|||
16781023|NCT02148952|37720204|FG000|Follow-Up|Withdrawal by Subject|46|||
16781024|NCT02148952|37720205|FG001|Follow-Up|Withdrawal by Subject|48|||
16781025|NCT02148718|37720229|FG000|Overall Study|Protocol Violation|26|||
16781026|NCT02148718|37720229|FG000|Overall Study|Discontinued Study Prematurely|5|||
16781027|NCT02148250|37720233|FG000|Screening|Withdrawal by Subject|5|||
16781028|NCT02148250|37720234|FG001|Screening|Withdrawal by Subject|0|||
16781029|NCT02147626|37720243|FG000|Overall Study|Lost to Follow-up|4|||
16781030|NCT02147626|37720244|FG001|Overall Study|Lost to Follow-up|4|||
16781031|NCT02147626|37720243|FG000|Overall Study|Pregnancy|1|||
16781032|NCT02147626|37720244|FG001|Overall Study|Pregnancy|2|||
16781033|NCT02147626|37720243|FG000|Overall Study|Withdrawal by Subject|0|||
16781034|NCT02147626|37720244|FG001|Overall Study|Withdrawal by Subject|1|||
16781035|NCT02172664|37720250|FG000|Overall Study|Lost to Follow-up|4|||
16781036|NCT02172664|37720251|FG001|Overall Study|Lost to Follow-up|4|||
16781037|NCT02172664|37720250|FG000|Overall Study|Death|1|||
16781038|NCT02172664|37720251|FG001|Overall Study|Death|1|||
16781039|NCT02172664|37720250|FG000|Overall Study|Moved out of area|1|||
16781040|NCT02172664|37720251|FG001|Overall Study|Moved out of area|1|||
16781041|NCT02172040|37720260|FG000|Overall Study|Adverse Event|0|||
16781042|NCT02172040|37720261|FG001|Overall Study|Adverse Event|2|||
16781043|NCT02172040|37720262|FG002|Overall Study|Adverse Event|0|||
16781044|NCT02172040|37720263|FG003|Overall Study|Adverse Event|0|||
16781045|NCT02172040|37720260|FG000|Overall Study|Protocol Violation|0|||
16781046|NCT02172040|37720261|FG001|Overall Study|Protocol Violation|1|||
16781047|NCT02172040|37720262|FG002|Overall Study|Protocol Violation|0|||
16781048|NCT02172040|37720263|FG003|Overall Study|Protocol Violation|0|||
16781049|NCT02172040|37720260|FG000|Overall Study|Withdrawal by Subject|0|||
16781050|NCT02172040|37720261|FG001|Overall Study|Withdrawal by Subject|0|||
16781051|NCT02172040|37720262|FG002|Overall Study|Withdrawal by Subject|1|||
16781052|NCT02172040|37720263|FG003|Overall Study|Withdrawal by Subject|0|||
16781053|NCT02172040|37720260|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
16781054|NCT02172040|37720261|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
16781055|NCT02172040|37720262|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
16781056|NCT02172040|37720263|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
16781057|NCT02172040|37720260|FG000|Overall Study|Family emergency abroad|0|||
16781058|NCT02172040|37720261|FG001|Overall Study|Family emergency abroad|0|||
16781059|NCT02172040|37720262|FG002|Overall Study|Family emergency abroad|0|||
16781060|NCT02172040|37720263|FG003|Overall Study|Family emergency abroad|1|||
16781061|NCT02112994|37720303|FG000|Overall Study|Progressive Disease|0|||
16781062|NCT02112994|37720304|FG001|Overall Study|Progressive Disease|0|||
16781063|NCT02112994|37720305|FG002|Overall Study|Progressive Disease|1|||
16781064|NCT02112994|37720303|FG000|Overall Study|Pregnancy|0|||
16781065|NCT02112994|37720304|FG001|Overall Study|Pregnancy|1|||
16781066|NCT02112994|37720305|FG002|Overall Study|Pregnancy|1|||
16781067|NCT02112994|37720303|FG000|Overall Study|Liver Transplant|0|||
16781068|NCT02112994|37720304|FG001|Overall Study|Liver Transplant|1|||
16781069|NCT02112994|37720305|FG002|Overall Study|Liver Transplant|0|||
16781070|NCT02112994|37720303|FG000|Overall Study|Withdrawal by Subject|0|||
16781071|NCT02112994|37720304|FG001|Overall Study|Withdrawal by Subject|0|||
16781072|NCT02112994|37720305|FG002|Overall Study|Withdrawal by Subject|1|||
16781073|NCT02147158|37720323|FG000|Treatment Course 1|Adverse Event|1|||
16781074|NCT02147158|37720324|FG001|Treatment Course 1|Adverse Event|4|||
16781075|NCT02147158|37720325|FG002|Treatment Course 1|Adverse Event|3|||
16781076|NCT02147158|37720326|FG003|Treatment Course 1|Adverse Event|4|||
16781077|NCT02147158|37720327|FG004|Treatment Course 1|Adverse Event|1|||
16781078|NCT02147158|37720328|FG005|Treatment Course 1|Adverse Event|2|||
16781079|NCT02147158|37720323|FG000|Treatment Course 1|Lost to Follow-up|2|||
16781080|NCT02147158|37720324|FG001|Treatment Course 1|Lost to Follow-up|4|||
16781081|NCT02147158|37720325|FG002|Treatment Course 1|Lost to Follow-up|3|||
16781082|NCT02147158|37720326|FG003|Treatment Course 1|Lost to Follow-up|3|||
16781083|NCT02147158|37720327|FG004|Treatment Course 1|Lost to Follow-up|2|||
16781084|NCT02147158|37720328|FG005|Treatment Course 1|Lost to Follow-up|4|||
16781085|NCT02147158|37720323|FG000|Treatment Course 1|Protocol Violation|0|||
16781086|NCT02147158|37720324|FG001|Treatment Course 1|Protocol Violation|0|||
16781087|NCT02147158|37720325|FG002|Treatment Course 1|Protocol Violation|1|||
16781088|NCT02147158|37720326|FG003|Treatment Course 1|Protocol Violation|1|||
16781089|NCT02147158|37720327|FG004|Treatment Course 1|Protocol Violation|0|||
16781090|NCT02147158|37720328|FG005|Treatment Course 1|Protocol Violation|0|||
16781091|NCT02147158|37720323|FG000|Treatment Course 1|Withdrawal of Consent|1|||
16781092|NCT02147158|37720324|FG001|Treatment Course 1|Withdrawal of Consent|1|||
16781093|NCT02147158|37720325|FG002|Treatment Course 1|Withdrawal of Consent|1|||
16781094|NCT02147158|37720326|FG003|Treatment Course 1|Withdrawal of Consent|5|||
16781095|NCT02147158|37720327|FG004|Treatment Course 1|Withdrawal of Consent|3|||
16781096|NCT02147158|37720328|FG005|Treatment Course 1|Withdrawal of Consent|2|||
16781097|NCT02147158|37720323|FG000|Off-Treatment Interval 1|Adverse Event|1|||
16781098|NCT02147158|37720324|FG001|Off-Treatment Interval 1|Adverse Event|0|||
16781099|NCT02147158|37720325|FG002|Off-Treatment Interval 1|Adverse Event|0|||
16781100|NCT02147158|37720326|FG003|Off-Treatment Interval 1|Adverse Event|1|||
16781101|NCT02147158|37720327|FG004|Off-Treatment Interval 1|Adverse Event|0|||
16781102|NCT02147158|37720328|FG005|Off-Treatment Interval 1|Adverse Event|0|||
16781103|NCT02147158|37720323|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
16781104|NCT02147158|37720324|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
16781105|NCT02147158|37720325|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
16781106|NCT02147158|37720326|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
16781107|NCT02147158|37720327|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
16781108|NCT02147158|37720328|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
16781109|NCT02147158|37720323|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
16781110|NCT02147158|37720324|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
16781111|NCT02147158|37720325|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
16781112|NCT02147158|37720326|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
16781113|NCT02147158|37720327|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
16781114|NCT02147158|37720328|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
16781115|NCT02147158|37720323|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
16781116|NCT02147158|37720324|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
16781117|NCT02147158|37720325|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
16781118|NCT02147158|37720326|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
16781119|NCT02147158|37720327|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
16781120|NCT02147158|37720328|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
16781121|NCT02147158|37720323|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
16781122|NCT02147158|37720324|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
16781123|NCT02147158|37720325|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
16781124|NCT02147158|37720326|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
16781125|NCT02147158|37720327|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
16781126|NCT02147158|37720328|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
16781127|NCT02147158|37720323|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
16781128|NCT02147158|37720324|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
16781129|NCT02147158|37720325|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
16781130|NCT02147158|37720326|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
16781131|NCT02147158|37720327|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
16781132|NCT02147158|37720328|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
16781133|NCT02147158|37720323|FG000|Treatment Course 2|Adverse Event|0|||
16781134|NCT02147158|37720324|FG001|Treatment Course 2|Adverse Event|4|||
16781135|NCT02147158|37720325|FG002|Treatment Course 2|Adverse Event|2|||
16781136|NCT02147158|37720326|FG003|Treatment Course 2|Adverse Event|1|||
16781137|NCT02147158|37720327|FG004|Treatment Course 2|Adverse Event|0|||
17059394|NCT00087607|38202462|FG001|Overall Study|Refused Treatment|7|||
17059395|NCT00087607|38202461|FG000|Overall Study|Other Protocol Violation|5|||
17059396|NCT00087607|38202462|FG001|Overall Study|Other Protocol Violation|2|||
17059397|NCT00087607|38202461|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
17059398|NCT00087607|38202462|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
17059399|NCT00069823|38202474|FG000|Overall Study|Did not have follow-up diary cards|6|||
17059400|NCT00069823|38202475|FG001|Overall Study|Did not have follow-up diary cards|3|||
17059401|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
17059402|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
17059403|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
17059404|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
17059405|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
17059406|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
17059407|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
17059408|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
17059409|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
17059410|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
17059411|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
17059412|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
17059413|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
17059414|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
17059415|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
17059416|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
17059417|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
17059418|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
17059419|NCT00086515|38202487|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
17059420|NCT00086515|38202488|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
17059421|NCT00086515|38202487|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
17059422|NCT00086515|38202488|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
17059423|NCT00086515|38202487|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
17059424|NCT00086515|38202488|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
17059425|NCT00086515|38202487|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
17059426|NCT00086515|38202488|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
17059427|NCT00086515|38202487|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
17059428|NCT00086515|38202488|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
16781138|NCT02147158|37720328|FG005|Treatment Course 2|Adverse Event|1|||
16781139|NCT02147158|37720323|FG000|Treatment Course 2|Withdrawal of Consent|0|||
16781140|NCT02147158|37720324|FG001|Treatment Course 2|Withdrawal of Consent|1|||
16781141|NCT02147158|37720325|FG002|Treatment Course 2|Withdrawal of Consent|2|||
16781142|NCT02147158|37720326|FG003|Treatment Course 2|Withdrawal of Consent|3|||
16781143|NCT02147158|37720327|FG004|Treatment Course 2|Withdrawal of Consent|0|||
16781144|NCT02147158|37720328|FG005|Treatment Course 2|Withdrawal of Consent|0|||
16781145|NCT02147158|37720323|FG000|Treatment Course 2|Lost to Follow-up|1|||
17059429|NCT00086515|38202487|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
17059430|NCT00086515|38202488|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
17059431|NCT00086515|38202487|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
17145321|NCT04052425|38289114|FG003|24-Week Double-blind Period|Adverse Event|0|||
17145322|NCT04052425|38289111|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
16781146|NCT02147158|37720324|FG001|Treatment Course 2|Lost to Follow-up|0|||
16781147|NCT02147158|37720325|FG002|Treatment Course 2|Lost to Follow-up|1|||
16781148|NCT02147158|37720326|FG003|Treatment Course 2|Lost to Follow-up|1|||
16781149|NCT02147158|37720327|FG004|Treatment Course 2|Lost to Follow-up|0|||
16781150|NCT02147158|37720328|FG005|Treatment Course 2|Lost to Follow-up|1|||
16781151|NCT02147158|37720323|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
16781152|NCT02147158|37720324|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
16781153|NCT02147158|37720325|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
16781154|NCT02147158|37720326|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
16781155|NCT02147158|37720327|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
16781156|NCT02147158|37720328|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
16781157|NCT02147158|37720323|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
16781158|NCT02147158|37720324|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
16781159|NCT02147158|37720325|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
16781160|NCT02147158|37720326|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
16781161|NCT02147158|37720327|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
16781162|NCT02147158|37720328|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
17145323|NCT04052425|38289112|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
17145324|NCT04052425|38289113|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
17145325|NCT04052425|38289114|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
17145326|NCT04052425|38289111|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
17145327|NCT04052425|38289112|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
17145328|NCT04052425|38289113|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
17145329|NCT04052425|38289114|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
17145330|NCT04052425|38289111|FG000|24-Week Double-blind Period|Physician Decision|1|||
17145331|NCT04052425|38289112|FG001|24-Week Double-blind Period|Physician Decision|0|||
17145332|NCT04052425|38289113|FG002|24-Week Double-blind Period|Physician Decision|0|||
17145333|NCT04052425|38289114|FG003|24-Week Double-blind Period|Physician Decision|0|||
17145334|NCT04052425|38289111|FG000|24-Week Double-blind Period|Protocol Violation|1|||
17145335|NCT04052425|38289112|FG001|24-Week Double-blind Period|Protocol Violation|0|||
17145336|NCT04052425|38289113|FG002|24-Week Double-blind Period|Protocol Violation|0|||
17145337|NCT04052425|38289114|FG003|24-Week Double-blind Period|Protocol Violation|0|||
17145338|NCT04052425|38289111|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
17145339|NCT04052425|38289112|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
17145340|NCT04052425|38289113|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
17145341|NCT04052425|38289114|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
17145342|NCT04052425|38289111|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
17145343|NCT04052425|38289112|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
17059432|NCT00086515|38202488|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
17059433|NCT00086515|38202487|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
17059434|NCT00086515|38202488|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
17059435|NCT00086515|38202487|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
17059436|NCT00086515|38202488|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
17059437|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
17059438|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
17059439|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
17059440|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
17059441|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
17059442|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
17059443|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
17059444|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
17059445|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
17059446|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
17059447|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
17145344|NCT04052425|38289113|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
17145345|NCT04052425|38289114|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
17145346|NCT04052425|38289111|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
17059448|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
17059449|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
17059450|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
17059451|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
17059452|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
17059453|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
17059454|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
17059455|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
17059456|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
17059457|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
17059458|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
17059459|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
17059460|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
17059461|NCT00086515|38202487|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
17059462|NCT00086515|38202488|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
17059463|NCT00541658|38202497|FG000|Overall Study|Adverse Event|28|||
17059464|NCT00541658|38202498|FG001|Overall Study|Adverse Event|37|||
17059465|NCT00541658|38202499|FG002|Overall Study|Adverse Event|25|||
17059466|NCT00541658|38202497|FG000|Overall Study|Physician Decision|0|||
17059467|NCT00541658|38202498|FG001|Overall Study|Physician Decision|0|||
17059468|NCT00541658|38202499|FG002|Overall Study|Physician Decision|4|||
17059469|NCT00541658|38202497|FG000|Overall Study|Lost to Follow-up|3|||
17059470|NCT00541658|38202498|FG001|Overall Study|Lost to Follow-up|3|||
17059471|NCT00541658|38202499|FG002|Overall Study|Lost to Follow-up|6|||
17059472|NCT00541658|38202497|FG000|Overall Study|Protocol Violation|0|||
17059473|NCT00541658|38202498|FG001|Overall Study|Protocol Violation|1|||
17059474|NCT00541658|38202499|FG002|Overall Study|Protocol Violation|1|||
17059475|NCT00541658|38202497|FG000|Overall Study|Withdrawal by Subject|28|||
17059476|NCT00541658|38202498|FG001|Overall Study|Withdrawal by Subject|32|||
17059477|NCT00541658|38202499|FG002|Overall Study|Withdrawal by Subject|32|||
17059478|NCT00541658|38202497|FG000|Overall Study|Took No Study Drug|1|||
17059479|NCT00541658|38202498|FG001|Overall Study|Took No Study Drug|0|||
17059480|NCT00541658|38202499|FG002|Overall Study|Took No Study Drug|0|||
17059481|NCT03907280|38202523|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
17059482|NCT03907280|38202524|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
17059483|NCT03907280|38202525|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
17059484|NCT04120376|38202537|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
17059485|NCT04120376|38202538|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
17059486|NCT03905642|38202545|FG000|Overall Study|Withdrawal by Subject|3|||
17059487|NCT03905642|38202545|FG000|Overall Study|Pregnancy|1|||
17059488|NCT03905642|38202545|FG000|Overall Study|Adverse Event|1|||
17059489|NCT03905642|38202545|FG000|Overall Study|Lack of Efficacy|1|||
17059490|NCT03905642|38202545|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
17059491|NCT00412984|38202585|FG000|Overall Study|Death|331|||
17059492|NCT00412984|38202586|FG001|Overall Study|Death|349|||
17059493|NCT00412984|38202585|FG000|Overall Study|Adverse Event|679|||
17145347|NCT04052425|38289112|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
17145348|NCT04052425|38289113|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
17059494|NCT00412984|38202586|FG001|Overall Study|Adverse Event|738|||
17059495|NCT00412984|38202585|FG000|Overall Study|Withdrawal by Subject|921|||
17059496|NCT00412984|38202586|FG001|Overall Study|Withdrawal by Subject|989|||
17059497|NCT00412984|38202585|FG000|Overall Study|Lost to Follow-up|51|||
17145349|NCT04052425|38289114|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
17145350|NCT04052425|38289111|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
17145351|NCT04052425|38289112|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
17145352|NCT04052425|38289113|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
17145353|NCT04052425|38289114|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
17059498|NCT00412984|38202586|FG001|Overall Study|Lost to Follow-up|39|||
17059499|NCT00412984|38202585|FG000|Overall Study|Poor/Noncompliance|57|||
16993332|NCT00792298|38137403|FG005|Treatment Period 1|Lost to Follow-up|0|||
16993333|NCT00792298|38137404|FG006|Treatment Period 1|Lost to Follow-up|1|||
16993334|NCT00792298|38137405|FG007|Treatment Period 1|Lost to Follow-up|0|||
16993335|NCT00792298|38137398|FG000|Treatment Period 1|Physician Decision|0|||
16993336|NCT00792298|38137399|FG001|Treatment Period 1|Physician Decision|0|||
16993337|NCT00792298|38137400|FG002|Treatment Period 1|Physician Decision|0|||
16993338|NCT00792298|38137401|FG003|Treatment Period 1|Physician Decision|1|||
16993339|NCT00792298|38137402|FG004|Treatment Period 1|Physician Decision|0|||
16993340|NCT00792298|38137403|FG005|Treatment Period 1|Physician Decision|0|||
16993341|NCT00792298|38137404|FG006|Treatment Period 1|Physician Decision|1|||
16993342|NCT00792298|38137405|FG007|Treatment Period 1|Physician Decision|0|||
16993343|NCT00792298|38137398|FG000|Treatment Period 1|Protocol Violation|0|||
16993344|NCT00792298|38137399|FG001|Treatment Period 1|Protocol Violation|0|||
16993345|NCT00792298|38137400|FG002|Treatment Period 1|Protocol Violation|0|||
16993346|NCT00792298|38137401|FG003|Treatment Period 1|Protocol Violation|0|||
16993347|NCT00792298|38137402|FG004|Treatment Period 1|Protocol Violation|0|||
16993348|NCT00792298|38137403|FG005|Treatment Period 1|Protocol Violation|0|||
16993349|NCT00792298|38137404|FG006|Treatment Period 1|Protocol Violation|0|||
16993350|NCT00792298|38137405|FG007|Treatment Period 1|Protocol Violation|1|||
16993351|NCT00792298|38137398|FG000|Washout|Adverse Event|0|||
16993352|NCT00792298|38137399|FG001|Washout|Adverse Event|0|||
16993353|NCT00792298|38137400|FG002|Washout|Adverse Event|0|||
16993354|NCT00792298|38137401|FG003|Washout|Adverse Event|0|||
16993355|NCT00792298|38137402|FG004|Washout|Adverse Event|0|||
16993356|NCT00792298|38137403|FG005|Washout|Adverse Event|1|||
16993357|NCT00792298|38137404|FG006|Washout|Adverse Event|0|||
17059500|NCT00412984|38202586|FG001|Overall Study|Poor/Noncompliance|77|||
17059501|NCT00412984|38202585|FG000|Overall Study|Pregnancy|1|||
17059502|NCT00412984|38202586|FG001|Overall Study|Pregnancy|0|||
17059503|NCT00412984|38202585|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
17059504|NCT00412984|38202586|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
17059505|NCT00412984|38202585|FG000|Overall Study|Administrative Reason by Sponsor|11|||
17059506|NCT00412984|38202586|FG001|Overall Study|Administrative Reason by Sponsor|8|||
17059507|NCT00412984|38202585|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
17059508|NCT00412984|38202586|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
17059509|NCT00412984|38202585|FG000|Overall Study|Other Reason|80|||
17059510|NCT00412984|38202586|FG001|Overall Study|Other Reason|92|||
17059511|NCT00412984|38202585|FG000|Overall Study|Not Reported|11|||
17059512|NCT00412984|38202586|FG001|Overall Study|Not Reported|12|||
17059513|NCT00539864|38202594|FG000|Overall Study|Lost to Follow-up|0|||
17059514|NCT00539864|38202595|FG001|Overall Study|Lost to Follow-up|1|||
17059515|NCT00539864|38202594|FG000|Overall Study|Withdrawal by Subject|1|||
17059516|NCT00539864|38202595|FG001|Overall Study|Withdrawal by Subject|1|||
17059517|NCT00673049|38202603|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
17059518|NCT00673049|38202604|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
17059519|NCT00673049|38202605|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
17059520|NCT00673049|38202606|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
17059521|NCT00673049|38202603|FG000|Before Progression on Erlotinib|Death|235|||
17059522|NCT00673049|38202604|FG001|Before Progression on Erlotinib|Death|167|||
17059523|NCT00673049|38202605|FG002|Before Progression on Erlotinib|Death|1|||
17059524|NCT00673049|38202606|FG003|Before Progression on Erlotinib|Death|0|||
17059525|NCT00673049|38202603|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
16993358|NCT00792298|38137405|FG007|Washout|Adverse Event|0|||
16993359|NCT00792298|38137398|FG000|Washout|Withdrawal by Subject|0|||
17059526|NCT00673049|38202604|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
17059527|NCT00673049|38202605|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
17145354|NCT04052425|38289111|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
16993360|NCT00792298|38137399|FG001|Washout|Withdrawal by Subject|0|||
17145355|NCT04052425|38289112|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
17059528|NCT00673049|38202606|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
17059529|NCT00673049|38202603|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
17059530|NCT00673049|38202604|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
17059531|NCT00673049|38202605|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
17059532|NCT00673049|38202606|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
17059533|NCT00673049|38202603|FG000|Before Progression on Erlotinib|Other|1|||
17059534|NCT00673049|38202604|FG001|Before Progression on Erlotinib|Other|2|||
17059535|NCT00673049|38202605|FG002|Before Progression on Erlotinib|Other|0|||
17059536|NCT00673049|38202606|FG003|Before Progression on Erlotinib|Other|0|||
17059537|NCT00673049|38202603|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
17059538|NCT00673049|38202604|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
17059539|NCT00673049|38202605|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
17059540|NCT00673049|38202606|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
17059541|NCT00673049|38202603|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
17059542|NCT00673049|38202604|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
17059543|NCT00673049|38202605|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
17059544|NCT00673049|38202606|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
17059545|NCT00673049|38202603|FG000|After Progression on Erlotinib|Death|0|||
17059546|NCT00673049|38202604|FG001|After Progression on Erlotinib|Death|0|||
17059547|NCT00673049|38202605|FG002|After Progression on Erlotinib|Death|0|||
17059548|NCT00673049|38202606|FG003|After Progression on Erlotinib|Death|71|||
16781163|NCT02147158|37720323|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
16781164|NCT02147158|37720324|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
16781165|NCT02147158|37720325|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
16781166|NCT02147158|37720326|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
16781167|NCT02147158|37720327|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
16781168|NCT02147158|37720328|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
16781169|NCT02147158|37720323|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
16781170|NCT02147158|37720324|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
16781171|NCT02147158|37720325|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
17059549|NCT00673049|38202603|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
17059550|NCT00673049|38202604|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
17059551|NCT00673049|38202605|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
17059552|NCT00673049|38202606|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
17059553|NCT00673049|38202603|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
17059554|NCT00673049|38202604|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
17059555|NCT00673049|38202605|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
17059556|NCT00673049|38202606|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
17059557|NCT00673049|38202603|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
17059558|NCT00673049|38202604|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
17059559|NCT00673049|38202605|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
17059560|NCT00673049|38202606|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
17059561|NCT00412750|38202617|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17059562|NCT00412750|38202618|FG001|Overall Study|Abnormal laboratory value(s)|0|||
17059563|NCT00412750|38202619|FG002|Overall Study|Abnormal laboratory value(s)|0|||
17059564|NCT00412750|38202617|FG000|Overall Study|Administrative problems|21|||
17059565|NCT00412750|38202618|FG001|Overall Study|Administrative problems|17|||
17059566|NCT00412750|38202619|FG002|Overall Study|Administrative problems|14|||
17059567|NCT00412750|38202617|FG000|Overall Study|Adverse Event|8|||
17059568|NCT00412750|38202618|FG001|Overall Study|Adverse Event|3|||
17059569|NCT00412750|38202619|FG002|Overall Study|Adverse Event|3|||
17059570|NCT00412750|38202617|FG000|Overall Study|Lost to Follow-up|1|||
17059571|NCT00412750|38202618|FG001|Overall Study|Lost to Follow-up|0|||
17059572|NCT00412750|38202619|FG002|Overall Study|Lost to Follow-up|1|||
17059573|NCT00412750|38202617|FG000|Overall Study|Withdrawal by Subject|0|||
17059574|NCT00412750|38202618|FG001|Overall Study|Withdrawal by Subject|1|||
17059575|NCT00412750|38202619|FG002|Overall Study|Withdrawal by Subject|2|||
17059576|NCT00412750|38202617|FG000|Overall Study|Lack of Efficacy|0|||
17059577|NCT00412750|38202618|FG001|Overall Study|Lack of Efficacy|0|||
17059578|NCT00412750|38202619|FG002|Overall Study|Lack of Efficacy|3|||
17059579|NCT00076999|38202633|FG000|Overall Study|Adverse Event|2|||
17059580|NCT00076999|38202634|FG001|Overall Study|Adverse Event|8|||
17059581|NCT00076999|38202635|FG002|Overall Study|Adverse Event|6|||
17059582|NCT00076999|38202636|FG003|Overall Study|Adverse Event|0|||
17059583|NCT00076999|38202637|FG004|Overall Study|Adverse Event|2|||
17059584|NCT00076999|38202633|FG000|Overall Study|Protocol Violation|0|||
17059585|NCT00076999|38202634|FG001|Overall Study|Protocol Violation|3|||
17059586|NCT00076999|38202635|FG002|Overall Study|Protocol Violation|4|||
17059587|NCT00076999|38202636|FG003|Overall Study|Protocol Violation|0|||
17059588|NCT00076999|38202637|FG004|Overall Study|Protocol Violation|9|||
17059589|NCT00076999|38202633|FG000|Overall Study|Lost to Follow-up|2|||
17059590|NCT00076999|38202634|FG001|Overall Study|Lost to Follow-up|1|||
17059591|NCT00076999|38202635|FG002|Overall Study|Lost to Follow-up|0|||
17145356|NCT04052425|38289113|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
17145357|NCT04052425|38289114|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
17145358|NCT04052425|38289111|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
17145359|NCT04052425|38289112|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
17145360|NCT04052425|38289113|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
17145361|NCT04052425|38289114|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
17145362|NCT04052425|38289111|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
17145363|NCT04052425|38289112|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
17145364|NCT04052425|38289113|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
17145365|NCT04052425|38289114|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
17145366|NCT04052425|38289111|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
17059592|NCT00076999|38202636|FG003|Overall Study|Lost to Follow-up|0|||
17059593|NCT00076999|38202637|FG004|Overall Study|Lost to Follow-up|0|||
17059594|NCT00076999|38202633|FG000|Overall Study|Withdrawal by Subject|0|||
17059595|NCT00076999|38202634|FG001|Overall Study|Withdrawal by Subject|4|||
17059596|NCT00076999|38202635|FG002|Overall Study|Withdrawal by Subject|3|||
17059597|NCT00076999|38202636|FG003|Overall Study|Withdrawal by Subject|0|||
17059598|NCT00076999|38202637|FG004|Overall Study|Withdrawal by Subject|1|||
17059599|NCT00076999|38202633|FG000|Overall Study|Other reason (not specified)|8|||
17059600|NCT00076999|38202634|FG001|Overall Study|Other reason (not specified)|8|||
17059601|NCT00076999|38202635|FG002|Overall Study|Other reason (not specified)|4|||
17059602|NCT00076999|38202636|FG003|Overall Study|Other reason (not specified)|1|||
17059603|NCT00076999|38202637|FG004|Overall Study|Other reason (not specified)|13|||
17059604|NCT03905096|38202652|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
17059605|NCT03905096|38202653|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
17059606|NCT00412360|38202668|FG000|Overall Study|Lost to Follow-up|0|||
17059607|NCT00412360|38202669|FG001|Overall Study|Lost to Follow-up|1|||
17059608|NCT00412360|38202668|FG000|Overall Study|Not Transplanted|1|||
17059609|NCT00412360|38202669|FG001|Overall Study|Not Transplanted|2|||
17059610|NCT00571103|38202675|FG000|Overall Study|Withdrawal by Subject|1|||
17059611|NCT00571103|38202675|FG000|Overall Study|Lost to Follow-up|1|||
17059612|NCT00084799|38202681|FG000|Overall Study|Disease Progression|1|||
17059613|NCT00084799|38202682|FG001|Overall Study|Disease Progression|0|||
17059614|NCT00069277|38202688|FG000|Overall Study|Adverse Event|3|||
17059615|NCT00069277|38202688|FG000|Overall Study|Withdrawal by Subject|1|||
17059616|NCT00069277|38202688|FG000|Overall Study|Progressive Disease|15|||
17059617|NCT00069277|38202688|FG000|Overall Study|Physician Decision|2|||
17059618|NCT00418522|38202694|FG000|Overall Study|Adverse Event|7|||
17059619|NCT00418522|38202695|FG001|Overall Study|Adverse Event|1|||
17059620|NCT00418522|38202694|FG000|Overall Study|Lack of Efficacy|1|||
17059621|NCT00418522|38202695|FG001|Overall Study|Lack of Efficacy|3|||
17059622|NCT00418522|38202694|FG000|Overall Study|Lost to Follow-up|10|||
17059623|NCT00418522|38202695|FG001|Overall Study|Lost to Follow-up|4|||
17059624|NCT00418522|38202694|FG000|Overall Study|Withdrawal by Subject|31|||
17059625|NCT00418522|38202695|FG001|Overall Study|Withdrawal by Subject|7|||
17059626|NCT00418522|38202694|FG000|Overall Study|Other|27|||
17059627|NCT00418522|38202695|FG001|Overall Study|Other|23|||
17145367|NCT04052425|38289112|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
17059628|NCT00418522|38202694|FG000|Overall Study|Randomized but did not receive treatment|7|||
17059629|NCT00418522|38202695|FG001|Overall Study|Randomized but did not receive treatment|4|||
17059630|NCT00403546|38202703|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
17059631|NCT00403546|38202704|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
17059632|NCT00403546|38202705|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
17059633|NCT00403546|38202703|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
17059634|NCT00403546|38202704|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
17059635|NCT00403546|38202705|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
17059636|NCT00403546|38202703|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
17059637|NCT00403546|38202704|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
17059638|NCT00403546|38202705|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
17059639|NCT00403546|38202703|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
17059640|NCT00403546|38202704|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
17059641|NCT00403546|38202705|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
17059642|NCT00403546|38202703|FG000|Screening Phase|Screening Failure|22|||
17059643|NCT00403546|38202704|FG001|Screening Phase|Screening Failure|0|||
17059644|NCT00403546|38202705|FG002|Screening Phase|Screening Failure|0|||
17059645|NCT00403546|38202703|FG000|Screening Phase|Adverse Event|1|||
16781172|NCT02147158|37720326|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
17059646|NCT00403546|38202704|FG001|Screening Phase|Adverse Event|0|||
17059647|NCT00403546|38202705|FG002|Screening Phase|Adverse Event|0|||
17059648|NCT00403546|38202703|FG000|Screening Phase|Terminated Prior to Randomization|5|||
17059649|NCT00403546|38202704|FG001|Screening Phase|Terminated Prior to Randomization|0|||
17059650|NCT00403546|38202705|FG002|Screening Phase|Terminated Prior to Randomization|0|||
17059651|NCT00403546|38202703|FG000|Randomized Trial|Early Terminations|0|||
17059652|NCT00403546|38202704|FG001|Randomized Trial|Early Terminations|17|||
17059653|NCT00403546|38202705|FG002|Randomized Trial|Early Terminations|16|||
17059654|NCT00403390|38202716|FG000|Overall Study|Withdrawal by Subject|1|||
17059655|NCT00403390|38202717|FG001|Overall Study|Withdrawal by Subject|0|||
17059656|NCT00403390|38202716|FG000|Overall Study|samples lost|1|||
17059657|NCT00403390|38202717|FG001|Overall Study|samples lost|0|||
17059658|NCT00403390|38202716|FG000|Overall Study|non-compliant|1|||
17059659|NCT00403390|38202717|FG001|Overall Study|non-compliant|0|||
17059660|NCT00403234|38202727|FG000|Overall Study|Withdrawal by Subject|0|||
17059661|NCT00403234|38202728|FG001|Overall Study|Withdrawal by Subject|1|||
17059662|NCT00403234|38202729|FG002|Overall Study|Withdrawal by Subject|0|||
17059663|NCT00403234|38202730|FG003|Overall Study|Withdrawal by Subject|0|||
17059664|NCT00403234|38202727|FG000|Overall Study|Adverse Event|1|||
17059665|NCT00403234|38202728|FG001|Overall Study|Adverse Event|0|||
17059666|NCT00403234|38202729|FG002|Overall Study|Adverse Event|1|||
17059667|NCT00403234|38202730|FG003|Overall Study|Adverse Event|0|||
17059668|NCT00402688|38202743|FG000|Overall Study|Adverse Event|12|||
17059669|NCT00402688|38202744|FG001|Overall Study|Adverse Event|9|||
17059670|NCT00402688|38202745|FG002|Overall Study|Adverse Event|3|||
17059671|NCT00402688|38202743|FG000|Overall Study|Withdrawal by Subject|3|||
17059672|NCT00402688|38202744|FG001|Overall Study|Withdrawal by Subject|1|||
17059673|NCT00402688|38202745|FG002|Overall Study|Withdrawal by Subject|1|||
17059674|NCT00402688|38202743|FG000|Overall Study|Physician Decision|0|||
17059675|NCT00402688|38202744|FG001|Overall Study|Physician Decision|0|||
17059676|NCT00402688|38202745|FG002|Overall Study|Physician Decision|1|||
17059677|NCT00402688|38202743|FG000|Overall Study|Lack of Efficacy|4|||
17059678|NCT00402688|38202744|FG001|Overall Study|Lack of Efficacy|4|||
17059679|NCT00402688|38202745|FG002|Overall Study|Lack of Efficacy|5|||
17059680|NCT00402688|38202743|FG000|Overall Study|Protocol Violation|1|||
17059681|NCT00402688|38202744|FG001|Overall Study|Protocol Violation|1|||
17059682|NCT00402688|38202745|FG002|Overall Study|Protocol Violation|1|||
17059683|NCT00402688|38202743|FG000|Overall Study|Lost to Follow-up|1|||
17059684|NCT00402688|38202744|FG001|Overall Study|Lost to Follow-up|0|||
17059685|NCT00402688|38202745|FG002|Overall Study|Lost to Follow-up|2|||
17059686|NCT00402688|38202743|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
17059687|NCT00402688|38202744|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
17059688|NCT00402688|38202745|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
17059689|NCT00402688|38202743|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
17059690|NCT00402688|38202744|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
17059691|NCT00402688|38202745|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
17059692|NCT00402688|38202743|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
17059693|NCT00402688|38202744|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
17059694|NCT00402688|38202745|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
17059695|NCT00671879|38202756|FG000|Overall Study|Withdrawal by Subject|0|||
17059696|NCT00671879|38202757|FG001|Overall Study|Withdrawal by Subject|4|||
17059697|NCT00671879|38202758|FG002|Overall Study|Withdrawal by Subject|6|||
17059698|NCT00402298|38202769|FG000|Overall Study|Withdrawal by Subject|1|||
16781173|NCT02147158|37720327|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
17059699|NCT00402298|38202770|FG001|Overall Study|Withdrawal by Subject|0|||
17059700|NCT00401830|38202778|FG000|Overall Study|Adverse Event|10|||
17059701|NCT00401830|38202779|FG001|Overall Study|Adverse Event|18|||
17145368|NCT04052425|38289113|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
17145369|NCT04052425|38289114|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
17145370|NCT04052425|38289111|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
17145371|NCT04052425|38289112|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
17145372|NCT04052425|38289113|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
17145373|NCT04052425|38289114|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
17145374|NCT03235089|38289124|FG000|Overall Study|Lost to Follow-up|1|||
17145375|NCT03235089|38289125|FG001|Overall Study|Lost to Follow-up|1|||
17145376|NCT03235089|38289124|FG000|Overall Study|Physician Decision|2|||
17145377|NCT03235089|38289125|FG001|Overall Study|Physician Decision|2|||
17145378|NCT04013191|38289134|FG000|Overall Study|Adverse Event|1|||
17145379|NCT04013191|38289135|FG001|Overall Study|Adverse Event|0|||
17059702|NCT00401830|38202778|FG000|Overall Study|Lack of Efficacy|11|||
17059703|NCT00401830|38202779|FG001|Overall Study|Lack of Efficacy|5|||
17059704|NCT00401830|38202778|FG000|Overall Study|Withdrawal by Subject|4|||
17059705|NCT00401830|38202779|FG001|Overall Study|Withdrawal by Subject|3|||
17059706|NCT00401830|38202778|FG000|Overall Study|Protocol Violation|3|||
17059707|NCT00401830|38202779|FG001|Overall Study|Protocol Violation|3|||
17059708|NCT00401830|38202778|FG000|Overall Study|Non-compliance with drug study|1|||
17059709|NCT00401830|38202779|FG001|Overall Study|Non-compliance with drug study|0|||
17059710|NCT00401830|38202778|FG000|Overall Study|Lost to Follow-up|1|||
17059711|NCT00401830|38202779|FG001|Overall Study|Lost to Follow-up|3|||
17059712|NCT00401830|38202778|FG000|Overall Study|Other: Personal / Family problems|1|||
17059713|NCT00401830|38202779|FG001|Overall Study|Other: Personal / Family problems|0|||
17059714|NCT02471144|38202789|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
17059715|NCT02471144|38202790|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
17059716|NCT02471144|38202791|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
17059717|NCT02471144|38202792|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
16993361|NCT00792298|38137400|FG002|Washout|Withdrawal by Subject|1|||
17059718|NCT02471144|38202793|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
17059719|NCT02471144|38202794|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
17059720|NCT02471144|38202795|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
17059721|NCT02471144|38202796|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
17059722|NCT02471144|38202797|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
17059723|NCT02471144|38202798|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
17059724|NCT02471144|38202799|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
17145380|NCT03285594|38289148|FG000|Overall Study|At the Participant's Own Request|10|||
16993362|NCT00792298|38137401|FG003|Washout|Withdrawal by Subject|0|||
16993363|NCT00792298|38137402|FG004|Washout|Withdrawal by Subject|0|||
16993364|NCT00792298|38137403|FG005|Washout|Withdrawal by Subject|1|||
16993365|NCT00792298|38137404|FG006|Washout|Withdrawal by Subject|0|||
16993366|NCT00792298|38137405|FG007|Washout|Withdrawal by Subject|0|||
16993367|NCT00792298|38137398|FG000|Treatment Period 2|Lack of Efficacy|0|||
16993368|NCT00792298|38137399|FG001|Treatment Period 2|Lack of Efficacy|0|||
16993369|NCT00792298|38137400|FG002|Treatment Period 2|Lack of Efficacy|0|||
16993370|NCT00792298|38137401|FG003|Treatment Period 2|Lack of Efficacy|0|||
16993371|NCT00792298|38137402|FG004|Treatment Period 2|Lack of Efficacy|1|||
16993372|NCT00792298|38137403|FG005|Treatment Period 2|Lack of Efficacy|0|||
16993373|NCT00792298|38137404|FG006|Treatment Period 2|Lack of Efficacy|0|||
16993374|NCT00792298|38137405|FG007|Treatment Period 2|Lack of Efficacy|0|||
16993375|NCT00792298|38137398|FG000|Treatment Period 2|Physician Decision|0|||
16993376|NCT00792298|38137399|FG001|Treatment Period 2|Physician Decision|0|||
16993377|NCT00792298|38137400|FG002|Treatment Period 2|Physician Decision|0|||
16993378|NCT00792298|38137401|FG003|Treatment Period 2|Physician Decision|0|||
16993379|NCT00792298|38137402|FG004|Treatment Period 2|Physician Decision|0|||
16993380|NCT00792298|38137403|FG005|Treatment Period 2|Physician Decision|0|||
16993381|NCT00792298|38137404|FG006|Treatment Period 2|Physician Decision|1|||
16993382|NCT00792298|38137405|FG007|Treatment Period 2|Physician Decision|0|||
16993383|NCT00792298|38137398|FG000|Treatment Period 2|Pregnancy|0|||
16993384|NCT00792298|38137399|FG001|Treatment Period 2|Pregnancy|0|||
16993385|NCT00792298|38137400|FG002|Treatment Period 2|Pregnancy|1|||
16993386|NCT00792298|38137401|FG003|Treatment Period 2|Pregnancy|0|||
16993387|NCT00792298|38137402|FG004|Treatment Period 2|Pregnancy|0|||
16993388|NCT00792298|38137403|FG005|Treatment Period 2|Pregnancy|0|||
16993389|NCT00792298|38137404|FG006|Treatment Period 2|Pregnancy|0|||
16993390|NCT00792298|38137405|FG007|Treatment Period 2|Pregnancy|0|||
16993391|NCT00792298|38137398|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16993392|NCT00792298|38137399|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16993393|NCT00792298|38137400|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16993394|NCT00792298|38137401|FG003|Treatment Period 2|Withdrawal by Subject|2|||
16993395|NCT00792298|38137402|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16993396|NCT00792298|38137403|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16993397|NCT00792298|38137404|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16993398|NCT00792298|38137405|FG007|Treatment Period 2|Withdrawal by Subject|2|||
16993399|NCT00718159|38137429|FG000|Overall Study|Progressive Disease|3|||
16993400|NCT00718159|38137430|FG001|Overall Study|Progressive Disease|3|||
16993401|NCT00718159|38137431|FG002|Overall Study|Progressive Disease|2|||
16993402|NCT00718159|38137432|FG003|Overall Study|Progressive Disease|0|||
16993403|NCT00718159|38137433|FG004|Overall Study|Progressive Disease|6|||
16993404|NCT00718159|38137434|FG005|Overall Study|Progressive Disease|0|||
16993405|NCT00718159|38137435|FG006|Overall Study|Progressive Disease|0|||
16993406|NCT00718159|38137429|FG000|Overall Study|Death due to Adverse Event|0|||
16993407|NCT00718159|38137430|FG001|Overall Study|Death due to Adverse Event|0|||
16993408|NCT00718159|38137431|FG002|Overall Study|Death due to Adverse Event|0|||
16993409|NCT00718159|38137432|FG003|Overall Study|Death due to Adverse Event|2|||
16993410|NCT00718159|38137433|FG004|Overall Study|Death due to Adverse Event|2|||
16993411|NCT00718159|38137434|FG005|Overall Study|Death due to Adverse Event|0|||
16993412|NCT00718159|38137435|FG006|Overall Study|Death due to Adverse Event|0|||
16993413|NCT00718159|38137429|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
16993414|NCT00718159|38137430|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
16993415|NCT00718159|38137431|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
16993416|NCT00718159|38137432|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
16993417|NCT00718159|38137433|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
16993418|NCT00718159|38137434|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
16993419|NCT00718159|38137435|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
16993420|NCT00718159|38137429|FG000|Overall Study|Investigator Decision|0|||
16993421|NCT00718159|38137430|FG001|Overall Study|Investigator Decision|0|||
16993422|NCT00718159|38137431|FG002|Overall Study|Investigator Decision|0|||
17059725|NCT02471144|38202789|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059726|NCT02471144|38202790|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059727|NCT02471144|38202791|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059728|NCT02471144|38202792|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
17059729|NCT02471144|38202793|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059730|NCT02471144|38202794|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059731|NCT02471144|38202795|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059732|NCT02471144|38202796|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059733|NCT02471144|38202797|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059734|NCT02471144|38202798|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059735|NCT02471144|38202799|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
17059736|NCT02471144|38202789|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059737|NCT02471144|38202790|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059738|NCT02471144|38202791|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
17059739|NCT02471144|38202792|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059740|NCT02471144|38202793|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059741|NCT02471144|38202794|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059742|NCT02471144|38202795|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059743|NCT02471144|38202796|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059744|NCT02471144|38202797|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059745|NCT02471144|38202798|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059746|NCT02471144|38202799|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
17059747|NCT02471144|38202789|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
17059748|NCT02471144|38202790|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
17059749|NCT02471144|38202791|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
17059750|NCT02471144|38202792|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
17059751|NCT02471144|38202793|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
17059752|NCT02471144|38202794|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16781174|NCT02147158|37720328|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
17059753|NCT02471144|38202795|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
17059754|NCT02471144|38202796|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
17059755|NCT02471144|38202797|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
17059756|NCT02471144|38202798|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
17059757|NCT02471144|38202799|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
17059758|NCT02471144|38202789|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
17059759|NCT02471144|38202790|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
17059760|NCT02471144|38202791|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
17059761|NCT02471144|38202792|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
17059762|NCT02471144|38202793|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
17059763|NCT02471144|38202794|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
17059764|NCT02471144|38202795|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
17059765|NCT02471144|38202796|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
17145381|NCT03285594|38289149|FG001|Overall Study|At the Participant's Own Request|5|||
17145382|NCT03285594|38289150|FG002|Overall Study|At the Participant's Own Request|21|||
17145383|NCT03285594|38289148|FG000|Overall Study|Adverse Event|2|||
17145384|NCT03285594|38289149|FG001|Overall Study|Adverse Event|2|||
17145385|NCT03285594|38289150|FG002|Overall Study|Adverse Event|6|||
17059766|NCT02471144|38202797|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
17059767|NCT02471144|38202798|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
17059768|NCT02471144|38202799|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
17059769|NCT02471144|38202789|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059770|NCT02471144|38202790|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059771|NCT02471144|38202791|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059772|NCT02471144|38202792|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059773|NCT02471144|38202793|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059774|NCT02471144|38202794|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
17059775|NCT02471144|38202795|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059776|NCT02471144|38202796|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059777|NCT02471144|38202797|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
17059778|NCT02471144|38202798|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059779|NCT02471144|38202799|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
17059780|NCT02471144|38202789|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17145386|NCT03285594|38289148|FG000|Overall Study|Poor Compliance to Protocol|0|||
17145387|NCT03285594|38289149|FG001|Overall Study|Poor Compliance to Protocol|0|||
17059781|NCT02471144|38202790|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059782|NCT02471144|38202791|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059783|NCT02471144|38202792|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059784|NCT02471144|38202793|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059785|NCT02471144|38202794|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059786|NCT02471144|38202795|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059787|NCT02471144|38202796|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059788|NCT02471144|38202797|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
17059789|NCT02471144|38202798|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059790|NCT02471144|38202799|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
17059791|NCT02471144|38202789|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059792|NCT02471144|38202790|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059793|NCT02471144|38202791|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059794|NCT02471144|38202792|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059795|NCT02471144|38202793|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059796|NCT02471144|38202794|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059797|NCT02471144|38202795|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059798|NCT02471144|38202796|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
17059799|NCT02471144|38202797|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
17059800|NCT02471144|38202798|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059801|NCT02471144|38202799|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
17059802|NCT02471144|38202789|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059803|NCT02471144|38202790|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059804|NCT02471144|38202791|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059805|NCT02471144|38202792|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059806|NCT02471144|38202793|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059807|NCT02471144|38202794|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059808|NCT02471144|38202795|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059809|NCT02471144|38202796|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059810|NCT02471144|38202797|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
17059811|NCT02471144|38202798|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5|||
17059812|NCT02471144|38202799|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2|||
17059813|NCT02471144|38202789|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059814|NCT02471144|38202790|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059815|NCT02471144|38202791|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059816|NCT02471144|38202792|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059817|NCT02471144|38202793|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059818|NCT02471144|38202794|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059819|NCT02471144|38202795|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17145388|NCT03285594|38289150|FG002|Overall Study|Poor Compliance to Protocol|1|||
17145389|NCT03285594|38289148|FG000|Overall Study|Lost to Follow-up|0|||
17145390|NCT03285594|38289149|FG001|Overall Study|Lost to Follow-up|0|||
17145391|NCT03285594|38289150|FG002|Overall Study|Lost to Follow-up|1|||
17145392|NCT03285594|38289148|FG000|Overall Study|Reason Not Specified|3|||
17145393|NCT03285594|38289149|FG001|Overall Study|Reason Not Specified|4|||
17145394|NCT03285594|38289150|FG002|Overall Study|Reason Not Specified|8|||
17145395|NCT03234465|38289161|FG000|Overall Study|Adverse Event|4|||
17145396|NCT03234465|38289162|FG001|Overall Study|Adverse Event|2|||
17145397|NCT03234465|38289161|FG000|Overall Study|Death|0|||
17145398|NCT03234465|38289162|FG001|Overall Study|Death|1|||
17059820|NCT02471144|38202796|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059821|NCT02471144|38202797|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059822|NCT02471144|38202798|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
17059823|NCT02471144|38202799|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
17059824|NCT02471144|38202789|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059825|NCT02471144|38202790|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059826|NCT02471144|38202791|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059827|NCT02471144|38202792|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059828|NCT02471144|38202793|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059829|NCT02471144|38202794|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059830|NCT02471144|38202795|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059831|NCT02471144|38202796|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059832|NCT02471144|38202797|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059833|NCT02471144|38202798|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
17059834|NCT02471144|38202799|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
17059835|NCT00401752|38202817|FG000|Overall Study|Adverse Event|2|||
17145399|NCT03234465|38289161|FG000|Overall Study|Lost to Follow-up|1|||
17145400|NCT03234465|38289162|FG001|Overall Study|Lost to Follow-up|1|||
17059836|NCT00401752|38202818|FG001|Overall Study|Adverse Event|5|||
17059837|NCT00401752|38202817|FG000|Overall Study|Withdrawal by Subject|2|||
17059838|NCT00401752|38202818|FG001|Overall Study|Withdrawal by Subject|6|||
17059839|NCT00401752|38202817|FG000|Overall Study|Lost to Follow-up|1|||
17059840|NCT00401752|38202818|FG001|Overall Study|Lost to Follow-up|4|||
17059841|NCT00401752|38202817|FG000|Overall Study|Development of any exclusion criteria|4|||
17059842|NCT00401752|38202818|FG001|Overall Study|Development of any exclusion criteria|2|||
17059843|NCT00401752|38202817|FG000|Overall Study|Physician Decision|1|||
17059844|NCT00401752|38202818|FG001|Overall Study|Physician Decision|1|||
17059845|NCT00539240|38202827|FG000|Overall Study|Withdrawal by Subject|0|||
17059846|NCT00539240|38202828|FG001|Overall Study|Withdrawal by Subject|2|||
17059847|NCT00539240|38202829|FG002|Overall Study|Withdrawal by Subject|0|||
17059848|NCT00539240|38202827|FG000|Overall Study|Protocol Violation|1|||
17059849|NCT00539240|38202828|FG001|Overall Study|Protocol Violation|1|||
17059850|NCT00539240|38202829|FG002|Overall Study|Protocol Violation|4|||
17059851|NCT00539240|38202827|FG000|Overall Study|Lost to Follow-up|2|||
17059852|NCT00539240|38202828|FG001|Overall Study|Lost to Follow-up|3|||
17059853|NCT00539240|38202829|FG002|Overall Study|Lost to Follow-up|1|||
17059854|NCT00539240|38202827|FG000|Overall Study|Adverse Event|3|||
17059855|NCT00539240|38202828|FG001|Overall Study|Adverse Event|1|||
17059856|NCT00539240|38202829|FG002|Overall Study|Adverse Event|10|||
17059857|NCT00417976|38202837|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
17059858|NCT00417976|38202837|FG000|Overall Study|Treatment -related toxicity|2|||
17059859|NCT00673673|38202842|FG000|Overall Study|Progressive disease|27|||
17059860|NCT00673673|38202842|FG000|Overall Study|Adverse Event|4|||
17059861|NCT00673673|38202842|FG000|Overall Study|Withdrawal by Subject|3|||
17145401|NCT03234465|38289161|FG000|Overall Study|Withdrawal by Subject|12|||
17145402|NCT03234465|38289162|FG001|Overall Study|Withdrawal by Subject|27|||
17145403|NCT03234465|38289161|FG000|Overall Study|Symptomatic deterioration|0|||
17145404|NCT03234465|38289162|FG001|Overall Study|Symptomatic deterioration|1|||
17145405|NCT03234465|38289161|FG000|Overall Study|Non-compliance|2|||
17145406|NCT03234465|38289162|FG001|Overall Study|Non-compliance|0|||
17145407|NCT03234465|38289161|FG000|Overall Study|Other|14|||
17145408|NCT03234465|38289162|FG001|Overall Study|Other|8|||
17145409|NCT03290131|38289171|FG000|Overall Study|Adverse Event|22|||
17145410|NCT03290131|38289172|FG001|Overall Study|Adverse Event|57|||
17145411|NCT03290131|38289173|FG002|Overall Study|Adverse Event|11|||
17145412|NCT03290131|38289171|FG000|Overall Study|Withdrawal by Subject|18|||
17145413|NCT03290131|38289172|FG001|Overall Study|Withdrawal by Subject|13|||
17145414|NCT03290131|38289173|FG002|Overall Study|Withdrawal by Subject|8|||
17145415|NCT03290131|38289171|FG000|Overall Study|MS Relapse|2|||
17059862|NCT00673673|38202842|FG000|Overall Study|Investigators' discretion|2|||
17059863|NCT00069121|38202848|FG000|Overall Study|Death|286|||
17059864|NCT00069121|38202849|FG001|Overall Study|Death|242|||
17059865|NCT00069121|38202848|FG000|Overall Study|Withdrawal by Subject|18|||
17059866|NCT00069121|38202849|FG001|Overall Study|Withdrawal by Subject|20|||
17059867|NCT00069121|38202848|FG000|Overall Study|Lost to Follow-up|63|||
17059868|NCT00069121|38202849|FG001|Overall Study|Lost to Follow-up|63|||
17059869|NCT00399802|38202861|FG000|Overall Study|Adverse Event|0|||
17059870|NCT00399802|38202862|FG001|Overall Study|Adverse Event|2|||
17059871|NCT00399802|38202861|FG000|Overall Study|Participant discontinued by mistake|0|||
17059872|NCT00399802|38202862|FG001|Overall Study|Participant discontinued by mistake|1|||
17059873|NCT03900728|38202871|FG000|Overall Study|No text responses|0|||
17059874|NCT03900728|38202872|FG001|Overall Study|No text responses|0|||
17059875|NCT03900728|38202873|FG002|Overall Study|No text responses|4|||
17059876|NCT00399568|38202883|FG000|Overall Study|Adverse Event|1|||
17059877|NCT00399568|38202884|FG001|Overall Study|Adverse Event|2|||
17059878|NCT00399568|38202883|FG000|Overall Study|Withdrawal by Subject|7|||
17059879|NCT00399568|38202884|FG001|Overall Study|Withdrawal by Subject|3|||
17059880|NCT00399568|38202883|FG000|Overall Study|Protocol non-compliance|2|||
17059881|NCT00399568|38202884|FG001|Overall Study|Protocol non-compliance|2|||
17059882|NCT00399568|38202883|FG000|Overall Study|Lost to Follow-up|2|||
17059883|NCT00399568|38202884|FG001|Overall Study|Lost to Follow-up|2|||
17059884|NCT00068419|38202892|FG000|Overall Study|Adverse Event|3|||
17059885|NCT00068419|38202892|FG000|Overall Study|Lack of Efficacy|24|||
17059886|NCT00068419|38202892|FG000|Overall Study|Lost to Follow-up|1|||
17059887|NCT00068419|38202892|FG000|Overall Study|Physician Decision|7|||
17059888|NCT00068419|38202892|FG000|Overall Study|Withdrawal by Subject|14|||
17059889|NCT00068419|38202892|FG000|Overall Study|Ineligible|11|||
17059890|NCT00068107|38202896|FG000|Overall Study|end-stage renal disease|6|||
17059891|NCT00068107|38202896|FG000|Overall Study|Death|2|||
17059892|NCT00068107|38202896|FG000|Overall Study|Withdrawal by Subject|1|||
17059893|NCT00394654|38202905|FG000|Overall Study|Lost to Follow-up|1|||
17059894|NCT00394654|38202906|FG001|Overall Study|Lost to Follow-up|0|||
17059895|NCT00394654|38202905|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
17059896|NCT00394654|38202906|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
17059897|NCT03900416|38202914|FG000|Six Week Follow-up|Lost to Follow-up|1|||
17059898|NCT03900416|38202915|FG001|Six Week Follow-up|Lost to Follow-up|0|||
17059899|NCT03900416|38202914|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
17059900|NCT03900416|38202915|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
17059901|NCT03900416|38202914|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
17059902|NCT03900416|38202915|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
17059903|NCT03900416|38202914|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
17059904|NCT03900416|38202915|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
17059905|NCT03900416|38202914|FG000|Twelve Week Follow-up|Adverse Event|1|||
17059906|NCT03900416|38202915|FG001|Twelve Week Follow-up|Adverse Event|1|||
17059907|NCT03900416|38202914|FG000|Six Month Follow-up|Lost to Follow-up|4|||
17059908|NCT03900416|38202915|FG001|Six Month Follow-up|Lost to Follow-up|3|||
17059909|NCT03900416|38202914|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
17059910|NCT03900416|38202915|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
17059911|NCT00399490|38202921|FG000|Overall Study|Adverse Event|19|||
17059912|NCT00399490|38202921|FG000|Overall Study|Lack of Efficacy|31|||
17059913|NCT00399490|38202921|FG000|Overall Study|Lost to Follow-up|5|||
17059914|NCT00399490|38202921|FG000|Overall Study|Withdrawal by Subject|18|||
17059915|NCT00399490|38202921|FG000|Overall Study|Other|25|||
17059916|NCT00398866|38202930|FG000|Overall Study|Adverse Event|1|||
17059917|NCT00398866|38202931|FG001|Overall Study|Adverse Event|0|||
17059918|NCT00398866|38202932|FG002|Overall Study|Adverse Event|0|||
17059919|NCT00398866|38202930|FG000|Overall Study|Lack of Efficacy|0|||
17059920|NCT00398866|38202931|FG001|Overall Study|Lack of Efficacy|0|||
17059921|NCT00398866|38202932|FG002|Overall Study|Lack of Efficacy|1|||
17059922|NCT00398866|38202930|FG000|Overall Study|Lost to Follow-up|7|||
17059923|NCT00398866|38202931|FG001|Overall Study|Lost to Follow-up|6|||
17059924|NCT00398866|38202932|FG002|Overall Study|Lost to Follow-up|4|||
17059925|NCT00398866|38202930|FG000|Overall Study|Withdrawal by Subject|5|||
17059926|NCT00398866|38202931|FG001|Overall Study|Withdrawal by Subject|1|||
17059927|NCT00398866|38202932|FG002|Overall Study|Withdrawal by Subject|2|||
17059928|NCT00398866|38202930|FG000|Overall Study|Unable to complete requirements of study|1|||
17059929|NCT00398866|38202931|FG001|Overall Study|Unable to complete requirements of study|1|||
17059930|NCT00398866|38202932|FG002|Overall Study|Unable to complete requirements of study|1|||
17059931|NCT00398632|38202941|FG000|Overall Study|Withdrawal by Subject|1|||
17059932|NCT00398632|38202941|FG000|Overall Study|Lack of Efficacy|1|||
17059933|NCT00673361|38202946|FG000|Overall Study|Screen Failure|2|||
17059934|NCT00393718|38202952|FG000|Overall Study|Adverse Event|20|||
17059935|NCT00393718|38202953|FG001|Overall Study|Adverse Event|8|||
17059936|NCT00393718|38202952|FG000|Overall Study|Protocol Violation|1|||
17059937|NCT00393718|38202953|FG001|Overall Study|Protocol Violation|2|||
17059938|NCT00393718|38202952|FG000|Overall Study|Lack of Efficacy|10|||
17059939|NCT00393718|38202953|FG001|Overall Study|Lack of Efficacy|9|||
17059940|NCT00393718|38202952|FG000|Overall Study|Hypoglycaemia|3|||
17059941|NCT00393718|38202953|FG001|Overall Study|Hypoglycaemia|2|||
17059942|NCT00393718|38202952|FG000|Overall Study|Subject decision|5|||
17059943|NCT00393718|38202953|FG001|Overall Study|Subject decision|0|||
17059944|NCT00393718|38202952|FG000|Overall Study|Withdrawal of consent|2|||
17059945|NCT00393718|38202953|FG001|Overall Study|Withdrawal of consent|1|||
17059946|NCT00393718|38202952|FG000|Overall Study|Missed measurement|1|||
17059947|NCT00393718|38202953|FG001|Overall Study|Missed measurement|0|||
17059948|NCT00393718|38202952|FG000|Overall Study|Move|1|||
17059949|NCT00393718|38202953|FG001|Overall Study|Move|0|||
17059950|NCT00669071|38202959|FG000|Overall Study|Lost to Follow-up|3|||
17059951|NCT00669071|38202959|FG000|Overall Study|Final visit 40 days out of window|1|||
17059952|NCT00398320|38202974|FG000|Overall Study|Death|1|||
17059953|NCT00398320|38202974|FG000|Overall Study|Adverse Event|4|||
17059954|NCT00398320|38202974|FG000|Overall Study|Physician Decision|1|||
17059955|NCT00670007|38202978|FG000|Overall Study|Drug abuse|1|||
17059956|NCT00670007|38202978|FG000|Overall Study|Lung transplant|1|||
17059957|NCT00670007|38202978|FG000|Overall Study|Travel/Vacation|1|||
17145416|NCT03290131|38289172|FG001|Overall Study|MS Relapse|1|||
17145417|NCT03290131|38289173|FG002|Overall Study|MS Relapse|0|||
17145418|NCT03290131|38289171|FG000|Overall Study|Unknown reason|0|||
17059958|NCT00670007|38202978|FG000|Overall Study|Adverse event, serious fatal|1|||
17059959|NCT00670007|38202978|FG000|Overall Study|Adverse Event|1|||
17059960|NCT00670007|38202978|FG000|Overall Study|Withdrawal by Subject|4|||
17059961|NCT00535496|38202985|FG000|Overall Study|Lost to Follow-up|0|||
17059962|NCT00535496|38202986|FG001|Overall Study|Lost to Follow-up|1|||
17059963|NCT00535496|38202987|FG002|Overall Study|Lost to Follow-up|0|||
17059964|NCT00535496|38202988|FG003|Overall Study|Lost to Follow-up|0|||
17059965|NCT00535496|38202985|FG000|Overall Study|Not treated with sugammadex|0|||
17059966|NCT00535496|38202986|FG001|Overall Study|Not treated with sugammadex|1|||
17059967|NCT00535496|38202987|FG002|Overall Study|Not treated with sugammadex|0|||
17059968|NCT00535496|38202988|FG003|Overall Study|Not treated with sugammadex|0|||
17059969|NCT00539006|38202999|FG000|Pre-treatment|Other|0|||
17059970|NCT00539006|38203000|FG001|Pre-treatment|Other|1|||
17059971|NCT00539006|38203001|FG002|Pre-treatment|Other|0|||
17059972|NCT00539006|38203002|FG003|Pre-treatment|Other|0|||
17145419|NCT03290131|38289172|FG001|Overall Study|Unknown reason|1|||
17145420|NCT03290131|38289173|FG002|Overall Study|Unknown reason|0|||
16993423|NCT00718159|38137432|FG003|Overall Study|Investigator Decision|0|||
17059973|NCT00539006|38202999|FG000|Treatment Period 1|Lost to Follow-up|0|||
17059974|NCT00539006|38203000|FG001|Treatment Period 1|Lost to Follow-up|0|||
17059975|NCT00539006|38203001|FG002|Treatment Period 1|Lost to Follow-up|1|||
17059976|NCT00539006|38203002|FG003|Treatment Period 1|Lost to Follow-up|0|||
17059977|NCT00539006|38202999|FG000|Treatment Period 1|Protocol Violation|0|||
17059978|NCT00539006|38203000|FG001|Treatment Period 1|Protocol Violation|0|||
17059979|NCT00539006|38203001|FG002|Treatment Period 1|Protocol Violation|1|||
17059980|NCT00539006|38203002|FG003|Treatment Period 1|Protocol Violation|0|||
17059981|NCT00539006|38202999|FG000|Treatment Period 1|Lack of Efficacy|0|||
17145421|NCT04050865|38289184|FG000|Overall Study|Adverse Event|1|||
16993424|NCT00718159|38137433|FG004|Overall Study|Investigator Decision|0|||
16993425|NCT00718159|38137434|FG005|Overall Study|Investigator Decision|1|||
16993426|NCT00718159|38137435|FG006|Overall Study|Investigator Decision|1|||
16993427|NCT00718081|38137454|FG000|Overall Study|Adverse Event|0|||
16993428|NCT00718081|38137455|FG001|Overall Study|Adverse Event|1|||
16993429|NCT00718081|38137456|FG002|Overall Study|Adverse Event|0|||
16993430|NCT00718081|38137454|FG000|Overall Study|Lack of Efficacy|7|||
16993431|NCT00718081|38137455|FG001|Overall Study|Lack of Efficacy|3|||
16993432|NCT00718081|38137456|FG002|Overall Study|Lack of Efficacy|21|||
16993433|NCT00788710|38137467|FG000|Overall Study|Adverse Event|1|||
16993434|NCT00788710|38137468|FG001|Overall Study|Adverse Event|3|||
16993435|NCT00788710|38137469|FG002|Overall Study|Adverse Event|4|||
16993436|NCT00788710|38137467|FG000|Overall Study|Lack of Efficacy|0|||
16993437|NCT00788710|38137468|FG001|Overall Study|Lack of Efficacy|0|||
16993438|NCT00788710|38137469|FG002|Overall Study|Lack of Efficacy|1|||
16993439|NCT00788710|38137467|FG000|Overall Study|Lost to Follow-up|0|||
16993440|NCT00788710|38137468|FG001|Overall Study|Lost to Follow-up|1|||
16993441|NCT00788710|38137469|FG002|Overall Study|Lost to Follow-up|0|||
16993442|NCT00788710|38137467|FG000|Overall Study|Physician Decision|2|||
16993443|NCT00788710|38137468|FG001|Overall Study|Physician Decision|1|||
16993444|NCT00788710|38137469|FG002|Overall Study|Physician Decision|0|||
16993445|NCT00788710|38137467|FG000|Overall Study|Protocol Violation|0|||
16993446|NCT00788710|38137468|FG001|Overall Study|Protocol Violation|1|||
16993447|NCT00788710|38137469|FG002|Overall Study|Protocol Violation|1|||
17145422|NCT04050865|38289185|FG001|Overall Study|Adverse Event|0|||
17059982|NCT00539006|38203000|FG001|Treatment Period 1|Lack of Efficacy|0|||
17059983|NCT00539006|38203001|FG002|Treatment Period 1|Lack of Efficacy|0|||
17059984|NCT00539006|38203002|FG003|Treatment Period 1|Lack of Efficacy|1|||
17059985|NCT00539006|38202999|FG000|Washout|Adverse Event|2|||
17059986|NCT00539006|38203000|FG001|Washout|Adverse Event|1|||
17059987|NCT00539006|38203001|FG002|Washout|Adverse Event|0|||
17059988|NCT00539006|38203002|FG003|Washout|Adverse Event|0|||
17059989|NCT00539006|38202999|FG000|Washout|Protocol Violation|1|||
17059990|NCT00539006|38203000|FG001|Washout|Protocol Violation|1|||
17059991|NCT00539006|38203001|FG002|Washout|Protocol Violation|0|||
17059992|NCT00539006|38203002|FG003|Washout|Protocol Violation|0|||
17059993|NCT00539006|38202999|FG000|Washout|Withdrawal by Subject|0|||
17059994|NCT00539006|38203000|FG001|Washout|Withdrawal by Subject|2|||
17059995|NCT00539006|38203001|FG002|Washout|Withdrawal by Subject|0|||
17059996|NCT00539006|38203002|FG003|Washout|Withdrawal by Subject|0|||
17059997|NCT00539006|38202999|FG000|Washout|Failed to meet continuation criteria|16|||
17059998|NCT00539006|38203000|FG001|Washout|Failed to meet continuation criteria|5|||
17059999|NCT00539006|38203001|FG002|Washout|Failed to meet continuation criteria|14|||
17060000|NCT00539006|38203002|FG003|Washout|Failed to meet continuation criteria|6|||
17060001|NCT00539006|38202999|FG000|Washout|Other|1|||
17060002|NCT00539006|38203000|FG001|Washout|Other|1|||
17060003|NCT00539006|38203001|FG002|Washout|Other|2|||
17060004|NCT00539006|38203002|FG003|Washout|Other|3|||
17060005|NCT00539006|38202999|FG000|Treatment Period 2|Protocol Violation|1|||
17060006|NCT00539006|38203000|FG001|Treatment Period 2|Protocol Violation|0|||
17060007|NCT00539006|38203001|FG002|Treatment Period 2|Protocol Violation|0|||
17060008|NCT00539006|38203002|FG003|Treatment Period 2|Protocol Violation|0|||
17060009|NCT00539006|38202999|FG000|Treatment Period 2|Other|0|||
17060010|NCT00539006|38203000|FG001|Treatment Period 2|Other|1|||
17060011|NCT00539006|38203001|FG002|Treatment Period 2|Other|0|||
17060012|NCT00539006|38203002|FG003|Treatment Period 2|Other|0|||
17060013|NCT00537056|38203018|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
17060014|NCT00535262|38203024|FG000|Overall Study|No funding|3|||
17060015|NCT00074581|38203030|FG000|Overall Study|Death|15|||
17060016|NCT00074581|38203031|FG001|Overall Study|Death|16|||
17060017|NCT00074581|38203030|FG000|Overall Study|Withdrawal by Subject|50|||
17060018|NCT00074581|38203031|FG001|Overall Study|Withdrawal by Subject|49|||
17060019|NCT00074581|38203030|FG000|Overall Study|Unable to adhere to visit schedule|13|||
17060020|NCT00074581|38203031|FG001|Overall Study|Unable to adhere to visit schedule|14|||
17060021|NCT00074581|38203030|FG000|Overall Study|Relocated|14|||
17060022|NCT00074581|38203031|FG001|Overall Study|Relocated|9|||
17060023|NCT00074581|38203030|FG000|Overall Study|Were withdrawn by investigator|5|||
17060024|NCT00074581|38203031|FG001|Overall Study|Were withdrawn by investigator|2|||
17060025|NCT00074581|38203030|FG000|Overall Study|Lost to Follow-up|16|||
17060026|NCT00074581|38203031|FG001|Overall Study|Lost to Follow-up|11|||
17060027|NCT00074581|38203030|FG000|Overall Study|Ended relationship w. index participant|117|||
17060028|NCT00074581|38203031|FG001|Overall Study|Ended relationship w. index participant|106|||
17060029|NCT00074581|38203030|FG000|Overall Study|Other|14|||
17060030|NCT00074581|38203031|FG001|Overall Study|Other|19|||
17060031|NCT03895034|38203037|FG000|Overall Study|Lost to Follow-up|2|||
17060032|NCT00536978|38203041|FG000|Overall Study|Not eligible for Adback Infusion|22|||
17060033|NCT03809611|38203047|FG000|Overall Study|Withdrawal by Subject|1|||
17060034|NCT03809611|38203048|FG001|Overall Study|Withdrawal by Subject|1|||
17060035|NCT03807739|38203059|FG000|Overall Study|Adverse Event|1|||
17060036|NCT03807739|38203060|FG001|Overall Study|Adverse Event|0|||
17060037|NCT03807739|38203061|FG002|Overall Study|Adverse Event|0|||
17060038|NCT03807739|38203062|FG003|Overall Study|Adverse Event|0|||
17060039|NCT03807739|38203059|FG000|Overall Study|Withdrawal by Subject|1|||
17060040|NCT03807739|38203060|FG001|Overall Study|Withdrawal by Subject|0|||
17145423|NCT04050865|38289184|FG000|Overall Study|no insert|1|||
17145424|NCT04050865|38289185|FG001|Overall Study|no insert|0|||
17060041|NCT03807739|38203061|FG002|Overall Study|Withdrawal by Subject|0|||
17060042|NCT03807739|38203062|FG003|Overall Study|Withdrawal by Subject|0|||
17060043|NCT00536744|38203074|FG000|Overall Study|Adverse Event|13|||
17060044|NCT00536744|38203075|FG001|Overall Study|Adverse Event|10|||
17060045|NCT00536744|38203074|FG000|Overall Study|Death|2|||
17060046|NCT00536744|38203075|FG001|Overall Study|Death|1|||
17060047|NCT00536744|38203074|FG000|Overall Study|Physician Decision|3|||
17060048|NCT00536744|38203075|FG001|Overall Study|Physician Decision|1|||
17060049|NCT00536744|38203074|FG000|Overall Study|Lost to Follow-up|3|||
17060050|NCT00536744|38203075|FG001|Overall Study|Lost to Follow-up|5|||
17060051|NCT00536744|38203074|FG000|Overall Study|Withdrawal by Subject|7|||
17060052|NCT00536744|38203075|FG001|Overall Study|Withdrawal by Subject|8|||
17060053|NCT00536744|38203074|FG000|Overall Study|PI tried alternative treatment|1|||
17060054|NCT00536744|38203075|FG001|Overall Study|PI tried alternative treatment|3|||
17060055|NCT00536510|38203092|FG000|Overall Study|Adverse Event|27|||
17060056|NCT00536510|38203093|FG001|Overall Study|Adverse Event|4|||
17060057|NCT00536510|38203092|FG000|Overall Study|Lost to Follow-up|11|||
17060058|NCT00536510|38203093|FG001|Overall Study|Lost to Follow-up|8|||
17060059|NCT00536510|38203092|FG000|Overall Study|Protocol Violation|4|||
17145425|NCT04050865|38289184|FG000|Overall Study|Only 1 insert|2|||
17145426|NCT04050865|38289185|FG001|Overall Study|Only 1 insert|3|||
17145427|NCT04050865|38289184|FG000|Overall Study|Physician Decision|0|||
17145428|NCT04050865|38289185|FG001|Overall Study|Physician Decision|1|||
17145429|NCT04050865|38289184|FG000|Overall Study|Withdrawal by Subject|0|||
17145430|NCT04050865|38289185|FG001|Overall Study|Withdrawal by Subject|1|||
17145431|NCT03283566|38289193|FG000|Overall Study|Lost to Follow-up|1|||
17145432|NCT03283566|38289194|FG001|Overall Study|Lost to Follow-up|2|||
17145433|NCT03210519|38289202|FG000|Overall Study|Adverse Event|2|||
17145434|NCT03210519|38289203|FG001|Overall Study|Adverse Event|0|||
17060060|NCT00536510|38203093|FG001|Overall Study|Protocol Violation|5|||
17060061|NCT00536510|38203092|FG000|Overall Study|Withdrawal by Subject|16|||
17060062|NCT00536510|38203093|FG001|Overall Study|Withdrawal by Subject|9|||
17060063|NCT00536510|38203092|FG000|Overall Study|Flushing with Product|20|||
17145435|NCT04048681|38289209|FG000|Overall Study|family emergency|0|||
17145436|NCT04048681|38289210|FG001|Overall Study|family emergency|0|||
17145437|NCT04048681|38289211|FG002|Overall Study|family emergency|0|||
17145438|NCT04048681|38289212|FG003|Overall Study|family emergency|1|||
17145439|NCT04048681|38289213|FG004|Overall Study|family emergency|0|||
17145440|NCT04007107|38289221|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
17145441|NCT04007107|38289222|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
17145442|NCT04007107|38289223|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
17145443|NCT04007107|38289224|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
17145444|NCT04046341|38289229|FG000|Overall Study|Lost to Follow-up|2|||
17145445|NCT04046341|38289229|FG000|Overall Study|Withdrawal by Subject|1|||
17145446|NCT03233529|38289233|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
17145447|NCT03233529|38289233|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
17145448|NCT04006171|38289243|FG000|Overall Study|Withdrawal by Subject|8|||
17145449|NCT04006171|38289244|FG001|Overall Study|Withdrawal by Subject|7|||
17145450|NCT04006171|38289243|FG000|Overall Study|missing serum samples|2|||
17145451|NCT04006171|38289244|FG001|Overall Study|missing serum samples|2|||
17145452|NCT04006171|38289243|FG000|Overall Study|insufficient sample volume|2|||
17145453|NCT04006171|38289244|FG001|Overall Study|insufficient sample volume|3|||
17145454|NCT04043143|38289257|FG000|Overall Study|Lost to Follow-up|5|||
17145455|NCT04043143|38289258|FG001|Overall Study|Lost to Follow-up|5|||
17145456|NCT04043143|38289257|FG000|Overall Study|screen failure|1|||
17145457|NCT04043143|38289258|FG001|Overall Study|screen failure|0|||
17145458|NCT03283098|38289266|FG000|Overall Study|Withdrawal by Subject|0|||
17145459|NCT03283098|38289267|FG001|Overall Study|Withdrawal by Subject|1|||
17145460|NCT03655951|38289275|FG000|Overall Study|Lost to Follow-up|39|||
17145461|NCT03655951|38289276|FG001|Overall Study|Lost to Follow-up|20|||
17145462|NCT03655951|38289275|FG000|Overall Study|Withdrawal by Subject|0|||
17145463|NCT03655951|38289276|FG001|Overall Study|Withdrawal by Subject|1|||
17145464|NCT02527798|38289288|FG000|Overall Study|Physician Decision|1|||
17145465|NCT02527798|38289289|FG001|Overall Study|Physician Decision|0|||
17145466|NCT02527798|38289290|FG002|Overall Study|Physician Decision|1|||
17145467|NCT02527798|38289291|FG003|Overall Study|Physician Decision|1|||
17145468|NCT02527798|38289292|FG004|Overall Study|Physician Decision|0|||
17145469|NCT02527798|38289293|FG005|Overall Study|Physician Decision|0|||
17145470|NCT02527798|38289288|FG000|Overall Study|Death|0|||
17145471|NCT02527798|38289289|FG001|Overall Study|Death|0|||
17145472|NCT02527798|38289290|FG002|Overall Study|Death|1|||
17145473|NCT02527798|38289291|FG003|Overall Study|Death|0|||
17145474|NCT02527798|38289292|FG004|Overall Study|Death|0|||
17145475|NCT02527798|38289293|FG005|Overall Study|Death|0|||
17145476|NCT02527798|38289288|FG000|Overall Study|Withdrawal by Subject|0|||
17145477|NCT02527798|38289289|FG001|Overall Study|Withdrawal by Subject|1|||
17145478|NCT02527798|38289290|FG002|Overall Study|Withdrawal by Subject|2|||
17145479|NCT02527798|38289291|FG003|Overall Study|Withdrawal by Subject|0|||
17145480|NCT02527798|38289292|FG004|Overall Study|Withdrawal by Subject|0|||
17145481|NCT02527798|38289293|FG005|Overall Study|Withdrawal by Subject|0|||
17145482|NCT02527798|38289288|FG000|Overall Study|Reason undisclosed|1|||
17145483|NCT02527798|38289289|FG001|Overall Study|Reason undisclosed|0|||
17145484|NCT02527798|38289290|FG002|Overall Study|Reason undisclosed|1|||
17145485|NCT02527798|38289291|FG003|Overall Study|Reason undisclosed|0|||
17145486|NCT02527798|38289292|FG004|Overall Study|Reason undisclosed|0|||
17145487|NCT02527798|38289293|FG005|Overall Study|Reason undisclosed|0|||
17145488|NCT02527798|38289288|FG000|Overall Study|Did not receive intervention|1|||
17145489|NCT02527798|38289289|FG001|Overall Study|Did not receive intervention|1|||
17145490|NCT02527798|38289290|FG002|Overall Study|Did not receive intervention|0|||
17145491|NCT02527798|38289291|FG003|Overall Study|Did not receive intervention|0|||
17145492|NCT02527798|38289292|FG004|Overall Study|Did not receive intervention|0|||
17145493|NCT02527798|38289293|FG005|Overall Study|Did not receive intervention|0|||
17145494|NCT03188991|38289324|FG000|Overall Study|Withdrawal by Subject|0|||
17145495|NCT03188991|38289325|FG001|Overall Study|Withdrawal by Subject|0|||
17145496|NCT03188991|38289326|FG002|Overall Study|Withdrawal by Subject|0|||
17145497|NCT03188991|38289327|FG003|Overall Study|Withdrawal by Subject|1|||
17145498|NCT03857542|38289339|FG000|Overall Study|Adverse Event|1|||
17145499|NCT03857542|38289340|FG001|Overall Study|Adverse Event|3|||
17145500|NCT03857542|38289339|FG000|Overall Study|Withdrawal by Subject|2|||
17145501|NCT03857542|38289340|FG001|Overall Study|Withdrawal by Subject|1|||
17145502|NCT03857542|38289339|FG000|Overall Study|Lost to Follow-up|2|||
17145503|NCT03857542|38289340|FG001|Overall Study|Lost to Follow-up|1|||
17145504|NCT03857542|38289339|FG000|Overall Study|Reason not Specified|1|||
17145505|NCT03857542|38289340|FG001|Overall Study|Reason not Specified|0|||
17145506|NCT03209973|38289347|FG000|Overall Study|Withdrawal by Subject|7|||
17145507|NCT03209973|38289347|FG000|Overall Study|Lost to Follow-up|2|||
17145508|NCT03209973|38289347|FG000|Overall Study|Death|8|||
17145509|NCT03209973|38289347|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
17145510|NCT03209973|38289347|FG000|Overall Study|Sponsor Decision|18|||
17145511|NCT03209973|38289347|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
17145512|NCT03209973|38289347|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
17145513|NCT03751631|38289353|FG000|Overall Study|Withdrawal by Subject|0|||
17145514|NCT03751631|38289354|FG001|Overall Study|Withdrawal by Subject|0|||
17145515|NCT03751631|38289355|FG002|Overall Study|Withdrawal by Subject|1|||
17145516|NCT03751631|38289356|FG003|Overall Study|Withdrawal by Subject|1|||
17145517|NCT03751631|38289357|FG004|Overall Study|Withdrawal by Subject|0|||
17145518|NCT03751631|38289358|FG005|Overall Study|Withdrawal by Subject|0|||
17145519|NCT03688711|38289371|FG000|Overall Study|Withdrawal by Subject|0|||
17145520|NCT03688711|38289372|FG001|Overall Study|Withdrawal by Subject|1|||
17145521|NCT03188055|38289380|FG000|Overall Study|Unavailable for training|0|||
17145522|NCT03188055|38289381|FG001|Overall Study|Unavailable for training|0|||
17145523|NCT03188055|38289382|FG002|Overall Study|Unavailable for training|19|||
17145524|NCT03188055|38289383|FG003|Overall Study|Unavailable for training|0|||
17145525|NCT03188055|38289384|FG004|Overall Study|Unavailable for training|0|||
17145526|NCT03188055|38289385|FG005|Overall Study|Unavailable for training||||
17145527|NCT03188055|38289380|FG000|Overall Study|Lost to Follow-up|0|||
17145528|NCT03188055|38289381|FG001|Overall Study|Lost to Follow-up|18|||
17145529|NCT03188055|38289382|FG002|Overall Study|Lost to Follow-up|0|||
17145530|NCT03188055|38289383|FG003|Overall Study|Lost to Follow-up|11|||
17145531|NCT03188055|38289384|FG004|Overall Study|Lost to Follow-up|0|||
17145532|NCT03188055|38289385|FG005|Overall Study|Lost to Follow-up||||
17145533|NCT03188055|38289380|FG000|Overall Study|Withdrawal by Subject|0|||
17145534|NCT03188055|38289381|FG001|Overall Study|Withdrawal by Subject|1|||
17145535|NCT03188055|38289382|FG002|Overall Study|Withdrawal by Subject|0|||
17145536|NCT03188055|38289383|FG003|Overall Study|Withdrawal by Subject|1|||
17145537|NCT03188055|38289384|FG004|Overall Study|Withdrawal by Subject|0|||
17145538|NCT03188055|38289385|FG005|Overall Study|Withdrawal by Subject||||
17145539|NCT04035577|38289396|FG000|Overall Study|Lost to Follow-up|1|||
17145540|NCT04035577|38289396|FG000|Overall Study|Withdrawal by Subject|1|||
17145541|NCT03655717|38289424|FG000|Overall Study|Withdrawal by Subject|4|||
17145542|NCT03655717|38289425|FG001|Overall Study|Withdrawal by Subject|8|||
17145543|NCT03655717|38289426|FG002|Overall Study|Withdrawal by Subject|1|||
17145544|NCT03655717|38289427|FG003|Overall Study|Withdrawal by Subject|0|||
17145545|NCT03655717|38289428|FG004|Overall Study|Withdrawal by Subject|0|||
17145546|NCT03655717|38289429|FG005|Overall Study|Withdrawal by Subject|1|||
17145547|NCT03655717|38289430|FG006|Overall Study|Withdrawal by Subject|3|||
17145548|NCT03655717|38289431|FG007|Overall Study|Withdrawal by Subject|1|||
17145549|NCT03655717|38289432|FG008|Overall Study|Withdrawal by Subject|2|||
17145550|NCT03655717|38289433|FG009|Overall Study|Withdrawal by Subject|0|||
17145551|NCT03655717|38289434|FG010|Overall Study|Withdrawal by Subject|0|||
16993448|NCT00788710|38137467|FG000|Overall Study|Withdrawal by Subject|2|||
16993449|NCT00788710|38137468|FG001|Overall Study|Withdrawal by Subject|2|||
16993450|NCT00788710|38137469|FG002|Overall Study|Withdrawal by Subject|0|||
17145552|NCT03655717|38289435|FG011|Overall Study|Withdrawal by Subject|1|||
16993451|NCT00787930|38137477|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
16993452|NCT00588094|38137487|FG000|Overall Study|Adverse Event|3|||
16993453|NCT00588094|38137487|FG000|Overall Study|Progression of Disease|2|||
16993454|NCT03373383|38137496|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
16993455|NCT03373383|38137497|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
16993456|NCT03373383|38137498|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
16993457|NCT03373383|38137499|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
16993458|NCT03373383|38137500|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
16993459|NCT03373383|38137496|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
16993460|NCT03373383|38137497|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
16993461|NCT03373383|38137498|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16993462|NCT03373383|38137499|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16993463|NCT03373383|38137500|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16993464|NCT03373383|38137496|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
16993465|NCT03373383|38137497|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
16993466|NCT03373383|38137498|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
16993467|NCT03373383|38137499|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
16993468|NCT03373383|38137500|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
16993469|NCT03373383|38137496|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
16993470|NCT03373383|38137497|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
16993471|NCT03373383|38137498|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
16993472|NCT03373383|38137499|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
16993473|NCT03373383|38137500|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
16993474|NCT03373383|38137496|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
16993475|NCT03373383|38137497|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
16993476|NCT03373383|38137498|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
16993477|NCT03373383|38137499|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
16993478|NCT03373383|38137500|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
17145553|NCT03655717|38289436|FG012|Overall Study|Withdrawal by Subject|0|||
17145554|NCT03655717|38289437|FG013|Overall Study|Withdrawal by Subject|3|||
17145555|NCT03655717|38289438|FG014|Overall Study|Withdrawal by Subject|0|||
17060064|NCT00536510|38203093|FG001|Overall Study|Flushing with Product|0|||
17060065|NCT00536510|38203092|FG000|Overall Study|Laboratory Adverse Event|2|||
17060066|NCT00536510|38203093|FG001|Overall Study|Laboratory Adverse Event|1|||
17060067|NCT00536510|38203092|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
17060068|NCT00536510|38203093|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
17060069|NCT00398086|38203102|FG000|Overall Study|Unacceptable Toxicity|2|||
17060070|NCT00398086|38203103|FG001|Overall Study|Unacceptable Toxicity|8|||
17060071|NCT00398086|38203104|FG002|Overall Study|Unacceptable Toxicity|2|||
17060072|NCT00398086|38203102|FG000|Overall Study|Adverse Event|1|||
17060073|NCT00398086|38203103|FG001|Overall Study|Adverse Event|4|||
17060074|NCT00398086|38203104|FG002|Overall Study|Adverse Event|0|||
17060075|NCT00398086|38203102|FG000|Overall Study|Physician Decision|1|||
17060076|NCT00398086|38203103|FG001|Overall Study|Physician Decision|4|||
17060077|NCT00398086|38203104|FG002|Overall Study|Physician Decision|0|||
17060078|NCT00398086|38203102|FG000|Overall Study|Withdrawal by Subject|5|||
17060079|NCT00398086|38203103|FG001|Overall Study|Withdrawal by Subject|7|||
17060080|NCT00398086|38203104|FG002|Overall Study|Withdrawal by Subject|0|||
17060081|NCT00536198|38203114|FG000|Overall Study|Lost to Follow-up|15|||
17060082|NCT00536198|38203115|FG001|Overall Study|Lost to Follow-up|14|||
17060083|NCT00536198|38203114|FG000|Overall Study|Withdrawal by Subject|16|||
17060084|NCT00536198|38203115|FG001|Overall Study|Withdrawal by Subject|12|||
17060085|NCT00536198|38203114|FG000|Overall Study|Adverse Event|2|||
17060086|NCT00536198|38203115|FG001|Overall Study|Adverse Event|2|||
17060087|NCT00536198|38203114|FG000|Overall Study|Rescue|3|||
17060088|NCT00536198|38203115|FG001|Overall Study|Rescue|9|||
17060089|NCT00536198|38203114|FG000|Overall Study|Pregnancy|1|||
17060090|NCT00536198|38203115|FG001|Overall Study|Pregnancy|1|||
17060091|NCT00536198|38203114|FG000|Overall Study|Protocol Violation|0|||
17060092|NCT00536198|38203115|FG001|Overall Study|Protocol Violation|1|||
17060093|NCT00393484|38203125|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
17060094|NCT00393484|38203126|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
17060095|NCT00393484|38203125|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
17060096|NCT00393484|38203126|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
17060097|NCT00393484|38203125|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
17060098|NCT00393484|38203126|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
17060099|NCT00393484|38203125|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
17145556|NCT03655717|38289439|FG015|Overall Study|Withdrawal by Subject|1|||
17145557|NCT03655717|38289440|FG016|Overall Study|Withdrawal by Subject|0|||
17145558|NCT03655717|38289441|FG017|Overall Study|Withdrawal by Subject|0|||
17145559|NCT03655717|38289442|FG018|Overall Study|Withdrawal by Subject|1|||
17145560|NCT03655717|38289443|FG019|Overall Study|Withdrawal by Subject|0|||
17145561|NCT03655717|38289444|FG020|Overall Study|Withdrawal by Subject|0|||
17060100|NCT00393484|38203126|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
17060101|NCT00393484|38203125|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
17060102|NCT00393484|38203126|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
17060103|NCT00393484|38203125|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
17060104|NCT00393484|38203126|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
17060105|NCT00393484|38203125|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
17060106|NCT00393484|38203126|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
17060107|NCT00393484|38203125|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
17060108|NCT00393484|38203126|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
17060109|NCT00393484|38203125|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
17060110|NCT00393484|38203126|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
17060111|NCT00393484|38203125|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
17060112|NCT00393484|38203126|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
17060113|NCT00667823|38203134|FG000|Overall Study|Lost to Follow-up|5|||
17060114|NCT00667823|38203134|FG000|Overall Study|Adverse Event|7|||
17060115|NCT00667823|38203134|FG000|Overall Study|Death|182|||
17060116|NCT00667823|38203134|FG000|Overall Study|Withdrawal by Subject|12|||
17060117|NCT00667823|38203134|FG000|Overall Study|Other|8|||
17060118|NCT00667823|38203134|FG000|Overall Study|Missing (completion page missing)|2|||
17060119|NCT00397930|38203140|FG000|Overall Study|Personal reasons|14|||
17060120|NCT00397930|38203141|FG001|Overall Study|Personal reasons|8|||
17060121|NCT00397930|38203140|FG000|Overall Study|Other medical|9|||
17060122|NCT00397930|38203141|FG001|Overall Study|Other medical|4|||
17060123|NCT00397930|38203140|FG000|Overall Study|Unknown reasons|9|||
17060124|NCT00397930|38203141|FG001|Overall Study|Unknown reasons|14|||
17060125|NCT00397930|38203140|FG000|Overall Study|Noncompliant|3|||
17060126|NCT00397930|38203141|FG001|Overall Study|Noncompliant|2|||
17060127|NCT00397930|38203140|FG000|Overall Study|Too time-consuming|2|||
17060128|NCT00397930|38203141|FG001|Overall Study|Too time-consuming|9|||
17060129|NCT00397930|38203140|FG000|Overall Study|Started own yoga program|1|||
17060130|NCT00397930|38203141|FG001|Overall Study|Started own yoga program|1|||
17060131|NCT00397930|38203140|FG000|Overall Study|Did not want to be in control group|0|||
17060132|NCT00397930|38203141|FG001|Overall Study|Did not want to be in control group|1|||
17060133|NCT00397930|38203140|FG000|Overall Study|Withdrawal by Subject|0|||
17060134|NCT00397930|38203141|FG001|Overall Study|Withdrawal by Subject|8|||
17060135|NCT00397930|38203140|FG000|Overall Study|Missing data|0|||
17060136|NCT00397930|38203141|FG001|Overall Study|Missing data|4|||
17060137|NCT00397540|38203149|FG000|Overall Study|short follow-up duration < 12 months|1|||
17060138|NCT00397540|38203150|FG001|Overall Study|short follow-up duration < 12 months|0|||
17060139|NCT00536120|38203159|FG000|Overall Study|Lost to Follow-up|1|||
17060140|NCT00536120|38203160|FG001|Overall Study|Lost to Follow-up|0|||
17060141|NCT00536120|38203159|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
17060142|NCT00536120|38203160|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
17060143|NCT00536120|38203159|FG000|Overall Study|Non-compliance|1|||
17060144|NCT00536120|38203160|FG001|Overall Study|Non-compliance|0|||
17060145|NCT00536120|38203159|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
17060146|NCT00536120|38203160|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
17060147|NCT00536120|38203159|FG000|Overall Study|Steroid Use|0|||
17060148|NCT00536120|38203160|FG001|Overall Study|Steroid Use|2|||
17060149|NCT00536120|38203159|FG000|Overall Study|Missed Study Visit|0|||
17060150|NCT00536120|38203160|FG001|Overall Study|Missed Study Visit|1|||
17060151|NCT00057811|38203168|FG000|Overall Study|Lack of Efficacy|1|||
17060152|NCT00057811|38203169|FG001|Overall Study|Lack of Efficacy|4|||
17060153|NCT00057811|38203168|FG000|Overall Study|Physician Decision|1|||
17060154|NCT00057811|38203169|FG001|Overall Study|Physician Decision|0|||
17060155|NCT00057811|38203168|FG000|Overall Study|Withdrawal by Subject|3|||
17060156|NCT00057811|38203169|FG001|Overall Study|Withdrawal by Subject|4|||
17145562|NCT03655717|38289445|FG021|Overall Study|Withdrawal by Subject|1|||
17145563|NCT03655717|38289446|FG022|Overall Study|Withdrawal by Subject|2|||
17145564|NCT03655717|38289447|FG023|Overall Study|Withdrawal by Subject|1|||
17145565|NCT03655717|38289448|FG024|Overall Study|Withdrawal by Subject|1|||
17145566|NCT03655717|38289449|FG025|Overall Study|Withdrawal by Subject|0|||
17145567|NCT03655717|38289424|FG000|Overall Study|Physician Decision|3|||
17145568|NCT03655717|38289425|FG001|Overall Study|Physician Decision|3|||
17145569|NCT03655717|38289426|FG002|Overall Study|Physician Decision|0|||
17145570|NCT03655717|38289427|FG003|Overall Study|Physician Decision|0|||
17145571|NCT03655717|38289428|FG004|Overall Study|Physician Decision|0|||
17145572|NCT03655717|38289429|FG005|Overall Study|Physician Decision|0|||
17145573|NCT03655717|38289430|FG006|Overall Study|Physician Decision|0|||
17145574|NCT03655717|38289431|FG007|Overall Study|Physician Decision|0|||
17145575|NCT03655717|38289432|FG008|Overall Study|Physician Decision|0|||
17145576|NCT03655717|38289433|FG009|Overall Study|Physician Decision|1|||
17060157|NCT00057811|38203168|FG000|Overall Study|Ineligible|4|||
17060158|NCT00057811|38203169|FG001|Overall Study|Ineligible|2|||
17060159|NCT00057811|38203168|FG000|Overall Study|Inevaluable|1|||
17060160|NCT00057811|38203169|FG001|Overall Study|Inevaluable|2|||
17060161|NCT00570713|38203191|FG000|Overall Study|Adverse Event|16|||
17060162|NCT00570713|38203192|FG001|Overall Study|Adverse Event|9|||
17060163|NCT00570713|38203191|FG000|Overall Study|Death|7|||
17060164|NCT00570713|38203192|FG001|Overall Study|Death|7|||
17060165|NCT00570713|38203191|FG000|Overall Study|Lack of Efficacy|40|||
17060166|NCT00570713|38203192|FG001|Overall Study|Lack of Efficacy|49|||
17060167|NCT00570713|38203191|FG000|Overall Study|Physician Decision|2|||
17060168|NCT00570713|38203192|FG001|Overall Study|Physician Decision|2|||
17060169|NCT00570713|38203191|FG000|Overall Study|Withdrawal by Subject|3|||
17060170|NCT00570713|38203192|FG001|Overall Study|Withdrawal by Subject|3|||
17145577|NCT03655717|38289434|FG010|Overall Study|Physician Decision|0|||
17145578|NCT03655717|38289435|FG011|Overall Study|Physician Decision|0|||
17145579|NCT03655717|38289436|FG012|Overall Study|Physician Decision|0|||
17145580|NCT03655717|38289437|FG013|Overall Study|Physician Decision|0|||
16781175|NCT02147158|37720323|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
17060171|NCT00570713|38203191|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
17060172|NCT00570713|38203192|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
17060173|NCT00669617|38203202|FG000|Period 1|Withdrawal by Subject|0|||
17060174|NCT00669617|38203203|FG001|Period 1|Withdrawal by Subject|0|||
17060175|NCT00669617|38203204|FG002|Period 1|Withdrawal by Subject|1|||
17060176|NCT00669617|38203205|FG003|Period 1|Withdrawal by Subject|0|||
17060177|NCT00669617|38203206|FG004|Period 1|Withdrawal by Subject|0|||
17060178|NCT00669617|38203202|FG000|Period 1|Protocol Deviation|0|||
17060179|NCT00669617|38203203|FG001|Period 1|Protocol Deviation|0|||
17060180|NCT00669617|38203204|FG002|Period 1|Protocol Deviation|0|||
17060181|NCT00669617|38203205|FG003|Period 1|Protocol Deviation|0|||
17060182|NCT00669617|38203206|FG004|Period 1|Protocol Deviation|1|||
17060183|NCT00669617|38203202|FG000|Period 3|Lost to Follow-up|1|||
17060184|NCT00669617|38203203|FG001|Period 3|Lost to Follow-up|0|||
17060185|NCT00669617|38203204|FG002|Period 3|Lost to Follow-up|0|||
17060186|NCT00669617|38203205|FG003|Period 3|Lost to Follow-up|0|||
17060187|NCT00669617|38203206|FG004|Period 3|Lost to Follow-up|0|||
17060188|NCT00535730|38203220|FG000|Overall Study|Adverse Event|1|||
17145581|NCT03655717|38289438|FG014|Overall Study|Physician Decision|0|||
17145582|NCT03655717|38289439|FG015|Overall Study|Physician Decision|0|||
17060189|NCT00535730|38203221|FG001|Overall Study|Adverse Event|1|||
17060190|NCT00535730|38203220|FG000|Overall Study|Lost to Follow-up|0|||
17060191|NCT00535730|38203221|FG001|Overall Study|Lost to Follow-up|1|||
17060192|NCT00535730|38203220|FG000|Overall Study|Physician Decision|0|||
17060193|NCT00535730|38203221|FG001|Overall Study|Physician Decision|1|||
17060194|NCT00535730|38203220|FG000|Overall Study|Protocol Violation|1|||
17060195|NCT00535730|38203221|FG001|Overall Study|Protocol Violation|0|||
17060196|NCT00535730|38203220|FG000|Overall Study|Withdrawal by Subject|0|||
17060197|NCT00535730|38203221|FG001|Overall Study|Withdrawal by Subject|4|||
17060198|NCT00666965|38203232|FG000|Overall Study|Adverse Event|0|||
17060199|NCT00666965|38203233|FG001|Overall Study|Adverse Event|2|||
17060200|NCT00666965|38203234|FG002|Overall Study|Adverse Event|1|||
17060201|NCT00666965|38203235|FG003|Overall Study|Adverse Event|9|||
17060202|NCT00666965|38203232|FG000|Overall Study|Lack of Efficacy|1|||
17060203|NCT00666965|38203233|FG001|Overall Study|Lack of Efficacy|1|||
17060204|NCT00666965|38203234|FG002|Overall Study|Lack of Efficacy|0|||
17060205|NCT00666965|38203235|FG003|Overall Study|Lack of Efficacy|0|||
17060206|NCT00666965|38203232|FG000|Overall Study|Protocol Violation|0|||
17060207|NCT00666965|38203233|FG001|Overall Study|Protocol Violation|0|||
16993479|NCT03373383|38137496|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
16993480|NCT03373383|38137497|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
16993481|NCT03373383|38137498|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
16993482|NCT03373383|38137499|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
16993483|NCT03373383|38137500|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
16993484|NCT03373383|38137496|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
16993485|NCT03373383|38137497|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
17060208|NCT00666965|38203234|FG002|Overall Study|Protocol Violation|0|||
17060209|NCT00666965|38203235|FG003|Overall Study|Protocol Violation|2|||
17060210|NCT00666965|38203232|FG000|Overall Study|Discontinuation criteria|2|||
17060211|NCT00666965|38203233|FG001|Overall Study|Discontinuation criteria|1|||
17060212|NCT00666965|38203234|FG002|Overall Study|Discontinuation criteria|1|||
17060213|NCT00666965|38203235|FG003|Overall Study|Discontinuation criteria|2|||
17060214|NCT00666965|38203232|FG000|Overall Study|Withdrawal by Subject|0|||
17060215|NCT00666965|38203233|FG001|Overall Study|Withdrawal by Subject|0|||
17060216|NCT00666965|38203234|FG002|Overall Study|Withdrawal by Subject|0|||
17060217|NCT00666965|38203235|FG003|Overall Study|Withdrawal by Subject|2|||
17060218|NCT03889886|38203249|FG000|Overall Study|Other|0|||
17060219|NCT03889886|38203250|FG001|Overall Study|Other|1|||
17060220|NCT03889886|38203251|FG002|Overall Study|Other|0|||
17060221|NCT03889886|38203252|FG003|Overall Study|Other|1|||
17060222|NCT03889886|38203249|FG000|Overall Study|Withdrawal by Subject|0|||
17060223|NCT03889886|38203250|FG001|Overall Study|Withdrawal by Subject|0|||
17060224|NCT03889886|38203251|FG002|Overall Study|Withdrawal by Subject|1|||
17060225|NCT03889886|38203252|FG003|Overall Study|Withdrawal by Subject|0|||
17060226|NCT03889886|38203249|FG000|Overall Study|Adverse Event|0|||
17060227|NCT03889886|38203250|FG001|Overall Study|Adverse Event|0|||
17060228|NCT03889886|38203251|FG002|Overall Study|Adverse Event|0|||
17060229|NCT03889886|38203252|FG003|Overall Study|Adverse Event|6|||
17060230|NCT03888482|38203264|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
17060231|NCT03888482|38203265|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
17060232|NCT03888482|38203264|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
17060233|NCT03888482|38203265|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
17060234|NCT00667355|38203273|FG000|Overall Study|Adverse Event|5|||
17060235|NCT00667355|38203273|FG000|Overall Study|Lost to Follow-up|1|||
17060236|NCT00667355|38203273|FG000|Overall Study|Other reason was not specified|5|||
17060237|NCT00532844|38203279|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
17060238|NCT00532844|38203280|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
17060239|NCT00532844|38203279|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
17060240|NCT00532844|38203280|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
17060241|NCT00532844|38203279|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
17060242|NCT00532844|38203280|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
17060243|NCT00532844|38203279|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
17060244|NCT00532844|38203280|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
17060245|NCT00532844|38203279|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
17060246|NCT00532844|38203280|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
17145583|NCT03655717|38289440|FG016|Overall Study|Physician Decision|0|||
17060247|NCT00666263|38203308|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
17060248|NCT00666263|38203309|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
17060249|NCT00666263|38203308|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
17060250|NCT00666263|38203309|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
17060251|NCT00666263|38203308|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
17060252|NCT00666263|38203309|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
17060253|NCT00667277|38203354|FG000|Overall Study|Withdrawal by Subject|2|||
17060254|NCT00534638|38203360|FG000|Overall Study|Withdrawal by Subject|3|||
17060255|NCT00534638|38203361|FG001|Overall Study|Withdrawal by Subject|4|||
17060256|NCT00534638|38203360|FG000|Overall Study|Migrated/moved from study area|13|||
17060257|NCT00534638|38203361|FG001|Overall Study|Migrated/moved from study area|11|||
17060258|NCT00534638|38203360|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
17060259|NCT00534638|38203361|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
17060260|NCT00534638|38203360|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
17060261|NCT00534638|38203361|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
17060262|NCT00534638|38203360|FG000|Overall Study|Other|1685|||
17060263|NCT00534638|38203361|FG001|Overall Study|Other|902|||
17060264|NCT00662129|38203372|FG000|Overall Study|Protocol Violation|1|||
17060265|NCT00662129|38203372|FG000|Overall Study|Cancel prior to beginning treatment|1|||
17060266|NCT00662129|38203372|FG000|Overall Study|Ineligible|1|||
17060267|NCT00664859|38203379|FG000|Overall Study|Adverse Event|2|||
17060268|NCT00664859|38203380|FG001|Overall Study|Adverse Event|1|||
17060269|NCT00664859|38203381|FG002|Overall Study|Adverse Event|3|||
17060270|NCT00664859|38203379|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
17060271|NCT00664859|38203380|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
17060272|NCT00664859|38203381|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
17060273|NCT00664859|38203379|FG000|Overall Study|Noncompliance with protocol|1|||
17060274|NCT00664859|38203380|FG001|Overall Study|Noncompliance with protocol|0|||
17060275|NCT00664859|38203381|FG002|Overall Study|Noncompliance with protocol|4|||
17060276|NCT00664859|38203379|FG000|Overall Study|Laboratory abnormality|2|||
17060277|NCT00664859|38203380|FG001|Overall Study|Laboratory abnormality|1|||
17060278|NCT00664859|38203381|FG002|Overall Study|Laboratory abnormality|4|||
17060279|NCT00664859|38203379|FG000|Overall Study|Withdrawal by Subject|4|||
17060280|NCT00664859|38203380|FG001|Overall Study|Withdrawal by Subject|1|||
17060281|NCT00664859|38203381|FG002|Overall Study|Withdrawal by Subject|3|||
17060282|NCT00664859|38203379|FG000|Overall Study|Lost to Follow-up|2|||
17060283|NCT00664859|38203380|FG001|Overall Study|Lost to Follow-up|2|||
17060284|NCT00664859|38203381|FG002|Overall Study|Lost to Follow-up|1|||
17060285|NCT00664859|38203379|FG000|Overall Study|Other|0|||
17060286|NCT00664859|38203380|FG001|Overall Study|Other|1|||
17060287|NCT00664859|38203381|FG002|Overall Study|Other|2|||
17060288|NCT00570401|38203389|FG000|Overall Study|Adverse Event|2|||
17060289|NCT00532298|38203399|FG000|Overall Study|Adverse Event|1|||
17060290|NCT00532298|38203400|FG001|Overall Study|Adverse Event|0|||
17060291|NCT00532298|38203401|FG002|Overall Study|Adverse Event|0|||
17060292|NCT00532298|38203402|FG003|Overall Study|Adverse Event|0|||
17060293|NCT00532298|38203403|FG004|Overall Study|Adverse Event|1|||
17060294|NCT00532298|38203404|FG005|Overall Study|Adverse Event|1|||
17060295|NCT00532298|38203399|FG000|Overall Study|Lost to Follow-up|1|||
17060296|NCT00532298|38203400|FG001|Overall Study|Lost to Follow-up|1|||
17060297|NCT00532298|38203401|FG002|Overall Study|Lost to Follow-up|1|||
17060298|NCT00532298|38203402|FG003|Overall Study|Lost to Follow-up|0|||
17060299|NCT00532298|38203403|FG004|Overall Study|Lost to Follow-up|0|||
17060300|NCT00532298|38203404|FG005|Overall Study|Lost to Follow-up|1|||
17060301|NCT00410410|38203424|FG000|Induction Period (IP)|Death|1|||
17060302|NCT00410410|38203425|FG001|Induction Period (IP)|Death|0|||
17060303|NCT00410410|38203426|FG002|Induction Period (IP)|Death|0|||
17060304|NCT00410410|38203427|FG003|Induction Period (IP)|Death|0|||
17145584|NCT03655717|38289441|FG017|Overall Study|Physician Decision|0|||
17145585|NCT03655717|38289442|FG018|Overall Study|Physician Decision|0|||
17145586|NCT03655717|38289443|FG019|Overall Study|Physician Decision|1|||
17145587|NCT03655717|38289444|FG020|Overall Study|Physician Decision|0|||
17145588|NCT03655717|38289445|FG021|Overall Study|Physician Decision|0|||
17145589|NCT03655717|38289446|FG022|Overall Study|Physician Decision|0|||
17145590|NCT03655717|38289447|FG023|Overall Study|Physician Decision|1|||
17145591|NCT03655717|38289448|FG024|Overall Study|Physician Decision|0|||
17145592|NCT03655717|38289449|FG025|Overall Study|Physician Decision|0|||
17145593|NCT03655717|38289424|FG000|Overall Study|Lost to Follow-up|3|||
17145594|NCT03655717|38289425|FG001|Overall Study|Lost to Follow-up|1|||
17060305|NCT00410410|38203428|FG004|Induction Period (IP)|Death|0|||
17060306|NCT00410410|38203429|FG005|Induction Period (IP)|Death|0|||
17060307|NCT00410410|38203430|FG006|Induction Period (IP)|Death|0|||
17060308|NCT00410410|38203431|FG007|Induction Period (IP)|Death|0|||
17145595|NCT03655717|38289426|FG002|Overall Study|Lost to Follow-up|0|||
17145596|NCT03655717|38289427|FG003|Overall Study|Lost to Follow-up|1|||
17145597|NCT03655717|38289428|FG004|Overall Study|Lost to Follow-up|0|||
17060309|NCT00410410|38203432|FG008|Induction Period (IP)|Death|0|||
17060310|NCT00410410|38203424|FG000|Induction Period (IP)|Adverse Event|3|||
17060311|NCT00410410|38203425|FG001|Induction Period (IP)|Adverse Event|4|||
17060312|NCT00410410|38203426|FG002|Induction Period (IP)|Adverse Event|2|||
17060313|NCT00410410|38203427|FG003|Induction Period (IP)|Adverse Event|4|||
17060314|NCT00410410|38203428|FG004|Induction Period (IP)|Adverse Event|1|||
17060315|NCT00410410|38203429|FG005|Induction Period (IP)|Adverse Event|0|||
17060316|NCT00410410|38203430|FG006|Induction Period (IP)|Adverse Event|0|||
17060317|NCT00410410|38203431|FG007|Induction Period (IP)|Adverse Event|0|||
17060318|NCT00410410|38203432|FG008|Induction Period (IP)|Adverse Event|0|||
17060319|NCT00410410|38203424|FG000|Induction Period (IP)|Lack of Efficacy|26|||
17060320|NCT00410410|38203425|FG001|Induction Period (IP)|Lack of Efficacy|24|||
17060321|NCT00410410|38203426|FG002|Induction Period (IP)|Lack of Efficacy|8|||
17060322|NCT00410410|38203427|FG003|Induction Period (IP)|Lack of Efficacy|8|||
17060323|NCT00410410|38203428|FG004|Induction Period (IP)|Lack of Efficacy|7|||
17060324|NCT00410410|38203429|FG005|Induction Period (IP)|Lack of Efficacy|7|||
17060325|NCT00410410|38203430|FG006|Induction Period (IP)|Lack of Efficacy|0|||
17060326|NCT00410410|38203431|FG007|Induction Period (IP)|Lack of Efficacy|0|||
17060327|NCT00410410|38203432|FG008|Induction Period (IP)|Lack of Efficacy|0|||
17060328|NCT00410410|38203424|FG000|Induction Period (IP)|Lost to Follow-up|2|||
17060329|NCT00410410|38203425|FG001|Induction Period (IP)|Lost to Follow-up|2|||
17060330|NCT00410410|38203426|FG002|Induction Period (IP)|Lost to Follow-up|2|||
17060331|NCT00410410|38203427|FG003|Induction Period (IP)|Lost to Follow-up|3|||
17060332|NCT00410410|38203428|FG004|Induction Period (IP)|Lost to Follow-up|0|||
17145598|NCT03655717|38289429|FG005|Overall Study|Lost to Follow-up|1|||
17145599|NCT03655717|38289430|FG006|Overall Study|Lost to Follow-up|0|||
17145600|NCT03655717|38289431|FG007|Overall Study|Lost to Follow-up|0|||
17060333|NCT00410410|38203429|FG005|Induction Period (IP)|Lost to Follow-up|1|||
17145601|NCT03655717|38289432|FG008|Overall Study|Lost to Follow-up|0|||
17145602|NCT03655717|38289433|FG009|Overall Study|Lost to Follow-up|0|||
17145603|NCT03655717|38289434|FG010|Overall Study|Lost to Follow-up|0|||
17145604|NCT03655717|38289435|FG011|Overall Study|Lost to Follow-up|1|||
17145605|NCT03655717|38289436|FG012|Overall Study|Lost to Follow-up|0|||
17145606|NCT03655717|38289437|FG013|Overall Study|Lost to Follow-up|0|||
17145607|NCT03655717|38289438|FG014|Overall Study|Lost to Follow-up|0|||
17145608|NCT03655717|38289439|FG015|Overall Study|Lost to Follow-up|0|||
17145609|NCT03655717|38289440|FG016|Overall Study|Lost to Follow-up|0|||
17145610|NCT03655717|38289441|FG017|Overall Study|Lost to Follow-up|0|||
17145611|NCT03655717|38289442|FG018|Overall Study|Lost to Follow-up|0|||
17145612|NCT03655717|38289443|FG019|Overall Study|Lost to Follow-up|0|||
17145613|NCT03655717|38289444|FG020|Overall Study|Lost to Follow-up|0|||
17145614|NCT03655717|38289445|FG021|Overall Study|Lost to Follow-up|0|||
17145615|NCT03655717|38289446|FG022|Overall Study|Lost to Follow-up|0|||
17145616|NCT03655717|38289447|FG023|Overall Study|Lost to Follow-up|0|||
17145617|NCT03655717|38289448|FG024|Overall Study|Lost to Follow-up|0|||
17060334|NCT00410410|38203430|FG006|Induction Period (IP)|Lost to Follow-up|0|||
17060335|NCT00410410|38203431|FG007|Induction Period (IP)|Lost to Follow-up|0|||
17060336|NCT00410410|38203432|FG008|Induction Period (IP)|Lost to Follow-up|0|||
17060337|NCT00410410|38203424|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
17060338|NCT00410410|38203425|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
17060339|NCT00410410|38203426|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
17060340|NCT00410410|38203427|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
17060341|NCT00410410|38203428|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
17060342|NCT00410410|38203429|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
17060343|NCT00410410|38203430|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
17060344|NCT00410410|38203431|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
17060345|NCT00410410|38203432|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
17060346|NCT00410410|38203424|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
17145618|NCT03655717|38289449|FG025|Overall Study|Lost to Follow-up|0|||
17145619|NCT04032613|38289465|FG000|Overall Study|Did not complete post-program assessment|5|||
17145620|NCT04032613|38289466|FG001|Overall Study|Did not complete post-program assessment|2|||
17145621|NCT04000165|38289472|FG000|Overall Study|Physician Decision|1|||
17145622|NCT04000165|38289472|FG000|Overall Study|Withdrawal by Subject|1|||
17145623|NCT03187197|38289479|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
17145624|NCT03187197|38289480|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
17145625|NCT03187197|38289481|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
17145626|NCT03187197|38289479|FG000|Overall Study|Withdrawal by Subject|8|||
17145627|NCT03187197|38289480|FG001|Overall Study|Withdrawal by Subject|63|||
17145628|NCT03187197|38289481|FG002|Overall Study|Withdrawal by Subject|4|||
17145629|NCT03187197|38289479|FG000|Overall Study|Lost to Follow-up|1|||
17145630|NCT03187197|38289480|FG001|Overall Study|Lost to Follow-up|60|||
17145631|NCT03187197|38289481|FG002|Overall Study|Lost to Follow-up|7|||
17145632|NCT03187197|38289479|FG000|Overall Study|Adverse Event|6|||
17145633|NCT03187197|38289480|FG001|Overall Study|Adverse Event|29|||
17145634|NCT03187197|38289481|FG002|Overall Study|Adverse Event|0|||
17060347|NCT00410410|38203425|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
17060348|NCT00410410|38203426|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
17060349|NCT00410410|38203427|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
17060350|NCT00410410|38203428|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
17060351|NCT00410410|38203429|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
17060352|NCT00410410|38203430|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
17060353|NCT00410410|38203431|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
17060354|NCT00410410|38203432|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
17060355|NCT00410410|38203424|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
17060356|NCT00410410|38203425|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
17060357|NCT00410410|38203426|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
17060358|NCT00410410|38203427|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
17060359|NCT00410410|38203428|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
17060360|NCT00410410|38203429|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
17060361|NCT00410410|38203430|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
17145635|NCT03187197|38289479|FG000|Overall Study|Death|0|||
17145636|NCT03187197|38289480|FG001|Overall Study|Death|11|||
17145637|NCT03187197|38289481|FG002|Overall Study|Death|0|||
17145638|NCT03187197|38289479|FG000|Overall Study|Administrative problem|1|||
17145639|NCT03187197|38289480|FG001|Overall Study|Administrative problem|1|||
17145640|NCT03187197|38289481|FG002|Overall Study|Administrative problem|0|||
17145641|NCT03187197|38289479|FG000|Overall Study|Reason not listed|2|||
17145642|NCT03187197|38289480|FG001|Overall Study|Reason not listed|54|||
17145643|NCT03187197|38289481|FG002|Overall Study|Reason not listed|1|||
17145644|NCT03187197|38289479|FG000|Overall Study|Missing|1|||
17145645|NCT03187197|38289480|FG001|Overall Study|Missing|32|||
17145646|NCT03187197|38289481|FG002|Overall Study|Missing|3|||
17145647|NCT03187197|38289479|FG000|Overall Study|Status missing|2|||
17145648|NCT03187197|38289480|FG001|Overall Study|Status missing|33|||
17145649|NCT03187197|38289481|FG002|Overall Study|Status missing|3|||
17060362|NCT00410410|38203431|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
17060363|NCT00410410|38203432|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
17060364|NCT00410410|38203424|FG000|Induction Period (IP)|Other|0|||
17060365|NCT00410410|38203425|FG001|Induction Period (IP)|Other|0|||
17060366|NCT00410410|38203426|FG002|Induction Period (IP)|Other|1|||
17060367|NCT00410410|38203427|FG003|Induction Period (IP)|Other|0|||
17060368|NCT00410410|38203428|FG004|Induction Period (IP)|Other|0|||
17060369|NCT00410410|38203429|FG005|Induction Period (IP)|Other|0|||
17060370|NCT00410410|38203430|FG006|Induction Period (IP)|Other|0|||
17060371|NCT00410410|38203431|FG007|Induction Period (IP)|Other|0|||
17060372|NCT00410410|38203432|FG008|Induction Period (IP)|Other|0|||
17060373|NCT00410410|38203424|FG000|Maintenance Period (MP)|Death|0|||
17060374|NCT00410410|38203425|FG001|Maintenance Period (MP)|Death|0|||
17060375|NCT00410410|38203426|FG002|Maintenance Period (MP)|Death|0|||
17060376|NCT00410410|38203427|FG003|Maintenance Period (MP)|Death|0|||
17145650|NCT03187197|38289479|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
17145651|NCT03187197|38289480|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
17145652|NCT03187197|38289481|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
17145653|NCT04000009|38289489|FG000|Overall Study|Adverse Event|13|||
17060377|NCT00410410|38203428|FG004|Maintenance Period (MP)|Death|0|||
17060378|NCT00410410|38203429|FG005|Maintenance Period (MP)|Death|0|||
17060379|NCT00410410|38203430|FG006|Maintenance Period (MP)|Death|1|||
17060380|NCT00410410|38203431|FG007|Maintenance Period (MP)|Death|0|||
17060381|NCT00410410|38203432|FG008|Maintenance Period (MP)|Death|0|||
17060382|NCT00410410|38203424|FG000|Maintenance Period (MP)|Adverse Event|0|||
17060383|NCT00410410|38203425|FG001|Maintenance Period (MP)|Adverse Event|0|||
17060384|NCT00410410|38203426|FG002|Maintenance Period (MP)|Adverse Event|0|||
17060385|NCT00410410|38203427|FG003|Maintenance Period (MP)|Adverse Event|0|||
17060386|NCT00410410|38203428|FG004|Maintenance Period (MP)|Adverse Event|0|||
17060387|NCT00410410|38203429|FG005|Maintenance Period (MP)|Adverse Event|0|||
17060388|NCT00410410|38203430|FG006|Maintenance Period (MP)|Adverse Event|1|||
17060389|NCT00410410|38203431|FG007|Maintenance Period (MP)|Adverse Event|3|||
17060390|NCT00410410|38203432|FG008|Maintenance Period (MP)|Adverse Event|0|||
17060391|NCT00410410|38203424|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
17060392|NCT00410410|38203425|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
17060393|NCT00410410|38203426|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
17060394|NCT00410410|38203427|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
17060395|NCT00410410|38203428|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
17060396|NCT00410410|38203429|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
17060397|NCT00410410|38203430|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
17060398|NCT00410410|38203431|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
17060399|NCT00410410|38203432|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
17060400|NCT00410410|38203424|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
17060401|NCT00410410|38203425|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
17060402|NCT00410410|38203426|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
17060403|NCT00410410|38203427|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
17060404|NCT00410410|38203428|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
17060405|NCT00410410|38203429|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
17060406|NCT00410410|38203430|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
17060407|NCT00410410|38203431|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
17060408|NCT00410410|38203432|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
17060409|NCT00410410|38203424|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
17060410|NCT00410410|38203425|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
17060411|NCT00410410|38203426|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
17060412|NCT00410410|38203427|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
17060413|NCT00410410|38203428|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
17060414|NCT00410410|38203429|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
16993486|NCT03373383|38137498|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
16993487|NCT03373383|38137499|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
16993488|NCT03373383|38137500|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
16993489|NCT03373383|38137496|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
16993490|NCT03373383|38137497|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
16993491|NCT03373383|38137498|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
16993492|NCT03373383|38137499|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
16993493|NCT03373383|38137500|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
16993494|NCT03373383|38137496|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
16993495|NCT03373383|38137497|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
16993496|NCT03373383|38137498|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
16993497|NCT03373383|38137499|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
16993498|NCT03373383|38137500|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
16993499|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
16993500|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
16993501|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
16993502|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
16993503|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
16993504|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
17060415|NCT00410410|38203430|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
17060416|NCT00410410|38203431|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
17060417|NCT00410410|38203432|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
17060418|NCT00410410|38203424|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
17060419|NCT00410410|38203425|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
17060420|NCT00410410|38203426|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
17060421|NCT00410410|38203427|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
17060422|NCT00410410|38203428|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
17060423|NCT00410410|38203429|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
17060424|NCT00410410|38203430|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
17060425|NCT00410410|38203431|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
17060426|NCT00410410|38203432|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
17060427|NCT00410410|38203424|FG000|Open-Label Period (OL)|Death|0|||
17060428|NCT00410410|38203425|FG001|Open-Label Period (OL)|Death|0|||
17060429|NCT00410410|38203426|FG002|Open-Label Period (OL)|Death|0|||
17060430|NCT00410410|38203427|FG003|Open-Label Period (OL)|Death|0|||
17060431|NCT00410410|38203428|FG004|Open-Label Period (OL)|Death|0|||
17060432|NCT00410410|38203429|FG005|Open-Label Period (OL)|Death|0|||
17060433|NCT00410410|38203430|FG006|Open-Label Period (OL)|Death|0|||
17060434|NCT00410410|38203431|FG007|Open-Label Period (OL)|Death|0|||
17060435|NCT00410410|38203432|FG008|Open-Label Period (OL)|Death|1|||
17060436|NCT00410410|38203424|FG000|Open-Label Period (OL)|Adverse Event|0|||
17060437|NCT00410410|38203425|FG001|Open-Label Period (OL)|Adverse Event|0|||
17060438|NCT00410410|38203426|FG002|Open-Label Period (OL)|Adverse Event|0|||
16993505|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
16993506|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
17060439|NCT00410410|38203427|FG003|Open-Label Period (OL)|Adverse Event|0|||
17060440|NCT00410410|38203428|FG004|Open-Label Period (OL)|Adverse Event|0|||
17060441|NCT00410410|38203429|FG005|Open-Label Period (OL)|Adverse Event|0|||
17060442|NCT00410410|38203430|FG006|Open-Label Period (OL)|Adverse Event|0|||
17060443|NCT00410410|38203431|FG007|Open-Label Period (OL)|Adverse Event|0|||
17060444|NCT00410410|38203432|FG008|Open-Label Period (OL)|Adverse Event|10|||
17060445|NCT00410410|38203424|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
17060446|NCT00410410|38203425|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
17060447|NCT00410410|38203426|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
17060448|NCT00410410|38203427|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
17060449|NCT00410410|38203428|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
17145654|NCT04000009|38289489|FG000|Overall Study|Lack of Efficacy|7|||
17145655|NCT04000009|38289489|FG000|Overall Study|Lost to Follow-up|8|||
17145656|NCT04000009|38289489|FG000|Overall Study|Noncompliance with study drug|4|||
17145657|NCT04000009|38289489|FG000|Overall Study|Physician Decision|1|||
17145658|NCT04000009|38289489|FG000|Overall Study|Use of prohibited medication|3|||
17145659|NCT04000009|38289489|FG000|Overall Study|Pregnancy|1|||
17145660|NCT04000009|38289489|FG000|Overall Study|Withdrawal by Subject|22|||
17145661|NCT04000009|38289489|FG000|Overall Study|Study terminated by sponsor|98|||
17145662|NCT04000009|38289489|FG000|Overall Study|Not further specified|8|||
17145663|NCT03282240|38289496|FG000|Overall Study|Adverse Event|2|||
17145664|NCT03282240|38289497|FG001|Overall Study|Adverse Event|2|||
17145665|NCT03282240|38289498|FG002|Overall Study|Adverse Event|0|||
17060450|NCT00410410|38203429|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
17060451|NCT00410410|38203430|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
17060452|NCT00410410|38203431|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
17060453|NCT00410410|38203432|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
17060454|NCT00410410|38203424|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
17060455|NCT00410410|38203425|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
17060456|NCT00410410|38203426|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
17060457|NCT00410410|38203427|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
17145666|NCT03282240|38289496|FG000|Overall Study|Lost to Follow-up|3|||
17145667|NCT03282240|38289497|FG001|Overall Study|Lost to Follow-up|0|||
17145668|NCT03282240|38289498|FG002|Overall Study|Lost to Follow-up|0|||
17145669|NCT03282240|38289496|FG000|Overall Study|Protocol Deviation|4|||
17145670|NCT03282240|38289497|FG001|Overall Study|Protocol Deviation|1|||
17145671|NCT03282240|38289498|FG002|Overall Study|Protocol Deviation|2|||
17145672|NCT03282240|38289496|FG000|Overall Study|Withdrawal by Subject|1|||
17145673|NCT03282240|38289497|FG001|Overall Study|Withdrawal by Subject|0|||
17145674|NCT03282240|38289498|FG002|Overall Study|Withdrawal by Subject|1|||
17145675|NCT03185949|38289511|FG000|ITT Analysis|Withdrawal by Subject|4|||
17145676|NCT03185949|38289512|FG001|ITT Analysis|Withdrawal by Subject|3|||
17145677|NCT03185949|38289511|FG000|PP Analysis|Protocol Violation|2|||
17145678|NCT03185949|38289512|FG001|PP Analysis|Protocol Violation|2|||
17060458|NCT00410410|38203428|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
17060459|NCT00410410|38203429|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
17060460|NCT00410410|38203430|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
17060461|NCT00410410|38203431|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
17060462|NCT00410410|38203432|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
17060463|NCT00410410|38203424|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
17060464|NCT00410410|38203425|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
17060465|NCT00410410|38203426|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
17060466|NCT00410410|38203427|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
17060467|NCT00410410|38203428|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
17060468|NCT00410410|38203429|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
17060469|NCT00410410|38203430|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
17060470|NCT00410410|38203431|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
17060471|NCT00410410|38203432|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
17060472|NCT00410410|38203424|FG000|Open-Label Period (OL)|Pregnancy|0|||
17060473|NCT00410410|38203425|FG001|Open-Label Period (OL)|Pregnancy|0|||
17060474|NCT00410410|38203426|FG002|Open-Label Period (OL)|Pregnancy|0|||
17060475|NCT00410410|38203427|FG003|Open-Label Period (OL)|Pregnancy|0|||
17060476|NCT00410410|38203428|FG004|Open-Label Period (OL)|Pregnancy|0|||
17060477|NCT00410410|38203429|FG005|Open-Label Period (OL)|Pregnancy|0|||
17060478|NCT00410410|38203430|FG006|Open-Label Period (OL)|Pregnancy|0|||
17060479|NCT00410410|38203431|FG007|Open-Label Period (OL)|Pregnancy|0|||
17060480|NCT00410410|38203432|FG008|Open-Label Period (OL)|Pregnancy|1|||
17060481|NCT00410410|38203424|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
17060482|NCT00410410|38203425|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
17060483|NCT00410410|38203426|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
17060484|NCT00410410|38203427|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
17060485|NCT00410410|38203428|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
17060486|NCT00410410|38203429|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
17060487|NCT00410410|38203430|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
17060488|NCT00410410|38203431|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
17145679|NCT03185949|38289511|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
17145680|NCT03185949|38289512|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
17145681|NCT03655405|38289522|FG000|Overall Study|Death after initial data collection|4|||
17145682|NCT03655405|38289523|FG001|Overall Study|Death after initial data collection|2|||
17060489|NCT00410410|38203432|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
17060490|NCT00410410|38203424|FG000|Open-Label Period (OL)|Other|0|||
17060491|NCT00410410|38203425|FG001|Open-Label Period (OL)|Other|0|||
17060492|NCT00410410|38203426|FG002|Open-Label Period (OL)|Other|0|||
17060493|NCT00410410|38203427|FG003|Open-Label Period (OL)|Other|0|||
17145683|NCT03655405|38289522|FG000|Overall Study|Died before initial data collection|1|||
17145684|NCT03655405|38289523|FG001|Overall Study|Died before initial data collection|2|||
17145685|NCT03655405|38289522|FG000|Overall Study|Protocol Violation|0|||
17145686|NCT03655405|38289523|FG001|Overall Study|Protocol Violation|1|||
17060494|NCT00410410|38203428|FG004|Open-Label Period (OL)|Other|0|||
17060495|NCT00410410|38203429|FG005|Open-Label Period (OL)|Other|0|||
17060496|NCT00410410|38203430|FG006|Open-Label Period (OL)|Other|0|||
17060497|NCT00410410|38203431|FG007|Open-Label Period (OL)|Other|0|||
17060498|NCT00410410|38203432|FG008|Open-Label Period (OL)|Other|7|||
17060499|NCT00534404|38203470|FG000|Overall Study|Death|0|||
17060500|NCT00534404|38203471|FG001|Overall Study|Death|0|||
17060501|NCT00534404|38203472|FG002|Overall Study|Death|2|||
17060502|NCT00534404|38203470|FG000|Overall Study|Withdrawal by Subject|8|||
17060503|NCT00534404|38203471|FG001|Overall Study|Withdrawal by Subject|2|||
17060504|NCT00534404|38203472|FG002|Overall Study|Withdrawal by Subject|38|||
17060505|NCT00534404|38203470|FG000|Overall Study|Removed by study staff|2|||
17060506|NCT00534404|38203471|FG001|Overall Study|Removed by study staff|3|||
17060507|NCT00534404|38203472|FG002|Overall Study|Removed by study staff|1|||
17060508|NCT00534404|38203470|FG000|Overall Study|Lost to Follow-up|170|||
17060509|NCT00534404|38203471|FG001|Overall Study|Lost to Follow-up|138|||
17060510|NCT00534404|38203472|FG002|Overall Study|Lost to Follow-up|201|||
17060511|NCT00393094|38203480|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
17060512|NCT00393094|38203480|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
17060513|NCT00409786|38203486|FG000|Overall Study|Withdrawal by Subject|3|||
17060514|NCT00409708|38203492|FG000|Treatment|Abnormal test procedure result(s)|1|||
17060515|NCT00409708|38203493|FG001|Treatment|Abnormal test procedure result(s)|0|||
17060516|NCT00409708|38203492|FG000|Treatment|Lack of Efficacy|0|||
17060517|NCT00409708|38203493|FG001|Treatment|Lack of Efficacy|1|||
17060518|NCT00409708|38203492|FG000|Treatment|Protocol Violation|6|||
17060519|NCT00409708|38203493|FG001|Treatment|Protocol Violation|2|||
17060520|NCT00409708|38203492|FG000|Treatment|Withdrawal by Subject|3|||
17060521|NCT00409708|38203493|FG001|Treatment|Withdrawal by Subject|8|||
17060522|NCT00409708|38203492|FG000|Treatment|Lost to Follow-up|0|||
17060523|NCT00409708|38203493|FG001|Treatment|Lost to Follow-up|6|||
17060524|NCT00409708|38203492|FG000|Treatment|Administrative problems|5|||
17060525|NCT00409708|38203493|FG001|Treatment|Administrative problems|0|||
17060526|NCT00409708|38203492|FG000|Washout|Lack of Efficacy|9|||
17060527|NCT00409708|38203493|FG001|Washout|Lack of Efficacy|1|||
17060528|NCT00409708|38203492|FG000|Washout|Protocol Violation|0|||
17060529|NCT00409708|38203493|FG001|Washout|Protocol Violation|1|||
17060530|NCT00409708|38203492|FG000|Washout|Withdrawal by Subject|11|||
17060531|NCT00409708|38203493|FG001|Washout|Withdrawal by Subject|5|||
17060532|NCT00409708|38203492|FG000|Washout|Lost to Follow-up|1|||
17060533|NCT00409708|38203493|FG001|Washout|Lost to Follow-up|3|||
17060534|NCT00391846|38203510|FG000|Overall Study|Adverse Event|4|||
17060535|NCT00391846|38203511|FG001|Overall Study|Adverse Event|1|||
17145687|NCT03510598|38289529|FG000|Overall Study|Withdrawal by Subject|1|||
16781176|NCT02147158|37720324|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
16993507|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
16993508|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
16993509|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
16993510|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
16993511|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
16993512|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
16993513|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
16993514|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
16993515|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
16993516|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
16993517|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
16993518|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
17060536|NCT00391846|38203510|FG000|Overall Study|Did not meet the required elig. crit|2|||
17060537|NCT00391846|38203511|FG001|Overall Study|Did not meet the required elig. crit|2|||
17060538|NCT00391846|38203510|FG000|Overall Study|Withdrawal by Subject|2|||
17060539|NCT00391846|38203511|FG001|Overall Study|Withdrawal by Subject|3|||
17060540|NCT00391846|38203510|FG000|Overall Study|Developed study specific DC criteria|0|||
17060541|NCT00391846|38203511|FG001|Overall Study|Developed study specific DC criteria|1|||
17060542|NCT00534248|38203536|FG000|Overall Study|Adverse Event|19|||
17060543|NCT00534248|38203537|FG001|Overall Study|Adverse Event|29|||
17060544|NCT00534248|38203536|FG000|Overall Study|Lost to Follow-up|353|||
17145688|NCT03222141|38289533|FG000|Overall Study|Death|15|||
17145689|NCT03222141|38289533|FG000|Overall Study|Lost to Follow-up|3|||
17145690|NCT04029961|38289540|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
17145691|NCT04029961|38289541|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
17145692|NCT04029961|38289540|FG000|Overall Study|Change in Treatment Course|0|||
17145693|NCT04029961|38289541|FG001|Overall Study|Change in Treatment Course|1|||
17145694|NCT03997825|38289547|FG000|Overall Study|Death|3|||
17145695|NCT03997825|38289547|FG000|Overall Study|Lost to Follow-up|10|||
17145696|NCT03997825|38289547|FG000|Overall Study|Withdrawal by Subject|3|||
17145697|NCT03997825|38289547|FG000|Overall Study|Refused participation|1|||
17145698|NCT04024891|38289553|FG000|Overall Study|Pregnancy|0|||
17145699|NCT04024891|38289554|FG001|Overall Study|Pregnancy|1|||
17145700|NCT03250182|38289560|FG000|Overall Study|Withdrawal by Subject|1|||
17145701|NCT03993379|38289568|FG000|Overall Study|The study was terminated early due to business decision.|0|||
17145702|NCT03993379|38289569|FG001|Overall Study|The study was terminated early due to business decision.|2|||
17145703|NCT03993379|38289570|FG002|Overall Study|The study was terminated early due to business decision.|0|||
17145704|NCT03993379|38289571|FG003|Overall Study|The study was terminated early due to business decision.|0|||
17145705|NCT03993379|38289568|FG000|Overall Study|Withdrawal by Subject|0|||
17145706|NCT03993379|38289569|FG001|Overall Study|Withdrawal by Subject|1|||
17145707|NCT03993379|38289570|FG002|Overall Study|Withdrawal by Subject|0|||
17145708|NCT03993379|38289571|FG003|Overall Study|Withdrawal by Subject|0|||
17060545|NCT00534248|38203537|FG001|Overall Study|Lost to Follow-up|375|||
17060546|NCT00534248|38203536|FG000|Overall Study|Other protocol specified criteria|13|||
17060547|NCT00534248|38203537|FG001|Overall Study|Other protocol specified criteria|3|||
17060548|NCT00534248|38203536|FG000|Overall Study|Physician Decision|10|||
17060549|NCT00534248|38203537|FG001|Overall Study|Physician Decision|7|||
17060550|NCT00534248|38203536|FG000|Overall Study|Protocol Violation|3|||
17060551|NCT00534248|38203537|FG001|Overall Study|Protocol Violation|4|||
17060552|NCT00534248|38203536|FG000|Overall Study|Withdrawal by Subject|263|||
17060553|NCT00534248|38203537|FG001|Overall Study|Withdrawal by Subject|255|||
17060554|NCT00391768|38203550|FG000|Overall Study|Withdrawal by Subject|0|||
17060555|NCT00391768|38203551|FG001|Overall Study|Withdrawal by Subject|0|||
17060556|NCT00391768|38203552|FG002|Overall Study|Withdrawal by Subject|1|||
17060557|NCT00391768|38203553|FG003|Overall Study|Withdrawal by Subject|0|||
17060558|NCT00391768|38203554|FG004|Overall Study|Withdrawal by Subject|0|||
17060559|NCT00391768|38203555|FG005|Overall Study|Withdrawal by Subject|1|||
17145709|NCT03370120|38289581|FG000|Overall Study|Adverse event, non-fatal|24|||
17145710|NCT03370120|38289581|FG000|Overall Study|Withdrawal by Subject|6|||
17145711|NCT03370120|38289581|FG000|Overall Study|Lost to Follow-up|1|||
17145712|NCT03370120|38289581|FG000|Overall Study|Lack of Efficacy|37|||
17145713|NCT03370120|38289581|FG000|Overall Study|Per sponsor's instructions|1|||
17145714|NCT03370120|38289581|FG000|Overall Study|Study was terminated by parent company UCB|2|||
17145715|NCT03370120|38289581|FG000|Overall Study|The study was ended by the promoter|3|||
17145716|NCT03370120|38289581|FG000|Overall Study|Discontinuation of drug development|3|||
17145717|NCT03370120|38289581|FG000|Overall Study|End of project|2|||
17145718|NCT03370120|38289581|FG000|Overall Study|Premature study closure|2|||
17145719|NCT03370120|38289581|FG000|Overall Study|Premature program termination|1|||
17145720|NCT03370120|38289581|FG000|Overall Study|Premature study termination|7|||
17145721|NCT03370120|38289581|FG000|Overall Study|Trial terminated by sponsor|2|||
17145722|NCT03370120|38289581|FG000|Overall Study|Trial discontinued by sponsor|2|||
17145723|NCT03370120|38289581|FG000|Overall Study|Study ended|15|||
17145724|NCT03370120|38289581|FG000|Overall Study|Clinical trial has been cancelled|1|||
17145725|NCT03370120|38289581|FG000|Overall Study|End of study per sponsor decision|2|||
17145726|NCT03370120|38289581|FG000|Overall Study|Promoter's decision|2|||
17145727|NCT03370120|38289581|FG000|Overall Study|The trial has been suspended|3|||
17145728|NCT03370120|38289581|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
17060560|NCT00391768|38203556|FG006|Overall Study|Withdrawal by Subject|1|||
17060561|NCT00391768|38203550|FG000|Overall Study|Lost to Follow-up|0|||
17060562|NCT00391768|38203551|FG001|Overall Study|Lost to Follow-up|0|||
17145729|NCT03370120|38289581|FG000|Overall Study|Early termination by order of sponsor|2|||
17060563|NCT00391768|38203552|FG002|Overall Study|Lost to Follow-up|0|||
17060564|NCT00391768|38203553|FG003|Overall Study|Lost to Follow-up|1|||
17060565|NCT00391768|38203554|FG004|Overall Study|Lost to Follow-up|2|||
17145730|NCT03370120|38289581|FG000|Overall Study|Discontinuation of the study|5|||
17145731|NCT03370120|38289581|FG000|Overall Study|End of clinical trial discontinuation|1|||
17145732|NCT03370120|38289581|FG000|Overall Study|Because the clinical trial ended halfway|4|||
17145733|NCT03370120|38289581|FG000|Overall Study|Development discontinued|5|||
17145734|NCT03370120|38289581|FG000|Overall Study|Padsenovil program closed|3|||
17145735|NCT03370120|38289581|FG000|Overall Study|End of project|2|||
17145736|NCT03370120|38289581|FG000|Overall Study|Termination of project|1|||
17145737|NCT03370120|38289581|FG000|Overall Study|The study was interrupted by sponsor|4|||
17145738|NCT03370120|38289581|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
17145739|NCT03370120|38289581|FG000|Overall Study|End of sponsor decision|1|||
17145740|NCT03370120|38289581|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
17145741|NCT03370120|38289581|FG000|Overall Study|Early termination of studies|5|||
17145742|NCT03370120|38289581|FG000|Overall Study|This study is ended early|1|||
17145743|NCT03370120|38289581|FG000|Overall Study|End of padsevonil program|2|||
17145744|NCT03370120|38289581|FG000|Overall Study|Decision of sponsor|6|||
17145745|NCT03370120|38289581|FG000|Overall Study|Asked by the sponsor|3|||
17145746|NCT03370120|38289581|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
17145747|NCT03370120|38289581|FG000|Overall Study|PI decision poor compliance from participant|1|||
17145748|NCT03370120|38289581|FG000|Overall Study|Promoter ended the study|3|||
17145749|NCT03370120|38289581|FG000|Overall Study|Premature study close by sponsor's decision|4|||
17145750|NCT03370120|38289581|FG000|Overall Study|Study terminated by sponsor|33|||
17145751|NCT03370120|38289581|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
17145752|NCT03370120|38289581|FG000|Overall Study|Sponsor decision to terminate study|63|||
17145753|NCT03370120|38289581|FG000|Overall Study|Program closure|3|||
17145754|NCT03370120|38289581|FG000|Overall Study|Study ended prematurely|1|||
17145755|NCT03370120|38289581|FG000|Overall Study|Study stopped by sponsor|2|||
17145756|NCT03370120|38289581|FG000|Overall Study|Program termination|55|||
17145757|NCT03370120|38289581|FG000|Overall Study|Sponsor decision|62|||
17145758|NCT03370120|38289581|FG000|Overall Study|Sponsor study closure|10|||
17145759|NCT03247686|38289589|FG000|Overall Study|Withdrawal by Subject|1|||
17145760|NCT03247686|38289590|FG001|Overall Study|Withdrawal by Subject|2|||
17145761|NCT03990649|38289601|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
17145762|NCT03990649|38289602|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
17145763|NCT03990649|38289603|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
17145764|NCT03990649|38289601|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
17145765|NCT03990649|38289602|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
17145766|NCT03990649|38289603|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
17145767|NCT03990649|38289601|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
17145768|NCT03990649|38289602|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
17145769|NCT03990649|38289603|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
17145770|NCT03990649|38289601|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
17145771|NCT03990649|38289602|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
17145772|NCT03990649|38289603|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
17145773|NCT03990649|38289601|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
17145774|NCT03990649|38289602|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
17145775|NCT03990649|38289603|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
17145776|NCT03990649|38289601|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
17145777|NCT03990649|38289602|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
17145778|NCT03990649|38289603|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
17145779|NCT03990649|38289601|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
17145780|NCT03990649|38289602|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
17145781|NCT03990649|38289603|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
17145782|NCT03220737|38289617|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
17145783|NCT03220737|38289618|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
17145784|NCT03220737|38289619|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
17145785|NCT03220737|38289620|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
17145786|NCT03220737|38289621|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
17145787|NCT03220737|38289622|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
17145788|NCT03220737|38289623|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
17145789|NCT03220737|38289617|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
17145790|NCT03220737|38289618|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
17060566|NCT00391768|38203555|FG005|Overall Study|Lost to Follow-up|2|||
17060567|NCT00391768|38203556|FG006|Overall Study|Lost to Follow-up|3|||
17060568|NCT00391222|38203593|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
17060569|NCT00391222|38203594|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
17060570|NCT00391222|38203595|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
17060571|NCT00391222|38203596|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
17060572|NCT00391222|38203593|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
17060573|NCT00391222|38203594|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
17060574|NCT00391222|38203595|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
17060575|NCT00391222|38203596|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
17060576|NCT00391222|38203593|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
17060577|NCT00391222|38203594|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
17060578|NCT00391222|38203595|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
17060579|NCT00391222|38203596|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
17060580|NCT00391222|38203593|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
17060581|NCT00391222|38203594|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
17060582|NCT00391222|38203595|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
17060583|NCT00391222|38203596|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
17060584|NCT00391222|38203593|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
17060585|NCT00391222|38203594|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
17060586|NCT00391222|38203595|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
17060587|NCT00391222|38203596|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
17060588|NCT00391222|38203593|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
17060589|NCT00391222|38203594|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
17060590|NCT00391222|38203595|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
17060591|NCT00391222|38203596|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
17060592|NCT00391222|38203593|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
17060593|NCT00391222|38203594|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
17060594|NCT00391222|38203595|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
17060595|NCT00391222|38203596|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
17060596|NCT00391222|38203593|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
17060597|NCT00391222|38203594|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
17060598|NCT00391222|38203595|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
17060599|NCT00391222|38203596|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
17060600|NCT00391222|38203593|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
17060601|NCT00391222|38203594|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
17060602|NCT00391222|38203595|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
17060603|NCT00391222|38203596|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
17060604|NCT00391222|38203593|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
17060605|NCT00391222|38203594|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
17060606|NCT00391222|38203595|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
17060607|NCT00391222|38203596|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
17060608|NCT00391222|38203593|FG000|Period III (Double-Blind Treatment)|Other|6|||
17060609|NCT00391222|38203594|FG001|Period III (Double-Blind Treatment)|Other|1|||
17060610|NCT00391222|38203595|FG002|Period III (Double-Blind Treatment)|Other|6|||
17060611|NCT00391222|38203596|FG003|Period III (Double-Blind Treatment)|Other|0|||
17060612|NCT00409006|38203608|FG000|Overall Study|Death|15|||
17145791|NCT03220737|38289619|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
17145792|NCT03220737|38289620|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
17145793|NCT03220737|38289621|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
17145794|NCT03220737|38289622|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
17145795|NCT03220737|38289623|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
17145796|NCT03220737|38289617|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
17145797|NCT03220737|38289618|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
17145798|NCT03220737|38289619|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
17145799|NCT03220737|38289620|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
17060613|NCT00409006|38203609|FG001|Overall Study|Death|6|||
17060614|NCT00409006|38203608|FG000|Overall Study|Lost to Follow-up|1|||
17060615|NCT00409006|38203609|FG001|Overall Study|Lost to Follow-up|2|||
17060616|NCT00409006|38203608|FG000|Overall Study|Withdrawal by Subject|3|||
17060617|NCT00409006|38203609|FG001|Overall Study|Withdrawal by Subject|2|||
17060618|NCT00409006|38203608|FG000|Overall Study|Physician Decision|1|||
17060619|NCT00409006|38203609|FG001|Overall Study|Physician Decision|2|||
17060620|NCT00534092|38203617|FG000|Overall Study|Lost to Follow-up|1|||
17060621|NCT00534092|38203618|FG001|Overall Study|Lost to Follow-up|0|||
17145800|NCT03220737|38289621|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
17145801|NCT03220737|38289622|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
17145802|NCT03220737|38289623|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
17145803|NCT03220737|38289617|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
17145804|NCT03220737|38289618|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
17145805|NCT03220737|38289619|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
17060622|NCT00534092|38203617|FG000|Overall Study|personal reasons/family concerns|1|||
17060623|NCT00534092|38203618|FG001|Overall Study|personal reasons/family concerns|0|||
17060624|NCT00408928|38203626|FG000|Overall Study|Withdrawal by Subject|1|||
17060625|NCT00408928|38203626|FG000|Overall Study|Death|1|||
17060626|NCT00408928|38203626|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
17060627|NCT00390910|38203633|FG000|Overall Study|Adverse Event|1|||
17060628|NCT00390910|38203634|FG001|Overall Study|Adverse Event|0|||
17060629|NCT00390910|38203635|FG002|Overall Study|Adverse Event|0|||
17060630|NCT00390910|38203633|FG000|Overall Study|Lost to Follow-up|0|||
17060631|NCT00390910|38203634|FG001|Overall Study|Lost to Follow-up|1|||
17060632|NCT00390910|38203635|FG002|Overall Study|Lost to Follow-up|5|||
17060633|NCT00390910|38203633|FG000|Overall Study|Withdrawal by Subject|1|||
17060634|NCT00390910|38203634|FG001|Overall Study|Withdrawal by Subject|3|||
17060635|NCT00390910|38203635|FG002|Overall Study|Withdrawal by Subject|2|||
17060636|NCT00390910|38203633|FG000|Overall Study|Migrated/moved from study area|0|||
17060637|NCT00390910|38203634|FG001|Overall Study|Migrated/moved from study area|0|||
17060638|NCT00390910|38203635|FG002|Overall Study|Migrated/moved from study area|3|||
17060639|NCT00533702|38203647|FG000|Overall Study|Withdrawal by Subject|3|||
17060640|NCT00533702|38203648|FG001|Overall Study|Withdrawal by Subject|1|||
17060641|NCT00533702|38203647|FG000|Overall Study|Found ineligible after randomization|2|||
17060642|NCT00533702|38203648|FG001|Overall Study|Found ineligible after randomization|1|||
17060643|NCT00408694|38203654|FG000|Overall Study|Ineligible|1|||
17060644|NCT00408694|38203654|FG000|Overall Study|No protocol treatment|1|||
17060645|NCT00396136|38203658|FG000|Overall Study|Death|43|||
17060646|NCT00396136|38203658|FG000|Overall Study|Withdrawal by Subject|59|||
17060647|NCT00396136|38203658|FG000|Overall Study|Lost to Follow-up|15|||
17060648|NCT00396136|38203658|FG000|Overall Study|Study device explanted|8|||
17060649|NCT00530894|38203666|FG000|Overall Study|Death|84|||
17060650|NCT00530894|38203667|FG001|Overall Study|Death|89|||
17060651|NCT00530894|38203668|FG002|Overall Study|Death|55|||
17060652|NCT00530894|38203669|FG003|Overall Study|Death|89|||
17060653|NCT00530894|38203666|FG000|Overall Study|Lost to Follow-up|1|||
17060654|NCT00530894|38203667|FG001|Overall Study|Lost to Follow-up|3|||
17060655|NCT00530894|38203668|FG002|Overall Study|Lost to Follow-up|0|||
17060656|NCT00530894|38203669|FG003|Overall Study|Lost to Follow-up|0|||
17060657|NCT00530894|38203666|FG000|Overall Study|Withdrawal by Subject|1|||
17060658|NCT00530894|38203667|FG001|Overall Study|Withdrawal by Subject|23|||
17060659|NCT00530894|38203668|FG002|Overall Study|Withdrawal by Subject|0|||
17060660|NCT00530894|38203669|FG003|Overall Study|Withdrawal by Subject|5|||
17060661|NCT00530894|38203666|FG000|Overall Study|Alive and censored prior to 1 year|2|||
17060662|NCT00530894|38203667|FG001|Overall Study|Alive and censored prior to 1 year|0|||
17060663|NCT00530894|38203668|FG002|Overall Study|Alive and censored prior to 1 year|0|||
17060664|NCT00530894|38203669|FG003|Overall Study|Alive and censored prior to 1 year|0|||
17060665|NCT00056407|38203683|FG000|Overall Study|Adverse Event|282|||
17060666|NCT00056407|38203684|FG001|Overall Study|Adverse Event|364|||
17060667|NCT00056407|38203683|FG000|Overall Study|Withdrawal by Subject|377|||
17060668|NCT00056407|38203684|FG001|Overall Study|Withdrawal by Subject|361|||
17060669|NCT00056407|38203683|FG000|Overall Study|Lost to Follow-up|123|||
17060670|NCT00056407|38203684|FG001|Overall Study|Lost to Follow-up|113|||
17060671|NCT00056407|38203683|FG000|Overall Study|Protocol Violation|104|||
17060672|NCT00056407|38203684|FG001|Overall Study|Protocol Violation|95|||
17060673|NCT00056407|38203683|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
17060674|NCT00056407|38203684|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
17060675|NCT00056407|38203683|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
17060676|NCT00056407|38203684|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
17060677|NCT00056407|38203683|FG000|Overall Study|Missing|25|||
17060678|NCT00056407|38203684|FG001|Overall Study|Missing|34|||
17060679|NCT00388726|38203692|FG000|Overall Study|Adverse Event|50|||
17060680|NCT00388726|38203693|FG001|Overall Study|Adverse Event|24|||
17060681|NCT00388726|38203692|FG000|Overall Study|Progressive Disease|336|||
17060682|NCT00388726|38203693|FG001|Overall Study|Progressive Disease|153|||
17060683|NCT00388726|38203692|FG000|Overall Study|Clinical Progression|61|||
17060684|NCT00388726|38203693|FG001|Overall Study|Clinical Progression|36|||
17060685|NCT00388726|38203692|FG000|Overall Study|Withdrawal by Subject|10|||
17060686|NCT00388726|38203693|FG001|Overall Study|Withdrawal by Subject|7|||
17060687|NCT00388726|38203692|FG000|Overall Study|Administrative|6|||
17060688|NCT00388726|38203693|FG001|Overall Study|Administrative|9|||
17060689|NCT00388726|38203692|FG000|Overall Study|Physician Decision|18|||
17060690|NCT00388726|38203693|FG001|Overall Study|Physician Decision|13|||
17060691|NCT00388726|38203692|FG000|Overall Study|Death|3|||
17060692|NCT00388726|38203693|FG001|Overall Study|Death|2|||
17060693|NCT00387790|38203699|FG000|Overall Study|Adverse Event|5|||
17060694|NCT00387790|38203699|FG000|Overall Study|Lack of Efficacy|2|||
17060695|NCT00387790|38203699|FG000|Overall Study|Physician Decision|2|||
17060696|NCT00387790|38203699|FG000|Overall Study|Withdrawal by Subject|3|||
17060697|NCT00387790|38203699|FG000|Overall Study|Ineligible for study|2|||
17060698|NCT00073021|38203705|FG000|Overall Study|Protocol Violation|2|||
17060699|NCT00073021|38203706|FG001|Overall Study|Protocol Violation|1|||
17060700|NCT00073021|38203705|FG000|Overall Study|Adverse Event|4|||
17060701|NCT00073021|38203706|FG001|Overall Study|Adverse Event|4|||
17145806|NCT03220737|38289620|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
17145807|NCT03220737|38289621|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
17145808|NCT03220737|38289622|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
17145809|NCT03220737|38289623|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
17145810|NCT03220737|38289617|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
17145811|NCT03220737|38289618|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
17145812|NCT03220737|38289619|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
17145813|NCT03220737|38289620|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
17145814|NCT03220737|38289621|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
17145815|NCT03220737|38289622|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
17145816|NCT03220737|38289623|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
17145817|NCT03220737|38289617|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
17145818|NCT03220737|38289618|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
17145819|NCT03220737|38289619|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
17145820|NCT03220737|38289620|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
17145821|NCT03220737|38289621|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
17145822|NCT03220737|38289622|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
17145823|NCT03220737|38289623|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
17145824|NCT03220737|38289617|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
17145825|NCT03220737|38289618|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
17060702|NCT00073021|38203705|FG000|Overall Study|Withdrawal by Subject|6|||
17060703|NCT00073021|38203706|FG001|Overall Study|Withdrawal by Subject|5|||
17060704|NCT00073021|38203705|FG000|Overall Study|Physician Decision|3|||
17060705|NCT00073021|38203706|FG001|Overall Study|Physician Decision|1|||
17060706|NCT00073021|38203705|FG000|Overall Study|Lack of Efficacy|11|||
17060707|NCT00073021|38203706|FG001|Overall Study|Lack of Efficacy|5|||
17060708|NCT00407758|38203712|FG000|Overall Study|ineligible -improper prior treatment|1|||
17060709|NCT00531752|38203720|FG000|First Double-blind Intervention Period|Adverse Event|2|||
17060710|NCT00531752|38203721|FG001|First Double-blind Intervention Period|Adverse Event|0|||
17060711|NCT00531752|38203722|FG002|First Double-blind Intervention Period|Adverse Event|1|||
17060712|NCT00531752|38203723|FG003|First Double-blind Intervention Period|Adverse Event|1|||
17060713|NCT00531752|38203720|FG000|First Double-blind Intervention Period|Other|1|||
17060714|NCT00531752|38203721|FG001|First Double-blind Intervention Period|Other|4|||
17060715|NCT00531752|38203722|FG002|First Double-blind Intervention Period|Other|4|||
17060716|NCT00531752|38203723|FG003|First Double-blind Intervention Period|Other|0|||
17060717|NCT00531752|38203720|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
17060718|NCT00531752|38203721|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
17060719|NCT00531752|38203722|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
17060720|NCT00531752|38203723|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
17060721|NCT00531752|38203720|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
17060722|NCT00531752|38203721|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
17060723|NCT00531752|38203722|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
17060724|NCT00531752|38203723|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
17060725|NCT00531752|38203720|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
17060726|NCT00531752|38203721|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
17060727|NCT00531752|38203722|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
17060728|NCT00531752|38203723|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
17060729|NCT00531752|38203720|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
17060730|NCT00531752|38203721|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
17060731|NCT00531752|38203722|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
17060732|NCT00531752|38203723|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
17060733|NCT00531752|38203720|FG000|Second Double-blind Intervention Period|Other|1|||
17060734|NCT00531752|38203721|FG001|Second Double-blind Intervention Period|Other|1|||
17060735|NCT00531752|38203722|FG002|Second Double-blind Intervention Period|Other|0|||
17060736|NCT00531752|38203723|FG003|Second Double-blind Intervention Period|Other|0|||
17060737|NCT00531752|38203720|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
17060738|NCT00531752|38203721|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
17060739|NCT00531752|38203722|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
17060740|NCT00531752|38203723|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
17060741|NCT00531752|38203720|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
17060742|NCT00531752|38203721|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
17060743|NCT00531752|38203722|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
17060744|NCT00531752|38203723|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
17060745|NCT00395746|38203734|FG000|Overall Study|Adverse Event|5|||
17060746|NCT00395746|38203735|FG001|Overall Study|Adverse Event|2|||
17060747|NCT00395746|38203736|FG002|Overall Study|Adverse Event|2|||
17060748|NCT00395746|38203734|FG000|Overall Study|Protocol Violation|0|||
17060749|NCT00395746|38203735|FG001|Overall Study|Protocol Violation|1|||
17060750|NCT00395746|38203736|FG002|Overall Study|Protocol Violation|0|||
17060751|NCT00395746|38203734|FG000|Overall Study|Lack of Efficacy|2|||
17060752|NCT00395746|38203735|FG001|Overall Study|Lack of Efficacy|0|||
17060753|NCT00395746|38203736|FG002|Overall Study|Lack of Efficacy|17|||
17060754|NCT00395746|38203734|FG000|Overall Study|Hypoglycaemia|2|||
17060755|NCT00395746|38203735|FG001|Overall Study|Hypoglycaemia|1|||
17060756|NCT00395746|38203736|FG002|Overall Study|Hypoglycaemia|0|||
17060757|NCT00395746|38203734|FG000|Overall Study|Subject decision|0|||
17060758|NCT00395746|38203735|FG001|Overall Study|Subject decision|0|||
17060759|NCT00395746|38203736|FG002|Overall Study|Subject decision|1|||
17060760|NCT00395746|38203734|FG000|Overall Study|Withdrawal of consent|0|||
17060761|NCT00395746|38203735|FG001|Overall Study|Withdrawal of consent|0|||
17060762|NCT00395746|38203736|FG002|Overall Study|Withdrawal of consent|1|||
17060763|NCT00395746|38203734|FG000|Overall Study|Difficultulty in use of device|0|||
17060764|NCT00395746|38203735|FG001|Overall Study|Difficultulty in use of device|0|||
17145826|NCT03220737|38289619|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
17145827|NCT03220737|38289620|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
17145828|NCT03220737|38289621|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
17145829|NCT03220737|38289622|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
17145830|NCT03220737|38289623|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
17145831|NCT03220737|38289617|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
17145832|NCT03220737|38289618|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
17145833|NCT03220737|38289619|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
17145834|NCT03220737|38289620|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
17145835|NCT03220737|38289621|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
17145836|NCT03220737|38289622|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
17145837|NCT03220737|38289623|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
17145838|NCT03185481|38289645|FG000|Overall Study|Adverse Event|1|||
17145839|NCT03185481|38289645|FG000|Overall Study|Study Terminated by Sponsor|4|||
17145840|NCT03652675|38289651|FG000|Overall Study|Lost to Follow-up|4|||
17145841|NCT03652675|38289652|FG001|Overall Study|Lost to Follow-up|4|||
17145842|NCT03241368|38289658|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
17145843|NCT03241368|38289658|FG000|Overall Study|Lost to Follow-up|1|||
17060765|NCT00395746|38203736|FG002|Overall Study|Difficultulty in use of device|1|||
17060766|NCT00395746|38203734|FG000|Overall Study|Unable to visit site on schedule|1|||
17060767|NCT00395746|38203735|FG001|Overall Study|Unable to visit site on schedule|0|||
17060768|NCT00395746|38203736|FG002|Overall Study|Unable to visit site on schedule|0|||
17060769|NCT00055471|38203747|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
17060770|NCT00055471|38203748|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
17060771|NCT00055471|38203749|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
17060772|NCT00055471|38203747|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
17060773|NCT00055471|38203748|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
17060774|NCT00055471|38203749|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
17060775|NCT00055471|38203747|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
17145844|NCT03241368|38289658|FG000|Overall Study|Physician Decision|6|||
17145845|NCT03241368|38289658|FG000|Overall Study|Withdrawal by Subject|6|||
17145846|NCT03241368|38289658|FG000|Overall Study|Protocol Violation|1|||
17145847|NCT03220581|38289665|FG000|Overall Study|Withdrawal by Subject|0|||
17145848|NCT03220581|38289666|FG001|Overall Study|Withdrawal by Subject|1|||
17060776|NCT00055471|38203748|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
17060777|NCT00055471|38203749|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
17060778|NCT00395512|38203761|FG000|Overall Study|Adverse Event|3|||
17060779|NCT00395512|38203762|FG001|Overall Study|Adverse Event|8|||
17060780|NCT00395512|38203763|FG002|Overall Study|Adverse Event|6|||
17060781|NCT00395512|38203764|FG003|Overall Study|Adverse Event|6|||
17060782|NCT00395512|38203761|FG000|Overall Study|Protocol Violation|2|||
17060783|NCT00395512|38203762|FG001|Overall Study|Protocol Violation|3|||
17060784|NCT00395512|38203763|FG002|Overall Study|Protocol Violation|6|||
17060785|NCT00395512|38203764|FG003|Overall Study|Protocol Violation|7|||
17060786|NCT00395512|38203761|FG000|Overall Study|Lost to Follow-up|2|||
17060787|NCT00395512|38203762|FG001|Overall Study|Lost to Follow-up|6|||
17060788|NCT00395512|38203763|FG002|Overall Study|Lost to Follow-up|5|||
17060789|NCT00395512|38203764|FG003|Overall Study|Lost to Follow-up|5|||
17060790|NCT00395512|38203761|FG000|Overall Study|Withdrawal by Subject|6|||
17060791|NCT00395512|38203762|FG001|Overall Study|Withdrawal by Subject|5|||
17060792|NCT00395512|38203763|FG002|Overall Study|Withdrawal by Subject|5|||
17060793|NCT00395512|38203764|FG003|Overall Study|Withdrawal by Subject|12|||
17060794|NCT00395512|38203761|FG000|Overall Study|Physician Decision|6|||
17060795|NCT00395512|38203762|FG001|Overall Study|Physician Decision|4|||
17060796|NCT00395512|38203763|FG002|Overall Study|Physician Decision|2|||
17060797|NCT00395512|38203764|FG003|Overall Study|Physician Decision|2|||
17060798|NCT00395512|38203761|FG000|Overall Study|Other|1|||
17060799|NCT00395512|38203762|FG001|Overall Study|Other|1|||
17060800|NCT00395512|38203763|FG002|Overall Study|Other|0|||
17060801|NCT00395512|38203764|FG003|Overall Study|Other|0|||
17060802|NCT00395512|38203761|FG000|Overall Study|Hyperglycemic Rescue|18|||
17060803|NCT00395512|38203762|FG001|Overall Study|Hyperglycemic Rescue|10|||
17060804|NCT00395512|38203763|FG002|Overall Study|Hyperglycemic Rescue|4|||
17060805|NCT00395512|38203764|FG003|Overall Study|Hyperglycemic Rescue|6|||
17060806|NCT00054691|38203774|FG000|Overall Study|Unmeasurable Disease|2|||
17060807|NCT00054691|38203774|FG000|Overall Study|Noncompliant|1|||
17060808|NCT00387712|38203780|FG000|Overall Study|Physician Decision|6|||
17060809|NCT00387712|38203781|FG001|Overall Study|Physician Decision|4|||
17060810|NCT00387712|38203780|FG000|Overall Study|Lost to Follow-up|17|||
17060811|NCT00387712|38203781|FG001|Overall Study|Lost to Follow-up|20|||
17060812|NCT00387712|38203780|FG000|Overall Study|Withdrawal by Subject|6|||
17060813|NCT00387712|38203781|FG001|Overall Study|Withdrawal by Subject|12|||
17060814|NCT00066703|38203789|FG000|Overall Study|Adverse Event|80|||
17060815|NCT00066703|38203790|FG001|Overall Study|Adverse Event|111|||
17060816|NCT00066703|38203789|FG000|Overall Study|Death|3|||
17060817|NCT00066703|38203790|FG001|Overall Study|Death|0|||
17060818|NCT00066703|38203789|FG000|Overall Study|Lack of Efficacy|114|||
17060819|NCT00066703|38203790|FG001|Overall Study|Lack of Efficacy|69|||
17060820|NCT00066703|38203789|FG000|Overall Study|Lost to Follow-up|31|||
17060821|NCT00066703|38203790|FG001|Overall Study|Lost to Follow-up|28|||
17060822|NCT00066703|38203789|FG000|Overall Study|Withdrawal by Subject|38|||
17060823|NCT00066703|38203790|FG001|Overall Study|Withdrawal by Subject|63|||
17060824|NCT00066703|38203789|FG000|Overall Study|Treatment ongoing|346|||
17060825|NCT00066703|38203790|FG001|Overall Study|Treatment ongoing|311|||
17060826|NCT00072475|38203796|FG000|Overall Study|Adverse Event|44|||
17060827|NCT00072475|38203796|FG000|Overall Study|Death|3|||
17060828|NCT00072475|38203796|FG000|Overall Study|Withdrawal by Subject|46|||
17060829|NCT00072475|38203796|FG000|Overall Study|Patient/Investigator Decision|4|||
17060830|NCT00066469|38203800|FG000|Overall Study|Death|3|||
17060831|NCT00066469|38203800|FG000|Overall Study|Lack of Efficacy|9|||
17060832|NCT00066469|38203800|FG000|Overall Study|Lost to Follow-up|1|||
17060833|NCT00066469|38203800|FG000|Overall Study|Physician Decision|1|||
17060834|NCT00066469|38203800|FG000|Overall Study|Withdrawal by Subject|1|||
17060835|NCT00066469|38203800|FG000|Overall Study|ineligible|1|||
17060836|NCT00387088|38203806|FG000|Overall Study|Adverse Event|143|||
17060837|NCT00387088|38203807|FG001|Overall Study|Adverse Event|156|||
16993519|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
16993520|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
16993521|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
16993522|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
16993523|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
16993524|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
16993525|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
16993526|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
16993527|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
16993528|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
16993529|NCT00784654|38137527|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
16993530|NCT00784654|38137528|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
16993531|NCT00784654|38137529|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
16993532|NCT00784654|38137527|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
16993533|NCT00784654|38137528|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
16993534|NCT00784654|38137529|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
16993535|NCT00784654|38137527|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
16993536|NCT00784654|38137528|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
16993537|NCT00784654|38137529|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
16993538|NCT00784654|38137527|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16993539|NCT00784654|38137528|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
16993540|NCT00784654|38137529|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
16993541|NCT00784654|38137527|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
16993542|NCT00784654|38137528|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
16993543|NCT00784654|38137529|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
16993544|NCT00784654|38137527|FG000|Randomized Withdrawal Period|Adverse Event|0|||
16993545|NCT00784654|38137528|FG001|Randomized Withdrawal Period|Adverse Event|1|||
16993546|NCT00784654|38137529|FG002|Randomized Withdrawal Period|Adverse Event|1|||
16993547|NCT00784654|38137527|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
16993548|NCT00784654|38137528|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
16993549|NCT00784654|38137529|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
16993550|NCT00784654|38137527|FG000|Randomized Withdrawal Period|Family reasons|0|||
16993551|NCT00784654|38137528|FG001|Randomized Withdrawal Period|Family reasons|0|||
16993552|NCT00784654|38137529|FG002|Randomized Withdrawal Period|Family reasons|1|||
16993553|NCT00787150|38137543|FG000|Overall Study|Adverse Event|4|||
16993554|NCT00787150|38137544|FG001|Overall Study|Adverse Event|4|||
16993555|NCT00787150|38137545|FG002|Overall Study|Adverse Event|4|||
16993556|NCT00787150|38137543|FG000|Overall Study|Physician Decision|1|||
16993557|NCT00787150|38137544|FG001|Overall Study|Physician Decision|2|||
16993558|NCT00787150|38137545|FG002|Overall Study|Physician Decision|1|||
16993559|NCT00787150|38137543|FG000|Overall Study|Withdrawal by Subject|2|||
16993560|NCT00787150|38137544|FG001|Overall Study|Withdrawal by Subject|1|||
16993561|NCT00787150|38137545|FG002|Overall Study|Withdrawal by Subject|0|||
16993562|NCT00787150|38137543|FG000|Overall Study|Dosing incorrect study durg|2|||
16993563|NCT00787150|38137544|FG001|Overall Study|Dosing incorrect study durg|0|||
16993564|NCT00787150|38137545|FG002|Overall Study|Dosing incorrect study durg|0|||
16993565|NCT00786838|38137555|FG000|Overall Study|Physician Decision|4|||
16993566|NCT00786838|38137555|FG000|Overall Study|Death|4|||
16993567|NCT00786838|38137555|FG000|Overall Study|Adverse Event|6|||
16993568|NCT00786838|38137555|FG000|Overall Study|Progressive disease|31|||
16993569|NCT00786838|38137555|FG000|Overall Study|Withdrawal by Subject|4|||
16993570|NCT00785980|38137564|FG000|7 Day Washout Period|Protocol Violation|3|||
16993571|NCT00791518|38137571|FG000|Overall Study|Protocol Violation|93|||
16993572|NCT00785512|38137592|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
16993573|NCT00785512|38137593|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
16993574|NCT00785512|38137592|FG000|Overall Study|Adverse Event|0|||
16993575|NCT00785512|38137593|FG001|Overall Study|Adverse Event|0|||
16993576|NCT00785512|38137592|FG000|Overall Study|Lack of Efficacy|0|||
16993577|NCT00785512|38137593|FG001|Overall Study|Lack of Efficacy|2|||
17060838|NCT00387088|38203806|FG000|Overall Study|Protocol Violation|47|||
17060839|NCT00387088|38203807|FG001|Overall Study|Protocol Violation|35|||
17145849|NCT03220581|38289665|FG000|Overall Study|Lost to Follow-up|3|||
17145850|NCT03220581|38289666|FG001|Overall Study|Lost to Follow-up|6|||
17060840|NCT00387088|38203806|FG000|Overall Study|Withdrawal by Subject|20|||
17060841|NCT00387088|38203807|FG001|Overall Study|Withdrawal by Subject|35|||
17060842|NCT00387088|38203806|FG000|Overall Study|Lack of Efficacy|28|||
17060843|NCT00387088|38203807|FG001|Overall Study|Lack of Efficacy|67|||
17060844|NCT00387088|38203806|FG000|Overall Study|Lost to Follow-up|22|||
17060845|NCT00387088|38203807|FG001|Overall Study|Lost to Follow-up|28|||
17060846|NCT00387088|38203806|FG000|Overall Study|Other|58|||
17060847|NCT00387088|38203807|FG001|Overall Study|Other|52|||
17060848|NCT00070291|38203813|FG000|Step 1|Withdrawal by Subject|1|||
17060849|NCT00070291|38203813|FG000|Step 1|Adverse Event|1|||
17060850|NCT00070291|38203813|FG000|Step 2|Adverse Event|1|||
17145851|NCT02954575|38289674|FG000|Overall Study|Withdrawal by Subject|2|||
17145852|NCT02954575|38289674|FG000|Overall Study|Adverse Event|1|||
17145853|NCT03184701|38289682|FG000|Overall Study|Death|3|||
17145854|NCT03184701|38289682|FG000|Overall Study|Physician Decision|3|||
17145855|NCT03184701|38289682|FG000|Overall Study|Withdrawal by Subject|6|||
17145856|NCT03184701|38289682|FG000|Overall Study|Lost to Follow-up|5|||
17145857|NCT03247530|38289689|FG000|Overall Study|Withdrawal by caregiver|19|||
17145858|NCT03247530|38289690|FG001|Overall Study|Withdrawal by caregiver|8|||
17145859|NCT03247530|38289691|FG002|Overall Study|Withdrawal by caregiver|10|||
17145860|NCT03247530|38289689|FG000|Overall Study|Lost to Follow-up|3|||
17145861|NCT03247530|38289690|FG001|Overall Study|Lost to Follow-up|9|||
17060851|NCT00053365|38203817|FG000|Overall Study|Incorrect cell type|1|||
17060852|NCT00053365|38203817|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
17060853|NCT00053365|38203817|FG000|Overall Study|Never treated|4|||
17060854|NCT00387010|38203823|FG000|Dose Titration Period|Adverse Event|12|||
17060855|NCT00387010|38203823|FG000|Dose Titration Period|Lack of Efficacy|5|||
17060856|NCT00387010|38203823|FG000|Dose Titration Period|Withdrawal by Subject|3|||
17060857|NCT00387010|38203823|FG000|Dose Titration Period|Protocol Violation|1|||
17060858|NCT00387010|38203823|FG000|Dose Titration Period|Lost to Follow-up|2|||
17060859|NCT00387010|38203823|FG000|Dose Titration Period|Noncompliance with study medication|8|||
17060860|NCT00387010|38203823|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
17060861|NCT00387010|38203823|FG000|Treatment Period|Adverse Event|4|||
17060862|NCT00387010|38203823|FG000|Treatment Period|Withdrawal by Subject|1|||
17060863|NCT00387010|38203823|FG000|Treatment Period|Noncompliance with study medication|2|||
17060864|NCT00387010|38203823|FG000|Treatment Period|Noncompliance with study procedures|3|||
17145862|NCT03247530|38289691|FG002|Overall Study|Lost to Follow-up|6|||
17145863|NCT03247530|38289689|FG000|Overall Study|Adverse Event|2|||
17145864|NCT03247530|38289690|FG001|Overall Study|Adverse Event|5|||
17145865|NCT03247530|38289691|FG002|Overall Study|Adverse Event|2|||
17145866|NCT03247530|38289689|FG000|Overall Study|Failure to follow procedure|1|||
17060865|NCT00387010|38203823|FG000|Treatment Period|Participant reported study drug stolen|1|||
17060866|NCT00386776|38203827|FG000|Overall Study|Withdrawal by Subject|8|||
17060867|NCT00065065|38203835|FG000|Overall Study|Adverse Event|3|||
17060868|NCT00065065|38203836|FG001|Overall Study|Adverse Event|2|||
17060869|NCT00065065|38203835|FG000|Overall Study|Withdrawal by Subject|1|||
17060870|NCT00065065|38203836|FG001|Overall Study|Withdrawal by Subject|5|||
17060871|NCT00065065|38203835|FG000|Overall Study|Lack of Efficacy|4|||
17060872|NCT00065065|38203836|FG001|Overall Study|Lack of Efficacy|11|||
17060873|NCT00065065|38203835|FG000|Overall Study|Other|2|||
17060874|NCT00065065|38203836|FG001|Overall Study|Other|2|||
17060875|NCT00386308|38203846|FG000|Overall Study|Adverse Event|3|||
17060876|NCT00386308|38203847|FG001|Overall Study|Adverse Event|3|||
17060877|NCT00386308|38203846|FG000|Overall Study|Protocol Violation|2|||
17060878|NCT00386308|38203847|FG001|Overall Study|Protocol Violation|5|||
17060879|NCT00386308|38203846|FG000|Overall Study|Lack of Efficacy|0|||
17145867|NCT03247530|38289690|FG001|Overall Study|Failure to follow procedure|1|||
17145868|NCT03247530|38289691|FG002|Overall Study|Failure to follow procedure|1|||
17145869|NCT03247530|38289689|FG000|Overall Study|Withdrawal by Subject|1|||
17145870|NCT03247530|38289690|FG001|Overall Study|Withdrawal by Subject|1|||
17145871|NCT03247530|38289691|FG002|Overall Study|Withdrawal by Subject|0|||
17145872|NCT03247530|38289689|FG000|Overall Study|Study medication misuse|0|||
17145873|NCT03247530|38289690|FG001|Overall Study|Study medication misuse|1|||
17145874|NCT03247530|38289691|FG002|Overall Study|Study medication misuse|0|||
17145875|NCT03247530|38289689|FG000|Overall Study|Other, multiple categories|1|||
17145876|NCT03247530|38289690|FG001|Overall Study|Other, multiple categories|3|||
17145877|NCT03247530|38289691|FG002|Overall Study|Other, multiple categories|1|||
17145878|NCT03246672|38289702|FG000|Overall Study|Lost to Follow-up|2|||
17145879|NCT03983317|38289706|FG000|Overall Study|Physician Decision|5|||
17145880|NCT03207243|38289712|FG000|Overall Study|Adverse Event|2|||
17145881|NCT03207243|38289713|FG001|Overall Study|Adverse Event|2|||
17145882|NCT03207243|38289712|FG000|Overall Study|Loss of Asthma Control|47|||
17145883|NCT03207243|38289713|FG001|Overall Study|Loss of Asthma Control|31|||
17145884|NCT03207243|38289712|FG000|Overall Study|Withdrawal by Subject|2|||
17145885|NCT03207243|38289713|FG001|Overall Study|Withdrawal by Subject|4|||
17145886|NCT03207243|38289712|FG000|Overall Study|Physician Decision|1|||
17145887|NCT03207243|38289713|FG001|Overall Study|Physician Decision|1|||
17145888|NCT03207243|38289712|FG000|Overall Study|Lost to Follow-up|0|||
17145889|NCT03207243|38289713|FG001|Overall Study|Lost to Follow-up|1|||
17145890|NCT03207243|38289712|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
17145891|NCT03207243|38289713|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
17145892|NCT03207243|38289712|FG000|Overall Study|Protocol Violation|0|||
17145893|NCT03207243|38289713|FG001|Overall Study|Protocol Violation|3|||
17145894|NCT03982069|38289724|FG000|Overall Study|Lost to Follow-up|5|||
17145895|NCT03982069|38289725|FG001|Overall Study|Lost to Follow-up|5|||
17145896|NCT03982069|38289726|FG002|Overall Study|Lost to Follow-up|3|||
17145897|NCT03982069|38289727|FG003|Overall Study|Lost to Follow-up|5|||
17145898|NCT03982069|38289724|FG000|Overall Study|Physician Decision|0|||
17145899|NCT03982069|38289725|FG001|Overall Study|Physician Decision|1|||
17145900|NCT03982069|38289726|FG002|Overall Study|Physician Decision|0|||
17145901|NCT03982069|38289727|FG003|Overall Study|Physician Decision|0|||
17145902|NCT03982069|38289724|FG000|Overall Study|Withdrawal by Subject|2|||
17145903|NCT03982069|38289725|FG001|Overall Study|Withdrawal by Subject|1|||
17145904|NCT03982069|38289726|FG002|Overall Study|Withdrawal by Subject|5|||
17145905|NCT03982069|38289727|FG003|Overall Study|Withdrawal by Subject|2|||
17145906|NCT03982069|38289724|FG000|Overall Study|Specimen loss|3|||
17145907|NCT03982069|38289725|FG001|Overall Study|Specimen loss|3|||
17145908|NCT03982069|38289726|FG002|Overall Study|Specimen loss|1|||
17145909|NCT03982069|38289727|FG003|Overall Study|Specimen loss|1|||
17145910|NCT02937870|38289735|FG000|Overall Study|Adverse Event|1|||
17145911|NCT02937870|38289735|FG000|Overall Study|Protocol Deviation|2|||
17145912|NCT03629041|38289749|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
17145913|NCT03629041|38289750|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
17145914|NCT03629041|38289751|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
17145915|NCT03629041|38289752|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
17145916|NCT03219723|38289770|FG000|Overall Study|Case Report Forms Uncollected|6|||
17145917|NCT03219723|38289770|FG000|Overall Study|Protocol Deviation|4|||
17145918|NCT03628417|38289774|FG000|Overall Study|Death|1|||
17145919|NCT03628417|38289775|FG001|Overall Study|Death|1|||
17145920|NCT03184077|38289787|FG000|Overall Study|Lost to Follow-up|21|||
17145921|NCT03184077|38289788|FG001|Overall Study|Lost to Follow-up|21|||
17145922|NCT03245736|38289794|FG000|Overall Study|Adverse Event|1|||
17060880|NCT00386308|38203847|FG001|Overall Study|Lack of Efficacy|2|||
17145923|NCT03245736|38289794|FG000|Overall Study|Progressive Disease|4|||
17145924|NCT02954887|38289798|FG000|Overall Study|Withdrawal by Subject|3|||
17145925|NCT02954887|38289798|FG000|Overall Study|Lack of Efficacy|3|||
17145926|NCT02954887|38289798|FG000|Overall Study|Other|1|||
17145927|NCT03183063|38289805|FG000|Overall Study|Withdrawal by Subject|2|||
17060881|NCT00386308|38203846|FG000|Overall Study|Lost to Follow-up|10|||
17060882|NCT00386308|38203847|FG001|Overall Study|Lost to Follow-up|6|||
17060883|NCT00386308|38203846|FG000|Overall Study|Withdrawal by Subject|6|||
17060884|NCT00386308|38203847|FG001|Overall Study|Withdrawal by Subject|2|||
17060885|NCT00386308|38203846|FG000|Overall Study|Other Event|8|||
17060886|NCT00386308|38203847|FG001|Overall Study|Other Event|1|||
17060887|NCT00064987|38203855|FG000|Overall Study|Physician Decision|3|||
17060888|NCT00064987|38203856|FG001|Overall Study|Physician Decision|0|||
17060889|NCT00374452|38203864|FG000|Overall Study|Left clinic before intervention started|4|||
17060890|NCT00374452|38203865|FG001|Overall Study|Left clinic before intervention started|1|||
17060891|NCT00374452|38203864|FG000|Overall Study|Change in job role before intervention|0|||
17060892|NCT00374452|38203865|FG001|Overall Study|Change in job role before intervention|1|||
17060893|NCT00374452|38203864|FG000|Overall Study|Left clinic after intervention started|1|||
17060894|NCT00374452|38203865|FG001|Overall Study|Left clinic after intervention started|1|||
17060895|NCT00374452|38203864|FG000|Overall Study|Withdrawal by Subject|0|||
17060896|NCT00374452|38203865|FG001|Overall Study|Withdrawal by Subject|2|||
17060897|NCT00064753|38203873|FG000|Overall Study|Death|251|||
17060898|NCT00064753|38203874|FG001|Overall Study|Death|242|||
17060899|NCT00064753|38203873|FG000|Overall Study|Withdrawal by Subject|198|||
17060900|NCT00064753|38203874|FG001|Overall Study|Withdrawal by Subject|171|||
17060901|NCT00064753|38203873|FG000|Overall Study|Lost to Follow-up|225|||
17060902|NCT00064753|38203874|FG001|Overall Study|Lost to Follow-up|235|||
17060903|NCT00374140|38203880|FG000|Overall Study|Lost to Follow-up|1|||
17060904|NCT00374140|38203880|FG000|Overall Study|Protocol Violation|1|||
17060905|NCT00665561|38203886|FG000|Overall Study|Death recorded on subject summary pages|75|||
17060906|NCT00665561|38203887|FG001|Overall Study|Death recorded on subject summary pages|75|||
17060907|NCT00665561|38203886|FG000|Overall Study|Does not meet entrance criteria|19|||
17060908|NCT00665561|38203887|FG001|Overall Study|Does not meet entrance criteria|21|||
17060909|NCT00665561|38203886|FG000|Overall Study|Lost to Follow-up|203|||
17060910|NCT00665561|38203887|FG001|Overall Study|Lost to Follow-up|264|||
17060911|NCT00665561|38203886|FG000|Overall Study|Withdrawal by Subject|74|||
17060912|NCT00665561|38203887|FG001|Overall Study|Withdrawal by Subject|65|||
17145928|NCT03183063|38289806|FG001|Overall Study|Withdrawal by Subject|0|||
17145929|NCT03183063|38289807|FG002|Overall Study|Withdrawal by Subject|0|||
17145930|NCT03183063|38289805|FG000|Overall Study|Physician Decision|3|||
17060913|NCT00665561|38203886|FG000|Overall Study|Other|123|||
17060914|NCT00665561|38203887|FG001|Overall Study|Other|108|||
17060915|NCT00665561|38203886|FG000|Overall Study|Site closed|8|||
17060916|NCT00665561|38203887|FG001|Overall Study|Site closed|0|||
17060917|NCT00665561|38203886|FG000|Overall Study|Withdrawn due to pregnancy|0|||
17060918|NCT00665561|38203887|FG001|Overall Study|Withdrawn due to pregnancy|1|||
17060919|NCT00663923|38203893|FG000|Overall Study|Lost to Follow-up|2|||
17060920|NCT00386152|38203902|FG000|Overall Study|Adverse Event|6|||
17060921|NCT00386152|38203903|FG001|Overall Study|Adverse Event|5|||
17060922|NCT00386152|38203904|FG002|Overall Study|Adverse Event|4|||
17060923|NCT00386152|38203902|FG000|Overall Study|Chang from original chemo stratification|4|||
17060924|NCT00386152|38203903|FG001|Overall Study|Chang from original chemo stratification|5|||
17060925|NCT00386152|38203904|FG002|Overall Study|Chang from original chemo stratification|6|||
17060926|NCT00386152|38203902|FG000|Overall Study|Death|3|||
17060927|NCT00386152|38203903|FG001|Overall Study|Death|0|||
17060928|NCT00386152|38203904|FG002|Overall Study|Death|1|||
17060929|NCT00386152|38203902|FG000|Overall Study|Disease progression|7|||
17060930|NCT00386152|38203903|FG001|Overall Study|Disease progression|4|||
17060931|NCT00386152|38203904|FG002|Overall Study|Disease progression|5|||
17060932|NCT00386152|38203902|FG000|Overall Study|Physician Decision|13|||
17060933|NCT00386152|38203903|FG001|Overall Study|Physician Decision|10|||
17060934|NCT00386152|38203904|FG002|Overall Study|Physician Decision|4|||
17060935|NCT00386152|38203902|FG000|Overall Study|Lost to Follow-up|1|||
17060936|NCT00386152|38203903|FG001|Overall Study|Lost to Follow-up|0|||
17060937|NCT00386152|38203904|FG002|Overall Study|Lost to Follow-up|0|||
17060938|NCT00386152|38203902|FG000|Overall Study|Completed chemotherapy|4|||
17060939|NCT00386152|38203903|FG001|Overall Study|Completed chemotherapy|5|||
17060940|NCT00386152|38203904|FG002|Overall Study|Completed chemotherapy|1|||
17060941|NCT00386152|38203902|FG000|Overall Study|Protocol Violation|3|||
17060942|NCT00386152|38203903|FG001|Overall Study|Protocol Violation|5|||
17060943|NCT00386152|38203904|FG002|Overall Study|Protocol Violation|2|||
17060944|NCT00386152|38203902|FG000|Overall Study|Withdrawal by Subject|3|||
17060945|NCT00386152|38203903|FG001|Overall Study|Withdrawal by Subject|6|||
17060946|NCT00386152|38203904|FG002|Overall Study|Withdrawal by Subject|10|||
17060947|NCT00385918|38203914|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
17060948|NCT00385918|38203915|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
17060949|NCT00385918|38203916|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
17060950|NCT00385918|38203914|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
17060951|NCT00385918|38203915|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
17060952|NCT00385918|38203916|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
17145931|NCT03183063|38289806|FG001|Overall Study|Physician Decision|4|||
17060953|NCT00385918|38203914|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
17060954|NCT00385918|38203915|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
17060955|NCT00385918|38203916|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
17060956|NCT00385918|38203914|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
17060957|NCT00385918|38203915|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
17060958|NCT00385918|38203916|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
17060959|NCT00385918|38203914|FG000|Intervention Phase After Randomization|Physician Decision|1|||
17060960|NCT00385918|38203915|FG001|Intervention Phase After Randomization|Physician Decision|0|||
17060961|NCT00385918|38203916|FG002|Intervention Phase After Randomization|Physician Decision|0|||
17060962|NCT00385918|38203914|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
17060963|NCT00385918|38203915|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
17060964|NCT00385918|38203916|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
17060965|NCT00385840|38203925|FG000|Overall Study|Adverse Event|1|||
17060966|NCT00385840|38203926|FG001|Overall Study|Adverse Event|1|||
17060967|NCT00385840|38203925|FG000|Overall Study|Lost to Follow-up|3|||
17060968|NCT00385840|38203926|FG001|Overall Study|Lost to Follow-up|13|||
17060969|NCT00385762|38203932|FG000|Overall Study|Adverse Event|1|||
17060970|NCT00385762|38203932|FG000|Overall Study|Lost to Follow-up|1|||
17060971|NCT00385684|38203936|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
17060972|NCT00385684|38203937|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
17145932|NCT03183063|38289807|FG002|Overall Study|Physician Decision|4|||
17060973|NCT00385684|38203936|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
17060974|NCT00385684|38203937|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
17060975|NCT00385684|38203936|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
17145933|NCT03182829|38289823|FG000|Overall Study|Protocol Violation|12|||
17060976|NCT00385684|38203937|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
17060977|NCT00661661|38203945|FG000|Overall Study|Adverse Event|99|||
17145934|NCT03182829|38289824|FG001|Overall Study|Protocol Violation|12|||
17145935|NCT03182829|38289823|FG000|Overall Study|Other|4|||
17145936|NCT03182829|38289824|FG001|Overall Study|Other|3|||
17145937|NCT03278028|38289832|FG000|Overall Study|Lost to Follow-up|1|||
17145938|NCT03278028|38289833|FG001|Overall Study|Lost to Follow-up|0|||
17145939|NCT03278028|38289832|FG000|Overall Study|Withdrawal by Subject|3|||
17145940|NCT03278028|38289833|FG001|Overall Study|Withdrawal by Subject|1|||
17145941|NCT03278028|38289832|FG000|Overall Study|Pregnancy|0|||
17145942|NCT03278028|38289833|FG001|Overall Study|Pregnancy|1|||
17145943|NCT03181503|38289841|FG000|Overall Study|Adverse Event|2|||
17145944|NCT03181503|38289842|FG001|Overall Study|Adverse Event|2|||
17145945|NCT03181503|38289841|FG000|Overall Study|Protocol Violation|1|||
17145946|NCT03181503|38289842|FG001|Overall Study|Protocol Violation|0|||
17145947|NCT03181503|38289841|FG000|Overall Study|Withdrawal by Subject|3|||
17145948|NCT03181503|38289842|FG001|Overall Study|Withdrawal by Subject|0|||
17145949|NCT03181503|38289841|FG000|Overall Study|Lost to Follow-up|1|||
16993578|NCT00785512|38137592|FG000|Overall Study|Withdrawal by Subject|0|||
16993579|NCT00785512|38137593|FG001|Overall Study|Withdrawal by Subject|1|||
16993580|NCT00785512|38137592|FG000|Overall Study|Lost to Follow-up|3|||
16993581|NCT00785512|38137593|FG001|Overall Study|Lost to Follow-up|0|||
16993582|NCT00785512|38137592|FG000|Overall Study|Precedure Refused|0|||
16993583|NCT00785512|38137593|FG001|Overall Study|Precedure Refused|0|||
16993584|NCT00785512|38137592|FG000|Overall Study|IVRS Programing Error|0|||
16993585|NCT00785512|38137593|FG001|Overall Study|IVRS Programing Error|0|||
16993586|NCT00785512|38137592|FG000|Overall Study|Physician Decision|0|||
16993587|NCT00785512|38137593|FG001|Overall Study|Physician Decision|0|||
16993588|NCT00785512|38137592|FG000|Overall Study|Lack of compliance|0|||
16993589|NCT00785512|38137593|FG001|Overall Study|Lack of compliance|1|||
16993590|NCT00785356|38137603|FG000|Overall Study|Study prematurely terminated|8|||
16993591|NCT00785044|38137611|FG000|Overall Study|Dosed at non-participating sites|152|||
16993592|NCT00785044|38137611|FG000|Overall Study|Death|77|||
16993593|NCT00785044|38137611|FG000|Overall Study|Lost to Follow-up|266|||
16993594|NCT00785044|38137611|FG000|Overall Study|Withdrawal by Subject|1|||
16993595|NCT00784810|38137618|FG000|Overall Study|Adverse Event|32|||
17145950|NCT03181503|38289842|FG001|Overall Study|Lost to Follow-up|1|||
17145951|NCT03277794|38289853|FG000|Overall Study|Lost to Follow-up|2|||
17145952|NCT03277794|38289854|FG001|Overall Study|Lost to Follow-up|4|||
17145953|NCT03277794|38289853|FG000|Overall Study|Withdrew due to high acuity|1|||
17145954|NCT03277794|38289854|FG001|Overall Study|Withdrew due to high acuity|0|||
17145955|NCT03276078|38289861|FG000|Overall Study|Adverse Event|1|||
17145956|NCT03180801|38289868|FG000|Overall Study|Physician Decision|3|||
17145957|NCT03180801|38289869|FG001|Overall Study|Physician Decision|3|||
17145958|NCT03180801|38289870|FG002|Overall Study|Physician Decision|1|||
17145959|NCT03180801|38289868|FG000|Overall Study|Non-compliance|1|||
17145960|NCT03180801|38289869|FG001|Overall Study|Non-compliance|4|||
17145961|NCT03180801|38289870|FG002|Overall Study|Non-compliance|0|||
17145962|NCT03180801|38289868|FG000|Overall Study|Inoculation Target Reached|1|||
17145963|NCT03180801|38289869|FG001|Overall Study|Inoculation Target Reached|1|||
17145964|NCT03180801|38289870|FG002|Overall Study|Inoculation Target Reached|3|||
17145965|NCT03180801|38289868|FG000|Overall Study|Adverse Event|1|||
17145966|NCT03180801|38289869|FG001|Overall Study|Adverse Event|0|||
17145967|NCT03180801|38289870|FG002|Overall Study|Adverse Event|2|||
17145968|NCT03180801|38289868|FG000|Overall Study|Withdrawal by Subject|2|||
17145969|NCT03180801|38289869|FG001|Overall Study|Withdrawal by Subject|2|||
17145970|NCT03180801|38289870|FG002|Overall Study|Withdrawal by Subject|1|||
17145971|NCT03180801|38289868|FG000|Overall Study|Lost to Follow-up|0|||
17145972|NCT03180801|38289869|FG001|Overall Study|Lost to Follow-up|2|||
17145973|NCT03180801|38289870|FG002|Overall Study|Lost to Follow-up|3|||
17060978|NCT00661661|38203946|FG001|Overall Study|Adverse Event|24|||
17060979|NCT00661661|38203945|FG000|Overall Study|Lack of Efficacy|3|||
17060980|NCT00661661|38203946|FG001|Overall Study|Lack of Efficacy|2|||
17060981|NCT00661661|38203945|FG000|Overall Study|Lost to Follow-up|0|||
17060982|NCT00661661|38203946|FG001|Overall Study|Lost to Follow-up|1|||
17060983|NCT00661661|38203945|FG000|Overall Study|Withdrawal by Subject|15|||
17060984|NCT00661661|38203946|FG001|Overall Study|Withdrawal by Subject|5|||
17060985|NCT00661661|38203945|FG000|Overall Study|Other|22|||
17060986|NCT00661661|38203946|FG001|Overall Study|Other|7|||
16993596|NCT00784810|38137619|FG001|Overall Study|Adverse Event|20|||
16993597|NCT00784810|38137618|FG000|Overall Study|Lack of Efficacy|14|||
16993598|NCT00784810|38137619|FG001|Overall Study|Lack of Efficacy|11|||
16993599|NCT00784810|38137618|FG000|Overall Study|Withdrawal by Subject|11|||
16993600|NCT00784810|38137619|FG001|Overall Study|Withdrawal by Subject|9|||
16993601|NCT00784810|38137618|FG000|Overall Study|Administrative|5|||
16993602|NCT00784810|38137619|FG001|Overall Study|Administrative|8|||
16993603|NCT00784810|38137618|FG000|Overall Study|Lost to Follow-up|1|||
17060987|NCT00661661|38203945|FG000|Overall Study|Not assigned treatment|1|||
17060988|NCT00661661|38203946|FG001|Overall Study|Not assigned treatment|0|||
17145974|NCT03742271|38289881|FG000|Overall Study|Unsatisfactory Visual Response|1|||
17145975|NCT03742271|38289881|FG000|Overall Study|Withdrawal by Subject|3|||
17145976|NCT03742271|38289881|FG000|Overall Study|Lost to Follow-up|4|||
16993604|NCT00784810|38137619|FG001|Overall Study|Lost to Follow-up|1|||
16993605|NCT00791128|38137625|FG000|Overall Study|Adverse Event|4|||
16993606|NCT00791128|38137625|FG000|Overall Study|Device migration|2|||
16993607|NCT00791128|38137625|FG000|Overall Study|non-compliance by subject|2|||
16993608|NCT00791128|38137625|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
16993609|NCT00776230|38137645|FG000|Overall Study|Lost to Follow-up|2|||
16993610|NCT00776230|38137646|FG001|Overall Study|Lost to Follow-up|1|||
16993611|NCT00776230|38137647|FG002|Overall Study|Lost to Follow-up|5|||
16993612|NCT00776230|38137645|FG000|Overall Study|Not vaccinated at Day 0|1|||
16993613|NCT00776230|38137646|FG001|Overall Study|Not vaccinated at Day 0|0|||
16993614|NCT00776230|38137647|FG002|Overall Study|Not vaccinated at Day 0|0|||
16993615|NCT00776230|38137645|FG000|Overall Study|Withdrawal by Subject|0|||
16993616|NCT00776230|38137646|FG001|Overall Study|Withdrawal by Subject|1|||
16993617|NCT00776230|38137647|FG002|Overall Study|Withdrawal by Subject|0|||
16993618|NCT00776230|38137645|FG000|Overall Study|Subject missed Visit 4|0|||
16993619|NCT00776230|38137646|FG001|Overall Study|Subject missed Visit 4|1|||
16993620|NCT00776230|38137647|FG002|Overall Study|Subject missed Visit 4|0|||
16993621|NCT00775606|38137657|FG000|Overall Study|Study sponsor terminated funding|3|||
16993622|NCT00775606|38137658|FG001|Overall Study|Study sponsor terminated funding|0|||
16993623|NCT02960763|38137671|FG000|Step 1|Withdrawal by Subject|10|||
16993624|NCT02960763|38137672|FG001|Step 1|Withdrawal by Subject|8|||
16993625|NCT02960763|38137673|FG002|Step 1|Withdrawal by Subject|13|||
16993626|NCT02960763|38137674|FG003|Step 1|Withdrawal by Subject|0|||
16993627|NCT02960763|38137675|FG004|Step 1|Withdrawal by Subject|0|||
16993628|NCT02960763|38137671|FG000|Step 1|Lost to Follow-up|7|||
16993629|NCT02960763|38137672|FG001|Step 1|Lost to Follow-up|9|||
16993630|NCT02960763|38137673|FG002|Step 1|Lost to Follow-up|12|||
16993631|NCT02960763|38137674|FG003|Step 1|Lost to Follow-up|0|||
16993632|NCT02960763|38137675|FG004|Step 1|Lost to Follow-up|0|||
16993633|NCT02960763|38137671|FG000|Step 1|Death|1|||
17145977|NCT03742271|38289881|FG000|Overall Study|Failed Insertion & removal|3|||
17145978|NCT03742271|38289881|FG000|Overall Study|Protocol Violation|1|||
17145979|NCT03214224|38289885|FG000|Overall Study|Protocol Violation|1|||
17145980|NCT03214224|38289885|FG000|Overall Study|Withdrawal by Subject|2|||
17145981|NCT03214224|38289885|FG000|Overall Study|Practice controls or therapists|6|||
17145982|NCT03180645|38289892|FG000|Overall Study|Adverse Event|0|||
17145983|NCT03180645|38289893|FG001|Overall Study|Adverse Event|1|||
17145984|NCT03180645|38289894|FG002|Overall Study|Adverse Event|2|||
17145985|NCT03750695|38289906|FG000|Overall Study|Lost to Follow-up|0|||
17145986|NCT03750695|38289907|FG001|Overall Study|Lost to Follow-up|1|||
17145987|NCT03748823|38289920|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
17145988|NCT03748823|38289921|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
17145989|NCT03748823|38289920|FG000|Extension Period|Withdrawal by Subject|1|||
17145990|NCT03748823|38289921|FG001|Extension Period|Withdrawal by Subject|2|||
17145991|NCT03748823|38289920|FG000|Extension Period|Death|0|||
17145992|NCT03748823|38289921|FG001|Extension Period|Death|1|||
17145993|NCT03748823|38289920|FG000|Extension Period|Protocol Violation|1|||
16993634|NCT02960763|38137672|FG001|Step 1|Death|1|||
16993635|NCT02960763|38137673|FG002|Step 1|Death|1|||
16993636|NCT02960763|38137674|FG003|Step 1|Death|0|||
16993637|NCT02960763|38137675|FG004|Step 1|Death|0|||
17145994|NCT03748823|38289921|FG001|Extension Period|Protocol Violation|0|||
17145995|NCT03748823|38289920|FG000|Extension Period|Ongoing in the Extension Period|41|||
17145996|NCT03748823|38289921|FG001|Extension Period|Ongoing in the Extension Period|84|||
17145997|NCT03231228|38289930|FG000|Overall Study|Lost to Follow-up|2|||
17145998|NCT03231228|38289931|FG001|Overall Study|Lost to Follow-up|0|||
17145999|NCT03231228|38289930|FG000|Overall Study|Physician Decision|1|||
17146000|NCT03231228|38289931|FG001|Overall Study|Physician Decision|0|||
17146001|NCT03213366|38289939|FG000|Overall Study|Lost to Follow-up|9|||
17146002|NCT03213366|38289940|FG001|Overall Study|Lost to Follow-up|4|||
17146003|NCT03230838|38289948|FG000|Overall Study|Withdrawal by Subject|3|||
17146004|NCT03230838|38289949|FG001|Overall Study|Withdrawal by Subject|0|||
17146005|NCT03230838|38289948|FG000|Overall Study|Temperature excursion|1|||
17146006|NCT03230838|38289949|FG001|Overall Study|Temperature excursion|0|||
17146007|NCT03213210|38289955|FG000|Overall Study|Lost to Follow-up|2|||
17146008|NCT03213210|38289955|FG000|Overall Study|Study termination|3|||
17146009|NCT02932878|38289961|FG000|Overall Study|Due to Lab Results|2|||
17146010|NCT02932878|38289962|FG001|Overall Study|Due to Lab Results|1|||
17146011|NCT03230292|38289968|FG000|Overall Study|Adverse Event|1|||
17146012|NCT03230292|38289968|FG000|Overall Study|Protocol Violation|1|||
17146013|NCT03230292|38289968|FG000|Overall Study|Lost to Follow-up|1|||
17146014|NCT03230292|38289968|FG000|Overall Study|Withdrawal by Subject|3|||
17146015|NCT03228420|38289980|FG000|Overall Study|Lost to Follow-up|5|||
17146016|NCT03228420|38289981|FG001|Overall Study|Lost to Follow-up|3|||
17146017|NCT03228420|38289980|FG000|Overall Study|Withdrawal by Subject|10|||
17146018|NCT03228420|38289981|FG001|Overall Study|Withdrawal by Subject|0|||
17146019|NCT03228420|38289980|FG000|Overall Study|Adverse Event|5|||
17146020|NCT03228420|38289981|FG001|Overall Study|Adverse Event|2|||
17146021|NCT03117049|38289989|FG000|Overall Study|Continued the follow-up period|109|||
17146022|NCT03117049|38289990|FG001|Overall Study|Continued the follow-up period|129|||
17146023|NCT03117049|38289989|FG000|Overall Study|Died|82|||
17146024|NCT03117049|38289990|FG001|Overall Study|Died|93|||
17146025|NCT03117049|38289989|FG000|Overall Study|Consent withdrawal|7|||
17146026|NCT03117049|38289990|FG001|Overall Study|Consent withdrawal|6|||
17146027|NCT03117049|38289989|FG000|Overall Study|Missing contact|3|||
17146028|NCT03117049|38289990|FG001|Overall Study|Missing contact|3|||
17060989|NCT00038467|38203956|FG000|Overall Study|Adverse Event|170|||
17060990|NCT00038467|38203957|FG001|Overall Study|Adverse Event|145|||
17060991|NCT00038467|38203956|FG000|Overall Study|Withdrawal by Subject|150|||
17060992|NCT00038467|38203957|FG001|Overall Study|Withdrawal by Subject|107|||
17060993|NCT00038467|38203956|FG000|Overall Study|Protocol Violation|19|||
17060994|NCT00038467|38203957|FG001|Overall Study|Protocol Violation|22|||
17060995|NCT00038467|38203956|FG000|Overall Study|Death|22|||
17060996|NCT00038467|38203957|FG001|Overall Study|Death|16|||
17060997|NCT00038467|38203956|FG000|Overall Study|Lost to Follow-up|15|||
17060998|NCT00038467|38203957|FG001|Overall Study|Lost to Follow-up|10|||
17060999|NCT00038467|38203956|FG000|Overall Study|Recurrence|109|||
17061000|NCT00038467|38203957|FG001|Overall Study|Recurrence|179|||
17061001|NCT00038467|38203956|FG000|Overall Study|Randomized, but not treated|31|||
17061002|NCT00038467|38203957|FG001|Overall Study|Randomized, but not treated|35|||
17061003|NCT00038467|38203956|FG000|Overall Study|Other|26|||
17061004|NCT00038467|38203957|FG001|Overall Study|Other|28|||
17061005|NCT00051025|38203965|FG000|Overall Study|Progressive Disease|1|||
17061006|NCT00051025|38203966|FG001|Overall Study|Progressive Disease|1|||
17061007|NCT00051025|38203965|FG000|Overall Study|Adverse Event|1|||
17061008|NCT00051025|38203966|FG001|Overall Study|Adverse Event|1|||
17061009|NCT00051025|38203965|FG000|Overall Study|Withdrawal by Subject|0|||
17061010|NCT00051025|38203966|FG001|Overall Study|Withdrawal by Subject|1|||
17061011|NCT00051025|38203965|FG000|Overall Study|Death|0|||
17061012|NCT00051025|38203966|FG001|Overall Study|Death|1|||
17061013|NCT00660179|38203975|FG000|Overall Study|Death|44|||
17061014|NCT00660179|38203976|FG001|Overall Study|Death|47|||
17061015|NCT00660179|38203977|FG002|Overall Study|Death|34|||
17061016|NCT00660179|38203975|FG000|Overall Study|Withdrawal of consent|4|||
17061017|NCT00660179|38203976|FG001|Overall Study|Withdrawal of consent|6|||
17061018|NCT00660179|38203977|FG002|Overall Study|Withdrawal of consent|4|||
17061019|NCT00660179|38203975|FG000|Overall Study|Lost to Follow-up|7|||
17061020|NCT00660179|38203976|FG001|Overall Study|Lost to Follow-up|5|||
17061021|NCT00660179|38203977|FG002|Overall Study|Lost to Follow-up|2|||
17061022|NCT00660179|38203975|FG000|Overall Study|Administrative reason|0|||
17061023|NCT00660179|38203976|FG001|Overall Study|Administrative reason|0|||
17061024|NCT00660179|38203977|FG002|Overall Study|Administrative reason|1|||
17061025|NCT00660179|38203975|FG000|Overall Study|Incorrect randomization|1|||
17061026|NCT00660179|38203976|FG001|Overall Study|Incorrect randomization|0|||
17061027|NCT00660179|38203977|FG002|Overall Study|Incorrect randomization|0|||
17061028|NCT00050167|38203987|FG000|Overall Study|not eligible not invasive|1|||
17061029|NCT00050167|38203988|FG001|Overall Study|not eligible not invasive|1|||
17061030|NCT00660023|38203994|FG000|Overall Study|Adverse Event|2|||
17061031|NCT00660023|38203994|FG000|Overall Study|Death|8|||
17061032|NCT00660023|38203994|FG000|Overall Study|Blood Transfusion|5|||
17146029|NCT03746483|38289998|FG000|Overall Study|Adverse Event|0|||
17146030|NCT03746483|38289999|FG001|Overall Study|Adverse Event|1|||
17146031|NCT03746483|38289998|FG000|Overall Study|Lack of Efficacy|3|||
17146032|NCT03746483|38289999|FG001|Overall Study|Lack of Efficacy|2|||
17146033|NCT03746483|38289998|FG000|Overall Study|Lost to Follow-up|1|||
17061033|NCT00660023|38203994|FG000|Overall Study|Renal Transplantation|3|||
17061034|NCT00660023|38203994|FG000|Overall Study|Withdrawal by Subject|1|||
17061035|NCT00660023|38203994|FG000|Overall Study|Missed Pregnancy Test|1|||
17061036|NCT00660023|38203994|FG000|Overall Study|Other Screening Failure|9|||
17061037|NCT00062647|38204000|FG000|Overall Study|Death|2|||
17061038|NCT00062647|38204001|FG001|Overall Study|Death|2|||
17061039|NCT00062647|38204000|FG000|Overall Study|Adverse Event|1|||
17061040|NCT00062647|38204001|FG001|Overall Study|Adverse Event|1|||
17061041|NCT00062647|38204000|FG000|Overall Study|Withdrawal by Subject|2|||
17061042|NCT00062647|38204001|FG001|Overall Study|Withdrawal by Subject|1|||
17061043|NCT00062647|38204000|FG000|Overall Study|Protocol Violation|1|||
17061044|NCT00062647|38204001|FG001|Overall Study|Protocol Violation|0|||
17061045|NCT00062647|38204000|FG000|Overall Study|Lost to Follow-up|1|||
17061046|NCT00062647|38204001|FG001|Overall Study|Lost to Follow-up|2|||
17061047|NCT00062647|38204000|FG000|Overall Study|Failed continuation criteria|4|||
17061048|NCT00062647|38204001|FG001|Overall Study|Failed continuation criteria|2|||
17061049|NCT00062647|38204000|FG000|Overall Study|Other|4|||
17061050|NCT00062647|38204001|FG001|Overall Study|Other|4|||
17061051|NCT00062647|38204000|FG000|Overall Study|Never received study treatment|1|||
17061052|NCT00062647|38204001|FG001|Overall Study|Never received study treatment|1|||
17061053|NCT00570323|38204009|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
17061054|NCT00570323|38204010|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
17061055|NCT00570323|38204009|FG000|Started Treatment After Randomization|Protocol Violation|1|||
17061056|NCT00570323|38204010|FG001|Started Treatment After Randomization|Protocol Violation|0|||
17061057|NCT00570323|38204009|FG000|Started Treatment After Randomization|Physician Decision|1|||
17146034|NCT03746483|38289999|FG001|Overall Study|Lost to Follow-up|0|||
17146035|NCT03746483|38289998|FG000|Overall Study|Protocol Violation|2|||
17146036|NCT03746483|38289999|FG001|Overall Study|Protocol Violation|0|||
17146037|NCT03746405|38290009|FG000|Overall Study|Withdrawal by Subject|3|||
17146038|NCT03746405|38290010|FG001|Overall Study|Withdrawal by Subject|0|||
17146039|NCT03746405|38290009|FG000|Overall Study|technical difficulties|0|||
17146040|NCT03746405|38290010|FG001|Overall Study|technical difficulties|2|||
17146041|NCT03226392|38290018|FG000|Overall Study|Protocol Deviation|1|||
17146042|NCT03226392|38290019|FG001|Overall Study|Protocol Deviation|0|||
17061058|NCT00570323|38204010|FG001|Started Treatment After Randomization|Physician Decision|0|||
17061059|NCT00570323|38204009|FG000|Complete Study After Start|Lost to Follow-up|0|||
17061060|NCT00570323|38204010|FG001|Complete Study After Start|Lost to Follow-up|1|||
17061061|NCT00570323|38204009|FG000|Complete Study After Start|Withdrawal by Subject|2|||
17061062|NCT00570323|38204010|FG001|Complete Study After Start|Withdrawal by Subject|0|||
16993638|NCT02960763|38137671|FG000|Step 1|Investigator discretion|1|||
16993639|NCT02960763|38137672|FG001|Step 1|Investigator discretion|0|||
16993640|NCT02960763|38137673|FG002|Step 1|Investigator discretion|1|||
16993641|NCT02960763|38137674|FG003|Step 1|Investigator discretion|0|||
16993642|NCT02960763|38137675|FG004|Step 1|Investigator discretion|0|||
16993643|NCT02960763|38137671|FG000|Step 1|Other|0|||
16993644|NCT02960763|38137672|FG001|Step 1|Other|0|||
16993645|NCT02960763|38137673|FG002|Step 1|Other|1|||
16993646|NCT02960763|38137674|FG003|Step 1|Other|0|||
16993647|NCT02960763|38137675|FG004|Step 1|Other|0|||
16993648|NCT02960763|38137671|FG000|Step 2|Withdrawal by Subject|0|||
16993649|NCT02960763|38137672|FG001|Step 2|Withdrawal by Subject|0|||
16993650|NCT02960763|38137673|FG002|Step 2|Withdrawal by Subject|0|||
16993651|NCT02960763|38137674|FG003|Step 2|Withdrawal by Subject|7|||
16993652|NCT02960763|38137675|FG004|Step 2|Withdrawal by Subject|3|||
16993653|NCT02960763|38137671|FG000|Step 2|Lost to Follow-up|0|||
16993654|NCT02960763|38137672|FG001|Step 2|Lost to Follow-up|0|||
16993655|NCT02960763|38137673|FG002|Step 2|Lost to Follow-up|0|||
16993656|NCT02960763|38137674|FG003|Step 2|Lost to Follow-up|4|||
16993657|NCT02960763|38137675|FG004|Step 2|Lost to Follow-up|1|||
16993658|NCT02960763|38137671|FG000|Step 2|Investigator discretion|0|||
16993659|NCT02960763|38137672|FG001|Step 2|Investigator discretion|0|||
16993660|NCT02960763|38137673|FG002|Step 2|Investigator discretion|0|||
16993661|NCT02960763|38137674|FG003|Step 2|Investigator discretion|0|||
16993662|NCT02960763|38137675|FG004|Step 2|Investigator discretion|1|||
16993663|NCT00775528|38137687|FG000|Overall Study|Protocol Violation|1|||
16993664|NCT00775450|38137696|FG000|Overall Study|Serious Adverse Event|2|||
16993665|NCT00775450|38137697|FG001|Overall Study|Serious Adverse Event|0|||
16993666|NCT00775450|38137698|FG002|Overall Study|Serious Adverse Event|0|||
16993667|NCT00775450|38137699|FG003|Overall Study|Serious Adverse Event|0|||
17061063|NCT00570323|38204009|FG000|Complete Study After Start|Physician Decision|1|||
17061064|NCT00570323|38204010|FG001|Complete Study After Start|Physician Decision|0|||
17061065|NCT00661505|38204018|FG000|Overall Study|Adverse Event|3|||
17061066|NCT00661505|38204018|FG000|Overall Study|Protocol Violation|14|||
17061067|NCT00661505|38204018|FG000|Overall Study|Withdrawal by Subject|8|||
16781177|NCT02147158|37720325|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
16781178|NCT02147158|37720326|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
16781179|NCT02147158|37720327|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
16781180|NCT02147158|37720328|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
17061068|NCT00661505|38204018|FG000|Overall Study|Lost to Follow-up|3|||
17061069|NCT00661505|38204018|FG000|Overall Study|Other|2|||
17061070|NCT00662909|38204026|FG000|Overall Study|Adverse Event|17|||
16781181|NCT02112448|37720347|FG000|Overall Study|lab values precluding use of ketorolac|2|||
16781182|NCT02112448|37720348|FG001|Overall Study|lab values precluding use of ketorolac|2|||
16781183|NCT02112448|37720347|FG000|Overall Study|Protocol Violation|1|||
16781184|NCT02112448|37720348|FG001|Overall Study|Protocol Violation|2|||
16781185|NCT02112448|37720347|FG000|Overall Study|Physician Decision|4|||
16781186|NCT02112448|37720348|FG001|Overall Study|Physician Decision|6|||
16781187|NCT02112448|37720347|FG000|Overall Study|required heparin so could not use ketoro|1|||
16781188|NCT02112448|37720348|FG001|Overall Study|required heparin so could not use ketoro|0|||
16781189|NCT02171260|37720360|FG000|Overall Study|Death|0|||
17061071|NCT00662909|38204027|FG001|Overall Study|Adverse Event|18|||
17061072|NCT00662909|38204028|FG002|Overall Study|Adverse Event|19|||
17061073|NCT00662909|38204026|FG000|Overall Study|Lack of Efficacy|9|||
17061074|NCT00662909|38204027|FG001|Overall Study|Lack of Efficacy|1|||
17061075|NCT00662909|38204028|FG002|Overall Study|Lack of Efficacy|5|||
17061076|NCT00662909|38204026|FG000|Overall Study|Withdrawal by Subject|29|||
17061077|NCT00662909|38204027|FG001|Overall Study|Withdrawal by Subject|22|||
17061078|NCT00662909|38204028|FG002|Overall Study|Withdrawal by Subject|16|||
17061079|NCT00662909|38204026|FG000|Overall Study|Lost to Follow-up|2|||
17061080|NCT00662909|38204027|FG001|Overall Study|Lost to Follow-up|9|||
17061081|NCT00662909|38204028|FG002|Overall Study|Lost to Follow-up|3|||
17061082|NCT00662909|38204026|FG000|Overall Study|Protocol Violation|7|||
17061083|NCT00662909|38204027|FG001|Overall Study|Protocol Violation|4|||
17061084|NCT00662909|38204028|FG002|Overall Study|Protocol Violation|5|||
17146043|NCT03226392|38290018|FG000|Overall Study|Physician Decision|1|||
17146044|NCT03226392|38290019|FG001|Overall Study|Physician Decision|0|||
17146045|NCT03226392|38290018|FG000|Overall Study|Lost to Follow-up|1|||
17146046|NCT03226392|38290019|FG001|Overall Study|Lost to Follow-up|0|||
17146047|NCT03226392|38290018|FG000|Overall Study|Adverse Event|1|||
17146048|NCT03226392|38290019|FG001|Overall Study|Adverse Event|0|||
17146049|NCT03226392|38290018|FG000|Overall Study|Technical Problems|0|||
17146050|NCT03226392|38290019|FG001|Overall Study|Technical Problems|2|||
17146051|NCT03226392|38290018|FG000|Overall Study|Subject/Guardian Decision|7|||
17146052|NCT03226392|38290019|FG001|Overall Study|Subject/Guardian Decision|6|||
17146053|NCT03205371|38290037|FG000|Overall Study|Withdrawal by Subject|4|||
17146054|NCT03205371|38290038|FG001|Overall Study|Withdrawal by Subject|1|||
17146055|NCT03205371|38290039|FG002|Overall Study|Withdrawal by Subject|0|||
17146056|NCT03205371|38290040|FG003|Overall Study|Withdrawal by Subject|0|||
17146057|NCT03205371|38290041|FG004|Overall Study|Withdrawal by Subject|0|||
17146058|NCT03205371|38290042|FG005|Overall Study|Withdrawal by Subject|0|||
17146059|NCT03205371|38290043|FG006|Overall Study|Withdrawal by Subject|4|||
17146060|NCT03205371|38290044|FG007|Overall Study|Withdrawal by Subject|0|||
17061085|NCT00662909|38204026|FG000|Overall Study|Randomized- never received study drug|1|||
17061086|NCT00662909|38204027|FG001|Overall Study|Randomized- never received study drug|0|||
17061087|NCT00662909|38204028|FG002|Overall Study|Randomized- never received study drug|0|||
17061088|NCT00662909|38204026|FG000|Overall Study|Non-compliance with study procedures|3|||
17061089|NCT00662909|38204027|FG001|Overall Study|Non-compliance with study procedures|3|||
17061090|NCT00662909|38204028|FG002|Overall Study|Non-compliance with study procedures|2|||
17061091|NCT00662909|38204026|FG000|Overall Study|Physician Decision|1|||
17061092|NCT00662909|38204027|FG001|Overall Study|Physician Decision|1|||
17061093|NCT00662909|38204028|FG002|Overall Study|Physician Decision|2|||
17061094|NCT00662909|38204026|FG000|Overall Study|Eligibility criterion not met|0|||
17061095|NCT00662909|38204027|FG001|Overall Study|Eligibility criterion not met|1|||
17061096|NCT00662909|38204028|FG002|Overall Study|Eligibility criterion not met|1|||
17061097|NCT00050011|38204038|FG000|Overall Study|Adverse Event|41|||
17061098|NCT00050011|38204039|FG001|Overall Study|Adverse Event|46|||
17061099|NCT00050011|38204038|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17061100|NCT00050011|38204039|FG001|Overall Study|Abnormal laboratory value(s)|1|||
17061101|NCT00050011|38204038|FG000|Overall Study|Abnormal test procedure results|0|||
17061102|NCT00050011|38204039|FG001|Overall Study|Abnormal test procedure results|1|||
17061103|NCT00050011|38204038|FG000|Overall Study|Lack of Efficacy|16|||
17061104|NCT00050011|38204039|FG001|Overall Study|Lack of Efficacy|21|||
17061105|NCT00050011|38204038|FG000|Overall Study|Participant condition no longer required|1|||
17061106|NCT00050011|38204039|FG001|Overall Study|Participant condition no longer required|0|||
17061107|NCT00050011|38204038|FG000|Overall Study|Protocol Violation|4|||
17061108|NCT00050011|38204039|FG001|Overall Study|Protocol Violation|10|||
17061109|NCT00050011|38204038|FG000|Overall Study|Withdrawal by Subject|34|||
17061110|NCT00050011|38204039|FG001|Overall Study|Withdrawal by Subject|26|||
17061111|NCT00050011|38204038|FG000|Overall Study|Lost to Follow-up|7|||
17061112|NCT00050011|38204039|FG001|Overall Study|Lost to Follow-up|9|||
17061113|NCT00050011|38204038|FG000|Overall Study|Administrative problems|10|||
17061114|NCT00050011|38204039|FG001|Overall Study|Administrative problems|6|||
17061115|NCT00050011|38204038|FG000|Overall Study|Death|7|||
17061116|NCT00050011|38204039|FG001|Overall Study|Death|4|||
17061117|NCT00050011|38204038|FG000|Overall Study|Unknown - Reason is missing|0|||
17061118|NCT00050011|38204039|FG001|Overall Study|Unknown - Reason is missing|2|||
17061119|NCT00661427|38204048|FG000|Overall Study|Adverse Event|5|||
17061120|NCT00661427|38204049|FG001|Overall Study|Adverse Event|5|||
17061121|NCT00661427|38204048|FG000|Overall Study|Patient not treated|0|||
17061122|NCT00661427|38204049|FG001|Overall Study|Patient not treated|2|||
17061123|NCT00049543|38204057|FG000|Overall Study|still on treatment|2|||
17061124|NCT00049543|38204058|FG001|Overall Study|still on treatment|9|||
17061125|NCT00048997|38204066|FG000|Overall Study|Protocol Violation|7|||
17061126|NCT00048997|38204067|FG001|Overall Study|Protocol Violation|2|||
17061127|NCT00048997|38204066|FG000|Overall Study|Withdrawal by Subject|6|||
17061128|NCT00048997|38204067|FG001|Overall Study|Withdrawal by Subject|1|||
17061129|NCT00035815|38204074|FG000|Overall Study|Withdrawal by Subject|17|||
17061130|NCT00035815|38204075|FG001|Overall Study|Withdrawal by Subject|11|||
17146061|NCT03205371|38290045|FG008|Overall Study|Withdrawal by Subject|2|||
17146062|NCT03205371|38290046|FG009|Overall Study|Withdrawal by Subject|0|||
17146063|NCT03205371|38290047|FG010|Overall Study|Withdrawal by Subject|0|||
17146064|NCT03205371|38290048|FG011|Overall Study|Withdrawal by Subject|1|||
17146065|NCT03205371|38290037|FG000|Overall Study|Lost to Follow-up|0|||
17146066|NCT03205371|38290038|FG001|Overall Study|Lost to Follow-up|0|||
17146067|NCT03205371|38290039|FG002|Overall Study|Lost to Follow-up|0|||
17146068|NCT03205371|38290040|FG003|Overall Study|Lost to Follow-up|0|||
17146069|NCT03205371|38290041|FG004|Overall Study|Lost to Follow-up|0|||
17146070|NCT03205371|38290042|FG005|Overall Study|Lost to Follow-up|0|||
17146071|NCT03205371|38290043|FG006|Overall Study|Lost to Follow-up|5|||
17146072|NCT03205371|38290044|FG007|Overall Study|Lost to Follow-up|2|||
17146073|NCT03205371|38290045|FG008|Overall Study|Lost to Follow-up|3|||
17146074|NCT03205371|38290046|FG009|Overall Study|Lost to Follow-up|0|||
17146075|NCT03205371|38290047|FG010|Overall Study|Lost to Follow-up|0|||
17146076|NCT03205371|38290048|FG011|Overall Study|Lost to Follow-up|0|||
17146077|NCT03205371|38290037|FG000|Overall Study|Protocol Violation|0|||
17146078|NCT03205371|38290038|FG001|Overall Study|Protocol Violation|0|||
17146079|NCT03205371|38290039|FG002|Overall Study|Protocol Violation|0|||
17146080|NCT03205371|38290040|FG003|Overall Study|Protocol Violation|0|||
17146081|NCT03205371|38290041|FG004|Overall Study|Protocol Violation|0|||
17146082|NCT03205371|38290042|FG005|Overall Study|Protocol Violation|0|||
17146083|NCT03205371|38290043|FG006|Overall Study|Protocol Violation|1|||
17146084|NCT03205371|38290044|FG007|Overall Study|Protocol Violation|0|||
17146085|NCT03205371|38290045|FG008|Overall Study|Protocol Violation|0|||
17146086|NCT03205371|38290046|FG009|Overall Study|Protocol Violation|0|||
17146087|NCT03205371|38290047|FG010|Overall Study|Protocol Violation|0|||
17146088|NCT03205371|38290048|FG011|Overall Study|Protocol Violation|0|||
17146089|NCT03205371|38290037|FG000|Overall Study|Adverse Event|0|||
17146090|NCT03205371|38290038|FG001|Overall Study|Adverse Event|0|||
17146091|NCT03205371|38290039|FG002|Overall Study|Adverse Event|0|||
17146092|NCT03205371|38290040|FG003|Overall Study|Adverse Event|0|||
17146093|NCT03205371|38290041|FG004|Overall Study|Adverse Event|0|||
17061131|NCT00662831|38204083|FG000|Overall Study|Death|4|||
17061132|NCT00662831|38204084|FG001|Overall Study|Death|1|||
17061133|NCT00662831|38204083|FG000|Overall Study|Lack of Efficacy|6|||
17061134|NCT00662831|38204084|FG001|Overall Study|Lack of Efficacy|6|||
17061135|NCT00662831|38204083|FG000|Overall Study|Lost to Follow-up|1|||
17061136|NCT00662831|38204084|FG001|Overall Study|Lost to Follow-up|0|||
17061137|NCT00662831|38204083|FG000|Overall Study|Withdrawal by Subject|2|||
17061138|NCT00662831|38204084|FG001|Overall Study|Withdrawal by Subject|1|||
17061139|NCT00662831|38204083|FG000|Overall Study|Other|62|||
17061140|NCT00662831|38204084|FG001|Overall Study|Other|31|||
17061141|NCT00662831|38204083|FG000|Overall Study|Protocol Violation|8|||
17061142|NCT00662831|38204084|FG001|Overall Study|Protocol Violation|4|||
17061143|NCT00662831|38204083|FG000|Overall Study|Adverse Event|23|||
17061144|NCT00662831|38204084|FG001|Overall Study|Adverse Event|16|||
17061145|NCT00662363|38204092|FG000|Overall Study|Withdrawal by Subject|6|||
17061146|NCT00662363|38204093|FG001|Overall Study|Withdrawal by Subject|5|||
17061147|NCT00662363|38204092|FG000|Overall Study|Adverse Event|0|||
17061148|NCT00662363|38204093|FG001|Overall Study|Adverse Event|3|||
17061149|NCT00662363|38204092|FG000|Overall Study|Discharged early from rehab|4|||
17061150|NCT00662363|38204093|FG001|Overall Study|Discharged early from rehab|1|||
17061151|NCT00662363|38204092|FG000|Overall Study|Protocol Violation|1|||
17061152|NCT00662363|38204093|FG001|Overall Study|Protocol Violation|1|||
17061153|NCT00661271|38204103|FG000|Overall Study|Lost to Follow-up|28|||
17061154|NCT00661271|38204104|FG001|Overall Study|Lost to Follow-up|25|||
17061155|NCT00661193|38204112|FG000|Overall Study|Adverse Event|2|||
17061156|NCT00661193|38204113|FG001|Overall Study|Adverse Event|1|||
17146094|NCT03205371|38290042|FG005|Overall Study|Adverse Event|0|||
17146095|NCT03205371|38290043|FG006|Overall Study|Adverse Event|0|||
17146096|NCT03205371|38290044|FG007|Overall Study|Adverse Event|1|||
17061157|NCT00661193|38204112|FG000|Overall Study|Withdrawal by Subject|3|||
17061158|NCT00661193|38204113|FG001|Overall Study|Withdrawal by Subject|1|||
17061159|NCT00661193|38204112|FG000|Overall Study|Progression|27|||
17061160|NCT00661193|38204113|FG001|Overall Study|Progression|24|||
17061161|NCT00661193|38204112|FG000|Overall Study|Not protocol specified|1|||
17061162|NCT00661193|38204113|FG001|Overall Study|Not protocol specified|0|||
17061163|NCT00658541|38204119|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
17061164|NCT00658541|38204120|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
17061165|NCT00658541|38204119|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
17061166|NCT00658541|38204120|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
17061167|NCT00048061|38204130|FG000|Overall Study|Adverse Event|41|||
17061168|NCT00048061|38204131|FG001|Overall Study|Adverse Event|32|||
17061169|NCT00048061|38204132|FG002|Overall Study|Adverse Event|44|||
17061170|NCT00048061|38204133|FG003|Overall Study|Adverse Event|37|||
17061171|NCT00048061|38204130|FG000|Overall Study|Lost to Follow-up|3|||
17061172|NCT00048061|38204131|FG001|Overall Study|Lost to Follow-up|2|||
17061173|NCT00048061|38204132|FG002|Overall Study|Lost to Follow-up|4|||
17061174|NCT00048061|38204133|FG003|Overall Study|Lost to Follow-up|5|||
17061175|NCT00048061|38204130|FG000|Overall Study|Withdrawal by Subject|20|||
17061176|NCT00048061|38204131|FG001|Overall Study|Withdrawal by Subject|29|||
17061177|NCT00048061|38204132|FG002|Overall Study|Withdrawal by Subject|29|||
17061178|NCT00048061|38204133|FG003|Overall Study|Withdrawal by Subject|32|||
17061179|NCT00048061|38204130|FG000|Overall Study|Did not follow-up|5|||
17061180|NCT00048061|38204131|FG001|Overall Study|Did not follow-up|5|||
17061181|NCT00048061|38204132|FG002|Overall Study|Did not follow-up|4|||
17061182|NCT00048061|38204133|FG003|Overall Study|Did not follow-up|5|||
17061183|NCT00048061|38204130|FG000|Overall Study|Early improvement|6|||
17061184|NCT00048061|38204131|FG001|Overall Study|Early improvement|5|||
17061185|NCT00048061|38204132|FG002|Overall Study|Early improvement|3|||
17061186|NCT00048061|38204133|FG003|Overall Study|Early improvement|0|||
17061187|NCT00656669|38204143|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
17061188|NCT00656669|38204143|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
17061189|NCT00656669|38204143|FG000|AC (Cycles 6-9)|Adverse Event|1|||
17061190|NCT00656669|38204143|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
17061191|NCT00656513|38204155|FG000|Overall Study|Protocol Violation|1|||
17061192|NCT00656513|38204156|FG001|Overall Study|Protocol Violation|0|||
17061193|NCT00656513|38204157|FG002|Overall Study|Protocol Violation|2|||
17061194|NCT00656513|38204155|FG000|Overall Study|Withdrawal by Subject|0|||
17061195|NCT00656513|38204156|FG001|Overall Study|Withdrawal by Subject|11|||
17061196|NCT00656513|38204157|FG002|Overall Study|Withdrawal by Subject|4|||
17061197|NCT00656513|38204155|FG000|Overall Study|Death|0|||
17061198|NCT00656513|38204156|FG001|Overall Study|Death|0|||
17061199|NCT00656513|38204157|FG002|Overall Study|Death|1|||
17061200|NCT00656513|38204155|FG000|Overall Study|Missing data|0|||
17061201|NCT00656513|38204156|FG001|Overall Study|Missing data|11|||
17061202|NCT00656513|38204157|FG002|Overall Study|Missing data|9|||
17061203|NCT00656513|38204155|FG000|Overall Study|Incomplete treatment|3|||
17061204|NCT00656513|38204156|FG001|Overall Study|Incomplete treatment|0|||
17061205|NCT00656513|38204157|FG002|Overall Study|Incomplete treatment|0|||
17061206|NCT00656513|38204155|FG000|Overall Study|Treatment completed outside of timeframe|0|||
17061207|NCT00656513|38204156|FG001|Overall Study|Treatment completed outside of timeframe|3|||
17061208|NCT00656513|38204157|FG002|Overall Study|Treatment completed outside of timeframe|1|||
17061209|NCT00656513|38204155|FG000|Overall Study|Missing baseline form|0|||
17061210|NCT00656513|38204156|FG001|Overall Study|Missing baseline form|5|||
17061211|NCT00656513|38204157|FG002|Overall Study|Missing baseline form|5|||
17061212|NCT00655889|38204165|FG000|Overall Study|Inadequate cell growth|1|||
17061213|NCT00655889|38204165|FG000|Overall Study|Protocol Violation|1|||
17061214|NCT00655733|38204171|FG000|Overall Study|Lost to Follow-up|2|||
17061215|NCT00655733|38204172|FG001|Overall Study|Lost to Follow-up|2|||
17061216|NCT00655733|38204171|FG000|Overall Study|Adverse Event|2|||
17061217|NCT00655733|38204172|FG001|Overall Study|Adverse Event|2|||
17061218|NCT00655733|38204171|FG000|Overall Study|Withdrawal by Subject|3|||
17061219|NCT00655733|38204172|FG001|Overall Study|Withdrawal by Subject|3|||
17061220|NCT00655733|38204171|FG000|Overall Study|Physician Decision|0|||
17061221|NCT00655733|38204172|FG001|Overall Study|Physician Decision|1|||
17061222|NCT00657371|38204180|FG000|Overall Study|Poor bowel preparation|15|||
17061223|NCT00657371|38204180|FG000|Overall Study|Unable to intubate the cecum|5|||
17061224|NCT00657371|38204180|FG000|Overall Study|Protocol Violation|2|||
17061225|NCT00657371|38204180|FG000|Overall Study|Device- related reasons|13|||
17061226|NCT00657371|38204180|FG000|Overall Study|Pre-existing medical condition|4|||
17061227|NCT00658775|38204186|FG000|Overall Study|Adverse Event|4|||
17061228|NCT00658775|38204187|FG001|Overall Study|Adverse Event|6|||
17061229|NCT00658775|38204186|FG000|Overall Study|Lost to Follow-up|17|||
17061230|NCT00658775|38204187|FG001|Overall Study|Lost to Follow-up|18|||
17061231|NCT00658775|38204186|FG000|Overall Study|Withdrawal by Subject|6|||
17061232|NCT00658775|38204187|FG001|Overall Study|Withdrawal by Subject|4|||
17146097|NCT03205371|38290045|FG008|Overall Study|Adverse Event|0|||
17061233|NCT00658775|38204186|FG000|Overall Study|Withdrawal of consent|8|||
17061234|NCT00658775|38204187|FG001|Overall Study|Withdrawal of consent|7|||
17061235|NCT00658775|38204186|FG000|Overall Study|Other|7|||
17061236|NCT00658775|38204187|FG001|Overall Study|Other|8|||
17061237|NCT00488631|38204199|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
17061238|NCT00488631|38204200|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
17061239|NCT00488631|38204201|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
17061240|NCT00488631|38204202|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
17061241|NCT00488631|38204203|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
17061242|NCT00488631|38204204|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
17061243|NCT00488631|38204205|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
17061244|NCT00488631|38204206|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
17061245|NCT00488631|38204207|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
17061246|NCT00488631|38204208|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
17061247|NCT00488631|38204199|FG000|Double Blind Period (Week 0-54)|Death|0|||
17061248|NCT00488631|38204200|FG001|Double Blind Period (Week 0-54)|Death|0|||
17061249|NCT00488631|38204201|FG002|Double Blind Period (Week 0-54)|Death|0|||
17061250|NCT00488631|38204202|FG003|Double Blind Period (Week 0-54)|Death|0|||
17061251|NCT00488631|38204203|FG004|Double Blind Period (Week 0-54)|Death|0|||
17061252|NCT00488631|38204204|FG005|Double Blind Period (Week 0-54)|Death|1|||
17061253|NCT00488631|38204205|FG006|Double Blind Period (Week 0-54)|Death|0|||
17061254|NCT00488631|38204206|FG007|Double Blind Period (Week 0-54)|Death|0|||
16781190|NCT02171260|37720361|FG001|Overall Study|Death|0|||
17061255|NCT00488631|38204207|FG008|Double Blind Period (Week 0-54)|Death|0|||
17061256|NCT00488631|38204208|FG009|Double Blind Period (Week 0-54)|Death|0|||
17061257|NCT00488631|38204199|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
17061258|NCT00488631|38204200|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
17061259|NCT00488631|38204201|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
17061260|NCT00488631|38204202|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
17061261|NCT00488631|38204203|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
17061262|NCT00488631|38204204|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
17061263|NCT00488631|38204205|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
17061264|NCT00488631|38204206|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
17061265|NCT00488631|38204207|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
17061266|NCT00488631|38204208|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
17061267|NCT00488631|38204199|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
17061268|NCT00488631|38204200|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
17061269|NCT00488631|38204201|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
17061270|NCT00488631|38204202|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
17061271|NCT00488631|38204203|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
17061272|NCT00488631|38204204|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
17061273|NCT00488631|38204205|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
17061274|NCT00488631|38204206|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
17061275|NCT00488631|38204207|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
17061276|NCT00488631|38204208|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
17061277|NCT00488631|38204199|FG000|Double Blind Period (Week 0-54)|Other|6|||
17061278|NCT00488631|38204200|FG001|Double Blind Period (Week 0-54)|Other|12|||
17061279|NCT00488631|38204201|FG002|Double Blind Period (Week 0-54)|Other|10|||
17061280|NCT00488631|38204202|FG003|Double Blind Period (Week 0-54)|Other|11|||
17061281|NCT00488631|38204203|FG004|Double Blind Period (Week 0-54)|Other|14|||
17061282|NCT00488631|38204204|FG005|Double Blind Period (Week 0-54)|Other|34|||
17146098|NCT03205371|38290046|FG009|Overall Study|Adverse Event|0|||
17146099|NCT03205371|38290047|FG010|Overall Study|Adverse Event|0|||
17061283|NCT00488631|38204205|FG006|Double Blind Period (Week 0-54)|Other|0|||
17061284|NCT00488631|38204206|FG007|Double Blind Period (Week 0-54)|Other|0|||
17061285|NCT00488631|38204207|FG008|Double Blind Period (Week 0-54)|Other|0|||
17061286|NCT00488631|38204208|FG009|Double Blind Period (Week 0-54)|Other|0|||
17061287|NCT00488631|38204199|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
17061288|NCT00488631|38204200|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
17061289|NCT00488631|38204201|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
17061290|NCT00488631|38204202|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
17061291|NCT00488631|38204203|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
17061292|NCT00488631|38204204|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
17061293|NCT00488631|38204205|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
17061294|NCT00488631|38204206|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
17061295|NCT00488631|38204207|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
17061296|NCT00488631|38204208|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
17061297|NCT00488631|38204199|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
17061298|NCT00488631|38204200|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
17146100|NCT03205371|38290048|FG011|Overall Study|Adverse Event|0|||
17146101|NCT03682705|38290100|FG000|Overall Study|Adverse Event|1|||
17061299|NCT00488631|38204201|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
17061300|NCT00488631|38204202|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
17061301|NCT00488631|38204203|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
17061302|NCT00488631|38204204|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
17061303|NCT00488631|38204205|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
17061304|NCT00488631|38204206|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
17061305|NCT00488631|38204207|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
17061306|NCT00488631|38204208|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
17061307|NCT00488631|38204199|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
17061308|NCT00488631|38204200|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
17061309|NCT00488631|38204201|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
17061310|NCT00488631|38204202|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
17061311|NCT00488631|38204203|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
17061312|NCT00488631|38204204|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
17061313|NCT00488631|38204205|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
17061314|NCT00488631|38204206|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
17061315|NCT00488631|38204207|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
17061316|NCT00488631|38204208|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
17061317|NCT00488631|38204199|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
17061318|NCT00488631|38204200|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
17061319|NCT00488631|38204201|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
17061320|NCT00488631|38204202|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
17061321|NCT00488631|38204203|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
17061322|NCT00488631|38204204|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
17061323|NCT00488631|38204205|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
17061324|NCT00488631|38204206|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
17061325|NCT00488631|38204207|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
17061326|NCT00488631|38204208|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
17061327|NCT00488631|38204199|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
17146102|NCT03682705|38290101|FG001|Overall Study|Adverse Event|1|||
17146103|NCT03682705|38290102|FG002|Overall Study|Adverse Event|1|||
17146104|NCT03682705|38290103|FG003|Overall Study|Adverse Event|0|||
17146105|NCT03682705|38290104|FG004|Overall Study|Adverse Event|1|||
17146106|NCT03682705|38290105|FG005|Overall Study|Adverse Event|1|||
17146107|NCT03682705|38290100|FG000|Overall Study|Withdrawal by Subject|1|||
17146108|NCT03682705|38290101|FG001|Overall Study|Withdrawal by Subject|3|||
17146109|NCT03682705|38290102|FG002|Overall Study|Withdrawal by Subject|2|||
17146110|NCT03682705|38290103|FG003|Overall Study|Withdrawal by Subject|4|||
17146111|NCT03682705|38290104|FG004|Overall Study|Withdrawal by Subject|0|||
17146112|NCT03682705|38290105|FG005|Overall Study|Withdrawal by Subject|1|||
17146113|NCT03682705|38290100|FG000|Overall Study|Other, not specified|0|||
17146114|NCT03682705|38290101|FG001|Overall Study|Other, not specified|0|||
17146115|NCT03682705|38290102|FG002|Overall Study|Other, not specified|0|||
17146116|NCT03682705|38290103|FG003|Overall Study|Other, not specified|1|||
17146117|NCT03682705|38290104|FG004|Overall Study|Other, not specified|2|||
17146118|NCT03682705|38290105|FG005|Overall Study|Other, not specified|0|||
17146119|NCT03682705|38290100|FG000|Overall Study|Lost to Follow-up|0|||
17146120|NCT03682705|38290101|FG001|Overall Study|Lost to Follow-up|0|||
17146121|NCT03682705|38290102|FG002|Overall Study|Lost to Follow-up|0|||
17146122|NCT03682705|38290103|FG003|Overall Study|Lost to Follow-up|0|||
17146123|NCT03682705|38290104|FG004|Overall Study|Lost to Follow-up|3|||
17146124|NCT03682705|38290105|FG005|Overall Study|Lost to Follow-up|0|||
16993668|NCT00775450|38137700|FG004|Overall Study|Serious Adverse Event|0|||
16993669|NCT00775450|38137696|FG000|Overall Study|Protocol Violation|0|||
16993670|NCT00775450|38137697|FG001|Overall Study|Protocol Violation|0|||
16993671|NCT00775450|38137698|FG002|Overall Study|Protocol Violation|0|||
16993672|NCT00775450|38137699|FG003|Overall Study|Protocol Violation|0|||
16993673|NCT00775450|38137700|FG004|Overall Study|Protocol Violation|1|||
16993674|NCT00775450|38137696|FG000|Overall Study|Withdrawal by Subject|1|||
16993675|NCT00775450|38137697|FG001|Overall Study|Withdrawal by Subject|0|||
17061328|NCT00488631|38204200|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
17061329|NCT00488631|38204201|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
17061330|NCT00488631|38204202|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
17061331|NCT00488631|38204203|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
17061332|NCT00488631|38204204|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
17061333|NCT00488631|38204205|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
17061334|NCT00488631|38204206|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
17061335|NCT00488631|38204207|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
17061336|NCT00488631|38204208|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
17061337|NCT00655499|38204231|FG000|Overall Study|not eligible|4|||
17061338|NCT00654875|38204238|FG000|Overall Study|Adverse Event|5|||
17061339|NCT00654875|38204239|FG001|Overall Study|Adverse Event|5|||
17061340|NCT00654875|38204238|FG000|Overall Study|Withdrawal by Subject|4|||
17061341|NCT00654875|38204239|FG001|Overall Study|Withdrawal by Subject|4|||
17061342|NCT00654875|38204238|FG000|Overall Study|Protocol Violation|3|||
17061343|NCT00654875|38204239|FG001|Overall Study|Protocol Violation|3|||
16781191|NCT02171260|37720362|FG002|Overall Study|Death|0|||
16993676|NCT00775450|38137698|FG002|Overall Study|Withdrawal by Subject|0|||
16993677|NCT00775450|38137699|FG003|Overall Study|Withdrawal by Subject|0|||
16993678|NCT00775450|38137700|FG004|Overall Study|Withdrawal by Subject|1|||
16993679|NCT00775138|38137716|FG000|Overall Study|Withdrawal by Subject|0|||
16993680|NCT00775138|38137717|FG001|Overall Study|Withdrawal by Subject|0|||
16993681|NCT00775138|38137718|FG002|Overall Study|Withdrawal by Subject|2|||
16993682|NCT00775138|38137719|FG003|Overall Study|Withdrawal by Subject|2|||
16993683|NCT00775138|38137716|FG000|Overall Study|Adverse Event|0|||
16993684|NCT00775138|38137717|FG001|Overall Study|Adverse Event|0|||
16993685|NCT00775138|38137718|FG002|Overall Study|Adverse Event|1|||
16993686|NCT00775138|38137719|FG003|Overall Study|Adverse Event|0|||
16993687|NCT04605991|38137731|FG000|Overall Study|Adverse Event|5|||
16993688|NCT04605991|38137731|FG000|Overall Study|Lack of Efficacy|1|||
16993689|NCT04605991|38137731|FG000|Overall Study|Lost to Follow-up|8|||
16993690|NCT04605991|38137731|FG000|Overall Study|Physician Decision|4|||
16993691|NCT04605991|38137731|FG000|Overall Study|Withdrawal by Subject|14|||
16993692|NCT04605991|38137731|FG000|Overall Study|Non-compliance with study|1|||
16993693|NCT00783796|38137735|FG000|Overall Study|Did not receive any stent|4|||
16993694|NCT00783796|38137735|FG000|Overall Study|Received non-XIENCE V stent|1|||
16993695|NCT00783796|38137735|FG000|Overall Study|Received commercial XIENCE V stent|1|||
16993696|NCT00783718|38137744|FG000|Induction Phase|Adverse Event|4|||
16993697|NCT00783718|38137745|FG001|Induction Phase|Adverse Event|0|||
16993698|NCT00783718|38137746|FG002|Induction Phase|Adverse Event|7|||
16993699|NCT00783718|38137747|FG003|Induction Phase|Adverse Event|0|||
16993700|NCT00783718|38137748|FG004|Induction Phase|Adverse Event|0|||
16993701|NCT00783718|38137749|FG005|Induction Phase|Adverse Event|0|||
16993702|NCT00783718|38137750|FG006|Induction Phase|Adverse Event|0|||
16993703|NCT00783718|38137744|FG000|Induction Phase|Protocol Violation|1|||
16993704|NCT00783718|38137745|FG001|Induction Phase|Protocol Violation|1|||
16993705|NCT00783718|38137746|FG002|Induction Phase|Protocol Violation|6|||
16993706|NCT00783718|38137747|FG003|Induction Phase|Protocol Violation|0|||
16993707|NCT00783718|38137748|FG004|Induction Phase|Protocol Violation|0|||
16993708|NCT00783718|38137749|FG005|Induction Phase|Protocol Violation|0|||
16993709|NCT00783718|38137750|FG006|Induction Phase|Protocol Violation|0|||
16993710|NCT00783718|38137744|FG000|Induction Phase|Lack of Efficacy|5|||
16993711|NCT00783718|38137745|FG001|Induction Phase|Lack of Efficacy|2|||
17061344|NCT00654875|38204238|FG000|Overall Study|Lack of Efficacy|2|||
17061345|NCT00654875|38204239|FG001|Overall Study|Lack of Efficacy|2|||
17061346|NCT00654875|38204238|FG000|Overall Study|Lost to Follow-up|1|||
17061347|NCT00654875|38204239|FG001|Overall Study|Lost to Follow-up|3|||
17061348|NCT00654875|38204238|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
17061349|NCT00654875|38204239|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
17061350|NCT00654875|38204238|FG000|Overall Study|Administrative Problems|1|||
17061351|NCT00654875|38204239|FG001|Overall Study|Administrative Problems|0|||
17061352|NCT00651755|38204245|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
17061353|NCT00651755|38204246|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
17061354|NCT00651755|38204245|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
17061355|NCT00651755|38204246|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
17061356|NCT00654641|38204255|FG000|Overall Study|Lost to Follow-up|2|||
17061357|NCT00654641|38204256|FG001|Overall Study|Lost to Follow-up|3|||
17061358|NCT00569777|38204264|FG000|Overall Study|Withdrawal by Subject|4|||
17061359|NCT00569777|38204265|FG001|Overall Study|Withdrawal by Subject|0|||
17061360|NCT00569777|38204264|FG000|Overall Study|Adverse Event|3|||
17061361|NCT00569777|38204265|FG001|Overall Study|Adverse Event|0|||
17061362|NCT00569777|38204264|FG000|Overall Study|Lost to Follow-up|1|||
17061363|NCT00569777|38204265|FG001|Overall Study|Lost to Follow-up|0|||
17061364|NCT00569777|38204264|FG000|Overall Study|scheduled eye surgery|0|||
17061365|NCT00569777|38204265|FG001|Overall Study|scheduled eye surgery|1|||
17146125|NCT03179787|38290119|FG000|Overall Study|Lost to Follow-up|15|||
17061366|NCT00569777|38204264|FG000|Overall Study|did not meet exclusion criteria|1|||
17061367|NCT00569777|38204265|FG001|Overall Study|did not meet exclusion criteria|2|||
17061368|NCT00569777|38204264|FG000|Overall Study|pregnant|1|||
17061369|NCT00569777|38204265|FG001|Overall Study|pregnant|0|||
17061370|NCT00569231|38204271|FG000|Overall Study|Study unrelated surgery|1|||
17061371|NCT00569231|38204271|FG000|Overall Study|Airfare expense|2|||
17061372|NCT00569231|38204271|FG000|Overall Study|Withdrawal by Subject|1|||
17061373|NCT00569231|38204271|FG000|Overall Study|Car accident injury|1|||
17061374|NCT00569231|38204271|FG000|Overall Study|Non-compliance|2|||
17061375|NCT00654095|38204275|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
17061376|NCT00654095|38204275|FG000|Overall Study|Elevated triglyceride level (2)|1|||
17061377|NCT00654095|38204275|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
17061378|NCT00654095|38204275|FG000|Overall Study|Adverse Event|11|||
17061379|NCT00654095|38204275|FG000|Overall Study|Withdrawal by Subject|5|||
17061380|NCT00654095|38204275|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
17061381|NCT00654095|38204275|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
17061382|NCT00654095|38204275|FG000|Overall Study|Did not meet inclusion criteria|1|||
17061383|NCT00650585|38204281|FG000|Overall Study|Lost to Follow-up|505|||
17061384|NCT00650585|38204282|FG001|Overall Study|Lost to Follow-up|482|||
17061385|NCT00650585|38204281|FG000|Overall Study|No parental consent|935|||
17061386|NCT00650585|38204282|FG001|Overall Study|No parental consent|866|||
17061387|NCT00650585|38204281|FG000|Overall Study|Excluded/ruled ineligible|357|||
17061388|NCT00650585|38204282|FG001|Overall Study|Excluded/ruled ineligible|129|||
17061389|NCT00653939|38204290|FG000|Overall Study|Adverse Event|1|||
17061390|NCT00653939|38204291|FG001|Overall Study|Adverse Event|3|||
17061391|NCT00653939|38204290|FG000|Overall Study|Withdrawal by Subject|3|||
17061392|NCT00653939|38204291|FG001|Overall Study|Withdrawal by Subject|3|||
17061393|NCT00653939|38204290|FG000|Overall Study|Physician Decision|4|||
17061394|NCT00653939|38204291|FG001|Overall Study|Physician Decision|0|||
17061395|NCT00653939|38204290|FG000|Overall Study|Disease Progression|2|||
17061396|NCT00653939|38204291|FG001|Overall Study|Disease Progression|3|||
17061397|NCT00653939|38204290|FG000|Overall Study|Other|2|||
17061398|NCT00653939|38204291|FG001|Overall Study|Other|6|||
17061399|NCT00646451|38204299|FG000|Overall Study|Adverse Event|3|||
17146126|NCT03179787|38290119|FG000|Overall Study|Case report failures|2|||
17146127|NCT03179787|38290119|FG000|Overall Study|Treatment not administered|1|||
17146128|NCT03745937|38290127|FG000|Overall Study|Withdrawal by Subject|0|||
17146129|NCT03745937|38290128|FG001|Overall Study|Withdrawal by Subject|0|||
17146130|NCT03745937|38290129|FG002|Overall Study|Withdrawal by Subject|0|||
17146131|NCT03745937|38290130|FG003|Overall Study|Withdrawal by Subject|1|||
17146132|NCT03745937|38290127|FG000|Overall Study|Not-specifed|0|||
17146133|NCT03745937|38290128|FG001|Overall Study|Not-specifed|1|||
17146134|NCT03745937|38290129|FG002|Overall Study|Not-specifed|0|||
17146135|NCT03745937|38290130|FG003|Overall Study|Not-specifed|1|||
17146136|NCT02956057|38290147|FG000|Overall Study|Discontinued intervention|14|||
17146137|NCT02956057|38290148|FG001|Overall Study|Discontinued intervention|10|||
17146138|NCT02956057|38290149|FG002|Overall Study|Discontinued intervention|7|||
17146139|NCT02956057|38290150|FG003|Overall Study|Discontinued intervention|14|||
17146140|NCT02956057|38290151|FG004|Overall Study|Discontinued intervention|4|||
17146141|NCT02956057|38290152|FG005|Overall Study|Discontinued intervention|17|||
17146142|NCT02956057|38290147|FG000|Overall Study|Lost to Follow-up|0|||
17146143|NCT02956057|38290148|FG001|Overall Study|Lost to Follow-up|2|||
17146144|NCT02956057|38290149|FG002|Overall Study|Lost to Follow-up|1|||
17146145|NCT02956057|38290150|FG003|Overall Study|Lost to Follow-up|1|||
17061400|NCT00646451|38204300|FG001|Overall Study|Adverse Event|0|||
17061401|NCT00646451|38204299|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
17061402|NCT00646451|38204300|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
17061403|NCT00642707|38204312|FG000|Overall Study|Adverse Event|0|||
17061404|NCT00642707|38204313|FG001|Overall Study|Adverse Event|0|||
17061405|NCT00642707|38204314|FG002|Overall Study|Adverse Event|0|||
17061406|NCT00642707|38204315|FG003|Overall Study|Adverse Event|2|||
17061407|NCT00642707|38204312|FG000|Overall Study|Withdrawal by Subject|1|||
17061408|NCT00642707|38204313|FG001|Overall Study|Withdrawal by Subject|0|||
17061409|NCT00642707|38204314|FG002|Overall Study|Withdrawal by Subject|0|||
17061410|NCT00642707|38204315|FG003|Overall Study|Withdrawal by Subject|0|||
17061411|NCT00568685|38204328|FG000|Overall Study|Adverse Event|2|||
17061412|NCT00568685|38204329|FG001|Overall Study|Adverse Event|3|||
17061413|NCT00568685|38204330|FG002|Overall Study|Adverse Event|3|||
17061414|NCT00568685|38204328|FG000|Overall Study|Withdrawal by Subject|7|||
17061415|NCT00568685|38204329|FG001|Overall Study|Withdrawal by Subject|2|||
17061416|NCT00568685|38204330|FG002|Overall Study|Withdrawal by Subject|2|||
16993712|NCT00783718|38137746|FG002|Induction Phase|Lack of Efficacy|14|||
16993713|NCT00783718|38137747|FG003|Induction Phase|Lack of Efficacy|0|||
16993714|NCT00783718|38137748|FG004|Induction Phase|Lack of Efficacy|0|||
16993715|NCT00783718|38137749|FG005|Induction Phase|Lack of Efficacy|0|||
16993716|NCT00783718|38137750|FG006|Induction Phase|Lack of Efficacy|0|||
16993717|NCT00783718|38137744|FG000|Induction Phase|Withdrawal by Subject|3|||
16993718|NCT00783718|38137745|FG001|Induction Phase|Withdrawal by Subject|4|||
16993719|NCT00783718|38137746|FG002|Induction Phase|Withdrawal by Subject|8|||
16993720|NCT00783718|38137747|FG003|Induction Phase|Withdrawal by Subject|0|||
16993721|NCT00783718|38137748|FG004|Induction Phase|Withdrawal by Subject|0|||
16993722|NCT00783718|38137749|FG005|Induction Phase|Withdrawal by Subject|0|||
17061417|NCT00568685|38204328|FG000|Overall Study|Protocol Violation|1|||
17061418|NCT00568685|38204329|FG001|Overall Study|Protocol Violation|0|||
17061419|NCT00568685|38204330|FG002|Overall Study|Protocol Violation|0|||
17061420|NCT00061945|38204344|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
17146146|NCT02956057|38290151|FG004|Overall Study|Lost to Follow-up|1|||
17146147|NCT02956057|38290152|FG005|Overall Study|Lost to Follow-up|0|||
17146148|NCT03179319|38290168|FG000|Overall Study|Lost to Follow-up|6|||
17146149|NCT03179319|38290169|FG001|Overall Study|Lost to Follow-up|0|||
17061421|NCT00061945|38204345|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
17061422|NCT00061945|38204344|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
17061423|NCT00061945|38204345|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
17061424|NCT00061945|38204344|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
17061425|NCT00061945|38204345|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
17061426|NCT00061945|38204344|FG000|Course IV: Alemtuzumab|Early exits|6|||
17061427|NCT00061945|38204345|FG001|Course IV: Alemtuzumab|Early exits|15|||
17061428|NCT00642473|38204356|FG000|Overall Study|Withdrawal by Subject|0|||
17061429|NCT00642473|38204357|FG001|Overall Study|Withdrawal by Subject|5|||
17061430|NCT00642473|38204356|FG000|Overall Study|Progression or death|2|||
17061431|NCT00642473|38204357|FG001|Overall Study|Progression or death|4|||
17061432|NCT00642473|38204356|FG000|Overall Study|Other|2|||
17061433|NCT00642473|38204357|FG001|Overall Study|Other|2|||
17061434|NCT00645671|38204368|FG000|Overall Study|Protocol Violation|1|||
17061435|NCT00645671|38204369|FG001|Overall Study|Protocol Violation|0|||
17061436|NCT00645671|38204368|FG000|Overall Study|Withdrawal by Subject|0|||
17061437|NCT00645671|38204369|FG001|Overall Study|Withdrawal by Subject|4|||
17061438|NCT00645671|38204368|FG000|Overall Study|Adverse Event|0|||
17061439|NCT00645671|38204369|FG001|Overall Study|Adverse Event|1|||
17061440|NCT00645671|38204368|FG000|Overall Study|Physician Decision|0|||
17061441|NCT00645671|38204369|FG001|Overall Study|Physician Decision|1|||
17061442|NCT00366340|38204377|FG000|Infant Series|Protocol Violation|3|||
17061443|NCT00366340|38204378|FG001|Infant Series|Protocol Violation|4|||
17061444|NCT00366340|38204377|FG000|Infant Series|Withdrawal by Subject|3|||
17061445|NCT00366340|38204378|FG001|Infant Series|Withdrawal by Subject|3|||
17061446|NCT00366340|38204377|FG000|Infant Series|Adverse Event|0|||
17061447|NCT00366340|38204378|FG001|Infant Series|Adverse Event|2|||
17061448|NCT00366340|38204377|FG000|Infant Series|Lost to Follow-up|1|||
17061449|NCT00366340|38204378|FG001|Infant Series|Lost to Follow-up|1|||
17061450|NCT00366340|38204377|FG000|Infant Series|Failure to return|1|||
17061451|NCT00366340|38204378|FG001|Infant Series|Failure to return|0|||
17061452|NCT00366340|38204377|FG000|After the Infant Series|Parent/legal guardian request|1|||
17061453|NCT00366340|38204378|FG001|After the Infant Series|Parent/legal guardian request|1|||
17061454|NCT00366340|38204377|FG000|After the Infant Series|Failed to return|0|||
17061455|NCT00366340|38204378|FG001|After the Infant Series|Failed to return|1|||
17061456|NCT00366340|38204377|FG000|After the Infant Series|Protocol Violation|2|||
17061457|NCT00366340|38204378|FG001|After the Infant Series|Protocol Violation|2|||
17061458|NCT00366340|38204377|FG000|After the Infant Series|Adverse Event|0|||
17061459|NCT00366340|38204378|FG001|After the Infant Series|Adverse Event|1|||
17061460|NCT00366340|38204377|FG000|After the Infant Series|Lost to Follow-up|0|||
17061461|NCT00366340|38204378|FG001|After the Infant Series|Lost to Follow-up|1|||
17061462|NCT00366340|38204377|FG000|Toddler Dose|Failed to return|1|||
17061463|NCT00366340|38204378|FG001|Toddler Dose|Failed to return|0|||
17061464|NCT00366340|38204377|FG000|Toddler Dose|Parent/legal guardian request|0|||
17061465|NCT00366340|38204378|FG001|Toddler Dose|Parent/legal guardian request|1|||
17061466|NCT00061633|38204410|FG000|Overall Study|Adverse Event|1|||
17061467|NCT00061633|38204411|FG001|Overall Study|Adverse Event|2|||
17061468|NCT00061633|38204410|FG000|Overall Study|Withdrawal by Subject|2|||
17061469|NCT00061633|38204411|FG001|Overall Study|Withdrawal by Subject|2|||
17061470|NCT00061633|38204410|FG000|Overall Study|Lost to Follow-up|1|||
17061471|NCT00061633|38204411|FG001|Overall Study|Lost to Follow-up|4|||
17061472|NCT00061633|38204410|FG000|Overall Study|Other|1|||
17061473|NCT00061633|38204411|FG001|Overall Study|Other|1|||
17061474|NCT00061633|38204410|FG000|Overall Study|Never received study treatment|0|||
17061475|NCT00061633|38204411|FG001|Overall Study|Never received study treatment|2|||
17061476|NCT00645593|38204419|FG000|Overall Study|Later found to be ineligible|1|||
17061477|NCT00645593|38204420|FG001|Overall Study|Later found to be ineligible|0|||
17061478|NCT03832738|38204429|FG000|Overall Study|Withdrawal by Subject|6|||
17061479|NCT03832738|38204430|FG001|Overall Study|Withdrawal by Subject|7|||
17061480|NCT03832738|38204431|FG002|Overall Study|Withdrawal by Subject|16|||
17061481|NCT03832738|38204429|FG000|Overall Study|Physician Decision|0|||
17061482|NCT03832738|38204430|FG001|Overall Study|Physician Decision|1|||
17061483|NCT03832738|38204431|FG002|Overall Study|Physician Decision|2|||
17061484|NCT03832738|38204429|FG000|Overall Study|Adverse Event|2|||
17061485|NCT03832738|38204430|FG001|Overall Study|Adverse Event|3|||
17061486|NCT03832738|38204431|FG002|Overall Study|Adverse Event|1|||
17061487|NCT03832738|38204429|FG000|Overall Study|Pregnancy|0|||
17061488|NCT03832738|38204430|FG001|Overall Study|Pregnancy|1|||
17061489|NCT03832738|38204431|FG002|Overall Study|Pregnancy|0|||
17061490|NCT00046891|38204441|FG000|Overall Study|Cancels|5|||
17061491|NCT00046891|38204442|FG001|Overall Study|Cancels|9|||
17061492|NCT00046891|38204441|FG000|Overall Study|Ineligible|1|||
17061493|NCT00046891|38204442|FG001|Overall Study|Ineligible|1|||
17061494|NCT00046891|38204441|FG000|Overall Study|Withdrawal by Subject|18|||
17061495|NCT00046891|38204442|FG001|Overall Study|Withdrawal by Subject|15|||
17061496|NCT00046891|38204441|FG000|Overall Study|Adverse Event|5|||
17061497|NCT00046891|38204442|FG001|Overall Study|Adverse Event|5|||
17061498|NCT00365794|38204456|FG000|Overall Study|Withdrawal by Subject|2|||
17061499|NCT00383500|38204464|FG000|Overall Study|Withdrawal by Subject|8|||
17061500|NCT00383500|38204465|FG001|Overall Study|Withdrawal by Subject|3|||
17061501|NCT00383500|38204466|FG002|Overall Study|Withdrawal by Subject|0|||
17061502|NCT00383500|38204464|FG000|Overall Study|Lost to Follow-up|0|||
17061503|NCT00383500|38204465|FG001|Overall Study|Lost to Follow-up|0|||
17061504|NCT00383500|38204466|FG002|Overall Study|Lost to Follow-up|2|||
17061505|NCT00365716|38204480|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
17061506|NCT00365716|38204481|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
17061507|NCT00365716|38204482|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
17061508|NCT00365716|38204483|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
17061509|NCT00365716|38204484|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
17061510|NCT00365716|38204485|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
17061511|NCT00365716|38204486|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
17061512|NCT00365716|38204480|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
17061513|NCT00365716|38204481|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
17061514|NCT00365716|38204482|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
17061515|NCT00365716|38204483|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
17061516|NCT00365716|38204484|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
17061517|NCT00365716|38204485|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
17061518|NCT00365716|38204486|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
17061519|NCT00365716|38204480|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
17061520|NCT00365716|38204481|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
17061521|NCT00365716|38204482|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
17061522|NCT00365716|38204483|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
17061523|NCT00365716|38204484|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
17061524|NCT00365716|38204485|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
17061525|NCT00365716|38204486|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
17061526|NCT00365716|38204480|FG000|Base Study (Day 1 to Month 7)|Other|0|||
17061527|NCT00365716|38204481|FG001|Base Study (Day 1 to Month 7)|Other|1|||
17061528|NCT00365716|38204482|FG002|Base Study (Day 1 to Month 7)|Other|0|||
17061529|NCT00365716|38204483|FG003|Base Study (Day 1 to Month 7)|Other|0|||
17061530|NCT00365716|38204484|FG004|Base Study (Day 1 to Month 7)|Other|0|||
17061531|NCT00365716|38204485|FG005|Base Study (Day 1 to Month 7)|Other|0|||
17061532|NCT00365716|38204486|FG006|Base Study (Day 1 to Month 7)|Other|0|||
17061533|NCT00365716|38204480|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
17061534|NCT00365716|38204481|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
17061535|NCT00365716|38204482|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
17061536|NCT00365716|38204483|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
17061537|NCT00365716|38204484|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
17061538|NCT00365716|38204485|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
17061539|NCT00365716|38204486|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
17061540|NCT00365716|38204480|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
17061541|NCT00365716|38204481|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
17061542|NCT00365716|38204482|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
17061543|NCT00365716|38204483|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
17061544|NCT00365716|38204484|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
17061545|NCT00365716|38204485|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
17061546|NCT00365716|38204486|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
17061547|NCT00365716|38204480|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
17061548|NCT00365716|38204481|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
17061549|NCT00365716|38204482|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
17061550|NCT00365716|38204483|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
17061551|NCT00365716|38204484|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
17061552|NCT00365716|38204485|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
17061553|NCT00365716|38204486|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
17061554|NCT00365716|38204480|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
17061555|NCT00365716|38204481|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
17061556|NCT00365716|38204482|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
17061557|NCT00365716|38204483|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
17146150|NCT03627091|38290178|FG000|Overall Study|Adverse Event|0|||
17146151|NCT03627091|38290179|FG001|Overall Study|Adverse Event|0|||
17146152|NCT03627091|38290180|FG002|Overall Study|Adverse Event|2|||
17146153|NCT03627091|38290178|FG000|Overall Study|Withdrawal by Subject|2|||
17146154|NCT03627091|38290179|FG001|Overall Study|Withdrawal by Subject|0|||
17146155|NCT03627091|38290180|FG002|Overall Study|Withdrawal by Subject|2|||
17061558|NCT00365716|38204484|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
17061559|NCT00365716|38204485|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
17061560|NCT00365716|38204486|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
17061561|NCT00365716|38204480|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
17146156|NCT03627091|38290178|FG000|Overall Study|Physician Decision|2|||
17146157|NCT03627091|38290179|FG001|Overall Study|Physician Decision|0|||
17146158|NCT03627091|38290180|FG002|Overall Study|Physician Decision|0|||
17146159|NCT03627091|38290178|FG000|Overall Study|Site terminated by sponsor|0|||
17146160|NCT03627091|38290179|FG001|Overall Study|Site terminated by sponsor|1|||
17146161|NCT03627091|38290180|FG002|Overall Study|Site terminated by sponsor|0|||
17146162|NCT03627091|38290178|FG000|Overall Study|Disease relapse|7|||
17146163|NCT03627091|38290179|FG001|Overall Study|Disease relapse|5|||
17146164|NCT03627091|38290180|FG002|Overall Study|Disease relapse|1|||
17146165|NCT03627091|38290178|FG000|Overall Study|Other|1|||
17146166|NCT03627091|38290179|FG001|Overall Study|Other|0|||
17146167|NCT03627091|38290180|FG002|Overall Study|Other|0|||
17146168|NCT04237584|38290193|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
17146169|NCT04237584|38290194|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
17146170|NCT04237584|38290195|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
17061562|NCT00365716|38204481|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
17061563|NCT00365716|38204482|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
17061564|NCT00365716|38204483|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
17061565|NCT00365716|38204484|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
17061566|NCT00365716|38204485|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
17061567|NCT00365716|38204486|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
17061568|NCT00365716|38204480|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
17061569|NCT00365716|38204481|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
17061570|NCT00365716|38204482|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
17061571|NCT00365716|38204483|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
17061572|NCT00365716|38204484|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
17061573|NCT00365716|38204485|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
17061574|NCT00365716|38204486|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
17061575|NCT00365716|38204480|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
17061576|NCT00365716|38204481|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
17061577|NCT00365716|38204482|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
17061578|NCT00365716|38204483|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
17061579|NCT00365716|38204484|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
17061580|NCT00365716|38204485|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
17061581|NCT00365716|38204486|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
17061582|NCT00365716|38204480|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
17061583|NCT00365716|38204481|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
17061584|NCT00365716|38204482|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
17061585|NCT00365716|38204483|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
17061586|NCT00365716|38204484|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
17061587|NCT00365716|38204485|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
17061588|NCT00365716|38204486|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
17061589|NCT00365716|38204480|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
17061590|NCT00365716|38204481|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
17061591|NCT00365716|38204482|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
17061592|NCT00365716|38204483|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
17061593|NCT00365716|38204484|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
17061594|NCT00365716|38204485|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
17061595|NCT00365716|38204486|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
17061596|NCT00365716|38204480|FG000|Extension 1|Lost to Follow-up|0|||
17061597|NCT00365716|38204481|FG001|Extension 1|Lost to Follow-up|0|||
17061598|NCT00365716|38204482|FG002|Extension 1|Lost to Follow-up|0|||
17061599|NCT00365716|38204483|FG003|Extension 1|Lost to Follow-up|0|||
17061600|NCT00365716|38204484|FG004|Extension 1|Lost to Follow-up|0|||
17061601|NCT00365716|38204485|FG005|Extension 1|Lost to Follow-up|1|||
17061602|NCT00365716|38204486|FG006|Extension 1|Lost to Follow-up|0|||
17061603|NCT00365716|38204480|FG000|Extension 1|Other|0|||
17061604|NCT00365716|38204481|FG001|Extension 1|Other|0|||
17061605|NCT00365716|38204482|FG002|Extension 1|Other|0|||
17061606|NCT00365716|38204483|FG003|Extension 1|Other|0|||
17061607|NCT00365716|38204484|FG004|Extension 1|Other|0|||
17061608|NCT00365716|38204485|FG005|Extension 1|Other|9|||
17061609|NCT00365716|38204486|FG006|Extension 1|Other|0|||
17061610|NCT00365716|38204480|FG000|Extension 1|Moved|0|||
17061611|NCT00365716|38204481|FG001|Extension 1|Moved|0|||
17061612|NCT00365716|38204482|FG002|Extension 1|Moved|0|||
17061613|NCT00365716|38204483|FG003|Extension 1|Moved|0|||
16781192|NCT02171260|37720363|FG003|Overall Study|Death|1|||
17061614|NCT00365716|38204484|FG004|Extension 1|Moved|0|||
17061615|NCT00365716|38204485|FG005|Extension 1|Moved|4|||
17061616|NCT00365716|38204486|FG006|Extension 1|Moved|0|||
17146171|NCT04237584|38290196|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
17146172|NCT04237584|38290193|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
17146173|NCT04237584|38290194|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
17146174|NCT04237584|38290195|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
17146175|NCT04237584|38290196|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
17146176|NCT04237584|38290193|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
17146177|NCT04237584|38290194|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
17146178|NCT04237584|38290195|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
17146179|NCT04237584|38290196|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
17146180|NCT04237584|38290193|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
17146181|NCT04237584|38290194|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
17146182|NCT04237584|38290195|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
17146183|NCT04237584|38290196|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
17146184|NCT04237584|38290193|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
17146185|NCT04237584|38290194|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
17146186|NCT04237584|38290195|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
17146187|NCT04237584|38290196|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
17146188|NCT03224598|38290213|FG000|Overall Study|Lost to Follow-up|0|||
17146189|NCT03224598|38290214|FG001|Overall Study|Lost to Follow-up|2|||
17146190|NCT03224598|38290215|FG002|Overall Study|Lost to Follow-up|0|||
17146191|NCT03224598|38290213|FG000|Overall Study|Other|0|||
17146192|NCT03224598|38290214|FG001|Overall Study|Other|1|||
17146193|NCT03224598|38290215|FG002|Overall Study|Other|0|||
17146194|NCT03681691|38290225|FG000|Overall Study|COVID|1|||
17146195|NCT03681691|38290226|FG001|Overall Study|COVID|0|||
17146196|NCT03681691|38290225|FG000|Overall Study|prolonged bleeding|1|||
17146197|NCT03681691|38290226|FG001|Overall Study|prolonged bleeding|0|||
17146198|NCT03681691|38290225|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
17146199|NCT03681691|38290226|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
17146200|NCT02935842|38290238|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
17146201|NCT02935842|38290239|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
17146202|NCT02935842|38290240|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
17146203|NCT02935842|38290241|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
17146204|NCT02935842|38290238|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
17146205|NCT02935842|38290239|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
17146206|NCT02935842|38290240|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
17146207|NCT02935842|38290241|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
17146208|NCT02935842|38290238|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
17146209|NCT02935842|38290239|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
17146210|NCT02935842|38290240|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
17146211|NCT02935842|38290241|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
17146212|NCT02935842|38290238|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
17146213|NCT02935842|38290239|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
17146214|NCT02935842|38290240|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
17146215|NCT02935842|38290241|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
17146216|NCT02935842|38290238|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
17146217|NCT02935842|38290239|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
17146218|NCT02935842|38290240|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
17146219|NCT02935842|38290241|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
17146220|NCT01064479|38290260|FG000|Overall Study|Death|10|||
17146221|NCT01064479|38290261|FG001|Overall Study|Death|11|||
17146222|NCT01064479|38290260|FG000|Overall Study|Withdrawal by Subject|2|||
17146223|NCT01064479|38290261|FG001|Overall Study|Withdrawal by Subject|2|||
17146224|NCT01064479|38290260|FG000|Overall Study|Disease progression|1|||
17146225|NCT01064479|38290261|FG001|Overall Study|Disease progression|1|||
17146226|NCT01064479|38290260|FG000|Overall Study|Toxicity|1|||
17061617|NCT00365716|38204480|FG000|Extension 1|Withdrawal by Subject|0|||
17061618|NCT00365716|38204481|FG001|Extension 1|Withdrawal by Subject|0|||
17061619|NCT00365716|38204482|FG002|Extension 1|Withdrawal by Subject|0|||
17061620|NCT00365716|38204483|FG003|Extension 1|Withdrawal by Subject|0|||
17061621|NCT00365716|38204484|FG004|Extension 1|Withdrawal by Subject|0|||
17061622|NCT00365716|38204485|FG005|Extension 1|Withdrawal by Subject|3|||
17061623|NCT00365716|38204486|FG006|Extension 1|Withdrawal by Subject|0|||
17061624|NCT00365716|38204480|FG000|Extension 1|Pregnancy|0|||
17061625|NCT00365716|38204481|FG001|Extension 1|Pregnancy|0|||
17061626|NCT00365716|38204482|FG002|Extension 1|Pregnancy|0|||
17061627|NCT00365716|38204483|FG003|Extension 1|Pregnancy|0|||
17061628|NCT00365716|38204484|FG004|Extension 1|Pregnancy|0|||
17061629|NCT00365716|38204485|FG005|Extension 1|Pregnancy|4|||
17061630|NCT00365716|38204486|FG006|Extension 1|Pregnancy|0|||
17061631|NCT00365716|38204480|FG000|Extension 1|Protocol Violation|0|||
17061632|NCT00365716|38204481|FG001|Extension 1|Protocol Violation|0|||
17061633|NCT00365716|38204482|FG002|Extension 1|Protocol Violation|0|||
17061634|NCT00365716|38204483|FG003|Extension 1|Protocol Violation|0|||
17061635|NCT00365716|38204484|FG004|Extension 1|Protocol Violation|0|||
17061636|NCT00365716|38204485|FG005|Extension 1|Protocol Violation|1|||
17061637|NCT00365716|38204486|FG006|Extension 1|Protocol Violation|0|||
17061638|NCT00365716|38204480|FG000|Extension 2|Lost to Follow-up|0|||
17061639|NCT00365716|38204481|FG001|Extension 2|Lost to Follow-up|0|||
17061640|NCT00365716|38204482|FG002|Extension 2|Lost to Follow-up|0|||
17061641|NCT00365716|38204483|FG003|Extension 2|Lost to Follow-up|0|||
17061642|NCT00365716|38204484|FG004|Extension 2|Lost to Follow-up|0|||
17061643|NCT00365716|38204485|FG005|Extension 2|Lost to Follow-up|0|||
17061644|NCT00365716|38204486|FG006|Extension 2|Lost to Follow-up|2|||
17061645|NCT00365716|38204480|FG000|Extension 2|Other|0|||
17061646|NCT00365716|38204481|FG001|Extension 2|Other|0|||
17061647|NCT00365716|38204482|FG002|Extension 2|Other|0|||
17061648|NCT00365716|38204483|FG003|Extension 2|Other|0|||
17061649|NCT00365716|38204484|FG004|Extension 2|Other|0|||
17061650|NCT00365716|38204485|FG005|Extension 2|Other|0|||
17061651|NCT00365716|38204486|FG006|Extension 2|Other|3|||
17061652|NCT00365716|38204480|FG000|Extension 2|Withdrawal by Subject|0|||
17061653|NCT00365716|38204481|FG001|Extension 2|Withdrawal by Subject|0|||
17061654|NCT00365716|38204482|FG002|Extension 2|Withdrawal by Subject|0|||
17061655|NCT00365716|38204483|FG003|Extension 2|Withdrawal by Subject|0|||
17061656|NCT00365716|38204484|FG004|Extension 2|Withdrawal by Subject|0|||
17061657|NCT00365716|38204485|FG005|Extension 2|Withdrawal by Subject|0|||
17061658|NCT00365716|38204486|FG006|Extension 2|Withdrawal by Subject|5|||
17061659|NCT00059839|38204502|FG000|Overall Study|Death|1|||
17061660|NCT00059839|38204503|FG001|Overall Study|Death|1|||
17061661|NCT00059839|38204502|FG000|Overall Study|Lack of Efficacy|6|||
17061662|NCT00059839|38204503|FG001|Overall Study|Lack of Efficacy|5|||
17061663|NCT00059839|38204502|FG000|Overall Study|Lost to Follow-up|2|||
17061664|NCT00059839|38204503|FG001|Overall Study|Lost to Follow-up|0|||
17061665|NCT00059839|38204502|FG000|Overall Study|Physician Decision|1|||
17061666|NCT00059839|38204503|FG001|Overall Study|Physician Decision|2|||
17061667|NCT00059839|38204502|FG000|Overall Study|Withdrawal by Subject|1|||
17061668|NCT00059839|38204503|FG001|Overall Study|Withdrawal by Subject|6|||
17061669|NCT00059839|38204502|FG000|Overall Study|Ineligible|1|||
17061670|NCT00059839|38204503|FG001|Overall Study|Ineligible|3|||
17061671|NCT00059215|38204513|FG000|Overall Study|Adverse Event|5|||
17061672|NCT00059215|38204514|FG001|Overall Study|Adverse Event|5|||
17061673|NCT00059215|38204515|FG002|Overall Study|Adverse Event|9|||
17061674|NCT00059215|38204516|FG003|Overall Study|Adverse Event|9|||
17061675|NCT00059215|38204513|FG000|Overall Study|Death|0|||
17061676|NCT00059215|38204514|FG001|Overall Study|Death|0|||
17061677|NCT00059215|38204515|FG002|Overall Study|Death|3|||
17061678|NCT00059215|38204516|FG003|Overall Study|Death|0|||
17061679|NCT00059215|38204513|FG000|Overall Study|Lost to Follow-up|1|||
17061680|NCT00059215|38204514|FG001|Overall Study|Lost to Follow-up|2|||
17061681|NCT00059215|38204515|FG002|Overall Study|Lost to Follow-up|0|||
17061682|NCT00059215|38204516|FG003|Overall Study|Lost to Follow-up|0|||
17061683|NCT00059215|38204513|FG000|Overall Study|Withdrawal by Subject|4|||
17061684|NCT00059215|38204514|FG001|Overall Study|Withdrawal by Subject|4|||
17061685|NCT00059215|38204515|FG002|Overall Study|Withdrawal by Subject|1|||
17061686|NCT00059215|38204516|FG003|Overall Study|Withdrawal by Subject|3|||
17061687|NCT00059215|38204513|FG000|Overall Study|Protocol Violation|1|||
17061688|NCT00059215|38204514|FG001|Overall Study|Protocol Violation|0|||
17061689|NCT00059215|38204515|FG002|Overall Study|Protocol Violation|1|||
17061690|NCT00059215|38204516|FG003|Overall Study|Protocol Violation|0|||
17061691|NCT00059215|38204513|FG000|Overall Study|Protocol entry criteria not met|1|||
17061692|NCT00059215|38204514|FG001|Overall Study|Protocol entry criteria not met|1|||
17061693|NCT00059215|38204515|FG002|Overall Study|Protocol entry criteria not met|0|||
17061694|NCT00059215|38204516|FG003|Overall Study|Protocol entry criteria not met|2|||
17061695|NCT00059215|38204513|FG000|Overall Study|Physician Decision|1|||
17061696|NCT00059215|38204514|FG001|Overall Study|Physician Decision|2|||
17061697|NCT00059215|38204515|FG002|Overall Study|Physician Decision|1|||
17061698|NCT00059215|38204516|FG003|Overall Study|Physician Decision|1|||
17061699|NCT00058825|38204527|FG000|Overall Study|Relapse|9|||
17061700|NCT00058825|38204527|FG000|Overall Study|Progressive Disease|5|||
17061701|NCT00058825|38204527|FG000|Overall Study|Graft Failure|5|||
17061702|NCT00058825|38204527|FG000|Overall Study|Death|3|||
17061703|NCT00364858|38204535|FG000|Overall Study|Adverse Event|1|||
17061704|NCT00364858|38204536|FG001|Overall Study|Adverse Event|5|||
17061705|NCT00364858|38204535|FG000|Overall Study|Withdrawal by Subject|1|||
17061706|NCT00364858|38204536|FG001|Overall Study|Withdrawal by Subject|1|||
17061707|NCT00364858|38204535|FG000|Overall Study|Pregnancy|1|||
17061708|NCT00364858|38204536|FG001|Overall Study|Pregnancy|1|||
17061709|NCT00364858|38204535|FG000|Overall Study|Clinical failure|2|||
17061710|NCT00364858|38204536|FG001|Overall Study|Clinical failure|13|||
17061711|NCT00364858|38204535|FG000|Overall Study|Discontinuation at baseline|1|||
17061712|NCT00364858|38204536|FG001|Overall Study|Discontinuation at baseline|0|||
17061713|NCT00364858|38204535|FG000|Overall Study|Non-compliant|1|||
17061714|NCT00364858|38204536|FG001|Overall Study|Non-compliant|0|||
17061715|NCT00364858|38204535|FG000|Overall Study|Return to Q2 regimen|0|||
17061716|NCT00364858|38204536|FG001|Overall Study|Return to Q2 regimen|1|||
17061717|NCT00364858|38204535|FG000|Overall Study|Clinical baseline issue|0|||
17061718|NCT00364858|38204536|FG001|Overall Study|Clinical baseline issue|1|||
17061719|NCT03803059|38204543|FG000|Overall Study|Protocol Violation|2|||
17061720|NCT03803059|38204543|FG000|Overall Study|Lost to Follow-up|1|||
17061721|NCT00372424|38204548|FG000|Overall Study|Adverse Event|2|||
17061722|NCT00372424|38204548|FG000|Overall Study|Withdrawal by Subject|1|||
17061723|NCT00372424|38204548|FG000|Overall Study|Death|1|||
17061724|NCT00372424|38204548|FG000|Overall Study|Objective Progression or Relapse|14|||
17061725|NCT00372424|38204548|FG000|Overall Study|Other|7|||
17061726|NCT00372424|38204548|FG000|Overall Study|Enrolled, Not Treated|1|||
17061727|NCT00372190|38204554|FG000|Overall Study|Lost to Follow-up|3|||
17061728|NCT00372190|38204555|FG001|Overall Study|Lost to Follow-up|1|||
17061729|NCT00044083|38204565|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
17061730|NCT00044083|38204566|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
17061731|NCT00044083|38204565|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
17061732|NCT00044083|38204566|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
17061733|NCT00044083|38204565|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
17061734|NCT00044083|38204566|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
17061735|NCT00044083|38204565|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
17061736|NCT00044083|38204566|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
17061737|NCT00044083|38204565|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
17061738|NCT00044083|38204566|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
17061739|NCT00044083|38204565|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
17061740|NCT00044083|38204566|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
17061741|NCT00044083|38204565|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
17061742|NCT00044083|38204566|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
17061743|NCT00044083|38204565|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
17061744|NCT00044083|38204566|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
17061745|NCT00044083|38204565|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
17061746|NCT00044083|38204566|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
17061747|NCT00044083|38204565|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
17061748|NCT00044083|38204566|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
17061749|NCT00058123|38204599|FG000|Overall Study|Wrong histology|9|||
17061750|NCT00058123|38204599|FG000|Overall Study|Received >3 prior treatments|1|||
17061751|NCT00022633|38204606|FG000|Overall Study|Adverse Event|11|||
17061752|NCT00022633|38204607|FG001|Overall Study|Adverse Event|1|||
17061753|NCT00022633|38204606|FG000|Overall Study|Refusal unrelated to adverse event|1|||
17061754|NCT00022633|38204607|FG001|Overall Study|Refusal unrelated to adverse event|0|||
17061755|NCT00022633|38204606|FG000|Overall Study|Progression/relapse|9|||
17061756|NCT00022633|38204607|FG001|Overall Study|Progression/relapse|2|||
17061757|NCT00022633|38204606|FG000|Overall Study|Death|4|||
17061758|NCT00022633|38204607|FG001|Overall Study|Death|0|||
17061759|NCT00022633|38204606|FG000|Overall Study|Other - not protocol specified|3|||
17061760|NCT00022633|38204607|FG001|Overall Study|Other - not protocol specified|2|||
17061761|NCT00022633|38204606|FG000|Overall Study|Ineligible|4|||
17061762|NCT00022633|38204607|FG001|Overall Study|Ineligible|0|||
17061763|NCT00021541|38204614|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
17061764|NCT00021541|38204615|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
17061765|NCT00021541|38204614|FG000|Period 1-First Treatment|Adverse Event|2|||
17061766|NCT00021541|38204615|FG001|Period 1-First Treatment|Adverse Event|1|||
17061767|NCT00021541|38204614|FG000|Period 1-First Treatment|non-adherence|3|||
17061768|NCT00021541|38204615|FG001|Period 1-First Treatment|non-adherence|0|||
17146227|NCT01064479|38290261|FG001|Overall Study|Toxicity|1|||
17146228|NCT01064479|38290260|FG000|Overall Study|Other|1|||
17146229|NCT01064479|38290261|FG001|Overall Study|Other|2|||
17146230|NCT03680911|38290269|FG000|At Home Treatment|Study Termination|3|||
17146231|NCT03680911|38290270|FG001|At Home Treatment|Study Termination|0|||
17146232|NCT03680911|38290269|FG000|At Home Treatment|Lost to Follow-up|0|||
17146233|NCT03680911|38290270|FG001|At Home Treatment|Lost to Follow-up|1|||
17146234|NCT03680911|38290269|FG000|At Home Treatment|Withdrawal by Subject|0|||
17146235|NCT03680911|38290270|FG001|At Home Treatment|Withdrawal by Subject|2|||
17146236|NCT03680911|38290269|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
17146237|NCT03680911|38290270|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
17146238|NCT03224130|38290278|FG000|Overall Study|consent issue|0|||
17146239|NCT03224130|38290279|FG001|Overall Study|consent issue|1|||
17146240|NCT03680521|38290287|FG000|Overall Study|Ongoing in long-term follow up|7|||
17146241|NCT03680521|38290288|FG001|Overall Study|Ongoing in long-term follow up|11|||
17146242|NCT03679741|38290297|FG000|Period 1|No longer meet eligibility criteria|1|||
17061769|NCT00021541|38204614|FG000|Period 1-First Treatment|Death|1|||
17061770|NCT00021541|38204615|FG001|Period 1-First Treatment|Death|0|||
17061771|NCT00021541|38204614|FG000|Period 1-First Treatment|Pts that did not progress|2|||
17061772|NCT00021541|38204615|FG001|Period 1-First Treatment|Pts that did not progress|2|||
17061773|NCT00021541|38204614|FG000|Period 1-First Treatment|Ineligible|0|||
17061774|NCT00021541|38204615|FG001|Period 1-First Treatment|Ineligible|2|||
16781193|NCT02171260|37720360|FG000|Overall Study|Physician Decision|1|||
17061775|NCT00021541|38204614|FG000|Period 2-crossover|refused phase B|2|||
17061776|NCT00021541|38204615|FG001|Period 2-crossover|refused phase B|2|||
17061777|NCT00021541|38204614|FG000|Period 2-crossover|Withdrawal by Subject|3|||
17061778|NCT00021541|38204615|FG001|Period 2-crossover|Withdrawal by Subject|4|||
17061779|NCT00021541|38204614|FG000|Period 2-crossover|Adverse Event|2|||
17061780|NCT00021541|38204615|FG001|Period 2-crossover|Adverse Event|2|||
17146243|NCT03679741|38290298|FG001|Period 1|No longer meet eligibility criteria|0|||
17146244|NCT03679741|38290297|FG000|Period 1|Lost to Follow-up|0|||
17146245|NCT03679741|38290298|FG001|Period 1|Lost to Follow-up|1|||
17146246|NCT03679741|38290297|FG000|Period 1|Adverse Event|1|||
17146247|NCT03679741|38290298|FG001|Period 1|Adverse Event|1|||
17146248|NCT03679741|38290297|FG000|Period 1|Withdrawal by Subject|0|||
17146249|NCT03679741|38290298|FG001|Period 1|Withdrawal by Subject|1|||
17146250|NCT03679741|38290297|FG000|Period 2|Adverse Event|2|||
16993723|NCT00783718|38137750|FG006|Induction Phase|Withdrawal by Subject|0|||
16993724|NCT00783718|38137744|FG000|Induction Phase|Lost to Follow-up|1|||
16993725|NCT00783718|38137745|FG001|Induction Phase|Lost to Follow-up|0|||
16993726|NCT00783718|38137746|FG002|Induction Phase|Lost to Follow-up|1|||
17061781|NCT00021541|38204614|FG000|Period 2-crossover|non-adherence|1|||
17061782|NCT00021541|38204615|FG001|Period 2-crossover|non-adherence|0|||
17061783|NCT00021541|38204614|FG000|Period 2-crossover|Pts that did not progress|2|||
17061784|NCT00021541|38204615|FG001|Period 2-crossover|Pts that did not progress|3|||
16993727|NCT00783718|38137747|FG003|Induction Phase|Lost to Follow-up|0|||
17061785|NCT00021229|38204626|FG000|Overall Study|Adverse Event|10|||
16993728|NCT00783718|38137748|FG004|Induction Phase|Lost to Follow-up|0|||
16993729|NCT00783718|38137749|FG005|Induction Phase|Lost to Follow-up|0|||
16993730|NCT00783718|38137750|FG006|Induction Phase|Lost to Follow-up|0|||
17061786|NCT00021229|38204627|FG001|Overall Study|Adverse Event|5|||
17061787|NCT00021229|38204628|FG002|Overall Study|Adverse Event|2|||
17061788|NCT00021229|38204626|FG000|Overall Study|Death|0|||
17061789|NCT00021229|38204627|FG001|Overall Study|Death|1|||
17061790|NCT00021229|38204628|FG002|Overall Study|Death|0|||
17061791|NCT00021229|38204626|FG000|Overall Study|Withdrawal by Subject|7|||
17061792|NCT00021229|38204627|FG001|Overall Study|Withdrawal by Subject|7|||
17061793|NCT00021229|38204628|FG002|Overall Study|Withdrawal by Subject|1|||
17061794|NCT00021229|38204626|FG000|Overall Study|Progressive Disease|15|||
17061795|NCT00021229|38204627|FG001|Overall Study|Progressive Disease|19|||
17061796|NCT00021229|38204628|FG002|Overall Study|Progressive Disease|12|||
17061797|NCT00021229|38204626|FG000|Overall Study|Protocol Violation|1|||
17061798|NCT00021229|38204627|FG001|Overall Study|Protocol Violation|1|||
17061799|NCT00021229|38204628|FG002|Overall Study|Protocol Violation|0|||
17061800|NCT00021229|38204626|FG000|Overall Study|Physician Decision|0|||
17061801|NCT00021229|38204627|FG001|Overall Study|Physician Decision|0|||
17061802|NCT00021229|38204628|FG002|Overall Study|Physician Decision|1|||
17061803|NCT00021229|38204626|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
17061804|NCT00021229|38204627|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
17061805|NCT00021229|38204628|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
17061806|NCT00372112|38204642|FG000|Overall Study|Adverse Event|0|||
17061807|NCT00372112|38204643|FG001|Overall Study|Adverse Event|1|||
17061808|NCT00372112|38204644|FG002|Overall Study|Adverse Event|1|||
17061809|NCT00372112|38204645|FG003|Overall Study|Adverse Event|1|||
17061810|NCT00372112|38204642|FG000|Overall Study|Withdrawal by Subject|0|||
17061811|NCT00372112|38204643|FG001|Overall Study|Withdrawal by Subject|0|||
17061812|NCT00372112|38204644|FG002|Overall Study|Withdrawal by Subject|2|||
17061813|NCT00372112|38204645|FG003|Overall Study|Withdrawal by Subject|1|||
17061814|NCT00372112|38204642|FG000|Overall Study|Exacerbation|0|||
17061815|NCT00372112|38204643|FG001|Overall Study|Exacerbation|0|||
17061816|NCT00372112|38204644|FG002|Overall Study|Exacerbation|0|||
17061817|NCT00372112|38204645|FG003|Overall Study|Exacerbation|1|||
17061818|NCT00372112|38204642|FG000|Overall Study|PR >240 at Visit 3|0|||
17061819|NCT00372112|38204643|FG001|Overall Study|PR >240 at Visit 3|0|||
17061820|NCT00372112|38204644|FG002|Overall Study|PR >240 at Visit 3|0|||
17061821|NCT00372112|38204645|FG003|Overall Study|PR >240 at Visit 3|1|||
17061822|NCT00372112|38204642|FG000|Overall Study|Hepatitis B|1|||
17061823|NCT00372112|38204643|FG001|Overall Study|Hepatitis B|0|||
17061824|NCT00372112|38204644|FG002|Overall Study|Hepatitis B|0|||
17061825|NCT00372112|38204645|FG003|Overall Study|Hepatitis B|0|||
17061826|NCT00372112|38204642|FG000|Overall Study|Other-protocol violation|0|||
17061827|NCT00372112|38204643|FG001|Overall Study|Other-protocol violation|0|||
17061828|NCT00372112|38204644|FG002|Overall Study|Other-protocol violation|1|||
17061829|NCT00372112|38204645|FG003|Overall Study|Other-protocol violation|0|||
17146251|NCT03679741|38290298|FG001|Period 2|Adverse Event|1|||
17146252|NCT03679741|38290297|FG000|Period 2|Withdrawal by Subject|1|||
17146253|NCT03679741|38290298|FG001|Period 2|Withdrawal by Subject|1|||
17146254|NCT03678103|38290304|FG000|Overall Study|Withdrawn prior to completion|4|||
17061830|NCT00488475|38204658|FG000|Overall Study|Other|1754|||
17061831|NCT00042991|38204669|FG000|Overall Study|Adverse Event|1|||
17061832|NCT00042991|38204670|FG001|Overall Study|Adverse Event|4|||
17061833|NCT00042991|38204671|FG002|Overall Study|Adverse Event|2|||
17061834|NCT00042991|38204672|FG003|Overall Study|Adverse Event|0|||
17146255|NCT03649477|38290311|FG000|Overall Study|Adverse Event|2|||
17061835|NCT00042991|38204673|FG004|Overall Study|Adverse Event|0|||
17061836|NCT00042991|38204674|FG005|Overall Study|Adverse Event|1|||
17061837|NCT00042991|38204675|FG006|Overall Study|Adverse Event|0|||
17061838|NCT00042991|38204669|FG000|Overall Study|Withdrawal by Subject|0|||
17061839|NCT00042991|38204670|FG001|Overall Study|Withdrawal by Subject|7|||
17061840|NCT00042991|38204671|FG002|Overall Study|Withdrawal by Subject|2|||
17061841|NCT00042991|38204672|FG003|Overall Study|Withdrawal by Subject|0|||
17061842|NCT00042991|38204673|FG004|Overall Study|Withdrawal by Subject|1|||
17061843|NCT00042991|38204674|FG005|Overall Study|Withdrawal by Subject|0|||
17061844|NCT00042991|38204675|FG006|Overall Study|Withdrawal by Subject|0|||
17061845|NCT00042991|38204669|FG000|Overall Study|Disease Progression|5|||
17061846|NCT00042991|38204670|FG001|Overall Study|Disease Progression|29|||
17061847|NCT00042991|38204671|FG002|Overall Study|Disease Progression|2|||
17061848|NCT00042991|38204672|FG003|Overall Study|Disease Progression|2|||
17061849|NCT00042991|38204673|FG004|Overall Study|Disease Progression|1|||
17061850|NCT00042991|38204674|FG005|Overall Study|Disease Progression|4|||
17061851|NCT00042991|38204675|FG006|Overall Study|Disease Progression|2|||
17061852|NCT00042991|38204669|FG000|Overall Study|Alternative Therapy|0|||
17061853|NCT00042991|38204670|FG001|Overall Study|Alternative Therapy|0|||
17061854|NCT00042991|38204671|FG002|Overall Study|Alternative Therapy|0|||
17061855|NCT00042991|38204672|FG003|Overall Study|Alternative Therapy|0|||
17061856|NCT00042991|38204673|FG004|Overall Study|Alternative Therapy|1|||
17061857|NCT00042991|38204674|FG005|Overall Study|Alternative Therapy|0|||
17061858|NCT00042991|38204675|FG006|Overall Study|Alternative Therapy|0|||
17061859|NCT00466167|38204696|FG000|Overall Study|Adverse Event|8|||
17061860|NCT00466167|38204697|FG001|Overall Study|Adverse Event|8|||
17061861|NCT00466167|38204698|FG002|Overall Study|Adverse Event|7|||
17061862|NCT00466167|38204696|FG000|Overall Study|Lack of Efficacy|2|||
17061863|NCT00466167|38204697|FG001|Overall Study|Lack of Efficacy|0|||
17061864|NCT00466167|38204698|FG002|Overall Study|Lack of Efficacy|3|||
17061865|NCT00466167|38204696|FG000|Overall Study|Protocol Violation|1|||
17061866|NCT00466167|38204697|FG001|Overall Study|Protocol Violation|1|||
17061867|NCT00466167|38204698|FG002|Overall Study|Protocol Violation|2|||
17061868|NCT00466167|38204696|FG000|Overall Study|Lost to Follow-up|3|||
17061869|NCT00466167|38204697|FG001|Overall Study|Lost to Follow-up|2|||
17061870|NCT00466167|38204698|FG002|Overall Study|Lost to Follow-up|2|||
17061871|NCT00466167|38204696|FG000|Overall Study|Withdrawal by Subject|4|||
17061872|NCT00466167|38204697|FG001|Overall Study|Withdrawal by Subject|1|||
17061873|NCT00466167|38204698|FG002|Overall Study|Withdrawal by Subject|6|||
17061874|NCT00466167|38204696|FG000|Overall Study|patient did not meet inclusion criteria|1|||
17061875|NCT00466167|38204697|FG001|Overall Study|patient did not meet inclusion criteria|0|||
17061876|NCT00466167|38204698|FG002|Overall Study|patient did not meet inclusion criteria|1|||
17061877|NCT00466167|38204696|FG000|Overall Study|Not treated|1|||
17061878|NCT00466167|38204697|FG001|Overall Study|Not treated|0|||
17061879|NCT00466167|38204698|FG002|Overall Study|Not treated|0|||
17061880|NCT00480441|38204708|FG000|Screening|Not Eligible|37|||
17061881|NCT00480441|38204709|FG001|Screening|Not Eligible|0|||
17061882|NCT00480441|38204710|FG002|Screening|Not Eligible|0|||
17061883|NCT00480441|38204708|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
17146256|NCT03649477|38290312|FG001|Overall Study|Adverse Event|0|||
17146257|NCT03649477|38290313|FG002|Overall Study|Adverse Event|0|||
17146258|NCT03677869|38290321|FG000|Overall Study|Withdrawal by Subject|1|||
17061884|NCT00480441|38204709|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
17061885|NCT00480441|38204710|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
17061886|NCT00480441|38204708|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
17061887|NCT00480441|38204709|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
17061888|NCT00480441|38204710|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
17061889|NCT00480441|38204708|FG000|Baseline Functional MRI|physical contraindication|4|||
17061890|NCT00480441|38204709|FG001|Baseline Functional MRI|physical contraindication|0|||
17061891|NCT00480441|38204710|FG002|Baseline Functional MRI|physical contraindication|0|||
17061892|NCT00480441|38204708|FG000|Randomization|Lost to Follow-up|0|||
17061893|NCT00480441|38204709|FG001|Randomization|Lost to Follow-up|7|||
17061894|NCT00480441|38204710|FG002|Randomization|Lost to Follow-up|2|||
17061895|NCT00488319|38204720|FG000|Overall Study|Adverse Event|1|||
17061896|NCT00488319|38204721|FG001|Overall Study|Adverse Event|2|||
17061897|NCT00488319|38204722|FG002|Overall Study|Adverse Event|23|||
17061898|NCT00488319|38204720|FG000|Overall Study|Lack of Efficacy|6|||
17061899|NCT00488319|38204721|FG001|Overall Study|Lack of Efficacy|12|||
17061900|NCT00488319|38204722|FG002|Overall Study|Lack of Efficacy|27|||
17061901|NCT00488319|38204720|FG000|Overall Study|Lost to Follow-up|3|||
17061902|NCT00488319|38204721|FG001|Overall Study|Lost to Follow-up|5|||
17061903|NCT00488319|38204722|FG002|Overall Study|Lost to Follow-up|16|||
17061904|NCT00488319|38204720|FG000|Overall Study|Withdrawal by Subject|5|||
17061905|NCT00488319|38204721|FG001|Overall Study|Withdrawal by Subject|20|||
17061906|NCT00488319|38204722|FG002|Overall Study|Withdrawal by Subject|44|||
17061907|NCT00488319|38204720|FG000|Overall Study|Other reasons for withdrawal|0|||
17061908|NCT00488319|38204721|FG001|Overall Study|Other reasons for withdrawal|4|||
17061909|NCT00488319|38204722|FG002|Overall Study|Other reasons for withdrawal|12|||
17061910|NCT00463047|38204731|FG000|Titration Period 1|Adverse Event|10|||
17061911|NCT00463047|38204732|FG001|Titration Period 1|Adverse Event|8|||
17061912|NCT00463047|38204731|FG000|Titration Period 1|Lack of Efficacy|10|||
17061913|NCT00463047|38204732|FG001|Titration Period 1|Lack of Efficacy|4|||
17061914|NCT00463047|38204731|FG000|Titration Period 1|Lost to Follow-up|2|||
17061915|NCT00463047|38204732|FG001|Titration Period 1|Lost to Follow-up|0|||
17061916|NCT00463047|38204731|FG000|Titration Period 1|Non-compliance with study medication|3|||
17061917|NCT00463047|38204732|FG001|Titration Period 1|Non-compliance with study medication|5|||
17061918|NCT00463047|38204731|FG000|Titration Period 1|Protocol Violation|5|||
17146259|NCT03677401|38290327|FG000|Overall Study|Adverse Event|4|||
17146260|NCT03677401|38290328|FG001|Overall Study|Adverse Event|14|||
17061919|NCT00463047|38204732|FG001|Titration Period 1|Protocol Violation|5|||
17061920|NCT00463047|38204731|FG000|Titration Period 1|Withdrawal by Subject|3|||
17061921|NCT00463047|38204732|FG001|Titration Period 1|Withdrawal by Subject|5|||
17061922|NCT00463047|38204731|FG000|Titration Period 1|Non-compliance procedures|4|||
17061923|NCT00463047|38204732|FG001|Titration Period 1|Non-compliance procedures|10|||
17146261|NCT03677401|38290327|FG000|Overall Study|Lack of Efficacy|3|||
17146262|NCT03677401|38290328|FG001|Overall Study|Lack of Efficacy|1|||
17146263|NCT03677401|38290327|FG000|Overall Study|Withdrawal by Subject|2|||
17146264|NCT03677401|38290328|FG001|Overall Study|Withdrawal by Subject|2|||
16993731|NCT00783718|38137744|FG000|Maintenance Phase|Adverse Event|12|||
17061924|NCT00463047|38204731|FG000|Titration Period 1|Other|0|||
17061925|NCT00463047|38204732|FG001|Titration Period 1|Other|2|||
17061926|NCT00463047|38204731|FG000|Titration Period 2|Adverse Event|9|||
17061927|NCT00463047|38204732|FG001|Titration Period 2|Adverse Event|9|||
17061928|NCT00463047|38204731|FG000|Titration Period 2|Lack of Efficacy|6|||
17061929|NCT00463047|38204732|FG001|Titration Period 2|Lack of Efficacy|4|||
17061930|NCT00463047|38204731|FG000|Titration Period 2|Withdrawal by Subject|1|||
17061931|NCT00463047|38204732|FG001|Titration Period 2|Withdrawal by Subject|0|||
17061932|NCT00463047|38204731|FG000|Titration Period 2|Protocol Violation|2|||
17061933|NCT00463047|38204732|FG001|Titration Period 2|Protocol Violation|3|||
17061934|NCT00463047|38204731|FG000|Titration Period 2|Lost to Follow-up|1|||
17061935|NCT00463047|38204732|FG001|Titration Period 2|Lost to Follow-up|2|||
17061936|NCT00463047|38204731|FG000|Titration Period 2|Non-compliance study medication|4|||
17061937|NCT00463047|38204732|FG001|Titration Period 2|Non-compliance study medication|2|||
17061938|NCT00463047|38204731|FG000|Titration Period 2|Non-compliance procedures|4|||
17061939|NCT00463047|38204732|FG001|Titration Period 2|Non-compliance procedures|1|||
17061940|NCT00463047|38204731|FG000|Titration Period 2|Other|3|||
17061941|NCT00463047|38204732|FG001|Titration Period 2|Other|2|||
17061942|NCT00463047|38204731|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
17061943|NCT00463047|38204732|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
17061944|NCT00463047|38204731|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
17061945|NCT00463047|38204732|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
17061946|NCT00463047|38204731|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
17061947|NCT00463047|38204732|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
17061948|NCT00463047|38204731|FG000|Double-Blind Treatment Period 1|Other|1|||
17061949|NCT00463047|38204732|FG001|Double-Blind Treatment Period 1|Other|0|||
17061950|NCT00463047|38204731|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
17061951|NCT00463047|38204732|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
17061952|NCT00463047|38204731|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
17061953|NCT00463047|38204732|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
17061954|NCT00463047|38204731|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
17061955|NCT00463047|38204732|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
17061956|NCT00487695|38204739|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
16993732|NCT00783718|38137745|FG001|Maintenance Phase|Adverse Event|0|||
16993733|NCT00783718|38137746|FG002|Maintenance Phase|Adverse Event|0|||
16993734|NCT00783718|38137747|FG003|Maintenance Phase|Adverse Event|15|||
16993735|NCT00783718|38137748|FG004|Maintenance Phase|Adverse Event|7|||
17061957|NCT00487695|38204740|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
17061958|NCT00487695|38204739|FG000|First Procedure|active wheezing (did not have procedure)|1|||
17061959|NCT00487695|38204740|FG001|First Procedure|active wheezing (did not have procedure)|0|||
17061960|NCT00487695|38204739|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
17061961|NCT00487695|38204740|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
17061962|NCT00487695|38204739|FG000|Second Procedure|active wheezing|0|||
17061963|NCT00487695|38204740|FG001|Second Procedure|active wheezing|1|||
17061964|NCT00487695|38204739|FG000|Second Procedure|Withdrawal by Subject|1|||
17061965|NCT00487695|38204740|FG001|Second Procedure|Withdrawal by Subject|2|||
16993736|NCT00783718|38137749|FG005|Maintenance Phase|Adverse Event|6|||
16993737|NCT00783718|38137750|FG006|Maintenance Phase|Adverse Event|16|||
16993738|NCT00783718|38137744|FG000|Maintenance Phase|Protocol Violation|1|||
17061966|NCT00487539|38204750|FG000|Overall Study|Adverse Event|3|||
17061967|NCT00487539|38204751|FG001|Overall Study|Adverse Event|2|||
17061968|NCT00487539|38204752|FG002|Overall Study|Adverse Event|1|||
17146265|NCT03677401|38290327|FG000|Overall Study|Sponsor decision|0|||
17061969|NCT00487539|38204753|FG003|Overall Study|Adverse Event|1|||
17061970|NCT00487539|38204750|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17061971|NCT00487539|38204751|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17061972|NCT00487539|38204752|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
17061973|NCT00487539|38204753|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
17061974|NCT00487539|38204750|FG000|Overall Study|Other|3|||
17061975|NCT00487539|38204751|FG001|Overall Study|Other|1|||
17061976|NCT00487539|38204752|FG002|Overall Study|Other|2|||
17061977|NCT00487539|38204753|FG003|Overall Study|Other|2|||
17061978|NCT00486837|38204764|FG000|Overall Study|Withdrawal by Subject|1|||
17061979|NCT00486837|38204765|FG001|Overall Study|Withdrawal by Subject|0|||
17061980|NCT00486837|38204764|FG000|Overall Study|Adverse Event|1|||
17061981|NCT00486837|38204765|FG001|Overall Study|Adverse Event|1|||
17061982|NCT00486837|38204764|FG000|Overall Study|Protocol Violation|4|||
17061983|NCT00486837|38204765|FG001|Overall Study|Protocol Violation|2|||
17061984|NCT00486837|38204764|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
17061985|NCT00486837|38204765|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
17061986|NCT00486759|38204775|FG000|Treatment|Adverse event/intercurrent illness|86|||
17061987|NCT00486759|38204776|FG001|Treatment|Adverse event/intercurrent illness|39|||
17061988|NCT00486759|38204775|FG000|Treatment|Insufficient therapeutic response|37|||
17061989|NCT00486759|38204776|FG001|Treatment|Insufficient therapeutic response|39|||
16781194|NCT02171260|37720361|FG001|Overall Study|Physician Decision|0|||
17061990|NCT00486759|38204775|FG000|Treatment|Death|17|||
17061991|NCT00486759|38204776|FG001|Treatment|Death|10|||
17061992|NCT00486759|38204775|FG000|Treatment|Withdrew consent|15|||
17061993|NCT00486759|38204776|FG001|Treatment|Withdrew consent|12|||
17146266|NCT03677401|38290328|FG001|Overall Study|Sponsor decision|1|||
17146267|NCT03677401|38290327|FG000|Overall Study|Reason Unspecified|1|||
17146268|NCT03677401|38290328|FG001|Overall Study|Reason Unspecified|0|||
17146269|NCT03218787|38290334|FG000|Overall Study|Lost to Follow-up|12|||
17146270|NCT03218787|38290334|FG000|Overall Study|Withdrawal by Subject|72|||
17061994|NCT00486759|38204775|FG000|Treatment|Administrative/reason not specified|17|||
17061995|NCT00486759|38204776|FG001|Treatment|Administrative/reason not specified|21|||
17061996|NCT00486759|38204775|FG000|Treatment|Refused treatment|10|||
17061997|NCT00486759|38204776|FG001|Treatment|Refused treatment|7|||
17061998|NCT00486759|38204775|FG000|Treatment|Violation of selection criteria at entry|3|||
17061999|NCT00486759|38204776|FG001|Treatment|Violation of selection criteria at entry|3|||
17062000|NCT00486759|38204775|FG000|Treatment|Other protocol violation|1|||
17062001|NCT00486759|38204776|FG001|Treatment|Other protocol violation|5|||
17062002|NCT00486759|38204775|FG000|Treatment|Failure to return|1|||
17062003|NCT00486759|38204776|FG001|Treatment|Failure to return|1|||
17062004|NCT00486759|38204775|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
17062005|NCT00486759|38204776|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
17062006|NCT00486759|38204775|FG000|Safety Follow-up|Death|40|||
17062007|NCT00486759|38204776|FG001|Safety Follow-up|Death|29|||
17062008|NCT00486759|38204775|FG000|Safety Follow-up|Withdrew consent|32|||
17062009|NCT00486759|38204776|FG001|Safety Follow-up|Withdrew consent|23|||
17062010|NCT00486759|38204775|FG000|Safety Follow-up|Failure to return|9|||
17062011|NCT00486759|38204776|FG001|Safety Follow-up|Failure to return|6|||
17062012|NCT00486759|38204775|FG000|Safety Follow-up|Administrative/not specified|8|||
17062013|NCT00486759|38204776|FG001|Safety Follow-up|Administrative/not specified|6|||
17062014|NCT00486759|38204775|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
17062015|NCT00486759|38204776|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
17062016|NCT00486759|38204775|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
17062017|NCT00486759|38204776|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
17062018|NCT00486603|38204784|FG000|Overall Study|Withdrawal by Subject|1|||
17062019|NCT00486603|38204785|FG001|Overall Study|Withdrawal by Subject|0|||
17062020|NCT00486603|38204786|FG002|Overall Study|Withdrawal by Subject|0|||
17062021|NCT00486603|38204787|FG003|Overall Study|Withdrawal by Subject|0|||
17062022|NCT00486603|38204788|FG004|Overall Study|Withdrawal by Subject|0|||
17062023|NCT00486603|38204784|FG000|Overall Study|Physician Decision|0|||
17062024|NCT00486603|38204785|FG001|Overall Study|Physician Decision|1|||
17062025|NCT00486603|38204786|FG002|Overall Study|Physician Decision|0|||
17062026|NCT00486603|38204787|FG003|Overall Study|Physician Decision|0|||
17062027|NCT00486603|38204788|FG004|Overall Study|Physician Decision|0|||
17062028|NCT00486291|38204805|FG000|Overall Study|Adverse Event|3|||
17062029|NCT00486291|38204806|FG001|Overall Study|Adverse Event|4|||
17146271|NCT03218787|38290334|FG000|Overall Study|Physician Decision|11|||
17062030|NCT00486291|38204805|FG000|Overall Study|Lost to Follow-up|3|||
17062031|NCT00486291|38204806|FG001|Overall Study|Lost to Follow-up|7|||
17062032|NCT00486291|38204805|FG000|Overall Study|protocol non-compliance|10|||
17062033|NCT00486291|38204806|FG001|Overall Study|protocol non-compliance|15|||
17062034|NCT00486291|38204805|FG000|Overall Study|requirement for restricted medication|0|||
17062035|NCT00486291|38204806|FG001|Overall Study|requirement for restricted medication|3|||
17062036|NCT00474045|38204814|FG000|Overall Study|Adverse Event|18|||
17062037|NCT00474045|38204815|FG001|Overall Study|Adverse Event|8|||
17062038|NCT00474045|38204814|FG000|Overall Study|Unclassified|1|||
17062039|NCT00474045|38204815|FG001|Overall Study|Unclassified|3|||
17062040|NCT00474045|38204814|FG000|Overall Study|Lack of Efficacy|0|||
17062041|NCT00474045|38204815|FG001|Overall Study|Lack of Efficacy|9|||
17062042|NCT00474045|38204814|FG000|Overall Study|Lost to Follow-up|1|||
17062043|NCT00474045|38204815|FG001|Overall Study|Lost to Follow-up|1|||
17062044|NCT00474045|38204814|FG000|Overall Study|Protocol Violation|10|||
17062045|NCT00474045|38204815|FG001|Overall Study|Protocol Violation|12|||
17062046|NCT00474045|38204814|FG000|Overall Study|Withdrawal by Subject|16|||
17062047|NCT00474045|38204815|FG001|Overall Study|Withdrawal by Subject|18|||
17062048|NCT00474045|38204814|FG000|Overall Study|Withdrawal criteria|60|||
17062049|NCT00474045|38204815|FG001|Overall Study|Withdrawal criteria|50|||
17062050|NCT00462501|38204821|FG000|Overall Study|Not treated|3|||
17146272|NCT03218787|38290334|FG000|Overall Study|Death|111|||
17146273|NCT01348087|38290338|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
17146274|NCT01348087|38290338|FG000|Overall Study|Administrative problems|79|||
17146275|NCT01348087|38290338|FG000|Overall Study|protocol deviation|1|||
17062051|NCT00462501|38204821|FG000|Overall Study|Adverse Event|2|||
17062052|NCT00383188|38204830|FG000|Overall Study|Adverse Event|4|||
17062053|NCT00383188|38204831|FG001|Overall Study|Adverse Event|7|||
17062054|NCT00383188|38204832|FG002|Overall Study|Adverse Event|9|||
17062055|NCT00383188|38204833|FG003|Overall Study|Adverse Event|8|||
17062056|NCT00383188|38204834|FG004|Overall Study|Adverse Event|8|||
17062057|NCT00383188|38204830|FG000|Overall Study|Lack of Efficacy|9|||
17062058|NCT00383188|38204831|FG001|Overall Study|Lack of Efficacy|3|||
17062059|NCT00383188|38204832|FG002|Overall Study|Lack of Efficacy|3|||
17062060|NCT00383188|38204833|FG003|Overall Study|Lack of Efficacy|2|||
17062061|NCT00383188|38204834|FG004|Overall Study|Lack of Efficacy|6|||
17062062|NCT00383188|38204830|FG000|Overall Study|Other|3|||
17062063|NCT00383188|38204831|FG001|Overall Study|Other|1|||
17062064|NCT00383188|38204832|FG002|Overall Study|Other|0|||
17062065|NCT00383188|38204833|FG003|Overall Study|Other|2|||
17062066|NCT00383188|38204834|FG004|Overall Study|Other|6|||
17062067|NCT00383188|38204830|FG000|Overall Study|No longer willing to participate|1|||
17062068|NCT00383188|38204831|FG001|Overall Study|No longer willing to participate|0|||
17062069|NCT00383188|38204832|FG002|Overall Study|No longer willing to participate|1|||
17062070|NCT00383188|38204833|FG003|Overall Study|No longer willing to participate|0|||
17062071|NCT00383188|38204834|FG004|Overall Study|No longer willing to participate|2|||
17062072|NCT00383188|38204830|FG000|Overall Study|Lost to Follow-up|0|||
17062073|NCT00383188|38204831|FG001|Overall Study|Lost to Follow-up|0|||
17062074|NCT00383188|38204832|FG002|Overall Study|Lost to Follow-up|0|||
17062075|NCT00383188|38204833|FG003|Overall Study|Lost to Follow-up|0|||
17062076|NCT00383188|38204834|FG004|Overall Study|Lost to Follow-up|1|||
17062077|NCT00462345|38204848|FG000|Overall Study|Withdrawal by Subject|2|||
17062078|NCT00462345|38204848|FG000|Overall Study|Did not complete second course|1|||
17062079|NCT00453999|38204855|FG000|Overall Study|Adverse Event|1|||
17062080|NCT00453999|38204856|FG001|Overall Study|Adverse Event|2|||
17062081|NCT00453999|38204857|FG002|Overall Study|Adverse Event|1|||
17062082|NCT00453999|38204855|FG000|Overall Study|Lost to Follow-up|0|||
17062083|NCT00453999|38204856|FG001|Overall Study|Lost to Follow-up|1|||
17062084|NCT00453999|38204857|FG002|Overall Study|Lost to Follow-up|1|||
17062085|NCT00453999|38204855|FG000|Overall Study|Withdrawal by Subject|2|||
17062086|NCT00453999|38204856|FG001|Overall Study|Withdrawal by Subject|1|||
17062087|NCT00453999|38204857|FG002|Overall Study|Withdrawal by Subject|1|||
17062088|NCT00453999|38204855|FG000|Overall Study|Subject Request|2|||
17062089|NCT00453999|38204856|FG001|Overall Study|Subject Request|1|||
17062090|NCT00453999|38204857|FG002|Overall Study|Subject Request|0|||
17146276|NCT01348087|38290338|FG000|Overall Study|Lost to Follow-up|1|||
17146277|NCT01348087|38290338|FG000|Overall Study|Subject withdrew consent|7|||
17146278|NCT01348087|38290338|FG000|Overall Study|Adverse Event|25|||
17062091|NCT00453921|38204870|FG000|Overall Study|Withdrawal by Subject|1|||
17062092|NCT00453921|38204871|FG001|Overall Study|Withdrawal by Subject|1|||
17062093|NCT00453921|38204872|FG002|Overall Study|Withdrawal by Subject|1|||
17062094|NCT00453921|38204873|FG003|Overall Study|Withdrawal by Subject|1|||
17062095|NCT00453921|38204870|FG000|Overall Study|Lost to Follow-up|0|||
17062096|NCT00453921|38204871|FG001|Overall Study|Lost to Follow-up|0|||
17062097|NCT00453921|38204872|FG002|Overall Study|Lost to Follow-up|1|||
17062098|NCT00453921|38204873|FG003|Overall Study|Lost to Follow-up|0|||
17062099|NCT00382720|38204890|FG000|Overall Study|Adverse Event|21|||
17062100|NCT00382720|38204891|FG001|Overall Study|Adverse Event|23|||
17062101|NCT00382720|38204892|FG002|Overall Study|Adverse Event|15|||
17062102|NCT00382720|38204890|FG000|Overall Study|Protocol Violation|2|||
17062103|NCT00382720|38204891|FG001|Overall Study|Protocol Violation|5|||
17062104|NCT00382720|38204892|FG002|Overall Study|Protocol Violation|1|||
17062105|NCT00382720|38204890|FG000|Overall Study|Death|0|||
17062106|NCT00382720|38204891|FG001|Overall Study|Death|1|||
17062107|NCT00382720|38204892|FG002|Overall Study|Death|2|||
17062108|NCT00382720|38204890|FG000|Overall Study|Progressive disease|37|||
17062109|NCT00382720|38204891|FG001|Overall Study|Progressive disease|28|||
17062110|NCT00382720|38204892|FG002|Overall Study|Progressive disease|38|||
17062111|NCT00382720|38204890|FG000|Overall Study|Withdrew consent|1|||
17062112|NCT00382720|38204891|FG001|Overall Study|Withdrew consent|1|||
17062113|NCT00382720|38204892|FG002|Overall Study|Withdrew consent|2|||
17062114|NCT00382720|38204890|FG000|Overall Study|Withdrawal by Subject|11|||
17062115|NCT00382720|38204891|FG001|Overall Study|Withdrawal by Subject|20|||
17062116|NCT00382720|38204892|FG002|Overall Study|Withdrawal by Subject|12|||
17062117|NCT00382720|38204890|FG000|Overall Study|Surgery|1|||
17062118|NCT00382720|38204891|FG001|Overall Study|Surgery|1|||
17062119|NCT00382720|38204892|FG002|Overall Study|Surgery|4|||
17062120|NCT00382720|38204890|FG000|Overall Study|Patient did not receive study medication|1|||
17062121|NCT00382720|38204891|FG001|Overall Study|Patient did not receive study medication|1|||
17062122|NCT00382720|38204892|FG002|Overall Study|Patient did not receive study medication|4|||
17062123|NCT00382720|38204890|FG000|Overall Study|Clinically progressive disease|0|||
17062124|NCT00382720|38204891|FG001|Overall Study|Clinically progressive disease|1|||
17062125|NCT00382720|38204892|FG002|Overall Study|Clinically progressive disease|0|||
17062126|NCT00382720|38204890|FG000|Overall Study|Good prognosis|0|||
17062127|NCT00382720|38204891|FG001|Overall Study|Good prognosis|1|||
17062128|NCT00382720|38204892|FG002|Overall Study|Good prognosis|0|||
17062129|NCT00382720|38204890|FG000|Overall Study|Investigator/Clinical decision|5|||
17062130|NCT00382720|38204891|FG001|Overall Study|Investigator/Clinical decision|6|||
17062131|NCT00382720|38204892|FG002|Overall Study|Investigator/Clinical decision|6|||
17062132|NCT00382720|38204890|FG000|Overall Study|Discontinued at end of study|0|||
17062133|NCT00382720|38204891|FG001|Overall Study|Discontinued at end of study|1|||
17062134|NCT00382720|38204892|FG002|Overall Study|Discontinued at end of study|2|||
17062135|NCT00453063|38204902|FG000|Overall Study|Adverse Event|1|||
17062136|NCT00453063|38204903|FG001|Overall Study|Adverse Event|2|||
17062137|NCT00453063|38204902|FG000|Overall Study|Withdrawal by Subject|1|||
17062138|NCT00453063|38204903|FG001|Overall Study|Withdrawal by Subject|1|||
17062139|NCT00453063|38204902|FG000|Overall Study|Protocol Violation|1|||
17062140|NCT00453063|38204903|FG001|Overall Study|Protocol Violation|0|||
17062141|NCT00371566|38204911|FG000|Treatment Phase|Withdrawal by Subject|0|||
17062142|NCT00371566|38204912|FG001|Treatment Phase|Withdrawal by Subject|1|||
17062143|NCT00371566|38204911|FG000|Treatment Phase|Adverse Event|0|||
17062144|NCT00371566|38204912|FG001|Treatment Phase|Adverse Event|1|||
17062145|NCT00371566|38204911|FG000|Treatment Phase|Protocol Violation|0|||
17062146|NCT00371566|38204912|FG001|Treatment Phase|Protocol Violation|1|||
17062147|NCT00371566|38204911|FG000|Chemoradiation Phase|Physician Decision|2|||
17062148|NCT00371566|38204912|FG001|Chemoradiation Phase|Physician Decision|0|||
17062149|NCT00371566|38204911|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
17062150|NCT00371566|38204912|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
17062151|NCT00371566|38204911|FG000|Chemoradiation Phase|Non compliant|0|||
17062152|NCT00371566|38204912|FG001|Chemoradiation Phase|Non compliant|1|||
17062153|NCT00371566|38204911|FG000|Chemoradiation Phase|Progressive Disease|1|||
17062154|NCT00371566|38204912|FG001|Chemoradiation Phase|Progressive Disease|1|||
17062155|NCT00371566|38204911|FG000|Chemoradiation Phase|Death|2|||
17062156|NCT00371566|38204912|FG001|Chemoradiation Phase|Death|0|||
17062157|NCT00371566|38204911|FG000|Follow Up Phase|Death|0|||
17062158|NCT00371566|38204912|FG001|Follow Up Phase|Death|5|||
17062159|NCT00371566|38204911|FG000|Follow Up Phase|Disease progression|1|||
17062160|NCT00371566|38204912|FG001|Follow Up Phase|Disease progression|0|||
17062161|NCT00371566|38204911|FG000|Follow Up Phase|Withdrawal by Subject|0|||
17062162|NCT00371566|38204912|FG001|Follow Up Phase|Withdrawal by Subject|1|||
17062163|NCT00371566|38204911|FG000|Follow Up Phase|Physician Decision|1|||
17062164|NCT00371566|38204912|FG001|Follow Up Phase|Physician Decision|1|||
17062165|NCT00371566|38204911|FG000|Follow Up Phase|Lost to Follow-up|1|||
17062166|NCT00371566|38204912|FG001|Follow Up Phase|Lost to Follow-up|0|||
17062167|NCT00382408|38204920|FG000|Overall Study|Did not meet protocol requirement|3|||
17062168|NCT00382408|38204921|FG001|Overall Study|Did not meet protocol requirement|3|||
17146279|NCT01347931|38290352|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
17146280|NCT03645421|38290362|FG000|Overall Study|Adverse Event|0|||
17146281|NCT03645421|38290363|FG001|Overall Study|Adverse Event|0|||
17146282|NCT03645421|38290364|FG002|Overall Study|Adverse Event|4|||
17146283|NCT03645421|38290365|FG003|Overall Study|Adverse Event|1|||
17146284|NCT03645421|38290362|FG000|Overall Study|Withdrawal by patient|0|||
17146285|NCT03645421|38290363|FG001|Overall Study|Withdrawal by patient|0|||
17146286|NCT03645421|38290364|FG002|Overall Study|Withdrawal by patient|0|||
17146287|NCT03645421|38290365|FG003|Overall Study|Withdrawal by patient|3|||
17146288|NCT03645421|38290362|FG000|Overall Study|Study specific withdrawal criteria|0|||
17062169|NCT00382408|38204920|FG000|Overall Study|Protocol Violation|2|||
17062170|NCT00382408|38204921|FG001|Overall Study|Protocol Violation|2|||
17062171|NCT00382408|38204920|FG000|Overall Study|Physician Decision|1|||
17062172|NCT00382408|38204921|FG001|Overall Study|Physician Decision|0|||
17062173|NCT00382408|38204920|FG000|Overall Study|Withdrawal by Subject|17|||
17062174|NCT00382408|38204921|FG001|Overall Study|Withdrawal by Subject|6|||
17062175|NCT00382408|38204920|FG000|Overall Study|Pregnancy|2|||
17062176|NCT00382408|38204921|FG001|Overall Study|Pregnancy|0|||
17062177|NCT00382408|38204920|FG000|Overall Study|Lost to Follow-up|19|||
17062178|NCT00382408|38204921|FG001|Overall Study|Lost to Follow-up|8|||
17062179|NCT00382408|38204920|FG000|Overall Study|Other|100|||
17062180|NCT00382408|38204921|FG001|Overall Study|Other|35|||
17062181|NCT00371254|38204929|FG000|Overall Study|Disease progression|13|||
17062182|NCT00371254|38204930|FG001|Overall Study|Disease progression|13|||
17062183|NCT00371254|38204929|FG000|Overall Study|Study drug toxicity|3|||
17062184|NCT00371254|38204930|FG001|Overall Study|Study drug toxicity|5|||
17062185|NCT00371254|38204929|FG000|Overall Study|Subject request|5|||
17062186|NCT00371254|38204930|FG001|Overall Study|Subject request|0|||
17062187|NCT00371254|38204929|FG000|Overall Study|Investigator Decision|2|||
17062188|NCT00371254|38204930|FG001|Overall Study|Investigator Decision|0|||
17062189|NCT00371254|38204929|FG000|Overall Study|Adverse event unrelated to study drug|0|||
17062190|NCT00371254|38204930|FG001|Overall Study|Adverse event unrelated to study drug|1|||
17062191|NCT00371254|38204929|FG000|Overall Study|Lost to Follow-up|0|||
17062192|NCT00371254|38204930|FG001|Overall Study|Lost to Follow-up|1|||
17062193|NCT00371254|38204929|FG000|Overall Study|Withdrawal by Subject|0|||
17062194|NCT00371254|38204930|FG001|Overall Study|Withdrawal by Subject|1|||
17062195|NCT00452673|38204940|FG000|Dose Escalation Period|Disease Progression|6|||
17062196|NCT00452673|38204941|FG001|Dose Escalation Period|Disease Progression|6|||
17062197|NCT00452673|38204942|FG002|Dose Escalation Period|Disease Progression|2|||
17062198|NCT00452673|38204943|FG003|Dose Escalation Period|Disease Progression|6|||
17062199|NCT00452673|38204944|FG004|Dose Escalation Period|Disease Progression|0|||
17062200|NCT00452673|38204940|FG000|Dose Escalation Period|study drug toxicity|1|||
17062201|NCT00452673|38204941|FG001|Dose Escalation Period|study drug toxicity|3|||
17062202|NCT00452673|38204942|FG002|Dose Escalation Period|study drug toxicity|3|||
17062203|NCT00452673|38204943|FG003|Dose Escalation Period|study drug toxicity|1|||
17062204|NCT00452673|38204944|FG004|Dose Escalation Period|study drug toxicity|0|||
17062205|NCT00452673|38204940|FG000|Dose Escalation Period|Other|0|||
17062206|NCT00452673|38204941|FG001|Dose Escalation Period|Other|0|||
17062207|NCT00452673|38204942|FG002|Dose Escalation Period|Other|1|||
17062208|NCT00452673|38204943|FG003|Dose Escalation Period|Other|0|||
17062209|NCT00452673|38204944|FG004|Dose Escalation Period|Other|0|||
17062210|NCT00452673|38204940|FG000|Dose Escalation Period|Adverse Event|0|||
17062211|NCT00452673|38204941|FG001|Dose Escalation Period|Adverse Event|0|||
17062212|NCT00452673|38204942|FG002|Dose Escalation Period|Adverse Event|0|||
17062213|NCT00452673|38204943|FG003|Dose Escalation Period|Adverse Event|1|||
17062214|NCT00452673|38204944|FG004|Dose Escalation Period|Adverse Event|0|||
17062215|NCT00452673|38204940|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
17062216|NCT00452673|38204941|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
17146289|NCT03645421|38290363|FG001|Overall Study|Study specific withdrawal criteria|0|||
17146290|NCT03645421|38290364|FG002|Overall Study|Study specific withdrawal criteria|1|||
17062217|NCT00452673|38204942|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
17062218|NCT00452673|38204943|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
17062219|NCT00452673|38204944|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
17062220|NCT00452673|38204940|FG000|Dose Expansion Period|Disease Progression|0|||
17062221|NCT00452673|38204941|FG001|Dose Expansion Period|Disease Progression|0|||
17062222|NCT00452673|38204942|FG002|Dose Expansion Period|Disease Progression|0|||
17062223|NCT00452673|38204943|FG003|Dose Expansion Period|Disease Progression|0|||
17062224|NCT00452673|38204944|FG004|Dose Expansion Period|Disease Progression|19|||
17062225|NCT00452673|38204940|FG000|Dose Expansion Period|Other|0|||
17062226|NCT00452673|38204941|FG001|Dose Expansion Period|Other|0|||
17062227|NCT00452673|38204942|FG002|Dose Expansion Period|Other|0|||
17062228|NCT00452673|38204943|FG003|Dose Expansion Period|Other|0|||
17062229|NCT00452673|38204944|FG004|Dose Expansion Period|Other|2|||
17062230|NCT00461253|38204957|FG000|Overall Study|Death|985|||
17062231|NCT00461253|38204958|FG001|Overall Study|Death|0|||
17062232|NCT00461253|38204957|FG000|Overall Study|Protocol Violation|613|||
17062233|NCT00461253|38204958|FG001|Overall Study|Protocol Violation|236|||
17062234|NCT00461253|38204957|FG000|Overall Study|no response|2609|||
17062235|NCT00461253|38204958|FG001|Overall Study|no response|11789|||
17062236|NCT00461253|38204957|FG000|Overall Study|administrative|773|||
17062237|NCT00461253|38204958|FG001|Overall Study|administrative|7773|||
17062238|NCT00469833|38204964|FG000|Overall Study|No IV access|2|||
17062239|NCT00382174|38204976|FG000|Overall Study|Lost to Follow-up|1|||
17062240|NCT00382174|38204977|FG001|Overall Study|Lost to Follow-up|4|||
17062241|NCT00382174|38204978|FG002|Overall Study|Lost to Follow-up|5|||
17062242|NCT00382174|38204976|FG000|Overall Study|Adverse Event|1|||
17062243|NCT00382174|38204977|FG001|Overall Study|Adverse Event|4|||
17062244|NCT00382174|38204978|FG002|Overall Study|Adverse Event|5|||
17062245|NCT00382174|38204976|FG000|Overall Study|Withdrawal by Subject|1|||
17062246|NCT00382174|38204977|FG001|Overall Study|Withdrawal by Subject|4|||
17062247|NCT00382174|38204978|FG002|Overall Study|Withdrawal by Subject|5|||
17062248|NCT00382174|38204976|FG000|Overall Study|Non compliance|1|||
17062249|NCT00382174|38204977|FG001|Overall Study|Non compliance|0|||
17062250|NCT00382174|38204978|FG002|Overall Study|Non compliance|1|||
17062251|NCT00382174|38204976|FG000|Overall Study|Physician Decision|0|||
17062252|NCT00382174|38204977|FG001|Overall Study|Physician Decision|2|||
17062253|NCT00382174|38204978|FG002|Overall Study|Physician Decision|2|||
17062254|NCT00382174|38204976|FG000|Overall Study|Failed to meet criteria|0|||
17062255|NCT00382174|38204977|FG001|Overall Study|Failed to meet criteria|1|||
17062256|NCT00382174|38204978|FG002|Overall Study|Failed to meet criteria|1|||
17062257|NCT00382174|38204976|FG000|Overall Study|Wounds merged|0|||
17062258|NCT00382174|38204977|FG001|Overall Study|Wounds merged|2|||
17062259|NCT00382174|38204978|FG002|Overall Study|Wounds merged|2|||
17062260|NCT00641537|38204991|FG000|96-week Period|Adverse Event|0|||
17062261|NCT00641537|38204992|FG001|96-week Period|Adverse Event|1|||
17062262|NCT00641537|38204993|FG002|96-week Period|Adverse Event|3|||
17062263|NCT00641537|38204994|FG003|96-week Period|Adverse Event|0|||
17062264|NCT00641537|38204995|FG004|96-week Period|Adverse Event|2|||
17062265|NCT00641537|38204996|FG005|96-week Period|Adverse Event|0|||
17062266|NCT00641537|38204997|FG006|96-week Period|Adverse Event|0|||
17062267|NCT00641537|38204998|FG007|96-week Period|Adverse Event|0|||
17062268|NCT00641537|38204991|FG000|96-week Period|Lost to Follow-up|3|||
17062269|NCT00641537|38204992|FG001|96-week Period|Lost to Follow-up|1|||
17062270|NCT00641537|38204993|FG002|96-week Period|Lost to Follow-up|2|||
17062271|NCT00641537|38204994|FG003|96-week Period|Lost to Follow-up|2|||
17062272|NCT00641537|38204995|FG004|96-week Period|Lost to Follow-up|4|||
17062273|NCT00641537|38204996|FG005|96-week Period|Lost to Follow-up|0|||
17062274|NCT00641537|38204997|FG006|96-week Period|Lost to Follow-up|1|||
17062275|NCT00641537|38204998|FG007|96-week Period|Lost to Follow-up|0|||
17062276|NCT00641537|38204991|FG000|96-week Period|Protocol Violation|0|||
17062277|NCT00641537|38204992|FG001|96-week Period|Protocol Violation|1|||
17062278|NCT00641537|38204993|FG002|96-week Period|Protocol Violation|0|||
17062279|NCT00641537|38204994|FG003|96-week Period|Protocol Violation|1|||
17062280|NCT00641537|38204995|FG004|96-week Period|Protocol Violation|0|||
17062281|NCT00641537|38204996|FG005|96-week Period|Protocol Violation|1|||
17062282|NCT00641537|38204997|FG006|96-week Period|Protocol Violation|0|||
17062283|NCT00641537|38204998|FG007|96-week Period|Protocol Violation|0|||
17062284|NCT00641537|38204991|FG000|96-week Period|Death|2|||
17062285|NCT00641537|38204992|FG001|96-week Period|Death|0|||
17062286|NCT00641537|38204993|FG002|96-week Period|Death|1|||
17062287|NCT00641537|38204994|FG003|96-week Period|Death|0|||
17062288|NCT00641537|38204995|FG004|96-week Period|Death|0|||
17062289|NCT00641537|38204996|FG005|96-week Period|Death|0|||
17062290|NCT00641537|38204997|FG006|96-week Period|Death|0|||
17062291|NCT00641537|38204998|FG007|96-week Period|Death|0|||
17062292|NCT00641537|38204991|FG000|96-week Period|Other|4|||
17062293|NCT00641537|38204992|FG001|96-week Period|Other|7|||
17062294|NCT00641537|38204993|FG002|96-week Period|Other|14|||
17062295|NCT00641537|38204994|FG003|96-week Period|Other|9|||
17062296|NCT00641537|38204995|FG004|96-week Period|Other|11|||
17062297|NCT00641537|38204996|FG005|96-week Period|Other|6|||
17062298|NCT00641537|38204997|FG006|96-week Period|Other|4|||
17062299|NCT00641537|38204998|FG007|96-week Period|Other|6|||
17062300|NCT00641537|38204991|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
17062301|NCT00641537|38204992|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
17062302|NCT00641537|38204993|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
17062303|NCT00641537|38204994|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
17062304|NCT00641537|38204995|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
17062305|NCT00641537|38204996|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
17062306|NCT00641537|38204997|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
17062307|NCT00641537|38204998|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
17062308|NCT00641537|38204991|FG000|24-Week Supplemental Follow-up Period|Other|0|||
17062309|NCT00641537|38204992|FG001|24-Week Supplemental Follow-up Period|Other|2|||
17062310|NCT00641537|38204993|FG002|24-Week Supplemental Follow-up Period|Other|2|||
17062311|NCT00641537|38204994|FG003|24-Week Supplemental Follow-up Period|Other|1|||
17062312|NCT00641537|38204995|FG004|24-Week Supplemental Follow-up Period|Other|3|||
17062313|NCT00641537|38204996|FG005|24-Week Supplemental Follow-up Period|Other|0|||
17062314|NCT00641537|38204997|FG006|24-Week Supplemental Follow-up Period|Other|1|||
17062315|NCT00641537|38204998|FG007|24-Week Supplemental Follow-up Period|Other|1|||
17062316|NCT03840135|38205018|FG000|Overall Study|Protocol Violation|6|||
17062317|NCT03840135|38205019|FG001|Overall Study|Protocol Violation|1|||
17062318|NCT03840135|38205018|FG000|Overall Study|Withdrawal by Subject|1|||
17062319|NCT03840135|38205019|FG001|Overall Study|Withdrawal by Subject|0|||
17062320|NCT00461175|38205031|FG000|Overall Study|Protocol Violation|522|||
17062321|NCT00461175|38205032|FG001|Overall Study|Protocol Violation|365|||
17062322|NCT00641147|38205040|FG000|Completed 4 Months.|Physician Decision|1|||
17062323|NCT00641147|38205041|FG001|Completed 4 Months.|Physician Decision|0|||
17062324|NCT00641147|38205040|FG000|Completed 4 Months.|Adverse Event|1|||
17062325|NCT00641147|38205041|FG001|Completed 4 Months.|Adverse Event|0|||
17062326|NCT00641147|38205040|FG000|Completed 8 Months.|Physician Decision|2|||
17062327|NCT00641147|38205041|FG001|Completed 8 Months.|Physician Decision|1|||
17062328|NCT00641147|38205040|FG000|Completed 8 Months.|non compliance|1|||
17062329|NCT00641147|38205041|FG001|Completed 8 Months.|non compliance|0|||
17062330|NCT00641147|38205040|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
17062331|NCT00641147|38205041|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
17062332|NCT00641147|38205040|FG000|Completed 12 Months.|Physician Decision|1|||
17062333|NCT00641147|38205041|FG001|Completed 12 Months.|Physician Decision|1|||
17062334|NCT00641147|38205040|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
17062335|NCT00641147|38205041|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
17146291|NCT03645421|38290365|FG003|Overall Study|Study specific withdrawal criteria|0|||
17146292|NCT03207750|38290380|FG000|Overall Study|Adverse Event|3|||
17062336|NCT00641147|38205040|FG000|Completed 16 Months.|Physician Decision|1|||
17062337|NCT00641147|38205041|FG001|Completed 16 Months.|Physician Decision|0|||
17062338|NCT00641147|38205040|FG000|Completed 16 Months.|Lost to Follow-up|1|||
17062339|NCT00641147|38205041|FG001|Completed 16 Months.|Lost to Follow-up|0|||
17062340|NCT00460239|38205051|FG000|Overall Study|Physician Decision|0|||
17062341|NCT00460239|38205052|FG001|Overall Study|Physician Decision|1|||
17062342|NCT00460239|38205053|FG002|Overall Study|Physician Decision|0|||
17062343|NCT00460239|38205054|FG003|Overall Study|Physician Decision|0|||
17062344|NCT00460239|38205055|FG004|Overall Study|Physician Decision|0|||
17062345|NCT00460239|38205056|FG005|Overall Study|Physician Decision|2|||
17062346|NCT00460239|38205057|FG006|Overall Study|Physician Decision|0|||
17062347|NCT00460239|38205058|FG007|Overall Study|Physician Decision|0|||
17062348|NCT00460239|38205059|FG008|Overall Study|Physician Decision|0|||
17062349|NCT00460239|38205051|FG000|Overall Study|Withdrawal by Subject|0|||
17062350|NCT00460239|38205052|FG001|Overall Study|Withdrawal by Subject|0|||
17062351|NCT00460239|38205053|FG002|Overall Study|Withdrawal by Subject|0|||
17062352|NCT00460239|38205054|FG003|Overall Study|Withdrawal by Subject|0|||
17062353|NCT00460239|38205055|FG004|Overall Study|Withdrawal by Subject|0|||
17062354|NCT00460239|38205056|FG005|Overall Study|Withdrawal by Subject|1|||
17062355|NCT00460239|38205057|FG006|Overall Study|Withdrawal by Subject|0|||
17146293|NCT03207750|38290381|FG001|Overall Study|Adverse Event|2|||
17146294|NCT03207750|38290380|FG000|Overall Study|Lost to Follow-up|21|||
17146295|NCT03207750|38290381|FG001|Overall Study|Lost to Follow-up|29|||
17146296|NCT03207750|38290380|FG000|Overall Study|Protocol Violation|0|||
17146297|NCT03207750|38290381|FG001|Overall Study|Protocol Violation|1|||
17146298|NCT03207750|38290380|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
17146299|NCT03207750|38290381|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
17146300|NCT03207750|38290380|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
17146301|NCT03207750|38290381|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
17146302|NCT03207750|38290380|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
17146303|NCT03207750|38290381|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
17146304|NCT03207750|38290380|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
17062356|NCT00460239|38205058|FG007|Overall Study|Withdrawal by Subject|0|||
17062357|NCT00460239|38205059|FG008|Overall Study|Withdrawal by Subject|0|||
17062358|NCT00640835|38205074|FG000|Overall Study|Adverse Event|5|||
17062359|NCT00640835|38205075|FG001|Overall Study|Adverse Event|3|||
17062360|NCT00640835|38205074|FG000|Overall Study|Withdrawal by Subject|12|||
17062361|NCT00640835|38205075|FG001|Overall Study|Withdrawal by Subject|14|||
17062362|NCT00640835|38205074|FG000|Overall Study|Physician Decision|10|||
17062363|NCT00640835|38205075|FG001|Overall Study|Physician Decision|14|||
17062364|NCT00640835|38205074|FG000|Overall Study|Sponsor's Decision|11|||
17062365|NCT00640835|38205075|FG001|Overall Study|Sponsor's Decision|7|||
17062366|NCT00640835|38205074|FG000|Overall Study|Protocol Violation|2|||
17062367|NCT00640835|38205075|FG001|Overall Study|Protocol Violation|2|||
17062368|NCT00640835|38205074|FG000|Overall Study|Lost to Follow-up|17|||
17062369|NCT00640835|38205075|FG001|Overall Study|Lost to Follow-up|13|||
17062370|NCT00640835|38205074|FG000|Overall Study|Other Reason|19|||
17062371|NCT00640835|38205075|FG001|Overall Study|Other Reason|4|||
17062372|NCT03839355|38205083|FG000|Overall Study|Withdrawal by Subject|1|||
17062373|NCT03839355|38205084|FG001|Overall Study|Withdrawal by Subject|0|||
17062374|NCT00382018|38205094|FG000|Overall Study|Progression|0|||
17062375|NCT00382018|38205095|FG001|Overall Study|Progression|136|||
17062376|NCT00382018|38205096|FG002|Overall Study|Progression|51|||
17062377|NCT00382018|38205097|FG003|Overall Study|Progression|43|||
17062378|NCT00382018|38205094|FG000|Overall Study|Death|0|||
17062379|NCT00382018|38205095|FG001|Overall Study|Death|9|||
17062380|NCT00382018|38205096|FG002|Overall Study|Death|7|||
17146305|NCT03207750|38290381|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
17146306|NCT03207750|38290380|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
17146307|NCT03207750|38290381|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
17146308|NCT03674281|38290390|FG000|Overall Study|screen failure|2|||
17146309|NCT03674281|38290391|FG001|Overall Study|screen failure|0|||
17146310|NCT03674281|38290392|FG002|Overall Study|screen failure|0|||
17062381|NCT00382018|38205097|FG003|Overall Study|Death|11|||
17062382|NCT00382018|38205094|FG000|Overall Study|Withdrawal by Subject|0|||
17062383|NCT00382018|38205095|FG001|Overall Study|Withdrawal by Subject|4|||
17062384|NCT00382018|38205096|FG002|Overall Study|Withdrawal by Subject|3|||
17062385|NCT00382018|38205097|FG003|Overall Study|Withdrawal by Subject|4|||
17062386|NCT00382018|38205094|FG000|Overall Study|Other, not protocol specified|0|||
17062387|NCT00382018|38205095|FG001|Overall Study|Other, not protocol specified|16|||
17062388|NCT00382018|38205096|FG002|Overall Study|Other, not protocol specified|3|||
17062389|NCT00382018|38205097|FG003|Overall Study|Other, not protocol specified|1|||
17062390|NCT00640601|38205110|FG000|Overall Study|Adverse Event|43|||
17062391|NCT00640601|38205110|FG000|Overall Study|Withdrawal by Subject|20|||
17062392|NCT00640601|38205110|FG000|Overall Study|Protocol Violation|6|||
17062393|NCT00640601|38205110|FG000|Overall Study|Lack of Efficacy|16|||
17146311|NCT03674281|38290390|FG000|Overall Study|Withdrawal by Subject|1|||
17062394|NCT00640601|38205110|FG000|Overall Study|Lost to Follow-up|9|||
17062395|NCT00640601|38205110|FG000|Overall Study|Physician Decision|8|||
17062396|NCT00640601|38205110|FG000|Overall Study|treatment naive, combination therapy|10|||
17062397|NCT03838731|38205116|FG000|Overall Study|Pregnancy|0|||
17062398|NCT03838731|38205117|FG001|Overall Study|Pregnancy|1|||
17062399|NCT03838731|38205116|FG000|Overall Study|Withdrawal of consent|1|||
17062400|NCT03838731|38205117|FG001|Overall Study|Withdrawal of consent|0|||
17062401|NCT00452439|38205125|FG000|Overall Study|Lost to Follow-up|1|||
17062402|NCT00452439|38205126|FG001|Overall Study|Lost to Follow-up|1|||
17062403|NCT00452439|38205125|FG000|Overall Study|Refused Treatment|4|||
17062404|NCT00452439|38205126|FG001|Overall Study|Refused Treatment|3|||
17062405|NCT00452439|38205125|FG000|Overall Study|Death|3|||
17062406|NCT00452439|38205126|FG001|Overall Study|Death|1|||
17062407|NCT00452439|38205125|FG000|Overall Study|Bone Marrow Transplant|0|||
17062408|NCT00452439|38205126|FG001|Overall Study|Bone Marrow Transplant|1|||
17062409|NCT00452439|38205125|FG000|Overall Study|Too Ill to Continue|0|||
17062410|NCT00452439|38205126|FG001|Overall Study|Too Ill to Continue|1|||
17062411|NCT00452439|38205125|FG000|Overall Study|Failed to achieve complete response|2|||
17062412|NCT00452439|38205126|FG001|Overall Study|Failed to achieve complete response|0|||
17062413|NCT00452439|38205125|FG000|Overall Study|Relapse|3|||
17062414|NCT00452439|38205126|FG001|Overall Study|Relapse|0|||
17062415|NCT00452439|38205125|FG000|Overall Study|Fracture|1|||
17062416|NCT00452439|38205126|FG001|Overall Study|Fracture|0|||
17062417|NCT00381940|38205132|FG000|Overall Study|Lack of Efficacy|3|||
17146312|NCT03674281|38290391|FG001|Overall Study|Withdrawal by Subject|3|||
17062418|NCT00381940|38205132|FG000|Overall Study|Protocol Violation|1|||
17062419|NCT00381940|38205132|FG000|Overall Study|Ineligible|1|||
17062420|NCT00364156|38205138|FG000|Overall Study|Withdrawal by Subject|73|||
17062421|NCT00364156|38205139|FG001|Overall Study|Withdrawal by Subject|80|||
17062422|NCT00364156|38205138|FG000|Overall Study|Protocol Violation|6|||
17062423|NCT00364156|38205139|FG001|Overall Study|Protocol Violation|1|||
17062424|NCT00452361|38205147|FG000|Overall Study|Adverse Event|8|||
17062425|NCT00452361|38205148|FG001|Overall Study|Adverse Event|0|||
17062426|NCT00452361|38205147|FG000|Overall Study|Withdrawal by Subject|0|||
17062427|NCT00452361|38205148|FG001|Overall Study|Withdrawal by Subject|1|||
17062428|NCT00452361|38205147|FG000|Overall Study|Premature termination|13|||
17062429|NCT00452361|38205148|FG001|Overall Study|Premature termination|9|||
17062430|NCT00640289|38205154|FG000|Overall Study|Death|3|||
17062431|NCT00640289|38205154|FG000|Overall Study|Withdrawal by Subject|1|||
17062432|NCT00640289|38205154|FG000|Overall Study|Lost to Follow-up|1|||
17062433|NCT00640289|38205154|FG000|Overall Study|Data collected under different amendment|2|||
17146313|NCT03674281|38290392|FG002|Overall Study|Withdrawal by Subject|3|||
17062434|NCT00640289|38205154|FG000|Overall Study|Transferred to another center|1|||
17146314|NCT03673345|38290416|FG000|Overall Study|Lost to Follow-up|1|||
17062435|NCT00640289|38205154|FG000|Overall Study|Missing status|5|||
17062436|NCT00568451|38205162|FG000|Overall Study|Disease Progression|0|||
17062437|NCT00568451|38205163|FG001|Overall Study|Disease Progression|0|||
17062438|NCT00568451|38205164|FG002|Overall Study|Disease Progression|2|||
17062439|NCT00568451|38205165|FG003|Overall Study|Disease Progression|7|||
17062440|NCT00459537|38205178|FG000|Overall Study|Adverse Event|1|||
17062441|NCT00459537|38205179|FG001|Overall Study|Adverse Event|6|||
17062442|NCT00459537|38205178|FG000|Overall Study|Lack of Efficacy|10|||
17062443|NCT00459537|38205179|FG001|Overall Study|Lack of Efficacy|11|||
17062444|NCT00459537|38205178|FG000|Overall Study|Withdrawal by Subject|20|||
17062445|NCT00459537|38205179|FG001|Overall Study|Withdrawal by Subject|26|||
17062446|NCT00459537|38205178|FG000|Overall Study|Lost to Follow-up|27|||
17062447|NCT00459537|38205179|FG001|Overall Study|Lost to Follow-up|30|||
17062448|NCT00459537|38205178|FG000|Overall Study|Administrative problems|3|||
17062449|NCT00459537|38205179|FG001|Overall Study|Administrative problems|0|||
17062450|NCT00459537|38205178|FG000|Overall Study|Protocol Violation|4|||
17062451|NCT00459537|38205179|FG001|Overall Study|Protocol Violation|3|||
17062452|NCT00459537|38205178|FG000|Overall Study|Missing|1|||
16781195|NCT02171260|37720362|FG002|Overall Study|Physician Decision|1|||
17062453|NCT00459537|38205179|FG001|Overall Study|Missing|0|||
17062454|NCT03850509|38205187|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
17062455|NCT03850509|38205188|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
17062456|NCT00635999|38205197|FG000|Overall Study|Withdrawal by Subject|4|||
17062457|NCT00635999|38205198|FG001|Overall Study|Withdrawal by Subject|2|||
17146315|NCT03673345|38290417|FG001|Overall Study|Lost to Follow-up|0|||
17062458|NCT00635999|38205199|FG002|Overall Study|Withdrawal by Subject|1|||
17062459|NCT00469209|38205210|FG000|Overall Study|Adverse Event|1|||
17062460|NCT00469209|38205211|FG001|Overall Study|Adverse Event|0|||
17062461|NCT00469209|38205212|FG002|Overall Study|Adverse Event|1|||
17062462|NCT00635219|38205225|FG000|Overall Study|Adverse Event|12|||
17062463|NCT00635219|38205226|FG001|Overall Study|Adverse Event|10|||
17062464|NCT00635219|38205227|FG002|Overall Study|Adverse Event|18|||
16993739|NCT00783718|38137745|FG001|Maintenance Phase|Protocol Violation|0|||
17062465|NCT00635219|38205228|FG003|Overall Study|Adverse Event|15|||
17062466|NCT00635219|38205229|FG004|Overall Study|Adverse Event|19|||
17062467|NCT00635219|38205225|FG000|Overall Study|Lack of Efficacy|5|||
17062468|NCT00635219|38205226|FG001|Overall Study|Lack of Efficacy|6|||
17062469|NCT00635219|38205227|FG002|Overall Study|Lack of Efficacy|3|||
17062470|NCT00635219|38205228|FG003|Overall Study|Lack of Efficacy|4|||
17062471|NCT00635219|38205229|FG004|Overall Study|Lack of Efficacy|6|||
17062472|NCT00635219|38205225|FG000|Overall Study|Non-compliance With Study Product|0|||
17062473|NCT00635219|38205226|FG001|Overall Study|Non-compliance With Study Product|0|||
17062474|NCT00635219|38205227|FG002|Overall Study|Non-compliance With Study Product|0|||
17062475|NCT00635219|38205228|FG003|Overall Study|Non-compliance With Study Product|2|||
17062476|NCT00635219|38205229|FG004|Overall Study|Non-compliance With Study Product|1|||
17146316|NCT03673345|38290418|FG002|Overall Study|Lost to Follow-up|3|||
16993740|NCT00783718|38137746|FG002|Maintenance Phase|Protocol Violation|0|||
16993741|NCT00783718|38137747|FG003|Maintenance Phase|Protocol Violation|0|||
16993742|NCT00783718|38137748|FG004|Maintenance Phase|Protocol Violation|0|||
16993743|NCT00783718|38137749|FG005|Maintenance Phase|Protocol Violation|0|||
16993744|NCT00783718|38137750|FG006|Maintenance Phase|Protocol Violation|2|||
16993745|NCT00783718|38137744|FG000|Maintenance Phase|Lack of Efficacy|83|||
16993746|NCT00783718|38137745|FG001|Maintenance Phase|Lack of Efficacy|0|||
16993747|NCT00783718|38137746|FG002|Maintenance Phase|Lack of Efficacy|0|||
16993748|NCT00783718|38137747|FG003|Maintenance Phase|Lack of Efficacy|61|||
16993749|NCT00783718|38137748|FG004|Maintenance Phase|Lack of Efficacy|31|||
16993750|NCT00783718|38137749|FG005|Maintenance Phase|Lack of Efficacy|33|||
16993751|NCT00783718|38137750|FG006|Maintenance Phase|Lack of Efficacy|155|||
16993752|NCT00783718|38137744|FG000|Maintenance Phase|Withdrawal by Subject|6|||
16993753|NCT00783718|38137745|FG001|Maintenance Phase|Withdrawal by Subject|0|||
16993754|NCT00783718|38137746|FG002|Maintenance Phase|Withdrawal by Subject|0|||
16993755|NCT00783718|38137747|FG003|Maintenance Phase|Withdrawal by Subject|2|||
16993756|NCT00783718|38137748|FG004|Maintenance Phase|Withdrawal by Subject|5|||
16993757|NCT00783718|38137749|FG005|Maintenance Phase|Withdrawal by Subject|2|||
16993758|NCT00783718|38137750|FG006|Maintenance Phase|Withdrawal by Subject|20|||
16993759|NCT00783718|38137744|FG000|Maintenance Phase|Lost to Follow-up|3|||
16993760|NCT00783718|38137745|FG001|Maintenance Phase|Lost to Follow-up|0|||
16993761|NCT00783718|38137746|FG002|Maintenance Phase|Lost to Follow-up|0|||
16993762|NCT00783718|38137747|FG003|Maintenance Phase|Lost to Follow-up|0|||
16993763|NCT00783718|38137748|FG004|Maintenance Phase|Lost to Follow-up|2|||
16993764|NCT00783718|38137749|FG005|Maintenance Phase|Lost to Follow-up|0|||
16993765|NCT00783718|38137750|FG006|Maintenance Phase|Lost to Follow-up|2|||
16993766|NCT00774748|38137769|FG000|Overall Study|Lost to Follow-up|3|||
16993767|NCT00587860|38137779|FG000|Overall Study|Lost to Follow-up|2|||
16993768|NCT00587860|38137780|FG001|Overall Study|Lost to Follow-up|2|||
16993769|NCT00587860|38137779|FG000|Overall Study|Withdrawal by Subject|3|||
16993770|NCT00587860|38137780|FG001|Overall Study|Withdrawal by Subject|3|||
16993771|NCT00583453|38137788|FG000|Overall Study|discontinued intervention|0|||
16993772|NCT00583453|38137789|FG001|Overall Study|discontinued intervention|2|||
16993773|NCT00583219|38137797|FG000|Phase 2|Withdrawal by Subject|1|||
16993774|NCT01072175|38137817|FG000|Part A (Drug-Drug Interaction)|Death|1|||
16993775|NCT01072175|38137818|FG001|Part A (Drug-Drug Interaction)|Death|0|||
16993776|NCT01072175|38137819|FG002|Part A (Drug-Drug Interaction)|Death|0|||
16993777|NCT01072175|38137820|FG003|Part A (Drug-Drug Interaction)|Death|0|||
17062477|NCT00635219|38205225|FG000|Overall Study|Protocol Violation|0|||
17062478|NCT00635219|38205226|FG001|Overall Study|Protocol Violation|2|||
17062479|NCT00635219|38205227|FG002|Overall Study|Protocol Violation|3|||
17146317|NCT03673345|38290419|FG003|Overall Study|Lost to Follow-up|3|||
17146318|NCT03673345|38290420|FG004|Overall Study|Lost to Follow-up|2|||
17062480|NCT00635219|38205228|FG003|Overall Study|Protocol Violation|2|||
17062481|NCT00635219|38205229|FG004|Overall Study|Protocol Violation|4|||
17062482|NCT00635219|38205225|FG000|Overall Study|Withdrawal of Consent|8|||
17062483|NCT00635219|38205226|FG001|Overall Study|Withdrawal of Consent|6|||
17062484|NCT00635219|38205227|FG002|Overall Study|Withdrawal of Consent|8|||
17062485|NCT00635219|38205228|FG003|Overall Study|Withdrawal of Consent|11|||
17062486|NCT00635219|38205229|FG004|Overall Study|Withdrawal of Consent|8|||
17062487|NCT00635219|38205225|FG000|Overall Study|Lost to Follow-up|0|||
17062488|NCT00635219|38205226|FG001|Overall Study|Lost to Follow-up|0|||
17062489|NCT00635219|38205227|FG002|Overall Study|Lost to Follow-up|2|||
17146319|NCT03673345|38290421|FG005|Overall Study|Lost to Follow-up|1|||
17062490|NCT00635219|38205228|FG003|Overall Study|Lost to Follow-up|0|||
17062491|NCT00635219|38205229|FG004|Overall Study|Lost to Follow-up|3|||
17062492|NCT00635219|38205225|FG000|Overall Study|Administrative or Other Reasons|0|||
17062493|NCT00635219|38205226|FG001|Overall Study|Administrative or Other Reasons|1|||
17062494|NCT00635219|38205227|FG002|Overall Study|Administrative or Other Reasons|1|||
17062495|NCT00635219|38205228|FG003|Overall Study|Administrative or Other Reasons|0|||
17062496|NCT00635219|38205229|FG004|Overall Study|Administrative or Other Reasons|1|||
17062497|NCT00363766|38205243|FG000|Overall Study|Progressive Disease|15|||
17062498|NCT00363766|38205244|FG001|Overall Study|Progressive Disease|9|||
17062499|NCT00363766|38205243|FG000|Overall Study|Adverse Event|10|||
17062500|NCT00363766|38205244|FG001|Overall Study|Adverse Event|2|||
17062501|NCT00363766|38205243|FG000|Overall Study|Disease Related Death|1|||
17146320|NCT03673345|38290422|FG006|Overall Study|Lost to Follow-up|0|||
17146321|NCT03673345|38290423|FG007|Overall Study|Lost to Follow-up|0|||
17146322|NCT03673345|38290416|FG000|Overall Study|Withdrawal by Subject|1|||
17146323|NCT03673345|38290417|FG001|Overall Study|Withdrawal by Subject|0|||
17146324|NCT03673345|38290418|FG002|Overall Study|Withdrawal by Subject|4|||
17146325|NCT03673345|38290419|FG003|Overall Study|Withdrawal by Subject|2|||
17062502|NCT00363766|38205244|FG001|Overall Study|Disease Related Death|3|||
17062503|NCT00363766|38205243|FG000|Overall Study|Not Disease Related Death|3|||
17062504|NCT00363766|38205244|FG001|Overall Study|Not Disease Related Death|4|||
17062505|NCT00363766|38205243|FG000|Overall Study|Withdrawal by Subject|2|||
17062506|NCT00363766|38205244|FG001|Overall Study|Withdrawal by Subject|0|||
17062507|NCT00363766|38205243|FG000|Overall Study|Physician Decision|1|||
17062508|NCT00363766|38205244|FG001|Overall Study|Physician Decision|2|||
17062509|NCT00468819|38205254|FG000|Overall Study|Withdrawal by Subject|4|||
17062510|NCT00468819|38205255|FG001|Overall Study|Withdrawal by Subject|0|||
17062511|NCT00468819|38205256|FG002|Overall Study|Withdrawal by Subject|1|||
17062512|NCT00468819|38205254|FG000|Overall Study|Lost to Follow-up|0|||
17062513|NCT00468819|38205255|FG001|Overall Study|Lost to Follow-up|0|||
17062514|NCT00468819|38205256|FG002|Overall Study|Lost to Follow-up|1|||
17062515|NCT00468819|38205254|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
17062516|NCT00468819|38205255|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
17062517|NCT00468819|38205256|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
17062518|NCT00451191|38205268|FG000|Overall Study|withdrawal or received alternate tx|15|||
17062519|NCT00451191|38205269|FG001|Overall Study|withdrawal or received alternate tx|11|||
17062520|NCT00451035|38205275|FG000|Overall Study|Disease progression|11|||
17062521|NCT00451035|38205275|FG000|Overall Study|Death|3|||
17062522|NCT00451035|38205275|FG000|Overall Study|New anti-neoplastic therapy|3|||
17062523|NCT00468585|38205284|FG000|Overall Study|Patient not treated|1|||
17062524|NCT00468585|38205285|FG001|Overall Study|Patient not treated|0|||
17062525|NCT00468585|38205286|FG002|Overall Study|Patient not treated|1|||
17062526|NCT00468585|38205287|FG003|Overall Study|Patient not treated|0|||
17062527|NCT00468585|38205284|FG000|Overall Study|Patient found to be ineligible|0|||
17062528|NCT00468585|38205285|FG001|Overall Study|Patient found to be ineligible|0|||
17062529|NCT00468585|38205286|FG002|Overall Study|Patient found to be ineligible|1|||
17062530|NCT00468585|38205287|FG003|Overall Study|Patient found to be ineligible|0|||
17062531|NCT00468585|38205284|FG000|Overall Study|Adverse Event|0|||
17062532|NCT00468585|38205285|FG001|Overall Study|Adverse Event|0|||
17062533|NCT00468585|38205286|FG002|Overall Study|Adverse Event|1|||
17062534|NCT00468585|38205287|FG003|Overall Study|Adverse Event|0|||
17062535|NCT00468585|38205284|FG000|Overall Study|Withdrawal by Subject|0|||
17062536|NCT00468585|38205285|FG001|Overall Study|Withdrawal by Subject|0|||
17062537|NCT00468585|38205286|FG002|Overall Study|Withdrawal by Subject|2|||
17062538|NCT00468585|38205287|FG003|Overall Study|Withdrawal by Subject|1|||
17062539|NCT00450801|38205297|FG000|Overall Study|Death|1|||
17062540|NCT00458211|38205306|FG000|Overall Study|Lack of Efficacy|12|||
17062541|NCT00458211|38205306|FG000|Overall Study|Withdrawal by Subject|2|||
17062542|NCT00458211|38205306|FG000|Overall Study|Protocol Violation|2|||
17062543|NCT00450723|38205314|FG000|Overall Study|Physician Decision|5|||
17062544|NCT00467961|38205319|FG000|Overall Study|Technical Failures|5|||
16781196|NCT02171260|37720363|FG003|Overall Study|Physician Decision|0|||
17062545|NCT00467961|38205319|FG000|Overall Study|Disease Progression|2|||
17062546|NCT00457821|38205331|FG000|Part 2|Withdrawal by Subject|0|||
17062547|NCT00457821|38205332|FG001|Part 2|Withdrawal by Subject|0|||
17062548|NCT00457821|38205333|FG002|Part 2|Withdrawal by Subject|0|||
17062549|NCT00457821|38205334|FG003|Part 2|Withdrawal by Subject|0|||
17062550|NCT00457821|38205335|FG004|Part 2|Withdrawal by Subject|0|||
17062551|NCT00457821|38205336|FG005|Part 2|Withdrawal by Subject|0|||
17062552|NCT00457821|38205337|FG006|Part 2|Withdrawal by Subject|0|||
17062553|NCT00457821|38205338|FG007|Part 2|Withdrawal by Subject|1|||
17062554|NCT00633893|38205358|FG000|Overall Study|Death|1|||
17062555|NCT00633893|38205359|FG001|Overall Study|Death|3|||
17062556|NCT00633893|38205360|FG002|Overall Study|Death|9|||
17146326|NCT03673345|38290420|FG004|Overall Study|Withdrawal by Subject|0|||
17146327|NCT03673345|38290421|FG005|Overall Study|Withdrawal by Subject|0|||
17062557|NCT00633893|38205358|FG000|Overall Study|Adverse Event|65|||
17062558|NCT00633893|38205359|FG001|Overall Study|Adverse Event|58|||
17146328|NCT03673345|38290422|FG006|Overall Study|Withdrawal by Subject|0|||
17146329|NCT03673345|38290423|FG007|Overall Study|Withdrawal by Subject|0|||
17146330|NCT03673345|38290416|FG000|Overall Study|Physician Decision|0|||
17146331|NCT03673345|38290417|FG001|Overall Study|Physician Decision|0|||
17146332|NCT03673345|38290418|FG002|Overall Study|Physician Decision|2|||
17146333|NCT03673345|38290419|FG003|Overall Study|Physician Decision|0|||
17146334|NCT03673345|38290420|FG004|Overall Study|Physician Decision|0|||
17146335|NCT03673345|38290421|FG005|Overall Study|Physician Decision|0|||
17146336|NCT03673345|38290422|FG006|Overall Study|Physician Decision|0|||
17146337|NCT03673345|38290423|FG007|Overall Study|Physician Decision|0|||
17146338|NCT03223662|38290441|FG000|Overall Study|Physician Decision|1|||
17146339|NCT03223662|38290441|FG000|Overall Study|Study closure|1|||
17146340|NCT03672097|38290445|FG000|Period 1|Withdrawal by Subject|2|||
17146341|NCT03672097|38290445|FG000|Period 1|Adverse Event|1|||
17146342|NCT03672097|38290445|FG000|Period 1|Did not receive treatment|1|||
17146343|NCT03672097|38290445|FG000|Period 2|Withdrawal by Subject|3|||
17146344|NCT03672097|38290445|FG000|Period 2|Other|1|||
17146345|NCT03847896|38290454|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
17146346|NCT03847896|38290455|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
17146347|NCT03847896|38290456|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
17146348|NCT03847896|38290457|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
17146349|NCT03847896|38290458|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
17146350|NCT03847896|38290454|FG000|Overall Study|Withdrawal by Subject|2|||
17146351|NCT03847896|38290455|FG001|Overall Study|Withdrawal by Subject|10|||
17146352|NCT03847896|38290456|FG002|Overall Study|Withdrawal by Subject|5|||
17146353|NCT03847896|38290457|FG003|Overall Study|Withdrawal by Subject|9|||
17146354|NCT03847896|38290458|FG004|Overall Study|Withdrawal by Subject|8|||
17146355|NCT03847896|38290454|FG000|Overall Study|Withdrawal by parent/guardian|0|||
17146356|NCT03847896|38290455|FG001|Overall Study|Withdrawal by parent/guardian|0|||
17146357|NCT03847896|38290456|FG002|Overall Study|Withdrawal by parent/guardian|1|||
17146358|NCT03847896|38290457|FG003|Overall Study|Withdrawal by parent/guardian|0|||
17146359|NCT03847896|38290458|FG004|Overall Study|Withdrawal by parent/guardian|0|||
17146360|NCT03847896|38290454|FG000|Overall Study|Adverse Event|2|||
17146361|NCT03847896|38290455|FG001|Overall Study|Adverse Event|1|||
17146362|NCT03847896|38290456|FG002|Overall Study|Adverse Event|3|||
17146363|NCT03847896|38290457|FG003|Overall Study|Adverse Event|2|||
17146364|NCT03847896|38290458|FG004|Overall Study|Adverse Event|4|||
17146365|NCT03847896|38290454|FG000|Overall Study|A severe exacerbation event|0|||
17146366|NCT03847896|38290455|FG001|Overall Study|A severe exacerbation event|0|||
17146367|NCT03847896|38290456|FG002|Overall Study|A severe exacerbation event|0|||
17146368|NCT03847896|38290457|FG003|Overall Study|A severe exacerbation event|0|||
17146369|NCT03847896|38290458|FG004|Overall Study|A severe exacerbation event|3|||
17146370|NCT03847896|38290454|FG000|Overall Study|Protocol Violation|0|||
17146371|NCT03847896|38290455|FG001|Overall Study|Protocol Violation|2|||
16993778|NCT01072175|38137821|FG004|Part A (Drug-Drug Interaction)|Death|0|||
16993779|NCT01072175|38137822|FG005|Part A (Drug-Drug Interaction)|Death|0|||
16993780|NCT01072175|38137823|FG006|Part A (Drug-Drug Interaction)|Death|0|||
16993781|NCT01072175|38137824|FG007|Part A (Drug-Drug Interaction)|Death|0|||
16993782|NCT01072175|38137825|FG008|Part A (Drug-Drug Interaction)|Death|0|||
16993783|NCT01072175|38137826|FG009|Part A (Drug-Drug Interaction)|Death|0|||
16993784|NCT01072175|38137827|FG010|Part A (Drug-Drug Interaction)|Death|0|||
16993785|NCT01072175|38137828|FG011|Part A (Drug-Drug Interaction)|Death|0|||
17146372|NCT03847896|38290456|FG002|Overall Study|Protocol Violation|1|||
17146373|NCT03847896|38290457|FG003|Overall Study|Protocol Violation|0|||
17146374|NCT03847896|38290458|FG004|Overall Study|Protocol Violation|2|||
16993786|NCT01072175|38137829|FG012|Part A (Drug-Drug Interaction)|Death|0|||
17146375|NCT03847896|38290454|FG000|Overall Study|Lost to Follow-up|0|||
17146376|NCT03847896|38290455|FG001|Overall Study|Lost to Follow-up|0|||
17146377|NCT03847896|38290456|FG002|Overall Study|Lost to Follow-up|0|||
17146378|NCT03847896|38290457|FG003|Overall Study|Lost to Follow-up|1|||
17146379|NCT03847896|38290458|FG004|Overall Study|Lost to Follow-up|0|||
17146380|NCT03847896|38290454|FG000|Overall Study|Condition under investigation worsened|0|||
16993787|NCT01072175|38137817|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
16993788|NCT01072175|38137818|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
17146381|NCT03847896|38290455|FG001|Overall Study|Condition under investigation worsened|0|||
17146382|NCT03847896|38290456|FG002|Overall Study|Condition under investigation worsened|0|||
17146383|NCT03847896|38290457|FG003|Overall Study|Condition under investigation worsened|1|||
17146384|NCT03847896|38290458|FG004|Overall Study|Condition under investigation worsened|1|||
17146385|NCT03847896|38290454|FG000|Overall Study|Lack of Efficacy|0|||
17146386|NCT03847896|38290455|FG001|Overall Study|Lack of Efficacy|0|||
17146387|NCT03847896|38290456|FG002|Overall Study|Lack of Efficacy|0|||
17146388|NCT03847896|38290457|FG003|Overall Study|Lack of Efficacy|2|||
17146389|NCT03847896|38290458|FG004|Overall Study|Lack of Efficacy|2|||
17146390|NCT03847896|38290454|FG000|Overall Study|Other reasons|3|||
17062559|NCT00633893|38205360|FG002|Overall Study|Adverse Event|126|||
17062560|NCT00633893|38205358|FG000|Overall Study|Withdrawal by Subject|7|||
17062561|NCT00633893|38205359|FG001|Overall Study|Withdrawal by Subject|12|||
17062562|NCT00633893|38205360|FG002|Overall Study|Withdrawal by Subject|6|||
17062563|NCT00633893|38205358|FG000|Overall Study|Lost to Follow-up|2|||
17062564|NCT00633893|38205359|FG001|Overall Study|Lost to Follow-up|4|||
17062565|NCT00633893|38205360|FG002|Overall Study|Lost to Follow-up|8|||
17062566|NCT00633893|38205358|FG000|Overall Study|Poor/non-compliance|5|||
17062567|NCT00633893|38205359|FG001|Overall Study|Poor/non-compliance|12|||
17062568|NCT00633893|38205360|FG002|Overall Study|Poor/non-compliance|3|||
17062569|NCT00633893|38205358|FG000|Overall Study|Pregnancy|2|||
17062570|NCT00633893|38205359|FG001|Overall Study|Pregnancy|1|||
17062571|NCT00633893|38205360|FG002|Overall Study|Pregnancy|1|||
17062572|NCT00633893|38205358|FG000|Overall Study|Not meet/no longer meets criteria|4|||
17062573|NCT00633893|38205359|FG001|Overall Study|Not meet/no longer meets criteria|6|||
17062574|NCT00633893|38205360|FG002|Overall Study|Not meet/no longer meets criteria|4|||
17062575|NCT00633893|38205358|FG000|Overall Study|Other|28|||
17062576|NCT00633893|38205359|FG001|Overall Study|Other|33|||
17146391|NCT03847896|38290455|FG001|Overall Study|Other reasons|3|||
17146392|NCT03847896|38290456|FG002|Overall Study|Other reasons|1|||
17146393|NCT03847896|38290457|FG003|Overall Study|Other reasons|2|||
17146394|NCT03847896|38290458|FG004|Overall Study|Other reasons|1|||
17146395|NCT03670537|38290470|FG000|Overall Study|Protocol Violation|1|||
17062577|NCT00633893|38205360|FG002|Overall Study|Other|31|||
17062578|NCT00457743|38205371|FG000|Overall Study|Adverse Event|0|||
16993789|NCT01072175|38137819|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993790|NCT01072175|38137820|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993791|NCT01072175|38137821|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993792|NCT01072175|38137822|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993793|NCT01072175|38137823|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993794|NCT01072175|38137824|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993795|NCT01072175|38137825|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993796|NCT01072175|38137826|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993797|NCT01072175|38137827|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993798|NCT01072175|38137828|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993799|NCT01072175|38137829|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16993800|NCT01072175|38137817|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
17062579|NCT00457743|38205372|FG001|Overall Study|Adverse Event|4|||
17062580|NCT00457743|38205373|FG002|Overall Study|Adverse Event|0|||
17062581|NCT00457743|38205371|FG000|Overall Study|Lack of Efficacy|3|||
17062582|NCT00457743|38205372|FG001|Overall Study|Lack of Efficacy|23|||
17146396|NCT03619837|38290474|FG000|Screening|received organs from HCV-negative donors|47|||
17062583|NCT00457743|38205373|FG002|Overall Study|Lack of Efficacy|3|||
17062584|NCT00450411|38205382|FG000|Overall Study|Protocol Violation|6|||
17062585|NCT00450411|38205382|FG000|Overall Study|No protocol treatment|2|||
17062586|NCT00644969|38205388|FG000|Treatment Phase|Randomized, not treated|1|||
17062587|NCT00644969|38205389|FG001|Treatment Phase|Randomized, not treated|0|||
17062588|NCT00644969|38205388|FG000|Treatment Phase|Adverse Event|3|||
17062589|NCT00644969|38205389|FG001|Treatment Phase|Adverse Event|0|||
17062590|NCT00644969|38205388|FG000|Treatment Phase|Withdrawal by Subject|4|||
17062591|NCT00644969|38205389|FG001|Treatment Phase|Withdrawal by Subject|0|||
17062592|NCT00644969|38205388|FG000|Treatment Phase|Lost to Follow-up|2|||
17062593|NCT00644969|38205389|FG001|Treatment Phase|Lost to Follow-up|2|||
17062594|NCT00644969|38205388|FG000|Treatment Phase|Other|4|||
17062595|NCT00644969|38205389|FG001|Treatment Phase|Other|1|||
17062596|NCT00644969|38205388|FG000|Post Treatment Phase|Death|1|||
17062597|NCT00644969|38205389|FG001|Post Treatment Phase|Death|0|||
17062598|NCT00644969|38205388|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
17062599|NCT00644969|38205389|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
17062600|NCT00644969|38205388|FG000|Post Treatment Phase|Lost to Follow-up|4|||
17062601|NCT00644969|38205389|FG001|Post Treatment Phase|Lost to Follow-up|1|||
17062602|NCT00644969|38205388|FG000|Post Treatment Phase|Other|1|||
17062603|NCT00644969|38205389|FG001|Post Treatment Phase|Other|0|||
17062604|NCT00644423|38205397|FG000|Overall Study|Lost to Follow-up|1|||
17062605|NCT00644423|38205398|FG001|Overall Study|Lost to Follow-up|1|||
17062606|NCT00628355|38205406|FG000|Overall Study|Withdrawal by Subject|1|||
17062607|NCT00628355|38205407|FG001|Overall Study|Withdrawal by Subject|1|||
17062608|NCT00627497|38205418|FG000|Overall Study|Lost to Follow-up|1|||
17062609|NCT00627497|38205419|FG001|Overall Study|Lost to Follow-up|1|||
17062610|NCT00627497|38205420|FG002|Overall Study|Lost to Follow-up|0|||
17062611|NCT00627497|38205421|FG003|Overall Study|Lost to Follow-up|0|||
17062612|NCT00648167|38205431|FG000|Overall Study|Adverse Event|6|||
17062613|NCT00648167|38205431|FG000|Overall Study|unable to swallow tablets|1|||
17062614|NCT00647699|38205465|FG000|Overall Study|Lost to Follow-up|5|||
17062615|NCT00647699|38205466|FG001|Overall Study|Lost to Follow-up|4|||
17062616|NCT00647699|38205465|FG000|Overall Study|Withdrawal by Subject|3|||
17062617|NCT00647699|38205466|FG001|Overall Study|Withdrawal by Subject|8|||
17062618|NCT00467649|38205474|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
17062619|NCT00467649|38205475|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
17062620|NCT00467649|38205476|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
17062621|NCT00467649|38205477|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
17062622|NCT00467649|38205478|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
17062623|NCT00467649|38205479|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
17062624|NCT00467649|38205474|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
17062625|NCT00467649|38205475|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
17062626|NCT00467649|38205476|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
17062627|NCT00467649|38205477|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
17062628|NCT00467649|38205478|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
17062629|NCT00467649|38205479|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
17062630|NCT00467649|38205474|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
17062631|NCT00467649|38205475|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
17062632|NCT00467649|38205476|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
17062633|NCT00467649|38205477|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
17062634|NCT00467649|38205478|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
17146397|NCT03619837|38290474|FG000|Screening|died on the wait-list|2|||
17146398|NCT03619837|38290474|FG000|Screening|remained on the wait list|40|||
17062635|NCT00467649|38205479|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
17062636|NCT00467649|38205474|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
17062637|NCT00467649|38205475|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
17062638|NCT00467649|38205476|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
17062639|NCT00467649|38205477|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
17062640|NCT00467649|38205478|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
17062641|NCT00467649|38205479|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
17062642|NCT00467649|38205474|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
17062643|NCT00467649|38205475|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
17062644|NCT00467649|38205476|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
17062645|NCT00467649|38205477|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
17062646|NCT00467649|38205478|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
17062647|NCT00467649|38205479|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
17062648|NCT00467649|38205474|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
17062649|NCT00467649|38205475|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
17062650|NCT00467649|38205476|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
17062651|NCT00467649|38205477|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
17062652|NCT00467649|38205478|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
17062653|NCT00467649|38205479|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
17062654|NCT00467649|38205474|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
17062655|NCT00467649|38205475|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
17062656|NCT00467649|38205476|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
17062657|NCT00467649|38205477|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
17062658|NCT00467649|38205478|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
17062659|NCT00467649|38205479|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
17062660|NCT00450333|38205501|FG000|Overall Study|Study terminated|47|||
17062661|NCT00450333|38205502|FG001|Overall Study|Study terminated|54|||
17062662|NCT00450333|38205503|FG002|Overall Study|Study terminated|16|||
17062663|NCT00450333|38205504|FG003|Overall Study|Study terminated|21|||
17062664|NCT00450333|38205501|FG000|Overall Study|Adverse Event|1|||
17062665|NCT00450333|38205502|FG001|Overall Study|Adverse Event|7|||
17062666|NCT00450333|38205503|FG002|Overall Study|Adverse Event|2|||
17062667|NCT00450333|38205504|FG003|Overall Study|Adverse Event|2|||
17062668|NCT00450333|38205501|FG000|Overall Study|Protocol Violation|1|||
17062669|NCT00450333|38205502|FG001|Overall Study|Protocol Violation|0|||
17062670|NCT00450333|38205503|FG002|Overall Study|Protocol Violation|1|||
17062671|NCT00450333|38205504|FG003|Overall Study|Protocol Violation|0|||
17062672|NCT00450333|38205501|FG000|Overall Study|Withdrawal by Subject|1|||
17062673|NCT00450333|38205502|FG001|Overall Study|Withdrawal by Subject|0|||
17062674|NCT00450333|38205503|FG002|Overall Study|Withdrawal by Subject|3|||
17062675|NCT00450333|38205504|FG003|Overall Study|Withdrawal by Subject|0|||
17062676|NCT00450333|38205501|FG000|Overall Study|Kidney transplant|1|||
17062677|NCT00450333|38205502|FG001|Overall Study|Kidney transplant|0|||
17062678|NCT00450333|38205503|FG002|Overall Study|Kidney transplant|1|||
17062679|NCT00450333|38205504|FG003|Overall Study|Kidney transplant|3|||
17062680|NCT00450333|38205501|FG000|Overall Study|Death|3|||
17062681|NCT00450333|38205502|FG001|Overall Study|Death|2|||
17062682|NCT00450333|38205503|FG002|Overall Study|Death|2|||
17062683|NCT00450333|38205504|FG003|Overall Study|Death|2|||
17062684|NCT00643565|38205516|FG000|Overall Study|Death|12|||
17062685|NCT00643565|38205517|FG001|Overall Study|Death|11|||
17062686|NCT00643565|38205516|FG000|Overall Study|Withdrawal by Subject|4|||
17062687|NCT00643565|38205517|FG001|Overall Study|Withdrawal by Subject|1|||
17062688|NCT00643565|38205516|FG000|Overall Study|Lost to Follow-up|0|||
17062689|NCT00643565|38205517|FG001|Overall Study|Lost to Follow-up|6|||
17062690|NCT00643565|38205516|FG000|Overall Study|Other|7|||
17062691|NCT00643565|38205517|FG001|Overall Study|Other|8|||
17062692|NCT00643565|38205516|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
17146399|NCT03619837|38290474|FG000|Screening|didn't meet eligibility criteria|3|||
17146400|NCT03619837|38290474|FG000|Screening|withdrew consent|2|||
17146401|NCT03619837|38290474|FG000|Screening|never listed for HCV-viremic donor|1|||
17146402|NCT03619837|38290474|FG000|Screening|developed exclusion criteria|2|||
17146403|NCT03619837|38290474|FG000|Screening|excluded by the investigator due to non-compliance|1|||
17146404|NCT03206970|38290478|FG000|Overall Study|Death|21|||
17146405|NCT03206970|38290478|FG000|Overall Study|Withdrawal by Subject|13|||
17146406|NCT03206970|38290478|FG000|Overall Study|Lost to Follow-up|3|||
17146407|NCT03206970|38290478|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
17146408|NCT03644173|38290482|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
17146409|NCT03644173|38290482|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
17146410|NCT03644173|38290482|FG000|Participants at the 1-month Follow up|Death|2|||
17146411|NCT03644173|38290482|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
17146412|NCT03178851|38290490|FG000|Overall Study|Death|48|||
17146413|NCT03178851|38290491|FG001|Overall Study|Death|2|||
17146414|NCT03178851|38290492|FG002|Overall Study|Death|25|||
17146415|NCT03178851|38290490|FG000|Overall Study|Withdrawal by Subject|8|||
17146416|NCT03178851|38290491|FG001|Overall Study|Withdrawal by Subject|0|||
17146417|NCT03178851|38290492|FG002|Overall Study|Withdrawal by Subject|0|||
17146418|NCT03178851|38290490|FG000|Overall Study|Lost to Follow-up|5|||
17146419|NCT03178851|38290491|FG001|Overall Study|Lost to Follow-up|2|||
17146420|NCT03178851|38290492|FG002|Overall Study|Lost to Follow-up|0|||
17146421|NCT03178851|38290490|FG000|Overall Study|Adverse Event|0|||
17062693|NCT00643565|38205517|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
17062694|NCT00643565|38205516|FG000|Overall Study|Recurrence of Disease|2|||
17062695|NCT00643565|38205517|FG001|Overall Study|Recurrence of Disease|1|||
17062696|NCT00643565|38205516|FG000|Overall Study|Progression of Disease|18|||
17062697|NCT00643565|38205517|FG001|Overall Study|Progression of Disease|14|||
17062698|NCT00643565|38205516|FG000|Overall Study|Protocol Violation|3|||
17062699|NCT00643565|38205517|FG001|Overall Study|Protocol Violation|0|||
17062700|NCT00643565|38205516|FG000|Overall Study|Did Not Cooperate|0|||
17062701|NCT00643565|38205517|FG001|Overall Study|Did Not Cooperate|1|||
17062702|NCT00643565|38205516|FG000|Overall Study|Administrative|22|||
17062703|NCT00643565|38205517|FG001|Overall Study|Administrative|16|||
17062704|NCT00643565|38205516|FG000|Overall Study|Adverse Event|5|||
17062705|NCT00643565|38205517|FG001|Overall Study|Adverse Event|8|||
17062706|NCT00643487|38205524|FG000|Overall Study|Technical difficulty|3|||
17062707|NCT00450255|38205528|FG000|Overall Study|Prior RFA ablation of liver|1|||
17062708|NCT00450177|38205535|FG000|Overall Study|Adverse Event|7|||
17062709|NCT00450177|38205536|FG001|Overall Study|Adverse Event|4|||
17062710|NCT00450177|38205535|FG000|Overall Study|Withdrawal by Subject|1|||
17062711|NCT00450177|38205536|FG001|Overall Study|Withdrawal by Subject|6|||
17062712|NCT00450177|38205535|FG000|Overall Study|Withdrawal by Primary Team|1|||
17062713|NCT00450177|38205536|FG001|Overall Study|Withdrawal by Primary Team|1|||
17062714|NCT03848949|38205544|FG000|Overall Study|Lost to Follow-up|5|||
17062715|NCT03848949|38205545|FG001|Overall Study|Lost to Follow-up|7|||
17146422|NCT03178851|38290491|FG001|Overall Study|Adverse Event|0|||
17062716|NCT00467259|38205553|FG000|Overall Study|Adverse Event|24|||
17062717|NCT00467259|38205554|FG001|Overall Study|Adverse Event|90|||
17062718|NCT00467259|38205553|FG000|Overall Study|Protocol Violation|1|||
17062719|NCT00467259|38205554|FG001|Overall Study|Protocol Violation|7|||
17062720|NCT00467259|38205553|FG000|Overall Study|Withdrawal by Subject|34|||
17062721|NCT00467259|38205554|FG001|Overall Study|Withdrawal by Subject|108|||
17062722|NCT00467259|38205553|FG000|Overall Study|Physician Decision|0|||
17062723|NCT00467259|38205554|FG001|Overall Study|Physician Decision|2|||
17062724|NCT00467259|38205553|FG000|Overall Study|Lost to Follow-up|14|||
17062725|NCT00467259|38205554|FG001|Overall Study|Lost to Follow-up|34|||
17062726|NCT00467259|38205553|FG000|Overall Study|Site Closed|2|||
17062727|NCT00467259|38205554|FG001|Overall Study|Site Closed|1|||
17062728|NCT00449865|38205562|FG000|Overall Study|Withdrawal by Subject|110|||
17062729|NCT00449865|38205563|FG001|Overall Study|Withdrawal by Subject|110|||
17062730|NCT00449865|38205562|FG000|Overall Study|Lost to Follow-up|36|||
17062731|NCT00449865|38205563|FG001|Overall Study|Lost to Follow-up|37|||
17062732|NCT00449865|38205562|FG000|Overall Study|Physician Decision|13|||
17062733|NCT00449865|38205563|FG001|Overall Study|Physician Decision|12|||
17062734|NCT00449865|38205562|FG000|Overall Study|Death|31|||
17062735|NCT00449865|38205563|FG001|Overall Study|Death|40|||
17062736|NCT00449865|38205562|FG000|Overall Study|Protocol Violation|8|||
17062737|NCT00449865|38205563|FG001|Overall Study|Protocol Violation|7|||
17062738|NCT00449865|38205562|FG000|Overall Study|Study was stopped|324|||
17062739|NCT00449865|38205563|FG001|Overall Study|Study was stopped|328|||
17062740|NCT00449787|38205571|FG000|Overall Study|Lost to Follow-up|10|||
17062741|NCT00449787|38205572|FG001|Overall Study|Lost to Follow-up|8|||
17062742|NCT00449787|38205571|FG000|Overall Study|Did not require medication|95|||
17062743|NCT00449787|38205572|FG001|Overall Study|Did not require medication|92|||
17062744|NCT00449163|38205580|FG000|Overall Study|Physician Decision|3|||
17062745|NCT00448539|38205586|FG000|Overall Study|Medication non-compliance|4|||
17062746|NCT00448539|38205587|FG001|Overall Study|Medication non-compliance|1|||
17062747|NCT00448539|38205586|FG000|Overall Study|Protocol Violation|1|||
17062748|NCT00448539|38205587|FG001|Overall Study|Protocol Violation|0|||
17062749|NCT00448539|38205586|FG000|Overall Study|Request of the investigator or sponsor|67|||
17062750|NCT00448539|38205587|FG001|Overall Study|Request of the investigator or sponsor|54|||
17062751|NCT00448539|38205586|FG000|Overall Study|Withdrawal by Subject|20|||
17062752|NCT00448539|38205587|FG001|Overall Study|Withdrawal by Subject|24|||
17062753|NCT00448539|38205586|FG000|Overall Study|Diary non-compliance|1|||
17062754|NCT00448539|38205587|FG001|Overall Study|Diary non-compliance|0|||
17062755|NCT00448539|38205586|FG000|Overall Study|Adverse Event|9|||
17062756|NCT00448539|38205587|FG001|Overall Study|Adverse Event|26|||
17146423|NCT03178851|38290492|FG002|Overall Study|Adverse Event|1|||
17146424|NCT03178851|38290490|FG000|Overall Study|Study Termination by Sponsor|31|||
17146425|NCT03178851|38290491|FG001|Overall Study|Study Termination by Sponsor|7|||
17146426|NCT03178851|38290492|FG002|Overall Study|Study Termination by Sponsor|26|||
17146427|NCT03643159|38290503|FG000|Overall Study|Adverse Event|1|||
17146428|NCT03643159|38290503|FG000|Overall Study|Withdrawal by Subject|1|||
17146429|NCT03205566|38290510|FG000|Phase 1|Protocol Violation|1|||
17146430|NCT03205566|38290511|FG001|Phase 1|Protocol Violation|1|||
17146431|NCT02935452|38290523|FG000|Overall Study|work and life commintment|3|||
17146432|NCT02935452|38290524|FG001|Overall Study|work and life commintment|1|||
17146433|NCT03178773|38290532|FG000|Overall Study|Death|0|||
17146434|NCT03178773|38290533|FG001|Overall Study|Death|1|||
17146435|NCT03178773|38290532|FG000|Overall Study|Lost to Follow-up|29|||
17146436|NCT03178773|38290533|FG001|Overall Study|Lost to Follow-up|25|||
17146437|NCT03178773|38290532|FG000|Overall Study|Withdrawal by Subject|10|||
17062757|NCT00448539|38205586|FG000|Overall Study|Lack of Efficacy|27|||
17146438|NCT03178773|38290533|FG001|Overall Study|Withdrawal by Subject|14|||
17146439|NCT03713034|38290542|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
17146440|NCT03713034|38290543|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
17146441|NCT03218397|38290553|FG000|Overall Study|Prior positive blood culture|8|||
17146442|NCT03218397|38290554|FG001|Overall Study|Prior positive blood culture|13|||
16993801|NCT01072175|38137818|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993802|NCT01072175|38137819|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993803|NCT01072175|38137820|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993804|NCT01072175|38137821|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993805|NCT01072175|38137822|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993806|NCT01072175|38137823|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993807|NCT01072175|38137824|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
17146443|NCT03218397|38290553|FG000|Overall Study|Comfort care|8|||
17062758|NCT00448539|38205587|FG001|Overall Study|Lack of Efficacy|40|||
17146444|NCT03218397|38290554|FG001|Overall Study|Comfort care|5|||
17146445|NCT03218397|38290553|FG000|Overall Study|Comfort care and positive blood culture|1|||
17146446|NCT03218397|38290554|FG001|Overall Study|Comfort care and positive blood culture|0|||
17146447|NCT03218397|38290553|FG000|Overall Study|Comfort care and mixed culture|0|||
17146448|NCT03218397|38290554|FG001|Overall Study|Comfort care and mixed culture|1|||
17146449|NCT03218397|38290553|FG000|Overall Study|Mixed culture|2|||
17146450|NCT03218397|38290554|FG001|Overall Study|Mixed culture|2|||
17146451|NCT03218397|38290553|FG000|Overall Study|Inaccessible hospital records|2|||
17146452|NCT03218397|38290554|FG001|Overall Study|Inaccessible hospital records|5|||
17146453|NCT03218397|38290553|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
17146454|NCT03218397|38290554|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
17146455|NCT03218397|38290553|FG000|Overall Study|Randomized during laboratory off hours|2|||
17146456|NCT03218397|38290554|FG001|Overall Study|Randomized during laboratory off hours|1|||
17146457|NCT03618823|38290562|FG000|Overall Study|Lost to Follow-up|63|||
17062759|NCT00448539|38205586|FG000|Overall Study|Miscellaneous|2|||
17062760|NCT00448539|38205587|FG001|Overall Study|Miscellaneous|1|||
17062761|NCT00448539|38205586|FG000|Overall Study|Change of meds|2|||
17062762|NCT00448539|38205587|FG001|Overall Study|Change of meds|3|||
17062763|NCT00448539|38205586|FG000|Overall Study|Lost to Follow-up|1|||
17062764|NCT00448539|38205587|FG001|Overall Study|Lost to Follow-up|3|||
17062765|NCT00457665|38205595|FG000|12 Months|Drug allergy|1|||
17062766|NCT00457665|38205596|FG001|12 Months|Drug allergy|1|||
17062767|NCT00457665|38205595|FG000|12 Months|High HIV viral load|5|||
17146458|NCT03618823|38290563|FG001|Overall Study|Lost to Follow-up|61|||
17146459|NCT03640507|38290575|FG000|Overall Study|Withdrawal by Subject|0|||
17146460|NCT03640507|38290576|FG001|Overall Study|Withdrawal by Subject|0|||
17146461|NCT03640507|38290577|FG002|Overall Study|Withdrawal by Subject|1|||
17146462|NCT02937636|38290587|FG000|Overall Study|Other (Not specified)|3|||
17146463|NCT02937636|38290588|FG001|Overall Study|Other (Not specified)|2|||
17146464|NCT03638635|38290597|FG000|Initial Hospitalization|Study terminated prematurely|0|||
17146465|NCT03638635|38290598|FG001|Initial Hospitalization|Study terminated prematurely|1|||
17146466|NCT03638635|38290597|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
17146467|NCT03638635|38290598|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
17146468|NCT03638635|38290597|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
17146469|NCT03638635|38290598|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
17146470|NCT03204981|38290604|FG000|Overall Study|Physician Decision|2|||
17146471|NCT03204981|38290604|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
17146472|NCT03205488|38290613|FG000|Overall Study|Adverse Event|1|||
17146473|NCT03205488|38290614|FG001|Overall Study|Adverse Event|2|||
17146474|NCT03205488|38290615|FG002|Overall Study|Adverse Event|4|||
17146475|NCT03205488|38290613|FG000|Overall Study|Protocol Violation|0|||
17146476|NCT03205488|38290614|FG001|Overall Study|Protocol Violation|0|||
17146477|NCT03205488|38290615|FG002|Overall Study|Protocol Violation|1|||
17146478|NCT02932332|38290631|FG000|Overall Study|Withdrawal by Subject|1|||
17146479|NCT02932332|38290632|FG001|Overall Study|Withdrawal by Subject|1|||
17146480|NCT02932332|38290633|FG002|Overall Study|Withdrawal by Subject|0|||
17062768|NCT00457665|38205596|FG001|12 Months|High HIV viral load|1|||
17146481|NCT02932332|38290634|FG003|Overall Study|Withdrawal by Subject|1|||
17146482|NCT02932332|38290631|FG000|Overall Study|Chest pain|0|||
17146483|NCT02932332|38290632|FG001|Overall Study|Chest pain|0|||
17146484|NCT02932332|38290633|FG002|Overall Study|Chest pain|0|||
17062769|NCT00457665|38205595|FG000|12 Months|Lipodystrophy|2|||
17062770|NCT00457665|38205596|FG001|12 Months|Lipodystrophy|0|||
17062771|NCT00457665|38205595|FG000|12 Months|Withdrawal by Subject|0|||
17062772|NCT00457665|38205596|FG001|12 Months|Withdrawal by Subject|2|||
17062773|NCT00457665|38205595|FG000|12 Months|Abnormal Liver function tests|0|||
17062774|NCT00457665|38205596|FG001|12 Months|Abnormal Liver function tests|5|||
17062775|NCT00457665|38205595|FG000|24 Months|Withdrawal by Subject|3|||
17062776|NCT00457665|38205596|FG001|24 Months|Withdrawal by Subject|2|||
17146485|NCT02932332|38290634|FG003|Overall Study|Chest pain|1|||
17062777|NCT00457665|38205595|FG000|24 Months|Lipodystrophy|1|||
17062778|NCT00457665|38205596|FG001|24 Months|Lipodystrophy|1|||
17062779|NCT00457665|38205595|FG000|24 Months|Abnormal liver function tests|1|||
17062780|NCT00457665|38205596|FG001|24 Months|Abnormal liver function tests|5|||
17146486|NCT02932332|38290631|FG000|Overall Study|Not Dyspneic cough|1|||
17146487|NCT02932332|38290632|FG001|Overall Study|Not Dyspneic cough|2|||
17146488|NCT02932332|38290633|FG002|Overall Study|Not Dyspneic cough|1|||
17146489|NCT02932332|38290634|FG003|Overall Study|Not Dyspneic cough|0|||
17146490|NCT03204279|38290646|FG000|Overall Study|Withdrawal by Subject|0|||
17146491|NCT03204279|38290647|FG001|Overall Study|Withdrawal by Subject|1|||
17146492|NCT03173547|38290656|FG000|Overall Study|Adverse Event|2|||
17146493|NCT03173547|38290657|FG001|Overall Study|Adverse Event|0|||
17062781|NCT00447603|38205602|FG000|Screening|Withdrawal by Subject|1|||
17062782|NCT00447603|38205603|FG001|Screening|Withdrawal by Subject|0|||
17062783|NCT00447603|38205604|FG002|Screening|Withdrawal by Subject|0|||
17062784|NCT00447603|38205602|FG000|Screening|Protocol Violation|1|||
17062785|NCT00447603|38205603|FG001|Screening|Protocol Violation|0|||
17062786|NCT00447603|38205604|FG002|Screening|Protocol Violation|0|||
17062787|NCT00447603|38205602|FG000|Screening|Screen Failure|4|||
17062788|NCT00447603|38205603|FG001|Screening|Screen Failure|0|||
17062789|NCT00447603|38205604|FG002|Screening|Screen Failure|0|||
17062790|NCT00447603|38205602|FG000|Screening|Study Terminated by Sponsor|15|||
17146494|NCT03173547|38290656|FG000|Overall Study|Withdrawal by Subject|2|||
17146495|NCT03173547|38290657|FG001|Overall Study|Withdrawal by Subject|2|||
17062791|NCT00447603|38205603|FG001|Screening|Study Terminated by Sponsor|0|||
17062792|NCT00447603|38205604|FG002|Screening|Study Terminated by Sponsor|0|||
17062793|NCT00447603|38205602|FG000|Filter Period|Adverse Event|0|||
17062794|NCT00447603|38205603|FG001|Filter Period|Adverse Event|0|||
17062795|NCT00447603|38205604|FG002|Filter Period|Adverse Event|1|||
17062796|NCT00447603|38205602|FG000|Filter Period|Screen Failure|0|||
17062797|NCT00447603|38205603|FG001|Filter Period|Screen Failure|3|||
17062798|NCT00447603|38205604|FG002|Filter Period|Screen Failure|4|||
17062799|NCT00447603|38205602|FG000|Filter Period|Study terminated by Sponsor|0|||
17062800|NCT00447603|38205603|FG001|Filter Period|Study terminated by Sponsor|1|||
17062801|NCT00447603|38205604|FG002|Filter Period|Study terminated by Sponsor|10|||
17062802|NCT00447057|38205616|FG000|Overall Study|Adverse Event|4|||
17062803|NCT00447057|38205617|FG001|Overall Study|Adverse Event|10|||
17062804|NCT00447057|38205618|FG002|Overall Study|Adverse Event|0|||
17062805|NCT00447057|38205619|FG003|Overall Study|Adverse Event|3|||
17062806|NCT00447057|38205616|FG000|Overall Study|Death due to study disease|6|||
17062807|NCT00447057|38205617|FG001|Overall Study|Death due to study disease|4|||
17062808|NCT00447057|38205618|FG002|Overall Study|Death due to study disease|1|||
17062809|NCT00447057|38205619|FG003|Overall Study|Death due to study disease|1|||
17062810|NCT00447057|38205616|FG000|Overall Study|Lost to Follow-up|0|||
17062811|NCT00447057|38205617|FG001|Overall Study|Lost to Follow-up|1|||
17062812|NCT00447057|38205618|FG002|Overall Study|Lost to Follow-up|0|||
17062813|NCT00447057|38205619|FG003|Overall Study|Lost to Follow-up|0|||
17062814|NCT00447057|38205616|FG000|Overall Study|Entry criteria not met|1|||
17062815|NCT00447057|38205617|FG001|Overall Study|Entry criteria not met|1|||
17146496|NCT02954653|38290665|FG000|Overall Study|Death|3|||
17146497|NCT02954653|38290666|FG001|Overall Study|Death|1|||
17146498|NCT02954653|38290667|FG002|Overall Study|Death|0|||
17146499|NCT02954653|38290668|FG003|Overall Study|Death|0|||
17146500|NCT02954653|38290669|FG004|Overall Study|Death|0|||
17146501|NCT02954653|38290670|FG005|Overall Study|Death|0|||
17146502|NCT02954653|38290671|FG006|Overall Study|Death|0|||
17146503|NCT02954653|38290672|FG007|Overall Study|Death|0|||
17146504|NCT02954653|38290673|FG008|Overall Study|Death|0|||
17062816|NCT00447057|38205618|FG002|Overall Study|Entry criteria not met|0|||
17146505|NCT02954653|38290665|FG000|Overall Study|Randomized but did not receive treatment|1|||
17146506|NCT02954653|38290666|FG001|Overall Study|Randomized but did not receive treatment|0|||
17146507|NCT02954653|38290667|FG002|Overall Study|Randomized but did not receive treatment|0|||
17146508|NCT02954653|38290668|FG003|Overall Study|Randomized but did not receive treatment|0|||
17146509|NCT02954653|38290669|FG004|Overall Study|Randomized but did not receive treatment|0|||
17146510|NCT02954653|38290670|FG005|Overall Study|Randomized but did not receive treatment|0|||
17146511|NCT02954653|38290671|FG006|Overall Study|Randomized but did not receive treatment|0|||
17146512|NCT02954653|38290672|FG007|Overall Study|Randomized but did not receive treatment|0|||
17146513|NCT02954653|38290673|FG008|Overall Study|Randomized but did not receive treatment|0|||
17146514|NCT02954653|38290665|FG000|Overall Study|Started another anti-cancer therapy|0|||
17146515|NCT02954653|38290666|FG001|Overall Study|Started another anti-cancer therapy|1|||
17062817|NCT00447057|38205619|FG003|Overall Study|Entry criteria not met|0|||
17062818|NCT00447057|38205616|FG000|Overall Study|Protocol Violation|0|||
17062819|NCT00447057|38205617|FG001|Overall Study|Protocol Violation|1|||
17062820|NCT00447057|38205618|FG002|Overall Study|Protocol Violation|0|||
17062821|NCT00447057|38205619|FG003|Overall Study|Protocol Violation|0|||
17062822|NCT00447057|38205616|FG000|Overall Study|Withdrawal by Subject|4|||
17062823|NCT00447057|38205617|FG001|Overall Study|Withdrawal by Subject|5|||
17062824|NCT00447057|38205618|FG002|Overall Study|Withdrawal by Subject|1|||
17062825|NCT00447057|38205619|FG003|Overall Study|Withdrawal by Subject|1|||
17062826|NCT00447057|38205616|FG000|Overall Study|Physician Decision|9|||
17062827|NCT00447057|38205617|FG001|Overall Study|Physician Decision|6|||
17062828|NCT00447057|38205618|FG002|Overall Study|Physician Decision|3|||
17062829|NCT00447057|38205619|FG003|Overall Study|Physician Decision|1|||
17062830|NCT00447057|38205616|FG000|Overall Study|Sponsor decision|1|||
17062831|NCT00447057|38205617|FG001|Overall Study|Sponsor decision|1|||
17062832|NCT00447057|38205618|FG002|Overall Study|Sponsor decision|0|||
17062833|NCT00447057|38205619|FG003|Overall Study|Sponsor decision|0|||
17062834|NCT00447057|38205616|FG000|Overall Study|Progressive disease|58|||
17146516|NCT02954653|38290667|FG002|Overall Study|Started another anti-cancer therapy|0|||
17146517|NCT02954653|38290668|FG003|Overall Study|Started another anti-cancer therapy|0|||
17146518|NCT02954653|38290669|FG004|Overall Study|Started another anti-cancer therapy|0|||
17146519|NCT02954653|38290670|FG005|Overall Study|Started another anti-cancer therapy|0|||
17146520|NCT02954653|38290671|FG006|Overall Study|Started another anti-cancer therapy|0|||
17146521|NCT02954653|38290672|FG007|Overall Study|Started another anti-cancer therapy|0|||
17146522|NCT02954653|38290673|FG008|Overall Study|Started another anti-cancer therapy|0|||
17146523|NCT02954653|38290665|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
17146524|NCT02954653|38290666|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
17146525|NCT02954653|38290667|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
17146526|NCT02954653|38290668|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
17146527|NCT02954653|38290669|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
17146528|NCT02954653|38290670|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
17146529|NCT02954653|38290671|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
17146530|NCT02954653|38290672|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
17146531|NCT02954653|38290673|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
17146532|NCT03173313|38290687|FG000|Overall Study|Lost to Follow-up|2|||
17146533|NCT03173313|38290688|FG001|Overall Study|Lost to Follow-up|3|||
17146534|NCT03173313|38290687|FG000|Overall Study|Withdrawal by Subject|0|||
17146535|NCT03173313|38290688|FG001|Overall Study|Withdrawal by Subject|1|||
17146536|NCT03173313|38290687|FG000|Overall Study|Death|5|||
17146537|NCT03173313|38290688|FG001|Overall Study|Death|0|||
17146538|NCT03173313|38290687|FG000|Overall Study|Physician Decision|1|||
17146539|NCT03173313|38290688|FG001|Overall Study|Physician Decision|0|||
17146540|NCT03173313|38290687|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
17146541|NCT03173313|38290688|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
17146542|NCT03173313|38290687|FG000|Overall Study|Bone Fracture|1|||
17146543|NCT03173313|38290688|FG001|Overall Study|Bone Fracture|0|||
17146544|NCT03215667|38290694|FG000|Overall Study|Physician Decision|4|||
17146545|NCT03634579|38290698|FG000|Overall Study|study termination|9|||
17146546|NCT02730208|38290704|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
17146547|NCT02730208|38290705|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
17146548|NCT03170349|38290711|FG000|At 30 Days Follow-up|Death|1|||
17146549|NCT03170349|38290711|FG000|At 6 Months Follow-up|Death|3|||
17146550|NCT03170349|38290711|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
17146551|NCT03170349|38290711|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
17146552|NCT03170349|38290711|FG000|At 1 Year Follow-up|Death|6|||
17146553|NCT03170349|38290711|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
17146554|NCT03201900|38290715|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
17146555|NCT03201900|38290715|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
17146556|NCT03201900|38290715|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
17146557|NCT03201900|38290715|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
17146558|NCT03201900|38290715|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
17146559|NCT03201900|38290715|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
17062835|NCT00447057|38205617|FG001|Overall Study|Progressive disease|43|||
17146560|NCT03201900|38290715|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
17146561|NCT03201900|38290715|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
17146562|NCT03201900|38290715|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
17146563|NCT03201900|38290715|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
17146564|NCT03201900|38290715|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
17146565|NCT03201900|38290715|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
17146566|NCT03201900|38290715|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
17146567|NCT03170271|38290730|FG000|Overall Study|Adverse Event|7|||
17146568|NCT03170271|38290731|FG001|Overall Study|Adverse Event|2|||
17146569|NCT03170271|38290730|FG000|Overall Study|Lost to Follow-up|0|||
17146570|NCT03170271|38290731|FG001|Overall Study|Lost to Follow-up|1|||
17146571|NCT03170271|38290730|FG000|Overall Study|Physician Decision|1|||
17146572|NCT03170271|38290731|FG001|Overall Study|Physician Decision|0|||
17146573|NCT03170271|38290730|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
17146574|NCT03170271|38290731|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
17146575|NCT03170271|38290730|FG000|Overall Study|Withdrawal by Subject|17|||
17146576|NCT03170271|38290731|FG001|Overall Study|Withdrawal by Subject|5|||
17146577|NCT03170271|38290730|FG000|Overall Study|Other|2|||
17146578|NCT03170271|38290731|FG001|Overall Study|Other|2|||
17146579|NCT03170271|38290730|FG000|Overall Study|Randomized in error|4|||
17146580|NCT03170271|38290731|FG001|Overall Study|Randomized in error|0|||
17062836|NCT00447057|38205618|FG002|Overall Study|Progressive disease|13|||
17062837|NCT00447057|38205619|FG003|Overall Study|Progressive disease|18|||
17062838|NCT00447057|38205616|FG000|Overall Study|Death due to adverse event|0|||
17062839|NCT00447057|38205617|FG001|Overall Study|Death due to adverse event|0|||
17062840|NCT00447057|38205618|FG002|Overall Study|Death due to adverse event|1|||
17062841|NCT00447057|38205619|FG003|Overall Study|Death due to adverse event|2|||
17062842|NCT00447057|38205616|FG000|Overall Study|Death, study drug related|0|||
17062843|NCT00447057|38205617|FG001|Overall Study|Death, study drug related|1|||
17062844|NCT00447057|38205618|FG002|Overall Study|Death, study drug related|0|||
17146581|NCT03613129|38290741|FG000|Pre-treatment Assessment|Protocol Violation|2|||
17146582|NCT03613129|38290742|FG001|Pre-treatment Assessment|Protocol Violation|0|||
17146583|NCT03613129|38290743|FG002|Pre-treatment Assessment|Protocol Violation|0|||
17146584|NCT03613129|38290744|FG003|Pre-treatment Assessment|Protocol Violation|0|||
17146585|NCT03613129|38290745|FG004|Pre-treatment Assessment|Protocol Violation|0|||
17146586|NCT03613129|38290741|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
17146587|NCT03613129|38290742|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
17146588|NCT03613129|38290743|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
17146589|NCT03613129|38290744|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
17146590|NCT03613129|38290745|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
17146591|NCT03235284|38290760|FG000|Overall Study|Adverse Event|1|||
17146592|NCT03235284|38290761|FG001|Overall Study|Adverse Event|2|||
17146593|NCT03235284|38290762|FG002|Overall Study|Adverse Event|1|||
17146594|NCT03170193|38290777|FG000|Overall Study|Withdrawal by Subject|0|||
17146595|NCT03170193|38290778|FG001|Overall Study|Withdrawal by Subject|0|||
17146596|NCT03170193|38290779|FG002|Overall Study|Withdrawal by Subject|0|||
17146597|NCT03170193|38290780|FG003|Overall Study|Withdrawal by Subject|1|||
17146598|NCT03170193|38290781|FG004|Overall Study|Withdrawal by Subject|0|||
17146599|NCT03170193|38290782|FG005|Overall Study|Withdrawal by Subject|0|||
17146600|NCT03170193|38290783|FG006|Overall Study|Withdrawal by Subject|0|||
17062845|NCT00447057|38205619|FG003|Overall Study|Death, study drug related|0|||
17146601|NCT03170193|38290777|FG000|Overall Study|Lost to Follow-up|1|||
17146602|NCT03170193|38290778|FG001|Overall Study|Lost to Follow-up|1|||
17146603|NCT03170193|38290779|FG002|Overall Study|Lost to Follow-up|0|||
17146604|NCT03170193|38290780|FG003|Overall Study|Lost to Follow-up|0|||
17146605|NCT03170193|38290781|FG004|Overall Study|Lost to Follow-up|0|||
17146606|NCT03170193|38290782|FG005|Overall Study|Lost to Follow-up|0|||
17146607|NCT03170193|38290783|FG006|Overall Study|Lost to Follow-up|0|||
17146608|NCT03633331|38290805|FG000|Overall Study|Withdrawal by Subject|1|||
17062846|NCT00446511|38205631|FG000|Overall Study|Adverse Event|7|||
17062847|NCT00446511|38205632|FG001|Overall Study|Adverse Event|2|||
17062848|NCT00446511|38205633|FG002|Overall Study|Adverse Event|3|||
17062849|NCT00446511|38205634|FG003|Overall Study|Adverse Event|1|||
17062850|NCT00446511|38205631|FG000|Overall Study|Protocol Violation|0|||
17062851|NCT00446511|38205632|FG001|Overall Study|Protocol Violation|0|||
17062852|NCT00446511|38205633|FG002|Overall Study|Protocol Violation|0|||
17062853|NCT00446511|38205634|FG003|Overall Study|Protocol Violation|1|||
17062854|NCT00446511|38205631|FG000|Overall Study|Withdrawal by Subject|0|||
17062855|NCT00446511|38205632|FG001|Overall Study|Withdrawal by Subject|0|||
17062856|NCT00446511|38205633|FG002|Overall Study|Withdrawal by Subject|0|||
17062857|NCT00446511|38205634|FG003|Overall Study|Withdrawal by Subject|3|||
17062858|NCT00446511|38205631|FG000|Overall Study|Administrative Problems|3|||
17062859|NCT00446511|38205632|FG001|Overall Study|Administrative Problems|0|||
17062860|NCT00446511|38205633|FG002|Overall Study|Administrative Problems|4|||
17062861|NCT00446511|38205634|FG003|Overall Study|Administrative Problems|1|||
17062862|NCT00446199|38205650|FG000|Overall Study|Adverse Event|7|||
17062863|NCT00446199|38205651|FG001|Overall Study|Adverse Event|4|||
17062864|NCT00446199|38205652|FG002|Overall Study|Adverse Event|6|||
17062865|NCT00446199|38205653|FG003|Overall Study|Adverse Event|4|||
17062866|NCT00446199|38205650|FG000|Overall Study|Lost to Follow-up|4|||
17062867|NCT00446199|38205651|FG001|Overall Study|Lost to Follow-up|5|||
17062868|NCT00446199|38205652|FG002|Overall Study|Lost to Follow-up|2|||
17062869|NCT00446199|38205653|FG003|Overall Study|Lost to Follow-up|6|||
17062870|NCT00446199|38205650|FG000|Overall Study|Protocol Violation|1|||
17062871|NCT00446199|38205651|FG001|Overall Study|Protocol Violation|2|||
17062872|NCT00446199|38205652|FG002|Overall Study|Protocol Violation|1|||
17062873|NCT00446199|38205653|FG003|Overall Study|Protocol Violation|3|||
17062874|NCT00446199|38205650|FG000|Overall Study|Withdrawal by Subject|2|||
17062875|NCT00446199|38205651|FG001|Overall Study|Withdrawal by Subject|5|||
17062876|NCT00446199|38205652|FG002|Overall Study|Withdrawal by Subject|9|||
17062877|NCT00446199|38205653|FG003|Overall Study|Withdrawal by Subject|10|||
17062878|NCT00446199|38205650|FG000|Overall Study|Site termination|2|||
17062879|NCT00446199|38205651|FG001|Overall Study|Site termination|0|||
17062880|NCT00446199|38205652|FG002|Overall Study|Site termination|0|||
17062881|NCT00446199|38205653|FG003|Overall Study|Site termination|1|||
17062882|NCT00446199|38205650|FG000|Overall Study|Randomization in Error|2|||
17062883|NCT00446199|38205651|FG001|Overall Study|Randomization in Error|0|||
17062884|NCT00446199|38205652|FG002|Overall Study|Randomization in Error|1|||
17062885|NCT00446199|38205653|FG003|Overall Study|Randomization in Error|1|||
17062886|NCT00446199|38205650|FG000|Overall Study|Lack of Efficacy|1|||
17062887|NCT00446199|38205651|FG001|Overall Study|Lack of Efficacy|0|||
17062888|NCT00446199|38205652|FG002|Overall Study|Lack of Efficacy|0|||
17062889|NCT00446199|38205653|FG003|Overall Study|Lack of Efficacy|1|||
17062890|NCT00446199|38205650|FG000|Overall Study|Non-compliant with study drug|1|||
17062891|NCT00446199|38205651|FG001|Overall Study|Non-compliant with study drug|0|||
17062892|NCT00446199|38205652|FG002|Overall Study|Non-compliant with study drug|5|||
17062893|NCT00446199|38205653|FG003|Overall Study|Non-compliant with study drug|0|||
17062894|NCT00446199|38205650|FG000|Overall Study|Non-compliant with visit schedule|1|||
17062895|NCT00446199|38205651|FG001|Overall Study|Non-compliant with visit schedule|1|||
17062896|NCT00446199|38205652|FG002|Overall Study|Non-compliant with visit schedule|1|||
17062897|NCT00446199|38205653|FG003|Overall Study|Non-compliant with visit schedule|2|||
17062898|NCT00446199|38205650|FG000|Overall Study|Hormone fear|0|||
17062899|NCT00446199|38205651|FG001|Overall Study|Hormone fear|0|||
17062900|NCT00446199|38205652|FG002|Overall Study|Hormone fear|0|||
17062901|NCT00446199|38205653|FG003|Overall Study|Hormone fear|1|||
17062902|NCT00446199|38205650|FG000|Overall Study|Lost interest in study participation|0|||
17062903|NCT00446199|38205651|FG001|Overall Study|Lost interest in study participation|1|||
17062904|NCT00446199|38205652|FG002|Overall Study|Lost interest in study participation|0|||
17062905|NCT00446199|38205653|FG003|Overall Study|Lost interest in study participation|0|||
17062906|NCT00446199|38205650|FG000|Overall Study|In-/Exclusion criterion violated|2|||
17062907|NCT00446199|38205651|FG001|Overall Study|In-/Exclusion criterion violated|1|||
17062908|NCT00446199|38205652|FG002|Overall Study|In-/Exclusion criterion violated|2|||
17062909|NCT00446199|38205653|FG003|Overall Study|In-/Exclusion criterion violated|1|||
17062910|NCT00446199|38205650|FG000|Overall Study|Move|0|||
17062911|NCT00446199|38205651|FG001|Overall Study|Move|1|||
17062912|NCT00446199|38205652|FG002|Overall Study|Move|0|||
17062913|NCT00446199|38205653|FG003|Overall Study|Move|0|||
17146609|NCT03201003|38290811|FG000|Overall Study|Adverse Event|14|||
17062914|NCT00456495|38205663|FG000|Overall Study|Physician Decision|2|||
17062915|NCT00445341|38205668|FG000|Overall Study|refused further treatment|1|||
17062916|NCT00445341|38205668|FG000|Overall Study|taken off treatment too early|1|||
17062917|NCT03846453|38205674|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
17062918|NCT03846453|38205675|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
17062919|NCT03846453|38205676|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
17062920|NCT03846453|38205674|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
17062921|NCT03846453|38205675|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
17062922|NCT03846453|38205676|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
17062923|NCT03846453|38205674|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
17062924|NCT03846453|38205675|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
17062925|NCT03846453|38205676|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
17146610|NCT03201003|38290812|FG001|Overall Study|Adverse Event|1|||
17146611|NCT03201003|38290811|FG000|Overall Study|Other reasons|5|||
17146612|NCT03201003|38290812|FG001|Overall Study|Other reasons|1|||
17146613|NCT03201003|38290811|FG000|Overall Study|Withdrawal by Subject|4|||
17146614|NCT03201003|38290812|FG001|Overall Study|Withdrawal by Subject|1|||
17146615|NCT03201003|38290811|FG000|Overall Study|Lost to Follow-up|2|||
17146616|NCT03201003|38290812|FG001|Overall Study|Lost to Follow-up|0|||
17146617|NCT03201003|38290811|FG000|Overall Study|Protocol Violation|1|||
17146618|NCT03201003|38290812|FG001|Overall Study|Protocol Violation|0|||
17146619|NCT03166215|38290820|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
17146620|NCT03166215|38290821|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
17146621|NCT03166215|38290822|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
17146622|NCT03166215|38290820|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
17146623|NCT03166215|38290821|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
17146624|NCT03166215|38290822|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
17146625|NCT03168711|38290844|FG000|Overall Study|Adverse Event|2|||
17146626|NCT03168711|38290845|FG001|Overall Study|Adverse Event|0|||
17146627|NCT03168711|38290844|FG000|Overall Study|Withdrawal by Subject|0|||
17146628|NCT03168711|38290845|FG001|Overall Study|Withdrawal by Subject|1|||
17146629|NCT03168711|38290844|FG000|Overall Study|Death|0|||
17146630|NCT03168711|38290845|FG001|Overall Study|Death|1|||
17146631|NCT03738215|38290854|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
17146632|NCT03738215|38290855|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
17146633|NCT03738215|38290856|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
17146634|NCT03738215|38290854|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
17146635|NCT03738215|38290855|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
17146636|NCT03738215|38290856|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
17146637|NCT03738215|38290854|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
17146638|NCT03738215|38290855|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
17146639|NCT03738215|38290856|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
17146640|NCT03738215|38290854|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
17146641|NCT03738215|38290855|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
17146642|NCT03738215|38290856|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
17146643|NCT03738215|38290854|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
17146644|NCT03738215|38290855|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
17146645|NCT03738215|38290856|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
17146646|NCT03738215|38290854|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
17146647|NCT03738215|38290855|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
17146648|NCT03738215|38290856|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
17146649|NCT03738215|38290854|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
17146650|NCT03738215|38290855|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
17146651|NCT03738215|38290856|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
17146652|NCT03738215|38290854|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
17146653|NCT03738215|38290855|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
17146654|NCT03738215|38290856|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
17146655|NCT03738215|38290854|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
17146656|NCT03738215|38290855|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
17146657|NCT03738215|38290856|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
17146658|NCT03738215|38290854|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
17146659|NCT03738215|38290855|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
17146660|NCT03738215|38290856|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
17146661|NCT03199911|38290866|FG000|Overall Study|Lost to Follow-up|5|||
17146662|NCT03199911|38290867|FG001|Overall Study|Lost to Follow-up|5|||
17146663|NCT03199911|38290866|FG000|Overall Study|Did not proceed with surgery|2|||
17062926|NCT03846453|38205674|FG000|Placebo Run-in (14 Days)|Other|2|||
17062927|NCT03846453|38205675|FG001|Placebo Run-in (14 Days)|Other|0|||
17062928|NCT03846453|38205676|FG002|Placebo Run-in (14 Days)|Other|0|||
17062929|NCT03846453|38205674|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
17062930|NCT03846453|38205675|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
17062931|NCT03846453|38205676|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
17062932|NCT03846453|38205674|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
17062933|NCT03846453|38205675|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
17062934|NCT03846453|38205676|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
17062935|NCT03846453|38205674|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
17062936|NCT03846453|38205675|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
17062937|NCT03846453|38205676|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
17062938|NCT03846453|38205674|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
17062939|NCT03846453|38205675|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
17062940|NCT03846453|38205676|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
17062941|NCT03846453|38205674|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
17062942|NCT03846453|38205675|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
17062943|NCT03846453|38205676|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
17062944|NCT00444951|38205687|FG000|Overall Study|Lost to Follow-up|1|||
17062945|NCT00444951|38205688|FG001|Overall Study|Lost to Follow-up|1|||
17062946|NCT00444951|38205689|FG002|Overall Study|Lost to Follow-up|0|||
17062947|NCT00444951|38205687|FG000|Overall Study|Withdrawal by Subject|4|||
17062948|NCT00444951|38205688|FG001|Overall Study|Withdrawal by Subject|5|||
17146664|NCT03199911|38290867|FG001|Overall Study|Did not proceed with surgery|1|||
17146665|NCT03736967|38290877|FG000|Overall Study|Withdrawal by Subject|26|||
17146666|NCT03736967|38290878|FG001|Overall Study|Withdrawal by Subject|25|||
17146667|NCT03736967|38290879|FG002|Overall Study|Withdrawal by Subject|23|||
17146668|NCT03736967|38290880|FG003|Overall Study|Withdrawal by Subject|26|||
17146669|NCT03736967|38290877|FG000|Overall Study|Lost to Follow-up|3|||
17146670|NCT03736967|38290878|FG001|Overall Study|Lost to Follow-up|2|||
17146671|NCT03736967|38290879|FG002|Overall Study|Lost to Follow-up|1|||
17146672|NCT03736967|38290880|FG003|Overall Study|Lost to Follow-up|1|||
17146673|NCT03736967|38290877|FG000|Overall Study|Physician Decision|1|||
17146674|NCT03736967|38290878|FG001|Overall Study|Physician Decision|0|||
17146675|NCT03736967|38290879|FG002|Overall Study|Physician Decision|0|||
17146676|NCT03736967|38290880|FG003|Overall Study|Physician Decision|1|||
17146677|NCT03736967|38290877|FG000|Overall Study|Adverse Event|0|||
17146678|NCT03736967|38290878|FG001|Overall Study|Adverse Event|1|||
17146679|NCT03736967|38290879|FG002|Overall Study|Adverse Event|0|||
17146680|NCT03736967|38290880|FG003|Overall Study|Adverse Event|1|||
17146681|NCT03736967|38290877|FG000|Overall Study|Death|0|||
17146682|NCT03736967|38290878|FG001|Overall Study|Death|0|||
17146683|NCT03736967|38290879|FG002|Overall Study|Death|0|||
17146684|NCT03736967|38290880|FG003|Overall Study|Death|1|||
17062949|NCT00444951|38205689|FG002|Overall Study|Withdrawal by Subject|3|||
17062950|NCT00444795|38205697|FG000|Overall Study|Not Treated|1|||
17062951|NCT00444795|38205697|FG000|Overall Study|Treated Prior to the Contract Date|2|||
17062952|NCT03846219|38205704|FG000|Overall Study|Withdrawal by Subject|3|||
17062953|NCT03846219|38205705|FG001|Overall Study|Withdrawal by Subject|2|||
17062954|NCT03846219|38205706|FG002|Overall Study|Withdrawal by Subject|2|||
17062955|NCT03846219|38205704|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
17062956|NCT03846219|38205705|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
17062957|NCT03846219|38205706|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
17062958|NCT03846219|38205704|FG000|Overall Study|Physician Decision|0|||
17062959|NCT03846219|38205705|FG001|Overall Study|Physician Decision|0|||
17062960|NCT03846219|38205706|FG002|Overall Study|Physician Decision|2|||
17062961|NCT00455325|38205722|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
17062962|NCT00455325|38205723|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
17062963|NCT00455325|38205724|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
17062964|NCT00455325|38205725|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
17146685|NCT03736967|38290877|FG000|Overall Study|Randomized but never treated|1|||
17146686|NCT03736967|38290878|FG001|Overall Study|Randomized but never treated|0|||
17062965|NCT00455325|38205722|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
17062966|NCT00455325|38205723|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
17062967|NCT00455325|38205724|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
17062968|NCT00455325|38205725|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
17062969|NCT00455325|38205722|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
17062970|NCT00455325|38205723|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
17146687|NCT03736967|38290879|FG002|Overall Study|Randomized but never treated|0|||
17146688|NCT03736967|38290880|FG003|Overall Study|Randomized but never treated|0|||
17146689|NCT03168555|38290893|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
17146690|NCT03168555|38290893|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
17146691|NCT03168555|38290893|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
17146692|NCT03168555|38290893|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
17146693|NCT03235050|38290905|FG000|Overall Study|Adverse Event|0|||
17146694|NCT03235050|38290906|FG001|Overall Study|Adverse Event|0|||
17146695|NCT03235050|38290907|FG002|Overall Study|Adverse Event|1|||
17146696|NCT03235050|38290908|FG003|Overall Study|Adverse Event|4|||
17146697|NCT03235050|38290909|FG004|Overall Study|Adverse Event|1|||
17146698|NCT03235050|38290905|FG000|Overall Study|Death|0|||
17146699|NCT03235050|38290906|FG001|Overall Study|Death|0|||
17062971|NCT00455325|38205724|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
17062972|NCT00455325|38205725|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
17062973|NCT00455325|38205722|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
17062974|NCT00455325|38205723|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
17062975|NCT00455325|38205724|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
17062976|NCT00455325|38205725|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
17062977|NCT00455325|38205722|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
17062978|NCT00455325|38205723|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
17062979|NCT00455325|38205724|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
17062980|NCT00455325|38205725|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
17062981|NCT00455325|38205722|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
17062982|NCT00455325|38205723|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
17062983|NCT00455325|38205724|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
17062984|NCT00455325|38205725|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
17062985|NCT00455325|38205722|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
17062986|NCT00455325|38205723|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
17062987|NCT00455325|38205724|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
17062988|NCT00455325|38205725|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
17062989|NCT00443781|38205736|FG000|Overall Study|Lost to Follow-up|10|||
17062990|NCT00443781|38205736|FG000|Overall Study|Physician Decision|2|||
17062991|NCT00443781|38205736|FG000|Overall Study|Protocol Violation|1|||
17062992|NCT00443781|38205736|FG000|Overall Study|Withdrawal by Subject|6|||
17062993|NCT00443781|38205736|FG000|Overall Study|Unable to comply with study follow up|2|||
17146700|NCT03235050|38290907|FG002|Overall Study|Death|0|||
17062994|NCT00443781|38205736|FG000|Overall Study|Investigator terminated participation|1|||
17062995|NCT00443781|38205736|FG000|Overall Study|Insurance not covered|2|||
17062996|NCT00443781|38205736|FG000|Overall Study|PD/FAD not done|1|||
17062997|NCT00443703|38205742|FG000|Overall Study|Never Treated|3|||
17062998|NCT00443703|38205743|FG001|Overall Study|Never Treated|1|||
17146701|NCT03235050|38290908|FG003|Overall Study|Death|2|||
17146702|NCT03235050|38290909|FG004|Overall Study|Death|1|||
17062999|NCT00443703|38205742|FG000|Overall Study|Adverse Event|7|||
17063000|NCT00443703|38205743|FG001|Overall Study|Adverse Event|3|||
17146703|NCT03235050|38290905|FG000|Overall Study|Lost to Follow-up|1|||
17146704|NCT03235050|38290906|FG001|Overall Study|Lost to Follow-up|2|||
17146705|NCT03235050|38290907|FG002|Overall Study|Lost to Follow-up|1|||
17146706|NCT03235050|38290908|FG003|Overall Study|Lost to Follow-up|2|||
17063001|NCT00443703|38205742|FG000|Overall Study|Lack of Efficacy|3|||
17063002|NCT00443703|38205743|FG001|Overall Study|Lack of Efficacy|1|||
17063003|NCT00443703|38205742|FG000|Overall Study|Lost to Follow-up|0|||
17063004|NCT00443703|38205743|FG001|Overall Study|Lost to Follow-up|4|||
17063005|NCT00443703|38205742|FG000|Overall Study|Physician Decision|4|||
17063006|NCT00443703|38205743|FG001|Overall Study|Physician Decision|2|||
17063007|NCT00443703|38205742|FG000|Overall Study|Protocol Violation|1|||
17063008|NCT00443703|38205743|FG001|Overall Study|Protocol Violation|1|||
17063009|NCT00443703|38205742|FG000|Overall Study|Withdrawal by Subject|9|||
17063010|NCT00443703|38205743|FG001|Overall Study|Withdrawal by Subject|6|||
17063011|NCT00443703|38205742|FG000|Overall Study|Progressive Disease|1|||
17063012|NCT00443703|38205743|FG001|Overall Study|Progressive Disease|0|||
17063013|NCT00381706|38205755|FG000|Overall Study|Never treated|7|||
17063014|NCT00381706|38205756|FG001|Overall Study|Never treated|2|||
17063015|NCT00381706|38205757|FG002|Overall Study|Never treated|1|||
17063016|NCT00535236|38205781|FG000|Overall Study|Adverse Event|1|||
17063017|NCT00535236|38205782|FG001|Overall Study|Adverse Event|0|||
17063018|NCT00535236|38205783|FG002|Overall Study|Adverse Event|9|||
17063019|NCT00535236|38205784|FG003|Overall Study|Adverse Event|3|||
17063020|NCT00535236|38205785|FG004|Overall Study|Adverse Event|3|||
17063021|NCT00535236|38205786|FG005|Overall Study|Adverse Event|0|||
17063022|NCT00535236|38205787|FG006|Overall Study|Adverse Event|5|||
17063023|NCT00535236|38205788|FG007|Overall Study|Adverse Event|1|||
17063024|NCT00535236|38205789|FG008|Overall Study|Adverse Event|2|||
17063025|NCT00535236|38205790|FG009|Overall Study|Adverse Event|1|||
17063026|NCT00535236|38205781|FG000|Overall Study|Lost to Follow-up|1|||
17063027|NCT00535236|38205782|FG001|Overall Study|Lost to Follow-up|2|||
17063028|NCT00535236|38205783|FG002|Overall Study|Lost to Follow-up|0|||
17063029|NCT00535236|38205784|FG003|Overall Study|Lost to Follow-up|0|||
17063030|NCT00535236|38205785|FG004|Overall Study|Lost to Follow-up|2|||
17063031|NCT00535236|38205786|FG005|Overall Study|Lost to Follow-up|0|||
17063032|NCT00535236|38205787|FG006|Overall Study|Lost to Follow-up|0|||
17063033|NCT00535236|38205788|FG007|Overall Study|Lost to Follow-up|0|||
17063034|NCT00535236|38205789|FG008|Overall Study|Lost to Follow-up|6|||
17063035|NCT00535236|38205790|FG009|Overall Study|Lost to Follow-up|1|||
17063036|NCT00535236|38205781|FG000|Overall Study|Physician Decision|0|||
17146707|NCT03235050|38290909|FG004|Overall Study|Lost to Follow-up|0|||
17146708|NCT03235050|38290905|FG000|Overall Study|Withdrawal by Subject|3|||
17146709|NCT03235050|38290906|FG001|Overall Study|Withdrawal by Subject|2|||
17146710|NCT03235050|38290907|FG002|Overall Study|Withdrawal by Subject|2|||
17146711|NCT03235050|38290908|FG003|Overall Study|Withdrawal by Subject|5|||
17146712|NCT03235050|38290909|FG004|Overall Study|Withdrawal by Subject|7|||
17146713|NCT03235050|38290905|FG000|Overall Study|Other reasons|0|||
17146714|NCT03235050|38290906|FG001|Overall Study|Other reasons|1|||
17146715|NCT03235050|38290907|FG002|Overall Study|Other reasons|0|||
17146716|NCT03235050|38290908|FG003|Overall Study|Other reasons|1|||
17146717|NCT03235050|38290909|FG004|Overall Study|Other reasons|2|||
17146718|NCT04502212|38290938|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
17146719|NCT04502212|38290938|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
17146720|NCT03167619|38290945|FG000|Overall Study|Death|11|||
17146721|NCT03167619|38290946|FG001|Overall Study|Death|8|||
17146722|NCT03167619|38290945|FG000|Overall Study|Withdrawal by Subject|1|||
17146723|NCT03167619|38290946|FG001|Overall Study|Withdrawal by Subject|2|||
17146724|NCT03167619|38290945|FG000|Overall Study|Physician Decision|0|||
17146725|NCT03167619|38290946|FG001|Overall Study|Physician Decision|1|||
17063037|NCT00535236|38205782|FG001|Overall Study|Physician Decision|0|||
17063038|NCT00535236|38205783|FG002|Overall Study|Physician Decision|0|||
17063039|NCT00535236|38205784|FG003|Overall Study|Physician Decision|0|||
17063040|NCT00535236|38205785|FG004|Overall Study|Physician Decision|1|||
17063041|NCT00535236|38205786|FG005|Overall Study|Physician Decision|0|||
17063042|NCT00535236|38205787|FG006|Overall Study|Physician Decision|1|||
17063043|NCT00535236|38205788|FG007|Overall Study|Physician Decision|0|||
17063044|NCT00535236|38205789|FG008|Overall Study|Physician Decision|0|||
17063045|NCT00535236|38205790|FG009|Overall Study|Physician Decision|0|||
17063046|NCT00535236|38205781|FG000|Overall Study|Protocol Violation|2|||
17063047|NCT00535236|38205782|FG001|Overall Study|Protocol Violation|0|||
17146726|NCT03578809|38290956|FG000|Overall Study|Death|0|||
17146727|NCT03578809|38290957|FG001|Overall Study|Death|2|||
17146728|NCT03578809|38290958|FG002|Overall Study|Death|0|||
17146729|NCT03578809|38290959|FG003|Overall Study|Death|1|||
17146730|NCT03578809|38290956|FG000|Overall Study|Lost to Follow-up|0|||
17146731|NCT03578809|38290957|FG001|Overall Study|Lost to Follow-up|1|||
17146732|NCT03578809|38290958|FG002|Overall Study|Lost to Follow-up|0|||
17146733|NCT03578809|38290959|FG003|Overall Study|Lost to Follow-up|0|||
17146734|NCT03578809|38290956|FG000|Overall Study|Withdrawal by Subject|3|||
17146735|NCT03578809|38290957|FG001|Overall Study|Withdrawal by Subject|5|||
17146736|NCT03578809|38290958|FG002|Overall Study|Withdrawal by Subject|2|||
17146737|NCT03578809|38290959|FG003|Overall Study|Withdrawal by Subject|0|||
17146738|NCT03578809|38290956|FG000|Overall Study|Other|3|||
17146739|NCT03578809|38290957|FG001|Overall Study|Other|6|||
17146740|NCT03578809|38290958|FG002|Overall Study|Other|2|||
17146741|NCT03578809|38290959|FG003|Overall Study|Other|8|||
17146742|NCT03198507|38290974|FG000|Overall Study|Withdrawal by Subject|1|||
17146743|NCT03198507|38290975|FG001|Overall Study|Withdrawal by Subject|0|||
17146744|NCT03610165|38290983|FG000|Overall Study|Device didn't work|0|||
17146745|NCT03610165|38290984|FG001|Overall Study|Device didn't work|1|||
17146746|NCT03609619|38290992|FG000|Overall Study|Adverse Event|1|||
17146747|NCT03609619|38290993|FG001|Overall Study|Adverse Event|0|||
17146748|NCT03609619|38290992|FG000|Overall Study|Lack of Efficacy|1|||
17146749|NCT03609619|38290993|FG001|Overall Study|Lack of Efficacy|2|||
17146750|NCT03609619|38290992|FG000|Overall Study|Protocol Violation|5|||
17146751|NCT03609619|38290993|FG001|Overall Study|Protocol Violation|0|||
17146752|NCT03609619|38290992|FG000|Overall Study|Withdrawal by Subject|2|||
17146753|NCT03609619|38290993|FG001|Overall Study|Withdrawal by Subject|3|||
17146754|NCT03609619|38290992|FG000|Overall Study|Lost to Follow-up|1|||
17146755|NCT03609619|38290993|FG001|Overall Study|Lost to Follow-up|1|||
17146756|NCT03167151|38291002|FG000|Overall Study|Withdrawal by Subject|1|||
17146757|NCT03167151|38291003|FG001|Overall Study|Withdrawal by Subject|0|||
17146758|NCT03167151|38291004|FG002|Overall Study|Withdrawal by Subject|0|||
17146759|NCT03167151|38291002|FG000|Overall Study|No evidence of tumour at surgery|0|||
17146760|NCT03167151|38291003|FG001|Overall Study|No evidence of tumour at surgery|1|||
17146761|NCT03167151|38291004|FG002|Overall Study|No evidence of tumour at surgery|1|||
17146762|NCT03660943|38291014|FG000|Overall Study|Adverse Event|5|||
17146763|NCT03660943|38291015|FG001|Overall Study|Adverse Event|3|||
17146764|NCT03660943|38291014|FG000|Overall Study|Death|0|||
17146765|NCT03660943|38291015|FG001|Overall Study|Death|2|||
17146766|NCT03660943|38291014|FG000|Overall Study|Lost to Follow-up|7|||
17146767|NCT03660943|38291015|FG001|Overall Study|Lost to Follow-up|3|||
17146768|NCT03660943|38291014|FG000|Overall Study|Protocol Violation|3|||
17146769|NCT03660943|38291015|FG001|Overall Study|Protocol Violation|5|||
17146770|NCT03660943|38291014|FG000|Overall Study|Withdrawal by Subject|8|||
17146771|NCT03660943|38291015|FG001|Overall Study|Withdrawal by Subject|15|||
17146772|NCT03660943|38291014|FG000|Overall Study|Lack of Efficacy|9|||
17146773|NCT03660943|38291015|FG001|Overall Study|Lack of Efficacy|12|||
17146774|NCT03660943|38291014|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
17146775|NCT03660943|38291015|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
17146776|NCT03167073|38291023|FG000|Overall Study|Stillbirth|1|||
17146777|NCT03167073|38291024|FG001|Overall Study|Stillbirth|0|||
17146778|NCT03657277|38291030|FG000|Overall Study|Physician Decision|2|||
17146779|NCT03657277|38291030|FG000|Overall Study|Lost to Follow-up|1|||
17146780|NCT03657277|38291030|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
17146781|NCT03197883|38291036|FG000|Overall Study|Adverse Event|1|||
17146782|NCT03197883|38291037|FG001|Overall Study|Adverse Event|1|||
17146783|NCT03197883|38291036|FG000|Overall Study|Lost to Follow-up|1|||
17063048|NCT00535236|38205783|FG002|Overall Study|Protocol Violation|1|||
17063049|NCT00535236|38205784|FG003|Overall Study|Protocol Violation|0|||
17063050|NCT00535236|38205785|FG004|Overall Study|Protocol Violation|0|||
17063051|NCT00535236|38205786|FG005|Overall Study|Protocol Violation|0|||
17063052|NCT00535236|38205787|FG006|Overall Study|Protocol Violation|0|||
17063053|NCT00535236|38205788|FG007|Overall Study|Protocol Violation|0|||
17063054|NCT00535236|38205789|FG008|Overall Study|Protocol Violation|1|||
17063055|NCT00535236|38205790|FG009|Overall Study|Protocol Violation|0|||
17063056|NCT00535236|38205781|FG000|Overall Study|Withdrawal by Subject|3|||
17063057|NCT00535236|38205782|FG001|Overall Study|Withdrawal by Subject|0|||
17063058|NCT00535236|38205783|FG002|Overall Study|Withdrawal by Subject|2|||
17146784|NCT03197883|38291037|FG001|Overall Study|Lost to Follow-up|0|||
17146785|NCT03197883|38291036|FG000|Overall Study|Protocol Violation|1|||
17146786|NCT03197883|38291037|FG001|Overall Study|Protocol Violation|0|||
17146787|NCT03197883|38291036|FG000|Overall Study|Other (Not Specified)|0|||
17146788|NCT03197883|38291037|FG001|Overall Study|Other (Not Specified)|5|||
17146789|NCT03234036|38291046|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
17146790|NCT03234036|38291047|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
17146791|NCT03234036|38291048|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
17146792|NCT03234036|38291049|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
17063059|NCT00535236|38205784|FG003|Overall Study|Withdrawal by Subject|1|||
17146793|NCT03606109|38291067|FG000|Overall Study|Lost to Follow-up|2|||
17146794|NCT03606109|38291068|FG001|Overall Study|Lost to Follow-up|1|||
17146795|NCT03768336|38291074|FG000|Overall Study|Lost to Follow-up|3|||
17146796|NCT03768336|38291075|FG001|Overall Study|Lost to Follow-up|2|||
17146797|NCT03768336|38291074|FG000|Overall Study|Became Ineligible|2|||
17146798|NCT03768336|38291075|FG001|Overall Study|Became Ineligible|0|||
17146799|NCT03768336|38291074|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
17146800|NCT03768336|38291075|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
17146801|NCT03768336|38291074|FG000|Overall Study|Missed final survey (post-treatment|0|||
17146802|NCT03768336|38291075|FG001|Overall Study|Missed final survey (post-treatment|1|||
17146803|NCT02729896|38291085|FG000|Overall Study|Death|0|||
17146804|NCT02729896|38291086|FG001|Overall Study|Death|2|||
17146805|NCT02729896|38291087|FG002|Overall Study|Death|13|||
17146806|NCT02729896|38291085|FG000|Overall Study|Lost to Follow-up|0|||
17146807|NCT02729896|38291086|FG001|Overall Study|Lost to Follow-up|2|||
17146808|NCT02729896|38291087|FG002|Overall Study|Lost to Follow-up|3|||
17146809|NCT02729896|38291085|FG000|Overall Study|Other|0|||
17146810|NCT02729896|38291086|FG001|Overall Study|Other|2|||
17146811|NCT02729896|38291087|FG002|Overall Study|Other|0|||
17146812|NCT02729896|38291085|FG000|Overall Study|Physician Decision|1|||
17146813|NCT02729896|38291086|FG001|Overall Study|Physician Decision|2|||
17146814|NCT02729896|38291087|FG002|Overall Study|Physician Decision|3|||
17146815|NCT02729896|38291085|FG000|Overall Study|Progressive Disease|0|||
17146816|NCT02729896|38291086|FG001|Overall Study|Progressive Disease|1|||
17146817|NCT02729896|38291087|FG002|Overall Study|Progressive Disease|0|||
17146818|NCT02729896|38291085|FG000|Overall Study|Withdrawal by Subject|1|||
17146819|NCT02729896|38291086|FG001|Overall Study|Withdrawal by Subject|0|||
17146820|NCT02729896|38291087|FG002|Overall Study|Withdrawal by Subject|3|||
17146821|NCT03575065|38291098|FG000|Overall Study|Death|31|||
17146822|NCT03575065|38291099|FG001|Overall Study|Death|12|||
17146823|NCT03575065|38291098|FG000|Overall Study|Sponsor's Decision|28|||
17146824|NCT03575065|38291099|FG001|Overall Study|Sponsor's Decision|13|||
17146825|NCT03575065|38291098|FG000|Overall Study|Withdrawal by Subject|2|||
17146826|NCT03575065|38291099|FG001|Overall Study|Withdrawal by Subject|1|||
17146827|NCT03575065|38291098|FG000|Overall Study|Lost to Follow-up|1|||
17146828|NCT03575065|38291099|FG001|Overall Study|Lost to Follow-up|0|||
17146829|NCT03188718|38291106|FG000|Overall Study|Participant noncompliance|4|||
17063060|NCT00535236|38205785|FG004|Overall Study|Withdrawal by Subject|6|||
17063061|NCT00535236|38205786|FG005|Overall Study|Withdrawal by Subject|1|||
17063062|NCT00535236|38205787|FG006|Overall Study|Withdrawal by Subject|5|||
17063063|NCT00535236|38205788|FG007|Overall Study|Withdrawal by Subject|0|||
17063064|NCT00535236|38205789|FG008|Overall Study|Withdrawal by Subject|4|||
17063065|NCT00535236|38205790|FG009|Overall Study|Withdrawal by Subject|2|||
17063066|NCT00370552|38205818|FG000|Overall Study|Adverse Event|2|||
17063067|NCT00370552|38205819|FG001|Overall Study|Adverse Event|2|||
17063068|NCT00370552|38205820|FG002|Overall Study|Adverse Event|2|||
17063069|NCT00370552|38205818|FG000|Overall Study|Disease progression|23|||
17063070|NCT00370552|38205819|FG001|Overall Study|Disease progression|23|||
17063071|NCT00370552|38205820|FG002|Overall Study|Disease progression|15|||
17063072|NCT00370552|38205818|FG000|Overall Study|Maximum clinical benefit|3|||
17063073|NCT00370552|38205819|FG001|Overall Study|Maximum clinical benefit|5|||
17063074|NCT00370552|38205820|FG002|Overall Study|Maximum clinical benefit|5|||
17063075|NCT00370552|38205818|FG000|Overall Study|Poor or noncompliance|0|||
17063076|NCT00370552|38205819|FG001|Overall Study|Poor or noncompliance|0|||
17063077|NCT00370552|38205820|FG002|Overall Study|Poor or noncompliance|1|||
17063078|NCT00370552|38205818|FG000|Overall Study|Study drug toxicity|11|||
17063079|NCT00370552|38205819|FG001|Overall Study|Study drug toxicity|8|||
17063080|NCT00370552|38205820|FG002|Overall Study|Study drug toxicity|6|||
17063081|NCT00370552|38205818|FG000|Overall Study|Withdrawal by Subject|2|||
17063082|NCT00370552|38205819|FG001|Overall Study|Withdrawal by Subject|0|||
17063083|NCT00370552|38205820|FG002|Overall Study|Withdrawal by Subject|1|||
17063084|NCT00370552|38205818|FG000|Overall Study|Still on treatment|1|||
17063085|NCT00370552|38205819|FG001|Overall Study|Still on treatment|3|||
17063086|NCT00370552|38205820|FG002|Overall Study|Still on treatment|2|||
17063087|NCT00370552|38205818|FG000|Overall Study|Never treated|1|||
17063088|NCT00370552|38205819|FG001|Overall Study|Never treated|0|||
17063089|NCT00370552|38205820|FG002|Overall Study|Never treated|0|||
17063090|NCT00370552|38205818|FG000|Overall Study|Physician Decision|1|||
17063091|NCT00370552|38205819|FG001|Overall Study|Physician Decision|1|||
17063092|NCT00370552|38205820|FG002|Overall Study|Physician Decision|0|||
17146830|NCT03188718|38291106|FG000|Overall Study|Withdrawal by Subject|1|||
17146831|NCT03188718|38291106|FG000|Overall Study|Device failure|3|||
17146832|NCT03574753|38291110|FG000|Overall Study|Adverse Event|3|||
17063093|NCT00370552|38205818|FG000|Overall Study|Investigator decision|2|||
17146833|NCT03574753|38291110|FG000|Overall Study|Progression/relapse|19|||
17146834|NCT03574753|38291110|FG000|Overall Study|Death|1|||
17146835|NCT03573505|38291117|FG000|Overall Study|Adverse Event|1|||
17063094|NCT00370552|38205819|FG001|Overall Study|Investigator decision|1|||
17063095|NCT00370552|38205820|FG002|Overall Study|Investigator decision|0|||
17063096|NCT00370552|38205818|FG000|Overall Study|High risk of allergic reaction|0|||
17063097|NCT00370552|38205819|FG001|Overall Study|High risk of allergic reaction|1|||
17063098|NCT00370552|38205820|FG002|Overall Study|High risk of allergic reaction|0|||
17063099|NCT00370552|38205818|FG000|Overall Study|Planned radiation for palliation|0|||
17063100|NCT00370552|38205819|FG001|Overall Study|Planned radiation for palliation|1|||
17063101|NCT00370552|38205820|FG002|Overall Study|Planned radiation for palliation|0|||
17063102|NCT00537030|38205828|FG000|Overall Study|Physician Decision|2|||
17063103|NCT00537030|38205828|FG000|Overall Study|Withdrawal by Subject|2|||
17063104|NCT00537030|38205828|FG000|Overall Study|≥ Grade 2 allergy|7|||
17063105|NCT00537030|38205828|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
17063106|NCT00537030|38205828|FG000|Overall Study|Ineligible|2|||
17063107|NCT00537030|38205828|FG000|Overall Study|Inevaluable|2|||
17063108|NCT00381238|38205832|FG000|Overall Study|Adverse Event|3|||
17063109|NCT00381238|38205832|FG000|Overall Study|Protocol Violation|1|||
17063110|NCT00381238|38205832|FG000|Overall Study|Withdrawal by Subject|4|||
17063111|NCT00381238|38205832|FG000|Overall Study|Lack of Efficacy|2|||
17063112|NCT00381238|38205832|FG000|Overall Study|Withdrew by physician|1|||
17063113|NCT00381238|38205832|FG000|Overall Study|Disease progression|1|||
17063114|NCT03896022|38205839|FG000|Overall Study|Withdrawal by Subject|1|||
17063115|NCT03896022|38205840|FG001|Overall Study|Withdrawal by Subject|0|||
17063116|NCT03896022|38205841|FG002|Overall Study|Withdrawal by Subject|0|||
17063117|NCT03896022|38205839|FG000|Overall Study|Did not have procedure|3|||
17063118|NCT03896022|38205840|FG001|Overall Study|Did not have procedure|0|||
17063119|NCT03896022|38205841|FG002|Overall Study|Did not have procedure|0|||
17063120|NCT03831880|38205853|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
17063121|NCT03831880|38205854|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
17063122|NCT03831880|38205853|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
17063123|NCT03831880|38205854|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
17063124|NCT00380692|38205877|FG000|Study Period II - Double Blind|Adverse Event|1|||
17063125|NCT00380692|38205878|FG001|Study Period II - Double Blind|Adverse Event|0|||
17063126|NCT00380692|38205877|FG000|Study Period II - Double Blind|Protocol Violation|2|||
17063127|NCT00380692|38205878|FG001|Study Period II - Double Blind|Protocol Violation|2|||
17063128|NCT00380692|38205877|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
17063129|NCT00380692|38205878|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
17063130|NCT00380692|38205877|FG000|Study Period II - Double Blind|Physician Decision|0|||
17063131|NCT00380692|38205878|FG001|Study Period II - Double Blind|Physician Decision|1|||
17063132|NCT00380692|38205877|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
17063133|NCT00380692|38205878|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
17063134|NCT00380692|38205877|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
17063135|NCT00380692|38205878|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
17063136|NCT00380692|38205877|FG000|Study Period III - Open Label|Adverse Event|5|||
17063137|NCT00380692|38205878|FG001|Study Period III - Open Label|Adverse Event|3|||
17063138|NCT00380692|38205877|FG000|Study Period III - Open Label|Protocol Violation|0|||
17063139|NCT00380692|38205878|FG001|Study Period III - Open Label|Protocol Violation|0|||
17063140|NCT00380692|38205877|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
17063141|NCT00380692|38205878|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
17063142|NCT00380692|38205877|FG000|Study Period III - Open Label|Physician Decision|0|||
17063143|NCT00380692|38205878|FG001|Study Period III - Open Label|Physician Decision|3|||
17063144|NCT00380692|38205877|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
17063145|NCT00380692|38205878|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
17063146|NCT00380692|38205877|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
17063147|NCT00380692|38205878|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
17063148|NCT00536874|38205884|FG000|Overall Study|Adverse Event|1|||
17063149|NCT00536874|38205884|FG000|Overall Study|Death|2|||
17063150|NCT00536874|38205884|FG000|Overall Study|Withdrawal by Subject|1|||
17146836|NCT03573505|38291118|FG001|Overall Study|Adverse Event|1|||
17146837|NCT03573505|38291117|FG000|Overall Study|Consent withdrawn|0|||
17146838|NCT03573505|38291118|FG001|Overall Study|Consent withdrawn|1|||
17146839|NCT03573505|38291117|FG000|Overall Study|Disease progression|0|||
17146840|NCT03573505|38291118|FG001|Overall Study|Disease progression|1|||
17146841|NCT03573505|38291117|FG000|Overall Study|Site Terminated by Sponsor|1|||
17146842|NCT03573505|38291118|FG001|Overall Study|Site Terminated by Sponsor|1|||
17146843|NCT03573505|38291117|FG000|Overall Study|Study terminated by sponsor|50|||
17146844|NCT03573505|38291118|FG001|Overall Study|Study terminated by sponsor|45|||
17146845|NCT03573505|38291117|FG000|Overall Study|Reason not specified|0|||
17146846|NCT03573505|38291118|FG001|Overall Study|Reason not specified|1|||
17146847|NCT03573505|38291117|FG000|Overall Study|Death|0|||
17146848|NCT03573505|38291118|FG001|Overall Study|Death|4|||
17146849|NCT01376908|38291127|FG000|Overall Study|Protocol Violation|1|||
17146850|NCT01376908|38291128|FG001|Overall Study|Protocol Violation|1|||
17146851|NCT01376908|38291127|FG000|Overall Study|Withdrawal by Subject|1|||
16781197|NCT02171260|37720360|FG000|Overall Study|Withdrawal by Subject|1|||
17146852|NCT01376908|38291128|FG001|Overall Study|Withdrawal by Subject|2|||
17146853|NCT02668653|38291143|FG000|Overall Study|Refractory disease|41|||
17146854|NCT02668653|38291144|FG001|Overall Study|Refractory disease|70|||
17146855|NCT02668653|38291143|FG000|Overall Study|Relapse|44|||
17146856|NCT02668653|38291144|FG001|Overall Study|Relapse|65|||
17146857|NCT02668653|38291143|FG000|Overall Study|Adverse Event|58|||
17146858|NCT02668653|38291144|FG001|Overall Study|Adverse Event|23|||
17146859|NCT02668653|38291143|FG000|Overall Study|Subject decision to stop study drug|25|||
17063151|NCT00380068|38205888|FG000|Overall Study|Adverse Event|40|||
17063152|NCT00380068|38205888|FG000|Overall Study|Withdrawal by Subject|10|||
17063153|NCT00380068|38205888|FG000|Overall Study|Not compliant|6|||
17063154|NCT00380068|38205888|FG000|Overall Study|Lost to Follow-up|1|||
17063155|NCT00380068|38205888|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
17063156|NCT00380068|38205888|FG000|Overall Study|Lung transplant|3|||
17063157|NCT00380068|38205888|FG000|Overall Study|Physician Decision|2|||
17063158|NCT00380068|38205888|FG000|Overall Study|Partipant moved away|1|||
17063159|NCT00380068|38205888|FG000|Overall Study|Lack of Efficacy|5|||
17063160|NCT00536484|38205894|FG000|Overall Study|Adverse Event|21|||
17146860|NCT02668653|38291144|FG001|Overall Study|Subject decision to stop study drug|23|||
17146861|NCT02668653|38291143|FG000|Overall Study|Other reasons not specified|16|||
17146862|NCT02668653|38291144|FG001|Overall Study|Other reasons not specified|11|||
17146863|NCT02668653|38291143|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
17146864|NCT02668653|38291144|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
17146865|NCT02668653|38291143|FG000|Overall Study|Investigator decision|10|||
17146866|NCT02668653|38291144|FG001|Overall Study|Investigator decision|7|||
17146867|NCT02668653|38291143|FG000|Overall Study|Failure to meet continuation criteria|5|||
17146868|NCT02668653|38291144|FG001|Overall Study|Failure to meet continuation criteria|12|||
17146869|NCT02668653|38291143|FG000|Overall Study|Lost to Follow-up|1|||
17146870|NCT02668653|38291144|FG001|Overall Study|Lost to Follow-up|0|||
17146871|NCT02668653|38291143|FG000|Overall Study|Pregnancy|0|||
17146872|NCT02668653|38291144|FG001|Overall Study|Pregnancy|1|||
17146873|NCT02668653|38291143|FG000|Overall Study|Death|0|||
17063161|NCT00536484|38205895|FG001|Overall Study|Adverse Event|34|||
17063162|NCT00536484|38205894|FG000|Overall Study|Withdrawal by Subject|11|||
17063163|NCT00536484|38205895|FG001|Overall Study|Withdrawal by Subject|11|||
17063164|NCT00536484|38205894|FG000|Overall Study|Lost to Follow-up|8|||
17063165|NCT00536484|38205895|FG001|Overall Study|Lost to Follow-up|6|||
17063166|NCT00536484|38205894|FG000|Overall Study|Lack of Efficacy|16|||
17063167|NCT00536484|38205895|FG001|Overall Study|Lack of Efficacy|5|||
17063168|NCT00536484|38205894|FG000|Overall Study|Other|4|||
17063169|NCT00536484|38205895|FG001|Overall Study|Other|0|||
17063170|NCT00370396|38205904|FG000|Overall Study|Withdrawal by Subject|0|||
17063171|NCT00370396|38205905|FG001|Overall Study|Withdrawal by Subject|0|||
17063172|NCT00370396|38205906|FG002|Overall Study|Withdrawal by Subject|1|||
17063173|NCT00370396|38205904|FG000|Overall Study|Lost to Follow-up|11|||
17063174|NCT00370396|38205905|FG001|Overall Study|Lost to Follow-up|1|||
17063175|NCT00370396|38205906|FG002|Overall Study|Lost to Follow-up|0|||
17063176|NCT00455013|38205917|FG000|Short Term Period|Adverse Event|2|||
17146874|NCT02668653|38291144|FG001|Overall Study|Death|1|||
17146875|NCT03736031|38291152|FG000|Overall Study|Death|2|||
17146876|NCT03736031|38291153|FG001|Overall Study|Death|4|||
17146877|NCT03736031|38291152|FG000|Overall Study|Lost to Follow-up|21|||
17146878|NCT03736031|38291153|FG001|Overall Study|Lost to Follow-up|2|||
17146879|NCT03736031|38291152|FG000|Overall Study|Withdrawal by Subject|9|||
17063177|NCT00455013|38205918|FG001|Short Term Period|Adverse Event|5|||
17063178|NCT00455013|38205919|FG002|Short Term Period|Adverse Event|0|||
17063179|NCT00455013|38205917|FG000|Short Term Period|Withdrawal by Subject|0|||
17063180|NCT00455013|38205918|FG001|Short Term Period|Withdrawal by Subject|0|||
17063181|NCT00455013|38205919|FG002|Short Term Period|Withdrawal by Subject|1|||
17063182|NCT00455013|38205917|FG000|Short Term Period|Lack of Efficacy|4|||
17063183|NCT00455013|38205918|FG001|Short Term Period|Lack of Efficacy|0|||
17063184|NCT00455013|38205919|FG002|Short Term Period|Lack of Efficacy|0|||
17063185|NCT00455013|38205917|FG000|Short Term Period|Other|0|||
17063186|NCT00455013|38205918|FG001|Short Term Period|Other|0|||
17063187|NCT00455013|38205919|FG002|Short Term Period|Other|1|||
17063188|NCT00455013|38205917|FG000|Long Term Extension (LTE)|Adverse Event|0|||
17063189|NCT00455013|38205918|FG001|Long Term Extension (LTE)|Adverse Event|1|||
17063190|NCT00455013|38205919|FG002|Long Term Extension (LTE)|Adverse Event|1|||
17063191|NCT00455013|38205917|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
17063192|NCT00455013|38205918|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
17063193|NCT00455013|38205919|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
17063194|NCT00455013|38205917|FG000|Long Term Extension (LTE)|Death|1|||
17063195|NCT00455013|38205918|FG001|Long Term Extension (LTE)|Death|1|||
17063196|NCT00455013|38205919|FG002|Long Term Extension (LTE)|Death|0|||
17063197|NCT00455013|38205917|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
17063198|NCT00455013|38205918|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
17063199|NCT00455013|38205919|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
17146880|NCT03736031|38291153|FG001|Overall Study|Withdrawal by Subject|0|||
17063200|NCT00455013|38205917|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
17063201|NCT00455013|38205918|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
17063202|NCT00455013|38205919|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
17063203|NCT00455013|38205917|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
17063204|NCT00455013|38205918|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
17063205|NCT00455013|38205919|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
17063206|NCT00455013|38205917|FG000|Long Term Extension (LTE)|non-specified|0|||
17063207|NCT00455013|38205918|FG001|Long Term Extension (LTE)|non-specified|0|||
17063208|NCT00455013|38205919|FG002|Long Term Extension (LTE)|non-specified|1|||
17063209|NCT00363298|38205929|FG000|First Study Week|Lack of Efficacy|6|||
17063210|NCT00363298|38205930|FG001|First Study Week|Lack of Efficacy|5|||
17063211|NCT00363298|38205929|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
17063212|NCT00363298|38205930|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
17063213|NCT00363142|38205939|FG000|Overall Study|Adverse Event|2|||
17063214|NCT00363142|38205940|FG001|Overall Study|Adverse Event|0|||
17063215|NCT00363142|38205939|FG000|Overall Study|Lack of Efficacy|0|||
17063216|NCT00363142|38205940|FG001|Overall Study|Lack of Efficacy|1|||
17063217|NCT00363142|38205939|FG000|Overall Study|Lost to Follow-up|1|||
17063218|NCT00363142|38205940|FG001|Overall Study|Lost to Follow-up|0|||
17063219|NCT00363142|38205939|FG000|Overall Study|Non-compliance|1|||
17063220|NCT00363142|38205940|FG001|Overall Study|Non-compliance|1|||
17063221|NCT00363142|38205939|FG000|Overall Study|Withdrawal by Subject|3|||
17063222|NCT00363142|38205940|FG001|Overall Study|Withdrawal by Subject|1|||
17146881|NCT03555565|38291159|FG000|Overall Study|Case Report Forms Uncollected|2|||
17146882|NCT03555565|38291159|FG000|Overall Study|Protocol Deviation|13|||
17146883|NCT03602053|38291166|FG000|Overall Study|Withdrawal by Subject|7|||
17146884|NCT03602053|38291167|FG001|Overall Study|Withdrawal by Subject|9|||
17146885|NCT03602053|38291168|FG002|Overall Study|Withdrawal by Subject|7|||
17146886|NCT03602053|38291166|FG000|Overall Study|Lost to Follow-up|5|||
17146887|NCT03602053|38291167|FG001|Overall Study|Lost to Follow-up|6|||
17146888|NCT03602053|38291168|FG002|Overall Study|Lost to Follow-up|0|||
17146889|NCT03602053|38291166|FG000|Overall Study|Protocol Violation|3|||
17146890|NCT03602053|38291167|FG001|Overall Study|Protocol Violation|0|||
17146891|NCT03602053|38291168|FG002|Overall Study|Protocol Violation|4|||
17146892|NCT03602053|38291166|FG000|Overall Study|Physician Decision|1|||
17146893|NCT03602053|38291167|FG001|Overall Study|Physician Decision|0|||
17146894|NCT03602053|38291168|FG002|Overall Study|Physician Decision|0|||
17146895|NCT03602053|38291166|FG000|Overall Study|migration|2|||
17063223|NCT00454857|38205949|FG000|Overall Study|Withdrawal by Subject|15|||
17063224|NCT00454857|38205949|FG000|Overall Study|Lost to Follow-up|16|||
17063225|NCT00454857|38205949|FG000|Overall Study|Noncompliance|6|||
17063226|NCT00454857|38205949|FG000|Overall Study|Death|5|||
17063227|NCT00454857|38205949|FG000|Overall Study|Other|11|||
17063228|NCT00454857|38205949|FG000|Overall Study|Reason unknown|1|||
17063229|NCT00379912|38205955|FG000|Overall Study|Lack of Efficacy|1|||
17063230|NCT00379912|38205956|FG001|Overall Study|Lack of Efficacy|0|||
17063231|NCT00379834|38205968|FG000|Overall Study|Time constraints|2|||
17063232|NCT00379210|38205974|FG000|Overall Study|Withdrawal by Subject|10|||
17063233|NCT00379210|38205975|FG001|Overall Study|Withdrawal by Subject|7|||
17063234|NCT00378898|38205983|FG000|Overall Study|Withdrawal by Subject|10|||
17063235|NCT00378898|38205984|FG001|Overall Study|Withdrawal by Subject|5|||
17063236|NCT00378898|38205983|FG000|Overall Study|Protocol Violation|1|||
17063237|NCT00378898|38205984|FG001|Overall Study|Protocol Violation|1|||
17063238|NCT00378508|38205994|FG000|Overall Study|Withdrawal by Subject|1|||
17063239|NCT00378508|38205995|FG001|Overall Study|Withdrawal by Subject|3|||
17063240|NCT00378508|38205994|FG000|Overall Study|Lost to Follow-up|1|||
17063241|NCT00378508|38205995|FG001|Overall Study|Lost to Follow-up|0|||
17063242|NCT00454779|38206004|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
17063243|NCT00454779|38206005|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
17063244|NCT00454779|38206004|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
17063245|NCT00454779|38206005|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
17063246|NCT00454779|38206004|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
17063247|NCT00454779|38206005|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
17063248|NCT00454779|38206004|FG000|First-line Treatment Phase|Protocol Violation|0|||
17063249|NCT00454779|38206005|FG001|First-line Treatment Phase|Protocol Violation|1|||
17063250|NCT00454779|38206004|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
17063251|NCT00454779|38206005|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
17063252|NCT00454779|38206004|FG000|First-line Treatment Phase|Ongoing|1|||
17063253|NCT00454779|38206005|FG001|First-line Treatment Phase|Ongoing|0|||
17063254|NCT00454779|38206004|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
17063255|NCT00454779|38206005|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
17063256|NCT00454779|38206004|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
17063257|NCT00454779|38206005|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
17063258|NCT00454779|38206004|FG000|Second-line Treatment Phase|Ongoing|0|||
17063259|NCT00454779|38206005|FG001|Second-line Treatment Phase|Ongoing|1|||
17063260|NCT00439569|38206011|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
17063261|NCT00439569|38206011|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
17063262|NCT00439569|38206011|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
17063263|NCT00443079|38206017|FG000|Overall Study|Lost to Follow-up|0|||
17063264|NCT00443079|38206018|FG001|Overall Study|Lost to Follow-up|1|||
17063265|NCT00427635|38206054|FG000|Treatment Phase|Withdrawal by Subject|1|||
17063266|NCT00427635|38206055|FG001|Treatment Phase|Withdrawal by Subject|0|||
17063267|NCT00427635|38206054|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
17063268|NCT00427635|38206055|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
17063269|NCT00427011|38206061|FG000|Overall Study|Adverse Event|10|||
17063270|NCT00427011|38206061|FG000|Overall Study|Withdrawal by Subject|1|||
17063271|NCT00427011|38206061|FG000|Overall Study|Lack of Efficacy|2|||
17063272|NCT00427011|38206061|FG000|Overall Study|Other|12|||
17063273|NCT03891264|38206066|FG000|Overall Study|Adverse Event|1|||
17063274|NCT03891264|38206066|FG000|Overall Study|Withdrawal by Subject|2|||
17063275|NCT03891264|38206066|FG000|Overall Study|Physician Decision|2|||
17063276|NCT00439179|38206074|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
17063277|NCT00439179|38206075|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
17063278|NCT00439179|38206076|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
17063279|NCT00439179|38206077|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
17063280|NCT00438633|38206092|FG000|Overall Study|Withdrawal by Subject|1|||
17063281|NCT00438633|38206093|FG001|Overall Study|Withdrawal by Subject|0|||
17063282|NCT00438633|38206092|FG000|Overall Study|Lost to Follow-up|15|||
17063283|NCT00438633|38206093|FG001|Overall Study|Lost to Follow-up|17|||
17063284|NCT00438399|38206102|FG000|Overall Study|Lost to Follow-up|2|||
17063285|NCT00438399|38206103|FG001|Overall Study|Lost to Follow-up|2|||
17063286|NCT00438399|38206104|FG002|Overall Study|Lost to Follow-up|1|||
17063287|NCT00438399|38206105|FG003|Overall Study|Lost to Follow-up|1|||
17063288|NCT00438399|38206106|FG004|Overall Study|Lost to Follow-up|1|||
17063289|NCT00438399|38206107|FG005|Overall Study|Lost to Follow-up|1|||
17063290|NCT00438399|38206102|FG000|Overall Study|Adverse Event|0|||
17063291|NCT00438399|38206103|FG001|Overall Study|Adverse Event|0|||
17063292|NCT00438399|38206104|FG002|Overall Study|Adverse Event|1|||
17063293|NCT00438399|38206105|FG003|Overall Study|Adverse Event|1|||
17063294|NCT00438399|38206106|FG004|Overall Study|Adverse Event|0|||
17063295|NCT00438399|38206107|FG005|Overall Study|Adverse Event|1|||
17063296|NCT00438399|38206102|FG000|Overall Study|Withdrawal by Subject|5|||
17063297|NCT00438399|38206103|FG001|Overall Study|Withdrawal by Subject|6|||
17063298|NCT00438399|38206104|FG002|Overall Study|Withdrawal by Subject|3|||
17063299|NCT00438399|38206105|FG003|Overall Study|Withdrawal by Subject|2|||
17063300|NCT00438399|38206106|FG004|Overall Study|Withdrawal by Subject|2|||
17063301|NCT00438399|38206107|FG005|Overall Study|Withdrawal by Subject|2|||
17063302|NCT00438399|38206102|FG000|Overall Study|Protocol Violation|0|||
17063303|NCT00438399|38206103|FG001|Overall Study|Protocol Violation|0|||
17063304|NCT00438399|38206104|FG002|Overall Study|Protocol Violation|1|||
17063305|NCT00438399|38206105|FG003|Overall Study|Protocol Violation|0|||
17063306|NCT00438399|38206106|FG004|Overall Study|Protocol Violation|0|||
17063307|NCT00438399|38206107|FG005|Overall Study|Protocol Violation|1|||
17063308|NCT00438399|38206102|FG000|Overall Study|Subje stopped study|0|||
17063309|NCT00438399|38206103|FG001|Overall Study|Subje stopped study|0|||
17063310|NCT00438399|38206104|FG002|Overall Study|Subje stopped study|1|||
17063311|NCT00438399|38206105|FG003|Overall Study|Subje stopped study|0|||
17063312|NCT00438399|38206106|FG004|Overall Study|Subje stopped study|0|||
17063313|NCT00438399|38206107|FG005|Overall Study|Subje stopped study|0|||
17063314|NCT00438399|38206102|FG000|Overall Study|Pregnancy|0|||
17063315|NCT00438399|38206103|FG001|Overall Study|Pregnancy|0|||
17063316|NCT00438399|38206104|FG002|Overall Study|Pregnancy|0|||
17063317|NCT00438399|38206105|FG003|Overall Study|Pregnancy|0|||
17063318|NCT00438399|38206106|FG004|Overall Study|Pregnancy|0|||
17063319|NCT00438399|38206107|FG005|Overall Study|Pregnancy|1|||
17063320|NCT00438399|38206102|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
17063321|NCT00438399|38206103|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
17063322|NCT00438399|38206104|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
17063323|NCT00438399|38206105|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
17063324|NCT00438399|38206106|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
17063325|NCT00438399|38206107|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
17063326|NCT00426231|38206118|FG000|Overall Study|Withdrawal by Subject|9|||
17063327|NCT00426231|38206119|FG001|Overall Study|Withdrawal by Subject|12|||
17063328|NCT00425607|38206125|FG000|Overall Study|Death|1|||
17063329|NCT00425607|38206125|FG000|Overall Study|Withdrawal by Subject|1|||
17063330|NCT00437073|38206131|FG000|Overall Study|Sponsor Terminated Study|1|||
17063331|NCT00437073|38206132|FG001|Overall Study|Sponsor Terminated Study|0|||
17063332|NCT00437073|38206131|FG000|Overall Study|Physician Decision|0|||
17063333|NCT00437073|38206132|FG001|Overall Study|Physician Decision|1|||
17063334|NCT00425373|38206147|FG000|Overall Study|Adverse Event|2|||
17063335|NCT00425373|38206148|FG001|Overall Study|Adverse Event|2|||
17063336|NCT00425373|38206149|FG002|Overall Study|Adverse Event|0|||
17063337|NCT00425373|38206150|FG003|Overall Study|Adverse Event|1|||
17063338|NCT00425373|38206151|FG004|Overall Study|Adverse Event|4|||
17063339|NCT00425373|38206152|FG005|Overall Study|Adverse Event|6|||
17063340|NCT00425373|38206153|FG006|Overall Study|Adverse Event|2|||
17063341|NCT00425373|38206154|FG007|Overall Study|Adverse Event|3|||
17063342|NCT00425373|38206155|FG008|Overall Study|Adverse Event|8|||
17063343|NCT00425373|38206147|FG000|Overall Study|Lost to Follow-up|0|||
17063344|NCT00425373|38206148|FG001|Overall Study|Lost to Follow-up|1|||
17063345|NCT00425373|38206149|FG002|Overall Study|Lost to Follow-up|0|||
17063346|NCT00425373|38206150|FG003|Overall Study|Lost to Follow-up|0|||
17063347|NCT00425373|38206151|FG004|Overall Study|Lost to Follow-up|1|||
17063348|NCT00425373|38206152|FG005|Overall Study|Lost to Follow-up|0|||
17063349|NCT00425373|38206153|FG006|Overall Study|Lost to Follow-up|0|||
17063350|NCT00425373|38206154|FG007|Overall Study|Lost to Follow-up|0|||
17063351|NCT00425373|38206155|FG008|Overall Study|Lost to Follow-up|0|||
17063352|NCT00425373|38206147|FG000|Overall Study|Protocol Violation|1|||
17063353|NCT00425373|38206148|FG001|Overall Study|Protocol Violation|0|||
17063354|NCT00425373|38206149|FG002|Overall Study|Protocol Violation|1|||
17063355|NCT00425373|38206150|FG003|Overall Study|Protocol Violation|0|||
17063356|NCT00425373|38206151|FG004|Overall Study|Protocol Violation|0|||
17063357|NCT00425373|38206152|FG005|Overall Study|Protocol Violation|0|||
17063358|NCT00425373|38206153|FG006|Overall Study|Protocol Violation|0|||
17063359|NCT00425373|38206154|FG007|Overall Study|Protocol Violation|5|||
17063360|NCT00425373|38206155|FG008|Overall Study|Protocol Violation|3|||
17063361|NCT00425373|38206147|FG000|Overall Study|Withdrawal by Subject|2|||
17063362|NCT00425373|38206148|FG001|Overall Study|Withdrawal by Subject|0|||
17063363|NCT00425373|38206149|FG002|Overall Study|Withdrawal by Subject|2|||
17063364|NCT00425373|38206150|FG003|Overall Study|Withdrawal by Subject|1|||
17063365|NCT00425373|38206151|FG004|Overall Study|Withdrawal by Subject|4|||
17063366|NCT00425373|38206152|FG005|Overall Study|Withdrawal by Subject|0|||
17063367|NCT00425373|38206153|FG006|Overall Study|Withdrawal by Subject|2|||
17063368|NCT00425373|38206154|FG007|Overall Study|Withdrawal by Subject|2|||
17063369|NCT00425373|38206155|FG008|Overall Study|Withdrawal by Subject|2|||
17063370|NCT00425373|38206147|FG000|Overall Study|Lack of Efficacy|0|||
17063371|NCT00425373|38206148|FG001|Overall Study|Lack of Efficacy|0|||
17063372|NCT00425373|38206149|FG002|Overall Study|Lack of Efficacy|0|||
17063373|NCT00425373|38206150|FG003|Overall Study|Lack of Efficacy|0|||
17063374|NCT00425373|38206151|FG004|Overall Study|Lack of Efficacy|1|||
17063375|NCT00425373|38206152|FG005|Overall Study|Lack of Efficacy|3|||
17063376|NCT00425373|38206153|FG006|Overall Study|Lack of Efficacy|3|||
17063377|NCT00425373|38206154|FG007|Overall Study|Lack of Efficacy|0|||
17063378|NCT00425373|38206155|FG008|Overall Study|Lack of Efficacy|5|||
17063379|NCT03894540|38206181|FG000|Overall Study|Adverse Event|0|||
17063380|NCT03894540|38206182|FG001|Overall Study|Adverse Event|0|||
17063381|NCT03894540|38206183|FG002|Overall Study|Adverse Event|0|||
17063382|NCT03894540|38206184|FG003|Overall Study|Adverse Event|0|||
17063383|NCT03894540|38206185|FG004|Overall Study|Adverse Event|1|||
17063384|NCT03894540|38206186|FG005|Overall Study|Adverse Event|0|||
17063385|NCT03894540|38206181|FG000|Overall Study|Withdrawal by Subject|0|||
17063386|NCT03894540|38206182|FG001|Overall Study|Withdrawal by Subject|0|||
17063387|NCT03894540|38206183|FG002|Overall Study|Withdrawal by Subject|0|||
17063388|NCT03894540|38206184|FG003|Overall Study|Withdrawal by Subject|0|||
17063389|NCT03894540|38206185|FG004|Overall Study|Withdrawal by Subject|1|||
17063390|NCT03894540|38206186|FG005|Overall Study|Withdrawal by Subject|0|||
17063391|NCT03894540|38206181|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
17063392|NCT03894540|38206182|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
17063393|NCT03894540|38206183|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
17063394|NCT03894540|38206184|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
17063395|NCT03894540|38206185|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
17063396|NCT03894540|38206186|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
17063397|NCT03894540|38206181|FG000|Overall Study|Progressive Disease Clinical|1|||
17063398|NCT03894540|38206182|FG001|Overall Study|Progressive Disease Clinical|1|||
17063399|NCT03894540|38206183|FG002|Overall Study|Progressive Disease Clinical|0|||
17063400|NCT03894540|38206184|FG003|Overall Study|Progressive Disease Clinical|1|||
17063401|NCT03894540|38206185|FG004|Overall Study|Progressive Disease Clinical|5|||
17063402|NCT03894540|38206186|FG005|Overall Study|Progressive Disease Clinical|1|||
17063403|NCT03894540|38206181|FG000|Overall Study|Study termination by sponsor|0|||
17063404|NCT03894540|38206182|FG001|Overall Study|Study termination by sponsor|0|||
17063405|NCT03894540|38206183|FG002|Overall Study|Study termination by sponsor|0|||
17063406|NCT03894540|38206184|FG003|Overall Study|Study termination by sponsor|0|||
17063407|NCT03894540|38206185|FG004|Overall Study|Study termination by sponsor|2|||
17063408|NCT03894540|38206186|FG005|Overall Study|Study termination by sponsor|0|||
17063409|NCT00535626|38206204|FG000|Overall Study|Death|15|||
17063410|NCT00535626|38206204|FG000|Overall Study|Lost to Follow-up|29|||
17063411|NCT00535626|38206204|FG000|Overall Study|Withdrawal by Subject|20|||
17063412|NCT00535626|38206204|FG000|Overall Study|Removal/revision of study component|8|||
17063413|NCT00535626|38206204|FG000|Overall Study|Subject terminated|31|||
17063414|NCT00535626|38206204|FG000|Overall Study|Unable to return|2|||
17063415|NCT03889704|38206227|FG000|Overall Study|Study terminated due to pandemic|1|||
17063416|NCT03887442|38206233|FG000|Overall Study|Adverse Event|1|||
17063417|NCT03887442|38206234|FG001|Overall Study|Adverse Event|0|||
17063418|NCT00425061|38206249|FG000|Overall Study|Adverse Event|1|||
17063419|NCT00425061|38206250|FG001|Overall Study|Adverse Event|0|||
17063420|NCT00425061|38206251|FG002|Overall Study|Adverse Event|0|||
17063421|NCT00425061|38206252|FG003|Overall Study|Adverse Event|2|||
17063422|NCT00425061|38206253|FG004|Overall Study|Adverse Event|2|||
17063423|NCT00425061|38206254|FG005|Overall Study|Adverse Event|0|||
17063424|NCT00425061|38206255|FG006|Overall Study|Adverse Event|0|||
17063425|NCT00425061|38206249|FG000|Overall Study|Lost to Follow-up|0|||
17063426|NCT00425061|38206250|FG001|Overall Study|Lost to Follow-up|1|||
17063427|NCT00425061|38206251|FG002|Overall Study|Lost to Follow-up|0|||
17063428|NCT00425061|38206252|FG003|Overall Study|Lost to Follow-up|0|||
17063429|NCT00425061|38206253|FG004|Overall Study|Lost to Follow-up|0|||
17063430|NCT00425061|38206254|FG005|Overall Study|Lost to Follow-up|0|||
17063431|NCT00425061|38206255|FG006|Overall Study|Lost to Follow-up|0|||
17063432|NCT00425061|38206249|FG000|Overall Study|Protocol Violation|1|||
17063433|NCT00425061|38206250|FG001|Overall Study|Protocol Violation|0|||
17063434|NCT00425061|38206251|FG002|Overall Study|Protocol Violation|0|||
17063435|NCT00425061|38206252|FG003|Overall Study|Protocol Violation|0|||
17063436|NCT00425061|38206253|FG004|Overall Study|Protocol Violation|0|||
17063437|NCT00425061|38206254|FG005|Overall Study|Protocol Violation|0|||
17063438|NCT00425061|38206255|FG006|Overall Study|Protocol Violation|0|||
17063439|NCT00425061|38206249|FG000|Overall Study|Withdrawal by Subject|0|||
17063440|NCT00425061|38206250|FG001|Overall Study|Withdrawal by Subject|1|||
17063441|NCT00425061|38206251|FG002|Overall Study|Withdrawal by Subject|0|||
17063442|NCT00425061|38206252|FG003|Overall Study|Withdrawal by Subject|0|||
17063443|NCT00425061|38206253|FG004|Overall Study|Withdrawal by Subject|1|||
17063444|NCT00425061|38206254|FG005|Overall Study|Withdrawal by Subject|0|||
17063445|NCT00425061|38206255|FG006|Overall Study|Withdrawal by Subject|3|||
17063446|NCT00425061|38206249|FG000|Overall Study|Sponsor's request|0|||
17063447|NCT00425061|38206250|FG001|Overall Study|Sponsor's request|0|||
17063448|NCT00425061|38206251|FG002|Overall Study|Sponsor's request|0|||
17063449|NCT00425061|38206252|FG003|Overall Study|Sponsor's request|0|||
17063450|NCT00425061|38206253|FG004|Overall Study|Sponsor's request|19|||
17063451|NCT00425061|38206254|FG005|Overall Study|Sponsor's request|4|||
17063452|NCT00425061|38206255|FG006|Overall Study|Sponsor's request|15|||
17063453|NCT00425061|38206249|FG000|Overall Study|Physician Decision|0|||
17063454|NCT00425061|38206250|FG001|Overall Study|Physician Decision|0|||
17146896|NCT03602053|38291167|FG001|Overall Study|migration|3|||
17146897|NCT03602053|38291168|FG002|Overall Study|migration|0|||
17146898|NCT03602053|38291166|FG000|Overall Study|Other|1|||
17146899|NCT03602053|38291167|FG001|Overall Study|Other|0|||
17146900|NCT03602053|38291168|FG002|Overall Study|Other|0|||
17146901|NCT04831515|38291180|FG000|First Intervention|Adverse Event|0|||
17146902|NCT04831515|38291181|FG001|First Intervention|Adverse Event|1|||
17063455|NCT00425061|38206251|FG002|Overall Study|Physician Decision|0|||
17063456|NCT00425061|38206252|FG003|Overall Study|Physician Decision|0|||
17063457|NCT00425061|38206253|FG004|Overall Study|Physician Decision|1|||
17063458|NCT00425061|38206254|FG005|Overall Study|Physician Decision|0|||
17063459|NCT00425061|38206255|FG006|Overall Study|Physician Decision|0|||
17063460|NCT00425061|38206249|FG000|Overall Study|Other|0|||
17063461|NCT00425061|38206250|FG001|Overall Study|Other|0|||
17063462|NCT00425061|38206251|FG002|Overall Study|Other|0|||
17063463|NCT00425061|38206252|FG003|Overall Study|Other|0|||
17063464|NCT00425061|38206253|FG004|Overall Study|Other|3|||
17063465|NCT00425061|38206254|FG005|Overall Study|Other|0|||
17063466|NCT00425061|38206255|FG006|Overall Study|Other|1|||
17063467|NCT00424827|38206273|FG000|Overall Study|Adverse Event|1|||
17063468|NCT03885726|38206278|FG000|Overall Study|Staffing issues/lost interest|1|||
17063469|NCT03885726|38206278|FG000|Overall Study|Early discharge from hospital|3|||
17063470|NCT00377962|38206288|FG000|Core Study: 0-12 Months|Adverse Event|18|||
17063471|NCT00377962|38206289|FG001|Core Study: 0-12 Months|Adverse Event|2|||
17146903|NCT03554629|38291187|FG000|Overall Study|Inadequate data|6|||
17146904|NCT03196791|38291217|FG000|Overall Study|Protocol Violation|7|||
17063472|NCT00377962|38206288|FG000|Core Study: 0-12 Months|Death|3|||
17063473|NCT00377962|38206289|FG001|Core Study: 0-12 Months|Death|0|||
17063474|NCT00377962|38206288|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
17063475|NCT00377962|38206289|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
17063476|NCT00377962|38206288|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
17063477|NCT00377962|38206289|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
17063478|NCT00377962|38206288|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
17063479|NCT00377962|38206289|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
17063480|NCT00377962|38206288|FG000|Extension Study: 12-24 Months|Death|1|||
17063481|NCT00377962|38206289|FG001|Extension Study: 12-24 Months|Death|1|||
17063482|NCT00377962|38206288|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
17063483|NCT00377962|38206289|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
17063484|NCT00377962|38206288|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
17063485|NCT00377962|38206289|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
17063486|NCT00377962|38206288|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
17063487|NCT00377962|38206289|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
17063488|NCT00424749|38206301|FG000|Overall Study|Withdrawal by Subject|1|||
17063489|NCT00424593|38206307|FG000|Acute Double-Blind Period|Adverse Event|16|||
17063490|NCT00424593|38206308|FG001|Acute Double-Blind Period|Adverse Event|7|||
17146905|NCT03196791|38291218|FG001|Overall Study|Protocol Violation|3|||
17146906|NCT03196791|38291217|FG000|Overall Study|Withdrawal by Subject|3|||
17146907|NCT03196791|38291218|FG001|Overall Study|Withdrawal by Subject|2|||
17146908|NCT03196635|38291224|FG000|Overall Study|Withdrawal by Subject|1|||
17146909|NCT03194217|38291246|FG000|Overall Study|Adverse Event|0|||
17146910|NCT03194217|38291247|FG001|Overall Study|Adverse Event|2|||
17063491|NCT00424593|38206307|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
17063492|NCT00424593|38206308|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
17063493|NCT00424593|38206307|FG000|Acute Double-Blind Period|Protocol Violation|2|||
17063494|NCT00424593|38206308|FG001|Acute Double-Blind Period|Protocol Violation|2|||
17063495|NCT00424593|38206307|FG000|Acute Double-Blind Period|Physician Decision|1|||
17063496|NCT00424593|38206308|FG001|Acute Double-Blind Period|Physician Decision|2|||
17063497|NCT00424593|38206307|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
17063498|NCT00424593|38206308|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
17063499|NCT00424593|38206307|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
17063500|NCT00424593|38206308|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
17063501|NCT00424593|38206307|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
17063502|NCT00424593|38206308|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
17063503|NCT00424593|38206307|FG000|Dose-Blind Extension Period|Adverse Event|18|||
17063504|NCT00424593|38206308|FG001|Dose-Blind Extension Period|Adverse Event|0|||
17063505|NCT00424593|38206307|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
17146911|NCT03194217|38291248|FG002|Overall Study|Adverse Event|3|||
17146912|NCT03194217|38291249|FG003|Overall Study|Adverse Event|3|||
17146913|NCT03194217|38291246|FG000|Overall Study|Failure to meet randomisation criteria|0|||
17146914|NCT03194217|38291247|FG001|Overall Study|Failure to meet randomisation criteria|0|||
17146915|NCT03194217|38291248|FG002|Overall Study|Failure to meet randomisation criteria|0|||
17146916|NCT03194217|38291249|FG003|Overall Study|Failure to meet randomisation criteria|1|||
17146917|NCT03194217|38291246|FG000|Overall Study|Other|0|||
17146918|NCT03194217|38291247|FG001|Overall Study|Other|1|||
17146919|NCT03194217|38291248|FG002|Overall Study|Other|1|||
17146920|NCT03194217|38291249|FG003|Overall Study|Other|0|||
17146921|NCT00709618|38291259|FG000|Overall Study|Withdrawal by Subject|4|||
17146922|NCT00709618|38291259|FG000|Overall Study|Lost to Follow-up|1|||
17146923|NCT00709618|38291259|FG000|Overall Study|Study Closed/Terminated|25|||
17146924|NCT03193047|38291265|FG000|Overall Study|Physician Decision|1|||
17146925|NCT03193047|38291266|FG001|Overall Study|Physician Decision|0|||
17146926|NCT03193047|38291265|FG000|Overall Study|Participant Left State|1|||
17063506|NCT00424593|38206308|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
17063507|NCT00424593|38206307|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
17063508|NCT00424593|38206308|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
17063509|NCT00424593|38206307|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
17146927|NCT03193047|38291266|FG001|Overall Study|Participant Left State|0|||
17146928|NCT02003924|38291276|FG000|Double-blind Phase|Lost to Follow-up|2|||
17146929|NCT02003924|38291277|FG001|Double-blind Phase|Lost to Follow-up|1|||
17146930|NCT02003924|38291278|FG002|Double-blind Phase|Lost to Follow-up|0|||
17146931|NCT02003924|38291276|FG000|Double-blind Phase|Protocol Violation|1|||
17146932|NCT02003924|38291277|FG001|Double-blind Phase|Protocol Violation|2|||
17146933|NCT02003924|38291278|FG002|Double-blind Phase|Protocol Violation|0|||
17146934|NCT02003924|38291276|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
17063510|NCT00424593|38206308|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
17063511|NCT00424593|38206307|FG000|Dose-Blind Extension Period|Physician Decision|3|||
17063512|NCT00424593|38206308|FG001|Dose-Blind Extension Period|Physician Decision|0|||
17063513|NCT00369382|38206316|FG000|Overall Study|Death|0|||
17063514|NCT00369382|38206317|FG001|Overall Study|Death|2|||
17063515|NCT00369382|38206316|FG000|Overall Study|Physician Decision|2|||
17063516|NCT00369382|38206317|FG001|Overall Study|Physician Decision|1|||
17063517|NCT00369382|38206316|FG000|Overall Study|Withdrawal by Subject|5|||
17063518|NCT00369382|38206317|FG001|Overall Study|Withdrawal by Subject|0|||
17063519|NCT00369382|38206316|FG000|Overall Study|Randomized, not treated|2|||
17063520|NCT00369382|38206317|FG001|Overall Study|Randomized, not treated|0|||
17063521|NCT00369382|38206316|FG000|Overall Study|Other|1|||
17063522|NCT00369382|38206317|FG001|Overall Study|Other|0|||
17063523|NCT00424515|38206326|FG000|Overall Study|Progressive Disease|10|||
17063524|NCT00424515|38206327|FG001|Overall Study|Progressive Disease|11|||
17063525|NCT00424515|38206326|FG000|Overall Study|Adverse Event|0|||
17063526|NCT00424515|38206327|FG001|Overall Study|Adverse Event|1|||
17063527|NCT00424515|38206326|FG000|Overall Study|Intercurrent Illness|0|||
17063528|NCT00424515|38206327|FG001|Overall Study|Intercurrent Illness|1|||
17063529|NCT00424515|38206326|FG000|Overall Study|Withdrawal by Subject|1|||
17063530|NCT00424515|38206327|FG001|Overall Study|Withdrawal by Subject|0|||
17146935|NCT02003924|38291277|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
17146936|NCT02003924|38291278|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
17146937|NCT02003924|38291276|FG000|Double-blind Phase|Disease Progression|229|||
17146938|NCT02003924|38291277|FG001|Double-blind Phase|Disease Progression|247|||
17146939|NCT02003924|38291278|FG002|Double-blind Phase|Disease Progression|0|||
17146940|NCT02003924|38291276|FG000|Double-blind Phase|Adverse Event|120|||
17146941|NCT02003924|38291277|FG001|Double-blind Phase|Adverse Event|31|||
17146942|NCT02003924|38291278|FG002|Double-blind Phase|Adverse Event|0|||
17146943|NCT02003924|38291276|FG000|Double-blind Phase|Randomized But not Treated|3|||
17146944|NCT02003924|38291277|FG001|Double-blind Phase|Randomized But not Treated|3|||
17146945|NCT02003924|38291278|FG002|Double-blind Phase|Randomized But not Treated|0|||
17146946|NCT02003924|38291276|FG000|Double-blind Phase|Other|29|||
17146947|NCT02003924|38291277|FG001|Double-blind Phase|Other|50|||
17146948|NCT02003924|38291278|FG002|Double-blind Phase|Other|0|||
17146949|NCT02003924|38291276|FG000|Open-label Phase|Lost to Follow-up|0|||
17146950|NCT02003924|38291277|FG001|Open-label Phase|Lost to Follow-up|0|||
17146951|NCT02003924|38291278|FG002|Open-label Phase|Lost to Follow-up|1|||
17146952|NCT02003924|38291276|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
17146953|NCT02003924|38291277|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
17146954|NCT02003924|38291278|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
17063531|NCT00377260|38206335|FG000|Overall Study|Lost to Follow-up|0|||
17063532|NCT00377260|38206336|FG001|Overall Study|Lost to Follow-up|1|||
17063533|NCT00377260|38206335|FG000|Overall Study|Withdrawal by Subject|2|||
17063534|NCT00377260|38206336|FG001|Overall Study|Withdrawal by Subject|4|||
17063535|NCT00441441|38206344|FG000|Overall Study|Adverse Event|2|||
17063536|NCT00441441|38206345|FG001|Overall Study|Adverse Event|1|||
17063537|NCT00441441|38206344|FG000|Overall Study|Protocol Violation|4|||
17063538|NCT00441441|38206345|FG001|Overall Study|Protocol Violation|6|||
17063539|NCT00441441|38206344|FG000|Overall Study|Exacerbation of asthma|1|||
17063540|NCT00441441|38206345|FG001|Overall Study|Exacerbation of asthma|2|||
17063541|NCT00441441|38206344|FG000|Overall Study|Withdrawal by Subject|1|||
17063542|NCT00441441|38206345|FG001|Overall Study|Withdrawal by Subject|2|||
17063543|NCT00441441|38206344|FG000|Overall Study|Other|3|||
17063544|NCT00441441|38206345|FG001|Overall Study|Other|3|||
17063545|NCT00436917|38206365|FG000|Overall Study|Withdrawal by Subject|13|||
17063546|NCT00436917|38206365|FG000|Overall Study|Adverse Event|2|||
17063547|NCT00436917|38206365|FG000|Overall Study|Physician Decision|1|||
17063548|NCT00436917|38206365|FG000|Overall Study|Death|1|||
17063549|NCT00436917|38206365|FG000|Overall Study|Lost to Follow-up|1|||
17063550|NCT00436917|38206365|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
17063551|NCT00436917|38206365|FG000|Overall Study|Increased creatinine|1|||
17063552|NCT00436917|38206365|FG000|Overall Study|Personal conflicts of patient|1|||
17063553|NCT00436605|38206369|FG000|Overall Study|Protocol Violation|3|||
17063554|NCT00368992|38206373|FG000|Overall Study|Ineligible|5|||
17063555|NCT00368992|38206373|FG000|Overall Study|Refused treatment|3|||
17063556|NCT00368992|38206373|FG000|Overall Study|Lack of Efficacy|63|||
17063557|NCT00368992|38206373|FG000|Overall Study|Adverse Event|26|||
17063558|NCT00368992|38206373|FG000|Overall Study|Death|4|||
17063559|NCT00368992|38206373|FG000|Overall Study|Other|9|||
17146955|NCT02003924|38291276|FG000|Open-label Phase|Disease Progression|59|||
17146956|NCT02003924|38291277|FG001|Open-label Phase|Disease Progression|0|||
17146957|NCT02003924|38291278|FG002|Open-label Phase|Disease Progression|5|||
17063560|NCT00376246|38206378|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
17063561|NCT00376246|38206379|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
17063562|NCT00376246|38206378|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
17063563|NCT00376246|38206379|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
17063564|NCT00376246|38206378|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
17063565|NCT00376246|38206379|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
17063566|NCT00368836|38206389|FG000|Phase II|Screen Failure|1|||
17063567|NCT00368836|38206389|FG000|Phase II|Withdrawal by Subject|1|||
17063568|NCT00368836|38206389|FG000|Phase II|unable to collect blood and/or breath|17|||
17063569|NCT00368836|38206389|FG000|Phase II|Protocol Violation|2|||
17063570|NCT00376168|38206398|FG000|Overall Study|Adverse Event|1|||
17063571|NCT00376168|38206399|FG001|Overall Study|Adverse Event|1|||
17063572|NCT00376168|38206398|FG000|Overall Study|Pregnancy|1|||
17063573|NCT00376168|38206399|FG001|Overall Study|Pregnancy|0|||
17063574|NCT00375934|38206407|FG000|Overall Study|Adverse Event|1|||
17063575|NCT00375934|38206408|FG001|Overall Study|Adverse Event|1|||
17063576|NCT00375934|38206407|FG000|Overall Study|Withdrawal by Subject|2|||
17063577|NCT00375934|38206408|FG001|Overall Study|Withdrawal by Subject|2|||
17063578|NCT00375934|38206407|FG000|Overall Study|Lack of Efficacy|0|||
17063579|NCT00375934|38206408|FG001|Overall Study|Lack of Efficacy|2|||
17063580|NCT00375934|38206407|FG000|Overall Study|Physician Decision|0|||
17063581|NCT00375934|38206408|FG001|Overall Study|Physician Decision|1|||
17063582|NCT00642941|38206426|FG000|Overall Study|Physician Decision|3|||
17063583|NCT00642941|38206427|FG001|Overall Study|Physician Decision|1|||
17063584|NCT00642941|38206428|FG002|Overall Study|Physician Decision|0|||
17063585|NCT00642941|38206429|FG003|Overall Study|Physician Decision|0|||
17063586|NCT00642941|38206430|FG004|Overall Study|Physician Decision|0|||
17063587|NCT00642941|38206431|FG005|Overall Study|Physician Decision|0|||
17063588|NCT00642941|38206432|FG006|Overall Study|Physician Decision|1|||
17063589|NCT00642941|38206433|FG007|Overall Study|Physician Decision|0|||
17063590|NCT00642941|38206434|FG008|Overall Study|Physician Decision|0|||
17063591|NCT00642941|38206435|FG009|Overall Study|Physician Decision|1|||
17063592|NCT00642941|38206436|FG010|Overall Study|Physician Decision|0|||
17063593|NCT00642941|38206437|FG011|Overall Study|Physician Decision|1|||
17063594|NCT00642941|38206426|FG000|Overall Study|Death|4|||
17063595|NCT00642941|38206427|FG001|Overall Study|Death|0|||
17063596|NCT00642941|38206428|FG002|Overall Study|Death|1|||
17063597|NCT00642941|38206429|FG003|Overall Study|Death|1|||
17063598|NCT00642941|38206430|FG004|Overall Study|Death|2|||
17063599|NCT00642941|38206431|FG005|Overall Study|Death|1|||
17063600|NCT00642941|38206432|FG006|Overall Study|Death|0|||
17063601|NCT00642941|38206433|FG007|Overall Study|Death|0|||
17063602|NCT00642941|38206434|FG008|Overall Study|Death|0|||
17063603|NCT00642941|38206435|FG009|Overall Study|Death|0|||
17063604|NCT00642941|38206436|FG010|Overall Study|Death|0|||
17063605|NCT00642941|38206437|FG011|Overall Study|Death|1|||
17063606|NCT00642941|38206426|FG000|Overall Study|Study closed by Sponsor|0|||
17063607|NCT00642941|38206427|FG001|Overall Study|Study closed by Sponsor|1|||
17063608|NCT00642941|38206428|FG002|Overall Study|Study closed by Sponsor|0|||
17063609|NCT00642941|38206429|FG003|Overall Study|Study closed by Sponsor|0|||
17063610|NCT00642941|38206430|FG004|Overall Study|Study closed by Sponsor|0|||
17063611|NCT00642941|38206431|FG005|Overall Study|Study closed by Sponsor|0|||
17063612|NCT00642941|38206432|FG006|Overall Study|Study closed by Sponsor|0|||
17063613|NCT00642941|38206433|FG007|Overall Study|Study closed by Sponsor|0|||
17063614|NCT00642941|38206434|FG008|Overall Study|Study closed by Sponsor|0|||
17063615|NCT00642941|38206435|FG009|Overall Study|Study closed by Sponsor|0|||
17063616|NCT00642941|38206436|FG010|Overall Study|Study closed by Sponsor|0|||
17063617|NCT00642941|38206437|FG011|Overall Study|Study closed by Sponsor|0|||
17063618|NCT00642941|38206426|FG000|Overall Study|Withdrawal by Subject|1|||
17063619|NCT00642941|38206427|FG001|Overall Study|Withdrawal by Subject|0|||
17063620|NCT00642941|38206428|FG002|Overall Study|Withdrawal by Subject|0|||
17063621|NCT00642941|38206429|FG003|Overall Study|Withdrawal by Subject|2|||
17063622|NCT00642941|38206430|FG004|Overall Study|Withdrawal by Subject|0|||
17063623|NCT00642941|38206431|FG005|Overall Study|Withdrawal by Subject|0|||
17063624|NCT00642941|38206432|FG006|Overall Study|Withdrawal by Subject|2|||
17063625|NCT00642941|38206433|FG007|Overall Study|Withdrawal by Subject|0|||
17063626|NCT00642941|38206434|FG008|Overall Study|Withdrawal by Subject|1|||
17063627|NCT00642941|38206435|FG009|Overall Study|Withdrawal by Subject|0|||
17063628|NCT00642941|38206436|FG010|Overall Study|Withdrawal by Subject|0|||
17146958|NCT02003924|38291276|FG000|Open-label Phase|Adverse Event|25|||
17063629|NCT00642941|38206437|FG011|Overall Study|Withdrawal by Subject|1|||
17063630|NCT00642941|38206426|FG000|Overall Study|Protocol Violation|0|||
17063631|NCT00642941|38206427|FG001|Overall Study|Protocol Violation|0|||
17063632|NCT00642941|38206428|FG002|Overall Study|Protocol Violation|0|||
17063633|NCT00642941|38206429|FG003|Overall Study|Protocol Violation|0|||
17063634|NCT00642941|38206430|FG004|Overall Study|Protocol Violation|0|||
17063635|NCT00642941|38206431|FG005|Overall Study|Protocol Violation|0|||
17063636|NCT00642941|38206432|FG006|Overall Study|Protocol Violation|1|||
17063637|NCT00642941|38206433|FG007|Overall Study|Protocol Violation|0|||
17063638|NCT00642941|38206434|FG008|Overall Study|Protocol Violation|0|||
17063639|NCT00642941|38206435|FG009|Overall Study|Protocol Violation|0|||
17063640|NCT00642941|38206436|FG010|Overall Study|Protocol Violation|0|||
17063641|NCT00642941|38206437|FG011|Overall Study|Protocol Violation|0|||
17063642|NCT00642941|38206426|FG000|Overall Study|Adverse Event|1|||
17063643|NCT00642941|38206427|FG001|Overall Study|Adverse Event|1|||
17063644|NCT00642941|38206428|FG002|Overall Study|Adverse Event|0|||
17063645|NCT00642941|38206429|FG003|Overall Study|Adverse Event|0|||
17063646|NCT00642941|38206430|FG004|Overall Study|Adverse Event|0|||
17063647|NCT00642941|38206431|FG005|Overall Study|Adverse Event|0|||
17063648|NCT00642941|38206432|FG006|Overall Study|Adverse Event|1|||
17063649|NCT00642941|38206433|FG007|Overall Study|Adverse Event|1|||
17063650|NCT00642941|38206434|FG008|Overall Study|Adverse Event|0|||
17063651|NCT00642941|38206435|FG009|Overall Study|Adverse Event|1|||
17063652|NCT00642941|38206436|FG010|Overall Study|Adverse Event|0|||
17063653|NCT00642941|38206437|FG011|Overall Study|Adverse Event|0|||
17063654|NCT00642941|38206426|FG000|Overall Study|Other|1|||
17063655|NCT00642941|38206427|FG001|Overall Study|Other|1|||
17063656|NCT00642941|38206428|FG002|Overall Study|Other|1|||
17063657|NCT00642941|38206429|FG003|Overall Study|Other|1|||
17063658|NCT00642941|38206430|FG004|Overall Study|Other|0|||
17063659|NCT00642941|38206431|FG005|Overall Study|Other|1|||
17063660|NCT00642941|38206432|FG006|Overall Study|Other|0|||
17063661|NCT00642941|38206433|FG007|Overall Study|Other|1|||
17063662|NCT00642941|38206434|FG008|Overall Study|Other|0|||
17063663|NCT00642941|38206435|FG009|Overall Study|Other|0|||
17063664|NCT00642941|38206436|FG010|Overall Study|Other|0|||
17063665|NCT00642941|38206437|FG011|Overall Study|Other|1|||
17063666|NCT00642941|38206426|FG000|Overall Study|Disease progression|60|||
17063667|NCT00642941|38206427|FG001|Overall Study|Disease progression|50|||
17063668|NCT00642941|38206428|FG002|Overall Study|Disease progression|5|||
17063669|NCT00642941|38206429|FG003|Overall Study|Disease progression|36|||
17063670|NCT00642941|38206430|FG004|Overall Study|Disease progression|23|||
17063671|NCT00642941|38206431|FG005|Overall Study|Disease progression|39|||
17063672|NCT00642941|38206432|FG006|Overall Study|Disease progression|18|||
17063673|NCT00642941|38206433|FG007|Overall Study|Disease progression|12|||
17063674|NCT00642941|38206434|FG008|Overall Study|Disease progression|10|||
17063675|NCT00642941|38206435|FG009|Overall Study|Disease progression|7|||
17063676|NCT00642941|38206436|FG010|Overall Study|Disease progression|12|||
17063677|NCT00642941|38206437|FG011|Overall Study|Disease progression|7|||
17063678|NCT00531960|38206486|FG000|Overall Study|Adverse Event|5|||
17063679|NCT00531960|38206487|FG001|Overall Study|Adverse Event|4|||
17063680|NCT00531960|38206486|FG000|Overall Study|Death|3|||
17063681|NCT00531960|38206487|FG001|Overall Study|Death|2|||
17063682|NCT00531960|38206486|FG000|Overall Study|Lack of Efficacy|42|||
17063683|NCT00531960|38206487|FG001|Overall Study|Lack of Efficacy|41|||
17063684|NCT00531960|38206486|FG000|Overall Study|Violation of Selection Criteria|2|||
17063685|NCT00531960|38206487|FG001|Overall Study|Violation of Selection Criteria|0|||
17063686|NCT00531960|38206486|FG000|Overall Study|Refused Treatment|5|||
17063687|NCT00531960|38206487|FG001|Overall Study|Refused Treatment|6|||
17063688|NCT00531960|38206486|FG000|Overall Study|Other|4|||
17063689|NCT00531960|38206487|FG001|Overall Study|Other|10|||
17063690|NCT00361504|38206495|FG000|Overall Study|Withdrawal by Subject|94|||
17063691|NCT00361504|38206496|FG001|Overall Study|Withdrawal by Subject|31|||
17063692|NCT00361504|38206495|FG000|Overall Study|Lost to Follow-up|40|||
17063693|NCT00361504|38206496|FG001|Overall Study|Lost to Follow-up|7|||
17063694|NCT00361504|38206495|FG000|Overall Study|Adverse Event|203|||
17063695|NCT00361504|38206496|FG001|Overall Study|Adverse Event|82|||
17063696|NCT00361504|38206495|FG000|Overall Study|Lack of Efficacy|72|||
17063697|NCT00361504|38206496|FG001|Overall Study|Lack of Efficacy|7|||
17063698|NCT00361504|38206495|FG000|Overall Study|Resolution of Pain|2|||
17063699|NCT00361504|38206496|FG001|Overall Study|Resolution of Pain|0|||
17063700|NCT00361504|38206495|FG000|Overall Study|Study medication non compliant|42|||
17063701|NCT00361504|38206496|FG001|Overall Study|Study medication non compliant|15|||
17063702|NCT00361504|38206495|FG000|Overall Study|All other|28|||
17063703|NCT00361504|38206496|FG001|Overall Study|All other|3|||
17063704|NCT00361270|38206506|FG000|Overall Study|Death|0|||
17063705|NCT00361270|38206507|FG001|Overall Study|Death|0|||
17063706|NCT00361270|38206508|FG002|Overall Study|Death|0|||
17063707|NCT00361270|38206509|FG003|Overall Study|Death|2|||
17063708|NCT00361270|38206506|FG000|Overall Study|Lost to Follow-up|4|||
17063709|NCT00361270|38206507|FG001|Overall Study|Lost to Follow-up|1|||
17063710|NCT00361270|38206508|FG002|Overall Study|Lost to Follow-up|0|||
17063711|NCT00361270|38206509|FG003|Overall Study|Lost to Follow-up|0|||
17063712|NCT00361270|38206506|FG000|Overall Study|Physician Decision|0|||
17063713|NCT00361270|38206507|FG001|Overall Study|Physician Decision|0|||
17063714|NCT00361270|38206508|FG002|Overall Study|Physician Decision|1|||
17063715|NCT00361270|38206509|FG003|Overall Study|Physician Decision|0|||
17063716|NCT00361270|38206506|FG000|Overall Study|Protocol Violation|9|||
17063717|NCT00361270|38206507|FG001|Overall Study|Protocol Violation|4|||
17063718|NCT00361270|38206508|FG002|Overall Study|Protocol Violation|5|||
17063719|NCT00361270|38206509|FG003|Overall Study|Protocol Violation|4|||
17063720|NCT00361270|38206506|FG000|Overall Study|Withdrawal by Subject|6|||
17063721|NCT00361270|38206507|FG001|Overall Study|Withdrawal by Subject|6|||
17063722|NCT00361270|38206508|FG002|Overall Study|Withdrawal by Subject|3|||
17063723|NCT00361270|38206509|FG003|Overall Study|Withdrawal by Subject|7|||
17063724|NCT00361270|38206506|FG000|Overall Study|Afraid of Hypnosis|1|||
17063725|NCT00361270|38206507|FG001|Overall Study|Afraid of Hypnosis|2|||
17063726|NCT00361270|38206508|FG002|Overall Study|Afraid of Hypnosis|0|||
17063727|NCT00361270|38206509|FG003|Overall Study|Afraid of Hypnosis|0|||
17063728|NCT00361270|38206506|FG000|Overall Study|Problems with Transportation|4|||
17063729|NCT00361270|38206507|FG001|Overall Study|Problems with Transportation|0|||
17063730|NCT00361270|38206508|FG002|Overall Study|Problems with Transportation|0|||
17063731|NCT00361270|38206509|FG003|Overall Study|Problems with Transportation|0|||
17063732|NCT00361270|38206506|FG000|Overall Study|Adverse Event|0|||
17063733|NCT00361270|38206507|FG001|Overall Study|Adverse Event|1|||
17063734|NCT00361270|38206508|FG002|Overall Study|Adverse Event|1|||
17063735|NCT00361270|38206509|FG003|Overall Study|Adverse Event|0|||
17146959|NCT02003924|38291277|FG001|Open-label Phase|Adverse Event|0|||
17063736|NCT00367744|38206528|FG000|Overall Study|Lost to Follow-up|4|||
17063737|NCT00367744|38206529|FG001|Overall Study|Lost to Follow-up|5|||
17063738|NCT03883386|38206538|FG000|First Assignment|Lost to Follow-up|1|||
17063739|NCT03883386|38206539|FG001|First Assignment|Lost to Follow-up|0|||
17063740|NCT03883386|38206538|FG000|First Assignment|Withdrawal by Subject|1|||
17063741|NCT03883386|38206539|FG001|First Assignment|Withdrawal by Subject|1|||
17063742|NCT00530946|38206549|FG000|Overall Study|Adverse Event|1|||
17063743|NCT00530946|38206550|FG001|Overall Study|Adverse Event|2|||
17063744|NCT00530946|38206551|FG002|Overall Study|Adverse Event|1|||
17063745|NCT00530946|38206552|FG003|Overall Study|Adverse Event|1|||
17063746|NCT00530946|38206549|FG000|Overall Study|Protocol Violation|0|||
17063747|NCT00530946|38206550|FG001|Overall Study|Protocol Violation|0|||
17063748|NCT00530946|38206551|FG002|Overall Study|Protocol Violation|0|||
17063749|NCT00530946|38206552|FG003|Overall Study|Protocol Violation|1|||
17063750|NCT00530946|38206549|FG000|Overall Study|Noncompliance|1|||
17063751|NCT00530946|38206550|FG001|Overall Study|Noncompliance|0|||
17063752|NCT00530946|38206551|FG002|Overall Study|Noncompliance|0|||
17063753|NCT00530946|38206552|FG003|Overall Study|Noncompliance|0|||
17063754|NCT00424047|38206564|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
17063755|NCT00424047|38206565|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
17063756|NCT00424047|38206564|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
17063757|NCT00424047|38206565|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
17063758|NCT00424047|38206564|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
17063759|NCT00424047|38206565|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
17063760|NCT00424047|38206564|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
17063761|NCT00424047|38206565|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
17063762|NCT00424047|38206564|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
17063763|NCT00424047|38206565|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
17063764|NCT00424047|38206564|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
17063765|NCT00424047|38206565|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
17063766|NCT00424047|38206564|FG000|On Study at Time of Unblinding|Adverse Event|22|||
17063767|NCT00424047|38206565|FG001|On Study at Time of Unblinding|Adverse Event|12|||
17063768|NCT00424047|38206564|FG000|On Study at Time of Unblinding|Progression of disease|92|||
17063769|NCT00424047|38206565|FG001|On Study at Time of Unblinding|Progression of disease|128|||
17063770|NCT00424047|38206564|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
17063771|NCT00424047|38206565|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
17063772|NCT00424047|38206564|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
17063773|NCT00424047|38206565|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
17063774|NCT00424047|38206564|FG000|On Study at Time of Unblinding|Death|11|||
17063775|NCT00424047|38206565|FG001|On Study at Time of Unblinding|Death|11|||
17063776|NCT00424047|38206564|FG000|On Study at Time of Unblinding|Other|5|||
17063777|NCT00424047|38206565|FG001|On Study at Time of Unblinding|Other|4|||
17063778|NCT00424047|38206564|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
17146960|NCT02003924|38291278|FG002|Open-label Phase|Adverse Event|10|||
17146961|NCT02003924|38291276|FG000|Open-label Phase|Other|7|||
17146962|NCT02003924|38291277|FG001|Open-label Phase|Other|0|||
17146963|NCT02003924|38291278|FG002|Open-label Phase|Other|0|||
17146964|NCT02003924|38291276|FG000|Long-term Follow-up Phase|Death|288|||
17146965|NCT02003924|38291277|FG001|Long-term Follow-up Phase|Death|174|||
17146966|NCT02003924|38291278|FG002|Long-term Follow-up Phase|Death|4|||
17146967|NCT02003924|38291276|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
17146968|NCT02003924|38291277|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
17146969|NCT02003924|38291278|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
17146970|NCT02003924|38291276|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
17146971|NCT02003924|38291277|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
17146972|NCT02003924|38291278|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
17146973|NCT02003924|38291276|FG000|Long-term Follow-up Phase|Other|5|||
17146974|NCT02003924|38291277|FG001|Long-term Follow-up Phase|Other|2|||
17063779|NCT00424047|38206565|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
17063780|NCT00424047|38206564|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
17063781|NCT00424047|38206565|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
17063782|NCT00424047|38206564|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
17063783|NCT00424047|38206565|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
17063784|NCT00424047|38206564|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
17063785|NCT00424047|38206565|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
17063786|NCT00424047|38206564|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
17063787|NCT00424047|38206565|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
17063788|NCT00530790|38206576|FG000|Overall Study|Adverse Event|2|||
17063789|NCT00530790|38206576|FG000|Overall Study|Withdrawal by Subject|2|||
17063790|NCT00530790|38206576|FG000|Overall Study|Physician Decision|1|||
17063791|NCT00530088|38206580|FG000|Overall Study|Disease Progression|4|||
17063792|NCT00530088|38206580|FG000|Overall Study|Physician Decision|4|||
17063793|NCT00530088|38206580|FG000|Overall Study|Other Not Specified|2|||
17063794|NCT00360568|38206586|FG000|Overall Study|Adverse Event|1|||
17063795|NCT00360568|38206587|FG001|Overall Study|Adverse Event|2|||
17063796|NCT00360568|38206586|FG000|Overall Study|Lack of Efficacy|1|||
17063797|NCT00360568|38206587|FG001|Overall Study|Lack of Efficacy|0|||
17063798|NCT00360568|38206586|FG000|Overall Study|Withdrawal by Subject|0|||
17063799|NCT00360568|38206587|FG001|Overall Study|Withdrawal by Subject|3|||
17063800|NCT00436215|38206595|FG000|Overall Study|Refused further treatment|3|||
17063801|NCT00436215|38206595|FG000|Overall Study|Small bowel obstruction|1|||
17063802|NCT00441363|38206601|FG000|Overall Study|Adverse Event|4|||
17063803|NCT00441363|38206602|FG001|Overall Study|Adverse Event|2|||
17063804|NCT00441363|38206601|FG000|Overall Study|Withdrawal by Subject|3|||
17063805|NCT00441363|38206602|FG001|Overall Study|Withdrawal by Subject|4|||
17063806|NCT00441363|38206601|FG000|Overall Study|Physician Decision|6|||
17063807|NCT00441363|38206602|FG001|Overall Study|Physician Decision|7|||
17063808|NCT00441363|38206601|FG000|Overall Study|Lost to Follow-up|2|||
17063809|NCT00441363|38206602|FG001|Overall Study|Lost to Follow-up|2|||
17063810|NCT00441363|38206601|FG000|Overall Study|Other|2|||
17063811|NCT00441363|38206602|FG001|Overall Study|Other|0|||
17063812|NCT00530712|38206608|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
17063813|NCT00530712|38206608|FG000|30 Day Follow-up Visit|Missed Visit|5|||
17063814|NCT00530712|38206608|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
17063815|NCT00530712|38206608|FG000|6 Month Follow-up Visit|Missed Visit|3|||
17063816|NCT00530712|38206608|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
17063817|NCT00530712|38206608|FG000|6 Month Follow-up Visit|Death|2|||
17063818|NCT00530712|38206608|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
17063819|NCT00530712|38206608|FG000|12 Month Follow-up Visit|Missed Visit|3|||
17063820|NCT00530712|38206608|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
17063821|NCT00530712|38206608|FG000|12 Month Follow-up Visit|Death|9|||
17063822|NCT00626795|38206616|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
17063823|NCT00626795|38206617|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
17063824|NCT00626795|38206618|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
17063825|NCT00626795|38206616|FG000|Blinded Treatment|Lack of Efficacy|2|||
17063826|NCT00626795|38206617|FG001|Blinded Treatment|Lack of Efficacy|0|||
17063827|NCT00626795|38206618|FG002|Blinded Treatment|Lack of Efficacy|0|||
17063828|NCT00626795|38206616|FG000|Blinded Treatment|Unacceptable adverse event|0|||
17063829|NCT00626795|38206617|FG001|Blinded Treatment|Unacceptable adverse event|0|||
17063830|NCT00626795|38206618|FG002|Blinded Treatment|Unacceptable adverse event|1|||
17063831|NCT00626795|38206616|FG000|Blinded Treatment|Protocol Violation|0|||
17063832|NCT00626795|38206617|FG001|Blinded Treatment|Protocol Violation|1|||
17063833|NCT00626795|38206618|FG002|Blinded Treatment|Protocol Violation|1|||
17063834|NCT00626795|38206616|FG000|Blinded Treatment|Withdrawal by Subject|1|||
17063835|NCT00626795|38206617|FG001|Blinded Treatment|Withdrawal by Subject|1|||
17063836|NCT00626795|38206618|FG002|Blinded Treatment|Withdrawal by Subject|0|||
17063837|NCT00626795|38206616|FG000|Blinded Treatment|Other reasons|2|||
17063838|NCT00626795|38206617|FG001|Blinded Treatment|Other reasons|0|||
17146975|NCT02003924|38291278|FG002|Long-term Follow-up Phase|Other|1|||
17146976|NCT02918019|38291289|FG000|Overall Study|Death|0|||
17063839|NCT00626795|38206618|FG002|Blinded Treatment|Other reasons|2|||
17063840|NCT00626795|38206616|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
17063841|NCT00626795|38206617|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
17063842|NCT00626795|38206618|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
17063843|NCT00626639|38206632|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
17063844|NCT00626639|38206633|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
17063845|NCT00626561|38206641|FG000|Overall Study|Withdrawal by Subject|2|||
17063846|NCT00626561|38206641|FG000|Overall Study|Disease Progression|2|||
17063847|NCT03880266|38206653|FG000|Overall Study|Withdrawal by Subject|0|||
17063848|NCT03880266|38206654|FG001|Overall Study|Withdrawal by Subject|1|||
17063849|NCT03880266|38206655|FG002|Overall Study|Withdrawal by Subject|1|||
17063850|NCT03880266|38206656|FG003|Overall Study|Withdrawal by Subject|0|||
17063851|NCT03880266|38206657|FG004|Overall Study|Withdrawal by Subject|0|||
17063852|NCT03880266|38206658|FG005|Overall Study|Withdrawal by Subject|0|||
17063853|NCT03880266|38206659|FG006|Overall Study|Withdrawal by Subject|0|||
17063854|NCT03880266|38206660|FG007|Overall Study|Withdrawal by Subject|0|||
17063855|NCT00423891|38206681|FG000|Enrolled|Withdrawal by Subject|0|||
17063856|NCT00423891|38206682|FG001|Enrolled|Withdrawal by Subject|0|||
17063857|NCT00423891|38206683|FG002|Enrolled|Withdrawal by Subject|1|||
17063858|NCT00423891|38206681|FG000|Enrolled|Lost to Follow-up|0|||
17063859|NCT00423891|38206682|FG001|Enrolled|Lost to Follow-up|0|||
17063860|NCT00423891|38206683|FG002|Enrolled|Lost to Follow-up|1|||
17063861|NCT00423891|38206681|FG000|Enrolled|No longer met criteria|11|||
17063862|NCT00423891|38206682|FG001|Enrolled|No longer met criteria|2|||
17063863|NCT00423891|38206683|FG002|Enrolled|No longer met criteria|1|||
17063864|NCT00423891|38206681|FG000|Treatment|Withdrawal by Subject|1|||
17063865|NCT00423891|38206682|FG001|Treatment|Withdrawal by Subject|0|||
17063866|NCT00423891|38206683|FG002|Treatment|Withdrawal by Subject|0|||
17063867|NCT00423891|38206681|FG000|Treatment|Lost to Follow-up|1|||
17063868|NCT00423891|38206682|FG001|Treatment|Lost to Follow-up|0|||
17063869|NCT00423891|38206683|FG002|Treatment|Lost to Follow-up|0|||
17063870|NCT00423891|38206681|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
17063871|NCT00423891|38206682|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
17063872|NCT00423891|38206683|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
17063873|NCT00423891|38206681|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
17063874|NCT00423891|38206682|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
17063875|NCT00423891|38206683|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
17063876|NCT00423813|38206696|FG000|Overall Study|Adverse Event|11|||
17063877|NCT00423813|38206697|FG001|Overall Study|Adverse Event|30|||
17063878|NCT00423813|38206698|FG002|Overall Study|Adverse Event|40|||
17063879|NCT00423813|38206696|FG000|Overall Study|Withdrawal by Subject|6|||
17063880|NCT00423813|38206697|FG001|Overall Study|Withdrawal by Subject|8|||
17063881|NCT00423813|38206698|FG002|Overall Study|Withdrawal by Subject|5|||
17063882|NCT00423813|38206696|FG000|Overall Study|Lost to Follow-up|5|||
17063883|NCT00423813|38206697|FG001|Overall Study|Lost to Follow-up|4|||
17063884|NCT00423813|38206698|FG002|Overall Study|Lost to Follow-up|4|||
17063885|NCT00423813|38206696|FG000|Overall Study|Lack of Efficacy|23|||
17063886|NCT00423813|38206697|FG001|Overall Study|Lack of Efficacy|18|||
17063887|NCT00423813|38206698|FG002|Overall Study|Lack of Efficacy|19|||
17063888|NCT00423813|38206696|FG000|Overall Study|Physician Decision|2|||
17063889|NCT00423813|38206697|FG001|Overall Study|Physician Decision|0|||
17063890|NCT00423813|38206698|FG002|Overall Study|Physician Decision|0|||
17063891|NCT00423813|38206696|FG000|Overall Study|Sponsor Decision|0|||
17063892|NCT00423813|38206697|FG001|Overall Study|Sponsor Decision|1|||
17063893|NCT00423813|38206698|FG002|Overall Study|Sponsor Decision|0|||
17063894|NCT00423813|38206696|FG000|Overall Study|Protocol Violation|9|||
17063895|NCT00423813|38206697|FG001|Overall Study|Protocol Violation|4|||
17063896|NCT00423813|38206698|FG002|Overall Study|Protocol Violation|4|||
17063897|NCT00423813|38206696|FG000|Overall Study|Pregnancy|0|||
17063898|NCT00423813|38206697|FG001|Overall Study|Pregnancy|0|||
17063899|NCT00423813|38206698|FG002|Overall Study|Pregnancy|1|||
17063900|NCT00423813|38206696|FG000|Overall Study|Subject started night shift work|1|||
17063901|NCT00423813|38206697|FG001|Overall Study|Subject started night shift work|0|||
17063902|NCT00423813|38206698|FG002|Overall Study|Subject started night shift work|0|||
17063903|NCT00423813|38206696|FG000|Overall Study|Will start exclusionary medications|0|||
17063904|NCT00423813|38206697|FG001|Overall Study|Will start exclusionary medications|1|||
17063905|NCT00423813|38206698|FG002|Overall Study|Will start exclusionary medications|0|||
17063906|NCT00423813|38206696|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
17063907|NCT00423813|38206697|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
17063908|NCT00423813|38206698|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
17063909|NCT03687372|38206708|FG000|Overall Study|Lost to Follow-up|12|||
17063910|NCT03687372|38206709|FG001|Overall Study|Lost to Follow-up|21|||
17063911|NCT03687372|38206708|FG000|Overall Study|Withdrawal by Subject|4|||
17063912|NCT03687372|38206709|FG001|Overall Study|Withdrawal by Subject|17|||
17063913|NCT03687372|38206708|FG000|Overall Study|Investigator Decision|1|||
17063914|NCT03687372|38206709|FG001|Overall Study|Investigator Decision|1|||
17063915|NCT00626405|38206719|FG000|Overall Study|Deemed Ineligible|1|||
17063916|NCT00626405|38206720|FG001|Overall Study|Deemed Ineligible|0|||
17063917|NCT00626405|38206719|FG000|Overall Study|Withdrawal by Subject|0|||
17063918|NCT00626405|38206720|FG001|Overall Study|Withdrawal by Subject|1|||
17063919|NCT00358150|38206726|FG000|Overall Study|Adverse Event|3|||
17063920|NCT00358150|38206726|FG000|Overall Study|Withdrawal by Subject|1|||
17063921|NCT00358150|38206726|FG000|Overall Study|Undefined|3|||
17063922|NCT00423735|38206736|FG000|Overall Study|Ineligible / No protocol treatment|8|||
17063923|NCT00423735|38206737|FG001|Overall Study|Ineligible / No protocol treatment|6|||
17063924|NCT00423735|38206738|FG002|Overall Study|Ineligible / No protocol treatment|0|||
17063925|NCT00626327|38206751|FG000|Overall Study|Withdrawal by Subject|21|||
17063926|NCT00626327|38206752|FG001|Overall Study|Withdrawal by Subject|29|||
17063927|NCT00626327|38206753|FG002|Overall Study|Withdrawal by Subject|30|||
17063928|NCT00626327|38206751|FG000|Overall Study|Adverse Event|1|||
17063929|NCT00626327|38206752|FG001|Overall Study|Adverse Event|0|||
17063930|NCT00626327|38206753|FG002|Overall Study|Adverse Event|0|||
17063931|NCT00626327|38206751|FG000|Overall Study|Lost to Follow-up|24|||
17063932|NCT00626327|38206752|FG001|Overall Study|Lost to Follow-up|21|||
17063933|NCT00626327|38206753|FG002|Overall Study|Lost to Follow-up|23|||
17063934|NCT00626327|38206751|FG000|Overall Study|Inappropriate enrollment|4|||
17063935|NCT00626327|38206752|FG001|Overall Study|Inappropriate enrollment|5|||
17063936|NCT00626327|38206753|FG002|Overall Study|Inappropriate enrollment|3|||
17063937|NCT00626327|38206751|FG000|Overall Study|Administrative Reason|2|||
17063938|NCT00626327|38206752|FG001|Overall Study|Administrative Reason|0|||
17063939|NCT00626327|38206753|FG002|Overall Study|Administrative Reason|6|||
17063940|NCT00626327|38206751|FG000|Overall Study|Protocol Violation|26|||
17063941|NCT00626327|38206752|FG001|Overall Study|Protocol Violation|4|||
17063942|NCT00626327|38206753|FG002|Overall Study|Protocol Violation|26|||
17063943|NCT00357994|38206771|FG000|Overall Study|Adverse Event|1|||
17063944|NCT00357994|38206772|FG001|Overall Study|Adverse Event|2|||
17063945|NCT00357994|38206771|FG000|Overall Study|Lack of Efficacy|0|||
17063946|NCT00357994|38206772|FG001|Overall Study|Lack of Efficacy|1|||
17063947|NCT00357994|38206771|FG000|Overall Study|Protocol Violation|1|||
17063948|NCT00357994|38206772|FG001|Overall Study|Protocol Violation|0|||
17063949|NCT00423657|38206780|FG000|Overall Study|Withdrew consent|10|||
17063950|NCT00423657|38206781|FG001|Overall Study|Withdrew consent|8|||
17063951|NCT00423657|38206780|FG000|Overall Study|Non-compliance|0|||
17063952|NCT00423657|38206781|FG001|Overall Study|Non-compliance|1|||
17063953|NCT00423657|38206780|FG000|Overall Study|Other|15|||
17063954|NCT00423657|38206781|FG001|Overall Study|Other|16|||
17063955|NCT00423657|38206780|FG000|Overall Study|Request of sponsor/investigator|1|||
17063956|NCT00423657|38206781|FG001|Overall Study|Request of sponsor/investigator|0|||
17063957|NCT00367432|38206787|FG000|First Period (16 Weeks)|Adverse Event|6|||
17063958|NCT00367432|38206788|FG001|First Period (16 Weeks)|Adverse Event|0|||
17063959|NCT00367432|38206787|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
17063960|NCT00367432|38206788|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
17063961|NCT00367432|38206787|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
17063962|NCT00367432|38206788|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
17063963|NCT00367432|38206787|FG000|First Period (16 Weeks)|Other Reason|2|||
17063964|NCT00367432|38206788|FG001|First Period (16 Weeks)|Other Reason|0|||
17063965|NCT00367432|38206787|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
17063966|NCT00367432|38206788|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
17063967|NCT00367432|38206787|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
17063968|NCT00367432|38206788|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
17063969|NCT00367432|38206787|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
17063970|NCT00367432|38206788|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
17063971|NCT00367432|38206787|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
17063972|NCT00367432|38206788|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
17146977|NCT02918019|38291290|FG001|Overall Study|Death|0|||
17146978|NCT02918019|38291291|FG002|Overall Study|Death|1|||
17146979|NCT02918019|38291292|FG003|Overall Study|Death|0|||
17146980|NCT02918019|38291289|FG000|Overall Study|Lost to Follow-up|1|||
17146981|NCT02918019|38291290|FG001|Overall Study|Lost to Follow-up|1|||
17146982|NCT02918019|38291291|FG002|Overall Study|Lost to Follow-up|0|||
17146983|NCT02918019|38291292|FG003|Overall Study|Lost to Follow-up|1|||
17146984|NCT02918019|38291289|FG000|Overall Study|Principal investigator request|0|||
17063973|NCT00367432|38206787|FG000|Second Period (up to 54 Months)|Other Reason|6|||
17063974|NCT00367432|38206788|FG001|Second Period (up to 54 Months)|Other Reason|2|||
17063975|NCT00623363|38206794|FG000|Overall Study|Adverse Event|2|||
17063976|NCT00623363|38206795|FG001|Overall Study|Adverse Event|2|||
17063977|NCT00423267|38206804|FG000|Period A|Withdrawal by Subject|0|||
17063978|NCT00423267|38206805|FG001|Period A|Withdrawal by Subject|1|||
17063979|NCT00423267|38206804|FG000|Period A|Non-compliance with protocol|1|||
17063980|NCT00423267|38206805|FG001|Period A|Non-compliance with protocol|0|||
17063981|NCT00423267|38206804|FG000|Period A|Administrative|1|||
17063982|NCT00423267|38206805|FG001|Period A|Administrative|0|||
17063983|NCT00626093|38206813|FG000|Overall Study|Lost to Follow-up|5|||
17063984|NCT00626093|38206813|FG000|Overall Study|Death|1|||
17063985|NCT00626093|38206813|FG000|Overall Study|Physician Decision|4|||
17063986|NCT00626093|38206813|FG000|Overall Study|Withdrawal by Subject|6|||
17063987|NCT00626093|38206813|FG000|Overall Study|Protocol Violation|1|||
17063988|NCT00626093|38206813|FG000|Overall Study|One of the required devices not implante|6|||
17063989|NCT00357760|38206819|FG000|Overall Study|Disease progression|44|||
17063990|NCT00357760|38206820|FG001|Overall Study|Disease progression|17|||
17063991|NCT00357760|38206819|FG000|Overall Study|Adverse Event|10|||
17063992|NCT00357760|38206820|FG001|Overall Study|Adverse Event|7|||
17063993|NCT00357760|38206819|FG000|Overall Study|Death|0|||
17063994|NCT00357760|38206820|FG001|Overall Study|Death|3|||
17063995|NCT00357760|38206819|FG000|Overall Study|Alternative therapy|1|||
17063996|NCT00357760|38206820|FG001|Overall Study|Alternative therapy|0|||
17063997|NCT00357760|38206819|FG000|Overall Study|Withdrawal by Subject|0|||
17063998|NCT00357760|38206820|FG001|Overall Study|Withdrawal by Subject|2|||
17063999|NCT00357760|38206819|FG000|Overall Study|Never started treatment|2|||
17064000|NCT00357760|38206820|FG001|Overall Study|Never started treatment|1|||
17064001|NCT00357760|38206819|FG000|Overall Study|Ineligible|0|||
17064002|NCT00357760|38206820|FG001|Overall Study|Ineligible|2|||
17064003|NCT00357760|38206819|FG000|Overall Study|Physician Decision|2|||
17064004|NCT00357760|38206820|FG001|Overall Study|Physician Decision|1|||
17064005|NCT00357760|38206819|FG000|Overall Study|Protocol Violation|0|||
17064006|NCT00357760|38206820|FG001|Overall Study|Protocol Violation|1|||
17064007|NCT00357760|38206819|FG000|Overall Study|To receive hospice care|0|||
17064008|NCT00357760|38206820|FG001|Overall Study|To receive hospice care|1|||
17064009|NCT00622739|38206828|FG000|Overall Study|Physician Decision|1|||
17064010|NCT00622739|38206829|FG001|Overall Study|Physician Decision|0|||
17064011|NCT00622739|38206828|FG000|Overall Study|Adverse Event|1|||
17064012|NCT00622739|38206829|FG001|Overall Study|Adverse Event|2|||
17064013|NCT00622739|38206828|FG000|Overall Study|Lack of Efficacy|0|||
17064014|NCT00622739|38206829|FG001|Overall Study|Lack of Efficacy|2|||
17064015|NCT00622739|38206828|FG000|Overall Study|Withdrawal by Subject|0|||
17064016|NCT00622739|38206829|FG001|Overall Study|Withdrawal by Subject|1|||
17064017|NCT00622739|38206828|FG000|Overall Study|Lost to Follow-up|0|||
17064018|NCT00622739|38206829|FG001|Overall Study|Lost to Follow-up|1|||
17064019|NCT00435825|38206841|FG000|Overall Study|Abnormality of Laboratory Test|0|||
17064020|NCT00435825|38206842|FG001|Overall Study|Abnormality of Laboratory Test|1|||
17064021|NCT00435825|38206843|FG002|Overall Study|Abnormality of Laboratory Test|0|||
17146985|NCT02918019|38291290|FG001|Overall Study|Principal investigator request|0|||
17146986|NCT02918019|38291291|FG002|Overall Study|Principal investigator request|0|||
17146987|NCT02918019|38291292|FG003|Overall Study|Principal investigator request|1|||
17064022|NCT00435825|38206844|FG003|Overall Study|Abnormality of Laboratory Test|0|||
17064023|NCT00435825|38206841|FG000|Overall Study|Insufficient Therapeutic Response|3|||
17064024|NCT00435825|38206842|FG001|Overall Study|Insufficient Therapeutic Response|1|||
17064025|NCT00435825|38206843|FG002|Overall Study|Insufficient Therapeutic Response|0|||
17064026|NCT00435825|38206844|FG003|Overall Study|Insufficient Therapeutic Response|3|||
17064027|NCT00435825|38206841|FG000|Overall Study|Other Protocol Violation|1|||
17064028|NCT00435825|38206842|FG001|Overall Study|Other Protocol Violation|0|||
17064029|NCT00435825|38206843|FG002|Overall Study|Other Protocol Violation|0|||
17146988|NCT02918019|38291289|FG000|Overall Study|Physician Decision|1|||
17146989|NCT02918019|38291290|FG001|Overall Study|Physician Decision|3|||
17146990|NCT02918019|38291291|FG002|Overall Study|Physician Decision|2|||
17146991|NCT02918019|38291292|FG003|Overall Study|Physician Decision|0|||
17146992|NCT02918019|38291289|FG000|Overall Study|Protocol deviation|1|||
17146993|NCT02918019|38291290|FG001|Overall Study|Protocol deviation|1|||
17146994|NCT02918019|38291291|FG002|Overall Study|Protocol deviation|0|||
17146995|NCT02918019|38291292|FG003|Overall Study|Protocol deviation|2|||
17146996|NCT02918019|38291289|FG000|Overall Study|Withdrawal by Subject|3|||
17064030|NCT00435825|38206844|FG003|Overall Study|Other Protocol Violation|0|||
17064031|NCT00435825|38206841|FG000|Overall Study|Refused treatment|2|||
17064032|NCT00435825|38206842|FG001|Overall Study|Refused treatment|0|||
17064033|NCT00435825|38206843|FG002|Overall Study|Refused treatment|0|||
17064034|NCT00435825|38206844|FG003|Overall Study|Refused treatment|5|||
17064035|NCT00435825|38206841|FG000|Overall Study|Failure to return|5|||
17064036|NCT00435825|38206842|FG001|Overall Study|Failure to return|0|||
17064037|NCT00435825|38206843|FG002|Overall Study|Failure to return|4|||
17064038|NCT00435825|38206844|FG003|Overall Study|Failure to return|0|||
17064039|NCT00435825|38206841|FG000|Overall Study|Did not receive study drug|1|||
17064040|NCT00435825|38206842|FG001|Overall Study|Did not receive study drug|0|||
17064041|NCT00435825|38206843|FG002|Overall Study|Did not receive study drug|2|||
17064042|NCT00435825|38206844|FG003|Overall Study|Did not receive study drug|0|||
17064043|NCT00435825|38206841|FG000|Overall Study|Did not enter follow-up|0|||
17064044|NCT00435825|38206842|FG001|Overall Study|Did not enter follow-up|4|||
17064045|NCT00435825|38206843|FG002|Overall Study|Did not enter follow-up|1|||
17064046|NCT00435825|38206844|FG003|Overall Study|Did not enter follow-up|3|||
17064047|NCT00435825|38206841|FG000|Overall Study|Did not complete full follow-up period|6|||
17064048|NCT00435825|38206842|FG001|Overall Study|Did not complete full follow-up period|6|||
17064049|NCT00435825|38206843|FG002|Overall Study|Did not complete full follow-up period|4|||
17064050|NCT00435825|38206844|FG003|Overall Study|Did not complete full follow-up period|5|||
17064051|NCT00574145|38206856|FG000|Overall Study|Withdrawal by Subject|2|||
17064052|NCT00574145|38206857|FG001|Overall Study|Withdrawal by Subject|1|||
17064053|NCT00423189|38206866|FG000|Overall Study|Death|0|||
17064054|NCT00423189|38206867|FG001|Overall Study|Death|1|||
17064055|NCT00423189|38206868|FG002|Overall Study|Death|0|||
17064056|NCT00422799|38206881|FG000|Overall Study|Withdrawal by Subject|6|||
17064057|NCT00422799|38206881|FG000|Overall Study|Adverse Event|7|||
17064058|NCT00435045|38206887|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
17064059|NCT00435045|38206888|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
17064060|NCT00435045|38206887|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
17064061|NCT00435045|38206888|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
17064062|NCT00435045|38206887|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
17064063|NCT00435045|38206888|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
17064064|NCT00435045|38206887|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
17064065|NCT00435045|38206888|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
17064066|NCT00435045|38206887|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
17064067|NCT00435045|38206888|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
17064068|NCT00435045|38206887|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
17064069|NCT00435045|38206888|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
17064070|NCT00435045|38206887|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
17064071|NCT00435045|38206888|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
17064072|NCT00435045|38206887|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
17064073|NCT00435045|38206888|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
17064074|NCT00435045|38206887|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
17064075|NCT00435045|38206888|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
17064076|NCT00435045|38206887|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
17064077|NCT00435045|38206888|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
17064078|NCT00435045|38206887|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
17064079|NCT00435045|38206888|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
17064080|NCT00441129|38206896|FG000|Overall Study|Withdrawal by Subject|6|||
17064081|NCT00441129|38206897|FG001|Overall Study|Withdrawal by Subject|14|||
17064082|NCT00622505|38206905|FG000|Overall Study|Adverse Event|9|||
17064083|NCT00622505|38206906|FG001|Overall Study|Adverse Event|7|||
17064084|NCT00622505|38206905|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
17064085|NCT00622505|38206906|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
17064086|NCT00622505|38206905|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
17146997|NCT02918019|38291290|FG001|Overall Study|Withdrawal by Subject|4|||
17146998|NCT02918019|38291291|FG002|Overall Study|Withdrawal by Subject|6|||
17146999|NCT02918019|38291292|FG003|Overall Study|Withdrawal by Subject|4|||
17147000|NCT02918019|38291289|FG000|Overall Study|Adverse Event|0|||
17147001|NCT02918019|38291290|FG001|Overall Study|Adverse Event|1|||
17064087|NCT00622505|38206906|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
17064088|NCT00622505|38206905|FG000|Overall Study|Withdrawal by Subject|12|||
17064089|NCT00622505|38206906|FG001|Overall Study|Withdrawal by Subject|5|||
17064090|NCT00622505|38206905|FG000|Overall Study|Administrative Problems|2|||
17064091|NCT00622505|38206906|FG001|Overall Study|Administrative Problems|4|||
17064092|NCT00622505|38206905|FG000|Overall Study|Death|2|||
17064093|NCT00622505|38206906|FG001|Overall Study|Death|2|||
17064094|NCT00350272|38206914|FG000|Blinded 12 Week Treatment|Adverse Event|1|||
17064095|NCT00350272|38206915|FG001|Blinded 12 Week Treatment|Adverse Event|0|||
17064096|NCT00350272|38206914|FG000|Blinded 12 Week Treatment|Death|1|||
17064097|NCT00350272|38206915|FG001|Blinded 12 Week Treatment|Death|0|||
17064098|NCT00350272|38206914|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2|||
17064099|NCT00350272|38206915|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0|||
17064100|NCT00350272|38206914|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3|||
17064101|NCT00350272|38206915|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0|||
17064102|NCT00350272|38206914|FG000|Blinded 12 Week Treatment|Physician Decision|2|||
17064103|NCT00350272|38206915|FG001|Blinded 12 Week Treatment|Physician Decision|1|||
17064104|NCT00350272|38206914|FG000|Blinded 12 Week Treatment|Sponsor decision|0|||
17064105|NCT00350272|38206915|FG001|Blinded 12 Week Treatment|Sponsor decision|1|||
17064106|NCT00350272|38206914|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
17064107|NCT00350272|38206915|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
17064108|NCT00350272|38206914|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
17064109|NCT00350272|38206915|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
17064110|NCT00350272|38206914|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
17064111|NCT00350272|38206915|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
17064112|NCT00350272|38206914|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
17064113|NCT00350272|38206915|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
17064114|NCT00350272|38206914|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
17064115|NCT00350272|38206915|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
17064116|NCT00357370|38206926|FG000|Cohort 2|Lack of Efficacy|0|||
17064117|NCT00357370|38206927|FG001|Cohort 2|Lack of Efficacy|2|||
17064118|NCT00357370|38206928|FG002|Cohort 2|Lack of Efficacy|1|||
17064119|NCT00357370|38206926|FG000|Cohort 2|Adverse Event|1|||
17064120|NCT00357370|38206927|FG001|Cohort 2|Adverse Event|1|||
17064121|NCT00357370|38206928|FG002|Cohort 2|Adverse Event|1|||
17064122|NCT00357370|38206926|FG000|Cohort 2|Lost to Follow-up|0|||
17064123|NCT00357370|38206927|FG001|Cohort 2|Lost to Follow-up|1|||
17064124|NCT00357370|38206928|FG002|Cohort 2|Lost to Follow-up|0|||
17064125|NCT00357370|38206926|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
17064126|NCT00357370|38206927|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
17064127|NCT00357370|38206928|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
17064128|NCT00357370|38206926|FG000|Cohort 2|Withdrawal by Subject|0|||
17064129|NCT00357370|38206927|FG001|Cohort 2|Withdrawal by Subject|2|||
17064130|NCT00357370|38206928|FG002|Cohort 2|Withdrawal by Subject|0|||
17064131|NCT00574847|38206938|FG000|Overall Study|Adverse Event|2|||
17064132|NCT00574847|38206939|FG001|Overall Study|Adverse Event|0|||
17064133|NCT00574847|38206938|FG000|Overall Study|Death|1|||
17064134|NCT00574847|38206939|FG001|Overall Study|Death|0|||
17064135|NCT00574847|38206938|FG000|Overall Study|Withdrawal by Subject|2|||
17064136|NCT00574847|38206939|FG001|Overall Study|Withdrawal by Subject|2|||
17064137|NCT00574847|38206938|FG000|Overall Study|Physician Decision|1|||
17064138|NCT00574847|38206939|FG001|Overall Study|Physician Decision|0|||
17064139|NCT00574847|38206938|FG000|Overall Study|Did not receive medication (declined)|2|||
17064140|NCT00574847|38206939|FG001|Overall Study|Did not receive medication (declined)|5|||
17064141|NCT00348790|38206945|FG000|Completed Treatment|Withdrawal by Subject|4|||
17064142|NCT00348790|38206945|FG000|Completed Treatment|Disease progression|14|||
17064143|NCT00348790|38206945|FG000|Completed Treatment|Adverse Event|4|||
17064144|NCT00348790|38206945|FG000|Completed Treatment|Required surgery|2|||
17064145|NCT00348790|38206945|FG000|Completed Treatment|Unable to travel to study site|1|||
17064146|NCT00360490|38206952|FG000|Overall Study|Adverse Event|4|||
17064147|NCT00360490|38206953|FG001|Overall Study|Adverse Event|2|||
17064148|NCT00360490|38206952|FG000|Overall Study|Lost to Follow-up|2|||
17064149|NCT00360490|38206953|FG001|Overall Study|Lost to Follow-up|1|||
17064150|NCT00360490|38206952|FG000|Overall Study|Physician Decision|2|||
17064151|NCT00360490|38206953|FG001|Overall Study|Physician Decision|1|||
17064152|NCT00360490|38206952|FG000|Overall Study|Protocol Violation|0|||
17064153|NCT00360490|38206953|FG001|Overall Study|Protocol Violation|4|||
17064154|NCT00360490|38206952|FG000|Overall Study|Withdrawal by Subject|1|||
17064155|NCT00360490|38206953|FG001|Overall Study|Withdrawal by Subject|3|||
17064156|NCT00624377|38206959|FG000|Overall Study|Lost to Follow-up|355|||
17064157|NCT00624377|38206959|FG000|Overall Study|Withdrawal by Subject|100|||
17064158|NCT00624377|38206959|FG000|Overall Study|Adverse Event|14|||
17064159|NCT00624377|38206959|FG000|Overall Study|Other|91|||
17064160|NCT00624377|38206959|FG000|Overall Study|Non-evaluable population|84|||
17064161|NCT00624065|38206965|FG000|Overall Study|Adverse Event|5|||
17064162|NCT00624065|38206966|FG001|Overall Study|Adverse Event|6|||
17064163|NCT00624065|38206965|FG000|Overall Study|Lost to Follow-up|4|||
17064164|NCT00624065|38206966|FG001|Overall Study|Lost to Follow-up|1|||
17064165|NCT00624065|38206965|FG000|Overall Study|Consent withdrawn|6|||
17064166|NCT00624065|38206966|FG001|Overall Study|Consent withdrawn|5|||
17064167|NCT00624065|38206965|FG000|Overall Study|Lack of Efficacy|0|||
17064168|NCT00624065|38206966|FG001|Overall Study|Lack of Efficacy|3|||
17064169|NCT00624065|38206965|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
17064170|NCT00624065|38206966|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
17064171|NCT00360412|38206974|FG000|Overall Study|Adverse Event|37|||
17064172|NCT00360412|38206975|FG001|Overall Study|Adverse Event|65|||
17064173|NCT00360412|38206974|FG000|Overall Study|Protocol Violation|2|||
17064174|NCT00360412|38206975|FG001|Overall Study|Protocol Violation|5|||
17064175|NCT00360412|38206974|FG000|Overall Study|Patient withdrew consent|27|||
17064176|NCT00360412|38206975|FG001|Overall Study|Patient withdrew consent|52|||
17064177|NCT00360412|38206974|FG000|Overall Study|Lack of therapeutic efficacy|46|||
17064178|NCT00360412|38206975|FG001|Overall Study|Lack of therapeutic efficacy|61|||
17064179|NCT00360412|38206974|FG000|Overall Study|Physician Decision|2|||
17064180|NCT00360412|38206975|FG001|Overall Study|Physician Decision|4|||
17064181|NCT00360412|38206974|FG000|Overall Study|Other|5|||
17147002|NCT02918019|38291291|FG002|Overall Study|Adverse Event|0|||
17147003|NCT02918019|38291292|FG003|Overall Study|Adverse Event|1|||
17147004|NCT03055988|38291310|FG000|Period 1|Adverse Event|0|||
17147005|NCT03055988|38291311|FG001|Period 1|Adverse Event|1|||
17064182|NCT00360412|38206975|FG001|Overall Study|Other|6|||
17064183|NCT00360412|38206974|FG000|Overall Study|Study termination by Sponsor|214|||
17064184|NCT00360412|38206975|FG001|Overall Study|Study termination by Sponsor|469|||
17064185|NCT00623831|38206983|FG000|Overall Study|Withdrawal by Subject|1|||
17064186|NCT00623831|38206984|FG001|Overall Study|Withdrawal by Subject|0|||
17147006|NCT03055988|38291310|FG000|Period 1|Lost to Follow-up|1|||
17064187|NCT00623831|38206983|FG000|Overall Study|Progressive Disease|0|||
17147007|NCT03055988|38291311|FG001|Period 1|Lost to Follow-up|0|||
17064188|NCT00623831|38206984|FG001|Overall Study|Progressive Disease|1|||
17064189|NCT00360334|38206995|FG000|Overall Study|Adverse Event|7|||
17064190|NCT00360334|38206996|FG001|Overall Study|Adverse Event|4|||
17064191|NCT00360334|38206995|FG000|Overall Study|Protocol Violation|1|||
17064192|NCT00360334|38206996|FG001|Overall Study|Protocol Violation|1|||
17064193|NCT00360334|38206995|FG000|Overall Study|Physician Decision|2|||
17147008|NCT03055988|38291310|FG000|Period 1|Withdrawal by Subject|0|||
17064194|NCT00360334|38206996|FG001|Overall Study|Physician Decision|3|||
17064195|NCT00360334|38206995|FG000|Overall Study|Lack of Efficacy|0|||
17064196|NCT00360334|38206996|FG001|Overall Study|Lack of Efficacy|1|||
17064197|NCT00360334|38206995|FG000|Overall Study|Entry criterion not met|1|||
17064198|NCT00360334|38206996|FG001|Overall Study|Entry criterion not met|2|||
17147009|NCT03055988|38291311|FG001|Period 1|Withdrawal by Subject|4|||
17064199|NCT00360334|38206995|FG000|Overall Study|Subject decision|8|||
17064200|NCT00360334|38206996|FG001|Overall Study|Subject decision|2|||
17064201|NCT00422097|38207008|FG000|Dose Level 2|Still on treatment|0|||
17064202|NCT00422097|38207009|FG001|Dose Level 2|Still on treatment|1|||
17064203|NCT00422097|38207010|FG002|Dose Level 2|Still on treatment|0|||
17064204|NCT00422097|38207011|FG003|Dose Level 2|Still on treatment|0|||
17064205|NCT00422097|38207012|FG004|Dose Level 2|Still on treatment|0|||
17064206|NCT00422097|38207013|FG005|Dose Level 2|Still on treatment|0|||
17064207|NCT00422097|38207014|FG006|Dose Level 2|Still on treatment|0|||
17064208|NCT00422097|38207015|FG007|Dose Level 2|Still on treatment|0|||
17064209|NCT00348556|38207039|FG000|Overall Study|Adverse Event|1|||
17064210|NCT00434967|38207047|FG000|Overall Study|Adverse Event|2|||
17064211|NCT00434967|38207048|FG001|Overall Study|Adverse Event|4|||
17064212|NCT00434967|38207049|FG002|Overall Study|Adverse Event|3|||
17064213|NCT00434967|38207050|FG003|Overall Study|Adverse Event|3|||
17064214|NCT00434967|38207047|FG000|Overall Study|Lost to Follow-up|0|||
17064215|NCT00434967|38207048|FG001|Overall Study|Lost to Follow-up|0|||
17064216|NCT00434967|38207049|FG002|Overall Study|Lost to Follow-up|1|||
17064217|NCT00434967|38207050|FG003|Overall Study|Lost to Follow-up|0|||
17064218|NCT00434967|38207047|FG000|Overall Study|Withdrawal by Subject|2|||
17064219|NCT00434967|38207048|FG001|Overall Study|Withdrawal by Subject|2|||
17064220|NCT00434967|38207049|FG002|Overall Study|Withdrawal by Subject|4|||
17064221|NCT00434967|38207050|FG003|Overall Study|Withdrawal by Subject|6|||
17064222|NCT00434967|38207047|FG000|Overall Study|Randomized in error|0|||
17064223|NCT00434967|38207048|FG001|Overall Study|Randomized in error|0|||
17064224|NCT00434967|38207049|FG002|Overall Study|Randomized in error|0|||
17064225|NCT00434967|38207050|FG003|Overall Study|Randomized in error|1|||
17064226|NCT00434967|38207047|FG000|Overall Study|Protocol Violation|0|||
17064227|NCT00434967|38207048|FG001|Overall Study|Protocol Violation|1|||
17064228|NCT00434967|38207049|FG002|Overall Study|Protocol Violation|0|||
17064229|NCT00434967|38207050|FG003|Overall Study|Protocol Violation|1|||
17064230|NCT00434967|38207047|FG000|Overall Study|Physician Decision|1|||
17064231|NCT00434967|38207048|FG001|Overall Study|Physician Decision|1|||
17064232|NCT00434967|38207049|FG002|Overall Study|Physician Decision|1|||
17064233|NCT00434967|38207050|FG003|Overall Study|Physician Decision|0|||
17064234|NCT00434967|38207047|FG000|Overall Study|Patient Disposition Challenges|2|||
17064235|NCT00434967|38207048|FG001|Overall Study|Patient Disposition Challenges|0|||
17147010|NCT03055988|38291310|FG000|Period 2|Adverse Event|0|||
17147011|NCT03055988|38291311|FG001|Period 2|Adverse Event|1|||
17064236|NCT00434967|38207049|FG002|Overall Study|Patient Disposition Challenges|0|||
17064237|NCT00434967|38207050|FG003|Overall Study|Patient Disposition Challenges|3|||
17064238|NCT00356590|38207060|FG000|Overall Study|Adverse Event|54|||
17064239|NCT00356590|38207060|FG000|Overall Study|Death|10|||
17064240|NCT00356590|38207060|FG000|Overall Study|Lost to Follow-up|35|||
17064241|NCT00356590|38207060|FG000|Overall Study|Physician Decision|46|||
17064242|NCT00356590|38207060|FG000|Overall Study|Withdrawal by Subject|41|||
17064243|NCT00356590|38207060|FG000|Overall Study|Completed month 12 only|2|||
17064244|NCT00356590|38207060|FG000|Overall Study|Protocol issues|6|||
17064245|NCT00356590|38207060|FG000|Overall Study|Response status|28|||
17064246|NCT00356590|38207060|FG000|Overall Study|Other|52|||
17064247|NCT00356278|38207067|FG000|Overall Study|Withdrawal by Subject|25|||
17064248|NCT00356278|38207068|FG001|Overall Study|Withdrawal by Subject|15|||
17064249|NCT00356278|38207069|FG002|Overall Study|Withdrawal by Subject|19|||
17064250|NCT00356200|38207079|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
17064251|NCT00356200|38207080|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
17064252|NCT00356200|38207079|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
17064253|NCT00356200|38207080|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
17064254|NCT00356122|38207092|FG000|TREATMENT|Lack of Efficacy|26|||
17064255|NCT00356122|38207092|FG000|TREATMENT|Adverse Event|10|||
17064256|NCT00356122|38207092|FG000|TREATMENT|Subject's request|4|||
17064257|NCT00356122|38207092|FG000|TREATMENT|Other|4|||
17064258|NCT00356122|38207092|FG000|TREATMENT|Did not receive study medication|1|||
17064259|NCT00356122|38207092|FG000|FOLLOW-UP|Death|37|||
17064260|NCT00356122|38207092|FG000|FOLLOW-UP|Lost to Follow-up|2|||
17064261|NCT00356122|38207092|FG000|FOLLOW-UP|Other|2|||
17064262|NCT00347932|38207098|FG000|Overall Study|Adverse Event|4|||
17064263|NCT00347932|38207099|FG001|Overall Study|Adverse Event|5|||
17064264|NCT00347932|38207098|FG000|Overall Study|Lack of Efficacy|3|||
17064265|NCT00347932|38207099|FG001|Overall Study|Lack of Efficacy|14|||
17064266|NCT00347932|38207098|FG000|Overall Study|Lost to Follow-up|10|||
17064267|NCT00347932|38207099|FG001|Overall Study|Lost to Follow-up|9|||
17064268|NCT00347932|38207098|FG000|Overall Study|Withdrawal by Subject|10|||
17064269|NCT00347932|38207099|FG001|Overall Study|Withdrawal by Subject|16|||
17064270|NCT00347932|38207098|FG000|Overall Study|Did not meet inclusion criteria|4|||
17064271|NCT00347932|38207099|FG001|Overall Study|Did not meet inclusion criteria|8|||
17064272|NCT00528996|38207110|FG000|Overall Study|Other reasons than listing|6|||
17064273|NCT00528996|38207111|FG001|Overall Study|Other reasons than listing|7|||
17064274|NCT00528996|38207112|FG002|Overall Study|Other reasons than listing|14|||
17064275|NCT00528996|38207113|FG003|Overall Study|Other reasons than listing|11|||
17064276|NCT00528996|38207114|FG004|Overall Study|Other reasons than listing|5|||
17064277|NCT00528996|38207110|FG000|Overall Study|Refused continue medication|16|||
17064278|NCT00528996|38207111|FG001|Overall Study|Refused continue medication|0|||
17064279|NCT00528996|38207112|FG002|Overall Study|Refused continue medication|3|||
17064280|NCT00528996|38207113|FG003|Overall Study|Refused continue medication|3|||
17064281|NCT00528996|38207114|FG004|Overall Study|Refused continue medication|6|||
17064282|NCT00528996|38207110|FG000|Overall Study|Lost to Follow-up|2|||
17064283|NCT00528996|38207111|FG001|Overall Study|Lost to Follow-up|0|||
17064284|NCT00528996|38207112|FG002|Overall Study|Lost to Follow-up|4|||
17064285|NCT00528996|38207113|FG003|Overall Study|Lost to Follow-up|1|||
17064286|NCT00528996|38207114|FG004|Overall Study|Lost to Follow-up|3|||
17064287|NCT00528996|38207110|FG000|Overall Study|Protocol Violation|1|||
17064288|NCT00528996|38207111|FG001|Overall Study|Protocol Violation|2|||
17064289|NCT00528996|38207112|FG002|Overall Study|Protocol Violation|3|||
17064290|NCT00528996|38207113|FG003|Overall Study|Protocol Violation|3|||
17064291|NCT00528996|38207114|FG004|Overall Study|Protocol Violation|2|||
17064292|NCT00528996|38207110|FG000|Overall Study|Lack of Efficacy|7|||
17064293|NCT00528996|38207111|FG001|Overall Study|Lack of Efficacy|2|||
17064294|NCT00528996|38207112|FG002|Overall Study|Lack of Efficacy|1|||
17064295|NCT00528996|38207113|FG003|Overall Study|Lack of Efficacy|3|||
17064296|NCT00528996|38207114|FG004|Overall Study|Lack of Efficacy|3|||
17064297|NCT00528996|38207110|FG000|Overall Study|Adverse Event|32|||
17064298|NCT00528996|38207111|FG001|Overall Study|Adverse Event|13|||
17064299|NCT00528996|38207112|FG002|Overall Study|Adverse Event|18|||
17064300|NCT00528996|38207113|FG003|Overall Study|Adverse Event|29|||
17064301|NCT00528996|38207114|FG004|Overall Study|Adverse Event|18|||
17064302|NCT00359788|38207131|FG000|Overall Study|Adverse Event|11|||
17064303|NCT00359788|38207132|FG001|Overall Study|Adverse Event|10|||
17064304|NCT00359788|38207131|FG000|Overall Study|Lack of Efficacy|1|||
17064305|NCT00359788|38207132|FG001|Overall Study|Lack of Efficacy|2|||
17064306|NCT00359788|38207131|FG000|Overall Study|Lost to Follow-up|3|||
17064307|NCT00359788|38207132|FG001|Overall Study|Lost to Follow-up|2|||
17064308|NCT00359788|38207131|FG000|Overall Study|Withdrawal by Subject|4|||
17064309|NCT00359788|38207132|FG001|Overall Study|Withdrawal by Subject|1|||
17064310|NCT00359788|38207131|FG000|Overall Study|Protocol Violation|4|||
17064311|NCT00359788|38207132|FG001|Overall Study|Protocol Violation|2|||
17064312|NCT03878160|38207141|FG000|Overall Study|Lost to Follow-up|1|||
17064313|NCT03878160|38207142|FG001|Overall Study|Lost to Follow-up|1|||
17064314|NCT03878160|38207143|FG002|Overall Study|Lost to Follow-up|1|||
17064315|NCT03878160|38207141|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
17064316|NCT03878160|38207142|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
17064317|NCT03878160|38207143|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
17064318|NCT00623597|38207153|FG000|Overall Study|Failed to return|1|||
17064319|NCT00623597|38207154|FG001|Overall Study|Failed to return|0|||
17064320|NCT00347776|38207165|FG000|1.5 Month Follow-up|Death|2|||
17064321|NCT00347776|38207166|FG001|1.5 Month Follow-up|Death|0|||
17064322|NCT00347776|38207167|FG002|1.5 Month Follow-up|Death|0|||
17064323|NCT00347776|38207165|FG000|1.5 Month Follow-up|reached the endpoint|12|||
17064324|NCT00347776|38207166|FG001|1.5 Month Follow-up|reached the endpoint|8|||
17064325|NCT00347776|38207167|FG002|1.5 Month Follow-up|reached the endpoint|12|||
17064326|NCT00347776|38207165|FG000|6 Month Follow-up|Death|2|||
17064327|NCT00347776|38207166|FG001|6 Month Follow-up|Death|1|||
17064328|NCT00347776|38207167|FG002|6 Month Follow-up|Death|3|||
17147012|NCT03055988|38291310|FG000|Period 2|Other than listed|1|||
17147013|NCT03055988|38291311|FG001|Period 2|Other than listed|1|||
17147014|NCT01250912|38291317|FG000|Overall Study|Lost to Follow-up|1|||
17147015|NCT03733301|38291327|FG000|Overall Study|Screen Fail|1|||
17147016|NCT03733301|38291328|FG001|Overall Study|Screen Fail|0|||
17064329|NCT00347776|38207165|FG000|6 Month Follow-up|reached endpont|20|||
17064330|NCT00347776|38207166|FG001|6 Month Follow-up|reached endpont|12|||
17064331|NCT00347776|38207167|FG002|6 Month Follow-up|reached endpont|15|||
17064332|NCT00347776|38207165|FG000|12 Month Follow-up|Lost to Follow-up|7|||
17064333|NCT00347776|38207166|FG001|12 Month Follow-up|Lost to Follow-up|6|||
17064334|NCT00347776|38207167|FG002|12 Month Follow-up|Lost to Follow-up|6|||
17064335|NCT00347776|38207165|FG000|12 Month Follow-up|Death|3|||
17064336|NCT00347776|38207166|FG001|12 Month Follow-up|Death|4|||
17064337|NCT00347776|38207167|FG002|12 Month Follow-up|Death|4|||
17064338|NCT00347776|38207165|FG000|12 Month Follow-up|Reached endpoint|13|||
17064339|NCT00347776|38207166|FG001|12 Month Follow-up|Reached endpoint|6|||
17064340|NCT00347776|38207167|FG002|12 Month Follow-up|Reached endpoint|9|||
17064341|NCT03829228|38207175|FG000|Overall Study|Protocol Violation|1|||
17064342|NCT00529542|38207181|FG000|Overall Study|Withdrawal by Subject|1|||
17064343|NCT00529542|38207182|FG001|Overall Study|Withdrawal by Subject|0|||
17064344|NCT00529542|38207181|FG000|Overall Study|Lost to Follow-up|0|||
17064345|NCT00529542|38207182|FG001|Overall Study|Lost to Follow-up|1|||
17064346|NCT00621959|38207190|FG000|Overall Study|Adverse Event|4|||
17064347|NCT00621959|38207191|FG001|Overall Study|Adverse Event|2|||
17064348|NCT00621959|38207190|FG000|Overall Study|Lack of Efficacy|1|||
17064349|NCT00621959|38207191|FG001|Overall Study|Lack of Efficacy|1|||
17064350|NCT00621959|38207190|FG000|Overall Study|Lost to Follow-up|0|||
17064351|NCT00621959|38207191|FG001|Overall Study|Lost to Follow-up|2|||
17064352|NCT00621959|38207190|FG000|Overall Study|Withdrawal by Subject|1|||
17064353|NCT00621959|38207191|FG001|Overall Study|Withdrawal by Subject|1|||
17064354|NCT00621959|38207190|FG000|Overall Study|Other|1|||
17064355|NCT00621959|38207191|FG001|Overall Study|Other|3|||
17064356|NCT03877224|38207199|FG000|Overall Study|Death|3|||
17064357|NCT03877224|38207200|FG001|Overall Study|Death|2|||
17064358|NCT03877224|38207199|FG000|Overall Study|Withdrawal by Subject|1|||
17064359|NCT03877224|38207200|FG001|Overall Study|Withdrawal by Subject|6|||
17064360|NCT03877224|38207199|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
17064361|NCT03877224|38207200|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
17064362|NCT00528606|38207208|FG000|Overall Study|Withdrew consent|4|||
17064363|NCT00528606|38207209|FG001|Overall Study|Withdrew consent|3|||
17064364|NCT00528606|38207208|FG000|Overall Study|Lost to Follow-up|4|||
17064365|NCT00528606|38207209|FG001|Overall Study|Lost to Follow-up|1|||
17064366|NCT00528606|38207208|FG000|Overall Study|Adverse Event|3|||
17064367|NCT00528606|38207209|FG001|Overall Study|Adverse Event|0|||
17064368|NCT00528606|38207208|FG000|Overall Study|Other|2|||
17064369|NCT00528606|38207209|FG001|Overall Study|Other|0|||
17064370|NCT00621257|38207220|FG000|Overall Study|Lost to Follow-up|4|||
17064371|NCT00621257|38207221|FG001|Overall Study|Lost to Follow-up|0|||
17064372|NCT00621257|38207222|FG002|Overall Study|Lost to Follow-up|2|||
17064373|NCT00621257|38207223|FG003|Overall Study|Lost to Follow-up|4|||
17064374|NCT00621257|38207224|FG004|Overall Study|Lost to Follow-up|7|||
17064375|NCT00621257|38207220|FG000|Overall Study|Adverse Event|0|||
17064376|NCT00621257|38207221|FG001|Overall Study|Adverse Event|1|||
17064377|NCT00621257|38207222|FG002|Overall Study|Adverse Event|1|||
17064378|NCT00621257|38207223|FG003|Overall Study|Adverse Event|0|||
17064379|NCT00621257|38207224|FG004|Overall Study|Adverse Event|0|||
17064380|NCT00621257|38207220|FG000|Overall Study|Physician Decision|0|||
17064381|NCT00621257|38207221|FG001|Overall Study|Physician Decision|2|||
17064382|NCT00621257|38207222|FG002|Overall Study|Physician Decision|0|||
17064383|NCT00621257|38207223|FG003|Overall Study|Physician Decision|1|||
17064384|NCT00621257|38207224|FG004|Overall Study|Physician Decision|1|||
17064385|NCT00621257|38207220|FG000|Overall Study|Withdrawal by Subject|0|||
17064386|NCT00621257|38207221|FG001|Overall Study|Withdrawal by Subject|0|||
17064387|NCT00621257|38207222|FG002|Overall Study|Withdrawal by Subject|0|||
17064388|NCT00621257|38207223|FG003|Overall Study|Withdrawal by Subject|1|||
17064389|NCT00621257|38207224|FG004|Overall Study|Withdrawal by Subject|1|||
17064390|NCT00528840|38207236|FG000|Overall Study|Lost to Follow-up|10|||
17064391|NCT00528840|38207236|FG000|Overall Study|Adverse Event|1|||
17064392|NCT00528840|38207236|FG000|Overall Study|Withdrawal by Subject|17|||
17064393|NCT00528840|38207236|FG000|Overall Study|Death|2|||
17064394|NCT00528840|38207236|FG000|Overall Study|Administrative Reasons|1|||
17064395|NCT00528840|38207236|FG000|Overall Study|Other|2|||
17064396|NCT00528528|38207244|FG000|Overall Study|Lost to Follow-up|0|||
17064397|NCT00528528|38207245|FG001|Overall Study|Lost to Follow-up|0|||
17064398|NCT00528528|38207246|FG002|Overall Study|Lost to Follow-up|1|||
17064399|NCT00528528|38207247|FG003|Overall Study|Lost to Follow-up|1|||
17064400|NCT00528528|38207244|FG000|Overall Study|Ineligible to continue the trial|0|||
17064401|NCT00528528|38207245|FG001|Overall Study|Ineligible to continue the trial|0|||
17064402|NCT00528528|38207246|FG002|Overall Study|Ineligible to continue the trial|0|||
17064403|NCT00528528|38207247|FG003|Overall Study|Ineligible to continue the trial|1|||
17064404|NCT00528528|38207244|FG000|Overall Study|Other|0|||
17064405|NCT00528528|38207245|FG001|Overall Study|Other|1|||
17064406|NCT00528528|38207246|FG002|Overall Study|Other|0|||
17064407|NCT00528528|38207247|FG003|Overall Study|Other|0|||
17064408|NCT00528528|38207244|FG000|Overall Study|Withdrawal by Subject|3|||
17064409|NCT00528528|38207245|FG001|Overall Study|Withdrawal by Subject|2|||
17064410|NCT00528528|38207246|FG002|Overall Study|Withdrawal by Subject|1|||
17064411|NCT00528528|38207247|FG003|Overall Study|Withdrawal by Subject|1|||
17064412|NCT00528528|38207244|FG000|Overall Study|Ongoing participant|0|||
17064413|NCT00528528|38207245|FG001|Overall Study|Ongoing participant|0|||
17064414|NCT00528528|38207246|FG002|Overall Study|Ongoing participant|1|||
17064415|NCT00528528|38207247|FG003|Overall Study|Ongoing participant|0|||
17064416|NCT00620555|38207259|FG000|Overall Study|Adverse Event|4|||
17064417|NCT00620555|38207259|FG000|Overall Study|Protocol Violation|2|||
17064418|NCT00620555|38207259|FG000|Overall Study|Lack of Efficacy|12|||
17064419|NCT00620555|38207259|FG000|Overall Study|Withdrawal by Subject|1|||
17064420|NCT00620555|38207259|FG000|Overall Study|Choice of other treatment|1|||
17064421|NCT00620555|38207259|FG000|Overall Study|Visit failure against planned|1|||
17064422|NCT00529386|38207263|FG000|Overall Study|Lost to Follow-up|1|||
17064423|NCT03875118|38207269|FG000|Overall Study|Withdrawal by Subject|4|||
17064424|NCT03875118|38207270|FG001|Overall Study|Withdrawal by Subject|4|||
17064425|NCT00529308|38207278|FG000|Overall Study|Withdrawal by Subject|1|||
17064426|NCT00529308|38207279|FG001|Overall Study|Withdrawal by Subject|1|||
17064427|NCT03875508|38207285|FG000|Overall Study|Adverse Event|1|||
17064428|NCT03875508|38207285|FG000|Overall Study|Lost to Follow-up|8|||
17064429|NCT03875508|38207285|FG000|Overall Study|Lack of Efficacy|1|||
17064430|NCT03875508|38207285|FG000|Overall Study|Other, not specified|2|||
17064431|NCT00620321|38207291|FG000|Overall Study|Adverse Event|1|||
17064432|NCT00620321|38207292|FG001|Overall Study|Adverse Event|1|||
17064433|NCT00620321|38207291|FG000|Overall Study|Death|1|||
17064434|NCT00620321|38207292|FG001|Overall Study|Death|1|||
17064435|NCT00620321|38207291|FG000|Overall Study|Physician Decision|0|||
17064436|NCT00620321|38207292|FG001|Overall Study|Physician Decision|7|||
17064437|NCT00620321|38207291|FG000|Overall Study|Progressive Disease|5|||
17064438|NCT00620321|38207292|FG001|Overall Study|Progressive Disease|5|||
17064439|NCT00620321|38207291|FG000|Overall Study|Sponsor Decision|0|||
17064440|NCT00620321|38207292|FG001|Overall Study|Sponsor Decision|1|||
17064441|NCT00620321|38207291|FG000|Overall Study|Withdrawal by Subject|1|||
17064442|NCT00620321|38207292|FG001|Overall Study|Withdrawal by Subject|1|||
17064443|NCT00621023|38207298|FG000|Overall Study|Death|5|||
17064444|NCT00621023|38207298|FG000|Overall Study|Follow up discontinued|1|||
17064445|NCT00528372|38207311|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
17064446|NCT00528372|38207312|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
17064447|NCT00528372|38207313|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
17064448|NCT00528372|38207314|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
17064449|NCT00528372|38207315|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
17064450|NCT00528372|38207316|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
17064451|NCT00528372|38207317|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
17064452|NCT00528372|38207318|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
17064453|NCT00528372|38207319|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
17064454|NCT00528372|38207311|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
17064455|NCT00528372|38207312|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
17064456|NCT00528372|38207313|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
17064457|NCT00528372|38207314|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
17064458|NCT00528372|38207315|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
17064459|NCT00528372|38207316|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
17064460|NCT00528372|38207317|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
17064461|NCT00528372|38207318|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
17064462|NCT00528372|38207319|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
17064463|NCT00528372|38207311|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
17064464|NCT00528372|38207312|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
17064465|NCT00528372|38207313|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
17064466|NCT00528372|38207314|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
17064467|NCT00528372|38207315|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
17064468|NCT00528372|38207316|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
17064469|NCT00528372|38207317|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
17064470|NCT00528372|38207318|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
17064471|NCT00528372|38207319|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
17147017|NCT03733301|38291329|FG002|Overall Study|Screen Fail|0|||
17064472|NCT00528372|38207311|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
17064473|NCT00528372|38207312|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
17064474|NCT00528372|38207313|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
17064475|NCT00528372|38207314|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
17064476|NCT00528372|38207315|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
17064477|NCT00528372|38207316|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
17064478|NCT00528372|38207317|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
17064479|NCT00528372|38207318|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
17064480|NCT00528372|38207319|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
17064481|NCT00528372|38207311|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
17064482|NCT00528372|38207312|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
17064483|NCT00528372|38207313|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
17064484|NCT00528372|38207314|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
17064485|NCT00528372|38207315|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
17064486|NCT00528372|38207316|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
17064487|NCT00528372|38207317|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
17064488|NCT00528372|38207318|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
17064489|NCT00528372|38207319|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
17064490|NCT00528372|38207311|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
17064491|NCT00528372|38207312|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
17064492|NCT00528372|38207313|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
17064493|NCT00528372|38207314|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
17064494|NCT00528372|38207315|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
17064495|NCT00528372|38207316|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
17064496|NCT00528372|38207317|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
17064497|NCT00528372|38207318|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
17064498|NCT00528372|38207319|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
17064499|NCT00528372|38207311|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
17064500|NCT00528372|38207312|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
17064501|NCT00528372|38207313|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
17064502|NCT00528372|38207314|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
17064503|NCT00528372|38207315|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
17064504|NCT00528372|38207316|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
17064505|NCT00528372|38207317|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
17064506|NCT00528372|38207318|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
17064507|NCT00528372|38207319|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
17064508|NCT00528372|38207311|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
17064509|NCT00528372|38207312|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
17064510|NCT00528372|38207313|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
17064511|NCT00528372|38207314|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
17064512|NCT00528372|38207315|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
17064513|NCT00528372|38207316|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
17064514|NCT00528372|38207317|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
17064515|NCT00528372|38207318|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
17064516|NCT00528372|38207319|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
17064517|NCT00528372|38207311|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
17064518|NCT00528372|38207312|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
17064519|NCT00528372|38207313|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
17064520|NCT00528372|38207314|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
17064521|NCT00528372|38207315|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
17064522|NCT00528372|38207316|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
17064523|NCT00528372|38207317|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
17064524|NCT00528372|38207318|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
17064525|NCT00528372|38207319|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
17064526|NCT00528372|38207311|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
17064527|NCT00528372|38207312|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
17064528|NCT00528372|38207313|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
17064529|NCT00528372|38207314|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
17064530|NCT00528372|38207315|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
17064531|NCT00528372|38207316|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
17064532|NCT00528372|38207317|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
17064533|NCT00528372|38207318|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
17064534|NCT00528372|38207319|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
17064535|NCT00528372|38207311|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
17064536|NCT00528372|38207312|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
17064537|NCT00528372|38207313|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
17064538|NCT00528372|38207314|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
17064539|NCT00528372|38207315|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
17064540|NCT00528372|38207316|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
17064541|NCT00528372|38207317|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
17064542|NCT00528372|38207318|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
17064543|NCT00528372|38207319|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
17064544|NCT00528372|38207311|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
17064545|NCT00528372|38207312|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
17064546|NCT00528372|38207313|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
17064547|NCT00528372|38207314|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
17064548|NCT00528372|38207315|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
17064549|NCT00528372|38207316|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
17064550|NCT00528372|38207317|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
17064551|NCT00528372|38207318|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
17064552|NCT00528372|38207319|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
17064553|NCT00528372|38207311|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
17064554|NCT00528372|38207312|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
17064555|NCT00528372|38207313|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
17064556|NCT00528372|38207314|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
17064557|NCT00528372|38207315|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
17064558|NCT00528372|38207316|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
17064559|NCT00528372|38207317|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
17064560|NCT00528372|38207318|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
17064561|NCT00528372|38207319|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
17064562|NCT00528372|38207311|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
17064563|NCT00528372|38207312|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
17064564|NCT00528372|38207313|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
17064565|NCT00528372|38207314|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
17064566|NCT00528372|38207315|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
17064567|NCT00528372|38207316|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
17064568|NCT00528372|38207317|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
17064569|NCT00528372|38207318|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
17064570|NCT00528372|38207319|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
17064571|NCT00528372|38207311|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
17064572|NCT00528372|38207312|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
17064573|NCT00528372|38207313|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
17064574|NCT00528372|38207314|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
17064575|NCT00528372|38207315|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
17064576|NCT00528372|38207316|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
17064577|NCT00528372|38207317|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
17064578|NCT00528372|38207318|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
17064579|NCT00528372|38207319|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
17064580|NCT00527982|38207367|FG000|Overall Study|Physician Decision|1|||
17064581|NCT00527982|38207368|FG001|Overall Study|Physician Decision|0|||
17064582|NCT00527904|38207374|FG000|Overall Study|Adverse Event|45|||
17064583|NCT00527904|38207374|FG000|Overall Study|Withdrawal by Subject|21|||
17064584|NCT00527904|38207374|FG000|Overall Study|Lost to Follow-up|8|||
17064585|NCT00527904|38207374|FG000|Overall Study|misc|22|||
17064586|NCT00619619|38207386|FG000|Overall Study|Physician Decision|0|||
17064587|NCT00619619|38207387|FG001|Overall Study|Physician Decision|0|||
17064588|NCT00619619|38207388|FG002|Overall Study|Physician Decision|1|||
17064589|NCT00619619|38207389|FG003|Overall Study|Physician Decision|0|||
17064590|NCT00619619|38207390|FG004|Overall Study|Physician Decision|0|||
17064591|NCT00619619|38207391|FG005|Overall Study|Physician Decision|0|||
17064592|NCT00619619|38207392|FG006|Overall Study|Physician Decision|0|||
17064593|NCT00619619|38207393|FG007|Overall Study|Physician Decision|0|||
17064594|NCT00619619|38207386|FG000|Overall Study|Protocol Violation|0|||
17064595|NCT00619619|38207387|FG001|Overall Study|Protocol Violation|0|||
17064596|NCT00619619|38207388|FG002|Overall Study|Protocol Violation|0|||
17064597|NCT00619619|38207389|FG003|Overall Study|Protocol Violation|1|||
17064598|NCT00619619|38207390|FG004|Overall Study|Protocol Violation|0|||
17064599|NCT00619619|38207391|FG005|Overall Study|Protocol Violation|0|||
17064600|NCT00619619|38207392|FG006|Overall Study|Protocol Violation|1|||
17064601|NCT00619619|38207393|FG007|Overall Study|Protocol Violation|1|||
17064602|NCT00619619|38207386|FG000|Overall Study|Adverse Event|0|||
17064603|NCT00619619|38207387|FG001|Overall Study|Adverse Event|0|||
17064604|NCT00619619|38207388|FG002|Overall Study|Adverse Event|0|||
17064605|NCT00619619|38207389|FG003|Overall Study|Adverse Event|0|||
17064606|NCT00619619|38207390|FG004|Overall Study|Adverse Event|2|||
17147018|NCT03733301|38291327|FG000|Overall Study|Non-compliance|1|||
17064607|NCT00619619|38207391|FG005|Overall Study|Adverse Event|0|||
17147019|NCT03733301|38291328|FG001|Overall Study|Non-compliance|0|||
17147020|NCT03733301|38291329|FG002|Overall Study|Non-compliance|0|||
17147021|NCT03733301|38291327|FG000|Overall Study|Lack of Efficacy|2|||
17147022|NCT03733301|38291328|FG001|Overall Study|Lack of Efficacy|3|||
17147023|NCT03733301|38291329|FG002|Overall Study|Lack of Efficacy|0|||
17147024|NCT03733301|38291327|FG000|Overall Study|Adverse Event|0|||
17147025|NCT03733301|38291328|FG001|Overall Study|Adverse Event|1|||
17064608|NCT00619619|38207392|FG006|Overall Study|Adverse Event|0|||
17064609|NCT00619619|38207393|FG007|Overall Study|Adverse Event|2|||
17064610|NCT00527826|38207416|FG000|Overall Study|Adverse Event|10|||
17064611|NCT00527826|38207417|FG001|Overall Study|Adverse Event|10|||
17064612|NCT00527826|38207416|FG000|Overall Study|Lost to Follow-up|3|||
17064613|NCT00527826|38207417|FG001|Overall Study|Lost to Follow-up|2|||
17064614|NCT00527826|38207416|FG000|Overall Study|Withdrawal by Subject|5|||
17064615|NCT00527826|38207417|FG001|Overall Study|Withdrawal by Subject|8|||
17064616|NCT00527826|38207416|FG000|Overall Study|Inclusion Criteria Not Met|3|||
17064617|NCT00527826|38207417|FG001|Overall Study|Inclusion Criteria Not Met|3|||
17064618|NCT00527826|38207416|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
17064619|NCT00527826|38207417|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
17064620|NCT00527826|38207416|FG000|Overall Study|Additional Intake of Viani forte|0|||
17064621|NCT00527826|38207417|FG001|Overall Study|Additional Intake of Viani forte|1|||
17064622|NCT00527826|38207416|FG000|Overall Study|Participant moved away|0|||
17064623|NCT00527826|38207417|FG001|Overall Study|Participant moved away|1|||
17064624|NCT00527748|38207435|FG000|Overall Study|Other|3|||
17064625|NCT00619385|38207442|FG000|Overall Study|Adverse Event|0|||
17064626|NCT00619385|38207443|FG001|Overall Study|Adverse Event|0|||
17064627|NCT00619385|38207444|FG002|Overall Study|Adverse Event|3|||
17064628|NCT00619385|38207442|FG000|Overall Study|Other|1|||
17064629|NCT00619385|38207443|FG001|Overall Study|Other|2|||
17064630|NCT00619385|38207444|FG002|Overall Study|Other|1|||
17064631|NCT00619307|38207457|FG000|Overall Study|Adverse Event|0|||
17064632|NCT00619307|38207458|FG001|Overall Study|Adverse Event|1|||
17064633|NCT00619307|38207457|FG000|Overall Study|Lost to Follow-up|0|||
17064634|NCT00619307|38207458|FG001|Overall Study|Lost to Follow-up|1|||
17064635|NCT00619307|38207457|FG000|Overall Study|Protocol Violation|3|||
17064636|NCT00619307|38207458|FG001|Overall Study|Protocol Violation|0|||
17064637|NCT00619307|38207457|FG000|Overall Study|Withdrew consent|1|||
17064638|NCT00619307|38207458|FG001|Overall Study|Withdrew consent|0|||
17064639|NCT00619307|38207457|FG000|Overall Study|Severe migraine|0|||
17064640|NCT00619307|38207458|FG001|Overall Study|Severe migraine|1|||
17064641|NCT00619307|38207457|FG000|Overall Study|MS attack plus steroids|0|||
17064642|NCT00619307|38207458|FG001|Overall Study|MS attack plus steroids|1|||
17064643|NCT00619229|38207466|FG000|Overall Study|Withdrawal by Subject|1|||
17064644|NCT00619229|38207467|FG001|Overall Study|Withdrawal by Subject|1|||
17064645|NCT00619229|38207466|FG000|Overall Study|Lost to Follow-up|1|||
17064646|NCT00619229|38207467|FG001|Overall Study|Lost to Follow-up|0|||
17064647|NCT00619229|38207466|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
17147026|NCT03733301|38291329|FG002|Overall Study|Adverse Event|3|||
17064648|NCT00619229|38207467|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
17064649|NCT00619229|38207466|FG000|Overall Study|Investigator planned Cataract Operation|1|||
17147027|NCT03733301|38291327|FG000|Overall Study|Withdrawal by Subject|3|||
17064650|NCT00619229|38207467|FG001|Overall Study|Investigator planned Cataract Operation|0|||
17064651|NCT00619151|38207475|FG000|Overall Study|Study terminated prior to followup|1|||
17064652|NCT00619151|38207476|FG001|Overall Study|Study terminated prior to followup|0|||
17064653|NCT00618995|38207482|FG000|Period 1|Adverse Event|0|||
17064654|NCT00618995|38207483|FG001|Period 1|Adverse Event|0|||
17064655|NCT00618995|38207484|FG002|Period 1|Adverse Event|1|||
17064656|NCT00618995|38207485|FG003|Period 1|Adverse Event|0|||
17064657|NCT00618995|38207482|FG000|Period 1|Protocol Violation|0|||
17064658|NCT00618995|38207483|FG001|Period 1|Protocol Violation|1|||
17064659|NCT00618995|38207484|FG002|Period 1|Protocol Violation|1|||
17064660|NCT00618995|38207485|FG003|Period 1|Protocol Violation|0|||
17064661|NCT00618995|38207482|FG000|Period 2|Protocol Violation|0|||
17064662|NCT00618995|38207483|FG001|Period 2|Protocol Violation|0|||
17064663|NCT00618995|38207484|FG002|Period 2|Protocol Violation|1|||
17064664|NCT00618995|38207485|FG003|Period 2|Protocol Violation|0|||
17064665|NCT00618995|38207482|FG000|Period 4|Adverse Event|1|||
17064666|NCT00618995|38207483|FG001|Period 4|Adverse Event|0|||
17064667|NCT00618995|38207484|FG002|Period 4|Adverse Event|0|||
17064668|NCT00618995|38207485|FG003|Period 4|Adverse Event|0|||
17064669|NCT03685344|38207499|FG000|Overall Study|Withdrawal by Subject|1|||
17064670|NCT03685344|38207500|FG001|Overall Study|Withdrawal by Subject|1|||
17064671|NCT03685344|38207501|FG002|Overall Study|Withdrawal by Subject|2|||
17064672|NCT03685344|38207502|FG003|Overall Study|Withdrawal by Subject|0|||
17064673|NCT03685344|38207499|FG000|Overall Study|Physician Decision|1|||
17064674|NCT03685344|38207500|FG001|Overall Study|Physician Decision|1|||
17064675|NCT03685344|38207501|FG002|Overall Study|Physician Decision|5|||
17064676|NCT03685344|38207502|FG003|Overall Study|Physician Decision|0|||
17064677|NCT03685344|38207499|FG000|Overall Study|Death|1|||
17064678|NCT03685344|38207500|FG001|Overall Study|Death|1|||
17064679|NCT03685344|38207501|FG002|Overall Study|Death|0|||
17147028|NCT03733301|38291328|FG001|Overall Study|Withdrawal by Subject|5|||
17147029|NCT03733301|38291329|FG002|Overall Study|Withdrawal by Subject|1|||
17064680|NCT03685344|38207502|FG003|Overall Study|Death|0|||
17064681|NCT00520572|38207518|FG000|Overall Study|Adverse Event|9|||
17064682|NCT00520572|38207519|FG001|Overall Study|Adverse Event|3|||
17064683|NCT00520572|38207520|FG002|Overall Study|Adverse Event|6|||
17064684|NCT00520572|38207521|FG003|Overall Study|Adverse Event|9|||
17064685|NCT00520572|38207522|FG004|Overall Study|Adverse Event|7|||
17064686|NCT00520572|38207523|FG005|Overall Study|Adverse Event|2|||
17064687|NCT00520572|38207518|FG000|Overall Study|Withdrawal by Subject|0|||
17064688|NCT00520572|38207519|FG001|Overall Study|Withdrawal by Subject|9|||
17064689|NCT00520572|38207520|FG002|Overall Study|Withdrawal by Subject|5|||
17064690|NCT00520572|38207521|FG003|Overall Study|Withdrawal by Subject|2|||
17064691|NCT00520572|38207522|FG004|Overall Study|Withdrawal by Subject|2|||
17064692|NCT00520572|38207523|FG005|Overall Study|Withdrawal by Subject|0|||
17064693|NCT00520572|38207518|FG000|Overall Study|Protocol Violation|0|||
17064694|NCT00520572|38207519|FG001|Overall Study|Protocol Violation|0|||
17064695|NCT00520572|38207520|FG002|Overall Study|Protocol Violation|1|||
17064696|NCT00520572|38207521|FG003|Overall Study|Protocol Violation|0|||
17064697|NCT00520572|38207522|FG004|Overall Study|Protocol Violation|0|||
17064698|NCT00520572|38207523|FG005|Overall Study|Protocol Violation|0|||
17064699|NCT00520572|38207518|FG000|Overall Study|Lack of Efficacy|1|||
17064700|NCT00520572|38207519|FG001|Overall Study|Lack of Efficacy|1|||
17064701|NCT00520572|38207520|FG002|Overall Study|Lack of Efficacy|1|||
17064702|NCT00520572|38207521|FG003|Overall Study|Lack of Efficacy|2|||
17064703|NCT00520572|38207522|FG004|Overall Study|Lack of Efficacy|1|||
17064704|NCT00520572|38207523|FG005|Overall Study|Lack of Efficacy|0|||
17064705|NCT00520572|38207518|FG000|Overall Study|Lost to Follow-up|0|||
17064706|NCT00520572|38207519|FG001|Overall Study|Lost to Follow-up|0|||
17064707|NCT00520572|38207520|FG002|Overall Study|Lost to Follow-up|0|||
17064708|NCT00520572|38207521|FG003|Overall Study|Lost to Follow-up|0|||
17064709|NCT00520572|38207522|FG004|Overall Study|Lost to Follow-up|1|||
17064710|NCT00520572|38207523|FG005|Overall Study|Lost to Follow-up|0|||
17064711|NCT00520572|38207518|FG000|Overall Study|Incorrect enrollment|1|||
17064712|NCT00520572|38207519|FG001|Overall Study|Incorrect enrollment|0|||
16781198|NCT02171260|37720361|FG001|Overall Study|Withdrawal by Subject|0|||
16781199|NCT02171260|37720362|FG002|Overall Study|Withdrawal by Subject|0|||
16781200|NCT02171260|37720363|FG003|Overall Study|Withdrawal by Subject|0|||
16781201|NCT02171260|37720360|FG000|Overall Study|Evidence of progressive disease|4|||
16781202|NCT02171260|37720361|FG001|Overall Study|Evidence of progressive disease|6|||
16781203|NCT02171260|37720362|FG002|Overall Study|Evidence of progressive disease|4|||
16781204|NCT02171260|37720363|FG003|Overall Study|Evidence of progressive disease|4|||
16781205|NCT02110732|37720381|FG000|Overall Study|Physician Decision|5|||
17064713|NCT00520572|38207520|FG002|Overall Study|Incorrect enrollment|1|||
17064714|NCT00520572|38207521|FG003|Overall Study|Incorrect enrollment|0|||
17064715|NCT00520572|38207522|FG004|Overall Study|Incorrect enrollment|1|||
17064716|NCT00520572|38207523|FG005|Overall Study|Incorrect enrollment|0|||
17064717|NCT00520572|38207518|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
17064718|NCT00520572|38207519|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
17064719|NCT00520572|38207520|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
17064720|NCT00520572|38207521|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
17064721|NCT00520572|38207522|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
17064722|NCT00520572|38207523|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
17064723|NCT00520572|38207518|FG000|Overall Study|Long break in taking Medication|0|||
17064724|NCT00520572|38207519|FG001|Overall Study|Long break in taking Medication|0|||
17147030|NCT02871297|38291338|FG000|Overall Study|Adverse Event|34|||
17064725|NCT00520572|38207520|FG002|Overall Study|Long break in taking Medication|0|||
17064726|NCT00520572|38207521|FG003|Overall Study|Long break in taking Medication|1|||
17064727|NCT00520572|38207522|FG004|Overall Study|Long break in taking Medication|0|||
17064728|NCT00520572|38207523|FG005|Overall Study|Long break in taking Medication|0|||
17064729|NCT00520572|38207518|FG000|Overall Study|Did not receive Treatment|1|||
17064730|NCT00520572|38207519|FG001|Overall Study|Did not receive Treatment|0|||
17064731|NCT00520572|38207520|FG002|Overall Study|Did not receive Treatment|1|||
17064732|NCT00520572|38207521|FG003|Overall Study|Did not receive Treatment|0|||
17064733|NCT00520572|38207522|FG004|Overall Study|Did not receive Treatment|0|||
17064734|NCT00520572|38207523|FG005|Overall Study|Did not receive Treatment|0|||
17064735|NCT00573833|38207537|FG000|Overall Study|Not Treated|2|||
17064736|NCT00520494|38207541|FG000|Overall Study|Withdrawal by Subject|1|||
17064737|NCT00527514|38207545|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
17064738|NCT00527514|38207545|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
17064739|NCT00527514|38207545|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
17064740|NCT00527514|38207545|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
17064741|NCT00527514|38207545|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
17064742|NCT00527514|38207545|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
17064743|NCT00527514|38207545|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
17064744|NCT00618449|38207558|FG000|Overall Study|Lost to Follow-up|98|||
17064745|NCT00618449|38207559|FG001|Overall Study|Lost to Follow-up|110|||
17064746|NCT03684642|38207568|FG000|Overall Study|Adverse Event|6|||
17064747|NCT03684642|38207569|FG001|Overall Study|Adverse Event|15|||
17064748|NCT03684642|38207570|FG002|Overall Study|Adverse Event|11|||
17064749|NCT03684642|38207568|FG000|Overall Study|Withdrawal by Subject|35|||
17064750|NCT03684642|38207569|FG001|Overall Study|Withdrawal by Subject|53|||
17064751|NCT03684642|38207570|FG002|Overall Study|Withdrawal by Subject|23|||
17064752|NCT03684642|38207568|FG000|Overall Study|Lack of Efficacy|0|||
17064753|NCT03684642|38207569|FG001|Overall Study|Lack of Efficacy|0|||
17064754|NCT03684642|38207570|FG002|Overall Study|Lack of Efficacy|1|||
17064755|NCT03684642|38207568|FG000|Overall Study|Poor compliance to protocol|0|||
17064756|NCT03684642|38207569|FG001|Overall Study|Poor compliance to protocol|4|||
17064757|NCT03684642|38207570|FG002|Overall Study|Poor compliance to protocol|1|||
17064758|NCT03684642|38207568|FG000|Overall Study|Other than specified|62|||
16781206|NCT02110732|37720382|FG001|Overall Study|Physician Decision|2|||
16781207|NCT02110732|37720381|FG000|Overall Study|Lost to Follow-up|1|||
16781208|NCT02110732|37720382|FG001|Overall Study|Lost to Follow-up|1|||
16781209|NCT02109562|37720391|FG000|Overall Study|Insufficient clinical response|2|||
16781210|NCT02109562|37720392|FG001|Overall Study|Insufficient clinical response|0|||
16781211|NCT02109562|37720393|FG002|Overall Study|Insufficient clinical response|4|||
17064759|NCT03684642|38207569|FG001|Overall Study|Other than specified|60|||
17064760|NCT03684642|38207570|FG002|Overall Study|Other than specified|67|||
17064761|NCT03684642|38207568|FG000|Overall Study|Randomized and not treated|0|||
17064762|NCT03684642|38207569|FG001|Overall Study|Randomized and not treated|0|||
17064763|NCT03684642|38207570|FG002|Overall Study|Randomized and not treated|1|||
17064764|NCT03684642|38207568|FG000|Overall Study|Missing completion status but alive at last contact|0|||
17064765|NCT03684642|38207569|FG001|Overall Study|Missing completion status but alive at last contact|1|||
17147031|NCT02871297|38291338|FG000|Overall Study|Lack of Efficacy|10|||
17147032|NCT02871297|38291338|FG000|Overall Study|Non-compliance with study drug|15|||
17147033|NCT02871297|38291338|FG000|Overall Study|Protocol Violation|3|||
17147034|NCT02871297|38291338|FG000|Overall Study|Withdrawal by Subject|20|||
17064766|NCT03684642|38207570|FG002|Overall Study|Missing completion status but alive at last contact|2|||
17147035|NCT02871297|38291338|FG000|Overall Study|Lost to Follow-up|13|||
16993808|NCT01072175|38137825|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993809|NCT01072175|38137826|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
17064767|NCT00519636|38207582|FG000|Treatment Period 1|Adverse Event|1|||
17064768|NCT00519636|38207583|FG001|Treatment Period 1|Adverse Event|0|||
17064769|NCT00519636|38207584|FG002|Treatment Period 1|Adverse Event|1|||
17064770|NCT00519636|38207585|FG003|Treatment Period 1|Adverse Event|0|||
17064771|NCT00519636|38207582|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
17064772|NCT00519636|38207583|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
16993810|NCT01072175|38137827|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993811|NCT01072175|38137828|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993812|NCT01072175|38137829|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16993813|NCT01072175|38137817|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
16993814|NCT01072175|38137818|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
16993815|NCT01072175|38137819|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
16993816|NCT01072175|38137820|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
16993817|NCT01072175|38137821|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
16993818|NCT01072175|38137822|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
16993819|NCT01072175|38137823|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
16993820|NCT01072175|38137824|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
16993821|NCT01072175|38137825|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
16993822|NCT01072175|38137826|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
16993823|NCT01072175|38137827|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
16993824|NCT01072175|38137828|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
16993825|NCT01072175|38137829|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
16993826|NCT01072175|38137817|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993827|NCT01072175|38137818|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
17064773|NCT00519636|38207584|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
17064774|NCT00519636|38207585|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
17147036|NCT02871297|38291338|FG000|Overall Study|Rolled over to 13546A|2|||
17147037|NCT02871297|38291338|FG000|Overall Study|Other than specified|39|||
17147038|NCT03554005|38291348|FG000|Overall Study|Not in participant's best interest|0|||
17147039|NCT03554005|38291349|FG001|Overall Study|Not in participant's best interest|0|||
17147040|NCT03554005|38291350|FG002|Overall Study|Not in participant's best interest|0|||
17064775|NCT00519636|38207582|FG000|Washout Period|Adverse Event|2|||
17064776|NCT00519636|38207583|FG001|Washout Period|Adverse Event|1|||
17064777|NCT00519636|38207584|FG002|Washout Period|Adverse Event|1|||
17064778|NCT00519636|38207585|FG003|Washout Period|Adverse Event|0|||
17147041|NCT03554005|38291351|FG003|Overall Study|Not in participant's best interest|0|||
17064779|NCT00519636|38207582|FG000|Washout Period|Lost to Follow-up|1|||
17064780|NCT00519636|38207583|FG001|Washout Period|Lost to Follow-up|0|||
17064781|NCT00519636|38207584|FG002|Washout Period|Lost to Follow-up|0|||
17064782|NCT00519636|38207585|FG003|Washout Period|Lost to Follow-up|0|||
17064783|NCT00519636|38207582|FG000|Washout Period|Protocol Violation|0|||
17064784|NCT00519636|38207583|FG001|Washout Period|Protocol Violation|0|||
17064785|NCT00519636|38207584|FG002|Washout Period|Protocol Violation|1|||
17064786|NCT00519636|38207585|FG003|Washout Period|Protocol Violation|2|||
17064787|NCT00519636|38207582|FG000|Washout Period|Withdrawal by Subject|1|||
17064788|NCT00519636|38207583|FG001|Washout Period|Withdrawal by Subject|0|||
17064789|NCT00519636|38207584|FG002|Washout Period|Withdrawal by Subject|1|||
17064790|NCT00519636|38207585|FG003|Washout Period|Withdrawal by Subject|0|||
17064791|NCT00519636|38207582|FG000|Washout Period|Failed to meet continuation criteria|14|||
17064792|NCT00519636|38207583|FG001|Washout Period|Failed to meet continuation criteria|11|||
17147042|NCT03554005|38291352|FG004|Overall Study|Not in participant's best interest|0|||
17147043|NCT03554005|38291353|FG005|Overall Study|Not in participant's best interest|1|||
17147044|NCT03554005|38291348|FG000|Overall Study|Disease Progression|1|||
17147045|NCT03554005|38291349|FG001|Overall Study|Disease Progression|1|||
17147046|NCT03554005|38291350|FG002|Overall Study|Disease Progression|1|||
17147047|NCT03554005|38291351|FG003|Overall Study|Disease Progression|1|||
17147048|NCT03554005|38291352|FG004|Overall Study|Disease Progression|5|||
17147049|NCT03554005|38291353|FG005|Overall Study|Disease Progression|6|||
17147050|NCT03554005|38291348|FG000|Overall Study|Adverse Event|0|||
17147051|NCT03554005|38291349|FG001|Overall Study|Adverse Event|0|||
17147052|NCT03554005|38291350|FG002|Overall Study|Adverse Event|0|||
17147053|NCT03554005|38291351|FG003|Overall Study|Adverse Event|0|||
17147054|NCT03554005|38291352|FG004|Overall Study|Adverse Event|0|||
17147055|NCT03554005|38291353|FG005|Overall Study|Adverse Event|3|||
17147056|NCT03554005|38291348|FG000|Overall Study|Physician Decision|0|||
17147057|NCT03554005|38291349|FG001|Overall Study|Physician Decision|0|||
17147058|NCT03554005|38291350|FG002|Overall Study|Physician Decision|0|||
17147059|NCT03554005|38291351|FG003|Overall Study|Physician Decision|0|||
17147060|NCT03554005|38291352|FG004|Overall Study|Physician Decision|1|||
17147061|NCT03554005|38291353|FG005|Overall Study|Physician Decision|0|||
17147062|NCT03554005|38291348|FG000|Overall Study|Other|0|||
17147063|NCT03554005|38291349|FG001|Overall Study|Other|0|||
17147064|NCT03554005|38291350|FG002|Overall Study|Other|0|||
17147065|NCT03554005|38291351|FG003|Overall Study|Other|0|||
17147066|NCT03554005|38291352|FG004|Overall Study|Other|0|||
17147067|NCT03554005|38291353|FG005|Overall Study|Other|1|||
17147068|NCT00709228|38291367|FG000|Overall Study|Not treated|14|||
17064793|NCT00519636|38207584|FG002|Washout Period|Failed to meet continuation criteria|9|||
17064794|NCT00519636|38207585|FG003|Washout Period|Failed to meet continuation criteria|3|||
17064795|NCT00519636|38207582|FG000|Washout Period|Out of pollen area > 48 hours|1|||
17064796|NCT00519636|38207583|FG001|Washout Period|Out of pollen area > 48 hours|0|||
17064797|NCT00519636|38207584|FG002|Washout Period|Out of pollen area > 48 hours|0|||
17064798|NCT00519636|38207585|FG003|Washout Period|Out of pollen area > 48 hours|0|||
17064799|NCT00519636|38207582|FG000|Washout Period|Participating in study at another site|1|||
17064800|NCT00519636|38207583|FG001|Washout Period|Participating in study at another site|0|||
17064801|NCT00519636|38207584|FG002|Washout Period|Participating in study at another site|0|||
17064802|NCT00519636|38207585|FG003|Washout Period|Participating in study at another site|0|||
17064803|NCT00519636|38207582|FG000|Washout Period|Non-compliant|0|||
17064804|NCT00519636|38207583|FG001|Washout Period|Non-compliant|1|||
17064805|NCT00519636|38207584|FG002|Washout Period|Non-compliant|0|||
17064806|NCT00519636|38207585|FG003|Washout Period|Non-compliant|0|||
17064807|NCT00519636|38207582|FG000|Washout Period|Per doctors request|0|||
17064808|NCT00519636|38207583|FG001|Washout Period|Per doctors request|1|||
17064809|NCT00519636|38207584|FG002|Washout Period|Per doctors request|0|||
17064810|NCT00519636|38207585|FG003|Washout Period|Per doctors request|0|||
17064811|NCT00519636|38207582|FG000|Washout Period|Subject randomized in error|0|||
17064812|NCT00519636|38207583|FG001|Washout Period|Subject randomized in error|0|||
17064813|NCT00519636|38207584|FG002|Washout Period|Subject randomized in error|1|||
17064814|NCT00519636|38207585|FG003|Washout Period|Subject randomized in error|0|||
17064815|NCT00519636|38207582|FG000|Washout Period|Prohibited medications|0|||
17064816|NCT00519636|38207583|FG001|Washout Period|Prohibited medications|0|||
17064817|NCT00519636|38207584|FG002|Washout Period|Prohibited medications|1|||
17064818|NCT00519636|38207585|FG003|Washout Period|Prohibited medications|0|||
17064819|NCT00519636|38207582|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
17064820|NCT00519636|38207583|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
17064821|NCT00519636|38207584|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
17064822|NCT00519636|38207585|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
17064823|NCT00519636|38207582|FG000|Treatment Period 2|Subject randomized in error|0|||
17064824|NCT00519636|38207583|FG001|Treatment Period 2|Subject randomized in error|1|||
17064825|NCT00519636|38207584|FG002|Treatment Period 2|Subject randomized in error|0|||
17064826|NCT00519636|38207585|FG003|Treatment Period 2|Subject randomized in error|0|||
17064827|NCT00519636|38207582|FG000|Treatment Period 2|Per doctors request|0|||
17064828|NCT00519636|38207583|FG001|Treatment Period 2|Per doctors request|0|||
17064829|NCT00519636|38207584|FG002|Treatment Period 2|Per doctors request|1|||
17064830|NCT00519636|38207585|FG003|Treatment Period 2|Per doctors request|0|||
17064831|NCT00519636|38207582|FG000|Treatment Period 2|Subject misrandomized|0|||
17064832|NCT00519636|38207583|FG001|Treatment Period 2|Subject misrandomized|0|||
17064833|NCT00519636|38207584|FG002|Treatment Period 2|Subject misrandomized|0|||
17064834|NCT00519636|38207585|FG003|Treatment Period 2|Subject misrandomized|1|||
17064835|NCT00519636|38207582|FG000|Post Study Period|Subject randomized in error|0|||
17064836|NCT00519636|38207583|FG001|Post Study Period|Subject randomized in error|0|||
17064837|NCT00519636|38207584|FG002|Post Study Period|Subject randomized in error|0|||
17147069|NCT00709228|38291367|FG000|Overall Study|Eligibility criteria not met|281|||
17064838|NCT00519636|38207585|FG003|Post Study Period|Subject randomized in error|1|||
17064839|NCT00618371|38207599|FG000|Overall Study|Withdrawal by Subject|2|||
17064840|NCT00526890|38207604|FG000|Overall Study|Adverse Event|2|||
17064841|NCT03864900|38207610|FG000|Overall Study|Withdrawal by Subject|1|||
17147070|NCT00709228|38291367|FG000|Overall Study|Adverse events|2|||
17147071|NCT00709228|38291367|FG000|Overall Study|Discontinued treatment|14|||
16993828|NCT01072175|38137819|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
16993829|NCT01072175|38137820|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993830|NCT01072175|38137821|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
16993831|NCT01072175|38137822|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993832|NCT01072175|38137823|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993833|NCT01072175|38137824|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993834|NCT01072175|38137825|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993835|NCT01072175|38137826|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993836|NCT01072175|38137827|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993837|NCT01072175|38137828|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993838|NCT01072175|38137829|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16993839|NCT01072175|38137817|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
17064842|NCT03864900|38207611|FG001|Overall Study|Withdrawal by Subject|1|||
17064843|NCT03864900|38207610|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
17064844|NCT03864900|38207611|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
17064845|NCT00526656|38207617|FG000|Overall Study|Death|1|||
17064846|NCT00526656|38207617|FG000|Overall Study|Refused surgery|1|||
17064847|NCT00617903|38207624|FG000|Overall Study|Withdrawal by Subject|2|||
17064848|NCT00617903|38207625|FG001|Overall Study|Withdrawal by Subject|3|||
17064849|NCT00617903|38207624|FG000|Overall Study|Lost to Follow-up|1|||
17064850|NCT00617903|38207625|FG001|Overall Study|Lost to Follow-up|1|||
17064851|NCT00617903|38207624|FG000|Overall Study|Lack of Efficacy|0|||
17064852|NCT00617903|38207625|FG001|Overall Study|Lack of Efficacy|1|||
17064853|NCT00617903|38207624|FG000|Overall Study|Adverse Event|0|||
17064854|NCT00617903|38207625|FG001|Overall Study|Adverse Event|1|||
17064855|NCT00617903|38207624|FG000|Overall Study|noncompliance|0|||
17064856|NCT00617903|38207625|FG001|Overall Study|noncompliance|1|||
17064857|NCT00526110|38207633|FG000|Overall Study|Adverse Event|2|||
17064858|NCT00526110|38207634|FG001|Overall Study|Adverse Event|9|||
17064859|NCT00526110|38207633|FG000|Overall Study|Disease Progression|0|||
17064860|NCT00526110|38207634|FG001|Overall Study|Disease Progression|19|||
17064861|NCT00526110|38207633|FG000|Overall Study|Maximal Response|0|||
17064862|NCT00526110|38207634|FG001|Overall Study|Maximal Response|6|||
16993840|NCT01072175|38137818|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
17064863|NCT00526110|38207633|FG000|Overall Study|Withdrawal by Subject|0|||
17064864|NCT00526110|38207634|FG001|Overall Study|Withdrawal by Subject|2|||
17064865|NCT00526110|38207633|FG000|Overall Study|Poor Tolerance|0|||
17064866|NCT00526110|38207634|FG001|Overall Study|Poor Tolerance|5|||
17064867|NCT00512148|38207640|FG000|Primay Study Period|Withdrawal by Subject|1|||
17064868|NCT00511836|38207648|FG000|Double-blind Period|Lost to Follow-up|1|||
16993841|NCT01072175|38137819|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
17064869|NCT00511836|38207649|FG001|Double-blind Period|Lost to Follow-up|0|||
17064870|NCT00573755|38207658|FG000|Overall Study|Still receiving treatment|1|||
17064871|NCT00573755|38207659|FG001|Overall Study|Still receiving treatment|0|||
17064872|NCT00524316|38207665|FG000|Overall Study|Withdrawal by Subject|2|||
17064873|NCT00524316|38207665|FG000|Overall Study|Adverse Event|7|||
17064874|NCT00524316|38207665|FG000|Overall Study|Disease Progression|7|||
17147072|NCT00709228|38291367|FG000|Overall Study|Did not enter follow-up|4|||
17147073|NCT00709228|38291367|FG000|Overall Study|Discontinued follow-up|5|||
17147074|NCT00709228|38291367|FG000|Overall Study|Disease progression|1|||
17147075|NCT00709228|38291367|FG000|Overall Study|Lost to Follow-up|6|||
17147076|NCT00709228|38291367|FG000|Overall Study|Non-compliance|5|||
17147077|NCT03055832|38291373|FG000|Week 2|Withdrawal by Subject|1|||
17147078|NCT03055832|38291374|FG001|Week 2|Withdrawal by Subject|0|||
17147079|NCT03219372|38291413|FG000|Overall Study|Withdrawal by Subject|1|||
17147080|NCT03219372|38291414|FG001|Overall Study|Withdrawal by Subject|0|||
17147081|NCT03056690|38291429|FG000|Overall Study|Adverse Event|3|||
17147082|NCT03056690|38291430|FG001|Overall Study|Adverse Event|2|||
17147083|NCT03056690|38291429|FG000|Overall Study|Lack of Efficacy|1|||
17147084|NCT03056690|38291430|FG001|Overall Study|Lack of Efficacy|2|||
17147085|NCT03056690|38291429|FG000|Overall Study|Lost to Follow-up|3|||
17147086|NCT03056690|38291430|FG001|Overall Study|Lost to Follow-up|2|||
17147087|NCT03056690|38291429|FG000|Overall Study|Protocol Violation|2|||
17147088|NCT03056690|38291430|FG001|Overall Study|Protocol Violation|2|||
17147089|NCT03056690|38291429|FG000|Overall Study|Withdrawal by Subject|3|||
17064875|NCT03861936|38207682|FG000|Overall Study|Withdrawal by Subject|4|||
17064876|NCT03861936|38207683|FG001|Overall Study|Withdrawal by Subject|1|||
17147090|NCT03056690|38291430|FG001|Overall Study|Withdrawal by Subject|6|||
17147091|NCT03056690|38291429|FG000|Overall Study|Non-compliance with Study Drug|1|||
17147092|NCT03056690|38291430|FG001|Overall Study|Non-compliance with Study Drug|0|||
17147093|NCT03056690|38291429|FG000|Overall Study|Miscellaneous|1|||
17147094|NCT03056690|38291430|FG001|Overall Study|Miscellaneous|2|||
17147095|NCT03191799|38291436|FG000|Overall Study|Withdrawal by Subject|4|||
17147096|NCT03191799|38291436|FG000|Overall Study|Physician Decision|2|||
17147097|NCT03191799|38291436|FG000|Overall Study|Lost to Follow-up|1|||
17147098|NCT03191799|38291436|FG000|Overall Study|Death|2|||
17147099|NCT00708916|38291452|FG000|Overall Study|Subject Noncompliance|2|||
17147100|NCT00708916|38291452|FG000|Overall Study|Adverse Event|2|||
17147101|NCT02352753|38291457|FG000|6-Month Dosing Period|Decision by sponsor|2|||
17147102|NCT02352753|38291457|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
17147103|NCT02352753|38291457|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
17147104|NCT02352753|38291457|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
17147105|NCT02352753|38291457|FG000|3-Month Dosing Period|Decision by sponsor|14|||
17147106|NCT02352753|38291457|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
17147107|NCT04532294|38291468|FG000|Overall Study|Withdrawal by Subject|0|||
17147108|NCT04532294|38291469|FG001|Overall Study|Withdrawal by Subject|0|||
17147109|NCT04532294|38291470|FG002|Overall Study|Withdrawal by Subject|1|||
17147110|NCT04532294|38291468|FG000|Overall Study|Participants Not Dosed|0|||
17147111|NCT04532294|38291469|FG001|Overall Study|Participants Not Dosed|0|||
17147112|NCT04532294|38291470|FG002|Overall Study|Participants Not Dosed|2|||
17147113|NCT03197766|38291482|FG000|Overall Study|Withdrawal by Subject|2|||
17147114|NCT03197766|38291483|FG001|Overall Study|Withdrawal by Subject|0|||
17147115|NCT03738332|38291489|FG000|Overall Study|Withdrawal by Subject|1|||
17147116|NCT03173456|38291499|FG000|Baseline|Medication dispensing system malfunction'|0|||
17147117|NCT03173456|38291500|FG001|Baseline|Medication dispensing system malfunction'|1|||
17147118|NCT03173456|38291501|FG002|Baseline|Medication dispensing system malfunction'|0|||
17147119|NCT03173456|38291502|FG003|Baseline|Medication dispensing system malfunction'|0|||
17064877|NCT03861936|38207684|FG002|Overall Study|Withdrawal by Subject|3|||
17064878|NCT03861936|38207682|FG000|Overall Study|Lost to Follow-up|5|||
17064879|NCT03861936|38207683|FG001|Overall Study|Lost to Follow-up|3|||
17064880|NCT03861936|38207684|FG002|Overall Study|Lost to Follow-up|3|||
17064881|NCT03861936|38207682|FG000|Overall Study|Physician Decision|0|||
17064882|NCT03861936|38207683|FG001|Overall Study|Physician Decision|1|||
17064883|NCT03861936|38207684|FG002|Overall Study|Physician Decision|0|||
17064884|NCT03861936|38207682|FG000|Overall Study|Protocol Deviation|0|||
17064885|NCT03861936|38207683|FG001|Overall Study|Protocol Deviation|0|||
17064886|NCT03861936|38207684|FG002|Overall Study|Protocol Deviation|1|||
17064887|NCT03861936|38207682|FG000|Overall Study|Reason not Specified|5|||
17064888|NCT03861936|38207683|FG001|Overall Study|Reason not Specified|5|||
17064889|NCT03861936|38207684|FG002|Overall Study|Reason not Specified|3|||
17064890|NCT00434577|38207697|FG000|Months 0-3|Serious Adverse Event|0|||
17064891|NCT00434577|38207698|FG001|Months 0-3|Serious Adverse Event|0|||
17064892|NCT00434577|38207699|FG002|Months 0-3|Serious Adverse Event|1|||
17064893|NCT00434577|38207700|FG003|Months 0-3|Serious Adverse Event|0|||
17064894|NCT00434577|38207701|FG004|Months 0-3|Serious Adverse Event|0|||
17064895|NCT00434577|38207697|FG000|Months 0-3|Adverse Event|0|||
17064896|NCT00434577|38207698|FG001|Months 0-3|Adverse Event|1|||
17147120|NCT03173456|38291503|FG004|Baseline|Medication dispensing system malfunction'|2|||
17147121|NCT03173456|38291499|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
17147122|NCT03173456|38291500|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
17147123|NCT03173456|38291501|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
17147124|NCT03173456|38291502|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
17147125|NCT03173456|38291503|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
17147126|NCT03197376|38291526|FG000|Primary and Booster Phase|Adverse Event|0|||
17147127|NCT03197376|38291527|FG001|Primary and Booster Phase|Adverse Event|0|||
17147128|NCT03197376|38291528|FG002|Primary and Booster Phase|Adverse Event|0|||
17147129|NCT03197376|38291529|FG003|Primary and Booster Phase|Adverse Event|1|||
17147130|NCT03197376|38291526|FG000|Primary and Booster Phase|Death|1|||
17147131|NCT03197376|38291527|FG001|Primary and Booster Phase|Death|0|||
17147132|NCT03197376|38291528|FG002|Primary and Booster Phase|Death|0|||
17147133|NCT03197376|38291529|FG003|Primary and Booster Phase|Death|2|||
17147134|NCT03197376|38291526|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
17064897|NCT00434577|38207699|FG002|Months 0-3|Adverse Event|1|||
17064898|NCT00434577|38207700|FG003|Months 0-3|Adverse Event|0|||
17064899|NCT00434577|38207701|FG004|Months 0-3|Adverse Event|0|||
17147135|NCT03197376|38291527|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
17147136|NCT03197376|38291528|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
17147137|NCT03197376|38291529|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
17147138|NCT03197376|38291526|FG000|Primary and Booster Phase|Physician Decision|1|||
17064900|NCT00434577|38207697|FG000|Months 0-3|Lost to Follow-up|0|||
17064901|NCT00434577|38207698|FG001|Months 0-3|Lost to Follow-up|0|||
17064902|NCT00434577|38207699|FG002|Months 0-3|Lost to Follow-up|0|||
17064903|NCT00434577|38207700|FG003|Months 0-3|Lost to Follow-up|0|||
17064904|NCT00434577|38207701|FG004|Months 0-3|Lost to Follow-up|2|||
17064905|NCT00434577|38207697|FG000|Months 0-3|Protocol Violation|1|||
17064906|NCT00434577|38207698|FG001|Months 0-3|Protocol Violation|0|||
17064907|NCT00434577|38207699|FG002|Months 0-3|Protocol Violation|1|||
17064908|NCT00434577|38207700|FG003|Months 0-3|Protocol Violation|0|||
17064909|NCT00434577|38207701|FG004|Months 0-3|Protocol Violation|0|||
17064910|NCT00434577|38207697|FG000|Months 0-3|Withdrawal by Subject|2|||
17064911|NCT00434577|38207698|FG001|Months 0-3|Withdrawal by Subject|1|||
17064912|NCT00434577|38207699|FG002|Months 0-3|Withdrawal by Subject|1|||
17064913|NCT00434577|38207700|FG003|Months 0-3|Withdrawal by Subject|1|||
17064914|NCT00434577|38207701|FG004|Months 0-3|Withdrawal by Subject|1|||
17064915|NCT00434421|38207713|FG000|Overall Study|Withdrawal by Subject|1|||
17147139|NCT03197376|38291527|FG001|Primary and Booster Phase|Physician Decision|0|||
17064916|NCT00434421|38207713|FG000|Overall Study|Non-compliance with study treatment|1|||
17064917|NCT00421707|38207719|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
17064918|NCT00421707|38207720|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
17064919|NCT00421707|38207719|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
17064920|NCT00421707|38207720|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
17064921|NCT00421707|38207719|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
17064922|NCT00421707|38207720|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
17064923|NCT00421707|38207719|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
17064924|NCT00421707|38207720|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
17064925|NCT00421707|38207719|FG000|Period 2: Washout|Adverse Event|1|||
17064926|NCT00421707|38207720|FG001|Period 2: Washout|Adverse Event|1|||
17064927|NCT00421707|38207719|FG000|Period 2: Washout|Withdrawal by Subject|0|||
17064928|NCT00421707|38207720|FG001|Period 2: Washout|Withdrawal by Subject|1|||
17064929|NCT00421707|38207719|FG000|Period 2: Washout|Lost to Follow-up|0|||
17064930|NCT00421707|38207720|FG001|Period 2: Washout|Lost to Follow-up|1|||
17064931|NCT00421707|38207719|FG000|Period 2: Washout|Other: Pregnancy|0|||
17064932|NCT00421707|38207720|FG001|Period 2: Washout|Other: Pregnancy|1|||
17064933|NCT00421707|38207719|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
17064934|NCT00421707|38207720|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
17064935|NCT00421707|38207719|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
17064936|NCT00421707|38207720|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
17064937|NCT00421707|38207719|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
17064938|NCT00421707|38207720|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
17064939|NCT00518622|38207746|FG000|Overall Study|Lost to Follow-up|0|||
17064940|NCT00518622|38207747|FG001|Overall Study|Lost to Follow-up|0|||
17064941|NCT00518622|38207748|FG002|Overall Study|Lost to Follow-up|1|||
17064942|NCT00518622|38207749|FG003|Overall Study|Lost to Follow-up|0|||
17064943|NCT00518622|38207750|FG004|Overall Study|Lost to Follow-up|0|||
17064944|NCT00518622|38207751|FG005|Overall Study|Lost to Follow-up|0|||
17064945|NCT00518622|38207752|FG006|Overall Study|Lost to Follow-up|0|||
17064946|NCT00518622|38207753|FG007|Overall Study|Lost to Follow-up|0|||
17064947|NCT00518622|38207746|FG000|Overall Study|Study medication taken incorrectly|0|||
17064948|NCT00518622|38207747|FG001|Overall Study|Study medication taken incorrectly|1|||
17064949|NCT00518622|38207748|FG002|Overall Study|Study medication taken incorrectly|0|||
17064950|NCT00518622|38207749|FG003|Overall Study|Study medication taken incorrectly|0|||
17064951|NCT00518622|38207750|FG004|Overall Study|Study medication taken incorrectly|0|||
17064952|NCT00518622|38207751|FG005|Overall Study|Study medication taken incorrectly|0|||
17064953|NCT00518622|38207752|FG006|Overall Study|Study medication taken incorrectly|0|||
17064954|NCT00518622|38207753|FG007|Overall Study|Study medication taken incorrectly|0|||
17064955|NCT03783078|38207771|FG000|Overall Study|Participants Ongoing|29|||
17064956|NCT03783078|38207771|FG000|Overall Study|Death|26|||
17064957|NCT00517296|38207777|FG000|Overall Study|Withdrawal by Subject|1|||
17064958|NCT00517296|38207778|FG001|Overall Study|Withdrawal by Subject|0|||
17064959|NCT00516906|38207786|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
17064960|NCT00516906|38207787|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
17064961|NCT00523848|38207793|FG000|Overall Study|Adverse Event|11|||
17064962|NCT00523848|38207793|FG000|Overall Study|Withdrawal by Subject|2|||
17064963|NCT00523848|38207793|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
17064964|NCT00523848|38207793|FG000|Overall Study|Disease Progression|5|||
17064965|NCT00523848|38207793|FG000|Overall Study|Other, unspecified|4|||
17064966|NCT00617669|38207799|FG000|Overall Study|Withdrawal by Subject|71|||
17064967|NCT00617669|38207800|FG001|Overall Study|Withdrawal by Subject|77|||
17064968|NCT00617669|38207799|FG000|Overall Study|Lost to Follow-up|3|||
17064969|NCT00617669|38207800|FG001|Overall Study|Lost to Follow-up|2|||
17064970|NCT00617669|38207799|FG000|Overall Study|Adverse Event|87|||
17064971|NCT00617669|38207800|FG001|Overall Study|Adverse Event|76|||
17064972|NCT00617669|38207799|FG000|Overall Study|Protocol Violation|2|||
17064973|NCT00617669|38207800|FG001|Overall Study|Protocol Violation|3|||
17064974|NCT00617669|38207799|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
17064975|NCT00617669|38207800|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
17064976|NCT00617669|38207799|FG000|Overall Study|Patients randomized but not treated|2|||
17064977|NCT00617669|38207800|FG001|Overall Study|Patients randomized but not treated|3|||
17064978|NCT03682848|38207806|FG000|Overall Study|Withdrawal by Subject|2|||
17064979|NCT03682848|38207806|FG000|Overall Study|Site closed|5|||
17064980|NCT03682848|38207806|FG000|Overall Study|Protocol Deviation|1|||
17064981|NCT03682848|38207806|FG000|Overall Study|Adverse Event|1|||
17064982|NCT00510510|38207813|FG000|Overall Study|Adverse Event|4|||
17064983|NCT00510510|38207814|FG001|Overall Study|Adverse Event|3|||
17064984|NCT00510510|38207815|FG002|Overall Study|Adverse Event|6|||
17064985|NCT00510510|38207813|FG000|Overall Study|Lack of Efficacy|0|||
17064986|NCT00510510|38207814|FG001|Overall Study|Lack of Efficacy|1|||
17064987|NCT00510510|38207815|FG002|Overall Study|Lack of Efficacy|1|||
17064988|NCT00510510|38207813|FG000|Overall Study|Subjects no longer requires study drug|0|||
17064989|NCT00510510|38207814|FG001|Overall Study|Subjects no longer requires study drug|0|||
17064990|NCT00510510|38207815|FG002|Overall Study|Subjects no longer requires study drug|2|||
17064991|NCT00510510|38207813|FG000|Overall Study|Withdrawal by Subject|1|||
17064992|NCT00510510|38207814|FG001|Overall Study|Withdrawal by Subject|2|||
17064993|NCT00510510|38207815|FG002|Overall Study|Withdrawal by Subject|3|||
17064994|NCT00510510|38207813|FG000|Overall Study|Lost to Follow-up|0|||
17064995|NCT00510510|38207814|FG001|Overall Study|Lost to Follow-up|0|||
17064996|NCT00510510|38207815|FG002|Overall Study|Lost to Follow-up|1|||
17064997|NCT00510510|38207813|FG000|Overall Study|Protocol Violation|0|||
17064998|NCT00510510|38207814|FG001|Overall Study|Protocol Violation|3|||
17064999|NCT00510510|38207815|FG002|Overall Study|Protocol Violation|4|||
17065000|NCT00617591|38207823|FG000|Overall Study|Withdrew consent during Induction|4|||
17065001|NCT00617591|38207823|FG000|Overall Study|Withdrew consent during Maintenance|6|||
17065002|NCT00510276|38207830|FG000|Acute Double-Blind Phase|Adverse Event|21|||
17065003|NCT00510276|38207831|FG001|Acute Double-Blind Phase|Adverse Event|6|||
17065004|NCT00510276|38207830|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
17065005|NCT00510276|38207831|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
17065006|NCT00510276|38207830|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
16993842|NCT01072175|38137820|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
16993843|NCT01072175|38137821|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
17065007|NCT00510276|38207831|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
17065008|NCT00510276|38207830|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
16993844|NCT01072175|38137822|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16993845|NCT01072175|38137823|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16993846|NCT01072175|38137824|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16993847|NCT01072175|38137825|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16993848|NCT01072175|38137826|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16993849|NCT01072175|38137827|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16993850|NCT01072175|38137828|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16993851|NCT01072175|38137829|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16993852|NCT01072175|38137817|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993853|NCT01072175|38137818|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993854|NCT01072175|38137819|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
16993855|NCT01072175|38137820|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
16993856|NCT01072175|38137821|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
16993857|NCT01072175|38137822|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993858|NCT01072175|38137823|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993859|NCT01072175|38137824|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993860|NCT01072175|38137825|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993861|NCT01072175|38137826|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993862|NCT01072175|38137827|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993863|NCT01072175|38137828|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993864|NCT01072175|38137829|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16993865|NCT01072175|38137817|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993866|NCT01072175|38137818|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
16993867|NCT01072175|38137819|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993868|NCT01072175|38137820|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
16993869|NCT01072175|38137821|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
16993870|NCT01072175|38137822|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993871|NCT01072175|38137823|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993872|NCT01072175|38137824|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993873|NCT01072175|38137825|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993874|NCT01072175|38137826|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993875|NCT01072175|38137827|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993876|NCT01072175|38137828|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993877|NCT01072175|38137829|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16993878|NCT01072175|38137817|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
16993879|NCT01072175|38137818|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
16993880|NCT01072175|38137819|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
16993881|NCT01072175|38137820|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
16993882|NCT01072175|38137821|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
16993883|NCT01072175|38137822|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
16993884|NCT01072175|38137823|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
16993885|NCT01072175|38137824|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
16993886|NCT01072175|38137825|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
16993887|NCT01072175|38137826|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
16993888|NCT01072175|38137827|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
16993889|NCT01072175|38137828|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
16993890|NCT01072175|38137829|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
16993891|NCT01072175|38137817|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993892|NCT01072175|38137818|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993893|NCT01072175|38137819|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993894|NCT01072175|38137820|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993895|NCT01072175|38137821|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993896|NCT01072175|38137822|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
16993897|NCT01072175|38137823|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
17065009|NCT00510276|38207831|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
17065010|NCT00510276|38207830|FG000|Acute Double-Blind Phase|Physician Decision|0|||
17065011|NCT00510276|38207831|FG001|Acute Double-Blind Phase|Physician Decision|3|||
17065012|NCT00510276|38207830|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
17065013|NCT00510276|38207831|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
17065014|NCT00510276|38207830|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
17065015|NCT00510276|38207831|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
17065016|NCT00510276|38207830|FG000|Acute Double-Blind Phase|Subject Decision|26|||
17065017|NCT00510276|38207831|FG001|Acute Double-Blind Phase|Subject Decision|28|||
17065018|NCT00510276|38207830|FG000|Extension Open-Label Phase|Adverse Event|9|||
17065019|NCT00510276|38207831|FG001|Extension Open-Label Phase|Adverse Event|18|||
17065020|NCT00510276|38207830|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
17065021|NCT00510276|38207831|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
17065022|NCT00510276|38207830|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
17065023|NCT00510276|38207831|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
17065024|NCT00510276|38207830|FG000|Extension Open-Label Phase|Physician Decision|2|||
17065025|NCT00510276|38207831|FG001|Extension Open-Label Phase|Physician Decision|3|||
17065026|NCT00510276|38207830|FG000|Extension Open-Label Phase|Protocol Violation|0|||
17065027|NCT00510276|38207831|FG001|Extension Open-Label Phase|Protocol Violation|1|||
17065028|NCT00510276|38207830|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
17065029|NCT00510276|38207831|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
17065030|NCT00510276|38207830|FG000|Extension Open-Label Phase|Subject Decision|7|||
17065031|NCT00510276|38207831|FG001|Extension Open-Label Phase|Subject Decision|9|||
17065032|NCT00616655|38207847|FG000|Overall Study|Adverse Event|10|||
17065033|NCT00616655|38207848|FG001|Overall Study|Adverse Event|7|||
17065034|NCT00616655|38207849|FG002|Overall Study|Adverse Event|12|||
17065035|NCT00616655|38207847|FG000|Overall Study|Lack of Efficacy|5|||
17065036|NCT00616655|38207848|FG001|Overall Study|Lack of Efficacy|5|||
17065037|NCT00616655|38207849|FG002|Overall Study|Lack of Efficacy|5|||
17065038|NCT00616655|38207847|FG000|Overall Study|Lost to Follow-up|3|||
17065039|NCT00616655|38207848|FG001|Overall Study|Lost to Follow-up|12|||
17065040|NCT00616655|38207849|FG002|Overall Study|Lost to Follow-up|10|||
17065041|NCT00616655|38207847|FG000|Overall Study|Protocol Violation|2|||
17065042|NCT00616655|38207848|FG001|Overall Study|Protocol Violation|4|||
17065043|NCT00616655|38207849|FG002|Overall Study|Protocol Violation|3|||
17065044|NCT00616655|38207847|FG000|Overall Study|Withdrawal by Subject|9|||
17065045|NCT00616655|38207848|FG001|Overall Study|Withdrawal by Subject|7|||
17065046|NCT00616655|38207849|FG002|Overall Study|Withdrawal by Subject|11|||
17065047|NCT00616655|38207847|FG000|Overall Study|Does not meet in/ex criteria|0|||
17065048|NCT00616655|38207848|FG001|Overall Study|Does not meet in/ex criteria|0|||
17065049|NCT00616655|38207849|FG002|Overall Study|Does not meet in/ex criteria|2|||
17065050|NCT00616655|38207847|FG000|Overall Study|Other|6|||
17065051|NCT00616655|38207848|FG001|Overall Study|Other|6|||
17065052|NCT00616655|38207849|FG002|Overall Study|Other|5|||
17065053|NCT00510198|38207859|FG000|Overall Study|Withdrawal by Subject|5|||
17065054|NCT00510198|38207860|FG001|Overall Study|Withdrawal by Subject|4|||
17065055|NCT00516048|38207870|FG000|Overall Study|Death|0|||
17065056|NCT00516048|38207871|FG001|Overall Study|Death|0|||
17065057|NCT00516048|38207872|FG002|Overall Study|Death|1|||
17065058|NCT00516048|38207870|FG000|Overall Study|Subject Decision|0|||
17065059|NCT00516048|38207871|FG001|Overall Study|Subject Decision|2|||
17065060|NCT00516048|38207872|FG002|Overall Study|Subject Decision|0|||
17065061|NCT00617357|38207880|FG000|Overall Study|Lost to Follow-up|7|||
17065062|NCT00617357|38207880|FG000|Overall Study|Death|5|||
17065063|NCT00617357|38207880|FG000|Overall Study|insurance concerns|2|||
17065064|NCT00617357|38207880|FG000|Overall Study|Withdrawal by Subject|1|||
17065065|NCT00617357|38207880|FG000|Overall Study|Physician Decision|1|||
17065066|NCT00420927|38207892|FG000|Period 1|Adverse Event|19|||
17065067|NCT00420927|38207893|FG001|Period 1|Adverse Event|15|||
17065068|NCT00420927|38207894|FG002|Period 1|Adverse Event|0|||
17065069|NCT00420927|38207895|FG003|Period 1|Adverse Event|0|||
17065070|NCT00420927|38207896|FG004|Period 1|Adverse Event|0|||
17065071|NCT00420927|38207897|FG005|Period 1|Adverse Event|0|||
17065072|NCT00420927|38207898|FG006|Period 1|Adverse Event|0|||
17065073|NCT00420927|38207892|FG000|Period 1|Withdrawal by Subject|7|||
17065074|NCT00420927|38207893|FG001|Period 1|Withdrawal by Subject|12|||
17065075|NCT00420927|38207894|FG002|Period 1|Withdrawal by Subject|0|||
17065076|NCT00420927|38207895|FG003|Period 1|Withdrawal by Subject|0|||
17065077|NCT00420927|38207896|FG004|Period 1|Withdrawal by Subject|0|||
17065078|NCT00420927|38207897|FG005|Period 1|Withdrawal by Subject|0|||
17065079|NCT00420927|38207898|FG006|Period 1|Withdrawal by Subject|0|||
17065080|NCT00420927|38207892|FG000|Period 1|Lost to Follow-up|8|||
17065081|NCT00420927|38207893|FG001|Period 1|Lost to Follow-up|6|||
17065082|NCT00420927|38207894|FG002|Period 1|Lost to Follow-up|0|||
17065083|NCT00420927|38207895|FG003|Period 1|Lost to Follow-up|0|||
17065084|NCT00420927|38207896|FG004|Period 1|Lost to Follow-up|0|||
17065085|NCT00420927|38207897|FG005|Period 1|Lost to Follow-up|0|||
17065086|NCT00420927|38207898|FG006|Period 1|Lost to Follow-up|0|||
17065087|NCT00420927|38207892|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
17065088|NCT00420927|38207893|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
17065089|NCT00420927|38207894|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
17065090|NCT00420927|38207895|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
17065091|NCT00420927|38207896|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
17065092|NCT00420927|38207897|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
17065093|NCT00420927|38207898|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
17065094|NCT00420927|38207892|FG000|Period 1|Death|2|||
17065095|NCT00420927|38207893|FG001|Period 1|Death|0|||
17065096|NCT00420927|38207894|FG002|Period 1|Death|0|||
17065097|NCT00420927|38207895|FG003|Period 1|Death|0|||
17065098|NCT00420927|38207896|FG004|Period 1|Death|0|||
17065099|NCT00420927|38207897|FG005|Period 1|Death|0|||
17065100|NCT00420927|38207898|FG006|Period 1|Death|0|||
17065101|NCT00420927|38207892|FG000|Period 1|Subject moved/relocated|0|||
17065102|NCT00420927|38207893|FG001|Period 1|Subject moved/relocated|2|||
17065103|NCT00420927|38207894|FG002|Period 1|Subject moved/relocated|0|||
17065104|NCT00420927|38207895|FG003|Period 1|Subject moved/relocated|0|||
17065105|NCT00420927|38207896|FG004|Period 1|Subject moved/relocated|0|||
17065106|NCT00420927|38207897|FG005|Period 1|Subject moved/relocated|0|||
17065107|NCT00420927|38207898|FG006|Period 1|Subject moved/relocated|0|||
17065108|NCT00420927|38207892|FG000|Period 1|Noncompliant with study drug|1|||
17065109|NCT00420927|38207893|FG001|Period 1|Noncompliant with study drug|1|||
17065110|NCT00420927|38207894|FG002|Period 1|Noncompliant with study drug|0|||
17065111|NCT00420927|38207895|FG003|Period 1|Noncompliant with study drug|0|||
17065112|NCT00420927|38207896|FG004|Period 1|Noncompliant with study drug|0|||
17065113|NCT00420927|38207897|FG005|Period 1|Noncompliant with study drug|0|||
17065114|NCT00420927|38207898|FG006|Period 1|Noncompliant with study drug|0|||
17065115|NCT00420927|38207892|FG000|Period 1|Randomization error|1|||
17065116|NCT00420927|38207893|FG001|Period 1|Randomization error|0|||
17065117|NCT00420927|38207894|FG002|Period 1|Randomization error|0|||
17065118|NCT00420927|38207895|FG003|Period 1|Randomization error|0|||
17147140|NCT03197376|38291528|FG002|Primary and Booster Phase|Physician Decision|1|||
17147141|NCT03197376|38291529|FG003|Primary and Booster Phase|Physician Decision|3|||
17065119|NCT00420927|38207896|FG004|Period 1|Randomization error|0|||
17065120|NCT00420927|38207897|FG005|Period 1|Randomization error|0|||
17065121|NCT00420927|38207898|FG006|Period 1|Randomization error|0|||
17065122|NCT00420927|38207892|FG000|Period 1|Suspected tuberculosis/positive test|1|||
17065123|NCT00420927|38207893|FG001|Period 1|Suspected tuberculosis/positive test|1|||
17065124|NCT00420927|38207894|FG002|Period 1|Suspected tuberculosis/positive test|0|||
17065125|NCT00420927|38207895|FG003|Period 1|Suspected tuberculosis/positive test|0|||
17065126|NCT00420927|38207896|FG004|Period 1|Suspected tuberculosis/positive test|0|||
17065127|NCT00420927|38207897|FG005|Period 1|Suspected tuberculosis/positive test|0|||
17065128|NCT00420927|38207898|FG006|Period 1|Suspected tuberculosis/positive test|0|||
17065129|NCT00420927|38207892|FG000|Period 1|Study site closure|0|||
17065130|NCT00420927|38207893|FG001|Period 1|Study site closure|1|||
17065131|NCT00420927|38207894|FG002|Period 1|Study site closure|0|||
17065132|NCT00420927|38207895|FG003|Period 1|Study site closure|0|||
17065133|NCT00420927|38207896|FG004|Period 1|Study site closure|0|||
17065134|NCT00420927|38207897|FG005|Period 1|Study site closure|0|||
17065135|NCT00420927|38207898|FG006|Period 1|Study site closure|0|||
17065136|NCT00420927|38207892|FG000|Period 1|Subject received new diagnosis|0|||
17065137|NCT00420927|38207893|FG001|Period 1|Subject received new diagnosis|2|||
17065138|NCT00420927|38207894|FG002|Period 1|Subject received new diagnosis|0|||
17065139|NCT00420927|38207895|FG003|Period 1|Subject received new diagnosis|0|||
17065140|NCT00420927|38207896|FG004|Period 1|Subject received new diagnosis|0|||
17065141|NCT00420927|38207897|FG005|Period 1|Subject received new diagnosis|0|||
17065142|NCT00420927|38207898|FG006|Period 1|Subject received new diagnosis|0|||
17065143|NCT00420927|38207892|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
17065144|NCT00420927|38207893|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
17065145|NCT00420927|38207894|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
17065146|NCT00420927|38207895|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
17065147|NCT00420927|38207896|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
17065148|NCT00420927|38207897|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
17065149|NCT00420927|38207898|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
17065150|NCT00420927|38207892|FG000|Period 1|Failed to meet entry criteria|8|||
17065151|NCT00420927|38207893|FG001|Period 1|Failed to meet entry criteria|7|||
17065152|NCT00420927|38207894|FG002|Period 1|Failed to meet entry criteria|0|||
17065153|NCT00420927|38207895|FG003|Period 1|Failed to meet entry criteria|0|||
17065154|NCT00420927|38207896|FG004|Period 1|Failed to meet entry criteria|0|||
17065155|NCT00420927|38207897|FG005|Period 1|Failed to meet entry criteria|0|||
17065156|NCT00420927|38207898|FG006|Period 1|Failed to meet entry criteria|0|||
17065157|NCT00420927|38207892|FG000|Period 1|Took prohibited medication|1|||
17065158|NCT00420927|38207893|FG001|Period 1|Took prohibited medication|3|||
17065159|NCT00420927|38207894|FG002|Period 1|Took prohibited medication|0|||
17065160|NCT00420927|38207895|FG003|Period 1|Took prohibited medication|0|||
17065161|NCT00420927|38207896|FG004|Period 1|Took prohibited medication|0|||
17065162|NCT00420927|38207897|FG005|Period 1|Took prohibited medication|0|||
17065163|NCT00420927|38207898|FG006|Period 1|Took prohibited medication|0|||
17065164|NCT00420927|38207892|FG000|Period 2|Adverse Event|0|||
17065165|NCT00420927|38207893|FG001|Period 2|Adverse Event|0|||
17065166|NCT00420927|38207894|FG002|Period 2|Adverse Event|7|||
17065167|NCT00420927|38207895|FG003|Period 2|Adverse Event|3|||
17065168|NCT00420927|38207896|FG004|Period 2|Adverse Event|17|||
17065169|NCT00420927|38207897|FG005|Period 2|Adverse Event|6|||
17065170|NCT00420927|38207898|FG006|Period 2|Adverse Event|20|||
17065171|NCT00420927|38207892|FG000|Period 2|Withdrawal by Subject|0|||
17065172|NCT00420927|38207893|FG001|Period 2|Withdrawal by Subject|0|||
17065173|NCT00420927|38207894|FG002|Period 2|Withdrawal by Subject|1|||
17065174|NCT00420927|38207895|FG003|Period 2|Withdrawal by Subject|3|||
17065175|NCT00420927|38207896|FG004|Period 2|Withdrawal by Subject|11|||
17147142|NCT03197376|38291526|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
17147143|NCT03197376|38291527|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
17147144|NCT03197376|38291528|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
17147145|NCT03197376|38291529|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
17147146|NCT03197376|38291526|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
17147147|NCT03197376|38291527|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
17147148|NCT03197376|38291528|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
17147149|NCT03197376|38291529|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
17147150|NCT03197376|38291526|FG000|Primary and Booster Phase|Not vaccine related|1|||
17147151|NCT03197376|38291527|FG001|Primary and Booster Phase|Not vaccine related|2|||
17147152|NCT03197376|38291528|FG002|Primary and Booster Phase|Not vaccine related|0|||
17147153|NCT03197376|38291529|FG003|Primary and Booster Phase|Not vaccine related|6|||
17147154|NCT03197376|38291526|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
17147155|NCT03197376|38291527|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
17147156|NCT03197376|38291528|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
17147157|NCT03197376|38291529|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
17147158|NCT03197376|38291526|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
17147159|NCT03197376|38291527|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
17147160|NCT03197376|38291528|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
17147161|NCT03197376|38291529|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
17147162|NCT03197376|38291526|FG000|Immune Persistence Phase|Not vaccine related|1|||
17065176|NCT00420927|38207897|FG005|Period 2|Withdrawal by Subject|2|||
17065177|NCT00420927|38207898|FG006|Period 2|Withdrawal by Subject|12|||
17065178|NCT00420927|38207892|FG000|Period 2|Lost to Follow-up|0|||
17147163|NCT03197376|38291527|FG001|Immune Persistence Phase|Not vaccine related|0|||
17147164|NCT03197376|38291528|FG002|Immune Persistence Phase|Not vaccine related|1|||
17147165|NCT03197376|38291529|FG003|Immune Persistence Phase|Not vaccine related|1|||
17147166|NCT03600805|38291566|FG000|Overall Study|Adverse Event|2|||
17147167|NCT03600805|38291567|FG001|Overall Study|Adverse Event|1|||
17065179|NCT00420927|38207893|FG001|Period 2|Lost to Follow-up|0|||
17065180|NCT00420927|38207894|FG002|Period 2|Lost to Follow-up|2|||
17065181|NCT00420927|38207895|FG003|Period 2|Lost to Follow-up|2|||
17065182|NCT00420927|38207896|FG004|Period 2|Lost to Follow-up|6|||
17065183|NCT00420927|38207897|FG005|Period 2|Lost to Follow-up|3|||
17065184|NCT00420927|38207898|FG006|Period 2|Lost to Follow-up|9|||
17065185|NCT00420927|38207892|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
17065186|NCT00420927|38207893|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
17065187|NCT00420927|38207894|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
17065188|NCT00420927|38207895|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
17065189|NCT00420927|38207896|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
17065190|NCT00420927|38207897|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
17065191|NCT00420927|38207898|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
17065192|NCT00420927|38207892|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
17147168|NCT03600805|38291568|FG002|Overall Study|Adverse Event|1|||
17147169|NCT03600805|38291569|FG003|Overall Study|Adverse Event|7|||
17147170|NCT03600805|38291566|FG000|Overall Study|Lack of Efficacy|2|||
17147171|NCT03600805|38291567|FG001|Overall Study|Lack of Efficacy|1|||
17147172|NCT03600805|38291568|FG002|Overall Study|Lack of Efficacy|0|||
17147173|NCT03600805|38291569|FG003|Overall Study|Lack of Efficacy|0|||
17147174|NCT03600805|38291566|FG000|Overall Study|Withdrawal by Subject|1|||
17147175|NCT03600805|38291567|FG001|Overall Study|Withdrawal by Subject|0|||
17147176|NCT03600805|38291568|FG002|Overall Study|Withdrawal by Subject|0|||
17147177|NCT03600805|38291569|FG003|Overall Study|Withdrawal by Subject|1|||
17147178|NCT03600805|38291566|FG000|Overall Study|Other unspecified|14|||
17147179|NCT03600805|38291567|FG001|Overall Study|Other unspecified|6|||
17147180|NCT03600805|38291568|FG002|Overall Study|Other unspecified|7|||
17147181|NCT03600805|38291569|FG003|Overall Study|Other unspecified|11|||
17065193|NCT00420927|38207893|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
17065194|NCT00420927|38207894|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
17065195|NCT00420927|38207895|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
17065196|NCT00420927|38207896|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
17065197|NCT00420927|38207897|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
17065198|NCT00420927|38207898|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
17065199|NCT00420927|38207892|FG000|Period 2|Subject unable to find transportation|0|||
17065200|NCT00420927|38207893|FG001|Period 2|Subject unable to find transportation|0|||
17065201|NCT00420927|38207894|FG002|Period 2|Subject unable to find transportation|0|||
17065202|NCT00420927|38207895|FG003|Period 2|Subject unable to find transportation|0|||
17065203|NCT00420927|38207896|FG004|Period 2|Subject unable to find transportation|0|||
17065204|NCT00420927|38207897|FG005|Period 2|Subject unable to find transportation|0|||
17065205|NCT00420927|38207898|FG006|Period 2|Subject unable to find transportation|1|||
17065206|NCT00420927|38207892|FG000|Period 2|Physician Decision|0|||
17065207|NCT00420927|38207893|FG001|Period 2|Physician Decision|0|||
17065208|NCT00420927|38207894|FG002|Period 2|Physician Decision|0|||
17065209|NCT00420927|38207895|FG003|Period 2|Physician Decision|0|||
17065210|NCT00420927|38207896|FG004|Period 2|Physician Decision|1|||
17065211|NCT00420927|38207897|FG005|Period 2|Physician Decision|1|||
17065212|NCT00420927|38207898|FG006|Period 2|Physician Decision|0|||
17065213|NCT00420927|38207892|FG000|Period 2|Sponsor decision|0|||
17065214|NCT00420927|38207893|FG001|Period 2|Sponsor decision|0|||
17065215|NCT00420927|38207894|FG002|Period 2|Sponsor decision|1|||
17065216|NCT00420927|38207895|FG003|Period 2|Sponsor decision|0|||
17065217|NCT00420927|38207896|FG004|Period 2|Sponsor decision|0|||
17065218|NCT00420927|38207897|FG005|Period 2|Sponsor decision|0|||
17065219|NCT00420927|38207898|FG006|Period 2|Sponsor decision|1|||
17147182|NCT02729740|38291581|FG000|Overall Study|Early Termination|130|||
17065220|NCT00420927|38207892|FG000|Period 2|Randomization error|0|||
17065221|NCT00420927|38207893|FG001|Period 2|Randomization error|0|||
17065222|NCT00420927|38207894|FG002|Period 2|Randomization error|0|||
17065223|NCT00420927|38207895|FG003|Period 2|Randomization error|0|||
17065224|NCT00420927|38207896|FG004|Period 2|Randomization error|1|||
17065225|NCT00420927|38207897|FG005|Period 2|Randomization error|1|||
17065226|NCT00420927|38207898|FG006|Period 2|Randomization error|0|||
17065227|NCT00420927|38207892|FG000|Period 2|Noncompliant with study drug|0|||
17065228|NCT00420927|38207893|FG001|Period 2|Noncompliant with study drug|0|||
17065229|NCT00420927|38207894|FG002|Period 2|Noncompliant with study drug|0|||
17065230|NCT00420927|38207895|FG003|Period 2|Noncompliant with study drug|1|||
17065231|NCT00420927|38207896|FG004|Period 2|Noncompliant with study drug|0|||
17065232|NCT00420927|38207897|FG005|Period 2|Noncompliant with study drug|0|||
17147183|NCT02729740|38291581|FG000|Overall Study|Other|1|||
17147184|NCT02297438|38291591|FG000|Overall Study|Death|79|||
17065233|NCT00420927|38207898|FG006|Period 2|Noncompliant with study drug|2|||
17065234|NCT00420927|38207892|FG000|Period 2|Methotrexate intolerance|0|||
17065235|NCT00420927|38207893|FG001|Period 2|Methotrexate intolerance|0|||
17065236|NCT00420927|38207894|FG002|Period 2|Methotrexate intolerance|0|||
17065237|NCT00420927|38207895|FG003|Period 2|Methotrexate intolerance|0|||
17147185|NCT02297438|38291592|FG001|Overall Study|Death|86|||
17147186|NCT02297438|38291591|FG000|Overall Study|Lost to Follow-up|9|||
17147187|NCT02297438|38291592|FG001|Overall Study|Lost to Follow-up|7|||
17147188|NCT02297438|38291591|FG000|Overall Study|Withdrawal by Subject|7|||
17147189|NCT02297438|38291592|FG001|Overall Study|Withdrawal by Subject|0|||
17147190|NCT02297438|38291591|FG000|Overall Study|Other|9|||
17147191|NCT02297438|38291592|FG001|Overall Study|Other|5|||
17147192|NCT02297438|38291591|FG000|Overall Study|Ongoing|65|||
17065238|NCT00420927|38207896|FG004|Period 2|Methotrexate intolerance|0|||
17065239|NCT00420927|38207897|FG005|Period 2|Methotrexate intolerance|0|||
17065240|NCT00420927|38207898|FG006|Period 2|Methotrexate intolerance|1|||
17065241|NCT00420927|38207892|FG000|Period 2|Took prohibited medication|0|||
17065242|NCT00420927|38207893|FG001|Period 2|Took prohibited medication|0|||
17065243|NCT00420927|38207894|FG002|Period 2|Took prohibited medication|0|||
17065244|NCT00420927|38207895|FG003|Period 2|Took prohibited medication|0|||
17065245|NCT00420927|38207896|FG004|Period 2|Took prohibited medication|1|||
17065246|NCT00420927|38207897|FG005|Period 2|Took prohibited medication|0|||
17065247|NCT00420927|38207898|FG006|Period 2|Took prohibited medication|0|||
17065248|NCT00573443|38207915|FG000|Double-Blind Phase|Lost to Follow-up|1|||
17065249|NCT00573443|38207916|FG001|Double-Blind Phase|Lost to Follow-up|3|||
17065250|NCT00573443|38207917|FG002|Double-Blind Phase|Lost to Follow-up|2|||
17065251|NCT00573443|38207915|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
17065252|NCT00573443|38207916|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
17065253|NCT00573443|38207917|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
17065254|NCT00573443|38207915|FG000|Double-Blind Phase|Adverse Event|1|||
17065255|NCT00573443|38207916|FG001|Double-Blind Phase|Adverse Event|5|||
16781212|NCT02109562|37720391|FG000|Overall Study|Adverse Event|0|||
17065256|NCT00573443|38207917|FG002|Double-Blind Phase|Adverse Event|0|||
17065257|NCT00573443|38207915|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
17147193|NCT02297438|38291592|FG001|Overall Study|Ongoing|73|||
17065258|NCT00573443|38207916|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
17065259|NCT00573443|38207917|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
17065260|NCT00573443|38207915|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
17065261|NCT00573443|38207916|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
17065262|NCT00573443|38207917|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
17065263|NCT00573443|38207915|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
17065264|NCT00573443|38207916|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
17065265|NCT00573443|38207917|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
17065266|NCT00573443|38207915|FG000|Double-Blind Phase|Protocol Violation|0|||
17065267|NCT00573443|38207916|FG001|Double-Blind Phase|Protocol Violation|2|||
17065268|NCT00573443|38207917|FG002|Double-Blind Phase|Protocol Violation|1|||
17147194|NCT03196284|38291600|FG000|Main Part|Withdrawal by Subject|0|||
17147195|NCT03196284|38291601|FG001|Main Part|Withdrawal by Subject|1|||
17147196|NCT03196284|38291602|FG002|Main Part|Withdrawal by Subject|0|||
17065269|NCT00573443|38207915|FG000|Double-Blind Phase|Other|0|||
17065270|NCT00573443|38207916|FG001|Double-Blind Phase|Other|2|||
17065271|NCT00573443|38207917|FG002|Double-Blind Phase|Other|3|||
17065272|NCT00573443|38207915|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
17065273|NCT00573443|38207916|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
17065274|NCT00573443|38207917|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
17065275|NCT00573443|38207915|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
17065276|NCT00573443|38207916|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
17065277|NCT00573443|38207917|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
17065278|NCT00573443|38207915|FG000|Open-Label Extension Phase|Adverse Event|3|||
17065279|NCT00573443|38207916|FG001|Open-Label Extension Phase|Adverse Event|0|||
17065280|NCT00573443|38207917|FG002|Open-Label Extension Phase|Adverse Event|0|||
17065281|NCT00573443|38207915|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
17065282|NCT00573443|38207916|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
17065283|NCT00573443|38207917|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
17065284|NCT00573443|38207915|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
17065285|NCT00573443|38207916|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
17065286|NCT00573443|38207917|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
17065287|NCT00573443|38207915|FG000|Open-Label Extension Phase|Protocol Violation|2|||
17147197|NCT03196284|38291600|FG000|Extension Part|Lack of Efficacy|0|||
17147198|NCT03196284|38291601|FG001|Extension Part|Lack of Efficacy|0|||
16781213|NCT02109562|37720392|FG001|Overall Study|Adverse Event|2|||
17065288|NCT00573443|38207916|FG001|Open-Label Extension Phase|Protocol Violation|0|||
17065289|NCT00573443|38207917|FG002|Open-Label Extension Phase|Protocol Violation|0|||
17065290|NCT00573443|38207915|FG000|Open-Label Extension Phase|Other|2|||
17065291|NCT00573443|38207916|FG001|Open-Label Extension Phase|Other|0|||
17065292|NCT00573443|38207917|FG002|Open-Label Extension Phase|Other|0|||
17065293|NCT00420849|38207939|FG000|Overall Study|Lack of Efficacy|154|||
17065294|NCT00420849|38207939|FG000|Overall Study|Adverse Event|107|||
17065295|NCT00420849|38207939|FG000|Overall Study|Withdrawal by Subject|28|||
17065296|NCT00420849|38207939|FG000|Overall Study|Death|18|||
17065297|NCT00420849|38207939|FG000|Overall Study|Other|14|||
17065298|NCT00420849|38207939|FG000|Overall Study|Transplant|8|||
17065299|NCT00420849|38207939|FG000|Overall Study|Protocol Violation|1|||
17065300|NCT00420849|38207939|FG000|Overall Study|Lost to Follow-up|1|||
17065301|NCT00617279|38207948|FG000|Overall Study|Study terminated by Sponsor|10|||
17065302|NCT00617279|38207949|FG001|Overall Study|Study terminated by Sponsor|15|||
17065303|NCT00617279|38207948|FG000|Overall Study|Graft abandonment|2|||
17065304|NCT00617279|38207949|FG001|Overall Study|Graft abandonment|0|||
17065305|NCT00617279|38207948|FG000|Overall Study|Lost to Follow-up|1|||
17065306|NCT00617279|38207949|FG001|Overall Study|Lost to Follow-up|0|||
17065307|NCT00617279|38207948|FG000|Overall Study|Death|1|||
17065308|NCT00617279|38207949|FG001|Overall Study|Death|2|||
17065309|NCT00420381|38207955|FG000|Overall Study|Protocol Violation|1|||
17065310|NCT00617201|38207961|FG000|Overall Study|Lost to Follow-up|9|||
17065311|NCT00617201|38207962|FG001|Overall Study|Lost to Follow-up|13|||
17065312|NCT00420303|38207972|FG000|Overall Study|Serious Adverse Event|1|||
17065313|NCT00420303|38207973|FG001|Overall Study|Serious Adverse Event|0|||
17065314|NCT00420303|38207972|FG000|Overall Study|Lack of Efficacy|0|||
17065315|NCT00420303|38207973|FG001|Overall Study|Lack of Efficacy|3|||
17065316|NCT00420303|38207972|FG000|Overall Study|Physician Decision|0|||
17065317|NCT00420303|38207973|FG001|Overall Study|Physician Decision|1|||
17065318|NCT00617123|38207981|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
17065319|NCT00617123|38207982|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
17065320|NCT00617123|38207981|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
17065321|NCT00617123|38207982|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
17065322|NCT00617123|38207981|FG000|Referral Screening Period|Adverse Event|0|||
17147199|NCT03196284|38291602|FG002|Extension Part|Lack of Efficacy|1|||
17147200|NCT03196284|38291600|FG000|Extension Part|Withdrawal by Subject|0|||
17147201|NCT03196284|38291601|FG001|Extension Part|Withdrawal by Subject|0|||
17065323|NCT00617123|38207982|FG001|Referral Screening Period|Adverse Event|1|||
17147202|NCT03196284|38291602|FG002|Extension Part|Withdrawal by Subject|1|||
17147203|NCT03196284|38291600|FG000|Extension Part|Physician Decision|0|||
17147204|NCT03196284|38291601|FG001|Extension Part|Physician Decision|0|||
17147205|NCT03196284|38291602|FG002|Extension Part|Physician Decision|1|||
17147206|NCT03730961|38291624|FG000|Overall Study|Adverse Event|0|||
17147207|NCT03730961|38291625|FG001|Overall Study|Adverse Event|1|||
17147208|NCT01078454|38291633|FG000|Overall Study|Adverse Event|1|||
17147209|NCT01078454|38291634|FG001|Overall Study|Adverse Event|1|||
17147210|NCT01078454|38291633|FG000|Overall Study|Death|0|||
17147211|NCT01078454|38291634|FG001|Overall Study|Death|1|||
16781214|NCT02109562|37720393|FG002|Overall Study|Adverse Event|3|||
17065324|NCT00617123|38207981|FG000|Study Treatment Period|Withdrawal by Subject|8|||
17147212|NCT03345004|38291651|FG000|Overall Study|Physician Decision|1|||
17147213|NCT03345004|38291652|FG001|Overall Study|Physician Decision|0|||
17147214|NCT03345004|38291651|FG000|Overall Study|Withdrawal by Subject|0|||
17147215|NCT03345004|38291652|FG001|Overall Study|Withdrawal by Subject|1|||
17147216|NCT03552757|38291663|FG000|Overall Study|Withdrawal by Subject|10|||
16993898|NCT01072175|38137824|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
16993899|NCT01072175|38137825|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993900|NCT01072175|38137826|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993901|NCT01072175|38137827|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993902|NCT01072175|38137828|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993903|NCT01072175|38137829|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16993904|NCT01072175|38137817|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993905|NCT01072175|38137818|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993906|NCT01072175|38137819|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993907|NCT01072175|38137820|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993908|NCT01072175|38137821|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993909|NCT01072175|38137822|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993910|NCT01072175|38137823|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
16993911|NCT01072175|38137824|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
16993912|NCT01072175|38137825|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993913|NCT01072175|38137826|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993914|NCT01072175|38137827|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993915|NCT01072175|38137828|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993916|NCT01072175|38137829|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16993917|NCT01072175|38137817|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993918|NCT01072175|38137818|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993919|NCT01072175|38137819|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993920|NCT01072175|38137820|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993921|NCT01072175|38137821|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993922|NCT01072175|38137822|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
16993923|NCT01072175|38137823|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
16993924|NCT01072175|38137824|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
16993925|NCT01072175|38137825|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993926|NCT01072175|38137826|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993927|NCT01072175|38137827|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993928|NCT01072175|38137828|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993929|NCT01072175|38137829|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16993930|NCT01072175|38137817|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993931|NCT01072175|38137818|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993932|NCT01072175|38137819|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
17147217|NCT03552757|38291664|FG001|Overall Study|Withdrawal by Subject|5|||
17147218|NCT03552757|38291665|FG002|Overall Study|Withdrawal by Subject|12|||
17147219|NCT03552757|38291663|FG000|Overall Study|Lost to Follow-up|2|||
17147220|NCT03552757|38291664|FG001|Overall Study|Lost to Follow-up|7|||
17147221|NCT03552757|38291665|FG002|Overall Study|Lost to Follow-up|7|||
17065325|NCT00617123|38207982|FG001|Study Treatment Period|Withdrawal by Subject|12|||
17065326|NCT00617123|38207981|FG000|Study Treatment Period|Adverse Event|7|||
17065327|NCT00617123|38207982|FG001|Study Treatment Period|Adverse Event|3|||
17065328|NCT00617123|38207981|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
17065329|NCT00617123|38207982|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
17065330|NCT00617123|38207981|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
17065331|NCT00617123|38207982|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
17065332|NCT00419757|38207990|FG000|Overall Study|Adverse Event|1|||
17065333|NCT00419757|38207991|FG001|Overall Study|Adverse Event|4|||
17065334|NCT00419757|38207990|FG000|Overall Study|Lost to Follow-up|1|||
17065335|NCT00419757|38207991|FG001|Overall Study|Lost to Follow-up|4|||
17147222|NCT03552757|38291663|FG000|Overall Study|Death|1|||
16993933|NCT01072175|38137820|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993934|NCT01072175|38137821|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993935|NCT01072175|38137822|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
17065336|NCT00419757|38207990|FG000|Overall Study|Withdrawal by Subject|7|||
17065337|NCT00419757|38207991|FG001|Overall Study|Withdrawal by Subject|1|||
17065338|NCT00419757|38207990|FG000|Overall Study|Protocol Violation|2|||
17065339|NCT00419757|38207991|FG001|Overall Study|Protocol Violation|3|||
17065340|NCT00419757|38207990|FG000|Overall Study|Study specific discontinuation criteria|4|||
17065341|NCT00419757|38207991|FG001|Overall Study|Study specific discontinuation criteria|8|||
17065342|NCT00419757|38207990|FG000|Overall Study|Multiple reasons|3|||
17147223|NCT03552757|38291664|FG001|Overall Study|Death|1|||
17147224|NCT03552757|38291665|FG002|Overall Study|Death|1|||
17147225|NCT03730103|38291678|FG000|Overall Study|Did not meet inclusion criteria|0|||
17147226|NCT03730103|38291679|FG001|Overall Study|Did not meet inclusion criteria|5|||
17147227|NCT03727841|38291687|FG000|Overall Study|Physician Decision|3|||
17147228|NCT03727841|38291688|FG001|Overall Study|Physician Decision|1|||
17147229|NCT03552523|38291694|FG000|Overall Study|Withdrawal by Subject|1|||
17147230|NCT03552523|38291695|FG001|Overall Study|Withdrawal by Subject|1|||
17147231|NCT03186378|38291703|FG000|Overall Study|Lost to Follow-up|1|||
17147232|NCT03186378|38291704|FG001|Overall Study|Lost to Follow-up|0|||
17147233|NCT00687596|38291712|FG000|Overall Study|Adverse Event (AE)|10|||
17065343|NCT00419757|38207991|FG001|Overall Study|Multiple reasons|1|||
17065344|NCT00434109|38207999|FG000|Overall Study|Physician Decision|9|||
17065345|NCT00434109|38207999|FG000|Overall Study|Adverse Event|5|||
16993936|NCT01072175|38137823|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
16993937|NCT01072175|38137824|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993938|NCT01072175|38137825|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993939|NCT01072175|38137826|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993940|NCT01072175|38137827|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993941|NCT01072175|38137828|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993942|NCT01072175|38137829|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16993943|NCT01072175|38137817|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993944|NCT01072175|38137818|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993945|NCT01072175|38137819|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993946|NCT01072175|38137820|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993947|NCT01072175|38137821|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993948|NCT01072175|38137822|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993949|NCT01072175|38137823|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
17065346|NCT00434109|38207999|FG000|Overall Study|Protocol Violation|1|||
17065347|NCT00434109|38207999|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
17147234|NCT00687596|38291713|FG001|Overall Study|Adverse Event (AE)|3|||
17147235|NCT00687596|38291712|FG000|Overall Study|Radiological Disease Progression|6|||
17147236|NCT00687596|38291713|FG001|Overall Study|Radiological Disease Progression|2|||
17147237|NCT00687596|38291712|FG000|Overall Study|Clinical Disease Progression|1|||
17147238|NCT00687596|38291713|FG001|Overall Study|Clinical Disease Progression|3|||
17147239|NCT00687596|38291712|FG000|Overall Study|Investigator Discretion|3|||
17065348|NCT00433329|38208003|FG000|Overall Study|Adverse Event|9|||
17065349|NCT00433329|38208003|FG000|Overall Study|Death|4|||
17065350|NCT00433329|38208003|FG000|Overall Study|Withdrew consent|3|||
17065351|NCT00433329|38208003|FG000|Overall Study|Discontinued sildenafil|2|||
17065352|NCT00433329|38208003|FG000|Overall Study|Moved out of state|1|||
16993950|NCT01072175|38137824|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993951|NCT01072175|38137825|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
16993952|NCT01072175|38137826|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993953|NCT01072175|38137827|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993954|NCT01072175|38137828|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993955|NCT01072175|38137829|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16993956|NCT01072175|38137817|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993957|NCT01072175|38137818|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993958|NCT01072175|38137819|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993959|NCT01072175|38137820|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
17147240|NCT00687596|38291713|FG001|Overall Study|Investigator Discretion|1|||
17147241|NCT00687596|38291712|FG000|Overall Study|Sponsor Terminated Study|6|||
17147242|NCT00687596|38291713|FG001|Overall Study|Sponsor Terminated Study|17|||
17147243|NCT02892409|38291721|FG000|Overall Study|Adverse Event|1|||
17147244|NCT02892409|38291722|FG001|Overall Study|Adverse Event|0|||
17147245|NCT02892409|38291721|FG000|Overall Study|Withdrawal by Subject|2|||
17147246|NCT02892409|38291722|FG001|Overall Study|Withdrawal by Subject|1|||
17147247|NCT03219216|38291730|FG000|Overall Study|Lost to Follow-up|0|||
17147248|NCT03219216|38291731|FG001|Overall Study|Lost to Follow-up|1|||
17147249|NCT03195660|38291745|FG000|Overall Study|The study was terminated|2|||
17147250|NCT03194490|38291751|FG000|Overall Study|Lost to Follow-up|1|||
17147251|NCT03194490|38291752|FG001|Overall Study|Lost to Follow-up|3|||
17147252|NCT03194490|38291751|FG000|Overall Study|participant developed specific neck pain|1|||
17147253|NCT03194490|38291752|FG001|Overall Study|participant developed specific neck pain|0|||
17147254|NCT03217968|38291759|FG000|Overall Study|Withdrawal by Subject|4|||
17147255|NCT03217968|38291759|FG000|Overall Study|Lost to Follow-up|1|||
17147256|NCT03217968|38291759|FG000|Overall Study|Protocol Violation|6|||
17147257|NCT03192306|38291765|FG000|Overall Study|Did not treat cold sore during study|149|||
17147258|NCT03192306|38291766|FG001|Overall Study|Did not treat cold sore during study|143|||
17147259|NCT03192306|38291765|FG000|Overall Study|Withdrawal by Subject|1|||
17147260|NCT03192306|38291766|FG001|Overall Study|Withdrawal by Subject|1|||
17147261|NCT03192306|38291765|FG000|Overall Study|Lost to Follow-up|1|||
17147262|NCT03192306|38291766|FG001|Overall Study|Lost to Follow-up|0|||
17147263|NCT03192306|38291765|FG000|Overall Study|Protocol Violation|1|||
17147264|NCT03192306|38291766|FG001|Overall Study|Protocol Violation|1|||
17147265|NCT03216954|38291789|FG000|Overall Study|Adverse Event|0|||
17147266|NCT03216954|38291790|FG001|Overall Study|Adverse Event|0|||
17065353|NCT00433329|38208003|FG000|Overall Study|Lost to Follow-up|1|||
17065354|NCT00433329|38208003|FG000|Overall Study|Physician Decision|1|||
17065355|NCT00616421|38208010|FG000|Overall Study|Withdrawal by Subject|9|||
17065356|NCT00616421|38208011|FG001|Overall Study|Withdrawal by Subject|11|||
17065357|NCT00616421|38208012|FG002|Overall Study|Withdrawal by Subject|8|||
17065358|NCT00616421|38208010|FG000|Overall Study|Lost to Follow-up|12|||
17065359|NCT00616421|38208011|FG001|Overall Study|Lost to Follow-up|26|||
17065360|NCT00616421|38208012|FG002|Overall Study|Lost to Follow-up|30|||
17065361|NCT00616421|38208010|FG000|Overall Study|Inappropriate enrollment|3|||
17065362|NCT00616421|38208011|FG001|Overall Study|Inappropriate enrollment|0|||
17065363|NCT00616421|38208012|FG002|Overall Study|Inappropriate enrollment|1|||
17065364|NCT00616421|38208010|FG000|Overall Study|Administrative reason|1|||
17065365|NCT00616421|38208011|FG001|Overall Study|Administrative reason|0|||
17065366|NCT00616421|38208012|FG002|Overall Study|Administrative reason|0|||
17065367|NCT00616421|38208010|FG000|Overall Study|Protocol Violation|0|||
17065368|NCT00616421|38208011|FG001|Overall Study|Protocol Violation|1|||
17065369|NCT00616421|38208012|FG002|Overall Study|Protocol Violation|2|||
17065370|NCT00616421|38208010|FG000|Overall Study|Unable to classify|1|||
17065371|NCT00616421|38208011|FG001|Overall Study|Unable to classify|0|||
17065372|NCT00616421|38208012|FG002|Overall Study|Unable to classify|0|||
17065373|NCT00433017|38208036|FG000|Overall Study|Adverse Event|5|||
17065374|NCT00433017|38208037|FG001|Overall Study|Adverse Event|3|||
17065375|NCT00433017|38208036|FG000|Overall Study|Withdrawal by Subject|4|||
17065376|NCT00433017|38208037|FG001|Overall Study|Withdrawal by Subject|5|||
17065377|NCT00433017|38208036|FG000|Overall Study|Lost to Follow-up|3|||
17065378|NCT00433017|38208037|FG001|Overall Study|Lost to Follow-up|4|||
17065379|NCT00433017|38208036|FG000|Overall Study|Administrative problems|80|||
17065380|NCT00433017|38208037|FG001|Overall Study|Administrative problems|86|||
17065381|NCT00433017|38208036|FG000|Overall Study|Protocol Violation|1|||
17065382|NCT00433017|38208037|FG001|Overall Study|Protocol Violation|0|||
17147267|NCT03216954|38291791|FG002|Overall Study|Adverse Event|1|||
17147268|NCT03216954|38291792|FG003|Overall Study|Adverse Event|0|||
17147269|NCT03216954|38291793|FG004|Overall Study|Adverse Event|1|||
17147270|NCT03216954|38291789|FG000|Overall Study|Withdrawal by Subject|2|||
17065383|NCT00433017|38208036|FG000|Overall Study|Death|2|||
17065384|NCT00433017|38208037|FG001|Overall Study|Death|2|||
17147271|NCT03216954|38291790|FG001|Overall Study|Withdrawal by Subject|0|||
17147272|NCT03216954|38291791|FG002|Overall Study|Withdrawal by Subject|0|||
17147273|NCT03216954|38291792|FG003|Overall Study|Withdrawal by Subject|0|||
16993960|NCT01072175|38137821|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993961|NCT01072175|38137822|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993962|NCT01072175|38137823|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993963|NCT01072175|38137824|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993964|NCT01072175|38137825|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
16993965|NCT01072175|38137826|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
17147274|NCT03216954|38291793|FG004|Overall Study|Withdrawal by Subject|0|||
17147275|NCT03216954|38291789|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
17147276|NCT03216954|38291790|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
17147277|NCT03216954|38291791|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
17147278|NCT03216954|38291792|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
17147279|NCT03216954|38291793|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
17147280|NCT03599089|38291805|FG000|Overall Study|Lost to Follow-up|1|||
17147281|NCT03599089|38291806|FG001|Overall Study|Lost to Follow-up|0|||
17147282|NCT03599089|38291807|FG002|Overall Study|Lost to Follow-up|0|||
17147283|NCT03599089|38291808|FG003|Overall Study|Lost to Follow-up|0|||
17147284|NCT03599089|38291805|FG000|Overall Study|Withdrawal by Subject|2|||
17147285|NCT03599089|38291806|FG001|Overall Study|Withdrawal by Subject|1|||
17147286|NCT03599089|38291807|FG002|Overall Study|Withdrawal by Subject|0|||
17147287|NCT03599089|38291808|FG003|Overall Study|Withdrawal by Subject|0|||
17147288|NCT03599089|38291805|FG000|Overall Study|Lack of Efficacy|0|||
17147289|NCT03599089|38291806|FG001|Overall Study|Lack of Efficacy|0|||
17147290|NCT03599089|38291807|FG002|Overall Study|Lack of Efficacy|1|||
17147291|NCT03599089|38291808|FG003|Overall Study|Lack of Efficacy|2|||
17147292|NCT03192150|38291820|FG000|Overall Study|Adverse Event|14|||
17147293|NCT03192150|38291821|FG001|Overall Study|Adverse Event|12|||
17147294|NCT03192150|38291820|FG000|Overall Study|Lack of Efficacy|23|||
17147295|NCT03192150|38291821|FG001|Overall Study|Lack of Efficacy|30|||
17147296|NCT03192150|38291820|FG000|Overall Study|Lost to Follow-up|1|||
17147297|NCT03192150|38291821|FG001|Overall Study|Lost to Follow-up|1|||
17147298|NCT03192150|38291820|FG000|Overall Study|Withdrawal by Subject|4|||
17147299|NCT03192150|38291821|FG001|Overall Study|Withdrawal by Subject|2|||
17147300|NCT03192150|38291820|FG000|Overall Study|Protocol Violation|5|||
17147301|NCT03192150|38291821|FG001|Overall Study|Protocol Violation|2|||
17147302|NCT03192150|38291820|FG000|Overall Study|Surgery Canceled|6|||
17147303|NCT03192150|38291821|FG001|Overall Study|Surgery Canceled|2|||
17147304|NCT03192150|38291820|FG000|Overall Study|Other-Various Administrative Reasons|2|||
17147305|NCT03192150|38291821|FG001|Overall Study|Other-Various Administrative Reasons|5|||
17147306|NCT03597529|38291829|FG000|Overall Study|Lost to Follow-up|10|||
17147307|NCT03597529|38291830|FG001|Overall Study|Lost to Follow-up|12|||
17147308|NCT03597529|38291829|FG000|Overall Study|Physician Decision|3|||
17147309|NCT03597529|38291830|FG001|Overall Study|Physician Decision|1|||
17147310|NCT03597529|38291829|FG000|Overall Study|Withdrawal by Subject|6|||
17147311|NCT03597529|38291830|FG001|Overall Study|Withdrawal by Subject|3|||
17065385|NCT00433017|38208036|FG000|Overall Study|Subject no longer requires study drug|1|||
17065386|NCT00433017|38208037|FG001|Overall Study|Subject no longer requires study drug|1|||
17065387|NCT00615719|38208069|FG000|Overall Study|Physician Decision|5|||
17065388|NCT00418665|38208076|FG000|Treatment Period|Ineligibility determined|1|||
17065389|NCT00418665|38208077|FG001|Treatment Period|Ineligibility determined|1|||
17065390|NCT00418665|38208078|FG002|Treatment Period|Ineligibility determined|0|||
17065391|NCT00418665|38208076|FG000|Treatment Period|Adverse Event|2|||
17065392|NCT00418665|38208077|FG001|Treatment Period|Adverse Event|2|||
17065393|NCT00418665|38208078|FG002|Treatment Period|Adverse Event|0|||
17065394|NCT00418665|38208076|FG000|Treatment Period|Withdrawal by Subject|0|||
17065395|NCT00418665|38208077|FG001|Treatment Period|Withdrawal by Subject|3|||
17065396|NCT00418665|38208078|FG002|Treatment Period|Withdrawal by Subject|1|||
17065397|NCT00418665|38208076|FG000|Treatment Period|Requirement for alternative therapy|1|||
17065398|NCT00418665|38208077|FG001|Treatment Period|Requirement for alternative therapy|0|||
17147312|NCT03597529|38291829|FG000|Overall Study|Non-compliant with study activities|1|||
17147313|NCT03597529|38291830|FG001|Overall Study|Non-compliant with study activities|2|||
17065399|NCT00418665|38208078|FG002|Treatment Period|Requirement for alternative therapy|0|||
17065400|NCT00418665|38208076|FG000|Treatment Period|Physician Decision|1|||
17147314|NCT03180528|38291836|FG000|Overall Study|Adverse Event|1|||
17065401|NCT00418665|38208077|FG001|Treatment Period|Physician Decision|0|||
17065402|NCT00418665|38208078|FG002|Treatment Period|Physician Decision|3|||
17065403|NCT00418665|38208076|FG000|Treatment Extension|Adverse Event|1|||
17065404|NCT00418665|38208077|FG001|Treatment Extension|Adverse Event|0|||
17065405|NCT00418665|38208078|FG002|Treatment Extension|Adverse Event|0|||
17065406|NCT00418665|38208076|FG000|Treatment Extension|Withdrawal by Subject|1|||
17065407|NCT00418665|38208077|FG001|Treatment Extension|Withdrawal by Subject|0|||
17065408|NCT00418665|38208078|FG002|Treatment Extension|Withdrawal by Subject|0|||
17065409|NCT00418665|38208076|FG000|Treatment Extension|Requirement for alternative therapy|2|||
17065410|NCT00418665|38208077|FG001|Treatment Extension|Requirement for alternative therapy|2|||
17065411|NCT00418665|38208078|FG002|Treatment Extension|Requirement for alternative therapy|0|||
17065412|NCT00418665|38208076|FG000|Treatment Extension|Physician Decision|2|||
17065413|NCT00418665|38208077|FG001|Treatment Extension|Physician Decision|2|||
17065414|NCT00418665|38208078|FG002|Treatment Extension|Physician Decision|1|||
17065415|NCT00418665|38208076|FG000|Treatment Extension|Death|0|||
17065416|NCT00418665|38208077|FG001|Treatment Extension|Death|0|||
17065417|NCT00418665|38208078|FG002|Treatment Extension|Death|1|||
17065418|NCT00432237|38208090|FG000|Overall Study|Adverse Event|0|||
17065419|NCT00432237|38208091|FG001|Overall Study|Adverse Event|0|||
17065420|NCT00432237|38208092|FG002|Overall Study|Adverse Event|0|||
17065421|NCT00432237|38208093|FG003|Overall Study|Adverse Event|1|||
17065422|NCT00432237|38208090|FG000|Overall Study|Lack of Efficacy|0|||
17065423|NCT00432237|38208091|FG001|Overall Study|Lack of Efficacy|0|||
17065424|NCT00432237|38208092|FG002|Overall Study|Lack of Efficacy|0|||
17065425|NCT00432237|38208093|FG003|Overall Study|Lack of Efficacy|1|||
17065426|NCT00432237|38208090|FG000|Overall Study|Lost to Follow-up|10|||
17147315|NCT03180528|38291836|FG000|Overall Study|Withdrawal by Subject|1|||
17147316|NCT03180528|38291836|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
17147317|NCT03597295|38291840|FG000|Overall Study|Death|70|||
17147318|NCT03597295|38291840|FG000|Overall Study|Lost to Follow-up|7|||
17147319|NCT03180138|38291847|FG000|Overall Study|Mobile-phone could not be verified|2|||
17147320|NCT03180138|38291848|FG001|Overall Study|Mobile-phone could not be verified|13|||
17147321|NCT03180138|38291849|FG002|Overall Study|Mobile-phone could not be verified|15|||
17147322|NCT03180138|38291847|FG000|Overall Study|No prior immunization records|17|||
16993966|NCT01072175|38137827|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993967|NCT01072175|38137828|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993968|NCT01072175|38137829|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16993969|NCT01072175|38137817|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993970|NCT01072175|38137818|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993971|NCT01072175|38137819|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993972|NCT01072175|38137820|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993973|NCT01072175|38137821|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993974|NCT01072175|38137822|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993975|NCT01072175|38137823|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993976|NCT01072175|38137824|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
17065427|NCT00432237|38208091|FG001|Overall Study|Lost to Follow-up|10|||
17147323|NCT03180138|38291848|FG001|Overall Study|No prior immunization records|0|||
17065428|NCT00432237|38208092|FG002|Overall Study|Lost to Follow-up|18|||
17065429|NCT00432237|38208093|FG003|Overall Study|Lost to Follow-up|18|||
17065430|NCT00432237|38208090|FG000|Overall Study|Physician Decision|1|||
17065431|NCT00432237|38208091|FG001|Overall Study|Physician Decision|3|||
17065432|NCT00432237|38208092|FG002|Overall Study|Physician Decision|2|||
17065433|NCT00432237|38208093|FG003|Overall Study|Physician Decision|1|||
17065434|NCT00432237|38208090|FG000|Overall Study|Pregnancy|0|||
17065435|NCT00432237|38208091|FG001|Overall Study|Pregnancy|1|||
17065436|NCT00432237|38208092|FG002|Overall Study|Pregnancy|0|||
17065437|NCT00432237|38208093|FG003|Overall Study|Pregnancy|0|||
17065438|NCT00432237|38208090|FG000|Overall Study|Protocol Violation|13|||
17065439|NCT00432237|38208091|FG001|Overall Study|Protocol Violation|10|||
17065440|NCT00432237|38208092|FG002|Overall Study|Protocol Violation|11|||
17065441|NCT00432237|38208093|FG003|Overall Study|Protocol Violation|8|||
17065442|NCT00432237|38208090|FG000|Overall Study|Withdrawal by Subject|5|||
17147324|NCT03180138|38291849|FG002|Overall Study|No prior immunization records|6|||
17147325|NCT03180138|38291847|FG000|Overall Study|Found to be >24 mon after randomization|3|||
17065443|NCT00432237|38208091|FG001|Overall Study|Withdrawal by Subject|6|||
17065444|NCT00432237|38208092|FG002|Overall Study|Withdrawal by Subject|9|||
17065445|NCT00432237|38208093|FG003|Overall Study|Withdrawal by Subject|11|||
17065446|NCT00432237|38208090|FG000|Overall Study|Lack of Qualifying Event|38|||
17065447|NCT00432237|38208091|FG001|Overall Study|Lack of Qualifying Event|71|||
17065448|NCT00432237|38208092|FG002|Overall Study|Lack of Qualifying Event|69|||
17065449|NCT00432237|38208093|FG003|Overall Study|Lack of Qualifying Event|84|||
17065450|NCT00531284|38208120|FG000|Overall Study|Progressive Disease|1|||
17065451|NCT00531284|38208121|FG001|Overall Study|Progressive Disease|3|||
17065452|NCT00531284|38208122|FG002|Overall Study|Progressive Disease|5|||
17065453|NCT00531284|38208123|FG003|Overall Study|Progressive Disease|42|||
17065454|NCT00531284|38208124|FG004|Overall Study|Progressive Disease|4|||
17065455|NCT00531284|38208125|FG005|Overall Study|Progressive Disease|4|||
17065456|NCT00531284|38208126|FG006|Overall Study|Progressive Disease|3|||
17065457|NCT00531284|38208127|FG007|Overall Study|Progressive Disease|8|||
17065458|NCT00531284|38208128|FG008|Overall Study|Progressive Disease|6|||
17065459|NCT00531284|38208129|FG009|Overall Study|Progressive Disease|3|||
17065460|NCT00531284|38208130|FG010|Overall Study|Progressive Disease|3|||
17065461|NCT00531284|38208131|FG011|Overall Study|Progressive Disease|14|||
17065462|NCT00531284|38208132|FG012|Overall Study|Progressive Disease|2|||
17065463|NCT00531284|38208133|FG013|Overall Study|Progressive Disease|1|||
17065464|NCT00531284|38208134|FG014|Overall Study|Progressive Disease|2|||
17065465|NCT00531284|38208135|FG015|Overall Study|Progressive Disease|11|||
17065466|NCT00531284|38208136|FG016|Overall Study|Progressive Disease|5|||
17065467|NCT00531284|38208120|FG000|Overall Study|Adverse Event|0|||
17065468|NCT00531284|38208121|FG001|Overall Study|Adverse Event|1|||
17065469|NCT00531284|38208122|FG002|Overall Study|Adverse Event|1|||
17065470|NCT00531284|38208123|FG003|Overall Study|Adverse Event|7|||
17065471|NCT00531284|38208124|FG004|Overall Study|Adverse Event|0|||
17065472|NCT00531284|38208125|FG005|Overall Study|Adverse Event|2|||
17147326|NCT03180138|38291848|FG001|Overall Study|Found to be >24 mon after randomization|0|||
17147327|NCT03180138|38291849|FG002|Overall Study|Found to be >24 mon after randomization|3|||
17147328|NCT03597139|38291859|FG000|Overall Study|Adverse Event|3|||
17147329|NCT03597139|38291860|FG001|Overall Study|Adverse Event|0|||
17147330|NCT03597139|38291859|FG000|Overall Study|Protocol Non-compliance|1|||
17147331|NCT03597139|38291860|FG001|Overall Study|Protocol Non-compliance|0|||
17147332|NCT03179202|38291866|FG000|Overall Study|Screen Failure|67|||
17147333|NCT03179202|38291866|FG000|Overall Study|Subject Lost to Follow Up|12|||
17147334|NCT03179202|38291866|FG000|Overall Study|Withdrawal by Subject|7|||
16993977|NCT01072175|38137825|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
16993978|NCT01072175|38137826|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993979|NCT01072175|38137827|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993980|NCT01072175|38137828|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993981|NCT01072175|38137829|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16993982|NCT01072175|38137817|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993983|NCT01072175|38137818|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993984|NCT01072175|38137819|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993985|NCT01072175|38137820|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
17065473|NCT00531284|38208126|FG006|Overall Study|Adverse Event|3|||
17065474|NCT00531284|38208127|FG007|Overall Study|Adverse Event|2|||
17065475|NCT00531284|38208128|FG008|Overall Study|Adverse Event|3|||
17147335|NCT03179202|38291866|FG000|Overall Study|Adverse Event|3|||
17147336|NCT03179202|38291866|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
17147337|NCT03179202|38291866|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
17147338|NCT03597061|38291874|FG000|Overall Study|Lost to Follow-up|1|||
17147339|NCT03597061|38291875|FG001|Overall Study|Lost to Follow-up|0|||
17147340|NCT03597061|38291874|FG000|Overall Study|Protocol Violation|0|||
17147341|NCT03597061|38291875|FG001|Overall Study|Protocol Violation|1|||
17147342|NCT00708214|38291884|FG000|Overall Study|Other Adverse Event|3|||
17147343|NCT00708214|38291885|FG001|Overall Study|Other Adverse Event|6|||
17147344|NCT00708214|38291886|FG002|Overall Study|Other Adverse Event|2|||
17147345|NCT00708214|38291884|FG000|Overall Study|Other|0|||
17147346|NCT00708214|38291885|FG001|Overall Study|Other|1|||
17147347|NCT00708214|38291886|FG002|Overall Study|Other|1|||
17147348|NCT00708214|38291884|FG000|Overall Study|Progressive Disease|4|||
17147349|NCT00708214|38291885|FG001|Overall Study|Progressive Disease|6|||
17065476|NCT00531284|38208129|FG009|Overall Study|Adverse Event|0|||
17065477|NCT00531284|38208130|FG010|Overall Study|Adverse Event|0|||
17065478|NCT00531284|38208131|FG011|Overall Study|Adverse Event|5|||
17065479|NCT00531284|38208132|FG012|Overall Study|Adverse Event|0|||
17065480|NCT00531284|38208133|FG013|Overall Study|Adverse Event|1|||
17065481|NCT00531284|38208134|FG014|Overall Study|Adverse Event|1|||
17065482|NCT00531284|38208135|FG015|Overall Study|Adverse Event|0|||
17065483|NCT00531284|38208136|FG016|Overall Study|Adverse Event|2|||
17065484|NCT00531284|38208120|FG000|Overall Study|Withdrawal by Subject|1|||
17065485|NCT00531284|38208121|FG001|Overall Study|Withdrawal by Subject|0|||
17065486|NCT00531284|38208122|FG002|Overall Study|Withdrawal by Subject|0|||
17065487|NCT00531284|38208123|FG003|Overall Study|Withdrawal by Subject|4|||
17065488|NCT00531284|38208124|FG004|Overall Study|Withdrawal by Subject|0|||
17065489|NCT00531284|38208125|FG005|Overall Study|Withdrawal by Subject|0|||
17065490|NCT00531284|38208126|FG006|Overall Study|Withdrawal by Subject|0|||
17065491|NCT00531284|38208127|FG007|Overall Study|Withdrawal by Subject|0|||
17065492|NCT00531284|38208128|FG008|Overall Study|Withdrawal by Subject|0|||
17065493|NCT00531284|38208129|FG009|Overall Study|Withdrawal by Subject|0|||
17065494|NCT00531284|38208130|FG010|Overall Study|Withdrawal by Subject|0|||
17065495|NCT00531284|38208131|FG011|Overall Study|Withdrawal by Subject|3|||
17065496|NCT00531284|38208132|FG012|Overall Study|Withdrawal by Subject|0|||
17065497|NCT00531284|38208133|FG013|Overall Study|Withdrawal by Subject|1|||
17065498|NCT00531284|38208134|FG014|Overall Study|Withdrawal by Subject|0|||
17065499|NCT00531284|38208135|FG015|Overall Study|Withdrawal by Subject|1|||
17065500|NCT00531284|38208136|FG016|Overall Study|Withdrawal by Subject|1|||
17065501|NCT00531284|38208120|FG000|Overall Study|Other|1|||
17065502|NCT00531284|38208121|FG001|Overall Study|Other|0|||
17065503|NCT00531284|38208122|FG002|Overall Study|Other|0|||
17065504|NCT00531284|38208123|FG003|Overall Study|Other|10|||
17065505|NCT00531284|38208124|FG004|Overall Study|Other|2|||
17065506|NCT00531284|38208125|FG005|Overall Study|Other|1|||
17065507|NCT00531284|38208126|FG006|Overall Study|Other|0|||
17065508|NCT00531284|38208127|FG007|Overall Study|Other|0|||
17065509|NCT00531284|38208128|FG008|Overall Study|Other|2|||
17065510|NCT00531284|38208129|FG009|Overall Study|Other|1|||
17065511|NCT00531284|38208130|FG010|Overall Study|Other|0|||
17065512|NCT00531284|38208131|FG011|Overall Study|Other|2|||
17065513|NCT00531284|38208132|FG012|Overall Study|Other|0|||
17065514|NCT00531284|38208133|FG013|Overall Study|Other|0|||
17065515|NCT00531284|38208134|FG014|Overall Study|Other|1|||
17065516|NCT00531284|38208135|FG015|Overall Study|Other|0|||
17065517|NCT00531284|38208136|FG016|Overall Study|Other|0|||
17065518|NCT00531206|38208192|FG000|Overall Study|Adverse Event related|5|||
17065519|NCT00531206|38208192|FG000|Overall Study|Lack of Efficacy|2|||
17065520|NCT00531206|38208192|FG000|Overall Study|Lost to Follow-up|5|||
17065521|NCT00531206|38208192|FG000|Overall Study|including non-related adverse events|8|||
17065522|NCT00530816|38208199|FG000|Overall Study|Progressive Disease|16|||
17065523|NCT00530816|38208200|FG001|Overall Study|Progressive Disease|24|||
17065524|NCT00530816|38208201|FG002|Overall Study|Progressive Disease|24|||
17065525|NCT00530816|38208199|FG000|Overall Study|Adverse Event|6|||
17065526|NCT00530816|38208200|FG001|Overall Study|Adverse Event|13|||
17065527|NCT00530816|38208201|FG002|Overall Study|Adverse Event|7|||
17065528|NCT00530816|38208199|FG000|Overall Study|Other|3|||
17065529|NCT00530816|38208200|FG001|Overall Study|Other|3|||
17065530|NCT00530816|38208201|FG002|Overall Study|Other|4|||
17065531|NCT00530816|38208199|FG000|Overall Study|Withdrawal by Subject|1|||
17065532|NCT00530816|38208200|FG001|Overall Study|Withdrawal by Subject|2|||
17065533|NCT00530816|38208201|FG002|Overall Study|Withdrawal by Subject|6|||
17065534|NCT00615017|38208215|FG000|Overall Study|Adverse Event|0|||
17065535|NCT00615017|38208216|FG001|Overall Study|Adverse Event|1|||
17147350|NCT00708214|38291886|FG002|Overall Study|Progressive Disease|5|||
17147351|NCT03570697|38291901|FG000|Overall Study|Lost to Follow-up|0|||
17065536|NCT00615017|38208217|FG002|Overall Study|Adverse Event|2|||
17065537|NCT00615017|38208218|FG003|Overall Study|Adverse Event|0|||
17065538|NCT00615017|38208219|FG004|Overall Study|Adverse Event|0|||
17147352|NCT03570697|38291902|FG001|Overall Study|Lost to Follow-up|1|||
17065539|NCT00615017|38208220|FG005|Overall Study|Adverse Event|1|||
17065540|NCT00615017|38208215|FG000|Overall Study|Death|0|||
17065541|NCT00615017|38208216|FG001|Overall Study|Death|0|||
17065542|NCT00615017|38208217|FG002|Overall Study|Death|2|||
17065543|NCT00615017|38208218|FG003|Overall Study|Death|0|||
17065544|NCT00615017|38208219|FG004|Overall Study|Death|1|||
17065545|NCT00615017|38208220|FG005|Overall Study|Death|1|||
17147353|NCT03570697|38291901|FG000|Overall Study|Death|2|||
17147354|NCT03570697|38291902|FG001|Overall Study|Death|0|||
17147355|NCT03570697|38291901|FG000|Overall Study|Withdrawal by Subject|4|||
17147356|NCT03570697|38291902|FG001|Overall Study|Withdrawal by Subject|2|||
17065546|NCT00615017|38208215|FG000|Overall Study|Sepsis resolved|0|||
17065547|NCT00615017|38208216|FG001|Overall Study|Sepsis resolved|0|||
17065548|NCT00615017|38208217|FG002|Overall Study|Sepsis resolved|1|||
17065549|NCT00615017|38208218|FG003|Overall Study|Sepsis resolved|0|||
17065550|NCT00615017|38208219|FG004|Overall Study|Sepsis resolved|0|||
17065551|NCT00615017|38208220|FG005|Overall Study|Sepsis resolved|0|||
17065552|NCT00615017|38208215|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
17065553|NCT00615017|38208216|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
17065554|NCT00615017|38208217|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
17065555|NCT00615017|38208218|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
17065556|NCT00615017|38208219|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
17065557|NCT00615017|38208220|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
17065558|NCT00615017|38208215|FG000|Overall Study|Physician discontinued drug|0|||
17065559|NCT00615017|38208216|FG001|Overall Study|Physician discontinued drug|0|||
17065560|NCT00615017|38208217|FG002|Overall Study|Physician discontinued drug|0|||
17065561|NCT00615017|38208218|FG003|Overall Study|Physician discontinued drug|0|||
17065562|NCT00615017|38208219|FG004|Overall Study|Physician discontinued drug|0|||
17065563|NCT00615017|38208220|FG005|Overall Study|Physician discontinued drug|1|||
17065564|NCT00614939|38208236|FG000|Overall Study|Withdrawal by Subject|10|||
17065565|NCT00614939|38208237|FG001|Overall Study|Withdrawal by Subject|17|||
17065566|NCT00614939|38208236|FG000|Overall Study|Study specific discontinuation criteris|13|||
17065567|NCT00614939|38208237|FG001|Overall Study|Study specific discontinuation criteris|16|||
17065568|NCT00614939|38208236|FG000|Overall Study|Adverse Event|2|||
17065569|NCT00614939|38208237|FG001|Overall Study|Adverse Event|5|||
17065570|NCT00614939|38208236|FG000|Overall Study|Incorrect enrollment|1|||
17065571|NCT00614939|38208237|FG001|Overall Study|Incorrect enrollment|2|||
17065572|NCT00614939|38208236|FG000|Overall Study|Death|4|||
17065573|NCT00614939|38208237|FG001|Overall Study|Death|3|||
17065574|NCT00614939|38208236|FG000|Overall Study|Poor/non-compliance|4|||
17065575|NCT00614939|38208237|FG001|Overall Study|Poor/non-compliance|0|||
17065576|NCT00614939|38208236|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
17065577|NCT00614939|38208237|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
17065578|NCT00530504|38208243|FG000|Overall Study|Death|54|||
17065579|NCT00530504|38208243|FG000|Overall Study|Lost to Follow-up|26|||
17065580|NCT00530504|38208243|FG000|Overall Study|Withdrawal by Subject|39|||
17065581|NCT00530504|38208243|FG000|Overall Study|Exited study due to other reasons|33|||
17065582|NCT00531050|38208253|FG000|Part 1: Period 1|Adverse Event|0|||
17065583|NCT00531050|38208254|FG001|Part 1: Period 1|Adverse Event|1|||
17065584|NCT00531050|38208255|FG002|Part 1: Period 1|Adverse Event|0|||
17065585|NCT00531050|38208256|FG003|Part 1: Period 1|Adverse Event|0|||
17065586|NCT00531050|38208257|FG004|Part 1: Period 1|Adverse Event|0|||
17065587|NCT00531050|38208258|FG005|Part 1: Period 1|Adverse Event|0|||
17065588|NCT00531050|38208253|FG000|Part 1: Period 1|Protocol Deviation|0|||
17065589|NCT00531050|38208254|FG001|Part 1: Period 1|Protocol Deviation|0|||
17147357|NCT03569371|38291919|FG000|Overall Study|Lack of Efficacy|1|||
17147358|NCT03569371|38291919|FG000|Overall Study|Lost to Follow-up|1|||
17147359|NCT03569371|38291919|FG000|Overall Study|Adverse Event|1|||
17147360|NCT01318070|38291926|FG000|Overall Study|Adverse Event|1|||
17147361|NCT01318070|38291927|FG001|Overall Study|Adverse Event|1|||
17147362|NCT01318070|38291928|FG002|Overall Study|Adverse Event|5|||
17065590|NCT00531050|38208255|FG002|Part 1: Period 1|Protocol Deviation|0|||
17065591|NCT00531050|38208256|FG003|Part 1: Period 1|Protocol Deviation|1|||
17065592|NCT00531050|38208257|FG004|Part 1: Period 1|Protocol Deviation|0|||
17065593|NCT00531050|38208258|FG005|Part 1: Period 1|Protocol Deviation|0|||
17065594|NCT00531050|38208253|FG000|Part 1: Period 3|Adverse Event|1|||
17065595|NCT00531050|38208254|FG001|Part 1: Period 3|Adverse Event|0|||
17065596|NCT00531050|38208255|FG002|Part 1: Period 3|Adverse Event|0|||
17065597|NCT00531050|38208256|FG003|Part 1: Period 3|Adverse Event|0|||
17065598|NCT00531050|38208257|FG004|Part 1: Period 3|Adverse Event|0|||
17065599|NCT00531050|38208258|FG005|Part 1: Period 3|Adverse Event|0|||
17065600|NCT00531050|38208253|FG000|Part 2: Period 1|Adverse Event|0|||
17065601|NCT00531050|38208254|FG001|Part 2: Period 1|Adverse Event|0|||
17065602|NCT00531050|38208255|FG002|Part 2: Period 1|Adverse Event|0|||
17065603|NCT00531050|38208256|FG003|Part 2: Period 1|Adverse Event|0|||
17065604|NCT00531050|38208257|FG004|Part 2: Period 1|Adverse Event|0|||
17147363|NCT01318070|38291926|FG000|Overall Study|Withdrawal by Subject|0|||
17147364|NCT01318070|38291927|FG001|Overall Study|Withdrawal by Subject|1|||
17147365|NCT01318070|38291928|FG002|Overall Study|Withdrawal by Subject|1|||
17147366|NCT01318070|38291926|FG000|Overall Study|Lack of Efficacy|0|||
17065605|NCT00531050|38208258|FG005|Part 2: Period 1|Adverse Event|1|||
17065606|NCT00531050|38208253|FG000|Part 2: Period 3|Abnormal test procedure|1|||
17065607|NCT00531050|38208254|FG001|Part 2: Period 3|Abnormal test procedure|0|||
17065608|NCT00531050|38208255|FG002|Part 2: Period 3|Abnormal test procedure|0|||
17065609|NCT00531050|38208256|FG003|Part 2: Period 3|Abnormal test procedure|0|||
17065610|NCT00531050|38208257|FG004|Part 2: Period 3|Abnormal test procedure|0|||
17065611|NCT00531050|38208258|FG005|Part 2: Period 3|Abnormal test procedure|1|||
17065612|NCT00530348|38208277|FG000|Overall Study|Adverse Event|5|||
17065613|NCT00530348|38208278|FG001|Overall Study|Adverse Event|1|||
17065614|NCT00530348|38208277|FG000|Overall Study|Death|0|||
17065615|NCT00530348|38208278|FG001|Overall Study|Death|1|||
17065616|NCT00530348|38208277|FG000|Overall Study|Lack of Efficacy|2|||
17065617|NCT00530348|38208278|FG001|Overall Study|Lack of Efficacy|0|||
17065618|NCT00530348|38208277|FG000|Overall Study|Lost to Follow-up|0|||
17065619|NCT00530348|38208278|FG001|Overall Study|Lost to Follow-up|2|||
17065620|NCT00530348|38208277|FG000|Overall Study|Physician Decision|1|||
17065621|NCT00530348|38208278|FG001|Overall Study|Physician Decision|2|||
17147367|NCT01318070|38291927|FG001|Overall Study|Lack of Efficacy|0|||
17147368|NCT01318070|38291928|FG002|Overall Study|Lack of Efficacy|1|||
17147369|NCT01318070|38291926|FG000|Overall Study|Principal Investigator Discretion|1|||
17147370|NCT01318070|38291927|FG001|Overall Study|Principal Investigator Discretion|0|||
17147371|NCT01318070|38291928|FG002|Overall Study|Principal Investigator Discretion|0|||
17147372|NCT02895295|38291939|FG000|Overall Study|Survey Non-response|71|||
17147373|NCT02895295|38291940|FG001|Overall Study|Survey Non-response|94|||
17147374|NCT02895295|38291941|FG002|Overall Study|Survey Non-response|92|||
17065622|NCT00530348|38208277|FG000|Overall Study|Pregnancy|1|||
17065623|NCT00530348|38208278|FG001|Overall Study|Pregnancy|0|||
17065624|NCT00530348|38208277|FG000|Overall Study|Withdrawal by Subject|12|||
17065625|NCT00530348|38208278|FG001|Overall Study|Withdrawal by Subject|12|||
17065626|NCT00530348|38208277|FG000|Overall Study|Randomised in error|1|||
17065627|NCT00530348|38208278|FG001|Overall Study|Randomised in error|0|||
17065628|NCT00530348|38208277|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
17065629|NCT00530348|38208278|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
17065630|NCT03886220|38208286|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
17065631|NCT03886220|38208287|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
17065632|NCT03886220|38208286|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
17065633|NCT03886220|38208287|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17065634|NCT03886220|38208286|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
17065635|NCT03886220|38208287|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
17065636|NCT00530270|38208295|FG000|Overall Study|Protocol Violation|1|||
17065637|NCT00530270|38208296|FG001|Overall Study|Protocol Violation|0|||
17147375|NCT00245960|38291951|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
17147376|NCT00245960|38291952|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
17147377|NCT00245960|38291951|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
17147378|NCT00245960|38291952|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
17147379|NCT00245960|38291951|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
17147380|NCT00245960|38291952|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
17147381|NCT00245960|38291951|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
17147382|NCT00245960|38291952|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
17065638|NCT03885596|38208306|FG000|Overall Study|Withdrawal by Subject|2|||
17065639|NCT03885596|38208307|FG001|Overall Study|Withdrawal by Subject|1|||
17065640|NCT03885596|38208308|FG002|Overall Study|Withdrawal by Subject|0|||
17065641|NCT03885596|38208309|FG003|Overall Study|Withdrawal by Subject|0|||
17065642|NCT00529100|38208325|FG000|Overall Study|Adverse Event|0|||
17065643|NCT00529100|38208326|FG001|Overall Study|Adverse Event|5|||
17065644|NCT00529100|38208325|FG000|Overall Study|Protocol Violation|0|||
17065645|NCT00529100|38208326|FG001|Overall Study|Protocol Violation|1|||
17065646|NCT00529100|38208325|FG000|Overall Study|Progressive Disease|0|||
17065647|NCT00529100|38208326|FG001|Overall Study|Progressive Disease|1|||
17065648|NCT00529100|38208325|FG000|Overall Study|Withdrawal by Subject|0|||
17065649|NCT00529100|38208326|FG001|Overall Study|Withdrawal by Subject|1|||
17065650|NCT00529100|38208325|FG000|Overall Study|Participant Ineligibility|0|||
17065651|NCT00529100|38208326|FG001|Overall Study|Participant Ineligibility|1|||
17065652|NCT03878108|38208338|FG000|Overall Study|Adverse Event|1|||
17065653|NCT03878108|38208339|FG001|Overall Study|Adverse Event|0|||
17065654|NCT00529958|38208348|FG000|2-Year Follow-up|Lost to Follow-up|1|||
17065655|NCT00529958|38208349|FG001|2-Year Follow-up|Lost to Follow-up|2|||
17065656|NCT00529958|38208350|FG002|2-Year Follow-up|Lost to Follow-up|2|||
17065657|NCT00529958|38208348|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
17065658|NCT00529958|38208349|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
17065659|NCT00529958|38208350|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
17147383|NCT00245960|38291951|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
17147384|NCT00245960|38291952|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
17147385|NCT00245960|38291951|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
17065660|NCT00529958|38208348|FG000|5-Year Follow-up|Lost to Follow-up|2|||
17065661|NCT00529958|38208349|FG001|5-Year Follow-up|Lost to Follow-up|3|||
17065662|NCT00529958|38208350|FG002|5-Year Follow-up|Lost to Follow-up|1|||
17065663|NCT00529958|38208348|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
17065664|NCT00529958|38208349|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
17065665|NCT00529958|38208350|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
17065666|NCT00529802|38208358|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
17065667|NCT00529802|38208358|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
17065668|NCT00529802|38208358|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
17065669|NCT00529802|38208358|FG000|Evaluable for Primary Endpoint|Death|1|||
17065670|NCT00529802|38208358|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
17065671|NCT00529802|38208358|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
17065672|NCT00529802|38208358|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
17065673|NCT00528866|38208364|FG000|Overall Study|Protocol Violation|6|||
17065674|NCT00614393|38208374|FG000|Overall Study|Adverse Event|20|||
17065675|NCT00614393|38208375|FG001|Overall Study|Adverse Event|2|||
17065676|NCT00614393|38208376|FG002|Overall Study|Adverse Event|3|||
17065677|NCT00614393|38208377|FG003|Overall Study|Adverse Event|13|||
17065678|NCT00614393|38208378|FG004|Overall Study|Adverse Event|21|||
17065679|NCT00614393|38208374|FG000|Overall Study|Lost to Follow-up|0|||
17065680|NCT00614393|38208375|FG001|Overall Study|Lost to Follow-up|0|||
17065681|NCT00614393|38208376|FG002|Overall Study|Lost to Follow-up|0|||
17065682|NCT00614393|38208377|FG003|Overall Study|Lost to Follow-up|1|||
17065683|NCT00614393|38208378|FG004|Overall Study|Lost to Follow-up|2|||
17065684|NCT00614393|38208374|FG000|Overall Study|Physician Decision|17|||
17065685|NCT00614393|38208375|FG001|Overall Study|Physician Decision|0|||
17065686|NCT00614393|38208376|FG002|Overall Study|Physician Decision|1|||
17065687|NCT00614393|38208377|FG003|Overall Study|Physician Decision|8|||
17065688|NCT00614393|38208378|FG004|Overall Study|Physician Decision|9|||
17065689|NCT00614393|38208374|FG000|Overall Study|Progressive Disease|118|||
17065690|NCT00614393|38208375|FG001|Overall Study|Progressive Disease|5|||
17065691|NCT00614393|38208376|FG002|Overall Study|Progressive Disease|5|||
17065692|NCT00614393|38208377|FG003|Overall Study|Progressive Disease|138|||
17147386|NCT00245960|38291952|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
17147387|NCT00245960|38291951|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
17147388|NCT00245960|38291952|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
17147389|NCT00245960|38291951|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
17065693|NCT00614393|38208378|FG004|Overall Study|Progressive Disease|130|||
17065694|NCT00614393|38208374|FG000|Overall Study|Protocol Violation|1|||
17065695|NCT00614393|38208375|FG001|Overall Study|Protocol Violation|0|||
17065696|NCT00614393|38208376|FG002|Overall Study|Protocol Violation|0|||
17065697|NCT00614393|38208377|FG003|Overall Study|Protocol Violation|0|||
17065698|NCT00614393|38208378|FG004|Overall Study|Protocol Violation|0|||
17065699|NCT00614393|38208374|FG000|Overall Study|Terminated by Sponsor|0|||
17065700|NCT00614393|38208375|FG001|Overall Study|Terminated by Sponsor|0|||
17065701|NCT00614393|38208376|FG002|Overall Study|Terminated by Sponsor|0|||
17065702|NCT00614393|38208377|FG003|Overall Study|Terminated by Sponsor|0|||
17065703|NCT00614393|38208378|FG004|Overall Study|Terminated by Sponsor|1|||
17065704|NCT00614393|38208374|FG000|Overall Study|Withdrawal by Subject|20|||
17065705|NCT00614393|38208375|FG001|Overall Study|Withdrawal by Subject|1|||
17065706|NCT00614393|38208376|FG002|Overall Study|Withdrawal by Subject|1|||
17065707|NCT00614393|38208377|FG003|Overall Study|Withdrawal by Subject|16|||
17065708|NCT00614393|38208378|FG004|Overall Study|Withdrawal by Subject|13|||
17065709|NCT00614393|38208374|FG000|Overall Study|Other|4|||
17065710|NCT00614393|38208375|FG001|Overall Study|Other|0|||
17065711|NCT00614393|38208376|FG002|Overall Study|Other|0|||
17065712|NCT00614393|38208377|FG003|Overall Study|Other|4|||
17065713|NCT00614393|38208378|FG004|Overall Study|Other|2|||
17065714|NCT00614393|38208374|FG000|Overall Study|Not Treated|0|||
17147390|NCT00245960|38291952|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
17147391|NCT00245960|38291951|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
17147392|NCT00245960|38291952|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
17147393|NCT00245960|38291951|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
17065715|NCT00614393|38208375|FG001|Overall Study|Not Treated|0|||
17065716|NCT00614393|38208376|FG002|Overall Study|Not Treated|0|||
17065717|NCT00614393|38208377|FG003|Overall Study|Not Treated|0|||
17065718|NCT00614393|38208378|FG004|Overall Study|Not Treated|2|||
17065719|NCT00612677|38208390|FG000|Overall Study|study closed before treatment started|1|||
17065720|NCT00613925|38208396|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
17065721|NCT00613925|38208397|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
17065722|NCT00613301|38208403|FG000|Overall Study|Adverse Event|49|||
17065723|NCT00613301|38208403|FG000|Overall Study|Lost to Follow-up|88|||
17065724|NCT00613301|38208403|FG000|Overall Study|Withdrawal by Subject|5|||
17065725|NCT00613301|38208403|FG000|Overall Study|Death|6|||
17065726|NCT00613301|38208403|FG000|Overall Study|Lack of Efficacy|13|||
17065727|NCT00613301|38208403|FG000|Overall Study|Physician Decision|2|||
17065728|NCT00613301|38208403|FG000|Overall Study|No data was collected|53|||
17065729|NCT00613301|38208403|FG000|Overall Study|Irregularly enrolled patients|12|||
17065730|NCT00609947|38208408|FG000|Overall Study|Death|1|||
17065731|NCT00609869|38208413|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
17065732|NCT00609869|38208413|FG000|Overall Study|Severe hematologic toxicity|1|||
17065733|NCT00609869|38208413|FG000|Overall Study|Withdrawal by Subject|1|||
17065734|NCT00609869|38208413|FG000|Overall Study|Seizures|1|||
17065735|NCT00609869|38208413|FG000|Overall Study|Severe tumor flare reaction|1|||
17065736|NCT00609869|38208413|FG000|Overall Study|Hepatitis B infection|1|||
17065737|NCT00609869|38208413|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
17065738|NCT00609869|38208413|FG000|Overall Study|Mantle cell: not evaluable|4|||
17065739|NCT00529568|38208419|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
17065740|NCT00529568|38208420|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
17065741|NCT00529568|38208421|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
17065742|NCT00529568|38208419|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
17065743|NCT00529568|38208420|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
17065744|NCT00529568|38208421|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
17065745|NCT00529568|38208419|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
17065746|NCT00529568|38208420|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
17065747|NCT00529568|38208421|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
17065748|NCT00529568|38208419|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
17065749|NCT00529568|38208420|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
17065750|NCT00529568|38208421|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
17065751|NCT00529568|38208419|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
17065752|NCT00529568|38208420|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
17065753|NCT00529568|38208421|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
17065754|NCT00529568|38208419|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
17065755|NCT00529568|38208420|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
17065756|NCT00529568|38208421|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
17065757|NCT00529568|38208419|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
17065758|NCT00529568|38208420|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
17065759|NCT00529568|38208421|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
17065760|NCT00529568|38208419|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
17065761|NCT00529568|38208420|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
17065762|NCT00529568|38208421|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
17065763|NCT00529568|38208419|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
17065764|NCT00529568|38208420|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
17065765|NCT00529568|38208421|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
17065766|NCT00529568|38208419|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
17065767|NCT00529568|38208420|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
17065768|NCT00529568|38208421|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
17065769|NCT00529568|38208419|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
17065770|NCT00529568|38208420|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
17065771|NCT00529568|38208421|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
17065772|NCT00611975|38208432|FG000|Overall Study|Withdrawal by Subject|3|||
17065773|NCT00611975|38208433|FG001|Overall Study|Withdrawal by Subject|7|||
17065774|NCT00611975|38208432|FG000|Overall Study|Pregnancy|2|||
17065775|NCT00611975|38208433|FG001|Overall Study|Pregnancy|1|||
17065776|NCT00573131|38208441|FG000|Overall Study|Withdrawal by Subject|10|||
17065777|NCT00573131|38208442|FG001|Overall Study|Withdrawal by Subject|8|||
17065778|NCT00521144|38208453|FG000|Overall Study|Not Treated|0|||
17065779|NCT00521144|38208454|FG001|Overall Study|Not Treated|0|||
17065780|NCT00521144|38208455|FG002|Overall Study|Not Treated|0|||
17065781|NCT00521144|38208456|FG003|Overall Study|Not Treated|1|||
17065782|NCT00521144|38208457|FG004|Overall Study|Not Treated|0|||
17065783|NCT00521144|38208453|FG000|Overall Study|Adverse Event|0|||
17065784|NCT00521144|38208454|FG001|Overall Study|Adverse Event|1|||
17065785|NCT00521144|38208455|FG002|Overall Study|Adverse Event|0|||
17065786|NCT00521144|38208456|FG003|Overall Study|Adverse Event|0|||
17065787|NCT00521144|38208457|FG004|Overall Study|Adverse Event|1|||
17065788|NCT00521144|38208453|FG000|Overall Study|Progressive Disease|4|||
17065789|NCT00521144|38208454|FG001|Overall Study|Progressive Disease|2|||
17065790|NCT00521144|38208455|FG002|Overall Study|Progressive Disease|2|||
17065791|NCT00521144|38208456|FG003|Overall Study|Progressive Disease|0|||
17065792|NCT00521144|38208457|FG004|Overall Study|Progressive Disease|6|||
17065793|NCT00520676|38208471|FG000|Overall Study|Death|84|||
17147394|NCT00245960|38291952|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
17147395|NCT00245960|38291951|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
17147396|NCT00245960|38291952|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
17147397|NCT00245960|38291951|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
17147398|NCT00245960|38291952|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
17147399|NCT02729194|38291958|FG000|Overall Study|Withdrawal by Subject|3|||
17147400|NCT03215706|38291964|FG000|Randomization|Adverse Event unrelated to study drug|1|||
17147401|NCT03215706|38291965|FG001|Randomization|Adverse Event unrelated to study drug|0|||
17065794|NCT00520676|38208472|FG001|Overall Study|Death|81|||
17065795|NCT00520676|38208471|FG000|Overall Study|Lost to Follow-up|6|||
17065796|NCT00520676|38208472|FG001|Overall Study|Lost to Follow-up|10|||
17065797|NCT00520676|38208471|FG000|Overall Study|Physician Decision|4|||
17065798|NCT00520676|38208472|FG001|Overall Study|Physician Decision|1|||
17065799|NCT00520676|38208471|FG000|Overall Study|Withdrawal by Subject|7|||
17065800|NCT00520676|38208472|FG001|Overall Study|Withdrawal by Subject|11|||
17065801|NCT00610649|38208489|FG000|Overall Study|Adverse Event|1|||
17065802|NCT00610649|38208490|FG001|Overall Study|Adverse Event|0|||
17065803|NCT00610649|38208491|FG002|Overall Study|Adverse Event|0|||
17065804|NCT00610649|38208492|FG003|Overall Study|Adverse Event|0|||
17065805|NCT00610649|38208493|FG004|Overall Study|Adverse Event|0|||
17065806|NCT00610649|38208494|FG005|Overall Study|Adverse Event|0|||
17065807|NCT00610649|38208495|FG006|Overall Study|Adverse Event|0|||
17065808|NCT00610649|38208496|FG007|Overall Study|Adverse Event|0|||
17065809|NCT00610649|38208497|FG008|Overall Study|Adverse Event|0|||
17065810|NCT00610649|38208498|FG009|Overall Study|Adverse Event|0|||
17065811|NCT00610649|38208499|FG010|Overall Study|Adverse Event|1|||
17065812|NCT00610649|38208489|FG000|Overall Study|Family Emergency|0|||
17065813|NCT00610649|38208490|FG001|Overall Study|Family Emergency|1|||
17065814|NCT00610649|38208491|FG002|Overall Study|Family Emergency|0|||
17147402|NCT03215706|38291964|FG000|Randomization|participant withdrew consent|1|||
17147403|NCT03215706|38291965|FG001|Randomization|participant withdrew consent|3|||
17065815|NCT00610649|38208492|FG003|Overall Study|Family Emergency|0|||
17065816|NCT00610649|38208493|FG004|Overall Study|Family Emergency|0|||
17065817|NCT00610649|38208494|FG005|Overall Study|Family Emergency|0|||
17065818|NCT00610649|38208495|FG006|Overall Study|Family Emergency|0|||
17065819|NCT00610649|38208496|FG007|Overall Study|Family Emergency|0|||
17147404|NCT03215706|38291964|FG000|Randomization|no longer meets study criteria|1|||
17147405|NCT03215706|38291965|FG001|Randomization|no longer meets study criteria|4|||
17147406|NCT03215706|38291964|FG000|Randomization|other reasons|0|||
17147407|NCT03215706|38291965|FG001|Randomization|other reasons|2|||
17147408|NCT03215706|38291964|FG000|Treatment Period|Disease Progression|150|||
17147409|NCT03215706|38291965|FG001|Treatment Period|Disease Progression|142|||
17147410|NCT03215706|38291964|FG000|Treatment Period|Study Drug Toxicity|53|||
17147411|NCT03215706|38291965|FG001|Treatment Period|Study Drug Toxicity|21|||
17147412|NCT03215706|38291964|FG000|Treatment Period|Death|2|||
17065820|NCT00610649|38208497|FG008|Overall Study|Family Emergency|0|||
17065821|NCT00610649|38208498|FG009|Overall Study|Family Emergency|0|||
17065822|NCT00610649|38208499|FG010|Overall Study|Family Emergency|0|||
17065823|NCT00610649|38208489|FG000|Overall Study|Withdrawal by Subject|0|||
17065824|NCT00610649|38208490|FG001|Overall Study|Withdrawal by Subject|0|||
17065825|NCT00610649|38208491|FG002|Overall Study|Withdrawal by Subject|0|||
17065826|NCT00610649|38208492|FG003|Overall Study|Withdrawal by Subject|0|||
17065827|NCT00610649|38208493|FG004|Overall Study|Withdrawal by Subject|0|||
17065828|NCT00610649|38208494|FG005|Overall Study|Withdrawal by Subject|0|||
17065829|NCT00610649|38208495|FG006|Overall Study|Withdrawal by Subject|0|||
17065830|NCT00610649|38208496|FG007|Overall Study|Withdrawal by Subject|0|||
17065831|NCT00610649|38208497|FG008|Overall Study|Withdrawal by Subject|0|||
17065832|NCT00610649|38208498|FG009|Overall Study|Withdrawal by Subject|1|||
17065833|NCT00610649|38208499|FG010|Overall Study|Withdrawal by Subject|0|||
17065834|NCT00608543|38208523|FG000|Overall Study|Adverse Event|4|||
17065835|NCT00520130|38208530|FG000|Overall Study|Disease progression on study|4|||
17065836|NCT00520130|38208531|FG001|Overall Study|Disease progression on study|0|||
16781215|NCT02109562|37720391|FG000|Overall Study|Lost to Follow-up|1|||
16781216|NCT02109562|37720392|FG001|Overall Study|Lost to Follow-up|0|||
17065837|NCT00520130|38208530|FG000|Overall Study|Physician Decision|1|||
17065838|NCT00520130|38208531|FG001|Overall Study|Physician Decision|1|||
17065839|NCT00519896|38208541|FG000|Overall Study|Protocol Violation|1|||
17065840|NCT00519896|38208541|FG000|Overall Study|Adverse Event|1|||
17065841|NCT00527618|38208554|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
17065842|NCT00527618|38208555|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
17065843|NCT00527618|38208554|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
17065844|NCT00527618|38208555|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
17065845|NCT00527618|38208554|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
17065846|NCT00527618|38208555|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
17065847|NCT00527618|38208554|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
17065848|NCT00527618|38208555|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
17065849|NCT00527618|38208554|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
17065850|NCT00527618|38208555|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
17065851|NCT00527618|38208554|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
17065852|NCT00527618|38208555|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
17065853|NCT00527072|38208562|FG000|Overall Study|Adverse Event|13|||
17065854|NCT00527072|38208562|FG000|Overall Study|Lack of Efficacy|11|||
17065855|NCT00527072|38208562|FG000|Overall Study|Lost to Follow-up|3|||
17065856|NCT00527072|38208562|FG000|Overall Study|Protocol Violation|2|||
17065857|NCT00527072|38208562|FG000|Overall Study|Withdrawal by Subject|7|||
17065858|NCT00526994|38208570|FG000|Overall Study|Lost to Follow-up|98|||
17065859|NCT00526994|38208571|FG001|Overall Study|Lost to Follow-up|108|||
17065860|NCT00526994|38208572|FG002|Overall Study|Lost to Follow-up|96|||
17065861|NCT00526994|38208570|FG000|Overall Study|Death|4|||
17065862|NCT00526994|38208571|FG001|Overall Study|Death|3|||
17065863|NCT00526994|38208572|FG002|Overall Study|Death|3|||
17065864|NCT00526994|38208570|FG000|Overall Study|Withdrawal by Subject|2|||
17065865|NCT00526994|38208571|FG001|Overall Study|Withdrawal by Subject|7|||
17065866|NCT00526994|38208572|FG002|Overall Study|Withdrawal by Subject|5|||
17065867|NCT00526994|38208570|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
17065868|NCT00526994|38208571|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
17065869|NCT00526994|38208572|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
17065870|NCT00519428|38208583|FG000|Overall Study|Adverse Event|5|||
17065871|NCT00519428|38208584|FG001|Overall Study|Adverse Event|2|||
17065872|NCT00519428|38208585|FG002|Overall Study|Adverse Event|10|||
17065873|NCT00519428|38208583|FG000|Overall Study|Lost to Follow-up|7|||
17065874|NCT00519428|38208584|FG001|Overall Study|Lost to Follow-up|7|||
17065875|NCT00519428|38208585|FG002|Overall Study|Lost to Follow-up|6|||
17065876|NCT00519428|38208583|FG000|Overall Study|Withdrawal by Subject|8|||
17065877|NCT00519428|38208584|FG001|Overall Study|Withdrawal by Subject|3|||
17065878|NCT00519428|38208585|FG002|Overall Study|Withdrawal by Subject|7|||
17065879|NCT00519428|38208583|FG000|Overall Study|unstated|1|||
17065880|NCT00519428|38208584|FG001|Overall Study|unstated|3|||
17065881|NCT00519428|38208585|FG002|Overall Study|unstated|2|||
17065882|NCT00432159|38208601|FG000|Overall Study|Death|0|||
17065883|NCT00432159|38208602|FG001|Overall Study|Death|1|||
17065884|NCT00432159|38208603|FG002|Overall Study|Death|0|||
17065885|NCT00432159|38208604|FG003|Overall Study|Death|0|||
17065886|NCT00432159|38208605|FG004|Overall Study|Death|0|||
17065887|NCT00432159|38208601|FG000|Overall Study|Failure|9|||
17065888|NCT00432159|38208602|FG001|Overall Study|Failure|5|||
17065889|NCT00432159|38208603|FG002|Overall Study|Failure|3|||
17065890|NCT00432159|38208604|FG003|Overall Study|Failure|2|||
17065891|NCT00432159|38208605|FG004|Overall Study|Failure|3|||
17065892|NCT00432159|38208601|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
17065893|NCT00432159|38208602|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
17065894|NCT00432159|38208603|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
17065895|NCT00432159|38208604|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
17065896|NCT00432159|38208605|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
17065897|NCT00519194|38208617|FG000|Overall Study|Withdrawal by Subject|9|||
17065898|NCT00519194|38208617|FG000|Overall Study|Death|9|||
17065899|NCT00519194|38208617|FG000|Overall Study|Lost to Follow-up|3|||
17065900|NCT00431847|38208625|FG000|Overall Study|completion of less than two study visits|6|||
17065901|NCT00431847|38208626|FG001|Overall Study|completion of less than two study visits|3|||
17065902|NCT00431847|38208627|FG002|Overall Study|completion of less than two study visits|4|||
17065903|NCT00431847|38208628|FG003|Overall Study|completion of less than two study visits|14|||
17065904|NCT00431847|38208629|FG004|Overall Study|completion of less than two study visits|0|||
17065905|NCT00431847|38208625|FG000|Overall Study|Protocol Violation|0|||
17065906|NCT00431847|38208626|FG001|Overall Study|Protocol Violation|0|||
17065907|NCT00431847|38208627|FG002|Overall Study|Protocol Violation|0|||
17065908|NCT00431847|38208628|FG003|Overall Study|Protocol Violation|0|||
17065909|NCT00431847|38208629|FG004|Overall Study|Protocol Violation|1|||
17065910|NCT00431067|38208639|FG000|Overall Study|Other Adverse Event|9|||
17065911|NCT00431067|38208639|FG000|Overall Study|Progressive disease|30|||
17065912|NCT00431067|38208639|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
17065913|NCT00430989|38208645|FG000|Overall Study|Lost to Follow-up|2|||
17065914|NCT00430989|38208646|FG001|Overall Study|Lost to Follow-up|3|||
17065915|NCT00430989|38208645|FG000|Overall Study|Withdrawal by Subject|15|||
17065916|NCT00430989|38208646|FG001|Overall Study|Withdrawal by Subject|14|||
17065917|NCT00430989|38208645|FG000|Overall Study|Protocol Violation|30|||
17065918|NCT00430989|38208646|FG001|Overall Study|Protocol Violation|37|||
17065919|NCT00430989|38208645|FG000|Overall Study|Not eligible|13|||
17065920|NCT00430989|38208646|FG001|Overall Study|Not eligible|6|||
17065921|NCT00430755|38208654|FG000|Overall Study|Withdrawal by Subject|53|||
17065922|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
17065923|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
17065924|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
17065925|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
17065926|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
17065927|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
17065928|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
17065929|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
17065930|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
17065931|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
17065932|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Subject decision|1|||
17065933|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Subject decision|1|||
17065934|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
17065935|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
17065936|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
17065937|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
17065938|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
17065939|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
17065940|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
17065941|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
17065942|NCT00518882|38208660|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
17065943|NCT00518882|38208661|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
17065944|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
17065945|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
17065946|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
17065947|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
17065948|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
17065949|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
17065950|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
17065951|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
17065952|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
17065953|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
17065954|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
17065955|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
17065956|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
17065957|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
17065958|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
17065959|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
17065960|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
17065961|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
17065962|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
17065963|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
17065964|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
17065965|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
17065966|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
17065967|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
17065968|NCT00518882|38208660|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
17065969|NCT00518882|38208661|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
17065970|NCT00518336|38208669|FG000|Year 7|Lost to Follow-up|2|||
17065971|NCT00518336|38208670|FG001|Year 7|Lost to Follow-up|0|||
17065972|NCT00518336|38208669|FG000|Year 7|Could not attend in time|0|||
17065973|NCT00518336|38208670|FG001|Year 7|Could not attend in time|3|||
17147413|NCT03215706|38291965|FG001|Treatment Period|Death|1|||
17147414|NCT03215706|38291964|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
17147415|NCT03215706|38291965|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
17147416|NCT03215706|38291964|FG000|Treatment Period|Request to D/C treatment|1|||
17147417|NCT03215706|38291965|FG001|Treatment Period|Request to D/C treatment|6|||
17147418|NCT03215706|38291964|FG000|Treatment Period|Participant withdrew consent|3|||
17147419|NCT03215706|38291965|FG001|Treatment Period|Participant withdrew consent|4|||
17147420|NCT03215706|38291964|FG000|Treatment Period|Lost to Follow-up|0|||
17147421|NCT03215706|38291965|FG001|Treatment Period|Lost to Follow-up|1|||
17147422|NCT03215706|38291964|FG000|Treatment Period|Other Reasons|4|||
17147423|NCT03215706|38291965|FG001|Treatment Period|Other Reasons|5|||
17147424|NCT03215706|38291964|FG000|Treatment Period|Ongoing in the treatment period|105|||
17147425|NCT03215706|38291965|FG001|Treatment Period|Ongoing in the treatment period|43|||
17147426|NCT03178266|38291973|FG000|Overall Study|Death|0|||
17147427|NCT03178266|38291974|FG001|Overall Study|Death|1|||
17147428|NCT03178266|38291973|FG000|Overall Study|Disont. Early|0|||
17147429|NCT03178266|38291974|FG001|Overall Study|Disont. Early|1|||
17147430|NCT03178266|38291973|FG000|Overall Study|Withdrawal by Subject|0|||
17147431|NCT03178266|38291974|FG001|Overall Study|Withdrawal by Subject|2|||
17147432|NCT03548935|38291982|FG000|Overall Study|Withdrawal by Subject|26|||
17147433|NCT03548935|38291983|FG001|Overall Study|Withdrawal by Subject|17|||
17147434|NCT03548935|38291982|FG000|Overall Study|Lost to Follow-up|39|||
17147435|NCT03548935|38291983|FG001|Overall Study|Lost to Follow-up|28|||
17147436|NCT03548935|38291982|FG000|Overall Study|Death|1|||
17147437|NCT03548935|38291983|FG001|Overall Study|Death|1|||
17147438|NCT03547687|38291989|FG000|Overall Study|Withdrawal by Subject|1|||
17147439|NCT03547687|38291989|FG000|Overall Study|Death|1|||
17147440|NCT03547531|38291995|FG000|Overall Study|not coming in data collection : sick|2|||
17147441|NCT03547531|38291996|FG001|Overall Study|not coming in data collection : sick|2|||
17147442|NCT03547531|38291995|FG000|Overall Study|having family occasion|0|||
17147443|NCT03547531|38291996|FG001|Overall Study|having family occasion|2|||
17147444|NCT03566485|38292004|FG000|Overall Study|Disease progression|5|||
17147445|NCT03566485|38292005|FG001|Overall Study|Disease progression|4|||
17147446|NCT03566485|38292004|FG000|Overall Study|Clinical progression|0|||
17147447|NCT03566485|38292005|FG001|Overall Study|Clinical progression|1|||
17147448|NCT03566485|38292004|FG000|Overall Study|Toxicity|0|||
17147449|NCT03566485|38292005|FG001|Overall Study|Toxicity|2|||
17147450|NCT03176238|38292013|FG000|Overall Study|Unacceptable AEs|15|||
17147451|NCT03176238|38292014|FG001|Overall Study|Unacceptable AEs|8|||
17147452|NCT03176238|38292013|FG000|Overall Study|Abnormal lab value(s)|2|||
17147453|NCT03176238|38292014|FG001|Overall Study|Abnormal lab value(s)|0|||
17147454|NCT03176238|38292013|FG000|Overall Study|Inter-current illness|0|||
17147455|NCT03176238|38292014|FG001|Overall Study|Inter-current illness|1|||
17147456|NCT03176238|38292013|FG000|Overall Study|Consent withdrawal|14|||
17147457|NCT03176238|38292014|FG001|Overall Study|Consent withdrawal|2|||
17147458|NCT03176238|38292013|FG000|Overall Study|Lost to Follow-up|3|||
17147459|NCT03176238|38292014|FG001|Overall Study|Lost to Follow-up|0|||
17147460|NCT03176238|38292013|FG000|Overall Study|Administrative problems|1|||
17147461|NCT03176238|38292014|FG001|Overall Study|Administrative problems|0|||
17147462|NCT03176238|38292013|FG000|Overall Study|Death|3|||
17147463|NCT03176238|38292014|FG001|Overall Study|Death|0|||
17147464|NCT03176238|38292013|FG000|Overall Study|Disease Progression|133|||
17147465|NCT03176238|38292014|FG001|Overall Study|Disease Progression|22|||
17147466|NCT03176238|38292013|FG000|Overall Study|Tx duration completed per EAP|0|||
17147467|NCT03176238|38292014|FG001|Overall Study|Tx duration completed per EAP|1|||
17147468|NCT03176238|38292013|FG000|Overall Study|Patient is switched to commercial drug|16|||
17147469|NCT03176238|38292014|FG001|Overall Study|Patient is switched to commercial drug|1|||
17147470|NCT03176238|38292013|FG000|Overall Study|Protocol Violation|1|||
17147471|NCT03176238|38292014|FG001|Overall Study|Protocol Violation|0|||
17147472|NCT03176238|38292013|FG000|Overall Study|Changes in the patient's condition|2|||
17147473|NCT03176238|38292014|FG001|Overall Study|Changes in the patient's condition|1|||
17147474|NCT03176238|38292013|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
17147475|NCT03176238|38292014|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
17147476|NCT03565315|38292028|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
17147477|NCT03565315|38292029|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
17147478|NCT03565315|38292030|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
17147479|NCT03565315|38292031|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
17147480|NCT03565237|38292054|FG000|Overall Study|Non-compliance of Investigational Product|1|||
17147481|NCT03565237|38292054|FG000|Overall Study|Physician Decision|1|||
17147482|NCT01345682|38292060|FG000|Overall Study|Progressive disease per RECIST|226|||
17147483|NCT01345682|38292061|FG001|Overall Study|Progressive disease per RECIST|93|||
16781217|NCT02109562|37720393|FG002|Overall Study|Lost to Follow-up|1|||
17147484|NCT01345682|38292060|FG000|Overall Study|Worsening of underlying cancer disease|23|||
17147485|NCT01345682|38292061|FG001|Overall Study|Worsening of underlying cancer disease|12|||
17147486|NCT01345682|38292060|FG000|Overall Study|Adverse Event|51|||
17147487|NCT01345682|38292061|FG001|Overall Study|Adverse Event|41|||
17147488|NCT01345682|38292060|FG000|Overall Study|Non-compliance with protocol|0|||
17147489|NCT01345682|38292061|FG001|Overall Study|Non-compliance with protocol|1|||
17147490|NCT01345682|38292060|FG000|Overall Study|Lost to Follow-up|0|||
17147491|NCT01345682|38292061|FG001|Overall Study|Lost to Follow-up|1|||
17147492|NCT01345682|38292060|FG000|Overall Study|Refused to continue trial medication|16|||
17147493|NCT01345682|38292061|FG001|Overall Study|Refused to continue trial medication|9|||
17147494|NCT01345682|38292060|FG000|Overall Study|Not treated|2|||
17065974|NCT00518336|38208669|FG000|Year 8|Lost to Follow-up|1|||
17065975|NCT00518336|38208670|FG001|Year 8|Lost to Follow-up|1|||
17065976|NCT00518336|38208669|FG000|Year 8|Could not attend in time|0|||
17065977|NCT00518336|38208670|FG001|Year 8|Could not attend in time|1|||
17065978|NCT00518336|38208669|FG000|Year 9|Migrated/moved from study area|1|||
17065979|NCT00518336|38208670|FG001|Year 9|Migrated/moved from study area|1|||
17065980|NCT00518336|38208669|FG000|Year 9|Lost to Follow-up|3|||
17065981|NCT00518336|38208670|FG001|Year 9|Lost to Follow-up|0|||
17065982|NCT00518336|38208669|FG000|Year 9|Personal reasons|1|||
17065983|NCT00518336|38208670|FG001|Year 9|Personal reasons|0|||
17065984|NCT00518180|38208679|FG000|Overall Study|Withdrawal by Subject|29|||
17065985|NCT00518180|38208680|FG001|Overall Study|Withdrawal by Subject|30|||
17065986|NCT00518180|38208681|FG002|Overall Study|Withdrawal by Subject|42|||
17065987|NCT00518180|38208679|FG000|Overall Study|Lost to Follow-up|30|||
17065988|NCT00518180|38208680|FG001|Overall Study|Lost to Follow-up|28|||
17065989|NCT00518180|38208681|FG002|Overall Study|Lost to Follow-up|34|||
17065990|NCT00518180|38208679|FG000|Overall Study|Administrative reason|0|||
17065991|NCT00518180|38208680|FG001|Overall Study|Administrative reason|2|||
17065992|NCT00518180|38208681|FG002|Overall Study|Administrative reason|2|||
17065993|NCT00518180|38208679|FG000|Overall Study|Protocol Violation|5|||
17065994|NCT00518180|38208680|FG001|Overall Study|Protocol Violation|7|||
17065995|NCT00518180|38208681|FG002|Overall Study|Protocol Violation|4|||
17065996|NCT00518180|38208679|FG000|Overall Study|Unable to classify|0|||
17065997|NCT00518180|38208680|FG001|Overall Study|Unable to classify|2|||
17065998|NCT00518180|38208681|FG002|Overall Study|Unable to classify|0|||
17065999|NCT00518180|38208679|FG000|Overall Study|Adverse Event|1|||
17066000|NCT00518180|38208680|FG001|Overall Study|Adverse Event|0|||
17066001|NCT00518180|38208681|FG002|Overall Study|Adverse Event|0|||
17066002|NCT00525902|38208698|FG000|Overall Study|Lack of Efficacy|1|||
17066003|NCT00525824|38208706|FG000|Overall Study|Adverse Event|7|||
17066004|NCT00525824|38208707|FG001|Overall Study|Adverse Event|11|||
17066005|NCT00525824|38208708|FG002|Overall Study|Adverse Event|6|||
17066006|NCT00525824|38208709|FG003|Overall Study|Adverse Event|7|||
17066007|NCT00525824|38208706|FG000|Overall Study|Withdrawal by Subject|5|||
17066008|NCT00525824|38208707|FG001|Overall Study|Withdrawal by Subject|9|||
17066009|NCT00525824|38208708|FG002|Overall Study|Withdrawal by Subject|3|||
17066010|NCT00525824|38208709|FG003|Overall Study|Withdrawal by Subject|4|||
17066011|NCT00525824|38208706|FG000|Overall Study|Lost to Follow-up|4|||
17066012|NCT00525824|38208707|FG001|Overall Study|Lost to Follow-up|2|||
17066013|NCT00525824|38208708|FG002|Overall Study|Lost to Follow-up|4|||
17066014|NCT00525824|38208709|FG003|Overall Study|Lost to Follow-up|0|||
17066015|NCT00525824|38208706|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
17066016|NCT00525824|38208707|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
17066017|NCT00525824|38208708|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
17066018|NCT00525824|38208709|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
17066019|NCT00525824|38208706|FG000|Overall Study|Severe non-compliance|0|||
17066020|NCT00525824|38208707|FG001|Overall Study|Severe non-compliance|1|||
17066021|NCT00525824|38208708|FG002|Overall Study|Severe non-compliance|1|||
17066022|NCT00525824|38208709|FG003|Overall Study|Severe non-compliance|1|||
17066023|NCT00525824|38208706|FG000|Overall Study|Safety reasons|1|||
17066024|NCT00525824|38208707|FG001|Overall Study|Safety reasons|0|||
17066025|NCT00525824|38208708|FG002|Overall Study|Safety reasons|1|||
17066026|NCT00525824|38208709|FG003|Overall Study|Safety reasons|0|||
17066027|NCT00525824|38208706|FG000|Overall Study|Other|1|||
17066028|NCT00525824|38208707|FG001|Overall Study|Other|3|||
17066029|NCT00525824|38208708|FG002|Overall Study|Other|3|||
16781218|NCT02109562|37720391|FG000|Overall Study|Protocol Violation|0|||
17147495|NCT01345682|38292061|FG001|Overall Study|Not treated|1|||
17066030|NCT00525824|38208709|FG003|Overall Study|Other|1|||
17066031|NCT00525590|38208723|FG000|Overall Study|Adverse Event|3|||
17066032|NCT00525590|38208723|FG000|Overall Study|Physician Decision|3|||
17066033|NCT00525590|38208723|FG000|Overall Study|Withdrawal by Subject|16|||
17066034|NCT00525590|38208723|FG000|Overall Study|Lost to Follow-up|1|||
17066035|NCT00525590|38208723|FG000|Overall Study|Death|9|||
17066036|NCT00525590|38208723|FG000|Overall Study|Other|13|||
17066037|NCT00430677|38208730|FG000|Short-term Period|Death|1|||
17066038|NCT00430677|38208731|FG001|Short-term Period|Death|1|||
17066039|NCT00430677|38208732|FG002|Short-term Period|Death|5|||
17066040|NCT00430677|38208730|FG000|Short-term Period|Adverse Event|15|||
17066041|NCT00430677|38208731|FG001|Short-term Period|Adverse Event|13|||
17066042|NCT00430677|38208732|FG002|Short-term Period|Adverse Event|9|||
17066043|NCT00430677|38208730|FG000|Short-term Period|Lack of Efficacy|5|||
17066044|NCT00430677|38208731|FG001|Short-term Period|Lack of Efficacy|6|||
17066045|NCT00430677|38208732|FG002|Short-term Period|Lack of Efficacy|4|||
17066046|NCT00430677|38208730|FG000|Short-term Period|Withdrawal by Subject|1|||
17066047|NCT00430677|38208731|FG001|Short-term Period|Withdrawal by Subject|1|||
17066048|NCT00430677|38208732|FG002|Short-term Period|Withdrawal by Subject|2|||
17066049|NCT00430677|38208730|FG000|Short-term Period|Participant no longer met study criteria|1|||
17066050|NCT00430677|38208731|FG001|Short-term Period|Participant no longer met study criteria|1|||
17066051|NCT00430677|38208732|FG002|Short-term Period|Participant no longer met study criteria|2|||
17066052|NCT00430677|38208730|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
17066053|NCT00430677|38208731|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
17066054|NCT00430677|38208732|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
17066055|NCT00430677|38208730|FG000|Short-term Period|Pregnancy|0|||
17066056|NCT00430677|38208731|FG001|Short-term Period|Pregnancy|2|||
17066057|NCT00430677|38208732|FG002|Short-term Period|Pregnancy|0|||
17066058|NCT00430677|38208730|FG000|Long-term Extension Period|Death|1|||
17066059|NCT00430677|38208731|FG001|Long-term Extension Period|Death|0|||
17066060|NCT00430677|38208732|FG002|Long-term Extension Period|Death|0|||
17066061|NCT00430677|38208730|FG000|Long-term Extension Period|Adverse Event|3|||
17066062|NCT00430677|38208731|FG001|Long-term Extension Period|Adverse Event|2|||
17066063|NCT00430677|38208732|FG002|Long-term Extension Period|Adverse Event|5|||
17066064|NCT00430677|38208730|FG000|Long-term Extension Period|Lack of Efficacy|5|||
17066065|NCT00430677|38208731|FG001|Long-term Extension Period|Lack of Efficacy|3|||
17066066|NCT00430677|38208732|FG002|Long-term Extension Period|Lack of Efficacy|8|||
17066067|NCT00430677|38208730|FG000|Long-term Extension Period|Lost to Follow-up|1|||
17066068|NCT00430677|38208731|FG001|Long-term Extension Period|Lost to Follow-up|1|||
17066069|NCT00430677|38208732|FG002|Long-term Extension Period|Lost to Follow-up|1|||
17066070|NCT00430677|38208730|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
17066071|NCT00430677|38208731|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
17066072|NCT00430677|38208732|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
17066073|NCT00430677|38208730|FG000|Long-term Extension Period|Pregnancy|1|||
17066074|NCT00430677|38208731|FG001|Long-term Extension Period|Pregnancy|1|||
17066075|NCT00430677|38208732|FG002|Long-term Extension Period|Pregnancy|0|||
17066076|NCT00430677|38208730|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
17066077|NCT00430677|38208731|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
17066078|NCT00430677|38208732|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
17066079|NCT00430677|38208730|FG000|Long-term Extension Period|Other|2|||
17066080|NCT00430677|38208731|FG001|Long-term Extension Period|Other|1|||
17066081|NCT00430677|38208732|FG002|Long-term Extension Period|Other|1|||
17066082|NCT00430677|38208730|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
17066083|NCT00430677|38208731|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
17066084|NCT00430677|38208732|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
17066085|NCT00525512|38208760|FG000|Double-Blind Phase|Adverse Event|48|||
17066086|NCT00525512|38208761|FG001|Double-Blind Phase|Adverse Event|28|||
17066087|NCT00525512|38208762|FG002|Double-Blind Phase|Adverse Event|0|||
17066088|NCT00525512|38208763|FG003|Double-Blind Phase|Adverse Event|0|||
17066089|NCT00525512|38208760|FG000|Double-Blind Phase|Protocol Violation|3|||
17066090|NCT00525512|38208761|FG001|Double-Blind Phase|Protocol Violation|1|||
17066091|NCT00525512|38208762|FG002|Double-Blind Phase|Protocol Violation|0|||
17066092|NCT00525512|38208763|FG003|Double-Blind Phase|Protocol Violation|0|||
17066093|NCT00525512|38208760|FG000|Double-Blind Phase|Lost to Follow-up|3|||
17066094|NCT00525512|38208761|FG001|Double-Blind Phase|Lost to Follow-up|7|||
17066095|NCT00525512|38208762|FG002|Double-Blind Phase|Lost to Follow-up|0|||
17066096|NCT00525512|38208763|FG003|Double-Blind Phase|Lost to Follow-up|0|||
17066097|NCT00525512|38208760|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
17066098|NCT00525512|38208761|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
17066099|NCT00525512|38208762|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
17066100|NCT00525512|38208763|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
17066101|NCT00525512|38208760|FG000|Double-Blind Phase|Lack of Efficacy|13|||
17147496|NCT01345682|38292060|FG000|Overall Study|Reason other than those specified above|4|||
17066102|NCT00525512|38208761|FG001|Double-Blind Phase|Lack of Efficacy|5|||
17147497|NCT01345682|38292061|FG001|Overall Study|Reason other than those specified above|3|||
17147498|NCT03562117|38292070|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
17147499|NCT03562117|38292071|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
17147500|NCT03562117|38292072|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
17147501|NCT03561883|38292082|FG000|Overall Study|Adverse Event|10|||
17147502|NCT03561883|38292083|FG001|Overall Study|Adverse Event|13|||
17147503|NCT03561883|38292082|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17147504|NCT03561883|38292083|FG001|Overall Study|Non-Compliance With Study Drug|2|||
17147505|NCT03561883|38292082|FG000|Overall Study|Protocol Violation|2|||
17147506|NCT03561883|38292083|FG001|Overall Study|Protocol Violation|3|||
17147507|NCT03561883|38292082|FG000|Overall Study|Withdrawal by Subject|14|||
17147508|NCT03561883|38292083|FG001|Overall Study|Withdrawal by Subject|6|||
17147509|NCT03561883|38292082|FG000|Overall Study|Lost to Follow-up|2|||
17147510|NCT03561883|38292083|FG001|Overall Study|Lost to Follow-up|6|||
17066103|NCT00525512|38208762|FG002|Double-Blind Phase|Lack of Efficacy|0|||
17066104|NCT00525512|38208763|FG003|Double-Blind Phase|Lack of Efficacy|0|||
17066105|NCT00525512|38208760|FG000|Double-Blind Phase|Other reason (not specified)|12|||
17066106|NCT00525512|38208761|FG001|Double-Blind Phase|Other reason (not specified)|13|||
17066107|NCT00525512|38208762|FG002|Double-Blind Phase|Other reason (not specified)|0|||
17066108|NCT00525512|38208763|FG003|Double-Blind Phase|Other reason (not specified)|0|||
17066109|NCT00525512|38208760|FG000|Open-Label Phase|Adverse Event|0|||
17066110|NCT00525512|38208761|FG001|Open-Label Phase|Adverse Event|0|||
17066111|NCT00525512|38208762|FG002|Open-Label Phase|Adverse Event|1|||
17066112|NCT00525512|38208763|FG003|Open-Label Phase|Adverse Event|0|||
17066113|NCT00525512|38208760|FG000|Open-Label Phase|Lost to Follow-up|0|||
17066114|NCT00525512|38208761|FG001|Open-Label Phase|Lost to Follow-up|0|||
17066115|NCT00525512|38208762|FG002|Open-Label Phase|Lost to Follow-up|1|||
17066116|NCT00525512|38208763|FG003|Open-Label Phase|Lost to Follow-up|0|||
17066117|NCT00525512|38208760|FG000|Open-Label Phase|Other reason (not specified)|0|||
17066118|NCT00525512|38208761|FG001|Open-Label Phase|Other reason (not specified)|0|||
17066119|NCT00525512|38208762|FG002|Open-Label Phase|Other reason (not specified)|4|||
17066120|NCT00525512|38208763|FG003|Open-Label Phase|Other reason (not specified)|5|||
17066121|NCT00517634|38208775|FG000|Second Treatment Period|Withdrawal by Subject|0|||
17066122|NCT00517634|38208776|FG001|Second Treatment Period|Withdrawal by Subject|0|||
17066123|NCT00517634|38208777|FG002|Second Treatment Period|Withdrawal by Subject|0|||
17066124|NCT00517634|38208778|FG003|Second Treatment Period|Withdrawal by Subject|0|||
17066125|NCT00517634|38208779|FG004|Second Treatment Period|Withdrawal by Subject|1|||
17066126|NCT00517634|38208780|FG005|Second Treatment Period|Withdrawal by Subject|0|||
17066127|NCT03683576|38208792|FG000|Overall Study|Withdrawal by Subject|2|||
17066128|NCT03683576|38208793|FG001|Overall Study|Withdrawal by Subject|0|||
17066129|NCT03683576|38208794|FG002|Overall Study|Withdrawal by Subject|8|||
17066130|NCT03683576|38208795|FG003|Overall Study|Withdrawal by Subject|3|||
17066131|NCT03683576|38208792|FG000|Overall Study|Adverse Event|3|||
17066132|NCT03683576|38208793|FG001|Overall Study|Adverse Event|0|||
17066133|NCT03683576|38208794|FG002|Overall Study|Adverse Event|0|||
17066134|NCT03683576|38208795|FG003|Overall Study|Adverse Event|4|||
17066135|NCT03683576|38208792|FG000|Overall Study|Lack of Efficacy|1|||
17066136|NCT03683576|38208793|FG001|Overall Study|Lack of Efficacy|0|||
17066137|NCT03683576|38208794|FG002|Overall Study|Lack of Efficacy|1|||
17066138|NCT03683576|38208795|FG003|Overall Study|Lack of Efficacy|1|||
17066139|NCT03683576|38208792|FG000|Overall Study|Lost to Follow-up|0|||
17066140|NCT03683576|38208793|FG001|Overall Study|Lost to Follow-up|1|||
17066141|NCT03683576|38208794|FG002|Overall Study|Lost to Follow-up|2|||
17066142|NCT03683576|38208795|FG003|Overall Study|Lost to Follow-up|0|||
17066143|NCT03683576|38208792|FG000|Overall Study|Other, Not Specified|0|||
17066144|NCT03683576|38208793|FG001|Overall Study|Other, Not Specified|2|||
17147511|NCT03561883|38292082|FG000|Overall Study|Study Terminated by Sponsor|12|||
17147512|NCT03561883|38292083|FG001|Overall Study|Study Terminated by Sponsor|11|||
17066145|NCT03683576|38208794|FG002|Overall Study|Other, Not Specified|0|||
17066146|NCT03683576|38208795|FG003|Overall Study|Other, Not Specified|0|||
17066147|NCT03683576|38208792|FG000|Overall Study|Protocol Violation|0|||
17066148|NCT03683576|38208793|FG001|Overall Study|Protocol Violation|1|||
17066149|NCT03683576|38208794|FG002|Overall Study|Protocol Violation|1|||
17066150|NCT03683576|38208795|FG003|Overall Study|Protocol Violation|0|||
17066151|NCT03863834|38208805|FG000|Overall Study|Lost to Follow-up|3|||
17066152|NCT00430521|38208817|FG000|Overall Study|Adverse Event|0|||
17066153|NCT00430521|38208818|FG001|Overall Study|Adverse Event|0|||
17066154|NCT00430521|38208819|FG002|Overall Study|Adverse Event|0|||
17066155|NCT00430521|38208820|FG003|Overall Study|Adverse Event|0|||
17066156|NCT00430521|38208821|FG004|Overall Study|Adverse Event|0|||
17066157|NCT00430521|38208822|FG005|Overall Study|Adverse Event|2|||
17066158|NCT00430521|38208823|FG006|Overall Study|Adverse Event|1|||
17066159|NCT00430521|38208824|FG007|Overall Study|Adverse Event|0|||
17066160|NCT00430521|38208817|FG000|Overall Study|Lost to Follow-up|7|||
17066161|NCT00430521|38208818|FG001|Overall Study|Lost to Follow-up|8|||
17066162|NCT00430521|38208819|FG002|Overall Study|Lost to Follow-up|3|||
17066163|NCT00430521|38208820|FG003|Overall Study|Lost to Follow-up|5|||
17066164|NCT00430521|38208821|FG004|Overall Study|Lost to Follow-up|5|||
17066165|NCT00430521|38208822|FG005|Overall Study|Lost to Follow-up|2|||
17066166|NCT00430521|38208823|FG006|Overall Study|Lost to Follow-up|8|||
17066167|NCT00430521|38208824|FG007|Overall Study|Lost to Follow-up|10|||
17066168|NCT00430521|38208817|FG000|Overall Study|Pregnancy|0|||
17066169|NCT00430521|38208818|FG001|Overall Study|Pregnancy|0|||
17066170|NCT00430521|38208819|FG002|Overall Study|Pregnancy|0|||
17066171|NCT00430521|38208820|FG003|Overall Study|Pregnancy|0|||
17066172|NCT00430521|38208821|FG004|Overall Study|Pregnancy|0|||
17066173|NCT00430521|38208822|FG005|Overall Study|Pregnancy|0|||
17066174|NCT00430521|38208823|FG006|Overall Study|Pregnancy|1|||
17066175|NCT00430521|38208824|FG007|Overall Study|Pregnancy|0|||
17147513|NCT03561883|38292082|FG000|Overall Study|Physician Decision|1|||
17147514|NCT03561883|38292083|FG001|Overall Study|Physician Decision|0|||
17147515|NCT03561883|38292082|FG000|Overall Study|Randomized by Mistake|1|||
17147516|NCT03561883|38292083|FG001|Overall Study|Randomized by Mistake|0|||
17147517|NCT03561883|38292082|FG000|Overall Study|Other, Not Specified|3|||
17147518|NCT03561883|38292083|FG001|Overall Study|Other, Not Specified|2|||
17147519|NCT03546907|38292091|FG000|Overall Study|Lack of Efficacy|1|||
17147520|NCT03546907|38292092|FG001|Overall Study|Lack of Efficacy|1|||
17147521|NCT03546907|38292091|FG000|Overall Study|Withdrawal by Subject|8|||
17147522|NCT03546907|38292092|FG001|Overall Study|Withdrawal by Subject|9|||
17147523|NCT03546907|38292091|FG000|Overall Study|Adverse events (AEs)|7|||
17147524|NCT03546907|38292092|FG001|Overall Study|Adverse events (AEs)|10|||
17147525|NCT03546907|38292091|FG000|Overall Study|Other-unspecified|1|||
17147526|NCT03546907|38292092|FG001|Overall Study|Other-unspecified|1|||
17147527|NCT01318382|38292098|FG000|Overall Study|Physician Decision|2|||
17147528|NCT01318382|38292098|FG000|Overall Study|Device Malfunction|10|||
17066176|NCT00430521|38208817|FG000|Overall Study|Vaccine Expired|0|||
17066177|NCT00430521|38208818|FG001|Overall Study|Vaccine Expired|0|||
17147529|NCT01318382|38292098|FG000|Overall Study|Protocol Violation|1|||
17066178|NCT00430521|38208819|FG002|Overall Study|Vaccine Expired|0|||
17066179|NCT00430521|38208820|FG003|Overall Study|Vaccine Expired|0|||
17147530|NCT03053180|38292116|FG000|Overall Study|Failure to Return|1|||
17147531|NCT03560869|38292120|FG000|Overall Study|Withdrawal by Subject|3|||
17147532|NCT03560869|38292121|FG001|Overall Study|Withdrawal by Subject|4|||
17147533|NCT03560869|38292120|FG000|Overall Study|Screening failure|4|||
17147534|NCT03560869|38292121|FG001|Overall Study|Screening failure|4|||
17147535|NCT03560869|38292120|FG000|Overall Study|Withdrawal by PI|0|||
17147536|NCT03560869|38292121|FG001|Overall Study|Withdrawal by PI|1|||
17147537|NCT03590743|38292129|FG000|Overall Study|Withdrawal by Subject|0|||
17147538|NCT03590743|38292130|FG001|Overall Study|Withdrawal by Subject|1|||
17147539|NCT03053102|38292136|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
17147540|NCT03053102|38292136|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
17147541|NCT03589885|38292144|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
17147542|NCT03589885|38292145|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
17147543|NCT03589885|38292146|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
17147544|NCT03589885|38292147|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
17147545|NCT03589885|38292148|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
17147546|NCT03589885|38292144|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
17147547|NCT03589885|38292145|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
17147548|NCT03589885|38292146|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
17147549|NCT03589885|38292147|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
17147550|NCT03589885|38292148|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
17147551|NCT03589885|38292144|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
17147552|NCT03589885|38292145|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
17147553|NCT03589885|38292146|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
17147554|NCT03589885|38292147|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
17147555|NCT03589885|38292148|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
17147556|NCT03589885|38292144|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
17147557|NCT03589885|38292145|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
17147558|NCT03589885|38292146|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
17147559|NCT03589885|38292147|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
17147560|NCT03589885|38292148|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
17147561|NCT03589885|38292144|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
17147562|NCT03589885|38292145|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
17147563|NCT03589885|38292146|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
17147564|NCT03589885|38292147|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
17147565|NCT03589885|38292148|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
17066180|NCT00430521|38208821|FG004|Overall Study|Vaccine Expired|0|||
17066181|NCT00430521|38208822|FG005|Overall Study|Vaccine Expired|1|||
17066182|NCT00430521|38208823|FG006|Overall Study|Vaccine Expired|0|||
17066183|NCT00430521|38208824|FG007|Overall Study|Vaccine Expired|0|||
17066184|NCT00430521|38208817|FG000|Overall Study|Protocol Violation|1|||
17066185|NCT00430521|38208818|FG001|Overall Study|Protocol Violation|0|||
17066186|NCT00430521|38208819|FG002|Overall Study|Protocol Violation|0|||
17066187|NCT00430521|38208820|FG003|Overall Study|Protocol Violation|0|||
17066188|NCT00430521|38208821|FG004|Overall Study|Protocol Violation|0|||
17066189|NCT00430521|38208822|FG005|Overall Study|Protocol Violation|0|||
17066190|NCT00430521|38208823|FG006|Overall Study|Protocol Violation|0|||
17066191|NCT00430521|38208824|FG007|Overall Study|Protocol Violation|0|||
17066192|NCT00430521|38208817|FG000|Overall Study|Withdrawal by Subject|3|||
17066193|NCT00430521|38208818|FG001|Overall Study|Withdrawal by Subject|1|||
17066194|NCT00430521|38208819|FG002|Overall Study|Withdrawal by Subject|0|||
17066195|NCT00430521|38208820|FG003|Overall Study|Withdrawal by Subject|3|||
17066196|NCT00430521|38208821|FG004|Overall Study|Withdrawal by Subject|0|||
17066197|NCT00430521|38208822|FG005|Overall Study|Withdrawal by Subject|0|||
17066198|NCT00430521|38208823|FG006|Overall Study|Withdrawal by Subject|0|||
17066199|NCT00430521|38208824|FG007|Overall Study|Withdrawal by Subject|2|||
17066200|NCT00429663|38208857|FG000|Overall Study|Lost to Follow-up|24|||
17066201|NCT00429663|38208858|FG001|Overall Study|Lost to Follow-up|31|||
17066202|NCT00429663|38208857|FG000|Overall Study|Physician Decision|6|||
17066203|NCT00429663|38208858|FG001|Overall Study|Physician Decision|3|||
17066204|NCT00429663|38208857|FG000|Overall Study|Withdrawal by Subject|2|||
17066205|NCT00429663|38208858|FG001|Overall Study|Withdrawal by Subject|5|||
17066206|NCT00429663|38208857|FG000|Overall Study|Death|4|||
17066207|NCT00429663|38208858|FG001|Overall Study|Death|0|||
17066208|NCT00429585|38208866|FG000|Overall Study|Death|1|||
17066209|NCT00429585|38208867|FG001|Overall Study|Death|0|||
17066210|NCT00429585|38208866|FG000|Overall Study|Lost to Follow-up|27|||
17066211|NCT00429585|38208867|FG001|Overall Study|Lost to Follow-up|20|||
17066212|NCT00429585|38208866|FG000|Overall Study|Physician Decision|2|||
17066213|NCT00429585|38208867|FG001|Overall Study|Physician Decision|0|||
17066214|NCT00440271|38208875|FG000|Overall Study|Protocol Violation|1|||
17066215|NCT00440271|38208876|FG001|Overall Study|Protocol Violation|1|||
17066216|NCT00440271|38208875|FG000|Overall Study|Adverse Event|0|||
17066217|NCT00440271|38208876|FG001|Overall Study|Adverse Event|1|||
17066218|NCT00440271|38208875|FG000|Overall Study|Lost to Follow-up|1|||
17066219|NCT00440271|38208876|FG001|Overall Study|Lost to Follow-up|0|||
17066220|NCT00440271|38208875|FG000|Overall Study|Withdrawal by Subject|0|||
17066221|NCT00440271|38208876|FG001|Overall Study|Withdrawal by Subject|2|||
17066222|NCT00440271|38208875|FG000|Overall Study|Lack of Efficacy|0|||
17066223|NCT00440271|38208876|FG001|Overall Study|Lack of Efficacy|1|||
17066224|NCT00440271|38208875|FG000|Overall Study|Due to closure of trial|8|||
17066225|NCT00440271|38208876|FG001|Overall Study|Due to closure of trial|10|||
17066226|NCT00440271|38208875|FG000|Overall Study|Other|2|||
17066227|NCT00440271|38208876|FG001|Overall Study|Other|0|||
17066228|NCT00346216|38208885|FG000|Overall Study|Other|181|||
17066229|NCT00346216|38208886|FG001|Overall Study|Other|231|||
17066230|NCT00346216|38208887|FG002|Overall Study|Other|205|||
17066231|NCT00346216|38208885|FG000|Overall Study|No longer willing to participate|600|||
17066232|NCT00346216|38208886|FG001|Overall Study|No longer willing to participate|606|||
17066233|NCT00346216|38208887|FG002|Overall Study|No longer willing to participate|585|||
17066234|NCT00346216|38208885|FG000|Overall Study|Withdrawal by Subject|661|||
17066235|NCT00346216|38208886|FG001|Overall Study|Withdrawal by Subject|692|||
17066236|NCT00346216|38208887|FG002|Overall Study|Withdrawal by Subject|651|||
17066237|NCT00346216|38208885|FG000|Overall Study|Lost to Follow-up|611|||
17066238|NCT00346216|38208886|FG001|Overall Study|Lost to Follow-up|588|||
17066239|NCT00346216|38208887|FG002|Overall Study|Lost to Follow-up|542|||
17066240|NCT00346216|38208885|FG000|Overall Study|Physician Decision|80|||
17066241|NCT00346216|38208886|FG001|Overall Study|Physician Decision|76|||
17066242|NCT00346216|38208887|FG002|Overall Study|Physician Decision|59|||
17066243|NCT00346216|38208885|FG000|Overall Study|Does not meet entrance criteria|13|||
17066244|NCT00346216|38208886|FG001|Overall Study|Does not meet entrance criteria|10|||
17066245|NCT00346216|38208887|FG002|Overall Study|Does not meet entrance criteria|8|||
17066246|NCT00346216|38208885|FG000|Overall Study|Death|189|||
17147566|NCT03589885|38292144|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
17147567|NCT03589885|38292145|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
17147568|NCT03589885|38292146|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
17147569|NCT03589885|38292147|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
17147570|NCT03589885|38292148|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
17066247|NCT00346216|38208886|FG001|Overall Study|Death|192|||
17066248|NCT00346216|38208887|FG002|Overall Study|Death|228|||
17066249|NCT00346216|38208885|FG000|Overall Study|Study terminated by sponsor|11|||
17066250|NCT00346216|38208886|FG001|Overall Study|Study terminated by sponsor|4|||
17066251|NCT00346216|38208887|FG002|Overall Study|Study terminated by sponsor|8|||
17066252|NCT00346216|38208885|FG000|Overall Study|Missing Subject Summary Status|62|||
17066253|NCT00346216|38208886|FG001|Overall Study|Missing Subject Summary Status|61|||
17066254|NCT00346216|38208887|FG002|Overall Study|Missing Subject Summary Status|62|||
17066255|NCT00417963|38208895|FG000|Overall Study|Lost to Follow-up|3|||
17066256|NCT00417963|38208895|FG000|Overall Study|Withdrawal by Subject|18|||
17066257|NCT00417963|38208895|FG000|Overall Study|Death|17|||
17066258|NCT00417963|38208895|FG000|Overall Study|Study device could not be deployed|3|||
17066259|NCT00429273|38208907|FG000|Overall Study|Lost to Follow-up|1|||
17066260|NCT00429273|38208908|FG001|Overall Study|Lost to Follow-up|2|||
17066261|NCT00429273|38208909|FG002|Overall Study|Lost to Follow-up|2|||
17066262|NCT00429273|38208907|FG000|Overall Study|Physician Decision|6|||
17066263|NCT00429273|38208908|FG001|Overall Study|Physician Decision|5|||
17066264|NCT00429273|38208909|FG002|Overall Study|Physician Decision|5|||
17066265|NCT00429273|38208907|FG000|Overall Study|Adverse Event|1|||
17066266|NCT00429273|38208908|FG001|Overall Study|Adverse Event|1|||
17066267|NCT00429273|38208909|FG002|Overall Study|Adverse Event|2|||
17147571|NCT03589885|38292144|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
17147572|NCT03589885|38292145|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
17147573|NCT03589885|38292146|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
17147574|NCT03589885|38292147|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
17147575|NCT03589885|38292148|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
17147576|NCT03589885|38292144|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
17147577|NCT03589885|38292145|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
17147578|NCT03589885|38292146|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
17147579|NCT03589885|38292147|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
17147580|NCT03589885|38292148|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
17147581|NCT03545503|38292168|FG000|Overall Study|Protocol Violation|14|||
17147582|NCT03545503|38292169|FG001|Overall Study|Protocol Violation|16|||
17147583|NCT03545113|38292177|FG000|Overall Study|Surgery Cancelled|1|||
17147584|NCT03545113|38292178|FG001|Overall Study|Surgery Cancelled|0|||
17147585|NCT03545113|38292177|FG000|Overall Study|Death|1|||
17066268|NCT00359632|38208919|FG000|Overall Study|Death|2|||
17066269|NCT00359632|38208920|FG001|Overall Study|Death|0|||
17066270|NCT00359632|38208919|FG000|Overall Study|Adverse Event|1|||
17066271|NCT00359632|38208920|FG001|Overall Study|Adverse Event|0|||
17066272|NCT00359632|38208919|FG000|Overall Study|Non-compliance with visit schedule|1|||
17066273|NCT00359632|38208920|FG001|Overall Study|Non-compliance with visit schedule|0|||
17066274|NCT00417885|38208926|FG000|Overall Study|Adverse Event|1|||
17066275|NCT00417885|38208926|FG000|Overall Study|Objective Progression or Relapse|3|||
17066276|NCT00417885|38208926|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
17066277|NCT04488770|38208943|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066278|NCT04488770|38208944|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066279|NCT04488770|38208945|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066280|NCT04488770|38208946|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
17066281|NCT04488770|38208947|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066282|NCT04488770|38208948|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066283|NCT04488770|38208949|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066284|NCT04488770|38208950|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066285|NCT04488770|38208951|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066286|NCT04488770|38208952|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066287|NCT04488770|38208953|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066288|NCT04488770|38208954|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17066289|NCT04488770|38208955|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
17147586|NCT03545113|38292178|FG001|Overall Study|Death|0|||
17147587|NCT03545113|38292177|FG000|Overall Study|Adverse Event|2|||
17147588|NCT03545113|38292178|FG001|Overall Study|Adverse Event|0|||
17147589|NCT03545113|38292177|FG000|Overall Study|Received different surgery|1|||
17147590|NCT03545113|38292178|FG001|Overall Study|Received different surgery|0|||
17147591|NCT03214380|38292190|FG000|Lead-in|Adverse Event|3|||
17147592|NCT03214380|38292191|FG001|Lead-in|Adverse Event|0|||
17147593|NCT03214380|38292192|FG002|Lead-in|Adverse Event|0|||
17147594|NCT03214380|38292193|FG003|Lead-in|Adverse Event|1|||
17147595|NCT03214380|38292194|FG004|Lead-in|Adverse Event|0|||
17147596|NCT03214380|38292195|FG005|Lead-in|Adverse Event|0|||
17147597|NCT03214380|38292190|FG000|Lead-in|Lost to Follow-up|4|||
17147598|NCT03214380|38292191|FG001|Lead-in|Lost to Follow-up|0|||
17147599|NCT03214380|38292192|FG002|Lead-in|Lost to Follow-up|0|||
17147600|NCT03214380|38292193|FG003|Lead-in|Lost to Follow-up|1|||
17147601|NCT03214380|38292194|FG004|Lead-in|Lost to Follow-up|0|||
17147602|NCT03214380|38292195|FG005|Lead-in|Lost to Follow-up|0|||
17147603|NCT03214380|38292190|FG000|Lead-in|Eligibility Criteria|3|||
17147604|NCT03214380|38292191|FG001|Lead-in|Eligibility Criteria|0|||
17147605|NCT03214380|38292192|FG002|Lead-in|Eligibility Criteria|0|||
17147606|NCT03214380|38292193|FG003|Lead-in|Eligibility Criteria|0|||
17147607|NCT03214380|38292194|FG004|Lead-in|Eligibility Criteria|0|||
17147608|NCT03214380|38292195|FG005|Lead-in|Eligibility Criteria|0|||
17147609|NCT03214380|38292190|FG000|Lead-in|Physician Decision|6|||
17147610|NCT03214380|38292191|FG001|Lead-in|Physician Decision|0|||
17147611|NCT03214380|38292192|FG002|Lead-in|Physician Decision|0|||
17147612|NCT03214380|38292193|FG003|Lead-in|Physician Decision|0|||
17147613|NCT03214380|38292194|FG004|Lead-in|Physician Decision|0|||
17147614|NCT03214380|38292195|FG005|Lead-in|Physician Decision|0|||
17147615|NCT03214380|38292190|FG000|Lead-in|Protocol Deviation|7|||
17147616|NCT03214380|38292191|FG001|Lead-in|Protocol Deviation|0|||
17147617|NCT03214380|38292192|FG002|Lead-in|Protocol Deviation|0|||
17147618|NCT03214380|38292193|FG003|Lead-in|Protocol Deviation|3|||
17147619|NCT03214380|38292194|FG004|Lead-in|Protocol Deviation|0|||
17147620|NCT03214380|38292195|FG005|Lead-in|Protocol Deviation|0|||
17147621|NCT03214380|38292190|FG000|Lead-in|Withdrawal by Subject|41|||
17147622|NCT03214380|38292191|FG001|Lead-in|Withdrawal by Subject|0|||
17147623|NCT03214380|38292192|FG002|Lead-in|Withdrawal by Subject|0|||
17147624|NCT03214380|38292193|FG003|Lead-in|Withdrawal by Subject|14|||
17147625|NCT03214380|38292194|FG004|Lead-in|Withdrawal by Subject|0|||
17147626|NCT03214380|38292195|FG005|Lead-in|Withdrawal by Subject|0|||
17147627|NCT03214380|38292190|FG000|Lead-in|Family Emergency|1|||
17147628|NCT03214380|38292191|FG001|Lead-in|Family Emergency|0|||
17147629|NCT03214380|38292192|FG002|Lead-in|Family Emergency|0|||
17147630|NCT03214380|38292193|FG003|Lead-in|Family Emergency|0|||
17147631|NCT03214380|38292194|FG004|Lead-in|Family Emergency|0|||
17147632|NCT03214380|38292195|FG005|Lead-in|Family Emergency|0|||
17147633|NCT03214380|38292190|FG000|Lead-in|Natural Disaster|9|||
17147634|NCT03214380|38292191|FG001|Lead-in|Natural Disaster|0|||
17147635|NCT03214380|38292192|FG002|Lead-in|Natural Disaster|0|||
17147636|NCT03214380|38292193|FG003|Lead-in|Natural Disaster|0|||
17147637|NCT03214380|38292194|FG004|Lead-in|Natural Disaster|0|||
17147638|NCT03214380|38292195|FG005|Lead-in|Natural Disaster|0|||
17147639|NCT03214380|38292190|FG000|Lead-in|Non Compliance|1|||
17147640|NCT03214380|38292191|FG001|Lead-in|Non Compliance|0|||
17147641|NCT03214380|38292192|FG002|Lead-in|Non Compliance|0|||
17147642|NCT03214380|38292193|FG003|Lead-in|Non Compliance|0|||
17147643|NCT03214380|38292194|FG004|Lead-in|Non Compliance|0|||
17147644|NCT03214380|38292195|FG005|Lead-in|Non Compliance|0|||
17147645|NCT03214380|38292190|FG000|Lead-in|Participant Schedule|2|||
17147646|NCT03214380|38292191|FG001|Lead-in|Participant Schedule|0|||
17147647|NCT03214380|38292192|FG002|Lead-in|Participant Schedule|0|||
17147648|NCT03214380|38292193|FG003|Lead-in|Participant Schedule|0|||
17147649|NCT03214380|38292194|FG004|Lead-in|Participant Schedule|0|||
17147650|NCT03214380|38292195|FG005|Lead-in|Participant Schedule|0|||
17147651|NCT03214380|38292190|FG000|Treatment Period|Adverse Event|0|||
17147652|NCT03214380|38292191|FG001|Treatment Period|Adverse Event|1|||
17147653|NCT03214380|38292192|FG002|Treatment Period|Adverse Event|1|||
17147654|NCT03214380|38292193|FG003|Treatment Period|Adverse Event|0|||
17147655|NCT03214380|38292194|FG004|Treatment Period|Adverse Event|1|||
17147656|NCT03214380|38292195|FG005|Treatment Period|Adverse Event|0|||
17147657|NCT03214380|38292190|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
17147658|NCT03214380|38292191|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
17147659|NCT03214380|38292192|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
17147660|NCT03214380|38292193|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
17147661|NCT03214380|38292194|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
17147662|NCT03214380|38292195|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
17147663|NCT03214380|38292190|FG000|Treatment Period|Withdrawal by Subject|0|||
17147664|NCT03214380|38292191|FG001|Treatment Period|Withdrawal by Subject|10|||
17147665|NCT03214380|38292192|FG002|Treatment Period|Withdrawal by Subject|8|||
17147666|NCT03214380|38292193|FG003|Treatment Period|Withdrawal by Subject|0|||
17147667|NCT03214380|38292194|FG004|Treatment Period|Withdrawal by Subject|7|||
17147668|NCT03214380|38292195|FG005|Treatment Period|Withdrawal by Subject|11|||
17147669|NCT03214380|38292190|FG000|Treatment Period|Death|0|||
17147670|NCT03214380|38292191|FG001|Treatment Period|Death|1|||
17147671|NCT03214380|38292192|FG002|Treatment Period|Death|2|||
17147672|NCT03214380|38292193|FG003|Treatment Period|Death|0|||
17147673|NCT03214380|38292194|FG004|Treatment Period|Death|0|||
17147674|NCT03214380|38292195|FG005|Treatment Period|Death|0|||
17147675|NCT03214380|38292190|FG000|Treatment Period|Lost to Follow-up|0|||
17147676|NCT03214380|38292191|FG001|Treatment Period|Lost to Follow-up|6|||
17147677|NCT03214380|38292192|FG002|Treatment Period|Lost to Follow-up|3|||
17147678|NCT03214380|38292193|FG003|Treatment Period|Lost to Follow-up|0|||
17147679|NCT03214380|38292194|FG004|Treatment Period|Lost to Follow-up|0|||
17147680|NCT03214380|38292195|FG005|Treatment Period|Lost to Follow-up|0|||
17147681|NCT03214380|38292190|FG000|Treatment Period|Participant schedule|0|||
17147682|NCT03214380|38292191|FG001|Treatment Period|Participant schedule|0|||
17147683|NCT03214380|38292192|FG002|Treatment Period|Participant schedule|1|||
17147684|NCT03214380|38292193|FG003|Treatment Period|Participant schedule|0|||
17147685|NCT03214380|38292194|FG004|Treatment Period|Participant schedule|0|||
17066290|NCT04488770|38208943|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
17066291|NCT04488770|38208944|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066292|NCT04488770|38208945|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066293|NCT04488770|38208946|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066294|NCT04488770|38208947|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066295|NCT04488770|38208948|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066296|NCT04488770|38208949|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066297|NCT04488770|38208950|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066298|NCT04488770|38208951|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066299|NCT04488770|38208952|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066300|NCT04488770|38208953|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066301|NCT04488770|38208954|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066302|NCT04488770|38208955|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
17066303|NCT04488770|38208943|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066304|NCT04488770|38208944|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066305|NCT04488770|38208945|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066306|NCT04488770|38208946|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066307|NCT04488770|38208947|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066308|NCT04488770|38208948|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
17066309|NCT04488770|38208949|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
17066310|NCT04488770|38208950|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066311|NCT04488770|38208951|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066312|NCT04488770|38208952|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066313|NCT04488770|38208953|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066314|NCT04488770|38208954|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066315|NCT04488770|38208955|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17066316|NCT04488770|38208943|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066317|NCT04488770|38208944|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066318|NCT04488770|38208945|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066319|NCT04488770|38208946|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17147686|NCT03214380|38292195|FG005|Treatment Period|Participant schedule|0|||
17147687|NCT03214380|38292190|FG000|Treatment Period|Treatment Interruption|0|||
17147688|NCT03214380|38292191|FG001|Treatment Period|Treatment Interruption|0|||
17066320|NCT04488770|38208947|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
17066321|NCT04488770|38208948|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066322|NCT04488770|38208949|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066323|NCT04488770|38208950|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066324|NCT04488770|38208951|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066325|NCT04488770|38208952|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066326|NCT04488770|38208953|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066327|NCT04488770|38208954|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066328|NCT04488770|38208955|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
17066329|NCT00525044|38209001|FG000|Overall Study|Lost to Follow-up|0|||
17066330|NCT00525044|38209002|FG001|Overall Study|Lost to Follow-up|1|||
17066331|NCT00355342|38209010|FG000|Overall Study|Adverse Event|13|||
17066332|NCT00355342|38209011|FG001|Overall Study|Adverse Event|15|||
17066333|NCT00355342|38209010|FG000|Overall Study|Lost to Follow-up|4|||
17066334|NCT00355342|38209011|FG001|Overall Study|Lost to Follow-up|2|||
17066335|NCT00355342|38209010|FG000|Overall Study|Withdrawal by Subject|14|||
17066336|NCT00355342|38209011|FG001|Overall Study|Withdrawal by Subject|11|||
17066337|NCT00355342|38209010|FG000|Overall Study|Sponsor terminated study|2|||
17066338|NCT00355342|38209011|FG001|Overall Study|Sponsor terminated study|2|||
17066339|NCT00355342|38209010|FG000|Overall Study|Overcompliant-PI discretion|1|||
17066340|NCT00355342|38209011|FG001|Overall Study|Overcompliant-PI discretion|0|||
17066341|NCT00355342|38209010|FG000|Overall Study|Use of prohibited medication|1|||
17066342|NCT00355342|38209011|FG001|Overall Study|Use of prohibited medication|0|||
17066343|NCT00355342|38209010|FG000|Overall Study|COPD exacerbation|1|||
17066344|NCT00355342|38209011|FG001|Overall Study|COPD exacerbation|1|||
17066345|NCT00355342|38209010|FG000|Overall Study|Dispensed wrong study drug kit|1|||
17066346|NCT00355342|38209011|FG001|Overall Study|Dispensed wrong study drug kit|0|||
17066347|NCT00355342|38209010|FG000|Overall Study|Non-compliance with Dexa scans|1|||
17066348|NCT00355342|38209011|FG001|Overall Study|Non-compliance with Dexa scans|0|||
17066349|NCT00355342|38209010|FG000|Overall Study|Withdrawal by participant and physician|1|||
17066350|NCT00355342|38209011|FG001|Overall Study|Withdrawal by participant and physician|0|||
17066351|NCT00355342|38209010|FG000|Overall Study|Participant relocated|0|||
17066352|NCT00355342|38209011|FG001|Overall Study|Participant relocated|1|||
17066353|NCT00355342|38209010|FG000|Overall Study|Participant discontinued study drug|0|||
17066354|NCT00355342|38209011|FG001|Overall Study|Participant discontinued study drug|1|||
17066355|NCT00355342|38209010|FG000|Overall Study|Study management|0|||
17147689|NCT03214380|38292192|FG002|Treatment Period|Treatment Interruption|1|||
17147690|NCT03214380|38292193|FG003|Treatment Period|Treatment Interruption|0|||
17147691|NCT03214380|38292194|FG004|Treatment Period|Treatment Interruption|0|||
17147692|NCT03214380|38292195|FG005|Treatment Period|Treatment Interruption|0|||
17147693|NCT02674464|38292209|FG000|Overall Study|Death|10|||
17147694|NCT02674464|38292210|FG001|Overall Study|Death|21|||
17147695|NCT02674464|38292209|FG000|Overall Study|Withdrawal by Subject|24|||
17147696|NCT02674464|38292210|FG001|Overall Study|Withdrawal by Subject|44|||
17066356|NCT00355342|38209011|FG001|Overall Study|Study management|1|||
17066357|NCT00355342|38209010|FG000|Overall Study|Protocol Violation|0|||
17066358|NCT00355342|38209011|FG001|Overall Study|Protocol Violation|1|||
17147697|NCT02674464|38292209|FG000|Overall Study|Lost to Follow-up|97|||
17147698|NCT02674464|38292210|FG001|Overall Study|Lost to Follow-up|92|||
17147699|NCT02674464|38292209|FG000|Overall Study|Outside survey window|6|||
17147700|NCT02674464|38292210|FG001|Overall Study|Outside survey window|3|||
17147701|NCT03172026|38292218|FG000|Overall Study|Withdrawal by Subject|1|||
17147702|NCT03172026|38292219|FG001|Overall Study|Withdrawal by Subject|0|||
17147703|NCT03172026|38292218|FG000|Overall Study|COVID restrictions|1|||
17147704|NCT03172026|38292219|FG001|Overall Study|COVID restrictions|0|||
17147705|NCT01343888|38292229|FG000|Overall Study|Adverse Event|12|||
17147706|NCT01343888|38292230|FG001|Overall Study|Adverse Event|22|||
17147707|NCT01343888|38292231|FG002|Overall Study|Adverse Event|5|||
17147708|NCT01343888|38292229|FG000|Overall Study|Lack of Efficacy|9|||
17147709|NCT01343888|38292230|FG001|Overall Study|Lack of Efficacy|9|||
17147710|NCT01343888|38292231|FG002|Overall Study|Lack of Efficacy|13|||
16781219|NCT02109562|37720392|FG001|Overall Study|Protocol Violation|3|||
17147711|NCT01343888|38292229|FG000|Overall Study|Lost to Follow-up|0|||
17147712|NCT01343888|38292230|FG001|Overall Study|Lost to Follow-up|2|||
17147713|NCT01343888|38292231|FG002|Overall Study|Lost to Follow-up|1|||
17147714|NCT01343888|38292229|FG000|Overall Study|Protocol Violation|0|||
17147715|NCT01343888|38292230|FG001|Overall Study|Protocol Violation|2|||
17147716|NCT01343888|38292231|FG002|Overall Study|Protocol Violation|0|||
17066359|NCT00355342|38209010|FG000|Overall Study|Use of protocol excluded medication|0|||
17066360|NCT00355342|38209011|FG001|Overall Study|Use of protocol excluded medication|1|||
17066361|NCT01573754|38209019|FG000|Overall Study|Noncompliance or remission not achieved|3|||
17066362|NCT01573754|38209020|FG001|Overall Study|Noncompliance or remission not achieved|15|||
17066363|NCT00355264|38209026|FG000|Extension (Variable Duration)|Adverse Event|1|||
17066364|NCT00355264|38209026|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
17066365|NCT00355030|38209037|FG000|Study Period 1 Treatment|Adverse Event|1|||
17066366|NCT00355030|38209038|FG001|Study Period 1 Treatment|Adverse Event|1|||
17066367|NCT00355030|38209037|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
17066368|NCT00355030|38209038|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
17066369|NCT00355030|38209037|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
17066370|NCT00355030|38209038|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
17066371|NCT00355030|38209037|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
17066372|NCT00355030|38209038|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
17066373|NCT00355030|38209037|FG000|Study Period 1 Treatment|Physician Decision|0|||
17066374|NCT00355030|38209038|FG001|Study Period 1 Treatment|Physician Decision|1|||
17066375|NCT00355030|38209037|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
17066376|NCT00355030|38209038|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
17066377|NCT00355030|38209037|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
17066378|NCT00355030|38209038|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
17147717|NCT01343888|38292229|FG000|Overall Study|Withdrawal by Subject|4|||
17147718|NCT01343888|38292230|FG001|Overall Study|Withdrawal by Subject|4|||
17147719|NCT01343888|38292231|FG002|Overall Study|Withdrawal by Subject|2|||
17147720|NCT01343888|38292229|FG000|Overall Study|other than stated above|0|||
17066379|NCT00355030|38209037|FG000|Study Period 1 Treatment|Other|2|||
17066380|NCT00355030|38209038|FG001|Study Period 1 Treatment|Other|6|||
17066381|NCT00355030|38209037|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
17066382|NCT00355030|38209038|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
17066383|NCT00355030|38209037|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
17066384|NCT00355030|38209038|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
17066385|NCT00354172|38209044|FG000|Overall Study|Did not receive transplant|1|||
17066386|NCT00345592|38209050|FG000|Overall Study|Death|14|||
17066387|NCT00345592|38209051|FG001|Overall Study|Death|16|||
17066388|NCT00345592|38209050|FG000|Overall Study|Withdrawal by Subject|11|||
17066389|NCT00345592|38209051|FG001|Overall Study|Withdrawal by Subject|8|||
17066390|NCT00353704|38209059|FG000|Overall Study|Protocol Violation|3|||
17066391|NCT00353704|38209060|FG001|Overall Study|Protocol Violation|1|||
17066392|NCT00512252|38209069|FG000|Overall Study|Lost to Follow-up|0|||
17066393|NCT00512252|38209070|FG001|Overall Study|Lost to Follow-up|0|||
17066394|NCT00512252|38209071|FG002|Overall Study|Lost to Follow-up|1|||
17066395|NCT00512252|38209069|FG000|Overall Study|Protocol Violation|0|||
17066396|NCT00512252|38209070|FG001|Overall Study|Protocol Violation|0|||
17066397|NCT00512252|38209071|FG002|Overall Study|Protocol Violation|1|||
17066398|NCT00512252|38209069|FG000|Overall Study|Death|0|||
17066399|NCT00512252|38209070|FG001|Overall Study|Death|0|||
17066400|NCT00512252|38209071|FG002|Overall Study|Death|1|||
17066401|NCT00516386|38209086|FG000|Overall Study|not interested in the study|4|||
17066402|NCT00516386|38209086|FG000|Overall Study|Lost to Follow-up|2|||
17147721|NCT01343888|38292230|FG001|Overall Study|other than stated above|0|||
17147722|NCT01343888|38292231|FG002|Overall Study|other than stated above|1|||
17147723|NCT03589807|38292245|FG000|Overall Study|Lost to Follow-up|0|||
17147724|NCT03589807|38292246|FG001|Overall Study|Lost to Follow-up|2|||
17147725|NCT03589807|38292247|FG002|Overall Study|Lost to Follow-up|2|||
17147726|NCT03589807|38292248|FG003|Overall Study|Lost to Follow-up|3|||
17147727|NCT03589807|38292249|FG004|Overall Study|Lost to Follow-up|1|||
17147728|NCT03589807|38292250|FG005|Overall Study|Lost to Follow-up|1|||
17147729|NCT03589807|38292245|FG000|Overall Study|Withdrawal by Subject|0|||
17147730|NCT03589807|38292246|FG001|Overall Study|Withdrawal by Subject|5|||
17147731|NCT03589807|38292247|FG002|Overall Study|Withdrawal by Subject|0|||
17147732|NCT03589807|38292248|FG003|Overall Study|Withdrawal by Subject|0|||
17066403|NCT00524420|38209092|FG000|Overall Study|Lack of Efficacy|1|||
17147733|NCT03589807|38292249|FG004|Overall Study|Withdrawal by Subject|0|||
17147734|NCT03589807|38292250|FG005|Overall Study|Withdrawal by Subject|0|||
17147735|NCT03589807|38292245|FG000|Overall Study|Protocol Violation|0|||
17147736|NCT03589807|38292246|FG001|Overall Study|Protocol Violation|0|||
17066404|NCT00524420|38209093|FG001|Overall Study|Lack of Efficacy|0|||
17066405|NCT00512096|38209101|FG000|Overall Study|Adverse Event|2|||
17066406|NCT00512096|38209101|FG000|Overall Study|Withdrawal by Subject|2|||
17066407|NCT00512096|38209101|FG000|Overall Study|Lack of Efficacy|3|||
17066408|NCT00524030|38209107|FG000|Overall Study|Lack of Efficacy|10|||
17066409|NCT00524030|38209108|FG001|Overall Study|Lack of Efficacy|24|||
17066410|NCT00524030|38209107|FG000|Overall Study|Lost to Follow-up|0|||
17066411|NCT00524030|38209108|FG001|Overall Study|Lost to Follow-up|2|||
17066412|NCT00524030|38209107|FG000|Overall Study|Withdrawal by Subject|3|||
17066413|NCT00524030|38209108|FG001|Overall Study|Withdrawal by Subject|8|||
17066414|NCT00524030|38209107|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
17066415|NCT00524030|38209108|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
17066416|NCT00524030|38209107|FG000|Overall Study|Protocol Violation|0|||
17066417|NCT00524030|38209108|FG001|Overall Study|Protocol Violation|1|||
17066418|NCT00524030|38209107|FG000|Overall Study|Pregnancy|1|||
17066419|NCT00524030|38209108|FG001|Overall Study|Pregnancy|0|||
17066420|NCT00524030|38209107|FG000|Overall Study|Adverse Event|3|||
17066421|NCT00524030|38209108|FG001|Overall Study|Adverse Event|21|||
17066422|NCT00524030|38209107|FG000|Overall Study|Death|0|||
17066423|NCT00524030|38209108|FG001|Overall Study|Death|1|||
17066424|NCT00523718|38209117|FG000|Overall Study|Withdrawal by Subject|1|||
17066425|NCT00523718|38209118|FG001|Overall Study|Withdrawal by Subject|0|||
17066426|NCT00523718|38209117|FG000|Overall Study|Protocol Violation|2|||
17066427|NCT00523718|38209118|FG001|Overall Study|Protocol Violation|0|||
17147737|NCT03589807|38292247|FG002|Overall Study|Protocol Violation|0|||
17147738|NCT03589807|38292248|FG003|Overall Study|Protocol Violation|1|||
17066428|NCT00523640|38209124|FG000|Overall Study|Death|1|||
17066429|NCT00345358|38209132|FG000|Primary Vaccination Phase|Other|0|||
17066430|NCT00345358|38209133|FG001|Primary Vaccination Phase|Other|1|||
17066431|NCT00345358|38209134|FG002|Primary Vaccination Phase|Other|1|||
17066432|NCT00345358|38209135|FG003|Primary Vaccination Phase|Other|0|||
17066433|NCT00345358|38209132|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
17066434|NCT00345358|38209133|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
17066435|NCT00345358|38209134|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
17066436|NCT00345358|38209135|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
17066437|NCT00345358|38209132|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
17066438|NCT00345358|38209133|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
17066439|NCT00345358|38209134|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
17066440|NCT00345358|38209135|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
17066441|NCT00345358|38209132|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
17066442|NCT00345358|38209133|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
17066443|NCT00345358|38209134|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
17066444|NCT00345358|38209135|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
17066445|NCT00345358|38209132|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
17066446|NCT00345358|38209133|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
17066447|NCT00345358|38209134|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
17147739|NCT03589807|38292249|FG004|Overall Study|Protocol Violation|0|||
17147740|NCT03589807|38292250|FG005|Overall Study|Protocol Violation|0|||
17066448|NCT00345358|38209135|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
17066449|NCT00345358|38209132|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
17066450|NCT00345358|38209133|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
17066451|NCT00345358|38209134|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
17066452|NCT00345358|38209135|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
17066453|NCT03869684|38209148|FG000|Overall Study|Adverse Event|0|||
17066454|NCT03869684|38209149|FG001|Overall Study|Adverse Event|3|||
17066455|NCT03869684|38209150|FG002|Overall Study|Adverse Event|1|||
17066456|NCT03869684|38209148|FG000|Overall Study|Withdrawal by Subject|1|||
17066457|NCT03869684|38209149|FG001|Overall Study|Withdrawal by Subject|0|||
17066458|NCT03869684|38209150|FG002|Overall Study|Withdrawal by Subject|0|||
17066459|NCT03869684|38209148|FG000|Overall Study|Lost to Follow-up|1|||
17066460|NCT03869684|38209149|FG001|Overall Study|Lost to Follow-up|0|||
17066461|NCT03869684|38209150|FG002|Overall Study|Lost to Follow-up|0|||
17066462|NCT03869684|38209148|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
17066463|NCT03869684|38209149|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
17066464|NCT03869684|38209150|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
17066465|NCT00516074|38209160|FG000|Overall Study|Adverse Event|0|||
17066466|NCT00516074|38209161|FG001|Overall Study|Adverse Event|1|||
17066467|NCT00516074|38209160|FG000|Overall Study|Subject Decision|4|||
17066468|NCT00516074|38209161|FG001|Overall Study|Subject Decision|2|||
17066469|NCT00516074|38209160|FG000|Overall Study|Loss of Glucose Control|2|||
17066470|NCT00516074|38209161|FG001|Overall Study|Loss of Glucose Control|0|||
17066471|NCT00515294|38209171|FG000|Overall Study|Lost to Follow-up|3|||
17066472|NCT00515294|38209172|FG001|Overall Study|Lost to Follow-up|2|||
17066473|NCT00515294|38209173|FG002|Overall Study|Lost to Follow-up|3|||
17066474|NCT00515294|38209174|FG003|Overall Study|Lost to Follow-up|1|||
17066475|NCT00515294|38209171|FG000|Overall Study|Driver simulator problems|1|||
17066476|NCT00515294|38209172|FG001|Overall Study|Driver simulator problems|1|||
17066477|NCT00515294|38209173|FG002|Overall Study|Driver simulator problems|1|||
17066478|NCT00515294|38209174|FG003|Overall Study|Driver simulator problems|3|||
17066479|NCT00515294|38209171|FG000|Overall Study|Caffeine amount inaccurate|5|||
17066480|NCT00515294|38209172|FG001|Overall Study|Caffeine amount inaccurate|0|||
17066481|NCT00515294|38209173|FG002|Overall Study|Caffeine amount inaccurate|7|||
17066482|NCT00515294|38209174|FG003|Overall Study|Caffeine amount inaccurate|0|||
17066483|NCT00345046|38209187|FG000|Overall Study|Protocol Violation|1|||
17066484|NCT00345046|38209188|FG001|Overall Study|Protocol Violation|1|||
17066485|NCT00345046|38209189|FG002|Overall Study|Protocol Violation|2|||
17066486|NCT00515216|38209197|FG000|Overall Study|Withdrawal by Subject|1|||
17066487|NCT01004978|38209204|FG000|Overall Study|Disease progression|31|||
17066488|NCT01004978|38209205|FG001|Overall Study|Disease progression|48|||
17066489|NCT01004978|38209204|FG000|Overall Study|Adverse Event|42|||
17066490|NCT01004978|38209205|FG001|Overall Study|Adverse Event|22|||
17066491|NCT01004978|38209204|FG000|Overall Study|Death|3|||
17066492|NCT01004978|38209205|FG001|Overall Study|Death|2|||
17066493|NCT01004978|38209204|FG000|Overall Study|Withdrawal by Subject|16|||
17066494|NCT01004978|38209205|FG001|Overall Study|Withdrawal by Subject|16|||
17066495|NCT01004978|38209204|FG000|Overall Study|Alternative therapy|4|||
17066496|NCT01004978|38209205|FG001|Overall Study|Alternative therapy|8|||
17066497|NCT01004978|38209204|FG000|Overall Study|Physician Decision|6|||
17066498|NCT01004978|38209205|FG001|Overall Study|Physician Decision|3|||
17066499|NCT01004978|38209204|FG000|Overall Study|Other complicating disease|2|||
17066500|NCT01004978|38209205|FG001|Overall Study|Other complicating disease|2|||
17066501|NCT01004978|38209204|FG000|Overall Study|Protocol Violation|2|||
17066502|NCT01004978|38209205|FG001|Overall Study|Protocol Violation|3|||
17066503|NCT01004978|38209204|FG000|Overall Study|Non-compliance|3|||
17066504|NCT01004978|38209205|FG001|Overall Study|Non-compliance|2|||
17066505|NCT01004978|38209204|FG000|Overall Study|Ineligible|1|||
17066506|NCT01004978|38209205|FG001|Overall Study|Ineligible|0|||
17066507|NCT01004978|38209204|FG000|Overall Study|Unblinded|0|||
17066508|NCT01004978|38209205|FG001|Overall Study|Unblinded|1|||
17066509|NCT01004978|38209204|FG000|Overall Study|Performance status worsening|0|||
17066510|NCT01004978|38209205|FG001|Overall Study|Performance status worsening|1|||
17066511|NCT01004978|38209204|FG000|Overall Study|Never started treatment|8|||
16781220|NCT02109562|37720393|FG002|Overall Study|Protocol Violation|1|||
17066512|NCT01004978|38209205|FG001|Overall Study|Never started treatment|9|||
17066513|NCT00522626|38209211|FG000|Overall Study|Lost to Follow-up|7|||
17066514|NCT00440193|38209217|FG000|Treatment Period|Adverse Event|74|||
17066515|NCT00440193|38209218|FG001|Treatment Period|Adverse Event|67|||
17066516|NCT00440193|38209217|FG000|Treatment Period|Death|19|||
17066517|NCT00440193|38209218|FG001|Treatment Period|Death|22|||
17066518|NCT00440193|38209217|FG000|Treatment Period|Lack of Efficacy|0|||
17066519|NCT00440193|38209218|FG001|Treatment Period|Lack of Efficacy|1|||
17066520|NCT00440193|38209217|FG000|Treatment Period|Lost to Follow-up|12|||
17066521|NCT00440193|38209218|FG001|Treatment Period|Lost to Follow-up|18|||
17066522|NCT00440193|38209217|FG000|Treatment Period|Physician Decision|3|||
17066523|NCT00440193|38209218|FG001|Treatment Period|Physician Decision|6|||
17066524|NCT00440193|38209217|FG000|Treatment Period|Protocol Violation|16|||
17066525|NCT00440193|38209218|FG001|Treatment Period|Protocol Violation|19|||
17066526|NCT00440193|38209217|FG000|Treatment Period|Withdrawal by Subject|36|||
17066527|NCT00440193|38209218|FG001|Treatment Period|Withdrawal by Subject|77|||
17066528|NCT00440193|38209217|FG000|Treatment Period|Clinical endpoint reached|28|||
17066529|NCT00440193|38209218|FG001|Treatment Period|Clinical endpoint reached|25|||
17066530|NCT00440193|38209217|FG000|Treatment Period|Study terminated by sponsor|102|||
17066531|NCT00440193|38209218|FG001|Treatment Period|Study terminated by sponsor|94|||
17066532|NCT00440193|38209217|FG000|Treatment Period|Protocol driven decision point|2|||
17066533|NCT00440193|38209218|FG001|Treatment Period|Protocol driven decision point|2|||
17066534|NCT00440193|38209217|FG000|Treatment Period|Switch to commercial drug|0|||
17066535|NCT00440193|38209218|FG001|Treatment Period|Switch to commercial drug|2|||
17066536|NCT00440193|38209217|FG000|Treatment Period|Technical problems|1|||
17066537|NCT00440193|38209218|FG001|Treatment Period|Technical problems|1|||
17066538|NCT00440193|38209217|FG000|Treatment Period|Participant convenience|5|||
17066539|NCT00440193|38209218|FG001|Treatment Period|Participant convenience|2|||
17066540|NCT00440193|38209217|FG000|Treatment Period|Participant did not receive treatment|7|||
17066541|NCT00440193|38209218|FG001|Treatment Period|Participant did not receive treatment|13|||
17066542|NCT00440193|38209217|FG000|Treatment Period|Site closed by investigator|0|||
17066543|NCT00440193|38209218|FG001|Treatment Period|Site closed by investigator|2|||
17066544|NCT00440193|38209217|FG000|Observational Period|Adverse Event|2|||
17066545|NCT00440193|38209218|FG001|Observational Period|Adverse Event|2|||
17066546|NCT00440193|38209217|FG000|Observational Period|Death|15|||
17066547|NCT00440193|38209218|FG001|Observational Period|Death|20|||
17066548|NCT00440193|38209217|FG000|Observational Period|Lost to Follow-up|12|||
17066549|NCT00440193|38209218|FG001|Observational Period|Lost to Follow-up|8|||
17066550|NCT00440193|38209217|FG000|Observational Period|Protocol Violation|1|||
17066551|NCT00440193|38209218|FG001|Observational Period|Protocol Violation|0|||
17066552|NCT00440193|38209217|FG000|Observational Period|Withdrawal by Subject|11|||
17066553|NCT00440193|38209218|FG001|Observational Period|Withdrawal by Subject|8|||
17066554|NCT00440193|38209217|FG000|Observational Period|Physician Decision|1|||
17066555|NCT00440193|38209218|FG001|Observational Period|Physician Decision|0|||
17066556|NCT00440193|38209217|FG000|Observational Period|Clinical endpoint reached|1|||
17066557|NCT00440193|38209218|FG001|Observational Period|Clinical endpoint reached|0|||
17066558|NCT00440193|38209217|FG000|Observational Period|Participant convenience|2|||
17066559|NCT00440193|38209218|FG001|Observational Period|Participant convenience|0|||
17066560|NCT00511472|38209226|FG000|Overall Study|Clinical Adverse Event|1|||
17066561|NCT00511472|38209227|FG001|Overall Study|Clinical Adverse Event|2|||
17066562|NCT00511472|38209226|FG000|Overall Study|Laboratory Adverse Event|0|||
17066563|NCT00511472|38209227|FG001|Overall Study|Laboratory Adverse Event|2|||
17066564|NCT00511472|38209226|FG000|Overall Study|Not reported|2|||
17066565|NCT00511472|38209227|FG001|Overall Study|Not reported|2|||
17066566|NCT00514904|38209244|FG000|Overall Study|Withdrawal by Subject|3|||
17066567|NCT00514904|38209245|FG001|Overall Study|Withdrawal by Subject|2|||
17066568|NCT00514904|38209244|FG000|Overall Study|Lost to Follow-up|21|||
17066569|NCT00514904|38209245|FG001|Overall Study|Lost to Follow-up|3|||
17066570|NCT00440115|38209254|FG000|Overall Study|Death|7|||
17066571|NCT00440115|38209255|FG001|Overall Study|Death|9|||
17066572|NCT00440115|38209256|FG002|Overall Study|Death|5|||
17066573|NCT00440115|38209254|FG000|Overall Study|Incarceration|0|||
17066574|NCT00440115|38209255|FG001|Overall Study|Incarceration|2|||
17066575|NCT00440115|38209256|FG002|Overall Study|Incarceration|1|||
17066576|NCT00440037|38209264|FG000|Overall Study|Withdrawal by Subject|6|||
17066577|NCT00440037|38209264|FG000|Overall Study|Administrative decision|3|||
17066578|NCT00417027|38209271|FG000|Overall Study|Protocol Violation|0|||
17066579|NCT00417027|38209272|FG001|Overall Study|Protocol Violation|5|||
17066580|NCT00417027|38209273|FG002|Overall Study|Protocol Violation|5|||
17066581|NCT00416949|38209281|FG000|Overall Study|Patients refused to participate|5|||
17066582|NCT00416715|38209285|FG000|Overall Study|Not evaluable for joint aches|7|||
17066583|NCT00416715|38209285|FG000|Overall Study|Vitamin D levels not evaluable|8|||
17066584|NCT00406029|38209297|FG000|Overall Study|Adverse Event|12|||
17066585|NCT00406029|38209298|FG001|Overall Study|Adverse Event|2|||
17066586|NCT00406029|38209299|FG002|Overall Study|Adverse Event|5|||
17066587|NCT00406029|38209300|FG003|Overall Study|Adverse Event|10|||
17066588|NCT00406029|38209301|FG004|Overall Study|Adverse Event|7|||
17066589|NCT00406029|38209297|FG000|Overall Study|Withdrawal by Subject|3|||
17066590|NCT00406029|38209298|FG001|Overall Study|Withdrawal by Subject|4|||
17066591|NCT00406029|38209299|FG002|Overall Study|Withdrawal by Subject|2|||
17066592|NCT00406029|38209300|FG003|Overall Study|Withdrawal by Subject|2|||
17066593|NCT00406029|38209301|FG004|Overall Study|Withdrawal by Subject|0|||
17066594|NCT00406029|38209297|FG000|Overall Study|Protocol Violation|1|||
17066595|NCT00406029|38209298|FG001|Overall Study|Protocol Violation|2|||
17066596|NCT00406029|38209299|FG002|Overall Study|Protocol Violation|0|||
17066597|NCT00406029|38209300|FG003|Overall Study|Protocol Violation|2|||
17066598|NCT00406029|38209301|FG004|Overall Study|Protocol Violation|0|||
17066599|NCT00406029|38209297|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
17066600|NCT00406029|38209298|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
17066601|NCT00406029|38209299|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
17066602|NCT00406029|38209300|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
17066603|NCT00406029|38209301|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
17066604|NCT00406029|38209297|FG000|Overall Study|Randomized in Error|0|||
17066605|NCT00406029|38209298|FG001|Overall Study|Randomized in Error|0|||
17066606|NCT00406029|38209299|FG002|Overall Study|Randomized in Error|2|||
17066607|NCT00406029|38209300|FG003|Overall Study|Randomized in Error|3|||
17066608|NCT00406029|38209301|FG004|Overall Study|Randomized in Error|1|||
17066609|NCT00514514|38209316|FG000|Pre-phase|Death|10|||
17066610|NCT00514514|38209317|FG001|Pre-phase|Death|0|||
17066611|NCT00514514|38209318|FG002|Pre-phase|Death|0|||
17066612|NCT00514514|38209316|FG000|Pre-phase|administrative problems|2|||
17066613|NCT00514514|38209317|FG001|Pre-phase|administrative problems|0|||
17066614|NCT00514514|38209318|FG002|Pre-phase|administrative problems|0|||
17066615|NCT00514514|38209316|FG000|Pre-phase|Protocol Violation|6|||
17066616|NCT00514514|38209317|FG001|Pre-phase|Protocol Violation|0|||
17066617|NCT00514514|38209318|FG002|Pre-phase|Protocol Violation|0|||
17066618|NCT00514514|38209316|FG000|Pre-phase|condition no longer requires study drug|7|||
17066619|NCT00514514|38209317|FG001|Pre-phase|condition no longer requires study drug|0|||
17066620|NCT00514514|38209318|FG002|Pre-phase|condition no longer requires study drug|0|||
17066621|NCT00514514|38209316|FG000|Pre-phase|abnormal test procedure results|15|||
17066622|NCT00514514|38209317|FG001|Pre-phase|abnormal test procedure results|0|||
17066623|NCT00514514|38209318|FG002|Pre-phase|abnormal test procedure results|0|||
17066624|NCT00514514|38209316|FG000|Pre-phase|Lost to Follow-up|2|||
17147741|NCT03589807|38292245|FG000|Overall Study|Enrolled but treatment not administered|0|||
17147742|NCT03589807|38292246|FG001|Overall Study|Enrolled but treatment not administered|0|||
17147743|NCT03589807|38292247|FG002|Overall Study|Enrolled but treatment not administered|0|||
17147744|NCT03589807|38292248|FG003|Overall Study|Enrolled but treatment not administered|0|||
17147745|NCT03589807|38292249|FG004|Overall Study|Enrolled but treatment not administered|1|||
17147746|NCT03589807|38292250|FG005|Overall Study|Enrolled but treatment not administered|0|||
17066625|NCT00514514|38209317|FG001|Pre-phase|Lost to Follow-up|0|||
17066626|NCT00514514|38209318|FG002|Pre-phase|Lost to Follow-up|0|||
17147747|NCT03544333|38292269|FG000|Overall Study|Withdrawal by Subject|1|||
17147748|NCT03544333|38292270|FG001|Overall Study|Withdrawal by Subject|0|||
17147749|NCT03560245|38292278|FG000|Overall Study|Withdrawal by Subject|3|||
17147750|NCT03560245|38292279|FG001|Overall Study|Withdrawal by Subject|2|||
17147751|NCT03560245|38292278|FG000|Overall Study|Adverse Event|1|||
17147752|NCT03560245|38292279|FG001|Overall Study|Adverse Event|1|||
17147753|NCT03560245|38292278|FG000|Overall Study|Protocol Violation|1|||
17147754|NCT03560245|38292279|FG001|Overall Study|Protocol Violation|0|||
17147755|NCT03560245|38292278|FG000|Overall Study|Death|0|||
17147756|NCT03560245|38292279|FG001|Overall Study|Death|1|||
17147757|NCT03560245|38292278|FG000|Overall Study|Lost to Follow-up|0|||
17147758|NCT03560245|38292279|FG001|Overall Study|Lost to Follow-up|1|||
17147759|NCT03560245|38292278|FG000|Overall Study|Physician Decision|0|||
17147760|NCT03560245|38292279|FG001|Overall Study|Physician Decision|1|||
17147761|NCT03560245|38292278|FG000|Overall Study|Other|0|||
17147762|NCT03560245|38292279|FG001|Overall Study|Other|1|||
17147763|NCT00707434|38292287|FG000|Overall Study|Adverse Event|1|||
17147764|NCT03054428|38292294|FG000|Overall Study|Physician Decision|0|||
17147765|NCT03054428|38292295|FG001|Overall Study|Physician Decision|1|||
17147766|NCT03054428|38292296|FG002|Overall Study|Physician Decision|1|||
17147767|NCT03054428|38292294|FG000|Overall Study|Lack of Efficacy|3|||
17147768|NCT03054428|38292295|FG001|Overall Study|Lack of Efficacy|1|||
17147769|NCT03054428|38292296|FG002|Overall Study|Lack of Efficacy|0|||
17147770|NCT03054428|38292294|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
17147771|NCT03054428|38292295|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
17066627|NCT00514514|38209316|FG000|Pre-phase|abnormal lab values|23|||
17066628|NCT00514514|38209317|FG001|Pre-phase|abnormal lab values|0|||
17066629|NCT00514514|38209318|FG002|Pre-phase|abnormal lab values|0|||
17066630|NCT00514514|38209316|FG000|Pre-phase|Lack of Efficacy|35|||
17066631|NCT00514514|38209317|FG001|Pre-phase|Lack of Efficacy|0|||
17066632|NCT00514514|38209318|FG002|Pre-phase|Lack of Efficacy|0|||
17066633|NCT00514514|38209316|FG000|Pre-phase|Adverse Event|137|||
17066634|NCT00514514|38209317|FG001|Pre-phase|Adverse Event|0|||
17066635|NCT00514514|38209318|FG002|Pre-phase|Adverse Event|0|||
17066636|NCT00514514|38209316|FG000|Pre-phase|Withdrawal by Subject|66|||
17066637|NCT00514514|38209317|FG001|Pre-phase|Withdrawal by Subject|0|||
17066638|NCT00514514|38209318|FG002|Pre-phase|Withdrawal by Subject|0|||
17066639|NCT00514514|38209316|FG000|Randomized - 9 Month|Death|3|||
17066640|NCT00514514|38209317|FG001|Randomized - 9 Month|Death|2|||
17066641|NCT00514514|38209318|FG002|Randomized - 9 Month|Death|2|||
17066642|NCT00514514|38209316|FG000|Randomized - 9 Month|Administrative problems|1|||
17147772|NCT03054428|38292296|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
17147773|NCT03054428|38292294|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
17147774|NCT03054428|38292295|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
17147775|NCT03054428|38292296|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
17066643|NCT00514514|38209317|FG001|Randomized - 9 Month|Administrative problems|1|||
17066644|NCT00514514|38209318|FG002|Randomized - 9 Month|Administrative problems|2|||
17066645|NCT00514514|38209316|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
17066646|NCT00514514|38209317|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
17066647|NCT00514514|38209318|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
17066648|NCT00514514|38209316|FG000|Randomized - 9 Month|Protocol Violation|1|||
17066649|NCT00514514|38209317|FG001|Randomized - 9 Month|Protocol Violation|1|||
17066650|NCT00514514|38209318|FG002|Randomized - 9 Month|Protocol Violation|0|||
17066651|NCT00514514|38209316|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
17066652|NCT00514514|38209317|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
17066653|NCT00514514|38209318|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
17066654|NCT00514514|38209316|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
17066655|NCT00514514|38209317|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
17066656|NCT00514514|38209318|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
17066657|NCT00514514|38209316|FG000|Randomized - 9 Month|Adverse Event|25|||
17066658|NCT00514514|38209317|FG001|Randomized - 9 Month|Adverse Event|44|||
17066659|NCT00514514|38209318|FG002|Randomized - 9 Month|Adverse Event|27|||
17066660|NCT00514514|38209316|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
17066661|NCT00514514|38209317|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
17066662|NCT00514514|38209318|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
17066663|NCT00514514|38209316|FG000|Extension - 4 Years|Lost to Follow-up|12|||
17066664|NCT00514514|38209317|FG001|Extension - 4 Years|Lost to Follow-up|10|||
17066665|NCT00514514|38209318|FG002|Extension - 4 Years|Lost to Follow-up|9|||
17066666|NCT00514514|38209316|FG000|Extension - 4 Years|Administrative problems|3|||
17066667|NCT00514514|38209317|FG001|Extension - 4 Years|Administrative problems|1|||
17066668|NCT00514514|38209318|FG002|Extension - 4 Years|Administrative problems|1|||
17066669|NCT00514514|38209316|FG000|Extension - 4 Years|Death|8|||
17066670|NCT00514514|38209317|FG001|Extension - 4 Years|Death|3|||
17066671|NCT00514514|38209318|FG002|Extension - 4 Years|Death|6|||
17066672|NCT00514514|38209316|FG000|Extension - 4 Years|Adverse Event|9|||
17066673|NCT00514514|38209317|FG001|Extension - 4 Years|Adverse Event|6|||
17066674|NCT00514514|38209318|FG002|Extension - 4 Years|Adverse Event|3|||
17066675|NCT00405639|38209328|FG000|Overall Study|Withdrawal by Subject|1|||
17066676|NCT00405639|38209329|FG001|Overall Study|Withdrawal by Subject|0|||
17066677|NCT00405639|38209328|FG000|Overall Study|Adverse Event|1|||
17066678|NCT00405639|38209329|FG001|Overall Study|Adverse Event|0|||
17066679|NCT00405639|38209328|FG000|Overall Study|Seizure prior to receiving BNP|1|||
17066680|NCT00405639|38209329|FG001|Overall Study|Seizure prior to receiving BNP|0|||
17066681|NCT00439725|38209337|FG000|Treatment Period|Withdrawal by Subject|22|||
17066682|NCT00439725|38209338|FG001|Treatment Period|Withdrawal by Subject|19|||
17066683|NCT00439725|38209337|FG000|Treatment Period|Study terminated by sponsor|156|||
17066684|NCT00439725|38209338|FG001|Treatment Period|Study terminated by sponsor|148|||
17066685|NCT00439725|38209337|FG000|Treatment Period|Site closed by investigator|1|||
17066686|NCT00439725|38209338|FG001|Treatment Period|Site closed by investigator|2|||
17066687|NCT00439725|38209337|FG000|Treatment Period|Adverse Event|39|||
17066688|NCT00439725|38209338|FG001|Treatment Period|Adverse Event|18|||
17066689|NCT00439725|38209337|FG000|Treatment Period|Physician Decision|1|||
17066690|NCT00439725|38209338|FG001|Treatment Period|Physician Decision|1|||
17147776|NCT03054428|38292294|FG000|Overall Study|Transitioned to OLE study|76|||
17147777|NCT03054428|38292295|FG001|Overall Study|Transitioned to OLE study|76|||
17147778|NCT03054428|38292296|FG002|Overall Study|Transitioned to OLE study|73|||
17147779|NCT03054428|38292294|FG000|Overall Study|Withdrawal by Subject|3|||
17147780|NCT03054428|38292295|FG001|Overall Study|Withdrawal by Subject|2|||
17147781|NCT03054428|38292296|FG002|Overall Study|Withdrawal by Subject|3|||
17147782|NCT03054428|38292294|FG000|Overall Study|Lost to Follow-up|0|||
17147783|NCT03054428|38292295|FG001|Overall Study|Lost to Follow-up|0|||
17147784|NCT03054428|38292296|FG002|Overall Study|Lost to Follow-up|1|||
17066691|NCT00439725|38209337|FG000|Treatment Period|Protocol Violation|2|||
17066692|NCT00439725|38209338|FG001|Treatment Period|Protocol Violation|1|||
17066693|NCT00439725|38209337|FG000|Treatment Period|Clinical endpoint reached|6|||
17066694|NCT00439725|38209338|FG001|Treatment Period|Clinical endpoint reached|50|||
17066695|NCT00439725|38209337|FG000|Treatment Period|Technical problems|1|||
17147785|NCT03558997|38292308|FG000|Overall Study|Adverse Event|0|||
17147786|NCT03558997|38292309|FG001|Overall Study|Adverse Event|2|||
17147787|NCT03558997|38292310|FG002|Overall Study|Adverse Event|5|||
17147788|NCT03558997|38292311|FG003|Overall Study|Adverse Event|1|||
17066696|NCT00439725|38209338|FG001|Treatment Period|Technical problems|0|||
17066697|NCT00439725|38209337|FG000|Treatment Period|Lost to Follow-up|1|||
17147789|NCT03558997|38292308|FG000|Overall Study|Physician Decision|0|||
17147790|NCT03558997|38292309|FG001|Overall Study|Physician Decision|0|||
17147791|NCT03558997|38292310|FG002|Overall Study|Physician Decision|1|||
17147792|NCT03558997|38292311|FG003|Overall Study|Physician Decision|0|||
17147793|NCT03558997|38292308|FG000|Overall Study|Withdrawal by Subject|1|||
17147794|NCT03558997|38292309|FG001|Overall Study|Withdrawal by Subject|0|||
17147795|NCT03558997|38292310|FG002|Overall Study|Withdrawal by Subject|1|||
17147796|NCT03558997|38292311|FG003|Overall Study|Withdrawal by Subject|1|||
17147797|NCT03558997|38292308|FG000|Overall Study|Lost to Follow-up|0|||
17147798|NCT03558997|38292309|FG001|Overall Study|Lost to Follow-up|0|||
17147799|NCT03558997|38292310|FG002|Overall Study|Lost to Follow-up|1|||
17147800|NCT03558997|38292311|FG003|Overall Study|Lost to Follow-up|0|||
17147801|NCT03052400|38292326|FG000|Overall Study|Lost to Follow-up|1|||
17147802|NCT03052400|38292327|FG001|Overall Study|Lost to Follow-up|0|||
17147803|NCT03052400|38292326|FG000|Overall Study|Withdrawal by Subject|0|||
17147804|NCT03052400|38292327|FG001|Overall Study|Withdrawal by Subject|1|||
17147805|NCT03538951|38292335|FG000|Overall Study|Withdrawal by Subject|1|||
17147806|NCT03538951|38292336|FG001|Overall Study|Withdrawal by Subject|2|||
17147807|NCT03052322|38292344|FG000|Overall Study|Other un-specified|1|||
17066698|NCT00439725|38209338|FG001|Treatment Period|Lost to Follow-up|1|||
17147808|NCT03052322|38292345|FG001|Overall Study|Other un-specified|2|||
17147809|NCT03052322|38292344|FG000|Overall Study|Withdrawal by Subject|10|||
17147810|NCT03052322|38292345|FG001|Overall Study|Withdrawal by Subject|9|||
17147811|NCT03052322|38292344|FG000|Overall Study|Death|0|||
17147812|NCT03052322|38292345|FG001|Overall Study|Death|2|||
17147813|NCT03052322|38292344|FG000|Overall Study|Lack of Efficacy|1|||
17147814|NCT03052322|38292345|FG001|Overall Study|Lack of Efficacy|2|||
17066699|NCT00439725|38209337|FG000|Treatment Period|Participant convenience|1|||
17066700|NCT00439725|38209338|FG001|Treatment Period|Participant convenience|0|||
17066701|NCT00439725|38209337|FG000|Treatment Period|Protocol driven decision point|1|||
17066702|NCT00439725|38209338|FG001|Treatment Period|Protocol driven decision point|1|||
17066703|NCT00439725|38209337|FG000|Treatment Period|Death|1|||
17066704|NCT00439725|38209338|FG001|Treatment Period|Death|1|||
17066705|NCT00439725|38209337|FG000|Treatment Period|Participant did not receive treatment|4|||
17066706|NCT00439725|38209338|FG001|Treatment Period|Participant did not receive treatment|4|||
17066707|NCT00439725|38209337|FG000|Observational Period|Withdrawal by Subject|2|||
17066708|NCT00439725|38209338|FG001|Observational Period|Withdrawal by Subject|2|||
17066709|NCT00439725|38209337|FG000|Observational Period|Lost to Follow-up|0|||
17066710|NCT00439725|38209338|FG001|Observational Period|Lost to Follow-up|1|||
17066711|NCT00439725|38209337|FG000|Observational Period|Death|0|||
17066712|NCT00439725|38209338|FG001|Observational Period|Death|2|||
17066713|NCT00439725|38209337|FG000|Observational Period|Study termination by sponsor|1|||
17066714|NCT00439725|38209338|FG001|Observational Period|Study termination by sponsor|1|||
17066715|NCT00439725|38209337|FG000|Observational Period|Clinical endpoint reached|3|||
17066716|NCT00439725|38209338|FG001|Observational Period|Clinical endpoint reached|1|||
17066717|NCT00439725|38209337|FG000|Observational Period|Technical problems|1|||
17066718|NCT00439725|38209338|FG001|Observational Period|Technical problems|0|||
17066719|NCT00439725|38209337|FG000|Observational Period|Participant convenience|1|||
17066720|NCT00439725|38209338|FG001|Observational Period|Participant convenience|0|||
17066721|NCT00521586|38209346|FG000|Initial Vaccination (Year 0)|Subject request|8|||
17066722|NCT00521586|38209347|FG001|Initial Vaccination (Year 0)|Subject request|11|||
17066723|NCT00521586|38209346|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
17066724|NCT00521586|38209347|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
17066725|NCT00521586|38209346|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
17066726|NCT00521586|38209347|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
17066727|NCT00521586|38209346|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
17066728|NCT00521586|38209347|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
17066729|NCT00521586|38209346|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
17066730|NCT00521586|38209347|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
17066731|NCT00521586|38209346|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
17066732|NCT00521586|38209347|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
17066733|NCT00521586|38209346|FG000|Initial Vaccination (Year 0)|Death|1|||
17066734|NCT00521586|38209347|FG001|Initial Vaccination (Year 0)|Death|0|||
17066735|NCT00521586|38209346|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
17066736|NCT00521586|38209347|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
17066737|NCT00521586|38209346|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
17066738|NCT00521586|38209347|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
17066739|NCT00521586|38209346|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
17066740|NCT00521586|38209347|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
17066741|NCT00521586|38209346|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
17066742|NCT00521586|38209347|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
17066743|NCT00521586|38209346|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
17066744|NCT00521586|38209347|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
17066745|NCT00521586|38209346|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
17066746|NCT00521586|38209347|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
17066747|NCT00521586|38209346|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
17066748|NCT00521586|38209347|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
17066749|NCT00521586|38209346|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
17066750|NCT00521586|38209347|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
17066751|NCT00521586|38209346|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
17066752|NCT00521586|38209347|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
17066753|NCT00521586|38209346|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
17066754|NCT00521586|38209347|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
17066755|NCT00521586|38209346|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
17066756|NCT00521586|38209347|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
17066757|NCT00521586|38209346|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
17066758|NCT00521586|38209347|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
17066759|NCT00515502|38209365|FG000|Treatment Period 1|Adverse Event|0|||
17066760|NCT00515502|38209366|FG001|Treatment Period 1|Adverse Event|0|||
17066761|NCT00515502|38209367|FG002|Treatment Period 1|Adverse Event|0|||
17066762|NCT00515502|38209368|FG003|Treatment Period 1|Adverse Event|0|||
17066763|NCT00515502|38209369|FG004|Treatment Period 1|Adverse Event|0|||
17066764|NCT00515502|38209370|FG005|Treatment Period 1|Adverse Event|0|||
17066765|NCT00515502|38209371|FG006|Treatment Period 1|Adverse Event|1|||
17066766|NCT00515502|38209372|FG007|Treatment Period 1|Adverse Event|0|||
17066767|NCT00515502|38209373|FG008|Treatment Period 1|Adverse Event|1|||
17066768|NCT00515502|38209374|FG009|Treatment Period 1|Adverse Event|0|||
17066769|NCT00515502|38209375|FG010|Treatment Period 1|Adverse Event|0|||
17066770|NCT00515502|38209376|FG011|Treatment Period 1|Adverse Event|1|||
17066771|NCT00515502|38209365|FG000|Treatment Period 2|Adverse Event|0|||
17066772|NCT00515502|38209366|FG001|Treatment Period 2|Adverse Event|1|||
17066773|NCT00515502|38209367|FG002|Treatment Period 2|Adverse Event|0|||
17066774|NCT00515502|38209368|FG003|Treatment Period 2|Adverse Event|0|||
17066775|NCT00515502|38209369|FG004|Treatment Period 2|Adverse Event|0|||
17066776|NCT00515502|38209370|FG005|Treatment Period 2|Adverse Event|0|||
17066777|NCT00515502|38209371|FG006|Treatment Period 2|Adverse Event|0|||
17066778|NCT00515502|38209372|FG007|Treatment Period 2|Adverse Event|0|||
17066779|NCT00515502|38209373|FG008|Treatment Period 2|Adverse Event|0|||
17066780|NCT00515502|38209374|FG009|Treatment Period 2|Adverse Event|0|||
17066781|NCT00515502|38209375|FG010|Treatment Period 2|Adverse Event|0|||
17066782|NCT00515502|38209376|FG011|Treatment Period 2|Adverse Event|0|||
17066783|NCT00439647|38209395|FG000|Overall Study|Withdrawal by Subject|25|||
17066784|NCT00439647|38209396|FG001|Overall Study|Withdrawal by Subject|22|||
17066785|NCT00439647|38209395|FG000|Overall Study|Death|15|||
17066786|NCT00439647|38209396|FG001|Overall Study|Death|18|||
17066787|NCT00439647|38209395|FG000|Overall Study|Adverse Event|11|||
17066788|NCT00439647|38209396|FG001|Overall Study|Adverse Event|11|||
17066789|NCT00439647|38209395|FG000|Overall Study|Lost to Follow-up|4|||
17066790|NCT00439647|38209396|FG001|Overall Study|Lost to Follow-up|12|||
17066791|NCT00439647|38209395|FG000|Overall Study|Protocol Violation|3|||
17066792|NCT00439647|38209396|FG001|Overall Study|Protocol Violation|4|||
17066793|NCT00439647|38209395|FG000|Overall Study|Lack of Efficacy|0|||
17066794|NCT00439647|38209396|FG001|Overall Study|Lack of Efficacy|4|||
17066795|NCT00515112|38209404|FG000|Overall Study|Death|0|||
17066796|NCT00515112|38209405|FG001|Overall Study|Death|1|||
17066797|NCT00515112|38209404|FG000|Overall Study|The study was terminated|3|||
17066798|NCT00515112|38209405|FG001|Overall Study|The study was terminated|2|||
17066799|NCT00404547|38209413|FG000|Overall Study|Adverse Event|39|||
17066800|NCT00404547|38209414|FG001|Overall Study|Adverse Event|6|||
17066801|NCT00404547|38209413|FG000|Overall Study|Withdrawal by Subject|19|||
17066802|NCT00404547|38209414|FG001|Overall Study|Withdrawal by Subject|2|||
17066803|NCT00404547|38209413|FG000|Overall Study|Protocol Violation|0|||
17066804|NCT00404547|38209414|FG001|Overall Study|Protocol Violation|1|||
17147815|NCT03052322|38292344|FG000|Overall Study|Protocol Violation|1|||
17147816|NCT03052322|38292345|FG001|Overall Study|Protocol Violation|0|||
17147817|NCT03052322|38292344|FG000|Overall Study|Lost to Follow-up|2|||
17147818|NCT03052322|38292345|FG001|Overall Study|Lost to Follow-up|4|||
17147819|NCT03052322|38292344|FG000|Overall Study|Adverse Event|6|||
17147820|NCT03052322|38292345|FG001|Overall Study|Adverse Event|13|||
17066805|NCT00404547|38209413|FG000|Overall Study|Lost to Follow-up|20|||
17066806|NCT00404547|38209414|FG001|Overall Study|Lost to Follow-up|9|||
17066807|NCT00404547|38209413|FG000|Overall Study|Lack of compliance|5|||
17066808|NCT00404547|38209414|FG001|Overall Study|Lack of compliance|1|||
17066809|NCT00404547|38209413|FG000|Overall Study|Other|4|||
17066810|NCT00404547|38209414|FG001|Overall Study|Other|0|||
17066811|NCT00404547|38209413|FG000|Overall Study|Reason not stated|3|||
17066812|NCT00404547|38209414|FG001|Overall Study|Reason not stated|6|||
17066813|NCT00515034|38209424|FG000|Overall Study|Adverse Event|2|||
17066814|NCT00515034|38209425|FG001|Overall Study|Adverse Event|0|||
17066815|NCT00515034|38209426|FG002|Overall Study|Adverse Event|1|||
17066816|NCT00515034|38209427|FG003|Overall Study|Adverse Event|0|||
17066817|NCT00515034|38209424|FG000|Overall Study|Death|4|||
17066818|NCT00515034|38209425|FG001|Overall Study|Death|2|||
17066819|NCT00515034|38209426|FG002|Overall Study|Death|1|||
17066820|NCT00515034|38209427|FG003|Overall Study|Death|3|||
17066821|NCT00515034|38209424|FG000|Overall Study|Withdrawal by Subject|1|||
17066822|NCT00515034|38209425|FG001|Overall Study|Withdrawal by Subject|0|||
17066823|NCT00515034|38209426|FG002|Overall Study|Withdrawal by Subject|3|||
17066824|NCT00515034|38209427|FG003|Overall Study|Withdrawal by Subject|0|||
17066825|NCT00515034|38209424|FG000|Overall Study|Physician Decision|0|||
17066826|NCT00515034|38209425|FG001|Overall Study|Physician Decision|0|||
17066827|NCT00515034|38209426|FG002|Overall Study|Physician Decision|1|||
17066828|NCT00515034|38209427|FG003|Overall Study|Physician Decision|1|||
17066829|NCT00515034|38209424|FG000|Overall Study|Other|1|||
17066830|NCT00515034|38209425|FG001|Overall Study|Other|0|||
17066831|NCT00515034|38209426|FG002|Overall Study|Other|2|||
17066832|NCT00515034|38209427|FG003|Overall Study|Other|1|||
17066833|NCT00404235|38209439|FG000|Overall Study|Withdrawal by Subject|1|||
17066834|NCT00404235|38209440|FG001|Overall Study|Withdrawal by Subject|2|||
17066835|NCT00404079|38209448|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
17066836|NCT00404079|38209449|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
17066837|NCT00403845|38209455|FG000|Treatment Period 1|Subject withdrew consent|1|||
17066838|NCT00403845|38209456|FG001|Treatment Period 1|Subject withdrew consent|0|||
17066839|NCT00403845|38209457|FG002|Treatment Period 1|Subject withdrew consent|0|||
17066840|NCT00403845|38209458|FG003|Treatment Period 1|Subject withdrew consent|0|||
17066841|NCT00403845|38209455|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
17066842|NCT00403845|38209456|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
17066843|NCT00403845|38209457|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
17066844|NCT00403845|38209458|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
17066845|NCT00403845|38209455|FG000|Treatment Period 2|Subject withdrew consent|1|||
17066846|NCT00403845|38209456|FG001|Treatment Period 2|Subject withdrew consent|0|||
17066847|NCT00403845|38209457|FG002|Treatment Period 2|Subject withdrew consent|0|||
17066848|NCT00403845|38209458|FG003|Treatment Period 2|Subject withdrew consent|0|||
17066849|NCT00403845|38209455|FG000|Treatment Period 3|Subject withdrew consent|0|||
17066850|NCT00403845|38209456|FG001|Treatment Period 3|Subject withdrew consent|0|||
17066851|NCT00403845|38209457|FG002|Treatment Period 3|Subject withdrew consent|0|||
17066852|NCT00403845|38209458|FG003|Treatment Period 3|Subject withdrew consent|1|||
17066853|NCT00403845|38209455|FG000|Treatment Period 3|Adverse Event|0|||
17066854|NCT00403845|38209456|FG001|Treatment Period 3|Adverse Event|0|||
17066855|NCT00403845|38209457|FG002|Treatment Period 3|Adverse Event|0|||
17066856|NCT00403845|38209458|FG003|Treatment Period 3|Adverse Event|1|||
17066857|NCT00509262|38209470|FG000|Overall Study|Adverse Event|16|||
17066858|NCT00509262|38209471|FG001|Overall Study|Adverse Event|18|||
17066859|NCT00509262|38209470|FG000|Overall Study|Other|2|||
17066860|NCT00509262|38209471|FG001|Overall Study|Other|2|||
17066861|NCT00509262|38209470|FG000|Overall Study|Lack of Efficacy|1|||
17066862|NCT00509262|38209471|FG001|Overall Study|Lack of Efficacy|0|||
17066863|NCT00509262|38209470|FG000|Overall Study|Lost to Follow-up|1|||
17066864|NCT00509262|38209471|FG001|Overall Study|Lost to Follow-up|6|||
17066865|NCT00509262|38209470|FG000|Overall Study|Physician Decision|1|||
17066866|NCT00509262|38209471|FG001|Overall Study|Physician Decision|3|||
17066867|NCT00509262|38209470|FG000|Overall Study|Protocol Violation|2|||
17066868|NCT00509262|38209471|FG001|Overall Study|Protocol Violation|2|||
17066869|NCT00509262|38209470|FG000|Overall Study|Withdrawal by Subject|24|||
17066870|NCT00509262|38209471|FG001|Overall Study|Withdrawal by Subject|11|||
17066871|NCT00607997|38209481|FG000|Overall Study|Lack of Efficacy|6|||
17066872|NCT00607997|38209482|FG001|Overall Study|Lack of Efficacy|20|||
17066873|NCT00607997|38209483|FG002|Overall Study|Lack of Efficacy|14|||
17066874|NCT00607997|38209484|FG003|Overall Study|Lack of Efficacy|10|||
17066875|NCT00607997|38209481|FG000|Overall Study|Death|8|||
17066876|NCT00607997|38209482|FG001|Overall Study|Death|5|||
17066877|NCT00607997|38209483|FG002|Overall Study|Death|2|||
17066878|NCT00607997|38209484|FG003|Overall Study|Death|5|||
17066879|NCT00607997|38209481|FG000|Overall Study|Adverse Event|3|||
17066880|NCT00607997|38209482|FG001|Overall Study|Adverse Event|1|||
17066881|NCT00607997|38209483|FG002|Overall Study|Adverse Event|2|||
17066882|NCT00607997|38209484|FG003|Overall Study|Adverse Event|0|||
17066883|NCT00607997|38209481|FG000|Overall Study|Physician Decision|4|||
17066884|NCT00607997|38209482|FG001|Overall Study|Physician Decision|1|||
17066885|NCT00607997|38209483|FG002|Overall Study|Physician Decision|0|||
17066886|NCT00607997|38209484|FG003|Overall Study|Physician Decision|0|||
17066887|NCT00607997|38209481|FG000|Overall Study|Relapse, recurrent illness|4|||
17066888|NCT00607997|38209482|FG001|Overall Study|Relapse, recurrent illness|0|||
17066889|NCT00607997|38209483|FG002|Overall Study|Relapse, recurrent illness|2|||
17066890|NCT00607997|38209484|FG003|Overall Study|Relapse, recurrent illness|0|||
17066891|NCT00607997|38209481|FG000|Overall Study|Other without explanation|2|||
17066892|NCT00607997|38209482|FG001|Overall Study|Other without explanation|0|||
17066893|NCT00607997|38209483|FG002|Overall Study|Other without explanation|4|||
17066894|NCT00607997|38209484|FG003|Overall Study|Other without explanation|1|||
17066895|NCT00509106|38209501|FG000|Overall Study|Adverse Event|3|||
17066896|NCT00509106|38209502|FG001|Overall Study|Adverse Event|2|||
17066897|NCT00509106|38209501|FG000|Overall Study|Noncompliance|0|||
17066898|NCT00509106|38209502|FG001|Overall Study|Noncompliance|1|||
17066899|NCT00509106|38209501|FG000|Overall Study|At the request of sponsor/investigator|1|||
17147821|NCT03521791|38292353|FG000|Overall Study|Protocol Violation|7|||
17147822|NCT03521791|38292354|FG001|Overall Study|Protocol Violation|17|||
17147823|NCT03521635|38292362|FG000|Overall Study|Adverse Event|1|||
17147824|NCT03521635|38292363|FG001|Overall Study|Adverse Event|1|||
17147825|NCT03521635|38292362|FG000|Overall Study|Refused to complete study visit|1|||
17147826|NCT03521635|38292363|FG001|Overall Study|Refused to complete study visit|0|||
17147827|NCT03521635|38292362|FG000|Overall Study|Refused to continue trial medication|2|||
17147828|NCT03521635|38292363|FG001|Overall Study|Refused to continue trial medication|2|||
17147829|NCT03521635|38292362|FG000|Overall Study|Lost to Follow-up|0|||
17147830|NCT03521635|38292363|FG001|Overall Study|Lost to Follow-up|1|||
17147831|NCT03521635|38292362|FG000|Overall Study|Meet exclusion criteria|0|||
17066900|NCT00509106|38209502|FG001|Overall Study|At the request of sponsor/investigator|2|||
17066901|NCT00509106|38209501|FG000|Overall Study|Withdrew consent|4|||
17066902|NCT00509106|38209502|FG001|Overall Study|Withdrew consent|8|||
17066903|NCT00509106|38209501|FG000|Overall Study|Lost to Follow-up|16|||
17066904|NCT00509106|38209502|FG001|Overall Study|Lost to Follow-up|10|||
17066905|NCT00509106|38209501|FG000|Overall Study|Other|1|||
17066906|NCT00509106|38209502|FG001|Overall Study|Other|0|||
17066907|NCT00509106|38209501|FG000|Overall Study|Death|6|||
17066908|NCT00509106|38209502|FG001|Overall Study|Death|6|||
17066909|NCT00607919|38209510|FG000|Acute Phase|Adverse Event|9|||
17066910|NCT00607919|38209511|FG001|Acute Phase|Adverse Event|2|||
17066911|NCT00607919|38209510|FG000|Acute Phase|Entry Criteria Not Met|1|||
17066912|NCT00607919|38209511|FG001|Acute Phase|Entry Criteria Not Met|1|||
17066913|NCT00607919|38209510|FG000|Acute Phase|Lack of Efficacy|1|||
17066914|NCT00607919|38209511|FG001|Acute Phase|Lack of Efficacy|2|||
17066915|NCT00607919|38209510|FG000|Acute Phase|Lost to Follow-up|9|||
17066916|NCT00607919|38209511|FG001|Acute Phase|Lost to Follow-up|3|||
17066917|NCT00607919|38209510|FG000|Acute Phase|Parent/Caregiver Decision|6|||
17066918|NCT00607919|38209511|FG001|Acute Phase|Parent/Caregiver Decision|4|||
17066919|NCT00607919|38209510|FG000|Acute Phase|Protocol Violation|5|||
17066920|NCT00607919|38209511|FG001|Acute Phase|Protocol Violation|1|||
17066921|NCT00607919|38209510|FG000|Acute Phase|Withdrawal by Subject|3|||
17066922|NCT00607919|38209511|FG001|Acute Phase|Withdrawal by Subject|3|||
17066923|NCT00607919|38209510|FG000|Open-Label Phase|Adverse Event|1|||
17066924|NCT00607919|38209511|FG001|Open-Label Phase|Adverse Event|5|||
17066925|NCT00607919|38209510|FG000|Open-Label Phase|Lost to Follow-up|4|||
17066926|NCT00607919|38209511|FG001|Open-Label Phase|Lost to Follow-up|1|||
17066927|NCT00607919|38209510|FG000|Open-Label Phase|Protocol Violation|2|||
17066928|NCT00607919|38209511|FG001|Open-Label Phase|Protocol Violation|2|||
17066929|NCT00607919|38209510|FG000|Open-Label Phase|Withdrawal by Subject|2|||
17066930|NCT00607919|38209511|FG001|Open-Label Phase|Withdrawal by Subject|2|||
17066931|NCT00607919|38209510|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
17066932|NCT00607919|38209511|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
17066933|NCT00344968|38209522|FG000|Overall Study|Adverse Event|5|||
17066934|NCT00344968|38209523|FG001|Overall Study|Adverse Event|4|||
17066935|NCT00344968|38209524|FG002|Overall Study|Adverse Event|15|||
17066936|NCT00344968|38209522|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
17066937|NCT00344968|38209523|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17066938|NCT00344968|38209524|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
17066939|NCT00344968|38209522|FG000|Overall Study|Protocol Violation|2|||
17066940|NCT00344968|38209523|FG001|Overall Study|Protocol Violation|2|||
17066941|NCT00344968|38209524|FG002|Overall Study|Protocol Violation|5|||
17066942|NCT00344968|38209522|FG000|Overall Study|Withdrawal by Subject|14|||
17066943|NCT00344968|38209523|FG001|Overall Study|Withdrawal by Subject|31|||
17066944|NCT00344968|38209524|FG002|Overall Study|Withdrawal by Subject|27|||
17066945|NCT00344968|38209522|FG000|Overall Study|Lost to Follow-up|24|||
17066946|NCT00344968|38209523|FG001|Overall Study|Lost to Follow-up|37|||
17066947|NCT00344968|38209524|FG002|Overall Study|Lost to Follow-up|37|||
17066948|NCT00344968|38209522|FG000|Overall Study|Death|11|||
17066949|NCT00344968|38209523|FG001|Overall Study|Death|27|||
17066950|NCT00344968|38209524|FG002|Overall Study|Death|31|||
17066951|NCT00344968|38209522|FG000|Overall Study|Other|0|||
17066952|NCT00344968|38209523|FG001|Overall Study|Other|1|||
17066953|NCT00344968|38209524|FG002|Overall Study|Other|0|||
17066954|NCT00509028|38209535|FG000|Overall Study|Adverse Event|2|||
17066955|NCT00509028|38209536|FG001|Overall Study|Adverse Event|0|||
17066956|NCT00509028|38209535|FG000|Overall Study|Withdrawal by Subject|4|||
17066957|NCT00509028|38209536|FG001|Overall Study|Withdrawal by Subject|3|||
17066958|NCT00509028|38209535|FG000|Overall Study|Lost to Follow-up|0|||
17066959|NCT00509028|38209536|FG001|Overall Study|Lost to Follow-up|1|||
17066960|NCT00509028|38209535|FG000|Overall Study|Protocol Violation|4|||
17066961|NCT00509028|38209536|FG001|Overall Study|Protocol Violation|2|||
17066962|NCT00509028|38209535|FG000|Overall Study|Non-compliance|2|||
17066963|NCT00509028|38209536|FG001|Overall Study|Non-compliance|1|||
17066964|NCT00352846|38209544|FG000|Overall Study|Disease progression|0|||
17066965|NCT00352846|38209545|FG001|Overall Study|Disease progression|2|||
17066966|NCT00352846|38209544|FG000|Overall Study|Withdrawal by Subject|3|||
17066967|NCT00352846|38209545|FG001|Overall Study|Withdrawal by Subject|8|||
17066968|NCT00352846|38209544|FG000|Overall Study|Ineligible|3|||
17066969|NCT00352846|38209545|FG001|Overall Study|Ineligible|2|||
17066970|NCT00352846|38209544|FG000|Overall Study|Non-compliance|2|||
17066971|NCT00352846|38209545|FG001|Overall Study|Non-compliance|0|||
17066972|NCT00352846|38209544|FG000|Overall Study|Death|0|||
17066973|NCT00352846|38209545|FG001|Overall Study|Death|1|||
17066974|NCT00508872|38209551|FG000|Overall Study|Lost to Follow-up|1|||
17066975|NCT00508872|38209551|FG000|Overall Study|Physician Decision|1|||
17066976|NCT00508482|38209558|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
17066977|NCT00508482|38209559|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
17066978|NCT00508482|38209560|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
17066979|NCT00508482|38209558|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
17147832|NCT03521635|38292363|FG001|Overall Study|Meet exclusion criteria|1|||
17147833|NCT03521635|38292362|FG000|Overall Study|Patient not taken study medicine|0|||
17147834|NCT03521635|38292363|FG001|Overall Study|Patient not taken study medicine|1|||
17066980|NCT00508482|38209559|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
17066981|NCT00508482|38209560|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
17066982|NCT00508482|38209558|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
17066983|NCT00508482|38209559|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
17066984|NCT00508482|38209560|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
17066985|NCT00344500|38209571|FG000|Overall Study|Adverse Event|6|||
17066986|NCT00344500|38209572|FG001|Overall Study|Adverse Event|2|||
17066987|NCT00344500|38209573|FG002|Overall Study|Adverse Event|0|||
17066988|NCT00344500|38209571|FG000|Overall Study|Lost to Follow-up|5|||
17066989|NCT00344500|38209572|FG001|Overall Study|Lost to Follow-up|13|||
17066990|NCT00344500|38209573|FG002|Overall Study|Lost to Follow-up|1|||
17066991|NCT00344500|38209571|FG000|Overall Study|Withdrawal by Subject|7|||
17066992|NCT00344500|38209572|FG001|Overall Study|Withdrawal by Subject|10|||
17066993|NCT00344500|38209573|FG002|Overall Study|Withdrawal by Subject|0|||
17066994|NCT00344500|38209571|FG000|Overall Study|Protocol Violation|4|||
17066995|NCT00344500|38209572|FG001|Overall Study|Protocol Violation|7|||
17066996|NCT00344500|38209573|FG002|Overall Study|Protocol Violation|1|||
17066997|NCT00344500|38209571|FG000|Overall Study|Not Noted|1|||
17066998|NCT00344500|38209572|FG001|Overall Study|Not Noted|3|||
17066999|NCT00344500|38209573|FG002|Overall Study|Not Noted|0|||
17067000|NCT00344032|38209582|FG000|Overall Study|Adverse Event|0|||
17067001|NCT00344032|38209583|FG001|Overall Study|Adverse Event|1|||
17067002|NCT00344032|38209582|FG000|Overall Study|Withdrawal by Subject|6|||
17067003|NCT00344032|38209583|FG001|Overall Study|Withdrawal by Subject|2|||
17067004|NCT00344032|38209582|FG000|Overall Study|Lost to Follow-up|4|||
17067005|NCT00344032|38209583|FG001|Overall Study|Lost to Follow-up|6|||
17067006|NCT00344032|38209582|FG000|Overall Study|Physician Decision|4|||
17067007|NCT00344032|38209583|FG001|Overall Study|Physician Decision|1|||
17067008|NCT00607373|38209591|FG000|Treatment Period|Adverse Event|0|||
17067009|NCT00607373|38209592|FG001|Treatment Period|Adverse Event|4|||
17067010|NCT00607373|38209591|FG000|Treatment Period|Physician Decision|0|||
17067011|NCT00607373|38209592|FG001|Treatment Period|Physician Decision|1|||
17067012|NCT00607373|38209591|FG000|Treatment Period|Withdrawal by Subject|0|||
17067013|NCT00607373|38209592|FG001|Treatment Period|Withdrawal by Subject|1|||
17067014|NCT00607373|38209591|FG000|Follow-up Period|Other|0|||
17067015|NCT00607373|38209592|FG001|Follow-up Period|Other|1|||
17067016|NCT00607373|38209591|FG000|Follow-up Period|Protocol Violation|0|||
17067017|NCT00607373|38209592|FG001|Follow-up Period|Protocol Violation|1|||
17067018|NCT00607373|38209591|FG000|Follow-up Period|Withdrawal by Subject|1|||
17067019|NCT00607373|38209592|FG001|Follow-up Period|Withdrawal by Subject|3|||
17067020|NCT00508404|38209598|FG000|Overall Study|Ongoing at Data Cut-off|12|||
17067021|NCT00508404|38209598|FG000|Overall Study|Adverse Event|2|||
17067022|NCT00508404|38209598|FG000|Overall Study|Death|16|||
17067023|NCT00508404|38209598|FG000|Overall Study|Physician Decision|2|||
17067024|NCT00508404|38209598|FG000|Overall Study|Withdrawal by Subject|3|||
17067025|NCT00508404|38209598|FG000|Overall Study|Protocol-specified Criteria|2|||
17067026|NCT00508404|38209598|FG000|Overall Study|Lost to Follow-up|2|||
17067027|NCT00508404|38209598|FG000|Overall Study|Other - Not Specified|3|||
17067028|NCT00352690|38209605|FG000|Overall Study|Determined to be ineligible|2|||
17067029|NCT00352690|38209606|FG001|Overall Study|Determined to be ineligible|0|||
17067030|NCT00609245|38209612|FG000|Overall Study|Adverse Event|1|||
17067031|NCT00343642|38209621|FG000|Overall Study|Lost to Follow-up|0|||
17067032|NCT00343642|38209622|FG001|Overall Study|Lost to Follow-up|1|||
17067033|NCT00343642|38209623|FG002|Overall Study|Lost to Follow-up|0|||
17067034|NCT00343642|38209621|FG000|Overall Study|Pregnancy|1|||
17067035|NCT00343642|38209622|FG001|Overall Study|Pregnancy|0|||
17067036|NCT00343642|38209623|FG002|Overall Study|Pregnancy|2|||
17067037|NCT00343642|38209621|FG000|Overall Study|Withdrawal by Subject|2|||
17067038|NCT00343642|38209622|FG001|Overall Study|Withdrawal by Subject|3|||
17067039|NCT00343642|38209623|FG002|Overall Study|Withdrawal by Subject|4|||
17067040|NCT00343642|38209621|FG000|Overall Study|Adverse Event|0|||
17067041|NCT00343642|38209622|FG001|Overall Study|Adverse Event|0|||
17067042|NCT00343642|38209623|FG002|Overall Study|Adverse Event|1|||
17067043|NCT00343642|38209621|FG000|Overall Study|Flare up|6|||
17067044|NCT00343642|38209622|FG001|Overall Study|Flare up|4|||
17067045|NCT00343642|38209623|FG002|Overall Study|Flare up|0|||
17067046|NCT00609167|38209636|FG000|Overall Study|Withdrawal by Subject|1|||
17067047|NCT00609167|38209637|FG001|Overall Study|Withdrawal by Subject|0|||
17067048|NCT00609167|38209636|FG000|Overall Study|Lack of Efficacy|1|||
17067049|NCT00609167|38209637|FG001|Overall Study|Lack of Efficacy|0|||
17067050|NCT00609167|38209636|FG000|Overall Study|Adverse Event|5|||
17067051|NCT00609167|38209637|FG001|Overall Study|Adverse Event|1|||
17067052|NCT00609167|38209636|FG000|Overall Study|Disease Progression|1|||
17067053|NCT00609167|38209637|FG001|Overall Study|Disease Progression|0|||
17067054|NCT00609167|38209636|FG000|Overall Study|Stem Cell Transplant|0|||
17067055|NCT00609167|38209637|FG001|Overall Study|Stem Cell Transplant|6|||
17067056|NCT00606281|38209645|FG000|Overall Study|Adverse Event|11|||
17067057|NCT00606281|38209646|FG001|Overall Study|Adverse Event|12|||
17067058|NCT00606281|38209645|FG000|Overall Study|Death|1|||
17067059|NCT00606281|38209646|FG001|Overall Study|Death|0|||
17067060|NCT00606281|38209645|FG000|Overall Study|Lack of Efficacy|28|||
17067061|NCT00606281|38209646|FG001|Overall Study|Lack of Efficacy|35|||
17067062|NCT00606281|38209645|FG000|Overall Study|Physician Decision|0|||
17067063|NCT00606281|38209646|FG001|Overall Study|Physician Decision|1|||
17067064|NCT00606281|38209645|FG000|Overall Study|Protocol Violation|3|||
17067065|NCT00606281|38209646|FG001|Overall Study|Protocol Violation|3|||
17067066|NCT00606281|38209645|FG000|Overall Study|Withdrawal by Subject|11|||
17067067|NCT00606281|38209646|FG001|Overall Study|Withdrawal by Subject|13|||
17067068|NCT00606281|38209645|FG000|Overall Study|Progression to depressive phase|1|||
17067069|NCT00606281|38209646|FG001|Overall Study|Progression to depressive phase|1|||
17067070|NCT00606281|38209645|FG000|Overall Study|Change of residence or other commitments|1|||
17067071|NCT00606281|38209646|FG001|Overall Study|Change of residence or other commitments|1|||
17067072|NCT00506142|38209654|FG000|Overall Study|Adverse Event|8|||
17067073|NCT00506142|38209655|FG001|Overall Study|Adverse Event|7|||
17067074|NCT00506142|38209654|FG000|Overall Study|Lack of Efficacy|21|||
17067075|NCT00506142|38209655|FG001|Overall Study|Lack of Efficacy|7|||
17067076|NCT00506142|38209654|FG000|Overall Study|Withdrawal by Subject|4|||
17067077|NCT00506142|38209655|FG001|Overall Study|Withdrawal by Subject|5|||
17067078|NCT00506142|38209654|FG000|Overall Study|Physician Decision|1|||
17067079|NCT00506142|38209655|FG001|Overall Study|Physician Decision|0|||
17067080|NCT00506142|38209654|FG000|Overall Study|New health condition|1|||
17067081|NCT00506142|38209655|FG001|Overall Study|New health condition|0|||
17067082|NCT00514020|38209661|FG000|Overall Study|Adverse Event|6|||
17067083|NCT00514020|38209661|FG000|Overall Study|Withdrawal by Subject|3|||
17067084|NCT00514020|38209661|FG000|Overall Study|Physician Decision|1|||
17067085|NCT00514020|38209661|FG000|Overall Study|disease progression|9|||
17067086|NCT00514020|38209661|FG000|Overall Study|other complicating disease|2|||
17067087|NCT00514020|38209661|FG000|Overall Study|patient went to radiation treatment|1|||
16993986|NCT01072175|38137821|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993987|NCT01072175|38137822|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
17067088|NCT00514020|38209661|FG000|Overall Study|"patients moved to the no tx group"|6|||
16993988|NCT01072175|38137823|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993989|NCT01072175|38137824|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993990|NCT01072175|38137825|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
16993991|NCT01072175|38137826|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993992|NCT01072175|38137827|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993993|NCT01072175|38137828|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
17067089|NCT00513708|38209668|FG000|Overall Study|Lost to Follow-up|4|||
16993994|NCT01072175|38137829|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16993995|NCT01072175|38137817|FG000|Part D (HPMC Capsules)|Death|0|||
16993996|NCT01072175|38137818|FG001|Part D (HPMC Capsules)|Death|0|||
16993997|NCT01072175|38137819|FG002|Part D (HPMC Capsules)|Death|0|||
16993998|NCT01072175|38137820|FG003|Part D (HPMC Capsules)|Death|0|||
16993999|NCT01072175|38137821|FG004|Part D (HPMC Capsules)|Death|0|||
16994000|NCT01072175|38137822|FG005|Part D (HPMC Capsules)|Death|0|||
16994001|NCT01072175|38137823|FG006|Part D (HPMC Capsules)|Death|0|||
16994002|NCT01072175|38137824|FG007|Part D (HPMC Capsules)|Death|0|||
16994003|NCT01072175|38137825|FG008|Part D (HPMC Capsules)|Death|0|||
16994004|NCT01072175|38137826|FG009|Part D (HPMC Capsules)|Death|10|||
16994005|NCT01072175|38137827|FG010|Part D (HPMC Capsules)|Death|12|||
17067090|NCT00513708|38209669|FG001|Overall Study|Lost to Follow-up|4|||
17067091|NCT00513708|38209670|FG002|Overall Study|Lost to Follow-up|4|||
17067092|NCT00513474|38209680|FG000|Overall Study|Death|6|||
17067093|NCT00513474|38209681|FG001|Overall Study|Death|9|||
17067094|NCT00513474|38209680|FG000|Overall Study|Participant Withdrew Consent|1|||
17067095|NCT00513474|38209681|FG001|Overall Study|Participant Withdrew Consent|0|||
17067096|NCT00505752|38209691|FG000|Overall Study|Adverse Event|1|||
17067097|NCT00505752|38209692|FG001|Overall Study|Adverse Event|0|||
17067098|NCT00505752|38209693|FG002|Overall Study|Adverse Event|1|||
17067099|NCT00505752|38209694|FG003|Overall Study|Adverse Event|0|||
17067100|NCT00505752|38209691|FG000|Overall Study|Lost to Follow-up|1|||
17067101|NCT00505752|38209692|FG001|Overall Study|Lost to Follow-up|0|||
17067102|NCT00505752|38209693|FG002|Overall Study|Lost to Follow-up|0|||
17067103|NCT00505752|38209694|FG003|Overall Study|Lost to Follow-up|0|||
17067104|NCT00505752|38209691|FG000|Overall Study|Lack of ovarian response|1|||
17067105|NCT00505752|38209692|FG001|Overall Study|Lack of ovarian response|3|||
17067106|NCT00505752|38209693|FG002|Overall Study|Lack of ovarian response|0|||
17067107|NCT00505752|38209694|FG003|Overall Study|Lack of ovarian response|0|||
17067108|NCT00505752|38209691|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
17067109|NCT00505752|38209692|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
17067110|NCT00505752|38209693|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
17067111|NCT00505752|38209694|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
17067112|NCT00505752|38209691|FG000|Overall Study|No oocytes retrieved|0|||
17067113|NCT00505752|38209692|FG001|Overall Study|No oocytes retrieved|2|||
17067114|NCT00505752|38209693|FG002|Overall Study|No oocytes retrieved|0|||
17067115|NCT00505752|38209694|FG003|Overall Study|No oocytes retrieved|1|||
17067116|NCT00505752|38209691|FG000|Overall Study|No Fertilization|1|||
17067117|NCT00505752|38209692|FG001|Overall Study|No Fertilization|1|||
17067118|NCT00505752|38209693|FG002|Overall Study|No Fertilization|2|||
17067119|NCT00505752|38209694|FG003|Overall Study|No Fertilization|1|||
17067120|NCT00505752|38209691|FG000|Overall Study|All embryos/blastocysts discarded|0|||
17067121|NCT00505752|38209692|FG001|Overall Study|All embryos/blastocysts discarded|0|||
17067122|NCT00505752|38209693|FG002|Overall Study|All embryos/blastocysts discarded|1|||
17067123|NCT00505752|38209694|FG003|Overall Study|All embryos/blastocysts discarded|1|||
17067124|NCT00505752|38209691|FG000|Overall Study|Other|1|||
17067125|NCT00505752|38209692|FG001|Overall Study|Other|2|||
17067126|NCT00505752|38209693|FG002|Overall Study|Other|1|||
17067127|NCT00505752|38209694|FG003|Overall Study|Other|2|||
17067128|NCT03601637|38209706|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
17067129|NCT03601637|38209707|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
16994006|NCT01072175|38137828|FG011|Part D (HPMC Capsules)|Death|28|||
16994007|NCT01072175|38137829|FG012|Part D (HPMC Capsules)|Death|26|||
16994008|NCT01072175|38137817|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
17067130|NCT03601637|38209706|FG000|Overall Study|Adverse Event|1|||
17067131|NCT03601637|38209707|FG001|Overall Study|Adverse Event|1|||
17067132|NCT03601637|38209706|FG000|Overall Study|Other|0|||
17067133|NCT03601637|38209707|FG001|Overall Study|Other|1|||
17067134|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
16994009|NCT01072175|38137818|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
16994010|NCT01072175|38137819|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
16994011|NCT01072175|38137820|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
16994012|NCT01072175|38137821|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
16994013|NCT01072175|38137822|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
16994014|NCT01072175|38137823|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
16994015|NCT01072175|38137824|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
16994016|NCT01072175|38137825|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
16994017|NCT01072175|38137826|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
16994018|NCT01072175|38137827|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
16994019|NCT01072175|38137828|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
16994020|NCT01072175|38137829|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
16994021|NCT01072175|38137817|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994022|NCT01072175|38137818|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994023|NCT01072175|38137819|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994024|NCT01072175|38137820|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994025|NCT01072175|38137821|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994026|NCT01072175|38137822|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
17067135|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
17067136|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Death|0|||
17067137|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Death|2|||
17067138|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
17067139|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
17067140|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
17067141|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
17067142|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
17067143|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
17067144|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
17067145|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
17067146|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
17067147|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
17067148|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
17067149|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
17067150|NCT00343252|38209722|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
17067151|NCT00343252|38209723|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
17067152|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
17067153|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
17067154|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Death|3|||
17067155|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Death|3|||
17067156|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
17067157|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
17067158|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
17067159|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
17067160|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
17067161|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
16781221|NCT02109562|37720391|FG000|Overall Study|Withdrawal by Subject|20|||
16781222|NCT02109562|37720392|FG001|Overall Study|Withdrawal by Subject|25|||
16781223|NCT02109562|37720393|FG002|Overall Study|Withdrawal by Subject|21|||
16781224|NCT02109562|37720391|FG000|Overall Study|Physician Decision|3|||
16781225|NCT02109562|37720392|FG001|Overall Study|Physician Decision|4|||
16781226|NCT02109562|37720393|FG002|Overall Study|Physician Decision|5|||
16868016|NCT01536145|37841036|FG003|Overall Study|Withdrawal by Subject|0|||
17067162|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
16994027|NCT01072175|38137823|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994028|NCT01072175|38137824|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994029|NCT01072175|38137825|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994030|NCT01072175|38137826|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16994031|NCT01072175|38137827|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
16994032|NCT01072175|38137828|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
16994033|NCT01072175|38137829|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
16994034|NCT01072175|38137817|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
16994035|NCT01072175|38137818|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
16994036|NCT01072175|38137819|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
16994037|NCT01072175|38137820|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
16994038|NCT01072175|38137821|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
16994039|NCT01072175|38137822|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
17067163|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
17067164|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
17147835|NCT03170544|38292381|FG000|Part 1|Lost to Follow-up|1|||
17147836|NCT03170544|38292382|FG001|Part 1|Lost to Follow-up|0|||
17147837|NCT03170544|38292383|FG002|Part 1|Lost to Follow-up|0|||
17067165|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
17067166|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
17067167|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
17067168|NCT00343252|38209722|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
16868017|NCT01536145|37841037|FG004|Overall Study|Withdrawal by Subject|0|||
16994040|NCT01072175|38137823|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
16994041|NCT01072175|38137824|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
17067169|NCT00343252|38209723|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
17067170|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
17147838|NCT03170544|38292384|FG003|Part 1|Lost to Follow-up|0|||
17067171|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
17067172|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Death|4|||
17067173|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Death|5|||
17067174|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
17067175|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
17067176|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
17067177|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
17067178|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
17067179|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
17067180|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
17067181|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
17067182|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
17067183|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
17067184|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
17067185|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
17067186|NCT00343252|38209722|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
16781227|NCT02109484|37720409|FG000|Overall Study|Lost to Follow-up|0|||
17067187|NCT00343252|38209723|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
17067188|NCT00342628|38209732|FG000|Overall Study|Withdrawal by Subject|19|||
17067189|NCT00342628|38209733|FG001|Overall Study|Withdrawal by Subject|19|||
17067190|NCT00342628|38209734|FG002|Overall Study|Withdrawal by Subject|18|||
16781228|NCT02109484|37720410|FG001|Overall Study|Lost to Follow-up|0|||
16781229|NCT02109484|37720411|FG002|Overall Study|Lost to Follow-up|0|||
16781230|NCT02109484|37720412|FG003|Overall Study|Lost to Follow-up|1|||
17067191|NCT00342628|38209732|FG000|Overall Study|Death|1|||
17067192|NCT00342628|38209733|FG001|Overall Study|Death|1|||
17067193|NCT00342628|38209734|FG002|Overall Study|Death|0|||
17067194|NCT00342628|38209732|FG000|Overall Study|moved residence|0|||
17067195|NCT00342628|38209733|FG001|Overall Study|moved residence|1|||
17067196|NCT00342628|38209734|FG002|Overall Study|moved residence|1|||
17067197|NCT00505284|38209747|FG000|Overall Study|Adverse Event|3|||
17067198|NCT00505284|38209748|FG001|Overall Study|Adverse Event|7|||
17067199|NCT00505284|38209749|FG002|Overall Study|Adverse Event|9|||
17067200|NCT00505284|38209750|FG003|Overall Study|Adverse Event|14|||
16781231|NCT02109484|37720413|FG004|Overall Study|Lost to Follow-up|1|||
16781232|NCT02109484|37720414|FG005|Overall Study|Lost to Follow-up|0|||
16781233|NCT02109484|37720415|FG006|Overall Study|Lost to Follow-up|1|||
16781234|NCT02109484|37720416|FG007|Overall Study|Lost to Follow-up|0|||
16781235|NCT02109484|37720409|FG000|Overall Study|Withdrawal by Subject|0|||
17067201|NCT00505284|38209751|FG004|Overall Study|Adverse Event|22|||
17067202|NCT00505284|38209747|FG000|Overall Study|Protocol Violation|0|||
17067203|NCT00505284|38209748|FG001|Overall Study|Protocol Violation|1|||
17067204|NCT00505284|38209749|FG002|Overall Study|Protocol Violation|1|||
17067205|NCT00505284|38209750|FG003|Overall Study|Protocol Violation|0|||
17067206|NCT00505284|38209751|FG004|Overall Study|Protocol Violation|0|||
17067207|NCT00505284|38209747|FG000|Overall Study|Withdrawal by Subject|2|||
17067208|NCT00505284|38209748|FG001|Overall Study|Withdrawal by Subject|6|||
17067209|NCT00505284|38209749|FG002|Overall Study|Withdrawal by Subject|1|||
17067210|NCT00505284|38209750|FG003|Overall Study|Withdrawal by Subject|0|||
17067211|NCT00505284|38209751|FG004|Overall Study|Withdrawal by Subject|6|||
17067212|NCT00505284|38209747|FG000|Overall Study|Lack of Efficacy|0|||
17067213|NCT00505284|38209748|FG001|Overall Study|Lack of Efficacy|1|||
17067214|NCT00505284|38209749|FG002|Overall Study|Lack of Efficacy|1|||
17067215|NCT00505284|38209750|FG003|Overall Study|Lack of Efficacy|1|||
17067216|NCT00505284|38209751|FG004|Overall Study|Lack of Efficacy|1|||
17067217|NCT00505284|38209747|FG000|Overall Study|Physician Decision|0|||
17067218|NCT00505284|38209748|FG001|Overall Study|Physician Decision|1|||
16781236|NCT02109484|37720410|FG001|Overall Study|Withdrawal by Subject|0|||
16781237|NCT02109484|37720411|FG002|Overall Study|Withdrawal by Subject|0|||
17067219|NCT00505284|38209749|FG002|Overall Study|Physician Decision|0|||
17067220|NCT00505284|38209750|FG003|Overall Study|Physician Decision|0|||
17067221|NCT00505284|38209751|FG004|Overall Study|Physician Decision|0|||
17067222|NCT00505284|38209747|FG000|Overall Study|Other|5|||
17067223|NCT00505284|38209748|FG001|Overall Study|Other|0|||
17067224|NCT00505284|38209749|FG002|Overall Study|Other|0|||
17067225|NCT00505284|38209750|FG003|Overall Study|Other|4|||
17067226|NCT00505284|38209751|FG004|Overall Study|Other|4|||
17067227|NCT00337168|38209763|FG000|Overall Study|Death|5|||
17067228|NCT00337168|38209763|FG000|Overall Study|Not protocol specified|2|||
17067229|NCT00337168|38209763|FG000|Overall Study|Did not start therapy|1|||
17067230|NCT00606905|38209770|FG000|Overall Study|No Pregnancy|9|||
17067231|NCT00606905|38209771|FG001|Overall Study|No Pregnancy|6|||
17067232|NCT00606905|38209770|FG000|Overall Study|Non-Index Pregnancy|1|||
17067233|NCT00606905|38209771|FG001|Overall Study|Non-Index Pregnancy|4|||
17147839|NCT03170544|38292385|FG004|Part 1|Lost to Follow-up|0|||
17147840|NCT03170544|38292386|FG005|Part 1|Lost to Follow-up|0|||
17147841|NCT03170544|38292387|FG006|Part 1|Lost to Follow-up|0|||
17147842|NCT03170544|38292388|FG007|Part 1|Lost to Follow-up|0|||
17067234|NCT00606905|38209770|FG000|Overall Study|Withdrew|5|||
17067235|NCT00606905|38209771|FG001|Overall Study|Withdrew|5|||
17067236|NCT00606593|38209777|FG000|Overall Study|Adverse Event|0|||
17067237|NCT00606593|38209778|FG001|Overall Study|Adverse Event|0|||
17067238|NCT00606593|38209779|FG002|Overall Study|Adverse Event|0|||
17067239|NCT00606593|38209780|FG003|Overall Study|Adverse Event|1|||
17067240|NCT00606593|38209781|FG004|Overall Study|Adverse Event|1|||
17067241|NCT00606593|38209782|FG005|Overall Study|Adverse Event|0|||
17067242|NCT00606593|38209783|FG006|Overall Study|Adverse Event|1|||
17067243|NCT00606593|38209784|FG007|Overall Study|Adverse Event|2|||
17067244|NCT00606593|38209785|FG008|Overall Study|Adverse Event|1|||
17067245|NCT00606593|38209786|FG009|Overall Study|Adverse Event|0|||
17067246|NCT00606593|38209777|FG000|Overall Study|Withdrawal of consent|1|||
17067247|NCT00606593|38209778|FG001|Overall Study|Withdrawal of consent|0|||
17067248|NCT00606593|38209779|FG002|Overall Study|Withdrawal of consent|1|||
17067249|NCT00606593|38209780|FG003|Overall Study|Withdrawal of consent|0|||
17067250|NCT00606593|38209781|FG004|Overall Study|Withdrawal of consent|0|||
17067251|NCT00606593|38209782|FG005|Overall Study|Withdrawal of consent|0|||
17067252|NCT00606593|38209783|FG006|Overall Study|Withdrawal of consent|0|||
17067253|NCT00606593|38209784|FG007|Overall Study|Withdrawal of consent|0|||
17067254|NCT00606593|38209785|FG008|Overall Study|Withdrawal of consent|0|||
17067255|NCT00606593|38209786|FG009|Overall Study|Withdrawal of consent|0|||
17067256|NCT00606593|38209777|FG000|Overall Study|Administrative/Other|0|||
17067257|NCT00606593|38209778|FG001|Overall Study|Administrative/Other|0|||
17067258|NCT00606593|38209779|FG002|Overall Study|Administrative/Other|1|||
17067259|NCT00606593|38209780|FG003|Overall Study|Administrative/Other|0|||
17067260|NCT00606593|38209781|FG004|Overall Study|Administrative/Other|0|||
17067261|NCT00606593|38209782|FG005|Overall Study|Administrative/Other|0|||
17067262|NCT00606593|38209783|FG006|Overall Study|Administrative/Other|0|||
17067263|NCT00606593|38209784|FG007|Overall Study|Administrative/Other|0|||
17067264|NCT00606593|38209785|FG008|Overall Study|Administrative/Other|0|||
17067265|NCT00606593|38209786|FG009|Overall Study|Administrative/Other|0|||
17067266|NCT00605267|38209801|FG000|Overall Study|Adverse Event|0|||
17067267|NCT00605267|38209802|FG001|Overall Study|Adverse Event|1|||
17067268|NCT00605267|38209801|FG000|Overall Study|Lack of Efficacy|1|||
17067269|NCT00605267|38209802|FG001|Overall Study|Lack of Efficacy|5|||
17067270|NCT00605267|38209801|FG000|Overall Study|Withdrawal by Subject|2|||
17067271|NCT00605267|38209802|FG001|Overall Study|Withdrawal by Subject|3|||
17067272|NCT00605813|38209808|FG000|Overall Study|Protocol Violation|25|||
17067273|NCT00604721|38209821|FG000|Overall Study|Physician Decision|1|||
17067274|NCT00604721|38209821|FG000|Overall Study|Withdrawal by Subject|1|||
17067275|NCT00605657|38209826|FG000|Overall Study|Adverse Event|1|||
17067276|NCT00605657|38209826|FG000|Overall Study|Protocol Violation|1|||
17067277|NCT00604565|38209832|FG000|Overall Study|Study terminated|0|||
17067278|NCT00604565|38209833|FG001|Overall Study|Study terminated|3|||
17067279|NCT00605345|38209841|FG000|Overall Study|Withdrawal by Subject|1|||
17067280|NCT00605345|38209842|FG001|Overall Study|Withdrawal by Subject|0|||
17067281|NCT00605345|38209841|FG000|Overall Study|Adverse Event|0|||
17067282|NCT00605345|38209842|FG001|Overall Study|Adverse Event|1|||
17067283|NCT00605345|38209841|FG000|Overall Study|Protocol Violation|0|||
17067284|NCT00605345|38209842|FG001|Overall Study|Protocol Violation|2|||
17067285|NCT00604175|38209851|FG000|Entry Through Week 28|Death|2|||
17067286|NCT00604175|38209852|FG001|Entry Through Week 28|Death|0|||
17067287|NCT00604175|38209853|FG002|Entry Through Week 28|Death|0|||
17067288|NCT00604175|38209851|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
17067289|NCT00604175|38209852|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
17067290|NCT00604175|38209853|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
17067291|NCT00604175|38209851|FG000|Entry Through Week 28|Lost to Follow-up|4|||
17067292|NCT00604175|38209852|FG001|Entry Through Week 28|Lost to Follow-up|3|||
17067293|NCT00604175|38209853|FG002|Entry Through Week 28|Lost to Follow-up|0|||
17067294|NCT00604175|38209851|FG000|Entry Through Week 28|Ineligible|1|||
17067295|NCT00604175|38209852|FG001|Entry Through Week 28|Ineligible|0|||
17067296|NCT00604175|38209853|FG002|Entry Through Week 28|Ineligible|0|||
17067297|NCT00604175|38209851|FG000|Entry Through Week 28|Did not start intervention|2|||
17067298|NCT00604175|38209852|FG001|Entry Through Week 28|Did not start intervention|0|||
17067299|NCT00604175|38209853|FG002|Entry Through Week 28|Did not start intervention|1|||
17067300|NCT00604175|38209851|FG000|Week 29 Through Week 72|Death|0|||
17067301|NCT00604175|38209852|FG001|Week 29 Through Week 72|Death|0|||
17067302|NCT00604175|38209853|FG002|Week 29 Through Week 72|Death|1|||
17067303|NCT00604175|38209851|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
17067304|NCT00604175|38209852|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
17067305|NCT00604175|38209853|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
17067306|NCT00604175|38209851|FG000|Week 29 Through Week 72|Site closure|0|||
17067307|NCT00604175|38209852|FG001|Week 29 Through Week 72|Site closure|1|||
17067308|NCT00604175|38209853|FG002|Week 29 Through Week 72|Site closure|0|||
17067309|NCT00604175|38209851|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
17067310|NCT00604175|38209852|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
17067311|NCT00604175|38209853|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
17067312|NCT00605189|38209888|FG000|Overall Study|Adverse Event|1|||
17067313|NCT00605189|38209889|FG001|Overall Study|Adverse Event|0|||
17067314|NCT00605189|38209890|FG002|Overall Study|Adverse Event|0|||
17067315|NCT00605189|38209888|FG000|Overall Study|Other|2|||
17067316|NCT00605189|38209889|FG001|Overall Study|Other|2|||
17067317|NCT00605189|38209890|FG002|Overall Study|Other|0|||
17067318|NCT00340834|38209903|FG000|Core Phase of Study|Adverse Event|26|||
17067319|NCT00340834|38209904|FG001|Core Phase of Study|Adverse Event|9|||
17067320|NCT00340834|38209905|FG002|Core Phase of Study|Adverse Event|9|||
17067321|NCT00340834|38209906|FG003|Core Phase of Study|Adverse Event|0|||
17067322|NCT00340834|38209907|FG004|Core Phase of Study|Adverse Event|0|||
17067323|NCT00340834|38209903|FG000|Core Phase of Study|Withdrawal by Subject|11|||
17067324|NCT00340834|38209904|FG001|Core Phase of Study|Withdrawal by Subject|9|||
17067325|NCT00340834|38209905|FG002|Core Phase of Study|Withdrawal by Subject|16|||
17067326|NCT00340834|38209906|FG003|Core Phase of Study|Withdrawal by Subject|0|||
17067327|NCT00340834|38209907|FG004|Core Phase of Study|Withdrawal by Subject|0|||
17067328|NCT00340834|38209903|FG000|Core Phase of Study|Administrative Problems|6|||
17067329|NCT00340834|38209904|FG001|Core Phase of Study|Administrative Problems|2|||
17067330|NCT00340834|38209905|FG002|Core Phase of Study|Administrative Problems|7|||
17067331|NCT00340834|38209906|FG003|Core Phase of Study|Administrative Problems|0|||
17067332|NCT00340834|38209907|FG004|Core Phase of Study|Administrative Problems|0|||
17067333|NCT00340834|38209903|FG000|Core Phase of Study|Lack of Efficacy|3|||
17067334|NCT00340834|38209904|FG001|Core Phase of Study|Lack of Efficacy|3|||
17067335|NCT00340834|38209905|FG002|Core Phase of Study|Lack of Efficacy|7|||
17067336|NCT00340834|38209906|FG003|Core Phase of Study|Lack of Efficacy|0|||
17067337|NCT00340834|38209907|FG004|Core Phase of Study|Lack of Efficacy|0|||
17067338|NCT00340834|38209903|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
17067339|NCT00340834|38209904|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
17147843|NCT03170544|38292389|FG008|Part 1|Lost to Follow-up|0|||
17147844|NCT03170544|38292390|FG009|Part 1|Lost to Follow-up|0|||
17147845|NCT03170544|38292391|FG010|Part 1|Lost to Follow-up|0|||
17147846|NCT03170544|38292392|FG011|Part 1|Lost to Follow-up|0|||
17147847|NCT03170544|38292381|FG000|Part 1|Not treated|0|||
17147848|NCT03170544|38292382|FG001|Part 1|Not treated|0|||
17067340|NCT00340834|38209905|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
17067341|NCT00340834|38209906|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
17067342|NCT00340834|38209907|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
17067343|NCT00340834|38209903|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
17067344|NCT00340834|38209904|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
17067345|NCT00340834|38209905|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
17067346|NCT00340834|38209906|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
17067347|NCT00340834|38209907|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
17067348|NCT00340834|38209903|FG000|Core Phase of Study|Lost to Follow-up|1|||
17067349|NCT00340834|38209904|FG001|Core Phase of Study|Lost to Follow-up|1|||
17067350|NCT00340834|38209905|FG002|Core Phase of Study|Lost to Follow-up|4|||
17067351|NCT00340834|38209906|FG003|Core Phase of Study|Lost to Follow-up|0|||
17067352|NCT00340834|38209907|FG004|Core Phase of Study|Lost to Follow-up|0|||
17067353|NCT00340834|38209903|FG000|Core Phase of Study|Death|2|||
17067354|NCT00340834|38209904|FG001|Core Phase of Study|Death|0|||
17067355|NCT00340834|38209905|FG002|Core Phase of Study|Death|0|||
17067356|NCT00340834|38209906|FG003|Core Phase of Study|Death|0|||
17067357|NCT00340834|38209907|FG004|Core Phase of Study|Death|0|||
17067358|NCT00340834|38209903|FG000|Core Phase of Study|Protocol Violation|0|||
17067359|NCT00340834|38209904|FG001|Core Phase of Study|Protocol Violation|0|||
17147849|NCT03170544|38292383|FG002|Part 1|Not treated|0|||
17067360|NCT00340834|38209905|FG002|Core Phase of Study|Protocol Violation|2|||
17067361|NCT00340834|38209906|FG003|Core Phase of Study|Protocol Violation|0|||
17067362|NCT00340834|38209907|FG004|Core Phase of Study|Protocol Violation|0|||
17067363|NCT00340834|38209903|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
17067364|NCT00340834|38209904|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
17067365|NCT00340834|38209905|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
17067366|NCT00340834|38209906|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
17067367|NCT00340834|38209907|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
17067368|NCT00340834|38209903|FG000|Extension Phase of Study|Subject withdrew consent|26|||
17067369|NCT00340834|38209904|FG001|Extension Phase of Study|Subject withdrew consent|31|||
17067370|NCT00340834|38209905|FG002|Extension Phase of Study|Subject withdrew consent|0|||
17067371|NCT00340834|38209906|FG003|Extension Phase of Study|Subject withdrew consent|12|||
17067372|NCT00340834|38209907|FG004|Extension Phase of Study|Subject withdrew consent|15|||
17067373|NCT00340834|38209903|FG000|Extension Phase of Study|Adverse Event|21|||
17067374|NCT00340834|38209904|FG001|Extension Phase of Study|Adverse Event|22|||
17067375|NCT00340834|38209905|FG002|Extension Phase of Study|Adverse Event|0|||
17067376|NCT00340834|38209906|FG003|Extension Phase of Study|Adverse Event|19|||
17067377|NCT00340834|38209907|FG004|Extension Phase of Study|Adverse Event|7|||
17067378|NCT00340834|38209903|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
17067379|NCT00340834|38209904|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
17067380|NCT00340834|38209905|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
17067381|NCT00340834|38209906|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
17067382|NCT00340834|38209907|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
17067383|NCT00340834|38209903|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
17067384|NCT00340834|38209904|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
17067385|NCT00340834|38209905|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
17067386|NCT00340834|38209906|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
17067387|NCT00340834|38209907|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
17067388|NCT00340834|38209903|FG000|Extension Phase of Study|Lost to Follow-up|1|||
17067389|NCT00340834|38209904|FG001|Extension Phase of Study|Lost to Follow-up|1|||
17067390|NCT00340834|38209905|FG002|Extension Phase of Study|Lost to Follow-up|0|||
17067391|NCT00340834|38209906|FG003|Extension Phase of Study|Lost to Follow-up|2|||
17067392|NCT00340834|38209907|FG004|Extension Phase of Study|Lost to Follow-up|3|||
17067393|NCT00340834|38209903|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
17067394|NCT00340834|38209904|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
17067395|NCT00340834|38209905|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
17067396|NCT00340834|38209906|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
17067397|NCT00340834|38209907|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
17067398|NCT00340834|38209903|FG000|Extension Phase of Study|Administrative problems|3|||
17067399|NCT00340834|38209904|FG001|Extension Phase of Study|Administrative problems|0|||
17067400|NCT00340834|38209905|FG002|Extension Phase of Study|Administrative problems|0|||
17067401|NCT00340834|38209906|FG003|Extension Phase of Study|Administrative problems|1|||
17067402|NCT00340834|38209907|FG004|Extension Phase of Study|Administrative problems|1|||
17067403|NCT00340834|38209903|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
17067404|NCT00340834|38209904|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
17067405|NCT00340834|38209905|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
17067406|NCT00340834|38209906|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
17067407|NCT00340834|38209907|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
17067408|NCT00340834|38209903|FG000|Extension Phase of Study|Protocol Violation|3|||
17067409|NCT00340834|38209904|FG001|Extension Phase of Study|Protocol Violation|0|||
17147850|NCT03170544|38292384|FG003|Part 1|Not treated|1|||
17147851|NCT03170544|38292385|FG004|Part 1|Not treated|0|||
17147852|NCT03170544|38292386|FG005|Part 1|Not treated|0|||
17067410|NCT00340834|38209905|FG002|Extension Phase of Study|Protocol Violation|0|||
17067411|NCT00340834|38209906|FG003|Extension Phase of Study|Protocol Violation|0|||
17067412|NCT00340834|38209907|FG004|Extension Phase of Study|Protocol Violation|0|||
17067413|NCT00340834|38209903|FG000|Extension Phase of Study|Death|0|||
17067414|NCT00340834|38209904|FG001|Extension Phase of Study|Death|0|||
17067415|NCT00340834|38209905|FG002|Extension Phase of Study|Death|0|||
17067416|NCT00340834|38209906|FG003|Extension Phase of Study|Death|0|||
17067417|NCT00340834|38209907|FG004|Extension Phase of Study|Death|1|||
17067418|NCT00603941|38209920|FG000|Overall Study|Disease progression|6|||
17067419|NCT00603941|38209921|FG001|Overall Study|Disease progression|7|||
17067420|NCT00603941|38209922|FG002|Overall Study|Disease progression|1|||
17067421|NCT00603941|38209920|FG000|Overall Study|Adverse Event|1|||
17067422|NCT00603941|38209921|FG001|Overall Study|Adverse Event|0|||
17067423|NCT00603941|38209922|FG002|Overall Study|Adverse Event|1|||
17067424|NCT00603941|38209920|FG000|Overall Study|Physician Decision|0|||
17067425|NCT00603941|38209921|FG001|Overall Study|Physician Decision|1|||
17067426|NCT00603941|38209922|FG002|Overall Study|Physician Decision|0|||
17067427|NCT00603941|38209920|FG000|Overall Study|Withdrawal by Subject|0|||
17067428|NCT00603941|38209921|FG001|Overall Study|Withdrawal by Subject|2|||
17067429|NCT00603941|38209922|FG002|Overall Study|Withdrawal by Subject|0|||
17067430|NCT00340678|38209935|FG000|Overall Study|Lost to Follow-up|1|||
17067431|NCT00340678|38209936|FG001|Overall Study|Lost to Follow-up|0|||
17067432|NCT00340678|38209937|FG002|Overall Study|Lost to Follow-up|0|||
17067433|NCT00340678|38209938|FG003|Overall Study|Lost to Follow-up|0|||
17067434|NCT00336856|38209946|FG000|Overall Study|Withdrawal by Subject|3|||
17067435|NCT00336856|38209946|FG000|Overall Study|Found ineligible at time of analysis|1|||
17067436|NCT00336544|38209952|FG000|Overall Study|Lack of Efficacy|8|||
17067437|NCT00336544|38209953|FG001|Overall Study|Lack of Efficacy|5|||
17067438|NCT00336544|38209952|FG000|Overall Study|Adverse Event|4|||
17067439|NCT00336544|38209953|FG001|Overall Study|Adverse Event|9|||
17147853|NCT03170544|38292387|FG006|Part 1|Not treated|0|||
17147854|NCT03170544|38292388|FG007|Part 1|Not treated|0|||
17147855|NCT03170544|38292389|FG008|Part 1|Not treated|0|||
17147856|NCT03170544|38292390|FG009|Part 1|Not treated|0|||
17147857|NCT03170544|38292391|FG010|Part 1|Not treated|0|||
17147858|NCT03170544|38292392|FG011|Part 1|Not treated|0|||
17147859|NCT03582943|38292477|FG000|Allocated to Groups|Withdrawal by Subject|1|||
17147860|NCT03582943|38292478|FG001|Allocated to Groups|Withdrawal by Subject|1|||
17067440|NCT00336544|38209952|FG000|Overall Study|Withdrawal by Subject|4|||
17067441|NCT00336544|38209953|FG001|Overall Study|Withdrawal by Subject|3|||
17067442|NCT00336544|38209952|FG000|Overall Study|Other|3|||
17067443|NCT00336544|38209953|FG001|Overall Study|Other|5|||
17067444|NCT00605033|38209961|FG000|Overall Study|Adverse Event|2|||
17067445|NCT00605033|38209962|FG001|Overall Study|Adverse Event|2|||
17067446|NCT00605033|38209961|FG000|Overall Study|Lost to Follow-up|1|||
17067447|NCT00605033|38209962|FG001|Overall Study|Lost to Follow-up|1|||
17067448|NCT00605033|38209961|FG000|Overall Study|Withdrawal by Subject|3|||
17067449|NCT00605033|38209962|FG001|Overall Study|Withdrawal by Subject|4|||
17067450|NCT00605033|38209961|FG000|Overall Study|Protocol Violation|1|||
17067451|NCT00605033|38209962|FG001|Overall Study|Protocol Violation|1|||
17067452|NCT00339040|38209970|FG000|Stage I|Not able to attend clinic|1|||
17067453|NCT00339040|38209971|FG001|Stage I|Not able to attend clinic|0|||
17067454|NCT00339040|38209970|FG000|Stage I|Protocol Violation|1|||
17067455|NCT00339040|38209971|FG001|Stage I|Protocol Violation|1|||
17067456|NCT00339040|38209970|FG000|Stage II|Lost to Follow-up|3|||
17067457|NCT00339040|38209971|FG001|Stage II|Lost to Follow-up|0|||
17147861|NCT03582943|38292477|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
17147862|NCT03582943|38292478|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
17147863|NCT03582943|38292477|FG000|Analyzed|Protocol Violation|4|||
17147864|NCT03582943|38292478|FG001|Analyzed|Protocol Violation|1|||
17147865|NCT03532009|38292486|FG000|Overall Study|Other|1|||
17147866|NCT03532009|38292487|FG001|Overall Study|Other|1|||
17147867|NCT03532009|38292486|FG000|Overall Study|Death|1|||
17147868|NCT03532009|38292487|FG001|Overall Study|Death|1|||
17147869|NCT03532009|38292486|FG000|Overall Study|Withdrawal by Patient|0|||
17147870|NCT03532009|38292487|FG001|Overall Study|Withdrawal by Patient|2|||
17067458|NCT00339040|38209970|FG000|Stage II|Withdrawal by Subject|1|||
17067459|NCT00339040|38209971|FG001|Stage II|Withdrawal by Subject|2|||
17067460|NCT00339040|38209970|FG000|Stage II|Protocol Violation|3|||
17067461|NCT00339040|38209971|FG001|Stage II|Protocol Violation|0|||
17147871|NCT03520387|38292498|FG000|Pre-Randomization|Withdrawal by Subject|1|||
17147872|NCT03520387|38292499|FG001|Pre-Randomization|Withdrawal by Subject|0|||
17147873|NCT03520387|38292500|FG002|Pre-Randomization|Withdrawal by Subject|0|||
17147874|NCT03520387|38292501|FG003|Pre-Randomization|Withdrawal by Subject|0|||
17147875|NCT03520387|38292502|FG004|Pre-Randomization|Withdrawal by Subject|0|||
17147876|NCT03520387|38292498|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
17147877|NCT03520387|38292499|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
17147878|NCT03520387|38292500|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
17147879|NCT03520387|38292501|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
17067462|NCT00339040|38209970|FG000|Stage II|Not able to attend clinic|1|||
17067463|NCT00339040|38209971|FG001|Stage II|Not able to attend clinic|0|||
17067464|NCT00339040|38209970|FG000|Stage II|Site closing|2|||
17067465|NCT00339040|38209971|FG001|Stage II|Site closing|0|||
17067466|NCT00338962|38209981|FG000|Overall Study|Lost to Follow-up|3|||
17067467|NCT00338962|38209982|FG001|Overall Study|Lost to Follow-up|3|||
17067468|NCT00338962|38209983|FG002|Overall Study|Lost to Follow-up|2|||
17067469|NCT00338962|38209984|FG003|Overall Study|Lost to Follow-up|3|||
17067470|NCT00338962|38209981|FG000|Overall Study|Withdrawal by Subject|1|||
17067471|NCT00338962|38209982|FG001|Overall Study|Withdrawal by Subject|0|||
17067472|NCT00338962|38209983|FG002|Overall Study|Withdrawal by Subject|0|||
17067473|NCT00338962|38209984|FG003|Overall Study|Withdrawal by Subject|0|||
17067474|NCT00338962|38209981|FG000|Overall Study|No Transportation|2|||
17067475|NCT00338962|38209982|FG001|Overall Study|No Transportation|0|||
17067476|NCT00338962|38209983|FG002|Overall Study|No Transportation|0|||
17067477|NCT00338962|38209984|FG003|Overall Study|No Transportation|0|||
17067478|NCT00338962|38209981|FG000|Overall Study|Time Constraint|2|||
17067479|NCT00338962|38209982|FG001|Overall Study|Time Constraint|0|||
17067480|NCT00338962|38209983|FG002|Overall Study|Time Constraint|0|||
17067481|NCT00338962|38209984|FG003|Overall Study|Time Constraint|0|||
17067482|NCT00338962|38209981|FG000|Overall Study|Moved|0|||
17067483|NCT00338962|38209982|FG001|Overall Study|Moved|1|||
17067484|NCT00338962|38209983|FG002|Overall Study|Moved|0|||
17067485|NCT00338962|38209984|FG003|Overall Study|Moved|0|||
17067486|NCT00338962|38209981|FG000|Overall Study|Adverse Event|0|||
17067487|NCT00338962|38209982|FG001|Overall Study|Adverse Event|0|||
17067488|NCT00338962|38209983|FG002|Overall Study|Adverse Event|2|||
17067489|NCT00338962|38209984|FG003|Overall Study|Adverse Event|0|||
17067490|NCT00338962|38209981|FG000|Overall Study|Poor Compliance|0|||
17067491|NCT00338962|38209982|FG001|Overall Study|Poor Compliance|0|||
17067492|NCT00338962|38209983|FG002|Overall Study|Poor Compliance|2|||
17067493|NCT00338962|38209984|FG003|Overall Study|Poor Compliance|0|||
17067494|NCT00568061|38209996|FG000|Overall Study|Inclusion / exclusion criteria|5|||
17067495|NCT00568061|38209997|FG001|Overall Study|Inclusion / exclusion criteria|1|||
17067496|NCT00568061|38209996|FG000|Overall Study|Adverse Event|0|||
17067497|NCT00568061|38209997|FG001|Overall Study|Adverse Event|1|||
17067498|NCT00338884|38210004|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
17067499|NCT00338884|38210004|FG000|Overall Study|Adverse Event|14|||
17067500|NCT00338884|38210004|FG000|Overall Study|Death|8|||
17067501|NCT00338884|38210004|FG000|Overall Study|Other|4|||
17067502|NCT00338884|38210004|FG000|Overall Study|Global Deterioration of Health Status|3|||
17067503|NCT00338884|38210004|FG000|Overall Study|Withdrawal by Subject|3|||
17067504|NCT00338884|38210004|FG000|Overall Study|Lost to Follow-up|1|||
17067505|NCT00338884|38210004|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
17067506|NCT00338806|38210010|FG000|Acute Phase|Withdrawal by Subject|0|||
17067507|NCT00338806|38210011|FG001|Acute Phase|Withdrawal by Subject|1|||
17067508|NCT00338806|38210010|FG000|Follow-up|Lost to Follow-up|1|||
17067509|NCT00338806|38210011|FG001|Follow-up|Lost to Follow-up|3|||
17067510|NCT03038100|38210021|FG000|Overall Study|Death|289|||
17067511|NCT03038100|38210022|FG001|Overall Study|Death|272|||
17067512|NCT03038100|38210021|FG000|Overall Study|Lost to Follow-up|9|||
17067513|NCT03038100|38210022|FG001|Overall Study|Lost to Follow-up|10|||
17067514|NCT03038100|38210021|FG000|Overall Study|Protocol Deviation|1|||
17067515|NCT03038100|38210022|FG001|Overall Study|Protocol Deviation|4|||
17067516|NCT03038100|38210021|FG000|Overall Study|Withdrawal by Subject|45|||
17067517|NCT03038100|38210022|FG001|Overall Study|Withdrawal by Subject|51|||
17067518|NCT03038100|38210021|FG000|Overall Study|Study Terminated By Sponsor|305|||
17067519|NCT03038100|38210022|FG001|Overall Study|Study Terminated By Sponsor|311|||
17067520|NCT03038100|38210021|FG000|Overall Study|Physician Decision|1|||
17067521|NCT03038100|38210022|FG001|Overall Study|Physician Decision|3|||
17067522|NCT00338728|38210029|FG000|Overall Study|Screen Failure|14|||
17067523|NCT00566501|38210035|FG000|Overall Study|Adverse Event|68|||
17067524|NCT00566501|38210036|FG001|Overall Study|Adverse Event|59|||
17067525|NCT00566501|38210035|FG000|Overall Study|Medication Non-compliance|5|||
17067526|NCT00566501|38210036|FG001|Overall Study|Medication Non-compliance|0|||
17067527|NCT00566501|38210035|FG000|Overall Study|Protocol Violation|2|||
17067528|NCT00566501|38210036|FG001|Overall Study|Protocol Violation|2|||
17067529|NCT00566501|38210035|FG000|Overall Study|Request of Investigator or Sponsor|6|||
17067530|NCT00566501|38210036|FG001|Overall Study|Request of Investigator or Sponsor|7|||
17067531|NCT00566501|38210035|FG000|Overall Study|Withdrawal by Subject|33|||
17067532|NCT00566501|38210036|FG001|Overall Study|Withdrawal by Subject|30|||
17067533|NCT00566501|38210035|FG000|Overall Study|Lack of Efficacy|8|||
17067534|NCT00566501|38210036|FG001|Overall Study|Lack of Efficacy|3|||
17067535|NCT00566501|38210035|FG000|Overall Study|Other|25|||
17067536|NCT00566501|38210036|FG001|Overall Study|Other|21|||
17067537|NCT00504894|38210045|FG000|Overall Study|fMRI technical problems|1|||
17067538|NCT00504894|38210046|FG001|Overall Study|fMRI technical problems|1|||
17067539|NCT00504894|38210047|FG002|Overall Study|fMRI technical problems|0|||
17067540|NCT00504894|38210045|FG000|Overall Study|Withdrawal by Subject|0|||
17067541|NCT00504894|38210046|FG001|Overall Study|Withdrawal by Subject|1|||
17067542|NCT00504894|38210047|FG002|Overall Study|Withdrawal by Subject|0|||
17067543|NCT00504894|38210045|FG000|Overall Study|Infusion technical problems|0|||
17067544|NCT00504894|38210046|FG001|Overall Study|Infusion technical problems|1|||
17067545|NCT00504894|38210047|FG002|Overall Study|Infusion technical problems|0|||
17067546|NCT00504894|38210045|FG000|Overall Study|poor subject data|2|||
17067547|NCT00504894|38210046|FG001|Overall Study|poor subject data|0|||
17067548|NCT00504894|38210047|FG002|Overall Study|poor subject data|0|||
17067549|NCT00504582|38210058|FG000|Overall Study|Lost to Follow-up|1|||
17067550|NCT00504582|38210059|FG001|Overall Study|Lost to Follow-up|0|||
17067551|NCT00504582|38210060|FG002|Overall Study|Lost to Follow-up|0|||
17067552|NCT00513240|38210070|FG000|Overall Study|Did not have intended surgery|3|||
17067553|NCT00513240|38210071|FG001|Overall Study|Did not have intended surgery|0|||
17067554|NCT00513240|38210070|FG000|Overall Study|Death|3|||
17067555|NCT00513240|38210071|FG001|Overall Study|Death|3|||
17067556|NCT00513240|38210070|FG000|Overall Study|Withdrawal by Subject|7|||
17067557|NCT00513240|38210071|FG001|Overall Study|Withdrawal by Subject|4|||
17067558|NCT00504426|38210084|FG000|Overall Study|Adverse Event|0|||
17067559|NCT00504426|38210085|FG001|Overall Study|Adverse Event|0|||
17067560|NCT00504426|38210086|FG002|Overall Study|Adverse Event|2|||
17067561|NCT00504426|38210087|FG003|Overall Study|Adverse Event|0|||
17067562|NCT00504426|38210084|FG000|Overall Study|Protocol Violation|1|||
17067563|NCT00504426|38210085|FG001|Overall Study|Protocol Violation|1|||
17067564|NCT00504426|38210086|FG002|Overall Study|Protocol Violation|2|||
17067565|NCT00504426|38210087|FG003|Overall Study|Protocol Violation|0|||
17067566|NCT00504426|38210084|FG000|Overall Study|Withdrawal by Subject|2|||
17067567|NCT00504426|38210085|FG001|Overall Study|Withdrawal by Subject|0|||
17067568|NCT00504426|38210086|FG002|Overall Study|Withdrawal by Subject|0|||
17067569|NCT00504426|38210087|FG003|Overall Study|Withdrawal by Subject|0|||
17067570|NCT00504348|38210100|FG000|Overall Study|Adverse Event|3|||
17067571|NCT00504348|38210100|FG000|Overall Study|Lack of Efficacy|4|||
17067572|NCT00504348|38210100|FG000|Overall Study|Physician Decision|1|||
16994042|NCT01072175|38137825|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
16994043|NCT01072175|38137826|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
16994044|NCT01072175|38137827|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
16994045|NCT01072175|38137828|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
16994046|NCT01072175|38137829|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
16994047|NCT01072175|38137817|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994048|NCT01072175|38137818|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994049|NCT01072175|38137819|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994050|NCT01072175|38137820|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994051|NCT01072175|38137821|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994052|NCT01072175|38137822|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994053|NCT01072175|38137823|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994054|NCT01072175|38137824|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994055|NCT01072175|38137825|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994056|NCT01072175|38137826|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994057|NCT01072175|38137827|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
16994058|NCT01072175|38137828|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
16994059|NCT01072175|38137829|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16994060|NCT01071317|38137863|FG000|Overall Study|Lost to Follow-up|2|||
17067573|NCT00507546|38210106|FG000|Overall Study|Withdrawal by Subject|1|||
17067574|NCT00507546|38210107|FG001|Overall Study|Withdrawal by Subject|0|||
17067575|NCT00507546|38210106|FG000|Overall Study|Protocol Violation|1|||
17067576|NCT00507546|38210107|FG001|Overall Study|Protocol Violation|0|||
17067577|NCT00507546|38210106|FG000|Overall Study|Physician Decision|0|||
17067578|NCT00507546|38210107|FG001|Overall Study|Physician Decision|1|||
17067579|NCT00567593|38210115|FG000|Overall Study|Adverse Event|1|||
17067580|NCT00567593|38210115|FG000|Overall Study|Physician Decision|1|||
17067581|NCT00335764|38210124|FG000|Overall Study|wrong histology|1|||
17067582|NCT00335764|38210125|FG001|Overall Study|wrong histology|0|||
17067583|NCT00335764|38210126|FG002|Overall Study|wrong histology|0|||
17067584|NCT00335764|38210127|FG003|Overall Study|wrong histology|0|||
17067585|NCT00335764|38210128|FG004|Overall Study|wrong histology|1|||
17067586|NCT00567359|38210164|FG000|Overall Study|Withdrawal by Subject|1|||
17067587|NCT00492726|38210170|FG000|Overall Study|Adverse Event|10|||
17067588|NCT00492726|38210171|FG001|Overall Study|Adverse Event|6|||
17067589|NCT00492726|38210170|FG000|Overall Study|Death|7|||
17067590|NCT00492726|38210171|FG001|Overall Study|Death|2|||
17067591|NCT00492726|38210170|FG000|Overall Study|Lack of Efficacy|0|||
17067592|NCT00492726|38210171|FG001|Overall Study|Lack of Efficacy|2|||
17067593|NCT00492726|38210170|FG000|Overall Study|Lost to Follow-up|27|||
17067594|NCT00492726|38210171|FG001|Overall Study|Lost to Follow-up|19|||
17067595|NCT00492726|38210170|FG000|Overall Study|Physician Decision|0|||
17067596|NCT00492726|38210171|FG001|Overall Study|Physician Decision|1|||
17067597|NCT00492726|38210170|FG000|Overall Study|Withdrawal by Subject|6|||
17067598|NCT00492726|38210171|FG001|Overall Study|Withdrawal by Subject|3|||
17067599|NCT00492726|38210170|FG000|Overall Study|Non compliant with study medication|0|||
17067600|NCT00492726|38210171|FG001|Overall Study|Non compliant with study medication|3|||
17067601|NCT00309946|38210177|FG000|Overall Study|Withdrawal by Subject|1|||
17067602|NCT00492648|38210183|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
17067603|NCT00492648|38210184|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
17067604|NCT00506922|38210195|FG000|Overall Study|Physician Decision|0|||
17067605|NCT00506922|38210196|FG001|Overall Study|Physician Decision|0|||
17067606|NCT00506922|38210197|FG002|Overall Study|Physician Decision|0|||
17067607|NCT00506922|38210198|FG003|Overall Study|Physician Decision|2|||
17067608|NCT00506922|38210199|FG004|Overall Study|Physician Decision|0|||
17067609|NCT00506922|38210195|FG000|Overall Study|Withdrawal by Subject|0|||
17067610|NCT00506922|38210196|FG001|Overall Study|Withdrawal by Subject|0|||
17067611|NCT00506922|38210197|FG002|Overall Study|Withdrawal by Subject|0|||
17067612|NCT00506922|38210198|FG003|Overall Study|Withdrawal by Subject|0|||
17067613|NCT00506922|38210199|FG004|Overall Study|Withdrawal by Subject|1|||
17067614|NCT00492024|38210209|FG000|Treatment|Adverse Event|3|||
17067615|NCT00492024|38210210|FG001|Treatment|Adverse Event|1|||
17067616|NCT00492024|38210209|FG000|Treatment|Lack of Efficacy|21|||
17067617|NCT00492024|38210210|FG001|Treatment|Lack of Efficacy|20|||
17067618|NCT00492024|38210209|FG000|Treatment|Lost to Follow-up|3|||
17067619|NCT00492024|38210210|FG001|Treatment|Lost to Follow-up|1|||
17067620|NCT00492024|38210209|FG000|Treatment|Withdrawal by Subject|2|||
17067621|NCT00492024|38210210|FG001|Treatment|Withdrawal by Subject|0|||
17067622|NCT00492024|38210209|FG000|Follow up|Lack of Efficacy|0|||
17067623|NCT00492024|38210210|FG001|Follow up|Lack of Efficacy|1|||
17067624|NCT00492024|38210209|FG000|Follow up|Lost to Follow-up|1|||
17067625|NCT00492024|38210210|FG001|Follow up|Lost to Follow-up|1|||
17067626|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
17067627|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
17067628|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
17067629|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
17067630|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
17067631|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
17067632|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
17067633|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
17067634|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
17067635|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
17067636|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
17067637|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
17067638|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
17067639|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
17067640|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
17067641|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
17067642|NCT00491556|38210218|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
17067643|NCT00491556|38210219|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
17067644|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
17067645|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
17067646|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
17067647|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
17067648|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
17067649|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
17067650|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
17067651|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
17067652|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
17067653|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
17067654|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
17067655|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
17067656|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
17067657|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
17067658|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
17067659|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
17067660|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
17067661|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
17067662|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
17067663|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
17067664|NCT00491556|38210218|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
17067665|NCT00491556|38210219|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
17067666|NCT00506454|38210235|FG000|Overall Study|Withdrawal by Subject|1|||
17067667|NCT00506454|38210236|FG001|Overall Study|Withdrawal by Subject|1|||
17067668|NCT00485472|38210244|FG000|Overall Study|Adverse Event|8|||
17067669|NCT00485472|38210245|FG001|Overall Study|Adverse Event|5|||
17067670|NCT00485472|38210244|FG000|Overall Study|Lack of Efficacy|5|||
17067671|NCT00485472|38210245|FG001|Overall Study|Lack of Efficacy|4|||
17067672|NCT00485472|38210244|FG000|Overall Study|Withdrawal by Subject|1|||
17067673|NCT00485472|38210245|FG001|Overall Study|Withdrawal by Subject|0|||
17147880|NCT03520387|38292502|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
17147881|NCT03170232|38292515|FG000|Overall Study|Adverse Event|0|||
17147882|NCT03170232|38292516|FG001|Overall Study|Adverse Event|1|||
17147883|NCT03170232|38292515|FG000|Overall Study|Protocol Violation|0|||
17147884|NCT03170232|38292516|FG001|Overall Study|Protocol Violation|1|||
17147885|NCT03170232|38292515|FG000|Overall Study|Lack of Efficacy|0|||
17147886|NCT03170232|38292516|FG001|Overall Study|Lack of Efficacy|1|||
17147887|NCT03170232|38292515|FG000|Overall Study|Study closed/terminated|26|||
17147888|NCT03170232|38292516|FG001|Overall Study|Study closed/terminated|23|||
17147889|NCT03170232|38292515|FG000|Overall Study|Lost to Follow-up|1|||
17147890|NCT03170232|38292516|FG001|Overall Study|Lost to Follow-up|0|||
17147891|NCT03170232|38292515|FG000|Overall Study|Withdrawal by Subject|0|||
17147892|NCT03170232|38292516|FG001|Overall Study|Withdrawal by Subject|1|||
17147893|NCT03519919|38292522|FG000|Overall Study|Withdrawal by Subject|1|||
17147894|NCT03519919|38292522|FG000|Overall Study|Lack of Efficacy|1|||
17147895|NCT03519919|38292522|FG000|Overall Study|Screen Failure|1|||
17147896|NCT03478969|38292555|FG000|Overall Study|Withdrawal by Subject|4|||
17067674|NCT00485472|38210244|FG000|Overall Study|Protocol Violation|0|||
17067675|NCT00485472|38210245|FG001|Overall Study|Protocol Violation|1|||
17147897|NCT03478969|38292556|FG001|Overall Study|Withdrawal by Subject|7|||
17147898|NCT03478969|38292557|FG002|Overall Study|Withdrawal by Subject|6|||
17147899|NCT03478969|38292555|FG000|Overall Study|Adverse Event|2|||
17147900|NCT03478969|38292556|FG001|Overall Study|Adverse Event|0|||
17147901|NCT03478969|38292557|FG002|Overall Study|Adverse Event|1|||
17147902|NCT03478969|38292555|FG000|Overall Study|Pregnancy|1|||
17147903|NCT03478969|38292556|FG001|Overall Study|Pregnancy|0|||
17147904|NCT03478969|38292557|FG002|Overall Study|Pregnancy|0|||
17147905|NCT03478969|38292555|FG000|Overall Study|Personal Reasons|1|||
17147906|NCT03478969|38292556|FG001|Overall Study|Personal Reasons|0|||
17147907|NCT03478969|38292557|FG002|Overall Study|Personal Reasons|1|||
17147908|NCT03478969|38292555|FG000|Overall Study|Covid-19|1|||
17147909|NCT03478969|38292556|FG001|Overall Study|Covid-19|4|||
17147910|NCT03478969|38292557|FG002|Overall Study|Covid-19|3|||
17147911|NCT03478969|38292555|FG000|Overall Study|Multiple Reasons|0|||
17147912|NCT03478969|38292556|FG001|Overall Study|Multiple Reasons|1|||
17147913|NCT03478969|38292557|FG002|Overall Study|Multiple Reasons|1|||
17147914|NCT03478969|38292555|FG000|Overall Study|Eligibility Criteria|0|||
17067676|NCT00485472|38210244|FG000|Overall Study|Other|2|||
17067677|NCT00485472|38210245|FG001|Overall Study|Other|1|||
17067678|NCT00485472|38210244|FG000|Overall Study|Lost to Follow-up|0|||
17067679|NCT00485472|38210245|FG001|Overall Study|Lost to Follow-up|1|||
17147915|NCT03478969|38292556|FG001|Overall Study|Eligibility Criteria|0|||
17147916|NCT03478969|38292557|FG002|Overall Study|Eligibility Criteria|5|||
17147917|NCT03478969|38292555|FG000|Overall Study|Lost to Follow-up|0|||
17147918|NCT03478969|38292556|FG001|Overall Study|Lost to Follow-up|0|||
17147919|NCT03478969|38292557|FG002|Overall Study|Lost to Follow-up|1|||
17147920|NCT02318784|38292567|FG000|Overall Study|Adverse Event|13|||
17147921|NCT02318784|38292567|FG000|Overall Study|Death|2|||
17147922|NCT02318784|38292567|FG000|Overall Study|Progressive Disease|37|||
17147923|NCT02318784|38292567|FG000|Overall Study|Withdrawal by Subject|10|||
17147924|NCT03170154|38292582|FG000|Overall Study|Lost to Follow-up|4|||
17147925|NCT03170154|38292582|FG000|Overall Study|Death|2|||
17147926|NCT03170154|38292582|FG000|Overall Study|Withdrawal by Subject|2|||
17147927|NCT03518125|38292597|FG000|Overall Study|Lost to Follow-up|0|||
17067680|NCT00491400|38210253|FG000|Overall Study|Withdrawal by Subject|5|||
17067681|NCT00491400|38210254|FG001|Overall Study|Withdrawal by Subject|4|||
17067682|NCT00491322|38210264|FG000|Overall Study|Protocol Violation|1|||
17067683|NCT00491322|38210265|FG001|Overall Study|Protocol Violation|0|||
17067684|NCT00491322|38210264|FG000|Overall Study|Pregnancy|0|||
17067685|NCT00491322|38210265|FG001|Overall Study|Pregnancy|1|||
17067686|NCT00502320|38210273|FG000|Overall Study|Lost to Follow-up|1|||
17067687|NCT00502320|38210274|FG001|Overall Study|Lost to Follow-up|1|||
17147928|NCT03518125|38292598|FG001|Overall Study|Lost to Follow-up|2|||
17147929|NCT03518125|38292599|FG002|Overall Study|Lost to Follow-up|0|||
17067688|NCT00502320|38210273|FG000|Overall Study|Withdrew Consent|1|||
17067689|NCT00502320|38210274|FG001|Overall Study|Withdrew Consent|0|||
17067690|NCT00502320|38210273|FG000|Overall Study|No longer met criteria|1|||
17067691|NCT00502320|38210274|FG001|Overall Study|No longer met criteria|0|||
17147930|NCT03518125|38292600|FG003|Overall Study|Lost to Follow-up|0|||
16994061|NCT01071317|38137864|FG001|Overall Study|Lost to Follow-up|2|||
16994062|NCT00783094|38137881|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
16994063|NCT00783094|38137882|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
16994064|NCT00783094|38137883|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
16994065|NCT00783094|38137881|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
16994066|NCT00783094|38137882|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
16994067|NCT00783094|38137883|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
16994068|NCT00783094|38137881|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
16994069|NCT00783094|38137882|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
16994070|NCT00783094|38137883|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
17067692|NCT00502320|38210273|FG000|Overall Study|Screen Failure|0|||
17067693|NCT00502320|38210274|FG001|Overall Study|Screen Failure|1|||
17067694|NCT00502320|38210273|FG000|Overall Study|Adverse Event|3|||
17067695|NCT00502320|38210274|FG001|Overall Study|Adverse Event|5|||
17067696|NCT02567825|38210282|FG000|Overall Study|No follow-up post-randomization|5|||
17067697|NCT02567825|38210283|FG001|Overall Study|No follow-up post-randomization|1|||
17067698|NCT02567825|38210282|FG000|Overall Study|Follow-up less than 23 months|16|||
17067699|NCT02567825|38210283|FG001|Overall Study|Follow-up less than 23 months|20|||
17067700|NCT00490776|38210289|FG000|Overall Study|Withdrawal by Subject|1|||
17067701|NCT00490776|38210289|FG000|Overall Study|Administrative Problems|1|||
17067702|NCT00490776|38210289|FG000|Overall Study|Death|1|||
17067703|NCT00490776|38210289|FG000|Overall Study|New Cancer Therapy|1|||
17067704|NCT00490776|38210289|FG000|Overall Study|Disease Progression|5|||
17067705|NCT00566735|38210295|FG000|Overall Study|Withdrawal by Subject|0|||
17067706|NCT00566735|38210296|FG001|Overall Study|Withdrawal by Subject|1|||
17067707|NCT00566735|38210295|FG000|Overall Study|Refused neuropsychological testing|2|||
17067708|NCT00566735|38210296|FG001|Overall Study|Refused neuropsychological testing|5|||
17067709|NCT00566735|38210295|FG000|Overall Study|Switched into a manic episode|0|||
17067710|NCT00566735|38210296|FG001|Overall Study|Switched into a manic episode|1|||
17067711|NCT00566111|38210304|FG000|Overall Study|Adverse Event|0|||
17067712|NCT00566111|38210305|FG001|Overall Study|Adverse Event|2|||
17067713|NCT00514046|38210320|FG000|Overall Study|transferred to another protocol|2|||
17067714|NCT00514046|38210321|FG001|Overall Study|transferred to another protocol|1|||
17067715|NCT00514046|38210322|FG002|Overall Study|transferred to another protocol|3|||
17067716|NCT00514046|38210323|FG003|Overall Study|transferred to another protocol|0|||
17067717|NCT00514046|38210324|FG004|Overall Study|transferred to another protocol|1|||
17067718|NCT00514046|38210325|FG005|Overall Study|transferred to another protocol|0|||
17067719|NCT00514046|38210326|FG006|Overall Study|transferred to another protocol|0|||
17067720|NCT00514046|38210327|FG007|Overall Study|transferred to another protocol|0|||
17067721|NCT00514046|38210328|FG008|Overall Study|transferred to another protocol|0|||
17067722|NCT00514046|38210320|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
17147931|NCT03518125|38292601|FG004|Overall Study|Lost to Follow-up|3|||
17147932|NCT03518125|38292602|FG005|Overall Study|Lost to Follow-up|5|||
17147933|NCT03518125|38292597|FG000|Overall Study|Physician Decision|0|||
17147934|NCT03518125|38292598|FG001|Overall Study|Physician Decision|1|||
17147935|NCT03518125|38292599|FG002|Overall Study|Physician Decision|0|||
17147936|NCT03518125|38292600|FG003|Overall Study|Physician Decision|0|||
17067723|NCT00514046|38210321|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
17067724|NCT00514046|38210322|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
17067725|NCT00514046|38210323|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
17067726|NCT00514046|38210324|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
17067727|NCT00514046|38210325|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
17067728|NCT00514046|38210326|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
17067729|NCT00514046|38210327|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
17067730|NCT00514046|38210328|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
17067731|NCT00514046|38210320|FG000|Overall Study|Disease progression on study|0|||
17067732|NCT00514046|38210321|FG001|Overall Study|Disease progression on study|0|||
17067733|NCT00514046|38210322|FG002|Overall Study|Disease progression on study|2|||
17067734|NCT00514046|38210323|FG003|Overall Study|Disease progression on study|0|||
17067735|NCT00514046|38210324|FG004|Overall Study|Disease progression on study|0|||
17067736|NCT00514046|38210325|FG005|Overall Study|Disease progression on study|1|||
17067737|NCT00514046|38210326|FG006|Overall Study|Disease progression on study|0|||
17067738|NCT00514046|38210327|FG007|Overall Study|Disease progression on study|0|||
17067739|NCT00514046|38210328|FG008|Overall Study|Disease progression on study|0|||
17067740|NCT00564629|38210352|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
17067741|NCT00564629|38210353|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
17147937|NCT03518125|38292601|FG004|Overall Study|Physician Decision|0|||
17067742|NCT00564395|38210359|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
17067743|NCT00564395|38210360|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
17067744|NCT00564395|38210359|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
17067745|NCT00564395|38210360|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
17067746|NCT00502242|38210368|FG000|Overall Study|Lack of Efficacy|1|||
17067747|NCT00502242|38210369|FG001|Overall Study|Lack of Efficacy|11|||
17067748|NCT00502242|38210368|FG000|Overall Study|Adverse Event|31|||
17067749|NCT00502242|38210369|FG001|Overall Study|Adverse Event|20|||
17067750|NCT00502242|38210368|FG000|Overall Study|Physician Decision|2|||
17067751|NCT00502242|38210369|FG001|Overall Study|Physician Decision|3|||
17067752|NCT00502242|38210368|FG000|Overall Study|Other - Unspecified|8|||
17067753|NCT00502242|38210369|FG001|Overall Study|Other - Unspecified|14|||
17067754|NCT00502242|38210368|FG000|Overall Study|Protocol Violation|3|||
17067755|NCT00502242|38210369|FG001|Overall Study|Protocol Violation|1|||
17067756|NCT00502242|38210368|FG000|Overall Study|Withdrawal by Subject|6|||
17147938|NCT03518125|38292602|FG005|Overall Study|Physician Decision|0|||
17147939|NCT03518125|38292597|FG000|Overall Study|Withdrawal by Subject|1|||
17067757|NCT00502242|38210369|FG001|Overall Study|Withdrawal by Subject|7|||
17067758|NCT03972137|38210379|FG000|Overall Study|Lost to Follow-up|2|||
17067759|NCT03972137|38210379|FG000|Overall Study|Withdrawal by Subject|4|||
17067760|NCT00490698|38210395|FG000|Overall Study|Withdrawal by Subject|1|||
17067761|NCT00490698|38210395|FG000|Overall Study|Disease Progression|7|||
17067762|NCT00490698|38210395|FG000|Overall Study|Physician Decision|2|||
17067763|NCT03970733|38210402|FG000|Overall Study|Withdrawal by Subject|0|||
17067764|NCT03970733|38210403|FG001|Overall Study|Withdrawal by Subject|5|||
17067765|NCT03970733|38210404|FG002|Overall Study|Withdrawal by Subject|1|||
17067766|NCT03970733|38210402|FG000|Overall Study|e.g.: moved from study area|1|||
17067767|NCT03970733|38210403|FG001|Overall Study|e.g.: moved from study area|0|||
17067768|NCT03970733|38210404|FG002|Overall Study|e.g.: moved from study area|0|||
17067769|NCT03970733|38210402|FG000|Overall Study|Lost to Follow-up|2|||
17067770|NCT03970733|38210403|FG001|Overall Study|Lost to Follow-up|1|||
17067771|NCT03970733|38210404|FG002|Overall Study|Lost to Follow-up|1|||
17067772|NCT03970733|38210402|FG000|Overall Study|Other|1|||
17067773|NCT03970733|38210403|FG001|Overall Study|Other|0|||
17067774|NCT03970733|38210404|FG002|Overall Study|Other|0|||
17067775|NCT03855228|38210416|FG000|Overall Study|Adverse Event|2|||
17067776|NCT03855228|38210417|FG001|Overall Study|Adverse Event|4|||
17067777|NCT03855228|38210418|FG002|Overall Study|Adverse Event|4|||
17067778|NCT03855228|38210419|FG003|Overall Study|Adverse Event|8|||
17067779|NCT03855228|38210416|FG000|Overall Study|Treatment Failure|1|||
17067780|NCT03855228|38210417|FG001|Overall Study|Treatment Failure|2|||
17067781|NCT03855228|38210418|FG002|Overall Study|Treatment Failure|1|||
17067782|NCT03855228|38210419|FG003|Overall Study|Treatment Failure|8|||
17067783|NCT03855228|38210416|FG000|Overall Study|Lost to Follow-up|0|||
17067784|NCT03855228|38210417|FG001|Overall Study|Lost to Follow-up|0|||
17067785|NCT03855228|38210418|FG002|Overall Study|Lost to Follow-up|0|||
17067786|NCT03855228|38210419|FG003|Overall Study|Lost to Follow-up|1|||
17067787|NCT03855228|38210416|FG000|Overall Study|Protocol Violation|0|||
17067788|NCT03855228|38210417|FG001|Overall Study|Protocol Violation|1|||
17067789|NCT03855228|38210418|FG002|Overall Study|Protocol Violation|2|||
17067790|NCT03855228|38210419|FG003|Overall Study|Protocol Violation|1|||
17067791|NCT03855228|38210416|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
17067792|NCT03855228|38210417|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
17067793|NCT03855228|38210418|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
17067794|NCT03855228|38210419|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
17067795|NCT00511238|38210431|FG000|Overall Study|Adverse Event|13|||
17067796|NCT00511238|38210432|FG001|Overall Study|Adverse Event|33|||
17067797|NCT00511238|38210431|FG000|Overall Study|Withdrawal by Subject|2|||
17067798|NCT00511238|38210432|FG001|Overall Study|Withdrawal by Subject|22|||
17067799|NCT00511238|38210431|FG000|Overall Study|Progressive Disease|23|||
17067800|NCT00511238|38210432|FG001|Overall Study|Progressive Disease|157|||
17067801|NCT00511238|38210431|FG000|Overall Study|various reasons|4|||
17067802|NCT00511238|38210432|FG001|Overall Study|various reasons|14|||
17067803|NCT00513500|38210450|FG000|Overall Study|Lost to Follow-up|35|||
17147940|NCT03518125|38292598|FG001|Overall Study|Withdrawal by Subject|1|||
17067804|NCT00513500|38210451|FG001|Overall Study|Lost to Follow-up|39|||
17067805|NCT00513500|38210450|FG000|Overall Study|Death|2|||
17067806|NCT00513500|38210451|FG001|Overall Study|Death|1|||
17067807|NCT00513500|38210450|FG000|Overall Study|Hospitalized|4|||
17067808|NCT00513500|38210451|FG001|Overall Study|Hospitalized|14|||
17067809|NCT03969719|38210460|FG000|Overall Study|Other reasons not specified|1|||
17067810|NCT03969719|38210461|FG001|Overall Study|Other reasons not specified|1|||
17067811|NCT03969719|38210462|FG002|Overall Study|Other reasons not specified|3|||
17067812|NCT03969719|38210460|FG000|Overall Study|Withdrawal by Subject|2|||
17067813|NCT03969719|38210461|FG001|Overall Study|Withdrawal by Subject|3|||
17067814|NCT03969719|38210462|FG002|Overall Study|Withdrawal by Subject|2|||
17067815|NCT03969719|38210460|FG000|Overall Study|Protocol Violation|1|||
17067816|NCT03969719|38210461|FG001|Overall Study|Protocol Violation|2|||
17067817|NCT03969719|38210462|FG002|Overall Study|Protocol Violation|0|||
17067818|NCT03969719|38210460|FG000|Overall Study|Adverse Event|0|||
17067819|NCT03969719|38210461|FG001|Overall Study|Adverse Event|2|||
17067820|NCT03969719|38210462|FG002|Overall Study|Adverse Event|0|||
17067821|NCT03969719|38210460|FG000|Overall Study|Lost to Follow-up|0|||
17067822|NCT03969719|38210461|FG001|Overall Study|Lost to Follow-up|1|||
17067823|NCT03969719|38210462|FG002|Overall Study|Lost to Follow-up|0|||
17067824|NCT00511004|38210473|FG000|Overall Study|Lost to Follow-up|0|||
17067825|NCT00511004|38210474|FG001|Overall Study|Lost to Follow-up|0|||
17067826|NCT00511004|38210475|FG002|Overall Study|Lost to Follow-up|4|||
17067827|NCT02877134|38210502|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067828|NCT02877134|38210503|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
17067829|NCT02877134|38210504|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067830|NCT02877134|38210505|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067831|NCT02877134|38210506|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067832|NCT02877134|38210507|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
17067833|NCT02877134|38210508|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067834|NCT02877134|38210509|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067835|NCT02877134|38210510|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067836|NCT02877134|38210511|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067837|NCT02877134|38210512|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067838|NCT02877134|38210513|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
17067839|NCT02877134|38210502|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067840|NCT02877134|38210503|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
17067841|NCT02877134|38210504|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067842|NCT02877134|38210505|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
17067843|NCT02877134|38210506|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067844|NCT02877134|38210507|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067845|NCT02877134|38210508|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
17067846|NCT02877134|38210509|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067847|NCT02877134|38210510|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067848|NCT02877134|38210511|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067849|NCT02877134|38210512|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067850|NCT02877134|38210513|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
17067851|NCT02877134|38210502|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
17067852|NCT02877134|38210503|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
17067853|NCT02877134|38210504|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
17067854|NCT02877134|38210505|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
17067855|NCT02877134|38210506|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
17067856|NCT02877134|38210507|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
17067857|NCT02877134|38210508|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
17067858|NCT02877134|38210509|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
17067859|NCT02877134|38210510|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
17067860|NCT02877134|38210511|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
17067861|NCT02877134|38210512|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
17147941|NCT03518125|38292599|FG002|Overall Study|Withdrawal by Subject|0|||
17067862|NCT02877134|38210513|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
17067863|NCT02877134|38210502|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
17067864|NCT02877134|38210503|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
17067865|NCT02877134|38210504|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
17067866|NCT02877134|38210505|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
17067867|NCT02877134|38210506|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
17067868|NCT02877134|38210507|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
17067869|NCT02877134|38210508|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
17067870|NCT02877134|38210509|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
17067871|NCT02877134|38210510|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
17067872|NCT02877134|38210511|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
17067873|NCT02877134|38210512|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
17067874|NCT02877134|38210513|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
17067875|NCT02877134|38210502|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067876|NCT02877134|38210503|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067877|NCT02877134|38210504|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067878|NCT02877134|38210505|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067879|NCT02877134|38210506|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067880|NCT02877134|38210507|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067881|NCT02877134|38210508|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067882|NCT02877134|38210509|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067883|NCT02877134|38210510|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
17067884|NCT02877134|38210511|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067885|NCT02877134|38210512|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17067886|NCT02877134|38210513|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
17147942|NCT03518125|38292600|FG003|Overall Study|Withdrawal by Subject|1|||
17147943|NCT03518125|38292601|FG004|Overall Study|Withdrawal by Subject|1|||
17147944|NCT03518125|38292602|FG005|Overall Study|Withdrawal by Subject|3|||
17147945|NCT03518125|38292597|FG000|Overall Study|Missed Day 394 Visit|1|||
17147946|NCT03518125|38292598|FG001|Overall Study|Missed Day 394 Visit|0|||
17147947|NCT03518125|38292599|FG002|Overall Study|Missed Day 394 Visit|0|||
17147948|NCT03518125|38292600|FG003|Overall Study|Missed Day 394 Visit|0|||
17147949|NCT03518125|38292601|FG004|Overall Study|Missed Day 394 Visit|0|||
17147950|NCT03518125|38292602|FG005|Overall Study|Missed Day 394 Visit|0|||
17147951|NCT03169530|38292619|FG000|Overall Study|Study ended by NIH|15|||
17147952|NCT03169530|38292620|FG001|Overall Study|Study ended by NIH|17|||
17147953|NCT03478891|38292638|FG000|Overall Study|Enrolled, but product never administered|0|||
17147954|NCT03478891|38292639|FG001|Overall Study|Enrolled, but product never administered|0|||
17147955|NCT03478891|38292640|FG002|Overall Study|Enrolled, but product never administered|1|||
17147956|NCT03478891|38292638|FG000|Overall Study|Moved from area|0|||
17147957|NCT03478891|38292639|FG001|Overall Study|Moved from area|0|||
17147958|NCT03478891|38292640|FG002|Overall Study|Moved from area|1|||
17147959|NCT03478891|38292638|FG000|Overall Study|Lost to Follow-up|1|||
17147960|NCT03478891|38292639|FG001|Overall Study|Lost to Follow-up|0|||
17147961|NCT03478891|38292640|FG002|Overall Study|Lost to Follow-up|1|||
17147962|NCT01585103|38292652|FG000|Overall Study|Unable to swallow Cytosponge|6|||
17147963|NCT03168906|38292658|FG000|Overall Study|Lack of Efficacy|6|||
17147964|NCT03168906|38292659|FG001|Overall Study|Lack of Efficacy|6|||
17147965|NCT00706966|38292666|FG000|Overall Study|Adverse Event|1|||
17067887|NCT02877134|38210502|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
17067888|NCT02877134|38210503|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
17067889|NCT02877134|38210504|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
17067890|NCT02877134|38210505|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
17067891|NCT02877134|38210506|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
17067892|NCT02877134|38210507|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
17067893|NCT02877134|38210508|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
17067894|NCT02877134|38210509|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
17067895|NCT02877134|38210510|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
17067896|NCT02877134|38210511|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
17067897|NCT02877134|38210512|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
17067898|NCT02877134|38210513|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
17067899|NCT02877134|38210502|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17067900|NCT02877134|38210503|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17067901|NCT02877134|38210504|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17147966|NCT03478657|38292700|FG000|Overall Study|Withdrawal by Subject|0|||
17067902|NCT02877134|38210505|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17147967|NCT03478657|38292701|FG001|Overall Study|Withdrawal by Subject|1|||
17147968|NCT03515941|38292709|FG000|Overall Study|Adverse Event|1|||
17147969|NCT03515941|38292710|FG001|Overall Study|Adverse Event|0|||
17147970|NCT03011034|38292718|FG000|Overall Study|Adverse Event|1|||
17147971|NCT03011034|38292719|FG001|Overall Study|Adverse Event|0|||
17147972|NCT03515629|38292727|FG000|Overall Study|Death|0|||
17147973|NCT03515629|38292728|FG001|Overall Study|Death|1|||
16781238|NCT02109484|37720412|FG003|Overall Study|Withdrawal by Subject|0|||
16994071|NCT00783094|38137881|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
16994072|NCT00783094|38137882|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
16994073|NCT00783094|38137883|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
17147974|NCT03515629|38292729|FG002|Overall Study|Death|1|||
17147975|NCT03515629|38292727|FG000|Overall Study|Progressive disease|0|||
17147976|NCT03515629|38292728|FG001|Overall Study|Progressive disease|1|||
17147977|NCT03515629|38292729|FG002|Overall Study|Progressive disease|0|||
17147978|NCT03512353|38292738|FG000|Overall Study|Sponsor Decision|3|||
17147979|NCT03512353|38292738|FG000|Overall Study|Death|1|||
17147980|NCT03512275|38292746|FG000|Overall Study|Withdrawal by Subject|1|||
17147981|NCT03512275|38292747|FG001|Overall Study|Withdrawal by Subject|3|||
17147982|NCT03512275|38292746|FG000|Overall Study|Physician Decision|0|||
17147983|NCT03512275|38292747|FG001|Overall Study|Physician Decision|1|||
17147984|NCT03512275|38292746|FG000|Overall Study|Lost to Follow-up|0|||
17147985|NCT03512275|38292747|FG001|Overall Study|Lost to Follow-up|3|||
17147986|NCT03512275|38292746|FG000|Overall Study|Other|1|||
17147987|NCT03512275|38292747|FG001|Overall Study|Other|0|||
17147988|NCT03473197|38292753|FG000|Overall Study|Adverse Event|4|||
17147989|NCT03473197|38292753|FG000|Overall Study|Lost to Follow-up|1|||
17147990|NCT03473197|38292753|FG000|Overall Study|Withdrawal by Subject|5|||
17147991|NCT03511105|38292759|FG000|Overall Study|Adverse Event|1|||
17147992|NCT03511105|38292760|FG001|Overall Study|Adverse Event|0|||
17067903|NCT02877134|38210506|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17067904|NCT02877134|38210507|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17067905|NCT02877134|38210508|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17067906|NCT02877134|38210509|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
17067907|NCT02877134|38210510|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
17067908|NCT02877134|38210511|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
16994074|NCT00783094|38137881|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
16994075|NCT00783094|38137882|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
16994076|NCT00783094|38137883|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
16994077|NCT00783094|38137881|FG000|Open-Label Extension Period|Adverse Event|12|||
16994078|NCT00783094|38137882|FG001|Open-Label Extension Period|Adverse Event|7|||
16994079|NCT00783094|38137883|FG002|Open-Label Extension Period|Adverse Event|16|||
16994080|NCT00783094|38137881|FG000|Open-Label Extension Period|Death|0|||
16994081|NCT00783094|38137882|FG001|Open-Label Extension Period|Death|0|||
16994082|NCT00783094|38137883|FG002|Open-Label Extension Period|Death|1|||
16994083|NCT00783094|38137881|FG000|Open-Label Extension Period|Protocol Violation|4|||
16994084|NCT00783094|38137882|FG001|Open-Label Extension Period|Protocol Violation|5|||
16994085|NCT00783094|38137883|FG002|Open-Label Extension Period|Protocol Violation|7|||
16994086|NCT00783094|38137881|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
16994087|NCT00783094|38137882|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
16994088|NCT00783094|38137883|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
16994089|NCT00783094|38137881|FG000|Open-Label Extension Period|Physician Decision|4|||
16994090|NCT00783094|38137882|FG001|Open-Label Extension Period|Physician Decision|2|||
16994091|NCT00783094|38137883|FG002|Open-Label Extension Period|Physician Decision|3|||
16994092|NCT00783094|38137881|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
16994093|NCT00783094|38137882|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
16994094|NCT00783094|38137883|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
16994095|NCT00790582|38137896|FG000|Overall Study|Death|14|||
16994096|NCT00790582|38137897|FG001|Overall Study|Death|32|||
16994097|NCT00790582|38137896|FG000|Overall Study|Physician Decision|7|||
16994098|NCT00790582|38137897|FG001|Overall Study|Physician Decision|1|||
16994099|NCT00790582|38137896|FG000|Overall Study|Lost to Follow-up|3|||
16994100|NCT00790582|38137897|FG001|Overall Study|Lost to Follow-up|3|||
16994101|NCT00790582|38137896|FG000|Overall Study|Withdrawal by Subject|7|||
17147993|NCT03511105|38292759|FG000|Overall Study|Withdrew consent|1|||
17147994|NCT03511105|38292760|FG001|Overall Study|Withdrew consent|0|||
17147995|NCT03510715|38292780|FG000|Overall Study|Adverse Event|1|||
17067909|NCT02877134|38210512|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17067910|NCT02877134|38210513|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
17067911|NCT02877134|38210502|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
17067912|NCT02877134|38210503|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
17067913|NCT02877134|38210504|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
17067914|NCT02877134|38210505|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
17067915|NCT02877134|38210506|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
17067916|NCT02877134|38210507|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
17067917|NCT02877134|38210508|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
17067918|NCT02877134|38210509|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
17067919|NCT02877134|38210510|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
17067920|NCT02877134|38210511|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
17067921|NCT02877134|38210512|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
17067922|NCT02877134|38210513|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
17067923|NCT00563381|38210539|FG000|Overall Study|Adverse Event|264|||
17067924|NCT00563381|38210540|FG001|Overall Study|Adverse Event|292|||
17067925|NCT00563381|38210539|FG000|Overall Study|Protocol Violation|66|||
17067926|NCT00563381|38210540|FG001|Overall Study|Protocol Violation|74|||
17067927|NCT00563381|38210539|FG000|Overall Study|Lost to Follow-up|7|||
17147996|NCT03510715|38292781|FG001|Overall Study|Adverse Event|0|||
17147997|NCT03508843|38292788|FG000|Overall Study|Withdrawal by Subject|1|||
17147998|NCT03508843|38292788|FG000|Overall Study|technical difficulties|2|||
17147999|NCT03508609|38292792|FG000|Overall Study|Withdrawal by Subject|1|||
17067928|NCT00563381|38210540|FG001|Overall Study|Lost to Follow-up|15|||
17067929|NCT00563381|38210539|FG000|Overall Study|Withdrawal by Subject|192|||
17148000|NCT03054350|38292802|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
17148001|NCT03054350|38292803|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
17148002|NCT03054350|38292804|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
17148003|NCT03054350|38292805|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
17148004|NCT03054350|38292806|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
17148005|NCT03054350|38292807|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
17148006|NCT03054350|38292802|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
17148007|NCT03054350|38292803|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
17148008|NCT03054350|38292804|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
17148009|NCT03054350|38292805|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
17148010|NCT03054350|38292806|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
17148011|NCT03054350|38292807|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
17148012|NCT03054350|38292802|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
17148013|NCT03054350|38292803|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
17148014|NCT03054350|38292804|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
17148015|NCT03054350|38292805|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
17148016|NCT03054350|38292806|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
17148017|NCT03054350|38292807|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
17148018|NCT03054350|38292802|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
17148019|NCT03054350|38292803|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
17148020|NCT03054350|38292804|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
17148021|NCT03054350|38292805|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
17148022|NCT03054350|38292806|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
17148023|NCT03054350|38292807|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
17148024|NCT03528577|38292838|FG000|Sequence 1|Failed Spirometry|1|||
17148025|NCT03528577|38292838|FG000|Sequence 1|Restricted medication|1|||
17148026|NCT03528577|38292838|FG000|Sequence 2|Adverse Event|1|||
17148027|NCT03528577|38292838|FG000|Sequence 2|Withdrawal by Subject|1|||
17148028|NCT03528577|38292838|FG000|Sequence 2|Failed Spirometry|1|||
17067930|NCT00563381|38210540|FG001|Overall Study|Withdrawal by Subject|209|||
17067931|NCT00563381|38210539|FG000|Overall Study|Lack of Efficacy|32|||
17067932|NCT00563381|38210540|FG001|Overall Study|Lack of Efficacy|24|||
17067933|NCT00563381|38210539|FG000|Overall Study|Individual different reasons|24|||
17067934|NCT00563381|38210540|FG001|Overall Study|Individual different reasons|34|||
17067935|NCT00512798|38210548|FG000|Overall Study|Death|0|||
17067936|NCT00512798|38210549|FG001|Overall Study|Death|3|||
17067937|NCT00512798|38210548|FG000|Overall Study|Adverse Event|2|||
17067938|NCT00512798|38210549|FG001|Overall Study|Adverse Event|4|||
17067939|NCT00512798|38210548|FG000|Overall Study|Progression of disease|14|||
17067940|NCT00512798|38210549|FG001|Overall Study|Progression of disease|20|||
17067941|NCT00512798|38210548|FG000|Overall Study|Withdrawal by Subject|3|||
17067942|NCT00512798|38210549|FG001|Overall Study|Withdrawal by Subject|0|||
17067943|NCT00565721|38210556|FG000|Overall Study|Screen Failure|2|||
17067944|NCT00565721|38210556|FG000|Overall Study|Lost to Follow-up|6|||
17067945|NCT00565721|38210556|FG000|Overall Study|Technical Problems|1|||
17067946|NCT00565721|38210556|FG000|Overall Study|Physician Decision|2|||
17067947|NCT00565721|38210556|FG000|Overall Study|Other reasons|6|||
17067948|NCT00561977|38210578|FG000|Overall Study|Withdrawal by Subject|0|||
17067949|NCT00561977|38210579|FG001|Overall Study|Withdrawal by Subject|2|||
17067950|NCT00561977|38210580|FG002|Overall Study|Withdrawal by Subject|1|||
17067951|NCT00561977|38210578|FG000|Overall Study|Pregnancy|0|||
17067952|NCT00561977|38210579|FG001|Overall Study|Pregnancy|1|||
17067953|NCT00561977|38210580|FG002|Overall Study|Pregnancy|1|||
17067954|NCT00561821|38210592|FG000|Overall Study|Not treated|0|||
17067955|NCT00561821|38210593|FG001|Overall Study|Not treated|0|||
17067956|NCT00561821|38210594|FG002|Overall Study|Not treated|1|||
17067957|NCT00561821|38210595|FG003|Overall Study|Not treated|0|||
17067958|NCT00561821|38210592|FG000|Overall Study|Withdrawal by Subject|0|||
17067959|NCT00561821|38210593|FG001|Overall Study|Withdrawal by Subject|1|||
17067960|NCT00561821|38210594|FG002|Overall Study|Withdrawal by Subject|0|||
17067961|NCT00561821|38210595|FG003|Overall Study|Withdrawal by Subject|2|||
17067962|NCT00561821|38210592|FG000|Overall Study|Reasons not related to trial|2|||
17067963|NCT00561821|38210593|FG001|Overall Study|Reasons not related to trial|1|||
17067964|NCT00561821|38210594|FG002|Overall Study|Reasons not related to trial|0|||
17067965|NCT00561821|38210595|FG003|Overall Study|Reasons not related to trial|0|||
17067966|NCT00561821|38210592|FG000|Overall Study|Other (reason not specified)|1|||
17067967|NCT00561821|38210593|FG001|Overall Study|Other (reason not specified)|1|||
17067968|NCT00561821|38210594|FG002|Overall Study|Other (reason not specified)|0|||
17067969|NCT00561821|38210595|FG003|Overall Study|Other (reason not specified)|0|||
17067970|NCT00561821|38210592|FG000|Overall Study|Adverse Event|2|||
17067971|NCT00561821|38210593|FG001|Overall Study|Adverse Event|3|||
17067972|NCT00561821|38210594|FG002|Overall Study|Adverse Event|1|||
17067973|NCT00561821|38210595|FG003|Overall Study|Adverse Event|1|||
17067974|NCT00558701|38210607|FG000|Overall Study|Protocol Deviations|1|||
17067975|NCT00558701|38210608|FG001|Overall Study|Protocol Deviations|4|||
17067976|NCT03684044|38210616|FG000|Overall Study|Adverse Event|3|||
17067977|NCT03684044|38210617|FG001|Overall Study|Adverse Event|0|||
17067978|NCT03684044|38210616|FG000|Overall Study|Death|4|||
17067979|NCT03684044|38210617|FG001|Overall Study|Death|7|||
17067980|NCT03684044|38210616|FG000|Overall Study|Lost to Follow-up|3|||
17067981|NCT03684044|38210617|FG001|Overall Study|Lost to Follow-up|2|||
17067982|NCT03684044|38210616|FG000|Overall Study|Patient Not Available|0|||
17067983|NCT03684044|38210617|FG001|Overall Study|Patient Not Available|2|||
17067984|NCT03684044|38210616|FG000|Overall Study|Physician Decision|1|||
17067985|NCT03684044|38210617|FG001|Overall Study|Physician Decision|0|||
17067986|NCT03684044|38210616|FG000|Overall Study|Withdrawal by Subject|11|||
17067987|NCT03684044|38210617|FG001|Overall Study|Withdrawal by Subject|9|||
17067988|NCT00510692|38210625|FG000|Overall Study|Adverse Event|1|||
17067989|NCT00510692|38210626|FG001|Overall Study|Adverse Event|3|||
17067990|NCT00510692|38210625|FG000|Overall Study|Withdrawal by Subject|1|||
17067991|NCT00510692|38210626|FG001|Overall Study|Withdrawal by Subject|0|||
17067992|NCT00335452|38210638|FG000|Overall Study|Death|156|||
17067993|NCT00335452|38210639|FG001|Overall Study|Death|144|||
17067994|NCT00335452|38210640|FG002|Overall Study|Death|158|||
17148029|NCT03528577|38292838|FG000|Sequence 3|Failed Spirometry|1|||
17148030|NCT03528577|38292838|FG000|Sequence 4|Failed Spirometry|2|||
17148031|NCT03528577|38292838|FG000|Sequence 4|Adverse Event|1|||
17148032|NCT00706654|38292848|FG000|Conversion Phase|Lost to Follow-up|4|||
17148033|NCT00706654|38292849|FG001|Conversion Phase|Lost to Follow-up|0|||
17148034|NCT00706654|38292850|FG002|Conversion Phase|Lost to Follow-up|0|||
17067995|NCT00335452|38210641|FG003|Overall Study|Death|129|||
17067996|NCT00335452|38210638|FG000|Overall Study|Lost to Follow-up|2|||
17067997|NCT00335452|38210639|FG001|Overall Study|Lost to Follow-up|3|||
17067998|NCT00335452|38210640|FG002|Overall Study|Lost to Follow-up|1|||
17067999|NCT00335452|38210641|FG003|Overall Study|Lost to Follow-up|2|||
17068000|NCT00522548|38210658|FG000|Overall Study|Adverse Event|2|||
17068001|NCT00522548|38210659|FG001|Overall Study|Adverse Event|2|||
17068002|NCT00522548|38210658|FG000|Overall Study|Withdrawal by Subject|0|||
17068003|NCT00522548|38210659|FG001|Overall Study|Withdrawal by Subject|2|||
17068004|NCT00522392|38210667|FG000|Overall Study|Disease progression|0|||
17068005|NCT00522392|38210668|FG001|Overall Study|Disease progression|3|||
17068006|NCT00522392|38210667|FG000|Overall Study|Adverse Event|7|||
17068007|NCT00522392|38210668|FG001|Overall Study|Adverse Event|7|||
17148035|NCT00706654|38292851|FG003|Conversion Phase|Lost to Follow-up|0|||
17148036|NCT00706654|38292848|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
17148037|NCT00706654|38292849|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
17148038|NCT00706654|38292850|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
17148039|NCT00706654|38292851|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
17148040|NCT00706654|38292848|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
17148041|NCT00706654|38292849|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
17148042|NCT00706654|38292850|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
17148043|NCT00706654|38292851|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
17148044|NCT00706654|38292848|FG000|Conversion Phase|Withdrawn by Investigator|14|||
17148045|NCT00706654|38292849|FG001|Conversion Phase|Withdrawn by Investigator|0|||
17148046|NCT00706654|38292850|FG002|Conversion Phase|Withdrawn by Investigator|0|||
17148047|NCT00706654|38292851|FG003|Conversion Phase|Withdrawn by Investigator|0|||
17148048|NCT00706654|38292848|FG000|Conversion Phase|Withdrew Consent|38|||
17148049|NCT00706654|38292849|FG001|Conversion Phase|Withdrew Consent|0|||
17148050|NCT00706654|38292850|FG002|Conversion Phase|Withdrew Consent|0|||
17148051|NCT00706654|38292851|FG003|Conversion Phase|Withdrew Consent|0|||
17148052|NCT00706654|38292848|FG000|Conversion Phase|Adverse Event|18|||
17148053|NCT00706654|38292849|FG001|Conversion Phase|Adverse Event|0|||
17148054|NCT00706654|38292850|FG002|Conversion Phase|Adverse Event|0|||
17148055|NCT00706654|38292851|FG003|Conversion Phase|Adverse Event|0|||
17148056|NCT00706654|38292848|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
17148057|NCT00706654|38292849|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
17148058|NCT00706654|38292850|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
17148059|NCT00706654|38292851|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
17148060|NCT00706654|38292848|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
17148061|NCT00706654|38292849|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
17148062|NCT00706654|38292850|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
17148063|NCT00706654|38292851|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
17148064|NCT00706654|38292848|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
17148065|NCT00706654|38292849|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
17148066|NCT00706654|38292850|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
17148067|NCT00706654|38292851|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
17148068|NCT00706654|38292848|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
17148069|NCT00706654|38292849|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
17148070|NCT00706654|38292850|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
17148071|NCT00706654|38292851|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
17148072|NCT00706654|38292848|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
17148073|NCT00706654|38292849|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
17148074|NCT00706654|38292850|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
17148075|NCT00706654|38292851|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
17148076|NCT00706654|38292848|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
17148077|NCT00706654|38292849|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
17148078|NCT00706654|38292850|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
17148079|NCT00706654|38292851|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
17148080|NCT00706654|38292848|FG000|Oral Stabilization Phase|Withdrew consent|55|||
17148081|NCT00706654|38292849|FG001|Oral Stabilization Phase|Withdrew consent|0|||
17148082|NCT00706654|38292850|FG002|Oral Stabilization Phase|Withdrew consent|0|||
17148083|NCT00706654|38292851|FG003|Oral Stabilization Phase|Withdrew consent|0|||
17148084|NCT00706654|38292848|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
17148085|NCT00706654|38292849|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
17148086|NCT00706654|38292850|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
17148087|NCT00706654|38292851|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
17148088|NCT00706654|38292848|FG000|Oral Stabilization Phase|Adverse Event|21|||
17148089|NCT00706654|38292849|FG001|Oral Stabilization Phase|Adverse Event|0|||
17068008|NCT00522392|38210667|FG000|Overall Study|Withdrawal by Subject|1|||
17068009|NCT00522392|38210668|FG001|Overall Study|Withdrawal by Subject|1|||
17068010|NCT00522392|38210667|FG000|Overall Study|Physician Decision|0|||
17068011|NCT00522392|38210668|FG001|Overall Study|Physician Decision|1|||
17068012|NCT00522392|38210667|FG000|Overall Study|Non-compliance|0|||
17068013|NCT00522392|38210668|FG001|Overall Study|Non-compliance|1|||
17068014|NCT00335140|38210674|FG000|Overall Study|Ineligible|1|||
17068015|NCT00309244|38210680|FG000|Overall Study|Adverse Event|29|||
17068016|NCT00309244|38210681|FG001|Overall Study|Adverse Event|12|||
17068017|NCT00309244|38210680|FG000|Overall Study|Lost to Follow-up|6|||
17068018|NCT00309244|38210681|FG001|Overall Study|Lost to Follow-up|22|||
17068019|NCT00309244|38210680|FG000|Overall Study|Physician Decision|5|||
17068020|NCT00309244|38210681|FG001|Overall Study|Physician Decision|8|||
17068021|NCT00309244|38210680|FG000|Overall Study|Protocol Violation|6|||
17068022|NCT00309244|38210681|FG001|Overall Study|Protocol Violation|3|||
17068023|NCT00309244|38210680|FG000|Overall Study|Withdrawal by Subject|50|||
17068024|NCT00309244|38210681|FG001|Overall Study|Withdrawal by Subject|32|||
17068025|NCT00309244|38210680|FG000|Overall Study|Various|7|||
17068026|NCT00309244|38210681|FG001|Overall Study|Various|7|||
17068027|NCT00309244|38210680|FG000|Overall Study|Randomized but not dosed|11|||
17068028|NCT00309244|38210681|FG001|Overall Study|Randomized but not dosed|12|||
17068029|NCT00309244|38210680|FG000|Overall Study|Death|4|||
17068030|NCT00309244|38210681|FG001|Overall Study|Death|1|||
17068031|NCT00483756|38210690|FG000|Overall Study|Death|2|||
17068032|NCT00483756|38210691|FG001|Overall Study|Death|0|||
17068033|NCT00483756|38210692|FG002|Overall Study|Death|1|||
17068034|NCT00483756|38210690|FG000|Overall Study|Adverse Event|19|||
17068035|NCT00483756|38210691|FG001|Overall Study|Adverse Event|38|||
17068036|NCT00483756|38210692|FG002|Overall Study|Adverse Event|40|||
17068037|NCT00483756|38210690|FG000|Overall Study|Lack of Efficacy|1|||
17068038|NCT00483756|38210691|FG001|Overall Study|Lack of Efficacy|0|||
17068039|NCT00483756|38210692|FG002|Overall Study|Lack of Efficacy|0|||
17068040|NCT00483756|38210690|FG000|Overall Study|Lost to Follow-up|3|||
17068041|NCT00483756|38210691|FG001|Overall Study|Lost to Follow-up|1|||
17068042|NCT00483756|38210692|FG002|Overall Study|Lost to Follow-up|0|||
17068043|NCT00483756|38210690|FG000|Overall Study|Withdrawal by Subject|5|||
17068044|NCT00483756|38210691|FG001|Overall Study|Withdrawal by Subject|3|||
17068045|NCT00483756|38210692|FG002|Overall Study|Withdrawal by Subject|4|||
17068046|NCT00483756|38210690|FG000|Overall Study|Other|2|||
17068047|NCT00483756|38210691|FG001|Overall Study|Other|4|||
17068048|NCT00483756|38210692|FG002|Overall Study|Other|3|||
17068049|NCT00483756|38210690|FG000|Overall Study|Randomized, Not Treated|1|||
17068050|NCT00483756|38210691|FG001|Overall Study|Randomized, Not Treated|4|||
17068051|NCT00483756|38210692|FG002|Overall Study|Randomized, Not Treated|4|||
17068052|NCT00309166|38210702|FG000|Overall Study|Adverse event, non-fatal|1|||
17068053|NCT00309166|38210703|FG001|Overall Study|Adverse event, non-fatal|0|||
17068054|NCT00309166|38210702|FG000|Overall Study|Withdrawal by Subject|4|||
17068055|NCT00309166|38210703|FG001|Overall Study|Withdrawal by Subject|3|||
17068056|NCT00501852|38210709|FG000|Overall Study|Adverse Event|3|||
17068057|NCT00501852|38210709|FG000|Overall Study|Withdrawal by Subject|2|||
17068058|NCT00482274|38210723|FG000|Overall Study|Adverse Event|1|||
17068059|NCT00490542|38210729|FG000|Overall Study|Lost to Follow-up|3|||
17068060|NCT00490542|38210730|FG001|Overall Study|Lost to Follow-up|0|||
17068061|NCT00490542|38210729|FG000|Overall Study|Adverse Event|3|||
17068062|NCT00490542|38210730|FG001|Overall Study|Adverse Event|3|||
17068063|NCT00490542|38210729|FG000|Overall Study|Lack of Efficacy|1|||
17068064|NCT00490542|38210730|FG001|Overall Study|Lack of Efficacy|1|||
17068065|NCT00501540|38210736|FG000|Overall Study|Death|5|||
17068066|NCT00322348|38210742|FG000|Overall Study|Adverse Event|0|||
17068067|NCT00322348|38210743|FG001|Overall Study|Adverse Event|1|||
17068068|NCT00322348|38210742|FG000|Overall Study|Withdrawal by Subject|1|||
17068069|NCT00322348|38210743|FG001|Overall Study|Withdrawal by Subject|4|||
17068070|NCT00322348|38210742|FG000|Overall Study|Lost to Follow-up|1|||
17068071|NCT00322348|38210743|FG001|Overall Study|Lost to Follow-up|0|||
17068072|NCT00322348|38210742|FG000|Overall Study|Death|0|||
17068073|NCT00322348|38210743|FG001|Overall Study|Death|2|||
17068074|NCT00322348|38210742|FG000|Overall Study|Disease Progression|30|||
17068075|NCT00322348|38210743|FG001|Overall Study|Disease Progression|25|||
17068076|NCT00322348|38210742|FG000|Overall Study|Reasons not specified|5|||
17068077|NCT00322348|38210743|FG001|Overall Study|Reasons not specified|1|||
17068078|NCT00501228|38210749|FG000|Overall Study|Withdrawal by Subject|1|||
17068079|NCT00308620|38210756|FG000|Overall Study|Death|1|||
17068080|NCT00308620|38210757|FG001|Overall Study|Death|1|||
17068081|NCT00308620|38210758|FG002|Overall Study|Death|0|||
17068082|NCT00308620|38210756|FG000|Overall Study|Lost to Follow-up|0|||
17068083|NCT00308620|38210757|FG001|Overall Study|Lost to Follow-up|0|||
17068084|NCT00308620|38210758|FG002|Overall Study|Lost to Follow-up|1|||
17068085|NCT00492752|38210768|FG000|Double Blind Treatment|Death|13|||
17068086|NCT00492752|38210769|FG001|Double Blind Treatment|Death|0|||
17068087|NCT00492752|38210770|FG002|Double Blind Treatment|Death|2|||
17068088|NCT00492752|38210771|FG003|Double Blind Treatment|Death|0|||
17068089|NCT00492752|38210768|FG000|Double Blind Treatment|Adverse Event|1|||
17068090|NCT00492752|38210769|FG001|Double Blind Treatment|Adverse Event|0|||
17068091|NCT00492752|38210770|FG002|Double Blind Treatment|Adverse Event|0|||
17068092|NCT00492752|38210771|FG003|Double Blind Treatment|Adverse Event|0|||
17068093|NCT00492752|38210768|FG000|Double Blind Treatment|Protocol Violation|0|||
17068094|NCT00492752|38210769|FG001|Double Blind Treatment|Protocol Violation|0|||
17068095|NCT00492752|38210770|FG002|Double Blind Treatment|Protocol Violation|1|||
17068096|NCT00492752|38210771|FG003|Double Blind Treatment|Protocol Violation|0|||
17068097|NCT00492752|38210768|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
17068098|NCT00492752|38210769|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
17068099|NCT00492752|38210770|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
17068100|NCT00492752|38210771|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
17068101|NCT00492752|38210768|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
17068102|NCT00492752|38210769|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
17068103|NCT00492752|38210770|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
17068104|NCT00492752|38210771|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
17068105|NCT00492752|38210768|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
17068106|NCT00492752|38210769|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
17068107|NCT00492752|38210770|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
17068108|NCT00492752|38210771|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
17068109|NCT00492752|38210768|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
17068110|NCT00492752|38210769|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
17068111|NCT00492752|38210770|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
17068112|NCT00492752|38210771|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
17068113|NCT00492752|38210768|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
17068114|NCT00492752|38210769|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
17068115|NCT00492752|38210770|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
17068116|NCT00492752|38210771|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
17068117|NCT00492752|38210768|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
17068118|NCT00492752|38210769|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
17068119|NCT00492752|38210770|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
17068120|NCT00492752|38210771|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
17068121|NCT00492752|38210768|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
17068122|NCT00492752|38210769|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
17068123|NCT00492752|38210770|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
17068124|NCT00492752|38210771|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
17068125|NCT00492752|38210768|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
17068126|NCT00492752|38210769|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
17068127|NCT00492752|38210770|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
17068128|NCT00492752|38210771|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
17068129|NCT00308308|38210780|FG000|Overall Study|Adverse Event|17|||
17068130|NCT00308308|38210781|FG001|Overall Study|Adverse Event|2|||
17068131|NCT00308308|38210780|FG000|Overall Study|Lost to Follow-up|5|||
17068132|NCT00308308|38210781|FG001|Overall Study|Lost to Follow-up|5|||
17068133|NCT00308308|38210780|FG000|Overall Study|Physician Decision|15|||
17068134|NCT00308308|38210781|FG001|Overall Study|Physician Decision|7|||
17068135|NCT00308308|38210780|FG000|Overall Study|Protocol Violation|3|||
17068136|NCT00308308|38210781|FG001|Overall Study|Protocol Violation|14|||
17068137|NCT00308308|38210780|FG000|Overall Study|Withdrawal by Subject|47|||
17068138|NCT00308308|38210781|FG001|Overall Study|Withdrawal by Subject|19|||
17068139|NCT00308308|38210780|FG000|Overall Study|Various|7|||
17068140|NCT00308308|38210781|FG001|Overall Study|Various|5|||
17068141|NCT00308308|38210780|FG000|Overall Study|Randomized but not dosed|8|||
17068142|NCT00308308|38210781|FG001|Overall Study|Randomized but not dosed|16|||
17068143|NCT00308308|38210780|FG000|Overall Study|Other|1|||
17068144|NCT00308308|38210781|FG001|Overall Study|Other|0|||
17068145|NCT00505934|38210787|FG000|Overall Study|Adverse Event|1|||
17068146|NCT00505934|38210787|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
17068147|NCT00505934|38210787|FG000|Overall Study|Other: IV dose needed to be changed|1|||
17068148|NCT00505778|38210793|FG000|Overall Study|Adverse Event|2|||
17068149|NCT00505778|38210794|FG001|Overall Study|Adverse Event|7|||
17068150|NCT00505778|38210793|FG000|Overall Study|Physician Decision|8|||
17068151|NCT00505778|38210794|FG001|Overall Study|Physician Decision|14|||
17068152|NCT00505778|38210793|FG000|Overall Study|Lost to Follow-up|17|||
17068153|NCT00505778|38210794|FG001|Overall Study|Lost to Follow-up|23|||
17068154|NCT00505778|38210793|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
17068155|NCT00505778|38210794|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
17068156|NCT00505778|38210793|FG000|Overall Study|Protocol Violation|7|||
17068157|NCT00505778|38210794|FG001|Overall Study|Protocol Violation|9|||
17068158|NCT00505778|38210793|FG000|Overall Study|Withdrawal by Subject|29|||
17068159|NCT00505778|38210794|FG001|Overall Study|Withdrawal by Subject|14|||
17068160|NCT00505778|38210793|FG000|Overall Study|Relapse|65|||
17068161|NCT00505778|38210794|FG001|Overall Study|Relapse|65|||
17068162|NCT00505778|38210793|FG000|Overall Study|Took No Study Drug|2|||
17068163|NCT00505778|38210794|FG001|Overall Study|Took No Study Drug|2|||
17068164|NCT00308074|38210800|FG000|Overall Study|Withdrawal by Subject|1|||
17068165|NCT00500760|38210806|FG000|Overall Study|Death|32|||
17068166|NCT00500760|38210807|FG001|Overall Study|Death|15|||
17068167|NCT00500760|38210806|FG000|Overall Study|Withdrawal by Subject|5|||
17068168|NCT00500760|38210807|FG001|Overall Study|Withdrawal by Subject|7|||
17068169|NCT00500760|38210806|FG000|Overall Study|Administrative decision|2|||
17068170|NCT00500760|38210807|FG001|Overall Study|Administrative decision|0|||
17068171|NCT00500760|38210806|FG000|Overall Study|Lost to Follow-up|3|||
17068172|NCT00500760|38210807|FG001|Overall Study|Lost to Follow-up|0|||
17068173|NCT00500760|38210806|FG000|Overall Study|Other|1|||
17068174|NCT00500760|38210807|FG001|Overall Study|Other|2|||
17068175|NCT00505622|38210816|FG000|Overall Study|Adverse Event|5|||
17068176|NCT00505622|38210817|FG001|Overall Study|Adverse Event|6|||
17068177|NCT00505622|38210818|FG002|Overall Study|Adverse Event|4|||
17068178|NCT00505622|38210816|FG000|Overall Study|Protocol Violation|1|||
17068179|NCT00505622|38210817|FG001|Overall Study|Protocol Violation|1|||
17068180|NCT00505622|38210818|FG002|Overall Study|Protocol Violation|0|||
17068181|NCT00505622|38210816|FG000|Overall Study|Withdrawal by Subject|0|||
17068182|NCT00505622|38210817|FG001|Overall Study|Withdrawal by Subject|3|||
17068183|NCT00505622|38210818|FG002|Overall Study|Withdrawal by Subject|2|||
17068184|NCT00505622|38210816|FG000|Overall Study|Study termination by sponsor|115|||
17068185|NCT00505622|38210817|FG001|Overall Study|Study termination by sponsor|98|||
17068186|NCT00505622|38210818|FG002|Overall Study|Study termination by sponsor|90|||
17068187|NCT03851094|38210828|FG000|Overall Study|Withdrawal by Subject|0|||
17068188|NCT03851094|38210829|FG001|Overall Study|Withdrawal by Subject|1|||
17068189|NCT03851094|38210828|FG000|Overall Study|Participant lost device|0|||
17068190|NCT03851094|38210829|FG001|Overall Study|Participant lost device|1|||
17068191|NCT03851094|38210828|FG000|Overall Study|Participant returned device|0|||
17068192|NCT03851094|38210829|FG001|Overall Study|Participant returned device|2|||
17068193|NCT00505076|38210840|FG000|Overall Study|Adverse Event|1|||
17068194|NCT00505076|38210841|FG001|Overall Study|Adverse Event|0|||
17068195|NCT00505076|38210842|FG002|Overall Study|Adverse Event|1|||
17068196|NCT00505076|38210840|FG000|Overall Study|Protocol Violation|2|||
17068197|NCT00505076|38210841|FG001|Overall Study|Protocol Violation|1|||
17068198|NCT00505076|38210842|FG002|Overall Study|Protocol Violation|2|||
17068199|NCT00505076|38210840|FG000|Overall Study|Withdrawal by Subject|0|||
17068200|NCT00505076|38210841|FG001|Overall Study|Withdrawal by Subject|1|||
17068201|NCT00505076|38210842|FG002|Overall Study|Withdrawal by Subject|2|||
17068202|NCT00307684|38210850|FG000|Open Label Phase|Lack of Efficacy|0|||
17068203|NCT00307684|38210851|FG001|Open Label Phase|Lack of Efficacy|0|||
17068204|NCT00307684|38210852|FG002|Open Label Phase|Lack of Efficacy|3|||
17068205|NCT00307684|38210850|FG000|Open Label Phase|Adverse Event|0|||
17068206|NCT00307684|38210851|FG001|Open Label Phase|Adverse Event|0|||
17068207|NCT00307684|38210852|FG002|Open Label Phase|Adverse Event|16|||
17148090|NCT00706654|38292850|FG002|Oral Stabilization Phase|Adverse Event|0|||
17148091|NCT00706654|38292851|FG003|Oral Stabilization Phase|Adverse Event|0|||
17148092|NCT00706654|38292848|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
17068208|NCT00307684|38210850|FG000|Open Label Phase|Withdrawal by Subject|0|||
17068209|NCT00307684|38210851|FG001|Open Label Phase|Withdrawal by Subject|0|||
17068210|NCT00307684|38210852|FG002|Open Label Phase|Withdrawal by Subject|15|||
17068211|NCT00307684|38210850|FG000|Open Label Phase|Lost to Follow-up|0|||
17068212|NCT00307684|38210851|FG001|Open Label Phase|Lost to Follow-up|0|||
17068213|NCT00307684|38210852|FG002|Open Label Phase|Lost to Follow-up|11|||
17068214|NCT00307684|38210850|FG000|Open Label Phase|non compliance|0|||
17068215|NCT00307684|38210851|FG001|Open Label Phase|non compliance|0|||
17068216|NCT00307684|38210852|FG002|Open Label Phase|non compliance|5|||
17068217|NCT00307684|38210850|FG000|Open Label Phase|other|0|||
17068218|NCT00307684|38210851|FG001|Open Label Phase|other|0|||
17068219|NCT00307684|38210852|FG002|Open Label Phase|other|6|||
17068220|NCT00307684|38210850|FG000|Double Blind Phase|Lack of Efficacy|2|||
17068221|NCT00307684|38210851|FG001|Double Blind Phase|Lack of Efficacy|5|||
17068222|NCT00307684|38210852|FG002|Double Blind Phase|Lack of Efficacy|0|||
17068223|NCT00489918|38210865|FG000|Overall Study|Withdrawal by Subject|2|||
17068224|NCT00489918|38210866|FG001|Overall Study|Withdrawal by Subject|1|||
17068225|NCT00489918|38210867|FG002|Overall Study|Withdrawal by Subject|1|||
17068226|NCT00489918|38210868|FG003|Overall Study|Withdrawal by Subject|0|||
17068227|NCT00489918|38210869|FG004|Overall Study|Withdrawal by Subject|1|||
17068228|NCT00489918|38210865|FG000|Overall Study|Adverse Event|0|||
17068229|NCT00489918|38210866|FG001|Overall Study|Adverse Event|1|||
17068230|NCT00489918|38210867|FG002|Overall Study|Adverse Event|1|||
17068231|NCT00489918|38210868|FG003|Overall Study|Adverse Event|0|||
17068232|NCT00489918|38210869|FG004|Overall Study|Adverse Event|0|||
17068233|NCT00489918|38210865|FG000|Overall Study|Lost to Follow-up|0|||
17148093|NCT00706654|38292849|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
17148094|NCT00706654|38292850|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
17068234|NCT00489918|38210866|FG001|Overall Study|Lost to Follow-up|0|||
17068235|NCT00489918|38210867|FG002|Overall Study|Lost to Follow-up|1|||
17068236|NCT00489918|38210868|FG003|Overall Study|Lost to Follow-up|1|||
17068237|NCT00489918|38210869|FG004|Overall Study|Lost to Follow-up|0|||
17068238|NCT00489918|38210865|FG000|Overall Study|Physician Decision|0|||
17068239|NCT00489918|38210866|FG001|Overall Study|Physician Decision|0|||
17068240|NCT00489918|38210867|FG002|Overall Study|Physician Decision|1|||
17068241|NCT00489918|38210868|FG003|Overall Study|Physician Decision|0|||
17068242|NCT00489918|38210869|FG004|Overall Study|Physician Decision|0|||
17068243|NCT00307294|38210881|FG000|Overall Study|Withdrawal by Subject|1|||
17068244|NCT03963401|38210892|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
17068245|NCT03963401|38210893|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
17068246|NCT03963401|38210894|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
17068247|NCT03963401|38210895|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
17068248|NCT03963401|38210896|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
17068249|NCT03963401|38210897|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
17068250|NCT03963401|38210892|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
17068251|NCT03963401|38210893|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
17068252|NCT03963401|38210894|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
17068253|NCT03963401|38210895|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
17068254|NCT03963401|38210896|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
17068255|NCT03963401|38210897|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
17068256|NCT03963401|38210892|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
17068257|NCT03963401|38210893|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
17068258|NCT03963401|38210894|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
17068259|NCT03963401|38210895|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
17068260|NCT03963401|38210896|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
17068261|NCT03963401|38210897|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
17068262|NCT03963401|38210892|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
17068263|NCT03963401|38210893|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
17068264|NCT03963401|38210894|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
17068265|NCT03963401|38210895|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
17068266|NCT03963401|38210896|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
17068267|NCT03963401|38210897|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
17068268|NCT03963401|38210892|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
17068269|NCT03963401|38210893|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
17068270|NCT03963401|38210894|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
17068271|NCT03963401|38210895|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
17068272|NCT03963401|38210896|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
17068273|NCT03963401|38210897|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
17068274|NCT03963401|38210892|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
17068275|NCT03963401|38210893|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
17068276|NCT03963401|38210894|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
17068277|NCT03963401|38210895|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
17068278|NCT03963401|38210896|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
17068279|NCT03963401|38210897|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
17068280|NCT03963401|38210892|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
17068281|NCT03963401|38210893|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
17068282|NCT03963401|38210894|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
17068283|NCT03963401|38210895|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
17068284|NCT03963401|38210896|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
17068285|NCT03963401|38210897|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
17068286|NCT03963401|38210892|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
17068287|NCT03963401|38210893|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
17068288|NCT03963401|38210894|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
17068289|NCT03963401|38210895|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
17068290|NCT03963401|38210896|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
17068291|NCT03963401|38210897|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
17068292|NCT03963401|38210892|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
17068293|NCT03963401|38210893|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
17068294|NCT03963401|38210894|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
17068295|NCT03963401|38210895|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
17068296|NCT03963401|38210896|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
17068297|NCT03963401|38210897|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
17068298|NCT03963401|38210892|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
17068299|NCT03963401|38210893|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
17068300|NCT03963401|38210894|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
17068301|NCT03963401|38210895|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
17068302|NCT03963401|38210896|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
17068303|NCT03963401|38210897|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
17068304|NCT03963401|38210892|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
17068305|NCT03963401|38210893|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
17068306|NCT03963401|38210894|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
17068307|NCT03963401|38210895|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
17068308|NCT03963401|38210896|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
17068309|NCT03963401|38210897|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
17068310|NCT00334282|38210917|FG000|Overall Study|Lost to Follow-up|11|||
17068311|NCT00334282|38210918|FG001|Overall Study|Lost to Follow-up|5|||
17068312|NCT00334282|38210917|FG000|Overall Study|Withdrawal by Subject|17|||
17068313|NCT00334282|38210918|FG001|Overall Study|Withdrawal by Subject|3|||
17068314|NCT00334282|38210917|FG000|Overall Study|Death|194|||
17068315|NCT00334282|38210918|FG001|Overall Study|Death|100|||
17068316|NCT00306670|38210930|FG000|Overall Study|patients recruited; Genentech, the st|0|||
17068317|NCT00306670|38210931|FG001|Overall Study|patients recruited; Genentech, the st|2|||
17068318|NCT00306592|38210937|FG000|Overall Study|Adverse Event|8|||
17068319|NCT00306592|38210938|FG001|Overall Study|Adverse Event|15|||
17068320|NCT00306592|38210937|FG000|Overall Study|Lost to Follow-up|1|||
17068321|NCT00306592|38210938|FG001|Overall Study|Lost to Follow-up|0|||
17068322|NCT00306592|38210937|FG000|Overall Study|Noncompliance|0|||
17068323|NCT00306592|38210938|FG001|Overall Study|Noncompliance|2|||
17068324|NCT00306592|38210937|FG000|Overall Study|Persistent Antibodies|6|||
17068325|NCT00306592|38210938|FG001|Overall Study|Persistent Antibodies|3|||
17068326|NCT00306592|38210937|FG000|Overall Study|Voluntary|10|||
17068327|NCT00306592|38210938|FG001|Overall Study|Voluntary|6|||
17068328|NCT00306592|38210937|FG000|Overall Study|Other|5|||
17068329|NCT00306592|38210938|FG001|Overall Study|Other|10|||
17068330|NCT00306592|38210937|FG000|Overall Study|Other|1|||
17068331|NCT00306592|38210938|FG001|Overall Study|Other|2|||
17068332|NCT00306592|38210937|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
17068333|NCT00306592|38210938|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
17068334|NCT00321646|38210942|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
17068335|NCT00321646|38210942|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
17068336|NCT00321646|38210942|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
17068337|NCT00403767|38210948|FG000|Overall Study|Adverse Event|993|||
17068338|NCT00403767|38210949|FG001|Overall Study|Adverse Event|919|||
17068339|NCT00403767|38210948|FG000|Overall Study|Non-compliant with study medication|134|||
17068340|NCT00403767|38210949|FG001|Overall Study|Non-compliant with study medication|164|||
17068341|NCT00403767|38210948|FG000|Overall Study|Consent withdrawn|671|||
17068342|NCT00403767|38210949|FG001|Overall Study|Consent withdrawn|673|||
17068343|NCT00403767|38210948|FG000|Overall Study|Investigator dec./not protocol-related|191|||
17068344|NCT00403767|38210949|FG001|Overall Study|Investigator dec./not protocol-related|178|||
17068345|NCT00403767|38210948|FG000|Overall Study|Lost to Follow-up|6|||
17068346|NCT00403767|38210949|FG001|Overall Study|Lost to Follow-up|8|||
17068347|NCT00403767|38210948|FG000|Overall Study|Protocol Violation|142|||
17068348|NCT00403767|38210949|FG001|Overall Study|Protocol Violation|124|||
17068349|NCT00403767|38210948|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
17068350|NCT00403767|38210949|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
17068351|NCT00403767|38210948|FG000|Overall Study|Study terminated by sponsor|82|||
17068352|NCT00403767|38210949|FG001|Overall Study|Study terminated by sponsor|69|||
17068353|NCT00403767|38210948|FG000|Overall Study|Missing/incomplete data|1|||
17068354|NCT00403767|38210949|FG001|Overall Study|Missing/incomplete data|1|||
17068355|NCT00492284|38210959|FG000|Overall Study|Adverse Event|0|||
17068356|NCT00492284|38210960|FG001|Overall Study|Adverse Event|1|||
17068357|NCT00492284|38210961|FG002|Overall Study|Adverse Event|1|||
17068358|NCT00492284|38210962|FG003|Overall Study|Adverse Event|2|||
17068359|NCT00492284|38210959|FG000|Overall Study|Lost to Follow-up|0|||
17068360|NCT00492284|38210960|FG001|Overall Study|Lost to Follow-up|0|||
17068361|NCT00492284|38210961|FG002|Overall Study|Lost to Follow-up|3|||
17068362|NCT00492284|38210962|FG003|Overall Study|Lost to Follow-up|1|||
17068363|NCT00492284|38210959|FG000|Overall Study|Death|0|||
17068364|NCT00492284|38210960|FG001|Overall Study|Death|3|||
17068365|NCT00492284|38210961|FG002|Overall Study|Death|2|||
17068366|NCT00492284|38210962|FG003|Overall Study|Death|5|||
17068367|NCT00492284|38210959|FG000|Overall Study|Withdrawal by Subject|1|||
17068368|NCT00492284|38210960|FG001|Overall Study|Withdrawal by Subject|0|||
17068369|NCT00492284|38210961|FG002|Overall Study|Withdrawal by Subject|0|||
17068370|NCT00492284|38210962|FG003|Overall Study|Withdrawal by Subject|2|||
17068371|NCT00510458|38210972|FG000|Overall Study|5 year not evaluable/missed|21|||
17068372|NCT00510458|38210972|FG000|Overall Study|Death|1|||
17068373|NCT00510458|38210972|FG000|Overall Study|Terminated|14|||
17068374|NCT00510458|38210972|FG000|Overall Study|Lost to Follow-up|6|||
17068375|NCT00510458|38210972|FG000|Overall Study|Withdrawal by Subject|3|||
17068376|NCT00510458|38210972|FG000|Overall Study|Revision|2|||
17068377|NCT00414765|38210979|FG000|Overall Study|Adverse Event|5|||
17068378|NCT00414765|38210980|FG001|Overall Study|Adverse Event|9|||
17068379|NCT00414765|38210979|FG000|Overall Study|Withdrawal by Subject|1|||
17068380|NCT00414765|38210980|FG001|Overall Study|Withdrawal by Subject|1|||
17068381|NCT00414765|38210979|FG000|Overall Study|Disease Progression|0|||
17068382|NCT00414765|38210980|FG001|Overall Study|Disease Progression|1|||
17068383|NCT00500682|38210988|FG000|Overall Study|Adverse Event|37|||
17068384|NCT00500682|38210989|FG001|Overall Study|Adverse Event|29|||
17068385|NCT00500682|38210988|FG000|Overall Study|Death|25|||
17068386|NCT00500682|38210989|FG001|Overall Study|Death|16|||
17068387|NCT00500682|38210988|FG000|Overall Study|Lost to Follow-up|11|||
17068388|NCT00500682|38210989|FG001|Overall Study|Lost to Follow-up|11|||
17068389|NCT00500682|38210988|FG000|Overall Study|Physician Decision|6|||
17068390|NCT00500682|38210989|FG001|Overall Study|Physician Decision|10|||
17068391|NCT00500682|38210988|FG000|Overall Study|Pregnancy|2|||
17068392|NCT00500682|38210989|FG001|Overall Study|Pregnancy|0|||
17068393|NCT00500682|38210988|FG000|Overall Study|Protocol Violation|1|||
17068394|NCT00500682|38210989|FG001|Overall Study|Protocol Violation|3|||
17068395|NCT00500682|38210988|FG000|Overall Study|Withdrawal by Subject|80|||
17068396|NCT00500682|38210989|FG001|Overall Study|Withdrawal by Subject|74|||
17068397|NCT00500682|38210988|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
17068398|NCT00500682|38210989|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
17068399|NCT00500370|38210997|FG000|Overall Study|Adverse Event|9|||
17068400|NCT00500370|38210998|FG001|Overall Study|Adverse Event|3|||
17068401|NCT00500370|38210997|FG000|Overall Study|Lost to Follow-up|10|||
17068402|NCT00500370|38210998|FG001|Overall Study|Lost to Follow-up|10|||
17068403|NCT00500370|38210997|FG000|Overall Study|Protocol Violation|2|||
17068404|NCT00500370|38210998|FG001|Overall Study|Protocol Violation|4|||
17068405|NCT00500370|38210997|FG000|Overall Study|Sponsor Decision|2|||
17148095|NCT00706654|38292851|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
17148096|NCT00706654|38292848|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
17068406|NCT00500370|38210998|FG001|Overall Study|Sponsor Decision|0|||
17068407|NCT00500370|38210997|FG000|Overall Study|Subject Decision|10|||
17068408|NCT00500370|38210998|FG001|Overall Study|Subject Decision|17|||
17068409|NCT00320788|38211009|FG000|Overall Study|Adverse Event|0|||
17068410|NCT00320788|38211010|FG001|Overall Study|Adverse Event|0|||
17068411|NCT00320788|38211011|FG002|Overall Study|Adverse Event|0|||
17068412|NCT00320788|38211012|FG003|Overall Study|Adverse Event|1|||
17068413|NCT00320788|38211013|FG004|Overall Study|Adverse Event|0|||
17068414|NCT00320788|38211009|FG000|Overall Study|Death|0|||
17068415|NCT00320788|38211010|FG001|Overall Study|Death|0|||
17068416|NCT00320788|38211011|FG002|Overall Study|Death|1|||
17068417|NCT00320788|38211012|FG003|Overall Study|Death|0|||
17068418|NCT00320788|38211013|FG004|Overall Study|Death|1|||
17068419|NCT00320788|38211009|FG000|Overall Study|Lost to Follow-up|0|||
17068420|NCT00320788|38211010|FG001|Overall Study|Lost to Follow-up|2|||
17068421|NCT00320788|38211011|FG002|Overall Study|Lost to Follow-up|1|||
17068422|NCT00320788|38211012|FG003|Overall Study|Lost to Follow-up|0|||
17068423|NCT00320788|38211013|FG004|Overall Study|Lost to Follow-up|0|||
17068424|NCT00320788|38211009|FG000|Overall Study|Decision by the Sponsor|1|||
17068425|NCT00320788|38211010|FG001|Overall Study|Decision by the Sponsor|1|||
17148097|NCT00706654|38292849|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
17148098|NCT00706654|38292850|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
17148099|NCT00706654|38292851|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
17148100|NCT00706654|38292848|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
17148101|NCT00706654|38292849|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
17148102|NCT00706654|38292850|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
17148103|NCT00706654|38292851|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
17148104|NCT00706654|38292848|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
17148105|NCT00706654|38292849|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
17148106|NCT00706654|38292850|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
17148107|NCT00706654|38292851|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
17148108|NCT00706654|38292848|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
17148109|NCT00706654|38292849|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
17148110|NCT00706654|38292850|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
17148111|NCT00706654|38292851|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
17148112|NCT00706654|38292848|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
17148113|NCT00706654|38292849|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
17148114|NCT00706654|38292850|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
17148115|NCT00706654|38292851|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
17148116|NCT00706654|38292848|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
17148117|NCT00706654|38292849|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
17148118|NCT00706654|38292850|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
17148119|NCT00706654|38292851|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
17148120|NCT00706654|38292848|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
17148121|NCT00706654|38292849|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
17148122|NCT00706654|38292850|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
17148123|NCT00706654|38292851|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
17148124|NCT00706654|38292848|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
17148125|NCT00706654|38292849|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
17148126|NCT00706654|38292850|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
17148127|NCT00706654|38292851|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
17068426|NCT00320788|38211011|FG002|Overall Study|Decision by the Sponsor|0|||
17068427|NCT00320788|38211012|FG003|Overall Study|Decision by the Sponsor|0|||
17068428|NCT00320788|38211013|FG004|Overall Study|Decision by the Sponsor|1|||
17068429|NCT00320788|38211009|FG000|Overall Study|Other|1|||
17068430|NCT00320788|38211010|FG001|Overall Study|Other|2|||
17068431|NCT00320788|38211011|FG002|Overall Study|Other|1|||
17148128|NCT00706654|38292848|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
17148129|NCT00706654|38292849|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
17148130|NCT00706654|38292850|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
17148131|NCT00706654|38292851|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
17148132|NCT03471871|38292863|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
17148133|NCT03471871|38292864|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
17148134|NCT03471871|38292865|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
17148135|NCT03471871|38292866|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
17148136|NCT03471871|38292867|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
17148137|NCT03471871|38292863|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
17148138|NCT03471871|38292864|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
17148139|NCT03471871|38292865|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
17148140|NCT03471871|38292866|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
17148141|NCT03471871|38292867|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
17148142|NCT03471871|38292863|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
17148143|NCT03471871|38292864|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
17148144|NCT03471871|38292865|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
17068432|NCT00320788|38211012|FG003|Overall Study|Other|1|||
17068433|NCT00320788|38211013|FG004|Overall Study|Other|1|||
17068434|NCT00320788|38211009|FG000|Overall Study|Physician Decision|1|||
17068435|NCT00320788|38211010|FG001|Overall Study|Physician Decision|1|||
17068436|NCT00320788|38211011|FG002|Overall Study|Physician Decision|0|||
17068437|NCT00320788|38211012|FG003|Overall Study|Physician Decision|0|||
17068438|NCT00320788|38211013|FG004|Overall Study|Physician Decision|0|||
17068439|NCT00320788|38211009|FG000|Overall Study|Protocol Violation|0|||
17068440|NCT00320788|38211010|FG001|Overall Study|Protocol Violation|0|||
17068441|NCT00320788|38211011|FG002|Overall Study|Protocol Violation|0|||
17068442|NCT00320788|38211012|FG003|Overall Study|Protocol Violation|0|||
17068443|NCT00320788|38211013|FG004|Overall Study|Protocol Violation|1|||
17068444|NCT00320788|38211009|FG000|Overall Study|Withdrawal by Subject|3|||
17068445|NCT00320788|38211010|FG001|Overall Study|Withdrawal by Subject|0|||
17068446|NCT00320788|38211011|FG002|Overall Study|Withdrawal by Subject|0|||
17068447|NCT00320788|38211012|FG003|Overall Study|Withdrawal by Subject|3|||
17068448|NCT00320788|38211013|FG004|Overall Study|Withdrawal by Subject|1|||
17068449|NCT00503984|38211033|FG000|Overall Study|Protocol Violation|0|||
17068450|NCT00503984|38211034|FG001|Overall Study|Protocol Violation|1|||
17068451|NCT00503984|38211035|FG002|Overall Study|Protocol Violation|0|||
17068452|NCT00503984|38211036|FG003|Overall Study|Protocol Violation|0|||
17068453|NCT00503984|38211037|FG004|Overall Study|Protocol Violation|0|||
17068454|NCT00503984|38211038|FG005|Overall Study|Protocol Violation|0|||
17068455|NCT00503984|38211033|FG000|Overall Study|Adverse Event|0|||
17068456|NCT00503984|38211034|FG001|Overall Study|Adverse Event|1|||
17068457|NCT00503984|38211035|FG002|Overall Study|Adverse Event|0|||
17068458|NCT00503984|38211036|FG003|Overall Study|Adverse Event|0|||
17068459|NCT00503984|38211037|FG004|Overall Study|Adverse Event|0|||
17068460|NCT00503984|38211038|FG005|Overall Study|Adverse Event|0|||
17068461|NCT00503984|38211033|FG000|Overall Study|Death|0|||
17068462|NCT00503984|38211034|FG001|Overall Study|Death|0|||
17068463|NCT00503984|38211035|FG002|Overall Study|Death|0|||
17068464|NCT00503984|38211036|FG003|Overall Study|Death|0|||
17068465|NCT00503984|38211037|FG004|Overall Study|Death|1|||
17068466|NCT00503984|38211038|FG005|Overall Study|Death|0|||
17068467|NCT00565409|38211062|FG000|Period 1 Open Label|Adverse Event|17|||
17068468|NCT00565409|38211063|FG001|Period 1 Open Label|Adverse Event|0|||
17068469|NCT00565409|38211064|FG002|Period 1 Open Label|Adverse Event|0|||
17068470|NCT00565409|38211065|FG003|Period 1 Open Label|Adverse Event|0|||
17068471|NCT00565409|38211062|FG000|Period 1 Open Label|Death|2|||
17068472|NCT00565409|38211063|FG001|Period 1 Open Label|Death|0|||
17068473|NCT00565409|38211064|FG002|Period 1 Open Label|Death|0|||
17068474|NCT00565409|38211065|FG003|Period 1 Open Label|Death|0|||
17068475|NCT00565409|38211062|FG000|Period 1 Open Label|Lost to Follow-up|1|||
17068476|NCT00565409|38211063|FG001|Period 1 Open Label|Lost to Follow-up|0|||
17068477|NCT00565409|38211064|FG002|Period 1 Open Label|Lost to Follow-up|0|||
17068478|NCT00565409|38211065|FG003|Period 1 Open Label|Lost to Follow-up|0|||
17068479|NCT00565409|38211062|FG000|Period 1 Open Label|Other|21|||
17068480|NCT00565409|38211063|FG001|Period 1 Open Label|Other|0|||
17148145|NCT03471871|38292866|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
17148146|NCT03471871|38292867|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
17148147|NCT03471871|38292863|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
16781239|NCT02109484|37720413|FG004|Overall Study|Withdrawal by Subject|1|||
17068481|NCT00565409|38211064|FG002|Period 1 Open Label|Other|0|||
17068482|NCT00565409|38211065|FG003|Period 1 Open Label|Other|0|||
17068483|NCT00565409|38211062|FG000|Period 1 Open Label|Protocol Violation|14|||
17068484|NCT00565409|38211063|FG001|Period 1 Open Label|Protocol Violation|0|||
17068485|NCT00565409|38211064|FG002|Period 1 Open Label|Protocol Violation|0|||
17148148|NCT03471871|38292864|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
17148149|NCT03471871|38292865|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
17148150|NCT03471871|38292866|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
17148151|NCT03471871|38292867|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
17148152|NCT03471871|38292863|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
17148153|NCT03471871|38292864|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
17148154|NCT03471871|38292865|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
17148155|NCT03471871|38292866|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
17148156|NCT03471871|38292867|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
17148157|NCT01957176|38292885|FG000|Overall Study|Adverse Event|2|||
17148158|NCT01957176|38292886|FG001|Overall Study|Adverse Event|0|||
17148159|NCT01957176|38292885|FG000|Overall Study|Physician Decision|2|||
17148160|NCT01957176|38292886|FG001|Overall Study|Physician Decision|1|||
17148161|NCT01957176|38292885|FG000|Overall Study|Withdrawal by Subject|1|||
17148162|NCT01957176|38292886|FG001|Overall Study|Withdrawal by Subject|0|||
17148163|NCT03527173|38292895|FG000|Overall Study|Lost to Follow-up|4|||
17148164|NCT03527173|38292896|FG001|Overall Study|Lost to Follow-up|2|||
17148165|NCT03527173|38292895|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
17148166|NCT03527173|38292896|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
17148167|NCT03527173|38292895|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
17148168|NCT03527173|38292896|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
17148169|NCT03527173|38292895|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
17148170|NCT03527173|38292896|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17148171|NCT00707980|38292902|FG000|Overall Study|Adverse Event|49|||
17148172|NCT00707980|38292902|FG000|Overall Study|Lack of Efficacy|35|||
17148173|NCT00707980|38292902|FG000|Overall Study|Non-Compliance with Study Drug|28|||
17148174|NCT00707980|38292902|FG000|Overall Study|Protocol Deviations|19|||
17148175|NCT00707980|38292902|FG000|Overall Study|Withdrawal of Consent|81|||
17148176|NCT00707980|38292902|FG000|Overall Study|Lost to Follow-up|59|||
17068486|NCT00565409|38211065|FG003|Period 1 Open Label|Protocol Violation|0|||
17068487|NCT00565409|38211062|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
17068488|NCT00565409|38211063|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
17068489|NCT00565409|38211064|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
17148177|NCT00707980|38292902|FG000|Overall Study|Other|39|||
17148178|NCT03506425|38292909|FG000|Overall Study|Adverse Event|1|||
17148179|NCT03506425|38292910|FG001|Overall Study|Adverse Event|3|||
17148180|NCT03506425|38292911|FG002|Overall Study|Adverse Event|0|||
17148181|NCT03506425|38292909|FG000|Overall Study|Death|1|||
17148182|NCT03506425|38292910|FG001|Overall Study|Death|0|||
17148183|NCT03506425|38292911|FG002|Overall Study|Death|0|||
17148184|NCT03506425|38292909|FG000|Overall Study|Withdrawal by Subject|0|||
17148185|NCT03506425|38292910|FG001|Overall Study|Withdrawal by Subject|0|||
17148186|NCT03506425|38292911|FG002|Overall Study|Withdrawal by Subject|1|||
17148187|NCT03051620|38292920|FG000|Overall Study|Lost to Follow-up|6|||
17148188|NCT03051620|38292920|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
17148189|NCT03053492|38292926|FG000|Overall Study|Adverse Event|1|||
17148190|NCT03053492|38292927|FG001|Overall Study|Adverse Event|1|||
17148191|NCT03053492|38292926|FG000|Overall Study|Withdrawal by Subject|7|||
17148192|NCT03053492|38292927|FG001|Overall Study|Withdrawal by Subject|5|||
17148193|NCT04239872|38292933|FG000|Overall Study|Lost to Follow-up|0|||
17148194|NCT04239872|38292934|FG001|Overall Study|Lost to Follow-up|1|||
17148195|NCT03164772|38292942|FG000|Overall Study|Death|4|||
17148196|NCT03164772|38292943|FG001|Overall Study|Death|2|||
17148197|NCT03164772|38292942|FG000|Overall Study|Adverse Event|1|||
17148198|NCT03164772|38292943|FG001|Overall Study|Adverse Event|4|||
17148199|NCT03164772|38292942|FG000|Overall Study|Progressive Disease|11|||
17148200|NCT03164772|38292943|FG001|Overall Study|Progressive Disease|21|||
17148201|NCT03164772|38292942|FG000|Overall Study|Physician Decision|2|||
17148202|NCT03164772|38292943|FG001|Overall Study|Physician Decision|0|||
17148203|NCT03164772|38292942|FG000|Overall Study|Withdrawal by Subject|0|||
17148204|NCT03164772|38292943|FG001|Overall Study|Withdrawal by Subject|4|||
17148205|NCT03050450|38292966|FG000|Overall Study|Physician Decision|1|||
17148206|NCT03050450|38292967|FG001|Overall Study|Physician Decision|0|||
17148207|NCT03050450|38292968|FG002|Overall Study|Physician Decision|0|||
17148208|NCT03050450|38292969|FG003|Overall Study|Physician Decision|0|||
17148209|NCT03050450|38292970|FG004|Overall Study|Physician Decision|0|||
17148210|NCT03505021|38292984|FG000|Overall Study|Protocol Violation|1|||
17068490|NCT00565409|38211065|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
17068491|NCT00565409|38211062|FG000|Period 1 Open Label|no conclusion of participation record|1|||
17068492|NCT00565409|38211063|FG001|Period 1 Open Label|no conclusion of participation record|0|||
17068493|NCT00565409|38211064|FG002|Period 1 Open Label|no conclusion of participation record|0|||
17068494|NCT00565409|38211065|FG003|Period 1 Open Label|no conclusion of participation record|0|||
17148211|NCT03505021|38292985|FG001|Overall Study|Protocol Violation|0|||
17148212|NCT03505021|38292984|FG000|Overall Study|Death|9|||
17068495|NCT00565409|38211062|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
17068496|NCT00565409|38211063|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
17068497|NCT00565409|38211064|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
17068498|NCT00565409|38211065|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
17068499|NCT00565409|38211062|FG000|Period 2 Double-Blind|Adverse Event|0|||
17068500|NCT00565409|38211063|FG001|Period 2 Double-Blind|Adverse Event|7|||
17068501|NCT00565409|38211064|FG002|Period 2 Double-Blind|Adverse Event|4|||
17068502|NCT00565409|38211065|FG003|Period 2 Double-Blind|Adverse Event|5|||
17068503|NCT00565409|38211062|FG000|Period 2 Double-Blind|Death|0|||
17068504|NCT00565409|38211063|FG001|Period 2 Double-Blind|Death|2|||
17068505|NCT00565409|38211064|FG002|Period 2 Double-Blind|Death|0|||
17068506|NCT00565409|38211065|FG003|Period 2 Double-Blind|Death|0|||
17068507|NCT00565409|38211062|FG000|Period 2 Double-Blind|Protocol Violation|0|||
17068508|NCT00565409|38211063|FG001|Period 2 Double-Blind|Protocol Violation|4|||
17068509|NCT00565409|38211064|FG002|Period 2 Double-Blind|Protocol Violation|6|||
17068510|NCT00565409|38211065|FG003|Period 2 Double-Blind|Protocol Violation|2|||
17068511|NCT00565409|38211062|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
17068512|NCT00565409|38211063|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
17068513|NCT00565409|38211064|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
17068514|NCT00565409|38211065|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
17068515|NCT00565409|38211062|FG000|Period 2 Double-Blind|Other|0|||
17068516|NCT00565409|38211063|FG001|Period 2 Double-Blind|Other|4|||
17068517|NCT00565409|38211064|FG002|Period 2 Double-Blind|Other|5|||
17068518|NCT00565409|38211065|FG003|Period 2 Double-Blind|Other|9|||
17068519|NCT00565409|38211062|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
17068520|NCT00565409|38211063|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
17068521|NCT00565409|38211064|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
17068522|NCT00565409|38211065|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
17148213|NCT03505021|38292985|FG001|Overall Study|Death|8|||
17148214|NCT03505021|38292984|FG000|Overall Study|Consent withdrawn by subject|6|||
17148215|NCT03505021|38292985|FG001|Overall Study|Consent withdrawn by subject|1|||
17148216|NCT03505021|38292984|FG000|Overall Study|Lost to Follow-up|5|||
17148217|NCT03505021|38292985|FG001|Overall Study|Lost to Follow-up|3|||
17148218|NCT03505021|38292984|FG000|Overall Study|Adverse Event|26|||
17068523|NCT00394251|38211077|FG000|Overall Study|Adverse Event|7|||
17068524|NCT00394251|38211078|FG001|Overall Study|Adverse Event|5|||
17148219|NCT03505021|38292985|FG001|Overall Study|Adverse Event|9|||
17148220|NCT03505021|38292984|FG000|Overall Study|Disease progression|33|||
17148221|NCT03505021|38292985|FG001|Overall Study|Disease progression|17|||
17148222|NCT03505021|38292984|FG000|Overall Study|Other|11|||
17148223|NCT03505021|38292985|FG001|Overall Study|Other|5|||
17148224|NCT03505021|38292984|FG000|Overall Study|Personal reason|21|||
17148225|NCT03505021|38292985|FG001|Overall Study|Personal reason|12|||
17148226|NCT03050372|38292991|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
17148227|NCT03050372|38292992|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
17148228|NCT03050372|38292991|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
17068525|NCT00394251|38211077|FG000|Overall Study|Unacceptable Toxicity|20|||
17068526|NCT00394251|38211078|FG001|Overall Study|Unacceptable Toxicity|18|||
17068527|NCT00394251|38211077|FG000|Overall Study|Physician Decision|1|||
17068528|NCT00394251|38211078|FG001|Overall Study|Physician Decision|1|||
17068529|NCT00394251|38211077|FG000|Overall Study|Protocol Violation|0|||
17068530|NCT00394251|38211078|FG001|Overall Study|Protocol Violation|1|||
17068531|NCT00394251|38211077|FG000|Overall Study|Withdrawal by Subject|7|||
17068532|NCT00394251|38211078|FG001|Overall Study|Withdrawal by Subject|11|||
17068533|NCT00394251|38211077|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
17068534|NCT00394251|38211078|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
17068535|NCT00394095|38211090|FG000|Overall Study|Adverse Event|1|||
17068536|NCT00394095|38211091|FG001|Overall Study|Adverse Event|0|||
17068537|NCT00503906|38211098|FG000|Overall Study|Withdrawal by Subject|1|||
17068538|NCT00305110|38211103|FG000|Overall Study|Missing data|29|||
17068539|NCT00491894|38211107|FG000|Overall Study|Adverse Event|14|||
17068540|NCT00491894|38211107|FG000|Overall Study|Withdrawal by Subject|5|||
17068541|NCT00491894|38211107|FG000|Overall Study|Death|3|||
17068542|NCT00491894|38211107|FG000|Overall Study|Lost to Follow-up|3|||
17068543|NCT00491894|38211107|FG000|Overall Study|Lack of Efficacy|2|||
17068544|NCT00491894|38211107|FG000|Overall Study|Other-Failed to meet any criteria|2|||
17068545|NCT00491894|38211107|FG000|Overall Study|Physician Decision|2|||
17068546|NCT00491894|38211107|FG000|Overall Study|Protocol Violation|2|||
17068547|NCT00491894|38211107|FG000|Overall Study|Other-Intake of prohibited medication|1|||
17068548|NCT00491504|38211115|FG000|Overall Study|Adverse Event|0|||
17068549|NCT00491504|38211116|FG001|Overall Study|Adverse Event|1|||
17068550|NCT00491504|38211117|FG002|Overall Study|Adverse Event|0|||
17068551|NCT00491504|38211118|FG003|Overall Study|Adverse Event|0|||
17068552|NCT00491504|38211115|FG000|Overall Study|Withdrawal by Subject|0|||
17068553|NCT00491504|38211116|FG001|Overall Study|Withdrawal by Subject|0|||
17148229|NCT03050372|38292992|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
17068554|NCT00491504|38211117|FG002|Overall Study|Withdrawal by Subject|1|||
17068555|NCT00491504|38211118|FG003|Overall Study|Withdrawal by Subject|2|||
17068556|NCT00491504|38211115|FG000|Overall Study|Protocol Violation|0|||
17068557|NCT00491504|38211116|FG001|Overall Study|Protocol Violation|0|||
17068558|NCT00491504|38211117|FG002|Overall Study|Protocol Violation|3|||
17068559|NCT00491504|38211118|FG003|Overall Study|Protocol Violation|2|||
17068560|NCT00500292|38211129|FG000|Overall Study|Adverse Event|3|||
17068561|NCT00500292|38211130|FG001|Overall Study|Adverse Event|6|||
17068562|NCT00500292|38211131|FG002|Overall Study|Adverse Event|4|||
17068563|NCT00500292|38211129|FG000|Overall Study|Condition under investigation worsened|21|||
17068564|NCT00500292|38211130|FG001|Overall Study|Condition under investigation worsened|23|||
17068565|NCT00500292|38211131|FG002|Overall Study|Condition under investigation worsened|19|||
17068566|NCT00500292|38211129|FG000|Overall Study|Withdrawal by Subject|0|||
17068567|NCT00500292|38211130|FG001|Overall Study|Withdrawal by Subject|1|||
17068568|NCT00500292|38211131|FG002|Overall Study|Withdrawal by Subject|0|||
17068569|NCT00500292|38211129|FG000|Overall Study|Other|1|||
17068570|NCT00500292|38211130|FG001|Overall Study|Other|1|||
17068571|NCT00500292|38211131|FG002|Overall Study|Other|4|||
17068572|NCT00499746|38211139|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
17068573|NCT00499746|38211139|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
17068574|NCT00499746|38211139|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
17068575|NCT00499746|38211139|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
17068576|NCT00489216|38211153|FG000|Overall Study|Adverse Event|1|||
17068577|NCT00499590|38211160|FG000|Overall Study|Study Terminated|112|||
17068578|NCT00499590|38211161|FG001|Overall Study|Study Terminated|112|||
17068579|NCT00499590|38211162|FG002|Overall Study|Study Terminated|112|||
17068580|NCT00499590|38211160|FG000|Overall Study|Not treated|1|||
17068581|NCT00499590|38211161|FG001|Overall Study|Not treated|0|||
17068582|NCT00499590|38211162|FG002|Overall Study|Not treated|1|||
17068583|NCT00510146|38211173|FG000|Double-Blind Treatment|Adverse Event|30|||
17068584|NCT00510146|38211174|FG001|Double-Blind Treatment|Adverse Event|13|||
17068585|NCT00510146|38211173|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
17068586|NCT00510146|38211174|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
17068587|NCT00510146|38211173|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
17068588|NCT00510146|38211174|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
17068589|NCT00510146|38211173|FG000|Double-Blind Treatment|Physician Decision|6|||
17068590|NCT00510146|38211174|FG001|Double-Blind Treatment|Physician Decision|0|||
17068591|NCT00510146|38211173|FG000|Double-Blind Treatment|Protocol Violation|1|||
17068592|NCT00510146|38211174|FG001|Double-Blind Treatment|Protocol Violation|2|||
17068593|NCT00510146|38211173|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
17068594|NCT00510146|38211174|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
17068595|NCT00510146|38211173|FG000|Double-Blind Treatment|Clinical Relapse|0|||
17068596|NCT00510146|38211174|FG001|Double-Blind Treatment|Clinical Relapse|1|||
17068597|NCT00510146|38211173|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
17068598|NCT00510146|38211174|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
17068599|NCT00510146|38211173|FG000|Open-Label Treatment|Adverse Event|22|||
17068600|NCT00510146|38211174|FG001|Open-Label Treatment|Adverse Event|8|||
17068601|NCT00510146|38211173|FG000|Open-Label Treatment|Death|1|||
17068602|NCT00510146|38211174|FG001|Open-Label Treatment|Death|1|||
17068603|NCT00510146|38211173|FG000|Open-Label Treatment|Lack of Efficacy|4|||
17068604|NCT00510146|38211174|FG001|Open-Label Treatment|Lack of Efficacy|0|||
17068605|NCT00510146|38211173|FG000|Open-Label Treatment|Lost to Follow-up|10|||
17068606|NCT00510146|38211174|FG001|Open-Label Treatment|Lost to Follow-up|1|||
17068607|NCT00510146|38211173|FG000|Open-Label Treatment|Physician Decision|3|||
17068608|NCT00510146|38211174|FG001|Open-Label Treatment|Physician Decision|1|||
17068609|NCT00510146|38211173|FG000|Open-Label Treatment|Protocol Violation|4|||
17068610|NCT00510146|38211174|FG001|Open-Label Treatment|Protocol Violation|2|||
17068611|NCT00510146|38211173|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
17068612|NCT00510146|38211174|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
17068613|NCT00510146|38211173|FG000|Open-Label Treatment|Clinical Relapse|1|||
17068614|NCT00510146|38211174|FG001|Open-Label Treatment|Clinical Relapse|1|||
17068615|NCT00510146|38211173|FG000|Open-Label Treatment|Sponsor Decision|2|||
17068616|NCT00510146|38211174|FG001|Open-Label Treatment|Sponsor Decision|0|||
17068617|NCT00480636|38211182|FG000|Overall Study|Death|12|||
17068618|NCT00480636|38211182|FG000|Overall Study|Lost to Follow-up|4|||
17068619|NCT00480636|38211182|FG000|Overall Study|Other|2|||
17068620|NCT00480636|38211182|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
17068621|NCT00499122|38211186|FG000|Overall Study|Withdrawal by Subject|2|||
17068622|NCT00393939|38211193|FG000|Overall Study|Protocol Violation|1|||
17068623|NCT00393939|38211194|FG001|Overall Study|Protocol Violation|1|||
17068624|NCT00393939|38211193|FG000|Overall Study|Lost to Follow-up|2|||
17068625|NCT00393939|38211194|FG001|Overall Study|Lost to Follow-up|4|||
17068626|NCT00393939|38211193|FG000|Overall Study|Death|10|||
17068627|NCT00393939|38211194|FG001|Overall Study|Death|4|||
17068628|NCT00393939|38211193|FG000|Overall Study|Sponsor|5|||
17068629|NCT00393939|38211194|FG001|Overall Study|Sponsor|13|||
17068630|NCT00393939|38211193|FG000|Overall Study|Objective progression or relapse|239|||
17068631|NCT00393939|38211194|FG001|Overall Study|Objective progression or relapse|223|||
17068632|NCT00393939|38211193|FG000|Overall Study|Withdrawal by Subject|2|||
17068633|NCT00393939|38211194|FG001|Overall Study|Withdrawal by Subject|7|||
17068634|NCT00393939|38211193|FG000|Overall Study|Other|37|||
17068635|NCT00393939|38211194|FG001|Overall Study|Other|45|||
17068636|NCT00488982|38211200|FG000|Course 1|Physician Decision|0|||
17068637|NCT00488982|38211201|FG001|Course 1|Physician Decision|2|||
17068638|NCT00488982|38211202|FG002|Course 1|Physician Decision|4|||
17068639|NCT00488982|38211200|FG000|Course 1|Withdrawal by Subject|0|||
17068640|NCT00488982|38211201|FG001|Course 1|Withdrawal by Subject|8|||
17068641|NCT00488982|38211202|FG002|Course 1|Withdrawal by Subject|2|||
17068642|NCT00488982|38211200|FG000|Course 1|nonprotocol therapy|0|||
17068643|NCT00488982|38211201|FG001|Course 1|nonprotocol therapy|2|||
17068644|NCT00488982|38211202|FG002|Course 1|nonprotocol therapy|2|||
17068645|NCT00488982|38211200|FG000|Course 1|Adverse Event|0|||
17068646|NCT00488982|38211201|FG001|Course 1|Adverse Event|0|||
17068647|NCT00488982|38211202|FG002|Course 1|Adverse Event|6|||
17068648|NCT00488826|38211219|FG000|Overall Study|Withdrawal by Subject|40|||
17068649|NCT00488826|38211220|FG001|Overall Study|Withdrawal by Subject|35|||
17148230|NCT03470545|38292999|FG000|Overall Study|Death|0|||
17148231|NCT03470545|38293000|FG001|Overall Study|Death|1|||
17148232|NCT03470545|38292999|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
17148233|NCT03470545|38293000|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
17068650|NCT00488826|38211221|FG002|Overall Study|Withdrawal by Subject|19|||
17068651|NCT00488826|38211219|FG000|Overall Study|Protocol Violation|0|||
17068652|NCT00488826|38211220|FG001|Overall Study|Protocol Violation|0|||
17068653|NCT00488826|38211221|FG002|Overall Study|Protocol Violation|2|||
17068654|NCT00488826|38211219|FG000|Overall Study|Adverse Event|9|||
17068655|NCT00488826|38211220|FG001|Overall Study|Adverse Event|15|||
17068656|NCT00488826|38211221|FG002|Overall Study|Adverse Event|4|||
17068657|NCT00488826|38211219|FG000|Overall Study|Lost to Follow-up|5|||
17148234|NCT03470545|38292999|FG000|Overall Study|Adverse Event|2|||
17148235|NCT03470545|38293000|FG001|Overall Study|Adverse Event|0|||
17148236|NCT03470545|38292999|FG000|Overall Study|Withdrawal by Subject|1|||
17148237|NCT03470545|38293000|FG001|Overall Study|Withdrawal by Subject|1|||
17148238|NCT03470545|38292999|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
17148239|NCT03470545|38293000|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
17148240|NCT03163446|38293009|FG000|Overall Study|Unable to return for Day 180 visit|2|||
17148241|NCT03163446|38293010|FG001|Overall Study|Unable to return for Day 180 visit|0|||
17148242|NCT03163446|38293009|FG000|Overall Study|Withdrawal by Subject|2|||
17148243|NCT03163446|38293010|FG001|Overall Study|Withdrawal by Subject|6|||
17148244|NCT03163446|38293009|FG000|Overall Study|Death|16|||
17148245|NCT03163446|38293010|FG001|Overall Study|Death|5|||
17148246|NCT03163446|38293009|FG000|Overall Study|Lost to Follow-up|6|||
17148247|NCT03163446|38293010|FG001|Overall Study|Lost to Follow-up|5|||
17148248|NCT03163446|38293009|FG000|Overall Study|Physician Decision|1|||
17148249|NCT03163446|38293010|FG001|Overall Study|Physician Decision|1|||
17148250|NCT03163446|38293009|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
17148251|NCT03163446|38293010|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
17148252|NCT03043664|38293040|FG000|Overall Study|Lost to Follow-up|1|||
17148253|NCT03043664|38293040|FG000|Overall Study|In Observation for Overall Survival|6|||
17148254|NCT03047720|38293050|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
17148255|NCT03047720|38293051|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
17148256|NCT01439802|38293061|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
17148257|NCT01439802|38293061|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
17148258|NCT03626168|38293080|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
17148259|NCT03626168|38293081|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
17148260|NCT03626168|38293080|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
17148261|NCT03626168|38293081|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
17148262|NCT03626168|38293080|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
17148263|NCT03626168|38293081|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
17148264|NCT01389024|38293089|FG000|Overall Study|Withdrawal by Subject|0|||
17148265|NCT01389024|38293090|FG001|Overall Study|Withdrawal by Subject|1|||
17148266|NCT01389024|38293089|FG000|Overall Study|Lost to Follow-up|1|||
17148267|NCT01389024|38293090|FG001|Overall Study|Lost to Follow-up|0|||
17148268|NCT03050060|38293100|FG000|Overall Study|Adverse Event|7|||
17068658|NCT00488826|38211220|FG001|Overall Study|Lost to Follow-up|1|||
17068659|NCT00488826|38211221|FG002|Overall Study|Lost to Follow-up|0|||
17068660|NCT00488826|38211219|FG000|Overall Study|Protocol Deviations|2|||
17068661|NCT00488826|38211220|FG001|Overall Study|Protocol Deviations|1|||
17068662|NCT00488826|38211221|FG002|Overall Study|Protocol Deviations|1|||
17068663|NCT00393861|38211229|FG000|Overall Study|Adverse Event|2|||
17068664|NCT00393861|38211229|FG000|Overall Study|Disease Progression|24|||
17148269|NCT03050060|38293100|FG000|Overall Study|Withdrawal by Subject|1|||
17148270|NCT03050060|38293100|FG000|Overall Study|Progression|7|||
17148271|NCT00706342|38293113|FG000|Overall Study|Adverse Event|3|||
17148272|NCT00706342|38293113|FG000|Overall Study|Not responding to treatment|2|||
17148273|NCT00706342|38293113|FG000|Overall Study|Withdrawn due to failure to respond|1|||
17148274|NCT00706342|38293113|FG000|Overall Study|Death|1|||
17148275|NCT00706342|38293113|FG000|Overall Study|Withdrew from the study on his own.|1|||
17148276|NCT00706342|38293113|FG000|Overall Study|Investigator discretion|2|||
17148277|NCT00706342|38293113|FG000|Overall Study|Non-responder Week 12|1|||
17148278|NCT00706342|38293113|FG000|Overall Study|Ongoing|6|||
17148279|NCT00706342|38293113|FG000|Overall Study|WIthdrawal of consent|1|||
17148280|NCT03049748|38293119|FG000|Overall Study|Lost to Follow-up|1|||
17148281|NCT03049748|38293120|FG001|Overall Study|Lost to Follow-up|0|||
17148282|NCT03049748|38293119|FG000|Overall Study|Death|3|||
17148283|NCT03049748|38293120|FG001|Overall Study|Death|0|||
17148284|NCT03049748|38293119|FG000|Overall Study|Withdrawal by Subject|0|||
17148285|NCT03049748|38293120|FG001|Overall Study|Withdrawal by Subject|3|||
17148286|NCT03049748|38293119|FG000|Overall Study|Protocol Violation|0|||
17148287|NCT03049748|38293120|FG001|Overall Study|Protocol Violation|2|||
17148288|NCT03049748|38293119|FG000|Overall Study|Moved out of state (relocation)|0|||
17148289|NCT03049748|38293120|FG001|Overall Study|Moved out of state (relocation)|1|||
17148290|NCT03526861|38293133|FG000|Initial Treatment Period|Not dosed|1|||
17148291|NCT03526861|38293134|FG001|Initial Treatment Period|Not dosed|1|||
17148292|NCT03526861|38293135|FG002|Initial Treatment Period|Not dosed|1|||
17148293|NCT03526861|38293136|FG003|Initial Treatment Period|Not dosed|0|||
17148294|NCT03526861|38293137|FG004|Initial Treatment Period|Not dosed|0|||
17148295|NCT03526861|38293138|FG005|Initial Treatment Period|Not dosed|0|||
17148296|NCT03526861|38293139|FG006|Initial Treatment Period|Not dosed|0|||
17068665|NCT00480324|38211235|FG000|Overall Study|Adverse Event|1|||
17068666|NCT00480324|38211236|FG001|Overall Study|Adverse Event|1|||
17068667|NCT00480324|38211235|FG000|Overall Study|Protocol Violation|0|||
17068668|NCT00480324|38211236|FG001|Overall Study|Protocol Violation|1|||
17068669|NCT00480324|38211235|FG000|Overall Study|Withdrawal by Subject|14|||
17068670|NCT00480324|38211236|FG001|Overall Study|Withdrawal by Subject|5|||
17068671|NCT00480324|38211235|FG000|Overall Study|Lost to Follow-up|17|||
17068672|NCT00480324|38211236|FG001|Overall Study|Lost to Follow-up|8|||
17068673|NCT00480324|38211235|FG000|Overall Study|Subject's mother pregnant|0|||
17068674|NCT00480324|38211236|FG001|Overall Study|Subject's mother pregnant|1|||
17068675|NCT00488592|38211242|FG000|Overall Study|Withdrawal by Subject|1|||
17068676|NCT00488592|38211242|FG000|Overall Study|Disease progression|1|||
17068677|NCT00488592|38211242|FG000|Overall Study|Enrolled but not treated|1|||
17068678|NCT00488514|38211246|FG000|Overall Study|Adverse Event|41|||
17068679|NCT00488514|38211246|FG000|Overall Study|Lost to Follow-up|44|||
17068680|NCT00488514|38211246|FG000|Overall Study|Protocol Violation|32|||
17068681|NCT00488514|38211246|FG000|Overall Study|Withdrawal by Subject|106|||
17068682|NCT00488514|38211246|FG000|Overall Study|Lack of Efficacy|28|||
17068683|NCT00488514|38211246|FG000|Overall Study|Did not meet criteria for treatment|30|||
17068684|NCT00488514|38211246|FG000|Overall Study|Postive drug screen|1|||
17068685|NCT00488514|38211246|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
17068686|NCT00488514|38211246|FG000|Overall Study|Investigator decision|1|||
17068687|NCT00488514|38211246|FG000|Overall Study|Participant had too few migraines|5|||
17068688|NCT00488514|38211246|FG000|Overall Study|Increase in number of migraines|2|||
17148297|NCT03526861|38293140|FG007|Initial Treatment Period|Not dosed|0|||
17148298|NCT03526861|38293141|FG008|Initial Treatment Period|Not dosed|0|||
17148299|NCT03526861|38293133|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
17068689|NCT00488514|38211246|FG000|Overall Study|Increased use of concomitant medication|1|||
17068690|NCT00320710|38211270|FG000|Overall Study|Disease progression|24|||
17068691|NCT00320710|38211271|FG001|Overall Study|Disease progression|19|||
17068692|NCT00320710|38211272|FG002|Overall Study|Disease progression|2|||
17068693|NCT00320710|38211270|FG000|Overall Study|Death|10|||
17068694|NCT00320710|38211271|FG001|Overall Study|Death|7|||
17068695|NCT00320710|38211272|FG002|Overall Study|Death|1|||
17068696|NCT00320710|38211270|FG000|Overall Study|Administrative problems|1|||
17148300|NCT03526861|38293134|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
17068697|NCT00320710|38211271|FG001|Overall Study|Administrative problems|2|||
17068698|NCT00320710|38211272|FG002|Overall Study|Administrative problems|0|||
17068699|NCT00320710|38211270|FG000|Overall Study|Withdrawal by Subject|20|||
17068700|NCT00320710|38211271|FG001|Overall Study|Withdrawal by Subject|26|||
17068701|NCT00320710|38211272|FG002|Overall Study|Withdrawal by Subject|1|||
17068702|NCT00320710|38211270|FG000|Overall Study|Protocol Violation|6|||
17068703|NCT00320710|38211271|FG001|Overall Study|Protocol Violation|5|||
17068704|NCT00320710|38211272|FG002|Overall Study|Protocol Violation|0|||
17068705|NCT00320710|38211270|FG000|Overall Study|Abnormal test procedure result(s)|2|||
17068706|NCT00320710|38211271|FG001|Overall Study|Abnormal test procedure result(s)|0|||
17068707|NCT00320710|38211272|FG002|Overall Study|Abnormal test procedure result(s)|0|||
17068708|NCT00320710|38211270|FG000|Overall Study|Abnormal laboratory value(s)|12|||
17068709|NCT00320710|38211271|FG001|Overall Study|Abnormal laboratory value(s)|3|||
17068710|NCT00320710|38211272|FG002|Overall Study|Abnormal laboratory value(s)|0|||
17068711|NCT00320710|38211270|FG000|Overall Study|Adverse Event|18|||
17068712|NCT00320710|38211271|FG001|Overall Study|Adverse Event|14|||
17068713|NCT00320710|38211272|FG002|Overall Study|Adverse Event|1|||
17068714|NCT00320710|38211270|FG000|Overall Study|Lost to Follow-up|1|||
17068715|NCT00320710|38211271|FG001|Overall Study|Lost to Follow-up|0|||
17068716|NCT00320710|38211272|FG002|Overall Study|Lost to Follow-up|0|||
17068717|NCT00320398|38211281|FG000|Overall Study|Adverse Event|1|||
17068718|NCT00320398|38211282|FG001|Overall Study|Adverse Event|4|||
17068719|NCT00320398|38211281|FG000|Overall Study|Other|1|||
17068720|NCT00320398|38211282|FG001|Overall Study|Other|0|||
17068721|NCT00498186|38211289|FG000|Overall Study|Protocol Violation|10|||
17068722|NCT00498186|38211289|FG000|Overall Study|Lack of Efficacy|31|||
17068723|NCT00498186|38211289|FG000|Overall Study|Adverse Event|89|||
17068724|NCT00498186|38211289|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
17068725|NCT00498186|38211289|FG000|Overall Study|Withdrawal by Subject|18|||
17068726|NCT00498186|38211289|FG000|Overall Study|Lost to Follow-up|3|||
17068727|NCT00498186|38211289|FG000|Overall Study|Other|10|||
17068728|NCT00333970|38211295|FG000|Overall Study|Withdrawal by Subject|13|||
17068729|NCT00333970|38211296|FG001|Overall Study|Withdrawal by Subject|7|||
17068730|NCT00477594|38211304|FG000|Year 1 and Year 2|Adverse Event|4|||
17068731|NCT00477594|38211305|FG001|Year 1 and Year 2|Adverse Event|2|||
17068732|NCT00477594|38211304|FG000|Year 1 and Year 2|Physician Decision|2|||
17068733|NCT00477594|38211305|FG001|Year 1 and Year 2|Physician Decision|1|||
17068734|NCT00477594|38211304|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
17068735|NCT00477594|38211305|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
17068736|NCT00477594|38211304|FG000|Year 1 and Year 2|Other|1|||
17068737|NCT00477594|38211305|FG001|Year 1 and Year 2|Other|0|||
17068738|NCT00477594|38211304|FG000|Year 3|Adverse Event|1|||
17068739|NCT00477594|38211305|FG001|Year 3|Adverse Event|0|||
17068740|NCT00477594|38211304|FG000|Year 3|Withdrawal by Subject|1|||
17068741|NCT00477594|38211305|FG001|Year 3|Withdrawal by Subject|0|||
17068742|NCT00477594|38211304|FG000|Follow-up Period|Withdrawal by Subject|2|||
17068743|NCT00477594|38211305|FG001|Follow-up Period|Withdrawal by Subject|1|||
17068744|NCT00477594|38211304|FG000|Follow-up Period|Other|1|||
17068745|NCT00477594|38211305|FG001|Follow-up Period|Other|0|||
17068746|NCT00475722|38211313|FG000|Overall Study|Withdrawal by Subject|12|||
17068747|NCT00475722|38211314|FG001|Overall Study|Withdrawal by Subject|12|||
17068748|NCT00475722|38211313|FG000|Overall Study|Protocol Violation|3|||
17068749|NCT00475722|38211314|FG001|Overall Study|Protocol Violation|0|||
17068750|NCT00304954|38211324|FG000|Overall Study|Withdrawal by Subject|0|||
17068751|NCT00304954|38211325|FG001|Overall Study|Withdrawal by Subject|0|||
17068752|NCT00304954|38211326|FG002|Overall Study|Withdrawal by Subject|1|||
17068753|NCT00304954|38211327|FG003|Overall Study|Withdrawal by Subject|0|||
17068754|NCT00304954|38211324|FG000|Overall Study|Adverse Event|1|||
17068755|NCT00304954|38211325|FG001|Overall Study|Adverse Event|0|||
17068756|NCT00304954|38211326|FG002|Overall Study|Adverse Event|0|||
17068757|NCT00304954|38211327|FG003|Overall Study|Adverse Event|0|||
17068758|NCT00475176|38211345|FG000|Overall Study|Adverse Event|2|||
17068759|NCT00475176|38211345|FG000|Overall Study|Withdrawal by Subject|1|||
17068760|NCT00475176|38211345|FG000|Overall Study|Protocol Violation|1|||
17068761|NCT00414609|38211351|FG000|Core Study|Adverse Event|9|||
17068762|NCT00414609|38211352|FG001|Core Study|Adverse Event|11|||
17068763|NCT00414609|38211353|FG002|Core Study|Adverse Event|0|||
17068764|NCT00414609|38211351|FG000|Core Study|Abnormal laboratory values|0|||
17068765|NCT00414609|38211352|FG001|Core Study|Abnormal laboratory values|1|||
17068766|NCT00414609|38211353|FG002|Core Study|Abnormal laboratory values|0|||
17068767|NCT00414609|38211351|FG000|Core Study|Abnormal test procedure results|1|||
17068768|NCT00414609|38211352|FG001|Core Study|Abnormal test procedure results|1|||
17068769|NCT00414609|38211353|FG002|Core Study|Abnormal test procedure results|0|||
17068770|NCT00414609|38211351|FG000|Core Study|Protocol deviation|0|||
17068771|NCT00414609|38211352|FG001|Core Study|Protocol deviation|1|||
17068772|NCT00414609|38211353|FG002|Core Study|Protocol deviation|0|||
17068773|NCT00414609|38211351|FG000|Core Study|Patient withdrew consent|10|||
17068774|NCT00414609|38211352|FG001|Core Study|Patient withdrew consent|11|||
17068775|NCT00414609|38211353|FG002|Core Study|Patient withdrew consent|0|||
17068776|NCT00414609|38211351|FG000|Core Study|Lost to Follow-up|7|||
17068777|NCT00414609|38211352|FG001|Core Study|Lost to Follow-up|4|||
17068778|NCT00414609|38211353|FG002|Core Study|Lost to Follow-up|0|||
17068779|NCT00414609|38211351|FG000|Core Study|Administrative problems|0|||
17068780|NCT00414609|38211352|FG001|Core Study|Administrative problems|2|||
17068781|NCT00414609|38211353|FG002|Core Study|Administrative problems|0|||
17068782|NCT00414609|38211351|FG000|Core Study|Death|7|||
17068783|NCT00414609|38211352|FG001|Core Study|Death|14|||
17068784|NCT00414609|38211353|FG002|Core Study|Death|0|||
17068785|NCT00414609|38211351|FG000|Extension Study|Adverse Event|0|||
17068786|NCT00414609|38211352|FG001|Extension Study|Adverse Event|0|||
17068787|NCT00414609|38211353|FG002|Extension Study|Adverse Event|14|||
17068788|NCT00414609|38211351|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
17068789|NCT00414609|38211352|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
17068790|NCT00414609|38211353|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
17068791|NCT00414609|38211351|FG000|Extension Study|Withdrawal by Subject|0|||
17068792|NCT00414609|38211352|FG001|Extension Study|Withdrawal by Subject|0|||
17068793|NCT00414609|38211353|FG002|Extension Study|Withdrawal by Subject|13|||
17068794|NCT00414609|38211351|FG000|Extension Study|Lost to Follow-up|0|||
17068795|NCT00414609|38211352|FG001|Extension Study|Lost to Follow-up|0|||
17148301|NCT03526861|38293135|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
17148302|NCT03526861|38293136|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148303|NCT03526861|38293137|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17068796|NCT00414609|38211353|FG002|Extension Study|Lost to Follow-up|10|||
17068797|NCT00414609|38211351|FG000|Extension Study|Administrative problems|0|||
17068798|NCT00414609|38211352|FG001|Extension Study|Administrative problems|0|||
17068799|NCT00414609|38211353|FG002|Extension Study|Administrative problems|1|||
17068800|NCT00414609|38211351|FG000|Extension Study|Death|0|||
17068801|NCT00414609|38211352|FG001|Extension Study|Death|0|||
17068802|NCT00414609|38211353|FG002|Extension Study|Death|17|||
17068803|NCT00393705|38211364|FG000|Overall Study|Adverse Event|0|||
17068804|NCT00393705|38211365|FG001|Overall Study|Adverse Event|2|||
17068805|NCT00393705|38211364|FG000|Overall Study|Death|0|||
17068806|NCT00393705|38211365|FG001|Overall Study|Death|1|||
17068807|NCT00393705|38211364|FG000|Overall Study|Lost to Follow-up|2|||
17068808|NCT00393705|38211365|FG001|Overall Study|Lost to Follow-up|2|||
17068809|NCT00393705|38211364|FG000|Overall Study|Entry Criteria Not Met|10|||
17068810|NCT00393705|38211365|FG001|Overall Study|Entry Criteria Not Met|10|||
17068811|NCT00393705|38211364|FG000|Overall Study|Protocol Violation|4|||
17068812|NCT00393705|38211365|FG001|Overall Study|Protocol Violation|3|||
17068813|NCT00393705|38211364|FG000|Overall Study|Withdrawal by Subject|5|||
17068814|NCT00393705|38211365|FG001|Overall Study|Withdrawal by Subject|3|||
17068815|NCT00393705|38211364|FG000|Overall Study|Physician Decision|2|||
17068816|NCT00393705|38211365|FG001|Overall Study|Physician Decision|2|||
17068817|NCT00303628|38211373|FG000|Overall Study|Disease progression|0|||
17068818|NCT00303628|38211374|FG001|Overall Study|Disease progression|1|||
17068819|NCT00303628|38211373|FG000|Overall Study|Adverse Event|26|||
17148304|NCT03526861|38293138|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148305|NCT03526861|38293139|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17068820|NCT00303628|38211374|FG001|Overall Study|Adverse Event|36|||
17068821|NCT00303628|38211373|FG000|Overall Study|Death|0|||
17068822|NCT00303628|38211374|FG001|Overall Study|Death|1|||
17068823|NCT00303628|38211373|FG000|Overall Study|Withdrawal by Subject|11|||
17068824|NCT00303628|38211374|FG001|Overall Study|Withdrawal by Subject|20|||
17068825|NCT00303628|38211373|FG000|Overall Study|Alternative therapy|2|||
17068826|NCT00303628|38211374|FG001|Overall Study|Alternative therapy|0|||
17068827|NCT00303628|38211373|FG000|Overall Study|Other complicating disease|0|||
17068828|NCT00303628|38211374|FG001|Overall Study|Other complicating disease|1|||
17068829|NCT00303628|38211373|FG000|Overall Study|Not start protocol therapy|3|||
17148306|NCT03526861|38293140|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148307|NCT03526861|38293141|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148308|NCT03526861|38293133|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
17148309|NCT03526861|38293134|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
17148310|NCT03526861|38293135|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
17148311|NCT03526861|38293136|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
17148312|NCT03526861|38293137|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
17148313|NCT03526861|38293138|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
17148314|NCT03526861|38293139|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
17148315|NCT03526861|38293140|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
17148316|NCT03526861|38293141|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
17148317|NCT03526861|38293133|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17068830|NCT00303628|38211374|FG001|Overall Study|Not start protocol therapy|5|||
17068831|NCT00303628|38211373|FG000|Overall Study|Other|8|||
17068832|NCT00303628|38211374|FG001|Overall Study|Other|9|||
17068833|NCT00414453|38211380|FG000|Overall Study|Abnormal lab work|16|||
17068834|NCT00332488|38211393|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
17068835|NCT00332488|38211394|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
17068836|NCT00332488|38211395|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
17068837|NCT00332488|38211393|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
17068838|NCT00332488|38211394|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
17148318|NCT03526861|38293134|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148319|NCT03526861|38293135|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148320|NCT03526861|38293136|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
17148321|NCT03526861|38293137|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
17148322|NCT03526861|38293138|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148323|NCT03526861|38293139|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
17148324|NCT03526861|38293140|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148325|NCT03526861|38293141|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148326|NCT03526861|38293133|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
17148327|NCT03526861|38293134|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
17148328|NCT03526861|38293135|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
17148329|NCT03526861|38293136|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
17148330|NCT03526861|38293137|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
17148331|NCT03526861|38293138|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
17148332|NCT03526861|38293139|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
17148333|NCT03526861|38293140|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
17068839|NCT00332488|38211395|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
17068840|NCT00332488|38211393|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
17068841|NCT00332488|38211394|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
17068842|NCT00332488|38211395|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
17068843|NCT00332488|38211393|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
17068844|NCT00332488|38211394|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
17068845|NCT00332488|38211395|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
17068846|NCT00332488|38211393|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
17068847|NCT00332488|38211394|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
17068848|NCT00332488|38211395|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
17068849|NCT00332488|38211393|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
17068850|NCT00332488|38211394|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
17068851|NCT00332488|38211395|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
17068852|NCT00332488|38211393|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
17068853|NCT00332488|38211394|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
17068854|NCT00332488|38211395|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
17148334|NCT03526861|38293141|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
17148335|NCT03526861|38293133|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148336|NCT03526861|38293134|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148337|NCT03526861|38293135|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148338|NCT03526861|38293136|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
17068855|NCT00332488|38211393|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
17068856|NCT00332488|38211394|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
17068857|NCT00332488|38211395|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
17068858|NCT00332488|38211393|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
17068859|NCT00332488|38211394|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
17068860|NCT00332488|38211395|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
17068861|NCT00332488|38211393|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
17068862|NCT00332488|38211394|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
17068863|NCT00332488|38211395|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
17068864|NCT00332488|38211393|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
17068865|NCT00332488|38211394|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
17068866|NCT00332488|38211395|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
17068867|NCT00332488|38211393|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
17068868|NCT00332488|38211394|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
17068869|NCT00332488|38211395|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
17068870|NCT00332332|38211405|FG000|Overall Study|Adverse Event|13|||
17068871|NCT00332332|38211405|FG000|Overall Study|Death|1|||
17068872|NCT00332332|38211405|FG000|Overall Study|Withdrawal by Subject|8|||
17068873|NCT00332332|38211405|FG000|Overall Study|Physician Decision|1|||
17068874|NCT00332332|38211405|FG000|Overall Study|Lost to Follow-up|3|||
17068875|NCT00332332|38211405|FG000|Overall Study|Protocol deviation|4|||
17068876|NCT00332332|38211405|FG000|Overall Study|Noncompliance|2|||
17068877|NCT00332332|38211405|FG000|Overall Study|Disease progression|2|||
17068878|NCT00332332|38211405|FG000|Overall Study|Other|18|||
17068879|NCT00332332|38211405|FG000|Overall Study|Did not receive study treatment|16|||
17068880|NCT00392925|38211413|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
17068881|NCT00392925|38211414|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
17068882|NCT00392925|38211415|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
17068883|NCT00392925|38211416|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
17068884|NCT00392925|38211413|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
17068885|NCT00392925|38211414|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
17148339|NCT03526861|38293137|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148340|NCT03526861|38293138|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148341|NCT03526861|38293139|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148342|NCT03526861|38293140|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148343|NCT03526861|38293141|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148344|NCT03526861|38293133|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148345|NCT03526861|38293134|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148346|NCT03526861|38293135|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17068886|NCT00392925|38211415|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
17068887|NCT00392925|38211416|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
17068888|NCT00392925|38211413|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
17068889|NCT00392925|38211414|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
17068890|NCT00392925|38211415|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
17068891|NCT00392925|38211416|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
17068892|NCT00392925|38211413|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
17068893|NCT00392925|38211414|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
17068894|NCT00392925|38211415|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
17068895|NCT00392925|38211416|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
17068896|NCT00392925|38211413|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
17068897|NCT00392925|38211414|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
17068898|NCT00392925|38211415|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
17068899|NCT00392925|38211416|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
17068900|NCT00392925|38211413|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
17068901|NCT00392925|38211414|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
17068902|NCT00392925|38211415|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
17068903|NCT00392925|38211416|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
17068904|NCT00392925|38211413|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
17068905|NCT00392925|38211414|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
17068906|NCT00392925|38211415|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
17068907|NCT00392925|38211416|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
17068908|NCT00392925|38211413|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
17068909|NCT00392925|38211414|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
17068910|NCT00392925|38211415|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
17068911|NCT00392925|38211416|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
17068912|NCT00392925|38211413|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
17068913|NCT00392925|38211414|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
17068914|NCT00392925|38211415|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
17068915|NCT00392925|38211416|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
17068916|NCT00474786|38211434|FG000|Overall Study|Not Meeting Study Criteria|0|||
17068917|NCT00474786|38211435|FG001|Overall Study|Not Meeting Study Criteria|1|||
17068918|NCT00474786|38211434|FG000|Overall Study|Investigator Request|2|||
17068919|NCT00474786|38211435|FG001|Overall Study|Investigator Request|1|||
17068920|NCT00474786|38211434|FG000|Overall Study|Death|189|||
17068921|NCT00474786|38211435|FG001|Overall Study|Death|170|||
17068922|NCT00474786|38211434|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
17068923|NCT00474786|38211435|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
17068924|NCT00474786|38211434|FG000|Overall Study|Lost to Follow-up|4|||
17068925|NCT00474786|38211435|FG001|Overall Study|Lost to Follow-up|7|||
17068926|NCT00474786|38211434|FG000|Overall Study|Protocol Violation|2|||
17068927|NCT00474786|38211435|FG001|Overall Study|Protocol Violation|0|||
17068928|NCT00474786|38211434|FG000|Overall Study|Withdrawal by Subject|15|||
17068929|NCT00474786|38211435|FG001|Overall Study|Withdrawal by Subject|15|||
17068930|NCT00474786|38211434|FG000|Overall Study|Other|5|||
17068931|NCT00474786|38211435|FG001|Overall Study|Other|0|||
17068932|NCT00392769|38211441|FG000|Overall Study|Clinical Deterioration|9|||
17068933|NCT00392769|38211441|FG000|Overall Study|Adverse Event|1|||
17068934|NCT00319696|38211445|FG000|Overall Study|Adverse Event|36|||
17068935|NCT00319696|38211445|FG000|Overall Study|withdrawal of consent|14|||
17068936|NCT00319696|38211445|FG000|Overall Study|administrative|7|||
17068937|NCT00319696|38211445|FG000|Overall Study|Lost to Follow-up|3|||
17068938|NCT00474630|38211457|FG000|Overall Study|Adverse Event|98|||
17068939|NCT00474630|38211458|FG001|Overall Study|Adverse Event|26|||
17068940|NCT00474630|38211457|FG000|Overall Study|Lost to Follow-up|22|||
17068941|NCT00474630|38211458|FG001|Overall Study|Lost to Follow-up|15|||
17068942|NCT00474630|38211457|FG000|Overall Study|Withdrawal by Subject|21|||
17068943|NCT00474630|38211458|FG001|Overall Study|Withdrawal by Subject|15|||
17068944|NCT00474630|38211457|FG000|Overall Study|Protocol Violation|3|||
17068945|NCT00474630|38211458|FG001|Overall Study|Protocol Violation|4|||
17068946|NCT00474630|38211457|FG000|Overall Study|Lack of Efficacy|5|||
17068947|NCT00474630|38211458|FG001|Overall Study|Lack of Efficacy|6|||
17068948|NCT00474630|38211457|FG000|Overall Study|Drug noncompliance, other|11|||
17068949|NCT00474630|38211458|FG001|Overall Study|Drug noncompliance, other|4|||
17068950|NCT00392379|38211467|FG000|Overall Study|Withdrawal by Subject|17|||
17068951|NCT00392379|38211468|FG001|Overall Study|Withdrawal by Subject|28|||
17068952|NCT00392379|38211467|FG000|Overall Study|Lost to Follow-up|4|||
17068953|NCT00392379|38211468|FG001|Overall Study|Lost to Follow-up|9|||
17068954|NCT00392379|38211467|FG000|Overall Study|Adverse Event|1|||
17068955|NCT00392379|38211468|FG001|Overall Study|Adverse Event|1|||
17068956|NCT00497874|38211476|FG000|Overall Study|Withdrawal by Subject|48|||
17068957|NCT00497874|38211477|FG001|Overall Study|Withdrawal by Subject|17|||
17068958|NCT00497874|38211476|FG000|Overall Study|Illness|8|||
17068959|NCT00497874|38211477|FG001|Overall Study|Illness|4|||
17068960|NCT00497874|38211476|FG000|Overall Study|Death|2|||
17068961|NCT00497874|38211477|FG001|Overall Study|Death|4|||
17068962|NCT00497874|38211476|FG000|Overall Study|Unable to contact|52|||
17068963|NCT00497874|38211477|FG001|Overall Study|Unable to contact|67|||
17068964|NCT00497874|38211476|FG000|Overall Study|Unable to schedule|37|||
17068965|NCT00497874|38211477|FG001|Overall Study|Unable to schedule|24|||
17068966|NCT00403455|38211485|FG000|Overall Study|Withdrawal by Subject|1|||
17068967|NCT00318370|38211489|FG000|Period 1|Lack of Efficacy|5|||
17068968|NCT00318370|38211490|FG001|Period 1|Lack of Efficacy|0|||
17068969|NCT00318370|38211491|FG002|Period 1|Lack of Efficacy|0|||
17068970|NCT00318370|38211489|FG000|Period 1|Physician Decision|1|||
17068971|NCT00318370|38211490|FG001|Period 1|Physician Decision|0|||
17068972|NCT00318370|38211491|FG002|Period 1|Physician Decision|0|||
17068973|NCT00318370|38211489|FG000|Period 1|Withdrawal by Subject|1|||
17068974|NCT00318370|38211490|FG001|Period 1|Withdrawal by Subject|0|||
17068975|NCT00318370|38211491|FG002|Period 1|Withdrawal by Subject|0|||
17068976|NCT00318370|38211489|FG000|Period 2|Adverse Event|0|||
17068977|NCT00318370|38211490|FG001|Period 2|Adverse Event|3|||
17068978|NCT00318370|38211491|FG002|Period 2|Adverse Event|0|||
17068979|NCT00318370|38211489|FG000|Period 2|Lack of Efficacy|0|||
17068980|NCT00318370|38211490|FG001|Period 2|Lack of Efficacy|5|||
17068981|NCT00318370|38211491|FG002|Period 2|Lack of Efficacy|0|||
17068982|NCT00318370|38211489|FG000|Period 2|Physician Decision|0|||
17068983|NCT00318370|38211490|FG001|Period 2|Physician Decision|1|||
17068984|NCT00318370|38211491|FG002|Period 2|Physician Decision|0|||
17068985|NCT00318370|38211489|FG000|Period 2|Withdrawal by Subject|0|||
17068986|NCT00318370|38211490|FG001|Period 2|Withdrawal by Subject|1|||
17068987|NCT00318370|38211491|FG002|Period 2|Withdrawal by Subject|0|||
17068988|NCT00318370|38211489|FG000|Period 2|Other|0|||
17068989|NCT00318370|38211490|FG001|Period 2|Other|1|||
17068990|NCT00318370|38211491|FG002|Period 2|Other|0|||
17068991|NCT00318370|38211489|FG000|Period 3|Adverse Event|0|||
17068992|NCT00318370|38211490|FG001|Period 3|Adverse Event|0|||
17068993|NCT00318370|38211491|FG002|Period 3|Adverse Event|1|||
17068994|NCT00318370|38211489|FG000|Period 3|Lack of Efficacy|0|||
17068995|NCT00318370|38211490|FG001|Period 3|Lack of Efficacy|0|||
17068996|NCT00318370|38211491|FG002|Period 3|Lack of Efficacy|24|||
16994102|NCT00790582|38137897|FG001|Overall Study|Withdrawal by Subject|51|||
16994103|NCT01048541|38137905|FG000|Overall Study|Withdrawal by Subject|1|||
16994104|NCT01048541|38137906|FG001|Overall Study|Withdrawal by Subject|0|||
16994105|NCT00774046|38137912|FG000|Screening|Not eligible|56|||
16994106|NCT00774046|38137912|FG000|Enrollment|Desired other therapy/refused|28|||
16994107|NCT00774046|38137912|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
16994108|NCT01046903|38137916|FG000|Overall Study|Lost to Follow-up|16|||
16994109|NCT01046903|38137916|FG000|Overall Study|Adverse Event|4|||
16994110|NCT01046903|38137916|FG000|Overall Study|Withdrawal by Subject|3|||
16994111|NCT01046903|38137916|FG000|Overall Study|Other|5|||
16994112|NCT00773968|38137920|FG000|Overall Study|Adverse Event|2|||
17068997|NCT00318370|38211489|FG000|Period 3|Death|0|||
17068998|NCT00318370|38211490|FG001|Period 3|Death|0|||
17068999|NCT00318370|38211491|FG002|Period 3|Death|1|||
17069000|NCT00318370|38211489|FG000|Period 3|Physician Decision|0|||
17069001|NCT00318370|38211490|FG001|Period 3|Physician Decision|0|||
17069002|NCT00318370|38211491|FG002|Period 3|Physician Decision|1|||
17069003|NCT00318370|38211489|FG000|Period 3|Withdrawal by Subject|0|||
17069004|NCT00318370|38211490|FG001|Period 3|Withdrawal by Subject|0|||
17069005|NCT00318370|38211491|FG002|Period 3|Withdrawal by Subject|3|||
17069006|NCT00318370|38211489|FG000|Period 3|Other|0|||
17069007|NCT00318370|38211490|FG001|Period 3|Other|0|||
17069008|NCT00318370|38211491|FG002|Period 3|Other|3|||
17069009|NCT00510068|38211499|FG000|Double-blind Period|Disease progression|98|||
17069010|NCT00510068|38211500|FG001|Double-blind Period|Disease progression|169|||
17069011|NCT00510068|38211499|FG000|Double-blind Period|Final primary analysis|52|||
17069012|NCT00510068|38211500|FG001|Double-blind Period|Final primary analysis|18|||
17069013|NCT00510068|38211499|FG000|Double-blind Period|Adverse Event|37|||
17069014|NCT00510068|38211500|FG001|Double-blind Period|Adverse Event|7|||
17069015|NCT00510068|38211499|FG000|Double-blind Period|Withdrawal by Subject|8|||
17069016|NCT00510068|38211500|FG001|Double-blind Period|Withdrawal by Subject|6|||
17069017|NCT00510068|38211499|FG000|Double-blind Period|Death|4|||
17069018|NCT00510068|38211500|FG001|Double-blind Period|Death|3|||
17069019|NCT00510068|38211499|FG000|Double-blind Period|Abnormal test result (s)|1|||
17069020|NCT00510068|38211500|FG001|Double-blind Period|Abnormal test result (s)|0|||
17069021|NCT00510068|38211499|FG000|Double-blind Period|Lost to Follow-up|1|||
17069022|NCT00510068|38211500|FG001|Double-blind Period|Lost to Follow-up|0|||
17069023|NCT00510068|38211499|FG000|Double-blind Period|Protocol Violation|6|||
17069024|NCT00510068|38211500|FG001|Double-blind Period|Protocol Violation|0|||
17069025|NCT00510068|38211499|FG000|Open-label Period|Disease Progression|124|||
17069026|NCT00510068|38211500|FG001|Open-label Period|Disease Progression|0|||
17069027|NCT00510068|38211499|FG000|Open-label Period|Adverse Event|46|||
17069028|NCT00510068|38211500|FG001|Open-label Period|Adverse Event|0|||
17069029|NCT00510068|38211499|FG000|Open-label Period|Withdrawal by Subject|21|||
17069030|NCT00510068|38211500|FG001|Open-label Period|Withdrawal by Subject|0|||
17069031|NCT00510068|38211499|FG000|Open-label Period|Administrative problems|17|||
17069032|NCT00510068|38211500|FG001|Open-label Period|Administrative problems|0|||
17069033|NCT00510068|38211499|FG000|Open-label Period|Death|7|||
17069034|NCT00510068|38211500|FG001|Open-label Period|Death|0|||
17069035|NCT00510068|38211499|FG000|Open-label Period|New cancer therapy|7|||
17069036|NCT00510068|38211500|FG001|Open-label Period|New cancer therapy|0|||
17069037|NCT00510068|38211499|FG000|Open-label Period|Protocol Violation|2|||
17069038|NCT00510068|38211500|FG001|Open-label Period|Protocol Violation|0|||
17069039|NCT00510068|38211499|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
17069040|NCT00510068|38211500|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
17069041|NCT00509600|38211508|FG000|Overall Study|Adverse Event|1|||
17069042|NCT00402987|38211516|FG000|Overall Study|Lack of Efficacy|0|||
17069043|NCT00402987|38211517|FG001|Overall Study|Lack of Efficacy|0|||
17069044|NCT00402987|38211518|FG002|Overall Study|Lack of Efficacy|1|||
17069045|NCT00402987|38211519|FG003|Overall Study|Lack of Efficacy|0|||
17069046|NCT00501644|38211543|FG000|Overall Study|Adverse Event|4|||
17069047|NCT00501644|38211543|FG000|Overall Study|Withdrawal by Subject|1|||
17069048|NCT00497796|38211549|FG000|Overall Study|Adverse event (not related)|9|||
17069049|NCT00497796|38211550|FG001|Overall Study|Adverse event (not related)|9|||
17069050|NCT00497796|38211549|FG000|Overall Study|Adverse event (related)|5|||
17069051|NCT00497796|38211550|FG001|Overall Study|Adverse event (related)|4|||
17069052|NCT00497796|38211549|FG000|Overall Study|CMV infection or disease treatment|30|||
17069053|NCT00497796|38211550|FG001|Overall Study|CMV infection or disease treatment|4|||
17069054|NCT00497796|38211549|FG000|Overall Study|Consent withdrawn|10|||
17069055|NCT00497796|38211550|FG001|Overall Study|Consent withdrawn|3|||
17069056|NCT00497796|38211549|FG000|Overall Study|Investigator/sponsor discretion|31|||
17069057|NCT00497796|38211550|FG001|Overall Study|Investigator/sponsor discretion|34|||
17069058|NCT00497796|38211549|FG000|Overall Study|Lost to Follow-up|0|||
17069059|NCT00497796|38211550|FG001|Overall Study|Lost to Follow-up|1|||
17069060|NCT00497796|38211549|FG000|Overall Study|Not applicable (randomized not treated)|0|||
17069061|NCT00497796|38211550|FG001|Overall Study|Not applicable (randomized not treated)|4|||
17069062|NCT00496782|38211558|FG000|Overall Study|Protocol Violation|1|||
17069063|NCT00496782|38211559|FG001|Overall Study|Protocol Violation|2|||
17069064|NCT00402831|38211567|FG000|Overall Study|Lost to Follow-up|1|||
17069065|NCT00402831|38211568|FG001|Overall Study|Lost to Follow-up|2|||
17069066|NCT00402831|38211567|FG000|Overall Study|Non-compliance with protocol|0|||
17069067|NCT00402831|38211568|FG001|Overall Study|Non-compliance with protocol|1|||
17069068|NCT00496626|38211578|FG000|Overall Study|Lost to Follow-up|0|||
17069069|NCT00496626|38211579|FG001|Overall Study|Lost to Follow-up|1|||
17069070|NCT00496626|38211578|FG000|Overall Study|Protocol Violation|1|||
17069071|NCT00496626|38211579|FG001|Overall Study|Protocol Violation|0|||
17069072|NCT00496626|38211578|FG000|Overall Study|Withdrawal by Subject|5|||
17069073|NCT00496626|38211579|FG001|Overall Study|Withdrawal by Subject|4|||
17069074|NCT00496626|38211578|FG000|Overall Study|Relocated|0|||
17069075|NCT00496626|38211579|FG001|Overall Study|Relocated|1|||
17069076|NCT00471822|38211589|FG000|Overall Study|Protocol Violation|2|||
17069077|NCT00471276|38211593|FG000|Overall Study|Death|2|||
17069078|NCT00471276|38211593|FG000|Overall Study|Adverse Event|16|||
17069079|NCT00471276|38211593|FG000|Overall Study|Protocol Violation|1|||
17069080|NCT00471276|38211593|FG000|Overall Study|Objective progression or relapse|54|||
17069081|NCT00471276|38211593|FG000|Overall Study|Global deterioration of health status|1|||
17069082|NCT00471276|38211593|FG000|Overall Study|Other|3|||
17069083|NCT00471276|38211593|FG000|Overall Study|Refused treatment|6|||
17069084|NCT00470262|38211599|FG000|Overall Study|Withdrawal by Subject|2|||
17069085|NCT00470262|38211600|FG001|Overall Study|Withdrawal by Subject|0|||
17069086|NCT00496470|38211609|FG000|Overall Study|Adverse Event|8|||
17069087|NCT00496470|38211610|FG001|Overall Study|Adverse Event|10|||
17069088|NCT00496470|38211609|FG000|Overall Study|Withdrawal by Subject|5|||
17069089|NCT00496470|38211610|FG001|Overall Study|Withdrawal by Subject|12|||
17069090|NCT00496470|38211609|FG000|Overall Study|Incorrectly enrolled|13|||
17069091|NCT00496470|38211610|FG001|Overall Study|Incorrectly enrolled|5|||
17069092|NCT00496470|38211609|FG000|Overall Study|Other reason|0|||
17148347|NCT03526861|38293136|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148348|NCT03526861|38293137|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148349|NCT03526861|38293138|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148350|NCT03526861|38293139|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148351|NCT03526861|38293140|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
17148352|NCT03526861|38293141|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
17148353|NCT03526861|38293133|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
17148354|NCT03526861|38293134|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
17148355|NCT03526861|38293135|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
17148356|NCT03526861|38293136|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
17148357|NCT03526861|38293137|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
17148358|NCT03526861|38293138|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
17148359|NCT03526861|38293139|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
17148360|NCT03526861|38293140|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
17148361|NCT03526861|38293141|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
17148362|NCT03526861|38293133|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148363|NCT03526861|38293134|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148364|NCT03526861|38293135|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148365|NCT03526861|38293136|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148366|NCT03526861|38293137|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148367|NCT03526861|38293138|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148368|NCT03526861|38293139|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148369|NCT03526861|38293140|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
17148370|NCT03526861|38293141|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
17148371|NCT03501277|38293165|FG000|Intervention Period 1 (4 Days)|Other|0|||
17148372|NCT03501277|38293166|FG001|Intervention Period 1 (4 Days)|Other|0|||
17148373|NCT03501277|38293167|FG002|Intervention Period 1 (4 Days)|Other|1|||
17069093|NCT00496470|38211610|FG001|Overall Study|Other reason|2|||
17069094|NCT00496080|38211616|FG000|Overall Study|Lost to Follow-up|9|||
17069095|NCT00496080|38211616|FG000|Overall Study|Surgical re-intervention|7|||
17069096|NCT00496080|38211616|FG000|Overall Study|Withdrawal by Subject|5|||
17069097|NCT00496080|38211616|FG000|Overall Study|Physician Decision|6|||
17069098|NCT00487578|38211623|FG000|Overall Study|Adverse Event|1|||
17069099|NCT00487578|38211624|FG001|Overall Study|Adverse Event|2|||
17069100|NCT00487578|38211623|FG000|Overall Study|Lack of Efficacy|0|||
17069101|NCT00487578|38211624|FG001|Overall Study|Lack of Efficacy|1|||
17069102|NCT00487578|38211623|FG000|Overall Study|Lost to Follow-up|0|||
17069103|NCT00487578|38211624|FG001|Overall Study|Lost to Follow-up|1|||
17069104|NCT00495612|38211632|FG000|Overall Study|Lost to Follow-up|1|||
17069105|NCT00495612|38211633|FG001|Overall Study|Lost to Follow-up|0|||
17069106|NCT00495612|38211632|FG000|Overall Study|Subject's Decision to Withdraw|3|||
17069107|NCT00495612|38211633|FG001|Overall Study|Subject's Decision to Withdraw|0|||
17069108|NCT00487188|38211641|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
17069109|NCT00487188|38211642|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
17069110|NCT00487188|38211643|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
17069111|NCT00487188|38211641|FG000|Induction Phase|Adverse Event|5|||
17069112|NCT00487188|38211642|FG001|Induction Phase|Adverse Event|0|||
17069113|NCT00487188|38211643|FG002|Induction Phase|Adverse Event|0|||
17069114|NCT00487188|38211641|FG000|Induction Phase|Lack of Efficacy|0|||
17069115|NCT00487188|38211642|FG001|Induction Phase|Lack of Efficacy|1|||
17069116|NCT00487188|38211643|FG002|Induction Phase|Lack of Efficacy|0|||
17148374|NCT03501277|38293168|FG003|Intervention Period 1 (4 Days)|Other|0|||
17148375|NCT03501277|38293165|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
17148376|NCT03501277|38293166|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
17148377|NCT03501277|38293167|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
17148378|NCT03501277|38293168|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
17148379|NCT03501277|38293165|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
17148380|NCT03501277|38293166|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
17148381|NCT03501277|38293167|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
17148382|NCT03501277|38293168|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
17148383|NCT03501277|38293165|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
17148384|NCT03501277|38293166|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
17148385|NCT03501277|38293167|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
17148386|NCT03501277|38293168|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
17148387|NCT03500419|38293180|FG000|Overall Study|Withdrawal by Subject|2|||
17069117|NCT00487188|38211641|FG000|Induction Phase|Protocol Violation|1|||
17069118|NCT00487188|38211642|FG001|Induction Phase|Protocol Violation|0|||
17069119|NCT00487188|38211643|FG002|Induction Phase|Protocol Violation|0|||
17069120|NCT00487188|38211641|FG000|Induction Phase|Refused Treatment|1|||
17069121|NCT00487188|38211642|FG001|Induction Phase|Refused Treatment|2|||
17069122|NCT00487188|38211643|FG002|Induction Phase|Refused Treatment|0|||
17069123|NCT00487188|38211641|FG000|Induction Phase|Lost to Follow-up|2|||
17069124|NCT00487188|38211642|FG001|Induction Phase|Lost to Follow-up|2|||
17069125|NCT00487188|38211643|FG002|Induction Phase|Lost to Follow-up|0|||
17069126|NCT00487188|38211641|FG000|Induction Phase|Administrative|0|||
17069127|NCT00487188|38211642|FG001|Induction Phase|Administrative|1|||
17069128|NCT00487188|38211643|FG002|Induction Phase|Administrative|0|||
17069129|NCT00487188|38211641|FG000|Maintenance Phase|Adverse Event|1|||
17069130|NCT00487188|38211642|FG001|Maintenance Phase|Adverse Event|0|||
17069131|NCT00487188|38211643|FG002|Maintenance Phase|Adverse Event|0|||
17069132|NCT00487188|38211641|FG000|Maintenance Phase|Death|1|||
17069133|NCT00487188|38211642|FG001|Maintenance Phase|Death|0|||
17069134|NCT00487188|38211643|FG002|Maintenance Phase|Death|0|||
17069135|NCT00487188|38211641|FG000|Maintenance Phase|Lost to Follow-up|1|||
17069136|NCT00487188|38211642|FG001|Maintenance Phase|Lost to Follow-up|0|||
17069137|NCT00487188|38211643|FG002|Maintenance Phase|Lost to Follow-up|0|||
17069138|NCT00487188|38211641|FG000|Maintenance Phase|Administrative|0|||
17069139|NCT00487188|38211642|FG001|Maintenance Phase|Administrative|0|||
17069140|NCT00487188|38211643|FG002|Maintenance Phase|Administrative|1|||
17069141|NCT00509366|38211664|FG000|Overall Study|Not Treated (Screen Failure)|1|||
17069142|NCT00509366|38211665|FG001|Overall Study|Not Treated (Screen Failure)|1|||
17069143|NCT00509366|38211666|FG002|Overall Study|Not Treated (Screen Failure)|1|||
17069144|NCT00509366|38211667|FG003|Overall Study|Not Treated (Screen Failure)|0|||
17069145|NCT00509366|38211668|FG004|Overall Study|Not Treated (Screen Failure)|0|||
17069146|NCT00500318|38211680|FG000|Overall Study|Adverse Event|3|||
17069147|NCT00500318|38211681|FG001|Overall Study|Adverse Event|8|||
17069148|NCT00500318|38211680|FG000|Overall Study|Protocol Violation|1|||
17069149|NCT00500318|38211681|FG001|Overall Study|Protocol Violation|3|||
17069150|NCT00500318|38211680|FG000|Overall Study|Withdrawal by Subject|1|||
17069151|NCT00500318|38211681|FG001|Overall Study|Withdrawal by Subject|2|||
17069152|NCT00500318|38211680|FG000|Overall Study|Lack of Efficacy|0|||
17069153|NCT00500318|38211681|FG001|Overall Study|Lack of Efficacy|3|||
17069154|NCT00500318|38211680|FG000|Overall Study|Other Reason|0|||
17069155|NCT00500318|38211681|FG001|Overall Study|Other Reason|1|||
17069156|NCT00508820|38211689|FG000|Overall Study|Adverse Event|6|||
17069157|NCT00508820|38211690|FG001|Overall Study|Adverse Event|10|||
17069158|NCT00508820|38211689|FG000|Overall Study|Death|6|||
17069159|NCT00508820|38211690|FG001|Overall Study|Death|8|||
17069160|NCT00508820|38211689|FG000|Overall Study|Lost to Follow-up|1|||
17069161|NCT00508820|38211690|FG001|Overall Study|Lost to Follow-up|1|||
17069162|NCT00508820|38211689|FG000|Overall Study|Physician Decision|8|||
17069163|NCT00508820|38211690|FG001|Overall Study|Physician Decision|2|||
17069164|NCT00508820|38211689|FG000|Overall Study|Pregnancy|0|||
17069165|NCT00508820|38211690|FG001|Overall Study|Pregnancy|2|||
17069166|NCT00508820|38211689|FG000|Overall Study|Protocol Violation|2|||
17069167|NCT00508820|38211690|FG001|Overall Study|Protocol Violation|0|||
17069168|NCT00508820|38211689|FG000|Overall Study|Withdrawal by Subject|10|||
17069169|NCT00508820|38211690|FG001|Overall Study|Withdrawal by Subject|12|||
17069170|NCT00508820|38211689|FG000|Overall Study|Other|11|||
17069171|NCT00508820|38211690|FG001|Overall Study|Other|2|||
17069172|NCT00508820|38211689|FG000|Overall Study|Noncompliance|1|||
17069173|NCT00508820|38211690|FG001|Overall Study|Noncompliance|0|||
17069174|NCT00508820|38211689|FG000|Overall Study|Requirement for alternative therapy|7|||
17069175|NCT00508820|38211690|FG001|Overall Study|Requirement for alternative therapy|15|||
17069176|NCT00508820|38211689|FG000|Overall Study|Protocol-specified Criteria|3|||
17069177|NCT00508820|38211690|FG001|Overall Study|Protocol-specified Criteria|12|||
17069178|NCT00499694|38211696|FG000|Overall Study|Patient never received treatment.|1|||
17069179|NCT00486954|38211705|FG000|Pilot Part|Adverse Event|4|||
17069180|NCT00486954|38211706|FG001|Pilot Part|Adverse Event|0|||
17069181|NCT00486954|38211707|FG002|Pilot Part|Adverse Event|5|||
17069182|NCT00486954|38211708|FG003|Pilot Part|Adverse Event|0|||
17069183|NCT00486954|38211709|FG004|Pilot Part|Adverse Event|0|||
17069184|NCT00486954|38211705|FG000|Pilot Part|Disease Progression|2|||
17069185|NCT00486954|38211706|FG001|Pilot Part|Disease Progression|0|||
17069186|NCT00486954|38211707|FG002|Pilot Part|Disease Progression|1|||
17069187|NCT00486954|38211708|FG003|Pilot Part|Disease Progression|0|||
17069188|NCT00486954|38211709|FG004|Pilot Part|Disease Progression|0|||
17069189|NCT00486954|38211705|FG000|Randomized Part|Lost to Follow-up|0|||
17069190|NCT00486954|38211706|FG001|Randomized Part|Lost to Follow-up|0|||
17069191|NCT00486954|38211707|FG002|Randomized Part|Lost to Follow-up|0|||
17069192|NCT00486954|38211708|FG003|Randomized Part|Lost to Follow-up|0|||
17069193|NCT00486954|38211709|FG004|Randomized Part|Lost to Follow-up|1|||
17069194|NCT00486954|38211705|FG000|Randomized Part|Withdrawal by Subject|0|||
17069195|NCT00486954|38211706|FG001|Randomized Part|Withdrawal by Subject|0|||
17069196|NCT00486954|38211707|FG002|Randomized Part|Withdrawal by Subject|0|||
17069197|NCT00486954|38211708|FG003|Randomized Part|Withdrawal by Subject|1|||
17069198|NCT00486954|38211709|FG004|Randomized Part|Withdrawal by Subject|0|||
17069199|NCT00486954|38211705|FG000|Randomized Part|Sponsor Terminated Study|0|||
17069200|NCT00486954|38211706|FG001|Randomized Part|Sponsor Terminated Study|0|||
17069201|NCT00486954|38211707|FG002|Randomized Part|Sponsor Terminated Study|0|||
17069202|NCT00486954|38211708|FG003|Randomized Part|Sponsor Terminated Study|19|||
17069203|NCT00486954|38211709|FG004|Randomized Part|Sponsor Terminated Study|13|||
17069204|NCT00494676|38211719|FG000|Allocation|Withdrawal by Subject|2|||
17069205|NCT00494676|38211720|FG001|Allocation|Withdrawal by Subject|4|||
17069206|NCT00494676|38211719|FG000|First Intervention|Withdrawal by Subject|1|||
17069207|NCT00494676|38211720|FG001|First Intervention|Withdrawal by Subject|3|||
17069208|NCT00494676|38211719|FG000|Second Intervention|Withdrawal by Subject|1|||
17069209|NCT00494676|38211720|FG001|Second Intervention|Withdrawal by Subject|1|||
17069210|NCT00486720|38211728|FG000|Overall Study|Adverse Event|1|||
17069211|NCT00486720|38211729|FG001|Overall Study|Adverse Event|2|||
17069212|NCT00486720|38211728|FG000|Overall Study|Lack of Efficacy|4|||
17069213|NCT00486720|38211729|FG001|Overall Study|Lack of Efficacy|6|||
17069214|NCT00486720|38211728|FG000|Overall Study|Physician Decision|1|||
17069215|NCT00486720|38211729|FG001|Overall Study|Physician Decision|2|||
17069216|NCT00486720|38211728|FG000|Overall Study|Protocol Violation|1|||
17069217|NCT00486720|38211729|FG001|Overall Study|Protocol Violation|0|||
17069218|NCT00486720|38211728|FG000|Overall Study|Withdrawal by Subject|3|||
17069219|NCT00486720|38211729|FG001|Overall Study|Withdrawal by Subject|1|||
17069220|NCT00486720|38211728|FG000|Overall Study|Progressive Disease|0|||
17069221|NCT00486720|38211729|FG001|Overall Study|Progressive Disease|1|||
17069222|NCT00486330|38211735|FG000|Overall Study|Adverse Event|2|||
17069223|NCT00486252|38211739|FG000|Overall Study|Adverse Event|7|||
17069224|NCT00486252|38211739|FG000|Overall Study|Lack of Efficacy|9|||
17069225|NCT00486252|38211739|FG000|Overall Study|Lost to Follow-up|24|||
17069226|NCT00486252|38211739|FG000|Overall Study|Other|18|||
17069227|NCT00494442|38211747|FG000|Overall Study|Death|1|||
17069228|NCT00494442|38211748|FG001|Overall Study|Death|1|||
17069229|NCT00494442|38211747|FG000|Overall Study|Lack of Efficacy|16|||
17069230|NCT00494442|38211748|FG001|Overall Study|Lack of Efficacy|10|||
17069231|NCT00494442|38211747|FG000|Overall Study|Adverse Event|0|||
17069232|NCT00494442|38211748|FG001|Overall Study|Adverse Event|2|||
17069233|NCT00494442|38211747|FG000|Overall Study|Physician Decision|0|||
17069234|NCT00494442|38211748|FG001|Overall Study|Physician Decision|1|||
17069235|NCT00494442|38211747|FG000|Overall Study|Non-compliance|0|||
17069236|NCT00494442|38211748|FG001|Overall Study|Non-compliance|1|||
17069237|NCT00494442|38211747|FG000|Overall Study|Intercurrent illness|0|||
17069238|NCT00494442|38211748|FG001|Overall Study|Intercurrent illness|1|||
17069239|NCT03851016|38211756|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
17069240|NCT03851016|38211757|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
17069241|NCT00493974|38211765|FG000|Overall Study|Death|1|||
17069242|NCT00493974|38211766|FG001|Overall Study|Death|2|||
17069243|NCT00493974|38211765|FG000|Overall Study|Withdrawal by Subject|8|||
17069244|NCT00493974|38211766|FG001|Overall Study|Withdrawal by Subject|6|||
17069245|NCT00493974|38211765|FG000|Overall Study|Lost to Follow-up|4|||
17069246|NCT00493974|38211766|FG001|Overall Study|Lost to Follow-up|6|||
17069247|NCT00469092|38211774|FG000|Overall Study|Adverse Event|5|||
17069248|NCT00469092|38211775|FG001|Overall Study|Adverse Event|4|||
17069249|NCT00469092|38211774|FG000|Overall Study|Lack of Efficacy|1|||
17069250|NCT00469092|38211775|FG001|Overall Study|Lack of Efficacy|0|||
17069251|NCT00469092|38211774|FG000|Overall Study|Lost to Follow-up|1|||
17069252|NCT00469092|38211775|FG001|Overall Study|Lost to Follow-up|2|||
17069253|NCT00469092|38211774|FG000|Overall Study|Protocol Violation|3|||
17069254|NCT00469092|38211775|FG001|Overall Study|Protocol Violation|3|||
17069255|NCT00469092|38211774|FG000|Overall Study|Withdrawal by Subject|4|||
17069256|NCT00469092|38211775|FG001|Overall Study|Withdrawal by Subject|4|||
17069257|NCT00469092|38211774|FG000|Overall Study|Withdrawal Criteria|3|||
17069258|NCT00469092|38211775|FG001|Overall Study|Withdrawal Criteria|4|||
17069259|NCT00469092|38211774|FG000|Overall Study|Incorrectly Randomised|4|||
17069260|NCT00469092|38211775|FG001|Overall Study|Incorrectly Randomised|3|||
17069261|NCT00469092|38211774|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
17069262|NCT00469092|38211775|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
17069263|NCT00469092|38211774|FG000|Overall Study|Use of lipid lowering drug|1|||
17069264|NCT00469092|38211775|FG001|Overall Study|Use of lipid lowering drug|0|||
17069265|NCT00469092|38211774|FG000|Overall Study|Hypoglycaemic Episodes|1|||
17069266|NCT00469092|38211775|FG001|Overall Study|Hypoglycaemic Episodes|1|||
17069267|NCT00469092|38211774|FG000|Overall Study|Abnormal lab value|1|||
17069268|NCT00469092|38211775|FG001|Overall Study|Abnormal lab value|0|||
17069269|NCT00469092|38211774|FG000|Overall Study|Use of Corticosteroid|1|||
17069270|NCT00469092|38211775|FG001|Overall Study|Use of Corticosteroid|0|||
17069271|NCT00499616|38211785|FG000|Overall Study|Death|1|||
17069272|NCT00499616|38211786|FG001|Overall Study|Death|5|||
17069273|NCT00499616|38211787|FG002|Overall Study|Death|3|||
17069274|NCT00499616|38211788|FG003|Overall Study|Death|1|||
17069275|NCT00499616|38211785|FG000|Overall Study|Lack of Efficacy|5|||
17069276|NCT00499616|38211786|FG001|Overall Study|Lack of Efficacy|0|||
17069277|NCT00499616|38211787|FG002|Overall Study|Lack of Efficacy|19|||
17069278|NCT00499616|38211788|FG003|Overall Study|Lack of Efficacy|0|||
17069279|NCT00499616|38211785|FG000|Overall Study|Lost to Follow-up|0|||
17069280|NCT00499616|38211786|FG001|Overall Study|Lost to Follow-up|0|||
17069281|NCT00499616|38211787|FG002|Overall Study|Lost to Follow-up|1|||
17069282|NCT00499616|38211788|FG003|Overall Study|Lost to Follow-up|0|||
17069283|NCT00499616|38211785|FG000|Overall Study|Physician Decision|6|||
17069284|NCT00499616|38211786|FG001|Overall Study|Physician Decision|16|||
17069285|NCT00499616|38211787|FG002|Overall Study|Physician Decision|9|||
17069286|NCT00499616|38211788|FG003|Overall Study|Physician Decision|0|||
17069287|NCT00499616|38211785|FG000|Overall Study|Withdrawal by Subject|1|||
17069288|NCT00499616|38211786|FG001|Overall Study|Withdrawal by Subject|0|||
17069289|NCT00499616|38211787|FG002|Overall Study|Withdrawal by Subject|1|||
17069290|NCT00499616|38211788|FG003|Overall Study|Withdrawal by Subject|0|||
17069291|NCT00499616|38211785|FG000|Overall Study|Ineligible|1|||
17069292|NCT00499616|38211786|FG001|Overall Study|Ineligible|2|||
17069293|NCT00499616|38211787|FG002|Overall Study|Ineligible|0|||
17069294|NCT00499616|38211788|FG003|Overall Study|Ineligible|15|||
17069295|NCT00499616|38211785|FG000|Overall Study|Not evaluable|0|||
17069296|NCT00499616|38211786|FG001|Overall Study|Not evaluable|0|||
17069297|NCT00499616|38211787|FG002|Overall Study|Not evaluable|0|||
17069298|NCT00499616|38211788|FG003|Overall Study|Not evaluable|41|||
17069299|NCT00499616|38211785|FG000|Overall Study|Patient/Parent Refusal|1|||
17069300|NCT00499616|38211786|FG001|Overall Study|Patient/Parent Refusal|5|||
17069301|NCT00499616|38211787|FG002|Overall Study|Patient/Parent Refusal|3|||
17069302|NCT00499616|38211788|FG003|Overall Study|Patient/Parent Refusal|0|||
17069303|NCT00402597|38211806|FG000|Overall Study|Death|15|||
17069304|NCT00402597|38211807|FG001|Overall Study|Death|7|||
17069305|NCT00402597|38211808|FG002|Overall Study|Death|6|||
17069306|NCT00402597|38211809|FG003|Overall Study|Death|4|||
17069307|NCT00402597|38211810|FG004|Overall Study|Death|6|||
17069308|NCT00402597|38211806|FG000|Overall Study|Adverse Event|81|||
17069309|NCT00402597|38211807|FG001|Overall Study|Adverse Event|18|||
17069310|NCT00402597|38211808|FG002|Overall Study|Adverse Event|106|||
17069311|NCT00402597|38211809|FG003|Overall Study|Adverse Event|39|||
17069312|NCT00402597|38211810|FG004|Overall Study|Adverse Event|71|||
17069313|NCT00402597|38211806|FG000|Overall Study|Lost to Follow-up|8|||
17069314|NCT00402597|38211807|FG001|Overall Study|Lost to Follow-up|1|||
17069315|NCT00402597|38211808|FG002|Overall Study|Lost to Follow-up|8|||
17069316|NCT00402597|38211809|FG003|Overall Study|Lost to Follow-up|2|||
17069317|NCT00402597|38211810|FG004|Overall Study|Lost to Follow-up|3|||
17069318|NCT00402597|38211806|FG000|Overall Study|Withdrawal by Subject|57|||
17069319|NCT00402597|38211807|FG001|Overall Study|Withdrawal by Subject|16|||
17069320|NCT00402597|38211808|FG002|Overall Study|Withdrawal by Subject|65|||
17069321|NCT00402597|38211809|FG003|Overall Study|Withdrawal by Subject|15|||
17069322|NCT00402597|38211810|FG004|Overall Study|Withdrawal by Subject|24|||
17069323|NCT00402597|38211806|FG000|Overall Study|reason not specified|30|||
17069324|NCT00402597|38211807|FG001|Overall Study|reason not specified|4|||
17069325|NCT00402597|38211808|FG002|Overall Study|reason not specified|27|||
17069326|NCT00402597|38211809|FG003|Overall Study|reason not specified|14|||
17069327|NCT00402597|38211810|FG004|Overall Study|reason not specified|20|||
17069328|NCT00402363|38211826|FG000|Overall Study|Adverse Event|9|||
17069329|NCT00402363|38211827|FG001|Overall Study|Adverse Event|14|||
17069330|NCT00402363|38211828|FG002|Overall Study|Adverse Event|2|||
17069331|NCT00402363|38211829|FG003|Overall Study|Adverse Event|2|||
17069332|NCT00402363|38211826|FG000|Overall Study|Withdrew Consent|10|||
17069333|NCT00402363|38211827|FG001|Overall Study|Withdrew Consent|5|||
17069334|NCT00402363|38211828|FG002|Overall Study|Withdrew Consent|2|||
17069335|NCT00402363|38211829|FG003|Overall Study|Withdrew Consent|1|||
17069336|NCT00402363|38211826|FG000|Overall Study|Protocol Violation|3|||
17069337|NCT00402363|38211827|FG001|Overall Study|Protocol Violation|5|||
17069338|NCT00402363|38211828|FG002|Overall Study|Protocol Violation|0|||
17069339|NCT00402363|38211829|FG003|Overall Study|Protocol Violation|3|||
17069340|NCT00402363|38211826|FG000|Overall Study|Lost to Follow-up|5|||
17069341|NCT00402363|38211827|FG001|Overall Study|Lost to Follow-up|4|||
17069342|NCT00402363|38211828|FG002|Overall Study|Lost to Follow-up|0|||
17069343|NCT00402363|38211829|FG003|Overall Study|Lost to Follow-up|2|||
17069344|NCT00402363|38211826|FG000|Overall Study|"Captured as Other"|6|||
17069345|NCT00402363|38211827|FG001|Overall Study|"Captured as Other"|2|||
17069346|NCT00402363|38211828|FG002|Overall Study|"Captured as Other"|2|||
17069347|NCT00402363|38211829|FG003|Overall Study|"Captured as Other"|2|||
17069348|NCT00469014|38211849|FG000|Initial Phase Randomization|Disease Progression|0|||
17069349|NCT00469014|38211850|FG001|Initial Phase Randomization|Disease Progression|1|||
17069350|NCT00469014|38211851|FG002|Initial Phase Randomization|Disease Progression|1|||
17069351|NCT00469014|38211852|FG003|Initial Phase Randomization|Disease Progression|0|||
17069352|NCT00469014|38211849|FG000|Initial Phase Randomization|No Response|1|||
17069353|NCT00469014|38211850|FG001|Initial Phase Randomization|No Response|0|||
17069354|NCT00469014|38211851|FG002|Initial Phase Randomization|No Response|0|||
17069355|NCT00469014|38211852|FG003|Initial Phase Randomization|No Response|1|||
17069356|NCT00469014|38211849|FG000|Adaptive Randomization|Not Evaluable|1|||
17069357|NCT00469014|38211850|FG001|Adaptive Randomization|Not Evaluable|0|||
17069358|NCT00469014|38211851|FG002|Adaptive Randomization|Not Evaluable|0|||
17069359|NCT00469014|38211852|FG003|Adaptive Randomization|Not Evaluable|1|||
17069360|NCT00469014|38211849|FG000|Adaptive Randomization|No Response|0|||
17069361|NCT00469014|38211850|FG001|Adaptive Randomization|No Response|1|||
17069362|NCT00469014|38211851|FG002|Adaptive Randomization|No Response|0|||
17069363|NCT00469014|38211852|FG003|Adaptive Randomization|No Response|0|||
17069364|NCT00469014|38211849|FG000|Adaptive Randomization|Death|0|||
17069365|NCT00469014|38211850|FG001|Adaptive Randomization|Death|0|||
17069366|NCT00469014|38211851|FG002|Adaptive Randomization|Death|1|||
17069367|NCT00469014|38211852|FG003|Adaptive Randomization|Death|0|||
17069368|NCT00493038|38211864|FG000|Treatment|Adverse Event|8|||
17069369|NCT00493038|38211865|FG001|Treatment|Adverse Event|4|||
17069370|NCT00493038|38211864|FG000|Treatment|Lost to Follow-up|5|||
17069371|NCT00493038|38211865|FG001|Treatment|Lost to Follow-up|3|||
17069372|NCT00493038|38211864|FG000|Treatment|Withdrawal by Subject|11|||
17069373|NCT00493038|38211865|FG001|Treatment|Withdrawal by Subject|12|||
17069374|NCT00493038|38211864|FG000|Treatment|Other|0|||
17069375|NCT00493038|38211865|FG001|Treatment|Other|1|||
17069376|NCT00493038|38211864|FG000|Follow-up|Lost to Follow-up|1|||
17069377|NCT00493038|38211865|FG001|Follow-up|Lost to Follow-up|0|||
17069378|NCT00392223|38211873|FG000|Overall Study|Adverse Event|5|||
17069379|NCT00392223|38211874|FG001|Overall Study|Adverse Event|4|||
17069380|NCT00392223|38211873|FG000|Overall Study|Lost to Follow-up|1|||
17069381|NCT00392223|38211874|FG001|Overall Study|Lost to Follow-up|4|||
17069382|NCT00392223|38211873|FG000|Overall Study|Protocol Violation|0|||
17069383|NCT00392223|38211874|FG001|Overall Study|Protocol Violation|3|||
17069384|NCT00392223|38211873|FG000|Overall Study|Withdrawal by Subject|3|||
17069385|NCT00392223|38211874|FG001|Overall Study|Withdrawal by Subject|2|||
17069386|NCT00402285|38211883|FG000|Overall Study|insufficient RNA quality|7|||
17069387|NCT00402285|38211884|FG001|Overall Study|insufficient RNA quality|6|||
17069388|NCT00402285|38211885|FG002|Overall Study|insufficient RNA quality|2|||
17069389|NCT00413283|38211895|FG000|Overall Study|Withdrawal by Subject|1|||
17069390|NCT00413283|38211896|FG001|Overall Study|Withdrawal by Subject|0|||
17069391|NCT00413283|38211897|FG002|Overall Study|Withdrawal by Subject|0|||
17069392|NCT00413283|38211898|FG003|Overall Study|Withdrawal by Subject|1|||
17069393|NCT00413283|38211895|FG000|Overall Study|Death|0|||
17069394|NCT00413283|38211896|FG001|Overall Study|Death|0|||
17069395|NCT00413283|38211897|FG002|Overall Study|Death|1|||
17069396|NCT00413283|38211898|FG003|Overall Study|Death|1|||
17069397|NCT00413283|38211895|FG000|Overall Study|Adverse Event|0|||
17069398|NCT00413283|38211896|FG001|Overall Study|Adverse Event|0|||
17069399|NCT00413283|38211897|FG002|Overall Study|Adverse Event|0|||
17069400|NCT00413283|38211898|FG003|Overall Study|Adverse Event|1|||
17069401|NCT00413283|38211895|FG000|Overall Study|Ineligibility determined|0|||
17069402|NCT00413283|38211896|FG001|Overall Study|Ineligibility determined|0|||
17069403|NCT00413283|38211897|FG002|Overall Study|Ineligibility determined|0|||
17069404|NCT00413283|38211898|FG003|Overall Study|Ineligibility determined|1|||
17069405|NCT00413283|38211895|FG000|Overall Study|Protocol deviation|0|||
17069406|NCT00413283|38211896|FG001|Overall Study|Protocol deviation|1|||
17069407|NCT00413283|38211897|FG002|Overall Study|Protocol deviation|0|||
17069408|NCT00413283|38211898|FG003|Overall Study|Protocol deviation|0|||
17069409|NCT00413283|38211895|FG000|Overall Study|Requirement for alternative therapy|0|||
17069410|NCT00413283|38211896|FG001|Overall Study|Requirement for alternative therapy|2|||
17069411|NCT00413283|38211897|FG002|Overall Study|Requirement for alternative therapy|0|||
17069412|NCT00413283|38211898|FG003|Overall Study|Requirement for alternative therapy|0|||
17069413|NCT00413283|38211895|FG000|Overall Study|Other|0|||
17069414|NCT00413283|38211896|FG001|Overall Study|Other|0|||
17069415|NCT00413283|38211897|FG002|Overall Study|Other|1|||
17069416|NCT00413283|38211898|FG003|Overall Study|Other|0|||
17069417|NCT00402051|38211910|FG000|Overall Study|Progressive Disease|13|||
17069418|NCT00402051|38211911|FG001|Overall Study|Progressive Disease|20|||
17069419|NCT00402051|38211910|FG000|Overall Study|Adverse Event|11|||
17069420|NCT00402051|38211911|FG001|Overall Study|Adverse Event|4|||
17069421|NCT00402051|38211910|FG000|Overall Study|Physician Decision|7|||
17069422|NCT00402051|38211911|FG001|Overall Study|Physician Decision|3|||
17069423|NCT00402051|38211910|FG000|Overall Study|Withdrawal by Subject|3|||
17069424|NCT00402051|38211911|FG001|Overall Study|Withdrawal by Subject|3|||
17069425|NCT00402051|38211910|FG000|Overall Study|Death - Related to Study Drug|1|||
17069426|NCT00402051|38211911|FG001|Overall Study|Death - Related to Study Drug|2|||
17069427|NCT00402051|38211910|FG000|Overall Study|Death Due to Study Disease|2|||
17069428|NCT00402051|38211911|FG001|Overall Study|Death Due to Study Disease|1|||
17069429|NCT00402051|38211910|FG000|Overall Study|Death Due to Adverse Event|0|||
17069430|NCT00402051|38211911|FG001|Overall Study|Death Due to Adverse Event|2|||
17069431|NCT00402051|38211910|FG000|Overall Study|Lost to Follow-up|1|||
17069432|NCT00402051|38211911|FG001|Overall Study|Lost to Follow-up|0|||
17069433|NCT00468858|38211920|FG000|Overall Study|Adverse Event|0|||
17069434|NCT00468858|38211921|FG001|Overall Study|Adverse Event|1|||
17069435|NCT00468858|38211922|FG002|Overall Study|Adverse Event|0|||
17069436|NCT00468858|38211920|FG000|Overall Study|Withdrawal by Subject|7|||
17069437|NCT00468858|38211921|FG001|Overall Study|Withdrawal by Subject|4|||
17069438|NCT00468858|38211922|FG002|Overall Study|Withdrawal by Subject|5|||
17069439|NCT00468858|38211920|FG000|Overall Study|Relocation|1|||
17069440|NCT00468858|38211921|FG001|Overall Study|Relocation|3|||
17069441|NCT00468858|38211922|FG002|Overall Study|Relocation|3|||
17069442|NCT00468858|38211920|FG000|Overall Study|Lost to Follow-up|1|||
17069443|NCT00468858|38211921|FG001|Overall Study|Lost to Follow-up|2|||
17069444|NCT00468858|38211922|FG002|Overall Study|Lost to Follow-up|5|||
17069445|NCT00468858|38211920|FG000|Overall Study|Other|0|||
17069446|NCT00468858|38211921|FG001|Overall Study|Other|0|||
17069447|NCT00468858|38211922|FG002|Overall Study|Other|1|||
17069448|NCT00401973|38211987|FG000|Overall Study|Adverse Event|2|||
17069449|NCT00401973|38211988|FG001|Overall Study|Adverse Event|8|||
17069450|NCT00401973|38211989|FG002|Overall Study|Adverse Event|4|||
17069451|NCT00401973|38211987|FG000|Overall Study|Clinical Relapse|0|||
17069452|NCT00401973|38211988|FG001|Overall Study|Clinical Relapse|1|||
17069453|NCT00401973|38211989|FG002|Overall Study|Clinical Relapse|1|||
17069454|NCT00401973|38211987|FG000|Overall Study|Lack of Efficacy|0|||
17069455|NCT00401973|38211988|FG001|Overall Study|Lack of Efficacy|0|||
17069456|NCT00401973|38211989|FG002|Overall Study|Lack of Efficacy|3|||
17069457|NCT00401973|38211987|FG000|Overall Study|Lost to Follow-up|2|||
17069458|NCT00401973|38211988|FG001|Overall Study|Lost to Follow-up|2|||
17069459|NCT00401973|38211989|FG002|Overall Study|Lost to Follow-up|2|||
17069460|NCT00401973|38211987|FG000|Overall Study|Physician Decision|2|||
17069461|NCT00401973|38211988|FG001|Overall Study|Physician Decision|0|||
17069462|NCT00401973|38211989|FG002|Overall Study|Physician Decision|1|||
17069463|NCT00401973|38211987|FG000|Overall Study|Protocol Violation|1|||
17069464|NCT00401973|38211988|FG001|Overall Study|Protocol Violation|2|||
17069465|NCT00401973|38211989|FG002|Overall Study|Protocol Violation|3|||
17069466|NCT00401973|38211987|FG000|Overall Study|Sponsor Decision|0|||
17069467|NCT00401973|38211988|FG001|Overall Study|Sponsor Decision|1|||
17069468|NCT00401973|38211989|FG002|Overall Study|Sponsor Decision|0|||
17069469|NCT00401973|38211987|FG000|Overall Study|Withdrawal by Subject|4|||
17069470|NCT00401973|38211988|FG001|Overall Study|Withdrawal by Subject|12|||
17069471|NCT00401973|38211989|FG002|Overall Study|Withdrawal by Subject|9|||
17069472|NCT00401193|38212002|FG000|Overall Study|Adverse Event|1|||
17069473|NCT00401193|38212003|FG001|Overall Study|Adverse Event|3|||
17069474|NCT00401193|38212004|FG002|Overall Study|Adverse Event|1|||
17069475|NCT00401193|38212002|FG000|Overall Study|Protocol Violation|3|||
17069476|NCT00401193|38212003|FG001|Overall Study|Protocol Violation|1|||
17069477|NCT00401193|38212004|FG002|Overall Study|Protocol Violation|1|||
17069478|NCT00401193|38212002|FG000|Overall Study|Lost to Follow-up|6|||
17069479|NCT00401193|38212003|FG001|Overall Study|Lost to Follow-up|5|||
17069480|NCT00401193|38212004|FG002|Overall Study|Lost to Follow-up|1|||
17069481|NCT00401193|38212002|FG000|Overall Study|Withdrawal by Subject|2|||
17069482|NCT00401193|38212003|FG001|Overall Study|Withdrawal by Subject|0|||
17069483|NCT00401193|38212004|FG002|Overall Study|Withdrawal by Subject|1|||
17069484|NCT00401193|38212002|FG000|Overall Study|Other Event|3|||
17069485|NCT00401193|38212003|FG001|Overall Study|Other Event|2|||
17069486|NCT00401193|38212004|FG002|Overall Study|Other Event|2|||
17069487|NCT00400569|38212013|FG000|Overall Study|Death|1|||
17069488|NCT00413049|38212022|FG000|Overall Study|Adverse Event|10|||
17069489|NCT00413049|38212023|FG001|Overall Study|Adverse Event|8|||
17069490|NCT00413049|38212022|FG000|Overall Study|Withdrawal by Subject|7|||
17069491|NCT00413049|38212023|FG001|Overall Study|Withdrawal by Subject|5|||
17069492|NCT00413049|38212022|FG000|Overall Study|Lost to Follow-up|2|||
17069493|NCT00413049|38212023|FG001|Overall Study|Lost to Follow-up|3|||
17069494|NCT00413049|38212022|FG000|Overall Study|Protocol Violation|3|||
17069495|NCT00413049|38212023|FG001|Overall Study|Protocol Violation|1|||
17069496|NCT00413049|38212022|FG000|Overall Study|Subject no longer requires study drug|0|||
17069497|NCT00413049|38212023|FG001|Overall Study|Subject no longer requires study drug|1|||
17069498|NCT00413049|38212022|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17069499|NCT00413049|38212023|FG001|Overall Study|Abnormal laboratory value(s)|0|||
17069500|NCT00413049|38212022|FG000|Overall Study|Lack of Efficacy|1|||
17069501|NCT00413049|38212023|FG001|Overall Study|Lack of Efficacy|0|||
17069502|NCT00454194|38212031|FG000|Overall Study|Adverse Event|7|||
17069503|NCT00454194|38212032|FG001|Overall Study|Adverse Event|2|||
17069504|NCT00454194|38212031|FG000|Overall Study|Withdrawal by Subject|12|||
17069505|NCT00454194|38212032|FG001|Overall Study|Withdrawal by Subject|8|||
17069506|NCT00454194|38212031|FG000|Overall Study|Other Medical Problems|1|||
17148388|NCT03500419|38293181|FG001|Overall Study|Withdrawal by Subject|25|||
17148389|NCT03500341|38293187|FG000|Overall Study|Withdrawn prior to Completion|2|||
17148390|NCT01316900|38293208|FG000|Overall Study|Adverse Event|10|||
17148391|NCT01316900|38293209|FG001|Overall Study|Adverse Event|10|||
17148392|NCT01316900|38293210|FG002|Overall Study|Adverse Event|15|||
17148393|NCT01316900|38293211|FG003|Overall Study|Adverse Event|9|||
17148394|NCT01316900|38293208|FG000|Overall Study|Lack of Efficacy|17|||
17148395|NCT01316900|38293209|FG001|Overall Study|Lack of Efficacy|9|||
17148396|NCT01316900|38293210|FG002|Overall Study|Lack of Efficacy|5|||
17148397|NCT01316900|38293211|FG003|Overall Study|Lack of Efficacy|7|||
17148398|NCT01316900|38293208|FG000|Overall Study|Protocol Violation|7|||
17148399|NCT01316900|38293209|FG001|Overall Study|Protocol Violation|1|||
17148400|NCT01316900|38293210|FG002|Overall Study|Protocol Violation|4|||
17148401|NCT01316900|38293211|FG003|Overall Study|Protocol Violation|0|||
17148402|NCT01316900|38293208|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
17148403|NCT01316900|38293209|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
17148404|NCT01316900|38293210|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
17148405|NCT01316900|38293211|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
17148406|NCT01316900|38293208|FG000|Overall Study|Lost to Follow-up|1|||
17148407|NCT01316900|38293209|FG001|Overall Study|Lost to Follow-up|0|||
17148408|NCT01316900|38293210|FG002|Overall Study|Lost to Follow-up|1|||
17148409|NCT01316900|38293211|FG003|Overall Study|Lost to Follow-up|1|||
17148410|NCT01316900|38293208|FG000|Overall Study|Withdrawal by Subject|7|||
17148411|NCT01316900|38293209|FG001|Overall Study|Withdrawal by Subject|8|||
17148412|NCT01316900|38293210|FG002|Overall Study|Withdrawal by Subject|6|||
17148413|NCT01316900|38293211|FG003|Overall Study|Withdrawal by Subject|9|||
17148414|NCT03714815|38293221|FG000|Overall Study|Physician Decision|2|||
17148415|NCT03714815|38293221|FG000|Overall Study|Withdrawal by Subject|2|||
17148416|NCT03714815|38293221|FG000|Overall Study|Death|11|||
17148417|NCT00936390|38293227|FG000|Overall Study|Protocol Violation|21|||
17148418|NCT00936390|38293228|FG001|Overall Study|Protocol Violation|25|||
17069507|NCT00454194|38212032|FG001|Overall Study|Other Medical Problems|2|||
17069508|NCT00454194|38212031|FG000|Overall Study|Other Unspecified Reason|2|||
17069509|NCT00454194|38212032|FG001|Overall Study|Other Unspecified Reason|2|||
17069510|NCT00412971|38212040|FG000|Overall Study|Lost to Follow-up|17|||
17069511|NCT00412971|38212041|FG001|Overall Study|Lost to Follow-up|9|||
17069512|NCT00412971|38212040|FG000|Overall Study|Protocol Violation|13|||
17069513|NCT00412971|38212041|FG001|Overall Study|Protocol Violation|1|||
17069514|NCT00303472|38212054|FG000|Treatment Period|Adverse Event|0|||
17069515|NCT00303472|38212055|FG001|Treatment Period|Adverse Event|0|||
17069516|NCT00303472|38212056|FG002|Treatment Period|Adverse Event|0|||
17069517|NCT00303472|38212057|FG003|Treatment Period|Adverse Event|0|||
17069518|NCT00303472|38212058|FG004|Treatment Period|Adverse Event|1|||
17069519|NCT00303472|38212059|FG005|Treatment Period|Adverse Event|0|||
17069520|NCT00303472|38212060|FG006|Treatment Period|Adverse Event|0|||
17069521|NCT00303472|38212054|FG000|Treatment Period|Death|0|||
17069522|NCT00303472|38212055|FG001|Treatment Period|Death|0|||
17069523|NCT00303472|38212056|FG002|Treatment Period|Death|0|||
17069524|NCT00303472|38212057|FG003|Treatment Period|Death|1|||
17148419|NCT03499873|38293239|FG000|Overall Study|Withdrawal by Subject|4|||
17148420|NCT03499873|38293240|FG001|Overall Study|Withdrawal by Subject|6|||
17148421|NCT03499873|38293241|FG002|Overall Study|Withdrawal by Subject|1|||
17148422|NCT03499873|38293239|FG000|Overall Study|Subjects condition worsened|0|||
17148423|NCT03499873|38293240|FG001|Overall Study|Subjects condition worsened|3|||
17148424|NCT03499873|38293241|FG002|Overall Study|Subjects condition worsened|11|||
17148425|NCT03499873|38293239|FG000|Overall Study|Adverse Event|8|||
17148426|NCT03499873|38293240|FG001|Overall Study|Adverse Event|3|||
17148427|NCT03499873|38293241|FG002|Overall Study|Adverse Event|6|||
17148428|NCT03499873|38293239|FG000|Overall Study|Physician Decision|1|||
17148429|NCT03499873|38293240|FG001|Overall Study|Physician Decision|0|||
17148430|NCT03499873|38293241|FG002|Overall Study|Physician Decision|0|||
17148431|NCT03499873|38293239|FG000|Overall Study|Administrative reasons|0|||
17148432|NCT03499873|38293240|FG001|Overall Study|Administrative reasons|1|||
17148433|NCT03499873|38293241|FG002|Overall Study|Administrative reasons|0|||
17148434|NCT03499873|38293239|FG000|Overall Study|Concomitant therapy|5|||
17069525|NCT00303472|38212058|FG004|Treatment Period|Death|0|||
17069526|NCT00303472|38212059|FG005|Treatment Period|Death|0|||
17069527|NCT00303472|38212060|FG006|Treatment Period|Death|1|||
17148435|NCT03499873|38293240|FG001|Overall Study|Concomitant therapy|4|||
17069528|NCT00303472|38212054|FG000|Treatment Period|Withdrawal by Subject|0|||
17069529|NCT00303472|38212055|FG001|Treatment Period|Withdrawal by Subject|0|||
17069530|NCT00303472|38212056|FG002|Treatment Period|Withdrawal by Subject|0|||
17069531|NCT00303472|38212057|FG003|Treatment Period|Withdrawal by Subject|1|||
17069532|NCT00303472|38212058|FG004|Treatment Period|Withdrawal by Subject|0|||
17069533|NCT00303472|38212059|FG005|Treatment Period|Withdrawal by Subject|1|||
17069534|NCT00303472|38212060|FG006|Treatment Period|Withdrawal by Subject|0|||
17069535|NCT00303472|38212054|FG000|Treatment Period|Other|0|||
17069536|NCT00303472|38212055|FG001|Treatment Period|Other|0|||
17069537|NCT00303472|38212056|FG002|Treatment Period|Other|0|||
17069538|NCT00303472|38212057|FG003|Treatment Period|Other|0|||
17069539|NCT00303472|38212058|FG004|Treatment Period|Other|1|||
17069540|NCT00303472|38212059|FG005|Treatment Period|Other|0|||
17069541|NCT00303472|38212060|FG006|Treatment Period|Other|1|||
17069542|NCT00303472|38212054|FG000|Treatment Period|Disease Progression (to AML)|0|||
17069543|NCT00303472|38212055|FG001|Treatment Period|Disease Progression (to AML)|0|||
17148436|NCT03499873|38293241|FG002|Overall Study|Concomitant therapy|7|||
17148437|NCT03499873|38293239|FG000|Overall Study|Miscellaneous|1|||
17148438|NCT03499873|38293240|FG001|Overall Study|Miscellaneous|2|||
17148439|NCT03499873|38293241|FG002|Overall Study|Miscellaneous|2|||
17148440|NCT03499873|38293239|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
17148441|NCT03499873|38293240|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
17148442|NCT03499873|38293241|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
17148443|NCT03467971|38293251|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17148444|NCT03467971|38293252|FG001|Treatment Period 2|Withdrawal by Subject|1|||
17148445|NCT03049280|38293268|FG000|Overall Study|Physician Decision|1|||
17148446|NCT03048500|38293274|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
17148447|NCT03048500|38293274|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
17148448|NCT03048500|38293274|FG000|Reached 1st Response/Continued Treatment|Death|1|||
17148449|NCT03048500|38293274|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
17148450|NCT03048500|38293274|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
17148451|NCT03048500|38293274|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
17148452|NCT03048500|38293274|FG000|Follow up for 3 Years|Death|12|||
17148453|NCT00908076|38293280|FG000|Overall Study|Lack of Efficacy|1|||
17148454|NCT00908076|38293281|FG001|Overall Study|Lack of Efficacy|1|||
17148455|NCT03467425|38293289|FG000|Overall Study|Adverse Event|9|||
17148456|NCT03467425|38293290|FG001|Overall Study|Adverse Event|9|||
17148457|NCT03467425|38293289|FG000|Overall Study|Lack of Efficacy|3|||
17069544|NCT00303472|38212056|FG002|Treatment Period|Disease Progression (to AML)|0|||
17069545|NCT00303472|38212057|FG003|Treatment Period|Disease Progression (to AML)|0|||
17069546|NCT00303472|38212058|FG004|Treatment Period|Disease Progression (to AML)|1|||
17069547|NCT00303472|38212059|FG005|Treatment Period|Disease Progression (to AML)|0|||
17069548|NCT00303472|38212060|FG006|Treatment Period|Disease Progression (to AML)|0|||
17069549|NCT00303472|38212054|FG000|Treatment Extension (Optional)|Adverse Event|1|||
17069550|NCT00303472|38212055|FG001|Treatment Extension (Optional)|Adverse Event|0|||
17069551|NCT00303472|38212056|FG002|Treatment Extension (Optional)|Adverse Event|1|||
17069552|NCT00303472|38212057|FG003|Treatment Extension (Optional)|Adverse Event|0|||
17069553|NCT00303472|38212058|FG004|Treatment Extension (Optional)|Adverse Event|0|||
17069554|NCT00303472|38212059|FG005|Treatment Extension (Optional)|Adverse Event|0|||
17069555|NCT00303472|38212060|FG006|Treatment Extension (Optional)|Adverse Event|0|||
17069556|NCT00303472|38212054|FG000|Treatment Extension (Optional)|Death|2|||
17069557|NCT00303472|38212055|FG001|Treatment Extension (Optional)|Death|0|||
17069558|NCT00303472|38212056|FG002|Treatment Extension (Optional)|Death|1|||
17069559|NCT00303472|38212057|FG003|Treatment Extension (Optional)|Death|0|||
17069560|NCT00303472|38212058|FG004|Treatment Extension (Optional)|Death|0|||
17069561|NCT00303472|38212059|FG005|Treatment Extension (Optional)|Death|0|||
17069562|NCT00303472|38212060|FG006|Treatment Extension (Optional)|Death|0|||
17148458|NCT03467425|38293290|FG001|Overall Study|Lack of Efficacy|1|||
17148459|NCT03467425|38293289|FG000|Overall Study|Protocol Violation|0|||
17148460|NCT03467425|38293290|FG001|Overall Study|Protocol Violation|1|||
17148461|NCT03467425|38293289|FG000|Overall Study|Lost to Follow-up|18|||
17148462|NCT03467425|38293290|FG001|Overall Study|Lost to Follow-up|25|||
16781240|NCT02109484|37720414|FG005|Overall Study|Withdrawal by Subject|1|||
16781241|NCT02109484|37720415|FG006|Overall Study|Withdrawal by Subject|1|||
16781242|NCT02109484|37720416|FG007|Overall Study|Withdrawal by Subject|0|||
17148463|NCT03467425|38293289|FG000|Overall Study|Physician Decision|2|||
17148464|NCT03467425|38293290|FG001|Overall Study|Physician Decision|1|||
17148465|NCT03467425|38293289|FG000|Overall Study|Withdrawal by Subject|15|||
17148466|NCT03467425|38293290|FG001|Overall Study|Withdrawal by Subject|17|||
17148467|NCT02886702|38293299|FG000|Overall Study|Other|4|||
17148468|NCT02886702|38293300|FG001|Overall Study|Other|3|||
17069563|NCT00303472|38212054|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
17069564|NCT00303472|38212055|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
17069565|NCT00303472|38212056|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
17148469|NCT02886702|38293301|FG002|Overall Study|Other|9|||
17148470|NCT02886702|38293299|FG000|Overall Study|Withdrawal by Subject|24|||
17148471|NCT02886702|38293300|FG001|Overall Study|Withdrawal by Subject|18|||
17148472|NCT02886702|38293301|FG002|Overall Study|Withdrawal by Subject|22|||
17148473|NCT02886702|38293299|FG000|Overall Study|Significant Worsening of Condition|0|||
17148474|NCT02886702|38293300|FG001|Overall Study|Significant Worsening of Condition|1|||
17148475|NCT02886702|38293301|FG002|Overall Study|Significant Worsening of Condition|0|||
17148476|NCT02886702|38293299|FG000|Overall Study|Protocol Violation|2|||
17148477|NCT02886702|38293300|FG001|Overall Study|Protocol Violation|2|||
17148478|NCT02886702|38293301|FG002|Overall Study|Protocol Violation|1|||
17148479|NCT02886702|38293299|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17069566|NCT00303472|38212057|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
17069567|NCT00303472|38212058|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
17069568|NCT00303472|38212059|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
17069569|NCT00303472|38212060|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
17148480|NCT02886702|38293300|FG001|Overall Study|Non-Compliance With Study Drug|1|||
17148481|NCT02886702|38293301|FG002|Overall Study|Non-Compliance With Study Drug|4|||
17148482|NCT02886702|38293299|FG000|Overall Study|Lost to Follow-up|11|||
17148483|NCT02886702|38293300|FG001|Overall Study|Lost to Follow-up|13|||
17148484|NCT02886702|38293301|FG002|Overall Study|Lost to Follow-up|8|||
17148485|NCT02886702|38293299|FG000|Overall Study|Lack of Efficacy|3|||
17148486|NCT02886702|38293300|FG001|Overall Study|Lack of Efficacy|4|||
17148487|NCT02886702|38293301|FG002|Overall Study|Lack of Efficacy|5|||
17148488|NCT02886702|38293299|FG000|Overall Study|Adverse Event|4|||
17148489|NCT02886702|38293300|FG001|Overall Study|Adverse Event|9|||
17148490|NCT02886702|38293301|FG002|Overall Study|Adverse Event|3|||
17148491|NCT02886702|38293299|FG000|Overall Study|Administrative Reasons|0|||
17148492|NCT02886702|38293300|FG001|Overall Study|Administrative Reasons|0|||
17148493|NCT02886702|38293301|FG002|Overall Study|Administrative Reasons|1|||
17148494|NCT03498313|38293315|FG000|Experimental Period 1|Adverse Event|1|||
17148495|NCT03498313|38293316|FG001|Experimental Period 1|Adverse Event|0|||
17148496|NCT03498313|38293317|FG002|Experimental Period 1|Adverse Event|0|||
17148497|NCT03498313|38293318|FG003|Experimental Period 1|Adverse Event|1|||
17148498|NCT03498313|38293319|FG004|Experimental Period 1|Adverse Event|0|||
17148499|NCT03498313|38293320|FG005|Experimental Period 1|Adverse Event|0|||
17148500|NCT03498313|38293315|FG000|Experimental Period 1|Withdrawal by Subject|0|||
17148501|NCT03498313|38293316|FG001|Experimental Period 1|Withdrawal by Subject|1|||
17148502|NCT03498313|38293317|FG002|Experimental Period 1|Withdrawal by Subject|0|||
17148503|NCT03498313|38293318|FG003|Experimental Period 1|Withdrawal by Subject|0|||
17069570|NCT00303472|38212054|FG000|Treatment Extension (Optional)|Physician Decision|0|||
17069571|NCT00303472|38212055|FG001|Treatment Extension (Optional)|Physician Decision|4|||
17069572|NCT00303472|38212056|FG002|Treatment Extension (Optional)|Physician Decision|2|||
17069573|NCT00303472|38212057|FG003|Treatment Extension (Optional)|Physician Decision|3|||
17069574|NCT00303472|38212058|FG004|Treatment Extension (Optional)|Physician Decision|2|||
17069575|NCT00303472|38212059|FG005|Treatment Extension (Optional)|Physician Decision|0|||
17069576|NCT00303472|38212060|FG006|Treatment Extension (Optional)|Physician Decision|0|||
17069577|NCT00303472|38212054|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
17069578|NCT00303472|38212055|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
17069579|NCT00303472|38212056|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
17069580|NCT00303472|38212057|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
17069581|NCT00303472|38212058|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
17069582|NCT00303472|38212059|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
17069583|NCT00303472|38212060|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
17069584|NCT00303472|38212054|FG000|Treatment Extension (Optional)|Other|0|||
17069585|NCT00303472|38212055|FG001|Treatment Extension (Optional)|Other|2|||
17069586|NCT00303472|38212056|FG002|Treatment Extension (Optional)|Other|4|||
17069587|NCT00303472|38212057|FG003|Treatment Extension (Optional)|Other|2|||
17069588|NCT00303472|38212058|FG004|Treatment Extension (Optional)|Other|1|||
17069589|NCT00303472|38212059|FG005|Treatment Extension (Optional)|Other|0|||
17069590|NCT00303472|38212060|FG006|Treatment Extension (Optional)|Other|0|||
17069591|NCT00303472|38212054|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
17069592|NCT00303472|38212055|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
17069593|NCT00303472|38212056|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
17069594|NCT00303472|38212057|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
17069595|NCT00303472|38212058|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
17069596|NCT00303472|38212059|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
17069597|NCT00303472|38212060|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
17069598|NCT00468546|38212078|FG000|Week 24 Analysis|Lack of Efficacy|83|||
17069599|NCT00468546|38212079|FG001|Week 24 Analysis|Lack of Efficacy|37|||
17069600|NCT00468546|38212078|FG000|Week 24 Analysis|Refused treatment|5|||
17069601|NCT00468546|38212079|FG001|Week 24 Analysis|Refused treatment|5|||
17069602|NCT00468546|38212078|FG000|Week 24 Analysis|Adverse Event|1|||
17069603|NCT00468546|38212079|FG001|Week 24 Analysis|Adverse Event|8|||
17069604|NCT00468546|38212078|FG000|Week 24 Analysis|Failure to return|3|||
17069605|NCT00468546|38212079|FG001|Week 24 Analysis|Failure to return|4|||
17148504|NCT03498313|38293319|FG004|Experimental Period 1|Withdrawal by Subject|0|||
17148505|NCT03498313|38293320|FG005|Experimental Period 1|Withdrawal by Subject|0|||
17148506|NCT03498313|38293315|FG000|Washout Period 1|Anovulation|1|||
17148507|NCT03498313|38293316|FG001|Washout Period 1|Anovulation|0|||
17148508|NCT03498313|38293317|FG002|Washout Period 1|Anovulation|0|||
17148509|NCT03498313|38293318|FG003|Washout Period 1|Anovulation|0|||
17148510|NCT03498313|38293319|FG004|Washout Period 1|Anovulation|0|||
17148511|NCT03498313|38293320|FG005|Washout Period 1|Anovulation|0|||
17069606|NCT00468546|38212078|FG000|Week 24 Analysis|Rescue therapy|2|||
17148512|NCT03498313|38293315|FG000|Washout Period 1|Withdrawal by Subject|0|||
17148513|NCT03498313|38293316|FG001|Washout Period 1|Withdrawal by Subject|3|||
17148514|NCT03498313|38293317|FG002|Washout Period 1|Withdrawal by Subject|0|||
17069607|NCT00468546|38212079|FG001|Week 24 Analysis|Rescue therapy|0|||
17069608|NCT00468546|38212078|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
17069609|NCT00468546|38212079|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
17069610|NCT00468546|38212078|FG000|Week 24 Analysis|Due to clinical hold|1|||
17069611|NCT00468546|38212079|FG001|Week 24 Analysis|Due to clinical hold|0|||
17069612|NCT00468546|38212078|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
17069613|NCT00468546|38212079|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
17069614|NCT00468546|38212078|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
17069615|NCT00468546|38212079|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
17069616|NCT00468546|38212078|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
17069617|NCT00468546|38212079|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
17069618|NCT00468546|38212078|FG000|Week 24 to Week 104 Analysis|Death|1|||
17069619|NCT00468546|38212079|FG001|Week 24 to Week 104 Analysis|Death|0|||
17069620|NCT00468546|38212078|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
17069621|NCT00468546|38212079|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
17069622|NCT00468546|38212078|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
17069623|NCT00468546|38212079|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
17069624|NCT00468546|38212078|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
17069625|NCT00468546|38212079|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
17069626|NCT00468546|38212078|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
17069627|NCT00468546|38212079|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
17069628|NCT00468546|38212078|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
17069629|NCT00468546|38212079|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
17069630|NCT00468546|38212078|FG000|Week 24 to Week 104 Analysis|Other|17|||
17069631|NCT00468546|38212079|FG001|Week 24 to Week 104 Analysis|Other|14|||
17069632|NCT00303316|38212087|FG000|Overall Study|Protocol Violation|1|||
17069633|NCT00303316|38212088|FG001|Overall Study|Protocol Violation|0|||
17069634|NCT00303316|38212087|FG000|Overall Study|Lost to Follow-up|0|||
17069635|NCT00303316|38212088|FG001|Overall Study|Lost to Follow-up|1|||
17069636|NCT00303316|38212087|FG000|Overall Study|Withdrawal by Subject|1|||
17069637|NCT00303316|38212088|FG001|Overall Study|Withdrawal by Subject|2|||
17069638|NCT00468312|38212096|FG000|Overall Study|Adverse Event|2|||
17069639|NCT00468312|38212097|FG001|Overall Study|Adverse Event|1|||
17069640|NCT00468312|38212096|FG000|Overall Study|Lack of Efficacy|0|||
17069641|NCT00468312|38212097|FG001|Overall Study|Lack of Efficacy|1|||
17069642|NCT00468312|38212096|FG000|Overall Study|Withdrawal by Subject|0|||
17069643|NCT00468312|38212097|FG001|Overall Study|Withdrawal by Subject|1|||
17069644|NCT00468312|38212096|FG000|Overall Study|Protocol Violation|2|||
17069645|NCT00468312|38212097|FG001|Overall Study|Protocol Violation|1|||
17069646|NCT00468312|38212096|FG000|Overall Study|Did not meet protocol eligibility|0|||
17069647|NCT00468312|38212097|FG001|Overall Study|Did not meet protocol eligibility|1|||
17069648|NCT00331864|38212105|FG000|Overall Study|Adverse Event|30|||
17069649|NCT00331864|38212106|FG001|Overall Study|Adverse Event|1|||
17069650|NCT00331864|38212105|FG000|Overall Study|Lack of Efficacy|4|||
17069651|NCT00331864|38212106|FG001|Overall Study|Lack of Efficacy|0|||
17069652|NCT00331864|38212105|FG000|Overall Study|Protocol Violation|3|||
17069653|NCT00331864|38212106|FG001|Overall Study|Protocol Violation|0|||
17069654|NCT00331864|38212105|FG000|Overall Study|Withdrawal by Subject|10|||
17069655|NCT00331864|38212106|FG001|Overall Study|Withdrawal by Subject|0|||
17069656|NCT00331864|38212105|FG000|Overall Study|Lost to Follow-up|4|||
17069657|NCT00331864|38212106|FG001|Overall Study|Lost to Follow-up|3|||
17069658|NCT00331864|38212105|FG000|Overall Study|Administrative Problems|1|||
17069659|NCT00331864|38212106|FG001|Overall Study|Administrative Problems|0|||
17069660|NCT00331864|38212105|FG000|Overall Study|Death|6|||
17069661|NCT00331864|38212106|FG001|Overall Study|Death|0|||
17069662|NCT00331630|38212112|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
17148515|NCT03498313|38293318|FG003|Washout Period 1|Withdrawal by Subject|1|||
17148516|NCT03498313|38293319|FG004|Washout Period 1|Withdrawal by Subject|0|||
17148517|NCT03498313|38293320|FG005|Washout Period 1|Withdrawal by Subject|1|||
17148518|NCT03498313|38293315|FG000|Experimental Period 2|Adverse Event|0|||
17148519|NCT03498313|38293316|FG001|Experimental Period 2|Adverse Event|0|||
17148520|NCT03498313|38293317|FG002|Experimental Period 2|Adverse Event|0|||
17069663|NCT00331630|38212112|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
17069664|NCT00331630|38212112|FG000|Follow up for 5 Years|Death|5|||
17069665|NCT00331630|38212112|FG000|Follow up for 5 Years|Data collection was stopped|24|||
17069666|NCT00331552|38212118|FG000|Period 3: Phase II|Neurological Symptoms|1|||
17069667|NCT00331552|38212119|FG001|Period 3: Phase II|Neurological Symptoms|0|||
17069668|NCT00331552|38212118|FG000|Period 3: Phase II|Severe Nausea|1|||
17069669|NCT00331552|38212119|FG001|Period 3: Phase II|Severe Nausea|0|||
17069670|NCT00317356|38212134|FG000|Overall Study|Adverse Event|0|||
17069671|NCT00317356|38212135|FG001|Overall Study|Adverse Event|0|||
17069672|NCT00317356|38212136|FG002|Overall Study|Adverse Event|1|||
17069673|NCT00317356|38212137|FG003|Overall Study|Adverse Event|0|||
17069674|NCT00317356|38212134|FG000|Overall Study|Lack of Efficacy|1|||
17069675|NCT00317356|38212135|FG001|Overall Study|Lack of Efficacy|1|||
17069676|NCT00317356|38212136|FG002|Overall Study|Lack of Efficacy|0|||
17069677|NCT00317356|38212137|FG003|Overall Study|Lack of Efficacy|3|||
17069678|NCT00317356|38212134|FG000|Overall Study|Physician Decision|0|||
17069679|NCT00317356|38212135|FG001|Overall Study|Physician Decision|1|||
17069680|NCT00317356|38212136|FG002|Overall Study|Physician Decision|0|||
17069681|NCT00317356|38212137|FG003|Overall Study|Physician Decision|0|||
17069682|NCT00331006|38212147|FG000|Screening Phase|Withdrawal by Subject|1|||
17069683|NCT00331006|38212147|FG000|Screening Phase|enrollment halted|1|||
17069684|NCT00331006|38212147|FG000|Screening Phase|Lost to Follow-up|1|||
17069685|NCT00331006|38212147|FG000|Screening Phase|Ineligible for treatment phase|4|||
17069686|NCT00331006|38212147|FG000|Treatment Phase|Withdrawal by Subject|1|||
17069687|NCT00331006|38212147|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
17069688|NCT00331006|38212147|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
17069689|NCT00302458|38212151|FG000|Overall Study|Lost to Follow-up|1|||
17069690|NCT00302458|38212151|FG000|Overall Study|Ineligible after screening|1|||
17069691|NCT00302458|38212151|FG000|Overall Study|Withdrawal by Subject|1|||
17069692|NCT00391053|38212163|FG000|Overall Study|Serious Adverse Events|1|||
17069693|NCT00391053|38212164|FG001|Overall Study|Serious Adverse Events|0|||
17069694|NCT00391053|38212165|FG002|Overall Study|Serious Adverse Events|1|||
17069695|NCT00391053|38212166|FG003|Overall Study|Serious Adverse Events|4|||
17069696|NCT00391053|38212163|FG000|Overall Study|Protocol Violation|2|||
17069697|NCT00391053|38212164|FG001|Overall Study|Protocol Violation|0|||
17069698|NCT00391053|38212165|FG002|Overall Study|Protocol Violation|0|||
17069699|NCT00391053|38212166|FG003|Overall Study|Protocol Violation|0|||
17069700|NCT00391053|38212163|FG000|Overall Study|Lost to Follow-up|1|||
17069701|NCT00391053|38212164|FG001|Overall Study|Lost to Follow-up|0|||
17069702|NCT00391053|38212165|FG002|Overall Study|Lost to Follow-up|0|||
17069703|NCT00391053|38212166|FG003|Overall Study|Lost to Follow-up|5|||
17069704|NCT00391053|38212163|FG000|Overall Study|Withdrawal by Subject|5|||
17069705|NCT00391053|38212164|FG001|Overall Study|Withdrawal by Subject|1|||
17069706|NCT00391053|38212165|FG002|Overall Study|Withdrawal by Subject|1|||
17069707|NCT00391053|38212166|FG003|Overall Study|Withdrawal by Subject|1|||
17069708|NCT00317044|38212179|FG000|Overall Study|Protocol Violation|28|||
17069709|NCT00317044|38212180|FG001|Overall Study|Protocol Violation|22|||
17069710|NCT00317044|38212181|FG002|Overall Study|Protocol Violation|20|||
17069711|NCT00317044|38212179|FG000|Overall Study|Adverse Event|4|||
17069712|NCT00317044|38212180|FG001|Overall Study|Adverse Event|7|||
17069713|NCT00317044|38212181|FG002|Overall Study|Adverse Event|4|||
17069714|NCT00317044|38212179|FG000|Overall Study|Withdrawal by Subject|10|||
17069715|NCT00317044|38212180|FG001|Overall Study|Withdrawal by Subject|7|||
17069716|NCT00317044|38212181|FG002|Overall Study|Withdrawal by Subject|12|||
17069717|NCT00317044|38212179|FG000|Overall Study|Lost to Follow-up|0|||
17069718|NCT00317044|38212180|FG001|Overall Study|Lost to Follow-up|2|||
17069719|NCT00317044|38212181|FG002|Overall Study|Lost to Follow-up|3|||
17069720|NCT00317044|38212179|FG000|Overall Study|Multiple Reasons|6|||
17069721|NCT00317044|38212180|FG001|Overall Study|Multiple Reasons|2|||
17069722|NCT00317044|38212181|FG002|Overall Study|Multiple Reasons|6|||
17069723|NCT00301834|38212189|FG000|Overall Study|Death|1|||
17069724|NCT00301366|38212196|FG000|Overall Study|Adverse Event|1|||
17069725|NCT00330928|38212200|FG000|Overall Study|Lost to Follow-up|6|||
17069726|NCT00330928|38212200|FG000|Overall Study|Physician Decision|9|||
17069727|NCT00330928|38212200|FG000|Overall Study|Death|1|||
17069728|NCT00330928|38212200|FG000|Overall Study|IVUS could not be performed.|1|||
17069729|NCT00330616|38212204|FG000|Overall Study|Adverse Event|13|||
17069730|NCT00330616|38212204|FG000|Overall Study|Lack of Efficacy|1|||
17069731|NCT00330616|38212204|FG000|Overall Study|Lost to Follow-up|2|||
17069732|NCT00330616|38212204|FG000|Overall Study|Withdrawal by Subject|4|||
17069733|NCT00330616|38212204|FG000|Overall Study|Other|1|||
17069734|NCT00466440|38212211|FG000|Overall Study|Adverse Event|0|||
17148521|NCT03498313|38293318|FG003|Experimental Period 2|Adverse Event|0|||
17069735|NCT00466440|38212212|FG001|Overall Study|Adverse Event|3|||
17069736|NCT00466440|38212213|FG002|Overall Study|Adverse Event|1|||
17069737|NCT00466440|38212211|FG000|Overall Study|Death|1|||
17069738|NCT00466440|38212212|FG001|Overall Study|Death|1|||
17069739|NCT00466440|38212213|FG002|Overall Study|Death|0|||
17069740|NCT00466440|38212211|FG000|Overall Study|Progressive disease|13|||
17069741|NCT00466440|38212212|FG001|Overall Study|Progressive disease|5|||
17069742|NCT00466440|38212213|FG002|Overall Study|Progressive disease|4|||
17069743|NCT00466440|38212211|FG000|Overall Study|Lost to Follow-up|0|||
17069744|NCT00466440|38212212|FG001|Overall Study|Lost to Follow-up|1|||
17069745|NCT00466440|38212213|FG002|Overall Study|Lost to Follow-up|0|||
17069746|NCT00466440|38212211|FG000|Overall Study|Physician Decision|0|||
17069747|NCT00466440|38212212|FG001|Overall Study|Physician Decision|1|||
17069748|NCT00466440|38212213|FG002|Overall Study|Physician Decision|2|||
17069749|NCT00466440|38212211|FG000|Overall Study|Protocol entry criteria not met|0|||
17069750|NCT00466440|38212212|FG001|Overall Study|Protocol entry criteria not met|0|||
17069751|NCT00466440|38212213|FG002|Overall Study|Protocol entry criteria not met|4|||
17069752|NCT00466440|38212211|FG000|Overall Study|Withdrawal by Subject|0|||
17069753|NCT00466440|38212212|FG001|Overall Study|Withdrawal by Subject|1|||
17069754|NCT00466440|38212213|FG002|Overall Study|Withdrawal by Subject|0|||
17069755|NCT00466440|38212211|FG000|Overall Study|Sponsor decision|0|||
17069756|NCT00466440|38212212|FG001|Overall Study|Sponsor decision|0|||
17069757|NCT00466440|38212213|FG002|Overall Study|Sponsor decision|1|||
17069758|NCT00465972|38212232|FG000|Overall Study|Withdrawal by Subject|2|||
17069759|NCT00465972|38212233|FG001|Overall Study|Withdrawal by Subject|1|||
17069760|NCT00465894|38212243|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
17069761|NCT00465894|38212244|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
17069762|NCT00465894|38212243|FG000|Treatment For 12 Weeks|Family Issues|1|||
17069763|NCT00465894|38212244|FG001|Treatment For 12 Weeks|Family Issues|1|||
17069764|NCT00465894|38212243|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
17069765|NCT00465894|38212244|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
17069766|NCT00330460|38212268|FG000|Overall Study|Physician Decision|1|||
17069767|NCT00330460|38212269|FG001|Overall Study|Physician Decision|0|||
17069768|NCT00330460|38212268|FG000|Overall Study|Adverse Event|10|||
17069769|NCT00330460|38212269|FG001|Overall Study|Adverse Event|8|||
17069770|NCT00330460|38212268|FG000|Overall Study|Withdrawal by Subject|18|||
17069771|NCT00330460|38212269|FG001|Overall Study|Withdrawal by Subject|17|||
17069772|NCT00330460|38212268|FG000|Overall Study|Death|1|||
17069773|NCT00330460|38212269|FG001|Overall Study|Death|1|||
17069774|NCT00330460|38212268|FG000|Overall Study|Ineligibility determined|1|||
17069775|NCT00330460|38212269|FG001|Overall Study|Ineligibility determined|3|||
17069776|NCT00330460|38212268|FG000|Overall Study|Lost to Follow-up|8|||
17069777|NCT00330460|38212269|FG001|Overall Study|Lost to Follow-up|3|||
17069778|NCT00330460|38212268|FG000|Overall Study|Noncompliance|2|||
17069779|NCT00330460|38212269|FG001|Overall Study|Noncompliance|1|||
17069780|NCT00330460|38212268|FG000|Overall Study|Other|1|||
17069781|NCT00330460|38212269|FG001|Overall Study|Other|0|||
17069782|NCT00454116|38212278|FG000|Overall Study|Adverse Event|5|||
17069783|NCT00454116|38212279|FG001|Overall Study|Adverse Event|11|||
17069784|NCT00454116|38212280|FG002|Overall Study|Adverse Event|9|||
17069785|NCT00454116|38212278|FG000|Overall Study|Condition under investigation worsened|17|||
17069786|NCT00454116|38212279|FG001|Overall Study|Condition under investigation worsened|13|||
17069787|NCT00454116|38212280|FG002|Overall Study|Condition under investigation worsened|18|||
17069788|NCT00454116|38212278|FG000|Overall Study|Withdrawal by Subject|3|||
17069789|NCT00454116|38212279|FG001|Overall Study|Withdrawal by Subject|3|||
17069790|NCT00454116|38212280|FG002|Overall Study|Withdrawal by Subject|1|||
17069791|NCT00454116|38212278|FG000|Overall Study|Other|2|||
17069792|NCT00454116|38212279|FG001|Overall Study|Other|2|||
17069793|NCT00454116|38212280|FG002|Overall Study|Other|0|||
17069794|NCT00465816|38212291|FG000|Overall Study|Lost to Follow-up|0|||
17069795|NCT00465816|38212292|FG001|Overall Study|Lost to Follow-up|0|||
17069796|NCT00465816|38212293|FG002|Overall Study|Lost to Follow-up|2|||
17069797|NCT00465738|38212304|FG000|Overall Study|Lost to Follow-up|2|||
17069798|NCT00465738|38212305|FG001|Overall Study|Lost to Follow-up|0|||
17069799|NCT00465738|38212304|FG000|Overall Study|Adverse Event|0|||
17069800|NCT00465738|38212305|FG001|Overall Study|Adverse Event|1|||
17069801|NCT00465738|38212304|FG000|Overall Study|Withdrawal by Subject|2|||
17069802|NCT00465738|38212305|FG001|Overall Study|Withdrawal by Subject|0|||
17069803|NCT00465738|38212304|FG000|Overall Study|Other|2|||
17069804|NCT00465738|38212305|FG001|Overall Study|Other|5|||
17069805|NCT00400179|38212313|FG000|Overall Study|Adverse Event|2|||
17069806|NCT00400179|38212314|FG001|Overall Study|Adverse Event|2|||
17069807|NCT00400179|38212313|FG000|Overall Study|Death|1|||
17069808|NCT00400179|38212314|FG001|Overall Study|Death|2|||
17069809|NCT00400179|38212313|FG000|Overall Study|Withdrew Consent|1|||
17069810|NCT00400179|38212314|FG001|Overall Study|Withdrew Consent|5|||
17069811|NCT00400179|38212313|FG000|Overall Study|Disease progression|1|||
17069812|NCT00400179|38212314|FG001|Overall Study|Disease progression|1|||
17069813|NCT00400179|38212313|FG000|Overall Study|Intercurrent illness|0|||
17069814|NCT00400179|38212314|FG001|Overall Study|Intercurrent illness|1|||
17069815|NCT00400179|38212313|FG000|Overall Study|Investigator judgment|0|||
17069816|NCT00400179|38212314|FG001|Overall Study|Investigator judgment|1|||
17069817|NCT00400179|38212313|FG000|Overall Study|Randomization error/patient ineligible|1|||
17069818|NCT00400179|38212314|FG001|Overall Study|Randomization error/patient ineligible|6|||
17069819|NCT00465270|38212322|FG000|Overall Study|Death|7|||
17069820|NCT00465270|38212323|FG001|Overall Study|Death|11|||
17069821|NCT00465270|38212322|FG000|Overall Study|Withdrawal by Subject|34|||
17069822|NCT00465270|38212323|FG001|Overall Study|Withdrawal by Subject|78|||
17069823|NCT00465270|38212322|FG000|Overall Study|Lost to Follow-up|60|||
17069824|NCT00465270|38212323|FG001|Overall Study|Lost to Follow-up|67|||
17069825|NCT00465270|38212322|FG000|Overall Study|Investigator request|3|||
17069826|NCT00465270|38212323|FG001|Overall Study|Investigator request|4|||
17069827|NCT00464568|38212329|FG000|Overall Study|Adverse Event|2|||
17069828|NCT00464490|38212348|FG000|Overall Study|Physician Decision|11|||
17069829|NCT00464490|38212349|FG001|Overall Study|Physician Decision|11|||
17069830|NCT03849300|38212359|FG000|Overall Study|move out to different area|1|||
17069831|NCT03849300|38212360|FG001|Overall Study|move out to different area|3|||
17069832|NCT03849300|38212361|FG002|Overall Study|move out to different area|1|||
17069833|NCT03849300|38212362|FG003|Overall Study|move out to different area|4|||
17069834|NCT03849300|38212359|FG000|Overall Study|scheduling/transportation conflict|4|||
17069835|NCT03849300|38212360|FG001|Overall Study|scheduling/transportation conflict|4|||
17069836|NCT03849300|38212361|FG002|Overall Study|scheduling/transportation conflict|3|||
17069837|NCT03849300|38212362|FG003|Overall Study|scheduling/transportation conflict|2|||
17069838|NCT00412893|38212376|FG000|Overall Study|Adverse Event|31|||
17069839|NCT00412893|38212377|FG001|Overall Study|Adverse Event|53|||
17069840|NCT00412893|38212376|FG000|Overall Study|Death|17|||
17069841|NCT00412893|38212377|FG001|Overall Study|Death|21|||
17069842|NCT00412893|38212376|FG000|Overall Study|Insufficient Therapeutic Response|39|||
17069843|NCT00412893|38212377|FG001|Overall Study|Insufficient Therapeutic Response|23|||
17069844|NCT00412893|38212376|FG000|Overall Study|Lost to Follow-up|2|||
17069845|NCT00412893|38212377|FG001|Overall Study|Lost to Follow-up|1|||
17069846|NCT00412893|38212376|FG000|Overall Study|Violation of Selection at Entry|17|||
17069847|NCT00412893|38212377|FG001|Overall Study|Violation of Selection at Entry|10|||
17069848|NCT00412893|38212376|FG000|Overall Study|Other Protocol Violation|10|||
17069849|NCT00412893|38212377|FG001|Overall Study|Other Protocol Violation|6|||
17069850|NCT00412893|38212376|FG000|Overall Study|Did Not Cooperate|12|||
17069851|NCT00412893|38212377|FG001|Overall Study|Did Not Cooperate|9|||
17069852|NCT00412893|38212376|FG000|Overall Study|Administrative Reason|12|||
17069853|NCT00412893|38212377|FG001|Overall Study|Administrative Reason|15|||
17069854|NCT00412893|38212376|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
17069855|NCT00412893|38212377|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
17069856|NCT00412737|38212385|FG000|Overall Study|Death|1|||
17069857|NCT00412737|38212386|FG001|Overall Study|Death|0|||
17069858|NCT00412737|38212385|FG000|Overall Study|Adverse Event|3|||
17069859|NCT00412737|38212386|FG001|Overall Study|Adverse Event|2|||
17069860|NCT00412737|38212385|FG000|Overall Study|Refused Treatment|6|||
17069861|NCT00412737|38212386|FG001|Overall Study|Refused Treatment|2|||
17069862|NCT00412737|38212385|FG000|Overall Study|Failure to Return|6|||
17069863|NCT00412737|38212386|FG001|Overall Study|Failure to Return|2|||
17148522|NCT03498313|38293319|FG004|Experimental Period 2|Adverse Event|1|||
17148523|NCT03498313|38293320|FG005|Experimental Period 2|Adverse Event|2|||
17069864|NCT00508742|38212394|FG000|Period 1: Infant Series|Adverse Event|5|||
17069865|NCT00508742|38212395|FG001|Period 1: Infant Series|Adverse Event|4|||
17069866|NCT00508742|38212394|FG000|Period 1: Infant Series|Protocol Violation|1|||
17069867|NCT00508742|38212395|FG001|Period 1: Infant Series|Protocol Violation|0|||
17069868|NCT00508742|38212394|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
17069869|NCT00508742|38212395|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
17069870|NCT00508742|38212394|FG000|Period 1: Infant Series|Physician Decision|1|||
17069871|NCT00508742|38212395|FG001|Period 1: Infant Series|Physician Decision|0|||
17069872|NCT00508742|38212394|FG000|Period 1: Infant Series|Other|4|||
17069873|NCT00508742|38212395|FG001|Period 1: Infant Series|Other|1|||
17069874|NCT00508742|38212394|FG000|Period 2: After Infant Series|Adverse Event|2|||
17069875|NCT00508742|38212395|FG001|Period 2: After Infant Series|Adverse Event|6|||
17069876|NCT00508742|38212394|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
17069877|NCT00508742|38212395|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
17148524|NCT03498313|38293315|FG000|Washout Period 2|Physician Decision|1|||
17148525|NCT03498313|38293316|FG001|Washout Period 2|Physician Decision|0|||
17148526|NCT03498313|38293317|FG002|Washout Period 2|Physician Decision|0|||
17148527|NCT03498313|38293318|FG003|Washout Period 2|Physician Decision|1|||
17148528|NCT03498313|38293319|FG004|Washout Period 2|Physician Decision|0|||
17148529|NCT03498313|38293320|FG005|Washout Period 2|Physician Decision|1|||
17148530|NCT03498313|38293315|FG000|Washout Period 2|Withdrawal by Subject|3|||
17148531|NCT03498313|38293316|FG001|Washout Period 2|Withdrawal by Subject|2|||
17148532|NCT03498313|38293317|FG002|Washout Period 2|Withdrawal by Subject|0|||
17148533|NCT03498313|38293318|FG003|Washout Period 2|Withdrawal by Subject|0|||
17148534|NCT03498313|38293319|FG004|Washout Period 2|Withdrawal by Subject|2|||
17148535|NCT03498313|38293320|FG005|Washout Period 2|Withdrawal by Subject|0|||
17148536|NCT03498313|38293315|FG000|Washout Period 2|Anovulation|0|||
17148537|NCT03498313|38293316|FG001|Washout Period 2|Anovulation|0|||
17148538|NCT03498313|38293317|FG002|Washout Period 2|Anovulation|0|||
17148539|NCT03498313|38293318|FG003|Washout Period 2|Anovulation|0|||
17148540|NCT03498313|38293319|FG004|Washout Period 2|Anovulation|0|||
17148541|NCT03498313|38293320|FG005|Washout Period 2|Anovulation|1|||
17148542|NCT02601014|38293330|FG000|Overall Study|Adverse Event|3|||
17148543|NCT02601014|38293331|FG001|Overall Study|Adverse Event|3|||
17148544|NCT02601014|38293330|FG000|Overall Study|Death|3|||
17148545|NCT02601014|38293331|FG001|Overall Study|Death|1|||
17148546|NCT02601014|38293330|FG000|Overall Study|Disease progression|4|||
17148547|NCT02601014|38293331|FG001|Overall Study|Disease progression|8|||
17148548|NCT01307046|38293339|FG000|Overall Study|Adverse Event|3|||
17148549|NCT01307046|38293340|FG001|Overall Study|Adverse Event|3|||
17148550|NCT01307046|38293339|FG000|Overall Study|Lack of Efficacy|0|||
17148551|NCT01307046|38293340|FG001|Overall Study|Lack of Efficacy|2|||
17148552|NCT01307046|38293339|FG000|Overall Study|Physician Decision|2|||
17148553|NCT01307046|38293340|FG001|Overall Study|Physician Decision|0|||
17148554|NCT01307046|38293339|FG000|Overall Study|Withdrawal by Subject|1|||
17148555|NCT01307046|38293340|FG001|Overall Study|Withdrawal by Subject|1|||
17148556|NCT01307046|38293339|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
17148557|NCT01307046|38293340|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
17148558|NCT01307046|38293339|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
17148559|NCT01307046|38293340|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
17148560|NCT03495817|38293346|FG000|26 Week Open Label|Adverse Event|3|||
17148561|NCT03495817|38293346|FG000|26 Week Open Label|Withdrawal by Subject|4|||
17148562|NCT03495817|38293346|FG000|26 Week Open Label|Lost to Follow-up|1|||
17148563|NCT03495817|38293346|FG000|26 Week Extension|Lost to Follow-up|2|||
17148564|NCT02886624|38293350|FG000|12-week Post Treatment Follow-up|Death|1|||
17148565|NCT02886624|38293350|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
17148566|NCT02963766|38293357|FG000|Double-Blind Period|Adverse Event|1|||
17148567|NCT02963766|38293358|FG001|Double-Blind Period|Adverse Event|0|||
17148568|NCT02963766|38293359|FG002|Double-Blind Period|Adverse Event|1|||
17148569|NCT02963766|38293357|FG000|Double-Blind Period|Physician Decision|1|||
17148570|NCT02963766|38293358|FG001|Double-Blind Period|Physician Decision|0|||
17148571|NCT02963766|38293359|FG002|Double-Blind Period|Physician Decision|0|||
17148572|NCT02963766|38293357|FG000|Double-Blind Period|Withdrawal by Subject|1|||
17148573|NCT02963766|38293358|FG001|Double-Blind Period|Withdrawal by Subject|1|||
17148574|NCT02963766|38293359|FG002|Double-Blind Period|Withdrawal by Subject|0|||
17148575|NCT02963766|38293357|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
17148576|NCT02963766|38293358|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
17148577|NCT02963766|38293359|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
17148578|NCT02963766|38293357|FG000|Double-Blind Period|Protocol Violation|1|||
17148579|NCT02963766|38293358|FG001|Double-Blind Period|Protocol Violation|0|||
17148580|NCT02963766|38293359|FG002|Double-Blind Period|Protocol Violation|0|||
17148581|NCT02963766|38293357|FG000|Double-Blind Period|Lost to Follow-up|0|||
17148582|NCT02963766|38293358|FG001|Double-Blind Period|Lost to Follow-up|1|||
17148583|NCT02963766|38293359|FG002|Double-Blind Period|Lost to Follow-up|0|||
17148584|NCT02963766|38293357|FG000|Open Label Extension (OLE)|Physician Decision|1|||
17148585|NCT02963766|38293358|FG001|Open Label Extension (OLE)|Physician Decision|2|||
17148586|NCT02963766|38293359|FG002|Open Label Extension (OLE)|Physician Decision|2|||
17148587|NCT02963766|38293357|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
17148588|NCT02963766|38293358|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
17148589|NCT02963766|38293359|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
17148590|NCT04839965|38293379|FG000|Overall Study|Death|6|||
17148591|NCT04839965|38293380|FG001|Overall Study|Death|6|||
17148592|NCT04839965|38293379|FG000|Overall Study|Lost to Follow-up|1|||
17148593|NCT04839965|38293380|FG001|Overall Study|Lost to Follow-up|0|||
17148594|NCT03466099|38293389|FG000|Overall Study|Adverse Event|1|||
17148595|NCT03466099|38293390|FG001|Overall Study|Adverse Event|1|||
17148596|NCT03466099|38293391|FG002|Overall Study|Adverse Event|1|||
17148597|NCT03466099|38293389|FG000|Overall Study|Withdrawal by Subject|2|||
17148598|NCT03466099|38293390|FG001|Overall Study|Withdrawal by Subject|3|||
17148599|NCT03466099|38293391|FG002|Overall Study|Withdrawal by Subject|1|||
17148600|NCT03466099|38293389|FG000|Overall Study|Use of rescue medication|8|||
17148601|NCT03466099|38293390|FG001|Overall Study|Use of rescue medication|9|||
17148602|NCT03466099|38293391|FG002|Overall Study|Use of rescue medication|13|||
17148603|NCT03466099|38293389|FG000|Overall Study|Rescued without meeting criteria|4|||
17148604|NCT03466099|38293390|FG001|Overall Study|Rescued without meeting criteria|1|||
17148605|NCT03466099|38293391|FG002|Overall Study|Rescued without meeting criteria|1|||
17148606|NCT03466099|38293389|FG000|Overall Study|Subject compliance|2|||
17148607|NCT03466099|38293390|FG001|Overall Study|Subject compliance|0|||
17148608|NCT03466099|38293391|FG002|Overall Study|Subject compliance|0|||
17148609|NCT03466099|38293389|FG000|Overall Study|Worsening disease|0|||
17148610|NCT03466099|38293390|FG001|Overall Study|Worsening disease|0|||
17148611|NCT03466099|38293391|FG002|Overall Study|Worsening disease|1|||
17148612|NCT00739674|38293401|FG000|Overall Study|Screening failures|19|||
17148613|NCT00739674|38293402|FG001|Overall Study|Screening failures|17|||
17148614|NCT00739674|38293401|FG000|Overall Study|Site 212 removal|19|||
17148615|NCT00739674|38293402|FG001|Overall Study|Site 212 removal|13|||
17148616|NCT00739674|38293401|FG000|Overall Study|No follow-up data|33|||
17148617|NCT00739674|38293402|FG001|Overall Study|No follow-up data|18|||
17148618|NCT00739674|38293401|FG000|Overall Study|Dietician consultation >30 days|1|||
17148619|NCT00739674|38293402|FG001|Overall Study|Dietician consultation >30 days|9|||
17148620|NCT00739674|38293401|FG000|Overall Study|Adverse Event|22|||
17148621|NCT00739674|38293402|FG001|Overall Study|Adverse Event|13|||
17148622|NCT00739674|38293401|FG000|Overall Study|Death|1|||
17148623|NCT00739674|38293402|FG001|Overall Study|Death|0|||
17148624|NCT00739674|38293401|FG000|Overall Study|Lack of Efficacy|1|||
17148625|NCT00739674|38293402|FG001|Overall Study|Lack of Efficacy|0|||
17148626|NCT00739674|38293401|FG000|Overall Study|Lost to Follow-up|52|||
17148627|NCT00739674|38293402|FG001|Overall Study|Lost to Follow-up|30|||
17148628|NCT00739674|38293401|FG000|Overall Study|Protocol Violation|5|||
17148629|NCT00739674|38293402|FG001|Overall Study|Protocol Violation|5|||
17148630|NCT00739674|38293401|FG000|Overall Study|Withdrawal by Subject|9|||
17148631|NCT00739674|38293402|FG001|Overall Study|Withdrawal by Subject|9|||
17148632|NCT00739674|38293401|FG000|Overall Study|Reason missing|2|||
17148633|NCT00739674|38293402|FG001|Overall Study|Reason missing|0|||
17148634|NCT00739674|38293401|FG000|Overall Study|Clinic closed|6|||
17148635|NCT00739674|38293402|FG001|Overall Study|Clinic closed|4|||
17148636|NCT00739674|38293401|FG000|Overall Study|Patient moved|3|||
17148637|NCT00739674|38293402|FG001|Overall Study|Patient moved|2|||
17148638|NCT00739674|38293401|FG000|Overall Study|Non compliant|4|||
17148639|NCT00739674|38293402|FG001|Overall Study|Non compliant|0|||
17148640|NCT00739674|38293401|FG000|Overall Study|Unable to attend visit|3|||
17148641|NCT00739674|38293402|FG001|Overall Study|Unable to attend visit|1|||
17148642|NCT00739674|38293401|FG000|Overall Study|Home monitoring off meds|1|||
17148643|NCT00739674|38293402|FG001|Overall Study|Home monitoring off meds|0|||
17148644|NCT00739674|38293401|FG000|Overall Study|Erectile dysfunction|0|||
17148645|NCT00739674|38293402|FG001|Overall Study|Erectile dysfunction|1|||
17148646|NCT03494725|38293410|FG000|Overall Study|Withdrawal by Subject|0|||
17148647|NCT03494725|38293411|FG001|Overall Study|Withdrawal by Subject|2|||
17148648|NCT03494725|38293410|FG000|Overall Study|Antibiotic use|1|||
17148649|NCT03494725|38293411|FG001|Overall Study|Antibiotic use|0|||
17148650|NCT00705718|38293425|FG000|Overall Study|Death|6|||
17148651|NCT00705718|38293426|FG001|Overall Study|Death|6|||
17148652|NCT00705718|38293425|FG000|Overall Study|Not due for Visit|0|||
17148653|NCT00705718|38293426|FG001|Overall Study|Not due for Visit|12|||
17148654|NCT00705718|38293425|FG000|Overall Study|Follow up not done|1|||
17148655|NCT00705718|38293426|FG001|Overall Study|Follow up not done|4|||
17148656|NCT03435211|38293441|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
17148657|NCT03465709|38293454|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
17148658|NCT03465709|38293454|FG000|Overall Study|Withdrawal by Subject|3|||
17148659|NCT03435055|38293460|FG000|Screening|Physician Decision|2|||
17148660|NCT03435055|38293460|FG000|Received Intervention|Did not complete nitrous administration|3|||
17148661|NCT03434977|38293473|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
17148662|NCT03434977|38293474|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
17148663|NCT03434119|38293482|FG000|Overall Study|Randomized but not treated|1|||
17148664|NCT03434119|38293483|FG001|Overall Study|Randomized but not treated|0|||
17148665|NCT03434119|38293482|FG000|Overall Study|Adverse Event|1|||
17148666|NCT03434119|38293483|FG001|Overall Study|Adverse Event|0|||
17148667|NCT03434119|38293482|FG000|Overall Study|Poor Compliance to Protocol|0|||
17148668|NCT03434119|38293483|FG001|Overall Study|Poor Compliance to Protocol|1|||
17148669|NCT03434119|38293482|FG000|Overall Study|Study Terminated by Sponsor|91|||
17148670|NCT03434119|38293483|FG001|Overall Study|Study Terminated by Sponsor|102|||
17148671|NCT03434119|38293482|FG000|Overall Study|Withdrawal by Subject|7|||
17148672|NCT03434119|38293483|FG001|Overall Study|Withdrawal by Subject|5|||
17148673|NCT03434119|38293482|FG000|Overall Study|Other than specified|7|||
17148674|NCT03434119|38293483|FG001|Overall Study|Other than specified|5|||
17148675|NCT00378378|38293492|FG000|Overall Study|Withdrawal by Subject|0|||
17148676|NCT00378378|38293493|FG001|Overall Study|Withdrawal by Subject|1|||
17148677|NCT00378378|38293494|FG002|Overall Study|Withdrawal by Subject|0|||
17148678|NCT00378378|38293492|FG000|Overall Study|Treatment Failure|0|||
17148679|NCT00378378|38293493|FG001|Overall Study|Treatment Failure|0|||
17148680|NCT00378378|38293494|FG002|Overall Study|Treatment Failure|1|||
17148681|NCT00378378|38293492|FG000|Overall Study|Non-compliance with protocol|0|||
17148682|NCT00378378|38293493|FG001|Overall Study|Non-compliance with protocol|0|||
17148683|NCT00378378|38293494|FG002|Overall Study|Non-compliance with protocol|1|||
17148684|NCT03490981|38293504|FG000|Overall Study|Lost to Follow-up|1|||
17148685|NCT03490981|38293505|FG001|Overall Study|Lost to Follow-up|2|||
17148686|NCT03160716|38293511|FG000|Overall Study|Lost to Follow-up|1|||
17148687|NCT03713021|38293515|FG000|Overall Study|Did not have CT sim scan available|6|||
17148688|NCT03713021|38293515|FG000|Overall Study|Not eligible|4|||
17148689|NCT03713021|38293515|FG000|Overall Study|Issues with TraceIT markers|5|||
17148690|NCT03160560|38293523|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
17148691|NCT03160560|38293524|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
17148692|NCT03160560|38293525|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
17148693|NCT03160560|38293526|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
17148694|NCT03160560|38293523|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
17148695|NCT03160560|38293524|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
17148696|NCT03160560|38293525|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
17148697|NCT03160560|38293526|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
17148698|NCT03489343|38293543|FG000|Overall Study|Documented progressive disease|1|||
17148699|NCT03489343|38293544|FG001|Overall Study|Documented progressive disease|0|||
17148700|NCT03489343|38293545|FG002|Overall Study|Documented progressive disease|3|||
17148701|NCT03489343|38293546|FG003|Overall Study|Documented progressive disease|1|||
17148702|NCT03489343|38293547|FG004|Overall Study|Documented progressive disease|3|||
17148703|NCT03489343|38293548|FG005|Overall Study|Documented progressive disease|5|||
17148704|NCT03489343|38293549|FG006|Overall Study|Documented progressive disease|4|||
17148705|NCT03489343|38293543|FG000|Overall Study|Adverse Event|0|||
17148706|NCT03489343|38293544|FG001|Overall Study|Adverse Event|1|||
17148707|NCT03489343|38293545|FG002|Overall Study|Adverse Event|0|||
17148708|NCT03489343|38293546|FG003|Overall Study|Adverse Event|0|||
17148709|NCT03489343|38293547|FG004|Overall Study|Adverse Event|0|||
17148710|NCT03489343|38293548|FG005|Overall Study|Adverse Event|1|||
17148711|NCT03489343|38293549|FG006|Overall Study|Adverse Event|0|||
17148712|NCT03489343|38293543|FG000|Overall Study|Withdrawal by Subject|0|||
17148713|NCT03489343|38293544|FG001|Overall Study|Withdrawal by Subject|0|||
17148714|NCT03489343|38293545|FG002|Overall Study|Withdrawal by Subject|0|||
17069878|NCT00508742|38212394|FG000|Period 2: After Infant Series|Protocol Violation|1|||
17069879|NCT00508742|38212395|FG001|Period 2: After Infant Series|Protocol Violation|0|||
17069880|NCT00508742|38212394|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
17069881|NCT00508742|38212395|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
17069882|NCT00508742|38212394|FG000|Period 2: After Infant Series|Failed to Return|1|||
17069883|NCT00508742|38212395|FG001|Period 2: After Infant Series|Failed to Return|0|||
17069884|NCT00508742|38212394|FG000|Period 2: After Infant Series|Other|2|||
17069885|NCT00508742|38212395|FG001|Period 2: After Infant Series|Other|1|||
17069886|NCT00508742|38212394|FG000|Period 3: Toddler Dose|Adverse Event|1|||
17069887|NCT00508742|38212395|FG001|Period 3: Toddler Dose|Adverse Event|0|||
17069888|NCT00508742|38212394|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
17069889|NCT00508742|38212395|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
17069890|NCT00508742|38212394|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
17069891|NCT00508742|38212395|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
17069892|NCT00508742|38212394|FG000|Period 3: Toddler Dose|Other|5|||
17069893|NCT00508742|38212395|FG001|Period 3: Toddler Dose|Other|4|||
17069894|NCT00508274|38212416|FG000|Overall Study|Adverse Event|5|||
17069895|NCT00508274|38212416|FG000|Overall Study|Death|7|||
17069896|NCT00508274|38212416|FG000|Overall Study|Disease progression|32|||
17069897|NCT00508274|38212416|FG000|Overall Study|Withdrawal by Subject|1|||
17069898|NCT00508274|38212416|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
17148715|NCT03489343|38293546|FG003|Overall Study|Withdrawal by Subject|1|||
17148716|NCT03489343|38293547|FG004|Overall Study|Withdrawal by Subject|0|||
17148717|NCT03489343|38293548|FG005|Overall Study|Withdrawal by Subject|1|||
17148718|NCT03489343|38293549|FG006|Overall Study|Withdrawal by Subject|1|||
17069899|NCT00508274|38212416|FG000|Overall Study|Missing|3|||
17069900|NCT00499460|38212422|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
17069901|NCT00499460|38212423|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
17069902|NCT00499460|38212422|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
17069903|NCT00499460|38212423|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
17069904|NCT00499460|38212422|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
17069905|NCT00499460|38212423|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
17069906|NCT00412113|38212441|FG000|Overall Study|Adverse Event|11|||
17069907|NCT00412113|38212442|FG001|Overall Study|Adverse Event|15|||
17148719|NCT03489343|38293543|FG000|Overall Study|Clinical progression|0|||
17148720|NCT03489343|38293544|FG001|Overall Study|Clinical progression|0|||
17148721|NCT03489343|38293545|FG002|Overall Study|Clinical progression|0|||
17148722|NCT03489343|38293546|FG003|Overall Study|Clinical progression|1|||
17148723|NCT03489343|38293547|FG004|Overall Study|Clinical progression|0|||
17148724|NCT03489343|38293548|FG005|Overall Study|Clinical progression|0|||
17148725|NCT03489343|38293549|FG006|Overall Study|Clinical progression|1|||
17148726|NCT03489109|38293567|FG000|Overall Study|Lost to Follow-up|1|||
17148727|NCT03489109|38293568|FG001|Overall Study|Lost to Follow-up|2|||
17069908|NCT00412113|38212441|FG000|Overall Study|did not receive treatment|1|||
17069909|NCT00412113|38212442|FG001|Overall Study|did not receive treatment|0|||
17069910|NCT00411645|38212450|FG000|Overall Study|Consent Withdrawn|13|||
17069911|NCT00411645|38212451|FG001|Overall Study|Consent Withdrawn|22|||
17069912|NCT00411645|38212450|FG000|Overall Study|Death|56|||
17069913|NCT00411645|38212451|FG001|Overall Study|Death|135|||
17069914|NCT00411645|38212450|FG000|Overall Study|Investigator/Sponsor Decision|10|||
17069915|NCT00411645|38212451|FG001|Overall Study|Investigator/Sponsor Decision|7|||
17069916|NCT00411645|38212450|FG000|Overall Study|Lost to Follow-up|2|||
17148728|NCT03709823|38293580|FG000|Overall Study|Adverse Event|0|||
17148729|NCT03709823|38293581|FG001|Overall Study|Adverse Event|0|||
17069917|NCT00411645|38212451|FG001|Overall Study|Lost to Follow-up|0|||
17069918|NCT00490724|38212461|FG000|Period I|Physician Decision|0|||
17069919|NCT00490724|38212462|FG001|Period I|Physician Decision|0|||
17069920|NCT00490724|38212463|FG002|Period I|Physician Decision|1|||
17069921|NCT00490724|38212461|FG000|Period II|Treatment Discontinuation|3|||
17069922|NCT00490724|38212462|FG001|Period II|Treatment Discontinuation|1|||
17069923|NCT00490724|38212463|FG002|Period II|Treatment Discontinuation|3|||
17069924|NCT03835221|38212471|FG000|Methafilcon A|Withdrawal by Subject|1|||
17069925|NCT00398073|38212479|FG000|Overall Study|Withdrawal by Subject|1|||
17069926|NCT00398073|38212480|FG001|Overall Study|Withdrawal by Subject|0|||
17069927|NCT00490646|38212488|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
17069928|NCT00490646|38212489|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
17069929|NCT00490646|38212488|FG000|Overall Study|Never Treated (had an adverse event)|1|||
17069930|NCT00490646|38212489|FG001|Overall Study|Never Treated (had an adverse event)|0|||
17069931|NCT00490646|38212488|FG000|Overall Study|Never Treated (withdrew consent)|0|||
17069932|NCT00490646|38212489|FG001|Overall Study|Never Treated (withdrew consent)|1|||
17069933|NCT00388947|38212495|FG000|Overall Study|Protocol Violation|47|||
17069934|NCT00490568|38212499|FG000|Overall Study|Adverse Event|116|||
17069935|NCT00490568|38212499|FG000|Overall Study|Lost to Follow-up|13|||
17069936|NCT00490568|38212499|FG000|Overall Study|Protocol Violation|45|||
17069937|NCT00490568|38212499|FG000|Overall Study|Withdrawal by Subject|135|||
17069938|NCT00490568|38212499|FG000|Overall Study|Still in the study at termination|974|||
17069939|NCT00490568|38212499|FG000|Overall Study|Other|1|||
17069940|NCT00490568|38212499|FG000|Overall Study|Exclusion criteria met|1|||
17069941|NCT00490568|38212499|FG000|Overall Study|Caregiver related|20|||
17069942|NCT00490568|38212499|FG000|Overall Study|Abnormal ECG|25|||
17069943|NCT00490568|38212499|FG000|Overall Study|Participant refused follow-up|9|||
17069944|NCT00490568|38212499|FG000|Overall Study|Legal representative withdrew consent|1|||
17069945|NCT00490568|38212499|FG000|Overall Study|Disease progression|4|||
17069946|NCT00490568|38212499|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
17069947|NCT00490568|38212499|FG000|Overall Study|Investigator decision|3|||
17069948|NCT00490568|38212499|FG000|Overall Study|Non-Compliance|7|||
17069949|NCT00490568|38212499|FG000|Overall Study|Efficacy related|3|||
17069950|NCT00490568|38212499|FG000|Overall Study|Participant died|1|||
17069951|NCT00490568|38212499|FG000|Overall Study|Participant withdrawal due to surgery|1|||
17069952|NCT00561353|38212514|FG000|Overall Study|Subject reached a virologic endpoint|2|||
17069953|NCT00561353|38212515|FG001|Overall Study|Subject reached a virologic endpoint|1|||
17069954|NCT00561353|38212516|FG002|Overall Study|Subject reached a virologic endpoint|1|||
17069955|NCT00561353|38212517|FG003|Overall Study|Subject reached a virologic endpoint|4|||
17069956|NCT00561353|38212518|FG004|Overall Study|Subject reached a virologic endpoint|1|||
17069957|NCT00561353|38212519|FG005|Overall Study|Subject reached a virologic endpoint|3|||
17069958|NCT00561353|38212520|FG006|Overall Study|Subject reached a virologic endpoint|4|||
17069959|NCT00561353|38212521|FG007|Overall Study|Subject reached a virologic endpoint|4|||
17069960|NCT00561353|38212522|FG008|Overall Study|Subject reached a virologic endpoint|5|||
17069961|NCT00561353|38212523|FG009|Overall Study|Subject reached a virologic endpoint|0|||
17069962|NCT00561353|38212514|FG000|Overall Study|Subject ineligible to continue the trial|0|||
17069963|NCT00561353|38212515|FG001|Overall Study|Subject ineligible to continue the trial|0|||
17069964|NCT00561353|38212516|FG002|Overall Study|Subject ineligible to continue the trial|0|||
17069965|NCT00561353|38212517|FG003|Overall Study|Subject ineligible to continue the trial|0|||
17069966|NCT00561353|38212518|FG004|Overall Study|Subject ineligible to continue the trial|0|||
17069967|NCT00561353|38212519|FG005|Overall Study|Subject ineligible to continue the trial|1|||
17069968|NCT00561353|38212520|FG006|Overall Study|Subject ineligible to continue the trial|1|||
17069969|NCT00561353|38212521|FG007|Overall Study|Subject ineligible to continue the trial|0|||
17069970|NCT00561353|38212522|FG008|Overall Study|Subject ineligible to continue the trial|2|||
17069971|NCT00561353|38212523|FG009|Overall Study|Subject ineligible to continue the trial|1|||
17069972|NCT00561353|38212514|FG000|Overall Study|Other|1|||
17069973|NCT00561353|38212515|FG001|Overall Study|Other|0|||
17069974|NCT00561353|38212516|FG002|Overall Study|Other|1|||
17069975|NCT00561353|38212517|FG003|Overall Study|Other|0|||
17069976|NCT00561353|38212518|FG004|Overall Study|Other|0|||
17069977|NCT00561353|38212519|FG005|Overall Study|Other|2|||
17069978|NCT00561353|38212520|FG006|Overall Study|Other|0|||
17069979|NCT00561353|38212521|FG007|Overall Study|Other|0|||
17069980|NCT00561353|38212522|FG008|Overall Study|Other|0|||
17069981|NCT00561353|38212523|FG009|Overall Study|Other|0|||
17069982|NCT00561353|38212514|FG000|Overall Study|Adverse Event|0|||
17069983|NCT00561353|38212515|FG001|Overall Study|Adverse Event|0|||
17069984|NCT00561353|38212516|FG002|Overall Study|Adverse Event|0|||
17069985|NCT00561353|38212517|FG003|Overall Study|Adverse Event|2|||
17069986|NCT00561353|38212518|FG004|Overall Study|Adverse Event|0|||
17069987|NCT00561353|38212519|FG005|Overall Study|Adverse Event|0|||
17069988|NCT00561353|38212520|FG006|Overall Study|Adverse Event|1|||
17069989|NCT00561353|38212521|FG007|Overall Study|Adverse Event|0|||
17069990|NCT00561353|38212522|FG008|Overall Study|Adverse Event|0|||
17069991|NCT00561353|38212523|FG009|Overall Study|Adverse Event|1|||
17069992|NCT00561353|38212514|FG000|Overall Study|Lost to Follow-up|2|||
17069993|NCT00561353|38212515|FG001|Overall Study|Lost to Follow-up|0|||
17069994|NCT00561353|38212516|FG002|Overall Study|Lost to Follow-up|1|||
17069995|NCT00561353|38212517|FG003|Overall Study|Lost to Follow-up|0|||
17069996|NCT00561353|38212518|FG004|Overall Study|Lost to Follow-up|0|||
17069997|NCT00561353|38212519|FG005|Overall Study|Lost to Follow-up|0|||
17069998|NCT00561353|38212520|FG006|Overall Study|Lost to Follow-up|0|||
17069999|NCT00561353|38212521|FG007|Overall Study|Lost to Follow-up|0|||
17070000|NCT00561353|38212522|FG008|Overall Study|Lost to Follow-up|0|||
17070001|NCT00561353|38212523|FG009|Overall Study|Lost to Follow-up|0|||
17070002|NCT00561353|38212514|FG000|Overall Study|Withdrawal by Subject|0|||
17070003|NCT00561353|38212515|FG001|Overall Study|Withdrawal by Subject|2|||
17070004|NCT00561353|38212516|FG002|Overall Study|Withdrawal by Subject|0|||
17070005|NCT00561353|38212517|FG003|Overall Study|Withdrawal by Subject|0|||
17070006|NCT00561353|38212518|FG004|Overall Study|Withdrawal by Subject|0|||
17070007|NCT00561353|38212519|FG005|Overall Study|Withdrawal by Subject|0|||
17070008|NCT00561353|38212520|FG006|Overall Study|Withdrawal by Subject|0|||
17070009|NCT00561353|38212521|FG007|Overall Study|Withdrawal by Subject|0|||
17070010|NCT00561353|38212522|FG008|Overall Study|Withdrawal by Subject|0|||
17070011|NCT00561353|38212523|FG009|Overall Study|Withdrawal by Subject|0|||
17070012|NCT00560885|38212590|FG000|Overall Study|Death|7|||
17070013|NCT00560885|38212590|FG000|Overall Study|Withdrawal by Subject|1|||
17070014|NCT00397215|38212598|FG000|Month 0 (Day 0)|Adverse Event|0|||
17070015|NCT00397215|38212599|FG001|Month 0 (Day 0)|Adverse Event|1|||
17070016|NCT00397215|38212600|FG002|Month 0 (Day 0)|Adverse Event|0|||
17070017|NCT00397215|38212601|FG003|Month 0 (Day 0)|Adverse Event|0|||
17070018|NCT00397215|38212598|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
17070019|NCT00397215|38212599|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
17070020|NCT00397215|38212600|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
17070021|NCT00397215|38212601|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
17070022|NCT00397215|38212598|FG000|Month 0 (Day 0)|Other|4|||
17070023|NCT00397215|38212599|FG001|Month 0 (Day 0)|Other|1|||
17070024|NCT00397215|38212600|FG002|Month 0 (Day 0)|Other|3|||
17070025|NCT00397215|38212601|FG003|Month 0 (Day 0)|Other|3|||
17070026|NCT00397215|38212598|FG000|Month 6 (Day 180)|Adverse Event|0|||
17070027|NCT00397215|38212599|FG001|Month 6 (Day 180)|Adverse Event|3|||
17070028|NCT00397215|38212600|FG002|Month 6 (Day 180)|Adverse Event|2|||
17070029|NCT00397215|38212601|FG003|Month 6 (Day 180)|Adverse Event|0|||
17070030|NCT00397215|38212598|FG000|Month 6 (Day 180)|Other|2|||
17070031|NCT00397215|38212599|FG001|Month 6 (Day 180)|Other|0|||
17070032|NCT00397215|38212600|FG002|Month 6 (Day 180)|Other|3|||
17070033|NCT00397215|38212601|FG003|Month 6 (Day 180)|Other|0|||
17070034|NCT00556439|38212618|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
17070035|NCT00556439|38212619|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
17070036|NCT00556439|38212620|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
17070037|NCT00556439|38212621|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
17070038|NCT00556439|38212618|FG000|Study Entry to Week 12|Physician Decision|1|||
17070039|NCT00556439|38212619|FG001|Study Entry to Week 12|Physician Decision|0|||
17070040|NCT00556439|38212620|FG002|Study Entry to Week 12|Physician Decision|0|||
17070041|NCT00556439|38212621|FG003|Study Entry to Week 12|Physician Decision|0|||
17070042|NCT00556439|38212618|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
17070043|NCT00556439|38212619|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
17070044|NCT00556439|38212620|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
17070045|NCT00556439|38212621|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
17070046|NCT00556439|38212618|FG000|Study Entry to Week 12|Recurrent infection|1|||
17070047|NCT00556439|38212619|FG001|Study Entry to Week 12|Recurrent infection|0|||
17070048|NCT00556439|38212620|FG002|Study Entry to Week 12|Recurrent infection|0|||
17070049|NCT00556439|38212621|FG003|Study Entry to Week 12|Recurrent infection|0|||
17070050|NCT00556439|38212618|FG000|Study Entry to Week 12|Malignancy|0|||
17070051|NCT00556439|38212619|FG001|Study Entry to Week 12|Malignancy|0|||
17070052|NCT00556439|38212620|FG002|Study Entry to Week 12|Malignancy|1|||
17070053|NCT00556439|38212621|FG003|Study Entry to Week 12|Malignancy|0|||
17070054|NCT00556439|38212618|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
17070055|NCT00556439|38212619|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
17070056|NCT00556439|38212620|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
17070057|NCT00556439|38212621|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
17070058|NCT00556439|38212618|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
17148730|NCT03709823|38293582|FG002|Overall Study|Adverse Event|1|||
17070059|NCT00556439|38212619|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
17070060|NCT00556439|38212620|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
17070061|NCT00556439|38212621|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
17070062|NCT00556439|38212618|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
17070063|NCT00556439|38212619|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
17070064|NCT00556439|38212620|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
17070065|NCT00556439|38212621|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
17070066|NCT00556439|38212618|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
17070067|NCT00556439|38212619|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
17070068|NCT00556439|38212620|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
17070069|NCT00556439|38212621|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
17070070|NCT00387465|38212634|FG000|Overall Study|Withdrawal by Subject|0|||
17070071|NCT00387465|38212635|FG001|Overall Study|Withdrawal by Subject|1|||
17070072|NCT00387465|38212636|FG002|Overall Study|Withdrawal by Subject|0|||
17070073|NCT00387153|38212653|FG000|Overall Study|Adverse Event|1|||
17070074|NCT00387153|38212653|FG000|Overall Study|Disease Progression|3|||
17070075|NCT00387153|38212653|FG000|Overall Study|Lack of Response|4|||
17070076|NCT00386607|38212657|FG000|Core|Adverse Event|40|||
17070077|NCT00386607|38212658|FG001|Core|Adverse Event|0|||
17070078|NCT00386607|38212657|FG000|Core|Abnormal laboratory value(s)|3|||
17070079|NCT00386607|38212658|FG001|Core|Abnormal laboratory value(s)|0|||
17070080|NCT00386607|38212657|FG000|Core|Unsatisfactory therapeutic effect|23|||
17070081|NCT00386607|38212658|FG001|Core|Unsatisfactory therapeutic effect|0|||
17070082|NCT00386607|38212657|FG000|Core|Condition no longer requires study drug|4|||
17070083|NCT00386607|38212658|FG001|Core|Condition no longer requires study drug|0|||
17070084|NCT00386607|38212657|FG000|Core|Patient withdrew consent|15|||
17070085|NCT00386607|38212658|FG001|Core|Patient withdrew consent|0|||
17070086|NCT00386607|38212657|FG000|Core|Lost to Follow-up|23|||
17070087|NCT00386607|38212658|FG001|Core|Lost to Follow-up|0|||
17070088|NCT00386607|38212657|FG000|Core|Administrative problems|1|||
17070089|NCT00386607|38212658|FG001|Core|Administrative problems|0|||
17148731|NCT03709823|38293583|FG003|Overall Study|Adverse Event|0|||
17148732|NCT03709823|38293584|FG004|Overall Study|Adverse Event|0|||
17070090|NCT00386607|38212657|FG000|Core|Protocol Deviation|6|||
17070091|NCT00386607|38212658|FG001|Core|Protocol Deviation|0|||
17070092|NCT00386607|38212657|FG000|Extension|Adverse Event|0|||
17070093|NCT00386607|38212658|FG001|Extension|Adverse Event|6|||
17070094|NCT00386607|38212657|FG000|Extension|Abnormal laboratory value(s)|0|||
17070095|NCT00386607|38212658|FG001|Extension|Abnormal laboratory value(s)|1|||
17070096|NCT00386607|38212657|FG000|Extension|Administrative problems|0|||
17070097|NCT00386607|38212658|FG001|Extension|Administrative problems|1|||
17070098|NCT00386607|38212657|FG000|Extension|Lost to Follow-up|0|||
17070099|NCT00386607|38212658|FG001|Extension|Lost to Follow-up|3|||
17070100|NCT00386607|38212657|FG000|Extension|Patient withdrew consent|0|||
17070101|NCT00386607|38212658|FG001|Extension|Patient withdrew consent|5|||
17070102|NCT00386607|38212657|FG000|Extension|Unsatisfactory therapeutic effect|0|||
17070103|NCT00386607|38212658|FG001|Extension|Unsatisfactory therapeutic effect|1|||
17070104|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
17070105|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
17070106|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
17070107|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
17070108|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
17070109|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
17070110|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
17070111|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
17070112|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
17070113|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
17070114|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
17070115|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
17070116|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
17070117|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
17070118|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
17070119|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
17070120|NCT00410163|38212672|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
17070121|NCT00410163|38212673|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
17070122|NCT00410163|38212672|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
17070123|NCT00410163|38212673|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
17070124|NCT00410163|38212672|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
17070125|NCT00410163|38212673|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
17070126|NCT00410163|38212672|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
17070127|NCT00410163|38212673|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
17070128|NCT00410163|38212672|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
17070129|NCT00410163|38212673|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
17070130|NCT00410163|38212672|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
17070131|NCT00410163|38212673|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
17070132|NCT00409617|38212709|FG000|Overall Study|Adverse Event|57|||
17070133|NCT00409617|38212709|FG000|Overall Study|Lack of Efficacy|54|||
17070134|NCT00409617|38212709|FG000|Overall Study|Lost to Follow-up|2|||
17070135|NCT00409617|38212709|FG000|Overall Study|Protocol Violation|24|||
17070136|NCT00409617|38212709|FG000|Overall Study|Withdrawal by Subject|8|||
17070137|NCT00409617|38212709|FG000|Overall Study|Administrative reasons|1|||
17070138|NCT00409617|38212709|FG000|Overall Study|Not described|14|||
17070139|NCT00300274|38212716|FG000|Overall Study|Withdrawal by Subject|12|||
17070140|NCT00300274|38212717|FG001|Overall Study|Withdrawal by Subject|3|||
17070141|NCT00300274|38212718|FG002|Overall Study|Withdrawal by Subject|14|||
17070142|NCT00300274|38212716|FG000|Overall Study|Lost to Follow-up|3|||
17070143|NCT00300274|38212717|FG001|Overall Study|Lost to Follow-up|4|||
17070144|NCT00300274|38212718|FG002|Overall Study|Lost to Follow-up|5|||
17070145|NCT00300274|38212716|FG000|Overall Study|Death|31|||
17070146|NCT00300274|38212717|FG001|Overall Study|Death|20|||
17070147|NCT00300274|38212718|FG002|Overall Study|Death|25|||
17070148|NCT00300274|38212716|FG000|Overall Study|Re-transplant|0|||
17070149|NCT00300274|38212717|FG001|Overall Study|Re-transplant|0|||
17070150|NCT00300274|38212718|FG002|Overall Study|Re-transplant|1|||
17070151|NCT00299728|38212728|FG000|Overall Study|Lost to Follow-up|0|||
17070152|NCT00299728|38212729|FG001|Overall Study|Lost to Follow-up|1|||
17070153|NCT00299728|38212728|FG000|Overall Study|Withdrawal by Subject|0|||
17070154|NCT00299728|38212729|FG001|Overall Study|Withdrawal by Subject|1|||
17070155|NCT00299728|38212728|FG000|Overall Study|Progressive disease|0|||
17070156|NCT00299728|38212729|FG001|Overall Study|Progressive disease|1|||
17070157|NCT00396591|38212735|FG000|Overall Study|Disease Progression|13|||
17070158|NCT00396591|38212735|FG000|Overall Study|Adverse Event|2|||
17070159|NCT00396591|38212735|FG000|Overall Study|Participant request|1|||
17070160|NCT00316264|38212742|FG000|Overall Study|Lost to Follow-up|0|||
17070161|NCT00316264|38212743|FG001|Overall Study|Lost to Follow-up|1|||
17070162|NCT00316264|38212744|FG002|Overall Study|Lost to Follow-up|0|||
17070163|NCT00316264|38212742|FG000|Overall Study|Withdrawal of Consent|3|||
17070164|NCT00316264|38212743|FG001|Overall Study|Withdrawal of Consent|5|||
17070165|NCT00316264|38212744|FG002|Overall Study|Withdrawal of Consent|6|||
17070166|NCT00316264|38212742|FG000|Overall Study|Death|2|||
17070167|NCT00316264|38212743|FG001|Overall Study|Death|0|||
17070168|NCT00316264|38212744|FG002|Overall Study|Death|0|||
17070169|NCT00316264|38212742|FG000|Overall Study|Other|1|||
17070170|NCT00316264|38212743|FG001|Overall Study|Other|1|||
17070171|NCT00316264|38212744|FG002|Overall Study|Other|0|||
17070172|NCT00385827|38212755|FG000|Part 1|Adverse Event|1|||
17070173|NCT00385827|38212756|FG001|Part 1|Adverse Event|0|||
17070174|NCT00385827|38212757|FG002|Part 1|Adverse Event|0|||
17070175|NCT00385827|38212755|FG000|Part 1|Death|2|||
17070176|NCT00385827|38212756|FG001|Part 1|Death|0|||
17070177|NCT00385827|38212757|FG002|Part 1|Death|0|||
17070178|NCT00385827|38212755|FG000|Part 1|Lack of Efficacy|5|||
17070179|NCT00385827|38212756|FG001|Part 1|Lack of Efficacy|0|||
17070180|NCT00385827|38212757|FG002|Part 1|Lack of Efficacy|0|||
17070181|NCT00385827|38212755|FG000|Part 1|Other|1|||
17070182|NCT00385827|38212756|FG001|Part 1|Other|0|||
17070183|NCT00385827|38212757|FG002|Part 1|Other|0|||
17070184|NCT00385827|38212755|FG000|Part 2|Adverse Event|0|||
17070185|NCT00385827|38212756|FG001|Part 2|Adverse Event|6|||
17070186|NCT00385827|38212757|FG002|Part 2|Adverse Event|10|||
17070187|NCT00385827|38212755|FG000|Part 2|Death|0|||
17070188|NCT00385827|38212756|FG001|Part 2|Death|0|||
17070189|NCT00385827|38212757|FG002|Part 2|Death|2|||
17070190|NCT00385827|38212755|FG000|Part 2|Lack of Efficacy|0|||
17070191|NCT00385827|38212756|FG001|Part 2|Lack of Efficacy|14|||
17070192|NCT00385827|38212757|FG002|Part 2|Lack of Efficacy|13|||
17070193|NCT00385827|38212755|FG000|Part 2|Randomized but not treated|0|||
17070194|NCT00385827|38212756|FG001|Part 2|Randomized but not treated|2|||
17070195|NCT00385827|38212757|FG002|Part 2|Randomized but not treated|2|||
17070196|NCT00385827|38212755|FG000|Part 2|Other|0|||
17070197|NCT00385827|38212756|FG001|Part 2|Other|11|||
17070198|NCT00385827|38212757|FG002|Part 2|Other|21|||
17070199|NCT00498602|38212774|FG000|Overall Study|Death|0|||
17070200|NCT00498602|38212775|FG001|Overall Study|Death|0|||
17070201|NCT00498602|38212776|FG002|Overall Study|Death|0|||
17070202|NCT00498602|38212777|FG003|Overall Study|Death|0|||
17070203|NCT00498602|38212778|FG004|Overall Study|Death|0|||
17070204|NCT00498602|38212779|FG005|Overall Study|Death|1|||
17070205|NCT00498602|38212780|FG006|Overall Study|Death|0|||
17070206|NCT00498602|38212774|FG000|Overall Study|Lack of Efficacy|1|||
17070207|NCT00498602|38212775|FG001|Overall Study|Lack of Efficacy|0|||
17070208|NCT00498602|38212776|FG002|Overall Study|Lack of Efficacy|0|||
17070209|NCT00498602|38212777|FG003|Overall Study|Lack of Efficacy|0|||
17070210|NCT00498602|38212778|FG004|Overall Study|Lack of Efficacy|0|||
17070211|NCT00498602|38212779|FG005|Overall Study|Lack of Efficacy|0|||
17070212|NCT00498602|38212780|FG006|Overall Study|Lack of Efficacy|0|||
17070213|NCT00498602|38212774|FG000|Overall Study|Lost to Follow-up|0|||
17070214|NCT00498602|38212775|FG001|Overall Study|Lost to Follow-up|2|||
17070215|NCT00498602|38212776|FG002|Overall Study|Lost to Follow-up|0|||
17070216|NCT00498602|38212777|FG003|Overall Study|Lost to Follow-up|2|||
17070217|NCT00498602|38212778|FG004|Overall Study|Lost to Follow-up|0|||
17070218|NCT00498602|38212779|FG005|Overall Study|Lost to Follow-up|0|||
17070219|NCT00498602|38212780|FG006|Overall Study|Lost to Follow-up|0|||
17070220|NCT00498602|38212774|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
17070221|NCT00498602|38212775|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
17070222|NCT00498602|38212776|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
17070223|NCT00498602|38212777|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
17070224|NCT00498602|38212778|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
17070225|NCT00498602|38212779|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
17070226|NCT00498602|38212780|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
17070227|NCT00498602|38212774|FG000|Overall Study|AE not related to Study Drug|1|||
17070228|NCT00498602|38212775|FG001|Overall Study|AE not related to Study Drug|3|||
17070229|NCT00498602|38212776|FG002|Overall Study|AE not related to Study Drug|0|||
17070230|NCT00498602|38212777|FG003|Overall Study|AE not related to Study Drug|0|||
17070231|NCT00498602|38212778|FG004|Overall Study|AE not related to Study Drug|2|||
17070232|NCT00498602|38212779|FG005|Overall Study|AE not related to Study Drug|2|||
17070233|NCT00498602|38212780|FG006|Overall Study|AE not related to Study Drug|1|||
17070234|NCT00498602|38212774|FG000|Overall Study|Caregiver Request|2|||
17070235|NCT00498602|38212775|FG001|Overall Study|Caregiver Request|2|||
17070236|NCT00498602|38212776|FG002|Overall Study|Caregiver Request|2|||
17070237|NCT00498602|38212777|FG003|Overall Study|Caregiver Request|0|||
17070238|NCT00498602|38212778|FG004|Overall Study|Caregiver Request|1|||
17070239|NCT00498602|38212779|FG005|Overall Study|Caregiver Request|2|||
17070240|NCT00498602|38212780|FG006|Overall Study|Caregiver Request|0|||
17070241|NCT00498602|38212774|FG000|Overall Study|Investigator Request|0|||
17070242|NCT00498602|38212775|FG001|Overall Study|Investigator Request|0|||
17070243|NCT00498602|38212776|FG002|Overall Study|Investigator Request|1|||
17070244|NCT00498602|38212777|FG003|Overall Study|Investigator Request|0|||
17070245|NCT00498602|38212778|FG004|Overall Study|Investigator Request|0|||
17070246|NCT00498602|38212779|FG005|Overall Study|Investigator Request|0|||
17070247|NCT00498602|38212780|FG006|Overall Study|Investigator Request|0|||
17070248|NCT00498602|38212774|FG000|Overall Study|Subject Request|3|||
17070249|NCT00498602|38212775|FG001|Overall Study|Subject Request|0|||
17070250|NCT00498602|38212776|FG002|Overall Study|Subject Request|1|||
17070251|NCT00498602|38212777|FG003|Overall Study|Subject Request|1|||
17070252|NCT00498602|38212778|FG004|Overall Study|Subject Request|1|||
17070253|NCT00498602|38212779|FG005|Overall Study|Subject Request|4|||
17070254|NCT00498602|38212780|FG006|Overall Study|Subject Request|1|||
17070255|NCT00498602|38212774|FG000|Overall Study|Other|2|||
17070256|NCT00498602|38212775|FG001|Overall Study|Other|3|||
17070257|NCT00498602|38212776|FG002|Overall Study|Other|1|||
17070258|NCT00498602|38212777|FG003|Overall Study|Other|0|||
17070259|NCT00498602|38212778|FG004|Overall Study|Other|0|||
17070260|NCT00498602|38212779|FG005|Overall Study|Other|3|||
17070261|NCT00498602|38212780|FG006|Overall Study|Other|0|||
17070262|NCT00507728|38212799|FG000|Randomization to Month 3|Lost to Follow-up|15|||
17070263|NCT00507728|38212800|FG001|Randomization to Month 3|Lost to Follow-up|14|||
17070264|NCT00507728|38212801|FG002|Randomization to Month 3|Lost to Follow-up|20|||
17070265|NCT00507728|38212799|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
17070266|NCT00507728|38212800|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
17070267|NCT00507728|38212801|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
17070268|NCT00498368|38212817|FG000|Overall Study|Withdrawal by Subject|3|||
17070269|NCT00498368|38212818|FG001|Overall Study|Withdrawal by Subject|2|||
17070270|NCT00385671|38212827|FG000|Overall Study|Adverse Event|14|||
17070271|NCT00385671|38212828|FG001|Overall Study|Adverse Event|27|||
17070272|NCT00385671|38212829|FG002|Overall Study|Adverse Event|18|||
17070273|NCT00385671|38212827|FG000|Overall Study|Lack of Efficacy|5|||
17070274|NCT00385671|38212828|FG001|Overall Study|Lack of Efficacy|9|||
17070275|NCT00385671|38212829|FG002|Overall Study|Lack of Efficacy|5|||
17070276|NCT00385671|38212827|FG000|Overall Study|Lost to Follow-up|6|||
17070277|NCT00385671|38212828|FG001|Overall Study|Lost to Follow-up|6|||
17070278|NCT00385671|38212829|FG002|Overall Study|Lost to Follow-up|5|||
17070279|NCT00385671|38212827|FG000|Overall Study|Physician Decision|2|||
17070280|NCT00385671|38212828|FG001|Overall Study|Physician Decision|1|||
17070281|NCT00385671|38212829|FG002|Overall Study|Physician Decision|2|||
17070282|NCT00385671|38212827|FG000|Overall Study|Protocol Violation|5|||
17070283|NCT00385671|38212828|FG001|Overall Study|Protocol Violation|2|||
17070284|NCT00385671|38212829|FG002|Overall Study|Protocol Violation|1|||
17070285|NCT00385671|38212827|FG000|Overall Study|Sponsor Decision|2|||
17070286|NCT00385671|38212828|FG001|Overall Study|Sponsor Decision|2|||
17070287|NCT00385671|38212829|FG002|Overall Study|Sponsor Decision|1|||
17070288|NCT00385671|38212827|FG000|Overall Study|Withdrawal by Subject|4|||
17148733|NCT03709823|38293585|FG005|Overall Study|Adverse Event|0|||
17148734|NCT03709823|38293580|FG000|Overall Study|Lost to Follow-up|2|||
17148735|NCT03709823|38293581|FG001|Overall Study|Lost to Follow-up|2|||
17148736|NCT03709823|38293582|FG002|Overall Study|Lost to Follow-up|2|||
17148737|NCT03709823|38293583|FG003|Overall Study|Lost to Follow-up|1|||
17148738|NCT03709823|38293584|FG004|Overall Study|Lost to Follow-up|1|||
17148739|NCT03709823|38293585|FG005|Overall Study|Lost to Follow-up|0|||
17148740|NCT03709823|38293580|FG000|Overall Study|Withdrawal by Subject|1|||
17148741|NCT03709823|38293581|FG001|Overall Study|Withdrawal by Subject|3|||
17148742|NCT03709823|38293582|FG002|Overall Study|Withdrawal by Subject|0|||
17148743|NCT03709823|38293583|FG003|Overall Study|Withdrawal by Subject|0|||
17148744|NCT03709823|38293584|FG004|Overall Study|Withdrawal by Subject|0|||
17148745|NCT03709823|38293585|FG005|Overall Study|Withdrawal by Subject|0|||
17148746|NCT03709823|38293580|FG000|Overall Study|Other, Not Specified|0|||
17148747|NCT03709823|38293581|FG001|Overall Study|Other, Not Specified|0|||
17148748|NCT03709823|38293582|FG002|Overall Study|Other, Not Specified|0|||
17148749|NCT03709823|38293583|FG003|Overall Study|Other, Not Specified|1|||
17148750|NCT03709823|38293584|FG004|Overall Study|Other, Not Specified|0|||
17148751|NCT03709823|38293585|FG005|Overall Study|Other, Not Specified|0|||
17148752|NCT03488563|38293605|FG000|Overall Study|Lost to Follow-up|7|||
17148753|NCT03488563|38293606|FG001|Overall Study|Lost to Follow-up|6|||
17148754|NCT03488563|38293607|FG002|Overall Study|Lost to Follow-up|7|||
17148755|NCT03488563|38293605|FG000|Overall Study|Withdrawal by Subject|8|||
17148756|NCT03488563|38293606|FG001|Overall Study|Withdrawal by Subject|7|||
17148757|NCT03488563|38293607|FG002|Overall Study|Withdrawal by Subject|7|||
17148758|NCT03488563|38293605|FG000|Overall Study|Physician Decision|0|||
17148759|NCT03488563|38293606|FG001|Overall Study|Physician Decision|0|||
17148760|NCT03488563|38293607|FG002|Overall Study|Physician Decision|1|||
17148761|NCT03488563|38293605|FG000|Overall Study|Protocol Violation|3|||
17148762|NCT03488563|38293606|FG001|Overall Study|Protocol Violation|2|||
17148763|NCT03488563|38293607|FG002|Overall Study|Protocol Violation|6|||
17148764|NCT03488563|38293605|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
17148765|NCT03488563|38293606|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
17148766|NCT03488563|38293607|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
17148767|NCT03488563|38293605|FG000|Overall Study|Use of prohibited medication|2|||
17148768|NCT03488563|38293606|FG001|Overall Study|Use of prohibited medication|0|||
17148769|NCT03488563|38293607|FG002|Overall Study|Use of prohibited medication|0|||
17148770|NCT03488563|38293605|FG000|Overall Study|Adverse Event|1|||
17148771|NCT03488563|38293606|FG001|Overall Study|Adverse Event|0|||
17070289|NCT00385671|38212828|FG001|Overall Study|Withdrawal by Subject|4|||
17070290|NCT00385671|38212829|FG002|Overall Study|Withdrawal by Subject|4|||
17070291|NCT00497198|38212841|FG000|Overall Study|Adverse Event|4|||
17070292|NCT00497198|38212842|FG001|Overall Study|Adverse Event|2|||
17070293|NCT00497198|38212841|FG000|Overall Study|Physician Decision|1|||
17070294|NCT00497198|38212842|FG001|Overall Study|Physician Decision|2|||
17070295|NCT00497198|38212841|FG000|Overall Study|Withdrawal by Subject|0|||
17070296|NCT00497198|38212842|FG001|Overall Study|Withdrawal by Subject|1|||
17148772|NCT03488563|38293607|FG002|Overall Study|Adverse Event|1|||
17148773|NCT03488563|38293605|FG000|Overall Study|Subject returned for ET visit|0|||
17148774|NCT03488563|38293606|FG001|Overall Study|Subject returned for ET visit|1|||
17148775|NCT03488563|38293607|FG002|Overall Study|Subject returned for ET visit|0|||
17148776|NCT03488563|38293605|FG000|Overall Study|Sponsor's decision|0|||
17148777|NCT03488563|38293606|FG001|Overall Study|Sponsor's decision|0|||
17148778|NCT03488563|38293607|FG002|Overall Study|Sponsor's decision|1|||
17148779|NCT00706030|38293621|FG000|Overall Study|Disease Progression|4|||
17148780|NCT00706030|38293622|FG001|Overall Study|Disease Progression|6|||
17148781|NCT00706030|38293623|FG002|Overall Study|Disease Progression|46|||
17070297|NCT00496964|38212850|FG000|Overall Study|Withdrawal by Subject|0|||
17070298|NCT00496964|38212851|FG001|Overall Study|Withdrawal by Subject|1|||
17070299|NCT00490490|38212859|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
17070300|NCT00490490|38212859|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
17070301|NCT00385593|38212865|FG000|Overall Study|Adverse Event|3|||
17070302|NCT00385593|38212866|FG001|Overall Study|Adverse Event|2|||
17070303|NCT00385593|38212865|FG000|Overall Study|Withdrawal by Subject|17|||
17070304|NCT00385593|38212866|FG001|Overall Study|Withdrawal by Subject|7|||
17070305|NCT00385593|38212865|FG000|Overall Study|Lost to Follow-up|12|||
17070306|NCT00385593|38212866|FG001|Overall Study|Lost to Follow-up|8|||
17070307|NCT00385593|38212865|FG000|Overall Study|Protocol Violation|7|||
17070308|NCT00385593|38212866|FG001|Overall Study|Protocol Violation|4|||
17070309|NCT00385593|38212865|FG000|Overall Study|Several reasons|17|||
17148782|NCT00706030|38293624|FG003|Overall Study|Disease Progression|12|||
17148783|NCT00706030|38293621|FG000|Overall Study|Adverse Event|1|||
17148784|NCT00706030|38293622|FG001|Overall Study|Adverse Event|0|||
17148785|NCT00706030|38293623|FG002|Overall Study|Adverse Event|4|||
17070310|NCT00385593|38212866|FG001|Overall Study|Several reasons|15|||
17070311|NCT00385593|38212865|FG000|Overall Study|Incorrect inclusion|2|||
17070312|NCT00385593|38212866|FG001|Overall Study|Incorrect inclusion|0|||
17070313|NCT00385593|38212865|FG000|Overall Study|Incorrect randomization|0|||
17070314|NCT00385593|38212866|FG001|Overall Study|Incorrect randomization|1|||
17070315|NCT00495794|38212874|FG000|Overall Study|Pharmacist did not activate patient|522|||
17070316|NCT00495794|38212875|FG001|Overall Study|Pharmacist did not activate patient|0|||
17070317|NCT00495170|38212881|FG000|Overall Study|Lost to Follow-up|9|||
17070318|NCT00495170|38212881|FG000|Overall Study|Withdrawal by Subject|3|||
17070319|NCT00495170|38212881|FG000|Overall Study|Inappropriate staging|8|||
17070320|NCT03853148|38212889|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
17070321|NCT03853148|38212890|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
17070322|NCT03853148|38212891|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
17070323|NCT03853148|38212892|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
17070324|NCT00385203|38212904|FG000|Overall Study|Adverse Event|5|||
17070325|NCT00385203|38212905|FG001|Overall Study|Adverse Event|4|||
17070326|NCT00385203|38212904|FG000|Overall Study|Death|1|||
17070327|NCT00385203|38212905|FG001|Overall Study|Death|0|||
17070328|NCT00385203|38212904|FG000|Overall Study|Condition under investigation worsened|18|||
17070329|NCT00385203|38212905|FG001|Overall Study|Condition under investigation worsened|3|||
17070330|NCT00385203|38212904|FG000|Overall Study|Incorrect enrollment|2|||
17070331|NCT00385203|38212905|FG001|Overall Study|Incorrect enrollment|0|||
17070332|NCT00408993|38212914|FG000|Overall Study|Adverse Event|15|||
17070333|NCT00408993|38212915|FG001|Overall Study|Adverse Event|4|||
17070334|NCT00408993|38212914|FG000|Overall Study|Protocol Violation|1|||
17070335|NCT00408993|38212915|FG001|Overall Study|Protocol Violation|6|||
17070336|NCT00408993|38212914|FG000|Overall Study|Lack of Efficacy|1|||
17070337|NCT00408993|38212915|FG001|Overall Study|Lack of Efficacy|4|||
17070338|NCT00408993|38212914|FG000|Overall Study|Withdrawal by Subject|2|||
17070339|NCT00408993|38212915|FG001|Overall Study|Withdrawal by Subject|3|||
17070340|NCT00395967|38212925|FG000|Treatment Period|Failed Mobilization|1|||
17148786|NCT00706030|38293624|FG003|Overall Study|Adverse Event|2|||
17148787|NCT00706030|38293621|FG000|Overall Study|Withdrawal by Subject|1|||
17148788|NCT00706030|38293622|FG001|Overall Study|Withdrawal by Subject|0|||
17148789|NCT00706030|38293623|FG002|Overall Study|Withdrawal by Subject|2|||
17148790|NCT00706030|38293624|FG003|Overall Study|Withdrawal by Subject|0|||
17148791|NCT00706030|38293621|FG000|Overall Study|Physician Decision|0|||
17148792|NCT00706030|38293622|FG001|Overall Study|Physician Decision|0|||
17148793|NCT00706030|38293623|FG002|Overall Study|Physician Decision|2|||
17148794|NCT00706030|38293624|FG003|Overall Study|Physician Decision|0|||
17148795|NCT00706030|38293621|FG000|Overall Study|Not recorded|0|||
17148796|NCT00706030|38293622|FG001|Overall Study|Not recorded|0|||
17148797|NCT00706030|38293623|FG002|Overall Study|Not recorded|2|||
17148798|NCT00706030|38293624|FG003|Overall Study|Not recorded|0|||
17148799|NCT00706030|38293621|FG000|Overall Study|Protocol Violation|0|||
17148800|NCT00706030|38293622|FG001|Overall Study|Protocol Violation|0|||
17148801|NCT00706030|38293623|FG002|Overall Study|Protocol Violation|1|||
17148802|NCT00706030|38293624|FG003|Overall Study|Protocol Violation|1|||
17148803|NCT00706030|38293621|FG000|Overall Study|Failed to return|0|||
17148804|NCT00706030|38293622|FG001|Overall Study|Failed to return|0|||
17148805|NCT00706030|38293623|FG002|Overall Study|Failed to return|1|||
17148806|NCT00706030|38293624|FG003|Overall Study|Failed to return|0|||
17148807|NCT00706030|38293621|FG000|Overall Study|Symptomatic Deterioration|0|||
17148808|NCT00706030|38293622|FG001|Overall Study|Symptomatic Deterioration|0|||
17148809|NCT00706030|38293623|FG002|Overall Study|Symptomatic Deterioration|1|||
17148810|NCT00706030|38293624|FG003|Overall Study|Symptomatic Deterioration|0|||
17148811|NCT00706030|38293621|FG000|Overall Study|No treatment received|0|||
17148812|NCT00706030|38293622|FG001|Overall Study|No treatment received|0|||
17148813|NCT00706030|38293623|FG002|Overall Study|No treatment received|0|||
17148814|NCT00706030|38293624|FG003|Overall Study|No treatment received|1|||
17148815|NCT00706030|38293621|FG000|Overall Study|Death|0|||
17148816|NCT00706030|38293622|FG001|Overall Study|Death|0|||
17148817|NCT00706030|38293623|FG002|Overall Study|Death|1|||
17148818|NCT00706030|38293624|FG003|Overall Study|Death|0|||
17148819|NCT03488251|38293639|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
17148820|NCT03488251|38293640|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
17148821|NCT03488251|38293641|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
17148822|NCT03488251|38293642|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
17148823|NCT03488251|38293639|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
17148824|NCT03488251|38293640|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
17070341|NCT00395967|38212925|FG000|Follow-up Period|Death|1|||
17070342|NCT00395967|38212925|FG000|Follow-up Period|Lost to Follow-up|1|||
17070343|NCT00395733|38212931|FG000|Period 2|Withdrawal by Subject|1|||
17148825|NCT03488251|38293641|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
17070344|NCT00395733|38212932|FG001|Period 2|Withdrawal by Subject|2|||
17070345|NCT00395733|38212931|FG000|Period 2|Protocol Violation|0|||
17070346|NCT00395733|38212932|FG001|Period 2|Protocol Violation|1|||
17070347|NCT00395733|38212931|FG000|Period 2|Adverse Event|0|||
17070348|NCT00395733|38212932|FG001|Period 2|Adverse Event|2|||
17070349|NCT00395733|38212931|FG000|Period 2|Technical problems|1|||
17070350|NCT00395733|38212932|FG001|Period 2|Technical problems|0|||
17070351|NCT00395343|38212940|FG000|Overall Study|Adverse Event|13|||
17070352|NCT00395343|38212941|FG001|Overall Study|Adverse Event|5|||
17070353|NCT00395343|38212940|FG000|Overall Study|Lack of Efficacy|0|||
17070354|NCT00395343|38212941|FG001|Overall Study|Lack of Efficacy|1|||
17070355|NCT00395343|38212940|FG000|Overall Study|Lost to Follow-up|4|||
17070356|NCT00395343|38212941|FG001|Overall Study|Lost to Follow-up|4|||
17070357|NCT00395343|38212940|FG000|Overall Study|Physician Decision|2|||
17070358|NCT00395343|38212941|FG001|Overall Study|Physician Decision|4|||
17070359|NCT00395343|38212940|FG000|Overall Study|Protocol Violation|6|||
17070360|NCT00395343|38212941|FG001|Overall Study|Protocol Violation|8|||
17070361|NCT00395343|38212940|FG000|Overall Study|Withdrawal by Subject|11|||
17070362|NCT00395343|38212941|FG001|Overall Study|Withdrawal by Subject|12|||
17148826|NCT03488251|38293642|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
17148827|NCT03488251|38293639|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
17148828|NCT03488251|38293640|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
17148829|NCT03488251|38293641|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
17148830|NCT03488251|38293642|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
17148831|NCT03488251|38293639|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
17148832|NCT03488251|38293640|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
17148833|NCT03488251|38293641|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
17148834|NCT03488251|38293642|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
17148835|NCT03488251|38293639|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
17148836|NCT03488251|38293640|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
17148837|NCT03488251|38293641|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
17148838|NCT03488251|38293642|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
17148839|NCT03158688|38293655|FG000|Overall Study|Continuing in study|107|||
17148840|NCT03158688|38293656|FG001|Overall Study|Continuing in study|233|||
17148841|NCT03158688|38293655|FG000|Overall Study|Death|36|||
17148842|NCT03158688|38293656|FG001|Overall Study|Death|59|||
17148843|NCT03158688|38293655|FG000|Overall Study|Withdrawal by Subject|9|||
17148844|NCT03158688|38293656|FG001|Overall Study|Withdrawal by Subject|14|||
17148845|NCT03158688|38293655|FG000|Overall Study|Decision by sponsor|2|||
17148846|NCT03158688|38293656|FG001|Overall Study|Decision by sponsor|3|||
17148847|NCT03158688|38293655|FG000|Overall Study|Lost to Follow-up|0|||
17148848|NCT03158688|38293656|FG001|Overall Study|Lost to Follow-up|3|||
17148849|NCT02727322|38293664|FG000|Overall Study|Withdrawal by Subject|1|||
17070363|NCT00395343|38212940|FG000|Overall Study|Other|5|||
17070364|NCT00395343|38212941|FG001|Overall Study|Other|2|||
17070365|NCT00560573|38212947|FG000|Overall Study|Death|4|||
17070366|NCT00560573|38212948|FG001|Overall Study|Death|1|||
17070367|NCT00560573|38212949|FG002|Overall Study|Death|4|||
17070368|NCT00560573|38212950|FG003|Overall Study|Death|5|||
17070369|NCT00560573|38212951|FG004|Overall Study|Death|1|||
17070370|NCT00560573|38212952|FG005|Overall Study|Death|10|||
17070371|NCT00560573|38212947|FG000|Overall Study|Lost to Follow-up|0|||
17070372|NCT00560573|38212948|FG001|Overall Study|Lost to Follow-up|0|||
17070373|NCT00560573|38212949|FG002|Overall Study|Lost to Follow-up|0|||
17070374|NCT00560573|38212950|FG003|Overall Study|Lost to Follow-up|1|||
17070375|NCT00560573|38212951|FG004|Overall Study|Lost to Follow-up|1|||
17070376|NCT00560573|38212952|FG005|Overall Study|Lost to Follow-up|0|||
17070377|NCT00560573|38212947|FG000|Overall Study|Withdrawal by Subject|0|||
17070378|NCT00560573|38212948|FG001|Overall Study|Withdrawal by Subject|0|||
17070379|NCT00560573|38212949|FG002|Overall Study|Withdrawal by Subject|0|||
16781243|NCT02109484|37720409|FG000|Overall Study|Physician Decision|0|||
17070380|NCT00560573|38212950|FG003|Overall Study|Withdrawal by Subject|1|||
17070381|NCT00560573|38212951|FG004|Overall Study|Withdrawal by Subject|1|||
17070382|NCT00560573|38212952|FG005|Overall Study|Withdrawal by Subject|0|||
17070383|NCT00560573|38212947|FG000|Overall Study|Other|2|||
17070384|NCT00560573|38212948|FG001|Overall Study|Other|2|||
17070385|NCT00560573|38212949|FG002|Overall Study|Other|2|||
17070386|NCT00560573|38212950|FG003|Overall Study|Other|3|||
17070387|NCT00560573|38212951|FG004|Overall Study|Other|3|||
17148850|NCT02727322|38293665|FG001|Overall Study|Withdrawal by Subject|1|||
17148851|NCT02727322|38293664|FG000|Overall Study|Protocol Violation|1|||
17070388|NCT00560573|38212952|FG005|Overall Study|Other|3|||
17070389|NCT00560573|38212947|FG000|Overall Study|Enrolled, not treated|0|||
17070390|NCT00560573|38212948|FG001|Overall Study|Enrolled, not treated|0|||
17070391|NCT00560573|38212949|FG002|Overall Study|Enrolled, not treated|0|||
17070392|NCT00560573|38212950|FG003|Overall Study|Enrolled, not treated|0|||
17070393|NCT00560573|38212951|FG004|Overall Study|Enrolled, not treated|1|||
17070394|NCT00560573|38212952|FG005|Overall Study|Enrolled, not treated|0|||
17070395|NCT03961529|38212985|FG000|Overall Study|Adverse Event|13|||
17070396|NCT03961529|38212986|FG001|Overall Study|Adverse Event|5|||
17070397|NCT03961529|38212987|FG002|Overall Study|Adverse Event|2|||
17070398|NCT03961529|38212985|FG000|Overall Study|Withdrawal by Subject|17|||
17148852|NCT02727322|38293665|FG001|Overall Study|Protocol Violation|0|||
17148853|NCT03431857|38293675|FG000|Overall Study|Death|6|||
17148854|NCT03431857|38293675|FG000|Overall Study|Lost to Follow-up|41|||
17148855|NCT03431857|38293675|FG000|Overall Study|Adverse Event|6|||
17148856|NCT03431857|38293675|FG000|Overall Study|Withdrawal by Subject|1|||
17148857|NCT03487549|38293681|FG000|Overall Study|Protocol Violation|0|||
17148858|NCT03487549|38293682|FG001|Overall Study|Protocol Violation|1|||
17148859|NCT03487549|38293681|FG000|Overall Study|Lost to Follow-up|2|||
17148860|NCT03487549|38293682|FG001|Overall Study|Lost to Follow-up|1|||
17148861|NCT03487549|38293681|FG000|Overall Study|Withdrawal by Subject|2|||
17148862|NCT03487549|38293682|FG001|Overall Study|Withdrawal by Subject|0|||
17148863|NCT03464383|38293691|FG000|Overall Study|Lost to Follow-up|1|||
17148864|NCT03464383|38293692|FG001|Overall Study|Lost to Follow-up|0|||
17148865|NCT03464383|38293693|FG002|Overall Study|Lost to Follow-up|0|||
17148866|NCT03464383|38293691|FG000|Overall Study|Withdrawal by Subject|0|||
17148867|NCT03464383|38293692|FG001|Overall Study|Withdrawal by Subject|1|||
17148868|NCT03464383|38293693|FG002|Overall Study|Withdrawal by Subject|0|||
17148869|NCT01444092|38293702|FG000|Overall Study|Adverse Event|8|||
17148870|NCT01444092|38293702|FG000|Overall Study|Protocol Violation|1|||
17148871|NCT01444092|38293702|FG000|Overall Study|Withdrawal by Subject|1|||
17148872|NCT01444092|38293702|FG000|Overall Study|Other Eligibility criteria|7|||
17148873|NCT01265784|38293709|FG000|Overall Study|Lost to Follow-up|5|||
17148874|NCT01265784|38293710|FG001|Overall Study|Lost to Follow-up|3|||
17148875|NCT01265784|38293711|FG002|Overall Study|Lost to Follow-up|2|||
17148876|NCT01265784|38293709|FG000|Overall Study|Withdrawal by Subject|0|||
17148877|NCT01265784|38293710|FG001|Overall Study|Withdrawal by Subject|5|||
17148878|NCT01265784|38293711|FG002|Overall Study|Withdrawal by Subject|0|||
17148879|NCT01265784|38293709|FG000|Overall Study|Physician Decision|1|||
17148880|NCT01265784|38293710|FG001|Overall Study|Physician Decision|0|||
16994113|NCT00773968|38137920|FG000|Overall Study|Death|1|||
16994114|NCT00773968|38137920|FG000|Overall Study|Failure to Return|2|||
16994115|NCT00773968|38137920|FG000|Overall Study|Lack of Efficacy|3|||
16994116|NCT00773968|38137920|FG000|Overall Study|Protocol Violation|1|||
17148881|NCT01265784|38293711|FG002|Overall Study|Physician Decision|1|||
17148882|NCT01265784|38293709|FG000|Overall Study|Adverse Event|1|||
17148883|NCT01265784|38293710|FG001|Overall Study|Adverse Event|0|||
17148884|NCT01265784|38293711|FG002|Overall Study|Adverse Event|0|||
17148885|NCT01265784|38293709|FG000|Overall Study|Death|3|||
17148886|NCT01265784|38293710|FG001|Overall Study|Death|0|||
17148887|NCT01265784|38293711|FG002|Overall Study|Death|0|||
17148888|NCT01265784|38293709|FG000|Overall Study|Protocol Violation|2|||
17148889|NCT01265784|38293710|FG001|Overall Study|Protocol Violation|0|||
17148890|NCT01265784|38293711|FG002|Overall Study|Protocol Violation|0|||
17148891|NCT01265784|38293709|FG000|Overall Study|Incorrectly Randomized|0|||
17148892|NCT01265784|38293710|FG001|Overall Study|Incorrectly Randomized|0|||
17148893|NCT01265784|38293711|FG002|Overall Study|Incorrectly Randomized|1|||
17148894|NCT03156504|38293719|FG000|Overall Study|Withdrawal by Subject|1|||
17148895|NCT03159468|38293729|FG000|Overall Study|Withdrawal by Subject|0|||
17148896|NCT03159468|38293730|FG001|Overall Study|Withdrawal by Subject|0|||
17148897|NCT03159468|38293731|FG002|Overall Study|Withdrawal by Subject|3|||
17148898|NCT03159468|38293732|FG003|Overall Study|Withdrawal by Subject|0|||
17148899|NCT03159468|38293733|FG004|Overall Study|Withdrawal by Subject|0|||
17148900|NCT03159468|38293734|FG005|Overall Study|Withdrawal by Subject|0|||
17148901|NCT03430063|38293751|FG000|Overall Study|Adverse Event|0|||
17148902|NCT03430063|38293752|FG001|Overall Study|Adverse Event|1|||
17148903|NCT03430063|38293753|FG002|Overall Study|Adverse Event|0|||
17148904|NCT03430063|38293751|FG000|Overall Study|Death|3|||
17148905|NCT03430063|38293752|FG001|Overall Study|Death|2|||
17148906|NCT03430063|38293753|FG002|Overall Study|Death|3|||
17070399|NCT03961529|38212986|FG001|Overall Study|Withdrawal by Subject|2|||
17070400|NCT03961529|38212987|FG002|Overall Study|Withdrawal by Subject|1|||
17070401|NCT03961529|38212985|FG000|Overall Study|Withdrawal by parent/guardian|0|||
17070402|NCT03961529|38212986|FG001|Overall Study|Withdrawal by parent/guardian|7|||
17070403|NCT03961529|38212987|FG002|Overall Study|Withdrawal by parent/guardian|0|||
17070404|NCT03961529|38212985|FG000|Overall Study|Physician Decision|2|||
17070405|NCT03961529|38212986|FG001|Overall Study|Physician Decision|1|||
17070406|NCT03961529|38212987|FG002|Overall Study|Physician Decision|1|||
17148907|NCT03430063|38293751|FG000|Overall Study|Lost to Follow-up|0|||
17148908|NCT03430063|38293752|FG001|Overall Study|Lost to Follow-up|1|||
17148909|NCT03430063|38293753|FG002|Overall Study|Lost to Follow-up|0|||
17148910|NCT03430063|38293751|FG000|Overall Study|Withdrawal by Subject|0|||
17148911|NCT03430063|38293752|FG001|Overall Study|Withdrawal by Subject|0|||
17070407|NCT03961529|38212985|FG000|Overall Study|Lost to Follow-up|2|||
17070408|NCT03961529|38212986|FG001|Overall Study|Lost to Follow-up|1|||
17070409|NCT03961529|38212987|FG002|Overall Study|Lost to Follow-up|0|||
17070410|NCT03961529|38212985|FG000|Overall Study|Lack of Efficacy|2|||
17070411|NCT03961529|38212986|FG001|Overall Study|Lack of Efficacy|0|||
17070412|NCT03961529|38212987|FG002|Overall Study|Lack of Efficacy|1|||
17070413|NCT03961529|38212985|FG000|Overall Study|Other|6|||
17070414|NCT03961529|38212986|FG001|Overall Study|Other|1|||
17070415|NCT03961529|38212987|FG002|Overall Study|Other|0|||
17070416|NCT00494780|38212997|FG000|Overall Study|Adverse Event|1|||
17070417|NCT00494780|38212998|FG001|Overall Study|Adverse Event|0|||
17070418|NCT00494780|38212997|FG000|Overall Study|Withdrew before Dosed|0|||
17070419|NCT00494780|38212998|FG001|Overall Study|Withdrew before Dosed|1|||
17070420|NCT00494780|38212997|FG000|Overall Study|Progression of Study Disease|7|||
17070421|NCT00494780|38212998|FG001|Overall Study|Progression of Study Disease|8|||
17070422|NCT00494780|38212997|FG000|Overall Study|New Treatment|2|||
17070423|NCT00494780|38212998|FG001|Overall Study|New Treatment|2|||
17070424|NCT00494780|38212997|FG000|Overall Study|Non-compliance|1|||
17070425|NCT00494780|38212998|FG001|Overall Study|Non-compliance|0|||
17070426|NCT00494780|38212997|FG000|Overall Study|Residual Tumour Mass|0|||
17070427|NCT00494780|38212998|FG001|Overall Study|Residual Tumour Mass|1|||
17070428|NCT00494780|38212997|FG000|Overall Study|Insurance Issues|0|||
17070429|NCT00494780|38212998|FG001|Overall Study|Insurance Issues|1|||
17070430|NCT00490022|38213008|FG000|Overall Study|Adverse Event|0|||
17070431|NCT00490022|38213009|FG001|Overall Study|Adverse Event|2|||
17070432|NCT00490022|38213008|FG000|Overall Study|Withdrawal by Subject|1|||
17070433|NCT00490022|38213009|FG001|Overall Study|Withdrawal by Subject|0|||
17070434|NCT00490022|38213008|FG000|Overall Study|Subject failed to disclose concommitant|0|||
17070435|NCT00490022|38213009|FG001|Overall Study|Subject failed to disclose concommitant|1|||
17070436|NCT00493454|38213015|FG000|Overall Study|Withdrawal by Subject|1|||
17070437|NCT00493220|38213025|FG000|Third Intervention|Withdrawal by Subject|1|||
17070438|NCT00493220|38213026|FG001|Third Intervention|Withdrawal by Subject|0|||
17070439|NCT00493220|38213027|FG002|Third Intervention|Withdrawal by Subject|0|||
17070440|NCT00493220|38213028|FG003|Third Intervention|Withdrawal by Subject|0|||
17070441|NCT00493220|38213029|FG004|Third Intervention|Withdrawal by Subject|0|||
17070442|NCT00493220|38213030|FG005|Third Intervention|Withdrawal by Subject|0|||
17070443|NCT00394953|38213042|FG000|First Treatment Period|Adverse Event|1|||
17070444|NCT00394953|38213043|FG001|First Treatment Period|Adverse Event|2|||
17148912|NCT03430063|38293753|FG002|Overall Study|Withdrawal by Subject|1|||
17148913|NCT03430063|38293751|FG000|Overall Study|Withdrawal of consent|3|||
17070445|NCT00394953|38213042|FG000|First Treatment Period|Death|6|||
17070446|NCT00394953|38213043|FG001|First Treatment Period|Death|7|||
17070447|NCT00394953|38213042|FG000|First Treatment Period|Lack of Efficacy|1|||
17070448|NCT00394953|38213043|FG001|First Treatment Period|Lack of Efficacy|1|||
17070449|NCT00394953|38213042|FG000|First Treatment Period|Withdrawal by Subject|6|||
17070450|NCT00394953|38213043|FG001|First Treatment Period|Withdrawal by Subject|3|||
16781244|NCT02109484|37720410|FG001|Overall Study|Physician Decision|0|||
17148914|NCT03430063|38293752|FG001|Overall Study|Withdrawal of consent|1|||
17148915|NCT03430063|38293753|FG002|Overall Study|Withdrawal of consent|2|||
17148916|NCT03430063|38293751|FG000|Overall Study|Progressive disease|1|||
17148917|NCT03430063|38293752|FG001|Overall Study|Progressive disease|2|||
17148918|NCT03430063|38293753|FG002|Overall Study|Progressive disease|1|||
17148919|NCT03430063|38293751|FG000|Overall Study|Other un-specified|1|||
17070451|NCT00394953|38213042|FG000|First Treatment Period|Lost to Follow-up|0|||
17070452|NCT00394953|38213043|FG001|First Treatment Period|Lost to Follow-up|1|||
17070453|NCT00394953|38213042|FG000|First Treatment Period|Renal transplant|11|||
17070454|NCT00394953|38213043|FG001|First Treatment Period|Renal transplant|7|||
17070455|NCT00394953|38213042|FG000|First Treatment Period|Not defined|4|||
17070456|NCT00394953|38213043|FG001|First Treatment Period|Not defined|1|||
17070457|NCT00394953|38213042|FG000|Second Treatment Period|Adverse Event|2|||
17070458|NCT00394953|38213043|FG001|Second Treatment Period|Adverse Event|5|||
17070459|NCT00394953|38213042|FG000|Second Treatment Period|Death|8|||
17070460|NCT00394953|38213043|FG001|Second Treatment Period|Death|4|||
17070461|NCT00394953|38213042|FG000|Second Treatment Period|Lack of Efficacy|9|||
17070462|NCT00394953|38213043|FG001|Second Treatment Period|Lack of Efficacy|47|||
17070463|NCT00394953|38213042|FG000|Second Treatment Period|Withdrawal by Subject|3|||
17070464|NCT00394953|38213043|FG001|Second Treatment Period|Withdrawal by Subject|3|||
17070465|NCT00394953|38213042|FG000|Second Treatment Period|Lost to Follow-up|0|||
17070466|NCT00394953|38213043|FG001|Second Treatment Period|Lost to Follow-up|1|||
17070467|NCT00394953|38213042|FG000|Second Treatment Period|Renal transplant|4|||
17070468|NCT00394953|38213043|FG001|Second Treatment Period|Renal transplant|6|||
17070469|NCT00394953|38213042|FG000|Second Treatment Period|Not defined|3|||
17070470|NCT00394953|38213043|FG001|Second Treatment Period|Not defined|8|||
17070471|NCT00485732|38213051|FG000|Overall Study|Protocol Violation|1|||
17070472|NCT00485732|38213052|FG001|Overall Study|Protocol Violation|3|||
17070473|NCT00485732|38213051|FG000|Overall Study|Withdrawal by Subject|5|||
17070474|NCT00485732|38213052|FG001|Overall Study|Withdrawal by Subject|4|||
17070475|NCT00485732|38213051|FG000|Overall Study|Lost to Follow-up|2|||
17070476|NCT00485732|38213052|FG001|Overall Study|Lost to Follow-up|2|||
17070477|NCT00489554|38213058|FG000|Overall Study|Adverse Event|2|||
17070478|NCT00489554|38213058|FG000|Overall Study|Withdrawal by Subject|1|||
17070479|NCT00489554|38213058|FG000|Overall Study|Lost to Follow-up|1|||
17070480|NCT00408681|38213062|FG000|Overall Study|Lack of Efficacy|2|||
17070481|NCT00408681|38213062|FG000|Overall Study|Adverse Event|7|||
17070482|NCT00560417|38213069|FG000|Overall Study|Adverse Event|3|||
17070483|NCT00560417|38213070|FG001|Overall Study|Adverse Event|2|||
17070484|NCT00560417|38213069|FG000|Overall Study|Entry Criteria Not Met|1|||
17070485|NCT00560417|38213070|FG001|Overall Study|Entry Criteria Not Met|0|||
17070486|NCT00560417|38213069|FG000|Overall Study|Lost to Follow-up|0|||
17070487|NCT00560417|38213070|FG001|Overall Study|Lost to Follow-up|1|||
17070488|NCT00560417|38213069|FG000|Overall Study|Physician Decision|2|||
17070489|NCT00560417|38213070|FG001|Overall Study|Physician Decision|6|||
17070490|NCT00560417|38213069|FG000|Overall Study|Protocol Violation|6|||
17070491|NCT00560417|38213070|FG001|Overall Study|Protocol Violation|5|||
17070492|NCT00560417|38213069|FG000|Overall Study|Sponsor Decision|2|||
17070493|NCT00560417|38213070|FG001|Overall Study|Sponsor Decision|0|||
17070494|NCT00560417|38213069|FG000|Overall Study|Withdrawal by Subject|3|||
17070495|NCT00560417|38213070|FG001|Overall Study|Withdrawal by Subject|3|||
17070496|NCT03968159|38213083|FG000|Overall Study|Adverse Event|4|||
17070497|NCT03968159|38213084|FG001|Overall Study|Adverse Event|4|||
17070498|NCT03968159|38213083|FG000|Overall Study|Lost to Follow-up|1|||
17070499|NCT03968159|38213084|FG001|Overall Study|Lost to Follow-up|1|||
17070500|NCT03968159|38213083|FG000|Overall Study|Use of prohibited medication|0|||
17070501|NCT03968159|38213084|FG001|Overall Study|Use of prohibited medication|1|||
17070502|NCT03968159|38213083|FG000|Overall Study|Protocol Violation|2|||
17070503|NCT03968159|38213084|FG001|Overall Study|Protocol Violation|2|||
17070504|NCT03968159|38213083|FG000|Overall Study|Withdrawal by Subject|4|||
17070505|NCT03968159|38213084|FG001|Overall Study|Withdrawal by Subject|6|||
17070506|NCT03968159|38213083|FG000|Overall Study|Lack of Efficacy|0|||
17070507|NCT03968159|38213084|FG001|Overall Study|Lack of Efficacy|1|||
17070508|NCT03968159|38213083|FG000|Overall Study|Not further specified|2|||
17070509|NCT03968159|38213084|FG001|Overall Study|Not further specified|0|||
17070510|NCT03966911|38213092|FG000|Overall Study|Adverse Event|1|||
17070511|NCT03966911|38213093|FG001|Overall Study|Adverse Event|1|||
17070512|NCT03966911|38213092|FG000|Overall Study|Withdrawal by Subject|8|||
17070513|NCT03966911|38213093|FG001|Overall Study|Withdrawal by Subject|2|||
17070514|NCT03966911|38213092|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
17070515|NCT03966911|38213093|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
17070516|NCT03966365|38213103|FG000|Overall Study|Protocol Violation|1|||
17148920|NCT03430063|38293752|FG001|Overall Study|Other un-specified|1|||
17148921|NCT03430063|38293753|FG002|Overall Study|Other un-specified|0|||
17148922|NCT03430063|38293751|FG000|Overall Study|Randomized, but never treated|0|||
17148923|NCT03430063|38293752|FG001|Overall Study|Randomized, but never treated|0|||
17148924|NCT03430063|38293753|FG002|Overall Study|Randomized, but never treated|1|||
17148925|NCT03158220|38293764|FG000|Overall Study|Screen Failure|0|||
17148926|NCT03158220|38293765|FG001|Overall Study|Screen Failure|1|||
17148927|NCT03158220|38293764|FG000|Overall Study|Withdrawal by Subject|8|||
17148928|NCT03158220|38293765|FG001|Overall Study|Withdrawal by Subject|9|||
17148929|NCT03158220|38293764|FG000|Overall Study|Status unknown|0|||
17148930|NCT03158220|38293765|FG001|Overall Study|Status unknown|1|||
17148931|NCT03158220|38293764|FG000|Overall Study|Lost to Follow-up|8|||
17148932|NCT03158220|38293765|FG001|Overall Study|Lost to Follow-up|5|||
17148933|NCT03158220|38293764|FG000|Overall Study|Physician Decision|1|||
17148934|NCT03158220|38293765|FG001|Overall Study|Physician Decision|0|||
17148935|NCT03156270|38293771|FG000|Overall Study|Failed pre-treatment screening|1|||
17148936|NCT03156270|38293771|FG000|Overall Study|Lost to Follow-up|1|||
17148937|NCT03429049|38293779|FG000|Overall Study|Adverse Event|2|||
17148938|NCT03429049|38293780|FG001|Overall Study|Adverse Event|3|||
17148939|NCT03429049|38293779|FG000|Overall Study|Death|0|||
17148940|NCT03429049|38293780|FG001|Overall Study|Death|1|||
17070517|NCT03966365|38213104|FG001|Overall Study|Protocol Violation|0|||
17070518|NCT00375219|38213113|FG000|Overall Study|Failure to achieve a response|16|||
17070519|NCT00375219|38213114|FG001|Overall Study|Failure to achieve a response|2|||
17070520|NCT00375219|38213115|FG002|Overall Study|Failure to achieve a response|0|||
17070521|NCT00375219|38213113|FG000|Overall Study|Adverse Event|8|||
17070522|NCT00375219|38213114|FG001|Overall Study|Adverse Event|2|||
17070523|NCT00375219|38213115|FG002|Overall Study|Adverse Event|1|||
17070524|NCT00375219|38213113|FG000|Overall Study|Protocol Violation|1|||
17070525|NCT00375219|38213114|FG001|Overall Study|Protocol Violation|0|||
17070526|NCT00375219|38213115|FG002|Overall Study|Protocol Violation|1|||
17070527|NCT00375219|38213113|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
17070528|NCT00375219|38213114|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
17070529|NCT00375219|38213115|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
17070530|NCT00375219|38213113|FG000|Overall Study|Lost to Follow-up|1|||
17070531|NCT00375219|38213114|FG001|Overall Study|Lost to Follow-up|1|||
17070532|NCT00375219|38213115|FG002|Overall Study|Lost to Follow-up|0|||
17070533|NCT00375219|38213113|FG000|Overall Study|Disease progression|18|||
17070534|NCT00375219|38213114|FG001|Overall Study|Disease progression|9|||
17070535|NCT00375219|38213115|FG002|Overall Study|Disease progression|12|||
17070536|NCT00375219|38213113|FG000|Overall Study|Death|4|||
17070537|NCT00375219|38213114|FG001|Overall Study|Death|3|||
17070538|NCT00375219|38213115|FG002|Overall Study|Death|7|||
17070539|NCT00375219|38213113|FG000|Overall Study|Hematologic resistance|1|||
17070540|NCT00375219|38213114|FG001|Overall Study|Hematologic resistance|0|||
17070541|NCT00375219|38213115|FG002|Overall Study|Hematologic resistance|0|||
17070542|NCT00375219|38213113|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
17148941|NCT03429049|38293779|FG000|Overall Study|Lack of Efficacy|4|||
17148942|NCT03429049|38293780|FG001|Overall Study|Lack of Efficacy|2|||
17148943|NCT03429049|38293779|FG000|Overall Study|Lost to Follow-up|9|||
17148944|NCT03429049|38293780|FG001|Overall Study|Lost to Follow-up|8|||
17148945|NCT03429049|38293779|FG000|Overall Study|Physician Decision|1|||
17148946|NCT03429049|38293780|FG001|Overall Study|Physician Decision|0|||
17148947|NCT03429049|38293779|FG000|Overall Study|Protocol Violation|3|||
17148948|NCT03429049|38293780|FG001|Overall Study|Protocol Violation|0|||
17148949|NCT03429049|38293779|FG000|Overall Study|Sponsor Decision|2|||
17148950|NCT03429049|38293780|FG001|Overall Study|Sponsor Decision|0|||
17148951|NCT03429049|38293779|FG000|Overall Study|Withdrawal by Subject|4|||
17148952|NCT03429049|38293780|FG001|Overall Study|Withdrawal by Subject|20|||
17148953|NCT03429049|38293779|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
17148954|NCT03429049|38293780|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
17148955|NCT03428815|38293788|FG000|Overall Study|Lost to Follow-up|2|||
17148956|NCT03428815|38293789|FG001|Overall Study|Lost to Follow-up|2|||
17148957|NCT03428815|38293788|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
17148958|NCT03428815|38293789|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
17148959|NCT03428815|38293788|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
17148960|NCT03428815|38293789|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
17148961|NCT03155724|38293795|FG000|Overall Study|Death|3|||
17070543|NCT00375219|38213114|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
17070544|NCT00375219|38213115|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
17070545|NCT00375219|38213113|FG000|Overall Study|Allograft|2|||
17070546|NCT00375219|38213114|FG001|Overall Study|Allograft|0|||
17070547|NCT00375219|38213115|FG002|Overall Study|Allograft|0|||
17148962|NCT03155724|38293795|FG000|Overall Study|Physician Decision|1|||
17070548|NCT00375219|38213113|FG000|Overall Study|Cord blood transplantation|1|||
17070549|NCT00375219|38213114|FG001|Overall Study|Cord blood transplantation|0|||
17070550|NCT00375219|38213115|FG002|Overall Study|Cord blood transplantation|0|||
17148963|NCT03155724|38293795|FG000|Overall Study|Study closure|7|||
17148964|NCT03426787|38293799|FG000|Overall Study|Withdrawal by Subject|6|||
17148965|NCT03426787|38293799|FG000|Overall Study|Lost to Follow-up|7|||
17148966|NCT03426787|38293799|FG000|Overall Study|Unrelated to intervention death|1|||
17070551|NCT00375219|38213113|FG000|Overall Study|Withdrawal by Subject|1|||
17070552|NCT00375219|38213114|FG001|Overall Study|Withdrawal by Subject|0|||
17070553|NCT00375219|38213115|FG002|Overall Study|Withdrawal by Subject|0|||
17070554|NCT03965351|38213124|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
17070555|NCT03965351|38213125|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
17148967|NCT03426631|38293809|FG000|Overall Study|Lost to Follow-up|0|||
17148968|NCT03426631|38293810|FG001|Overall Study|Lost to Follow-up|1|||
17148969|NCT03484429|38293818|FG000|Overall Study|Withdrawal by Subject|1|||
17148970|NCT03484429|38293819|FG001|Overall Study|Withdrawal by Subject|0|||
17070556|NCT03965351|38213124|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
17070557|NCT03965351|38213125|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
17070558|NCT00554801|38213133|FG000|Overall Study|left area before completion|5|||
17070559|NCT00554801|38213134|FG001|Overall Study|left area before completion|0|||
17070560|NCT00554801|38213133|FG000|Overall Study|Withdrawal by Subject|14|||
17070561|NCT00554801|38213134|FG001|Overall Study|Withdrawal by Subject|0|||
17070562|NCT00374907|38213144|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
17070563|NCT00374907|38213145|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
17070564|NCT00374907|38213144|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
17070565|NCT00374907|38213145|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
17070566|NCT00374907|38213144|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
17070567|NCT00374907|38213145|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
17070568|NCT00374907|38213144|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
17070569|NCT00374907|38213145|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
17070570|NCT00374907|38213144|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
17070571|NCT00374907|38213145|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
17070572|NCT00374127|38213153|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
17070573|NCT00374127|38213153|FG000|Overall Study|Blood could not be drawn.|2|||
17070574|NCT00374127|38213153|FG000|Overall Study|Protocol Violation|5|||
17070575|NCT00374127|38213153|FG000|Overall Study|Pregnancy|1|||
17070576|NCT00553787|38213166|FG000|Overall Study|Adverse Event|34|||
17070577|NCT00553787|38213167|FG001|Overall Study|Adverse Event|21|||
17070578|NCT00553787|38213168|FG002|Overall Study|Adverse Event|67|||
17070579|NCT00553787|38213166|FG000|Overall Study|Lost to Follow-up|132|||
17070580|NCT00553787|38213167|FG001|Overall Study|Lost to Follow-up|44|||
17148971|NCT03484429|38293818|FG000|Overall Study|Adverse Event|2|||
17148972|NCT03484429|38293819|FG001|Overall Study|Adverse Event|0|||
17148973|NCT03484273|38293825|FG000|Overall Study|Equipment Malfunction|1|||
17148974|NCT03484273|38293825|FG000|Overall Study|Data excluded from analysis|1|||
17148975|NCT02724592|38293839|FG000|Overall Study|Lost to Follow-up|4|||
17148976|NCT02724592|38293840|FG001|Overall Study|Lost to Follow-up|1|||
17148977|NCT03154476|38293848|FG000|Overall Study|Lost to Follow-up|4|||
17148978|NCT03154476|38293849|FG001|Overall Study|Lost to Follow-up|4|||
17148979|NCT02726074|38293855|FG000|Overall Study|Withdrawal by Subject|4|||
17148980|NCT02726074|38293855|FG000|Overall Study|Adverse Event|14|||
17148981|NCT02726074|38293855|FG000|Overall Study|Protocol Violation|3|||
17148982|NCT02726074|38293855|FG000|Overall Study|Lost to Follow-up|2|||
17148983|NCT02726074|38293855|FG000|Overall Study|Others|3|||
17148984|NCT03483961|38293869|FG000|Overall Study|Lost to Follow-up|7|||
17148985|NCT03483961|38293870|FG001|Overall Study|Lost to Follow-up|6|||
17148986|NCT03483961|38293871|FG002|Overall Study|Lost to Follow-up|6|||
17148987|NCT03483961|38293872|FG003|Overall Study|Lost to Follow-up|6|||
17148988|NCT03483961|38293873|FG004|Overall Study|Lost to Follow-up|6|||
17148989|NCT03483961|38293874|FG005|Overall Study|Lost to Follow-up|4|||
17148990|NCT03483961|38293875|FG006|Overall Study|Lost to Follow-up|4|||
17148991|NCT03483961|38293876|FG007|Overall Study|Lost to Follow-up|11|||
17148992|NCT03483961|38293877|FG008|Overall Study|Lost to Follow-up|1|||
17148993|NCT03483961|38293878|FG009|Overall Study|Lost to Follow-up|0|||
17148994|NCT03483961|38293869|FG000|Overall Study|Withdrawal by Subject|3|||
17148995|NCT03483961|38293870|FG001|Overall Study|Withdrawal by Subject|4|||
17148996|NCT03483961|38293871|FG002|Overall Study|Withdrawal by Subject|5|||
17148997|NCT03483961|38293872|FG003|Overall Study|Withdrawal by Subject|3|||
17148998|NCT03483961|38293873|FG004|Overall Study|Withdrawal by Subject|4|||
17148999|NCT03483961|38293874|FG005|Overall Study|Withdrawal by Subject|2|||
17149000|NCT03483961|38293875|FG006|Overall Study|Withdrawal by Subject|1|||
17149001|NCT03483961|38293876|FG007|Overall Study|Withdrawal by Subject|2|||
17149002|NCT03483961|38293877|FG008|Overall Study|Withdrawal by Subject|1|||
17149003|NCT03483961|38293878|FG009|Overall Study|Withdrawal by Subject|0|||
17149004|NCT03483961|38293869|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
17149005|NCT03483961|38293870|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149006|NCT03483961|38293871|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149007|NCT03483961|38293872|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149008|NCT03483961|38293873|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149009|NCT03483961|38293874|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149010|NCT03483961|38293875|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149011|NCT03483961|38293876|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149012|NCT03483961|38293877|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149013|NCT03483961|38293878|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
17149014|NCT03483961|38293869|FG000|Overall Study|Adverse Event|0|||
17149015|NCT03483961|38293870|FG001|Overall Study|Adverse Event|0|||
17149016|NCT03483961|38293871|FG002|Overall Study|Adverse Event|1|||
17070581|NCT00553787|38213168|FG002|Overall Study|Lost to Follow-up|78|||
17070582|NCT00553787|38213166|FG000|Overall Study|Withdrawal by Subject|151|||
17070583|NCT00553787|38213167|FG001|Overall Study|Withdrawal by Subject|40|||
17070584|NCT00553787|38213168|FG002|Overall Study|Withdrawal by Subject|83|||
17070585|NCT00553787|38213166|FG000|Overall Study|Lack of Efficacy|31|||
17070586|NCT00553787|38213167|FG001|Overall Study|Lack of Efficacy|1|||
17070587|NCT00553787|38213168|FG002|Overall Study|Lack of Efficacy|3|||
17070588|NCT00553787|38213166|FG000|Overall Study|Pregnancy|0|||
17070589|NCT00553787|38213167|FG001|Overall Study|Pregnancy|1|||
17070590|NCT00553787|38213168|FG002|Overall Study|Pregnancy|2|||
17070591|NCT00553787|38213166|FG000|Overall Study|non compliance|4|||
17070592|NCT00553787|38213167|FG001|Overall Study|non compliance|0|||
17070593|NCT00553787|38213168|FG002|Overall Study|non compliance|11|||
17070594|NCT00553787|38213166|FG000|Overall Study|Requirement for restricted medication|8|||
17070595|NCT00553787|38213167|FG001|Overall Study|Requirement for restricted medication|7|||
17070596|NCT00553787|38213168|FG002|Overall Study|Requirement for restricted medication|5|||
17070597|NCT00553787|38213166|FG000|Overall Study|Other|18|||
17070598|NCT00553787|38213167|FG001|Overall Study|Other|10|||
17070599|NCT00553787|38213168|FG002|Overall Study|Other|13|||
17070600|NCT00407745|38213178|FG000|Overall Study|Lack of Efficacy|1|||
17070601|NCT00407745|38213179|FG001|Overall Study|Lack of Efficacy|2|||
17070602|NCT00407745|38213178|FG000|Overall Study|Withdrawal by Subject|3|||
17070603|NCT00407745|38213179|FG001|Overall Study|Withdrawal by Subject|3|||
17070604|NCT00407745|38213178|FG000|Overall Study|Protocol Violation|5|||
17070605|NCT00407745|38213179|FG001|Overall Study|Protocol Violation|3|||
17070606|NCT00407745|38213178|FG000|Overall Study|Adverse Event|8|||
17070607|NCT00407745|38213179|FG001|Overall Study|Adverse Event|8|||
17070608|NCT00407745|38213178|FG000|Overall Study|Other|2|||
17070609|NCT00407745|38213179|FG001|Overall Study|Other|0|||
17149017|NCT03483961|38293872|FG003|Overall Study|Adverse Event|0|||
17149018|NCT03483961|38293873|FG004|Overall Study|Adverse Event|0|||
17149019|NCT03483961|38293874|FG005|Overall Study|Adverse Event|0|||
17149020|NCT03483961|38293875|FG006|Overall Study|Adverse Event|0|||
17149021|NCT03483961|38293876|FG007|Overall Study|Adverse Event|0|||
17149022|NCT03483961|38293877|FG008|Overall Study|Adverse Event|0|||
17149023|NCT03483961|38293878|FG009|Overall Study|Adverse Event|0|||
17149024|NCT03482635|38293903|FG000|Overall Study|Lack of Efficacy|0|||
17149025|NCT03482635|38293904|FG001|Overall Study|Lack of Efficacy|0|||
17149026|NCT03482635|38293905|FG002|Overall Study|Lack of Efficacy|1|||
17149027|NCT03482635|38293906|FG003|Overall Study|Lack of Efficacy|3|||
17149028|NCT03482635|38293903|FG000|Overall Study|Adverse Event|2|||
17149029|NCT03482635|38293904|FG001|Overall Study|Adverse Event|2|||
17149030|NCT03482635|38293905|FG002|Overall Study|Adverse Event|0|||
17149031|NCT03482635|38293906|FG003|Overall Study|Adverse Event|3|||
17149032|NCT03482635|38293903|FG000|Overall Study|Withdrawal by Subject|2|||
17149033|NCT03482635|38293904|FG001|Overall Study|Withdrawal by Subject|1|||
17149034|NCT03482635|38293905|FG002|Overall Study|Withdrawal by Subject|0|||
17149035|NCT03482635|38293906|FG003|Overall Study|Withdrawal by Subject|1|||
17149036|NCT03482635|38293903|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
17149037|NCT03482635|38293904|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
17149038|NCT03482635|38293905|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
17149039|NCT03482635|38293906|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
17149040|NCT03482635|38293903|FG000|Overall Study|Not treated|0|||
17149041|NCT03482635|38293904|FG001|Overall Study|Not treated|0|||
17149042|NCT03482635|38293905|FG002|Overall Study|Not treated|0|||
17149043|NCT03482635|38293906|FG003|Overall Study|Not treated|1|||
17149044|NCT03712787|38293920|FG000|Overall Study|Adverse Event|2|||
17149045|NCT03712787|38293921|FG001|Overall Study|Adverse Event|3|||
17149046|NCT03712787|38293922|FG002|Overall Study|Adverse Event|0|||
17149047|NCT03712787|38293923|FG003|Overall Study|Adverse Event|4|||
17149048|NCT03712787|38293920|FG000|Overall Study|Withdrawal by Subject|4|||
17149049|NCT03712787|38293921|FG001|Overall Study|Withdrawal by Subject|14|||
17149050|NCT03712787|38293922|FG002|Overall Study|Withdrawal by Subject|12|||
17149051|NCT03712787|38293923|FG003|Overall Study|Withdrawal by Subject|8|||
17149052|NCT03712787|38293920|FG000|Overall Study|Lost to Follow-up|1|||
17149053|NCT03712787|38293921|FG001|Overall Study|Lost to Follow-up|1|||
17149054|NCT03712787|38293922|FG002|Overall Study|Lost to Follow-up|2|||
17070610|NCT00407745|38213178|FG000|Overall Study|Randomized, unknown if treated|0|||
17149055|NCT03712787|38293923|FG003|Overall Study|Lost to Follow-up|1|||
17149056|NCT03712787|38293920|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
17149057|NCT03712787|38293921|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
17149058|NCT03712787|38293922|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
17149059|NCT03712787|38293923|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
16994117|NCT00773968|38137920|FG000|Overall Study|Withdrawal by Subject|11|||
16994118|NCT00773968|38137920|FG000|Overall Study|Screen Failure|17|||
16994119|NCT00773968|38137920|FG000|Overall Study|Other|8|||
16994120|NCT00782626|38137924|FG000|Overall Study|Adverse Event|1|||
16994121|NCT00782626|38137924|FG000|Overall Study|Progressive Disease|5|||
16994122|NCT00782626|38137924|FG000|Overall Study|Other Complicating Disease|1|||
16994123|NCT01071083|38137933|FG000|Overall Study|Adverse Event|1|||
16994124|NCT01071083|38137934|FG001|Overall Study|Adverse Event|0|||
16994125|NCT01071083|38137935|FG002|Overall Study|Adverse Event|1|||
16994126|NCT01071083|38137936|FG003|Overall Study|Adverse Event|0|||
16994127|NCT01071083|38137937|FG004|Overall Study|Adverse Event|1|||
16994128|NCT01071083|38137933|FG000|Overall Study|Withdrawal by Subject|3|||
16994129|NCT01071083|38137934|FG001|Overall Study|Withdrawal by Subject|0|||
16994130|NCT01071083|38137935|FG002|Overall Study|Withdrawal by Subject|2|||
16994131|NCT01071083|38137936|FG003|Overall Study|Withdrawal by Subject|0|||
16994132|NCT01071083|38137937|FG004|Overall Study|Withdrawal by Subject|3|||
16994133|NCT01071083|38137933|FG000|Overall Study|Physician Decision|1|||
16994134|NCT01071083|38137934|FG001|Overall Study|Physician Decision|0|||
16994135|NCT01071083|38137935|FG002|Overall Study|Physician Decision|0|||
16994136|NCT01071083|38137936|FG003|Overall Study|Physician Decision|1|||
16994137|NCT01071083|38137937|FG004|Overall Study|Physician Decision|1|||
16994138|NCT01071083|38137933|FG000|Overall Study|Early Rescue|1|||
16994139|NCT01071083|38137934|FG001|Overall Study|Early Rescue|0|||
16994140|NCT01071083|38137935|FG002|Overall Study|Early Rescue|0|||
16994141|NCT01071083|38137936|FG003|Overall Study|Early Rescue|0|||
16994142|NCT01071083|38137937|FG004|Overall Study|Early Rescue|1|||
16994143|NCT01071083|38137933|FG000|Overall Study|Subject Moved|0|||
16994144|NCT01071083|38137934|FG001|Overall Study|Subject Moved|1|||
16994145|NCT01071083|38137935|FG002|Overall Study|Subject Moved|0|||
16994146|NCT01071083|38137936|FG003|Overall Study|Subject Moved|0|||
16994147|NCT01071083|38137937|FG004|Overall Study|Subject Moved|0|||
16994148|NCT01071083|38137933|FG000|Overall Study|Images Not Usable (Motion)|0|||
16994149|NCT01071083|38137934|FG001|Overall Study|Images Not Usable (Motion)|1|||
16994150|NCT01071083|38137935|FG002|Overall Study|Images Not Usable (Motion)|0|||
16994151|NCT01071083|38137936|FG003|Overall Study|Images Not Usable (Motion)|0|||
16994152|NCT01071083|38137937|FG004|Overall Study|Images Not Usable (Motion)|0|||
16994153|NCT01071083|38137933|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
16994154|NCT01071083|38137934|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
16994155|NCT01071083|38137935|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
16994156|NCT01071083|38137936|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
16994157|NCT01071083|38137937|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
16994158|NCT01071083|38137933|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
16994159|NCT01071083|38137934|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
16994160|NCT01071083|38137935|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
16994161|NCT01071083|38137936|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
16994162|NCT01071083|38137937|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
16994163|NCT01071083|38137933|FG000|Overall Study|Subject Refused to Continue|1|||
16994164|NCT01071083|38137934|FG001|Overall Study|Subject Refused to Continue|0|||
16994165|NCT01071083|38137935|FG002|Overall Study|Subject Refused to Continue|0|||
16994166|NCT01071083|38137936|FG003|Overall Study|Subject Refused to Continue|0|||
16994167|NCT01071083|38137937|FG004|Overall Study|Subject Refused to Continue|0|||
16994168|NCT01070771|38137949|FG000|Overall Study|Adverse Event|2|||
16994169|NCT01070771|38137949|FG000|Overall Study|Protocol Violation|1|||
16994170|NCT01070381|38137954|FG000|Period 2, 1 Week of Wear|Handling|0|||
16994171|NCT01070381|38137955|FG001|Period 2, 1 Week of Wear|Handling|1|||
16994172|NCT01070381|38137954|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
16994173|NCT01070381|38137955|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
16994174|NCT01010126|38137976|FG000|Overall Study|Withdrawal by Subject|1|||
16994175|NCT01010126|38137977|FG001|Overall Study|Withdrawal by Subject|0|||
16994176|NCT01010126|38137978|FG002|Overall Study|Withdrawal by Subject|1|||
16994177|NCT01010126|38137979|FG003|Overall Study|Withdrawal by Subject|0|||
16994178|NCT01010126|38137980|FG004|Overall Study|Withdrawal by Subject|3|||
16994179|NCT01010126|38137981|FG005|Overall Study|Withdrawal by Subject|0|||
16994180|NCT01043705|38137998|FG000|Overall Study|Death|28|||
16994181|NCT01043705|38137999|FG001|Overall Study|Death|60|||
16994182|NCT01043705|38138000|FG002|Overall Study|Death|26|||
16781245|NCT02109484|37720411|FG002|Overall Study|Physician Decision|0|||
16994183|NCT01043705|38137998|FG000|Overall Study|Lost to Follow-up|27|||
16994184|NCT01043705|38137999|FG001|Overall Study|Lost to Follow-up|12|||
16994185|NCT01043705|38138000|FG002|Overall Study|Lost to Follow-up|0|||
16994186|NCT01043705|38137998|FG000|Overall Study|Multiple Reasons|4|||
16994187|NCT01043705|38137999|FG001|Overall Study|Multiple Reasons|7|||
17070611|NCT00407745|38213179|FG001|Overall Study|Randomized, unknown if treated|1|||
17070612|NCT03958955|38213185|FG000|Overall Study|Adverse Event|1|||
17070613|NCT00464334|38213202|FG000|Overall Study|Adverse Event|0|||
17149060|NCT03712787|38293920|FG000|Overall Study|COVID-19 Infection|0|||
17149061|NCT03712787|38293921|FG001|Overall Study|COVID-19 Infection|1|||
17149062|NCT03712787|38293922|FG002|Overall Study|COVID-19 Infection|0|||
17149063|NCT03712787|38293923|FG003|Overall Study|COVID-19 Infection|0|||
17149064|NCT03712787|38293920|FG000|Overall Study|Other, Not Specified|79|||
17149065|NCT03712787|38293921|FG001|Overall Study|Other, Not Specified|77|||
17149066|NCT03712787|38293922|FG002|Overall Study|Other, Not Specified|74|||
17149067|NCT03712787|38293923|FG003|Overall Study|Other, Not Specified|78|||
17149068|NCT03048422|38293955|FG000|Overall Study|Death|1|||
17149069|NCT03048422|38293956|FG001|Overall Study|Death|0|||
17149070|NCT03048422|38293957|FG002|Overall Study|Death|0|||
17149071|NCT03048422|38293955|FG000|Overall Study|Lost to Follow-up|5|||
17149072|NCT03048422|38293956|FG001|Overall Study|Lost to Follow-up|0|||
17149073|NCT03048422|38293957|FG002|Overall Study|Lost to Follow-up|1|||
17149074|NCT03048422|38293955|FG000|Overall Study|Withdrawal by Subject|5|||
17149075|NCT03048422|38293956|FG001|Overall Study|Withdrawal by Subject|7|||
17149076|NCT03048422|38293957|FG002|Overall Study|Withdrawal by Subject|4|||
17149077|NCT03048422|38293955|FG000|Overall Study|Moved|3|||
17149078|NCT03048422|38293956|FG001|Overall Study|Moved|2|||
17149079|NCT03048422|38293957|FG002|Overall Study|Moved|2|||
17149080|NCT03048422|38293955|FG000|Overall Study|Noncompliant with Study Requirements|2|||
17149081|NCT03048422|38293956|FG001|Overall Study|Noncompliant with Study Requirements|1|||
17149082|NCT03048422|38293957|FG002|Overall Study|Noncompliant with Study Requirements|2|||
17149083|NCT03048422|38293955|FG000|Overall Study|Not Able to Get to Clinic|1|||
17149084|NCT03048422|38293956|FG001|Overall Study|Not Able to Get to Clinic|0|||
17149085|NCT03048422|38293957|FG002|Overall Study|Not Able to Get to Clinic|0|||
17149086|NCT04664855|38293977|FG000|Overall Study|Withdrawal by Subject|0|||
17149087|NCT04664855|38293978|FG001|Overall Study|Withdrawal by Subject|2|||
17149088|NCT04664153|38293988|FG000|Overall Study|Lack of Efficacy|0|||
17149089|NCT04664153|38293989|FG001|Overall Study|Lack of Efficacy|0|||
17149090|NCT04664153|38293990|FG002|Overall Study|Lack of Efficacy|1|||
17149091|NCT04664153|38293991|FG003|Overall Study|Lack of Efficacy|0|||
17149092|NCT04664153|38293988|FG000|Overall Study|Physician Decision|0|||
17149093|NCT04664153|38293989|FG001|Overall Study|Physician Decision|0|||
17149094|NCT04664153|38293990|FG002|Overall Study|Physician Decision|1|||
17149095|NCT04664153|38293991|FG003|Overall Study|Physician Decision|0|||
17149096|NCT04664153|38293988|FG000|Overall Study|Withdrawal by Subject|3|||
17149097|NCT04664153|38293989|FG001|Overall Study|Withdrawal by Subject|2|||
17149098|NCT04664153|38293990|FG002|Overall Study|Withdrawal by Subject|1|||
17149099|NCT04664153|38293991|FG003|Overall Study|Withdrawal by Subject|2|||
17149100|NCT04664153|38293988|FG000|Overall Study|Other|0|||
17149101|NCT04664153|38293989|FG001|Overall Study|Other|1|||
17149102|NCT04664153|38293990|FG002|Overall Study|Other|0|||
17149103|NCT04664153|38293991|FG003|Overall Study|Other|0|||
17149104|NCT04664153|38293988|FG000|Overall Study|Adverse Event|4|||
17149105|NCT04664153|38293989|FG001|Overall Study|Adverse Event|0|||
17149106|NCT04664153|38293990|FG002|Overall Study|Adverse Event|1|||
17149107|NCT04664153|38293991|FG003|Overall Study|Adverse Event|0|||
17149108|NCT04663295|38294003|FG000|Run-in Period|Withdrawal by Subject|3|||
17149109|NCT04663295|38294003|FG000|Overall Study Period|Pregnancy|1|||
17149110|NCT04663295|38294003|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
17149111|NCT04228445|38294014|FG000|Overall Study|Lost to Follow-up|1|||
17149112|NCT04228445|38294015|FG001|Overall Study|Lost to Follow-up|1|||
17149113|NCT04228445|38294014|FG000|Overall Study|Physician Decision|1|||
17149114|NCT04228445|38294015|FG001|Overall Study|Physician Decision|2|||
17149115|NCT04228445|38294014|FG000|Overall Study|Withdrawal by Subject|0|||
17149116|NCT04228445|38294015|FG001|Overall Study|Withdrawal by Subject|1|||
17149117|NCT04228445|38294014|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
16781246|NCT02109484|37720412|FG003|Overall Study|Physician Decision|0|||
17070614|NCT00464334|38213203|FG001|Overall Study|Adverse Event|0|||
17070615|NCT00464334|38213204|FG002|Overall Study|Adverse Event|0|||
17070616|NCT00464334|38213205|FG003|Overall Study|Adverse Event|1|||
17070617|NCT00464334|38213206|FG004|Overall Study|Adverse Event|1|||
17070618|NCT00464334|38213207|FG005|Overall Study|Adverse Event|1|||
17070619|NCT00464334|38213208|FG006|Overall Study|Adverse Event|0|||
17070620|NCT00464334|38213209|FG007|Overall Study|Adverse Event|0|||
17070621|NCT00464334|38213210|FG008|Overall Study|Adverse Event|2|||
17070622|NCT00464334|38213211|FG009|Overall Study|Adverse Event|1|||
17149118|NCT04228445|38294015|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
17149119|NCT04641299|38294027|FG000|Overall Study|Adverse Event|0|||
17149120|NCT04641299|38294028|FG001|Overall Study|Adverse Event|0|||
17149121|NCT04641299|38294029|FG002|Overall Study|Adverse Event|2|||
17149122|NCT04641299|38294030|FG003|Overall Study|Adverse Event|0|||
17149123|NCT04641299|38294027|FG000|Overall Study|Lost to Follow-up|0|||
17149124|NCT04641299|38294028|FG001|Overall Study|Lost to Follow-up|1|||
17149125|NCT04641299|38294029|FG002|Overall Study|Lost to Follow-up|0|||
17149126|NCT04641299|38294030|FG003|Overall Study|Lost to Follow-up|0|||
17149127|NCT04641299|38294027|FG000|Overall Study|Withdrawal by Subject|1|||
17149128|NCT04641299|38294028|FG001|Overall Study|Withdrawal by Subject|0|||
17149129|NCT04641299|38294029|FG002|Overall Study|Withdrawal by Subject|0|||
17149130|NCT04641299|38294030|FG003|Overall Study|Withdrawal by Subject|0|||
17149131|NCT04641299|38294027|FG000|Overall Study|Reason not given|1|||
17149132|NCT04641299|38294028|FG001|Overall Study|Reason not given|0|||
17149133|NCT04641299|38294029|FG002|Overall Study|Reason not given|0|||
17149134|NCT04641299|38294030|FG003|Overall Study|Reason not given|0|||
17070623|NCT00464334|38213212|FG010|Overall Study|Adverse Event|2|||
17070624|NCT00464334|38213202|FG000|Overall Study|Lack of Efficacy|0|||
17070625|NCT00464334|38213203|FG001|Overall Study|Lack of Efficacy|1|||
17070626|NCT00464334|38213204|FG002|Overall Study|Lack of Efficacy|0|||
17070627|NCT00464334|38213205|FG003|Overall Study|Lack of Efficacy|0|||
17070628|NCT00464334|38213206|FG004|Overall Study|Lack of Efficacy|0|||
17149135|NCT03703817|38294046|FG000|Overall Study|Not meeting eligibility criteria|7|||
17149136|NCT03703817|38294047|FG001|Overall Study|Not meeting eligibility criteria|4|||
17149137|NCT03698591|38294055|FG000|Overall Study|Withdrawal by Subject|2|||
17149138|NCT03698591|38294056|FG001|Overall Study|Withdrawal by Subject|2|||
17149139|NCT03698591|38294055|FG000|Overall Study|Failed drug screen|1|||
17149140|NCT03698591|38294056|FG001|Overall Study|Failed drug screen|1|||
17149141|NCT03698591|38294055|FG000|Overall Study|Failed health screen|0|||
17149142|NCT03698591|38294056|FG001|Overall Study|Failed health screen|1|||
17149143|NCT03698591|38294055|FG000|Overall Study|Ineligible for financial compensation|1|||
17149144|NCT03698591|38294056|FG001|Overall Study|Ineligible for financial compensation|0|||
17149145|NCT03698591|38294055|FG000|Overall Study|Equipment Error|1|||
17149146|NCT03698591|38294056|FG001|Overall Study|Equipment Error|0|||
17149147|NCT03698591|38294055|FG000|Overall Study|Could not establish TMS dosage|0|||
17149148|NCT03698591|38294056|FG001|Overall Study|Could not establish TMS dosage|1|||
17149149|NCT04606199|38294062|FG000|Overall Study|Withdrawal by Subject|2|||
17149150|NCT05085665|38294068|FG000|Overall Study|Physician Decision|2|||
17149151|NCT05017493|38294074|FG000|Overall Study|Withdrawal by Subject|26|||
17149152|NCT05017493|38294075|FG001|Overall Study|Withdrawal by Subject|0|||
17149153|NCT05017493|38294074|FG000|Overall Study|Physician Decision|15|||
17149154|NCT05017493|38294075|FG001|Overall Study|Physician Decision|0|||
17149155|NCT05017493|38294074|FG000|Overall Study|Protocol Violation|81|||
17149156|NCT05017493|38294075|FG001|Overall Study|Protocol Violation|0|||
17149157|NCT04599803|38294081|FG000|Overall Study|Withdrawal by Subject|5|||
17149158|NCT04599803|38294081|FG000|Overall Study|Lost to Follow-up|26|||
17149159|NCT05002985|38294085|FG000|Overall Study|Withdrawal by Subject|1|||
17149160|NCT04580303|38294091|FG000|Overall Study|Adverse Event|0|||
17149161|NCT04580303|38294092|FG001|Overall Study|Adverse Event|1|||
17149162|NCT04580303|38294093|FG002|Overall Study|Adverse Event|0|||
17149163|NCT04580303|38294094|FG003|Overall Study|Adverse Event|0|||
17149164|NCT04580303|38294091|FG000|Overall Study|Withdrawal by Subject|0|||
17149165|NCT04580303|38294092|FG001|Overall Study|Withdrawal by Subject|0|||
17149166|NCT04580303|38294093|FG002|Overall Study|Withdrawal by Subject|1|||
17149167|NCT04580303|38294094|FG003|Overall Study|Withdrawal by Subject|0|||
17149168|NCT04577183|38294104|FG000|Overall Study|Death|1|||
17149169|NCT04577183|38294104|FG000|Overall Study|Withdrawal by Subject|3|||
17149170|NCT04577183|38294104|FG000|Overall Study|Early termination|2|||
17149171|NCT02928224|38294112|FG000|Overall Study|Randomized, Not Treated|0|||
17149172|NCT02928224|38294113|FG001|Overall Study|Randomized, Not Treated|2|||
17149173|NCT02928224|38294114|FG002|Overall Study|Randomized, Not Treated|4|||
17149174|NCT02928224|38294115|FG003|Overall Study|Randomized, Not Treated|28|||
17149175|NCT02928224|38294112|FG000|Overall Study|Treatment Ongoing|6|||
17149176|NCT02928224|38294113|FG001|Overall Study|Treatment Ongoing|78|||
17149177|NCT02928224|38294114|FG002|Overall Study|Treatment Ongoing|78|||
17149178|NCT02928224|38294115|FG003|Overall Study|Treatment Ongoing|37|||
17149179|NCT02928224|38294112|FG000|Overall Study|Progressive Disease|23|||
17149180|NCT02928224|38294113|FG001|Overall Study|Progressive Disease|104|||
17149181|NCT02928224|38294114|FG002|Overall Study|Progressive Disease|101|||
17149182|NCT02928224|38294115|FG003|Overall Study|Progressive Disease|103|||
17149183|NCT02928224|38294112|FG000|Overall Study|Adverse Event|2|||
17149184|NCT02928224|38294113|FG001|Overall Study|Adverse Event|11|||
17070629|NCT00464334|38213207|FG005|Overall Study|Lack of Efficacy|0|||
17070630|NCT00464334|38213208|FG006|Overall Study|Lack of Efficacy|0|||
17070631|NCT00464334|38213209|FG007|Overall Study|Lack of Efficacy|0|||
17149185|NCT02928224|38294114|FG002|Overall Study|Adverse Event|11|||
17149186|NCT02928224|38294115|FG003|Overall Study|Adverse Event|10|||
17149187|NCT02928224|38294112|FG000|Overall Study|Changes in Patient's Condition|3|||
17149188|NCT02928224|38294113|FG001|Overall Study|Changes in Patient's Condition|9|||
17149189|NCT02928224|38294114|FG002|Overall Study|Changes in Patient's Condition|9|||
17149190|NCT02928224|38294115|FG003|Overall Study|Changes in Patient's Condition|13|||
17149191|NCT02928224|38294112|FG000|Overall Study|Death|1|||
17070632|NCT00464334|38213210|FG008|Overall Study|Lack of Efficacy|0|||
17070633|NCT00464334|38213211|FG009|Overall Study|Lack of Efficacy|0|||
17149192|NCT02928224|38294113|FG001|Overall Study|Death|7|||
17149193|NCT02928224|38294114|FG002|Overall Study|Death|5|||
17070634|NCT00464334|38213212|FG010|Overall Study|Lack of Efficacy|0|||
17070635|NCT00464334|38213202|FG000|Overall Study|Lost to Follow-up|0|||
17070636|NCT00464334|38213203|FG001|Overall Study|Lost to Follow-up|0|||
17070637|NCT00464334|38213204|FG002|Overall Study|Lost to Follow-up|1|||
17070638|NCT00464334|38213205|FG003|Overall Study|Lost to Follow-up|0|||
17070639|NCT00464334|38213206|FG004|Overall Study|Lost to Follow-up|1|||
17149194|NCT02928224|38294115|FG003|Overall Study|Death|11|||
17149195|NCT02928224|38294112|FG000|Overall Study|Withdrawal by Subject|1|||
17149196|NCT02928224|38294113|FG001|Overall Study|Withdrawal by Subject|4|||
17149197|NCT02928224|38294114|FG002|Overall Study|Withdrawal by Subject|3|||
17149198|NCT02928224|38294115|FG003|Overall Study|Withdrawal by Subject|9|||
17149199|NCT02928224|38294112|FG000|Overall Study|Dose Interruptions>28|1|||
17149200|NCT02928224|38294113|FG001|Overall Study|Dose Interruptions>28|2|||
17149201|NCT02928224|38294114|FG002|Overall Study|Dose Interruptions>28|2|||
17149202|NCT02928224|38294115|FG003|Overall Study|Dose Interruptions>28|4|||
17149203|NCT02928224|38294112|FG000|Overall Study|Patient Decision to Discontinue Drug|0|||
17149204|NCT02928224|38294113|FG001|Overall Study|Patient Decision to Discontinue Drug|2|||
17149205|NCT02928224|38294114|FG002|Overall Study|Patient Decision to Discontinue Drug|2|||
17149206|NCT02928224|38294115|FG003|Overall Study|Patient Decision to Discontinue Drug|4|||
17070640|NCT00464334|38213207|FG005|Overall Study|Lost to Follow-up|0|||
17070641|NCT00464334|38213208|FG006|Overall Study|Lost to Follow-up|1|||
17149207|NCT02928224|38294112|FG000|Overall Study|Physician Decision|0|||
17070642|NCT00464334|38213209|FG007|Overall Study|Lost to Follow-up|0|||
17070643|NCT00464334|38213210|FG008|Overall Study|Lost to Follow-up|0|||
17070644|NCT00464334|38213211|FG009|Overall Study|Lost to Follow-up|0|||
17070645|NCT00464334|38213212|FG010|Overall Study|Lost to Follow-up|2|||
17149208|NCT02928224|38294113|FG001|Overall Study|Physician Decision|2|||
17149209|NCT02928224|38294114|FG002|Overall Study|Physician Decision|4|||
17149210|NCT02928224|38294115|FG003|Overall Study|Physician Decision|2|||
17149211|NCT02928224|38294112|FG000|Overall Study|not listed|0|||
17070646|NCT00464334|38213202|FG000|Overall Study|Progressive Disease|0|||
17070647|NCT00464334|38213203|FG001|Overall Study|Progressive Disease|0|||
17149212|NCT02928224|38294113|FG001|Overall Study|not listed|3|||
17149213|NCT02928224|38294114|FG002|Overall Study|not listed|1|||
17149214|NCT02928224|38294115|FG003|Overall Study|not listed|0|||
17149215|NCT03704051|38294130|FG000|Overall Study|Withdrawal by Subject|4|||
17149216|NCT03704051|38294131|FG001|Overall Study|Withdrawal by Subject|0|||
17149217|NCT04574999|38294141|FG000|Overall Study|Adverse Event|1|||
17149218|NCT04574999|38294142|FG001|Overall Study|Adverse Event|0|||
17149219|NCT04574999|38294141|FG000|Overall Study|Lack of Efficacy|2|||
17149220|NCT04574999|38294142|FG001|Overall Study|Lack of Efficacy|3|||
17149221|NCT04574999|38294141|FG000|Overall Study|Protocol Violation|1|||
17149222|NCT04574999|38294142|FG001|Overall Study|Protocol Violation|0|||
17149223|NCT04574999|38294141|FG000|Overall Study|Withdrawal by Subject|2|||
17149224|NCT04574999|38294142|FG001|Overall Study|Withdrawal by Subject|2|||
17149225|NCT04574999|38294141|FG000|Overall Study|Lost to Follow-up|1|||
17149226|NCT04574999|38294142|FG001|Overall Study|Lost to Follow-up|0|||
17149227|NCT04574999|38294141|FG000|Overall Study|Personal problems|1|||
17149228|NCT04574999|38294142|FG001|Overall Study|Personal problems|0|||
17149229|NCT04574999|38294141|FG000|Overall Study|Previous planned surgery|1|||
17149230|NCT04574999|38294142|FG001|Overall Study|Previous planned surgery|0|||
17149231|NCT04565249|38294152|FG000|Overall Study|Death|0|||
17149232|NCT04565249|38294153|FG001|Overall Study|Death|0|||
17149233|NCT04565249|38294154|FG002|Overall Study|Death|0|||
17149234|NCT04565249|38294155|FG003|Overall Study|Death|1|||
17149235|NCT04942925|38294167|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
17149236|NCT04942925|38294168|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
17149237|NCT04942925|38294167|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
17149238|NCT04942925|38294168|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
17149239|NCT04854707|38294180|FG000|Overall Study|Lack of Efficacy|78|||
17149240|NCT04854707|38294181|FG001|Overall Study|Lack of Efficacy|59|||
17149241|NCT04854707|38294182|FG002|Overall Study|Lack of Efficacy|30|||
17149242|NCT04557371|38294197|FG000|Overall Study|Covid-19-related|0|||
17149243|NCT04557371|38294198|FG001|Overall Study|Covid-19-related|1|||
17149244|NCT04557371|38294199|FG002|Overall Study|Covid-19-related|0|||
17149245|NCT04557371|38294197|FG000|Overall Study|Withdrawal by Subject|0|||
17149246|NCT04557371|38294198|FG001|Overall Study|Withdrawal by Subject|1|||
17149247|NCT04557371|38294199|FG002|Overall Study|Withdrawal by Subject|0|||
17149248|NCT04557371|38294197|FG000|Overall Study|Adverse Event|1|||
17149249|NCT04557371|38294198|FG001|Overall Study|Adverse Event|0|||
17149250|NCT04557371|38294199|FG002|Overall Study|Adverse Event|0|||
17149251|NCT04821245|38294207|FG000|Overall Study|Withdrawal by Subject|3|||
17149252|NCT04821245|38294207|FG000|Overall Study|Physician Decision|1|||
17149253|NCT04821245|38294207|FG000|Overall Study|Protocol Violation|5|||
17070648|NCT00464334|38213204|FG002|Overall Study|Progressive Disease|0|||
17070649|NCT00464334|38213205|FG003|Overall Study|Progressive Disease|0|||
17149254|NCT04539275|38294215|FG000|Overall Study|Death|2|||
17149255|NCT04539275|38294216|FG001|Overall Study|Death|4|||
17149256|NCT04539275|38294215|FG000|Overall Study|Lost to Follow-up|1|||
17149257|NCT04539275|38294216|FG001|Overall Study|Lost to Follow-up|1|||
17149258|NCT04539275|38294215|FG000|Overall Study|Withdrawal by Subject|3|||
17149259|NCT04539275|38294216|FG001|Overall Study|Withdrawal by Subject|0|||
17149260|NCT04784897|38294225|FG000|Overall Study|Death|4|||
17149261|NCT04784897|38294226|FG001|Overall Study|Death|2|||
17149262|NCT04784897|38294227|FG002|Overall Study|Death|1|||
17149263|NCT04784897|38294225|FG000|Overall Study|Withdrawal by Subject|0|||
17149264|NCT04784897|38294226|FG001|Overall Study|Withdrawal by Subject|0|||
17149265|NCT04784897|38294227|FG002|Overall Study|Withdrawal by Subject|1|||
17149266|NCT02780804|38294241|FG000|Overall Study|Death|1|||
17149267|NCT02780804|38294242|FG001|Overall Study|Death|0|||
17149268|NCT02780804|38294243|FG002|Overall Study|Death|0|||
17149269|NCT02780804|38294241|FG000|Overall Study|Lack of Efficacy|5|||
17149270|NCT02780804|38294242|FG001|Overall Study|Lack of Efficacy|8|||
17149271|NCT02780804|38294243|FG002|Overall Study|Lack of Efficacy|4|||
17149272|NCT02780804|38294241|FG000|Overall Study|Physician Decision|0|||
17149273|NCT02780804|38294242|FG001|Overall Study|Physician Decision|0|||
17149274|NCT02780804|38294243|FG002|Overall Study|Physician Decision|2|||
17149275|NCT02780804|38294241|FG000|Overall Study|Withdrawal by Subject|0|||
17149276|NCT02780804|38294242|FG001|Overall Study|Withdrawal by Subject|1|||
17149277|NCT02780804|38294243|FG002|Overall Study|Withdrawal by Subject|0|||
17149278|NCT04537949|38294260|FG000|Overall Study|personal reasons not related to the IMP|1|||
17149279|NCT04537949|38294261|FG001|Overall Study|personal reasons not related to the IMP|0|||
17149280|NCT04537949|38294262|FG002|Overall Study|personal reasons not related to the IMP|0|||
17149281|NCT04537949|38294263|FG003|Overall Study|personal reasons not related to the IMP|0|||
17149282|NCT04537949|38294264|FG004|Overall Study|personal reasons not related to the IMP|0|||
17149283|NCT04537949|38294265|FG005|Overall Study|personal reasons not related to the IMP|0|||
17149284|NCT04537949|38294266|FG006|Overall Study|personal reasons not related to the IMP|0|||
17149285|NCT04537949|38294267|FG007|Overall Study|personal reasons not related to the IMP|0|||
17149286|NCT04532099|38294288|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
17149287|NCT04532099|38294289|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
17149288|NCT04532099|38294290|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
17149289|NCT03041792|38294304|FG000|Overall Study|Adverse Event|4|||
17149290|NCT03041792|38294305|FG001|Overall Study|Adverse Event|0|||
17149291|NCT03041792|38294304|FG000|Overall Study|Death in the family|0|||
17149292|NCT03041792|38294305|FG001|Overall Study|Death in the family|2|||
17070650|NCT00464334|38213206|FG004|Overall Study|Progressive Disease|0|||
17070651|NCT00464334|38213207|FG005|Overall Study|Progressive Disease|1|||
17070652|NCT00464334|38213208|FG006|Overall Study|Progressive Disease|0|||
17070653|NCT00464334|38213209|FG007|Overall Study|Progressive Disease|0|||
17070654|NCT00464334|38213210|FG008|Overall Study|Progressive Disease|1|||
17070655|NCT00464334|38213211|FG009|Overall Study|Progressive Disease|0|||
17070656|NCT00464334|38213212|FG010|Overall Study|Progressive Disease|0|||
17070657|NCT00464334|38213202|FG000|Overall Study|Study Terminated by Sponsor|0|||
17070658|NCT00464334|38213203|FG001|Overall Study|Study Terminated by Sponsor|0|||
17070659|NCT00464334|38213204|FG002|Overall Study|Study Terminated by Sponsor|0|||
17070660|NCT00464334|38213205|FG003|Overall Study|Study Terminated by Sponsor|1|||
17070661|NCT00464334|38213206|FG004|Overall Study|Study Terminated by Sponsor|0|||
17070662|NCT00464334|38213207|FG005|Overall Study|Study Terminated by Sponsor|0|||
17070663|NCT00464334|38213208|FG006|Overall Study|Study Terminated by Sponsor|0|||
17070664|NCT00464334|38213209|FG007|Overall Study|Study Terminated by Sponsor|0|||
17070665|NCT00464334|38213210|FG008|Overall Study|Study Terminated by Sponsor|0|||
17070666|NCT00464334|38213211|FG009|Overall Study|Study Terminated by Sponsor|0|||
17070667|NCT00464334|38213212|FG010|Overall Study|Study Terminated by Sponsor|0|||
17070668|NCT00464334|38213202|FG000|Overall Study|Withdrawal by Subject|1|||
17070669|NCT00464334|38213203|FG001|Overall Study|Withdrawal by Subject|7|||
17070670|NCT00464334|38213204|FG002|Overall Study|Withdrawal by Subject|4|||
17070671|NCT00464334|38213205|FG003|Overall Study|Withdrawal by Subject|2|||
17070672|NCT00464334|38213206|FG004|Overall Study|Withdrawal by Subject|2|||
17070673|NCT00464334|38213207|FG005|Overall Study|Withdrawal by Subject|2|||
17070674|NCT00464334|38213208|FG006|Overall Study|Withdrawal by Subject|2|||
17070675|NCT00464334|38213209|FG007|Overall Study|Withdrawal by Subject|1|||
17070676|NCT00464334|38213210|FG008|Overall Study|Withdrawal by Subject|3|||
17070677|NCT00464334|38213211|FG009|Overall Study|Withdrawal by Subject|0|||
17070678|NCT00464334|38213212|FG010|Overall Study|Withdrawal by Subject|0|||
17070679|NCT00299494|38213253|FG000|Overall Study|Withdrawal by Subject|0|||
17070680|NCT00299494|38213254|FG001|Overall Study|Withdrawal by Subject|0|||
17070681|NCT00299494|38213255|FG002|Overall Study|Withdrawal by Subject|0|||
17070682|NCT00299494|38213256|FG003|Overall Study|Withdrawal by Subject|3|||
17070683|NCT00299494|38213257|FG004|Overall Study|Withdrawal by Subject|1|||
17070684|NCT00299494|38213258|FG005|Overall Study|Withdrawal by Subject|4|||
17070685|NCT00299494|38213253|FG000|Overall Study|Physician Decision|0|||
17149293|NCT03041792|38294304|FG000|Overall Study|Randomized but not treated|0|||
17149294|NCT03041792|38294305|FG001|Overall Study|Randomized but not treated|1|||
17070686|NCT00299494|38213254|FG001|Overall Study|Physician Decision|0|||
17070687|NCT00299494|38213255|FG002|Overall Study|Physician Decision|0|||
17070688|NCT00299494|38213256|FG003|Overall Study|Physician Decision|0|||
17070689|NCT00299494|38213257|FG004|Overall Study|Physician Decision|1|||
17070690|NCT00299494|38213258|FG005|Overall Study|Physician Decision|0|||
17070691|NCT00299494|38213253|FG000|Overall Study|Death|3|||
17070692|NCT00299494|38213254|FG001|Overall Study|Death|1|||
17070693|NCT00299494|38213255|FG002|Overall Study|Death|4|||
17070694|NCT00299494|38213256|FG003|Overall Study|Death|6|||
17070695|NCT00299494|38213257|FG004|Overall Study|Death|18|||
17070696|NCT00299494|38213258|FG005|Overall Study|Death|19|||
17070697|NCT00299494|38213253|FG000|Overall Study|Lost to Follow-up|0|||
17070698|NCT00299494|38213254|FG001|Overall Study|Lost to Follow-up|0|||
17070699|NCT00299494|38213255|FG002|Overall Study|Lost to Follow-up|0|||
17070700|NCT00299494|38213256|FG003|Overall Study|Lost to Follow-up|0|||
17070701|NCT00299494|38213257|FG004|Overall Study|Lost to Follow-up|3|||
17070702|NCT00299494|38213258|FG005|Overall Study|Lost to Follow-up|1|||
17070703|NCT00299494|38213253|FG000|Overall Study|Other - Unspecified|0|||
17070704|NCT00299494|38213254|FG001|Overall Study|Other - Unspecified|0|||
17070705|NCT00299494|38213255|FG002|Overall Study|Other - Unspecified|0|||
17070706|NCT00299494|38213256|FG003|Overall Study|Other - Unspecified|0|||
17070707|NCT00299494|38213257|FG004|Overall Study|Other - Unspecified|3|||
17070708|NCT00299494|38213258|FG005|Overall Study|Other - Unspecified|1|||
17070709|NCT00299494|38213253|FG000|Overall Study|Other - site closure|0|||
17070710|NCT00299494|38213254|FG001|Overall Study|Other - site closure|0|||
17070711|NCT00299494|38213255|FG002|Overall Study|Other - site closure|0|||
17070712|NCT00299494|38213256|FG003|Overall Study|Other - site closure|1|||
17070713|NCT00299494|38213257|FG004|Overall Study|Other - site closure|1|||
17070714|NCT00299494|38213258|FG005|Overall Study|Other - site closure|1|||
17070715|NCT00453180|38213285|FG000|Overall Study|Lost to Follow-up|2|||
17070716|NCT00453180|38213286|FG001|Overall Study|Lost to Follow-up|1|||
17070717|NCT00453180|38213285|FG000|Overall Study|Adverse Event|1|||
17070718|NCT00453180|38213286|FG001|Overall Study|Adverse Event|2|||
17070719|NCT00464178|38213292|FG000|Overall Study|Protocol Violation|1|||
17070720|NCT00464178|38213292|FG000|Overall Study|Withdrawal by Subject|1|||
17070721|NCT00560105|38213299|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
17070722|NCT00560105|38213300|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
17070723|NCT00467610|38213306|FG000|Overall Study|Withdrawal by Subject|1|||
17070724|NCT00316186|38213310|FG000|Overall Study|Adverse Event|6|||
17070725|NCT00316186|38213310|FG000|Overall Study|Disease Progression|4|||
17149295|NCT04507763|38294311|FG000|Overall Study|Participants did not meet entrance criteria|201|||
17070726|NCT00316186|38213310|FG000|Overall Study|Lost to Follow-up|1|||
17070727|NCT00316186|38213310|FG000|Overall Study|Other|1|||
17149296|NCT03045302|38294318|FG000|Overall Study|Pre-treatment adverse event|1|||
17149297|NCT00705484|38294324|FG000|Overall Study|Adverse Event|28|||
17149298|NCT00705484|38294325|FG001|Overall Study|Adverse Event|27|||
17149299|NCT00705484|38294324|FG000|Overall Study|Lost to Follow-up|169|||
17149300|NCT00705484|38294325|FG001|Overall Study|Lost to Follow-up|250|||
17149301|NCT00705484|38294324|FG000|Overall Study|Withdrawal by Subject|96|||
17149302|NCT00705484|38294325|FG001|Overall Study|Withdrawal by Subject|72|||
17149303|NCT00705484|38294324|FG000|Overall Study|Administrative|89|||
17149304|NCT00705484|38294325|FG001|Overall Study|Administrative|59|||
17149305|NCT04523831|38294335|FG000|Overall Study|Lost to Follow-up|15|||
17149306|NCT04523831|38294336|FG001|Overall Study|Lost to Follow-up|17|||
17149307|NCT04523831|38294335|FG000|Overall Study|Death|0|||
17070728|NCT00453102|38213314|FG000|Overall Study|Withdrawal by Subject|2|||
17070729|NCT00299182|38213325|FG000|Overall Study|Withdrawal by Subject|0|||
17070730|NCT00299182|38213326|FG001|Overall Study|Withdrawal by Subject|0|||
17070731|NCT00299182|38213327|FG002|Overall Study|Withdrawal by Subject|1|||
17149308|NCT04523831|38294336|FG001|Overall Study|Death|3|||
17149309|NCT04523831|38294335|FG000|Overall Study|Adverse Event|2|||
17149310|NCT04523831|38294336|FG001|Overall Study|Adverse Event|0|||
17149311|NCT04707664|38294347|FG000|Overall Study|Adverse Event|2|||
17149312|NCT04707664|38294348|FG001|Overall Study|Adverse Event|0|||
17149313|NCT04707664|38294347|FG000|Overall Study|Death|1|||
17149314|NCT04707664|38294348|FG001|Overall Study|Death|2|||
17149315|NCT04707664|38294347|FG000|Overall Study|Withdrawal by Subject|13|||
17149316|NCT04707664|38294348|FG001|Overall Study|Withdrawal by Subject|21|||
17149317|NCT04707664|38294347|FG000|Overall Study|Lost to Follow-up|11|||
17149318|NCT04707664|38294348|FG001|Overall Study|Lost to Follow-up|13|||
17070732|NCT00299182|38213328|FG003|Overall Study|Withdrawal by Subject|0|||
17070733|NCT00299182|38213329|FG004|Overall Study|Withdrawal by Subject|1|||
17070734|NCT00299182|38213330|FG005|Overall Study|Withdrawal by Subject|2|||
17149319|NCT04707664|38294347|FG000|Overall Study|Not treated|2|||
17149320|NCT04707664|38294348|FG001|Overall Study|Not treated|0|||
17070735|NCT00299182|38213331|FG006|Overall Study|Withdrawal by Subject|0|||
17070736|NCT00299182|38213325|FG000|Overall Study|Chemotherapy Changed|0|||
17070737|NCT00299182|38213326|FG001|Overall Study|Chemotherapy Changed|0|||
17070738|NCT00299182|38213327|FG002|Overall Study|Chemotherapy Changed|1|||
17149321|NCT01316276|38294354|FG000|Overall Study|Death|1|||
17149322|NCT01316276|38294354|FG000|Overall Study|Adverse Event|19|||
17149323|NCT01316276|38294354|FG000|Overall Study|Withdrawal of consent|24|||
17149324|NCT01316276|38294354|FG000|Overall Study|Lost to Follow-up|1|||
17149325|NCT01316276|38294354|FG000|Overall Study|Other|22|||
17149326|NCT04668989|38294359|FG000|First Intervention|Covid-19 related self-isolation|0|||
17149327|NCT04668989|38294360|FG001|First Intervention|Covid-19 related self-isolation|1|||
17149328|NCT04668989|38294359|FG000|Second Intervention|Adverse Event|0|||
17149329|NCT04668989|38294360|FG001|Second Intervention|Adverse Event|1|||
17149330|NCT03700385|38294366|FG000|Overall Study|Lost to Follow-up|1|||
17149331|NCT04498403|38294372|FG000|Overall Study|Adverse Event|1|||
17149332|NCT04498403|38294373|FG001|Overall Study|Adverse Event|0|||
17149333|NCT04498403|38294372|FG000|Overall Study|Study Terminated By Sponsor|29|||
17149334|NCT04498403|38294373|FG001|Overall Study|Study Terminated By Sponsor|10|||
17149335|NCT04362137|38294381|FG000|Overall Study|Death|9|||
17149336|NCT04362137|38294382|FG001|Overall Study|Death|3|||
17149337|NCT04362137|38294381|FG000|Overall Study|Patient decision|6|||
17149338|NCT04362137|38294382|FG001|Overall Study|Patient decision|3|||
17149339|NCT04362137|38294381|FG000|Overall Study|Adverse Event|1|||
17149340|NCT04362137|38294382|FG001|Overall Study|Adverse Event|0|||
17149341|NCT04362137|38294381|FG000|Overall Study|Lost to Follow-up|1|||
17149342|NCT04362137|38294382|FG001|Overall Study|Lost to Follow-up|0|||
17149343|NCT04362137|38294381|FG000|Overall Study|Protocol deviation|1|||
17149344|NCT04362137|38294382|FG001|Overall Study|Protocol deviation|0|||
17149345|NCT05099380|38294390|FG000|Overall Study|Subject enrolled in error|1|||
17149346|NCT05099380|38294391|FG001|Overall Study|Subject enrolled in error|0|||
17149347|NCT05099380|38294390|FG000|Overall Study|Study Procedure|1|||
17149348|NCT05099380|38294391|FG001|Overall Study|Study Procedure|0|||
17149349|NCT05099380|38294390|FG000|Overall Study|Protocol Violation|1|||
17149350|NCT05099380|38294391|FG001|Overall Study|Protocol Violation|0|||
17149351|NCT05099380|38294390|FG000|Overall Study|Adverse Event|1|||
17149352|NCT05099380|38294391|FG001|Overall Study|Adverse Event|1|||
17070739|NCT00299182|38213328|FG003|Overall Study|Chemotherapy Changed|0|||
17070740|NCT00299182|38213329|FG004|Overall Study|Chemotherapy Changed|1|||
17070741|NCT00299182|38213330|FG005|Overall Study|Chemotherapy Changed|0|||
17070742|NCT00299182|38213331|FG006|Overall Study|Chemotherapy Changed|1|||
17070743|NCT00299182|38213325|FG000|Overall Study|Adverse Event|0|||
17070744|NCT00299182|38213326|FG001|Overall Study|Adverse Event|0|||
17070745|NCT00299182|38213327|FG002|Overall Study|Adverse Event|0|||
17070746|NCT00299182|38213328|FG003|Overall Study|Adverse Event|0|||
17070747|NCT00299182|38213329|FG004|Overall Study|Adverse Event|0|||
17070748|NCT00299182|38213330|FG005|Overall Study|Adverse Event|1|||
17070749|NCT00299182|38213331|FG006|Overall Study|Adverse Event|0|||
17070750|NCT00299182|38213325|FG000|Overall Study|Not Eligible|0|||
17149353|NCT05099380|38294390|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
17149354|NCT05099380|38294391|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
17149355|NCT03614728|38294401|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
17149356|NCT03614728|38294402|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
17149357|NCT03614728|38294403|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
17149358|NCT03614728|38294404|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
17149359|NCT03614728|38294401|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
17149360|NCT03614728|38294402|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
17149361|NCT03614728|38294403|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
17149362|NCT03614728|38294404|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
17149363|NCT03154086|38294427|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149364|NCT03154086|38294428|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149365|NCT03154086|38294429|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149366|NCT03154086|38294430|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
17149367|NCT03154086|38294431|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149368|NCT03154086|38294432|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149369|NCT03154086|38294433|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149370|NCT03154086|38294434|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149371|NCT03154086|38294435|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149372|NCT03154086|38294436|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149373|NCT03154086|38294437|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149374|NCT03154086|38294438|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149375|NCT03154086|38294439|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149376|NCT03154086|38294440|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149377|NCT03154086|38294441|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
17149378|NCT03154086|38294427|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149379|NCT03154086|38294428|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
17149380|NCT03154086|38294429|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17070751|NCT00299182|38213326|FG001|Overall Study|Not Eligible|0|||
17149381|NCT03154086|38294430|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149382|NCT03154086|38294431|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149383|NCT03154086|38294432|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149384|NCT03154086|38294433|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149385|NCT03154086|38294434|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149386|NCT03154086|38294435|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149387|NCT03154086|38294436|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149388|NCT03154086|38294437|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149389|NCT03154086|38294438|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149390|NCT03154086|38294439|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149391|NCT03154086|38294440|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149392|NCT03154086|38294441|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
17149393|NCT03154086|38294427|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149394|NCT03154086|38294428|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149395|NCT03154086|38294429|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
17149396|NCT03154086|38294430|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149397|NCT03154086|38294431|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149398|NCT03154086|38294432|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149399|NCT03154086|38294433|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149400|NCT03154086|38294434|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149401|NCT03154086|38294435|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149402|NCT03154086|38294436|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149403|NCT03154086|38294437|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149404|NCT03154086|38294438|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149405|NCT03154086|38294439|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149406|NCT03154086|38294440|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149407|NCT03154086|38294441|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
17149408|NCT03154086|38294427|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
17149409|NCT03154086|38294428|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149410|NCT03154086|38294429|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149411|NCT03154086|38294430|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149412|NCT03154086|38294431|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149413|NCT03154086|38294432|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149414|NCT03154086|38294433|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149415|NCT03154086|38294434|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149416|NCT03154086|38294435|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149417|NCT03154086|38294436|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149418|NCT03154086|38294437|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149419|NCT03154086|38294438|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149420|NCT03154086|38294439|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149421|NCT03154086|38294440|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17070752|NCT00299182|38213327|FG002|Overall Study|Not Eligible|0|||
17070753|NCT00299182|38213328|FG003|Overall Study|Not Eligible|0|||
17070754|NCT00299182|38213329|FG004|Overall Study|Not Eligible|1|||
17070755|NCT00299182|38213330|FG005|Overall Study|Not Eligible|0|||
17070756|NCT00299182|38213331|FG006|Overall Study|Not Eligible|0|||
17070757|NCT00467142|38213349|FG000|Overall Study|Withdrawal by Subject|1|||
17149422|NCT03154086|38294441|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
17149423|NCT03154086|38294427|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149424|NCT03154086|38294428|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149425|NCT03154086|38294429|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149426|NCT03154086|38294430|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149427|NCT03154086|38294431|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149428|NCT03154086|38294432|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149429|NCT03154086|38294433|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149430|NCT03154086|38294434|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149431|NCT03154086|38294435|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
17149432|NCT03154086|38294436|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149433|NCT03154086|38294437|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149434|NCT03154086|38294438|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17070758|NCT00467142|38213349|FG000|Overall Study|Adverse Event|1|||
17070759|NCT00467142|38213349|FG000|Overall Study|Protocol Violation|1|||
17070760|NCT00553475|38213356|FG000|Overall Study|Adverse Event|7|||
17070761|NCT00553475|38213357|FG001|Overall Study|Adverse Event|17|||
17070762|NCT00553475|38213358|FG002|Overall Study|Adverse Event|13|||
17070763|NCT00553475|38213356|FG000|Overall Study|Lack of Efficacy|7|||
17070764|NCT00553475|38213357|FG001|Overall Study|Lack of Efficacy|1|||
17149435|NCT03154086|38294439|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149436|NCT03154086|38294440|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149437|NCT03154086|38294441|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
17149438|NCT03154086|38294427|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149439|NCT03154086|38294428|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149440|NCT03154086|38294429|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149441|NCT03154086|38294430|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149442|NCT03154086|38294431|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149443|NCT03154086|38294432|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149444|NCT03154086|38294433|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149445|NCT03154086|38294434|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
17149446|NCT03154086|38294435|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149447|NCT03154086|38294436|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149448|NCT03154086|38294437|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149449|NCT03154086|38294438|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149450|NCT03154086|38294439|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149451|NCT03154086|38294440|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149452|NCT03154086|38294441|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
17149453|NCT03154086|38294427|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
17070765|NCT00553475|38213358|FG002|Overall Study|Lack of Efficacy|0|||
17070766|NCT00553475|38213356|FG000|Overall Study|Withdrawal by Subject|1|||
17070767|NCT00553475|38213357|FG001|Overall Study|Withdrawal by Subject|1|||
17070768|NCT00553475|38213358|FG002|Overall Study|Withdrawal by Subject|0|||
17070769|NCT00553475|38213356|FG000|Overall Study|Physician Decision|1|||
17070770|NCT00553475|38213357|FG001|Overall Study|Physician Decision|0|||
17070771|NCT00553475|38213358|FG002|Overall Study|Physician Decision|0|||
17070772|NCT00553475|38213356|FG000|Overall Study|Due to moving|0|||
17070773|NCT00553475|38213357|FG001|Overall Study|Due to moving|1|||
17149454|NCT03154086|38294428|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
17149455|NCT03154086|38294429|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
17149456|NCT03154086|38294430|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
17149457|NCT03154086|38294431|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
17149458|NCT03154086|38294432|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
17149459|NCT03154086|38294433|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
17149460|NCT03154086|38294434|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
17149461|NCT03154086|38294435|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
17149462|NCT03154086|38294436|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
17149463|NCT03154086|38294437|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
17149464|NCT03154086|38294438|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
17149465|NCT03154086|38294439|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
17149466|NCT03154086|38294440|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
17149467|NCT03154086|38294441|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
17149468|NCT02723344|38294504|FG000|Overall Study|Lost to Follow-up|0|||
17149469|NCT02723344|38294505|FG001|Overall Study|Lost to Follow-up|4|||
17149470|NCT02723188|38294514|FG000|Overall Study|Withdrawal by Subject|1|||
17149471|NCT02723188|38294515|FG001|Overall Study|Withdrawal by Subject|0|||
17149472|NCT02723188|38294516|FG002|Overall Study|Withdrawal by Subject|0|||
17149473|NCT00705406|38294526|FG000|Overall Study|Lost to Follow-up|3|||
17149474|NCT00705406|38294527|FG001|Overall Study|Lost to Follow-up|3|||
17149475|NCT00705406|38294526|FG000|Overall Study|Did not receive study drug|1|||
17149476|NCT00705406|38294527|FG001|Overall Study|Did not receive study drug|2|||
17149477|NCT03155178|38294538|FG000|Overall Study|Did not meet treatment day baseline|7|||
17149478|NCT03155178|38294539|FG001|Overall Study|Did not meet treatment day baseline|7|||
17149479|NCT03155178|38294540|FG002|Overall Study|Did not meet treatment day baseline|7|||
17149480|NCT03155178|38294541|FG003|Overall Study|Did not meet treatment day baseline|7|||
17149481|NCT00705250|38294565|FG000|Overall Study|Withdrawal by Subject|1|||
17149482|NCT00705250|38294565|FG000|Overall Study|Patient died in car accident|1|||
17149483|NCT03078192|38294571|FG000|Overall Study|Withdrawal by Subject|2|||
17149484|NCT03078192|38294572|FG001|Overall Study|Withdrawal by Subject|1|||
17149485|NCT03078192|38294571|FG000|Overall Study|screen failure|0|||
17149486|NCT03078192|38294572|FG001|Overall Study|screen failure|3|||
17149487|NCT00703846|38294578|FG000|Overall Study|Adverse Event|8|||
17149488|NCT00703846|38294578|FG000|Overall Study|Lost to Follow-up|55|||
17149489|NCT00703846|38294578|FG000|Overall Study|Lack of Efficacy|15|||
17070774|NCT00553475|38213358|FG002|Overall Study|Due to moving|0|||
17070775|NCT00329602|38213370|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
17070776|NCT00329602|38213371|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
17090093|NCT00317642|38230167|FG001|Overall Study|Referred For Transplantation|0|||
17149490|NCT00703846|38294578|FG000|Overall Study|Noncompliance with Study Treatment|2|||
17149491|NCT00703846|38294578|FG000|Overall Study|Withdrawal by Subject|40|||
17149492|NCT00703846|38294578|FG000|Overall Study|Death|1|||
17149493|NCT00703846|38294578|FG000|Overall Study|Other|14|||
17149494|NCT00703846|38294578|FG000|Overall Study|Did Not Receive Study Drug|2|||
17149495|NCT01314872|38294602|FG000|Treatment Period 1|Protocol Violation|2|||
17149496|NCT01314872|38294603|FG001|Treatment Period 1|Protocol Violation|1|||
17149497|NCT01314872|38294604|FG002|Treatment Period 1|Protocol Violation|1|||
17149498|NCT01314872|38294605|FG003|Treatment Period 1|Protocol Violation|0|||
17149499|NCT01314872|38294606|FG004|Treatment Period 1|Protocol Violation|1|||
17149500|NCT01314872|38294607|FG005|Treatment Period 1|Protocol Violation|0|||
17149501|NCT01314872|38294608|FG006|Treatment Period 1|Protocol Violation|0|||
17149502|NCT01314872|38294609|FG007|Treatment Period 1|Protocol Violation|0|||
17149503|NCT01314872|38294610|FG008|Treatment Period 1|Protocol Violation|0|||
17149504|NCT01314872|38294611|FG009|Treatment Period 1|Protocol Violation|1|||
17149505|NCT01314872|38294612|FG010|Treatment Period 1|Protocol Violation|1|||
17149506|NCT01314872|38294613|FG011|Treatment Period 1|Protocol Violation|0|||
17149507|NCT01314872|38294614|FG012|Treatment Period 1|Protocol Violation|0|||
17149508|NCT01314872|38294615|FG013|Treatment Period 1|Protocol Violation|0|||
17149509|NCT01314872|38294616|FG014|Treatment Period 1|Protocol Violation|0|||
17149510|NCT01314872|38294602|FG000|Treatment Period 1|Physician Decision|0|||
17149511|NCT01314872|38294603|FG001|Treatment Period 1|Physician Decision|1|||
17149512|NCT01314872|38294604|FG002|Treatment Period 1|Physician Decision|0|||
17149513|NCT01314872|38294605|FG003|Treatment Period 1|Physician Decision|1|||
17149514|NCT01314872|38294606|FG004|Treatment Period 1|Physician Decision|0|||
17149515|NCT01314872|38294607|FG005|Treatment Period 1|Physician Decision|0|||
17149516|NCT01314872|38294608|FG006|Treatment Period 1|Physician Decision|0|||
17149517|NCT01314872|38294609|FG007|Treatment Period 1|Physician Decision|0|||
17149518|NCT01314872|38294610|FG008|Treatment Period 1|Physician Decision|0|||
17149519|NCT01314872|38294611|FG009|Treatment Period 1|Physician Decision|1|||
17149520|NCT01314872|38294612|FG010|Treatment Period 1|Physician Decision|0|||
17149521|NCT01314872|38294613|FG011|Treatment Period 1|Physician Decision|0|||
17149522|NCT01314872|38294614|FG012|Treatment Period 1|Physician Decision|0|||
17149523|NCT01314872|38294615|FG013|Treatment Period 1|Physician Decision|0|||
17149524|NCT01314872|38294616|FG014|Treatment Period 1|Physician Decision|0|||
17149525|NCT01314872|38294602|FG000|Treatment Period 1|Lack of Efficacy|1|||
17149526|NCT01314872|38294603|FG001|Treatment Period 1|Lack of Efficacy|0|||
17149527|NCT01314872|38294604|FG002|Treatment Period 1|Lack of Efficacy|0|||
17149528|NCT01314872|38294605|FG003|Treatment Period 1|Lack of Efficacy|0|||
17149529|NCT01314872|38294606|FG004|Treatment Period 1|Lack of Efficacy|0|||
17149530|NCT01314872|38294607|FG005|Treatment Period 1|Lack of Efficacy|1|||
17149531|NCT01314872|38294608|FG006|Treatment Period 1|Lack of Efficacy|0|||
17149532|NCT01314872|38294609|FG007|Treatment Period 1|Lack of Efficacy|2|||
17149533|NCT01314872|38294610|FG008|Treatment Period 1|Lack of Efficacy|0|||
17149534|NCT01314872|38294611|FG009|Treatment Period 1|Lack of Efficacy|0|||
17149535|NCT01314872|38294612|FG010|Treatment Period 1|Lack of Efficacy|0|||
17149536|NCT01314872|38294613|FG011|Treatment Period 1|Lack of Efficacy|0|||
17149537|NCT01314872|38294614|FG012|Treatment Period 1|Lack of Efficacy|0|||
17149538|NCT01314872|38294615|FG013|Treatment Period 1|Lack of Efficacy|0|||
17149539|NCT01314872|38294616|FG014|Treatment Period 1|Lack of Efficacy|0|||
17149540|NCT01314872|38294602|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
17149541|NCT01314872|38294603|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
17149542|NCT01314872|38294604|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
17149543|NCT01314872|38294605|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
17149544|NCT01314872|38294606|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
17149545|NCT01314872|38294607|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
17149546|NCT01314872|38294608|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
17149547|NCT01314872|38294609|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
17149548|NCT01314872|38294610|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
17149549|NCT01314872|38294611|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
17149550|NCT01314872|38294612|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
17149551|NCT01314872|38294613|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
17149552|NCT01314872|38294614|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
17149553|NCT01314872|38294615|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
17149554|NCT01314872|38294616|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
17149555|NCT01314872|38294602|FG000|Treatment Period 1|Withdrawal by Subject|3|||
17149556|NCT01314872|38294603|FG001|Treatment Period 1|Withdrawal by Subject|1|||
17149557|NCT01314872|38294604|FG002|Treatment Period 1|Withdrawal by Subject|0|||
17149558|NCT01314872|38294605|FG003|Treatment Period 1|Withdrawal by Subject|2|||
17149559|NCT01314872|38294606|FG004|Treatment Period 1|Withdrawal by Subject|3|||
17149560|NCT01314872|38294607|FG005|Treatment Period 1|Withdrawal by Subject|1|||
17149561|NCT01314872|38294608|FG006|Treatment Period 1|Withdrawal by Subject|3|||
17149562|NCT01314872|38294609|FG007|Treatment Period 1|Withdrawal by Subject|2|||
17149563|NCT01314872|38294610|FG008|Treatment Period 1|Withdrawal by Subject|2|||
17149564|NCT01314872|38294611|FG009|Treatment Period 1|Withdrawal by Subject|2|||
17149565|NCT01314872|38294612|FG010|Treatment Period 1|Withdrawal by Subject|1|||
17149566|NCT01314872|38294613|FG011|Treatment Period 1|Withdrawal by Subject|0|||
17149567|NCT01314872|38294614|FG012|Treatment Period 1|Withdrawal by Subject|0|||
17149568|NCT01314872|38294615|FG013|Treatment Period 1|Withdrawal by Subject|0|||
17149569|NCT01314872|38294616|FG014|Treatment Period 1|Withdrawal by Subject|0|||
17149570|NCT01314872|38294602|FG000|Treatment Period 1|Lost to Follow-up|0|||
17149571|NCT01314872|38294603|FG001|Treatment Period 1|Lost to Follow-up|1|||
17149572|NCT01314872|38294604|FG002|Treatment Period 1|Lost to Follow-up|2|||
17149573|NCT01314872|38294605|FG003|Treatment Period 1|Lost to Follow-up|2|||
17149574|NCT01314872|38294606|FG004|Treatment Period 1|Lost to Follow-up|1|||
17149575|NCT01314872|38294607|FG005|Treatment Period 1|Lost to Follow-up|1|||
17149576|NCT01314872|38294608|FG006|Treatment Period 1|Lost to Follow-up|1|||
17149577|NCT01314872|38294609|FG007|Treatment Period 1|Lost to Follow-up|1|||
17149578|NCT01314872|38294610|FG008|Treatment Period 1|Lost to Follow-up|1|||
17149579|NCT01314872|38294611|FG009|Treatment Period 1|Lost to Follow-up|0|||
17149580|NCT01314872|38294612|FG010|Treatment Period 1|Lost to Follow-up|0|||
17149581|NCT01314872|38294613|FG011|Treatment Period 1|Lost to Follow-up|0|||
17149582|NCT01314872|38294614|FG012|Treatment Period 1|Lost to Follow-up|0|||
17149583|NCT01314872|38294615|FG013|Treatment Period 1|Lost to Follow-up|0|||
17149584|NCT01314872|38294616|FG014|Treatment Period 1|Lost to Follow-up|0|||
17149585|NCT01314872|38294602|FG000|Period 2|Protocol Violation|0|||
17149586|NCT01314872|38294603|FG001|Period 2|Protocol Violation|0|||
17149587|NCT01314872|38294604|FG002|Period 2|Protocol Violation|0|||
17149588|NCT01314872|38294605|FG003|Period 2|Protocol Violation|0|||
17149589|NCT01314872|38294606|FG004|Period 2|Protocol Violation|0|||
17149590|NCT01314872|38294607|FG005|Period 2|Protocol Violation|0|||
17149591|NCT01314872|38294608|FG006|Period 2|Protocol Violation|0|||
17149592|NCT01314872|38294609|FG007|Period 2|Protocol Violation|0|||
17149593|NCT01314872|38294610|FG008|Period 2|Protocol Violation|0|||
17149594|NCT01314872|38294611|FG009|Period 2|Protocol Violation|0|||
17149595|NCT01314872|38294612|FG010|Period 2|Protocol Violation|0|||
17070777|NCT00329602|38213372|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
17070778|NCT00329602|38213370|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
17070779|NCT00329602|38213371|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
17070780|NCT00329602|38213372|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
17070781|NCT00329602|38213370|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
17070782|NCT00329602|38213371|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
17070783|NCT00329602|38213372|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
17070784|NCT00329602|38213370|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
17070785|NCT00329602|38213371|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
17070786|NCT00329602|38213372|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
17070787|NCT00329602|38213370|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
17070788|NCT00329602|38213371|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
17070789|NCT00329602|38213372|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
17070790|NCT00329602|38213370|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
17070791|NCT00329602|38213371|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
17070792|NCT00329602|38213372|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
17070793|NCT00463866|38213390|FG000|Overall Study|Adverse Event|70|||
17070794|NCT00463866|38213391|FG001|Overall Study|Adverse Event|93|||
17070795|NCT00463866|38213390|FG000|Overall Study|Withdrawal by Subject|81|||
17070796|NCT00463866|38213391|FG001|Overall Study|Withdrawal by Subject|79|||
17070797|NCT00463866|38213390|FG000|Overall Study|Lost to Follow-up|46|||
17070798|NCT00463866|38213391|FG001|Overall Study|Lost to Follow-up|55|||
17070799|NCT00463866|38213390|FG000|Overall Study|Incorrect Enrolment|64|||
17070800|NCT00463866|38213391|FG001|Overall Study|Incorrect Enrolment|66|||
17070801|NCT00463866|38213390|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
17070802|NCT00463866|38213391|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
17070803|NCT00463866|38213390|FG000|Overall Study|Safety Reason|1|||
17070804|NCT00463866|38213391|FG001|Overall Study|Safety Reason|3|||
17070805|NCT00463866|38213390|FG000|Overall Study|Mis-Randomization of subject|0|||
17070806|NCT00463866|38213391|FG001|Overall Study|Mis-Randomization of subject|1|||
17070807|NCT00463866|38213390|FG000|Overall Study|Other|22|||
17070808|NCT00463866|38213391|FG001|Overall Study|Other|22|||
17070809|NCT00313846|38213399|FG000|Overall Study|Withdrawal by Subject|2|||
17070810|NCT00313846|38213400|FG001|Overall Study|Withdrawal by Subject|0|||
17070811|NCT00313846|38213399|FG000|Overall Study|Adverse Event|1|||
17070812|NCT00313846|38213400|FG001|Overall Study|Adverse Event|8|||
17070813|NCT00313846|38213399|FG000|Overall Study|Administrative|2|||
17070814|NCT00313846|38213400|FG001|Overall Study|Administrative|3|||
17070815|NCT00551135|38213411|FG000|Overall Study|Adverse Event|1|||
17070816|NCT00551135|38213412|FG001|Overall Study|Adverse Event|0|||
17070817|NCT00551135|38213413|FG002|Overall Study|Adverse Event|1|||
17070818|NCT00551135|38213414|FG003|Overall Study|Adverse Event|1|||
17070819|NCT00551135|38213411|FG000|Overall Study|Lost to Follow-up|0|||
16781247|NCT02109484|37720413|FG004|Overall Study|Physician Decision|2|||
17070820|NCT00551135|38213412|FG001|Overall Study|Lost to Follow-up|0|||
17070821|NCT00551135|38213413|FG002|Overall Study|Lost to Follow-up|0|||
17149596|NCT01314872|38294613|FG011|Period 2|Protocol Violation|3|||
17070822|NCT00551135|38213414|FG003|Overall Study|Lost to Follow-up|1|||
17070823|NCT00551135|38213411|FG000|Overall Study|Other|3|||
17070824|NCT00551135|38213412|FG001|Overall Study|Other|2|||
17070825|NCT00551135|38213413|FG002|Overall Study|Other|1|||
17070826|NCT00551135|38213414|FG003|Overall Study|Other|2|||
17070827|NCT00551135|38213411|FG000|Overall Study|Withdrawal by Subject|1|||
17070828|NCT00551135|38213412|FG001|Overall Study|Withdrawal by Subject|0|||
17070829|NCT00551135|38213413|FG002|Overall Study|Withdrawal by Subject|3|||
17070830|NCT00551135|38213414|FG003|Overall Study|Withdrawal by Subject|1|||
17070831|NCT00299104|38213427|FG000|Treatment Period|Adverse Event|14|||
17070832|NCT00299104|38213428|FG001|Treatment Period|Adverse Event|9|||
17070833|NCT00299104|38213429|FG002|Treatment Period|Adverse Event|7|||
17070834|NCT00299104|38213427|FG000|Treatment Period|Death|1|||
17070835|NCT00299104|38213428|FG001|Treatment Period|Death|1|||
17070836|NCT00299104|38213429|FG002|Treatment Period|Death|1|||
17070837|NCT00299104|38213427|FG000|Treatment Period|Insufficient therapeutic response|34|||
17070838|NCT00299104|38213428|FG001|Treatment Period|Insufficient therapeutic response|13|||
17070839|NCT00299104|38213429|FG002|Treatment Period|Insufficient therapeutic response|8|||
17070840|NCT00299104|38213427|FG000|Treatment Period|Failure to return|9|||
17070841|NCT00299104|38213428|FG001|Treatment Period|Failure to return|8|||
17070842|NCT00299104|38213429|FG002|Treatment Period|Failure to return|8|||
17070843|NCT00299104|38213427|FG000|Treatment Period|Violation of selection criteria|1|||
17070844|NCT00299104|38213428|FG001|Treatment Period|Violation of selection criteria|2|||
17070845|NCT00299104|38213429|FG002|Treatment Period|Violation of selection criteria|0|||
17070846|NCT00299104|38213427|FG000|Treatment Period|Protocol Violation|1|||
17070847|NCT00299104|38213428|FG001|Treatment Period|Protocol Violation|1|||
17070848|NCT00299104|38213429|FG002|Treatment Period|Protocol Violation|0|||
17070849|NCT00299104|38213427|FG000|Treatment Period|Refused treatment|9|||
17070850|NCT00299104|38213428|FG001|Treatment Period|Refused treatment|2|||
17149597|NCT01314872|38294614|FG012|Period 2|Protocol Violation|3|||
17149598|NCT01314872|38294615|FG013|Period 2|Protocol Violation|2|||
17149599|NCT01314872|38294616|FG014|Period 2|Protocol Violation|0|||
17149600|NCT01314872|38294602|FG000|Period 2|Non-compliance with study drug|0|||
17149601|NCT01314872|38294603|FG001|Period 2|Non-compliance with study drug|0|||
17149602|NCT01314872|38294604|FG002|Period 2|Non-compliance with study drug|0|||
17149603|NCT01314872|38294605|FG003|Period 2|Non-compliance with study drug|0|||
17149604|NCT01314872|38294606|FG004|Period 2|Non-compliance with study drug|0|||
17149605|NCT01314872|38294607|FG005|Period 2|Non-compliance with study drug|0|||
17149606|NCT01314872|38294608|FG006|Period 2|Non-compliance with study drug|0|||
17149607|NCT01314872|38294609|FG007|Period 2|Non-compliance with study drug|0|||
17149608|NCT01314872|38294610|FG008|Period 2|Non-compliance with study drug|0|||
17149609|NCT01314872|38294611|FG009|Period 2|Non-compliance with study drug|0|||
17149610|NCT01314872|38294612|FG010|Period 2|Non-compliance with study drug|0|||
17149611|NCT01314872|38294613|FG011|Period 2|Non-compliance with study drug|3|||
17149612|NCT01314872|38294614|FG012|Period 2|Non-compliance with study drug|3|||
17149613|NCT01314872|38294615|FG013|Period 2|Non-compliance with study drug|1|||
17149614|NCT01314872|38294616|FG014|Period 2|Non-compliance with study drug|2|||
17149615|NCT01314872|38294602|FG000|Period 2|Lack of Efficacy|0|||
17149616|NCT01314872|38294603|FG001|Period 2|Lack of Efficacy|0|||
17149617|NCT01314872|38294604|FG002|Period 2|Lack of Efficacy|0|||
17149618|NCT01314872|38294605|FG003|Period 2|Lack of Efficacy|0|||
17149619|NCT01314872|38294606|FG004|Period 2|Lack of Efficacy|0|||
17149620|NCT01314872|38294607|FG005|Period 2|Lack of Efficacy|0|||
17149621|NCT01314872|38294608|FG006|Period 2|Lack of Efficacy|0|||
17149622|NCT01314872|38294609|FG007|Period 2|Lack of Efficacy|0|||
17149623|NCT01314872|38294610|FG008|Period 2|Lack of Efficacy|0|||
17149624|NCT01314872|38294611|FG009|Period 2|Lack of Efficacy|0|||
17149625|NCT01314872|38294612|FG010|Period 2|Lack of Efficacy|0|||
17149626|NCT01314872|38294613|FG011|Period 2|Lack of Efficacy|7|||
17149627|NCT01314872|38294614|FG012|Period 2|Lack of Efficacy|12|||
17149628|NCT01314872|38294615|FG013|Period 2|Lack of Efficacy|9|||
17149629|NCT01314872|38294616|FG014|Period 2|Lack of Efficacy|2|||
17149630|NCT01314872|38294602|FG000|Period 2|Pregnancy|0|||
17149631|NCT01314872|38294603|FG001|Period 2|Pregnancy|0|||
17149632|NCT01314872|38294604|FG002|Period 2|Pregnancy|0|||
17149633|NCT01314872|38294605|FG003|Period 2|Pregnancy|0|||
17149634|NCT01314872|38294606|FG004|Period 2|Pregnancy|0|||
17149635|NCT01314872|38294607|FG005|Period 2|Pregnancy|0|||
17149636|NCT01314872|38294608|FG006|Period 2|Pregnancy|0|||
17149637|NCT01314872|38294609|FG007|Period 2|Pregnancy|0|||
17149638|NCT01314872|38294610|FG008|Period 2|Pregnancy|0|||
17149639|NCT01314872|38294611|FG009|Period 2|Pregnancy|0|||
17149640|NCT01314872|38294612|FG010|Period 2|Pregnancy|0|||
17149641|NCT01314872|38294613|FG011|Period 2|Pregnancy|0|||
17149642|NCT01314872|38294614|FG012|Period 2|Pregnancy|0|||
17149643|NCT01314872|38294615|FG013|Period 2|Pregnancy|0|||
17149644|NCT01314872|38294616|FG014|Period 2|Pregnancy|1|||
17149645|NCT01314872|38294602|FG000|Period 2|Study terminated by Sponsor|0|||
17149646|NCT01314872|38294603|FG001|Period 2|Study terminated by Sponsor|0|||
17149647|NCT01314872|38294604|FG002|Period 2|Study terminated by Sponsor|0|||
16994188|NCT01043705|38138000|FG002|Overall Study|Multiple Reasons|0|||
16994189|NCT01043705|38137998|FG000|Overall Study|Protocol Violation|2|||
16994190|NCT01043705|38137999|FG001|Overall Study|Protocol Violation|1|||
16994191|NCT01043705|38138000|FG002|Overall Study|Protocol Violation|0|||
16994192|NCT01043705|38137998|FG000|Overall Study|Withdrawal by Subject|8|||
16994193|NCT01043705|38137999|FG001|Overall Study|Withdrawal by Subject|6|||
16994194|NCT01043705|38138000|FG002|Overall Study|Withdrawal by Subject|0|||
17070851|NCT00299104|38213429|FG002|Treatment Period|Refused treatment|2|||
17070852|NCT00299104|38213427|FG000|Treatment Period|Withdrew consent|14|||
17070853|NCT00299104|38213428|FG001|Treatment Period|Withdrew consent|19|||
17070854|NCT00299104|38213429|FG002|Treatment Period|Withdrew consent|9|||
17070855|NCT00299104|38213427|FG000|Treatment Period|Administrative reasons|106|||
17070856|NCT00299104|38213428|FG001|Treatment Period|Administrative reasons|120|||
17070857|NCT00299104|38213429|FG002|Treatment Period|Administrative reasons|137|||
17070858|NCT00299104|38213427|FG000|Safety Follow-Up (SFU) Period|Death|3|||
17070859|NCT00299104|38213428|FG001|Safety Follow-Up (SFU) Period|Death|2|||
17070860|NCT00299104|38213429|FG002|Safety Follow-Up (SFU) Period|Death|1|||
17070861|NCT00299104|38213427|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
17070862|NCT00299104|38213428|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
17070863|NCT00299104|38213429|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
17070864|NCT00299104|38213427|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
16994195|NCT01043705|38137998|FG000|Overall Study|Site Closure|8|||
16994196|NCT01043705|38137999|FG001|Overall Study|Site Closure|0|||
16994197|NCT01043705|38138000|FG002|Overall Study|Site Closure|0|||
16994198|NCT01043705|38137998|FG000|Overall Study|Subsequent Procedure|9|||
16994199|NCT01043705|38137999|FG001|Overall Study|Subsequent Procedure|24|||
16994200|NCT01043705|38138000|FG002|Overall Study|Subsequent Procedure|29|||
16994201|NCT01043705|38137998|FG000|Overall Study|Adverse Event|0|||
16994202|NCT01043705|38137999|FG001|Overall Study|Adverse Event|2|||
17149648|NCT01314872|38294605|FG003|Period 2|Study terminated by Sponsor|0|||
17149649|NCT01314872|38294606|FG004|Period 2|Study terminated by Sponsor|0|||
17149650|NCT01314872|38294607|FG005|Period 2|Study terminated by Sponsor|0|||
17149651|NCT01314872|38294608|FG006|Period 2|Study terminated by Sponsor|0|||
17149652|NCT01314872|38294609|FG007|Period 2|Study terminated by Sponsor|0|||
17149653|NCT01314872|38294610|FG008|Period 2|Study terminated by Sponsor|0|||
17149654|NCT01314872|38294611|FG009|Period 2|Study terminated by Sponsor|0|||
17149655|NCT01314872|38294612|FG010|Period 2|Study terminated by Sponsor|0|||
17149656|NCT01314872|38294613|FG011|Period 2|Study terminated by Sponsor|2|||
17149657|NCT01314872|38294614|FG012|Period 2|Study terminated by Sponsor|2|||
17149658|NCT01314872|38294615|FG013|Period 2|Study terminated by Sponsor|3|||
17149659|NCT01314872|38294616|FG014|Period 2|Study terminated by Sponsor|0|||
17149660|NCT01314872|38294602|FG000|Period 2|Adverse event, non-fatal|0|||
17149661|NCT01314872|38294603|FG001|Period 2|Adverse event, non-fatal|0|||
17149662|NCT01314872|38294604|FG002|Period 2|Adverse event, non-fatal|0|||
17149663|NCT01314872|38294605|FG003|Period 2|Adverse event, non-fatal|0|||
17149664|NCT01314872|38294606|FG004|Period 2|Adverse event, non-fatal|0|||
17149665|NCT01314872|38294607|FG005|Period 2|Adverse event, non-fatal|0|||
17149666|NCT01314872|38294608|FG006|Period 2|Adverse event, non-fatal|0|||
17149667|NCT01314872|38294609|FG007|Period 2|Adverse event, non-fatal|0|||
17149668|NCT01314872|38294610|FG008|Period 2|Adverse event, non-fatal|0|||
17149669|NCT01314872|38294611|FG009|Period 2|Adverse event, non-fatal|0|||
17149670|NCT01314872|38294612|FG010|Period 2|Adverse event, non-fatal|0|||
17149671|NCT01314872|38294613|FG011|Period 2|Adverse event, non-fatal|13|||
17149672|NCT01314872|38294614|FG012|Period 2|Adverse event, non-fatal|16|||
17149673|NCT01314872|38294615|FG013|Period 2|Adverse event, non-fatal|24|||
17149674|NCT01314872|38294616|FG014|Period 2|Adverse event, non-fatal|9|||
17149675|NCT01314872|38294602|FG000|Period 2|Withdrawal by Subject|0|||
17149676|NCT01314872|38294603|FG001|Period 2|Withdrawal by Subject|0|||
17149677|NCT01314872|38294604|FG002|Period 2|Withdrawal by Subject|0|||
17149678|NCT01314872|38294605|FG003|Period 2|Withdrawal by Subject|0|||
17149679|NCT01314872|38294606|FG004|Period 2|Withdrawal by Subject|0|||
17149680|NCT01314872|38294607|FG005|Period 2|Withdrawal by Subject|0|||
17149681|NCT01314872|38294608|FG006|Period 2|Withdrawal by Subject|0|||
17149682|NCT01314872|38294609|FG007|Period 2|Withdrawal by Subject|0|||
17149683|NCT01314872|38294610|FG008|Period 2|Withdrawal by Subject|0|||
17149684|NCT01314872|38294611|FG009|Period 2|Withdrawal by Subject|0|||
17149685|NCT01314872|38294612|FG010|Period 2|Withdrawal by Subject|0|||
17149686|NCT01314872|38294613|FG011|Period 2|Withdrawal by Subject|14|||
17149687|NCT01314872|38294614|FG012|Period 2|Withdrawal by Subject|17|||
17149688|NCT01314872|38294615|FG013|Period 2|Withdrawal by Subject|12|||
17149689|NCT01314872|38294616|FG014|Period 2|Withdrawal by Subject|4|||
17149690|NCT01314872|38294602|FG000|Period 2|Lost to Follow-up|0|||
17149691|NCT01314872|38294603|FG001|Period 2|Lost to Follow-up|0|||
17149692|NCT01314872|38294604|FG002|Period 2|Lost to Follow-up|0|||
17149693|NCT01314872|38294605|FG003|Period 2|Lost to Follow-up|0|||
17149694|NCT01314872|38294606|FG004|Period 2|Lost to Follow-up|0|||
17149695|NCT01314872|38294607|FG005|Period 2|Lost to Follow-up|0|||
17149696|NCT01314872|38294608|FG006|Period 2|Lost to Follow-up|0|||
17149697|NCT01314872|38294609|FG007|Period 2|Lost to Follow-up|0|||
17149698|NCT01314872|38294610|FG008|Period 2|Lost to Follow-up|0|||
17149699|NCT01314872|38294611|FG009|Period 2|Lost to Follow-up|0|||
17149700|NCT01314872|38294612|FG010|Period 2|Lost to Follow-up|0|||
17149701|NCT01314872|38294613|FG011|Period 2|Lost to Follow-up|6|||
17149702|NCT01314872|38294614|FG012|Period 2|Lost to Follow-up|7|||
17149703|NCT01314872|38294615|FG013|Period 2|Lost to Follow-up|2|||
17149704|NCT01314872|38294616|FG014|Period 2|Lost to Follow-up|6|||
17149705|NCT00703924|38294650|FG000|Overall Study|Withdrawal by Subject|1|||
17149706|NCT00703924|38294651|FG001|Overall Study|Withdrawal by Subject|1|||
17149707|NCT03152526|38294663|FG000|Overall Study|Withdrawal by Subject|0|||
17149708|NCT03152526|38294664|FG001|Overall Study|Withdrawal by Subject|1|||
17149709|NCT03149328|38294672|FG000|Overall Study|Withdrawal by Subject|30|||
17149710|NCT03149328|38294673|FG001|Overall Study|Withdrawal by Subject|26|||
16994203|NCT01043705|38138000|FG002|Overall Study|Adverse Event|0|||
17149711|NCT03149328|38294672|FG000|Overall Study|Changed Dialysis Modality|18|||
17149712|NCT03149328|38294673|FG001|Overall Study|Changed Dialysis Modality|1|||
17149713|NCT03149328|38294672|FG000|Overall Study|Transplant|9|||
17149714|NCT03149328|38294673|FG001|Overall Study|Transplant|1|||
17149715|NCT03149328|38294672|FG000|Overall Study|Lost to Follow-up|25|||
17149716|NCT03149328|38294673|FG001|Overall Study|Lost to Follow-up|16|||
17149717|NCT03149328|38294672|FG000|Overall Study|Left Study Site|1|||
17149718|NCT03149328|38294673|FG001|Overall Study|Left Study Site|2|||
17149719|NCT03149328|38294672|FG000|Overall Study|Language Barrier|1|||
17149720|NCT03149328|38294673|FG001|Overall Study|Language Barrier|0|||
17149721|NCT04296942|38294722|FG000|Overall Study|Study closure by sponsor|1|||
17149722|NCT04296942|38294723|FG001|Overall Study|Study closure by sponsor|0|||
17149723|NCT04296942|38294724|FG002|Overall Study|Study closure by sponsor|0|||
17149724|NCT01522976|38294762|FG000|Overall Study|Ineligible|4|||
17070865|NCT00299104|38213428|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
17070866|NCT00299104|38213429|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
17070867|NCT00299104|38213427|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
17070868|NCT00299104|38213428|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
17070869|NCT00299104|38213429|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
17070870|NCT00299104|38213427|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
17070871|NCT00299104|38213428|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
17070872|NCT00299104|38213429|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
17070873|NCT00299104|38213427|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
17070874|NCT00299104|38213428|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
17070875|NCT00299104|38213429|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
17070876|NCT00299104|38213427|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
17070877|NCT00299104|38213428|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
17070878|NCT00299104|38213429|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
17070879|NCT00299104|38213427|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
17070880|NCT00299104|38213428|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
17070881|NCT00299104|38213429|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
17070882|NCT00313612|38213439|FG000|Overall Study|Patient never received treatment|0|||
17070883|NCT00313612|38213440|FG001|Overall Study|Patient never received treatment|1|||
17070884|NCT00507416|38213449|FG000|Overall Study|Adverse Event|58|||
17070885|NCT00507416|38213450|FG001|Overall Study|Adverse Event|67|||
17070886|NCT00507416|38213451|FG002|Overall Study|Adverse Event|65|||
17070887|NCT00507416|38213449|FG000|Overall Study|Protocol Violation|1|||
17070888|NCT00507416|38213450|FG001|Overall Study|Protocol Violation|2|||
17149725|NCT01522976|38294763|FG001|Overall Study|Ineligible|0|||
17149726|NCT01522976|38294764|FG002|Overall Study|Ineligible|1|||
17149727|NCT01522976|38294762|FG000|Overall Study|Death|7|||
17149728|NCT01522976|38294763|FG001|Overall Study|Death|6|||
17149729|NCT01522976|38294764|FG002|Overall Study|Death|2|||
17149730|NCT01522976|38294762|FG000|Overall Study|Still on treatment|9|||
17149731|NCT01522976|38294763|FG001|Overall Study|Still on treatment|9|||
17149732|NCT01522976|38294764|FG002|Overall Study|Still on treatment|6|||
17149733|NCT01522976|38294762|FG000|Overall Study|Disease progression|28|||
17149734|NCT01522976|38294763|FG001|Overall Study|Disease progression|30|||
17149735|NCT01522976|38294764|FG002|Overall Study|Disease progression|25|||
17149736|NCT01522976|38294762|FG000|Overall Study|Adverse Event|17|||
17149737|NCT01522976|38294763|FG001|Overall Study|Adverse Event|7|||
16994204|NCT01043705|38137998|FG000|Overall Study|Screen Fail|21|||
16994205|NCT01043705|38137999|FG001|Overall Study|Screen Fail|0|||
16994206|NCT01043705|38138000|FG002|Overall Study|Screen Fail|0|||
16994207|NCT01043705|38137998|FG000|Overall Study|Other|0|||
16994208|NCT01043705|38137999|FG001|Overall Study|Other|19|||
16994209|NCT01043705|38138000|FG002|Overall Study|Other|25|||
16994210|NCT03141177|38138011|FG000|Overall Study|Death|62|||
16994211|NCT03141177|38138012|FG001|Overall Study|Death|13|||
16994212|NCT03141177|38138013|FG002|Overall Study|Death|84|||
16994213|NCT03141177|38138011|FG000|Overall Study|Participant withdrew consent|9|||
17149738|NCT01522976|38294764|FG002|Overall Study|Adverse Event|18|||
16994214|NCT03141177|38138012|FG001|Overall Study|Participant withdrew consent|2|||
16994215|NCT03141177|38138013|FG002|Overall Study|Participant withdrew consent|13|||
16994216|NCT03141177|38138011|FG000|Overall Study|Not reported|1|||
17070889|NCT00507416|38213451|FG002|Overall Study|Protocol Violation|0|||
17070890|NCT00507416|38213449|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
17070891|NCT00507416|38213450|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
17070892|NCT00507416|38213451|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
17070893|NCT00507416|38213449|FG000|Overall Study|Progressive Disease|20|||
17070894|NCT00507416|38213450|FG001|Overall Study|Progressive Disease|10|||
17070895|NCT00507416|38213451|FG002|Overall Study|Progressive Disease|13|||
17070896|NCT00507416|38213449|FG000|Overall Study|Patient declined further treatment|18|||
17149739|NCT01522976|38294762|FG000|Overall Study|Refusal unrelated to adverse event|10|||
17149740|NCT01522976|38294763|FG001|Overall Study|Refusal unrelated to adverse event|13|||
17149741|NCT01522976|38294764|FG002|Overall Study|Refusal unrelated to adverse event|14|||
17070897|NCT00507416|38213450|FG001|Overall Study|Patient declined further treatment|14|||
17070898|NCT00507416|38213451|FG002|Overall Study|Patient declined further treatment|11|||
17149742|NCT01522976|38294762|FG000|Overall Study|Not protocol specified|22|||
17149743|NCT01522976|38294763|FG001|Overall Study|Not protocol specified|27|||
17149744|NCT01522976|38294764|FG002|Overall Study|Not protocol specified|27|||
17149745|NCT03144804|38294775|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
17149746|NCT01315028|38294811|FG000|Overall Study|Lost to Follow-up|1|||
17149747|NCT01315028|38294812|FG001|Overall Study|Lost to Follow-up|0|||
17149748|NCT01315028|38294811|FG000|Overall Study|Death|0|||
17149749|NCT01315028|38294812|FG001|Overall Study|Death|1|||
17149750|NCT02720536|38294818|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
17149751|NCT02720536|38294818|FG000|Overall Study|PR - pregnancy|2|||
17149752|NCT02720536|38294818|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
17149753|NCT02720536|38294818|FG000|Overall Study|PR - death|1|||
17149754|NCT02720536|38294818|FG000|Overall Study|PR - adverse event|1|||
17149755|NCT02720536|38294818|FG000|Overall Study|PR - abnormal lab value(s)|1|||
17149756|NCT02720536|38294818|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
17149757|NCT03168438|38294830|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
17149758|NCT03168438|38294831|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
17149759|NCT03137784|38294838|FG000|Overall Study|Adverse Event|1|||
17149760|NCT03137784|38294839|FG001|Overall Study|Adverse Event|1|||
17149761|NCT03137784|38294840|FG002|Overall Study|Adverse Event|0|||
17149762|NCT03137784|38294841|FG003|Overall Study|Adverse Event|0|||
17149763|NCT03137784|38294842|FG004|Overall Study|Adverse Event|0|||
17149764|NCT03137784|38294843|FG005|Overall Study|Adverse Event|0|||
17149765|NCT03137784|38294838|FG000|Overall Study|Subject/guardian decision|1|||
17149766|NCT03137784|38294839|FG001|Overall Study|Subject/guardian decision|0|||
17149767|NCT03137784|38294840|FG002|Overall Study|Subject/guardian decision|0|||
17149768|NCT03137784|38294841|FG003|Overall Study|Subject/guardian decision|0|||
17149769|NCT03137784|38294842|FG004|Overall Study|Subject/guardian decision|0|||
17149770|NCT03137784|38294843|FG005|Overall Study|Subject/guardian decision|0|||
17149771|NCT03137784|38294838|FG000|Overall Study|Non-compliance with study treatment|0|||
17149772|NCT03137784|38294839|FG001|Overall Study|Non-compliance with study treatment|0|||
17149773|NCT03137784|38294840|FG002|Overall Study|Non-compliance with study treatment|0|||
17149774|NCT03137784|38294841|FG003|Overall Study|Non-compliance with study treatment|0|||
17070899|NCT00507416|38213449|FG000|Overall Study|Other|11|||
17070900|NCT00507416|38213450|FG001|Overall Study|Other|16|||
17070901|NCT00507416|38213451|FG002|Overall Study|Other|13|||
17070902|NCT00507416|38213449|FG000|Overall Study|Did not Receive Study Treatment|3|||
17070903|NCT00507416|38213450|FG001|Overall Study|Did not Receive Study Treatment|9|||
17070904|NCT00507416|38213451|FG002|Overall Study|Did not Receive Study Treatment|4|||
17070905|NCT00489476|38213463|FG000|Overall Study|Lost to Follow-up|0|||
17070906|NCT00489476|38213464|FG001|Overall Study|Lost to Follow-up|1|||
17070907|NCT00489476|38213465|FG002|Overall Study|Lost to Follow-up|0|||
17070908|NCT00489476|38213466|FG003|Overall Study|Lost to Follow-up|0|||
17070909|NCT00550745|38213478|FG000|Overall Study|Death|20|||
17149775|NCT03137784|38294842|FG004|Overall Study|Non-compliance with study treatment|1|||
17149776|NCT03137784|38294843|FG005|Overall Study|Non-compliance with study treatment|0|||
17149777|NCT01314716|38294853|FG000|Double-Blind Phase|Randomized but not treated|1|||
17149778|NCT01314716|38294854|FG001|Double-Blind Phase|Randomized but not treated|1|||
17149779|NCT01314716|38294853|FG000|Double-Blind Phase|Adverse Event|10|||
17149780|NCT01314716|38294854|FG001|Double-Blind Phase|Adverse Event|4|||
17149781|NCT01314716|38294853|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
17149782|NCT01314716|38294854|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
17149783|NCT01314716|38294853|FG000|Double-Blind Phase|Lost to Follow-up|0|||
17149784|NCT01314716|38294854|FG001|Double-Blind Phase|Lost to Follow-up|1|||
17149785|NCT01314716|38294853|FG000|Double-Blind Phase|Sponsor request|1|||
17149786|NCT01314716|38294854|FG001|Double-Blind Phase|Sponsor request|2|||
17149787|NCT01314716|38294853|FG000|Double-Blind Phase|Physician Decision|0|||
17149788|NCT01314716|38294854|FG001|Double-Blind Phase|Physician Decision|1|||
17070910|NCT00550745|38213479|FG001|Overall Study|Death|16|||
17070911|NCT00550745|38213478|FG000|Overall Study|Lost to Follow-up|45|||
17070912|NCT00550745|38213479|FG001|Overall Study|Lost to Follow-up|30|||
17149789|NCT01314716|38294853|FG000|Open-Label Phase|Adverse Event|4|||
17149790|NCT01314716|38294854|FG001|Open-Label Phase|Adverse Event|6|||
17149791|NCT01314716|38294853|FG000|Open-Label Phase|Withdrawal by Subject|1|||
17149792|NCT01314716|38294854|FG001|Open-Label Phase|Withdrawal by Subject|2|||
17149793|NCT01314716|38294853|FG000|Open-Label Phase|Physician Decision|5|||
17149794|NCT01314716|38294854|FG001|Open-Label Phase|Physician Decision|4|||
17149795|NCT03144180|38294864|FG000|Overall Study|STAT Delivery|1|||
17149796|NCT03144180|38294865|FG001|Overall Study|STAT Delivery|1|||
17149797|NCT03144180|38294864|FG000|Overall Study|Provider forgot to fill out forms|1|||
17149798|NCT03144180|38294865|FG001|Overall Study|Provider forgot to fill out forms|3|||
17149799|NCT03144180|38294864|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
17149800|NCT03144180|38294865|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
17149801|NCT03144180|38294864|FG000|Overall Study|Scrub tech removed tube cap|0|||
17149802|NCT03144180|38294865|FG001|Overall Study|Scrub tech removed tube cap|1|||
17149803|NCT01465334|38294875|FG000|Overall Study|Disease Progression|1|||
17149804|NCT01465334|38294876|FG001|Overall Study|Disease Progression|0|||
17149805|NCT01465334|38294875|FG000|Overall Study|Adverse Event|1|||
17149806|NCT01465334|38294876|FG001|Overall Study|Adverse Event|0|||
17149807|NCT01465334|38294875|FG000|Overall Study|Richter's transformation|0|||
17149808|NCT01465334|38294876|FG001|Overall Study|Richter's transformation|3|||
17149809|NCT01465334|38294875|FG000|Overall Study|Refractory Disease|0|||
17149810|NCT01465334|38294876|FG001|Overall Study|Refractory Disease|3|||
17149811|NCT00702208|38294882|FG000|Overall Study|Lost to Follow-up|28|||
17149812|NCT00702208|38294882|FG000|Overall Study|Did not self-lavage|1|||
17149813|NCT00702208|38294882|FG000|Overall Study|Unsatisfactory colposcopy|2|||
17149814|NCT02718898|38294899|FG000|Blinded Treatment Period|Adverse Event|5|||
17149815|NCT02718898|38294900|FG001|Blinded Treatment Period|Adverse Event|1|||
17149816|NCT02718898|38294901|FG002|Blinded Treatment Period|Adverse Event|0|||
17149817|NCT02718898|38294902|FG003|Blinded Treatment Period|Adverse Event|0|||
17149818|NCT02718898|38294903|FG004|Blinded Treatment Period|Adverse Event|0|||
17149819|NCT02718898|38294904|FG005|Blinded Treatment Period|Adverse Event|0|||
17149820|NCT02718898|38294905|FG006|Blinded Treatment Period|Adverse Event|0|||
17149821|NCT02718898|38294899|FG000|Blinded Treatment Period|Physician Decision|1|||
17149822|NCT02718898|38294900|FG001|Blinded Treatment Period|Physician Decision|0|||
17149823|NCT02718898|38294901|FG002|Blinded Treatment Period|Physician Decision|0|||
17149824|NCT02718898|38294902|FG003|Blinded Treatment Period|Physician Decision|0|||
17149825|NCT02718898|38294903|FG004|Blinded Treatment Period|Physician Decision|0|||
17149826|NCT02718898|38294904|FG005|Blinded Treatment Period|Physician Decision|0|||
17149827|NCT02718898|38294905|FG006|Blinded Treatment Period|Physician Decision|0|||
17149828|NCT02718898|38294899|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
17149829|NCT02718898|38294900|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
17149830|NCT02718898|38294901|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
17149831|NCT02718898|38294902|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
17149832|NCT02718898|38294903|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
17149833|NCT02718898|38294904|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
17149834|NCT02718898|38294905|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
17149835|NCT02718898|38294899|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
17149836|NCT02718898|38294900|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
17149837|NCT02718898|38294901|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
17149838|NCT02718898|38294902|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
17149839|NCT02718898|38294903|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
17149840|NCT02718898|38294904|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
17149841|NCT02718898|38294905|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
17149842|NCT02718898|38294899|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
17149843|NCT02718898|38294900|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
17149844|NCT02718898|38294901|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
17149845|NCT02718898|38294902|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
17149846|NCT02718898|38294903|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
17149847|NCT02718898|38294904|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
17149848|NCT02718898|38294905|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
17149849|NCT02718898|38294899|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
17149850|NCT02718898|38294900|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
17149851|NCT02718898|38294901|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
17149852|NCT02718898|38294902|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
17149853|NCT02718898|38294903|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
17149854|NCT02718898|38294904|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
17149855|NCT02718898|38294905|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
17149856|NCT02718898|38294899|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
17149857|NCT02718898|38294900|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
17149858|NCT02718898|38294901|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
17149859|NCT02718898|38294902|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
17149860|NCT02718898|38294903|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
17149861|NCT02718898|38294904|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
17149862|NCT02718898|38294905|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
17149863|NCT02718898|38294899|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
17149864|NCT02718898|38294900|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
17149865|NCT02718898|38294901|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
17149866|NCT02718898|38294902|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
17149867|NCT02718898|38294903|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
17149868|NCT02718898|38294904|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
17149869|NCT02718898|38294905|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
17149870|NCT02718898|38294899|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
17149871|NCT02718898|38294900|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
17149872|NCT02718898|38294901|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
17149873|NCT02718898|38294902|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
17149874|NCT02718898|38294903|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
17149875|NCT02718898|38294904|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
17149876|NCT02718898|38294905|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
17149877|NCT02718898|38294899|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
17149878|NCT02718898|38294900|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
17149879|NCT02718898|38294901|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
17149880|NCT02718898|38294902|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
17149881|NCT02718898|38294903|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
17149882|NCT02718898|38294904|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
17149883|NCT02718898|38294905|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
17149884|NCT02718898|38294899|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
17149885|NCT02718898|38294900|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
17149886|NCT02718898|38294901|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
17149887|NCT02718898|38294902|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
17149888|NCT02718898|38294903|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
17149889|NCT02718898|38294904|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
17149890|NCT02718898|38294905|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
17149891|NCT02718898|38294899|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
17149892|NCT02718898|38294900|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
17149893|NCT02718898|38294901|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
17149894|NCT02718898|38294902|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
17149895|NCT02718898|38294903|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
17149896|NCT02718898|38294904|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
17149897|NCT02718898|38294905|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
17149898|NCT02718898|38294899|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
17149899|NCT02718898|38294900|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
17149900|NCT02718898|38294901|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
17149901|NCT02718898|38294902|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
17149902|NCT02718898|38294903|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
17149903|NCT02718898|38294904|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
17149904|NCT02718898|38294905|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
17149905|NCT03143166|38294922|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
17149906|NCT02879994|38294928|FG000|Overall Study|off treatment early|7|||
17149907|NCT02879994|38294928|FG000|Overall Study|Adverse Event|2|||
17149908|NCT02879994|38294928|FG000|Overall Study|Death|2|||
17149909|NCT03142932|38294934|FG000|Overall Study|Lost to Follow-up|2|||
17149910|NCT03142932|38294935|FG001|Overall Study|Lost to Follow-up|11|||
17149911|NCT00702052|38294941|FG000|Overall Study|Adverse Event|23|||
17149912|NCT00702052|38294941|FG000|Overall Study|Disease Progression|30|||
17149913|NCT00702052|38294941|FG000|Overall Study|Withdrawal by Subject|5|||
17149914|NCT03140280|38294945|FG000|Overall Study|Physician Decision|5|||
17149915|NCT00658814|38294951|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
17149916|NCT00658814|38294952|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
17149917|NCT00658814|38294951|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
17070913|NCT00550745|38213478|FG000|Overall Study|Physician Decision|0|||
17070914|NCT00550745|38213479|FG001|Overall Study|Physician Decision|2|||
17070915|NCT00550745|38213478|FG000|Overall Study|Protocol Violation|4|||
17070916|NCT00550745|38213479|FG001|Overall Study|Protocol Violation|2|||
17070917|NCT00550745|38213478|FG000|Overall Study|Withdrawal by Subject|17|||
17070918|NCT00550745|38213479|FG001|Overall Study|Withdrawal by Subject|10|||
17070919|NCT00550745|38213478|FG000|Overall Study|Screen failure|1|||
17070920|NCT00550745|38213479|FG001|Overall Study|Screen failure|0|||
17070921|NCT00452790|38213487|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
17070922|NCT00452790|38213488|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
17070923|NCT00452790|38213487|FG000|Infant Series|Parent/legal guardian request|8|||
17070924|NCT00452790|38213488|FG001|Infant Series|Parent/legal guardian request|6|||
17149918|NCT00658814|38294952|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
17149919|NCT00658814|38294951|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
17149920|NCT00658814|38294952|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
17149921|NCT00658814|38294951|FG000|Remission Induction Chemotherapy|Death|1|||
17149922|NCT00658814|38294952|FG001|Remission Induction Chemotherapy|Death|4|||
17149923|NCT00658814|38294951|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
17149924|NCT00658814|38294952|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
17149925|NCT00658814|38294951|FG000|Remission Induction Chemotherapy|Not eligible|1|||
17149926|NCT00658814|38294952|FG001|Remission Induction Chemotherapy|Not eligible|2|||
17149927|NCT00658814|38294951|FG000|Consolidation Therapy|Not protocol specified|0|||
17149928|NCT00658814|38294952|FG001|Consolidation Therapy|Not protocol specified|1|||
17149929|NCT00658814|38294951|FG000|Consolidation Therapy|Not eligible|2|||
17149930|NCT00658814|38294952|FG001|Consolidation Therapy|Not eligible|2|||
17149931|NCT00658814|38294951|FG000|Maintenance Therapy|Adverse Event|1|||
17149932|NCT00658814|38294952|FG001|Maintenance Therapy|Adverse Event|1|||
17149933|NCT00658814|38294951|FG000|Maintenance Therapy|Not protocol specified|1|||
17149934|NCT00658814|38294952|FG001|Maintenance Therapy|Not protocol specified|0|||
17149935|NCT00658814|38294951|FG000|Maintenance Therapy|Not eligible|1|||
17149936|NCT00658814|38294952|FG001|Maintenance Therapy|Not eligible|0|||
17149937|NCT03136380|38294964|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
17149938|NCT03136380|38294965|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
17149939|NCT03136380|38294966|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
17149940|NCT03136380|38294967|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
17149941|NCT03136380|38294968|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
17149942|NCT03136068|38294988|FG000|Overall Study|Lost to Follow-up|1|||
17149943|NCT03136068|38294989|FG001|Overall Study|Lost to Follow-up|1|||
17149944|NCT03136068|38294988|FG000|Overall Study|Protocol Violation|1|||
17149945|NCT03136068|38294989|FG001|Overall Study|Protocol Violation|0|||
17149946|NCT02585232|38294997|FG000|Overall Study|Lost to Follow-up|8|||
17149947|NCT02585232|38294998|FG001|Overall Study|Lost to Follow-up|8|||
17149948|NCT02585232|38294997|FG000|Overall Study|Withdrawal by Subject|4|||
17149949|NCT02585232|38294998|FG001|Overall Study|Withdrawal by Subject|8|||
17149950|NCT03377790|38295027|FG000|Overall Study|Withdrawal by Subject|1|||
17149951|NCT03377790|38295028|FG001|Overall Study|Withdrawal by Subject|0|||
17149952|NCT03377790|38295027|FG000|Overall Study|Adverse Event|1|||
17149953|NCT03377790|38295028|FG001|Overall Study|Adverse Event|0|||
17149954|NCT03377790|38295027|FG000|Overall Study|Lost to Follow-up|0|||
17149955|NCT03377790|38295028|FG001|Overall Study|Lost to Follow-up|2|||
17149956|NCT03377790|38295027|FG000|Overall Study|Randomized but not treated|1|||
17149957|NCT03377790|38295028|FG001|Overall Study|Randomized but not treated|0|||
17149958|NCT03377790|38295027|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
17149959|NCT03377790|38295028|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
17149960|NCT02717494|38295037|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
17149961|NCT02717494|38295038|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
17149962|NCT02717494|38295039|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
17149963|NCT02717494|38295037|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
17149964|NCT02717494|38295038|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
17149965|NCT02717494|38295039|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
17149966|NCT02717494|38295037|FG000|First Intervention (Step 1)|Death|0|||
17149967|NCT02717494|38295038|FG001|First Intervention (Step 1)|Death|0|||
17149968|NCT02717494|38295039|FG002|First Intervention (Step 1)|Death|1|||
17149969|NCT02717494|38295037|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
17149970|NCT02717494|38295038|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
17149971|NCT02717494|38295039|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
17149972|NCT00644228|38295067|FG000|Randomization & Eligibility|Ineligible|31|||
17070925|NCT00452790|38213487|FG000|Infant Series|Failed to return|4|||
17070926|NCT00452790|38213488|FG001|Infant Series|Failed to return|1|||
17070927|NCT00452790|38213487|FG000|Infant Series|Protocol Violation|1|||
17070928|NCT00452790|38213488|FG001|Infant Series|Protocol Violation|3|||
17070929|NCT00452790|38213487|FG000|Infant Series|Lost to Follow-up|2|||
17070930|NCT00452790|38213488|FG001|Infant Series|Lost to Follow-up|2|||
17070931|NCT00452790|38213487|FG000|Infant Series|Adverse Event|1|||
17070932|NCT00452790|38213488|FG001|Infant Series|Adverse Event|2|||
17070933|NCT00452790|38213487|FG000|Infant Series|Other reasons|1|||
17070934|NCT00452790|38213488|FG001|Infant Series|Other reasons|2|||
17070935|NCT00452790|38213487|FG000|Infant Series|Investigator request|0|||
17070936|NCT00452790|38213488|FG001|Infant Series|Investigator request|1|||
17070937|NCT00452790|38213487|FG000|Infant Series|Death|0|||
17070938|NCT00452790|38213488|FG001|Infant Series|Death|1|||
17070939|NCT00452790|38213487|FG000|After Infant Series|Investigator request|10|||
17070940|NCT00452790|38213488|FG001|After Infant Series|Investigator request|10|||
17070941|NCT00452790|38213487|FG000|After Infant Series|Adverse Event|4|||
17070942|NCT00452790|38213488|FG001|After Infant Series|Adverse Event|1|||
17070943|NCT00452790|38213487|FG000|After Infant Series|Parent/legal guardian request|1|||
17070944|NCT00452790|38213488|FG001|After Infant Series|Parent/legal guardian request|3|||
17070945|NCT00452790|38213487|FG000|After Infant Series|Lost to Follow-up|4|||
17070946|NCT00452790|38213488|FG001|After Infant Series|Lost to Follow-up|0|||
17070947|NCT00452790|38213487|FG000|After Infant Series|Failed to return|1|||
17149973|NCT00644228|38295068|FG001|Randomization & Eligibility|Ineligible|21|||
17149974|NCT00644228|38295067|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
17149975|NCT00644228|38295068|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
17149976|NCT00644228|38295067|FG000|Randomization & Eligibility|Invalid Consent|0|||
17149977|NCT00644228|38295068|FG001|Randomization & Eligibility|Invalid Consent|1|||
17149978|NCT00644228|38295067|FG000|Induction Therapy|Adverse Event|22|||
17149979|NCT00644228|38295068|FG001|Induction Therapy|Adverse Event|55|||
17149980|NCT00644228|38295067|FG000|Induction Therapy|Withdrawal by Subject|10|||
17149981|NCT00644228|38295068|FG001|Induction Therapy|Withdrawal by Subject|3|||
17149982|NCT00644228|38295067|FG000|Induction Therapy|Progression/Relapse|24|||
17149983|NCT00644228|38295068|FG001|Induction Therapy|Progression/Relapse|12|||
17149984|NCT00644228|38295067|FG000|Induction Therapy|Death|3|||
17149985|NCT00644228|38295068|FG001|Induction Therapy|Death|7|||
17149986|NCT00644228|38295067|FG000|Induction Therapy|Not Protocol-Specified|24|||
17149987|NCT00644228|38295068|FG001|Induction Therapy|Not Protocol-Specified|28|||
17149988|NCT00644228|38295067|FG000|Maintenance|Adverse Event|27|||
17149989|NCT00644228|38295068|FG001|Maintenance|Adverse Event|31|||
17149990|NCT00644228|38295067|FG000|Maintenance|Withdrawal by Subject|6|||
17149991|NCT00644228|38295068|FG001|Maintenance|Withdrawal by Subject|4|||
17149992|NCT00644228|38295067|FG000|Maintenance|Progression/Relapse|67|||
17149993|NCT00644228|38295068|FG001|Maintenance|Progression/Relapse|42|||
17149994|NCT00644228|38295067|FG000|Maintenance|Death|3|||
17149995|NCT00644228|38295068|FG001|Maintenance|Death|3|||
17149996|NCT00644228|38295067|FG000|Maintenance|Not Protocol-Specified|14|||
17149997|NCT00644228|38295068|FG001|Maintenance|Not Protocol-Specified|15|||
17149998|NCT00644228|38295067|FG000|Maintenance|On Treatment|26|||
17149999|NCT00644228|38295068|FG001|Maintenance|On Treatment|40|||
17150000|NCT01844856|38295076|FG000|Overall Study|Lost to Follow-up|15|||
17150001|NCT01844856|38295077|FG001|Overall Study|Lost to Follow-up|3|||
17150002|NCT01844856|38295076|FG000|Overall Study|Adverse Event|3|||
17150003|NCT01844856|38295077|FG001|Overall Study|Adverse Event|6|||
17150004|NCT01844856|38295076|FG000|Overall Study|Withdrawal by Subject|3|||
17150005|NCT01844856|38295077|FG001|Overall Study|Withdrawal by Subject|2|||
17150006|NCT01844856|38295076|FG000|Overall Study|Noncompliance|2|||
17150007|NCT01844856|38295077|FG001|Overall Study|Noncompliance|3|||
17150008|NCT01844856|38295076|FG000|Overall Study|Enterococcus Resistant|0|||
17150009|NCT01844856|38295077|FG001|Overall Study|Enterococcus Resistant|1|||
17150010|NCT01844856|38295076|FG000|Overall Study|Inadvertently Not Scheduled|1|||
17150011|NCT01844856|38295077|FG001|Overall Study|Inadvertently Not Scheduled|0|||
17150012|NCT01844856|38295076|FG000|Overall Study|Randomized but was a Screen Failure|0|||
17150013|NCT01844856|38295077|FG001|Overall Study|Randomized but was a Screen Failure|1|||
17150014|NCT03135210|38295113|FG000|Overall Study|Death|0|||
17150015|NCT03135210|38295114|FG001|Overall Study|Death|1|||
17150016|NCT00588770|38295122|FG000|Overall Study|Disease progression|85|||
17150017|NCT00588770|38295123|FG001|Overall Study|Disease progression|68|||
17150018|NCT00588770|38295122|FG000|Overall Study|Adverse Event|29|||
17150019|NCT00588770|38295123|FG001|Overall Study|Adverse Event|58|||
17150020|NCT00588770|38295122|FG000|Overall Study|Death|13|||
17150021|NCT00588770|38295123|FG001|Overall Study|Death|22|||
17070948|NCT00452790|38213488|FG001|After Infant Series|Failed to return|0|||
17070949|NCT00452790|38213487|FG000|After Infant Series|Other reasons|1|||
17070950|NCT00452790|38213488|FG001|After Infant Series|Other reasons|0|||
17070951|NCT00452790|38213487|FG000|Toddler Dose|Failed to return|0|||
17070952|NCT00452790|38213488|FG001|Toddler Dose|Failed to return|1|||
17070953|NCT00452790|38213487|FG000|Toddler Dose|Parent/legal guardian request|0|||
17070954|NCT00452790|38213488|FG001|Toddler Dose|Parent/legal guardian request|1|||
17070955|NCT00463788|38213500|FG000|Overall Study|Progressive Disease|86|||
17070956|NCT00463788|38213501|FG001|Overall Study|Progressive Disease|42|||
17070957|NCT00463788|38213500|FG000|Overall Study|Adverse Event|6|||
17070958|NCT00463788|38213501|FG001|Overall Study|Adverse Event|2|||
17070959|NCT00463788|38213500|FG000|Overall Study|Withdrawal by Subject|6|||
17070960|NCT00463788|38213501|FG001|Overall Study|Withdrawal by Subject|2|||
17070961|NCT00463788|38213500|FG000|Overall Study|Death|4|||
17070962|NCT00463788|38213501|FG001|Overall Study|Death|3|||
17070963|NCT00463788|38213500|FG000|Overall Study|Symptomatic Deterioration|2|||
17070964|NCT00463788|38213501|FG001|Overall Study|Symptomatic Deterioration|3|||
17070965|NCT00463788|38213500|FG000|Overall Study|Lost to Follow-up|1|||
17070966|NCT00463788|38213501|FG001|Overall Study|Lost to Follow-up|0|||
17070967|NCT00463788|38213500|FG000|Overall Study|Protocol Violation|0|||
17070968|NCT00463788|38213501|FG001|Overall Study|Protocol Violation|1|||
17070969|NCT00463788|38213500|FG000|Overall Study|Other|3|||
17150022|NCT00588770|38295122|FG000|Overall Study|Withdrawal by Subject|15|||
17150023|NCT00588770|38295123|FG001|Overall Study|Withdrawal by Subject|25|||
17150024|NCT00588770|38295122|FG000|Overall Study|Alternative therapy|2|||
17150025|NCT00588770|38295123|FG001|Overall Study|Alternative therapy|4|||
17150026|NCT00588770|38295122|FG000|Overall Study|Other complicating disease|3|||
17150027|NCT00588770|38295123|FG001|Overall Study|Other complicating disease|2|||
17150028|NCT00588770|38295122|FG000|Overall Study|Not start protocol therapy|0|||
17150029|NCT00588770|38295123|FG001|Overall Study|Not start protocol therapy|9|||
17150030|NCT00588770|38295122|FG000|Overall Study|Lack of Efficacy|8|||
17150031|NCT00588770|38295123|FG001|Overall Study|Lack of Efficacy|10|||
17150032|NCT00588770|38295122|FG000|Overall Study|Physician discretion|2|||
17150033|NCT00588770|38295123|FG001|Overall Study|Physician discretion|0|||
17150034|NCT00588770|38295122|FG000|Overall Study|Patient non-compliance|2|||
17150035|NCT00588770|38295123|FG001|Overall Study|Patient non-compliance|2|||
17150036|NCT02147184|38295131|FG000|Overall Study|Lost to Follow-up|28|||
17150037|NCT02147184|38295132|FG001|Overall Study|Lost to Follow-up|15|||
17150038|NCT02147184|38295131|FG000|Overall Study|Study Burden|11|||
17150039|NCT02147184|38295132|FG001|Overall Study|Study Burden|7|||
17150040|NCT02147184|38295131|FG000|Overall Study|Pregnancy|6|||
17150041|NCT02147184|38295132|FG001|Overall Study|Pregnancy|0|||
17150042|NCT02147184|38295131|FG000|Overall Study|Moved out of state|3|||
17150043|NCT02147184|38295132|FG001|Overall Study|Moved out of state|3|||
17150044|NCT02147184|38295131|FG000|Overall Study|Physician Decision|0|||
17150045|NCT02147184|38295132|FG001|Overall Study|Physician Decision|2|||
17150046|NCT02147184|38295131|FG000|Overall Study|Other|1|||
17150047|NCT02147184|38295132|FG001|Overall Study|Other|0|||
17150048|NCT00701662|38295138|FG000|Overall Study|Lack of Efficacy|1|||
17150049|NCT02878590|38295142|FG000|Overall Study|Withdrawal by Subject|2|||
17150050|NCT04634409|38295173|FG000|Overall Study|Death|0|||
17150051|NCT04634409|38295174|FG001|Overall Study|Death|0|||
17150052|NCT04634409|38295175|FG002|Overall Study|Death|0|||
17150053|NCT04634409|38295176|FG003|Overall Study|Death|0|||
17150054|NCT04634409|38295177|FG004|Overall Study|Death|0|||
17150055|NCT04634409|38295178|FG005|Overall Study|Death|0|||
17150056|NCT04634409|38295179|FG006|Overall Study|Death|0|||
17150057|NCT04634409|38295180|FG007|Overall Study|Death|0|||
17150058|NCT04634409|38295181|FG008|Overall Study|Death|0|||
17150059|NCT04634409|38295182|FG009|Overall Study|Death|0|||
17150060|NCT04634409|38295183|FG010|Overall Study|Death|1|||
17150061|NCT04634409|38295184|FG011|Overall Study|Death|0|||
17150062|NCT04634409|38295185|FG012|Overall Study|Death|1|||
17150063|NCT04634409|38295186|FG013|Overall Study|Death|0|||
17150064|NCT04634409|38295187|FG014|Overall Study|Death|0|||
17150065|NCT04634409|38295188|FG015|Overall Study|Death|0|||
17150066|NCT04634409|38295189|FG016|Overall Study|Death|0|||
17150067|NCT04634409|38295190|FG017|Overall Study|Death|0|||
17150068|NCT04634409|38295191|FG018|Overall Study|Death|0|||
17150069|NCT04634409|38295192|FG019|Overall Study|Death|0|||
17070970|NCT00463788|38213501|FG001|Overall Study|Other|0|||
17070971|NCT00463788|38213500|FG000|Overall Study|Randomized but not treated|1|||
17070972|NCT00463788|38213501|FG001|Overall Study|Randomized but not treated|1|||
17070973|NCT00548249|38213513|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
17070974|NCT00548249|38213514|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
17070975|NCT00548249|38213515|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
17070976|NCT00548249|38213516|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
17070977|NCT00548249|38213517|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
17150070|NCT04634409|38295193|FG020|Overall Study|Death|0|||
17150071|NCT04634409|38295194|FG021|Overall Study|Death|0|||
17150072|NCT04634409|38295195|FG022|Overall Study|Death|0|||
17150073|NCT04634409|38295196|FG023|Overall Study|Death|0|||
17150074|NCT04634409|38295197|FG024|Overall Study|Death|0|||
17150075|NCT04634409|38295198|FG025|Overall Study|Death|0|||
17150076|NCT04634409|38295199|FG026|Overall Study|Death|0|||
17150077|NCT04634409|38295173|FG000|Overall Study|Adverse Event|0|||
17150078|NCT04634409|38295174|FG001|Overall Study|Adverse Event|0|||
17150079|NCT04634409|38295175|FG002|Overall Study|Adverse Event|1|||
17150080|NCT04634409|38295176|FG003|Overall Study|Adverse Event|0|||
17150081|NCT04634409|38295177|FG004|Overall Study|Adverse Event|0|||
17150082|NCT04634409|38295178|FG005|Overall Study|Adverse Event|1|||
17150083|NCT04634409|38295179|FG006|Overall Study|Adverse Event|0|||
17150084|NCT04634409|38295180|FG007|Overall Study|Adverse Event|0|||
17150085|NCT04634409|38295181|FG008|Overall Study|Adverse Event|0|||
17150086|NCT04634409|38295182|FG009|Overall Study|Adverse Event|0|||
17150087|NCT04634409|38295183|FG010|Overall Study|Adverse Event|0|||
17150088|NCT04634409|38295184|FG011|Overall Study|Adverse Event|0|||
17150089|NCT04634409|38295185|FG012|Overall Study|Adverse Event|0|||
17150090|NCT04634409|38295186|FG013|Overall Study|Adverse Event|0|||
17150091|NCT04634409|38295187|FG014|Overall Study|Adverse Event|0|||
17150092|NCT04634409|38295188|FG015|Overall Study|Adverse Event|0|||
17150093|NCT04634409|38295189|FG016|Overall Study|Adverse Event|0|||
17150094|NCT04634409|38295190|FG017|Overall Study|Adverse Event|0|||
17150095|NCT04634409|38295191|FG018|Overall Study|Adverse Event|0|||
17150096|NCT04634409|38295192|FG019|Overall Study|Adverse Event|0|||
17150097|NCT04634409|38295193|FG020|Overall Study|Adverse Event|0|||
17150098|NCT04634409|38295194|FG021|Overall Study|Adverse Event|0|||
17150099|NCT04634409|38295195|FG022|Overall Study|Adverse Event|0|||
17150100|NCT04634409|38295196|FG023|Overall Study|Adverse Event|0|||
17150101|NCT04634409|38295197|FG024|Overall Study|Adverse Event|0|||
17150102|NCT04634409|38295198|FG025|Overall Study|Adverse Event|0|||
17150103|NCT04634409|38295199|FG026|Overall Study|Adverse Event|0|||
17150104|NCT04634409|38295173|FG000|Overall Study|Lost to Follow-up|3|||
17150105|NCT04634409|38295174|FG001|Overall Study|Lost to Follow-up|1|||
17150106|NCT04634409|38295175|FG002|Overall Study|Lost to Follow-up|1|||
17150107|NCT04634409|38295176|FG003|Overall Study|Lost to Follow-up|3|||
17150108|NCT04634409|38295177|FG004|Overall Study|Lost to Follow-up|1|||
17150109|NCT04634409|38295178|FG005|Overall Study|Lost to Follow-up|1|||
17150110|NCT04634409|38295179|FG006|Overall Study|Lost to Follow-up|1|||
17150111|NCT04634409|38295180|FG007|Overall Study|Lost to Follow-up|3|||
17150112|NCT04634409|38295181|FG008|Overall Study|Lost to Follow-up|3|||
17150113|NCT04634409|38295182|FG009|Overall Study|Lost to Follow-up|11|||
17150114|NCT04634409|38295183|FG010|Overall Study|Lost to Follow-up|8|||
17150115|NCT04634409|38295184|FG011|Overall Study|Lost to Follow-up|15|||
17150116|NCT04634409|38295185|FG012|Overall Study|Lost to Follow-up|3|||
17150117|NCT04634409|38295186|FG013|Overall Study|Lost to Follow-up|2|||
17150118|NCT04634409|38295187|FG014|Overall Study|Lost to Follow-up|7|||
17150119|NCT04634409|38295188|FG015|Overall Study|Lost to Follow-up|0|||
17150120|NCT04634409|38295189|FG016|Overall Study|Lost to Follow-up|0|||
17150121|NCT04634409|38295190|FG017|Overall Study|Lost to Follow-up|0|||
17150122|NCT04634409|38295191|FG018|Overall Study|Lost to Follow-up|0|||
17150123|NCT04634409|38295192|FG019|Overall Study|Lost to Follow-up|0|||
17150124|NCT04634409|38295193|FG020|Overall Study|Lost to Follow-up|0|||
17150125|NCT04634409|38295194|FG021|Overall Study|Lost to Follow-up|0|||
17150126|NCT04634409|38295195|FG022|Overall Study|Lost to Follow-up|0|||
17150127|NCT04634409|38295196|FG023|Overall Study|Lost to Follow-up|0|||
17150128|NCT04634409|38295197|FG024|Overall Study|Lost to Follow-up|0|||
17150129|NCT04634409|38295198|FG025|Overall Study|Lost to Follow-up|0|||
17150130|NCT04634409|38295199|FG026|Overall Study|Lost to Follow-up|0|||
17150131|NCT04634409|38295173|FG000|Overall Study|Withdrawal by Subject|3|||
17150132|NCT04634409|38295174|FG001|Overall Study|Withdrawal by Subject|1|||
17150133|NCT04634409|38295175|FG002|Overall Study|Withdrawal by Subject|6|||
17150134|NCT04634409|38295176|FG003|Overall Study|Withdrawal by Subject|4|||
17150135|NCT04634409|38295177|FG004|Overall Study|Withdrawal by Subject|2|||
17150136|NCT04634409|38295178|FG005|Overall Study|Withdrawal by Subject|0|||
17150137|NCT04634409|38295179|FG006|Overall Study|Withdrawal by Subject|0|||
17150138|NCT04634409|38295180|FG007|Overall Study|Withdrawal by Subject|2|||
17150139|NCT04634409|38295181|FG008|Overall Study|Withdrawal by Subject|3|||
17150140|NCT04634409|38295182|FG009|Overall Study|Withdrawal by Subject|2|||
17150141|NCT04634409|38295183|FG010|Overall Study|Withdrawal by Subject|3|||
17150142|NCT04634409|38295184|FG011|Overall Study|Withdrawal by Subject|2|||
17150143|NCT04634409|38295185|FG012|Overall Study|Withdrawal by Subject|2|||
17150144|NCT04634409|38295186|FG013|Overall Study|Withdrawal by Subject|1|||
17150145|NCT04634409|38295187|FG014|Overall Study|Withdrawal by Subject|5|||
17150146|NCT04634409|38295188|FG015|Overall Study|Withdrawal by Subject|0|||
17150147|NCT04634409|38295189|FG016|Overall Study|Withdrawal by Subject|0|||
17150148|NCT04634409|38295190|FG017|Overall Study|Withdrawal by Subject|1|||
17150149|NCT04634409|38295191|FG018|Overall Study|Withdrawal by Subject|0|||
17150150|NCT04634409|38295192|FG019|Overall Study|Withdrawal by Subject|0|||
17150151|NCT04634409|38295193|FG020|Overall Study|Withdrawal by Subject|0|||
17070978|NCT00548249|38213513|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
17150152|NCT04634409|38295194|FG021|Overall Study|Withdrawal by Subject|0|||
17150153|NCT04634409|38295195|FG022|Overall Study|Withdrawal by Subject|0|||
17150154|NCT04634409|38295196|FG023|Overall Study|Withdrawal by Subject|1|||
17150155|NCT04634409|38295197|FG024|Overall Study|Withdrawal by Subject|0|||
17150156|NCT04634409|38295198|FG025|Overall Study|Withdrawal by Subject|0|||
17070979|NCT00548249|38213514|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
17070980|NCT00548249|38213515|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
17070981|NCT00548249|38213516|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
17070982|NCT00548249|38213517|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
17070983|NCT00548249|38213513|FG000|Overall Study|Protocol Violation|1|||
17070984|NCT00548249|38213514|FG001|Overall Study|Protocol Violation|1|||
17150157|NCT04634409|38295199|FG026|Overall Study|Withdrawal by Subject|0|||
17150158|NCT04634409|38295173|FG000|Overall Study|Other - As reported by Investigator|1|||
17150159|NCT04634409|38295174|FG001|Overall Study|Other - As reported by Investigator|0|||
17150160|NCT04634409|38295175|FG002|Overall Study|Other - As reported by Investigator|0|||
17150161|NCT04634409|38295176|FG003|Overall Study|Other - As reported by Investigator|0|||
17150162|NCT04634409|38295177|FG004|Overall Study|Other - As reported by Investigator|0|||
17150163|NCT04634409|38295178|FG005|Overall Study|Other - As reported by Investigator|0|||
17150164|NCT04634409|38295179|FG006|Overall Study|Other - As reported by Investigator|0|||
17070985|NCT00548249|38213515|FG002|Overall Study|Protocol Violation|4|||
17150165|NCT04634409|38295180|FG007|Overall Study|Other - As reported by Investigator|6|||
17150166|NCT04634409|38295181|FG008|Overall Study|Other - As reported by Investigator|4|||
17150167|NCT04634409|38295182|FG009|Overall Study|Other - As reported by Investigator|0|||
17150168|NCT04634409|38295183|FG010|Overall Study|Other - As reported by Investigator|1|||
17150169|NCT04634409|38295184|FG011|Overall Study|Other - As reported by Investigator|2|||
17150170|NCT04634409|38295185|FG012|Overall Study|Other - As reported by Investigator|2|||
17150171|NCT04634409|38295186|FG013|Overall Study|Other - As reported by Investigator|1|||
17150172|NCT04634409|38295187|FG014|Overall Study|Other - As reported by Investigator|0|||
17150173|NCT04634409|38295188|FG015|Overall Study|Other - As reported by Investigator|0|||
17150174|NCT04634409|38295189|FG016|Overall Study|Other - As reported by Investigator|0|||
17150175|NCT04634409|38295190|FG017|Overall Study|Other - As reported by Investigator|0|||
17150176|NCT04634409|38295191|FG018|Overall Study|Other - As reported by Investigator|0|||
17150177|NCT04634409|38295192|FG019|Overall Study|Other - As reported by Investigator|0|||
17150178|NCT04634409|38295193|FG020|Overall Study|Other - As reported by Investigator|0|||
17150179|NCT04634409|38295194|FG021|Overall Study|Other - As reported by Investigator|0|||
17150180|NCT04634409|38295195|FG022|Overall Study|Other - As reported by Investigator|0|||
17150181|NCT04634409|38295196|FG023|Overall Study|Other - As reported by Investigator|0|||
17150182|NCT04634409|38295197|FG024|Overall Study|Other - As reported by Investigator|0|||
17150183|NCT04634409|38295198|FG025|Overall Study|Other - As reported by Investigator|0|||
17150184|NCT04634409|38295199|FG026|Overall Study|Other - As reported by Investigator|0|||
17150185|NCT00005780|38295277|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
17150186|NCT01978938|38295286|FG000|Overall Study|Lost to Follow-up|12|||
17150187|NCT01978938|38295287|FG001|Overall Study|Lost to Follow-up|6|||
17150188|NCT01978938|38295286|FG000|Overall Study|Withdrawal by Subject|8|||
17150189|NCT01978938|38295287|FG001|Overall Study|Withdrawal by Subject|4|||
17150190|NCT01978938|38295286|FG000|Overall Study|Adverse Event, non-fatal|2|||
17150191|NCT01978938|38295287|FG001|Overall Study|Adverse Event, non-fatal|1|||
17150192|NCT01978938|38295286|FG000|Overall Study|Participant noncompliance|1|||
17150193|NCT01978938|38295287|FG001|Overall Study|Participant noncompliance|1|||
17150194|NCT01978938|38295286|FG000|Overall Study|Did not meet inclusion criteria|0|||
17150195|NCT01978938|38295287|FG001|Overall Study|Did not meet inclusion criteria|1|||
17150196|NCT01978938|38295286|FG000|Overall Study|Previously scheduled procedure|0|||
17150197|NCT01978938|38295287|FG001|Overall Study|Previously scheduled procedure|1|||
17150198|NCT03041090|38295295|FG000|Overall Study|technical error|0|||
17150199|NCT03041090|38295296|FG001|Overall Study|technical error|3|||
17150200|NCT00116142|38295304|FG000|Overall Study|Adverse Event|8|||
17150201|NCT00116142|38295305|FG001|Overall Study|Adverse Event|7|||
17150202|NCT00116142|38295304|FG000|Overall Study|Protocol Violation|2|||
17150203|NCT00116142|38295305|FG001|Overall Study|Protocol Violation|1|||
17150204|NCT00116142|38295304|FG000|Overall Study|Withdrawal by Subject|5|||
17150205|NCT00116142|38295305|FG001|Overall Study|Withdrawal by Subject|5|||
17150206|NCT00116142|38295304|FG000|Overall Study|Physician Decision|3|||
17150207|NCT00116142|38295305|FG001|Overall Study|Physician Decision|1|||
17150208|NCT00116142|38295304|FG000|Overall Study|Delayed Radiation Therapy|1|||
17150209|NCT00116142|38295305|FG001|Overall Study|Delayed Radiation Therapy|0|||
17150210|NCT00116142|38295304|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
17150211|NCT00116142|38295305|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
17150212|NCT00116142|38295304|FG000|Overall Study|Patient stopped due to depression|0|||
17150213|NCT00116142|38295305|FG001|Overall Study|Patient stopped due to depression|1|||
17150214|NCT00116142|38295304|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
17150215|NCT00116142|38295305|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
17150216|NCT00116142|38295304|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
17150217|NCT00116142|38295305|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
17150218|NCT00116142|38295304|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
17150219|NCT00116142|38295305|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
17150220|NCT03135522|38295316|FG000|Overall Study|Adverse Event|1|||
17150221|NCT03135522|38295317|FG001|Overall Study|Adverse Event|0|||
17150222|NCT02875080|38295340|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
17150223|NCT02875080|38295341|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
17150224|NCT02875080|38295342|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
17150225|NCT03129360|38295353|FG000|Overall Study|Did not meet entry criteria|0|||
17150226|NCT03129360|38295354|FG001|Overall Study|Did not meet entry criteria|2|||
17150227|NCT03129360|38295355|FG002|Overall Study|Did not meet entry criteria|1|||
17150228|NCT03129360|38295353|FG000|Overall Study|Excluded due to motion in scanner|1|||
17150229|NCT03129360|38295354|FG001|Overall Study|Excluded due to motion in scanner|0|||
17150230|NCT03129360|38295355|FG002|Overall Study|Excluded due to motion in scanner|0|||
17150231|NCT03165045|38295363|FG000|Visit 1|No registration after visit 1|9|||
17150232|NCT03165045|38295363|FG000|Visit 1|No treatment documented|10|||
17150233|NCT03165045|38295363|FG000|Visit 1|No visit 1|10|||
17150234|NCT03165045|38295363|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
17150235|NCT03165045|38295363|FG000|Visit 2|No available total CCQ score at all|29|||
17150236|NCT03165045|38295363|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
17150237|NCT01928199|38295371|FG000|Overall Study|Lost to Follow-up|2|||
17150238|NCT01928199|38295372|FG001|Overall Study|Lost to Follow-up|1|||
17150239|NCT01928199|38295371|FG000|Overall Study|Withdrawal by Subject|3|||
17150240|NCT01928199|38295372|FG001|Overall Study|Withdrawal by Subject|5|||
17150241|NCT03128892|38295378|FG000|Overall Study|Withdrawal by Subject|2|||
17150242|NCT03128892|38295378|FG000|Overall Study|Physician Decision|1|||
17150243|NCT03039686|38295394|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
17150244|NCT03039686|38295395|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
17150245|NCT03039686|38295396|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
17150246|NCT03039686|38295394|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
17150247|NCT03039686|38295395|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
17150248|NCT03039686|38295396|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
17150249|NCT03039686|38295394|FG000|Double-blind Period|Withdrawal by Subject|2|||
17150250|NCT03039686|38295395|FG001|Double-blind Period|Withdrawal by Subject|2|||
17150251|NCT03039686|38295396|FG002|Double-blind Period|Withdrawal by Subject|1|||
17150252|NCT03039686|38295394|FG000|Double-blind Period|Death|0|||
17150253|NCT03039686|38295395|FG001|Double-blind Period|Death|0|||
17150254|NCT03039686|38295396|FG002|Double-blind Period|Death|1|||
17150255|NCT03039686|38295394|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
17150256|NCT03039686|38295395|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
17150257|NCT03039686|38295396|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
17150258|NCT03039686|38295394|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
17150259|NCT03039686|38295395|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
17150260|NCT03039686|38295396|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
17150261|NCT03039686|38295394|FG000|Open Label Period|Withdrawal by Subject|0|||
17150262|NCT03039686|38295395|FG001|Open Label Period|Withdrawal by Subject|3|||
17150263|NCT03039686|38295396|FG002|Open Label Period|Withdrawal by Subject|1|||
17150264|NCT01822275|38295414|FG000|Overall Study|Withdrawal by Subject|3|||
17150265|NCT01822275|38295414|FG000|Overall Study|Adverse Event|3|||
17150266|NCT01822275|38295414|FG000|Overall Study|Progression|14|||
17150267|NCT01822275|38295414|FG000|Overall Study|Physician Decision|2|||
17150268|NCT01656434|38295426|FG000|Overall Study|Adverse Event|199|||
17150269|NCT01656434|38295427|FG001|Overall Study|Adverse Event|63|||
17150270|NCT01656434|38295426|FG000|Overall Study|Enrollment terminated at trial site|2|||
17150271|NCT01656434|38295427|FG001|Overall Study|Enrollment terminated at trial site|0|||
17150272|NCT01656434|38295426|FG000|Overall Study|Lost to Follow-up|309|||
17150273|NCT01656434|38295427|FG001|Overall Study|Lost to Follow-up|76|||
17150274|NCT01656434|38295426|FG000|Overall Study|Site discontinued study participation|24|||
17150275|NCT01656434|38295427|FG001|Overall Study|Site discontinued study participation|9|||
17150276|NCT01656434|38295426|FG000|Overall Study|Screen failure|2|||
17150277|NCT01656434|38295427|FG001|Overall Study|Screen failure|0|||
17150278|NCT01656434|38295426|FG000|Overall Study|Protocol Violation|7|||
17150279|NCT01656434|38295427|FG001|Overall Study|Protocol Violation|0|||
17150280|NCT01656434|38295426|FG000|Overall Study|Pregnancy wish|18|||
17150281|NCT01656434|38295427|FG001|Overall Study|Pregnancy wish|6|||
17150282|NCT01656434|38295426|FG000|Overall Study|Pregnancy|45|||
17150283|NCT01656434|38295427|FG001|Overall Study|Pregnancy|10|||
17150284|NCT01656434|38295426|FG000|Overall Study|Physician Decision|7|||
17150285|NCT01656434|38295427|FG001|Overall Study|Physician Decision|2|||
17150286|NCT01656434|38295426|FG000|Overall Study|Non-compliance with study drug|48|||
17150287|NCT01656434|38295427|FG001|Overall Study|Non-compliance with study drug|9|||
17150288|NCT01656434|38295426|FG000|Overall Study|Study terminated by sponsor|1501|||
17150289|NCT01656434|38295427|FG001|Overall Study|Study terminated by sponsor|348|||
17150290|NCT01656434|38295426|FG000|Overall Study|Participant discontinued; drug related|13|||
17150291|NCT01656434|38295427|FG001|Overall Study|Participant discontinued; drug related|4|||
17150292|NCT01656434|38295426|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
17150293|NCT01656434|38295427|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
17150294|NCT01656434|38295426|FG000|Overall Study|Non-compliance with protocol|39|||
17150295|NCT01656434|38295427|FG001|Overall Study|Non-compliance with protocol|15|||
17150296|NCT01656434|38295426|FG000|Overall Study|Participant moved|40|||
17150297|NCT01656434|38295427|FG001|Overall Study|Participant moved|12|||
17150298|NCT01656434|38295426|FG000|Overall Study|Participant withdrew consent|28|||
17150299|NCT01656434|38295427|FG001|Overall Study|Participant withdrew consent|9|||
17150300|NCT01656434|38295426|FG000|Overall Study|Withdrawal by Subject|64|||
17150301|NCT01656434|38295427|FG001|Overall Study|Withdrawal by Subject|7|||
17150302|NCT02931396|38295435|FG000|Overall Study|Lost to Follow-up|3|||
17150303|NCT02931396|38295436|FG001|Overall Study|Lost to Follow-up|0|||
17150304|NCT02931396|38295435|FG000|Overall Study|Withdrawal by Subject|2|||
17150305|NCT02931396|38295436|FG001|Overall Study|Withdrawal by Subject|0|||
17150306|NCT03037580|38295444|FG000|Overall Study|Withdrawal by Subject|3|||
17150307|NCT03037580|38295445|FG001|Overall Study|Withdrawal by Subject|0|||
17150308|NCT03037580|38295444|FG000|Overall Study|Adverse Event|1|||
17150309|NCT03037580|38295445|FG001|Overall Study|Adverse Event|0|||
17150310|NCT03037580|38295444|FG000|Overall Study|Study Terminated by Sponsor|12|||
17150311|NCT03037580|38295445|FG001|Overall Study|Study Terminated by Sponsor|15|||
17150312|NCT03037580|38295444|FG000|Overall Study|Death|0|||
17150313|NCT03037580|38295445|FG001|Overall Study|Death|1|||
17150314|NCT01755195|38295451|FG000|Overall Study|Participant noncompliance|2|||
17150315|NCT01755195|38295451|FG000|Overall Study|Switched to alternative treatment|4|||
17150316|NCT01755195|38295451|FG000|Overall Study|Withdrawal by Subject|1|||
17150317|NCT01755195|38295451|FG000|Overall Study|Participant refused to start treatment|1|||
17150318|NCT01755195|38295451|FG000|Overall Study|Participant has been consented for another trial|1|||
17150319|NCT01755195|38295451|FG000|Overall Study|Refused further treatment|3|||
17150320|NCT01755195|38295451|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
17150321|NCT00897104|38295458|FG000|Overall Study|Lost to Follow-up|12|||
17150322|NCT00897104|38295459|FG001|Overall Study|Lost to Follow-up|17|||
17150323|NCT00897104|38295460|FG002|Overall Study|Lost to Follow-up|2|||
17150324|NCT00897104|38295458|FG000|Overall Study|Pregnancy|0|||
17150325|NCT00897104|38295459|FG001|Overall Study|Pregnancy|1|||
17150326|NCT00897104|38295460|FG002|Overall Study|Pregnancy|0|||
17150327|NCT00897104|38295458|FG000|Overall Study|Protocol Violation|0|||
17150328|NCT00897104|38295459|FG001|Overall Study|Protocol Violation|1|||
17150329|NCT00897104|38295460|FG002|Overall Study|Protocol Violation|0|||
17150330|NCT00897104|38295458|FG000|Overall Study|Withdrawal by Subject|23|||
17150331|NCT00897104|38295459|FG001|Overall Study|Withdrawal by Subject|27|||
17150332|NCT00897104|38295460|FG002|Overall Study|Withdrawal by Subject|3|||
17150333|NCT00897104|38295458|FG000|Overall Study|Abnormal Prestudy Labs|2|||
17150334|NCT00897104|38295459|FG001|Overall Study|Abnormal Prestudy Labs|0|||
17150335|NCT00897104|38295460|FG002|Overall Study|Abnormal Prestudy Labs|0|||
17150336|NCT00897104|38295458|FG000|Overall Study|Abnormal Baseline ECG|2|||
17150337|NCT00897104|38295459|FG001|Overall Study|Abnormal Baseline ECG|2|||
17150338|NCT00897104|38295460|FG002|Overall Study|Abnormal Baseline ECG|0|||
17150339|NCT00897104|38295458|FG000|Overall Study|Need for Concom. Med.|0|||
17150340|NCT00897104|38295459|FG001|Overall Study|Need for Concom. Med.|1|||
17150341|NCT00897104|38295460|FG002|Overall Study|Need for Concom. Med.|1|||
17150342|NCT00897104|38295458|FG000|Overall Study|Lack of Migraine Attack|20|||
17150343|NCT00897104|38295459|FG001|Overall Study|Lack of Migraine Attack|22|||
17150344|NCT00897104|38295460|FG002|Overall Study|Lack of Migraine Attack|1|||
17150345|NCT00897104|38295458|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
17150346|NCT00897104|38295459|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
17150347|NCT00897104|38295460|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
17150348|NCT00897104|38295458|FG000|Overall Study|Other|3|||
17150349|NCT00897104|38295459|FG001|Overall Study|Other|0|||
17150350|NCT00897104|38295460|FG002|Overall Study|Other|0|||
17150351|NCT00897104|38295458|FG000|Overall Study|Protocol Violation|1|||
17150352|NCT00897104|38295459|FG001|Overall Study|Protocol Violation|0|||
17150353|NCT00897104|38295460|FG002|Overall Study|Protocol Violation|0|||
17150354|NCT00897104|38295458|FG000|Overall Study|Withdrawal by Subject|0|||
17070986|NCT00548249|38213516|FG003|Overall Study|Protocol Violation|0|||
17070987|NCT00548249|38213517|FG004|Overall Study|Protocol Violation|3|||
17070988|NCT00548249|38213513|FG000|Overall Study|Miscellaneous|2|||
17070989|NCT00548249|38213514|FG001|Overall Study|Miscellaneous|3|||
17070990|NCT00548249|38213515|FG002|Overall Study|Miscellaneous|2|||
17070991|NCT00548249|38213516|FG003|Overall Study|Miscellaneous|0|||
17070992|NCT00548249|38213517|FG004|Overall Study|Miscellaneous|2|||
17070993|NCT00548249|38213513|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
17070994|NCT00548249|38213514|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
17070995|NCT00548249|38213515|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
17070996|NCT00548249|38213516|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
17070997|NCT00548249|38213517|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
17070998|NCT00548249|38213513|FG000|Overall Study|Adverse Event|2|||
17070999|NCT00548249|38213514|FG001|Overall Study|Adverse Event|2|||
17071000|NCT00548249|38213515|FG002|Overall Study|Adverse Event|0|||
17071001|NCT00548249|38213516|FG003|Overall Study|Adverse Event|1|||
17071002|NCT00548249|38213517|FG004|Overall Study|Adverse Event|1|||
17071003|NCT00548249|38213513|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
17071004|NCT00548249|38213514|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
17150355|NCT00897104|38295459|FG001|Overall Study|Withdrawal by Subject|0|||
17150356|NCT00897104|38295460|FG002|Overall Study|Withdrawal by Subject|1|||
17071005|NCT00548249|38213515|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
17071006|NCT00548249|38213516|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
17071007|NCT00548249|38213517|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
17071008|NCT00548249|38213513|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
17071009|NCT00548249|38213514|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
17150357|NCT01339689|38295470|FG000|Overall Study|Adverse Event|1|||
17150358|NCT01339689|38295471|FG001|Overall Study|Adverse Event|2|||
17150359|NCT01339689|38295470|FG000|Overall Study|Lost to Follow-up|9|||
17150360|NCT01339689|38295471|FG001|Overall Study|Lost to Follow-up|3|||
17150361|NCT01339689|38295470|FG000|Overall Study|Withdrawal by Subject|3|||
17150362|NCT01339689|38295471|FG001|Overall Study|Withdrawal by Subject|0|||
17150363|NCT01339689|38295470|FG000|Overall Study|Noncompliance|1|||
17150364|NCT01339689|38295471|FG001|Overall Study|Noncompliance|0|||
17150365|NCT01339689|38295470|FG000|Overall Study|Relocated out of area|0|||
17150366|NCT01339689|38295471|FG001|Overall Study|Relocated out of area|1|||
17150367|NCT01339689|38295470|FG000|Overall Study|Other|2|||
17150368|NCT01339689|38295471|FG001|Overall Study|Other|2|||
17150369|NCT01339689|38295470|FG000|Overall Study|multiple reasons|1|||
17150370|NCT01339689|38295471|FG001|Overall Study|multiple reasons|1|||
17150371|NCT03038126|38295479|FG000|Overall Study|Death|1|||
17150372|NCT03038126|38295480|FG001|Overall Study|Death|1|||
17150373|NCT03038126|38295479|FG000|Overall Study|Withdrawal by Subject|5|||
17150374|NCT03038126|38295480|FG001|Overall Study|Withdrawal by Subject|0|||
17150375|NCT03038126|38295479|FG000|Overall Study|Lost to Follow-up|0|||
17150376|NCT03038126|38295480|FG001|Overall Study|Lost to Follow-up|1|||
17150377|NCT03038126|38295479|FG000|Overall Study|Long Term Hospitalization|2|||
17150378|NCT03038126|38295480|FG001|Overall Study|Long Term Hospitalization|0|||
17150379|NCT03038126|38295479|FG000|Overall Study|Too Ill to Participate|1|||
17150380|NCT03038126|38295480|FG001|Overall Study|Too Ill to Participate|2|||
17150381|NCT02550652|38295500|FG000|Overall Study|Death|1|||
17150382|NCT02550652|38295501|FG001|Overall Study|Death|4|||
17150383|NCT02550652|38295500|FG000|Overall Study|Lack of Efficacy|1|||
17150384|NCT02550652|38295501|FG001|Overall Study|Lack of Efficacy|0|||
17150385|NCT02550652|38295500|FG000|Overall Study|Withdrawal by Subject|3|||
17150386|NCT02550652|38295501|FG001|Overall Study|Withdrawal by Subject|7|||
17150387|NCT02550652|38295500|FG000|Overall Study|Post Trial Access|1|||
17150388|NCT02550652|38295501|FG001|Overall Study|Post Trial Access|0|||
17150389|NCT02550652|38295500|FG000|Overall Study|Lost to Follow-up|1|||
17150390|NCT02550652|38295501|FG001|Overall Study|Lost to Follow-up|3|||
17150391|NCT02550652|38295500|FG000|Overall Study|Physician Decision|0|||
17150392|NCT02550652|38295501|FG001|Overall Study|Physician Decision|2|||
17150393|NCT02550652|38295500|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
17150394|NCT02550652|38295501|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
16781248|NCT02109484|37720414|FG005|Overall Study|Physician Decision|0|||
17071010|NCT00548249|38213515|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
17071011|NCT00548249|38213516|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
17071012|NCT00548249|38213517|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
17071013|NCT00548249|38213513|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
17071014|NCT00548249|38213514|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
17071015|NCT00548249|38213515|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
17071016|NCT00548249|38213516|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
17071017|NCT00548249|38213517|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
17071018|NCT00548249|38213513|FG000|Overall Study|Prolonged hospitalization|0|||
17071019|NCT00548249|38213514|FG001|Overall Study|Prolonged hospitalization|0|||
17071020|NCT00548249|38213515|FG002|Overall Study|Prolonged hospitalization|2|||
17071021|NCT00548249|38213516|FG003|Overall Study|Prolonged hospitalization|1|||
17071022|NCT00548249|38213517|FG004|Overall Study|Prolonged hospitalization|0|||
17071023|NCT00548249|38213513|FG000|Overall Study|Withdrawal by Subject|2|||
17071024|NCT00548249|38213514|FG001|Overall Study|Withdrawal by Subject|0|||
17071025|NCT00548249|38213515|FG002|Overall Study|Withdrawal by Subject|0|||
17071026|NCT00548249|38213516|FG003|Overall Study|Withdrawal by Subject|0|||
17071027|NCT00548249|38213517|FG004|Overall Study|Withdrawal by Subject|0|||
17150395|NCT00696878|38295507|FG000|Overall Study|Adverse Event|8|||
17150396|NCT00696878|38295507|FG000|Overall Study|Withdrawal by Subject|87|||
17150397|NCT00696878|38295507|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
17150398|NCT00696878|38295507|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
17150399|NCT00696878|38295507|FG000|Overall Study|Trial stopped|32|||
17150400|NCT00696878|38295507|FG000|Overall Study|Other reason (not specified)|55|||
17150401|NCT00696800|38295513|FG000|Overall Study|Adverse Event|16|||
17150402|NCT00696800|38295514|FG001|Overall Study|Adverse Event|3|||
17150403|NCT00696800|38295513|FG000|Overall Study|Insufficient compliance with medication|2|||
17150404|NCT00696800|38295514|FG001|Overall Study|Insufficient compliance with medication|1|||
17150405|NCT00696800|38295513|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
17150406|NCT00696800|38295514|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
17150407|NCT00696800|38295513|FG000|Overall Study|Insufficient ovarian response|4|||
17150408|NCT00696800|38295514|FG001|Overall Study|Insufficient ovarian response|1|||
17150409|NCT00696800|38295513|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
17150410|NCT00696800|38295514|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
17150411|NCT00696800|38295513|FG000|Overall Study|Too high ovarian response|6|||
17150412|NCT00696800|38295514|FG001|Overall Study|Too high ovarian response|1|||
17150413|NCT00696800|38295513|FG000|Overall Study|No/too few/bad quality oocytes|4|||
17150414|NCT00696800|38295514|FG001|Overall Study|No/too few/bad quality oocytes|3|||
17150415|NCT00696800|38295513|FG000|Overall Study|No/abnormal fertilization|11|||
17150416|NCT00696800|38295514|FG001|Overall Study|No/abnormal fertilization|13|||
17150417|NCT00696800|38295513|FG000|Overall Study|No/too few/bad quality embryos|24|||
17150418|NCT00696800|38295514|FG001|Overall Study|No/too few/bad quality embryos|18|||
17150419|NCT00696800|38295513|FG000|Overall Study|Other Reasons|5|||
17150420|NCT00696800|38295514|FG001|Overall Study|Other Reasons|3|||
17150421|NCT00696800|38295513|FG000|Overall Study|Not treated|1|||
17150422|NCT00696800|38295514|FG001|Overall Study|Not treated|2|||
17150423|NCT00289874|38295522|FG000|Overall Study|Adverse Event|1|||
17150424|NCT00289874|38295523|FG001|Overall Study|Adverse Event|5|||
17150425|NCT00289874|38295522|FG000|Overall Study|Lost to Follow-up|1|||
17150426|NCT00289874|38295523|FG001|Overall Study|Lost to Follow-up|1|||
17150427|NCT00289874|38295522|FG000|Overall Study|Protocol Violation|3|||
17150428|NCT00289874|38295523|FG001|Overall Study|Protocol Violation|2|||
17150429|NCT00289874|38295522|FG000|Overall Study|Did not meet eligibility|1|||
17150430|NCT00289874|38295523|FG001|Overall Study|Did not meet eligibility|0|||
17150431|NCT00245570|38295529|FG000|Washout Between Periods III and IV|Adverse Event|0|||
17150432|NCT00245570|38295530|FG001|Washout Between Periods III and IV|Adverse Event|1|||
17150433|NCT00245570|38295531|FG002|Washout Between Periods III and IV|Adverse Event|0|||
17150434|NCT00245570|38295532|FG003|Washout Between Periods III and IV|Adverse Event|0|||
17150435|NCT00245570|38295533|FG004|Washout Between Periods III and IV|Adverse Event|0|||
17150436|NCT00245570|38295534|FG005|Washout Between Periods III and IV|Adverse Event|0|||
17150437|NCT00840177|38295561|FG000|Overall Study|Adverse Event|5|||
17150438|NCT00840177|38295562|FG001|Overall Study|Adverse Event|1|||
17150439|NCT00840177|38295563|FG002|Overall Study|Adverse Event|1|||
17150440|NCT00840177|38295561|FG000|Overall Study|Refusal unrelated to adverse events|1|||
17150441|NCT00840177|38295562|FG001|Overall Study|Refusal unrelated to adverse events|0|||
17150442|NCT00840177|38295563|FG002|Overall Study|Refusal unrelated to adverse events|1|||
17150443|NCT00840177|38295561|FG000|Overall Study|Progression/relapse|2|||
17150444|NCT00840177|38295562|FG001|Overall Study|Progression/relapse|0|||
17150445|NCT00840177|38295563|FG002|Overall Study|Progression/relapse|0|||
17150446|NCT00840177|38295561|FG000|Overall Study|Death|4|||
17150447|NCT00840177|38295562|FG001|Overall Study|Death|5|||
17150448|NCT00840177|38295563|FG002|Overall Study|Death|5|||
17150449|NCT00840177|38295561|FG000|Overall Study|not protocol specified|6|||
17150450|NCT00840177|38295562|FG001|Overall Study|not protocol specified|3|||
17150451|NCT00840177|38295563|FG002|Overall Study|not protocol specified|0|||
17150452|NCT00840177|38295561|FG000|Overall Study|Ineligible|0|||
17150453|NCT00840177|38295562|FG001|Overall Study|Ineligible|0|||
17150454|NCT00840177|38295563|FG002|Overall Study|Ineligible|3|||
17150455|NCT00840177|38295561|FG000|Overall Study|Did not start treatment|0|||
17150456|NCT00840177|38295562|FG001|Overall Study|Did not start treatment|0|||
17150457|NCT00840177|38295563|FG002|Overall Study|Did not start treatment|1|||
17150458|NCT03512210|38295575|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
17150459|NCT03512210|38295575|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
17150460|NCT03512210|38295575|FG000|Step 2:Post-MINMON|Death|2|||
17150461|NCT03512210|38295575|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
17150462|NCT03512210|38295575|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
17150463|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
17150464|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
17150465|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
17150466|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
17150467|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
17150468|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
17150469|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
17150470|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
17150471|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
17150472|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
17150473|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
17150474|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
17150475|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
17150476|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
17150477|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
17071028|NCT00548249|38213513|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
17071029|NCT00548249|38213514|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
17071030|NCT00548249|38213515|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
17150478|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
17150479|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
17150480|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
17150481|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
17150482|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
17150483|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
17150484|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
17150485|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
17150486|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
17150487|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
17150488|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
17150489|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
17150490|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
17150491|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
17150492|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
17150493|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
17150494|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
17150495|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
17150496|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
17150497|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
17150498|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
17150499|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
17150500|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
17150501|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
17150502|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
17150503|NCT00383721|38295584|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
17150504|NCT00383721|38295585|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
17150505|NCT00383721|38295586|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
17150506|NCT00383721|38295587|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
17150507|NCT00383721|38295588|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
17071031|NCT00548249|38213516|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
17071032|NCT00548249|38213517|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
17150508|NCT00383721|38295584|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
17150509|NCT00383721|38295585|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
17150510|NCT00383721|38295586|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
17150511|NCT00383721|38295587|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
17150512|NCT00383721|38295588|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
17150513|NCT00383721|38295584|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
17150514|NCT00383721|38295585|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
17150515|NCT00383721|38295586|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
17150516|NCT00383721|38295587|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
17150517|NCT00383721|38295588|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
17150518|NCT00383721|38295584|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
17071033|NCT00548249|38213513|FG000|Overall Study|Sponsor's request|0|||
17071034|NCT00548249|38213514|FG001|Overall Study|Sponsor's request|0|||
17071035|NCT00548249|38213515|FG002|Overall Study|Sponsor's request|0|||
17071036|NCT00548249|38213516|FG003|Overall Study|Sponsor's request|1|||
17071037|NCT00548249|38213517|FG004|Overall Study|Sponsor's request|0|||
17071038|NCT00463476|38213531|FG000|Overall Study|Withdrawal by Subject|1|||
17071039|NCT00463476|38213532|FG001|Overall Study|Withdrawal by Subject|2|||
17071040|NCT00463476|38213531|FG000|Overall Study|Lost to Follow-up|1|||
17071041|NCT00463476|38213532|FG001|Overall Study|Lost to Follow-up|1|||
17071042|NCT03840174|38213542|FG000|Overall Study|Withdrawal by Subject|1|||
17071043|NCT03840174|38213543|FG001|Overall Study|Withdrawal by Subject|0|||
17071044|NCT03840174|38213544|FG002|Overall Study|Withdrawal by Subject|0|||
17071045|NCT03840174|38213545|FG003|Overall Study|Withdrawal by Subject|0|||
17071046|NCT03839940|38213558|FG000|Overall Study|Withdrawal by Subject|3|||
17071047|NCT03839940|38213559|FG001|Overall Study|Withdrawal by Subject|0|||
17071048|NCT03839940|38213558|FG000|Overall Study|Protocol Violation|0|||
17071049|NCT03839940|38213559|FG001|Overall Study|Protocol Violation|1|||
17071050|NCT03839940|38213558|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
17071051|NCT03839940|38213559|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
17150519|NCT00383721|38295585|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
17150520|NCT00383721|38295586|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
17150521|NCT00383721|38295587|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
17150522|NCT00383721|38295588|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
17071052|NCT03839628|38213567|FG000|Overall Study|Withdrawal by Subject|1|||
17150523|NCT00383721|38295584|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
17150524|NCT00383721|38295585|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
17150525|NCT00383721|38295586|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
17150526|NCT00383721|38295587|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
17150527|NCT00383721|38295588|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
17150528|NCT00383721|38295584|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
17150529|NCT00383721|38295585|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
17150530|NCT00383721|38295586|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
17150531|NCT00383721|38295587|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
17150532|NCT00383721|38295588|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
17150533|NCT00383721|38295584|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
17150534|NCT00383721|38295585|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
17150535|NCT00383721|38295586|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
17150536|NCT00383721|38295587|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
17150537|NCT00383721|38295588|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
17150538|NCT00383721|38295584|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
17150539|NCT00383721|38295585|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
17150540|NCT00383721|38295586|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
17150541|NCT00383721|38295587|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
17150542|NCT00383721|38295588|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
17150543|NCT00383721|38295584|FG000|26-Week Treatment Safety Extension|Administrative|1|||
17150544|NCT00383721|38295585|FG001|26-Week Treatment Safety Extension|Administrative|2|||
17150545|NCT00383721|38295586|FG002|26-Week Treatment Safety Extension|Administrative|3|||
17150546|NCT00383721|38295587|FG003|26-Week Treatment Safety Extension|Administrative|1|||
17150547|NCT00383721|38295588|FG004|26-Week Treatment Safety Extension|Administrative|0|||
17150548|NCT03035942|38295616|FG000|Overall Study|Adverse Event|8|||
17150549|NCT03035942|38295617|FG001|Overall Study|Adverse Event|4|||
17150550|NCT03035942|38295618|FG002|Overall Study|Adverse Event|5|||
17150551|NCT02616146|38295630|FG000|Overall Study|Adverse Event|64|||
17150552|NCT02616146|38295631|FG001|Overall Study|Adverse Event|24|||
17150553|NCT02616146|38295630|FG000|Overall Study|Lost to Follow-up|23|||
17150554|NCT02616146|38295631|FG001|Overall Study|Lost to Follow-up|13|||
17150555|NCT02616146|38295630|FG000|Overall Study|Non-compliance with study protocol|2|||
16781249|NCT02109484|37720415|FG006|Overall Study|Physician Decision|0|||
17071053|NCT00462462|38213573|FG000|Overall Study|Physician Decision|0|||
17071054|NCT00462462|38213574|FG001|Overall Study|Physician Decision|1|||
17071055|NCT00462384|38213582|FG000|Overall Study|Adverse Event|2|||
17071056|NCT00462384|38213582|FG000|Overall Study|Death|2|||
17071057|NCT00462384|38213582|FG000|Overall Study|Withdrawal by Subject|1|||
17071058|NCT00462384|38213582|FG000|Overall Study|Other|4|||
17071059|NCT00452400|38213591|FG000|Overall Study|Adverse Event|1|||
17071060|NCT00452400|38213592|FG001|Overall Study|Adverse Event|1|||
17071061|NCT00452400|38213593|FG002|Overall Study|Adverse Event|5|||
17071062|NCT00452400|38213594|FG003|Overall Study|Adverse Event|0|||
17071063|NCT00452400|38213595|FG004|Overall Study|Adverse Event|2|||
17071064|NCT00452400|38213591|FG000|Overall Study|Protocol Violation|0|||
17071065|NCT00452400|38213592|FG001|Overall Study|Protocol Violation|0|||
17071066|NCT00452400|38213593|FG002|Overall Study|Protocol Violation|1|||
17071067|NCT00452400|38213594|FG003|Overall Study|Protocol Violation|0|||
17071068|NCT00452400|38213595|FG004|Overall Study|Protocol Violation|0|||
17071069|NCT00452400|38213591|FG000|Overall Study|Lost to Follow-up|1|||
17071070|NCT00452400|38213592|FG001|Overall Study|Lost to Follow-up|0|||
17071071|NCT00452400|38213593|FG002|Overall Study|Lost to Follow-up|0|||
17071072|NCT00452400|38213594|FG003|Overall Study|Lost to Follow-up|0|||
17071073|NCT00452400|38213595|FG004|Overall Study|Lost to Follow-up|0|||
17071074|NCT00452400|38213591|FG000|Overall Study|Withdrawal by Subject|1|||
17071075|NCT00452400|38213592|FG001|Overall Study|Withdrawal by Subject|0|||
17071076|NCT00452400|38213593|FG002|Overall Study|Withdrawal by Subject|1|||
17071077|NCT00452400|38213594|FG003|Overall Study|Withdrawal by Subject|0|||
17071078|NCT00452400|38213595|FG004|Overall Study|Withdrawal by Subject|0|||
17071079|NCT00452400|38213591|FG000|Overall Study|Lack of Efficacy|2|||
17071080|NCT00452400|38213592|FG001|Overall Study|Lack of Efficacy|0|||
17071081|NCT00452400|38213593|FG002|Overall Study|Lack of Efficacy|0|||
17150556|NCT02616146|38295631|FG001|Overall Study|Non-compliance with study protocol|0|||
17150557|NCT02616146|38295630|FG000|Overall Study|Non-compliance with study drug|4|||
17150558|NCT02616146|38295631|FG001|Overall Study|Non-compliance with study drug|2|||
17150559|NCT02616146|38295630|FG000|Overall Study|Pregnancy|2|||
17150560|NCT02616146|38295631|FG001|Overall Study|Pregnancy|2|||
17150561|NCT02616146|38295630|FG000|Overall Study|Pregnancy wish|3|||
17150562|NCT02616146|38295631|FG001|Overall Study|Pregnancy wish|0|||
17150563|NCT02616146|38295630|FG000|Overall Study|Protocol Violation|6|||
17150564|NCT02616146|38295631|FG001|Overall Study|Protocol Violation|3|||
17150565|NCT02616146|38295630|FG000|Overall Study|Study terminated by sponsor|1372|||
17150566|NCT02616146|38295631|FG001|Overall Study|Study terminated by sponsor|432|||
17150567|NCT02616146|38295630|FG000|Overall Study|Participant moved|4|||
17150568|NCT02616146|38295631|FG001|Overall Study|Participant moved|3|||
17150569|NCT02616146|38295630|FG000|Overall Study|Withdrawal by Subject|30|||
17150570|NCT02616146|38295631|FG001|Overall Study|Withdrawal by Subject|24|||
17150571|NCT02616146|38295630|FG000|Overall Study|Physician Decision|2|||
17150572|NCT02616146|38295631|FG001|Overall Study|Physician Decision|1|||
17150573|NCT03035864|38295639|FG000|Treatment Period|Adverse Event|1|||
17150574|NCT03035864|38295640|FG001|Treatment Period|Adverse Event|0|||
17150575|NCT03035864|38295639|FG000|Treatment Period|Other|3|||
17150576|NCT03035864|38295640|FG001|Treatment Period|Other|1|||
17150577|NCT03035864|38295639|FG000|Follow-up Period|Adverse Event|1|||
17150578|NCT03035864|38295640|FG001|Follow-up Period|Adverse Event|0|||
17150579|NCT03035864|38295639|FG000|Follow-up Period|Lost to Follow-up|6|||
17150580|NCT03035864|38295640|FG001|Follow-up Period|Lost to Follow-up|2|||
17150581|NCT03035864|38295639|FG000|Follow-up Period|Physician Decision|1|||
17150582|NCT03035864|38295640|FG001|Follow-up Period|Physician Decision|0|||
17150583|NCT03035864|38295639|FG000|Follow-up Period|Other|3|||
17150584|NCT03035864|38295640|FG001|Follow-up Period|Other|2|||
17150585|NCT02885181|38295658|FG000|Overall Study|Investigator's Discretion|0|||
17150586|NCT02885181|38295659|FG001|Overall Study|Investigator's Discretion|1|||
17150587|NCT02885181|38295660|FG002|Overall Study|Investigator's Discretion|0|||
17150588|NCT02885181|38295661|FG003|Overall Study|Investigator's Discretion|1|||
17150589|NCT02885181|38295658|FG000|Overall Study|Adverse Event|0|||
17150590|NCT02885181|38295659|FG001|Overall Study|Adverse Event|0|||
17150591|NCT02885181|38295660|FG002|Overall Study|Adverse Event|0|||
17150592|NCT02885181|38295661|FG003|Overall Study|Adverse Event|1|||
17150593|NCT02885181|38295658|FG000|Overall Study|Withdrawal by Subject|0|||
17150594|NCT02885181|38295659|FG001|Overall Study|Withdrawal by Subject|0|||
17150595|NCT02885181|38295660|FG002|Overall Study|Withdrawal by Subject|0|||
17150596|NCT02885181|38295661|FG003|Overall Study|Withdrawal by Subject|1|||
17150597|NCT02884089|38295675|FG000|Period 1|Dosing error|2|||
17150598|NCT02884089|38295676|FG001|Period 1|Dosing error|2|||
16781250|NCT02109484|37720416|FG007|Overall Study|Physician Decision|0|||
17071082|NCT00452400|38213594|FG003|Overall Study|Lack of Efficacy|0|||
17071083|NCT00452400|38213595|FG004|Overall Study|Lack of Efficacy|0|||
17071084|NCT00452400|38213591|FG000|Overall Study|Other reasons not listed above|0|||
17071085|NCT00452400|38213592|FG001|Overall Study|Other reasons not listed above|0|||
17071086|NCT00452400|38213593|FG002|Overall Study|Other reasons not listed above|0|||
17071087|NCT00452400|38213594|FG003|Overall Study|Other reasons not listed above|1|||
17071088|NCT00452400|38213595|FG004|Overall Study|Other reasons not listed above|1|||
17071089|NCT00462306|38213609|FG000|Overall Study|insufficient data|0|||
17071090|NCT00462306|38213610|FG001|Overall Study|insufficient data|13|||
17071091|NCT00461682|38213618|FG000|Overall Study|Protocol Violation|1|||
17071092|NCT00443430|38213626|FG000|Overall Study|Lack of Efficacy|3|||
17071093|NCT00443430|38213627|FG001|Overall Study|Lack of Efficacy|3|||
17071094|NCT00443430|38213626|FG000|Overall Study|Adverse Event|1|||
17071095|NCT00443430|38213627|FG001|Overall Study|Adverse Event|1|||
17071096|NCT00460746|38213633|FG000|Overall Study|Adverse Event|1|||
17071097|NCT00460746|38213633|FG000|Overall Study|Lost to Follow-up|1|||
17071098|NCT00443118|38213640|FG000|Overall Study|unknown primary outcome|3|||
17071099|NCT00443118|38213641|FG001|Overall Study|unknown primary outcome|1|||
17071100|NCT00443118|38213642|FG002|Overall Study|unknown primary outcome|0|||
17150599|NCT02884089|38295677|FG002|Period 1|Dosing error|0|||
17150600|NCT02884089|38295678|FG003|Period 1|Dosing error|0|||
17150601|NCT02884089|38295675|FG000|Washout Period 1|Lost to Follow-up|0|||
17150602|NCT02884089|38295676|FG001|Washout Period 1|Lost to Follow-up|1|||
17150603|NCT02884089|38295677|FG002|Washout Period 1|Lost to Follow-up|0|||
17150604|NCT02884089|38295678|FG003|Washout Period 1|Lost to Follow-up|1|||
17150605|NCT02884089|38295675|FG000|Washout Period 1|Withdrawal by Subject|0|||
17150606|NCT02884089|38295676|FG001|Washout Period 1|Withdrawal by Subject|1|||
17150607|NCT02884089|38295677|FG002|Washout Period 1|Withdrawal by Subject|0|||
17150608|NCT02884089|38295678|FG003|Washout Period 1|Withdrawal by Subject|0|||
17150609|NCT02884089|38295675|FG000|Period 2|Adverse Event|1|||
17150610|NCT02884089|38295676|FG001|Period 2|Adverse Event|0|||
17150611|NCT02884089|38295677|FG002|Period 2|Adverse Event|0|||
17150612|NCT02884089|38295678|FG003|Period 2|Adverse Event|0|||
17150613|NCT02884089|38295675|FG000|Period 3|Withdrawal by Subject|0|||
17150614|NCT02884089|38295676|FG001|Period 3|Withdrawal by Subject|0|||
17150615|NCT02884089|38295677|FG002|Period 3|Withdrawal by Subject|1|||
17150616|NCT02884089|38295678|FG003|Period 3|Withdrawal by Subject|0|||
17150617|NCT02884089|38295675|FG000|Washout Period 3|Withdrawal by Subject|0|||
17150618|NCT02884089|38295676|FG001|Washout Period 3|Withdrawal by Subject|0|||
17150619|NCT02884089|38295677|FG002|Washout Period 3|Withdrawal by Subject|1|||
17150620|NCT02884089|38295678|FG003|Washout Period 3|Withdrawal by Subject|0|||
17150621|NCT02884089|38295675|FG000|Washout Period 3|Lost to Follow-up|0|||
17150622|NCT02884089|38295676|FG001|Washout Period 3|Lost to Follow-up|0|||
17150623|NCT02884089|38295677|FG002|Washout Period 3|Lost to Follow-up|0|||
17150624|NCT02884089|38295678|FG003|Washout Period 3|Lost to Follow-up|1|||
17150625|NCT02884089|38295675|FG000|Period 4|Withdrawal by Subject|0|||
17150626|NCT02884089|38295676|FG001|Period 4|Withdrawal by Subject|1|||
17150627|NCT02884089|38295677|FG002|Period 4|Withdrawal by Subject|0|||
17150628|NCT02884089|38295678|FG003|Period 4|Withdrawal by Subject|0|||
17150629|NCT02884089|38295675|FG000|Period 4|Lost to Follow-up|1|||
17150630|NCT02884089|38295676|FG001|Period 4|Lost to Follow-up|0|||
17150631|NCT02884089|38295677|FG002|Period 4|Lost to Follow-up|0|||
17150632|NCT02884089|38295678|FG003|Period 4|Lost to Follow-up|0|||
17150633|NCT02884089|38295675|FG000|Follow-up Visit|Withdrawal by Subject|1|||
17150634|NCT02884089|38295676|FG001|Follow-up Visit|Withdrawal by Subject|0|||
17150635|NCT02884089|38295677|FG002|Follow-up Visit|Withdrawal by Subject|0|||
17150636|NCT02884089|38295678|FG003|Follow-up Visit|Withdrawal by Subject|1|||
17150637|NCT02809677|38295688|FG000|Overall Study|Withdrawal by Subject|8|||
17150638|NCT02881047|38295693|FG000|Overall Study|Adverse Event|1|||
17150639|NCT02881047|38295693|FG000|Overall Study|Withdrawal by Subject|1|||
17150640|NCT03157089|38295699|FG000|Overall Study|Treated only with pembrolizumab|1|||
17150641|NCT03157089|38295700|FG001|Overall Study|Treated only with pembrolizumab|0|||
17150642|NCT03157089|38295699|FG000|Overall Study|Adverse Event|5|||
17150643|NCT03157089|38295700|FG001|Overall Study|Adverse Event|4|||
17150644|NCT03157089|38295699|FG000|Overall Study|Progressive disease|6|||
17150645|NCT03157089|38295700|FG001|Overall Study|Progressive disease|8|||
17150646|NCT03158727|38295709|FG000|Overall Study|Withdrawal by Subject|2|||
17150647|NCT03158727|38295710|FG001|Overall Study|Withdrawal by Subject|6|||
17150648|NCT03158727|38295709|FG000|Overall Study|Death|11|||
17150649|NCT03158727|38295710|FG001|Overall Study|Death|12|||
17150650|NCT03158727|38295709|FG000|Overall Study|Lost to Follow-up|1|||
17150651|NCT03158727|38295710|FG001|Overall Study|Lost to Follow-up|0|||
17150652|NCT03158727|38295709|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
17150653|NCT03158727|38295710|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
17150654|NCT03158727|38295709|FG000|Overall Study|Visit 11 not done by mistake|0|||
17150655|NCT03158727|38295710|FG001|Overall Study|Visit 11 not done by mistake|1|||
17150656|NCT03158727|38295709|FG000|Overall Study|Enrolled, not treated|1|||
17150657|NCT03158727|38295710|FG001|Overall Study|Enrolled, not treated|0|||
17150658|NCT00089895|38295718|FG000|Overall Study|Consent Withdrawn|11|||
17150659|NCT00089895|38295719|FG001|Overall Study|Consent Withdrawn|14|||
17150660|NCT00089895|38295718|FG000|Overall Study|Technical reason|7|||
17150661|NCT00089895|38295719|FG001|Overall Study|Technical reason|2|||
17150662|NCT00089895|38295718|FG000|Overall Study|Surgery|0|||
17071101|NCT00443118|38213640|FG000|Overall Study|Withdrawal by Subject|1|||
17071102|NCT00443118|38213641|FG001|Overall Study|Withdrawal by Subject|0|||
17071103|NCT00443118|38213642|FG002|Overall Study|Withdrawal by Subject|0|||
17071104|NCT00460434|38213670|FG000|Overall Study|Lost to Follow-up|3|||
17071105|NCT00460434|38213671|FG001|Overall Study|Lost to Follow-up|7|||
17071106|NCT00373425|38213682|FG000|Overall Study|Relapse of NSCLC|116|||
17150663|NCT00089895|38295719|FG001|Overall Study|Surgery|1|||
17071107|NCT00373425|38213683|FG001|Overall Study|Relapse of NSCLC|104|||
17071108|NCT00373425|38213684|FG002|Overall Study|Relapse of NSCLC|19|||
17071109|NCT00373425|38213685|FG003|Overall Study|Relapse of NSCLC|2|||
17150664|NCT00089895|38295718|FG000|Overall Study|Bleeding|0|||
17150665|NCT00089895|38295719|FG001|Overall Study|Bleeding|2|||
17150666|NCT00089895|38295718|FG000|Overall Study|Physician Decision|3|||
17150667|NCT00089895|38295719|FG001|Overall Study|Physician Decision|7|||
17150668|NCT00089895|38295718|FG000|Overall Study|Exclusion criteria met|6|||
17150669|NCT00089895|38295719|FG001|Overall Study|Exclusion criteria met|6|||
17150670|NCT00089895|38295718|FG000|Overall Study|Not otherwise specified|4|||
17150671|NCT00089895|38295719|FG001|Overall Study|Not otherwise specified|8|||
17150672|NCT00089895|38295718|FG000|Overall Study|Missing|4|||
17150673|NCT00089895|38295719|FG001|Overall Study|Missing|2|||
17150674|NCT02714218|38295728|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
17150675|NCT02714218|38295729|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
17150676|NCT02714218|38295730|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
17150677|NCT02714218|38295728|FG000|Pre-Treatment Period|Other reasons|0|||
17071110|NCT00373425|38213686|FG004|Overall Study|Relapse of NSCLC|26|||
17071111|NCT00373425|38213682|FG000|Overall Study|Adverse Event|191|||
17071112|NCT00373425|38213683|FG001|Overall Study|Adverse Event|22|||
17071113|NCT00373425|38213684|FG002|Overall Study|Adverse Event|59|||
17071114|NCT00373425|38213685|FG003|Overall Study|Adverse Event|0|||
17071115|NCT00373425|38213686|FG004|Overall Study|Adverse Event|34|||
17071116|NCT00373425|38213682|FG000|Overall Study|Patient request|35|||
17071117|NCT00373425|38213683|FG001|Overall Study|Patient request|18|||
17071118|NCT00373425|38213684|FG002|Overall Study|Patient request|43|||
17071119|NCT00373425|38213685|FG003|Overall Study|Patient request|6|||
17071120|NCT00373425|38213686|FG004|Overall Study|Patient request|7|||
17071121|NCT00373425|38213682|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
17071122|NCT00373425|38213683|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
17071123|NCT00373425|38213684|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
17071124|NCT00373425|38213685|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
17071125|NCT00373425|38213686|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
17071126|NCT00373425|38213682|FG000|Overall Study|Death|7|||
17071127|NCT00373425|38213683|FG001|Overall Study|Death|0|||
17071128|NCT00373425|38213684|FG002|Overall Study|Death|3|||
17071129|NCT00373425|38213685|FG003|Overall Study|Death|1|||
17071130|NCT00373425|38213686|FG004|Overall Study|Death|0|||
17071131|NCT00459342|38213695|FG000|Overall Study|Not eligible|1|||
17071132|NCT00443040|38213702|FG000|Overall Study|Withdrawal by Subject|1|||
17071133|NCT00443040|38213703|FG001|Overall Study|Withdrawal by Subject|0|||
17071134|NCT00443040|38213704|FG002|Overall Study|Withdrawal by Subject|0|||
17071135|NCT00443040|38213702|FG000|Overall Study|Converted to an open laparotomy|3|||
17071136|NCT00443040|38213703|FG001|Overall Study|Converted to an open laparotomy|0|||
17071137|NCT00443040|38213704|FG002|Overall Study|Converted to an open laparotomy|1|||
17071138|NCT00442962|38213712|FG000|Overall Study|Pregnancy|1|||
17071139|NCT00442962|38213712|FG000|Overall Study|Lost to Follow-up|7|||
17071140|NCT00313300|38213721|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
17071141|NCT00313300|38213722|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
17071142|NCT00313300|38213723|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
17071143|NCT00313300|38213724|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
17071144|NCT00313300|38213725|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
17071145|NCT00313300|38213721|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
17071146|NCT00313300|38213722|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
17071147|NCT00313300|38213723|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
17071148|NCT00313300|38213724|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
17071149|NCT00313300|38213725|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
17071150|NCT00313300|38213721|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
17071151|NCT00313300|38213722|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
17071152|NCT00313300|38213723|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
17071153|NCT00313300|38213724|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
17071154|NCT00313300|38213725|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
17071155|NCT00313300|38213721|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
17071156|NCT00313300|38213722|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
17071157|NCT00313300|38213723|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
17071158|NCT00313300|38213724|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
17071159|NCT00313300|38213725|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
17071160|NCT00313300|38213721|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
17071161|NCT00313300|38213722|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
17071162|NCT00313300|38213723|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
17071163|NCT00313300|38213724|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
17071164|NCT00313300|38213725|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
17071165|NCT00313300|38213721|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
17071166|NCT00313300|38213722|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
17071167|NCT00313300|38213723|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
17071168|NCT00313300|38213724|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
17071169|NCT00313300|38213725|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
17071170|NCT00313300|38213721|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
17071171|NCT00313300|38213722|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
17071172|NCT00313300|38213723|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
17071173|NCT00313300|38213724|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
17150678|NCT02714218|38295729|FG001|Pre-Treatment Period|Other reasons|1|||
17150679|NCT02714218|38295730|FG002|Pre-Treatment Period|Other reasons|0|||
17150680|NCT02714218|38295728|FG000|Treatment Period|Disease Progression|55|||
17150681|NCT02714218|38295729|FG001|Treatment Period|Disease Progression|52|||
17071174|NCT00313300|38213725|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
17071175|NCT00313300|38213721|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
17071176|NCT00313300|38213722|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
17150682|NCT02714218|38295730|FG002|Treatment Period|Disease Progression|14|||
17150683|NCT02714218|38295728|FG000|Treatment Period|Study drug toxicity|46|||
17150684|NCT02714218|38295729|FG001|Treatment Period|Study drug toxicity|70|||
17150685|NCT02714218|38295730|FG002|Treatment Period|Study drug toxicity|6|||
17150686|NCT02714218|38295728|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
17150687|NCT02714218|38295729|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
17150688|NCT02714218|38295730|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
17150689|NCT02714218|38295728|FG000|Treatment Period|Request to discontinue treatment|1|||
17150690|NCT02714218|38295729|FG001|Treatment Period|Request to discontinue treatment|4|||
17150691|NCT02714218|38295730|FG002|Treatment Period|Request to discontinue treatment|1|||
17150692|NCT02714218|38295728|FG000|Treatment Period|Participant withdrew consent|2|||
17150693|NCT02714218|38295729|FG001|Treatment Period|Participant withdrew consent|2|||
17150694|NCT02714218|38295730|FG002|Treatment Period|Participant withdrew consent|0|||
17150695|NCT02714218|38295728|FG000|Treatment Period|Maximum clinical benefit|4|||
17150696|NCT02714218|38295729|FG001|Treatment Period|Maximum clinical benefit|2|||
17150697|NCT02714218|38295730|FG002|Treatment Period|Maximum clinical benefit|0|||
17150698|NCT02714218|38295728|FG000|Treatment Period|Administrative reason by sponsor|2|||
17071177|NCT00313300|38213723|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
17071178|NCT00313300|38213724|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
17071179|NCT00313300|38213725|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
17071180|NCT00313300|38213721|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
17071181|NCT00313300|38213722|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
17071182|NCT00313300|38213723|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
17071183|NCT00313300|38213724|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
17071184|NCT00313300|38213725|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
17071185|NCT00313300|38213721|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
17071186|NCT00313300|38213722|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
17071187|NCT00313300|38213723|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
17071188|NCT00313300|38213724|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
17071189|NCT00313300|38213725|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
17071190|NCT00313300|38213721|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
17071191|NCT00313300|38213722|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
17071192|NCT00313300|38213723|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
17071193|NCT00313300|38213724|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
17071194|NCT00313300|38213725|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
17071195|NCT00313300|38213721|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
17071196|NCT00313300|38213722|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
17071197|NCT00313300|38213723|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
17071198|NCT00313300|38213724|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
17071199|NCT00313300|38213725|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
17071200|NCT00313300|38213721|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
17071201|NCT00313300|38213722|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
17071202|NCT00313300|38213723|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
17071203|NCT00313300|38213724|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
17071204|NCT00313300|38213725|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
17071205|NCT00313300|38213721|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
17071206|NCT00313300|38213722|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
17071207|NCT00313300|38213723|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
17071208|NCT00313300|38213724|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
17071209|NCT00313300|38213725|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
17071210|NCT00313300|38213721|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
17071211|NCT00313300|38213722|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
17071212|NCT00313300|38213723|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
17071213|NCT00313300|38213724|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
17071214|NCT00313300|38213725|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
17071215|NCT00313300|38213721|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
17071216|NCT00313300|38213722|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
17071217|NCT00313300|38213723|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
17071218|NCT00313300|38213724|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
17071219|NCT00313300|38213725|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
17071220|NCT00313300|38213721|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
17071221|NCT00313300|38213722|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
17071222|NCT00313300|38213723|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
17071223|NCT00313300|38213724|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
17071224|NCT00313300|38213725|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
17071225|NCT00313300|38213721|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
17150699|NCT02714218|38295729|FG001|Treatment Period|Administrative reason by sponsor|1|||
17150700|NCT02714218|38295730|FG002|Treatment Period|Administrative reason by sponsor|0|||
17150701|NCT02714218|38295728|FG000|Treatment Period|Other reasons|6|||
17150702|NCT02714218|38295729|FG001|Treatment Period|Other reasons|6|||
17150703|NCT02714218|38295730|FG002|Treatment Period|Other reasons|0|||
17150704|NCT02714218|38295728|FG000|Treatment Period|Completed treatment as per protocol|36|||
17150705|NCT02714218|38295729|FG001|Treatment Period|Completed treatment as per protocol|27|||
17150706|NCT02714218|38295730|FG002|Treatment Period|Completed treatment as per protocol|3|||
17150707|NCT02714218|38295728|FG000|Treatment Period|Not reported|9|||
17150708|NCT02714218|38295729|FG001|Treatment Period|Not reported|6|||
17150709|NCT02714218|38295730|FG002|Treatment Period|Not reported|0|||
17150710|NCT03154047|38295737|FG000|Overall Study|Death|1|||
17150711|NCT03154047|38295737|FG000|Overall Study|Study terminated by sponsor|76|||
17150712|NCT03154047|38295737|FG000|Overall Study|Withdrawal by Subject|3|||
17150713|NCT03156621|38295743|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
17150714|NCT03156621|38295744|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
17150715|NCT03156621|38295743|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
17150716|NCT03156621|38295744|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
17150717|NCT03156543|38295755|FG000|Overall Study|Withdrawal by Subject|1|||
17150718|NCT03156543|38295756|FG001|Overall Study|Withdrawal by Subject|0|||
17150719|NCT02713594|38295764|FG000|Overall Study|Withdrawal by Subject|32|||
17150720|NCT02713594|38295765|FG001|Overall Study|Withdrawal by Subject|22|||
17150721|NCT02713594|38295764|FG000|Overall Study|Lost to Follow-up|358|||
17150722|NCT02713594|38295765|FG001|Overall Study|Lost to Follow-up|374|||
17150723|NCT03152019|38295775|FG000|Overall Study|Adverse Event|0|||
17150724|NCT03152019|38295776|FG001|Overall Study|Adverse Event|1|||
17150725|NCT02714062|38295789|FG000|Overall Study|Adverse Event|0|||
17150726|NCT02714062|38295790|FG001|Overall Study|Adverse Event|0|||
17150727|NCT02714062|38295791|FG002|Overall Study|Adverse Event|2|||
17150728|NCT02714062|38295789|FG000|Overall Study|Withdrawal by Subject|1|||
17150729|NCT02714062|38295790|FG001|Overall Study|Withdrawal by Subject|0|||
17150730|NCT02714062|38295791|FG002|Overall Study|Withdrawal by Subject|1|||
17150731|NCT02714062|38295789|FG000|Overall Study|Protocol Violation|0|||
17150732|NCT02714062|38295790|FG001|Overall Study|Protocol Violation|1|||
17150733|NCT02714062|38295791|FG002|Overall Study|Protocol Violation|0|||
17150734|NCT03151395|38295801|FG000|Overall Study|Adverse Event|2|||
17150735|NCT03151395|38295801|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
17150736|NCT03151395|38295801|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
17150737|NCT03151395|38295801|FG000|Overall Study|Unspecified reason|4|||
17150738|NCT02713828|38295807|FG000|Overall Study|Death|2|||
17150739|NCT02713828|38295808|FG001|Overall Study|Death|0|||
17150740|NCT02713828|38295807|FG000|Overall Study|Withdrawal by Subject|1|||
17150741|NCT02713828|38295808|FG001|Overall Study|Withdrawal by Subject|0|||
17150742|NCT02713828|38295807|FG000|Overall Study|study terminated but patient allowed to|2|||
17150743|NCT02713828|38295808|FG001|Overall Study|study terminated but patient allowed to|0|||
17150744|NCT02876328|38295837|FG000|Overall Study|Death|2|||
17150745|NCT02876328|38295838|FG001|Overall Study|Death|1|||
17150746|NCT02876328|38295839|FG002|Overall Study|Death|3|||
17150747|NCT02876328|38295840|FG003|Overall Study|Death|0|||
17150748|NCT02876328|38295841|FG004|Overall Study|Death|0|||
17150749|NCT02876328|38295842|FG005|Overall Study|Death|0|||
17150750|NCT02876328|38295843|FG006|Overall Study|Death|1|||
17150751|NCT02876328|38295844|FG007|Overall Study|Death|3|||
17150752|NCT02876328|38295845|FG008|Overall Study|Death|0|||
17150753|NCT02876328|38295846|FG009|Overall Study|Death|1|||
17150754|NCT02876328|38295847|FG010|Overall Study|Death|1|||
17150755|NCT02876328|38295848|FG011|Overall Study|Death|0|||
17150756|NCT02876328|38295849|FG012|Overall Study|Death|0|||
17150757|NCT02876328|38295850|FG013|Overall Study|Death|0|||
17150758|NCT02876328|38295851|FG014|Overall Study|Death|0|||
17150759|NCT02876328|38295852|FG015|Overall Study|Death|0|||
17150760|NCT02876328|38295853|FG016|Overall Study|Death|1|||
17150761|NCT02876328|38295854|FG017|Overall Study|Death|1|||
17150762|NCT02876328|38295855|FG018|Overall Study|Death|0|||
17150763|NCT02876328|38295856|FG019|Overall Study|Death|0|||
17150764|NCT02876328|38295857|FG020|Overall Study|Death|0|||
17150765|NCT02876328|38295858|FG021|Overall Study|Death|1|||
17150766|NCT02876328|38295859|FG022|Overall Study|Death|0|||
17150767|NCT02876328|38295860|FG023|Overall Study|Death|0|||
17150768|NCT02876328|38295837|FG000|Overall Study|Withdrawal by Subject|0|||
17150769|NCT02876328|38295838|FG001|Overall Study|Withdrawal by Subject|2|||
17150770|NCT02876328|38295839|FG002|Overall Study|Withdrawal by Subject|3|||
17150771|NCT02876328|38295840|FG003|Overall Study|Withdrawal by Subject|3|||
17150772|NCT02876328|38295841|FG004|Overall Study|Withdrawal by Subject|0|||
17150773|NCT02876328|38295842|FG005|Overall Study|Withdrawal by Subject|1|||
17150774|NCT02876328|38295843|FG006|Overall Study|Withdrawal by Subject|0|||
17150775|NCT02876328|38295844|FG007|Overall Study|Withdrawal by Subject|1|||
17150776|NCT02876328|38295845|FG008|Overall Study|Withdrawal by Subject|1|||
17150777|NCT02876328|38295846|FG009|Overall Study|Withdrawal by Subject|2|||
17150778|NCT02876328|38295847|FG010|Overall Study|Withdrawal by Subject|0|||
17150779|NCT02876328|38295848|FG011|Overall Study|Withdrawal by Subject|0|||
17150780|NCT02876328|38295849|FG012|Overall Study|Withdrawal by Subject|0|||
17150781|NCT02876328|38295850|FG013|Overall Study|Withdrawal by Subject|0|||
17150782|NCT02876328|38295851|FG014|Overall Study|Withdrawal by Subject|0|||
17150783|NCT02876328|38295852|FG015|Overall Study|Withdrawal by Subject|0|||
17150784|NCT02876328|38295853|FG016|Overall Study|Withdrawal by Subject|1|||
17150785|NCT02876328|38295854|FG017|Overall Study|Withdrawal by Subject|3|||
17150786|NCT02876328|38295855|FG018|Overall Study|Withdrawal by Subject|0|||
17150787|NCT02876328|38295856|FG019|Overall Study|Withdrawal by Subject|0|||
17150788|NCT02876328|38295857|FG020|Overall Study|Withdrawal by Subject|1|||
17150789|NCT02876328|38295858|FG021|Overall Study|Withdrawal by Subject|0|||
17150790|NCT02876328|38295859|FG022|Overall Study|Withdrawal by Subject|0|||
17150791|NCT02876328|38295860|FG023|Overall Study|Withdrawal by Subject|0|||
17150792|NCT02876328|38295837|FG000|Overall Study|Missed 12 Month Visit|15|||
17150793|NCT02876328|38295838|FG001|Overall Study|Missed 12 Month Visit|10|||
17150794|NCT02876328|38295839|FG002|Overall Study|Missed 12 Month Visit|11|||
17150795|NCT02876328|38295840|FG003|Overall Study|Missed 12 Month Visit|6|||
17150796|NCT02876328|38295841|FG004|Overall Study|Missed 12 Month Visit|10|||
17150797|NCT02876328|38295842|FG005|Overall Study|Missed 12 Month Visit|14|||
17150798|NCT02876328|38295843|FG006|Overall Study|Missed 12 Month Visit|3|||
17150799|NCT02876328|38295844|FG007|Overall Study|Missed 12 Month Visit|8|||
17150800|NCT02876328|38295845|FG008|Overall Study|Missed 12 Month Visit|9|||
17150801|NCT02876328|38295846|FG009|Overall Study|Missed 12 Month Visit|5|||
17150802|NCT02876328|38295847|FG010|Overall Study|Missed 12 Month Visit|4|||
17150803|NCT02876328|38295848|FG011|Overall Study|Missed 12 Month Visit|1|||
17150804|NCT02876328|38295849|FG012|Overall Study|Missed 12 Month Visit|5|||
17150805|NCT02876328|38295850|FG013|Overall Study|Missed 12 Month Visit|4|||
17150806|NCT02876328|38295851|FG014|Overall Study|Missed 12 Month Visit|4|||
17150807|NCT02876328|38295852|FG015|Overall Study|Missed 12 Month Visit|4|||
17150808|NCT02876328|38295853|FG016|Overall Study|Missed 12 Month Visit|3|||
17150809|NCT02876328|38295854|FG017|Overall Study|Missed 12 Month Visit|6|||
17150810|NCT02876328|38295855|FG018|Overall Study|Missed 12 Month Visit|2|||
17150811|NCT02876328|38295856|FG019|Overall Study|Missed 12 Month Visit|2|||
17150812|NCT02876328|38295857|FG020|Overall Study|Missed 12 Month Visit|11|||
17150813|NCT02876328|38295858|FG021|Overall Study|Missed 12 Month Visit|7|||
17150814|NCT02876328|38295859|FG022|Overall Study|Missed 12 Month Visit|1|||
17150815|NCT02876328|38295860|FG023|Overall Study|Missed 12 Month Visit|0|||
17150816|NCT02875860|38295888|FG000|Overall Study|Withdrawal by Subject|0|||
17150817|NCT02875860|38295889|FG001|Overall Study|Withdrawal by Subject|1|||
17150818|NCT02875392|38295897|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
17150819|NCT02875392|38295898|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
17150820|NCT03127644|38295907|FG000|Overall Study|Study-specific withdrawal criteria|0|||
17150821|NCT03127644|38295908|FG001|Overall Study|Study-specific withdrawal criteria|0|||
17150822|NCT03127644|38295909|FG002|Overall Study|Study-specific withdrawal criteria|2|||
17150823|NCT03965962|38295923|FG000|Overall Study|Adverse Event|1|||
17150824|NCT03965962|38295924|FG001|Overall Study|Adverse Event|0|||
17150825|NCT03965962|38295925|FG002|Overall Study|Adverse Event|0|||
17150826|NCT03965962|38295926|FG003|Overall Study|Adverse Event|0|||
17150827|NCT03965962|38295923|FG000|Overall Study|Protocol Violation|21|||
17150828|NCT03965962|38295924|FG001|Overall Study|Protocol Violation|4|||
17150829|NCT03965962|38295925|FG002|Overall Study|Protocol Violation|10|||
17150830|NCT03965962|38295926|FG003|Overall Study|Protocol Violation|5|||
17150831|NCT03965962|38295923|FG000|Overall Study|Lost to Follow-up|0|||
17150832|NCT03965962|38295924|FG001|Overall Study|Lost to Follow-up|1|||
17150833|NCT03965962|38295925|FG002|Overall Study|Lost to Follow-up|0|||
17150834|NCT03965962|38295926|FG003|Overall Study|Lost to Follow-up|0|||
17150835|NCT03965962|38295923|FG000|Overall Study|Withdrawal by Subject|3|||
17150836|NCT03965962|38295924|FG001|Overall Study|Withdrawal by Subject|0|||
17150837|NCT03965962|38295925|FG002|Overall Study|Withdrawal by Subject|0|||
17150838|NCT03965962|38295926|FG003|Overall Study|Withdrawal by Subject|1|||
17150839|NCT03151551|38295938|FG000|Open-Label Treatment Period|Adverse Event|0|||
17150840|NCT03151551|38295939|FG001|Open-Label Treatment Period|Adverse Event|2|||
17150841|NCT03151551|38295938|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
17150842|NCT03151551|38295939|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
17150843|NCT03151551|38295938|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
17150844|NCT03151551|38295939|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
17150845|NCT03151551|38295938|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
17150846|NCT03151551|38295939|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
17150847|NCT03151551|38295938|FG000|Open-Label Treatment Period|Physician Decision|3|||
17150848|NCT03151551|38295939|FG001|Open-Label Treatment Period|Physician Decision|0|||
17150849|NCT03151551|38295938|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
17150850|NCT03151551|38295939|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
17150851|NCT03151551|38295938|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
17150852|NCT03151551|38295939|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
17150853|NCT03151551|38295938|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
17150854|NCT03151551|38295939|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
17150855|NCT03151551|38295938|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
17150856|NCT03151551|38295939|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
17150857|NCT03151551|38295938|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
17150858|NCT03151551|38295939|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
17150859|NCT03147495|38295949|FG000|Overall Study|Physician Decision|0|||
17150860|NCT03147495|38295950|FG001|Overall Study|Physician Decision|6|||
17150861|NCT03126786|38295958|FG000|Overall Study|Adverse Event|3|||
17150862|NCT03126786|38295959|FG001|Overall Study|Adverse Event|0|||
17150863|NCT03126786|38295958|FG000|Overall Study|Lost to Follow-up|0|||
17150864|NCT03126786|38295959|FG001|Overall Study|Lost to Follow-up|1|||
17150865|NCT03126786|38295958|FG000|Overall Study|Withdrawal by Subject|3|||
17150866|NCT03126786|38295959|FG001|Overall Study|Withdrawal by Subject|1|||
17150867|NCT03146403|38295967|FG000|Overall Study|Withdrawal by Subject|0|||
17150868|NCT03146403|38295968|FG001|Overall Study|Withdrawal by Subject|3|||
17150869|NCT03146403|38295967|FG000|Overall Study|Lost to Follow-up|2|||
17150870|NCT03146403|38295968|FG001|Overall Study|Lost to Follow-up|0|||
17150871|NCT03132636|38295976|FG000|Overall Study|Adverse Event|1|||
17150872|NCT03132636|38295977|FG001|Overall Study|Adverse Event|2|||
17150873|NCT03132636|38295976|FG000|Overall Study|Death|4|||
17150874|NCT03132636|38295977|FG001|Overall Study|Death|7|||
17150875|NCT03132636|38295976|FG000|Overall Study|Lost to Follow-up|2|||
17150876|NCT03132636|38295977|FG001|Overall Study|Lost to Follow-up|2|||
17150877|NCT03132636|38295976|FG000|Overall Study|Protocol Violation|1|||
17150878|NCT03132636|38295977|FG001|Overall Study|Protocol Violation|1|||
17150879|NCT03132636|38295976|FG000|Overall Study|Participant Decision|1|||
17150880|NCT03132636|38295977|FG001|Overall Study|Participant Decision|9|||
17150881|NCT03132636|38295976|FG000|Overall Study|Sponsor Decision|0|||
17150882|NCT03132636|38295977|FG001|Overall Study|Sponsor Decision|1|||
17150883|NCT03132636|38295976|FG000|Overall Study|Progressive disease|32|||
17150884|NCT03132636|38295977|FG001|Overall Study|Progressive disease|36|||
17150885|NCT03132636|38295976|FG000|Overall Study|Withdrawal of consent|2|||
17150886|NCT03132636|38295977|FG001|Overall Study|Withdrawal of consent|5|||
17150887|NCT03132636|38295976|FG000|Overall Study|Study ongoing|9|||
17150888|NCT03132636|38295977|FG001|Overall Study|Study ongoing|10|||
17150889|NCT03132636|38295976|FG000|Overall Study|Other|1|||
17150890|NCT03132636|38295977|FG001|Overall Study|Other|2|||
17150891|NCT02713204|38295986|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
17150892|NCT02713204|38295987|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
17150893|NCT02713204|38295988|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
17150894|NCT02713204|38295989|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
17150895|NCT02713204|38295990|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
17150896|NCT02713204|38295991|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
17150897|NCT02713204|38295992|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
17150898|NCT02713204|38295993|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
17150899|NCT02713204|38295986|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17150900|NCT02713204|38295987|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17150901|NCT02713204|38295988|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
17150902|NCT02713204|38295989|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17150903|NCT02713204|38295990|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17150904|NCT02713204|38295991|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17150905|NCT02713204|38295992|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17150906|NCT02713204|38295993|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17150907|NCT02713204|38295986|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17150908|NCT02713204|38295987|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
17150909|NCT02713204|38295988|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17150910|NCT02713204|38295989|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17150911|NCT02713204|38295990|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17150912|NCT02713204|38295991|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17150913|NCT02713204|38295992|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17150914|NCT02713204|38295993|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17150915|NCT02713204|38295986|FG000|From Week 12 up to Week 36|Adverse Event|1|||
17150916|NCT02713204|38295987|FG001|From Week 12 up to Week 36|Adverse Event|0|||
17150917|NCT02713204|38295988|FG002|From Week 12 up to Week 36|Adverse Event|0|||
17150918|NCT02713204|38295989|FG003|From Week 12 up to Week 36|Adverse Event|1|||
17150919|NCT02713204|38295990|FG004|From Week 12 up to Week 36|Adverse Event|1|||
17150920|NCT02713204|38295991|FG005|From Week 12 up to Week 36|Adverse Event|0|||
17150921|NCT02713204|38295992|FG006|From Week 12 up to Week 36|Adverse Event|2|||
17150922|NCT02713204|38295993|FG007|From Week 12 up to Week 36|Adverse Event|1|||
17150923|NCT02713204|38295986|FG000|From Week 12 up to Week 36|Death|0|||
17150924|NCT02713204|38295987|FG001|From Week 12 up to Week 36|Death|0|||
17150925|NCT02713204|38295988|FG002|From Week 12 up to Week 36|Death|0|||
17150926|NCT02713204|38295989|FG003|From Week 12 up to Week 36|Death|1|||
17150927|NCT02713204|38295990|FG004|From Week 12 up to Week 36|Death|0|||
17150928|NCT02713204|38295991|FG005|From Week 12 up to Week 36|Death|1|||
17150929|NCT02713204|38295992|FG006|From Week 12 up to Week 36|Death|0|||
17150930|NCT02713204|38295993|FG007|From Week 12 up to Week 36|Death|3|||
17150931|NCT02713204|38295986|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
17150932|NCT02713204|38295987|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
17150933|NCT02713204|38295988|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
17150934|NCT02713204|38295989|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
17150935|NCT02713204|38295990|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
17150936|NCT02713204|38295991|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
17150937|NCT02713204|38295992|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
17150938|NCT02713204|38295993|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
17071226|NCT00313300|38213722|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
17071227|NCT00313300|38213723|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
17071228|NCT00313300|38213724|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
17150939|NCT02713204|38295986|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
17150940|NCT02713204|38295987|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
17150941|NCT02713204|38295988|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
17150942|NCT02713204|38295989|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
17150943|NCT02713204|38295990|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
17150944|NCT02713204|38295991|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
17150945|NCT02713204|38295992|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
17150946|NCT02713204|38295993|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
17150947|NCT03695172|38296013|FG000|Overall Study|Withdrawal by Subject|1|||
17150948|NCT03695172|38296014|FG001|Overall Study|Withdrawal by Subject|1|||
17150949|NCT03695172|38296015|FG002|Overall Study|Withdrawal by Subject|0|||
17150950|NCT03721107|38296027|FG000|Overall Study|Adverse Event|1|||
17150951|NCT03721107|38296028|FG001|Overall Study|Adverse Event|1|||
17150952|NCT03721107|38296029|FG002|Overall Study|Adverse Event|6|||
17150953|NCT03721107|38296030|FG003|Overall Study|Adverse Event|5|||
17150954|NCT03721107|38296027|FG000|Overall Study|Lost to Follow-up|2|||
17150955|NCT03721107|38296028|FG001|Overall Study|Lost to Follow-up|0|||
17150956|NCT03721107|38296029|FG002|Overall Study|Lost to Follow-up|3|||
17150957|NCT03721107|38296030|FG003|Overall Study|Lost to Follow-up|0|||
17150958|NCT03721107|38296027|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
17150959|NCT03721107|38296028|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
17150960|NCT03721107|38296029|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
17150961|NCT03721107|38296030|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
17150962|NCT03721107|38296027|FG000|Overall Study|Physician Decision|0|||
17150963|NCT03721107|38296028|FG001|Overall Study|Physician Decision|1|||
17150964|NCT03721107|38296029|FG002|Overall Study|Physician Decision|0|||
17150965|NCT03721107|38296030|FG003|Overall Study|Physician Decision|0|||
17150966|NCT03721107|38296027|FG000|Overall Study|Pregnancy|0|||
17150967|NCT03721107|38296028|FG001|Overall Study|Pregnancy|0|||
17150968|NCT03721107|38296029|FG002|Overall Study|Pregnancy|1|||
17150969|NCT03721107|38296030|FG003|Overall Study|Pregnancy|0|||
17150970|NCT03721107|38296027|FG000|Overall Study|Withdrawal by Subject|1|||
17150971|NCT03721107|38296028|FG001|Overall Study|Withdrawal by Subject|1|||
17150972|NCT03721107|38296029|FG002|Overall Study|Withdrawal by Subject|5|||
17150973|NCT03721107|38296030|FG003|Overall Study|Withdrawal by Subject|5|||
17150974|NCT03721107|38296027|FG000|Overall Study|Other|1|||
17150975|NCT03721107|38296028|FG001|Overall Study|Other|0|||
17150976|NCT03721107|38296029|FG002|Overall Study|Other|0|||
17150977|NCT03721107|38296030|FG003|Overall Study|Other|1|||
17150978|NCT03052920|38296049|FG000|Overall Study|Withdrawal by Subject|1|||
17150979|NCT02930226|38296059|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
17150980|NCT02930226|38296060|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
17150981|NCT02930226|38296061|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
17150982|NCT02930226|38296062|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
17071229|NCT00313300|38213725|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
17071230|NCT00313300|38213721|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
17071231|NCT00313300|38213722|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
17150983|NCT02930226|38296063|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
17150984|NCT02930226|38296064|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
17150985|NCT02722434|38296101|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
17150986|NCT02722434|38296102|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
17150987|NCT02722434|38296101|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
17150988|NCT02722434|38296102|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
17150989|NCT03539601|38296112|FG000|Overall Study|Withdraw by parent/guardian|1|||
17150990|NCT03539601|38296113|FG001|Overall Study|Withdraw by parent/guardian|0|||
17150991|NCT03539601|38296114|FG002|Overall Study|Withdraw by parent/guardian|1|||
17150992|NCT03539601|38296115|FG003|Overall Study|Withdraw by parent/guardian|0|||
17150993|NCT03539601|38296112|FG000|Overall Study|Adverse Event|0|||
17150994|NCT03539601|38296113|FG001|Overall Study|Adverse Event|2|||
17150995|NCT03539601|38296114|FG002|Overall Study|Adverse Event|0|||
17150996|NCT03539601|38296115|FG003|Overall Study|Adverse Event|0|||
17150997|NCT03539601|38296112|FG000|Overall Study|Lost to Follow-up|2|||
17150998|NCT03539601|38296113|FG001|Overall Study|Lost to Follow-up|4|||
17150999|NCT03539601|38296114|FG002|Overall Study|Lost to Follow-up|5|||
17151000|NCT03539601|38296115|FG003|Overall Study|Lost to Follow-up|0|||
17151001|NCT03539601|38296112|FG000|Overall Study|Withdrawal by Subject|2|||
17151002|NCT03539601|38296113|FG001|Overall Study|Withdrawal by Subject|0|||
17151003|NCT03539601|38296114|FG002|Overall Study|Withdrawal by Subject|0|||
17151004|NCT03539601|38296115|FG003|Overall Study|Withdrawal by Subject|1|||
17151005|NCT03539601|38296112|FG000|Overall Study|Randomized but not treated|1|||
17151006|NCT03539601|38296113|FG001|Overall Study|Randomized but not treated|1|||
17151007|NCT03539601|38296114|FG002|Overall Study|Randomized but not treated|0|||
17151008|NCT03539601|38296115|FG003|Overall Study|Randomized but not treated|0|||
17151009|NCT00700804|38296135|FG000|Overall Study|Withdrawal by Subject|1|||
17151010|NCT00700804|38296136|FG001|Overall Study|Withdrawal by Subject|2|||
17151011|NCT00700804|38296135|FG000|Overall Study|Protocol Violation|1|||
17151012|NCT00700804|38296136|FG001|Overall Study|Protocol Violation|1|||
17151013|NCT00700804|38296135|FG000|Overall Study|Loose Stools|1|||
17071232|NCT00313300|38213723|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
17071233|NCT00313300|38213724|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
17151014|NCT00700804|38296136|FG001|Overall Study|Loose Stools|1|||
17151015|NCT02903823|38296142|FG000|Overall Study|Physician Decision|5|||
17151016|NCT02903823|38296142|FG000|Overall Study|Could not advance catheter|1|||
17151017|NCT02903823|38296142|FG000|Overall Study|Catheter dislodgement|1|||
17151018|NCT00832455|38296171|FG000|Overall Study|Adverse Event|13|||
17151019|NCT00832455|38296171|FG000|Overall Study|Lost to Follow-up|26|||
17151020|NCT00832455|38296171|FG000|Overall Study|Protocol Violation|4|||
17071234|NCT00313300|38213725|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
17071235|NCT00313300|38213721|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
17071236|NCT00313300|38213722|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
17071237|NCT00313300|38213723|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
17151021|NCT00832455|38296171|FG000|Overall Study|Withdrawal by Subject|17|||
17151022|NCT00832455|38296171|FG000|Overall Study|Screening Failure|2|||
17151023|NCT00832455|38296171|FG000|Overall Study|Stopped Medication|4|||
17151024|NCT00832455|38296171|FG000|Overall Study|Parent misunderstood study|1|||
17151025|NCT00832455|38296171|FG000|Overall Study|Parent dissatisfied|1|||
17151026|NCT00832455|38296171|FG000|Overall Study|No improvement|3|||
17151027|NCT00832455|38296171|FG000|Overall Study|Patient moved|1|||
17151028|NCT00687531|38296184|FG000|Overall Study|Did not meet protocol eligibility|104|||
17151029|NCT00687531|38296184|FG000|Overall Study|Adverse Event|5|||
17151030|NCT00687531|38296184|FG000|Overall Study|Lost to Follow-up|26|||
17151031|NCT00423579|38296190|FG000|Overall Study|Lost to Follow-up|3|||
17151032|NCT00423579|38296191|FG001|Overall Study|Lost to Follow-up|0|||
17151033|NCT00423579|38296190|FG000|Overall Study|Protocol Violation|1|||
17151034|NCT00423579|38296191|FG001|Overall Study|Protocol Violation|3|||
17151035|NCT00423579|38296190|FG000|Overall Study|Diagnosis of diabetes|0|||
17151036|NCT00423579|38296191|FG001|Overall Study|Diagnosis of diabetes|1|||
17151037|NCT03268005|38296199|FG000|Overall Study|Death|2|||
17151038|NCT03268005|38296200|FG001|Overall Study|Death|1|||
17151039|NCT03268005|38296199|FG000|Overall Study|Lost to Follow-up|2|||
17151040|NCT03268005|38296200|FG001|Overall Study|Lost to Follow-up|2|||
17151041|NCT03268005|38296199|FG000|Overall Study|Withdrawal by Subject|11|||
17151042|NCT03268005|38296200|FG001|Overall Study|Withdrawal by Subject|11|||
17151043|NCT03149055|38296206|FG000|Overall Study|Not treated|4|||
17151044|NCT03137121|38296221|FG000|Overall Study|Withdrawal by Subject|0|||
17151045|NCT03137121|38296222|FG001|Overall Study|Withdrawal by Subject|1|||
16781251|NCT02109484|37720409|FG000|Overall Study|Death|0|||
17071238|NCT00313300|38213724|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
17071239|NCT00313300|38213725|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
17071240|NCT00313300|38213721|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
17071241|NCT00313300|38213722|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
17071242|NCT00313300|38213723|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
17071243|NCT00313300|38213724|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
17071244|NCT00313300|38213725|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
17151046|NCT00700570|38296265|FG000|Overall Study|Adverse Event|2|||
17151047|NCT00700570|38296266|FG001|Overall Study|Adverse Event|6|||
17151048|NCT00700570|38296265|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
17151049|NCT00700570|38296266|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
17151050|NCT00700570|38296265|FG000|Overall Study|Disease Progression|8|||
17071245|NCT00459186|38213743|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
17151051|NCT00700570|38296266|FG001|Overall Study|Disease Progression|11|||
17151052|NCT00700570|38296265|FG000|Overall Study|Withdrawal by Subject|1|||
17151053|NCT00700570|38296266|FG001|Overall Study|Withdrawal by Subject|6|||
17151054|NCT04427501|38296307|FG000|Overall Study|Death|0|||
17151055|NCT04427501|38296308|FG001|Overall Study|Death|0|||
17151056|NCT04427501|38296309|FG002|Overall Study|Death|0|||
17151057|NCT04427501|38296310|FG003|Overall Study|Death|0|||
17151058|NCT04427501|38296311|FG004|Overall Study|Death|0|||
17151059|NCT04427501|38296312|FG005|Overall Study|Death|15|||
17151060|NCT04427501|38296313|FG006|Overall Study|Death|0|||
17151061|NCT04427501|38296314|FG007|Overall Study|Death|0|||
17151062|NCT04427501|38296315|FG008|Overall Study|Death|0|||
17071246|NCT00459186|38213743|FG000|PET Imaging and Assessment|Adverse Event|3|||
17071247|NCT00328510|38213749|FG000|Overall Study|Gag disorder, could not use frame|4|||
17071248|NCT00328510|38213750|FG001|Overall Study|Gag disorder, could not use frame|0|||
17071249|NCT00328510|38213749|FG000|Overall Study|Dentition problems, could not use frame|1|||
17071250|NCT00328510|38213750|FG001|Overall Study|Dentition problems, could not use frame|0|||
17071251|NCT00328510|38213749|FG000|Overall Study|Withdrawal by Subject|4|||
17071252|NCT00328510|38213750|FG001|Overall Study|Withdrawal by Subject|2|||
17071253|NCT00328510|38213749|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
17071254|NCT00328510|38213750|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
17071255|NCT00328510|38213749|FG000|Overall Study|Treatment changed to a single fraction|1|||
17071256|NCT00328510|38213750|FG001|Overall Study|Treatment changed to a single fraction|1|||
17151063|NCT04427501|38296316|FG009|Overall Study|Death|0|||
17151064|NCT04427501|38296307|FG000|Overall Study|Lost to Follow-up|5|||
17151065|NCT04427501|38296308|FG001|Overall Study|Lost to Follow-up|1|||
17151066|NCT04427501|38296309|FG002|Overall Study|Lost to Follow-up|2|||
17151067|NCT04427501|38296310|FG003|Overall Study|Lost to Follow-up|0|||
17151068|NCT04427501|38296311|FG004|Overall Study|Lost to Follow-up|2|||
17151069|NCT04427501|38296312|FG005|Overall Study|Lost to Follow-up|11|||
17151070|NCT04427501|38296313|FG006|Overall Study|Lost to Follow-up|10|||
17151071|NCT04427501|38296314|FG007|Overall Study|Lost to Follow-up|10|||
17151072|NCT04427501|38296315|FG008|Overall Study|Lost to Follow-up|2|||
17151073|NCT04427501|38296316|FG009|Overall Study|Lost to Follow-up|5|||
17151074|NCT04427501|38296307|FG000|Overall Study|Physician Decision|0|||
17151075|NCT04427501|38296308|FG001|Overall Study|Physician Decision|3|||
17151076|NCT04427501|38296309|FG002|Overall Study|Physician Decision|0|||
17151077|NCT04427501|38296310|FG003|Overall Study|Physician Decision|0|||
17151078|NCT04427501|38296311|FG004|Overall Study|Physician Decision|0|||
17151079|NCT04427501|38296312|FG005|Overall Study|Physician Decision|0|||
17151080|NCT04427501|38296313|FG006|Overall Study|Physician Decision|2|||
17151081|NCT04427501|38296314|FG007|Overall Study|Physician Decision|0|||
17151082|NCT04427501|38296315|FG008|Overall Study|Physician Decision|0|||
17151083|NCT04427501|38296316|FG009|Overall Study|Physician Decision|0|||
17151084|NCT04427501|38296307|FG000|Overall Study|Withdrawal by Subject|9|||
17151085|NCT04427501|38296308|FG001|Overall Study|Withdrawal by Subject|2|||
17151086|NCT04427501|38296309|FG002|Overall Study|Withdrawal by Subject|2|||
17151087|NCT04427501|38296310|FG003|Overall Study|Withdrawal by Subject|3|||
17151088|NCT04427501|38296311|FG004|Overall Study|Withdrawal by Subject|7|||
17151089|NCT04427501|38296312|FG005|Overall Study|Withdrawal by Subject|25|||
17151090|NCT04427501|38296313|FG006|Overall Study|Withdrawal by Subject|15|||
17151091|NCT04427501|38296314|FG007|Overall Study|Withdrawal by Subject|7|||
17151092|NCT04427501|38296315|FG008|Overall Study|Withdrawal by Subject|4|||
17151093|NCT04427501|38296316|FG009|Overall Study|Withdrawal by Subject|1|||
17151094|NCT04427501|38296307|FG000|Overall Study|Other - as reported by the investigator|1|||
17151095|NCT04427501|38296308|FG001|Overall Study|Other - as reported by the investigator|0|||
17151096|NCT04427501|38296309|FG002|Overall Study|Other - as reported by the investigator|0|||
17151097|NCT04427501|38296310|FG003|Overall Study|Other - as reported by the investigator|0|||
17151098|NCT04427501|38296311|FG004|Overall Study|Other - as reported by the investigator|0|||
17151099|NCT04427501|38296312|FG005|Overall Study|Other - as reported by the investigator|6|||
17151100|NCT04427501|38296313|FG006|Overall Study|Other - as reported by the investigator|6|||
17151101|NCT04427501|38296314|FG007|Overall Study|Other - as reported by the investigator|0|||
17151102|NCT04427501|38296315|FG008|Overall Study|Other - as reported by the investigator|0|||
17151103|NCT04427501|38296316|FG009|Overall Study|Other - as reported by the investigator|0|||
17151104|NCT02874924|38296352|FG000|Overall Study|Adverse Event|2|||
16781252|NCT02109484|37720410|FG001|Overall Study|Death|0|||
17071257|NCT00313144|38213756|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
17071258|NCT00313144|38213756|FG000|Overall Study|Death|7|||
17151105|NCT02874924|38296353|FG001|Overall Study|Adverse Event|0|||
17151106|NCT02874924|38296354|FG002|Overall Study|Adverse Event|0|||
17151107|NCT02874924|38296352|FG000|Overall Study|Withdrawal by Subject|1|||
17151108|NCT02874924|38296353|FG001|Overall Study|Withdrawal by Subject|0|||
17151109|NCT02874924|38296354|FG002|Overall Study|Withdrawal by Subject|0|||
17071259|NCT00313144|38213756|FG000|Overall Study|Lost to Follow-up|5|||
17071260|NCT00313144|38213756|FG000|Overall Study|Withdrawal by Subject|4|||
17071261|NCT00313144|38213756|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
17151110|NCT04425863|38296365|FG000|Overall Study|Death|0|||
17151111|NCT04425863|38296366|FG001|Overall Study|Death|0|||
17151112|NCT04425863|38296367|FG002|Overall Study|Death|1|||
17151113|NCT04360187|38296389|FG000|Double-Blind Treatment|Adverse Event|9|||
17151114|NCT04360187|38296390|FG001|Double-Blind Treatment|Adverse Event|11|||
17151115|NCT04360187|38296389|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
17151116|NCT04360187|38296390|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
17151117|NCT04360187|38296389|FG000|Double-Blind Treatment|Physician Decision|1|||
17151118|NCT04360187|38296390|FG001|Double-Blind Treatment|Physician Decision|0|||
17151119|NCT04360187|38296389|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
17151120|NCT04360187|38296390|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
17151121|NCT04360187|38296389|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
17151122|NCT04360187|38296390|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
17151123|NCT04360187|38296389|FG000|Follow-Up|Lost to Follow-up|1|||
17151124|NCT04360187|38296390|FG001|Follow-Up|Lost to Follow-up|0|||
17151125|NCT04498169|38296398|FG000|Study Completion|Adverse Event|1|||
17151126|NCT04498169|38296399|FG001|Study Completion|Adverse Event|1|||
17151127|NCT03695393|38296407|FG000|Overall Study|Death|3|||
17151128|NCT03695393|38296408|FG001|Overall Study|Death|1|||
17151129|NCT03695393|38296407|FG000|Overall Study|Lost to Follow-up|0|||
17151130|NCT03695393|38296408|FG001|Overall Study|Lost to Follow-up|1|||
17151131|NCT01164228|38296416|FG000|Overall Study|Progression|24|||
17151132|NCT01164228|38296417|FG001|Overall Study|Progression|25|||
17151133|NCT01164228|38296416|FG000|Overall Study|Adverse Event|13|||
17151134|NCT01164228|38296417|FG001|Overall Study|Adverse Event|7|||
17151135|NCT01164228|38296416|FG000|Overall Study|Death|1|||
17151136|NCT01164228|38296417|FG001|Overall Study|Death|1|||
17151137|NCT01164228|38296416|FG000|Overall Study|Withdrawal by Subject|2|||
17151138|NCT01164228|38296417|FG001|Overall Study|Withdrawal by Subject|0|||
17151139|NCT01164228|38296416|FG000|Overall Study|Physician Decision|1|||
17151140|NCT01164228|38296417|FG001|Overall Study|Physician Decision|2|||
17151141|NCT01164228|38296416|FG000|Overall Study|Symptomatic deterioration|1|||
17151142|NCT01164228|38296417|FG001|Overall Study|Symptomatic deterioration|0|||
17151143|NCT01164228|38296416|FG000|Overall Study|Never started treatment|1|||
17151144|NCT01164228|38296417|FG001|Overall Study|Never started treatment|3|||
17151145|NCT01164228|38296416|FG000|Overall Study|Ineligible|1|||
17151146|NCT01164228|38296417|FG001|Overall Study|Ineligible|0|||
17151147|NCT03694925|38296426|FG000|Overall Study|Inadequate laboratory testing|0|||
17151148|NCT03694925|38296427|FG001|Overall Study|Inadequate laboratory testing|3|||
17151149|NCT03694925|38296428|FG002|Overall Study|Inadequate laboratory testing|0|||
17151150|NCT04495829|38296438|FG000|Overall Study|Lost to Follow-up|2|||
17151151|NCT04495829|38296438|FG000|Overall Study|Inclusion criterion not met|3|||
17151152|NCT04258020|38296444|FG000|Overall Study|Withdrawal by Subject|1|||
17151153|NCT04258020|38296445|FG001|Overall Study|Withdrawal by Subject|0|||
17151154|NCT04495283|38296454|FG000|Overall Study|Physician Decision|0|||
17151155|NCT04495283|38296455|FG001|Overall Study|Physician Decision|0|||
17071262|NCT00313144|38213756|FG000|Overall Study|Physician Decision|4|||
17071263|NCT00313144|38213756|FG000|Overall Study|Adverse event - transient|5|||
17071264|NCT00313144|38213756|FG000|Overall Study|Liver transplant|1|||
17071265|NCT00313144|38213756|FG000|Overall Study|Insurance (homecare provider) change|1|||
17071266|NCT00313144|38213756|FG000|Overall Study|Change to different product|1|||
17071267|NCT00313144|38213756|FG000|Overall Study|Due to termination of the study|66|||
17071268|NCT00459108|38213769|FG000|Overall Study|Withdrawal by Subject|5|||
17071269|NCT00459108|38213769|FG000|Overall Study|Adverse Event|3|||
17071270|NCT00459108|38213769|FG000|Overall Study|Death|2|||
17071271|NCT00459108|38213769|FG000|Overall Study|Progression|1|||
17071272|NCT00458484|38213781|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
17071273|NCT00458484|38213782|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
17071274|NCT00458484|38213783|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
17071275|NCT00458484|38213784|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
17071276|NCT00458484|38213785|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
17071277|NCT00458484|38213786|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
17071278|NCT00458484|38213787|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
17071279|NCT00328198|38213812|FG000|Treatment|Adverse Event|21|||
17071280|NCT00328198|38213812|FG000|Treatment|Death|1|||
17071281|NCT00328198|38213812|FG000|Treatment|Physician Decision|5|||
17071282|NCT00328198|38213812|FG000|Treatment|Withdrawal by Subject|5|||
17071283|NCT00328198|38213812|FG000|Treatment|Evidence of disease progression|2|||
17071284|NCT00328198|38213812|FG000|Treatment|Non-compliance|1|||
17071285|NCT00328198|38213812|FG000|Treatment|Confirmed complete response, MRD -|3|||
17071286|NCT00328198|38213812|FG000|Follow-up|Lost to Follow-up|4|||
17071287|NCT00328198|38213812|FG000|Follow-up|Death|31|||
17071288|NCT00450450|38213818|FG000|Overall Study|Death|1|||
17071289|NCT00450450|38213819|FG001|Overall Study|Death|3|||
17071290|NCT00450450|38213818|FG000|Overall Study|Relapse|2|||
17071291|NCT00450450|38213819|FG001|Overall Study|Relapse|0|||
17151156|NCT04495283|38296456|FG002|Overall Study|Physician Decision|1|||
17151157|NCT04495283|38296454|FG000|Overall Study|Withdrawal by Subject|0|||
17151158|NCT04495283|38296455|FG001|Overall Study|Withdrawal by Subject|1|||
17151159|NCT04495283|38296456|FG002|Overall Study|Withdrawal by Subject|1|||
17151160|NCT04495283|38296454|FG000|Overall Study|Other|1|||
17151161|NCT04495283|38296455|FG001|Overall Study|Other|0|||
17151162|NCT04495283|38296456|FG002|Overall Study|Other|1|||
17151163|NCT03117738|38296469|FG000|Overall Study|Withdrawal by Subject|3|||
17151164|NCT03117738|38296470|FG001|Overall Study|Withdrawal by Subject|1|||
17151165|NCT03117738|38296469|FG000|Overall Study|Lost to Follow-up|1|||
17151166|NCT03117738|38296470|FG001|Overall Study|Lost to Follow-up|4|||
17151167|NCT04234464|38296478|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
17151168|NCT04234464|38296479|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
17151169|NCT03123588|38296487|FG000|Overall Study|Study Terminated by Sponsor|2|||
17151170|NCT03123588|38296488|FG001|Overall Study|Study Terminated by Sponsor|5|||
17151171|NCT03123588|38296487|FG000|Overall Study|Withdrawal by Subject|1|||
17151172|NCT03123588|38296488|FG001|Overall Study|Withdrawal by Subject|0|||
17151173|NCT03123588|38296487|FG000|Overall Study|Adverse Event|1|||
17151174|NCT03123588|38296488|FG001|Overall Study|Adverse Event|0|||
17151175|NCT03123588|38296487|FG000|Overall Study|Physician Decision|2|||
17151176|NCT03123588|38296488|FG001|Overall Study|Physician Decision|1|||
17071292|NCT00450450|38213818|FG000|Overall Study|Missing Data|2|||
17071293|NCT00450450|38213819|FG001|Overall Study|Missing Data|0|||
17071294|NCT00442572|38213827|FG000|Overall Study|Relapse|8|||
17071295|NCT00442572|38213828|FG001|Overall Study|Relapse|1|||
17071296|NCT00442572|38213827|FG000|Overall Study|Lost to Follow-up|0|||
17071297|NCT00442572|38213828|FG001|Overall Study|Lost to Follow-up|1|||
17071298|NCT00442572|38213827|FG000|Overall Study|Withdrawal by Subject|0|||
17071299|NCT00442572|38213828|FG001|Overall Study|Withdrawal by Subject|1|||
17071300|NCT00442416|38213837|FG000|Overall Study|Adverse Event|4|||
17071301|NCT00442416|38213838|FG001|Overall Study|Adverse Event|1|||
17071302|NCT00442416|38213837|FG000|Overall Study|Death|1|||
17071303|NCT00442416|38213838|FG001|Overall Study|Death|0|||
17071304|NCT00442416|38213837|FG000|Overall Study|Lack of Efficacy|2|||
17071305|NCT00442416|38213838|FG001|Overall Study|Lack of Efficacy|0|||
17071306|NCT00442416|38213837|FG000|Overall Study|Protocol Violation|2|||
17071307|NCT00442416|38213838|FG001|Overall Study|Protocol Violation|3|||
17071308|NCT00442416|38213837|FG000|Overall Study|Withdrew consent|1|||
17071309|NCT00442416|38213838|FG001|Overall Study|Withdrew consent|2|||
17071310|NCT00442416|38213837|FG000|Overall Study|Administrative/Other|27|||
17071311|NCT00442416|38213838|FG001|Overall Study|Administrative/Other|33|||
17071312|NCT00441792|38213846|FG000|Overall Study|Lost to Follow-up|0|||
17071313|NCT00441792|38213847|FG001|Overall Study|Lost to Follow-up|2|||
17071314|NCT00312208|38213855|FG000|Overall Study|Adverse Event|97|||
17071315|NCT00312208|38213856|FG001|Overall Study|Adverse Event|61|||
17071316|NCT00312208|38213855|FG000|Overall Study|Protocol Violation|5|||
17071317|NCT00312208|38213856|FG001|Overall Study|Protocol Violation|3|||
17071318|NCT00312208|38213855|FG000|Overall Study|Death|2|||
17071319|NCT00312208|38213856|FG001|Overall Study|Death|1|||
17071320|NCT00312208|38213855|FG000|Overall Study|Lack of Efficacy|7|||
17071321|NCT00312208|38213856|FG001|Overall Study|Lack of Efficacy|4|||
17071322|NCT00312208|38213855|FG000|Overall Study|Lost to Follow-up|3|||
17071323|NCT00312208|38213856|FG001|Overall Study|Lost to Follow-up|5|||
17071324|NCT00312208|38213855|FG000|Overall Study|Withdrawal by Subject|53|||
17071325|NCT00312208|38213856|FG001|Overall Study|Withdrawal by Subject|42|||
17071326|NCT00312208|38213855|FG000|Overall Study|Other|5|||
17071327|NCT00312208|38213856|FG001|Overall Study|Other|7|||
17071328|NCT00297778|38213864|FG000|Overall Study|Adverse Event|16|||
17071329|NCT00297778|38213865|FG001|Overall Study|Adverse Event|10|||
17071330|NCT00297778|38213864|FG000|Overall Study|Withdrawal by Subject|1|||
17071331|NCT00297778|38213865|FG001|Overall Study|Withdrawal by Subject|5|||
17071332|NCT00297778|38213864|FG000|Overall Study|Lack of Efficacy|2|||
17071333|NCT00297778|38213865|FG001|Overall Study|Lack of Efficacy|1|||
17071334|NCT00297778|38213864|FG000|Overall Study|Non-compliant with trial protocol|0|||
17071335|NCT00297778|38213865|FG001|Overall Study|Non-compliant with trial protocol|3|||
17071336|NCT00297778|38213864|FG000|Overall Study|Other|0|||
17071337|NCT00297778|38213865|FG001|Overall Study|Other|1|||
17071338|NCT03848832|38213874|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
17071339|NCT03848832|38213875|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
17071340|NCT03848832|38213876|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
17151177|NCT03123354|38296495|FG000|Overall Study|Physician Decision|6|||
17151178|NCT04421027|38296501|FG000|Treatment Period|Adverse Event|5|||
17151179|NCT04421027|38296502|FG001|Treatment Period|Adverse Event|3|||
17151180|NCT04421027|38296503|FG002|Treatment Period|Adverse Event|0|||
17151181|NCT04421027|38296504|FG003|Treatment Period|Adverse Event|0|||
17151182|NCT04421027|38296501|FG000|Treatment Period|Death|98|||
17151183|NCT04421027|38296502|FG001|Treatment Period|Death|61|||
17151184|NCT04421027|38296503|FG002|Treatment Period|Death|0|||
17151185|NCT04421027|38296504|FG003|Treatment Period|Death|0|||
17151186|NCT04421027|38296501|FG000|Treatment Period|Lost to Follow-up|22|||
17071341|NCT03848832|38213874|FG000|Overall Study|Withdrawal by Subject|0|||
17151187|NCT04421027|38296502|FG001|Treatment Period|Lost to Follow-up|20|||
17151188|NCT04421027|38296503|FG002|Treatment Period|Lost to Follow-up|0|||
17151189|NCT04421027|38296504|FG003|Treatment Period|Lost to Follow-up|0|||
17151190|NCT04421027|38296501|FG000|Treatment Period|Other-Unknown|15|||
17151191|NCT04421027|38296502|FG001|Treatment Period|Other-Unknown|9|||
17151192|NCT04421027|38296503|FG002|Treatment Period|Other-Unknown|0|||
17151193|NCT04421027|38296504|FG003|Treatment Period|Other-Unknown|0|||
17151194|NCT04421027|38296501|FG000|Treatment Period|Physician Decision|1|||
17151195|NCT04421027|38296502|FG001|Treatment Period|Physician Decision|1|||
17151196|NCT04421027|38296503|FG002|Treatment Period|Physician Decision|0|||
17151197|NCT04421027|38296504|FG003|Treatment Period|Physician Decision|0|||
17151198|NCT04421027|38296501|FG000|Treatment Period|Withdrawal by Subject|7|||
17151199|NCT04421027|38296502|FG001|Treatment Period|Withdrawal by Subject|12|||
17151200|NCT04421027|38296503|FG002|Treatment Period|Withdrawal by Subject|0|||
17151201|NCT04421027|38296504|FG003|Treatment Period|Withdrawal by Subject|0|||
17151202|NCT04421027|38296501|FG000|Treatment Period|Randomized Not Dosed|9|||
17151203|NCT04421027|38296502|FG001|Treatment Period|Randomized Not Dosed|14|||
17151204|NCT04421027|38296503|FG002|Treatment Period|Randomized Not Dosed|0|||
17151205|NCT04421027|38296504|FG003|Treatment Period|Randomized Not Dosed|0|||
17151206|NCT04421027|38296501|FG000|Follow-Up Period|Adverse Event|0|||
17151207|NCT04421027|38296502|FG001|Follow-Up Period|Adverse Event|0|||
17151208|NCT04421027|38296503|FG002|Follow-Up Period|Adverse Event|0|||
17151209|NCT04421027|38296504|FG003|Follow-Up Period|Adverse Event|3|||
17151210|NCT04421027|38296501|FG000|Follow-Up Period|Death|0|||
17151211|NCT04421027|38296502|FG001|Follow-Up Period|Death|0|||
17151212|NCT04421027|38296503|FG002|Follow-Up Period|Death|16|||
17151213|NCT04421027|38296504|FG003|Follow-Up Period|Death|17|||
17151214|NCT04421027|38296501|FG000|Follow-Up Period|Lost to Follow-up|0|||
17151215|NCT04421027|38296502|FG001|Follow-Up Period|Lost to Follow-up|0|||
17151216|NCT04421027|38296503|FG002|Follow-Up Period|Lost to Follow-up|7|||
17151217|NCT04421027|38296504|FG003|Follow-Up Period|Lost to Follow-up|7|||
17151218|NCT04421027|38296501|FG000|Follow-Up Period|Protocol Deviation|0|||
17151219|NCT04421027|38296502|FG001|Follow-Up Period|Protocol Deviation|0|||
17151220|NCT04421027|38296503|FG002|Follow-Up Period|Protocol Deviation|1|||
17151221|NCT04421027|38296504|FG003|Follow-Up Period|Protocol Deviation|0|||
17151222|NCT04421027|38296501|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
17151223|NCT04421027|38296502|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
17151224|NCT04421027|38296503|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
17151225|NCT04421027|38296504|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
17151226|NCT04421027|38296501|FG000|Follow-Up Period|Left message, participant did not call back|0|||
17151227|NCT04421027|38296502|FG001|Follow-Up Period|Left message, participant did not call back|0|||
17151228|NCT04421027|38296503|FG002|Follow-Up Period|Left message, participant did not call back|0|||
17071342|NCT03848832|38213875|FG001|Overall Study|Withdrawal by Subject|0|||
17071343|NCT03848832|38213876|FG002|Overall Study|Withdrawal by Subject|1|||
17151229|NCT04421027|38296504|FG003|Follow-Up Period|Left message, participant did not call back|1|||
17151230|NCT04421027|38296501|FG000|Follow-Up Period|Participant died|0|||
17151231|NCT04421027|38296502|FG001|Follow-Up Period|Participant died|0|||
17151232|NCT04421027|38296503|FG002|Follow-Up Period|Participant died|0|||
17151233|NCT04421027|38296504|FG003|Follow-Up Period|Participant died|1|||
17151234|NCT04421027|38296501|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
17151235|NCT04421027|38296502|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
17151236|NCT04421027|38296503|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
17151237|NCT04421027|38296504|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
17151238|NCT04419311|38296514|FG000|Overall Study|Lost to Follow-up|1|||
17151239|NCT04419311|38296515|FG001|Overall Study|Lost to Follow-up|0|||
17151240|NCT04411667|38296525|FG000|Overall Study|Physician Decision|1|||
17151241|NCT04411667|38296526|FG001|Overall Study|Physician Decision|0|||
17151242|NCT04358549|38296534|FG000|Overall Study|Adverse Event|0|||
17151243|NCT04358549|38296535|FG001|Overall Study|Adverse Event|1|||
17151244|NCT04358549|38296534|FG000|Overall Study|Death|1|||
17151245|NCT04358549|38296535|FG001|Overall Study|Death|0|||
17151246|NCT04358549|38296534|FG000|Overall Study|Lost to Follow-up|2|||
17151247|NCT04358549|38296535|FG001|Overall Study|Lost to Follow-up|1|||
17071344|NCT03848832|38213874|FG000|Overall Study|Withdrawal (Covid-19)|0|||
17071345|NCT03848832|38213875|FG001|Overall Study|Withdrawal (Covid-19)|2|||
17071346|NCT03848832|38213876|FG002|Overall Study|Withdrawal (Covid-19)|0|||
17071347|NCT03848832|38213874|FG000|Overall Study|Physician Decision|2|||
17071348|NCT03848832|38213875|FG001|Overall Study|Physician Decision|1|||
17071349|NCT03848832|38213876|FG002|Overall Study|Physician Decision|3|||
17071350|NCT03848832|38213874|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
17071351|NCT03848832|38213875|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
17151248|NCT04358549|38296534|FG000|Overall Study|Withdrawal by Subject|6|||
17151249|NCT04358549|38296535|FG001|Overall Study|Withdrawal by Subject|6|||
17151250|NCT04358549|38296534|FG000|Overall Study|Start remdesivir|1|||
17151251|NCT04358549|38296535|FG001|Overall Study|Start remdesivir|0|||
17071352|NCT03848832|38213876|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
17071353|NCT03848832|38213874|FG000|Overall Study|Adverse Event|1|||
17071354|NCT03848832|38213875|FG001|Overall Study|Adverse Event|0|||
17151252|NCT00700180|38296543|FG000|Overall Study|Death|99|||
17151253|NCT00700180|38296544|FG001|Overall Study|Death|114|||
17151254|NCT00700180|38296543|FG000|Overall Study|Alive on treatment|5|||
17151255|NCT00700180|38296544|FG001|Overall Study|Alive on treatment|3|||
17151256|NCT00700180|38296543|FG000|Overall Study|Alive in follow-up|46|||
17151257|NCT00700180|38296544|FG001|Overall Study|Alive in follow-up|27|||
17151258|NCT00700180|38296543|FG000|Overall Study|Lost to Follow-up|4|||
17151259|NCT00700180|38296544|FG001|Overall Study|Lost to Follow-up|5|||
17151260|NCT00238420|38296552|FG000|Overall Study|Protocol Violation|1|||
17151261|NCT00238420|38296553|FG001|Overall Study|Protocol Violation|1|||
17071355|NCT03848832|38213876|FG002|Overall Study|Adverse Event|0|||
17071356|NCT00450372|38213886|FG000|Overall Study|Physician Decision|1|||
17071357|NCT00327340|38213895|FG000|Overall Study|Withdrawal by Subject|1|||
17071358|NCT00327340|38213896|FG001|Overall Study|Withdrawal by Subject|5|||
17071359|NCT00327340|38213895|FG000|Overall Study|Physician Decision|1|||
17071360|NCT00327340|38213896|FG001|Overall Study|Physician Decision|1|||
17071361|NCT00327340|38213895|FG000|Overall Study|Disease Progression|10|||
17071362|NCT00327340|38213896|FG001|Overall Study|Disease Progression|19|||
17071363|NCT00327340|38213895|FG000|Overall Study|Symptomatic Disease|0|||
17071364|NCT00327340|38213896|FG001|Overall Study|Symptomatic Disease|2|||
17071365|NCT00327340|38213895|FG000|Overall Study|Adverse Event|3|||
17071366|NCT00327340|38213896|FG001|Overall Study|Adverse Event|3|||
17071367|NCT00548093|38213906|FG000|Overall Study|Death|33|||
17071368|NCT00548093|38213907|FG001|Overall Study|Death|13|||
17071369|NCT00548093|38213906|FG000|Overall Study|Lost to Follow-up|3|||
17071370|NCT00548093|38213907|FG001|Overall Study|Lost to Follow-up|1|||
17071371|NCT00548093|38213906|FG000|Overall Study|Objective progression or relapse|1|||
17071372|NCT00548093|38213907|FG001|Overall Study|Objective progression or relapse|1|||
17071373|NCT00548093|38213906|FG000|Overall Study|Other|11|||
17071374|NCT00548093|38213907|FG001|Overall Study|Other|1|||
17071375|NCT00548093|38213906|FG000|Overall Study|Withdrawal by Subject|1|||
17071376|NCT00548093|38213907|FG001|Overall Study|Withdrawal by Subject|0|||
17071377|NCT00548093|38213906|FG000|Overall Study|Completed post-treatment follow-up|1|||
17071378|NCT00548093|38213907|FG001|Overall Study|Completed post-treatment follow-up|0|||
17071379|NCT03824704|38213916|FG000|Overall Study|Study Terminated by Sponsor|1|||
17071380|NCT00450216|38213922|FG000|Overall Study|Adverse Event|38|||
17071381|NCT00450216|38213923|FG001|Overall Study|Adverse Event|23|||
17071382|NCT00450216|38213922|FG000|Overall Study|Withdrawal by Subject|48|||
17071383|NCT00450216|38213923|FG001|Overall Study|Withdrawal by Subject|26|||
17071384|NCT00450216|38213922|FG000|Overall Study|Lost to Follow-up|16|||
17071385|NCT00450216|38213923|FG001|Overall Study|Lost to Follow-up|9|||
17071386|NCT00450216|38213922|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
17071387|NCT00450216|38213923|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
17071388|NCT00450216|38213922|FG000|Overall Study|misc|21|||
17071389|NCT00450216|38213923|FG001|Overall Study|misc|20|||
17071390|NCT00441480|38213931|FG000|Overall Study|Protocol Violation|1|||
17071391|NCT00441480|38213932|FG001|Overall Study|Protocol Violation|1|||
17071392|NCT00441480|38213931|FG000|Overall Study|Withdrawal by Subject|2|||
17071393|NCT00441480|38213932|FG001|Overall Study|Withdrawal by Subject|3|||
17071394|NCT00547703|38213940|FG000|Overall Study|Lost to Follow-up|1|||
17071395|NCT00547703|38213941|FG001|Overall Study|Lost to Follow-up|0|||
17071396|NCT00297232|38213947|FG000|Overall Study|Lack of Efficacy|7|||
17071397|NCT00297232|38213947|FG000|Overall Study|Lost to Follow-up|10|||
17071398|NCT00297232|38213947|FG000|Overall Study|Adverse Event|63|||
17071399|NCT00297232|38213947|FG000|Overall Study|Voluntary Withdrawal|120|||
17071400|NCT00297232|38213947|FG000|Overall Study|Subject was Noncompliant|9|||
17151262|NCT04492475|38296561|FG000|Overall Study|Enrolled but not treated|8|||
17151263|NCT04492475|38296562|FG001|Overall Study|Enrolled but not treated|8|||
17151264|NCT04492475|38296561|FG000|Overall Study|Withdrawal by Subject|4|||
17151265|NCT04492475|38296562|FG001|Overall Study|Withdrawal by Subject|0|||
17151266|NCT04492475|38296561|FG000|Overall Study|Became ineligible after enrollment|2|||
17151267|NCT04492475|38296562|FG001|Overall Study|Became ineligible after enrollment|0|||
17151268|NCT04486235|38296577|FG000|Overall Study|Pregnancy|1|||
17151269|NCT04486235|38296578|FG001|Overall Study|Pregnancy|0|||
17151270|NCT04486235|38296577|FG000|Overall Study|Lost to Follow-up|1|||
17151271|NCT04486235|38296578|FG001|Overall Study|Lost to Follow-up|0|||
17151272|NCT04358081|38296588|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
17151273|NCT04358081|38296589|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
17151274|NCT04358081|38296590|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
17151275|NCT04358081|38296588|FG000|Treatment Phase of Study|Adverse Event|1|||
17151276|NCT04358081|38296589|FG001|Treatment Phase of Study|Adverse Event|0|||
17151277|NCT04358081|38296590|FG002|Treatment Phase of Study|Adverse Event|1|||
17151278|NCT04358081|38296588|FG000|Treatment Phase of Study|Physician Decision|2|||
17151279|NCT04358081|38296589|FG001|Treatment Phase of Study|Physician Decision|0|||
17071401|NCT00297232|38213947|FG000|Overall Study|Death|9|||
17151280|NCT04358081|38296590|FG002|Treatment Phase of Study|Physician Decision|1|||
17151281|NCT04358081|38296588|FG000|Treatment Phase of Study|Protocol Violation|1|||
17151282|NCT04358081|38296589|FG001|Treatment Phase of Study|Protocol Violation|0|||
17151283|NCT04358081|38296590|FG002|Treatment Phase of Study|Protocol Violation|0|||
17151284|NCT04358081|38296588|FG000|Study Completion Phase|Death|0|||
17151285|NCT04358081|38296589|FG001|Study Completion Phase|Death|0|||
17151286|NCT04358081|38296590|FG002|Study Completion Phase|Death|1|||
17151287|NCT04358081|38296588|FG000|Study Completion Phase|Lost to Follow-up|1|||
17151288|NCT04358081|38296589|FG001|Study Completion Phase|Lost to Follow-up|0|||
17151289|NCT04358081|38296590|FG002|Study Completion Phase|Lost to Follow-up|1|||
17151290|NCT04355663|38296603|FG000|Overall Study|Physician Decision|2|||
17151291|NCT04355663|38296604|FG001|Overall Study|Physician Decision|7|||
17151292|NCT04355663|38296605|FG002|Overall Study|Physician Decision|0|||
17151293|NCT04355663|38296603|FG000|Overall Study|Adverse Event|0|||
17151294|NCT04355663|38296604|FG001|Overall Study|Adverse Event|0|||
17151295|NCT04355663|38296605|FG002|Overall Study|Adverse Event|1|||
17151296|NCT04355663|38296603|FG000|Overall Study|Withdrawal by Subject|0|||
17151297|NCT04355663|38296604|FG001|Overall Study|Withdrawal by Subject|8|||
17151298|NCT04355663|38296605|FG002|Overall Study|Withdrawal by Subject|3|||
17151299|NCT04482647|38296613|FG000|Overall Study|Time constraints|2|||
17151300|NCT04482647|38296613|FG000|Overall Study|Health issues|1|||
17151301|NCT04482647|38296613|FG000|Overall Study|Death in the family|1|||
17151302|NCT04482647|38296613|FG000|Overall Study|Disliked the intervention|1|||
17151303|NCT04482647|38296613|FG000|Overall Study|No reasons specified|7|||
17151304|NCT04345367|38296619|FG000|Overall Study|Other|3|||
17151305|NCT04345367|38296620|FG001|Overall Study|Other|4|||
17151306|NCT04345367|38296619|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
17151307|NCT04345367|38296620|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
17151308|NCT04345367|38296619|FG000|Overall Study|Withdrawal by Subject|11|||
17151309|NCT04345367|38296620|FG001|Overall Study|Withdrawal by Subject|11|||
17151310|NCT04345367|38296619|FG000|Overall Study|Protocol Violation|4|||
17151311|NCT04345367|38296620|FG001|Overall Study|Protocol Violation|3|||
17151312|NCT04345367|38296619|FG000|Overall Study|Lost to Follow-up|2|||
17151313|NCT04345367|38296620|FG001|Overall Study|Lost to Follow-up|4|||
17151314|NCT04345367|38296619|FG000|Overall Study|Lack of Efficacy|2|||
17151315|NCT04345367|38296620|FG001|Overall Study|Lack of Efficacy|0|||
17151316|NCT04345367|38296619|FG000|Overall Study|Death|2|||
17151317|NCT04345367|38296620|FG001|Overall Study|Death|0|||
17151318|NCT04345367|38296619|FG000|Overall Study|Adverse Event|10|||
17151319|NCT04345367|38296620|FG001|Overall Study|Adverse Event|9|||
17151320|NCT04404725|38296626|FG000|First Intervention|Withdrawal by Subject|0|||
17151321|NCT04404725|38296627|FG001|First Intervention|Withdrawal by Subject|2|||
17151322|NCT04404725|38296626|FG000|Second Intervention|Adverse Event|1|||
17151323|NCT04404725|38296627|FG001|Second Intervention|Adverse Event|1|||
17151324|NCT04404725|38296626|FG000|Second Intervention|Withdrawal by Subject|0|||
17151325|NCT04404725|38296627|FG001|Second Intervention|Withdrawal by Subject|1|||
17151326|NCT04343261|38296633|FG000|Overall Study|Adverse Event|1|||
17151327|NCT04343261|38296633|FG000|Overall Study|received inadequate amount of antibodies|7|||
17151328|NCT04336475|38296639|FG000|Overall Study|pain|1|||
17151329|NCT04336475|38296640|FG001|Overall Study|pain|0|||
17151330|NCT04336475|38296639|FG000|Overall Study|upper respiratory infection|1|||
17151331|NCT04336475|38296640|FG001|Overall Study|upper respiratory infection|0|||
17151332|NCT04336475|38296639|FG000|Overall Study|Lost to Follow-up|0|||
17151333|NCT04336475|38296640|FG001|Overall Study|Lost to Follow-up|2|||
17151334|NCT04335929|38296646|FG000|Overall Study|Lost to Follow-up|10|||
17151335|NCT04333199|38296653|FG000|Evaluated Patients|Lost to Follow-up|0|||
17151336|NCT04333199|38296654|FG001|Evaluated Patients|Lost to Follow-up|1|||
17151337|NCT04333199|38296655|FG002|Evaluated Patients|Lost to Follow-up|2|||
17151338|NCT04332419|38296664|FG000|Overall Study|Withdrawal by Subject|1|||
17071402|NCT00297232|38213947|FG000|Overall Study|Anti-natalizumab Positive|8|||
17071403|NCT00297232|38213947|FG000|Overall Study|Switched to Commercial Tysabri|22|||
17071404|NCT00297232|38213947|FG000|Overall Study|Disease Progression|8|||
17071405|NCT00297232|38213947|FG000|Overall Study|Fear of PML|10|||
17071406|NCT00297232|38213947|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
17071407|NCT00297232|38213947|FG000|Overall Study|Miscellaneous|5|||
17151339|NCT04330157|38296668|FG000|Overall Study|Protocol Violation|4|||
17151340|NCT04330157|38296668|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
17151341|NCT04329923|38296683|FG000|Overall Study|Withdrawal by Subject|1|||
17151342|NCT04329923|38296684|FG001|Overall Study|Withdrawal by Subject|4|||
17151343|NCT04329923|38296685|FG002|Overall Study|Withdrawal by Subject|1|||
17151344|NCT04329923|38296686|FG003|Overall Study|Withdrawal by Subject|1|||
17151345|NCT04329923|38296687|FG004|Overall Study|Withdrawal by Subject|1|||
17151346|NCT04329923|38296688|FG005|Overall Study|Withdrawal by Subject|1|||
17071408|NCT00297232|38213947|FG000|Overall Study|Sponsor Decision|34|||
17071409|NCT00297232|38213947|FG000|Overall Study|Subject Relocated|7|||
17071410|NCT00297232|38213947|FG000|Overall Study|Subject Withdrew Consent|37|||
17151347|NCT04329923|38296683|FG000|Overall Study|early termination of study|0|||
17151348|NCT04329923|38296684|FG001|Overall Study|early termination of study|0|||
17151349|NCT04329923|38296685|FG002|Overall Study|early termination of study|0|||
17151350|NCT04329923|38296686|FG003|Overall Study|early termination of study|0|||
17151351|NCT04329923|38296687|FG004|Overall Study|early termination of study|1|||
17151352|NCT04329923|38296688|FG005|Overall Study|early termination of study|2|||
17151353|NCT04329923|38296683|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
17151354|NCT04329923|38296684|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
17151355|NCT04329923|38296685|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
17151356|NCT04329923|38296686|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
17151357|NCT04329923|38296687|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
17151358|NCT04329923|38296688|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
17151359|NCT04403399|38296704|FG000|Period 2|Physician Decision|0|||
17151360|NCT04403399|38296705|FG001|Period 2|Physician Decision|1|||
17151361|NCT04401293|38296713|FG000|Overall Study|Withdrawal by Subject|1|||
17151362|NCT04401293|38296714|FG001|Overall Study|Withdrawal by Subject|3|||
17151363|NCT04319159|38296722|FG000|Overall Study|Screening failure|13|||
17151364|NCT04319159|38296722|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
17151365|NCT04319159|38296722|FG000|Overall Study|Withdrawal by Subject|1|||
17151366|NCT04318535|38296728|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
17151367|NCT04318535|38296729|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
17151368|NCT04318535|38296730|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
17151369|NCT04454567|38296741|FG000|Overall Study|Study Terminated by Sponsor|1|||
17151370|NCT04454567|38296742|FG001|Overall Study|Study Terminated by Sponsor|1|||
17151371|NCT04449341|38296750|FG000|Overall Study|Protocol Violation|1|||
17151372|NCT04449341|38296751|FG001|Overall Study|Protocol Violation|0|||
17151373|NCT04448561|38296759|FG000|Overall Study|Noncompliance|1|||
17151374|NCT04448561|38296760|FG001|Overall Study|Noncompliance|0|||
17151375|NCT04308239|38296776|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
17151376|NCT04308239|38296777|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
17151377|NCT04308239|38296776|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
17151378|NCT04308239|38296777|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
17151379|NCT04308239|38296776|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
17151380|NCT04308239|38296777|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
17151381|NCT04308239|38296776|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
17151382|NCT04308239|38296777|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
17151383|NCT04302545|38296789|FG000|Overall Study|Lost to Follow-up|3|||
17151384|NCT04302545|38296790|FG001|Overall Study|Lost to Follow-up|4|||
17151385|NCT04297241|38296807|FG000|Overall Study|Withdrawal by Subject|1|||
17151386|NCT04297241|38296807|FG000|Overall Study|Adverse Event|1|||
17151387|NCT04297241|38296807|FG000|Overall Study|Physician Decision|3|||
17151388|NCT04292171|38296823|FG000|Overall Study|Pharmacy error|2|||
17151389|NCT04292171|38296824|FG001|Overall Study|Pharmacy error|0|||
17151390|NCT04292171|38296823|FG000|Overall Study|Delivered prior to procedure|0|||
17151391|NCT04292171|38296824|FG001|Overall Study|Delivered prior to procedure|1|||
17151392|NCT04393493|38296832|FG000|First 4 Days of Intervention|Early improvement|5|||
17151393|NCT04393493|38296833|FG001|First 4 Days of Intervention|Early improvement|7|||
17151394|NCT04285229|38296843|FG000|Overall Study|Adverse Event|1|||
17151395|NCT04285229|38296844|FG001|Overall Study|Adverse Event|2|||
17151396|NCT04285229|38296843|FG000|Overall Study|Withdrawal by Subject|1|||
17151397|NCT04285229|38296844|FG001|Overall Study|Withdrawal by Subject|0|||
17151398|NCT04285229|38296843|FG000|Overall Study|Sponsor Decision|1|||
17151399|NCT04285229|38296844|FG001|Overall Study|Sponsor Decision|0|||
17151400|NCT04280705|38296855|FG000|Overall Study|Enrolled but not treated|4|||
17151401|NCT04280705|38296856|FG001|Overall Study|Enrolled but not treated|10|||
17151402|NCT04280705|38296855|FG000|Overall Study|Physician Decision|1|||
17151403|NCT04280705|38296856|FG001|Overall Study|Physician Decision|0|||
17151404|NCT04280705|38296855|FG000|Overall Study|Withdrawal by Subject|7|||
17151405|NCT04280705|38296856|FG001|Overall Study|Withdrawal by Subject|9|||
17151406|NCT04280705|38296855|FG000|Overall Study|Adverse Event|0|||
17151407|NCT04280705|38296856|FG001|Overall Study|Adverse Event|4|||
17151408|NCT04280705|38296855|FG000|Overall Study|Transferred to another hospital|1|||
17151409|NCT04280705|38296856|FG001|Overall Study|Transferred to another hospital|1|||
17151410|NCT02077166|38296869|FG000|Overall Study|Death|6|||
17151411|NCT02077166|38296870|FG001|Overall Study|Death|7|||
17151412|NCT02077166|38296871|FG002|Overall Study|Death|5|||
17151413|NCT02077166|38296872|FG003|Overall Study|Death|6|||
17151414|NCT02077166|38296873|FG004|Overall Study|Death|4|||
17151415|NCT02077166|38296874|FG005|Overall Study|Death|32|||
17151416|NCT02077166|38296875|FG006|Overall Study|Death|22|||
17151417|NCT02077166|38296869|FG000|Overall Study|Study Closure by Sponsor|3|||
17151418|NCT02077166|38296870|FG001|Overall Study|Study Closure by Sponsor|0|||
17151419|NCT02077166|38296871|FG002|Overall Study|Study Closure by Sponsor|2|||
17151420|NCT02077166|38296872|FG003|Overall Study|Study Closure by Sponsor|2|||
17151421|NCT02077166|38296873|FG004|Overall Study|Study Closure by Sponsor|2|||
17151422|NCT02077166|38296874|FG005|Overall Study|Study Closure by Sponsor|12|||
17151423|NCT02077166|38296875|FG006|Overall Study|Study Closure by Sponsor|4|||
17151424|NCT02077166|38296869|FG000|Overall Study|Lost to Follow-up|0|||
17151425|NCT02077166|38296870|FG001|Overall Study|Lost to Follow-up|0|||
17151426|NCT02077166|38296871|FG002|Overall Study|Lost to Follow-up|0|||
17151427|NCT02077166|38296872|FG003|Overall Study|Lost to Follow-up|0|||
17151428|NCT02077166|38296873|FG004|Overall Study|Lost to Follow-up|0|||
17151429|NCT02077166|38296874|FG005|Overall Study|Lost to Follow-up|1|||
17151430|NCT02077166|38296875|FG006|Overall Study|Lost to Follow-up|0|||
17151431|NCT02077166|38296869|FG000|Overall Study|Withdrawal by Subject|3|||
17151432|NCT02077166|38296870|FG001|Overall Study|Withdrawal by Subject|0|||
17151433|NCT02077166|38296871|FG002|Overall Study|Withdrawal by Subject|1|||
17151434|NCT02077166|38296872|FG003|Overall Study|Withdrawal by Subject|1|||
17151435|NCT02077166|38296873|FG004|Overall Study|Withdrawal by Subject|1|||
17151436|NCT02077166|38296874|FG005|Overall Study|Withdrawal by Subject|3|||
17151437|NCT02077166|38296875|FG006|Overall Study|Withdrawal by Subject|0|||
17151438|NCT02077166|38296869|FG000|Overall Study|Other, Not Specified|0|||
17151439|NCT02077166|38296870|FG001|Overall Study|Other, Not Specified|0|||
17151440|NCT02077166|38296871|FG002|Overall Study|Other, Not Specified|1|||
17151441|NCT02077166|38296872|FG003|Overall Study|Other, Not Specified|0|||
17151442|NCT02077166|38296873|FG004|Overall Study|Other, Not Specified|1|||
17151443|NCT02077166|38296874|FG005|Overall Study|Other, Not Specified|7|||
17151444|NCT02077166|38296875|FG006|Overall Study|Other, Not Specified|8|||
17151445|NCT04273217|38296902|FG000|Overall Study|Lost to Follow-up|0|||
17151446|NCT04273217|38296903|FG001|Overall Study|Lost to Follow-up|0|||
17151447|NCT04273217|38296904|FG002|Overall Study|Lost to Follow-up|0|||
17151448|NCT04273217|38296905|FG003|Overall Study|Lost to Follow-up|0|||
17151449|NCT04273217|38296906|FG004|Overall Study|Lost to Follow-up|0|||
17151450|NCT04273217|38296907|FG005|Overall Study|Lost to Follow-up|1|||
17151451|NCT04273217|38296902|FG000|Overall Study|Participant non-compliance|0|||
17151452|NCT04273217|38296903|FG001|Overall Study|Participant non-compliance|0|||
17151453|NCT04273217|38296904|FG002|Overall Study|Participant non-compliance|0|||
17151454|NCT04273217|38296905|FG003|Overall Study|Participant non-compliance|0|||
17151455|NCT04273217|38296906|FG004|Overall Study|Participant non-compliance|1|||
17151456|NCT04273217|38296907|FG005|Overall Study|Participant non-compliance|0|||
17151457|NCT04273217|38296902|FG000|Overall Study|Positive urine drug screen|1|||
17151458|NCT04273217|38296903|FG001|Overall Study|Positive urine drug screen|0|||
17151459|NCT04273217|38296904|FG002|Overall Study|Positive urine drug screen|1|||
17151460|NCT04273217|38296905|FG003|Overall Study|Positive urine drug screen|0|||
17151461|NCT04273217|38296906|FG004|Overall Study|Positive urine drug screen|0|||
17151462|NCT04273217|38296907|FG005|Overall Study|Positive urine drug screen|1|||
17151463|NCT04384523|38296927|FG000|Overall Study|Lost to Follow-up|0|||
17151464|NCT04384523|38296928|FG001|Overall Study|Lost to Follow-up|0|||
17151465|NCT04384523|38296929|FG002|Overall Study|Lost to Follow-up|0|||
17151466|NCT04384523|38296930|FG003|Overall Study|Lost to Follow-up|0|||
17151467|NCT04384523|38296931|FG004|Overall Study|Lost to Follow-up|0|||
17151468|NCT04384523|38296932|FG005|Overall Study|Lost to Follow-up|1|||
17151469|NCT04384523|38296927|FG000|Overall Study|Protocol Violation|0|||
17151470|NCT04384523|38296928|FG001|Overall Study|Protocol Violation|1|||
17151471|NCT04384523|38296929|FG002|Overall Study|Protocol Violation|0|||
17151472|NCT04384523|38296930|FG003|Overall Study|Protocol Violation|0|||
17151473|NCT04384523|38296931|FG004|Overall Study|Protocol Violation|0|||
17151474|NCT04384523|38296932|FG005|Overall Study|Protocol Violation|0|||
17151475|NCT04384523|38296927|FG000|Overall Study|Withdrawal by Subject|1|||
17151476|NCT04384523|38296928|FG001|Overall Study|Withdrawal by Subject|0|||
17151477|NCT04384523|38296929|FG002|Overall Study|Withdrawal by Subject|0|||
17151478|NCT04384523|38296930|FG003|Overall Study|Withdrawal by Subject|0|||
17151479|NCT04384523|38296931|FG004|Overall Study|Withdrawal by Subject|0|||
17151480|NCT04384523|38296932|FG005|Overall Study|Withdrawal by Subject|0|||
17151481|NCT04382651|38296967|FG000|Overall Study|Death|26|||
17151482|NCT04382651|38296968|FG001|Overall Study|Death|23|||
17151483|NCT04382651|38296967|FG000|Overall Study|Lost to Follow-up|3|||
17151484|NCT04382651|38296968|FG001|Overall Study|Lost to Follow-up|4|||
17151485|NCT04382651|38296967|FG000|Overall Study|Withdrawal by Subject|2|||
17151486|NCT04382651|38296968|FG001|Overall Study|Withdrawal by Subject|0|||
17151487|NCT04382651|38296967|FG000|Overall Study|Physician Decision|0|||
17151488|NCT04382651|38296968|FG001|Overall Study|Physician Decision|1|||
17151489|NCT04238663|38296983|FG000|Overall Study|Lost to Follow-up|0|||
17151490|NCT04238663|38296984|FG001|Overall Study|Lost to Follow-up|1|||
17151491|NCT04238663|38296985|FG002|Overall Study|Lost to Follow-up|0|||
17151492|NCT03442088|38296993|FG000|Overall Study|Adverse Event|1|||
17151493|NCT03442088|38296993|FG000|Overall Study|Lack of Efficacy|2|||
17151494|NCT03442088|38296993|FG000|Overall Study|Lost to Follow-up|2|||
17151495|NCT04223687|38296999|FG000|Overall Study|Missing primary outcome|1|||
16781253|NCT02109484|37720411|FG002|Overall Study|Death|0|||
16781254|NCT02109484|37720412|FG003|Overall Study|Death|0|||
17151496|NCT04223687|38297000|FG001|Overall Study|Missing primary outcome|0|||
17151497|NCT03722576|38297006|FG000|Overall Study|Withdrawal by Subject|3|||
17151498|NCT03722576|38297006|FG000|Overall Study|Adverse Event|2|||
17151499|NCT03722576|38297006|FG000|Overall Study|Physician Decision|1|||
17151500|NCT03722576|38297006|FG000|Overall Study|Lost to Follow-up|1|||
17151501|NCT03693989|38297012|FG000|Overall Study|Protocol Violation|3|||
17151502|NCT03693989|38297013|FG001|Overall Study|Protocol Violation|4|||
17151503|NCT04206293|38297019|FG000|Overall Study|Consent withdrawal|1|||
17151504|NCT02727998|38297026|FG000|Overall Study|Lost to Follow-up|3|||
17151505|NCT02727998|38297027|FG001|Overall Study|Lost to Follow-up|3|||
17151506|NCT02727998|38297026|FG000|Overall Study|Withdrawal by Subject|0|||
17151507|NCT02727998|38297027|FG001|Overall Study|Withdrawal by Subject|1|||
17151508|NCT04366349|38297039|FG000|Overall Study|Withdrawal by Subject|1|||
17151509|NCT04366349|38297040|FG001|Overall Study|Withdrawal by Subject|0|||
17151510|NCT04366349|38297041|FG002|Overall Study|Withdrawal by Subject|0|||
17151511|NCT04366349|38297042|FG003|Overall Study|Withdrawal by Subject|0|||
17151512|NCT04366349|38297043|FG004|Overall Study|Withdrawal by Subject|0|||
17151513|NCT04366349|38297044|FG005|Overall Study|Withdrawal by Subject|0|||
17151514|NCT04179461|38297062|FG000|Overall Study|Lost to Follow-up|4|||
17151515|NCT04017611|38297066|FG000|Overall Study|Withdrawn prior to completion|1|||
17151516|NCT04172831|38297081|FG000|Overall Study|Adverse Event|21|||
17151517|NCT04172831|38297082|FG001|Overall Study|Adverse Event|9|||
17151518|NCT04172831|38297081|FG000|Overall Study|Lack of Efficacy|2|||
17151519|NCT04172831|38297082|FG001|Overall Study|Lack of Efficacy|8|||
17151520|NCT04172831|38297081|FG000|Overall Study|Physician Decision|0|||
17151521|NCT04172831|38297082|FG001|Overall Study|Physician Decision|1|||
17151522|NCT04172831|38297081|FG000|Overall Study|Withdrawal by Subject|12|||
17151523|NCT04172831|38297082|FG001|Overall Study|Withdrawal by Subject|11|||
17151524|NCT04172831|38297081|FG000|Overall Study|Lost to Follow-up|4|||
17151525|NCT04172831|38297082|FG001|Overall Study|Lost to Follow-up|9|||
17151526|NCT04172831|38297081|FG000|Overall Study|COVID-19 related crisis|3|||
17151527|NCT04172831|38297082|FG001|Overall Study|COVID-19 related crisis|3|||
17151528|NCT04172831|38297081|FG000|Overall Study|Subject non-compliance|1|||
17151529|NCT04172831|38297082|FG001|Overall Study|Subject non-compliance|1|||
17151530|NCT04172831|38297081|FG000|Overall Study|Family emergency|1|||
17151531|NCT04172831|38297082|FG001|Overall Study|Family emergency|0|||
17151532|NCT04165031|38297099|FG000|Overall Study|Adverse Event|1|||
17151533|NCT04165031|38297100|FG001|Overall Study|Adverse Event|1|||
17151534|NCT04165031|38297101|FG002|Overall Study|Adverse Event|0|||
17151535|NCT04165031|38297102|FG003|Overall Study|Adverse Event|0|||
17151536|NCT04165031|38297103|FG004|Overall Study|Adverse Event|0|||
17151537|NCT04165031|38297104|FG005|Overall Study|Adverse Event|0|||
17151538|NCT04165031|38297099|FG000|Overall Study|Withdrawal by Subject|0|||
17151539|NCT04165031|38297100|FG001|Overall Study|Withdrawal by Subject|0|||
17151540|NCT04165031|38297101|FG002|Overall Study|Withdrawal by Subject|1|||
17151541|NCT04165031|38297102|FG003|Overall Study|Withdrawal by Subject|0|||
17151542|NCT04165031|38297103|FG004|Overall Study|Withdrawal by Subject|0|||
17151543|NCT04165031|38297104|FG005|Overall Study|Withdrawal by Subject|0|||
17151544|NCT02712424|38297121|FG000|Overall Study|Lost to Follow-up|34|||
17151545|NCT02712424|38297122|FG001|Overall Study|Lost to Follow-up|32|||
17151546|NCT02968004|38297130|FG000|Overall Study|Adverse Event|1|||
17151547|NCT02968004|38297131|FG001|Overall Study|Adverse Event|0|||
17151548|NCT02968004|38297130|FG000|Overall Study|Withdrawal by Subject|0|||
17151549|NCT02968004|38297131|FG001|Overall Study|Withdrawal by Subject|1|||
17151550|NCT03034772|38297139|FG000|Overall Study|Adverse Event|0|||
17151551|NCT03034772|38297140|FG001|Overall Study|Adverse Event|1|||
17151552|NCT03034772|38297139|FG000|Overall Study|Withdrawal by Subject|0|||
17151553|NCT03034772|38297140|FG001|Overall Study|Withdrawal by Subject|1|||
17151554|NCT03032198|38297146|FG000|Overall Study|Screen Fail|1|||
17151555|NCT02431364|38297155|FG000|Overall Study|Adverse Event|0|||
17151556|NCT02431364|38297156|FG001|Overall Study|Adverse Event|1|||
17151557|NCT02431364|38297157|FG002|Overall Study|Adverse Event|0|||
17151558|NCT02431364|38297158|FG003|Overall Study|Adverse Event|0|||
17151559|NCT02431364|38297159|FG004|Overall Study|Adverse Event|0|||
17151560|NCT02431364|38297155|FG000|Overall Study|Randomized but never treated|0|||
17151561|NCT02431364|38297156|FG001|Overall Study|Randomized but never treated|0|||
17151562|NCT02431364|38297157|FG002|Overall Study|Randomized but never treated|0|||
17151563|NCT02431364|38297158|FG003|Overall Study|Randomized but never treated|1|||
17151564|NCT02431364|38297159|FG004|Overall Study|Randomized but never treated|0|||
17151565|NCT03034460|38297177|FG000|Overall Study|Adverse Event|0|||
17151566|NCT03034460|38297178|FG001|Overall Study|Adverse Event|1|||
17151567|NCT03034460|38297177|FG000|Overall Study|Withdrawal by Subject|2|||
17151568|NCT03034460|38297178|FG001|Overall Study|Withdrawal by Subject|2|||
17151569|NCT03034460|38297177|FG000|Overall Study|Personal Reasons|1|||
17151570|NCT03034460|38297178|FG001|Overall Study|Personal Reasons|0|||
17151571|NCT04162769|38297191|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
17151572|NCT04162769|38297192|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
17151573|NCT04162769|38297193|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
17151574|NCT04162769|38297194|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
17151575|NCT04162769|38297191|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
17151576|NCT04162769|38297192|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
17151577|NCT04162769|38297193|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
17151578|NCT04162769|38297194|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
17151579|NCT04162769|38297191|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
17151580|NCT04162769|38297192|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
17151581|NCT04162769|38297193|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
17151582|NCT04162769|38297194|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
17151583|NCT04162769|38297191|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
17151584|NCT04162769|38297192|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
17151585|NCT04162769|38297193|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
17071411|NCT00297232|38213947|FG000|Overall Study|Persistently Positive Antibodies|11|||
17071412|NCT00297232|38213947|FG000|Overall Study|Investigator Withdrew From Program|19|||
17071413|NCT00297232|38213947|FG000|Overall Study|Did Not Enroll to Week 264|34|||
17151586|NCT04162769|38297194|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
17151587|NCT04162769|38297191|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
17151588|NCT04162769|38297192|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
17151589|NCT04162769|38297193|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
17151590|NCT04162769|38297194|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
17151591|NCT04162769|38297191|FG000|Double-blind Treatment (12-Week)|Other|0|||
17151592|NCT04162769|38297192|FG001|Double-blind Treatment (12-Week)|Other|1|||
17151593|NCT04162769|38297193|FG002|Double-blind Treatment (12-Week)|Other|1|||
17151594|NCT04162769|38297194|FG003|Double-blind Treatment (12-Week)|Other|0|||
17151595|NCT04162769|38297191|FG000|OLE Period (52-Week)|Adverse Event|0|||
17151596|NCT04162769|38297192|FG001|OLE Period (52-Week)|Adverse Event|0|||
17151597|NCT04162769|38297193|FG002|OLE Period (52-Week)|Adverse Event|0|||
17151598|NCT04162769|38297194|FG003|OLE Period (52-Week)|Adverse Event|5|||
17151599|NCT04162769|38297191|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
17151600|NCT04162769|38297192|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
17151601|NCT04162769|38297193|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
17151602|NCT04162769|38297194|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
17151603|NCT04162769|38297191|FG000|OLE Period (52-Week)|Physician Decision|0|||
17151604|NCT04162769|38297192|FG001|OLE Period (52-Week)|Physician Decision|0|||
17151605|NCT04162769|38297193|FG002|OLE Period (52-Week)|Physician Decision|0|||
17151606|NCT04162769|38297194|FG003|OLE Period (52-Week)|Physician Decision|1|||
17151607|NCT04162769|38297191|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
17151608|NCT04162769|38297192|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
17151609|NCT04162769|38297193|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
17151610|NCT04162769|38297194|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
17151611|NCT04162769|38297191|FG000|OLE Period (52-Week)|Protocol deviation|0|||
17151612|NCT04162769|38297192|FG001|OLE Period (52-Week)|Protocol deviation|0|||
17151613|NCT04162769|38297193|FG002|OLE Period (52-Week)|Protocol deviation|0|||
17151614|NCT04162769|38297194|FG003|OLE Period (52-Week)|Protocol deviation|2|||
17151615|NCT04161131|38297205|FG000|Overall Study|Ineligible|2|||
17151616|NCT04161131|38297205|FG000|Overall Study|Lost to Follow-up|4|||
17151617|NCT04155047|38297211|FG000|Overall Study|Adverse Event|1|||
17151618|NCT04155047|38297212|FG001|Overall Study|Adverse Event|0|||
17151619|NCT04155047|38297211|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
17151620|NCT04155047|38297212|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
17151621|NCT04152083|38297220|FG000|Overall Study|Lost to Follow-up|2|||
17151622|NCT04152083|38297221|FG001|Overall Study|Lost to Follow-up|1|||
17151623|NCT04152083|38297220|FG000|Overall Study|Adverse Event|1|||
17071414|NCT00297232|38213947|FG000|Overall Study|Did Not Enroll to Week 480|17|||
17071415|NCT00297232|38213947|FG000|Overall Study|No data available after Week 264|161|||
17071416|NCT00297232|38213947|FG000|Overall Study|Other|1|||
17071417|NCT00449670|38213963|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
17071418|NCT00449670|38213964|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
17071419|NCT00449670|38213963|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
17071420|NCT00449670|38213964|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
17071421|NCT00449670|38213963|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
17071422|NCT00449670|38213964|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
17071423|NCT00449670|38213963|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
17071424|NCT00449670|38213964|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
17071425|NCT00449670|38213963|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
17071426|NCT00449670|38213964|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
17071427|NCT00449670|38213963|FG000|Booster Phase (Study no.109873)|Other|0|||
17071428|NCT00449670|38213964|FG001|Booster Phase (Study no.109873)|Other|2|||
17071429|NCT00296374|38213980|FG000|Overall Study|Adverse Event|14|||
17071430|NCT00296374|38213981|FG001|Overall Study|Adverse Event|10|||
17071431|NCT00296374|38213982|FG002|Overall Study|Adverse Event|7|||
17071432|NCT00296374|38213980|FG000|Overall Study|Withdrawal by Subject|3|||
17071433|NCT00296374|38213981|FG001|Overall Study|Withdrawal by Subject|5|||
17071434|NCT00296374|38213982|FG002|Overall Study|Withdrawal by Subject|11|||
17071435|NCT00296374|38213980|FG000|Overall Study|Incorrect enrollment|3|||
17071436|NCT00296374|38213981|FG001|Overall Study|Incorrect enrollment|3|||
17071437|NCT00296374|38213982|FG002|Overall Study|Incorrect enrollment|4|||
17071438|NCT00296374|38213980|FG000|Overall Study|Protocol Violation|1|||
17071439|NCT00296374|38213981|FG001|Overall Study|Protocol Violation|2|||
17071440|NCT00296374|38213982|FG002|Overall Study|Protocol Violation|3|||
17071441|NCT00296374|38213980|FG000|Overall Study|Lost to Follow-up|3|||
17071442|NCT00296374|38213981|FG001|Overall Study|Lost to Follow-up|1|||
17071443|NCT00296374|38213982|FG002|Overall Study|Lost to Follow-up|1|||
17071444|NCT00296374|38213980|FG000|Overall Study|Relocated to another state|1|||
17071445|NCT00296374|38213981|FG001|Overall Study|Relocated to another state|0|||
17071446|NCT00296374|38213982|FG002|Overall Study|Relocated to another state|0|||
17071447|NCT00296374|38213980|FG000|Overall Study|Stopped drug before end of study visit|0|||
17071448|NCT00296374|38213981|FG001|Overall Study|Stopped drug before end of study visit|1|||
17071449|NCT00296374|38213982|FG002|Overall Study|Stopped drug before end of study visit|0|||
17071450|NCT00296374|38213980|FG000|Overall Study|Nephrologist introduced ACE|0|||
17071451|NCT00296374|38213981|FG001|Overall Study|Nephrologist introduced ACE|1|||
17071452|NCT00296374|38213982|FG002|Overall Study|Nephrologist introduced ACE|0|||
17071453|NCT00296374|38213980|FG000|Overall Study|Pregnancy|0|||
17071454|NCT00296374|38213981|FG001|Overall Study|Pregnancy|0|||
17071455|NCT00296374|38213982|FG002|Overall Study|Pregnancy|2|||
17071456|NCT00296374|38213980|FG000|Overall Study|Other|0|||
17071457|NCT00296374|38213981|FG001|Overall Study|Other|0|||
17071458|NCT00296374|38213982|FG002|Overall Study|Other|1|||
17071459|NCT00326950|38214005|FG000|Overall Study|Progressive Disease|1|||
17071460|NCT00548717|38214011|FG000|Overall Study|Death|5|||
17071461|NCT00548717|38214012|FG001|Overall Study|Death|2|||
17071462|NCT00548717|38214011|FG000|Overall Study|Relapse|3|||
17071463|NCT00548717|38214012|FG001|Overall Study|Relapse|0|||
17071464|NCT00548717|38214011|FG000|Overall Study|Alternative treatment for GVHD|1|||
17071465|NCT00548717|38214012|FG001|Overall Study|Alternative treatment for GVHD|0|||
17071466|NCT00441168|38214023|FG000|Treatment Period|Death|3|||
17071467|NCT00441168|38214024|FG001|Treatment Period|Death|0|||
17071468|NCT00441168|38214023|FG000|Treatment Period|Adverse Event|1|||
17071469|NCT00441168|38214024|FG001|Treatment Period|Adverse Event|2|||
17071470|NCT00441168|38214023|FG000|Treatment Period|Progressive Disease|0|||
17071471|NCT00441168|38214024|FG001|Treatment Period|Progressive Disease|2|||
17071472|NCT00441168|38214023|FG000|Treatment Period|Protocol Violation|0|||
17071473|NCT00441168|38214024|FG001|Treatment Period|Protocol Violation|1|||
17071474|NCT00441168|38214023|FG000|Treatment Period|Lost to Follow-up|0|||
17071475|NCT00441168|38214024|FG001|Treatment Period|Lost to Follow-up|1|||
17071476|NCT00441168|38214023|FG000|Treatment Period|Withdrawal by Subject|3|||
17071477|NCT00441168|38214024|FG001|Treatment Period|Withdrawal by Subject|0|||
17071478|NCT00441168|38214023|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
17151624|NCT04152083|38297221|FG001|Overall Study|Adverse Event|0|||
17151625|NCT04152083|38297220|FG000|Overall Study|Randomized but not treated|3|||
17151626|NCT04152083|38297221|FG001|Overall Study|Randomized but not treated|2|||
17151627|NCT02711956|38297242|FG000|Overall Study|Adverse Event|0|||
17151628|NCT02711956|38297243|FG001|Overall Study|Adverse Event|0|||
17151629|NCT02711956|38297244|FG002|Overall Study|Adverse Event|0|||
17151630|NCT02711956|38297245|FG003|Overall Study|Adverse Event|1|||
17151631|NCT02711956|38297246|FG004|Overall Study|Adverse Event|2|||
17151632|NCT02711956|38297247|FG005|Overall Study|Adverse Event|0|||
17151633|NCT02711956|38297248|FG006|Overall Study|Adverse Event|0|||
17151634|NCT02711956|38297249|FG007|Overall Study|Adverse Event|1|||
17151635|NCT02711956|38297250|FG008|Overall Study|Adverse Event|1|||
17151636|NCT02711956|38297251|FG009|Overall Study|Adverse Event|1|||
17151637|NCT02711956|38297252|FG010|Overall Study|Adverse Event|1|||
17151638|NCT02711956|38297253|FG011|Overall Study|Adverse Event|0|||
17151639|NCT02711956|38297254|FG012|Overall Study|Adverse Event|0|||
17151640|NCT02711956|38297255|FG013|Overall Study|Adverse Event|0|||
17151641|NCT02711956|38297256|FG014|Overall Study|Adverse Event|2|||
17151642|NCT02711956|38297242|FG000|Overall Study|Physician Decision|0|||
17151643|NCT02711956|38297243|FG001|Overall Study|Physician Decision|0|||
17151644|NCT02711956|38297244|FG002|Overall Study|Physician Decision|0|||
17151645|NCT02711956|38297245|FG003|Overall Study|Physician Decision|2|||
17151646|NCT02711956|38297246|FG004|Overall Study|Physician Decision|0|||
17151647|NCT02711956|38297247|FG005|Overall Study|Physician Decision|0|||
17151648|NCT02711956|38297248|FG006|Overall Study|Physician Decision|0|||
17151649|NCT02711956|38297249|FG007|Overall Study|Physician Decision|0|||
17151650|NCT02711956|38297250|FG008|Overall Study|Physician Decision|0|||
17151651|NCT02711956|38297251|FG009|Overall Study|Physician Decision|0|||
17151652|NCT02711956|38297252|FG010|Overall Study|Physician Decision|0|||
17071479|NCT00441168|38214024|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
17071480|NCT00441168|38214023|FG000|Treatment Period|refractory disease|1|||
17151653|NCT02711956|38297253|FG011|Overall Study|Physician Decision|0|||
17151654|NCT02711956|38297254|FG012|Overall Study|Physician Decision|0|||
17151655|NCT02711956|38297255|FG013|Overall Study|Physician Decision|0|||
17151656|NCT02711956|38297256|FG014|Overall Study|Physician Decision|0|||
17151657|NCT02711956|38297242|FG000|Overall Study|Withdrawal by Subject|0|||
17151658|NCT02711956|38297243|FG001|Overall Study|Withdrawal by Subject|0|||
17151659|NCT02711956|38297244|FG002|Overall Study|Withdrawal by Subject|0|||
17151660|NCT02711956|38297245|FG003|Overall Study|Withdrawal by Subject|0|||
17151661|NCT02711956|38297246|FG004|Overall Study|Withdrawal by Subject|0|||
17151662|NCT02711956|38297247|FG005|Overall Study|Withdrawal by Subject|0|||
17151663|NCT02711956|38297248|FG006|Overall Study|Withdrawal by Subject|1|||
17151664|NCT02711956|38297249|FG007|Overall Study|Withdrawal by Subject|0|||
17151665|NCT02711956|38297250|FG008|Overall Study|Withdrawal by Subject|0|||
17151666|NCT02711956|38297251|FG009|Overall Study|Withdrawal by Subject|0|||
17151667|NCT02711956|38297252|FG010|Overall Study|Withdrawal by Subject|0|||
17151668|NCT02711956|38297253|FG011|Overall Study|Withdrawal by Subject|1|||
17151669|NCT02711956|38297254|FG012|Overall Study|Withdrawal by Subject|6|||
17151670|NCT02711956|38297255|FG013|Overall Study|Withdrawal by Subject|0|||
17151671|NCT02711956|38297256|FG014|Overall Study|Withdrawal by Subject|1|||
17151672|NCT02711956|38297242|FG000|Overall Study|Clinical progression|1|||
17151673|NCT02711956|38297243|FG001|Overall Study|Clinical progression|0|||
17151674|NCT02711956|38297244|FG002|Overall Study|Clinical progression|0|||
17151675|NCT02711956|38297245|FG003|Overall Study|Clinical progression|0|||
17151676|NCT02711956|38297246|FG004|Overall Study|Clinical progression|0|||
17151677|NCT02711956|38297247|FG005|Overall Study|Clinical progression|0|||
17151678|NCT02711956|38297248|FG006|Overall Study|Clinical progression|1|||
17151679|NCT02711956|38297249|FG007|Overall Study|Clinical progression|0|||
17151680|NCT02711956|38297250|FG008|Overall Study|Clinical progression|1|||
17151681|NCT02711956|38297251|FG009|Overall Study|Clinical progression|0|||
17151682|NCT02711956|38297252|FG010|Overall Study|Clinical progression|0|||
17151683|NCT02711956|38297253|FG011|Overall Study|Clinical progression|2|||
17151684|NCT02711956|38297254|FG012|Overall Study|Clinical progression|4|||
17151685|NCT02711956|38297255|FG013|Overall Study|Clinical progression|1|||
17151686|NCT02711956|38297256|FG014|Overall Study|Clinical progression|1|||
17151687|NCT02711956|38297242|FG000|Overall Study|Radiographic progression|1|||
17151688|NCT02711956|38297243|FG001|Overall Study|Radiographic progression|1|||
17151689|NCT02711956|38297244|FG002|Overall Study|Radiographic progression|2|||
17151690|NCT02711956|38297245|FG003|Overall Study|Radiographic progression|0|||
17151691|NCT02711956|38297246|FG004|Overall Study|Radiographic progression|1|||
17151692|NCT02711956|38297247|FG005|Overall Study|Radiographic progression|0|||
17151693|NCT02711956|38297248|FG006|Overall Study|Radiographic progression|0|||
17151694|NCT02711956|38297249|FG007|Overall Study|Radiographic progression|0|||
17151695|NCT02711956|38297250|FG008|Overall Study|Radiographic progression|2|||
17151696|NCT02711956|38297251|FG009|Overall Study|Radiographic progression|1|||
17151697|NCT02711956|38297252|FG010|Overall Study|Radiographic progression|0|||
17151698|NCT02711956|38297253|FG011|Overall Study|Radiographic progression|5|||
17151699|NCT02711956|38297254|FG012|Overall Study|Radiographic progression|3|||
17151700|NCT02711956|38297255|FG013|Overall Study|Radiographic progression|0|||
17151701|NCT02711956|38297256|FG014|Overall Study|Radiographic progression|1|||
17151702|NCT02711956|38297242|FG000|Overall Study|PSA progression with clinical progression|0|||
17151703|NCT02711956|38297243|FG001|Overall Study|PSA progression with clinical progression|0|||
17151704|NCT02711956|38297244|FG002|Overall Study|PSA progression with clinical progression|0|||
17151705|NCT02711956|38297245|FG003|Overall Study|PSA progression with clinical progression|0|||
17151706|NCT02711956|38297246|FG004|Overall Study|PSA progression with clinical progression|1|||
17151707|NCT02711956|38297247|FG005|Overall Study|PSA progression with clinical progression|0|||
17151708|NCT02711956|38297248|FG006|Overall Study|PSA progression with clinical progression|0|||
17151709|NCT02711956|38297249|FG007|Overall Study|PSA progression with clinical progression|0|||
17151710|NCT02711956|38297250|FG008|Overall Study|PSA progression with clinical progression|0|||
17151711|NCT02711956|38297251|FG009|Overall Study|PSA progression with clinical progression|0|||
17151712|NCT02711956|38297252|FG010|Overall Study|PSA progression with clinical progression|0|||
17151713|NCT02711956|38297253|FG011|Overall Study|PSA progression with clinical progression|0|||
17151714|NCT02711956|38297254|FG012|Overall Study|PSA progression with clinical progression|1|||
17151715|NCT02711956|38297255|FG013|Overall Study|PSA progression with clinical progression|1|||
17151716|NCT02711956|38297256|FG014|Overall Study|PSA progression with clinical progression|0|||
17151717|NCT02711956|38297242|FG000|Overall Study|PSA progression with radiographic progression|0|||
17151718|NCT02711956|38297243|FG001|Overall Study|PSA progression with radiographic progression|1|||
17151719|NCT02711956|38297244|FG002|Overall Study|PSA progression with radiographic progression|0|||
17151720|NCT02711956|38297245|FG003|Overall Study|PSA progression with radiographic progression|0|||
17151721|NCT02711956|38297246|FG004|Overall Study|PSA progression with radiographic progression|0|||
17151722|NCT02711956|38297247|FG005|Overall Study|PSA progression with radiographic progression|2|||
17151723|NCT02711956|38297248|FG006|Overall Study|PSA progression with radiographic progression|2|||
17151724|NCT02711956|38297249|FG007|Overall Study|PSA progression with radiographic progression|1|||
17151725|NCT02711956|38297250|FG008|Overall Study|PSA progression with radiographic progression|0|||
17151726|NCT02711956|38297251|FG009|Overall Study|PSA progression with radiographic progression|1|||
17151727|NCT02711956|38297252|FG010|Overall Study|PSA progression with radiographic progression|0|||
17151728|NCT02711956|38297253|FG011|Overall Study|PSA progression with radiographic progression|1|||
17151729|NCT02711956|38297254|FG012|Overall Study|PSA progression with radiographic progression|2|||
17151730|NCT02711956|38297255|FG013|Overall Study|PSA progression with radiographic progression|3|||
17151731|NCT02711956|38297256|FG014|Overall Study|PSA progression with radiographic progression|3|||
17151732|NCT04149353|38297297|FG000|Overall Study|Study terminated|1|||
17151733|NCT02711800|38297302|FG000|Overall Study|Lost to Follow-up|1|||
17151734|NCT02711800|38297302|FG000|Overall Study|Withdrawal by Subject|1|||
17151735|NCT03031496|38297306|FG000|Period 1|Adverse Event|2|||
17151736|NCT03031496|38297307|FG001|Period 1|Adverse Event|0|||
17151737|NCT03031496|38297306|FG000|Period 1|Withdrawal by Subject|0|||
17151738|NCT03031496|38297307|FG001|Period 1|Withdrawal by Subject|2|||
17151739|NCT02659020|38297320|FG000|Overall Study|Adverse Event|0|||
17151740|NCT02659020|38297321|FG001|Overall Study|Adverse Event|0|||
17151741|NCT02659020|38297322|FG002|Overall Study|Adverse Event|0|||
17151742|NCT02659020|38297323|FG003|Overall Study|Adverse Event|2|||
17151743|NCT02659020|38297324|FG004|Overall Study|Adverse Event|0|||
17151744|NCT02659020|38297325|FG005|Overall Study|Adverse Event|0|||
17151745|NCT02659020|38297326|FG006|Overall Study|Adverse Event|2|||
17151746|NCT02659020|38297320|FG000|Overall Study|Lost to Follow-up|1|||
17151747|NCT02659020|38297321|FG001|Overall Study|Lost to Follow-up|2|||
17151748|NCT02659020|38297322|FG002|Overall Study|Lost to Follow-up|1|||
17151749|NCT02659020|38297323|FG003|Overall Study|Lost to Follow-up|6|||
17151750|NCT02659020|38297324|FG004|Overall Study|Lost to Follow-up|1|||
17151751|NCT02659020|38297325|FG005|Overall Study|Lost to Follow-up|5|||
17151752|NCT02659020|38297326|FG006|Overall Study|Lost to Follow-up|0|||
17151753|NCT02659020|38297320|FG000|Overall Study|Physician Decision|0|||
17151754|NCT02659020|38297321|FG001|Overall Study|Physician Decision|0|||
17151755|NCT02659020|38297322|FG002|Overall Study|Physician Decision|0|||
17151756|NCT02659020|38297323|FG003|Overall Study|Physician Decision|1|||
17151757|NCT02659020|38297324|FG004|Overall Study|Physician Decision|1|||
17151758|NCT02659020|38297325|FG005|Overall Study|Physician Decision|0|||
17151759|NCT02659020|38297326|FG006|Overall Study|Physician Decision|1|||
17151760|NCT02659020|38297320|FG000|Overall Study|Withdrawal by Subject|2|||
17151761|NCT02659020|38297321|FG001|Overall Study|Withdrawal by Subject|1|||
17151762|NCT02659020|38297322|FG002|Overall Study|Withdrawal by Subject|0|||
17151763|NCT02659020|38297323|FG003|Overall Study|Withdrawal by Subject|3|||
17151764|NCT02659020|38297324|FG004|Overall Study|Withdrawal by Subject|3|||
17151765|NCT02659020|38297325|FG005|Overall Study|Withdrawal by Subject|6|||
17151766|NCT02659020|38297326|FG006|Overall Study|Withdrawal by Subject|3|||
17151767|NCT02659020|38297320|FG000|Overall Study|Progressive Disease|0|||
17151768|NCT02659020|38297321|FG001|Overall Study|Progressive Disease|0|||
17151769|NCT02659020|38297322|FG002|Overall Study|Progressive Disease|0|||
17151770|NCT02659020|38297323|FG003|Overall Study|Progressive Disease|4|||
17151771|NCT02659020|38297324|FG004|Overall Study|Progressive Disease|1|||
17151772|NCT02659020|38297325|FG005|Overall Study|Progressive Disease|0|||
17151773|NCT02659020|38297326|FG006|Overall Study|Progressive Disease|2|||
17151774|NCT03482011|38297351|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
17151775|NCT03482011|38297352|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
17151776|NCT03482011|38297353|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
17151777|NCT03482011|38297354|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
17151778|NCT03482011|38297355|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
17151779|NCT03482011|38297356|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
17151780|NCT03482011|38297357|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
17151781|NCT03482011|38297358|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
17151782|NCT03482011|38297351|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
17151783|NCT03482011|38297352|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
17151784|NCT03482011|38297353|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17151785|NCT03482011|38297354|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17151786|NCT03482011|38297355|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17151787|NCT03482011|38297356|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17151788|NCT03482011|38297357|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17151789|NCT03482011|38297358|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17151790|NCT03482011|38297351|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
17151791|NCT03482011|38297352|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
17151792|NCT03482011|38297353|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
17151793|NCT03482011|38297354|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
17151794|NCT03482011|38297355|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
17151795|NCT03482011|38297356|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
17151796|NCT03482011|38297357|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
17151797|NCT03482011|38297358|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
17151798|NCT03482011|38297351|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
17151799|NCT03482011|38297352|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
17151800|NCT03482011|38297353|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
17151801|NCT03482011|38297354|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
17151802|NCT03482011|38297355|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
17151803|NCT03482011|38297356|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
17151804|NCT03482011|38297357|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
17151805|NCT03482011|38297358|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
17151806|NCT03482011|38297351|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
17151807|NCT03482011|38297352|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
17151808|NCT03482011|38297353|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17071481|NCT00441168|38214024|FG001|Treatment Period|refractory disease|0|||
17071482|NCT00441168|38214023|FG000|Follow-up Period|Death|3|||
17071483|NCT00441168|38214024|FG001|Follow-up Period|Death|0|||
17071484|NCT00441168|38214023|FG000|Follow-up Period|Lost to Follow-up|5|||
17071485|NCT00441168|38214024|FG001|Follow-up Period|Lost to Follow-up|6|||
17071486|NCT00441168|38214023|FG000|Follow-up Period|Withdrawal by Subject|3|||
17151809|NCT03482011|38297354|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17151810|NCT03482011|38297355|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17151811|NCT03482011|38297356|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17151812|NCT03482011|38297357|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17151813|NCT03482011|38297358|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17151814|NCT03482011|38297351|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
17151815|NCT03482011|38297352|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
17151816|NCT03482011|38297353|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
17151817|NCT03482011|38297354|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
17151818|NCT03482011|38297355|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
17151819|NCT03482011|38297356|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
17151820|NCT03482011|38297357|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
17151821|NCT03482011|38297358|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
17151822|NCT03482011|38297351|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
17151823|NCT03482011|38297352|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
17151824|NCT03482011|38297353|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
17151825|NCT03482011|38297354|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
17151826|NCT03482011|38297355|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
17151827|NCT03482011|38297356|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
17151828|NCT03482011|38297357|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
17151829|NCT03482011|38297358|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
17151830|NCT03482011|38297351|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17151831|NCT03482011|38297352|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17151832|NCT03482011|38297353|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17151833|NCT03482011|38297354|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17151834|NCT03482011|38297355|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
17151835|NCT03482011|38297356|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17151836|NCT03482011|38297357|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17151837|NCT03482011|38297358|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
17151838|NCT03482011|38297351|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
17151839|NCT03482011|38297352|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
17151840|NCT03482011|38297353|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
17151841|NCT03482011|38297354|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
17151842|NCT03482011|38297355|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
17151843|NCT03482011|38297356|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
17151844|NCT03482011|38297357|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
17151845|NCT03482011|38297358|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
17151846|NCT03482011|38297351|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17151847|NCT03482011|38297352|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17151848|NCT03482011|38297353|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17151849|NCT03482011|38297354|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
17151850|NCT03482011|38297355|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
17151851|NCT03482011|38297356|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
17151852|NCT03482011|38297357|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
17151853|NCT03482011|38297358|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
17071487|NCT00441168|38214024|FG001|Follow-up Period|Withdrawal by Subject|0|||
17071488|NCT00441168|38214023|FG000|Follow-up Period|Other|1|||
17071489|NCT00441168|38214024|FG001|Follow-up Period|Other|3|||
17071490|NCT00296140|38214032|FG000|Overall Study|Lost to Follow-up|1|||
17071491|NCT00296140|38214033|FG001|Overall Study|Lost to Follow-up|0|||
17071492|NCT00296140|38214032|FG000|Overall Study|Withdrawal by Subject|1|||
17071493|NCT00296140|38214033|FG001|Overall Study|Withdrawal by Subject|0|||
17071494|NCT00296140|38214032|FG000|Overall Study|Discharge to Nursing Home|1|||
17071495|NCT00296140|38214033|FG001|Overall Study|Discharge to Nursing Home|0|||
17071496|NCT03958331|38214042|FG000|Overall Study|Withdrawal by Subject|3|||
17071497|NCT03958331|38214043|FG001|Overall Study|Withdrawal by Subject|1|||
17071498|NCT03958331|38214044|FG002|Overall Study|Withdrawal by Subject|5|||
17071499|NCT03958331|38214042|FG000|Overall Study|Weaned from medicine|2|||
17071500|NCT03958331|38214043|FG001|Overall Study|Weaned from medicine|0|||
17071501|NCT03958331|38214044|FG002|Overall Study|Weaned from medicine|0|||
17151854|NCT03482011|38297351|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17151855|NCT03482011|38297352|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17151856|NCT03482011|38297353|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17151857|NCT03482011|38297354|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
17151858|NCT03482011|38297355|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
17151859|NCT03482011|38297356|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
17151860|NCT03482011|38297357|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
17151861|NCT03482011|38297358|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
17151862|NCT03482011|38297351|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
17151863|NCT03482011|38297352|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
17151864|NCT03482011|38297353|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
17151865|NCT03482011|38297354|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
17151866|NCT03482011|38297355|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
17151867|NCT03482011|38297356|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
17151868|NCT03482011|38297357|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
17151869|NCT03482011|38297358|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
17151870|NCT03482011|38297351|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
17151871|NCT03482011|38297352|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
17151872|NCT03482011|38297353|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
17151873|NCT03482011|38297354|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
17151874|NCT03482011|38297355|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
17151875|NCT03482011|38297356|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
17151876|NCT03482011|38297357|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
17151877|NCT03482011|38297358|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
17151878|NCT03482011|38297351|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
17151879|NCT03482011|38297352|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
17151880|NCT03482011|38297353|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
17151881|NCT03482011|38297354|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
17151882|NCT03482011|38297355|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
17151883|NCT03482011|38297356|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
17151884|NCT03482011|38297357|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
17151885|NCT03482011|38297358|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
17151886|NCT03482011|38297351|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
17151887|NCT03482011|38297352|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
17151888|NCT03482011|38297353|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
17151889|NCT03482011|38297354|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
17151890|NCT03482011|38297355|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
17151891|NCT03482011|38297356|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
17151892|NCT03482011|38297357|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
17151893|NCT03482011|38297358|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
17151894|NCT03481309|38297389|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
17151895|NCT03481309|38297390|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
17151896|NCT03481309|38297391|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
17151897|NCT03481309|38297392|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
17151898|NCT03481309|38297393|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
17151899|NCT03481309|38297394|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
17151900|NCT03480841|38297402|FG000|Overall Study|Lost to Follow-up|2|||
17151901|NCT02709538|38297409|FG000|Overall Study|Adverse Event|13|||
17151902|NCT02709538|38297410|FG001|Overall Study|Adverse Event|2|||
17151903|NCT02709538|38297411|FG002|Overall Study|Adverse Event|3|||
17151904|NCT02709538|38297409|FG000|Overall Study|Lack of Efficacy|1|||
17151905|NCT02709538|38297410|FG001|Overall Study|Lack of Efficacy|0|||
17151906|NCT02709538|38297411|FG002|Overall Study|Lack of Efficacy|0|||
17151907|NCT02709538|38297409|FG000|Overall Study|Lost to Follow-up|24|||
17151908|NCT02709538|38297410|FG001|Overall Study|Lost to Follow-up|8|||
17151909|NCT02709538|38297411|FG002|Overall Study|Lost to Follow-up|4|||
17151910|NCT02709538|38297409|FG000|Overall Study|Physician Decision|1|||
17151911|NCT02709538|38297410|FG001|Overall Study|Physician Decision|0|||
17151912|NCT02709538|38297411|FG002|Overall Study|Physician Decision|0|||
17151913|NCT02709538|38297409|FG000|Overall Study|Withdrawal by Subject|40|||
17151914|NCT02709538|38297410|FG001|Overall Study|Withdrawal by Subject|7|||
17151915|NCT02709538|38297411|FG002|Overall Study|Withdrawal by Subject|4|||
17151916|NCT02709538|38297409|FG000|Overall Study|Non-compliance with study procedures|5|||
17151917|NCT02709538|38297410|FG001|Overall Study|Non-compliance with study procedures|0|||
17151918|NCT02709538|38297411|FG002|Overall Study|Non-compliance with study procedures|0|||
17151919|NCT02709538|38297409|FG000|Overall Study|Non-compliance with study drug|2|||
17151920|NCT02709538|38297410|FG001|Overall Study|Non-compliance with study drug|0|||
17151921|NCT02709538|38297411|FG002|Overall Study|Non-compliance with study drug|0|||
17151922|NCT02709538|38297409|FG000|Overall Study|Protocol deviation|10|||
17151923|NCT02709538|38297410|FG001|Overall Study|Protocol deviation|4|||
17151924|NCT02709538|38297411|FG002|Overall Study|Protocol deviation|4|||
17151925|NCT02709538|38297409|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
17151926|NCT02709538|38297410|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
17151927|NCT02709538|38297411|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
17151928|NCT02709538|38297409|FG000|Overall Study|Other|16|||
17151929|NCT02709538|38297410|FG001|Overall Study|Other|7|||
17151930|NCT02709538|38297411|FG002|Overall Study|Other|5|||
17151931|NCT03789318|38297424|FG000|Overall Study|Adverse Event|0|||
17151932|NCT03789318|38297425|FG001|Overall Study|Adverse Event|0|||
17151933|NCT03789318|38297426|FG002|Overall Study|Adverse Event|1|||
17151934|NCT03789318|38297427|FG003|Overall Study|Adverse Event|1|||
17151935|NCT03789318|38297428|FG004|Overall Study|Adverse Event|0|||
17151936|NCT03789318|38297424|FG000|Overall Study|Lost to Follow-up|0|||
17151937|NCT03789318|38297425|FG001|Overall Study|Lost to Follow-up|0|||
17151938|NCT03789318|38297426|FG002|Overall Study|Lost to Follow-up|1|||
17151939|NCT03789318|38297427|FG003|Overall Study|Lost to Follow-up|0|||
17151940|NCT03789318|38297428|FG004|Overall Study|Lost to Follow-up|0|||
17151941|NCT03789318|38297424|FG000|Overall Study|Withdrawal by Subject|0|||
17151942|NCT03789318|38297425|FG001|Overall Study|Withdrawal by Subject|0|||
17151943|NCT03789318|38297426|FG002|Overall Study|Withdrawal by Subject|1|||
17151944|NCT03789318|38297427|FG003|Overall Study|Withdrawal by Subject|0|||
17151945|NCT03789318|38297428|FG004|Overall Study|Withdrawal by Subject|0|||
17151946|NCT00511134|38297446|FG000|Overall Study|Withdrawal by Subject|0|||
17151947|NCT00511134|38297447|FG001|Overall Study|Withdrawal by Subject|2|||
17151948|NCT01372384|38297453|FG000|Overall Study|Progression of disease|3|||
17151949|NCT03115476|38297460|FG000|LP0084-1369|Death|1|||
17071502|NCT03958331|38214042|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
17071503|NCT03958331|38214043|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
17071504|NCT03958331|38214044|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
17071505|NCT03956615|38214050|FG000|Overall Study|No multiple myeloma confirmed|2|||
17071506|NCT03956615|38214050|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
17071507|NCT03956615|38214050|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
17071508|NCT03956615|38214050|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
17071509|NCT03956225|38214056|FG000|Overall Study|Lack of Efficacy|1|||
17071510|NCT03956225|38214057|FG001|Overall Study|Lack of Efficacy|1|||
17071511|NCT03956225|38214056|FG000|Overall Study|Lost to Follow-up|0|||
17071512|NCT03956225|38214057|FG001|Overall Study|Lost to Follow-up|1|||
17071513|NCT03956225|38214056|FG000|Overall Study|Withdrawal by Subject|2|||
17071514|NCT03956225|38214057|FG001|Overall Study|Withdrawal by Subject|1|||
17071515|NCT03956225|38214056|FG000|Overall Study|Other Reasons|2|||
17071516|NCT03956225|38214057|FG001|Overall Study|Other Reasons|1|||
17071517|NCT00457626|38214066|FG000|Overall Study|Adverse Event|3|||
17071518|NCT00457626|38214066|FG000|Overall Study|Administrative Problems|2|||
17071519|NCT00457626|38214066|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
17071520|NCT00373113|38214072|FG000|Overall Study|Death|1|||
17071521|NCT00373113|38214073|FG001|Overall Study|Death|7|||
17151950|NCT03115476|38297461|FG001|LP0084-1369|Death|0|||
17151951|NCT03115476|38297462|FG002|LP0084-1369|Death|2|||
17151952|NCT03115476|38297460|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
17151953|NCT03115476|38297461|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
17151954|NCT03115476|38297462|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
17151955|NCT03480763|38297472|FG000|Overall Study|Withdrawal by Subject|18|||
17151956|NCT03480763|38297473|FG001|Overall Study|Withdrawal by Subject|10|||
17151957|NCT03480763|38297472|FG000|Overall Study|Lost to Follow-up|4|||
17151958|NCT03480763|38297473|FG001|Overall Study|Lost to Follow-up|7|||
17151959|NCT03480763|38297472|FG000|Overall Study|non-study pneumococcal vaccine|1|||
17151960|NCT03480763|38297473|FG001|Overall Study|non-study pneumococcal vaccine|0|||
17151961|NCT03480763|38297472|FG000|Overall Study|oncological treatment|0|||
17151962|NCT03480763|38297473|FG001|Overall Study|oncological treatment|2|||
17151963|NCT03480763|38297472|FG000|Overall Study|pain with vaccination|1|||
17151964|NCT03480763|38297473|FG001|Overall Study|pain with vaccination|0|||
17151965|NCT03123120|38297487|FG000|Overall Study|Lost to Follow-up|0|||
17151966|NCT03123120|38297488|FG001|Overall Study|Lost to Follow-up|1|||
17151967|NCT03123120|38297487|FG000|Overall Study|Withdrawal by Subject|0|||
17151968|NCT03123120|38297488|FG001|Overall Study|Withdrawal by Subject|1|||
17151969|NCT01319994|38297498|FG000|Overall Study|Protocol Violation|7|||
17151970|NCT01319994|38297499|FG001|Overall Study|Protocol Violation|6|||
17151971|NCT03453151|38297509|FG000|Overall Study|Withdrawal by Subject|1|||
17151972|NCT03453151|38297509|FG000|Overall Study|Physician Decision|3|||
17151973|NCT02887248|38297513|FG000|Overall Study|Withdrawal by Subject|1|||
17151974|NCT02887248|38297513|FG000|Overall Study|Adverse Event|1|||
17151975|NCT02887248|38297513|FG000|Overall Study|Progressive Disease|1|||
17151976|NCT03452527|38297519|FG000|Overall Study|Withdrawal by Subject|1|||
17151977|NCT03452527|38297520|FG001|Overall Study|Withdrawal by Subject|1|||
17151978|NCT03452527|38297519|FG000|Overall Study|Study Terminated|2|||
17071522|NCT00373113|38214072|FG000|Overall Study|Adverse Event|38|||
17071523|NCT00373113|38214073|FG001|Overall Study|Adverse Event|24|||
17071524|NCT00373113|38214072|FG000|Overall Study|Study terminated by sponsor|9|||
17071525|NCT00373113|38214073|FG001|Overall Study|Study terminated by sponsor|1|||
17151979|NCT03452527|38297520|FG001|Overall Study|Study Terminated|3|||
17151980|NCT03028142|38297526|FG000|Overall Study|Adverse Event|1|||
17151981|NCT03028142|38297527|FG001|Overall Study|Adverse Event|1|||
17151982|NCT03028142|38297528|FG002|Overall Study|Adverse Event|0|||
17151983|NCT03028142|38297529|FG003|Overall Study|Adverse Event|0|||
17151984|NCT03028142|38297530|FG004|Overall Study|Adverse Event|0|||
17151985|NCT03028142|38297531|FG005|Overall Study|Adverse Event|1|||
17151986|NCT03028142|38297526|FG000|Overall Study|Withdrawal by Subject|0|||
17151987|NCT03028142|38297527|FG001|Overall Study|Withdrawal by Subject|0|||
17151988|NCT03028142|38297528|FG002|Overall Study|Withdrawal by Subject|0|||
17151989|NCT03028142|38297529|FG003|Overall Study|Withdrawal by Subject|0|||
17151990|NCT03028142|38297530|FG004|Overall Study|Withdrawal by Subject|1|||
17151991|NCT03028142|38297531|FG005|Overall Study|Withdrawal by Subject|0|||
17151992|NCT03122886|38297542|FG000|Overall Study|Withdrawal by Subject|1|||
17151993|NCT03122886|38297543|FG001|Overall Study|Withdrawal by Subject|2|||
17151994|NCT02708524|38297553|FG000|Overall Study|Adverse Event|0|||
17151995|NCT02708524|38297554|FG001|Overall Study|Adverse Event|1|||
17151996|NCT02708524|38297555|FG002|Overall Study|Adverse Event|0|||
17151997|NCT02708524|38297556|FG003|Overall Study|Adverse Event|0|||
17151998|NCT02708524|38297553|FG000|Overall Study|Lens Discomfort|1|||
17151999|NCT02708524|38297554|FG001|Overall Study|Lens Discomfort|0|||
17152000|NCT02708524|38297555|FG002|Overall Study|Lens Discomfort|1|||
17152001|NCT02708524|38297556|FG003|Overall Study|Lens Discomfort|0|||
17152002|NCT02708524|38297553|FG000|Overall Study|Lost to Follow-up|1|||
17152003|NCT02708524|38297554|FG001|Overall Study|Lost to Follow-up|1|||
17152004|NCT02708524|38297555|FG002|Overall Study|Lost to Follow-up|1|||
17152005|NCT02708524|38297556|FG003|Overall Study|Lost to Follow-up|0|||
17152006|NCT02708524|38297553|FG000|Overall Study|Protocol Violation|0|||
17152007|NCT02708524|38297554|FG001|Overall Study|Protocol Violation|1|||
17152008|NCT02708524|38297555|FG002|Overall Study|Protocol Violation|0|||
17152009|NCT02708524|38297556|FG003|Overall Study|Protocol Violation|0|||
17152010|NCT02708524|38297553|FG000|Overall Study|Withdrawal by Subject|1|||
17152011|NCT02708524|38297554|FG001|Overall Study|Withdrawal by Subject|1|||
17152012|NCT02708524|38297555|FG002|Overall Study|Withdrawal by Subject|0|||
17152013|NCT02708524|38297556|FG003|Overall Study|Withdrawal by Subject|0|||
17152014|NCT02708524|38297553|FG000|Overall Study|Dispensed incorrect study lens|0|||
17152015|NCT02708524|38297554|FG001|Overall Study|Dispensed incorrect study lens|1|||
17152016|NCT02708524|38297555|FG002|Overall Study|Dispensed incorrect study lens|1|||
17152017|NCT02708524|38297556|FG003|Overall Study|Dispensed incorrect study lens|0|||
17152018|NCT02708524|38297553|FG000|Overall Study|Did not wear lens at final visit|0|||
17152019|NCT02708524|38297554|FG001|Overall Study|Did not wear lens at final visit|1|||
17152020|NCT02708524|38297555|FG002|Overall Study|Did not wear lens at final visit|0|||
17152021|NCT02708524|38297556|FG003|Overall Study|Did not wear lens at final visit|0|||
17152022|NCT02708524|38297553|FG000|Overall Study|Subject lost study lens|1|||
17152023|NCT02708524|38297554|FG001|Overall Study|Subject lost study lens|0|||
17152024|NCT02708524|38297555|FG002|Overall Study|Subject lost study lens|0|||
17152025|NCT02708524|38297556|FG003|Overall Study|Subject lost study lens|0|||
17152026|NCT03418675|38297568|FG000|Overall Study|Lost to Follow-up|13|||
17152027|NCT03418675|38297569|FG001|Overall Study|Lost to Follow-up|10|||
17152028|NCT03418675|38297568|FG000|Overall Study|Adverse Event|2|||
17152029|NCT03418675|38297569|FG001|Overall Study|Adverse Event|0|||
17152030|NCT03417505|38297575|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
17152031|NCT03417505|38297576|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
17152032|NCT02953639|38297585|FG000|Overall Study|Adverse Event|2|||
17152033|NCT02953639|38297586|FG001|Overall Study|Adverse Event|0|||
17152034|NCT02953639|38297587|FG002|Overall Study|Adverse Event|1|||
17152035|NCT02953639|38297585|FG000|Overall Study|Lost to Follow-up|8|||
17152036|NCT02953639|38297586|FG001|Overall Study|Lost to Follow-up|4|||
17152037|NCT02953639|38297587|FG002|Overall Study|Lost to Follow-up|3|||
17152038|NCT02953639|38297585|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17152039|NCT02953639|38297586|FG001|Overall Study|Non-Compliance With Study Drug|2|||
17152040|NCT02953639|38297587|FG002|Overall Study|Non-Compliance With Study Drug|1|||
17152041|NCT02953639|38297585|FG000|Overall Study|Multiple Reasons|1|||
17152042|NCT02953639|38297586|FG001|Overall Study|Multiple Reasons|0|||
17152043|NCT02953639|38297587|FG002|Overall Study|Multiple Reasons|1|||
17152044|NCT02953639|38297585|FG000|Overall Study|Physician Decision|1|||
17152045|NCT02953639|38297586|FG001|Overall Study|Physician Decision|0|||
17152046|NCT02953639|38297587|FG002|Overall Study|Physician Decision|0|||
17152047|NCT02953639|38297585|FG000|Overall Study|Withdrawal by Subject|7|||
17152048|NCT02953639|38297586|FG001|Overall Study|Withdrawal by Subject|8|||
17152049|NCT02953639|38297587|FG002|Overall Study|Withdrawal by Subject|10|||
17152050|NCT02953639|38297585|FG000|Overall Study|Completed or Discontinued information is missing|1|||
17152051|NCT02953639|38297586|FG001|Overall Study|Completed or Discontinued information is missing|0|||
17152052|NCT02953639|38297587|FG002|Overall Study|Completed or Discontinued information is missing|0|||
17152053|NCT04147715|38297609|FG000|Overall Study|Adverse Event|0|||
17152054|NCT04147715|38297610|FG001|Overall Study|Adverse Event|0|||
17152055|NCT04147715|38297611|FG002|Overall Study|Adverse Event|0|||
17152056|NCT04147715|38297612|FG003|Overall Study|Adverse Event|0|||
17152057|NCT04147715|38297613|FG004|Overall Study|Adverse Event|0|||
17152058|NCT04147715|38297614|FG005|Overall Study|Adverse Event|0|||
17152059|NCT04147715|38297615|FG006|Overall Study|Adverse Event|0|||
17152060|NCT04147715|38297616|FG007|Overall Study|Adverse Event|2|||
17152061|NCT04147715|38297617|FG008|Overall Study|Adverse Event|1|||
17152062|NCT04147715|38297618|FG009|Overall Study|Adverse Event|0|||
17152063|NCT04147715|38297619|FG010|Overall Study|Adverse Event|0|||
17152064|NCT04147715|38297620|FG011|Overall Study|Adverse Event|0|||
17152065|NCT02452554|38297707|FG000|Overall Study|Death|2|||
17152066|NCT02452554|38297708|FG001|Overall Study|Death|1|||
17152067|NCT02452554|38297709|FG002|Overall Study|Death|0|||
17152068|NCT02452554|38297710|FG003|Overall Study|Death|0|||
17152069|NCT02452554|38297711|FG004|Overall Study|Death|0|||
17152070|NCT02452554|38297712|FG005|Overall Study|Death|0|||
17152071|NCT02452554|38297707|FG000|Overall Study|Lack of Efficacy|13|||
17152072|NCT02452554|38297708|FG001|Overall Study|Lack of Efficacy|14|||
17152073|NCT02452554|38297709|FG002|Overall Study|Lack of Efficacy|9|||
17152074|NCT02452554|38297710|FG003|Overall Study|Lack of Efficacy|1|||
17152075|NCT02452554|38297711|FG004|Overall Study|Lack of Efficacy|5|||
17152076|NCT02452554|38297712|FG005|Overall Study|Lack of Efficacy|8|||
17071526|NCT00373113|38214072|FG000|Overall Study|Global deterioration of health status|10|||
17071527|NCT00373113|38214073|FG001|Overall Study|Global deterioration of health status|7|||
17071528|NCT00373113|38214072|FG000|Overall Study|Lost to Follow-up|1|||
17071529|NCT00373113|38214073|FG001|Overall Study|Lost to Follow-up|3|||
17071530|NCT00373113|38214072|FG000|Overall Study|Objective progression or relapse|150|||
17071531|NCT00373113|38214073|FG001|Overall Study|Objective progression or relapse|169|||
17071532|NCT00373113|38214072|FG000|Overall Study|Other|14|||
17071533|NCT00373113|38214073|FG001|Overall Study|Other|17|||
17071534|NCT00373113|38214072|FG000|Overall Study|Protocol Violation|5|||
17071535|NCT00373113|38214073|FG001|Overall Study|Protocol Violation|1|||
17152077|NCT02452554|38297707|FG000|Overall Study|Physician Decision|0|||
17152078|NCT02452554|38297708|FG001|Overall Study|Physician Decision|1|||
17152079|NCT02452554|38297709|FG002|Overall Study|Physician Decision|0|||
17152080|NCT02452554|38297710|FG003|Overall Study|Physician Decision|0|||
17152081|NCT02452554|38297711|FG004|Overall Study|Physician Decision|0|||
17152082|NCT02452554|38297712|FG005|Overall Study|Physician Decision|0|||
17152083|NCT02452554|38297707|FG000|Overall Study|Withdrawal by Subject|1|||
17152084|NCT02452554|38297708|FG001|Overall Study|Withdrawal by Subject|0|||
17152085|NCT02452554|38297709|FG002|Overall Study|Withdrawal by Subject|2|||
17152086|NCT02452554|38297710|FG003|Overall Study|Withdrawal by Subject|0|||
17152087|NCT02452554|38297711|FG004|Overall Study|Withdrawal by Subject|0|||
17152088|NCT02452554|38297712|FG005|Overall Study|Withdrawal by Subject|1|||
17152089|NCT02452554|38297707|FG000|Overall Study|Ineligible|0|||
17152090|NCT02452554|38297708|FG001|Overall Study|Ineligible|1|||
17152091|NCT02452554|38297709|FG002|Overall Study|Ineligible|0|||
17152092|NCT02452554|38297710|FG003|Overall Study|Ineligible|0|||
17071536|NCT00373113|38214072|FG000|Overall Study|Withdrawal by Subject|10|||
17071537|NCT00373113|38214073|FG001|Overall Study|Withdrawal by Subject|15|||
17071538|NCT00407511|38214079|FG000|Overall Study|Adverse Event|9|||
17071539|NCT00407511|38214079|FG000|Overall Study|Lost to Follow-up|4|||
17071540|NCT00407511|38214079|FG000|Overall Study|Other|5|||
17071541|NCT00407511|38214079|FG000|Overall Study|Withdrawal by Subject|4|||
17071542|NCT00384189|38214087|FG000|Overall Study|Reason Not Specified|50|||
17152093|NCT02452554|38297711|FG004|Overall Study|Ineligible|0|||
17152094|NCT02452554|38297712|FG005|Overall Study|Ineligible|0|||
17152095|NCT02452554|38297707|FG000|Overall Study|Never Received Treatment|1|||
17152096|NCT02452554|38297708|FG001|Overall Study|Never Received Treatment|0|||
17152097|NCT02452554|38297709|FG002|Overall Study|Never Received Treatment|0|||
17152098|NCT02452554|38297710|FG003|Overall Study|Never Received Treatment|0|||
17152099|NCT02452554|38297711|FG004|Overall Study|Never Received Treatment|0|||
17152100|NCT02452554|38297712|FG005|Overall Study|Never Received Treatment|0|||
17152101|NCT04009577|38297731|FG000|Core Study|Adverse Event|1|||
17152102|NCT04009577|38297732|FG001|Core Study|Adverse Event|0|||
17152103|NCT04009577|38297733|FG002|Core Study|Adverse Event|2|||
17152104|NCT04009577|38297734|FG003|Core Study|Adverse Event|4|||
17152105|NCT04009577|38297731|FG000|Core Study|Withdrawal by Subject|0|||
17152106|NCT04009577|38297732|FG001|Core Study|Withdrawal by Subject|0|||
17152107|NCT04009577|38297733|FG002|Core Study|Withdrawal by Subject|2|||
17152108|NCT04009577|38297734|FG003|Core Study|Withdrawal by Subject|0|||
17152109|NCT04009577|38297731|FG000|Core Study|Other|0|||
17152110|NCT04009577|38297732|FG001|Core Study|Other|0|||
17152111|NCT04009577|38297733|FG002|Core Study|Other|0|||
17152112|NCT04009577|38297734|FG003|Core Study|Other|1|||
17152113|NCT04009577|38297731|FG000|Extension Phase|Adverse Event|0|||
17152114|NCT04009577|38297732|FG001|Extension Phase|Adverse Event|0|||
17152115|NCT04009577|38297733|FG002|Extension Phase|Adverse Event|0|||
17152116|NCT04009577|38297734|FG003|Extension Phase|Adverse Event|1|||
17152117|NCT04009577|38297731|FG000|Extension Phase|Inadequate therapeutic effect|0|||
17152118|NCT04009577|38297732|FG001|Extension Phase|Inadequate therapeutic effect|0|||
17152119|NCT04009577|38297733|FG002|Extension Phase|Inadequate therapeutic effect|1|||
17152120|NCT04009577|38297734|FG003|Extension Phase|Inadequate therapeutic effect|0|||
17152121|NCT04009577|38297731|FG000|Extension Phase|Withdrawal by Subject|0|||
17152122|NCT04009577|38297732|FG001|Extension Phase|Withdrawal by Subject|0|||
17152123|NCT04009577|38297733|FG002|Extension Phase|Withdrawal by Subject|1|||
17152124|NCT04009577|38297734|FG003|Extension Phase|Withdrawal by Subject|0|||
17152125|NCT04009577|38297731|FG000|Extension Phase|Not Treated|0|||
17152126|NCT04009577|38297732|FG001|Extension Phase|Not Treated|0|||
17152127|NCT04009577|38297733|FG002|Extension Phase|Not Treated|2|||
17152128|NCT04009577|38297734|FG003|Extension Phase|Not Treated|0|||
17152129|NCT04146467|38297762|FG000|Overall Study|Adverse Event|0|||
17152130|NCT04146467|38297763|FG001|Overall Study|Adverse Event|1|||
17152131|NCT04146467|38297762|FG000|Overall Study|Lost to Follow-up|0|||
17152132|NCT04146467|38297763|FG001|Overall Study|Lost to Follow-up|2|||
17152133|NCT02705716|38297774|FG000|Overall Study|Adverse Event|0|||
17152134|NCT02705716|38297775|FG001|Overall Study|Adverse Event|1|||
17152135|NCT02705716|38297774|FG000|Overall Study|Protocol Violation|3|||
17152136|NCT02705716|38297775|FG001|Overall Study|Protocol Violation|0|||
17152137|NCT02705716|38297774|FG000|Overall Study|Withdrawal of Consent|1|||
17152138|NCT02705716|38297775|FG001|Overall Study|Withdrawal of Consent|1|||
17152139|NCT04138043|38297783|FG000|Overall Study|Withdrawal by Subject|0|||
17152140|NCT04138043|38297784|FG001|Overall Study|Withdrawal by Subject|1|||
17152141|NCT04135937|38297800|FG000|Overall Study|Lost to Follow-up|2|||
17152142|NCT04135937|38297800|FG000|Overall Study|Withdrawal by Subject|1|||
17152143|NCT03443713|38297807|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
17152144|NCT03443713|38297808|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
17152145|NCT03443713|38297809|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
17152146|NCT04133519|38297823|FG000|Overall Study|Withdrawal by Subject|5|||
17152147|NCT04133519|38297824|FG001|Overall Study|Withdrawal by Subject|4|||
17152148|NCT04133519|38297823|FG000|Overall Study|Protocol Violation|0|||
17152149|NCT04133519|38297824|FG001|Overall Study|Protocol Violation|1|||
17152150|NCT04133519|38297823|FG000|Overall Study|Never started treatment|1|||
17152151|NCT04133519|38297824|FG001|Overall Study|Never started treatment|1|||
17152152|NCT04007159|38297830|FG000|Induction Phase|(missed study visits)|16|||
17152153|NCT04007159|38297830|FG000|Induction Phase|Withdrawal by Subject|4|||
17152154|NCT04007159|38297830|FG000|Induction Phase|Adverse Event|2|||
17152155|NCT04007159|38297830|FG000|Challenge Phase|missed study visits|3|||
17152156|NCT03119688|38297841|FG000|Overall Study|Adverse Event|4|||
17152157|NCT03389893|38297860|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
17152158|NCT03389893|38297861|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
17152159|NCT03389893|38297862|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
17152160|NCT03389893|38297863|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
17152161|NCT03389893|38297860|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
17152162|NCT03389893|38297861|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
17152163|NCT03389893|38297862|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
17152164|NCT03389893|38297863|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
17152165|NCT03389893|38297860|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
17152166|NCT03389893|38297861|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
17152167|NCT03389893|38297862|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
17152168|NCT03389893|38297863|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
17152169|NCT03389893|38297860|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
17152170|NCT03389893|38297861|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
17152171|NCT03389893|38297862|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
17152172|NCT03389893|38297863|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
17071543|NCT00384189|38214088|FG001|Overall Study|Reason Not Specified|57|||
17071544|NCT00384189|38214089|FG002|Overall Study|Reason Not Specified|58|||
17071545|NCT00384189|38214090|FG003|Overall Study|Reason Not Specified|40|||
17071546|NCT00326716|38214102|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
17071547|NCT00326716|38214103|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
17071548|NCT00326716|38214104|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
17071549|NCT00326716|38214105|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
17071550|NCT00548405|38214138|FG000|Overall Study|Adverse Event|6|||
17071551|NCT00548405|38214139|FG001|Overall Study|Adverse Event|2|||
17071552|NCT00548405|38214140|FG002|Overall Study|Adverse Event|0|||
17071553|NCT00548405|38214138|FG000|Overall Study|Lack of Efficacy|6|||
17071554|NCT00548405|38214139|FG001|Overall Study|Lack of Efficacy|0|||
17071555|NCT00548405|38214140|FG002|Overall Study|Lack of Efficacy|0|||
17071556|NCT00548405|38214138|FG000|Overall Study|Physician Decision|3|||
17071557|NCT00548405|38214139|FG001|Overall Study|Physician Decision|4|||
17071558|NCT00548405|38214140|FG002|Overall Study|Physician Decision|1|||
17071559|NCT00548405|38214138|FG000|Overall Study|Pregnancy|1|||
17071560|NCT00548405|38214139|FG001|Overall Study|Pregnancy|0|||
17071561|NCT00548405|38214140|FG002|Overall Study|Pregnancy|0|||
17071562|NCT00548405|38214138|FG000|Overall Study|Protocol Violation|1|||
17071563|NCT00548405|38214139|FG001|Overall Study|Protocol Violation|0|||
17071564|NCT00548405|38214140|FG002|Overall Study|Protocol Violation|0|||
17071565|NCT00548405|38214138|FG000|Overall Study|Withdrawal by Subject|36|||
17071566|NCT00548405|38214139|FG001|Overall Study|Withdrawal by Subject|12|||
17071567|NCT00548405|38214140|FG002|Overall Study|Withdrawal by Subject|5|||
17071568|NCT00548405|38214138|FG000|Overall Study|Lost to Follow-up|1|||
17071569|NCT00548405|38214139|FG001|Overall Study|Lost to Follow-up|1|||
17152173|NCT04128293|38297873|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
17152174|NCT04128293|38297874|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
17152175|NCT04128293|38297875|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
17152176|NCT04128293|38297876|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
17152177|NCT00787176|38297895|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
17152178|NCT00787176|38297896|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
17152179|NCT00787176|38297897|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
17152180|NCT00787176|38297898|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
17152181|NCT03691571|38297911|FG000|Overall Study|Withdrawal by Subject|9|||
17152182|NCT03691571|38297912|FG001|Overall Study|Withdrawal by Subject|2|||
17152183|NCT03113916|38297921|FG000|Overall Study|Withdrawal by Subject|9|||
17152184|NCT03113916|38297922|FG001|Overall Study|Withdrawal by Subject|7|||
17152185|NCT03113916|38297921|FG000|Overall Study|Pregnancy|1|||
17152186|NCT03113916|38297922|FG001|Overall Study|Pregnancy|3|||
17152187|NCT03113916|38297921|FG000|Overall Study|Lost to Follow-up|1|||
17152188|NCT03113916|38297922|FG001|Overall Study|Lost to Follow-up|2|||
17152189|NCT02925494|38297937|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
17152190|NCT02925494|38297938|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
17152191|NCT02925494|38297939|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
17152192|NCT02925494|38297940|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
17152193|NCT02925494|38297937|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
17152194|NCT02925494|38297938|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
17152195|NCT02925494|38297939|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
17152196|NCT02925494|38297940|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
17152197|NCT02925494|38297937|FG000|Post-Treatment Follow-Up Period|Other|1|||
17152198|NCT02925494|38297938|FG001|Post-Treatment Follow-Up Period|Other|4|||
17152199|NCT02925494|38297939|FG002|Post-Treatment Follow-Up Period|Other|3|||
17152200|NCT02925494|38297940|FG003|Post-Treatment Follow-Up Period|Other|6|||
17152201|NCT02925494|38297937|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
17071570|NCT00548405|38214140|FG002|Overall Study|Lost to Follow-up|2|||
17071571|NCT00548405|38214138|FG000|Overall Study|Death|0|||
17152202|NCT02925494|38297938|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
17152203|NCT02925494|38297939|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
17152204|NCT02925494|38297940|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
17152205|NCT02925494|38297937|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
17152206|NCT02925494|38297938|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
17152207|NCT02925494|38297939|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
17152208|NCT02925494|38297940|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
17152209|NCT02925494|38297937|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
17152210|NCT02925494|38297938|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
17152211|NCT02925494|38297939|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
17152212|NCT02925494|38297940|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
17152213|NCT02925494|38297937|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
17152214|NCT02925494|38297938|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
17152215|NCT02925494|38297939|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
17152216|NCT02925494|38297940|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
17152217|NCT04006145|38297953|FG000|Overall Study|Lost to Follow-up|0|||
17152218|NCT04006145|38297954|FG001|Overall Study|Lost to Follow-up|1|||
17152219|NCT04006145|38297953|FG000|Overall Study|Other|1|||
17152220|NCT04006145|38297954|FG001|Overall Study|Other|2|||
17152221|NCT03386773|38297962|FG000|Overall Study|Lost to Follow-up|24|||
17152222|NCT03386773|38297963|FG001|Overall Study|Lost to Follow-up|33|||
17152223|NCT03386773|38297962|FG000|Overall Study|Withdrawal by Subject|3|||
17152224|NCT03386773|38297963|FG001|Overall Study|Withdrawal by Subject|2|||
17152225|NCT04126343|38297975|FG000|Overall Study|Adverse Event|0|||
17152226|NCT04126343|38297976|FG001|Overall Study|Adverse Event|0|||
17152227|NCT04126343|38297977|FG002|Overall Study|Adverse Event|0|||
17152228|NCT04126343|38297978|FG003|Overall Study|Adverse Event|0|||
17152229|NCT04126343|38297979|FG004|Overall Study|Adverse Event|0|||
17152230|NCT04126343|38297980|FG005|Overall Study|Adverse Event|1|||
17152231|NCT04126343|38297975|FG000|Overall Study|Withdrawal by Subject|0|||
17152232|NCT04126343|38297976|FG001|Overall Study|Withdrawal by Subject|0|||
17152233|NCT04126343|38297977|FG002|Overall Study|Withdrawal by Subject|0|||
17152234|NCT04126343|38297978|FG003|Overall Study|Withdrawal by Subject|1|||
17071572|NCT00548405|38214139|FG001|Overall Study|Death|1|||
17071573|NCT00548405|38214140|FG002|Overall Study|Death|1|||
17071574|NCT00548405|38214138|FG000|Overall Study|Sponsor decision|1|||
17071575|NCT00548405|38214139|FG001|Overall Study|Sponsor decision|0|||
17152235|NCT04126343|38297979|FG004|Overall Study|Withdrawal by Subject|0|||
17152236|NCT04126343|38297980|FG005|Overall Study|Withdrawal by Subject|0|||
17152237|NCT04126343|38297975|FG000|Overall Study|Related to COVID-19 pandemic|3|||
17152238|NCT04126343|38297976|FG001|Overall Study|Related to COVID-19 pandemic|4|||
17152239|NCT04126343|38297977|FG002|Overall Study|Related to COVID-19 pandemic|3|||
17152240|NCT04126343|38297978|FG003|Overall Study|Related to COVID-19 pandemic|3|||
17152241|NCT04126343|38297979|FG004|Overall Study|Related to COVID-19 pandemic|3|||
17152242|NCT04126343|38297980|FG005|Overall Study|Related to COVID-19 pandemic|3|||
17152243|NCT02952313|38297995|FG000|Primary Endpoint|Lost to Follow-up|4|||
17152244|NCT02952313|38297995|FG000|Primary Endpoint|Withdrawal by Subject|1|||
17152245|NCT02952313|38297995|FG000|Primary Endpoint|Lack of Efficacy|1|||
17152246|NCT02952313|38297995|FG000|Primary Endpoint|Missed visit|1|||
17152247|NCT02952313|38297995|FG000|Long-term Follow-up|Lost to Follow-up|12|||
17152248|NCT02952313|38297995|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
17152249|NCT02952313|38297995|FG000|Long-term Follow-up|Lack of Efficacy|6|||
17152250|NCT02952313|38297995|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
17152251|NCT02952313|38297995|FG000|Long-term Follow-up|Physician Decision|1|||
17152252|NCT02952313|38297995|FG000|Long-term Follow-up|Death|1|||
17152253|NCT03119610|38298002|FG000|Overall Study|Adverse Event|1|||
17152254|NCT03119610|38298003|FG001|Overall Study|Adverse Event|0|||
17152255|NCT03119610|38298002|FG000|Overall Study|Lost to Follow-up|0|||
17152256|NCT03119610|38298003|FG001|Overall Study|Lost to Follow-up|1|||
17152257|NCT04005755|38298009|FG000|Overall Study|Adverse Event|6|||
17152258|NCT04005755|38298009|FG000|Overall Study|Physician Decision|3|||
17152259|NCT04005755|38298009|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
17152260|NCT04005755|38298009|FG000|Overall Study|Withdrawal by Subject|3|||
17152261|NCT04005755|38298009|FG000|Overall Study|Lost to Follow-up|1|||
17071576|NCT00548405|38214140|FG002|Overall Study|Sponsor decision|0|||
17071577|NCT00548405|38214138|FG000|Overall Study|Randomized but not treated|1|||
17071578|NCT00548405|38214139|FG001|Overall Study|Randomized but not treated|0|||
17071579|NCT00548405|38214140|FG002|Overall Study|Randomized but not treated|0|||
17071580|NCT00295750|38214152|FG000|Overall Study|Adverse Event|19|||
17071581|NCT00295750|38214153|FG001|Overall Study|Adverse Event|15|||
17071582|NCT00295750|38214154|FG002|Overall Study|Adverse Event|12|||
17071583|NCT00295750|38214152|FG000|Overall Study|Lack of Efficacy|1|||
17071584|NCT00295750|38214153|FG001|Overall Study|Lack of Efficacy|1|||
17071585|NCT00295750|38214154|FG002|Overall Study|Lack of Efficacy|0|||
17071586|NCT00295750|38214152|FG000|Overall Study|Lost to Follow-up|1|||
17071587|NCT00295750|38214153|FG001|Overall Study|Lost to Follow-up|4|||
17071588|NCT00295750|38214154|FG002|Overall Study|Lost to Follow-up|1|||
17071589|NCT00295750|38214152|FG000|Overall Study|Taking prohibited therapy|2|||
17071590|NCT00295750|38214153|FG001|Overall Study|Taking prohibited therapy|3|||
17071591|NCT00295750|38214154|FG002|Overall Study|Taking prohibited therapy|2|||
17071592|NCT00295750|38214152|FG000|Overall Study|Administrative errors|2|||
17071593|NCT00295750|38214153|FG001|Overall Study|Administrative errors|4|||
17071594|NCT00295750|38214154|FG002|Overall Study|Administrative errors|5|||
17152262|NCT03442777|38298016|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
17152263|NCT03442777|38298017|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
17152264|NCT03442777|38298018|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
17152265|NCT03401749|38298027|FG000|Overall Study|Lost to Follow-up|20|||
17152266|NCT03401749|38298028|FG001|Overall Study|Lost to Follow-up|16|||
17152267|NCT03401749|38298029|FG002|Overall Study|Lost to Follow-up|26|||
17152268|NCT03029624|38298037|FG000|Overall Study|Adverse Event|1|||
17152269|NCT03029624|38298037|FG000|Overall Study|Withdrawal by Subject|1|||
17152270|NCT03029624|38298037|FG000|Overall Study|Lack of Efficacy|1|||
17152271|NCT03029624|38298037|FG000|Overall Study|MRI need|2|||
17152272|NCT03689855|38298043|FG000|Overall Study|Adverse Event|3|||
17152273|NCT03689855|38298043|FG000|Overall Study|Withdrawal by Subject|1|||
17152274|NCT02952001|38298049|FG000|Overall Study|Adverse Event|3|||
17152275|NCT02952001|38298050|FG001|Overall Study|Adverse Event|0|||
17152276|NCT02952001|38298049|FG000|Overall Study|Prohibited therapy|10|||
17152277|NCT02952001|38298050|FG001|Overall Study|Prohibited therapy|3|||
17152278|NCT02952001|38298049|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
17152279|NCT02952001|38298050|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
17152280|NCT04123067|38298059|FG000|Overall Study|Lost to Follow-up|0|||
17152281|NCT04123067|38298060|FG001|Overall Study|Lost to Follow-up|1|||
17152282|NCT04117607|38298069|FG000|Overall Study|Early Termination|0|||
17152283|NCT04117607|38298070|FG001|Overall Study|Early Termination|1|||
17071595|NCT00295750|38214152|FG000|Overall Study|Trial drug errors|1|||
17152284|NCT04117607|38298071|FG002|Overall Study|Early Termination|0|||
17152285|NCT04117607|38298072|FG003|Overall Study|Early Termination|0|||
17152286|NCT04117607|38298073|FG004|Overall Study|Early Termination|0|||
17071596|NCT00295750|38214153|FG001|Overall Study|Trial drug errors|1|||
17071597|NCT00295750|38214154|FG002|Overall Study|Trial drug errors|0|||
17071598|NCT00295750|38214152|FG000|Overall Study|Disease progression|2|||
17152287|NCT04117607|38298074|FG005|Overall Study|Early Termination|0|||
17152288|NCT04117607|38298075|FG006|Overall Study|Early Termination|1|||
17152289|NCT04117607|38298076|FG007|Overall Study|Early Termination|0|||
17152290|NCT04117607|38298077|FG008|Overall Study|Early Termination|0|||
17152291|NCT04117607|38298078|FG009|Overall Study|Early Termination|0|||
17152292|NCT04117607|38298079|FG010|Overall Study|Early Termination|0|||
17152293|NCT04117607|38298080|FG011|Overall Study|Early Termination|0|||
17071599|NCT00295750|38214153|FG001|Overall Study|Disease progression|1|||
17071600|NCT00295750|38214154|FG002|Overall Study|Disease progression|0|||
17071601|NCT00295750|38214152|FG000|Overall Study|Personal reasons|0|||
17152294|NCT04117607|38298081|FG012|Overall Study|Early Termination|0|||
17152295|NCT04117607|38298082|FG013|Overall Study|Early Termination|0|||
17152296|NCT04112303|38298098|FG000|Overall Study|Death|1|||
17152297|NCT03998189|38298104|FG000|Overall Study|Lack of Efficacy|0|||
17152298|NCT03998189|38298105|FG001|Overall Study|Lack of Efficacy|1|||
17152299|NCT04099277|38298111|FG000|Overall Study|Physician Decision|1|||
17152300|NCT04099277|38298111|FG000|Overall Study|Withdrawal by Subject|1|||
17152301|NCT03990389|38298117|FG000|Overall Study|Lost to Follow-up|3|||
17152302|NCT03990389|38298118|FG001|Overall Study|Lost to Follow-up|0|||
17152303|NCT03988907|38298126|FG000|Overall Study|Unable to complete visit|0|||
17152304|NCT03988907|38298127|FG001|Overall Study|Unable to complete visit|1|||
17152305|NCT03987191|38298141|FG000|Overall Study|COVID-19 related research disruption|0|||
17152306|NCT03987191|38298142|FG001|Overall Study|COVID-19 related research disruption|2|||
17152307|NCT04098809|38298150|FG000|Overall Study|Withdrawal by Subject|1|||
17152308|NCT04098809|38298151|FG001|Overall Study|Withdrawal by Subject|3|||
17152309|NCT04098809|38298150|FG000|Overall Study|Physician Decision|2|||
17152310|NCT04098809|38298151|FG001|Overall Study|Physician Decision|1|||
17152311|NCT03122184|38298159|FG000|Overall Study|Lost to Follow-up|4|||
17152312|NCT03122184|38298160|FG001|Overall Study|Lost to Follow-up|6|||
17152313|NCT03122184|38298159|FG000|Overall Study|Withdrawal by Subject|3|||
17152314|NCT03122184|38298160|FG001|Overall Study|Withdrawal by Subject|0|||
17152315|NCT03122184|38298159|FG000|Overall Study|Terminated due to cognitive problem|1|||
17152316|NCT03122184|38298160|FG001|Overall Study|Terminated due to cognitive problem|0|||
17152317|NCT04091087|38298185|FG000|Overall Study|Not treated|1|||
17152318|NCT04091087|38298186|FG001|Overall Study|Not treated|0|||
17152319|NCT04091087|38298185|FG000|Overall Study|Adverse Event|4|||
17152320|NCT04091087|38298186|FG001|Overall Study|Adverse Event|4|||
17152321|NCT04091087|38298185|FG000|Overall Study|Protocol Violation|0|||
17152322|NCT04091087|38298186|FG001|Overall Study|Protocol Violation|1|||
17152323|NCT04091087|38298185|FG000|Overall Study|Withdrawal by Subject|5|||
17152324|NCT04091087|38298186|FG001|Overall Study|Withdrawal by Subject|2|||
17152325|NCT03400033|38298204|FG000|Overall Study|Withdrawal by Subject|1|||
17152326|NCT03400033|38298205|FG001|Overall Study|Withdrawal by Subject|2|||
17152327|NCT04089761|38298220|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
17152328|NCT04089761|38298220|FG000|"Run In Phase"|Lost to Follow-up|1|||
17152329|NCT04089761|38298220|FG000|"Treatment Phase"|No evaluable data|5|||
17152330|NCT04089761|38298220|FG000|"Treatment Phase"|Lost to Follow-up|1|||
17152331|NCT03118518|38298226|FG000|Overall Study|Early Exit after treatment|2|||
17152332|NCT03118518|38298227|FG001|Overall Study|Early Exit after treatment|8|||
17152333|NCT03118518|38298226|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
17071602|NCT00295750|38214153|FG001|Overall Study|Personal reasons|1|||
17071603|NCT00295750|38214154|FG002|Overall Study|Personal reasons|0|||
17071604|NCT00295750|38214152|FG000|Overall Study|Randomized but never received trial drug|4|||
17071605|NCT00295750|38214153|FG001|Overall Study|Randomized but never received trial drug|3|||
17071606|NCT00295750|38214154|FG002|Overall Study|Randomized but never received trial drug|3|||
17071607|NCT00295750|38214152|FG000|Overall Study|Withdrawal by Subject|9|||
17071608|NCT00295750|38214153|FG001|Overall Study|Withdrawal by Subject|4|||
17071609|NCT00295750|38214154|FG002|Overall Study|Withdrawal by Subject|7|||
17071610|NCT00295750|38214152|FG000|Overall Study|Protocol Violation|2|||
17071611|NCT00295750|38214153|FG001|Overall Study|Protocol Violation|4|||
17071612|NCT00295750|38214154|FG002|Overall Study|Protocol Violation|2|||
17071613|NCT03948581|38214164|FG000|Overall Study|Lost to Follow-up|0|||
17071614|NCT03948581|38214165|FG001|Overall Study|Lost to Follow-up|1|||
17071615|NCT00548327|38214173|FG000|Overall Study|Adverse Event|0|||
17071616|NCT00548327|38214174|FG001|Overall Study|Adverse Event|1|||
17071617|NCT03953183|38214196|FG000|Overall Study|Physician Decision|0|||
17071618|NCT03953183|38214197|FG001|Overall Study|Physician Decision|1|||
17071619|NCT03953183|38214196|FG000|Overall Study|Withdrawal by Subject|0|||
17071620|NCT03953183|38214197|FG001|Overall Study|Withdrawal by Subject|1|||
17071621|NCT00406653|38214207|FG000|Induction Period|Adverse Event|1|||
17071622|NCT00406653|38214208|FG001|Induction Period|Adverse Event|10|||
17071623|NCT00406653|38214209|FG002|Induction Period|Adverse Event|4|||
17071624|NCT00406653|38214210|FG003|Induction Period|Adverse Event|11|||
17071625|NCT00406653|38214211|FG004|Induction Period|Adverse Event|0|||
17071626|NCT00406653|38214212|FG005|Induction Period|Adverse Event|0|||
17071627|NCT00406653|38214213|FG006|Induction Period|Adverse Event|0|||
17071628|NCT00406653|38214207|FG000|Induction Period|Lack of Efficacy|11|||
17071629|NCT00406653|38214208|FG001|Induction Period|Lack of Efficacy|14|||
17152334|NCT03118518|38298227|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
17152335|NCT03984305|38298235|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
17152336|NCT03984305|38298236|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
17152337|NCT03984305|38298235|FG000|Overall Study|Withdrawal by Subject|3|||
17152338|NCT03984305|38298236|FG001|Overall Study|Withdrawal by Subject|3|||
17152339|NCT03984305|38298235|FG000|Overall Study|Lost to Follow-up|1|||
17152340|NCT03984305|38298236|FG001|Overall Study|Lost to Follow-up|0|||
17152341|NCT03397771|38298244|FG000|Overall Study|2 erroneously randomized, never treated|3|||
17152342|NCT03397771|38298245|FG001|Overall Study|2 erroneously randomized, never treated|1|||
17152343|NCT03397771|38298244|FG000|Overall Study|Withdrawal by Subject|1|||
17152344|NCT03397771|38298245|FG001|Overall Study|Withdrawal by Subject|3|||
17152345|NCT03397771|38298244|FG000|Overall Study|Protocol Violation|2|||
17152346|NCT03397771|38298245|FG001|Overall Study|Protocol Violation|2|||
17152347|NCT03397771|38298244|FG000|Overall Study|Adverse Event|2|||
17152348|NCT03397771|38298245|FG001|Overall Study|Adverse Event|1|||
17152349|NCT02876835|38298253|FG000|Treatment Period (51.1 Month)|Other|1|||
17152350|NCT02876835|38298254|FG001|Treatment Period (51.1 Month)|Other|0|||
17152351|NCT02876835|38298253|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
17152352|NCT02876835|38298254|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
17152353|NCT02876835|38298253|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
17152354|NCT02876835|38298254|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
17152355|NCT02876835|38298253|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
17152356|NCT02876835|38298254|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
17152357|NCT04086641|38298263|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
17152358|NCT04086641|38298264|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
17152359|NCT03503318|38298273|FG000|Overall Study|Death|1|||
17152360|NCT03503318|38298274|FG001|Overall Study|Death|0|||
17152361|NCT03503318|38298275|FG002|Overall Study|Death|4|||
17152362|NCT03503318|38298273|FG000|Overall Study|Adverse Event|3|||
17152363|NCT03503318|38298274|FG001|Overall Study|Adverse Event|4|||
17152364|NCT03503318|38298275|FG002|Overall Study|Adverse Event|2|||
17152365|NCT03503318|38298273|FG000|Overall Study|Withdrawal by Subject|12|||
17152366|NCT03503318|38298274|FG001|Overall Study|Withdrawal by Subject|17|||
17071630|NCT00406653|38214209|FG002|Induction Period|Lack of Efficacy|8|||
17071631|NCT00406653|38214210|FG003|Induction Period|Lack of Efficacy|10|||
17071632|NCT00406653|38214211|FG004|Induction Period|Lack of Efficacy|0|||
17071633|NCT00406653|38214212|FG005|Induction Period|Lack of Efficacy|0|||
17071634|NCT00406653|38214213|FG006|Induction Period|Lack of Efficacy|0|||
17071635|NCT00406653|38214207|FG000|Induction Period|Lost to Follow-up|0|||
17071636|NCT00406653|38214208|FG001|Induction Period|Lost to Follow-up|2|||
17071637|NCT00406653|38214209|FG002|Induction Period|Lost to Follow-up|0|||
17071638|NCT00406653|38214210|FG003|Induction Period|Lost to Follow-up|0|||
17071639|NCT00406653|38214211|FG004|Induction Period|Lost to Follow-up|0|||
17071640|NCT00406653|38214212|FG005|Induction Period|Lost to Follow-up|0|||
17071641|NCT00406653|38214213|FG006|Induction Period|Lost to Follow-up|0|||
17071642|NCT00406653|38214207|FG000|Induction Period|Withdrawal of Consent|2|||
17071643|NCT00406653|38214208|FG001|Induction Period|Withdrawal of Consent|5|||
17071644|NCT00406653|38214209|FG002|Induction Period|Withdrawal of Consent|1|||
17071645|NCT00406653|38214210|FG003|Induction Period|Withdrawal of Consent|2|||
17071646|NCT00406653|38214211|FG004|Induction Period|Withdrawal of Consent|0|||
17071647|NCT00406653|38214212|FG005|Induction Period|Withdrawal of Consent|0|||
17071648|NCT00406653|38214213|FG006|Induction Period|Withdrawal of Consent|0|||
17071649|NCT00406653|38214207|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
17071650|NCT00406653|38214208|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
17071651|NCT00406653|38214209|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
17071652|NCT00406653|38214210|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
17071653|NCT00406653|38214211|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
17071654|NCT00406653|38214212|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
17071655|NCT00406653|38214213|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
17071656|NCT00406653|38214207|FG000|Induction Period|Pregnancy|1|||
17071657|NCT00406653|38214208|FG001|Induction Period|Pregnancy|0|||
17071658|NCT00406653|38214209|FG002|Induction Period|Pregnancy|0|||
17071659|NCT00406653|38214210|FG003|Induction Period|Pregnancy|0|||
17071660|NCT00406653|38214211|FG004|Induction Period|Pregnancy|0|||
17071661|NCT00406653|38214212|FG005|Induction Period|Pregnancy|0|||
17071662|NCT00406653|38214213|FG006|Induction Period|Pregnancy|0|||
17071663|NCT00406653|38214207|FG000|Induction Period|Declined participation but followup done|0|||
17071664|NCT00406653|38214208|FG001|Induction Period|Declined participation but followup done|2|||
17071665|NCT00406653|38214209|FG002|Induction Period|Declined participation but followup done|1|||
17071666|NCT00406653|38214210|FG003|Induction Period|Declined participation but followup done|1|||
17071667|NCT00406653|38214211|FG004|Induction Period|Declined participation but followup done|0|||
17071668|NCT00406653|38214212|FG005|Induction Period|Declined participation but followup done|0|||
17152367|NCT03503318|38298275|FG002|Overall Study|Withdrawal by Subject|16|||
17152368|NCT03503318|38298273|FG000|Overall Study|Protocol Violation|5|||
17152369|NCT03503318|38298274|FG001|Overall Study|Protocol Violation|0|||
17152370|NCT03503318|38298275|FG002|Overall Study|Protocol Violation|3|||
17152371|NCT03503318|38298273|FG000|Overall Study|Lost to Follow-up|17|||
17152372|NCT03503318|38298274|FG001|Overall Study|Lost to Follow-up|15|||
17152373|NCT03503318|38298275|FG002|Overall Study|Lost to Follow-up|12|||
17152374|NCT03503318|38298273|FG000|Overall Study|Other than specified|1|||
17152375|NCT03503318|38298274|FG001|Overall Study|Other than specified|3|||
17152376|NCT03503318|38298275|FG002|Overall Study|Other than specified|3|||
17152377|NCT03396913|38298285|FG000|Overall Study|Lost to Follow-up|0|||
17152378|NCT03396913|38298286|FG001|Overall Study|Lost to Follow-up|6|||
17152379|NCT03982433|38298292|FG000|Overall Study|Lost to Follow-up|1|||
17152380|NCT03396835|38298296|FG000|Overall Study|Withdrawn prior to completion|1|||
17152381|NCT03396835|38298296|FG000|Overall Study|Did not meet criteria for data analysis|1|||
17152382|NCT03122106|38298300|FG000|Overall Study|Not enough tissue|1|||
17152383|NCT03122106|38298300|FG000|Overall Study|Disease progression during screening|2|||
17152384|NCT03122106|38298300|FG000|Overall Study|Poor RNA quality for vaccine|1|||
17152385|NCT04084769|38298308|FG000|Overall Study|Protocol Violation|1|||
17152386|NCT04084769|38298309|FG001|Overall Study|Protocol Violation|3|||
17152387|NCT04084769|38298310|FG002|Overall Study|Protocol Violation|0|||
17152388|NCT04084769|38298311|FG003|Overall Study|Protocol Violation|1|||
17152389|NCT04084769|38298308|FG000|Overall Study|Withdrawal by Subject|0|||
17152390|NCT04084769|38298309|FG001|Overall Study|Withdrawal by Subject|1|||
17152391|NCT04084769|38298310|FG002|Overall Study|Withdrawal by Subject|0|||
17152392|NCT04084769|38298311|FG003|Overall Study|Withdrawal by Subject|0|||
17152393|NCT04084769|38298308|FG000|Overall Study|Withdrawal by parent/guardian|1|||
17152394|NCT04084769|38298309|FG001|Overall Study|Withdrawal by parent/guardian|0|||
17152395|NCT04084769|38298310|FG002|Overall Study|Withdrawal by parent/guardian|0|||
17152396|NCT04084769|38298311|FG003|Overall Study|Withdrawal by parent/guardian|1|||
17152397|NCT04084769|38298308|FG000|Overall Study|Lost to Follow-up|2|||
17152398|NCT04084769|38298309|FG001|Overall Study|Lost to Follow-up|0|||
17152399|NCT04084769|38298310|FG002|Overall Study|Lost to Follow-up|0|||
17152400|NCT04084769|38298311|FG003|Overall Study|Lost to Follow-up|0|||
17152401|NCT03121950|38298328|FG000|Overall Study|Withdrawal by Subject|11|||
17152402|NCT03121950|38298329|FG001|Overall Study|Withdrawal by Subject|2|||
17152403|NCT03395353|38298337|FG000|Overall Study|Adverse Event|20|||
17152404|NCT03395353|38298337|FG000|Overall Study|Protocol Violation|1|||
17152405|NCT03395353|38298337|FG000|Overall Study|Lack of Efficacy|3|||
17152406|NCT03395353|38298337|FG000|Overall Study|Withdrawal by Subject|24|||
17152407|NCT03395353|38298337|FG000|Overall Study|Discontinued visit|1|||
17152408|NCT03395353|38298337|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
17152409|NCT03395353|38298337|FG000|Overall Study|Physician Decision|4|||
17152410|NCT03395353|38298337|FG000|Overall Study|Early termination of overall study|33|||
17152411|NCT04082663|38298345|FG000|Overall Study|Adverse Event|6|||
17152412|NCT04082663|38298345|FG000|Overall Study|Lost to Follow-up|1|||
17152413|NCT03682367|38298351|FG000|Overall Study|Protocol Violation|2|||
17152414|NCT03682367|38298352|FG001|Overall Study|Protocol Violation|1|||
17152415|NCT03682367|38298351|FG000|Overall Study|Closed Study Early|0|||
17152416|NCT03682367|38298352|FG001|Overall Study|Closed Study Early|3|||
17152417|NCT03681353|38298358|FG000|Overall Study|Lost to Follow-up|2|||
17071669|NCT00406653|38214213|FG006|Induction Period|Declined participation but followup done|0|||
17071670|NCT00406653|38214207|FG000|Induction Period|Given prohibited drug|0|||
17071671|NCT00406653|38214208|FG001|Induction Period|Given prohibited drug|1|||
17071672|NCT00406653|38214209|FG002|Induction Period|Given prohibited drug|2|||
17071673|NCT00406653|38214210|FG003|Induction Period|Given prohibited drug|0|||
17071674|NCT00406653|38214211|FG004|Induction Period|Given prohibited drug|0|||
17071675|NCT00406653|38214212|FG005|Induction Period|Given prohibited drug|0|||
17071676|NCT00406653|38214213|FG006|Induction Period|Given prohibited drug|0|||
17071677|NCT00406653|38214207|FG000|Induction Period|Incarcerated|0|||
17071678|NCT00406653|38214208|FG001|Induction Period|Incarcerated|0|||
17071679|NCT00406653|38214209|FG002|Induction Period|Incarcerated|1|||
17071680|NCT00406653|38214210|FG003|Induction Period|Incarcerated|0|||
17071681|NCT00406653|38214211|FG004|Induction Period|Incarcerated|0|||
17071682|NCT00406653|38214212|FG005|Induction Period|Incarcerated|0|||
17071683|NCT00406653|38214213|FG006|Induction Period|Incarcerated|0|||
17071684|NCT00406653|38214207|FG000|Induction Period|Patient relocated|0|||
17071685|NCT00406653|38214208|FG001|Induction Period|Patient relocated|0|||
17071686|NCT00406653|38214209|FG002|Induction Period|Patient relocated|1|||
17071687|NCT00406653|38214210|FG003|Induction Period|Patient relocated|0|||
17071688|NCT00406653|38214211|FG004|Induction Period|Patient relocated|0|||
17152418|NCT03681353|38298358|FG000|Overall Study|Withdrawal by Subject|3|||
17152419|NCT03681353|38298358|FG000|Overall Study|withdrawn by PI|2|||
17152420|NCT03394885|38298362|FG000|Overall Study|Adverse Event|4|||
17152421|NCT03394885|38298362|FG000|Overall Study|Lack of Efficacy|1|||
17152422|NCT03394885|38298362|FG000|Overall Study|Physician Decision|1|||
17152423|NCT03394885|38298362|FG000|Overall Study|Withdrawal by Subject|8|||
17152424|NCT03394885|38298362|FG000|Overall Study|Alternative Therapy|1|||
17152425|NCT02877927|38298368|FG000|Overall Study|Adverse Event|1|||
17071689|NCT00406653|38214212|FG005|Induction Period|Patient relocated|0|||
17071690|NCT00406653|38214213|FG006|Induction Period|Patient relocated|0|||
17071691|NCT00406653|38214207|FG000|Maintenance Period|Adverse Event|0|||
17071692|NCT00406653|38214208|FG001|Maintenance Period|Adverse Event|0|||
17071693|NCT00406653|38214209|FG002|Maintenance Period|Adverse Event|0|||
17071694|NCT00406653|38214210|FG003|Maintenance Period|Adverse Event|0|||
17071695|NCT00406653|38214211|FG004|Maintenance Period|Adverse Event|1|||
17071696|NCT00406653|38214212|FG005|Maintenance Period|Adverse Event|1|||
17071697|NCT00406653|38214213|FG006|Maintenance Period|Adverse Event|0|||
17071698|NCT00406653|38214207|FG000|Maintenance Period|Lack of Efficacy|0|||
17071699|NCT00406653|38214208|FG001|Maintenance Period|Lack of Efficacy|0|||
17071700|NCT00406653|38214209|FG002|Maintenance Period|Lack of Efficacy|0|||
17071701|NCT00406653|38214210|FG003|Maintenance Period|Lack of Efficacy|0|||
17071702|NCT00406653|38214211|FG004|Maintenance Period|Lack of Efficacy|20|||
17071703|NCT00406653|38214212|FG005|Maintenance Period|Lack of Efficacy|26|||
17071704|NCT00406653|38214213|FG006|Maintenance Period|Lack of Efficacy|0|||
17071705|NCT00406653|38214207|FG000|Maintenance Period|Lost to Follow-up|0|||
17071706|NCT00406653|38214208|FG001|Maintenance Period|Lost to Follow-up|0|||
17071707|NCT00406653|38214209|FG002|Maintenance Period|Lost to Follow-up|0|||
17071708|NCT00406653|38214210|FG003|Maintenance Period|Lost to Follow-up|0|||
17071709|NCT00406653|38214211|FG004|Maintenance Period|Lost to Follow-up|2|||
17071710|NCT00406653|38214212|FG005|Maintenance Period|Lost to Follow-up|1|||
17071711|NCT00406653|38214213|FG006|Maintenance Period|Lost to Follow-up|0|||
17071712|NCT00406653|38214207|FG000|Maintenance Period|Withdrawal of Consent|0|||
17071713|NCT00406653|38214208|FG001|Maintenance Period|Withdrawal of Consent|0|||
17071714|NCT00406653|38214209|FG002|Maintenance Period|Withdrawal of Consent|0|||
17071715|NCT00406653|38214210|FG003|Maintenance Period|Withdrawal of Consent|0|||
17071716|NCT00406653|38214211|FG004|Maintenance Period|Withdrawal of Consent|2|||
17071717|NCT00406653|38214212|FG005|Maintenance Period|Withdrawal of Consent|0|||
17071718|NCT00406653|38214213|FG006|Maintenance Period|Withdrawal of Consent|0|||
17071719|NCT00406653|38214207|FG000|Maintenance Period|Pregnancy|0|||
17071720|NCT00406653|38214208|FG001|Maintenance Period|Pregnancy|0|||
17071721|NCT00406653|38214209|FG002|Maintenance Period|Pregnancy|0|||
17071722|NCT00406653|38214210|FG003|Maintenance Period|Pregnancy|0|||
17071723|NCT00406653|38214211|FG004|Maintenance Period|Pregnancy|0|||
17071724|NCT00406653|38214212|FG005|Maintenance Period|Pregnancy|1|||
17071725|NCT00406653|38214213|FG006|Maintenance Period|Pregnancy|0|||
17071726|NCT00406653|38214207|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
17071727|NCT00406653|38214208|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
17071728|NCT00406653|38214209|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
17071729|NCT00406653|38214210|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
17071730|NCT00406653|38214211|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
17071731|NCT00406653|38214212|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
17071732|NCT00406653|38214213|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
17152426|NCT02877927|38298369|FG001|Overall Study|Adverse Event|0|||
17152427|NCT02877927|38298368|FG000|Overall Study|Lost to Follow-up|37|||
17152428|NCT02877927|38298369|FG001|Overall Study|Lost to Follow-up|38|||
17152429|NCT02877927|38298368|FG000|Overall Study|Withdrawal by Subject|11|||
17152430|NCT02877927|38298369|FG001|Overall Study|Withdrawal by Subject|12|||
17152431|NCT02877927|38298368|FG000|Overall Study|Physician Decision|0|||
17152432|NCT02877927|38298369|FG001|Overall Study|Physician Decision|1|||
17152433|NCT02877927|38298368|FG000|Overall Study|Missed EOT/PTE Visit|5|||
17152434|NCT02877927|38298369|FG001|Overall Study|Missed EOT/PTE Visit|6|||
17152435|NCT02706886|38298384|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
17152436|NCT02706886|38298385|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
17152437|NCT02706886|38298386|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
17152438|NCT02706886|38298387|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
17152439|NCT02706886|38298388|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
17152440|NCT02706886|38298389|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
17152441|NCT02706886|38298390|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
17152442|NCT02706886|38298391|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
17152443|NCT02706886|38298392|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
17152444|NCT03112590|38298438|FG000|Overall Study|Adverse Event|0|||
17152445|NCT03112590|38298439|FG001|Overall Study|Adverse Event|1|||
16994217|NCT03141177|38138012|FG001|Overall Study|Not reported|0|||
16994218|NCT03141177|38138013|FG002|Overall Study|Not reported|1|||
16994219|NCT03141177|38138011|FG000|Overall Study|Lost to Follow-up|2|||
16994220|NCT03141177|38138012|FG001|Overall Study|Lost to Follow-up|1|||
16994221|NCT03141177|38138013|FG002|Overall Study|Lost to Follow-up|1|||
16994222|NCT03141177|38138011|FG000|Overall Study|Other reasons|4|||
16994223|NCT03141177|38138012|FG001|Overall Study|Other reasons|0|||
16994224|NCT03141177|38138013|FG002|Overall Study|Other reasons|11|||
16994225|NCT03141177|38138011|FG000|Overall Study|Participants did not start treatment period|3|||
16994226|NCT03141177|38138012|FG001|Overall Study|Participants did not start treatment period|0|||
16994227|NCT03141177|38138013|FG002|Overall Study|Participants did not start treatment period|8|||
16994228|NCT01070303|38138024|FG000|Overall Study|Adverse Event|39|||
17152446|NCT03112590|38298440|FG002|Overall Study|Adverse Event|0|||
17152447|NCT04074161|38298460|FG000|Overall Study|Withdrawal by Subject|2|||
17152448|NCT04074161|38298461|FG001|Overall Study|Withdrawal by Subject|4|||
17152449|NCT04074161|38298462|FG002|Overall Study|Withdrawal by Subject|1|||
17152450|NCT04074161|38298460|FG000|Overall Study|Lost to Follow-up|4|||
17152451|NCT04074161|38298461|FG001|Overall Study|Lost to Follow-up|5|||
17152452|NCT04074161|38298462|FG002|Overall Study|Lost to Follow-up|3|||
17152453|NCT04069715|38298472|FG000|Overall Study|Lost to Follow-up|1|||
17152454|NCT04069715|38298473|FG001|Overall Study|Lost to Follow-up|1|||
17152455|NCT04069715|38298472|FG000|Overall Study|Physician Decision|1|||
17152456|NCT04069715|38298473|FG001|Overall Study|Physician Decision|1|||
17152457|NCT04069715|38298472|FG000|Overall Study|Withdrawal by Subject|3|||
17152458|NCT04069715|38298473|FG001|Overall Study|Withdrawal by Subject|3|||
17152459|NCT03681119|38298481|FG000|Overall Study|No specific reason|4|||
17152460|NCT03681119|38298482|FG001|Overall Study|No specific reason|0|||
17152461|NCT03681119|38298481|FG000|Overall Study|Sickness|2|||
17152462|NCT03681119|38298482|FG001|Overall Study|Sickness|0|||
17152463|NCT03111108|38298488|FG000|Overall Study|Death|0|||
17071733|NCT00406653|38214207|FG000|Maintenance Period|Error in disease score evaluation|0|||
17071734|NCT00406653|38214208|FG001|Maintenance Period|Error in disease score evaluation|0|||
17071735|NCT00406653|38214209|FG002|Maintenance Period|Error in disease score evaluation|0|||
17071736|NCT00406653|38214210|FG003|Maintenance Period|Error in disease score evaluation|0|||
17071737|NCT00406653|38214211|FG004|Maintenance Period|Error in disease score evaluation|1|||
17071738|NCT00406653|38214212|FG005|Maintenance Period|Error in disease score evaluation|0|||
17152464|NCT03111108|38298489|FG001|Overall Study|Death|1|||
17152465|NCT03111108|38298488|FG000|Overall Study|Withdrawal by Subject|1|||
17152466|NCT03111108|38298489|FG001|Overall Study|Withdrawal by Subject|0|||
17152467|NCT03677375|38298495|FG000|Overall Study|Incomplete procedure|8|||
17152468|NCT03677375|38298495|FG000|Overall Study|Adverse Event|3|||
17152469|NCT03677375|38298495|FG000|Overall Study|Physician Decision|1|||
17152470|NCT00702520|38298501|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
17152471|NCT00702520|38298502|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
17152472|NCT00702520|38298503|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
17152473|NCT00702520|38298504|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
17152474|NCT00702520|38298501|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
17152475|NCT00702520|38298502|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
17152476|NCT00702520|38298503|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
17152477|NCT00702520|38298504|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
17152478|NCT00702520|38298501|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
17152479|NCT00702520|38298502|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
17152480|NCT00702520|38298503|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
17152481|NCT00702520|38298504|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
17152482|NCT04067141|38298514|FG000|First Intervention|Withdrawal by Subject|0|||
17152483|NCT04067141|38298515|FG001|First Intervention|Withdrawal by Subject|1|||
17152484|NCT04067141|38298514|FG000|Second Intervention|Adverse Event|0|||
17152485|NCT04067141|38298515|FG001|Second Intervention|Adverse Event|2|||
17152486|NCT02876601|38298525|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
17152487|NCT02876601|38298526|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
17152488|NCT02876601|38298527|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
17152489|NCT02876601|38298528|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
17152490|NCT04054193|38298573|FG000|Cycle 1|Physician Decision|1|||
17152491|NCT04054193|38298573|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
16994229|NCT01070303|38138024|FG000|Overall Study|Withdrawal by Subject|20|||
17071739|NCT00406653|38214213|FG006|Maintenance Period|Error in disease score evaluation|0|||
17071740|NCT00406653|38214207|FG000|Open-Label Period|Death|0|||
17071741|NCT00406653|38214208|FG001|Open-Label Period|Death|0|||
17071742|NCT00406653|38214209|FG002|Open-Label Period|Death|0|||
17071743|NCT00406653|38214210|FG003|Open-Label Period|Death|0|||
17071744|NCT00406653|38214211|FG004|Open-Label Period|Death|0|||
17071745|NCT00406653|38214212|FG005|Open-Label Period|Death|0|||
17071746|NCT00406653|38214213|FG006|Open-Label Period|Death|1|||
17071747|NCT00406653|38214207|FG000|Open-Label Period|Adverse Event|0|||
17071748|NCT00406653|38214208|FG001|Open-Label Period|Adverse Event|0|||
17071749|NCT00406653|38214209|FG002|Open-Label Period|Adverse Event|0|||
17071750|NCT00406653|38214210|FG003|Open-Label Period|Adverse Event|0|||
17071751|NCT00406653|38214211|FG004|Open-Label Period|Adverse Event|0|||
17071752|NCT00406653|38214212|FG005|Open-Label Period|Adverse Event|0|||
17071753|NCT00406653|38214213|FG006|Open-Label Period|Adverse Event|18|||
17071754|NCT00406653|38214207|FG000|Open-Label Period|Lack of Efficacy|0|||
17071755|NCT00406653|38214208|FG001|Open-Label Period|Lack of Efficacy|0|||
17071756|NCT00406653|38214209|FG002|Open-Label Period|Lack of Efficacy|0|||
17071757|NCT00406653|38214210|FG003|Open-Label Period|Lack of Efficacy|0|||
17071758|NCT00406653|38214211|FG004|Open-Label Period|Lack of Efficacy|0|||
17071759|NCT00406653|38214212|FG005|Open-Label Period|Lack of Efficacy|0|||
17152492|NCT04054193|38298573|FG000|Cycle 1|Allocated but not treated|3|||
17152493|NCT04054193|38298573|FG000|Cycles 2-3|Physician Decision|2|||
17152494|NCT04054193|38298573|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
17152495|NCT04054193|38298573|FG000|Cycles 2-3|Various reasons|17|||
17152496|NCT03394027|38298581|FG000|Overall Study|Ineligible|3|||
17152497|NCT03394027|38298582|FG001|Overall Study|Ineligible|1|||
17152498|NCT03394027|38298583|FG002|Overall Study|Ineligible|3|||
17152499|NCT03394027|38298581|FG000|Overall Study|Participant declined to participate before treatment started|0|||
17152500|NCT03394027|38298582|FG001|Overall Study|Participant declined to participate before treatment started|0|||
17152501|NCT03394027|38298583|FG002|Overall Study|Participant declined to participate before treatment started|1|||
17152502|NCT03136107|38298609|FG000|Overall Study|Other (Not specified)|1|||
17152503|NCT02916056|38298617|FG000|Overall Study|Adverse Event|6|||
17152504|NCT02916056|38298617|FG000|Overall Study|Lost to Follow-up|1|||
17152505|NCT02916056|38298617|FG000|Overall Study|Other|12|||
17152506|NCT02916056|38298617|FG000|Overall Study|Protocol Violation|1|||
17152507|NCT02916056|38298617|FG000|Overall Study|Withdrawal by Subject|8|||
17152508|NCT02916056|38298617|FG000|Overall Study|Study Terminated by Sponsor|269|||
17152509|NCT04854642|38298621|FG000|Overall Study|Adverse Event|1|||
17152510|NCT04854642|38298622|FG001|Overall Study|Adverse Event|2|||
17152511|NCT04854642|38298621|FG000|Overall Study|Withdrawal by Subject|0|||
17152512|NCT04854642|38298622|FG001|Overall Study|Withdrawal by Subject|1|||
17152513|NCT03384745|38298636|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
17152514|NCT03384745|38298637|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
17152515|NCT03384745|38298638|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
17152516|NCT03384745|38298639|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
17152517|NCT03384745|38298640|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
17152518|NCT03384745|38298641|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
17152519|NCT03384745|38298636|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
17152520|NCT03384745|38298637|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
17152521|NCT03384745|38298638|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
17152522|NCT03384745|38298639|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
17152523|NCT03384745|38298640|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
17152524|NCT03384745|38298641|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
17152525|NCT03384745|38298636|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
17152526|NCT03384745|38298637|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
17152527|NCT03384745|38298638|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
17152528|NCT03384745|38298639|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
17152529|NCT03384745|38298640|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
17152530|NCT03384745|38298641|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
17152531|NCT03384745|38298636|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
17152532|NCT03384745|38298637|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
17152533|NCT03384745|38298638|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
17152534|NCT03384745|38298639|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
17152535|NCT03384745|38298640|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
17152536|NCT03384745|38298641|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
17152537|NCT03384745|38298636|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
17152538|NCT03384745|38298637|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
17152539|NCT03384745|38298638|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
17152540|NCT03384745|38298639|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
17152541|NCT03384745|38298640|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
17152542|NCT03384745|38298641|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
17152543|NCT03384745|38298636|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
17152544|NCT03384745|38298637|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
17152545|NCT03384745|38298638|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
17152546|NCT03384745|38298639|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
17152547|NCT03384745|38298640|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
17152548|NCT03384745|38298641|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
17152549|NCT03384745|38298636|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
17152550|NCT03384745|38298637|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
17152551|NCT03384745|38298638|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
17152552|NCT03384745|38298639|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
17152553|NCT03384745|38298640|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
17152554|NCT03384745|38298641|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
17152555|NCT03384745|38298636|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
17152556|NCT03384745|38298637|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
17152557|NCT03384745|38298638|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
17152558|NCT03384745|38298639|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
17152559|NCT03384745|38298640|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
17152560|NCT03384745|38298641|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
17071760|NCT00406653|38214213|FG006|Open-Label Period|Lack of Efficacy|160|||
17071761|NCT00406653|38214207|FG000|Open-Label Period|Lost to Follow-up|0|||
17071762|NCT00406653|38214208|FG001|Open-Label Period|Lost to Follow-up|0|||
17071763|NCT00406653|38214209|FG002|Open-Label Period|Lost to Follow-up|0|||
17071764|NCT00406653|38214210|FG003|Open-Label Period|Lost to Follow-up|0|||
17071765|NCT00406653|38214211|FG004|Open-Label Period|Lost to Follow-up|0|||
17071766|NCT00406653|38214212|FG005|Open-Label Period|Lost to Follow-up|0|||
17071767|NCT00406653|38214213|FG006|Open-Label Period|Lost to Follow-up|6|||
17071768|NCT00406653|38214207|FG000|Open-Label Period|Withdrawal of Consent|0|||
17071769|NCT00406653|38214208|FG001|Open-Label Period|Withdrawal of Consent|0|||
17071770|NCT00406653|38214209|FG002|Open-Label Period|Withdrawal of Consent|0|||
17071771|NCT00406653|38214210|FG003|Open-Label Period|Withdrawal of Consent|0|||
17071772|NCT00406653|38214211|FG004|Open-Label Period|Withdrawal of Consent|0|||
17071773|NCT00406653|38214212|FG005|Open-Label Period|Withdrawal of Consent|0|||
17071774|NCT00406653|38214213|FG006|Open-Label Period|Withdrawal of Consent|11|||
17071775|NCT00406653|38214207|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
17071776|NCT00406653|38214208|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
17071777|NCT00406653|38214209|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
17071778|NCT00406653|38214210|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
17071779|NCT00406653|38214211|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
17071780|NCT00406653|38214212|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
17071781|NCT00406653|38214213|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
17071782|NCT00406653|38214207|FG000|Open-Label Period|Pregnancy|0|||
17071783|NCT00406653|38214208|FG001|Open-Label Period|Pregnancy|0|||
17071784|NCT00406653|38214209|FG002|Open-Label Period|Pregnancy|0|||
17071785|NCT00406653|38214210|FG003|Open-Label Period|Pregnancy|0|||
17071786|NCT00406653|38214211|FG004|Open-Label Period|Pregnancy|0|||
17071787|NCT00406653|38214212|FG005|Open-Label Period|Pregnancy|0|||
17152561|NCT03384745|38298636|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
17152562|NCT03384745|38298637|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
17152563|NCT03384745|38298638|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
17152564|NCT03384745|38298639|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
17152565|NCT03384745|38298640|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
17152566|NCT03384745|38298641|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
17152567|NCT03384745|38298636|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
17152568|NCT03384745|38298637|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
17152569|NCT03384745|38298638|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
17152570|NCT03384745|38298639|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
17152571|NCT03384745|38298640|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
17152572|NCT03384745|38298641|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
17152573|NCT03384745|38298636|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
17152574|NCT03384745|38298637|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
17152575|NCT03384745|38298638|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
17152576|NCT03384745|38298639|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
17152577|NCT03384745|38298640|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
17152578|NCT03384745|38298641|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
17152579|NCT03383887|38298661|FG000|Overall Study|Lost to Follow-up|0|||
17152580|NCT03383887|38298662|FG001|Overall Study|Lost to Follow-up|1|||
17152581|NCT03379753|38298670|FG000|Overall Study|Withdrawal by Subject|2|||
17152582|NCT03379753|38298671|FG001|Overall Study|Withdrawal by Subject|1|||
17152583|NCT03379753|38298670|FG000|Overall Study|not having correct procedure|1|||
17152584|NCT03379753|38298671|FG001|Overall Study|not having correct procedure|2|||
17152585|NCT03379753|38298670|FG000|Overall Study|No primary outcome|12|||
17152586|NCT03379753|38298671|FG001|Overall Study|No primary outcome|22|||
17152587|NCT03548064|38298685|FG000|Overall Study|Withdrawal by Subject|0|||
17152588|NCT03548064|38298686|FG001|Overall Study|Withdrawal by Subject|0|||
17152589|NCT03548064|38298687|FG002|Overall Study|Withdrawal by Subject|0|||
17152590|NCT03548064|38298688|FG003|Overall Study|Withdrawal by Subject|1|||
17152591|NCT03548064|38298689|FG004|Overall Study|Withdrawal by Subject|0|||
17152592|NCT03548064|38298690|FG005|Overall Study|Withdrawal by Subject|0|||
17152593|NCT03548064|38298691|FG006|Overall Study|Withdrawal by Subject|0|||
17152594|NCT03548064|38298692|FG007|Overall Study|Withdrawal by Subject|0|||
17152595|NCT03548064|38298685|FG000|Overall Study|Lost to Follow-up|0|||
17152596|NCT03548064|38298686|FG001|Overall Study|Lost to Follow-up|0|||
17152597|NCT03548064|38298687|FG002|Overall Study|Lost to Follow-up|0|||
17152598|NCT03548064|38298688|FG003|Overall Study|Lost to Follow-up|0|||
17152599|NCT03548064|38298689|FG004|Overall Study|Lost to Follow-up|2|||
17152600|NCT03548064|38298690|FG005|Overall Study|Lost to Follow-up|0|||
17152601|NCT03548064|38298691|FG006|Overall Study|Lost to Follow-up|0|||
17152602|NCT03548064|38298692|FG007|Overall Study|Lost to Follow-up|0|||
17071788|NCT00406653|38214213|FG006|Open-Label Period|Pregnancy|2|||
17152603|NCT03548064|38298685|FG000|Overall Study|Covid-19 Pandemic|0|||
17071789|NCT00406653|38214207|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
17071790|NCT00406653|38214208|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
17071791|NCT00406653|38214209|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
17071792|NCT00406653|38214210|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
17071793|NCT00406653|38214211|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
17071794|NCT00406653|38214212|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
17071795|NCT00406653|38214213|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
17071796|NCT00406653|38214207|FG000|Open-Label Period|Declined participation but followup done|0|||
17071797|NCT00406653|38214208|FG001|Open-Label Period|Declined participation but followup done|0|||
17071798|NCT00406653|38214209|FG002|Open-Label Period|Declined participation but followup done|0|||
17071799|NCT00406653|38214210|FG003|Open-Label Period|Declined participation but followup done|0|||
17071800|NCT00406653|38214211|FG004|Open-Label Period|Declined participation but followup done|0|||
17071801|NCT00406653|38214212|FG005|Open-Label Period|Declined participation but followup done|0|||
17071802|NCT00406653|38214213|FG006|Open-Label Period|Declined participation but followup done|8|||
17071803|NCT00406653|38214207|FG000|Open-Label Period|Discontinued by Sponsor|0|||
17071804|NCT00406653|38214208|FG001|Open-Label Period|Discontinued by Sponsor|0|||
17071805|NCT00406653|38214209|FG002|Open-Label Period|Discontinued by Sponsor|0|||
17071806|NCT00406653|38214210|FG003|Open-Label Period|Discontinued by Sponsor|0|||
17071807|NCT00406653|38214211|FG004|Open-Label Period|Discontinued by Sponsor|0|||
17071808|NCT00406653|38214212|FG005|Open-Label Period|Discontinued by Sponsor|0|||
17071809|NCT00406653|38214213|FG006|Open-Label Period|Discontinued by Sponsor|1|||
17071810|NCT00406653|38214207|FG000|Open-Label Period|Refused followup|0|||
17071811|NCT00406653|38214208|FG001|Open-Label Period|Refused followup|0|||
16994230|NCT01070303|38138024|FG000|Overall Study|Lost to Follow-up|9|||
16994231|NCT01070303|38138024|FG000|Overall Study|Protocol Violation|0|||
16994232|NCT01070303|38138024|FG000|Overall Study|Lack of Efficacy|2|||
17071812|NCT00406653|38214209|FG002|Open-Label Period|Refused followup|0|||
17071813|NCT00406653|38214210|FG003|Open-Label Period|Refused followup|0|||
17071814|NCT00406653|38214211|FG004|Open-Label Period|Refused followup|0|||
17071815|NCT00406653|38214212|FG005|Open-Label Period|Refused followup|0|||
17071816|NCT00406653|38214213|FG006|Open-Label Period|Refused followup|1|||
17071817|NCT00547157|38214235|FG000|Overall Study|Other|1|||
17071818|NCT00547157|38214236|FG001|Overall Study|Other|0|||
17071819|NCT00547157|38214235|FG000|Overall Study|Death|38|||
17071820|NCT00547157|38214236|FG001|Overall Study|Death|18|||
17071821|NCT00547157|38214235|FG000|Overall Study|Withdrawal by Subject|3|||
17071822|NCT00547157|38214236|FG001|Overall Study|Withdrawal by Subject|1|||
17071823|NCT00547157|38214235|FG000|Overall Study|Administrative decision|3|||
17071824|NCT00547157|38214236|FG001|Overall Study|Administrative decision|2|||
16994233|NCT01070303|38138024|FG000|Overall Study|Administrative Reason|1|||
16994234|NCT01070303|38138024|FG000|Overall Study|Other|18|||
16994235|NCT01009814|38138039|FG000|Overall Study|No longer met study criteria|1|||
16994236|NCT01009814|38138040|FG001|Overall Study|No longer met study criteria|1|||
16994237|NCT01009814|38138041|FG002|Overall Study|No longer met study criteria|0|||
16994238|NCT01009814|38138042|FG003|Overall Study|No longer met study criteria|0|||
16994239|NCT01009814|38138043|FG004|Overall Study|No longer met study criteria|0|||
16994240|NCT03824587|38138061|FG000|Run-in Period|Screen Failure|0|||
16994241|NCT03824587|38138062|FG001|Run-in Period|Screen Failure|275|||
16994242|NCT03824587|38138061|FG000|Treatment Period|Adverse Event|4|||
16994243|NCT03824587|38138062|FG001|Treatment Period|Adverse Event|1|||
16994244|NCT03824587|38138061|FG000|Treatment Period|Withdrawal by Subject|0|||
16994245|NCT03824587|38138062|FG001|Treatment Period|Withdrawal by Subject|1|||
16994246|NCT03824587|38138061|FG000|Treatment Period|Kidney Transplant|1|||
16994247|NCT03824587|38138062|FG001|Treatment Period|Kidney Transplant|1|||
16994248|NCT00773734|38138072|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
16994249|NCT00773734|38138073|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
16994250|NCT00773734|38138074|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
16994251|NCT00773734|38138075|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
16994252|NCT00773734|38138076|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
16994253|NCT00773734|38138077|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
16994254|NCT00773734|38138072|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
16994255|NCT00773734|38138073|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
16994256|NCT00773734|38138074|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
16994257|NCT00773734|38138075|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
16994258|NCT00773734|38138076|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
17071825|NCT00547157|38214235|FG000|Overall Study|Lost to Follow-up|4|||
17071826|NCT00547157|38214236|FG001|Overall Study|Lost to Follow-up|2|||
17071827|NCT00384033|38214246|FG000|Overall Study|Adverse Event|10|||
17071828|NCT00384033|38214247|FG001|Overall Study|Adverse Event|8|||
17071829|NCT00384033|38214248|FG002|Overall Study|Adverse Event|11|||
17071830|NCT00384033|38214249|FG003|Overall Study|Adverse Event|20|||
17071831|NCT00384033|38214246|FG000|Overall Study|Failed to return|1|||
17071832|NCT00384033|38214247|FG001|Overall Study|Failed to return|3|||
17071833|NCT00384033|38214248|FG002|Overall Study|Failed to return|2|||
17071834|NCT00384033|38214249|FG003|Overall Study|Failed to return|2|||
17071835|NCT00384033|38214246|FG000|Overall Study|Physician Decision|1|||
17071836|NCT00384033|38214247|FG001|Overall Study|Physician Decision|0|||
17071837|NCT00384033|38214248|FG002|Overall Study|Physician Decision|0|||
17071838|NCT00384033|38214249|FG003|Overall Study|Physician Decision|0|||
17071839|NCT00384033|38214246|FG000|Overall Study|Lost to Follow-up|6|||
17071840|NCT00384033|38214247|FG001|Overall Study|Lost to Follow-up|12|||
17071841|NCT00384033|38214248|FG002|Overall Study|Lost to Follow-up|7|||
17071842|NCT00384033|38214249|FG003|Overall Study|Lost to Follow-up|7|||
17071843|NCT00384033|38214246|FG000|Overall Study|Other|2|||
17071844|NCT00384033|38214247|FG001|Overall Study|Other|0|||
17071845|NCT00384033|38214248|FG002|Overall Study|Other|0|||
17071846|NCT00384033|38214249|FG003|Overall Study|Other|0|||
17071847|NCT00384033|38214246|FG000|Overall Study|Protocol Violation|5|||
17071848|NCT00384033|38214247|FG001|Overall Study|Protocol Violation|0|||
17071849|NCT00384033|38214248|FG002|Overall Study|Protocol Violation|5|||
17071850|NCT00384033|38214249|FG003|Overall Study|Protocol Violation|6|||
17071851|NCT00384033|38214246|FG000|Overall Study|Withdrawal by Subject|6|||
17152604|NCT03548064|38298686|FG001|Overall Study|Covid-19 Pandemic|0|||
17152605|NCT03548064|38298687|FG002|Overall Study|Covid-19 Pandemic|0|||
17152606|NCT03548064|38298688|FG003|Overall Study|Covid-19 Pandemic|0|||
17152607|NCT03548064|38298689|FG004|Overall Study|Covid-19 Pandemic|10|||
17152608|NCT03548064|38298690|FG005|Overall Study|Covid-19 Pandemic|3|||
17152609|NCT03548064|38298691|FG006|Overall Study|Covid-19 Pandemic|0|||
17152610|NCT03548064|38298692|FG007|Overall Study|Covid-19 Pandemic|0|||
17152611|NCT03379675|38298719|FG000|Overall Study|Lost to Follow-up|0|||
17152612|NCT03379675|38298720|FG001|Overall Study|Lost to Follow-up|1|||
17152613|NCT03379675|38298721|FG002|Overall Study|Lost to Follow-up|0|||
17152614|NCT03379675|38298719|FG000|Overall Study|Adverse Event|2|||
17152615|NCT03379675|38298720|FG001|Overall Study|Adverse Event|0|||
17152616|NCT03379675|38298721|FG002|Overall Study|Adverse Event|0|||
17152617|NCT03379675|38298719|FG000|Overall Study|Withdrawal by Subject|2|||
17152618|NCT03379675|38298720|FG001|Overall Study|Withdrawal by Subject|1|||
17152619|NCT03379675|38298721|FG002|Overall Study|Withdrawal by Subject|2|||
17152620|NCT02930889|38298729|FG000|Overall Study|Lost to Follow-up|2|||
17152621|NCT02930889|38298729|FG000|Overall Study|Withdrawal by Subject|6|||
17152622|NCT02930889|38298729|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
17152623|NCT02875977|38298735|FG000|Overall Study|Lost to Follow-up|42|||
17152624|NCT02875977|38298736|FG001|Overall Study|Lost to Follow-up|29|||
17152625|NCT02703532|38298755|FG000|Overall Study|Withdrawal by Subject|0|||
17152626|NCT02703532|38298756|FG001|Overall Study|Withdrawal by Subject|1|||
17152627|NCT02703532|38298757|FG002|Overall Study|Withdrawal by Subject|0|||
17152628|NCT02703532|38298758|FG003|Overall Study|Withdrawal by Subject|1|||
17152629|NCT02703532|38298755|FG000|Overall Study|Lost to Follow-up|2|||
17152630|NCT02703532|38298756|FG001|Overall Study|Lost to Follow-up|0|||
17152631|NCT02703532|38298757|FG002|Overall Study|Lost to Follow-up|2|||
17152632|NCT02703532|38298758|FG003|Overall Study|Lost to Follow-up|0|||
17152633|NCT02930343|38298791|FG000|Overall Study|Lost to Follow-up|9|||
17152634|NCT02930343|38298792|FG001|Overall Study|Lost to Follow-up|7|||
17152635|NCT02703454|38298800|FG000|Overall Study|Not treated|1|||
17152636|NCT02703454|38298801|FG001|Overall Study|Not treated|3|||
17152637|NCT02703454|38298800|FG000|Overall Study|Withdrawal by Subject|4|||
17152638|NCT02703454|38298801|FG001|Overall Study|Withdrawal by Subject|3|||
17152639|NCT02703454|38298800|FG000|Overall Study|Lost to Follow-up|1|||
17152640|NCT02703454|38298801|FG001|Overall Study|Lost to Follow-up|2|||
17152641|NCT02703454|38298800|FG000|Overall Study|Study discontinuation|5|||
17152642|NCT02703454|38298801|FG001|Overall Study|Study discontinuation|8|||
17152643|NCT03103542|38298807|FG000|Overall Study|Physician Decision|2|||
17152644|NCT03103542|38298807|FG000|Overall Study|Adverse Event|2|||
17071852|NCT00384033|38214247|FG001|Overall Study|Withdrawal by Subject|2|||
17071853|NCT00384033|38214248|FG002|Overall Study|Withdrawal by Subject|5|||
17071854|NCT00384033|38214249|FG003|Overall Study|Withdrawal by Subject|2|||
17071855|NCT00384033|38214246|FG000|Overall Study|Lack of Efficacy|7|||
17071856|NCT00384033|38214247|FG001|Overall Study|Lack of Efficacy|3|||
17152645|NCT03103542|38298807|FG000|Overall Study|Other|2|||
17152646|NCT03103542|38298807|FG000|Overall Study|Withdrawal by Subject|1|||
17071857|NCT00384033|38214248|FG002|Overall Study|Lack of Efficacy|3|||
17071858|NCT00384033|38214249|FG003|Overall Study|Lack of Efficacy|1|||
17071859|NCT00384033|38214246|FG000|Overall Study|Randomized but not treated|3|||
17152647|NCT03376321|38298834|FG000|Overall Study|Other|5|||
17152648|NCT03376321|38298835|FG001|Overall Study|Other|1|||
17152649|NCT03376321|38298834|FG000|Overall Study|Withdrawal by Subject|8|||
17152650|NCT03376321|38298835|FG001|Overall Study|Withdrawal by Subject|14|||
17152651|NCT03376321|38298834|FG000|Overall Study|Lost to Follow-up|1|||
17152652|NCT03376321|38298835|FG001|Overall Study|Lost to Follow-up|7|||
17152653|NCT03376321|38298834|FG000|Overall Study|Death|4|||
17071860|NCT00384033|38214247|FG001|Overall Study|Randomized but not treated|7|||
17071861|NCT00384033|38214248|FG002|Overall Study|Randomized but not treated|10|||
17071862|NCT00384033|38214249|FG003|Overall Study|Randomized but not treated|2|||
17071863|NCT00546377|38214259|FG000|Overall Study|Deemed ineligible|1|||
17071864|NCT00546377|38214259|FG000|Overall Study|Adverse Event|6|||
17071865|NCT03941483|38214266|FG000|Overall Study|Miscellaneous|2|||
17071866|NCT03941483|38214267|FG001|Overall Study|Miscellaneous|3|||
17071867|NCT03941483|38214268|FG002|Overall Study|Miscellaneous|0|||
17152654|NCT03376321|38298835|FG001|Overall Study|Death|0|||
17152655|NCT03376321|38298834|FG000|Overall Study|Randomized, not treated|5|||
17152656|NCT03376321|38298835|FG001|Overall Study|Randomized, not treated|3|||
17071868|NCT03941483|38214266|FG000|Overall Study|Study Terminated by Sponsor|1|||
17071869|NCT03941483|38214267|FG001|Overall Study|Study Terminated by Sponsor|0|||
17071870|NCT03941483|38214268|FG002|Overall Study|Study Terminated by Sponsor|0|||
17071871|NCT03941483|38214266|FG000|Overall Study|Withdrawal by Subject|1|||
17071872|NCT03941483|38214267|FG001|Overall Study|Withdrawal by Subject|4|||
17071873|NCT03941483|38214268|FG002|Overall Study|Withdrawal by Subject|1|||
17071874|NCT03941483|38214266|FG000|Overall Study|Lost to Follow-up|2|||
17071875|NCT03941483|38214267|FG001|Overall Study|Lost to Follow-up|1|||
17071876|NCT03941483|38214268|FG002|Overall Study|Lost to Follow-up|8|||
17071877|NCT03941483|38214266|FG000|Overall Study|Death|3|||
17071878|NCT03941483|38214267|FG001|Overall Study|Death|2|||
17071879|NCT03941483|38214268|FG002|Overall Study|Death|6|||
17071880|NCT00545753|38214278|FG000|Overall Study|Withdrawal by Subject|0|||
17071881|NCT00545753|38214279|FG001|Overall Study|Withdrawal by Subject|1|||
17071882|NCT00545753|38214280|FG002|Overall Study|Withdrawal by Subject|10|||
17071883|NCT00545753|38214278|FG000|Overall Study|Lost to Follow-up|13|||
17071884|NCT00545753|38214279|FG001|Overall Study|Lost to Follow-up|3|||
17071885|NCT00545753|38214280|FG002|Overall Study|Lost to Follow-up|12|||
17071886|NCT00545753|38214278|FG000|Overall Study|Protocol Violation|3|||
17071887|NCT00545753|38214279|FG001|Overall Study|Protocol Violation|1|||
17071888|NCT00545753|38214280|FG002|Overall Study|Protocol Violation|4|||
17071889|NCT00406419|38214292|FG000|Overall Study|Death|3|||
17071890|NCT00406419|38214293|FG001|Overall Study|Death|1|||
17071891|NCT00406419|38214294|FG002|Overall Study|Death|4|||
17071892|NCT00406419|38214292|FG000|Overall Study|Protocol Violation|6|||
17071893|NCT00406419|38214293|FG001|Overall Study|Protocol Violation|2|||
17071894|NCT00406419|38214294|FG002|Overall Study|Protocol Violation|5|||
17071895|NCT00406419|38214292|FG000|Overall Study|Study Terminated by Sponsor|260|||
17071896|NCT00406419|38214293|FG001|Overall Study|Study Terminated by Sponsor|288|||
17071897|NCT00406419|38214294|FG002|Overall Study|Study Terminated by Sponsor|282|||
17071898|NCT00406419|38214292|FG000|Overall Study|Withdrawal by Subject|17|||
17071899|NCT00406419|38214293|FG001|Overall Study|Withdrawal by Subject|24|||
17071900|NCT00406419|38214294|FG002|Overall Study|Withdrawal by Subject|26|||
17071901|NCT00406419|38214292|FG000|Overall Study|Lack of Efficacy|12|||
17071902|NCT00406419|38214293|FG001|Overall Study|Lack of Efficacy|1|||
17071903|NCT00406419|38214294|FG002|Overall Study|Lack of Efficacy|6|||
17071904|NCT00406419|38214292|FG000|Overall Study|Non-Compliance with Study Drug|5|||
17071905|NCT00406419|38214293|FG001|Overall Study|Non-Compliance with Study Drug|6|||
17071906|NCT00406419|38214294|FG002|Overall Study|Non-Compliance with Study Drug|3|||
17071907|NCT00406419|38214292|FG000|Overall Study|Adverse Event|10|||
17071908|NCT00406419|38214293|FG001|Overall Study|Adverse Event|12|||
17071909|NCT00406419|38214294|FG002|Overall Study|Adverse Event|16|||
17071910|NCT00406419|38214292|FG000|Overall Study|Lost to Follow-up|11|||
17071911|NCT00406419|38214293|FG001|Overall Study|Lost to Follow-up|10|||
17071912|NCT00406419|38214294|FG002|Overall Study|Lost to Follow-up|5|||
17071913|NCT00325468|38214307|FG000|Overall Study|Adverse Event|1|||
17071914|NCT00325468|38214308|FG001|Overall Study|Adverse Event|1|||
17071915|NCT00325468|38214309|FG002|Overall Study|Adverse Event|0|||
17071916|NCT00325468|38214310|FG003|Overall Study|Adverse Event|5|||
17071917|NCT00325468|38214311|FG004|Overall Study|Adverse Event|1|||
17071918|NCT00325468|38214307|FG000|Overall Study|Death|2|||
17071919|NCT00325468|38214308|FG001|Overall Study|Death|0|||
17071920|NCT00325468|38214309|FG002|Overall Study|Death|2|||
17071921|NCT00325468|38214310|FG003|Overall Study|Death|4|||
17071922|NCT00325468|38214311|FG004|Overall Study|Death|0|||
17071923|NCT00325468|38214307|FG000|Overall Study|Lost to Follow-up|0|||
17071924|NCT00325468|38214308|FG001|Overall Study|Lost to Follow-up|0|||
17071925|NCT00325468|38214309|FG002|Overall Study|Lost to Follow-up|1|||
17071926|NCT00325468|38214310|FG003|Overall Study|Lost to Follow-up|2|||
17071927|NCT00325468|38214311|FG004|Overall Study|Lost to Follow-up|2|||
17071928|NCT00325468|38214307|FG000|Overall Study|Physician Decision|1|||
17071929|NCT00325468|38214308|FG001|Overall Study|Physician Decision|1|||
17071930|NCT00325468|38214309|FG002|Overall Study|Physician Decision|0|||
17071931|NCT00325468|38214310|FG003|Overall Study|Physician Decision|1|||
17071932|NCT00325468|38214311|FG004|Overall Study|Physician Decision|0|||
17071933|NCT00325468|38214307|FG000|Overall Study|Withdrawal by Subject|3|||
17071934|NCT00325468|38214308|FG001|Overall Study|Withdrawal by Subject|1|||
17071935|NCT00325468|38214309|FG002|Overall Study|Withdrawal by Subject|0|||
17152657|NCT03374995|38298843|FG000|Overall Study|Withdrawal by Subject|0|||
17152658|NCT03374995|38298844|FG001|Overall Study|Withdrawal by Subject|1|||
17152659|NCT02828982|38298850|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
17152660|NCT02828982|38298851|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
17152661|NCT03133767|38298861|FG000|Overall Study|Lost to Follow-up|38|||
17152662|NCT03133767|38298862|FG001|Overall Study|Lost to Follow-up|24|||
17152663|NCT03133767|38298861|FG000|Overall Study|Protocol Violation|0|||
17152664|NCT03133767|38298862|FG001|Overall Study|Protocol Violation|1|||
17152665|NCT03391765|38298872|FG000|Overall Study|Adverse Event|2|||
17152666|NCT03391765|38298873|FG001|Overall Study|Adverse Event|0|||
17152667|NCT03391765|38298874|FG002|Overall Study|Adverse Event|0|||
17152668|NCT03391765|38298875|FG003|Overall Study|Adverse Event|2|||
17152669|NCT03391765|38298872|FG000|Overall Study|Withdrew consent|5|||
17152670|NCT03391765|38298873|FG001|Overall Study|Withdrew consent|7|||
17152671|NCT03391765|38298874|FG002|Overall Study|Withdrew consent|2|||
17152672|NCT03391765|38298875|FG003|Overall Study|Withdrew consent|5|||
17152673|NCT03391765|38298872|FG000|Overall Study|Other, not specified|44|||
17152674|NCT03391765|38298873|FG001|Overall Study|Other, not specified|38|||
17152675|NCT03391765|38298874|FG002|Overall Study|Other, not specified|21|||
17152676|NCT03391765|38298875|FG003|Overall Study|Other, not specified|16|||
17152677|NCT02802228|38298887|FG000|Overall Study|Withdrawal by Subject|2|||
17152678|NCT02802228|38298888|FG001|Overall Study|Withdrawal by Subject|0|||
17152679|NCT02802228|38298887|FG000|Overall Study|Lost to Follow-up|1|||
17152680|NCT02802228|38298888|FG001|Overall Study|Lost to Follow-up|0|||
17071936|NCT00325468|38214310|FG003|Overall Study|Withdrawal by Subject|14|||
17071937|NCT00325468|38214311|FG004|Overall Study|Withdrawal by Subject|4|||
17071938|NCT00325468|38214307|FG000|Overall Study|site closure etc|4|||
17071939|NCT00325468|38214308|FG001|Overall Study|site closure etc|2|||
17071940|NCT00325468|38214309|FG002|Overall Study|site closure etc|1|||
17071941|NCT00325468|38214310|FG003|Overall Study|site closure etc|8|||
17071942|NCT00325468|38214311|FG004|Overall Study|site closure etc|1|||
17071943|NCT03833661|38214324|FG000|Overall Study|Treatment ongoing|9|||
17071944|NCT00311584|38214330|FG000|Overall Study|Death|1|||
17071945|NCT00311584|38214331|FG001|Overall Study|Death|0|||
17071946|NCT00311584|38214330|FG000|Overall Study|Lack of Efficacy|12|||
17071947|NCT00311584|38214331|FG001|Overall Study|Lack of Efficacy|15|||
17071948|NCT00311584|38214330|FG000|Overall Study|Physician Decision|4|||
17071949|NCT00311584|38214331|FG001|Overall Study|Physician Decision|5|||
17071950|NCT00311584|38214330|FG000|Overall Study|Withdrawal by Subject|1|||
17071951|NCT00311584|38214331|FG001|Overall Study|Withdrawal by Subject|1|||
17071952|NCT00311584|38214330|FG000|Overall Study|ineligible|2|||
17071953|NCT00311584|38214331|FG001|Overall Study|ineligible|2|||
17071954|NCT00383331|38214339|FG000|Overall Study|Protocol Violation|0|||
17071955|NCT00383331|38214340|FG001|Overall Study|Protocol Violation|1|||
17071956|NCT03934541|38214350|FG000|Overall Study|Study Terminated by Sponsor|0|||
17071957|NCT03934541|38214351|FG001|Overall Study|Study Terminated by Sponsor|1|||
17071958|NCT03934541|38214352|FG002|Overall Study|Study Terminated by Sponsor|0|||
17071959|NCT03934541|38214353|FG003|Overall Study|Study Terminated by Sponsor|0|||
17071960|NCT00325234|38214365|FG000|Overall Study|Adverse Event|10|||
17071961|NCT00325234|38214366|FG001|Overall Study|Adverse Event|7|||
17071962|NCT00325234|38214365|FG000|Overall Study|Death due to Study Disease|1|||
17071963|NCT00325234|38214366|FG001|Overall Study|Death due to Study Disease|0|||
17071964|NCT00325234|38214365|FG000|Overall Study|Entry Criteria Not Met|1|||
17071965|NCT00325234|38214366|FG001|Overall Study|Entry Criteria Not Met|2|||
17071966|NCT00325234|38214365|FG000|Overall Study|Subject Decision|6|||
17071967|NCT00325234|38214366|FG001|Overall Study|Subject Decision|8|||
17071968|NCT00325234|38214365|FG000|Overall Study|Physician Decision|17|||
17071969|NCT00325234|38214366|FG001|Overall Study|Physician Decision|12|||
17071970|NCT00325234|38214365|FG000|Overall Study|Progressive Disease|34|||
17071971|NCT00325234|38214366|FG001|Overall Study|Progressive Disease|37|||
17152681|NCT02802228|38298887|FG000|Overall Study|Adverse Event|1|||
17152682|NCT02802228|38298888|FG001|Overall Study|Adverse Event|0|||
17152683|NCT02802228|38298887|FG000|Overall Study|Physician Decision|1|||
17152684|NCT02802228|38298888|FG001|Overall Study|Physician Decision|0|||
17152685|NCT03130257|38298897|FG000|Overall Study|Withdrawal by Subject|1|||
17152686|NCT03130257|38298898|FG001|Overall Study|Withdrawal by Subject|0|||
17152687|NCT03130257|38298899|FG002|Overall Study|Withdrawal by Subject|2|||
17152688|NCT03674177|38298911|FG000|Overall Study|Lost to Follow-up|2|||
17152689|NCT03674177|38298912|FG001|Overall Study|Lost to Follow-up|1|||
17152690|NCT03674177|38298913|FG002|Overall Study|Lost to Follow-up|0|||
17152691|NCT03674177|38298914|FG003|Overall Study|Lost to Follow-up|2|||
17152692|NCT03354637|38298940|FG000|Double-blind Period|Protocol Violation|2|||
17152693|NCT03354637|38298941|FG001|Double-blind Period|Protocol Violation|0|||
17152694|NCT03354637|38298942|FG002|Double-blind Period|Protocol Violation|0|||
17152695|NCT03354637|38298940|FG000|Double-blind Period|Adverse Event|1|||
17152696|NCT03354637|38298941|FG001|Double-blind Period|Adverse Event|2|||
17071972|NCT00366249|38214376|FG000|Overall Study|Adverse Event|53|||
17071973|NCT00366249|38214377|FG001|Overall Study|Adverse Event|28|||
17071974|NCT00366249|38214376|FG000|Overall Study|Death|0|||
17071975|NCT00366249|38214377|FG001|Overall Study|Death|1|||
17152697|NCT03354637|38298942|FG002|Double-blind Period|Adverse Event|0|||
17152698|NCT03354637|38298940|FG000|Double-blind Period|Lost to Follow-up|3|||
17152699|NCT03354637|38298941|FG001|Double-blind Period|Lost to Follow-up|4|||
17152700|NCT03354637|38298942|FG002|Double-blind Period|Lost to Follow-up|3|||
17152701|NCT03354637|38298940|FG000|Double-blind Period|Withdrawal by Subject|10|||
17152702|NCT03354637|38298941|FG001|Double-blind Period|Withdrawal by Subject|6|||
17152703|NCT03354637|38298942|FG002|Double-blind Period|Withdrawal by Subject|4|||
17152704|NCT03354637|38298940|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
17152705|NCT03354637|38298941|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
17152706|NCT03354637|38298942|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
17152707|NCT03354637|38298940|FG000|Open Label Extension|Adverse Event|0|||
17152708|NCT03354637|38298941|FG001|Open Label Extension|Adverse Event|0|||
17152709|NCT03354637|38298942|FG002|Open Label Extension|Adverse Event|1|||
17152710|NCT03354637|38298940|FG000|Open Label Extension|Lost to Follow-up|0|||
17152711|NCT03354637|38298941|FG001|Open Label Extension|Lost to Follow-up|0|||
17152712|NCT03354637|38298942|FG002|Open Label Extension|Lost to Follow-up|2|||
17152713|NCT03354637|38298940|FG000|Open Label Extension|Withdrawal by Subject|0|||
17152714|NCT03354637|38298941|FG001|Open Label Extension|Withdrawal by Subject|0|||
17071976|NCT00366249|38214376|FG000|Overall Study|Physician Decision|5|||
17071977|NCT00366249|38214377|FG001|Overall Study|Physician Decision|2|||
17071978|NCT00366249|38214376|FG000|Overall Study|Lost to Follow-up|2|||
17071979|NCT00366249|38214377|FG001|Overall Study|Lost to Follow-up|0|||
17071980|NCT00366249|38214376|FG000|Overall Study|Protocol Violation|1|||
17071981|NCT00366249|38214377|FG001|Overall Study|Protocol Violation|2|||
17071982|NCT00366249|38214376|FG000|Overall Study|Withdrawal by Subject|18|||
17071983|NCT00366249|38214377|FG001|Overall Study|Withdrawal by Subject|4|||
17071984|NCT00366249|38214376|FG000|Overall Study|Lack of Efficacy|21|||
17071985|NCT00366249|38214377|FG001|Overall Study|Lack of Efficacy|21|||
17071986|NCT00366249|38214376|FG000|Overall Study|Most due to osteomylitis status|31|||
17071987|NCT00366249|38214377|FG001|Overall Study|Most due to osteomylitis status|20|||
17071988|NCT00325156|38214383|FG000|Overall Study|Protocol Violation|8|||
17071989|NCT00325156|38214383|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
17071990|NCT00325156|38214383|FG000|Overall Study|Migrated/moved from study area|12|||
17071991|NCT00325156|38214383|FG000|Overall Study|Adverse event, non-fatal|3|||
17071992|NCT00325156|38214383|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
17071993|NCT00325156|38214383|FG000|Overall Study|Other|1|||
17071994|NCT00325156|38214383|FG000|Overall Study|Withdrawal by Subject|31|||
17071995|NCT03927911|38214393|FG000|Overall Study|problems with eDiary|0|||
17071996|NCT03927911|38214394|FG001|Overall Study|problems with eDiary|1|||
17071997|NCT03927911|38214395|FG002|Overall Study|problems with eDiary|0|||
17071998|NCT03927911|38214396|FG003|Overall Study|problems with eDiary|1|||
17071999|NCT03927911|38214397|FG004|Overall Study|problems with eDiary|0|||
17072000|NCT03927911|38214398|FG005|Overall Study|problems with eDiary|4|||
17072001|NCT03927911|38214393|FG000|Overall Study|Adverse Event|0|||
17072002|NCT03927911|38214394|FG001|Overall Study|Adverse Event|0|||
17072003|NCT03927911|38214395|FG002|Overall Study|Adverse Event|0|||
17072004|NCT03927911|38214396|FG003|Overall Study|Adverse Event|0|||
17072005|NCT03927911|38214397|FG004|Overall Study|Adverse Event|0|||
17152715|NCT03354637|38298942|FG002|Open Label Extension|Withdrawal by Subject|5|||
17152716|NCT03354637|38298940|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
17152717|NCT03354637|38298941|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
17152718|NCT03354637|38298942|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
17152719|NCT03354637|38298940|FG000|Open Label Extension|Subject Noncompliance|0|||
17152720|NCT03354637|38298941|FG001|Open Label Extension|Subject Noncompliance|0|||
17152721|NCT03354637|38298942|FG002|Open Label Extension|Subject Noncompliance|1|||
17152722|NCT03354637|38298940|FG000|Open Label Extension|Lack of Efficacy|0|||
17152723|NCT03354637|38298941|FG001|Open Label Extension|Lack of Efficacy|0|||
17152724|NCT03354637|38298942|FG002|Open Label Extension|Lack of Efficacy|1|||
17152725|NCT03354637|38298940|FG000|Open Label Extension|Physician Decision|0|||
17152726|NCT03354637|38298941|FG001|Open Label Extension|Physician Decision|0|||
17152727|NCT03354637|38298942|FG002|Open Label Extension|Physician Decision|1|||
17152728|NCT04053023|38298953|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
17152729|NCT04053023|38298954|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
17152730|NCT03352453|38298966|FG000|Overall Study|Miscellaneous Reasons|1|||
17152731|NCT03352453|38298967|FG001|Overall Study|Miscellaneous Reasons|2|||
17152732|NCT03352453|38298966|FG000|Overall Study|Lack of Efficacy|1|||
17152733|NCT03352453|38298967|FG001|Overall Study|Lack of Efficacy|0|||
17152734|NCT03352453|38298966|FG000|Overall Study|Withdrawal by Subject|8|||
17152735|NCT03352453|38298967|FG001|Overall Study|Withdrawal by Subject|14|||
17152736|NCT03352453|38298966|FG000|Overall Study|Study Terminated by Sponsor|2|||
17152737|NCT03352453|38298967|FG001|Overall Study|Study Terminated by Sponsor|1|||
17072006|NCT03927911|38214398|FG005|Overall Study|Adverse Event|1|||
17152738|NCT03352453|38298966|FG000|Overall Study|Protocol Deviation|1|||
17152739|NCT03352453|38298967|FG001|Overall Study|Protocol Deviation|0|||
17152740|NCT03352453|38298966|FG000|Overall Study|Lost to Follow-up|7|||
17152741|NCT03352453|38298967|FG001|Overall Study|Lost to Follow-up|6|||
17152742|NCT03352453|38298966|FG000|Overall Study|Adverse Event|2|||
17152743|NCT03352453|38298967|FG001|Overall Study|Adverse Event|9|||
17152744|NCT03128931|38298973|FG000|Overall Study|Physician Decision|1|||
17152745|NCT03128931|38298973|FG000|Overall Study|Equipment Issues|3|||
17152746|NCT03107052|38298980|FG000|Overall Study|Adverse Event|6|||
17152747|NCT03107052|38298981|FG001|Overall Study|Adverse Event|1|||
17152748|NCT03107052|38298982|FG002|Overall Study|Adverse Event|2|||
17152749|NCT03107052|38298980|FG000|Overall Study|Withdrawal by Subject|9|||
17152750|NCT03107052|38298981|FG001|Overall Study|Withdrawal by Subject|5|||
17152751|NCT03107052|38298982|FG002|Overall Study|Withdrawal by Subject|8|||
17152752|NCT03107052|38298980|FG000|Overall Study|Protocol Violation|6|||
17152753|NCT03107052|38298981|FG001|Overall Study|Protocol Violation|0|||
17152754|NCT03107052|38298982|FG002|Overall Study|Protocol Violation|3|||
17152755|NCT03107052|38298980|FG000|Overall Study|Lost to Follow-up|4|||
17152756|NCT03107052|38298981|FG001|Overall Study|Lost to Follow-up|0|||
17152757|NCT03107052|38298982|FG002|Overall Study|Lost to Follow-up|1|||
17152758|NCT03107052|38298980|FG000|Overall Study|Lack of Efficacy|23|||
17152759|NCT03107052|38298981|FG001|Overall Study|Lack of Efficacy|7|||
17152760|NCT03107052|38298982|FG002|Overall Study|Lack of Efficacy|4|||
17152761|NCT03107052|38298980|FG000|Overall Study|Other than specified|4|||
17152762|NCT03107052|38298981|FG001|Overall Study|Other than specified|2|||
17152763|NCT03107052|38298982|FG002|Overall Study|Other than specified|0|||
17152764|NCT03107052|38298980|FG000|Overall Study|Study terminated due to futility|67|||
17152765|NCT03107052|38298981|FG001|Overall Study|Study terminated due to futility|31|||
17152766|NCT03107052|38298982|FG002|Overall Study|Study terminated due to futility|23|||
17152767|NCT04050371|38298992|FG000|Overall Study|Withdrawal by Subject|1|||
17152768|NCT04050371|38298993|FG001|Overall Study|Withdrawal by Subject|0|||
17152769|NCT04447287|38299002|FG000|Period 1: Run-in Period|Adverse Event|3|||
17152770|NCT04447287|38299003|FG001|Period 1: Run-in Period|Adverse Event|0|||
17152771|NCT04447287|38299004|FG002|Period 1: Run-in Period|Adverse Event|0|||
17152772|NCT04447287|38299002|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
17152773|NCT04447287|38299003|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
17152774|NCT04447287|38299004|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
17152775|NCT04447287|38299002|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
17152776|NCT04447287|38299003|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
17152777|NCT04447287|38299004|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
17152778|NCT01879319|38299025|FG000|Overall Study|Withdrawal by Subject|1|||
17152779|NCT01879319|38299026|FG001|Overall Study|Withdrawal by Subject|0|||
17152780|NCT01879319|38299025|FG000|Overall Study|Lost to Follow-up|1|||
17152781|NCT01879319|38299026|FG001|Overall Study|Lost to Follow-up|5|||
17152782|NCT03102918|38299034|FG000|Overall Study|Protocol Violation|1|||
17152783|NCT03102918|38299035|FG001|Overall Study|Protocol Violation|0|||
17152784|NCT03128307|38299041|FG000|Overall Study|Lost to Follow-up|29|||
17152785|NCT03128307|38299041|FG000|Overall Study|Withdrawal by Subject|5|||
17152786|NCT03102762|38299047|FG000|Overall Study|Lost to Follow-up|1|||
17152787|NCT03102762|38299048|FG001|Overall Study|Lost to Follow-up|0|||
17152788|NCT01346475|38299061|FG000|First Intervention|Lost to Follow-up|4|||
17152789|NCT01346475|38299062|FG001|First Intervention|Lost to Follow-up|3|||
17152790|NCT01338636|38299068|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
17152791|NCT00322218|38299074|FG000|Overall Study|Death|3|||
17152792|NCT00322218|38299075|FG001|Overall Study|Death|6|||
17152793|NCT02873754|38299081|FG000|Overall Study|Lost to Follow-up|5|||
17152794|NCT02873754|38299081|FG000|Overall Study|Couldn't complete study procedures|1|||
17152795|NCT03287414|38299087|FG000|Treatment Epoch|Adverse Event|0|||
17152796|NCT03287414|38299088|FG001|Treatment Epoch|Adverse Event|1|||
17152797|NCT03287414|38299087|FG000|Treatment Epoch|Study terminated by sponsor|2|||
17152798|NCT03287414|38299088|FG001|Treatment Epoch|Study terminated by sponsor|2|||
17152799|NCT03287414|38299087|FG000|Treatment Epoch|Subject/Guardian decision|4|||
17152800|NCT03287414|38299088|FG001|Treatment Epoch|Subject/Guardian decision|0|||
17152801|NCT03287414|38299087|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
17152802|NCT03287414|38299088|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
17152803|NCT03287414|38299087|FG000|Treatment Epoch|Withdrawal by Subject|1|||
17152804|NCT03287414|38299088|FG001|Treatment Epoch|Withdrawal by Subject|0|||
17152805|NCT03287414|38299087|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
17152806|NCT03287414|38299088|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
17152807|NCT03287414|38299087|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
17152808|NCT03287414|38299088|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
17152809|NCT03101592|38299118|FG000|Overall Study|participant files could not be located|111|||
17152810|NCT03101592|38299119|FG001|Overall Study|participant files could not be located|170|||
17152811|NCT03101592|38299120|FG002|Overall Study|participant files could not be located|118|||
17152812|NCT04046939|38299138|FG000|Primary Assessment Period|Adverse Event|1|||
17152813|NCT04046939|38299139|FG001|Primary Assessment Period|Adverse Event|0|||
17152814|NCT04046939|38299140|FG002|Primary Assessment Period|Adverse Event|0|||
17152815|NCT04046939|38299141|FG003|Primary Assessment Period|Adverse Event|0|||
17152816|NCT04046939|38299138|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
17152817|NCT04046939|38299139|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
17152818|NCT04046939|38299140|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
17152819|NCT04046939|38299141|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
17152820|NCT04046939|38299138|FG000|Primary Assessment Period|Physician Decision|0|||
17152821|NCT04046939|38299139|FG001|Primary Assessment Period|Physician Decision|0|||
17152822|NCT04046939|38299140|FG002|Primary Assessment Period|Physician Decision|1|||
17152823|NCT04046939|38299141|FG003|Primary Assessment Period|Physician Decision|0|||
17152824|NCT04046939|38299138|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
17152825|NCT04046939|38299139|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
17152826|NCT04046939|38299140|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
17152827|NCT04046939|38299141|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
17152828|NCT04042103|38299157|FG000|Overall Study|Lost to Follow-up|1|||
17152829|NCT04042103|38299157|FG000|Overall Study|Withdrawal by Subject|1|||
17152830|NCT02955797|38299165|FG000|Overall Study|Protocol Violation|1|||
17152831|NCT02955797|38299166|FG001|Overall Study|Protocol Violation|0|||
17152832|NCT02955797|38299167|FG002|Overall Study|Protocol Violation|0|||
17152833|NCT02955797|38299168|FG003|Overall Study|Protocol Violation|1|||
17152834|NCT02955797|38299165|FG000|Overall Study|Withdrawal by Subject|2|||
17152835|NCT02955797|38299166|FG001|Overall Study|Withdrawal by Subject|2|||
17152836|NCT02955797|38299167|FG002|Overall Study|Withdrawal by Subject|0|||
17152837|NCT02955797|38299168|FG003|Overall Study|Withdrawal by Subject|1|||
17152838|NCT02955797|38299165|FG000|Overall Study|Lost to Follow-up|0|||
17152839|NCT02955797|38299166|FG001|Overall Study|Lost to Follow-up|1|||
17152840|NCT02955797|38299167|FG002|Overall Study|Lost to Follow-up|0|||
17152841|NCT02955797|38299168|FG003|Overall Study|Lost to Follow-up|0|||
17152842|NCT03101514|38299181|FG000|Overall Study|Withdrawal by Subject|4|||
17152843|NCT03101514|38299181|FG000|Overall Study|Protocol Violation|2|||
17152844|NCT03101514|38299181|FG000|Overall Study|patient's information was incomplete|1|||
17152845|NCT04040933|38299185|FG000|Overall Study|Protocol Violation|1|||
17152846|NCT04040933|38299185|FG000|Overall Study|Withdrawal by Subject|2|||
17152847|NCT02702518|38299198|FG000|Overall Study|Lost to Follow-up|3|||
17152848|NCT02702518|38299199|FG001|Overall Study|Lost to Follow-up|4|||
17152849|NCT04039503|38299209|FG000|Overall Study|Adverse Event|3|||
17152850|NCT04039503|38299210|FG001|Overall Study|Adverse Event|0|||
17152851|NCT04039503|38299211|FG002|Overall Study|Adverse Event|2|||
17152852|NCT04039503|38299212|FG003|Overall Study|Adverse Event|0|||
17152853|NCT04039503|38299209|FG000|Overall Study|Lost to Follow-up|0|||
17152854|NCT04039503|38299210|FG001|Overall Study|Lost to Follow-up|0|||
17152855|NCT04039503|38299211|FG002|Overall Study|Lost to Follow-up|1|||
17152856|NCT04039503|38299212|FG003|Overall Study|Lost to Follow-up|0|||
17152857|NCT04039503|38299209|FG000|Overall Study|Protocol Violation|0|||
17152858|NCT04039503|38299210|FG001|Overall Study|Protocol Violation|1|||
17152859|NCT04039503|38299211|FG002|Overall Study|Protocol Violation|2|||
17152860|NCT04039503|38299212|FG003|Overall Study|Protocol Violation|1|||
17152861|NCT04039503|38299209|FG000|Overall Study|Withdrawal by Subject|4|||
17152862|NCT04039503|38299210|FG001|Overall Study|Withdrawal by Subject|3|||
17152863|NCT04039503|38299211|FG002|Overall Study|Withdrawal by Subject|5|||
17152864|NCT04039503|38299212|FG003|Overall Study|Withdrawal by Subject|2|||
17152865|NCT03131895|38299249|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
17152866|NCT03131895|38299250|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
17152867|NCT03131895|38299251|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
17152868|NCT03131895|38299252|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
17152869|NCT03131895|38299249|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
17152870|NCT03131895|38299250|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
17152871|NCT03131895|38299251|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
17152872|NCT03131895|38299252|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
17152873|NCT03131895|38299249|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17152874|NCT03131895|38299250|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
17152875|NCT03131895|38299251|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17152876|NCT03131895|38299252|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
17152877|NCT03131895|38299249|FG000|Washout Period (at Least 5 Days)|Other|0|||
17152878|NCT03131895|38299250|FG001|Washout Period (at Least 5 Days)|Other|0|||
17152879|NCT03131895|38299251|FG002|Washout Period (at Least 5 Days)|Other|2|||
17152880|NCT03131895|38299252|FG003|Washout Period (at Least 5 Days)|Other|0|||
17152881|NCT03131895|38299249|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
17152882|NCT03131895|38299250|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
17152883|NCT03131895|38299251|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
17152884|NCT03131895|38299252|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
17152885|NCT03131895|38299249|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
17152886|NCT03131895|38299250|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
17152887|NCT03131895|38299251|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
17152888|NCT03131895|38299252|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
17152889|NCT04039919|38299267|FG000|Treatment Period 1|Withdrawal by Subject|1|||
17152890|NCT04039919|38299268|FG001|Treatment Period 1|Withdrawal by Subject|0|||
17152891|NCT04039919|38299269|FG002|Treatment Period 1|Withdrawal by Subject|0|||
17152892|NCT04039919|38299270|FG003|Treatment Period 1|Withdrawal by Subject|0|||
17152893|NCT04039919|38299271|FG004|Treatment Period 1|Withdrawal by Subject|0|||
17152894|NCT04039919|38299267|FG000|Treatment Period 1|Sponsor's decision|0|||
17152895|NCT04039919|38299268|FG001|Treatment Period 1|Sponsor's decision|0|||
17152896|NCT04039919|38299269|FG002|Treatment Period 1|Sponsor's decision|0|||
17152897|NCT04039919|38299270|FG003|Treatment Period 1|Sponsor's decision|0|||
17152898|NCT04039919|38299271|FG004|Treatment Period 1|Sponsor's decision|16|||
17152899|NCT04039919|38299267|FG000|Treatment Period 5|Withdrawal by Subject|1|||
17152900|NCT04039919|38299268|FG001|Treatment Period 5|Withdrawal by Subject|0|||
17152901|NCT04039919|38299269|FG002|Treatment Period 5|Withdrawal by Subject|0|||
17152902|NCT04039919|38299270|FG003|Treatment Period 5|Withdrawal by Subject|0|||
17152903|NCT04039919|38299271|FG004|Treatment Period 5|Withdrawal by Subject|0|||
17152904|NCT04035473|38299307|FG000|Screening/Baseline|Death|0|||
17152905|NCT04035473|38299308|FG001|Screening/Baseline|Death|1|||
17152906|NCT04035473|38299307|FG000|Screening/Baseline|Adverse Event|0|||
17152907|NCT04035473|38299308|FG001|Screening/Baseline|Adverse Event|1|||
17152908|NCT04035473|38299307|FG000|Follow-up Period|Adverse Event|2|||
17152909|NCT04035473|38299308|FG001|Follow-up Period|Adverse Event|0|||
17152910|NCT04032977|38299316|FG000|Overall Study|Withdrawal by Subject|6|||
17152911|NCT04032977|38299317|FG001|Overall Study|Withdrawal by Subject|1|||
17152912|NCT04032977|38299316|FG000|Overall Study|Lost to Follow-up|2|||
17152913|NCT04032977|38299317|FG001|Overall Study|Lost to Follow-up|7|||
17152914|NCT04032977|38299316|FG000|Overall Study|Pregnancy|1|||
17152915|NCT04032977|38299317|FG001|Overall Study|Pregnancy|0|||
17152916|NCT04030247|38299323|FG000|Overall Study|Withdrawal by Subject|4|||
17152917|NCT04030247|38299323|FG000|Overall Study|Lost to Follow-up|13|||
17152918|NCT02915978|38299330|FG000|Overall Study|Adverse Event|2|||
17152919|NCT02915978|38299331|FG001|Overall Study|Adverse Event|1|||
17152920|NCT02915978|38299332|FG002|Overall Study|Adverse Event|0|||
17152921|NCT02701192|38299340|FG000|Overall Study|Protocol Violation|2|||
17152922|NCT02701192|38299340|FG000|Overall Study|Lost to Follow-up|4|||
17152923|NCT03101358|38299348|FG000|Overall Study|Non-compliance with study schedule|1|||
17152924|NCT03101358|38299349|FG001|Overall Study|Non-compliance with study schedule|0|||
17072007|NCT03927911|38214393|FG000|Overall Study|not treated -study terminated by sponsor|0|||
17072008|NCT03927911|38214394|FG001|Overall Study|not treated -study terminated by sponsor|1|||
17072009|NCT03927911|38214395|FG002|Overall Study|not treated -study terminated by sponsor|0|||
17072010|NCT03927911|38214396|FG003|Overall Study|not treated -study terminated by sponsor|0|||
17072011|NCT03927911|38214397|FG004|Overall Study|not treated -study terminated by sponsor|0|||
17072012|NCT03927911|38214398|FG005|Overall Study|not treated -study terminated by sponsor|0|||
17072013|NCT03927911|38214393|FG000|Overall Study|Surgery cancelled|0|||
17072014|NCT03927911|38214394|FG001|Overall Study|Surgery cancelled|0|||
17072015|NCT03927911|38214395|FG002|Overall Study|Surgery cancelled|0|||
17072016|NCT03927911|38214396|FG003|Overall Study|Surgery cancelled|1|||
17072017|NCT03927911|38214397|FG004|Overall Study|Surgery cancelled|0|||
17072018|NCT03927911|38214398|FG005|Overall Study|Surgery cancelled|1|||
17072019|NCT03927911|38214393|FG000|Overall Study|Protocol Violation|0|||
17072020|NCT03927911|38214394|FG001|Overall Study|Protocol Violation|0|||
17072021|NCT03927911|38214395|FG002|Overall Study|Protocol Violation|0|||
17072022|NCT03927911|38214396|FG003|Overall Study|Protocol Violation|0|||
17072023|NCT03927911|38214397|FG004|Overall Study|Protocol Violation|0|||
17072024|NCT03927911|38214398|FG005|Overall Study|Protocol Violation|1|||
17072025|NCT00383019|38214414|FG000|Overall Study|Adverse Event|5|||
17072026|NCT00383019|38214415|FG001|Overall Study|Adverse Event|1|||
17072027|NCT00383019|38214414|FG000|Overall Study|Withdrawal by Subject|0|||
17072028|NCT00383019|38214415|FG001|Overall Study|Withdrawal by Subject|1|||
17072029|NCT00310804|38214423|FG000|Overall Study|Lost to Follow-up|2|||
17072030|NCT00310804|38214424|FG001|Overall Study|Lost to Follow-up|0|||
17072031|NCT00310804|38214423|FG000|Overall Study|Withdrawal by Subject|3|||
17072032|NCT00310804|38214424|FG001|Overall Study|Withdrawal by Subject|0|||
17072033|NCT03826186|38214446|FG000|Overall Study|Protocol Violation|2|||
17072034|NCT03826186|38214447|FG001|Overall Study|Protocol Violation|0|||
17072035|NCT03826186|38214446|FG000|Overall Study|Withdrawal by Subject|1|||
17072036|NCT03826186|38214447|FG001|Overall Study|Withdrawal by Subject|0|||
17072037|NCT00382863|38214455|FG000|Overall Study|Death|9|||
17072038|NCT00382863|38214456|FG001|Overall Study|Death|9|||
17072039|NCT00382863|38214455|FG000|Overall Study|Lost to Follow-up|1|||
17072040|NCT00382863|38214456|FG001|Overall Study|Lost to Follow-up|2|||
17072041|NCT00382863|38214455|FG000|Overall Study|Withdrawal by Subject|5|||
17072042|NCT00382863|38214456|FG001|Overall Study|Withdrawal by Subject|25|||
17072043|NCT03933449|38214464|FG000|Overall Study|Adverse Event|6|||
17072044|NCT03933449|38214465|FG001|Overall Study|Adverse Event|4|||
17072045|NCT03933449|38214464|FG000|Overall Study|Death|55|||
17152925|NCT03101358|38299350|FG002|Overall Study|Non-compliance with study schedule|0|||
17152926|NCT03101358|38299351|FG003|Overall Study|Non-compliance with study schedule|1|||
17152927|NCT03101358|38299348|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
17152928|NCT03101358|38299349|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
17152929|NCT03101358|38299350|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
17152930|NCT03101358|38299351|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
17152931|NCT03101358|38299348|FG000|Overall Study|Physician Decision|1|||
17152932|NCT03101358|38299349|FG001|Overall Study|Physician Decision|0|||
17152933|NCT03101358|38299350|FG002|Overall Study|Physician Decision|0|||
17152934|NCT03101358|38299351|FG003|Overall Study|Physician Decision|3|||
17152935|NCT03101358|38299348|FG000|Overall Study|Adverse Event|0|||
17152936|NCT03101358|38299349|FG001|Overall Study|Adverse Event|0|||
17152937|NCT03101358|38299350|FG002|Overall Study|Adverse Event|1|||
17152938|NCT03101358|38299351|FG003|Overall Study|Adverse Event|0|||
17152939|NCT03101358|38299348|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
17152940|NCT03101358|38299349|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
17152941|NCT03101358|38299350|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
17152942|NCT03101358|38299351|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
17152943|NCT03101358|38299348|FG000|Overall Study|Lost to Follow-up|1|||
17152944|NCT03101358|38299349|FG001|Overall Study|Lost to Follow-up|0|||
17152945|NCT03101358|38299350|FG002|Overall Study|Lost to Follow-up|0|||
17152946|NCT03101358|38299351|FG003|Overall Study|Lost to Follow-up|1|||
17152947|NCT03657095|38299364|FG000|Overall Study|Withdrawal by Subject|1|||
17152948|NCT03657095|38299365|FG001|Overall Study|Withdrawal by Subject|1|||
17152949|NCT03657095|38299364|FG000|Overall Study|Adverse Event|0|||
17152950|NCT03657095|38299365|FG001|Overall Study|Adverse Event|3|||
17152951|NCT03657095|38299364|FG000|Overall Study|Study Terminated by Sponsor|58|||
17152952|NCT03657095|38299365|FG001|Overall Study|Study Terminated by Sponsor|49|||
17152953|NCT03100344|38299375|FG000|Overall Study|Adverse Event|0|||
17152954|NCT03100344|38299376|FG001|Overall Study|Adverse Event|3|||
17072046|NCT03933449|38214465|FG001|Overall Study|Death|57|||
17072047|NCT03933449|38214464|FG000|Overall Study|Sponsor Decision|1|||
17072048|NCT03933449|38214465|FG001|Overall Study|Sponsor Decision|0|||
17072049|NCT00290758|38214488|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
17072050|NCT00290758|38214489|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
17072051|NCT00290758|38214488|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
17072052|NCT00290758|38214489|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
17072053|NCT00290758|38214488|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
17072054|NCT00290758|38214489|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
17072055|NCT00290758|38214488|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
17072056|NCT00290758|38214489|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
17072057|NCT00290758|38214488|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
17072058|NCT00290758|38214489|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
17072059|NCT00290758|38214488|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
17072060|NCT00290758|38214489|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
17072061|NCT00290758|38214488|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
17072062|NCT00290758|38214489|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
17072063|NCT00290758|38214488|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
17072064|NCT00290758|38214489|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
17072065|NCT00372567|38214502|FG000|Phase 3 Study|Adverse Event|5|||
17072066|NCT00372567|38214503|FG001|Phase 3 Study|Adverse Event|1|||
17072067|NCT00372567|38214504|FG002|Phase 3 Study|Adverse Event|1|||
17072068|NCT00372567|38214502|FG000|Phase 3 Study|Death|1|||
17072069|NCT00372567|38214503|FG001|Phase 3 Study|Death|1|||
17072070|NCT00372567|38214504|FG002|Phase 3 Study|Death|0|||
17072071|NCT00372567|38214502|FG000|Phase 3 Study|Protocol Violation|0|||
17072072|NCT00372567|38214503|FG001|Phase 3 Study|Protocol Violation|0|||
17072073|NCT00372567|38214504|FG002|Phase 3 Study|Protocol Violation|1|||
17072074|NCT00372567|38214502|FG000|Phase 3 Study|Objective progression or relapse|10|||
17072075|NCT00372567|38214503|FG001|Phase 3 Study|Objective progression or relapse|13|||
17072076|NCT00372567|38214504|FG002|Phase 3 Study|Objective progression or relapse|4|||
17072077|NCT00372567|38214502|FG000|Phase 3 Study|Global deterioration of health status|0|||
17072078|NCT00372567|38214503|FG001|Phase 3 Study|Global deterioration of health status|1|||
17072079|NCT00372567|38214504|FG002|Phase 3 Study|Global deterioration of health status|0|||
17072080|NCT00372567|38214502|FG000|Phase 3 Study|Other|2|||
17072081|NCT00372567|38214503|FG001|Phase 3 Study|Other|2|||
17152955|NCT03100344|38299377|FG002|Overall Study|Adverse Event|2|||
17152956|NCT03100344|38299378|FG003|Overall Study|Adverse Event|3|||
17152957|NCT03100344|38299375|FG000|Overall Study|Lack of Efficacy|2|||
17152958|NCT03100344|38299376|FG001|Overall Study|Lack of Efficacy|0|||
17152959|NCT03100344|38299377|FG002|Overall Study|Lack of Efficacy|0|||
17152960|NCT03100344|38299378|FG003|Overall Study|Lack of Efficacy|0|||
17152961|NCT03100344|38299375|FG000|Overall Study|Protocol Violation|1|||
17152962|NCT03100344|38299376|FG001|Overall Study|Protocol Violation|0|||
17152963|NCT03100344|38299377|FG002|Overall Study|Protocol Violation|0|||
17152964|NCT03100344|38299378|FG003|Overall Study|Protocol Violation|0|||
17152965|NCT03100344|38299375|FG000|Overall Study|Withdrawal by Subject|10|||
17152966|NCT03100344|38299376|FG001|Overall Study|Withdrawal by Subject|7|||
17152967|NCT03100344|38299377|FG002|Overall Study|Withdrawal by Subject|4|||
17152968|NCT03100344|38299378|FG003|Overall Study|Withdrawal by Subject|8|||
17152969|NCT03100344|38299375|FG000|Overall Study|Lost to Follow-up|1|||
17152970|NCT03100344|38299376|FG001|Overall Study|Lost to Follow-up|1|||
17152971|NCT03100344|38299377|FG002|Overall Study|Lost to Follow-up|1|||
17152972|NCT03100344|38299378|FG003|Overall Study|Lost to Follow-up|1|||
17152973|NCT02951533|38299391|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
17152974|NCT02951533|38299392|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
17152975|NCT02951533|38299393|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
17152976|NCT02951533|38299391|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
17152977|NCT02951533|38299392|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
17152978|NCT02951533|38299393|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
17152979|NCT02951533|38299391|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
17152980|NCT02951533|38299392|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
17152981|NCT02951533|38299393|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
17152982|NCT02951533|38299391|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
17152983|NCT02951533|38299392|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
17152984|NCT02951533|38299393|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
17152985|NCT02951533|38299391|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
17152986|NCT02951533|38299392|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
17152987|NCT02951533|38299393|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
17152988|NCT02951533|38299391|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
17152989|NCT02951533|38299392|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
17152990|NCT02951533|38299393|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
17152991|NCT02951533|38299391|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
17152992|NCT02951533|38299392|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
17152993|NCT02951533|38299393|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
17152994|NCT02951533|38299391|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
17152995|NCT02951533|38299392|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
17152996|NCT02951533|38299393|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
17152997|NCT02951533|38299391|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
17152998|NCT02951533|38299392|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
17152999|NCT02951533|38299393|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
17153000|NCT02951533|38299391|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
17153001|NCT02951533|38299392|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
17153002|NCT02951533|38299393|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
17153003|NCT02951533|38299391|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
17153004|NCT02951533|38299392|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
17153005|NCT02951533|38299393|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
17153006|NCT02700412|38299410|FG000|Overall Study|Adverse Event|6|||
17153007|NCT02700412|38299410|FG000|Overall Study|Death|1|||
17153008|NCT02700412|38299410|FG000|Overall Study|Lack of Efficacy|19|||
17153009|NCT02700412|38299410|FG000|Overall Study|Protocol Violation|5|||
17153010|NCT02700412|38299410|FG000|Overall Study|Withdrawal by Subject|2|||
17153011|NCT03665441|38299416|FG000|Overall Study|survival follow up ongoing|23|||
17153012|NCT03665441|38299417|FG001|Overall Study|survival follow up ongoing|0|||
17153013|NCT03665441|38299416|FG000|Overall Study|Patients ongoing on treatment|9|||
17153014|NCT03665441|38299417|FG001|Overall Study|Patients ongoing on treatment|6|||
17153015|NCT03665441|38299416|FG000|Overall Study|Randomized but not treated|7|||
17153016|NCT03665441|38299417|FG001|Overall Study|Randomized but not treated|11|||
17153017|NCT02699866|38299423|FG000|Overall Study|Withdrawal by Subject|3|||
17153018|NCT02699866|38299423|FG000|Overall Study|Physician Decision|2|||
17153019|NCT02699866|38299423|FG000|Overall Study|Adverse Event|3|||
17153020|NCT03663569|38299427|FG000|Overall Study|Discontinuation of study|11|||
17072082|NCT00372567|38214504|FG002|Phase 3 Study|Other|1|||
17072083|NCT00372567|38214502|FG000|Phase 3 Study|study terminated by sponsor|13|||
17072084|NCT00372567|38214503|FG001|Phase 3 Study|study terminated by sponsor|8|||
17072085|NCT00372567|38214504|FG002|Phase 3 Study|study terminated by sponsor|5|||
17072086|NCT00365547|38214512|FG000|Overall Study|Insurance did not cover Avastin|1|||
17072087|NCT00365547|38214512|FG000|Overall Study|Screen failure|1|||
17072088|NCT00365547|38214512|FG000|Overall Study|Withdrawal by Subject|1|||
17072089|NCT00545441|38214521|FG000|Overall Study|Fistula draining at 6 months|2|||
17072090|NCT00545441|38214522|FG001|Overall Study|Fistula draining at 6 months|4|||
17072091|NCT00545441|38214521|FG000|Overall Study|Lost to Follow-up|9|||
17072092|NCT00545441|38214522|FG001|Overall Study|Lost to Follow-up|5|||
17072093|NCT00545441|38214521|FG000|Overall Study|Technical failure|0|||
17072094|NCT00545441|38214522|FG001|Overall Study|Technical failure|1|||
17153021|NCT03663569|38299427|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
17153022|NCT03663569|38299427|FG000|Overall Study|Deceased patient|6|||
17153023|NCT03663569|38299427|FG000|Overall Study|Lost to Follow-up|18|||
17153024|NCT03663569|38299427|FG000|Overall Study|Withdrawal of consent|5|||
17153025|NCT03663569|38299427|FG000|Overall Study|Patient's request|11|||
17153026|NCT03663569|38299427|FG000|Overall Study|Adverse Event|4|||
17153027|NCT03663569|38299427|FG000|Overall Study|Not come to second visit|3|||
17153028|NCT03663569|38299427|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
17153029|NCT03663569|38299427|FG000|Overall Study|Serious adverse event|1|||
17153030|NCT03596762|38299436|FG000|Overall Study|Protocol Violation|0|||
17153031|NCT03596762|38299437|FG001|Overall Study|Protocol Violation|0|||
17153032|NCT03596762|38299438|FG002|Overall Study|Protocol Violation|0|||
17153033|NCT03596762|38299439|FG003|Overall Study|Protocol Violation|0|||
17153034|NCT03596762|38299440|FG004|Overall Study|Protocol Violation|1|||
17153035|NCT03596762|38299436|FG000|Overall Study|Adverse Event|2|||
17153036|NCT03596762|38299437|FG001|Overall Study|Adverse Event|0|||
17153037|NCT03596762|38299438|FG002|Overall Study|Adverse Event|1|||
17153038|NCT03596762|38299439|FG003|Overall Study|Adverse Event|0|||
17153039|NCT03596762|38299440|FG004|Overall Study|Adverse Event|5|||
17153040|NCT03596762|38299436|FG000|Overall Study|Withdrawal by Subject|2|||
17153041|NCT03596762|38299437|FG001|Overall Study|Withdrawal by Subject|1|||
17153042|NCT03596762|38299438|FG002|Overall Study|Withdrawal by Subject|0|||
17153043|NCT03596762|38299439|FG003|Overall Study|Withdrawal by Subject|1|||
17153044|NCT03596762|38299440|FG004|Overall Study|Withdrawal by Subject|1|||
17153045|NCT03663179|38299458|FG000|Overall Study|Withdrawal by Subject|2|||
17153046|NCT03663179|38299459|FG001|Overall Study|Withdrawal by Subject|0|||
17153047|NCT03663179|38299458|FG000|Overall Study|Lost to Follow-up|1|||
17153048|NCT03663179|38299459|FG001|Overall Study|Lost to Follow-up|1|||
17153049|NCT03663179|38299458|FG000|Overall Study|Revealed exclusionary condition|1|||
17153050|NCT03663179|38299459|FG001|Overall Study|Revealed exclusionary condition|0|||
17153051|NCT03662789|38299467|FG000|Overall Study|Lost to Follow-up|1|||
17153052|NCT03662789|38299468|FG001|Overall Study|Lost to Follow-up|2|||
17153053|NCT03662789|38299467|FG000|Overall Study|Could not perform treadmill test|4|||
17153054|NCT03662789|38299468|FG001|Overall Study|Could not perform treadmill test|4|||
17153055|NCT03662789|38299467|FG000|Overall Study|Death|0|||
17153056|NCT03662789|38299468|FG001|Overall Study|Death|1|||
17153057|NCT03658889|38299476|FG000|Overall Study|Protocol Violation|2|||
17153058|NCT03658889|38299477|FG001|Overall Study|Protocol Violation|0|||
17153059|NCT03655691|38299485|FG000|Overall Study|Adverse Event|0|||
17153060|NCT03655691|38299486|FG001|Overall Study|Adverse Event|0|||
17153061|NCT03655691|38299487|FG002|Overall Study|Adverse Event|1|||
17153062|NCT03655691|38299485|FG000|Overall Study|Lost to Follow-up|1|||
17153063|NCT03655691|38299486|FG001|Overall Study|Lost to Follow-up|1|||
17153064|NCT03655691|38299487|FG002|Overall Study|Lost to Follow-up|2|||
17153065|NCT03655691|38299485|FG000|Overall Study|Protocol Violation|0|||
17153066|NCT03655691|38299486|FG001|Overall Study|Protocol Violation|1|||
17153067|NCT03655691|38299487|FG002|Overall Study|Protocol Violation|0|||
17153068|NCT03655691|38299485|FG000|Overall Study|Withdrawal by Subject|1|||
17153069|NCT03655691|38299486|FG001|Overall Study|Withdrawal by Subject|1|||
17153070|NCT03655691|38299487|FG002|Overall Study|Withdrawal by Subject|0|||
17153071|NCT03658811|38299495|FG000|Overall Study|Lost to Follow-up|3|||
17153072|NCT03631355|38299505|FG000|Overall Study|Lost to Follow-up|1|||
17153073|NCT03631355|38299506|FG001|Overall Study|Lost to Follow-up|2|||
17153074|NCT03629249|38299515|FG000|Overall Study|Study terminated by sponsor|197|||
17072095|NCT00545441|38214521|FG000|Overall Study|Withdrawal by Subject|1|||
17072096|NCT00545441|38214522|FG001|Overall Study|Withdrawal by Subject|1|||
17072097|NCT00545441|38214521|FG000|Overall Study|Persistence or recurrence of fistula|5|||
17072098|NCT00545441|38214522|FG001|Overall Study|Persistence or recurrence of fistula|2|||
17072099|NCT00545441|38214521|FG000|Overall Study|Patients were not treated|1|||
17072100|NCT00545441|38214522|FG001|Overall Study|Patients were not treated|3|||
17072101|NCT00294658|38214530|FG000|Overall Study|Death|0|||
17072102|NCT00294658|38214531|FG001|Overall Study|Death|1|||
17072103|NCT00294658|38214530|FG000|Overall Study|Lost to Follow-up|4|||
17072104|NCT00294658|38214531|FG001|Overall Study|Lost to Follow-up|0|||
17072105|NCT00294658|38214530|FG000|Overall Study|Physician Decision|1|||
17072106|NCT00294658|38214531|FG001|Overall Study|Physician Decision|2|||
17072107|NCT00294658|38214530|FG000|Overall Study|Pregnancy|0|||
17072108|NCT00294658|38214531|FG001|Overall Study|Pregnancy|1|||
17072109|NCT00294658|38214530|FG000|Overall Study|Withdrawal by Subject|0|||
17072110|NCT00294658|38214531|FG001|Overall Study|Withdrawal by Subject|4|||
17072111|NCT00294658|38214530|FG000|Overall Study|Found to have invasive thymoma|1|||
17072112|NCT00294658|38214531|FG001|Overall Study|Found to have invasive thymoma|0|||
17072113|NCT00294658|38214530|FG000|Overall Study|Patient and family were not satisfied|0|||
17072114|NCT00294658|38214531|FG001|Overall Study|Patient and family were not satisfied|1|||
17072115|NCT03923933|38214539|FG000|Overall Study|Lost to Follow-up|1|||
17153075|NCT03629249|38299516|FG001|Overall Study|Study terminated by sponsor|197|||
17153076|NCT03629249|38299517|FG002|Overall Study|Study terminated by sponsor|194|||
17153077|NCT03629249|38299515|FG000|Overall Study|Protocol deviation|0|||
17072116|NCT03923933|38214540|FG001|Overall Study|Lost to Follow-up|0|||
17072117|NCT03923933|38214539|FG000|Overall Study|Withdrawal by Subject|0|||
17072118|NCT03923933|38214540|FG001|Overall Study|Withdrawal by Subject|1|||
17072119|NCT00372489|38214546|FG000|Overall Study|Adverse Event|18|||
17072120|NCT00372489|38214546|FG000|Overall Study|Lack of Efficacy|1|||
17072121|NCT00372489|38214546|FG000|Overall Study|Lost to Follow-up|3|||
17072122|NCT00372489|38214546|FG000|Overall Study|Physician Decision|3|||
17072123|NCT00372489|38214546|FG000|Overall Study|Withdrawal by Subject|5|||
17072124|NCT00372489|38214546|FG000|Overall Study|Patient Relocation|2|||
17072125|NCT00372489|38214546|FG000|Overall Study|Renal transplant|6|||
17072126|NCT00372489|38214546|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
17072127|NCT00372411|38214553|FG000|Overall Study|Withdrawal by Subject|3|||
17072128|NCT00372411|38214554|FG001|Overall Study|Withdrawal by Subject|4|||
17072129|NCT00372411|38214555|FG002|Overall Study|Withdrawal by Subject|1|||
17072130|NCT00372411|38214553|FG000|Overall Study|Death|0|||
17072131|NCT00372411|38214554|FG001|Overall Study|Death|2|||
17072132|NCT00372411|38214555|FG002|Overall Study|Death|1|||
17072133|NCT00372411|38214553|FG000|Overall Study|Lost to Follow-up|1|||
17072134|NCT00372411|38214554|FG001|Overall Study|Lost to Follow-up|1|||
17072135|NCT00372411|38214555|FG002|Overall Study|Lost to Follow-up|1|||
17072136|NCT00372411|38214553|FG000|Overall Study|Adverse Event|1|||
17072137|NCT00372411|38214554|FG001|Overall Study|Adverse Event|1|||
17072138|NCT00372411|38214555|FG002|Overall Study|Adverse Event|0|||
17090094|NCT00317642|38230166|FG000|Overall Study|AML Not Centrally Confirmed|1|||
17090095|NCT00317642|38230167|FG001|Overall Study|AML Not Centrally Confirmed|5|||
17090096|NCT00295022|38230183|FG000|Overall Study|Adverse Event|1|||
17090097|NCT00295022|38230184|FG001|Overall Study|Adverse Event|1|||
17153078|NCT03629249|38299516|FG001|Overall Study|Protocol deviation|2|||
17153079|NCT03629249|38299517|FG002|Overall Study|Protocol deviation|5|||
17153080|NCT03629249|38299515|FG000|Overall Study|Subject decision|1|||
17153081|NCT03629249|38299516|FG001|Overall Study|Subject decision|1|||
17153082|NCT03629249|38299517|FG002|Overall Study|Subject decision|3|||
17153083|NCT03629249|38299515|FG000|Overall Study|Adverse Event|1|||
17153084|NCT03629249|38299516|FG001|Overall Study|Adverse Event|1|||
17153085|NCT03629249|38299517|FG002|Overall Study|Adverse Event|0|||
17153086|NCT03629249|38299515|FG000|Overall Study|Death|1|||
17090098|NCT00295022|38230185|FG002|Overall Study|Adverse Event|2|||
17153087|NCT03629249|38299516|FG001|Overall Study|Death|0|||
17153088|NCT03629249|38299517|FG002|Overall Study|Death|0|||
17153089|NCT03629249|38299515|FG000|Overall Study|Physician Decision|1|||
17153090|NCT03629249|38299516|FG001|Overall Study|Physician Decision|0|||
17153091|NCT03629249|38299517|FG002|Overall Study|Physician Decision|0|||
17153092|NCT03628781|38299527|FG000|Overall Study|Lost to Follow-up|16|||
17153093|NCT03628781|38299528|FG001|Overall Study|Lost to Follow-up|8|||
17153094|NCT03628781|38299527|FG000|Overall Study|Withdrawal by Subject|16|||
17153095|NCT03628781|38299528|FG001|Overall Study|Withdrawal by Subject|1|||
17153096|NCT03371251|38299540|FG000|Overall Study|Withdrawal by Subject|1|||
17153097|NCT03371251|38299541|FG001|Overall Study|Withdrawal by Subject|0|||
17153098|NCT03371251|38299542|FG002|Overall Study|Withdrawal by Subject|1|||
17153099|NCT03371251|38299543|FG003|Overall Study|Withdrawal by Subject|0|||
17153100|NCT03371251|38299544|FG004|Overall Study|Withdrawal by Subject|2|||
17153101|NCT03371251|38299545|FG005|Overall Study|Withdrawal by Subject|2|||
17153102|NCT03371251|38299540|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
17153103|NCT03371251|38299541|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
17153104|NCT03371251|38299542|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
17153105|NCT03371251|38299543|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
17153106|NCT03371251|38299544|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
17153107|NCT03371251|38299545|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
17153108|NCT03371251|38299540|FG000|Overall Study|Adverse Event|0|||
17153109|NCT03371251|38299541|FG001|Overall Study|Adverse Event|0|||
17153110|NCT03371251|38299542|FG002|Overall Study|Adverse Event|0|||
17153111|NCT03371251|38299543|FG003|Overall Study|Adverse Event|0|||
17153112|NCT03371251|38299544|FG004|Overall Study|Adverse Event|1|||
17153113|NCT03371251|38299545|FG005|Overall Study|Adverse Event|0|||
17153114|NCT03371251|38299540|FG000|Overall Study|Decision by Sponsor|0|||
17153115|NCT03371251|38299541|FG001|Overall Study|Decision by Sponsor|0|||
17153116|NCT03371251|38299542|FG002|Overall Study|Decision by Sponsor|0|||
17153117|NCT03371251|38299543|FG003|Overall Study|Decision by Sponsor|0|||
17153118|NCT03371251|38299544|FG004|Overall Study|Decision by Sponsor|2|||
17090099|NCT00295022|38230183|FG000|Overall Study|Lost to Follow-up|0|||
17090100|NCT00295022|38230184|FG001|Overall Study|Lost to Follow-up|0|||
17090101|NCT00295022|38230185|FG002|Overall Study|Lost to Follow-up|1|||
17153119|NCT03371251|38299545|FG005|Overall Study|Decision by Sponsor|0|||
17153120|NCT03370471|38299564|FG000|Overall Study|Withdrawal by Subject|6|||
17153121|NCT03370471|38299565|FG001|Overall Study|Withdrawal by Subject|1|||
17153122|NCT03370471|38299564|FG000|Overall Study|Unable to access veins for blood draw|0|||
17153123|NCT03370471|38299565|FG001|Overall Study|Unable to access veins for blood draw|1|||
17153124|NCT03370471|38299564|FG000|Overall Study|Screen fail|1|||
17153125|NCT03370471|38299565|FG001|Overall Study|Screen fail|0|||
17153126|NCT03349645|38299573|FG000|Overall Study|Sponsor Terminated Study|75|||
17153127|NCT03349645|38299573|FG000|Overall Study|Withdrawal by Subject|4|||
17153128|NCT03349645|38299573|FG000|Overall Study|Protocol Violation|1|||
17153129|NCT03349645|38299573|FG000|Overall Study|Other|2|||
17153130|NCT03349333|38299577|FG000|Overall Study|Progression of Disease|36|||
17153131|NCT03349333|38299577|FG000|Overall Study|Adverse Event|11|||
17153132|NCT03349333|38299577|FG000|Overall Study|Other|6|||
17153133|NCT03349333|38299577|FG000|Overall Study|Withdrawal by Subject|5|||
17153134|NCT03349333|38299577|FG000|Overall Study|Conditions interfere with participation|2|||
17153135|NCT03349333|38299577|FG000|Overall Study|Physician Decision|2|||
17153136|NCT03349333|38299577|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
17153137|NCT03349333|38299577|FG000|Overall Study|Patients in treatment less than 24 month|8|||
17153138|NCT03349099|38299583|FG000|Overall Study|Physician Decision|3|||
17153139|NCT03349099|38299584|FG001|Overall Study|Physician Decision|4|||
17153140|NCT03349099|38299583|FG000|Overall Study|Stone migrated from the kidney|1|||
17153141|NCT03349099|38299584|FG001|Overall Study|Stone migrated from the kidney|0|||
17153142|NCT03348163|38299592|FG000|Overall Study|Withdrawal by Subject|2|||
17153143|NCT03348163|38299593|FG001|Overall Study|Withdrawal by Subject|0|||
17153144|NCT03347695|38299601|FG000|Overall Study|Death|0|||
17153145|NCT03347695|38299602|FG001|Overall Study|Death|4|||
17153146|NCT03347695|38299601|FG000|Overall Study|Lost to Follow-up|0|||
17153147|NCT03347695|38299602|FG001|Overall Study|Lost to Follow-up|1|||
17153148|NCT02892019|38299612|FG000|Overall Study|randomized but not treated|0|||
17153149|NCT02892019|38299613|FG001|Overall Study|randomized but not treated|1|||
17153150|NCT02892019|38299612|FG000|Overall Study|Withdrawal by Subject|0|||
17153151|NCT02892019|38299613|FG001|Overall Study|Withdrawal by Subject|1|||
17153152|NCT02892019|38299612|FG000|Overall Study|Adverse Event|1|||
17153153|NCT02892019|38299613|FG001|Overall Study|Adverse Event|1|||
17153154|NCT03365791|38299619|FG000|Overall Study|Adverse Event|5|||
17153155|NCT03365791|38299619|FG000|Overall Study|Death|1|||
17153156|NCT03365791|38299619|FG000|Overall Study|Lost to Follow-up|1|||
17153157|NCT03365791|38299619|FG000|Overall Study|Physician Decision|9|||
17153158|NCT03365791|38299619|FG000|Overall Study|Progressive disease|51|||
17153159|NCT03365791|38299619|FG000|Overall Study|Subject/guardian decision|5|||
17153160|NCT03365011|38299626|FG000|Overall Study|Withdrawal by Subject|1|||
17153161|NCT03365011|38299627|FG001|Overall Study|Withdrawal by Subject|2|||
17153162|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
17153163|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
17153164|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
17153165|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
17153166|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
17153167|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
17153168|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
17153169|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
17153170|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
17153171|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
17153172|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
17153173|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
17153174|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
17072139|NCT00372255|38214565|FG000|Overall Study|Withdrawn for other reasons|2|||
17072140|NCT00372255|38214566|FG001|Overall Study|Withdrawn for other reasons|1|||
17072141|NCT00274456|38214577|FG000|Overall Study|Still on treatment|2|||
17072142|NCT00274456|38214578|FG001|Overall Study|Still on treatment|3|||
17072143|NCT00274456|38214579|FG002|Overall Study|Still on treatment|5|||
17072144|NCT00274456|38214580|FG003|Overall Study|Still on treatment|1|||
17072145|NCT00274456|38214577|FG000|Overall Study|Unacceptable toxicity|10|||
17072146|NCT00274456|38214578|FG001|Overall Study|Unacceptable toxicity|5|||
17072147|NCT00274456|38214579|FG002|Overall Study|Unacceptable toxicity|12|||
17072148|NCT00274456|38214580|FG003|Overall Study|Unacceptable toxicity|16|||
17072149|NCT00274456|38214577|FG000|Overall Study|Adverse Event|0|||
17072150|NCT00274456|38214578|FG001|Overall Study|Adverse Event|1|||
17072151|NCT00274456|38214579|FG002|Overall Study|Adverse Event|2|||
17072152|NCT00274456|38214580|FG003|Overall Study|Adverse Event|2|||
17072153|NCT00274456|38214577|FG000|Overall Study|Physician Decision|7|||
17072154|NCT00274456|38214578|FG001|Overall Study|Physician Decision|5|||
17153175|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
17153176|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
17153177|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
17153178|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
17153179|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
17153180|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
17153181|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
17153182|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
17153183|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
17153184|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
17153185|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
17153186|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
17072155|NCT00274456|38214579|FG002|Overall Study|Physician Decision|6|||
17072156|NCT00274456|38214580|FG003|Overall Study|Physician Decision|13|||
17072157|NCT00274456|38214577|FG000|Overall Study|Lost to Follow-up|0|||
17072158|NCT00274456|38214578|FG001|Overall Study|Lost to Follow-up|0|||
17072159|NCT00274456|38214579|FG002|Overall Study|Lost to Follow-up|1|||
17072160|NCT00274456|38214580|FG003|Overall Study|Lost to Follow-up|0|||
17072161|NCT00274456|38214577|FG000|Overall Study|Withdrawal by Subject|18|||
17072162|NCT00274456|38214578|FG001|Overall Study|Withdrawal by Subject|13|||
17072163|NCT00274456|38214579|FG002|Overall Study|Withdrawal by Subject|9|||
17072164|NCT00274456|38214580|FG003|Overall Study|Withdrawal by Subject|13|||
17072165|NCT00364923|38214590|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
17072166|NCT00364923|38214590|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
17153187|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
17153188|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
17153189|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
17153190|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
17153191|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
17153192|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
17153193|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
17153194|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
17153195|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
17153196|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
17153197|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
17153198|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
17153199|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
17153200|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
17153201|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
17153202|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
17153203|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
17153204|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
17153205|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
17153206|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
17153207|NCT03627767|38299636|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
17153208|NCT03627767|38299637|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
17153209|NCT03627767|38299638|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
17153210|NCT03627767|38299639|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
17153211|NCT03627767|38299640|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
17153212|NCT03627767|38299636|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
17153213|NCT03627767|38299637|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
17153214|NCT03627767|38299638|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
17153215|NCT03627767|38299639|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
17153216|NCT03627767|38299640|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
17153217|NCT03627767|38299636|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
17153218|NCT03627767|38299637|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
17153219|NCT03627767|38299638|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
17153220|NCT03627767|38299639|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
17153221|NCT03627767|38299640|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
17072167|NCT00381849|38214596|FG000|Wash Out|Withdrawal by Subject|0|||
17153222|NCT03627767|38299636|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
17153223|NCT03627767|38299637|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
17153224|NCT03627767|38299638|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
17153225|NCT03627767|38299639|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
17153226|NCT03627767|38299640|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
17153227|NCT03627767|38299636|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
17153228|NCT03627767|38299637|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
17153229|NCT03627767|38299638|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
17153230|NCT03627767|38299639|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
17153231|NCT03627767|38299640|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
17153232|NCT03627767|38299636|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
17153233|NCT03627767|38299637|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
17153234|NCT03627767|38299638|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
17153235|NCT03627767|38299639|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
17153236|NCT03627767|38299640|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
17153237|NCT03627767|38299636|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
17153238|NCT03627767|38299637|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
17153239|NCT03627767|38299638|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
17153240|NCT03627767|38299639|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
17153241|NCT03627767|38299640|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
17153242|NCT03627767|38299636|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
17153243|NCT03627767|38299637|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
17153244|NCT03627767|38299638|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
17153245|NCT03627767|38299639|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
17153246|NCT03627767|38299640|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
17153247|NCT03627767|38299636|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
17153248|NCT03627767|38299637|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
17153249|NCT03627767|38299638|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
17153250|NCT03627767|38299639|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
17153251|NCT03627767|38299640|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
17153252|NCT03627767|38299636|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
17153253|NCT03627767|38299637|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
17153254|NCT03627767|38299638|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
17153255|NCT03627767|38299639|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
17153256|NCT03627767|38299640|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
17153257|NCT03627767|38299636|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
17153258|NCT03627767|38299637|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
17072168|NCT00381849|38214597|FG001|Wash Out|Withdrawal by Subject|1|||
17072169|NCT00273052|38214605|FG000|Overall Study|Withdrawal by Subject|16|||
17153259|NCT03627767|38299638|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
17153260|NCT03627767|38299639|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
17153261|NCT03627767|38299640|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
17153262|NCT03627065|38299651|FG000|Overall Study|Study Terminated by sponsor|1|||
17153263|NCT03627065|38299651|FG000|Overall Study|Withdrawal by Subject|2|||
17153264|NCT03624881|38299657|FG000|Overall Study|Screen Failure|14|||
17153265|NCT03624881|38299658|FG001|Overall Study|Screen Failure|0|||
17153266|NCT03624881|38299657|FG000|Overall Study|No Catheter Inserted|6|||
17153267|NCT03624881|38299658|FG001|Overall Study|No Catheter Inserted|1|||
17153268|NCT03624881|38299657|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
17153269|NCT03624881|38299658|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
17153270|NCT03624881|38299657|FG000|Overall Study|Death|2|||
17153271|NCT03624881|38299658|FG001|Overall Study|Death|0|||
17153272|NCT03624881|38299657|FG000|Overall Study|Lost to Follow-up|10|||
17153273|NCT03624881|38299658|FG001|Overall Study|Lost to Follow-up|4|||
17153274|NCT03624881|38299657|FG000|Overall Study|Withdrawal by Subject|12|||
17153275|NCT03624881|38299658|FG001|Overall Study|Withdrawal by Subject|1|||
17153276|NCT02142738|38299666|FG000|Overall Study|Adverse Event|13|||
17153277|NCT02142738|38299667|FG001|Overall Study|Adverse Event|9|||
17072170|NCT00273052|38214606|FG001|Overall Study|Withdrawal by Subject|19|||
17072171|NCT00273052|38214605|FG000|Overall Study|Adverse Event|21|||
17072172|NCT00273052|38214606|FG001|Overall Study|Adverse Event|19|||
17072173|NCT00273052|38214605|FG000|Overall Study|Protocol Violation|14|||
17072174|NCT00273052|38214606|FG001|Overall Study|Protocol Violation|18|||
17072175|NCT00273052|38214605|FG000|Overall Study|Lost to Follow-up|7|||
17072176|NCT00273052|38214606|FG001|Overall Study|Lost to Follow-up|25|||
17072177|NCT00273052|38214605|FG000|Overall Study|Lack of Efficacy|6|||
17153278|NCT02142738|38299666|FG000|Overall Study|Death|92|||
17153279|NCT02142738|38299667|FG001|Overall Study|Death|112|||
17153280|NCT02142738|38299666|FG000|Overall Study|Lost to Follow-up|0|||
17153281|NCT02142738|38299667|FG001|Overall Study|Lost to Follow-up|3|||
17153282|NCT02142738|38299666|FG000|Overall Study|Withdrawal by Subject|6|||
17153283|NCT02142738|38299667|FG001|Overall Study|Withdrawal by Subject|7|||
17153284|NCT02142738|38299666|FG000|Overall Study|Follow up ended by sponsor|43|||
17153285|NCT02142738|38299667|FG001|Overall Study|Follow up ended by sponsor|20|||
17153286|NCT03617861|38299678|FG000|Second Intervention (1 Day)|Adverse Event|0|||
17153287|NCT03617861|38299679|FG001|Second Intervention (1 Day)|Adverse Event|0|||
17072178|NCT00273052|38214606|FG001|Overall Study|Lack of Efficacy|4|||
17072179|NCT00273052|38214605|FG000|Overall Study|Non-Compliance|3|||
17072180|NCT00273052|38214606|FG001|Overall Study|Non-Compliance|1|||
17072181|NCT00273052|38214605|FG000|Overall Study|Other|2|||
17072182|NCT00273052|38214606|FG001|Overall Study|Other|0|||
17072183|NCT00273052|38214605|FG000|Overall Study|Worsening serum lipid levels|0|||
17072184|NCT00273052|38214606|FG001|Overall Study|Worsening serum lipid levels|2|||
17072185|NCT00290290|38214614|FG000|Overall Study|Death|3|||
17153288|NCT03617861|38299680|FG002|Second Intervention (1 Day)|Adverse Event|1|||
17153289|NCT03617861|38299681|FG003|Second Intervention (1 Day)|Adverse Event|0|||
17153290|NCT03099096|38299691|FG000|Overall Study|Adverse Event|1|||
17153291|NCT03099096|38299691|FG000|Overall Study|Physician Decision|1|||
17153292|NCT03614975|38299697|FG000|Overall Study|Physician Decision|7|||
17153293|NCT03614975|38299698|FG001|Overall Study|Physician Decision|5|||
17153294|NCT03614975|38299697|FG000|Overall Study|Withdrawal by Subject|2|||
17153295|NCT03614975|38299698|FG001|Overall Study|Withdrawal by Subject|2|||
17153296|NCT03614975|38299697|FG000|Overall Study|Specimens not in lab batch shipment|1|||
17153297|NCT03614975|38299698|FG001|Overall Study|Specimens not in lab batch shipment|1|||
17153298|NCT03613649|38299716|FG000|Second Treatment|Lost to Follow-up|0|||
17153299|NCT03613649|38299717|FG001|Second Treatment|Lost to Follow-up|0|||
17153300|NCT03613649|38299718|FG002|Second Treatment|Lost to Follow-up|1|||
17153301|NCT03613649|38299719|FG003|Second Treatment|Lost to Follow-up|0|||
17153302|NCT03613649|38299720|FG004|Second Treatment|Lost to Follow-up|0|||
17153303|NCT03613649|38299721|FG005|Second Treatment|Lost to Follow-up|0|||
17153304|NCT03613649|38299722|FG006|Second Treatment|Lost to Follow-up|0|||
17153305|NCT03613649|38299723|FG007|Second Treatment|Lost to Follow-up|0|||
17153306|NCT03613649|38299724|FG008|Second Treatment|Lost to Follow-up|0|||
17153307|NCT03613649|38299725|FG009|Second Treatment|Lost to Follow-up|0|||
17153308|NCT03613649|38299726|FG010|Second Treatment|Lost to Follow-up|0|||
17153309|NCT03613649|38299727|FG011|Second Treatment|Lost to Follow-up|0|||
17153310|NCT03613649|38299716|FG000|Second Treatment|Withdrawal by Subject|0|||
17153311|NCT03613649|38299717|FG001|Second Treatment|Withdrawal by Subject|0|||
17153312|NCT03613649|38299718|FG002|Second Treatment|Withdrawal by Subject|0|||
17153313|NCT03613649|38299719|FG003|Second Treatment|Withdrawal by Subject|0|||
17153314|NCT03613649|38299720|FG004|Second Treatment|Withdrawal by Subject|1|||
17153315|NCT03613649|38299721|FG005|Second Treatment|Withdrawal by Subject|0|||
17153316|NCT03613649|38299722|FG006|Second Treatment|Withdrawal by Subject|0|||
17153317|NCT03613649|38299723|FG007|Second Treatment|Withdrawal by Subject|0|||
17153318|NCT03613649|38299724|FG008|Second Treatment|Withdrawal by Subject|0|||
17153319|NCT03613649|38299725|FG009|Second Treatment|Withdrawal by Subject|0|||
17153320|NCT03613649|38299726|FG010|Second Treatment|Withdrawal by Subject|0|||
17153321|NCT03613649|38299727|FG011|Second Treatment|Withdrawal by Subject|0|||
17153322|NCT03613649|38299716|FG000|Third Treatment|Lost to Follow-up|0|||
17153323|NCT03613649|38299717|FG001|Third Treatment|Lost to Follow-up|0|||
17153324|NCT03613649|38299718|FG002|Third Treatment|Lost to Follow-up|0|||
17153325|NCT03613649|38299719|FG003|Third Treatment|Lost to Follow-up|0|||
17153326|NCT03613649|38299720|FG004|Third Treatment|Lost to Follow-up|1|||
17153327|NCT03613649|38299721|FG005|Third Treatment|Lost to Follow-up|0|||
17153328|NCT03613649|38299722|FG006|Third Treatment|Lost to Follow-up|0|||
17153329|NCT03613649|38299723|FG007|Third Treatment|Lost to Follow-up|0|||
17153330|NCT03613649|38299724|FG008|Third Treatment|Lost to Follow-up|0|||
17153331|NCT03613649|38299725|FG009|Third Treatment|Lost to Follow-up|0|||
17153332|NCT03613649|38299726|FG010|Third Treatment|Lost to Follow-up|0|||
17072186|NCT00290290|38214615|FG001|Overall Study|Death|4|||
17072187|NCT00290290|38214614|FG000|Overall Study|Withdrawal by Subject|2|||
17153333|NCT03613649|38299727|FG011|Third Treatment|Lost to Follow-up|1|||
17153334|NCT03613649|38299716|FG000|Third Treatment|Protocol Violation|0|||
17153335|NCT03613649|38299717|FG001|Third Treatment|Protocol Violation|0|||
17072188|NCT00290290|38214615|FG001|Overall Study|Withdrawal by Subject|2|||
17072189|NCT00290290|38214614|FG000|Overall Study|Underwent clean surgical procedure|13|||
17153336|NCT03613649|38299718|FG002|Third Treatment|Protocol Violation|0|||
17153337|NCT03613649|38299719|FG003|Third Treatment|Protocol Violation|0|||
17153338|NCT03613649|38299720|FG004|Third Treatment|Protocol Violation|0|||
17153339|NCT03613649|38299721|FG005|Third Treatment|Protocol Violation|0|||
17153340|NCT03613649|38299722|FG006|Third Treatment|Protocol Violation|1|||
17153341|NCT03613649|38299723|FG007|Third Treatment|Protocol Violation|0|||
17072190|NCT00290290|38214615|FG001|Overall Study|Underwent clean surgical procedure|12|||
17153342|NCT03613649|38299724|FG008|Third Treatment|Protocol Violation|0|||
17153343|NCT03613649|38299725|FG009|Third Treatment|Protocol Violation|0|||
17153344|NCT03613649|38299726|FG010|Third Treatment|Protocol Violation|0|||
17153345|NCT03613649|38299727|FG011|Third Treatment|Protocol Violation|1|||
17153346|NCT03613649|38299716|FG000|Fourth Treatment|Protocol Violation|1|||
17153347|NCT03613649|38299717|FG001|Fourth Treatment|Protocol Violation|0|||
17153348|NCT03613649|38299718|FG002|Fourth Treatment|Protocol Violation|0|||
17153349|NCT03613649|38299719|FG003|Fourth Treatment|Protocol Violation|0|||
17153350|NCT03613649|38299720|FG004|Fourth Treatment|Protocol Violation|1|||
17153351|NCT03613649|38299721|FG005|Fourth Treatment|Protocol Violation|0|||
17153352|NCT03613649|38299722|FG006|Fourth Treatment|Protocol Violation|0|||
17153353|NCT03613649|38299723|FG007|Fourth Treatment|Protocol Violation|0|||
17153354|NCT03613649|38299724|FG008|Fourth Treatment|Protocol Violation|0|||
17153355|NCT03613649|38299725|FG009|Fourth Treatment|Protocol Violation|0|||
17153356|NCT03613649|38299726|FG010|Fourth Treatment|Protocol Violation|0|||
17153357|NCT03613649|38299727|FG011|Fourth Treatment|Protocol Violation|0|||
17153358|NCT03613649|38299716|FG000|Fourth Treatment|Physician Decision|0|||
17153359|NCT03613649|38299717|FG001|Fourth Treatment|Physician Decision|0|||
17072191|NCT00272038|38214621|FG000|Overall Study|withdrew before they received 2 cycles|7|||
17072192|NCT00271024|38214630|FG000|Overall Study|Lost Interest|3|||
17072193|NCT00271024|38214631|FG001|Overall Study|Lost Interest|4|||
17072194|NCT00271024|38214632|FG002|Overall Study|Lost Interest|2|||
17072195|NCT00271024|38214633|FG003|Overall Study|Lost Interest|3|||
17072196|NCT00271024|38214630|FG000|Overall Study|Unknown/Unspecified|11|||
17072197|NCT00271024|38214631|FG001|Overall Study|Unknown/Unspecified|11|||
17072198|NCT00271024|38214632|FG002|Overall Study|Unknown/Unspecified|8|||
17072199|NCT00271024|38214633|FG003|Overall Study|Unknown/Unspecified|4|||
17072200|NCT00271024|38214630|FG000|Overall Study|Protocol Violation|1|||
17072201|NCT00271024|38214631|FG001|Overall Study|Protocol Violation|6|||
17072202|NCT00271024|38214632|FG002|Overall Study|Protocol Violation|5|||
17072203|NCT00271024|38214633|FG003|Overall Study|Protocol Violation|11|||
17072204|NCT00271024|38214630|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
17072205|NCT00271024|38214631|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
17072206|NCT00271024|38214632|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
17072207|NCT00271024|38214633|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
17072208|NCT00271024|38214630|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
17153360|NCT03613649|38299718|FG002|Fourth Treatment|Physician Decision|0|||
17153361|NCT03613649|38299719|FG003|Fourth Treatment|Physician Decision|0|||
17153362|NCT03613649|38299720|FG004|Fourth Treatment|Physician Decision|0|||
17153363|NCT03613649|38299721|FG005|Fourth Treatment|Physician Decision|0|||
17153364|NCT03613649|38299722|FG006|Fourth Treatment|Physician Decision|1|||
17153365|NCT03613649|38299723|FG007|Fourth Treatment|Physician Decision|0|||
17153366|NCT03613649|38299724|FG008|Fourth Treatment|Physician Decision|0|||
17153367|NCT03613649|38299725|FG009|Fourth Treatment|Physician Decision|0|||
17153368|NCT03613649|38299726|FG010|Fourth Treatment|Physician Decision|0|||
17153369|NCT03613649|38299727|FG011|Fourth Treatment|Physician Decision|0|||
17153370|NCT03096288|38299749|FG000|Overall Study|Withdrawal by Subject|0|||
17153371|NCT03096288|38299750|FG001|Overall Study|Withdrawal by Subject|1|||
17072209|NCT00271024|38214631|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
17072210|NCT00271024|38214632|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
17072211|NCT00271024|38214633|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
17072212|NCT00381693|38214643|FG000|Overall Study|Death|1|||
17072213|NCT00381693|38214643|FG000|Overall Study|Adverse Event|4|||
17072214|NCT00381693|38214643|FG000|Overall Study|Patient Choice|1|||
17072215|NCT00381693|38214643|FG000|Overall Study|Progression|2|||
17072216|NCT00545363|38214649|FG000|Overall Study|Adverse Event|6|||
17072217|NCT00545363|38214650|FG001|Overall Study|Adverse Event|7|||
17072218|NCT00545363|38214649|FG000|Overall Study|Withdrawal by Subject|6|||
17072219|NCT00545363|38214650|FG001|Overall Study|Withdrawal by Subject|5|||
17072220|NCT00545363|38214649|FG000|Overall Study|Non-compliance|3|||
17072221|NCT00545363|38214650|FG001|Overall Study|Non-compliance|1|||
17072222|NCT00545363|38214649|FG000|Overall Study|Did not meet entry criteria|1|||
17072223|NCT00545363|38214650|FG001|Overall Study|Did not meet entry criteria|1|||
17072224|NCT00545363|38214649|FG000|Overall Study|Lost to Follow-up|2|||
17072225|NCT00545363|38214650|FG001|Overall Study|Lost to Follow-up|0|||
17072226|NCT00545363|38214649|FG000|Overall Study|Other|1|||
17072227|NCT00545363|38214650|FG001|Overall Study|Other|1|||
17072228|NCT00457392|38214658|FG000|Overall Study|Objective Progression or Relapse|229|||
17072229|NCT00457392|38214659|FG001|Overall Study|Objective Progression or Relapse|296|||
17072230|NCT00457392|38214658|FG000|Overall Study|Death|106|||
17072231|NCT00457392|38214659|FG001|Overall Study|Death|106|||
17153372|NCT03096288|38299751|FG002|Overall Study|Withdrawal by Subject|0|||
17153373|NCT03096288|38299752|FG003|Overall Study|Withdrawal by Subject|1|||
17072232|NCT00457392|38214658|FG000|Overall Study|Adverse Event|84|||
17072233|NCT00457392|38214659|FG001|Overall Study|Adverse Event|41|||
17072234|NCT00457392|38214658|FG000|Overall Study|Global Deterioration of Health Status|22|||
17072235|NCT00457392|38214659|FG001|Overall Study|Global Deterioration of Health Status|8|||
17072236|NCT00457392|38214658|FG000|Overall Study|Withdrawal by Subject|14|||
17072237|NCT00457392|38214659|FG001|Overall Study|Withdrawal by Subject|8|||
17072238|NCT00457392|38214658|FG000|Overall Study|Lost to Follow-up|6|||
17072239|NCT00457392|38214659|FG001|Overall Study|Lost to Follow-up|7|||
17072240|NCT00457392|38214658|FG000|Overall Study|Protocol Violation|4|||
17072241|NCT00457392|38214659|FG001|Overall Study|Protocol Violation|3|||
17153374|NCT03611075|38299771|FG000|Overall Study|Physician Decision|0|||
17153375|NCT03611075|38299772|FG001|Overall Study|Physician Decision|1|||
17153376|NCT03611075|38299773|FG002|Overall Study|Physician Decision|1|||
17153377|NCT03611075|38299774|FG003|Overall Study|Physician Decision|0|||
17153378|NCT03611075|38299775|FG004|Overall Study|Physician Decision|0|||
17153379|NCT03611075|38299776|FG005|Overall Study|Physician Decision|0|||
17153380|NCT03611075|38299777|FG006|Overall Study|Physician Decision|0|||
17153381|NCT03611075|38299778|FG007|Overall Study|Physician Decision|0|||
17153382|NCT03611075|38299779|FG008|Overall Study|Physician Decision|0|||
17153383|NCT03611075|38299771|FG000|Overall Study|Lost to Follow-up|1|||
17153384|NCT03611075|38299772|FG001|Overall Study|Lost to Follow-up|0|||
17153385|NCT03611075|38299773|FG002|Overall Study|Lost to Follow-up|0|||
17153386|NCT03611075|38299774|FG003|Overall Study|Lost to Follow-up|2|||
17153387|NCT03611075|38299775|FG004|Overall Study|Lost to Follow-up|0|||
17153388|NCT03611075|38299776|FG005|Overall Study|Lost to Follow-up|0|||
17153389|NCT03611075|38299777|FG006|Overall Study|Lost to Follow-up|0|||
17153390|NCT03611075|38299778|FG007|Overall Study|Lost to Follow-up|0|||
17153391|NCT03611075|38299779|FG008|Overall Study|Lost to Follow-up|0|||
17153392|NCT03611075|38299771|FG000|Overall Study|Withdrawal by Subject|0|||
17153393|NCT03611075|38299772|FG001|Overall Study|Withdrawal by Subject|1|||
17153394|NCT03611075|38299773|FG002|Overall Study|Withdrawal by Subject|1|||
17153395|NCT03611075|38299774|FG003|Overall Study|Withdrawal by Subject|1|||
17153396|NCT03611075|38299775|FG004|Overall Study|Withdrawal by Subject|0|||
17153397|NCT03611075|38299776|FG005|Overall Study|Withdrawal by Subject|0|||
17153398|NCT03611075|38299777|FG006|Overall Study|Withdrawal by Subject|1|||
17153399|NCT03611075|38299778|FG007|Overall Study|Withdrawal by Subject|0|||
17153400|NCT03611075|38299779|FG008|Overall Study|Withdrawal by Subject|0|||
17153401|NCT03611075|38299771|FG000|Overall Study|Reason unknown|0|||
17153402|NCT03611075|38299772|FG001|Overall Study|Reason unknown|0|||
17153403|NCT03611075|38299773|FG002|Overall Study|Reason unknown|0|||
17153404|NCT03611075|38299774|FG003|Overall Study|Reason unknown|1|||
17153405|NCT03611075|38299775|FG004|Overall Study|Reason unknown|0|||
17153406|NCT03611075|38299776|FG005|Overall Study|Reason unknown|0|||
17153407|NCT03611075|38299777|FG006|Overall Study|Reason unknown|1|||
17153408|NCT03611075|38299778|FG007|Overall Study|Reason unknown|0|||
17153409|NCT03611075|38299779|FG008|Overall Study|Reason unknown|0|||
17153410|NCT03095508|38299824|FG000|Overall Study|Adverse Event|0|||
17153411|NCT03095508|38299825|FG001|Overall Study|Adverse Event|1|||
17072242|NCT00457392|38214658|FG000|Overall Study|Other|7|||
17072243|NCT00457392|38214659|FG001|Overall Study|Other|4|||
17072244|NCT00457392|38214658|FG000|Overall Study|Study Terminated by Sponsor|1|||
17072245|NCT00457392|38214659|FG001|Overall Study|Study Terminated by Sponsor|4|||
17072246|NCT00457392|38214658|FG000|Overall Study|Randomized, Not Treated|7|||
17072247|NCT00457392|38214659|FG001|Overall Study|Randomized, Not Treated|3|||
17072248|NCT00545051|38214667|FG000|Overall Study|Adverse Event|7|||
17072249|NCT00545051|38214668|FG001|Overall Study|Adverse Event|3|||
17072250|NCT00545051|38214667|FG000|Overall Study|Death|1|||
17072251|NCT00545051|38214668|FG001|Overall Study|Death|0|||
17072252|NCT00545051|38214667|FG000|Overall Study|Violation of inclusion/exclusion|0|||
17072253|NCT00545051|38214668|FG001|Overall Study|Violation of inclusion/exclusion|2|||
17072254|NCT00545051|38214667|FG000|Overall Study|Protocol Violation|1|||
17072255|NCT00545051|38214668|FG001|Overall Study|Protocol Violation|0|||
17072256|NCT00545051|38214667|FG000|Overall Study|Withdrawal by Subject|0|||
17072257|NCT00545051|38214668|FG001|Overall Study|Withdrawal by Subject|1|||
17072258|NCT00545051|38214667|FG000|Overall Study|Administrative reasons|0|||
17072259|NCT00545051|38214668|FG001|Overall Study|Administrative reasons|1|||
17072260|NCT00381615|38214678|FG000|Overall Study|Withdrawal by Subject|1|||
17072261|NCT00381615|38214679|FG001|Overall Study|Withdrawal by Subject|3|||
17072262|NCT00381615|38214680|FG002|Overall Study|Withdrawal by Subject|0|||
17072263|NCT00381615|38214681|FG003|Overall Study|Withdrawal by Subject|1|||
17072264|NCT00381615|38214678|FG000|Overall Study|Lost to Follow-up|3|||
17072265|NCT00381615|38214679|FG001|Overall Study|Lost to Follow-up|2|||
17072266|NCT00381615|38214680|FG002|Overall Study|Lost to Follow-up|0|||
17072267|NCT00381615|38214681|FG003|Overall Study|Lost to Follow-up|1|||
17072268|NCT00381615|38214678|FG000|Overall Study|Protocol Violation|0|||
17072269|NCT00381615|38214679|FG001|Overall Study|Protocol Violation|0|||
17072270|NCT00381615|38214680|FG002|Overall Study|Protocol Violation|1|||
17072271|NCT00381615|38214681|FG003|Overall Study|Protocol Violation|0|||
17153412|NCT03607487|38299835|FG000|Overall Study|Withdrawal by Subject|2|||
17153413|NCT03607487|38299836|FG001|Overall Study|Withdrawal by Subject|0|||
17153414|NCT03607487|38299837|FG002|Overall Study|Withdrawal by Subject|0|||
17153415|NCT03607487|38299838|FG003|Overall Study|Withdrawal by Subject|1|||
17153416|NCT03605693|38299852|FG000|Overall Study|Lost to Follow-up|4|||
17153417|NCT03605693|38299853|FG001|Overall Study|Lost to Follow-up|0|||
17153418|NCT03605693|38299852|FG000|Overall Study|Physician Decision|1|||
17153419|NCT03605693|38299853|FG001|Overall Study|Physician Decision|0|||
17153420|NCT03605303|38299859|FG000|Period 1|Study Terminated|2|||
17153421|NCT03605303|38299860|FG001|Period 1|Study Terminated|1|||
17153422|NCT03604523|38299868|FG000|Overall Study|Physician Decision|1|||
17153423|NCT03604523|38299869|FG001|Overall Study|Physician Decision|0|||
17153424|NCT03602339|38299875|FG000|Overall Study|Withdrawal by Subject|9|||
17153425|NCT03602339|38299875|FG000|Overall Study|Physician Decision|2|||
17153426|NCT03602339|38299875|FG000|Overall Study|Other reason|4|||
17153427|NCT03653429|38299884|FG000|Overall Study|Physician Decision|4|||
17153428|NCT03653429|38299885|FG001|Overall Study|Physician Decision|10|||
17153429|NCT03601715|38299894|FG000|Second Intervention|Lost to Follow-up|1|||
17153430|NCT03601715|38299895|FG001|Second Intervention|Lost to Follow-up|1|||
17153431|NCT03601715|38299896|FG002|Second Intervention|Lost to Follow-up|0|||
17153432|NCT03594227|38299908|FG000|Overall Study|Adverse Event|2|||
17153433|NCT03594227|38299909|FG001|Overall Study|Adverse Event|1|||
17153434|NCT03594227|38299910|FG002|Overall Study|Adverse Event|0|||
17153435|NCT03594227|38299911|FG003|Overall Study|Adverse Event|2|||
17153436|NCT03594227|38299908|FG000|Overall Study|Lost to Follow-up|1|||
17153437|NCT03594227|38299909|FG001|Overall Study|Lost to Follow-up|1|||
17153438|NCT03594227|38299910|FG002|Overall Study|Lost to Follow-up|1|||
17153439|NCT03594227|38299911|FG003|Overall Study|Lost to Follow-up|0|||
17153440|NCT03594227|38299908|FG000|Overall Study|Withdrawal by Subject|1|||
17153441|NCT03594227|38299909|FG001|Overall Study|Withdrawal by Subject|1|||
17072272|NCT00371865|38214695|FG000|Overall Study|Lack of Efficacy|0|||
17072273|NCT00371865|38214696|FG001|Overall Study|Lack of Efficacy|2|||
17072274|NCT00371865|38214695|FG000|Overall Study|Protocol Violation|3|||
17072275|NCT00371865|38214696|FG001|Overall Study|Protocol Violation|2|||
17072276|NCT00371865|38214695|FG000|Overall Study|Withdrawal by Subject|12|||
17072277|NCT00371865|38214696|FG001|Overall Study|Withdrawal by Subject|10|||
17072278|NCT00364845|38214704|FG000|Overall Study|Adverse Event|1|||
17072279|NCT00364845|38214705|FG001|Overall Study|Adverse Event|0|||
17072280|NCT00364845|38214704|FG000|Overall Study|Withdrawal by Subject|2|||
17072281|NCT00364845|38214705|FG001|Overall Study|Withdrawal by Subject|1|||
17153442|NCT03594227|38299910|FG002|Overall Study|Withdrawal by Subject|1|||
17153443|NCT03594227|38299911|FG003|Overall Study|Withdrawal by Subject|1|||
17153444|NCT03594227|38299908|FG000|Overall Study|Pregnancy|0|||
17153445|NCT03594227|38299909|FG001|Overall Study|Pregnancy|1|||
17153446|NCT03594227|38299910|FG002|Overall Study|Pregnancy|0|||
17153447|NCT03594227|38299911|FG003|Overall Study|Pregnancy|0|||
17153448|NCT03594227|38299908|FG000|Overall Study|Sponsor Decision|0|||
17153449|NCT03594227|38299909|FG001|Overall Study|Sponsor Decision|0|||
17153450|NCT03594227|38299910|FG002|Overall Study|Sponsor Decision|0|||
17153451|NCT03594227|38299911|FG003|Overall Study|Sponsor Decision|1|||
17153452|NCT03594227|38299908|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
17153453|NCT03594227|38299909|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
17153454|NCT03594227|38299910|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
17153455|NCT03594227|38299911|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
17153456|NCT03098550|38299935|FG000|Overall Study|Disease Progression|30|||
17153457|NCT03098550|38299936|FG001|Overall Study|Disease Progression|19|||
17153458|NCT03098550|38299937|FG002|Overall Study|Disease Progression|41|||
17153459|NCT03098550|38299935|FG000|Overall Study|Study Drug Toxicity|2|||
17153460|NCT03098550|38299936|FG001|Overall Study|Study Drug Toxicity|1|||
17153461|NCT03098550|38299937|FG002|Overall Study|Study Drug Toxicity|0|||
17153462|NCT03098550|38299935|FG000|Overall Study|Death|1|||
17153463|NCT03098550|38299936|FG001|Overall Study|Death|0|||
17153464|NCT03098550|38299937|FG002|Overall Study|Death|0|||
17153465|NCT03098550|38299935|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
17153466|NCT03098550|38299936|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
17153467|NCT03098550|38299937|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
17153468|NCT03098550|38299935|FG000|Overall Study|Administrative reason by sponsor|0|||
17153469|NCT03098550|38299936|FG001|Overall Study|Administrative reason by sponsor|0|||
17153470|NCT03098550|38299937|FG002|Overall Study|Administrative reason by sponsor|1|||
17153471|NCT03098550|38299935|FG000|Overall Study|Other reasons|2|||
17153472|NCT03098550|38299936|FG001|Overall Study|Other reasons|0|||
17153473|NCT03098550|38299937|FG002|Overall Study|Other reasons|0|||
17153474|NCT03095118|38299949|FG000|Overall Study|Adverse Event|1|||
17153475|NCT03095118|38299949|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
17153476|NCT03594071|38299953|FG000|Overall Study|Re-operation|3|||
17072282|NCT00364845|38214704|FG000|Overall Study|Physician Decision|8|||
17153477|NCT03594071|38299953|FG000|Overall Study|Missed visit|2|||
17153478|NCT02696902|38299960|FG000|Overall Study|Lost to Follow-up|0|||
17153479|NCT02696902|38299961|FG001|Overall Study|Lost to Follow-up|1|||
17153480|NCT02696902|38299962|FG002|Overall Study|Lost to Follow-up|1|||
17153481|NCT02696902|38299960|FG000|Overall Study|Withdrawal by Subject|0|||
17153482|NCT02696902|38299961|FG001|Overall Study|Withdrawal by Subject|0|||
17153483|NCT02696902|38299962|FG002|Overall Study|Withdrawal by Subject|1|||
17153484|NCT02696902|38299960|FG000|Overall Study|Death|19|||
17153485|NCT02696902|38299961|FG001|Overall Study|Death|3|||
17153486|NCT02696902|38299962|FG002|Overall Study|Death|24|||
17153487|NCT02696902|38299960|FG000|Overall Study|Participant not fit post-randomization|0|||
17153488|NCT02696902|38299961|FG001|Overall Study|Participant not fit post-randomization|0|||
17153489|NCT02696902|38299962|FG002|Overall Study|Participant not fit post-randomization|1|||
17153490|NCT02696902|38299960|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
17153491|NCT02696902|38299961|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
17153492|NCT02696902|38299962|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
17153493|NCT02696902|38299960|FG000|Overall Study|Principal investigator's decision|1|||
17153494|NCT02696902|38299961|FG001|Overall Study|Principal investigator's decision|0|||
17153495|NCT02696902|38299962|FG002|Overall Study|Principal investigator's decision|0|||
17153496|NCT02696902|38299960|FG000|Overall Study|Sponsor's decision|1|||
17153497|NCT02696902|38299961|FG001|Overall Study|Sponsor's decision|0|||
17153498|NCT02696902|38299962|FG002|Overall Study|Sponsor's decision|0|||
17153499|NCT02696902|38299960|FG000|Overall Study|Transferred to other hospital|1|||
17153500|NCT02696902|38299961|FG001|Overall Study|Transferred to other hospital|0|||
17153501|NCT02696902|38299962|FG002|Overall Study|Transferred to other hospital|0|||
17153502|NCT02694562|38299972|FG000|Overall Study|Death|8|||
17153503|NCT02694562|38299972|FG000|Overall Study|Protocol Violation|4|||
17153504|NCT02694562|38299972|FG000|Overall Study|Lost to Follow-up|3|||
17153505|NCT02694562|38299972|FG000|Overall Study|Screen Failure|2|||
17153506|NCT02694562|38299972|FG000|Overall Study|Physician Decision|1|||
17153507|NCT02874534|38299978|FG000|Overall Study|Withdrawal by Subject|5|||
17153508|NCT02874534|38299979|FG001|Overall Study|Withdrawal by Subject|8|||
17153509|NCT02874534|38299978|FG000|Overall Study|Lost to Follow-up|2|||
17153510|NCT02874534|38299979|FG001|Overall Study|Lost to Follow-up|2|||
17153511|NCT02874534|38299978|FG000|Overall Study|Ongoing in study|1|||
17153512|NCT02874534|38299979|FG001|Overall Study|Ongoing in study|1|||
17153513|NCT03097614|38299985|FG000|Overall Study|Adverse Event|3|||
17153514|NCT03364309|38299992|FG000|Induction Period|Adverse Event|4|||
17153515|NCT03364309|38299993|FG001|Induction Period|Adverse Event|0|||
17153516|NCT03364309|38299994|FG002|Induction Period|Adverse Event|1|||
17153517|NCT03364309|38299995|FG003|Induction Period|Adverse Event|0|||
17153518|NCT03364309|38299996|FG004|Induction Period|Adverse Event|0|||
17153519|NCT03364309|38299997|FG005|Induction Period|Adverse Event|0|||
17153520|NCT03364309|38299998|FG006|Induction Period|Adverse Event|0|||
17153521|NCT03364309|38299999|FG007|Induction Period|Adverse Event|0|||
17153522|NCT03364309|38300000|FG008|Induction Period|Adverse Event|0|||
17153523|NCT03364309|38300001|FG009|Induction Period|Adverse Event|0|||
17153524|NCT03364309|38300002|FG010|Induction Period|Adverse Event|0|||
17153525|NCT03364309|38300003|FG011|Induction Period|Adverse Event|0|||
17153526|NCT03364309|38300004|FG012|Induction Period|Adverse Event|0|||
17153527|NCT03364309|38300005|FG013|Induction Period|Adverse Event|0|||
17153528|NCT03364309|38300006|FG014|Induction Period|Adverse Event|0|||
17153529|NCT03364309|38300007|FG015|Induction Period|Adverse Event|0|||
17153530|NCT03364309|38300008|FG016|Induction Period|Adverse Event|0|||
17153531|NCT03364309|38300009|FG017|Induction Period|Adverse Event|0|||
17153532|NCT03364309|38300010|FG018|Induction Period|Adverse Event|0|||
17153533|NCT03364309|38299992|FG000|Induction Period|Withdrawal by Subject|1|||
17153534|NCT03364309|38299993|FG001|Induction Period|Withdrawal by Subject|3|||
17153535|NCT03364309|38299994|FG002|Induction Period|Withdrawal by Subject|0|||
17153536|NCT03364309|38299995|FG003|Induction Period|Withdrawal by Subject|0|||
17153537|NCT03364309|38299996|FG004|Induction Period|Withdrawal by Subject|0|||
17153538|NCT03364309|38299997|FG005|Induction Period|Withdrawal by Subject|0|||
17153539|NCT03364309|38299998|FG006|Induction Period|Withdrawal by Subject|0|||
17153540|NCT03364309|38299999|FG007|Induction Period|Withdrawal by Subject|0|||
17153541|NCT03364309|38300000|FG008|Induction Period|Withdrawal by Subject|0|||
17153542|NCT03364309|38300001|FG009|Induction Period|Withdrawal by Subject|0|||
17153543|NCT03364309|38300002|FG010|Induction Period|Withdrawal by Subject|0|||
17153544|NCT03364309|38300003|FG011|Induction Period|Withdrawal by Subject|0|||
17153545|NCT03364309|38300004|FG012|Induction Period|Withdrawal by Subject|0|||
17153546|NCT03364309|38300005|FG013|Induction Period|Withdrawal by Subject|0|||
17153547|NCT03364309|38300006|FG014|Induction Period|Withdrawal by Subject|0|||
17153548|NCT03364309|38300007|FG015|Induction Period|Withdrawal by Subject|0|||
17153549|NCT03364309|38300008|FG016|Induction Period|Withdrawal by Subject|0|||
17153550|NCT03364309|38300009|FG017|Induction Period|Withdrawal by Subject|0|||
17153551|NCT03364309|38300010|FG018|Induction Period|Withdrawal by Subject|0|||
17153552|NCT03364309|38299992|FG000|Induction Period|Lost to Follow-up|1|||
17153553|NCT03364309|38299993|FG001|Induction Period|Lost to Follow-up|0|||
17153554|NCT03364309|38299994|FG002|Induction Period|Lost to Follow-up|0|||
17153555|NCT03364309|38299995|FG003|Induction Period|Lost to Follow-up|0|||
17153556|NCT03364309|38299996|FG004|Induction Period|Lost to Follow-up|0|||
17153557|NCT03364309|38299997|FG005|Induction Period|Lost to Follow-up|0|||
17153558|NCT03364309|38299998|FG006|Induction Period|Lost to Follow-up|0|||
17153559|NCT03364309|38299999|FG007|Induction Period|Lost to Follow-up|0|||
17153560|NCT03364309|38300000|FG008|Induction Period|Lost to Follow-up|0|||
17153561|NCT03364309|38300001|FG009|Induction Period|Lost to Follow-up|0|||
17153562|NCT03364309|38300002|FG010|Induction Period|Lost to Follow-up|0|||
17153563|NCT03364309|38300003|FG011|Induction Period|Lost to Follow-up|0|||
17153564|NCT03364309|38300004|FG012|Induction Period|Lost to Follow-up|0|||
17153565|NCT03364309|38300005|FG013|Induction Period|Lost to Follow-up|0|||
17153566|NCT03364309|38300006|FG014|Induction Period|Lost to Follow-up|0|||
17153567|NCT03364309|38300007|FG015|Induction Period|Lost to Follow-up|0|||
17153568|NCT03364309|38300008|FG016|Induction Period|Lost to Follow-up|0|||
17153569|NCT03364309|38300009|FG017|Induction Period|Lost to Follow-up|0|||
17153570|NCT03364309|38300010|FG018|Induction Period|Lost to Follow-up|0|||
17153571|NCT03364309|38299992|FG000|Induction Period|Physician Decision|0|||
17153572|NCT03364309|38299993|FG001|Induction Period|Physician Decision|1|||
17153573|NCT03364309|38299994|FG002|Induction Period|Physician Decision|0|||
17153574|NCT03364309|38299995|FG003|Induction Period|Physician Decision|0|||
17153575|NCT03364309|38299996|FG004|Induction Period|Physician Decision|0|||
17153576|NCT03364309|38299997|FG005|Induction Period|Physician Decision|0|||
17153577|NCT03364309|38299998|FG006|Induction Period|Physician Decision|0|||
17153578|NCT03364309|38299999|FG007|Induction Period|Physician Decision|0|||
17153579|NCT03364309|38300000|FG008|Induction Period|Physician Decision|0|||
17153580|NCT03364309|38300001|FG009|Induction Period|Physician Decision|0|||
17153581|NCT03364309|38300002|FG010|Induction Period|Physician Decision|0|||
17153582|NCT03364309|38300003|FG011|Induction Period|Physician Decision|0|||
17153583|NCT03364309|38300004|FG012|Induction Period|Physician Decision|0|||
17153584|NCT03364309|38300005|FG013|Induction Period|Physician Decision|0|||
17153585|NCT03364309|38300006|FG014|Induction Period|Physician Decision|0|||
17153586|NCT03364309|38300007|FG015|Induction Period|Physician Decision|0|||
17153587|NCT03364309|38300008|FG016|Induction Period|Physician Decision|0|||
17153588|NCT03364309|38300009|FG017|Induction Period|Physician Decision|0|||
17153589|NCT03364309|38300010|FG018|Induction Period|Physician Decision|0|||
17153590|NCT03364309|38299992|FG000|Maintenance Period|Withdrawal by Subject|0|||
17153591|NCT03364309|38299993|FG001|Maintenance Period|Withdrawal by Subject|0|||
17153592|NCT03364309|38299994|FG002|Maintenance Period|Withdrawal by Subject|0|||
17153593|NCT03364309|38299995|FG003|Maintenance Period|Withdrawal by Subject|1|||
17153594|NCT03364309|38299996|FG004|Maintenance Period|Withdrawal by Subject|3|||
17153595|NCT03364309|38299997|FG005|Maintenance Period|Withdrawal by Subject|1|||
17153596|NCT03364309|38299998|FG006|Maintenance Period|Withdrawal by Subject|3|||
17153597|NCT03364309|38299999|FG007|Maintenance Period|Withdrawal by Subject|0|||
17153598|NCT03364309|38300000|FG008|Maintenance Period|Withdrawal by Subject|1|||
17153599|NCT03364309|38300001|FG009|Maintenance Period|Withdrawal by Subject|1|||
17153600|NCT03364309|38300002|FG010|Maintenance Period|Withdrawal by Subject|2|||
17153601|NCT03364309|38300003|FG011|Maintenance Period|Withdrawal by Subject|0|||
17153602|NCT03364309|38300004|FG012|Maintenance Period|Withdrawal by Subject|0|||
17153603|NCT03364309|38300005|FG013|Maintenance Period|Withdrawal by Subject|0|||
17153604|NCT03364309|38300006|FG014|Maintenance Period|Withdrawal by Subject|0|||
17153605|NCT03364309|38300007|FG015|Maintenance Period|Withdrawal by Subject|0|||
17153606|NCT03364309|38300008|FG016|Maintenance Period|Withdrawal by Subject|0|||
17153607|NCT03364309|38300009|FG017|Maintenance Period|Withdrawal by Subject|0|||
17153608|NCT03364309|38300010|FG018|Maintenance Period|Withdrawal by Subject|0|||
17153609|NCT03364309|38299992|FG000|Maintenance Period|Adverse Event|0|||
17153610|NCT03364309|38299993|FG001|Maintenance Period|Adverse Event|0|||
17153611|NCT03364309|38299994|FG002|Maintenance Period|Adverse Event|0|||
17153612|NCT03364309|38299995|FG003|Maintenance Period|Adverse Event|0|||
17153613|NCT03364309|38299996|FG004|Maintenance Period|Adverse Event|2|||
17153614|NCT03364309|38299997|FG005|Maintenance Period|Adverse Event|0|||
17153615|NCT03364309|38299998|FG006|Maintenance Period|Adverse Event|3|||
17153616|NCT03364309|38299999|FG007|Maintenance Period|Adverse Event|0|||
17153617|NCT03364309|38300000|FG008|Maintenance Period|Adverse Event|1|||
17153618|NCT03364309|38300001|FG009|Maintenance Period|Adverse Event|0|||
17153619|NCT03364309|38300002|FG010|Maintenance Period|Adverse Event|2|||
17153620|NCT03364309|38300003|FG011|Maintenance Period|Adverse Event|0|||
17153621|NCT03364309|38300004|FG012|Maintenance Period|Adverse Event|0|||
17153622|NCT03364309|38300005|FG013|Maintenance Period|Adverse Event|0|||
17153623|NCT03364309|38300006|FG014|Maintenance Period|Adverse Event|0|||
17153624|NCT03364309|38300007|FG015|Maintenance Period|Adverse Event|0|||
17153625|NCT03364309|38300008|FG016|Maintenance Period|Adverse Event|0|||
17153626|NCT03364309|38300009|FG017|Maintenance Period|Adverse Event|0|||
17153627|NCT03364309|38300010|FG018|Maintenance Period|Adverse Event|0|||
17153628|NCT03364309|38299992|FG000|Maintenance Period|Relapsed|0|||
17153629|NCT03364309|38299993|FG001|Maintenance Period|Relapsed|0|||
17153630|NCT03364309|38299994|FG002|Maintenance Period|Relapsed|0|||
17153631|NCT03364309|38299995|FG003|Maintenance Period|Relapsed|43|||
17153632|NCT03364309|38299996|FG004|Maintenance Period|Relapsed|7|||
17153633|NCT03364309|38299997|FG005|Maintenance Period|Relapsed|45|||
17153634|NCT03364309|38299998|FG006|Maintenance Period|Relapsed|10|||
17153635|NCT03364309|38299999|FG007|Maintenance Period|Relapsed|2|||
17153636|NCT03364309|38300000|FG008|Maintenance Period|Relapsed|0|||
17153637|NCT03364309|38300001|FG009|Maintenance Period|Relapsed|0|||
17153638|NCT03364309|38300002|FG010|Maintenance Period|Relapsed|0|||
17153639|NCT03364309|38300003|FG011|Maintenance Period|Relapsed|0|||
17153640|NCT03364309|38300004|FG012|Maintenance Period|Relapsed|0|||
17153641|NCT03364309|38300005|FG013|Maintenance Period|Relapsed|0|||
17153642|NCT03364309|38300006|FG014|Maintenance Period|Relapsed|0|||
17153643|NCT03364309|38300007|FG015|Maintenance Period|Relapsed|0|||
17153644|NCT03364309|38300008|FG016|Maintenance Period|Relapsed|0|||
17072283|NCT00364845|38214705|FG001|Overall Study|Physician Decision|8|||
17153645|NCT03364309|38300009|FG017|Maintenance Period|Relapsed|0|||
17153646|NCT03364309|38300010|FG018|Maintenance Period|Relapsed|0|||
17153647|NCT03364309|38299992|FG000|Maintenance Period|Lack of Efficacy|0|||
17153648|NCT03364309|38299993|FG001|Maintenance Period|Lack of Efficacy|0|||
17153649|NCT03364309|38299994|FG002|Maintenance Period|Lack of Efficacy|0|||
17153650|NCT03364309|38299995|FG003|Maintenance Period|Lack of Efficacy|0|||
17153651|NCT03364309|38299996|FG004|Maintenance Period|Lack of Efficacy|0|||
17153652|NCT03364309|38299997|FG005|Maintenance Period|Lack of Efficacy|0|||
17153653|NCT03364309|38299998|FG006|Maintenance Period|Lack of Efficacy|0|||
17153654|NCT03364309|38299999|FG007|Maintenance Period|Lack of Efficacy|0|||
17153655|NCT03364309|38300000|FG008|Maintenance Period|Lack of Efficacy|1|||
17153656|NCT03364309|38300001|FG009|Maintenance Period|Lack of Efficacy|3|||
17153657|NCT03364309|38300002|FG010|Maintenance Period|Lack of Efficacy|2|||
17153658|NCT03364309|38300003|FG011|Maintenance Period|Lack of Efficacy|0|||
17153659|NCT03364309|38300004|FG012|Maintenance Period|Lack of Efficacy|0|||
17072284|NCT00364845|38214704|FG000|Overall Study|Lost to Follow-up|0|||
17072285|NCT00364845|38214705|FG001|Overall Study|Lost to Follow-up|1|||
17072286|NCT00364845|38214704|FG000|Overall Study|Death|0|||
17072287|NCT00364845|38214705|FG001|Overall Study|Death|1|||
17072288|NCT00293722|38214711|FG000|Overall Study|Other|427|||
17072289|NCT00381303|38214717|FG000|Overall Study|Lost to Follow-up|25|||
17072290|NCT00381303|38214718|FG001|Overall Study|Lost to Follow-up|9|||
17072291|NCT00381303|38214717|FG000|Overall Study|AE/HIV-related event|22|||
17072292|NCT00381303|38214718|FG001|Overall Study|AE/HIV-related event|6|||
17072293|NCT00381303|38214717|FG000|Overall Study|Non-Adherence|13|||
17072294|NCT00381303|38214718|FG001|Overall Study|Non-Adherence|6|||
17072295|NCT00381303|38214717|FG000|Overall Study|Withdrawal by Subject|13|||
17072296|NCT00381303|38214718|FG001|Overall Study|Withdrawal by Subject|6|||
17072297|NCT00381303|38214717|FG000|Overall Study|Virologic failure|6|||
17072298|NCT00381303|38214718|FG001|Overall Study|Virologic failure|4|||
17072299|NCT00381303|38214717|FG000|Overall Study|Ineligible to continue the trial|2|||
17153660|NCT03364309|38300005|FG013|Maintenance Period|Lack of Efficacy|0|||
17153661|NCT03364309|38300006|FG014|Maintenance Period|Lack of Efficacy|0|||
17153662|NCT03364309|38300007|FG015|Maintenance Period|Lack of Efficacy|0|||
17072300|NCT00381303|38214718|FG001|Overall Study|Ineligible to continue the trial|1|||
17072301|NCT00381303|38214717|FG000|Overall Study|Pregnancy|2|||
17072302|NCT00381303|38214718|FG001|Overall Study|Pregnancy|0|||
17072303|NCT00381303|38214717|FG000|Overall Study|Physician Decision|1|||
17072304|NCT00381303|38214718|FG001|Overall Study|Physician Decision|0|||
17072305|NCT00381303|38214717|FG000|Overall Study|Physician's decision to close the site|3|||
17072306|NCT00381303|38214718|FG001|Overall Study|Physician's decision to close the site|1|||
16781255|NCT02109484|37720413|FG004|Overall Study|Death|0|||
17072307|NCT00381303|38214717|FG000|Overall Study|Subject moved out of state|2|||
17072308|NCT00381303|38214718|FG001|Overall Study|Subject moved out of state|0|||
17072309|NCT00381303|38214717|FG000|Overall Study|Subject taking too many different meds|1|||
17072310|NCT00381303|38214718|FG001|Overall Study|Subject taking too many different meds|0|||
17072311|NCT00381303|38214717|FG000|Overall Study|No virologic response by week 12|1|||
17072312|NCT00381303|38214718|FG001|Overall Study|No virologic response by week 12|0|||
17072313|NCT00381303|38214717|FG000|Overall Study|Subject was too busy for appointments|1|||
17072314|NCT00381303|38214718|FG001|Overall Study|Subject was too busy for appointments|0|||
17072315|NCT00381303|38214717|FG000|Overall Study|Subject did not continue visits|1|||
17072316|NCT00381303|38214718|FG001|Overall Study|Subject did not continue visits|0|||
17072317|NCT00381303|38214717|FG000|Overall Study|Subject primary physician's decision|1|||
17072318|NCT00381303|38214718|FG001|Overall Study|Subject primary physician's decision|0|||
17072319|NCT00448812|38214738|FG000|Year 2|Missed visit but remained in study|4|||
17153663|NCT03364309|38300008|FG016|Maintenance Period|Lack of Efficacy|0|||
17153664|NCT03364309|38300009|FG017|Maintenance Period|Lack of Efficacy|0|||
17153665|NCT03364309|38300010|FG018|Maintenance Period|Lack of Efficacy|0|||
17153666|NCT03364309|38299992|FG000|Maintenance Period|Death|0|||
17153667|NCT03364309|38299993|FG001|Maintenance Period|Death|0|||
17153668|NCT03364309|38299994|FG002|Maintenance Period|Death|0|||
17153669|NCT03364309|38299995|FG003|Maintenance Period|Death|0|||
17153670|NCT03364309|38299996|FG004|Maintenance Period|Death|0|||
17153671|NCT03364309|38299997|FG005|Maintenance Period|Death|0|||
17153672|NCT03364309|38299998|FG006|Maintenance Period|Death|0|||
17153673|NCT03364309|38299999|FG007|Maintenance Period|Death|0|||
17153674|NCT03364309|38300000|FG008|Maintenance Period|Death|1|||
17153675|NCT03364309|38300001|FG009|Maintenance Period|Death|0|||
17153676|NCT03364309|38300002|FG010|Maintenance Period|Death|0|||
17153677|NCT03364309|38300003|FG011|Maintenance Period|Death|0|||
17153678|NCT03364309|38300004|FG012|Maintenance Period|Death|0|||
17153679|NCT03364309|38300005|FG013|Maintenance Period|Death|0|||
17153680|NCT03364309|38300006|FG014|Maintenance Period|Death|0|||
17153681|NCT03364309|38300007|FG015|Maintenance Period|Death|0|||
17153682|NCT03364309|38300008|FG016|Maintenance Period|Death|0|||
17153683|NCT03364309|38300009|FG017|Maintenance Period|Death|0|||
17153684|NCT03364309|38300010|FG018|Maintenance Period|Death|0|||
17153685|NCT03364309|38299992|FG000|Maintenance Period|Lost to Follow-up|0|||
17153686|NCT03364309|38299993|FG001|Maintenance Period|Lost to Follow-up|0|||
17153687|NCT03364309|38299994|FG002|Maintenance Period|Lost to Follow-up|0|||
17153688|NCT03364309|38299995|FG003|Maintenance Period|Lost to Follow-up|0|||
17153689|NCT03364309|38299996|FG004|Maintenance Period|Lost to Follow-up|0|||
17153690|NCT03364309|38299997|FG005|Maintenance Period|Lost to Follow-up|0|||
17153691|NCT03364309|38299998|FG006|Maintenance Period|Lost to Follow-up|0|||
17153692|NCT03364309|38299999|FG007|Maintenance Period|Lost to Follow-up|0|||
17153693|NCT03364309|38300000|FG008|Maintenance Period|Lost to Follow-up|1|||
17153694|NCT03364309|38300001|FG009|Maintenance Period|Lost to Follow-up|0|||
17153695|NCT03364309|38300002|FG010|Maintenance Period|Lost to Follow-up|0|||
17153696|NCT03364309|38300003|FG011|Maintenance Period|Lost to Follow-up|0|||
17153697|NCT03364309|38300004|FG012|Maintenance Period|Lost to Follow-up|0|||
17153698|NCT03364309|38300005|FG013|Maintenance Period|Lost to Follow-up|0|||
17153699|NCT03364309|38300006|FG014|Maintenance Period|Lost to Follow-up|0|||
17153700|NCT03364309|38300007|FG015|Maintenance Period|Lost to Follow-up|0|||
17153701|NCT03364309|38300008|FG016|Maintenance Period|Lost to Follow-up|0|||
17153702|NCT03364309|38300009|FG017|Maintenance Period|Lost to Follow-up|0|||
17153703|NCT03364309|38300010|FG018|Maintenance Period|Lost to Follow-up|0|||
17153704|NCT03364309|38299992|FG000|Maintenance Period|Miscellaneous|0|||
17153705|NCT03364309|38299993|FG001|Maintenance Period|Miscellaneous|0|||
17153706|NCT03364309|38299994|FG002|Maintenance Period|Miscellaneous|0|||
17153707|NCT03364309|38299995|FG003|Maintenance Period|Miscellaneous|0|||
17153708|NCT03364309|38299996|FG004|Maintenance Period|Miscellaneous|0|||
17153709|NCT03364309|38299997|FG005|Maintenance Period|Miscellaneous|0|||
17153710|NCT03364309|38299998|FG006|Maintenance Period|Miscellaneous|0|||
17153711|NCT03364309|38299999|FG007|Maintenance Period|Miscellaneous|0|||
17153712|NCT03364309|38300000|FG008|Maintenance Period|Miscellaneous|1|||
17153713|NCT03364309|38300001|FG009|Maintenance Period|Miscellaneous|0|||
17153714|NCT03364309|38300002|FG010|Maintenance Period|Miscellaneous|0|||
17153715|NCT03364309|38300003|FG011|Maintenance Period|Miscellaneous|0|||
17072320|NCT00448812|38214739|FG001|Year 2|Missed visit but remained in study|1|||
17072321|NCT00448812|38214738|FG000|Year 3|Withdrawal by Subject|1|||
17072322|NCT00448812|38214739|FG001|Year 3|Withdrawal by Subject|3|||
17153716|NCT03364309|38300004|FG012|Maintenance Period|Miscellaneous|0|||
17153717|NCT03364309|38300005|FG013|Maintenance Period|Miscellaneous|0|||
17153718|NCT03364309|38300006|FG014|Maintenance Period|Miscellaneous|0|||
17153719|NCT03364309|38300007|FG015|Maintenance Period|Miscellaneous|0|||
17153720|NCT03364309|38300008|FG016|Maintenance Period|Miscellaneous|0|||
17153721|NCT03364309|38300009|FG017|Maintenance Period|Miscellaneous|0|||
17153722|NCT03364309|38300010|FG018|Maintenance Period|Miscellaneous|0|||
17072323|NCT00448812|38214738|FG000|Year 3|Lost to Follow-up|1|||
17072324|NCT00448812|38214739|FG001|Year 3|Lost to Follow-up|0|||
17072325|NCT00448812|38214738|FG000|Year 3|Missed visit but remained in study|2|||
17072326|NCT00448812|38214739|FG001|Year 3|Missed visit but remained in study|0|||
17072327|NCT00448812|38214738|FG000|Year 5|Missed visit but remained in study|1|||
17072328|NCT00448812|38214739|FG001|Year 5|Missed visit but remained in study|0|||
17072329|NCT00364689|38214760|FG000|Overall Study|Lost to Follow-up|1|||
17153723|NCT03364309|38299992|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153724|NCT03364309|38299993|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153725|NCT03364309|38299994|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153726|NCT03364309|38299995|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153727|NCT03364309|38299996|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153728|NCT03364309|38299997|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153729|NCT03364309|38299998|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153730|NCT03364309|38299999|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153731|NCT03364309|38300000|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153732|NCT03364309|38300001|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153733|NCT03364309|38300002|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153734|NCT03364309|38300003|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153735|NCT03364309|38300004|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153736|NCT03364309|38300005|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
17153737|NCT03364309|38300006|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
17153738|NCT03364309|38300007|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
17153739|NCT03364309|38300008|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153740|NCT03364309|38300009|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153741|NCT03364309|38300010|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
17153742|NCT03364309|38299992|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153743|NCT03364309|38299993|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153744|NCT03364309|38299994|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153745|NCT03364309|38299995|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153746|NCT03364309|38299996|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153747|NCT03364309|38299997|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153748|NCT03364309|38299998|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153749|NCT03364309|38299999|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153750|NCT03364309|38300000|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153751|NCT03364309|38300001|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153752|NCT03364309|38300002|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153753|NCT03364309|38300003|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153754|NCT03364309|38300004|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153755|NCT03364309|38300005|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153756|NCT03364309|38300006|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
17153757|NCT03364309|38300007|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153758|NCT03364309|38300008|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153759|NCT03364309|38300009|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153760|NCT03364309|38300010|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
17153761|NCT03364309|38299992|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
17153762|NCT03364309|38299993|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
17153763|NCT03364309|38299994|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
17153764|NCT03364309|38299995|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
17153765|NCT03364309|38299996|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
17153766|NCT03364309|38299997|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
17153767|NCT03364309|38299998|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
17153768|NCT03364309|38299999|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
17153769|NCT03364309|38300000|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
17153770|NCT03364309|38300001|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
17153771|NCT03364309|38300002|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
17153772|NCT03364309|38300003|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
17153773|NCT03364309|38300004|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
17153774|NCT03364309|38300005|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
17153775|NCT03364309|38300006|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
17153776|NCT03364309|38300007|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
17153777|NCT03364309|38300008|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
17153778|NCT03364309|38300009|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
17153779|NCT03364309|38300010|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
17153780|NCT03364309|38299992|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153781|NCT03364309|38299993|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153782|NCT03364309|38299994|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153783|NCT03364309|38299995|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153784|NCT03364309|38299996|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153785|NCT03364309|38299997|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153786|NCT03364309|38299998|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153787|NCT03364309|38299999|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153788|NCT03364309|38300000|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153789|NCT03364309|38300001|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153790|NCT03364309|38300002|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153791|NCT03364309|38300003|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153792|NCT03364309|38300004|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153793|NCT03364309|38300005|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153794|NCT03364309|38300006|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153795|NCT03364309|38300007|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
17153796|NCT03364309|38300008|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
17153797|NCT03364309|38300009|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
17153798|NCT03364309|38300010|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
17153799|NCT03364309|38299992|FG000|Post-Treatment Followup Period|Adverse Event|0|||
17153800|NCT03364309|38299993|FG001|Post-Treatment Followup Period|Adverse Event|0|||
17153801|NCT03364309|38299994|FG002|Post-Treatment Followup Period|Adverse Event|0|||
17153802|NCT03364309|38299995|FG003|Post-Treatment Followup Period|Adverse Event|0|||
17153803|NCT03364309|38299996|FG004|Post-Treatment Followup Period|Adverse Event|0|||
17153804|NCT03364309|38299997|FG005|Post-Treatment Followup Period|Adverse Event|0|||
17153805|NCT03364309|38299998|FG006|Post-Treatment Followup Period|Adverse Event|0|||
17153806|NCT03364309|38299999|FG007|Post-Treatment Followup Period|Adverse Event|0|||
17153807|NCT03364309|38300000|FG008|Post-Treatment Followup Period|Adverse Event|0|||
17153808|NCT03364309|38300001|FG009|Post-Treatment Followup Period|Adverse Event|0|||
17153809|NCT03364309|38300002|FG010|Post-Treatment Followup Period|Adverse Event|0|||
17153810|NCT03364309|38300003|FG011|Post-Treatment Followup Period|Adverse Event|0|||
17153811|NCT03364309|38300004|FG012|Post-Treatment Followup Period|Adverse Event|0|||
17153812|NCT03364309|38300005|FG013|Post-Treatment Followup Period|Adverse Event|0|||
17153813|NCT03364309|38300006|FG014|Post-Treatment Followup Period|Adverse Event|0|||
17153814|NCT03364309|38300007|FG015|Post-Treatment Followup Period|Adverse Event|0|||
17153815|NCT03364309|38300008|FG016|Post-Treatment Followup Period|Adverse Event|2|||
17153816|NCT03364309|38300009|FG017|Post-Treatment Followup Period|Adverse Event|6|||
17153817|NCT03364309|38300010|FG018|Post-Treatment Followup Period|Adverse Event|1|||
17153818|NCT03364309|38299992|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153819|NCT03364309|38299993|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153820|NCT03364309|38299994|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153821|NCT03364309|38299995|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153822|NCT03364309|38299996|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153823|NCT03364309|38299997|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153824|NCT03364309|38299998|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153825|NCT03364309|38299999|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153826|NCT03364309|38300000|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153827|NCT03364309|38300001|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153828|NCT03364309|38300002|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153829|NCT03364309|38300003|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153830|NCT03364309|38300004|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153831|NCT03364309|38300005|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153832|NCT03364309|38300006|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153833|NCT03364309|38300007|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153834|NCT03364309|38300008|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153835|NCT03364309|38300009|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
17153836|NCT03364309|38300010|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
17153837|NCT03364309|38299992|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
17153838|NCT03364309|38299993|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
17153839|NCT03364309|38299994|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
17153840|NCT03364309|38299995|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
17153841|NCT03364309|38299996|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
17153842|NCT03364309|38299997|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
17153843|NCT03364309|38299998|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
17153844|NCT03364309|38299999|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
17153845|NCT03364309|38300000|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
17153846|NCT03364309|38300001|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
17153847|NCT03364309|38300002|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
17153848|NCT03364309|38300003|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
17153849|NCT03364309|38300004|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
17153850|NCT03364309|38300005|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
17153851|NCT03364309|38300006|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
17153852|NCT03364309|38300007|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
17153853|NCT03364309|38300008|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
17153854|NCT03364309|38300009|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
17153855|NCT03364309|38300010|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
17153856|NCT03334903|38300036|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
17153857|NCT03334903|38300037|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
17153858|NCT03334903|38300036|FG000|Overall Study|Protocol Violation|1|||
17153859|NCT03334903|38300037|FG001|Overall Study|Protocol Violation|3|||
17153860|NCT03334903|38300036|FG000|Overall Study|Surgery postponed|1|||
17153861|NCT03334903|38300037|FG001|Overall Study|Surgery postponed|0|||
17153862|NCT03334903|38300036|FG000|Overall Study|Adverse Event|1|||
17153863|NCT03334903|38300037|FG001|Overall Study|Adverse Event|1|||
17153864|NCT03334903|38300036|FG000|Overall Study|Withdrawal by Subject|0|||
17153865|NCT03334903|38300037|FG001|Overall Study|Withdrawal by Subject|1|||
17153866|NCT01353664|38300043|FG000|Overall Study|Other|3|||
17153867|NCT01353664|38300043|FG000|Overall Study|Disease Progression|16|||
17153868|NCT02694328|38300049|FG000|Overall Study|Adverse Event|27|||
17153869|NCT02694328|38300050|FG001|Overall Study|Adverse Event|33|||
17153870|NCT02694328|38300049|FG000|Overall Study|Withdrawal by Subject|27|||
17153871|NCT02694328|38300050|FG001|Overall Study|Withdrawal by Subject|23|||
17153872|NCT02694328|38300049|FG000|Overall Study|Lost to Follow-up|26|||
17153873|NCT02694328|38300050|FG001|Overall Study|Lost to Follow-up|22|||
17153874|NCT02694328|38300049|FG000|Overall Study|Noncompliant with study drug|11|||
17153875|NCT02694328|38300050|FG001|Overall Study|Noncompliant with study drug|8|||
17153876|NCT02694328|38300049|FG000|Overall Study|Incarceration|1|||
17153877|NCT02694328|38300050|FG001|Overall Study|Incarceration|1|||
17153878|NCT02694328|38300049|FG000|Overall Study|Lack of Efficacy|1|||
17153879|NCT02694328|38300050|FG001|Overall Study|Lack of Efficacy|2|||
17153880|NCT02694328|38300049|FG000|Overall Study|Pregnancy|1|||
17153881|NCT02694328|38300050|FG001|Overall Study|Pregnancy|1|||
17153882|NCT02694328|38300049|FG000|Overall Study|Protocol Violation|6|||
17153883|NCT02694328|38300050|FG001|Overall Study|Protocol Violation|5|||
17153884|NCT02694328|38300049|FG000|Overall Study|Abnormal Laboratory Value|0|||
17153885|NCT02694328|38300050|FG001|Overall Study|Abnormal Laboratory Value|3|||
17153886|NCT03334747|38300065|FG000|Treatment Phase|Technical problems|0|||
17153887|NCT03334747|38300066|FG001|Treatment Phase|Technical problems|0|||
17153888|NCT03334747|38300067|FG002|Treatment Phase|Technical problems|0|||
17153889|NCT03334747|38300068|FG003|Treatment Phase|Technical problems|0|||
17153890|NCT03334747|38300069|FG004|Treatment Phase|Technical problems|1|||
17153891|NCT03334747|38300070|FG005|Treatment Phase|Technical problems|0|||
17153892|NCT03334747|38300071|FG006|Treatment Phase|Technical problems|0|||
17153893|NCT03334747|38300072|FG007|Treatment Phase|Technical problems|0|||
17153894|NCT03334747|38300073|FG008|Treatment Phase|Technical problems|0|||
17153895|NCT03334747|38300065|FG000|Treatment Phase|Subject/guardian decision|1|||
17153896|NCT03334747|38300066|FG001|Treatment Phase|Subject/guardian decision|0|||
17153897|NCT03334747|38300067|FG002|Treatment Phase|Subject/guardian decision|0|||
17153898|NCT03334747|38300068|FG003|Treatment Phase|Subject/guardian decision|0|||
17153899|NCT03334747|38300069|FG004|Treatment Phase|Subject/guardian decision|0|||
17153900|NCT03334747|38300070|FG005|Treatment Phase|Subject/guardian decision|1|||
17153901|NCT03334747|38300071|FG006|Treatment Phase|Subject/guardian decision|0|||
17153902|NCT03334747|38300072|FG007|Treatment Phase|Subject/guardian decision|0|||
17153903|NCT03334747|38300073|FG008|Treatment Phase|Subject/guardian decision|0|||
17153904|NCT03334747|38300065|FG000|Follow-Up Phase|Subject/guardian decision|0|||
17153905|NCT03334747|38300066|FG001|Follow-Up Phase|Subject/guardian decision|0|||
17153906|NCT03334747|38300067|FG002|Follow-Up Phase|Subject/guardian decision|0|||
17153907|NCT03334747|38300068|FG003|Follow-Up Phase|Subject/guardian decision|0|||
17153908|NCT03334747|38300069|FG004|Follow-Up Phase|Subject/guardian decision|0|||
17153909|NCT03334747|38300070|FG005|Follow-Up Phase|Subject/guardian decision|0|||
17153910|NCT03334747|38300071|FG006|Follow-Up Phase|Subject/guardian decision|1|||
17153911|NCT03334747|38300072|FG007|Follow-Up Phase|Subject/guardian decision|0|||
17153912|NCT03334747|38300073|FG008|Follow-Up Phase|Subject/guardian decision|1|||
17153913|NCT03346759|38300095|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
17153914|NCT03346759|38300096|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
17153915|NCT03346759|38300095|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
17153916|NCT03346759|38300096|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
17153917|NCT03346759|38300095|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
17153918|NCT03346759|38300096|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
17153919|NCT03361423|38300105|FG000|Overall Study|Withdrawal by Subject|4|||
17153920|NCT03361423|38300106|FG001|Overall Study|Withdrawal by Subject|3|||
17153921|NCT03361423|38300105|FG000|Overall Study|Did not treat|19|||
17153922|NCT03361423|38300106|FG001|Overall Study|Did not treat|18|||
17153923|NCT03361423|38300105|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
17153924|NCT03361423|38300106|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
17153925|NCT03361423|38300105|FG000|Overall Study|Missing data|4|||
17153926|NCT03361423|38300106|FG001|Overall Study|Missing data|1|||
17153927|NCT02693002|38300114|FG000|Overall Study|Withdrawal by Subject|1|||
17153928|NCT02693002|38300115|FG001|Overall Study|Withdrawal by Subject|0|||
17153929|NCT03093870|38300124|FG000|Overall Study|Withdrawal by Subject|2|||
17153930|NCT03093870|38300125|FG001|Overall Study|Withdrawal by Subject|6|||
17153931|NCT03093870|38300126|FG002|Overall Study|Withdrawal by Subject|5|||
17153932|NCT03093870|38300124|FG000|Overall Study|Death|1|||
17153933|NCT03093870|38300125|FG001|Overall Study|Death|35|||
17153934|NCT03093870|38300126|FG002|Overall Study|Death|35|||
17153935|NCT03093870|38300124|FG000|Overall Study|Radiographic disease progression|10|||
17153936|NCT03093870|38300125|FG001|Overall Study|Radiographic disease progression|0|||
17153937|NCT03093870|38300126|FG002|Overall Study|Radiographic disease progression|0|||
17153938|NCT03093870|38300124|FG000|Overall Study|Clinical disease progression|1|||
17153939|NCT03093870|38300125|FG001|Overall Study|Clinical disease progression|0|||
17153940|NCT03093870|38300126|FG002|Overall Study|Clinical disease progression|0|||
17153941|NCT03093870|38300124|FG000|Overall Study|Physician Decision|2|||
17153942|NCT03093870|38300125|FG001|Overall Study|Physician Decision|0|||
17153943|NCT03093870|38300126|FG002|Overall Study|Physician Decision|0|||
17153944|NCT03093870|38300124|FG000|Overall Study|Adverse Event|7|||
17153945|NCT03093870|38300125|FG001|Overall Study|Adverse Event|0|||
17153946|NCT03093870|38300126|FG002|Overall Study|Adverse Event|0|||
17189047|NCT02502526|38342018|FG000|Overall Study|Withdrawal by Subject|0|||
17153947|NCT03093870|38300124|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
17153948|NCT03093870|38300125|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
17153949|NCT03093870|38300126|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
17153950|NCT03093870|38300124|FG000|Overall Study|Lost to Follow-up|0|||
17153951|NCT03093870|38300125|FG001|Overall Study|Lost to Follow-up|0|||
17153952|NCT03093870|38300126|FG002|Overall Study|Lost to Follow-up|1|||
17153953|NCT03346057|38300149|FG000|Overall Study|Death|1|||
17153954|NCT03346057|38300150|FG001|Overall Study|Death|2|||
17153955|NCT03346057|38300151|FG002|Overall Study|Death|0|||
17153956|NCT03346057|38300152|FG003|Overall Study|Death|0|||
17153957|NCT03346057|38300149|FG000|Overall Study|Lost to Follow-up|0|||
17153958|NCT03346057|38300150|FG001|Overall Study|Lost to Follow-up|2|||
17153959|NCT03346057|38300151|FG002|Overall Study|Lost to Follow-up|1|||
17153960|NCT03346057|38300152|FG003|Overall Study|Lost to Follow-up|0|||
17153961|NCT03346057|38300149|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
17153962|NCT03346057|38300150|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
17153963|NCT03346057|38300151|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
17153964|NCT03346057|38300152|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
17153965|NCT03346057|38300149|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
17153966|NCT03346057|38300150|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
17072330|NCT00545129|38214768|FG000|Overall Study|Lack of Efficacy|2|||
17072331|NCT00545129|38214769|FG001|Overall Study|Lack of Efficacy|5|||
17072332|NCT00545129|38214768|FG000|Overall Study|Death|2|||
17072333|NCT00545129|38214769|FG001|Overall Study|Death|1|||
17072334|NCT00545129|38214768|FG000|Overall Study|Adverse Event|1|||
17072335|NCT00545129|38214769|FG001|Overall Study|Adverse Event|1|||
17072336|NCT00545129|38214768|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
17072337|NCT00545129|38214769|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
17072338|NCT00545129|38214768|FG000|Overall Study|Other|3|||
17072339|NCT00545129|38214769|FG001|Overall Study|Other|3|||
17072340|NCT00364611|38214777|FG000|Overall Study|Did not receive study medication|0|||
17153967|NCT03346057|38300151|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
17153968|NCT03346057|38300152|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
17153969|NCT03346057|38300149|FG000|Overall Study|Physician Decision|3|||
17153970|NCT03346057|38300150|FG001|Overall Study|Physician Decision|2|||
17153971|NCT03346057|38300151|FG002|Overall Study|Physician Decision|0|||
17153972|NCT03346057|38300152|FG003|Overall Study|Physician Decision|2|||
17153973|NCT03346057|38300149|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
17153974|NCT03346057|38300150|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
17153975|NCT03346057|38300151|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
17153976|NCT03346057|38300152|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
17153977|NCT03346057|38300149|FG000|Overall Study|Withdrawal by Subject|1|||
17153978|NCT03346057|38300150|FG001|Overall Study|Withdrawal by Subject|0|||
17153979|NCT03346057|38300151|FG002|Overall Study|Withdrawal by Subject|0|||
17153980|NCT03346057|38300152|FG003|Overall Study|Withdrawal by Subject|0|||
17153981|NCT03345979|38300164|FG000|Overall Study|Withdrawal by Subject|20|||
17153982|NCT03345979|38300165|FG001|Overall Study|Withdrawal by Subject|31|||
17153983|NCT03345979|38300164|FG000|Overall Study|Adverse Event|10|||
17153984|NCT03345979|38300165|FG001|Overall Study|Adverse Event|11|||
17153985|NCT03345979|38300164|FG000|Overall Study|Lost to Follow-up|8|||
17153986|NCT03345979|38300165|FG001|Overall Study|Lost to Follow-up|9|||
17153987|NCT03345979|38300164|FG000|Overall Study|Lack of Efficacy|4|||
17153988|NCT03345979|38300165|FG001|Overall Study|Lack of Efficacy|2|||
17153989|NCT03345979|38300164|FG000|Overall Study|Protocol Violation|1|||
17153990|NCT03345979|38300165|FG001|Overall Study|Protocol Violation|3|||
17153991|NCT03345979|38300164|FG000|Overall Study|Physician Decision|0|||
17153992|NCT03345979|38300165|FG001|Overall Study|Physician Decision|2|||
17153993|NCT02696434|38300173|FG000|Overall Study|Adverse Event|3|||
17153994|NCT02696434|38300174|FG001|Overall Study|Adverse Event|1|||
17153995|NCT02696434|38300173|FG000|Overall Study|Lost to Follow-up|5|||
17153996|NCT02696434|38300174|FG001|Overall Study|Lost to Follow-up|4|||
17153997|NCT02696434|38300173|FG000|Overall Study|Withdrawal by Subject|14|||
17153998|NCT02696434|38300174|FG001|Overall Study|Withdrawal by Subject|12|||
17153999|NCT02696434|38300173|FG000|Overall Study|Physician Decision|0|||
17154000|NCT02696434|38300174|FG001|Overall Study|Physician Decision|1|||
17154001|NCT03345901|38300180|FG000|Overall Study|The study was terminated|18|||
17154002|NCT02950831|38300185|FG000|Overall Study|Lost to Follow-up|1|||
17154003|NCT02950831|38300185|FG000|Overall Study|Withdrawal by Subject|3|||
17154004|NCT02950831|38300185|FG000|Overall Study|stimulation trail failure|5|||
17154005|NCT03593915|38300195|FG000|Overall Study|Adverse Event|0|||
17154006|NCT03593915|38300196|FG001|Overall Study|Adverse Event|0|||
17154007|NCT03593915|38300197|FG002|Overall Study|Adverse Event|0|||
17154008|NCT03593915|38300198|FG003|Overall Study|Adverse Event|1|||
17072341|NCT00364611|38214778|FG001|Overall Study|Did not receive study medication|1|||
17154009|NCT03593915|38300199|FG004|Overall Study|Adverse Event|0|||
17154010|NCT03593915|38300200|FG005|Overall Study|Adverse Event|0|||
17154011|NCT03593915|38300195|FG000|Overall Study|Physician Decision|0|||
17154012|NCT03593915|38300196|FG001|Overall Study|Physician Decision|0|||
17154013|NCT03593915|38300197|FG002|Overall Study|Physician Decision|0|||
17154014|NCT03593915|38300198|FG003|Overall Study|Physician Decision|0|||
17154015|NCT03593915|38300199|FG004|Overall Study|Physician Decision|0|||
17154016|NCT03593915|38300200|FG005|Overall Study|Physician Decision|1|||
17154017|NCT03593681|38300214|FG000|Overall Study|Inadequate sample collected|12|||
17154018|NCT03593681|38300214|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
17154019|NCT03593681|38300214|FG000|Overall Study|Protocol Violation|3|||
17154020|NCT03593681|38300214|FG000|Overall Study|Withdrawal by Subject|3|||
17154021|NCT03593681|38300214|FG000|Overall Study|Procedure not attempted|3|||
17154022|NCT03593681|38300214|FG000|Overall Study|Adverse Event|2|||
17154023|NCT03593681|38300214|FG000|Overall Study|Physician Decision|1|||
17154024|NCT03592745|38300237|FG000|Overall Study|Adverse Event|0|||
17154025|NCT03592745|38300238|FG001|Overall Study|Adverse Event|2|||
17154026|NCT03592745|38300237|FG000|Overall Study|Lost to Follow-up|2|||
17154027|NCT03592745|38300238|FG001|Overall Study|Lost to Follow-up|0|||
17154028|NCT03592745|38300237|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
17154029|NCT03592745|38300238|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
17154030|NCT03592277|38300246|FG000|Overall Study|Withdrawal by Subject|6|||
17154031|NCT03592277|38300247|FG001|Overall Study|Withdrawal by Subject|8|||
17154032|NCT03401112|38300258|FG000|Overall Study|Adverse Event|1|||
17154033|NCT03401112|38300259|FG001|Overall Study|Adverse Event|2|||
17154034|NCT03401112|38300260|FG002|Overall Study|Adverse Event|3|||
17154035|NCT03401112|38300261|FG003|Overall Study|Adverse Event|2|||
17154036|NCT03401112|38300262|FG004|Overall Study|Adverse Event|0|||
17154037|NCT03401112|38300258|FG000|Overall Study|Lost to Follow-up|1|||
17154038|NCT03401112|38300259|FG001|Overall Study|Lost to Follow-up|0|||
17154039|NCT03401112|38300260|FG002|Overall Study|Lost to Follow-up|0|||
17154040|NCT03401112|38300261|FG003|Overall Study|Lost to Follow-up|0|||
17154041|NCT03401112|38300262|FG004|Overall Study|Lost to Follow-up|0|||
17154042|NCT03401112|38300258|FG000|Overall Study|Noncompliance|1|||
17154043|NCT03401112|38300259|FG001|Overall Study|Noncompliance|2|||
17154044|NCT03401112|38300260|FG002|Overall Study|Noncompliance|3|||
17154045|NCT03401112|38300261|FG003|Overall Study|Noncompliance|0|||
17154046|NCT03401112|38300262|FG004|Overall Study|Noncompliance|0|||
17154047|NCT03401112|38300258|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
17154048|NCT03401112|38300259|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
17154049|NCT03401112|38300260|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
17154050|NCT03401112|38300261|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
17154051|NCT03401112|38300262|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
17154052|NCT03401112|38300258|FG000|Overall Study|Withdrawal by Subject|0|||
17154053|NCT03401112|38300259|FG001|Overall Study|Withdrawal by Subject|3|||
17154054|NCT03401112|38300260|FG002|Overall Study|Withdrawal by Subject|2|||
17072342|NCT00364611|38214777|FG000|Overall Study|Adverse Event|7|||
17072343|NCT00364611|38214778|FG001|Overall Study|Adverse Event|4|||
17072344|NCT00364611|38214777|FG000|Overall Study|Participant's Request|3|||
17072345|NCT00364611|38214778|FG001|Overall Study|Participant's Request|4|||
17072346|NCT00364611|38214777|FG000|Overall Study|Disease Progression|38|||
17072347|NCT00364611|38214778|FG001|Overall Study|Disease Progression|8|||
17072348|NCT00364611|38214777|FG000|Overall Study|Investigator decision|2|||
17072349|NCT00364611|38214778|FG001|Overall Study|Investigator decision|2|||
17072350|NCT00364611|38214777|FG000|Overall Study|Found Ineligible|1|||
17072351|NCT00364611|38214778|FG001|Overall Study|Found Ineligible|0|||
17072352|NCT00364611|38214777|FG000|Overall Study|Presumed CR on Study|0|||
17072353|NCT00364611|38214778|FG001|Overall Study|Presumed CR on Study|1|||
17072354|NCT00364611|38214777|FG000|Overall Study|Receiving Liver Ablation|0|||
17072355|NCT00364611|38214778|FG001|Overall Study|Receiving Liver Ablation|1|||
17072356|NCT00364533|38214789|FG000|Overall Study|Adverse Event|8|||
17072357|NCT00364533|38214790|FG001|Overall Study|Adverse Event|7|||
17072358|NCT00364533|38214791|FG002|Overall Study|Adverse Event|15|||
17072359|NCT00364533|38214792|FG003|Overall Study|Adverse Event|5|||
17072360|NCT00364533|38214793|FG004|Overall Study|Adverse Event|2|||
17072361|NCT00364533|38214789|FG000|Overall Study|Withdrawal by Subject|4|||
17072362|NCT00364533|38214790|FG001|Overall Study|Withdrawal by Subject|8|||
17072363|NCT00364533|38214791|FG002|Overall Study|Withdrawal by Subject|6|||
17072364|NCT00364533|38214792|FG003|Overall Study|Withdrawal by Subject|6|||
17072365|NCT00364533|38214793|FG004|Overall Study|Withdrawal by Subject|6|||
17072366|NCT00364533|38214789|FG000|Overall Study|Lack of Efficacy|22|||
17072367|NCT00364533|38214790|FG001|Overall Study|Lack of Efficacy|22|||
17154055|NCT03401112|38300261|FG003|Overall Study|Withdrawal by Subject|1|||
17154056|NCT03401112|38300262|FG004|Overall Study|Withdrawal by Subject|0|||
17154057|NCT03401112|38300258|FG000|Overall Study|Physician Decision|0|||
17154058|NCT03401112|38300259|FG001|Overall Study|Physician Decision|0|||
17154059|NCT03401112|38300260|FG002|Overall Study|Physician Decision|0|||
17072368|NCT00364533|38214791|FG002|Overall Study|Lack of Efficacy|21|||
17072369|NCT00364533|38214792|FG003|Overall Study|Lack of Efficacy|17|||
17072370|NCT00364533|38214793|FG004|Overall Study|Lack of Efficacy|42|||
17154060|NCT03401112|38300261|FG003|Overall Study|Physician Decision|2|||
17154061|NCT03401112|38300262|FG004|Overall Study|Physician Decision|0|||
17154062|NCT03401112|38300258|FG000|Overall Study|Study was Terminated by Sponsor|0|||
17154063|NCT03401112|38300259|FG001|Overall Study|Study was Terminated by Sponsor|0|||
17154064|NCT03401112|38300260|FG002|Overall Study|Study was Terminated by Sponsor|0|||
17154065|NCT03401112|38300261|FG003|Overall Study|Study was Terminated by Sponsor|1|||
17154066|NCT03401112|38300262|FG004|Overall Study|Study was Terminated by Sponsor|0|||
17154067|NCT03401112|38300258|FG000|Overall Study|Day 1 Assessment not Done|1|||
17154068|NCT03401112|38300259|FG001|Overall Study|Day 1 Assessment not Done|0|||
17154069|NCT03401112|38300260|FG002|Overall Study|Day 1 Assessment not Done|0|||
17154070|NCT03401112|38300261|FG003|Overall Study|Day 1 Assessment not Done|0|||
17154071|NCT03401112|38300262|FG004|Overall Study|Day 1 Assessment not Done|0|||
17154072|NCT03401112|38300258|FG000|Overall Study|Not Dosed|0|||
17154073|NCT03401112|38300259|FG001|Overall Study|Not Dosed|0|||
17154074|NCT03401112|38300260|FG002|Overall Study|Not Dosed|1|||
17154075|NCT03401112|38300261|FG003|Overall Study|Not Dosed|0|||
17154076|NCT03401112|38300262|FG004|Overall Study|Not Dosed|0|||
17154077|NCT03401112|38300258|FG000|Overall Study|Missed Clinical Visit|0|||
17154078|NCT03401112|38300259|FG001|Overall Study|Missed Clinical Visit|0|||
17154079|NCT03401112|38300260|FG002|Overall Study|Missed Clinical Visit|1|||
17154080|NCT03401112|38300261|FG003|Overall Study|Missed Clinical Visit|0|||
17154081|NCT03401112|38300262|FG004|Overall Study|Missed Clinical Visit|0|||
17154082|NCT03401112|38300258|FG000|Overall Study|Missed Doses|0|||
17154083|NCT03401112|38300259|FG001|Overall Study|Missed Doses|0|||
17154084|NCT03401112|38300260|FG002|Overall Study|Missed Doses|1|||
17154085|NCT03401112|38300261|FG003|Overall Study|Missed Doses|0|||
17154086|NCT03401112|38300262|FG004|Overall Study|Missed Doses|0|||
17154087|NCT02697916|38300291|FG000|Overall Study|Death|357|||
17154088|NCT02697916|38300292|FG001|Overall Study|Death|315|||
17154089|NCT02697916|38300291|FG000|Overall Study|Withdrawal by Subject|221|||
17154090|NCT02697916|38300292|FG001|Overall Study|Withdrawal by Subject|393|||
17154091|NCT03650387|38300298|FG000|Overall Study|Withdrawal by Subject|13|||
17154092|NCT03650387|38300298|FG000|Overall Study|Lost to Follow-up|12|||
17154093|NCT03650387|38300298|FG000|Overall Study|Adverse Event (Not related)|1|||
17154094|NCT03650387|38300298|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
17154095|NCT03359473|38300324|FG000|Overall Study|Adverse Event|0|||
17154096|NCT03359473|38300325|FG001|Overall Study|Adverse Event|2|||
17154097|NCT03359473|38300326|FG002|Overall Study|Adverse Event|5|||
17154098|NCT03359473|38300327|FG003|Overall Study|Adverse Event|3|||
17154099|NCT03359473|38300324|FG000|Overall Study|Lost to Follow-up|0|||
17154100|NCT03359473|38300325|FG001|Overall Study|Lost to Follow-up|1|||
17154101|NCT03359473|38300326|FG002|Overall Study|Lost to Follow-up|0|||
17154102|NCT03359473|38300327|FG003|Overall Study|Lost to Follow-up|0|||
17154103|NCT03359473|38300324|FG000|Overall Study|Physician Decision|0|||
17154104|NCT03359473|38300325|FG001|Overall Study|Physician Decision|1|||
17154105|NCT03359473|38300326|FG002|Overall Study|Physician Decision|0|||
17154106|NCT03359473|38300327|FG003|Overall Study|Physician Decision|1|||
17154107|NCT03359473|38300324|FG000|Overall Study|Withdrawal by Subject|1|||
17154108|NCT03359473|38300325|FG001|Overall Study|Withdrawal by Subject|2|||
17154109|NCT03359473|38300326|FG002|Overall Study|Withdrawal by Subject|1|||
17154110|NCT03359473|38300327|FG003|Overall Study|Withdrawal by Subject|0|||
17154111|NCT03359473|38300324|FG000|Overall Study|Protocol-defined stopping criteria|1|||
17154112|NCT03359473|38300325|FG001|Overall Study|Protocol-defined stopping criteria|0|||
17072371|NCT00364533|38214789|FG000|Overall Study|Subject discharged from hospital|4|||
17072372|NCT00364533|38214790|FG001|Overall Study|Subject discharged from hospital|1|||
17072373|NCT00364533|38214791|FG002|Overall Study|Subject discharged from hospital|2|||
17154113|NCT03359473|38300326|FG002|Overall Study|Protocol-defined stopping criteria|0|||
17154114|NCT03359473|38300327|FG003|Overall Study|Protocol-defined stopping criteria|1|||
17154115|NCT03589469|38300340|FG000|Overall Study|Ongoing in study|58|||
17154116|NCT03589469|38300340|FG000|Overall Study|Withdrawal by Subject|6|||
17154117|NCT03589469|38300340|FG000|Overall Study|Physician Decision|1|||
17154118|NCT03589469|38300340|FG000|Overall Study|Death|77|||
17154119|NCT03589469|38300340|FG000|Overall Study|Lost to Follow-up|3|||
17154120|NCT03359395|38300346|FG000|First Intervention A / B|Withdrawal by Subject|1|||
17154121|NCT03359395|38300347|FG001|First Intervention A / B|Withdrawal by Subject|0|||
17072374|NCT00364533|38214792|FG003|Overall Study|Subject discharged from hospital|3|||
17072375|NCT00364533|38214793|FG004|Overall Study|Subject discharged from hospital|1|||
17072376|NCT00364533|38214789|FG000|Overall Study|Variations in drug compliance|2|||
17072377|NCT00364533|38214790|FG001|Overall Study|Variations in drug compliance|1|||
17072378|NCT00364533|38214791|FG002|Overall Study|Variations in drug compliance|1|||
17072379|NCT00364533|38214792|FG003|Overall Study|Variations in drug compliance|0|||
17072380|NCT00364533|38214793|FG004|Overall Study|Variations in drug compliance|0|||
17072381|NCT00364533|38214789|FG000|Overall Study|Non-compliance|1|||
17072382|NCT00364533|38214790|FG001|Overall Study|Non-compliance|0|||
17072383|NCT00364533|38214791|FG002|Overall Study|Non-compliance|0|||
17072384|NCT00364533|38214792|FG003|Overall Study|Non-compliance|0|||
17154122|NCT03359395|38300346|FG000|First Intervention A / B|Lost to Follow-up|2|||
17154123|NCT03359395|38300347|FG001|First Intervention A / B|Lost to Follow-up|3|||
17154124|NCT03359395|38300346|FG000|Second Intervention B/A|Exclusion criteria|0|||
17154125|NCT03359395|38300347|FG001|Second Intervention B/A|Exclusion criteria|1|||
17154126|NCT03359395|38300346|FG000|Second Intervention B/A|Lost to Follow-up|3|||
17154127|NCT03359395|38300347|FG001|Second Intervention B/A|Lost to Follow-up|2|||
17154128|NCT03586427|38300358|FG000|Overall Study|Lost to Follow-up|0|||
17154129|NCT03586427|38300359|FG001|Overall Study|Lost to Follow-up|3|||
17154130|NCT03586427|38300360|FG002|Overall Study|Lost to Follow-up|1|||
17154131|NCT03586427|38300361|FG003|Overall Study|Lost to Follow-up|3|||
17154132|NCT03586427|38300362|FG004|Overall Study|Lost to Follow-up|3|||
17154133|NCT03586427|38300358|FG000|Overall Study|Withdrawal by Subject|0|||
17154134|NCT03586427|38300359|FG001|Overall Study|Withdrawal by Subject|1|||
17154135|NCT03586427|38300360|FG002|Overall Study|Withdrawal by Subject|2|||
17154136|NCT03586427|38300361|FG003|Overall Study|Withdrawal by Subject|1|||
17154137|NCT03586427|38300362|FG004|Overall Study|Withdrawal by Subject|1|||
17154138|NCT03586427|38300358|FG000|Overall Study|Adverse Event|0|||
17154139|NCT03586427|38300359|FG001|Overall Study|Adverse Event|0|||
17154140|NCT03586427|38300360|FG002|Overall Study|Adverse Event|1|||
17154141|NCT03586427|38300361|FG003|Overall Study|Adverse Event|0|||
17154142|NCT03586427|38300362|FG004|Overall Study|Adverse Event|0|||
17154143|NCT03586427|38300358|FG000|Overall Study|Protocol Violation|0|||
17154144|NCT03586427|38300359|FG001|Overall Study|Protocol Violation|0|||
17154145|NCT03586427|38300360|FG002|Overall Study|Protocol Violation|1|||
17154146|NCT03586427|38300361|FG003|Overall Study|Protocol Violation|0|||
17154147|NCT03586427|38300362|FG004|Overall Study|Protocol Violation|1|||
17154148|NCT03586427|38300358|FG000|Overall Study|Noncompliance with study drug|0|||
17154149|NCT03586427|38300359|FG001|Overall Study|Noncompliance with study drug|0|||
17154150|NCT03586427|38300360|FG002|Overall Study|Noncompliance with study drug|1|||
17154151|NCT03586427|38300361|FG003|Overall Study|Noncompliance with study drug|0|||
17154152|NCT03586427|38300362|FG004|Overall Study|Noncompliance with study drug|0|||
17154153|NCT03648983|38300379|FG000|Overall Study|Study was terminated due to PI departure|95|||
17154154|NCT02695420|38300388|FG000|Overall Study|Death|0|||
17154155|NCT02695420|38300389|FG001|Overall Study|Death|1|||
17154156|NCT02695420|38300390|FG002|Overall Study|Death|0|||
17154157|NCT02695420|38300391|FG003|Overall Study|Death|0|||
17154158|NCT03358147|38300409|FG000|Overall Study|Withdrawal by Subject|13|||
17154159|NCT03358147|38300410|FG001|Overall Study|Withdrawal by Subject|19|||
17154160|NCT03358147|38300411|FG002|Overall Study|Withdrawal by Subject|16|||
17154161|NCT03358147|38300412|FG003|Overall Study|Withdrawal by Subject|10|||
17154162|NCT03358147|38300413|FG004|Overall Study|Withdrawal by Subject|5|||
17154163|NCT03358147|38300409|FG000|Overall Study|Adverse Event|3|||
17154164|NCT03358147|38300410|FG001|Overall Study|Adverse Event|9|||
17154165|NCT03358147|38300411|FG002|Overall Study|Adverse Event|7|||
17154166|NCT03358147|38300412|FG003|Overall Study|Adverse Event|5|||
17154167|NCT03358147|38300413|FG004|Overall Study|Adverse Event|2|||
17154168|NCT03358147|38300409|FG000|Overall Study|Lost to Follow-up|4|||
17154169|NCT03358147|38300410|FG001|Overall Study|Lost to Follow-up|3|||
17154170|NCT03358147|38300411|FG002|Overall Study|Lost to Follow-up|7|||
17154171|NCT03358147|38300412|FG003|Overall Study|Lost to Follow-up|6|||
17154172|NCT03358147|38300413|FG004|Overall Study|Lost to Follow-up|4|||
17154173|NCT03358147|38300409|FG000|Overall Study|Major Protocol Deviation|11|||
17154174|NCT03358147|38300410|FG001|Overall Study|Major Protocol Deviation|3|||
17154175|NCT03358147|38300411|FG002|Overall Study|Major Protocol Deviation|2|||
17154176|NCT03358147|38300412|FG003|Overall Study|Major Protocol Deviation|3|||
17154177|NCT03358147|38300413|FG004|Overall Study|Major Protocol Deviation|1|||
17154178|NCT03358147|38300409|FG000|Overall Study|Protocol specified criteria|2|||
17154179|NCT03358147|38300410|FG001|Overall Study|Protocol specified criteria|3|||
17154180|NCT03358147|38300411|FG002|Overall Study|Protocol specified criteria|0|||
17154181|NCT03358147|38300412|FG003|Overall Study|Protocol specified criteria|3|||
17154182|NCT03358147|38300413|FG004|Overall Study|Protocol specified criteria|1|||
17154183|NCT03358147|38300409|FG000|Overall Study|Physician Decision|1|||
17154184|NCT03358147|38300410|FG001|Overall Study|Physician Decision|0|||
17154185|NCT03358147|38300411|FG002|Overall Study|Physician Decision|1|||
17154186|NCT03358147|38300412|FG003|Overall Study|Physician Decision|6|||
17154187|NCT03358147|38300413|FG004|Overall Study|Physician Decision|1|||
17154188|NCT03358147|38300409|FG000|Overall Study|Administrative reasons|0|||
17154189|NCT03358147|38300410|FG001|Overall Study|Administrative reasons|1|||
17154190|NCT03358147|38300411|FG002|Overall Study|Administrative reasons|0|||
17154191|NCT03358147|38300412|FG003|Overall Study|Administrative reasons|3|||
17154192|NCT03358147|38300413|FG004|Overall Study|Administrative reasons|0|||
17154193|NCT03358147|38300409|FG000|Overall Study|Lack of Efficacy|0|||
17154194|NCT03358147|38300410|FG001|Overall Study|Lack of Efficacy|1|||
17154195|NCT03358147|38300411|FG002|Overall Study|Lack of Efficacy|1|||
17154196|NCT03358147|38300412|FG003|Overall Study|Lack of Efficacy|0|||
17154197|NCT03358147|38300413|FG004|Overall Study|Lack of Efficacy|0|||
17154198|NCT03093402|38300429|FG000|Overall Study|Lost to Follow-up|1|||
17154199|NCT03093402|38300430|FG001|Overall Study|Lost to Follow-up|0|||
17154200|NCT03093402|38300431|FG002|Overall Study|Lost to Follow-up|0|||
17154201|NCT03093402|38300432|FG003|Overall Study|Lost to Follow-up|0|||
17154202|NCT03093402|38300429|FG000|Overall Study|Withdrawal by Subject|3|||
17154203|NCT03093402|38300430|FG001|Overall Study|Withdrawal by Subject|3|||
17154204|NCT03093402|38300431|FG002|Overall Study|Withdrawal by Subject|0|||
17154205|NCT03093402|38300432|FG003|Overall Study|Withdrawal by Subject|1|||
17154206|NCT03093402|38300429|FG000|Overall Study|Withdrew prior to dosing|2|||
17154207|NCT03093402|38300430|FG001|Overall Study|Withdrew prior to dosing|1|||
17154208|NCT03093402|38300431|FG002|Overall Study|Withdrew prior to dosing|2|||
17154209|NCT03093402|38300432|FG003|Overall Study|Withdrew prior to dosing|3|||
17154210|NCT03093402|38300429|FG000|Overall Study|Ineligible for study|1|||
17154211|NCT03093402|38300430|FG001|Overall Study|Ineligible for study|0|||
17154212|NCT03093402|38300431|FG002|Overall Study|Ineligible for study|0|||
17154213|NCT03093402|38300432|FG003|Overall Study|Ineligible for study|0|||
17154214|NCT03093402|38300429|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
17154215|NCT03093402|38300430|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
17154216|NCT03093402|38300431|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
17154217|NCT03093402|38300432|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
17154218|NCT03585959|38300442|FG000|Overall Study|Physician Decision|1|||
17154219|NCT03585959|38300442|FG000|Overall Study|Unsuccessful Procedure|2|||
17154220|NCT03584789|38300451|FG000|Overall Study|refused EHR permission|19|||
17154221|NCT03584789|38300452|FG001|Overall Study|refused EHR permission|28|||
17154222|NCT03584789|38300453|FG002|Overall Study|refused EHR permission|23|||
17154223|NCT03584789|38300451|FG000|Overall Study|patients tied to a provider who retired|0|||
17154224|NCT03584789|38300452|FG001|Overall Study|patients tied to a provider who retired|0|||
17154225|NCT03584789|38300453|FG002|Overall Study|patients tied to a provider who retired|3|||
17154226|NCT03343639|38300463|FG000|Overall Study|Withdrawal by Subject|10|||
17154227|NCT03343639|38300464|FG001|Overall Study|Withdrawal by Subject|6|||
17154228|NCT03343639|38300463|FG000|Overall Study|Lost to Follow-up|4|||
17154229|NCT03343639|38300464|FG001|Overall Study|Lost to Follow-up|5|||
17154230|NCT03343639|38300463|FG000|Overall Study|Protocol Violation|0|||
17154231|NCT03343639|38300464|FG001|Overall Study|Protocol Violation|1|||
17154232|NCT03647267|38300472|FG000|Overall Study|Lost to Follow-up|1|||
17154233|NCT03647267|38300473|FG001|Overall Study|Lost to Follow-up|0|||
17154234|NCT03356977|38300481|FG000|Overall Study|Lost to Follow-up|3|||
17154235|NCT03356977|38300481|FG000|Overall Study|Withdrawal by parent/guardian|2|||
17154236|NCT02690974|38300485|FG000|Overall Study|Adverse Event|16|||
17154237|NCT02690974|38300485|FG000|Overall Study|Death|9|||
17154238|NCT02690974|38300485|FG000|Overall Study|Subject/guardian decision|4|||
17154239|NCT02690974|38300485|FG000|Overall Study|Lost to Follow-up|3|||
17154240|NCT02690974|38300485|FG000|Overall Study|Withdrawal of Informed Consent|3|||
17154241|NCT02690974|38300485|FG000|Overall Study|Physician Decision|2|||
17154242|NCT02690974|38300485|FG000|Overall Study|Non-compliance with study treatment|1|||
17154243|NCT02690974|38300485|FG000|Overall Study|Protocol-defined stopping criteria|1|||
17154244|NCT02690974|38300485|FG000|Overall Study|Protocol Deviation|1|||
17154245|NCT03093324|38300491|FG000|Overall Study|Adverse Event|4|||
17154246|NCT03093324|38300492|FG001|Overall Study|Adverse Event|15|||
17154247|NCT03093324|38300491|FG000|Overall Study|Lost to Follow-up|1|||
17154248|NCT03093324|38300492|FG001|Overall Study|Lost to Follow-up|0|||
17154249|NCT03093324|38300491|FG000|Overall Study|Protocol Deviation|2|||
17154250|NCT03093324|38300492|FG001|Overall Study|Protocol Deviation|2|||
17154251|NCT03093324|38300491|FG000|Overall Study|Withdrawal by Subject|2|||
17154252|NCT03093324|38300492|FG001|Overall Study|Withdrawal by Subject|2|||
17154253|NCT03584009|38300500|FG000|Overall Study|Death|25|||
17154254|NCT03584009|38300501|FG001|Overall Study|Death|18|||
17154255|NCT03584009|38300500|FG000|Overall Study|Lost to Follow-up|0|||
17154256|NCT03584009|38300501|FG001|Overall Study|Lost to Follow-up|1|||
17154257|NCT03584009|38300500|FG000|Overall Study|Physician Decision|1|||
17154258|NCT03584009|38300501|FG001|Overall Study|Physician Decision|1|||
17154259|NCT03584009|38300500|FG000|Overall Study|Study Terminated by Sponsor|22|||
17154260|NCT03584009|38300501|FG001|Overall Study|Study Terminated by Sponsor|30|||
17154261|NCT03584009|38300500|FG000|Overall Study|Withdrawal by Subject|3|||
17154262|NCT03584009|38300501|FG001|Overall Study|Withdrawal by Subject|2|||
17154263|NCT04167462|38300512|FG000|Overall Study|Other reasons|3|||
17154264|NCT04167462|38300513|FG001|Overall Study|Other reasons|2|||
17154265|NCT04167462|38300512|FG000|Overall Study|Withdrawal by Subject|6|||
17154266|NCT04167462|38300513|FG001|Overall Study|Withdrawal by Subject|7|||
17154267|NCT04167462|38300512|FG000|Overall Study|Adverse Event|4|||
17154268|NCT04167462|38300513|FG001|Overall Study|Adverse Event|0|||
17154269|NCT04167462|38300512|FG000|Overall Study|Pregnancy|1|||
17154270|NCT04167462|38300513|FG001|Overall Study|Pregnancy|0|||
17154271|NCT04167462|38300512|FG000|Overall Study|Lack of Efficacy|0|||
17154272|NCT04167462|38300513|FG001|Overall Study|Lack of Efficacy|1|||
17154273|NCT03583385|38300520|FG000|Treatment Period 1|Withdrawal by Subject|1|||
17154274|NCT03583385|38300521|FG001|Treatment Period 1|Withdrawal by Subject|1|||
17154275|NCT03583385|38300520|FG000|Treatment Period 2|Adverse Event|1|||
17154276|NCT03583385|38300521|FG001|Treatment Period 2|Adverse Event|0|||
17154277|NCT04350372|38300527|FG000|Overall Study|Death|1|||
17154278|NCT02949973|38300531|FG000|Overall Study|Physician Decision|1|||
17154279|NCT02948959|38300537|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
17154280|NCT02948959|38300538|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
17154281|NCT02948959|38300537|FG000|52 Weeks Treatment Period|Adverse Event|2|||
17154282|NCT02948959|38300538|FG001|52 Weeks Treatment Period|Adverse Event|5|||
17154283|NCT02948959|38300537|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
17154284|NCT02948959|38300538|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
17154285|NCT02948959|38300537|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
17154286|NCT02948959|38300538|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
17154287|NCT02948959|38300537|FG000|52 Weeks Treatment Period|Randomized by error|0|||
17154288|NCT02948959|38300538|FG001|52 Weeks Treatment Period|Randomized by error|5|||
17154289|NCT02948959|38300537|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
17154290|NCT02948959|38300538|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
17154291|NCT02948959|38300537|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
17154292|NCT02948959|38300538|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
17154293|NCT02948959|38300537|FG000|52 Weeks Treatment Period|Change of residence location|0|||
17154294|NCT02948959|38300538|FG001|52 Weeks Treatment Period|Change of residence location|1|||
17154295|NCT02948959|38300537|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
17154296|NCT02948959|38300538|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
17154297|NCT02948959|38300537|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
17154298|NCT02948959|38300538|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
17154299|NCT02948959|38300537|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
17154300|NCT02948959|38300538|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
17154301|NCT02948959|38300537|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
17072385|NCT00364533|38214793|FG004|Overall Study|Non-compliance|0|||
17072386|NCT00364533|38214789|FG000|Overall Study|Protocol Violation|1|||
17072387|NCT00364533|38214790|FG001|Overall Study|Protocol Violation|1|||
17154302|NCT02948959|38300538|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
17154303|NCT02948959|38300537|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
17154304|NCT02948959|38300538|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
17154305|NCT02948959|38300537|FG000|12 Weeks Follow-up Period|Study site closure|1|||
17154306|NCT02948959|38300538|FG001|12 Weeks Follow-up Period|Study site closure|0|||
17154307|NCT03582215|38300560|FG000|Overall Study|Adverse Event|1|||
17154308|NCT03582215|38300561|FG001|Overall Study|Adverse Event|0|||
17154309|NCT03582215|38300562|FG002|Overall Study|Adverse Event|0|||
17154310|NCT03582215|38300563|FG003|Overall Study|Adverse Event|0|||
17154311|NCT03582215|38300564|FG004|Overall Study|Adverse Event|0|||
17154312|NCT03582215|38300565|FG005|Overall Study|Adverse Event|0|||
17154313|NCT03582215|38300566|FG006|Overall Study|Adverse Event|2|||
17154314|NCT03582215|38300567|FG007|Overall Study|Adverse Event|2|||
17154315|NCT03089580|38300596|FG000|Overall Study|Lost to Follow-up|2|||
17154316|NCT03645395|38300606|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
17154317|NCT03645395|38300607|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
17154318|NCT03645395|38300608|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
17154319|NCT03645395|38300609|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
17154320|NCT03645395|38300606|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
17154321|NCT03645395|38300607|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
17154322|NCT03645395|38300608|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
17154323|NCT03645395|38300609|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
17154324|NCT03645395|38300606|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
17154325|NCT03645395|38300607|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
17154326|NCT03645395|38300608|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
17154327|NCT03645395|38300609|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
17154328|NCT03645395|38300606|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
17154329|NCT03645395|38300607|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
17154330|NCT03645395|38300608|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
17154331|NCT03645395|38300609|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
17072388|NCT00364533|38214791|FG002|Overall Study|Protocol Violation|0|||
17072389|NCT00364533|38214792|FG003|Overall Study|Protocol Violation|0|||
17072390|NCT00364533|38214793|FG004|Overall Study|Protocol Violation|0|||
17072391|NCT04006847|38214805|FG000|Overall Study|Product issue|1|||
17072392|NCT00380367|38214809|FG000|Overall Study|Lost to Follow-up|1|||
17072393|NCT00380367|38214809|FG000|Overall Study|Withdrawal by Subject|1|||
17072394|NCT00544817|38214813|FG000|Combined Modality|Lack of Efficacy|2|||
17072395|NCT00544817|38214813|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
17072396|NCT00544817|38214813|FG000|Combined Modality|Adverse Event|2|||
17072397|NCT00544817|38214813|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
17072398|NCT00544817|38214813|FG000|No Treatment Interval|Lack of Efficacy|8|||
17072399|NCT00544817|38214813|FG000|No Treatment Interval|Physician Decision|3|||
17072400|NCT00544817|38214813|FG000|No Treatment Interval|Adverse Event|1|||
17072401|NCT00544817|38214813|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
17072402|NCT00544817|38214813|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
17072403|NCT00544817|38214813|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
17072404|NCT00289978|38214820|FG000|Overall Study|Withdrawal by Subject|31|||
17072405|NCT00289978|38214821|FG001|Overall Study|Withdrawal by Subject|17|||
17072406|NCT00289978|38214822|FG002|Overall Study|Withdrawal by Subject|28|||
17154332|NCT03342469|38300622|FG000|Overall Study|Withdrawal by Subject|0|||
17154333|NCT03342469|38300623|FG001|Overall Study|Withdrawal by Subject|1|||
17154334|NCT03342469|38300624|FG002|Overall Study|Withdrawal by Subject|0|||
17154335|NCT03342469|38300625|FG003|Overall Study|Withdrawal by Subject|0|||
17154336|NCT03581825|38300636|FG000|Period 1|Lens Discomfort|1|||
17154337|NCT03581825|38300637|FG001|Period 1|Lens Discomfort|0|||
17154338|NCT03581825|38300636|FG000|Period 2|Unsatisfactory Vision to Test|0|||
17154339|NCT03581825|38300637|FG001|Period 2|Unsatisfactory Vision to Test|1|||
17154340|NCT03342001|38300643|FG000|Overall Study|Adverse Event|1|||
17154341|NCT03342001|38300643|FG000|Overall Study|Lost to Follow-up|1|||
17154342|NCT03341923|38300647|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
17154343|NCT03341923|38300648|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
17154344|NCT03579719|38300656|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
17154345|NCT03341533|38300662|FG000|Overall Study|Withdrawal by Subject|1|||
17072407|NCT00289978|38214820|FG000|Overall Study|Adverse Event|22|||
17072408|NCT00289978|38214821|FG001|Overall Study|Adverse Event|13|||
17072409|NCT00289978|38214822|FG002|Overall Study|Adverse Event|18|||
17072410|NCT00289978|38214820|FG000|Overall Study|Lack of Efficacy|13|||
17154346|NCT03341533|38300663|FG001|Overall Study|Withdrawal by Subject|1|||
17154347|NCT03341533|38300662|FG000|Overall Study|Not eligible after randomization|2|||
17154348|NCT03341533|38300663|FG001|Overall Study|Not eligible after randomization|1|||
17154349|NCT02688088|38300669|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
17154350|NCT02688088|38300670|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
17154351|NCT02688088|38300671|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
17154352|NCT02688088|38300672|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
17154353|NCT02688088|38300673|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
17154354|NCT02688088|38300669|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
17154355|NCT02688088|38300670|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
17154356|NCT02688088|38300671|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
17154357|NCT02688088|38300672|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
17154358|NCT02688088|38300673|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
17154359|NCT02688088|38300669|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
17154360|NCT02688088|38300670|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
17154361|NCT02688088|38300671|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
17154362|NCT02688088|38300672|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
17154363|NCT02688088|38300673|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
17154364|NCT02688088|38300669|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
17154365|NCT02688088|38300670|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
17154366|NCT02688088|38300671|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
17154367|NCT02688088|38300672|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
17154368|NCT02688088|38300673|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
17154369|NCT02688088|38300669|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
17154370|NCT02688088|38300670|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
17154371|NCT02688088|38300671|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
17154372|NCT02688088|38300672|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
17154373|NCT02688088|38300673|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
17154374|NCT02688088|38300669|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
17154375|NCT02688088|38300670|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
17154376|NCT02688088|38300671|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
17154377|NCT02688088|38300672|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
17154378|NCT02688088|38300673|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
17154379|NCT02688088|38300669|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
17154380|NCT02688088|38300670|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
17154381|NCT02688088|38300671|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
17154382|NCT02688088|38300672|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
17154383|NCT02688088|38300673|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
17154384|NCT02688088|38300669|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
17154385|NCT02688088|38300670|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
17154386|NCT02688088|38300671|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
17154387|NCT02688088|38300672|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
17154388|NCT02688088|38300673|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
17154389|NCT02688088|38300669|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
17072411|NCT00289978|38214821|FG001|Overall Study|Lack of Efficacy|6|||
17072412|NCT00289978|38214822|FG002|Overall Study|Lack of Efficacy|25|||
17072413|NCT00289978|38214820|FG000|Overall Study|Abnormal laboratory value(s)|20|||
17072414|NCT00289978|38214821|FG001|Overall Study|Abnormal laboratory value(s)|9|||
17072415|NCT00289978|38214822|FG002|Overall Study|Abnormal laboratory value(s)|1|||
17072416|NCT00289978|38214820|FG000|Overall Study|Lost to Follow-up|3|||
17072417|NCT00289978|38214821|FG001|Overall Study|Lost to Follow-up|5|||
17072418|NCT00289978|38214822|FG002|Overall Study|Lost to Follow-up|7|||
17154390|NCT02688088|38300670|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
17154391|NCT02688088|38300671|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
17154392|NCT02688088|38300672|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
17154393|NCT02688088|38300673|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
17154394|NCT03641651|38300698|FG000|Overall Study|organizational issues at one study site|1|||
17154395|NCT03341299|38300702|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
17154396|NCT03341299|38300703|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
17154397|NCT03341299|38300704|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
17154398|NCT03341299|38300705|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
17154399|NCT02949271|38300719|FG000|Overall Study|Lack of Efficacy|5|||
17154400|NCT02949271|38300720|FG001|Overall Study|Lack of Efficacy|4|||
17154401|NCT02949271|38300719|FG000|Overall Study|Lost to Follow-up|3|||
17154402|NCT02949271|38300720|FG001|Overall Study|Lost to Follow-up|6|||
17154403|NCT02949271|38300719|FG000|Overall Study|Physician Decision|5|||
17154404|NCT02949271|38300720|FG001|Overall Study|Physician Decision|5|||
17154405|NCT02949271|38300719|FG000|Overall Study|Protocol Violation|6|||
17154406|NCT02949271|38300720|FG001|Overall Study|Protocol Violation|3|||
17154407|NCT02949271|38300719|FG000|Overall Study|Withdrawal by Subject|1|||
17154408|NCT02949271|38300720|FG001|Overall Study|Withdrawal by Subject|0|||
17154409|NCT02949271|38300719|FG000|Overall Study|Delivered prior to intervention|7|||
17154410|NCT02949271|38300720|FG001|Overall Study|Delivered prior to intervention|9|||
17154411|NCT02949271|38300719|FG000|Overall Study|Outside the window for cervical dilation|2|||
17154412|NCT02949271|38300720|FG001|Overall Study|Outside the window for cervical dilation|3|||
17154413|NCT03640559|38300728|FG000|Overall Study|Physician Decision|1|||
17154414|NCT03640559|38300729|FG001|Overall Study|Physician Decision|1|||
17154415|NCT03640559|38300728|FG000|Overall Study|Withdrawal by Subject|1|||
17154416|NCT03640559|38300729|FG001|Overall Study|Withdrawal by Subject|0|||
17154417|NCT03339583|38300737|FG000|First Intervention (14 Days)|Adverse Event|1|||
17154418|NCT03339583|38300738|FG001|First Intervention (14 Days)|Adverse Event|0|||
17154419|NCT03339583|38300737|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
17154420|NCT03339583|38300738|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
17154421|NCT03339583|38300737|FG000|Second Intervention (14 Days)|Adverse Event|0|||
17154422|NCT03339583|38300738|FG001|Second Intervention (14 Days)|Adverse Event|1|||
17154423|NCT03339583|38300737|FG000|Follow-up (14 Days)|Physician Decision|6|||
17154424|NCT03339583|38300738|FG001|Follow-up (14 Days)|Physician Decision|3|||
17154425|NCT03639779|38300746|FG000|Overall Study|Lost to Follow-up|1|||
17154426|NCT03575975|38300755|FG000|Overall Study|Lost to Follow-up|1|||
17154427|NCT03575975|38300756|FG001|Overall Study|Lost to Follow-up|0|||
17154428|NCT03575975|38300757|FG002|Overall Study|Lost to Follow-up|0|||
17154429|NCT03636893|38300765|FG000|Overall Study|Death|0|||
17154430|NCT03636893|38300766|FG001|Overall Study|Death|1|||
17154431|NCT03636893|38300765|FG000|Overall Study|Protocol Violation|0|||
17154432|NCT03636893|38300766|FG001|Overall Study|Protocol Violation|3|||
17154433|NCT03636893|38300765|FG000|Overall Study|Withdrawal by Subject|1|||
17154434|NCT03636893|38300766|FG001|Overall Study|Withdrawal by Subject|2|||
17154435|NCT03636893|38300765|FG000|Overall Study|Refusal to surgery|4|||
17154436|NCT03636893|38300766|FG001|Overall Study|Refusal to surgery|3|||
17154437|NCT03636893|38300765|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
17154438|NCT03636893|38300766|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
17154439|NCT03636893|38300765|FG000|Overall Study|Adverse Event|1|||
17154440|NCT03636893|38300766|FG001|Overall Study|Adverse Event|1|||
17154441|NCT01353586|38300774|FG000|Overall Study|Procedure terminated prior to ablation|3|||
17154442|NCT01353586|38300775|FG001|Overall Study|Procedure terminated prior to ablation|0|||
17154443|NCT01353586|38300774|FG000|Overall Study|Never had insertion of study catheter|4|||
17154444|NCT01353586|38300775|FG001|Overall Study|Never had insertion of study catheter|1|||
17154445|NCT01353586|38300774|FG000|Overall Study|Neurological exam not done|0|||
17154446|NCT01353586|38300775|FG001|Overall Study|Neurological exam not done|1|||
17154447|NCT03091920|38300787|FG000|Overall Study|Adverse Event|0|||
17154448|NCT03091920|38300788|FG001|Overall Study|Adverse Event|1|||
17154449|NCT03091920|38300789|FG002|Overall Study|Adverse Event|0|||
17154450|NCT03338569|38300805|FG000|Overall Study|Physician Decision|8|||
17072419|NCT00289978|38214820|FG000|Overall Study|Protocol Violation|5|||
17072420|NCT00289978|38214821|FG001|Overall Study|Protocol Violation|5|||
17072421|NCT00289978|38214822|FG002|Overall Study|Protocol Violation|4|||
17072422|NCT00289978|38214820|FG000|Overall Study|Abnormal test procedure result(s)|2|||
17072423|NCT00289978|38214821|FG001|Overall Study|Abnormal test procedure result(s)|1|||
17072424|NCT00289978|38214822|FG002|Overall Study|Abnormal test procedure result(s)|1|||
17072425|NCT00289978|38214820|FG000|Overall Study|Death|1|||
17154451|NCT03338569|38300806|FG001|Overall Study|Physician Decision|3|||
17154452|NCT03338569|38300805|FG000|Overall Study|Withdrawal by Subject|0|||
17154453|NCT03338569|38300806|FG001|Overall Study|Withdrawal by Subject|1|||
17154454|NCT03338569|38300805|FG000|Overall Study|Lost to Follow-up|0|||
17154455|NCT03338569|38300806|FG001|Overall Study|Lost to Follow-up|1|||
17154456|NCT03338023|38300814|FG000|Overall Study|Withdrawal by Subject|3|||
17154457|NCT03338023|38300815|FG001|Overall Study|Withdrawal by Subject|4|||
17154458|NCT03338023|38300814|FG000|Overall Study|Protocol Violation|3|||
17154459|NCT03338023|38300815|FG001|Overall Study|Protocol Violation|3|||
17154460|NCT03338023|38300814|FG000|Overall Study|Lost to Follow-up|2|||
17154461|NCT03338023|38300815|FG001|Overall Study|Lost to Follow-up|1|||
17154462|NCT03338023|38300814|FG000|Overall Study|Physician Decision|1|||
17154463|NCT03338023|38300815|FG001|Overall Study|Physician Decision|2|||
17154464|NCT03337477|38300823|FG000|Overall Study|not categorized into the listed ones|11|||
17154465|NCT03337477|38300824|FG001|Overall Study|not categorized into the listed ones|9|||
17154466|NCT03337477|38300823|FG000|Overall Study|Withdrawal by Subject|0|||
17154467|NCT03337477|38300824|FG001|Overall Study|Withdrawal by Subject|1|||
17154468|NCT03337477|38300823|FG000|Overall Study|Death|0|||
17154469|NCT03337477|38300824|FG001|Overall Study|Death|1|||
17154470|NCT03337477|38300823|FG000|Overall Study|Lost to Follow-up|0|||
17154471|NCT03337477|38300824|FG001|Overall Study|Lost to Follow-up|2|||
17154472|NCT02687542|38300837|FG000|Overall Study|Medication error without associated AEs|0|||
17154473|NCT02687542|38300838|FG001|Overall Study|Medication error without associated AEs|0|||
17154474|NCT02687542|38300839|FG002|Overall Study|Medication error without associated AEs|0|||
17154475|NCT02687542|38300840|FG003|Overall Study|Medication error without associated AEs|0|||
17154476|NCT02687542|38300841|FG004|Overall Study|Medication error without associated AEs|1|||
17154477|NCT02687542|38300837|FG000|Overall Study|Lost to Follow-up|0|||
17154478|NCT02687542|38300838|FG001|Overall Study|Lost to Follow-up|0|||
17154479|NCT02687542|38300839|FG002|Overall Study|Lost to Follow-up|0|||
17072426|NCT00289978|38214821|FG001|Overall Study|Death|0|||
17072427|NCT00289978|38214822|FG002|Overall Study|Death|2|||
17154480|NCT02687542|38300840|FG003|Overall Study|Lost to Follow-up|0|||
17154481|NCT02687542|38300841|FG004|Overall Study|Lost to Follow-up|1|||
17154482|NCT02687542|38300837|FG000|Overall Study|Protocol Violation|0|||
17072428|NCT00543803|38214830|FG000|Overall Study|Adverse Event|14|||
17072429|NCT00543803|38214830|FG000|Overall Study|Lack of Efficacy|22|||
17072430|NCT00543803|38214830|FG000|Overall Study|Lost to Follow-up|20|||
17072431|NCT00543803|38214830|FG000|Overall Study|Other|86|||
17154483|NCT02687542|38300838|FG001|Overall Study|Protocol Violation|1|||
17154484|NCT02687542|38300839|FG002|Overall Study|Protocol Violation|0|||
17154485|NCT02687542|38300840|FG003|Overall Study|Protocol Violation|0|||
17154486|NCT02687542|38300841|FG004|Overall Study|Protocol Violation|0|||
17072432|NCT00542321|38214838|FG000|Overall Study|Death|0|||
17072433|NCT00542321|38214839|FG001|Overall Study|Death|1|||
17072434|NCT00289900|38214851|FG000|Overall Study|Adverse Event|28|||
17072435|NCT00289900|38214852|FG001|Overall Study|Adverse Event|40|||
17072436|NCT00289900|38214853|FG002|Overall Study|Adverse Event|13|||
17072437|NCT00289900|38214854|FG003|Overall Study|Adverse Event|19|||
17072438|NCT00289900|38214855|FG004|Overall Study|Adverse Event|20|||
17072439|NCT00289900|38214856|FG005|Overall Study|Adverse Event|33|||
17072440|NCT00289900|38214851|FG000|Overall Study|Lost to Follow-up|7|||
17072441|NCT00289900|38214852|FG001|Overall Study|Lost to Follow-up|7|||
17072442|NCT00289900|38214853|FG002|Overall Study|Lost to Follow-up|8|||
17072443|NCT00289900|38214854|FG003|Overall Study|Lost to Follow-up|8|||
17072444|NCT00289900|38214855|FG004|Overall Study|Lost to Follow-up|4|||
17072445|NCT00289900|38214856|FG005|Overall Study|Lost to Follow-up|8|||
17072446|NCT00289900|38214851|FG000|Overall Study|Participant had flushing|18|||
17072447|NCT00289900|38214852|FG001|Overall Study|Participant had flushing|42|||
17072448|NCT00289900|38214853|FG002|Overall Study|Participant had flushing|1|||
17072449|NCT00289900|38214854|FG003|Overall Study|Participant had flushing|2|||
17072450|NCT00289900|38214855|FG004|Overall Study|Participant had flushing|0|||
17072451|NCT00289900|38214856|FG005|Overall Study|Participant had flushing|4|||
17072452|NCT00289900|38214851|FG000|Overall Study|Other|0|||
17072453|NCT00289900|38214852|FG001|Overall Study|Other|0|||
17072454|NCT00289900|38214853|FG002|Overall Study|Other|0|||
17072455|NCT00289900|38214854|FG003|Overall Study|Other|5|||
17154487|NCT02687542|38300837|FG000|Overall Study|Other|5|||
17154488|NCT02687542|38300838|FG001|Overall Study|Other|9|||
17154489|NCT02687542|38300839|FG002|Overall Study|Other|10|||
17154490|NCT02687542|38300840|FG003|Overall Study|Other|6|||
17072456|NCT00289900|38214855|FG004|Overall Study|Other|1|||
17072457|NCT00289900|38214856|FG005|Overall Study|Other|0|||
17072458|NCT00289900|38214851|FG000|Overall Study|Participant moved|1|||
17072459|NCT00289900|38214852|FG001|Overall Study|Participant moved|0|||
17072460|NCT00289900|38214853|FG002|Overall Study|Participant moved|0|||
17072461|NCT00289900|38214854|FG003|Overall Study|Participant moved|1|||
17072462|NCT00289900|38214855|FG004|Overall Study|Participant moved|1|||
17072463|NCT00289900|38214856|FG005|Overall Study|Participant moved|1|||
17072464|NCT00289900|38214851|FG000|Overall Study|Withdrawal by Subject|10|||
17072465|NCT00289900|38214852|FG001|Overall Study|Withdrawal by Subject|21|||
17154491|NCT02687542|38300841|FG004|Overall Study|Other|5|||
17154492|NCT02687542|38300837|FG000|Overall Study|Adverse Event|3|||
17154493|NCT02687542|38300838|FG001|Overall Study|Adverse Event|1|||
17154494|NCT02687542|38300839|FG002|Overall Study|Adverse Event|3|||
17154495|NCT02687542|38300840|FG003|Overall Study|Adverse Event|2|||
17154496|NCT02687542|38300841|FG004|Overall Study|Adverse Event|9|||
17154497|NCT02687542|38300837|FG000|Overall Study|Withdrawal by Subject|0|||
17154498|NCT02687542|38300838|FG001|Overall Study|Withdrawal by Subject|1|||
17154499|NCT02687542|38300839|FG002|Overall Study|Withdrawal by Subject|1|||
17154500|NCT02687542|38300840|FG003|Overall Study|Withdrawal by Subject|2|||
17154501|NCT02687542|38300841|FG004|Overall Study|Withdrawal by Subject|4|||
17154502|NCT03336619|38300855|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
17154503|NCT03336619|38300856|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
17154504|NCT03336619|38300855|FG000|Overall Study|Withdrawal by Subject|17|||
17154505|NCT03336619|38300856|FG001|Overall Study|Withdrawal by Subject|16|||
17154506|NCT03336619|38300855|FG000|Overall Study|Adverse Event|2|||
17154507|NCT03336619|38300856|FG001|Overall Study|Adverse Event|5|||
17154508|NCT03336619|38300855|FG000|Overall Study|Physician Decision|3|||
17154509|NCT03336619|38300856|FG001|Overall Study|Physician Decision|0|||
17154510|NCT01353508|38300878|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
17154511|NCT01353508|38300879|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
17154512|NCT01353508|38300880|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
17154513|NCT01353508|38300881|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
17154514|NCT01353508|38300878|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
17154515|NCT01353508|38300879|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
17154516|NCT01353508|38300880|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
17154517|NCT01353508|38300881|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
17154518|NCT03636269|38300893|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
17154519|NCT03636269|38300894|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
17154520|NCT03636269|38300895|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
17154521|NCT03636269|38300893|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
17154522|NCT03636269|38300894|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
17154523|NCT03636269|38300895|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
17154524|NCT03636269|38300893|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
17154525|NCT03636269|38300894|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
17154526|NCT03636269|38300895|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
17154527|NCT03636269|38300893|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
17154528|NCT03636269|38300894|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
17154529|NCT03636269|38300895|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
17154530|NCT03636269|38300893|FG000|Period 1: Double-blind Phase|Other|6|||
17154531|NCT03636269|38300894|FG001|Period 1: Double-blind Phase|Other|3|||
17154532|NCT03636269|38300895|FG002|Period 1: Double-blind Phase|Other|0|||
17154533|NCT03636269|38300893|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
17154534|NCT03636269|38300894|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
17154535|NCT03636269|38300895|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
17154536|NCT03636269|38300893|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
17154537|NCT03636269|38300894|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
17154538|NCT03636269|38300895|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
17154539|NCT03636269|38300893|FG000|Period 2: Open-label Phase|Adverse Event|0|||
17154540|NCT03636269|38300894|FG001|Period 2: Open-label Phase|Adverse Event|0|||
17154541|NCT03636269|38300895|FG002|Period 2: Open-label Phase|Adverse Event|21|||
17154542|NCT03636269|38300893|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
17154543|NCT03636269|38300894|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
17154544|NCT03636269|38300895|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
17154545|NCT03636269|38300893|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
17154546|NCT03636269|38300894|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
17154547|NCT03636269|38300895|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
17154548|NCT03636269|38300893|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
17154549|NCT03636269|38300894|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
17154550|NCT03636269|38300895|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
17154551|NCT03636269|38300893|FG000|Period 2: Open-label Phase|Administrative|0|||
17154552|NCT03636269|38300894|FG001|Period 2: Open-label Phase|Administrative|0|||
17154553|NCT03636269|38300895|FG002|Period 2: Open-label Phase|Administrative|36|||
17154554|NCT03636269|38300893|FG000|Period 2: Open-label Phase|Other|0|||
17154555|NCT03636269|38300894|FG001|Period 2: Open-label Phase|Other|0|||
17154556|NCT03636269|38300895|FG002|Period 2: Open-label Phase|Other|9|||
17154557|NCT03636269|38300893|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
17154558|NCT03636269|38300894|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
17154559|NCT03636269|38300895|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
17154560|NCT02685202|38300904|FG000|Overall Study|Lost to Follow-up|9|||
17154561|NCT03087786|38300910|FG000|Overall Study|Withdrawal by Subject|2|||
17154562|NCT03087786|38300911|FG001|Overall Study|Withdrawal by Subject|0|||
17154563|NCT03635957|38300917|FG000|Run-In Period|Lost to Follow-up|1|||
17154564|NCT03635957|38300917|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
17154565|NCT01353274|38300922|FG000|Overall Study|No case report form (CRF) collected|28|||
17154566|NCT02690194|38300929|FG000|Overall Study|Withdrawal by Subject|1|||
17154567|NCT02690194|38300930|FG001|Overall Study|Withdrawal by Subject|4|||
17154568|NCT02690194|38300931|FG002|Overall Study|Withdrawal by Subject|0|||
17154569|NCT02684344|38300941|FG000|Overall Study|Withdrawal by Subject|0|||
17154570|NCT02684344|38300942|FG001|Overall Study|Withdrawal by Subject|1|||
17154571|NCT02683876|38300950|FG000|Overall Study|samples damaged during shipping|2|||
17154572|NCT02683876|38300951|FG001|Overall Study|samples damaged during shipping|0|||
17154573|NCT03974100|38300961|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
17154574|NCT03974100|38300962|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
17154575|NCT03974100|38300963|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
17154576|NCT03974100|38300964|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
17154577|NCT03974100|38300965|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
17154578|NCT03974100|38300961|FG000|TP1 - Day 1 to Week 52|Death|1|||
17154579|NCT03974100|38300962|FG001|TP1 - Day 1 to Week 52|Death|0|||
17154580|NCT03974100|38300963|FG002|TP1 - Day 1 to Week 52|Death|0|||
17154581|NCT03974100|38300964|FG003|TP1 - Day 1 to Week 52|Death|0|||
17154582|NCT03974100|38300965|FG004|TP1 - Day 1 to Week 52|Death|0|||
17154583|NCT03974100|38300961|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
17154584|NCT03974100|38300962|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
17154585|NCT03974100|38300963|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
17154586|NCT03974100|38300964|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
17154587|NCT03974100|38300965|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
17154588|NCT03974100|38300961|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
17154589|NCT03974100|38300962|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
17154590|NCT03974100|38300963|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
17154591|NCT03974100|38300964|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
17154592|NCT03974100|38300965|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
17154593|NCT03974100|38300961|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
17154594|NCT03974100|38300962|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
17154595|NCT03974100|38300963|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
17154596|NCT03974100|38300964|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
17154597|NCT03974100|38300965|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
17154598|NCT03974100|38300961|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
17154599|NCT03974100|38300962|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
17154600|NCT03974100|38300963|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
17154601|NCT03974100|38300964|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
17154602|NCT03974100|38300965|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
17154603|NCT03974100|38300961|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
17154604|NCT03974100|38300962|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
17154605|NCT03974100|38300963|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
17154606|NCT03974100|38300964|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
17154607|NCT03974100|38300965|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
17154608|NCT02689804|38300979|FG000|Overall Study|Withdrawal by Subject|2|||
17154609|NCT02689804|38300980|FG001|Overall Study|Withdrawal by Subject|0|||
17154610|NCT02946931|38300989|FG000|Overall Study|Did not require collection of CRFs|588|||
17154611|NCT02946931|38300989|FG000|Overall Study|Other than listed|37|||
17154612|NCT02946931|38300989|FG000|Overall Study|Discharge from hospital|118|||
17154613|NCT02946931|38300989|FG000|Overall Study|Adverse Event|81|||
17154614|NCT02946931|38300989|FG000|Overall Study|CRFs not valid|1|||
17154615|NCT02946931|38300989|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
17154616|NCT02689492|38300993|FG000|Overall Study|Lost to Follow-up|61|||
17154617|NCT02689492|38300993|FG000|Overall Study|Withdrawal by Subject|11|||
17154618|NCT02689492|38300993|FG000|Overall Study|Death|9|||
17154619|NCT02689492|38300993|FG000|Overall Study|Physician Decision|2|||
17154620|NCT02689492|38300993|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
17154621|NCT02689492|38300993|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
17154622|NCT02689492|38300993|FG000|Overall Study|Other than listed|1|||
17154623|NCT01374568|38301011|FG000|Overall Study|Lab unable to analyze BTM|0|||
17154624|NCT01374568|38301012|FG001|Overall Study|Lab unable to analyze BTM|2|||
17154625|NCT02682784|38301022|FG000|Overall Study|Withdrawal by Subject|0|||
17154626|NCT02682784|38301023|FG001|Overall Study|Withdrawal by Subject|2|||
17154627|NCT02682784|38301024|FG002|Overall Study|Withdrawal by Subject|1|||
17154628|NCT02682784|38301025|FG003|Overall Study|Withdrawal by Subject|2|||
17154629|NCT02682784|38301022|FG000|Overall Study|Physician Decision|1|||
17154630|NCT02682784|38301023|FG001|Overall Study|Physician Decision|0|||
17154631|NCT02682784|38301024|FG002|Overall Study|Physician Decision|1|||
17154632|NCT02682784|38301025|FG003|Overall Study|Physician Decision|1|||
17154633|NCT02946463|38301037|FG000|Primary Evaluation Period|Physician Decision|0|||
17154634|NCT02946463|38301038|FG001|Primary Evaluation Period|Physician Decision|1|||
17154635|NCT02946463|38301037|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
17154636|NCT02946463|38301038|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
17154637|NCT03387852|38301048|FG000|Overall Study|Adverse event (AE)|3|||
17154638|NCT03387852|38301049|FG001|Overall Study|Adverse event (AE)|0|||
17154639|NCT03387852|38301050|FG002|Overall Study|Adverse event (AE)|2|||
17154640|NCT03387852|38301051|FG003|Overall Study|Adverse event (AE)|0|||
17154641|NCT03387852|38301048|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
17154642|NCT03387852|38301049|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
17154643|NCT03387852|38301050|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
17154644|NCT03387852|38301051|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
17154645|NCT03387852|38301048|FG000|Overall Study|Withdrawal by participant|1|||
17154646|NCT03387852|38301049|FG001|Overall Study|Withdrawal by participant|1|||
17154647|NCT03387852|38301050|FG002|Overall Study|Withdrawal by participant|3|||
17154648|NCT03387852|38301051|FG003|Overall Study|Withdrawal by participant|2|||
17154649|NCT03387852|38301048|FG000|Overall Study|Other- Unspecified|1|||
17154650|NCT03387852|38301049|FG001|Overall Study|Other- Unspecified|1|||
17154651|NCT03387852|38301050|FG002|Overall Study|Other- Unspecified|2|||
17154652|NCT03387852|38301051|FG003|Overall Study|Other- Unspecified|1|||
17154653|NCT03387852|38301048|FG000|Overall Study|Poor compliance to protocol|0|||
17154654|NCT03387852|38301049|FG001|Overall Study|Poor compliance to protocol|0|||
17154655|NCT03387852|38301050|FG002|Overall Study|Poor compliance to protocol|0|||
17154656|NCT03387852|38301051|FG003|Overall Study|Poor compliance to protocol|1|||
17154657|NCT03387852|38301048|FG000|Overall Study|Randomized and not treated|0|||
17154658|NCT03387852|38301049|FG001|Overall Study|Randomized and not treated|0|||
17154659|NCT03387852|38301050|FG002|Overall Study|Randomized and not treated|0|||
17154660|NCT03387852|38301051|FG003|Overall Study|Randomized and not treated|1|||
17154661|NCT02679274|38301064|FG000|Overall Study|Withdrawal by Subject|1|||
17154662|NCT02679274|38301065|FG001|Overall Study|Withdrawal by Subject|0|||
17154663|NCT05009251|38301076|FG000|Overall Study|Protocol Violation|100|||
17154664|NCT05009251|38301077|FG001|Overall Study|Protocol Violation|105|||
17154665|NCT05009251|38301078|FG002|Overall Study|Protocol Violation|119|||
17154666|NCT05009251|38301079|FG003|Overall Study|Protocol Violation|120|||
17154667|NCT05009251|38301080|FG004|Overall Study|Protocol Violation|119|||
17154668|NCT05009251|38301076|FG000|Overall Study|Death|25|||
17154669|NCT05009251|38301077|FG001|Overall Study|Death|22|||
17154670|NCT05009251|38301078|FG002|Overall Study|Death|24|||
17154671|NCT05009251|38301079|FG003|Overall Study|Death|19|||
17154672|NCT05009251|38301080|FG004|Overall Study|Death|15|||
17154673|NCT04969861|38301094|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
17154674|NCT04969861|38301095|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
17154675|NCT02678416|38301103|FG000|Part 1|Withdrawal by Subject|1|||
17154676|NCT02678416|38301103|FG000|Part 2|Adverse Event|2|||
17154677|NCT02678416|38301103|FG000|Part 2|Withdrawal by Subject|1|||
17154678|NCT02680834|38301123|FG000|Overall Study|Physician Decision|5|||
17154679|NCT02680834|38301124|FG001|Overall Study|Physician Decision|2|||
17154680|NCT02680834|38301123|FG000|Overall Study|Withdrawal by Subject|6|||
17154681|NCT02680834|38301124|FG001|Overall Study|Withdrawal by Subject|0|||
17154682|NCT02680834|38301123|FG000|Overall Study|Lost to Follow-up|0|||
17154683|NCT02680834|38301124|FG001|Overall Study|Lost to Follow-up|1|||
17154684|NCT03343704|38301132|FG000|Overall Study|Refused to complete follow up|0|||
17154685|NCT03343704|38301133|FG001|Overall Study|Refused to complete follow up|1|||
17154686|NCT03343704|38301132|FG000|Overall Study|Death|0|||
17154687|NCT03343704|38301133|FG001|Overall Study|Death|1|||
17154688|NCT03343704|38301132|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
17154689|NCT03343704|38301133|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
17154690|NCT02677922|38301147|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
17154691|NCT02677922|38301148|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
17154692|NCT02677922|38301149|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
17154693|NCT02677922|38301150|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
17154694|NCT02677922|38301151|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
17154695|NCT02677922|38301152|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
17154696|NCT02677922|38301147|FG000|Treatment Period|Adverse Event|0|||
17154697|NCT02677922|38301148|FG001|Treatment Period|Adverse Event|0|||
17154698|NCT02677922|38301149|FG002|Treatment Period|Adverse Event|1|||
17154699|NCT02677922|38301150|FG003|Treatment Period|Adverse Event|3|||
17154700|NCT02677922|38301151|FG004|Treatment Period|Adverse Event|5|||
17154701|NCT02677922|38301152|FG005|Treatment Period|Adverse Event|2|||
17154702|NCT02677922|38301147|FG000|Treatment Period|Progressive Disease|1|||
17154703|NCT02677922|38301148|FG001|Treatment Period|Progressive Disease|1|||
17154704|NCT02677922|38301149|FG002|Treatment Period|Progressive Disease|0|||
17154705|NCT02677922|38301150|FG003|Treatment Period|Progressive Disease|0|||
17154706|NCT02677922|38301151|FG004|Treatment Period|Progressive Disease|8|||
17154707|NCT02677922|38301152|FG005|Treatment Period|Progressive Disease|7|||
17154708|NCT02677922|38301147|FG000|Treatment Period|Lack of Efficacy|0|||
17154709|NCT02677922|38301148|FG001|Treatment Period|Lack of Efficacy|0|||
17154710|NCT02677922|38301149|FG002|Treatment Period|Lack of Efficacy|0|||
17154711|NCT02677922|38301150|FG003|Treatment Period|Lack of Efficacy|1|||
17154712|NCT02677922|38301151|FG004|Treatment Period|Lack of Efficacy|1|||
17154713|NCT02677922|38301152|FG005|Treatment Period|Lack of Efficacy|6|||
17154714|NCT02677922|38301147|FG000|Treatment Period|Withdrawal by Subject|0|||
17154715|NCT02677922|38301148|FG001|Treatment Period|Withdrawal by Subject|0|||
17154716|NCT02677922|38301149|FG002|Treatment Period|Withdrawal by Subject|1|||
17154717|NCT02677922|38301150|FG003|Treatment Period|Withdrawal by Subject|3|||
17154718|NCT02677922|38301151|FG004|Treatment Period|Withdrawal by Subject|5|||
17154719|NCT02677922|38301152|FG005|Treatment Period|Withdrawal by Subject|5|||
17154720|NCT02677922|38301147|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
17154721|NCT02677922|38301148|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
17154722|NCT02677922|38301149|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
17154723|NCT02677922|38301150|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
17154724|NCT02677922|38301151|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
17154725|NCT02677922|38301152|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
17154726|NCT02677922|38301147|FG000|Treatment Period|Disease Relapse|0|||
17154727|NCT02677922|38301148|FG001|Treatment Period|Disease Relapse|0|||
17154728|NCT02677922|38301149|FG002|Treatment Period|Disease Relapse|0|||
17154729|NCT02677922|38301150|FG003|Treatment Period|Disease Relapse|3|||
17154730|NCT02677922|38301151|FG004|Treatment Period|Disease Relapse|6|||
17154731|NCT02677922|38301152|FG005|Treatment Period|Disease Relapse|1|||
17154732|NCT02677922|38301147|FG000|Treatment Period|Allogeneic HSCT|1|||
17154733|NCT02677922|38301148|FG001|Treatment Period|Allogeneic HSCT|0|||
17154734|NCT02677922|38301149|FG002|Treatment Period|Allogeneic HSCT|0|||
17154735|NCT02677922|38301150|FG003|Treatment Period|Allogeneic HSCT|1|||
17154736|NCT02677922|38301151|FG004|Treatment Period|Allogeneic HSCT|4|||
17154737|NCT02677922|38301152|FG005|Treatment Period|Allogeneic HSCT|1|||
17154738|NCT02677922|38301147|FG000|Treatment Period|Other Reasons|0|||
17154739|NCT02677922|38301148|FG001|Treatment Period|Other Reasons|0|||
17154740|NCT02677922|38301149|FG002|Treatment Period|Other Reasons|0|||
17154741|NCT02677922|38301150|FG003|Treatment Period|Other Reasons|1|||
17154742|NCT02677922|38301151|FG004|Treatment Period|Other Reasons|3|||
17154743|NCT02677922|38301152|FG005|Treatment Period|Other Reasons|5|||
17154744|NCT02677922|38301147|FG000|Treatment Period|Death|0|||
17154745|NCT02677922|38301148|FG001|Treatment Period|Death|0|||
17154746|NCT02677922|38301149|FG002|Treatment Period|Death|0|||
17154747|NCT02677922|38301150|FG003|Treatment Period|Death|0|||
17154748|NCT02677922|38301151|FG004|Treatment Period|Death|12|||
17154749|NCT02677922|38301152|FG005|Treatment Period|Death|1|||
17154750|NCT02677922|38301147|FG000|Treatment Period|Non-compliance with Study Drug|0|||
17154751|NCT02677922|38301148|FG001|Treatment Period|Non-compliance with Study Drug|0|||
17154752|NCT02677922|38301149|FG002|Treatment Period|Non-compliance with Study Drug|0|||
17154753|NCT02677922|38301150|FG003|Treatment Period|Non-compliance with Study Drug|0|||
17154754|NCT02677922|38301151|FG004|Treatment Period|Non-compliance with Study Drug|1|||
17154755|NCT02677922|38301152|FG005|Treatment Period|Non-compliance with Study Drug|0|||
17154756|NCT02677922|38301147|FG000|Treatment Period|Physician Decision|0|||
17154757|NCT02677922|38301148|FG001|Treatment Period|Physician Decision|0|||
17154758|NCT02677922|38301149|FG002|Treatment Period|Physician Decision|0|||
17154759|NCT02677922|38301150|FG003|Treatment Period|Physician Decision|0|||
17154760|NCT02677922|38301151|FG004|Treatment Period|Physician Decision|0|||
17154761|NCT02677922|38301152|FG005|Treatment Period|Physician Decision|1|||
17154762|NCT02677922|38301147|FG000|Treatment Period|Symptomatic Deterioration|0|||
17154763|NCT02677922|38301148|FG001|Treatment Period|Symptomatic Deterioration|0|||
17154764|NCT02677922|38301149|FG002|Treatment Period|Symptomatic Deterioration|0|||
17154765|NCT02677922|38301150|FG003|Treatment Period|Symptomatic Deterioration|0|||
17154766|NCT02677922|38301151|FG004|Treatment Period|Symptomatic Deterioration|1|||
17154767|NCT02677922|38301152|FG005|Treatment Period|Symptomatic Deterioration|0|||
17154768|NCT02680756|38301169|FG000|Overall Study|Adverse Event|10|||
17154769|NCT02680756|38301170|FG001|Overall Study|Adverse Event|2|||
17154770|NCT02680756|38301169|FG000|Overall Study|Lost to Follow-up|7|||
17154771|NCT02680756|38301170|FG001|Overall Study|Lost to Follow-up|6|||
17072466|NCT00289900|38214853|FG002|Overall Study|Withdrawal by Subject|8|||
17072467|NCT00289900|38214854|FG003|Overall Study|Withdrawal by Subject|18|||
17072468|NCT00289900|38214855|FG004|Overall Study|Withdrawal by Subject|12|||
17072469|NCT00289900|38214856|FG005|Overall Study|Withdrawal by Subject|11|||
17072470|NCT00289900|38214851|FG000|Overall Study|Protocol Violation|3|||
17072471|NCT00289900|38214852|FG001|Overall Study|Protocol Violation|9|||
17154772|NCT02680756|38301169|FG000|Overall Study|Withdrawal by Subject|5|||
17154773|NCT02680756|38301170|FG001|Overall Study|Withdrawal by Subject|5|||
17154774|NCT02680756|38301169|FG000|Overall Study|Physician Decision|4|||
17154775|NCT02680756|38301170|FG001|Overall Study|Physician Decision|1|||
17154776|NCT02680756|38301169|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
17154777|NCT02680756|38301170|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
17154778|NCT02680756|38301169|FG000|Overall Study|Blood transfusion for any reason|0|||
17154779|NCT02680756|38301170|FG001|Overall Study|Blood transfusion for any reason|1|||
17154780|NCT02680756|38301169|FG000|Overall Study|Death|1|||
17154781|NCT02680756|38301170|FG001|Overall Study|Death|0|||
17154782|NCT02680756|38301169|FG000|Overall Study|Protocol Violation|1|||
17154783|NCT02680756|38301170|FG001|Overall Study|Protocol Violation|0|||
17154784|NCT02680756|38301169|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
17154785|NCT02680756|38301170|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
17154786|NCT02680756|38301169|FG000|Overall Study|None of above or not recorded|3|||
17154787|NCT02680756|38301170|FG001|Overall Study|None of above or not recorded|2|||
17154788|NCT03086460|38301176|FG000|Study Participants|Lost to Follow-up|2|||
17154789|NCT03086460|38301176|FG000|Study Participants|Protocol Violation|1|||
17154790|NCT03086460|38301176|FG000|Study Participants|Withdrawal by Subject|6|||
17154791|NCT03086460|38301176|FG000|Treatment A|Lost to Follow-up|1|||
17154792|NCT03086460|38301176|FG000|Treatment A|Protocol Violation|1|||
17154793|NCT03086460|38301176|FG000|Treatment A|Withdrawal by Subject|2|||
17154794|NCT03086460|38301176|FG000|Treatment C|Withdrawal by Subject|2|||
17154795|NCT03086460|38301176|FG000|Treatment E|Lost to Follow-up|1|||
17154796|NCT03086460|38301176|FG000|Treatment E|Withdrawal by Subject|3|||
17154797|NCT02677714|38301202|FG000|Overall Study|Withdrawal by Subject|2|||
17154798|NCT02677714|38301203|FG001|Overall Study|Withdrawal by Subject|0|||
17154799|NCT02677324|38301209|FG000|Overall Study|Disease Progression|6|||
17154800|NCT02677324|38301209|FG000|Overall Study|Inability to Swallow pills|1|||
17154801|NCT02677324|38301209|FG000|Overall Study|Non-compliance|1|||
17154802|NCT02677324|38301209|FG000|Overall Study|Lack of Efficacy|1|||
17154803|NCT02677324|38301209|FG000|Overall Study|Medical insurance coverage|1|||
17154804|NCT02677324|38301209|FG000|Overall Study|Adverse Event|1|||
17154805|NCT02677324|38301209|FG000|Overall Study|IgM Myeloma diagnosis|1|||
17154806|NCT01971008|38301217|FG000|Overall Study|Protocol Violation|2|||
17154807|NCT01971008|38301218|FG001|Overall Study|Protocol Violation|1|||
17154808|NCT01374178|38301227|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
17154809|NCT01374178|38301228|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
17154810|NCT01374178|38301227|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
17154811|NCT01374178|38301228|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
17072472|NCT00289900|38214853|FG002|Overall Study|Protocol Violation|2|||
17072473|NCT00289900|38214854|FG003|Overall Study|Protocol Violation|6|||
17072474|NCT00289900|38214855|FG004|Overall Study|Protocol Violation|7|||
17072475|NCT00289900|38214856|FG005|Overall Study|Protocol Violation|4|||
17072476|NCT00289900|38214851|FG000|Overall Study|site terminated|1|||
17072477|NCT00289900|38214852|FG001|Overall Study|site terminated|0|||
17072478|NCT00289900|38214853|FG002|Overall Study|site terminated|1|||
17072479|NCT00289900|38214854|FG003|Overall Study|site terminated|0|||
17072480|NCT00289900|38214855|FG004|Overall Study|site terminated|0|||
17154812|NCT03025542|38301236|FG000|Overall Study|Adverse Event|0|||
17154813|NCT03025542|38301237|FG001|Overall Study|Adverse Event|2|||
17154814|NCT03025542|38301236|FG000|Overall Study|Lost to Follow-up|1|||
17154815|NCT03025542|38301237|FG001|Overall Study|Lost to Follow-up|0|||
17154816|NCT03025542|38301236|FG000|Overall Study|Withdrawal by Subject|1|||
17154817|NCT03025542|38301237|FG001|Overall Study|Withdrawal by Subject|0|||
17154818|NCT03022370|38301251|FG000|Overall Study|Death|6|||
17154819|NCT03022370|38301252|FG001|Overall Study|Death|12|||
17154820|NCT03022370|38301251|FG000|Overall Study|Lost to Follow-up|174|||
17154821|NCT03022370|38301252|FG001|Overall Study|Lost to Follow-up|109|||
17154822|NCT03021668|38301264|FG000|Overall Study|Physician Decision|0|||
17154823|NCT03021668|38301265|FG001|Overall Study|Physician Decision|1|||
16994259|NCT00773734|38138077|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
16994260|NCT00773734|38138072|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
17072481|NCT00289900|38214856|FG005|Overall Study|site terminated|0|||
17072482|NCT00289900|38214851|FG000|Overall Study|Not treated|0|||
17072483|NCT00289900|38214852|FG001|Overall Study|Not treated|1|||
17072484|NCT00289900|38214853|FG002|Overall Study|Not treated|0|||
17072485|NCT00289900|38214854|FG003|Overall Study|Not treated|0|||
17072486|NCT00289900|38214855|FG004|Overall Study|Not treated|0|||
17072487|NCT00289900|38214856|FG005|Overall Study|Not treated|0|||
17154824|NCT03020888|38301271|FG000|Overall Study|Physician Decision|4|||
17154825|NCT03020888|38301271|FG000|Overall Study|Withdrawal by Subject|6|||
17154826|NCT03020888|38301271|FG000|Overall Study|Insurance coverage|2|||
17154827|NCT03020888|38301271|FG000|Overall Study|Lost to Follow-up|1|||
17154828|NCT02250300|38301279|FG000|Expansion Phase|Death|6|||
17154829|NCT02250300|38301280|FG001|Expansion Phase|Death|7|||
17154830|NCT02250300|38301281|FG002|Expansion Phase|Death|0|||
17154831|NCT02250300|38301282|FG003|Expansion Phase|Death|0|||
17154832|NCT03020966|38301295|FG000|Overall Study|Withdrawal by Subject|2|||
17154833|NCT03020966|38301296|FG001|Overall Study|Withdrawal by Subject|0|||
17154834|NCT03020576|38301304|FG000|Overall Study|Withdrawal by Subject|1|||
17154835|NCT03020576|38301305|FG001|Overall Study|Withdrawal by Subject|2|||
17154836|NCT03017612|38301311|FG000|Overall Study|Adverse Event|2|||
17154837|NCT03635099|38301323|FG000|Period 1|Adverse Event|1|||
17154838|NCT03635099|38301324|FG001|Period 1|Adverse Event|0|||
17154839|NCT03635099|38301325|FG002|Period 1|Adverse Event|0|||
17154840|NCT03635099|38301326|FG003|Period 1|Adverse Event|1|||
17154841|NCT03635099|38301327|FG004|Period 1|Adverse Event|0|||
17154842|NCT03635099|38301328|FG005|Period 1|Adverse Event|0|||
17154843|NCT03635099|38301329|FG006|Period 1|Adverse Event|0|||
17154844|NCT03635099|38301330|FG007|Period 1|Adverse Event|0|||
17154845|NCT03635099|38301323|FG000|Period 1|Protocol Violation|0|||
17154846|NCT03635099|38301324|FG001|Period 1|Protocol Violation|0|||
17154847|NCT03635099|38301325|FG002|Period 1|Protocol Violation|1|||
17154848|NCT03635099|38301326|FG003|Period 1|Protocol Violation|0|||
17154849|NCT03635099|38301327|FG004|Period 1|Protocol Violation|0|||
17154850|NCT03635099|38301328|FG005|Period 1|Protocol Violation|0|||
17154851|NCT03635099|38301329|FG006|Period 1|Protocol Violation|0|||
17154852|NCT03635099|38301330|FG007|Period 1|Protocol Violation|0|||
17154853|NCT03635099|38301323|FG000|Period 1|Lost to Follow-up|0|||
17154854|NCT03635099|38301324|FG001|Period 1|Lost to Follow-up|0|||
17154855|NCT03635099|38301325|FG002|Period 1|Lost to Follow-up|1|||
17154856|NCT03635099|38301326|FG003|Period 1|Lost to Follow-up|2|||
17154857|NCT03635099|38301327|FG004|Period 1|Lost to Follow-up|1|||
17154858|NCT03635099|38301328|FG005|Period 1|Lost to Follow-up|0|||
17154859|NCT03635099|38301329|FG006|Period 1|Lost to Follow-up|1|||
17154860|NCT03635099|38301330|FG007|Period 1|Lost to Follow-up|2|||
17154861|NCT03635099|38301323|FG000|Period 1|Withdrawal by Subject|3|||
17154862|NCT03635099|38301324|FG001|Period 1|Withdrawal by Subject|3|||
17154863|NCT03635099|38301325|FG002|Period 1|Withdrawal by Subject|5|||
17154864|NCT03635099|38301326|FG003|Period 1|Withdrawal by Subject|2|||
17154865|NCT03635099|38301327|FG004|Period 1|Withdrawal by Subject|2|||
17154866|NCT03635099|38301328|FG005|Period 1|Withdrawal by Subject|0|||
17154867|NCT03635099|38301329|FG006|Period 1|Withdrawal by Subject|3|||
17154868|NCT03635099|38301330|FG007|Period 1|Withdrawal by Subject|0|||
17154869|NCT03635099|38301323|FG000|Period 1|History of suicidal ideation|0|||
17154870|NCT03635099|38301324|FG001|Period 1|History of suicidal ideation|0|||
17154871|NCT03635099|38301325|FG002|Period 1|History of suicidal ideation|1|||
17154872|NCT03635099|38301326|FG003|Period 1|History of suicidal ideation|0|||
17154873|NCT03635099|38301327|FG004|Period 1|History of suicidal ideation|0|||
17154874|NCT03635099|38301328|FG005|Period 1|History of suicidal ideation|0|||
17154875|NCT03635099|38301329|FG006|Period 1|History of suicidal ideation|0|||
17154876|NCT03635099|38301330|FG007|Period 1|History of suicidal ideation|0|||
17154877|NCT03635099|38301323|FG000|Period 1|pursue other treatment options|0|||
17154878|NCT03635099|38301324|FG001|Period 1|pursue other treatment options|0|||
17154879|NCT03635099|38301325|FG002|Period 1|pursue other treatment options|0|||
17154880|NCT03635099|38301326|FG003|Period 1|pursue other treatment options|0|||
17154881|NCT03635099|38301327|FG004|Period 1|pursue other treatment options|0|||
17154882|NCT03635099|38301328|FG005|Period 1|pursue other treatment options|1|||
17154883|NCT03635099|38301329|FG006|Period 1|pursue other treatment options|0|||
17154884|NCT03635099|38301330|FG007|Period 1|pursue other treatment options|0|||
17154885|NCT03635099|38301323|FG000|Not Eligible for Period 2|Pregnancy|0|||
17154886|NCT03635099|38301324|FG001|Not Eligible for Period 2|Pregnancy|0|||
17154887|NCT03635099|38301325|FG002|Not Eligible for Period 2|Pregnancy|0|||
17154888|NCT03635099|38301326|FG003|Not Eligible for Period 2|Pregnancy|1|||
17154889|NCT03635099|38301327|FG004|Not Eligible for Period 2|Pregnancy|0|||
17154890|NCT03635099|38301328|FG005|Not Eligible for Period 2|Pregnancy|0|||
17154891|NCT03635099|38301329|FG006|Not Eligible for Period 2|Pregnancy|0|||
17154892|NCT03635099|38301330|FG007|Not Eligible for Period 2|Pregnancy|0|||
17154893|NCT03635099|38301323|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
16994261|NCT00773734|38138073|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
17154894|NCT03635099|38301324|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
17154895|NCT03635099|38301325|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
17154896|NCT03635099|38301326|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
17154897|NCT03635099|38301327|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
17154898|NCT03635099|38301328|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
17154899|NCT03635099|38301329|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
17154900|NCT03635099|38301330|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
17154901|NCT03635099|38301323|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
17154902|NCT03635099|38301324|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
17154903|NCT03635099|38301325|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
17154904|NCT03635099|38301326|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
17154905|NCT03635099|38301327|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
17154906|NCT03635099|38301328|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
17154907|NCT03635099|38301329|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
17154908|NCT03635099|38301330|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
17154909|NCT03635099|38301323|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
17154910|NCT03635099|38301324|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
17154911|NCT03635099|38301325|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
17154912|NCT03635099|38301326|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
17154913|NCT03635099|38301327|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
17154914|NCT03635099|38301328|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
17154915|NCT03635099|38301329|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
17154916|NCT03635099|38301330|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
17154917|NCT03635099|38301323|FG000|Period 2|Adverse Event|0|||
17154918|NCT03635099|38301324|FG001|Period 2|Adverse Event|0|||
17154919|NCT03635099|38301325|FG002|Period 2|Adverse Event|1|||
17072488|NCT00543725|38214875|FG000|Overall Study|Adverse Event|18|||
17072489|NCT00543725|38214876|FG001|Overall Study|Adverse Event|27|||
17072490|NCT00543725|38214875|FG000|Overall Study|Sponsor's Decision|0|||
17072491|NCT00543725|38214876|FG001|Overall Study|Sponsor's Decision|1|||
17072492|NCT00543725|38214875|FG000|Overall Study|Subject Non-Compliant|4|||
17072493|NCT00543725|38214876|FG001|Overall Study|Subject Non-Compliant|4|||
17154920|NCT03635099|38301326|FG003|Period 2|Adverse Event|0|||
17154921|NCT03635099|38301327|FG004|Period 2|Adverse Event|1|||
17154922|NCT03635099|38301328|FG005|Period 2|Adverse Event|0|||
17154923|NCT03635099|38301329|FG006|Period 2|Adverse Event|0|||
17154924|NCT03635099|38301330|FG007|Period 2|Adverse Event|0|||
17154925|NCT03635099|38301323|FG000|Period 2|Lost to Follow-up|0|||
17154926|NCT03635099|38301324|FG001|Period 2|Lost to Follow-up|0|||
17154927|NCT03635099|38301325|FG002|Period 2|Lost to Follow-up|1|||
17154928|NCT03635099|38301326|FG003|Period 2|Lost to Follow-up|0|||
17154929|NCT03635099|38301327|FG004|Period 2|Lost to Follow-up|4|||
17154930|NCT03635099|38301328|FG005|Period 2|Lost to Follow-up|0|||
17154931|NCT03635099|38301329|FG006|Period 2|Lost to Follow-up|0|||
17154932|NCT03635099|38301330|FG007|Period 2|Lost to Follow-up|0|||
17154933|NCT03635099|38301323|FG000|Period 2|Withdrawal by Subject|0|||
17154934|NCT03635099|38301324|FG001|Period 2|Withdrawal by Subject|0|||
17154935|NCT03635099|38301325|FG002|Period 2|Withdrawal by Subject|7|||
17154936|NCT03635099|38301326|FG003|Period 2|Withdrawal by Subject|4|||
17154937|NCT03635099|38301327|FG004|Period 2|Withdrawal by Subject|7|||
17154938|NCT03635099|38301328|FG005|Period 2|Withdrawal by Subject|0|||
17154939|NCT03635099|38301329|FG006|Period 2|Withdrawal by Subject|0|||
17154940|NCT03635099|38301330|FG007|Period 2|Withdrawal by Subject|0|||
17154941|NCT02108652|38301356|FG000|Overall Study|Death|226|||
17154942|NCT02108652|38301356|FG000|Overall Study|Lost to Follow-up|2|||
17154943|NCT02108652|38301356|FG000|Overall Study|Withdrawal by Subject|8|||
17154944|NCT02108652|38301356|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
17154945|NCT03634085|38301362|FG000|Overall Study|Adverse Event|1|||
17154946|NCT03634085|38301363|FG001|Overall Study|Adverse Event|0|||
17154947|NCT03634085|38301362|FG000|Overall Study|Withdrawal by Subject|0|||
17154948|NCT03634085|38301363|FG001|Overall Study|Withdrawal by Subject|2|||
17154949|NCT03633929|38301376|FG000|Overall Study|Lost to Follow-up|1|||
17154950|NCT03633929|38301376|FG000|Overall Study|Did not login to software. Did not participate|3|||
16994262|NCT00773734|38138074|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
16994263|NCT00773734|38138075|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
16994264|NCT00773734|38138076|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
16994265|NCT00773734|38138077|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
16994266|NCT00773734|38138072|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
16994267|NCT00773734|38138073|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
16994268|NCT00773734|38138074|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
17072494|NCT00543725|38214875|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
17072495|NCT00543725|38214876|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
17072496|NCT00543725|38214875|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
17072497|NCT00543725|38214876|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
17154951|NCT02676778|38301383|FG000|Overall Study|Disease Progression|7|||
17154952|NCT02676778|38301384|FG001|Overall Study|Disease Progression|3|||
17154953|NCT02676778|38301385|FG002|Overall Study|Disease Progression|1|||
17154954|NCT02676778|38301383|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
17154955|NCT02676778|38301384|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
17154956|NCT02676778|38301385|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
17154957|NCT02676778|38301383|FG000|Overall Study|Withdrawal by Subject|3|||
17154958|NCT02676778|38301384|FG001|Overall Study|Withdrawal by Subject|2|||
17154959|NCT02676778|38301385|FG002|Overall Study|Withdrawal by Subject|0|||
17154960|NCT02676778|38301383|FG000|Overall Study|Other|4|||
17154961|NCT02676778|38301384|FG001|Overall Study|Other|3|||
17154962|NCT02676778|38301385|FG002|Overall Study|Other|0|||
17154963|NCT02676778|38301383|FG000|Overall Study|Adverse Event|2|||
17154964|NCT02676778|38301384|FG001|Overall Study|Adverse Event|3|||
17154965|NCT02676778|38301385|FG002|Overall Study|Adverse Event|0|||
17154966|NCT02946385|38301400|FG000|Overall Study|Lost to Follow-up|0|||
17154967|NCT02946385|38301401|FG001|Overall Study|Lost to Follow-up|0|||
17154968|NCT02946385|38301402|FG002|Overall Study|Lost to Follow-up|3|||
17154969|NCT02946385|38301403|FG003|Overall Study|Lost to Follow-up|0|||
17154970|NCT02946385|38301404|FG004|Overall Study|Lost to Follow-up|2|||
17154971|NCT02946385|38301405|FG005|Overall Study|Lost to Follow-up|1|||
17154972|NCT02694718|38301425|FG000|Overall Study|Death|1|||
17154973|NCT02694718|38301425|FG000|Overall Study|Withdrawal by Subject|1|||
17154974|NCT02944513|38301431|FG000|Overall Study|Withdrawal by Subject|4|||
17154975|NCT02944513|38301432|FG001|Overall Study|Withdrawal by Subject|1|||
17154976|NCT03179761|38301440|FG000|Overall Study|Death|2|||
17154977|NCT03179761|38301441|FG001|Overall Study|Death|5|||
17154978|NCT03179761|38301440|FG000|Overall Study|Lost to Follow-up|2|||
17154979|NCT03179761|38301441|FG001|Overall Study|Lost to Follow-up|2|||
17154980|NCT03179761|38301440|FG000|Overall Study|Protocol Violation|1|||
17154981|NCT03179761|38301441|FG001|Overall Study|Protocol Violation|0|||
17154982|NCT03179761|38301440|FG000|Overall Study|Withdrawal by Subject|1|||
17154983|NCT03179761|38301441|FG001|Overall Study|Withdrawal by Subject|4|||
17154984|NCT03179761|38301440|FG000|Overall Study|Investigator Request|0|||
17154985|NCT03179761|38301441|FG001|Overall Study|Investigator Request|2|||
17154986|NCT01772472|38301449|FG000|Overall Study|Death|56|||
17154987|NCT01772472|38301450|FG001|Overall Study|Death|42|||
17154988|NCT01772472|38301449|FG000|Overall Study|Physician Decision|1|||
17154989|NCT01772472|38301450|FG001|Overall Study|Physician Decision|3|||
17154990|NCT01772472|38301449|FG000|Overall Study|Other|5|||
17154991|NCT01772472|38301450|FG001|Overall Study|Other|5|||
17154992|NCT01772472|38301449|FG000|Overall Study|Lost to Follow-up|12|||
17154993|NCT01772472|38301450|FG001|Overall Study|Lost to Follow-up|8|||
17154994|NCT01772472|38301449|FG000|Overall Study|Withdrawal by Subject|72|||
17154995|NCT01772472|38301450|FG001|Overall Study|Withdrawal by Subject|50|||
17154996|NCT01772472|38301449|FG000|Overall Study|Ongoing|597|||
17154997|NCT01772472|38301450|FG001|Overall Study|Ongoing|635|||
17154998|NCT03018938|38301465|FG000|Overall Study|Death|0|||
17154999|NCT03018938|38301466|FG001|Overall Study|Death|1|||
17155000|NCT03018938|38301465|FG000|Overall Study|Lost to Follow-up|21|||
17155001|NCT03018938|38301466|FG001|Overall Study|Lost to Follow-up|32|||
17155002|NCT03018938|38301465|FG000|Overall Study|Withdrawal by Subject|38|||
17155003|NCT03018938|38301466|FG001|Overall Study|Withdrawal by Subject|45|||
17155004|NCT03018938|38301465|FG000|Overall Study|Physician Decision|3|||
17155005|NCT03018938|38301466|FG001|Overall Study|Physician Decision|2|||
17155006|NCT03018938|38301465|FG000|Overall Study|Sponsor Decision|0|||
17155007|NCT03018938|38301466|FG001|Overall Study|Sponsor Decision|1|||
17155008|NCT03018938|38301465|FG000|Overall Study|Screen failure-After randomization|4|||
17155009|NCT03018938|38301466|FG001|Overall Study|Screen failure-After randomization|2|||
17155010|NCT03018938|38301465|FG000|Overall Study|Not recorded|0|||
17155011|NCT03018938|38301466|FG001|Overall Study|Not recorded|2|||
17155012|NCT02943577|38301474|FG000|Overall Study|Protocol Violation|0|||
17155013|NCT02943577|38301475|FG001|Overall Study|Protocol Violation|1|||
17155014|NCT02943577|38301474|FG000|Overall Study|Adverse Event|3|||
17155015|NCT02943577|38301475|FG001|Overall Study|Adverse Event|2|||
17155016|NCT02943577|38301474|FG000|Overall Study|Lost to Follow-up|0|||
17155017|NCT02943577|38301475|FG001|Overall Study|Lost to Follow-up|1|||
17155018|NCT02943577|38301474|FG000|Overall Study|Withdrawal by Subject|1|||
17155019|NCT02943577|38301475|FG001|Overall Study|Withdrawal by Subject|1|||
17155020|NCT02943577|38301474|FG000|Overall Study|Pregnancy|1|||
17155021|NCT02943577|38301475|FG001|Overall Study|Pregnancy|0|||
17155022|NCT03016598|38301483|FG000|Overall Study|Lost to Follow-up|0|||
17155023|NCT03016598|38301484|FG001|Overall Study|Lost to Follow-up|2|||
17155024|NCT03017846|38301490|FG000|Overall Study|Lost to Follow-up|3|||
17155025|NCT03017846|38301490|FG000|Overall Study|Adverse Event|2|||
17155026|NCT03014180|38301496|FG000|Overall Study|Protocol Violation|2|||
17155027|NCT03011840|38301506|FG000|Overall Study|Not received PIL in post PIL phase|0|||
17155028|NCT03011840|38301507|FG001|Overall Study|Not received PIL in post PIL phase|21|||
17155029|NCT02942485|38301515|FG000|Overall Study|Lost to Follow-up|1|||
17155030|NCT02942485|38301516|FG001|Overall Study|Lost to Follow-up|0|||
17155031|NCT02942407|38301524|FG000|Overall Study|Lost to Follow-up|3|||
17155032|NCT02942407|38301525|FG001|Overall Study|Lost to Follow-up|2|||
17155033|NCT02942407|38301524|FG000|Overall Study|Withdrawal by Subject|7|||
17155034|NCT02942407|38301525|FG001|Overall Study|Withdrawal by Subject|9|||
17155035|NCT02942407|38301524|FG000|Overall Study|Death|16|||
17155036|NCT02942407|38301525|FG001|Overall Study|Death|13|||
17155037|NCT03009344|38301539|FG000|Overall Study|Lack of Efficacy|5|||
17155038|NCT03009344|38301539|FG000|Overall Study|Withdrawal by Subject|1|||
17155039|NCT03009344|38301539|FG000|Overall Study|Adverse Event|1|||
17155040|NCT03322423|38301543|FG000|Period 1|Subject no longer eligible|0|||
17155041|NCT03322423|38301544|FG001|Period 1|Subject no longer eligible|1|||
17155042|NCT03322423|38301543|FG000|Period 1|Withdrawal by Subject|0|||
17155043|NCT03322423|38301544|FG001|Period 1|Withdrawal by Subject|1|||
17155044|NCT03322423|38301543|FG000|Period 1|Incorrect Lens Dispensed|1|||
17155045|NCT03322423|38301544|FG001|Period 1|Incorrect Lens Dispensed|0|||
17155046|NCT03322423|38301543|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
17155047|NCT03322423|38301544|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
17155048|NCT03322423|38301543|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
17155049|NCT03322423|38301544|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
17155050|NCT03322423|38301543|FG000|Period 2|Protocol Violation|1|||
17155051|NCT03322423|38301544|FG001|Period 2|Protocol Violation|0|||
17155052|NCT03322423|38301543|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
17155053|NCT03322423|38301544|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
17155054|NCT03007472|38301550|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
17155055|NCT03007472|38301550|FG000|Overall Study|Death|2|||
17155056|NCT03007472|38301550|FG000|Overall Study|Loss to Follow Up|1|||
17155057|NCT03321721|38301557|FG000|Overall Study|Lost to Follow-up|4|||
17155058|NCT03321721|38301558|FG001|Overall Study|Lost to Follow-up|8|||
17155059|NCT03321721|38301559|FG002|Overall Study|Lost to Follow-up|11|||
17155060|NCT03015116|38301571|FG000|Overall Study|Lost to Follow-up|3|||
17155061|NCT03015116|38301572|FG001|Overall Study|Lost to Follow-up|0|||
17155062|NCT03015116|38301573|FG002|Overall Study|Lost to Follow-up|2|||
17155063|NCT03015116|38301571|FG000|Overall Study|Withdrawal by Subject|3|||
17155064|NCT03015116|38301572|FG001|Overall Study|Withdrawal by Subject|1|||
17155065|NCT03015116|38301573|FG002|Overall Study|Withdrawal by Subject|0|||
17155066|NCT03015116|38301571|FG000|Overall Study|Subject has New Medical Status|1|||
17155067|NCT03015116|38301572|FG001|Overall Study|Subject has New Medical Status|0|||
17155068|NCT03015116|38301573|FG002|Overall Study|Subject has New Medical Status|0|||
17155069|NCT03015116|38301571|FG000|Overall Study|Physician Decision|0|||
17155070|NCT03015116|38301572|FG001|Overall Study|Physician Decision|1|||
17155071|NCT03015116|38301573|FG002|Overall Study|Physician Decision|0|||
17155072|NCT03006848|38301583|FG000|Overall Study|Adverse Event|1|||
17155073|NCT03006848|38301583|FG000|Overall Study|Physician Decision|1|||
17155074|NCT03006848|38301583|FG000|Overall Study|Lack of Efficacy|16|||
17155075|NCT03006458|38301594|FG000|First Intervention|Unsatisfied Vision|0|||
17155076|NCT03006458|38301595|FG001|First Intervention|Unsatisfied Vision|3|||
17155077|NCT03320941|38301606|FG000|Overall Study|subject/guardian decision|0|||
17155078|NCT03320941|38301607|FG001|Overall Study|subject/guardian decision|0|||
17155079|NCT03320941|38301608|FG002|Overall Study|subject/guardian decision|0|||
17155080|NCT03320941|38301609|FG003|Overall Study|subject/guardian decision|1|||
17155081|NCT03320941|38301610|FG004|Overall Study|subject/guardian decision|0|||
17155082|NCT03005288|38301624|FG000|Overall Study|Withdrawal by Subject|7|||
17155083|NCT03005288|38301625|FG001|Overall Study|Withdrawal by Subject|5|||
17155084|NCT03005288|38301624|FG000|Overall Study|Lost to Follow-up|0|||
17155085|NCT03005288|38301625|FG001|Overall Study|Lost to Follow-up|1|||
17155086|NCT03005288|38301624|FG000|Overall Study|Adverse Event|5|||
17155087|NCT03005288|38301625|FG001|Overall Study|Adverse Event|0|||
17155088|NCT03005288|38301624|FG000|Overall Study|Protocol deviation|0|||
17155089|NCT03005288|38301625|FG001|Overall Study|Protocol deviation|1|||
17155090|NCT03005288|38301624|FG000|Overall Study|Physician Decision|0|||
17155091|NCT03005288|38301625|FG001|Overall Study|Physician Decision|1|||
17155092|NCT03003494|38301631|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
17155093|NCT03559699|38301635|FG000|Overall Study|Withdrawal by Subject|6|||
17155094|NCT03559699|38301635|FG000|Overall Study|Lost to Follow-up|1|||
17155095|NCT03085758|38301642|FG000|Overall Study|Death|26|||
17155096|NCT03085758|38301643|FG001|Overall Study|Death|24|||
17155097|NCT03085758|38301644|FG002|Overall Study|Death|53|||
17155098|NCT03085758|38301642|FG000|Overall Study|Lost to Follow-up|1|||
17155099|NCT03085758|38301643|FG001|Overall Study|Lost to Follow-up|1|||
17155100|NCT03085758|38301644|FG002|Overall Study|Lost to Follow-up|1|||
17155101|NCT03085758|38301642|FG000|Overall Study|Withdrawal by Subject|2|||
17155102|NCT03085758|38301643|FG001|Overall Study|Withdrawal by Subject|2|||
17155103|NCT03085758|38301644|FG002|Overall Study|Withdrawal by Subject|1|||
17155104|NCT03085758|38301642|FG000|Overall Study|Refusal to recall it up to day 90|0|||
17155105|NCT03085758|38301643|FG001|Overall Study|Refusal to recall it up to day 90|0|||
17155106|NCT03085758|38301644|FG002|Overall Study|Refusal to recall it up to day 90|1|||
17155107|NCT03085758|38301642|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
17155108|NCT03085758|38301643|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
17155109|NCT03085758|38301644|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
17155110|NCT03935880|38301668|FG000|Overall Study|Lost to Follow-up|0|||
17155111|NCT03935880|38301669|FG001|Overall Study|Lost to Follow-up|1|||
17155112|NCT03315793|38301677|FG000|Overall Study|Adverse Event|4|||
17155113|NCT03315793|38301678|FG001|Overall Study|Adverse Event|2|||
17155114|NCT03315793|38301677|FG000|Overall Study|Protocol Deviation|1|||
17155115|NCT03315793|38301678|FG001|Overall Study|Protocol Deviation|0|||
17155116|NCT03315793|38301677|FG000|Overall Study|Difficult for regular visit|0|||
17155117|NCT03315793|38301678|FG001|Overall Study|Difficult for regular visit|1|||
17155118|NCT02676466|38301694|FG000|Overall Study|Death|0|||
17155119|NCT02676466|38301695|FG001|Overall Study|Death|2|||
17155120|NCT02676466|38301696|FG002|Overall Study|Death|1|||
17155121|NCT02676466|38301697|FG003|Overall Study|Death|0|||
17155122|NCT02676466|38301698|FG004|Overall Study|Death|0|||
17155123|NCT02676466|38301699|FG005|Overall Study|Death|0|||
17155124|NCT02676466|38301700|FG006|Overall Study|Death|0|||
17155125|NCT02676466|38301701|FG007|Overall Study|Death|0|||
17155126|NCT02676466|38301694|FG000|Overall Study|Withdrawal by Subject|4|||
17155127|NCT02676466|38301695|FG001|Overall Study|Withdrawal by Subject|3|||
17155128|NCT02676466|38301696|FG002|Overall Study|Withdrawal by Subject|1|||
17155129|NCT02676466|38301697|FG003|Overall Study|Withdrawal by Subject|0|||
17155130|NCT02676466|38301698|FG004|Overall Study|Withdrawal by Subject|3|||
17155131|NCT02676466|38301699|FG005|Overall Study|Withdrawal by Subject|1|||
17155132|NCT02676466|38301700|FG006|Overall Study|Withdrawal by Subject|1|||
17155133|NCT02676466|38301701|FG007|Overall Study|Withdrawal by Subject|1|||
17155134|NCT03314857|38301723|FG000|Overall Study|Death|4|||
17155135|NCT03314857|38301723|FG000|Overall Study|Physician Decision|1|||
17155136|NCT03633695|38301729|FG000|Overall Study|Lost to Follow-up|4|||
17155137|NCT03633695|38301730|FG001|Overall Study|Lost to Follow-up|5|||
17155138|NCT03633695|38301729|FG000|Overall Study|Discontinued|8|||
17155139|NCT03633695|38301730|FG001|Overall Study|Discontinued|4|||
17155140|NCT03314233|38301752|FG000|Overall Study|No longer eligible at time of delivery|1|||
17155141|NCT02675998|38301760|FG000|8-Week Treatment Period|Adverse Event|6|||
17155142|NCT02675998|38301761|FG001|8-Week Treatment Period|Adverse Event|5|||
17155143|NCT02675998|38301762|FG002|8-Week Treatment Period|Adverse Event|6|||
17155144|NCT02675998|38301763|FG003|8-Week Treatment Period|Adverse Event|0|||
17155145|NCT02675998|38301760|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
17155146|NCT02675998|38301761|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
17155147|NCT02675998|38301762|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
17155148|NCT02675998|38301763|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
17155149|NCT02675998|38301760|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
17155150|NCT02675998|38301761|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
17155151|NCT02675998|38301762|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
17155152|NCT02675998|38301763|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
17155153|NCT02675998|38301760|FG000|8-Week Treatment Period|Physician Decision|1|||
17155154|NCT02675998|38301761|FG001|8-Week Treatment Period|Physician Decision|0|||
17155155|NCT02675998|38301762|FG002|8-Week Treatment Period|Physician Decision|2|||
17155156|NCT02675998|38301763|FG003|8-Week Treatment Period|Physician Decision|0|||
17155157|NCT02675998|38301760|FG000|8-Week Treatment Period|GI side Effects|1|||
17155158|NCT02675998|38301761|FG001|8-Week Treatment Period|GI side Effects|4|||
17155159|NCT02675998|38301762|FG002|8-Week Treatment Period|GI side Effects|2|||
17155160|NCT02675998|38301763|FG003|8-Week Treatment Period|GI side Effects|0|||
17155161|NCT02675998|38301760|FG000|8-Week Treatment Period|Protocol Violation|1|||
17155162|NCT02675998|38301761|FG001|8-Week Treatment Period|Protocol Violation|1|||
17155163|NCT02675998|38301762|FG002|8-Week Treatment Period|Protocol Violation|1|||
17155164|NCT02675998|38301763|FG003|8-Week Treatment Period|Protocol Violation|0|||
17155165|NCT02675998|38301760|FG000|8-Week Treatment Period|Other|3|||
17155166|NCT02675998|38301761|FG001|8-Week Treatment Period|Other|1|||
17155167|NCT02675998|38301762|FG002|8-Week Treatment Period|Other|2|||
17155168|NCT02675998|38301763|FG003|8-Week Treatment Period|Other|0|||
17155169|NCT02675998|38301760|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
17155170|NCT02675998|38301761|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
17155171|NCT02675998|38301762|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
17155172|NCT02675998|38301763|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
17155173|NCT02675998|38301760|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
17155174|NCT02675998|38301761|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
17155175|NCT02675998|38301762|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
17155176|NCT02675998|38301763|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
17155177|NCT02675998|38301760|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
17155178|NCT02675998|38301761|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
17155179|NCT02675998|38301762|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
17155180|NCT02675998|38301763|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
17155181|NCT02675998|38301760|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
17155182|NCT02675998|38301761|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
17155183|NCT02675998|38301762|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
17155184|NCT02675998|38301763|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
17155185|NCT02675998|38301760|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
17155186|NCT02675998|38301761|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
17155187|NCT02675998|38301762|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
17155188|NCT02675998|38301763|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
17155189|NCT02674204|38301779|FG000|Overall Study|Adverse Event|1|||
17155190|NCT02674204|38301780|FG001|Overall Study|Adverse Event|0|||
17155191|NCT03291067|38301790|FG000|Overall Study|Adverse Event|0|||
17155192|NCT03291067|38301791|FG001|Overall Study|Adverse Event|2|||
17155193|NCT03291067|38301792|FG002|Overall Study|Adverse Event|17|||
17155194|NCT03291067|38301793|FG003|Overall Study|Adverse Event|3|||
17155195|NCT03291067|38301790|FG000|Overall Study|Lost to Follow-up|2|||
17155196|NCT03291067|38301791|FG001|Overall Study|Lost to Follow-up|1|||
17155197|NCT03291067|38301792|FG002|Overall Study|Lost to Follow-up|0|||
17155198|NCT03291067|38301793|FG003|Overall Study|Lost to Follow-up|1|||
17155199|NCT03291067|38301790|FG000|Overall Study|Physician Decision|0|||
17155200|NCT03291067|38301791|FG001|Overall Study|Physician Decision|0|||
17155201|NCT03291067|38301792|FG002|Overall Study|Physician Decision|1|||
17155202|NCT03291067|38301793|FG003|Overall Study|Physician Decision|0|||
17155203|NCT03291067|38301790|FG000|Overall Study|Protocol Violation|5|||
17155204|NCT03291067|38301791|FG001|Overall Study|Protocol Violation|3|||
17155205|NCT03291067|38301792|FG002|Overall Study|Protocol Violation|4|||
17155206|NCT03291067|38301793|FG003|Overall Study|Protocol Violation|2|||
17155207|NCT03291067|38301790|FG000|Overall Study|Withdrawal by Subject|3|||
17155208|NCT03291067|38301791|FG001|Overall Study|Withdrawal by Subject|4|||
17155209|NCT03291067|38301792|FG002|Overall Study|Withdrawal by Subject|7|||
17155210|NCT03291067|38301793|FG003|Overall Study|Withdrawal by Subject|5|||
17155211|NCT03291067|38301790|FG000|Overall Study|Other|0|||
17155212|NCT03291067|38301791|FG001|Overall Study|Other|4|||
17155213|NCT03291067|38301792|FG002|Overall Study|Other|4|||
17155214|NCT03291067|38301793|FG003|Overall Study|Other|6|||
17155215|NCT02941627|38301803|FG000|Overall Study|Death|1|||
17155216|NCT02941627|38301803|FG000|Overall Study|Surgical failure|1|||
17155217|NCT02941627|38301803|FG000|Overall Study|cholesteatoma prevented implantation|1|||
17155218|NCT03521934|38301815|FG000|Overall Study|Death|65|||
17155219|NCT03521934|38301816|FG001|Overall Study|Death|73|||
17155220|NCT03521934|38301815|FG000|Overall Study|Withdrawal by Subject|18|||
17155221|NCT03521934|38301816|FG001|Overall Study|Withdrawal by Subject|23|||
17155222|NCT03521934|38301815|FG000|Overall Study|Site Terminated by Sponsor|39|||
17155223|NCT03521934|38301816|FG001|Overall Study|Site Terminated by Sponsor|35|||
17155224|NCT03521934|38301815|FG000|Overall Study|Study Terminated by Sponsor|483|||
17155225|NCT03521934|38301816|FG001|Overall Study|Study Terminated by Sponsor|477|||
17155226|NCT03521934|38301815|FG000|Overall Study|Reason not Specified|3|||
17155227|NCT03521934|38301816|FG001|Overall Study|Reason not Specified|6|||
17155228|NCT03434353|38301827|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
17155229|NCT03434353|38301828|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
17155230|NCT03434353|38301829|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
17155231|NCT03434353|38301830|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
17155232|NCT03434353|38301831|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
17155233|NCT03434353|38301827|FG000|Overall Study|Withdrew consent|1|||
17155234|NCT03434353|38301828|FG001|Overall Study|Withdrew consent|0|||
17155235|NCT03434353|38301829|FG002|Overall Study|Withdrew consent|3|||
17155236|NCT03434353|38301830|FG003|Overall Study|Withdrew consent|0|||
17155237|NCT03434353|38301831|FG004|Overall Study|Withdrew consent|0|||
17155238|NCT03434353|38301827|FG000|Overall Study|Adverse Event|1|||
17155239|NCT03434353|38301828|FG001|Overall Study|Adverse Event|0|||
17155240|NCT03434353|38301829|FG002|Overall Study|Adverse Event|0|||
17155241|NCT03434353|38301830|FG003|Overall Study|Adverse Event|0|||
17155242|NCT03434353|38301831|FG004|Overall Study|Adverse Event|1|||
17155243|NCT03434353|38301827|FG000|Overall Study|Lost to Follow-up|2|||
17155244|NCT03434353|38301828|FG001|Overall Study|Lost to Follow-up|0|||
17155245|NCT03434353|38301829|FG002|Overall Study|Lost to Follow-up|0|||
17155246|NCT03434353|38301830|FG003|Overall Study|Lost to Follow-up|0|||
17155247|NCT03434353|38301831|FG004|Overall Study|Lost to Follow-up|0|||
17155248|NCT02914184|38301847|FG000|Overall Study|Lost to Follow-up|7|||
17155249|NCT02914184|38301848|FG001|Overall Study|Lost to Follow-up|10|||
16994269|NCT00773734|38138075|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
17155250|NCT02914184|38301849|FG002|Overall Study|Lost to Follow-up|8|||
17155251|NCT02914184|38301850|FG003|Overall Study|Lost to Follow-up|7|||
17155252|NCT02914184|38301847|FG000|Overall Study|Withdrawal by Subject|4|||
17155253|NCT02914184|38301848|FG001|Overall Study|Withdrawal by Subject|2|||
17155254|NCT02914184|38301849|FG002|Overall Study|Withdrawal by Subject|7|||
17155255|NCT02914184|38301850|FG003|Overall Study|Withdrawal by Subject|3|||
17155256|NCT02914184|38301847|FG000|Overall Study|Other|1|||
17155257|NCT02914184|38301848|FG001|Overall Study|Other|0|||
17155258|NCT02914184|38301849|FG002|Overall Study|Other|0|||
17155259|NCT02914184|38301850|FG003|Overall Study|Other|0|||
17155260|NCT02914184|38301847|FG000|Overall Study|Migrated/moved from the study area|2|||
17155261|NCT02914184|38301848|FG001|Overall Study|Migrated/moved from the study area|1|||
17155262|NCT02914184|38301849|FG002|Overall Study|Migrated/moved from the study area|2|||
17155263|NCT02914184|38301850|FG003|Overall Study|Migrated/moved from the study area|1|||
17155264|NCT03633227|38301864|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
17155265|NCT03633227|38301865|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
17155266|NCT03633227|38301864|FG000|Double Blind (DB), up to Week 48|Death|2|||
17155267|NCT03633227|38301865|FG001|Double Blind (DB), up to Week 48|Death|1|||
17155268|NCT03633227|38301864|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
17155269|NCT03633227|38301865|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
17155270|NCT03633227|38301864|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
17155271|NCT03633227|38301865|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
17155272|NCT03633227|38301864|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
17155273|NCT03633227|38301865|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
17155274|NCT03633227|38301864|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
17155275|NCT03633227|38301865|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
17155276|NCT03633227|38301864|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
17155277|NCT03633227|38301865|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
17155278|NCT03633227|38301864|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
17155279|NCT03633227|38301865|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
17155280|NCT03633227|38301864|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
17155281|NCT03633227|38301865|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
17155282|NCT03633227|38301864|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
17155283|NCT03633227|38301865|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
17155284|NCT03633227|38301864|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
17155285|NCT03633227|38301865|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
17155286|NCT03633227|38301864|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
17155287|NCT03633227|38301865|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
17155288|NCT02913326|38301878|FG000|Overall Study|Reason not listed|0|||
17155289|NCT02913326|38301879|FG001|Overall Study|Reason not listed|1|||
17155290|NCT02913326|38301878|FG000|Overall Study|Lost to Follow-up|0|||
17155291|NCT02913326|38301879|FG001|Overall Study|Lost to Follow-up|1|||
17155292|NCT02913326|38301878|FG000|Overall Study|Adverse Event|1|||
17155293|NCT02913326|38301879|FG001|Overall Study|Adverse Event|0|||
17155294|NCT02912468|38301887|FG000|Overall Study|Adverse Event|3|||
17155295|NCT02912468|38301888|FG001|Overall Study|Adverse Event|2|||
17155296|NCT02912468|38301887|FG000|Overall Study|Withdrawal by Subject|6|||
17155297|NCT02912468|38301888|FG001|Overall Study|Withdrawal by Subject|2|||
17155298|NCT02912468|38301887|FG000|Overall Study|Randomized and not treated|0|||
17155299|NCT02912468|38301888|FG001|Overall Study|Randomized and not treated|1|||
17155300|NCT04438499|38301895|FG000|Overall Study|Lack of Efficacy|2|||
17155301|NCT00002874|38301901|FG000|Overall Study|Withdrawal by Subject|1|||
17155302|NCT00002874|38301902|FG001|Overall Study|Withdrawal by Subject|1|||
17155303|NCT00002874|38301901|FG000|Overall Study|Protocol Violation|44|||
17155304|NCT00002874|38301902|FG001|Overall Study|Protocol Violation|34|||
17155305|NCT03001076|38301910|FG000|Overall Study|Withdrawal by patient|2|||
17155306|NCT03001076|38301911|FG001|Overall Study|Withdrawal by patient|0|||
17155307|NCT03001076|38301910|FG000|Overall Study|Other|1|||
17155308|NCT03001076|38301911|FG001|Overall Study|Other|0|||
17155309|NCT03001076|38301910|FG000|Overall Study|Adverse Event|3|||
17155310|NCT03001076|38301911|FG001|Overall Study|Adverse Event|3|||
17155311|NCT03001076|38301910|FG000|Overall Study|Sponsor decision|1|||
17155312|NCT03001076|38301911|FG001|Overall Study|Sponsor decision|0|||
17155313|NCT03001076|38301910|FG000|Overall Study|Lost to Follow-up|0|||
17155314|NCT03001076|38301911|FG001|Overall Study|Lost to Follow-up|2|||
17155315|NCT03555305|38301917|FG000|Period 1|Physician Decision|0|||
17155316|NCT03555305|38301918|FG001|Period 1|Physician Decision|1|||
17155317|NCT03555305|38301917|FG000|Period 1|Adverse Event|0|||
17155318|NCT03555305|38301918|FG001|Period 1|Adverse Event|1|||
17155319|NCT03553823|38301926|FG000|Overall Study|Physician Decision|0|||
17155320|NCT03553823|38301927|FG001|Overall Study|Physician Decision|1|||
17155321|NCT03000686|38301935|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
17155322|NCT03000686|38301936|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
17155323|NCT03000686|38301937|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
17155324|NCT03000686|38301938|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
17155325|NCT02493660|38301956|FG000|Overall Study|Physician Decision|0|||
17155326|NCT02493660|38301957|FG001|Overall Study|Physician Decision|1|||
17155327|NCT02493660|38301956|FG000|Overall Study|Adverse Event|4|||
17155328|NCT02493660|38301957|FG001|Overall Study|Adverse Event|2|||
17155329|NCT02493660|38301956|FG000|Overall Study|Withdrawal by Subject|2|||
17155330|NCT02493660|38301957|FG001|Overall Study|Withdrawal by Subject|3|||
17155331|NCT02493660|38301956|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
17155332|NCT02493660|38301957|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
17155333|NCT02493660|38301956|FG000|Overall Study|Protocol Violation|0|||
17155334|NCT02493660|38301957|FG001|Overall Study|Protocol Violation|1|||
17155335|NCT02493660|38301956|FG000|Overall Study|Death|0|||
17155336|NCT02493660|38301957|FG001|Overall Study|Death|1|||
17155337|NCT02493660|38301956|FG000|Overall Study|Lost to Follow-up|2|||
17155338|NCT02493660|38301957|FG001|Overall Study|Lost to Follow-up|4|||
17155339|NCT03552029|38301967|FG000|Overall Study|Death|3|||
17155340|NCT03552029|38301968|FG001|Overall Study|Death|0|||
17155341|NCT03552029|38301967|FG000|Overall Study|Adverse Event|1|||
17155342|NCT03552029|38301968|FG001|Overall Study|Adverse Event|0|||
17155343|NCT03552029|38301967|FG000|Overall Study|Lack of Efficacy|0|||
17155344|NCT03552029|38301968|FG001|Overall Study|Lack of Efficacy|2|||
17155345|NCT03552029|38301967|FG000|Overall Study|Physician Decision|0|||
17155346|NCT03552029|38301968|FG001|Overall Study|Physician Decision|1|||
17155347|NCT03552029|38301967|FG000|Overall Study|Study terminated by Sponsor|0|||
17155348|NCT03552029|38301968|FG001|Overall Study|Study terminated by Sponsor|1|||
17155349|NCT03552029|38301967|FG000|Overall Study|Other|0|||
17155350|NCT03552029|38301968|FG001|Overall Study|Other|2|||
17155351|NCT03521141|38301977|FG000|Overall Study|Death|1|||
17155352|NCT03521141|38301978|FG001|Overall Study|Death|0|||
17155353|NCT03521141|38301979|FG002|Overall Study|Death|1|||
17155354|NCT02997176|38301991|FG000|Overall Study|Adverse Event|0|||
17155355|NCT02997176|38301992|FG001|Overall Study|Adverse Event|0|||
17155356|NCT02997176|38301993|FG002|Overall Study|Adverse Event|0|||
17155357|NCT02997176|38301994|FG003|Overall Study|Adverse Event|8|||
17155358|NCT02997176|38301991|FG000|Overall Study|Progressive Disease|1|||
17155359|NCT02997176|38301992|FG001|Overall Study|Progressive Disease|0|||
17155360|NCT02997176|38301993|FG002|Overall Study|Progressive Disease|1|||
17155361|NCT02997176|38301994|FG003|Overall Study|Progressive Disease|1|||
17155362|NCT02997176|38301991|FG000|Overall Study|Death|0|||
17155363|NCT02997176|38301992|FG001|Overall Study|Death|0|||
17155364|NCT02997176|38301993|FG002|Overall Study|Death|1|||
17155365|NCT02997176|38301994|FG003|Overall Study|Death|1|||
17155366|NCT02997176|38301991|FG000|Overall Study|Withdrawal by Subject|0|||
17155367|NCT02997176|38301992|FG001|Overall Study|Withdrawal by Subject|2|||
17155368|NCT02997176|38301993|FG002|Overall Study|Withdrawal by Subject|0|||
17155369|NCT02997176|38301994|FG003|Overall Study|Withdrawal by Subject|1|||
17155370|NCT03000452|38302004|FG000|Treatment Period|Death|1|||
17155371|NCT03000452|38302004|FG000|Treatment Period|Progressive Disease (PD)|14|||
17155372|NCT03000452|38302004|FG000|Treatment Period|Physician Decision|1|||
17155373|NCT03000452|38302004|FG000|Treatment Period|Miscellaneous|2|||
17155374|NCT03000452|38302004|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
17155375|NCT03000452|38302004|FG000|Follow-Up Period|Death|3|||
17155376|NCT03000452|38302004|FG000|Follow-Up Period|Withdrawal by Subject|3|||
17155377|NCT01373164|38302013|FG000|Overall Study|Lost to Follow-up|0|||
17155378|NCT01373164|38302014|FG001|Overall Study|Lost to Follow-up|0|||
17155379|NCT01373164|38302015|FG002|Overall Study|Lost to Follow-up|1|||
17155380|NCT01373164|38302016|FG003|Overall Study|Lost to Follow-up|2|||
17155381|NCT01373164|38302017|FG004|Overall Study|Lost to Follow-up|0|||
17155382|NCT01373164|38302013|FG000|Overall Study|Withdrawal by Subject|0|||
17155383|NCT01373164|38302014|FG001|Overall Study|Withdrawal by Subject|1|||
17155384|NCT01373164|38302015|FG002|Overall Study|Withdrawal by Subject|0|||
17155385|NCT01373164|38302016|FG003|Overall Study|Withdrawal by Subject|10|||
17155386|NCT01373164|38302017|FG004|Overall Study|Withdrawal by Subject|2|||
17155387|NCT02999984|38302032|FG000|Overall Study|Treatment Failure|1|||
17155388|NCT03550313|38302039|FG000|Overall Study|Adverse Event|0|||
17155389|NCT03550313|38302040|FG001|Overall Study|Adverse Event|1|||
17155390|NCT03550313|38302041|FG002|Overall Study|Adverse Event|0|||
17155391|NCT03550313|38302039|FG000|Overall Study|Lost to Follow-up|5|||
17155392|NCT03550313|38302040|FG001|Overall Study|Lost to Follow-up|7|||
17155393|NCT03550313|38302041|FG002|Overall Study|Lost to Follow-up|12|||
17155394|NCT03550313|38302039|FG000|Overall Study|Study terminated by sponsor|44|||
17155395|NCT03550313|38302040|FG001|Overall Study|Study terminated by sponsor|37|||
17155396|NCT03550313|38302041|FG002|Overall Study|Study terminated by sponsor|48|||
17155397|NCT03550313|38302039|FG000|Overall Study|No longer met eligibility criteria|3|||
17155398|NCT03550313|38302040|FG001|Overall Study|No longer met eligibility criteria|5|||
17155399|NCT03550313|38302041|FG002|Overall Study|No longer met eligibility criteria|6|||
17155400|NCT03550313|38302039|FG000|Overall Study|Withdrawal by parent/guardian|20|||
17155401|NCT03550313|38302040|FG001|Overall Study|Withdrawal by parent/guardian|18|||
17155402|NCT03550313|38302041|FG002|Overall Study|Withdrawal by parent/guardian|26|||
17155403|NCT03550313|38302039|FG000|Overall Study|Other|4|||
17155404|NCT03550313|38302040|FG001|Overall Study|Other|2|||
17155405|NCT03550313|38302041|FG002|Overall Study|Other|2|||
17155406|NCT03550313|38302039|FG000|Overall Study|Randomized but not vaccinated|3|||
17155407|NCT03550313|38302040|FG001|Overall Study|Randomized but not vaccinated|23|||
17155408|NCT03550313|38302041|FG002|Overall Study|Randomized but not vaccinated|2|||
17155409|NCT03550313|38302039|FG000|Overall Study|Sites terminated due to quality issues|18|||
17155410|NCT03550313|38302040|FG001|Overall Study|Sites terminated due to quality issues|17|||
17155411|NCT03550313|38302041|FG002|Overall Study|Sites terminated due to quality issues|18|||
17155412|NCT03312907|38302053|FG000|Overall Study|Adverse Event|1|||
17155413|NCT03312907|38302054|FG001|Overall Study|Adverse Event|6|||
17155414|NCT03312907|38302055|FG002|Overall Study|Adverse Event|1|||
17155415|NCT03312907|38302053|FG000|Overall Study|Protocol Violation|2|||
17155416|NCT03312907|38302054|FG001|Overall Study|Protocol Violation|3|||
17155417|NCT03312907|38302055|FG002|Overall Study|Protocol Violation|4|||
17155418|NCT03312907|38302053|FG000|Overall Study|Lost to Follow-up|2|||
17155419|NCT03312907|38302054|FG001|Overall Study|Lost to Follow-up|3|||
17155420|NCT03312907|38302055|FG002|Overall Study|Lost to Follow-up|2|||
17155421|NCT03312907|38302053|FG000|Overall Study|Physician Decision|3|||
17155422|NCT03312907|38302054|FG001|Overall Study|Physician Decision|4|||
17155423|NCT03312907|38302055|FG002|Overall Study|Physician Decision|2|||
17155424|NCT03312907|38302053|FG000|Overall Study|Withdrawal by Subject|9|||
17155425|NCT03312907|38302054|FG001|Overall Study|Withdrawal by Subject|14|||
17155426|NCT03312907|38302055|FG002|Overall Study|Withdrawal by Subject|10|||
17155427|NCT02999672|38302065|FG000|Overall Study|Death|0|||
17155428|NCT02999672|38302066|FG001|Overall Study|Death|1|||
17155429|NCT02999672|38302065|FG000|Overall Study|Study Terminated by Sponsor|0|||
17155430|NCT02999672|38302066|FG001|Overall Study|Study Terminated by Sponsor|1|||
17155431|NCT02999672|38302065|FG000|Overall Study|Progressive Disease|9|||
17155432|NCT02999672|38302066|FG001|Overall Study|Progressive Disease|5|||
17155433|NCT02999672|38302065|FG000|Overall Study|Adverse Event|4|||
17155434|NCT02999672|38302066|FG001|Overall Study|Adverse Event|0|||
17155435|NCT01911676|38302076|FG000|Period 1 of Study|Withdrawal by Subject|4|||
17155436|NCT01911676|38302077|FG001|Period 1 of Study|Withdrawal by Subject|2|||
17155437|NCT01911676|38302078|FG002|Period 1 of Study|Withdrawal by Subject|1|||
17155438|NCT01911676|38302079|FG003|Period 1 of Study|Withdrawal by Subject|2|||
17155439|NCT01911676|38302076|FG000|Period 1 of Study|Physician Decision|2|||
17155440|NCT01911676|38302077|FG001|Period 1 of Study|Physician Decision|0|||
17155441|NCT01911676|38302078|FG002|Period 1 of Study|Physician Decision|0|||
17155442|NCT01911676|38302079|FG003|Period 1 of Study|Physician Decision|1|||
17155443|NCT01911676|38302076|FG000|Period 2 of Study|Physician Decision|2|||
17155444|NCT01911676|38302077|FG001|Period 2 of Study|Physician Decision|0|||
17155445|NCT01911676|38302078|FG002|Period 2 of Study|Physician Decision|0|||
17155446|NCT01911676|38302079|FG003|Period 2 of Study|Physician Decision|1|||
17155447|NCT01911676|38302076|FG000|Period 2 of Study|Lost to Follow-up|0|||
17155448|NCT01911676|38302077|FG001|Period 2 of Study|Lost to Follow-up|0|||
17155449|NCT01911676|38302078|FG002|Period 2 of Study|Lost to Follow-up|0|||
17155450|NCT01911676|38302079|FG003|Period 2 of Study|Lost to Follow-up|1|||
17155451|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
17155452|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
17155453|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
17155454|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
17155455|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
17155456|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
17155457|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
17155458|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
17155459|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
17155460|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
17155461|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
17155462|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
17155463|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
17155464|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
17155465|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
17155466|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
17155467|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
17155468|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
17155469|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
17155470|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
17155471|NCT03573323|38302096|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
17155472|NCT03573323|38302097|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
17155473|NCT03573323|38302096|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
17155474|NCT03573323|38302097|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
17155475|NCT03573323|38302096|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
17155476|NCT03573323|38302097|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
17155477|NCT03573323|38302096|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
17155478|NCT03573323|38302097|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
17155479|NCT03573323|38302096|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
17155480|NCT03573323|38302097|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
17155481|NCT03573323|38302096|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
17155482|NCT03573323|38302097|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
17155483|NCT03573323|38302096|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
17155484|NCT03573323|38302097|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
17155485|NCT03573323|38302096|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
17155486|NCT03573323|38302097|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
17155487|NCT03573323|38302096|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
17155488|NCT03573323|38302097|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
17155489|NCT03306043|38302123|FG000|Overall Study|Adverse Event|1|||
17155490|NCT03306043|38302123|FG000|Overall Study|Lost to Follow-up|1|||
17155491|NCT03306043|38302123|FG000|Overall Study|Withdrawal by Subject|2|||
17155492|NCT01069172|38302127|FG000|Overall Study|Withdrawal by Subject|1|||
17155493|NCT01069172|38302128|FG001|Overall Study|Withdrawal by Subject|0|||
17155494|NCT02911688|38302137|FG000|Washout|Lost to Follow-up|1|||
17155495|NCT02911688|38302138|FG001|Washout|Lost to Follow-up|1|||
17155496|NCT02911688|38302137|FG000|Washout|Withdrawal by Subject|0|||
17155497|NCT02911688|38302138|FG001|Washout|Withdrawal by Subject|1|||
17155498|NCT02670928|38302148|FG000|Overall Study|Adverse Event|3|||
17155499|NCT02670928|38302149|FG001|Overall Study|Adverse Event|1|||
17155500|NCT02670928|38302148|FG000|Overall Study|Withdrawal by Subject|4|||
17155501|NCT02670928|38302149|FG001|Overall Study|Withdrawal by Subject|0|||
17155502|NCT02670928|38302148|FG000|Overall Study|Lost to Follow-up|1|||
17155503|NCT02670928|38302149|FG001|Overall Study|Lost to Follow-up|0|||
17155504|NCT02670928|38302148|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
17155505|NCT02670928|38302149|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
17155506|NCT03572933|38302157|FG000|Overall Study|Adverse Event|4|||
17155507|NCT03572933|38302158|FG001|Overall Study|Adverse Event|1|||
17155508|NCT03572933|38302157|FG000|Overall Study|Withdrawal by Subject|0|||
17155509|NCT03572933|38302158|FG001|Overall Study|Withdrawal by Subject|1|||
17155510|NCT03305809|38302168|FG000|Overall Study|Adverse Event|2|||
17155511|NCT03305809|38302169|FG001|Overall Study|Adverse Event|2|||
17155512|NCT03305809|38302170|FG002|Overall Study|Adverse Event|6|||
17155513|NCT03305809|38302171|FG003|Overall Study|Adverse Event|6|||
17155514|NCT03305809|38302168|FG000|Overall Study|Death|0|||
17155515|NCT03305809|38302169|FG001|Overall Study|Death|0|||
17155516|NCT03305809|38302170|FG002|Overall Study|Death|1|||
17155517|NCT03305809|38302171|FG003|Overall Study|Death|1|||
17155518|NCT03305809|38302168|FG000|Overall Study|Lost to Follow-up|1|||
17155519|NCT03305809|38302169|FG001|Overall Study|Lost to Follow-up|2|||
17155520|NCT03305809|38302170|FG002|Overall Study|Lost to Follow-up|0|||
17155521|NCT03305809|38302171|FG003|Overall Study|Lost to Follow-up|0|||
17155522|NCT03305809|38302168|FG000|Overall Study|Sponsor Decision|1|||
17155523|NCT03305809|38302169|FG001|Overall Study|Sponsor Decision|0|||
17155524|NCT03305809|38302170|FG002|Overall Study|Sponsor Decision|1|||
17155525|NCT03305809|38302171|FG003|Overall Study|Sponsor Decision|8|||
17155526|NCT03305809|38302168|FG000|Overall Study|Physician Decision|0|||
17155527|NCT03305809|38302169|FG001|Overall Study|Physician Decision|0|||
17155528|NCT03305809|38302170|FG002|Overall Study|Physician Decision|2|||
17155529|NCT03305809|38302171|FG003|Overall Study|Physician Decision|4|||
17155530|NCT03305809|38302168|FG000|Overall Study|Progressive Disease|0|||
17155531|NCT03305809|38302169|FG001|Overall Study|Progressive Disease|0|||
17155532|NCT03305809|38302170|FG002|Overall Study|Progressive Disease|1|||
17155533|NCT03305809|38302171|FG003|Overall Study|Progressive Disease|0|||
17155534|NCT03305809|38302168|FG000|Overall Study|Protocol Violation|1|||
17155535|NCT03305809|38302169|FG001|Overall Study|Protocol Violation|0|||
17155536|NCT03305809|38302170|FG002|Overall Study|Protocol Violation|2|||
17155537|NCT03305809|38302171|FG003|Overall Study|Protocol Violation|3|||
17155538|NCT03305809|38302168|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
17155539|NCT03305809|38302169|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
17155540|NCT03305809|38302170|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
17155541|NCT03305809|38302171|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
17155542|NCT03305809|38302168|FG000|Overall Study|Withdrawal by Subject|2|||
17155543|NCT03305809|38302169|FG001|Overall Study|Withdrawal by Subject|4|||
17155544|NCT03305809|38302170|FG002|Overall Study|Withdrawal by Subject|5|||
17155545|NCT03305809|38302171|FG003|Overall Study|Withdrawal by Subject|2|||
17155546|NCT03305809|38302168|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
17155547|NCT03305809|38302169|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
17155548|NCT03305809|38302170|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
17155549|NCT03305809|38302171|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
17155550|NCT02994056|38302184|FG000|Overall Study|Death|8|||
17155551|NCT02994056|38302184|FG000|Overall Study|Withdrew Consent|1|||
17155552|NCT03548051|38302203|FG000|Overall Study|Death|1|||
17155553|NCT03548051|38302204|FG001|Overall Study|Death|1|||
17155554|NCT03548051|38302203|FG000|Overall Study|Withdrawal by Subject|1|||
17155555|NCT03548051|38302204|FG001|Overall Study|Withdrawal by Subject|0|||
17155556|NCT03305731|38302210|FG000|Overall Study|Protocol Violation|1|||
17155557|NCT03305575|38302216|FG000|Overall Study|Physician Decision|1|||
17155558|NCT03305575|38302217|FG001|Overall Study|Physician Decision|0|||
17155559|NCT02993822|38302227|FG000|Overall Study|Lack of Efficacy|1|||
17155560|NCT02993822|38302228|FG001|Overall Study|Lack of Efficacy|1|||
17155561|NCT02993822|38302229|FG002|Overall Study|Lack of Efficacy|0|||
17155562|NCT02993822|38302230|FG003|Overall Study|Lack of Efficacy|0|||
17155563|NCT02993822|38302227|FG000|Overall Study|Protocol Violation|1|||
17155564|NCT02993822|38302228|FG001|Overall Study|Protocol Violation|0|||
17155565|NCT02993822|38302229|FG002|Overall Study|Protocol Violation|0|||
17155566|NCT02993822|38302230|FG003|Overall Study|Protocol Violation|0|||
17155567|NCT02993822|38302227|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
17155568|NCT02993822|38302228|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
17155569|NCT02993822|38302229|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
17155570|NCT02993822|38302230|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
17155571|NCT02993822|38302227|FG000|Overall Study|Adverse Event|3|||
17155572|NCT02993822|38302228|FG001|Overall Study|Adverse Event|1|||
17155573|NCT02993822|38302229|FG002|Overall Study|Adverse Event|7|||
17155574|NCT02993822|38302230|FG003|Overall Study|Adverse Event|0|||
17155575|NCT02993822|38302227|FG000|Overall Study|Withdrawal by Subject|4|||
17155576|NCT02993822|38302228|FG001|Overall Study|Withdrawal by Subject|2|||
17155577|NCT02993822|38302229|FG002|Overall Study|Withdrawal by Subject|2|||
17155578|NCT02993822|38302230|FG003|Overall Study|Withdrawal by Subject|3|||
17155579|NCT02993822|38302227|FG000|Overall Study|Lost to Follow-up|1|||
17155580|NCT02993822|38302228|FG001|Overall Study|Lost to Follow-up|0|||
17155581|NCT02993822|38302229|FG002|Overall Study|Lost to Follow-up|1|||
17155582|NCT02993822|38302230|FG003|Overall Study|Lost to Follow-up|0|||
17155583|NCT02674750|38302243|FG000|Overall Study|Death|4|||
17155584|NCT02674750|38302244|FG001|Overall Study|Death|5|||
17155585|NCT02674750|38302245|FG002|Overall Study|Death|8|||
17155586|NCT02674750|38302243|FG000|Overall Study|Lost to Follow-up|0|||
17155587|NCT02674750|38302244|FG001|Overall Study|Lost to Follow-up|8|||
17155588|NCT02674750|38302245|FG002|Overall Study|Lost to Follow-up|0|||
17155589|NCT02674750|38302243|FG000|Overall Study|Lack of Efficacy|1|||
17155590|NCT02674750|38302244|FG001|Overall Study|Lack of Efficacy|17|||
17155591|NCT02674750|38302245|FG002|Overall Study|Lack of Efficacy|3|||
17155592|NCT02674750|38302243|FG000|Overall Study|Withdrawal by Subject|0|||
17155593|NCT02674750|38302244|FG001|Overall Study|Withdrawal by Subject|7|||
17155594|NCT02674750|38302245|FG002|Overall Study|Withdrawal by Subject|1|||
17155595|NCT02674750|38302243|FG000|Overall Study|Other|0|||
17155596|NCT02674750|38302244|FG001|Overall Study|Other|8|||
17155597|NCT02674750|38302245|FG002|Overall Study|Other|0|||
17155598|NCT01068860|38302262|FG000|Overall Study|Withdrawal by Subject|0|||
17155599|NCT01068860|38302263|FG001|Overall Study|Withdrawal by Subject|0|||
17155600|NCT01068860|38302264|FG002|Overall Study|Withdrawal by Subject|0|||
17155601|NCT01068860|38302265|FG003|Overall Study|Withdrawal by Subject|0|||
17155602|NCT01068860|38302266|FG004|Overall Study|Withdrawal by Subject|0|||
17155603|NCT01068860|38302267|FG005|Overall Study|Withdrawal by Subject|2|||
17155604|NCT01068860|38302268|FG006|Overall Study|Withdrawal by Subject|0|||
17155605|NCT01068860|38302269|FG007|Overall Study|Withdrawal by Subject|0|||
17155606|NCT01068860|38302270|FG008|Overall Study|Withdrawal by Subject|0|||
17155607|NCT01068860|38302271|FG009|Overall Study|Withdrawal by Subject|3|||
17155608|NCT01068860|38302262|FG000|Overall Study|Administrative problems; misrandomized|0|||
17155609|NCT01068860|38302263|FG001|Overall Study|Administrative problems; misrandomized|0|||
17155610|NCT01068860|38302264|FG002|Overall Study|Administrative problems; misrandomized|0|||
17155611|NCT01068860|38302265|FG003|Overall Study|Administrative problems; misrandomized|1|||
17155612|NCT01068860|38302266|FG004|Overall Study|Administrative problems; misrandomized|0|||
17155613|NCT01068860|38302267|FG005|Overall Study|Administrative problems; misrandomized|0|||
17155614|NCT01068860|38302268|FG006|Overall Study|Administrative problems; misrandomized|0|||
17155615|NCT01068860|38302269|FG007|Overall Study|Administrative problems; misrandomized|0|||
17155616|NCT01068860|38302270|FG008|Overall Study|Administrative problems; misrandomized|0|||
17155617|NCT01068860|38302271|FG009|Overall Study|Administrative problems; misrandomized|1|||
17155618|NCT01068860|38302262|FG000|Overall Study|Lost to Follow-up|0|||
17155619|NCT01068860|38302263|FG001|Overall Study|Lost to Follow-up|1|||
17155620|NCT01068860|38302264|FG002|Overall Study|Lost to Follow-up|0|||
17155621|NCT01068860|38302265|FG003|Overall Study|Lost to Follow-up|0|||
17155622|NCT01068860|38302266|FG004|Overall Study|Lost to Follow-up|0|||
17155623|NCT01068860|38302267|FG005|Overall Study|Lost to Follow-up|0|||
17155624|NCT01068860|38302268|FG006|Overall Study|Lost to Follow-up|0|||
17155625|NCT01068860|38302269|FG007|Overall Study|Lost to Follow-up|0|||
17155626|NCT01068860|38302270|FG008|Overall Study|Lost to Follow-up|0|||
17155627|NCT01068860|38302271|FG009|Overall Study|Lost to Follow-up|0|||
17155628|NCT02989610|38302293|FG000|Overall Study|Withdrawal/Other reasons|39|||
17155629|NCT01372774|38302299|FG000|Overall Study|Withdrawal prior to treatment|4|||
17155630|NCT01372774|38302300|FG001|Overall Study|Withdrawal prior to treatment|5|||
17155631|NCT02670538|38302311|FG000|Overall Study|Withdrawal of Consent|8|||
17155632|NCT02670538|38302312|FG001|Overall Study|Withdrawal of Consent|6|||
17155633|NCT02670538|38302313|FG002|Overall Study|Withdrawal of Consent|5|||
17155634|NCT02670538|38302311|FG000|Overall Study|Lost to Follow-up|8|||
17155635|NCT02670538|38302312|FG001|Overall Study|Lost to Follow-up|12|||
17155636|NCT02670538|38302313|FG002|Overall Study|Lost to Follow-up|7|||
17155637|NCT02670538|38302311|FG000|Overall Study|Adverse Event|5|||
17155638|NCT02670538|38302312|FG001|Overall Study|Adverse Event|5|||
17155639|NCT02670538|38302313|FG002|Overall Study|Adverse Event|11|||
17155640|NCT02670538|38302311|FG000|Overall Study|Lack of Efficacy|7|||
17155641|NCT02670538|38302312|FG001|Overall Study|Lack of Efficacy|1|||
17155642|NCT02670538|38302313|FG002|Overall Study|Lack of Efficacy|2|||
17155643|NCT02670538|38302311|FG000|Overall Study|Protocol Violation|3|||
17155644|NCT02670538|38302312|FG001|Overall Study|Protocol Violation|4|||
17155645|NCT02670538|38302313|FG002|Overall Study|Protocol Violation|1|||
17155646|NCT02670538|38302311|FG000|Overall Study|Noncompliance with Study Drug|1|||
17155647|NCT02670538|38302312|FG001|Overall Study|Noncompliance with Study Drug|3|||
17155648|NCT02670538|38302313|FG002|Overall Study|Noncompliance with Study Drug|2|||
17155649|NCT02670538|38302311|FG000|Overall Study|Other Miscellaneous Reasons|0|||
17155650|NCT02670538|38302312|FG001|Overall Study|Other Miscellaneous Reasons|1|||
17155651|NCT02670538|38302313|FG002|Overall Study|Other Miscellaneous Reasons|2|||
17155652|NCT03547583|38302324|FG000|Overall Study|Adverse Event|16|||
17155653|NCT03547583|38302325|FG001|Overall Study|Adverse Event|11|||
17155654|NCT03547583|38302326|FG002|Overall Study|Adverse Event|10|||
17155655|NCT03547583|38302324|FG000|Overall Study|Death|11|||
17155656|NCT03547583|38302325|FG001|Overall Study|Death|7|||
17155657|NCT03547583|38302326|FG002|Overall Study|Death|4|||
17155658|NCT03547583|38302324|FG000|Overall Study|Lost to Follow-up|1|||
17155659|NCT03547583|38302325|FG001|Overall Study|Lost to Follow-up|0|||
17155660|NCT03547583|38302326|FG002|Overall Study|Lost to Follow-up|0|||
17155661|NCT03547583|38302324|FG000|Overall Study|Non-compliance with study drug|0|||
17155662|NCT03547583|38302325|FG001|Overall Study|Non-compliance with study drug|0|||
17155663|NCT03547583|38302326|FG002|Overall Study|Non-compliance with study drug|1|||
17155664|NCT03547583|38302324|FG000|Overall Study|Physician Decision|1|||
17155665|NCT03547583|38302325|FG001|Overall Study|Physician Decision|0|||
17155666|NCT03547583|38302326|FG002|Overall Study|Physician Decision|3|||
17155667|NCT03547583|38302324|FG000|Overall Study|Protocol Violation|2|||
17155668|NCT03547583|38302325|FG001|Overall Study|Protocol Violation|1|||
17155669|NCT03547583|38302326|FG002|Overall Study|Protocol Violation|1|||
17155670|NCT03547583|38302324|FG000|Overall Study|Withdrawal by Subject|12|||
17155671|NCT03547583|38302325|FG001|Overall Study|Withdrawal by Subject|19|||
17155672|NCT03547583|38302326|FG002|Overall Study|Withdrawal by Subject|10|||
17155673|NCT03547583|38302324|FG000|Overall Study|Other|2|||
17155674|NCT03547583|38302325|FG001|Overall Study|Other|2|||
17155675|NCT03547583|38302326|FG002|Overall Study|Other|3|||
17155676|NCT02670382|38302337|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
17155677|NCT02670382|38302338|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
17155678|NCT02991482|38302348|FG000|Overall Study|Disease progression|56|||
17155679|NCT02991482|38302349|FG001|Overall Study|Disease progression|47|||
17155680|NCT02991482|38302348|FG000|Overall Study|Death|4|||
17155681|NCT02991482|38302349|FG001|Overall Study|Death|4|||
17155682|NCT02991482|38302348|FG000|Overall Study|Adverse Event|1|||
17155683|NCT02991482|38302349|FG001|Overall Study|Adverse Event|6|||
17155684|NCT02991482|38302348|FG000|Overall Study|Patient decision|1|||
17155685|NCT02991482|38302349|FG001|Overall Study|Patient decision|1|||
17155686|NCT02991482|38302348|FG000|Overall Study|Physician Decision|0|||
17155687|NCT02991482|38302349|FG001|Overall Study|Physician Decision|6|||
17155688|NCT02991482|38302348|FG000|Overall Study|Clinical deterioration|1|||
17155689|NCT02991482|38302349|FG001|Overall Study|Clinical deterioration|0|||
16994270|NCT00773734|38138076|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
17072498|NCT00543725|38214875|FG000|Overall Study|Protocol Violation|0|||
17072499|NCT00543725|38214876|FG001|Overall Study|Protocol Violation|1|||
17072500|NCT00543725|38214875|FG000|Overall Study|Withdrawal by Subject|4|||
17072501|NCT00543725|38214876|FG001|Overall Study|Withdrawal by Subject|13|||
17072502|NCT00543725|38214875|FG000|Overall Study|Lost to Follow-up|15|||
17072503|NCT00543725|38214876|FG001|Overall Study|Lost to Follow-up|11|||
17072504|NCT00543725|38214875|FG000|Overall Study|Other|3|||
17072505|NCT00543725|38214876|FG001|Overall Study|Other|3|||
17072506|NCT00269152|38214884|FG000|Overall Study|Adverse Event|9|||
17072507|NCT00269152|38214885|FG001|Overall Study|Adverse Event|3|||
17072508|NCT00269152|38214884|FG000|Overall Study|Withdrawal by Subject|7|||
17072509|NCT00269152|38214885|FG001|Overall Study|Withdrawal by Subject|3|||
17072510|NCT00269152|38214884|FG000|Overall Study|Physician Decision|2|||
17155690|NCT02991482|38302348|FG000|Overall Study|Patient feeling too unwell|1|||
17155691|NCT02991482|38302349|FG001|Overall Study|Patient feeling too unwell|0|||
17155692|NCT02991482|38302348|FG000|Overall Study|Worsening of performance status|0|||
17155693|NCT02991482|38302349|FG001|Overall Study|Worsening of performance status|1|||
17155694|NCT02991482|38302348|FG000|Overall Study|Death prior to study drug initiation|1|||
17155695|NCT02991482|38302349|FG001|Overall Study|Death prior to study drug initiation|0|||
17155696|NCT02991482|38302348|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
17155697|NCT02991482|38302349|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
17155698|NCT02987972|38302377|FG000|Overall Study|Adverse Event|1|||
17155699|NCT02987972|38302378|FG001|Overall Study|Adverse Event|1|||
17155700|NCT02987972|38302379|FG002|Overall Study|Adverse Event|0|||
17155701|NCT02987972|38302377|FG000|Overall Study|Death|1|||
17155702|NCT02987972|38302378|FG001|Overall Study|Death|0|||
17155703|NCT02987972|38302379|FG002|Overall Study|Death|0|||
17155704|NCT02987972|38302377|FG000|Overall Study|Lack of Efficacy|9|||
17155705|NCT02987972|38302378|FG001|Overall Study|Lack of Efficacy|12|||
17155706|NCT02987972|38302379|FG002|Overall Study|Lack of Efficacy|12|||
17155707|NCT02987972|38302377|FG000|Overall Study|Lost to Follow-up|7|||
17155708|NCT02987972|38302378|FG001|Overall Study|Lost to Follow-up|8|||
17155709|NCT02987972|38302379|FG002|Overall Study|Lost to Follow-up|4|||
17155710|NCT02987972|38302377|FG000|Overall Study|Physician Decision|1|||
17155711|NCT02987972|38302378|FG001|Overall Study|Physician Decision|6|||
17155712|NCT02987972|38302379|FG002|Overall Study|Physician Decision|0|||
17155713|NCT02987972|38302377|FG000|Overall Study|Protocol Violation|2|||
17155714|NCT02987972|38302378|FG001|Overall Study|Protocol Violation|1|||
17155715|NCT02987972|38302379|FG002|Overall Study|Protocol Violation|5|||
17155716|NCT02987972|38302377|FG000|Overall Study|Withdrawal by Subject|22|||
17155717|NCT02987972|38302378|FG001|Overall Study|Withdrawal by Subject|17|||
17155718|NCT02987972|38302379|FG002|Overall Study|Withdrawal by Subject|21|||
17155719|NCT03305419|38302395|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
17155720|NCT03305419|38302396|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
17155721|NCT03305419|38302397|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
17155722|NCT03305419|38302398|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
17155723|NCT03305419|38302399|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
17155724|NCT03305419|38302400|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
17155725|NCT03305419|38302401|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
17155726|NCT03305419|38302402|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
17155727|NCT03305419|38302395|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
17155728|NCT03305419|38302396|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
17155729|NCT03305419|38302397|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
17155730|NCT03305419|38302398|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
17155731|NCT03305419|38302399|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
17155732|NCT03305419|38302400|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
17155733|NCT03305419|38302401|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
17155734|NCT03305419|38302402|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
17155735|NCT03305419|38302395|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
17155736|NCT03305419|38302396|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
17155737|NCT03305419|38302397|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
17155738|NCT03305419|38302398|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
17155739|NCT03305419|38302399|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
17155740|NCT03305419|38302400|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
17155741|NCT03305419|38302401|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
17155742|NCT03305419|38302402|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
17155743|NCT03305419|38302395|FG000|Part B (14 Days)|Adverse Event|0|||
17155744|NCT03305419|38302396|FG001|Part B (14 Days)|Adverse Event|0|||
17072511|NCT00269152|38214885|FG001|Overall Study|Physician Decision|3|||
17072512|NCT00269152|38214884|FG000|Overall Study|Protocol Violation|0|||
17072513|NCT00269152|38214885|FG001|Overall Study|Protocol Violation|1|||
17072514|NCT00379899|38214893|FG000|Overall Study|Adverse Event|7|||
17072515|NCT00379899|38214894|FG001|Overall Study|Adverse Event|3|||
17072516|NCT00379899|38214893|FG000|Overall Study|Death|10|||
17072517|NCT00379899|38214894|FG001|Overall Study|Death|10|||
17072518|NCT00379899|38214893|FG000|Overall Study|Lost to Follow-up|2|||
17072519|NCT00379899|38214894|FG001|Overall Study|Lost to Follow-up|4|||
17072520|NCT00379899|38214893|FG000|Overall Study|Physician Decision|3|||
17072521|NCT00379899|38214894|FG001|Overall Study|Physician Decision|4|||
17072522|NCT00379899|38214893|FG000|Overall Study|Withdrawal by Subject|5|||
17072523|NCT00379899|38214894|FG001|Overall Study|Withdrawal by Subject|5|||
17072524|NCT00379899|38214893|FG000|Overall Study|Ineligibility determined|0|||
17072525|NCT00379899|38214894|FG001|Overall Study|Ineligibility determined|1|||
17072526|NCT00379899|38214893|FG000|Overall Study|Noncompliance|1|||
17072527|NCT00379899|38214894|FG001|Overall Study|Noncompliance|1|||
17072528|NCT00379899|38214893|FG000|Overall Study|Parathyroidectomy|0|||
17072529|NCT00379899|38214894|FG001|Overall Study|Parathyroidectomy|2|||
17072530|NCT00379899|38214893|FG000|Overall Study|Renal transplantation|5|||
17072531|NCT00379899|38214894|FG001|Overall Study|Renal transplantation|4|||
17072532|NCT00379899|38214893|FG000|Overall Study|Coronary artery bypass graft|1|||
17155745|NCT03305419|38302397|FG002|Part B (14 Days)|Adverse Event|0|||
17155746|NCT03305419|38302398|FG003|Part B (14 Days)|Adverse Event|0|||
17155747|NCT03305419|38302399|FG004|Part B (14 Days)|Adverse Event|1|||
17155748|NCT03305419|38302400|FG005|Part B (14 Days)|Adverse Event|2|||
17155749|NCT03305419|38302401|FG006|Part B (14 Days)|Adverse Event|4|||
17155750|NCT03305419|38302402|FG007|Part B (14 Days)|Adverse Event|0|||
17155751|NCT03305419|38302395|FG000|Part B (14 Days)|Physician Decision|0|||
17155752|NCT03305419|38302396|FG001|Part B (14 Days)|Physician Decision|0|||
17155753|NCT03305419|38302397|FG002|Part B (14 Days)|Physician Decision|0|||
17155754|NCT03305419|38302398|FG003|Part B (14 Days)|Physician Decision|0|||
17155755|NCT03305419|38302399|FG004|Part B (14 Days)|Physician Decision|2|||
17155756|NCT03305419|38302400|FG005|Part B (14 Days)|Physician Decision|8|||
17155757|NCT03305419|38302401|FG006|Part B (14 Days)|Physician Decision|1|||
17155758|NCT03305419|38302402|FG007|Part B (14 Days)|Physician Decision|0|||
17155759|NCT01372618|38302425|FG000|Overall Study|PI Died. Study Terminated|9|||
17155760|NCT03304873|38302431|FG000|Overall Study|Lost to Follow-up|1|||
17155761|NCT03304873|38302432|FG001|Overall Study|Lost to Follow-up|8|||
17155762|NCT02669758|38302438|FG000|Overall Study|Withdrawal by Subject|43|||
17155763|NCT02669758|38302438|FG000|Overall Study|Lost to Follow-up|19|||
17155764|NCT02669758|38302438|FG000|Overall Study|Adverse Event|16|||
17155765|NCT02669758|38302438|FG000|Overall Study|Non-Compliance with Study Drug|8|||
17155766|NCT02669758|38302438|FG000|Overall Study|Lack of Efficacy|5|||
17155767|NCT02669758|38302438|FG000|Overall Study|Pregnancy|1|||
17155768|NCT02669758|38302438|FG000|Overall Study|Study noncompliance|1|||
17155769|NCT02669758|38302438|FG000|Overall Study|Protocol Violation|1|||
17155770|NCT02987660|38302444|FG000|Overall Study|Study terminated by sponsor|10|||
17155771|NCT02987660|38302445|FG001|Overall Study|Study terminated by sponsor|10|||
17155772|NCT04528069|38302451|FG000|Overall Study|Adverse Event|1|||
17155773|NCT04528069|38302451|FG000|Overall Study|Lost to Follow-up|1|||
17155774|NCT04528069|38302451|FG000|Overall Study|Patient Unable to Come|1|||
17155775|NCT04528069|38302451|FG000|Overall Study|Patient Unable to Attend|1|||
17155776|NCT03303469|38302467|FG000|Overall Study|Lost to Follow-up|2|||
17155777|NCT02990000|38302473|FG000|Overall Study|Failed to provide data beyond baseline|36|||
17155778|NCT02990000|38302474|FG001|Overall Study|Failed to provide data beyond baseline|34|||
17155779|NCT01068626|38302482|FG000|Overall Study|Adverse Event|3|||
17155780|NCT01068626|38302483|FG001|Overall Study|Adverse Event|0|||
17155781|NCT01068626|38302482|FG000|Overall Study|Withdrawal by Subject|0|||
17155782|NCT01068626|38302483|FG001|Overall Study|Withdrawal by Subject|2|||
17155783|NCT02921750|38302491|FG000|Overall Study|Adverse Event|1|||
17155784|NCT02921750|38302492|FG001|Overall Study|Adverse Event|2|||
17155785|NCT02921750|38302491|FG000|Overall Study|Withdrawal by Subject|1|||
17155786|NCT02921750|38302492|FG001|Overall Study|Withdrawal by Subject|1|||
17155787|NCT02921750|38302491|FG000|Overall Study|Lost to Follow-up|3|||
17155788|NCT02921750|38302492|FG001|Overall Study|Lost to Follow-up|3|||
17155789|NCT02921750|38302491|FG000|Overall Study|Wound healed|3|||
17155790|NCT02921750|38302492|FG001|Overall Study|Wound healed|3|||
17155791|NCT02921750|38302491|FG000|Overall Study|Serious Adverse Event|1|||
17155792|NCT02921750|38302492|FG001|Overall Study|Serious Adverse Event|2|||
17155793|NCT02920970|38302501|FG000|First Intervention|Protocol Violation|0|||
17155794|NCT02920970|38302502|FG001|First Intervention|Protocol Violation|1|||
17155795|NCT02920970|38302501|FG000|First Intervention|Adverse Event|0|||
17155796|NCT02920970|38302502|FG001|First Intervention|Adverse Event|1|||
17155797|NCT02920970|38302501|FG000|Second Intervention|Poor Lens Fit|1|||
17155798|NCT02920970|38302502|FG001|Second Intervention|Poor Lens Fit|0|||
17155799|NCT01068158|38302512|FG000|Overall Study|Withdrawal by Subject|1|||
17155800|NCT01068158|38302513|FG001|Overall Study|Withdrawal by Subject|2|||
17155801|NCT01068158|38302512|FG000|Overall Study|Lost to Follow-up|7|||
17155802|NCT01068158|38302513|FG001|Overall Study|Lost to Follow-up|0|||
17155803|NCT01068158|38302512|FG000|Overall Study|Protocol Violation|0|||
17155804|NCT01068158|38302513|FG001|Overall Study|Protocol Violation|2|||
17155805|NCT03303079|38302522|FG000|Overall Study|Adverse Event|0|||
17155806|NCT03303079|38302523|FG001|Overall Study|Adverse Event|1|||
17155807|NCT03303079|38302524|FG002|Overall Study|Adverse Event|3|||
17155808|NCT03303079|38302522|FG000|Overall Study|Protocol Violation|5|||
17155809|NCT03303079|38302523|FG001|Overall Study|Protocol Violation|4|||
17155810|NCT03303079|38302524|FG002|Overall Study|Protocol Violation|7|||
17155811|NCT03303079|38302522|FG000|Overall Study|Withdrawal by Subject|2|||
17155812|NCT03303079|38302523|FG001|Overall Study|Withdrawal by Subject|4|||
17072533|NCT00379899|38214894|FG001|Overall Study|Coronary artery bypass graft|1|||
17072534|NCT00379899|38214893|FG000|Overall Study|Other protocol-specified criteria|3|||
17072535|NCT00379899|38214894|FG001|Overall Study|Other protocol-specified criteria|4|||
17072536|NCT00379899|38214893|FG000|Overall Study|Other|3|||
17072537|NCT00379899|38214894|FG001|Overall Study|Other|1|||
17072538|NCT00371787|38214902|FG000|Overall Study|Withdrawal by Subject|3|||
17072539|NCT00371787|38214903|FG001|Overall Study|Withdrawal by Subject|1|||
17072540|NCT00363129|38214911|FG000|Overall Study|Withdrawal by Subject|11|||
17072541|NCT00363129|38214912|FG001|Overall Study|Withdrawal by Subject|18|||
17155813|NCT03303079|38302524|FG002|Overall Study|Withdrawal by Subject|2|||
17072542|NCT00363129|38214911|FG000|Overall Study|Adverse Event|8|||
17072543|NCT00363129|38214912|FG001|Overall Study|Adverse Event|3|||
17072544|NCT00363129|38214911|FG000|Overall Study|Alternate Treatment|2|||
17072545|NCT00363129|38214912|FG001|Overall Study|Alternate Treatment|4|||
17072546|NCT00363129|38214911|FG000|Overall Study|Other Medical Problems|2|||
17072547|NCT00363129|38214912|FG001|Overall Study|Other Medical Problems|4|||
17072548|NCT00363129|38214911|FG000|Overall Study|Death|0|||
17072549|NCT00363129|38214912|FG001|Overall Study|Death|1|||
17072550|NCT00363129|38214911|FG000|Overall Study|Other Reasons|6|||
17072551|NCT00363129|38214912|FG001|Overall Study|Other Reasons|3|||
17072552|NCT00268996|38214920|FG000|Overall Study|Adverse Event|11|||
17155814|NCT03303079|38302522|FG000|Overall Study|Other than specified|0|||
17155815|NCT03303079|38302523|FG001|Overall Study|Other than specified|2|||
17155816|NCT03303079|38302524|FG002|Overall Study|Other than specified|0|||
17155817|NCT01067846|38302534|FG000|Overall Study|Lost to Follow-up|17|||
17155818|NCT01067846|38302535|FG001|Overall Study|Lost to Follow-up|19|||
17155819|NCT01067846|38302534|FG000|Overall Study|Withdrawal by Subject|1|||
17155820|NCT01067846|38302535|FG001|Overall Study|Withdrawal by Subject|0|||
17155821|NCT01067846|38302534|FG000|Overall Study|participation in other tx study|1|||
17155822|NCT01067846|38302535|FG001|Overall Study|participation in other tx study|0|||
17155823|NCT03311659|38302541|FG000|Overall Study|Protocol Violation|1|||
17155824|NCT03874234|38302558|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155825|NCT03874234|38302559|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155826|NCT03874234|38302560|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155827|NCT03874234|38302561|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
17155828|NCT03874234|38302562|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155829|NCT03874234|38302563|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155830|NCT03874234|38302564|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155831|NCT03874234|38302565|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155832|NCT03874234|38302566|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155833|NCT03874234|38302567|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155834|NCT03874234|38302568|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155835|NCT03874234|38302569|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155836|NCT03874234|38302570|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
17155837|NCT03874234|38302558|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
17155838|NCT03874234|38302559|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155839|NCT03874234|38302560|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155840|NCT03874234|38302561|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155841|NCT03874234|38302562|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155842|NCT03874234|38302563|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155843|NCT03874234|38302564|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155844|NCT03874234|38302565|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155845|NCT03874234|38302566|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17072553|NCT00268996|38214921|FG001|Overall Study|Adverse Event|7|||
17072554|NCT00268996|38214920|FG000|Overall Study|Lost to Follow-up|3|||
17072555|NCT00268996|38214921|FG001|Overall Study|Lost to Follow-up|1|||
17072556|NCT00268996|38214920|FG000|Overall Study|Withdrawal by Subject|5|||
17072557|NCT00268996|38214921|FG001|Overall Study|Withdrawal by Subject|11|||
17072558|NCT00268996|38214920|FG000|Overall Study|Non-compliance|1|||
17072559|NCT00268996|38214921|FG001|Overall Study|Non-compliance|0|||
17072560|NCT00268996|38214920|FG000|Overall Study|Other|1|||
17072561|NCT00268996|38214921|FG001|Overall Study|Other|1|||
17072562|NCT00371397|38214929|FG000|Session 1|Withdrawal by Subject|1|||
17072563|NCT00371397|38214930|FG001|Session 1|Withdrawal by Subject|0|||
17072564|NCT00371397|38214931|FG002|Session 1|Withdrawal by Subject|0|||
17072565|NCT00371397|38214932|FG003|Session 1|Withdrawal by Subject|0|||
17072566|NCT00371397|38214933|FG004|Session 1|Withdrawal by Subject|0|||
17072567|NCT00371397|38214934|FG005|Session 1|Withdrawal by Subject|0|||
17072568|NCT00371397|38214935|FG006|Session 1|Withdrawal by Subject|0|||
17072569|NCT00371397|38214936|FG007|Session 1|Withdrawal by Subject|1|||
17072570|NCT00371397|38214937|FG008|Session 1|Withdrawal by Subject|0|||
17072571|NCT00371397|38214938|FG009|Session 1|Withdrawal by Subject|0|||
17072572|NCT00371397|38214939|FG010|Session 1|Withdrawal by Subject|0|||
17072573|NCT00371397|38214940|FG011|Session 1|Withdrawal by Subject|0|||
17072574|NCT00379587|38214946|FG000|Overall Study|Lost to Follow-up|2|||
17072575|NCT00289276|38214952|FG000|Second Part of FAST Study (Expansion)|Death|0|||
17072576|NCT00289276|38214953|FG001|Second Part of FAST Study (Expansion)|Death|2|||
17072577|NCT00289276|38214952|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
17072578|NCT00289276|38214953|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
17072579|NCT00289198|38214961|FG000|Overall Study|Adverse Event|0|||
17072580|NCT00289198|38214962|FG001|Overall Study|Adverse Event|2|||
17072581|NCT00289198|38214961|FG000|Overall Study|Protocol Violation|2|||
17072582|NCT00289198|38214962|FG001|Overall Study|Protocol Violation|1|||
17072583|NCT00289198|38214961|FG000|Overall Study|Withdrawal by Subject|4|||
17155846|NCT03874234|38302567|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155847|NCT03874234|38302568|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155848|NCT03874234|38302569|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155849|NCT03874234|38302570|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
17155850|NCT03874234|38302558|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155851|NCT03874234|38302559|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17072584|NCT00289198|38214962|FG001|Overall Study|Withdrawal by Subject|1|||
17072585|NCT00289198|38214961|FG000|Overall Study|Lack of Efficacy|2|||
17072586|NCT00289198|38214962|FG001|Overall Study|Lack of Efficacy|0|||
17072587|NCT00289198|38214961|FG000|Overall Study|Other: Low compliance|0|||
17155852|NCT03874234|38302560|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155853|NCT03874234|38302561|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
17155854|NCT03874234|38302562|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155855|NCT03874234|38302563|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155856|NCT03874234|38302564|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155857|NCT03874234|38302565|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155858|NCT03874234|38302566|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155859|NCT03874234|38302567|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155860|NCT03874234|38302568|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155861|NCT03874234|38302569|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17072588|NCT00289198|38214962|FG001|Overall Study|Other: Low compliance|1|||
17072589|NCT00289198|38214961|FG000|Overall Study|Other: Physician's decision|0|||
17072590|NCT00289198|38214962|FG001|Overall Study|Other: Physician's decision|1|||
17072591|NCT00289198|38214961|FG000|Overall Study|Other: Unable to attend on schedule|2|||
17072592|NCT00289198|38214962|FG001|Overall Study|Other: Unable to attend on schedule|1|||
17072593|NCT00289198|38214961|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
17072594|NCT00289198|38214962|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
17072595|NCT00289198|38214961|FG000|Overall Study|Other: Impossible to come on visit|0|||
17072596|NCT00289198|38214962|FG001|Overall Study|Other: Impossible to come on visit|1|||
17072597|NCT00363051|38214971|FG000|Overall Study|Adminstrative problems|1|||
17072598|NCT00363051|38214972|FG001|Overall Study|Adminstrative problems|1|||
17072599|NCT00363051|38214971|FG000|Overall Study|Adverse Event|21|||
17072600|NCT00363051|38214972|FG001|Overall Study|Adverse Event|12|||
17072601|NCT00363051|38214971|FG000|Overall Study|New Cancer Therapy|2|||
17155862|NCT03874234|38302570|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
17155863|NCT03874234|38302558|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155864|NCT03874234|38302559|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155865|NCT03874234|38302560|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155866|NCT03874234|38302561|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155867|NCT03874234|38302562|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
17155868|NCT03874234|38302563|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155869|NCT03874234|38302564|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155870|NCT03874234|38302565|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155871|NCT03874234|38302566|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155872|NCT03874234|38302567|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155873|NCT03874234|38302568|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155874|NCT03874234|38302569|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17155875|NCT03874234|38302570|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
17072602|NCT00363051|38214972|FG001|Overall Study|New Cancer Therapy|1|||
17072603|NCT00363051|38214971|FG000|Overall Study|Withdrawal by Subject|11|||
17072604|NCT00363051|38214972|FG001|Overall Study|Withdrawal by Subject|3|||
17072605|NCT00363051|38214971|FG000|Overall Study|Lost to Follow-up|0|||
17072606|NCT00363051|38214972|FG001|Overall Study|Lost to Follow-up|1|||
17072607|NCT00363051|38214971|FG000|Overall Study|Protocol Violation|0|||
17072608|NCT00363051|38214972|FG001|Overall Study|Protocol Violation|2|||
17072609|NCT00363051|38214971|FG000|Overall Study|Death|3|||
17072610|NCT00363051|38214972|FG001|Overall Study|Death|2|||
17072611|NCT00379353|38214982|FG000|Overall Study|Hospitalization|3|||
17072612|NCT00379353|38214983|FG001|Overall Study|Hospitalization|3|||
17072613|NCT00379353|38214982|FG000|Overall Study|Withdrawal by Subject|5|||
17072614|NCT00379353|38214983|FG001|Overall Study|Withdrawal by Subject|2|||
17072615|NCT00379353|38214982|FG000|Overall Study|Death|1|||
17072616|NCT00379353|38214983|FG001|Overall Study|Death|0|||
17072617|NCT00379353|38214982|FG000|Overall Study|Cardiac Tamponade|1|||
17072618|NCT00379353|38214983|FG001|Overall Study|Cardiac Tamponade|0|||
17072619|NCT00379353|38214982|FG000|Overall Study|Non-compliance|1|||
17072620|NCT00379353|38214983|FG001|Overall Study|Non-compliance|0|||
17072621|NCT00379353|38214982|FG000|Overall Study|Conflicting drug treatment|0|||
17072622|NCT00379353|38214983|FG001|Overall Study|Conflicting drug treatment|1|||
17072623|NCT00378573|38214999|FG000|Treatment Period|Adverse Event|9|||
17072624|NCT00378573|38214999|FG000|Treatment Period|Physician Decision|1|||
17072625|NCT00378573|38214999|FG000|Treatment Period|Withdrawal by Subject|2|||
17072626|NCT00378573|38214999|FG000|Treatment Period|Disease Progression|4|||
17155876|NCT03874234|38302558|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155877|NCT03874234|38302559|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155878|NCT03874234|38302560|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155879|NCT03874234|38302561|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155880|NCT03874234|38302562|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155881|NCT03874234|38302563|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155882|NCT03874234|38302564|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155883|NCT03874234|38302565|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
17155884|NCT03874234|38302566|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155885|NCT03874234|38302567|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155886|NCT03874234|38302568|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155887|NCT03874234|38302569|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155888|NCT03874234|38302570|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
17155889|NCT03874234|38302558|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155890|NCT03874234|38302559|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155891|NCT03874234|38302560|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155892|NCT03874234|38302561|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155893|NCT03874234|38302562|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
17155894|NCT03874234|38302563|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
17155895|NCT03874234|38302564|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155896|NCT03874234|38302565|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155897|NCT03874234|38302566|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155898|NCT03874234|38302567|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155899|NCT03874234|38302568|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155900|NCT03874234|38302569|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155901|NCT03874234|38302570|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
17155902|NCT03874234|38302558|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155903|NCT03874234|38302559|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155904|NCT03874234|38302560|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155905|NCT03874234|38302561|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155906|NCT03874234|38302562|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155907|NCT03874234|38302563|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155908|NCT03874234|38302564|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
17155909|NCT03874234|38302565|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155910|NCT03874234|38302566|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155911|NCT03874234|38302567|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155912|NCT03874234|38302568|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155913|NCT03874234|38302569|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155914|NCT03874234|38302570|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
17155915|NCT03874234|38302558|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155916|NCT03874234|38302559|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155917|NCT03874234|38302560|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155918|NCT03874234|38302561|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155919|NCT03874234|38302562|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
17155920|NCT03874234|38302563|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155921|NCT03874234|38302564|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155922|NCT03874234|38302565|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155923|NCT03874234|38302566|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155924|NCT03874234|38302567|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155925|NCT03874234|38302568|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155926|NCT03874234|38302569|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155927|NCT03874234|38302570|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
17155928|NCT02985398|38302606|FG000|Overall Study|Adverse Event|1|||
17155929|NCT02985398|38302606|FG000|Overall Study|Lost to Follow-up|4|||
17155930|NCT02985398|38302606|FG000|Overall Study|Withdrawal by Subject|8|||
17155931|NCT02985398|38302606|FG000|Overall Study|Study Burden|9|||
17155932|NCT03310723|38302612|FG000|Overall Study|Withdrawal by Subject|0|||
17155933|NCT03310723|38302613|FG001|Overall Study|Withdrawal by Subject|1|||
17155934|NCT03310723|38302612|FG000|Overall Study|Protocol Violation|0|||
17155935|NCT03310723|38302613|FG001|Overall Study|Protocol Violation|2|||
17155936|NCT02663674|38302621|FG000|Overall Study|Lost to Follow-up|5|||
17155937|NCT02663674|38302622|FG001|Overall Study|Lost to Follow-up|4|||
17155938|NCT02663674|38302621|FG000|Overall Study|Withdrawal by Subject|1|||
17155939|NCT02663674|38302622|FG001|Overall Study|Withdrawal by Subject|4|||
17155940|NCT02663674|38302621|FG000|Overall Study|Physician Decision|1|||
17155941|NCT02663674|38302622|FG001|Overall Study|Physician Decision|1|||
16781256|NCT02109484|37720414|FG005|Overall Study|Death|0|||
17155942|NCT02663674|38302621|FG000|Overall Study|Other Event (Health Related)|0|||
17155943|NCT02663674|38302622|FG001|Overall Study|Other Event (Health Related)|1|||
17155944|NCT01005745|38302628|FG000|Overall Study|No TIL growth|1|||
17155945|NCT01005745|38302628|FG000|Overall Study|Disease progressed during TIL growth|3|||
17155946|NCT01005745|38302628|FG000|Overall Study|Death prior to treatment|1|||
17155947|NCT01005745|38302628|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
17155948|NCT02908880|38302632|FG000|Overall Study|Lost to Follow-up|4|||
17155949|NCT02908880|38302632|FG000|Overall Study|Explantation of the device|1|||
17155950|NCT02908880|38302632|FG000|Overall Study|Withdrawal by Subject|17|||
17155951|NCT02908880|38302632|FG000|Overall Study|Death|5|||
17155952|NCT03310411|38302636|FG000|Period 1|Adverse Event|0|||
17155953|NCT03310411|38302637|FG001|Period 1|Adverse Event|0|||
17155954|NCT03310411|38302638|FG002|Period 1|Adverse Event|0|||
17155955|NCT03310411|38302639|FG003|Period 1|Adverse Event|1|||
17155956|NCT03301831|38302657|FG000|Overall Study|Lost to Follow-up|5|||
17155957|NCT03301831|38302658|FG001|Overall Study|Lost to Follow-up|3|||
17155958|NCT03301831|38302657|FG000|Overall Study|Protocol Violation|4|||
17155959|NCT03301831|38302658|FG001|Overall Study|Protocol Violation|0|||
17155960|NCT03301831|38302657|FG000|Overall Study|Withdrawal by Subject|11|||
17155961|NCT03301831|38302658|FG001|Overall Study|Withdrawal by Subject|0|||
17155962|NCT02909504|38302664|FG000|Overall Study|Adverse Event|2|||
17155963|NCT02909504|38302664|FG000|Overall Study|Lack of Efficacy|3|||
17155964|NCT02909504|38302664|FG000|Overall Study|Withdrawal by Subject|4|||
17155965|NCT02909504|38302664|FG000|Overall Study|Pregnancy|1|||
17155966|NCT02909504|38302664|FG000|Overall Study|Subject moved|1|||
17155967|NCT02909504|38302664|FG000|Overall Study|Lost to Follow-up|1|||
17155968|NCT02199691|38302673|FG000|Overall Study|Protocol Violation|3|||
17155969|NCT02199691|38302674|FG001|Overall Study|Protocol Violation|3|||
17155970|NCT02199691|38302675|FG002|Overall Study|Protocol Violation|6|||
17155971|NCT02199691|38302676|FG003|Overall Study|Protocol Violation|7|||
17155972|NCT02199691|38302673|FG000|Overall Study|Withdrawal by Subject|5|||
17155973|NCT02199691|38302674|FG001|Overall Study|Withdrawal by Subject|3|||
17155974|NCT02199691|38302675|FG002|Overall Study|Withdrawal by Subject|12|||
17072627|NCT00378573|38214999|FG000|Treatment Period|Sponsor decision to close study|1|||
17072628|NCT00378573|38214999|FG000|Follow-up|Death|12|||
17072629|NCT00378573|38214999|FG000|Follow-up|Lost to Follow-up|1|||
17072630|NCT00378573|38214999|FG000|Follow-up|Withdrawal by Subject|1|||
17072631|NCT03831945|38215005|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
17072632|NCT03831945|38215006|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
17072633|NCT03831945|38215005|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
17072634|NCT03831945|38215006|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
17155975|NCT02199691|38302676|FG003|Overall Study|Withdrawal by Subject|13|||
17155976|NCT02199691|38302673|FG000|Overall Study|Lost to Follow-up|2|||
17155977|NCT02199691|38302674|FG001|Overall Study|Lost to Follow-up|1|||
17155978|NCT02199691|38302675|FG002|Overall Study|Lost to Follow-up|9|||
17155979|NCT02199691|38302676|FG003|Overall Study|Lost to Follow-up|10|||
17155980|NCT03299881|38302690|FG000|Overall Study|Study Termination|17|||
17155981|NCT03299881|38302691|FG001|Overall Study|Study Termination|13|||
17072635|NCT03831945|38215005|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
17072636|NCT03831945|38215006|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
17072637|NCT00378105|38215014|FG000|Overall Study|Adverse Event|3|||
17072638|NCT00378105|38215015|FG001|Overall Study|Adverse Event|1|||
17072639|NCT00378105|38215014|FG000|Overall Study|Withdrawal by Subject|3|||
17072640|NCT00378105|38215015|FG001|Overall Study|Withdrawal by Subject|3|||
17072641|NCT00378105|38215014|FG000|Overall Study|Death|1|||
17072642|NCT00378105|38215015|FG001|Overall Study|Death|0|||
17072643|NCT00378105|38215014|FG000|Overall Study|Going to transplant|7|||
17072644|NCT00378105|38215015|FG001|Overall Study|Going to transplant|8|||
17072645|NCT00378105|38215014|FG000|Overall Study|Progressive disease|3|||
17072646|NCT00378105|38215015|FG001|Overall Study|Progressive disease|3|||
17072647|NCT00378105|38215014|FG000|Overall Study|remain on study|3|||
17072648|NCT00378105|38215015|FG001|Overall Study|remain on study|11|||
17072649|NCT00378105|38215014|FG000|Overall Study|Physician Decision|0|||
17072650|NCT00378105|38215015|FG001|Overall Study|Physician Decision|2|||
17072651|NCT00378105|38215014|FG000|Overall Study|Going non-protocol therapy|0|||
17072652|NCT00378105|38215015|FG001|Overall Study|Going non-protocol therapy|1|||
17072653|NCT00378105|38215014|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
17072654|NCT00378105|38215015|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
17072655|NCT00457002|38215024|FG000|Overall Study|Death|40|||
17072656|NCT00457002|38215025|FG001|Overall Study|Death|47|||
17155982|NCT03299101|38302697|FG000|Overall Study|Lost to Follow-up|1|||
17155983|NCT03299101|38302697|FG000|Overall Study|Withdrawal by Subject|5|||
17155984|NCT03299101|38302697|FG000|Overall Study|Surgery was changed|3|||
17155985|NCT03299101|38302697|FG000|Overall Study|Not enough time to complete prehab|1|||
17155986|NCT02663128|38302703|FG000|Period 2|Physician Decision|0|||
17155987|NCT02663128|38302704|FG001|Period 2|Physician Decision|0|||
17155988|NCT02663128|38302705|FG002|Period 2|Physician Decision|0|||
17155989|NCT02663128|38302706|FG003|Period 2|Physician Decision|0|||
17155990|NCT02663128|38302707|FG004|Period 2|Physician Decision|1|||
17155991|NCT02663128|38302708|FG005|Period 2|Physician Decision|0|||
17155992|NCT03298867|38302719|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
17155993|NCT03298867|38302720|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
17155994|NCT03298867|38302719|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
17155995|NCT03298867|38302720|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
17155996|NCT03298867|38302719|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
17155997|NCT03298867|38302720|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
17155998|NCT03298867|38302719|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
17155999|NCT03298867|38302720|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
17156000|NCT03298867|38302719|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
17156001|NCT03298867|38302720|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
17156002|NCT03298867|38302719|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
17156003|NCT03298867|38302720|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
17156004|NCT03298867|38302719|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
17156005|NCT03298867|38302720|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
17156006|NCT03298867|38302719|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
17156007|NCT03298867|38302720|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
17156008|NCT03298867|38302719|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
17156009|NCT03298867|38302720|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
17156010|NCT02906930|38302730|FG000|Overall Study|Withdrawal by Subject|0|||
17156011|NCT02906930|38302731|FG001|Overall Study|Withdrawal by Subject|5|||
17156012|NCT02906930|38302732|FG002|Overall Study|Withdrawal by Subject|5|||
17156013|NCT02906930|38302733|FG003|Overall Study|Withdrawal by Subject|4|||
17156014|NCT02906930|38302730|FG000|Overall Study|Lost to Follow-up|5|||
17156015|NCT02906930|38302731|FG001|Overall Study|Lost to Follow-up|7|||
17156016|NCT02906930|38302732|FG002|Overall Study|Lost to Follow-up|5|||
17156017|NCT02906930|38302733|FG003|Overall Study|Lost to Follow-up|2|||
17156018|NCT02906930|38302730|FG000|Overall Study|Death|0|||
17156019|NCT02906930|38302731|FG001|Overall Study|Death|0|||
17156020|NCT02906930|38302732|FG002|Overall Study|Death|1|||
17156021|NCT02906930|38302733|FG003|Overall Study|Death|0|||
17156022|NCT02906930|38302730|FG000|Overall Study|Other|1|||
17156023|NCT02906930|38302731|FG001|Overall Study|Other|2|||
17072657|NCT00457002|38215024|FG000|Overall Study|Adverse Event|284|||
17072658|NCT00457002|38215025|FG001|Overall Study|Adverse Event|260|||
17072659|NCT00457002|38215024|FG000|Overall Study|Withdrawal by Subject|299|||
17072660|NCT00457002|38215025|FG001|Overall Study|Withdrawal by Subject|271|||
17072661|NCT00457002|38215024|FG000|Overall Study|Lost to Follow-up|72|||
17072662|NCT00457002|38215025|FG001|Overall Study|Lost to Follow-up|71|||
17072663|NCT00457002|38215024|FG000|Overall Study|Poor/Non-compliance|46|||
17072664|NCT00457002|38215025|FG001|Overall Study|Poor/Non-compliance|33|||
17072665|NCT00457002|38215024|FG000|Overall Study|No longer met criteria|41|||
17072666|NCT00457002|38215025|FG001|Overall Study|No longer met criteria|37|||
17072667|NCT00457002|38215024|FG000|Overall Study|Administrative reason by Sponsor|1|||
17072668|NCT00457002|38215025|FG001|Overall Study|Administrative reason by Sponsor|0|||
17072669|NCT00457002|38215024|FG000|Overall Study|non-specified|29|||
17072670|NCT00457002|38215025|FG001|Overall Study|non-specified|38|||
17072671|NCT00457002|38215024|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
17072672|NCT00457002|38215025|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
17156024|NCT02906930|38302732|FG002|Overall Study|Other|1|||
17156025|NCT02906930|38302733|FG003|Overall Study|Other|2|||
17156026|NCT02983604|38302747|FG000|Overall Study|Enrolled but not Treated|0|||
17156027|NCT02983604|38302748|FG001|Overall Study|Enrolled but not Treated|0|||
17156028|NCT02983604|38302749|FG002|Overall Study|Enrolled but not Treated|1|||
17156029|NCT02983604|38302750|FG003|Overall Study|Enrolled but not Treated|0|||
17156030|NCT02662582|38302762|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
17156031|NCT02662582|38302763|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
17156032|NCT02662582|38302762|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
17156033|NCT02662582|38302763|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
17156034|NCT02662582|38302762|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
17156035|NCT02662582|38302763|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
17156036|NCT02662582|38302762|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
17156037|NCT02662582|38302763|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
17156038|NCT02908100|38302773|FG000|Overall Study|Adverse Event|7|||
17156039|NCT02908100|38302774|FG001|Overall Study|Adverse Event|6|||
17072673|NCT00362115|38215038|FG000|Overall Study|Adverse Event|0|||
17072674|NCT00362115|38215039|FG001|Overall Study|Adverse Event|1|||
17072675|NCT00362115|38215040|FG002|Overall Study|Adverse Event|1|||
17072676|NCT00362115|38215041|FG003|Overall Study|Adverse Event|1|||
17156040|NCT02908100|38302775|FG002|Overall Study|Adverse Event|9|||
17156041|NCT02908100|38302773|FG000|Overall Study|Death|2|||
17156042|NCT02908100|38302774|FG001|Overall Study|Death|0|||
17156043|NCT02908100|38302775|FG002|Overall Study|Death|0|||
17156044|NCT02908100|38302773|FG000|Overall Study|Lack of Efficacy|2|||
17156045|NCT02908100|38302774|FG001|Overall Study|Lack of Efficacy|3|||
17156046|NCT02908100|38302775|FG002|Overall Study|Lack of Efficacy|3|||
17156047|NCT02908100|38302773|FG000|Overall Study|Lost to Follow-up|0|||
17156048|NCT02908100|38302774|FG001|Overall Study|Lost to Follow-up|1|||
17156049|NCT02908100|38302775|FG002|Overall Study|Lost to Follow-up|2|||
17156050|NCT02908100|38302773|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17156051|NCT02908100|38302774|FG001|Overall Study|Non-Compliance With Study Drug|1|||
17156052|NCT02908100|38302775|FG002|Overall Study|Non-Compliance With Study Drug|2|||
17156053|NCT02908100|38302773|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
17072677|NCT00362115|38215042|FG004|Overall Study|Adverse Event|2|||
17072678|NCT00362115|38215043|FG005|Overall Study|Adverse Event|2|||
17072679|NCT00362115|38215044|FG006|Overall Study|Adverse Event|1|||
17072680|NCT00362115|38215038|FG000|Overall Study|Protocol Violation|0|||
17156054|NCT02908100|38302774|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
17156055|NCT02908100|38302775|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
17156056|NCT02908100|38302773|FG000|Overall Study|Physician Decision|0|||
17156057|NCT02908100|38302774|FG001|Overall Study|Physician Decision|1|||
17156058|NCT02908100|38302775|FG002|Overall Study|Physician Decision|0|||
17156059|NCT02908100|38302773|FG000|Overall Study|Pregnancy|1|||
17156060|NCT02908100|38302774|FG001|Overall Study|Pregnancy|2|||
17156061|NCT02908100|38302775|FG002|Overall Study|Pregnancy|0|||
17156062|NCT02908100|38302773|FG000|Overall Study|Withdrawal by Subject|8|||
17156063|NCT02908100|38302774|FG001|Overall Study|Withdrawal by Subject|7|||
17156064|NCT02908100|38302775|FG002|Overall Study|Withdrawal by Subject|5|||
17156065|NCT02908100|38302773|FG000|Overall Study|Randomised in Error|1|||
17156066|NCT02908100|38302774|FG001|Overall Study|Randomised in Error|0|||
17156067|NCT02908100|38302775|FG002|Overall Study|Randomised in Error|0|||
17156068|NCT02982590|38302799|FG000|Overall Study|Lost to Follow-up|0|||
17156069|NCT02982590|38302800|FG001|Overall Study|Lost to Follow-up|1|||
17156070|NCT02982590|38302799|FG000|Overall Study|Death|4|||
17156071|NCT02982590|38302800|FG001|Overall Study|Death|0|||
17156072|NCT03310021|38302826|FG000|Overall Study|Withdrawal by Subject|0|||
17156073|NCT03310021|38302827|FG001|Overall Study|Withdrawal by Subject|0|||
17156074|NCT03310021|38302828|FG002|Overall Study|Withdrawal by Subject|0|||
17156075|NCT03310021|38302829|FG003|Overall Study|Withdrawal by Subject|0|||
17072681|NCT00362115|38215039|FG001|Overall Study|Protocol Violation|0|||
17072682|NCT00362115|38215040|FG002|Overall Study|Protocol Violation|0|||
17072683|NCT00362115|38215041|FG003|Overall Study|Protocol Violation|0|||
17072684|NCT00362115|38215042|FG004|Overall Study|Protocol Violation|0|||
17072685|NCT00362115|38215043|FG005|Overall Study|Protocol Violation|1|||
17072686|NCT00362115|38215044|FG006|Overall Study|Protocol Violation|0|||
17072687|NCT00362115|38215038|FG000|Overall Study|Lost to Follow-up|0|||
17072688|NCT00362115|38215039|FG001|Overall Study|Lost to Follow-up|1|||
17072689|NCT00362115|38215040|FG002|Overall Study|Lost to Follow-up|0|||
17072690|NCT00362115|38215041|FG003|Overall Study|Lost to Follow-up|0|||
17072691|NCT00362115|38215042|FG004|Overall Study|Lost to Follow-up|2|||
17072692|NCT00362115|38215043|FG005|Overall Study|Lost to Follow-up|0|||
17072693|NCT00362115|38215044|FG006|Overall Study|Lost to Follow-up|1|||
17072694|NCT00362115|38215038|FG000|Overall Study|Withdrawal by Subject|1|||
17072695|NCT00362115|38215039|FG001|Overall Study|Withdrawal by Subject|3|||
17072696|NCT00362115|38215040|FG002|Overall Study|Withdrawal by Subject|1|||
17072697|NCT00362115|38215041|FG003|Overall Study|Withdrawal by Subject|0|||
17072698|NCT00362115|38215042|FG004|Overall Study|Withdrawal by Subject|1|||
17072699|NCT00362115|38215043|FG005|Overall Study|Withdrawal by Subject|3|||
17072700|NCT00362115|38215044|FG006|Overall Study|Withdrawal by Subject|4|||
17072701|NCT00362115|38215038|FG000|Overall Study|Lack of Efficacy|1|||
17072702|NCT00362115|38215039|FG001|Overall Study|Lack of Efficacy|0|||
17072703|NCT00362115|38215040|FG002|Overall Study|Lack of Efficacy|5|||
17072704|NCT00362115|38215041|FG003|Overall Study|Lack of Efficacy|2|||
17072705|NCT00362115|38215042|FG004|Overall Study|Lack of Efficacy|2|||
17072706|NCT00362115|38215043|FG005|Overall Study|Lack of Efficacy|0|||
17072707|NCT00362115|38215044|FG006|Overall Study|Lack of Efficacy|3|||
17072708|NCT00362115|38215038|FG000|Overall Study|Physician Decision|0|||
17072709|NCT00362115|38215039|FG001|Overall Study|Physician Decision|0|||
17072710|NCT00362115|38215040|FG002|Overall Study|Physician Decision|0|||
17072711|NCT00362115|38215041|FG003|Overall Study|Physician Decision|0|||
17072712|NCT00362115|38215042|FG004|Overall Study|Physician Decision|0|||
17072713|NCT00362115|38215043|FG005|Overall Study|Physician Decision|0|||
17072714|NCT00362115|38215044|FG006|Overall Study|Physician Decision|3|||
17156076|NCT03310021|38302830|FG004|Overall Study|Withdrawal by Subject|0|||
17156077|NCT03310021|38302831|FG005|Overall Study|Withdrawal by Subject|0|||
17156078|NCT03310021|38302832|FG006|Overall Study|Withdrawal by Subject|1|||
17156079|NCT03310021|38302833|FG007|Overall Study|Withdrawal by Subject|0|||
17156080|NCT03310021|38302834|FG008|Overall Study|Withdrawal by Subject|0|||
17156081|NCT03310021|38302835|FG009|Overall Study|Withdrawal by Subject|0|||
17156082|NCT03310021|38302836|FG010|Overall Study|Withdrawal by Subject|0|||
17156083|NCT03310021|38302837|FG011|Overall Study|Withdrawal by Subject|0|||
17156084|NCT03310021|38302838|FG012|Overall Study|Withdrawal by Subject|0|||
17156085|NCT03310021|38302839|FG013|Overall Study|Withdrawal by Subject|0|||
17156086|NCT03310021|38302840|FG014|Overall Study|Withdrawal by Subject|0|||
17156087|NCT03310021|38302841|FG015|Overall Study|Withdrawal by Subject|0|||
17156088|NCT03310021|38302842|FG016|Overall Study|Withdrawal by Subject|0|||
17156089|NCT03310021|38302843|FG017|Overall Study|Withdrawal by Subject|0|||
17156090|NCT03310021|38302844|FG018|Overall Study|Withdrawal by Subject|0|||
17156091|NCT03310021|38302845|FG019|Overall Study|Withdrawal by Subject|0|||
17156092|NCT03310021|38302826|FG000|Overall Study|Lost to Follow-up|0|||
17156093|NCT03310021|38302827|FG001|Overall Study|Lost to Follow-up|0|||
17156094|NCT03310021|38302828|FG002|Overall Study|Lost to Follow-up|0|||
16994271|NCT00773734|38138077|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
16994272|NCT00773734|38138072|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
16994273|NCT00773734|38138073|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
16994274|NCT00773734|38138074|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
16994275|NCT00773734|38138075|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
16994276|NCT00773734|38138076|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
16994277|NCT00773734|38138077|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
16994278|NCT00773734|38138072|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
17072715|NCT00362115|38215038|FG000|Overall Study|Other|0|||
17072716|NCT00362115|38215039|FG001|Overall Study|Other|1|||
17072717|NCT00362115|38215040|FG002|Overall Study|Other|0|||
17072718|NCT00362115|38215041|FG003|Overall Study|Other|1|||
17072719|NCT00362115|38215042|FG004|Overall Study|Other|0|||
17072720|NCT00362115|38215043|FG005|Overall Study|Other|1|||
17072721|NCT00362115|38215044|FG006|Overall Study|Other|0|||
17072722|NCT00485264|38215066|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
17072723|NCT00485264|38215067|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
17156095|NCT03310021|38302829|FG003|Overall Study|Lost to Follow-up|0|||
17156096|NCT03310021|38302830|FG004|Overall Study|Lost to Follow-up|0|||
17156097|NCT03310021|38302831|FG005|Overall Study|Lost to Follow-up|0|||
17156098|NCT03310021|38302832|FG006|Overall Study|Lost to Follow-up|0|||
17156099|NCT03310021|38302833|FG007|Overall Study|Lost to Follow-up|0|||
17156100|NCT03310021|38302834|FG008|Overall Study|Lost to Follow-up|0|||
17156101|NCT03310021|38302835|FG009|Overall Study|Lost to Follow-up|0|||
17156102|NCT03310021|38302836|FG010|Overall Study|Lost to Follow-up|1|||
17156103|NCT03310021|38302837|FG011|Overall Study|Lost to Follow-up|0|||
17156104|NCT03310021|38302838|FG012|Overall Study|Lost to Follow-up|0|||
17156105|NCT03310021|38302839|FG013|Overall Study|Lost to Follow-up|0|||
16994279|NCT00773734|38138073|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
16994280|NCT00773734|38138074|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
16994281|NCT00773734|38138075|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
17156106|NCT03310021|38302840|FG014|Overall Study|Lost to Follow-up|0|||
17156107|NCT03310021|38302841|FG015|Overall Study|Lost to Follow-up|0|||
17156108|NCT03310021|38302842|FG016|Overall Study|Lost to Follow-up|0|||
17156109|NCT03310021|38302843|FG017|Overall Study|Lost to Follow-up|0|||
17156110|NCT03310021|38302844|FG018|Overall Study|Lost to Follow-up|0|||
17156111|NCT03310021|38302845|FG019|Overall Study|Lost to Follow-up|0|||
17156112|NCT03333109|38302890|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
17156113|NCT03333109|38302891|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
17156114|NCT03333109|38302892|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
17156115|NCT03333109|38302890|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
17156116|NCT03333109|38302891|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
17156117|NCT03333109|38302892|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
17156118|NCT03333109|38302890|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
17156119|NCT03333109|38302891|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
17156120|NCT03333109|38302892|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
17156121|NCT03333109|38302890|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
17156122|NCT03333109|38302891|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
17156123|NCT03333109|38302892|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
17156124|NCT03333109|38302890|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
17156125|NCT03333109|38302891|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
17156126|NCT03333109|38302892|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
17156127|NCT03333109|38302890|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
17156128|NCT03333109|38302891|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
17156129|NCT03333109|38302892|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
17156130|NCT03333109|38302890|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
17156131|NCT03333109|38302891|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
17156132|NCT03333109|38302892|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
17156133|NCT03333109|38302890|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
17156134|NCT03333109|38302891|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
17156135|NCT03333109|38302892|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
17156136|NCT02940223|38302902|FG000|Overall Study|Failed Requirement|2|||
17156137|NCT02940223|38302903|FG001|Overall Study|Failed Requirement|0|||
17156138|NCT03296527|38302911|FG000|Overall Study|Adverse Event|15|||
17156139|NCT03296527|38302912|FG001|Overall Study|Adverse Event|33|||
17156140|NCT03296527|38302911|FG000|Overall Study|Protocol Deviation|4|||
17156141|NCT03296527|38302912|FG001|Overall Study|Protocol Deviation|0|||
17156142|NCT03296527|38302911|FG000|Overall Study|Subject withdrew consent|3|||
17156143|NCT03296527|38302912|FG001|Overall Study|Subject withdrew consent|1|||
17156144|NCT03296527|38302911|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
17156145|NCT03296527|38302912|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
17156146|NCT03296527|38302911|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
17156147|NCT03296527|38302912|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
17156148|NCT03296527|38302911|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
17156149|NCT03296527|38302912|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
17156150|NCT03296527|38302911|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
17156151|NCT03296527|38302912|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
17156152|NCT03296527|38302911|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
17156153|NCT03296527|38302912|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
17156154|NCT03295201|38302921|FG000|Overall Study|Lost to Follow-up|1|||
17156155|NCT03295201|38302922|FG001|Overall Study|Lost to Follow-up|1|||
17072724|NCT00485264|38215068|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
17072725|NCT00485264|38215069|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
17156156|NCT03295201|38302921|FG000|Overall Study|Hospital admission|0|||
17156157|NCT03295201|38302922|FG001|Overall Study|Hospital admission|1|||
17156158|NCT03293485|38302928|FG000|Overall Study|Death|1|||
17156159|NCT03293485|38302928|FG000|Overall Study|Screen Failure|2|||
17156160|NCT03293485|38302928|FG000|Overall Study|Withdrawal by Subject|2|||
17156161|NCT03309943|38302936|FG000|Overall Study|Withdrawal by Subject|0|||
17156162|NCT03309943|38302937|FG001|Overall Study|Withdrawal by Subject|1|||
17156163|NCT03309943|38302936|FG000|Overall Study|Inappropriate behavior towards staff|0|||
17156164|NCT03309943|38302937|FG001|Overall Study|Inappropriate behavior towards staff|1|||
17072726|NCT00485264|38215070|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
17072727|NCT00485264|38215071|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
17072728|NCT00485264|38215066|FG000|Overall Study|Death|1|||
17072729|NCT00485264|38215067|FG001|Overall Study|Death|0|||
17072730|NCT00485264|38215068|FG002|Overall Study|Death|0|||
17072731|NCT00485264|38215069|FG003|Overall Study|Death|0|||
17156165|NCT01732627|38302945|FG000|Overall Study|Withdrawal by Subject|1|||
17156166|NCT01732627|38302946|FG001|Overall Study|Withdrawal by Subject|0|||
17156167|NCT03307837|38302958|FG000|Overall Study|Withdrawal by Subject|0|||
17156168|NCT03307837|38302959|FG001|Overall Study|Withdrawal by Subject|0|||
17156169|NCT03307837|38302960|FG002|Overall Study|Withdrawal by Subject|1|||
17156170|NCT03307837|38302961|FG003|Overall Study|Withdrawal by Subject|0|||
17156171|NCT03307837|38302962|FG004|Overall Study|Withdrawal by Subject|0|||
17156172|NCT03307837|38302963|FG005|Overall Study|Withdrawal by Subject|1|||
16994282|NCT00773734|38138076|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
16994283|NCT00773734|38138077|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
16994284|NCT00773734|38138072|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
16994285|NCT00773734|38138073|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
16994286|NCT00773734|38138074|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
16994287|NCT00773734|38138075|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
17072732|NCT00485264|38215070|FG004|Overall Study|Death|1|||
17072733|NCT00485264|38215071|FG005|Overall Study|Death|0|||
17072734|NCT00485264|38215066|FG000|Overall Study|Adverse Event|1|||
17072735|NCT00485264|38215067|FG001|Overall Study|Adverse Event|0|||
17072736|NCT00485264|38215068|FG002|Overall Study|Adverse Event|2|||
17072737|NCT00485264|38215069|FG003|Overall Study|Adverse Event|3|||
17072738|NCT00485264|38215070|FG004|Overall Study|Adverse Event|1|||
17072739|NCT00485264|38215071|FG005|Overall Study|Adverse Event|3|||
17072740|NCT00485264|38215066|FG000|Overall Study|Pregnancy|4|||
17072741|NCT00485264|38215067|FG001|Overall Study|Pregnancy|0|||
17072742|NCT00485264|38215068|FG002|Overall Study|Pregnancy|0|||
17072743|NCT00485264|38215069|FG003|Overall Study|Pregnancy|0|||
17072744|NCT00485264|38215070|FG004|Overall Study|Pregnancy|0|||
17072745|NCT00485264|38215071|FG005|Overall Study|Pregnancy|0|||
17072746|NCT00485264|38215066|FG000|Overall Study|Disallowed Medication|0|||
16781257|NCT02109484|37720415|FG006|Overall Study|Death|0|||
16994288|NCT00773734|38138076|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
16994289|NCT00773734|38138077|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
16994290|NCT00773734|38138072|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
16994291|NCT00773734|38138073|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
16994292|NCT00773734|38138074|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
16994293|NCT00773734|38138075|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
16994294|NCT00773734|38138076|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
16994295|NCT00773734|38138077|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
16994296|NCT00773734|38138072|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
16994297|NCT00773734|38138073|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
16994298|NCT00773734|38138074|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
16994299|NCT00773734|38138075|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
16994300|NCT00773734|38138076|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
16994301|NCT00773734|38138077|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
16994302|NCT00773734|38138072|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
16994303|NCT00773734|38138073|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
16994304|NCT00773734|38138074|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
16994305|NCT00773734|38138075|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
16994306|NCT00773734|38138076|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
16994307|NCT00773734|38138077|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
16994308|NCT00773734|38138072|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
16994309|NCT00773734|38138073|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
16994310|NCT00773734|38138074|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
16994311|NCT00773734|38138075|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
16994312|NCT00773734|38138076|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
16994313|NCT00773734|38138077|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
16994314|NCT00773734|38138072|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
16994315|NCT00773734|38138073|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
16994316|NCT00773734|38138074|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
16994317|NCT00773734|38138075|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
16994318|NCT00773734|38138076|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
17156173|NCT03307837|38302958|FG000|Overall Study|Lost to Follow-up|1|||
17156174|NCT03307837|38302959|FG001|Overall Study|Lost to Follow-up|1|||
17156175|NCT03307837|38302960|FG002|Overall Study|Lost to Follow-up|0|||
17156176|NCT03307837|38302961|FG003|Overall Study|Lost to Follow-up|0|||
17156177|NCT03307837|38302962|FG004|Overall Study|Lost to Follow-up|0|||
17156178|NCT03307837|38302963|FG005|Overall Study|Lost to Follow-up|1|||
17156179|NCT03331315|38302984|FG000|Overall Study|Physician Decision|18|||
17156180|NCT03331315|38302985|FG001|Overall Study|Physician Decision|14|||
17156181|NCT03329989|38302993|FG000|Overall Study|Withdrawal by Subject|9|||
17156182|NCT03329989|38302993|FG000|Overall Study|Lost to Follow-up|8|||
17156183|NCT03329989|38302993|FG000|Overall Study|Adverse Event|5|||
17156184|NCT03329989|38302993|FG000|Overall Study|Protocol Violation|1|||
17156185|NCT03287869|38302999|FG000|Overall Study|Adverse Event|14|||
17156186|NCT03287869|38303000|FG001|Overall Study|Adverse Event|12|||
17156187|NCT03287869|38302999|FG000|Overall Study|Lack of Efficacy|1|||
17156188|NCT03287869|38303000|FG001|Overall Study|Lack of Efficacy|0|||
17156189|NCT03287869|38302999|FG000|Overall Study|Lost to Follow-up|13|||
17156190|NCT03287869|38303000|FG001|Overall Study|Lost to Follow-up|19|||
17156191|NCT03287869|38302999|FG000|Overall Study|Non-Compliance With Study Drug|5|||
17156192|NCT03287869|38303000|FG001|Overall Study|Non-Compliance With Study Drug|9|||
17156193|NCT03287869|38302999|FG000|Overall Study|Progressive Disease|1|||
17156194|NCT03287869|38303000|FG001|Overall Study|Progressive Disease|0|||
17156195|NCT03287869|38302999|FG000|Overall Study|Protocol Deviation|2|||
17156196|NCT03287869|38303000|FG001|Overall Study|Protocol Deviation|1|||
17156197|NCT03287869|38302999|FG000|Overall Study|Withdrawal by Subject|36|||
17156198|NCT03287869|38303000|FG001|Overall Study|Withdrawal by Subject|43|||
17156199|NCT03287869|38302999|FG000|Overall Study|Early Closure of the Site|0|||
17156200|NCT03287869|38303000|FG001|Overall Study|Early Closure of the Site|1|||
17156201|NCT03287869|38302999|FG000|Overall Study|Physician Decision|5|||
17156202|NCT03287869|38303000|FG001|Overall Study|Physician Decision|5|||
17156203|NCT03287869|38302999|FG000|Overall Study|Reason not Specified|6|||
17156204|NCT03287869|38303000|FG001|Overall Study|Reason not Specified|3|||
17156205|NCT02661490|38303011|FG000|Overall Study|Lost to Follow-up|0|||
17156206|NCT02661490|38303012|FG001|Overall Study|Lost to Follow-up|1|||
17156207|NCT02661490|38303013|FG002|Overall Study|Lost to Follow-up|0|||
17156208|NCT02661490|38303014|FG003|Overall Study|Lost to Follow-up|0|||
17072747|NCT00485264|38215067|FG001|Overall Study|Disallowed Medication|0|||
17072748|NCT00485264|38215068|FG002|Overall Study|Disallowed Medication|0|||
17072749|NCT00485264|38215069|FG003|Overall Study|Disallowed Medication|0|||
17072750|NCT00485264|38215070|FG004|Overall Study|Disallowed Medication|0|||
17072751|NCT00485264|38215071|FG005|Overall Study|Disallowed Medication|1|||
17072752|NCT00485264|38215066|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
17072753|NCT00485264|38215067|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
17156209|NCT02661490|38303015|FG004|Overall Study|Lost to Follow-up|2|||
17156210|NCT02661490|38303011|FG000|Overall Study|Withdrawal by Subject|2|||
17156211|NCT02661490|38303012|FG001|Overall Study|Withdrawal by Subject|0|||
17156212|NCT02661490|38303013|FG002|Overall Study|Withdrawal by Subject|2|||
17156213|NCT02661490|38303014|FG003|Overall Study|Withdrawal by Subject|0|||
17156214|NCT02661490|38303015|FG004|Overall Study|Withdrawal by Subject|0|||
17156215|NCT02661490|38303011|FG000|Overall Study|Death|1|||
17156216|NCT02661490|38303012|FG001|Overall Study|Death|1|||
17156217|NCT02661490|38303013|FG002|Overall Study|Death|0|||
17156218|NCT02661490|38303014|FG003|Overall Study|Death|1|||
17156219|NCT02661490|38303015|FG004|Overall Study|Death|0|||
17156220|NCT02661490|38303011|FG000|Overall Study|Reason not Specified|0|||
17156221|NCT02661490|38303012|FG001|Overall Study|Reason not Specified|0|||
17156222|NCT02661490|38303013|FG002|Overall Study|Reason not Specified|0|||
17156223|NCT02661490|38303014|FG003|Overall Study|Reason not Specified|0|||
17156224|NCT02661490|38303015|FG004|Overall Study|Reason not Specified|1|||
17156225|NCT03287791|38303030|FG000|Overall Study|Insufficient Therapeutic Response|0|||
17156226|NCT03287791|38303031|FG001|Overall Study|Insufficient Therapeutic Response|0|||
17156227|NCT03287791|38303032|FG002|Overall Study|Insufficient Therapeutic Response|1|||
17156228|NCT03287791|38303030|FG000|Overall Study|Adverse Event|0|||
17072754|NCT00485264|38215068|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
17156229|NCT03287791|38303031|FG001|Overall Study|Adverse Event|4|||
17156230|NCT03287791|38303032|FG002|Overall Study|Adverse Event|3|||
17156231|NCT03287791|38303030|FG000|Overall Study|Withdrawal by Subject|12|||
17156232|NCT03287791|38303031|FG001|Overall Study|Withdrawal by Subject|12|||
17156233|NCT03287791|38303032|FG002|Overall Study|Withdrawal by Subject|17|||
17156234|NCT03287791|38303030|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
17156235|NCT03287791|38303031|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
17156236|NCT03287791|38303032|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
17156237|NCT03287791|38303030|FG000|Overall Study|Lost to Follow-up|8|||
17156238|NCT03287791|38303031|FG001|Overall Study|Lost to Follow-up|14|||
17156239|NCT03287791|38303032|FG002|Overall Study|Lost to Follow-up|11|||
17156240|NCT03287791|38303030|FG000|Overall Study|Protocol Violation|7|||
17156241|NCT03287791|38303031|FG001|Overall Study|Protocol Violation|2|||
17156242|NCT03287791|38303032|FG002|Overall Study|Protocol Violation|1|||
17156243|NCT03287791|38303030|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
17156244|NCT03287791|38303031|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
17156245|NCT03287791|38303032|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
17156246|NCT03287791|38303030|FG000|Overall Study|Too much time between 2 visits|0|||
17156247|NCT03287791|38303031|FG001|Overall Study|Too much time between 2 visits|1|||
17156248|NCT03287791|38303032|FG002|Overall Study|Too much time between 2 visits|0|||
17156249|NCT03287791|38303030|FG000|Overall Study|Non-compliance|0|||
17156250|NCT03287791|38303031|FG001|Overall Study|Non-compliance|1|||
17156251|NCT03287791|38303032|FG002|Overall Study|Non-compliance|0|||
17156252|NCT03287791|38303030|FG000|Overall Study|Did not meet inclusion criteria|1|||
17156253|NCT03287791|38303031|FG001|Overall Study|Did not meet inclusion criteria|0|||
17156254|NCT03287791|38303032|FG002|Overall Study|Did not meet inclusion criteria|0|||
17156255|NCT03287635|38303040|FG000|Overall Study|Lost to Follow-up|5|||
17156256|NCT03287635|38303040|FG000|Overall Study|Withdrawal by Subject|1|||
17156257|NCT03287635|38303040|FG000|Overall Study|Physician Decision|1|||
17156258|NCT03287089|38303046|FG000|Overall Study|Lost to Follow-up|0|||
17156259|NCT03287089|38303047|FG001|Overall Study|Lost to Follow-up|2|||
17156260|NCT03287089|38303046|FG000|Overall Study|Physician Decision|0|||
17156261|NCT03287089|38303047|FG001|Overall Study|Physician Decision|2|||
17156262|NCT03287089|38303046|FG000|Overall Study|Withdrawal by Subject|0|||
17156263|NCT03287089|38303047|FG001|Overall Study|Withdrawal by Subject|2|||
17156264|NCT03286543|38303055|FG000|Consented|Screen failure before randomization|2|||
17156265|NCT03286543|38303056|FG001|Consented|Screen failure before randomization|0|||
17156266|NCT03286543|38303057|FG002|Consented|Screen failure before randomization|0|||
17156267|NCT03286543|38303055|FG000|Consented|Screen failure before enrollment|4|||
17156268|NCT03286543|38303056|FG001|Consented|Screen failure before enrollment|0|||
17156269|NCT03286543|38303057|FG002|Consented|Screen failure before enrollment|0|||
17156270|NCT03286543|38303055|FG000|Consented|TKA cancelled after enrollment|1|||
17156271|NCT03286543|38303056|FG001|Consented|TKA cancelled after enrollment|0|||
17156272|NCT03286543|38303057|FG002|Consented|TKA cancelled after enrollment|0|||
17156273|NCT03286543|38303055|FG000|Consented|Withdrawn from study|12|||
17156274|NCT03286543|38303056|FG001|Consented|Withdrawn from study|0|||
17156275|NCT03286543|38303057|FG002|Consented|Withdrawn from study|0|||
17156276|NCT03286543|38303055|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
17156277|NCT03286543|38303056|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
17156278|NCT03286543|38303057|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
17156279|NCT03286543|38303055|FG000|Study Enrollment|Withdrawn from study|0|||
17156280|NCT03286543|38303056|FG001|Study Enrollment|Withdrawn from study|6|||
17156281|NCT03286543|38303057|FG002|Study Enrollment|Withdrawn from study|6|||
17156282|NCT03306433|38303063|FG000|Overall Study|Lost to Follow-up|3|||
17156283|NCT03306433|38303063|FG000|Overall Study|Patient did not have teeth extracted|1|||
17156284|NCT03306433|38303063|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
17156285|NCT02940691|38303071|FG000|Overall Study|Lost to Follow-up|5|||
17156286|NCT02940691|38303071|FG000|Overall Study|Incarceration|1|||
17156287|NCT03306277|38303109|FG000|Overall Study|Death|1|||
17156288|NCT03306277|38303109|FG000|Overall Study|Adverse Event|1|||
17156289|NCT03306277|38303109|FG000|Overall Study|Withdrawal by Subject|1|||
17156290|NCT03130959|38303123|FG000|Overall Study|Disease progression|19|||
17156291|NCT03130959|38303124|FG001|Overall Study|Disease progression|7|||
17156292|NCT03130959|38303125|FG002|Overall Study|Disease progression|12|||
17156293|NCT03130959|38303126|FG003|Overall Study|Disease progression|7|||
17156294|NCT03130959|38303127|FG004|Overall Study|Disease progression|12|||
17156295|NCT03130959|38303128|FG005|Overall Study|Disease progression|3|||
17156296|NCT03130959|38303129|FG006|Overall Study|Disease progression|6|||
17156297|NCT03130959|38303130|FG007|Overall Study|Disease progression|3|||
17156298|NCT03130959|38303131|FG008|Overall Study|Disease progression|15|||
17156299|NCT03130959|38303132|FG009|Overall Study|Disease progression|8|||
17156300|NCT03130959|38303123|FG000|Overall Study|Study drug toxicity|2|||
17156301|NCT03130959|38303124|FG001|Overall Study|Study drug toxicity|2|||
17156302|NCT03130959|38303125|FG002|Overall Study|Study drug toxicity|1|||
17156303|NCT03130959|38303126|FG003|Overall Study|Study drug toxicity|2|||
17156304|NCT03130959|38303127|FG004|Overall Study|Study drug toxicity|1|||
17156305|NCT03130959|38303128|FG005|Overall Study|Study drug toxicity|1|||
17156306|NCT03130959|38303129|FG006|Overall Study|Study drug toxicity|3|||
17156307|NCT03130959|38303130|FG007|Overall Study|Study drug toxicity|0|||
17156308|NCT03130959|38303131|FG008|Overall Study|Study drug toxicity|3|||
17156309|NCT03130959|38303132|FG009|Overall Study|Study drug toxicity|3|||
17156310|NCT03130959|38303123|FG000|Overall Study|Other reasons|0|||
17156311|NCT03130959|38303124|FG001|Overall Study|Other reasons|0|||
17156312|NCT03130959|38303125|FG002|Overall Study|Other reasons|0|||
17156313|NCT03130959|38303126|FG003|Overall Study|Other reasons|0|||
17156314|NCT03130959|38303127|FG004|Overall Study|Other reasons|0|||
17156315|NCT03130959|38303128|FG005|Overall Study|Other reasons|1|||
17156316|NCT03130959|38303129|FG006|Overall Study|Other reasons|1|||
17156317|NCT03130959|38303130|FG007|Overall Study|Other reasons|0|||
17156318|NCT03130959|38303131|FG008|Overall Study|Other reasons|0|||
17156319|NCT03130959|38303132|FG009|Overall Study|Other reasons|0|||
17156320|NCT03130959|38303123|FG000|Overall Study|Subject request to discontinue therapy|0|||
17156321|NCT03130959|38303124|FG001|Overall Study|Subject request to discontinue therapy|0|||
17156322|NCT03130959|38303125|FG002|Overall Study|Subject request to discontinue therapy|1|||
17156323|NCT03130959|38303126|FG003|Overall Study|Subject request to discontinue therapy|1|||
17156324|NCT03130959|38303127|FG004|Overall Study|Subject request to discontinue therapy|0|||
17156325|NCT03130959|38303128|FG005|Overall Study|Subject request to discontinue therapy|0|||
17156326|NCT03130959|38303129|FG006|Overall Study|Subject request to discontinue therapy|1|||
17156327|NCT03130959|38303130|FG007|Overall Study|Subject request to discontinue therapy|1|||
17156328|NCT03130959|38303131|FG008|Overall Study|Subject request to discontinue therapy|0|||
17156329|NCT03130959|38303132|FG009|Overall Study|Subject request to discontinue therapy|0|||
17156330|NCT03130959|38303123|FG000|Overall Study|Not reported|0|||
17156331|NCT03130959|38303124|FG001|Overall Study|Not reported|0|||
17156332|NCT03130959|38303125|FG002|Overall Study|Not reported|0|||
17156333|NCT03130959|38303126|FG003|Overall Study|Not reported|1|||
17156334|NCT03130959|38303127|FG004|Overall Study|Not reported|0|||
17156335|NCT03130959|38303128|FG005|Overall Study|Not reported|1|||
17156336|NCT03130959|38303129|FG006|Overall Study|Not reported|0|||
17156337|NCT03130959|38303130|FG007|Overall Study|Not reported|0|||
17156338|NCT03130959|38303131|FG008|Overall Study|Not reported|0|||
17156339|NCT03130959|38303132|FG009|Overall Study|Not reported|1|||
17156340|NCT03130959|38303123|FG000|Overall Study|Adverse Event unrelated to drug|0|||
17156341|NCT03130959|38303124|FG001|Overall Study|Adverse Event unrelated to drug|0|||
17156342|NCT03130959|38303125|FG002|Overall Study|Adverse Event unrelated to drug|1|||
17156343|NCT03130959|38303126|FG003|Overall Study|Adverse Event unrelated to drug|1|||
17156344|NCT03130959|38303127|FG004|Overall Study|Adverse Event unrelated to drug|1|||
17156345|NCT03130959|38303128|FG005|Overall Study|Adverse Event unrelated to drug|0|||
17156346|NCT03130959|38303129|FG006|Overall Study|Adverse Event unrelated to drug|1|||
17156347|NCT03130959|38303130|FG007|Overall Study|Adverse Event unrelated to drug|0|||
17156348|NCT03130959|38303131|FG008|Overall Study|Adverse Event unrelated to drug|1|||
17156349|NCT03130959|38303132|FG009|Overall Study|Adverse Event unrelated to drug|1|||
17156350|NCT03130959|38303123|FG000|Overall Study|Participant withdrew consent|0|||
17156351|NCT03130959|38303124|FG001|Overall Study|Participant withdrew consent|1|||
17156352|NCT03130959|38303125|FG002|Overall Study|Participant withdrew consent|0|||
17156353|NCT03130959|38303126|FG003|Overall Study|Participant withdrew consent|2|||
17156354|NCT03130959|38303127|FG004|Overall Study|Participant withdrew consent|1|||
17156355|NCT03130959|38303128|FG005|Overall Study|Participant withdrew consent|0|||
17156356|NCT03130959|38303129|FG006|Overall Study|Participant withdrew consent|0|||
17156357|NCT03130959|38303130|FG007|Overall Study|Participant withdrew consent|0|||
17156358|NCT03130959|38303131|FG008|Overall Study|Participant withdrew consent|0|||
17072755|NCT00485264|38215069|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
17072756|NCT00485264|38215070|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
17072757|NCT00485264|38215071|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
17072758|NCT00485264|38215066|FG000|Overall Study|Lack of Efficacy|0|||
17072759|NCT00485264|38215067|FG001|Overall Study|Lack of Efficacy|1|||
17072760|NCT00485264|38215068|FG002|Overall Study|Lack of Efficacy|0|||
17072761|NCT00485264|38215069|FG003|Overall Study|Lack of Efficacy|0|||
17072762|NCT00485264|38215070|FG004|Overall Study|Lack of Efficacy|0|||
17072763|NCT00485264|38215071|FG005|Overall Study|Lack of Efficacy|0|||
17072764|NCT00485264|38215066|FG000|Overall Study|Guardian Consent Withdrawn|1|||
17072765|NCT00485264|38215067|FG001|Overall Study|Guardian Consent Withdrawn|0|||
17072766|NCT00485264|38215068|FG002|Overall Study|Guardian Consent Withdrawn|0|||
17072767|NCT00485264|38215069|FG003|Overall Study|Guardian Consent Withdrawn|0|||
17072768|NCT00485264|38215070|FG004|Overall Study|Guardian Consent Withdrawn|1|||
17072769|NCT00485264|38215071|FG005|Overall Study|Guardian Consent Withdrawn|0|||
17072770|NCT00485264|38215066|FG000|Overall Study|Physician Decision|0|||
17072771|NCT00485264|38215067|FG001|Overall Study|Physician Decision|2|||
17072772|NCT00485264|38215068|FG002|Overall Study|Physician Decision|0|||
17072773|NCT00485264|38215069|FG003|Overall Study|Physician Decision|0|||
17072774|NCT00485264|38215070|FG004|Overall Study|Physician Decision|0|||
17072775|NCT00485264|38215071|FG005|Overall Study|Physician Decision|0|||
17156359|NCT03130959|38303132|FG009|Overall Study|Participant withdrew consent|2|||
17156360|NCT03130959|38303123|FG000|Overall Study|Administrative reason by sponsor|1|||
17156361|NCT03130959|38303124|FG001|Overall Study|Administrative reason by sponsor|0|||
17156362|NCT03130959|38303125|FG002|Overall Study|Administrative reason by sponsor|1|||
17156363|NCT03130959|38303126|FG003|Overall Study|Administrative reason by sponsor|0|||
17156364|NCT03130959|38303127|FG004|Overall Study|Administrative reason by sponsor|0|||
17156365|NCT03130959|38303128|FG005|Overall Study|Administrative reason by sponsor|0|||
17156366|NCT03130959|38303129|FG006|Overall Study|Administrative reason by sponsor|0|||
17156367|NCT03130959|38303130|FG007|Overall Study|Administrative reason by sponsor|0|||
17156368|NCT03130959|38303131|FG008|Overall Study|Administrative reason by sponsor|0|||
17156369|NCT03130959|38303132|FG009|Overall Study|Administrative reason by sponsor|0|||
17156370|NCT03130959|38303123|FG000|Overall Study|Lost to Follow-up|1|||
17156371|NCT03130959|38303124|FG001|Overall Study|Lost to Follow-up|0|||
17156372|NCT03130959|38303125|FG002|Overall Study|Lost to Follow-up|0|||
17156373|NCT03130959|38303126|FG003|Overall Study|Lost to Follow-up|0|||
17156374|NCT03130959|38303127|FG004|Overall Study|Lost to Follow-up|0|||
17156375|NCT03130959|38303128|FG005|Overall Study|Lost to Follow-up|0|||
17156376|NCT03130959|38303129|FG006|Overall Study|Lost to Follow-up|0|||
17156377|NCT03130959|38303130|FG007|Overall Study|Lost to Follow-up|0|||
17156378|NCT03130959|38303131|FG008|Overall Study|Lost to Follow-up|0|||
17156379|NCT03130959|38303132|FG009|Overall Study|Lost to Follow-up|0|||
17156380|NCT03124407|38303171|FG000|Overall Study|Lost to Follow-up|1|||
17156381|NCT03124407|38303172|FG001|Overall Study|Lost to Follow-up|0|||
17156382|NCT03124407|38303173|FG002|Overall Study|Lost to Follow-up|0|||
17156383|NCT03124407|38303174|FG003|Overall Study|Lost to Follow-up|0|||
17156384|NCT03124407|38303171|FG000|Overall Study|Adverse Event|0|||
17156385|NCT03124407|38303172|FG001|Overall Study|Adverse Event|0|||
17156386|NCT03124407|38303173|FG002|Overall Study|Adverse Event|1|||
17156387|NCT03124407|38303174|FG003|Overall Study|Adverse Event|0|||
17156388|NCT02929407|38303188|FG000|Overall Study|Adverse Event|1|||
17156389|NCT03123939|38303192|FG000|Overall Study|Lack of Efficacy|6|||
17156390|NCT03123939|38303192|FG000|Overall Study|Death|5|||
17156391|NCT03123939|38303192|FG000|Overall Study|Physician Decision|2|||
17156392|NCT03123939|38303192|FG000|Overall Study|Subject/guardian decision|2|||
17156393|NCT03123939|38303192|FG000|Overall Study|Lost to Follow-up|1|||
17156394|NCT03123939|38303192|FG000|Overall Study|New therapy for study indication|1|||
17156395|NCT03123939|38303192|FG000|Overall Study|Protocol deviation|1|||
17156396|NCT03123939|38303192|FG000|Overall Study|Progressive disease|18|||
17156397|NCT03123939|38303192|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
17156398|NCT03123939|38303192|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
17156399|NCT03123861|38303207|FG000|Overall Study|Protocol Violation|1|||
17156400|NCT03123861|38303208|FG001|Overall Study|Protocol Violation|1|||
17156401|NCT03123861|38303207|FG000|Overall Study|Withdrawal by Subject|2|||
17156402|NCT03123861|38303208|FG001|Overall Study|Withdrawal by Subject|2|||
17156403|NCT03123471|38303216|FG000|Placebo-controlled Phase|Adverse Event|3|||
17156404|NCT03123471|38303217|FG001|Placebo-controlled Phase|Adverse Event|8|||
17156405|NCT03123471|38303216|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
17156406|NCT03123471|38303217|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
17156407|NCT03123471|38303216|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
17156408|NCT03123471|38303217|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
17156409|NCT03123471|38303216|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
17156410|NCT03123471|38303217|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
17156411|NCT03123471|38303216|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
17156412|NCT03123471|38303217|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
17156413|NCT03123471|38303216|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
17156414|NCT03123471|38303217|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
17156415|NCT03123471|38303216|FG000|Placebo-controlled Phase|Miscellaneous|0|||
17156416|NCT03123471|38303217|FG001|Placebo-controlled Phase|Miscellaneous|1|||
17156417|NCT03123471|38303216|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
17156418|NCT03123471|38303217|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
17156419|NCT03123471|38303216|FG000|Apremilast Extension Phase|Adverse Event|1|||
17156420|NCT03123471|38303217|FG001|Apremilast Extension Phase|Adverse Event|5|||
17156421|NCT03123471|38303216|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
17156422|NCT03123471|38303217|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
17156423|NCT03123471|38303216|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
17156424|NCT03123471|38303217|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
17156425|NCT02661178|38303244|FG000|Part 1|Protocol Violation|1|||
17156426|NCT02661178|38303245|FG001|Part 1|Protocol Violation|0|||
17156427|NCT02661178|38303246|FG002|Part 1|Protocol Violation|0|||
17156428|NCT02661178|38303247|FG003|Part 1|Protocol Violation|0|||
17156429|NCT02661178|38303248|FG004|Part 1|Protocol Violation|0|||
17156430|NCT02661178|38303249|FG005|Part 1|Protocol Violation|0|||
17156431|NCT02661178|38303250|FG006|Part 1|Protocol Violation|0|||
17156432|NCT02661178|38303251|FG007|Part 1|Protocol Violation|0|||
17156433|NCT02661178|38303252|FG008|Part 1|Protocol Violation|0|||
17156434|NCT02661178|38303253|FG009|Part 1|Protocol Violation|0|||
17156435|NCT02661178|38303254|FG010|Part 1|Protocol Violation|0|||
17156436|NCT02661178|38303255|FG011|Part 1|Protocol Violation|0|||
17156437|NCT02661178|38303256|FG012|Part 1|Protocol Violation|0|||
17156438|NCT02661178|38303257|FG013|Part 1|Protocol Violation|0|||
17156439|NCT02661178|38303258|FG014|Part 1|Protocol Violation|0|||
17156440|NCT02660944|38303310|FG000|Overall Study|Adverse Event|3|||
17156441|NCT02660944|38303311|FG001|Overall Study|Adverse Event|4|||
17156442|NCT02660944|38303310|FG000|Overall Study|Physician Decision|3|||
17156443|NCT02660944|38303311|FG001|Overall Study|Physician Decision|1|||
17156444|NCT02660944|38303310|FG000|Overall Study|Withdrawal by Subject|5|||
17156445|NCT02660944|38303311|FG001|Overall Study|Withdrawal by Subject|3|||
17156446|NCT02660944|38303310|FG000|Overall Study|Lost to Follow-up|4|||
17156447|NCT02660944|38303311|FG001|Overall Study|Lost to Follow-up|1|||
17156448|NCT02660944|38303310|FG000|Overall Study|Subject schedule|0|||
17156449|NCT02660944|38303311|FG001|Overall Study|Subject schedule|1|||
17156450|NCT02660944|38303310|FG000|Overall Study|Exclusion criteria met|2|||
17156451|NCT02660944|38303311|FG001|Overall Study|Exclusion criteria met|0|||
17156452|NCT02975336|38303321|FG000|DBPC (52 Weeks)|Adverse Event|16|||
17156453|NCT02975336|38303322|FG001|DBPC (52 Weeks)|Adverse Event|17|||
17072776|NCT00485264|38215066|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
17072777|NCT00485264|38215067|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
17072778|NCT00485264|38215068|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
17072779|NCT00485264|38215069|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
17072780|NCT00485264|38215070|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
17072781|NCT00485264|38215071|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
17072782|NCT00485264|38215066|FG000|Overall Study|Not Able to Attend Clinic|5|||
17072783|NCT00485264|38215067|FG001|Overall Study|Not Able to Attend Clinic|0|||
17072784|NCT00485264|38215068|FG002|Overall Study|Not Able to Attend Clinic|0|||
17072785|NCT00485264|38215069|FG003|Overall Study|Not Able to Attend Clinic|1|||
17072786|NCT00485264|38215070|FG004|Overall Study|Not Able to Attend Clinic|1|||
17072787|NCT00485264|38215071|FG005|Overall Study|Not Able to Attend Clinic|2|||
17072788|NCT00485264|38215066|FG000|Overall Study|Non-Compliant|17|||
17072789|NCT00485264|38215067|FG001|Overall Study|Non-Compliant|2|||
17072790|NCT00485264|38215068|FG002|Overall Study|Non-Compliant|1|||
17072791|NCT00485264|38215069|FG003|Overall Study|Non-Compliant|0|||
17072792|NCT00485264|38215070|FG004|Overall Study|Non-Compliant|1|||
17072793|NCT00485264|38215071|FG005|Overall Study|Non-Compliant|0|||
17072794|NCT00485264|38215066|FG000|Overall Study|Lost to Follow-up|2|||
17072795|NCT00485264|38215067|FG001|Overall Study|Lost to Follow-up|1|||
17072796|NCT00485264|38215068|FG002|Overall Study|Lost to Follow-up|1|||
17156454|NCT02975336|38303323|FG002|DBPC (52 Weeks)|Adverse Event|13|||
17156455|NCT02975336|38303324|FG003|DBPC (52 Weeks)|Adverse Event|18|||
17156456|NCT02975336|38303325|FG004|DBPC (52 Weeks)|Adverse Event|0|||
17156457|NCT02975336|38303326|FG005|DBPC (52 Weeks)|Adverse Event|0|||
17156458|NCT02975336|38303327|FG006|DBPC (52 Weeks)|Adverse Event|0|||
17156459|NCT02975336|38303328|FG007|DBPC (52 Weeks)|Adverse Event|0|||
17156460|NCT02975336|38303321|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
17072797|NCT00485264|38215069|FG003|Overall Study|Lost to Follow-up|0|||
17072798|NCT00485264|38215070|FG004|Overall Study|Lost to Follow-up|0|||
17072799|NCT00485264|38215071|FG005|Overall Study|Lost to Follow-up|1|||
17072800|NCT00485264|38215066|FG000|Overall Study|Other Reason|3|||
17072801|NCT00485264|38215067|FG001|Overall Study|Other Reason|0|||
17072802|NCT00485264|38215068|FG002|Overall Study|Other Reason|0|||
17072803|NCT00485264|38215069|FG003|Overall Study|Other Reason|0|||
17072804|NCT00485264|38215070|FG004|Overall Study|Other Reason|0|||
17072805|NCT00485264|38215071|FG005|Overall Study|Other Reason|0|||
17072806|NCT00293254|38215092|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
17072807|NCT00293254|38215093|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
17072808|NCT00293254|38215092|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
17072809|NCT00293254|38215093|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
17072810|NCT00293254|38215092|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
17072811|NCT00293254|38215093|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
17072812|NCT00293254|38215092|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
17072813|NCT00293254|38215093|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
17072814|NCT00293254|38215092|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
17072815|NCT00293254|38215093|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
17072816|NCT00293254|38215092|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
17072817|NCT00293254|38215093|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
17072818|NCT00293254|38215092|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
17072819|NCT00293254|38215093|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
17072820|NCT00293254|38215092|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
17072821|NCT00293254|38215093|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
17072822|NCT00293254|38215092|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
17156461|NCT02975336|38303322|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
17156462|NCT02975336|38303323|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
17072823|NCT00293254|38215093|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
17072824|NCT00293254|38215092|FG000|Extension - Double-Blind Week 49-156|Death|4|||
17156463|NCT02975336|38303324|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
17156464|NCT02975336|38303325|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
17156465|NCT02975336|38303326|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
17156466|NCT02975336|38303327|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
17156467|NCT02975336|38303328|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
17156468|NCT02975336|38303321|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
17156469|NCT02975336|38303322|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
17156470|NCT02975336|38303323|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
17156471|NCT02975336|38303324|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
17156472|NCT02975336|38303325|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
17156473|NCT02975336|38303326|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
17156474|NCT02975336|38303327|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
17156475|NCT02975336|38303328|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
17156476|NCT02975336|38303321|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
17156477|NCT02975336|38303322|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
17156478|NCT02975336|38303323|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
17156479|NCT02975336|38303324|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
17156480|NCT02975336|38303325|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
17156481|NCT02975336|38303326|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
17156482|NCT02975336|38303327|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
17156483|NCT02975336|38303328|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
17156484|NCT02975336|38303321|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
17156485|NCT02975336|38303322|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
17156486|NCT02975336|38303323|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
17156487|NCT02975336|38303324|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
17156488|NCT02975336|38303325|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
17156489|NCT02975336|38303326|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
17156490|NCT02975336|38303327|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
17156491|NCT02975336|38303328|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
17156492|NCT02975336|38303321|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
17156493|NCT02975336|38303322|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
17156494|NCT02975336|38303323|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
17156495|NCT02975336|38303324|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
17156496|NCT02975336|38303325|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
17156497|NCT02975336|38303326|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
17156498|NCT02975336|38303327|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
17156499|NCT02975336|38303328|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
17156500|NCT02975336|38303321|FG000|LTE (104 Weeks)|Adverse Event|0|||
17156501|NCT02975336|38303322|FG001|LTE (104 Weeks)|Adverse Event|0|||
17156502|NCT02975336|38303323|FG002|LTE (104 Weeks)|Adverse Event|0|||
17156503|NCT02975336|38303324|FG003|LTE (104 Weeks)|Adverse Event|0|||
17156504|NCT02975336|38303325|FG004|LTE (104 Weeks)|Adverse Event|7|||
17156505|NCT02975336|38303326|FG005|LTE (104 Weeks)|Adverse Event|4|||
17156506|NCT02975336|38303327|FG006|LTE (104 Weeks)|Adverse Event|2|||
17156507|NCT02975336|38303328|FG007|LTE (104 Weeks)|Adverse Event|0|||
17156508|NCT02975336|38303321|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
17156509|NCT02975336|38303322|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
17156510|NCT02975336|38303323|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
17072825|NCT00293254|38215093|FG001|Extension - Double-Blind Week 49-156|Death|1|||
17072826|NCT00293254|38215092|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
17072827|NCT00293254|38215093|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
17072828|NCT00293254|38215092|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
17072829|NCT00293254|38215093|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
17072830|NCT00293254|38215092|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
17072831|NCT00293254|38215093|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
17072832|NCT00293254|38215092|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
17072833|NCT00293254|38215093|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
17072834|NCT00293254|38215092|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
17156511|NCT02975336|38303324|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
17156512|NCT02975336|38303325|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
17156513|NCT02975336|38303326|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
17156514|NCT02975336|38303327|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
17156515|NCT02975336|38303328|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
17156516|NCT02975336|38303321|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
17156517|NCT02975336|38303322|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
17156518|NCT02975336|38303323|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
17156519|NCT02975336|38303324|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
16781258|NCT02109484|37720416|FG007|Overall Study|Death|2|||
17156520|NCT02975336|38303325|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
17156521|NCT02975336|38303326|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
17156522|NCT02975336|38303327|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
17156523|NCT02975336|38303328|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
17156524|NCT02975336|38303321|FG000|LTE (104 Weeks)|Other|0|||
17156525|NCT02975336|38303322|FG001|LTE (104 Weeks)|Other|0|||
17156526|NCT02975336|38303323|FG002|LTE (104 Weeks)|Other|0|||
17156527|NCT02975336|38303324|FG003|LTE (104 Weeks)|Other|0|||
17156528|NCT02975336|38303325|FG004|LTE (104 Weeks)|Other|55|||
17156529|NCT02975336|38303326|FG005|LTE (104 Weeks)|Other|63|||
17156530|NCT02975336|38303327|FG006|LTE (104 Weeks)|Other|76|||
17156531|NCT02975336|38303328|FG007|LTE (104 Weeks)|Other|72|||
17156532|NCT03124563|38303344|FG000|Overall Study|Lost to Follow-up|1|||
17156533|NCT03124563|38303345|FG001|Overall Study|Lost to Follow-up|1|||
17156534|NCT03124563|38303344|FG000|Overall Study|Withdrawal by Subject|1|||
17156535|NCT03124563|38303345|FG001|Overall Study|Withdrawal by Subject|1|||
17156536|NCT03079869|38303353|FG000|Overall Study|Adverse Event|6|||
17156537|NCT03079869|38303354|FG001|Overall Study|Adverse Event|8|||
17156538|NCT03079869|38303353|FG000|Overall Study|Withdrawal by Subject|4|||
17156539|NCT03079869|38303354|FG001|Overall Study|Withdrawal by Subject|1|||
17156540|NCT03079869|38303353|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
17156541|NCT03079869|38303354|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
17156542|NCT03085914|38303367|FG000|Overall Study|Death|6|||
17156543|NCT03085914|38303368|FG001|Overall Study|Death|6|||
17156544|NCT03085914|38303369|FG002|Overall Study|Death|4|||
17156545|NCT03085914|38303370|FG003|Overall Study|Death|1|||
17156546|NCT03085914|38303371|FG004|Overall Study|Death|5|||
17156547|NCT03085914|38303372|FG005|Overall Study|Death|2|||
17156548|NCT03085914|38303373|FG006|Overall Study|Death|2|||
17156549|NCT03085914|38303367|FG000|Overall Study|Withdrawal by Subject|1|||
17156550|NCT03085914|38303368|FG001|Overall Study|Withdrawal by Subject|1|||
17156551|NCT03085914|38303369|FG002|Overall Study|Withdrawal by Subject|2|||
17156552|NCT03085914|38303370|FG003|Overall Study|Withdrawal by Subject|2|||
17156553|NCT03085914|38303371|FG004|Overall Study|Withdrawal by Subject|2|||
17156554|NCT03085914|38303372|FG005|Overall Study|Withdrawal by Subject|0|||
17156555|NCT03085914|38303373|FG006|Overall Study|Withdrawal by Subject|1|||
17156556|NCT03085914|38303367|FG000|Overall Study|Lost to Follow-up|0|||
17156557|NCT03085914|38303368|FG001|Overall Study|Lost to Follow-up|0|||
17156558|NCT03085914|38303369|FG002|Overall Study|Lost to Follow-up|1|||
17156559|NCT03085914|38303370|FG003|Overall Study|Lost to Follow-up|0|||
17156560|NCT03085914|38303371|FG004|Overall Study|Lost to Follow-up|0|||
17156561|NCT03085914|38303372|FG005|Overall Study|Lost to Follow-up|1|||
17156562|NCT03085914|38303373|FG006|Overall Study|Lost to Follow-up|1|||
17156563|NCT03085914|38303367|FG000|Overall Study|Reason was not specified,|2|||
17156564|NCT03085914|38303368|FG001|Overall Study|Reason was not specified,|2|||
17156565|NCT03085914|38303369|FG002|Overall Study|Reason was not specified,|2|||
17156566|NCT03085914|38303370|FG003|Overall Study|Reason was not specified,|3|||
17156567|NCT03085914|38303371|FG004|Overall Study|Reason was not specified,|3|||
17156568|NCT03085914|38303372|FG005|Overall Study|Reason was not specified,|3|||
17156569|NCT03085914|38303373|FG006|Overall Study|Reason was not specified,|6|||
17156570|NCT03085914|38303367|FG000|Overall Study|Progressive Disease|0|||
17156571|NCT03085914|38303368|FG001|Overall Study|Progressive Disease|0|||
17156572|NCT03085914|38303369|FG002|Overall Study|Progressive Disease|2|||
17156573|NCT03085914|38303370|FG003|Overall Study|Progressive Disease|2|||
17156574|NCT03085914|38303371|FG004|Overall Study|Progressive Disease|1|||
17156575|NCT03085914|38303372|FG005|Overall Study|Progressive Disease|1|||
17156576|NCT03085914|38303373|FG006|Overall Study|Progressive Disease|1|||
17156577|NCT03085914|38303367|FG000|Overall Study|Study Terminated by the Sponsor|0|||
17156578|NCT03085914|38303368|FG001|Overall Study|Study Terminated by the Sponsor|0|||
17156579|NCT03085914|38303369|FG002|Overall Study|Study Terminated by the Sponsor|0|||
17156580|NCT03085914|38303370|FG003|Overall Study|Study Terminated by the Sponsor|1|||
17156581|NCT03085914|38303371|FG004|Overall Study|Study Terminated by the Sponsor|2|||
17156582|NCT03085914|38303372|FG005|Overall Study|Study Terminated by the Sponsor|1|||
17156583|NCT03085914|38303373|FG006|Overall Study|Study Terminated by the Sponsor|0|||
17156584|NCT01889238|38303390|FG000|Overall Study|Treatment ongoing|9|||
17156585|NCT03078582|38303396|FG000|Overall Study|Adverse Event|0|||
17156586|NCT03078582|38303397|FG001|Overall Study|Adverse Event|8|||
17156587|NCT03077724|38303405|FG000|Overall Study|Lost to Follow-up|5|||
17156588|NCT03077724|38303406|FG001|Overall Study|Lost to Follow-up|1|||
17156589|NCT03077724|38303405|FG000|Overall Study|Withdrawal by Subject|3|||
17156590|NCT03077724|38303406|FG001|Overall Study|Withdrawal by Subject|1|||
17156591|NCT00979212|38303414|FG000|Overall Study|Protocol Violation|1|||
17156592|NCT00979212|38303415|FG001|Overall Study|Protocol Violation|8|||
16994319|NCT00773734|38138077|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
16994320|NCT00773734|38138072|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
17156593|NCT00979212|38303414|FG000|Overall Study|No protocol therapy received|1|||
17156594|NCT00979212|38303415|FG001|Overall Study|No protocol therapy received|0|||
17156595|NCT03080454|38303421|FG000|Baseline|Adverse Event|2|||
17156596|NCT03080454|38303421|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
17156597|NCT03080454|38303421|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
17156598|NCT02981342|38303445|FG000|Overall Study|Adverse Event|0|||
17156599|NCT02981342|38303446|FG001|Overall Study|Adverse Event|0|||
17156600|NCT02981342|38303447|FG002|Overall Study|Adverse Event|0|||
17156601|NCT02981342|38303448|FG003|Overall Study|Adverse Event|1|||
17156602|NCT02981342|38303445|FG000|Overall Study|Death|0|||
17156603|NCT02981342|38303446|FG001|Overall Study|Death|9|||
17156604|NCT02981342|38303447|FG002|Overall Study|Death|9|||
17156605|NCT02981342|38303448|FG003|Overall Study|Death|4|||
17156606|NCT02981342|38303445|FG000|Overall Study|Withdrawal by Subject|0|||
17156607|NCT02981342|38303446|FG001|Overall Study|Withdrawal by Subject|0|||
17156608|NCT02981342|38303447|FG002|Overall Study|Withdrawal by Subject|3|||
17156609|NCT02981342|38303448|FG003|Overall Study|Withdrawal by Subject|1|||
17156610|NCT02981342|38303445|FG000|Overall Study|Study closed by sponsor|0|||
17156611|NCT02981342|38303446|FG001|Overall Study|Study closed by sponsor|0|||
17156612|NCT02981342|38303447|FG002|Overall Study|Study closed by sponsor|1|||
16994321|NCT00773734|38138073|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
16994322|NCT00773734|38138074|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
16994323|NCT00773734|38138075|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
16994324|NCT00773734|38138076|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
16994325|NCT00773734|38138077|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
16994326|NCT00773734|38138072|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
16994327|NCT00773734|38138073|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
16994328|NCT00773734|38138074|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
16994329|NCT00773734|38138075|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
16994330|NCT00773734|38138076|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
16994331|NCT00773734|38138077|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
16994332|NCT00773734|38138072|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
16994333|NCT00773734|38138073|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
16994334|NCT00773734|38138074|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
16994335|NCT00773734|38138075|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
16994336|NCT00773734|38138076|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
16994337|NCT00773734|38138077|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
16994338|NCT00773734|38138072|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
16994339|NCT00773734|38138073|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
16994340|NCT00773734|38138074|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
16994341|NCT00773734|38138075|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
16994342|NCT00773734|38138076|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
17072835|NCT00293254|38215093|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
17072836|NCT00293254|38215092|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
17072837|NCT00293254|38215093|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
17072838|NCT00293254|38215092|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
17072839|NCT00293254|38215093|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
17072840|NCT00293254|38215092|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
17072841|NCT00293254|38215093|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
17072842|NCT00293254|38215092|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
17072843|NCT00293254|38215093|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
17156613|NCT02981342|38303448|FG003|Overall Study|Study closed by sponsor|1|||
17156614|NCT02981342|38303445|FG000|Overall Study|Randomized, Never Treated|0|||
17156615|NCT02981342|38303446|FG001|Overall Study|Randomized, Never Treated|1|||
17156616|NCT02981342|38303447|FG002|Overall Study|Randomized, Never Treated|0|||
17156617|NCT02981342|38303448|FG003|Overall Study|Randomized, Never Treated|7|||
17156618|NCT02981342|38303445|FG000|Overall Study|Lost to Follow-up|0|||
17156619|NCT02981342|38303446|FG001|Overall Study|Lost to Follow-up|1|||
17156620|NCT02981342|38303447|FG002|Overall Study|Lost to Follow-up|0|||
17156621|NCT02981342|38303448|FG003|Overall Study|Lost to Follow-up|0|||
17156622|NCT02794246|38303460|FG000|Overall Study|Withdrawal by Subject|2|||
17156623|NCT02794246|38303460|FG000|Overall Study|Physician Decision|4|||
17156624|NCT03428100|38303468|FG000|Overall Study|Adverse Event|1|||
17156625|NCT03428100|38303469|FG001|Overall Study|Adverse Event|0|||
17156626|NCT03428100|38303470|FG002|Overall Study|Adverse Event|3|||
17156627|NCT03428100|38303471|FG003|Overall Study|Adverse Event|1|||
17156628|NCT03428100|38303468|FG000|Overall Study|Lack of Efficacy|16|||
17156629|NCT03428100|38303469|FG001|Overall Study|Lack of Efficacy|10|||
17156630|NCT03428100|38303470|FG002|Overall Study|Lack of Efficacy|7|||
17156631|NCT03428100|38303471|FG003|Overall Study|Lack of Efficacy|6|||
17156632|NCT03428100|38303468|FG000|Overall Study|Protocol Deviation|0|||
17156633|NCT03428100|38303469|FG001|Overall Study|Protocol Deviation|2|||
17156634|NCT03428100|38303470|FG002|Overall Study|Protocol Deviation|2|||
17156635|NCT03428100|38303471|FG003|Overall Study|Protocol Deviation|0|||
17156636|NCT03428100|38303468|FG000|Overall Study|Withdrawal by Subject|4|||
17156637|NCT03428100|38303469|FG001|Overall Study|Withdrawal by Subject|0|||
17156638|NCT03428100|38303470|FG002|Overall Study|Withdrawal by Subject|0|||
17156639|NCT03428100|38303471|FG003|Overall Study|Withdrawal by Subject|0|||
17156640|NCT03428100|38303468|FG000|Overall Study|Physician Decision|0|||
17156641|NCT03428100|38303469|FG001|Overall Study|Physician Decision|1|||
17156642|NCT03428100|38303470|FG002|Overall Study|Physician Decision|0|||
17156643|NCT03428100|38303471|FG003|Overall Study|Physician Decision|0|||
17156644|NCT02980874|38303493|FG000|Overall Study|Adverse Event|2|||
17156645|NCT02980874|38303494|FG001|Overall Study|Adverse Event|7|||
17156646|NCT02980874|38303493|FG000|Overall Study|Withdrawal by Subject|7|||
17156647|NCT02980874|38303494|FG001|Overall Study|Withdrawal by Subject|2|||
17156648|NCT02980874|38303493|FG000|Overall Study|Lost to Follow-up|5|||
17156649|NCT02980874|38303494|FG001|Overall Study|Lost to Follow-up|5|||
17156650|NCT02980874|38303493|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
17156651|NCT02980874|38303494|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
17156652|NCT02980874|38303493|FG000|Overall Study|Unknown study completion status|1|||
17156653|NCT02980874|38303494|FG001|Overall Study|Unknown study completion status|0|||
17156654|NCT01066052|38303502|FG000|Overall Study|Enrolled But Not Treated|3|||
17156655|NCT01066052|38303503|FG001|Overall Study|Enrolled But Not Treated|0|||
17156656|NCT03077646|38303511|FG000|Overall Study|Lost to Follow-up|29|||
17156657|NCT03077646|38303512|FG001|Overall Study|Lost to Follow-up|30|||
17156658|NCT03077646|38303513|FG002|Overall Study|Lost to Follow-up|31|||
17156659|NCT02892149|38303523|FG000|Overall Study|Death|262|||
17156660|NCT02892149|38303524|FG001|Overall Study|Death|278|||
17156661|NCT02892149|38303523|FG000|Overall Study|Withdrawal by Subject|53|||
17156662|NCT02892149|38303524|FG001|Overall Study|Withdrawal by Subject|47|||
17156663|NCT02892149|38303523|FG000|Overall Study|Lost to Follow-up|37|||
17156664|NCT02892149|38303524|FG001|Overall Study|Lost to Follow-up|31|||
17156665|NCT04187092|38303532|FG000|Overall Study|Lost to Follow-up|1|||
17156666|NCT04187092|38303533|FG001|Overall Study|Lost to Follow-up|1|||
17156667|NCT04187092|38303532|FG000|Overall Study|Withdrawal by Subject|1|||
17156668|NCT04187092|38303533|FG001|Overall Study|Withdrawal by Subject|1|||
17156669|NCT04187092|38303532|FG000|Overall Study|Adverse Event|0|||
17156670|NCT04187092|38303533|FG001|Overall Study|Adverse Event|1|||
17156671|NCT02896127|38303541|FG000|COMPLETED WEEK 52|Adverse Event|9|||
17156672|NCT02896127|38303542|FG001|COMPLETED WEEK 52|Adverse Event|2|||
17156673|NCT02896127|38303541|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
17156674|NCT02896127|38303542|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
17156675|NCT02896127|38303541|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
17156676|NCT02896127|38303542|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
17156677|NCT02896127|38303541|FG000|COMPLETED WEEK 52|Physician Decision|1|||
17156678|NCT02896127|38303542|FG001|COMPLETED WEEK 52|Physician Decision|1|||
17156679|NCT02896127|38303541|FG000|COMPLETED WEEK 52|Pregnancy|2|||
17156680|NCT02896127|38303542|FG001|COMPLETED WEEK 52|Pregnancy|0|||
17156681|NCT02896127|38303541|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
17156682|NCT02896127|38303542|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
17156683|NCT02896127|38303541|FG000|COMPLETED WEEK 52|Technical problems|1|||
17156684|NCT02896127|38303542|FG001|COMPLETED WEEK 52|Technical problems|0|||
17156685|NCT02896127|38303541|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
17156686|NCT02896127|38303542|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
17156687|NCT02896127|38303541|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
17156688|NCT02896127|38303542|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
17156689|NCT02896127|38303541|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
17156690|NCT02896127|38303542|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
17156691|NCT02896127|38303541|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
17156692|NCT02896127|38303542|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
17156693|NCT02896127|38303541|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
17156694|NCT02896127|38303542|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
17156695|NCT03546647|38303548|FG000|Overall Study|Adverse Event|1|||
17156696|NCT03546647|38303549|FG001|Overall Study|Adverse Event|0|||
17156697|NCT03077412|38303558|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
17156698|NCT03077412|38303559|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
17156699|NCT03077412|38303560|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
17156700|NCT03077412|38303558|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
17156701|NCT03077412|38303559|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
17156702|NCT03077412|38303560|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
17156703|NCT03077412|38303558|FG000|Overall Study|Adverse Event|1|||
17156704|NCT03077412|38303559|FG001|Overall Study|Adverse Event|2|||
17156705|NCT03077412|38303560|FG002|Overall Study|Adverse Event|2|||
17156706|NCT03077412|38303558|FG000|Overall Study|Investigator's Discretion|0|||
17156707|NCT03077412|38303559|FG001|Overall Study|Investigator's Discretion|1|||
17156708|NCT03077412|38303560|FG002|Overall Study|Investigator's Discretion|1|||
17156709|NCT03077412|38303558|FG000|Overall Study|Withdrew Consent|0|||
17156710|NCT03077412|38303559|FG001|Overall Study|Withdrew Consent|2|||
17156711|NCT03077412|38303560|FG002|Overall Study|Withdrew Consent|0|||
17156712|NCT03544229|38303572|FG000|Overall Study|Adverse Event|1|||
17156713|NCT03544229|38303573|FG001|Overall Study|Adverse Event|0|||
17156714|NCT03544229|38303574|FG002|Overall Study|Adverse Event|1|||
17156715|NCT03544229|38303575|FG003|Overall Study|Adverse Event|0|||
17156716|NCT03544229|38303572|FG000|Overall Study|Protocol Deviation|0|||
17156717|NCT03544229|38303573|FG001|Overall Study|Protocol Deviation|0|||
17156718|NCT03544229|38303574|FG002|Overall Study|Protocol Deviation|1|||
17156719|NCT03544229|38303575|FG003|Overall Study|Protocol Deviation|0|||
17156720|NCT03544229|38303572|FG000|Overall Study|Lost to Follow-up|3|||
17156721|NCT03544229|38303573|FG001|Overall Study|Lost to Follow-up|0|||
17156722|NCT03544229|38303574|FG002|Overall Study|Lost to Follow-up|0|||
17156723|NCT03544229|38303575|FG003|Overall Study|Lost to Follow-up|2|||
17072844|NCT00293254|38215092|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
17072845|NCT00293254|38215093|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
17072846|NCT00293254|38215092|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
17072847|NCT00293254|38215093|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
17072848|NCT00293254|38215092|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
17072849|NCT00293254|38215093|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
17072850|NCT00293254|38215092|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
17072851|NCT00293254|38215093|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
17072852|NCT00293254|38215092|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
17072853|NCT00293254|38215093|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
17072854|NCT00293254|38215092|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
17072855|NCT00293254|38215093|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
17072856|NCT00293254|38215092|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
17072857|NCT00293254|38215093|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
17072858|NCT00293254|38215092|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
17072859|NCT00293254|38215093|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
17072860|NCT00456846|38215107|FG000|Overall Study|Adverse Event|2|||
17072861|NCT00456846|38215108|FG001|Overall Study|Adverse Event|15|||
17072862|NCT00456846|38215107|FG000|Overall Study|Physician Decision|11|||
17072863|NCT00456846|38215108|FG001|Overall Study|Physician Decision|6|||
17072864|NCT00456846|38215107|FG000|Overall Study|Protocol Deviation|2|||
17072865|NCT00456846|38215108|FG001|Overall Study|Protocol Deviation|0|||
17072866|NCT00456846|38215107|FG000|Overall Study|Participant Discretion|1|||
17072867|NCT00456846|38215108|FG001|Overall Study|Participant Discretion|5|||
17072868|NCT00456846|38215107|FG000|Overall Study|Other|0|||
17156724|NCT03544229|38303572|FG000|Overall Study|Voluntary Withdrawal|2|||
17156725|NCT03544229|38303573|FG001|Overall Study|Voluntary Withdrawal|1|||
17156726|NCT03544229|38303574|FG002|Overall Study|Voluntary Withdrawal|3|||
17156727|NCT03544229|38303575|FG003|Overall Study|Voluntary Withdrawal|0|||
17156728|NCT03544229|38303572|FG000|Overall Study|Lack of Efficacy|0|||
17156729|NCT03544229|38303573|FG001|Overall Study|Lack of Efficacy|1|||
17156730|NCT03544229|38303574|FG002|Overall Study|Lack of Efficacy|0|||
17156731|NCT03544229|38303575|FG003|Overall Study|Lack of Efficacy|0|||
17156732|NCT03078816|38303585|FG000|Overall Study|Withdrawal by Subject|1|||
17156733|NCT03510455|38303589|FG000|Overall Study|Physician Decision|1|||
17156734|NCT03509675|38303597|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
17156735|NCT03509675|38303598|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
17156736|NCT03509675|38303597|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
17156737|NCT03509675|38303598|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
17156738|NCT03509675|38303597|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
17156739|NCT03509675|38303598|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
17156740|NCT03509675|38303597|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
17156741|NCT03509675|38303598|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
17156742|NCT03509207|38303604|FG000|Overall Study|Death|2|||
17156743|NCT03543137|38303608|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
17156744|NCT03543137|38303609|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
17156745|NCT03543137|38303608|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
17156746|NCT03543137|38303609|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
17156747|NCT03543137|38303608|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
17156748|NCT03543137|38303609|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
17156749|NCT02895347|38303619|FG000|Overall Study|Withdrawal by Subject|3|||
17156750|NCT02895347|38303620|FG001|Overall Study|Withdrawal by Subject|1|||
17156751|NCT03539549|38303627|FG000|Overall Study|Adverse Event|12|||
17156752|NCT03539549|38303627|FG000|Overall Study|Lost to Follow-up|1|||
17156753|NCT03539549|38303627|FG000|Overall Study|Death|2|||
17156754|NCT03539549|38303627|FG000|Overall Study|Progressive Disease|1|||
17156755|NCT03539549|38303627|FG000|Overall Study|Reason not Specified|1|||
17156756|NCT03506477|38303633|FG000|Overall Study|Withdrawal by Subject|1|||
17156757|NCT03506477|38303634|FG001|Overall Study|Withdrawal by Subject|0|||
17156758|NCT03073980|38303643|FG000|Overall Study|Lost to Follow-up|10|||
17156759|NCT03073980|38303644|FG001|Overall Study|Lost to Follow-up|2|||
17156760|NCT03073980|38303645|FG002|Overall Study|Lost to Follow-up|9|||
17156761|NCT03073980|38303643|FG000|Overall Study|No post-procedure data|0|||
17156762|NCT03073980|38303644|FG001|Overall Study|No post-procedure data|0|||
17156763|NCT03073980|38303645|FG002|Overall Study|No post-procedure data|2|||
17156764|NCT03930186|38303657|FG000|Weeks 0 to 16|Adverse Event|6|||
17156765|NCT03930186|38303657|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
17156766|NCT03930186|38303657|FG000|Weeks 16 to 32|Adverse Event|1|||
17156767|NCT03930186|38303657|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
17156768|NCT03504917|38303663|FG000|Blinded Treatment Period|Protocol Violation|1|||
17156769|NCT03504917|38303664|FG001|Blinded Treatment Period|Protocol Violation|0|||
17156770|NCT03504917|38303663|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
17156771|NCT03504917|38303664|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
17156772|NCT03504917|38303663|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
17156773|NCT03504917|38303664|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
17156774|NCT03504917|38303663|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
17156775|NCT03504917|38303664|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
17156776|NCT03504917|38303663|FG000|Blinded Treatment Period|Adverse Event|4|||
17156777|NCT03504917|38303664|FG001|Blinded Treatment Period|Adverse Event|4|||
17156778|NCT03504917|38303663|FG000|Blinded Treatment Period|Physician Decision|1|||
17156779|NCT03504917|38303664|FG001|Blinded Treatment Period|Physician Decision|0|||
17156780|NCT03504917|38303663|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
17072869|NCT00456846|38215108|FG001|Overall Study|Other|2|||
17072870|NCT00448344|38215116|FG000|Overall Study|Lost to Follow-up|20|||
17072871|NCT00448344|38215117|FG001|Overall Study|Lost to Follow-up|22|||
17072872|NCT00448344|38215116|FG000|Overall Study|Withdrawal by Subject|6|||
17072873|NCT00448344|38215117|FG001|Overall Study|Withdrawal by Subject|8|||
17072874|NCT00448344|38215116|FG000|Overall Study|Death|3|||
17072875|NCT00448344|38215117|FG001|Overall Study|Death|4|||
17156781|NCT03504917|38303664|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
17156782|NCT03504917|38303663|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
17156783|NCT03504917|38303664|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
17156784|NCT03504917|38303663|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
17156785|NCT03504917|38303664|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
17156786|NCT03504917|38303663|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
17156787|NCT03504917|38303664|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
17156788|NCT03504917|38303663|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
17156789|NCT03504917|38303664|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
17156790|NCT03504917|38303663|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
17156791|NCT03504917|38303664|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
17156792|NCT03504917|38303663|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
17156793|NCT03504917|38303664|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
17156794|NCT03504917|38303663|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
17156795|NCT03504917|38303664|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
17156796|NCT03504917|38303663|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
17156797|NCT03504917|38303664|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
17156798|NCT03504917|38303663|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
17156799|NCT03504917|38303664|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
17072876|NCT00448344|38215116|FG000|Overall Study|Physician Decision|1|||
17072877|NCT00448344|38215117|FG001|Overall Study|Physician Decision|2|||
17156800|NCT03536663|38303676|FG000|Endexo|Protocol Violation|1|||
17156801|NCT03565211|38303685|FG000|Overall Study|Withdrawal by Subject|2|||
17156802|NCT03565211|38303685|FG000|Overall Study|Lost to Follow-up|1|||
17156803|NCT03565211|38303685|FG000|Overall Study|Adverse Event|44|||
17156804|NCT03565211|38303685|FG000|Overall Study|Personal issues|1|||
17156805|NCT03740100|38303689|FG000|Overall Study|Adverse Event|1|||
17156806|NCT03740100|38303689|FG000|Overall Study|Death|1|||
17156807|NCT03531905|38303696|FG000|Overall Study|Withdrawal by Subject|3|||
17072878|NCT00484094|38215123|FG000|Overall Study|Discontinued|39|||
17072879|NCT00484094|38215123|FG000|Overall Study|Other|3|||
17072880|NCT00447876|38215129|FG000|Overall Study|Withdrawal by Subject|1|||
17072881|NCT00447876|38215130|FG001|Overall Study|Withdrawal by Subject|4|||
17072882|NCT00447876|38215129|FG000|Overall Study|Lost to Follow-up|1|||
17072883|NCT00447876|38215130|FG001|Overall Study|Lost to Follow-up|0|||
17072884|NCT00447876|38215129|FG000|Overall Study|Deterioration of symptomology|1|||
17072885|NCT00447876|38215130|FG001|Overall Study|Deterioration of symptomology|0|||
17072886|NCT00456612|38215136|FG000|Overall Study|Withdrawal by Subject|3|||
17072887|NCT00456300|38215141|FG000|Overall Study|Adverse Event|1|||
17072888|NCT00456300|38215142|FG001|Overall Study|Adverse Event|0|||
17072889|NCT00267748|38215153|FG000|Non-randomized Period|Progressive disease|10|||
17072890|NCT00267748|38215154|FG001|Non-randomized Period|Progressive disease|0|||
17072891|NCT00267748|38215155|FG002|Non-randomized Period|Progressive disease|0|||
17072892|NCT00267748|38215153|FG000|Non-randomized Period|Adverse Event|8|||
17072893|NCT00267748|38215154|FG001|Non-randomized Period|Adverse Event|0|||
17072894|NCT00267748|38215155|FG002|Non-randomized Period|Adverse Event|0|||
17072895|NCT00267748|38215153|FG000|Non-randomized Period|Death|1|||
17072896|NCT00267748|38215154|FG001|Non-randomized Period|Death|0|||
17072897|NCT00267748|38215155|FG002|Non-randomized Period|Death|0|||
17072898|NCT00267748|38215153|FG000|Non-randomized Period|Participant not willing to participate|1|||
17072899|NCT00267748|38215154|FG001|Non-randomized Period|Participant not willing to participate|0|||
17072900|NCT00267748|38215155|FG002|Non-randomized Period|Participant not willing to participate|0|||
17072901|NCT00267748|38215153|FG000|Non-randomized Period|Other|3|||
17072902|NCT00267748|38215154|FG001|Non-randomized Period|Other|0|||
17072903|NCT00267748|38215155|FG002|Non-randomized Period|Other|0|||
17072904|NCT00267748|38215153|FG000|Randomized Period|Death|0|||
17072905|NCT00267748|38215154|FG001|Randomized Period|Death|2|||
17072906|NCT00267748|38215155|FG002|Randomized Period|Death|3|||
17072907|NCT00267748|38215153|FG000|Randomized Period|Adverse Event|0|||
17072908|NCT00267748|38215154|FG001|Randomized Period|Adverse Event|23|||
17072909|NCT00267748|38215155|FG002|Randomized Period|Adverse Event|25|||
17156808|NCT03531905|38303697|FG001|Overall Study|Withdrawal by Subject|3|||
17156809|NCT03531905|38303698|FG002|Overall Study|Withdrawal by Subject|2|||
17156810|NCT03531905|38303696|FG000|Overall Study|Lost to Follow-up|2|||
17156811|NCT03531905|38303697|FG001|Overall Study|Lost to Follow-up|2|||
17156812|NCT03531905|38303698|FG002|Overall Study|Lost to Follow-up|1|||
17156813|NCT03531905|38303696|FG000|Overall Study|Participant was out of town|1|||
17156814|NCT03531905|38303697|FG001|Overall Study|Participant was out of town|0|||
17156815|NCT03531905|38303698|FG002|Overall Study|Participant was out of town|0|||
17156816|NCT03531905|38303696|FG000|Overall Study|Could not speak with the participant|1|||
17156817|NCT03531905|38303697|FG001|Overall Study|Could not speak with the participant|0|||
17156818|NCT03531905|38303698|FG002|Overall Study|Could not speak with the participant|0|||
17156819|NCT03531827|38303708|FG000|Overall Study|Adverse Event|2|||
17156820|NCT03531827|38303709|FG001|Overall Study|Adverse Event|0|||
17156821|NCT03531827|38303708|FG000|Overall Study|Progressive disease|1|||
17156822|NCT03531827|38303709|FG001|Overall Study|Progressive disease|0|||
17156823|NCT03530345|38303738|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
17072910|NCT00267748|38215153|FG000|Randomized Period|Global deterioration of health status|0|||
17072911|NCT00267748|38215154|FG001|Randomized Period|Global deterioration of health status|6|||
17072912|NCT00267748|38215155|FG002|Randomized Period|Global deterioration of health status|7|||
17072913|NCT00267748|38215153|FG000|Randomized Period|Lost to Follow-up|0|||
17072914|NCT00267748|38215154|FG001|Randomized Period|Lost to Follow-up|1|||
17072915|NCT00267748|38215155|FG002|Randomized Period|Lost to Follow-up|0|||
17072916|NCT00267748|38215153|FG000|Randomized Period|Objective progression or relapse|0|||
17072917|NCT00267748|38215154|FG001|Randomized Period|Objective progression or relapse|77|||
17072918|NCT00267748|38215155|FG002|Randomized Period|Objective progression or relapse|86|||
17072919|NCT00267748|38215153|FG000|Randomized Period|Withdrawal by Subject|0|||
17072920|NCT00267748|38215154|FG001|Randomized Period|Withdrawal by Subject|9|||
17072921|NCT00267748|38215155|FG002|Randomized Period|Withdrawal by Subject|2|||
17072922|NCT00267748|38215153|FG000|Randomized Period|Other|0|||
17072923|NCT00267748|38215154|FG001|Randomized Period|Other|9|||
17072924|NCT00267748|38215155|FG002|Randomized Period|Other|6|||
17072925|NCT00267748|38215153|FG000|Randomized Period|randomized but not treated|0|||
17072926|NCT00267748|38215154|FG001|Randomized Period|randomized but not treated|0|||
17072927|NCT00267748|38215155|FG002|Randomized Period|randomized but not treated|3|||
17072928|NCT00267202|38215164|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
17072929|NCT00267202|38215165|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
17072930|NCT00267202|38215164|FG000|Overall Study|Withdrawal by Subject|12|||
17072931|NCT00267202|38215165|FG001|Overall Study|Withdrawal by Subject|15|||
17072932|NCT00267202|38215164|FG000|Overall Study|Adverse Event|13|||
17072933|NCT00267202|38215165|FG001|Overall Study|Adverse Event|7|||
17072934|NCT00267202|38215164|FG000|Overall Study|Protocol Violation|2|||
17072935|NCT00267202|38215165|FG001|Overall Study|Protocol Violation|3|||
17072936|NCT00267202|38215164|FG000|Overall Study|Administrative problems|2|||
17072937|NCT00267202|38215165|FG001|Overall Study|Administrative problems|1|||
17072938|NCT00267202|38215164|FG000|Overall Study|Lost to Follow-up|3|||
17072939|NCT00267202|38215165|FG001|Overall Study|Lost to Follow-up|0|||
17072940|NCT00267046|38215174|FG000|Overall Study|Disease progression|4|||
17072941|NCT00267046|38215175|FG001|Overall Study|Disease progression|2|||
17072942|NCT00267046|38215174|FG000|Overall Study|Chemotoxicity|2|||
17072943|NCT00267046|38215175|FG001|Overall Study|Chemotoxicity|0|||
17072944|NCT00267046|38215174|FG000|Overall Study|Open-label palifermin|2|||
17072945|NCT00267046|38215175|FG001|Overall Study|Open-label palifermin|7|||
17072946|NCT00267046|38215174|FG000|Overall Study|Surgery|3|||
17072947|NCT00267046|38215175|FG001|Overall Study|Surgery|1|||
16994343|NCT00773734|38138077|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
16994344|NCT00773734|38138072|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
16994345|NCT00773734|38138073|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
16994346|NCT00773734|38138074|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
16994347|NCT00773734|38138075|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
16994348|NCT00773734|38138076|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
16994349|NCT00773734|38138077|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
16994350|NCT00773734|38138072|FG000|Extension: Active Treatment Week 24-52|Other|0|||
16994351|NCT00773734|38138073|FG001|Extension: Active Treatment Week 24-52|Other|0|||
16994352|NCT00773734|38138074|FG002|Extension: Active Treatment Week 24-52|Other|1|||
16994353|NCT00773734|38138075|FG003|Extension: Active Treatment Week 24-52|Other|2|||
16994354|NCT00773734|38138076|FG004|Extension: Active Treatment Week 24-52|Other|0|||
16994355|NCT00773734|38138077|FG005|Extension: Active Treatment Week 24-52|Other|1|||
16994356|NCT00773734|38138072|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16994357|NCT00773734|38138073|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16994358|NCT00773734|38138074|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
17072948|NCT00267046|38215174|FG000|Overall Study|Withdrawal by Subject|1|||
17072949|NCT00267046|38215175|FG001|Overall Study|Withdrawal by Subject|0|||
17072950|NCT00267046|38215174|FG000|Overall Study|Radiation|0|||
17072951|NCT00267046|38215175|FG001|Overall Study|Radiation|1|||
17072952|NCT00441090|38215186|FG000|Overall Study|Adverse Event|0|||
17072953|NCT00441090|38215187|FG001|Overall Study|Adverse Event|1|||
17072954|NCT00441090|38215188|FG002|Overall Study|Adverse Event|1|||
17072955|NCT00441090|38215189|FG003|Overall Study|Adverse Event|0|||
17072956|NCT00441090|38215190|FG004|Overall Study|Adverse Event|0|||
16994359|NCT00773734|38138075|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
16994360|NCT00773734|38138076|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16994361|NCT00773734|38138077|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16994362|NCT00773734|38138072|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
16994363|NCT00773734|38138073|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
16994364|NCT00773734|38138074|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
16994365|NCT00773734|38138075|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
16994366|NCT00773734|38138076|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
16994367|NCT00773734|38138077|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
16994368|NCT00773734|38138072|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
16994369|NCT00773734|38138073|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
16994370|NCT00773734|38138074|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
17072957|NCT00441090|38215186|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
17072958|NCT00441090|38215187|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
17072959|NCT00441090|38215188|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
17072960|NCT00441090|38215189|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
17072961|NCT00441090|38215190|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
17072962|NCT00441090|38215186|FG000|Overall Study|Withdrawal by Subject|1|||
16994371|NCT00773734|38138075|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
16994372|NCT00773734|38138076|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
16994373|NCT00773734|38138077|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
17072963|NCT00441090|38215187|FG001|Overall Study|Withdrawal by Subject|0|||
17072964|NCT00441090|38215188|FG002|Overall Study|Withdrawal by Subject|1|||
17072965|NCT00441090|38215189|FG003|Overall Study|Withdrawal by Subject|0|||
17072966|NCT00441090|38215190|FG004|Overall Study|Withdrawal by Subject|0|||
17072967|NCT00441090|38215186|FG000|Overall Study|Lack of Efficacy|1|||
17072968|NCT00441090|38215187|FG001|Overall Study|Lack of Efficacy|0|||
17072969|NCT00441090|38215188|FG002|Overall Study|Lack of Efficacy|0|||
17072970|NCT00441090|38215189|FG003|Overall Study|Lack of Efficacy|0|||
16994374|NCT00773734|38138072|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
16994375|NCT00773734|38138073|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
16994376|NCT00773734|38138074|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
16994377|NCT00773734|38138075|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
16994378|NCT00773734|38138076|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
16994379|NCT00773734|38138077|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
16994380|NCT01009580|38138136|FG000|Overall Study|Adverse Event|4|||
16994381|NCT01009580|38138137|FG001|Overall Study|Adverse Event|4|||
16994382|NCT01009580|38138136|FG000|Overall Study|Lack of Efficacy|0|||
17072971|NCT00441090|38215190|FG004|Overall Study|Lack of Efficacy|0|||
17072972|NCT00441012|38215204|FG000|Overall Study|Adverse Event|0|||
17072973|NCT00441012|38215205|FG001|Overall Study|Adverse Event|1|||
17072974|NCT00441012|38215204|FG000|Overall Study|Lost to Follow-up|3|||
17072975|NCT00441012|38215205|FG001|Overall Study|Lost to Follow-up|3|||
17072976|NCT00441012|38215204|FG000|Overall Study|Protocol Violation|10|||
17072977|NCT00441012|38215205|FG001|Overall Study|Protocol Violation|9|||
17072978|NCT00441012|38215204|FG000|Overall Study|Withdrawal by Subject|4|||
17072979|NCT00441012|38215205|FG001|Overall Study|Withdrawal by Subject|0|||
17072980|NCT00441012|38215204|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
17072981|NCT00441012|38215205|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
17072982|NCT00286468|38215214|FG000|Overall Study|Hyperglycemic Rescue|28|||
17072983|NCT00286468|38215215|FG001|Overall Study|Hyperglycemic Rescue|30|||
17072984|NCT00286468|38215216|FG002|Overall Study|Hyperglycemic Rescue|31|||
17072985|NCT00286468|38215214|FG000|Overall Study|Adverse Event|2|||
17072986|NCT00286468|38215215|FG001|Overall Study|Adverse Event|6|||
17072987|NCT00286468|38215216|FG002|Overall Study|Adverse Event|4|||
17072988|NCT00286468|38215214|FG000|Overall Study|Protocol Violation|0|||
17072989|NCT00286468|38215215|FG001|Overall Study|Protocol Violation|3|||
17072990|NCT00286468|38215216|FG002|Overall Study|Protocol Violation|1|||
17072991|NCT00286468|38215214|FG000|Overall Study|Lost to Follow-up|1|||
17072992|NCT00286468|38215215|FG001|Overall Study|Lost to Follow-up|1|||
17072993|NCT00286468|38215216|FG002|Overall Study|Lost to Follow-up|2|||
17072994|NCT00286468|38215214|FG000|Overall Study|Withdrawal by Subject|3|||
17072995|NCT00286468|38215215|FG001|Overall Study|Withdrawal by Subject|8|||
17072996|NCT00286468|38215216|FG002|Overall Study|Withdrawal by Subject|11|||
17072997|NCT00286468|38215214|FG000|Overall Study|Physician Decision|3|||
17072998|NCT00286468|38215215|FG001|Overall Study|Physician Decision|2|||
17072999|NCT00286468|38215216|FG002|Overall Study|Physician Decision|1|||
17073000|NCT00507026|38215227|FG000|Overall Study|Lack of Efficacy|6|||
17073001|NCT00507026|38215228|FG001|Overall Study|Lack of Efficacy|4|||
17073002|NCT00507026|38215229|FG002|Overall Study|Lack of Efficacy|21|||
17073003|NCT00507026|38215227|FG000|Overall Study|Withdrawal by Subject|2|||
17073004|NCT00507026|38215228|FG001|Overall Study|Withdrawal by Subject|0|||
17073005|NCT00507026|38215229|FG002|Overall Study|Withdrawal by Subject|0|||
17156824|NCT03530345|38303739|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
17156825|NCT03530345|38303738|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
17156826|NCT03530345|38303739|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
17156827|NCT03530345|38303738|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
17156828|NCT03530345|38303739|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
16994383|NCT01009580|38138137|FG001|Overall Study|Lack of Efficacy|1|||
17073006|NCT00507026|38215227|FG000|Overall Study|Investigator Decision|1|||
17073007|NCT00507026|38215228|FG001|Overall Study|Investigator Decision|0|||
17073008|NCT00507026|38215229|FG002|Overall Study|Investigator Decision|0|||
17073009|NCT00507026|38215227|FG000|Overall Study|Adverse Event|2|||
17073010|NCT00507026|38215228|FG001|Overall Study|Adverse Event|0|||
17073011|NCT00507026|38215229|FG002|Overall Study|Adverse Event|0|||
17073012|NCT00507026|38215227|FG000|Overall Study|Protocol Violation|1|||
17073013|NCT00507026|38215228|FG001|Overall Study|Protocol Violation|0|||
17073014|NCT00507026|38215229|FG002|Overall Study|Protocol Violation|0|||
17073015|NCT00507026|38215227|FG000|Overall Study|Other|1|||
17073016|NCT00507026|38215228|FG001|Overall Study|Other|0|||
17073017|NCT00507026|38215229|FG002|Overall Study|Other|0|||
17073018|NCT00446550|38215239|FG000|Overall Study|Adverse Event|1|||
17073019|NCT00446550|38215240|FG001|Overall Study|Adverse Event|0|||
17073020|NCT03847974|38215247|FG000|Overall Study|relocated out of region|3|||
17073021|NCT03847974|38215247|FG000|Overall Study|Withdrawal by Subject|2|||
17073022|NCT03847974|38215247|FG000|Overall Study|Adverse Event|1|||
17073023|NCT00506948|38215251|FG000|Overall Study|Death|4|||
17073024|NCT00506948|38215251|FG000|Overall Study|Adverse Event|5|||
17073025|NCT00506948|38215251|FG000|Overall Study|Physician Decision|1|||
17073026|NCT00286234|38215259|FG000|Overall Study|Protocol Violation|1|||
17073027|NCT00286234|38215260|FG001|Overall Study|Protocol Violation|2|||
17073028|NCT00286234|38215261|FG002|Overall Study|Protocol Violation|0|||
16994384|NCT01009580|38138136|FG000|Overall Study|Protocol Violation|2|||
17073029|NCT00286234|38215262|FG003|Overall Study|Protocol Violation|1|||
17073030|NCT00286234|38215259|FG000|Overall Study|Physician Decision|1|||
17073031|NCT00286234|38215260|FG001|Overall Study|Physician Decision|0|||
17073032|NCT00286234|38215261|FG002|Overall Study|Physician Decision|0|||
17073033|NCT00286234|38215262|FG003|Overall Study|Physician Decision|1|||
17156829|NCT03530345|38303738|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
16994385|NCT01009580|38138137|FG001|Overall Study|Protocol Violation|3|||
17156830|NCT03530345|38303739|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
17156831|NCT03500159|38303753|FG000|Overall Study|Study Terminated|2|||
17156832|NCT03500159|38303754|FG001|Overall Study|Study Terminated|1|||
17156833|NCT03785340|38303762|FG000|Overall Study|Lost to Follow-up|2|||
17156834|NCT03785340|38303763|FG001|Overall Study|Lost to Follow-up|0|||
17156835|NCT03785340|38303762|FG000|Overall Study|Adverse Event|1|||
17156836|NCT03785340|38303763|FG001|Overall Study|Adverse Event|0|||
17156837|NCT03499067|38303769|FG000|First Intervention|Physician Decision|2|||
17156838|NCT03499067|38303770|FG001|First Intervention|Physician Decision|1|||
16994386|NCT01009580|38138136|FG000|Overall Study|Withdrawal Criteria|4|||
16994387|NCT01009580|38138137|FG001|Overall Study|Withdrawal Criteria|6|||
16994388|NCT01009580|38138136|FG000|Overall Study|Unclassified|17|||
16994389|NCT01009580|38138137|FG001|Overall Study|Unclassified|21|||
16994390|NCT01009346|38138143|FG000|Overall Study|Adverse Event|4|||
16994391|NCT01001702|38138148|FG000|Overall Study|Lost to Follow-up|7|||
16994392|NCT01001702|38138148|FG000|Overall Study|Adverse Event|7|||
16994393|NCT01001702|38138148|FG000|Overall Study|Sponsor Discontinued Study|4|||
16994394|NCT01001702|38138148|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
16994395|NCT01001702|38138148|FG000|Overall Study|Investigator withdrew Subject|10|||
16994396|NCT01001702|38138148|FG000|Overall Study|Withdrawal by Subject|19|||
16994397|NCT01001702|38138148|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
16994398|NCT01070069|38138157|FG000|Overall Study|Death|1|||
16994399|NCT01070069|38138158|FG001|Overall Study|Death|0|||
16994400|NCT01070069|38138159|FG002|Overall Study|Death|2|||
16994401|NCT01070069|38138160|FG003|Overall Study|Death|0|||
16994402|NCT01070069|38138161|FG004|Overall Study|Death|1|||
16994403|NCT01070069|38138157|FG000|Overall Study|Withdrawal by Subject|1|||
16994404|NCT01070069|38138158|FG001|Overall Study|Withdrawal by Subject|1|||
16994405|NCT01070069|38138159|FG002|Overall Study|Withdrawal by Subject|4|||
16994406|NCT01070069|38138160|FG003|Overall Study|Withdrawal by Subject|0|||
16994407|NCT01070069|38138161|FG004|Overall Study|Withdrawal by Subject|0|||
16994408|NCT01070069|38138157|FG000|Overall Study|Lost to Follow-up|4|||
16994409|NCT01070069|38138158|FG001|Overall Study|Lost to Follow-up|1|||
16994410|NCT01070069|38138159|FG002|Overall Study|Lost to Follow-up|0|||
16994411|NCT01070069|38138160|FG003|Overall Study|Lost to Follow-up|0|||
16994412|NCT01070069|38138161|FG004|Overall Study|Lost to Follow-up|3|||
16994413|NCT01068665|38138178|FG000|Overall Study|Adverse Event|5|||
16994414|NCT01068665|38138179|FG001|Overall Study|Adverse Event|4|||
16994415|NCT01068665|38138178|FG000|Overall Study|Lack of Efficacy|0|||
16994416|NCT01068665|38138179|FG001|Overall Study|Lack of Efficacy|2|||
16994417|NCT01068665|38138178|FG000|Overall Study|Protocol Violation|5|||
16994418|NCT01068665|38138179|FG001|Overall Study|Protocol Violation|2|||
16994419|NCT01068665|38138178|FG000|Overall Study|Withdrawal Criteria|3|||
16994420|NCT01068665|38138179|FG001|Overall Study|Withdrawal Criteria|9|||
16994421|NCT01068665|38138178|FG000|Overall Study|Other|17|||
16994422|NCT01068665|38138179|FG001|Overall Study|Other|12|||
16994423|NCT01001390|38138185|FG000|Overall Study|Failure to wear AFO device|2|||
16994424|NCT01001390|38138186|FG001|Overall Study|Failure to wear AFO device|0|||
16994425|NCT00772954|38138194|FG000|Overall Study|Adverse Event|0|||
16994426|NCT00772954|38138195|FG001|Overall Study|Adverse Event|0|||
16994427|NCT00772954|38138196|FG002|Overall Study|Adverse Event|1|||
16994428|NCT00781768|38138206|FG000|Overall Study|Not transplanted.|0|||
17073034|NCT00286234|38215259|FG000|Overall Study|Adverse Event|0|||
17073035|NCT00286234|38215260|FG001|Overall Study|Adverse Event|0|||
17073036|NCT00286234|38215261|FG002|Overall Study|Adverse Event|0|||
16994429|NCT00781768|38138207|FG001|Overall Study|Not transplanted.|2|||
16994430|NCT01005680|38138215|FG000|Overall Study|Lost to Follow-up|4|||
16994431|NCT01005680|38138216|FG001|Overall Study|Lost to Follow-up|6|||
17156839|NCT03499067|38303769|FG000|First Intervention|Withdrawal by Subject|3|||
17156840|NCT03499067|38303770|FG001|First Intervention|Withdrawal by Subject|6|||
17156841|NCT03562481|38303778|FG000|First Intervention|Lost to Follow-up|1|||
17156842|NCT03562481|38303779|FG001|First Intervention|Lost to Follow-up|0|||
17156843|NCT03529409|38303805|FG000|Randomized|Lost to Follow-up|0|||
17156844|NCT03529409|38303806|FG001|Randomized|Lost to Follow-up|0|||
17156845|NCT03529409|38303807|FG002|Randomized|Lost to Follow-up|4|||
17156846|NCT03529409|38303805|FG000|Randomized|Excluded|0|||
17156847|NCT03529409|38303806|FG001|Randomized|Excluded|0|||
17156848|NCT03529409|38303807|FG002|Randomized|Excluded|1|||
17156849|NCT03529409|38303805|FG000|Post-treatment Assessment|Death|1|||
17156850|NCT03529409|38303806|FG001|Post-treatment Assessment|Death|0|||
17156851|NCT03529409|38303807|FG002|Post-treatment Assessment|Death|0|||
17156852|NCT03529409|38303805|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
17156853|NCT03529409|38303806|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
17156854|NCT03529409|38303807|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
17156855|NCT03529409|38303805|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
17156856|NCT03529409|38303806|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
17156857|NCT03529409|38303807|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
17156858|NCT03529409|38303805|FG000|Follow-up Assessment|Death|1|||
17156859|NCT03529409|38303806|FG001|Follow-up Assessment|Death|0|||
17156860|NCT03529409|38303807|FG002|Follow-up Assessment|Death|0|||
17156861|NCT03529409|38303805|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
17156862|NCT03529409|38303806|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
16994432|NCT01005680|38138215|FG000|Overall Study|Withdrawal by Subject|1|||
16994433|NCT01005680|38138216|FG001|Overall Study|Withdrawal by Subject|4|||
16994434|NCT01005680|38138215|FG000|Overall Study|Physician Decision|1|||
16994435|NCT01005680|38138216|FG001|Overall Study|Physician Decision|1|||
16994436|NCT01005602|38138225|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
17073037|NCT00286234|38215262|FG003|Overall Study|Adverse Event|1|||
17073038|NCT00286234|38215259|FG000|Overall Study|Adverse Event|0|||
17073039|NCT00286234|38215260|FG001|Overall Study|Adverse Event|0|||
17073040|NCT00286234|38215261|FG002|Overall Study|Adverse Event|0|||
17073041|NCT00286234|38215262|FG003|Overall Study|Adverse Event|1|||
17073042|NCT00445848|38215272|FG000|Overall Study|Adverse Event|14|||
17073043|NCT00445848|38215272|FG000|Overall Study|Withdrawal by Subject|4|||
17073044|NCT00445848|38215272|FG000|Overall Study|Progression|62|||
17073045|NCT00445848|38215272|FG000|Overall Study|Other-Not protocol specified|5|||
17073046|NCT00286156|38215279|FG000|Overall Study|Missed 12 month visit|0|||
16994437|NCT01005602|38138226|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
16994438|NCT01068509|38138242|FG000|Overall Study|Death|0|||
16994439|NCT01068509|38138243|FG001|Overall Study|Death|0|||
16994440|NCT01068509|38138244|FG002|Overall Study|Death|1|||
16994441|NCT01068509|38138242|FG000|Overall Study|Disease Progression|5|||
16994442|NCT01068509|38138243|FG001|Overall Study|Disease Progression|20|||
16994443|NCT01068509|38138244|FG002|Overall Study|Disease Progression|18|||
16994444|NCT01068509|38138242|FG000|Overall Study|Lost to Follow-up|1|||
16994445|NCT01068509|38138243|FG001|Overall Study|Lost to Follow-up|0|||
16994446|NCT01068509|38138244|FG002|Overall Study|Lost to Follow-up|0|||
16994447|NCT01068509|38138242|FG000|Overall Study|Withdrew Consent|0|||
16994448|NCT01068509|38138243|FG001|Overall Study|Withdrew Consent|1|||
16994449|NCT01068509|38138244|FG002|Overall Study|Withdrew Consent|2|||
16994450|NCT01068509|38138242|FG000|Overall Study|Reason Not Specified|0|||
16994451|NCT01068509|38138243|FG001|Overall Study|Reason Not Specified|1|||
16994452|NCT01068509|38138244|FG002|Overall Study|Reason Not Specified|0|||
16994453|NCT01009034|38138251|FG000|Overall Study|Lost to Follow-up|2|||
16994454|NCT01009034|38138251|FG000|Overall Study|Withdrawal by Subject|2|||
16994455|NCT00768430|38138257|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
16994456|NCT00768430|38138258|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
16994457|NCT01064297|38138267|FG000|Overall Study|Lost to Follow-up|791|||
16994458|NCT01064297|38138268|FG001|Overall Study|Lost to Follow-up|48|||
16994459|NCT01064297|38138269|FG002|Overall Study|Lost to Follow-up|133|||
16994460|NCT00781456|38138286|FG000|Overall Study|Adverse Event|3|||
16994461|NCT00781456|38138287|FG001|Overall Study|Adverse Event|3|||
16994462|NCT00781456|38138286|FG000|Overall Study|Withdrawal by Subject|3|||
16994463|NCT00781456|38138287|FG001|Overall Study|Withdrawal by Subject|5|||
16994464|NCT00781456|38138286|FG000|Overall Study|Protocol Violation|4|||
17156863|NCT03529409|38303807|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
17156864|NCT03498287|38303816|FG000|Overall Study|Withdrawal by Subject|3|||
17156865|NCT03498287|38303817|FG001|Overall Study|Withdrawal by Subject|0|||
16994465|NCT00781456|38138287|FG001|Overall Study|Protocol Violation|1|||
17073047|NCT00286156|38215280|FG001|Overall Study|Missed 12 month visit|0|||
17156866|NCT03498287|38303816|FG000|Overall Study|Protocol Violation|0|||
17073048|NCT00286156|38215281|FG002|Overall Study|Missed 12 month visit|1|||
17073049|NCT00286156|38215279|FG000|Overall Study|AE: pulmonary embolus|0|||
17073050|NCT00286156|38215280|FG001|Overall Study|AE: pulmonary embolus|1|||
17073051|NCT00286156|38215281|FG002|Overall Study|AE: pulmonary embolus|0|||
17073052|NCT00286156|38215279|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
17073053|NCT00286156|38215280|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
17073054|NCT00286156|38215281|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
17073055|NCT00286156|38215279|FG000|Overall Study|AE: pneumonia|1|||
17073056|NCT00286156|38215280|FG001|Overall Study|AE: pneumonia|0|||
17073057|NCT00286156|38215281|FG002|Overall Study|AE: pneumonia|0|||
17073058|NCT00455520|38215291|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
17073059|NCT00455520|38215292|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
17073060|NCT00455520|38215291|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
17073061|NCT00455520|38215292|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
17073062|NCT00455520|38215291|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
17073063|NCT00455520|38215292|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
17073064|NCT00455520|38215291|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
17073065|NCT00455520|38215292|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
17073066|NCT00455520|38215291|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
17073067|NCT00455520|38215292|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
17073068|NCT00455520|38215291|FG000|Open Label Tapentadol Extended Release|All other|33|||
17073069|NCT00455520|38215292|FG001|Open Label Tapentadol Extended Release|All other|0|||
17073070|NCT00455520|38215291|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
17073071|NCT00455520|38215292|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
17073072|NCT00455520|38215291|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
17073073|NCT00455520|38215292|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
17073074|NCT00455520|38215291|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
17073075|NCT00455520|38215292|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
17073076|NCT00455520|38215291|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
17073077|NCT00455520|38215292|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
17073078|NCT00455520|38215291|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
17073079|NCT00455520|38215292|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
17073080|NCT00455520|38215291|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
17073081|NCT00455520|38215292|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
17073082|NCT00440700|38215301|FG000|Overall Study|Withdrawal by Subject|8|||
17073083|NCT00440700|38215302|FG001|Overall Study|Withdrawal by Subject|8|||
17073084|NCT00440700|38215303|FG002|Overall Study|Withdrawal by Subject|4|||
17073085|NCT00284050|38215314|FG000|Overall Study|Adverse Event|1|||
17073086|NCT00284050|38215315|FG001|Overall Study|Adverse Event|1|||
17073087|NCT00284050|38215316|FG002|Overall Study|Adverse Event|1|||
17073088|NCT00284050|38215314|FG000|Overall Study|Lack of Efficacy|0|||
17073089|NCT00284050|38215315|FG001|Overall Study|Lack of Efficacy|1|||
17073090|NCT00284050|38215316|FG002|Overall Study|Lack of Efficacy|3|||
17073091|NCT00284050|38215314|FG000|Overall Study|Protocol Violation|0|||
17073092|NCT00284050|38215315|FG001|Overall Study|Protocol Violation|1|||
17073093|NCT00284050|38215316|FG002|Overall Study|Protocol Violation|2|||
17073094|NCT00284050|38215314|FG000|Overall Study|Withdrawal by Subject|2|||
17073095|NCT00284050|38215315|FG001|Overall Study|Withdrawal by Subject|2|||
17073096|NCT00284050|38215316|FG002|Overall Study|Withdrawal by Subject|2|||
17073097|NCT00284050|38215314|FG000|Overall Study|Lost to Follow-up|1|||
17073098|NCT00284050|38215315|FG001|Overall Study|Lost to Follow-up|0|||
17073099|NCT00284050|38215316|FG002|Overall Study|Lost to Follow-up|1|||
17073100|NCT00284050|38215314|FG000|Overall Study|Death|1|||
17073101|NCT00284050|38215315|FG001|Overall Study|Death|0|||
17073102|NCT00284050|38215316|FG002|Overall Study|Death|0|||
17073103|NCT00293020|38215324|FG000|Overall Study|Withdrawal by Subject|34|||
17073104|NCT00293020|38215324|FG000|Overall Study|Adverse Event|30|||
17073105|NCT00293020|38215324|FG000|Overall Study|Death|32|||
17073106|NCT00293020|38215324|FG000|Overall Study|Lack of Efficacy|12|||
17073107|NCT00293020|38215324|FG000|Overall Study|Lost to Follow-up|4|||
17073108|NCT00293020|38215324|FG000|Overall Study|Protocol Violation|6|||
17073109|NCT00293020|38215324|FG000|Overall Study|Physician Decision|21|||
17073110|NCT00293020|38215324|FG000|Overall Study|Other Reason|22|||
17073111|NCT00293020|38215324|FG000|Overall Study|No dose taken|1|||
17073112|NCT00377637|38215332|FG000|Induction Phase|Adverse Event|12|||
17073113|NCT00377637|38215333|FG001|Induction Phase|Adverse Event|21|||
17073114|NCT00377637|38215334|FG002|Induction Phase|Adverse Event|0|||
17073115|NCT00377637|38215335|FG003|Induction Phase|Adverse Event|0|||
17073116|NCT00377637|38215332|FG000|Induction Phase|Deterioration/serum creatinine|2|||
17073117|NCT00377637|38215333|FG001|Induction Phase|Deterioration/serum creatinine|0|||
17073118|NCT00377637|38215334|FG002|Induction Phase|Deterioration/serum creatinine|0|||
17073119|NCT00377637|38215335|FG003|Induction Phase|Deterioration/serum creatinine|0|||
17073120|NCT00377637|38215332|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
16994466|NCT00781456|38138286|FG000|Overall Study|Noncompliance With Protocol|1|||
16994467|NCT00781456|38138287|FG001|Overall Study|Noncompliance With Protocol|1|||
16994468|NCT00781456|38138286|FG000|Overall Study|Lost to Follow-up|10|||
17073121|NCT00377637|38215333|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
17073122|NCT00377637|38215334|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
17073123|NCT00377637|38215335|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
17073124|NCT00377637|38215332|FG000|Induction Phase|Lost to Follow-up|2|||
17073125|NCT00377637|38215333|FG001|Induction Phase|Lost to Follow-up|1|||
17073126|NCT00377637|38215334|FG002|Induction Phase|Lost to Follow-up|0|||
17073127|NCT00377637|38215335|FG003|Induction Phase|Lost to Follow-up|0|||
17073128|NCT00377637|38215332|FG000|Induction Phase|Death|1|||
17073129|NCT00377637|38215333|FG001|Induction Phase|Death|3|||
17156867|NCT03498287|38303817|FG001|Overall Study|Protocol Violation|4|||
17156868|NCT03498287|38303816|FG000|Overall Study|Adverse Event|0|||
17156869|NCT03498287|38303817|FG001|Overall Study|Adverse Event|1|||
17156870|NCT03497429|38303825|FG000|Overall Study|Progressive disease|3|||
17156871|NCT03497429|38303826|FG001|Overall Study|Progressive disease|4|||
17156872|NCT03497429|38303825|FG000|Overall Study|Adverse Event|0|||
17156873|NCT03497429|38303826|FG001|Overall Study|Adverse Event|2|||
17156874|NCT03497039|38303834|FG000|Overall Study|Withdrawal by Subject|1|||
17156875|NCT03497039|38303835|FG001|Overall Study|Withdrawal by Subject|0|||
17156876|NCT03497039|38303834|FG000|Overall Study|Protocol Violation|0|||
17156877|NCT03497039|38303835|FG001|Overall Study|Protocol Violation|1|||
17156878|NCT03495869|38303854|FG000|Overall Study|Lost to Follow-up|4|||
17156879|NCT03495869|38303855|FG001|Overall Study|Lost to Follow-up|17|||
17156880|NCT03495869|38303856|FG002|Overall Study|Lost to Follow-up|8|||
17156881|NCT03495869|38303857|FG003|Overall Study|Lost to Follow-up|14|||
17156882|NCT03495869|38303854|FG000|Overall Study|Withdrawal by Subject|0|||
17156883|NCT03495869|38303855|FG001|Overall Study|Withdrawal by Subject|3|||
17156884|NCT03495869|38303856|FG002|Overall Study|Withdrawal by Subject|0|||
17156885|NCT03495869|38303857|FG003|Overall Study|Withdrawal by Subject|3|||
16994469|NCT00781456|38138287|FG001|Overall Study|Lost to Follow-up|5|||
16994470|NCT00781456|38138286|FG000|Overall Study|Other Reason, Unknown|0|||
16994471|NCT00781456|38138287|FG001|Overall Study|Other Reason, Unknown|1|||
16994472|NCT00587158|38138295|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
16994473|NCT00587158|38138296|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
16994474|NCT00587158|38138295|FG000|Overall Study|Physician Decision|0|||
16994475|NCT00587158|38138296|FG001|Overall Study|Physician Decision|1|||
16994476|NCT00587158|38138295|FG000|Overall Study|Lost to Follow-up|1|||
16994477|NCT00587158|38138296|FG001|Overall Study|Lost to Follow-up|2|||
16994478|NCT00587158|38138295|FG000|Overall Study|Death|0|||
16994479|NCT00587158|38138296|FG001|Overall Study|Death|1|||
16994480|NCT00587158|38138295|FG000|Overall Study|Subject did not want to take study med|0|||
16994481|NCT00587158|38138296|FG001|Overall Study|Subject did not want to take study med|1|||
17073130|NCT00377637|38215334|FG002|Induction Phase|Death|0|||
17073131|NCT00377637|38215335|FG003|Induction Phase|Death|0|||
16994482|NCT00582907|38138302|FG000|1st Course|Withdrawal by Subject|1|||
16994483|NCT00582907|38138303|FG001|1st Course|Withdrawal by Subject|0|||
16994484|NCT00582907|38138304|FG002|1st Course|Withdrawal by Subject|0|||
16994485|NCT00582907|38138305|FG003|1st Course|Withdrawal by Subject|0|||
16994486|NCT00582907|38138302|FG000|1st Course|Lost to Follow-up|0|||
16994487|NCT00582907|38138303|FG001|1st Course|Lost to Follow-up|0|||
16994488|NCT00582907|38138304|FG002|1st Course|Lost to Follow-up|0|||
16994489|NCT00582907|38138305|FG003|1st Course|Lost to Follow-up|1|||
16994490|NCT00582907|38138302|FG000|2nd Course|Lack of Efficacy|1|||
16994491|NCT00582907|38138303|FG001|2nd Course|Lack of Efficacy|0|||
16994492|NCT00582907|38138304|FG002|2nd Course|Lack of Efficacy|0|||
17073132|NCT00377637|38215332|FG000|Induction Phase|Withdrawal by Subject|5|||
17073133|NCT00377637|38215333|FG001|Induction Phase|Withdrawal by Subject|6|||
17073134|NCT00377637|38215334|FG002|Induction Phase|Withdrawal by Subject|0|||
17073135|NCT00377637|38215335|FG003|Induction Phase|Withdrawal by Subject|0|||
17073136|NCT00377637|38215332|FG000|Induction Phase|Physician Decision|3|||
17073137|NCT00377637|38215333|FG001|Induction Phase|Physician Decision|1|||
17073138|NCT00377637|38215334|FG002|Induction Phase|Physician Decision|0|||
17073139|NCT00377637|38215335|FG003|Induction Phase|Physician Decision|0|||
17073140|NCT00377637|38215332|FG000|Induction Phase|Sponsor decision|1|||
17073141|NCT00377637|38215333|FG001|Induction Phase|Sponsor decision|2|||
17073142|NCT00377637|38215334|FG002|Induction Phase|Sponsor decision|0|||
17073143|NCT00377637|38215335|FG003|Induction Phase|Sponsor decision|0|||
17073144|NCT00377637|38215332|FG000|Induction Phase|Non-Compliance|1|||
17073145|NCT00377637|38215333|FG001|Induction Phase|Non-Compliance|0|||
17156886|NCT03495869|38303854|FG000|Overall Study|Dropped from study|0|||
17156887|NCT03495869|38303855|FG001|Overall Study|Dropped from study|7|||
17156888|NCT03495869|38303856|FG002|Overall Study|Dropped from study|2|||
17073146|NCT00377637|38215334|FG002|Induction Phase|Non-Compliance|0|||
17156889|NCT03495869|38303857|FG003|Overall Study|Dropped from study|4|||
17156890|NCT03071094|38303869|FG000|Overall Study|Death|1|||
17073147|NCT00377637|38215335|FG003|Induction Phase|Non-Compliance|0|||
17073148|NCT00377637|38215332|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
17073149|NCT00377637|38215333|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
17073150|NCT00377637|38215334|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
17073151|NCT00377637|38215335|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
17073152|NCT00377637|38215332|FG000|Maintenance Phase|Adverse Event|0|||
17073153|NCT00377637|38215333|FG001|Maintenance Phase|Adverse Event|0|||
17073154|NCT00377637|38215334|FG002|Maintenance Phase|Adverse Event|29|||
17073155|NCT00377637|38215335|FG003|Maintenance Phase|Adverse Event|43|||
17073156|NCT00377637|38215332|FG000|Maintenance Phase|Physician Decision|0|||
17073157|NCT00377637|38215333|FG001|Maintenance Phase|Physician Decision|0|||
17073158|NCT00377637|38215334|FG002|Maintenance Phase|Physician Decision|5|||
17073159|NCT00377637|38215335|FG003|Maintenance Phase|Physician Decision|4|||
17073160|NCT00377637|38215332|FG000|Maintenance Phase|Lost to Follow-up|0|||
17073161|NCT00377637|38215333|FG001|Maintenance Phase|Lost to Follow-up|0|||
17073162|NCT00377637|38215334|FG002|Maintenance Phase|Lost to Follow-up|3|||
17073163|NCT00377637|38215335|FG003|Maintenance Phase|Lost to Follow-up|1|||
17073164|NCT00377637|38215332|FG000|Maintenance Phase|Withdrawal by Subject|0|||
17073165|NCT00377637|38215333|FG001|Maintenance Phase|Withdrawal by Subject|0|||
17073166|NCT00377637|38215334|FG002|Maintenance Phase|Withdrawal by Subject|3|||
17073167|NCT00377637|38215335|FG003|Maintenance Phase|Withdrawal by Subject|3|||
17156891|NCT03071094|38303870|FG001|Overall Study|Death|1|||
17156892|NCT03071094|38303869|FG000|Overall Study|Adverse Event|1|||
17156893|NCT03071094|38303870|FG001|Overall Study|Adverse Event|0|||
17073168|NCT00377637|38215332|FG000|Maintenance Phase|Sponsor decision|0|||
17073169|NCT00377637|38215333|FG001|Maintenance Phase|Sponsor decision|0|||
17073170|NCT00377637|38215334|FG002|Maintenance Phase|Sponsor decision|2|||
17073171|NCT00377637|38215335|FG003|Maintenance Phase|Sponsor decision|3|||
17073172|NCT00377637|38215332|FG000|Maintenance Phase|Non-compliance|0|||
16994493|NCT00582907|38138305|FG003|2nd Course|Lack of Efficacy|0|||
17073173|NCT00377637|38215333|FG001|Maintenance Phase|Non-compliance|0|||
17073174|NCT00377637|38215334|FG002|Maintenance Phase|Non-compliance|1|||
17073175|NCT00377637|38215335|FG003|Maintenance Phase|Non-compliance|1|||
17073176|NCT00377637|38215332|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
17073177|NCT00377637|38215333|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
17073178|NCT00377637|38215334|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
17073179|NCT00377637|38215335|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
17073180|NCT00377637|38215332|FG000|Maintenance Phase|Death|0|||
17073181|NCT00377637|38215333|FG001|Maintenance Phase|Death|0|||
17073182|NCT00377637|38215334|FG002|Maintenance Phase|Death|0|||
17073183|NCT00377637|38215335|FG003|Maintenance Phase|Death|1|||
17073184|NCT00377403|38215351|FG000|Overall Study|Unable to contact for telephone intervie|4|||
17073185|NCT00377403|38215352|FG001|Overall Study|Unable to contact for telephone intervie|7|||
17073186|NCT00370149|38215360|FG000|Overall Study|Physician Decision|16|||
17073187|NCT00370149|38215361|FG001|Overall Study|Physician Decision|16|||
17073188|NCT00370149|38215360|FG000|Overall Study|Protocol Violation|1|||
17073189|NCT00370149|38215361|FG001|Overall Study|Protocol Violation|0|||
17073190|NCT00370149|38215360|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
17073191|NCT00370149|38215361|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
16994494|NCT01062113|38138314|FG000|Overall Study|Adverse Event|1|||
16994495|NCT01062113|38138315|FG001|Overall Study|Adverse Event|0|||
16994496|NCT01062113|38138316|FG002|Overall Study|Adverse Event|0|||
16994497|NCT01062113|38138314|FG000|Overall Study|Lack of Efficacy|38|||
16994498|NCT01062113|38138315|FG001|Overall Study|Lack of Efficacy|22|||
16994499|NCT01062113|38138316|FG002|Overall Study|Lack of Efficacy|31|||
16994500|NCT01062113|38138314|FG000|Overall Study|Withdrawal by Subject|1|||
16994501|NCT01062113|38138315|FG001|Overall Study|Withdrawal by Subject|0|||
16994502|NCT01062113|38138316|FG002|Overall Study|Withdrawal by Subject|0|||
16994503|NCT00772330|38138324|FG000|Overall Study|Lost to Follow-up|3|||
16994504|NCT01038869|38138331|FG000|Overall Study|Withdrawal by Subject|1|||
16994505|NCT01038869|38138331|FG000|Overall Study|Lost to Follow-up|6|||
17073192|NCT00370149|38215360|FG000|Overall Study|Pre-existing infection|0|||
17073193|NCT00370149|38215361|FG001|Overall Study|Pre-existing infection|1|||
17073194|NCT00370149|38215360|FG000|Overall Study|Antibiotic coated dressing placed|0|||
17073195|NCT00370149|38215361|FG001|Overall Study|Antibiotic coated dressing placed|1|||
17073196|NCT00292942|38215374|FG000|Overall Study|Withdrawal by Subject|0|||
17073197|NCT00292942|38215375|FG001|Overall Study|Withdrawal by Subject|0|||
17073198|NCT00292942|38215376|FG002|Overall Study|Withdrawal by Subject|1|||
17073199|NCT00292942|38215377|FG003|Overall Study|Withdrawal by Subject|0|||
17073200|NCT00292942|38215374|FG000|Overall Study|Adverse Event|0|||
17073201|NCT00292942|38215375|FG001|Overall Study|Adverse Event|0|||
17073202|NCT00292942|38215376|FG002|Overall Study|Adverse Event|0|||
17073203|NCT00292942|38215377|FG003|Overall Study|Adverse Event|1|||
17073204|NCT00483938|38215397|FG000|Overall Study|Protocol Violation|0|||
17073205|NCT00483938|38215398|FG001|Overall Study|Protocol Violation|0|||
17073206|NCT00483938|38215399|FG002|Overall Study|Protocol Violation|0|||
17073207|NCT00483938|38215400|FG003|Overall Study|Protocol Violation|0|||
17073208|NCT00483938|38215401|FG004|Overall Study|Protocol Violation|0|||
17073209|NCT00483938|38215402|FG005|Overall Study|Protocol Violation|0|||
17073210|NCT00483938|38215403|FG006|Overall Study|Protocol Violation|3|||
17073211|NCT00483938|38215397|FG000|Overall Study|Withdrawal by Subject|1|||
17073212|NCT00483938|38215398|FG001|Overall Study|Withdrawal by Subject|6|||
17073213|NCT00483938|38215399|FG002|Overall Study|Withdrawal by Subject|0|||
17073214|NCT00483938|38215400|FG003|Overall Study|Withdrawal by Subject|0|||
17073215|NCT00483938|38215401|FG004|Overall Study|Withdrawal by Subject|1|||
17156894|NCT03559517|38303879|FG000|Overall Study|Withdrawal by Subject|1|||
17156895|NCT03559517|38303880|FG001|Overall Study|Withdrawal by Subject|0|||
17156896|NCT03559517|38303881|FG002|Overall Study|Withdrawal by Subject|0|||
17156897|NCT02509494|38303898|FG000|Overall Study|Lost to Follow-up|8|||
17156898|NCT02509494|38303899|FG001|Overall Study|Lost to Follow-up|47|||
17156899|NCT02509494|38303900|FG002|Overall Study|Lost to Follow-up|19|||
17156900|NCT02509494|38303901|FG003|Overall Study|Lost to Follow-up|6|||
17156901|NCT02509494|38303902|FG004|Overall Study|Lost to Follow-up|3|||
17156902|NCT02509494|38303903|FG005|Overall Study|Lost to Follow-up|3|||
17156903|NCT02509494|38303904|FG006|Overall Study|Lost to Follow-up|1|||
17156904|NCT02509494|38303905|FG007|Overall Study|Lost to Follow-up|3|||
17156905|NCT02509494|38303906|FG008|Overall Study|Lost to Follow-up|1|||
17156906|NCT02509494|38303898|FG000|Overall Study|Physician Decision|2|||
16994506|NCT01038713|38138342|FG000|Overall Study|Patient to hospice|1|||
16994507|NCT01038713|38138343|FG001|Overall Study|Patient to hospice|1|||
16994508|NCT01038713|38138344|FG002|Overall Study|Patient to hospice|1|||
16994509|NCT01038713|38138342|FG000|Overall Study|Lost to Follow-up|3|||
16994510|NCT01038713|38138343|FG001|Overall Study|Lost to Follow-up|0|||
16994511|NCT01038713|38138344|FG002|Overall Study|Lost to Follow-up|0|||
16994512|NCT01038713|38138342|FG000|Overall Study|Neuroendocrine Tumor|0|||
16994513|NCT01038713|38138343|FG001|Overall Study|Neuroendocrine Tumor|1|||
16994514|NCT01038713|38138344|FG002|Overall Study|Neuroendocrine Tumor|0|||
16994515|NCT01038713|38138342|FG000|Overall Study|died from PEP|0|||
16994516|NCT01038713|38138343|FG001|Overall Study|died from PEP|1|||
16994517|NCT01038713|38138344|FG002|Overall Study|died from PEP|0|||
16994518|NCT01038713|38138342|FG000|Overall Study|Autoimmune Pancreatitis|1|||
16994519|NCT01038713|38138343|FG001|Overall Study|Autoimmune Pancreatitis|0|||
16994520|NCT01038713|38138344|FG002|Overall Study|Autoimmune Pancreatitis|0|||
16994521|NCT00768040|38138354|FG000|Overall Study|Adverse Event|3|||
16994522|NCT00768040|38138355|FG001|Overall Study|Adverse Event|2|||
16994523|NCT00768040|38138354|FG000|Overall Study|Abnormal laboratory value|1|||
16994524|NCT00768040|38138355|FG001|Overall Study|Abnormal laboratory value|1|||
16994525|NCT00767806|38138363|FG000|Overall Study|Adverse Event|30|||
16994526|NCT00767806|38138364|FG001|Overall Study|Adverse Event|11|||
16994527|NCT00767806|38138363|FG000|Overall Study|Withdrawal by Subject|8|||
16994528|NCT00767806|38138364|FG001|Overall Study|Withdrawal by Subject|13|||
16994529|NCT00767806|38138363|FG000|Overall Study|Protocol Violation|6|||
16994530|NCT00767806|38138364|FG001|Overall Study|Protocol Violation|5|||
16994531|NCT00767806|38138363|FG000|Overall Study|Lack of Efficacy|1|||
16994532|NCT00767806|38138364|FG001|Overall Study|Lack of Efficacy|9|||
16994533|NCT00767806|38138363|FG000|Overall Study|Physician Decision|4|||
16994534|NCT00767806|38138364|FG001|Overall Study|Physician Decision|3|||
16994535|NCT00767806|38138363|FG000|Overall Study|Lost to Follow-up|1|||
16994536|NCT00767806|38138364|FG001|Overall Study|Lost to Follow-up|4|||
16994537|NCT00767806|38138363|FG000|Overall Study|Entry Criteria Not Met|1|||
16994538|NCT00767806|38138364|FG001|Overall Study|Entry Criteria Not Met|1|||
16994539|NCT00767806|38138363|FG000|Overall Study|Sponsor Decision|0|||
16994540|NCT00767806|38138364|FG001|Overall Study|Sponsor Decision|1|||
16994541|NCT00780910|38138370|FG000|Overall Study|Adverse Event|2|||
16994542|NCT00767104|38138376|FG000|Overall Study|Lost to Follow-up|1|||
16994543|NCT00767104|38138377|FG001|Overall Study|Lost to Follow-up|2|||
16994544|NCT00771472|38138385|FG000|Overall Study|Physician Decision|2|||
16994545|NCT00771472|38138386|FG001|Overall Study|Physician Decision|3|||
16994546|NCT00771472|38138385|FG000|Overall Study|Progressive Disease|3|||
16994547|NCT00771472|38138386|FG001|Overall Study|Progressive Disease|1|||
17073216|NCT00483938|38215402|FG005|Overall Study|Withdrawal by Subject|3|||
16994548|NCT00771472|38138385|FG000|Overall Study|Protocol Violation|1|||
16994549|NCT00771472|38138386|FG001|Overall Study|Protocol Violation|0|||
16994550|NCT00771316|38138393|FG000|Overall Study|Adverse Event|0|||
16994551|NCT00771316|38138394|FG001|Overall Study|Adverse Event|1|||
16994552|NCT00771316|38138393|FG000|Overall Study|Patient withdrew consent|1|||
16994553|NCT00771316|38138394|FG001|Overall Study|Patient withdrew consent|0|||
16994554|NCT00771316|38138393|FG000|Overall Study|Discontinued due to early termination|1|||
16994555|NCT00771316|38138394|FG001|Overall Study|Discontinued due to early termination|0|||
16994556|NCT00770770|38138402|FG000|Overall Study|Lost to Follow-up|1|||
16994557|NCT00770770|38138403|FG001|Overall Study|Lost to Follow-up|0|||
16994558|NCT00770770|38138402|FG000|Overall Study|Withdrawal by Subject|1|||
16994559|NCT00770770|38138403|FG001|Overall Study|Withdrawal by Subject|0|||
16994560|NCT00770770|38138402|FG000|Overall Study|Death|0|||
16994561|NCT00770770|38138403|FG001|Overall Study|Death|1|||
16994562|NCT00770770|38138402|FG000|Overall Study|Study Terminated|8|||
16994563|NCT00770770|38138403|FG001|Overall Study|Study Terminated|0|||
16994564|NCT00766636|38138411|FG000|Overall Study|Withdrawal by Subject|1|||
16994565|NCT00766636|38138412|FG001|Overall Study|Withdrawal by Subject|1|||
16994566|NCT00766636|38138411|FG000|Overall Study|Incomplete Treatment|0|||
16994567|NCT00766636|38138412|FG001|Overall Study|Incomplete Treatment|1|||
16994568|NCT00766636|38138411|FG000|Overall Study|Adverse Event|1|||
16994569|NCT00766636|38138412|FG001|Overall Study|Adverse Event|0|||
16994570|NCT00766636|38138411|FG000|Overall Study|Disease Progression|1|||
16994571|NCT00766636|38138412|FG001|Overall Study|Disease Progression|0|||
16994572|NCT00770692|38138422|FG000|Overall Study|Withdrawal by Subject|7|||
16994573|NCT00770692|38138423|FG001|Overall Study|Withdrawal by Subject|9|||
16994574|NCT00770692|38138424|FG002|Overall Study|Withdrawal by Subject|9|||
17073217|NCT00483938|38215403|FG006|Overall Study|Withdrawal by Subject|2|||
17073218|NCT00483938|38215397|FG000|Overall Study|Lost to Follow-up|1|||
17073219|NCT00483938|38215398|FG001|Overall Study|Lost to Follow-up|2|||
17073220|NCT00483938|38215399|FG002|Overall Study|Lost to Follow-up|0|||
17073221|NCT00483938|38215400|FG003|Overall Study|Lost to Follow-up|2|||
17073222|NCT00483938|38215401|FG004|Overall Study|Lost to Follow-up|1|||
17073223|NCT00483938|38215402|FG005|Overall Study|Lost to Follow-up|1|||
17073224|NCT00483938|38215403|FG006|Overall Study|Lost to Follow-up|3|||
17073225|NCT00483938|38215397|FG000|Overall Study|Death|0|||
17073226|NCT00483938|38215398|FG001|Overall Study|Death|2|||
17073227|NCT00483938|38215399|FG002|Overall Study|Death|0|||
17073228|NCT00483938|38215400|FG003|Overall Study|Death|0|||
17073229|NCT00483938|38215401|FG004|Overall Study|Death|0|||
17073230|NCT00483938|38215402|FG005|Overall Study|Death|0|||
17073231|NCT00483938|38215403|FG006|Overall Study|Death|0|||
17073232|NCT00483938|38215397|FG000|Overall Study|Other|3|||
17073233|NCT00483938|38215398|FG001|Overall Study|Other|9|||
17073234|NCT00483938|38215399|FG002|Overall Study|Other|0|||
17073235|NCT00483938|38215400|FG003|Overall Study|Other|4|||
17073236|NCT00483938|38215401|FG004|Overall Study|Other|0|||
17073237|NCT00483938|38215402|FG005|Overall Study|Other|4|||
17073238|NCT00483938|38215403|FG006|Overall Study|Other|32|||
17073239|NCT00370071|38215422|FG000|Overall Study|Withdrawal by Subject|2|||
17073240|NCT00369915|38215428|FG000|Overall Study|expected side effects|2|||
17073241|NCT00369915|38215429|FG001|Overall Study|expected side effects|1|||
17073242|NCT00369915|38215428|FG000|Overall Study|Withdrawal by Subject|4|||
17073243|NCT00369915|38215429|FG001|Overall Study|Withdrawal by Subject|1|||
17073244|NCT00369915|38215428|FG000|Overall Study|W/drawl by investigators|0|||
17073245|NCT00369915|38215429|FG001|Overall Study|W/drawl by investigators|1|||
17073246|NCT00369681|38215435|FG000|Overall Study|Death|1|||
17073247|NCT00266812|38215441|FG000|Overall Study|Disease Progression|9|||
17073248|NCT00266812|38215442|FG001|Overall Study|Disease Progression|3|||
17073249|NCT00266812|38215441|FG000|Overall Study|Death|5|||
17073250|NCT00266812|38215442|FG001|Overall Study|Death|4|||
17073251|NCT00266812|38215441|FG000|Overall Study|Adverse Event|3|||
17073252|NCT00266812|38215442|FG001|Overall Study|Adverse Event|1|||
17073253|NCT00266812|38215441|FG000|Overall Study|Protocol Violation|0|||
17073254|NCT00266812|38215442|FG001|Overall Study|Protocol Violation|1|||
17073255|NCT00266812|38215441|FG000|Overall Study|Withdrawal by Subject|0|||
17073256|NCT00266812|38215442|FG001|Overall Study|Withdrawal by Subject|2|||
17073257|NCT00266812|38215441|FG000|Overall Study|Discontinued before starting study drug|4|||
17073258|NCT00266812|38215442|FG001|Overall Study|Discontinued before starting study drug|0|||
16994575|NCT00770692|38138425|FG003|Overall Study|Withdrawal by Subject|6|||
17073259|NCT00488774|38215452|FG000|Overall Study|Withdrawal of consent|2|||
17073260|NCT00488774|38215453|FG001|Overall Study|Withdrawal of consent|2|||
17073261|NCT00488774|38215454|FG002|Overall Study|Withdrawal of consent|2|||
17073262|NCT00488774|38215455|FG003|Overall Study|Withdrawal of consent|0|||
17073263|NCT00488774|38215452|FG000|Overall Study|Other|6|||
17073264|NCT00488774|38215453|FG001|Overall Study|Other|3|||
17073265|NCT00488774|38215454|FG002|Overall Study|Other|2|||
17073266|NCT00488774|38215455|FG003|Overall Study|Other|2|||
17073267|NCT00488774|38215452|FG000|Overall Study|Lost to Follow-up|0|||
17073268|NCT00488774|38215453|FG001|Overall Study|Lost to Follow-up|0|||
17073269|NCT00488774|38215454|FG002|Overall Study|Lost to Follow-up|1|||
17073270|NCT00488774|38215455|FG003|Overall Study|Lost to Follow-up|1|||
17073271|NCT00361569|38215470|FG000|Overall Study|Protocol Violation|3|||
17073272|NCT00361569|38215471|FG001|Overall Study|Protocol Violation|2|||
17073273|NCT00361569|38215472|FG002|Overall Study|Protocol Violation|4|||
17073274|NCT00361569|38215473|FG003|Overall Study|Protocol Violation|2|||
17073275|NCT00361569|38215470|FG000|Overall Study|Withdrawal by Subject|2|||
17073276|NCT00361569|38215471|FG001|Overall Study|Withdrawal by Subject|1|||
17073277|NCT00361569|38215472|FG002|Overall Study|Withdrawal by Subject|9|||
17073278|NCT00361569|38215473|FG003|Overall Study|Withdrawal by Subject|14|||
17073279|NCT00361569|38215470|FG000|Overall Study|Adverse Event|3|||
17073280|NCT00361569|38215471|FG001|Overall Study|Adverse Event|5|||
17073281|NCT00361569|38215472|FG002|Overall Study|Adverse Event|2|||
17073282|NCT00361569|38215473|FG003|Overall Study|Adverse Event|2|||
17073283|NCT00361569|38215470|FG000|Overall Study|Lost to Follow-up|2|||
17073284|NCT00361569|38215471|FG001|Overall Study|Lost to Follow-up|3|||
17073285|NCT00361569|38215472|FG002|Overall Study|Lost to Follow-up|3|||
17073286|NCT00361569|38215473|FG003|Overall Study|Lost to Follow-up|2|||
17073287|NCT00361569|38215470|FG000|Overall Study|Not specified by investigator|2|||
17073288|NCT00361569|38215471|FG001|Overall Study|Not specified by investigator|0|||
17073289|NCT00361569|38215472|FG002|Overall Study|Not specified by investigator|0|||
17073290|NCT00361569|38215473|FG003|Overall Study|Not specified by investigator|1|||
17073291|NCT00488618|38215485|FG000|Overall Study|Adverse Event|13|||
17073292|NCT00488618|38215486|FG001|Overall Study|Adverse Event|17|||
17073293|NCT00488618|38215485|FG000|Overall Study|Insufficient Therapeutic Response|18|||
17073294|NCT00488618|38215486|FG001|Overall Study|Insufficient Therapeutic Response|11|||
17073295|NCT00488618|38215485|FG000|Overall Study|Protocol Violation|0|||
17073296|NCT00488618|38215486|FG001|Overall Study|Protocol Violation|2|||
17073297|NCT00488618|38215485|FG000|Overall Study|Withdrawal of Consent|15|||
17073298|NCT00488618|38215486|FG001|Overall Study|Withdrawal of Consent|13|||
17073299|NCT00488618|38215485|FG000|Overall Study|Lost to Follow-up|1|||
17073300|NCT00488618|38215486|FG001|Overall Study|Lost to Follow-up|0|||
17073301|NCT00266656|38215494|FG000|Overall Study|Death|1|||
17073302|NCT00266656|38215495|FG001|Overall Study|Death|0|||
17073303|NCT00266656|38215494|FG000|Overall Study|Lost to Follow-up|4|||
17073304|NCT00266656|38215495|FG001|Overall Study|Lost to Follow-up|1|||
17073305|NCT00266656|38215494|FG000|Overall Study|Withdrawal by Subject|4|||
17073306|NCT00266656|38215495|FG001|Overall Study|Withdrawal by Subject|2|||
17073307|NCT00266656|38215494|FG000|Overall Study|Did Not Reach Final Height|4|||
17073308|NCT00266656|38215495|FG001|Overall Study|Did Not Reach Final Height|8|||
17073309|NCT00266656|38215494|FG000|Overall Study|Parent/Caregiver Decision|1|||
16994576|NCT00770692|38138422|FG000|Overall Study|Adverse Event|3|||
16994577|NCT00770692|38138423|FG001|Overall Study|Adverse Event|0|||
16994578|NCT00770692|38138424|FG002|Overall Study|Adverse Event|4|||
16994579|NCT00770692|38138425|FG003|Overall Study|Adverse Event|4|||
16994580|NCT00770692|38138422|FG000|Overall Study|Investigator judgment|2|||
16994581|NCT00770692|38138423|FG001|Overall Study|Investigator judgment|0|||
16994582|NCT00770692|38138424|FG002|Overall Study|Investigator judgment|1|||
16994583|NCT00770692|38138425|FG003|Overall Study|Investigator judgment|1|||
16994584|NCT03213691|38138435|FG000|Overall Study|Adverse Event|2|||
16994585|NCT03213691|38138435|FG000|Overall Study|Death|3|||
16994586|NCT03213691|38138435|FG000|Overall Study|Physician Decision|1|||
16994587|NCT03213691|38138435|FG000|Overall Study|Progressive Disease|14|||
16994588|NCT03213691|38138435|FG000|Overall Study|Ineligible|1|||
16994589|NCT02743819|38138439|FG000|Overall Study|Lack of Efficacy|5|||
16994590|NCT02743819|38138439|FG000|Overall Study|Death|2|||
16994591|NCT02743819|38138439|FG000|Overall Study|Adverse Event|1|||
16994592|NCT01004822|38138451|FG000|Overall Study|Objective progression or relapse|3|||
16994593|NCT01004822|38138452|FG001|Overall Study|Objective progression or relapse|3|||
16994594|NCT01004822|38138453|FG002|Overall Study|Objective progression or relapse|0|||
16994595|NCT01004822|38138454|FG003|Overall Study|Objective progression or relapse|1|||
16994596|NCT01004822|38138455|FG004|Overall Study|Objective progression or relapse|2|||
16994597|NCT01004822|38138456|FG005|Overall Study|Objective progression or relapse|2|||
16994598|NCT01004822|38138457|FG006|Overall Study|Objective progression or relapse|1|||
16994599|NCT01004822|38138458|FG007|Overall Study|Objective progression or relapse|4|||
16994600|NCT01004822|38138451|FG000|Overall Study|Global deterioration of health status|0|||
16994601|NCT01004822|38138452|FG001|Overall Study|Global deterioration of health status|0|||
16994602|NCT01004822|38138453|FG002|Overall Study|Global deterioration of health status|0|||
16994603|NCT01004822|38138454|FG003|Overall Study|Global deterioration of health status|1|||
16994604|NCT01004822|38138455|FG004|Overall Study|Global deterioration of health status|0|||
16994605|NCT01004822|38138456|FG005|Overall Study|Global deterioration of health status|0|||
16994606|NCT01004822|38138457|FG006|Overall Study|Global deterioration of health status|1|||
16994607|NCT01004822|38138458|FG007|Overall Study|Global deterioration of health status|0|||
16994608|NCT01004822|38138451|FG000|Overall Study|No longer willing to continue|0|||
17073310|NCT00266656|38215495|FG001|Overall Study|Parent/Caregiver Decision|2|||
16994609|NCT01004822|38138452|FG001|Overall Study|No longer willing to continue|0|||
16994610|NCT01004822|38138453|FG002|Overall Study|No longer willing to continue|0|||
16994611|NCT01004822|38138454|FG003|Overall Study|No longer willing to continue|1|||
16994612|NCT01004822|38138455|FG004|Overall Study|No longer willing to continue|2|||
16994613|NCT01004822|38138456|FG005|Overall Study|No longer willing to continue|1|||
16994614|NCT01004822|38138457|FG006|Overall Study|No longer willing to continue|1|||
16994615|NCT01004822|38138458|FG007|Overall Study|No longer willing to continue|0|||
16994616|NCT01004822|38138451|FG000|Overall Study|Adverse Event|0|||
16994617|NCT01004822|38138452|FG001|Overall Study|Adverse Event|0|||
16994618|NCT01004822|38138453|FG002|Overall Study|Adverse Event|0|||
16994619|NCT01004822|38138454|FG003|Overall Study|Adverse Event|0|||
16994620|NCT01004822|38138455|FG004|Overall Study|Adverse Event|0|||
16994621|NCT01004822|38138456|FG005|Overall Study|Adverse Event|0|||
16994622|NCT01004822|38138457|FG006|Overall Study|Adverse Event|1|||
17073311|NCT00483704|38215504|FG000|Randomization|Withdrawal by Subject|19|||
17073312|NCT00483704|38215505|FG001|Randomization|Withdrawal by Subject|28|||
17073313|NCT00483704|38215506|FG002|Randomization|Withdrawal by Subject|18|||
17073314|NCT00483704|38215504|FG000|Randomization|Protocol Violation|14|||
16994623|NCT01004822|38138458|FG007|Overall Study|Adverse Event|1|||
16994624|NCT01004822|38138451|FG000|Overall Study|Other|0|||
16994625|NCT01004822|38138452|FG001|Overall Study|Other|0|||
16994626|NCT01004822|38138453|FG002|Overall Study|Other|4|||
16994627|NCT01004822|38138454|FG003|Overall Study|Other|1|||
16994628|NCT01004822|38138455|FG004|Overall Study|Other|0|||
16994629|NCT01004822|38138456|FG005|Overall Study|Other|1|||
16994630|NCT01004822|38138457|FG006|Overall Study|Other|0|||
16994631|NCT01004822|38138458|FG007|Overall Study|Other|0|||
16994632|NCT01001234|38138483|FG000|Overall Study|Withdrawal by Subject|2|||
16994633|NCT01001234|38138484|FG001|Overall Study|Withdrawal by Subject|0|||
16994634|NCT01001234|38138485|FG002|Overall Study|Withdrawal by Subject|3|||
16994635|NCT01001234|38138486|FG003|Overall Study|Withdrawal by Subject|0|||
16994636|NCT01001234|38138487|FG004|Overall Study|Withdrawal by Subject|0|||
17156907|NCT02509494|38303899|FG001|Overall Study|Physician Decision|1|||
17156908|NCT02509494|38303900|FG002|Overall Study|Physician Decision|0|||
17156909|NCT02509494|38303901|FG003|Overall Study|Physician Decision|0|||
17156910|NCT02509494|38303902|FG004|Overall Study|Physician Decision|0|||
17156911|NCT02509494|38303903|FG005|Overall Study|Physician Decision|0|||
17156912|NCT02509494|38303904|FG006|Overall Study|Physician Decision|0|||
17156913|NCT02509494|38303905|FG007|Overall Study|Physician Decision|0|||
17156914|NCT02509494|38303906|FG008|Overall Study|Physician Decision|0|||
17156915|NCT02509494|38303898|FG000|Overall Study|Withdrawal by Subject|4|||
17156916|NCT02509494|38303899|FG001|Overall Study|Withdrawal by Subject|17|||
17156917|NCT02509494|38303900|FG002|Overall Study|Withdrawal by Subject|7|||
17156918|NCT02509494|38303901|FG003|Overall Study|Withdrawal by Subject|5|||
17156919|NCT02509494|38303902|FG004|Overall Study|Withdrawal by Subject|0|||
17156920|NCT02509494|38303903|FG005|Overall Study|Withdrawal by Subject|6|||
17156921|NCT02509494|38303904|FG006|Overall Study|Withdrawal by Subject|1|||
16994637|NCT01001234|38138483|FG000|Overall Study|Protocol Violation|34|||
16994638|NCT01001234|38138484|FG001|Overall Study|Protocol Violation|3|||
17073315|NCT00483704|38215505|FG001|Randomization|Protocol Violation|25|||
17073316|NCT00483704|38215506|FG002|Randomization|Protocol Violation|22|||
17073317|NCT00483704|38215504|FG000|Randomization|Lost to Follow-up|14|||
17073318|NCT00483704|38215505|FG001|Randomization|Lost to Follow-up|14|||
17073319|NCT00483704|38215506|FG002|Randomization|Lost to Follow-up|19|||
17073320|NCT00483704|38215504|FG000|Randomization|Pregnancy|1|||
17073321|NCT00483704|38215505|FG001|Randomization|Pregnancy|0|||
17073322|NCT00483704|38215506|FG002|Randomization|Pregnancy|0|||
17156922|NCT02509494|38303905|FG007|Overall Study|Withdrawal by Subject|2|||
17156923|NCT02509494|38303906|FG008|Overall Study|Withdrawal by Subject|1|||
17156924|NCT02509494|38303898|FG000|Overall Study|Death|0|||
16994639|NCT01001234|38138485|FG002|Overall Study|Protocol Violation|19|||
16994640|NCT01001234|38138486|FG003|Overall Study|Protocol Violation|18|||
16994641|NCT01001234|38138487|FG004|Overall Study|Protocol Violation|0|||
16994642|NCT01001234|38138483|FG000|Overall Study|Lost to Follow-up|0|||
16994643|NCT01001234|38138484|FG001|Overall Study|Lost to Follow-up|0|||
16994644|NCT01001234|38138485|FG002|Overall Study|Lost to Follow-up|1|||
16994645|NCT01001234|38138486|FG003|Overall Study|Lost to Follow-up|2|||
16994646|NCT01001234|38138487|FG004|Overall Study|Lost to Follow-up|0|||
17073323|NCT00483704|38215504|FG000|Randomization|Physician Decision|2|||
17073324|NCT00483704|38215505|FG001|Randomization|Physician Decision|4|||
17073325|NCT00483704|38215506|FG002|Randomization|Physician Decision|0|||
17073326|NCT00483704|38215504|FG000|Randomization|Progressive disease|0|||
17073327|NCT00483704|38215505|FG001|Randomization|Progressive disease|0|||
17073328|NCT00483704|38215506|FG002|Randomization|Progressive disease|1|||
16994647|NCT01001234|38138483|FG000|Overall Study|Physician Decision|1|||
17073329|NCT00483704|38215504|FG000|Randomization|Lack of qualifying migraines|21|||
17156925|NCT02509494|38303899|FG001|Overall Study|Death|1|||
16994648|NCT01001234|38138484|FG001|Overall Study|Physician Decision|0|||
16994649|NCT01001234|38138485|FG002|Overall Study|Physician Decision|0|||
17156926|NCT02509494|38303900|FG002|Overall Study|Death|0|||
17073330|NCT00483704|38215505|FG001|Randomization|Lack of qualifying migraines|25|||
17073331|NCT00483704|38215506|FG002|Randomization|Lack of qualifying migraines|31|||
17073332|NCT00483704|38215504|FG000|Treatment|Lack of qualifying migraines|101|||
17073333|NCT00483704|38215505|FG001|Treatment|Lack of qualifying migraines|99|||
17073334|NCT00483704|38215506|FG002|Treatment|Lack of qualifying migraines|116|||
17073335|NCT00483704|38215504|FG000|Treatment|Adverse Event|3|||
17156927|NCT02509494|38303901|FG003|Overall Study|Death|0|||
17156928|NCT02509494|38303902|FG004|Overall Study|Death|1|||
17156929|NCT02509494|38303903|FG005|Overall Study|Death|0|||
17156930|NCT02509494|38303904|FG006|Overall Study|Death|0|||
17156931|NCT02509494|38303905|FG007|Overall Study|Death|1|||
17156932|NCT02509494|38303906|FG008|Overall Study|Death|0|||
17156933|NCT02509494|38303898|FG000|Overall Study|Other|0|||
17156934|NCT02509494|38303899|FG001|Overall Study|Other|4|||
17156935|NCT02509494|38303900|FG002|Overall Study|Other|5|||
17156936|NCT02509494|38303901|FG003|Overall Study|Other|0|||
17156937|NCT02509494|38303902|FG004|Overall Study|Other|0|||
17156938|NCT02509494|38303903|FG005|Overall Study|Other|0|||
17156939|NCT02509494|38303904|FG006|Overall Study|Other|0|||
17156940|NCT02509494|38303905|FG007|Overall Study|Other|0|||
17156941|NCT02509494|38303906|FG008|Overall Study|Other|0|||
17156942|NCT02509494|38303898|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17156943|NCT02509494|38303899|FG001|Overall Study|Non-Compliance With Study Drug|11|||
17156944|NCT02509494|38303900|FG002|Overall Study|Non-Compliance With Study Drug|7|||
17156945|NCT02509494|38303901|FG003|Overall Study|Non-Compliance With Study Drug|0|||
17156946|NCT02509494|38303902|FG004|Overall Study|Non-Compliance With Study Drug|1|||
17156947|NCT02509494|38303903|FG005|Overall Study|Non-Compliance With Study Drug|2|||
17156948|NCT02509494|38303904|FG006|Overall Study|Non-Compliance With Study Drug|1|||
17073336|NCT00483704|38215505|FG001|Treatment|Adverse Event|5|||
17073337|NCT00483704|38215506|FG002|Treatment|Adverse Event|4|||
17073338|NCT00483704|38215504|FG000|Treatment|Withdrawal by Subject|16|||
17073339|NCT00483704|38215505|FG001|Treatment|Withdrawal by Subject|12|||
17073340|NCT00483704|38215506|FG002|Treatment|Withdrawal by Subject|21|||
17073341|NCT00483704|38215504|FG000|Treatment|Protocol Violation|6|||
17073342|NCT00483704|38215505|FG001|Treatment|Protocol Violation|3|||
17073343|NCT00483704|38215506|FG002|Treatment|Protocol Violation|5|||
17073344|NCT00483704|38215504|FG000|Treatment|Lost to Follow-up|2|||
17073345|NCT00483704|38215505|FG001|Treatment|Lost to Follow-up|7|||
17073346|NCT00483704|38215506|FG002|Treatment|Lost to Follow-up|5|||
17073347|NCT00483704|38215504|FG000|Treatment|Lack of Efficacy|1|||
17073348|NCT00483704|38215505|FG001|Treatment|Lack of Efficacy|1|||
17073349|NCT00483704|38215506|FG002|Treatment|Lack of Efficacy|1|||
17073350|NCT00483704|38215504|FG000|Treatment|Pregnancy|0|||
17073351|NCT00483704|38215505|FG001|Treatment|Pregnancy|1|||
17073352|NCT00483704|38215506|FG002|Treatment|Pregnancy|0|||
17073353|NCT00483704|38215504|FG000|Treatment|Physician Decision|0|||
17073354|NCT00483704|38215505|FG001|Treatment|Physician Decision|1|||
17073355|NCT00483704|38215506|FG002|Treatment|Physician Decision|4|||
17073356|NCT00483548|38215519|FG000|Overall Study|Randomized; not treated with study drug|1|||
17073357|NCT00483548|38215520|FG001|Overall Study|Randomized; not treated with study drug|3|||
17073358|NCT00483548|38215519|FG000|Overall Study|Adverse Event|25|||
17073359|NCT00483548|38215520|FG001|Overall Study|Adverse Event|14|||
17073360|NCT00483548|38215519|FG000|Overall Study|Laboratory abnormality|1|||
17073361|NCT00483548|38215520|FG001|Overall Study|Laboratory abnormality|2|||
17073362|NCT00483548|38215519|FG000|Overall Study|Lack of Efficacy|4|||
17073363|NCT00483548|38215520|FG001|Overall Study|Lack of Efficacy|8|||
17073364|NCT00483548|38215519|FG000|Overall Study|Protocol Violation|11|||
17073365|NCT00483548|38215520|FG001|Overall Study|Protocol Violation|7|||
17073366|NCT00483548|38215519|FG000|Overall Study|Pregnancy|1|||
17073367|NCT00483548|38215520|FG001|Overall Study|Pregnancy|0|||
17073368|NCT00483548|38215519|FG000|Overall Study|Protocol required discontinuation|6|||
17073369|NCT00483548|38215520|FG001|Overall Study|Protocol required discontinuation|6|||
17073370|NCT00483548|38215519|FG000|Overall Study|Unable to comply with protocol schedule|1|||
17073371|NCT00483548|38215520|FG001|Overall Study|Unable to comply with protocol schedule|0|||
17073372|NCT00483548|38215519|FG000|Overall Study|Non-compliance with medication|2|||
17073373|NCT00483548|38215520|FG001|Overall Study|Non-compliance with medication|0|||
17073374|NCT00483548|38215519|FG000|Overall Study|Lost to Follow-up|3|||
17073375|NCT00483548|38215520|FG001|Overall Study|Lost to Follow-up|4|||
17073376|NCT00483548|38215519|FG000|Overall Study|Withdrawal by Subject|5|||
17073377|NCT00483548|38215520|FG001|Overall Study|Withdrawal by Subject|2|||
17073378|NCT00445770|38215529|FG000|Overall Study|Adverse Event|9|||
17073379|NCT00445770|38215530|FG001|Overall Study|Adverse Event|15|||
17073380|NCT00445770|38215531|FG002|Overall Study|Adverse Event|19|||
17073381|NCT00445770|38215529|FG000|Overall Study|Lack of Efficacy|38|||
17073382|NCT00445770|38215530|FG001|Overall Study|Lack of Efficacy|13|||
17073383|NCT00445770|38215531|FG002|Overall Study|Lack of Efficacy|6|||
17156949|NCT02509494|38303905|FG007|Overall Study|Non-Compliance With Study Drug|1|||
17073384|NCT00445770|38215529|FG000|Overall Study|Lost to Follow-up|0|||
17156950|NCT02509494|38303906|FG008|Overall Study|Non-Compliance With Study Drug|0|||
17073385|NCT00445770|38215530|FG001|Overall Study|Lost to Follow-up|2|||
17073386|NCT00445770|38215531|FG002|Overall Study|Lost to Follow-up|0|||
17073387|NCT00445770|38215529|FG000|Overall Study|Other|6|||
17073388|NCT00445770|38215530|FG001|Overall Study|Other|5|||
17073389|NCT00445770|38215531|FG002|Overall Study|Other|6|||
17073390|NCT00266032|38215544|FG000|Treatment|Adverse Event|42|||
17073391|NCT00266032|38215545|FG001|Treatment|Adverse Event|26|||
17073392|NCT00266032|38215546|FG002|Treatment|Adverse Event|10|||
17073393|NCT00266032|38215544|FG000|Treatment|Lost to Follow-up|19|||
17156951|NCT03493451|38303943|FG000|Overall Study|Death|11|||
17156952|NCT03493451|38303944|FG001|Overall Study|Death|26|||
17156953|NCT03493451|38303945|FG002|Overall Study|Death|3|||
17156954|NCT03493451|38303943|FG000|Overall Study|Lost to Follow-up|1|||
17156955|NCT03493451|38303944|FG001|Overall Study|Lost to Follow-up|4|||
17156956|NCT03493451|38303945|FG002|Overall Study|Lost to Follow-up|1|||
17156957|NCT03493451|38303943|FG000|Overall Study|Withdrawal by Subject|1|||
17156958|NCT03493451|38303944|FG001|Overall Study|Withdrawal by Subject|1|||
17156959|NCT03493451|38303945|FG002|Overall Study|Withdrawal by Subject|2|||
17156960|NCT03493451|38303943|FG000|Overall Study|Progressive Disease|1|||
17156961|NCT03493451|38303944|FG001|Overall Study|Progressive Disease|0|||
17156962|NCT03493451|38303945|FG002|Overall Study|Progressive Disease|0|||
17156963|NCT03493451|38303943|FG000|Overall Study|Transferred to long term extension study|8|||
17156964|NCT03493451|38303944|FG001|Overall Study|Transferred to long term extension study|13|||
17156965|NCT03493451|38303945|FG002|Overall Study|Transferred to long term extension study|5|||
17156966|NCT03492281|38303956|FG000|Overall Study|Withdrawal by Subject|21|||
17156967|NCT03492281|38303957|FG001|Overall Study|Withdrawal by Subject|14|||
17156968|NCT03492281|38303958|FG002|Overall Study|Withdrawal by Subject|13|||
17156969|NCT03492281|38303956|FG000|Overall Study|Lost to Follow-up|14|||
17156970|NCT03492281|38303957|FG001|Overall Study|Lost to Follow-up|15|||
17156971|NCT03492281|38303958|FG002|Overall Study|Lost to Follow-up|10|||
17156972|NCT03492281|38303956|FG000|Overall Study|Adverse Event|6|||
17156973|NCT03492281|38303957|FG001|Overall Study|Adverse Event|8|||
17156974|NCT03492281|38303958|FG002|Overall Study|Adverse Event|13|||
17156975|NCT03492281|38303956|FG000|Overall Study|Lack of Efficacy|3|||
17156976|NCT03492281|38303957|FG001|Overall Study|Lack of Efficacy|0|||
17156977|NCT03492281|38303958|FG002|Overall Study|Lack of Efficacy|1|||
17156978|NCT03492281|38303956|FG000|Overall Study|Physician Decision|1|||
17156979|NCT03492281|38303957|FG001|Overall Study|Physician Decision|0|||
17156980|NCT03492281|38303958|FG002|Overall Study|Physician Decision|3|||
17156981|NCT03492281|38303956|FG000|Overall Study|Protocol Violation|0|||
17156982|NCT03492281|38303957|FG001|Overall Study|Protocol Violation|2|||
17156983|NCT03492281|38303958|FG002|Overall Study|Protocol Violation|1|||
17156984|NCT03492281|38303956|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
17156985|NCT03492281|38303957|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
17156986|NCT03492281|38303958|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
17156987|NCT03492281|38303956|FG000|Overall Study|Death|0|||
17156988|NCT03492281|38303957|FG001|Overall Study|Death|0|||
17156989|NCT03492281|38303958|FG002|Overall Study|Death|1|||
17073394|NCT00266032|38215545|FG001|Treatment|Lost to Follow-up|4|||
17156990|NCT03492281|38303956|FG000|Overall Study|Captured as Other in Database|8|||
17156991|NCT03492281|38303957|FG001|Overall Study|Captured as Other in Database|6|||
17156992|NCT03492281|38303958|FG002|Overall Study|Captured as Other in Database|3|||
17156993|NCT03070782|38303975|FG000|Overall Study|Adverse Event|3|||
17156994|NCT03070782|38303976|FG001|Overall Study|Adverse Event|0|||
17156995|NCT03070782|38303977|FG002|Overall Study|Adverse Event|3|||
16994650|NCT01001234|38138486|FG003|Overall Study|Physician Decision|0|||
16994651|NCT01001234|38138487|FG004|Overall Study|Physician Decision|0|||
16994652|NCT01001234|38138483|FG000|Overall Study|Not Treated: Adverse Event|1|||
16994653|NCT01001234|38138484|FG001|Overall Study|Not Treated: Adverse Event|0|||
16994654|NCT01001234|38138485|FG002|Overall Study|Not Treated: Adverse Event|0|||
16994655|NCT01001234|38138486|FG003|Overall Study|Not Treated: Adverse Event|0|||
16994656|NCT01001234|38138487|FG004|Overall Study|Not Treated: Adverse Event|0|||
16994657|NCT01001234|38138483|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
16994658|NCT01001234|38138484|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
16994659|NCT01001234|38138485|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
16994660|NCT01001234|38138486|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
16994661|NCT01001234|38138487|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
16994662|NCT01001234|38138483|FG000|Overall Study|Not Treated: Protocol Violation|3|||
16994663|NCT01001234|38138484|FG001|Overall Study|Not Treated: Protocol Violation|0|||
16994664|NCT01001234|38138485|FG002|Overall Study|Not Treated: Protocol Violation|0|||
16994665|NCT01001234|38138486|FG003|Overall Study|Not Treated: Protocol Violation|0|||
16994666|NCT01001234|38138487|FG004|Overall Study|Not Treated: Protocol Violation|0|||
16994667|NCT01001234|38138483|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
17073395|NCT00266032|38215546|FG002|Treatment|Lost to Follow-up|2|||
17073396|NCT00266032|38215544|FG000|Treatment|Pregnancy|3|||
17073397|NCT00266032|38215545|FG001|Treatment|Pregnancy|2|||
17156996|NCT03070782|38303978|FG003|Overall Study|Adverse Event|1|||
17073398|NCT00266032|38215546|FG002|Treatment|Pregnancy|2|||
17073399|NCT00266032|38215544|FG000|Treatment|Protocol Violation|6|||
17073400|NCT00266032|38215545|FG001|Treatment|Protocol Violation|14|||
17073401|NCT00266032|38215546|FG002|Treatment|Protocol Violation|13|||
17156997|NCT03070782|38303979|FG004|Overall Study|Adverse Event|6|||
17156998|NCT03070782|38303980|FG005|Overall Study|Adverse Event|2|||
17156999|NCT03070782|38303975|FG000|Overall Study|Withdrawal by Subject|2|||
17157000|NCT03070782|38303976|FG001|Overall Study|Withdrawal by Subject|1|||
17073402|NCT00266032|38215544|FG000|Treatment|Withdrawal by Subject|28|||
17073403|NCT00266032|38215545|FG001|Treatment|Withdrawal by Subject|13|||
17073404|NCT00266032|38215546|FG002|Treatment|Withdrawal by Subject|12|||
17157001|NCT03070782|38303977|FG002|Overall Study|Withdrawal by Subject|1|||
17157002|NCT03070782|38303978|FG003|Overall Study|Withdrawal by Subject|0|||
17157003|NCT03070782|38303979|FG004|Overall Study|Withdrawal by Subject|4|||
17157004|NCT03070782|38303980|FG005|Overall Study|Withdrawal by Subject|3|||
17157005|NCT03070782|38303975|FG000|Overall Study|Reason Not Specified|2|||
16994668|NCT01001234|38138484|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
16994669|NCT01001234|38138485|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
16994670|NCT01001234|38138486|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
16994671|NCT01001234|38138487|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
16994672|NCT01001234|38138483|FG000|Overall Study|Not Treated: Pregnancy|3|||
16994673|NCT01001234|38138484|FG001|Overall Study|Not Treated: Pregnancy|0|||
16994674|NCT01001234|38138485|FG002|Overall Study|Not Treated: Pregnancy|0|||
16994675|NCT01001234|38138486|FG003|Overall Study|Not Treated: Pregnancy|0|||
16994676|NCT01001234|38138487|FG004|Overall Study|Not Treated: Pregnancy|0|||
16994677|NCT01001234|38138483|FG000|Overall Study|Not Treated: Physician Decision|37|||
16994678|NCT01001234|38138484|FG001|Overall Study|Not Treated: Physician Decision|4|||
16994679|NCT01001234|38138485|FG002|Overall Study|Not Treated: Physician Decision|0|||
16994680|NCT01001234|38138486|FG003|Overall Study|Not Treated: Physician Decision|0|||
16994681|NCT01001234|38138487|FG004|Overall Study|Not Treated: Physician Decision|0|||
16994682|NCT01001234|38138483|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
16994683|NCT01001234|38138484|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
16994684|NCT01001234|38138485|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
16994685|NCT01001234|38138486|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
17073405|NCT00266032|38215544|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
17073406|NCT00266032|38215545|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
17073407|NCT00266032|38215546|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
17073408|NCT00266032|38215544|FG000|Open-label Safety Extension|Adverse Event|5|||
17073409|NCT00266032|38215545|FG001|Open-label Safety Extension|Adverse Event|0|||
17073410|NCT00266032|38215546|FG002|Open-label Safety Extension|Adverse Event|4|||
17073411|NCT00266032|38215544|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
17073412|NCT00266032|38215545|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
17073413|NCT00266032|38215546|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
17073414|NCT00266032|38215544|FG000|Open-label Safety Extension|Pregnancy|4|||
17073415|NCT00266032|38215545|FG001|Open-label Safety Extension|Pregnancy|1|||
17073416|NCT00266032|38215546|FG002|Open-label Safety Extension|Pregnancy|2|||
17073417|NCT00266032|38215544|FG000|Open-label Safety Extension|Protocol Violation|1|||
17073418|NCT00266032|38215545|FG001|Open-label Safety Extension|Protocol Violation|3|||
17073419|NCT00266032|38215546|FG002|Open-label Safety Extension|Protocol Violation|2|||
17073420|NCT00266032|38215544|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
17073421|NCT00266032|38215545|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
17073422|NCT00266032|38215546|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
17073423|NCT00266032|38215544|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
17073424|NCT00266032|38215545|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
17073425|NCT00266032|38215546|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
17073426|NCT00483002|38215554|FG000|Overall Study|Adverse Event|68|||
17073427|NCT00483002|38215554|FG000|Overall Study|Lack of Efficacy|555|||
17073428|NCT00483002|38215554|FG000|Overall Study|Lost to Follow-up|962|||
17073429|NCT00483002|38215554|FG000|Overall Study|Other|2|||
17073430|NCT00483002|38215554|FG000|Overall Study|Other|967|||
17073431|NCT00482612|38215562|FG000|In-treatment Period|No study medication administered|0|||
17073432|NCT00482612|38215563|FG001|In-treatment Period|No study medication administered|0|||
17073433|NCT00482612|38215564|FG002|In-treatment Period|No study medication administered|1|||
17073434|NCT00482612|38215565|FG003|In-treatment Period|No study medication administered|0|||
17073435|NCT00482612|38215562|FG000|Follow-up Period|Other|4|||
17073436|NCT00482612|38215563|FG001|Follow-up Period|Other|2|||
17073437|NCT00482612|38215564|FG002|Follow-up Period|Other|1|||
17073438|NCT00482612|38215565|FG003|Follow-up Period|Other|2|||
17073439|NCT00482612|38215562|FG000|Follow-up Period|Lack of compliance|0|||
17073440|NCT00482612|38215563|FG001|Follow-up Period|Lack of compliance|0|||
17073441|NCT00482612|38215564|FG002|Follow-up Period|Lack of compliance|1|||
17073442|NCT00482612|38215565|FG003|Follow-up Period|Lack of compliance|0|||
17157006|NCT03070782|38303976|FG001|Overall Study|Reason Not Specified|0|||
17073443|NCT00482612|38215562|FG000|Follow-up Period|Lost to Follow-up|0|||
17073444|NCT00482612|38215563|FG001|Follow-up Period|Lost to Follow-up|4|||
17073445|NCT00482612|38215564|FG002|Follow-up Period|Lost to Follow-up|2|||
17073446|NCT00482612|38215565|FG003|Follow-up Period|Lost to Follow-up|1|||
17073447|NCT00482612|38215562|FG000|Follow-up Period|Adverse Event|4|||
17073448|NCT00482612|38215563|FG001|Follow-up Period|Adverse Event|7|||
17073449|NCT00482612|38215564|FG002|Follow-up Period|Adverse Event|9|||
17073450|NCT00482612|38215565|FG003|Follow-up Period|Adverse Event|0|||
17073451|NCT00482612|38215562|FG000|Follow-up Period|Lack of Efficacy|2|||
17073452|NCT00482612|38215563|FG001|Follow-up Period|Lack of Efficacy|0|||
17073453|NCT00482612|38215564|FG002|Follow-up Period|Lack of Efficacy|1|||
17073454|NCT00482612|38215565|FG003|Follow-up Period|Lack of Efficacy|0|||
17073455|NCT00482612|38215562|FG000|Follow-up Period|Withdrawal by Subject|3|||
17073456|NCT00482612|38215563|FG001|Follow-up Period|Withdrawal by Subject|5|||
17073457|NCT00482612|38215564|FG002|Follow-up Period|Withdrawal by Subject|7|||
17073458|NCT00482612|38215565|FG003|Follow-up Period|Withdrawal by Subject|2|||
17073459|NCT00482612|38215562|FG000|Follow-up Period|Reasons not related to trial|1|||
17073460|NCT00482612|38215563|FG001|Follow-up Period|Reasons not related to trial|0|||
17073461|NCT00482612|38215564|FG002|Follow-up Period|Reasons not related to trial|1|||
17073462|NCT00482612|38215565|FG003|Follow-up Period|Reasons not related to trial|3|||
17073463|NCT00282568|38215579|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
17073464|NCT00282568|38215579|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
17073465|NCT00282568|38215579|FG000|Extended Treatment Period|Adverse Event|17|||
17073466|NCT00282568|38215579|FG000|Extended Treatment Period|Non-compliance|4|||
17073467|NCT00282568|38215579|FG000|Extended Treatment Period|Physician Decision|1|||
17073468|NCT00282568|38215579|FG000|Extended Treatment Period|Lost to Follow-up|2|||
17073469|NCT00265564|38215585|FG000|Overall Study|Lost to Follow-up|5|||
17073470|NCT00265564|38215586|FG001|Overall Study|Lost to Follow-up|7|||
17073471|NCT00265564|38215585|FG000|Overall Study|met exclusion criteria|5|||
17073472|NCT00265564|38215586|FG001|Overall Study|met exclusion criteria|2|||
17073473|NCT00376623|38215595|FG000|Overall Study|Progressive disease|35|||
17073474|NCT00376623|38215596|FG001|Overall Study|Progressive disease|22|||
17073475|NCT00376623|38215597|FG002|Overall Study|Progressive disease|17|||
17073476|NCT00376623|38215595|FG000|Overall Study|Lost to Follow-up|0|||
17073477|NCT00376623|38215596|FG001|Overall Study|Lost to Follow-up|1|||
17073478|NCT00376623|38215597|FG002|Overall Study|Lost to Follow-up|0|||
17073479|NCT00376623|38215595|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
17073480|NCT00376623|38215596|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
17073481|NCT00376623|38215597|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
17073482|NCT00376623|38215595|FG000|Overall Study|Not treated with BI 2536|1|||
17073483|NCT00376623|38215596|FG001|Overall Study|Not treated with BI 2536|0|||
17073484|NCT00376623|38215597|FG002|Overall Study|Not treated with BI 2536|0|||
17073485|NCT00376623|38215595|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
17073486|NCT00376623|38215596|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
17073487|NCT00376623|38215597|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
17073488|NCT00376623|38215595|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
17073489|NCT00376623|38215596|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
17073490|NCT00376623|38215597|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
17073491|NCT00376623|38215595|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
17073492|NCT00376623|38215596|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
17073493|NCT00376623|38215597|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
17073494|NCT00376623|38215595|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
17073495|NCT00376623|38215596|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
17073496|NCT00376623|38215597|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
17073497|NCT00376623|38215595|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
17073498|NCT00376623|38215596|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
17073499|NCT00376623|38215597|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
17073500|NCT00376623|38215595|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
17157007|NCT03070782|38303977|FG002|Overall Study|Reason Not Specified|0|||
17157008|NCT03070782|38303978|FG003|Overall Study|Reason Not Specified|1|||
17157009|NCT03070782|38303979|FG004|Overall Study|Reason Not Specified|2|||
17157010|NCT03070782|38303980|FG005|Overall Study|Reason Not Specified|1|||
17157011|NCT03070782|38303975|FG000|Overall Study|Ineligibility|0|||
17073501|NCT00376623|38215596|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
17073502|NCT00376623|38215597|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
17073503|NCT00376623|38215595|FG000|Overall Study|Increase of tumour markers|0|||
17073504|NCT00376623|38215596|FG001|Overall Study|Increase of tumour markers|1|||
17073505|NCT00376623|38215597|FG002|Overall Study|Increase of tumour markers|0|||
17073506|NCT00376623|38215595|FG000|Overall Study|Bone metastasis|1|||
17073507|NCT00376623|38215596|FG001|Overall Study|Bone metastasis|0|||
17073508|NCT00376623|38215597|FG002|Overall Study|Bone metastasis|0|||
16994686|NCT01001234|38138487|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
16994687|NCT01004510|38138493|FG000|Overall Study|Adverse Event|1|||
17073509|NCT00445692|38215611|FG000|Overall Study|Adverse Event|11|||
17073510|NCT00445692|38215611|FG000|Overall Study|Lack of Efficacy|5|||
17073511|NCT03824236|38215620|FG000|Overall Study|Lost to Follow-up|0|||
17073512|NCT03824236|38215621|FG001|Overall Study|Lost to Follow-up|0|||
17073513|NCT03824236|38215622|FG002|Overall Study|Lost to Follow-up|1|||
17073514|NCT00282412|38215630|FG000|Overall Study|Death|2|||
17073515|NCT00282334|38215636|FG000|Overall Study|Withdrawal by Subject|8|||
17073516|NCT00282334|38215637|FG001|Overall Study|Withdrawal by Subject|5|||
17073517|NCT00282256|38215643|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
17073518|NCT00282256|38215643|FG000|Extension Treatment Period|Adverse Event|2|||
17073519|NCT00265330|38215647|FG000|Overall Study|Adverse Event|41|||
17073520|NCT00265330|38215647|FG000|Overall Study|Lost to Follow-up|8|||
17073521|NCT00265330|38215647|FG000|Overall Study|Withdrawal by Subject|34|||
17073522|NCT00265330|38215647|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
17073523|NCT00265330|38215647|FG000|Overall Study|Lack of Efficacy|4|||
17073524|NCT00265330|38215647|FG000|Overall Study|Family Scheduling Conflicts|1|||
17073525|NCT00265330|38215647|FG000|Overall Study|Began Taking Formulary Geodon|1|||
17073526|NCT00265330|38215647|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
17073527|NCT00265330|38215647|FG000|Overall Study|Site Closed by Sponsor|1|||
17073528|NCT00265330|38215647|FG000|Overall Study|Principal Investigators Request|1|||
17073529|NCT00265330|38215647|FG000|Overall Study|Withdrew Consent|1|||
17073530|NCT00265330|38215647|FG000|Overall Study|Protocol Violation|1|||
17157012|NCT03070782|38303976|FG001|Overall Study|Ineligibility|0|||
17157013|NCT03070782|38303977|FG002|Overall Study|Ineligibility|0|||
17073531|NCT00292318|38215653|FG000|Overall Study|Study terminated by officials|2|||
17073532|NCT00292318|38215654|FG001|Overall Study|Study terminated by officials|1|||
17073533|NCT00281632|38215660|FG000|Overall Study|Adverse Event|7|||
17073534|NCT00281632|38215660|FG000|Overall Study|Withdrawal by Subject|2|||
17073535|NCT00281632|38215660|FG000|Overall Study|Disease Progression|22|||
17073536|NCT00281632|38215660|FG000|Overall Study|Death|1|||
17073537|NCT00281632|38215660|FG000|Overall Study|Physician Decision|1|||
17073538|NCT00281632|38215660|FG000|Overall Study|Ongoing|3|||
16994688|NCT02609503|38138497|FG000|Overall Study|Adverse Event|1|||
16994689|NCT02609503|38138497|FG000|Overall Study|Death|1|||
16994690|NCT02609503|38138497|FG000|Overall Study|Withdrawal by Subject|1|||
16994691|NCT02609503|38138497|FG000|Overall Study|Disease progression|1|||
16994692|NCT01004432|38138504|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
16994693|NCT01004432|38138505|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
16994694|NCT01004432|38138506|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
16994695|NCT01004432|38138507|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
16994696|NCT01004432|38138508|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
16994697|NCT01004432|38138504|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
16994698|NCT01004432|38138505|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
16994699|NCT01004432|38138506|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
16994700|NCT01004432|38138507|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
16994701|NCT01004432|38138508|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
16994702|NCT01004432|38138504|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
16994703|NCT01004432|38138505|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
16994704|NCT01004432|38138506|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
16994705|NCT01004432|38138507|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
16994706|NCT01004432|38138508|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
16994707|NCT01004432|38138504|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
17073539|NCT00543569|38215676|FG000|Overall Study|Death|2|||
17073540|NCT00543569|38215677|FG001|Overall Study|Death|2|||
17157014|NCT03070782|38303978|FG003|Overall Study|Ineligibility|1|||
17157015|NCT03070782|38303979|FG004|Overall Study|Ineligibility|0|||
17157016|NCT03070782|38303980|FG005|Overall Study|Ineligibility|1|||
17157017|NCT03070782|38303975|FG000|Overall Study|Pregnancy|0|||
17157018|NCT03070782|38303976|FG001|Overall Study|Pregnancy|0|||
17073541|NCT00543569|38215678|FG002|Overall Study|Death|3|||
17073542|NCT00543569|38215679|FG003|Overall Study|Death|1|||
17073543|NCT00543569|38215676|FG000|Overall Study|Lost to Follow-up|0|||
17073544|NCT00543569|38215677|FG001|Overall Study|Lost to Follow-up|0|||
17073545|NCT00543569|38215678|FG002|Overall Study|Lost to Follow-up|1|||
17073546|NCT00543569|38215679|FG003|Overall Study|Lost to Follow-up|1|||
17073547|NCT00543569|38215676|FG000|Overall Study|Miscellaneous Reasons|7|||
17073548|NCT00543569|38215677|FG001|Overall Study|Miscellaneous Reasons|3|||
17073549|NCT00543569|38215678|FG002|Overall Study|Miscellaneous Reasons|11|||
17073550|NCT00543569|38215679|FG003|Overall Study|Miscellaneous Reasons|4|||
17073551|NCT00543569|38215676|FG000|Overall Study|Randomized but never received study drug|3|||
17073552|NCT00543569|38215677|FG001|Overall Study|Randomized but never received study drug|3|||
17073553|NCT00543569|38215678|FG002|Overall Study|Randomized but never received study drug|5|||
17073554|NCT00543569|38215679|FG003|Overall Study|Randomized but never received study drug|3|||
17073555|NCT00445458|38215693|FG000|Overall Study|Disease Progression|3|||
17073556|NCT00445458|38215694|FG001|Overall Study|Disease Progression|4|||
17073557|NCT00445458|38215695|FG002|Overall Study|Disease Progression|54|||
17073558|NCT00445458|38215696|FG003|Overall Study|Disease Progression|27|||
17073559|NCT00445458|38215693|FG000|Overall Study|Withdrawal by Subject|0|||
17073560|NCT00445458|38215694|FG001|Overall Study|Withdrawal by Subject|0|||
17073561|NCT00445458|38215695|FG002|Overall Study|Withdrawal by Subject|7|||
17073562|NCT00445458|38215696|FG003|Overall Study|Withdrawal by Subject|0|||
17073563|NCT00445458|38215693|FG000|Overall Study|Adverse Event|0|||
17073564|NCT00445458|38215694|FG001|Overall Study|Adverse Event|0|||
17073565|NCT00445458|38215695|FG002|Overall Study|Adverse Event|3|||
17073566|NCT00445458|38215696|FG003|Overall Study|Adverse Event|0|||
17073567|NCT00445458|38215693|FG000|Overall Study|Death|0|||
17073568|NCT00445458|38215694|FG001|Overall Study|Death|1|||
17073569|NCT00445458|38215695|FG002|Overall Study|Death|2|||
17073570|NCT00445458|38215696|FG003|Overall Study|Death|0|||
17073571|NCT00445458|38215693|FG000|Overall Study|Physician Decision|0|||
17073572|NCT00445458|38215694|FG001|Overall Study|Physician Decision|0|||
17073573|NCT00445458|38215695|FG002|Overall Study|Physician Decision|1|||
17073574|NCT00445458|38215696|FG003|Overall Study|Physician Decision|1|||
17073575|NCT00445458|38215693|FG000|Overall Study|Surgery|0|||
17073576|NCT00445458|38215694|FG001|Overall Study|Surgery|0|||
17073577|NCT00445458|38215695|FG002|Overall Study|Surgery|1|||
17073578|NCT00445458|38215696|FG003|Overall Study|Surgery|0|||
17073579|NCT03914417|38215709|FG000|Overall Study|Withdrawal by Subject|2|||
17073580|NCT00541385|38215715|FG000|Overall Study|Adverse Event|6|||
17073581|NCT00541385|38215716|FG001|Overall Study|Adverse Event|3|||
17073582|NCT00541385|38215715|FG000|Overall Study|Withdrawal by Subject|2|||
17073583|NCT00541385|38215716|FG001|Overall Study|Withdrawal by Subject|2|||
17073584|NCT00541385|38215715|FG000|Overall Study|Lost to Follow-up|6|||
17073585|NCT00541385|38215716|FG001|Overall Study|Lost to Follow-up|1|||
17073586|NCT00541385|38215715|FG000|Overall Study|Parasite reappearance/malaria|67|||
17073587|NCT00541385|38215716|FG001|Overall Study|Parasite reappearance/malaria|32|||
17073588|NCT00265096|38215725|FG000|Overall Study|Adverse Event|14|||
17073589|NCT00265096|38215726|FG001|Overall Study|Adverse Event|18|||
17073590|NCT00265096|38215727|FG002|Overall Study|Adverse Event|18|||
17073591|NCT00265096|38215725|FG000|Overall Study|Lost to Follow-up|2|||
17073592|NCT00265096|38215726|FG001|Overall Study|Lost to Follow-up|5|||
17073593|NCT00265096|38215727|FG002|Overall Study|Lost to Follow-up|3|||
17073594|NCT00265096|38215725|FG000|Overall Study|Death|0|||
17073595|NCT00265096|38215726|FG001|Overall Study|Death|1|||
17073596|NCT00265096|38215727|FG002|Overall Study|Death|2|||
17073597|NCT00265096|38215725|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
17073598|NCT00265096|38215726|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
17073599|NCT00265096|38215727|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
17073600|NCT00265096|38215725|FG000|Overall Study|Other|11|||
17073601|NCT00265096|38215726|FG001|Overall Study|Other|19|||
17073602|NCT00265096|38215727|FG002|Overall Study|Other|10|||
17073603|NCT02201108|38215739|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
17073604|NCT02201108|38215740|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
17157019|NCT03070782|38303977|FG002|Overall Study|Pregnancy|0|||
17073605|NCT02201108|38215739|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
17073606|NCT02201108|38215740|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
17073607|NCT02201108|38215739|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
17073608|NCT02201108|38215740|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
17073609|NCT02201108|38215739|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
17073610|NCT02201108|38215740|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
17073611|NCT02201108|38215739|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
17073612|NCT02201108|38215740|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
17073613|NCT02201108|38215739|FG000|Open Label Period (up to Week 192)|Other reason|4|||
17073614|NCT02201108|38215740|FG001|Open Label Period (up to Week 192)|Other reason|7|||
17073615|NCT02201108|38215739|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
17073616|NCT02201108|38215740|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
17073617|NCT00281320|38215761|FG000|Overall Study|Adverse Event|12|||
17073618|NCT00281320|38215762|FG001|Overall Study|Adverse Event|9|||
17073619|NCT00281320|38215761|FG000|Overall Study|Lack of Efficacy|4|||
17073620|NCT00281320|38215762|FG001|Overall Study|Lack of Efficacy|3|||
17073621|NCT00281320|38215761|FG000|Overall Study|Withdrawal by Subject|5|||
17073622|NCT00281320|38215762|FG001|Overall Study|Withdrawal by Subject|6|||
17073623|NCT00281320|38215761|FG000|Overall Study|Lost to Follow-up|1|||
17073624|NCT00281320|38215762|FG001|Overall Study|Lost to Follow-up|2|||
17073625|NCT00281320|38215761|FG000|Overall Study|Other|3|||
17073626|NCT00281320|38215762|FG001|Overall Study|Other|1|||
17073627|NCT00541307|38215774|FG000|Overall Study|Death|5|||
17073628|NCT00541307|38215774|FG000|Overall Study|Physician Decision|3|||
17073629|NCT00541307|38215774|FG000|Overall Study|Withdrawal by Subject|6|||
17073630|NCT00541307|38215774|FG000|Overall Study|Lost to Follow-up|4|||
17073631|NCT00541307|38215774|FG000|Overall Study|Subject returned early (outside window)|1|||
17073632|NCT00541307|38215774|FG000|Overall Study|Surgical Bypass|5|||
17073633|NCT00541229|38215784|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
17073634|NCT00541229|38215785|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
17073635|NCT00541229|38215786|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
17073636|NCT00541229|38215787|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
17073637|NCT00541229|38215788|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
17073638|NCT00541229|38215789|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
17073639|NCT00541229|38215784|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
17073640|NCT00541229|38215785|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
17073641|NCT00541229|38215786|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
17073642|NCT00541229|38215787|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
17073643|NCT00541229|38215788|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
17073644|NCT00541229|38215789|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
17073645|NCT00541229|38215784|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
17073646|NCT00541229|38215785|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
17073647|NCT00541229|38215786|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
17073648|NCT00541229|38215787|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
16994708|NCT01004432|38138505|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
16994709|NCT01004432|38138506|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
16994710|NCT01004432|38138507|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
16994711|NCT01004432|38138508|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
16994712|NCT01004432|38138504|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
16994713|NCT01004432|38138505|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
16994714|NCT01004432|38138506|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
16994715|NCT01004432|38138507|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
16994716|NCT01004432|38138508|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
16994717|NCT01004432|38138504|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
16994718|NCT01004432|38138505|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
16994719|NCT01004432|38138506|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
16994720|NCT01004432|38138507|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
16994721|NCT01004432|38138508|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
16994722|NCT01004432|38138504|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
16994723|NCT01004432|38138505|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
16994724|NCT01004432|38138506|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
17073649|NCT00541229|38215788|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
17073650|NCT00541229|38215789|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
17073651|NCT00541229|38215784|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
17073652|NCT00541229|38215785|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
17073653|NCT00541229|38215786|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
17073654|NCT00541229|38215787|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
17073655|NCT00541229|38215788|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
17073656|NCT00541229|38215789|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
16994725|NCT01004432|38138507|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
16994726|NCT01004432|38138508|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
16994727|NCT01004432|38138504|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
16994728|NCT01004432|38138505|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
16994729|NCT01004432|38138506|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
16994730|NCT01004432|38138507|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
16994731|NCT01004432|38138508|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
16994732|NCT01004432|38138504|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
16994733|NCT01004432|38138505|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
16994734|NCT01004432|38138506|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
16994735|NCT01004432|38138507|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
17073657|NCT00541229|38215784|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
17073658|NCT00541229|38215785|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
17073659|NCT00541229|38215786|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
17073660|NCT00541229|38215787|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
17073661|NCT00541229|38215788|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
17073662|NCT00541229|38215789|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
17073663|NCT00541229|38215784|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
17073664|NCT00541229|38215785|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
17073665|NCT00541229|38215786|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
17073666|NCT00541229|38215787|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
17073667|NCT00541229|38215788|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
17073668|NCT00541229|38215789|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
17073669|NCT00541229|38215784|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
17073670|NCT00541229|38215785|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
17073671|NCT00541229|38215786|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
17073672|NCT00541229|38215787|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
17073673|NCT00541229|38215788|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
17073674|NCT00541229|38215789|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
17073675|NCT00541229|38215784|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
17073676|NCT00541229|38215785|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
17073677|NCT00541229|38215786|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
17073678|NCT00541229|38215787|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
17073679|NCT00541229|38215788|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
17073680|NCT00541229|38215789|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
17073681|NCT00541229|38215784|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
17157020|NCT03070782|38303978|FG003|Overall Study|Pregnancy|1|||
17157021|NCT03070782|38303979|FG004|Overall Study|Pregnancy|0|||
17073682|NCT00541229|38215785|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
17073683|NCT00541229|38215786|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
17073684|NCT00541229|38215787|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
17073685|NCT00541229|38215788|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
17073686|NCT00541229|38215789|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
17073687|NCT00541229|38215784|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
17073688|NCT00541229|38215785|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
17073689|NCT00541229|38215786|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
17073690|NCT00541229|38215787|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
17073691|NCT00541229|38215788|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
17073692|NCT00541229|38215789|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
17073693|NCT00541229|38215784|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
17073694|NCT00541229|38215785|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
17073695|NCT00541229|38215786|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
17073696|NCT00541229|38215787|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
17073697|NCT00541229|38215788|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
17073698|NCT00541229|38215789|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
17073699|NCT00541229|38215784|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
17073700|NCT00541229|38215785|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
17073701|NCT00541229|38215786|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
17073702|NCT00541229|38215787|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
17073703|NCT00541229|38215788|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
17073704|NCT00541229|38215789|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
17157022|NCT03070782|38303980|FG005|Overall Study|Pregnancy|0|||
16994736|NCT01004432|38138508|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
16994737|NCT01004432|38138504|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
16994738|NCT01004432|38138505|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
16994739|NCT01004432|38138506|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
16994740|NCT01004432|38138507|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
16994741|NCT01004432|38138508|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
16994742|NCT01004432|38138504|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
16994743|NCT01004432|38138505|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
16994744|NCT01004432|38138506|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
16994745|NCT01004432|38138507|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
16994746|NCT01004432|38138508|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
16994747|NCT01004432|38138504|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
16994748|NCT01004432|38138505|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
16994749|NCT01004432|38138506|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
16994750|NCT01004432|38138507|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
16994751|NCT01004432|38138508|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
16994752|NCT01004432|38138504|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
16994753|NCT01004432|38138505|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
17073705|NCT00541229|38215784|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
17073706|NCT00541229|38215785|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
17073707|NCT00541229|38215786|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
17073708|NCT00541229|38215787|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
17073709|NCT00541229|38215788|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
17073710|NCT00541229|38215789|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
17073711|NCT00541229|38215784|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
17073712|NCT00541229|38215785|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
17073713|NCT00541229|38215786|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
17073714|NCT00541229|38215787|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
17073715|NCT00541229|38215788|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
17073716|NCT00541229|38215789|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
17073717|NCT00541229|38215784|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
17073718|NCT00541229|38215785|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
17073719|NCT00541229|38215786|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
17073720|NCT00541229|38215787|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
17073721|NCT00541229|38215788|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
17073722|NCT00541229|38215789|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
17073723|NCT00541229|38215784|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
17073724|NCT00541229|38215785|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
17073725|NCT00541229|38215786|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
17073726|NCT00541229|38215787|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
17073727|NCT00541229|38215788|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
17073728|NCT00541229|38215789|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
17073729|NCT00481988|38215799|FG000|Overall Study|Withdrawal by Subject|1|||
17073730|NCT00481988|38215800|FG001|Overall Study|Withdrawal by Subject|1|||
17073731|NCT00481832|38215817|FG000|Enrollment|Physician Decision|8|||
17073732|NCT00481832|38215817|FG000|Enrollment|Unable to collect enough stem cells|2|||
17073733|NCT00481832|38215817|FG000|Inter-transplant Period|Adverse Event|4|||
17073734|NCT00481832|38215817|FG000|Inter-transplant Period|Death|3|||
17073735|NCT00481832|38215817|FG000|Inter-transplant Period|Physician Decision|4|||
17073736|NCT00481832|38215817|FG000|Inter-transplant Period|Disease relapse|11|||
17073737|NCT00481832|38215817|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
17073738|NCT00481676|38215823|FG000|Overall Study|Adverse Event|0|||
17073739|NCT00481676|38215824|FG001|Overall Study|Adverse Event|1|||
17157023|NCT03070782|38303975|FG000|Overall Study|Investigator Judgement|0|||
17157024|NCT03070782|38303976|FG001|Overall Study|Investigator Judgement|0|||
17157025|NCT03070782|38303977|FG002|Overall Study|Investigator Judgement|0|||
17073740|NCT00481676|38215823|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17073741|NCT00481676|38215824|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
17073742|NCT00481676|38215823|FG000|Overall Study|Administrative problem|1|||
17073743|NCT00481676|38215824|FG001|Overall Study|Administrative problem|0|||
17073744|NCT00542789|38215832|FG000|Overall Study|Adverse Event|18|||
17073745|NCT00542789|38215833|FG001|Overall Study|Adverse Event|17|||
17073746|NCT00542789|38215832|FG000|Overall Study|Withdrawal by Subject|7|||
17073747|NCT00542789|38215833|FG001|Overall Study|Withdrawal by Subject|3|||
17073748|NCT00542789|38215832|FG000|Overall Study|Protocol Violation|8|||
17073749|NCT00542789|38215833|FG001|Overall Study|Protocol Violation|1|||
17073750|NCT00542789|38215832|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
17073751|NCT00542789|38215833|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
17073752|NCT00464672|38215841|FG000|Overall Study|withdrawal of consent|0|||
17073753|NCT00464672|38215842|FG001|Overall Study|withdrawal of consent|0|||
17073754|NCT00464672|38215843|FG002|Overall Study|withdrawal of consent|0|||
17073755|NCT00464672|38215844|FG003|Overall Study|withdrawal of consent|1|||
17073756|NCT00464672|38215845|FG004|Overall Study|withdrawal of consent|9|||
17073757|NCT00464672|38215846|FG005|Overall Study|withdrawal of consent|4|||
17073758|NCT00464672|38215841|FG000|Overall Study|Lost to Follow-up|25|||
17073759|NCT00464672|38215842|FG001|Overall Study|Lost to Follow-up|10|||
17073760|NCT00464672|38215843|FG002|Overall Study|Lost to Follow-up|0|||
17073761|NCT00464672|38215844|FG003|Overall Study|Lost to Follow-up|0|||
17073762|NCT00464672|38215845|FG004|Overall Study|Lost to Follow-up|1|||
17073763|NCT00464672|38215846|FG005|Overall Study|Lost to Follow-up|0|||
17073764|NCT00473876|38215876|FG000|Overall Study|Lost to Follow-up|3|||
17073765|NCT00473876|38215877|FG001|Overall Study|Lost to Follow-up|1|||
17073766|NCT00463580|38215887|FG000|Overall Study|Lost to Follow-up|1|||
17073767|NCT00463580|38215888|FG001|Overall Study|Lost to Follow-up|0|||
17073768|NCT00463580|38215887|FG000|Overall Study|Schedule conflict|2|||
17073769|NCT00463580|38215888|FG001|Overall Study|Schedule conflict|0|||
17073770|NCT00463580|38215887|FG000|Overall Study|Medical/psychiatric complications|0|||
17073771|NCT00463580|38215888|FG001|Overall Study|Medical/psychiatric complications|2|||
17073772|NCT00540449|38215902|FG000|Overall Study|Adverse Event|12|||
17073773|NCT00540449|38215903|FG001|Overall Study|Adverse Event|32|||
17073774|NCT00540449|38215902|FG000|Overall Study|Sponsor's Decision|1|||
17073775|NCT00540449|38215903|FG001|Overall Study|Sponsor's Decision|1|||
17073776|NCT00540449|38215902|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
17073777|NCT00540449|38215903|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
17073778|NCT00540449|38215902|FG000|Overall Study|Lost to Follow-up|19|||
17073779|NCT00540449|38215903|FG001|Overall Study|Lost to Follow-up|17|||
17073780|NCT00540449|38215902|FG000|Overall Study|Subject Non-Compliant|7|||
17073781|NCT00540449|38215903|FG001|Overall Study|Subject Non-Compliant|5|||
17073782|NCT00540449|38215902|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
17073783|NCT00540449|38215903|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
17073784|NCT00540449|38215902|FG000|Overall Study|Withdrawal by Subject|10|||
17073785|NCT00540449|38215903|FG001|Overall Study|Withdrawal by Subject|10|||
17073786|NCT00540449|38215902|FG000|Overall Study|Other|1|||
17073787|NCT00540449|38215903|FG001|Overall Study|Other|4|||
17073788|NCT03911843|38215911|FG000|Overall Study|Adverse Event|2|||
17073789|NCT03911843|38215912|FG001|Overall Study|Adverse Event|0|||
17073790|NCT03911843|38215911|FG000|Overall Study|Protocol Violation|2|||
17073791|NCT03911843|38215912|FG001|Overall Study|Protocol Violation|0|||
17073792|NCT03911843|38215911|FG000|Overall Study|Lost to Follow-up|0|||
17073793|NCT03911843|38215912|FG001|Overall Study|Lost to Follow-up|1|||
17157026|NCT03070782|38303978|FG003|Overall Study|Investigator Judgement|1|||
17157027|NCT03070782|38303979|FG004|Overall Study|Investigator Judgement|0|||
17157028|NCT03070782|38303980|FG005|Overall Study|Investigator Judgement|0|||
17157029|NCT03525119|38304016|FG000|Overall Study|Adverse Event|0|||
17157030|NCT03525119|38304017|FG001|Overall Study|Adverse Event|1|||
17157031|NCT03525119|38304018|FG002|Overall Study|Adverse Event|0|||
17157032|NCT03525119|38304016|FG000|Overall Study|Lost to Follow-up|32|||
17073794|NCT00361335|38215923|FG000|IV Period: Baseline to E0|Adverse Event|9|||
17073795|NCT00361335|38215924|FG001|IV Period: Baseline to E0|Adverse Event|4|||
17073796|NCT00361335|38215925|FG002|IV Period: Baseline to E0|Adverse Event|5|||
17073797|NCT00361335|38215926|FG003|IV Period: Baseline to E0|Adverse Event|9|||
17073798|NCT00361335|38215927|FG004|IV Period: Baseline to E0|Adverse Event|8|||
17073799|NCT00361335|38215928|FG005|IV Period: Baseline to E0|Adverse Event|0|||
17073800|NCT00361335|38215929|FG006|IV Period: Baseline to E0|Adverse Event|0|||
17073801|NCT00361335|38215923|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
17073802|NCT00361335|38215924|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
17073803|NCT00361335|38215925|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
17073804|NCT00361335|38215926|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
17073805|NCT00361335|38215927|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
17073806|NCT00361335|38215928|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
17073807|NCT00361335|38215929|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
17073808|NCT00361335|38215923|FG000|IV Period: Baseline to E0|Death|1|||
17157033|NCT03525119|38304017|FG001|Overall Study|Lost to Follow-up|33|||
17073809|NCT00361335|38215924|FG001|IV Period: Baseline to E0|Death|1|||
17073810|NCT00361335|38215925|FG002|IV Period: Baseline to E0|Death|1|||
17073811|NCT00361335|38215926|FG003|IV Period: Baseline to E0|Death|1|||
17073812|NCT00361335|38215927|FG004|IV Period: Baseline to E0|Death|0|||
17073813|NCT00361335|38215928|FG005|IV Period: Baseline to E0|Death|0|||
17073814|NCT00361335|38215929|FG006|IV Period: Baseline to E0|Death|0|||
17073815|NCT00361335|38215923|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
17073816|NCT00361335|38215924|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
17073817|NCT00361335|38215925|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
17073818|NCT00361335|38215926|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
17073819|NCT00361335|38215927|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
17073820|NCT00361335|38215928|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
17073821|NCT00361335|38215929|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
17073822|NCT00361335|38215923|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
17073823|NCT00361335|38215924|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
17073824|NCT00361335|38215925|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
17073825|NCT00361335|38215926|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
17073826|NCT00361335|38215927|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
17073827|NCT00361335|38215928|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
17073828|NCT00361335|38215929|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
17073829|NCT00361335|38215923|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
17073830|NCT00361335|38215924|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
17073831|NCT00361335|38215925|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
17073832|NCT00361335|38215926|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
17073833|NCT00361335|38215927|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
17073834|NCT00361335|38215928|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
17073835|NCT00361335|38215929|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
17073836|NCT00361335|38215923|FG000|IV Period: Baseline to E0|Other|2|||
17073837|NCT00361335|38215924|FG001|IV Period: Baseline to E0|Other|9|||
17073838|NCT00361335|38215925|FG002|IV Period: Baseline to E0|Other|9|||
17073839|NCT00361335|38215926|FG003|IV Period: Baseline to E0|Other|3|||
17073840|NCT00361335|38215927|FG004|IV Period: Baseline to E0|Other|2|||
16994754|NCT01004432|38138506|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
16994755|NCT01004432|38138507|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
16994756|NCT01004432|38138508|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
16994757|NCT01004432|38138504|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
17073841|NCT00361335|38215928|FG005|IV Period: Baseline to E0|Other|0|||
17073842|NCT00361335|38215929|FG006|IV Period: Baseline to E0|Other|0|||
17073843|NCT00361335|38215923|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
17073844|NCT00361335|38215924|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
17073845|NCT00361335|38215925|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
17073846|NCT00361335|38215926|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
17073847|NCT00361335|38215927|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
17073848|NCT00361335|38215928|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
17073849|NCT00361335|38215929|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
17073850|NCT00361335|38215923|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
17073851|NCT00361335|38215924|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
17073852|NCT00361335|38215925|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
17073853|NCT00361335|38215926|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
17073854|NCT00361335|38215927|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
17073855|NCT00361335|38215928|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
17073856|NCT00361335|38215929|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
17073857|NCT00361335|38215923|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
17073858|NCT00361335|38215924|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
17073859|NCT00361335|38215925|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
17073860|NCT00361335|38215926|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
17157034|NCT03525119|38304018|FG002|Overall Study|Lost to Follow-up|37|||
17157035|NCT03525119|38304016|FG000|Overall Study|Withdrawal by Subject|5|||
17157036|NCT03525119|38304017|FG001|Overall Study|Withdrawal by Subject|4|||
17157037|NCT03525119|38304018|FG002|Overall Study|Withdrawal by Subject|2|||
17073861|NCT00361335|38215927|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
17073862|NCT00361335|38215928|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
17073863|NCT00361335|38215929|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
17073864|NCT00361335|38215923|FG000|SC Period: Week E0 to Week E24|Death|0|||
17073865|NCT00361335|38215924|FG001|SC Period: Week E0 to Week E24|Death|0|||
17157038|NCT03525119|38304016|FG000|Overall Study|Reason not Specified|2|||
16994758|NCT01004432|38138505|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
16994759|NCT01004432|38138506|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
16994760|NCT01004432|38138507|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
16994761|NCT01004432|38138508|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
16994762|NCT01004432|38138504|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
17073866|NCT00361335|38215925|FG002|SC Period: Week E0 to Week E24|Death|0|||
17073867|NCT00361335|38215926|FG003|SC Period: Week E0 to Week E24|Death|0|||
17073868|NCT00361335|38215927|FG004|SC Period: Week E0 to Week E24|Death|0|||
17073869|NCT00361335|38215928|FG005|SC Period: Week E0 to Week E24|Death|0|||
17073870|NCT00361335|38215929|FG006|SC Period: Week E0 to Week E24|Death|1|||
17073871|NCT00361335|38215923|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
17073872|NCT00361335|38215924|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
17073873|NCT00361335|38215925|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
16994763|NCT01004432|38138505|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
16994764|NCT01004432|38138506|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
17157039|NCT03525119|38304017|FG001|Overall Study|Reason not Specified|1|||
17157040|NCT03525119|38304018|FG002|Overall Study|Reason not Specified|2|||
17157041|NCT03525119|38304016|FG000|Overall Study|Randomized but not Vaccinated|1|||
17157042|NCT03525119|38304017|FG001|Overall Study|Randomized but not Vaccinated|0|||
17157043|NCT03525119|38304018|FG002|Overall Study|Randomized but not Vaccinated|2|||
17157044|NCT03558503|38304026|FG000|Overall Study|Adverse Event|1|||
17157045|NCT03558503|38304026|FG000|Overall Study|Death|1|||
17157046|NCT03558503|38304026|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
17157047|NCT03489863|38304032|FG000|Overall Study|Withdrawal by Subject|0|||
17157048|NCT03489863|38304033|FG001|Overall Study|Withdrawal by Subject|1|||
17157049|NCT03489551|38304039|FG000|Overall Study|Withdrawal by Subject|2|||
17157050|NCT03557801|38304046|FG000|Overall Study|Protocol Violation|1|||
17157051|NCT03557801|38304047|FG001|Overall Study|Protocol Violation|0|||
17157052|NCT03557801|38304048|FG002|Overall Study|Protocol Violation|0|||
17157053|NCT03557801|38304046|FG000|Overall Study|Withdrawal by Subject|1|||
17157054|NCT03557801|38304047|FG001|Overall Study|Withdrawal by Subject|0|||
17157055|NCT03557801|38304048|FG002|Overall Study|Withdrawal by Subject|3|||
17157056|NCT03557801|38304046|FG000|Overall Study|Lost to Follow-up|0|||
17157057|NCT03557801|38304047|FG001|Overall Study|Lost to Follow-up|1|||
17157058|NCT03557801|38304048|FG002|Overall Study|Lost to Follow-up|0|||
17157059|NCT04210180|38304056|FG000|Overall Study|Withdrawal by Subject|2|||
17157060|NCT03523871|38304060|FG000|Overall Study|Death|1|||
17157061|NCT03523715|38304066|FG000|Overall Study|Lost to Follow-up|11|||
17157062|NCT03523715|38304067|FG001|Overall Study|Lost to Follow-up|14|||
17073874|NCT00361335|38215926|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
17073875|NCT00361335|38215927|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
17073876|NCT00361335|38215928|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
17073877|NCT00361335|38215929|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
17073878|NCT00361335|38215923|FG000|SC Period: Week E0 to Week E24|Other|1|||
17157063|NCT03523715|38304066|FG000|Overall Study|Did not meet inclusion criteria|1|||
17157064|NCT03523715|38304067|FG001|Overall Study|Did not meet inclusion criteria|0|||
17073879|NCT00361335|38215924|FG001|SC Period: Week E0 to Week E24|Other|0|||
17073880|NCT00361335|38215925|FG002|SC Period: Week E0 to Week E24|Other|0|||
17073881|NCT00361335|38215926|FG003|SC Period: Week E0 to Week E24|Other|1|||
17073882|NCT00361335|38215927|FG004|SC Period: Week E0 to Week E24|Other|0|||
17157065|NCT03523715|38304066|FG000|Overall Study|Internally inconsistent reporting|0|||
17157066|NCT03523715|38304067|FG001|Overall Study|Internally inconsistent reporting|2|||
17157067|NCT03980730|38304075|FG000|Overall Study|Study Terminated by Sponsor|0|||
17157068|NCT03980730|38304076|FG001|Overall Study|Study Terminated by Sponsor|3|||
17157069|NCT03980730|38304075|FG000|Overall Study|Adverse Event|2|||
17157070|NCT03980730|38304076|FG001|Overall Study|Adverse Event|0|||
17157071|NCT03980730|38304075|FG000|Overall Study|Sponsor Request|0|||
17157072|NCT03980730|38304076|FG001|Overall Study|Sponsor Request|1|||
17157073|NCT03523091|38304084|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
17157074|NCT03523091|38304085|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
17157075|NCT03523091|38304084|FG000|Overall Study|Withdrawal by Subject|0|||
17157076|NCT03523091|38304085|FG001|Overall Study|Withdrawal by Subject|3|||
16994765|NCT01004432|38138507|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
16994766|NCT01004432|38138508|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
16994767|NCT01000610|38138522|FG000|Overall Study|Adverse Event|1|||
17157077|NCT03523091|38304084|FG000|Overall Study|Increase Botox dose|0|||
17157078|NCT03523091|38304085|FG001|Overall Study|Increase Botox dose|1|||
16994768|NCT01000610|38138522|FG000|Overall Study|Lost to Follow-up|4|||
16994769|NCT01000610|38138522|FG000|Overall Study|Treatment failure|1|||
16994770|NCT01877655|38138528|FG000|Overall Study|Death|57|||
16994771|NCT01877655|38138529|FG001|Overall Study|Death|52|||
16994772|NCT01877655|38138528|FG000|Overall Study|Withdrawal by Subject|18|||
16994773|NCT01877655|38138529|FG001|Overall Study|Withdrawal by Subject|26|||
16994774|NCT01877655|38138528|FG000|Overall Study|Physician Decision|11|||
16994775|NCT01877655|38138529|FG001|Overall Study|Physician Decision|10|||
16994776|NCT01877655|38138528|FG000|Overall Study|Miscellaneous|4|||
17157079|NCT03438383|38304106|FG000|Overall Study|Protocol Violation|9|||
17157080|NCT03438383|38304107|FG001|Overall Study|Protocol Violation|3|||
17157081|NCT03478787|38304115|FG000|Overall Study|Adverse Event|5|||
17157082|NCT03478787|38304116|FG001|Overall Study|Adverse Event|1|||
17157083|NCT03478787|38304115|FG000|Overall Study|Protocol Violation|3|||
17157084|NCT03478787|38304116|FG001|Overall Study|Protocol Violation|0|||
17157085|NCT03478787|38304115|FG000|Overall Study|Lack of Efficacy|7|||
17157086|NCT03478787|38304116|FG001|Overall Study|Lack of Efficacy|1|||
17157087|NCT03478787|38304115|FG000|Overall Study|Lost to Follow-up|9|||
17073883|NCT00361335|38215928|FG005|SC Period: Week E0 to Week E24|Other|1|||
17073884|NCT00361335|38215929|FG006|SC Period: Week E0 to Week E24|Other|2|||
17073885|NCT00361335|38215923|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
17073886|NCT00361335|38215924|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
17073887|NCT00361335|38215925|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
17073888|NCT00361335|38215926|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
17073889|NCT00361335|38215927|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
17073890|NCT00361335|38215928|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
17073891|NCT00361335|38215929|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
17073892|NCT00264550|38215949|FG000|Overall Study|Death|0|||
17073893|NCT00264550|38215950|FG001|Overall Study|Death|3|||
17073894|NCT00264550|38215951|FG002|Overall Study|Death|0|||
17073895|NCT00264550|38215952|FG003|Overall Study|Death|0|||
17073896|NCT00264550|38215949|FG000|Overall Study|Lost to Follow-up|3|||
17073897|NCT00264550|38215950|FG001|Overall Study|Lost to Follow-up|1|||
17073898|NCT00264550|38215951|FG002|Overall Study|Lost to Follow-up|1|||
17073899|NCT00264550|38215952|FG003|Overall Study|Lost to Follow-up|1|||
17073900|NCT00264550|38215949|FG000|Overall Study|Adverse Event|23|||
17073901|NCT00264550|38215950|FG001|Overall Study|Adverse Event|18|||
17073902|NCT00264550|38215951|FG002|Overall Study|Adverse Event|9|||
17073903|NCT00264550|38215952|FG003|Overall Study|Adverse Event|14|||
17073904|NCT00264550|38215949|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
17073905|NCT00264550|38215950|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
17073906|NCT00264550|38215951|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
17073907|NCT00264550|38215952|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
17073908|NCT00264550|38215949|FG000|Overall Study|Discontinued oral study agent|0|||
17073909|NCT00264550|38215950|FG001|Overall Study|Discontinued oral study agent|1|||
17073910|NCT00264550|38215951|FG002|Overall Study|Discontinued oral study agent|0|||
17073911|NCT00264550|38215952|FG003|Overall Study|Discontinued oral study agent|0|||
17073912|NCT00264550|38215949|FG000|Overall Study|Other|13|||
17073913|NCT00264550|38215950|FG001|Overall Study|Other|7|||
17073914|NCT00264550|38215951|FG002|Overall Study|Other|3|||
17073915|NCT00264550|38215952|FG003|Overall Study|Other|9|||
17073916|NCT00541931|38215964|FG000|Overall Study|Adverse Event|1|||
17073917|NCT00541931|38215965|FG001|Overall Study|Adverse Event|0|||
17073918|NCT00541931|38215964|FG000|Overall Study|Lost to Follow-up|3|||
17073919|NCT00541931|38215965|FG001|Overall Study|Lost to Follow-up|3|||
17073920|NCT00541931|38215964|FG000|Overall Study|Withdrawal by Subject|1|||
17073921|NCT00541931|38215965|FG001|Overall Study|Withdrawal by Subject|0|||
17073922|NCT00541931|38215964|FG000|Overall Study|Transportation Issue|0|||
17073923|NCT00541931|38215965|FG001|Overall Study|Transportation Issue|1|||
17073924|NCT00368979|38215975|FG000|Overall Study|Adverse Event|9|||
17073925|NCT00368979|38215976|FG001|Overall Study|Adverse Event|16|||
17073926|NCT00368979|38215975|FG000|Overall Study|Lack of Efficacy|5|||
17073927|NCT00368979|38215976|FG001|Overall Study|Lack of Efficacy|3|||
17073928|NCT00368979|38215975|FG000|Overall Study|Other|3|||
17073929|NCT00368979|38215976|FG001|Overall Study|Other|1|||
17073930|NCT00368979|38215975|FG000|Overall Study|Lost to Follow-up|1|||
16994777|NCT01877655|38138529|FG001|Overall Study|Miscellaneous|4|||
16994778|NCT01877655|38138528|FG000|Overall Study|Randomized but Never Received Drug|8|||
16994779|NCT01877655|38138529|FG001|Overall Study|Randomized but Never Received Drug|5|||
16994780|NCT00586924|38138541|FG000|Overall Study|Adverse event/serious adverse event|0|||
17073931|NCT00368979|38215976|FG001|Overall Study|Lost to Follow-up|0|||
17073932|NCT00368979|38215975|FG000|Overall Study|Protocol Violation|2|||
17073933|NCT00368979|38215976|FG001|Overall Study|Protocol Violation|1|||
17073934|NCT00368979|38215975|FG000|Overall Study|Withdrawal by Subject|5|||
17073935|NCT00368979|38215976|FG001|Overall Study|Withdrawal by Subject|9|||
17073936|NCT00264238|38215982|FG000|Overall Study|Protocol Violation|1|||
17073937|NCT00540293|38215988|FG000|Overall Study|Adverse event related to study drug|10|||
17073938|NCT00540293|38215988|FG000|Overall Study|Adverse event not related to study drug|7|||
17157088|NCT03478787|38304116|FG001|Overall Study|Lost to Follow-up|5|||
16994781|NCT00586924|38138542|FG001|Overall Study|Adverse event/serious adverse event|0|||
16994782|NCT00586924|38138543|FG002|Overall Study|Adverse event/serious adverse event|0|||
16994783|NCT00586924|38138544|FG003|Overall Study|Adverse event/serious adverse event|1|||
16994784|NCT00586924|38138545|FG004|Overall Study|Adverse event/serious adverse event|0|||
16994785|NCT00586924|38138546|FG005|Overall Study|Adverse event/serious adverse event|2|||
17073939|NCT00540293|38215988|FG000|Overall Study|Withdrawal by Subject|6|||
17073940|NCT00540293|38215988|FG000|Overall Study|Protocol violation, & subject schedule|12|||
17073941|NCT00375609|38216001|FG000|Overall Study|Did not receive treatment|1|||
17073942|NCT00375609|38216002|FG001|Overall Study|Did not receive treatment|0|||
17073943|NCT00375609|38216003|FG002|Overall Study|Did not receive treatment|0|||
17157089|NCT03478787|38304115|FG000|Overall Study|Withdrawal by Subject|2|||
17073944|NCT00375609|38216001|FG000|Overall Study|Adverse Event|0|||
17073945|NCT00375609|38216002|FG001|Overall Study|Adverse Event|3|||
17073946|NCT00375609|38216003|FG002|Overall Study|Adverse Event|0|||
17073947|NCT00375609|38216001|FG000|Overall Study|Lost to Follow-up|1|||
17073948|NCT00375609|38216002|FG001|Overall Study|Lost to Follow-up|0|||
17073949|NCT00375609|38216003|FG002|Overall Study|Lost to Follow-up|0|||
17073950|NCT00375609|38216001|FG000|Overall Study|Physician Decision|0|||
17157090|NCT03478787|38304116|FG001|Overall Study|Withdrawal by Subject|6|||
17157091|NCT03478787|38304115|FG000|Overall Study|Other, Not Specified|3|||
17157092|NCT03478787|38304116|FG001|Overall Study|Other, Not Specified|0|||
17157093|NCT03488927|38304125|FG000|Overall Study|Withdrawal by Subject|44|||
17157094|NCT03488927|38304126|FG001|Overall Study|Withdrawal by Subject|118|||
17157095|NCT03488927|38304127|FG002|Overall Study|Withdrawal by Subject|217|||
17073951|NCT00375609|38216002|FG001|Overall Study|Physician Decision|0|||
17073952|NCT00375609|38216003|FG002|Overall Study|Physician Decision|1|||
17073953|NCT00375609|38216001|FG000|Overall Study|Withdrawal by Subject|1|||
17073954|NCT00375609|38216002|FG001|Overall Study|Withdrawal by Subject|4|||
17073955|NCT00375609|38216003|FG002|Overall Study|Withdrawal by Subject|0|||
17073956|NCT00375609|38216001|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
17073957|NCT00375609|38216002|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
17073958|NCT00375609|38216003|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
17073959|NCT00359073|38216042|FG000|Overall Study|Withdrawal by Subject|1|||
17073960|NCT00359073|38216043|FG001|Overall Study|Withdrawal by Subject|1|||
17073961|NCT00359073|38216042|FG000|Overall Study|Eligibility criteria no longer met|3|||
17073962|NCT00359073|38216043|FG001|Overall Study|Eligibility criteria no longer met|0|||
17073963|NCT00359073|38216042|FG000|Overall Study|developed RV16 antibody|0|||
17073964|NCT00359073|38216043|FG001|Overall Study|developed RV16 antibody|1|||
17073965|NCT03918239|38216053|FG000|Overall Study|Lost to Follow-up|3|||
17073966|NCT03918239|38216054|FG001|Overall Study|Lost to Follow-up|1|||
17157096|NCT03488225|38304135|FG000|Overall Study|Off Protocol Therapy|2|||
17073967|NCT03918239|38216053|FG000|Overall Study|Pregnancy|0|||
17073968|NCT03918239|38216054|FG001|Overall Study|Pregnancy|2|||
17073969|NCT03918239|38216053|FG000|Overall Study|Withdrawal by Subject|3|||
17073970|NCT03918239|38216054|FG001|Overall Study|Withdrawal by Subject|3|||
17073971|NCT03918239|38216053|FG000|Overall Study|positive urine drug screening results|4|||
17073972|NCT03918239|38216054|FG001|Overall Study|positive urine drug screening results|1|||
17073973|NCT00368745|38216062|FG000|Double-blind Treatment Period|Adverse Event|6|||
17073974|NCT00368745|38216063|FG001|Double-blind Treatment Period|Adverse Event|6|||
17157097|NCT03488225|38304135|FG000|Overall Study|Stem Cell Transplant|2|||
17157098|NCT03437447|38304142|FG000|Treatment Period 1|Withdrawal by Subject|0|||
17157099|NCT03437447|38304143|FG001|Treatment Period 1|Withdrawal by Subject|0|||
17157100|NCT03437447|38304144|FG002|Treatment Period 1|Withdrawal by Subject|1|||
17157101|NCT03487445|38304167|FG000|Randomization|Not treated for administrative reasons|1|||
17157102|NCT03487445|38304168|FG001|Randomization|Not treated for administrative reasons|0|||
17157103|NCT02109172|38304174|FG000|Overall Study|Withdrawal by Subject|1|||
17157104|NCT02109172|38304175|FG001|Overall Study|Withdrawal by Subject|0|||
17157105|NCT02109172|38304176|FG002|Overall Study|Withdrawal by Subject|0|||
17157106|NCT02109172|38304177|FG003|Overall Study|Withdrawal by Subject|1|||
17073975|NCT00368745|38216062|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
17073976|NCT00368745|38216063|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
17073977|NCT00368745|38216062|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
17073978|NCT00368745|38216063|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
17073979|NCT00368745|38216062|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
17073980|NCT00368745|38216063|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
17073981|NCT00368745|38216062|FG000|Double-blind Treatment Period|Other|7|||
17073982|NCT00368745|38216063|FG001|Double-blind Treatment Period|Other|6|||
17073983|NCT00454818|38216077|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
17073984|NCT00454818|38216078|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
17073985|NCT00454818|38216079|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
17073986|NCT00454818|38216080|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
16994786|NCT00586924|38138541|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
16994787|NCT00586924|38138542|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
16994788|NCT00586924|38138543|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
16994789|NCT00586924|38138544|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
16994790|NCT00586924|38138545|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
16994791|NCT00586924|38138546|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
16994792|NCT00586924|38138541|FG000|Overall Study|Disease progression|0|||
16994793|NCT00586924|38138542|FG001|Overall Study|Disease progression|0|||
17073987|NCT00454818|38216081|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
17073988|NCT00454818|38216077|FG000|Phase I: Open-label Dose-escalation|Death|0|||
17073989|NCT00454818|38216078|FG001|Phase I: Open-label Dose-escalation|Death|1|||
16994794|NCT00586924|38138543|FG002|Overall Study|Disease progression|0|||
17073990|NCT00454818|38216079|FG002|Phase I: Open-label Dose-escalation|Death|0|||
17073991|NCT00454818|38216080|FG003|Phase I: Open-label Dose-escalation|Death|0|||
17073992|NCT00454818|38216081|FG004|Phase I: Open-label Dose-escalation|Death|0|||
17073993|NCT00454818|38216077|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
17073994|NCT00454818|38216078|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
17073995|NCT00454818|38216079|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
17073996|NCT00454818|38216080|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
17073997|NCT00454818|38216081|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
17073998|NCT00454818|38216077|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
17073999|NCT00454818|38216078|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
17074000|NCT00454818|38216079|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
17074001|NCT00454818|38216080|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
17074002|NCT00454818|38216081|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
17074003|NCT00454818|38216077|FG000|Phase 2: Randomized Double-blind|Death|0|||
17074004|NCT00454818|38216078|FG001|Phase 2: Randomized Double-blind|Death|1|||
17074005|NCT00454818|38216079|FG002|Phase 2: Randomized Double-blind|Death|0|||
17074006|NCT00454818|38216080|FG003|Phase 2: Randomized Double-blind|Death|0|||
17157107|NCT02109172|38304178|FG004|Overall Study|Withdrawal by Subject|0|||
17157108|NCT02109172|38304179|FG005|Overall Study|Withdrawal by Subject|0|||
17157109|NCT02109172|38304174|FG000|Overall Study|Adverse Event|0|||
17157110|NCT02109172|38304175|FG001|Overall Study|Adverse Event|0|||
17157111|NCT02109172|38304176|FG002|Overall Study|Adverse Event|1|||
16994795|NCT00586924|38138544|FG003|Overall Study|Disease progression|1|||
16994796|NCT00586924|38138545|FG004|Overall Study|Disease progression|1|||
16994797|NCT00586924|38138546|FG005|Overall Study|Disease progression|0|||
16994798|NCT00586924|38138541|FG000|Overall Study|Development of neutralizing antibodies|2|||
16994799|NCT00586924|38138542|FG001|Overall Study|Development of neutralizing antibodies|2|||
16994800|NCT00586924|38138543|FG002|Overall Study|Development of neutralizing antibodies|2|||
16994801|NCT00586924|38138544|FG003|Overall Study|Development of neutralizing antibodies|0|||
16994802|NCT00586924|38138545|FG004|Overall Study|Development of neutralizing antibodies|0|||
16994803|NCT00586924|38138546|FG005|Overall Study|Development of neutralizing antibodies|22|||
16994804|NCT00586924|38138541|FG000|Overall Study|Complete response|0|||
16994805|NCT00586924|38138542|FG001|Overall Study|Complete response|1|||
16994806|NCT00586924|38138543|FG002|Overall Study|Complete response|0|||
16994807|NCT00586924|38138544|FG003|Overall Study|Complete response|0|||
16994808|NCT00586924|38138545|FG004|Overall Study|Complete response|2|||
16994809|NCT00586924|38138546|FG005|Overall Study|Complete response|2|||
16994810|NCT00586924|38138541|FG000|Overall Study|Other|1|||
16994811|NCT00586924|38138542|FG001|Overall Study|Other|0|||
16994812|NCT00586924|38138543|FG002|Overall Study|Other|1|||
16994813|NCT00586924|38138544|FG003|Overall Study|Other|1|||
16994814|NCT00586924|38138545|FG004|Overall Study|Other|1|||
16994815|NCT00586924|38138546|FG005|Overall Study|Other|6|||
16994816|NCT01000376|38138562|FG000|Cycle 1 Day 1|Adverse Event|1|||
17074007|NCT00454818|38216081|FG004|Phase 2: Randomized Double-blind|Death|1|||
17074008|NCT00454818|38216077|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
17074009|NCT00454818|38216078|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
17074010|NCT00454818|38216079|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
17074011|NCT00454818|38216080|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
17074012|NCT00454818|38216081|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
17074013|NCT00454818|38216077|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
17074014|NCT00454818|38216078|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
17074015|NCT00454818|38216079|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
17074016|NCT00454818|38216080|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
17074017|NCT00454818|38216081|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
17074018|NCT00445224|38216100|FG000|Specific Exercises|Withdrawal by Subject|3|||
17074019|NCT00445224|38216101|FG001|Specific Exercises|Withdrawal by Subject|3|||
17074020|NCT00445224|38216100|FG000|Specific Exercises|Withdrawal by Subject|1|||
17074021|NCT00445224|38216101|FG001|Specific Exercises|Withdrawal by Subject|0|||
17074022|NCT00358917|38216118|FG000|Overall Study|Adverse Event|14|||
17074023|NCT00358917|38216119|FG001|Overall Study|Adverse Event|21|||
17074024|NCT00358917|38216118|FG000|Overall Study|Withdrawal by Subject|5|||
17074025|NCT00358917|38216119|FG001|Overall Study|Withdrawal by Subject|7|||
17074026|NCT00358917|38216118|FG000|Overall Study|Lost to Follow-up|20|||
17074027|NCT00358917|38216119|FG001|Overall Study|Lost to Follow-up|17|||
17074028|NCT00358917|38216118|FG000|Overall Study|Noncompliance|12|||
17074029|NCT00358917|38216119|FG001|Overall Study|Noncompliance|11|||
17157112|NCT02109172|38304177|FG003|Overall Study|Adverse Event|0|||
16994817|NCT01000376|38138563|FG001|Cycle 1 Day 1|Adverse Event|0|||
17074030|NCT00358917|38216118|FG000|Overall Study|Death|2|||
17074031|NCT00358917|38216119|FG001|Overall Study|Death|3|||
17157113|NCT02109172|38304178|FG004|Overall Study|Adverse Event|0|||
17157114|NCT02109172|38304179|FG005|Overall Study|Adverse Event|1|||
17157115|NCT02109172|38304174|FG000|Overall Study|Death|0|||
17157116|NCT02109172|38304175|FG001|Overall Study|Death|0|||
17157117|NCT02109172|38304176|FG002|Overall Study|Death|0|||
17157118|NCT02109172|38304177|FG003|Overall Study|Death|0|||
17157119|NCT02109172|38304178|FG004|Overall Study|Death|1|||
17157120|NCT02109172|38304179|FG005|Overall Study|Death|0|||
17157121|NCT02974868|38304190|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
17157122|NCT02974868|38304191|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
17157123|NCT02974868|38304192|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
17157124|NCT02974868|38304193|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
17157125|NCT02974868|38304190|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
17157126|NCT02974868|38304191|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
17157127|NCT02974868|38304192|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
17157128|NCT02974868|38304193|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
17157129|NCT02974868|38304190|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
17157130|NCT02974868|38304191|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
17157131|NCT02974868|38304192|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
17157132|NCT02974868|38304193|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
17074032|NCT00358917|38216118|FG000|Overall Study|Virologic failure|11|||
17074033|NCT00358917|38216119|FG001|Overall Study|Virologic failure|8|||
17074034|NCT00358917|38216118|FG000|Overall Study|Unable to Continue Participation|2|||
17074035|NCT00358917|38216119|FG001|Overall Study|Unable to Continue Participation|2|||
17074036|NCT00264004|38216131|FG000|Overall Study|Adverse Event|2|||
17074037|NCT00264004|38216132|FG001|Overall Study|Adverse Event|3|||
17074038|NCT00264004|38216133|FG002|Overall Study|Adverse Event|6|||
17074039|NCT00264004|38216134|FG003|Overall Study|Adverse Event|4|||
17074040|NCT00264004|38216131|FG000|Overall Study|Withdrawal by Subject|0|||
17074041|NCT00264004|38216132|FG001|Overall Study|Withdrawal by Subject|1|||
17157133|NCT02974868|38304190|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
17157134|NCT02974868|38304191|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
17157135|NCT02974868|38304192|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
17157136|NCT02974868|38304193|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
17157137|NCT03486899|38304238|FG000|Overall Study|Lost to Follow-up|4|||
17157138|NCT03486899|38304239|FG001|Overall Study|Lost to Follow-up|1|||
17157139|NCT03486899|38304240|FG002|Overall Study|Lost to Follow-up|4|||
17157140|NCT03486899|38304241|FG003|Overall Study|Lost to Follow-up|3|||
17157141|NCT03486899|38304238|FG000|Overall Study|Death|1|||
17157142|NCT03486899|38304239|FG001|Overall Study|Death|0|||
17157143|NCT03486899|38304240|FG002|Overall Study|Death|0|||
17157144|NCT03486899|38304241|FG003|Overall Study|Death|1|||
17157145|NCT03486899|38304238|FG000|Overall Study|Adverse Event|0|||
17157146|NCT03486899|38304239|FG001|Overall Study|Adverse Event|2|||
17157147|NCT03486899|38304240|FG002|Overall Study|Adverse Event|0|||
17074042|NCT00264004|38216133|FG002|Overall Study|Withdrawal by Subject|2|||
17074043|NCT00264004|38216134|FG003|Overall Study|Withdrawal by Subject|2|||
17074044|NCT00264004|38216131|FG000|Overall Study|Other|2|||
17074045|NCT00264004|38216132|FG001|Overall Study|Other|2|||
17074046|NCT00264004|38216133|FG002|Overall Study|Other|0|||
17157148|NCT03486899|38304241|FG003|Overall Study|Adverse Event|2|||
17157149|NCT03486899|38304238|FG000|Overall Study|Withdrawal by Subject|3|||
17157150|NCT03486899|38304239|FG001|Overall Study|Withdrawal by Subject|7|||
17157151|NCT03486899|38304240|FG002|Overall Study|Withdrawal by Subject|4|||
17157152|NCT03486899|38304241|FG003|Overall Study|Withdrawal by Subject|3|||
17157153|NCT03486899|38304238|FG000|Overall Study|Other Reasons|0|||
17157154|NCT03486899|38304239|FG001|Overall Study|Other Reasons|1|||
17157155|NCT03486899|38304240|FG002|Overall Study|Other Reasons|0|||
17157156|NCT03486899|38304241|FG003|Overall Study|Other Reasons|1|||
17157157|NCT02918552|38304253|FG000|Overall Study|Failed Pharmacokinetics|1|||
17157158|NCT02918552|38304254|FG001|Overall Study|Failed Pharmacokinetics|0|||
17157159|NCT02918552|38304253|FG000|Overall Study|Withdrawal by Subject|0|||
17157160|NCT02918552|38304254|FG001|Overall Study|Withdrawal by Subject|1|||
17157161|NCT02918552|38304253|FG000|Overall Study|Lost to Follow-up|0|||
17157162|NCT02918552|38304254|FG001|Overall Study|Lost to Follow-up|1|||
17157163|NCT03485495|38304262|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
17157164|NCT03485495|38304263|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
17157165|NCT01065818|38304269|FG000|Overall Study|Withdrawal by Subject|1|||
17074047|NCT00264004|38216134|FG003|Overall Study|Other|3|||
17074048|NCT00264004|38216131|FG000|Overall Study|Development study specific disc. crit.|1|||
17074049|NCT00264004|38216132|FG001|Overall Study|Development study specific disc. crit.|0|||
17074050|NCT00264004|38216133|FG002|Overall Study|Development study specific disc. crit.|1|||
17157166|NCT01065818|38304269|FG000|Overall Study|Not a candidate for surgery|1|||
17157167|NCT03483623|38304273|FG000|Overall Study|43 complete sets achieved|1|||
17157168|NCT02318277|38304285|FG000|Overall Study|Physician Decision|0|||
17074051|NCT00264004|38216134|FG003|Overall Study|Development study specific disc. crit.|0|||
17074052|NCT00264004|38216131|FG000|Overall Study|Cond. under inv. worsened|9|||
17074053|NCT00264004|38216132|FG001|Overall Study|Cond. under inv. worsened|5|||
17074054|NCT00264004|38216133|FG002|Overall Study|Cond. under inv. worsened|3|||
17074055|NCT00264004|38216134|FG003|Overall Study|Cond. under inv. worsened|4|||
17074056|NCT00264004|38216131|FG000|Overall Study|Not treated|3|||
17074057|NCT00264004|38216132|FG001|Overall Study|Not treated|0|||
17074058|NCT00264004|38216133|FG002|Overall Study|Not treated|2|||
17074059|NCT00264004|38216134|FG003|Overall Study|Not treated|2|||
17074060|NCT00368355|38216146|FG000|Overall Study|Adverse Event|1|||
17074061|NCT00368355|38216147|FG001|Overall Study|Adverse Event|0|||
17074062|NCT00368355|38216146|FG000|Overall Study|Death|2|||
17074063|NCT00368355|38216147|FG001|Overall Study|Death|4|||
17157169|NCT02318277|38304286|FG001|Overall Study|Physician Decision|0|||
17157170|NCT02318277|38304287|FG002|Overall Study|Physician Decision|0|||
17157171|NCT02318277|38304288|FG003|Overall Study|Physician Decision|0|||
16994818|NCT01000376|38138562|FG000|Cycle 1 Day 1|Progressive Disease|1|||
16994819|NCT01000376|38138563|FG001|Cycle 1 Day 1|Progressive Disease|0|||
16994820|NCT01038635|38138578|FG000|Overall Study|Disease Progression|2|||
16994821|NCT01038635|38138579|FG001|Overall Study|Disease Progression|0|||
16994822|NCT01038635|38138580|FG002|Overall Study|Disease Progression|0|||
16994823|NCT01038635|38138581|FG003|Overall Study|Disease Progression|0|||
16994824|NCT01038635|38138582|FG004|Overall Study|Disease Progression|0|||
16994825|NCT01038635|38138583|FG005|Overall Study|Disease Progression|0|||
16994826|NCT01038635|38138584|FG006|Overall Study|Disease Progression|1|||
16994827|NCT01038635|38138585|FG007|Overall Study|Disease Progression|4|||
16994828|NCT01038635|38138586|FG008|Overall Study|Disease Progression|0|||
16994829|NCT01038635|38138578|FG000|Overall Study|Death|0|||
16994830|NCT01038635|38138579|FG001|Overall Study|Death|0|||
16994831|NCT01038635|38138580|FG002|Overall Study|Death|0|||
16994832|NCT01038635|38138581|FG003|Overall Study|Death|0|||
16994833|NCT01038635|38138582|FG004|Overall Study|Death|1|||
16994834|NCT01038635|38138583|FG005|Overall Study|Death|0|||
16994835|NCT01038635|38138584|FG006|Overall Study|Death|1|||
16994836|NCT01038635|38138585|FG007|Overall Study|Death|1|||
16994837|NCT01038635|38138586|FG008|Overall Study|Death|2|||
16994838|NCT01000064|38138607|FG000|Overall Study|Withdrawal by Subject|1|||
16994839|NCT01000064|38138608|FG001|Overall Study|Withdrawal by Subject|1|||
16994840|NCT00766090|38138619|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994841|NCT00766090|38138620|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994842|NCT00766090|38138621|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994843|NCT00766090|38138622|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994844|NCT00766090|38138623|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994845|NCT00766090|38138624|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994846|NCT00766090|38138625|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994847|NCT00766090|38138626|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994848|NCT00766090|38138627|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
16994849|NCT00766090|38138628|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994850|NCT00766090|38138629|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994851|NCT00766090|38138630|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16994852|NCT00766090|38138619|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
16994853|NCT00766090|38138620|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994854|NCT00766090|38138621|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994855|NCT00766090|38138622|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994856|NCT00766090|38138623|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994857|NCT00766090|38138624|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994858|NCT00766090|38138625|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994859|NCT00766090|38138626|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994860|NCT00766090|38138627|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994861|NCT00766090|38138628|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994862|NCT00766090|38138629|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994863|NCT00766090|38138630|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16994864|NCT00766090|38138619|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16994865|NCT00766090|38138620|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994866|NCT00766090|38138621|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994867|NCT00766090|38138622|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16994868|NCT00766090|38138623|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994869|NCT00766090|38138624|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994870|NCT00766090|38138625|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994871|NCT00766090|38138626|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994872|NCT00766090|38138627|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
17074064|NCT00368355|38216146|FG000|Overall Study|Relapse|6|||
17074065|NCT00368355|38216147|FG001|Overall Study|Relapse|10|||
17074066|NCT00368355|38216146|FG000|Overall Study|Subsequent transplant|0|||
17157172|NCT02318277|38304289|FG004|Overall Study|Physician Decision|0|||
16994873|NCT00766090|38138628|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994874|NCT00766090|38138629|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994875|NCT00766090|38138630|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16994876|NCT00766090|38138619|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994877|NCT00766090|38138620|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994878|NCT00766090|38138621|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
16994879|NCT00766090|38138622|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994880|NCT00766090|38138623|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994881|NCT00766090|38138624|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994882|NCT00766090|38138625|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994883|NCT00766090|38138626|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994884|NCT00766090|38138627|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994885|NCT00766090|38138628|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994886|NCT00766090|38138629|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994887|NCT00766090|38138630|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
16994888|NCT00766090|38138619|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994889|NCT00766090|38138620|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994890|NCT00766090|38138621|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994891|NCT00766090|38138622|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994892|NCT00766090|38138623|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
16994893|NCT00766090|38138624|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994894|NCT00766090|38138625|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994895|NCT00766090|38138626|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994896|NCT00766090|38138627|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994897|NCT00766090|38138628|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994898|NCT00766090|38138629|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994899|NCT00766090|38138630|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16994900|NCT00766090|38138619|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16994901|NCT00766090|38138620|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16994902|NCT00766090|38138621|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
16994903|NCT00766090|38138622|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16994904|NCT00766090|38138623|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16994905|NCT00766090|38138624|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16994906|NCT00766090|38138625|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16994907|NCT00766090|38138626|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
17157173|NCT02318277|38304290|FG005|Overall Study|Physician Decision|0|||
17157174|NCT02318277|38304291|FG006|Overall Study|Physician Decision|0|||
17074067|NCT00368355|38216147|FG001|Overall Study|Subsequent transplant|3|||
17074068|NCT00368355|38216146|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
17074069|NCT00368355|38216147|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
17074070|NCT00445146|38216153|FG000|Overall Study|Withdrew Consent|29|||
17074071|NCT00445146|38216153|FG000|Overall Study|Lack of Efficacy|28|||
17074072|NCT00445146|38216153|FG000|Overall Study|Investigator's Discretion|22|||
17074073|NCT00445146|38216153|FG000|Overall Study|Adverse Event|13|||
17074074|NCT00445146|38216153|FG000|Overall Study|Lost to Follow-up|13|||
17074075|NCT00445146|38216153|FG000|Overall Study|Death|9|||
17074076|NCT00445146|38216153|FG000|Overall Study|Protocol Violation|4|||
17074077|NCT00445146|38216153|FG000|Overall Study|Pregnancy|1|||
17074078|NCT00368277|38216159|FG000|Overall Study|Adverse Event|33|||
17074079|NCT00368277|38216160|FG001|Overall Study|Adverse Event|49|||
17074080|NCT00368277|38216159|FG000|Overall Study|Death|2|||
17074081|NCT00368277|38216160|FG001|Overall Study|Death|1|||
17074082|NCT00368277|38216159|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
17074083|NCT00368277|38216160|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
17074084|NCT00368277|38216159|FG000|Overall Study|Protocol deviation|7|||
17074085|NCT00368277|38216160|FG001|Overall Study|Protocol deviation|0|||
17074086|NCT00368277|38216159|FG000|Overall Study|Patient withdrew consent|32|||
17074087|NCT00368277|38216160|FG001|Overall Study|Patient withdrew consent|28|||
17157175|NCT02318277|38304292|FG007|Overall Study|Physician Decision|1|||
17157176|NCT02318277|38304285|FG000|Overall Study|Other|0|||
17074088|NCT00368277|38216159|FG000|Overall Study|Lost to Follow-up|8|||
17074089|NCT00368277|38216160|FG001|Overall Study|Lost to Follow-up|6|||
17074090|NCT00280150|38216170|FG000|Overall Study|Adverse Event|0|||
17074091|NCT00280150|38216171|FG001|Overall Study|Adverse Event|1|||
17074092|NCT00280150|38216172|FG002|Overall Study|Adverse Event|2|||
17074093|NCT00280150|38216173|FG003|Overall Study|Adverse Event|3|||
17074094|NCT00280150|38216170|FG000|Overall Study|Lack of Efficacy|0|||
17074095|NCT00280150|38216171|FG001|Overall Study|Lack of Efficacy|0|||
16994908|NCT00766090|38138627|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
17074096|NCT00280150|38216172|FG002|Overall Study|Lack of Efficacy|0|||
17157177|NCT02318277|38304286|FG001|Overall Study|Other|0|||
16994909|NCT00766090|38138628|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
17074097|NCT00280150|38216173|FG003|Overall Study|Lack of Efficacy|3|||
17074098|NCT00280150|38216170|FG000|Overall Study|Physician Decision|0|||
17074099|NCT00280150|38216171|FG001|Overall Study|Physician Decision|0|||
17074100|NCT00280150|38216172|FG002|Overall Study|Physician Decision|0|||
17074101|NCT00280150|38216173|FG003|Overall Study|Physician Decision|1|||
17074102|NCT00280150|38216170|FG000|Overall Study|Protocol Violation|0|||
17074103|NCT00280150|38216171|FG001|Overall Study|Protocol Violation|0|||
17074104|NCT00280150|38216172|FG002|Overall Study|Protocol Violation|0|||
17074105|NCT00280150|38216173|FG003|Overall Study|Protocol Violation|1|||
17074106|NCT00280150|38216170|FG000|Overall Study|Withdrawal by Subject|0|||
17074107|NCT00280150|38216171|FG001|Overall Study|Withdrawal by Subject|0|||
17074108|NCT00280150|38216172|FG002|Overall Study|Withdrawal by Subject|0|||
16994910|NCT00766090|38138629|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16994911|NCT00766090|38138630|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16994912|NCT00766090|38138619|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
16994913|NCT00766090|38138620|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
16994914|NCT00766090|38138621|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
16994915|NCT00766090|38138622|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
16994916|NCT00766090|38138623|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
16994917|NCT00766090|38138624|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
16994918|NCT00766090|38138625|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
16994919|NCT00766090|38138626|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
16994920|NCT00766090|38138627|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
16994921|NCT00766090|38138628|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
16994922|NCT00766090|38138629|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
16994923|NCT00766090|38138630|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
16994924|NCT00766090|38138619|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994925|NCT00766090|38138620|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994926|NCT00766090|38138621|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994927|NCT00766090|38138622|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994928|NCT00766090|38138623|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994929|NCT00766090|38138624|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
16994930|NCT00766090|38138625|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994931|NCT00766090|38138626|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994932|NCT00766090|38138627|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994933|NCT00766090|38138628|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994934|NCT00766090|38138629|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994935|NCT00766090|38138630|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16994936|NCT00766090|38138619|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994937|NCT00766090|38138620|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
16994938|NCT00766090|38138621|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994939|NCT00766090|38138622|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
16994940|NCT00766090|38138623|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994941|NCT00766090|38138624|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994942|NCT00766090|38138625|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994943|NCT00766090|38138626|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994944|NCT00766090|38138627|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994945|NCT00766090|38138628|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994946|NCT00766090|38138629|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16994947|NCT00766090|38138630|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
16994948|NCT00766090|38138619|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994949|NCT00766090|38138620|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994950|NCT00766090|38138621|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994951|NCT00766090|38138622|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994952|NCT00766090|38138623|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
16994953|NCT00766090|38138624|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994954|NCT00766090|38138625|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994955|NCT00766090|38138626|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
17074109|NCT00280150|38216173|FG003|Overall Study|Withdrawal by Subject|1|||
17074110|NCT00280150|38216170|FG000|Overall Study|Did not get consolidation therapy|3|||
17074111|NCT00280150|38216171|FG001|Overall Study|Did not get consolidation therapy|0|||
17074112|NCT00280150|38216172|FG002|Overall Study|Did not get consolidation therapy|3|||
17074113|NCT00280150|38216173|FG003|Overall Study|Did not get consolidation therapy|0|||
17074114|NCT00280150|38216170|FG000|Overall Study|Declining Performance Status|0|||
17074115|NCT00280150|38216171|FG001|Overall Study|Declining Performance Status|0|||
17074116|NCT00280150|38216172|FG002|Overall Study|Declining Performance Status|0|||
17074117|NCT00280150|38216173|FG003|Overall Study|Declining Performance Status|1|||
17074118|NCT00279916|38216186|FG000|Overall Study|Withdrawal by Subject|4|||
17074119|NCT00279916|38216187|FG001|Overall Study|Withdrawal by Subject|3|||
17074120|NCT00279916|38216186|FG000|Overall Study|Lost to Follow-up|3|||
17157178|NCT02318277|38304287|FG002|Overall Study|Other|0|||
17074121|NCT00279916|38216187|FG001|Overall Study|Lost to Follow-up|2|||
17074122|NCT00358527|38216195|FG000|Overall Study|Adverse Event|4|||
17074123|NCT00358527|38216196|FG001|Overall Study|Adverse Event|0|||
17074124|NCT00358527|38216195|FG000|Overall Study|Withdrawal by Subject|1|||
17074125|NCT00358527|38216196|FG001|Overall Study|Withdrawal by Subject|1|||
17074126|NCT00358527|38216195|FG000|Overall Study|Non-compliance with protocol|6|||
17074127|NCT00358527|38216196|FG001|Overall Study|Non-compliance with protocol|1|||
17074128|NCT00358527|38216195|FG000|Overall Study|Administrative|2|||
17074129|NCT00358527|38216196|FG001|Overall Study|Administrative|1|||
17074130|NCT00251758|38216205|FG000|Overall Study|Adverse Event|7|||
17074131|NCT00251758|38216206|FG001|Overall Study|Adverse Event|9|||
17074132|NCT00251758|38216207|FG002|Overall Study|Adverse Event|11|||
17074133|NCT00251758|38216205|FG000|Overall Study|Lost to Follow-up|4|||
17074134|NCT00251758|38216206|FG001|Overall Study|Lost to Follow-up|2|||
17074135|NCT00251758|38216207|FG002|Overall Study|Lost to Follow-up|5|||
17074136|NCT00251758|38216205|FG000|Overall Study|Withdrawal by Subject|13|||
17074137|NCT00251758|38216206|FG001|Overall Study|Withdrawal by Subject|7|||
17074138|NCT00251758|38216207|FG002|Overall Study|Withdrawal by Subject|3|||
17074139|NCT00251758|38216205|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
17074140|NCT00251758|38216206|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
17074141|NCT00251758|38216207|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
17074142|NCT00251758|38216205|FG000|Overall Study|Lack of Efficacy|3|||
17074143|NCT00251758|38216206|FG001|Overall Study|Lack of Efficacy|0|||
17074144|NCT00251758|38216207|FG002|Overall Study|Lack of Efficacy|0|||
17074145|NCT00251758|38216205|FG000|Overall Study|Noncompliant|0|||
17074146|NCT00251758|38216206|FG001|Overall Study|Noncompliant|2|||
17074147|NCT00251758|38216207|FG002|Overall Study|Noncompliant|2|||
17074148|NCT00251758|38216205|FG000|Overall Study|Pregnancy|0|||
17074149|NCT00251758|38216206|FG001|Overall Study|Pregnancy|1|||
17074150|NCT00251758|38216207|FG002|Overall Study|Pregnancy|0|||
17074151|NCT00251758|38216205|FG000|Overall Study|Per Subject Request|0|||
17074152|NCT00251758|38216206|FG001|Overall Study|Per Subject Request|0|||
17074153|NCT00251758|38216207|FG002|Overall Study|Per Subject Request|1|||
17074154|NCT00251758|38216205|FG000|Overall Study|Per Investigator Request|1|||
17074155|NCT00251758|38216206|FG001|Overall Study|Per Investigator Request|0|||
17074156|NCT00251758|38216207|FG002|Overall Study|Per Investigator Request|0|||
17074157|NCT00279214|38216217|FG000|Overall Study|Physician Decision|3|||
17074158|NCT00279214|38216218|FG001|Overall Study|Physician Decision|2|||
17074159|NCT00262834|38216226|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
17074160|NCT00262834|38216227|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
17074161|NCT00539591|38216236|FG000|Overall Study|Toxicity|3|||
17074162|NCT00539591|38216237|FG001|Overall Study|Toxicity|0|||
17074163|NCT00539591|38216238|FG002|Overall Study|Toxicity|0|||
17157179|NCT02318277|38304288|FG003|Overall Study|Other|0|||
17157180|NCT02318277|38304289|FG004|Overall Study|Other|0|||
17157181|NCT02318277|38304290|FG005|Overall Study|Other|0|||
17157182|NCT02318277|38304291|FG006|Overall Study|Other|1|||
17157183|NCT02318277|38304292|FG007|Overall Study|Other|0|||
17157184|NCT02318277|38304285|FG000|Overall Study|Withdrawal by Subject|0|||
17157185|NCT02318277|38304286|FG001|Overall Study|Withdrawal by Subject|0|||
17157186|NCT02318277|38304287|FG002|Overall Study|Withdrawal by Subject|1|||
17157187|NCT02318277|38304288|FG003|Overall Study|Withdrawal by Subject|0|||
17157188|NCT02318277|38304289|FG004|Overall Study|Withdrawal by Subject|1|||
17074164|NCT00539591|38216236|FG000|Overall Study|Disease progression|2|||
17074165|NCT00539591|38216237|FG001|Overall Study|Disease progression|2|||
17074166|NCT00539591|38216238|FG002|Overall Study|Disease progression|3|||
17074167|NCT00541775|38216281|FG000|Overall Study|Adverse Event|3|||
17074168|NCT00541775|38216282|FG001|Overall Study|Adverse Event|2|||
17074169|NCT00541775|38216283|FG002|Overall Study|Adverse Event|1|||
17074170|NCT00541775|38216281|FG000|Overall Study|Lack of Efficacy|0|||
17157189|NCT02318277|38304290|FG005|Overall Study|Withdrawal by Subject|1|||
17074171|NCT00541775|38216282|FG001|Overall Study|Lack of Efficacy|0|||
16781259|NCT02109484|37720409|FG000|Overall Study|Moved away from study area|0|||
16781260|NCT02109484|37720410|FG001|Overall Study|Moved away from study area|0|||
16781261|NCT02109484|37720411|FG002|Overall Study|Moved away from study area|0|||
16781262|NCT02109484|37720412|FG003|Overall Study|Moved away from study area|0|||
16781263|NCT02109484|37720413|FG004|Overall Study|Moved away from study area|0|||
16781264|NCT02109484|37720414|FG005|Overall Study|Moved away from study area|0|||
16781265|NCT02109484|37720415|FG006|Overall Study|Moved away from study area|1|||
16781266|NCT02109484|37720416|FG007|Overall Study|Moved away from study area|1|||
16781267|NCT02105974|37720453|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
16781268|NCT02105974|37720454|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
16781269|NCT02105974|37720455|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
16781270|NCT02105974|37720453|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
16781271|NCT02105974|37720454|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
16781272|NCT02105974|37720455|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
16781273|NCT02105974|37720453|FG000|2 Week Run-in Period|Adverse Event|6|||
16781274|NCT02105974|37720454|FG001|2 Week Run-in Period|Adverse Event|0|||
17074172|NCT00541775|38216283|FG002|Overall Study|Lack of Efficacy|3|||
17074173|NCT00541775|38216281|FG000|Overall Study|Lost to Follow-up|0|||
16994956|NCT00766090|38138627|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994957|NCT00766090|38138628|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994958|NCT00766090|38138629|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994959|NCT00766090|38138630|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16994960|NCT00580801|38138647|FG000|Overall Study|Physician Decision|1|||
16994961|NCT00580801|38138648|FG001|Overall Study|Physician Decision|0|||
16994962|NCT00580801|38138649|FG002|Overall Study|Physician Decision|0|||
16994963|NCT00580801|38138647|FG000|Overall Study|Adverse Event|2|||
17074174|NCT00541775|38216282|FG001|Overall Study|Lost to Follow-up|0|||
17074175|NCT00541775|38216283|FG002|Overall Study|Lost to Follow-up|2|||
17074176|NCT00541775|38216281|FG000|Overall Study|Protocol Violation|1|||
17074177|NCT00541775|38216282|FG001|Overall Study|Protocol Violation|0|||
17074178|NCT00541775|38216283|FG002|Overall Study|Protocol Violation|0|||
17074179|NCT00541775|38216281|FG000|Overall Study|Withdrawal by Subject and Other|5|||
17074180|NCT00541775|38216282|FG001|Overall Study|Withdrawal by Subject and Other|0|||
17074181|NCT00541775|38216283|FG002|Overall Study|Withdrawal by Subject and Other|2|||
17074182|NCT00539513|38216293|FG000|Overall Study|Withdrawal by Subject|2|||
17074183|NCT00539513|38216294|FG001|Overall Study|Withdrawal by Subject|1|||
17074184|NCT00539513|38216293|FG000|Overall Study|Lost to Follow-up|0|||
17074185|NCT00539513|38216294|FG001|Overall Study|Lost to Follow-up|1|||
17074186|NCT02969915|38216304|FG000|Overall Study|Death|104|||
17074187|NCT02969915|38216305|FG001|Overall Study|Death|125|||
17074188|NCT02969915|38216304|FG000|Overall Study|Lost to Follow-up|108|||
17074189|NCT02969915|38216305|FG001|Overall Study|Lost to Follow-up|112|||
17074190|NCT02969915|38216304|FG000|Overall Study|Censored due to COVID-19|481|||
17074191|NCT02969915|38216305|FG001|Overall Study|Censored due to COVID-19|471|||
17074192|NCT00454584|38216314|FG000|Controlled Period|Adverse Event|5|||
17074193|NCT00454584|38216315|FG001|Controlled Period|Adverse Event|2|||
16781275|NCT02105974|37720455|FG002|2 Week Run-in Period|Adverse Event|0|||
16781276|NCT02105974|37720453|FG000|2 Week Run-in Period|Study closed/terminated|1|||
17074194|NCT00454584|38216316|FG002|Controlled Period|Adverse Event|1|||
17074195|NCT00454584|38216317|FG003|Controlled Period|Adverse Event|0|||
17074196|NCT00454584|38216318|FG004|Controlled Period|Adverse Event|0|||
17074197|NCT00454584|38216319|FG005|Controlled Period|Adverse Event|0|||
17074198|NCT00454584|38216314|FG000|Controlled Period|Lost to Follow-up|1|||
17074199|NCT00454584|38216315|FG001|Controlled Period|Lost to Follow-up|2|||
17074200|NCT00454584|38216316|FG002|Controlled Period|Lost to Follow-up|2|||
17074201|NCT00454584|38216317|FG003|Controlled Period|Lost to Follow-up|0|||
17074202|NCT00454584|38216318|FG004|Controlled Period|Lost to Follow-up|0|||
17074203|NCT00454584|38216319|FG005|Controlled Period|Lost to Follow-up|0|||
17074204|NCT00454584|38216314|FG000|Controlled Period|Other|5|||
17074205|NCT00454584|38216315|FG001|Controlled Period|Other|4|||
17074206|NCT00454584|38216316|FG002|Controlled Period|Other|2|||
17074207|NCT00454584|38216317|FG003|Controlled Period|Other|0|||
17074208|NCT00454584|38216318|FG004|Controlled Period|Other|0|||
17074209|NCT00454584|38216319|FG005|Controlled Period|Other|0|||
17074210|NCT00454584|38216314|FG000|After Controlled Period|Adverse Event|0|||
17074211|NCT00454584|38216315|FG001|After Controlled Period|Adverse Event|0|||
17074212|NCT00454584|38216316|FG002|After Controlled Period|Adverse Event|0|||
17074213|NCT00454584|38216317|FG003|After Controlled Period|Adverse Event|9|||
17074214|NCT00454584|38216318|FG004|After Controlled Period|Adverse Event|3|||
17074215|NCT00454584|38216319|FG005|After Controlled Period|Adverse Event|9|||
17074216|NCT00454584|38216314|FG000|After Controlled Period|Lack of Efficacy|0|||
17074217|NCT00454584|38216315|FG001|After Controlled Period|Lack of Efficacy|0|||
17074218|NCT00454584|38216316|FG002|After Controlled Period|Lack of Efficacy|0|||
17074219|NCT00454584|38216317|FG003|After Controlled Period|Lack of Efficacy|1|||
17074220|NCT00454584|38216318|FG004|After Controlled Period|Lack of Efficacy|0|||
17074221|NCT00454584|38216319|FG005|After Controlled Period|Lack of Efficacy|0|||
17074222|NCT00454584|38216314|FG000|After Controlled Period|Lost to Follow-up|0|||
17074223|NCT00454584|38216315|FG001|After Controlled Period|Lost to Follow-up|0|||
17074224|NCT00454584|38216316|FG002|After Controlled Period|Lost to Follow-up|0|||
17074225|NCT00454584|38216317|FG003|After Controlled Period|Lost to Follow-up|2|||
17074226|NCT00454584|38216318|FG004|After Controlled Period|Lost to Follow-up|4|||
17074227|NCT00454584|38216319|FG005|After Controlled Period|Lost to Follow-up|6|||
17074228|NCT00454584|38216314|FG000|After Controlled Period|Other|0|||
17074229|NCT00454584|38216315|FG001|After Controlled Period|Other|0|||
17074230|NCT00454584|38216316|FG002|After Controlled Period|Other|0|||
17074231|NCT00454584|38216317|FG003|After Controlled Period|Other|1|||
17074232|NCT00454584|38216318|FG004|After Controlled Period|Other|0|||
17074233|NCT00454584|38216319|FG005|After Controlled Period|Other|0|||
17074234|NCT00454584|38216314|FG000|After Controlled Period|Other|0|||
17074235|NCT00454584|38216315|FG001|After Controlled Period|Other|0|||
17074236|NCT00454584|38216316|FG002|After Controlled Period|Other|0|||
17074237|NCT00454584|38216317|FG003|After Controlled Period|Other|13|||
17074238|NCT00454584|38216318|FG004|After Controlled Period|Other|5|||
17074239|NCT00454584|38216319|FG005|After Controlled Period|Other|17|||
17074240|NCT00445068|38216333|FG000|Overall Study|Disease progression|26|||
17074241|NCT00445068|38216333|FG000|Overall Study|Adverse Event|5|||
17074242|NCT00445068|38216333|FG000|Overall Study|Abnormal laboratory value|2|||
17074243|NCT00445068|38216333|FG000|Overall Study|Withdrawal by Subject|2|||
17074244|NCT00445068|38216333|FG000|Overall Study|Death|1|||
17074245|NCT00539279|38216339|FG000|Treatment|Withdrawal by Subject|10|||
17074246|NCT00539279|38216340|FG001|Treatment|Withdrawal by Subject|8|||
17074247|NCT00539279|38216339|FG000|Treatment|Death|1|||
17074248|NCT00539279|38216340|FG001|Treatment|Death|0|||
17074249|NCT00539279|38216339|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
17074250|NCT00539279|38216340|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
17074251|NCT00539279|38216339|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
17074252|NCT00539279|38216340|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
17074253|NCT00444912|38216348|FG000|Overall Study|Death|1|||
17074254|NCT00444912|38216349|FG001|Overall Study|Death|2|||
17074255|NCT00444912|38216348|FG000|Overall Study|Lost to Follow-up|1|||
17074256|NCT00444912|38216349|FG001|Overall Study|Lost to Follow-up|0|||
17074257|NCT00444912|38216348|FG000|Overall Study|Participant Failed Mobilization|1|||
17074258|NCT00444912|38216349|FG001|Overall Study|Participant Failed Mobilization|0|||
17074259|NCT00538733|38216355|FG000|Overall Study|Adverse Event|8|||
17074260|NCT00538733|38216355|FG000|Overall Study|Death|1|||
17074261|NCT00538733|38216355|FG000|Overall Study|declined to participate|2|||
17074262|NCT00538733|38216355|FG000|Overall Study|still on therapy|1|||
17074263|NCT00444678|38216362|FG000|Overall Study|Toxicity|11|||
17074264|NCT00444678|38216362|FG000|Overall Study|Disease Progression|12|||
17074265|NCT00444678|38216362|FG000|Overall Study|Death|3|||
17074266|NCT00444678|38216362|FG000|Overall Study|Physician Decision|3|||
17074267|NCT00444678|38216362|FG000|Overall Study|Withdrawal by Subject|2|||
17074268|NCT00358449|38216369|FG000|Overall Study|Adverse Event|1|||
17074269|NCT00358449|38216370|FG001|Overall Study|Adverse Event|0|||
16868018|NCT01536145|37841038|FG005|Overall Study|Withdrawal by Subject|1|||
16868019|NCT01536145|37841039|FG006|Overall Study|Withdrawal by Subject|0|||
17074270|NCT00358449|38216371|FG002|Overall Study|Adverse Event|1|||
17074271|NCT00358449|38216369|FG000|Overall Study|Lost to Follow-up|1|||
17074272|NCT00358449|38216370|FG001|Overall Study|Lost to Follow-up|0|||
17074273|NCT00358449|38216371|FG002|Overall Study|Lost to Follow-up|0|||
17074274|NCT00358449|38216369|FG000|Overall Study|Withdrawal by Subject|2|||
17074275|NCT00358449|38216370|FG001|Overall Study|Withdrawal by Subject|0|||
17074276|NCT00358449|38216371|FG002|Overall Study|Withdrawal by Subject|0|||
17074277|NCT00358449|38216369|FG000|Overall Study|Lack of Efficacy|0|||
17074278|NCT00358449|38216370|FG001|Overall Study|Lack of Efficacy|1|||
17074279|NCT00358449|38216371|FG002|Overall Study|Lack of Efficacy|0|||
17074280|NCT00358449|38216369|FG000|Overall Study|Steriod Inhaler was Increased|0|||
17074281|NCT00358449|38216370|FG001|Overall Study|Steriod Inhaler was Increased|0|||
17074282|NCT00358449|38216371|FG002|Overall Study|Steriod Inhaler was Increased|1|||
17074283|NCT00539981|38216383|FG000|Overall Study|Adverse events (AE)|3|||
17074284|NCT00539981|38216384|FG001|Overall Study|Adverse events (AE)|3|||
17074285|NCT00539981|38216383|FG000|Overall Study|Lost to Follow-up|260|||
17074286|NCT00539981|38216384|FG001|Overall Study|Lost to Follow-up|251|||
17074287|NCT00539981|38216383|FG000|Overall Study|Withdrew consent|22|||
17074288|NCT00539981|38216384|FG001|Overall Study|Withdrew consent|14|||
17074289|NCT00539981|38216383|FG000|Overall Study|Death|1|||
17074290|NCT00539981|38216384|FG001|Overall Study|Death|1|||
17074291|NCT00539981|38216383|FG000|Overall Study|Other reason-unspecified|9|||
17074292|NCT00539981|38216384|FG001|Overall Study|Other reason-unspecified|13|||
17074293|NCT00367341|38216395|FG000|Overall Study|Physician Decision|1|||
17074294|NCT00367341|38216396|FG001|Overall Study|Physician Decision|0|||
16994964|NCT00580801|38138648|FG001|Overall Study|Adverse Event|0|||
16994965|NCT00580801|38138649|FG002|Overall Study|Adverse Event|0|||
16994966|NCT00580801|38138647|FG000|Overall Study|Lost to Follow-up|2|||
16994967|NCT00580801|38138648|FG001|Overall Study|Lost to Follow-up|0|||
16994968|NCT00580801|38138649|FG002|Overall Study|Lost to Follow-up|0|||
16994969|NCT00580801|38138647|FG000|Overall Study|Reached a virologic endpoint|0|||
16994970|NCT00580801|38138648|FG001|Overall Study|Reached a virologic endpoint|1|||
16994971|NCT00580801|38138649|FG002|Overall Study|Reached a virologic endpoint|2|||
16994972|NCT00580801|38138647|FG000|Overall Study|Participant non-compliant|0|||
16994973|NCT00580801|38138648|FG001|Overall Study|Participant non-compliant|0|||
16994974|NCT00580801|38138649|FG002|Overall Study|Participant non-compliant|1|||
17074295|NCT00367341|38216395|FG000|Overall Study|Protocol Violation|1|||
17074296|NCT00367341|38216396|FG001|Overall Study|Protocol Violation|0|||
17074297|NCT00440466|38216405|FG000|Overall Study|Death|3|||
17074298|NCT00440466|38216406|FG001|Overall Study|Death|2|||
17074299|NCT00440466|38216407|FG002|Overall Study|Death|9|||
17074300|NCT00440466|38216405|FG000|Overall Study|Adverse Event|3|||
17074301|NCT00440466|38216406|FG001|Overall Study|Adverse Event|4|||
17074302|NCT00440466|38216407|FG002|Overall Study|Adverse Event|11|||
17074303|NCT00440466|38216405|FG000|Overall Study|Lost to Follow-up|1|||
17074304|NCT00440466|38216406|FG001|Overall Study|Lost to Follow-up|0|||
17074305|NCT00440466|38216407|FG002|Overall Study|Lost to Follow-up|2|||
17074306|NCT00440466|38216405|FG000|Overall Study|Physician Decision|2|||
17074307|NCT00440466|38216406|FG001|Overall Study|Physician Decision|0|||
17074308|NCT00440466|38216407|FG002|Overall Study|Physician Decision|1|||
17074309|NCT00440466|38216405|FG000|Overall Study|Protocol Violation|2|||
17074310|NCT00440466|38216406|FG001|Overall Study|Protocol Violation|0|||
17074311|NCT00440466|38216407|FG002|Overall Study|Protocol Violation|4|||
17074312|NCT00440466|38216405|FG000|Overall Study|Withdrawal by Subject|2|||
17074313|NCT00440466|38216406|FG001|Overall Study|Withdrawal by Subject|5|||
17074314|NCT00440466|38216407|FG002|Overall Study|Withdrawal by Subject|9|||
17074315|NCT00440466|38216405|FG000|Overall Study|Began Dialysis|0|||
17074316|NCT00440466|38216406|FG001|Overall Study|Began Dialysis|0|||
17074317|NCT00440466|38216407|FG002|Overall Study|Began Dialysis|1|||
17074318|NCT00440466|38216405|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
17074319|NCT00440466|38216406|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
17074320|NCT00440466|38216407|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
17074321|NCT00537485|38216439|FG000|Overall Study|Adverse Event|10|||
17074322|NCT00537485|38216440|FG001|Overall Study|Adverse Event|5|||
17074323|NCT00537485|38216439|FG000|Overall Study|Withdrawal by Subject|3|||
17074324|NCT00537485|38216440|FG001|Overall Study|Withdrawal by Subject|2|||
17074325|NCT00537485|38216439|FG000|Overall Study|Withdrawal by Subject|1|||
17074326|NCT00537485|38216440|FG001|Overall Study|Withdrawal by Subject|3|||
17074327|NCT00537485|38216439|FG000|Overall Study|Physician Decision|1|||
17074328|NCT00537485|38216440|FG001|Overall Study|Physician Decision|0|||
17074329|NCT00616967|38216448|FG000|Overall Study|Withdrawal by Subject|0|||
17074330|NCT00616967|38216449|FG001|Overall Study|Withdrawal by Subject|0|||
17074331|NCT00616967|38216450|FG002|Overall Study|Withdrawal by Subject|1|||
17074332|NCT00537329|38216468|FG000|Overall Study|Death|10|||
17074333|NCT00537329|38216468|FG000|Overall Study|Adverse Event|3|||
17074334|NCT00537329|38216468|FG000|Overall Study|Lack of Efficacy|2|||
17074335|NCT00537329|38216468|FG000|Overall Study|Lost to Follow-up|6|||
17074336|NCT00537329|38216468|FG000|Overall Study|Withdrawal by Subject|4|||
17074337|NCT00537329|38216468|FG000|Overall Study|Other|1|||
17074338|NCT03897179|38216472|FG000|Overall Study|Withdrawal by Subject|1|||
17074339|NCT03905135|38216478|FG000|Dose Escalation|Adverse Event|1|||
17074340|NCT03905135|38216479|FG001|Dose Escalation|Adverse Event|1|||
17074341|NCT03905135|38216478|FG000|Dose Escalation|Progressive disease|3|||
17074342|NCT03905135|38216479|FG001|Dose Escalation|Progressive disease|1|||
17074343|NCT03905135|38216478|FG000|Dose Escalation|Intercurrent illness|1|||
17074344|NCT03905135|38216479|FG001|Dose Escalation|Intercurrent illness|0|||
17074345|NCT00357903|38216489|FG000|Overall Study|Adverse Event|87|||
17074346|NCT00357903|38216490|FG001|Overall Study|Adverse Event|4|||
17074347|NCT00357903|38216489|FG000|Overall Study|Death|33|||
17074348|NCT00357903|38216490|FG001|Overall Study|Death|0|||
17074349|NCT00357903|38216489|FG000|Overall Study|Lost to Follow-up|23|||
17074350|NCT00357903|38216490|FG001|Overall Study|Lost to Follow-up|4|||
17074351|NCT00357903|38216489|FG000|Overall Study|Physician Decision|39|||
17074352|NCT00357903|38216490|FG001|Overall Study|Physician Decision|5|||
17074353|NCT00357903|38216489|FG000|Overall Study|Withdrawal by Subject|57|||
17074354|NCT00357903|38216490|FG001|Overall Study|Withdrawal by Subject|7|||
17157190|NCT02318277|38304291|FG006|Overall Study|Withdrawal by Subject|6|||
17157191|NCT02318277|38304292|FG007|Overall Study|Withdrawal by Subject|14|||
17157192|NCT02318277|38304285|FG000|Overall Study|Participant trial terminated by sponsor|0|||
17074355|NCT00357903|38216489|FG000|Overall Study|Completed month 12 only|0|||
17074356|NCT00357903|38216490|FG001|Overall Study|Completed month 12 only|1|||
17074357|NCT00357903|38216489|FG000|Overall Study|Protocol issues|14|||
17074358|NCT00357903|38216490|FG001|Overall Study|Protocol issues|3|||
17074359|NCT00357903|38216489|FG000|Overall Study|Response status|61|||
17074360|NCT00357903|38216490|FG001|Overall Study|Response status|9|||
17074361|NCT00357903|38216489|FG000|Overall Study|Other|49|||
17074362|NCT00357903|38216490|FG001|Overall Study|Other|10|||
17074363|NCT00348933|38216497|FG000|Overall Study|Withdrawal by Subject|10|||
17074364|NCT00348933|38216497|FG000|Overall Study|Lost to Follow-up|6|||
17074365|NCT00348933|38216497|FG000|Overall Study|Protocol Violation|2|||
17074366|NCT00348933|38216497|FG000|Overall Study|Adverse Event|7|||
17074367|NCT03896477|38216505|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
17074368|NCT03896477|38216506|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
17074369|NCT03896477|38216507|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
17074370|NCT03896477|38216505|FG000|Overall Study|Parent Requested Withdrawal|8|||
17074371|NCT03896477|38216506|FG001|Overall Study|Parent Requested Withdrawal|12|||
17074372|NCT03896477|38216507|FG002|Overall Study|Parent Requested Withdrawal|9|||
17074373|NCT03896477|38216505|FG000|Overall Study|Adverse Event|0|||
17074374|NCT03896477|38216506|FG001|Overall Study|Adverse Event|0|||
17074375|NCT03896477|38216507|FG002|Overall Study|Adverse Event|1|||
17074376|NCT03896477|38216505|FG000|Overall Study|Death|1|||
17074377|NCT03896477|38216506|FG001|Overall Study|Death|0|||
17074378|NCT03896477|38216507|FG002|Overall Study|Death|0|||
17074379|NCT03896477|38216505|FG000|Overall Study|Other|5|||
17074380|NCT03896477|38216506|FG001|Overall Study|Other|6|||
17074381|NCT03896477|38216507|FG002|Overall Study|Other|7|||
17074382|NCT03896477|38216505|FG000|Overall Study|Lost to Follow-up|2|||
17074383|NCT03896477|38216506|FG001|Overall Study|Lost to Follow-up|1|||
17074384|NCT03896477|38216507|FG002|Overall Study|Lost to Follow-up|1|||
17074385|NCT00444600|38216522|FG000|Overall Study|Death|7|||
17157193|NCT02318277|38304286|FG001|Overall Study|Participant trial terminated by sponsor|0|||
17157194|NCT02318277|38304287|FG002|Overall Study|Participant trial terminated by sponsor|1|||
17157195|NCT02318277|38304288|FG003|Overall Study|Participant trial terminated by sponsor|0|||
17157196|NCT02318277|38304289|FG004|Overall Study|Participant trial terminated by sponsor|1|||
17157197|NCT02318277|38304290|FG005|Overall Study|Participant trial terminated by sponsor|2|||
17157198|NCT02318277|38304291|FG006|Overall Study|Participant trial terminated by sponsor|5|||
17157199|NCT02318277|38304292|FG007|Overall Study|Participant trial terminated by sponsor|16|||
17157200|NCT02318277|38304285|FG000|Overall Study|Lost to Follow-up|1|||
17157201|NCT02318277|38304286|FG001|Overall Study|Lost to Follow-up|0|||
17157202|NCT02318277|38304287|FG002|Overall Study|Lost to Follow-up|1|||
17157203|NCT02318277|38304288|FG003|Overall Study|Lost to Follow-up|0|||
17157204|NCT02318277|38304289|FG004|Overall Study|Lost to Follow-up|0|||
16994975|NCT00580801|38138647|FG000|Overall Study|Travel|1|||
16994976|NCT00580801|38138648|FG001|Overall Study|Travel|0|||
16994977|NCT00580801|38138649|FG002|Overall Study|Travel|0|||
17074386|NCT00444600|38216523|FG001|Overall Study|Death|5|||
17074387|NCT00444600|38216524|FG002|Overall Study|Death|3|||
17074388|NCT00444600|38216525|FG003|Overall Study|Death|2|||
16994978|NCT01059539|38138657|FG000|Overall Study|Adverse Event|66|||
16994979|NCT01059539|38138657|FG000|Overall Study|Insufficient Therapeutic Response|26|||
16994980|NCT01059539|38138657|FG000|Overall Study|Protocol Violation|55|||
16994981|NCT01059539|38138657|FG000|Overall Study|Withdrawal of Consent|80|||
16994982|NCT01059539|38138657|FG000|Overall Study|Lost to Follow-up|42|||
17074389|NCT00444600|38216522|FG000|Overall Study|Dropped|11|||
17074390|NCT00444600|38216523|FG001|Overall Study|Dropped|11|||
17074391|NCT00444600|38216524|FG002|Overall Study|Dropped|7|||
17074392|NCT00444600|38216525|FG003|Overall Study|Dropped|7|||
17074393|NCT00444600|38216522|FG000|Overall Study|Missed visit|1|||
17074394|NCT00444600|38216523|FG001|Overall Study|Missed visit|0|||
17074395|NCT00444600|38216524|FG002|Overall Study|Missed visit|0|||
17074396|NCT00444600|38216525|FG003|Overall Study|Missed visit|1|||
17074397|NCT00537095|38216543|FG000|Overall Study|surgery|1|||
17074398|NCT00537095|38216544|FG001|Overall Study|surgery|0|||
17074399|NCT00537095|38216543|FG000|Overall Study|Adverse Event|24|||
17074400|NCT00537095|38216544|FG001|Overall Study|Adverse Event|4|||
17074401|NCT00537095|38216543|FG000|Overall Study|disease progression|21|||
17074402|NCT00537095|38216544|FG001|Overall Study|disease progression|48|||
17074403|NCT00537095|38216543|FG000|Overall Study|Death|3|||
17074404|NCT00537095|38216544|FG001|Overall Study|Death|1|||
17074405|NCT00537095|38216543|FG000|Overall Study|Withdrawal by Subject|2|||
17074406|NCT00537095|38216544|FG001|Overall Study|Withdrawal by Subject|2|||
17074407|NCT00537095|38216543|FG000|Overall Study|subjective disease progression|0|||
17074408|NCT00537095|38216544|FG001|Overall Study|subjective disease progression|1|||
17074409|NCT00537095|38216543|FG000|Overall Study|Incorrect enrolment|0|||
17074410|NCT00537095|38216544|FG001|Overall Study|Incorrect enrolment|1|||
17074411|NCT00443898|38216554|FG000|Overall Study|Adverse Event|0|||
17074412|NCT00443898|38216555|FG001|Overall Study|Adverse Event|0|||
17074413|NCT00443898|38216556|FG002|Overall Study|Adverse Event|1|||
17074414|NCT00443898|38216557|FG003|Overall Study|Adverse Event|1|||
17074415|NCT00443898|38216554|FG000|Overall Study|Lack of Efficacy|2|||
17074416|NCT00443898|38216555|FG001|Overall Study|Lack of Efficacy|3|||
17074417|NCT00443898|38216556|FG002|Overall Study|Lack of Efficacy|3|||
17074418|NCT00443898|38216557|FG003|Overall Study|Lack of Efficacy|1|||
17074419|NCT00443898|38216554|FG000|Overall Study|Protocol Violation|1|||
17074420|NCT00443898|38216555|FG001|Overall Study|Protocol Violation|1|||
17074421|NCT00443898|38216556|FG002|Overall Study|Protocol Violation|1|||
17074422|NCT00443898|38216557|FG003|Overall Study|Protocol Violation|0|||
17074423|NCT00443898|38216554|FG000|Overall Study|Withdrawal by Subject|11|||
17157205|NCT02318277|38304290|FG005|Overall Study|Lost to Follow-up|0|||
17074424|NCT00443898|38216555|FG001|Overall Study|Withdrawal by Subject|10|||
17074425|NCT00443898|38216556|FG002|Overall Study|Withdrawal by Subject|10|||
17074426|NCT00443898|38216557|FG003|Overall Study|Withdrawal by Subject|6|||
17074427|NCT00443898|38216554|FG000|Overall Study|Lost to Follow-up|10|||
17074428|NCT00443898|38216555|FG001|Overall Study|Lost to Follow-up|10|||
17074429|NCT00443898|38216556|FG002|Overall Study|Lost to Follow-up|14|||
17157206|NCT02318277|38304291|FG006|Overall Study|Lost to Follow-up|3|||
17157207|NCT02318277|38304292|FG007|Overall Study|Lost to Follow-up|4|||
17157208|NCT02318277|38304285|FG000|Overall Study|Death|5|||
17157209|NCT02318277|38304286|FG001|Overall Study|Death|3|||
17074430|NCT00443898|38216557|FG003|Overall Study|Lost to Follow-up|10|||
17074431|NCT00443898|38216554|FG000|Overall Study|Death|0|||
17074432|NCT00443898|38216555|FG001|Overall Study|Death|1|||
17074433|NCT00443898|38216556|FG002|Overall Study|Death|0|||
17074434|NCT00443898|38216557|FG003|Overall Study|Death|0|||
17074435|NCT00537017|38216567|FG000|Treatment Phase|Adverse Event|19|||
17074436|NCT00537017|38216567|FG000|Treatment Phase|Withdrawal by Subject|13|||
17074437|NCT00537017|38216567|FG000|Treatment Phase|Protocol Violation|2|||
17074438|NCT00537017|38216567|FG000|Follow-up Phase|Withdrawal by Subject|9|||
17074439|NCT00348309|38216574|FG000|Overall Study|Adverse Event|56|||
17074440|NCT00348309|38216575|FG001|Overall Study|Adverse Event|28|||
17074441|NCT00348309|38216576|FG002|Overall Study|Adverse Event|63|||
17074442|NCT00348309|38216574|FG000|Overall Study|Lost to Follow-up|6|||
17074443|NCT00348309|38216575|FG001|Overall Study|Lost to Follow-up|7|||
17074444|NCT00348309|38216576|FG002|Overall Study|Lost to Follow-up|4|||
17074445|NCT00348309|38216574|FG000|Overall Study|Protocol Violation|7|||
17074446|NCT00348309|38216575|FG001|Overall Study|Protocol Violation|12|||
17074447|NCT00348309|38216576|FG002|Overall Study|Protocol Violation|7|||
17074448|NCT00348309|38216574|FG000|Overall Study|Withdrawal by Subject|33|||
17074449|NCT00348309|38216575|FG001|Overall Study|Withdrawal by Subject|37|||
17074450|NCT00348309|38216576|FG002|Overall Study|Withdrawal by Subject|40|||
17074451|NCT00348309|38216574|FG000|Overall Study|Non-compliance|8|||
17074452|NCT00348309|38216575|FG001|Overall Study|Non-compliance|6|||
17074453|NCT00348309|38216576|FG002|Overall Study|Non-compliance|8|||
17074454|NCT00348309|38216574|FG000|Overall Study|Death of caregiver|1|||
17074455|NCT00348309|38216575|FG001|Overall Study|Death of caregiver|0|||
17074456|NCT00348309|38216576|FG002|Overall Study|Death of caregiver|1|||
17074457|NCT00348309|38216574|FG000|Overall Study|Lack of insight, dementia|1|||
17074458|NCT00348309|38216575|FG001|Overall Study|Lack of insight, dementia|0|||
17074459|NCT00348309|38216576|FG002|Overall Study|Lack of insight, dementia|0|||
17074460|NCT00348309|38216574|FG000|Overall Study|Wrong bottle allocated|1|||
17074461|NCT00348309|38216575|FG001|Overall Study|Wrong bottle allocated|0|||
17074462|NCT00348309|38216576|FG002|Overall Study|Wrong bottle allocated|0|||
17074463|NCT00348309|38216574|FG000|Overall Study|Caregiver sick|1|||
17074464|NCT00348309|38216575|FG001|Overall Study|Caregiver sick|0|||
17074465|NCT00348309|38216576|FG002|Overall Study|Caregiver sick|0|||
17074466|NCT00348309|38216574|FG000|Overall Study|Use of prohibited medication|5|||
17074467|NCT00348309|38216575|FG001|Overall Study|Use of prohibited medication|2|||
17074468|NCT00348309|38216576|FG002|Overall Study|Use of prohibited medication|2|||
17074469|NCT00348309|38216574|FG000|Overall Study|Caregiver withdrawal|3|||
17074470|NCT00348309|38216575|FG001|Overall Study|Caregiver withdrawal|0|||
17157210|NCT02318277|38304287|FG002|Overall Study|Death|1|||
17157211|NCT02318277|38304288|FG003|Overall Study|Death|4|||
16868020|NCT01536145|37841040|FG007|Overall Study|Withdrawal by Subject|0|||
16994983|NCT01059539|38138657|FG000|Overall Study|Reason Not Specified|2|||
16994984|NCT00999908|38138661|FG000|Treatment Period 1|Subject withdrew consent|2|||
16994985|NCT00999908|38138662|FG001|Treatment Period 1|Subject withdrew consent|0|||
16994986|NCT00999908|38138663|FG002|Treatment Period 1|Subject withdrew consent|0|||
16994987|NCT00999908|38138661|FG000|Treatment Period 2|Protocol Violation|1|||
16994988|NCT00999908|38138662|FG001|Treatment Period 2|Protocol Violation|0|||
16994989|NCT00999908|38138663|FG002|Treatment Period 2|Protocol Violation|0|||
16994990|NCT00580723|38138671|FG000|Overall Study|Did not want to participate in extension|3|||
16994991|NCT00580723|38138671|FG000|Overall Study|Lost to Follow-up|5|||
17074471|NCT00348309|38216576|FG002|Overall Study|Caregiver withdrawal|7|||
17074472|NCT00348309|38216574|FG000|Overall Study|Unable to complete ET visit|1|||
17074473|NCT00348309|38216575|FG001|Overall Study|Unable to complete ET visit|0|||
17074474|NCT00348309|38216576|FG002|Overall Study|Unable to complete ET visit|0|||
17074475|NCT00348309|38216574|FG000|Overall Study|PI closing medical practice|1|||
17074476|NCT00348309|38216575|FG001|Overall Study|PI closing medical practice|0|||
17074477|NCT00348309|38216576|FG002|Overall Study|PI closing medical practice|0|||
17074478|NCT00348309|38216574|FG000|Overall Study|Principal investigator's decision|1|||
17074479|NCT00348309|38216575|FG001|Overall Study|Principal investigator's decision|0|||
17074480|NCT00348309|38216576|FG002|Overall Study|Principal investigator's decision|0|||
17074481|NCT00348309|38216574|FG000|Overall Study|No disponibility of medication|1|||
17074482|NCT00348309|38216575|FG001|Overall Study|No disponibility of medication|0|||
17157212|NCT02318277|38304289|FG004|Overall Study|Death|6|||
17157213|NCT02318277|38304290|FG005|Overall Study|Death|5|||
17157214|NCT02318277|38304291|FG006|Overall Study|Death|34|||
16994992|NCT00999596|38138675|FG000|Overall Study|Statistical population not required|101|||
16994993|NCT04676867|38138684|FG000|Overall Study|Screen failure|0|||
16994994|NCT04676867|38138685|FG001|Overall Study|Screen failure|0|||
16994995|NCT04676867|38138686|FG002|Overall Study|Screen failure|6|||
16994996|NCT04676867|38138687|FG003|Overall Study|Screen failure|2|||
16994997|NCT04676867|38138684|FG000|Overall Study|Death|0|||
16994998|NCT04676867|38138685|FG001|Overall Study|Death|0|||
16994999|NCT04676867|38138686|FG002|Overall Study|Death|1|||
16995000|NCT04676867|38138687|FG003|Overall Study|Death|0|||
16995001|NCT04676867|38138684|FG000|Overall Study|Withdrawal by Subject|2|||
16995002|NCT04676867|38138685|FG001|Overall Study|Withdrawal by Subject|2|||
16995003|NCT04676867|38138686|FG002|Overall Study|Withdrawal by Subject|4|||
16995004|NCT04676867|38138687|FG003|Overall Study|Withdrawal by Subject|4|||
16995005|NCT04676867|38138684|FG000|Overall Study|Lost to Follow-up|1|||
16995006|NCT04676867|38138685|FG001|Overall Study|Lost to Follow-up|0|||
17157215|NCT02318277|38304292|FG007|Overall Study|Death|58|||
17157216|NCT02318277|38304285|FG000|Overall Study|Transitioned to Hospice|0|||
17074483|NCT00348309|38216576|FG002|Overall Study|No disponibility of medication|0|||
17074484|NCT00348309|38216574|FG000|Overall Study|Worsened neurodegenerative disease|1|||
17074485|NCT00348309|38216575|FG001|Overall Study|Worsened neurodegenerative disease|0|||
17074486|NCT00348309|38216576|FG002|Overall Study|Worsened neurodegenerative disease|0|||
17074487|NCT00348309|38216574|FG000|Overall Study|Cognitive and behaviour worsening|2|||
17074488|NCT00348309|38216575|FG001|Overall Study|Cognitive and behaviour worsening|0|||
17074489|NCT00348309|38216576|FG002|Overall Study|Cognitive and behaviour worsening|0|||
17074490|NCT00348309|38216574|FG000|Overall Study|Worsening of alzheimer|1|||
17074491|NCT00348309|38216575|FG001|Overall Study|Worsening of alzheimer|0|||
17074492|NCT00348309|38216576|FG002|Overall Study|Worsening of alzheimer|1|||
17074493|NCT00348309|38216574|FG000|Overall Study|Did not appear in time for Visit 3|1|||
17074494|NCT00348309|38216575|FG001|Overall Study|Did not appear in time for Visit 3|0|||
17074495|NCT00348309|38216576|FG002|Overall Study|Did not appear in time for Visit 3|0|||
17074496|NCT00348309|38216574|FG000|Overall Study|Participant died|2|||
17074497|NCT00348309|38216575|FG001|Overall Study|Participant died|1|||
17074498|NCT00348309|38216576|FG002|Overall Study|Participant died|1|||
17074499|NCT00348309|38216574|FG000|Overall Study|Decision of sponsor|1|||
17074500|NCT00348309|38216575|FG001|Overall Study|Decision of sponsor|0|||
17074501|NCT00348309|38216576|FG002|Overall Study|Decision of sponsor|0|||
17074502|NCT00348309|38216574|FG000|Overall Study|Ineffectiveness of treatment|0|||
17074503|NCT00348309|38216575|FG001|Overall Study|Ineffectiveness of treatment|1|||
17074504|NCT00348309|38216576|FG002|Overall Study|Ineffectiveness of treatment|0|||
17074505|NCT00348309|38216574|FG000|Overall Study|A foul of exclusion criteria|0|||
17074506|NCT00348309|38216575|FG001|Overall Study|A foul of exclusion criteria|1|||
17074507|NCT00348309|38216576|FG002|Overall Study|A foul of exclusion criteria|0|||
17074508|NCT00348309|38216574|FG000|Overall Study|Participant was hospitalized|0|||
17074509|NCT00348309|38216575|FG001|Overall Study|Participant was hospitalized|1|||
17074510|NCT00348309|38216576|FG002|Overall Study|Participant was hospitalized|0|||
17074511|NCT00348309|38216574|FG000|Overall Study|Sponsor refuseal|0|||
17074512|NCT00348309|38216575|FG001|Overall Study|Sponsor refuseal|1|||
16995007|NCT04676867|38138686|FG002|Overall Study|Lost to Follow-up|0|||
16995008|NCT04676867|38138687|FG003|Overall Study|Lost to Follow-up|0|||
17074513|NCT00348309|38216576|FG002|Overall Study|Sponsor refuseal|1|||
17074514|NCT00348309|38216574|FG000|Overall Study|Forgot often medication|0|||
17074515|NCT00348309|38216575|FG001|Overall Study|Forgot often medication|1|||
17157217|NCT02318277|38304286|FG001|Overall Study|Transitioned to Hospice|0|||
17157218|NCT02318277|38304287|FG002|Overall Study|Transitioned to Hospice|0|||
17157219|NCT02318277|38304288|FG003|Overall Study|Transitioned to Hospice|0|||
17157220|NCT02318277|38304289|FG004|Overall Study|Transitioned to Hospice|0|||
17157221|NCT02318277|38304290|FG005|Overall Study|Transitioned to Hospice|1|||
17157222|NCT02318277|38304291|FG006|Overall Study|Transitioned to Hospice|0|||
17157223|NCT02318277|38304292|FG007|Overall Study|Transitioned to Hospice|0|||
17157224|NCT01063868|38304337|FG000|Overall Study|Adverse Event|9|||
17157225|NCT01063868|38304338|FG001|Overall Study|Adverse Event|7|||
17157226|NCT01063868|38304337|FG000|Overall Study|Withdrawal by Subject|3|||
17157227|NCT01063868|38304338|FG001|Overall Study|Withdrawal by Subject|1|||
17157228|NCT01063868|38304337|FG000|Overall Study|Study Terminated By Sponsor|23|||
17157229|NCT01063868|38304338|FG001|Overall Study|Study Terminated By Sponsor|4|||
17157230|NCT02974088|38304346|FG000|Overall Study|Lost to Follow-up|0|||
17157231|NCT02974088|38304347|FG001|Overall Study|Lost to Follow-up|2|||
16995009|NCT00770224|38138697|FG000|Step 1: Induction|Adverse Event|3|||
17074516|NCT00348309|38216576|FG002|Overall Study|Forgot often medication|0|||
17074517|NCT00348309|38216574|FG000|Overall Study|Medical Monitor decision|0|||
17074518|NCT00348309|38216575|FG001|Overall Study|Medical Monitor decision|0|||
17074519|NCT00348309|38216576|FG002|Overall Study|Medical Monitor decision|1|||
17074520|NCT00348309|38216574|FG000|Overall Study|Increased dose of Aricept|0|||
17157232|NCT02974088|38304346|FG000|Overall Study|Adverse Event|0|||
17157233|NCT02974088|38304347|FG001|Overall Study|Adverse Event|1|||
17157234|NCT02385045|38304353|FG000|Overall Study|Endoscopy could not be completed|4|||
17157235|NCT02974010|38304361|FG000|Overall Study|Lost to Follow-up|3|||
17157236|NCT02974010|38304362|FG001|Overall Study|Lost to Follow-up|1|||
17157237|NCT02974010|38304363|FG002|Overall Study|Lost to Follow-up|0|||
17157238|NCT02974010|38304364|FG003|Overall Study|Lost to Follow-up|0|||
17157239|NCT02974010|38304361|FG000|Overall Study|Withdrawal by Subject|2|||
17157240|NCT02974010|38304362|FG001|Overall Study|Withdrawal by Subject|1|||
17157241|NCT02974010|38304363|FG002|Overall Study|Withdrawal by Subject|0|||
17157242|NCT02974010|38304364|FG003|Overall Study|Withdrawal by Subject|0|||
17157243|NCT02974010|38304361|FG000|Overall Study|Adverse Event|0|||
17157244|NCT02974010|38304362|FG001|Overall Study|Adverse Event|1|||
17157245|NCT02974010|38304363|FG002|Overall Study|Adverse Event|0|||
17157246|NCT02974010|38304364|FG003|Overall Study|Adverse Event|0|||
17157247|NCT02974010|38304361|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
17074521|NCT00348309|38216575|FG001|Overall Study|Increased dose of Aricept|0|||
17074522|NCT00348309|38216576|FG002|Overall Study|Increased dose of Aricept|1|||
17074523|NCT00348309|38216574|FG000|Overall Study|Site closure|0|||
17074524|NCT00348309|38216575|FG001|Overall Study|Site closure|0|||
17074525|NCT00348309|38216576|FG002|Overall Study|Site closure|1|||
17074526|NCT00348309|38216574|FG000|Overall Study|Adverse event not attended|0|||
17074527|NCT00348309|38216575|FG001|Overall Study|Adverse event not attended|0|||
17074528|NCT00348309|38216576|FG002|Overall Study|Adverse event not attended|1|||
17074529|NCT00348309|38216574|FG000|Overall Study|ECG abnormal|0|||
17074530|NCT00348309|38216575|FG001|Overall Study|ECG abnormal|0|||
17074531|NCT00348309|38216576|FG002|Overall Study|ECG abnormal|2|||
17074532|NCT00348309|38216574|FG000|Overall Study|Cardiologist recommendations|0|||
17074533|NCT00348309|38216575|FG001|Overall Study|Cardiologist recommendations|0|||
17074534|NCT00348309|38216576|FG002|Overall Study|Cardiologist recommendations|1|||
17074535|NCT00348309|38216574|FG000|Overall Study|HCV career|0|||
17074536|NCT00348309|38216575|FG001|Overall Study|HCV career|0|||
17074537|NCT00348309|38216576|FG002|Overall Study|HCV career|1|||
17074538|NCT00440310|38216587|FG000|Overall Study|Lost to Follow-up|4|||
17074539|NCT00440310|38216588|FG001|Overall Study|Lost to Follow-up|5|||
17074540|NCT00440310|38216587|FG000|Overall Study|Protocol Violation|0|||
17074541|NCT00440310|38216588|FG001|Overall Study|Protocol Violation|1|||
17074542|NCT00440310|38216587|FG000|Overall Study|Withdrawal by Subject|15|||
17074543|NCT00440310|38216588|FG001|Overall Study|Withdrawal by Subject|14|||
17074544|NCT00440310|38216587|FG000|Overall Study|No Reply at EOS|7|||
17074545|NCT00440310|38216588|FG001|Overall Study|No Reply at EOS|7|||
17074546|NCT00440310|38216587|FG000|Overall Study|Other|1|||
17074547|NCT00440310|38216588|FG001|Overall Study|Other|0|||
17074548|NCT00440310|38216587|FG000|Overall Study|Status Unknown|1|||
17074549|NCT00440310|38216588|FG001|Overall Study|Status Unknown|3|||
17074550|NCT00440232|38216596|FG000|Overall Study|Lost to Follow-up|1|||
17074551|NCT00440232|38216597|FG001|Overall Study|Lost to Follow-up|1|||
17074552|NCT00440232|38216596|FG000|Overall Study|Unable to treat within allowed time|0|||
17074553|NCT00440232|38216597|FG001|Overall Study|Unable to treat within allowed time|1|||
17074554|NCT00440232|38216596|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
17074555|NCT00440232|38216597|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
17074556|NCT00356889|38216603|FG000|Overall Study|Protocol Violation|2|||
17074557|NCT00356889|38216603|FG000|Overall Study|Adverse Event|1|||
17074558|NCT00356811|38216608|FG000|Overall Study|Death|35|||
17074559|NCT00356811|38216608|FG000|Overall Study|Lost to Follow-up|2|||
17074560|NCT00356811|38216608|FG000|Overall Study|Withdrawal by Subject|6|||
17074561|NCT00356811|38216608|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
17074562|NCT00356811|38216608|FG000|Overall Study|Study Is Terminating|3|||
17074563|NCT00356811|38216608|FG000|Overall Study|Site Closed during Follow-up|2|||
17074564|NCT00439218|38216613|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
17074565|NCT00535223|38216632|FG000|Overall Study|Withdrawal by Subject|4|||
17074566|NCT00535223|38216633|FG001|Overall Study|Withdrawal by Subject|1|||
17074567|NCT00536939|38216639|FG000|Overall Study|Withdrawal by Subject|1|||
17074568|NCT00536939|38216640|FG001|Overall Study|Withdrawal by Subject|0|||
17074569|NCT00536939|38216639|FG000|Overall Study|Other Complicating Disease|1|||
17074570|NCT00536939|38216640|FG001|Overall Study|Other Complicating Disease|0|||
17074571|NCT00347919|38216648|FG000|Overall Study|Lost to Follow-up|11|||
17074572|NCT00347919|38216649|FG001|Overall Study|Lost to Follow-up|13|||
17074573|NCT00347919|38216650|FG002|Overall Study|Lost to Follow-up|0|||
17074574|NCT00347919|38216648|FG000|Overall Study|Withdrawal by Subject|6|||
17074575|NCT00347919|38216649|FG001|Overall Study|Withdrawal by Subject|8|||
17074576|NCT00347919|38216650|FG002|Overall Study|Withdrawal by Subject|0|||
17074577|NCT00347919|38216648|FG000|Overall Study|Physician Decision|1|||
17074578|NCT00347919|38216649|FG001|Overall Study|Physician Decision|1|||
17074579|NCT00347919|38216650|FG002|Overall Study|Physician Decision|0|||
17074580|NCT00347919|38216648|FG000|Overall Study|Sponsor terminated study|15|||
17074581|NCT00347919|38216649|FG001|Overall Study|Sponsor terminated study|10|||
17074582|NCT00347919|38216650|FG002|Overall Study|Sponsor terminated study|16|||
17157248|NCT02974010|38304362|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
17157249|NCT02974010|38304363|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
17074583|NCT00347919|38216648|FG000|Overall Study|Death|35|||
17074584|NCT00347919|38216649|FG001|Overall Study|Death|42|||
17074585|NCT00347919|38216650|FG002|Overall Study|Death|19|||
17074586|NCT00347919|38216648|FG000|Overall Study|Par. Started Other Treatment|1|||
17074587|NCT00347919|38216649|FG001|Overall Study|Par. Started Other Treatment|1|||
17074588|NCT00347919|38216650|FG002|Overall Study|Par. Started Other Treatment|1|||
17074589|NCT00347919|38216648|FG000|Overall Study|Missing|2|||
17074590|NCT00347919|38216649|FG001|Overall Study|Missing|1|||
17074591|NCT00347919|38216650|FG002|Overall Study|Missing|2|||
17074592|NCT00439140|38216663|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
17074593|NCT00439140|38216664|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
17074594|NCT00439140|38216665|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
17074595|NCT00439140|38216663|FG000|Treatment Cycle 1|Personal reasons|0|||
17074596|NCT00439140|38216664|FG001|Treatment Cycle 1|Personal reasons|2|||
17074597|NCT00439140|38216665|FG002|Treatment Cycle 1|Personal reasons|0|||
17074598|NCT00439140|38216663|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
17074599|NCT00439140|38216664|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
17074600|NCT00439140|38216665|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
17074601|NCT00439140|38216663|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
17074602|NCT00439140|38216664|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
17074603|NCT00439140|38216665|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
17074604|NCT00439140|38216663|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
16995010|NCT00770224|38138698|FG001|Step 1: Induction|Adverse Event|0|||
17074605|NCT00439140|38216664|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
17074606|NCT00439140|38216665|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
17074607|NCT00356421|38216675|FG000|Overall Study|Lack of Efficacy|3|||
17074608|NCT00356421|38216676|FG001|Overall Study|Lack of Efficacy|0|||
17074609|NCT00356421|38216675|FG000|Overall Study|Withdrawal by Subject|9|||
17074610|NCT00356421|38216676|FG001|Overall Study|Withdrawal by Subject|2|||
17074611|NCT00356421|38216675|FG000|Overall Study|Related to study drug|15|||
17074612|NCT00356421|38216676|FG001|Overall Study|Related to study drug|12|||
17074613|NCT00356421|38216675|FG000|Overall Study|Not related to study drug|5|||
17074614|NCT00356421|38216676|FG001|Overall Study|Not related to study drug|3|||
17074615|NCT00443820|38216686|FG000|Overall Study|Adverse Event|1|||
17074616|NCT00443820|38216687|FG001|Overall Study|Adverse Event|1|||
17074617|NCT00443820|38216688|FG002|Overall Study|Adverse Event|0|||
17074618|NCT00443820|38216689|FG003|Overall Study|Adverse Event|0|||
17074619|NCT00443820|38216686|FG000|Overall Study|Lack of Efficacy|3|||
17074620|NCT00443820|38216687|FG001|Overall Study|Lack of Efficacy|2|||
17074621|NCT00443820|38216688|FG002|Overall Study|Lack of Efficacy|1|||
17074622|NCT00443820|38216689|FG003|Overall Study|Lack of Efficacy|1|||
17074623|NCT00443820|38216686|FG000|Overall Study|Protocol Violation|2|||
17074624|NCT00443820|38216687|FG001|Overall Study|Protocol Violation|1|||
17074625|NCT00443820|38216688|FG002|Overall Study|Protocol Violation|2|||
17074626|NCT00443820|38216689|FG003|Overall Study|Protocol Violation|1|||
17074627|NCT00443820|38216686|FG000|Overall Study|Withdrawal by Subject|6|||
17074628|NCT00443820|38216687|FG001|Overall Study|Withdrawal by Subject|7|||
17074629|NCT00443820|38216688|FG002|Overall Study|Withdrawal by Subject|8|||
17074630|NCT00443820|38216689|FG003|Overall Study|Withdrawal by Subject|9|||
17074631|NCT00443820|38216686|FG000|Overall Study|Lost to Follow-up|9|||
17074632|NCT00443820|38216687|FG001|Overall Study|Lost to Follow-up|8|||
17074633|NCT00443820|38216688|FG002|Overall Study|Lost to Follow-up|6|||
17074634|NCT00443820|38216689|FG003|Overall Study|Lost to Follow-up|5|||
17074635|NCT00443820|38216686|FG000|Overall Study|Administrative problems|0|||
17074636|NCT00443820|38216687|FG001|Overall Study|Administrative problems|0|||
17074637|NCT00443820|38216688|FG002|Overall Study|Administrative problems|0|||
17074638|NCT00443820|38216689|FG003|Overall Study|Administrative problems|1|||
17074639|NCT00443820|38216686|FG000|Overall Study|Death|0|||
17074640|NCT00443820|38216687|FG001|Overall Study|Death|0|||
17074641|NCT00443820|38216688|FG002|Overall Study|Death|1|||
17074642|NCT00443820|38216689|FG003|Overall Study|Death|0|||
17074643|NCT00438672|38216701|FG000|Overall Study|Lost to Follow-up|7|||
17074644|NCT00438672|38216702|FG001|Overall Study|Lost to Follow-up|9|||
17074645|NCT00438360|38216710|FG000|Overall Study|Adverse Event|6|||
17074646|NCT00438360|38216711|FG001|Overall Study|Adverse Event|1|||
16995011|NCT00770224|38138697|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
16995012|NCT00770224|38138698|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
16995013|NCT00770224|38138697|FG000|Step 1: Induction|Other reason not protocol specified|2|||
16995014|NCT00770224|38138698|FG001|Step 1: Induction|Other reason not protocol specified|0|||
16995015|NCT00770224|38138697|FG000|Step 1: Induction|Ineligible|2|||
16995016|NCT00770224|38138698|FG001|Step 1: Induction|Ineligible|0|||
16995017|NCT00770224|38138697|FG000|Step 1: Induction|No protocol treatment given|1|||
16995018|NCT00770224|38138698|FG001|Step 1: Induction|No protocol treatment given|0|||
16995019|NCT00770224|38138697|FG000|Step 2: Maintenance|Adverse Event|0|||
17074647|NCT00438360|38216710|FG000|Overall Study|Lack of Efficacy|42|||
17074648|NCT00438360|38216711|FG001|Overall Study|Lack of Efficacy|27|||
17074649|NCT00438360|38216710|FG000|Overall Study|Other|24|||
17074650|NCT00438360|38216711|FG001|Overall Study|Other|15|||
17074651|NCT00536471|38216721|FG000|Overall Study|Lost to Follow-up|48|||
17074652|NCT00536471|38216722|FG001|Overall Study|Lost to Follow-up|23|||
17074653|NCT00536471|38216723|FG002|Overall Study|Lost to Follow-up|48|||
17074654|NCT00536471|38216724|FG003|Overall Study|Lost to Follow-up|22|||
17074655|NCT00536471|38216721|FG000|Overall Study|Adverse Event|32|||
17074656|NCT00536471|38216722|FG001|Overall Study|Adverse Event|16|||
17074657|NCT00536471|38216723|FG002|Overall Study|Adverse Event|28|||
17074658|NCT00536471|38216724|FG003|Overall Study|Adverse Event|13|||
17074659|NCT00536471|38216721|FG000|Overall Study|Withdrawal by Subject|40|||
17074660|NCT00536471|38216722|FG001|Overall Study|Withdrawal by Subject|24|||
17074661|NCT00536471|38216723|FG002|Overall Study|Withdrawal by Subject|43|||
17074662|NCT00536471|38216724|FG003|Overall Study|Withdrawal by Subject|21|||
17074663|NCT00536471|38216721|FG000|Overall Study|Lack of Efficacy|17|||
17074664|NCT00536471|38216722|FG001|Overall Study|Lack of Efficacy|18|||
17074665|NCT00536471|38216723|FG002|Overall Study|Lack of Efficacy|11|||
17074666|NCT00536471|38216724|FG003|Overall Study|Lack of Efficacy|9|||
17074667|NCT00536471|38216721|FG000|Overall Study|Protocol Violation|8|||
17074668|NCT00536471|38216722|FG001|Overall Study|Protocol Violation|1|||
17074669|NCT00536471|38216723|FG002|Overall Study|Protocol Violation|2|||
17074670|NCT00536471|38216724|FG003|Overall Study|Protocol Violation|3|||
17074671|NCT00536471|38216721|FG000|Overall Study|Physician Decision|11|||
17074672|NCT00536471|38216722|FG001|Overall Study|Physician Decision|1|||
17074673|NCT00536471|38216723|FG002|Overall Study|Physician Decision|3|||
17074674|NCT00536471|38216724|FG003|Overall Study|Physician Decision|2|||
17074675|NCT00536471|38216721|FG000|Overall Study|Death|0|||
17074676|NCT00536471|38216722|FG001|Overall Study|Death|0|||
17074677|NCT00536471|38216723|FG002|Overall Study|Death|1|||
17074678|NCT00536471|38216724|FG003|Overall Study|Death|2|||
17074679|NCT00536471|38216721|FG000|Overall Study|Sponsor Decision|0|||
17074680|NCT00536471|38216722|FG001|Overall Study|Sponsor Decision|1|||
17074681|NCT00536471|38216723|FG002|Overall Study|Sponsor Decision|3|||
17074682|NCT00536471|38216724|FG003|Overall Study|Sponsor Decision|2|||
17074683|NCT00359619|38216748|FG000|Overall Study|Adverse Event|0|||
17074684|NCT00359619|38216749|FG001|Overall Study|Adverse Event|0|||
17074685|NCT00359619|38216750|FG002|Overall Study|Adverse Event|1|||
17074686|NCT00359619|38216751|FG003|Overall Study|Adverse Event|0|||
17074687|NCT00359619|38216752|FG004|Overall Study|Adverse Event|0|||
17074688|NCT00359619|38216753|FG005|Overall Study|Adverse Event|0|||
17074689|NCT00359619|38216754|FG006|Overall Study|Adverse Event|1|||
17074690|NCT00359619|38216748|FG000|Overall Study|Withdrawal by Subject|3|||
17074691|NCT00359619|38216749|FG001|Overall Study|Withdrawal by Subject|1|||
17074692|NCT00359619|38216750|FG002|Overall Study|Withdrawal by Subject|4|||
17074693|NCT00359619|38216751|FG003|Overall Study|Withdrawal by Subject|2|||
17074694|NCT00359619|38216752|FG004|Overall Study|Withdrawal by Subject|2|||
17074695|NCT00359619|38216753|FG005|Overall Study|Withdrawal by Subject|0|||
17074696|NCT00359619|38216754|FG006|Overall Study|Withdrawal by Subject|3|||
17074697|NCT00359619|38216748|FG000|Overall Study|Other|1|||
17074698|NCT00359619|38216749|FG001|Overall Study|Other|0|||
17157250|NCT02974010|38304364|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
17157251|NCT02974010|38304361|FG000|Overall Study|Lack of Efficacy|0|||
17157252|NCT02974010|38304362|FG001|Overall Study|Lack of Efficacy|0|||
17157253|NCT02974010|38304363|FG002|Overall Study|Lack of Efficacy|1|||
17157254|NCT02974010|38304364|FG003|Overall Study|Lack of Efficacy|0|||
17157255|NCT02030938|38304374|FG000|Overall Study|Lost to Follow-up|4|||
17074699|NCT00359619|38216750|FG002|Overall Study|Other|0|||
17157256|NCT02030938|38304374|FG000|Overall Study|Withdrawal by Subject|1|||
17157257|NCT03122535|38304382|FG000|Overall Study|Lost to Follow-up|68|||
17157258|NCT03122535|38304383|FG001|Overall Study|Lost to Follow-up|68|||
17157259|NCT03122535|38304382|FG000|Overall Study|Physician Decision|3|||
17157260|NCT03122535|38304383|FG001|Overall Study|Physician Decision|3|||
17157261|NCT03122535|38304382|FG000|Overall Study|Withdrawal by Subject|2|||
17074700|NCT00359619|38216751|FG003|Overall Study|Other|0|||
17074701|NCT00359619|38216752|FG004|Overall Study|Other|0|||
17074702|NCT00359619|38216753|FG005|Overall Study|Other|0|||
17074703|NCT00359619|38216754|FG006|Overall Study|Other|0|||
17074704|NCT00359619|38216748|FG000|Overall Study|Lost to Follow-up|4|||
17074705|NCT00359619|38216749|FG001|Overall Study|Lost to Follow-up|4|||
16781277|NCT02105974|37720454|FG001|2 Week Run-in Period|Study closed/terminated|0|||
16781278|NCT02105974|37720455|FG002|2 Week Run-in Period|Study closed/terminated|0|||
17074706|NCT00359619|38216750|FG002|Overall Study|Lost to Follow-up|2|||
17157262|NCT03122535|38304383|FG001|Overall Study|Withdrawal by Subject|2|||
17157263|NCT01061606|38304389|FG000|Overall Study|Adverse Event|1|||
16781279|NCT02105974|37720453|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
17074707|NCT00359619|38216751|FG003|Overall Study|Lost to Follow-up|1|||
17074708|NCT00359619|38216752|FG004|Overall Study|Lost to Follow-up|1|||
17074709|NCT00359619|38216753|FG005|Overall Study|Lost to Follow-up|5|||
17074710|NCT00359619|38216754|FG006|Overall Study|Lost to Follow-up|0|||
17074711|NCT00437658|38216773|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
17157264|NCT01061606|38304389|FG000|Overall Study|Death|1|||
17157265|NCT01061606|38304389|FG000|Overall Study|Disease Progression|4|||
17157266|NCT01061606|38304389|FG000|Overall Study|alternative therapy|2|||
17157267|NCT03122457|38304393|FG000|Overall Study|Withdrawal by Subject|6|||
17157268|NCT03482453|38304409|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157269|NCT03482453|38304410|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157270|NCT03482453|38304411|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157271|NCT03482453|38304412|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157272|NCT03482453|38304413|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157273|NCT03482453|38304414|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157274|NCT03482453|38304415|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157275|NCT03482453|38304416|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157276|NCT03482453|38304417|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157277|NCT03482453|38304418|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157278|NCT03482453|38304419|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
17157279|NCT03482453|38304420|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
17157280|NCT03480425|38304456|FG000|Overall Study|Force transducer technical failure|1|||
17157281|NCT03472547|38304460|FG000|Overall Study|Withdrawal by Subject|30|||
17157282|NCT00799396|38304464|FG000|Clopidogrel Treatment|Adverse Event|6|||
17157283|NCT00799396|38304464|FG000|Clopidogrel Treatment|Physician Decision|5|||
17157284|NCT00799396|38304464|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
17157285|NCT00799396|38304464|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
17157286|NCT00799396|38304464|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
17157287|NCT03469349|38304470|FG000|Overall Study|Withdrawal by Subject|1|||
17157288|NCT03469349|38304471|FG001|Overall Study|Withdrawal by Subject|3|||
17157289|NCT03469349|38304470|FG000|Overall Study|Progressive Disease|0|||
17157290|NCT03469349|38304471|FG001|Overall Study|Progressive Disease|1|||
17157291|NCT03469349|38304470|FG000|Overall Study|Lost to Follow-up|2|||
17157292|NCT03469349|38304471|FG001|Overall Study|Lost to Follow-up|2|||
17157293|NCT03469349|38304470|FG000|Overall Study|Adverse Event|2|||
17157294|NCT03469349|38304471|FG001|Overall Study|Adverse Event|4|||
17157295|NCT03467945|38304481|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17157296|NCT03467945|38304482|FG001|Treatment Period 2|Withdrawal by Subject|1|||
17157297|NCT03467945|38304483|FG002|Treatment Period 2|Withdrawal by Subject|0|||
17157298|NCT03467945|38304484|FG003|Treatment Period 2|Withdrawal by Subject|0|||
17157299|NCT03467945|38304481|FG000|Treatment Period 3|Withdrawal by Subject|1|||
17157300|NCT03467945|38304482|FG001|Treatment Period 3|Withdrawal by Subject|0|||
17157301|NCT03467945|38304483|FG002|Treatment Period 3|Withdrawal by Subject|2|||
17157302|NCT03467945|38304484|FG003|Treatment Period 3|Withdrawal by Subject|1|||
17157303|NCT00069238|38304495|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
17157304|NCT00069238|38304496|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
17157305|NCT00069238|38304497|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
17157306|NCT00069238|38304495|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
17157307|NCT00069238|38304496|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
17157308|NCT00069238|38304497|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
17157309|NCT00069238|38304495|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
17157310|NCT00069238|38304496|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
17074712|NCT00437658|38216774|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
17074713|NCT00437658|38216775|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
17074714|NCT00437658|38216773|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
17074715|NCT00437658|38216774|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
17074716|NCT00437658|38216775|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
17074717|NCT00437658|38216773|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
17074718|NCT00437658|38216774|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
17074719|NCT00437658|38216775|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
17074720|NCT00437658|38216773|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
17074721|NCT00437658|38216774|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
17074722|NCT00437658|38216775|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
17074723|NCT00437658|38216773|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
17074724|NCT00437658|38216774|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
17074725|NCT00437658|38216775|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
17074726|NCT00437658|38216773|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
17074727|NCT00437658|38216774|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
17074728|NCT00437658|38216775|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
17074729|NCT00437658|38216773|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
17074730|NCT00437658|38216774|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
17074731|NCT00437658|38216775|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
17074732|NCT00437658|38216773|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
17074733|NCT00437658|38216774|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
17074734|NCT00437658|38216775|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
17157311|NCT00069238|38304497|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
17157312|NCT03435497|38304504|FG000|Overall Study|Lost to Follow-up|1|||
17157313|NCT03435497|38304505|FG001|Overall Study|Lost to Follow-up|0|||
17157314|NCT03435497|38304504|FG000|Overall Study|Death|1|||
17074735|NCT00437658|38216773|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
17074736|NCT00437658|38216774|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
17074737|NCT00437658|38216775|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
17074738|NCT00437658|38216773|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
17074739|NCT00437658|38216774|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
17074740|NCT00437658|38216775|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
17074741|NCT00437658|38216773|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
17074742|NCT00437658|38216774|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
17074743|NCT00437658|38216775|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
17074744|NCT00437658|38216773|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
17074745|NCT00437658|38216774|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
17074746|NCT00437658|38216775|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
17074747|NCT03828747|38216785|FG000|Double-Blind Treatment Period|Adverse Event|6|||
17074748|NCT03828747|38216786|FG001|Double-Blind Treatment Period|Adverse Event|6|||
17074749|NCT03828747|38216785|FG000|Double-Blind Treatment Period|Death|1|||
17074750|NCT03828747|38216786|FG001|Double-Blind Treatment Period|Death|2|||
17074751|NCT03828747|38216785|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
17074752|NCT03828747|38216786|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
17074753|NCT03828747|38216785|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
17074754|NCT03828747|38216786|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
17074755|NCT03828747|38216785|FG000|Double-Blind Treatment Period|Physician Decision|0|||
17074756|NCT03828747|38216786|FG001|Double-Blind Treatment Period|Physician Decision|3|||
17074757|NCT03828747|38216785|FG000|Double-Blind Treatment Period|Various reasons|5|||
17074758|NCT03828747|38216786|FG001|Double-Blind Treatment Period|Various reasons|3|||
17074759|NCT03828747|38216785|FG000|Open-Label Extension|Continuing on Study|77|||
17074760|NCT03828747|38216786|FG001|Open-Label Extension|Continuing on Study|72|||
17074761|NCT03828747|38216785|FG000|Open-Label Extension|Adverse Event|3|||
17074762|NCT03828747|38216786|FG001|Open-Label Extension|Adverse Event|4|||
17074763|NCT03828747|38216785|FG000|Open-Label Extension|Death|0|||
17074764|NCT03828747|38216786|FG001|Open-Label Extension|Death|2|||
17074765|NCT03828747|38216785|FG000|Open-Label Extension|Lost to Follow-up|4|||
17074766|NCT03828747|38216786|FG001|Open-Label Extension|Lost to Follow-up|0|||
17074767|NCT03828747|38216785|FG000|Open-Label Extension|Withdrawal by Subject|19|||
17157315|NCT03435497|38304505|FG001|Overall Study|Death|0|||
17157316|NCT03435497|38304504|FG000|Overall Study|Withdrawal by Subject|0|||
17074768|NCT03828747|38216786|FG001|Open-Label Extension|Withdrawal by Subject|16|||
17074769|NCT03828747|38216785|FG000|Open-Label Extension|Various reasons|1|||
17074770|NCT03828747|38216786|FG001|Open-Label Extension|Various reasons|1|||
17074771|NCT00356265|38216796|FG000|Overall Study|Withdrawal by Subject|0|||
17074772|NCT00356265|38216797|FG001|Overall Study|Withdrawal by Subject|0|||
17074773|NCT00356265|38216798|FG002|Overall Study|Withdrawal by Subject|1|||
17074774|NCT00535145|38216807|FG000|Phase I|Adverse Event|3|||
17074775|NCT00535145|38216807|FG000|Phase I|Lost to Follow-up|7|||
17074776|NCT00535145|38216807|FG000|Phase I|Withdrawal by Subject|6|||
17074777|NCT00535145|38216807|FG000|Phase I|(eligibility)|8|||
17074778|NCT00535145|38216807|FG000|Phase I|(protocol violation)|1|||
17074779|NCT00535145|38216807|FG000|Phase I|(PI decision)|1|||
17074780|NCT00535145|38216807|FG000|Phase I|(diagnosis)|3|||
17074781|NCT00535145|38216807|FG000|Phase II|Adverse Event|2|||
17074782|NCT00535145|38216807|FG000|Phase II|Lack of Efficacy|1|||
17074783|NCT00535145|38216807|FG000|Phase II|Lost to Follow-up|5|||
17074784|NCT00535145|38216807|FG000|Phase II|Withdrawal by Subject|5|||
17074785|NCT00535145|38216807|FG000|Phase II|Subject non-compliance|2|||
17074786|NCT00437268|38216817|FG000|Overall Study|Adverse Event|1|||
17074787|NCT00437268|38216818|FG001|Overall Study|Adverse Event|1|||
17074788|NCT00437268|38216817|FG000|Overall Study|Withdrawal by Subject|2|||
17074789|NCT00437268|38216818|FG001|Overall Study|Withdrawal by Subject|2|||
17074790|NCT00437268|38216817|FG000|Overall Study|Progressive disease|9|||
17074791|NCT00437268|38216818|FG001|Overall Study|Progressive disease|9|||
17074792|NCT00437268|38216817|FG000|Overall Study|Physician Decision|1|||
17074793|NCT00437268|38216818|FG001|Overall Study|Physician Decision|0|||
17074794|NCT00437268|38216817|FG000|Overall Study|Death|0|||
17074795|NCT00437268|38216818|FG001|Overall Study|Death|1|||
17074796|NCT00437034|38216826|FG000|Overall Study|Adverse Event|1|||
17074797|NCT00437034|38216826|FG000|Overall Study|Disease progression during treatment|5|||
17074798|NCT00337467|38216830|FG000|Overall Study|Adverse Event|3|||
17074799|NCT00337467|38216830|FG000|Overall Study|Subject Withdrew Consent|2|||
17074800|NCT00337467|38216830|FG000|Overall Study|Pregnancy|1|||
17074801|NCT00337467|38216830|FG000|Overall Study|Lost to Follow-up|2|||
17074802|NCT00337467|38216830|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
17074803|NCT00337077|38216840|FG000|Overall Study|Progressive disease|25|||
17074804|NCT00337077|38216841|FG001|Overall Study|Progressive disease|37|||
17074805|NCT00337077|38216842|FG002|Overall Study|Progressive disease|19|||
17074806|NCT00337077|38216840|FG000|Overall Study|Adverse Event|7|||
17074807|NCT00337077|38216841|FG001|Overall Study|Adverse Event|7|||
17074808|NCT00337077|38216842|FG002|Overall Study|Adverse Event|1|||
17074809|NCT00337077|38216840|FG000|Overall Study|Death|0|||
17074810|NCT00337077|38216841|FG001|Overall Study|Death|1|||
17074811|NCT00337077|38216842|FG002|Overall Study|Death|0|||
17074812|NCT00337077|38216840|FG000|Overall Study|Withdrawal by Subject|7|||
17074813|NCT00337077|38216841|FG001|Overall Study|Withdrawal by Subject|2|||
17074814|NCT00337077|38216842|FG002|Overall Study|Withdrawal by Subject|2|||
17074815|NCT00337077|38216840|FG000|Overall Study|Alternative therapy|1|||
17074816|NCT00337077|38216841|FG001|Overall Study|Alternative therapy|0|||
17074817|NCT00337077|38216842|FG002|Overall Study|Alternative therapy|0|||
17074818|NCT00337077|38216840|FG000|Overall Study|Physician Decision|1|||
17074819|NCT00337077|38216841|FG001|Overall Study|Physician Decision|4|||
17074820|NCT00337077|38216842|FG002|Overall Study|Physician Decision|2|||
17074821|NCT00337077|38216840|FG000|Overall Study|Never started treatment|1|||
17074822|NCT00337077|38216841|FG001|Overall Study|Never started treatment|1|||
17074823|NCT00337077|38216842|FG002|Overall Study|Never started treatment|0|||
17157317|NCT03435497|38304505|FG001|Overall Study|Withdrawal by Subject|4|||
17157318|NCT03435497|38304504|FG000|Overall Study|Wrong survey administered|0|||
17157319|NCT03435497|38304505|FG001|Overall Study|Wrong survey administered|2|||
17074824|NCT00337077|38216840|FG000|Overall Study|Ineligible|1|||
17074825|NCT00337077|38216841|FG001|Overall Study|Ineligible|1|||
17074826|NCT00337077|38216842|FG002|Overall Study|Ineligible|1|||
17074827|NCT00428220|38216848|FG000|Overall Study|Participant died|8|||
17074828|NCT00428220|38216848|FG000|Overall Study|Global deterioration of health status|7|||
17074829|NCT00428220|38216848|FG000|Overall Study|Lost to Follow-up|4|||
17074830|NCT00428220|38216848|FG000|Overall Study|Objective progression or relapse|123|||
17074831|NCT00428220|38216848|FG000|Overall Study|Participant refused continued treatment|7|||
17074832|NCT00428220|38216848|FG000|Overall Study|Adverse Event|51|||
17074833|NCT00428220|38216848|FG000|Overall Study|Other|23|||
17074834|NCT00345579|38216878|FG000|Overall Study|Adverse Event|9|||
17074835|NCT00345579|38216879|FG001|Overall Study|Adverse Event|6|||
17074836|NCT00345579|38216878|FG000|Overall Study|Protocol Violation|14|||
17074837|NCT00345579|38216879|FG001|Overall Study|Protocol Violation|5|||
17074838|NCT00345579|38216878|FG000|Overall Study|Withdrawal by Subject|50|||
17074839|NCT00345579|38216879|FG001|Overall Study|Withdrawal by Subject|17|||
17074840|NCT00345579|38216878|FG000|Overall Study|Lost to Follow-up|82|||
17074841|NCT00345579|38216879|FG001|Overall Study|Lost to Follow-up|36|||
17074842|NCT00345579|38216878|FG000|Overall Study|Other|9|||
17074843|NCT00345579|38216879|FG001|Overall Study|Other|1|||
17074844|NCT00335829|38216886|FG000|Overall Study|Withdrawal by Subject|1|||
17074845|NCT00335829|38216886|FG000|Overall Study|Lost to Follow-up|1|||
17074846|NCT00335829|38216886|FG000|Overall Study|Adverse Event|1|||
17074847|NCT00344019|38216893|FG000|Overall Study|did not meet final inclusion criteria|0|||
17074848|NCT00344019|38216894|FG001|Overall Study|did not meet final inclusion criteria|0|||
17074849|NCT00344019|38216895|FG002|Overall Study|did not meet final inclusion criteria|74|||
17074850|NCT00535847|38216909|FG000|Overall Study|Adverse Event|5|||
17074851|NCT00535847|38216910|FG001|Overall Study|Adverse Event|3|||
17074852|NCT00535847|38216911|FG002|Overall Study|Adverse Event|2|||
17074853|NCT00535847|38216909|FG000|Overall Study|Non compliance|1|||
17074854|NCT00535847|38216910|FG001|Overall Study|Non compliance|1|||
17074855|NCT00535847|38216911|FG002|Overall Study|Non compliance|0|||
17074856|NCT00535847|38216909|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
17074857|NCT00535847|38216910|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
17074858|NCT00535847|38216911|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
17074859|NCT00334893|38216925|FG000|Overall Study|Not Treated|1|||
17074860|NCT00334893|38216926|FG001|Overall Study|Not Treated|0|||
17074861|NCT00334737|38216937|FG000|Hospital Phase|Death|1|||
17074862|NCT00334737|38216938|FG001|Hospital Phase|Death|2|||
17074863|NCT00334737|38216939|FG002|Hospital Phase|Death|3|||
17074864|NCT00334737|38216937|FG000|Hospital Phase|Withdrawal by Subject|0|||
17074865|NCT00334737|38216938|FG001|Hospital Phase|Withdrawal by Subject|0|||
17074866|NCT00334737|38216939|FG002|Hospital Phase|Withdrawal by Subject|1|||
17074867|NCT00334737|38216937|FG000|Hospital Phase|Did not receive study drug|1|||
17074868|NCT00334737|38216938|FG001|Hospital Phase|Did not receive study drug|0|||
17074869|NCT00334737|38216939|FG002|Hospital Phase|Did not receive study drug|0|||
17074870|NCT00334737|38216937|FG000|Follow up Phase|Lost to Follow-up|5|||
17074871|NCT00334737|38216938|FG001|Follow up Phase|Lost to Follow-up|3|||
17074872|NCT00334737|38216939|FG002|Follow up Phase|Lost to Follow-up|6|||
17074873|NCT00427908|38216951|FG000|Primary Phase|Lost to Follow-up|4|||
17074874|NCT00427908|38216952|FG001|Primary Phase|Lost to Follow-up|0|||
17074875|NCT00427908|38216953|FG002|Primary Phase|Lost to Follow-up|2|||
17074876|NCT00427908|38216954|FG003|Primary Phase|Lost to Follow-up|0|||
17074877|NCT00427908|38216951|FG000|Primary Phase|Withdrawal by Subject|1|||
17074878|NCT00427908|38216952|FG001|Primary Phase|Withdrawal by Subject|2|||
17074879|NCT00427908|38216953|FG002|Primary Phase|Withdrawal by Subject|1|||
17074880|NCT00427908|38216954|FG003|Primary Phase|Withdrawal by Subject|0|||
17074881|NCT00427908|38216951|FG000|Primary Phase|Adverse Event|0|||
17074882|NCT00427908|38216952|FG001|Primary Phase|Adverse Event|1|||
17074883|NCT00427908|38216953|FG002|Primary Phase|Adverse Event|0|||
17074884|NCT00427908|38216954|FG003|Primary Phase|Adverse Event|0|||
17074885|NCT00334113|38216991|FG000|Overall Study|Lost to Follow-up|2|||
17074886|NCT00334113|38216992|FG001|Overall Study|Lost to Follow-up|2|||
17074887|NCT00334113|38216991|FG000|Overall Study|Withdrawal by Subject|0|||
16995020|NCT00770224|38138698|FG001|Step 2: Maintenance|Adverse Event|10|||
16995021|NCT00770224|38138697|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
16995022|NCT00770224|38138698|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
16995023|NCT00770224|38138697|FG000|Step 2: Maintenance|Progression/relapse|0|||
16995024|NCT00770224|38138698|FG001|Step 2: Maintenance|Progression/relapse|1|||
16995025|NCT00770224|38138697|FG000|Step 2: Maintenance|Death|0|||
16995026|NCT00770224|38138698|FG001|Step 2: Maintenance|Death|2|||
17157320|NCT03073200|38304514|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16995027|NCT00770224|38138697|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
16995028|NCT00770224|38138698|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
16995029|NCT00770224|38138697|FG000|Step 2: Maintenance|Ineligible|0|||
16995030|NCT00770224|38138698|FG001|Step 2: Maintenance|Ineligible|2|||
16995031|NCT02399215|38138705|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
16995032|NCT02399215|38138705|FG000|Overall Study|Withdrawal by Subject|1|||
16995033|NCT01057589|38138709|FG000|Overall Study|Disease Progression|35|||
16995034|NCT01057589|38138709|FG000|Overall Study|Adverse Event|10|||
16995035|NCT01057589|38138709|FG000|Overall Study|Physician Decision|8|||
16995036|NCT01057589|38138709|FG000|Overall Study|Withdrawal by Subject|3|||
16995037|NCT01057589|38138709|FG000|Overall Study|Sponsor Decision|1|||
16995038|NCT01057589|38138709|FG000|Overall Study|Death|8|||
16995039|NCT01057589|38138709|FG000|Overall Study|Lost to Follow-up|1|||
16995040|NCT01716117|38138715|FG000|Overall Study|Death|5|||
16995041|NCT01716117|38138716|FG001|Overall Study|Death|2|||
16995042|NCT01716117|38138715|FG000|Overall Study|Withdrawal by Subject|2|||
16995043|NCT01716117|38138716|FG001|Overall Study|Withdrawal by Subject|0|||
17157321|NCT03073200|38304515|FG001|Double Blind Treatment Period|Protocol Violation|0|||
17157322|NCT03073200|38304516|FG002|Double Blind Treatment Period|Protocol Violation|0|||
17157323|NCT03073200|38304517|FG003|Double Blind Treatment Period|Protocol Violation|0|||
17157324|NCT03073200|38304518|FG004|Double Blind Treatment Period|Protocol Violation|0|||
17157325|NCT03073200|38304519|FG005|Double Blind Treatment Period|Protocol Violation|0|||
17157326|NCT03073200|38304520|FG006|Double Blind Treatment Period|Protocol Violation|0|||
17157327|NCT03073200|38304521|FG007|Double Blind Treatment Period|Protocol Violation|0|||
17157328|NCT03073200|38304522|FG008|Double Blind Treatment Period|Protocol Violation|0|||
17157329|NCT03073200|38304523|FG009|Double Blind Treatment Period|Protocol Violation|0|||
17157330|NCT03073200|38304524|FG010|Double Blind Treatment Period|Protocol Violation|0|||
17157331|NCT03073200|38304525|FG011|Double Blind Treatment Period|Protocol Violation|0|||
17157332|NCT03073200|38304526|FG012|Double Blind Treatment Period|Protocol Violation|0|||
17157333|NCT03073200|38304527|FG013|Double Blind Treatment Period|Protocol Violation|0|||
17157334|NCT03073200|38304528|FG014|Double Blind Treatment Period|Protocol Violation|0|||
17157335|NCT03073200|38304514|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157336|NCT03073200|38304515|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
17157337|NCT03073200|38304516|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157338|NCT03073200|38304517|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157339|NCT03073200|38304518|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16995044|NCT00579553|38138732|FG000|Overall Study|Lost to Follow-up|16|||
16995045|NCT00579553|38138733|FG001|Overall Study|Lost to Follow-up|13|||
16995046|NCT01650831|38138739|FG000|Overall Study|Screen failure|1|||
16995047|NCT00581893|38138747|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
16995048|NCT00581893|38138748|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
16995049|NCT00770146|38138756|FG000|Treatment Period|Withdrawal by Subject|6|||
16995050|NCT00770146|38138757|FG001|Treatment Period|Withdrawal by Subject|13|||
16995051|NCT00770146|38138756|FG000|Treatment Period|Adverse Event|2|||
16995052|NCT00770146|38138757|FG001|Treatment Period|Adverse Event|26|||
16995053|NCT00770146|38138756|FG000|Treatment Period|Other|1|||
16995054|NCT00770146|38138757|FG001|Treatment Period|Other|5|||
16995055|NCT00770146|38138756|FG000|Treatment Period|Protocol non-compliance|0|||
16995056|NCT00770146|38138757|FG001|Treatment Period|Protocol non-compliance|1|||
16995057|NCT00770146|38138756|FG000|Follow-up Period|Withdrawal by Subject|7|||
16995058|NCT00770146|38138757|FG001|Follow-up Period|Withdrawal by Subject|13|||
16995059|NCT00770146|38138756|FG000|Follow-up Period|Adverse Event|0|||
16995060|NCT00770146|38138757|FG001|Follow-up Period|Adverse Event|2|||
16995061|NCT00770146|38138756|FG000|Follow-up Period|Other|4|||
16995062|NCT00770146|38138757|FG001|Follow-up Period|Other|5|||
16995063|NCT01056341|38138768|FG000|Overall Study|Treatment Intolerance|0|||
16995064|NCT01056341|38138769|FG001|Overall Study|Treatment Intolerance|2|||
16995065|NCT01056341|38138770|FG002|Overall Study|Treatment Intolerance|0|||
17074888|NCT00334113|38216992|FG001|Overall Study|Withdrawal by Subject|1|||
17074889|NCT00416598|38216998|FG000|Induction & Intensification|Adverse Event|38|||
17074890|NCT00416598|38216998|FG000|Induction & Intensification|Death|32|||
17157340|NCT03073200|38304519|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157341|NCT03073200|38304520|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157342|NCT03073200|38304521|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157343|NCT03073200|38304522|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16995066|NCT01056341|38138771|FG003|Overall Study|Treatment Intolerance|2|||
16995067|NCT01056341|38138772|FG004|Overall Study|Treatment Intolerance|0|||
16995068|NCT01056341|38138768|FG000|Overall Study|Lack of Efficacy|32|||
16995069|NCT01056341|38138769|FG001|Overall Study|Lack of Efficacy|30|||
16995070|NCT01056341|38138770|FG002|Overall Study|Lack of Efficacy|7|||
16995071|NCT01056341|38138771|FG003|Overall Study|Lack of Efficacy|25|||
16995072|NCT01056341|38138772|FG004|Overall Study|Lack of Efficacy|9|||
16995073|NCT01056341|38138768|FG000|Overall Study|Other reasons|4|||
16995074|NCT01056341|38138769|FG001|Overall Study|Other reasons|4|||
16995075|NCT01056341|38138770|FG002|Overall Study|Other reasons|8|||
16995076|NCT01056341|38138771|FG003|Overall Study|Other reasons|9|||
16995077|NCT01056341|38138772|FG004|Overall Study|Other reasons|5|||
16995078|NCT00999518|38138795|FG000|Overall Study|Adverse Event|1|||
16995079|NCT00999518|38138796|FG001|Overall Study|Adverse Event|6|||
16995080|NCT00999518|38138797|FG002|Overall Study|Adverse Event|3|||
16995081|NCT00999518|38138798|FG003|Overall Study|Adverse Event|1|||
16995082|NCT00999518|38138799|FG004|Overall Study|Adverse Event|2|||
16995083|NCT00999518|38138795|FG000|Overall Study|Lack of Efficacy|2|||
16995084|NCT00999518|38138796|FG001|Overall Study|Lack of Efficacy|0|||
17157344|NCT03073200|38304523|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157345|NCT03073200|38304524|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157346|NCT03073200|38304525|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157347|NCT03073200|38304526|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157348|NCT03073200|38304527|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157349|NCT03073200|38304528|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
17157350|NCT03073200|38304514|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
16995085|NCT00999518|38138797|FG002|Overall Study|Lack of Efficacy|0|||
16995086|NCT00999518|38138798|FG003|Overall Study|Lack of Efficacy|2|||
16995087|NCT00999518|38138799|FG004|Overall Study|Lack of Efficacy|2|||
17074891|NCT00416598|38216998|FG000|Induction & Intensification|Withdrawal by Subject|46|||
17074892|NCT00416598|38216998|FG000|Induction & Intensification|Alternative Treatment|135|||
17074893|NCT00416598|38216998|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
17074894|NCT00416598|38216998|FG000|Induction & Intensification|Relapse/progression|29|||
17074895|NCT00416598|38216998|FG000|Induction & Intensification|Failed induction|87|||
17074896|NCT00416598|38216998|FG000|Decitabine Maintenance|Adverse Event|5|||
17157351|NCT03073200|38304515|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157352|NCT03073200|38304516|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157353|NCT03073200|38304517|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157354|NCT03073200|38304518|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157355|NCT03073200|38304519|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157356|NCT03073200|38304520|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157357|NCT03073200|38304521|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157358|NCT03073200|38304522|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157359|NCT03073200|38304523|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157360|NCT03073200|38304524|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157361|NCT03073200|38304525|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
17074897|NCT00416598|38216998|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
17074898|NCT00416598|38216998|FG000|Decitabine Maintenance|Progression/relapse|38|||
17074899|NCT00416598|38216998|FG000|Decitabine Maintenance|Alternative treatment|2|||
17074900|NCT00416598|38216998|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
17074901|NCT00534599|38217004|FG000|Overall Study|Adverse Event|25|||
17074902|NCT00534599|38217005|FG001|Overall Study|Adverse Event|4|||
17074903|NCT00534599|38217004|FG000|Overall Study|Incorrect enrollment|2|||
17074904|NCT00534599|38217005|FG001|Overall Study|Incorrect enrollment|1|||
17074905|NCT00534599|38217004|FG000|Overall Study|Mis-randomization|2|||
17074906|NCT00534599|38217005|FG001|Overall Study|Mis-randomization|2|||
17074907|NCT00534599|38217004|FG000|Overall Study|Developed study-specific d/c criteria|5|||
17074908|NCT00534599|38217005|FG001|Overall Study|Developed study-specific d/c criteria|0|||
17074909|NCT00534599|38217004|FG000|Overall Study|Lack of Efficacy|0|||
17074910|NCT00534599|38217005|FG001|Overall Study|Lack of Efficacy|1|||
17074911|NCT00534599|38217004|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
17074912|NCT00534599|38217005|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
17074913|NCT00534599|38217004|FG000|Overall Study|Protocol Violation|1|||
17074914|NCT00534599|38217005|FG001|Overall Study|Protocol Violation|3|||
17074915|NCT00534599|38217004|FG000|Overall Study|Lost to Follow-up|11|||
17074916|NCT00534599|38217005|FG001|Overall Study|Lost to Follow-up|14|||
17074917|NCT00534599|38217004|FG000|Overall Study|Withdrawal by Subject|4|||
17074918|NCT00534599|38217005|FG001|Overall Study|Withdrawal by Subject|6|||
17074919|NCT00534599|38217004|FG000|Overall Study|Other|7|||
17074920|NCT00534599|38217005|FG001|Overall Study|Other|0|||
17074921|NCT03892889|38217028|FG000|Overall Study|Adverse Event|17|||
17074922|NCT03892889|38217028|FG000|Overall Study|Lack of Efficacy|1|||
17074923|NCT03892889|38217028|FG000|Overall Study|Lost to Follow-up|46|||
17074924|NCT03892889|38217028|FG000|Overall Study|Non-compliance with study drug|22|||
17074925|NCT03892889|38217028|FG000|Overall Study|Pregnancy|1|||
17074926|NCT03892889|38217028|FG000|Overall Study|Protocol Deviation|3|||
17074927|NCT03892889|38217028|FG000|Overall Study|Withdrawal by Subject|50|||
17074928|NCT03892889|38217028|FG000|Overall Study|Withdrawal by Caregiver|1|||
17074929|NCT03892889|38217028|FG000|Overall Study|Study Terminated by Sponsor|50|||
17074930|NCT03892889|38217028|FG000|Overall Study|Physician Decision|8|||
17074931|NCT03892889|38217028|FG000|Overall Study|Reason not Specified|5|||
17074932|NCT00473330|38217035|FG000|Core Study|Adverse Event|4|||
17074933|NCT00473330|38217036|FG001|Core Study|Adverse Event|4|||
17074934|NCT00473330|38217037|FG002|Core Study|Adverse Event|1|||
17074935|NCT00473330|38217035|FG000|Core Study|Death|6|||
17074936|NCT00473330|38217036|FG001|Core Study|Death|4|||
17074937|NCT00473330|38217037|FG002|Core Study|Death|4|||
17074938|NCT00473330|38217035|FG000|Core Study|Lost to Follow-up|5|||
17074939|NCT00473330|38217036|FG001|Core Study|Lost to Follow-up|5|||
17074940|NCT00473330|38217037|FG002|Core Study|Lost to Follow-up|10|||
17074941|NCT00473330|38217035|FG000|Core Study|Physician Decision|2|||
17074942|NCT00473330|38217036|FG001|Core Study|Physician Decision|1|||
17074943|NCT00473330|38217037|FG002|Core Study|Physician Decision|3|||
17074944|NCT00473330|38217035|FG000|Core Study|Subject Non-compliance|1|||
17074945|NCT00473330|38217036|FG001|Core Study|Subject Non-compliance|2|||
17074946|NCT00473330|38217037|FG002|Core Study|Subject Non-compliance|1|||
17074947|NCT00473330|38217035|FG000|Core Study|Subject Required Other Therapy|0|||
17074948|NCT00473330|38217036|FG001|Core Study|Subject Required Other Therapy|1|||
17074949|NCT00473330|38217037|FG002|Core Study|Subject Required Other Therapy|3|||
17074950|NCT00473330|38217035|FG000|Core Study|Subject's Decision|9|||
17074951|NCT00473330|38217036|FG001|Core Study|Subject's Decision|8|||
17074952|NCT00473330|38217037|FG002|Core Study|Subject's Decision|19|||
17074953|NCT00473330|38217035|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
17074954|NCT00473330|38217036|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
17074955|NCT00473330|38217037|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
17074956|NCT00473330|38217035|FG000|Open-label Extension Through Month 48|Death|2|||
17074957|NCT00473330|38217036|FG001|Open-label Extension Through Month 48|Death|0|||
17074958|NCT00473330|38217037|FG002|Open-label Extension Through Month 48|Death|0|||
17074959|NCT00473330|38217035|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
17074960|NCT00473330|38217036|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
17074961|NCT00473330|38217037|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
17074962|NCT00473330|38217035|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
17074963|NCT00473330|38217036|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
17074964|NCT00473330|38217037|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
17074965|NCT00473330|38217035|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
17074966|NCT00473330|38217036|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
17074967|NCT00473330|38217037|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
17074968|NCT00473330|38217035|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
17074969|NCT00473330|38217036|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
17074970|NCT00473330|38217037|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
17074971|NCT00473330|38217035|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
17074972|NCT00473330|38217036|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
17074973|NCT00473330|38217037|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
17074974|NCT00473330|38217035|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
17074975|NCT00473330|38217036|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
17074976|NCT00473330|38217037|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
17074977|NCT00473330|38217035|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
17074978|NCT00473330|38217036|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
17074979|NCT00473330|38217037|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
17074980|NCT00473330|38217035|FG000|Open-label Extension Through Month 60|Death|2|||
17074981|NCT00473330|38217036|FG001|Open-label Extension Through Month 60|Death|2|||
17074982|NCT00473330|38217037|FG002|Open-label Extension Through Month 60|Death|1|||
17074983|NCT00473330|38217035|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
17074984|NCT00473330|38217036|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
17074985|NCT00473330|38217037|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
17074986|NCT00473330|38217035|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
17074987|NCT00473330|38217036|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
17074988|NCT00473330|38217037|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
17074989|NCT00473330|38217035|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
17074990|NCT00473330|38217036|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
17074991|NCT00473330|38217037|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
17074992|NCT00473330|38217035|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
17074993|NCT00473330|38217036|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
17074994|NCT00473330|38217037|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
17074995|NCT00473330|38217035|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
17074996|NCT00473330|38217036|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
17074997|NCT00473330|38217037|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
17074998|NCT00473330|38217035|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
17074999|NCT00473330|38217036|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
17075000|NCT00473330|38217037|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
17075001|NCT00416520|38217067|FG000|Open-label Period|Adverse Event|28|||
17075002|NCT00416520|38217068|FG001|Open-label Period|Adverse Event|10|||
17075003|NCT00416520|38217069|FG002|Open-label Period|Adverse Event|0|||
17075004|NCT00416520|38217070|FG003|Open-label Period|Adverse Event|0|||
17075005|NCT00416520|38217067|FG000|Open-label Period|Death|2|||
17075006|NCT00416520|38217068|FG001|Open-label Period|Death|1|||
17075007|NCT00416520|38217069|FG002|Open-label Period|Death|0|||
17075008|NCT00416520|38217070|FG003|Open-label Period|Death|0|||
17075009|NCT00416520|38217067|FG000|Open-label Period|Lack of Efficacy|8|||
17075010|NCT00416520|38217068|FG001|Open-label Period|Lack of Efficacy|1|||
17075011|NCT00416520|38217069|FG002|Open-label Period|Lack of Efficacy|0|||
17075012|NCT00416520|38217070|FG003|Open-label Period|Lack of Efficacy|0|||
17075013|NCT00416520|38217067|FG000|Open-label Period|Protocol Violation|3|||
17075014|NCT00416520|38217068|FG001|Open-label Period|Protocol Violation|3|||
17075015|NCT00416520|38217069|FG002|Open-label Period|Protocol Violation|0|||
17075016|NCT00416520|38217070|FG003|Open-label Period|Protocol Violation|0|||
17075017|NCT00416520|38217067|FG000|Open-label Period|Withdrawal by Subject|16|||
17075018|NCT00416520|38217068|FG001|Open-label Period|Withdrawal by Subject|5|||
17075019|NCT00416520|38217069|FG002|Open-label Period|Withdrawal by Subject|0|||
17075020|NCT00416520|38217070|FG003|Open-label Period|Withdrawal by Subject|0|||
17075021|NCT00416520|38217067|FG000|Open-label Period|Other Reasons|3|||
17075022|NCT00416520|38217068|FG001|Open-label Period|Other Reasons|12|||
17075023|NCT00416520|38217069|FG002|Open-label Period|Other Reasons|0|||
17075024|NCT00416520|38217070|FG003|Open-label Period|Other Reasons|0|||
17075025|NCT00416520|38217067|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
17075026|NCT00416520|38217068|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
17075027|NCT00416520|38217069|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
17075028|NCT00416520|38217070|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
17075029|NCT00416520|38217067|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
17075030|NCT00416520|38217068|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
17075031|NCT00416520|38217069|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
17075032|NCT00416520|38217070|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
17075033|NCT00416520|38217067|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
17075034|NCT00416520|38217068|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
17075035|NCT00416520|38217069|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
17075036|NCT00416520|38217070|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
17075037|NCT00533429|38217082|FG000|Overall Study|Adverse Event|3|||
17075038|NCT00533429|38217083|FG001|Overall Study|Adverse Event|1|||
17075039|NCT00533429|38217082|FG000|Overall Study|Death|1|||
17075040|NCT00533429|38217083|FG001|Overall Study|Death|0|||
17075041|NCT00533429|38217082|FG000|Overall Study|Withdrawal by Subject|2|||
17075042|NCT00533429|38217083|FG001|Overall Study|Withdrawal by Subject|0|||
17075043|NCT00533429|38217082|FG000|Overall Study|Progressive Disease|12|||
17075044|NCT00533429|38217083|FG001|Overall Study|Progressive Disease|13|||
17075045|NCT00533429|38217082|FG000|Overall Study|Symptomatic deterioration|1|||
17075046|NCT00533429|38217083|FG001|Overall Study|Symptomatic deterioration|2|||
17075047|NCT00533273|38217093|FG000|Double-blind|Withdrew consent|0|||
17075048|NCT00533273|38217094|FG001|Double-blind|Withdrew consent|2|||
17075049|NCT00533273|38217093|FG000|Open-label|Withdrawal by Subject|6|||
17075050|NCT00533273|38217094|FG001|Open-label|Withdrawal by Subject|0|||
17075051|NCT03891641|38217102|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
17075052|NCT03891641|38217103|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
17075053|NCT00339183|38217111|FG000|Overall Study|Adverse Event|5|||
17075054|NCT00339183|38217112|FG001|Overall Study|Adverse Event|3|||
17075055|NCT00339183|38217111|FG000|Overall Study|Withdrawal by Subject|16|||
17075056|NCT00339183|38217112|FG001|Overall Study|Withdrawal by Subject|19|||
17075057|NCT00339183|38217111|FG000|Overall Study|Physician Decision|2|||
17075058|NCT00339183|38217112|FG001|Overall Study|Physician Decision|4|||
17075059|NCT00339183|38217111|FG000|Overall Study|Lost to Follow-up|17|||
17075060|NCT00339183|38217112|FG001|Overall Study|Lost to Follow-up|17|||
17075061|NCT00339183|38217111|FG000|Overall Study|Protocol-specified criteria|12|||
17075062|NCT00339183|38217112|FG001|Overall Study|Protocol-specified criteria|8|||
17075063|NCT00339183|38217111|FG000|Overall Study|Missing reason|3|||
17075064|NCT00339183|38217112|FG001|Overall Study|Missing reason|1|||
17075065|NCT00339183|38217111|FG000|Overall Study|Other|46|||
17075066|NCT00339183|38217112|FG001|Overall Study|Other|40|||
17075067|NCT00339183|38217111|FG000|Overall Study|Ongoing|20|||
17075068|NCT00339183|38217112|FG001|Overall Study|Ongoing|13|||
17075069|NCT00333801|38217124|FG000|Overall Study|Moved to another state|5|||
17075070|NCT00333801|38217125|FG001|Overall Study|Moved to another state|3|||
17075071|NCT00333801|38217124|FG000|Overall Study|Lost to Follow-up|2|||
17075072|NCT00333801|38217125|FG001|Overall Study|Lost to Follow-up|0|||
17075073|NCT00333801|38217124|FG000|Overall Study|Incarcerated|1|||
17075074|NCT00333801|38217125|FG001|Overall Study|Incarcerated|2|||
17075075|NCT00333801|38217124|FG000|Overall Study|Withdrawal by Subject|0|||
17075076|NCT00333801|38217125|FG001|Overall Study|Withdrawal by Subject|1|||
17075077|NCT00532883|38217135|FG000|Overall Study|Adverse Event|1|||
17075078|NCT00532883|38217136|FG001|Overall Study|Adverse Event|0|||
17075079|NCT00532883|38217137|FG002|Overall Study|Adverse Event|0|||
17075080|NCT00532883|38217138|FG003|Overall Study|Adverse Event|1|||
17075081|NCT00532883|38217135|FG000|Overall Study|Lost to Follow-up|1|||
17075082|NCT00532883|38217136|FG001|Overall Study|Lost to Follow-up|1|||
17157362|NCT03073200|38304526|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157363|NCT03073200|38304527|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
17075083|NCT00532883|38217137|FG002|Overall Study|Lost to Follow-up|1|||
17075084|NCT00532883|38217138|FG003|Overall Study|Lost to Follow-up|0|||
17075085|NCT00532883|38217135|FG000|Overall Study|Withdrawal by Subject|0|||
17075086|NCT00532883|38217136|FG001|Overall Study|Withdrawal by Subject|1|||
17075087|NCT00532883|38217137|FG002|Overall Study|Withdrawal by Subject|1|||
17157364|NCT03073200|38304528|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
17157365|NCT03073200|38304514|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157366|NCT03073200|38304515|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157367|NCT03073200|38304516|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157368|NCT03073200|38304517|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
17157369|NCT03073200|38304518|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
17157370|NCT03073200|38304519|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157371|NCT03073200|38304520|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157372|NCT03073200|38304521|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157373|NCT03073200|38304522|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157374|NCT03073200|38304523|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157375|NCT03073200|38304524|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157376|NCT03073200|38304525|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157377|NCT03073200|38304526|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157378|NCT03073200|38304527|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157379|NCT03073200|38304528|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
17157380|NCT03073200|38304514|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
17157381|NCT03073200|38304515|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
17157382|NCT03073200|38304516|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
17157383|NCT03073200|38304517|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
17157384|NCT03073200|38304518|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
17157385|NCT03073200|38304519|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
17157386|NCT03073200|38304520|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
17157387|NCT03073200|38304521|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
17157388|NCT03073200|38304522|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
17157389|NCT03073200|38304523|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
17157390|NCT03073200|38304524|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
17157391|NCT03073200|38304525|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
17157392|NCT03073200|38304526|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
17157393|NCT03073200|38304527|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
17157394|NCT03073200|38304528|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
17157395|NCT03073200|38304514|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157396|NCT03073200|38304515|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157397|NCT03073200|38304516|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157398|NCT03073200|38304517|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157399|NCT03073200|38304518|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
17157400|NCT03073200|38304519|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157401|NCT03073200|38304520|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157402|NCT03073200|38304521|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157403|NCT03073200|38304522|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157404|NCT03073200|38304523|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157405|NCT03073200|38304524|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157406|NCT03073200|38304525|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
17075088|NCT00532883|38217138|FG003|Overall Study|Withdrawal by Subject|0|||
17157407|NCT03073200|38304526|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157408|NCT03073200|38304527|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157409|NCT03073200|38304528|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
17157410|NCT03073200|38304514|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157411|NCT03073200|38304515|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157412|NCT03073200|38304516|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157413|NCT03073200|38304517|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
17157414|NCT03073200|38304518|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
17157415|NCT03073200|38304519|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157416|NCT03073200|38304520|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157417|NCT03073200|38304521|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157418|NCT03073200|38304522|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157419|NCT03073200|38304523|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157420|NCT03073200|38304524|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157421|NCT03073200|38304525|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157422|NCT03073200|38304526|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157423|NCT03073200|38304527|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17075089|NCT00532883|38217135|FG000|Overall Study|Subject was Nonadherent|0|||
17075090|NCT00532883|38217136|FG001|Overall Study|Subject was Nonadherent|1|||
17075091|NCT00532883|38217137|FG002|Overall Study|Subject was Nonadherent|1|||
17075092|NCT00532883|38217138|FG003|Overall Study|Subject was Nonadherent|0|||
17075093|NCT00532883|38217135|FG000|Overall Study|Early Study Termination|4|||
17075094|NCT00532883|38217136|FG001|Overall Study|Early Study Termination|4|||
17075095|NCT00532883|38217137|FG002|Overall Study|Early Study Termination|1|||
17075096|NCT00532883|38217138|FG003|Overall Study|Early Study Termination|4|||
17075097|NCT00354159|38217150|FG000|Randomized Study Period|Withdrawal by Subject|5|||
17075098|NCT00354159|38217151|FG001|Randomized Study Period|Withdrawal by Subject|3|||
17075099|NCT00354159|38217150|FG000|Randomized Study Period|Physician Decision|6|||
17075100|NCT00354159|38217151|FG001|Randomized Study Period|Physician Decision|10|||
17075101|NCT00354159|38217150|FG000|Randomized Study Period|Lost to Follow-up|4|||
17075102|NCT00354159|38217151|FG001|Randomized Study Period|Lost to Follow-up|0|||
17075103|NCT00354159|38217150|FG000|Randomized Study Period|Death|7|||
17075104|NCT00354159|38217151|FG001|Randomized Study Period|Death|9|||
17075105|NCT00354159|38217150|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
17075106|NCT00354159|38217151|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
17075107|NCT00354159|38217150|FG000|Long-term Follow-up|Physician Decision|127|||
17075108|NCT00354159|38217151|FG001|Long-term Follow-up|Physician Decision|122|||
17075109|NCT00354159|38217150|FG000|Long-term Follow-up|Lost to Follow-up|1|||
17075110|NCT00354159|38217151|FG001|Long-term Follow-up|Lost to Follow-up|0|||
17075111|NCT00354159|38217150|FG000|Long-term Follow-up|Death|14|||
17075112|NCT00354159|38217151|FG001|Long-term Follow-up|Death|11|||
17075113|NCT00354159|38217150|FG000|Long-term Follow-up|Study Closed|29|||
17075114|NCT00354159|38217151|FG001|Long-term Follow-up|Study Closed|34|||
17075115|NCT00338949|38217166|FG000|Subject Screening|Screen failures|11|||
17075116|NCT00338949|38217167|FG001|Subject Screening|Screen failures|11|||
17075117|NCT00338949|38217166|FG000|Randomization|Withdrawal by Subject|1|||
17075118|NCT00338949|38217167|FG001|Randomization|Withdrawal by Subject|0|||
17075119|NCT00338949|38217166|FG000|Randomization|Adverse Event|0|||
17075120|NCT00338949|38217167|FG001|Randomization|Adverse Event|5|||
17075121|NCT00332709|38217175|FG000|Overall Study|Adverse Event|11|||
17075122|NCT00332709|38217176|FG001|Overall Study|Adverse Event|14|||
17075123|NCT00332709|38217175|FG000|Overall Study|Withdrawal by Subject|2|||
17075124|NCT00332709|38217176|FG001|Overall Study|Withdrawal by Subject|3|||
17075125|NCT00332709|38217175|FG000|Overall Study|Lost to Follow-up|2|||
17075126|NCT00332709|38217176|FG001|Overall Study|Lost to Follow-up|0|||
17075127|NCT00332709|38217175|FG000|Overall Study|Administrative Problems|0|||
17075128|NCT00332709|38217176|FG001|Overall Study|Administrative Problems|3|||
17075129|NCT00332709|38217175|FG000|Overall Study|Abnormal test procedure result|1|||
17075130|NCT00332709|38217176|FG001|Overall Study|Abnormal test procedure result|0|||
17075131|NCT00332241|38217184|FG000|Overall Study|Lack of Efficacy|6|||
17157424|NCT03073200|38304528|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
17157425|NCT03073200|38304514|FG000|Extension Period|Lost to Follow-up|0|||
17157426|NCT03073200|38304515|FG001|Extension Period|Lost to Follow-up|0|||
17157427|NCT03073200|38304516|FG002|Extension Period|Lost to Follow-up|0|||
17157428|NCT03073200|38304517|FG003|Extension Period|Lost to Follow-up|0|||
17157429|NCT03073200|38304518|FG004|Extension Period|Lost to Follow-up|0|||
17157430|NCT03073200|38304519|FG005|Extension Period|Lost to Follow-up|0|||
17157431|NCT03073200|38304520|FG006|Extension Period|Lost to Follow-up|1|||
17157432|NCT03073200|38304521|FG007|Extension Period|Lost to Follow-up|1|||
17157433|NCT03073200|38304522|FG008|Extension Period|Lost to Follow-up|0|||
17157434|NCT03073200|38304523|FG009|Extension Period|Lost to Follow-up|0|||
17157435|NCT03073200|38304524|FG010|Extension Period|Lost to Follow-up|0|||
17157436|NCT03073200|38304525|FG011|Extension Period|Lost to Follow-up|0|||
17075132|NCT00332241|38217185|FG001|Overall Study|Lack of Efficacy|1|||
17157437|NCT03073200|38304526|FG012|Extension Period|Lost to Follow-up|0|||
17157438|NCT03073200|38304527|FG013|Extension Period|Lost to Follow-up|0|||
17157439|NCT03073200|38304528|FG014|Extension Period|Lost to Follow-up|0|||
17075133|NCT00332241|38217184|FG000|Overall Study|Adverse Event|3|||
17075134|NCT00332241|38217185|FG001|Overall Study|Adverse Event|5|||
17075135|NCT00332241|38217184|FG000|Overall Study|Withdrawal by Subject|2|||
17075136|NCT00332241|38217185|FG001|Overall Study|Withdrawal by Subject|1|||
17075137|NCT00332241|38217184|FG000|Overall Study|Lost to Follow-up|4|||
17075138|NCT00332241|38217185|FG001|Overall Study|Lost to Follow-up|1|||
17075139|NCT00337935|38217193|FG000|Overall Study|Adverse Event|2|||
17075140|NCT00337935|38217194|FG001|Overall Study|Adverse Event|5|||
17075141|NCT00337935|38217193|FG000|Overall Study|Death|2|||
17075142|NCT00337935|38217194|FG001|Overall Study|Death|8|||
17075143|NCT00337935|38217193|FG000|Overall Study|Physician Decision|1|||
17075144|NCT00337935|38217194|FG001|Overall Study|Physician Decision|1|||
17075145|NCT00337935|38217193|FG000|Overall Study|Lost to Follow-up|0|||
17075146|NCT00337935|38217194|FG001|Overall Study|Lost to Follow-up|1|||
17075147|NCT00337935|38217193|FG000|Overall Study|Protocol Violation|4|||
17075148|NCT00337935|38217194|FG001|Overall Study|Protocol Violation|3|||
17075149|NCT00337935|38217193|FG000|Overall Study|Withdrawal by Subject|1|||
17075150|NCT00337935|38217194|FG001|Overall Study|Withdrawal by Subject|7|||
17075151|NCT00337935|38217193|FG000|Overall Study|Other|0|||
17075152|NCT00337935|38217194|FG001|Overall Study|Other|1|||
17075153|NCT00337935|38217193|FG000|Overall Study|Lack of Efficacy|0|||
17075154|NCT00337935|38217194|FG001|Overall Study|Lack of Efficacy|1|||
17075155|NCT00337779|38217203|FG000|Overall Study|Withdrawal by Subject|10|||
17075156|NCT00337779|38217204|FG001|Overall Study|Withdrawal by Subject|12|||
17075157|NCT00337779|38217203|FG000|Overall Study|Sponsor decision|1|||
17075158|NCT00337779|38217204|FG001|Overall Study|Sponsor decision|1|||
17075159|NCT00337779|38217203|FG000|Overall Study|Physician Decision|3|||
17075160|NCT00337779|38217204|FG001|Overall Study|Physician Decision|6|||
17075161|NCT00337779|38217203|FG000|Overall Study|Protocol Violation|1|||
17075162|NCT00337779|38217204|FG001|Overall Study|Protocol Violation|1|||
17075163|NCT00337779|38217203|FG000|Overall Study|Lost to Follow-up|6|||
17075164|NCT00337779|38217204|FG001|Overall Study|Lost to Follow-up|5|||
17075165|NCT00337779|38217203|FG000|Overall Study|Adverse Event|28|||
17075166|NCT00337779|38217204|FG001|Overall Study|Adverse Event|51|||
17075167|NCT00337779|38217203|FG000|Overall Study|Pregnancy|3|||
17075168|NCT00337779|38217204|FG001|Overall Study|Pregnancy|2|||
17075169|NCT00337779|38217203|FG000|Overall Study|Death|0|||
17075170|NCT00337779|38217204|FG001|Overall Study|Death|1|||
17075171|NCT00352755|38217210|FG000|Overall Study|Physician Decision|1|||
17075172|NCT00352755|38217210|FG000|Overall Study|Adverse Event|1|||
17075173|NCT00533897|38217217|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
17075174|NCT00533897|38217218|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
17075175|NCT00533897|38217219|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
17075176|NCT00533897|38217220|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
17075177|NCT00533897|38217221|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
17075178|NCT00533897|38217222|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
17075179|NCT00533897|38217223|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
17075180|NCT00533897|38217224|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
17075181|NCT00533897|38217217|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
17075182|NCT00533897|38217218|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
17075183|NCT00533897|38217219|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
17075184|NCT00533897|38217220|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
17075185|NCT00533897|38217221|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
17075186|NCT00533897|38217222|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
17075187|NCT00533897|38217223|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
17075188|NCT00533897|38217224|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
17075189|NCT00533897|38217217|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
17075190|NCT00533897|38217218|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
17075191|NCT00533897|38217219|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
17075192|NCT00533897|38217220|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
17075193|NCT00533897|38217221|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
17075194|NCT00533897|38217222|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
17075195|NCT00533897|38217223|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
17075196|NCT00533897|38217224|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
17075197|NCT00533897|38217217|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
17075198|NCT00533897|38217218|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
17075199|NCT00533897|38217219|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
17075200|NCT00533897|38217220|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
17075201|NCT00533897|38217221|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
17075202|NCT00533897|38217222|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
17075203|NCT00533897|38217223|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
17075204|NCT00533897|38217224|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
17075205|NCT00533897|38217217|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
17075206|NCT00533897|38217218|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
17075207|NCT00533897|38217219|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
17075208|NCT00533897|38217220|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
17075209|NCT00533897|38217221|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
17075210|NCT00533897|38217222|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
17075211|NCT00533897|38217223|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
17075212|NCT00533897|38217224|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
17075213|NCT00533897|38217217|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
17075214|NCT00533897|38217218|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
17075215|NCT00533897|38217219|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
17075216|NCT00533897|38217220|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
17075217|NCT00533897|38217221|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
17075218|NCT00533897|38217222|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
17157440|NCT03073200|38304514|FG000|Extension Period|Sponsor Decision|0|||
17157441|NCT03073200|38304515|FG001|Extension Period|Sponsor Decision|0|||
17157442|NCT03073200|38304516|FG002|Extension Period|Sponsor Decision|0|||
17157443|NCT03073200|38304517|FG003|Extension Period|Sponsor Decision|0|||
17157444|NCT03073200|38304518|FG004|Extension Period|Sponsor Decision|0|||
17157445|NCT03073200|38304519|FG005|Extension Period|Sponsor Decision|0|||
17157446|NCT03073200|38304520|FG006|Extension Period|Sponsor Decision|0|||
17157447|NCT03073200|38304521|FG007|Extension Period|Sponsor Decision|0|||
17157448|NCT03073200|38304522|FG008|Extension Period|Sponsor Decision|1|||
17157449|NCT03073200|38304523|FG009|Extension Period|Sponsor Decision|0|||
17157450|NCT03073200|38304524|FG010|Extension Period|Sponsor Decision|0|||
17157451|NCT03073200|38304525|FG011|Extension Period|Sponsor Decision|0|||
17157452|NCT03073200|38304526|FG012|Extension Period|Sponsor Decision|0|||
17157453|NCT03073200|38304527|FG013|Extension Period|Sponsor Decision|0|||
17157454|NCT03073200|38304528|FG014|Extension Period|Sponsor Decision|0|||
17157455|NCT03073200|38304514|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
17157456|NCT03073200|38304515|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
17157457|NCT03073200|38304516|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
17157458|NCT03073200|38304517|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
17157459|NCT03073200|38304518|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
17157460|NCT03073200|38304519|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
17157461|NCT03073200|38304520|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
17157462|NCT03073200|38304521|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
17157463|NCT03073200|38304522|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
17157464|NCT03073200|38304523|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
17157465|NCT03073200|38304524|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
17157466|NCT03073200|38304525|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
17157467|NCT03073200|38304526|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
17157468|NCT03073200|38304527|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
17157469|NCT03073200|38304528|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
17157470|NCT03073200|38304514|FG000|Extension Period|Withdrawal by Subject|0|||
17157471|NCT03073200|38304515|FG001|Extension Period|Withdrawal by Subject|0|||
17157472|NCT03073200|38304516|FG002|Extension Period|Withdrawal by Subject|0|||
17157473|NCT03073200|38304517|FG003|Extension Period|Withdrawal by Subject|0|||
17157474|NCT03073200|38304518|FG004|Extension Period|Withdrawal by Subject|0|||
17157475|NCT03073200|38304519|FG005|Extension Period|Withdrawal by Subject|0|||
17157476|NCT03073200|38304520|FG006|Extension Period|Withdrawal by Subject|1|||
17157477|NCT03073200|38304521|FG007|Extension Period|Withdrawal by Subject|2|||
17157478|NCT03073200|38304522|FG008|Extension Period|Withdrawal by Subject|0|||
17157479|NCT03073200|38304523|FG009|Extension Period|Withdrawal by Subject|0|||
17157480|NCT03073200|38304524|FG010|Extension Period|Withdrawal by Subject|0|||
17157481|NCT03073200|38304525|FG011|Extension Period|Withdrawal by Subject|0|||
17157482|NCT03073200|38304526|FG012|Extension Period|Withdrawal by Subject|0|||
17157483|NCT03073200|38304527|FG013|Extension Period|Withdrawal by Subject|0|||
17157484|NCT03073200|38304528|FG014|Extension Period|Withdrawal by Subject|0|||
17157485|NCT03073200|38304514|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157486|NCT03073200|38304515|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157487|NCT03073200|38304516|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157488|NCT03073200|38304517|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157489|NCT03073200|38304518|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157490|NCT03073200|38304519|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157491|NCT03073200|38304520|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157492|NCT03073200|38304521|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157493|NCT03073200|38304522|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157494|NCT03073200|38304523|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157495|NCT03073200|38304524|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157496|NCT03073200|38304525|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
17157497|NCT03073200|38304526|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157498|NCT03073200|38304527|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157499|NCT03073200|38304528|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
17157500|NCT03073200|38304514|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157501|NCT03073200|38304515|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157502|NCT03073200|38304516|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157503|NCT03073200|38304517|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157504|NCT03073200|38304518|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157505|NCT03073200|38304519|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157506|NCT03073200|38304520|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157507|NCT03073200|38304521|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157508|NCT03073200|38304522|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157509|NCT03073200|38304523|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157510|NCT03073200|38304524|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157511|NCT03073200|38304525|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
17157512|NCT03073200|38304526|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157513|NCT03073200|38304527|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157514|NCT03073200|38304528|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
17157515|NCT03073200|38304514|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157516|NCT03073200|38304515|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157517|NCT03073200|38304516|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157518|NCT03073200|38304517|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157519|NCT03073200|38304518|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157520|NCT03073200|38304519|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157521|NCT03073200|38304520|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157522|NCT03073200|38304521|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157523|NCT03073200|38304522|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157524|NCT03073200|38304523|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157525|NCT03073200|38304524|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
17157526|NCT03073200|38304525|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
17157527|NCT03073200|38304526|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157528|NCT03073200|38304527|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157529|NCT03073200|38304528|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
17157530|NCT03073200|38304514|FG000|Randomized Withdrawal Period|Adverse Event|0|||
17157531|NCT03073200|38304515|FG001|Randomized Withdrawal Period|Adverse Event|0|||
17157532|NCT03073200|38304516|FG002|Randomized Withdrawal Period|Adverse Event|0|||
17157533|NCT03073200|38304517|FG003|Randomized Withdrawal Period|Adverse Event|0|||
17157534|NCT03073200|38304518|FG004|Randomized Withdrawal Period|Adverse Event|0|||
17157535|NCT03073200|38304519|FG005|Randomized Withdrawal Period|Adverse Event|0|||
17157536|NCT03073200|38304520|FG006|Randomized Withdrawal Period|Adverse Event|0|||
17157537|NCT03073200|38304521|FG007|Randomized Withdrawal Period|Adverse Event|0|||
17157538|NCT03073200|38304522|FG008|Randomized Withdrawal Period|Adverse Event|0|||
17157539|NCT03073200|38304523|FG009|Randomized Withdrawal Period|Adverse Event|0|||
17157540|NCT03073200|38304524|FG010|Randomized Withdrawal Period|Adverse Event|1|||
17157541|NCT03073200|38304525|FG011|Randomized Withdrawal Period|Adverse Event|0|||
17157542|NCT03073200|38304526|FG012|Randomized Withdrawal Period|Adverse Event|0|||
17157543|NCT03073200|38304527|FG013|Randomized Withdrawal Period|Adverse Event|0|||
17157544|NCT03073200|38304528|FG014|Randomized Withdrawal Period|Adverse Event|0|||
17157545|NCT03073200|38304514|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157546|NCT03073200|38304515|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157547|NCT03073200|38304516|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157548|NCT03073200|38304517|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157549|NCT03073200|38304518|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157550|NCT03073200|38304519|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157551|NCT03073200|38304520|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157552|NCT03073200|38304521|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157553|NCT03073200|38304522|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157554|NCT03073200|38304523|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157555|NCT03073200|38304524|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157556|NCT03073200|38304525|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157557|NCT03073200|38304526|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157558|NCT03073200|38304527|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
17157559|NCT03073200|38304528|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
17157560|NCT03073200|38304514|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157561|NCT03073200|38304515|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157562|NCT03073200|38304516|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157563|NCT03073200|38304517|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157564|NCT03073200|38304518|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17075219|NCT00533897|38217223|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
17075220|NCT00533897|38217224|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
17075221|NCT00533897|38217217|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
17075222|NCT00533897|38217218|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
17075223|NCT00533897|38217219|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
17075224|NCT00533897|38217220|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
17075225|NCT00533897|38217221|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
17075226|NCT00533897|38217222|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
17075227|NCT00533897|38217223|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
17075228|NCT00533897|38217224|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
17075229|NCT00533897|38217217|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
17075230|NCT00533897|38217218|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
17075231|NCT00533897|38217219|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
17075232|NCT00533897|38217220|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
17075233|NCT00533897|38217221|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
17075234|NCT00533897|38217222|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
17075235|NCT00533897|38217223|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
17075236|NCT00533897|38217224|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
17075237|NCT00533897|38217217|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
17075238|NCT00533897|38217218|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
17075239|NCT00533897|38217219|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
17075240|NCT00533897|38217220|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
17075241|NCT00533897|38217221|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
17075242|NCT00533897|38217222|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
17075243|NCT00533897|38217223|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
17075244|NCT00533897|38217224|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
17075245|NCT00533897|38217217|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
17075246|NCT00533897|38217218|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
17075247|NCT00533897|38217219|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
17075248|NCT00533897|38217220|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
17075249|NCT00533897|38217221|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
17075250|NCT00533897|38217222|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
17075251|NCT00533897|38217223|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
17075252|NCT00533897|38217224|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
17075253|NCT00533897|38217217|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
17075254|NCT00533897|38217218|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
17157565|NCT03073200|38304519|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157566|NCT03073200|38304520|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157567|NCT03073200|38304521|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157568|NCT03073200|38304522|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157569|NCT03073200|38304523|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157570|NCT03073200|38304524|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157571|NCT03073200|38304525|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157572|NCT03073200|38304526|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17075255|NCT00533897|38217219|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
17075256|NCT00533897|38217220|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
17075257|NCT00533897|38217221|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
17075258|NCT00533897|38217222|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
17075259|NCT00533897|38217223|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
17075260|NCT00533897|38217224|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
17075261|NCT00533897|38217217|FG000|Long Term Extension (LTE)|Death|0|||
17075262|NCT00533897|38217218|FG001|Long Term Extension (LTE)|Death|0|||
17075263|NCT00533897|38217219|FG002|Long Term Extension (LTE)|Death|0|||
17075264|NCT00533897|38217220|FG003|Long Term Extension (LTE)|Death|0|||
17075265|NCT00533897|38217221|FG004|Long Term Extension (LTE)|Death|0|||
17075266|NCT00533897|38217222|FG005|Long Term Extension (LTE)|Death|0|||
17075267|NCT00533897|38217223|FG006|Long Term Extension (LTE)|Death|1|||
17075268|NCT00533897|38217224|FG007|Long Term Extension (LTE)|Death|3|||
17075269|NCT00533897|38217217|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
17075270|NCT00533897|38217218|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
17075271|NCT00533897|38217219|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
17075272|NCT00533897|38217220|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
17075273|NCT00533897|38217221|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
17075274|NCT00533897|38217222|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
17075275|NCT00533897|38217223|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
17075276|NCT00533897|38217224|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
17075277|NCT00533897|38217217|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
17075278|NCT00533897|38217218|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
17075279|NCT00533897|38217219|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
17075280|NCT00533897|38217220|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
17075281|NCT00533897|38217221|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
17075282|NCT00533897|38217222|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
17075283|NCT00533897|38217223|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
17075284|NCT00533897|38217224|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
17075285|NCT00533897|38217217|FG000|Long Term Extension (LTE)|Adverse Event|0|||
17075286|NCT00533897|38217218|FG001|Long Term Extension (LTE)|Adverse Event|0|||
17075287|NCT00533897|38217219|FG002|Long Term Extension (LTE)|Adverse Event|0|||
17075288|NCT00533897|38217220|FG003|Long Term Extension (LTE)|Adverse Event|0|||
17075289|NCT00533897|38217221|FG004|Long Term Extension (LTE)|Adverse Event|0|||
17075290|NCT00533897|38217222|FG005|Long Term Extension (LTE)|Adverse Event|0|||
17075291|NCT00533897|38217223|FG006|Long Term Extension (LTE)|Adverse Event|2|||
17075292|NCT00533897|38217224|FG007|Long Term Extension (LTE)|Adverse Event|5|||
17075293|NCT00533897|38217217|FG000|Long Term Extension (LTE)|Pregnancy|0|||
17075294|NCT00533897|38217218|FG001|Long Term Extension (LTE)|Pregnancy|0|||
17075295|NCT00533897|38217219|FG002|Long Term Extension (LTE)|Pregnancy|0|||
17075296|NCT00533897|38217220|FG003|Long Term Extension (LTE)|Pregnancy|0|||
17075297|NCT00533897|38217221|FG004|Long Term Extension (LTE)|Pregnancy|0|||
17075298|NCT00533897|38217222|FG005|Long Term Extension (LTE)|Pregnancy|0|||
17075299|NCT00533897|38217223|FG006|Long Term Extension (LTE)|Pregnancy|0|||
17075300|NCT00533897|38217224|FG007|Long Term Extension (LTE)|Pregnancy|2|||
17075301|NCT00533897|38217217|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
17075302|NCT00533897|38217218|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
17075303|NCT00533897|38217219|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
17075304|NCT00533897|38217220|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
17075305|NCT00533897|38217221|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
17075306|NCT00533897|38217222|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
17075307|NCT00533897|38217223|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
17075308|NCT00533897|38217224|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
17075309|NCT00533897|38217217|FG000|Long Term Extension (LTE)|Other|0|||
17075310|NCT00533897|38217218|FG001|Long Term Extension (LTE)|Other|0|||
17075311|NCT00533897|38217219|FG002|Long Term Extension (LTE)|Other|0|||
17075312|NCT00533897|38217220|FG003|Long Term Extension (LTE)|Other|0|||
17075313|NCT00533897|38217221|FG004|Long Term Extension (LTE)|Other|0|||
17075314|NCT00533897|38217222|FG005|Long Term Extension (LTE)|Other|0|||
17075315|NCT00533897|38217223|FG006|Long Term Extension (LTE)|Other|1|||
17075316|NCT00533897|38217224|FG007|Long Term Extension (LTE)|Other|6|||
17075317|NCT00426660|38217255|FG000|Overall Study|Death|14|||
17075318|NCT00426660|38217255|FG000|Overall Study|Adverse Event|23|||
17075319|NCT00426660|38217255|FG000|Overall Study|Insufficient Clinical Response|22|||
17075320|NCT00426660|38217255|FG000|Overall Study|Lost to Follow-up|15|||
17075321|NCT00426660|38217255|FG000|Overall Study|Other|23|||
17075322|NCT00426660|38217255|FG000|Overall Study|Withdrawal by Subject|18|||
17075323|NCT00426660|38217255|FG000|Overall Study|Protocol Violation|1|||
17075324|NCT00426660|38217255|FG000|Overall Study|Enrolled Not Treated|15|||
17075325|NCT00426270|38217259|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
17075326|NCT00426270|38217259|FG000|Overall Study|Adverse Event|5|||
17075327|NCT00330681|38217265|FG000|Overall Study|Adverse Event|3|||
17075328|NCT00330681|38217266|FG001|Overall Study|Adverse Event|6|||
17075329|NCT00330681|38217265|FG000|Overall Study|Protocol Violation|0|||
17075330|NCT00330681|38217266|FG001|Overall Study|Protocol Violation|1|||
17075331|NCT00330681|38217265|FG000|Overall Study|Withdrawal by Subject|5|||
17075332|NCT00330681|38217266|FG001|Overall Study|Withdrawal by Subject|5|||
17075333|NCT00330681|38217265|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
17075334|NCT00330681|38217266|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
17075335|NCT00329901|38217275|FG000|Overall Study|Withdrawal by Subject|4|||
17075336|NCT00329901|38217276|FG001|Overall Study|Withdrawal by Subject|3|||
17075337|NCT00329901|38217277|FG002|Overall Study|Withdrawal by Subject|2|||
17075338|NCT00329901|38217275|FG000|Overall Study|Lost to Follow-up|2|||
17075339|NCT00329901|38217276|FG001|Overall Study|Lost to Follow-up|0|||
17075340|NCT00329901|38217277|FG002|Overall Study|Lost to Follow-up|1|||
17075341|NCT00329901|38217275|FG000|Overall Study|Protocol Violation|1|||
17075342|NCT00329901|38217276|FG001|Overall Study|Protocol Violation|0|||
17075343|NCT00329901|38217277|FG002|Overall Study|Protocol Violation|1|||
17075344|NCT00329901|38217275|FG000|Overall Study|Unable to classify|2|||
17075345|NCT00329901|38217276|FG001|Overall Study|Unable to classify|2|||
17075346|NCT00329901|38217277|FG002|Overall Study|Unable to classify|0|||
17075347|NCT00436956|38217289|FG000|Overall Study|Not evaluable|1|||
17075348|NCT00436956|38217290|FG001|Overall Study|Not evaluable|0|||
17075349|NCT00329745|38217299|FG000|Overall Study|Protocol Violation|1|||
17075350|NCT00329745|38217300|FG001|Overall Study|Protocol Violation|0|||
17075351|NCT00329745|38217299|FG000|Overall Study|Withdrawal by Subject|0|||
17075352|NCT00329745|38217300|FG001|Overall Study|Withdrawal by Subject|1|||
17075353|NCT00329745|38217299|FG000|Overall Study|Lost to Follow-up|86|||
17075354|NCT00329745|38217300|FG001|Overall Study|Lost to Follow-up|101|||
17075355|NCT00436644|38217306|FG000|Overall Study|Adverse Event|2|||
17075356|NCT00436644|38217306|FG000|Overall Study|Death|1|||
17075357|NCT00324987|38217312|FG000|Overall Study|Adverse Event|2|||
17075358|NCT00324987|38217313|FG001|Overall Study|Adverse Event|1|||
17075359|NCT00324987|38217312|FG000|Overall Study|Withdrawal by Subject|1|||
17075360|NCT00324987|38217313|FG001|Overall Study|Withdrawal by Subject|1|||
17075361|NCT00324987|38217312|FG000|Overall Study|Progression|1|||
17075362|NCT00324987|38217313|FG001|Overall Study|Progression|1|||
17075363|NCT00324987|38217312|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
17075364|NCT00324987|38217313|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
17075365|NCT00324675|38217321|FG000|Overall Study|Adverse Event|1|||
17075366|NCT00324675|38217322|FG001|Overall Study|Adverse Event|0|||
17075367|NCT00436566|38217328|FG000|Overall Study|Withdrawal by Subject|2|||
17075368|NCT00436566|38217328|FG000|Overall Study|Protocol Violation|1|||
17075369|NCT00352365|38217332|FG000|Induction Therapy|Adverse Event|7|||
17075370|NCT00352365|38217332|FG000|Induction Therapy|Progression/Relapse|8|||
17075371|NCT00352365|38217332|FG000|Induction Therapy|Death|7|||
17075372|NCT00352365|38217332|FG000|Induction Therapy|Not protocol specified|1|||
17075373|NCT00352365|38217332|FG000|Induction Therapy|Not eligible|3|||
17075374|NCT00352365|38217332|FG000|Induction Therapy|Death before starting protocol therapy|1|||
17075375|NCT00352365|38217332|FG000|Maintenance Therapy|Progression/Relapse|3|||
17075376|NCT00352365|38217332|FG000|Maintenance Therapy|Death|2|||
17075377|NCT00352365|38217332|FG000|Maintenance Therapy|Not protocol specified|3|||
17075378|NCT00352365|38217332|FG000|Maintenance Therapy|Not eligible|4|||
17075379|NCT00532493|38217342|FG000|Overall Study|Death|1|||
17075380|NCT00532493|38217343|FG001|Overall Study|Death|1|||
17075381|NCT00532493|38217342|FG000|Overall Study|Lost to Follow-up|10|||
17075382|NCT00532493|38217343|FG001|Overall Study|Lost to Follow-up|7|||
17075383|NCT00532493|38217342|FG000|Overall Study|Withdrawal by Subject|7|||
17075384|NCT00532493|38217343|FG001|Overall Study|Withdrawal by Subject|9|||
17075385|NCT00532493|38217342|FG000|Overall Study|Physician Decision|1|||
17075386|NCT00532493|38217343|FG001|Overall Study|Physician Decision|6|||
17075387|NCT00532493|38217342|FG000|Overall Study|Adverse Event|6|||
17075388|NCT00532493|38217343|FG001|Overall Study|Adverse Event|5|||
17075389|NCT00532493|38217342|FG000|Overall Study|Protocol Deviation|1|||
17075390|NCT00532493|38217343|FG001|Overall Study|Protocol Deviation|0|||
17075391|NCT00532493|38217342|FG000|Overall Study|Subject Moved Away|3|||
17075392|NCT00532493|38217343|FG001|Overall Study|Subject Moved Away|1|||
17075393|NCT00532493|38217342|FG000|Overall Study|Contraindicative Medication|1|||
17075394|NCT00532493|38217343|FG001|Overall Study|Contraindicative Medication|0|||
17075395|NCT00533507|38217351|FG000|Overall Study|Withdrawal by Subject|1|||
17075396|NCT03886493|38217355|FG000|Overall Study|Adverse Event|1|||
17075397|NCT00352053|38217361|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
17075398|NCT00352053|38217362|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
17075399|NCT00352053|38217361|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
17075400|NCT00352053|38217362|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
17075401|NCT00352053|38217361|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
17075402|NCT00352053|38217362|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
17075403|NCT00352053|38217361|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
17075404|NCT00352053|38217362|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
17075405|NCT00352053|38217361|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
17075406|NCT00352053|38217362|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
17075407|NCT00352053|38217361|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
17075408|NCT00352053|38217362|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
17075409|NCT00352053|38217361|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
17075410|NCT00352053|38217362|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
17075411|NCT00352053|38217361|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
17075412|NCT00352053|38217362|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
17075413|NCT00352053|38217361|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
17075414|NCT00352053|38217362|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
17075415|NCT00352053|38217361|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
17075416|NCT00352053|38217362|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
17075417|NCT00352053|38217361|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
17075418|NCT00352053|38217362|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
17075419|NCT00352053|38217361|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
17075420|NCT00352053|38217362|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
17075421|NCT00352053|38217361|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
17075422|NCT00352053|38217362|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
17075423|NCT00351819|38217378|FG000|Overall Study|Lost to Follow-up|4|||
17075424|NCT00351819|38217379|FG001|Overall Study|Lost to Follow-up|4|||
17075425|NCT00351819|38217378|FG000|Overall Study|Withdrawal by Subject|0|||
17075426|NCT00351819|38217379|FG001|Overall Study|Withdrawal by Subject|4|||
17075427|NCT00351819|38217378|FG000|Overall Study|Elevated PSA|1|||
17075428|NCT00351819|38217379|FG001|Overall Study|Elevated PSA|1|||
17075429|NCT00351819|38217378|FG000|Overall Study|Traumatic ankle fracture|1|||
17075430|NCT00351819|38217379|FG001|Overall Study|Traumatic ankle fracture|0|||
17075431|NCT00351819|38217378|FG000|Overall Study|Unprofessional behavior|1|||
17075432|NCT00351819|38217379|FG001|Overall Study|Unprofessional behavior|0|||
17075433|NCT00351819|38217378|FG000|Overall Study|Non-compliance|0|||
17075434|NCT00351819|38217379|FG001|Overall Study|Non-compliance|1|||
17075435|NCT00351819|38217378|FG000|Overall Study|Incarcerated|0|||
17075436|NCT00351819|38217379|FG001|Overall Study|Incarcerated|1|||
17075437|NCT00351819|38217378|FG000|Overall Study|Enrolled in another trial|0|||
17075438|NCT00351819|38217379|FG001|Overall Study|Enrolled in another trial|1|||
17075439|NCT00351351|38217387|FG000|Overall Study|surgical access pbs; device issues|9|||
17075440|NCT00351351|38217388|FG001|Overall Study|surgical access pbs; device issues|4|||
17075441|NCT00323115|38217394|FG000|Vaccine Administration|Adverse Event|1|||
17075442|NCT00323115|38217394|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
17075443|NCT00322881|38217403|FG000|Overall Study|Death|2|||
17075444|NCT00322881|38217403|FG000|Overall Study|Adverse Event|1|||
17075445|NCT00322881|38217403|FG000|Overall Study|Disease Progression|2|||
17075446|NCT00415194|38217409|FG000|Overall Study|Adverse Event|37|||
17075447|NCT00415194|38217410|FG001|Overall Study|Adverse Event|32|||
17075448|NCT00415194|38217409|FG000|Overall Study|Entry Criteria Not Met|4|||
17075449|NCT00415194|38217410|FG001|Overall Study|Entry Criteria Not Met|8|||
17075450|NCT00415194|38217409|FG000|Overall Study|Lost to Follow-up|1|||
17075451|NCT00415194|38217410|FG001|Overall Study|Lost to Follow-up|0|||
17075452|NCT00415194|38217409|FG000|Overall Study|Physician Decision|10|||
17075453|NCT00415194|38217410|FG001|Overall Study|Physician Decision|16|||
17075454|NCT00415194|38217409|FG000|Overall Study|Progressive Disease|180|||
17075455|NCT00415194|38217410|FG001|Overall Study|Progressive Disease|217|||
17075456|NCT00415194|38217409|FG000|Overall Study|Protocol Violation|4|||
17075457|NCT00415194|38217410|FG001|Overall Study|Protocol Violation|2|||
17075458|NCT00415194|38217409|FG000|Overall Study|Withdrawal by Subject|28|||
17075459|NCT00415194|38217410|FG001|Overall Study|Withdrawal by Subject|21|||
17075460|NCT00415194|38217409|FG000|Overall Study|Death Due to Study Disease|26|||
17075461|NCT00415194|38217410|FG001|Overall Study|Death Due to Study Disease|29|||
17075462|NCT00415194|38217409|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
17075463|NCT00415194|38217410|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
17075464|NCT00415194|38217409|FG000|Overall Study|Death Due to Procedural Related AE|0|||
17075465|NCT00415194|38217410|FG001|Overall Study|Death Due to Procedural Related AE|1|||
17075466|NCT00415194|38217409|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
17075467|NCT00415194|38217410|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
17075468|NCT00436332|38217416|FG000|Overall Study|Adverse Event|9|||
17075469|NCT00436332|38217416|FG000|Overall Study|Withdrawal by Subject|2|||
17075470|NCT00436332|38217416|FG000|Overall Study|Progression|59|||
17075471|NCT00436332|38217416|FG000|Overall Study|Death|2|||
17075472|NCT00436332|38217416|FG000|Overall Study|Not Protocol Specified|6|||
17075473|NCT00436332|38217416|FG000|Overall Study|Ineligible|2|||
17075474|NCT00436332|38217416|FG000|Overall Study|Never Received Treatment|3|||
17075475|NCT00532259|38217420|FG000|Overall Study|Withdrawal by Subject|2|||
17075476|NCT00532259|38217420|FG000|Overall Study|Adverse Event|1|||
17075477|NCT00532259|38217420|FG000|Overall Study|Death|1|||
17075478|NCT00532259|38217420|FG000|Overall Study|Lack of Efficacy|21|||
17075479|NCT00532259|38217420|FG000|Overall Study|Lost to Follow-up|3|||
17075480|NCT00532259|38217420|FG000|Overall Study|Physician Decision|3|||
17075481|NCT00532259|38217420|FG000|Overall Study|Protocol Violation|1|||
17075482|NCT00322491|38217427|FG000|Overall Study|Adverse Event|1|||
17075483|NCT00322491|38217428|FG001|Overall Study|Adverse Event|0|||
17075484|NCT00322491|38217427|FG000|Overall Study|Death|1|||
17075485|NCT00322491|38217428|FG001|Overall Study|Death|2|||
17075486|NCT00322023|38217438|FG000|Overall Study|various|0|||
17075487|NCT00322023|38217439|FG001|Overall Study|various|2|||
17075488|NCT00322023|38217440|FG002|Overall Study|various|6|||
17075489|NCT00414960|38217450|FG000|Overall Study|Adverse Event|4|||
17075490|NCT00414960|38217451|FG001|Overall Study|Adverse Event|0|||
17075491|NCT00414960|38217450|FG000|Overall Study|Withdrawal by Subject|3|||
17075492|NCT00414960|38217451|FG001|Overall Study|Withdrawal by Subject|0|||
17075493|NCT00414960|38217450|FG000|Overall Study|Physician Decision|0|||
17075494|NCT00414960|38217451|FG001|Overall Study|Physician Decision|1|||
17075495|NCT00321789|38217459|FG000|Overall Study|Lost to Follow-up|4|||
17075496|NCT00321789|38217460|FG001|Overall Study|Lost to Follow-up|7|||
17075497|NCT00321789|38217459|FG000|Overall Study|Withdrawal by Subject|6|||
17075498|NCT00321789|38217460|FG001|Overall Study|Withdrawal by Subject|6|||
17075499|NCT00321789|38217459|FG000|Overall Study|Protocol Violation|5|||
17075500|NCT00321789|38217460|FG001|Overall Study|Protocol Violation|3|||
17075501|NCT00414726|38217468|FG000|Overall Study|Withdrawal by Subject|0|||
17075502|NCT00414726|38217469|FG001|Overall Study|Withdrawal by Subject|1|||
17075503|NCT00531947|38217477|FG000|Overall Study|Adverse Event|5|||
17075504|NCT00531947|38217478|FG001|Overall Study|Adverse Event|10|||
17075505|NCT00531947|38217477|FG000|Overall Study|Lost to Follow-up|12|||
17075506|NCT00531947|38217478|FG001|Overall Study|Lost to Follow-up|9|||
17075507|NCT00531947|38217477|FG000|Overall Study|Withdrawal by Subject|14|||
17075508|NCT00531947|38217478|FG001|Overall Study|Withdrawal by Subject|19|||
17075509|NCT00531947|38217477|FG000|Overall Study|Protocol Violation|2|||
17075510|NCT00531947|38217478|FG001|Overall Study|Protocol Violation|1|||
17075511|NCT00531947|38217477|FG000|Overall Study|Non-Compliance|4|||
17075512|NCT00531947|38217478|FG001|Overall Study|Non-Compliance|7|||
17075513|NCT00531947|38217477|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
17075514|NCT00531947|38217478|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
17075515|NCT00530855|38217484|FG000|Overall Study|Lack of Efficacy|20|||
17075516|NCT00530855|38217484|FG000|Overall Study|Withdrawal by Subject|30|||
17075517|NCT00530855|38217484|FG000|Overall Study|Fatal Serious AE|3|||
17075518|NCT00530855|38217484|FG000|Overall Study|Non Fatal Serious AE|7|||
17075519|NCT00530855|38217484|FG000|Overall Study|Non Fatal Non Serious AE|12|||
17075520|NCT00530855|38217484|FG000|Overall Study|Protocol Violation|3|||
17075521|NCT00530855|38217484|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
17075522|NCT00530855|38217484|FG000|Overall Study|Lost to Follow-up|9|||
17075523|NCT00530855|38217484|FG000|Overall Study|Other reason for premature termination|17|||
17075524|NCT00530777|38217490|FG000|Overall Study|Lost to Follow-up|0|||
17075525|NCT00530777|38217491|FG001|Overall Study|Lost to Follow-up|1|||
17075526|NCT00530777|38217490|FG000|Overall Study|Death|1|||
17075527|NCT00530777|38217491|FG001|Overall Study|Death|2|||
17075528|NCT00530777|38217490|FG000|Overall Study|Physician Decision|1|||
17075529|NCT00530777|38217491|FG001|Overall Study|Physician Decision|0|||
17075530|NCT00530777|38217490|FG000|Overall Study|Withdrawal by Subject|0|||
17075531|NCT00530777|38217491|FG001|Overall Study|Withdrawal by Subject|1|||
17075532|NCT00530777|38217490|FG000|Overall Study|Unable to adhere to visit schedule|5|||
17075533|NCT00530777|38217491|FG001|Overall Study|Unable to adhere to visit schedule|1|||
17075534|NCT03882047|38217500|FG000|Overall Study|Adverse Event|0|||
17075535|NCT03882047|38217501|FG001|Overall Study|Adverse Event|2|||
17075536|NCT03882047|38217502|FG002|Overall Study|Adverse Event|2|||
17075537|NCT03882047|38217500|FG000|Overall Study|Treatment Failure|3|||
17075538|NCT03882047|38217501|FG001|Overall Study|Treatment Failure|3|||
17075539|NCT03882047|38217502|FG002|Overall Study|Treatment Failure|12|||
17075540|NCT03882047|38217500|FG000|Overall Study|Lost to Follow-up|0|||
17075541|NCT03882047|38217501|FG001|Overall Study|Lost to Follow-up|1|||
17075542|NCT03882047|38217502|FG002|Overall Study|Lost to Follow-up|0|||
17075543|NCT03882047|38217500|FG000|Overall Study|Did Not Wish to Continue|1|||
17075544|NCT03882047|38217501|FG001|Overall Study|Did Not Wish to Continue|4|||
17075545|NCT03882047|38217502|FG002|Overall Study|Did Not Wish to Continue|1|||
17075546|NCT03882047|38217500|FG000|Overall Study|Noncompliance With Protocol|2|||
17075547|NCT03882047|38217501|FG001|Overall Study|Noncompliance With Protocol|0|||
17075548|NCT03882047|38217502|FG002|Overall Study|Noncompliance With Protocol|0|||
17075549|NCT03882047|38217500|FG000|Overall Study|Did Not Meet Eligibility|0|||
17075550|NCT03882047|38217501|FG001|Overall Study|Did Not Meet Eligibility|0|||
17075551|NCT03882047|38217502|FG002|Overall Study|Did Not Meet Eligibility|1|||
17075552|NCT00530621|38217512|FG000|Overall Study|Adverse Event|11|||
17075553|NCT00530621|38217513|FG001|Overall Study|Adverse Event|8|||
17075554|NCT00530621|38217512|FG000|Overall Study|Physician Decision|2|||
17075555|NCT00530621|38217513|FG001|Overall Study|Physician Decision|4|||
17075556|NCT00530621|38217512|FG000|Overall Study|Progressive Disease (PD)|47|||
17075557|NCT00530621|38217513|FG001|Overall Study|Progressive Disease (PD)|40|||
17075558|NCT00530621|38217512|FG000|Overall Study|Sponsor Decision|12|||
17075559|NCT00530621|38217513|FG001|Overall Study|Sponsor Decision|15|||
17075560|NCT00530621|38217512|FG000|Overall Study|Subject Decision|4|||
17075561|NCT00530621|38217513|FG001|Overall Study|Subject Decision|7|||
17075562|NCT00530621|38217512|FG000|Overall Study|Death|3|||
17075563|NCT00530621|38217513|FG001|Overall Study|Death|6|||
17075564|NCT00530621|38217512|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
17075565|NCT00530621|38217513|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
17075566|NCT00531479|38217525|FG000|Overall Study|Death|68|||
17075567|NCT00531479|38217526|FG001|Overall Study|Death|71|||
17075568|NCT00531479|38217525|FG000|Overall Study|Lost to Follow-up|0|||
17075569|NCT00531479|38217526|FG001|Overall Study|Lost to Follow-up|2|||
17075570|NCT00531479|38217525|FG000|Overall Study|Other|0|||
17075571|NCT00531479|38217526|FG001|Overall Study|Other|1|||
17075572|NCT00531479|38217525|FG000|Overall Study|Withdrawal by Subject|6|||
17075573|NCT00531479|38217526|FG001|Overall Study|Withdrawal by Subject|6|||
17075574|NCT00531479|38217525|FG000|Overall Study|Did not receive treatment|2|||
17075575|NCT00531479|38217526|FG001|Overall Study|Did not receive treatment|3|||
17075576|NCT00530075|38217532|FG000|Overall Study|Adverse Event|1|||
17075577|NCT00530075|38217532|FG000|Overall Study|Death|1|||
17157573|NCT03073200|38304527|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
17075578|NCT00530075|38217532|FG000|Overall Study|Lack of Efficacy|3|||
17075579|NCT00530075|38217532|FG000|Overall Study|Protocol Violation|1|||
17075580|NCT00530075|38217532|FG000|Overall Study|Withdrawal by Subject|1|||
17075581|NCT00531011|38217538|FG000|Overall Study|Withdrawal by Subject|2|||
17075582|NCT00531011|38217539|FG001|Overall Study|Withdrawal by Subject|4|||
17075583|NCT00531011|38217538|FG000|Overall Study|Death|1|||
17075584|NCT00531011|38217539|FG001|Overall Study|Death|0|||
17075585|NCT00531011|38217538|FG000|Overall Study|Lost to Follow-up|1|||
17075586|NCT00531011|38217539|FG001|Overall Study|Lost to Follow-up|0|||
17075587|NCT00531011|38217538|FG000|Overall Study|Physician Decision|0|||
17075588|NCT00531011|38217539|FG001|Overall Study|Physician Decision|3|||
17075589|NCT00529217|38217545|FG000|Overall Study|Lack of Efficacy|2|||
17075590|NCT00529217|38217545|FG000|Overall Study|Unable to adhere to study schedule|2|||
17075591|NCT00471146|38217552|FG000|Overall Study|Adverse Event|32|||
17075592|NCT00471146|38217553|FG001|Overall Study|Adverse Event|33|||
17075593|NCT00471146|38217552|FG000|Overall Study|Withdrawal by Subject|14|||
17075594|NCT00471146|38217553|FG001|Overall Study|Withdrawal by Subject|11|||
17075595|NCT00471146|38217552|FG000|Overall Study|Death|11|||
17075596|NCT00471146|38217553|FG001|Overall Study|Death|12|||
17075597|NCT00471146|38217552|FG000|Overall Study|Lost to Follow-up|4|||
17075598|NCT00471146|38217553|FG001|Overall Study|Lost to Follow-up|2|||
17075599|NCT00471146|38217552|FG000|Overall Study|Protocol Violation|2|||
17075600|NCT00471146|38217553|FG001|Overall Study|Protocol Violation|2|||
17075601|NCT00471146|38217552|FG000|Overall Study|Objective progression or relapse|84|||
17075602|NCT00471146|38217553|FG001|Overall Study|Objective progression or relapse|87|||
17075603|NCT00471146|38217552|FG000|Overall Study|Global deterioration of health status|12|||
17075604|NCT00471146|38217553|FG001|Overall Study|Global deterioration of health status|14|||
17075605|NCT00471146|38217552|FG000|Overall Study|Randomized but not treated|9|||
17075606|NCT00471146|38217553|FG001|Overall Study|Randomized but not treated|8|||
17075607|NCT00471146|38217552|FG000|Overall Study|Other|4|||
17075608|NCT00471146|38217553|FG001|Overall Study|Other|5|||
17075609|NCT00469898|38217559|FG000|Overall Study|Adverse Event|7|||
17075610|NCT00469898|38217559|FG000|Overall Study|Withdrawal by Subject|4|||
17075611|NCT00469898|38217559|FG000|Overall Study|Death|4|||
17075612|NCT00469898|38217559|FG000|Overall Study|Disease progression|9|||
17075613|NCT00469898|38217559|FG000|Overall Study|Decreased performance status|1|||
17075614|NCT00529763|38217566|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
17075615|NCT00529763|38217567|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
17075616|NCT00529763|38217568|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
17075617|NCT00529763|38217566|FG000|Overall Study|Death|0|||
17075618|NCT00529763|38217567|FG001|Overall Study|Death|1|||
17075619|NCT00529763|38217568|FG002|Overall Study|Death|1|||
17075620|NCT00529763|38217566|FG000|Overall Study|Disease Progression|6|||
17075621|NCT00529763|38217567|FG001|Overall Study|Disease Progression|16|||
17075622|NCT00529763|38217568|FG002|Overall Study|Disease Progression|1|||
17075623|NCT00529763|38217566|FG000|Overall Study|Lost to Follow-up|0|||
17075624|NCT00529763|38217567|FG001|Overall Study|Lost to Follow-up|1|||
17075625|NCT00529763|38217568|FG002|Overall Study|Lost to Follow-up|1|||
17075626|NCT00529763|38217566|FG000|Overall Study|Stem Cell Transplant|0|||
17075627|NCT00529763|38217567|FG001|Overall Study|Stem Cell Transplant|3|||
17075628|NCT00529763|38217568|FG002|Overall Study|Stem Cell Transplant|0|||
17075629|NCT00529763|38217566|FG000|Overall Study|Study Drug Toxicity|1|||
17075630|NCT00529763|38217567|FG001|Overall Study|Study Drug Toxicity|6|||
17075631|NCT00529763|38217568|FG002|Overall Study|Study Drug Toxicity|1|||
17075632|NCT00529763|38217566|FG000|Overall Study|Patient Withdrew Consent|2|||
17075633|NCT00529763|38217567|FG001|Overall Study|Patient Withdrew Consent|3|||
17075634|NCT00529763|38217568|FG002|Overall Study|Patient Withdrew Consent|2|||
17075635|NCT00486902|38217585|FG000|Overall Study|Withdrawal by Subject|1|||
17075636|NCT00486902|38217586|FG001|Overall Study|Withdrawal by Subject|2|||
17075637|NCT00486902|38217585|FG000|Overall Study|decision for postpartum tubal ligation|3|||
17075638|NCT00486902|38217586|FG001|Overall Study|decision for postpartum tubal ligation|1|||
17075639|NCT00486902|38217585|FG000|Overall Study|spinal anesthetic protocal violation|1|||
17075640|NCT00486902|38217586|FG001|Overall Study|spinal anesthetic protocal violation|1|||
17075641|NCT00486902|38217585|FG000|Overall Study|Did not meet inclusion criteria|1|||
17075642|NCT00486902|38217586|FG001|Overall Study|Did not meet inclusion criteria|0|||
17075643|NCT00486902|38217585|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
17075644|NCT00486902|38217586|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
17075645|NCT03687827|38217592|FG000|Treatment Period 1|Death|0|||
17075646|NCT03687827|38217593|FG001|Treatment Period 1|Death|1|||
17075647|NCT03687827|38217592|FG000|Treatment Period 1|Lost to Follow-up|2|||
17075648|NCT03687827|38217593|FG001|Treatment Period 1|Lost to Follow-up|2|||
17075649|NCT03687827|38217592|FG000|Treatment Period 1|Physician Decision|5|||
17075650|NCT03687827|38217593|FG001|Treatment Period 1|Physician Decision|2|||
17075651|NCT03687827|38217592|FG000|Treatment Period 1|Withdrawal by Subject|7|||
17075652|NCT03687827|38217593|FG001|Treatment Period 1|Withdrawal by Subject|3|||
17075653|NCT03687827|38217592|FG000|Treatment Period 2|Physician Decision|4|||
17075654|NCT03687827|38217593|FG001|Treatment Period 2|Physician Decision|1|||
17075655|NCT03687827|38217592|FG000|Treatment Period 2|Withdrawal by Subject|1|||
17075656|NCT03687827|38217593|FG001|Treatment Period 2|Withdrawal by Subject|2|||
17075657|NCT00529529|38217602|FG000|Overall Study|Adverse Event|12|||
17075658|NCT00529529|38217603|FG001|Overall Study|Adverse Event|17|||
17075659|NCT00529529|38217604|FG002|Overall Study|Adverse Event|8|||
17075660|NCT00529529|38217602|FG000|Overall Study|Subject withdrew consent|12|||
17075661|NCT00529529|38217603|FG001|Overall Study|Subject withdrew consent|9|||
17075662|NCT00529529|38217604|FG002|Overall Study|Subject withdrew consent|12|||
17075663|NCT00529529|38217602|FG000|Overall Study|Protocol deviation|8|||
17075664|NCT00529529|38217603|FG001|Overall Study|Protocol deviation|12|||
17075665|NCT00529529|38217604|FG002|Overall Study|Protocol deviation|5|||
17075666|NCT00529529|38217602|FG000|Overall Study|Lost to Follow-up|5|||
17075667|NCT00529529|38217603|FG001|Overall Study|Lost to Follow-up|3|||
17075668|NCT00529529|38217604|FG002|Overall Study|Lost to Follow-up|1|||
17075669|NCT00529529|38217602|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
17075670|NCT00529529|38217603|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
17075671|NCT00529529|38217604|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
17075672|NCT00529529|38217602|FG000|Overall Study|Death|2|||
17075673|NCT00529529|38217603|FG001|Overall Study|Death|0|||
17075674|NCT00529529|38217604|FG002|Overall Study|Death|0|||
17075675|NCT00529529|38217602|FG000|Overall Study|Abnormal test procedure result(s)|1|||
17075676|NCT00529529|38217603|FG001|Overall Study|Abnormal test procedure result(s)|0|||
17075677|NCT00529529|38217604|FG002|Overall Study|Abnormal test procedure result(s)|0|||
17075678|NCT00529529|38217602|FG000|Overall Study|Administrative problems|1|||
17075679|NCT00529529|38217603|FG001|Overall Study|Administrative problems|0|||
17075680|NCT00529529|38217604|FG002|Overall Study|Administrative problems|3|||
17075681|NCT05655377|38217612|FG000|Overall Study|Withdrawal by Subject|2|||
17075682|NCT00486434|38217618|FG000|Overall Study|Withdrawal by Subject|34|||
17075683|NCT00486434|38217619|FG001|Overall Study|Withdrawal by Subject|39|||
17075684|NCT00486434|38217618|FG000|Overall Study|Adverse Event|118|||
17075685|NCT00486434|38217619|FG001|Overall Study|Adverse Event|44|||
17075686|NCT00486434|38217618|FG000|Overall Study|Protocol Violation|22|||
17075687|NCT00486434|38217619|FG001|Overall Study|Protocol Violation|21|||
17075688|NCT00486434|38217618|FG000|Overall Study|Lack of Efficacy|12|||
17075689|NCT00486434|38217619|FG001|Overall Study|Lack of Efficacy|19|||
17075690|NCT00486434|38217618|FG000|Overall Study|Lost to Follow-up|2|||
17075691|NCT00486434|38217619|FG001|Overall Study|Lost to Follow-up|3|||
17075692|NCT00486434|38217618|FG000|Overall Study|Death|1|||
17075693|NCT00486434|38217619|FG001|Overall Study|Death|2|||
17075694|NCT00486434|38217618|FG000|Overall Study|Personal reasons|5|||
17075695|NCT00486434|38217619|FG001|Overall Study|Personal reasons|6|||
17075696|NCT00424632|38217628|FG000|Overall Study|Death|0|||
17075697|NCT00424632|38217629|FG001|Overall Study|Death|0|||
17075698|NCT00424632|38217630|FG002|Overall Study|Death|0|||
17075699|NCT00424632|38217631|FG003|Overall Study|Death|0|||
17075700|NCT00424632|38217632|FG004|Overall Study|Death|0|||
17075701|NCT00424632|38217633|FG005|Overall Study|Death|2|||
17075702|NCT00424632|38217634|FG006|Overall Study|Death|0|||
17075703|NCT00424632|38217635|FG007|Overall Study|Death|0|||
17075704|NCT00424632|38217636|FG008|Overall Study|Death|0|||
17075705|NCT00424632|38217637|FG009|Overall Study|Death|0|||
17075706|NCT00424632|38217628|FG000|Overall Study|Adverse Event|0|||
17075707|NCT00424632|38217629|FG001|Overall Study|Adverse Event|0|||
17075708|NCT00424632|38217630|FG002|Overall Study|Adverse Event|0|||
17075709|NCT00424632|38217631|FG003|Overall Study|Adverse Event|0|||
17075710|NCT00424632|38217632|FG004|Overall Study|Adverse Event|0|||
17075711|NCT00424632|38217633|FG005|Overall Study|Adverse Event|0|||
17075712|NCT00424632|38217634|FG006|Overall Study|Adverse Event|0|||
17075713|NCT00424632|38217635|FG007|Overall Study|Adverse Event|0|||
17075714|NCT00424632|38217636|FG008|Overall Study|Adverse Event|3|||
17075715|NCT00424632|38217637|FG009|Overall Study|Adverse Event|2|||
17075716|NCT00424632|38217628|FG000|Overall Study|Global deterioration of health status|0|||
17075717|NCT00424632|38217629|FG001|Overall Study|Global deterioration of health status|0|||
17075718|NCT00424632|38217630|FG002|Overall Study|Global deterioration of health status|0|||
17075719|NCT00424632|38217631|FG003|Overall Study|Global deterioration of health status|1|||
17075720|NCT00424632|38217632|FG004|Overall Study|Global deterioration of health status|1|||
17075721|NCT00424632|38217633|FG005|Overall Study|Global deterioration of health status|0|||
17075722|NCT00424632|38217634|FG006|Overall Study|Global deterioration of health status|0|||
17075723|NCT00424632|38217635|FG007|Overall Study|Global deterioration of health status|0|||
17075724|NCT00424632|38217636|FG008|Overall Study|Global deterioration of health status|0|||
17075725|NCT00424632|38217637|FG009|Overall Study|Global deterioration of health status|0|||
17075726|NCT00424632|38217628|FG000|Overall Study|Objective progression or relapse|1|||
17075727|NCT00424632|38217629|FG001|Overall Study|Objective progression or relapse|1|||
17075728|NCT00424632|38217630|FG002|Overall Study|Objective progression or relapse|1|||
17075729|NCT00424632|38217631|FG003|Overall Study|Objective progression or relapse|2|||
17075730|NCT00424632|38217632|FG004|Overall Study|Objective progression or relapse|2|||
17075731|NCT00424632|38217633|FG005|Overall Study|Objective progression or relapse|13|||
17075732|NCT00424632|38217634|FG006|Overall Study|Objective progression or relapse|7|||
17075733|NCT00424632|38217635|FG007|Overall Study|Objective progression or relapse|3|||
17075734|NCT00424632|38217636|FG008|Overall Study|Objective progression or relapse|12|||
17075735|NCT00424632|38217637|FG009|Overall Study|Objective progression or relapse|4|||
17075736|NCT00424632|38217628|FG000|Overall Study|Other|0|||
17075737|NCT00424632|38217629|FG001|Overall Study|Other|0|||
17075738|NCT00424632|38217630|FG002|Overall Study|Other|0|||
17157574|NCT03073200|38304528|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17157575|NCT03073200|38304514|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17075739|NCT00424632|38217631|FG003|Overall Study|Other|1|||
17075740|NCT00424632|38217632|FG004|Overall Study|Other|0|||
17075741|NCT00424632|38217633|FG005|Overall Study|Other|0|||
17075742|NCT00424632|38217634|FG006|Overall Study|Other|0|||
17075743|NCT00424632|38217635|FG007|Overall Study|Other|0|||
17075744|NCT00424632|38217636|FG008|Overall Study|Other|1|||
17075745|NCT00424632|38217637|FG009|Overall Study|Other|0|||
17075746|NCT00529451|38217672|FG000|Overall Study|Subject withdrew consent|16|||
17075747|NCT00529451|38217673|FG001|Overall Study|Subject withdrew consent|21|||
17075748|NCT00529451|38217674|FG002|Overall Study|Subject withdrew consent|13|||
17075749|NCT00529451|38217675|FG003|Overall Study|Subject withdrew consent|12|||
17075750|NCT00529451|38217672|FG000|Overall Study|Adverse Event|9|||
17075751|NCT00529451|38217673|FG001|Overall Study|Adverse Event|16|||
17075752|NCT00529451|38217674|FG002|Overall Study|Adverse Event|14|||
17075753|NCT00529451|38217675|FG003|Overall Study|Adverse Event|8|||
17075754|NCT00529451|38217672|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
17075755|NCT00529451|38217673|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
17075756|NCT00529451|38217674|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
17075757|NCT00529451|38217675|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
17075758|NCT00529451|38217672|FG000|Overall Study|Lost to Follow-up|4|||
17075759|NCT00529451|38217673|FG001|Overall Study|Lost to Follow-up|7|||
17075760|NCT00529451|38217674|FG002|Overall Study|Lost to Follow-up|4|||
17075761|NCT00529451|38217675|FG003|Overall Study|Lost to Follow-up|4|||
17075762|NCT00529451|38217672|FG000|Overall Study|Protocol deviation|1|||
17075763|NCT00529451|38217673|FG001|Overall Study|Protocol deviation|1|||
17075764|NCT00529451|38217674|FG002|Overall Study|Protocol deviation|4|||
17075765|NCT00529451|38217675|FG003|Overall Study|Protocol deviation|1|||
17075766|NCT00529451|38217672|FG000|Overall Study|Administrative problems|1|||
17075767|NCT00529451|38217673|FG001|Overall Study|Administrative problems|1|||
17075768|NCT00529451|38217674|FG002|Overall Study|Administrative problems|0|||
17075769|NCT00529451|38217675|FG003|Overall Study|Administrative problems|2|||
17075770|NCT03876743|38217692|FG000|Overall Study|Lost to Follow-up|6|||
17075771|NCT03876743|38217693|FG001|Overall Study|Lost to Follow-up|4|||
17075772|NCT03876743|38217694|FG002|Overall Study|Lost to Follow-up|4|||
17075773|NCT03876743|38217695|FG003|Overall Study|Lost to Follow-up|7|||
17075774|NCT00486278|38217709|FG000|Overall Study|Adverse Event|5|||
17075775|NCT00486278|38217709|FG000|Overall Study|Withdrawal by Subject|2|||
17075776|NCT00486278|38217709|FG000|Overall Study|Physician Decision|2|||
17075777|NCT00321711|38217728|FG000|Part A|Adverse Event|3|||
17075778|NCT00321711|38217729|FG001|Part A|Adverse Event|3|||
17075779|NCT00321711|38217730|FG002|Part A|Adverse Event|2|||
17075780|NCT00321711|38217731|FG003|Part A|Adverse Event|0|||
17075781|NCT00321711|38217732|FG004|Part A|Adverse Event|0|||
17075782|NCT00321711|38217728|FG000|Part A|Withdrawal by Subject|1|||
17075783|NCT00321711|38217729|FG001|Part A|Withdrawal by Subject|1|||
17075784|NCT00321711|38217730|FG002|Part A|Withdrawal by Subject|1|||
17075785|NCT00321711|38217731|FG003|Part A|Withdrawal by Subject|0|||
17075786|NCT00321711|38217732|FG004|Part A|Withdrawal by Subject|0|||
17075787|NCT00321711|38217728|FG000|Part A|Disease progression|0|||
17075788|NCT00321711|38217729|FG001|Part A|Disease progression|1|||
17075789|NCT00321711|38217730|FG002|Part A|Disease progression|0|||
17075790|NCT00321711|38217731|FG003|Part A|Disease progression|0|||
17075791|NCT00321711|38217732|FG004|Part A|Disease progression|0|||
17075792|NCT00321711|38217728|FG000|Part A|Requirement for alternative therapy|0|||
17075793|NCT00321711|38217729|FG001|Part A|Requirement for alternative therapy|2|||
17075794|NCT00321711|38217730|FG002|Part A|Requirement for alternative therapy|1|||
17075795|NCT00321711|38217731|FG003|Part A|Requirement for alternative therapy|0|||
17075796|NCT00321711|38217732|FG004|Part A|Requirement for alternative therapy|0|||
17075797|NCT00321711|38217728|FG000|Part A|Physician Decision|0|||
17075798|NCT00321711|38217729|FG001|Part A|Physician Decision|1|||
17075799|NCT00321711|38217730|FG002|Part A|Physician Decision|3|||
17075800|NCT00321711|38217731|FG003|Part A|Physician Decision|0|||
17075801|NCT00321711|38217732|FG004|Part A|Physician Decision|0|||
17075802|NCT00321711|38217728|FG000|Part A|Other|1|||
17075803|NCT00321711|38217729|FG001|Part A|Other|2|||
17075804|NCT00321711|38217730|FG002|Part A|Other|3|||
17075805|NCT00321711|38217731|FG003|Part A|Other|0|||
17075806|NCT00321711|38217732|FG004|Part A|Other|0|||
17075807|NCT00321711|38217728|FG000|Part A|Protocol deviation|0|||
17075808|NCT00321711|38217729|FG001|Part A|Protocol deviation|0|||
17075809|NCT00321711|38217730|FG002|Part A|Protocol deviation|1|||
17075810|NCT00321711|38217731|FG003|Part A|Protocol deviation|0|||
17075811|NCT00321711|38217732|FG004|Part A|Protocol deviation|0|||
17075812|NCT00321711|38217728|FG000|Part B|Noncompliance|0|||
17075813|NCT00321711|38217729|FG001|Part B|Noncompliance|0|||
17075814|NCT00321711|38217730|FG002|Part B|Noncompliance|0|||
17075815|NCT00321711|38217731|FG003|Part B|Noncompliance|0|||
17075816|NCT00321711|38217732|FG004|Part B|Noncompliance|1|||
17075817|NCT00321711|38217728|FG000|Part B|Adverse Event|0|||
17075818|NCT00321711|38217729|FG001|Part B|Adverse Event|0|||
17075819|NCT00321711|38217730|FG002|Part B|Adverse Event|0|||
17075820|NCT00321711|38217731|FG003|Part B|Adverse Event|2|||
17075821|NCT00321711|38217732|FG004|Part B|Adverse Event|1|||
17075822|NCT00321711|38217728|FG000|Part B|Disease progression|0|||
17075823|NCT00321711|38217729|FG001|Part B|Disease progression|0|||
17075824|NCT00321711|38217730|FG002|Part B|Disease progression|0|||
17075825|NCT00321711|38217731|FG003|Part B|Disease progression|1|||
17075826|NCT00321711|38217732|FG004|Part B|Disease progression|0|||
17075827|NCT00321711|38217728|FG000|Part B|Physician Decision|0|||
17075828|NCT00321711|38217729|FG001|Part B|Physician Decision|0|||
17075829|NCT00321711|38217730|FG002|Part B|Physician Decision|0|||
17075830|NCT00321711|38217731|FG003|Part B|Physician Decision|1|||
17075831|NCT00321711|38217732|FG004|Part B|Physician Decision|2|||
17075832|NCT00321711|38217728|FG000|Part B|Death|0|||
17075833|NCT00321711|38217729|FG001|Part B|Death|0|||
17075834|NCT00321711|38217730|FG002|Part B|Death|0|||
17075835|NCT00321711|38217731|FG003|Part B|Death|2|||
17075836|NCT00321711|38217732|FG004|Part B|Death|1|||
17075837|NCT00486044|38217746|FG000|Overall Study|Withdrawal by Subject|2|||
17075838|NCT00486044|38217747|FG001|Overall Study|Withdrawal by Subject|1|||
17075839|NCT00486044|38217746|FG000|Overall Study|Adverse Event|0|||
17075840|NCT00486044|38217747|FG001|Overall Study|Adverse Event|1|||
17075841|NCT00486044|38217746|FG000|Overall Study|Lost to Follow-up|0|||
17075842|NCT00486044|38217747|FG001|Overall Study|Lost to Follow-up|1|||
17075843|NCT00351273|38217756|FG000|Overall Study|Lost to Follow-up|1|||
17157576|NCT03073200|38304515|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157577|NCT03073200|38304516|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157578|NCT03073200|38304517|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157579|NCT03073200|38304518|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157580|NCT03073200|38304519|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157581|NCT03073200|38304520|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157582|NCT03073200|38304521|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157583|NCT03073200|38304522|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157584|NCT03073200|38304523|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17075844|NCT00351273|38217757|FG001|Overall Study|Lost to Follow-up|2|||
17075845|NCT00351273|38217758|FG002|Overall Study|Lost to Follow-up|5|||
17075846|NCT00327717|38217773|FG000|Overall Study|Adverse Event|6|||
17075847|NCT00327717|38217774|FG001|Overall Study|Adverse Event|6|||
17075848|NCT00327717|38217773|FG000|Overall Study|Lack of Efficacy|0|||
17075849|NCT00327717|38217774|FG001|Overall Study|Lack of Efficacy|1|||
17075850|NCT00327717|38217773|FG000|Overall Study|Withdrawal by Subject|3|||
17075851|NCT00327717|38217774|FG001|Overall Study|Withdrawal by Subject|7|||
17075852|NCT00463346|38217782|FG000|Overall Study|Withdrawal by Subject|3|||
17075853|NCT00463346|38217783|FG001|Overall Study|Withdrawal by Subject|3|||
17075854|NCT00462488|38217793|FG000|Overall Study|Protocol Violation|1|||
17075855|NCT00462488|38217794|FG001|Overall Study|Protocol Violation|0|||
17075856|NCT00462488|38217793|FG000|Overall Study|Lack of Efficacy|19|||
17075857|NCT00462488|38217794|FG001|Overall Study|Lack of Efficacy|17|||
17075858|NCT00454142|38217800|FG000|Overall Study|Withdrawal by Subject|1|||
17075859|NCT00424476|38217809|FG000|Overall Study|Withdrawal by Subject|7|||
17075860|NCT00424476|38217810|FG001|Overall Study|Withdrawal by Subject|6|||
17075861|NCT00424476|38217811|FG002|Overall Study|Withdrawal by Subject|3|||
17075862|NCT00424476|38217809|FG000|Overall Study|Adverse Event|19|||
17075863|NCT00424476|38217810|FG001|Overall Study|Adverse Event|16|||
17075864|NCT00424476|38217811|FG002|Overall Study|Adverse Event|15|||
17075865|NCT00424476|38217809|FG000|Overall Study|Lack of Efficacy|16|||
17075866|NCT00424476|38217810|FG001|Overall Study|Lack of Efficacy|12|||
17075867|NCT00424476|38217811|FG002|Overall Study|Lack of Efficacy|12|||
17075868|NCT00424476|38217809|FG000|Overall Study|Lack of Compliance|1|||
17075869|NCT00424476|38217810|FG001|Overall Study|Lack of Compliance|1|||
17075870|NCT00424476|38217811|FG002|Overall Study|Lack of Compliance|1|||
17075871|NCT00424476|38217809|FG000|Overall Study|Lost to Follow-up|4|||
17075872|NCT00424476|38217810|FG001|Overall Study|Lost to Follow-up|6|||
17075873|NCT00424476|38217811|FG002|Overall Study|Lost to Follow-up|3|||
17075874|NCT00424476|38217809|FG000|Overall Study|Protocol Violation|7|||
17075875|NCT00424476|38217810|FG001|Overall Study|Protocol Violation|2|||
17075876|NCT00424476|38217811|FG002|Overall Study|Protocol Violation|3|||
17075877|NCT00424476|38217809|FG000|Overall Study|Physician Decision|3|||
17075878|NCT00424476|38217810|FG001|Overall Study|Physician Decision|2|||
17075879|NCT00424476|38217811|FG002|Overall Study|Physician Decision|3|||
17075880|NCT00424476|38217809|FG000|Overall Study|Other|4|||
17075881|NCT00424476|38217810|FG001|Overall Study|Other|3|||
17075882|NCT00424476|38217811|FG002|Overall Study|Other|9|||
17075883|NCT00453986|38217824|FG000|Overall Study|Lost to Follow-up|6|||
17075884|NCT00453986|38217825|FG001|Overall Study|Lost to Follow-up|5|||
17075885|NCT00453986|38217826|FG002|Overall Study|Lost to Follow-up|6|||
17075886|NCT00453986|38217827|FG003|Overall Study|Lost to Follow-up|2|||
17075887|NCT00453986|38217828|FG004|Overall Study|Lost to Follow-up|0|||
17075888|NCT00435942|38217846|FG000|Overall Study|Death|17|||
17075889|NCT00435942|38217847|FG001|Overall Study|Death|10|||
17075890|NCT00435942|38217846|FG000|Overall Study|Withdrawal by Subject|2|||
17075891|NCT00435942|38217847|FG001|Overall Study|Withdrawal by Subject|0|||
17075892|NCT00435942|38217846|FG000|Overall Study|Lost to Follow-up|0|||
17075893|NCT00435942|38217847|FG001|Overall Study|Lost to Follow-up|16|||
17075894|NCT00435942|38217846|FG000|Overall Study|Conversion to Open Repair|1|||
17075895|NCT00435942|38217847|FG001|Overall Study|Conversion to Open Repair|0|||
17075896|NCT00435942|38217846|FG000|Overall Study|Technical Failure|3|||
17075897|NCT00435942|38217847|FG001|Overall Study|Technical Failure|0|||
17075898|NCT00435942|38217846|FG000|Overall Study|Other|0|||
17075899|NCT00435942|38217847|FG001|Overall Study|Other|1|||
17075900|NCT00453362|38217853|FG000|Overall Study|Adverse Event|5|||
17075901|NCT00453362|38217853|FG000|Overall Study|Death|7|||
17157585|NCT03073200|38304524|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157586|NCT03073200|38304525|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157587|NCT03073200|38304526|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157588|NCT03073200|38304527|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
17157589|NCT03073200|38304528|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
17157590|NCT03073200|38304514|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157591|NCT03073200|38304515|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157592|NCT03073200|38304516|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157593|NCT03073200|38304517|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157594|NCT03073200|38304518|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157595|NCT03073200|38304519|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157596|NCT03073200|38304520|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157597|NCT03073200|38304521|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157598|NCT03073200|38304522|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157599|NCT03073200|38304523|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157600|NCT03073200|38304524|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157601|NCT03073200|38304525|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157602|NCT03073200|38304526|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157603|NCT03073200|38304527|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
17157604|NCT03073200|38304528|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
17157605|NCT03073200|38304514|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157606|NCT03073200|38304515|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157607|NCT03073200|38304516|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157608|NCT03073200|38304517|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157609|NCT03073200|38304518|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157610|NCT03073200|38304519|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157611|NCT03073200|38304520|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157612|NCT03073200|38304521|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157613|NCT03073200|38304522|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157614|NCT03073200|38304523|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157615|NCT03073200|38304524|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157616|NCT03073200|38304525|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157617|NCT03073200|38304526|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157618|NCT03073200|38304527|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
17157619|NCT03073200|38304528|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
17157620|NCT03073200|38304514|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157621|NCT03073200|38304515|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157622|NCT03073200|38304516|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157623|NCT03073200|38304517|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157624|NCT03073200|38304518|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157625|NCT03073200|38304519|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157626|NCT03073200|38304520|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157627|NCT03073200|38304521|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157628|NCT03073200|38304522|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157629|NCT03073200|38304523|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157630|NCT03073200|38304524|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157631|NCT03073200|38304525|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17075902|NCT00453362|38217853|FG000|Overall Study|Physician Decision|2|||
17157632|NCT03073200|38304526|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157633|NCT03073200|38304527|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
17075903|NCT00453362|38217853|FG000|Overall Study|Withdrawal by Subject|3|||
17075904|NCT00453362|38217853|FG000|Overall Study|Progression of disease|56|||
17157634|NCT03073200|38304528|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
17157635|NCT03073200|38304514|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157636|NCT03073200|38304515|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157637|NCT03073200|38304516|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157638|NCT03073200|38304517|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157639|NCT03073200|38304518|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157640|NCT03073200|38304519|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157641|NCT03073200|38304520|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17075905|NCT00453362|38217853|FG000|Overall Study|Screening Failure|14|||
17075906|NCT00424398|38217872|FG000|Overall Study|Withdrawal by Subject|2|||
17075907|NCT00424398|38217873|FG001|Overall Study|Withdrawal by Subject|1|||
17075908|NCT00424398|38217874|FG002|Overall Study|Withdrawal by Subject|0|||
17075909|NCT00424398|38217872|FG000|Overall Study|Subject met exclusion criteria|1|||
17075910|NCT00424398|38217873|FG001|Overall Study|Subject met exclusion criteria|0|||
17075911|NCT00424398|38217874|FG002|Overall Study|Subject met exclusion criteria|0|||
17075912|NCT00461786|38217882|FG000|Overall Study|Entry Criteria Not Met|2|||
17075913|NCT00461786|38217882|FG000|Overall Study|Inevaluable (Never Treated)|1|||
17075914|NCT00435162|38217889|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
17075915|NCT00435162|38217890|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
17157642|NCT03073200|38304521|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157643|NCT03073200|38304522|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157644|NCT03073200|38304523|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157645|NCT03073200|38304524|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157646|NCT03073200|38304525|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157647|NCT03073200|38304526|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157648|NCT03073200|38304527|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
17157649|NCT03073200|38304528|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
17157650|NCT03073200|38304514|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157651|NCT03073200|38304515|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157652|NCT03073200|38304516|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157653|NCT03073200|38304517|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157654|NCT03073200|38304518|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17075916|NCT00435162|38217891|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
17075917|NCT00435162|38217892|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
17075918|NCT00435162|38217893|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
17075919|NCT00435162|38217894|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
17075920|NCT03836664|38217909|FG000|Overall Study|Didn't complete forms and lost drug|3|||
17075921|NCT03836664|38217910|FG001|Overall Study|Didn't complete forms and lost drug|3|||
17075922|NCT00350727|38217923|FG000|Phase I: Dose Escalation|Adverse Event|4|||
17075923|NCT00350727|38217924|FG001|Phase I: Dose Escalation|Adverse Event|0|||
17075924|NCT00350727|38217925|FG002|Phase I: Dose Escalation|Adverse Event|0|||
17075925|NCT00350727|38217923|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
17075926|NCT00350727|38217924|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
17075927|NCT00350727|38217925|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
17075928|NCT00350727|38217923|FG000|Phase I: Dose Escalation|Death|1|||
17075929|NCT00350727|38217924|FG001|Phase I: Dose Escalation|Death|0|||
17075930|NCT00350727|38217925|FG002|Phase I: Dose Escalation|Death|0|||
17075931|NCT00350727|38217923|FG000|Phase I: Dose Escalation|Physician Decision|1|||
17075932|NCT00350727|38217924|FG001|Phase I: Dose Escalation|Physician Decision|0|||
17075933|NCT00350727|38217925|FG002|Phase I: Dose Escalation|Physician Decision|0|||
17075934|NCT00350727|38217923|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
17075935|NCT00350727|38217924|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
17075936|NCT00350727|38217925|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
17075937|NCT00350727|38217923|FG000|Phase II|Disease Progression|0|||
17075938|NCT00350727|38217924|FG001|Phase II|Disease Progression|15|||
17075939|NCT00350727|38217925|FG002|Phase II|Disease Progression|16|||
17075940|NCT00350727|38217923|FG000|Phase II|Clinical Deterioration|0|||
17075941|NCT00350727|38217924|FG001|Phase II|Clinical Deterioration|1|||
17075942|NCT00350727|38217925|FG002|Phase II|Clinical Deterioration|0|||
17075943|NCT00350727|38217923|FG000|Phase II|Withdrawal by Subject|0|||
17075944|NCT00350727|38217924|FG001|Phase II|Withdrawal by Subject|2|||
17075945|NCT00350727|38217925|FG002|Phase II|Withdrawal by Subject|1|||
17075946|NCT00350727|38217923|FG000|Phase II|Adverse Event|0|||
17075947|NCT00350727|38217924|FG001|Phase II|Adverse Event|1|||
17075948|NCT00350727|38217925|FG002|Phase II|Adverse Event|1|||
17075949|NCT00350727|38217923|FG000|Phase II|Death|0|||
17075950|NCT00350727|38217924|FG001|Phase II|Death|0|||
17075951|NCT00350727|38217925|FG002|Phase II|Death|2|||
17075952|NCT00350727|38217923|FG000|Phase II|Sponsor Terminated Study|0|||
17075953|NCT00350727|38217924|FG001|Phase II|Sponsor Terminated Study|0|||
17075954|NCT00350727|38217925|FG002|Phase II|Sponsor Terminated Study|1|||
17075955|NCT00350727|38217923|FG000|Phase II|Enrolled in Rollover Study|0|||
17075956|NCT00350727|38217924|FG001|Phase II|Enrolled in Rollover Study|0|||
17075957|NCT00350727|38217925|FG002|Phase II|Enrolled in Rollover Study|1|||
17075958|NCT00434304|38217944|FG000|Overall Study|Adverse Event|14|||
17075959|NCT00434304|38217944|FG000|Overall Study|Lack of Efficacy|2|||
17075960|NCT00434304|38217944|FG000|Overall Study|Withdrawal by Subject|4|||
17075961|NCT00424008|38217951|FG000|Overall Study|Adverse Event|8|||
17075962|NCT00424008|38217952|FG001|Overall Study|Adverse Event|6|||
17075963|NCT00424008|38217951|FG000|Overall Study|Lack of Efficacy|40|||
17075964|NCT00424008|38217952|FG001|Overall Study|Lack of Efficacy|34|||
17075965|NCT00424008|38217951|FG000|Overall Study|Lost to Follow-up|1|||
17075966|NCT00424008|38217952|FG001|Overall Study|Lost to Follow-up|2|||
17075967|NCT00424008|38217951|FG000|Overall Study|Withdrawal by Subject|5|||
17075968|NCT00424008|38217952|FG001|Overall Study|Withdrawal by Subject|8|||
17075969|NCT00424008|38217951|FG000|Overall Study|Noncompliance with protocol|13|||
17075970|NCT00424008|38217952|FG001|Overall Study|Noncompliance with protocol|7|||
17075971|NCT00424008|38217951|FG000|Overall Study|Did not meet protocol eligibility|16|||
17075972|NCT00424008|38217952|FG001|Overall Study|Did not meet protocol eligibility|21|||
17075973|NCT00424008|38217951|FG000|Overall Study|Administrative|266|||
17075974|NCT00424008|38217952|FG001|Overall Study|Administrative|257|||
17075975|NCT00423930|38217959|FG000|Overall Study|Withdrawal by Subject|2|||
17075976|NCT00423852|38217963|FG000|Overall Study|Removed pior to the high-dose portion|3|||
17075977|NCT00461708|38217969|FG000|Overall Study|Adverse Event|17|||
17075978|NCT00461708|38217970|FG001|Overall Study|Adverse Event|7|||
17075979|NCT00461708|38217969|FG000|Overall Study|Lack of Efficacy|68|||
17075980|NCT00461708|38217970|FG001|Overall Study|Lack of Efficacy|20|||
17075981|NCT00461708|38217969|FG000|Overall Study|Physician Decision|10|||
17075982|NCT00461708|38217970|FG001|Overall Study|Physician Decision|4|||
17075983|NCT00461708|38217969|FG000|Overall Study|Withdrawal by Subject|8|||
17075984|NCT00461708|38217970|FG001|Overall Study|Withdrawal by Subject|2|||
17075985|NCT00461708|38217969|FG000|Overall Study|Other|4|||
17075986|NCT00461708|38217970|FG001|Overall Study|Other|4|||
17075987|NCT00461708|38217969|FG000|Overall Study|Death|8|||
17075988|NCT00461708|38217970|FG001|Overall Study|Death|1|||
17075989|NCT00327171|38217981|FG000|Overall Study|Did not receive study medication|3|||
17075990|NCT00327171|38217982|FG001|Overall Study|Did not receive study medication|0|||
17157655|NCT03073200|38304519|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157656|NCT03073200|38304520|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157657|NCT03073200|38304521|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157658|NCT03073200|38304522|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157659|NCT03073200|38304523|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157660|NCT03073200|38304524|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157661|NCT03073200|38304525|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157662|NCT03073200|38304526|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157663|NCT03073200|38304527|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
17157664|NCT03073200|38304528|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
17157665|NCT03290781|38304557|FG000|Overall Study|Adverse Event|5|||
17157666|NCT03290781|38304558|FG001|Overall Study|Adverse Event|7|||
17157667|NCT03290781|38304559|FG002|Overall Study|Adverse Event|4|||
17157668|NCT03290781|38304560|FG003|Overall Study|Adverse Event|1|||
17157669|NCT03290781|38304561|FG004|Overall Study|Adverse Event|0|||
17157670|NCT03290781|38304562|FG005|Overall Study|Adverse Event|0|||
17157671|NCT03290781|38304563|FG006|Overall Study|Adverse Event|0|||
17157672|NCT03290781|38304557|FG000|Overall Study|Death|0|||
17157673|NCT03290781|38304558|FG001|Overall Study|Death|0|||
17157674|NCT03290781|38304559|FG002|Overall Study|Death|1|||
17157675|NCT03290781|38304560|FG003|Overall Study|Death|0|||
17157676|NCT03290781|38304561|FG004|Overall Study|Death|1|||
17157677|NCT03290781|38304562|FG005|Overall Study|Death|0|||
17157678|NCT03290781|38304563|FG006|Overall Study|Death|0|||
17157679|NCT03290781|38304557|FG000|Overall Study|Withdrawal by Subject|6|||
17157680|NCT03290781|38304558|FG001|Overall Study|Withdrawal by Subject|5|||
17157681|NCT03290781|38304559|FG002|Overall Study|Withdrawal by Subject|9|||
17157682|NCT03290781|38304560|FG003|Overall Study|Withdrawal by Subject|10|||
17157683|NCT03290781|38304561|FG004|Overall Study|Withdrawal by Subject|1|||
17157684|NCT03290781|38304562|FG005|Overall Study|Withdrawal by Subject|2|||
17157685|NCT03290781|38304563|FG006|Overall Study|Withdrawal by Subject|0|||
17157686|NCT03290781|38304557|FG000|Overall Study|Physician Decision|0|||
17157687|NCT03290781|38304558|FG001|Overall Study|Physician Decision|1|||
17157688|NCT03290781|38304559|FG002|Overall Study|Physician Decision|0|||
17157689|NCT03290781|38304560|FG003|Overall Study|Physician Decision|0|||
17157690|NCT03290781|38304561|FG004|Overall Study|Physician Decision|0|||
17157691|NCT03290781|38304562|FG005|Overall Study|Physician Decision|0|||
17157692|NCT03290781|38304563|FG006|Overall Study|Physician Decision|0|||
17157693|NCT03290781|38304557|FG000|Overall Study|Site Terminated by Sponsor|1|||
17157694|NCT03290781|38304558|FG001|Overall Study|Site Terminated by Sponsor|0|||
17157695|NCT03290781|38304559|FG002|Overall Study|Site Terminated by Sponsor|2|||
17157696|NCT03290781|38304560|FG003|Overall Study|Site Terminated by Sponsor|1|||
17157697|NCT03290781|38304561|FG004|Overall Study|Site Terminated by Sponsor|0|||
17157698|NCT03290781|38304562|FG005|Overall Study|Site Terminated by Sponsor|0|||
17157699|NCT03290781|38304563|FG006|Overall Study|Site Terminated by Sponsor|0|||
17075991|NCT00327171|38217981|FG000|Overall Study|Adverse Event|23|||
17075992|NCT00327171|38217982|FG001|Overall Study|Adverse Event|23|||
17075993|NCT00327171|38217981|FG000|Overall Study|Disease progression/lack of efficacy|68|||
17075994|NCT00327171|38217982|FG001|Overall Study|Disease progression/lack of efficacy|69|||
17075995|NCT00327171|38217981|FG000|Overall Study|Investigator/participant request|1|||
17075996|NCT00327171|38217982|FG001|Overall Study|Investigator/participant request|8|||
17075997|NCT00327171|38217981|FG000|Overall Study|Clinical progression|12|||
17075998|NCT00327171|38217982|FG001|Overall Study|Clinical progression|8|||
17075999|NCT00327171|38217981|FG000|Overall Study|Undisclosed history of ischemia|0|||
17076000|NCT00327171|38217982|FG001|Overall Study|Undisclosed history of ischemia|1|||
17076001|NCT00327171|38217981|FG000|Overall Study|Other|1|||
17076002|NCT00327171|38217982|FG001|Overall Study|Other|0|||
17076003|NCT00461630|38217990|FG000|Overall Study|Death|798|||
17076004|NCT00461630|38217991|FG001|Overall Study|Death|732|||
17076005|NCT00461630|38217990|FG000|Overall Study|Lost to Follow-up|108|||
17076006|NCT00461630|38217991|FG001|Overall Study|Lost to Follow-up|95|||
17076007|NCT00461552|38217999|FG000|Overall Study|Drug Dispensing error|0|||
17076008|NCT00461552|38218000|FG001|Overall Study|Drug Dispensing error|2|||
17076009|NCT00453206|38218006|FG000|Overall Study|Death|1|||
17076010|NCT03850496|38218013|FG000|Overall Study|Withdrawal by Subject|1|||
17076011|NCT03850496|38218014|FG001|Overall Study|Withdrawal by Subject|0|||
17076012|NCT03850496|38218015|FG002|Overall Study|Withdrawal by Subject|0|||
17076013|NCT03850496|38218013|FG000|Overall Study|Lost to Follow-up|0|||
17076014|NCT03850496|38218014|FG001|Overall Study|Lost to Follow-up|1|||
17076015|NCT03850496|38218015|FG002|Overall Study|Lost to Follow-up|4|||
17076016|NCT00327015|38218027|FG000|Overall Study|Lack of Efficacy|18|||
17076017|NCT00327015|38218028|FG001|Overall Study|Lack of Efficacy|18|||
17076018|NCT00327015|38218029|FG002|Overall Study|Lack of Efficacy|35|||
17076019|NCT00327015|38218030|FG003|Overall Study|Lack of Efficacy|29|||
17076020|NCT00327015|38218027|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
17076021|NCT00327015|38218028|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
17076022|NCT00327015|38218029|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
17076023|NCT00327015|38218030|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
17076024|NCT00327015|38218027|FG000|Overall Study|Lost to Follow-up|22|||
17076025|NCT00327015|38218028|FG001|Overall Study|Lost to Follow-up|23|||
17076026|NCT00327015|38218029|FG002|Overall Study|Lost to Follow-up|29|||
17076027|NCT00327015|38218030|FG003|Overall Study|Lost to Follow-up|22|||
17076028|NCT00327015|38218027|FG000|Overall Study|Adverse Event|14|||
17076029|NCT00327015|38218028|FG001|Overall Study|Adverse Event|10|||
17076030|NCT00327015|38218029|FG002|Overall Study|Adverse Event|14|||
17076031|NCT00327015|38218030|FG003|Overall Study|Adverse Event|14|||
17076032|NCT00327015|38218027|FG000|Overall Study|Subject no longer meets study criteria|4|||
17076033|NCT00327015|38218028|FG001|Overall Study|Subject no longer meets study criteria|2|||
17076034|NCT00327015|38218029|FG002|Overall Study|Subject no longer meets study criteria|8|||
17076035|NCT00327015|38218030|FG003|Overall Study|Subject no longer meets study criteria|7|||
17076036|NCT00327015|38218027|FG000|Overall Study|Poor/Noncompliance|11|||
17076037|NCT00327015|38218028|FG001|Overall Study|Poor/Noncompliance|8|||
17076038|NCT00327015|38218029|FG002|Overall Study|Poor/Noncompliance|4|||
17076039|NCT00327015|38218030|FG003|Overall Study|Poor/Noncompliance|5|||
17076040|NCT00327015|38218027|FG000|Overall Study|Physician Decision|0|||
17076041|NCT00327015|38218028|FG001|Overall Study|Physician Decision|1|||
17076042|NCT00327015|38218029|FG002|Overall Study|Physician Decision|3|||
17076043|NCT00327015|38218030|FG003|Overall Study|Physician Decision|2|||
17076044|NCT00327015|38218027|FG000|Overall Study|Death|1|||
17076045|NCT00327015|38218028|FG001|Overall Study|Death|2|||
17076046|NCT00327015|38218029|FG002|Overall Study|Death|2|||
17076047|NCT00327015|38218030|FG003|Overall Study|Death|3|||
17076048|NCT00327015|38218027|FG000|Overall Study|Pregnancy|0|||
17076049|NCT00327015|38218028|FG001|Overall Study|Pregnancy|2|||
17076050|NCT00327015|38218029|FG002|Overall Study|Pregnancy|1|||
17076051|NCT00327015|38218030|FG003|Overall Study|Pregnancy|1|||
17076052|NCT00327015|38218027|FG000|Overall Study|Administrative Reason by Sponsor|1|||
17076053|NCT00327015|38218028|FG001|Overall Study|Administrative Reason by Sponsor|2|||
17076054|NCT00327015|38218029|FG002|Overall Study|Administrative Reason by Sponsor|2|||
17076055|NCT00327015|38218030|FG003|Overall Study|Administrative Reason by Sponsor|1|||
17076056|NCT00434148|38218042|FG000|Overall Study|Adverse Event|18|||
17076057|NCT00434148|38218043|FG001|Overall Study|Adverse Event|18|||
17076058|NCT00434148|38218042|FG000|Overall Study|Lack of Efficacy|25|||
17157700|NCT03290781|38304557|FG000|Overall Study|Lost to Follow-up|0|||
17076059|NCT00434148|38218043|FG001|Overall Study|Lack of Efficacy|28|||
17076060|NCT00434148|38218042|FG000|Overall Study|Withdrawal by Subject|15|||
17157701|NCT03290781|38304558|FG001|Overall Study|Lost to Follow-up|0|||
17157702|NCT03290781|38304559|FG002|Overall Study|Lost to Follow-up|0|||
17157703|NCT03290781|38304560|FG003|Overall Study|Lost to Follow-up|1|||
17157704|NCT03290781|38304561|FG004|Overall Study|Lost to Follow-up|0|||
17157705|NCT03290781|38304562|FG005|Overall Study|Lost to Follow-up|0|||
17157706|NCT03290781|38304563|FG006|Overall Study|Lost to Follow-up|0|||
17157707|NCT03290781|38304557|FG000|Overall Study|Protocol Deviation|2|||
17157708|NCT03290781|38304558|FG001|Overall Study|Protocol Deviation|0|||
17157709|NCT03290781|38304559|FG002|Overall Study|Protocol Deviation|0|||
17157710|NCT03290781|38304560|FG003|Overall Study|Protocol Deviation|1|||
17157711|NCT03290781|38304561|FG004|Overall Study|Protocol Deviation|0|||
17157712|NCT03290781|38304562|FG005|Overall Study|Protocol Deviation|0|||
17157713|NCT03290781|38304563|FG006|Overall Study|Protocol Deviation|0|||
17157714|NCT03290781|38304557|FG000|Overall Study|Disease Relapse|32|||
17157715|NCT03290781|38304558|FG001|Overall Study|Disease Relapse|5|||
17157716|NCT03290781|38304559|FG002|Overall Study|Disease Relapse|38|||
17157717|NCT03290781|38304560|FG003|Overall Study|Disease Relapse|7|||
17157718|NCT03290781|38304561|FG004|Overall Study|Disease Relapse|3|||
17157719|NCT03290781|38304562|FG005|Overall Study|Disease Relapse|1|||
17157720|NCT03290781|38304563|FG006|Overall Study|Disease Relapse|4|||
17157721|NCT03290781|38304557|FG000|Overall Study|Other|3|||
17157722|NCT03290781|38304558|FG001|Overall Study|Other|0|||
17157723|NCT03290781|38304559|FG002|Overall Study|Other|2|||
17157724|NCT03290781|38304560|FG003|Overall Study|Other|2|||
17157725|NCT03290781|38304561|FG004|Overall Study|Other|0|||
17157726|NCT03290781|38304562|FG005|Overall Study|Other|0|||
17157727|NCT03290781|38304563|FG006|Overall Study|Other|0|||
17157728|NCT03466073|38304592|FG000|Overall Study|Death|1|||
17157729|NCT03466073|38304593|FG001|Overall Study|Death|0|||
17157730|NCT03466073|38304594|FG002|Overall Study|Death|0|||
17076061|NCT00434148|38218043|FG001|Overall Study|Withdrawal by Subject|15|||
17076062|NCT00434148|38218042|FG000|Overall Study|Protocol Violation|4|||
17076063|NCT00434148|38218043|FG001|Overall Study|Protocol Violation|0|||
17076064|NCT00434148|38218042|FG000|Overall Study|Administrative problems|6|||
17076065|NCT00434148|38218043|FG001|Overall Study|Administrative problems|10|||
17076066|NCT00434148|38218042|FG000|Overall Study|Lost to Follow-up|0|||
17076067|NCT00434148|38218043|FG001|Overall Study|Lost to Follow-up|1|||
17076068|NCT00434148|38218042|FG000|Overall Study|Condition no longer requires study drug|1|||
17076069|NCT00434148|38218043|FG001|Overall Study|Condition no longer requires study drug|0|||
17076070|NCT00434148|38218042|FG000|Overall Study|Abnormal test procedure result|0|||
17076071|NCT00434148|38218043|FG001|Overall Study|Abnormal test procedure result|1|||
17076072|NCT00468728|38218051|FG000|Treatment|criteria for mITT population|4|||
17076073|NCT00468728|38218052|FG001|Treatment|criteria for mITT population|11|||
17076074|NCT00468728|38218051|FG000|Follow-up|mITT failure|34|||
17076075|NCT00468728|38218052|FG001|Follow-up|mITT failure|31|||
17076076|NCT00433914|38218062|FG000|Overall Study|Withdrawal by Subject|0|||
17076077|NCT00433914|38218063|FG001|Overall Study|Withdrawal by Subject|2|||
17076078|NCT00433914|38218062|FG000|Overall Study|Lost to Follow-up|0|||
17076079|NCT00433914|38218063|FG001|Overall Study|Lost to Follow-up|1|||
17076080|NCT00321555|38218069|FG000|Overall Study|Developed antibodies|1|||
17076081|NCT00321555|38218069|FG000|Overall Study|Switched to alternative treatment|3|||
17076082|NCT00321555|38218069|FG000|Overall Study|Physician Decision|1|||
17076083|NCT00321555|38218069|FG000|Overall Study|Disease progression on study|1|||
17076084|NCT00468650|38218073|FG000|Overall Study|Lost to Follow-up|4|||
17076085|NCT00468650|38218073|FG000|Overall Study|Withdrawal by Subject|2|||
17076086|NCT00468650|38218073|FG000|Overall Study|Protocol Violation|1|||
17076087|NCT00423150|38218078|FG000|Overall Study|Adverse Event|11|||
17076088|NCT00423150|38218078|FG000|Overall Study|Progression of disease being studied|69|||
17076089|NCT00423150|38218078|FG000|Overall Study|Withdrawal by Subject|1|||
17076090|NCT00423150|38218078|FG000|Overall Study|Non-compliance with protocol|1|||
17076091|NCT00423150|38218078|FG000|Overall Study|Administrative|4|||
17076092|NCT00433836|38218084|FG000|Overall Study|Adverse Event|7|||
17076093|NCT00433836|38218085|FG001|Overall Study|Adverse Event|0|||
17076094|NCT00433836|38218084|FG000|Overall Study|Lost to Follow-up|3|||
17076095|NCT00433836|38218085|FG001|Overall Study|Lost to Follow-up|0|||
17076096|NCT00433836|38218084|FG000|Overall Study|Withdrawal by Subject|2|||
17076097|NCT00433836|38218085|FG001|Overall Study|Withdrawal by Subject|1|||
17157731|NCT03466073|38304595|FG003|Overall Study|Death|0|||
17157732|NCT03466073|38304596|FG004|Overall Study|Death|0|||
17157733|NCT03466073|38304597|FG005|Overall Study|Death|1|||
17076098|NCT00433836|38218084|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17076099|NCT00433836|38218085|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
17076100|NCT00433836|38218084|FG000|Overall Study|Protocol Violation|0|||
17076101|NCT00433836|38218085|FG001|Overall Study|Protocol Violation|2|||
17076102|NCT00433836|38218084|FG000|Overall Study|Condition no longer requires study drug|0|||
17157734|NCT03412019|38304620|FG000|Overall Study|Withdrawal by Subject|1|||
17157735|NCT03412019|38304621|FG001|Overall Study|Withdrawal by Subject|1|||
17076103|NCT00433836|38218085|FG001|Overall Study|Condition no longer requires study drug|1|||
17076104|NCT00433836|38218084|FG000|Overall Study|Abnormal laboratory values|0|||
17076105|NCT00433836|38218085|FG001|Overall Study|Abnormal laboratory values|1|||
17076106|NCT00433446|38218091|FG000|Overall Study|Adverse Event|4|||
17076107|NCT00433446|38218091|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
17076108|NCT00433446|38218091|FG000|Overall Study|Progression|44|||
17076109|NCT00433446|38218091|FG000|Overall Study|Other - Not Protocol specified|3|||
17076110|NCT00433446|38218091|FG000|Overall Study|Ineligible|9|||
17076111|NCT00468104|38218095|FG000|First Intervention|Protocol Violation|2|||
17076112|NCT00468104|38218096|FG001|First Intervention|Protocol Violation|1|||
17076113|NCT00468104|38218095|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
17076114|NCT00468104|38218096|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
17076115|NCT00468104|38218095|FG000|First Intervention|died within 3 weeks|1|||
17076116|NCT00468104|38218096|FG001|First Intervention|died within 3 weeks|0|||
17076117|NCT00468104|38218095|FG000|First Intervention|malposition/blocked chest tube tube|2|||
17076118|NCT00468104|38218096|FG001|First Intervention|malposition/blocked chest tube tube|0|||
17076119|NCT00468104|38218095|FG000|First Intervention|large lung mass with minimal effusion|1|||
17076120|NCT00468104|38218096|FG001|First Intervention|large lung mass with minimal effusion|0|||
17076121|NCT00468104|38218095|FG000|First Intervention|associated prolonged pneumothorax|1|||
17076122|NCT00468104|38218096|FG001|First Intervention|associated prolonged pneumothorax|0|||
17076123|NCT00468104|38218095|FG000|First Intervention|trapped lung|1|||
17076124|NCT00468104|38218096|FG001|First Intervention|trapped lung|0|||
17076125|NCT00468104|38218095|FG000|Second Intervention|Withdrawal by Subject|5|||
17076126|NCT00468104|38218096|FG001|Second Intervention|Withdrawal by Subject|2|||
17076127|NCT00468104|38218095|FG000|Second Intervention|discarded for malposition of chest tube|0|||
17076128|NCT00468104|38218096|FG001|Second Intervention|discarded for malposition of chest tube|2|||
17076129|NCT00326625|38218107|FG000|Overall Study|Adverse Event|20|||
17076130|NCT00326625|38218108|FG001|Overall Study|Adverse Event|9|||
17076131|NCT00326625|38218107|FG000|Overall Study|Withdrawal by Subject|15|||
17076132|NCT00326625|38218108|FG001|Overall Study|Withdrawal by Subject|12|||
17076133|NCT00326625|38218107|FG000|Overall Study|Death|18|||
17076134|NCT00326625|38218108|FG001|Overall Study|Death|16|||
17076135|NCT00326625|38218107|FG000|Overall Study|Lost to Follow-up|1|||
17076136|NCT00326625|38218108|FG001|Overall Study|Lost to Follow-up|0|||
17076137|NCT00326625|38218107|FG000|Overall Study|prescheduled medical intervention|0|||
17076138|NCT00326625|38218108|FG001|Overall Study|prescheduled medical intervention|1|||
17076139|NCT00433290|38218116|FG000|Overall Study|Adverse Event|24|||
17076140|NCT00433290|38218117|FG001|Overall Study|Adverse Event|7|||
17076141|NCT00433290|38218116|FG000|Overall Study|Lack of Efficacy|1|||
17076142|NCT00433290|38218117|FG001|Overall Study|Lack of Efficacy|5|||
17076143|NCT00433290|38218116|FG000|Overall Study|Withdrawal by Subject|4|||
17076144|NCT00433290|38218117|FG001|Overall Study|Withdrawal by Subject|2|||
17076145|NCT00433290|38218116|FG000|Overall Study|Protocol Violation|3|||
17076146|NCT00433290|38218117|FG001|Overall Study|Protocol Violation|2|||
17076147|NCT00433290|38218116|FG000|Overall Study|Physician Decision|2|||
17076148|NCT00433290|38218117|FG001|Overall Study|Physician Decision|0|||
17076149|NCT00433290|38218116|FG000|Overall Study|Entry Criteria Not Met|0|||
17076150|NCT00433290|38218117|FG001|Overall Study|Entry Criteria Not Met|1|||
17076151|NCT00433290|38218116|FG000|Overall Study|Lost to Follow-up|1|||
17076152|NCT00433290|38218117|FG001|Overall Study|Lost to Follow-up|0|||
17076153|NCT00467870|38218129|FG000|Overall Study|Adverse Event|13|||
17076154|NCT00467870|38218130|FG001|Overall Study|Adverse Event|9|||
17076155|NCT00467870|38218131|FG002|Overall Study|Adverse Event|1|||
17076156|NCT00467870|38218132|FG003|Overall Study|Adverse Event|15|||
17076157|NCT00467870|38218133|FG004|Overall Study|Adverse Event|15|||
17076158|NCT00467870|38218134|FG005|Overall Study|Adverse Event|1|||
17076159|NCT00467870|38218129|FG000|Overall Study|Protocol Violation|2|||
17076160|NCT00467870|38218130|FG001|Overall Study|Protocol Violation|1|||
17076161|NCT00467870|38218131|FG002|Overall Study|Protocol Violation|1|||
17076162|NCT00467870|38218132|FG003|Overall Study|Protocol Violation|2|||
17076163|NCT00467870|38218133|FG004|Overall Study|Protocol Violation|0|||
17076164|NCT00467870|38218134|FG005|Overall Study|Protocol Violation|0|||
17076165|NCT00467870|38218129|FG000|Overall Study|Withdrawal by Subject|14|||
17076166|NCT00467870|38218130|FG001|Overall Study|Withdrawal by Subject|21|||
17076167|NCT00467870|38218131|FG002|Overall Study|Withdrawal by Subject|0|||
17076168|NCT00467870|38218132|FG003|Overall Study|Withdrawal by Subject|9|||
17076169|NCT00467870|38218133|FG004|Overall Study|Withdrawal by Subject|10|||
17076170|NCT00467870|38218134|FG005|Overall Study|Withdrawal by Subject|1|||
17076171|NCT00467870|38218129|FG000|Overall Study|Lost to Follow-up|5|||
17076172|NCT00467870|38218130|FG001|Overall Study|Lost to Follow-up|3|||
17076173|NCT00467870|38218131|FG002|Overall Study|Lost to Follow-up|1|||
17076174|NCT00467870|38218132|FG003|Overall Study|Lost to Follow-up|1|||
17076175|NCT00467870|38218133|FG004|Overall Study|Lost to Follow-up|3|||
17076176|NCT00467870|38218134|FG005|Overall Study|Lost to Follow-up|0|||
17076177|NCT00467870|38218129|FG000|Overall Study|Subject Non-compliance|3|||
17076178|NCT00467870|38218130|FG001|Overall Study|Subject Non-compliance|4|||
17076179|NCT00467870|38218131|FG002|Overall Study|Subject Non-compliance|0|||
17076180|NCT00467870|38218132|FG003|Overall Study|Subject Non-compliance|1|||
17076181|NCT00467870|38218133|FG004|Overall Study|Subject Non-compliance|5|||
17076182|NCT00467870|38218134|FG005|Overall Study|Subject Non-compliance|0|||
17076183|NCT00467870|38218129|FG000|Overall Study|Other/Unknown|8|||
17076184|NCT00467870|38218130|FG001|Overall Study|Other/Unknown|5|||
17076185|NCT00467870|38218131|FG002|Overall Study|Other/Unknown|1|||
17076186|NCT00467870|38218132|FG003|Overall Study|Other/Unknown|5|||
17076187|NCT00467870|38218133|FG004|Overall Study|Other/Unknown|4|||
17076188|NCT00467870|38218134|FG005|Overall Study|Other/Unknown|0|||
17076189|NCT00467558|38218146|FG000|Overall Study|Lost to Follow-up|2|||
17076190|NCT00467558|38218147|FG001|Overall Study|Lost to Follow-up|0|||
17076191|NCT00422292|38218157|FG000|Overall Study|Serious adverse events|1|||
17076192|NCT00422292|38218158|FG001|Overall Study|Serious adverse events|4|||
17076193|NCT00422292|38218159|FG002|Overall Study|Serious adverse events|0|||
17076194|NCT00422292|38218160|FG003|Overall Study|Serious adverse events|0|||
17076195|NCT00422292|38218157|FG000|Overall Study|Adverse Event|1|||
17076196|NCT00422292|38218158|FG001|Overall Study|Adverse Event|0|||
17076197|NCT00422292|38218159|FG002|Overall Study|Adverse Event|1|||
17076198|NCT00422292|38218160|FG003|Overall Study|Adverse Event|0|||
17076199|NCT00422292|38218157|FG000|Overall Study|Protocol Violation|4|||
17076200|NCT00422292|38218158|FG001|Overall Study|Protocol Violation|25|||
17076201|NCT00422292|38218159|FG002|Overall Study|Protocol Violation|8|||
17076202|NCT00422292|38218160|FG003|Overall Study|Protocol Violation|5|||
17076203|NCT00422292|38218157|FG000|Overall Study|Lost to Follow-up|6|||
17076204|NCT00422292|38218158|FG001|Overall Study|Lost to Follow-up|12|||
17076205|NCT00422292|38218159|FG002|Overall Study|Lost to Follow-up|6|||
17076206|NCT00422292|38218160|FG003|Overall Study|Lost to Follow-up|6|||
17076207|NCT00422292|38218157|FG000|Overall Study|Withdrawal by Subject|6|||
17076208|NCT00422292|38218158|FG001|Overall Study|Withdrawal by Subject|25|||
17076209|NCT00422292|38218159|FG002|Overall Study|Withdrawal by Subject|7|||
17076210|NCT00422292|38218160|FG003|Overall Study|Withdrawal by Subject|13|||
17076211|NCT00452348|38218172|FG000|Overall Study|Adverse Event|6|||
17076212|NCT00452348|38218173|FG001|Overall Study|Adverse Event|9|||
17076213|NCT00452348|38218172|FG000|Overall Study|Lack of Efficacy|10|||
17076214|NCT00452348|38218173|FG001|Overall Study|Lack of Efficacy|9|||
17076215|NCT00452348|38218172|FG000|Overall Study|Lost to Follow-up|14|||
17076216|NCT00452348|38218173|FG001|Overall Study|Lost to Follow-up|8|||
17076217|NCT00452348|38218172|FG000|Overall Study|Protocol Violation|22|||
17076218|NCT00452348|38218173|FG001|Overall Study|Protocol Violation|28|||
17076219|NCT00452348|38218172|FG000|Overall Study|Withdrawal by Subject|18|||
17076220|NCT00452348|38218173|FG001|Overall Study|Withdrawal by Subject|21|||
17076221|NCT00452348|38218172|FG000|Overall Study|Other|9|||
17076222|NCT00452348|38218173|FG001|Overall Study|Other|9|||
17076223|NCT00452114|38218181|FG000|Overall Study|Physician Decision|3|||
17076224|NCT00452114|38218182|FG001|Overall Study|Physician Decision|3|||
17076225|NCT00320541|38218190|FG000|Overall Study|Adverse Event|21|||
17076226|NCT00320541|38218191|FG001|Overall Study|Adverse Event|19|||
17076227|NCT00320541|38218190|FG000|Overall Study|Protocol Violation|0|||
17076228|NCT00320541|38218191|FG001|Overall Study|Protocol Violation|1|||
17076229|NCT00320541|38218190|FG000|Overall Study|Withdrawal by Subject|12|||
17076230|NCT00320541|38218191|FG001|Overall Study|Withdrawal by Subject|16|||
17076231|NCT00320541|38218190|FG000|Overall Study|Physician Decision|9|||
17076232|NCT00320541|38218191|FG001|Overall Study|Physician Decision|13|||
17076233|NCT00320541|38218190|FG000|Overall Study|Other|3|||
17076234|NCT00320541|38218191|FG001|Overall Study|Other|4|||
17076235|NCT00320541|38218190|FG000|Overall Study|Sponsor Decision|2|||
17076236|NCT00320541|38218191|FG001|Overall Study|Sponsor Decision|1|||
17076237|NCT00320541|38218190|FG000|Overall Study|Death due to Study Disease|1|||
17076238|NCT00320541|38218191|FG001|Overall Study|Death due to Study Disease|3|||
17076239|NCT00320541|38218190|FG000|Overall Study|Death due to Adverse Event(s)|1|||
17076240|NCT00320541|38218191|FG001|Overall Study|Death due to Adverse Event(s)|0|||
17076241|NCT00320541|38218190|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
17076242|NCT00320541|38218191|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
17076243|NCT00320385|38218199|FG000|Overall Study|Lost to Follow-up|7|||
17076244|NCT00320385|38218200|FG001|Overall Study|Lost to Follow-up|10|||
17076245|NCT00320385|38218199|FG000|Overall Study|Withdrawal by Subject|6|||
17076246|NCT00320385|38218200|FG001|Overall Study|Withdrawal by Subject|7|||
17076247|NCT00320385|38218199|FG000|Overall Study|Sponsor Terminated Study|2|||
17076248|NCT00320385|38218200|FG001|Overall Study|Sponsor Terminated Study|1|||
17076249|NCT00320385|38218199|FG000|Overall Study|Investigator Decision|0|||
17076250|NCT00320385|38218200|FG001|Overall Study|Investigator Decision|1|||
17076251|NCT00320385|38218199|FG000|Overall Study|Death|1|||
17076252|NCT00320385|38218200|FG001|Overall Study|Death|2|||
17076253|NCT00320385|38218199|FG000|Overall Study|Serious Adverse Event|1|||
17076254|NCT00320385|38218200|FG001|Overall Study|Serious Adverse Event|0|||
17076255|NCT00320385|38218199|FG000|Overall Study|Withdrew Consent|1|||
17076256|NCT00320385|38218200|FG001|Overall Study|Withdrew Consent|0|||
17076257|NCT00320385|38218199|FG000|Overall Study|Adverse Event|0|||
17076258|NCT00320385|38218200|FG001|Overall Study|Adverse Event|1|||
17076259|NCT00326001|38218208|FG000|Overall Study|Adverse Event|4|||
17076260|NCT00326001|38218209|FG001|Overall Study|Adverse Event|5|||
17076261|NCT00326001|38218208|FG000|Overall Study|Physician Decision|3|||
17076262|NCT00326001|38218209|FG001|Overall Study|Physician Decision|3|||
17076263|NCT00309777|38218219|FG000|Overall Study|Adverse Event|13|||
17076264|NCT00309777|38218220|FG001|Overall Study|Adverse Event|2|||
17076265|NCT00309777|38218221|FG002|Overall Study|Adverse Event|8|||
17076266|NCT00309777|38218222|FG003|Overall Study|Adverse Event|1|||
17076267|NCT00309777|38218219|FG000|Overall Study|Protocol Violation|4|||
17076268|NCT00309777|38218220|FG001|Overall Study|Protocol Violation|1|||
17076269|NCT00309777|38218221|FG002|Overall Study|Protocol Violation|3|||
17076270|NCT00309777|38218222|FG003|Overall Study|Protocol Violation|1|||
17076271|NCT00309777|38218219|FG000|Overall Study|Withdrawal by Subject|6|||
17076272|NCT00309777|38218220|FG001|Overall Study|Withdrawal by Subject|5|||
17076273|NCT00309777|38218221|FG002|Overall Study|Withdrawal by Subject|7|||
17076274|NCT00309777|38218222|FG003|Overall Study|Withdrawal by Subject|2|||
17076275|NCT00309777|38218219|FG000|Overall Study|Lost to Follow-up|0|||
17076276|NCT00309777|38218220|FG001|Overall Study|Lost to Follow-up|0|||
17076277|NCT00309777|38218221|FG002|Overall Study|Lost to Follow-up|1|||
17076278|NCT00309777|38218222|FG003|Overall Study|Lost to Follow-up|0|||
17076279|NCT00309777|38218219|FG000|Overall Study|Death|0|||
17076280|NCT00309777|38218220|FG001|Overall Study|Death|1|||
17076281|NCT00309777|38218221|FG002|Overall Study|Death|0|||
17076282|NCT00309777|38218222|FG003|Overall Study|Death|0|||
17076283|NCT00309387|38218234|FG000|Overall Study|Death|72|||
17076284|NCT00309387|38218235|FG001|Overall Study|Death|73|||
17076285|NCT00309387|38218234|FG000|Overall Study|Lost to Follow-up|70|||
17076286|NCT00309387|38218235|FG001|Overall Study|Lost to Follow-up|86|||
17076287|NCT00325143|38218242|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
17076288|NCT00325143|38218242|FG000|Overall Study|Migrated/moved from study area|1|||
17076289|NCT00325143|38218242|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
17076290|NCT00325143|38218242|FG000|Overall Study|Withdrawal by Subject|8|||
17076291|NCT00319839|38218246|FG000|Overall Study|Adverse Event|5|||
17076292|NCT00319839|38218246|FG000|Overall Study|Withdrawal by Subject|1|||
17076293|NCT00319449|38218252|FG000|Overall Study|Subject did not wish to continue|1|||
17076294|NCT00319449|38218253|FG001|Overall Study|Subject did not wish to continue|0|||
17076295|NCT00319449|38218252|FG000|Overall Study|Noncompliance with the protocol|1|||
17076296|NCT00319449|38218253|FG001|Overall Study|Noncompliance with the protocol|0|||
17076297|NCT00308997|38218261|FG000|Overall Study|Subject feigned clinical data|0|||
17076298|NCT00308997|38218262|FG001|Overall Study|Subject feigned clinical data|1|||
17076299|NCT00308997|38218261|FG000|Overall Study|Unable to tolerate intervention|1|||
17076300|NCT00308997|38218262|FG001|Overall Study|Unable to tolerate intervention|0|||
17076301|NCT00308685|38218270|FG000|Overall Study|Lost to Follow-up|1|||
17076302|NCT00308685|38218271|FG001|Overall Study|Lost to Follow-up|0|||
17076303|NCT00308685|38218270|FG000|Overall Study|Need to administer prohibited medication|1|||
17076304|NCT00308685|38218271|FG001|Overall Study|Need to administer prohibited medication|2|||
17076305|NCT00308685|38218270|FG000|Overall Study|Other than specified|1|||
17076306|NCT00308685|38218271|FG001|Overall Study|Other than specified|3|||
17076307|NCT00317109|38218279|FG000|Overall Study|Withdrawal by Subject|2|||
16781280|NCT02105974|37720454|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
16781281|NCT02105974|37720455|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
16781282|NCT02105974|37720453|FG000|2 Week Run-in Period|Withdrew consent|23|||
16781283|NCT02105974|37720454|FG001|2 Week Run-in Period|Withdrew consent|0|||
16781284|NCT02105974|37720455|FG002|2 Week Run-in Period|Withdrew consent|0|||
16781285|NCT02105974|37720453|FG000|2 Week Run-in Period|Investigator discretion|8|||
17076308|NCT00317109|38218280|FG001|Overall Study|Withdrawal by Subject|0|||
17076309|NCT00317109|38218279|FG000|Overall Study|Migated/moved from study area|1|||
17076310|NCT00317109|38218280|FG001|Overall Study|Migated/moved from study area|0|||
17076311|NCT00316719|38218288|FG000|Overall Study|Adverse Event|0|||
17076312|NCT00316719|38218289|FG001|Overall Study|Adverse Event|6|||
17076313|NCT00316719|38218288|FG000|Overall Study|Consent withdrawn|2|||
17076314|NCT00316719|38218289|FG001|Overall Study|Consent withdrawn|0|||
17076315|NCT00422058|38218301|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
17076316|NCT00422058|38218302|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
17076317|NCT00422058|38218303|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
16995088|NCT00999518|38138795|FG000|Overall Study|Lost to Follow-up|0|||
16995089|NCT00999518|38138796|FG001|Overall Study|Lost to Follow-up|0|||
16995090|NCT00999518|38138797|FG002|Overall Study|Lost to Follow-up|0|||
16995091|NCT00999518|38138798|FG003|Overall Study|Lost to Follow-up|4|||
16995092|NCT00999518|38138799|FG004|Overall Study|Lost to Follow-up|1|||
16995093|NCT00999518|38138795|FG000|Overall Study|Did not meet entrance criteria|0|||
16995094|NCT00999518|38138796|FG001|Overall Study|Did not meet entrance criteria|0|||
16995095|NCT00999518|38138797|FG002|Overall Study|Did not meet entrance criteria|0|||
16995096|NCT00999518|38138798|FG003|Overall Study|Did not meet entrance criteria|0|||
16995097|NCT00999518|38138799|FG004|Overall Study|Did not meet entrance criteria|1|||
17076318|NCT00422058|38218304|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
17076319|NCT00422058|38218305|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
17076320|NCT00422058|38218306|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
17076321|NCT00422058|38218301|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
17076322|NCT00422058|38218302|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
17076323|NCT00422058|38218303|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
17076324|NCT00422058|38218304|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
17076325|NCT00422058|38218305|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
17076326|NCT00422058|38218306|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
17076327|NCT00422058|38218301|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
17076328|NCT00422058|38218302|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
17076329|NCT00422058|38218303|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
17076330|NCT00422058|38218304|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
17076331|NCT00422058|38218305|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
17076332|NCT00422058|38218306|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
17076333|NCT00422058|38218301|FG000|Double-Blind, Week 0-20|Other|11|||
17076334|NCT00422058|38218302|FG001|Double-Blind, Week 0-20|Other|3|||
17076335|NCT00422058|38218303|FG002|Double-Blind, Week 0-20|Other|8|||
17076336|NCT00422058|38218304|FG003|Double-Blind, Week 0-20|Other|8|||
17076337|NCT00422058|38218305|FG004|Double-Blind, Week 0-20|Other|4|||
17076338|NCT00422058|38218306|FG005|Double-Blind, Week 0-20|Other|10|||
17076339|NCT00422058|38218301|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
17076340|NCT00422058|38218302|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
17076341|NCT00422058|38218303|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
17076342|NCT00422058|38218304|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
17076343|NCT00422058|38218305|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
17076344|NCT00422058|38218306|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
17076345|NCT00422058|38218301|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
17076346|NCT00422058|38218302|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
17076347|NCT00422058|38218303|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
17076348|NCT00422058|38218304|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
17076349|NCT00422058|38218305|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
17076350|NCT00422058|38218306|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
17076351|NCT00422058|38218301|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
17076352|NCT00422058|38218302|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
17076353|NCT00422058|38218303|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
17076354|NCT00422058|38218304|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
17076355|NCT00422058|38218305|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
17076356|NCT00422058|38218306|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
17076357|NCT00422058|38218301|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
17076358|NCT00422058|38218302|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
17076359|NCT00422058|38218303|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
17076360|NCT00422058|38218304|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
17076361|NCT00422058|38218305|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
17076362|NCT00422058|38218306|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
17076363|NCT00422058|38218301|FG000|Open-Label Extension, Week 20-104|Other|13|||
17076364|NCT00422058|38218302|FG001|Open-Label Extension, Week 20-104|Other|14|||
17076365|NCT00422058|38218303|FG002|Open-Label Extension, Week 20-104|Other|6|||
17076366|NCT00422058|38218304|FG003|Open-Label Extension, Week 20-104|Other|13|||
17076367|NCT00422058|38218305|FG004|Open-Label Extension, Week 20-104|Other|16|||
17076368|NCT00422058|38218306|FG005|Open-Label Extension, Week 20-104|Other|18|||
17076369|NCT00413244|38218330|FG000|Overall Study|Withdrawal by Subject|10|||
17076370|NCT00413244|38218331|FG001|Overall Study|Withdrawal by Subject|1|||
17076371|NCT00420420|38218359|FG000|Overall Study|Adverse Event|5|||
17076372|NCT00420420|38218360|FG001|Overall Study|Adverse Event|3|||
17076373|NCT00420420|38218359|FG000|Overall Study|Protocol Violation|1|||
17157736|NCT03070002|38304627|FG000|Follow up for 2 Years|Death|1|||
17157737|NCT02918318|38304635|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
17157738|NCT02918318|38304636|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
17157739|NCT02918318|38304637|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
17157740|NCT02918318|38304638|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
17157741|NCT02918318|38304639|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
17157742|NCT02918318|38304635|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
17157743|NCT02918318|38304636|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
17157744|NCT02918318|38304637|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
17157745|NCT02918318|38304638|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
17157746|NCT02918318|38304639|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
17157747|NCT02918318|38304635|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
17157748|NCT02918318|38304636|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
17157749|NCT02918318|38304637|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
17157750|NCT02918318|38304638|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
17157751|NCT02918318|38304639|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
17076374|NCT00420420|38218360|FG001|Overall Study|Protocol Violation|1|||
17076375|NCT00420420|38218359|FG000|Overall Study|Withdrawal by Subject|1|||
17076376|NCT00420420|38218360|FG001|Overall Study|Withdrawal by Subject|0|||
17076377|NCT00420420|38218359|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
17076378|NCT00420420|38218360|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
17076379|NCT00420342|38218369|FG000|Overall Study|Lost to Follow-up|1|||
17076380|NCT00420342|38218370|FG001|Overall Study|Lost to Follow-up|0|||
17076381|NCT00420342|38218371|FG002|Overall Study|Lost to Follow-up|1|||
17076382|NCT00420342|38218369|FG000|Overall Study|Withdrawal by Subject|0|||
17076383|NCT00420342|38218370|FG001|Overall Study|Withdrawal by Subject|2|||
17076384|NCT00420342|38218371|FG002|Overall Study|Withdrawal by Subject|0|||
17076385|NCT00432744|38218381|FG000|Months 0-6|Withdrawal by Subject|4|||
17076386|NCT00432744|38218382|FG001|Months 0-6|Withdrawal by Subject|4|||
17076387|NCT00432744|38218381|FG000|Months 0-6|Too disabled to score|1|||
17076388|NCT00432744|38218382|FG001|Months 0-6|Too disabled to score|0|||
17076389|NCT00432744|38218381|FG000|Months 7 - 12|Withdrawal by Subject|1|||
17076390|NCT00432744|38218382|FG001|Months 7 - 12|Withdrawal by Subject|0|||
17076391|NCT00432744|38218381|FG000|Months 7 - 12|Too disabled to score|0|||
17076392|NCT00432744|38218382|FG001|Months 7 - 12|Too disabled to score|1|||
17076393|NCT00432666|38218390|FG000|Main Period|Adverse Event|1|||
17076394|NCT00432666|38218391|FG001|Main Period|Adverse Event|1|||
17076395|NCT00432666|38218390|FG000|Main Period|Consent Withdrawn|1|||
17076396|NCT00432666|38218391|FG001|Main Period|Consent Withdrawn|0|||
17076397|NCT00432666|38218390|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
17076398|NCT00432666|38218391|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
17076399|NCT00432666|38218390|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
17076400|NCT00432666|38218391|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
17076401|NCT00432666|38218390|FG000|Open-Label Extension Period|Adverse Event|5|||
17076402|NCT00432666|38218391|FG001|Open-Label Extension Period|Adverse Event|0|||
17076403|NCT00432666|38218390|FG000|Open-Label Extension Period|Consent withdrawn|10|||
17076404|NCT00432666|38218391|FG001|Open-Label Extension Period|Consent withdrawn|0|||
17076405|NCT00432666|38218390|FG000|Open-Label Extension Period|Physician Decision|3|||
17076406|NCT00432666|38218391|FG001|Open-Label Extension Period|Physician Decision|0|||
17076407|NCT00451958|38218401|FG000|CS21A (NCT00451958)|Adverse Event|21|||
17076408|NCT00451958|38218402|FG001|CS21A (NCT00451958)|Adverse Event|34|||
17076409|NCT00451958|38218403|FG002|CS21A (NCT00451958)|Adverse Event|14|||
17076410|NCT00451958|38218404|FG003|CS21A (NCT00451958)|Adverse Event|17|||
17076411|NCT00451958|38218405|FG004|CS21A (NCT00451958)|Adverse Event|0|||
17076412|NCT00451958|38218401|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
17076413|NCT00451958|38218402|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
17076414|NCT00451958|38218403|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
17076415|NCT00451958|38218404|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
17076416|NCT00451958|38218405|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
17076417|NCT00451958|38218401|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
17076418|NCT00451958|38218402|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
17076419|NCT00451958|38218403|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
17076420|NCT00451958|38218404|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
17076421|NCT00451958|38218405|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
17076422|NCT00451958|38218401|FG000|CS21A (NCT00451958)|Physician Decision|2|||
17076423|NCT00451958|38218402|FG001|CS21A (NCT00451958)|Physician Decision|4|||
17076424|NCT00451958|38218403|FG002|CS21A (NCT00451958)|Physician Decision|4|||
17076425|NCT00451958|38218404|FG003|CS21A (NCT00451958)|Physician Decision|4|||
17076426|NCT00451958|38218405|FG004|CS21A (NCT00451958)|Physician Decision|0|||
17076427|NCT00451958|38218401|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
17076428|NCT00451958|38218402|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
17076429|NCT00451958|38218403|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
17076430|NCT00451958|38218404|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
17076431|NCT00451958|38218405|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
17076432|NCT00451958|38218401|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
17076433|NCT00451958|38218402|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
17076434|NCT00451958|38218403|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
17076435|NCT00451958|38218404|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
17076436|NCT00451958|38218405|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
17076437|NCT00432276|38218421|FG000|Overall Study|Hyperglycemic Rescue|44|||
17076438|NCT00432276|38218422|FG001|Overall Study|Hyperglycemic Rescue|87|||
17076439|NCT00432276|38218421|FG000|Overall Study|Adverse Event|13|||
17076440|NCT00432276|38218422|FG001|Overall Study|Adverse Event|16|||
17076441|NCT00432276|38218421|FG000|Overall Study|Protocol Violation|25|||
17076442|NCT00432276|38218422|FG001|Overall Study|Protocol Violation|20|||
17076443|NCT00432276|38218421|FG000|Overall Study|Lost to Follow-up|6|||
17076444|NCT00432276|38218422|FG001|Overall Study|Lost to Follow-up|2|||
17076445|NCT00432276|38218421|FG000|Overall Study|Withdrawal by Subject|25|||
17076446|NCT00432276|38218422|FG001|Overall Study|Withdrawal by Subject|20|||
17076447|NCT00432276|38218421|FG000|Overall Study|Physician Decision|6|||
17076448|NCT00432276|38218422|FG001|Overall Study|Physician Decision|8|||
17076449|NCT00432276|38218421|FG000|Overall Study|Other|2|||
17076450|NCT00432276|38218422|FG001|Overall Study|Other|3|||
17076451|NCT00413010|38218430|FG000|Overall Study|Adverse Event|8|||
17076452|NCT00413010|38218431|FG001|Overall Study|Adverse Event|4|||
17076453|NCT00413010|38218430|FG000|Overall Study|Laboratory abnormality|0|||
17076454|NCT00413010|38218431|FG001|Overall Study|Laboratory abnormality|2|||
17076455|NCT00413010|38218430|FG000|Overall Study|Lack of Efficacy|0|||
17076456|NCT00413010|38218431|FG001|Overall Study|Lack of Efficacy|3|||
17076457|NCT00413010|38218430|FG000|Overall Study|Lost to Follow-up|3|||
17076458|NCT00413010|38218431|FG001|Overall Study|Lost to Follow-up|0|||
17076459|NCT00413010|38218430|FG000|Overall Study|Withdrawal by Subject|7|||
17076460|NCT00413010|38218431|FG001|Overall Study|Withdrawal by Subject|2|||
17076461|NCT00413010|38218430|FG000|Overall Study|Due to termination of the study|54|||
17076462|NCT00413010|38218431|FG001|Overall Study|Due to termination of the study|52|||
17076463|NCT00459290|38218437|FG000|Overall Study|Adverse Event|3|||
17076464|NCT00459290|38218437|FG000|Overall Study|Ineligible|2|||
17076465|NCT00443534|38218448|FG000|Overall Study|Lack of Efficacy|67|||
17076466|NCT00443534|38218448|FG000|Overall Study|Adverse Event|16|||
17076467|NCT00443534|38218448|FG000|Overall Study|Death|9|||
17076468|NCT00443534|38218448|FG000|Overall Study|Withdrawal by Subject|8|||
17076469|NCT00443534|38218448|FG000|Overall Study|Study Terminated by Sponsor|12|||
17076470|NCT00443534|38218448|FG000|Overall Study|Other|10|||
17076471|NCT00443534|38218448|FG000|Overall Study|Enrolled, Not Treated|1|||
17076472|NCT00419952|38218454|FG000|Overall Study|Adverse Event|8|||
17076473|NCT00419952|38218455|FG001|Overall Study|Adverse Event|10|||
17076474|NCT00419952|38218454|FG000|Overall Study|Withdrawal by Subject|44|||
17076475|NCT00419952|38218455|FG001|Overall Study|Withdrawal by Subject|43|||
17076476|NCT00419952|38218454|FG000|Overall Study|Lost to Follow-up|43|||
17076477|NCT00419952|38218455|FG001|Overall Study|Lost to Follow-up|34|||
17076478|NCT00419952|38218454|FG000|Overall Study|Protocol Violation|32|||
17076479|NCT00419952|38218455|FG001|Overall Study|Protocol Violation|24|||
17076480|NCT00419952|38218454|FG000|Overall Study|Pregnancy|4|||
17076481|NCT00419952|38218455|FG001|Overall Study|Pregnancy|2|||
17076482|NCT00419952|38218454|FG000|Overall Study|Physician Decision|1|||
17076483|NCT00419952|38218455|FG001|Overall Study|Physician Decision|3|||
17076484|NCT00419952|38218454|FG000|Overall Study|Incorrectly enrolled|10|||
17076485|NCT00419952|38218455|FG001|Overall Study|Incorrectly enrolled|3|||
17076486|NCT00419952|38218454|FG000|Overall Study|Intake of prohibited medication|2|||
17076487|NCT00419952|38218455|FG001|Overall Study|Intake of prohibited medication|2|||
17076488|NCT00419952|38218454|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
17076489|NCT00419952|38218455|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
17157752|NCT02918318|38304635|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
17157753|NCT02918318|38304636|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
17157754|NCT02918318|38304637|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
17076490|NCT00419952|38218454|FG000|Overall Study|Diary or medication non-compliance|2|||
17076491|NCT00419952|38218455|FG001|Overall Study|Diary or medication non-compliance|4|||
17076492|NCT00419952|38218454|FG000|Overall Study|Abnormal ECG|1|||
17076493|NCT00419952|38218455|FG001|Overall Study|Abnormal ECG|0|||
17076494|NCT00443456|38218461|FG000|Overall Study|Adverse Event|16|||
17076495|NCT00443456|38218461|FG000|Overall Study|Move|1|||
17076496|NCT00443456|38218461|FG000|Overall Study|Withdrawal by Subject|1|||
17076497|NCT00419562|38218471|FG000|Overall Study|Lost to Follow-up|12|||
17076498|NCT00419562|38218472|FG001|Overall Study|Lost to Follow-up|13|||
17076499|NCT00419562|38218471|FG000|Overall Study|Withdrawal by Subject|20|||
17076500|NCT00419562|38218472|FG001|Overall Study|Withdrawal by Subject|18|||
17076501|NCT00419562|38218471|FG000|Overall Study|Participant Institutionalized|1|||
17076502|NCT00419562|38218472|FG001|Overall Study|Participant Institutionalized|0|||
17076503|NCT00432042|38218481|FG000|Overall Study|Protocol Violation|2|||
17076504|NCT00432042|38218482|FG001|Overall Study|Protocol Violation|0|||
17076505|NCT00432042|38218483|FG002|Overall Study|Protocol Violation|0|||
17076506|NCT00432042|38218481|FG000|Overall Study|Withdrawal by Subject|0|||
17076507|NCT00432042|38218482|FG001|Overall Study|Withdrawal by Subject|0|||
17076508|NCT00432042|38218483|FG002|Overall Study|Withdrawal by Subject|2|||
17076509|NCT00432042|38218481|FG000|Overall Study|Lost to Follow-up|5|||
17076510|NCT00432042|38218482|FG001|Overall Study|Lost to Follow-up|1|||
17076511|NCT00432042|38218483|FG002|Overall Study|Lost to Follow-up|0|||
17076512|NCT00308139|38218493|FG000|Overall Study|Adverse Event|20|||
17076513|NCT00308139|38218494|FG001|Overall Study|Adverse Event|14|||
17076514|NCT00308139|38218493|FG000|Overall Study|Lost to Follow-up|13|||
17076515|NCT00308139|38218494|FG001|Overall Study|Lost to Follow-up|8|||
17076516|NCT00308139|38218493|FG000|Overall Study|Protocol Violation|3|||
17076517|NCT00308139|38218494|FG001|Overall Study|Protocol Violation|2|||
17076518|NCT00308139|38218493|FG000|Overall Study|Withdrawal of Consent|40|||
17076519|NCT00308139|38218494|FG001|Overall Study|Withdrawal of Consent|42|||
17076520|NCT00308139|38218493|FG000|Overall Study|Investigator Decision|11|||
17076521|NCT00308139|38218494|FG001|Overall Study|Investigator Decision|10|||
17076522|NCT00308139|38218493|FG000|Overall Study|Loss of Glucose Control|5|||
17076523|NCT00308139|38218494|FG001|Overall Study|Loss of Glucose Control|7|||
17076524|NCT00308139|38218493|FG000|Overall Study|Administrative|1|||
17076525|NCT00308139|38218494|FG001|Overall Study|Administrative|4|||
17076526|NCT00308139|38218493|FG000|Overall Study|Other|1|||
17076527|NCT00308139|38218494|FG001|Overall Study|Other|0|||
17076528|NCT00459134|38218522|FG000|Overall Study|Physician Decision|1|||
17076529|NCT00459134|38218523|FG001|Overall Study|Physician Decision|1|||
17076530|NCT00459134|38218522|FG000|Overall Study|Withdrawal by Subject|8|||
17076531|NCT00459134|38218523|FG001|Overall Study|Withdrawal by Subject|7|||
17076532|NCT00459134|38218522|FG000|Overall Study|Lost to Follow-up|6|||
17076533|NCT00459134|38218523|FG001|Overall Study|Lost to Follow-up|7|||
17076534|NCT00459134|38218522|FG000|Overall Study|Surgery|1|||
17076535|NCT00459134|38218523|FG001|Overall Study|Surgery|2|||
17076536|NCT00459134|38218522|FG000|Overall Study|Toxicity|4|||
17076537|NCT00459134|38218523|FG001|Overall Study|Toxicity|5|||
17076538|NCT00459134|38218522|FG000|Overall Study|Progression|1|||
17076539|NCT00459134|38218523|FG001|Overall Study|Progression|0|||
17076540|NCT00459134|38218522|FG000|Overall Study|Multiple Reasons|2|||
17076541|NCT00459134|38218523|FG001|Overall Study|Multiple Reasons|3|||
17076542|NCT00459056|38218531|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
17076543|NCT00459056|38218532|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
17076544|NCT00431964|38218540|FG000|Overall Study|Adverse Event|1|||
17076545|NCT00431964|38218541|FG001|Overall Study|Adverse Event|0|||
17076546|NCT00431964|38218540|FG000|Overall Study|Lost to Follow-up|1|||
17076547|NCT00431964|38218541|FG001|Overall Study|Lost to Follow-up|2|||
17076548|NCT00431964|38218540|FG000|Overall Study|Physician Decision|2|||
17076549|NCT00431964|38218541|FG001|Overall Study|Physician Decision|2|||
17076550|NCT00431964|38218540|FG000|Overall Study|Withdrawal by Subject|2|||
17076551|NCT00431964|38218541|FG001|Overall Study|Withdrawal by Subject|1|||
17076552|NCT00431964|38218540|FG000|Overall Study|Parental Consent Withdrawn|0|||
17076553|NCT00431964|38218541|FG001|Overall Study|Parental Consent Withdrawn|2|||
17076554|NCT00431964|38218540|FG000|Overall Study|Due to Unstable Health|0|||
17076555|NCT00431964|38218541|FG001|Overall Study|Due to Unstable Health|1|||
17076556|NCT00412854|38218549|FG000|Overall Study|Withdrawn due to adverse events|1|||
17076557|NCT00412854|38218550|FG001|Overall Study|Withdrawn due to adverse events|5|||
17076558|NCT00412854|38218549|FG000|Overall Study|Withdrawn for other reasons|13|||
17076559|NCT00412854|38218550|FG001|Overall Study|Withdrawn for other reasons|11|||
17076560|NCT00431496|38218556|FG000|Overall Study|Adverse Event|3|||
17076561|NCT00431496|38218556|FG000|Overall Study|Lost to Follow-up|1|||
17076562|NCT00431496|38218556|FG000|Overall Study|Withdrawal by Subject|2|||
17076563|NCT00431496|38218556|FG000|Overall Study|Protocol-specified criteria|5|||
17076564|NCT00316173|38218562|FG000|Run-in Phase|Adverse Event|1|||
17157755|NCT02918318|38304638|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
17157756|NCT02918318|38304639|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
17157757|NCT02918318|38304635|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
17157758|NCT02918318|38304636|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
17157759|NCT02918318|38304637|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
17157760|NCT02918318|38304638|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
17157761|NCT02918318|38304639|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
17157762|NCT02918318|38304635|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
17157763|NCT02918318|38304636|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
17157764|NCT02918318|38304637|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
17157765|NCT02918318|38304638|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
17157766|NCT02918318|38304639|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
17157767|NCT02918318|38304635|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
17076565|NCT00316173|38218563|FG001|Run-in Phase|Adverse Event|0|||
17076566|NCT00316173|38218562|FG000|Run-in Phase|Protocol Violation|1|||
17076567|NCT00316173|38218563|FG001|Run-in Phase|Protocol Violation|0|||
17076568|NCT00316173|38218562|FG000|Run-in Phase|Study Follow-up Stopped|5|||
17076569|NCT00316173|38218563|FG001|Run-in Phase|Study Follow-up Stopped|0|||
17076570|NCT00316173|38218562|FG000|Treatment Phase|Adverse Event|0|||
17076571|NCT00316173|38218563|FG001|Treatment Phase|Adverse Event|1|||
17076572|NCT00316173|38218562|FG000|Treatment Phase|Lack of Efficacy|0|||
17076573|NCT00316173|38218563|FG001|Treatment Phase|Lack of Efficacy|3|||
17076574|NCT00316173|38218562|FG000|Treatment Phase|Lost to Follow-up|0|||
17076575|NCT00316173|38218563|FG001|Treatment Phase|Lost to Follow-up|3|||
17076576|NCT00316173|38218562|FG000|Treatment Phase|Withdrawal by Subject|0|||
17076577|NCT00316173|38218563|FG001|Treatment Phase|Withdrawal by Subject|1|||
17076578|NCT00316173|38218562|FG000|Treatment Phase|Study Follow-up Stopped|0|||
17076579|NCT00316173|38218563|FG001|Treatment Phase|Study Follow-up Stopped|34|||
17076580|NCT00412542|38218570|FG000|Overall Study|Withdrawal by Subject|0|||
17076581|NCT00412542|38218571|FG001|Overall Study|Withdrawal by Subject|2|||
17076582|NCT00412542|38218570|FG000|Overall Study|Not Eligible|0|||
17076583|NCT00412542|38218571|FG001|Overall Study|Not Eligible|1|||
17076584|NCT00316017|38218578|FG000|Overall Study|Protocol Violation|11|||
17076585|NCT00316017|38218579|FG001|Overall Study|Protocol Violation|13|||
17076586|NCT00316017|38218580|FG002|Overall Study|Protocol Violation|19|||
17076587|NCT00451178|38218590|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
17076588|NCT00451178|38218591|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
17076589|NCT00451178|38218590|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
17076590|NCT00451178|38218591|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
17076591|NCT00451178|38218590|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
17157768|NCT02918318|38304636|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
17157769|NCT02918318|38304637|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
17157770|NCT02918318|38304638|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
17157771|NCT02918318|38304639|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
17157772|NCT02918318|38304635|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
17157773|NCT02918318|38304636|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
17157774|NCT02918318|38304637|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
17157775|NCT02918318|38304638|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
17157776|NCT02918318|38304639|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
17157777|NCT02918318|38304635|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
17157778|NCT02918318|38304636|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
17157779|NCT02918318|38304637|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
16995098|NCT00999518|38138795|FG000|Overall Study|Study terminated by sponsor|10|||
16995099|NCT00999518|38138796|FG001|Overall Study|Study terminated by sponsor|6|||
17076592|NCT00451178|38218591|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
17076593|NCT00451178|38218590|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
17076594|NCT00451178|38218591|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
17076595|NCT00451178|38218590|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
17076596|NCT00451178|38218591|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
17076597|NCT00451178|38218590|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
17076598|NCT00451178|38218591|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
17076599|NCT00451178|38218590|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
17076600|NCT00451178|38218591|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
17076601|NCT00451178|38218590|FG000|Prior to Maintenance Therapy|PD|2|||
17076602|NCT00451178|38218591|FG001|Prior to Maintenance Therapy|PD|0|||
17076603|NCT00451178|38218590|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
17076604|NCT00451178|38218591|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
17076605|NCT00451178|38218590|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
17076606|NCT00451178|38218591|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
17076607|NCT00451178|38218590|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
17076608|NCT00451178|38218591|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
17076609|NCT00451178|38218590|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
17076610|NCT00451178|38218591|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
17076611|NCT00451178|38218590|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
17076612|NCT00451178|38218591|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
17076613|NCT00451178|38218590|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
16995100|NCT00999518|38138797|FG002|Overall Study|Study terminated by sponsor|5|||
16995101|NCT00999518|38138798|FG003|Overall Study|Study terminated by sponsor|5|||
16995102|NCT00999518|38138799|FG004|Overall Study|Study terminated by sponsor|9|||
16995103|NCT00999518|38138795|FG000|Overall Study|Pregnancy|0|||
16995104|NCT00999518|38138796|FG001|Overall Study|Pregnancy|0|||
16995105|NCT00999518|38138797|FG002|Overall Study|Pregnancy|1|||
16995106|NCT00999518|38138798|FG003|Overall Study|Pregnancy|0|||
16995107|NCT00999518|38138799|FG004|Overall Study|Pregnancy|0|||
16995108|NCT00999518|38138795|FG000|Overall Study|Protocol Violation|0|||
16995109|NCT00999518|38138796|FG001|Overall Study|Protocol Violation|1|||
16995110|NCT00999518|38138797|FG002|Overall Study|Protocol Violation|0|||
16995111|NCT00999518|38138798|FG003|Overall Study|Protocol Violation|0|||
16995112|NCT00999518|38138799|FG004|Overall Study|Protocol Violation|2|||
16995113|NCT00999518|38138795|FG000|Overall Study|Withdrawal by Subject|5|||
16995114|NCT00999518|38138796|FG001|Overall Study|Withdrawal by Subject|4|||
16995115|NCT00999518|38138797|FG002|Overall Study|Withdrawal by Subject|10|||
16995116|NCT00999518|38138798|FG003|Overall Study|Withdrawal by Subject|6|||
16995117|NCT00999518|38138799|FG004|Overall Study|Withdrawal by Subject|1|||
16995118|NCT00999518|38138795|FG000|Overall Study|Other|5|||
16995119|NCT00999518|38138796|FG001|Overall Study|Other|7|||
16995120|NCT00999518|38138797|FG002|Overall Study|Other|1|||
16995121|NCT00999518|38138798|FG003|Overall Study|Other|4|||
17076614|NCT00451178|38218591|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
17076615|NCT00451178|38218590|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
17076616|NCT00451178|38218591|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
17076617|NCT00450866|38218601|FG000|Overall Study|Adverse Event|0|||
17076618|NCT00450866|38218602|FG001|Overall Study|Adverse Event|1|||
17076619|NCT00450866|38218601|FG000|Overall Study|Withdrawal by Subject|5|||
17076620|NCT00450866|38218602|FG001|Overall Study|Withdrawal by Subject|2|||
17076621|NCT00450866|38218601|FG000|Overall Study|Death|1|||
17076622|NCT00450866|38218602|FG001|Overall Study|Death|0|||
17076623|NCT00450866|38218601|FG000|Overall Study|Physician Decision|1|||
17076624|NCT00450866|38218602|FG001|Overall Study|Physician Decision|0|||
17076625|NCT00442598|38218611|FG000|Overall Study|Adverse Event|1|||
17157780|NCT02918318|38304638|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
17157781|NCT02918318|38304639|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
17157782|NCT02918318|38304635|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
17157783|NCT02918318|38304636|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
17157784|NCT02918318|38304637|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
17157785|NCT02918318|38304638|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
17157786|NCT02918318|38304639|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
17157787|NCT02918318|38304635|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
17076626|NCT00442598|38218612|FG001|Overall Study|Adverse Event|0|||
17076627|NCT00442598|38218613|FG002|Overall Study|Adverse Event|0|||
17076628|NCT00442598|38218611|FG000|Overall Study|Tumor progression|3|||
17076629|NCT00442598|38218612|FG001|Overall Study|Tumor progression|4|||
17076630|NCT00442598|38218613|FG002|Overall Study|Tumor progression|0|||
17076631|NCT00442598|38218611|FG000|Overall Study|Clinical deterioration|1|||
17076632|NCT00442598|38218612|FG001|Overall Study|Clinical deterioration|2|||
17076633|NCT00442598|38218613|FG002|Overall Study|Clinical deterioration|0|||
17076634|NCT00442598|38218611|FG000|Overall Study|CA125 progression|0|||
17076635|NCT00442598|38218612|FG001|Overall Study|CA125 progression|1|||
17076636|NCT00442598|38218613|FG002|Overall Study|CA125 progression|0|||
17076637|NCT00442598|38218611|FG000|Overall Study|Reduced creatinine clearance|1|||
17076638|NCT00442598|38218612|FG001|Overall Study|Reduced creatinine clearance|0|||
17076639|NCT00442598|38218613|FG002|Overall Study|Reduced creatinine clearance|0|||
17076640|NCT00442598|38218611|FG000|Overall Study|Death|0|||
17076641|NCT00442598|38218612|FG001|Overall Study|Death|1|||
17076642|NCT00442598|38218613|FG002|Overall Study|Death|0|||
17076643|NCT00442286|38218623|FG000|Overall Study|Death|2|||
17076644|NCT00442286|38218624|FG001|Overall Study|Death|2|||
17076645|NCT00442286|38218623|FG000|Overall Study|Lost to Follow-up|1|||
17076646|NCT00442286|38218624|FG001|Overall Study|Lost to Follow-up|0|||
17076647|NCT00442286|38218623|FG000|Overall Study|Withdrawal by Subject|2|||
17076648|NCT00442286|38218624|FG001|Overall Study|Withdrawal by Subject|0|||
17076649|NCT00442286|38218623|FG000|Overall Study|System explanted|1|||
17076650|NCT00442286|38218624|FG001|Overall Study|System explanted|0|||
17076651|NCT00442286|38218623|FG000|Overall Study|Patient Injury|1|||
17076652|NCT00442286|38218624|FG001|Overall Study|Patient Injury|0|||
17076653|NCT00441974|38218632|FG000|Overall Study|Adverse Event|6|||
17076654|NCT00441974|38218632|FG000|Overall Study|Consent Withdrawn|35|||
17076655|NCT00441974|38218632|FG000|Overall Study|Lost to Follow-up|80|||
17076656|NCT00441974|38218632|FG000|Overall Study|Protocol Violation|7|||
17076657|NCT00441584|38218639|FG000|Overall Study|Lack of Efficacy|79|||
17076658|NCT00441584|38218639|FG000|Overall Study|Withdrawal by Subject|8|||
17076659|NCT00441584|38218639|FG000|Overall Study|Adverse Event|6|||
17076660|NCT00441584|38218639|FG000|Overall Study|Protocol Violation|5|||
17076661|NCT00441584|38218639|FG000|Overall Study|Lost to Follow-up|4|||
17076662|NCT00441584|38218639|FG000|Overall Study|Failure to meet eligibility criteria|3|||
17076663|NCT00430716|38218646|FG000|Double Blind Phase|Death|1|||
17076664|NCT00430716|38218647|FG001|Double Blind Phase|Death|0|||
17076665|NCT00430716|38218648|FG002|Double Blind Phase|Death|0|||
17076666|NCT00430716|38218646|FG000|Double Blind Phase|No longer willing to participate|2|||
17076667|NCT00430716|38218647|FG001|Double Blind Phase|No longer willing to participate|1|||
17076668|NCT00430716|38218648|FG002|Double Blind Phase|No longer willing to participate|1|||
17076669|NCT00430716|38218646|FG000|Double Blind Phase|Other|0|||
17076670|NCT00430716|38218647|FG001|Double Blind Phase|Other|2|||
17076671|NCT00430716|38218648|FG002|Double Blind Phase|Other|0|||
17076672|NCT00430716|38218646|FG000|Double Blind Phase|Study terminated by sponsor|1|||
17076673|NCT00430716|38218647|FG001|Double Blind Phase|Study terminated by sponsor|1|||
17076674|NCT00430716|38218648|FG002|Double Blind Phase|Study terminated by sponsor|2|||
17076675|NCT00430716|38218646|FG000|Double Blind Phase|Adverse Event|1|||
17076676|NCT00430716|38218647|FG001|Double Blind Phase|Adverse Event|1|||
17076677|NCT00430716|38218648|FG002|Double Blind Phase|Adverse Event|3|||
17157788|NCT02918318|38304636|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
17157789|NCT02918318|38304637|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
17076678|NCT00430716|38218646|FG000|Double Blind Phase|Not treated|1|||
17076679|NCT00430716|38218647|FG001|Double Blind Phase|Not treated|0|||
17076680|NCT00430716|38218648|FG002|Double Blind Phase|Not treated|0|||
17076681|NCT00430716|38218646|FG000|Open Label Phase|Lost to Follow-up|1|||
17076682|NCT00430716|38218647|FG001|Open Label Phase|Lost to Follow-up|0|||
17157790|NCT02918318|38304638|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
17076683|NCT00430716|38218648|FG002|Open Label Phase|Lost to Follow-up|1|||
17076684|NCT00430716|38218646|FG000|Open Label Phase|No longer willing to participate|0|||
17076685|NCT00430716|38218647|FG001|Open Label Phase|No longer willing to participate|1|||
17076686|NCT00430716|38218648|FG002|Open Label Phase|No longer willing to participate|1|||
17076687|NCT00430716|38218646|FG000|Open Label Phase|Other|3|||
17076688|NCT00430716|38218647|FG001|Open Label Phase|Other|1|||
17076689|NCT00430716|38218648|FG002|Open Label Phase|Other|1|||
17076690|NCT00430716|38218646|FG000|Open Label Phase|Protocol Violation|1|||
17076691|NCT00430716|38218647|FG001|Open Label Phase|Protocol Violation|0|||
17076692|NCT00430716|38218648|FG002|Open Label Phase|Protocol Violation|0|||
17076693|NCT00430716|38218646|FG000|Open Label Phase|Study terminated by sponsor|4|||
17076694|NCT00430716|38218647|FG001|Open Label Phase|Study terminated by sponsor|5|||
17076695|NCT00430716|38218648|FG002|Open Label Phase|Study terminated by sponsor|4|||
17076696|NCT00441272|38218658|FG000|Overall Study|Study terminated prior to enrollment|25|||
17076697|NCT00441272|38218659|FG001|Overall Study|Study terminated prior to enrollment|25|||
17076698|NCT00430638|38218667|FG000|Overall Study|Adverse Event|15|||
17076699|NCT00430638|38218668|FG001|Overall Study|Adverse Event|15|||
17076700|NCT00430638|38218667|FG000|Overall Study|Uncontrolled blood pressure|48|||
17076701|NCT00430638|38218668|FG001|Overall Study|Uncontrolled blood pressure|13|||
17076702|NCT00430638|38218667|FG000|Overall Study|Lost to Follow-up|1|||
17076703|NCT00430638|38218668|FG001|Overall Study|Lost to Follow-up|7|||
17076704|NCT00430638|38218667|FG000|Overall Study|Protocol Violation|6|||
17076705|NCT00430638|38218668|FG001|Overall Study|Protocol Violation|4|||
17076706|NCT00430638|38218667|FG000|Overall Study|Withdrawal by Subject|4|||
17076707|NCT00430638|38218668|FG001|Overall Study|Withdrawal by Subject|6|||
17157791|NCT02918318|38304639|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
17157792|NCT02918318|38304635|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
17157793|NCT02918318|38304636|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
17157794|NCT02918318|38304637|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
17157795|NCT02918318|38304638|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
17157796|NCT02918318|38304639|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
17157797|NCT03411863|38304684|FG000|Overall Study|Withdrawal by Subject|3|||
17157798|NCT03411863|38304685|FG001|Overall Study|Withdrawal by Subject|1|||
17157799|NCT03411863|38304684|FG000|Overall Study|Physician Decision|0|||
17157800|NCT03411863|38304685|FG001|Overall Study|Physician Decision|1|||
17157801|NCT01065350|38304694|FG000|Overall Study|Received incorrect drug allocation|0|||
17157802|NCT01065350|38304695|FG001|Overall Study|Received incorrect drug allocation|1|||
17076708|NCT00430638|38218667|FG000|Overall Study|Non-compliant|2|||
17076709|NCT00430638|38218668|FG001|Overall Study|Non-compliant|1|||
17157803|NCT03434249|38304703|FG000|Overall Study|Adverse Event|1|||
17157804|NCT03434249|38304704|FG001|Overall Study|Adverse Event|0|||
17157805|NCT03434249|38304703|FG000|Overall Study|Lost to Follow-up|0|||
17157806|NCT03434249|38304704|FG001|Overall Study|Lost to Follow-up|1|||
17157807|NCT03434249|38304703|FG000|Overall Study|Non-compliance of family|2|||
17076710|NCT00430638|38218667|FG000|Overall Study|Other|2|||
17076711|NCT00430638|38218668|FG001|Overall Study|Other|2|||
17076712|NCT00430482|38218680|FG000|Completed Treatment|Insufficient Treatment|7|||
17076713|NCT00430482|38218681|FG001|Completed Treatment|Insufficient Treatment|11|||
17076714|NCT00449930|38218689|FG000|Overall Study|Adverse Event|9|||
17076715|NCT00449930|38218690|FG001|Overall Study|Adverse Event|19|||
17076716|NCT00449930|38218689|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
17076717|NCT00449930|38218690|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
17076718|NCT00449930|38218689|FG000|Overall Study|Lack of Efficacy|10|||
17076719|NCT00449930|38218690|FG001|Overall Study|Lack of Efficacy|1|||
17076720|NCT00449930|38218689|FG000|Overall Study|Lost to Follow-up|9|||
17076721|NCT00449930|38218690|FG001|Overall Study|Lost to Follow-up|14|||
17076722|NCT00449930|38218689|FG000|Overall Study|Physician Decision|1|||
17076723|NCT00449930|38218690|FG001|Overall Study|Physician Decision|2|||
17076724|NCT00449930|38218689|FG000|Overall Study|Protocol Violation|14|||
17076725|NCT00449930|38218690|FG001|Overall Study|Protocol Violation|15|||
17076726|NCT00449930|38218689|FG000|Overall Study|Withdrawal by Subject|16|||
17076727|NCT00449930|38218690|FG001|Overall Study|Withdrawal by Subject|23|||
17076728|NCT00449930|38218689|FG000|Overall Study|Glycemic discontinuation criteria|1|||
17076729|NCT00449930|38218690|FG001|Overall Study|Glycemic discontinuation criteria|1|||
17076730|NCT00449696|38218698|FG000|Overall Study|Other Treatment Required|6|||
17076731|NCT00449696|38218699|FG001|Overall Study|Other Treatment Required|1|||
17076732|NCT00449696|38218698|FG000|Overall Study|Withdrawal by Subject|5|||
17076733|NCT00449696|38218699|FG001|Overall Study|Withdrawal by Subject|5|||
17076734|NCT00449696|38218698|FG000|Overall Study|Lost to Follow-up|2|||
17157808|NCT03434249|38304704|FG001|Overall Study|Non-compliance of family|1|||
17076735|NCT00449696|38218699|FG001|Overall Study|Lost to Follow-up|3|||
17076736|NCT00449696|38218698|FG000|Overall Study|Others|7|||
17076737|NCT00449696|38218699|FG001|Overall Study|Others|0|||
17076738|NCT00441116|38218707|FG000|Overall Study|Adverse Event|1|||
17157809|NCT03434249|38304703|FG000|Overall Study|Difficulties in completing daily diary|2|||
17076739|NCT00441116|38218708|FG001|Overall Study|Adverse Event|1|||
17076740|NCT00441116|38218707|FG000|Overall Study|Withdrawal by Subject|1|||
17076741|NCT00441116|38218708|FG001|Overall Study|Withdrawal by Subject|0|||
17076742|NCT00441116|38218707|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
17076743|NCT00441116|38218708|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
17076744|NCT00430248|38218717|FG000|Overall Study|Adverse Event|49|||
17157810|NCT03434249|38304704|FG001|Overall Study|Difficulties in completing daily diary|1|||
17157811|NCT03114969|38304719|FG000|Overall Study|Lost to Follow-up|0|||
17157812|NCT03114969|38304720|FG001|Overall Study|Lost to Follow-up|0|||
16995122|NCT00999518|38138799|FG004|Overall Study|Other|5|||
17076745|NCT00430248|38218718|FG001|Overall Study|Adverse Event|61|||
17076746|NCT00430248|38218719|FG002|Overall Study|Adverse Event|64|||
17076747|NCT00430248|38218717|FG000|Overall Study|Protocol Violation|10|||
17076748|NCT00430248|38218718|FG001|Overall Study|Protocol Violation|2|||
17076749|NCT00430248|38218719|FG002|Overall Study|Protocol Violation|4|||
17076750|NCT00430248|38218717|FG000|Overall Study|Personal Reasons|12|||
17076751|NCT00430248|38218718|FG001|Overall Study|Personal Reasons|24|||
17076752|NCT00430248|38218719|FG002|Overall Study|Personal Reasons|9|||
17076753|NCT00430248|38218717|FG000|Overall Study|Lost to Follow-up|28|||
17076754|NCT00430248|38218718|FG001|Overall Study|Lost to Follow-up|33|||
17076755|NCT00430248|38218719|FG002|Overall Study|Lost to Follow-up|28|||
17076756|NCT00430248|38218717|FG000|Overall Study|Therapeutic Failure|1|||
17076757|NCT00430248|38218718|FG001|Overall Study|Therapeutic Failure|1|||
17076758|NCT00430248|38218719|FG002|Overall Study|Therapeutic Failure|1|||
17076759|NCT00430248|38218717|FG000|Overall Study|Withdrawal by Subject|14|||
17076760|NCT00430248|38218718|FG001|Overall Study|Withdrawal by Subject|20|||
17076761|NCT00430248|38218719|FG002|Overall Study|Withdrawal by Subject|16|||
17076762|NCT00430248|38218717|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17076763|NCT00430248|38218718|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
17076764|NCT00430248|38218719|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17076765|NCT00430248|38218717|FG000|Overall Study|Gout Flare|3|||
17076766|NCT00430248|38218718|FG001|Overall Study|Gout Flare|7|||
17076767|NCT00430248|38218719|FG002|Overall Study|Gout Flare|2|||
17076768|NCT00430248|38218717|FG000|Overall Study|Reason Not Specified|8|||
17076769|NCT00430248|38218718|FG001|Overall Study|Reason Not Specified|8|||
17076770|NCT00430248|38218719|FG002|Overall Study|Reason Not Specified|11|||
17076771|NCT00449540|38218729|FG000|Pretreatment Phase|No migraine experienced|66|||
17076772|NCT00449540|38218730|FG001|Pretreatment Phase|No migraine experienced|0|||
17076773|NCT00449540|38218731|FG002|Pretreatment Phase|No migraine experienced|0|||
17076774|NCT00449540|38218729|FG000|Treatment Phase|did not experience or treat migraine|0|||
17076775|NCT00449540|38218730|FG001|Treatment Phase|did not experience or treat migraine|20|||
17076776|NCT00449540|38218731|FG002|Treatment Phase|did not experience or treat migraine|17|||
17076777|NCT00411762|38218739|FG000|Overall Study|Withdrawal by Subject|5|||
17076778|NCT00429858|38218743|FG000|Overall Study|Withdrawal by Subject|1|||
17076779|NCT00429858|38218743|FG000|Overall Study|Study Termination|1|||
17076780|NCT00449150|38218751|FG000|Overall Study|Adverse Event|11|||
17076781|NCT00449150|38218752|FG001|Overall Study|Adverse Event|18|||
17157813|NCT03114969|38304721|FG002|Overall Study|Lost to Follow-up|3|||
16995123|NCT00999518|38138795|FG000|Overall Study|Randomized but not Treated|1|||
16995124|NCT00999518|38138796|FG001|Overall Study|Randomized but not Treated|1|||
16995125|NCT00999518|38138797|FG002|Overall Study|Randomized but not Treated|2|||
16995126|NCT00999518|38138798|FG003|Overall Study|Randomized but not Treated|0|||
16995127|NCT00999518|38138799|FG004|Overall Study|Randomized but not Treated|1|||
16995128|NCT01056263|38138815|FG000|Overall Study|Adverse Event|12|||
16995129|NCT01056263|38138815|FG000|Overall Study|Death|1|||
16995130|NCT01056263|38138815|FG000|Overall Study|Withdrawal by Subject|1|||
16995131|NCT01056263|38138815|FG000|Overall Study|Lack of Efficacy|29|||
16995132|NCT01056263|38138815|FG000|Overall Study|Progressive disease|2|||
16995133|NCT01056263|38138815|FG000|Overall Study|Neoplasm progression|1|||
16995134|NCT01056263|38138815|FG000|Overall Study|Objective progression or relapse|1|||
16995135|NCT01056263|38138815|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
16995136|NCT01056107|38138823|FG000|Overall Study|Withdrawal by Subject|0|||
16995137|NCT01056107|38138824|FG001|Overall Study|Withdrawal by Subject|1|||
16995138|NCT01056107|38138825|FG002|Overall Study|Withdrawal by Subject|3|||
16995139|NCT01056107|38138826|FG003|Overall Study|Withdrawal by Subject|0|||
16995140|NCT01003886|38138836|FG000|Overall Study|Lack of Efficacy|5|||
16995141|NCT01003886|38138836|FG000|Overall Study|Lost to Follow-up|169|||
16995142|NCT01003886|38138836|FG000|Overall Study|Withdrawal by Subject|39|||
16995143|NCT01003886|38138836|FG000|Overall Study|Other|14|||
16995144|NCT01003886|38138836|FG000|Overall Study|Adverse Event|3|||
16995145|NCT01003184|38138842|FG000|Overall Study|Adverse Event|12|||
17076782|NCT00449150|38218753|FG002|Overall Study|Adverse Event|9|||
17076783|NCT00449150|38218751|FG000|Overall Study|Lack of Efficacy|1|||
17076784|NCT00449150|38218752|FG001|Overall Study|Lack of Efficacy|2|||
17076785|NCT00449150|38218753|FG002|Overall Study|Lack of Efficacy|2|||
17076786|NCT00449150|38218751|FG000|Overall Study|Other|16|||
17076787|NCT00449150|38218752|FG001|Overall Study|Other|13|||
17076788|NCT00449150|38218753|FG002|Overall Study|Other|14|||
17076789|NCT00449150|38218751|FG000|Overall Study|Withdrawal by Subject|17|||
17076790|NCT00449150|38218752|FG001|Overall Study|Withdrawal by Subject|18|||
17076791|NCT00449150|38218753|FG002|Overall Study|Withdrawal by Subject|21|||
17076792|NCT00449150|38218751|FG000|Overall Study|Protocol Violation|1|||
17076793|NCT00449150|38218752|FG001|Overall Study|Protocol Violation|2|||
17076794|NCT00449150|38218753|FG002|Overall Study|Protocol Violation|1|||
17076795|NCT00428844|38218767|FG000|Completed Study Drug Treatment|Adverse Event|2|||
17076796|NCT00428844|38218768|FG001|Completed Study Drug Treatment|Adverse Event|4|||
17076797|NCT00428844|38218769|FG002|Completed Study Drug Treatment|Adverse Event|4|||
17076798|NCT00428844|38218767|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
17076799|NCT00428844|38218768|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
17076800|NCT00428844|38218769|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
17076801|NCT00428844|38218767|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
17076802|NCT00428844|38218768|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
17076803|NCT00428844|38218769|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
17076804|NCT00428844|38218767|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
17076805|NCT00428844|38218768|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
17076806|NCT00428844|38218769|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
17076807|NCT00428844|38218767|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
17076808|NCT00428844|38218768|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
17076809|NCT00428844|38218769|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
17076810|NCT00428844|38218767|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
17076811|NCT00428844|38218768|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
17076812|NCT00428844|38218769|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
17076813|NCT00428844|38218767|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
17076814|NCT00428844|38218768|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
17076815|NCT00428844|38218769|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
17076816|NCT00428844|38218767|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
17076817|NCT00428844|38218768|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
17076818|NCT00428844|38218769|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
17076819|NCT00428844|38218767|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
17076820|NCT00428844|38218768|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
17076821|NCT00428844|38218769|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
17076822|NCT00457418|38218777|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
17076823|NCT00457418|38218777|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
17076824|NCT00457418|38218777|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
17076825|NCT00457418|38218777|FG000|Post PK Maintenance|Adverse Event|10|||
17076826|NCT00457418|38218777|FG000|Post PK Maintenance|Progression of Disease|6|||
17076827|NCT00457418|38218777|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
17076828|NCT00457418|38218777|FG000|Post PK Maintenance|Lost to Follow-up|1|||
17076829|NCT00449072|38218783|FG000|Overall Study|Adverse Event|3|||
17076830|NCT00449072|38218784|FG001|Overall Study|Adverse Event|1|||
17076831|NCT00449072|38218783|FG000|Overall Study|Protocol Violation|14|||
17076832|NCT00449072|38218784|FG001|Overall Study|Protocol Violation|12|||
17076833|NCT00449072|38218783|FG000|Overall Study|Lost to Follow-up|5|||
17076834|NCT00449072|38218784|FG001|Overall Study|Lost to Follow-up|7|||
17076835|NCT00449072|38218783|FG000|Overall Study|Withdrawal by Subject|11|||
17076836|NCT00449072|38218784|FG001|Overall Study|Withdrawal by Subject|8|||
17076837|NCT00449072|38218783|FG000|Overall Study|Lack of Efficacy|1|||
17076838|NCT00449072|38218784|FG001|Overall Study|Lack of Efficacy|1|||
17076839|NCT00449072|38218783|FG000|Overall Study|Physician Decision|1|||
17076840|NCT00449072|38218784|FG001|Overall Study|Physician Decision|0|||
17076841|NCT00449072|38218783|FG000|Overall Study|Not treated|0|||
17076842|NCT00449072|38218784|FG001|Overall Study|Not treated|1|||
17076843|NCT00449072|38218783|FG000|Overall Study|Excluded medication|0|||
17076844|NCT00449072|38218784|FG001|Overall Study|Excluded medication|2|||
17076845|NCT00449072|38218783|FG000|Overall Study|Non-compliance|2|||
17076846|NCT00449072|38218784|FG001|Overall Study|Non-compliance|5|||
17076847|NCT00449072|38218783|FG000|Overall Study|Sponsor decision|1|||
17076848|NCT00449072|38218784|FG001|Overall Study|Sponsor decision|3|||
17076849|NCT00449072|38218783|FG000|Overall Study|Relocation|3|||
17076850|NCT00449072|38218784|FG001|Overall Study|Relocation|2|||
17076851|NCT00428610|38218793|FG000|Overall Study|Death Due to Adverse Event|3|||
17076852|NCT00428610|38218794|FG001|Overall Study|Death Due to Adverse Event|0|||
17076853|NCT00428610|38218795|FG002|Overall Study|Death Due to Adverse Event|5|||
17076854|NCT00428610|38218793|FG000|Overall Study|Death Due to Progressive Disease|0|||
17076855|NCT00428610|38218794|FG001|Overall Study|Death Due to Progressive Disease|0|||
17076856|NCT00428610|38218795|FG002|Overall Study|Death Due to Progressive Disease|2|||
17076857|NCT00428610|38218793|FG000|Overall Study|Adverse Event|2|||
17076858|NCT00428610|38218794|FG001|Overall Study|Adverse Event|3|||
17076859|NCT00428610|38218795|FG002|Overall Study|Adverse Event|2|||
17076860|NCT00428610|38218793|FG000|Overall Study|Investigator Decision|2|||
17076861|NCT00428610|38218794|FG001|Overall Study|Investigator Decision|1|||
17076862|NCT00428610|38218795|FG002|Overall Study|Investigator Decision|1|||
17076863|NCT00428610|38218793|FG000|Overall Study|Progressive Disease|42|||
17076864|NCT00428610|38218794|FG001|Overall Study|Progressive Disease|14|||
17076865|NCT00428610|38218795|FG002|Overall Study|Progressive Disease|22|||
17076866|NCT00428610|38218793|FG000|Overall Study|Withdrawal by Subject|4|||
17076867|NCT00428610|38218794|FG001|Overall Study|Withdrawal by Subject|0|||
17076868|NCT00428610|38218795|FG002|Overall Study|Withdrawal by Subject|0|||
17076869|NCT00419094|38218805|FG000|Overall Study|Adverse Event|3|||
17076870|NCT00419094|38218806|FG001|Overall Study|Adverse Event|7|||
17076871|NCT00419094|38218805|FG000|Overall Study|Lack of Efficacy|1|||
17076872|NCT00419094|38218806|FG001|Overall Study|Lack of Efficacy|0|||
17157814|NCT03114969|38304722|FG003|Overall Study|Lost to Follow-up|2|||
17157815|NCT03114969|38304723|FG004|Overall Study|Lost to Follow-up|0|||
17157816|NCT03114969|38304724|FG005|Overall Study|Lost to Follow-up|0|||
17076873|NCT00419094|38218805|FG000|Overall Study|Lost to Follow-up|0|||
17076874|NCT00419094|38218806|FG001|Overall Study|Lost to Follow-up|2|||
17076875|NCT00419094|38218805|FG000|Overall Study|Protocol Violation|1|||
17076876|NCT00419094|38218806|FG001|Overall Study|Protocol Violation|14|||
17157817|NCT03114969|38304725|FG006|Overall Study|Lost to Follow-up|0|||
17157818|NCT03114969|38304726|FG007|Overall Study|Lost to Follow-up|0|||
17157819|NCT03114969|38304727|FG008|Overall Study|Lost to Follow-up|0|||
17157820|NCT03114969|38304719|FG000|Overall Study|Adverse Event|0|||
17157821|NCT03114969|38304720|FG001|Overall Study|Adverse Event|0|||
17157822|NCT03114969|38304721|FG002|Overall Study|Adverse Event|1|||
17157823|NCT03114969|38304722|FG003|Overall Study|Adverse Event|0|||
17157824|NCT03114969|38304723|FG004|Overall Study|Adverse Event|0|||
17157825|NCT03114969|38304724|FG005|Overall Study|Adverse Event|1|||
17157826|NCT03114969|38304725|FG006|Overall Study|Adverse Event|1|||
17076877|NCT00419094|38218805|FG000|Overall Study|Withdrawal of consent|1|||
17076878|NCT00419094|38218806|FG001|Overall Study|Withdrawal of consent|5|||
17076879|NCT00419094|38218805|FG000|Overall Study|Other: Error determining exit criteria|1|||
17076880|NCT00419094|38218806|FG001|Overall Study|Other: Error determining exit criteria|0|||
17076881|NCT00419094|38218805|FG000|Overall Study|Other: Patient non-compliant|0|||
17076882|NCT00419094|38218806|FG001|Overall Study|Other: Patient non-compliant|1|||
17076883|NCT00419094|38218805|FG000|Overall Study|Other: No contact for extended period|0|||
17076884|NCT00419094|38218806|FG001|Overall Study|Other: No contact for extended period|1|||
17076885|NCT00448916|38218816|FG000|Overall Study|Adverse Event|2|||
17076886|NCT00448916|38218817|FG001|Overall Study|Adverse Event|2|||
17076887|NCT00448916|38218818|FG002|Overall Study|Adverse Event|3|||
17076888|NCT00448916|38218819|FG003|Overall Study|Adverse Event|2|||
17076889|NCT00448916|38218816|FG000|Overall Study|Lack of Efficacy|1|||
17076890|NCT00448916|38218817|FG001|Overall Study|Lack of Efficacy|0|||
17076891|NCT00448916|38218818|FG002|Overall Study|Lack of Efficacy|2|||
17076892|NCT00448916|38218819|FG003|Overall Study|Lack of Efficacy|1|||
17076893|NCT00448916|38218816|FG000|Overall Study|Withdrawal by Subject|3|||
17076894|NCT00448916|38218817|FG001|Overall Study|Withdrawal by Subject|3|||
17076895|NCT00448916|38218818|FG002|Overall Study|Withdrawal by Subject|1|||
17076896|NCT00448916|38218819|FG003|Overall Study|Withdrawal by Subject|1|||
17076897|NCT00448916|38218816|FG000|Overall Study|Other|1|||
17076898|NCT00448916|38218817|FG001|Overall Study|Other|0|||
17076899|NCT00448916|38218818|FG002|Overall Study|Other|0|||
17076900|NCT00448916|38218819|FG003|Overall Study|Other|0|||
17076901|NCT00448916|38218816|FG000|Overall Study|Lost to Follow-up|0|||
17076902|NCT00448916|38218817|FG001|Overall Study|Lost to Follow-up|1|||
17076903|NCT00448916|38218818|FG002|Overall Study|Lost to Follow-up|0|||
17076904|NCT00448916|38218819|FG003|Overall Study|Lost to Follow-up|1|||
17076905|NCT00448916|38218816|FG000|Overall Study|Protocol Violation|0|||
17076906|NCT00448916|38218817|FG001|Overall Study|Protocol Violation|0|||
17076907|NCT00448916|38218818|FG002|Overall Study|Protocol Violation|0|||
17076908|NCT00448916|38218819|FG003|Overall Study|Protocol Violation|1|||
17076909|NCT00418938|38218833|FG000|Overall Study|Reimbursement|1|||
17076910|NCT00418938|38218834|FG001|Overall Study|Reimbursement|0|||
17076911|NCT00418938|38218833|FG000|Overall Study|Administrative decision|3|||
17076912|NCT00418938|38218834|FG001|Overall Study|Administrative decision|3|||
17076913|NCT00418938|38218833|FG000|Overall Study|Withdrawal by Subject|16|||
17076914|NCT00418938|38218834|FG001|Overall Study|Withdrawal by Subject|15|||
17076915|NCT00418938|38218833|FG000|Overall Study|Lost to Follow-up|1|||
17076916|NCT00418938|38218834|FG001|Overall Study|Lost to Follow-up|3|||
17076917|NCT00418938|38218833|FG000|Overall Study|Adverse Event|1|||
17076918|NCT00418938|38218834|FG001|Overall Study|Adverse Event|1|||
17076919|NCT00418938|38218833|FG000|Overall Study|On-going|1|||
17157827|NCT03114969|38304726|FG007|Overall Study|Adverse Event|0|||
17157828|NCT03114969|38304727|FG008|Overall Study|Adverse Event|2|||
17157829|NCT02046096|38304756|FG000|Overall Study|Death|28|||
17076920|NCT00418938|38218834|FG001|Overall Study|On-going|1|||
17076921|NCT00418938|38218833|FG000|Overall Study|Ineligibility Determined|1|||
17076922|NCT00418938|38218834|FG001|Overall Study|Ineligibility Determined|0|||
17076923|NCT00448760|38218840|FG000|Overall Study|Death|3|||
17076924|NCT00418314|38218846|FG000|Overall Study|Withdrawal by Subject|1|||
17076925|NCT00418314|38218847|FG001|Overall Study|Withdrawal by Subject|2|||
17076926|NCT00448448|38218855|FG000|Overall Study|Withdrawal by Subject|13|||
17076927|NCT00448448|38218856|FG001|Overall Study|Withdrawal by Subject|2|||
17076928|NCT00448448|38218855|FG000|Overall Study|On protocol when study ended|83|||
17076929|NCT00448448|38218856|FG001|Overall Study|On protocol when study ended|36|||
17076930|NCT00448448|38218855|FG000|Overall Study|Lost to Follow-up|2|||
17076931|NCT00448448|38218856|FG001|Overall Study|Lost to Follow-up|1|||
17076932|NCT00448448|38218855|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
17076933|NCT00448448|38218856|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
17076934|NCT00448448|38218855|FG000|Overall Study|Signed consent lost|0|||
17076935|NCT00448448|38218856|FG001|Overall Study|Signed consent lost|1|||
17076936|NCT00405912|38218865|FG000|Overall Study|Withdrawal by Subject|12|||
17076937|NCT00405912|38218866|FG001|Overall Study|Withdrawal by Subject|11|||
17076938|NCT00405912|38218867|FG002|Overall Study|Withdrawal by Subject|12|||
17076939|NCT00405912|38218865|FG000|Overall Study|Lost to Follow-up|4|||
17076940|NCT00405912|38218866|FG001|Overall Study|Lost to Follow-up|8|||
17076941|NCT00405912|38218867|FG002|Overall Study|Lost to Follow-up|4|||
17076942|NCT00448136|38218877|FG000|Overall Study|Death|3|||
17076943|NCT00448136|38218878|FG001|Overall Study|Death|8|||
17076944|NCT00448136|38218877|FG000|Overall Study|Investigator's decision (progression)|1|||
17076945|NCT00448136|38218878|FG001|Overall Study|Investigator's decision (progression)|0|||
17076946|NCT00447902|38218886|FG000|Overall Study|Adverse Event|0|||
17076947|NCT00447902|38218887|FG001|Overall Study|Adverse Event|3|||
17076948|NCT00447902|38218886|FG000|Overall Study|Protocol Violation|1|||
17076949|NCT00447902|38218887|FG001|Overall Study|Protocol Violation|0|||
17076950|NCT00447902|38218886|FG000|Overall Study|Withdrawal by Subject|0|||
17157830|NCT02046096|38304757|FG001|Overall Study|Death|45|||
17157831|NCT02046096|38304756|FG000|Overall Study|Lost to Follow-up|9|||
17157832|NCT02046096|38304757|FG001|Overall Study|Lost to Follow-up|20|||
17157833|NCT02046096|38304756|FG000|Overall Study|Withdrawal by Subject|5|||
17076951|NCT00447902|38218887|FG001|Overall Study|Withdrawal by Subject|1|||
17076952|NCT00447902|38218886|FG000|Overall Study|included patients who discontinued|1|||
17076953|NCT00447902|38218887|FG001|Overall Study|included patients who discontinued|1|||
17076954|NCT00447902|38218886|FG000|Overall Study|Lack of Efficacy|2|||
17076955|NCT00447902|38218887|FG001|Overall Study|Lack of Efficacy|1|||
17076956|NCT00307437|38218896|FG000|Controlled Period|Adverse Event|7|||
17076957|NCT00307437|38218897|FG001|Controlled Period|Adverse Event|2|||
17076958|NCT00307437|38218898|FG002|Controlled Period|Adverse Event|5|||
17076959|NCT00307437|38218899|FG003|Controlled Period|Adverse Event|0|||
17076960|NCT00307437|38218900|FG004|Controlled Period|Adverse Event|0|||
17076961|NCT00307437|38218901|FG005|Controlled Period|Adverse Event|0|||
17076962|NCT00307437|38218902|FG006|Controlled Period|Adverse Event|0|||
17076963|NCT00307437|38218896|FG000|Controlled Period|Death|0|||
17076964|NCT00307437|38218897|FG001|Controlled Period|Death|0|||
17076965|NCT00307437|38218898|FG002|Controlled Period|Death|1|||
17076966|NCT00307437|38218899|FG003|Controlled Period|Death|0|||
17076967|NCT00307437|38218900|FG004|Controlled Period|Death|0|||
17076968|NCT00307437|38218901|FG005|Controlled Period|Death|0|||
17076969|NCT00307437|38218902|FG006|Controlled Period|Death|0|||
17076970|NCT00307437|38218896|FG000|Controlled Period|Lack of Efficacy|2|||
17076971|NCT00307437|38218897|FG001|Controlled Period|Lack of Efficacy|0|||
17076972|NCT00307437|38218898|FG002|Controlled Period|Lack of Efficacy|0|||
17076973|NCT00307437|38218899|FG003|Controlled Period|Lack of Efficacy|0|||
17076974|NCT00307437|38218900|FG004|Controlled Period|Lack of Efficacy|0|||
17076975|NCT00307437|38218901|FG005|Controlled Period|Lack of Efficacy|0|||
17076976|NCT00307437|38218902|FG006|Controlled Period|Lack of Efficacy|0|||
17076977|NCT00307437|38218896|FG000|Controlled Period|Lost to Follow-up|2|||
17076978|NCT00307437|38218897|FG001|Controlled Period|Lost to Follow-up|3|||
17157834|NCT02046096|38304757|FG001|Overall Study|Withdrawal by Subject|17|||
17157835|NCT02046096|38304756|FG000|Overall Study|Other endpoint|2|||
17157836|NCT02046096|38304757|FG001|Overall Study|Other endpoint|19|||
17157837|NCT03463577|38304771|FG000|Overall Study|Lost to Follow-up|238|||
17157838|NCT03463577|38304772|FG001|Overall Study|Lost to Follow-up|435|||
17157839|NCT03463577|38304773|FG002|Overall Study|Lost to Follow-up|0|||
17157840|NCT03463577|38304774|FG003|Overall Study|Lost to Follow-up|0|||
17157841|NCT03463577|38304775|FG004|Overall Study|Lost to Follow-up|0|||
17157842|NCT03463577|38304776|FG005|Overall Study|Lost to Follow-up|0|||
17157843|NCT03463577|38304771|FG000|Overall Study|With unknown pregnancy outcome|0|||
17076979|NCT00307437|38218898|FG002|Controlled Period|Lost to Follow-up|0|||
17076980|NCT00307437|38218899|FG003|Controlled Period|Lost to Follow-up|0|||
17076981|NCT00307437|38218900|FG004|Controlled Period|Lost to Follow-up|0|||
17076982|NCT00307437|38218901|FG005|Controlled Period|Lost to Follow-up|0|||
17076983|NCT00307437|38218902|FG006|Controlled Period|Lost to Follow-up|0|||
17157844|NCT03463577|38304772|FG001|Overall Study|With unknown pregnancy outcome|5|||
17157845|NCT03463577|38304773|FG002|Overall Study|With unknown pregnancy outcome|0|||
17157846|NCT03463577|38304774|FG003|Overall Study|With unknown pregnancy outcome|0|||
17157847|NCT03463577|38304775|FG004|Overall Study|With unknown pregnancy outcome|0|||
17157848|NCT03463577|38304776|FG005|Overall Study|With unknown pregnancy outcome|0|||
17157849|NCT03463577|38304771|FG000|Overall Study|Maternal death|2|||
17157850|NCT03463577|38304772|FG001|Overall Study|Maternal death|0|||
17157851|NCT03463577|38304773|FG002|Overall Study|Maternal death|0|||
17157852|NCT03463577|38304774|FG003|Overall Study|Maternal death|0|||
17157853|NCT03463577|38304775|FG004|Overall Study|Maternal death|0|||
17157854|NCT03463577|38304776|FG005|Overall Study|Maternal death|0|||
17157855|NCT03463577|38304771|FG000|Overall Study|Neonatal death|0|||
17157856|NCT03463577|38304772|FG001|Overall Study|Neonatal death|0|||
17157857|NCT03463577|38304773|FG002|Overall Study|Neonatal death|0|||
17157858|NCT03463577|38304774|FG003|Overall Study|Neonatal death|15|||
17157859|NCT03463577|38304775|FG004|Overall Study|Neonatal death|17|||
17157860|NCT03463577|38304776|FG005|Overall Study|Neonatal death|0|||
17157861|NCT03122145|38304792|FG000|Overall Study|Concurrent respiratory disease|3|||
17157862|NCT03122145|38304793|FG001|Overall Study|Concurrent respiratory disease|0|||
17157863|NCT03114657|38304801|FG000|Overall Study|Adverse Event|9|||
17157864|NCT03114657|38304802|FG001|Overall Study|Adverse Event|6|||
17157865|NCT03114657|38304801|FG000|Overall Study|Death|4|||
17157866|NCT03114657|38304802|FG001|Overall Study|Death|0|||
17157867|NCT03114657|38304801|FG000|Overall Study|Multiple Reasons|1|||
17157868|NCT03114657|38304802|FG001|Overall Study|Multiple Reasons|2|||
17157869|NCT03114657|38304801|FG000|Overall Study|Physician Decision|2|||
17157870|NCT03114657|38304802|FG001|Overall Study|Physician Decision|2|||
17157871|NCT03114657|38304801|FG000|Overall Study|Study Terminated By Sponsor|355|||
17157872|NCT03114657|38304802|FG001|Overall Study|Study Terminated By Sponsor|374|||
17157873|NCT03114657|38304801|FG000|Overall Study|Symptomatic Deterioration|0|||
17157874|NCT03114657|38304802|FG001|Overall Study|Symptomatic Deterioration|1|||
17157875|NCT03114657|38304801|FG000|Overall Study|Withdrawal by Subject|28|||
17157876|NCT03114657|38304802|FG001|Overall Study|Withdrawal by Subject|22|||
17157877|NCT02926950|38304811|FG000|Overall Study|Adverse Event|4|||
17157878|NCT02926950|38304812|FG001|Overall Study|Adverse Event|6|||
17157879|NCT02926950|38304811|FG000|Overall Study|At the participant's own request|21|||
17157880|NCT02926950|38304812|FG001|Overall Study|At the participant's own request|25|||
17157881|NCT02926950|38304811|FG000|Overall Study|Reason not Specified|17|||
17157882|NCT02926950|38304812|FG001|Overall Study|Reason not Specified|9|||
17157883|NCT02926950|38304811|FG000|Overall Study|Lost to Follow-up|7|||
17157884|NCT02926950|38304812|FG001|Overall Study|Lost to Follow-up|8|||
17157885|NCT03410693|38304821|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
17157886|NCT03410693|38304822|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
17157887|NCT03410693|38304821|FG000|Overall Study|Disc trt: Lost to follow up|0|||
17157888|NCT03410693|38304822|FG001|Overall Study|Disc trt: Lost to follow up|1|||
17157889|NCT03410693|38304821|FG000|Overall Study|Disc trt: radiological progression|58|||
17157890|NCT03410693|38304822|FG001|Overall Study|Disc trt: radiological progression|50|||
17157891|NCT03410693|38304821|FG000|Overall Study|Disc trt: Other|1|||
17157892|NCT03410693|38304822|FG001|Overall Study|Disc trt: Other|0|||
17157893|NCT03410693|38304821|FG000|Overall Study|Study drug never administered|1|||
17157894|NCT03410693|38304822|FG001|Overall Study|Study drug never administered|6|||
17157895|NCT03410693|38304821|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
17157896|NCT03410693|38304822|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
17157897|NCT03410693|38304821|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
17157898|NCT03410693|38304822|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
17157899|NCT03410693|38304821|FG000|Overall Study|Disc trt: Physician decision|0|||
17157900|NCT03410693|38304822|FG001|Overall Study|Disc trt: Physician decision|5|||
17157901|NCT03410693|38304821|FG000|Overall Study|Disc trt: clinical progression|1|||
17157902|NCT03410693|38304822|FG001|Overall Study|Disc trt: clinical progression|5|||
17157903|NCT03410693|38304821|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
17157904|NCT03410693|38304822|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
17157905|NCT01064414|38304837|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
17157906|NCT01064414|38304838|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
17157907|NCT01064414|38304839|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
17157908|NCT01064414|38304837|FG000|Core Period: Baseline to Week 26|Death|0|||
17157909|NCT01064414|38304838|FG001|Core Period: Baseline to Week 26|Death|1|||
17157910|NCT01064414|38304839|FG002|Core Period: Baseline to Week 26|Death|0|||
17157911|NCT01064414|38304837|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
17157912|NCT01064414|38304838|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
17157913|NCT01064414|38304839|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
17157914|NCT01064414|38304837|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
17157915|NCT01064414|38304838|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
17157916|NCT01064414|38304839|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
17157917|NCT01064414|38304837|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
17157918|NCT01064414|38304838|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
17157919|NCT01064414|38304839|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
17157920|NCT01064414|38304837|FG000|Core Period: Baseline to Week 26|Other|4|||
17157921|NCT01064414|38304838|FG001|Core Period: Baseline to Week 26|Other|7|||
17157922|NCT01064414|38304839|FG002|Core Period: Baseline to Week 26|Other|2|||
17157923|NCT01064414|38304837|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
17157924|NCT01064414|38304838|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
17157925|NCT01064414|38304839|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
17157926|NCT01064414|38304837|FG000|Extension Period: Week 26 to Week 52|Death|0|||
17157927|NCT01064414|38304838|FG001|Extension Period: Week 26 to Week 52|Death|1|||
17157928|NCT01064414|38304839|FG002|Extension Period: Week 26 to Week 52|Death|0|||
17157929|NCT01064414|38304837|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
17157930|NCT01064414|38304838|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
17076984|NCT00307437|38218896|FG000|Controlled Period|Other|5|||
17076985|NCT00307437|38218897|FG001|Controlled Period|Other|1|||
17076986|NCT00307437|38218898|FG002|Controlled Period|Other|3|||
17076987|NCT00307437|38218899|FG003|Controlled Period|Other|0|||
17076988|NCT00307437|38218900|FG004|Controlled Period|Other|0|||
17076989|NCT00307437|38218901|FG005|Controlled Period|Other|0|||
17076990|NCT00307437|38218902|FG006|Controlled Period|Other|0|||
17076991|NCT00307437|38218896|FG000|After Controlled Period|Adverse Event|0|||
17076992|NCT00307437|38218897|FG001|After Controlled Period|Adverse Event|0|||
17157931|NCT01064414|38304839|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
17157932|NCT01064414|38304837|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
17157933|NCT01064414|38304838|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
17157934|NCT01064414|38304839|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
17157935|NCT01064414|38304837|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
17157936|NCT01064414|38304838|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
17157937|NCT01064414|38304839|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
17157938|NCT01064414|38304837|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
17157939|NCT01064414|38304838|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
17157940|NCT01064414|38304839|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
17157941|NCT01064414|38304837|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
17157942|NCT01064414|38304838|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
17157943|NCT01064414|38304839|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
17157944|NCT01064414|38304837|FG000|Extension Period: Week 26 to Week 52|Other|5|||
17157945|NCT01064414|38304838|FG001|Extension Period: Week 26 to Week 52|Other|2|||
17157946|NCT01064414|38304839|FG002|Extension Period: Week 26 to Week 52|Other|1|||
17157947|NCT03433703|38304850|FG000|Overall Study|Study terminated by Sponsor|2|||
17157948|NCT03463031|38304860|FG000|Overall Study|Withdrawal by Subject|4|||
17157949|NCT03463031|38304861|FG001|Overall Study|Withdrawal by Subject|2|||
17157950|NCT03463031|38304860|FG000|Overall Study|Investigator/Sponsor Decision|0|||
17157951|NCT03463031|38304861|FG001|Overall Study|Investigator/Sponsor Decision|1|||
17157952|NCT03463031|38304860|FG000|Overall Study|Lost to Follow-up|1|||
17157953|NCT03463031|38304861|FG001|Overall Study|Lost to Follow-up|1|||
17157954|NCT03463031|38304860|FG000|Overall Study|Adverse Event|4|||
17157955|NCT03463031|38304861|FG001|Overall Study|Adverse Event|1|||
17157956|NCT03463031|38304860|FG000|Overall Study|Use of prohibited medication by subject|1|||
17157957|NCT03463031|38304861|FG001|Overall Study|Use of prohibited medication by subject|0|||
17157958|NCT03462641|38304869|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
17157959|NCT03462641|38304870|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
17157960|NCT03462641|38304869|FG000|Visit 2|Withdrawal by Subject|0|||
17157961|NCT03462641|38304870|FG001|Visit 2|Withdrawal by Subject|1|||
17157962|NCT02974634|38304880|FG000|Overall Study|Advanced disease|12|||
17157963|NCT02974634|38304881|FG001|Overall Study|Advanced disease|3|||
17157964|NCT02974634|38304880|FG000|Overall Study|Noncompliance|3|||
17157965|NCT02974634|38304881|FG001|Overall Study|Noncompliance|7|||
17157966|NCT02974634|38304880|FG000|Overall Study|intervention technology related issues|5|||
17157967|NCT02974634|38304881|FG001|Overall Study|intervention technology related issues|0|||
17157968|NCT02974634|38304880|FG000|Overall Study|Death|8|||
17157969|NCT02974634|38304881|FG001|Overall Study|Death|11|||
17157970|NCT01060670|38304890|FG000|Run In|screen failure|0|||
17076993|NCT00307437|38218898|FG002|After Controlled Period|Adverse Event|0|||
17076994|NCT00307437|38218899|FG003|After Controlled Period|Adverse Event|18|||
17076995|NCT00307437|38218900|FG004|After Controlled Period|Adverse Event|16|||
17076996|NCT00307437|38218901|FG005|After Controlled Period|Adverse Event|31|||
17157971|NCT01060670|38304891|FG001|Run In|screen failure|238|||
17157972|NCT02971670|38304903|FG000|Overall Study|Withdrawal by Subject|4|||
17157973|NCT02971670|38304904|FG001|Overall Study|Withdrawal by Subject|1|||
17157974|NCT02971670|38304905|FG002|Overall Study|Withdrawal by Subject|1|||
17157975|NCT02971670|38304906|FG003|Overall Study|Withdrawal by Subject|2|||
17157976|NCT02971202|38304919|FG000|Overall Study|Pregnancy|1|||
17157977|NCT02971202|38304920|FG001|Overall Study|Pregnancy|0|||
17157978|NCT02971202|38304921|FG002|Overall Study|Pregnancy|0|||
17157979|NCT02971202|38304919|FG000|Overall Study|screen fail after consent|1|||
17157980|NCT02971202|38304920|FG001|Overall Study|screen fail after consent|0|||
17157981|NCT02971202|38304921|FG002|Overall Study|screen fail after consent|1|||
17157982|NCT02926638|38304931|FG000|Overall Study|Progression|2|||
17076997|NCT00307437|38218902|FG006|After Controlled Period|Adverse Event|40|||
17076998|NCT00307437|38218896|FG000|After Controlled Period|Death|0|||
17076999|NCT00307437|38218897|FG001|After Controlled Period|Death|0|||
17077000|NCT00307437|38218898|FG002|After Controlled Period|Death|0|||
17077001|NCT00307437|38218899|FG003|After Controlled Period|Death|3|||
17077002|NCT00307437|38218900|FG004|After Controlled Period|Death|1|||
17077003|NCT00307437|38218901|FG005|After Controlled Period|Death|1|||
17077004|NCT00307437|38218902|FG006|After Controlled Period|Death|3|||
17077005|NCT00307437|38218896|FG000|After Controlled Period|Lack of Efficacy|0|||
17077006|NCT00307437|38218897|FG001|After Controlled Period|Lack of Efficacy|0|||
17077007|NCT00307437|38218898|FG002|After Controlled Period|Lack of Efficacy|0|||
17077008|NCT00307437|38218899|FG003|After Controlled Period|Lack of Efficacy|15|||
17077009|NCT00307437|38218900|FG004|After Controlled Period|Lack of Efficacy|17|||
17077010|NCT00307437|38218901|FG005|After Controlled Period|Lack of Efficacy|37|||
17077011|NCT00307437|38218902|FG006|After Controlled Period|Lack of Efficacy|24|||
17077012|NCT00307437|38218896|FG000|After Controlled Period|Lost to Follow-up|0|||
17077013|NCT00307437|38218897|FG001|After Controlled Period|Lost to Follow-up|0|||
17077014|NCT00307437|38218898|FG002|After Controlled Period|Lost to Follow-up|0|||
17077015|NCT00307437|38218899|FG003|After Controlled Period|Lost to Follow-up|7|||
17077016|NCT00307437|38218900|FG004|After Controlled Period|Lost to Follow-up|12|||
17077017|NCT00307437|38218901|FG005|After Controlled Period|Lost to Follow-up|13|||
17077018|NCT00307437|38218902|FG006|After Controlled Period|Lost to Follow-up|18|||
17077019|NCT00307437|38218896|FG000|After Controlled Period|Other|0|||
17077020|NCT00307437|38218897|FG001|After Controlled Period|Other|0|||
17077021|NCT00307437|38218898|FG002|After Controlled Period|Other|0|||
17157983|NCT02926638|38304932|FG001|Overall Study|Progression|5|||
17157984|NCT02926638|38304931|FG000|Overall Study|Ineligible|1|||
17157985|NCT02926638|38304932|FG001|Overall Study|Ineligible|0|||
17157986|NCT02926638|38304931|FG000|Overall Study|Not protocol specified|1|||
17157987|NCT02926638|38304932|FG001|Overall Study|Not protocol specified|0|||
17077022|NCT00307437|38218899|FG003|After Controlled Period|Other|15|||
17077023|NCT00307437|38218900|FG004|After Controlled Period|Other|9|||
17077024|NCT00307437|38218901|FG005|After Controlled Period|Other|40|||
17077025|NCT00307437|38218902|FG006|After Controlled Period|Other|28|||
17077026|NCT00440726|38218927|FG000|Phase 1|Dose-Limiting Toxicity|0|||
17077027|NCT00440726|38218928|FG001|Phase 1|Dose-Limiting Toxicity|1|||
17077028|NCT00440726|38218929|FG002|Phase 1|Dose-Limiting Toxicity|0|||
17077029|NCT00440726|38218927|FG000|Phase 1|Physician Decision|1|||
17077030|NCT00440726|38218928|FG001|Phase 1|Physician Decision|0|||
17157988|NCT02903030|38304940|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
17157989|NCT02903030|38304941|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
17157990|NCT02969408|38304950|FG000|Overall Study|Adverse Event|2|||
17157991|NCT02969408|38304950|FG000|Overall Study|Withdrawal by Subject|8|||
17157992|NCT02969408|38304950|FG000|Overall Study|Lost to Follow-up|4|||
17157993|NCT02969408|38304950|FG000|Overall Study|Protocol Violation|1|||
17157994|NCT02969408|38304950|FG000|Overall Study|Other than specified|1|||
17157995|NCT03462563|38304956|FG000|Overall Study|Death|1|||
17157996|NCT03462563|38304957|FG001|Overall Study|Death|1|||
17077031|NCT00440726|38218929|FG002|Phase 1|Physician Decision|0|||
17077032|NCT00440726|38218927|FG000|Phase 2|Death|0|||
17077033|NCT00440726|38218928|FG001|Phase 2|Death|0|||
17157997|NCT03462563|38304956|FG000|Overall Study|Termination of study|2|||
17157998|NCT03462563|38304957|FG001|Overall Study|Termination of study|1|||
17157999|NCT03462563|38304956|FG000|Overall Study|Adverse Event|1|||
17158000|NCT03462563|38304957|FG001|Overall Study|Adverse Event|3|||
17158001|NCT03462563|38304956|FG000|Overall Study|Unspecified reason|10|||
17158002|NCT03462563|38304957|FG001|Overall Study|Unspecified reason|12|||
17158003|NCT03462563|38304956|FG000|Overall Study|Physician Decision|1|||
17158004|NCT03462563|38304957|FG001|Overall Study|Physician Decision|0|||
17158005|NCT01060124|38304963|FG000|Overall Study|Other|16|||
17158006|NCT01060124|38304963|FG000|Overall Study|Adverse Event|14|||
17077034|NCT00440726|38218929|FG002|Phase 2|Death|1|||
17077035|NCT00440726|38218927|FG000|Phase 2|Adverse Event|0|||
17077036|NCT00440726|38218928|FG001|Phase 2|Adverse Event|0|||
17077037|NCT00440726|38218929|FG002|Phase 2|Adverse Event|1|||
17077038|NCT00447590|38218940|FG000|Overall Study|Withdrawal by Subject|26|||
17077039|NCT00447590|38218940|FG000|Overall Study|Lost to Follow-up|24|||
17158007|NCT01060124|38304963|FG000|Overall Study|Withdrawal by Subject|7|||
17158008|NCT03461003|38304969|FG000|Overall Study|Lost to Follow-up|2|||
17158009|NCT03461003|38304970|FG001|Overall Study|Lost to Follow-up|2|||
17158010|NCT03461003|38304969|FG000|Overall Study|Withdrawal by Subject|3|||
17158011|NCT03461003|38304970|FG001|Overall Study|Withdrawal by Subject|1|||
17158012|NCT02904902|38304976|FG000|Overall Study|Withdrawal by Subject|1|||
17158013|NCT04425720|38304982|FG000|Overall Study|Withdrawal by Subject|0|||
17158014|NCT04425720|38304983|FG001|Overall Study|Withdrawal by Subject|20|||
17158015|NCT03459443|38304990|FG000|Overall Study|Lack of Efficacy|3|||
17158016|NCT03459443|38304990|FG000|Overall Study|Adverse Event|1|||
17158017|NCT03459443|38304990|FG000|Overall Study|Sponsor's decision to close the study|18|||
17158018|NCT02904512|38304996|FG000|Overall Study|Withdrawal by Subject|1|||
17158019|NCT02904512|38304997|FG001|Overall Study|Withdrawal by Subject|0|||
17158020|NCT02904512|38304996|FG000|Overall Study|Transferred to ICU|1|||
17158021|NCT02904512|38304997|FG001|Overall Study|Transferred to ICU|0|||
17077040|NCT00447590|38218940|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
17077041|NCT00447278|38218946|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
17077042|NCT00447278|38218947|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
17077043|NCT00447278|38218946|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
17077044|NCT00447278|38218947|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
17077045|NCT00447278|38218946|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
17077046|NCT00447278|38218947|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
17077047|NCT00447278|38218946|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
17077048|NCT00447278|38218947|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
17158022|NCT02904512|38304996|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
17158023|NCT02904512|38304997|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
17158024|NCT02904200|38305003|FG000|Overall Study|Withdrawal by Subject|1|||
17158025|NCT02904200|38305004|FG001|Overall Study|Withdrawal by Subject|0|||
17158026|NCT03432533|38305010|FG000|Overall Study|Lost to Follow-up|1|||
17158027|NCT03432533|38305011|FG001|Overall Study|Lost to Follow-up|2|||
17158028|NCT03432533|38305010|FG000|Overall Study|Withdrawal by Subject|14|||
17158029|NCT03432533|38305011|FG001|Overall Study|Withdrawal by Subject|9|||
17077049|NCT00447278|38218946|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
17077050|NCT00447278|38218947|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
17077051|NCT00447278|38218946|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
17077052|NCT00447278|38218947|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
17077053|NCT00447278|38218946|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
17077054|NCT00447278|38218947|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
17077055|NCT00447278|38218946|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
17077056|NCT00447278|38218947|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
17077057|NCT00447278|38218946|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
17077058|NCT00447278|38218947|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
17077059|NCT00447278|38218946|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
17077060|NCT00447278|38218947|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
17077061|NCT00447278|38218946|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
17077062|NCT00447278|38218947|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
17077063|NCT00447278|38218946|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
17077064|NCT00447278|38218947|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
17077065|NCT00447278|38218946|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
17077066|NCT00447278|38218947|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
17077067|NCT00447278|38218946|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
17077068|NCT00447278|38218947|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
17077069|NCT00446966|38218956|FG000|Overall Study|Lost to Follow-up|10|||
17077070|NCT00446966|38218957|FG001|Overall Study|Lost to Follow-up|7|||
17077071|NCT00446654|38218965|FG000|Overall Study|Withdrawal by Subject|1|||
17077072|NCT00446654|38218966|FG001|Overall Study|Withdrawal by Subject|0|||
17077073|NCT00446654|38218965|FG000|Overall Study|Adverse Event|1|||
17077074|NCT00446654|38218966|FG001|Overall Study|Adverse Event|0|||
17077075|NCT00405756|38218975|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
17077076|NCT00405756|38218976|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
17077077|NCT00405756|38218977|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
17077078|NCT00405756|38218975|FG000|Double-blind Treatment|Adverse Event|31|||
17077079|NCT00405756|38218976|FG001|Double-blind Treatment|Adverse Event|27|||
17077080|NCT00405756|38218977|FG002|Double-blind Treatment|Adverse Event|12|||
17077081|NCT00405756|38218975|FG000|Double-blind Treatment|Disease Progression|47|||
17077082|NCT00405756|38218976|FG001|Double-blind Treatment|Disease Progression|81|||
17077083|NCT00405756|38218977|FG002|Double-blind Treatment|Disease Progression|102|||
17077084|NCT00405756|38218975|FG000|Double-blind Treatment|Lack of Efficacy|1|||
17077085|NCT00405756|38218976|FG001|Double-blind Treatment|Lack of Efficacy|4|||
17077086|NCT00405756|38218977|FG002|Double-blind Treatment|Lack of Efficacy|2|||
17077087|NCT00405756|38218975|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
17077088|NCT00405756|38218976|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
17077089|NCT00405756|38218977|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
17158030|NCT02901548|38305017|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
17158031|NCT02903966|38305023|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
17158032|NCT02903966|38305024|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
17158033|NCT02903966|38305023|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
17158034|NCT02903966|38305024|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
17077090|NCT00405756|38218975|FG000|Double-blind Treatment|Lost to Follow-up|1|||
17158035|NCT02903966|38305023|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
17158036|NCT02903966|38305024|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
17158037|NCT03457727|38305040|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
17158038|NCT03457727|38305041|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
17158039|NCT03457727|38305042|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
17158040|NCT03457727|38305043|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
17158041|NCT03431441|38305075|FG000|Overall Study|Withdrawal by Subject|2|||
17158042|NCT03431441|38305075|FG000|Overall Study|Adverse Event|2|||
17158043|NCT03431441|38305075|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
17158044|NCT03457103|38305081|FG000|Overall Study|illness/hospitalization|4|||
17077091|NCT00405756|38218976|FG001|Double-blind Treatment|Lost to Follow-up|0|||
17077092|NCT00405756|38218977|FG002|Double-blind Treatment|Lost to Follow-up|0|||
17077093|NCT00405756|38218975|FG000|Double-blind Treatment|Death|4|||
17077094|NCT00405756|38218976|FG001|Double-blind Treatment|Death|4|||
17077095|NCT00405756|38218977|FG002|Double-blind Treatment|Death|4|||
17077096|NCT00405756|38218975|FG000|Double-blind Treatment|Protocol Violation|1|||
17077097|NCT00405756|38218976|FG001|Double-blind Treatment|Protocol Violation|0|||
17077098|NCT00405756|38218977|FG002|Double-blind Treatment|Protocol Violation|2|||
17077099|NCT00405756|38218975|FG000|Double-blind Treatment|Other|7|||
17077100|NCT00405756|38218976|FG001|Double-blind Treatment|Other|4|||
17077101|NCT00405756|38218977|FG002|Double-blind Treatment|Other|4|||
17077102|NCT00405756|38218975|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
17077103|NCT00405756|38218976|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
17077104|NCT00405756|38218977|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
17077105|NCT00405756|38218975|FG000|Open-label Extension|Adverse Event|1|||
17077106|NCT00405756|38218976|FG001|Open-label Extension|Adverse Event|3|||
17077107|NCT00405756|38218977|FG002|Open-label Extension|Adverse Event|7|||
17077108|NCT00405756|38218975|FG000|Open-label Extension|Disease Progression|8|||
17077109|NCT00405756|38218976|FG001|Open-label Extension|Disease Progression|23|||
17077110|NCT00405756|38218977|FG002|Open-label Extension|Disease Progression|26|||
17077111|NCT00405756|38218975|FG000|Open-label Extension|Withdrawal by Subject|2|||
17077112|NCT00405756|38218976|FG001|Open-label Extension|Withdrawal by Subject|3|||
17077113|NCT00405756|38218977|FG002|Open-label Extension|Withdrawal by Subject|3|||
17077114|NCT00405756|38218975|FG000|Open-label Extension|Death|1|||
17077115|NCT00405756|38218976|FG001|Open-label Extension|Death|2|||
17077116|NCT00405756|38218977|FG002|Open-label Extension|Death|4|||
17077117|NCT00405756|38218975|FG000|Open-label Extension|Other|0|||
17077118|NCT00405756|38218976|FG001|Open-label Extension|Other|1|||
17077119|NCT00405756|38218977|FG002|Open-label Extension|Other|7|||
17077120|NCT00405756|38218975|FG000|Follow-up|Ongoing in Follow-up Period|52|||
17077121|NCT00405756|38218976|FG001|Follow-up|Ongoing in Follow-up Period|51|||
17077122|NCT00405756|38218977|FG002|Follow-up|Ongoing in Follow-up Period|60|||
17077123|NCT00405756|38218975|FG000|Follow-up|Death|21|||
17077124|NCT00405756|38218976|FG001|Follow-up|Death|31|||
17077125|NCT00405756|38218977|FG002|Follow-up|Death|24|||
17077126|NCT00405756|38218975|FG000|Follow-up|Lost to Follow-up|2|||
17077127|NCT00405756|38218976|FG001|Follow-up|Lost to Follow-up|8|||
17077128|NCT00405756|38218977|FG002|Follow-up|Lost to Follow-up|4|||
17077129|NCT00456092|38218988|FG000|Extension Phase|Grade 2 or Greater AE|2|||
17077130|NCT00456092|38218989|FG001|Extension Phase|Grade 2 or Greater AE|2|||
17158045|NCT03457103|38305082|FG001|Overall Study|illness/hospitalization|2|||
17158046|NCT03457103|38305081|FG000|Overall Study|Lost to Follow-up|2|||
17158047|NCT03457103|38305082|FG001|Overall Study|Lost to Follow-up|1|||
17077131|NCT00456092|38218990|FG002|Extension Phase|Grade 2 or Greater AE|0|||
17077132|NCT00456092|38218991|FG003|Extension Phase|Grade 2 or Greater AE|0|||
17077133|NCT00456092|38218992|FG004|Extension Phase|Grade 2 or Greater AE|2|||
17077134|NCT00456092|38218988|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
17077135|NCT00456092|38218989|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
17077136|NCT00456092|38218990|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
17158048|NCT03457103|38305081|FG000|Overall Study|Withdrawal by Subject|1|||
17158049|NCT03457103|38305082|FG001|Overall Study|Withdrawal by Subject|2|||
17158050|NCT03457103|38305081|FG000|Overall Study|financial/ insurance issues|1|||
17158051|NCT03457103|38305082|FG001|Overall Study|financial/ insurance issues|1|||
17158052|NCT03455543|38305090|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
17158053|NCT03455543|38305091|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
17158054|NCT03455543|38305092|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
17158055|NCT03455543|38305090|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
17158056|NCT03455543|38305091|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
17158057|NCT03455543|38305092|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
17158058|NCT03455543|38305090|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
17077137|NCT00456092|38218991|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
17077138|NCT00456092|38218992|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
17077139|NCT00456092|38218988|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
17077140|NCT00456092|38218989|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
17077141|NCT00456092|38218990|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
17077142|NCT00456092|38218991|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
17077143|NCT00456092|38218992|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
17077144|NCT00456092|38218988|FG000|Extension Phase|Withdrew Consent|2|||
17077145|NCT00456092|38218989|FG001|Extension Phase|Withdrew Consent|0|||
17077146|NCT00456092|38218990|FG002|Extension Phase|Withdrew Consent|0|||
17077147|NCT00456092|38218991|FG003|Extension Phase|Withdrew Consent|0|||
17077148|NCT00456092|38218992|FG004|Extension Phase|Withdrew Consent|0|||
17077149|NCT00456092|38218988|FG000|Extension Phase|Lost to Follow-up|1|||
17077150|NCT00456092|38218989|FG001|Extension Phase|Lost to Follow-up|1|||
17077151|NCT00456092|38218990|FG002|Extension Phase|Lost to Follow-up|0|||
17077152|NCT00456092|38218991|FG003|Extension Phase|Lost to Follow-up|0|||
17077153|NCT00456092|38218992|FG004|Extension Phase|Lost to Follow-up|1|||
17077154|NCT00456092|38218988|FG000|Extension Phase|Other|2|||
17077155|NCT00456092|38218989|FG001|Extension Phase|Other|0|||
17077156|NCT00456092|38218990|FG002|Extension Phase|Other|0|||
17077157|NCT00456092|38218991|FG003|Extension Phase|Other|1|||
17077158|NCT00456092|38218992|FG004|Extension Phase|Other|1|||
17077159|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
17077160|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
17077161|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
17077162|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
17077163|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
17077164|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
17077165|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
17077166|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
17077167|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
17077168|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
17077169|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
17077170|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
17158059|NCT03455543|38305091|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
17077171|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
17077172|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
17077173|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
17077174|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
17077175|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
17077176|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
17077177|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
17077178|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
17077179|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
17077180|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
17077181|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
17077182|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
17077183|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
17077184|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
17077185|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
17077186|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
17077187|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
17077188|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
17077189|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
17077190|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
17077191|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
17077192|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
17077193|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
17077194|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
17077195|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
17077196|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
17077197|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
17077198|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
17077199|NCT00456092|38218988|FG000|Treatment Phase (12 Weeks)|Other|1|||
17077200|NCT00456092|38218989|FG001|Treatment Phase (12 Weeks)|Other|0|||
17077201|NCT00456092|38218990|FG002|Treatment Phase (12 Weeks)|Other|1|||
17077202|NCT00456092|38218991|FG003|Treatment Phase (12 Weeks)|Other|0|||
17077203|NCT00456092|38218992|FG004|Treatment Phase (12 Weeks)|Other|0|||
17077204|NCT00411450|38219006|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
17077205|NCT00404820|38219014|FG000|Overall Study|Adverse Event|4|||
17077206|NCT00404820|38219015|FG001|Overall Study|Adverse Event|16|||
17158060|NCT03455543|38305092|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
17158061|NCT03455543|38305090|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
17158062|NCT03455543|38305091|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
17158063|NCT03455543|38305092|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
17158064|NCT03455543|38305090|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
17158065|NCT03455543|38305091|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
17158066|NCT03455543|38305092|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
17158067|NCT03455543|38305090|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
17158068|NCT03455543|38305091|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
17158069|NCT03455543|38305092|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
17158070|NCT03455543|38305090|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
17158071|NCT03455543|38305091|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
17158072|NCT03455543|38305092|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
17158073|NCT03455543|38305090|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
17158074|NCT03455543|38305091|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
17158075|NCT03455543|38305092|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
17158076|NCT03455543|38305090|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
17158077|NCT03455543|38305091|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
17158078|NCT03455543|38305092|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
17077207|NCT00404820|38219014|FG000|Overall Study|Withdrawal by Subject|5|||
17077208|NCT00404820|38219015|FG001|Overall Study|Withdrawal by Subject|3|||
17077209|NCT00404820|38219014|FG000|Overall Study|Lost to Follow-up|7|||
17077210|NCT00404820|38219015|FG001|Overall Study|Lost to Follow-up|3|||
17077211|NCT00404820|38219014|FG000|Overall Study|Administrative problems|2|||
17077212|NCT00404820|38219015|FG001|Overall Study|Administrative problems|0|||
17077213|NCT00404820|38219014|FG000|Overall Study|Death|1|||
17077214|NCT00404820|38219015|FG001|Overall Study|Death|0|||
17077215|NCT00404820|38219014|FG000|Overall Study|Other|0|||
17077216|NCT00404820|38219015|FG001|Overall Study|Other|2|||
17077217|NCT00417612|38219023|FG000|Overall Study|Errant diagnosis|0|||
17077218|NCT00417612|38219024|FG001|Overall Study|Errant diagnosis|1|||
17077219|NCT00417612|38219023|FG000|Overall Study|Adverse Event|2|||
17077220|NCT00417612|38219024|FG001|Overall Study|Adverse Event|0|||
17077221|NCT00417612|38219023|FG000|Overall Study|Protocol Violation|0|||
17077222|NCT00417612|38219024|FG001|Overall Study|Protocol Violation|2|||
17077223|NCT00417612|38219023|FG000|Overall Study|Lost to Follow-up|1|||
17077224|NCT00417612|38219024|FG001|Overall Study|Lost to Follow-up|0|||
17077225|NCT00446030|38219034|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
17077226|NCT00446030|38219035|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
17077227|NCT00446030|38219034|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
17077228|NCT00446030|38219035|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
17077229|NCT00446030|38219034|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
17077230|NCT00446030|38219035|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
17077231|NCT00446030|38219034|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
17077232|NCT00446030|38219035|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
17077233|NCT00446030|38219034|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
17077234|NCT00446030|38219035|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
17077235|NCT00446030|38219034|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
17077236|NCT00446030|38219035|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
17077237|NCT00446030|38219034|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
17077238|NCT00446030|38219035|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
17077239|NCT00446030|38219034|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
17077240|NCT00446030|38219035|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
17077241|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
17077242|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
17077243|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
17077244|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
17077245|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
17077246|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
17077247|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
17077248|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
17077249|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
17077250|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
17077251|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
17077252|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
17077253|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
17077254|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
17077255|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
17077256|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
17077257|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
17077258|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
17077259|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
17077260|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
17077261|NCT00446030|38219034|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
17077262|NCT00446030|38219035|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
17077263|NCT00411216|38219043|FG000|Overall Study|Ten participants were entered into the c|0|||
17077264|NCT00411216|38219044|FG001|Overall Study|Ten participants were entered into the c|2|||
17077265|NCT00410514|38219053|FG000|Overall Study|Adverse Event|2|||
17077266|NCT00410514|38219054|FG001|Overall Study|Adverse Event|2|||
17077267|NCT00410514|38219055|FG002|Overall Study|Adverse Event|2|||
17077268|NCT00410514|38219053|FG000|Overall Study|Protocol Violation|0|||
17077269|NCT00410514|38219054|FG001|Overall Study|Protocol Violation|1|||
17077270|NCT00410514|38219055|FG002|Overall Study|Protocol Violation|1|||
17077271|NCT00410514|38219053|FG000|Overall Study|Lost to Follow-up|0|||
17077272|NCT00410514|38219054|FG001|Overall Study|Lost to Follow-up|0|||
17077273|NCT00410514|38219055|FG002|Overall Study|Lost to Follow-up|2|||
17077274|NCT00410514|38219053|FG000|Overall Study|Non-compliant with study procedures|0|||
17077275|NCT00410514|38219054|FG001|Overall Study|Non-compliant with study procedures|0|||
17158079|NCT03068754|38305102|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
17158080|NCT03068754|38305103|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
17158081|NCT03068754|38305104|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
17158082|NCT03068754|38305105|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
17158083|NCT03068754|38305102|FG000|Randomized Treatment Period (RTP)|Death|2|||
17077276|NCT00410514|38219055|FG002|Overall Study|Non-compliant with study procedures|2|||
17077277|NCT03847610|38219063|FG000|Overall Study|Withdrawal by Subject|1|||
17077278|NCT03843632|38219071|FG000|Overall Study|Withdrawal by Subject|1|||
17077279|NCT03843632|38219072|FG001|Overall Study|Withdrawal by Subject|0|||
17077280|NCT03843632|38219073|FG002|Overall Study|Withdrawal by Subject|0|||
17077281|NCT03843632|38219074|FG003|Overall Study|Withdrawal by Subject|0|||
17077282|NCT00455858|38219084|FG000|Overall Study|Lost to Follow-up|2|||
17077283|NCT00455858|38219084|FG000|Overall Study|Protocol Violation|1|||
17077284|NCT00455858|38219084|FG000|Overall Study|Lack of Efficacy|1|||
17077285|NCT00455858|38219084|FG000|Overall Study|Well controlled FPG without insulin|1|||
17077286|NCT00455858|38219084|FG000|Overall Study|Withdrawal|1|||
17077287|NCT00439556|38219091|FG000|Overall Study|Patient was taken off study for non-comp|0|||
17077288|NCT00439556|38219092|FG001|Overall Study|Patient was taken off study for non-comp|1|||
17077289|NCT00439556|38219093|FG002|Overall Study|Patient was taken off study for non-comp|0|||
17077290|NCT00410202|38219105|FG000|On-Treatment|Continuing treatment|69|||
17077291|NCT00410202|38219106|FG001|On-Treatment|Continuing treatment|71|||
17077292|NCT00410202|38219107|FG002|On-Treatment|Continuing treatment|66|||
17077293|NCT00410202|38219105|FG000|On-Treatment|Adverse Event|1|||
17077294|NCT00410202|38219106|FG001|On-Treatment|Adverse Event|3|||
17077295|NCT00410202|38219107|FG002|On-Treatment|Adverse Event|2|||
17077296|NCT00410202|38219105|FG000|On-Treatment|Death|1|||
17077297|NCT00410202|38219106|FG001|On-Treatment|Death|0|||
17077298|NCT00410202|38219107|FG002|On-Treatment|Death|0|||
17077299|NCT00410202|38219105|FG000|On-Treatment|Lost to Follow-up|1|||
17077300|NCT00410202|38219106|FG001|On-Treatment|Lost to Follow-up|0|||
17077301|NCT00410202|38219107|FG002|On-Treatment|Lost to Follow-up|1|||
17077302|NCT00410202|38219105|FG000|On-Treatment|Lack of Efficacy|1|||
17077303|NCT00410202|38219106|FG001|On-Treatment|Lack of Efficacy|4|||
17077304|NCT00410202|38219107|FG002|On-Treatment|Lack of Efficacy|0|||
17077305|NCT00410202|38219105|FG000|On-Treatment|Withdrawal by Subject|2|||
17077306|NCT00410202|38219106|FG001|On-Treatment|Withdrawal by Subject|1|||
17077307|NCT00410202|38219107|FG002|On-Treatment|Withdrawal by Subject|1|||
17077308|NCT00410202|38219105|FG000|On-Treatment|Other Reason|0|||
17077309|NCT00410202|38219106|FG001|On-Treatment|Other Reason|0|||
17077310|NCT00410202|38219107|FG002|On-Treatment|Other Reason|1|||
17158084|NCT03068754|38305103|FG001|Randomized Treatment Period (RTP)|Death|2|||
17158085|NCT03068754|38305104|FG002|Randomized Treatment Period (RTP)|Death|0|||
17158086|NCT03068754|38305105|FG003|Randomized Treatment Period (RTP)|Death|0|||
17077311|NCT00410202|38219105|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
17077312|NCT00410202|38219106|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
17077313|NCT00410202|38219107|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
17077314|NCT00410202|38219105|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
17077315|NCT00410202|38219106|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
17158087|NCT03068754|38305102|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
17158088|NCT03068754|38305103|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
17077316|NCT00410202|38219107|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
17077317|NCT00410202|38219105|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
17077318|NCT00410202|38219106|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
17077319|NCT00410202|38219107|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
17077320|NCT00445328|38219118|FG000|Overall Study|Death|0|||
17077321|NCT00445328|38219119|FG001|Overall Study|Death|1|||
17077322|NCT00445328|38219118|FG000|Overall Study|Adverse Event|0|||
17077323|NCT00445328|38219119|FG001|Overall Study|Adverse Event|3|||
17077324|NCT00445328|38219118|FG000|Overall Study|Other|0|||
17077325|NCT00445328|38219119|FG001|Overall Study|Other|2|||
17077326|NCT00445328|38219118|FG000|Overall Study|Withdrawal by Subject|2|||
17077327|NCT00445328|38219119|FG001|Overall Study|Withdrawal by Subject|0|||
17077328|NCT00445328|38219118|FG000|Overall Study|Protocol Violation|1|||
17077329|NCT00445328|38219119|FG001|Overall Study|Protocol Violation|0|||
17077330|NCT00455312|38219127|FG000|Overall Study|Death|0|||
17077331|NCT00455312|38219128|FG001|Overall Study|Death|1|||
17077332|NCT00444626|38219134|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
17077333|NCT00444626|38219134|FG000|Initial Treatment Period|Adverse Event|1|||
17077334|NCT00444626|38219134|FG000|Initial Treatment Period|Lost to Follow-up|9|||
17077335|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
17077336|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
17077337|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
17158089|NCT03068754|38305104|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
17158090|NCT03068754|38305105|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
17158091|NCT03068754|38305102|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
17158092|NCT03068754|38305103|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
17158093|NCT03068754|38305104|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
17158094|NCT03068754|38305105|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
17158095|NCT03068754|38305102|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
17077338|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
17077339|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
17077340|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
17077341|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
17077342|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
17077343|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
17077344|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
17077345|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
17077346|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
17077347|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
17077348|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
17077349|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
17077350|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
17077351|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
17077352|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
17077353|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Death|0|||
17158096|NCT03068754|38305103|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
17158097|NCT03068754|38305104|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
17158098|NCT03068754|38305105|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
17158099|NCT03068754|38305102|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
17077354|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Death|0|||
17077355|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Death|1|||
17077356|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Death|0|||
17158100|NCT03068754|38305103|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
17158101|NCT03068754|38305104|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
17158102|NCT03068754|38305105|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
17158103|NCT03068754|38305102|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
17158104|NCT03068754|38305103|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
17158105|NCT03068754|38305104|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
17158106|NCT03068754|38305105|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
17158107|NCT03068754|38305102|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
17158108|NCT03068754|38305103|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
17158109|NCT03068754|38305104|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
17158110|NCT03068754|38305105|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
17158111|NCT03068754|38305102|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
17158112|NCT03068754|38305103|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
17158113|NCT03068754|38305104|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
17158114|NCT03068754|38305105|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
17158115|NCT03068754|38305102|FG000|Open Label Extension Period (OLE)|Death|0|||
17158116|NCT03068754|38305103|FG001|Open Label Extension Period (OLE)|Death|0|||
17158117|NCT03068754|38305104|FG002|Open Label Extension Period (OLE)|Death|0|||
17077357|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Death|0|||
17077358|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Death|0|||
17077359|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Death|0|||
17077360|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Death|0|||
17077361|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Death|0|||
17077362|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
17077363|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
17077364|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
17077365|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
17077366|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
17077367|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
17077368|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
17158118|NCT03068754|38305105|FG003|Open Label Extension Period (OLE)|Death|1|||
17158119|NCT03068754|38305102|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
17077369|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
17077370|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
17077371|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
17077372|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
17158120|NCT03068754|38305103|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
17158121|NCT03068754|38305104|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
17158122|NCT03068754|38305105|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
17158123|NCT03068754|38305102|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
17077373|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
17077374|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
17077375|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
17077376|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
17077377|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
17077378|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
17077379|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
17077380|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
17077381|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
17077382|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
17077383|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
17077384|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
17077385|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
17077386|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
17077387|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
17077388|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
17077389|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
17077390|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
17077391|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
17077392|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
17077393|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
17077394|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
17158124|NCT03068754|38305103|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
17077395|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
17077396|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
17077397|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
17077398|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
17077399|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
17077400|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
17158125|NCT03068754|38305104|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
17158126|NCT03068754|38305105|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
17158127|NCT03068754|38305102|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
17158128|NCT03068754|38305103|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
17158129|NCT03068754|38305104|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
17158130|NCT03068754|38305105|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
17158131|NCT03068754|38305102|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
17158132|NCT03068754|38305103|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
17158133|NCT03068754|38305104|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
17158134|NCT03068754|38305105|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
17158135|NCT02965820|38305115|FG000|Period 2, Second 30 Days|Adverse Event|1|||
17158136|NCT02965820|38305116|FG001|Period 2, Second 30 Days|Adverse Event|1|||
17158137|NCT03430895|38305122|FG000|Overall Study|Not Treated|2|||
17158138|NCT03452189|38305126|FG000|First Intervention (3 Months)|Adverse Event|1|||
17158139|NCT03452189|38305127|FG001|First Intervention (3 Months)|Adverse Event|0|||
17158140|NCT03452189|38305126|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
17158141|NCT03452189|38305127|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
17158142|NCT03451721|38305133|FG000|Overall Study|Death|1|||
17158143|NCT00603954|38305139|FG000|Overall Study|Protocol Violation|1|||
17158144|NCT00603954|38305140|FG001|Overall Study|Protocol Violation|2|||
17158145|NCT03427619|38305147|FG000|Overall Study|Physician Decision|3|||
17158146|NCT03427619|38305147|FG000|Overall Study|Withdrawal by Subject|4|||
17158147|NCT03427619|38305147|FG000|Overall Study|Lost to Follow-up|5|||
17077401|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
17077402|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
17077403|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
17077404|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
17077405|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
17077406|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
17077407|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
17077408|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
17077409|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
17077410|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
17077411|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
17077412|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
17077413|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
17077414|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
17077415|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
17077416|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
17077417|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
17077418|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
17077419|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
17077420|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
17077421|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
17077422|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
17077423|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
17077424|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
17077425|NCT00404352|38219161|FG000|Double Blind (up to 24 Month)|Other|0|||
17077426|NCT00404352|38219162|FG001|Double Blind (up to 24 Month)|Other|1|||
17077427|NCT00404352|38219163|FG002|Double Blind (up to 24 Month)|Other|0|||
17077428|NCT00404352|38219164|FG003|Double Blind (up to 24 Month)|Other|0|||
17077429|NCT00404352|38219165|FG004|Double Blind (up to 24 Month)|Other|0|||
17077430|NCT00404352|38219166|FG005|Double Blind (up to 24 Month)|Other|0|||
17077431|NCT00404352|38219167|FG006|Double Blind (up to 24 Month)|Other|0|||
17077432|NCT00404352|38219168|FG007|Double Blind (up to 24 Month)|Other|0|||
17077433|NCT00404352|38219169|FG008|Double Blind (up to 24 Month)|Other|0|||
17077434|NCT00404352|38219161|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
17077435|NCT00404352|38219162|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
17077436|NCT00404352|38219163|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
17077437|NCT00404352|38219164|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
17077438|NCT00404352|38219165|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
17158148|NCT03427619|38305147|FG000|Overall Study|Administrative|4|||
17158149|NCT03427619|38305147|FG000|Overall Study|Other|2|||
17158150|NCT03427619|38305147|FG000|Overall Study|Unknown or Missing Completion Status|48|||
17158151|NCT03407729|38305153|FG000|Overall Study|Lost to Follow-up|2|||
17158152|NCT03407729|38305154|FG001|Overall Study|Lost to Follow-up|0|||
17158153|NCT03407729|38305153|FG000|Overall Study|Unable to schedule|0|||
17158154|NCT03407729|38305154|FG001|Overall Study|Unable to schedule|3|||
17158155|NCT02435433|38305165|FG000|Overall Study|Withdrawal by Subject|2|||
17158156|NCT02435433|38305166|FG001|Overall Study|Withdrawal by Subject|3|||
17158157|NCT02435433|38305167|FG002|Overall Study|Withdrawal by Subject|1|||
17158158|NCT02435433|38305168|FG003|Overall Study|Withdrawal by Subject|0|||
17158159|NCT02435433|38305169|FG004|Overall Study|Withdrawal by Subject|0|||
17077439|NCT00404352|38219166|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
17077440|NCT00404352|38219167|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
17077441|NCT00404352|38219168|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
17077442|NCT00404352|38219169|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
17077443|NCT00404352|38219161|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
17077444|NCT00404352|38219162|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
17077445|NCT00404352|38219163|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
17077446|NCT00404352|38219164|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
17077447|NCT00404352|38219165|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
17077448|NCT00404352|38219166|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
17077449|NCT00404352|38219167|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
17077450|NCT00404352|38219168|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
17077451|NCT00404352|38219169|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
17077452|NCT00404352|38219161|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
17077453|NCT00404352|38219162|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
17158160|NCT02435433|38305165|FG000|Overall Study|Lost to Follow-up|2|||
17158161|NCT02435433|38305166|FG001|Overall Study|Lost to Follow-up|2|||
17158162|NCT02435433|38305167|FG002|Overall Study|Lost to Follow-up|4|||
17158163|NCT02435433|38305168|FG003|Overall Study|Lost to Follow-up|1|||
17158164|NCT02435433|38305169|FG004|Overall Study|Lost to Follow-up|0|||
17158165|NCT03120351|38305182|FG000|Overall Study|Physician Decision|1|||
17158166|NCT03120351|38305183|FG001|Overall Study|Physician Decision|1|||
17158167|NCT02354703|38305193|FG000|Overall Study|Withdrawal by Subject|1|||
17077454|NCT00404352|38219163|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
17077455|NCT00404352|38219164|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
17077456|NCT00404352|38219165|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
17077457|NCT00404352|38219166|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
17077458|NCT00404352|38219167|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
17077459|NCT00404352|38219168|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
17077460|NCT00404352|38219169|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
17077461|NCT00404352|38219161|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
17077462|NCT00404352|38219162|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
17077463|NCT00404352|38219163|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
17077464|NCT00404352|38219164|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
17077465|NCT00404352|38219165|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
17077466|NCT00404352|38219166|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
17077467|NCT00404352|38219167|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
17077468|NCT00404352|38219168|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
17077469|NCT00404352|38219169|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
17077470|NCT00404352|38219161|FG000|Open Label (up to 24 Month)|Disease progression|0|||
17077471|NCT00404352|38219162|FG001|Open Label (up to 24 Month)|Disease progression|0|||
17158168|NCT02354703|38305194|FG001|Overall Study|Withdrawal by Subject|1|||
17158169|NCT02354703|38305195|FG002|Overall Study|Withdrawal by Subject|1|||
17077472|NCT00404352|38219163|FG002|Open Label (up to 24 Month)|Disease progression|0|||
17077473|NCT00404352|38219164|FG003|Open Label (up to 24 Month)|Disease progression|1|||
17077474|NCT00404352|38219165|FG004|Open Label (up to 24 Month)|Disease progression|0|||
17077475|NCT00404352|38219166|FG005|Open Label (up to 24 Month)|Disease progression|0|||
17077476|NCT00404352|38219167|FG006|Open Label (up to 24 Month)|Disease progression|0|||
17077477|NCT00404352|38219168|FG007|Open Label (up to 24 Month)|Disease progression|0|||
17077478|NCT00404352|38219169|FG008|Open Label (up to 24 Month)|Disease progression|0|||
17077479|NCT00404352|38219161|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
17077480|NCT00404352|38219162|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
17077481|NCT00404352|38219163|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
17077482|NCT00404352|38219164|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
17077483|NCT00404352|38219165|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
17077484|NCT00404352|38219166|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
17077485|NCT00404352|38219167|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
17077486|NCT00404352|38219168|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
17077487|NCT00404352|38219169|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
17077488|NCT00404352|38219161|FG000|Open Label Extension (up to 36 Months)|Other|0|||
17077489|NCT00404352|38219162|FG001|Open Label Extension (up to 36 Months)|Other|0|||
17077490|NCT00404352|38219163|FG002|Open Label Extension (up to 36 Months)|Other|0|||
17077491|NCT00404352|38219164|FG003|Open Label Extension (up to 36 Months)|Other|0|||
17077492|NCT00404352|38219165|FG004|Open Label Extension (up to 36 Months)|Other|0|||
17077493|NCT00404352|38219166|FG005|Open Label Extension (up to 36 Months)|Other|0|||
17077494|NCT00404352|38219167|FG006|Open Label Extension (up to 36 Months)|Other|0|||
17077495|NCT00404352|38219168|FG007|Open Label Extension (up to 36 Months)|Other|0|||
17077496|NCT00404352|38219169|FG008|Open Label Extension (up to 36 Months)|Other|2|||
17077497|NCT00439244|38219189|FG000|Overall Study|Adverse Event|5|||
17077498|NCT00439244|38219190|FG001|Overall Study|Adverse Event|2|||
17077499|NCT00439244|38219191|FG002|Overall Study|Adverse Event|3|||
17077500|NCT00439244|38219189|FG000|Overall Study|Withdrawal by Subject|3|||
17077501|NCT00439244|38219190|FG001|Overall Study|Withdrawal by Subject|1|||
17077502|NCT00439244|38219191|FG002|Overall Study|Withdrawal by Subject|2|||
17077503|NCT00439244|38219189|FG000|Overall Study|Lost to Follow-up|2|||
17077504|NCT00439244|38219190|FG001|Overall Study|Lost to Follow-up|1|||
17077505|NCT00439244|38219191|FG002|Overall Study|Lost to Follow-up|2|||
17077506|NCT00439244|38219189|FG000|Overall Study|Death|0|||
17077507|NCT00439244|38219190|FG001|Overall Study|Death|1|||
17077508|NCT00439244|38219191|FG002|Overall Study|Death|0|||
17077509|NCT00439244|38219189|FG000|Overall Study|Protocol Violation|0|||
17077510|NCT00439244|38219190|FG001|Overall Study|Protocol Violation|1|||
17077511|NCT00439244|38219191|FG002|Overall Study|Protocol Violation|0|||
17077512|NCT00439244|38219189|FG000|Overall Study|Administrative problems|1|||
17077513|NCT00439244|38219190|FG001|Overall Study|Administrative problems|0|||
17077514|NCT00439244|38219191|FG002|Overall Study|Administrative problems|0|||
17077515|NCT00438464|38219210|FG000|Overall Study|Terminated Early|14|||
17077516|NCT00438464|38219211|FG001|Overall Study|Terminated Early|5|||
17077517|NCT00438464|38219210|FG000|Overall Study|Incomplete data submission|0|||
17077518|NCT00438464|38219211|FG001|Overall Study|Incomplete data submission|2|||
17077519|NCT00437294|38219231|FG000|Overall Study|Adverse Event|5|||
17077520|NCT00437294|38219232|FG001|Overall Study|Adverse Event|4|||
17077521|NCT00437294|38219231|FG000|Overall Study|Death|5|||
17077522|NCT00437294|38219232|FG001|Overall Study|Death|2|||
17077523|NCT00437294|38219231|FG000|Overall Study|Physician Decision|0|||
17158170|NCT02354703|38305196|FG003|Overall Study|Withdrawal by Subject|1|||
17077524|NCT00437294|38219232|FG001|Overall Study|Physician Decision|3|||
17077525|NCT00437294|38219231|FG000|Overall Study|Withdrawal by Subject|5|||
17077526|NCT00437294|38219232|FG001|Overall Study|Withdrawal by Subject|0|||
17077527|NCT00437294|38219231|FG000|Overall Study|Progressive Disease|19|||
17077528|NCT00437294|38219232|FG001|Overall Study|Progressive Disease|23|||
17158171|NCT02354703|38305193|FG000|Overall Study|Lost to Follow-up|2|||
17077529|NCT00437294|38219231|FG000|Overall Study|Sponsor Decision|8|||
17077530|NCT00437294|38219232|FG001|Overall Study|Sponsor Decision|9|||
17158172|NCT02354703|38305194|FG001|Overall Study|Lost to Follow-up|7|||
17077531|NCT00437294|38219231|FG000|Overall Study|Protocol Violation|0|||
17077532|NCT00437294|38219232|FG001|Overall Study|Protocol Violation|1|||
17077533|NCT00437294|38219231|FG000|Overall Study|Entry criteria not met|1|||
17077534|NCT00437294|38219232|FG001|Overall Study|Entry criteria not met|1|||
17077535|NCT00436982|38219246|FG000|Overall Study|Withdrawal by Subject|3|||
17077536|NCT00436982|38219247|FG001|Overall Study|Withdrawal by Subject|1|||
17077537|NCT00436982|38219246|FG000|Overall Study|Did not receive allocated intervention|0|||
17077538|NCT00436982|38219247|FG001|Overall Study|Did not receive allocated intervention|1|||
17077539|NCT00436982|38219246|FG000|Overall Study|no RSA data|1|||
17077540|NCT00436982|38219247|FG001|Overall Study|no RSA data|2|||
17077541|NCT00443846|38219259|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
17077542|NCT00443846|38219260|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
17077543|NCT00443846|38219259|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
17077544|NCT00443846|38219260|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
17077545|NCT00443846|38219259|FG000|Overall Study|Adverse Event|0|||
17077546|NCT00443846|38219260|FG001|Overall Study|Adverse Event|1|||
17077547|NCT00443846|38219259|FG000|Overall Study|Personal reason|8|||
17077548|NCT00443846|38219260|FG001|Overall Study|Personal reason|3|||
17158173|NCT02354703|38305195|FG002|Overall Study|Lost to Follow-up|9|||
17158174|NCT02354703|38305196|FG003|Overall Study|Lost to Follow-up|2|||
17158175|NCT02354703|38305193|FG000|Overall Study|Adverse Event|0|||
17158176|NCT02354703|38305194|FG001|Overall Study|Adverse Event|0|||
17077549|NCT00443846|38219259|FG000|Overall Study|Lost to Follow-up|1|||
17077550|NCT00443846|38219260|FG001|Overall Study|Lost to Follow-up|2|||
17077551|NCT00436826|38219268|FG000|Double Blind Period (DBP)|Adverse Event|2|||
17077552|NCT00436826|38219269|FG001|Double Blind Period (DBP)|Adverse Event|0|||
17077553|NCT00436826|38219270|FG002|Double Blind Period (DBP)|Adverse Event|0|||
17077554|NCT00436826|38219271|FG003|Double Blind Period (DBP)|Adverse Event|0|||
17077555|NCT00436826|38219272|FG004|Double Blind Period (DBP)|Adverse Event|0|||
17077556|NCT00436826|38219273|FG005|Double Blind Period (DBP)|Adverse Event|0|||
17077557|NCT00436826|38219268|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
17077558|NCT00436826|38219269|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
17077559|NCT00436826|38219270|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
17077560|NCT00436826|38219271|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
17077561|NCT00436826|38219272|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
17077562|NCT00436826|38219273|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
17077563|NCT00436826|38219268|FG000|Double Blind Period (DBP)|Other|10|||
17077564|NCT00436826|38219269|FG001|Double Blind Period (DBP)|Other|11|||
17077565|NCT00436826|38219270|FG002|Double Blind Period (DBP)|Other|0|||
17077566|NCT00436826|38219271|FG003|Double Blind Period (DBP)|Other|0|||
17077567|NCT00436826|38219272|FG004|Double Blind Period (DBP)|Other|0|||
17077568|NCT00436826|38219273|FG005|Double Blind Period (DBP)|Other|0|||
17077569|NCT00436826|38219268|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
17077570|NCT00436826|38219269|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
17077571|NCT00436826|38219270|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
17077572|NCT00436826|38219271|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
17077573|NCT00436826|38219272|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
17077574|NCT00436826|38219273|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
17077575|NCT00436826|38219268|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
17077576|NCT00436826|38219269|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
17077577|NCT00436826|38219270|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
17077578|NCT00436826|38219271|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
17077579|NCT00436826|38219272|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
17077580|NCT00436826|38219273|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
17077581|NCT00436826|38219268|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
17077582|NCT00436826|38219269|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
17077583|NCT00436826|38219270|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
17077584|NCT00436826|38219271|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
17158177|NCT02354703|38305195|FG002|Overall Study|Adverse Event|1|||
17158178|NCT02354703|38305196|FG003|Overall Study|Adverse Event|0|||
17158179|NCT00384111|38305212|FG000|Overall Study|Disease Progression|3|||
17158180|NCT00384111|38305212|FG000|Overall Study|Adverse Event|1|||
17158181|NCT00384111|38305212|FG000|Overall Study|Investigator Decision|3|||
17077585|NCT00436826|38219272|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
17077586|NCT00436826|38219273|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
17077587|NCT00410124|38219291|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
17077588|NCT00410124|38219292|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
17077589|NCT00410124|38219291|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
17077590|NCT00410124|38219292|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
17077591|NCT00410124|38219291|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
17077592|NCT00410124|38219292|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
17077593|NCT00410124|38219291|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
17077594|NCT00410124|38219292|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
17077595|NCT00410124|38219291|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
17077596|NCT00410124|38219292|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
17077597|NCT00410124|38219291|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
17077598|NCT00410124|38219292|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
17077599|NCT00410124|38219291|FG000|Core Phase Double Blind (15 Months)|Death|7|||
17077600|NCT00410124|38219292|FG001|Core Phase Double Blind (15 Months)|Death|4|||
17077601|NCT00410124|38219291|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
17077602|NCT00410124|38219292|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
17077603|NCT00410124|38219291|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
17077604|NCT00410124|38219292|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
17077605|NCT00410124|38219291|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
17077606|NCT00410124|38219292|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
17077607|NCT00410124|38219291|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
17077608|NCT00410124|38219292|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
17077609|NCT00410124|38219291|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
17077610|NCT00410124|38219292|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
17077611|NCT00410124|38219291|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
17077612|NCT00410124|38219292|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
17077613|NCT00410124|38219291|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
17077614|NCT00410124|38219292|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
17077615|NCT00410124|38219291|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
17077616|NCT00410124|38219292|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
17077617|NCT00410124|38219291|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
17158182|NCT00384111|38305212|FG000|Overall Study|Study Terminated by the Sponsor|19|||
17158183|NCT03113409|38305216|FG000|Overall Study|Withdrawal by Subject|5|||
17158184|NCT03113409|38305217|FG001|Overall Study|Withdrawal by Subject|0|||
17158185|NCT03113409|38305218|FG002|Overall Study|Withdrawal by Subject|0|||
17158186|NCT01319877|38305224|FG000|Overall Study|Lost to Follow-up|100|||
17158187|NCT01319877|38305225|FG001|Overall Study|Lost to Follow-up|37|||
17077618|NCT00410124|38219292|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
17077619|NCT00410046|38219302|FG000|Overall Study|Adverse Event|3|||
17158188|NCT01319877|38305224|FG000|Overall Study|Physician Decision|2|||
17158189|NCT01319877|38305225|FG001|Overall Study|Physician Decision|0|||
17158190|NCT01319877|38305224|FG000|Overall Study|Disease Progression|2|||
17158191|NCT01319877|38305225|FG001|Overall Study|Disease Progression|2|||
17158192|NCT01319877|38305224|FG000|Overall Study|Withdrawal by Subject|0|||
17158193|NCT01319877|38305225|FG001|Overall Study|Withdrawal by Subject|1|||
17158194|NCT01319877|38305224|FG000|Overall Study|Reason Not Specified|4|||
17158195|NCT01319877|38305225|FG001|Overall Study|Reason Not Specified|5|||
17158196|NCT03427073|38305238|FG000|Overall Study|Disease Progression|1|||
17158197|NCT03427073|38305239|FG001|Overall Study|Disease Progression|1|||
17158198|NCT03427073|38305240|FG002|Overall Study|Disease Progression|1|||
17158199|NCT03427073|38305241|FG003|Overall Study|Disease Progression|3|||
17158200|NCT03427073|38305242|FG004|Overall Study|Disease Progression|3|||
17077620|NCT00410046|38219302|FG000|Overall Study|Withdrawal by Subject|1|||
17077621|NCT00410046|38219302|FG000|Overall Study|Lost to Follow-up|1|||
17077622|NCT00416624|38219311|FG000|Overall Study|Withdrawal by Subject|1|||
17077623|NCT00416624|38219312|FG001|Overall Study|Withdrawal by Subject|6|||
17077624|NCT00416624|38219313|FG002|Overall Study|Withdrawal by Subject|4|||
17077625|NCT00416624|38219314|FG003|Overall Study|Withdrawal by Subject|9|||
17077626|NCT00416624|38219311|FG000|Overall Study|Death|4|||
17077627|NCT00416624|38219312|FG001|Overall Study|Death|7|||
17077628|NCT00416624|38219313|FG002|Overall Study|Death|7|||
17077629|NCT00416624|38219314|FG003|Overall Study|Death|1|||
17077630|NCT00416624|38219311|FG000|Overall Study|Adverse Event|8|||
17158201|NCT03427073|38305243|FG005|Overall Study|Disease Progression|4|||
17158202|NCT03427073|38305244|FG006|Overall Study|Disease Progression|2|||
17158203|NCT03427073|38305245|FG007|Overall Study|Disease Progression|3|||
17158204|NCT03427073|38305238|FG000|Overall Study|Physician Decision|0|||
17158205|NCT03427073|38305239|FG001|Overall Study|Physician Decision|0|||
17158206|NCT03427073|38305240|FG002|Overall Study|Physician Decision|0|||
17077631|NCT00416624|38219312|FG001|Overall Study|Adverse Event|3|||
17077632|NCT00416624|38219313|FG002|Overall Study|Adverse Event|2|||
17077633|NCT00416624|38219314|FG003|Overall Study|Adverse Event|2|||
17077634|NCT00416624|38219311|FG000|Overall Study|Other|8|||
17077635|NCT00416624|38219312|FG001|Overall Study|Other|11|||
17077636|NCT00416624|38219313|FG002|Overall Study|Other|5|||
17077637|NCT00416624|38219314|FG003|Overall Study|Other|5|||
17077638|NCT00416624|38219311|FG000|Overall Study|Cancel|1|||
17077639|NCT00416624|38219312|FG001|Overall Study|Cancel|0|||
17077640|NCT00416624|38219313|FG002|Overall Study|Cancel|0|||
17077641|NCT00416624|38219314|FG003|Overall Study|Cancel|0|||
17077642|NCT00262600|38219327|FG000|Overall Study|Lost to Follow-up|17|||
17077643|NCT00262600|38219328|FG001|Overall Study|Lost to Follow-up|31|||
17077644|NCT00262600|38219329|FG002|Overall Study|Lost to Follow-up|41|||
17077645|NCT00262600|38219327|FG000|Overall Study|Withdrawal by Subject|128|||
17077646|NCT00262600|38219328|FG001|Overall Study|Withdrawal by Subject|145|||
17077647|NCT00262600|38219329|FG002|Overall Study|Withdrawal by Subject|139|||
17077648|NCT00262600|38219327|FG000|Overall Study|Not Treated|32|||
17077649|NCT00262600|38219328|FG001|Overall Study|Not Treated|17|||
17077650|NCT00262600|38219329|FG002|Overall Study|Not Treated|24|||
17077651|NCT00262600|38219327|FG000|Overall Study|Other|58|||
17077652|NCT00262600|38219328|FG001|Overall Study|Other|59|||
17077653|NCT00262600|38219329|FG002|Overall Study|Other|62|||
17077654|NCT00409578|38219341|FG000|Overall Study|Adverse Event|27|||
17077655|NCT00409578|38219342|FG001|Overall Study|Adverse Event|37|||
17077656|NCT00409578|38219343|FG002|Overall Study|Adverse Event|25|||
17077657|NCT00409578|38219344|FG003|Overall Study|Adverse Event|33|||
17077658|NCT00409578|38219341|FG000|Overall Study|Abnormal laboratory value(s)|2|||
17077659|NCT00409578|38219342|FG001|Overall Study|Abnormal laboratory value(s)|2|||
17077660|NCT00409578|38219343|FG002|Overall Study|Abnormal laboratory value(s)|2|||
17077661|NCT00409578|38219344|FG003|Overall Study|Abnormal laboratory value(s)|4|||
17077662|NCT00409578|38219341|FG000|Overall Study|Lack of Efficacy|0|||
17077663|NCT00409578|38219342|FG001|Overall Study|Lack of Efficacy|0|||
17077664|NCT00409578|38219343|FG002|Overall Study|Lack of Efficacy|0|||
17077665|NCT00409578|38219344|FG003|Overall Study|Lack of Efficacy|2|||
17077666|NCT00409578|38219341|FG000|Overall Study|Subject no longer requires study drug|0|||
17077667|NCT00409578|38219342|FG001|Overall Study|Subject no longer requires study drug|0|||
17077668|NCT00409578|38219343|FG002|Overall Study|Subject no longer requires study drug|0|||
17077669|NCT00409578|38219344|FG003|Overall Study|Subject no longer requires study drug|1|||
17077670|NCT00409578|38219341|FG000|Overall Study|Withdrawal by Subject|8|||
17077671|NCT00409578|38219342|FG001|Overall Study|Withdrawal by Subject|15|||
17077672|NCT00409578|38219343|FG002|Overall Study|Withdrawal by Subject|16|||
17077673|NCT00409578|38219344|FG003|Overall Study|Withdrawal by Subject|17|||
17077674|NCT00409578|38219341|FG000|Overall Study|Lost to Follow-up|2|||
17077675|NCT00409578|38219342|FG001|Overall Study|Lost to Follow-up|0|||
17077676|NCT00409578|38219343|FG002|Overall Study|Lost to Follow-up|2|||
17077677|NCT00409578|38219344|FG003|Overall Study|Lost to Follow-up|2|||
17077678|NCT00409578|38219341|FG000|Overall Study|Administrative problems|8|||
17077679|NCT00409578|38219342|FG001|Overall Study|Administrative problems|9|||
17077680|NCT00409578|38219343|FG002|Overall Study|Administrative problems|2|||
17077681|NCT00409578|38219344|FG003|Overall Study|Administrative problems|4|||
17077682|NCT00409578|38219341|FG000|Overall Study|Death|2|||
17077683|NCT00409578|38219342|FG001|Overall Study|Death|4|||
17077684|NCT00409578|38219343|FG002|Overall Study|Death|4|||
17077685|NCT00409578|38219344|FG003|Overall Study|Death|2|||
17077686|NCT00409578|38219341|FG000|Overall Study|Protocol Violation|3|||
17077687|NCT00409578|38219342|FG001|Overall Study|Protocol Violation|2|||
17077688|NCT00409578|38219343|FG002|Overall Study|Protocol Violation|3|||
17077689|NCT00409578|38219344|FG003|Overall Study|Protocol Violation|1|||
17077690|NCT00409578|38219341|FG000|Overall Study|Missing|0|||
17077691|NCT00409578|38219342|FG001|Overall Study|Missing|1|||
17077692|NCT00409578|38219343|FG002|Overall Study|Missing|0|||
17077693|NCT00409578|38219344|FG003|Overall Study|Missing|1|||
17077694|NCT00428090|38219358|FG000|Overall Study|Adverse Event|10|||
17077695|NCT00428090|38219359|FG001|Overall Study|Adverse Event|8|||
17077696|NCT00428090|38219360|FG002|Overall Study|Adverse Event|10|||
17077697|NCT00428090|38219361|FG003|Overall Study|Adverse Event|11|||
17077698|NCT00428090|38219358|FG000|Overall Study|Lost to Follow-up|3|||
17077699|NCT00428090|38219359|FG001|Overall Study|Lost to Follow-up|6|||
17077700|NCT00428090|38219360|FG002|Overall Study|Lost to Follow-up|1|||
17077701|NCT00428090|38219361|FG003|Overall Study|Lost to Follow-up|4|||
17077702|NCT00428090|38219358|FG000|Overall Study|Protocol Violation|3|||
17077703|NCT00428090|38219359|FG001|Overall Study|Protocol Violation|1|||
17077704|NCT00428090|38219360|FG002|Overall Study|Protocol Violation|3|||
17158207|NCT03427073|38305241|FG003|Overall Study|Physician Decision|0|||
17077705|NCT00428090|38219361|FG003|Overall Study|Protocol Violation|3|||
17077706|NCT00428090|38219358|FG000|Overall Study|Withdrawal by Subject|10|||
17077707|NCT00428090|38219359|FG001|Overall Study|Withdrawal by Subject|12|||
17077708|NCT00428090|38219360|FG002|Overall Study|Withdrawal by Subject|15|||
17077709|NCT00428090|38219361|FG003|Overall Study|Withdrawal by Subject|5|||
17077710|NCT00428090|38219358|FG000|Overall Study|Sponsor terminated study|0|||
17077711|NCT00428090|38219359|FG001|Overall Study|Sponsor terminated study|1|||
17077712|NCT00428090|38219360|FG002|Overall Study|Sponsor terminated study|0|||
17077713|NCT00428090|38219361|FG003|Overall Study|Sponsor terminated study|0|||
17077714|NCT00428090|38219358|FG000|Overall Study|Non-compliance|4|||
17077715|NCT00428090|38219359|FG001|Overall Study|Non-compliance|0|||
17077716|NCT00428090|38219360|FG002|Overall Study|Non-compliance|1|||
17077717|NCT00428090|38219361|FG003|Overall Study|Non-compliance|3|||
17077718|NCT00428090|38219358|FG000|Overall Study|Par. did not returned to visit|1|||
17077719|NCT00428090|38219359|FG001|Overall Study|Par. did not returned to visit|0|||
17077720|NCT00428090|38219360|FG002|Overall Study|Par. did not returned to visit|0|||
17077721|NCT00428090|38219361|FG003|Overall Study|Par. did not returned to visit|1|||
17077722|NCT00428090|38219358|FG000|Overall Study|Follow-Up visit not possible|1|||
17077723|NCT00428090|38219359|FG001|Overall Study|Follow-Up visit not possible|0|||
17077724|NCT00428090|38219360|FG002|Overall Study|Follow-Up visit not possible|0|||
17077725|NCT00428090|38219361|FG003|Overall Study|Follow-Up visit not possible|0|||
17077726|NCT00428090|38219358|FG000|Overall Study|Prohibited medication used for SAE|1|||
17077727|NCT00428090|38219359|FG001|Overall Study|Prohibited medication used for SAE|0|||
17077728|NCT00428090|38219360|FG002|Overall Study|Prohibited medication used for SAE|0|||
17077729|NCT00428090|38219361|FG003|Overall Study|Prohibited medication used for SAE|0|||
17077730|NCT00428090|38219358|FG000|Overall Study|Death of par.|1|||
17077731|NCT00428090|38219359|FG001|Overall Study|Death of par.|0|||
17077732|NCT00428090|38219360|FG002|Overall Study|Death of par.|1|||
17077733|NCT00428090|38219361|FG003|Overall Study|Death of par.|0|||
17077734|NCT00428090|38219358|FG000|Overall Study|Visit 7 exceed the visit window|0|||
17077735|NCT00428090|38219359|FG001|Overall Study|Visit 7 exceed the visit window|1|||
17077736|NCT00428090|38219360|FG002|Overall Study|Visit 7 exceed the visit window|0|||
17077737|NCT00428090|38219361|FG003|Overall Study|Visit 7 exceed the visit window|0|||
17077738|NCT00428090|38219358|FG000|Overall Study|Medical monitor terminated par.|0|||
17077739|NCT00428090|38219359|FG001|Overall Study|Medical monitor terminated par.|1|||
17077740|NCT00428090|38219360|FG002|Overall Study|Medical monitor terminated par.|0|||
17077741|NCT00428090|38219361|FG003|Overall Study|Medical monitor terminated par.|0|||
17077742|NCT00428090|38219358|FG000|Overall Study|Mental status of par. was|0|||
17077743|NCT00428090|38219359|FG001|Overall Study|Mental status of par. was|1|||
17077744|NCT00428090|38219360|FG002|Overall Study|Mental status of par. was|0|||
17077745|NCT00428090|38219361|FG003|Overall Study|Mental status of par. was|0|||
17077746|NCT00428090|38219358|FG000|Overall Study|Worsening of AD|0|||
17077747|NCT00428090|38219359|FG001|Overall Study|Worsening of AD|0|||
17077748|NCT00428090|38219360|FG002|Overall Study|Worsening of AD|1|||
17077749|NCT00428090|38219361|FG003|Overall Study|Worsening of AD|0|||
17077750|NCT00428090|38219358|FG000|Overall Study|Excluded for concerning QTc value|0|||
17077751|NCT00428090|38219359|FG001|Overall Study|Excluded for concerning QTc value|0|||
17077752|NCT00428090|38219360|FG002|Overall Study|Excluded for concerning QTc value|1|||
17077753|NCT00428090|38219361|FG003|Overall Study|Excluded for concerning QTc value|0|||
17077754|NCT00428090|38219358|FG000|Overall Study|Insufficient AD documentation|0|||
17077755|NCT00428090|38219359|FG001|Overall Study|Insufficient AD documentation|0|||
17077756|NCT00428090|38219360|FG002|Overall Study|Insufficient AD documentation|1|||
17077757|NCT00428090|38219361|FG003|Overall Study|Insufficient AD documentation|0|||
17077758|NCT00428090|38219358|FG000|Overall Study|High MMSE scores|0|||
17077759|NCT00428090|38219359|FG001|Overall Study|High MMSE scores|0|||
17077760|NCT00428090|38219360|FG002|Overall Study|High MMSE scores|1|||
17077761|NCT00428090|38219361|FG003|Overall Study|High MMSE scores|0|||
17077762|NCT00428090|38219358|FG000|Overall Study|Deterioration of cognitive status|0|||
17077763|NCT00428090|38219359|FG001|Overall Study|Deterioration of cognitive status|0|||
17077764|NCT00428090|38219360|FG002|Overall Study|Deterioration of cognitive status|1|||
17158208|NCT03427073|38305242|FG004|Overall Study|Physician Decision|0|||
17158209|NCT03427073|38305243|FG005|Overall Study|Physician Decision|0|||
17158210|NCT03427073|38305244|FG006|Overall Study|Physician Decision|1|||
17077765|NCT00428090|38219361|FG003|Overall Study|Deterioration of cognitive status|0|||
17077766|NCT00428090|38219358|FG000|Overall Study|Serious adverse event|0|||
17077767|NCT00428090|38219359|FG001|Overall Study|Serious adverse event|0|||
17077768|NCT00428090|38219360|FG002|Overall Study|Serious adverse event|1|||
17077769|NCT00428090|38219361|FG003|Overall Study|Serious adverse event|0|||
17077770|NCT00428090|38219358|FG000|Overall Study|Excluded for heart insufficiency|0|||
17077771|NCT00428090|38219359|FG001|Overall Study|Excluded for heart insufficiency|0|||
17077772|NCT00428090|38219360|FG002|Overall Study|Excluded for heart insufficiency|1|||
17077773|NCT00428090|38219361|FG003|Overall Study|Excluded for heart insufficiency|0|||
17077774|NCT00428090|38219358|FG000|Overall Study|Raised Creatinine Value|0|||
17077775|NCT00428090|38219359|FG001|Overall Study|Raised Creatinine Value|0|||
17077776|NCT00428090|38219360|FG002|Overall Study|Raised Creatinine Value|0|||
17077777|NCT00428090|38219361|FG003|Overall Study|Raised Creatinine Value|1|||
17077778|NCT00416312|38219379|FG000|Overall Study|tumors not visible on imaging|2|||
17077779|NCT00436436|38219383|FG000|Overall Study|Progression|4|||
17077780|NCT00436436|38219383|FG000|Overall Study|Adverse Event|2|||
17077781|NCT00436436|38219383|FG000|Overall Study|Death|6|||
17077782|NCT00262522|38219391|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
17077783|NCT00262522|38219392|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
17077784|NCT00262522|38219393|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
17077785|NCT00262522|38219394|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
17077786|NCT00262522|38219391|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
17077787|NCT00262522|38219392|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
17077788|NCT00262522|38219393|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
17077789|NCT00262522|38219394|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
17077790|NCT00262522|38219391|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
17077791|NCT00262522|38219392|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
17077792|NCT00262522|38219393|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
17077793|NCT00262522|38219394|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
17077794|NCT00262522|38219391|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
17077795|NCT00262522|38219392|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
17077796|NCT00262522|38219393|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
17077797|NCT00262522|38219394|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
17077798|NCT00262522|38219391|FG000|Study Start Through 8 Weeks|Death|1|||
17077799|NCT00262522|38219392|FG001|Study Start Through 8 Weeks|Death|0|||
17077800|NCT00262522|38219393|FG002|Study Start Through 8 Weeks|Death|0|||
17077801|NCT00262522|38219394|FG003|Study Start Through 8 Weeks|Death|0|||
17077802|NCT00262522|38219391|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
17077803|NCT00262522|38219392|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
17077804|NCT00262522|38219393|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
17077805|NCT00262522|38219394|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
17077806|NCT00262522|38219391|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
17077807|NCT00262522|38219392|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
17077808|NCT00262522|38219393|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
17077809|NCT00262522|38219394|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
17077810|NCT00262522|38219391|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
17077811|NCT00262522|38219392|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
17077812|NCT00262522|38219393|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
17077813|NCT00262522|38219394|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
17077814|NCT00262522|38219391|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
17077815|NCT00262522|38219392|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
17077816|NCT00262522|38219393|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
17077817|NCT00262522|38219394|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
17077818|NCT00262522|38219391|FG000|Study Start Through 48 Weeks|Death|2|||
17077819|NCT00262522|38219392|FG001|Study Start Through 48 Weeks|Death|0|||
17077820|NCT00262522|38219393|FG002|Study Start Through 48 Weeks|Death|1|||
17077821|NCT00262522|38219394|FG003|Study Start Through 48 Weeks|Death|0|||
17077822|NCT00262522|38219391|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
17077823|NCT00262522|38219392|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
17077824|NCT00262522|38219393|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
17077825|NCT00262522|38219394|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
17077826|NCT00262522|38219391|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
17077827|NCT00262522|38219392|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
17077828|NCT00262522|38219393|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
17077829|NCT00262522|38219394|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
17077830|NCT00262522|38219391|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
17077831|NCT00262522|38219392|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
17077832|NCT00262522|38219393|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
17077833|NCT00262522|38219394|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
17077834|NCT00262522|38219391|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
16995146|NCT01003184|38138843|FG001|Overall Study|Adverse Event|5|||
16995147|NCT01003184|38138842|FG000|Overall Study|Lost to Follow-up|1|||
16995148|NCT01003184|38138843|FG001|Overall Study|Lost to Follow-up|0|||
16995149|NCT01003184|38138842|FG000|Overall Study|Loss of glucose control|1|||
16995150|NCT01003184|38138843|FG001|Overall Study|Loss of glucose control|1|||
16995151|NCT01003184|38138842|FG000|Overall Study|Protocol Violation|3|||
16995152|NCT01003184|38138843|FG001|Overall Study|Protocol Violation|0|||
16995153|NCT01003184|38138842|FG000|Overall Study|Withdrawal by Subject|1|||
16995154|NCT01003184|38138843|FG001|Overall Study|Withdrawal by Subject|6|||
16995155|NCT01003184|38138842|FG000|Overall Study|Physician Decision|1|||
17077835|NCT00262522|38219392|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
17077836|NCT00262522|38219393|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
17077837|NCT00262522|38219394|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
17077838|NCT00262522|38219391|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
17077839|NCT00262522|38219392|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
17077840|NCT00262522|38219393|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
17077841|NCT00262522|38219394|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
17077842|NCT00262522|38219391|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
17077843|NCT00262522|38219392|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
17077844|NCT00262522|38219393|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
17077845|NCT00262522|38219394|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
17077846|NCT00262522|38219391|FG000|Study Start Through 96 Weeks|Death|2|||
17077847|NCT00262522|38219392|FG001|Study Start Through 96 Weeks|Death|0|||
17077848|NCT00262522|38219393|FG002|Study Start Through 96 Weeks|Death|2|||
17077849|NCT00262522|38219394|FG003|Study Start Through 96 Weeks|Death|0|||
17077850|NCT00262522|38219391|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
17077851|NCT00262522|38219392|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
17077852|NCT00262522|38219393|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
17077853|NCT00262522|38219394|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
17077854|NCT00262522|38219391|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
17077855|NCT00262522|38219392|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
17077856|NCT00262522|38219393|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
17077857|NCT00262522|38219394|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
17077858|NCT00436280|38219402|FG000|Period 1: Induction|Adverse Event|8|||
17077859|NCT00436280|38219402|FG000|Period 1: Induction|Progressive Disease|12|||
17077860|NCT00436280|38219402|FG000|Period 1: Induction|Stable Disease|6|||
17158211|NCT03427073|38305245|FG007|Overall Study|Physician Decision|1|||
17158212|NCT03066804|38305265|FG000|Overall Study|Physician Decision|0|||
17158213|NCT03066804|38305266|FG001|Overall Study|Physician Decision|4|||
17158214|NCT03066804|38305265|FG000|Overall Study|Death|23|||
17158215|NCT03066804|38305266|FG001|Overall Study|Death|17|||
17158216|NCT03066804|38305265|FG000|Overall Study|Withdrawal by Subject|19|||
16995156|NCT01003184|38138843|FG001|Overall Study|Physician Decision|0|||
17158217|NCT03066804|38305266|FG001|Overall Study|Withdrawal by Subject|25|||
17158218|NCT03066804|38305265|FG000|Overall Study|Lost to Follow-up|2|||
17158219|NCT03066804|38305266|FG001|Overall Study|Lost to Follow-up|0|||
17158220|NCT03066804|38305265|FG000|Overall Study|Adverse Event|2|||
17158221|NCT03066804|38305266|FG001|Overall Study|Adverse Event|3|||
17158222|NCT03066804|38305265|FG000|Overall Study|Technical problems|5|||
17158223|NCT03066804|38305266|FG001|Overall Study|Technical problems|1|||
17158224|NCT02954237|38305273|FG000|Overall Study|Withdrawal by Subject|25|||
17158225|NCT02954237|38305273|FG000|Overall Study|Missed visit|16|||
17158226|NCT02954237|38305273|FG000|Overall Study|Death|2|||
17158227|NCT04250337|38305279|FG000|Overall Study|Adverse Event|0|||
17158228|NCT04250337|38305280|FG001|Overall Study|Adverse Event|3|||
17158229|NCT04250337|38305279|FG000|Overall Study|Lack of Efficacy|1|||
17158230|NCT04250337|38305280|FG001|Overall Study|Lack of Efficacy|3|||
17158231|NCT04250337|38305279|FG000|Overall Study|Physician Decision|1|||
17158232|NCT04250337|38305280|FG001|Overall Study|Physician Decision|0|||
17158233|NCT04250337|38305279|FG000|Overall Study|Protocol Deviation|2|||
17158234|NCT04250337|38305280|FG001|Overall Study|Protocol Deviation|2|||
17158235|NCT04250337|38305279|FG000|Overall Study|Withdrawal by Subject|4|||
17158236|NCT04250337|38305280|FG001|Overall Study|Withdrawal by Subject|3|||
17158237|NCT03118947|38305287|FG000|Overall Study|Adverse Event|7|||
17158238|NCT03118947|38305287|FG000|Overall Study|Death|3|||
17158239|NCT03118947|38305287|FG000|Overall Study|Lack of Efficacy|4|||
16995157|NCT01029353|38138853|FG000|Overall Study|Lost to Follow-up|4|||
16995158|NCT01029353|38138854|FG001|Overall Study|Lost to Follow-up|5|||
16995159|NCT01029353|38138855|FG002|Overall Study|Lost to Follow-up|5|||
16995160|NCT01029353|38138856|FG003|Overall Study|Lost to Follow-up|4|||
16995161|NCT01029353|38138853|FG000|Overall Study|Consent Withdrawn|2|||
16995162|NCT01029353|38138854|FG001|Overall Study|Consent Withdrawn|0|||
16995163|NCT01029353|38138855|FG002|Overall Study|Consent Withdrawn|0|||
16995164|NCT01029353|38138856|FG003|Overall Study|Consent Withdrawn|0|||
16995165|NCT01029353|38138853|FG000|Overall Study|Primary Outcome Indeterminate|1|||
16995166|NCT01029353|38138854|FG001|Overall Study|Primary Outcome Indeterminate|3|||
16995167|NCT01029353|38138855|FG002|Overall Study|Primary Outcome Indeterminate|2|||
16995168|NCT01029353|38138856|FG003|Overall Study|Primary Outcome Indeterminate|0|||
16995169|NCT01008410|38138868|FG000|Overall Study|Adverse Event|13|||
16995170|NCT01008410|38138869|FG001|Overall Study|Adverse Event|7|||
17077861|NCT00436280|38219402|FG000|Period 1: Induction|Withdrawal by Subject|1|||
17077862|NCT00436280|38219402|FG000|Period 1: Induction|Death|1|||
17077863|NCT00436280|38219402|FG000|Period 2: Consolidation|Adverse Event|1|||
17077864|NCT00436280|38219402|FG000|Period 2: Consolidation|Progressive Disease|10|||
17077865|NCT00436280|38219402|FG000|Period 2: Consolidation|Stable Disease|1|||
17077866|NCT00436280|38219402|FG000|Period 2: Consolidation|Physician Decision|2|||
17077867|NCT00436280|38219402|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
17077868|NCT00436280|38219402|FG000|Period 2: Consolidation|Death|1|||
17077869|NCT00436280|38219402|FG000|Period 3: Maintenance|Adverse Event|6|||
17077870|NCT00436280|38219402|FG000|Period 3: Maintenance|Progressive Disease|12|||
17077871|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
17077872|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
17077873|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
17077874|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
17077875|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
17077876|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
17077877|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
17077878|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
17077879|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Death|0|||
17077880|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Death|1|||
17077881|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
17077882|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
17077883|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
17077884|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
17077885|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
17077886|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
17077887|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
17077888|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
17077889|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
17077890|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
17077891|NCT00394836|38219408|FG000|Teatment or Follow-up Phase|Non compliance|0|||
17077892|NCT00394836|38219409|FG001|Teatment or Follow-up Phase|Non compliance|1|||
17077893|NCT00394836|38219408|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
17077894|NCT00394836|38219409|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
17077895|NCT00394836|38219408|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
17077896|NCT00394836|38219409|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
17077897|NCT00394836|38219408|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
17077898|NCT00394836|38219409|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
17158240|NCT03118947|38305287|FG000|Overall Study|Non-compliance with study drug|1|||
17158241|NCT03118947|38305287|FG000|Overall Study|Protocol Violation|2|||
17158242|NCT03118947|38305287|FG000|Overall Study|Withdrawal by Subject|3|||
17158243|NCT03118947|38305287|FG000|Overall Study|Withdrawal by caregiver|3|||
17158244|NCT03118947|38305287|FG000|Overall Study|Change in patient's living situation|4|||
17158245|NCT03118947|38305287|FG000|Overall Study|Lost to Follow-up|2|||
17158246|NCT03953079|38305294|FG000|Core Study|Withdrawal by Subject|1|||
17158247|NCT03953079|38305295|FG001|Core Study|Withdrawal by Subject|2|||
17158248|NCT03953079|38305296|FG002|Core Study|Withdrawal by Subject|1|||
17158249|NCT03953079|38305294|FG000|Core Study|COVID-19|0|||
17158250|NCT03953079|38305295|FG001|Core Study|COVID-19|1|||
17158251|NCT03953079|38305296|FG002|Core Study|COVID-19|0|||
17158252|NCT03953079|38305294|FG000|Core Study|Difficulties leaving the house|0|||
17158253|NCT03953079|38305295|FG001|Core Study|Difficulties leaving the house|1|||
17158254|NCT03953079|38305296|FG002|Core Study|Difficulties leaving the house|0|||
17158255|NCT03953079|38305294|FG000|Extension Study|Withdrawal by Subject|1|||
17158256|NCT03953079|38305295|FG001|Extension Study|Withdrawal by Subject|0|||
17158257|NCT03953079|38305296|FG002|Extension Study|Withdrawal by Subject|0|||
17158258|NCT03953079|38305294|FG000|Extension Study|Received Rescue Treatment|5|||
17158259|NCT03953079|38305295|FG001|Extension Study|Received Rescue Treatment|6|||
17158260|NCT03953079|38305296|FG002|Extension Study|Received Rescue Treatment|5|||
17158261|NCT03885999|38305309|FG000|Overall Study|Adverse Event|1|||
17158262|NCT03108027|38305323|FG000|Period 1|Subject/Guardian Decision|0|||
17158263|NCT03108027|38305324|FG001|Period 1|Subject/Guardian Decision|0|||
17158264|NCT03108027|38305325|FG002|Period 1|Subject/Guardian Decision|0|||
17158265|NCT03108027|38305326|FG003|Period 1|Subject/Guardian Decision|2|||
17158266|NCT03108027|38305327|FG004|Period 1|Subject/Guardian Decision|0|||
17158267|NCT03108027|38305328|FG005|Period 1|Subject/Guardian Decision|0|||
17158268|NCT03108027|38305323|FG000|Period 3|Adverse Event|0|||
17158269|NCT03108027|38305324|FG001|Period 3|Adverse Event|1|||
17077899|NCT00394836|38219408|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
17158270|NCT03108027|38305325|FG002|Period 3|Adverse Event|0|||
17077900|NCT00394836|38219409|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
17077901|NCT00250588|38219420|FG000|Overall Study|Withdrawal by Subject|3|||
17077902|NCT00250588|38219421|FG001|Overall Study|Withdrawal by Subject|6|||
17077903|NCT00250588|38219422|FG002|Overall Study|Withdrawal by Subject|0|||
17077904|NCT00250588|38219420|FG000|Overall Study|Lost to Follow-up|6|||
17077905|NCT00250588|38219421|FG001|Overall Study|Lost to Follow-up|13|||
17077906|NCT00250588|38219422|FG002|Overall Study|Lost to Follow-up|13|||
17077907|NCT00416078|38219432|FG000|Overall Study|Death|3|||
17077908|NCT00416078|38219433|FG001|Overall Study|Death|4|||
17077909|NCT00416078|38219432|FG000|Overall Study|Withdrawal by Subject|3|||
17077910|NCT00416078|38219433|FG001|Overall Study|Withdrawal by Subject|2|||
17077911|NCT00416078|38219432|FG000|Overall Study|Physician Decision|1|||
17077912|NCT00416078|38219433|FG001|Overall Study|Physician Decision|0|||
17077913|NCT00416078|38219432|FG000|Overall Study|Lost to Follow-up|4|||
17077914|NCT00416078|38219433|FG001|Overall Study|Lost to Follow-up|2|||
17077915|NCT00394524|38219441|FG000|Overall Study|Protocol Violation|2|||
17077916|NCT00394524|38219442|FG001|Overall Study|Protocol Violation|3|||
17077917|NCT00394524|38219441|FG000|Overall Study|Death|1|||
17077918|NCT00394524|38219442|FG001|Overall Study|Death|0|||
17077919|NCT00394524|38219441|FG000|Overall Study|Withdrawal by Subject|0|||
17077920|NCT00394524|38219442|FG001|Overall Study|Withdrawal by Subject|1|||
17077921|NCT00409344|38219452|FG000|Overall Study|no enrollment|0|||
17077922|NCT00409344|38219453|FG001|Overall Study|no enrollment|0|||
17077923|NCT00415610|38219462|FG000|Overall Study|Death|3|||
17077924|NCT00415610|38219463|FG001|Overall Study|Death|2|||
17077925|NCT00415610|38219464|FG002|Overall Study|Death|5|||
17077926|NCT00394212|38219474|FG000|Overall Study|Lost to Follow-up|3|||
17077927|NCT00394212|38219475|FG001|Overall Study|Lost to Follow-up|0|||
17077928|NCT00394212|38219474|FG000|Overall Study|Withdrawal by Subject|4|||
17077929|NCT00394212|38219475|FG001|Overall Study|Withdrawal by Subject|1|||
17077930|NCT00250432|38219483|FG000|Overall Study|Adverse Event|25|||
17077931|NCT00250432|38219484|FG001|Overall Study|Adverse Event|29|||
17077932|NCT00250432|38219483|FG000|Overall Study|Lack of Efficacy|2|||
17077933|NCT00250432|38219484|FG001|Overall Study|Lack of Efficacy|1|||
17077934|NCT00250432|38219483|FG000|Overall Study|Lost to Follow-up|6|||
17077935|NCT00250432|38219484|FG001|Overall Study|Lost to Follow-up|5|||
17077936|NCT00250432|38219483|FG000|Overall Study|Patient Moved|0|||
17077937|NCT00250432|38219484|FG001|Overall Study|Patient Moved|1|||
17077938|NCT00250432|38219483|FG000|Overall Study|Protocol Violation|0|||
17077939|NCT00250432|38219484|FG001|Overall Study|Protocol Violation|3|||
17077940|NCT00250432|38219483|FG000|Overall Study|Withdrawal by Subject|6|||
17077941|NCT00250432|38219484|FG001|Overall Study|Withdrawal by Subject|2|||
17077942|NCT00250432|38219483|FG000|Overall Study|Pt died out of posttherapy report period|6|||
17077943|NCT00250432|38219484|FG001|Overall Study|Pt died out of posttherapy report period|5|||
17077944|NCT00250432|38219483|FG000|Overall Study|Pt was considered untreatable|0|||
17077945|NCT00250432|38219484|FG001|Overall Study|Pt was considered untreatable|1|||
17077946|NCT00250276|38219494|FG000|Overall Study|Serious Adverse Event|0|||
17077947|NCT00250276|38219495|FG001|Overall Study|Serious Adverse Event|0|||
17077948|NCT00250276|38219496|FG002|Overall Study|Serious Adverse Event|1|||
17077949|NCT00250276|38219497|FG003|Overall Study|Serious Adverse Event|0|||
17077950|NCT00250276|38219494|FG000|Overall Study|Non-serious Adverse Event|2|||
17077951|NCT00250276|38219495|FG001|Overall Study|Non-serious Adverse Event|0|||
17077952|NCT00250276|38219496|FG002|Overall Study|Non-serious Adverse Event|0|||
17077953|NCT00250276|38219497|FG003|Overall Study|Non-serious Adverse Event|2|||
17077954|NCT00250276|38219494|FG000|Overall Study|Protocol Violation|0|||
17077955|NCT00250276|38219495|FG001|Overall Study|Protocol Violation|1|||
17077956|NCT00250276|38219496|FG002|Overall Study|Protocol Violation|0|||
17077957|NCT00250276|38219497|FG003|Overall Study|Protocol Violation|0|||
17077958|NCT00250276|38219494|FG000|Overall Study|Withdrawal by Subject|1|||
17077959|NCT00250276|38219495|FG001|Overall Study|Withdrawal by Subject|2|||
17077960|NCT00250276|38219496|FG002|Overall Study|Withdrawal by Subject|3|||
17158271|NCT03108027|38305326|FG003|Period 3|Adverse Event|0|||
17158272|NCT03108027|38305327|FG004|Period 3|Adverse Event|0|||
17158273|NCT03108027|38305328|FG005|Period 3|Adverse Event|0|||
17158274|NCT03107715|38305344|FG000|Overall Study|did not deliver at the home hospital|4|||
17077961|NCT00250276|38219497|FG003|Overall Study|Withdrawal by Subject|2|||
17077962|NCT00250276|38219494|FG000|Overall Study|Migrated/moved from study area|3|||
17077963|NCT00250276|38219495|FG001|Overall Study|Migrated/moved from study area|0|||
17077964|NCT00250276|38219496|FG002|Overall Study|Migrated/moved from study area|2|||
17158275|NCT03107715|38305345|FG001|Overall Study|did not deliver at the home hospital|6|||
17158276|NCT03107715|38305344|FG000|Overall Study|infant stillborn|0|||
17158277|NCT03107715|38305345|FG001|Overall Study|infant stillborn|1|||
17158278|NCT03567057|38305354|FG000|Overall Study|Adverse Event|56|||
17158279|NCT03567057|38305355|FG001|Overall Study|Adverse Event|53|||
17077965|NCT00250276|38219497|FG003|Overall Study|Migrated/moved from study area|7|||
17077966|NCT00250276|38219494|FG000|Overall Study|Lost to Follow-up|11|||
17077967|NCT00250276|38219495|FG001|Overall Study|Lost to Follow-up|18|||
17077968|NCT00250276|38219496|FG002|Overall Study|Lost to Follow-up|13|||
17158280|NCT03567057|38305356|FG002|Overall Study|Adverse Event|28|||
17158281|NCT03567057|38305354|FG000|Overall Study|Withdrawal by Subject|22|||
17158282|NCT03567057|38305355|FG001|Overall Study|Withdrawal by Subject|24|||
17158283|NCT03567057|38305356|FG002|Overall Study|Withdrawal by Subject|13|||
17158284|NCT03567057|38305354|FG000|Overall Study|Lost to Follow-up|3|||
17158285|NCT03567057|38305355|FG001|Overall Study|Lost to Follow-up|5|||
17158286|NCT03567057|38305356|FG002|Overall Study|Lost to Follow-up|2|||
17158287|NCT03567057|38305354|FG000|Overall Study|COVID-19 pandemic|4|||
17158288|NCT03567057|38305355|FG001|Overall Study|COVID-19 pandemic|3|||
17158289|NCT03567057|38305356|FG002|Overall Study|COVID-19 pandemic|0|||
17158290|NCT03567057|38305354|FG000|Overall Study|Non-compliance with study drug|4|||
17077969|NCT00250276|38219497|FG003|Overall Study|Lost to Follow-up|8|||
17077970|NCT00249808|38219512|FG000|Overall Study|Other|27|||
17077971|NCT00249808|38219512|FG000|Overall Study|Protocol Violation|3|||
17077972|NCT00249808|38219512|FG000|Overall Study|Lost to Follow-up|8|||
17077973|NCT00249808|38219512|FG000|Overall Study|Adverse Event|81|||
17077974|NCT00249808|38219512|FG000|Overall Study|Lack of Efficacy|52|||
17077975|NCT00249808|38219512|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
17077976|NCT00278512|38219518|FG000|Overall Study|Death|1|||
17077977|NCT00278512|38219519|FG001|Overall Study|Death|0|||
17077978|NCT00427934|38219529|FG000|Overall Study|Adverse Event|1|||
17077979|NCT00427934|38219530|FG001|Overall Study|Adverse Event|0|||
17077980|NCT00427934|38219531|FG002|Overall Study|Adverse Event|5|||
17077981|NCT00427934|38219532|FG003|Overall Study|Adverse Event|4|||
17077982|NCT00427934|38219529|FG000|Overall Study|Lack of Efficacy|0|||
17077983|NCT00427934|38219530|FG001|Overall Study|Lack of Efficacy|0|||
17077984|NCT00427934|38219531|FG002|Overall Study|Lack of Efficacy|5|||
17077985|NCT00427934|38219532|FG003|Overall Study|Lack of Efficacy|2|||
17077986|NCT00427934|38219529|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
17077987|NCT00427934|38219530|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
17077988|NCT00427934|38219531|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
17077989|NCT00427934|38219532|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
17077990|NCT00427934|38219529|FG000|Overall Study|Other|0|||
17077991|NCT00427934|38219530|FG001|Overall Study|Other|0|||
17077992|NCT00427934|38219531|FG002|Overall Study|Other|11|||
17077993|NCT00427934|38219532|FG003|Overall Study|Other|5|||
17077994|NCT00427934|38219529|FG000|Overall Study|Withdrawal by Subject|0|||
17077995|NCT00427934|38219530|FG001|Overall Study|Withdrawal by Subject|0|||
17077996|NCT00427934|38219531|FG002|Overall Study|Withdrawal by Subject|1|||
17077997|NCT00427934|38219532|FG003|Overall Study|Withdrawal by Subject|3|||
17077998|NCT00278200|38219546|FG000|Overall Study|Death|1|||
17077999|NCT00278200|38219547|FG001|Overall Study|Death|3|||
17078000|NCT00278200|38219546|FG000|Overall Study|Physician Decision|0|||
17158291|NCT03567057|38305355|FG001|Overall Study|Non-compliance with study drug|2|||
17158292|NCT03567057|38305356|FG002|Overall Study|Non-compliance with study drug|0|||
17158293|NCT03567057|38305354|FG000|Overall Study|Lack of Efficacy|3|||
17158294|NCT03567057|38305355|FG001|Overall Study|Lack of Efficacy|0|||
17158295|NCT03567057|38305356|FG002|Overall Study|Lack of Efficacy|1|||
17158296|NCT03567057|38305354|FG000|Overall Study|Death|1|||
17158297|NCT03567057|38305355|FG001|Overall Study|Death|0|||
17158298|NCT03567057|38305356|FG002|Overall Study|Death|0|||
17158299|NCT03567057|38305354|FG000|Overall Study|Physician Decision|1|||
17158300|NCT03567057|38305355|FG001|Overall Study|Physician Decision|0|||
17158301|NCT03567057|38305356|FG002|Overall Study|Physician Decision|0|||
17158302|NCT03567057|38305354|FG000|Overall Study|Unstable medical condition|1|||
17158303|NCT03567057|38305355|FG001|Overall Study|Unstable medical condition|0|||
17158304|NCT03567057|38305356|FG002|Overall Study|Unstable medical condition|0|||
17158305|NCT03567057|38305354|FG000|Overall Study|Medical history event|0|||
17158306|NCT03567057|38305355|FG001|Overall Study|Medical history event|0|||
17158307|NCT03567057|38305356|FG002|Overall Study|Medical history event|1|||
17158308|NCT03567057|38305354|FG000|Overall Study|Other|0|||
17158309|NCT03567057|38305355|FG001|Overall Study|Other|0|||
17158310|NCT03567057|38305356|FG002|Overall Study|Other|1|||
17158311|NCT04388787|38305364|FG000|Blinded Period|Patient could not follow instructions|1|||
17158312|NCT04388787|38305364|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
17158313|NCT03057600|38305376|FG000|Overall Study|Adverse Event|0|||
17158314|NCT03057600|38305377|FG001|Overall Study|Adverse Event|0|||
17158315|NCT03057600|38305378|FG002|Overall Study|Adverse Event|4|||
17158316|NCT03057600|38305379|FG003|Overall Study|Adverse Event|0|||
17158317|NCT03057600|38305376|FG000|Overall Study|Radiologic Disease Progression|8|||
17158318|NCT03057600|38305377|FG001|Overall Study|Radiologic Disease Progression|7|||
17078001|NCT00278200|38219547|FG001|Overall Study|Physician Decision|1|||
17078002|NCT00435188|38219555|FG000|Overall Study|Death|1|||
17078003|NCT00435188|38219556|FG001|Overall Study|Death|6|||
17078004|NCT00435188|38219555|FG000|Overall Study|Withdrawal by Subject|16|||
17078005|NCT00435188|38219556|FG001|Overall Study|Withdrawal by Subject|11|||
17078006|NCT00435188|38219555|FG000|Overall Study|Lost to Follow-up|5|||
17078007|NCT00435188|38219556|FG001|Overall Study|Lost to Follow-up|6|||
17158319|NCT03057600|38305378|FG002|Overall Study|Radiologic Disease Progression|13|||
17158320|NCT03057600|38305379|FG003|Overall Study|Radiologic Disease Progression|10|||
17158321|NCT03057600|38305376|FG000|Overall Study|Symptomatic Deterioration|0|||
17158322|NCT03057600|38305377|FG001|Overall Study|Symptomatic Deterioration|1|||
17158323|NCT03057600|38305378|FG002|Overall Study|Symptomatic Deterioration|1|||
17158324|NCT03057600|38305379|FG003|Overall Study|Symptomatic Deterioration|0|||
17158325|NCT03057600|38305376|FG000|Overall Study|Investigator Decision|0|||
17158326|NCT03057600|38305377|FG001|Overall Study|Investigator Decision|0|||
17158327|NCT03057600|38305378|FG002|Overall Study|Investigator Decision|1|||
17158328|NCT03057600|38305379|FG003|Overall Study|Investigator Decision|0|||
17158329|NCT03057600|38305376|FG000|Overall Study|Study Termination by Sponsor|0|||
17158330|NCT03057600|38305377|FG001|Overall Study|Study Termination by Sponsor|0|||
17158331|NCT03057600|38305378|FG002|Overall Study|Study Termination by Sponsor|0|||
17158332|NCT03057600|38305379|FG003|Overall Study|Study Termination by Sponsor|2|||
17158333|NCT03057600|38305376|FG000|Overall Study|Withdrawal by Subject|0|||
17158334|NCT03057600|38305377|FG001|Overall Study|Withdrawal by Subject|1|||
17078008|NCT00427778|38219564|FG000|First Intervention (4 Weeks)|no longer interested|1|||
17078009|NCT00427778|38219565|FG001|First Intervention (4 Weeks)|no longer interested|0|||
17078010|NCT00427778|38219564|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
17078011|NCT00427778|38219565|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
17078012|NCT00427778|38219564|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
17078013|NCT00427778|38219565|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
17078014|NCT00427778|38219564|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
17078015|NCT00427778|38219565|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
17078016|NCT00427700|38219586|FG000|Overall Study|Lost to Follow-up|2|||
17078017|NCT00427700|38219587|FG001|Overall Study|Lost to Follow-up|5|||
17078018|NCT00427700|38219586|FG000|Overall Study|no induction of menses|1|||
17078019|NCT00427700|38219587|FG001|Overall Study|no induction of menses|4|||
17078020|NCT00427700|38219586|FG000|Overall Study|Pregnancy|0|||
16995171|NCT01008410|38138868|FG000|Overall Study|Withdrawal by Subject|6|||
17158335|NCT03057600|38305378|FG002|Overall Study|Withdrawal by Subject|0|||
17158336|NCT03057600|38305379|FG003|Overall Study|Withdrawal by Subject|0|||
17158337|NCT03057600|38305376|FG000|Overall Study|Other, Not Specified|1|||
17158338|NCT03057600|38305377|FG001|Overall Study|Other, Not Specified|1|||
17158339|NCT03057600|38305378|FG002|Overall Study|Other, Not Specified|1|||
17158340|NCT03057600|38305379|FG003|Overall Study|Other, Not Specified|1|||
17158341|NCT03371823|38305409|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
17158342|NCT03371823|38305410|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
17158343|NCT02966301|38305425|FG000|Overall Study|Death|2|||
17158344|NCT02966301|38305425|FG000|Overall Study|Withdrawal by Subject|1|||
17158345|NCT03107091|38305429|FG000|Overall Study|Physician Decision|1|||
17158346|NCT03065400|38305443|FG000|Overall Study|Adverse Event|1|||
17078021|NCT00427700|38219587|FG001|Overall Study|Pregnancy|2|||
17078022|NCT00409188|38219596|FG000|Overall Study|Ongoing at data cut-off|383|||
17078023|NCT00409188|38219597|FG001|Overall Study|Ongoing at data cut-off|175|||
17078024|NCT00434954|38219605|FG000|Overall Study|Adverse Event|17|||
17078025|NCT00434954|38219606|FG001|Overall Study|Adverse Event|2|||
17078026|NCT00434954|38219605|FG000|Overall Study|Entry criteria not met|14|||
17078027|NCT00434954|38219606|FG001|Overall Study|Entry criteria not met|16|||
17078028|NCT00434954|38219605|FG000|Overall Study|Lost to Follow-up|0|||
17078029|NCT00434954|38219606|FG001|Overall Study|Lost to Follow-up|1|||
17078030|NCT00434954|38219605|FG000|Overall Study|Physician Decision|6|||
17078031|NCT00434954|38219606|FG001|Overall Study|Physician Decision|3|||
17078032|NCT00434954|38219605|FG000|Overall Study|Protocol Violation|36|||
17078033|NCT00434954|38219606|FG001|Overall Study|Protocol Violation|27|||
17078034|NCT00434954|38219605|FG000|Overall Study|Sponsor decision|1|||
17078035|NCT00434954|38219606|FG001|Overall Study|Sponsor decision|0|||
17078036|NCT00434954|38219605|FG000|Overall Study|Subject decision|8|||
17078037|NCT00434954|38219606|FG001|Overall Study|Subject decision|22|||
17078038|NCT00276484|38219614|FG000|Overall Study|Adverse Event|4|||
17078039|NCT00276484|38219615|FG001|Overall Study|Adverse Event|7|||
16995172|NCT01008410|38138869|FG001|Overall Study|Withdrawal by Subject|2|||
16995173|NCT01008410|38138868|FG000|Overall Study|Lost to Follow-up|1|||
16995174|NCT01008410|38138869|FG001|Overall Study|Lost to Follow-up|0|||
16995175|NCT01008410|38138868|FG000|Overall Study|Noncompliance|1|||
16995176|NCT01008410|38138869|FG001|Overall Study|Noncompliance|0|||
16995177|NCT01008410|38138868|FG000|Overall Study|Low Cortisol|2|||
16995178|NCT01008410|38138869|FG001|Overall Study|Low Cortisol|0|||
16995179|NCT01008410|38138868|FG000|Overall Study|Lack of Efficacy|2|||
17158347|NCT03065400|38305443|FG000|Overall Study|Physician Decision|3|||
16995180|NCT01008410|38138869|FG001|Overall Study|Lack of Efficacy|6|||
17078040|NCT00276484|38219614|FG000|Overall Study|Lost to Follow-up|1|||
17078041|NCT00276484|38219615|FG001|Overall Study|Lost to Follow-up|1|||
17078042|NCT00276484|38219614|FG000|Overall Study|Protocol Violation|0|||
17078043|NCT00276484|38219615|FG001|Overall Study|Protocol Violation|1|||
17078044|NCT00276484|38219614|FG000|Overall Study|Withdrawal by Subject|4|||
16995181|NCT01008410|38138868|FG000|Overall Study|Met Exclusion Criterion|0|||
16995182|NCT01008410|38138869|FG001|Overall Study|Met Exclusion Criterion|1|||
16995183|NCT01023269|38138875|FG000|Overall Study|early termination of the study|2|||
16995184|NCT01023269|38138876|FG001|Overall Study|early termination of the study|0|||
16995185|NCT01007942|38138908|FG000|Overall Study|Adverse Event|29|||
16995186|NCT01007942|38138909|FG001|Overall Study|Adverse Event|14|||
16995187|NCT01007942|38138908|FG000|Overall Study|Abnormal test procedure|0|||
16995188|NCT01007942|38138909|FG001|Overall Study|Abnormal test procedure|1|||
16995189|NCT01007942|38138908|FG000|Overall Study|Disease progression|217|||
16995190|NCT01007942|38138909|FG001|Overall Study|Disease progression|242|||
16995191|NCT01007942|38138908|FG000|Overall Study|New cancer therapy|5|||
16995192|NCT01007942|38138909|FG001|Overall Study|New cancer therapy|1|||
16995193|NCT01007942|38138908|FG000|Overall Study|Protocol Violation|1|||
16995194|NCT01007942|38138909|FG001|Overall Study|Protocol Violation|1|||
16995195|NCT01007942|38138908|FG000|Overall Study|Withdrawal by Subject|19|||
16995196|NCT01007942|38138909|FG001|Overall Study|Withdrawal by Subject|14|||
16995197|NCT01007942|38138908|FG000|Overall Study|Lost to Follow-up|1|||
16995198|NCT01007942|38138909|FG001|Overall Study|Lost to Follow-up|0|||
16995199|NCT01007942|38138908|FG000|Overall Study|Administrative problems|2|||
16995200|NCT01007942|38138909|FG001|Overall Study|Administrative problems|0|||
17078045|NCT00276484|38219615|FG001|Overall Study|Withdrawal by Subject|3|||
17078046|NCT00276484|38219614|FG000|Overall Study|Could not take time off work|0|||
17078047|NCT00276484|38219615|FG001|Overall Study|Could not take time off work|1|||
17078048|NCT00426842|38219621|FG000|Overall Study|Lost to Follow-up|1|||
17078049|NCT00434876|38219629|FG000|Overall Study|Lost to Follow-up|1|||
17078050|NCT00434876|38219630|FG001|Overall Study|Lost to Follow-up|1|||
17078051|NCT00276094|38219639|FG000|Overall Study|Adverse Event|15|||
17078052|NCT00276094|38219640|FG001|Overall Study|Adverse Event|13|||
17078053|NCT00276094|38219641|FG002|Overall Study|Adverse Event|11|||
17078054|NCT00276094|38219639|FG000|Overall Study|Withdrawal by Subject|14|||
17078055|NCT00276094|38219640|FG001|Overall Study|Withdrawal by Subject|14|||
17078056|NCT00276094|38219641|FG002|Overall Study|Withdrawal by Subject|12|||
17078057|NCT00276094|38219639|FG000|Overall Study|Protocol Violation|16|||
17078058|NCT00276094|38219640|FG001|Overall Study|Protocol Violation|7|||
17078059|NCT00276094|38219641|FG002|Overall Study|Protocol Violation|10|||
17078060|NCT00276094|38219639|FG000|Overall Study|Lost to Follow-up|8|||
17078061|NCT00276094|38219640|FG001|Overall Study|Lost to Follow-up|6|||
17078062|NCT00276094|38219641|FG002|Overall Study|Lost to Follow-up|4|||
17078063|NCT00276094|38219639|FG000|Overall Study|Other-Subject moved out of country|1|||
17078064|NCT00276094|38219640|FG001|Overall Study|Other-Subject moved out of country|0|||
17078065|NCT00276094|38219641|FG002|Overall Study|Other-Subject moved out of country|0|||
17078066|NCT00276094|38219639|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
17078067|NCT00276094|38219640|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
17078068|NCT00276094|38219641|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
17078069|NCT00276094|38219639|FG000|Overall Study|Other-Lack of efficacy|1|||
17078070|NCT00276094|38219640|FG001|Overall Study|Other-Lack of efficacy|0|||
17078071|NCT00276094|38219641|FG002|Overall Study|Other-Lack of efficacy|0|||
17078072|NCT00276094|38219639|FG000|Overall Study|Other-Refused follow-up visit|1|||
17078073|NCT00276094|38219640|FG001|Overall Study|Other-Refused follow-up visit|0|||
17078074|NCT00276094|38219641|FG002|Overall Study|Other-Refused follow-up visit|0|||
17078075|NCT00276094|38219639|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
17078076|NCT00276094|38219640|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
17078077|NCT00276094|38219641|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
17158348|NCT03065400|38305443|FG000|Overall Study|Withdrawal by Subject|1|||
17158349|NCT03065400|38305443|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
17158350|NCT03085095|38305449|FG000|Overall Study|Adverse Event|23|||
17158351|NCT03085095|38305450|FG001|Overall Study|Adverse Event|8|||
17078078|NCT00276094|38219639|FG000|Overall Study|Other-Relocation|0|||
17078079|NCT00276094|38219640|FG001|Overall Study|Other-Relocation|1|||
17078080|NCT00276094|38219641|FG002|Overall Study|Other-Relocation|0|||
17078081|NCT00276094|38219639|FG000|Overall Study|Other-Study medication lost|0|||
17078082|NCT00276094|38219640|FG001|Overall Study|Other-Study medication lost|0|||
17078083|NCT00276094|38219641|FG002|Overall Study|Other-Study medication lost|1|||
17078084|NCT00276016|38219655|FG000|Intervention 1|Withdrawal by Subject|0|||
17078085|NCT00276016|38219656|FG001|Intervention 1|Withdrawal by Subject|1|||
17078086|NCT00276016|38219657|FG002|Intervention 1|Withdrawal by Subject|0|||
17078087|NCT00276016|38219658|FG003|Intervention 1|Withdrawal by Subject|0|||
17078088|NCT00276016|38219659|FG004|Intervention 1|Withdrawal by Subject|0|||
17078089|NCT00276016|38219660|FG005|Intervention 1|Withdrawal by Subject|0|||
17078090|NCT00434642|38219671|FG000|Blinded Treatment Phase|Adverse Event|12|||
17078091|NCT00434642|38219672|FG001|Blinded Treatment Phase|Adverse Event|58|||
16995201|NCT01007942|38138908|FG000|Overall Study|Death|3|||
16995202|NCT01007942|38138909|FG001|Overall Study|Death|2|||
16995203|NCT01007942|38138908|FG000|Overall Study|Patients untreated|4|||
16995204|NCT01007942|38138909|FG001|Overall Study|Patients untreated|3|||
17078092|NCT00434642|38219671|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
17078093|NCT00434642|38219672|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
17078094|NCT00434642|38219671|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
17078095|NCT00434642|38219672|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
17078096|NCT00434642|38219671|FG000|Blinded Treatment Phase|Physician Decision|19|||
17078097|NCT00434642|38219672|FG001|Blinded Treatment Phase|Physician Decision|27|||
17078098|NCT00434642|38219671|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
17078099|NCT00434642|38219672|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
17158352|NCT03085095|38305449|FG000|Overall Study|Protocol Violation|0|||
17158353|NCT03085095|38305450|FG001|Overall Study|Protocol Violation|1|||
17158354|NCT03085095|38305449|FG000|Overall Study|Lost to Follow-up|2|||
17078100|NCT00434642|38219671|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
17078101|NCT00434642|38219672|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
17078102|NCT00434642|38219671|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
17078103|NCT00434642|38219672|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
17078104|NCT00434642|38219671|FG000|Open-label Treatment Phase|Adverse Event|0|||
17078105|NCT00434642|38219672|FG001|Open-label Treatment Phase|Adverse Event|5|||
17078106|NCT00434642|38219671|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
17078107|NCT00434642|38219672|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
17078108|NCT00434330|38219684|FG000|Overall Study|Adverse Event|0|||
17078109|NCT00434330|38219685|FG001|Overall Study|Adverse Event|0|||
17078110|NCT00434330|38219686|FG002|Overall Study|Adverse Event|1|||
17078111|NCT00434330|38219687|FG003|Overall Study|Adverse Event|0|||
17078112|NCT00434330|38219688|FG004|Overall Study|Adverse Event|0|||
17078113|NCT00434330|38219689|FG005|Overall Study|Adverse Event|0|||
17078114|NCT00434330|38219684|FG000|Overall Study|Death|1|||
17078115|NCT00434330|38219685|FG001|Overall Study|Death|0|||
17078116|NCT00434330|38219686|FG002|Overall Study|Death|0|||
17078117|NCT00434330|38219687|FG003|Overall Study|Death|0|||
17078118|NCT00434330|38219688|FG004|Overall Study|Death|1|||
17078119|NCT00434330|38219689|FG005|Overall Study|Death|1|||
17078120|NCT00434330|38219684|FG000|Overall Study|Withdrawal by Subject|0|||
17078121|NCT00434330|38219685|FG001|Overall Study|Withdrawal by Subject|0|||
17078122|NCT00434330|38219686|FG002|Overall Study|Withdrawal by Subject|1|||
17078123|NCT00434330|38219687|FG003|Overall Study|Withdrawal by Subject|1|||
17078124|NCT00434330|38219688|FG004|Overall Study|Withdrawal by Subject|0|||
17078125|NCT00434330|38219689|FG005|Overall Study|Withdrawal by Subject|0|||
17078126|NCT00434330|38219684|FG000|Overall Study|Renal transplant|0|||
17078127|NCT00434330|38219685|FG001|Overall Study|Renal transplant|0|||
17078128|NCT00434330|38219686|FG002|Overall Study|Renal transplant|0|||
17078129|NCT00434330|38219687|FG003|Overall Study|Renal transplant|1|||
17078130|NCT00434330|38219688|FG004|Overall Study|Renal transplant|0|||
17078131|NCT00434330|38219689|FG005|Overall Study|Renal transplant|0|||
17078132|NCT00434330|38219684|FG000|Overall Study|Subject Not Compliant With Study|0|||
17078133|NCT00434330|38219685|FG001|Overall Study|Subject Not Compliant With Study|0|||
17078134|NCT00434330|38219686|FG002|Overall Study|Subject Not Compliant With Study|1|||
17158355|NCT03085095|38305450|FG001|Overall Study|Lost to Follow-up|1|||
17078135|NCT00434330|38219687|FG003|Overall Study|Subject Not Compliant With Study|0|||
17078136|NCT00434330|38219688|FG004|Overall Study|Subject Not Compliant With Study|0|||
17078137|NCT00434330|38219689|FG005|Overall Study|Subject Not Compliant With Study|0|||
17078138|NCT00426764|38219703|FG000|Overall Study|Protocol Violation|1|||
17078139|NCT00426764|38219703|FG000|Overall Study|Withdrawal by Subject|4|||
17078140|NCT00426764|38219703|FG000|Overall Study|Physician Decision|6|||
17078141|NCT00426764|38219703|FG000|Overall Study|Compassionate Use|1|||
17078142|NCT00426764|38219703|FG000|Overall Study|Progressive Disease|83|||
17078143|NCT00426764|38219703|FG000|Overall Study|Adverse Event|24|||
17078144|NCT00426764|38219703|FG000|Overall Study|Other|1|||
17078145|NCT00426764|38219703|FG000|Overall Study|Death|1|||
17078146|NCT00426764|38219703|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
17078147|NCT00434252|38219715|FG000|Overall Study|Lack of Efficacy|50|||
17078148|NCT00434252|38219716|FG001|Overall Study|Lack of Efficacy|100|||
17158356|NCT03085095|38305449|FG000|Overall Study|Withdrawal by Subject|17|||
17158357|NCT03085095|38305450|FG001|Overall Study|Withdrawal by Subject|6|||
17158358|NCT03085095|38305449|FG000|Overall Study|Physician Decision|9|||
17158359|NCT03085095|38305450|FG001|Overall Study|Physician Decision|3|||
17158360|NCT03085095|38305449|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
17158361|NCT03085095|38305450|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
17158362|NCT03085095|38305449|FG000|Overall Study|Did not Receive Study Drug|2|||
17158363|NCT03085095|38305450|FG001|Overall Study|Did not Receive Study Drug|2|||
17158364|NCT03085095|38305449|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
17158365|NCT03085095|38305450|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
17158366|NCT04097301|38305459|FG000|Overall Study|Death|1|||
17158367|NCT04097301|38305459|FG000|Overall Study|Withdrawal by Subject|1|||
17158368|NCT04097301|38305459|FG000|Overall Study|Screening Failure|5|||
17078149|NCT00434252|38219715|FG000|Overall Study|Adverse Event|6|||
17078150|NCT00434252|38219716|FG001|Overall Study|Adverse Event|13|||
17078151|NCT00434252|38219715|FG000|Overall Study|Death|1|||
17078152|NCT00434252|38219716|FG001|Overall Study|Death|2|||
17078153|NCT00434252|38219715|FG000|Overall Study|Lost to Follow-up|0|||
17078154|NCT00434252|38219716|FG001|Overall Study|Lost to Follow-up|1|||
17078155|NCT00434252|38219715|FG000|Overall Study|Physician Decision|4|||
17078156|NCT00434252|38219716|FG001|Overall Study|Physician Decision|8|||
17078157|NCT00434252|38219715|FG000|Overall Study|Withdrawal by Subject|3|||
17078158|NCT00434252|38219716|FG001|Overall Study|Withdrawal by Subject|7|||
17078159|NCT00425750|38219722|FG000|Overall Study|Death|1|||
17078160|NCT00425750|38219722|FG000|Overall Study|Withdrawal by Subject|3|||
17078161|NCT00425750|38219722|FG000|Overall Study|Adverse Event|3|||
17078162|NCT00425750|38219722|FG000|Overall Study|Progression of disease|18|||
17078163|NCT00414908|38219728|FG000|Overall Study|Protocol Violation|1|||
17078164|NCT00414908|38219729|FG001|Overall Study|Protocol Violation|1|||
17078165|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Adverse Event|30|||
17078166|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Adverse Event|25|||
17078167|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Adverse Event|23|||
17078168|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Adverse Event|14|||
17078169|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Death|0|||
17078170|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Death|0|||
17078171|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Death|1|||
17078172|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Death|0|||
17078173|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Physician Decision|0|||
17078174|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Physician Decision|1|||
17078175|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Physician Decision|0|||
17078176|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Physician Decision|1|||
17078177|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
17078178|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
17078179|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
17078180|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
17078181|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Other|6|||
17078182|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Other|1|||
17078183|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Other|0|||
17078184|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Other|2|||
17078185|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
17078186|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
17078187|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
17078188|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
17078189|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
17078190|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
17078191|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
17078192|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
17078193|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
17078194|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
17078195|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
17158369|NCT02276547|38305465|FG000|Overall Study|Death|2|||
17158370|NCT02276547|38305465|FG000|Overall Study|Explant|2|||
17158371|NCT02966834|38305475|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
17158372|NCT02966834|38305476|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
17158373|NCT02966834|38305477|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
17158374|NCT02966834|38305478|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
17158375|NCT02966834|38305479|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
17158376|NCT02966834|38305480|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
17158377|NCT02966834|38305475|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
17158378|NCT02966834|38305476|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
17158379|NCT02966834|38305477|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
17158380|NCT02966834|38305478|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
17158381|NCT02966834|38305479|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
17158382|NCT02966834|38305480|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
17158383|NCT02966834|38305475|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
17158384|NCT02966834|38305476|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
16995205|NCT01023035|38138922|FG000|Treatment Period|Adverse Event|27|||
16995206|NCT01023035|38138923|FG001|Treatment Period|Adverse Event|32|||
16995207|NCT01023035|38138924|FG002|Treatment Period|Adverse Event|50|||
16995208|NCT01023035|38138922|FG000|Treatment Period|Non-Medical Reasons|19|||
16995209|NCT01023035|38138923|FG001|Treatment Period|Non-Medical Reasons|22|||
16995210|NCT01023035|38138924|FG002|Treatment Period|Non-Medical Reasons|44|||
16995211|NCT01023035|38138922|FG000|Treatment Period|Treatment Failure|26|||
16995212|NCT01023035|38138923|FG001|Treatment Period|Treatment Failure|31|||
16995213|NCT01023035|38138924|FG002|Treatment Period|Treatment Failure|24|||
16995214|NCT01023035|38138922|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
16995215|NCT01023035|38138923|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
16995216|NCT01023035|38138924|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
16995217|NCT01023035|38138922|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
17158385|NCT02966834|38305477|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
17158386|NCT02966834|38305478|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
17078196|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
17078197|NCT00242710|38219741|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
17078198|NCT00242710|38219742|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
17078199|NCT00242710|38219743|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
17158387|NCT02966834|38305479|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
17158388|NCT02966834|38305480|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
17158389|NCT02966834|38305475|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
17158390|NCT02966834|38305476|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
17158391|NCT02966834|38305477|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
17158392|NCT02966834|38305478|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
17078200|NCT00242710|38219744|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
17078201|NCT00242710|38219741|FG000|Period Between Core Study and Extension|Adverse Event|2|||
17158393|NCT02966834|38305479|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
17158394|NCT02966834|38305480|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
17158395|NCT02966834|38305475|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
17158396|NCT02966834|38305476|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
17158397|NCT02966834|38305477|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
17158398|NCT02966834|38305478|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
17158399|NCT02966834|38305479|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
17158400|NCT02966834|38305480|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
17158401|NCT02966834|38305475|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
17158402|NCT02966834|38305476|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
17158403|NCT02966834|38305477|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
17158404|NCT02966834|38305478|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
17158405|NCT02966834|38305479|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
17158406|NCT02966834|38305480|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
17158407|NCT03106077|38305529|FG000|Overall Study|Screen Failure|94|||
17158408|NCT03106077|38305530|FG001|Overall Study|Screen Failure|0|||
17158409|NCT03105297|38305535|FG000|Baseline Phase (Day 1)|Other|21|||
17158410|NCT03105297|38305535|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
17158411|NCT03105297|38305535|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
17158412|NCT03426995|38305565|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158413|NCT03426995|38305566|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17078202|NCT00242710|38219742|FG001|Period Between Core Study and Extension|Adverse Event|3|||
17078203|NCT00242710|38219743|FG002|Period Between Core Study and Extension|Adverse Event|5|||
17078204|NCT00242710|38219744|FG003|Period Between Core Study and Extension|Adverse Event|2|||
17078205|NCT00242710|38219741|FG000|Period Between Core Study and Extension|Physician Decision|1|||
17078206|NCT00242710|38219742|FG001|Period Between Core Study and Extension|Physician Decision|1|||
17078207|NCT00242710|38219743|FG002|Period Between Core Study and Extension|Physician Decision|0|||
17078208|NCT00242710|38219744|FG003|Period Between Core Study and Extension|Physician Decision|0|||
17078209|NCT00242710|38219741|FG000|Period Between Core Study and Extension|Other|24|||
17078210|NCT00242710|38219742|FG001|Period Between Core Study and Extension|Other|24|||
17078211|NCT00242710|38219743|FG002|Period Between Core Study and Extension|Other|9|||
17078212|NCT00242710|38219744|FG003|Period Between Core Study and Extension|Other|11|||
17078213|NCT00242710|38219741|FG000|Period Between Core Study and Extension|Extension not Available|17|||
17078214|NCT00242710|38219742|FG001|Period Between Core Study and Extension|Extension not Available|21|||
17078215|NCT00242710|38219743|FG002|Period Between Core Study and Extension|Extension not Available|8|||
17078216|NCT00242710|38219744|FG003|Period Between Core Study and Extension|Extension not Available|7|||
17078217|NCT00242710|38219741|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
17078218|NCT00242710|38219742|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
17078219|NCT00242710|38219743|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
17078220|NCT00242710|38219744|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
17078221|NCT00242710|38219741|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
17078222|NCT00242710|38219742|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
17158414|NCT03426995|38305567|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
17158415|NCT03426995|38305568|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158416|NCT03426995|38305569|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158417|NCT03426995|38305570|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158418|NCT03426995|38305571|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158419|NCT03426995|38305572|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158420|NCT03426995|38305573|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158421|NCT03426995|38305574|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158422|NCT03426995|38305575|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158423|NCT03426995|38305576|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158424|NCT03426995|38305577|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158425|NCT03426995|38305578|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158426|NCT03426995|38305579|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158427|NCT03426995|38305580|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17078223|NCT00242710|38219743|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
17078224|NCT00242710|38219744|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
17078225|NCT00242710|38219741|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
17078226|NCT00242710|38219742|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
17078227|NCT00242710|38219743|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
17078228|NCT00242710|38219744|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
17078229|NCT00242710|38219741|FG000|Study Extension (up to Year 2)|Death|0|||
17078230|NCT00242710|38219742|FG001|Study Extension (up to Year 2)|Death|0|||
17078231|NCT00242710|38219743|FG002|Study Extension (up to Year 2)|Death|0|||
17078232|NCT00242710|38219744|FG003|Study Extension (up to Year 2)|Death|1|||
17078233|NCT00242710|38219741|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
17078234|NCT00242710|38219742|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
17158428|NCT03426995|38305581|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158429|NCT03426995|38305582|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158430|NCT03426995|38305583|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
17158431|NCT03426995|38305565|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158432|NCT03426995|38305566|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158433|NCT03426995|38305567|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158434|NCT03426995|38305568|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158435|NCT03426995|38305569|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158436|NCT03426995|38305570|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
17158437|NCT03426995|38305571|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158438|NCT03426995|38305572|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158439|NCT03426995|38305573|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158440|NCT03426995|38305574|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158441|NCT03426995|38305575|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158442|NCT03426995|38305576|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158443|NCT03426995|38305577|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158444|NCT03426995|38305578|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17078235|NCT00242710|38219743|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
17078236|NCT00242710|38219744|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
17078237|NCT00242710|38219741|FG000|Study Extension (up to Year 2)|Other|3|||
17078238|NCT00242710|38219742|FG001|Study Extension (up to Year 2)|Other|5|||
17078239|NCT00242710|38219743|FG002|Study Extension (up to Year 2)|Other|4|||
17078240|NCT00242710|38219744|FG003|Study Extension (up to Year 2)|Other|3|||
17078241|NCT00242710|38219741|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
17078242|NCT00242710|38219742|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
17078243|NCT00242710|38219743|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
17078244|NCT00242710|38219744|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
17078245|NCT00242710|38219741|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
17078246|NCT00242710|38219742|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
17078247|NCT00242710|38219743|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
17078248|NCT00242710|38219744|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
17078249|NCT00408876|38219758|FG000|Overall Study|Adverse Event|9|||
17078250|NCT00408876|38219759|FG001|Overall Study|Adverse Event|17|||
17078251|NCT00408876|38219760|FG002|Overall Study|Adverse Event|27|||
17078252|NCT00408876|38219761|FG003|Overall Study|Adverse Event|10|||
17078253|NCT00408876|38219758|FG000|Overall Study|Withdrawal by Subject|3|||
17078254|NCT00408876|38219759|FG001|Overall Study|Withdrawal by Subject|6|||
17078255|NCT00408876|38219760|FG002|Overall Study|Withdrawal by Subject|6|||
17078256|NCT00408876|38219761|FG003|Overall Study|Withdrawal by Subject|14|||
17078257|NCT00408876|38219758|FG000|Overall Study|Lack of Efficacy|2|||
17078258|NCT00408876|38219759|FG001|Overall Study|Lack of Efficacy|4|||
17078259|NCT00408876|38219760|FG002|Overall Study|Lack of Efficacy|5|||
17078260|NCT00408876|38219761|FG003|Overall Study|Lack of Efficacy|6|||
17078261|NCT00408876|38219758|FG000|Overall Study|Lost to Follow-up|1|||
17078262|NCT00408876|38219759|FG001|Overall Study|Lost to Follow-up|6|||
17078263|NCT00408876|38219760|FG002|Overall Study|Lost to Follow-up|5|||
17078264|NCT00408876|38219761|FG003|Overall Study|Lost to Follow-up|2|||
17078265|NCT00408876|38219758|FG000|Overall Study|Protocol Violation|0|||
17078266|NCT00408876|38219759|FG001|Overall Study|Protocol Violation|3|||
17078267|NCT00408876|38219760|FG002|Overall Study|Protocol Violation|4|||
17078268|NCT00408876|38219761|FG003|Overall Study|Protocol Violation|3|||
17078269|NCT00408876|38219758|FG000|Overall Study|Physician Decision|1|||
17078270|NCT00408876|38219759|FG001|Overall Study|Physician Decision|0|||
17078271|NCT00408876|38219760|FG002|Overall Study|Physician Decision|3|||
17078272|NCT00408876|38219761|FG003|Overall Study|Physician Decision|0|||
17078273|NCT00240994|38219771|FG000|Overall Study|Lost to Follow-up|1|||
17078274|NCT00240994|38219771|FG000|Overall Study|Protocol Violation|1|||
17078275|NCT00240994|38219771|FG000|Overall Study|Graft failure|1|||
17078276|NCT00239590|38219775|FG000|Randomized|Lost to Follow-up|0|||
17078277|NCT00239590|38219776|FG001|Randomized|Lost to Follow-up|1|||
17078278|NCT00239590|38219775|FG000|Randomized|Withdrawal by Subject|0|||
17078279|NCT00239590|38219776|FG001|Randomized|Withdrawal by Subject|1|||
17078280|NCT00239590|38219775|FG000|Completed Study Protocol|Adverse Event|1|||
17078281|NCT00239590|38219776|FG001|Completed Study Protocol|Adverse Event|1|||
17078282|NCT00239590|38219775|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
17078283|NCT00239590|38219776|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
17078284|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
17078285|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
17078286|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Death|0|||
17078287|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Death|0|||
17078288|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
17078289|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
17078290|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
17078291|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
17078292|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
17078293|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
17078294|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
17078295|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
17078296|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
17078297|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
17078298|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
17078299|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
17078300|NCT00433160|38219786|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
17078301|NCT00433160|38219787|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
17078302|NCT00433160|38219786|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
17078303|NCT00433160|38219787|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
17078304|NCT00433160|38219786|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
17078305|NCT00433160|38219787|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
17158445|NCT03426995|38305579|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158446|NCT03426995|38305580|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158447|NCT03426995|38305581|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158448|NCT03426995|38305582|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158449|NCT03426995|38305583|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
17158450|NCT03426995|38305565|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158451|NCT03426995|38305566|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158452|NCT03426995|38305567|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158453|NCT03426995|38305568|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158454|NCT03426995|38305569|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
17158455|NCT03426995|38305570|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
17158456|NCT03426995|38305571|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158457|NCT03426995|38305572|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158458|NCT03426995|38305573|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158459|NCT03426995|38305574|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158460|NCT03426995|38305575|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158461|NCT03426995|38305576|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158462|NCT03426995|38305577|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158463|NCT03426995|38305578|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158464|NCT03426995|38305579|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158465|NCT03426995|38305580|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158466|NCT03426995|38305581|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158467|NCT03426995|38305582|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158468|NCT03426995|38305583|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
17158469|NCT03426995|38305565|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158470|NCT03426995|38305566|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158471|NCT03426995|38305567|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158472|NCT03426995|38305568|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17078306|NCT00433160|38219786|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
17078307|NCT00433160|38219787|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
17078308|NCT00433160|38219786|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
17078309|NCT00433160|38219787|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
17158473|NCT03426995|38305569|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158474|NCT03426995|38305570|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17078310|NCT00433160|38219786|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
17078311|NCT00433160|38219787|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
17078312|NCT00433160|38219786|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
17078313|NCT00433160|38219787|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
17078314|NCT00433160|38219786|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
17078315|NCT00433160|38219787|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
17078316|NCT00239356|38219799|FG000|Overall Study|Lack of Efficacy|1|||
17078317|NCT00239356|38219800|FG001|Overall Study|Lack of Efficacy|0|||
17078318|NCT00239356|38219799|FG000|Overall Study|Adverse Event|6|||
17078319|NCT00239356|38219800|FG001|Overall Study|Adverse Event|0|||
17078320|NCT00239356|38219799|FG000|Overall Study|Withdrawal by Subject|15|||
17078321|NCT00239356|38219800|FG001|Overall Study|Withdrawal by Subject|6|||
17158475|NCT03426995|38305571|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158476|NCT03426995|38305572|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158477|NCT03426995|38305573|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158478|NCT03426995|38305574|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158479|NCT03426995|38305575|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
17158480|NCT03426995|38305576|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158481|NCT03426995|38305577|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158482|NCT03426995|38305578|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158483|NCT03426995|38305579|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158484|NCT03426995|38305580|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158485|NCT03426995|38305581|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158486|NCT03426995|38305582|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158487|NCT03426995|38305583|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
17158488|NCT03426995|38305565|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158489|NCT03426995|38305566|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158490|NCT03426995|38305567|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158491|NCT03426995|38305568|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158492|NCT03426995|38305569|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158493|NCT03426995|38305570|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158494|NCT03426995|38305571|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158495|NCT03426995|38305572|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
17158496|NCT03426995|38305573|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158497|NCT03426995|38305574|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158498|NCT03426995|38305575|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158499|NCT03426995|38305576|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158500|NCT03426995|38305577|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158501|NCT03426995|38305578|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158502|NCT03426995|38305579|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158503|NCT03426995|38305580|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158504|NCT03426995|38305581|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158505|NCT03426995|38305582|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158506|NCT03426995|38305583|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
17158507|NCT03426995|38305565|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158508|NCT03426995|38305566|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158509|NCT03426995|38305567|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158510|NCT03426995|38305568|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17078322|NCT00239356|38219799|FG000|Overall Study|Lost to Follow-up|3|||
17078323|NCT00239356|38219800|FG001|Overall Study|Lost to Follow-up|0|||
17078324|NCT00239356|38219799|FG000|Overall Study|poor/non-compliance|2|||
17078325|NCT00239356|38219800|FG001|Overall Study|poor/non-compliance|0|||
17078326|NCT00239356|38219799|FG000|Overall Study|Pregnancy|1|||
17078327|NCT00239356|38219800|FG001|Overall Study|Pregnancy|0|||
17078328|NCT00239356|38219799|FG000|Overall Study|Administrative reason|0|||
17078329|NCT00239356|38219800|FG001|Overall Study|Administrative reason|1|||
17078330|NCT00239356|38219799|FG000|Overall Study|Drug available on market|11|||
17078331|NCT00239356|38219800|FG001|Overall Study|Drug available on market|2|||
17078332|NCT00393510|38219808|FG000|Overall Study|Physician Decision|3|||
17078333|NCT00393510|38219809|FG001|Overall Study|Physician Decision|9|||
17078334|NCT00425438|38219817|FG000|Overall Study|Termination by Sponsor|25|||
17078335|NCT00425438|38219818|FG001|Overall Study|Termination by Sponsor|27|||
17078336|NCT00275002|38219826|FG000|Overall Study|Death|1|||
17078337|NCT00275002|38219827|FG001|Overall Study|Death|0|||
17078338|NCT00275002|38219826|FG000|Overall Study|Disease progression|21|||
17078339|NCT00275002|38219827|FG001|Overall Study|Disease progression|15|||
17078340|NCT00275002|38219826|FG000|Overall Study|Adverse Event|0|||
17078341|NCT00275002|38219827|FG001|Overall Study|Adverse Event|1|||
17078342|NCT00433004|38219835|FG000|Overall Study|Lost to Follow-up|5|||
17078343|NCT00433004|38219836|FG001|Overall Study|Lost to Follow-up|7|||
17078344|NCT00238264|38219842|FG000|Overall Study|Death|7|||
17078345|NCT00238264|38219842|FG000|Overall Study|Lost to Follow-up|18|||
17078346|NCT00238264|38219842|FG000|Overall Study|Withdrawal by Subject|4|||
17078347|NCT00238264|38219842|FG000|Overall Study|Ineligible|7|||
17078348|NCT00414596|38219846|FG000|Overall Study|Protocol Violation|2|||
17078349|NCT00393042|38219850|FG000|First Intervention|Withdrawal by Subject|1|||
17078350|NCT00393042|38219851|FG001|First Intervention|Withdrawal by Subject|2|||
17078351|NCT00393042|38219850|FG000|First Intervention|Lost to Follow-up|3|||
17078352|NCT00393042|38219851|FG001|First Intervention|Lost to Follow-up|3|||
17078353|NCT00393042|38219850|FG000|First Intervention|Protocol Violation|1|||
17078354|NCT00393042|38219851|FG001|First Intervention|Protocol Violation|0|||
17078355|NCT00393042|38219850|FG000|First Intervention|Adverse Event|0|||
17078356|NCT00393042|38219851|FG001|First Intervention|Adverse Event|1|||
17158511|NCT03426995|38305569|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158512|NCT03426995|38305570|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158513|NCT03426995|38305571|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158514|NCT03426995|38305572|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158515|NCT03426995|38305573|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158516|NCT03426995|38305574|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17078357|NCT00393042|38219850|FG000|Second Intervetion|Adverse Event|0|||
17078358|NCT00393042|38219851|FG001|Second Intervetion|Adverse Event|3|||
17078359|NCT00393042|38219850|FG000|Second Intervetion|Withdrawal by Subject|0|||
17158517|NCT03426995|38305575|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158518|NCT03426995|38305576|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158519|NCT03426995|38305577|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158520|NCT03426995|38305578|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158521|NCT03426995|38305579|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
17158522|NCT03426995|38305580|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
17158523|NCT03426995|38305581|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158524|NCT03426995|38305582|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158525|NCT03426995|38305583|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
17158526|NCT03426995|38305565|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158527|NCT03426995|38305566|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158528|NCT03426995|38305567|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158529|NCT03426995|38305568|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158530|NCT03426995|38305569|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158531|NCT03426995|38305570|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17078360|NCT00393042|38219851|FG001|Second Intervetion|Withdrawal by Subject|2|||
17078361|NCT00393042|38219850|FG000|Second Intervetion|Lack of Efficacy|1|||
17078362|NCT00393042|38219851|FG001|Second Intervetion|Lack of Efficacy|0|||
17078363|NCT00393042|38219850|FG000|Second Intervetion|Lost to Follow-up|0|||
17158532|NCT03426995|38305571|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158533|NCT03426995|38305572|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158534|NCT03426995|38305573|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158535|NCT03426995|38305574|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17078364|NCT00393042|38219851|FG001|Second Intervetion|Lost to Follow-up|2|||
17078365|NCT00393042|38219850|FG000|Second Intervetion|Protocol Violation|1|||
17078366|NCT00393042|38219851|FG001|Second Intervetion|Protocol Violation|1|||
17158536|NCT03426995|38305575|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158537|NCT03426995|38305576|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17078367|NCT00392808|38219909|FG000|Overall Study|Lost to Follow-up|3|||
17078368|NCT00392808|38219910|FG001|Overall Study|Lost to Follow-up|2|||
17078369|NCT00392808|38219911|FG002|Overall Study|Lost to Follow-up|1|||
17078370|NCT00392808|38219912|FG003|Overall Study|Lost to Follow-up|2|||
17078371|NCT00392808|38219909|FG000|Overall Study|Unable to withdraw blood|3|||
17078372|NCT00392808|38219910|FG001|Overall Study|Unable to withdraw blood|1|||
17078373|NCT00392808|38219911|FG002|Overall Study|Unable to withdraw blood|1|||
17078374|NCT00392808|38219912|FG003|Overall Study|Unable to withdraw blood|2|||
17078375|NCT00274924|38219934|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
17078376|NCT00274924|38219935|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
17078377|NCT00274924|38219936|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
17078378|NCT00274924|38219934|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
17078379|NCT00274924|38219935|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
17078380|NCT00274924|38219936|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
17078381|NCT00274924|38219934|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
17078382|NCT00274924|38219935|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
17078383|NCT00274924|38219936|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
17078384|NCT00274924|38219934|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
17078385|NCT00274924|38219935|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
17078386|NCT00274924|38219936|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
17078387|NCT00274924|38219934|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
17078388|NCT00274924|38219935|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
17078389|NCT00274924|38219936|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
17078390|NCT00274924|38219934|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
17078391|NCT00274924|38219935|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
17078392|NCT00274924|38219936|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
17078393|NCT00274924|38219934|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
17078394|NCT00274924|38219935|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
17078395|NCT00274924|38219936|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
17078396|NCT00274924|38219934|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
17078397|NCT00274924|38219935|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
17158538|NCT03426995|38305577|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158539|NCT03426995|38305578|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158540|NCT03426995|38305579|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
17158541|NCT03426995|38305580|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
17158542|NCT03426995|38305581|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158543|NCT03426995|38305582|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158544|NCT03426995|38305583|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
17158545|NCT03424265|38305632|FG000|Overall Study|screening failure|1|||
17158546|NCT03424265|38305633|FG001|Overall Study|screening failure|0|||
17158547|NCT03424265|38305632|FG000|Overall Study|Withdrawal by Subject|0|||
17158548|NCT03424265|38305633|FG001|Overall Study|Withdrawal by Subject|2|||
17158549|NCT03322566|38305642|FG000|Overall Study|Death|34|||
17158550|NCT03322566|38305643|FG001|Overall Study|Death|35|||
17158551|NCT03322566|38305644|FG002|Overall Study|Death|23|||
17158552|NCT03322566|38305642|FG000|Overall Study|Physician Decision|6|||
17158553|NCT03322566|38305643|FG001|Overall Study|Physician Decision|7|||
17158554|NCT03322566|38305644|FG002|Overall Study|Physician Decision|2|||
17158555|NCT03322566|38305642|FG000|Overall Study|Withdrawal by Subject|4|||
17158556|NCT03322566|38305643|FG001|Overall Study|Withdrawal by Subject|3|||
17158557|NCT03322566|38305644|FG002|Overall Study|Withdrawal by Subject|6|||
17158558|NCT03322566|38305642|FG000|Overall Study|Lost to Follow-up|0|||
17158559|NCT03322566|38305643|FG001|Overall Study|Lost to Follow-up|0|||
17158560|NCT03322566|38305644|FG002|Overall Study|Lost to Follow-up|1|||
17158561|NCT03322566|38305642|FG000|Overall Study|Study terminated by sponsor|1|||
17158562|NCT03322566|38305643|FG001|Overall Study|Study terminated by sponsor|0|||
17158563|NCT03322566|38305644|FG002|Overall Study|Study terminated by sponsor|1|||
17158564|NCT02969018|38305660|FG000|Overall Study|Adverse Event|2|||
17158565|NCT02969018|38305661|FG001|Overall Study|Adverse Event|4|||
17158566|NCT02969018|38305662|FG002|Overall Study|Adverse Event|1|||
17158567|NCT02969018|38305663|FG003|Overall Study|Adverse Event|2|||
17158568|NCT02969018|38305664|FG004|Overall Study|Adverse Event|0|||
17158569|NCT02969018|38305665|FG005|Overall Study|Adverse Event|1|||
17158570|NCT02969018|38305666|FG006|Overall Study|Adverse Event|2|||
17158571|NCT02969018|38305667|FG007|Overall Study|Adverse Event|0|||
17158572|NCT02969018|38305660|FG000|Overall Study|Lack of Efficacy|0|||
17158573|NCT02969018|38305661|FG001|Overall Study|Lack of Efficacy|1|||
17078398|NCT00274924|38219936|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
17078399|NCT00274924|38219934|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
17078400|NCT00274924|38219935|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
17078401|NCT00274924|38219936|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
17078402|NCT00274924|38219934|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
17078403|NCT00274924|38219935|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
17158574|NCT02969018|38305662|FG002|Overall Study|Lack of Efficacy|0|||
17158575|NCT02969018|38305663|FG003|Overall Study|Lack of Efficacy|0|||
17158576|NCT02969018|38305664|FG004|Overall Study|Lack of Efficacy|1|||
17158577|NCT02969018|38305665|FG005|Overall Study|Lack of Efficacy|1|||
17158578|NCT02969018|38305666|FG006|Overall Study|Lack of Efficacy|1|||
17158579|NCT02969018|38305667|FG007|Overall Study|Lack of Efficacy|1|||
17158580|NCT02969018|38305660|FG000|Overall Study|Lost to Follow-up|1|||
17158581|NCT02969018|38305661|FG001|Overall Study|Lost to Follow-up|2|||
17158582|NCT02969018|38305662|FG002|Overall Study|Lost to Follow-up|2|||
17158583|NCT02969018|38305663|FG003|Overall Study|Lost to Follow-up|0|||
17158584|NCT02969018|38305664|FG004|Overall Study|Lost to Follow-up|1|||
17158585|NCT02969018|38305665|FG005|Overall Study|Lost to Follow-up|1|||
17078404|NCT00274924|38219936|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
17078405|NCT00274924|38219934|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
17078406|NCT00274924|38219935|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
17078407|NCT00274924|38219936|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
17078408|NCT00274924|38219934|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
17158586|NCT02969018|38305666|FG006|Overall Study|Lost to Follow-up|0|||
17158587|NCT02969018|38305667|FG007|Overall Study|Lost to Follow-up|1|||
17158588|NCT02969018|38305660|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
17158589|NCT02969018|38305661|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
17158590|NCT02969018|38305662|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
17078409|NCT00274924|38219935|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
17078410|NCT00274924|38219936|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
17078411|NCT00274924|38219934|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
17078412|NCT00274924|38219935|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
17078413|NCT00274924|38219936|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
17078414|NCT00274846|38219943|FG000|Overall Study|Did not receive adequate NK cells|1|||
17078415|NCT00237796|38219950|FG000|Overall Study|Baseline and one other ILSS required|10|||
17078416|NCT00237796|38219951|FG001|Overall Study|Baseline and one other ILSS required|5|||
17078417|NCT00414440|38219960|FG000|Core Period|Withdrawal by Subject|70|||
17078418|NCT00414440|38219961|FG001|Core Period|Withdrawal by Subject|32|||
17078419|NCT00414440|38219960|FG000|Extension Period|Lost to Follow-up|44|||
17078420|NCT00414440|38219961|FG001|Extension Period|Lost to Follow-up|52|||
17078421|NCT00414440|38219960|FG000|Extension Period|Did not consent to continue follow up|61|||
17078422|NCT00414440|38219961|FG001|Extension Period|Did not consent to continue follow up|54|||
17078423|NCT00414440|38219960|FG000|Extension Period|Other|1|||
17078424|NCT00414440|38219961|FG001|Extension Period|Other|1|||
17078425|NCT00414440|38219960|FG000|Extension Period|Administrative|16|||
17078426|NCT00414440|38219961|FG001|Extension Period|Administrative|16|||
17078427|NCT00414440|38219960|FG000|Extension Period|Death|1|||
17078428|NCT00414440|38219961|FG001|Extension Period|Death|2|||
17078429|NCT00414440|38219960|FG000|Extension Period|Withdrawal by Subject|9|||
17078430|NCT00414440|38219961|FG001|Extension Period|Withdrawal by Subject|7|||
17078431|NCT00414440|38219960|FG000|Extension Period|Not included in follow up period|18|||
17078432|NCT00414440|38219961|FG001|Extension Period|Not included in follow up period|8|||
17078433|NCT00209560|38219969|FG000|Overall Study|Lack of Efficacy|1|||
17078434|NCT00209560|38219970|FG001|Overall Study|Lack of Efficacy|0|||
17078435|NCT00236080|38219981|FG000|Overall Study|Adverse Event|0|||
17078436|NCT00236080|38219982|FG001|Overall Study|Adverse Event|0|||
17078437|NCT00236080|38219983|FG002|Overall Study|Adverse Event|3|||
17078438|NCT00236080|38219984|FG003|Overall Study|Adverse Event|1|||
17078439|NCT00236080|38219985|FG004|Overall Study|Adverse Event|0|||
17078440|NCT00236080|38219981|FG000|Overall Study|Lost to Follow-up|0|||
17078441|NCT00236080|38219982|FG001|Overall Study|Lost to Follow-up|1|||
17078442|NCT00236080|38219983|FG002|Overall Study|Lost to Follow-up|0|||
17078443|NCT00236080|38219984|FG003|Overall Study|Lost to Follow-up|0|||
17078444|NCT00236080|38219985|FG004|Overall Study|Lost to Follow-up|0|||
17078445|NCT00236080|38219981|FG000|Overall Study|Physician Decision|1|||
17158591|NCT02969018|38305663|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
17158592|NCT02969018|38305664|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
17158593|NCT02969018|38305665|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
17158594|NCT02969018|38305666|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
17158595|NCT02969018|38305667|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
17158596|NCT02969018|38305660|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17158597|NCT02969018|38305661|FG001|Overall Study|Non-Compliance With Study Drug|0|||
17158598|NCT02969018|38305662|FG002|Overall Study|Non-Compliance With Study Drug|0|||
17158599|NCT02969018|38305663|FG003|Overall Study|Non-Compliance With Study Drug|0|||
17078446|NCT00236080|38219982|FG001|Overall Study|Physician Decision|0|||
17078447|NCT00236080|38219983|FG002|Overall Study|Physician Decision|1|||
17078448|NCT00236080|38219984|FG003|Overall Study|Physician Decision|1|||
17078449|NCT00236080|38219985|FG004|Overall Study|Physician Decision|1|||
17078450|NCT00236080|38219981|FG000|Overall Study|Withdrawal by Subject|1|||
17078451|NCT00236080|38219982|FG001|Overall Study|Withdrawal by Subject|0|||
17078452|NCT00236080|38219983|FG002|Overall Study|Withdrawal by Subject|0|||
17078453|NCT00236080|38219984|FG003|Overall Study|Withdrawal by Subject|0|||
17078454|NCT00236080|38219985|FG004|Overall Study|Withdrawal by Subject|0|||
17078455|NCT00236080|38219981|FG000|Overall Study|Miscellaneous|0|||
17078456|NCT00236080|38219982|FG001|Overall Study|Miscellaneous|0|||
17078457|NCT00236080|38219983|FG002|Overall Study|Miscellaneous|1|||
17078458|NCT00236080|38219984|FG003|Overall Study|Miscellaneous|0|||
17078459|NCT00236080|38219985|FG004|Overall Study|Miscellaneous|0|||
17078460|NCT00432380|38220000|FG000|Overall Study|Migrated/moved from study area|3|||
17078461|NCT00432380|38220001|FG001|Overall Study|Migrated/moved from study area|4|||
17078462|NCT00432380|38220002|FG002|Overall Study|Migrated/moved from study area|1|||
17078463|NCT00432380|38220000|FG000|Overall Study|Adverse Event|1|||
17078464|NCT00432380|38220001|FG001|Overall Study|Adverse Event|0|||
17078465|NCT00432380|38220002|FG002|Overall Study|Adverse Event|0|||
17078466|NCT00234052|38220011|FG000|Treatment|Withdrawal by Subject|3|||
17078467|NCT00234052|38220011|FG000|Treatment|Adverse Event|5|||
17078468|NCT00234052|38220011|FG000|Treatment|Death|2|||
17078469|NCT00234052|38220011|FG000|Treatment|Progressive Disease|11|||
17078470|NCT00234052|38220011|FG000|Follow-up for 5 Years|Death|41|||
17078471|NCT00234052|38220011|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
17078472|NCT00234052|38220011|FG000|Follow-up for 5 Years|Other|7|||
17078473|NCT00408408|38220021|FG000|Overall Study|No follow up data|2|||
17078474|NCT00408408|38220022|FG001|Overall Study|No follow up data|3|||
17078475|NCT00408408|38220023|FG002|Overall Study|No follow up data|0|||
17078476|NCT00408408|38220024|FG003|Overall Study|No follow up data|7|||
17078477|NCT00408408|38220025|FG004|Overall Study|No follow up data|5|||
17078478|NCT00408408|38220026|FG005|Overall Study|No follow up data|3|||
17078479|NCT00414050|38220044|FG000|Overall Study|Adverse Event|1|||
17078480|NCT00414050|38220045|FG001|Overall Study|Adverse Event|1|||
17078481|NCT00414050|38220046|FG002|Overall Study|Adverse Event|1|||
17078482|NCT00414050|38220047|FG003|Overall Study|Adverse Event|1|||
17078483|NCT00414050|38220044|FG000|Overall Study|Lost to Follow-up|2|||
17078484|NCT00414050|38220045|FG001|Overall Study|Lost to Follow-up|2|||
17078485|NCT00414050|38220046|FG002|Overall Study|Lost to Follow-up|1|||
17078486|NCT00414050|38220047|FG003|Overall Study|Lost to Follow-up|1|||
17078487|NCT00414050|38220044|FG000|Overall Study|Withdrawal by Subject|5|||
17078488|NCT00414050|38220045|FG001|Overall Study|Withdrawal by Subject|3|||
17078489|NCT00414050|38220046|FG002|Overall Study|Withdrawal by Subject|2|||
17078490|NCT00414050|38220047|FG003|Overall Study|Withdrawal by Subject|4|||
17078491|NCT00414050|38220044|FG000|Overall Study|Subject discontinued for other reason|1|||
17078492|NCT00414050|38220045|FG001|Overall Study|Subject discontinued for other reason|2|||
17078493|NCT00414050|38220046|FG002|Overall Study|Subject discontinued for other reason|2|||
17078494|NCT00414050|38220047|FG003|Overall Study|Subject discontinued for other reason|1|||
17078495|NCT00414050|38220044|FG000|Overall Study|Subject Moved|0|||
17078496|NCT00414050|38220045|FG001|Overall Study|Subject Moved|0|||
17078497|NCT00414050|38220046|FG002|Overall Study|Subject Moved|0|||
17078498|NCT00414050|38220047|FG003|Overall Study|Subject Moved|1|||
17078499|NCT00413972|38220061|FG000|Overall Study|Adverse Event|2|||
17078500|NCT00413972|38220062|FG001|Overall Study|Adverse Event|1|||
17078501|NCT00413972|38220063|FG002|Overall Study|Adverse Event|0|||
17078502|NCT00413972|38220064|FG003|Overall Study|Adverse Event|0|||
17078503|NCT00413972|38220061|FG000|Overall Study|Lost to Follow-up|1|||
17078504|NCT00413972|38220062|FG001|Overall Study|Lost to Follow-up|2|||
17078505|NCT00413972|38220063|FG002|Overall Study|Lost to Follow-up|1|||
17078506|NCT00413972|38220064|FG003|Overall Study|Lost to Follow-up|0|||
17078507|NCT00413972|38220061|FG000|Overall Study|Withdrawal by Subject|4|||
17078508|NCT00413972|38220062|FG001|Overall Study|Withdrawal by Subject|5|||
17158600|NCT02969018|38305664|FG004|Overall Study|Non-Compliance With Study Drug|0|||
17078509|NCT00413972|38220063|FG002|Overall Study|Withdrawal by Subject|7|||
17078510|NCT00413972|38220064|FG003|Overall Study|Withdrawal by Subject|2|||
17078511|NCT00413972|38220061|FG000|Overall Study|Protocol Violation|0|||
17078512|NCT00413972|38220062|FG001|Overall Study|Protocol Violation|0|||
17078513|NCT00413972|38220063|FG002|Overall Study|Protocol Violation|2|||
17078514|NCT00413972|38220064|FG003|Overall Study|Protocol Violation|0|||
17078515|NCT00413972|38220061|FG000|Overall Study|Other|0|||
17078516|NCT00413972|38220062|FG001|Overall Study|Other|0|||
17078517|NCT00413972|38220063|FG002|Overall Study|Other|0|||
17158601|NCT02969018|38305665|FG005|Overall Study|Non-Compliance With Study Drug|0|||
17078518|NCT00413972|38220064|FG003|Overall Study|Other|1|||
17078519|NCT00259012|38220076|FG000|Overall Study|Adverse Event|0|||
17078520|NCT00259012|38220077|FG001|Overall Study|Adverse Event|1|||
17078521|NCT00259012|38220076|FG000|Overall Study|Withdrawal by Subject|1|||
17078522|NCT00259012|38220077|FG001|Overall Study|Withdrawal by Subject|0|||
17078523|NCT00259012|38220076|FG000|Overall Study|Physician Decision|0|||
17078524|NCT00259012|38220077|FG001|Overall Study|Physician Decision|1|||
17078525|NCT00259012|38220076|FG000|Overall Study|Lost to Follow-up|0|||
17078526|NCT00259012|38220077|FG001|Overall Study|Lost to Follow-up|1|||
17078527|NCT00259012|38220076|FG000|Overall Study|Protocol Violation|1|||
17078528|NCT00259012|38220077|FG001|Overall Study|Protocol Violation|1|||
17078529|NCT00209170|38220085|FG000|Overall Study|Adverse Event|0|||
17078530|NCT00209170|38220086|FG001|Overall Study|Adverse Event|1|||
17078531|NCT00209170|38220085|FG000|Overall Study|Withdrawal by Subject|2|||
17078532|NCT00209170|38220086|FG001|Overall Study|Withdrawal by Subject|1|||
17078533|NCT00209170|38220085|FG000|Overall Study|Lack of Efficacy|0|||
17078534|NCT00209170|38220086|FG001|Overall Study|Lack of Efficacy|1|||
17078535|NCT00413894|38220092|FG000|Overall Study|Withdrawal by Subject|10|||
17078536|NCT00413894|38220092|FG000|Overall Study|Administrative Reasons|1|||
17078537|NCT00413894|38220092|FG000|Overall Study|Hb <10 grams/deciliter|12|||
17078538|NCT00413894|38220092|FG000|Overall Study|Adverse Event|28|||
17078539|NCT00413894|38220092|FG000|Overall Study|Protocol Violation|11|||
17078540|NCT00413894|38220092|FG000|Overall Study|Other|18|||
17078541|NCT00407550|38220101|FG000|Overall Study|Adverse Event|0|||
17078542|NCT00407550|38220102|FG001|Overall Study|Adverse Event|1|||
17078543|NCT00407550|38220101|FG000|Overall Study|Withdrawal by Subject|0|||
17078544|NCT00407550|38220102|FG001|Overall Study|Withdrawal by Subject|2|||
17078545|NCT00407550|38220101|FG000|Overall Study|Death|1|||
17078546|NCT00407550|38220102|FG001|Overall Study|Death|0|||
17078547|NCT00407550|38220101|FG000|Overall Study|Insurance or Other medical condition|2|||
17078548|NCT00407550|38220102|FG001|Overall Study|Insurance or Other medical condition|1|||
17078549|NCT00209092|38220110|FG000|Overall Study|Progression of disease|7|||
17078550|NCT00209092|38220111|FG001|Overall Study|Progression of disease|1|||
17078551|NCT00209092|38220110|FG000|Overall Study|Adverse Event|0|||
17078552|NCT00209092|38220111|FG001|Overall Study|Adverse Event|1|||
17078553|NCT00209092|38220110|FG000|Overall Study|Withdrawal by Subject|1|||
17078554|NCT00209092|38220111|FG001|Overall Study|Withdrawal by Subject|0|||
17078555|NCT00403494|38220119|FG000|Overall Study|Adverse Event|10|||
17078556|NCT00403494|38220120|FG001|Overall Study|Adverse Event|8|||
17078557|NCT00403494|38220119|FG000|Overall Study|Withdrew Consent|3|||
17078558|NCT00403494|38220120|FG001|Overall Study|Withdrew Consent|2|||
17078559|NCT00403494|38220119|FG000|Overall Study|Inappropriately enrolled|0|||
17078560|NCT00403494|38220120|FG001|Overall Study|Inappropriately enrolled|1|||
17078561|NCT00403494|38220119|FG000|Overall Study|Lost to Follow-up|0|||
17078562|NCT00403494|38220120|FG001|Overall Study|Lost to Follow-up|2|||
17078563|NCT00403494|38220119|FG000|Overall Study|Protocol noncompliance|0|||
17078564|NCT00403494|38220120|FG001|Overall Study|Protocol noncompliance|1|||
17078565|NCT00403494|38220119|FG000|Overall Study|Death|1|||
17078566|NCT00403494|38220120|FG001|Overall Study|Death|0|||
17078567|NCT00403494|38220119|FG000|Overall Study|Sponsor Request|1|||
17078568|NCT00403494|38220120|FG001|Overall Study|Sponsor Request|0|||
17078569|NCT00403260|38220130|FG000|Overall Study|Adverse Event|5|||
17078570|NCT00403260|38220131|FG001|Overall Study|Adverse Event|4|||
17078571|NCT00403260|38220130|FG000|Overall Study|Withdrawal by Subject|5|||
17158602|NCT02969018|38305666|FG006|Overall Study|Non-Compliance With Study Drug|0|||
17158603|NCT02969018|38305667|FG007|Overall Study|Non-Compliance With Study Drug|0|||
17078572|NCT00403260|38220131|FG001|Overall Study|Withdrawal by Subject|6|||
17078573|NCT00403260|38220130|FG000|Overall Study|Lost to Follow-up|49|||
17078574|NCT00403260|38220131|FG001|Overall Study|Lost to Follow-up|25|||
17078575|NCT00403260|38220130|FG000|Overall Study|Re-appearance of P. falciparum|34|||
17078576|NCT00403260|38220131|FG001|Overall Study|Re-appearance of P. falciparum|25|||
17078577|NCT00403260|38220130|FG000|Overall Study|P. vivax infection|26|||
17078578|NCT00403260|38220131|FG001|Overall Study|P. vivax infection|4|||
17078579|NCT00403260|38220130|FG000|Overall Study|Mixed infection with P. vivax|2|||
17158604|NCT02969018|38305660|FG000|Overall Study|Other|0|||
17158605|NCT02969018|38305661|FG001|Overall Study|Other|0|||
17158606|NCT02969018|38305662|FG002|Overall Study|Other|0|||
17158607|NCT02969018|38305663|FG003|Overall Study|Other|1|||
17158608|NCT02969018|38305664|FG004|Overall Study|Other|0|||
17158609|NCT02969018|38305665|FG005|Overall Study|Other|0|||
17158610|NCT02969018|38305666|FG006|Overall Study|Other|0|||
17158611|NCT02969018|38305667|FG007|Overall Study|Other|2|||
17158612|NCT02969018|38305660|FG000|Overall Study|Pregnancy|0|||
17158613|NCT02969018|38305661|FG001|Overall Study|Pregnancy|0|||
17158614|NCT02969018|38305662|FG002|Overall Study|Pregnancy|0|||
17158615|NCT02969018|38305663|FG003|Overall Study|Pregnancy|0|||
17158616|NCT02969018|38305664|FG004|Overall Study|Pregnancy|0|||
17158617|NCT02969018|38305665|FG005|Overall Study|Pregnancy|1|||
17158618|NCT02969018|38305666|FG006|Overall Study|Pregnancy|0|||
17158619|NCT02969018|38305667|FG007|Overall Study|Pregnancy|0|||
17078580|NCT00403260|38220131|FG001|Overall Study|Mixed infection with P. vivax|0|||
17078581|NCT00403260|38220130|FG000|Overall Study|Mixed infection with P. falciparum|1|||
17078582|NCT00403260|38220131|FG001|Overall Study|Mixed infection with P. falciparum|0|||
17078583|NCT00403260|38220130|FG000|Overall Study|P. vivax infection at screening|1|||
17078584|NCT00403260|38220131|FG001|Overall Study|P. vivax infection at screening|0|||
17158620|NCT02969018|38305660|FG000|Overall Study|Protocol Violation|0|||
17078585|NCT00403260|38220130|FG000|Overall Study|P. ovale infection|1|||
17078586|NCT00403260|38220131|FG001|Overall Study|P. ovale infection|0|||
17078587|NCT00403260|38220130|FG000|Overall Study|Gametocyte re-appearance|1|||
17078588|NCT00403260|38220131|FG001|Overall Study|Gametocyte re-appearance|1|||
17078589|NCT00403260|38220130|FG000|Overall Study|Withdrawn from study accidentally|0|||
17078590|NCT00403260|38220131|FG001|Overall Study|Withdrawn from study accidentally|1|||
17078591|NCT00406848|38220139|FG000|Overall Study|Withdrawal by Subject|27|||
17078592|NCT00406848|38220140|FG001|Overall Study|Withdrawal by Subject|22|||
17078593|NCT00406848|38220139|FG000|Overall Study|Adverse Event|38|||
17078594|NCT00406848|38220140|FG001|Overall Study|Adverse Event|7|||
17158621|NCT02969018|38305661|FG001|Overall Study|Protocol Violation|0|||
17158622|NCT02969018|38305662|FG002|Overall Study|Protocol Violation|1|||
17158623|NCT02969018|38305663|FG003|Overall Study|Protocol Violation|1|||
17158624|NCT02969018|38305664|FG004|Overall Study|Protocol Violation|0|||
17158625|NCT02969018|38305665|FG005|Overall Study|Protocol Violation|0|||
17158626|NCT02969018|38305666|FG006|Overall Study|Protocol Violation|0|||
17158627|NCT02969018|38305667|FG007|Overall Study|Protocol Violation|0|||
17158628|NCT02969018|38305660|FG000|Overall Study|Withdrawal by Subject|0|||
17078595|NCT00406848|38220139|FG000|Overall Study|Lack of Efficacy|9|||
17078596|NCT00406848|38220140|FG001|Overall Study|Lack of Efficacy|14|||
17078597|NCT00406848|38220139|FG000|Overall Study|Protocol Violation|10|||
17078598|NCT00406848|38220140|FG001|Overall Study|Protocol Violation|6|||
17078599|NCT00406848|38220139|FG000|Overall Study|Lost to Follow-up|6|||
17078600|NCT00406848|38220140|FG001|Overall Study|Lost to Follow-up|2|||
17078601|NCT00406848|38220139|FG000|Overall Study|Physician Decision|2|||
17078602|NCT00406848|38220140|FG001|Overall Study|Physician Decision|2|||
17078603|NCT00406848|38220139|FG000|Overall Study|Sponsor Decision|1|||
17158629|NCT02969018|38305661|FG001|Overall Study|Withdrawal by Subject|1|||
17078604|NCT00406848|38220140|FG001|Overall Study|Sponsor Decision|1|||
17078605|NCT00406692|38220149|FG000|Overall Study|Withdrawal by Subject|4|||
17078606|NCT00406692|38220149|FG000|Overall Study|Physician Decision|1|||
17078607|NCT00406692|38220149|FG000|Overall Study|Adverse Event|1|||
17078608|NCT00406692|38220149|FG000|Overall Study|Lack of Efficacy|1|||
17078609|NCT00315705|38220155|FG000|Phase 1|Refused further treatment|1|||
17078610|NCT00315705|38220155|FG000|Phase 1|Failure to achieve response|8|||
17078611|NCT00315705|38220155|FG000|Phase 1|Disease relapse|4|||
17078612|NCT00315705|38220155|FG000|Phase 1|Scheduled for transplant|9|||
17078613|NCT00315705|38220155|FG000|Phase 1|Death|3|||
17078614|NCT00315705|38220155|FG000|Phase 2|Physician Decision|4|||
17078615|NCT00315705|38220155|FG000|Phase 2|Adverse Event|1|||
17078616|NCT00315705|38220155|FG000|Phase 2|Failure to achieve response|3|||
17078617|NCT00315705|38220155|FG000|Phase 2|Disease relapse|1|||
17078618|NCT00315705|38220155|FG000|Phase 2|Scheduled for transplant|8|||
17078619|NCT00315705|38220155|FG000|Phase 2|Other|1|||
17078620|NCT00315705|38220155|FG000|Phase 2|Death|7|||
17078621|NCT00307125|38220174|FG000|Screening Phase|Adverse Event|1|||
17078622|NCT00307125|38220175|FG001|Screening Phase|Adverse Event|0|||
17078623|NCT00307125|38220176|FG002|Screening Phase|Adverse Event|0|||
17078624|NCT00307125|38220174|FG000|Screening Phase|Protocol Violation|27|||
17078625|NCT00307125|38220175|FG001|Screening Phase|Protocol Violation|0|||
17078626|NCT00307125|38220176|FG002|Screening Phase|Protocol Violation|0|||
17078627|NCT00307125|38220174|FG000|Screening Phase|Lost to Follow-up|87|||
17078628|NCT00307125|38220175|FG001|Screening Phase|Lost to Follow-up|0|||
17078629|NCT00307125|38220176|FG002|Screening Phase|Lost to Follow-up|0|||
17078630|NCT00307125|38220174|FG000|Screening Phase|Death|10|||
17078631|NCT00307125|38220175|FG001|Screening Phase|Death|0|||
17078632|NCT00307125|38220176|FG002|Screening Phase|Death|0|||
17078633|NCT00307125|38220174|FG000|Screening Phase|Withdrawal by Subject|77|||
17078634|NCT00307125|38220175|FG001|Screening Phase|Withdrawal by Subject|0|||
17078635|NCT00307125|38220176|FG002|Screening Phase|Withdrawal by Subject|0|||
17078636|NCT00307125|38220174|FG000|Screening Phase|Physician Decision|26|||
17078637|NCT00307125|38220175|FG001|Screening Phase|Physician Decision|0|||
17078638|NCT00307125|38220176|FG002|Screening Phase|Physician Decision|0|||
17078639|NCT00307125|38220174|FG000|Screening Phase|Sponsor Decision|4|||
17078640|NCT00307125|38220175|FG001|Screening Phase|Sponsor Decision|0|||
17078641|NCT00307125|38220176|FG002|Screening Phase|Sponsor Decision|0|||
17078642|NCT00307125|38220174|FG000|Screening Phase|Study Terminated|17|||
17078643|NCT00307125|38220175|FG001|Screening Phase|Study Terminated|0|||
17078644|NCT00307125|38220176|FG002|Screening Phase|Study Terminated|0|||
17078645|NCT00307125|38220174|FG000|Screening Phase|Graft Loss|3|||
17078646|NCT00307125|38220175|FG001|Screening Phase|Graft Loss|0|||
17078647|NCT00307125|38220176|FG002|Screening Phase|Graft Loss|0|||
17158630|NCT02969018|38305662|FG002|Overall Study|Withdrawal by Subject|2|||
17158631|NCT02969018|38305663|FG003|Overall Study|Withdrawal by Subject|1|||
17078648|NCT00307125|38220174|FG000|Screening Phase|Graft Failure|8|||
17078649|NCT00307125|38220175|FG001|Screening Phase|Graft Failure|0|||
17078650|NCT00307125|38220176|FG002|Screening Phase|Graft Failure|0|||
17078651|NCT00307125|38220174|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
17078652|NCT00307125|38220175|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
17078653|NCT00307125|38220176|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
17078654|NCT00307125|38220174|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
17078655|NCT00307125|38220175|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
17078656|NCT00307125|38220176|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
17078657|NCT00307125|38220174|FG000|Screening Phase|Moved or transferred facilities|34|||
17078658|NCT00307125|38220175|FG001|Screening Phase|Moved or transferred facilities|0|||
17078659|NCT00307125|38220176|FG002|Screening Phase|Moved or transferred facilities|0|||
17078660|NCT00307125|38220174|FG000|Screening Phase|Received Pancreas Transplant|8|||
17078661|NCT00307125|38220175|FG001|Screening Phase|Received Pancreas Transplant|0|||
17078662|NCT00307125|38220176|FG002|Screening Phase|Received Pancreas Transplant|0|||
17078663|NCT00307125|38220174|FG000|Screening Phase|Ineligible for pilot|4|||
17078664|NCT00307125|38220175|FG001|Screening Phase|Ineligible for pilot|0|||
17078665|NCT00307125|38220176|FG002|Screening Phase|Ineligible for pilot|0|||
17078666|NCT00307125|38220174|FG000|Screening Phase|Try to get pregnant|1|||
17078667|NCT00307125|38220175|FG001|Screening Phase|Try to get pregnant|0|||
17078668|NCT00307125|38220176|FG002|Screening Phase|Try to get pregnant|0|||
17078669|NCT00307125|38220174|FG000|Screening Phase|Developed acute leukemia|1|||
17078670|NCT00307125|38220175|FG001|Screening Phase|Developed acute leukemia|0|||
17078671|NCT00307125|38220176|FG002|Screening Phase|Developed acute leukemia|0|||
17078672|NCT00307125|38220174|FG000|Screening Phase|Metastatic colon cancer|1|||
17078673|NCT00307125|38220175|FG001|Screening Phase|Metastatic colon cancer|0|||
17078674|NCT00307125|38220176|FG002|Screening Phase|Metastatic colon cancer|0|||
17078675|NCT00307125|38220174|FG000|Screening Phase|Malignancy|1|||
17078676|NCT00307125|38220175|FG001|Screening Phase|Malignancy|0|||
17078677|NCT00307125|38220176|FG002|Screening Phase|Malignancy|0|||
17078678|NCT00307125|38220174|FG000|Screening Phase|PAK|1|||
17078679|NCT00307125|38220175|FG001|Screening Phase|PAK|0|||
17078680|NCT00307125|38220176|FG002|Screening Phase|PAK|0|||
17078681|NCT00307125|38220174|FG000|Screening Phase|Ineligible|1|||
17078682|NCT00307125|38220175|FG001|Screening Phase|Ineligible|0|||
17078683|NCT00307125|38220176|FG002|Screening Phase|Ineligible|0|||
17078684|NCT00307125|38220174|FG000|Screening Phase|Screen Error|1|||
17078685|NCT00307125|38220175|FG001|Screening Phase|Screen Error|0|||
17078686|NCT00307125|38220176|FG002|Screening Phase|Screen Error|0|||
17078687|NCT00307125|38220174|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
17078688|NCT00307125|38220175|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
17078689|NCT00307125|38220176|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
17078690|NCT00307125|38220174|FG000|Screening Phase|AMR and treated with rituximab|1|||
17078691|NCT00307125|38220175|FG001|Screening Phase|AMR and treated with rituximab|0|||
17078692|NCT00307125|38220176|FG002|Screening Phase|AMR and treated with rituximab|0|||
17078693|NCT00307125|38220174|FG000|Screening Phase|Coronary artery bypass|1|||
17078694|NCT00307125|38220175|FG001|Screening Phase|Coronary artery bypass|0|||
17078695|NCT00307125|38220176|FG002|Screening Phase|Coronary artery bypass|0|||
17078696|NCT00307125|38220174|FG000|Pilot Phase|Lost to Follow-up|0|||
17078697|NCT00307125|38220175|FG001|Pilot Phase|Lost to Follow-up|1|||
17078698|NCT00307125|38220176|FG002|Pilot Phase|Lost to Follow-up|0|||
17078699|NCT00307125|38220174|FG000|Pilot Phase|Withdrawal by Subject|0|||
17078700|NCT00307125|38220175|FG001|Pilot Phase|Withdrawal by Subject|1|||
17078701|NCT00307125|38220176|FG002|Pilot Phase|Withdrawal by Subject|1|||
17078702|NCT00307047|38220188|FG000|Overall Study|Lost to Follow-up|35|||
17078703|NCT00307047|38220189|FG001|Overall Study|Lost to Follow-up|24|||
17078704|NCT00307047|38220188|FG000|Overall Study|Withdrawal by Subject|6|||
17078705|NCT00307047|38220189|FG001|Overall Study|Withdrawal by Subject|6|||
17078706|NCT00307047|38220188|FG000|Overall Study|Physician Decision|1|||
17078707|NCT00307047|38220189|FG001|Overall Study|Physician Decision|2|||
17078708|NCT00307047|38220188|FG000|Overall Study|Lost to follow-up for other reasons|0|||
17078709|NCT00307047|38220189|FG001|Overall Study|Lost to follow-up for other reasons|1|||
17078710|NCT00307047|38220188|FG000|Overall Study|All death, all MI, all Revascularization|27|||
17078711|NCT00307047|38220189|FG001|Overall Study|All death, all MI, all Revascularization|16|||
17078712|NCT00306891|38220199|FG000|Part A|Withdrawal by Subject|1|||
17158632|NCT02969018|38305664|FG004|Overall Study|Withdrawal by Subject|0|||
17158633|NCT02969018|38305665|FG005|Overall Study|Withdrawal by Subject|4|||
17158634|NCT02969018|38305666|FG006|Overall Study|Withdrawal by Subject|4|||
17158635|NCT02969018|38305667|FG007|Overall Study|Withdrawal by Subject|3|||
17158636|NCT01319721|38305690|FG000|Overall Study|Lost to Follow-up|1|||
17158637|NCT01319721|38305691|FG001|Overall Study|Lost to Follow-up|6|||
17078713|NCT00306891|38220200|FG001|Part A|Withdrawal by Subject|1|||
17078714|NCT00306891|38220201|FG002|Part A|Withdrawal by Subject|0|||
17078715|NCT00306891|38220202|FG003|Part A|Withdrawal by Subject|0|||
17078716|NCT00306891|38220199|FG000|Part A|Condition under investigation worsened|2|||
17078717|NCT00306891|38220200|FG001|Part A|Condition under investigation worsened|2|||
17078718|NCT00306891|38220201|FG002|Part A|Condition under investigation worsened|0|||
17078719|NCT00306891|38220202|FG003|Part A|Condition under investigation worsened|0|||
17078720|NCT00306891|38220199|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
17078721|NCT00306891|38220200|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
17078722|NCT00306891|38220201|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
17078723|NCT00306891|38220202|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
17078724|NCT00306891|38220199|FG000|Part A|Partial bowel obstruction|1|||
17078725|NCT00306891|38220200|FG001|Part A|Partial bowel obstruction|0|||
17078726|NCT00306891|38220201|FG002|Part A|Partial bowel obstruction|0|||
17078727|NCT00306891|38220202|FG003|Part A|Partial bowel obstruction|0|||
17078728|NCT00306891|38220199|FG000|Part A|Reaccumul. of ascites following drainage|0|||
17078729|NCT00306891|38220200|FG001|Part A|Reaccumul. of ascites following drainage|1|||
17078730|NCT00306891|38220201|FG002|Part A|Reaccumul. of ascites following drainage|0|||
17078731|NCT00306891|38220202|FG003|Part A|Reaccumul. of ascites following drainage|0|||
17078732|NCT00306891|38220199|FG000|Part A|Suspicion of second malignancy|0|||
17078733|NCT00306891|38220200|FG001|Part A|Suspicion of second malignancy|1|||
17078734|NCT00306891|38220201|FG002|Part A|Suspicion of second malignancy|0|||
17078735|NCT00306891|38220202|FG003|Part A|Suspicion of second malignancy|0|||
17078736|NCT00306891|38220199|FG000|Part A|QTC interval outwith elig. criteria|1|||
17078737|NCT00306891|38220200|FG001|Part A|QTC interval outwith elig. criteria|0|||
17078738|NCT00306891|38220201|FG002|Part A|QTC interval outwith elig. criteria|0|||
17078739|NCT00306891|38220202|FG003|Part A|QTC interval outwith elig. criteria|0|||
17078740|NCT00306891|38220199|FG000|Part B|Death|0|||
17078741|NCT00306891|38220200|FG001|Part B|Death|0|||
17078742|NCT00306891|38220201|FG002|Part B|Death|1|||
17078743|NCT00306891|38220202|FG003|Part B|Death|2|||
17078744|NCT00306891|38220199|FG000|Part B|Adverse Event|0|||
17078745|NCT00306891|38220200|FG001|Part B|Adverse Event|0|||
17078746|NCT00306891|38220201|FG002|Part B|Adverse Event|5|||
17078747|NCT00306891|38220202|FG003|Part B|Adverse Event|5|||
17078748|NCT00306891|38220199|FG000|Part B|Withdrawal by Subject|0|||
17078749|NCT00306891|38220200|FG001|Part B|Withdrawal by Subject|0|||
17078750|NCT00306891|38220201|FG002|Part B|Withdrawal by Subject|3|||
17078751|NCT00306891|38220202|FG003|Part B|Withdrawal by Subject|1|||
17078752|NCT00306891|38220199|FG000|Part B|Condition under investigation worsened|0|||
17078753|NCT00306891|38220200|FG001|Part B|Condition under investigation worsened|0|||
17078754|NCT00306891|38220201|FG002|Part B|Condition under investigation worsened|2|||
17078755|NCT00306891|38220202|FG003|Part B|Condition under investigation worsened|8|||
17158638|NCT02905032|38305700|FG000|Overall Study|Withdrawal by Subject|2|||
17158639|NCT02905032|38305701|FG001|Overall Study|Withdrawal by Subject|0|||
17158640|NCT02905032|38305702|FG002|Overall Study|Withdrawal by Subject|0|||
17158641|NCT02905032|38305700|FG000|Overall Study|Protocol Violation|6|||
17158642|NCT02905032|38305701|FG001|Overall Study|Protocol Violation|12|||
17158643|NCT02905032|38305702|FG002|Overall Study|Protocol Violation|0|||
17158644|NCT03259425|38305709|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
17158645|NCT03101241|38305715|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
17158646|NCT03101241|38305716|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
17158647|NCT03101241|38305715|FG000|Overall Study|Participant withdrew consent|3|||
17158648|NCT03101241|38305716|FG001|Overall Study|Participant withdrew consent|1|||
17158649|NCT03101241|38305715|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
17158650|NCT03101241|38305716|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
17158651|NCT03101241|38305715|FG000|Overall Study|Lost to Follow-up|2|||
17158652|NCT03101241|38305716|FG001|Overall Study|Lost to Follow-up|0|||
17158653|NCT03101241|38305715|FG000|Overall Study|Lack of Efficacy|0|||
17158654|NCT03101241|38305716|FG001|Overall Study|Lack of Efficacy|1|||
17158655|NCT03101241|38305715|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
17158656|NCT03101241|38305716|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
17158657|NCT03061188|38305726|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
17158658|NCT03061188|38305727|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
17158659|NCT03061188|38305728|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
17158660|NCT03061188|38305729|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
17158661|NCT03061188|38305726|FG000|On Follow-up for 3 Years|Death|0|||
17158662|NCT03061188|38305727|FG001|On Follow-up for 3 Years|Death|3|||
17158663|NCT03061188|38305728|FG002|On Follow-up for 3 Years|Death|5|||
17158664|NCT03061188|38305729|FG003|On Follow-up for 3 Years|Death|2|||
17158665|NCT03061188|38305726|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
17158666|NCT03061188|38305727|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
17158667|NCT03061188|38305728|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
17158668|NCT03061188|38305729|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
17158669|NCT03449147|38305747|FG000|52-week Treatment Period|Death|0|||
17158670|NCT03449147|38305748|FG001|52-week Treatment Period|Death|1|||
17158671|NCT03449147|38305749|FG002|52-week Treatment Period|Death|0|||
17158672|NCT03449147|38305747|FG000|52-week Treatment Period|Lost to Follow-up|6|||
17158673|NCT03449147|38305748|FG001|52-week Treatment Period|Lost to Follow-up|2|||
17158674|NCT03449147|38305749|FG002|52-week Treatment Period|Lost to Follow-up|5|||
17158675|NCT03449147|38305747|FG000|52-week Treatment Period|Other|0|||
17078756|NCT00306891|38220199|FG000|Part B|Development of study specific disc crit.|0|||
17078757|NCT00306891|38220200|FG001|Part B|Development of study specific disc crit.|0|||
17078758|NCT00306891|38220201|FG002|Part B|Development of study specific disc crit.|0|||
17078759|NCT00306891|38220202|FG003|Part B|Development of study specific disc crit.|1|||
17078760|NCT00314145|38220215|FG000|Overall Study|Withdrawal by Subject|8|||
17078761|NCT00314145|38220216|FG001|Overall Study|Withdrawal by Subject|10|||
17078762|NCT00314145|38220215|FG000|Overall Study|Lost to Follow-up|5|||
17078763|NCT00314145|38220216|FG001|Overall Study|Lost to Follow-up|12|||
17078764|NCT00314145|38220215|FG000|Overall Study|Physician Decision|3|||
17078765|NCT00314145|38220216|FG001|Overall Study|Physician Decision|4|||
17078766|NCT00314145|38220215|FG000|Overall Study|Adverse Event|0|||
17078767|NCT00314145|38220216|FG001|Overall Study|Adverse Event|3|||
17078768|NCT00314145|38220215|FG000|Overall Study|Protocol Violation|3|||
17078769|NCT00314145|38220216|FG001|Overall Study|Protocol Violation|0|||
17078770|NCT00314145|38220215|FG000|Overall Study|Sponsor Decision|2|||
17078771|NCT00314145|38220216|FG001|Overall Study|Sponsor Decision|0|||
17078772|NCT00313911|38220225|FG000|Overall Study|Serious adverse event|6|||
17078773|NCT00313911|38220226|FG001|Overall Study|Serious adverse event|1|||
17078774|NCT00313911|38220225|FG000|Overall Study|Adverse Event|2|||
17078775|NCT00313911|38220226|FG001|Overall Study|Adverse Event|3|||
17078776|NCT00313911|38220225|FG000|Overall Study|Protocol Violation|19|||
17078777|NCT00313911|38220226|FG001|Overall Study|Protocol Violation|10|||
17078778|NCT00313911|38220225|FG000|Overall Study|Lost to Follow-up|27|||
17078779|NCT00313911|38220226|FG001|Overall Study|Lost to Follow-up|14|||
17078780|NCT00313911|38220225|FG000|Overall Study|Withdrawal by Subject|39|||
17078781|NCT00313911|38220226|FG001|Overall Study|Withdrawal by Subject|12|||
17078782|NCT00313911|38220225|FG000|Overall Study|Did not meet age criteria|1|||
17078783|NCT00313911|38220226|FG001|Overall Study|Did not meet age criteria|1|||
17078784|NCT00391872|38220234|FG000|Overall Study|Protocol Violation|7|||
17078785|NCT00391872|38220235|FG001|Overall Study|Protocol Violation|2|||
17078786|NCT00391872|38220234|FG000|Overall Study|Withdrawal by Subject|296|||
17078787|NCT00391872|38220235|FG001|Overall Study|Withdrawal by Subject|249|||
17078788|NCT00391872|38220234|FG000|Overall Study|Reason unknown|2|||
17078789|NCT00391872|38220235|FG001|Overall Study|Reason unknown|4|||
17078790|NCT00391872|38220234|FG000|Overall Study|Lost to Follow-up|2|||
17078791|NCT00391872|38220235|FG001|Overall Study|Lost to Follow-up|0|||
17078792|NCT00391170|38220243|FG000|Overall Study|Withdrawal by Subject|1|||
17078793|NCT00391170|38220244|FG001|Overall Study|Withdrawal by Subject|0|||
17078794|NCT00391170|38220243|FG000|Overall Study|Adverse Event|3|||
17078795|NCT00391170|38220244|FG001|Overall Study|Adverse Event|2|||
17078796|NCT00391170|38220243|FG000|Overall Study|Physician Decision|2|||
17078797|NCT00391170|38220244|FG001|Overall Study|Physician Decision|2|||
17078798|NCT00402324|38220252|FG000|Overall Study|Lost to Follow-up|11|||
17078799|NCT00402324|38220253|FG001|Overall Study|Lost to Follow-up|11|||
17078800|NCT00402324|38220252|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
17078801|NCT00402324|38220253|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
17078802|NCT00402324|38220252|FG000|Overall Study|Protocol Violation|8|||
17078803|NCT00402324|38220253|FG001|Overall Study|Protocol Violation|7|||
17078804|NCT00402324|38220252|FG000|Overall Study|Withdrawal by Subject|5|||
17078805|NCT00402324|38220253|FG001|Overall Study|Withdrawal by Subject|2|||
17078806|NCT00402324|38220252|FG000|Overall Study|Physician Decision|2|||
17078807|NCT00402324|38220253|FG001|Overall Study|Physician Decision|4|||
17078808|NCT00402324|38220252|FG000|Overall Study|Sponsor Decision|4|||
17078809|NCT00402324|38220253|FG001|Overall Study|Sponsor Decision|5|||
17078810|NCT00402324|38220252|FG000|Overall Study|Lack of Efficacy|1|||
17078811|NCT00402324|38220253|FG001|Overall Study|Lack of Efficacy|4|||
17078812|NCT00402324|38220252|FG000|Overall Study|Adverse Event|6|||
17078813|NCT00402324|38220253|FG001|Overall Study|Adverse Event|4|||
17078814|NCT00402324|38220252|FG000|Overall Study|Death|1|||
17078815|NCT00402324|38220253|FG001|Overall Study|Death|0|||
17078816|NCT00294723|38220262|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
17078817|NCT00294723|38220263|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
17078818|NCT00294723|38220264|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
17078819|NCT00294723|38220262|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
17078820|NCT00294723|38220263|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
17078821|NCT00294723|38220264|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
17078822|NCT00294723|38220262|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
17078823|NCT00294723|38220263|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
17078824|NCT00294723|38220264|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
17078825|NCT00294723|38220262|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
17078826|NCT00294723|38220263|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
17078827|NCT00294723|38220264|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
17078828|NCT00294723|38220262|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
17078829|NCT00294723|38220263|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
17078830|NCT00294723|38220264|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
17078831|NCT00294723|38220262|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
17078832|NCT00294723|38220263|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
17078833|NCT00294723|38220264|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
17078834|NCT00294723|38220262|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
17078835|NCT00294723|38220263|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
17078836|NCT00294723|38220264|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
17078837|NCT00294723|38220262|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
17078838|NCT00294723|38220263|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
17078839|NCT00294723|38220264|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
17078840|NCT00294723|38220262|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
17078841|NCT00294723|38220263|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
17078842|NCT00294723|38220264|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
17078843|NCT00294723|38220262|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
17078844|NCT00294723|38220263|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
17078845|NCT00294723|38220264|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
17078846|NCT00294723|38220262|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
17078847|NCT00294723|38220263|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
17078848|NCT00294723|38220264|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
17078849|NCT00294723|38220262|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
17078850|NCT00294723|38220263|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
17078851|NCT00294723|38220264|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
17078852|NCT00402246|38220277|FG000|Overall Study|Death|62|||
17078853|NCT00402246|38220278|FG001|Overall Study|Death|58|||
17078854|NCT00402246|38220277|FG000|Overall Study|Lost to Follow-up|20|||
17078855|NCT00402246|38220278|FG001|Overall Study|Lost to Follow-up|28|||
17078856|NCT00402246|38220277|FG000|Overall Study|Withdrawal by Subject|72|||
17078857|NCT00402246|38220278|FG001|Overall Study|Withdrawal by Subject|87|||
17078858|NCT00402246|38220277|FG000|Overall Study|Physician Decision|24|||
17158676|NCT03449147|38305748|FG001|52-week Treatment Period|Other|1|||
17158677|NCT03449147|38305749|FG002|52-week Treatment Period|Other|2|||
17158678|NCT03449147|38305747|FG000|52-week Treatment Period|Physician Decision|1|||
17158679|NCT03449147|38305748|FG001|52-week Treatment Period|Physician Decision|0|||
17158680|NCT03449147|38305749|FG002|52-week Treatment Period|Physician Decision|3|||
17158681|NCT03449147|38305747|FG000|52-week Treatment Period|Screen Failure|1|||
17078859|NCT00402246|38220278|FG001|Overall Study|Physician Decision|26|||
17078860|NCT00402246|38220277|FG000|Overall Study|Protocol Violation|25|||
17078861|NCT00402246|38220278|FG001|Overall Study|Protocol Violation|24|||
17078862|NCT00402246|38220277|FG000|Overall Study|Missed Final Visit|1|||
17078863|NCT00402246|38220278|FG001|Overall Study|Missed Final Visit|2|||
17078864|NCT00402246|38220277|FG000|Overall Study|Insurance Issues|2|||
17078865|NCT00402246|38220278|FG001|Overall Study|Insurance Issues|1|||
17078866|NCT00402246|38220277|FG000|Overall Study|Heart Transplant|0|||
17078867|NCT00402246|38220278|FG001|Overall Study|Heart Transplant|1|||
17078868|NCT00402246|38220277|FG000|Overall Study|Patient's device explanted|6|||
17078869|NCT00402246|38220278|FG001|Overall Study|Patient's device explanted|2|||
17078870|NCT00402246|38220277|FG000|Overall Study|Center Closure|5|||
17078871|NCT00402246|38220278|FG001|Overall Study|Center Closure|3|||
17078872|NCT00402246|38220277|FG000|Overall Study|Deterioriating Condition|3|||
17078873|NCT00402246|38220278|FG001|Overall Study|Deterioriating Condition|2|||
17078874|NCT00375492|38220288|FG000|Overall Study|Adverse Event|4|||
17078875|NCT00375492|38220289|FG001|Overall Study|Adverse Event|5|||
17078876|NCT00375492|38220288|FG000|Overall Study|Entry Criteria Not Met|0|||
17078877|NCT00375492|38220289|FG001|Overall Study|Entry Criteria Not Met|1|||
17078878|NCT00375492|38220288|FG000|Overall Study|Loss of Glucose Control|0|||
17078879|NCT00375492|38220289|FG001|Overall Study|Loss of Glucose Control|1|||
17078880|NCT00375492|38220288|FG000|Overall Study|Lost to Follow-up|10|||
17078881|NCT00375492|38220289|FG001|Overall Study|Lost to Follow-up|5|||
17158682|NCT03449147|38305748|FG001|52-week Treatment Period|Screen Failure|2|||
17158683|NCT03449147|38305749|FG002|52-week Treatment Period|Screen Failure|0|||
17158684|NCT03449147|38305747|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
17158685|NCT03449147|38305748|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
17158686|NCT03449147|38305749|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
17158687|NCT03449147|38305747|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
17158688|NCT03449147|38305748|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
17158689|NCT03449147|38305749|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
17158690|NCT03449147|38305747|FG000|12-Week Off-Treatment Durability Period|Other|0|||
17158691|NCT03449147|38305748|FG001|12-Week Off-Treatment Durability Period|Other|1|||
17158692|NCT03449147|38305749|FG002|12-Week Off-Treatment Durability Period|Other|0|||
17189048|NCT02502526|38342019|FG001|Overall Study|Withdrawal by Subject|1|||
17189049|NCT02502526|38342020|FG002|Overall Study|Withdrawal by Subject|1|||
17189050|NCT02502526|38342018|FG000|Overall Study|Disqualified due to cataract grading|0|||
17189051|NCT02502526|38342019|FG001|Overall Study|Disqualified due to cataract grading|0|||
17189052|NCT02502526|38342020|FG002|Overall Study|Disqualified due to cataract grading|1|||
17189053|NCT02502526|38342018|FG000|Overall Study|Enrollment suspension|4|||
17189054|NCT02502526|38342019|FG001|Overall Study|Enrollment suspension|1|||
17189055|NCT02502526|38342020|FG002|Overall Study|Enrollment suspension|1|||
17189056|NCT02972515|38342029|FG000|Overall Study|Lost to Follow-up|78|||
17189057|NCT02972359|38342033|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
17189058|NCT02972359|38342033|FG000|Overall Study|Lack of Efficacy|1|||
17189059|NCT02972359|38342033|FG000|Overall Study|Adverse Event|4|||
17189060|NCT02972359|38342033|FG000|Overall Study|Death|1|||
17189061|NCT02972359|38342033|FG000|Overall Study|Withdrawal by Subject|30|||
17189062|NCT02972359|38342033|FG000|Overall Study|Protocol Violation|1|||
17189063|NCT02972359|38342033|FG000|Overall Study|Lost to Follow-up|26|||
17189064|NCT02972359|38342033|FG000|Overall Study|Other reasons|5|||
17189065|NCT02972359|38342033|FG000|Overall Study|Missing|1|||
17189066|NCT01060111|38342040|FG000|Overall Study|Adverse Event|9|||
17078882|NCT00375492|38220288|FG000|Overall Study|Physician Decision|0|||
17078883|NCT00375492|38220289|FG001|Overall Study|Physician Decision|4|||
17078884|NCT00375492|38220288|FG000|Overall Study|Protocol Violation|6|||
17078885|NCT00375492|38220289|FG001|Overall Study|Protocol Violation|3|||
17078886|NCT00375492|38220288|FG000|Overall Study|Sponsor Decision|0|||
17078887|NCT00375492|38220289|FG001|Overall Study|Sponsor Decision|1|||
17078888|NCT00375492|38220288|FG000|Overall Study|Withdrawal by Subject|6|||
17078889|NCT00375492|38220289|FG001|Overall Study|Withdrawal by Subject|6|||
17078890|NCT00306189|38220299|FG000|Overall Study|Physician Decision|0|||
17078891|NCT00306189|38220300|FG001|Overall Study|Physician Decision|0|||
17078892|NCT00306189|38220301|FG002|Overall Study|Physician Decision|0|||
17078893|NCT00306189|38220302|FG003|Overall Study|Physician Decision|1|||
17078894|NCT00306189|38220299|FG000|Overall Study|Adverse Event|3|||
17078895|NCT00306189|38220300|FG001|Overall Study|Adverse Event|3|||
17078896|NCT00306189|38220301|FG002|Overall Study|Adverse Event|2|||
17078897|NCT00306189|38220302|FG003|Overall Study|Adverse Event|2|||
17078898|NCT00306189|38220299|FG000|Overall Study|Withdrawal by Subject|4|||
17078899|NCT00306189|38220300|FG001|Overall Study|Withdrawal by Subject|2|||
17078900|NCT00306189|38220301|FG002|Overall Study|Withdrawal by Subject|8|||
17078901|NCT00306189|38220302|FG003|Overall Study|Withdrawal by Subject|1|||
17078902|NCT00306189|38220299|FG000|Overall Study|Ineligibility determined|1|||
17078903|NCT00306189|38220300|FG001|Overall Study|Ineligibility determined|1|||
17078904|NCT00306189|38220301|FG002|Overall Study|Ineligibility determined|1|||
17078905|NCT00306189|38220302|FG003|Overall Study|Ineligibility determined|1|||
17078906|NCT00306189|38220299|FG000|Overall Study|Other|1|||
17078907|NCT00306189|38220300|FG001|Overall Study|Other|0|||
17078908|NCT00306189|38220301|FG002|Overall Study|Other|0|||
17078909|NCT00306189|38220302|FG003|Overall Study|Other|0|||
17078910|NCT00312897|38220314|FG000|Overall Study|Adverse Event|1|||
17078911|NCT00312897|38220315|FG001|Overall Study|Adverse Event|0|||
17078912|NCT00312897|38220314|FG000|Overall Study|Lost to Follow-up|2|||
17078913|NCT00312897|38220315|FG001|Overall Study|Lost to Follow-up|0|||
17078914|NCT00312897|38220314|FG000|Overall Study|Physician Decision|1|||
17078915|NCT00312897|38220315|FG001|Overall Study|Physician Decision|0|||
17078916|NCT00312897|38220314|FG000|Overall Study|Withdrawal by Subject|1|||
17078917|NCT00312897|38220315|FG001|Overall Study|Withdrawal by Subject|3|||
17078918|NCT00312897|38220314|FG000|Overall Study|Pregnancy|1|||
17078919|NCT00312897|38220315|FG001|Overall Study|Pregnancy|0|||
17078920|NCT00312897|38220314|FG000|Overall Study|discontinued prior to getting treatment|0|||
17078921|NCT00312897|38220315|FG001|Overall Study|discontinued prior to getting treatment|3|||
17078922|NCT00312663|38220324|FG000|Immunization Phase|Adverse Event|0|||
17078923|NCT00312663|38220325|FG001|Immunization Phase|Adverse Event|1|||
17078924|NCT00312663|38220326|FG002|Immunization Phase|Adverse Event|0|||
17078925|NCT00294645|38220337|FG000|Overall Study|Death|10|||
17078926|NCT00294645|38220338|FG001|Overall Study|Death|18|||
17078927|NCT00294645|38220337|FG000|Overall Study|Lost to Follow-up|1|||
17078928|NCT00294645|38220338|FG001|Overall Study|Lost to Follow-up|10|||
17078929|NCT00294645|38220337|FG000|Overall Study|Withdrawal by Subject|18|||
17078930|NCT00294645|38220338|FG001|Overall Study|Withdrawal by Subject|34|||
17078931|NCT00294645|38220337|FG000|Overall Study|Physician Decision|15|||
17078932|NCT00294645|38220338|FG001|Overall Study|Physician Decision|20|||
17078933|NCT00294645|38220337|FG000|Overall Study|Other|4|||
17078934|NCT00294645|38220338|FG001|Overall Study|Other|10|||
17078935|NCT00305877|38220346|FG000|Overall Study|Lack of Efficacy|6|||
17078936|NCT00305877|38220347|FG001|Overall Study|Lack of Efficacy|9|||
17078937|NCT00305877|38220346|FG000|Overall Study|Adverse Event|9|||
17078938|NCT00305877|38220347|FG001|Overall Study|Adverse Event|14|||
17078939|NCT00305877|38220346|FG000|Overall Study|Death|0|||
17078940|NCT00305877|38220347|FG001|Overall Study|Death|1|||
17078941|NCT00305877|38220346|FG000|Overall Study|Withdrawal by Subject|4|||
17078942|NCT00305877|38220347|FG001|Overall Study|Withdrawal by Subject|2|||
17078943|NCT00305877|38220346|FG000|Overall Study|Physician Decision|1|||
17078944|NCT00305877|38220347|FG001|Overall Study|Physician Decision|1|||
17078945|NCT00305877|38220346|FG000|Overall Study|Never start treatment|2|||
17078946|NCT00305877|38220347|FG001|Overall Study|Never start treatment|5|||
17078947|NCT00305877|38220346|FG000|Overall Study|Ineligible|2|||
17078948|NCT00305877|38220347|FG001|Overall Study|Ineligible|1|||
17078949|NCT00305877|38220346|FG000|Overall Study|Transportation issue with daily RT|0|||
17078950|NCT00305877|38220347|FG001|Overall Study|Transportation issue with daily RT|1|||
17078951|NCT00312195|38220355|FG000|Overall Study|Adverse Event|4|||
17078952|NCT00312195|38220356|FG001|Overall Study|Adverse Event|6|||
17078953|NCT00312195|38220355|FG000|Overall Study|Lost to Follow-up|1|||
17078954|NCT00312195|38220356|FG001|Overall Study|Lost to Follow-up|0|||
17078955|NCT00312195|38220355|FG000|Overall Study|Protocol Violation|1|||
17078956|NCT00312195|38220356|FG001|Overall Study|Protocol Violation|0|||
17078957|NCT00305253|38220366|FG000|Overall Study|Withdrawal by Subject|0|||
17078958|NCT00305253|38220367|FG001|Overall Study|Withdrawal by Subject|1|||
17078959|NCT00293709|38220373|FG000|Overall Study|Other|47|||
17078960|NCT00311181|38220377|FG000|Overall Study|Final DFTs were not obtained|96|||
17078961|NCT00293397|38220381|FG000|Overall Study|Death|2|||
17078962|NCT00290745|38220386|FG000|Overall Study|Withdrawal by Subject|4|||
17078963|NCT00290745|38220386|FG000|Overall Study|Physician Decision|2|||
17078964|NCT00290745|38220386|FG000|Overall Study|Surgery after 3 months for progression|3|||
17078965|NCT00290745|38220386|FG000|Overall Study|Baseline MRI not available|3|||
17078966|NCT00402168|38220392|FG000|Randomized|Lost to Follow-up|1|||
17078967|NCT00402168|38220393|FG001|Randomized|Lost to Follow-up|0|||
17078968|NCT00402168|38220392|FG000|Randomized|Withdrawal by Subject|0|||
17078969|NCT00402168|38220393|FG001|Randomized|Withdrawal by Subject|1|||
17078970|NCT00402168|38220392|FG000|Treatment (up to 12 Months)|Death|0|||
17078971|NCT00402168|38220393|FG001|Treatment (up to 12 Months)|Death|1|||
17078972|NCT00402168|38220392|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
17078973|NCT00402168|38220393|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
17078974|NCT00402168|38220392|FG000|Treatment (up to 12 Months)|non-specified|0|||
17078975|NCT00402168|38220393|FG001|Treatment (up to 12 Months)|non-specified|1|||
17078976|NCT00402168|38220392|FG000|Long Term (LT)|Adverse Event|1|||
17078977|NCT00402168|38220393|FG001|Long Term (LT)|Adverse Event|5|||
17078978|NCT00402168|38220392|FG000|Long Term (LT)|Withdrawal by Subject|4|||
17078979|NCT00402168|38220393|FG001|Long Term (LT)|Withdrawal by Subject|7|||
17078980|NCT00402168|38220392|FG000|Long Term (LT)|Pregnancy|0|||
17078981|NCT00402168|38220393|FG001|Long Term (LT)|Pregnancy|1|||
17078982|NCT00402168|38220392|FG000|Long Term (LT)|Lost to Follow-up|1|||
17078983|NCT00402168|38220393|FG001|Long Term (LT)|Lost to Follow-up|0|||
17078984|NCT00402168|38220392|FG000|Long Term (LT)|Death|4|||
17078985|NCT00402168|38220393|FG001|Long Term (LT)|Death|0|||
17158693|NCT03423173|38305765|FG000|Overall Study|Randomized but not vaccinated|1|||
17158694|NCT03423173|38305766|FG001|Overall Study|Randomized but not vaccinated|0|||
17158695|NCT03423173|38305767|FG002|Overall Study|Randomized but not vaccinated|2|||
17158696|NCT03423173|38305768|FG003|Overall Study|Randomized but not vaccinated|1|||
17158697|NCT03423173|38305765|FG000|Overall Study|Adverse Event|1|||
17158698|NCT03423173|38305766|FG001|Overall Study|Adverse Event|1|||
17158699|NCT03423173|38305767|FG002|Overall Study|Adverse Event|1|||
17158700|NCT03423173|38305768|FG003|Overall Study|Adverse Event|1|||
17158701|NCT03423173|38305765|FG000|Overall Study|Lost to Follow-up|10|||
17158702|NCT03423173|38305766|FG001|Overall Study|Lost to Follow-up|19|||
17158703|NCT03423173|38305767|FG002|Overall Study|Lost to Follow-up|17|||
17158704|NCT03423173|38305768|FG003|Overall Study|Lost to Follow-up|22|||
17158705|NCT03423173|38305765|FG000|Overall Study|Withdrawal of consent|4|||
17158706|NCT03423173|38305766|FG001|Overall Study|Withdrawal of consent|10|||
17158707|NCT03423173|38305767|FG002|Overall Study|Withdrawal of consent|4|||
17158708|NCT03423173|38305768|FG003|Overall Study|Withdrawal of consent|5|||
17158709|NCT03423173|38305765|FG000|Overall Study|Death|1|||
17158710|NCT03423173|38305766|FG001|Overall Study|Death|0|||
17158711|NCT03423173|38305767|FG002|Overall Study|Death|0|||
17158712|NCT03423173|38305768|FG003|Overall Study|Death|0|||
17158713|NCT03423173|38305765|FG000|Overall Study|Reason not Specified|2|||
17158714|NCT03423173|38305766|FG001|Overall Study|Reason not Specified|5|||
17158715|NCT03423173|38305767|FG002|Overall Study|Reason not Specified|3|||
17158716|NCT03423173|38305768|FG003|Overall Study|Reason not Specified|1|||
17158717|NCT03447821|38305781|FG000|Overall Study|Withdrawal by Subject|1|||
17158718|NCT03447821|38305782|FG001|Overall Study|Withdrawal by Subject|1|||
17158719|NCT03447821|38305783|FG002|Overall Study|Withdrawal by Subject|0|||
17158720|NCT03447821|38305781|FG000|Overall Study|Lost to Follow-up|0|||
17158721|NCT03447821|38305782|FG001|Overall Study|Lost to Follow-up|0|||
17158722|NCT03447821|38305783|FG002|Overall Study|Lost to Follow-up|1|||
17158723|NCT03447353|38305797|FG000|Overall Study|Failure at Screening Visit|2|||
17158724|NCT03447353|38305797|FG000|Overall Study|Lost to Follow-up|4|||
17158725|NCT03447353|38305797|FG000|Overall Study|Scheduling Conflicts|3|||
17158726|NCT03447353|38305797|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
17158727|NCT03446885|38305807|FG000|Overall Study|Lost to Follow-up|1|||
17158728|NCT03446885|38305808|FG001|Overall Study|Lost to Follow-up|0|||
17158729|NCT03446885|38305807|FG000|Overall Study|Did not complete entire visit|1|||
17158730|NCT03446885|38305808|FG001|Overall Study|Did not complete entire visit|0|||
17158731|NCT00710970|38305816|FG000|Overall Study|Never took drug|3|||
17158732|NCT03422159|38305822|FG000|Overall Study|Exclusion due to terminal disease|2|||
17158733|NCT03422159|38305823|FG001|Overall Study|Exclusion due to terminal disease|1|||
17158734|NCT03421379|38305833|FG000|Period 1|Withdrawal by Subject|0|||
17158735|NCT03421379|38305834|FG001|Period 1|Withdrawal by Subject|1|||
17158736|NCT03421379|38305833|FG000|Period 1|Physician Decision|1|||
17158737|NCT03421379|38305834|FG001|Period 1|Physician Decision|1|||
17158738|NCT03421379|38305833|FG000|Period 1|Did not receive treatment|1|||
17158739|NCT03421379|38305834|FG001|Period 1|Did not receive treatment|2|||
17158740|NCT02900378|38305842|FG000|Randomization (Visit 2)|Adverse Event|14|||
17158741|NCT02900378|38305843|FG001|Randomization (Visit 2)|Adverse Event|11|||
17158742|NCT02900378|38305842|FG000|Randomization (Visit 2)|Death|1|||
17158743|NCT02900378|38305843|FG001|Randomization (Visit 2)|Death|4|||
17158744|NCT02900378|38305842|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
17158745|NCT02900378|38305843|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
17158746|NCT02900378|38305842|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
17158747|NCT02900378|38305843|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
17158748|NCT02900378|38305842|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
17158749|NCT02900378|38305843|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
17158750|NCT02900378|38305842|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
17158751|NCT02900378|38305843|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
17078986|NCT00402168|38220392|FG000|Long Term (LT)|Lack of Efficacy|0|||
17078987|NCT00402168|38220393|FG001|Long Term (LT)|Lack of Efficacy|2|||
17158752|NCT02900378|38305842|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
17158753|NCT02900378|38305843|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
17158754|NCT03058692|38305851|FG000|Overall Study|Lost to Follow-up|2|||
17158755|NCT03058692|38305852|FG001|Overall Study|Lost to Follow-up|1|||
17158756|NCT03058692|38305851|FG000|Overall Study|Withdrawal by Subject|1|||
17158757|NCT03058692|38305852|FG001|Overall Study|Withdrawal by Subject|1|||
17189067|NCT01060111|38342041|FG001|Overall Study|Adverse Event|5|||
17158758|NCT02964338|38305862|FG000|Overall Study|Sponsor terminated study for futility|12|||
17158759|NCT02964338|38305863|FG001|Overall Study|Sponsor terminated study for futility|15|||
17158760|NCT02964338|38305864|FG002|Overall Study|Sponsor terminated study for futility|14|||
17158761|NCT02964338|38305862|FG000|Overall Study|Lack of Efficacy|0|||
17158762|NCT02964338|38305863|FG001|Overall Study|Lack of Efficacy|3|||
17158763|NCT02964338|38305864|FG002|Overall Study|Lack of Efficacy|0|||
17158764|NCT02964338|38305862|FG000|Overall Study|Lost to Follow-up|1|||
17158765|NCT02964338|38305863|FG001|Overall Study|Lost to Follow-up|0|||
17158766|NCT02964338|38305864|FG002|Overall Study|Lost to Follow-up|3|||
17158767|NCT02964338|38305862|FG000|Overall Study|Protocol Violation|0|||
17078988|NCT00402168|38220392|FG000|Long Term (LT)|non-specified|1|||
17078989|NCT00402168|38220393|FG001|Long Term (LT)|non-specified|2|||
17078990|NCT00402168|38220392|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
17078991|NCT00402168|38220393|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
17078992|NCT00402168|38220392|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
17078993|NCT00402168|38220393|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
17078994|NCT00290589|38220409|FG000|Overall Study|Lost to Follow-up|2|||
17078995|NCT00290589|38220410|FG001|Overall Study|Lost to Follow-up|2|||
17078996|NCT00290511|38220416|FG000|Overall Study|Adverse Event|1|||
17078997|NCT00290511|38220416|FG000|Overall Study|Death|1|||
17078998|NCT00290511|38220416|FG000|Overall Study|Physician Decision|1|||
17078999|NCT00290511|38220416|FG000|Overall Study|Withdrawal by Subject|1|||
17079000|NCT00290433|38220420|FG000|Overall Study|Disease Progression|13|||
17079001|NCT00290433|38220420|FG000|Overall Study|Adverse Event|14|||
17079002|NCT00290433|38220420|FG000|Overall Study|Withdrawal by Subject|1|||
17079003|NCT00290433|38220420|FG000|Overall Study|Non-Compliance|1|||
17079004|NCT00290433|38220420|FG000|Overall Study|Congestive Heart Failure|1|||
17079005|NCT00290433|38220420|FG000|Overall Study|Transplant in CR|5|||
17079006|NCT00290433|38220420|FG000|Overall Study|Unrelated Infection/Death|1|||
17158768|NCT02964338|38305863|FG001|Overall Study|Protocol Violation|1|||
17158769|NCT02964338|38305864|FG002|Overall Study|Protocol Violation|0|||
17158770|NCT02964338|38305862|FG000|Overall Study|Withdrawal by Subject|1|||
17158771|NCT02964338|38305863|FG001|Overall Study|Withdrawal by Subject|3|||
17158772|NCT02964338|38305864|FG002|Overall Study|Withdrawal by Subject|1|||
17158773|NCT02964338|38305862|FG000|Overall Study|Adverse Event|2|||
17158774|NCT02964338|38305863|FG001|Overall Study|Adverse Event|1|||
17158775|NCT02964338|38305864|FG002|Overall Study|Adverse Event|1|||
17158776|NCT02964338|38305862|FG000|Overall Study|Non-compliant with e-diary|0|||
17158777|NCT02964338|38305863|FG001|Overall Study|Non-compliant with e-diary|1|||
17158778|NCT02964338|38305864|FG002|Overall Study|Non-compliant with e-diary|0|||
17158779|NCT02964338|38305862|FG000|Overall Study|Did not meet criteria|1|||
17158780|NCT02964338|38305863|FG001|Overall Study|Did not meet criteria|0|||
17158781|NCT02964338|38305864|FG002|Overall Study|Did not meet criteria|0|||
16995218|NCT01023035|38138923|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
16995219|NCT01023035|38138924|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
16995220|NCT01028651|38138934|FG000|Overall Study|Death|2|||
16995221|NCT01028651|38138934|FG000|Overall Study|Adverse Event|1|||
16995222|NCT01028027|38138942|FG000|Overall Study|Lost to Follow-up|4|||
16995223|NCT01028027|38138943|FG001|Overall Study|Lost to Follow-up|1|||
16995224|NCT01028027|38138942|FG000|Overall Study|Withdrawal by Subject|5|||
16995225|NCT01028027|38138943|FG001|Overall Study|Withdrawal by Subject|3|||
16995226|NCT01028027|38138942|FG000|Overall Study|Adverse Event|4|||
16995227|NCT01028027|38138943|FG001|Overall Study|Adverse Event|7|||
16995228|NCT01028027|38138942|FG000|Overall Study|Protocol Violation|3|||
16995229|NCT01028027|38138943|FG001|Overall Study|Protocol Violation|1|||
16995230|NCT01028027|38138942|FG000|Overall Study|Lack of Efficacy|0|||
16995231|NCT01028027|38138943|FG001|Overall Study|Lack of Efficacy|1|||
16995232|NCT01007552|38138949|FG000|Overall Study|Withdrawal by Subject|1|||
16995233|NCT01007396|38138953|FG000|Overall Study|Lost to Follow-up|47|||
16995234|NCT00998738|38138957|FG000|Overall Study|Uknown|1|||
16995235|NCT00997334|38138961|FG000|Overall Study|still on therapy|12|||
16995236|NCT00997334|38138961|FG000|Overall Study|Adverse Event|3|||
16995237|NCT00997334|38138961|FG000|Overall Study|Patient non-compliance|1|||
16995238|NCT00997334|38138961|FG000|Overall Study|Withdrawal by Subject|3|||
16995239|NCT00997334|38138961|FG000|Overall Study|Death|2|||
16995240|NCT00997334|38138961|FG000|Overall Study|Urgent Palliative Care|2|||
16995241|NCT00997334|38138961|FG000|Overall Study|No lesion amenable|1|||
16995242|NCT00997334|38138961|FG000|Overall Study|Ineligible|1|||
16995243|NCT00996944|38138967|FG000|Double-blind Treatment Period|Adverse Event|2|||
16995244|NCT00996944|38138968|FG001|Double-blind Treatment Period|Adverse Event|1|||
16995245|NCT00996944|38138967|FG000|Double-blind Treatment Period|Protocol Violation|1|||
16995246|NCT00996944|38138968|FG001|Double-blind Treatment Period|Protocol Violation|0|||
16995247|NCT00996944|38138967|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
17079007|NCT00304083|38220426|FG000|Overall Study|Withdrawal by Subject|4|||
17079008|NCT00304083|38220427|FG001|Overall Study|Withdrawal by Subject|2|||
17079009|NCT00304083|38220426|FG000|Overall Study|Physician Decision|8|||
17079010|NCT00304083|38220427|FG001|Overall Study|Physician Decision|3|||
17079011|NCT00304083|38220426|FG000|Overall Study|Disease Progression|5|||
17079012|NCT00304083|38220427|FG001|Overall Study|Disease Progression|1|||
17079013|NCT00304083|38220426|FG000|Overall Study|Other|5|||
17079014|NCT00304083|38220427|FG001|Overall Study|Other|2|||
17079015|NCT00293241|38220435|FG000|Overall Study|Lost to Follow-up|9|||
17079016|NCT00293241|38220436|FG001|Overall Study|Lost to Follow-up|16|||
17079017|NCT00293241|38220435|FG000|Overall Study|Physician Decision|23|||
17079018|NCT00293241|38220436|FG001|Overall Study|Physician Decision|17|||
17079019|NCT00293241|38220435|FG000|Overall Study|Withdrawal by Subject|4|||
17079020|NCT00293241|38220436|FG001|Overall Study|Withdrawal by Subject|8|||
17158782|NCT03056352|38305872|FG000|Overall Study|Lost to Follow-up|1|||
17158783|NCT03446573|38305878|FG000|Overall Study|Withdrawal by Subject|7|||
17158784|NCT03446573|38305879|FG001|Overall Study|Withdrawal by Subject|16|||
17158785|NCT03446573|38305878|FG000|Overall Study|Physician Decision|1|||
17158786|NCT03446573|38305879|FG001|Overall Study|Physician Decision|1|||
17158787|NCT03446573|38305878|FG000|Overall Study|Lost to Follow-up|3|||
17079021|NCT00391092|38220447|FG000|Overall Study|Death|78|||
17079022|NCT00391092|38220448|FG001|Overall Study|Death|81|||
17079023|NCT00391092|38220447|FG000|Overall Study|Lost to Follow-up|13|||
17079024|NCT00391092|38220448|FG001|Overall Study|Lost to Follow-up|18|||
17079025|NCT00391092|38220447|FG000|Overall Study|Alive on treatment|29|||
17079026|NCT00391092|38220448|FG001|Overall Study|Alive on treatment|33|||
17079027|NCT00391092|38220447|FG000|Overall Study|Alive in follow-up|88|||
17079028|NCT00391092|38220448|FG001|Overall Study|Alive in follow-up|84|||
17079029|NCT00374868|38220454|FG000|Overall Study|Adverse Event|12|||
17079030|NCT00374868|38220454|FG000|Overall Study|Progressive Disease|7|||
17079031|NCT00374868|38220454|FG000|Overall Study|Physician Decision|13|||
17079032|NCT00374868|38220454|FG000|Overall Study|Lost to Follow-up|1|||
17079033|NCT00374868|38220454|FG000|Overall Study|Death|2|||
17079034|NCT00374868|38220454|FG000|Overall Study|Other - Not Specified|1|||
17079035|NCT00374556|38220460|FG000|Overall Study|Lost to Follow-up|1|||
17079036|NCT00374556|38220461|FG001|Overall Study|Lost to Follow-up|0|||
17079037|NCT00374556|38220460|FG000|Overall Study|Removed at baseline due to medical cond|0|||
17079038|NCT00374556|38220461|FG001|Overall Study|Removed at baseline due to medical cond|1|||
17079039|NCT00290355|38220469|FG000|Overall Study|Serious adverse event|7|||
17079040|NCT00290355|38220470|FG001|Overall Study|Serious adverse event|4|||
17079041|NCT00290355|38220469|FG000|Overall Study|Study product reactogenicity|1|||
17079042|NCT00290355|38220470|FG001|Overall Study|Study product reactogenicity|0|||
17158788|NCT03446573|38305879|FG001|Overall Study|Lost to Follow-up|5|||
17158789|NCT03446573|38305878|FG000|Overall Study|Protocol Violation|3|||
17158790|NCT03446573|38305879|FG001|Overall Study|Protocol Violation|2|||
17158791|NCT03446573|38305878|FG000|Overall Study|Lack of Efficacy|0|||
17158792|NCT03446573|38305879|FG001|Overall Study|Lack of Efficacy|3|||
17158793|NCT03446573|38305878|FG000|Overall Study|Adverse Event|13|||
17158794|NCT03446573|38305879|FG001|Overall Study|Adverse Event|2|||
17158795|NCT03446573|38305878|FG000|Overall Study|Ongoing at the time of interim analysis|342|||
17158796|NCT03446573|38305879|FG001|Overall Study|Ongoing at the time of interim analysis|343|||
17158797|NCT02898662|38305890|FG000|Overall Study|Adverse Event|1|||
17158798|NCT02898662|38305891|FG001|Overall Study|Adverse Event|0|||
17158799|NCT02898662|38305890|FG000|Overall Study|Loss of asthma control|23|||
17158800|NCT02898662|38305891|FG001|Overall Study|Loss of asthma control|24|||
17158801|NCT02898662|38305890|FG000|Overall Study|Withdrawal by Subject|4|||
17158802|NCT02898662|38305891|FG001|Overall Study|Withdrawal by Subject|1|||
17158803|NCT02898662|38305890|FG000|Overall Study|Technical issue|0|||
17158804|NCT02898662|38305891|FG001|Overall Study|Technical issue|1|||
17158805|NCT02898662|38305890|FG000|Overall Study|Randomized in error|0|||
17158806|NCT02898662|38305891|FG001|Overall Study|Randomized in error|1|||
17158807|NCT02898662|38305890|FG000|Overall Study|Subject decision|1|||
17158808|NCT02898662|38305891|FG001|Overall Study|Subject decision|0|||
17158809|NCT02898662|38305890|FG000|Overall Study|Other|0|||
17158810|NCT02898662|38305891|FG001|Overall Study|Other|1|||
17158811|NCT03055338|38305900|FG000|Overall Study|Lost to Follow-up|9|||
17079043|NCT00290355|38220469|FG000|Overall Study|Protocol Violation|1|||
17079044|NCT00290355|38220470|FG001|Overall Study|Protocol Violation|0|||
17079045|NCT00290355|38220469|FG000|Overall Study|Withdrawal by Subject|2|||
17079046|NCT00290355|38220470|FG001|Overall Study|Withdrawal by Subject|0|||
17079047|NCT00290355|38220469|FG000|Overall Study|Migrated / moved from the study area|1|||
17079048|NCT00290355|38220470|FG001|Overall Study|Migrated / moved from the study area|0|||
17079049|NCT00290355|38220469|FG000|Overall Study|Lost to Follow-up|3|||
17079050|NCT00290355|38220470|FG001|Overall Study|Lost to Follow-up|1|||
17079051|NCT00290355|38220469|FG000|Overall Study|Other|2|||
17079052|NCT00290355|38220470|FG001|Overall Study|Other|0|||
17079053|NCT00374322|38220478|FG000|Overall Study|Lost to Follow-up|92|||
17079054|NCT00374322|38220479|FG001|Overall Study|Lost to Follow-up|90|||
17079055|NCT00374322|38220478|FG000|Overall Study|Protocol Violation|8|||
17079056|NCT00374322|38220479|FG001|Overall Study|Protocol Violation|3|||
17079057|NCT00374322|38220478|FG000|Overall Study|Withdrawal by Subject|235|||
17158812|NCT03055338|38305901|FG001|Overall Study|Lost to Follow-up|2|||
17158813|NCT03055338|38305902|FG002|Overall Study|Lost to Follow-up|3|||
17079058|NCT00374322|38220479|FG001|Overall Study|Withdrawal by Subject|167|||
17079059|NCT00374322|38220478|FG000|Overall Study|Sponsor Terminated Study|866|||
17079060|NCT00374322|38220479|FG001|Overall Study|Sponsor Terminated Study|990|||
17079061|NCT00374322|38220478|FG000|Overall Study|Physician Decision|36|||
17079062|NCT00374322|38220479|FG001|Overall Study|Physician Decision|32|||
17079063|NCT00374322|38220478|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
17079064|NCT00374322|38220479|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
17079065|NCT00374322|38220478|FG000|Overall Study|Sponsor Decision|2|||
17079066|NCT00374322|38220479|FG001|Overall Study|Sponsor Decision|3|||
17079067|NCT00374322|38220478|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
17079068|NCT00374322|38220479|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
17079069|NCT00374322|38220478|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
17079070|NCT00374322|38220479|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
17079071|NCT00374322|38220478|FG000|Overall Study|Severe Toxicity|1|||
17079072|NCT00374322|38220479|FG001|Overall Study|Severe Toxicity|0|||
17079073|NCT00374322|38220478|FG000|Overall Study|Site Closed|2|||
17079074|NCT00374322|38220479|FG001|Overall Study|Site Closed|2|||
17079075|NCT00374322|38220478|FG000|Overall Study|Participant Changed Physician|1|||
17079076|NCT00374322|38220479|FG001|Overall Study|Participant Changed Physician|0|||
17079077|NCT00374322|38220478|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
17079078|NCT00374322|38220479|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
17079079|NCT00374322|38220478|FG000|Overall Study|Noncompliance with Study Requirements|0|||
17079080|NCT00374322|38220479|FG001|Overall Study|Noncompliance with Study Requirements|1|||
17079081|NCT00374322|38220478|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
17079082|NCT00374322|38220479|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
17079083|NCT00374322|38220478|FG000|Overall Study|Did Not Receive Study Medication|8|||
17079084|NCT00374322|38220479|FG001|Overall Study|Did Not Receive Study Medication|6|||
17079085|NCT00303459|38220488|FG000|Overall Study|Death|33|||
17079086|NCT00303459|38220489|FG001|Overall Study|Death|44|||
17079087|NCT00303459|38220488|FG000|Overall Study|Withdrawal of consent|32|||
17079088|NCT00303459|38220489|FG001|Overall Study|Withdrawal of consent|26|||
17079089|NCT00303459|38220488|FG000|Overall Study|Lost to Follow-up|5|||
17079090|NCT00303459|38220489|FG001|Overall Study|Lost to Follow-up|4|||
17079091|NCT00303459|38220488|FG000|Overall Study|Administrative reason|7|||
17079092|NCT00303459|38220489|FG001|Overall Study|Administrative reason|7|||
17079093|NCT00303459|38220488|FG000|Overall Study|Decision by the investigator|5|||
17079094|NCT00303459|38220489|FG001|Overall Study|Decision by the investigator|7|||
17079095|NCT00303459|38220488|FG000|Overall Study|Lung transplantation|1|||
17079096|NCT00303459|38220489|FG001|Overall Study|Lung transplantation|1|||
17079097|NCT00289887|38220498|FG000|Overall Study|Adverse Event|3|||
17079098|NCT00289887|38220499|FG001|Overall Study|Adverse Event|3|||
17079099|NCT00289887|38220498|FG000|Overall Study|Lack of Efficacy|3|||
17079100|NCT00289887|38220499|FG001|Overall Study|Lack of Efficacy|11|||
17079101|NCT00289887|38220498|FG000|Overall Study|Lost to Follow-up|3|||
17079102|NCT00289887|38220499|FG001|Overall Study|Lost to Follow-up|3|||
17079103|NCT00289887|38220498|FG000|Overall Study|Protocol Violation|3|||
17079104|NCT00289887|38220499|FG001|Overall Study|Protocol Violation|1|||
17079105|NCT00289887|38220498|FG000|Overall Study|Withdrawal by Subject|3|||
17079106|NCT00289887|38220499|FG001|Overall Study|Withdrawal by Subject|8|||
17079107|NCT00289887|38220498|FG000|Overall Study|Other|7|||
17079108|NCT00289887|38220499|FG001|Overall Study|Other|3|||
17079109|NCT00303069|38220509|FG000|Overall Study|Lost to Follow-up|1|||
17079110|NCT00303069|38220510|FG001|Overall Study|Lost to Follow-up|0|||
17079111|NCT00303069|38220511|FG002|Overall Study|Lost to Follow-up|0|||
17079112|NCT00303069|38220512|FG003|Overall Study|Lost to Follow-up|2|||
17079113|NCT00303069|38220509|FG000|Overall Study|subject moved|1|||
17079114|NCT00303069|38220510|FG001|Overall Study|subject moved|0|||
17079115|NCT00303069|38220511|FG002|Overall Study|subject moved|0|||
17079116|NCT00303069|38220512|FG003|Overall Study|subject moved|0|||
17079117|NCT00303069|38220509|FG000|Overall Study|Recruitment into Army Reserves|0|||
17079118|NCT00303069|38220510|FG001|Overall Study|Recruitment into Army Reserves|0|||
17079119|NCT00303069|38220511|FG002|Overall Study|Recruitment into Army Reserves|1|||
17079120|NCT00303069|38220512|FG003|Overall Study|Recruitment into Army Reserves|0|||
17079121|NCT00401544|38220526|FG000|Overall Study|Adverse Event|5|||
17079122|NCT00401544|38220527|FG001|Overall Study|Adverse Event|1|||
17079123|NCT00401544|38220528|FG002|Overall Study|Adverse Event|1|||
17079124|NCT00401544|38220529|FG003|Overall Study|Adverse Event|1|||
17079125|NCT00401544|38220526|FG000|Overall Study|Death|3|||
17079126|NCT00401544|38220527|FG001|Overall Study|Death|6|||
17158814|NCT03055338|38305900|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
17158815|NCT03055338|38305901|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
17158816|NCT03055338|38305902|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
17079127|NCT00401544|38220528|FG002|Overall Study|Death|2|||
17079128|NCT00401544|38220529|FG003|Overall Study|Death|5|||
17079129|NCT00401544|38220526|FG000|Overall Study|Lost to Follow-up|2|||
17079130|NCT00401544|38220527|FG001|Overall Study|Lost to Follow-up|0|||
17158817|NCT03055338|38305900|FG000|Overall Study|Physician Decision|0|||
17079131|NCT00401544|38220528|FG002|Overall Study|Lost to Follow-up|1|||
17079132|NCT00401544|38220529|FG003|Overall Study|Lost to Follow-up|1|||
17079133|NCT00401544|38220526|FG000|Overall Study|Withdrawal by Subject|7|||
17079134|NCT00401544|38220527|FG001|Overall Study|Withdrawal by Subject|6|||
17079135|NCT00401544|38220528|FG002|Overall Study|Withdrawal by Subject|6|||
17079136|NCT00401544|38220529|FG003|Overall Study|Withdrawal by Subject|5|||
17079137|NCT00401544|38220526|FG000|Overall Study|Physician Decision|1|||
17079138|NCT00401544|38220527|FG001|Overall Study|Physician Decision|3|||
17079139|NCT00401544|38220528|FG002|Overall Study|Physician Decision|0|||
17079140|NCT00401544|38220529|FG003|Overall Study|Physician Decision|0|||
17079141|NCT00401544|38220526|FG000|Overall Study|Ineligibility determined|0|||
17079142|NCT00401544|38220527|FG001|Overall Study|Ineligibility determined|1|||
17079143|NCT00401544|38220528|FG002|Overall Study|Ineligibility determined|0|||
17079144|NCT00401544|38220529|FG003|Overall Study|Ineligibility determined|2|||
17079145|NCT00401544|38220526|FG000|Overall Study|Disease progression|0|||
17079146|NCT00401544|38220527|FG001|Overall Study|Disease progression|1|||
17079147|NCT00401544|38220528|FG002|Overall Study|Disease progression|0|||
17079148|NCT00401544|38220529|FG003|Overall Study|Disease progression|0|||
17158818|NCT03055338|38305901|FG001|Overall Study|Physician Decision|0|||
17158819|NCT03055338|38305902|FG002|Overall Study|Physician Decision|2|||
17079149|NCT00401544|38220526|FG000|Overall Study|Other|0|||
17079150|NCT00401544|38220527|FG001|Overall Study|Other|0|||
17079151|NCT00401544|38220528|FG002|Overall Study|Other|2|||
17079152|NCT00401544|38220529|FG003|Overall Study|Other|2|||
17079153|NCT00289731|38220547|FG000|Overall Study|Adverse Event|1|||
17079154|NCT00289731|38220548|FG001|Overall Study|Adverse Event|2|||
17079155|NCT00289731|38220549|FG002|Overall Study|Adverse Event|2|||
17079156|NCT00289731|38220547|FG000|Overall Study|Other|1|||
17079157|NCT00289731|38220548|FG001|Overall Study|Other|0|||
17079158|NCT00289731|38220549|FG002|Overall Study|Other|0|||
17079159|NCT00289185|38220561|FG000|Overall Study|Withdrawal by Subject|4|||
17079160|NCT00289185|38220562|FG001|Overall Study|Withdrawal by Subject|8|||
17079161|NCT00289185|38220561|FG000|Overall Study|Lost to Follow-up|23|||
17079162|NCT00289185|38220562|FG001|Overall Study|Lost to Follow-up|17|||
17079163|NCT00289185|38220561|FG000|Overall Study|Death|1|||
17079164|NCT00289185|38220562|FG001|Overall Study|Death|1|||
17079165|NCT00292461|38220571|FG000|Overall Study|Adverse Event|4|||
17079166|NCT00292461|38220572|FG001|Overall Study|Adverse Event|2|||
17079167|NCT00292461|38220571|FG000|Overall Study|Lack of Efficacy|1|||
17079168|NCT00292461|38220572|FG001|Overall Study|Lack of Efficacy|0|||
17079169|NCT00292461|38220571|FG000|Overall Study|Withdrawal by Subject|0|||
17079170|NCT00292461|38220572|FG001|Overall Study|Withdrawal by Subject|1|||
17079171|NCT00292461|38220571|FG000|Overall Study|Protocol Violation|4|||
17079172|NCT00292461|38220572|FG001|Overall Study|Protocol Violation|3|||
17079173|NCT00292461|38220571|FG000|Overall Study|Lost to Follow-up|1|||
17079174|NCT00292461|38220572|FG001|Overall Study|Lost to Follow-up|0|||
17079175|NCT00288639|38220578|FG000|Overall Study|Adverse Event|5|||
17079176|NCT00288639|38220578|FG000|Overall Study|Lack of Efficacy|4|||
17079177|NCT00288639|38220578|FG000|Overall Study|Withdrawal by Subject|2|||
17079178|NCT00288639|38220578|FG000|Overall Study|Other|1|||
17079179|NCT00390858|38220584|FG000|Overall Study|Adverse Event|6|||
17158820|NCT03055338|38305900|FG000|Overall Study|Withdrawal by Subject|9|||
16995248|NCT00996944|38138968|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
16995249|NCT00996944|38138967|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16995250|NCT00996944|38138968|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
16995251|NCT00996944|38138967|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
16995252|NCT00996944|38138968|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
16995253|NCT01002482|38138978|FG000|Overall Study|Withdrawal by Subject|14|||
16995254|NCT01002482|38138979|FG001|Overall Study|Withdrawal by Subject|21|||
16995255|NCT01002482|38138978|FG000|Overall Study|Included twice|1|||
16995256|NCT01002482|38138979|FG001|Overall Study|Included twice|0|||
16995257|NCT01027949|38138985|FG000|Overall Study|Death|174|||
16995258|NCT01027949|38138985|FG000|Overall Study|Progressive Disease|163|||
16995259|NCT01027949|38138985|FG000|Overall Study|Adverse Event|172|||
16995260|NCT01027949|38138985|FG000|Overall Study|Withdrawal by Subject|113|||
16995261|NCT01027949|38138985|FG000|Overall Study|Lost to Follow-up|17|||
16995262|NCT01027949|38138985|FG000|Overall Study|Protocol Violation|13|||
16995263|NCT01027949|38138985|FG000|Overall Study|PI Decision|8|||
16995264|NCT01027949|38138985|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
17079180|NCT00390858|38220585|FG001|Overall Study|Adverse Event|2|||
17079181|NCT00390858|38220584|FG000|Overall Study|Lack of Efficacy|0|||
17079182|NCT00390858|38220585|FG001|Overall Study|Lack of Efficacy|1|||
17079183|NCT00390858|38220584|FG000|Overall Study|Withdrawal by Subject|3|||
17079184|NCT00390858|38220585|FG001|Overall Study|Withdrawal by Subject|4|||
17079185|NCT00390780|38220593|FG000|Overall Study|Not completed|10|||
17079186|NCT00390780|38220594|FG001|Overall Study|Not completed|4|||
17079187|NCT00390780|38220593|FG000|Overall Study|Protocol Violation|6|||
17079188|NCT00390780|38220594|FG001|Overall Study|Protocol Violation|4|||
17079189|NCT00390780|38220593|FG000|Overall Study|Lost to Follow-up|3|||
17158821|NCT03055338|38305901|FG001|Overall Study|Withdrawal by Subject|8|||
17158822|NCT03055338|38305902|FG002|Overall Study|Withdrawal by Subject|7|||
17158823|NCT03913130|38305910|FG000|Overall Study|Sponsor Decision|1|||
17158824|NCT03419741|38305916|FG000|Overall Study|Adverse Event|1|||
17158825|NCT03419741|38305917|FG001|Overall Study|Adverse Event|0|||
17158826|NCT03419741|38305916|FG000|Overall Study|Withdrawal by Subject|1|||
17158827|NCT03419741|38305917|FG001|Overall Study|Withdrawal by Subject|2|||
17158828|NCT02896400|38305939|FG000|1 Month Follow-up|Lost to Follow-up|7|||
17158829|NCT02896400|38305940|FG001|1 Month Follow-up|Lost to Follow-up|7|||
17158830|NCT02896400|38305941|FG002|1 Month Follow-up|Lost to Follow-up|5|||
17158831|NCT02896400|38305942|FG003|1 Month Follow-up|Lost to Follow-up|8|||
17158832|NCT02896400|38305943|FG004|1 Month Follow-up|Lost to Follow-up|9|||
17158833|NCT02896400|38305944|FG005|1 Month Follow-up|Lost to Follow-up|6|||
17158834|NCT02896400|38305945|FG006|1 Month Follow-up|Lost to Follow-up|5|||
17158835|NCT02896400|38305946|FG007|1 Month Follow-up|Lost to Follow-up|6|||
17158836|NCT02896400|38305947|FG008|1 Month Follow-up|Lost to Follow-up|4|||
17158837|NCT02896400|38305948|FG009|1 Month Follow-up|Lost to Follow-up|7|||
17158838|NCT02896400|38305949|FG010|1 Month Follow-up|Lost to Follow-up|5|||
17158839|NCT02896400|38305950|FG011|1 Month Follow-up|Lost to Follow-up|5|||
17158840|NCT02896400|38305951|FG012|1 Month Follow-up|Lost to Follow-up|3|||
17158841|NCT02896400|38305952|FG013|1 Month Follow-up|Lost to Follow-up|4|||
17158842|NCT02896400|38305953|FG014|1 Month Follow-up|Lost to Follow-up|1|||
17158843|NCT02896400|38305954|FG015|1 Month Follow-up|Lost to Follow-up|2|||
17158844|NCT02896400|38305939|FG000|1 Month Follow-up|Death|0|||
17158845|NCT02896400|38305940|FG001|1 Month Follow-up|Death|0|||
17158846|NCT02896400|38305941|FG002|1 Month Follow-up|Death|0|||
17158847|NCT02896400|38305942|FG003|1 Month Follow-up|Death|0|||
17158848|NCT02896400|38305943|FG004|1 Month Follow-up|Death|0|||
17158849|NCT02896400|38305944|FG005|1 Month Follow-up|Death|0|||
17158850|NCT02896400|38305945|FG006|1 Month Follow-up|Death|0|||
17158851|NCT02896400|38305946|FG007|1 Month Follow-up|Death|0|||
17158852|NCT02896400|38305947|FG008|1 Month Follow-up|Death|0|||
17158853|NCT02896400|38305948|FG009|1 Month Follow-up|Death|0|||
17158854|NCT02896400|38305949|FG010|1 Month Follow-up|Death|0|||
17079190|NCT00390780|38220594|FG001|Overall Study|Lost to Follow-up|6|||
17079191|NCT00390780|38220593|FG000|Overall Study|Adverse Event|2|||
17079192|NCT00390780|38220594|FG001|Overall Study|Adverse Event|3|||
17079193|NCT00390780|38220593|FG000|Overall Study|Death|1|||
17079194|NCT00390780|38220594|FG001|Overall Study|Death|3|||
17079195|NCT00390780|38220593|FG000|Overall Study|Withdrawal by Subject|1|||
17079196|NCT00390780|38220594|FG001|Overall Study|Withdrawal by Subject|2|||
17079197|NCT00390780|38220593|FG000|Overall Study|Inclusion criteria not satisfied|0|||
17079198|NCT00390780|38220594|FG001|Overall Study|Inclusion criteria not satisfied|2|||
17079199|NCT00390780|38220593|FG000|Overall Study|Lost to follow up and other reasons|0|||
17079200|NCT00390780|38220594|FG001|Overall Study|Lost to follow up and other reasons|1|||
17079201|NCT00390780|38220593|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
17079202|NCT00390780|38220594|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
17079203|NCT00390780|38220593|FG000|Overall Study|SAE, death|0|||
17079204|NCT00390780|38220594|FG001|Overall Study|SAE, death|1|||
17079205|NCT00390546|38220602|FG000|Overall Study|Renal impairment|1|||
17079206|NCT00390546|38220603|FG001|Overall Study|Renal impairment|0|||
17079207|NCT00390546|38220602|FG000|Overall Study|Physician Decision|5|||
17079208|NCT00390546|38220603|FG001|Overall Study|Physician Decision|5|||
17079209|NCT00390468|38220610|FG000|Overall Study|Protocol Violation|2|||
17079210|NCT00390468|38220610|FG000|Overall Study|Lack of Efficacy|1|||
17079211|NCT00400764|38220619|FG000|Phase Ib|Adverse Event|1|||
17079212|NCT00400764|38220620|FG001|Phase Ib|Adverse Event|0|||
17079213|NCT00400764|38220621|FG002|Phase Ib|Adverse Event|0|||
17079214|NCT00400764|38220622|FG003|Phase Ib|Adverse Event|0|||
17079215|NCT00400764|38220623|FG004|Phase Ib|Adverse Event|0|||
17079216|NCT00400764|38220619|FG000|Phase Ib|Death|1|||
17079217|NCT00400764|38220620|FG001|Phase Ib|Death|0|||
17079218|NCT00400764|38220621|FG002|Phase Ib|Death|0|||
17079219|NCT00400764|38220622|FG003|Phase Ib|Death|0|||
17079220|NCT00400764|38220623|FG004|Phase Ib|Death|0|||
17079221|NCT00400764|38220619|FG000|Phase Ib|Disease Progression|4|||
17079222|NCT00400764|38220620|FG001|Phase Ib|Disease Progression|4|||
17079223|NCT00400764|38220621|FG002|Phase Ib|Disease Progression|0|||
17079224|NCT00400764|38220622|FG003|Phase Ib|Disease Progression|0|||
17079225|NCT00400764|38220623|FG004|Phase Ib|Disease Progression|0|||
17079226|NCT00400764|38220619|FG000|Phase II|Death|0|||
17079227|NCT00400764|38220620|FG001|Phase II|Death|0|||
17079228|NCT00400764|38220621|FG002|Phase II|Death|1|||
17079229|NCT00400764|38220622|FG003|Phase II|Death|2|||
17079230|NCT00400764|38220623|FG004|Phase II|Death|0|||
17158855|NCT02896400|38305950|FG011|1 Month Follow-up|Death|0|||
17079231|NCT00400764|38220619|FG000|Phase II|Lost to Follow-up|0|||
17079232|NCT00400764|38220620|FG001|Phase II|Lost to Follow-up|0|||
17079233|NCT00400764|38220621|FG002|Phase II|Lost to Follow-up|1|||
17079234|NCT00400764|38220622|FG003|Phase II|Lost to Follow-up|0|||
17079235|NCT00400764|38220623|FG004|Phase II|Lost to Follow-up|0|||
17079236|NCT00400764|38220619|FG000|Phase II|Physician Decision|0|||
17079237|NCT00400764|38220620|FG001|Phase II|Physician Decision|0|||
17079238|NCT00400764|38220621|FG002|Phase II|Physician Decision|1|||
17079239|NCT00400764|38220622|FG003|Phase II|Physician Decision|1|||
17079240|NCT00400764|38220623|FG004|Phase II|Physician Decision|0|||
17079241|NCT00400764|38220619|FG000|Phase II|Sponsor's decision to terminate|0|||
17079242|NCT00400764|38220620|FG001|Phase II|Sponsor's decision to terminate|0|||
17158856|NCT02896400|38305951|FG012|1 Month Follow-up|Death|0|||
17158857|NCT02896400|38305952|FG013|1 Month Follow-up|Death|0|||
17158858|NCT02896400|38305953|FG014|1 Month Follow-up|Death|0|||
17158859|NCT02896400|38305954|FG015|1 Month Follow-up|Death|1|||
17158860|NCT02896400|38305939|FG000|3 Month Follow-up|Lost to Follow-up|6|||
17158861|NCT02896400|38305940|FG001|3 Month Follow-up|Lost to Follow-up|3|||
17158862|NCT02896400|38305941|FG002|3 Month Follow-up|Lost to Follow-up|6|||
17158863|NCT02896400|38305942|FG003|3 Month Follow-up|Lost to Follow-up|11|||
17158864|NCT02896400|38305943|FG004|3 Month Follow-up|Lost to Follow-up|12|||
17158865|NCT02896400|38305944|FG005|3 Month Follow-up|Lost to Follow-up|6|||
17158866|NCT02896400|38305945|FG006|3 Month Follow-up|Lost to Follow-up|4|||
17158867|NCT02896400|38305946|FG007|3 Month Follow-up|Lost to Follow-up|3|||
17158868|NCT02896400|38305947|FG008|3 Month Follow-up|Lost to Follow-up|6|||
17158869|NCT02896400|38305948|FG009|3 Month Follow-up|Lost to Follow-up|5|||
17158870|NCT02896400|38305949|FG010|3 Month Follow-up|Lost to Follow-up|6|||
17158871|NCT02896400|38305950|FG011|3 Month Follow-up|Lost to Follow-up|6|||
17158872|NCT02896400|38305951|FG012|3 Month Follow-up|Lost to Follow-up|3|||
17158873|NCT02896400|38305952|FG013|3 Month Follow-up|Lost to Follow-up|5|||
17158874|NCT02896400|38305953|FG014|3 Month Follow-up|Lost to Follow-up|3|||
17158875|NCT02896400|38305954|FG015|3 Month Follow-up|Lost to Follow-up|2|||
17158876|NCT02896400|38305939|FG000|3 Month Follow-up|Death|0|||
17158877|NCT02896400|38305940|FG001|3 Month Follow-up|Death|0|||
17158878|NCT02896400|38305941|FG002|3 Month Follow-up|Death|0|||
17158879|NCT02896400|38305942|FG003|3 Month Follow-up|Death|0|||
17158880|NCT02896400|38305943|FG004|3 Month Follow-up|Death|0|||
17158881|NCT02896400|38305944|FG005|3 Month Follow-up|Death|0|||
17158882|NCT02896400|38305945|FG006|3 Month Follow-up|Death|0|||
17079243|NCT00400764|38220621|FG002|Phase II|Sponsor's decision to terminate|18|||
17079244|NCT00400764|38220622|FG003|Phase II|Sponsor's decision to terminate|22|||
17079245|NCT00400764|38220623|FG004|Phase II|Sponsor's decision to terminate|11|||
17079246|NCT00400764|38220619|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
17079247|NCT00400764|38220620|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
17079248|NCT00400764|38220621|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
17079249|NCT00400764|38220622|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
17079250|NCT00400764|38220623|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
17079251|NCT00400764|38220619|FG000|Phase II|Withdrawal by Subject|0|||
17079252|NCT00400764|38220620|FG001|Phase II|Withdrawal by Subject|0|||
17079253|NCT00400764|38220621|FG002|Phase II|Withdrawal by Subject|1|||
17079254|NCT00400764|38220622|FG003|Phase II|Withdrawal by Subject|1|||
17079255|NCT00400764|38220623|FG004|Phase II|Withdrawal by Subject|0|||
17079256|NCT00302211|38220643|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
17079257|NCT00302211|38220644|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
17079258|NCT00302211|38220645|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
17079259|NCT00302211|38220646|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
17079260|NCT00302211|38220647|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
17079261|NCT00302211|38220643|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
17079262|NCT00302211|38220644|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
17079263|NCT00302211|38220645|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
17079264|NCT00302211|38220646|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
17079265|NCT00302211|38220647|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
17079266|NCT00302211|38220643|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
17079267|NCT00302211|38220644|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
17079268|NCT00302211|38220645|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
17079269|NCT00302211|38220646|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
17079270|NCT00302211|38220647|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
17158883|NCT02896400|38305946|FG007|3 Month Follow-up|Death|0|||
17158884|NCT02896400|38305947|FG008|3 Month Follow-up|Death|0|||
17158885|NCT02896400|38305948|FG009|3 Month Follow-up|Death|0|||
17158886|NCT02896400|38305949|FG010|3 Month Follow-up|Death|0|||
17158887|NCT02896400|38305950|FG011|3 Month Follow-up|Death|0|||
17158888|NCT02896400|38305951|FG012|3 Month Follow-up|Death|0|||
17158889|NCT02896400|38305952|FG013|3 Month Follow-up|Death|1|||
17158890|NCT02896400|38305953|FG014|3 Month Follow-up|Death|1|||
17158891|NCT02896400|38305954|FG015|3 Month Follow-up|Death|0|||
17189068|NCT01060111|38342042|FG002|Overall Study|Adverse Event|18|||
17158892|NCT02896400|38305939|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
17158893|NCT02896400|38305940|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
17158894|NCT02896400|38305941|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
17158895|NCT02896400|38305942|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
17158896|NCT02896400|38305943|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
17158897|NCT02896400|38305944|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
17158898|NCT02896400|38305945|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
17158899|NCT02896400|38305946|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
17158900|NCT02896400|38305947|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
17158901|NCT02896400|38305948|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
17158902|NCT02896400|38305949|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
17158903|NCT02896400|38305950|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
17158904|NCT02896400|38305951|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
17158905|NCT02896400|38305952|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
17158906|NCT02896400|38305953|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
17158907|NCT02896400|38305954|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
17158908|NCT02896400|38305939|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
17158909|NCT02896400|38305940|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
17158910|NCT02896400|38305941|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
17158911|NCT02896400|38305942|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
17079271|NCT00302211|38220643|FG000|Double Blind Period (New Patients)|Disease progression|0|||
17079272|NCT00302211|38220644|FG001|Double Blind Period (New Patients)|Disease progression|1|||
17079273|NCT00302211|38220645|FG002|Double Blind Period (New Patients)|Disease progression|1|||
17079274|NCT00302211|38220646|FG003|Double Blind Period (New Patients)|Disease progression|0|||
17079275|NCT00302211|38220647|FG004|Double Blind Period (New Patients)|Disease progression|0|||
17079276|NCT00302211|38220643|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
17079277|NCT00302211|38220644|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
17079278|NCT00302211|38220645|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
17079279|NCT00302211|38220646|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
17158912|NCT02896400|38305943|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
17158913|NCT02896400|38305944|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
17079280|NCT00302211|38220647|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
17079281|NCT00302211|38220643|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
17079282|NCT00302211|38220644|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
17079283|NCT00302211|38220645|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
17079284|NCT00302211|38220646|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
17079285|NCT00302211|38220647|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
17079286|NCT00302211|38220643|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
17079287|NCT00302211|38220644|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
17079288|NCT00302211|38220645|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
17079289|NCT00302211|38220646|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
17079290|NCT00302211|38220647|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
17079291|NCT00302211|38220643|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
17079292|NCT00302211|38220644|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
17079293|NCT00302211|38220645|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
17158914|NCT02896400|38305945|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
17158915|NCT02896400|38305946|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
17158916|NCT02896400|38305947|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
17158917|NCT02896400|38305948|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
17079294|NCT00302211|38220646|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
17158918|NCT02896400|38305949|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
17158919|NCT02896400|38305950|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
17158920|NCT02896400|38305951|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
17158921|NCT02896400|38305952|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
17158922|NCT02896400|38305953|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
17158923|NCT02896400|38305954|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
17158924|NCT03405935|38305980|FG000|Overall Study|Adverse Event|3|||
17158925|NCT03405935|38305980|FG000|Overall Study|Death|2|||
17158926|NCT03405935|38305980|FG000|Overall Study|Withdrawal by Subject|1|||
17158927|NCT03405935|38305980|FG000|Overall Study|Lost to Follow-up|2|||
17158928|NCT03055260|38305986|FG000|Overall Study|Withdrawal by Subject|1|||
17158929|NCT03055260|38305987|FG001|Overall Study|Withdrawal by Subject|0|||
16781286|NCT02105974|37720454|FG001|2 Week Run-in Period|Investigator discretion|0|||
17158930|NCT03404843|38305995|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
17158931|NCT03404843|38305996|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
17158932|NCT03444155|38306020|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
17079295|NCT00302211|38220647|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
17079296|NCT00302211|38220643|FG000|Open Label-Patients From Double-Blind|Death|0|||
17079297|NCT00302211|38220644|FG001|Open Label-Patients From Double-Blind|Death|0|||
17079298|NCT00302211|38220645|FG002|Open Label-Patients From Double-Blind|Death|0|||
17079299|NCT00302211|38220646|FG003|Open Label-Patients From Double-Blind|Death|1|||
17079300|NCT00302211|38220647|FG004|Open Label-Patients From Double-Blind|Death|1|||
17079301|NCT00302211|38220643|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
17079302|NCT00302211|38220644|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
17079303|NCT00302211|38220645|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
17079304|NCT00302211|38220646|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
17079305|NCT00302211|38220647|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
17079306|NCT00302211|38220643|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
17079307|NCT00302211|38220644|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
17079308|NCT00302211|38220645|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
17079309|NCT00302211|38220646|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
17079310|NCT00302211|38220647|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
17079311|NCT00302211|38220643|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
17079312|NCT00302211|38220644|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
17079313|NCT00302211|38220645|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
17079314|NCT00302211|38220646|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
17079315|NCT00302211|38220647|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
17079316|NCT00288015|38220659|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
17079317|NCT00288015|38220659|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
17079318|NCT00288015|38220659|FG000|First Response Assessment|Withdrawal by Subject|1|||
17079319|NCT00288015|38220659|FG000|First Response Assessment|Death|1|||
17079320|NCT00288015|38220659|FG000|First Response Assessment|Physician Decision|2|||
17079321|NCT00288015|38220659|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
17079322|NCT00288015|38220659|FG000|Follow up for Survival x 2 Years|Death|13|||
17079323|NCT00288015|38220659|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
17079324|NCT00288015|38220659|FG000|Follow up for Survival x 2 Years|Other|9|||
17079325|NCT00389064|38220665|FG000|Overall Study|Adverse Event|11|||
17079326|NCT00389064|38220666|FG001|Overall Study|Adverse Event|3|||
17079327|NCT00389064|38220665|FG000|Overall Study|Lack of Efficacy|3|||
17079328|NCT00389064|38220666|FG001|Overall Study|Lack of Efficacy|14|||
17079329|NCT00389064|38220665|FG000|Overall Study|Withdrawal by Subject|17|||
17079330|NCT00389064|38220666|FG001|Overall Study|Withdrawal by Subject|27|||
17079331|NCT00389064|38220665|FG000|Overall Study|Physician Decision|2|||
17079332|NCT00389064|38220666|FG001|Overall Study|Physician Decision|2|||
17079333|NCT00389064|38220665|FG000|Overall Study|Lost to Follow-up|1|||
17079334|NCT00389064|38220666|FG001|Overall Study|Lost to Follow-up|2|||
17079335|NCT00389064|38220665|FG000|Overall Study|Protocol Violation|2|||
17079336|NCT00389064|38220666|FG001|Overall Study|Protocol Violation|0|||
17079337|NCT00389064|38220665|FG000|Overall Study|Multiple Reasons|9|||
17079338|NCT00389064|38220666|FG001|Overall Study|Multiple Reasons|11|||
17079339|NCT00388674|38220674|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
17079340|NCT00388674|38220675|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
17079341|NCT00388674|38220674|FG000|Initial Treatment|Adverse Event|22|||
17079342|NCT00388674|38220675|FG001|Initial Treatment|Adverse Event|87|||
17079343|NCT00388674|38220674|FG000|Initial Treatment|Death|215|||
17079344|NCT00388674|38220675|FG001|Initial Treatment|Death|216|||
17079345|NCT00388674|38220674|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
17079346|NCT00388674|38220675|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
17079347|NCT00388674|38220674|FG000|Initial Treatment|HCC|12|||
17079348|NCT00388674|38220675|FG001|Initial Treatment|HCC|20|||
17079349|NCT00388674|38220674|FG000|Initial Treatment|Lost to Follow-up|526|||
17079350|NCT00388674|38220675|FG001|Initial Treatment|Lost to Follow-up|624|||
17079351|NCT00388674|38220674|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
17079352|NCT00388674|38220675|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
17079353|NCT00388674|38220674|FG000|Initial Treatment|Never Treated with Study Medication|1|||
17079354|NCT00388674|38220675|FG001|Initial Treatment|Never Treated with Study Medication|7|||
17079355|NCT00388674|38220674|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
17079356|NCT00388674|38220675|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
17079357|NCT00388674|38220674|FG000|Initial Treatment|Not Defined|125|||
17079358|NCT00388674|38220675|FG001|Initial Treatment|Not Defined|172|||
17079359|NCT00388674|38220674|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
17079360|NCT00388674|38220675|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
17079361|NCT00388674|38220674|FG000|Initial Treatment|Pregnancy|26|||
17079362|NCT00388674|38220675|FG001|Initial Treatment|Pregnancy|16|||
17079363|NCT00388674|38220674|FG000|Initial Treatment|Study Drug Toxicity|5|||
17079364|NCT00388674|38220675|FG001|Initial Treatment|Study Drug Toxicity|92|||
17079365|NCT00388674|38220674|FG000|Initial Treatment|Participant Request|501|||
17079366|NCT00388674|38220675|FG001|Initial Treatment|Participant Request|673|||
17079367|NCT00388674|38220674|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
17079368|NCT00388674|38220675|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
17079369|NCT00388674|38220674|FG000|Initial Treatment|Not Reported|10|||
17079370|NCT00388674|38220675|FG001|Initial Treatment|Not Reported|12|||
17079371|NCT00388674|38220674|FG000|End of Study|Administrative Reason By Sponsor|299|||
17079372|NCT00388674|38220675|FG001|End of Study|Administrative Reason By Sponsor|253|||
17079373|NCT00388674|38220674|FG000|End of Study|Death|239|||
17079374|NCT00388674|38220675|FG001|End of Study|Death|262|||
17079375|NCT00388674|38220674|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
17079376|NCT00388674|38220675|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
17079377|NCT00388674|38220674|FG000|End of Study|HCC|8|||
17079378|NCT00388674|38220675|FG001|End of Study|HCC|7|||
17079379|NCT00388674|38220674|FG000|End of Study|Lost to Follow-up|587|||
17079380|NCT00388674|38220675|FG001|End of Study|Lost to Follow-up|715|||
17079381|NCT00388674|38220674|FG000|End of Study|Malignancy (Non-HCC)|1|||
17079382|NCT00388674|38220675|FG001|End of Study|Malignancy (Non-HCC)|1|||
17079383|NCT00388674|38220674|FG000|End of Study|Non-Study Related Comorbidities|3|||
17079384|NCT00388674|38220675|FG001|End of Study|Non-Study Related Comorbidities|4|||
17079385|NCT00388674|38220674|FG000|End of Study|Not Defined|135|||
17079386|NCT00388674|38220675|FG001|End of Study|Not Defined|214|||
17079387|NCT00388674|38220674|FG000|End of Study|Participant Withdrew Consent|437|||
17079388|NCT00388674|38220675|FG001|End of Study|Participant Withdrew Consent|673|||
17079389|NCT00388674|38220674|FG000|End of Study|No Off-Treatment Status Data|22|||
17079390|NCT00388674|38220675|FG001|End of Study|No Off-Treatment Status Data|30|||
17079391|NCT00388674|38220674|FG000|End of Study|Not Reported|0|||
17079392|NCT00388674|38220675|FG001|End of Study|Not Reported|1|||
17079393|NCT00388362|38220681|FG000|Enrolled|Ineligible|1|||
17079394|NCT00388362|38220681|FG000|Enrolled|Adverse Event|9|||
17079395|NCT00388362|38220681|FG000|Enrolled|Death|1|||
17079396|NCT00388362|38220681|FG000|Enrolled|Loss insurance|1|||
17079397|NCT00388362|38220681|FG000|Enrolled|Withdrawal by Subject|1|||
17079398|NCT00388362|38220681|FG000|Remained on Study Median of 514 Days|Death|2|||
17079399|NCT00387894|38220685|FG000|Overall Study|Withdrawal by Subject|1|||
17079400|NCT00387426|38220689|FG000|Overall Study|Lack of Response|7|||
17079401|NCT00387426|38220689|FG000|Overall Study|Toxicities|4|||
17079402|NCT00387426|38220689|FG000|Overall Study|Disease Progression|3|||
17079403|NCT00387348|38220696|FG000|Overall Study|Death|1|||
17079404|NCT00387348|38220697|FG001|Overall Study|Death|1|||
17079405|NCT00387348|38220698|FG002|Overall Study|Death|0|||
17158933|NCT03444155|38306021|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
17158934|NCT02898116|38306027|FG000|Overall Study|Adverse Event|1|||
17158935|NCT02898116|38306027|FG000|Overall Study|Progressive disease|1|||
17158936|NCT03658304|38306031|FG000|Overall Study|participants still on follow up|8|||
17158937|NCT03403751|38306037|FG000|Overall Study|Death|5|||
17158938|NCT03403751|38306038|FG001|Overall Study|Death|6|||
17158939|NCT03403751|38306037|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
17158940|NCT03403751|38306038|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
17158941|NCT02297412|38306048|FG000|Overall Study|Canceled|1|||
17079406|NCT00387348|38220696|FG000|Overall Study|Physician Decision|1|||
17079407|NCT00387348|38220697|FG001|Overall Study|Physician Decision|0|||
17079408|NCT00387348|38220698|FG002|Overall Study|Physician Decision|1|||
17079409|NCT00387348|38220696|FG000|Overall Study|Withdrawal by Subject|0|||
17079410|NCT00387348|38220697|FG001|Overall Study|Withdrawal by Subject|2|||
17079411|NCT00387348|38220698|FG002|Overall Study|Withdrawal by Subject|2|||
17158942|NCT02297412|38306049|FG001|Overall Study|Canceled|1|||
17158943|NCT03418727|38306058|FG000|Overall Study|Adverse Event|1|||
17158944|NCT03418727|38306059|FG001|Overall Study|Adverse Event|2|||
17158945|NCT03418727|38306060|FG002|Overall Study|Adverse Event|0|||
17158946|NCT03418727|38306058|FG000|Overall Study|Withdrawal by Subject|0|||
17079412|NCT00387348|38220696|FG000|Overall Study|Adverse Event|1|||
17079413|NCT00387348|38220697|FG001|Overall Study|Adverse Event|0|||
17079414|NCT00387348|38220698|FG002|Overall Study|Adverse Event|1|||
17079415|NCT00413660|38220718|FG000|Up To Week 12|Adverse Event|1|||
17079416|NCT00413660|38220719|FG001|Up To Week 12|Adverse Event|3|||
17079417|NCT00413660|38220720|FG002|Up To Week 12|Adverse Event|1|||
17079418|NCT00413660|38220721|FG003|Up To Week 12|Adverse Event|4|||
17079419|NCT00413660|38220722|FG004|Up To Week 12|Adverse Event|6|||
17079420|NCT00413660|38220723|FG005|Up To Week 12|Adverse Event|4|||
17079421|NCT00413660|38220724|FG006|Up To Week 12|Adverse Event|1|||
17079422|NCT00413660|38220725|FG007|Up To Week 12|Adverse Event|0|||
17079423|NCT00413660|38220726|FG008|Up To Week 12|Adverse Event|0|||
17079424|NCT00413660|38220727|FG009|Up To Week 12|Adverse Event|0|||
17079425|NCT00413660|38220728|FG010|Up To Week 12|Adverse Event|0|||
17158947|NCT03418727|38306059|FG001|Overall Study|Withdrawal by Subject|0|||
17158948|NCT03418727|38306060|FG002|Overall Study|Withdrawal by Subject|2|||
17079426|NCT00413660|38220718|FG000|Up To Week 12|Lack of Efficacy|2|||
17158949|NCT03418571|38306070|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
17158950|NCT03418571|38306071|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
17158951|NCT03402893|38306077|FG000|Overall Study|Withdrawal by Subject|1|||
17158952|NCT03442985|38306085|FG000|Overall Study|Sponsor Request|55|||
17158953|NCT03442985|38306086|FG001|Overall Study|Sponsor Request|60|||
17158954|NCT03442985|38306087|FG002|Overall Study|Sponsor Request|54|||
17158955|NCT03442985|38306085|FG000|Overall Study|Lost to Follow-up|5|||
17158956|NCT03442985|38306086|FG001|Overall Study|Lost to Follow-up|2|||
17158957|NCT03442985|38306087|FG002|Overall Study|Lost to Follow-up|7|||
17158958|NCT03442985|38306085|FG000|Overall Study|Withdrawal by Subject|2|||
17158959|NCT03442985|38306086|FG001|Overall Study|Withdrawal by Subject|3|||
17158960|NCT03442985|38306087|FG002|Overall Study|Withdrawal by Subject|4|||
17158961|NCT03442985|38306085|FG000|Overall Study|Adverse Event|0|||
17158962|NCT03442985|38306086|FG001|Overall Study|Adverse Event|1|||
17158963|NCT03442985|38306087|FG002|Overall Study|Adverse Event|0|||
17158964|NCT01318122|38306099|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17158965|NCT01318122|38306100|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17158966|NCT01318122|38306101|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
17158967|NCT01318122|38306102|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
17158968|NCT01318122|38306099|FG000|Enrolled - Long-Term Extension Study|Other|1|||
17158969|NCT01318122|38306100|FG001|Enrolled - Long-Term Extension Study|Other|0|||
17158970|NCT01318122|38306101|FG002|Enrolled - Long-Term Extension Study|Other|0|||
17158971|NCT01318122|38306102|FG003|Enrolled - Long-Term Extension Study|Other|0|||
17158972|NCT01318122|38306099|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
17158973|NCT01318122|38306100|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
17158974|NCT01318122|38306101|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
17158975|NCT01318122|38306102|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
17158976|NCT01318122|38306099|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
17158977|NCT01318122|38306100|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
17079427|NCT00413660|38220719|FG001|Up To Week 12|Lack of Efficacy|0|||
17079428|NCT00413660|38220720|FG002|Up To Week 12|Lack of Efficacy|0|||
17079429|NCT00413660|38220721|FG003|Up To Week 12|Lack of Efficacy|0|||
17158978|NCT01318122|38306101|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
17158979|NCT01318122|38306102|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
17158980|NCT01318122|38306099|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
17158981|NCT01318122|38306100|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
17158982|NCT01318122|38306101|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
17158983|NCT01318122|38306102|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
17158984|NCT01318122|38306099|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
17158985|NCT01318122|38306100|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
17158986|NCT01318122|38306101|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
17158987|NCT01318122|38306102|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
17158988|NCT02954159|38306110|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
17158989|NCT02954159|38306111|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
17158990|NCT02954159|38306110|FG000|Overall Study|Withdrawal by Subject|0|||
17158991|NCT02954159|38306111|FG001|Overall Study|Withdrawal by Subject|1|||
17158992|NCT03442829|38306119|FG000|Overall Study|Scheduling clash|3|||
17158993|NCT03442829|38306120|FG001|Overall Study|Scheduling clash|1|||
17158994|NCT03442829|38306119|FG000|Overall Study|Illness unrelated to study|1|||
17158995|NCT03442829|38306120|FG001|Overall Study|Illness unrelated to study|1|||
17158996|NCT03442595|38306128|FG000|Overall Study|Lost to Follow-up|94|||
17158997|NCT03442595|38306129|FG001|Overall Study|Lost to Follow-up|0|||
17158998|NCT03440411|38306138|FG000|Overall Study|Adverse Event|0|||
17158999|NCT03440411|38306139|FG001|Overall Study|Adverse Event|0|||
17159000|NCT03440411|38306140|FG002|Overall Study|Adverse Event|1|||
17159001|NCT03440411|38306141|FG003|Overall Study|Adverse Event|0|||
17159002|NCT03440411|38306138|FG000|Overall Study|PD|2|||
17159003|NCT03440411|38306139|FG001|Overall Study|PD|1|||
17079430|NCT00413660|38220722|FG004|Up To Week 12|Lack of Efficacy|0|||
17079431|NCT00413660|38220723|FG005|Up To Week 12|Lack of Efficacy|0|||
17079432|NCT00413660|38220724|FG006|Up To Week 12|Lack of Efficacy|5|||
17079433|NCT00413660|38220725|FG007|Up To Week 12|Lack of Efficacy|0|||
17079434|NCT00413660|38220726|FG008|Up To Week 12|Lack of Efficacy|0|||
17079435|NCT00413660|38220727|FG009|Up To Week 12|Lack of Efficacy|0|||
17079436|NCT00413660|38220728|FG010|Up To Week 12|Lack of Efficacy|0|||
17079437|NCT00413660|38220718|FG000|Up To Week 12|Lost to Follow-up|0|||
17079438|NCT00413660|38220719|FG001|Up To Week 12|Lost to Follow-up|1|||
17079439|NCT00413660|38220720|FG002|Up To Week 12|Lost to Follow-up|0|||
17079440|NCT00413660|38220721|FG003|Up To Week 12|Lost to Follow-up|0|||
17079441|NCT00413660|38220722|FG004|Up To Week 12|Lost to Follow-up|1|||
17079442|NCT00413660|38220723|FG005|Up To Week 12|Lost to Follow-up|0|||
17079443|NCT00413660|38220724|FG006|Up To Week 12|Lost to Follow-up|0|||
17079444|NCT00413660|38220725|FG007|Up To Week 12|Lost to Follow-up|0|||
17079445|NCT00413660|38220726|FG008|Up To Week 12|Lost to Follow-up|0|||
17079446|NCT00413660|38220727|FG009|Up To Week 12|Lost to Follow-up|0|||
17079447|NCT00413660|38220728|FG010|Up To Week 12|Lost to Follow-up|0|||
17159004|NCT03440411|38306140|FG002|Overall Study|PD|1|||
17159005|NCT03440411|38306141|FG003|Overall Study|PD|1|||
17159006|NCT03440411|38306138|FG000|Overall Study|Withdrawal by Subject|1|||
17159007|NCT03440411|38306139|FG001|Overall Study|Withdrawal by Subject|0|||
17159008|NCT03440411|38306140|FG002|Overall Study|Withdrawal by Subject|0|||
17159009|NCT03440411|38306141|FG003|Overall Study|Withdrawal by Subject|0|||
17159010|NCT03440411|38306138|FG000|Overall Study|Closed study by sponsor|0|||
17159011|NCT03440411|38306139|FG001|Overall Study|Closed study by sponsor|0|||
17159012|NCT03440411|38306140|FG002|Overall Study|Closed study by sponsor|0|||
17159013|NCT03440411|38306141|FG003|Overall Study|Closed study by sponsor|1|||
17159014|NCT03438539|38306162|FG000|Overall Study|Lost to Follow-up|8|||
17159015|NCT03438539|38306163|FG001|Overall Study|Lost to Follow-up|4|||
17159016|NCT03438539|38306164|FG002|Overall Study|Lost to Follow-up|10|||
17159017|NCT03438539|38306165|FG003|Overall Study|Lost to Follow-up|9|||
17159018|NCT03438539|38306166|FG004|Overall Study|Lost to Follow-up|3|||
17159019|NCT03438539|38306167|FG005|Overall Study|Lost to Follow-up|8|||
17159020|NCT03400787|38306183|FG000|Overall Study|Lost to Follow-up|1|||
17159021|NCT03400787|38306184|FG001|Overall Study|Lost to Follow-up|0|||
17159022|NCT03400787|38306183|FG000|Overall Study|Death|1|||
17159023|NCT03400787|38306184|FG001|Overall Study|Death|0|||
17159024|NCT03400787|38306183|FG000|Overall Study|Protocol Violation|0|||
17159025|NCT03400787|38306184|FG001|Overall Study|Protocol Violation|2|||
17159026|NCT03400787|38306183|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
17159027|NCT03400787|38306184|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
17159028|NCT03417245|38306192|FG000|Overall Study|Adverse Event|1|||
17159029|NCT03417245|38306193|FG001|Overall Study|Adverse Event|0|||
17159030|NCT03417245|38306192|FG000|Overall Study|Protocol Violation|1|||
17159031|NCT03417245|38306193|FG001|Overall Study|Protocol Violation|0|||
17159032|NCT03417245|38306192|FG000|Overall Study|Withdrawal by Subject|1|||
17159033|NCT03417245|38306193|FG001|Overall Study|Withdrawal by Subject|1|||
17159034|NCT03389555|38306201|FG000|Overall Study|Protocol Violation|1|||
17159035|NCT03389555|38306202|FG001|Overall Study|Protocol Violation|3|||
17159036|NCT03389555|38306201|FG000|Overall Study|Death|1|||
17159037|NCT03389555|38306202|FG001|Overall Study|Death|0|||
17159038|NCT03505710|38306211|FG000|Overall Study|Progressive Disease|22|||
17159039|NCT03505710|38306212|FG001|Overall Study|Progressive Disease|9|||
17079448|NCT00413660|38220718|FG000|Up To Week 12|Withdrawal by Subject|0|||
17079449|NCT00413660|38220719|FG001|Up To Week 12|Withdrawal by Subject|2|||
17079450|NCT00413660|38220720|FG002|Up To Week 12|Withdrawal by Subject|0|||
17079451|NCT00413660|38220721|FG003|Up To Week 12|Withdrawal by Subject|2|||
17079452|NCT00413660|38220722|FG004|Up To Week 12|Withdrawal by Subject|0|||
17079453|NCT00413660|38220723|FG005|Up To Week 12|Withdrawal by Subject|2|||
17079454|NCT00413660|38220724|FG006|Up To Week 12|Withdrawal by Subject|2|||
17079455|NCT00413660|38220725|FG007|Up To Week 12|Withdrawal by Subject|0|||
17079456|NCT00413660|38220726|FG008|Up To Week 12|Withdrawal by Subject|0|||
17079457|NCT00413660|38220727|FG009|Up To Week 12|Withdrawal by Subject|0|||
17079458|NCT00413660|38220728|FG010|Up To Week 12|Withdrawal by Subject|0|||
17079459|NCT00413660|38220718|FG000|Up To Week 12|Randomized, Not Treated|1|||
17079460|NCT00413660|38220719|FG001|Up To Week 12|Randomized, Not Treated|0|||
17079461|NCT00413660|38220720|FG002|Up To Week 12|Randomized, Not Treated|0|||
17079462|NCT00413660|38220721|FG003|Up To Week 12|Randomized, Not Treated|1|||
17079463|NCT00413660|38220722|FG004|Up To Week 12|Randomized, Not Treated|0|||
17079464|NCT00413660|38220723|FG005|Up To Week 12|Randomized, Not Treated|0|||
17079465|NCT00413660|38220724|FG006|Up To Week 12|Randomized, Not Treated|0|||
17079466|NCT00413660|38220725|FG007|Up To Week 12|Randomized, Not Treated|0|||
17079467|NCT00413660|38220726|FG008|Up To Week 12|Randomized, Not Treated|0|||
17079468|NCT00413660|38220727|FG009|Up To Week 12|Randomized, Not Treated|0|||
17079469|NCT00413660|38220728|FG010|Up To Week 12|Randomized, Not Treated|0|||
17079470|NCT00413660|38220718|FG000|Up To Week 12|Other|3|||
17079471|NCT00413660|38220719|FG001|Up To Week 12|Other|1|||
17079472|NCT00413660|38220720|FG002|Up To Week 12|Other|6|||
17079473|NCT00413660|38220721|FG003|Up To Week 12|Other|1|||
17079474|NCT00413660|38220722|FG004|Up To Week 12|Other|2|||
17079475|NCT00413660|38220723|FG005|Up To Week 12|Other|4|||
17079476|NCT00413660|38220724|FG006|Up To Week 12|Other|3|||
17079477|NCT00413660|38220725|FG007|Up To Week 12|Other|0|||
17079478|NCT00413660|38220726|FG008|Up To Week 12|Other|0|||
17079479|NCT00413660|38220727|FG009|Up To Week 12|Other|0|||
17079480|NCT00413660|38220728|FG010|Up To Week 12|Other|0|||
17079481|NCT00413660|38220718|FG000|Post Week 12|Adverse Event|2|||
17079482|NCT00413660|38220719|FG001|Post Week 12|Adverse Event|0|||
17079483|NCT00413660|38220720|FG002|Post Week 12|Adverse Event|2|||
17079484|NCT00413660|38220721|FG003|Post Week 12|Adverse Event|1|||
17079485|NCT00413660|38220722|FG004|Post Week 12|Adverse Event|4|||
17079486|NCT00413660|38220723|FG005|Post Week 12|Adverse Event|2|||
17079487|NCT00413660|38220724|FG006|Post Week 12|Adverse Event|2|||
17159040|NCT03505710|38306213|FG002|Overall Study|Progressive Disease|34|||
17159041|NCT03505710|38306211|FG000|Overall Study|Clinical Progression|6|||
17159042|NCT03505710|38306212|FG001|Overall Study|Clinical Progression|6|||
17159043|NCT03505710|38306213|FG002|Overall Study|Clinical Progression|3|||
17159044|NCT03505710|38306211|FG000|Overall Study|Adverse Event|12|||
17159045|NCT03505710|38306212|FG001|Overall Study|Adverse Event|5|||
17159046|NCT03505710|38306213|FG002|Overall Study|Adverse Event|27|||
17159047|NCT03505710|38306211|FG000|Overall Study|Withdrawal by Subject|1|||
17159048|NCT03505710|38306212|FG001|Overall Study|Withdrawal by Subject|3|||
17159049|NCT03505710|38306213|FG002|Overall Study|Withdrawal by Subject|3|||
17159050|NCT03505710|38306211|FG000|Overall Study|Physician Decision|1|||
17159051|NCT03505710|38306212|FG001|Overall Study|Physician Decision|0|||
17159052|NCT03505710|38306213|FG002|Overall Study|Physician Decision|2|||
17159053|NCT03505710|38306211|FG000|Overall Study|Death|4|||
17159054|NCT03505710|38306212|FG001|Overall Study|Death|3|||
17159055|NCT03505710|38306213|FG002|Overall Study|Death|6|||
17159056|NCT03505710|38306211|FG000|Overall Study|Other Reasons|1|||
17159057|NCT03505710|38306212|FG001|Overall Study|Other Reasons|1|||
17159058|NCT03505710|38306213|FG002|Overall Study|Other Reasons|1|||
17159059|NCT03395639|38306223|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
17159060|NCT03395639|38306224|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
17159061|NCT03395639|38306225|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
17159062|NCT03395639|38306223|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
17159063|NCT03395639|38306224|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
17159064|NCT03395639|38306225|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
17159065|NCT03395639|38306223|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
17159066|NCT03395639|38306224|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
17159067|NCT03395639|38306225|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
17159068|NCT03395639|38306223|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
17159069|NCT03395639|38306224|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
17159070|NCT03395639|38306225|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
17159071|NCT03395639|38306223|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
17159072|NCT03395639|38306224|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
17159073|NCT03395639|38306225|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
17159074|NCT03353922|38306232|FG000|Overall Study|Withdrawal by Subject|1|||
17159075|NCT03353922|38306233|FG001|Overall Study|Withdrawal by Subject|0|||
17159076|NCT03353922|38306234|FG002|Overall Study|Withdrawal by Subject|1|||
17159077|NCT03353922|38306235|FG003|Overall Study|Withdrawal by Subject|1|||
17159078|NCT03353922|38306236|FG004|Overall Study|Withdrawal by Subject|0|||
17159079|NCT03353922|38306237|FG005|Overall Study|Withdrawal by Subject|0|||
17159080|NCT03353922|38306232|FG000|Overall Study|Adverse Event|0|||
17159081|NCT03353922|38306233|FG001|Overall Study|Adverse Event|1|||
17159082|NCT03353922|38306234|FG002|Overall Study|Adverse Event|0|||
17159083|NCT03353922|38306235|FG003|Overall Study|Adverse Event|0|||
17159084|NCT03353922|38306236|FG004|Overall Study|Adverse Event|0|||
17159085|NCT03353922|38306237|FG005|Overall Study|Adverse Event|0|||
17159086|NCT03395405|38306250|FG000|Overall Study|Death|0|||
17159087|NCT03395405|38306251|FG001|Overall Study|Death|2|||
17079488|NCT00413660|38220725|FG007|Post Week 12|Adverse Event|0|||
17079489|NCT00413660|38220726|FG008|Post Week 12|Adverse Event|0|||
17079490|NCT00413660|38220727|FG009|Post Week 12|Adverse Event|0|||
17079491|NCT00413660|38220728|FG010|Post Week 12|Adverse Event|0|||
17079492|NCT00413660|38220718|FG000|Post Week 12|Lack of Efficacy|0|||
17079493|NCT00413660|38220719|FG001|Post Week 12|Lack of Efficacy|0|||
17079494|NCT00413660|38220720|FG002|Post Week 12|Lack of Efficacy|1|||
17079495|NCT00413660|38220721|FG003|Post Week 12|Lack of Efficacy|0|||
17079496|NCT00413660|38220722|FG004|Post Week 12|Lack of Efficacy|0|||
17079497|NCT00413660|38220723|FG005|Post Week 12|Lack of Efficacy|0|||
17079498|NCT00413660|38220724|FG006|Post Week 12|Lack of Efficacy|0|||
17079499|NCT00413660|38220725|FG007|Post Week 12|Lack of Efficacy|0|||
17079500|NCT00413660|38220726|FG008|Post Week 12|Lack of Efficacy|0|||
17079501|NCT00413660|38220727|FG009|Post Week 12|Lack of Efficacy|1|||
17079502|NCT00413660|38220728|FG010|Post Week 12|Lack of Efficacy|0|||
17079503|NCT00413660|38220718|FG000|Post Week 12|Lost to Follow-up|0|||
17079504|NCT00413660|38220719|FG001|Post Week 12|Lost to Follow-up|1|||
17079505|NCT00413660|38220720|FG002|Post Week 12|Lost to Follow-up|1|||
17079506|NCT00413660|38220721|FG003|Post Week 12|Lost to Follow-up|0|||
17079507|NCT00413660|38220722|FG004|Post Week 12|Lost to Follow-up|0|||
17079508|NCT00413660|38220723|FG005|Post Week 12|Lost to Follow-up|0|||
17079509|NCT00413660|38220724|FG006|Post Week 12|Lost to Follow-up|0|||
17079510|NCT00413660|38220725|FG007|Post Week 12|Lost to Follow-up|0|||
17079511|NCT00413660|38220726|FG008|Post Week 12|Lost to Follow-up|0|||
17079512|NCT00413660|38220727|FG009|Post Week 12|Lost to Follow-up|0|||
17079513|NCT00413660|38220728|FG010|Post Week 12|Lost to Follow-up|0|||
17079514|NCT00413660|38220718|FG000|Post Week 12|Withdrawal by Subject|0|||
17079515|NCT00413660|38220719|FG001|Post Week 12|Withdrawal by Subject|1|||
17079516|NCT00413660|38220720|FG002|Post Week 12|Withdrawal by Subject|1|||
17079517|NCT00413660|38220721|FG003|Post Week 12|Withdrawal by Subject|0|||
17079518|NCT00413660|38220722|FG004|Post Week 12|Withdrawal by Subject|1|||
17079519|NCT00413660|38220723|FG005|Post Week 12|Withdrawal by Subject|0|||
17079520|NCT00413660|38220724|FG006|Post Week 12|Withdrawal by Subject|0|||
17079521|NCT00413660|38220725|FG007|Post Week 12|Withdrawal by Subject|0|||
17079522|NCT00413660|38220726|FG008|Post Week 12|Withdrawal by Subject|0|||
17079523|NCT00413660|38220727|FG009|Post Week 12|Withdrawal by Subject|0|||
17079524|NCT00413660|38220728|FG010|Post Week 12|Withdrawal by Subject|1|||
17079525|NCT00413660|38220718|FG000|Post Week 12|Other|1|||
17079526|NCT00413660|38220719|FG001|Post Week 12|Other|2|||
17079527|NCT00413660|38220720|FG002|Post Week 12|Other|3|||
17079528|NCT00413660|38220721|FG003|Post Week 12|Other|0|||
17079529|NCT00413660|38220722|FG004|Post Week 12|Other|1|||
17079530|NCT00413660|38220723|FG005|Post Week 12|Other|1|||
17079531|NCT00413660|38220724|FG006|Post Week 12|Other|1|||
17159088|NCT03395405|38306250|FG000|Overall Study|Lost to Follow-up|0|||
17159089|NCT03395405|38306251|FG001|Overall Study|Lost to Follow-up|1|||
17159090|NCT03395405|38306250|FG000|Overall Study|Protocol Violation|0|||
17159091|NCT03395405|38306251|FG001|Overall Study|Protocol Violation|1|||
17159092|NCT03395405|38306250|FG000|Overall Study|Withdrawal by Subject|3|||
17159093|NCT03395405|38306251|FG001|Overall Study|Withdrawal by Subject|1|||
17159094|NCT03395405|38306250|FG000|Overall Study|COVID-19 Pandemic|1|||
17159095|NCT03395405|38306251|FG001|Overall Study|COVID-19 Pandemic|0|||
17159096|NCT03387683|38306259|FG000|Overall Study|In receipt of disallowed medication|1|||
17079532|NCT00413660|38220725|FG007|Post Week 12|Other|0|||
17079533|NCT00413660|38220726|FG008|Post Week 12|Other|0|||
17079534|NCT00413660|38220727|FG009|Post Week 12|Other|0|||
17079535|NCT00413660|38220728|FG010|Post Week 12|Other|0|||
17079536|NCT00431834|38220762|FG000|Overall Study|Withdrawal by Subject|7|||
17079537|NCT00431834|38220762|FG000|Overall Study|Death|3|||
17079538|NCT00431834|38220762|FG000|Overall Study|Missed Endpoint Visit|2|||
17079539|NCT00431834|38220762|FG000|Overall Study|Lost to Follow-up|1|||
17079540|NCT00431444|38220771|FG000|Overall Study|Protocol Violation|1|||
17079541|NCT00431444|38220772|FG001|Overall Study|Protocol Violation|4|||
17079542|NCT00431444|38220771|FG000|Overall Study|Adverse Event|2|||
17079543|NCT00431444|38220772|FG001|Overall Study|Adverse Event|1|||
17079544|NCT00431444|38220771|FG000|Overall Study|Withdrawal by Subject|1|||
17079545|NCT00431444|38220772|FG001|Overall Study|Withdrawal by Subject|1|||
17079546|NCT00431444|38220771|FG000|Overall Study|Lost to Follow-up|1|||
17079547|NCT00431444|38220772|FG001|Overall Study|Lost to Follow-up|0|||
17079548|NCT00431444|38220771|FG000|Overall Study|Administrative Problems|0|||
17079549|NCT00431444|38220772|FG001|Overall Study|Administrative Problems|1|||
17079550|NCT00430352|38220778|FG000|Overall Study|Disease progression|58|||
17079551|NCT00430352|38220778|FG000|Overall Study|Withdrawal by Subject|11|||
17079552|NCT00430352|38220778|FG000|Overall Study|Adverse Event|16|||
17079553|NCT00430352|38220778|FG000|Overall Study|Death|5|||
17079554|NCT00430352|38220778|FG000|Overall Study|Other|48|||
17079555|NCT00287469|38220784|FG000|Overall Study|serious adverse event|1|||
17079556|NCT00287469|38220785|FG001|Overall Study|serious adverse event|6|||
17079557|NCT00287469|38220784|FG000|Overall Study|Adverse Event|1|||
17079558|NCT00287469|38220785|FG001|Overall Study|Adverse Event|1|||
17079559|NCT00287469|38220784|FG000|Overall Study|moved from area|144|||
17079560|NCT00287469|38220785|FG001|Overall Study|moved from area|138|||
17079561|NCT00287469|38220784|FG000|Overall Study|Lost to Follow-up|74|||
17079562|NCT00287469|38220785|FG001|Overall Study|Lost to Follow-up|69|||
17079563|NCT00429572|38220793|FG000|Overall Study|Disease progression|1|||
17079564|NCT00287079|38220799|FG000|Overall Study|Qualifying relapse|12|||
17079565|NCT00287079|38220800|FG001|Overall Study|Qualifying relapse|1|||
17079566|NCT00287079|38220799|FG000|Overall Study|Non-qualifying relapse|1|||
17079567|NCT00287079|38220800|FG001|Overall Study|Non-qualifying relapse|0|||
17079568|NCT00287079|38220799|FG000|Overall Study|Adverse Event|5|||
17079569|NCT00287079|38220800|FG001|Overall Study|Adverse Event|0|||
17079570|NCT00287079|38220799|FG000|Overall Study|Protocol Violation|1|||
17159097|NCT03387683|38306260|FG001|Overall Study|In receipt of disallowed medication|0|||
17159098|NCT03387683|38306259|FG000|Overall Study|Did not receive treatment|1|||
17159099|NCT03387683|38306260|FG001|Overall Study|Did not receive treatment|0|||
17159100|NCT03387059|38306268|FG000|Overall Study|Study termination|5|||
17159101|NCT03387059|38306269|FG001|Overall Study|Study termination|4|||
17079571|NCT00287079|38220800|FG001|Overall Study|Protocol Violation|0|||
17079572|NCT00287079|38220799|FG000|Overall Study|Other|3|||
17079573|NCT00287079|38220800|FG001|Overall Study|Other|0|||
17079574|NCT00429494|38220806|FG000|Overall Study|Withdrawal by Subject|9|||
17079575|NCT00429494|38220806|FG000|Overall Study|Death|6|||
17079576|NCT00429416|38220810|FG000|Overall Study|Death|1|||
17079577|NCT00429182|38220814|FG000|Overall Study|Not evaluable, Disease Progression|2|||
17079578|NCT00429182|38220814|FG000|Overall Study|Not eligible|5|||
17079579|NCT00429104|38220818|FG000|Overall Study|Protocol Violation|1|||
17079580|NCT00429026|38220822|FG000|Overall Study|Inevaluable for response.|40|||
17079581|NCT00301821|38220826|FG000|Overall Study|Ineligible|25|||
17079582|NCT00301821|38220826|FG000|Overall Study|Cancel|1|||
17079583|NCT00372996|38220832|FG000|Overall Study|Death|11|||
17079584|NCT00372996|38220833|FG001|Overall Study|Death|4|||
17079585|NCT00372996|38220834|FG002|Overall Study|Death|8|||
17079586|NCT00372996|38220835|FG003|Overall Study|Death|7|||
17079587|NCT00372996|38220832|FG000|Overall Study|Lost to Follow-up|0|||
17079588|NCT00372996|38220833|FG001|Overall Study|Lost to Follow-up|2|||
17159102|NCT02942004|38306278|FG000|Overall Study|Withdrawal by Subject|0|||
17159103|NCT02942004|38306279|FG001|Overall Study|Withdrawal by Subject|2|||
17159104|NCT02942004|38306280|FG002|Overall Study|Withdrawal by Subject|3|||
17159105|NCT02942004|38306278|FG000|Overall Study|Lost to Follow-up|1|||
17159106|NCT02942004|38306279|FG001|Overall Study|Lost to Follow-up|1|||
17159107|NCT02942004|38306280|FG002|Overall Study|Lost to Follow-up|2|||
17159108|NCT02942004|38306278|FG000|Overall Study|Randomized but not dosed|3|||
17159109|NCT02942004|38306279|FG001|Overall Study|Randomized but not dosed|9|||
17159110|NCT02942004|38306280|FG002|Overall Study|Randomized but not dosed|4|||
17159111|NCT03394391|38306290|FG000|Overall Study|Lost to Follow-up|1|||
17159112|NCT03394391|38306291|FG001|Overall Study|Lost to Follow-up|2|||
17159113|NCT03386435|38306299|FG000|Overall Study|Protocol Violation|5|||
17159114|NCT03386435|38306300|FG001|Overall Study|Protocol Violation|7|||
17159115|NCT02726880|38306308|FG000|Overall Study|Withdrawal by Subject|2|||
17159116|NCT02726880|38306309|FG001|Overall Study|Withdrawal by Subject|0|||
17159117|NCT02726880|38306308|FG000|Overall Study|Lost to Follow-up|1|||
17159118|NCT02726880|38306309|FG001|Overall Study|Lost to Follow-up|3|||
17159119|NCT03275389|38306326|FG000|Overall Study|Lost to Follow-up|10|||
17159120|NCT03275389|38306327|FG001|Overall Study|Lost to Follow-up|10|||
17159121|NCT03275389|38306328|FG002|Overall Study|Lost to Follow-up|19|||
17159122|NCT03275389|38306329|FG003|Overall Study|Lost to Follow-up|12|||
17159123|NCT03275389|38306330|FG004|Overall Study|Lost to Follow-up|11|||
17159124|NCT03275389|38306331|FG005|Overall Study|Lost to Follow-up|12|||
17159125|NCT03275389|38306332|FG006|Overall Study|Lost to Follow-up|21|||
17159126|NCT03275389|38306333|FG007|Overall Study|Lost to Follow-up|15|||
17159127|NCT03275389|38306334|FG008|Overall Study|Lost to Follow-up|12|||
17159128|NCT03275389|38306335|FG009|Overall Study|Lost to Follow-up|14|||
17159129|NCT03275389|38306326|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
17159130|NCT03275389|38306327|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
17159131|NCT03275389|38306328|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
17159132|NCT03275389|38306329|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
17159133|NCT03275389|38306330|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
17159134|NCT03275389|38306331|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
17159135|NCT03275389|38306332|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
17159136|NCT03275389|38306333|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
17159137|NCT03275389|38306334|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
17159138|NCT03275389|38306335|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
17159139|NCT03275389|38306326|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
17159140|NCT03275389|38306327|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
17159141|NCT03275389|38306328|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
17159142|NCT03275389|38306329|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
17159143|NCT03275389|38306330|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
17159144|NCT03275389|38306331|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
17159145|NCT03275389|38306332|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
17159146|NCT03275389|38306333|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
17159147|NCT03275389|38306334|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
17159148|NCT03275389|38306335|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
17159149|NCT03275389|38306326|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17159150|NCT03275389|38306327|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
17159151|NCT03275389|38306328|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17159152|NCT03275389|38306329|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
17159153|NCT03275389|38306330|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17159154|NCT03275389|38306331|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17159155|NCT03275389|38306332|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
17159156|NCT03275389|38306333|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17159157|NCT03275389|38306334|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17159158|NCT03275389|38306335|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17159159|NCT03275389|38306326|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17159160|NCT03275389|38306327|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17079589|NCT00372996|38220834|FG002|Overall Study|Lost to Follow-up|0|||
17079590|NCT00372996|38220835|FG003|Overall Study|Lost to Follow-up|1|||
17079591|NCT00372996|38220832|FG000|Overall Study|Withdrawal by Subject|12|||
17079592|NCT00372996|38220833|FG001|Overall Study|Withdrawal by Subject|6|||
17079593|NCT00372996|38220834|FG002|Overall Study|Withdrawal by Subject|9|||
17079594|NCT00372996|38220835|FG003|Overall Study|Withdrawal by Subject|5|||
17079595|NCT00372996|38220832|FG000|Overall Study|Study Terminated by Sponsor|4|||
17159161|NCT03275389|38306328|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
17159162|NCT03275389|38306329|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17159163|NCT03275389|38306330|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17159164|NCT03275389|38306331|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17159165|NCT03275389|38306332|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17159166|NCT03275389|38306333|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17159167|NCT03275389|38306334|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
17159168|NCT03275389|38306335|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
17159169|NCT03275389|38306326|FG000|Overall Study|Other|0|||
17159170|NCT03275389|38306327|FG001|Overall Study|Other|4|||
17159171|NCT03275389|38306328|FG002|Overall Study|Other|3|||
17159172|NCT03275389|38306329|FG003|Overall Study|Other|2|||
17159173|NCT03275389|38306330|FG004|Overall Study|Other|2|||
17159174|NCT03275389|38306331|FG005|Overall Study|Other|2|||
17159175|NCT03275389|38306332|FG006|Overall Study|Other|0|||
17159176|NCT03275389|38306333|FG007|Overall Study|Other|0|||
17159177|NCT03275389|38306334|FG008|Overall Study|Other|1|||
17159178|NCT03275389|38306335|FG009|Overall Study|Other|0|||
17159179|NCT03414983|38306359|FG000|Pre-Treatment|Other reasons|1|||
17159180|NCT03414983|38306360|FG001|Pre-Treatment|Other reasons|0|||
17159181|NCT03414983|38306359|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
17159182|NCT03414983|38306360|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
17159183|NCT03414983|38306359|FG000|Pre-Treatment|Participant withdrew consent|1|||
17159184|NCT03414983|38306360|FG001|Pre-Treatment|Participant withdrew consent|3|||
17159185|NCT03414983|38306359|FG000|Treatment|Participant withdrew consent|4|||
17159186|NCT03414983|38306360|FG001|Treatment|Participant withdrew consent|3|||
17159187|NCT03414983|38306359|FG000|Treatment|Participant request to discontinue study treatment|8|||
17159188|NCT03414983|38306360|FG001|Treatment|Participant request to discontinue study treatment|10|||
17159189|NCT03414983|38306359|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
17159190|NCT03414983|38306360|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
17159191|NCT03414983|38306359|FG000|Treatment|Death|0|||
17159192|NCT03414983|38306360|FG001|Treatment|Death|2|||
17159193|NCT03414983|38306359|FG000|Treatment|Study Drug Toxicity|11|||
17159194|NCT03414983|38306360|FG001|Treatment|Study Drug Toxicity|4|||
17159195|NCT03414983|38306359|FG000|Treatment|Disease Progression|72|||
17159196|NCT03414983|38306360|FG001|Treatment|Disease Progression|27|||
17159197|NCT03414983|38306359|FG000|Treatment|Not reported|1|||
17159198|NCT03414983|38306360|FG001|Treatment|Not reported|0|||
17159199|NCT03414983|38306359|FG000|Treatment|Other reasons|3|||
17159200|NCT03414983|38306360|FG001|Treatment|Other reasons|2|||
17159201|NCT03414983|38306359|FG000|Treatment|Completed treatment as per protocol|8|||
17159202|NCT03414983|38306360|FG001|Treatment|Completed treatment as per protocol|0|||
17159203|NCT03414983|38306359|FG000|Treatment|Poor/non-compliance|2|||
17159204|NCT03414983|38306360|FG001|Treatment|Poor/non-compliance|0|||
17159205|NCT03414983|38306359|FG000|Treatment|Maximum clinical benefit|5|||
17159206|NCT03414983|38306360|FG001|Treatment|Maximum clinical benefit|9|||
17159207|NCT03414983|38306359|FG000|Treatment|Lost to Follow-up|0|||
17159208|NCT03414983|38306360|FG001|Treatment|Lost to Follow-up|1|||
17159209|NCT03414359|38306368|FG000|Overall Study|Lack of Efficacy|1|||
17159210|NCT03414359|38306369|FG001|Overall Study|Lack of Efficacy|1|||
17159211|NCT03414359|38306368|FG000|Overall Study|Protocol Violation|0|||
17159212|NCT03414359|38306369|FG001|Overall Study|Protocol Violation|1|||
17159213|NCT03285295|38306380|FG000|Alinity s HBsAg|Protocol Violation|11|||
17159214|NCT03285295|38306381|FG001|Alinity s HBsAg|Protocol Violation|0|||
17159215|NCT03285295|38306382|FG002|Alinity s HBsAg|Protocol Violation|0|||
17159216|NCT03285295|38306383|FG003|Alinity s HBsAg|Protocol Violation|0|||
17159217|NCT03285295|38306384|FG004|Alinity s HBsAg|Protocol Violation|0|||
17159218|NCT03285295|38306380|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
17159219|NCT03285295|38306381|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
17159220|NCT03285295|38306382|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
17159221|NCT03285295|38306383|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
17159222|NCT03285295|38306384|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
17159223|NCT03285295|38306380|FG000|Alinity s HBsAg|No Results Generated|74|||
17159224|NCT03285295|38306381|FG001|Alinity s HBsAg|No Results Generated|6|||
17159225|NCT03285295|38306382|FG002|Alinity s HBsAg|No Results Generated|0|||
17159226|NCT03285295|38306383|FG003|Alinity s HBsAg|No Results Generated|0|||
17159227|NCT03285295|38306384|FG004|Alinity s HBsAg|No Results Generated|0|||
17159228|NCT03285295|38306380|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
17159229|NCT03285295|38306381|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
17159230|NCT03285295|38306382|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
17159231|NCT03285295|38306383|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
17159232|NCT03285295|38306384|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
17159233|NCT03285295|38306380|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
17159234|NCT03285295|38306381|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
17159235|NCT03285295|38306382|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
17159236|NCT03285295|38306383|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
17159237|NCT03285295|38306384|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
17159238|NCT03285295|38306380|FG000|Alinity s HTLV I/II|No Results Generated|70|||
17159239|NCT03285295|38306381|FG001|Alinity s HTLV I/II|No Results Generated|0|||
17159240|NCT03285295|38306382|FG002|Alinity s HTLV I/II|No Results Generated|0|||
17159241|NCT03285295|38306383|FG003|Alinity s HTLV I/II|No Results Generated|0|||
17159242|NCT03285295|38306384|FG004|Alinity s HTLV I/II|No Results Generated|0|||
17159243|NCT03285295|38306380|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
17159244|NCT03285295|38306381|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
17159245|NCT03285295|38306382|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
17159246|NCT03285295|38306383|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
17159247|NCT03285295|38306384|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
17159248|NCT03285295|38306380|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
17159249|NCT03285295|38306381|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
17159250|NCT03285295|38306382|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
17159251|NCT03285295|38306383|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
17159252|NCT03285295|38306384|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
17159253|NCT03285295|38306380|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
17159254|NCT03285295|38306381|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
17159255|NCT03285295|38306382|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
17159256|NCT03285295|38306383|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
17159257|NCT03285295|38306384|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
17159258|NCT03285295|38306380|FG000|Alinity s Anti-HCV|No Results Generated|71|||
17159259|NCT03285295|38306381|FG001|Alinity s Anti-HCV|No Results Generated|0|||
17159260|NCT03285295|38306382|FG002|Alinity s Anti-HCV|No Results Generated|0|||
17159261|NCT03285295|38306383|FG003|Alinity s Anti-HCV|No Results Generated|0|||
17159262|NCT03285295|38306384|FG004|Alinity s Anti-HCV|No Results Generated|0|||
17159263|NCT03285295|38306380|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
17159264|NCT03285295|38306381|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
17159265|NCT03285295|38306382|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
17159266|NCT03285295|38306383|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
17159267|NCT03285295|38306384|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
17159268|NCT03285295|38306380|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
17159269|NCT03285295|38306381|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
17159270|NCT03285295|38306382|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
17159271|NCT03285295|38306383|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
17159272|NCT03285295|38306384|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
17159273|NCT03285295|38306380|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
17159274|NCT03285295|38306381|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
17159275|NCT03285295|38306382|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
17159276|NCT03285295|38306383|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
17159277|NCT03285295|38306384|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
17159278|NCT03285295|38306380|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
17159279|NCT03285295|38306381|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
17159280|NCT03285295|38306382|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
17159281|NCT03285295|38306383|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
17159282|NCT03285295|38306384|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
17159283|NCT03285295|38306380|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
17159284|NCT03285295|38306381|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
17159285|NCT03285295|38306382|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
17159286|NCT03285295|38306383|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
17159287|NCT03285295|38306384|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
17159288|NCT03285295|38306380|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
17159289|NCT03285295|38306381|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
17159290|NCT03285295|38306382|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
17159291|NCT03285295|38306383|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
17159292|NCT03285295|38306384|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
17159293|NCT03285295|38306380|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
17159294|NCT03285295|38306381|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
17159295|NCT03285295|38306382|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
17159296|NCT03285295|38306383|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
17159297|NCT03285295|38306384|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
17159298|NCT03285295|38306380|FG000|Alinity s Anti-HBc|No Results Generated|70|||
17159299|NCT03285295|38306381|FG001|Alinity s Anti-HBc|No Results Generated|0|||
17159300|NCT03285295|38306382|FG002|Alinity s Anti-HBc|No Results Generated|0|||
17159301|NCT03285295|38306383|FG003|Alinity s Anti-HBc|No Results Generated|0|||
17159302|NCT03285295|38306384|FG004|Alinity s Anti-HBc|No Results Generated|0|||
17159303|NCT03285295|38306380|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
17159304|NCT03285295|38306381|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
17159305|NCT03285295|38306382|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
17159306|NCT03285295|38306383|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
17159307|NCT03285295|38306384|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
17159308|NCT03285295|38306380|FG000|Alinity s Chagas|Protocol Violation|76|||
17159309|NCT03285295|38306381|FG001|Alinity s Chagas|Protocol Violation|0|||
17159310|NCT03285295|38306382|FG002|Alinity s Chagas|Protocol Violation|0|||
17159311|NCT03285295|38306383|FG003|Alinity s Chagas|Protocol Violation|0|||
17159312|NCT03285295|38306384|FG004|Alinity s Chagas|Protocol Violation|0|||
17159313|NCT03285295|38306380|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
17159314|NCT03285295|38306381|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
17159315|NCT03285295|38306382|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
17159316|NCT03285295|38306383|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
17159317|NCT03285295|38306384|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
17159318|NCT03285295|38306380|FG000|Alinity s Chagas|No Results Generated|105|||
17159319|NCT03285295|38306381|FG001|Alinity s Chagas|No Results Generated|0|||
17159320|NCT03285295|38306382|FG002|Alinity s Chagas|No Results Generated|0|||
17159321|NCT03285295|38306383|FG003|Alinity s Chagas|No Results Generated|0|||
17159322|NCT03285295|38306384|FG004|Alinity s Chagas|No Results Generated|0|||
17159323|NCT03285295|38306380|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
17159324|NCT03285295|38306381|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
17159325|NCT03285295|38306382|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
17159326|NCT03285295|38306383|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
17159327|NCT03285295|38306384|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
17159328|NCT02583048|38306416|FG000|Overall Study|Withdrawal by Subject|0|||
17159329|NCT02583048|38306417|FG001|Overall Study|Withdrawal by Subject|1|||
17159330|NCT02583048|38306418|FG002|Overall Study|Withdrawal by Subject|0|||
17159331|NCT02583048|38306416|FG000|Overall Study|Failed to meet eligibility criterion|0|||
17159332|NCT02583048|38306417|FG001|Overall Study|Failed to meet eligibility criterion|0|||
17159333|NCT02583048|38306418|FG002|Overall Study|Failed to meet eligibility criterion|1|||
17159334|NCT02939599|38306431|FG000|Overall Study|Adverse Event|1|||
17159335|NCT02939599|38306432|FG001|Overall Study|Adverse Event|0|||
17159336|NCT02939599|38306431|FG000|Overall Study|Study Terminated By Sponsor|2|||
17159337|NCT02939599|38306432|FG001|Overall Study|Study Terminated By Sponsor|2|||
17159338|NCT01318512|38306439|FG000|Maintenance Period (6 Months)|Death|2|||
17159339|NCT01318512|38306439|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
17159340|NCT03274687|38306460|FG000|Overall Study|Protocol Violation|1|||
17159341|NCT03274687|38306461|FG001|Overall Study|Protocol Violation|1|||
17159342|NCT04651218|38306467|FG000|Overall Study|Withdrawal by Subject|0|||
17159343|NCT04651218|38306468|FG001|Overall Study|Withdrawal by Subject|2|||
17159344|NCT03274453|38306478|FG000|Overall Study|Lost to Follow-up|2|||
17159345|NCT03274453|38306479|FG001|Overall Study|Lost to Follow-up|5|||
17159346|NCT03274453|38306480|FG002|Overall Study|Lost to Follow-up|4|||
17159347|NCT03274453|38306481|FG003|Overall Study|Lost to Follow-up|1|||
17159348|NCT03274453|38306478|FG000|Overall Study|Physician Decision|2|||
17159349|NCT03274453|38306479|FG001|Overall Study|Physician Decision|0|||
17159350|NCT03274453|38306480|FG002|Overall Study|Physician Decision|0|||
17159351|NCT03274453|38306481|FG003|Overall Study|Physician Decision|3|||
17159352|NCT03274453|38306478|FG000|Overall Study|Surgery Cancelled|0|||
17159353|NCT03274453|38306479|FG001|Overall Study|Surgery Cancelled|1|||
17159354|NCT03274453|38306480|FG002|Overall Study|Surgery Cancelled|0|||
17159355|NCT03274453|38306481|FG003|Overall Study|Surgery Cancelled|0|||
17159356|NCT03273907|38306491|FG000|Overall Study|Death|1|||
17159357|NCT03273907|38306491|FG000|Overall Study|Lost to Follow-up|4|||
17159358|NCT03273907|38306491|FG000|Overall Study|Withdrawal by Subject|2|||
17159359|NCT03273907|38306491|FG000|Overall Study|COVID 19|2|||
17159360|NCT00659646|38306513|FG000|Overall Study|Protocol Violation|12|||
17159361|NCT00659646|38306514|FG001|Overall Study|Protocol Violation|8|||
17159362|NCT00659646|38306513|FG000|Overall Study|Adverse Event|1|||
17159363|NCT00659646|38306514|FG001|Overall Study|Adverse Event|0|||
17159364|NCT00659646|38306513|FG000|Overall Study|Lost to Follow-up|1|||
17159365|NCT00659646|38306514|FG001|Overall Study|Lost to Follow-up|0|||
17159366|NCT00659646|38306513|FG000|Overall Study|protocol noncompliance after randomized|1|||
17159367|NCT00659646|38306514|FG001|Overall Study|protocol noncompliance after randomized|0|||
17159368|NCT02236572|38306522|FG000|Overall Study|Withdrawal by Subject|1|||
17159369|NCT02236572|38306522|FG000|Overall Study|Protocol Violation|1|||
17159370|NCT02236572|38306522|FG000|Overall Study|Lost to Follow-up|1|||
17159371|NCT03054870|38306526|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
17159372|NCT03054870|38306526|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
17159373|NCT03414047|38306545|FG000|Overall Study|Adverse Event|0|||
17159374|NCT03414047|38306546|FG001|Overall Study|Adverse Event|0|||
17159375|NCT03414047|38306547|FG002|Overall Study|Adverse Event|1|||
17159376|NCT03414047|38306548|FG003|Overall Study|Adverse Event|1|||
17159377|NCT03414047|38306545|FG000|Overall Study|Physician Decision|1|||
17159378|NCT03414047|38306546|FG001|Overall Study|Physician Decision|0|||
17159379|NCT03414047|38306547|FG002|Overall Study|Physician Decision|0|||
17159380|NCT03414047|38306548|FG003|Overall Study|Physician Decision|1|||
17159381|NCT03414047|38306545|FG000|Overall Study|Withdrawal by Subject|1|||
17159382|NCT03414047|38306546|FG001|Overall Study|Withdrawal by Subject|0|||
17159383|NCT03414047|38306547|FG002|Overall Study|Withdrawal by Subject|2|||
17159384|NCT03414047|38306548|FG003|Overall Study|Withdrawal by Subject|0|||
17159385|NCT01411332|38306561|FG000|Overall Study|Lost to Follow-up|1|||
17159386|NCT01411332|38306562|FG001|Overall Study|Lost to Follow-up|0|||
17159387|NCT01411332|38306561|FG000|Overall Study|Protocol Violation|1|||
17159388|NCT01411332|38306562|FG001|Overall Study|Protocol Violation|1|||
17079596|NCT00372996|38220833|FG001|Overall Study|Study Terminated by Sponsor|0|||
17079597|NCT00372996|38220834|FG002|Overall Study|Study Terminated by Sponsor|4|||
17079598|NCT00372996|38220835|FG003|Overall Study|Study Terminated by Sponsor|0|||
17079599|NCT00372996|38220832|FG000|Overall Study|Other|10|||
17079600|NCT00372996|38220833|FG001|Overall Study|Other|2|||
17079601|NCT00372996|38220834|FG002|Overall Study|Other|7|||
17159389|NCT01411332|38306561|FG000|Overall Study|Withdrawal by Subject|0|||
17159390|NCT01411332|38306562|FG001|Overall Study|Withdrawal by Subject|1|||
17159391|NCT03351335|38306571|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
17159392|NCT03351335|38306572|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
17159393|NCT03351335|38306573|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
17159394|NCT03055806|38306585|FG000|Overall Study|Adverse Event|0|||
17159395|NCT03055806|38306586|FG001|Overall Study|Adverse Event|0|||
17159396|NCT03055806|38306587|FG002|Overall Study|Adverse Event|1|||
17159397|NCT03055806|38306588|FG003|Overall Study|Adverse Event|1|||
17159398|NCT03055806|38306585|FG000|Overall Study|Lost to Follow-up|0|||
17159399|NCT03055806|38306586|FG001|Overall Study|Lost to Follow-up|3|||
17159400|NCT03055806|38306587|FG002|Overall Study|Lost to Follow-up|6|||
17159401|NCT03055806|38306588|FG003|Overall Study|Lost to Follow-up|7|||
17159402|NCT03055806|38306585|FG000|Overall Study|Physician Decision|1|||
17159403|NCT03055806|38306586|FG001|Overall Study|Physician Decision|0|||
17159404|NCT03055806|38306587|FG002|Overall Study|Physician Decision|0|||
17159405|NCT03055806|38306588|FG003|Overall Study|Physician Decision|1|||
17159406|NCT03055806|38306585|FG000|Overall Study|Protocol Violation|1|||
17079602|NCT00372996|38220835|FG003|Overall Study|Other|7|||
17079603|NCT00399516|38220845|FG000|Overall Study|Lost to Follow-up|2|||
17079604|NCT00399360|38220853|FG000|Overall Study|Lost to Follow-up|2|||
17079605|NCT00399360|38220854|FG001|Overall Study|Lost to Follow-up|1|||
17079606|NCT00399360|38220855|FG002|Overall Study|Lost to Follow-up|2|||
17079607|NCT00399360|38220856|FG003|Overall Study|Lost to Follow-up|4|||
17079608|NCT00399360|38220853|FG000|Overall Study|Adverse Event|0|||
17079609|NCT00399360|38220854|FG001|Overall Study|Adverse Event|0|||
17159407|NCT03055806|38306586|FG001|Overall Study|Protocol Violation|0|||
17159408|NCT03055806|38306587|FG002|Overall Study|Protocol Violation|0|||
17159409|NCT03055806|38306588|FG003|Overall Study|Protocol Violation|0|||
17159410|NCT03055806|38306585|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
17159411|NCT03055806|38306586|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
17159412|NCT03055806|38306587|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
17159413|NCT03055806|38306588|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
17159414|NCT03055806|38306585|FG000|Overall Study|Withdrawal of consent to continue study|2|||
17159415|NCT03055806|38306586|FG001|Overall Study|Withdrawal of consent to continue study|3|||
17159416|NCT03055806|38306587|FG002|Overall Study|Withdrawal of consent to continue study|4|||
17159417|NCT03055806|38306588|FG003|Overall Study|Withdrawal of consent to continue study|6|||
17159418|NCT03055806|38306585|FG000|Overall Study|Partner not willing to try intercourse|1|||
17159419|NCT03055806|38306586|FG001|Overall Study|Partner not willing to try intercourse|0|||
17159420|NCT03055806|38306587|FG002|Overall Study|Partner not willing to try intercourse|0|||
17159421|NCT03055806|38306588|FG003|Overall Study|Partner not willing to try intercourse|0|||
17159422|NCT04620798|38306600|FG000|Overall Study|Lost to Follow-up|126|||
17159423|NCT04620798|38306601|FG001|Overall Study|Lost to Follow-up|138|||
17159424|NCT03052764|38306609|FG000|Double-Blind Treatment Period|Adverse Event|2|||
17159425|NCT03052764|38306610|FG001|Double-Blind Treatment Period|Adverse Event|0|||
17159426|NCT03052764|38306609|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
17079610|NCT00399360|38220855|FG002|Overall Study|Adverse Event|1|||
17079611|NCT00399360|38220856|FG003|Overall Study|Adverse Event|0|||
17079612|NCT00399360|38220853|FG000|Overall Study|Withdrawal by Subject|0|||
17079613|NCT00399360|38220854|FG001|Overall Study|Withdrawal by Subject|2|||
17079614|NCT00399360|38220855|FG002|Overall Study|Withdrawal by Subject|0|||
17079615|NCT00399360|38220856|FG003|Overall Study|Withdrawal by Subject|2|||
17079616|NCT00428948|38220873|FG000|Overall Study|Lost to Follow-up|15|||
17079617|NCT00428948|38220874|FG001|Overall Study|Lost to Follow-up|8|||
17079618|NCT00428948|38220873|FG000|Overall Study|Adverse Event|148|||
17159427|NCT03052764|38306610|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
17189069|NCT01060111|38342040|FG000|Overall Study|Lack of Efficacy|2|||
17079619|NCT00428948|38220874|FG001|Overall Study|Adverse Event|24|||
17079620|NCT00428948|38220873|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
17079621|NCT00428948|38220874|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
17079622|NCT00428948|38220873|FG000|Overall Study|Investigator Withdrew Subject|3|||
17079623|NCT00428948|38220874|FG001|Overall Study|Investigator Withdrew Subject|4|||
17079624|NCT00428948|38220873|FG000|Overall Study|Subject Withdrew Consent|50|||
17079625|NCT00428948|38220874|FG001|Overall Study|Subject Withdrew Consent|30|||
17079626|NCT00428948|38220873|FG000|Overall Study|Protocol Deviation|1|||
17159428|NCT03052764|38306609|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
17159429|NCT03052764|38306610|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
17159430|NCT03052764|38306609|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
17159431|NCT03052764|38306610|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
17159432|NCT03052764|38306609|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
17159433|NCT03052764|38306610|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
17159434|NCT02951819|38306620|FG000|Overall Study|Death|9|||
17159435|NCT02951819|38306621|FG001|Overall Study|Death|7|||
17159436|NCT02951819|38306620|FG000|Overall Study|Withdrawal by Subject|3|||
17079627|NCT00428948|38220874|FG001|Overall Study|Protocol Deviation|1|||
17079628|NCT00428792|38220882|FG000|Overall Study|Lack of Efficacy|1|||
17079629|NCT00428792|38220883|FG001|Overall Study|Lack of Efficacy|3|||
17079630|NCT00428792|38220882|FG000|Overall Study|Lost to Follow-up|0|||
17079631|NCT00428792|38220883|FG001|Overall Study|Lost to Follow-up|1|||
17079632|NCT00300885|38220891|FG000|Treatment|Adverse Event|134|||
17079633|NCT00300885|38220892|FG001|Treatment|Adverse Event|82|||
17079634|NCT00300885|38220891|FG000|Treatment|Death|20|||
17079635|NCT00300885|38220892|FG001|Treatment|Death|7|||
17079636|NCT00300885|38220891|FG000|Treatment|Lack of Efficacy|1|||
17079637|NCT00300885|38220892|FG001|Treatment|Lack of Efficacy|1|||
17159437|NCT02951819|38306621|FG001|Overall Study|Withdrawal by Subject|0|||
17079638|NCT00300885|38220891|FG000|Treatment|Lost to Follow-up|3|||
17159438|NCT02951819|38306620|FG000|Overall Study|Adverse Event|1|||
17159439|NCT02951819|38306621|FG001|Overall Study|Adverse Event|0|||
17159440|NCT02951819|38306620|FG000|Overall Study|Lack of Efficacy|4|||
17159441|NCT02951819|38306621|FG001|Overall Study|Lack of Efficacy|0|||
17159442|NCT02951819|38306620|FG000|Overall Study|Lost to Follow-up|1|||
17159443|NCT02951819|38306621|FG001|Overall Study|Lost to Follow-up|0|||
17159444|NCT02951819|38306620|FG000|Overall Study|Progressive Disease|1|||
17159445|NCT02951819|38306621|FG001|Overall Study|Progressive Disease|0|||
17079639|NCT00300885|38220892|FG001|Treatment|Lost to Follow-up|2|||
17079640|NCT00300885|38220891|FG000|Treatment|Physician Decision|4|||
17079641|NCT00300885|38220892|FG001|Treatment|Physician Decision|5|||
17079642|NCT00300885|38220891|FG000|Treatment|Protocol Violation|11|||
17079643|NCT00300885|38220892|FG001|Treatment|Protocol Violation|11|||
17079644|NCT00300885|38220891|FG000|Treatment|Withdrawal by Subject|26|||
17079645|NCT00300885|38220892|FG001|Treatment|Withdrawal by Subject|23|||
17079646|NCT00300885|38220891|FG000|Treatment|Disease progression|171|||
17079647|NCT00300885|38220892|FG001|Treatment|Disease progression|238|||
17079648|NCT00300885|38220891|FG000|Treatment|Random code broken (subject died)|0|||
17079649|NCT00300885|38220892|FG001|Treatment|Random code broken (subject died)|1|||
17079650|NCT00300885|38220891|FG000|Treatment|Non-compliant with study medication|3|||
17079651|NCT00300885|38220892|FG001|Treatment|Non-compliant with study medication|4|||
17079652|NCT00300885|38220891|FG000|Follow-up|Death|141|||
17079653|NCT00300885|38220892|FG001|Follow-up|Death|163|||
17079654|NCT00300885|38220891|FG000|Follow-up|Lost to Follow-up|11|||
17079655|NCT00300885|38220892|FG001|Follow-up|Lost to Follow-up|7|||
17079656|NCT00300885|38220891|FG000|Follow-up|Withdrawal by Subject|26|||
17079657|NCT00300885|38220892|FG001|Follow-up|Withdrawal by Subject|25|||
17079658|NCT00386334|38220900|FG000|Double Blind Period|Adverse Event|9|||
17079659|NCT00386334|38220901|FG001|Double Blind Period|Adverse Event|14|||
17079660|NCT00386334|38220900|FG000|Double Blind Period|Protocol Violation|1|||
17079661|NCT00386334|38220901|FG001|Double Blind Period|Protocol Violation|1|||
17079662|NCT00386334|38220900|FG000|Double Blind Period|Withdrawal by Subject|9|||
17079663|NCT00386334|38220901|FG001|Double Blind Period|Withdrawal by Subject|13|||
17079664|NCT00386334|38220900|FG000|Double Blind Period|Lack of Efficacy|20|||
17079665|NCT00386334|38220901|FG001|Double Blind Period|Lack of Efficacy|11|||
17079666|NCT00386334|38220900|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
17079667|NCT00386334|38220901|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
17079668|NCT00386334|38220900|FG000|Double Blind Period|Other|3|||
17079669|NCT00386334|38220901|FG001|Double Blind Period|Other|3|||
17079670|NCT00386334|38220900|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
17079671|NCT00386334|38220901|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
17079672|NCT00428714|38220918|FG000|Overall Study|Progressive Disease|28|||
17079673|NCT00428714|38220919|FG001|Overall Study|Progressive Disease|36|||
17079674|NCT00428714|38220918|FG000|Overall Study|Withdrawal by Subject|0|||
17079675|NCT00428714|38220919|FG001|Overall Study|Withdrawal by Subject|3|||
17079676|NCT00428714|38220918|FG000|Overall Study|Adverse Event|0|||
17079677|NCT00428714|38220919|FG001|Overall Study|Adverse Event|2|||
17079678|NCT00428714|38220918|FG000|Overall Study|Physician Decision|1|||
17079679|NCT00428714|38220919|FG001|Overall Study|Physician Decision|1|||
17079680|NCT00428714|38220918|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
17079681|NCT00428714|38220919|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
17159446|NCT02951819|38306620|FG000|Overall Study|Other|9|||
17079682|NCT00428714|38220918|FG000|Overall Study|Death due to other then PD|1|||
17079683|NCT00428714|38220919|FG001|Overall Study|Death due to other then PD|0|||
17079684|NCT00292227|38220928|FG000|Patch Period|Adverse Event|1|||
17079685|NCT00292227|38220929|FG001|Patch Period|Adverse Event|0|||
17079686|NCT00292227|38220930|FG002|Patch Period|Adverse Event|2|||
17079687|NCT00292227|38220928|FG000|Patch Period|Withdrawal by Subject|0|||
17079688|NCT00292227|38220929|FG001|Patch Period|Withdrawal by Subject|0|||
17079689|NCT00292227|38220930|FG002|Patch Period|Withdrawal by Subject|1|||
17079690|NCT00386100|38220940|FG000|Overall Study|Did not receive study medication|6|||
17079691|NCT00386100|38220941|FG001|Overall Study|Did not receive study medication|4|||
17079692|NCT00386100|38220940|FG000|Overall Study|Adverse Event|15|||
17079693|NCT00386100|38220941|FG001|Overall Study|Adverse Event|25|||
17079694|NCT00386100|38220940|FG000|Overall Study|Death|0|||
17079695|NCT00386100|38220941|FG001|Overall Study|Death|1|||
17079696|NCT00386100|38220940|FG000|Overall Study|Insufficient therapeutic effect|30|||
17079697|NCT00386100|38220941|FG001|Overall Study|Insufficient therapeutic effect|6|||
17079698|NCT00386100|38220940|FG000|Overall Study|Lost to Follow-up|29|||
17079699|NCT00386100|38220941|FG001|Overall Study|Lost to Follow-up|29|||
17079700|NCT00386100|38220940|FG000|Overall Study|Non-compliance|18|||
17079701|NCT00386100|38220941|FG001|Overall Study|Non-compliance|19|||
17079702|NCT00386100|38220940|FG000|Overall Study|Protocol Violation|5|||
17079703|NCT00386100|38220941|FG001|Overall Study|Protocol Violation|3|||
17079704|NCT00386100|38220940|FG000|Overall Study|Withdrawal by Subject|32|||
17079705|NCT00386100|38220941|FG001|Overall Study|Withdrawal by Subject|31|||
17079706|NCT00386100|38220940|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
17079707|NCT00386100|38220941|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
17079708|NCT00386100|38220940|FG000|Overall Study|BMD <2.5|1|||
17079709|NCT00386100|38220941|FG001|Overall Study|BMD <2.5|0|||
17079710|NCT00386100|38220940|FG000|Overall Study|Consecutive elevated Hba1C|1|||
17079711|NCT00386100|38220941|FG001|Overall Study|Consecutive elevated Hba1C|0|||
17079712|NCT00386100|38220940|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
17079713|NCT00386100|38220941|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
17079714|NCT00386100|38220940|FG000|Overall Study|Laboratory findings|1|||
17079715|NCT00386100|38220941|FG001|Overall Study|Laboratory findings|0|||
17079716|NCT00386100|38220940|FG000|Overall Study|Participant's concern due to CPK levels|1|||
17079717|NCT00386100|38220941|FG001|Overall Study|Participant's concern due to CPK levels|0|||
17079718|NCT00386100|38220940|FG000|Overall Study|Participant moving out of state|2|||
17079719|NCT00386100|38220941|FG001|Overall Study|Participant moving out of state|0|||
17079720|NCT00386100|38220940|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
17079721|NCT00386100|38220941|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
17079722|NCT00386100|38220940|FG000|Overall Study|Didn't meet entry criteria|1|||
17159447|NCT02951819|38306621|FG001|Overall Study|Other|0|||
17159448|NCT03383783|38306627|FG000|Overall Study|Withdrawal by Subject|2|||
17159449|NCT03334721|38306645|FG000|Overall Study|Withdrawal by Subject|1|||
17159450|NCT03334721|38306646|FG001|Overall Study|Withdrawal by Subject|0|||
17159451|NCT03334721|38306645|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
17159452|NCT03334721|38306646|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
16995265|NCT01027949|38138985|FG000|Overall Study|Non-compliance with Study Procedures|7|||
16995266|NCT01027949|38138985|FG000|Overall Study|Lung Transplant|5|||
16995267|NCT01027949|38138985|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
16995268|NCT01027949|38138985|FG000|Overall Study|Use of Excluded Medication|2|||
16995269|NCT01027949|38138985|FG000|Overall Study|Patient Self-discontinuation|1|||
16995270|NCT01027949|38138985|FG000|Overall Study|Pregnancy|1|||
16995271|NCT01027949|38138985|FG000|Overall Study|Surgery|1|||
16995272|NCT01038323|38138992|FG000|Overall Study|Withdrawal by Subject|3|||
16995273|NCT01038323|38138993|FG001|Overall Study|Withdrawal by Subject|2|||
16995274|NCT01038323|38138994|FG002|Overall Study|Withdrawal by Subject|4|||
16995275|NCT01027871|38139005|FG000|Overall Study|Physician Decision|1|||
16995276|NCT01027871|38139006|FG001|Overall Study|Physician Decision|5|||
16995277|NCT01027871|38139007|FG002|Overall Study|Physician Decision|0|||
16995278|NCT01027871|38139005|FG000|Overall Study|Protocol Violation|0|||
16995279|NCT01027871|38139006|FG001|Overall Study|Protocol Violation|2|||
16995280|NCT01027871|38139007|FG002|Overall Study|Protocol Violation|2|||
16995281|NCT01027871|38139005|FG000|Overall Study|Withdrawal by Subject|1|||
16995282|NCT01027871|38139006|FG001|Overall Study|Withdrawal by Subject|2|||
16995283|NCT01027871|38139007|FG002|Overall Study|Withdrawal by Subject|2|||
16995284|NCT01027871|38139005|FG000|Overall Study|Adverse Event|0|||
16995285|NCT01027871|38139006|FG001|Overall Study|Adverse Event|2|||
16995286|NCT01027871|38139007|FG002|Overall Study|Adverse Event|2|||
16995287|NCT01027871|38139005|FG000|Overall Study|Sponsor Decision|0|||
16995288|NCT01027871|38139006|FG001|Overall Study|Sponsor Decision|2|||
16995289|NCT01027871|38139007|FG002|Overall Study|Sponsor Decision|0|||
16995290|NCT01027871|38139005|FG000|Overall Study|Discontinued Prior to Treatment|0|||
16995291|NCT01027871|38139006|FG001|Overall Study|Discontinued Prior to Treatment|0|||
16995292|NCT01027871|38139007|FG002|Overall Study|Discontinued Prior to Treatment|1|||
16995293|NCT01021553|38139023|FG000|Overall Study|Adverse Event|1|||
16995294|NCT01021553|38139024|FG001|Overall Study|Adverse Event|0|||
17079723|NCT00386100|38220941|FG001|Overall Study|Didn't meet entry criteria|1|||
16995295|NCT01021553|38139025|FG002|Overall Study|Adverse Event|0|||
17159453|NCT03515551|38306659|FG000|Overall Study|Death|4|||
17159454|NCT03515551|38306660|FG001|Overall Study|Death|1|||
17159455|NCT03515551|38306661|FG002|Overall Study|Death|2|||
17159456|NCT03515551|38306662|FG003|Overall Study|Death|2|||
17159457|NCT03515551|38306663|FG004|Overall Study|Death|2|||
17159458|NCT03515551|38306664|FG005|Overall Study|Death|4|||
17159459|NCT03515551|38306665|FG006|Overall Study|Death|1|||
17159460|NCT03515551|38306659|FG000|Overall Study|Lost to Follow-up|0|||
17159461|NCT03515551|38306660|FG001|Overall Study|Lost to Follow-up|0|||
17159462|NCT03515551|38306661|FG002|Overall Study|Lost to Follow-up|1|||
17159463|NCT03515551|38306662|FG003|Overall Study|Lost to Follow-up|0|||
17159464|NCT03515551|38306663|FG004|Overall Study|Lost to Follow-up|0|||
17159465|NCT03515551|38306664|FG005|Overall Study|Lost to Follow-up|0|||
17159466|NCT03515551|38306665|FG006|Overall Study|Lost to Follow-up|0|||
17159467|NCT03515551|38306659|FG000|Overall Study|Withdrawal by Subject|0|||
17079724|NCT00386100|38220940|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
17079725|NCT00386100|38220941|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
17079726|NCT00386100|38220940|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
17079727|NCT00386100|38220941|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
17079728|NCT00386100|38220940|FG000|Overall Study|Bad metabolic control & patient security|1|||
17079729|NCT00386100|38220941|FG001|Overall Study|Bad metabolic control & patient security|0|||
17079730|NCT00386100|38220940|FG000|Overall Study|Bone loss by DXA bone scan|1|||
17079731|NCT00386100|38220941|FG001|Overall Study|Bone loss by DXA bone scan|0|||
17079732|NCT00386100|38220940|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
17079733|NCT00386100|38220941|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
17079734|NCT00386100|38220940|FG000|Overall Study|7.6% bone loss|1|||
17079735|NCT00386100|38220941|FG001|Overall Study|7.6% bone loss|0|||
17079736|NCT00386100|38220940|FG000|Overall Study|Osteoporosis|0|||
17079737|NCT00386100|38220941|FG001|Overall Study|Osteoporosis|1|||
17079738|NCT00386100|38220940|FG000|Overall Study|Positive pregnancy test|1|||
17079739|NCT00386100|38220941|FG001|Overall Study|Positive pregnancy test|3|||
17079740|NCT00386100|38220940|FG000|Overall Study|Out of country for 5 months|1|||
17079741|NCT00386100|38220941|FG001|Overall Study|Out of country for 5 months|0|||
17079742|NCT00386100|38220940|FG000|Overall Study|Hb1Ac >8%|0|||
17079743|NCT00386100|38220941|FG001|Overall Study|Hb1Ac >8%|1|||
17079744|NCT00386100|38220940|FG000|Overall Study|Participant randomized in error|1|||
17079745|NCT00386100|38220941|FG001|Overall Study|Participant randomized in error|0|||
17079746|NCT00300495|38220949|FG000|Overall Study|Protocol Violation|4|||
17079747|NCT00300495|38220950|FG001|Overall Study|Protocol Violation|1|||
17079748|NCT00386022|38220958|FG000|Plus Estrogen|Lost to Follow-up|2|||
17079749|NCT00386022|38220959|FG001|Plus Estrogen|Lost to Follow-up|0|||
17079750|NCT00386022|38220958|FG000|Plus Estrogen|Adverse Event|0|||
17079751|NCT00386022|38220959|FG001|Plus Estrogen|Adverse Event|1|||
17079752|NCT00286455|38220970|FG000|Overall Study|Hyperglycemia rescue|19|||
17079753|NCT00286455|38220971|FG001|Overall Study|Hyperglycemia rescue|13|||
17159468|NCT03515551|38306660|FG001|Overall Study|Withdrawal by Subject|1|||
17159469|NCT03515551|38306661|FG002|Overall Study|Withdrawal by Subject|0|||
17159470|NCT03515551|38306662|FG003|Overall Study|Withdrawal by Subject|0|||
17159471|NCT03515551|38306663|FG004|Overall Study|Withdrawal by Subject|0|||
17159472|NCT03515551|38306664|FG005|Overall Study|Withdrawal by Subject|0|||
17159473|NCT03515551|38306665|FG006|Overall Study|Withdrawal by Subject|1|||
17159474|NCT03515551|38306659|FG000|Overall Study|Study ended by sponsor|0|||
17159475|NCT03515551|38306660|FG001|Overall Study|Study ended by sponsor|0|||
17079754|NCT00286455|38220972|FG002|Overall Study|Hyperglycemia rescue|10|||
17079755|NCT00286455|38220970|FG000|Overall Study|Adverse Event|1|||
17159476|NCT03515551|38306661|FG002|Overall Study|Study ended by sponsor|2|||
17159477|NCT03515551|38306662|FG003|Overall Study|Study ended by sponsor|1|||
17159478|NCT03515551|38306663|FG004|Overall Study|Study ended by sponsor|3|||
17159479|NCT03515551|38306664|FG005|Overall Study|Study ended by sponsor|0|||
17159480|NCT03515551|38306665|FG006|Overall Study|Study ended by sponsor|3|||
17159481|NCT03515551|38306659|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
17159482|NCT03515551|38306660|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
17159483|NCT03515551|38306661|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
17159484|NCT03515551|38306662|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
17159485|NCT03515551|38306663|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
17159486|NCT03515551|38306664|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
17159487|NCT03515551|38306665|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
17159488|NCT03380429|38306691|FG000|Overall Study|Physician Decision|0|||
17159489|NCT03380429|38306692|FG001|Overall Study|Physician Decision|1|||
17159490|NCT03380429|38306693|FG002|Overall Study|Physician Decision|0|||
17159491|NCT03380429|38306694|FG003|Overall Study|Physician Decision|1|||
17159492|NCT03380429|38306695|FG004|Overall Study|Physician Decision|1|||
17159493|NCT03380429|38306691|FG000|Overall Study|Withdrawal by Subject|3|||
17159494|NCT03380429|38306692|FG001|Overall Study|Withdrawal by Subject|3|||
17159495|NCT03380429|38306693|FG002|Overall Study|Withdrawal by Subject|5|||
17159496|NCT03380429|38306694|FG003|Overall Study|Withdrawal by Subject|2|||
17159497|NCT03380429|38306695|FG004|Overall Study|Withdrawal by Subject|1|||
17159498|NCT03380429|38306691|FG000|Overall Study|Lost to Follow-up|0|||
17159499|NCT03380429|38306692|FG001|Overall Study|Lost to Follow-up|2|||
17159500|NCT03380429|38306693|FG002|Overall Study|Lost to Follow-up|4|||
17159501|NCT03380429|38306694|FG003|Overall Study|Lost to Follow-up|3|||
17159502|NCT03380429|38306695|FG004|Overall Study|Lost to Follow-up|1|||
17159503|NCT03380429|38306691|FG000|Overall Study|Protocol Violation|1|||
17159504|NCT03380429|38306692|FG001|Overall Study|Protocol Violation|0|||
17159505|NCT03380429|38306693|FG002|Overall Study|Protocol Violation|1|||
17159506|NCT03380429|38306694|FG003|Overall Study|Protocol Violation|0|||
17159507|NCT03380429|38306695|FG004|Overall Study|Protocol Violation|1|||
17159508|NCT03380429|38306691|FG000|Overall Study|Lack of Efficacy|0|||
17159509|NCT03380429|38306692|FG001|Overall Study|Lack of Efficacy|0|||
17159510|NCT03380429|38306693|FG002|Overall Study|Lack of Efficacy|0|||
17159511|NCT03380429|38306694|FG003|Overall Study|Lack of Efficacy|2|||
17159512|NCT03380429|38306695|FG004|Overall Study|Lack of Efficacy|1|||
17159513|NCT03380429|38306691|FG000|Overall Study|Adverse Event|1|||
17159514|NCT03380429|38306692|FG001|Overall Study|Adverse Event|1|||
17159515|NCT03380429|38306693|FG002|Overall Study|Adverse Event|1|||
17079756|NCT00286455|38220971|FG001|Overall Study|Adverse Event|3|||
17079757|NCT00286455|38220972|FG002|Overall Study|Adverse Event|2|||
17079758|NCT00286455|38220970|FG000|Overall Study|Lost to Follow-up|0|||
17079759|NCT00286455|38220971|FG001|Overall Study|Lost to Follow-up|3|||
17079760|NCT00286455|38220972|FG002|Overall Study|Lost to Follow-up|3|||
17079761|NCT00286455|38220970|FG000|Overall Study|Physician Decision|3|||
17079762|NCT00286455|38220971|FG001|Overall Study|Physician Decision|0|||
17079763|NCT00286455|38220972|FG002|Overall Study|Physician Decision|2|||
17079764|NCT00286455|38220970|FG000|Overall Study|Protocol Violation|1|||
17079765|NCT00286455|38220971|FG001|Overall Study|Protocol Violation|1|||
17079766|NCT00286455|38220972|FG002|Overall Study|Protocol Violation|0|||
17079767|NCT00286455|38220970|FG000|Overall Study|Participant Non-compliance|1|||
17079768|NCT00286455|38220971|FG001|Overall Study|Participant Non-compliance|0|||
17079769|NCT00286455|38220972|FG002|Overall Study|Participant Non-compliance|0|||
17159516|NCT03380429|38306694|FG003|Overall Study|Adverse Event|2|||
17159517|NCT03380429|38306695|FG004|Overall Study|Adverse Event|0|||
17159518|NCT03280615|38306714|FG000|Overall Study|Lost to Follow-up|1|||
17159519|NCT03280615|38306715|FG001|Overall Study|Lost to Follow-up|2|||
17159520|NCT03280615|38306714|FG000|Overall Study|Adverse Event|1|||
17159521|NCT03280615|38306715|FG001|Overall Study|Adverse Event|1|||
17159522|NCT03280615|38306714|FG000|Overall Study|Withdrawal by Subject|2|||
17159523|NCT03280615|38306715|FG001|Overall Study|Withdrawal by Subject|2|||
17159524|NCT03280537|38306723|FG000|Overall Study|Withdrawal by Subject|2|||
17159525|NCT03280537|38306724|FG001|Overall Study|Withdrawal by Subject|4|||
17159526|NCT03280381|38306732|FG000|Overall Study|Physician Decision|0|||
17159527|NCT03280381|38306733|FG001|Overall Study|Physician Decision|2|||
17159528|NCT03270085|38306742|FG000|Overall Study|Withdrawal by Subject|1|||
17159529|NCT03270085|38306743|FG001|Overall Study|Withdrawal by Subject|0|||
17159530|NCT03267511|38306753|FG000|Overall Study|Lost to Follow-up|0|||
17159531|NCT03267511|38306754|FG001|Overall Study|Lost to Follow-up|0|||
17159532|NCT03267511|38306755|FG002|Overall Study|Lost to Follow-up|0|||
17159533|NCT03267511|38306756|FG003|Overall Study|Lost to Follow-up|1|||
17159534|NCT03379259|38306783|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
17159535|NCT03379259|38306784|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
17159536|NCT03379259|38306785|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
17159537|NCT03379259|38306786|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
17159538|NCT03379259|38306787|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
17159539|NCT03379259|38306788|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
17159540|NCT03379259|38306783|FG000|Overall Study|Death|0|||
17159541|NCT03379259|38306784|FG001|Overall Study|Death|1|||
17159542|NCT03379259|38306785|FG002|Overall Study|Death|2|||
17159543|NCT03379259|38306786|FG003|Overall Study|Death|1|||
17159544|NCT03379259|38306787|FG004|Overall Study|Death|4|||
17159545|NCT03379259|38306788|FG005|Overall Study|Death|2|||
17159546|NCT03379259|38306783|FG000|Overall Study|Withdrawal by Subject|0|||
17159547|NCT03379259|38306784|FG001|Overall Study|Withdrawal by Subject|0|||
17159548|NCT03379259|38306785|FG002|Overall Study|Withdrawal by Subject|1|||
17159549|NCT03379259|38306786|FG003|Overall Study|Withdrawal by Subject|0|||
17079770|NCT00286455|38220970|FG000|Overall Study|Withdrawal by Subject|0|||
17159550|NCT03379259|38306787|FG004|Overall Study|Withdrawal by Subject|2|||
17159551|NCT03379259|38306788|FG005|Overall Study|Withdrawal by Subject|0|||
17079771|NCT00286455|38220971|FG001|Overall Study|Withdrawal by Subject|8|||
17159552|NCT03379259|38306783|FG000|Overall Study|Study terminated by sponsor|0|||
17159553|NCT03379259|38306784|FG001|Overall Study|Study terminated by sponsor|0|||
17159554|NCT03379259|38306785|FG002|Overall Study|Study terminated by sponsor|0|||
17159555|NCT03379259|38306786|FG003|Overall Study|Study terminated by sponsor|1|||
17159556|NCT03379259|38306787|FG004|Overall Study|Study terminated by sponsor|1|||
17159557|NCT03379259|38306788|FG005|Overall Study|Study terminated by sponsor|4|||
17159558|NCT03379259|38306783|FG000|Overall Study|Disease progression|0|||
17159559|NCT03379259|38306784|FG001|Overall Study|Disease progression|0|||
17159560|NCT03379259|38306785|FG002|Overall Study|Disease progression|0|||
17159561|NCT03379259|38306786|FG003|Overall Study|Disease progression|1|||
17159562|NCT03379259|38306787|FG004|Overall Study|Disease progression|0|||
17159563|NCT03379259|38306788|FG005|Overall Study|Disease progression|1|||
17159564|NCT03379259|38306783|FG000|Overall Study|Lost to Follow-up|0|||
17159565|NCT03379259|38306784|FG001|Overall Study|Lost to Follow-up|0|||
17159566|NCT03379259|38306785|FG002|Overall Study|Lost to Follow-up|0|||
17159567|NCT03379259|38306786|FG003|Overall Study|Lost to Follow-up|0|||
17159568|NCT03379259|38306787|FG004|Overall Study|Lost to Follow-up|1|||
17159569|NCT03379259|38306788|FG005|Overall Study|Lost to Follow-up|0|||
17159570|NCT03379259|38306783|FG000|Overall Study|Deteriorating condition|0|||
17159571|NCT03379259|38306784|FG001|Overall Study|Deteriorating condition|0|||
17159572|NCT03379259|38306785|FG002|Overall Study|Deteriorating condition|0|||
17079772|NCT00286455|38220972|FG002|Overall Study|Withdrawal by Subject|7|||
17079773|NCT00385944|38220982|FG000|1st Maintenance Dose Period|Physician Decision|1|||
17079774|NCT00385944|38220983|FG001|1st Maintenance Dose Period|Physician Decision|0|||
17079775|NCT00385944|38220984|FG002|1st Maintenance Dose Period|Physician Decision|0|||
17079776|NCT00385944|38220982|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
17079777|NCT00385944|38220983|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
17079778|NCT00385944|38220984|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
17079779|NCT00385944|38220982|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
17159573|NCT03379259|38306786|FG003|Overall Study|Deteriorating condition|0|||
17159574|NCT03379259|38306787|FG004|Overall Study|Deteriorating condition|1|||
17159575|NCT03379259|38306788|FG005|Overall Study|Deteriorating condition|0|||
17159576|NCT03328897|38306808|FG000|Randomized-treatment Epoch|Adverse Event|4|||
17159577|NCT03328897|38306809|FG001|Randomized-treatment Epoch|Adverse Event|1|||
17159578|NCT03328897|38306810|FG002|Randomized-treatment Epoch|Adverse Event|1|||
17159579|NCT03328897|38306808|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
17159580|NCT03328897|38306809|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
17159581|NCT03328897|38306810|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
17159582|NCT03328897|38306808|FG000|Randomized-treatment Epoch|Pregnancy|3|||
17159583|NCT03328897|38306809|FG001|Randomized-treatment Epoch|Pregnancy|0|||
17159584|NCT03328897|38306810|FG002|Randomized-treatment Epoch|Pregnancy|0|||
17159585|NCT03328897|38306808|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
17159586|NCT03328897|38306809|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
17159587|NCT03328897|38306810|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
17159588|NCT03328897|38306808|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
17159589|NCT03328897|38306809|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
17159590|NCT03328897|38306810|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
17159591|NCT03328897|38306808|FG000|Follow-up Epoch|Adverse Event|4|||
17159592|NCT03328897|38306809|FG001|Follow-up Epoch|Adverse Event|0|||
17159593|NCT03328897|38306810|FG002|Follow-up Epoch|Adverse Event|1|||
17159594|NCT03328897|38306808|FG000|Follow-up Epoch|Lack of Efficacy|1|||
17159595|NCT03328897|38306809|FG001|Follow-up Epoch|Lack of Efficacy|1|||
17159596|NCT03328897|38306810|FG002|Follow-up Epoch|Lack of Efficacy|1|||
17159597|NCT03328897|38306808|FG000|Follow-up Epoch|Lost to Follow-up|0|||
17159598|NCT03328897|38306809|FG001|Follow-up Epoch|Lost to Follow-up|1|||
17159599|NCT03328897|38306810|FG002|Follow-up Epoch|Lost to Follow-up|0|||
17159600|NCT03328897|38306808|FG000|Follow-up Epoch|Pregnancy|1|||
17159601|NCT03328897|38306809|FG001|Follow-up Epoch|Pregnancy|0|||
17159602|NCT03328897|38306810|FG002|Follow-up Epoch|Pregnancy|0|||
17159603|NCT03328897|38306808|FG000|Follow-up Epoch|Patient/guardian decision|2|||
17159604|NCT03328897|38306809|FG001|Follow-up Epoch|Patient/guardian decision|1|||
17159605|NCT03328897|38306810|FG002|Follow-up Epoch|Patient/guardian decision|0|||
17079780|NCT00385944|38220983|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
17079781|NCT00385944|38220984|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
17079782|NCT00385944|38220982|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
17079783|NCT00385944|38220983|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
17079784|NCT00385944|38220984|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
17079785|NCT00286221|38221003|FG000|Overall Study|Protocol Violation|2|||
17079786|NCT00286221|38221004|FG001|Overall Study|Protocol Violation|1|||
17079787|NCT00286221|38221005|FG002|Overall Study|Protocol Violation|6|||
17079788|NCT00286221|38221006|FG003|Overall Study|Protocol Violation|4|||
17079789|NCT00286221|38221003|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
17079790|NCT00286221|38221004|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
17079791|NCT00286221|38221005|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
17079792|NCT00286221|38221006|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
17079793|NCT00286221|38221003|FG000|Overall Study|Inability to trigger PCA|2|||
17159606|NCT03266107|38306818|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
17159607|NCT03266107|38306818|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
17159608|NCT03266107|38306818|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
17159609|NCT03266107|38306818|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
17159610|NCT03378635|38306827|FG000|Overall Study|Adverse Event|1|||
17159611|NCT03378635|38306828|FG001|Overall Study|Adverse Event|0|||
17159612|NCT03378635|38306829|FG002|Overall Study|Adverse Event|0|||
17159613|NCT03378635|38306827|FG000|Overall Study|Withdrawal by Subject|1|||
17159614|NCT03378635|38306828|FG001|Overall Study|Withdrawal by Subject|0|||
17159615|NCT03378635|38306829|FG002|Overall Study|Withdrawal by Subject|0|||
17159616|NCT03326869|38306840|FG000|Overall Study|Study data has been lost to natural disa|1|||
17159617|NCT03326869|38306841|FG001|Overall Study|Study data has been lost to natural disa|1|||
17159618|NCT03334409|38306853|FG000|Overall Study|Did not meet inclusion criteria|1|||
17159619|NCT03334409|38306854|FG001|Overall Study|Did not meet inclusion criteria|0|||
17159620|NCT02891915|38306862|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
17159621|NCT02891915|38306863|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
17159622|NCT02891915|38306862|FG000|Overall Study|Withdrawal by Subject|3|||
17159623|NCT02891915|38306863|FG001|Overall Study|Withdrawal by Subject|3|||
17159624|NCT02891915|38306862|FG000|Overall Study|Became Ineligible After Enrollment|2|||
17159625|NCT02891915|38306863|FG001|Overall Study|Became Ineligible After Enrollment|1|||
17159626|NCT02891915|38306862|FG000|Overall Study|Lost to Follow-up|1|||
17159627|NCT02891915|38306863|FG001|Overall Study|Lost to Follow-up|4|||
17159628|NCT02891915|38306862|FG000|Overall Study|Physician Decision|1|||
17159629|NCT02891915|38306863|FG001|Overall Study|Physician Decision|0|||
17159630|NCT02891681|38306872|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
17159631|NCT02891681|38306873|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
17159632|NCT02891681|38306874|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
17159633|NCT02891681|38306872|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
17159634|NCT02891681|38306873|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
17159635|NCT02891681|38306874|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
17159636|NCT02891681|38306872|FG000|Overall Study|Taken off study after first imaging appointment|1|||
17159637|NCT02891681|38306873|FG001|Overall Study|Taken off study after first imaging appointment|0|||
17159638|NCT02891681|38306874|FG002|Overall Study|Taken off study after first imaging appointment|0|||
17159639|NCT04671342|38306882|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
17159640|NCT04671342|38306882|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
17159641|NCT04671342|38306882|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
17159642|NCT04671342|38306882|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
17159643|NCT04671342|38306882|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
17159644|NCT04671342|38306882|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
17159645|NCT03046446|38306886|FG000|Overall Study|Lack of Efficacy|7|||
17159646|NCT03046446|38306886|FG000|Overall Study|Adverse Event|6|||
17159647|NCT03046446|38306886|FG000|Overall Study|Lost to Follow-up|3|||
17159648|NCT03046446|38306886|FG000|Overall Study|Withdrawal by Subject|14|||
17159649|NCT03046446|38306886|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
17159650|NCT03046446|38306886|FG000|Overall Study|Disease Progression (see caveats)|25|||
17159651|NCT03046446|38306886|FG000|Overall Study|Non OA related knee surgery|1|||
17159652|NCT03051217|38306893|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
17159653|NCT03051217|38306894|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
17159654|NCT03051217|38306895|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
17159655|NCT03051217|38306896|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
17159656|NCT03051217|38306897|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
17159657|NCT03051217|38306898|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
17159658|NCT03051217|38306899|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
17159659|NCT03051217|38306893|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
17159660|NCT03051217|38306894|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
17159661|NCT03051217|38306895|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
17159662|NCT03051217|38306896|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
17159663|NCT03051217|38306897|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
17159664|NCT03051217|38306898|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
17159665|NCT03051217|38306899|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
17159666|NCT03051217|38306893|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
17159667|NCT03051217|38306894|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
17159668|NCT03051217|38306895|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
17159669|NCT03051217|38306896|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
17159670|NCT03051217|38306897|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
17159671|NCT03051217|38306898|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
17159672|NCT03051217|38306899|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
17159673|NCT03051217|38306893|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
17159674|NCT03051217|38306894|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
17159675|NCT03051217|38306895|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
16781287|NCT02105974|37720455|FG002|2 Week Run-in Period|Investigator discretion|0|||
17159676|NCT03051217|38306896|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
17159677|NCT03051217|38306897|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
17189070|NCT01060111|38342041|FG001|Overall Study|Lack of Efficacy|1|||
17159678|NCT03051217|38306898|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
17159679|NCT03051217|38306899|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
17159680|NCT03051217|38306893|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
17159681|NCT03051217|38306894|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
17159682|NCT03051217|38306895|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
17159683|NCT03051217|38306896|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
17159684|NCT03051217|38306897|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
17159685|NCT03051217|38306898|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
17159686|NCT03051217|38306899|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
17159687|NCT03051217|38306893|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
17159688|NCT03051217|38306894|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
17159689|NCT03051217|38306895|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
17159690|NCT03051217|38306896|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
17159691|NCT03051217|38306897|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
17159692|NCT03051217|38306898|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
17159693|NCT03051217|38306899|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
17159694|NCT03051217|38306893|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
17159695|NCT03051217|38306894|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
17159696|NCT03051217|38306895|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
17159697|NCT03051217|38306896|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
17159698|NCT03051217|38306897|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
17159699|NCT03051217|38306898|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
17159700|NCT03051217|38306899|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
17159701|NCT03051217|38306893|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
17159702|NCT03051217|38306894|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
17159703|NCT03051217|38306895|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
17159704|NCT03051217|38306896|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
17159705|NCT03051217|38306897|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
17159706|NCT03051217|38306898|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
17159707|NCT03051217|38306899|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
17159708|NCT03046056|38306925|FG000|Overall Study|Non-responder at Week 10|6|||
17159709|NCT03046056|38306926|FG001|Overall Study|Non-responder at Week 10|6|||
17159710|NCT03046056|38306927|FG002|Overall Study|Non-responder at Week 10|4|||
17159711|NCT03046056|38306925|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
17159712|NCT03046056|38306926|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
17159713|NCT03046056|38306927|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
17159714|NCT03046056|38306925|FG000|Overall Study|Adverse Event|1|||
17159715|NCT03046056|38306926|FG001|Overall Study|Adverse Event|5|||
17159716|NCT03046056|38306927|FG002|Overall Study|Adverse Event|0|||
17159717|NCT03046056|38306925|FG000|Overall Study|Non-compliance With Study Drug|0|||
17159718|NCT03046056|38306926|FG001|Overall Study|Non-compliance With Study Drug|0|||
17159719|NCT03046056|38306927|FG002|Overall Study|Non-compliance With Study Drug|2|||
17159720|NCT03046056|38306925|FG000|Overall Study|Protocol Violation|1|||
17159721|NCT03046056|38306926|FG001|Overall Study|Protocol Violation|1|||
17159722|NCT03046056|38306927|FG002|Overall Study|Protocol Violation|0|||
17159723|NCT03046056|38306925|FG000|Overall Study|Investigator's Discretion|0|||
17159724|NCT03046056|38306926|FG001|Overall Study|Investigator's Discretion|1|||
17159725|NCT03046056|38306927|FG002|Overall Study|Investigator's Discretion|0|||
17159726|NCT03046056|38306925|FG000|Overall Study|Withdrew Consent|1|||
17159727|NCT03046056|38306926|FG001|Overall Study|Withdrew Consent|0|||
17159728|NCT03046056|38306927|FG002|Overall Study|Withdrew Consent|0|||
17159729|NCT02849587|38306938|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
17159730|NCT02849587|38306939|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
17159731|NCT02849587|38306940|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
17159732|NCT02849587|38306938|FG000|Overall Study|Withdrawal by Subject|0|||
17159733|NCT02849587|38306939|FG001|Overall Study|Withdrawal by Subject|1|||
17079794|NCT00286221|38221004|FG001|Overall Study|Inability to trigger PCA|0|||
17079795|NCT00286221|38221005|FG002|Overall Study|Inability to trigger PCA|0|||
17079796|NCT00286221|38221006|FG003|Overall Study|Inability to trigger PCA|0|||
17079797|NCT00286221|38221003|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
17079798|NCT00286221|38221004|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
17079799|NCT00286221|38221005|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
17079800|NCT00286221|38221006|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
17079801|NCT00285207|38221018|FG000|Overall Study|Lost to Follow-up|3|||
17079802|NCT00285207|38221019|FG001|Overall Study|Lost to Follow-up|2|||
17079803|NCT00285207|38221018|FG000|Overall Study|Withdrawal by Subject|5|||
17079804|NCT00285207|38221019|FG001|Overall Study|Withdrawal by Subject|2|||
17159734|NCT02849587|38306940|FG002|Overall Study|Withdrawal by Subject|0|||
17159735|NCT03347279|38306954|FG000|Overall Study|Withdrawal by Subject|8|||
17159736|NCT03347279|38306955|FG001|Overall Study|Withdrawal by Subject|15|||
17159737|NCT03347279|38306954|FG000|Overall Study|Death|0|||
17159738|NCT03347279|38306955|FG001|Overall Study|Death|2|||
17159739|NCT03347279|38306954|FG000|Overall Study|Lost to Follow-up|5|||
17159740|NCT03347279|38306955|FG001|Overall Study|Lost to Follow-up|2|||
17159741|NCT03347279|38306954|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
17159742|NCT03347279|38306955|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
17159743|NCT03262441|38306961|FG000|Overall Study|Withdrawal by Subject|1|||
17159744|NCT04580394|38306965|FG000|First Intervention|Incorrectly Randomized|1|||
17159745|NCT04580394|38306965|FG000|First Intervention|Physician Decision|1|||
17159746|NCT04580394|38306965|FG000|First Intervention|Lost to Follow-up|1|||
17159747|NCT04580394|38306965|FG000|Washout (One Week)|Withdrawal by Subject|1|||
17159748|NCT04580394|38306965|FG000|Washout (One Week)|Adverse Event|1|||
17159749|NCT04580394|38306965|FG000|Washout (One Week)|Withdrawal by Subject|2|||
17159750|NCT04580394|38306965|FG000|Third Intervention|Adverse Event|1|||
17159751|NCT04580394|38306965|FG000|Third Intervention|Withdrawal by Subject|1|||
17159752|NCT04580394|38306965|FG000|Washout (One Week)|Withdrawal by Subject|2|||
17159753|NCT02781727|38306977|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
17159754|NCT02781727|38306978|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
17159755|NCT02781727|38306977|FG000|Treatment Period|Withdrawal by Subject|1|||
17159756|NCT02781727|38306978|FG001|Treatment Period|Withdrawal by Subject|0|||
17159757|NCT02781727|38306977|FG000|Treatment Period|Lost to Follow-up|0|||
17159758|NCT02781727|38306978|FG001|Treatment Period|Lost to Follow-up|1|||
17159759|NCT01343082|38306984|FG000|The run-in Period|Not meeting criteria|3|||
17159760|NCT01343082|38306985|FG001|The run-in Period|Not meeting criteria|4|||
17159761|NCT01343082|38306986|FG002|The run-in Period|Not meeting criteria|5|||
17159762|NCT01343082|38306984|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
17159763|NCT01343082|38306985|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
17159764|NCT01343082|38306986|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
17079805|NCT00285207|38221018|FG000|Overall Study|Pregnancy|1|||
17079806|NCT00285207|38221019|FG001|Overall Study|Pregnancy|1|||
17079807|NCT00285207|38221018|FG000|Overall Study|non-compliance|0|||
17079808|NCT00285207|38221019|FG001|Overall Study|non-compliance|1|||
17079809|NCT00398112|38221025|FG000|Overall Study|Adverse Event|4|||
17079810|NCT00398112|38221025|FG000|Overall Study|Disease progression|9|||
17079811|NCT00398112|38221025|FG000|Overall Study|Alternative treatment|1|||
17079812|NCT00398112|38221025|FG000|Overall Study|Withdrawal by Subject|3|||
17079813|NCT00398112|38221025|FG000|Overall Study|Death|1|||
17079814|NCT00424346|38221033|FG000|Core Study|Adverse Event|5|||
17079815|NCT00424346|38221034|FG001|Core Study|Adverse Event|3|||
17079816|NCT00424346|38221035|FG002|Core Study|Adverse Event|1|||
17079817|NCT00424346|38221036|FG003|Core Study|Adverse Event|1|||
17079818|NCT00424346|38221033|FG000|Core Study|Abnormal Laboratory Values|0|||
17079819|NCT00424346|38221034|FG001|Core Study|Abnormal Laboratory Values|1|||
17079820|NCT00424346|38221035|FG002|Core Study|Abnormal Laboratory Values|0|||
17079821|NCT00424346|38221036|FG003|Core Study|Abnormal Laboratory Values|0|||
17079822|NCT00424346|38221033|FG000|Core Study|Lack of Efficacy|1|||
17079823|NCT00424346|38221034|FG001|Core Study|Lack of Efficacy|3|||
17079824|NCT00424346|38221035|FG002|Core Study|Lack of Efficacy|0|||
17079825|NCT00424346|38221036|FG003|Core Study|Lack of Efficacy|4|||
17079826|NCT00424346|38221033|FG000|Core Study|Withdrawal by Subject|1|||
17079827|NCT00424346|38221034|FG001|Core Study|Withdrawal by Subject|0|||
17079828|NCT00424346|38221035|FG002|Core Study|Withdrawal by Subject|0|||
17079829|NCT00424346|38221036|FG003|Core Study|Withdrawal by Subject|2|||
17079830|NCT00424346|38221033|FG000|Core Study|Lost to Follow-up|1|||
17079831|NCT00424346|38221034|FG001|Core Study|Lost to Follow-up|1|||
17079832|NCT00424346|38221035|FG002|Core Study|Lost to Follow-up|0|||
17079833|NCT00424346|38221036|FG003|Core Study|Lost to Follow-up|0|||
17079834|NCT00424346|38221033|FG000|Core Study|Administrative Problems|1|||
17079835|NCT00424346|38221034|FG001|Core Study|Administrative Problems|0|||
17079836|NCT00424346|38221035|FG002|Core Study|Administrative Problems|1|||
17079837|NCT00424346|38221036|FG003|Core Study|Administrative Problems|0|||
17159765|NCT01343082|38306984|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
16995296|NCT01021553|38139023|FG000|Overall Study|Lack of Efficacy|2|||
16995297|NCT01021553|38139024|FG001|Overall Study|Lack of Efficacy|2|||
16995298|NCT01021553|38139025|FG002|Overall Study|Lack of Efficacy|0|||
16995299|NCT01021553|38139023|FG000|Overall Study|Protocol Violation|0|||
16995300|NCT01021553|38139024|FG001|Overall Study|Protocol Violation|2|||
16995301|NCT01021553|38139025|FG002|Overall Study|Protocol Violation|2|||
16995302|NCT01021553|38139023|FG000|Overall Study|Lost to Follow-up|0|||
16995303|NCT01021553|38139024|FG001|Overall Study|Lost to Follow-up|0|||
16995304|NCT01021553|38139025|FG002|Overall Study|Lost to Follow-up|1|||
16995305|NCT01021553|38139023|FG000|Overall Study|Withdrawal by Subject|1|||
17079838|NCT00424346|38221033|FG000|Core Study|Protocol Violation|0|||
17079839|NCT00424346|38221034|FG001|Core Study|Protocol Violation|0|||
16995306|NCT01021553|38139024|FG001|Overall Study|Withdrawal by Subject|1|||
16995307|NCT01021553|38139025|FG002|Overall Study|Withdrawal by Subject|0|||
16995308|NCT01026389|38139040|FG000|Overall Study|Withdrawal by Subject|1|||
16995309|NCT01026389|38139041|FG001|Overall Study|Withdrawal by Subject|3|||
17079840|NCT00424346|38221035|FG002|Core Study|Protocol Violation|2|||
17079841|NCT00424346|38221036|FG003|Core Study|Protocol Violation|0|||
17079842|NCT00424346|38221033|FG000|Extension Phase|Adverse Event|0|||
17079843|NCT00424346|38221034|FG001|Extension Phase|Adverse Event|9|||
17159766|NCT01343082|38306985|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
17159767|NCT01343082|38306986|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
17159768|NCT01343082|38306984|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
17159769|NCT01343082|38306985|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
17159770|NCT01343082|38306986|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
17159771|NCT01343082|38306984|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
17159772|NCT01343082|38306985|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
17159773|NCT01343082|38306986|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
17159774|NCT03374189|38306992|FG000|Overall Study|Lost to Follow-up|1|||
17159775|NCT03374189|38306993|FG001|Overall Study|Lost to Follow-up|0|||
17159776|NCT03261037|38307003|FG000|Overall Study|Withdrawal by Subject|2|||
17159777|NCT03261037|38307004|FG001|Overall Study|Withdrawal by Subject|13|||
17159778|NCT03261037|38307005|FG002|Overall Study|Withdrawal by Subject|0|||
17159779|NCT03261037|38307006|FG003|Overall Study|Withdrawal by Subject|18|||
17159780|NCT03261037|38307003|FG000|Overall Study|Non-compliance with study procedures|0|||
17159781|NCT03261037|38307004|FG001|Overall Study|Non-compliance with study procedures|2|||
17159782|NCT03261037|38307005|FG002|Overall Study|Non-compliance with study procedures|0|||
17159783|NCT03261037|38307006|FG003|Overall Study|Non-compliance with study procedures|6|||
17159784|NCT03261037|38307003|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
17159785|NCT03261037|38307004|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
17159786|NCT03261037|38307005|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
17159787|NCT03261037|38307006|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
17159788|NCT03261037|38307003|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
17159789|NCT03261037|38307004|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
17159790|NCT03261037|38307005|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
17159791|NCT03261037|38307006|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
17159792|NCT03261037|38307003|FG000|Overall Study|Diagnosed but protocol deviation|1|||
17159793|NCT03261037|38307004|FG001|Overall Study|Diagnosed but protocol deviation|0|||
17159794|NCT03261037|38307005|FG002|Overall Study|Diagnosed but protocol deviation|0|||
17159795|NCT03261037|38307006|FG003|Overall Study|Diagnosed but protocol deviation|0|||
17159796|NCT03261037|38307003|FG000|Overall Study|Participant did not want to continue the study|0|||
17159797|NCT03261037|38307004|FG001|Overall Study|Participant did not want to continue the study|1|||
17159798|NCT03261037|38307005|FG002|Overall Study|Participant did not want to continue the study|0|||
17159799|NCT03261037|38307006|FG003|Overall Study|Participant did not want to continue the study|0|||
17159800|NCT03261037|38307003|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
17159801|NCT03261037|38307004|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
16995310|NCT01026389|38139040|FG000|Overall Study|change of treatment, patient moved|4|||
16995311|NCT01026389|38139041|FG001|Overall Study|change of treatment, patient moved|2|||
17079844|NCT00424346|38221035|FG002|Extension Phase|Adverse Event|5|||
17079845|NCT00424346|38221036|FG003|Extension Phase|Adverse Event|4|||
17079846|NCT00424346|38221033|FG000|Extension Phase|Lack of Efficacy|0|||
17079847|NCT00424346|38221034|FG001|Extension Phase|Lack of Efficacy|16|||
17079848|NCT00424346|38221035|FG002|Extension Phase|Lack of Efficacy|14|||
17079849|NCT00424346|38221036|FG003|Extension Phase|Lack of Efficacy|11|||
17079850|NCT00424346|38221033|FG000|Extension Phase|Withdrawal by Subject|0|||
17079851|NCT00424346|38221034|FG001|Extension Phase|Withdrawal by Subject|5|||
17079852|NCT00424346|38221035|FG002|Extension Phase|Withdrawal by Subject|3|||
17079853|NCT00424346|38221036|FG003|Extension Phase|Withdrawal by Subject|4|||
17079854|NCT00424346|38221033|FG000|Extension Phase|Lost to Follow-up|0|||
17079855|NCT00424346|38221034|FG001|Extension Phase|Lost to Follow-up|2|||
17079856|NCT00424346|38221035|FG002|Extension Phase|Lost to Follow-up|0|||
17079857|NCT00424346|38221036|FG003|Extension Phase|Lost to Follow-up|0|||
17079858|NCT00424346|38221033|FG000|Extension Phase|Administrative Problems|0|||
17079859|NCT00424346|38221034|FG001|Extension Phase|Administrative Problems|69|||
17079860|NCT00424346|38221035|FG002|Extension Phase|Administrative Problems|32|||
17079861|NCT00424346|38221036|FG003|Extension Phase|Administrative Problems|35|||
17079862|NCT00424346|38221033|FG000|Extension Phase|Death|0|||
17079863|NCT00424346|38221034|FG001|Extension Phase|Death|0|||
17079864|NCT00424346|38221035|FG002|Extension Phase|Death|0|||
17079865|NCT00424346|38221036|FG003|Extension Phase|Death|1|||
16995312|NCT01006616|38139051|FG000|Period 1 (6 Months)|Adverse Event|10|||
16995313|NCT01006616|38139052|FG001|Period 1 (6 Months)|Adverse Event|31|||
17079866|NCT00424346|38221033|FG000|Extension Phase|Protocol Violation|0|||
17079867|NCT00424346|38221034|FG001|Extension Phase|Protocol Violation|1|||
17079868|NCT00424346|38221035|FG002|Extension Phase|Protocol Violation|1|||
17079869|NCT00424346|38221036|FG003|Extension Phase|Protocol Violation|0|||
17079870|NCT00283959|38221049|FG000|Extension Period|Low Compliance|1|||
17079871|NCT00372528|38221053|FG000|Overall Study|Lack of Efficacy|1|||
17079872|NCT00372528|38221053|FG000|Overall Study|Adverse Event|1|||
17079873|NCT00372528|38221053|FG000|Overall Study|Study Terminated by Sponsor|18|||
17079874|NCT00372528|38221053|FG000|Overall Study|Other|1|||
17079875|NCT00283803|38221057|FG000|Overall Study|Physician Decision|9|||
17079876|NCT00283803|38221057|FG000|Overall Study|Withdrawal by Subject|4|||
17079877|NCT00397488|38221061|FG000|Overall Study|Withdrawal by Subject|3|||
17079878|NCT00397488|38221061|FG000|Overall Study|Adverse Event|3|||
17079879|NCT00397488|38221061|FG000|Overall Study|Death|1|||
17079880|NCT00424190|38221067|FG000|Overall Study|Withdrew consent|3|||
17079881|NCT00424190|38221068|FG001|Overall Study|Withdrew consent|4|||
17079882|NCT00424190|38221067|FG000|Overall Study|Death|3|||
17079883|NCT00424190|38221068|FG001|Overall Study|Death|0|||
17079884|NCT00424190|38221067|FG000|Overall Study|Noncompliance|1|||
17079885|NCT00424190|38221068|FG001|Overall Study|Noncompliance|2|||
17079886|NCT00424190|38221067|FG000|Overall Study|Request of sponsor or investigator|0|||
17079887|NCT00424190|38221068|FG001|Overall Study|Request of sponsor or investigator|2|||
17079888|NCT00424190|38221067|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
17079889|NCT00424190|38221068|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
17079890|NCT00424190|38221067|FG000|Overall Study|Other|15|||
17079891|NCT00424190|38221068|FG001|Overall Study|Other|21|||
17079892|NCT00428246|38221077|FG000|Overall Study|Withdrawal by Subject|0|||
17079893|NCT00428246|38221078|FG001|Overall Study|Withdrawal by Subject|0|||
17079894|NCT00428246|38221079|FG002|Overall Study|Withdrawal by Subject|1|||
17079895|NCT00428246|38221077|FG000|Overall Study|Adverse Event|1|||
17079896|NCT00428246|38221078|FG001|Overall Study|Adverse Event|0|||
17079897|NCT00428246|38221079|FG002|Overall Study|Adverse Event|0|||
17079898|NCT00274287|38221087|FG000|Overall Study|Withdrawal by Subject|1|||
17079899|NCT00274287|38221087|FG000|Overall Study|subject non-compliance|1|||
17079900|NCT00423800|38221094|FG000|Overall Study|Protocol Violation|0|||
17079901|NCT00423800|38221095|FG001|Overall Study|Protocol Violation|1|||
17079902|NCT00405548|38221104|FG000|Overall Study|Cognitive Memory problems on study day|1|||
17079903|NCT00405548|38221105|FG001|Overall Study|Cognitive Memory problems on study day|0|||
17079904|NCT00405548|38221104|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
17079905|NCT00405548|38221105|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
17079906|NCT00405548|38221104|FG000|Overall Study|Unable to self-administer shots|1|||
17079907|NCT00405548|38221105|FG001|Overall Study|Unable to self-administer shots|0|||
17079908|NCT00405548|38221104|FG000|Overall Study|Venous access failed during study day|1|||
17079909|NCT00405548|38221105|FG001|Overall Study|Venous access failed during study day|0|||
17079910|NCT00405548|38221104|FG000|Overall Study|Withdrawal by Subject|1|||
17079911|NCT00405548|38221105|FG001|Overall Study|Withdrawal by Subject|0|||
17079912|NCT00405392|38221113|FG000|Overall Study|Adverse Event|15|||
17079913|NCT00405392|38221114|FG001|Overall Study|Adverse Event|14|||
17079914|NCT00405392|38221113|FG000|Overall Study|Did not meet Eligibility criteria|7|||
17079915|NCT00405392|38221114|FG001|Overall Study|Did not meet Eligibility criteria|2|||
17079916|NCT00405392|38221113|FG000|Overall Study|Withdrawal by Subject|4|||
17079917|NCT00405392|38221114|FG001|Overall Study|Withdrawal by Subject|3|||
17079918|NCT00405392|38221113|FG000|Overall Study|Lost to Follow-up|1|||
17079919|NCT00405392|38221114|FG001|Overall Study|Lost to Follow-up|2|||
17079920|NCT00405392|38221113|FG000|Overall Study|Data missing|2|||
17079921|NCT00405392|38221114|FG001|Overall Study|Data missing|0|||
17079922|NCT00405392|38221113|FG000|Overall Study|Non-compliance|0|||
17159802|NCT03261037|38307005|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
17159803|NCT03261037|38307006|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
17159804|NCT03261037|38307003|FG000|Overall Study|Participant presented clinical improvement|0|||
17159805|NCT03261037|38307004|FG001|Overall Study|Participant presented clinical improvement|2|||
17159806|NCT03261037|38307005|FG002|Overall Study|Participant presented clinical improvement|0|||
17159807|NCT03261037|38307006|FG003|Overall Study|Participant presented clinical improvement|0|||
17159808|NCT03261037|38307003|FG000|Overall Study|Technical difficulties|0|||
17159809|NCT03261037|38307004|FG001|Overall Study|Technical difficulties|0|||
17159810|NCT03261037|38307005|FG002|Overall Study|Technical difficulties|0|||
17159811|NCT03261037|38307006|FG003|Overall Study|Technical difficulties|1|||
17159812|NCT03261037|38307003|FG000|Overall Study|Equipment failed to work|0|||
17159813|NCT03261037|38307004|FG001|Overall Study|Equipment failed to work|0|||
17159814|NCT03261037|38307005|FG002|Overall Study|Equipment failed to work|0|||
17159815|NCT03261037|38307006|FG003|Overall Study|Equipment failed to work|1|||
17159816|NCT03261037|38307003|FG000|Overall Study|End of study for participant and no follow up|0|||
17159817|NCT03261037|38307004|FG001|Overall Study|End of study for participant and no follow up|0|||
17189071|NCT01060111|38342042|FG002|Overall Study|Lack of Efficacy|0|||
16868021|NCT01536145|37841041|FG008|Overall Study|Withdrawal by Subject|2|||
17159818|NCT03261037|38307005|FG002|Overall Study|End of study for participant and no follow up|0|||
17159819|NCT03261037|38307006|FG003|Overall Study|End of study for participant and no follow up|1|||
17159820|NCT03261037|38307003|FG000|Overall Study|Participant was too weak to continue in study|1|||
17159821|NCT03261037|38307004|FG001|Overall Study|Participant was too weak to continue in study|0|||
17159822|NCT03261037|38307005|FG002|Overall Study|Participant was too weak to continue in study|0|||
17159823|NCT03261037|38307006|FG003|Overall Study|Participant was too weak to continue in study|0|||
17159824|NCT03372551|38307017|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
17159825|NCT03372551|38307018|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
17159826|NCT03326323|38307031|FG000|Overall Study|Unable to receive ANH protocol|3|||
17159827|NCT03259789|38307042|FG000|Overall Study|Adverse Event|3|||
17159828|NCT03259789|38307043|FG001|Overall Study|Adverse Event|2|||
17159829|NCT03259789|38307044|FG002|Overall Study|Adverse Event|1|||
17159830|NCT03259789|38307042|FG000|Overall Study|Withdrawal by Subject|9|||
17159831|NCT03259789|38307043|FG001|Overall Study|Withdrawal by Subject|5|||
17159832|NCT03259789|38307044|FG002|Overall Study|Withdrawal by Subject|1|||
17079923|NCT00405392|38221114|FG001|Overall Study|Non-compliance|1|||
17079924|NCT00405392|38221113|FG000|Overall Study|Other|1|||
17079925|NCT00405392|38221114|FG001|Overall Study|Other|5|||
17079926|NCT00282243|38221120|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
17079927|NCT00282243|38221120|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
17079928|NCT00282243|38221120|FG000|Extension Treatment Period|Adverse Event|15|||
17079929|NCT00282243|38221120|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
17079930|NCT00282243|38221120|FG000|Extension Treatment Period|Non-compliance|2|||
17079931|NCT00282243|38221120|FG000|Extension Treatment Period|Physician Decision|1|||
17079932|NCT00272961|38221129|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
17079933|NCT00272961|38221130|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
17079934|NCT00272961|38221131|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
17079935|NCT00272961|38221132|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
17079936|NCT00272961|38221133|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
17079937|NCT00272961|38221129|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
17079938|NCT00272961|38221130|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
17079939|NCT00272961|38221131|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
17079940|NCT00272961|38221132|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
17079941|NCT00272961|38221133|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
17079942|NCT00272961|38221129|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
17079943|NCT00272961|38221130|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
17079944|NCT00272961|38221131|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
17079945|NCT00272961|38221132|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
17079946|NCT00272961|38221133|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
17079947|NCT00272961|38221129|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
17079948|NCT00272961|38221130|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
17079949|NCT00272961|38221131|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
17079950|NCT00272961|38221132|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
17079951|NCT00272961|38221133|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
17079952|NCT00272961|38221129|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
17079953|NCT00272961|38221130|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
17079954|NCT00272961|38221131|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
17079955|NCT00272961|38221132|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
17079956|NCT00272961|38221133|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
17079957|NCT00272961|38221129|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
17079958|NCT00272961|38221130|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
17079959|NCT00272961|38221131|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
17079960|NCT00272961|38221132|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
17079961|NCT00272961|38221133|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
17079962|NCT00272961|38221129|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
17079963|NCT00272961|38221130|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
17079964|NCT00272961|38221131|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
17079965|NCT00272961|38221132|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
17079966|NCT00272961|38221133|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
17079967|NCT00272961|38221129|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
17079968|NCT00272961|38221130|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
17079969|NCT00272961|38221131|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
17079970|NCT00272961|38221132|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
17079971|NCT00272961|38221133|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
17079972|NCT00282087|38221145|FG000|Overall Study|Death|1|||
17079973|NCT00404924|38221152|FG000|Overall Study|Adverse Event|75|||
17079974|NCT00404924|38221153|FG001|Overall Study|Adverse Event|16|||
17079975|NCT00404924|38221152|FG000|Overall Study|Condition under investigation worsened|475|||
17079976|NCT00404924|38221153|FG001|Overall Study|Condition under investigation worsened|264|||
17079977|NCT00404924|38221152|FG000|Overall Study|Lost to Follow-up|1|||
17079978|NCT00404924|38221153|FG001|Overall Study|Lost to Follow-up|1|||
17079979|NCT00404924|38221152|FG000|Overall Study|Withdrawal by Subject|26|||
17079980|NCT00404924|38221153|FG001|Overall Study|Withdrawal by Subject|13|||
17079981|NCT00404924|38221152|FG000|Overall Study|Other|25|||
17079982|NCT00404924|38221153|FG001|Overall Study|Other|11|||
17079983|NCT00404924|38221152|FG000|Overall Study|Randomised but not received treatment|1|||
17079984|NCT00404924|38221153|FG001|Overall Study|Randomised but not received treatment|1|||
17079985|NCT00281697|38221161|FG000|Overall Study|> 60 days since last dose of study drug|4|||
17079986|NCT00281697|38221162|FG001|Overall Study|> 60 days since last dose of study drug|4|||
17079987|NCT00281697|38221161|FG000|Overall Study|Adverse Event|54|||
17079988|NCT00281697|38221162|FG001|Overall Study|Adverse Event|15|||
17079989|NCT00281697|38221161|FG000|Overall Study|Death|8|||
17079990|NCT00281697|38221162|FG001|Overall Study|Death|3|||
17079991|NCT00281697|38221161|FG000|Overall Study|Disease progression|279|||
17079992|NCT00281697|38221162|FG001|Overall Study|Disease progression|149|||
17079993|NCT00281697|38221161|FG000|Overall Study|Other|5|||
17079994|NCT00281697|38221162|FG001|Overall Study|Other|6|||
17079995|NCT00281697|38221161|FG000|Overall Study|Physician's decision to withdraw|15|||
17079996|NCT00281697|38221162|FG001|Overall Study|Physician's decision to withdraw|12|||
17079997|NCT00281697|38221161|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
17079998|NCT00281697|38221162|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
17079999|NCT00281697|38221161|FG000|Overall Study|Did not receive study drug|3|||
17159833|NCT03259789|38307042|FG000|Overall Study|Lost to Follow-up|5|||
17159834|NCT03259789|38307043|FG001|Overall Study|Lost to Follow-up|9|||
17159835|NCT03259789|38307044|FG002|Overall Study|Lost to Follow-up|4|||
17159836|NCT03259789|38307042|FG000|Overall Study|Physician Decision|0|||
17159837|NCT03259789|38307043|FG001|Overall Study|Physician Decision|1|||
17080000|NCT00281697|38221162|FG001|Overall Study|Did not receive study drug|2|||
17080001|NCT00271947|38221168|FG000|Overall Study|Lost to Follow-up|1|||
17080002|NCT00232180|38221174|FG000|Double-blind (DB) Phase|Death|186|||
17080003|NCT00232180|38221175|FG001|Double-blind (DB) Phase|Death|222|||
17080004|NCT00232180|38221176|FG002|Double-blind (DB) Phase|Death|0|||
17080005|NCT00232180|38221174|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
17080006|NCT00232180|38221175|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
17159838|NCT03259789|38307044|FG002|Overall Study|Physician Decision|0|||
17159839|NCT03259555|38307055|FG000|Overall Study|Adverse Event|6|||
17159840|NCT03259555|38307056|FG001|Overall Study|Adverse Event|4|||
17159841|NCT03259555|38307055|FG000|Overall Study|Lack of Efficacy|6|||
17159842|NCT03259555|38307056|FG001|Overall Study|Lack of Efficacy|4|||
17159843|NCT03259555|38307055|FG000|Overall Study|Lost to Follow-up|0|||
17159844|NCT03259555|38307056|FG001|Overall Study|Lost to Follow-up|2|||
17159845|NCT03259555|38307055|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17159846|NCT03259555|38307056|FG001|Overall Study|Non-Compliance With Study Drug|0|||
17159847|NCT03259555|38307055|FG000|Overall Study|Progressive Disease|0|||
17159848|NCT03259555|38307056|FG001|Overall Study|Progressive Disease|2|||
17159849|NCT03259555|38307055|FG000|Overall Study|Withdrawal by Subject|19|||
17080007|NCT00232180|38221176|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
17080008|NCT00232180|38221174|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
17159850|NCT03259555|38307056|FG001|Overall Study|Withdrawal by Subject|16|||
17159851|NCT03259555|38307055|FG000|Overall Study|Physician Decision|1|||
17080009|NCT00232180|38221175|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
17080010|NCT00232180|38221176|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
17080011|NCT00232180|38221174|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
17080012|NCT00232180|38221175|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
17080013|NCT00232180|38221176|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
17080014|NCT00232180|38221174|FG000|Double-blind (DB) Phase|Adverse Event|83|||
17080015|NCT00232180|38221175|FG001|Double-blind (DB) Phase|Adverse Event|100|||
17080016|NCT00232180|38221176|FG002|Double-blind (DB) Phase|Adverse Event|0|||
17080017|NCT00232180|38221174|FG000|Double-blind (DB) Phase|Other|70|||
17080018|NCT00232180|38221175|FG001|Double-blind (DB) Phase|Other|75|||
17080019|NCT00232180|38221176|FG002|Double-blind (DB) Phase|Other|0|||
17080020|NCT00232180|38221174|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
17080021|NCT00232180|38221175|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
17080022|NCT00232180|38221176|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
17159852|NCT03259555|38307056|FG001|Overall Study|Physician Decision|2|||
17159853|NCT03259555|38307055|FG000|Overall Study|Other|1|||
17159854|NCT03259555|38307056|FG001|Overall Study|Other|0|||
17159855|NCT03259087|38307067|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
17159856|NCT03259087|38307068|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
17159857|NCT03259087|38307069|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
17159858|NCT03259087|38307070|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
17159859|NCT03259087|38307071|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
17159860|NCT03259087|38307067|FG000|Period 2 of Part 2|Adverse Event|0|||
17159861|NCT03259087|38307068|FG001|Period 2 of Part 2|Adverse Event|0|||
17080023|NCT00232180|38221174|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
17080024|NCT00232180|38221175|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
17159862|NCT03259087|38307069|FG002|Period 2 of Part 2|Adverse Event|0|||
17159863|NCT03259087|38307070|FG003|Period 2 of Part 2|Adverse Event|0|||
17159864|NCT03259087|38307071|FG004|Period 2 of Part 2|Adverse Event|1|||
17159865|NCT03257995|38307093|FG000|Overall Study|Adverse Event|0|||
17159866|NCT03257995|38307094|FG001|Overall Study|Adverse Event|1|||
17159867|NCT03257995|38307095|FG002|Overall Study|Adverse Event|0|||
17159868|NCT03257995|38307096|FG003|Overall Study|Adverse Event|0|||
17159869|NCT03257995|38307097|FG004|Overall Study|Adverse Event|0|||
17159870|NCT03257995|38307098|FG005|Overall Study|Adverse Event|0|||
17159871|NCT03257995|38307093|FG000|Overall Study|Protocol deviation|0|||
17159872|NCT03257995|38307094|FG001|Overall Study|Protocol deviation|0|||
17159873|NCT03257995|38307095|FG002|Overall Study|Protocol deviation|0|||
17159874|NCT03257995|38307096|FG003|Overall Study|Protocol deviation|0|||
17159875|NCT03257995|38307097|FG004|Overall Study|Protocol deviation|0|||
17159876|NCT03257995|38307098|FG005|Overall Study|Protocol deviation|2|||
17159877|NCT03049488|38307116|FG000|Overall Study|Lost to Follow-up|1|||
17159878|NCT03049488|38307117|FG001|Overall Study|Lost to Follow-up|1|||
17159879|NCT03049488|38307118|FG002|Overall Study|Lost to Follow-up|0|||
17159880|NCT03049488|38307119|FG003|Overall Study|Lost to Follow-up|0|||
17159881|NCT03049488|38307120|FG004|Overall Study|Lost to Follow-up|0|||
17159882|NCT03049488|38307121|FG005|Overall Study|Lost to Follow-up|0|||
17159883|NCT03049488|38307116|FG000|Overall Study|Moved from Area|1|||
17159884|NCT03049488|38307117|FG001|Overall Study|Moved from Area|0|||
17159885|NCT03049488|38307118|FG002|Overall Study|Moved from Area|0|||
17159886|NCT03049488|38307119|FG003|Overall Study|Moved from Area|1|||
17159887|NCT03049488|38307120|FG004|Overall Study|Moved from Area|1|||
17159888|NCT03049488|38307121|FG005|Overall Study|Moved from Area|0|||
17159889|NCT03049488|38307116|FG000|Overall Study|Physician Decision|0|||
17159890|NCT03049488|38307117|FG001|Overall Study|Physician Decision|1|||
17159891|NCT03049488|38307118|FG002|Overall Study|Physician Decision|0|||
17159892|NCT03049488|38307119|FG003|Overall Study|Physician Decision|0|||
17159893|NCT03049488|38307120|FG004|Overall Study|Physician Decision|0|||
17159894|NCT03049488|38307121|FG005|Overall Study|Physician Decision|0|||
17159895|NCT03049488|38307116|FG000|Overall Study|Withdrawal by Subject|0|||
17080025|NCT00232180|38221176|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
17080026|NCT00232180|38221174|FG000|Open Label Phase|Death|0|||
17080027|NCT00232180|38221175|FG001|Open Label Phase|Death|0|||
17080028|NCT00232180|38221176|FG002|Open Label Phase|Death|48|||
17080029|NCT00232180|38221174|FG000|Open Label Phase|Lost to Follow-up|0|||
17080030|NCT00232180|38221175|FG001|Open Label Phase|Lost to Follow-up|0|||
17080031|NCT00232180|38221176|FG002|Open Label Phase|Lost to Follow-up|5|||
17080032|NCT00232180|38221174|FG000|Open Label Phase|Protocol Violation|0|||
17080033|NCT00232180|38221175|FG001|Open Label Phase|Protocol Violation|0|||
17080034|NCT00232180|38221176|FG002|Open Label Phase|Protocol Violation|3|||
17080035|NCT00232180|38221174|FG000|Open Label Phase|Study terminated by sponsor|0|||
17080036|NCT00232180|38221175|FG001|Open Label Phase|Study terminated by sponsor|0|||
17080037|NCT00232180|38221176|FG002|Open Label Phase|Study terminated by sponsor|3|||
17080038|NCT00232180|38221174|FG000|Open Label Phase|Withdrawal by Subject|0|||
17080039|NCT00232180|38221175|FG001|Open Label Phase|Withdrawal by Subject|0|||
17080040|NCT00232180|38221176|FG002|Open Label Phase|Withdrawal by Subject|37|||
17080041|NCT00232180|38221174|FG000|Open Label Phase|Other|0|||
17080042|NCT00232180|38221175|FG001|Open Label Phase|Other|0|||
17080043|NCT00232180|38221176|FG002|Open Label Phase|Other|16|||
17080044|NCT00232180|38221174|FG000|Open Label Phase|Adverse Event|0|||
17080045|NCT00232180|38221175|FG001|Open Label Phase|Adverse Event|0|||
17080046|NCT00232180|38221176|FG002|Open Label Phase|Adverse Event|25|||
17080047|NCT00232180|38221174|FG000|Open Label Phase|Laboratory abnormality|0|||
17080048|NCT00232180|38221175|FG001|Open Label Phase|Laboratory abnormality|0|||
17080049|NCT00232180|38221176|FG002|Open Label Phase|Laboratory abnormality|10|||
17080050|NCT00232180|38221174|FG000|Open Label Phase|Randomized but not treated|0|||
17080051|NCT00232180|38221175|FG001|Open Label Phase|Randomized but not treated|0|||
17080052|NCT00232180|38221176|FG002|Open Label Phase|Randomized but not treated|1|||
17080053|NCT00280917|38221189|FG000|Overall Study|Adverse Event|1|||
17080054|NCT00280917|38221190|FG001|Overall Study|Adverse Event|1|||
17080055|NCT00280917|38221191|FG002|Overall Study|Adverse Event|4|||
17080056|NCT00280917|38221192|FG003|Overall Study|Adverse Event|1|||
17080057|NCT00280917|38221189|FG000|Overall Study|Change Therapy|1|||
17159896|NCT03049488|38307117|FG001|Overall Study|Withdrawal by Subject|0|||
17159897|NCT03049488|38307118|FG002|Overall Study|Withdrawal by Subject|0|||
17159898|NCT03049488|38307119|FG003|Overall Study|Withdrawal by Subject|1|||
17159899|NCT03049488|38307120|FG004|Overall Study|Withdrawal by Subject|1|||
17159900|NCT03049488|38307121|FG005|Overall Study|Withdrawal by Subject|0|||
17159901|NCT03257371|38307136|FG000|Overall Study|Lost to Follow-up|1|||
17159902|NCT03242863|38307140|FG000|Study Week 1|Withdrawal by Subject|0|||
17159903|NCT03242863|38307141|FG001|Study Week 1|Withdrawal by Subject|1|||
17159904|NCT03242863|38307142|FG002|Study Week 1|Withdrawal by Subject|0|||
17080058|NCT00280917|38221190|FG001|Overall Study|Change Therapy|2|||
17080059|NCT00280917|38221191|FG002|Overall Study|Change Therapy|0|||
17080060|NCT00280917|38221192|FG003|Overall Study|Change Therapy|0|||
17080061|NCT00280917|38221189|FG000|Overall Study|Withdrawal by Subject|0|||
17080062|NCT00280917|38221190|FG001|Overall Study|Withdrawal by Subject|2|||
17080063|NCT00280917|38221191|FG002|Overall Study|Withdrawal by Subject|0|||
17080064|NCT00280917|38221192|FG003|Overall Study|Withdrawal by Subject|1|||
17080065|NCT00280917|38221189|FG000|Overall Study|Noncompliance|0|||
17080066|NCT00280917|38221190|FG001|Overall Study|Noncompliance|1|||
17080067|NCT00280917|38221191|FG002|Overall Study|Noncompliance|2|||
17080068|NCT00280917|38221192|FG003|Overall Study|Noncompliance|0|||
17080069|NCT00280683|38221204|FG000|Overall Study|Withdrawal by Subject|1|||
17080070|NCT00280683|38221205|FG001|Overall Study|Withdrawal by Subject|2|||
17080071|NCT00280683|38221204|FG000|Overall Study|Adverse Event|1|||
17080072|NCT00280683|38221205|FG001|Overall Study|Adverse Event|1|||
17080073|NCT00270855|38221215|FG000|Overall Study|Withdrawal by Subject|8|||
17080074|NCT00270855|38221216|FG001|Overall Study|Withdrawal by Subject|8|||
17080075|NCT00404768|38221228|FG000|Part A and B|Withdrawn due to labor progression|1|||
17080076|NCT00404768|38221229|FG001|Part A and B|Withdrawn due to labor progression|0|||
17080077|NCT00404768|38221230|FG002|Part A and B|Withdrawn due to labor progression|0|||
17080078|NCT00404768|38221231|FG003|Part A and B|Withdrawn due to labor progression|0|||
17080079|NCT00404768|38221228|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
17080080|NCT00404768|38221229|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
17080081|NCT00404768|38221230|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
17080082|NCT00404768|38221231|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
17080083|NCT00404768|38221228|FG000|Part C|Adverse Event|0|||
17080084|NCT00404768|38221229|FG001|Part C|Adverse Event|0|||
17080085|NCT00404768|38221230|FG002|Part C|Adverse Event|0|||
17080086|NCT00404768|38221231|FG003|Part C|Adverse Event|3|||
17080087|NCT00404768|38221228|FG000|Part C|Lost to Follow-up|0|||
17080088|NCT00404768|38221229|FG001|Part C|Lost to Follow-up|0|||
17080089|NCT00404768|38221230|FG002|Part C|Lost to Follow-up|3|||
17080090|NCT00404768|38221231|FG003|Part C|Lost to Follow-up|1|||
17080091|NCT00404768|38221228|FG000|Part C|Withdrawal by Subject|0|||
17159905|NCT03242863|38307143|FG003|Study Week 1|Withdrawal by Subject|0|||
17159906|NCT03242863|38307144|FG004|Study Week 1|Withdrawal by Subject|3|||
17159907|NCT03242863|38307145|FG005|Study Week 1|Withdrawal by Subject|0|||
17159908|NCT03044106|38307153|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
17159909|NCT03044106|38307154|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
17159910|NCT03043560|38307180|FG000|Overall Study|Discontinued Intervention|1|||
17159911|NCT03043560|38307181|FG001|Overall Study|Discontinued Intervention|2|||
17159912|NCT03043560|38307180|FG000|Overall Study|Lost to Follow-up|0|||
17159913|NCT03043560|38307181|FG001|Overall Study|Lost to Follow-up|1|||
17159914|NCT03255733|38307207|FG000|Overall Study|Lost to Follow-up|4|||
17159915|NCT03255655|38307213|FG000|Overall Study|Lost to Follow-up|7|||
17159916|NCT03255655|38307214|FG001|Overall Study|Lost to Follow-up|4|||
17159917|NCT02899988|38307224|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
17159918|NCT02899988|38307225|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
17159919|NCT02899988|38307226|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17159920|NCT02899988|38307227|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17159921|NCT02899988|38307228|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17159922|NCT02899988|38307229|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17159923|NCT02899988|38307230|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17080092|NCT00404768|38221229|FG001|Part C|Withdrawal by Subject|0|||
17080093|NCT00404768|38221230|FG002|Part C|Withdrawal by Subject|2|||
17080094|NCT00404768|38221231|FG003|Part C|Withdrawal by Subject|1|||
17080095|NCT00404768|38221228|FG000|Part C|Early withdrawal from study medication|0|||
17080096|NCT00404768|38221229|FG001|Part C|Early withdrawal from study medication|0|||
17080097|NCT00404768|38221230|FG002|Part C|Early withdrawal from study medication|1|||
17080098|NCT00404768|38221231|FG003|Part C|Early withdrawal from study medication|0|||
17080099|NCT00404768|38221228|FG000|Part C|Participant did not respond to therapy|0|||
17080100|NCT00404768|38221229|FG001|Part C|Participant did not respond to therapy|0|||
17080101|NCT00404768|38221230|FG002|Part C|Participant did not respond to therapy|1|||
17080102|NCT00404768|38221231|FG003|Part C|Participant did not respond to therapy|1|||
17080103|NCT00404768|38221228|FG000|Part C|Physician withdrew the study medication|0|||
17080104|NCT00404768|38221229|FG001|Part C|Physician withdrew the study medication|0|||
17080105|NCT00404768|38221230|FG002|Part C|Physician withdrew the study medication|1|||
17080106|NCT00404768|38221231|FG003|Part C|Physician withdrew the study medication|0|||
17080107|NCT00404768|38221228|FG000|Part C|Participant delivered baby|0|||
17080108|NCT00404768|38221229|FG001|Part C|Participant delivered baby|0|||
17080109|NCT00404768|38221230|FG002|Part C|Participant delivered baby|0|||
17080110|NCT00404768|38221231|FG003|Part C|Participant delivered baby|1|||
17080111|NCT00404768|38221228|FG000|Part C|Unsatisfactory uterine response to IP|0|||
17080112|NCT00404768|38221229|FG001|Part C|Unsatisfactory uterine response to IP|0|||
17080113|NCT00404768|38221230|FG002|Part C|Unsatisfactory uterine response to IP|0|||
17080114|NCT00404768|38221231|FG003|Part C|Unsatisfactory uterine response to IP|1|||
17080115|NCT00404768|38221228|FG000|Part C|Active labor|0|||
17080116|NCT00404768|38221229|FG001|Part C|Active labor|0|||
17080117|NCT00404768|38221230|FG002|Part C|Active labor|0|||
17080118|NCT00404768|38221231|FG003|Part C|Active labor|1|||
17080119|NCT00404768|38221228|FG000|Part C|Lack of Efficacy|0|||
17080120|NCT00404768|38221229|FG001|Part C|Lack of Efficacy|0|||
17080121|NCT00404768|38221230|FG002|Part C|Lack of Efficacy|0|||
17080122|NCT00404768|38221231|FG003|Part C|Lack of Efficacy|2|||
17080123|NCT00404768|38221228|FG000|Part C|Treatment failure|0|||
17080124|NCT00404768|38221229|FG001|Part C|Treatment failure|0|||
17080125|NCT00404768|38221230|FG002|Part C|Treatment failure|0|||
17080126|NCT00404768|38221231|FG003|Part C|Treatment failure|1|||
17080127|NCT00404768|38221228|FG000|Part C|Investigator discretion|0|||
17080128|NCT00404768|38221229|FG001|Part C|Investigator discretion|0|||
17080129|NCT00404768|38221230|FG002|Part C|Investigator discretion|0|||
17080130|NCT00404768|38221231|FG003|Part C|Investigator discretion|1|||
17080131|NCT00404768|38221228|FG000|Part C|Researcher suspended study medication|0|||
17080132|NCT00404768|38221229|FG001|Part C|Researcher suspended study medication|0|||
17080133|NCT00404768|38221230|FG002|Part C|Researcher suspended study medication|0|||
17080134|NCT00404768|38221231|FG003|Part C|Researcher suspended study medication|1|||
17080135|NCT00270231|38221246|FG000|First Intervention|Lost to Follow-up|1|||
17080136|NCT00270231|38221247|FG001|First Intervention|Lost to Follow-up|1|||
17080137|NCT00270231|38221246|FG000|Washout Period|Lost to Follow-up|1|||
17080138|NCT00270231|38221247|FG001|Washout Period|Lost to Follow-up|0|||
17080139|NCT00270231|38221246|FG000|Second Intervention|Lost to Follow-up|0|||
17080140|NCT00270231|38221247|FG001|Second Intervention|Lost to Follow-up|1|||
17159924|NCT02899988|38307231|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17159925|NCT02899988|38307232|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17159926|NCT02899988|38307233|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17080141|NCT00258856|38221257|FG000|Overall Study|Lost to Follow-up|1|||
17080142|NCT00258856|38221258|FG001|Overall Study|Lost to Follow-up|0|||
17080143|NCT00258856|38221259|FG002|Overall Study|Lost to Follow-up|2|||
17080144|NCT00258856|38221260|FG003|Overall Study|Lost to Follow-up|0|||
17080145|NCT00258856|38221257|FG000|Overall Study|Non-compliance|2|||
17080146|NCT00258856|38221258|FG001|Overall Study|Non-compliance|0|||
17080147|NCT00258856|38221259|FG002|Overall Study|Non-compliance|0|||
17080148|NCT00258856|38221260|FG003|Overall Study|Non-compliance|1|||
17080149|NCT00269919|38221270|FG000|Overall Study|Other|26|||
17080150|NCT00269919|38221270|FG000|Overall Study|Started but not treated|1|||
17080151|NCT00258154|38221277|FG000|Overall Study|Adverse Event|1|||
17080152|NCT00258154|38221278|FG001|Overall Study|Adverse Event|0|||
17080153|NCT00258154|38221277|FG000|Overall Study|Lost to Follow-up|0|||
17080154|NCT00258154|38221278|FG001|Overall Study|Lost to Follow-up|1|||
17080155|NCT00258154|38221277|FG000|Overall Study|Protocol Violation|2|||
17080156|NCT00258154|38221278|FG001|Overall Study|Protocol Violation|1|||
17080157|NCT00258154|38221277|FG000|Overall Study|Withdrawal by Subject|3|||
17080158|NCT00258154|38221278|FG001|Overall Study|Withdrawal by Subject|4|||
17080159|NCT00258154|38221277|FG000|Overall Study|Patient Moved|3|||
17080160|NCT00258154|38221278|FG001|Overall Study|Patient Moved|1|||
17080161|NCT00257920|38221286|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
17080162|NCT00257920|38221287|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
17080163|NCT00257920|38221286|FG000|Period: Second Intervention|Other|2|||
17080164|NCT00257920|38221287|FG001|Period: Second Intervention|Other|1|||
17080165|NCT00268983|38221296|FG000|Overall Study|Death|3|||
17080166|NCT00268983|38221297|FG001|Overall Study|Death|0|||
17080167|NCT00257608|38221305|FG000|Chemotherapy Phase|Adverse Event|138|||
17080168|NCT00257608|38221306|FG001|Chemotherapy Phase|Adverse Event|0|||
17080169|NCT00257608|38221307|FG002|Chemotherapy Phase|Adverse Event|0|||
17080170|NCT00257608|38221305|FG000|Chemotherapy Phase|Disease progression|139|||
17080171|NCT00257608|38221306|FG001|Chemotherapy Phase|Disease progression|0|||
17080172|NCT00257608|38221307|FG002|Chemotherapy Phase|Disease progression|0|||
17080173|NCT00257608|38221305|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
17080174|NCT00257608|38221306|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
17080175|NCT00257608|38221307|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
17080176|NCT00257608|38221305|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
17080177|NCT00257608|38221306|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
17080178|NCT00257608|38221307|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
17080179|NCT00257608|38221305|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
17080180|NCT00257608|38221306|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
17080181|NCT00257608|38221307|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
17080182|NCT00257608|38221305|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
17080183|NCT00257608|38221306|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
17080184|NCT00257608|38221307|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
17080185|NCT00257608|38221305|FG000|Chemotherapy Phase|Physician Decision|28|||
17080186|NCT00257608|38221306|FG001|Chemotherapy Phase|Physician Decision|0|||
17080187|NCT00257608|38221307|FG002|Chemotherapy Phase|Physician Decision|0|||
17159927|NCT02899988|38307234|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17080188|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Adverse Event|0|||
17080189|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Adverse Event|34|||
17080190|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Adverse Event|38|||
17080191|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Disease progression|0|||
17080192|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Disease progression|204|||
17080193|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Disease progression|168|||
17080194|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
17080195|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
17080196|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
17080197|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
17080198|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
17080199|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
17080200|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
17080201|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
17080202|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
17080203|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
17080204|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
17080205|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
17080206|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
17080207|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
17080208|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
17159928|NCT02899988|38307224|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
17159929|NCT02899988|38307225|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
17159930|NCT02899988|38307226|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
17159931|NCT02899988|38307227|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
17159932|NCT02899988|38307228|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
17159933|NCT02899988|38307229|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
17159934|NCT02899988|38307230|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
17159935|NCT02899988|38307231|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
17159936|NCT02899988|38307232|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
17159937|NCT02899988|38307233|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
17159938|NCT02899988|38307234|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
17159939|NCT02899988|38307224|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
17159940|NCT02899988|38307225|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
17159941|NCT02899988|38307226|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
17159942|NCT02899988|38307227|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
17159943|NCT02899988|38307228|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
17159944|NCT02899988|38307229|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
17159945|NCT02899988|38307230|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
17159946|NCT02899988|38307231|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
17159947|NCT02899988|38307232|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
17159948|NCT02899988|38307233|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
17159949|NCT02899988|38307234|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
17159950|NCT02899988|38307224|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
17159951|NCT02899988|38307225|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
17159952|NCT02899988|38307226|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
17159953|NCT02899988|38307227|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
17159954|NCT02899988|38307228|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
17080209|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Physician Decision|0|||
17080210|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Physician Decision|8|||
17080211|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Physician Decision|11|||
17080212|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
17080213|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
17080214|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
17080215|NCT00257608|38221305|FG000|Post Chemotherapy Phase|Not treated|0|||
17080216|NCT00257608|38221306|FG001|Post Chemotherapy Phase|Not treated|4|||
17159955|NCT02899988|38307229|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
17159956|NCT02899988|38307230|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
17159957|NCT02899988|38307231|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
17159958|NCT02899988|38307232|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
17159959|NCT02899988|38307233|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
17080217|NCT00257608|38221307|FG002|Post Chemotherapy Phase|Not treated|7|||
17080218|NCT00231478|38221322|FG000|Overall Study|Protocol Violation|3|||
17080219|NCT00231478|38221323|FG001|Overall Study|Protocol Violation|2|||
17080220|NCT00231478|38221322|FG000|Overall Study|Refused Treatment|1|||
17080221|NCT00231478|38221323|FG001|Overall Study|Refused Treatment|1|||
17080222|NCT00231478|38221322|FG000|Overall Study|Withdrawal by Subject|1|||
17080223|NCT00231478|38221323|FG001|Overall Study|Withdrawal by Subject|0|||
17080224|NCT00231478|38221322|FG000|Overall Study|Adverse Event|0|||
17080225|NCT00231478|38221323|FG001|Overall Study|Adverse Event|1|||
17080226|NCT00231478|38221322|FG000|Overall Study|Administrative|3|||
17080227|NCT00231478|38221323|FG001|Overall Study|Administrative|2|||
17080228|NCT00413192|38221333|FG000|Overall Study|Disease progression|26|||
17159960|NCT02899988|38307234|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
17159961|NCT02899988|38307224|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17159962|NCT02899988|38307225|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17159963|NCT02899988|38307226|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17159964|NCT02899988|38307227|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17159965|NCT02899988|38307228|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17159966|NCT02899988|38307229|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
17159967|NCT02899988|38307230|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17159968|NCT02899988|38307231|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
17159969|NCT02899988|38307232|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17159970|NCT02899988|38307233|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17080229|NCT00413192|38221334|FG001|Overall Study|Disease progression|31|||
17080230|NCT00413192|38221335|FG002|Overall Study|Disease progression|16|||
17159971|NCT02899988|38307234|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
17159972|NCT02899988|38307224|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
17159973|NCT02899988|38307225|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
17159974|NCT02899988|38307226|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
17159975|NCT02899988|38307227|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
17159976|NCT02899988|38307228|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
17159977|NCT02899988|38307229|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
17159978|NCT02899988|38307230|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
16995314|NCT01006616|38139053|FG002|Period 1 (6 Months)|Adverse Event|37|||
16995315|NCT01006616|38139054|FG003|Period 1 (6 Months)|Adverse Event|9|||
16995316|NCT01006616|38139051|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
16995317|NCT01006616|38139052|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
16995318|NCT01006616|38139053|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
16995319|NCT01006616|38139054|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
16995320|NCT01006616|38139051|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
16995321|NCT01006616|38139052|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
16995322|NCT01006616|38139053|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
16995323|NCT01006616|38139054|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
17080231|NCT00413192|38221336|FG003|Overall Study|Disease progression|25|||
17080232|NCT00413192|38221333|FG000|Overall Study|Toxicity|3|||
17080233|NCT00413192|38221334|FG001|Overall Study|Toxicity|2|||
17080234|NCT00413192|38221335|FG002|Overall Study|Toxicity|2|||
17080235|NCT00413192|38221336|FG003|Overall Study|Toxicity|2|||
17080236|NCT00413192|38221333|FG000|Overall Study|Withdrawal by Subject|3|||
17080237|NCT00413192|38221334|FG001|Overall Study|Withdrawal by Subject|5|||
17080238|NCT00413192|38221335|FG002|Overall Study|Withdrawal by Subject|0|||
17080239|NCT00413192|38221336|FG003|Overall Study|Withdrawal by Subject|1|||
17080240|NCT00413192|38221333|FG000|Overall Study|Intercurrent illness|0|||
17080241|NCT00413192|38221334|FG001|Overall Study|Intercurrent illness|0|||
17080242|NCT00413192|38221335|FG002|Overall Study|Intercurrent illness|0|||
17080243|NCT00413192|38221336|FG003|Overall Study|Intercurrent illness|1|||
17080244|NCT00413192|38221333|FG000|Overall Study|Intercurrent death|0|||
16995324|NCT01006616|38139051|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
16995325|NCT01006616|38139052|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
16995326|NCT01006616|38139053|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
16995327|NCT01006616|38139054|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
16995328|NCT01006616|38139051|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
16995329|NCT01006616|38139052|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
16995330|NCT01006616|38139053|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
16995331|NCT01006616|38139054|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
16995332|NCT01006616|38139051|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
16995333|NCT01006616|38139052|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
16995334|NCT01006616|38139053|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
16995335|NCT01006616|38139054|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
16995336|NCT01006616|38139051|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
16995337|NCT01006616|38139052|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
16995338|NCT01006616|38139053|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
16995339|NCT01006616|38139054|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
16995340|NCT01006616|38139051|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
16995341|NCT01006616|38139052|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
16995342|NCT01006616|38139053|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
16995343|NCT01006616|38139054|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
16995344|NCT01006616|38139051|FG000|Period 1 (6 Months)|Not Treated|0|||
16995345|NCT01006616|38139052|FG001|Period 1 (6 Months)|Not Treated|0|||
17080245|NCT00413192|38221334|FG001|Overall Study|Intercurrent death|1|||
17080246|NCT00413192|38221335|FG002|Overall Study|Intercurrent death|0|||
16995346|NCT01006616|38139053|FG002|Period 1 (6 Months)|Not Treated|1|||
17080247|NCT00413192|38221336|FG003|Overall Study|Intercurrent death|0|||
17080248|NCT00413192|38221333|FG000|Overall Study|Other|5|||
17080249|NCT00413192|38221334|FG001|Overall Study|Other|1|||
17080250|NCT00413192|38221335|FG002|Overall Study|Other|1|||
17080251|NCT00413192|38221336|FG003|Overall Study|Other|2|||
17080252|NCT00413192|38221333|FG000|Overall Study|Not treated|0|||
17080253|NCT00413192|38221334|FG001|Overall Study|Not treated|0|||
17080254|NCT00413192|38221335|FG002|Overall Study|Not treated|0|||
17080255|NCT00413192|38221336|FG003|Overall Study|Not treated|1|||
17080256|NCT00207142|38221349|FG000|Induction Phase|Adverse Event|9|||
17080257|NCT00207142|38221350|FG001|Induction Phase|Adverse Event|0|||
17080258|NCT00207142|38221351|FG002|Induction Phase|Adverse Event|0|||
17080259|NCT00207142|38221352|FG003|Induction Phase|Adverse Event|0|||
17080260|NCT00207142|38221349|FG000|Induction Phase|Death|1|||
17080261|NCT00207142|38221350|FG001|Induction Phase|Death|0|||
17080262|NCT00207142|38221351|FG002|Induction Phase|Death|0|||
17080263|NCT00207142|38221352|FG003|Induction Phase|Death|0|||
17080264|NCT00207142|38221349|FG000|Induction Phase|Lack of Efficacy|1|||
17080265|NCT00207142|38221350|FG001|Induction Phase|Lack of Efficacy|0|||
17080266|NCT00207142|38221351|FG002|Induction Phase|Lack of Efficacy|0|||
17080267|NCT00207142|38221352|FG003|Induction Phase|Lack of Efficacy|0|||
17080268|NCT00207142|38221349|FG000|Induction Phase|Lost to Follow-up|5|||
17080269|NCT00207142|38221350|FG001|Induction Phase|Lost to Follow-up|0|||
17080270|NCT00207142|38221351|FG002|Induction Phase|Lost to Follow-up|0|||
17080271|NCT00207142|38221352|FG003|Induction Phase|Lost to Follow-up|0|||
17080272|NCT00207142|38221349|FG000|Induction Phase|Physician Decision|2|||
17080273|NCT00207142|38221350|FG001|Induction Phase|Physician Decision|0|||
17080274|NCT00207142|38221351|FG002|Induction Phase|Physician Decision|0|||
17080275|NCT00207142|38221352|FG003|Induction Phase|Physician Decision|0|||
17080276|NCT00207142|38221349|FG000|Induction Phase|Poor/noncompliance|2|||
17080277|NCT00207142|38221350|FG001|Induction Phase|Poor/noncompliance|0|||
17080278|NCT00207142|38221351|FG002|Induction Phase|Poor/noncompliance|0|||
17080279|NCT00207142|38221352|FG003|Induction Phase|Poor/noncompliance|0|||
17080280|NCT00207142|38221349|FG000|Induction Phase|Pregnancy|1|||
17080281|NCT00207142|38221350|FG001|Induction Phase|Pregnancy|0|||
17080282|NCT00207142|38221351|FG002|Induction Phase|Pregnancy|0|||
17080283|NCT00207142|38221352|FG003|Induction Phase|Pregnancy|0|||
17080284|NCT00207142|38221349|FG000|Induction Phase|Subject no longer meets study criteria|3|||
17080285|NCT00207142|38221350|FG001|Induction Phase|Subject no longer meets study criteria|0|||
17080286|NCT00207142|38221351|FG002|Induction Phase|Subject no longer meets study criteria|0|||
17080287|NCT00207142|38221352|FG003|Induction Phase|Subject no longer meets study criteria|0|||
17080288|NCT00207142|38221349|FG000|Induction Phase|Withdrawal by Subject|4|||
17080289|NCT00207142|38221350|FG001|Induction Phase|Withdrawal by Subject|0|||
17080290|NCT00207142|38221351|FG002|Induction Phase|Withdrawal by Subject|0|||
17080291|NCT00207142|38221352|FG003|Induction Phase|Withdrawal by Subject|0|||
17080292|NCT00207142|38221349|FG000|Induction Phase|Incarceration|1|||
17080293|NCT00207142|38221350|FG001|Induction Phase|Incarceration|0|||
17080294|NCT00207142|38221351|FG002|Induction Phase|Incarceration|0|||
17080295|NCT00207142|38221352|FG003|Induction Phase|Incarceration|0|||
17080296|NCT00207142|38221349|FG000|Induction Phase|Missing lab data|1|||
17080297|NCT00207142|38221350|FG001|Induction Phase|Missing lab data|0|||
17080298|NCT00207142|38221351|FG002|Induction Phase|Missing lab data|0|||
17080299|NCT00207142|38221352|FG003|Induction Phase|Missing lab data|0|||
17080300|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
17080301|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
17080302|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
17080303|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
17080304|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
17080305|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
17080306|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
17080307|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
17080308|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
17080309|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
17080310|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
17080311|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
16781288|NCT02105974|37720453|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
17080312|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
16995347|NCT01006616|38139054|FG003|Period 1 (6 Months)|Not Treated|1|||
16995348|NCT01006616|38139051|FG000|Period 2 (18 Months)|Adverse Event|6|||
16995349|NCT01006616|38139052|FG001|Period 2 (18 Months)|Adverse Event|6|||
16995350|NCT01006616|38139053|FG002|Period 2 (18 Months)|Adverse Event|6|||
16995351|NCT01006616|38139054|FG003|Period 2 (18 Months)|Adverse Event|4|||
16995352|NCT01006616|38139051|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
16995353|NCT01006616|38139052|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
17080313|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
17080314|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
17080315|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
17080316|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
17080317|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
17080318|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
17080319|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
17080320|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
17080321|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
17080322|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
17080323|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
17080324|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
17080325|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
17080326|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
17080327|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
17080328|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|Death|0|||
17080329|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|Death|0|||
17080330|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|Death|0|||
17080331|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|Death|1|||
17080332|NCT00207142|38221349|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
17080333|NCT00207142|38221350|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
17080334|NCT00207142|38221351|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
17080335|NCT00207142|38221352|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
17080336|NCT00268905|38221370|FG000|Overall Study|Adverse Event|3|||
17080337|NCT00268905|38221371|FG001|Overall Study|Adverse Event|0|||
17080338|NCT00268905|38221372|FG002|Overall Study|Adverse Event|4|||
17080339|NCT00268905|38221370|FG000|Overall Study|Lost to Follow-up|0|||
17080340|NCT00268905|38221371|FG001|Overall Study|Lost to Follow-up|1|||
17080341|NCT00268905|38221372|FG002|Overall Study|Lost to Follow-up|0|||
17080342|NCT00268905|38221370|FG000|Overall Study|Withdrawal by Subject|0|||
17080343|NCT00268905|38221371|FG001|Overall Study|Withdrawal by Subject|0|||
17080344|NCT00268905|38221372|FG002|Overall Study|Withdrawal by Subject|3|||
17080345|NCT00268905|38221370|FG000|Overall Study|Progressive Disease|28|||
17080346|NCT00268905|38221371|FG001|Overall Study|Progressive Disease|4|||
17080347|NCT00268905|38221372|FG002|Overall Study|Progressive Disease|3|||
17080348|NCT00268905|38221370|FG000|Overall Study|Physician Decision|3|||
17080349|NCT00268905|38221371|FG001|Overall Study|Physician Decision|0|||
17080350|NCT00268905|38221372|FG002|Overall Study|Physician Decision|1|||
17080351|NCT00268905|38221370|FG000|Overall Study|Clinical Progression|9|||
17080352|NCT00268905|38221371|FG001|Overall Study|Clinical Progression|4|||
17080353|NCT00268905|38221372|FG002|Overall Study|Clinical Progression|1|||
17080354|NCT00206518|38221382|FG000|Overall Study|Lack of Efficacy|6|||
17080355|NCT00206518|38221383|FG001|Overall Study|Lack of Efficacy|4|||
17080356|NCT00206518|38221382|FG000|Overall Study|Adverse Event|2|||
17080357|NCT00206518|38221383|FG001|Overall Study|Adverse Event|1|||
17080358|NCT00206518|38221382|FG000|Overall Study|Physician Decision|1|||
17080359|NCT00206518|38221383|FG001|Overall Study|Physician Decision|0|||
17080360|NCT00206518|38221382|FG000|Overall Study|Protocol Violation|1|||
17080361|NCT00206518|38221383|FG001|Overall Study|Protocol Violation|1|||
17080362|NCT00423722|38221391|FG000|Overall Study|Death|4|||
17080363|NCT00423722|38221392|FG001|Overall Study|Death|4|||
17080364|NCT00423722|38221391|FG000|Overall Study|Declined to participate|2|||
17080365|NCT00423722|38221392|FG001|Overall Study|Declined to participate|3|||
17080366|NCT00423722|38221391|FG000|Overall Study|Unable to complete questionnaires|4|||
17080367|NCT00423722|38221392|FG001|Overall Study|Unable to complete questionnaires|4|||
17080368|NCT00423722|38221391|FG000|Overall Study|Withdrawal by Subject|4|||
17080369|NCT00423722|38221392|FG001|Overall Study|Withdrawal by Subject|2|||
17080370|NCT00206440|38221406|FG000|Overall Study|Protocol Violation|1|||
17080371|NCT00206440|38221407|FG001|Overall Study|Protocol Violation|2|||
17080372|NCT00206440|38221406|FG000|Overall Study|Adverse Event|4|||
17080373|NCT00206440|38221407|FG001|Overall Study|Adverse Event|2|||
17080374|NCT00268437|38221413|FG000|Overall Study|Ineligible|1|||
17080375|NCT00423488|38221420|FG000|Overall Study|No evidence of study drug intake|2|||
17080376|NCT00423488|38221421|FG001|Overall Study|No evidence of study drug intake|1|||
17080377|NCT00423488|38221420|FG000|Overall Study|No post baseline data|3|||
17080378|NCT00423488|38221421|FG001|Overall Study|No post baseline data|0|||
17080379|NCT00404066|38221427|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
17080380|NCT00404066|38221427|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
17080381|NCT00423332|38221433|FG000|Overall Study|Adverse Event|6|||
17080382|NCT00423332|38221434|FG001|Overall Study|Adverse Event|2|||
17080383|NCT00423332|38221433|FG000|Overall Study|Withdrawal by Subject|1|||
17080384|NCT00423332|38221434|FG001|Overall Study|Withdrawal by Subject|0|||
17080385|NCT00423332|38221433|FG000|Overall Study|Condition under investigation worsened|1|||
17080386|NCT00423332|38221434|FG001|Overall Study|Condition under investigation worsened|1|||
17080387|NCT00423332|38221433|FG000|Overall Study|Progressive at Week 6|0|||
17080388|NCT00423332|38221434|FG001|Overall Study|Progressive at Week 6|1|||
17080389|NCT00423332|38221433|FG000|Overall Study|Unblinded before 12 weeks|1|||
17080390|NCT00423332|38221434|FG001|Overall Study|Unblinded before 12 weeks|3|||
17080391|NCT00413036|38221441|FG000|Overall Study|Adverse Event|44|||
17080392|NCT00413036|38221441|FG000|Overall Study|Lack of Efficacy|129|||
17080393|NCT00413036|38221441|FG000|Overall Study|Withdrawal by Subject|7|||
17080394|NCT00413036|38221441|FG000|Overall Study|Death|9|||
17080395|NCT00413036|38221441|FG000|Overall Study|Other|26|||
17080396|NCT00413036|38221441|FG000|Overall Study|Missing|2|||
17080397|NCT00412958|38221449|FG000|Overall Study|Withdrawal by Subject|3|||
17080398|NCT00412958|38221450|FG001|Overall Study|Withdrawal by Subject|0|||
17080399|NCT00412958|38221451|FG002|Overall Study|Withdrawal by Subject|0|||
17080400|NCT00412958|38221452|FG003|Overall Study|Withdrawal by Subject|1|||
17080401|NCT00412958|38221449|FG000|Overall Study|Adverse Event|0|||
17080402|NCT00412958|38221450|FG001|Overall Study|Adverse Event|1|||
17080403|NCT00412958|38221451|FG002|Overall Study|Adverse Event|0|||
17080404|NCT00412958|38221452|FG003|Overall Study|Adverse Event|0|||
17080405|NCT00412958|38221449|FG000|Overall Study|Lost to Follow-up|0|||
17080406|NCT00412958|38221450|FG001|Overall Study|Lost to Follow-up|1|||
17080407|NCT00412958|38221451|FG002|Overall Study|Lost to Follow-up|0|||
17080408|NCT00412958|38221452|FG003|Overall Study|Lost to Follow-up|0|||
17080409|NCT00412958|38221449|FG000|Overall Study|Death|0|||
17080410|NCT00412958|38221450|FG001|Overall Study|Death|1|||
17080411|NCT00412958|38221451|FG002|Overall Study|Death|0|||
17080412|NCT00412958|38221452|FG003|Overall Study|Death|0|||
17080413|NCT00412958|38221449|FG000|Overall Study|Transport issue|0|||
17080414|NCT00412958|38221450|FG001|Overall Study|Transport issue|1|||
17080415|NCT00412958|38221451|FG002|Overall Study|Transport issue|0|||
17080416|NCT00412958|38221452|FG003|Overall Study|Transport issue|0|||
17080417|NCT00423176|38221464|FG000|Overall Study|Adverse Event|4|||
17080418|NCT00423176|38221465|FG001|Overall Study|Adverse Event|6|||
17080419|NCT00423176|38221464|FG000|Overall Study|Treatment Failure|1|||
17080420|NCT00423176|38221465|FG001|Overall Study|Treatment Failure|6|||
17080421|NCT00423176|38221464|FG000|Overall Study|Lost to Follow-up|4|||
17080422|NCT00423176|38221465|FG001|Overall Study|Lost to Follow-up|7|||
17080423|NCT00423176|38221464|FG000|Overall Study|Withdrawal by Subject|4|||
17080424|NCT00423176|38221465|FG001|Overall Study|Withdrawal by Subject|3|||
17080425|NCT00423176|38221464|FG000|Overall Study|Protocol Violation|1|||
17080426|NCT00423176|38221465|FG001|Overall Study|Protocol Violation|3|||
17080427|NCT00423176|38221464|FG000|Overall Study|Did not meet protocol eligibility|2|||
17080428|NCT00423176|38221465|FG001|Overall Study|Did not meet protocol eligibility|4|||
17080429|NCT00412880|38221471|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
17080430|NCT00412880|38221471|FG000|Overall Study|Consent withdrawn|1|||
17080431|NCT00412880|38221471|FG000|Overall Study|Adverse Event|1|||
17080432|NCT00412880|38221471|FG000|Overall Study|Progressive disease|20|||
17080433|NCT00268203|38221475|FG000|Overall Study|Lost to Follow-up|92|||
17080434|NCT00268203|38221475|FG000|Overall Study|Withdrawal by Subject|9|||
17080435|NCT00268203|38221475|FG000|Overall Study|Received Other NHL Therapy|7|||
17080436|NCT00268203|38221475|FG000|Overall Study|Progressive Disease|359|||
17080437|NCT00268203|38221475|FG000|Overall Study|Death|84|||
17080438|NCT00268203|38221475|FG000|Overall Study|Reason Not Specified|34|||
17080439|NCT00268203|38221475|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
17080440|NCT00384930|38221484|FG000|Overall Study|Adverse Event|5|||
17080441|NCT00384930|38221485|FG001|Overall Study|Adverse Event|4|||
17080442|NCT00384930|38221486|FG002|Overall Study|Adverse Event|12|||
17080443|NCT00384930|38221487|FG003|Overall Study|Adverse Event|11|||
17080444|NCT00384930|38221488|FG004|Overall Study|Adverse Event|14|||
17080445|NCT00384930|38221484|FG000|Overall Study|Entry Criteria Not Met|2|||
17080446|NCT00384930|38221485|FG001|Overall Study|Entry Criteria Not Met|6|||
17080447|NCT00384930|38221486|FG002|Overall Study|Entry Criteria Not Met|7|||
17080448|NCT00384930|38221487|FG003|Overall Study|Entry Criteria Not Met|8|||
17080449|NCT00384930|38221488|FG004|Overall Study|Entry Criteria Not Met|4|||
17080450|NCT00384930|38221484|FG000|Overall Study|Lack of Efficacy|1|||
17080451|NCT00384930|38221485|FG001|Overall Study|Lack of Efficacy|1|||
17080452|NCT00384930|38221486|FG002|Overall Study|Lack of Efficacy|2|||
17080453|NCT00384930|38221487|FG003|Overall Study|Lack of Efficacy|1|||
17080454|NCT00384930|38221488|FG004|Overall Study|Lack of Efficacy|2|||
17080455|NCT00384930|38221484|FG000|Overall Study|Lost to Follow-up|5|||
17080456|NCT00384930|38221485|FG001|Overall Study|Lost to Follow-up|3|||
17080457|NCT00384930|38221486|FG002|Overall Study|Lost to Follow-up|0|||
17080458|NCT00384930|38221487|FG003|Overall Study|Lost to Follow-up|4|||
17080459|NCT00384930|38221488|FG004|Overall Study|Lost to Follow-up|6|||
17080460|NCT00384930|38221484|FG000|Overall Study|Physician Decision|0|||
17080461|NCT00384930|38221485|FG001|Overall Study|Physician Decision|1|||
17080462|NCT00384930|38221486|FG002|Overall Study|Physician Decision|1|||
17080463|NCT00384930|38221487|FG003|Overall Study|Physician Decision|0|||
17080464|NCT00384930|38221488|FG004|Overall Study|Physician Decision|1|||
17080465|NCT00384930|38221484|FG000|Overall Study|Protocol Violation|1|||
17080466|NCT00384930|38221485|FG001|Overall Study|Protocol Violation|0|||
17080467|NCT00384930|38221486|FG002|Overall Study|Protocol Violation|1|||
17080468|NCT00384930|38221487|FG003|Overall Study|Protocol Violation|6|||
17080469|NCT00384930|38221488|FG004|Overall Study|Protocol Violation|4|||
17080470|NCT00384930|38221484|FG000|Overall Study|Sponsor Decision|3|||
17080471|NCT00384930|38221485|FG001|Overall Study|Sponsor Decision|4|||
17080472|NCT00384930|38221486|FG002|Overall Study|Sponsor Decision|0|||
17080473|NCT00384930|38221487|FG003|Overall Study|Sponsor Decision|5|||
17080474|NCT00384930|38221488|FG004|Overall Study|Sponsor Decision|0|||
17080475|NCT00384930|38221484|FG000|Overall Study|Withdrawal by Subject|9|||
17080476|NCT00384930|38221485|FG001|Overall Study|Withdrawal by Subject|7|||
17080477|NCT00384930|38221486|FG002|Overall Study|Withdrawal by Subject|7|||
17080478|NCT00384930|38221487|FG003|Overall Study|Withdrawal by Subject|6|||
17080479|NCT00384930|38221488|FG004|Overall Study|Withdrawal by Subject|16|||
17080480|NCT00384930|38221484|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
17080481|NCT00384930|38221485|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
17080482|NCT00384930|38221486|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
17080483|NCT00384930|38221487|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
17080484|NCT00384930|38221488|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
17080485|NCT00423098|38221505|FG000|Overall Study|Adverse Event|1|||
17080486|NCT00423098|38221506|FG001|Overall Study|Adverse Event|2|||
17080487|NCT00423098|38221505|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
17080488|NCT00423098|38221506|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
17080489|NCT00423098|38221505|FG000|Overall Study|Administrative problems|0|||
17080490|NCT00423098|38221506|FG001|Overall Study|Administrative problems|1|||
17080491|NCT00423098|38221505|FG000|Overall Study|Death|2|||
17080492|NCT00423098|38221506|FG001|Overall Study|Death|0|||
17080493|NCT00411788|38221521|FG000|Overall Study|Protocol Violation|1|||
17080494|NCT00411788|38221521|FG000|Overall Study|Adverse Event|1|||
17080495|NCT00422942|38221525|FG000|Overall Study|Study terminated by Sponsor|3|||
17080496|NCT00422162|38221531|FG000|Overall Study|Adverse Event|11|||
17080497|NCT00422162|38221532|FG001|Overall Study|Adverse Event|9|||
17080498|NCT00422162|38221531|FG000|Overall Study|Lack of Efficacy|4|||
17080499|NCT00422162|38221532|FG001|Overall Study|Lack of Efficacy|10|||
17080500|NCT00422162|38221531|FG000|Overall Study|Withdrawal by Subject|7|||
17080501|NCT00422162|38221532|FG001|Overall Study|Withdrawal by Subject|6|||
17080502|NCT00422162|38221531|FG000|Overall Study|Lost to Follow-up|1|||
17080503|NCT00422162|38221532|FG001|Overall Study|Lost to Follow-up|2|||
17080504|NCT00422162|38221531|FG000|Overall Study|Non-Compliant with Protocol|1|||
17080505|NCT00422162|38221532|FG001|Overall Study|Non-Compliant with Protocol|1|||
17080506|NCT00422162|38221531|FG000|Overall Study|Other|0|||
17080507|NCT00422162|38221532|FG001|Overall Study|Other|1|||
17080508|NCT00422162|38221531|FG000|Overall Study|Didn't Receive Treatment|0|||
17080509|NCT00422162|38221532|FG001|Overall Study|Didn't Receive Treatment|1|||
17080510|NCT00411632|38221548|FG000|Overall Study|Death|1|||
17080511|NCT00422084|38221554|FG000|Overall Study|Adverse Event|21|||
17080512|NCT00422084|38221555|FG001|Overall Study|Adverse Event|7|||
17080513|NCT00422084|38221554|FG000|Overall Study|Withdrawal by Subject|12|||
17080514|NCT00422084|38221555|FG001|Overall Study|Withdrawal by Subject|9|||
17080515|NCT00422084|38221554|FG000|Overall Study|Lost to Follow-up|14|||
17080516|NCT00422084|38221555|FG001|Overall Study|Lost to Follow-up|9|||
17080517|NCT00422084|38221554|FG000|Overall Study|Protocol Violation|4|||
17080518|NCT00422084|38221555|FG001|Overall Study|Protocol Violation|1|||
17080519|NCT00422084|38221554|FG000|Overall Study|Lack of Efficacy|40|||
17080520|NCT00422084|38221555|FG001|Overall Study|Lack of Efficacy|42|||
17080521|NCT00422084|38221554|FG000|Overall Study|P. vivax infection|3|||
17080522|NCT00422084|38221555|FG001|Overall Study|P. vivax infection|6|||
17080523|NCT00422084|38221554|FG000|Overall Study|Cyesis|1|||
17080524|NCT00422084|38221555|FG001|Overall Study|Cyesis|0|||
17159979|NCT02899988|38307231|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
17159980|NCT02899988|38307232|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
17159981|NCT02899988|38307233|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
17159982|NCT02899988|38307234|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
17159983|NCT02939131|38307268|FG000|Overall Study|Unable to get to clinic|6|||
17159984|NCT02939131|38307269|FG001|Overall Study|Unable to get to clinic|4|||
17159985|NCT02939131|38307268|FG000|Overall Study|Lost to Follow-up|2|||
17159986|NCT02939131|38307269|FG001|Overall Study|Lost to Follow-up|4|||
17159987|NCT02939131|38307268|FG000|Overall Study|severe debilitation|1|||
17080525|NCT00422084|38221554|FG000|Overall Study|Withdrawn from study accidentally|1|||
17080526|NCT00422084|38221555|FG001|Overall Study|Withdrawn from study accidentally|0|||
17080527|NCT00422084|38221554|FG000|Overall Study|Non-compliance|1|||
17080528|NCT00422084|38221555|FG001|Overall Study|Non-compliance|0|||
17080529|NCT00422084|38221554|FG000|Overall Study|Re-location|0|||
17080530|NCT00422084|38221555|FG001|Overall Study|Re-location|1|||
17080531|NCT00422084|38221554|FG000|Overall Study|Not defined|1|||
17080532|NCT00422084|38221555|FG001|Overall Study|Not defined|1|||
17080533|NCT00421928|38221564|FG000|Overall Study|Adverse Event|61|||
17080534|NCT00421928|38221565|FG001|Overall Study|Adverse Event|140|||
17080535|NCT00421928|38221566|FG002|Overall Study|Adverse Event|22|||
17080536|NCT00421928|38221564|FG000|Overall Study|Lost to Follow-up|5|||
17080537|NCT00421928|38221565|FG001|Overall Study|Lost to Follow-up|0|||
17080538|NCT00421928|38221566|FG002|Overall Study|Lost to Follow-up|3|||
17080539|NCT00421928|38221564|FG000|Overall Study|Withdrawal by Subject|50|||
17080540|NCT00421928|38221565|FG001|Overall Study|Withdrawal by Subject|48|||
17080541|NCT00421928|38221566|FG002|Overall Study|Withdrawal by Subject|43|||
17080542|NCT00421928|38221564|FG000|Overall Study|Lack of Efficacy|15|||
17080543|NCT00421928|38221565|FG001|Overall Study|Lack of Efficacy|7|||
17080544|NCT00421928|38221566|FG002|Overall Study|Lack of Efficacy|35|||
17080545|NCT00421928|38221564|FG000|Overall Study|Study drug non-compliant|6|||
17080546|NCT00421928|38221565|FG001|Overall Study|Study drug non-compliant|7|||
17080547|NCT00421928|38221566|FG002|Overall Study|Study drug non-compliant|4|||
17080548|NCT00421928|38221564|FG000|Overall Study|All other|26|||
17080549|NCT00421928|38221565|FG001|Overall Study|All other|21|||
17080550|NCT00421928|38221566|FG002|Overall Study|All other|27|||
17080551|NCT00421928|38221564|FG000|Overall Study|Death|0|||
17080552|NCT00421928|38221565|FG001|Overall Study|Death|1|||
17080553|NCT00421928|38221566|FG002|Overall Study|Death|0|||
17080554|NCT00383292|38221577|FG000|Overall Study|Adverse Event|4|||
17080555|NCT00383292|38221578|FG001|Overall Study|Adverse Event|1|||
17080556|NCT00383292|38221579|FG002|Overall Study|Adverse Event|2|||
17080557|NCT00383292|38221577|FG000|Overall Study|Death|3|||
17080558|NCT00383292|38221578|FG001|Overall Study|Death|3|||
17080559|NCT00383292|38221579|FG002|Overall Study|Death|3|||
17080560|NCT00383292|38221577|FG000|Overall Study|Physician Decision|4|||
17080561|NCT00383292|38221578|FG001|Overall Study|Physician Decision|0|||
17080562|NCT00383292|38221579|FG002|Overall Study|Physician Decision|1|||
17080563|NCT00383292|38221577|FG000|Overall Study|Withdrawal by Subject|3|||
17080564|NCT00383292|38221578|FG001|Overall Study|Withdrawal by Subject|2|||
17080565|NCT00383292|38221579|FG002|Overall Study|Withdrawal by Subject|2|||
17080566|NCT00383292|38221577|FG000|Overall Study|Other|1|||
17080567|NCT00383292|38221578|FG001|Overall Study|Other|0|||
17080568|NCT00383292|38221579|FG002|Overall Study|Other|0|||
17080569|NCT00372060|38221590|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
17080570|NCT00372060|38221591|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
17080571|NCT00372060|38221590|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
17080572|NCT00372060|38221591|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
17080573|NCT00372060|38221590|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
17080574|NCT00372060|38221591|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
17080575|NCT00372060|38221590|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
17080576|NCT00372060|38221591|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
17080577|NCT00372060|38221590|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
17080578|NCT00372060|38221591|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
17080579|NCT00372060|38221590|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
17080580|NCT00372060|38221591|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
17080581|NCT00421304|38221603|FG000|Overall Study|Lost to Follow-up|5|||
17080582|NCT00421304|38221604|FG001|Overall Study|Lost to Follow-up|2|||
17080583|NCT00421304|38221605|FG002|Overall Study|Lost to Follow-up|5|||
17080584|NCT00421304|38221603|FG000|Overall Study|Withdrawal by Subject|2|||
17080585|NCT00421304|38221604|FG001|Overall Study|Withdrawal by Subject|2|||
17080586|NCT00421304|38221605|FG002|Overall Study|Withdrawal by Subject|2|||
17080587|NCT00421304|38221603|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
17080588|NCT00421304|38221604|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
17080589|NCT00421304|38221605|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
17080590|NCT00421304|38221603|FG000|Overall Study|Did not attend Day 360 visit|0|||
17080591|NCT00421304|38221604|FG001|Overall Study|Did not attend Day 360 visit|0|||
17080592|NCT00421304|38221605|FG002|Overall Study|Did not attend Day 360 visit|1|||
17080593|NCT00396630|38221617|FG000|Overall Study|Lost to Follow-up|1|||
17080594|NCT00396630|38221618|FG001|Overall Study|Lost to Follow-up|1|||
17080595|NCT00396630|38221617|FG000|Overall Study|Withdrawal by Subject|1|||
17080596|NCT00396630|38221618|FG001|Overall Study|Withdrawal by Subject|1|||
17080597|NCT00396630|38221617|FG000|Overall Study|Not vaccinated at Visit 3|3|||
17080598|NCT00396630|38221618|FG001|Overall Study|Not vaccinated at Visit 3|3|||
17080599|NCT00396318|38221625|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
17080600|NCT00396162|38221631|FG000|Overall Study|Withdrawal by Subject|2|||
17080601|NCT00396162|38221632|FG001|Overall Study|Withdrawal by Subject|3|||
17080602|NCT00381888|38221642|FG000|Overall Study|Death|1|||
17080603|NCT00381888|38221642|FG000|Overall Study|Withdrawal by Subject|1|||
17080604|NCT00381888|38221642|FG000|Overall Study|Physician Decision|1|||
17080605|NCT00381888|38221642|FG000|Overall Study|Protocol Violation|9|||
17080606|NCT00381888|38221642|FG000|Overall Study|Had laparoscopic surgery|2|||
17080607|NCT00381888|38221642|FG000|Overall Study|Surgery was cancelled|2|||
17080608|NCT00381888|38221642|FG000|Overall Study|Adverse Event|1|||
17080609|NCT00267969|38221649|FG000|Controlled Period|Adverse Event|6|||
17080610|NCT00267969|38221650|FG001|Controlled Period|Adverse Event|0|||
17080611|NCT00267969|38221651|FG002|Controlled Period|Adverse Event|2|||
17080612|NCT00267969|38221652|FG003|Controlled Period|Adverse Event|0|||
17080613|NCT00267969|38221653|FG004|Controlled Period|Adverse Event|0|||
17080614|NCT00267969|38221654|FG005|Controlled Period|Adverse Event|0|||
17080615|NCT00267969|38221655|FG006|Controlled Period|Adverse Event|0|||
17080616|NCT00267969|38221649|FG000|Controlled Period|Lack of Efficacy|3|||
17080617|NCT00267969|38221650|FG001|Controlled Period|Lack of Efficacy|0|||
17080618|NCT00267969|38221651|FG002|Controlled Period|Lack of Efficacy|1|||
17080619|NCT00267969|38221652|FG003|Controlled Period|Lack of Efficacy|0|||
17080620|NCT00267969|38221653|FG004|Controlled Period|Lack of Efficacy|0|||
17080621|NCT00267969|38221654|FG005|Controlled Period|Lack of Efficacy|0|||
17080622|NCT00267969|38221655|FG006|Controlled Period|Lack of Efficacy|0|||
17080623|NCT00267969|38221649|FG000|Controlled Period|Lost to Follow-up|1|||
17080624|NCT00267969|38221650|FG001|Controlled Period|Lost to Follow-up|0|||
17080625|NCT00267969|38221651|FG002|Controlled Period|Lost to Follow-up|1|||
17080626|NCT00267969|38221652|FG003|Controlled Period|Lost to Follow-up|0|||
17080627|NCT00267969|38221653|FG004|Controlled Period|Lost to Follow-up|0|||
17080628|NCT00267969|38221654|FG005|Controlled Period|Lost to Follow-up|0|||
17080629|NCT00267969|38221655|FG006|Controlled Period|Lost to Follow-up|0|||
17080630|NCT00267969|38221649|FG000|Controlled Period|Randomized but not treated|0|||
17080631|NCT00267969|38221650|FG001|Controlled Period|Randomized but not treated|0|||
17080632|NCT00267969|38221651|FG002|Controlled Period|Randomized but not treated|1|||
17080633|NCT00267969|38221652|FG003|Controlled Period|Randomized but not treated|0|||
17080634|NCT00267969|38221653|FG004|Controlled Period|Randomized but not treated|0|||
17080635|NCT00267969|38221654|FG005|Controlled Period|Randomized but not treated|0|||
17080636|NCT00267969|38221655|FG006|Controlled Period|Randomized but not treated|0|||
17080637|NCT00267969|38221649|FG000|Controlled Period|Other|2|||
17159988|NCT02939131|38307269|FG001|Overall Study|severe debilitation|0|||
17159989|NCT02939131|38307268|FG000|Overall Study|Other|0|||
17159990|NCT02939131|38307269|FG001|Overall Study|Other|1|||
17159991|NCT02939131|38307268|FG000|Overall Study|not willing to adhere to protocol|2|||
17159992|NCT02939131|38307269|FG001|Overall Study|not willing to adhere to protocol|0|||
17159993|NCT04373460|38307278|FG000|Overall Study|Did not receive tranfusion|18|||
17159994|NCT04373460|38307279|FG001|Overall Study|Did not receive tranfusion|26|||
17159995|NCT03345407|38307296|FG000|Overall Study|Withdrawal by Subject|11|||
17159996|NCT03345407|38307297|FG001|Overall Study|Withdrawal by Subject|1|||
17159997|NCT03345407|38307298|FG002|Overall Study|Withdrawal by Subject|5|||
17159998|NCT03345407|38307299|FG003|Overall Study|Withdrawal by Subject|6|||
17159999|NCT03345407|38307300|FG004|Overall Study|Withdrawal by Subject|3|||
17160000|NCT03345407|38307301|FG005|Overall Study|Withdrawal by Subject|6|||
17160001|NCT03345407|38307302|FG006|Overall Study|Withdrawal by Subject|16|||
17160002|NCT03345407|38307296|FG000|Overall Study|Physician Decision|3|||
17160003|NCT03345407|38307297|FG001|Overall Study|Physician Decision|1|||
17160004|NCT03345407|38307298|FG002|Overall Study|Physician Decision|0|||
17160005|NCT03345407|38307299|FG003|Overall Study|Physician Decision|0|||
17160006|NCT03345407|38307300|FG004|Overall Study|Physician Decision|1|||
17160007|NCT03345407|38307301|FG005|Overall Study|Physician Decision|2|||
17160008|NCT03345407|38307302|FG006|Overall Study|Physician Decision|3|||
17160009|NCT03345407|38307296|FG000|Overall Study|Lost to Follow-up|2|||
17160010|NCT03345407|38307297|FG001|Overall Study|Lost to Follow-up|0|||
17160011|NCT03345407|38307298|FG002|Overall Study|Lost to Follow-up|1|||
17160012|NCT03345407|38307299|FG003|Overall Study|Lost to Follow-up|0|||
17160013|NCT03345407|38307300|FG004|Overall Study|Lost to Follow-up|1|||
17160014|NCT03345407|38307301|FG005|Overall Study|Lost to Follow-up|2|||
17160015|NCT03345407|38307302|FG006|Overall Study|Lost to Follow-up|3|||
17160016|NCT03345407|38307296|FG000|Overall Study|Protocol-defined stopping criteria|9|||
17160017|NCT03345407|38307297|FG001|Overall Study|Protocol-defined stopping criteria|0|||
17160018|NCT03345407|38307298|FG002|Overall Study|Protocol-defined stopping criteria|0|||
17160019|NCT03345407|38307299|FG003|Overall Study|Protocol-defined stopping criteria|0|||
17160020|NCT03345407|38307300|FG004|Overall Study|Protocol-defined stopping criteria|2|||
17160021|NCT03345407|38307301|FG005|Overall Study|Protocol-defined stopping criteria|1|||
17160022|NCT03345407|38307302|FG006|Overall Study|Protocol-defined stopping criteria|1|||
17160023|NCT03345407|38307296|FG000|Overall Study|Protocol Violation|2|||
17160024|NCT03345407|38307297|FG001|Overall Study|Protocol Violation|0|||
17160025|NCT03345407|38307298|FG002|Overall Study|Protocol Violation|0|||
17160026|NCT03345407|38307299|FG003|Overall Study|Protocol Violation|0|||
17160027|NCT03345407|38307300|FG004|Overall Study|Protocol Violation|1|||
17160028|NCT03345407|38307301|FG005|Overall Study|Protocol Violation|0|||
17160029|NCT03345407|38307302|FG006|Overall Study|Protocol Violation|3|||
17160030|NCT03345407|38307296|FG000|Overall Study|Lack of Efficacy|1|||
17160031|NCT03345407|38307297|FG001|Overall Study|Lack of Efficacy|1|||
17160032|NCT03345407|38307298|FG002|Overall Study|Lack of Efficacy|1|||
17160033|NCT03345407|38307299|FG003|Overall Study|Lack of Efficacy|1|||
17160034|NCT03345407|38307300|FG004|Overall Study|Lack of Efficacy|1|||
17160035|NCT03345407|38307301|FG005|Overall Study|Lack of Efficacy|0|||
17160036|NCT03345407|38307302|FG006|Overall Study|Lack of Efficacy|3|||
17160037|NCT03345407|38307296|FG000|Overall Study|Adverse Event|4|||
17160038|NCT03345407|38307297|FG001|Overall Study|Adverse Event|0|||
17160039|NCT03345407|38307298|FG002|Overall Study|Adverse Event|5|||
17160040|NCT03345407|38307299|FG003|Overall Study|Adverse Event|4|||
17160041|NCT03345407|38307300|FG004|Overall Study|Adverse Event|6|||
17160042|NCT03345407|38307301|FG005|Overall Study|Adverse Event|5|||
17160043|NCT03345407|38307302|FG006|Overall Study|Adverse Event|16|||
17160044|NCT03255187|38307326|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
17160045|NCT03255187|38307327|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
17160046|NCT03255187|38307326|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
17080638|NCT00267969|38221650|FG001|Controlled Period|Other|1|||
17080639|NCT00267969|38221651|FG002|Controlled Period|Other|6|||
17160047|NCT03255187|38307327|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
17160048|NCT02929329|38307335|FG000|Overall Study|Withdrawal by Subject|24|||
17160049|NCT02929329|38307336|FG001|Overall Study|Withdrawal by Subject|21|||
17160050|NCT02929329|38307335|FG000|Overall Study|Lost to Follow-up|26|||
17160051|NCT02929329|38307336|FG001|Overall Study|Lost to Follow-up|20|||
17160052|NCT02929329|38307335|FG000|Overall Study|Death|1054|||
17160053|NCT02929329|38307336|FG001|Overall Study|Death|1051|||
17160054|NCT03240133|38307349|FG000|Overall Study|Withdrawal by Subject|0|||
17160055|NCT03240133|38307350|FG001|Overall Study|Withdrawal by Subject|1|||
17160056|NCT03240133|38307351|FG002|Overall Study|Withdrawal by Subject|0|||
17160057|NCT03240133|38307349|FG000|Overall Study|Adverse Event|1|||
17160058|NCT03240133|38307350|FG001|Overall Study|Adverse Event|1|||
17160059|NCT03240133|38307351|FG002|Overall Study|Adverse Event|0|||
17160060|NCT03240133|38307349|FG000|Overall Study|Rash|1|||
17160061|NCT03240133|38307350|FG001|Overall Study|Rash|0|||
17160062|NCT03240133|38307351|FG002|Overall Study|Rash|0|||
17160063|NCT03240133|38307349|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
17160064|NCT03240133|38307350|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
17160065|NCT03240133|38307351|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
17160066|NCT03240133|38307349|FG000|Overall Study|Intercurrent illness.|0|||
17080640|NCT00267969|38221652|FG003|Controlled Period|Other|0|||
17080641|NCT00267969|38221653|FG004|Controlled Period|Other|0|||
17080642|NCT00267969|38221654|FG005|Controlled Period|Other|0|||
17080643|NCT00267969|38221655|FG006|Controlled Period|Other|0|||
17080644|NCT00267969|38221649|FG000|After Controlled Period|Adverse Event|0|||
17080645|NCT00267969|38221650|FG001|After Controlled Period|Adverse Event|0|||
17080646|NCT00267969|38221651|FG002|After Controlled Period|Adverse Event|0|||
17080647|NCT00267969|38221652|FG003|After Controlled Period|Adverse Event|7|||
17080648|NCT00267969|38221653|FG004|After Controlled Period|Adverse Event|8|||
17080649|NCT00267969|38221654|FG005|After Controlled Period|Adverse Event|23|||
17080650|NCT00267969|38221655|FG006|After Controlled Period|Adverse Event|21|||
17080651|NCT00267969|38221649|FG000|After Controlled Period|Death|0|||
17080652|NCT00267969|38221650|FG001|After Controlled Period|Death|0|||
17080653|NCT00267969|38221651|FG002|After Controlled Period|Death|0|||
17080654|NCT00267969|38221652|FG003|After Controlled Period|Death|1|||
17080655|NCT00267969|38221653|FG004|After Controlled Period|Death|2|||
17080656|NCT00267969|38221654|FG005|After Controlled Period|Death|0|||
17080657|NCT00267969|38221655|FG006|After Controlled Period|Death|1|||
17080658|NCT00267969|38221649|FG000|After Controlled Period|Lack of Efficacy|0|||
17080659|NCT00267969|38221650|FG001|After Controlled Period|Lack of Efficacy|0|||
17080660|NCT00267969|38221651|FG002|After Controlled Period|Lack of Efficacy|0|||
17080661|NCT00267969|38221652|FG003|After Controlled Period|Lack of Efficacy|10|||
17080662|NCT00267969|38221653|FG004|After Controlled Period|Lack of Efficacy|6|||
17080663|NCT00267969|38221654|FG005|After Controlled Period|Lack of Efficacy|28|||
17080664|NCT00267969|38221655|FG006|After Controlled Period|Lack of Efficacy|15|||
17080665|NCT00267969|38221649|FG000|After Controlled Period|Lost to Follow-up|0|||
17080666|NCT00267969|38221650|FG001|After Controlled Period|Lost to Follow-up|0|||
17080667|NCT00267969|38221651|FG002|After Controlled Period|Lost to Follow-up|0|||
17080668|NCT00267969|38221652|FG003|After Controlled Period|Lost to Follow-up|5|||
17080669|NCT00267969|38221653|FG004|After Controlled Period|Lost to Follow-up|8|||
17080670|NCT00267969|38221654|FG005|After Controlled Period|Lost to Follow-up|9|||
17080671|NCT00267969|38221655|FG006|After Controlled Period|Lost to Follow-up|10|||
17080672|NCT00267969|38221649|FG000|After Controlled Period|Other|0|||
17080673|NCT00267969|38221650|FG001|After Controlled Period|Other|0|||
17080674|NCT00267969|38221651|FG002|After Controlled Period|Other|0|||
17080675|NCT00267969|38221652|FG003|After Controlled Period|Other|13|||
17080676|NCT00267969|38221653|FG004|After Controlled Period|Other|11|||
17080677|NCT00267969|38221654|FG005|After Controlled Period|Other|22|||
17080678|NCT00267969|38221655|FG006|After Controlled Period|Other|25|||
17080679|NCT00280293|38221675|FG000|Overall Study|Protocol Violation|3|||
17080680|NCT00280293|38221676|FG001|Overall Study|Protocol Violation|0|||
17080681|NCT00280293|38221675|FG000|Overall Study|Physician Decision|5|||
17080682|NCT00280293|38221676|FG001|Overall Study|Physician Decision|4|||
17080683|NCT00280293|38221675|FG000|Overall Study|Lost to Follow-up|14|||
17080684|NCT00280293|38221676|FG001|Overall Study|Lost to Follow-up|12|||
17080685|NCT00280293|38221675|FG000|Overall Study|Withdrawal by Subject|3|||
17080686|NCT00280293|38221676|FG001|Overall Study|Withdrawal by Subject|5|||
17080687|NCT00280293|38221675|FG000|Overall Study|Incarceration/Legal Reasons|1|||
17080688|NCT00280293|38221676|FG001|Overall Study|Incarceration/Legal Reasons|1|||
17080689|NCT00280293|38221675|FG000|Overall Study|Adverse Event|0|||
17080690|NCT00280293|38221676|FG001|Overall Study|Adverse Event|1|||
17080691|NCT00421148|38221702|FG000|Overall Study|Lost to Follow-up|0|||
17080692|NCT00421148|38221703|FG001|Overall Study|Lost to Follow-up|0|||
17080693|NCT00421148|38221704|FG002|Overall Study|Lost to Follow-up|0|||
17080694|NCT00421148|38221705|FG003|Overall Study|Lost to Follow-up|0|||
17080695|NCT00421148|38221706|FG004|Overall Study|Lost to Follow-up|0|||
17080696|NCT00421148|38221707|FG005|Overall Study|Lost to Follow-up|0|||
17080697|NCT00421148|38221708|FG006|Overall Study|Lost to Follow-up|0|||
17080698|NCT00421148|38221709|FG007|Overall Study|Lost to Follow-up|0|||
17080699|NCT00421148|38221710|FG008|Overall Study|Lost to Follow-up|0|||
17080700|NCT00421148|38221711|FG009|Overall Study|Lost to Follow-up|0|||
17080701|NCT00421148|38221712|FG010|Overall Study|Lost to Follow-up|0|||
17080702|NCT00421148|38221713|FG011|Overall Study|Lost to Follow-up|0|||
17080703|NCT00421148|38221714|FG012|Overall Study|Lost to Follow-up|0|||
17080704|NCT00421148|38221715|FG013|Overall Study|Lost to Follow-up|0|||
17080705|NCT00421148|38221716|FG014|Overall Study|Lost to Follow-up|0|||
17080706|NCT00421148|38221717|FG015|Overall Study|Lost to Follow-up|0|||
17080707|NCT00421148|38221718|FG016|Overall Study|Lost to Follow-up|0|||
17080708|NCT00421148|38221719|FG017|Overall Study|Lost to Follow-up|1|||
17080709|NCT00421148|38221720|FG018|Overall Study|Lost to Follow-up|0|||
17080710|NCT00421148|38221721|FG019|Overall Study|Lost to Follow-up|0|||
17080711|NCT00421148|38221702|FG000|Overall Study|Withdrawal by Subject|0|||
17080712|NCT00421148|38221703|FG001|Overall Study|Withdrawal by Subject|0|||
17080713|NCT00421148|38221704|FG002|Overall Study|Withdrawal by Subject|0|||
17080714|NCT00421148|38221705|FG003|Overall Study|Withdrawal by Subject|0|||
17080715|NCT00421148|38221706|FG004|Overall Study|Withdrawal by Subject|0|||
17080716|NCT00421148|38221707|FG005|Overall Study|Withdrawal by Subject|0|||
17080717|NCT00421148|38221708|FG006|Overall Study|Withdrawal by Subject|0|||
17080718|NCT00421148|38221709|FG007|Overall Study|Withdrawal by Subject|0|||
17080719|NCT00421148|38221710|FG008|Overall Study|Withdrawal by Subject|0|||
17080720|NCT00421148|38221711|FG009|Overall Study|Withdrawal by Subject|0|||
17080721|NCT00421148|38221712|FG010|Overall Study|Withdrawal by Subject|0|||
17080722|NCT00421148|38221713|FG011|Overall Study|Withdrawal by Subject|0|||
17080723|NCT00421148|38221714|FG012|Overall Study|Withdrawal by Subject|0|||
17080724|NCT00421148|38221715|FG013|Overall Study|Withdrawal by Subject|0|||
17080725|NCT00421148|38221716|FG014|Overall Study|Withdrawal by Subject|0|||
17080726|NCT00421148|38221717|FG015|Overall Study|Withdrawal by Subject|0|||
17080727|NCT00421148|38221718|FG016|Overall Study|Withdrawal by Subject|0|||
17080728|NCT00421148|38221719|FG017|Overall Study|Withdrawal by Subject|1|||
17080729|NCT00421148|38221720|FG018|Overall Study|Withdrawal by Subject|0|||
17080730|NCT00421148|38221721|FG019|Overall Study|Withdrawal by Subject|0|||
17080731|NCT00421148|38221702|FG000|Overall Study|Protocol Violation|0|||
17080732|NCT00421148|38221703|FG001|Overall Study|Protocol Violation|0|||
17080733|NCT00421148|38221704|FG002|Overall Study|Protocol Violation|0|||
17080734|NCT00421148|38221705|FG003|Overall Study|Protocol Violation|0|||
17080735|NCT00421148|38221706|FG004|Overall Study|Protocol Violation|0|||
17080736|NCT00421148|38221707|FG005|Overall Study|Protocol Violation|1|||
17080737|NCT00421148|38221708|FG006|Overall Study|Protocol Violation|0|||
17080738|NCT00421148|38221709|FG007|Overall Study|Protocol Violation|0|||
17080739|NCT00421148|38221710|FG008|Overall Study|Protocol Violation|0|||
17080740|NCT00421148|38221711|FG009|Overall Study|Protocol Violation|0|||
17080741|NCT00421148|38221712|FG010|Overall Study|Protocol Violation|0|||
17080742|NCT00421148|38221713|FG011|Overall Study|Protocol Violation|0|||
17080743|NCT00421148|38221714|FG012|Overall Study|Protocol Violation|0|||
17080744|NCT00421148|38221715|FG013|Overall Study|Protocol Violation|0|||
17080745|NCT00421148|38221716|FG014|Overall Study|Protocol Violation|0|||
17080746|NCT00421148|38221717|FG015|Overall Study|Protocol Violation|0|||
17080747|NCT00421148|38221718|FG016|Overall Study|Protocol Violation|0|||
17080748|NCT00421148|38221719|FG017|Overall Study|Protocol Violation|0|||
17080749|NCT00421148|38221720|FG018|Overall Study|Protocol Violation|1|||
17080750|NCT00421148|38221721|FG019|Overall Study|Protocol Violation|0|||
17080751|NCT00403754|38221763|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
17080752|NCT00403754|38221764|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
17080753|NCT00403754|38221765|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
17080754|NCT00403754|38221766|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
17080755|NCT00403754|38221763|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
17080756|NCT00403754|38221764|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
17080757|NCT00403754|38221765|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
17080758|NCT00403754|38221766|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
17080759|NCT00280059|38221780|FG000|Efficacy Assessment Phase|Death|2|||
17080760|NCT00280059|38221781|FG001|Efficacy Assessment Phase|Death|0|||
17080761|NCT00280059|38221780|FG000|Efficacy Assessment Phase|Adverse Event|33|||
17080762|NCT00280059|38221781|FG001|Efficacy Assessment Phase|Adverse Event|31|||
17080763|NCT00280059|38221780|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
17080764|NCT00280059|38221781|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
17080765|NCT00280059|38221780|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
17080766|NCT00280059|38221781|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
17080767|NCT00280059|38221780|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
17080768|NCT00280059|38221781|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
17080769|NCT00280059|38221780|FG000|Efficacy Assessment Phase|Other|7|||
17080770|NCT00280059|38221781|FG001|Efficacy Assessment Phase|Other|8|||
17080771|NCT00280059|38221780|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
17080772|NCT00280059|38221781|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
17080773|NCT00403130|38221795|FG000|2 Years From Start of Treatment|Not Eligible|3|||
17080774|NCT00403130|38221795|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
17080775|NCT00403130|38221795|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
17080776|NCT00403130|38221795|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
17080777|NCT00402740|38221799|FG000|Overall Study|Withdrawal by Subject|18|||
17080778|NCT00402740|38221799|FG000|Overall Study|Death|50|||
17080779|NCT00402740|38221799|FG000|Overall Study|Lost to Follow-up|6|||
17080780|NCT00402740|38221799|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
17080781|NCT00402740|38221799|FG000|Overall Study|Subject disposition unknown.|1|||
17080782|NCT00420290|38221809|FG000|Overall Study|Adverse Event|3|||
17080783|NCT00420290|38221810|FG001|Overall Study|Adverse Event|1|||
17080784|NCT00420290|38221809|FG000|Overall Study|Withdrawal by Subject|0|||
17080785|NCT00420290|38221810|FG001|Overall Study|Withdrawal by Subject|2|||
17080786|NCT00420290|38221809|FG000|Overall Study|did not meet inclusion/exclusion|1|||
17080787|NCT00420290|38221810|FG001|Overall Study|did not meet inclusion/exclusion|1|||
17080788|NCT00267189|38221818|FG000|Overall Study|Patient withdrew consent|1|||
17080789|NCT00267189|38221819|FG001|Overall Study|Patient withdrew consent|1|||
17080790|NCT00267189|38221818|FG000|Overall Study|Death|1|||
17080791|NCT00267189|38221819|FG001|Overall Study|Death|0|||
17080792|NCT00267189|38221818|FG000|Overall Study|Missing|3|||
17080793|NCT00267189|38221819|FG001|Overall Study|Missing|0|||
17080794|NCT03834350|38221825|FG000|Overall Study|Withdrawal by Subject|1|||
17080795|NCT00402116|38221833|FG000|Overall Study|Jaw infection after surgery-other|1|||
17080796|NCT00402116|38221834|FG001|Overall Study|Jaw infection after surgery-other|0|||
17080797|NCT00402116|38221835|FG002|Overall Study|Jaw infection after surgery-other|0|||
17080798|NCT00402116|38221833|FG000|Overall Study|Withdrawal by Subject|1|||
17080799|NCT00402116|38221834|FG001|Overall Study|Withdrawal by Subject|0|||
17080800|NCT00402116|38221835|FG002|Overall Study|Withdrawal by Subject|5|||
17080801|NCT00402116|38221833|FG000|Overall Study|Treatment completed per protocol|1|||
17080802|NCT00402116|38221834|FG001|Overall Study|Treatment completed per protocol|1|||
17080803|NCT00402116|38221835|FG002|Overall Study|Treatment completed per protocol|2|||
17080804|NCT00402116|38221833|FG000|Overall Study|other complicating disease|0|||
17080805|NCT00402116|38221834|FG001|Overall Study|other complicating disease|0|||
17080806|NCT00402116|38221835|FG002|Overall Study|other complicating disease|2|||
17080807|NCT00402116|38221833|FG000|Overall Study|Disease Progression|0|||
17080808|NCT00402116|38221834|FG001|Overall Study|Disease Progression|4|||
17080809|NCT00402116|38221835|FG002|Overall Study|Disease Progression|38|||
17080810|NCT00402116|38221833|FG000|Overall Study|mistaken thrombocytopenia|0|||
17080811|NCT00402116|38221834|FG001|Overall Study|mistaken thrombocytopenia|0|||
17080812|NCT00402116|38221835|FG002|Overall Study|mistaken thrombocytopenia|1|||
17080813|NCT00402116|38221833|FG000|Overall Study|decline related hyponatremia/tumor|0|||
17080814|NCT00402116|38221834|FG001|Overall Study|decline related hyponatremia/tumor|0|||
17080815|NCT00402116|38221835|FG002|Overall Study|decline related hyponatremia/tumor|1|||
17080816|NCT00402116|38221833|FG000|Overall Study|Adverse Event|0|||
17080817|NCT00402116|38221834|FG001|Overall Study|Adverse Event|1|||
17080818|NCT00402116|38221835|FG002|Overall Study|Adverse Event|6|||
17080819|NCT00401960|38221865|FG000|Overall Study|Lost to Follow-up|3|||
17080820|NCT00401960|38221866|FG001|Overall Study|Lost to Follow-up|0|||
17080821|NCT00401960|38221865|FG000|Overall Study|Death|2|||
17080822|NCT00401960|38221866|FG001|Overall Study|Death|0|||
17080823|NCT00401726|38221876|FG000|Overall Study|Adverse Event|34|||
17080824|NCT00401726|38221877|FG001|Overall Study|Adverse Event|45|||
17080825|NCT00401726|38221876|FG000|Overall Study|Death|0|||
17080826|NCT00401726|38221877|FG001|Overall Study|Death|3|||
17080827|NCT00401726|38221876|FG000|Overall Study|Sponsor Request|0|||
17080828|NCT00401726|38221877|FG001|Overall Study|Sponsor Request|1|||
17080829|NCT00401726|38221876|FG000|Overall Study|Physician Decision|3|||
17080830|NCT00401726|38221877|FG001|Overall Study|Physician Decision|6|||
17080831|NCT00401726|38221876|FG000|Overall Study|Lost to Follow-up|23|||
17080832|NCT00401726|38221877|FG001|Overall Study|Lost to Follow-up|20|||
17080833|NCT00401726|38221876|FG000|Overall Study|Protocol Violation|6|||
17080834|NCT00401726|38221877|FG001|Overall Study|Protocol Violation|3|||
17080835|NCT00401726|38221876|FG000|Overall Study|Withdrawal by Subject|18|||
17080836|NCT00401726|38221877|FG001|Overall Study|Withdrawal by Subject|24|||
17080837|NCT00401726|38221876|FG000|Overall Study|Lack of Efficacy|4|||
17080838|NCT00401726|38221877|FG001|Overall Study|Lack of Efficacy|6|||
17080839|NCT00401726|38221876|FG000|Overall Study|Protocol Deviation|9|||
17080840|NCT00401726|38221877|FG001|Overall Study|Protocol Deviation|4|||
17080841|NCT00371826|38221886|FG000|Core Phase (12 Months)|Adverse Event|15|||
17080842|NCT00371826|38221887|FG001|Core Phase (12 Months)|Adverse Event|4|||
17080843|NCT00371826|38221888|FG002|Core Phase (12 Months)|Adverse Event|9|||
17080844|NCT00371826|38221886|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
17080845|NCT00371826|38221887|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
17080846|NCT00371826|38221888|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
17080847|NCT00371826|38221886|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
17080848|NCT00371826|38221887|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
17080849|NCT00371826|38221888|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
17080850|NCT00371826|38221886|FG000|Core Phase (12 Months)|Protocol Violation|1|||
17080851|NCT00371826|38221887|FG001|Core Phase (12 Months)|Protocol Violation|0|||
17080852|NCT00371826|38221888|FG002|Core Phase (12 Months)|Protocol Violation|1|||
17080853|NCT00371826|38221886|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
17080854|NCT00371826|38221887|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
17080855|NCT00371826|38221888|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
17080856|NCT00371826|38221886|FG000|Core Phase (12 Months)|Administrative problems|1|||
17080857|NCT00371826|38221887|FG001|Core Phase (12 Months)|Administrative problems|0|||
17080858|NCT00371826|38221888|FG002|Core Phase (12 Months)|Administrative problems|8|||
17080859|NCT00371826|38221886|FG000|Core Phase (12 Months)|Graft Loss|0|||
17080860|NCT00371826|38221887|FG001|Core Phase (12 Months)|Graft Loss|1|||
17080861|NCT00371826|38221888|FG002|Core Phase (12 Months)|Graft Loss|0|||
17080862|NCT00371826|38221886|FG000|Extension Phase (24 Months)|Adverse Event|4|||
17080863|NCT00371826|38221887|FG001|Extension Phase (24 Months)|Adverse Event|5|||
17080864|NCT00371826|38221888|FG002|Extension Phase (24 Months)|Adverse Event|0|||
17080865|NCT00371826|38221886|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
17080866|NCT00371826|38221887|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
17080867|NCT00371826|38221888|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
17080868|NCT00371826|38221886|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
17080869|NCT00371826|38221887|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
17080870|NCT00371826|38221888|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
17080871|NCT00371826|38221886|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
17080872|NCT00371826|38221887|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
17080873|NCT00371826|38221888|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
17080874|NCT00371826|38221886|FG000|Extension Phase (24 Months)|Administrative problems|0|||
17080875|NCT00371826|38221887|FG001|Extension Phase (24 Months)|Administrative problems|0|||
17080876|NCT00371826|38221888|FG002|Extension Phase (24 Months)|Administrative problems|2|||
17080877|NCT00396084|38221902|FG000|Overall Study|Adverse Event|0|||
17080878|NCT00396084|38221903|FG001|Overall Study|Adverse Event|0|||
17080879|NCT00396084|38221904|FG002|Overall Study|Adverse Event|0|||
17080880|NCT00396084|38221905|FG003|Overall Study|Adverse Event|0|||
17080881|NCT00396084|38221906|FG004|Overall Study|Adverse Event|1|||
17080882|NCT00396084|38221907|FG005|Overall Study|Adverse Event|2|||
17080883|NCT00396084|38221902|FG000|Overall Study|Withdrawal by Subject|0|||
17080884|NCT00396084|38221903|FG001|Overall Study|Withdrawal by Subject|0|||
17080885|NCT00396084|38221904|FG002|Overall Study|Withdrawal by Subject|0|||
17080886|NCT00396084|38221905|FG003|Overall Study|Withdrawal by Subject|1|||
17080887|NCT00396084|38221906|FG004|Overall Study|Withdrawal by Subject|0|||
17080888|NCT00396084|38221907|FG005|Overall Study|Withdrawal by Subject|0|||
17080889|NCT00395850|38221929|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
17080890|NCT00395850|38221930|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
17080891|NCT00395850|38221931|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
17080892|NCT00395850|38221932|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
17080893|NCT00395850|38221929|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
17080894|NCT00395850|38221930|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
17080895|NCT00395850|38221931|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
17080896|NCT00395850|38221932|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
17080897|NCT00395850|38221929|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
17080898|NCT00395850|38221930|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
17080899|NCT00395850|38221931|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
17080900|NCT00395850|38221932|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
17080901|NCT00395850|38221929|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
17080902|NCT00395850|38221930|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
17080903|NCT00395850|38221931|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
17080904|NCT00395850|38221932|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
17080905|NCT00395850|38221929|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
17080906|NCT00395850|38221930|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
17080907|NCT00395850|38221931|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
17080908|NCT00395850|38221932|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
17080909|NCT00395850|38221929|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
17080910|NCT00395850|38221930|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
17080911|NCT00395850|38221931|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
17080912|NCT00395850|38221932|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
17080913|NCT00395850|38221929|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
17080914|NCT00395850|38221930|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
17080915|NCT00395850|38221931|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
17080916|NCT00395850|38221932|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
17080917|NCT00420212|38221945|FG000|Overall Study|Adverse Event|22|||
17080918|NCT00420212|38221946|FG001|Overall Study|Adverse Event|40|||
17080919|NCT00420212|38221947|FG002|Overall Study|Adverse Event|36|||
17080920|NCT00420212|38221945|FG000|Overall Study|Lost to Follow-up|9|||
17080921|NCT00420212|38221946|FG001|Overall Study|Lost to Follow-up|11|||
17080922|NCT00420212|38221947|FG002|Overall Study|Lost to Follow-up|11|||
17080923|NCT00420212|38221945|FG000|Overall Study|Withdrawal by Subject|31|||
17080924|NCT00420212|38221946|FG001|Overall Study|Withdrawal by Subject|22|||
17080925|NCT00420212|38221947|FG002|Overall Study|Withdrawal by Subject|19|||
17080926|NCT00420212|38221945|FG000|Overall Study|Physician Decision|4|||
17080927|NCT00420212|38221946|FG001|Overall Study|Physician Decision|4|||
17080928|NCT00420212|38221947|FG002|Overall Study|Physician Decision|3|||
17080929|NCT00420212|38221945|FG000|Overall Study|Protocol Violation|4|||
17080930|NCT00420212|38221946|FG001|Overall Study|Protocol Violation|4|||
17080931|NCT00420212|38221947|FG002|Overall Study|Protocol Violation|8|||
17080932|NCT00420212|38221945|FG000|Overall Study|Death|0|||
17080933|NCT00420212|38221946|FG001|Overall Study|Death|0|||
17080934|NCT00420212|38221947|FG002|Overall Study|Death|1|||
17080935|NCT00420212|38221945|FG000|Overall Study|Other-Unspecified|21|||
17080936|NCT00420212|38221946|FG001|Overall Study|Other-Unspecified|14|||
17080937|NCT00420212|38221947|FG002|Overall Study|Other-Unspecified|18|||
17080938|NCT00401258|38221958|FG000|Overall Study|Adverse Event|7|||
17080939|NCT00380874|38221964|FG000|Overall Study|Adverse Event|7|||
17080940|NCT00380874|38221965|FG001|Overall Study|Adverse Event|7|||
17080941|NCT00380874|38221964|FG000|Overall Study|Death|1|||
17080942|NCT00380874|38221965|FG001|Overall Study|Death|0|||
17080943|NCT00380874|38221964|FG000|Overall Study|Withdrawal by Subject|2|||
17080944|NCT00380874|38221965|FG001|Overall Study|Withdrawal by Subject|1|||
17080945|NCT00380874|38221964|FG000|Overall Study|Not related to study drug|3|||
17080946|NCT00380874|38221965|FG001|Overall Study|Not related to study drug|2|||
17080947|NCT00420056|38221971|FG000|Overall Study|Objective progression or relapse|17|||
17080948|NCT00411554|38221977|FG000|Overall Study|Adverse Event|2|||
17080949|NCT00411554|38221978|FG001|Overall Study|Adverse Event|4|||
17080950|NCT00411554|38221977|FG000|Overall Study|Lack of Efficacy|2|||
17080951|NCT00411554|38221978|FG001|Overall Study|Lack of Efficacy|5|||
17080952|NCT00411554|38221977|FG000|Overall Study|Withdrawal by Subject|3|||
17080953|NCT00411554|38221978|FG001|Overall Study|Withdrawal by Subject|0|||
17080954|NCT00411554|38221977|FG000|Overall Study|Patient Moved|1|||
17080955|NCT00411554|38221978|FG001|Overall Study|Patient Moved|0|||
17080956|NCT00400712|38221986|FG000|Overall Study|Death|1|||
17080957|NCT00400712|38221987|FG001|Overall Study|Death|0|||
17080958|NCT00400712|38221986|FG000|Overall Study|Withdrawal by Subject|11|||
17080959|NCT00400712|38221987|FG001|Overall Study|Withdrawal by Subject|12|||
17080960|NCT00400712|38221986|FG000|Overall Study|Physician Decision|5|||
17080961|NCT00400712|38221987|FG001|Overall Study|Physician Decision|4|||
17080962|NCT00380718|38221995|FG000|Overall Study|Adverse Event|1|||
17080963|NCT00380718|38221995|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
17080964|NCT00380250|38222001|FG000|Overall Study|Withdrawal by Subject|39|||
17080965|NCT00380250|38222002|FG001|Overall Study|Withdrawal by Subject|28|||
17080966|NCT00380250|38222001|FG000|Overall Study|Adverse Event|20|||
17080967|NCT00380250|38222002|FG001|Overall Study|Adverse Event|9|||
17080968|NCT00380250|38222001|FG000|Overall Study|Lack of Efficacy|10|||
17080969|NCT00380250|38222002|FG001|Overall Study|Lack of Efficacy|8|||
17080970|NCT00380250|38222001|FG000|Overall Study|Protocol Violation|15|||
17080971|NCT00380250|38222002|FG001|Overall Study|Protocol Violation|5|||
17080972|NCT00380250|38222001|FG000|Overall Study|Lost to Follow-up|14|||
17080973|NCT00380250|38222002|FG001|Overall Study|Lost to Follow-up|5|||
17080974|NCT00380250|38222001|FG000|Overall Study|Physician Decision|1|||
17080975|NCT00380250|38222002|FG001|Overall Study|Physician Decision|0|||
17080976|NCT00400400|38222010|FG000|Overall Study|Adverse Event|9|||
17080977|NCT00400400|38222011|FG001|Overall Study|Adverse Event|8|||
17080978|NCT00400400|38222010|FG000|Overall Study|Protocol Violation|2|||
17080979|NCT00400400|38222011|FG001|Overall Study|Protocol Violation|0|||
17080980|NCT00400400|38222010|FG000|Overall Study|Withdrawal by Subject|1|||
17080981|NCT00400400|38222011|FG001|Overall Study|Withdrawal by Subject|3|||
17080982|NCT00400400|38222010|FG000|Overall Study|Administrative Problem|1|||
17080983|NCT00400400|38222011|FG001|Overall Study|Administrative Problem|0|||
17080984|NCT00400400|38222010|FG000|Overall Study|Lost to Follow-up|0|||
17080985|NCT00400400|38222011|FG001|Overall Study|Lost to Follow-up|1|||
17080986|NCT00400400|38222010|FG000|Overall Study|Did not receive study drug|1|||
17080987|NCT00400400|38222011|FG001|Overall Study|Did not receive study drug|3|||
17080988|NCT00395694|38222019|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
17080989|NCT00395694|38222020|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
17080990|NCT00395694|38222019|FG000|Continuation Phase|Adverse Event|1|||
17080991|NCT00395694|38222020|FG001|Continuation Phase|Adverse Event|0|||
17080992|NCT00395694|38222019|FG000|Continuation Phase|Lack of Efficacy|12|||
17080993|NCT00395694|38222020|FG001|Continuation Phase|Lack of Efficacy|11|||
17080994|NCT00395694|38222019|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
17080995|NCT00395694|38222020|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
17080996|NCT00395694|38222019|FG000|Continuation Phase|Poor Compliance|1|||
17080997|NCT00395694|38222020|FG001|Continuation Phase|Poor Compliance|0|||
17080998|NCT00395694|38222019|FG000|Continuation Phase|Withdrawal by Subject|0|||
17080999|NCT00395694|38222020|FG001|Continuation Phase|Withdrawal by Subject|2|||
17081000|NCT00419744|38222032|FG000|Overall Study|Adverse Event|39|||
17081001|NCT00419744|38222033|FG001|Overall Study|Adverse Event|40|||
17081002|NCT00419744|38222034|FG002|Overall Study|Adverse Event|50|||
17081003|NCT00419744|38222032|FG000|Overall Study|Withdrawal by Subject|45|||
17081004|NCT00419744|38222033|FG001|Overall Study|Withdrawal by Subject|49|||
17081005|NCT00419744|38222034|FG002|Overall Study|Withdrawal by Subject|52|||
17081006|NCT00419744|38222032|FG000|Overall Study|Lost to Follow-up|8|||
17081007|NCT00419744|38222033|FG001|Overall Study|Lost to Follow-up|10|||
17081008|NCT00419744|38222034|FG002|Overall Study|Lost to Follow-up|6|||
17081009|NCT00419744|38222032|FG000|Overall Study|Protocol Violation|4|||
17081010|NCT00419744|38222033|FG001|Overall Study|Protocol Violation|7|||
17081011|NCT00419744|38222034|FG002|Overall Study|Protocol Violation|8|||
17081012|NCT00419744|38222032|FG000|Overall Study|Randomized in error|9|||
17081013|NCT00419744|38222033|FG001|Overall Study|Randomized in error|6|||
17081014|NCT00419744|38222034|FG002|Overall Study|Randomized in error|7|||
17081015|NCT00419744|38222032|FG000|Overall Study|Moving out of state|2|||
17081016|NCT00419744|38222033|FG001|Overall Study|Moving out of state|0|||
17081017|NCT00419744|38222034|FG002|Overall Study|Moving out of state|1|||
17081018|NCT00419744|38222032|FG000|Overall Study|Physician Decision|10|||
17081019|NCT00419744|38222033|FG001|Overall Study|Physician Decision|5|||
17081020|NCT00419744|38222034|FG002|Overall Study|Physician Decision|6|||
17081021|NCT00419744|38222032|FG000|Overall Study|Spirometry mouthpiece issues|0|||
17081022|NCT00419744|38222033|FG001|Overall Study|Spirometry mouthpiece issues|1|||
17081023|NCT00419744|38222034|FG002|Overall Study|Spirometry mouthpiece issues|2|||
17081024|NCT00419744|38222032|FG000|Overall Study|Incorrect medication kit dispensed|0|||
17081025|NCT00419744|38222033|FG001|Overall Study|Incorrect medication kit dispensed|0|||
17081026|NCT00419744|38222034|FG002|Overall Study|Incorrect medication kit dispensed|1|||
17081027|NCT00395538|38222045|FG000|Overall Study|Did not re-consent to revised protocol|1|||
17081028|NCT00395538|38222046|FG001|Overall Study|Did not re-consent to revised protocol|10|||
17081029|NCT00395538|38222047|FG002|Overall Study|Did not re-consent to revised protocol|0|||
17081030|NCT00395538|38222045|FG000|Overall Study|FDA partial hold on PTH|0|||
17081031|NCT00395538|38222046|FG001|Overall Study|FDA partial hold on PTH|0|||
17081032|NCT00395538|38222047|FG002|Overall Study|FDA partial hold on PTH|11|||
17081033|NCT00395538|38222045|FG000|Overall Study|Failed screening|0|||
17081034|NCT00395538|38222046|FG001|Overall Study|Failed screening|0|||
17081035|NCT00395538|38222047|FG002|Overall Study|Failed screening|4|||
17081036|NCT00395538|38222045|FG000|Overall Study|Switch to Natpara|0|||
17081037|NCT00395538|38222046|FG001|Overall Study|Switch to Natpara|0|||
17081038|NCT00395538|38222047|FG002|Overall Study|Switch to Natpara|3|||
17081039|NCT00395538|38222045|FG000|Overall Study|Adverse Event|1|||
17081040|NCT00395538|38222046|FG001|Overall Study|Adverse Event|0|||
17081041|NCT00395538|38222047|FG002|Overall Study|Adverse Event|2|||
17081042|NCT00395538|38222045|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
16995354|NCT01006616|38139053|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
16995355|NCT01006616|38139054|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
16995356|NCT01006616|38139051|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
16995357|NCT01006616|38139052|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
16995358|NCT01006616|38139053|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
16995359|NCT01006616|38139054|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
16995360|NCT01006616|38139051|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
16995361|NCT01006616|38139052|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
16995362|NCT01006616|38139053|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
16995363|NCT01006616|38139054|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
16995364|NCT01006616|38139051|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
16995365|NCT01006616|38139052|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
16995366|NCT01006616|38139053|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
16995367|NCT01006616|38139054|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
17081043|NCT00395538|38222046|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
17081044|NCT00395538|38222047|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
17081045|NCT00395538|38222045|FG000|Overall Study|Non-compliance with study protocol|0|||
17081046|NCT00395538|38222046|FG001|Overall Study|Non-compliance with study protocol|1|||
17081047|NCT00395538|38222047|FG002|Overall Study|Non-compliance with study protocol|0|||
17081048|NCT00395538|38222045|FG000|Overall Study|PTH resistance|0|||
17081049|NCT00395538|38222046|FG001|Overall Study|PTH resistance|0|||
17081050|NCT00395538|38222047|FG002|Overall Study|PTH resistance|1|||
17081051|NCT00395538|38222045|FG000|Overall Study|Pregnancy|1|||
17081052|NCT00395538|38222046|FG001|Overall Study|Pregnancy|0|||
17081053|NCT00395538|38222047|FG002|Overall Study|Pregnancy|0|||
17081054|NCT00395538|38222045|FG000|Overall Study|Partial recovery of parathyroid function|0|||
17081055|NCT00395538|38222046|FG001|Overall Study|Partial recovery of parathyroid function|0|||
17081056|NCT00395538|38222047|FG002|Overall Study|Partial recovery of parathyroid function|1|||
17081057|NCT00395538|38222045|FG000|Overall Study|Participant elected to discontinue|0|||
17081058|NCT00395538|38222046|FG001|Overall Study|Participant elected to discontinue|0|||
17081059|NCT00395538|38222047|FG002|Overall Study|Participant elected to discontinue|1|||
17081060|NCT00395460|38222057|FG000|Overall Study|Withdrawal by Subject|1|||
17081061|NCT00395460|38222058|FG001|Overall Study|Withdrawal by Subject|0|||
17081062|NCT00395304|38222064|FG000|Treatment Period 1|Withdrawal by Subject|0|||
17081063|NCT00395304|38222065|FG001|Treatment Period 1|Withdrawal by Subject|3|||
17081064|NCT00395304|38222066|FG002|Treatment Period 1|Withdrawal by Subject|0|||
17081065|NCT00395304|38222067|FG003|Treatment Period 1|Withdrawal by Subject|2|||
17081066|NCT00395304|38222068|FG004|Treatment Period 1|Withdrawal by Subject|1|||
17081067|NCT00395304|38222069|FG005|Treatment Period 1|Withdrawal by Subject|1|||
17081068|NCT00395304|38222064|FG000|Treatment Period 1|Lost to Follow-up|1|||
17081069|NCT00395304|38222065|FG001|Treatment Period 1|Lost to Follow-up|0|||
17081070|NCT00395304|38222066|FG002|Treatment Period 1|Lost to Follow-up|0|||
17081071|NCT00395304|38222067|FG003|Treatment Period 1|Lost to Follow-up|1|||
17081072|NCT00395304|38222068|FG004|Treatment Period 1|Lost to Follow-up|0|||
17081073|NCT00395304|38222069|FG005|Treatment Period 1|Lost to Follow-up|1|||
17081074|NCT00395304|38222064|FG000|Treatment Period 1|Physician Decision|0|||
17081075|NCT00395304|38222065|FG001|Treatment Period 1|Physician Decision|1|||
17081076|NCT00395304|38222066|FG002|Treatment Period 1|Physician Decision|0|||
17081077|NCT00395304|38222067|FG003|Treatment Period 1|Physician Decision|0|||
17081078|NCT00395304|38222068|FG004|Treatment Period 1|Physician Decision|0|||
17081079|NCT00395304|38222069|FG005|Treatment Period 1|Physician Decision|0|||
17081080|NCT00395304|38222064|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17081081|NCT00395304|38222065|FG001|Treatment Period 2|Withdrawal by Subject|0|||
17081082|NCT00395304|38222066|FG002|Treatment Period 2|Withdrawal by Subject|0|||
17081083|NCT00395304|38222067|FG003|Treatment Period 2|Withdrawal by Subject|1|||
17081084|NCT00395304|38222068|FG004|Treatment Period 2|Withdrawal by Subject|0|||
17081085|NCT00395304|38222069|FG005|Treatment Period 2|Withdrawal by Subject|2|||
17081086|NCT00395304|38222064|FG000|Treatment Period 2|Lost to Follow-up|0|||
17081087|NCT00395304|38222065|FG001|Treatment Period 2|Lost to Follow-up|3|||
17081088|NCT00395304|38222066|FG002|Treatment Period 2|Lost to Follow-up|0|||
17081089|NCT00395304|38222067|FG003|Treatment Period 2|Lost to Follow-up|0|||
17081090|NCT00395304|38222068|FG004|Treatment Period 2|Lost to Follow-up|0|||
17081091|NCT00395304|38222069|FG005|Treatment Period 2|Lost to Follow-up|0|||
17081092|NCT00395304|38222064|FG000|Treatment Period 2|Physician Decision|0|||
17081093|NCT00395304|38222065|FG001|Treatment Period 2|Physician Decision|0|||
17081094|NCT00395304|38222066|FG002|Treatment Period 2|Physician Decision|1|||
17081095|NCT00395304|38222067|FG003|Treatment Period 2|Physician Decision|0|||
17081096|NCT00395304|38222068|FG004|Treatment Period 2|Physician Decision|0|||
17081097|NCT00395304|38222069|FG005|Treatment Period 2|Physician Decision|0|||
17081098|NCT00395304|38222064|FG000|Treatment Period 2|Other|0|||
17081099|NCT00395304|38222065|FG001|Treatment Period 2|Other|1|||
17081100|NCT00395304|38222066|FG002|Treatment Period 2|Other|0|||
17081101|NCT00395304|38222067|FG003|Treatment Period 2|Other|0|||
17081102|NCT00395304|38222068|FG004|Treatment Period 2|Other|0|||
17081103|NCT00395304|38222069|FG005|Treatment Period 2|Other|0|||
17081104|NCT00395304|38222064|FG000|Treatment Period 3|Withdrawal by Subject|0|||
17081105|NCT00395304|38222065|FG001|Treatment Period 3|Withdrawal by Subject|0|||
17081106|NCT00395304|38222066|FG002|Treatment Period 3|Withdrawal by Subject|0|||
17081107|NCT00395304|38222067|FG003|Treatment Period 3|Withdrawal by Subject|1|||
17081108|NCT00395304|38222068|FG004|Treatment Period 3|Withdrawal by Subject|0|||
17081109|NCT00395304|38222069|FG005|Treatment Period 3|Withdrawal by Subject|1|||
17081110|NCT00395304|38222064|FG000|Treatment Period 3|Lost to Follow-up|1|||
17160067|NCT03240133|38307350|FG001|Overall Study|Intercurrent illness.|1|||
17160068|NCT03240133|38307351|FG002|Overall Study|Intercurrent illness.|0|||
17160069|NCT03240133|38307349|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
17160070|NCT03240133|38307350|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
17160071|NCT03240133|38307351|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
17160072|NCT03372083|38307375|FG000|Overall Study|Adverse Event|3|||
17160073|NCT03372083|38307375|FG000|Overall Study|Physician Decision|1|||
17160074|NCT03372083|38307375|FG000|Overall Study|Withdrawal by Subject|1|||
17160075|NCT03044886|38307382|FG000|Overall Study|Lost to Follow-up|15|||
17160076|NCT03044886|38307383|FG001|Overall Study|Lost to Follow-up|10|||
17160077|NCT03044886|38307384|FG002|Overall Study|Lost to Follow-up|12|||
17160078|NCT02961764|38307394|FG000|Overall Study|Protocol Violation|0|||
17160079|NCT02961764|38307395|FG001|Overall Study|Protocol Violation|1|||
17160080|NCT02961764|38307394|FG000|Overall Study|Death|2|||
17160081|NCT02961764|38307395|FG001|Overall Study|Death|0|||
17160082|NCT02961764|38307394|FG000|Overall Study|Lost to Follow-up|35|||
17160083|NCT02961764|38307395|FG001|Overall Study|Lost to Follow-up|24|||
17160084|NCT02961764|38307394|FG000|Overall Study|Withdrawal by Subject|2|||
17160085|NCT02961764|38307395|FG001|Overall Study|Withdrawal by Subject|0|||
17160086|NCT03371459|38307401|FG000|Washout|Lost to Follow-up|0|||
17160087|NCT03371459|38307402|FG001|Washout|Lost to Follow-up|1|||
17081111|NCT00395304|38222065|FG001|Treatment Period 3|Lost to Follow-up|1|||
17081112|NCT00395304|38222066|FG002|Treatment Period 3|Lost to Follow-up|0|||
17081113|NCT00395304|38222067|FG003|Treatment Period 3|Lost to Follow-up|0|||
17081114|NCT00395304|38222068|FG004|Treatment Period 3|Lost to Follow-up|0|||
17081115|NCT00395304|38222069|FG005|Treatment Period 3|Lost to Follow-up|0|||
17081116|NCT00395304|38222064|FG000|Treatment Period 3|Physician Decision|0|||
17081117|NCT00395304|38222065|FG001|Treatment Period 3|Physician Decision|1|||
17081118|NCT00395304|38222066|FG002|Treatment Period 3|Physician Decision|0|||
17081119|NCT00395304|38222067|FG003|Treatment Period 3|Physician Decision|0|||
17160088|NCT02961920|38307410|FG000|Overall Study|did not achive stydy protocol schedule|1|||
17160089|NCT02961920|38307411|FG001|Overall Study|did not achive stydy protocol schedule|1|||
17160090|NCT03371381|38307417|FG000|Overall Study|Death|5|||
17081120|NCT00395304|38222068|FG004|Treatment Period 3|Physician Decision|0|||
17081121|NCT00395304|38222069|FG005|Treatment Period 3|Physician Decision|0|||
17081122|NCT00395304|38222064|FG000|Treatment Period 3|Other|0|||
17081123|NCT00395304|38222065|FG001|Treatment Period 3|Other|0|||
17081124|NCT00395304|38222066|FG002|Treatment Period 3|Other|0|||
17081125|NCT00395304|38222067|FG003|Treatment Period 3|Other|1|||
17081126|NCT00395304|38222068|FG004|Treatment Period 3|Other|0|||
17081127|NCT00395304|38222069|FG005|Treatment Period 3|Other|0|||
17081128|NCT00395226|38222078|FG000|Overall Study|Adverse Event|4|||
17081129|NCT00395226|38222079|FG001|Overall Study|Adverse Event|3|||
17081130|NCT00395226|38222078|FG000|Overall Study|Withdrawal by Subject|0|||
17081131|NCT00395226|38222079|FG001|Overall Study|Withdrawal by Subject|1|||
17081132|NCT00395226|38222078|FG000|Overall Study|Lost to Follow-up|0|||
17081133|NCT00395226|38222079|FG001|Overall Study|Lost to Follow-up|1|||
17081134|NCT00394914|38222087|FG000|Treatment Period|Adverse Event|0|||
17081135|NCT00394914|38222088|FG001|Treatment Period|Adverse Event|3|||
17081136|NCT00394914|38222089|FG002|Treatment Period|Adverse Event|1|||
17081137|NCT00394914|38222087|FG000|Treatment Period|Lost to Follow-up|0|||
17081138|NCT00394914|38222088|FG001|Treatment Period|Lost to Follow-up|1|||
17081139|NCT00394914|38222089|FG002|Treatment Period|Lost to Follow-up|0|||
16995368|NCT01006616|38139051|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
16995369|NCT01006616|38139052|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
16995370|NCT01006616|38139053|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
16995371|NCT01006616|38139054|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
16995372|NCT01006616|38139051|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
16995373|NCT01006616|38139052|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
16995374|NCT01006616|38139053|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
16995375|NCT01006616|38139054|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
16995376|NCT01006616|38139051|FG000|Period 2 (18 Months)|Study Terminated|63|||
16995377|NCT01006616|38139052|FG001|Period 2 (18 Months)|Study Terminated|46|||
16995378|NCT01006616|38139053|FG002|Period 2 (18 Months)|Study Terminated|44|||
16995379|NCT01006616|38139054|FG003|Period 2 (18 Months)|Study Terminated|70|||
16995380|NCT00996632|38139066|FG000|Overall Study|Physician Decision|0|||
16995381|NCT00996632|38139067|FG001|Overall Study|Physician Decision|0|||
16995382|NCT01025843|38139083|FG000|Washout 4|Withdrawal by Subject|0|||
16995383|NCT01025843|38139084|FG001|Washout 4|Withdrawal by Subject|0|||
16995384|NCT01025843|38139085|FG002|Washout 4|Withdrawal by Subject|1|||
16995385|NCT01025843|38139086|FG003|Washout 4|Withdrawal by Subject|1|||
16995386|NCT01025843|38139087|FG004|Washout 4|Withdrawal by Subject|0|||
16995387|NCT01025843|38139088|FG005|Washout 4|Withdrawal by Subject|0|||
16995388|NCT01025843|38139089|FG006|Washout 4|Withdrawal by Subject|0|||
16995389|NCT01025843|38139090|FG007|Washout 4|Withdrawal by Subject|0|||
16995390|NCT01025843|38139091|FG008|Washout 4|Withdrawal by Subject|0|||
16995391|NCT01025843|38139092|FG009|Washout 4|Withdrawal by Subject|0|||
16995392|NCT01036763|38139120|FG000|Overall Study|Adverse Event|25|||
16995393|NCT01036763|38139120|FG000|Overall Study|Lost to Follow-up|28|||
16995394|NCT01036763|38139120|FG000|Overall Study|Other reason (not specified)|40|||
16995395|NCT01021007|38139126|FG000|Overall Study|Lost to Follow-up|1|||
16995396|NCT01021007|38139127|FG001|Overall Study|Lost to Follow-up|1|||
16995397|NCT01021007|38139126|FG000|Overall Study|Adverse Event|1|||
16995398|NCT01021007|38139127|FG001|Overall Study|Adverse Event|3|||
16995399|NCT01020773|38139135|FG000|Overall Study|Withdrawal by Subject|4|||
16995400|NCT01020773|38139136|FG001|Overall Study|Withdrawal by Subject|3|||
16995401|NCT01020305|38139142|FG000|Overall Study|Adverse Event|2|||
16995402|NCT01036529|38139148|FG000|Overall Study|Adverse Event|0|||
16995403|NCT01036529|38139149|FG001|Overall Study|Adverse Event|1|||
16995404|NCT01036529|38139148|FG000|Overall Study|Lost to Follow-up|0|||
16995405|NCT01036529|38139149|FG001|Overall Study|Lost to Follow-up|1|||
16995406|NCT01036529|38139148|FG000|Overall Study|Physician Decision|1|||
16995407|NCT01036529|38139149|FG001|Overall Study|Physician Decision|0|||
16995408|NCT01036529|38139148|FG000|Overall Study|Withdrawal by Subject|1|||
16995409|NCT01036529|38139149|FG001|Overall Study|Withdrawal by Subject|1|||
16995410|NCT01036529|38139148|FG000|Overall Study|Sponsor study termination|11|||
16995411|NCT01036529|38139149|FG001|Overall Study|Sponsor study termination|12|||
16995412|NCT01024751|38139157|FG000|Enrolled Participants|Ineligible at baseline|3|||
16995413|NCT01024751|38139158|FG001|Enrolled Participants|Ineligible at baseline|4|||
16995414|NCT01024751|38139157|FG000|Eligible Participants|Withdrawal by Subject|0|||
16995415|NCT01024751|38139158|FG001|Eligible Participants|Withdrawal by Subject|1|||
16995416|NCT01024751|38139157|FG000|Eligible Participants|Lost to Follow-up|0|||
16995417|NCT01024751|38139158|FG001|Eligible Participants|Lost to Follow-up|1|||
16995418|NCT01024751|38139157|FG000|Eligible Participants|Ineligible|0|||
16995419|NCT01024751|38139158|FG001|Eligible Participants|Ineligible|1|||
16995420|NCT01019369|38139166|FG000|Overall Study|Lost to Follow-up|10|||
16995421|NCT01019369|38139167|FG001|Overall Study|Lost to Follow-up|6|||
16995422|NCT01019369|38139166|FG000|Overall Study|Withdrawal by Subject|0|||
16995423|NCT01019369|38139167|FG001|Overall Study|Withdrawal by Subject|1|||
16995424|NCT01019135|38139177|FG000|Overall Study|Did not receive allocated intervention|12|||
16995425|NCT01019135|38139178|FG001|Overall Study|Did not receive allocated intervention|6|||
16995426|NCT01019135|38139179|FG002|Overall Study|Did not receive allocated intervention|25|||
16995427|NCT01019135|38139177|FG000|Overall Study|Did not attend CR|8|||
16995428|NCT01019135|38139178|FG001|Overall Study|Did not attend CR|13|||
16995429|NCT01019135|38139179|FG002|Overall Study|Did not attend CR|6|||
16995430|NCT01018979|38139189|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
16995431|NCT01018979|38139190|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
16995432|NCT01018979|38139189|FG000|Overall Study|Not received at least one dose|0|||
17081140|NCT00394914|38222087|FG000|Treatment Period|Withdrawal by Subject|0|||
16995433|NCT01018979|38139190|FG001|Overall Study|Not received at least one dose|1|||
16995434|NCT01572493|38139208|FG000|Overall Study|Physician Decision|1|||
16995435|NCT01572493|38139209|FG001|Overall Study|Physician Decision|0|||
16995436|NCT01572493|38139210|FG002|Overall Study|Physician Decision|0|||
16995437|NCT01572493|38139211|FG003|Overall Study|Physician Decision|0|||
16995438|NCT01572493|38139212|FG004|Overall Study|Physician Decision|0|||
16995439|NCT01572493|38139213|FG005|Overall Study|Physician Decision|0|||
16995440|NCT01572493|38139214|FG006|Overall Study|Physician Decision|0|||
16995441|NCT01572493|38139215|FG007|Overall Study|Physician Decision|0|||
17081141|NCT00394914|38222088|FG001|Treatment Period|Withdrawal by Subject|2|||
17081142|NCT00394914|38222089|FG002|Treatment Period|Withdrawal by Subject|2|||
17081143|NCT00394914|38222087|FG000|Treatment Period|Noncompliance with protocol|0|||
17081144|NCT00394914|38222088|FG001|Treatment Period|Noncompliance with protocol|3|||
17081145|NCT00394914|38222089|FG002|Treatment Period|Noncompliance with protocol|2|||
17081146|NCT00394914|38222087|FG000|Treatment Period|Did not meet protocol eligibility|0|||
17081147|NCT00394914|38222088|FG001|Treatment Period|Did not meet protocol eligibility|1|||
17081148|NCT00394914|38222089|FG002|Treatment Period|Did not meet protocol eligibility|1|||
17081149|NCT00366444|38222097|FG000|Overall Study|Withdrawal by Subject|1|||
17081150|NCT00366444|38222098|FG001|Overall Study|Withdrawal by Subject|1|||
17081151|NCT00366444|38222097|FG000|Overall Study|Lack of Efficacy|0|||
17081152|NCT00366444|38222098|FG001|Overall Study|Lack of Efficacy|1|||
17081153|NCT00365976|38222106|FG000|Overall Study|Withdrawal by Subject|1|||
17081154|NCT00365976|38222107|FG001|Overall Study|Withdrawal by Subject|5|||
17081155|NCT00379236|38222115|FG000|Double-blind|Adverse Event|11|||
17081156|NCT00379236|38222116|FG001|Double-blind|Adverse Event|6|||
17081157|NCT00379236|38222117|FG002|Double-blind|Adverse Event|0|||
17081158|NCT00379236|38222115|FG000|Double-blind|Protocol Violation|3|||
17081159|NCT00379236|38222116|FG001|Double-blind|Protocol Violation|3|||
17081160|NCT00379236|38222117|FG002|Double-blind|Protocol Violation|0|||
17081161|NCT00379236|38222115|FG000|Double-blind|Withdrawal by Subject|12|||
17081162|NCT00379236|38222116|FG001|Double-blind|Withdrawal by Subject|13|||
17081163|NCT00379236|38222117|FG002|Double-blind|Withdrawal by Subject|0|||
17081164|NCT00379236|38222115|FG000|Double-blind|Lost to Follow-up|4|||
17081165|NCT00379236|38222116|FG001|Double-blind|Lost to Follow-up|3|||
17081166|NCT00379236|38222117|FG002|Double-blind|Lost to Follow-up|0|||
17081167|NCT00379236|38222115|FG000|Double-blind|Use of exclusionary medication|1|||
17081168|NCT00379236|38222116|FG001|Double-blind|Use of exclusionary medication|2|||
17081169|NCT00379236|38222117|FG002|Double-blind|Use of exclusionary medication|0|||
17081170|NCT00379236|38222115|FG000|Double-blind|Other|3|||
17081171|NCT00379236|38222116|FG001|Double-blind|Other|7|||
17081172|NCT00379236|38222117|FG002|Double-blind|Other|0|||
17081173|NCT00379236|38222115|FG000|Double-blind|Data could not be retrieved|2|||
17081174|NCT00379236|38222116|FG001|Double-blind|Data could not be retrieved|2|||
17081175|NCT00379236|38222117|FG002|Double-blind|Data could not be retrieved|0|||
17081176|NCT00379236|38222115|FG000|Open-label Extension|Adverse Event|0|||
17081177|NCT00379236|38222116|FG001|Open-label Extension|Adverse Event|0|||
17081178|NCT00379236|38222117|FG002|Open-label Extension|Adverse Event|13|||
17081179|NCT00379236|38222115|FG000|Open-label Extension|Protocol Violation|0|||
17081180|NCT00379236|38222116|FG001|Open-label Extension|Protocol Violation|0|||
17081181|NCT00379236|38222117|FG002|Open-label Extension|Protocol Violation|7|||
17081182|NCT00379236|38222115|FG000|Open-label Extension|Withdrawal by Subject|0|||
17081183|NCT00379236|38222116|FG001|Open-label Extension|Withdrawal by Subject|0|||
16995442|NCT01572493|38139216|FG008|Overall Study|Physician Decision|0|||
16995443|NCT01572493|38139208|FG000|Overall Study|Switched to alternative treatment|0|||
16995444|NCT01572493|38139209|FG001|Overall Study|Switched to alternative treatment|1|||
16995445|NCT01572493|38139210|FG002|Overall Study|Switched to alternative treatment|2|||
17081184|NCT00379236|38222117|FG002|Open-label Extension|Withdrawal by Subject|13|||
17081185|NCT00379236|38222115|FG000|Open-label Extension|Lost to Follow-up|0|||
17081186|NCT00379236|38222116|FG001|Open-label Extension|Lost to Follow-up|0|||
17081187|NCT00379236|38222117|FG002|Open-label Extension|Lost to Follow-up|12|||
17081188|NCT00379236|38222115|FG000|Open-label Extension|Use of exclusionary medication|0|||
17081189|NCT00379236|38222116|FG001|Open-label Extension|Use of exclusionary medication|0|||
17081190|NCT00379236|38222117|FG002|Open-label Extension|Use of exclusionary medication|3|||
17160091|NCT03371381|38307417|FG000|Overall Study|Study terminated by sponsor|3|||
17160092|NCT03371381|38307417|FG000|Overall Study|Other|4|||
17160093|NCT03044730|38307421|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
17160094|NCT03044730|38307421|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
17160095|NCT03044730|38307421|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
17160096|NCT03044730|38307421|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
16995446|NCT01572493|38139211|FG003|Overall Study|Switched to alternative treatment|1|||
16995447|NCT01572493|38139212|FG004|Overall Study|Switched to alternative treatment|2|||
16995448|NCT01572493|38139213|FG005|Overall Study|Switched to alternative treatment|0|||
16995449|NCT01572493|38139214|FG006|Overall Study|Switched to alternative treatment|2|||
16995450|NCT01572493|38139215|FG007|Overall Study|Switched to alternative treatment|0|||
16995451|NCT01572493|38139216|FG008|Overall Study|Switched to alternative treatment|2|||
17081191|NCT00379236|38222115|FG000|Open-label Extension|Other|0|||
17081192|NCT00379236|38222116|FG001|Open-label Extension|Other|0|||
17081193|NCT00379236|38222117|FG002|Open-label Extension|Other|7|||
17081194|NCT00379080|38222132|FG000|Overall Study|Withdrawal by Subject|0|||
17081195|NCT00379080|38222133|FG001|Overall Study|Withdrawal by Subject|4|||
17081196|NCT00379080|38222134|FG002|Overall Study|Withdrawal by Subject|0|||
17081197|NCT00378534|38222159|FG000|Overall Study|Participants did not receive transplant|3|||
17081198|NCT00378534|38222160|FG001|Overall Study|Participants did not receive transplant|0|||
17160097|NCT03044730|38307421|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
17160098|NCT03044730|38307421|FG000|Cycles 4 and Beyond|Adverse Event|1|||
17160099|NCT03044730|38307421|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
17160100|NCT03044730|38307421|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
17160101|NCT03044730|38307421|FG000|On Follow-up for 2 Years|Death|17|||
17160102|NCT02961374|38307426|FG000|Overall Study|Adverse Event|4|||
17160103|NCT02951429|38307432|FG000|Overall Study|Adverse Event|3|||
17160104|NCT02951429|38307433|FG001|Overall Study|Adverse Event|7|||
17160105|NCT02951429|38307432|FG000|Overall Study|Death|28|||
17160106|NCT02951429|38307433|FG001|Overall Study|Death|36|||
17160107|NCT02951429|38307432|FG000|Overall Study|Lack of Efficacy|0|||
17160108|NCT02951429|38307433|FG001|Overall Study|Lack of Efficacy|1|||
17160109|NCT02951429|38307432|FG000|Overall Study|Lost to Follow-up|0|||
17160110|NCT02951429|38307433|FG001|Overall Study|Lost to Follow-up|1|||
17160111|NCT02951429|38307432|FG000|Overall Study|Lung Transplantation|9|||
17160112|NCT02951429|38307433|FG001|Overall Study|Lung Transplantation|6|||
17160113|NCT02951429|38307432|FG000|Overall Study|Other|1|||
17160114|NCT02951429|38307433|FG001|Overall Study|Other|3|||
17160115|NCT02951429|38307432|FG000|Overall Study|Progressive Disease|1|||
17160116|NCT02951429|38307433|FG001|Overall Study|Progressive Disease|1|||
17160117|NCT02951429|38307432|FG000|Overall Study|Withdrawal by Subject|7|||
17160118|NCT02951429|38307433|FG001|Overall Study|Withdrawal by Subject|11|||
17160119|NCT02951429|38307432|FG000|Overall Study|Participant ongoing in the study|23|||
17160120|NCT02951429|38307433|FG001|Overall Study|Participant ongoing in the study|17|||
17160121|NCT03343067|38307446|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
17160122|NCT03343067|38307447|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
17160123|NCT03343067|38307448|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
17160124|NCT03103503|38307456|FG000|Overall Study|Death|64|||
17160125|NCT03103503|38307456|FG000|Overall Study|Physician Decision|57|||
17160126|NCT03103503|38307456|FG000|Overall Study|Withdrawal by Subject|10|||
17160127|NCT03103503|38307456|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
17160128|NCT03103503|38307456|FG000|Overall Study|Lost to Follow-up|3|||
17160129|NCT03103503|38307456|FG000|Overall Study|Study Closure|757|||
17160130|NCT02961218|38307462|FG000|Overall Study|Lost to Follow-up|0|||
17160131|NCT02961218|38307463|FG001|Overall Study|Lost to Follow-up|2|||
17160132|NCT02961218|38307462|FG000|Overall Study|Physician Decision|0|||
17160133|NCT02961218|38307463|FG001|Overall Study|Physician Decision|2|||
17160134|NCT02961218|38307462|FG000|Overall Study|Subject/Guardian Decision|3|||
17160135|NCT02961218|38307463|FG001|Overall Study|Subject/Guardian Decision|1|||
17160136|NCT02949947|38307473|FG000|Overall Study|Non Compliance|0|||
17160137|NCT02949947|38307474|FG001|Overall Study|Non Compliance|1|||
17160138|NCT02949947|38307473|FG000|Overall Study|Insurance change|1|||
17160139|NCT02949947|38307474|FG001|Overall Study|Insurance change|0|||
17160140|NCT03341507|38307480|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
17160141|NCT03341273|38307486|FG000|Overall Study|Lost to Follow-up|7|||
17160142|NCT03341273|38307487|FG001|Overall Study|Lost to Follow-up|7|||
17160143|NCT03341273|38307486|FG000|Overall Study|Withdrawal by Subject|4|||
17160144|NCT03341273|38307487|FG001|Overall Study|Withdrawal by Subject|2|||
17160145|NCT03341273|38307486|FG000|Overall Study|Physician Decision|1|||
17160146|NCT03341273|38307487|FG001|Overall Study|Physician Decision|0|||
17160147|NCT03341273|38307486|FG000|Overall Study|Protocol Violation|0|||
17160148|NCT03341273|38307487|FG001|Overall Study|Protocol Violation|1|||
17160149|NCT03341273|38307486|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
17160150|NCT03341273|38307487|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
17160151|NCT03341273|38307486|FG000|Overall Study|Became ineligible after enrollment|1|||
17160152|NCT03341273|38307487|FG001|Overall Study|Became ineligible after enrollment|0|||
17160153|NCT03341273|38307486|FG000|Overall Study|Not Eligible at Enrollment|0|||
17160154|NCT03341273|38307487|FG001|Overall Study|Not Eligible at Enrollment|1|||
17160155|NCT03341273|38307486|FG000|Overall Study|Participant incarcerated|1|||
17160156|NCT03341273|38307487|FG001|Overall Study|Participant incarcerated|0|||
17160157|NCT01345058|38307495|FG000|Overall Study|Withdrawal by Subject|1|||
17160158|NCT01345058|38307496|FG001|Overall Study|Withdrawal by Subject|0|||
17160159|NCT01345058|38307495|FG000|Overall Study|Participant Reported Increase in Events|1|||
17160160|NCT01345058|38307496|FG001|Overall Study|Participant Reported Increase in Events|0|||
17160161|NCT01345058|38307495|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
17160162|NCT01345058|38307496|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
17160163|NCT01345058|38307495|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
17160164|NCT01345058|38307496|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
17160165|NCT01345058|38307495|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
17160166|NCT01345058|38307496|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
17160167|NCT01345292|38307505|FG000|Overall Study|Withdrawal by Subject|2|||
17160168|NCT01345292|38307506|FG001|Overall Study|Withdrawal by Subject|0|||
17160169|NCT01345292|38307507|FG002|Overall Study|Withdrawal by Subject|1|||
17160170|NCT03340961|38307519|FG000|Overall Study|Adverse Event|1|||
17160171|NCT03340961|38307520|FG001|Overall Study|Adverse Event|3|||
17160172|NCT03340961|38307521|FG002|Overall Study|Adverse Event|2|||
17160173|NCT03340961|38307522|FG003|Overall Study|Adverse Event|4|||
17160174|NCT03340961|38307519|FG000|Overall Study|Lost to Follow-up|0|||
17160175|NCT03340961|38307520|FG001|Overall Study|Lost to Follow-up|1|||
17160176|NCT03340961|38307521|FG002|Overall Study|Lost to Follow-up|0|||
17160177|NCT03340961|38307522|FG003|Overall Study|Lost to Follow-up|1|||
17160178|NCT03340961|38307519|FG000|Overall Study|Withdrawal by Subject|3|||
17160179|NCT03340961|38307520|FG001|Overall Study|Withdrawal by Subject|2|||
17160180|NCT03340961|38307521|FG002|Overall Study|Withdrawal by Subject|4|||
17160181|NCT03340961|38307522|FG003|Overall Study|Withdrawal by Subject|7|||
17160182|NCT03340961|38307519|FG000|Overall Study|Use of prohibited treatment|0|||
17160183|NCT03340961|38307520|FG001|Overall Study|Use of prohibited treatment|3|||
17160184|NCT03340961|38307521|FG002|Overall Study|Use of prohibited treatment|2|||
17160185|NCT03340961|38307522|FG003|Overall Study|Use of prohibited treatment|4|||
17160186|NCT03340961|38307519|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
17160187|NCT03340961|38307520|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
17160188|NCT03340961|38307521|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
17160189|NCT03340961|38307522|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
17160190|NCT03340961|38307519|FG000|Overall Study|Subject developed an exclusion criterion|0|||
17160191|NCT03340961|38307520|FG001|Overall Study|Subject developed an exclusion criterion|1|||
17160192|NCT03340961|38307521|FG002|Overall Study|Subject developed an exclusion criterion|0|||
17160193|NCT03340961|38307522|FG003|Overall Study|Subject developed an exclusion criterion|0|||
17160194|NCT03340961|38307519|FG000|Overall Study|Protocol Violation|1|||
17160195|NCT03340961|38307520|FG001|Overall Study|Protocol Violation|0|||
17160196|NCT03340961|38307521|FG002|Overall Study|Protocol Violation|1|||
17160197|NCT03340961|38307522|FG003|Overall Study|Protocol Violation|0|||
17160198|NCT03340961|38307519|FG000|Overall Study|Adverse Event|1|||
17160199|NCT03340961|38307520|FG001|Overall Study|Adverse Event|1|||
17160200|NCT03340961|38307521|FG002|Overall Study|Adverse Event|0|||
17160201|NCT03340961|38307522|FG003|Overall Study|Adverse Event|0|||
17160202|NCT03340961|38307519|FG000|Overall Study|Lack of Efficacy|0|||
17160203|NCT03340961|38307520|FG001|Overall Study|Lack of Efficacy|0|||
17160204|NCT03340961|38307521|FG002|Overall Study|Lack of Efficacy|0|||
17160205|NCT03340961|38307522|FG003|Overall Study|Lack of Efficacy|1|||
17160206|NCT03340025|38307534|FG000|Overall Study|Lost to Follow-up|2|||
17160207|NCT03340025|38307535|FG001|Overall Study|Lost to Follow-up|2|||
17160208|NCT03339713|38307543|FG000|Overall Study|Lost to Follow-up|2|||
17160209|NCT03339713|38307544|FG001|Overall Study|Lost to Follow-up|1|||
17160210|NCT03339713|38307543|FG000|Overall Study|Protocol Violation|1|||
17160211|NCT03339713|38307544|FG001|Overall Study|Protocol Violation|0|||
17160212|NCT03339713|38307543|FG000|Overall Study|Withdrawal by Subject|1|||
17160213|NCT03339713|38307544|FG001|Overall Study|Withdrawal by Subject|1|||
17160214|NCT03254485|38307556|FG000|Overall Study|Adverse Event|3|||
17160215|NCT03254485|38307557|FG001|Overall Study|Adverse Event|0|||
17160216|NCT03254485|38307558|FG002|Overall Study|Adverse Event|0|||
17160217|NCT03254485|38307559|FG003|Overall Study|Adverse Event|6|||
17160218|NCT03254485|38307556|FG000|Overall Study|Protocol Violation|6|||
17160219|NCT03254485|38307557|FG001|Overall Study|Protocol Violation|0|||
17160220|NCT03254485|38307558|FG002|Overall Study|Protocol Violation|0|||
17160221|NCT03254485|38307559|FG003|Overall Study|Protocol Violation|2|||
17160222|NCT03254485|38307556|FG000|Overall Study|Withdrawal by Subject|1|||
17160223|NCT03254485|38307557|FG001|Overall Study|Withdrawal by Subject|0|||
17160224|NCT03254485|38307558|FG002|Overall Study|Withdrawal by Subject|0|||
17160225|NCT03254485|38307559|FG003|Overall Study|Withdrawal by Subject|4|||
17160226|NCT03254485|38307556|FG000|Overall Study|Death|0|||
17160227|NCT03254485|38307557|FG001|Overall Study|Death|0|||
17160228|NCT03254485|38307558|FG002|Overall Study|Death|0|||
17160229|NCT03254485|38307559|FG003|Overall Study|Death|1|||
17160230|NCT03254485|38307556|FG000|Overall Study|Lost to Follow-up|1|||
17160231|NCT03254485|38307557|FG001|Overall Study|Lost to Follow-up|0|||
17160232|NCT03254485|38307558|FG002|Overall Study|Lost to Follow-up|0|||
17160233|NCT03254485|38307559|FG003|Overall Study|Lost to Follow-up|0|||
17160234|NCT03254485|38307556|FG000|Overall Study|Other|1|||
17160235|NCT03254485|38307557|FG001|Overall Study|Other|0|||
17081199|NCT00377676|38222167|FG000|Overall Study|Adverse Event|498|||
17081200|NCT00377676|38222168|FG001|Overall Study|Adverse Event|107|||
17081201|NCT00377676|38222167|FG000|Overall Study|Protocol Violation|33|||
17081202|NCT00377676|38222168|FG001|Overall Study|Protocol Violation|27|||
17081203|NCT00377676|38222167|FG000|Overall Study|Death|5|||
17081204|NCT00377676|38222168|FG001|Overall Study|Death|2|||
17081205|NCT00377676|38222167|FG000|Overall Study|Withdrawal by Subject|187|||
17160236|NCT03254485|38307558|FG002|Overall Study|Other|0|||
17160237|NCT03254485|38307559|FG003|Overall Study|Other|2|||
17160238|NCT03339401|38307582|FG000|Overall Study|Death|2|||
17160239|NCT03339401|38307583|FG001|Overall Study|Death|1|||
17160240|NCT03339401|38307582|FG000|Overall Study|Withdrawal by Subject|2|||
17160241|NCT03339401|38307583|FG001|Overall Study|Withdrawal by Subject|0|||
17081206|NCT00377676|38222168|FG001|Overall Study|Withdrawal by Subject|72|||
17081207|NCT00377676|38222167|FG000|Overall Study|Lost to Follow-up|120|||
17160242|NCT03339401|38307582|FG000|Overall Study|Study terminated|4|||
17160243|NCT03339401|38307583|FG001|Overall Study|Study terminated|3|||
17160244|NCT03339401|38307582|FG000|Overall Study|Investigator Decision|1|||
17160245|NCT03339401|38307583|FG001|Overall Study|Investigator Decision|0|||
17160246|NCT03370289|38307589|FG000|Overall Study|Screen Failure|1|||
17160247|NCT03370289|38307589|FG000|Overall Study|Sample Size Sufficient|4|||
17160248|NCT01344824|38307593|FG000|Overall Study|Adverse Event|15|||
17160249|NCT01344824|38307593|FG000|Overall Study|Withdrawal by Subject|6|||
17160250|NCT01344824|38307593|FG000|Overall Study|Other complicating disease|1|||
17160251|NCT01344824|38307593|FG000|Overall Study|Progression|15|||
17160252|NCT03339245|38307600|FG000|Overall Study|Adverse Event|1|||
17160253|NCT03339245|38307601|FG001|Overall Study|Adverse Event|1|||
17081208|NCT00377676|38222168|FG001|Overall Study|Lost to Follow-up|56|||
17081209|NCT00377676|38222167|FG000|Overall Study|Other|118|||
17081210|NCT00377676|38222168|FG001|Overall Study|Other|58|||
17081211|NCT00377520|38222174|FG000|Overall Study|Ineligible (Prior radiation)|1|||
17081212|NCT00377364|38222180|FG000|Overall Study|Lost to Follow-up|1|||
17081213|NCT00377364|38222181|FG001|Overall Study|Lost to Follow-up|0|||
17160254|NCT03339245|38307600|FG000|Overall Study|Withdrawal by Subject|1|||
17160255|NCT03339245|38307601|FG001|Overall Study|Withdrawal by Subject|0|||
17160256|NCT03044574|38307609|FG000|Overall Study|Lost to Follow-up|37|||
17160257|NCT03044574|38307610|FG001|Overall Study|Lost to Follow-up|45|||
17160258|NCT02959892|38307618|FG000|Overall Study|PET tracer synthesis failure|1|||
17160259|NCT02959892|38307619|FG001|Overall Study|PET tracer synthesis failure|0|||
17160260|NCT02959892|38307618|FG000|Overall Study|Study termination|0|||
17160261|NCT02959892|38307619|FG001|Overall Study|Study termination|1|||
17160262|NCT03252145|38307627|FG000|Overall Study|Withdrawal by Subject|1|||
17081214|NCT00377364|38222180|FG000|Overall Study|Withdrawal by Subject|1|||
17081215|NCT00377364|38222181|FG001|Overall Study|Withdrawal by Subject|0|||
17081216|NCT03831282|38222189|FG000|Overall Study|Could not place sensor|1|||
17081217|NCT00365508|38222195|FG000|Overall Study|Lost to Follow-up|139|||
17081218|NCT00365508|38222196|FG001|Overall Study|Lost to Follow-up|154|||
17081219|NCT00365352|38222205|FG000|Overall Study|Adverse Event|6|||
17081220|NCT00365352|38222206|FG001|Overall Study|Adverse Event|7|||
17081221|NCT00365352|38222207|FG002|Overall Study|Adverse Event|8|||
17081222|NCT00365352|38222205|FG000|Overall Study|Participant Withdrew Consent|8|||
17081223|NCT00365352|38222206|FG001|Overall Study|Participant Withdrew Consent|3|||
17081224|NCT00365352|38222207|FG002|Overall Study|Participant Withdrew Consent|4|||
17081225|NCT00365352|38222205|FG000|Overall Study|Lack of Efficacy|3|||
17081226|NCT00365352|38222206|FG001|Overall Study|Lack of Efficacy|0|||
17081227|NCT00365352|38222207|FG002|Overall Study|Lack of Efficacy|0|||
17081228|NCT00365352|38222205|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
17081229|NCT00365352|38222206|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
17081230|NCT00365352|38222207|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
17081231|NCT00365352|38222205|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
17081232|NCT00365352|38222206|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
17081233|NCT00365352|38222207|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
17081234|NCT00365352|38222205|FG000|Overall Study|Lost to Follow-up|1|||
17081235|NCT00365352|38222206|FG001|Overall Study|Lost to Follow-up|1|||
17081236|NCT00365352|38222207|FG002|Overall Study|Lost to Follow-up|0|||
17081237|NCT00365352|38222205|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
17081238|NCT00365352|38222206|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
17081239|NCT00365352|38222207|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
17081240|NCT00376506|38222220|FG000|Overall Study|Death|0|||
17081241|NCT00376506|38222221|FG001|Overall Study|Death|2|||
17081242|NCT00410384|38222233|FG000|Overall Study|Withdrawal by Subject|28|||
17081243|NCT00410384|38222234|FG001|Overall Study|Withdrawal by Subject|17|||
17081244|NCT00410384|38222235|FG002|Overall Study|Withdrawal by Subject|20|||
17081245|NCT00410384|38222233|FG000|Overall Study|Adverse Event|23|||
17081246|NCT00410384|38222234|FG001|Overall Study|Adverse Event|18|||
17081247|NCT00410384|38222235|FG002|Overall Study|Adverse Event|23|||
17081248|NCT00410384|38222233|FG000|Overall Study|Lack of Efficacy|20|||
17081249|NCT00410384|38222234|FG001|Overall Study|Lack of Efficacy|12|||
17081250|NCT00410384|38222235|FG002|Overall Study|Lack of Efficacy|17|||
17081251|NCT00410384|38222233|FG000|Overall Study|Lack of Compliance|2|||
17081252|NCT00410384|38222234|FG001|Overall Study|Lack of Compliance|2|||
17081253|NCT00410384|38222235|FG002|Overall Study|Lack of Compliance|2|||
17160263|NCT03252145|38307628|FG001|Overall Study|Withdrawal by Subject|0|||
17160264|NCT03252145|38307627|FG000|Overall Study|Complicating Disease|1|||
17081254|NCT00410384|38222233|FG000|Overall Study|Lost to Follow-up|4|||
17081255|NCT00410384|38222234|FG001|Overall Study|Lost to Follow-up|6|||
17081256|NCT00410384|38222235|FG002|Overall Study|Lost to Follow-up|6|||
17081257|NCT00410384|38222233|FG000|Overall Study|Protocol Violation|6|||
17081258|NCT00410384|38222234|FG001|Overall Study|Protocol Violation|6|||
17081259|NCT00410384|38222235|FG002|Overall Study|Protocol Violation|6|||
17081260|NCT00410384|38222233|FG000|Overall Study|Physician Decision|3|||
17081261|NCT00410384|38222234|FG001|Overall Study|Physician Decision|3|||
17160265|NCT03252145|38307628|FG001|Overall Study|Complicating Disease|2|||
17160266|NCT02959814|38307634|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
17160267|NCT02959814|38307634|FG000|Overall Study|Excluded based on anatomical criteria|2|||
17160268|NCT02959814|38307634|FG000|Overall Study|Protocol Violation|7|||
16995452|NCT01572493|38139208|FG000|Overall Study|Death|0|||
16995453|NCT01572493|38139209|FG001|Overall Study|Death|0|||
16995454|NCT01572493|38139210|FG002|Overall Study|Death|0|||
16995455|NCT01572493|38139211|FG003|Overall Study|Death|1|||
17081262|NCT00410384|38222235|FG002|Overall Study|Physician Decision|4|||
17160269|NCT02959814|38307634|FG000|Overall Study|FFR not measured|2|||
17160270|NCT02959814|38307634|FG000|Overall Study|In-procedure QFR not computed|6|||
17160271|NCT02959814|38307634|FG000|Overall Study|Excluded by FFR core-lab|24|||
17160272|NCT03666624|38307641|FG000|Overall Study|participant grieving over recent death of parent|1|||
17160273|NCT03666624|38307642|FG001|Overall Study|participant grieving over recent death of parent|0|||
17160274|NCT03368807|38307648|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
17160275|NCT03368807|38307648|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
17160276|NCT03368807|38307648|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
17160277|NCT03368807|38307648|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
17160278|NCT03338855|38307656|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
17160279|NCT03338855|38307657|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
17160280|NCT03367793|38307669|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
17160281|NCT03367793|38307670|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
17160282|NCT03367793|38307671|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
17160283|NCT03367793|38307672|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
17160284|NCT03367793|38307673|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
17160285|NCT03367793|38307674|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
17160286|NCT01347307|38307696|FG000|Overall Study|Death|0|||
17160287|NCT01347307|38307697|FG001|Overall Study|Death|4|||
17160288|NCT01347307|38307696|FG000|Overall Study|Physician Decision|0|||
17160289|NCT01347307|38307697|FG001|Overall Study|Physician Decision|1|||
17160290|NCT03247543|38307737|FG000|Overall Study|Adverse Event|3|||
17160291|NCT03247543|38307738|FG001|Overall Study|Adverse Event|6|||
17160292|NCT03247543|38307739|FG002|Overall Study|Adverse Event|4|||
17160293|NCT03247543|38307737|FG000|Overall Study|Lost to Follow-up|10|||
17160294|NCT03247543|38307738|FG001|Overall Study|Lost to Follow-up|7|||
17160295|NCT03247543|38307739|FG002|Overall Study|Lost to Follow-up|8|||
17160296|NCT03247543|38307737|FG000|Overall Study|Consent withdrawn by caregiver|2|||
17160297|NCT03247543|38307738|FG001|Overall Study|Consent withdrawn by caregiver|2|||
17160298|NCT03247543|38307739|FG002|Overall Study|Consent withdrawn by caregiver|9|||
17160299|NCT03247543|38307737|FG000|Overall Study|Withdrawal by Subject|0|||
17160300|NCT03247543|38307738|FG001|Overall Study|Withdrawal by Subject|0|||
17160301|NCT03247543|38307739|FG002|Overall Study|Withdrawal by Subject|1|||
17160302|NCT03247543|38307737|FG000|Overall Study|Failure to Follow study procedures|1|||
17160303|NCT03247543|38307738|FG001|Overall Study|Failure to Follow study procedures|3|||
17160304|NCT03247543|38307739|FG002|Overall Study|Failure to Follow study procedures|1|||
17160305|NCT03247543|38307737|FG000|Overall Study|Lack of Efficacy|1|||
17160306|NCT03247543|38307738|FG001|Overall Study|Lack of Efficacy|0|||
17160307|NCT03247543|38307739|FG002|Overall Study|Lack of Efficacy|0|||
17160308|NCT03247543|38307737|FG000|Overall Study|Non-compliance with study visits|0|||
17160309|NCT03247543|38307738|FG001|Overall Study|Non-compliance with study visits|1|||
17160310|NCT03247543|38307739|FG002|Overall Study|Non-compliance with study visits|0|||
17081263|NCT00410384|38222233|FG000|Overall Study|Other|3|||
17081264|NCT00410384|38222234|FG001|Overall Study|Other|8|||
17081265|NCT00410384|38222235|FG002|Overall Study|Other|4|||
17081266|NCT00370032|38222245|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
17081267|NCT00370032|38222246|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
17081268|NCT00370032|38222245|FG000|Washout Period|Withdrawal by Subject|0|||
17081269|NCT00370032|38222246|FG001|Washout Period|Withdrawal by Subject|1|||
17081270|NCT00370032|38222245|FG000|Washout Period|Lost to Follow-up|0|||
17081271|NCT00370032|38222246|FG001|Washout Period|Lost to Follow-up|1|||
17081272|NCT00370032|38222245|FG000|Washout Period|Adverse Event|1|||
17160311|NCT01347073|38307749|FG000|Overall Study|Adverse Event|1|||
17160312|NCT01347073|38307749|FG000|Overall Study|Liver Transplant|1|||
17160313|NCT03246061|38307761|FG000|Overall Study|Still in follow-up|15|||
17160314|NCT03246061|38307762|FG001|Overall Study|Still in follow-up|21|||
17160315|NCT01315236|38307772|FG000|Double-blind Phase|Death|1|||
17160316|NCT01315236|38307773|FG001|Double-blind Phase|Death|0|||
17160317|NCT01315236|38307772|FG000|Double-blind Phase|Adverse Event|1|||
17160318|NCT01315236|38307773|FG001|Double-blind Phase|Adverse Event|0|||
17160319|NCT01315236|38307772|FG000|Double-blind Phase|Withdrawal of Consent|1|||
17160320|NCT01315236|38307773|FG001|Double-blind Phase|Withdrawal of Consent|0|||
17160321|NCT01315236|38307772|FG000|Double-blind Phase|Lost to Follow-up|1|||
16995456|NCT01572493|38139212|FG004|Overall Study|Death|0|||
16995457|NCT01572493|38139213|FG005|Overall Study|Death|1|||
17081273|NCT00370032|38222246|FG001|Washout Period|Adverse Event|0|||
17081274|NCT00370032|38222245|FG000|Follow-up Period|Withdrawal by Subject|1|||
17160322|NCT01315236|38307773|FG001|Double-blind Phase|Lost to Follow-up|0|||
17160323|NCT01315236|38307772|FG000|Open-label Phase|Death|1|||
17160324|NCT01315236|38307773|FG001|Open-label Phase|Death|0|||
17160325|NCT01315236|38307772|FG000|Open-label Phase|Adverse Event|0|||
17160326|NCT01315236|38307773|FG001|Open-label Phase|Adverse Event|1|||
17160327|NCT01315236|38307772|FG000|Open-label Phase|Other|0|||
17160328|NCT01315236|38307773|FG001|Open-label Phase|Other|1|||
17160329|NCT01315236|38307772|FG000|12-Month Follow-up Period|Death|0|||
17160330|NCT01315236|38307773|FG001|12-Month Follow-up Period|Death|1|||
17160331|NCT01315236|38307772|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
17160332|NCT01315236|38307773|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
17160333|NCT03232567|38307785|FG000|Overall Study|Withdrawal by Subject|0|||
17160334|NCT03232567|38307786|FG001|Overall Study|Withdrawal by Subject|1|||
17160335|NCT03232567|38307787|FG002|Overall Study|Withdrawal by Subject|0|||
17160336|NCT03232567|38307788|FG003|Overall Study|Withdrawal by Subject|0|||
17160337|NCT01348490|38307809|FG000|Overall Study|Death|1|||
17160338|NCT01348490|38307809|FG000|Overall Study|Adverse Event|3|||
17160339|NCT01348490|38307809|FG000|Overall Study|Consent withdrawn|7|||
17160340|NCT01348490|38307809|FG000|Overall Study|Disease progression|3|||
17160341|NCT01348490|38307809|FG000|Overall Study|Lost to Follow-up|1|||
17160342|NCT01348490|38307809|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
17160343|NCT01348490|38307809|FG000|Overall Study|Other Unspecified|8|||
17160344|NCT03040674|38307830|FG000|Overall Study|Lost to Follow-up|225|||
17160345|NCT03040674|38307830|FG000|Overall Study|Death|23|||
17160346|NCT03232333|38307835|FG000|Overall Study|Infection or Osteomyelitis|9|||
17160347|NCT03232333|38307835|FG000|Overall Study|Lost to Follow-up|4|||
17160348|NCT03232333|38307835|FG000|Overall Study|Withdrawal by Subject|2|||
17160349|NCT03364049|38307843|FG000|Overall Study|Death|6|||
17160350|NCT03364049|38307844|FG001|Overall Study|Death|4|||
17081275|NCT00370032|38222246|FG001|Follow-up Period|Withdrawal by Subject|0|||
17081276|NCT00410072|38222263|FG000|Day 1 to Week 48|Adverse Event|1|||
17160351|NCT03364049|38307845|FG002|Overall Study|Death|5|||
17160352|NCT03364049|38307846|FG003|Overall Study|Death|14|||
17160353|NCT03364049|38307843|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
17160354|NCT03364049|38307844|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
17160355|NCT03364049|38307845|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
17160356|NCT03364049|38307846|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
17160357|NCT03364049|38307843|FG000|Overall Study|Withdrawal by Subject|0|||
17160358|NCT03364049|38307844|FG001|Overall Study|Withdrawal by Subject|1|||
17160359|NCT03364049|38307845|FG002|Overall Study|Withdrawal by Subject|1|||
17160360|NCT03364049|38307846|FG003|Overall Study|Withdrawal by Subject|1|||
17160361|NCT03238963|38307858|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
17160362|NCT03238963|38307859|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
17160363|NCT03238963|38307858|FG000|Overall Study|Withdrawal by Subject|1|||
17081277|NCT00410072|38222264|FG001|Day 1 to Week 48|Adverse Event|2|||
17081278|NCT00410072|38222263|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
17081279|NCT00410072|38222264|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
17081280|NCT00410072|38222263|FG000|Day 1 to Week 48|Other|0|||
17160364|NCT03238963|38307859|FG001|Overall Study|Withdrawal by Subject|1|||
17160365|NCT03238963|38307858|FG000|Overall Study|Lost to Follow-up|1|||
17160366|NCT03238963|38307859|FG001|Overall Study|Lost to Follow-up|0|||
17160367|NCT03238963|38307858|FG000|Overall Study|Protocol Violation|1|||
17160368|NCT03238963|38307859|FG001|Overall Study|Protocol Violation|1|||
17160369|NCT03238963|38307858|FG000|Overall Study|Adverse Event|1|||
17160370|NCT03238963|38307859|FG001|Overall Study|Adverse Event|0|||
17160371|NCT03337139|38307867|FG000|Phase I|Withdrawal by Subject|10|||
17160372|NCT03337139|38307868|FG001|Phase I|Withdrawal by Subject|0|||
17160373|NCT03042312|38307876|FG000|Overall Study|Administrative Reason|1|||
17160374|NCT03042312|38307877|FG001|Overall Study|Administrative Reason|1|||
17160375|NCT03042312|38307876|FG000|Overall Study|Adverse Event|0|||
17160376|NCT03042312|38307877|FG001|Overall Study|Adverse Event|1|||
17081281|NCT00410072|38222264|FG001|Day 1 to Week 48|Other|1|||
17081282|NCT00410072|38222263|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
17081283|NCT00410072|38222264|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
17081284|NCT00410072|38222263|FG000|Day 1 to Week 48|Pregnancy|0|||
17160377|NCT03042312|38307876|FG000|Overall Study|Lost to Follow-up|1|||
17160378|NCT03042312|38307877|FG001|Overall Study|Lost to Follow-up|3|||
17160379|NCT03042312|38307876|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
17160380|NCT03042312|38307877|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
17160381|NCT03042312|38307876|FG000|Overall Study|Withdrawal by Subject|4|||
17160382|NCT03042312|38307877|FG001|Overall Study|Withdrawal by Subject|5|||
17160383|NCT03360071|38307885|FG000|Overall Study|Lost to Follow-up|1|||
17081285|NCT00410072|38222264|FG001|Day 1 to Week 48|Pregnancy|2|||
17081286|NCT00410072|38222263|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
17160384|NCT03360071|38307886|FG001|Overall Study|Lost to Follow-up|0|||
17160385|NCT02949011|38307895|FG000|Overall Study|Adverse Event|6|||
17160386|NCT02949011|38307896|FG001|Overall Study|Adverse Event|7|||
17160387|NCT02949011|38307897|FG002|Overall Study|Adverse Event|3|||
17160388|NCT02949011|38307895|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
17160389|NCT02949011|38307896|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
17160390|NCT02949011|38307897|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
17160391|NCT02949011|38307895|FG000|Overall Study|Protocol Deviation|5|||
17160392|NCT02949011|38307896|FG001|Overall Study|Protocol Deviation|3|||
17160393|NCT02949011|38307897|FG002|Overall Study|Protocol Deviation|3|||
17160394|NCT02949011|38307895|FG000|Overall Study|Lack of Efficacy|0|||
17160395|NCT02949011|38307896|FG001|Overall Study|Lack of Efficacy|2|||
17160396|NCT02949011|38307897|FG002|Overall Study|Lack of Efficacy|0|||
17160397|NCT02949011|38307895|FG000|Overall Study|Withdrawal by Subject|13|||
17160398|NCT02949011|38307896|FG001|Overall Study|Withdrawal by Subject|13|||
17160399|NCT02949011|38307897|FG002|Overall Study|Withdrawal by Subject|21|||
17160400|NCT02949011|38307895|FG000|Overall Study|Lost to Follow-up|7|||
17160401|NCT02949011|38307896|FG001|Overall Study|Lost to Follow-up|5|||
17160402|NCT02949011|38307897|FG002|Overall Study|Lost to Follow-up|5|||
17160403|NCT02949011|38307895|FG000|Overall Study|Death|0|||
17160404|NCT02949011|38307896|FG001|Overall Study|Death|0|||
17160405|NCT02949011|38307897|FG002|Overall Study|Death|1|||
17160406|NCT02949011|38307895|FG000|Overall Study|Miscellaneous|2|||
17160407|NCT02949011|38307896|FG001|Overall Study|Miscellaneous|4|||
17160408|NCT02949011|38307897|FG002|Overall Study|Miscellaneous|6|||
17160409|NCT03357731|38307909|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
17160410|NCT03357731|38307910|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
17160411|NCT03357731|38307911|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
17160412|NCT03357731|38307912|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
17160413|NCT03357731|38307913|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
17160414|NCT03357731|38307914|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
17160415|NCT03357731|38307909|FG000|Overall Study|Acute bradycardia and hypotension|0|||
17160416|NCT03357731|38307910|FG001|Overall Study|Acute bradycardia and hypotension|0|||
17160417|NCT03357731|38307911|FG002|Overall Study|Acute bradycardia and hypotension|0|||
17160418|NCT03357731|38307912|FG003|Overall Study|Acute bradycardia and hypotension|1|||
17160419|NCT03357731|38307913|FG004|Overall Study|Acute bradycardia and hypotension|0|||
17160420|NCT03357731|38307914|FG005|Overall Study|Acute bradycardia and hypotension|0|||
17160421|NCT03357731|38307909|FG000|Overall Study|Adverse Event|0|||
17160422|NCT03357731|38307910|FG001|Overall Study|Adverse Event|0|||
17160423|NCT03357731|38307911|FG002|Overall Study|Adverse Event|0|||
17160424|NCT03357731|38307912|FG003|Overall Study|Adverse Event|0|||
17081287|NCT00410072|38222264|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
17081288|NCT00410072|38222263|FG000|After Week 48 to Week 96|Adverse Event|1|||
17081289|NCT00410072|38222264|FG001|After Week 48 to Week 96|Adverse Event|2|||
17081290|NCT00410072|38222263|FG000|After Week 48 to Week 96|Death|0|||
17081291|NCT00410072|38222264|FG001|After Week 48 to Week 96|Death|1|||
17081292|NCT00410072|38222263|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
17081293|NCT00410072|38222264|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
17081294|NCT00410072|38222263|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
17081295|NCT00410072|38222264|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
17081296|NCT00410072|38222263|FG000|After Week 48 to Week 96|Other|2|||
17160425|NCT03357731|38307913|FG004|Overall Study|Adverse Event|0|||
17160426|NCT03357731|38307914|FG005|Overall Study|Adverse Event|1|||
17160427|NCT03357731|38307909|FG000|Overall Study|Hypotension|0|||
17160428|NCT03357731|38307910|FG001|Overall Study|Hypotension|0|||
17160429|NCT03357731|38307911|FG002|Overall Study|Hypotension|1|||
17160430|NCT03357731|38307912|FG003|Overall Study|Hypotension|1|||
17160431|NCT03357731|38307913|FG004|Overall Study|Hypotension|0|||
17160432|NCT03357731|38307914|FG005|Overall Study|Hypotension|0|||
17160433|NCT03357731|38307909|FG000|Overall Study|Lost to Follow-up|0|||
17160434|NCT03357731|38307910|FG001|Overall Study|Lost to Follow-up|0|||
17160435|NCT03357731|38307911|FG002|Overall Study|Lost to Follow-up|0|||
17160436|NCT03357731|38307912|FG003|Overall Study|Lost to Follow-up|1|||
17160437|NCT03357731|38307913|FG004|Overall Study|Lost to Follow-up|0|||
17160438|NCT03357731|38307914|FG005|Overall Study|Lost to Follow-up|0|||
17160439|NCT03357341|38307924|FG000|Overall Study|Withdrawal by Subject|3|||
17160440|NCT03357341|38307925|FG001|Overall Study|Withdrawal by Subject|6|||
17160441|NCT03357341|38307924|FG000|Overall Study|Lost to Follow-up|4|||
17160442|NCT03357341|38307925|FG001|Overall Study|Lost to Follow-up|5|||
17160443|NCT03357341|38307924|FG000|Overall Study|Death|0|||
17160444|NCT03357341|38307925|FG001|Overall Study|Death|1|||
17160445|NCT03039738|38307934|FG000|Overall Study|Incomplete data sets|54|||
17160446|NCT03039738|38307935|FG001|Overall Study|Incomplete data sets|0|||
17160447|NCT02946515|38307952|FG000|Overall Study|Lost to Follow-up|2|||
17160448|NCT02946515|38307953|FG001|Overall Study|Lost to Follow-up|1|||
17160449|NCT03036852|38307965|FG000|Overall Study|Death|2|||
17160450|NCT03036852|38307965|FG000|Overall Study|Lack of Efficacy|2|||
17160451|NCT03036852|38307965|FG000|Overall Study|Adverse Event|1|||
17160452|NCT03036852|38307965|FG000|Overall Study|Lost to Follow-up|1|||
17160453|NCT02945657|38307976|FG000|Overall Study|Adverse Event|1|||
17160454|NCT02945657|38307976|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
17160455|NCT02948777|38307981|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
17160456|NCT03324581|38307989|FG000|Overall Study|Adverse Event|18|||
17160457|NCT03324581|38307990|FG001|Overall Study|Adverse Event|11|||
17160458|NCT03324581|38307991|FG002|Overall Study|Adverse Event|7|||
17160459|NCT03324581|38307989|FG000|Overall Study|Lack of Efficacy|0|||
17081297|NCT00410072|38222264|FG001|After Week 48 to Week 96|Other|0|||
17081298|NCT00410072|38222263|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
17081299|NCT00410072|38222264|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
17081300|NCT00410072|38222263|FG000|After Week 48 to Week 96|Pregnancy|0|||
17081301|NCT00410072|38222264|FG001|After Week 48 to Week 96|Pregnancy|2|||
17081302|NCT00410072|38222263|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
17160460|NCT03324581|38307990|FG001|Overall Study|Lack of Efficacy|1|||
17160461|NCT03324581|38307991|FG002|Overall Study|Lack of Efficacy|0|||
17160462|NCT03324581|38307989|FG000|Overall Study|Lost to Follow-up|5|||
17160463|NCT03324581|38307990|FG001|Overall Study|Lost to Follow-up|3|||
17160464|NCT03324581|38307991|FG002|Overall Study|Lost to Follow-up|6|||
17160465|NCT03324581|38307989|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
17160466|NCT03324581|38307990|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
17160467|NCT03324581|38307991|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
17160468|NCT03324581|38307989|FG000|Overall Study|Physician Decision|0|||
17160469|NCT03324581|38307990|FG001|Overall Study|Physician Decision|1|||
17160470|NCT03324581|38307991|FG002|Overall Study|Physician Decision|2|||
17160471|NCT03324581|38307989|FG000|Overall Study|Protocol Deviation|8|||
17160472|NCT03324581|38307990|FG001|Overall Study|Protocol Deviation|9|||
17160473|NCT03324581|38307991|FG002|Overall Study|Protocol Deviation|4|||
17160474|NCT03324581|38307989|FG000|Overall Study|Withdrawal by Subject|6|||
17160475|NCT03324581|38307990|FG001|Overall Study|Withdrawal by Subject|8|||
17160476|NCT03324581|38307991|FG002|Overall Study|Withdrawal by Subject|6|||
17160477|NCT03324581|38307989|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
17160478|NCT03324581|38307990|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
17160479|NCT03324581|38307991|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
17160480|NCT02943473|38307999|FG000|Overall Study|enrolled but not dosed|1|||
17160481|NCT02943473|38307999|FG000|Overall Study|screen failure|1|||
17160482|NCT02943473|38307999|FG000|Overall Study|Physician Decision|4|||
17160483|NCT03073733|38308006|FG000|Overall Study|Lost to Follow-up|1|||
17160484|NCT03073733|38308007|FG001|Overall Study|Lost to Follow-up|0|||
17160485|NCT03073733|38308008|FG002|Overall Study|Lost to Follow-up|0|||
17160486|NCT03073733|38308006|FG000|Overall Study|Physician Decision|0|||
17160487|NCT03073733|38308007|FG001|Overall Study|Physician Decision|1|||
17160488|NCT03073733|38308008|FG002|Overall Study|Physician Decision|0|||
17160489|NCT03073733|38308006|FG000|Overall Study|Withdrawal by Subject|0|||
17160490|NCT03073733|38308007|FG001|Overall Study|Withdrawal by Subject|0|||
17160491|NCT03073733|38308008|FG002|Overall Study|Withdrawal by Subject|1|||
17160492|NCT03320369|38308018|FG000|Overall Study|Adverse Event|1|||
17160493|NCT03320369|38308018|FG000|Overall Study|Withdrawal by Subject|2|||
17160494|NCT02650895|38308028|FG000|Overall Study|Withdrawal by Subject|0|||
17160495|NCT02650895|38308029|FG001|Overall Study|Withdrawal by Subject|1|||
17160496|NCT02650895|38308030|FG002|Overall Study|Withdrawal by Subject|0|||
17160497|NCT02650895|38308031|FG003|Overall Study|Withdrawal by Subject|0|||
17160498|NCT02650895|38308032|FG004|Overall Study|Withdrawal by Subject|0|||
17160499|NCT02650895|38308033|FG005|Overall Study|Withdrawal by Subject|0|||
17160500|NCT03320057|38308052|FG000|Overall Study|Lost to Follow-up|4|||
17160501|NCT03320057|38308053|FG001|Overall Study|Lost to Follow-up|17|||
17160502|NCT03320057|38308052|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
17160503|NCT03320057|38308053|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
17160504|NCT03316547|38308061|FG000|Overall Study|Death|3|||
17160505|NCT03316547|38308062|FG001|Overall Study|Death|1|||
17160506|NCT03316547|38308061|FG000|Overall Study|Lost to Follow-up|6|||
17160507|NCT03316547|38308062|FG001|Overall Study|Lost to Follow-up|6|||
17160508|NCT03316547|38308061|FG000|Overall Study|Withdrawal by Subject|3|||
17160509|NCT03316547|38308062|FG001|Overall Study|Withdrawal by Subject|2|||
17160510|NCT03316547|38308061|FG000|Overall Study|Transfer to another hospital|6|||
17160511|NCT03316547|38308062|FG001|Overall Study|Transfer to another hospital|4|||
17160512|NCT02227199|38308086|FG000|Overall Study|Physician Decision|0|||
17160513|NCT02227199|38308087|FG001|Overall Study|Physician Decision|0|||
17160514|NCT02227199|38308088|FG002|Overall Study|Physician Decision|1|||
17081303|NCT00410072|38222264|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
17081304|NCT00409838|38222272|FG000|Short-term Period|Adverse Event|0|||
17081305|NCT00409838|38222273|FG001|Short-term Period|Adverse Event|1|||
17081306|NCT00409838|38222272|FG000|Short-term Period|Lost to Follow-up|0|||
17081307|NCT00409838|38222273|FG001|Short-term Period|Lost to Follow-up|1|||
17081308|NCT00409838|38222272|FG000|Short-term Period|Withdrawal by Subject|2|||
17160515|NCT02227199|38308086|FG000|Overall Study|Adverse Event|0|||
17160516|NCT02227199|38308087|FG001|Overall Study|Adverse Event|0|||
17160517|NCT02227199|38308088|FG002|Overall Study|Adverse Event|3|||
17160518|NCT03315689|38308102|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
17160519|NCT03315689|38308103|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
17160520|NCT03315689|38308102|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
17160521|NCT03315689|38308103|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
17160522|NCT03315689|38308102|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
17081309|NCT00409838|38222273|FG001|Short-term Period|Withdrawal by Subject|3|||
17081310|NCT00409838|38222272|FG000|Short-term Period|Never Treated|1|||
17081311|NCT00409838|38222273|FG001|Short-term Period|Never Treated|0|||
17081312|NCT00409838|38222272|FG000|Long-term Extension Period|Adverse Event|10|||
17081313|NCT00409838|38222273|FG001|Long-term Extension Period|Adverse Event|0|||
17081314|NCT00409838|38222272|FG000|Long-term Extension Period|Death|1|||
17081315|NCT00409838|38222273|FG001|Long-term Extension Period|Death|0|||
17081316|NCT00409838|38222272|FG000|Long-term Extension Period|Lack of Efficacy|2|||
17081317|NCT00409838|38222273|FG001|Long-term Extension Period|Lack of Efficacy|0|||
17081318|NCT00409838|38222272|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
17081319|NCT00409838|38222273|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
17081320|NCT00409838|38222272|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
17081321|NCT00409838|38222273|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
17081322|NCT00409838|38222272|FG000|Long-term Extension Period|Pregnancy|1|||
17081323|NCT00409838|38222273|FG001|Long-term Extension Period|Pregnancy|0|||
17081324|NCT00399542|38222298|FG000|Overall Study|Adverse Event|18|||
17081325|NCT00399542|38222299|FG001|Overall Study|Adverse Event|15|||
17081326|NCT00399542|38222298|FG000|Overall Study|Protocol Violation|13|||
17081327|NCT00399542|38222299|FG001|Overall Study|Protocol Violation|3|||
17160523|NCT03315689|38308103|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
17160524|NCT03314519|38308113|FG000|Overall Study|Protocol Violation|3|||
17160525|NCT03314519|38308114|FG001|Overall Study|Protocol Violation|2|||
17160526|NCT03313037|38308126|FG000|Overall Study|Protocol Violation|4|||
17160527|NCT03313037|38308127|FG001|Overall Study|Protocol Violation|1|||
17160528|NCT03313037|38308126|FG000|Overall Study|Other|1|||
17160529|NCT03313037|38308127|FG001|Overall Study|Other|1|||
17160530|NCT03313037|38308126|FG000|Overall Study|Withdrawal by Subject|4|||
17160531|NCT03313037|38308127|FG001|Overall Study|Withdrawal by Subject|3|||
17160532|NCT03313037|38308126|FG000|Overall Study|No longer meets eligibility criteria|1|||
17160533|NCT03313037|38308127|FG001|Overall Study|No longer meets eligibility criteria|7|||
17160534|NCT03313037|38308126|FG000|Overall Study|Lost to Follow-up|9|||
17160535|NCT03313037|38308127|FG001|Overall Study|Lost to Follow-up|8|||
17160536|NCT03313037|38308126|FG000|Overall Study|Randomized but not treated|1|||
17160537|NCT03313037|38308127|FG001|Overall Study|Randomized but not treated|0|||
17160538|NCT02420795|38308136|FG000|Overall Study|Withdrawal by Subject|1|||
17160539|NCT02420795|38308137|FG001|Overall Study|Withdrawal by Subject|0|||
17160540|NCT02420795|38308138|FG002|Overall Study|Withdrawal by Subject|0|||
17160541|NCT02420795|38308136|FG000|Overall Study|Adverse Event|1|||
17160542|NCT02420795|38308137|FG001|Overall Study|Adverse Event|0|||
17160543|NCT02420795|38308138|FG002|Overall Study|Adverse Event|0|||
17160544|NCT02420795|38308136|FG000|Overall Study|Progressive disease|2|||
17160545|NCT02420795|38308137|FG001|Overall Study|Progressive disease|2|||
17160546|NCT02420795|38308138|FG002|Overall Study|Progressive disease|4|||
17160547|NCT02420795|38308136|FG000|Overall Study|Death|0|||
17160548|NCT02420795|38308137|FG001|Overall Study|Death|0|||
17160549|NCT02420795|38308138|FG002|Overall Study|Death|1|||
17160550|NCT03334175|38308150|FG000|Overall Study|Lost to Follow-up|0|||
17160551|NCT03334175|38308151|FG001|Overall Study|Lost to Follow-up|1|||
17160552|NCT03333941|38308157|FG000|Overall Study|Lost to Follow-up|10|||
17160553|NCT03333941|38308157|FG000|Overall Study|Death|2|||
17160554|NCT03333941|38308157|FG000|Overall Study|Adverse Event|1|||
17160555|NCT02942771|38308166|FG000|Overall Study|Adverse Event|1|||
17160556|NCT02942771|38308167|FG001|Overall Study|Adverse Event|0|||
17160557|NCT02942771|38308168|FG002|Overall Study|Adverse Event|0|||
17160558|NCT02942771|38308169|FG003|Overall Study|Adverse Event|0|||
17160559|NCT02942771|38308170|FG004|Overall Study|Adverse Event|2|||
17160560|NCT02942771|38308166|FG000|Overall Study|Lost to Follow-up|1|||
17160561|NCT02942771|38308167|FG001|Overall Study|Lost to Follow-up|0|||
17160562|NCT02942771|38308168|FG002|Overall Study|Lost to Follow-up|0|||
17160563|NCT02942771|38308169|FG003|Overall Study|Lost to Follow-up|0|||
17160564|NCT02942771|38308170|FG004|Overall Study|Lost to Follow-up|0|||
17160565|NCT02942771|38308166|FG000|Overall Study|Withdrawal by Subject|1|||
17160566|NCT02942771|38308167|FG001|Overall Study|Withdrawal by Subject|0|||
17160567|NCT02942771|38308168|FG002|Overall Study|Withdrawal by Subject|0|||
17160568|NCT02942771|38308169|FG003|Overall Study|Withdrawal by Subject|0|||
17160569|NCT02942771|38308170|FG004|Overall Study|Withdrawal by Subject|2|||
17081328|NCT00399542|38222298|FG000|Overall Study|Withdrawal by Subject|28|||
17160570|NCT03036150|38308184|FG000|Overall Study|Withdrawal by Subject|8|||
17160571|NCT03036150|38308185|FG001|Overall Study|Withdrawal by Subject|3|||
17081329|NCT00399542|38222299|FG001|Overall Study|Withdrawal by Subject|10|||
17081330|NCT00399542|38222298|FG000|Overall Study|Lack of Efficacy|18|||
17081331|NCT00399542|38222299|FG001|Overall Study|Lack of Efficacy|8|||
17081332|NCT00399542|38222298|FG000|Overall Study|Lost to Follow-up|6|||
17081333|NCT00399542|38222299|FG001|Overall Study|Lost to Follow-up|6|||
17081334|NCT00399542|38222298|FG000|Overall Study|Other|1|||
17081335|NCT00399542|38222299|FG001|Overall Study|Other|0|||
17081336|NCT00399542|38222298|FG000|Overall Study|Physician Decision|0|||
17081337|NCT00399542|38222299|FG001|Overall Study|Physician Decision|1|||
17081338|NCT00409682|38222308|FG000|Open-label Induction Period|Adverse Event|1|||
17081339|NCT00409682|38222309|FG001|Open-label Induction Period|Adverse Event|0|||
17081340|NCT00409682|38222310|FG002|Open-label Induction Period|Adverse Event|0|||
17081341|NCT00409682|38222308|FG000|Open-label Induction Period|Lack of Efficacy|1|||
17081342|NCT00409682|38222309|FG001|Open-label Induction Period|Lack of Efficacy|0|||
17081343|NCT00409682|38222310|FG002|Open-label Induction Period|Lack of Efficacy|0|||
17081344|NCT00409682|38222308|FG000|Open-label Induction Period|Protocol Violation|1|||
17081345|NCT00409682|38222309|FG001|Open-label Induction Period|Protocol Violation|0|||
17081346|NCT00409682|38222310|FG002|Open-label Induction Period|Protocol Violation|0|||
17081347|NCT00409682|38222308|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
17081348|NCT00409682|38222309|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
17081349|NCT00409682|38222310|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
17081350|NCT00409682|38222308|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
17081351|NCT00409682|38222309|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
17081352|NCT00409682|38222310|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
17081353|NCT00409682|38222308|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
17081354|NCT00409682|38222309|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
17081355|NCT00409682|38222310|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
17081356|NCT00409682|38222308|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
17081357|NCT00409682|38222309|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
17081358|NCT00409682|38222310|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
17081359|NCT00409682|38222308|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
17081360|NCT00409682|38222309|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
17081361|NCT00409682|38222310|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
17081362|NCT00409682|38222308|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
17081363|NCT00409682|38222309|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
17081364|NCT00409682|38222310|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
17081365|NCT00409682|38222308|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
17081366|NCT00409682|38222309|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
17081367|NCT00409682|38222310|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
17081368|NCT00398216|38222322|FG000|Overall Study|Adverse Event|4|||
17081369|NCT00398216|38222323|FG001|Overall Study|Adverse Event|2|||
17081370|NCT00398216|38222324|FG002|Overall Study|Adverse Event|5|||
17081371|NCT00398216|38222325|FG003|Overall Study|Adverse Event|7|||
17081372|NCT00398216|38222326|FG004|Overall Study|Adverse Event|2|||
17081373|NCT00398216|38222322|FG000|Overall Study|Protocol Violation|2|||
17081374|NCT00398216|38222323|FG001|Overall Study|Protocol Violation|4|||
17081375|NCT00398216|38222324|FG002|Overall Study|Protocol Violation|5|||
17081376|NCT00398216|38222325|FG003|Overall Study|Protocol Violation|7|||
17081377|NCT00398216|38222326|FG004|Overall Study|Protocol Violation|5|||
17081378|NCT00398216|38222322|FG000|Overall Study|Lost to Follow-up|1|||
17081379|NCT00398216|38222323|FG001|Overall Study|Lost to Follow-up|6|||
17081380|NCT00398216|38222324|FG002|Overall Study|Lost to Follow-up|4|||
17081381|NCT00398216|38222325|FG003|Overall Study|Lost to Follow-up|4|||
17081382|NCT00398216|38222326|FG004|Overall Study|Lost to Follow-up|1|||
17081383|NCT00398216|38222322|FG000|Overall Study|Death|0|||
17081384|NCT00398216|38222323|FG001|Overall Study|Death|3|||
17081385|NCT00398216|38222324|FG002|Overall Study|Death|0|||
17081386|NCT00398216|38222325|FG003|Overall Study|Death|0|||
17081387|NCT00398216|38222326|FG004|Overall Study|Death|0|||
17081388|NCT00398216|38222322|FG000|Overall Study|Withdrawal by Subject|1|||
17081389|NCT00398216|38222323|FG001|Overall Study|Withdrawal by Subject|0|||
17081390|NCT00398216|38222324|FG002|Overall Study|Withdrawal by Subject|3|||
17081391|NCT00398216|38222325|FG003|Overall Study|Withdrawal by Subject|1|||
17081392|NCT00398216|38222326|FG004|Overall Study|Withdrawal by Subject|2|||
16995458|NCT01572493|38139214|FG006|Overall Study|Death|0|||
16995459|NCT01572493|38139215|FG007|Overall Study|Death|0|||
16995460|NCT01572493|38139216|FG008|Overall Study|Death|0|||
16995461|NCT01572493|38139208|FG000|Overall Study|Adverse Event|0|||
16995462|NCT01572493|38139209|FG001|Overall Study|Adverse Event|0|||
16995463|NCT01572493|38139210|FG002|Overall Study|Adverse Event|0|||
16995464|NCT01572493|38139211|FG003|Overall Study|Adverse Event|0|||
16995465|NCT01572493|38139212|FG004|Overall Study|Adverse Event|0|||
16995466|NCT01572493|38139213|FG005|Overall Study|Adverse Event|0|||
17160572|NCT03036150|38308184|FG000|Overall Study|Lost to Follow-up|2|||
17160573|NCT03036150|38308185|FG001|Overall Study|Lost to Follow-up|2|||
17160574|NCT03332771|38308195|FG000|Overall Study|Adverse Event|6|||
17160575|NCT03332771|38308196|FG001|Overall Study|Adverse Event|4|||
17160576|NCT03332771|38308197|FG002|Overall Study|Adverse Event|1|||
17160577|NCT03332771|38308198|FG003|Overall Study|Adverse Event|3|||
17160578|NCT03332771|38308195|FG000|Overall Study|Poor Compliance to Protocol|0|||
17160579|NCT03332771|38308196|FG001|Overall Study|Poor Compliance to Protocol|1|||
17160580|NCT03332771|38308197|FG002|Overall Study|Poor Compliance to Protocol|0|||
17160581|NCT03332771|38308198|FG003|Overall Study|Poor Compliance to Protocol|1|||
17160582|NCT03332771|38308195|FG000|Overall Study|Lost to Follow-up|2|||
17160583|NCT03332771|38308196|FG001|Overall Study|Lost to Follow-up|2|||
17160584|NCT03332771|38308197|FG002|Overall Study|Lost to Follow-up|1|||
17160585|NCT03332771|38308198|FG003|Overall Study|Lost to Follow-up|2|||
17160586|NCT03332771|38308195|FG000|Overall Study|At the Participant's own request|20|||
17160587|NCT03332771|38308196|FG001|Overall Study|At the Participant's own request|26|||
17160588|NCT03332771|38308197|FG002|Overall Study|At the Participant's own request|14|||
17160589|NCT03332771|38308198|FG003|Overall Study|At the Participant's own request|23|||
17160590|NCT03332771|38308195|FG000|Overall Study|Reason Not Specified|6|||
17160591|NCT03332771|38308196|FG001|Overall Study|Reason Not Specified|18|||
17160592|NCT03332771|38308197|FG002|Overall Study|Reason Not Specified|16|||
17160593|NCT03332771|38308198|FG003|Overall Study|Reason Not Specified|19|||
17160594|NCT03310775|38308210|FG000|Overall Study|Lost to Follow-up|2|||
17160595|NCT03310775|38308211|FG001|Overall Study|Lost to Follow-up|3|||
17160596|NCT03310775|38308210|FG000|Overall Study|aggravation of depression|0|||
17160597|NCT03310775|38308211|FG001|Overall Study|aggravation of depression|1|||
17160598|NCT03330119|38308223|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
17160599|NCT03330119|38308224|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
17160600|NCT03040986|38308232|FG000|Overall Study|Hospice|1|||
17160601|NCT03040986|38308233|FG001|Overall Study|Hospice|0|||
17160602|NCT03040986|38308232|FG000|Overall Study|Adverse Event|2|||
17160603|NCT03040986|38308233|FG001|Overall Study|Adverse Event|1|||
17160604|NCT03040986|38308232|FG000|Overall Study|Disease progression on study|3|||
17160605|NCT03040986|38308233|FG001|Overall Study|Disease progression on study|1|||
17160606|NCT03039192|38308243|FG000|Overall Study|Lost to Follow-up|4|||
17160607|NCT03039192|38308244|FG001|Overall Study|Lost to Follow-up|4|||
17160608|NCT03039192|38308243|FG000|Overall Study|Adverse event, serious fatal|0|||
17160609|NCT03039192|38308244|FG001|Overall Study|Adverse event, serious fatal|1|||
17160610|NCT03039192|38308243|FG000|Overall Study|Adverse event, non-fatal|0|||
17160611|NCT03039192|38308244|FG001|Overall Study|Adverse event, non-fatal|2|||
17160612|NCT03039192|38308243|FG000|Overall Study|Withdrawal by Subject|6|||
17160613|NCT03039192|38308244|FG001|Overall Study|Withdrawal by Subject|9|||
17160614|NCT03039192|38308243|FG000|Overall Study|Discontinued from treatment phase|19|||
17160615|NCT03039192|38308244|FG001|Overall Study|Discontinued from treatment phase|12|||
17160616|NCT03039192|38308243|FG000|Overall Study|Other|3|||
17160617|NCT03039192|38308244|FG001|Overall Study|Other|2|||
17160618|NCT03698279|38308256|FG000|Overall Study|Withdrawal by parent/guardian|1|||
17160619|NCT03698279|38308257|FG001|Overall Study|Withdrawal by parent/guardian|1|||
17160620|NCT03698279|38308258|FG002|Overall Study|Withdrawal by parent/guardian|1|||
17160621|NCT03698279|38308259|FG003|Overall Study|Withdrawal by parent/guardian|1|||
17160622|NCT03698279|38308260|FG004|Overall Study|Withdrawal by parent/guardian|0|||
17160623|NCT03698279|38308261|FG005|Overall Study|Withdrawal by parent/guardian|0|||
17160624|NCT03698279|38308256|FG000|Overall Study|Protocol deviation|1|||
17160625|NCT03698279|38308257|FG001|Overall Study|Protocol deviation|0|||
17160626|NCT03698279|38308258|FG002|Overall Study|Protocol deviation|1|||
17160627|NCT03698279|38308259|FG003|Overall Study|Protocol deviation|0|||
17160628|NCT03698279|38308260|FG004|Overall Study|Protocol deviation|0|||
17160629|NCT03698279|38308261|FG005|Overall Study|Protocol deviation|0|||
17160630|NCT03698279|38308256|FG000|Overall Study|Withdrawal by Subject|0|||
17160631|NCT03698279|38308257|FG001|Overall Study|Withdrawal by Subject|0|||
17081393|NCT00398216|38222322|FG000|Overall Study|administrative reasons|3|||
17160632|NCT03698279|38308258|FG002|Overall Study|Withdrawal by Subject|1|||
17160633|NCT03698279|38308259|FG003|Overall Study|Withdrawal by Subject|0|||
17081394|NCT00398216|38222323|FG001|Overall Study|administrative reasons|4|||
17081395|NCT00398216|38222324|FG002|Overall Study|administrative reasons|4|||
17081396|NCT00398216|38222325|FG003|Overall Study|administrative reasons|3|||
17081397|NCT00398216|38222326|FG004|Overall Study|administrative reasons|3|||
17081398|NCT00398216|38222322|FG000|Overall Study|entrance criteria|0|||
17081399|NCT00398216|38222323|FG001|Overall Study|entrance criteria|0|||
17081400|NCT00398216|38222324|FG002|Overall Study|entrance criteria|0|||
17081401|NCT00398216|38222325|FG003|Overall Study|entrance criteria|0|||
17081402|NCT00398216|38222326|FG004|Overall Study|entrance criteria|2|||
17081403|NCT00398138|38222338|FG000|Overall Study|Adverse Event|2|||
17160634|NCT03698279|38308260|FG004|Overall Study|Withdrawal by Subject|0|||
17160635|NCT03698279|38308261|FG005|Overall Study|Withdrawal by Subject|0|||
17160636|NCT03698279|38308256|FG000|Overall Study|Lost to Follow-up|3|||
17160637|NCT03698279|38308257|FG001|Overall Study|Lost to Follow-up|1|||
17160638|NCT03698279|38308258|FG002|Overall Study|Lost to Follow-up|4|||
17160639|NCT03698279|38308259|FG003|Overall Study|Lost to Follow-up|5|||
17160640|NCT03698279|38308260|FG004|Overall Study|Lost to Follow-up|0|||
17160641|NCT03698279|38308261|FG005|Overall Study|Lost to Follow-up|0|||
17160642|NCT01529034|38308280|FG000|Overall Study|Discontinued prior to study treatment|14|||
17160643|NCT01529034|38308280|FG000|Overall Study|Site closure|62|||
17160644|NCT01529034|38308280|FG000|Overall Study|Study termination|29|||
17160645|NCT01529034|38308280|FG000|Overall Study|Withdrawal by Subject|25|||
17160646|NCT01529034|38308280|FG000|Overall Study|No treated SCs within protocol window|13|||
17160647|NCT01529034|38308280|FG000|Overall Study|Noncompliance|8|||
17160648|NCT01529034|38308280|FG000|Overall Study|Caregiver no longer available|7|||
17160649|NCT01529034|38308280|FG000|Overall Study|Adverse Event|4|||
17160650|NCT01529034|38308280|FG000|Overall Study|Protocol Violation|4|||
17160651|NCT01529034|38308280|FG000|Overall Study|Lack of Efficacy|4|||
17160652|NCT01529034|38308280|FG000|Overall Study|Investigator no longer available|2|||
17160653|NCT01529034|38308280|FG000|Overall Study|Study drug not available|2|||
17160654|NCT03036072|38308287|FG000|Overall Study|Death|0|||
17160655|NCT03036072|38308288|FG001|Overall Study|Death|1|||
17160656|NCT03036072|38308287|FG000|Overall Study|Withdrawal by Subject|0|||
17160657|NCT03036072|38308288|FG001|Overall Study|Withdrawal by Subject|1|||
17160658|NCT03036072|38308287|FG000|Overall Study|Physician Decision|0|||
17160659|NCT03036072|38308288|FG001|Overall Study|Physician Decision|1|||
17160660|NCT03038880|38308297|FG000|Overall Study|Death|1|||
17160661|NCT03038880|38308298|FG001|Overall Study|Death|2|||
17160662|NCT03038880|38308299|FG002|Overall Study|Death|0|||
17160663|NCT03038880|38308297|FG000|Overall Study|Physician Decision|2|||
17160664|NCT03038880|38308298|FG001|Overall Study|Physician Decision|1|||
17160665|NCT03038880|38308299|FG002|Overall Study|Physician Decision|0|||
17160666|NCT03035916|38308310|FG000|Overall Study|Puncture failed|0|||
17160667|NCT03035916|38308311|FG001|Overall Study|Puncture failed|2|||
17160668|NCT03035916|38308312|FG002|Overall Study|Puncture failed|0|||
17160669|NCT01702571|38308322|FG000|Overall Study|Death|1067|||
17160670|NCT01702571|38308323|FG001|Overall Study|Death|76|||
17160671|NCT01702571|38308322|FG000|Overall Study|Lost to Follow-up|144|||
17160672|NCT01702571|38308323|FG001|Overall Study|Lost to Follow-up|10|||
17160673|NCT01702571|38308322|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
17160674|NCT01702571|38308323|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
17160675|NCT01702571|38308322|FG000|Overall Study|Investigator Decision|5|||
17160676|NCT01702571|38308323|FG001|Overall Study|Investigator Decision|0|||
17160677|NCT01702571|38308322|FG000|Overall Study|Not Classifiable|1|||
17160678|NCT01702571|38308323|FG001|Overall Study|Not Classifiable|0|||
17160679|NCT01702571|38308322|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
17160680|NCT01702571|38308323|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
17160681|NCT01702571|38308322|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
17160682|NCT01702571|38308323|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
17160683|NCT01702571|38308322|FG000|Overall Study|Progressive Disease|3|||
17160684|NCT01702571|38308323|FG001|Overall Study|Progressive Disease|0|||
17160685|NCT01702571|38308322|FG000|Overall Study|Protocol Violation|2|||
17160686|NCT01702571|38308323|FG001|Overall Study|Protocol Violation|0|||
17160687|NCT01702571|38308322|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
17160688|NCT01702571|38308323|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
17160689|NCT01702571|38308322|FG000|Overall Study|Termination By Sponsor|4|||
17160690|NCT01702571|38308323|FG001|Overall Study|Termination By Sponsor|0|||
17160691|NCT01702571|38308322|FG000|Overall Study|Withdrawal by Subject|177|||
17160692|NCT01702571|38308323|FG001|Overall Study|Withdrawal by Subject|29|||
17160693|NCT03231943|38308346|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160694|NCT03231943|38308347|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
17160695|NCT03231943|38308348|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
17160696|NCT03231943|38308349|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160697|NCT03231943|38308350|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16995467|NCT01572493|38139214|FG006|Overall Study|Adverse Event|1|||
17160698|NCT03231943|38308351|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160699|NCT03231943|38308352|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160700|NCT03231943|38308353|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160701|NCT03231943|38308354|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160702|NCT03231943|38308355|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160703|NCT03231943|38308356|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160704|NCT03231943|38308357|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160705|NCT03231943|38308358|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
17160706|NCT03231943|38308346|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160707|NCT03231943|38308347|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
17160708|NCT03231943|38308348|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160709|NCT03231943|38308349|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160710|NCT03231943|38308350|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160711|NCT03231943|38308351|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160712|NCT03231943|38308352|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160713|NCT03231943|38308353|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160714|NCT03231943|38308354|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160715|NCT03231943|38308355|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160716|NCT03231943|38308356|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160717|NCT03231943|38308357|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160718|NCT03231943|38308358|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
17160719|NCT03231943|38308346|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
17160720|NCT03231943|38308347|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160721|NCT03231943|38308348|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160722|NCT03231943|38308349|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160723|NCT03231943|38308350|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160724|NCT03231943|38308351|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160725|NCT03231943|38308352|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160726|NCT03231943|38308353|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160727|NCT03231943|38308354|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160728|NCT03231943|38308355|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160729|NCT03231943|38308356|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160730|NCT03231943|38308357|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160731|NCT03231943|38308358|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
17160732|NCT03231943|38308346|FG000|Part 2|Adverse Event|0|||
17160733|NCT03231943|38308347|FG001|Part 2|Adverse Event|0|||
17160734|NCT03231943|38308348|FG002|Part 2|Adverse Event|0|||
17160735|NCT03231943|38308349|FG003|Part 2|Adverse Event|0|||
17160736|NCT03231943|38308350|FG004|Part 2|Adverse Event|0|||
17160737|NCT03231943|38308351|FG005|Part 2|Adverse Event|0|||
17160738|NCT03231943|38308352|FG006|Part 2|Adverse Event|0|||
17160739|NCT03231943|38308353|FG007|Part 2|Adverse Event|0|||
17160740|NCT03231943|38308354|FG008|Part 2|Adverse Event|0|||
17160741|NCT03231943|38308355|FG009|Part 2|Adverse Event|0|||
17160742|NCT03231943|38308356|FG010|Part 2|Adverse Event|1|||
17160743|NCT03231943|38308357|FG011|Part 2|Adverse Event|0|||
17160744|NCT03231943|38308358|FG012|Part 2|Adverse Event|0|||
17160745|NCT03231943|38308346|FG000|Part 2|Withdrawal by Subject|0|||
17160746|NCT03231943|38308347|FG001|Part 2|Withdrawal by Subject|0|||
17160747|NCT03231943|38308348|FG002|Part 2|Withdrawal by Subject|0|||
17160748|NCT03231943|38308349|FG003|Part 2|Withdrawal by Subject|0|||
17160749|NCT03231943|38308350|FG004|Part 2|Withdrawal by Subject|0|||
17160750|NCT03231943|38308351|FG005|Part 2|Withdrawal by Subject|0|||
17160751|NCT03231943|38308352|FG006|Part 2|Withdrawal by Subject|0|||
17160752|NCT03231943|38308353|FG007|Part 2|Withdrawal by Subject|0|||
17160753|NCT03231943|38308354|FG008|Part 2|Withdrawal by Subject|0|||
17160754|NCT03231943|38308355|FG009|Part 2|Withdrawal by Subject|0|||
17160755|NCT03231943|38308356|FG010|Part 2|Withdrawal by Subject|0|||
17160756|NCT03231943|38308357|FG011|Part 2|Withdrawal by Subject|1|||
17160757|NCT03231943|38308358|FG012|Part 2|Withdrawal by Subject|0|||
17160758|NCT01578239|38308390|FG000|Treatment Period|Progressive Disease|19|||
17160759|NCT01578239|38308391|FG001|Treatment Period|Progressive Disease|64|||
17160760|NCT01578239|38308390|FG000|Treatment Period|Physician Decision|17|||
17160761|NCT01578239|38308391|FG001|Treatment Period|Physician Decision|17|||
17160762|NCT01578239|38308390|FG000|Treatment Period|Adverse Event|13|||
17160763|NCT01578239|38308391|FG001|Treatment Period|Adverse Event|10|||
17160764|NCT01578239|38308390|FG000|Treatment Period|Non-compliance|2|||
17160765|NCT01578239|38308391|FG001|Treatment Period|Non-compliance|0|||
17160766|NCT01578239|38308390|FG000|Treatment Period|Withdrawal by Subject|10|||
17160767|NCT01578239|38308391|FG001|Treatment Period|Withdrawal by Subject|9|||
17160768|NCT01578239|38308390|FG000|Treatment Period|Other|6|||
17160769|NCT01578239|38308391|FG001|Treatment Period|Other|1|||
17160770|NCT01578239|38308390|FG000|Long-term Follow-Up Period|Death|69|||
17081404|NCT00397982|38222342|FG000|Overall Study|Withdrawal by Subject|1|||
17081405|NCT00397982|38222342|FG000|Overall Study|Adverse Event|1|||
17081406|NCT00397982|38222342|FG000|Overall Study|noncompliance|1|||
17081407|NCT00397982|38222342|FG000|Overall Study|Unrelated health issues|1|||
17081408|NCT00408902|38222347|FG000|Overall Study|Lack of Efficacy|7|||
17081409|NCT00408902|38222347|FG000|Overall Study|Adverse Event|3|||
17081410|NCT00397514|38222352|FG000|Overall Study|Withdrawal by Subject|1|||
17081411|NCT00397514|38222352|FG000|Overall Study|Pacing wire malfunction|1|||
17081412|NCT00397514|38222352|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
17160771|NCT01578239|38308391|FG001|Long-term Follow-Up Period|Death|64|||
17081413|NCT00397514|38222352|FG000|Overall Study|early extubation|2|||
17160772|NCT01578239|38308390|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
17160773|NCT01578239|38308391|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
17160774|NCT01578239|38308390|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
17160775|NCT01578239|38308391|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
17160776|NCT01578239|38308390|FG000|Long-term Follow-Up Period|Other|2|||
17160777|NCT01578239|38308391|FG001|Long-term Follow-Up Period|Other|2|||
17160778|NCT03231709|38308399|FG000|Treatment Period 1|Reason not Specified|0|||
17160779|NCT03231709|38308400|FG001|Treatment Period 1|Reason not Specified|1|||
17081414|NCT00397514|38222352|FG000|Overall Study|poor echocardiographic windows|1|||
17081415|NCT00397046|38222366|FG000|Overall Study|Disease Progression|3|||
17081416|NCT00397046|38222367|FG001|Overall Study|Disease Progression|3|||
17081417|NCT00397046|38222368|FG002|Overall Study|Disease Progression|10|||
17081418|NCT00397046|38222369|FG003|Overall Study|Disease Progression|5|||
17081419|NCT00419120|38222380|FG000|Long Term Follow up Period|study ongoing|10|||
17081420|NCT00396812|38222384|FG000|Overall Study|Physician Decision|1|||
17160780|NCT03231709|38308399|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
17160781|NCT03231709|38308400|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
17160782|NCT03241927|38308410|FG000|Overall Study|study terminated|1|||
17160783|NCT03241927|38308411|FG001|Overall Study|study terminated|0|||
17160784|NCT03329885|38308423|FG000|Overall Study|Sponsor discontinued the study early|0|||
17160785|NCT03329885|38308424|FG001|Overall Study|Sponsor discontinued the study early|0|||
17081421|NCT00396656|38222388|FG000|First Treatment Period|Withdrawal by Subject|0|||
17081422|NCT00396656|38222389|FG001|First Treatment Period|Withdrawal by Subject|2|||
17081423|NCT00396656|38222388|FG000|Second Treatment Period|Adverse Event|0|||
17081424|NCT00396656|38222389|FG001|Second Treatment Period|Adverse Event|1|||
17081425|NCT00408434|38222402|FG000|Overall Study|Adverse Event|0|||
17081426|NCT00408434|38222403|FG001|Overall Study|Adverse Event|0|||
17081427|NCT00408434|38222404|FG002|Overall Study|Adverse Event|1|||
17081428|NCT00408434|38222405|FG003|Overall Study|Adverse Event|0|||
17081429|NCT00408434|38222406|FG004|Overall Study|Adverse Event|0|||
17081430|NCT00408434|38222407|FG005|Overall Study|Adverse Event|0|||
17081431|NCT00408434|38222408|FG006|Overall Study|Adverse Event|0|||
17081432|NCT00408434|38222402|FG000|Overall Study|Progressive disease|6|||
17081433|NCT00408434|38222403|FG001|Overall Study|Progressive disease|3|||
17081434|NCT00408434|38222404|FG002|Overall Study|Progressive disease|4|||
17081435|NCT00408434|38222405|FG003|Overall Study|Progressive disease|3|||
17081436|NCT00408434|38222406|FG004|Overall Study|Progressive disease|3|||
17160786|NCT03329885|38308425|FG002|Overall Study|Sponsor discontinued the study early|0|||
17160787|NCT03329885|38308426|FG003|Overall Study|Sponsor discontinued the study early|0|||
17160788|NCT03329885|38308427|FG004|Overall Study|Sponsor discontinued the study early|0|||
17160789|NCT03329885|38308428|FG005|Overall Study|Sponsor discontinued the study early|0|||
17160790|NCT03329885|38308429|FG006|Overall Study|Sponsor discontinued the study early|1|||
17160791|NCT03329885|38308430|FG007|Overall Study|Sponsor discontinued the study early|1|||
17160792|NCT03329885|38308431|FG008|Overall Study|Sponsor discontinued the study early|0|||
17081437|NCT00408434|38222407|FG005|Overall Study|Progressive disease|1|||
17081438|NCT00408434|38222408|FG006|Overall Study|Progressive disease|4|||
17081439|NCT00408434|38222402|FG000|Overall Study|Other|0|||
17081440|NCT00408434|38222403|FG001|Overall Study|Other|0|||
17160793|NCT02941523|38308453|FG000|Monotherapy|Withdrawal by Subject|0|||
17160794|NCT02941523|38308454|FG001|Monotherapy|Withdrawal by Subject|1|||
17160795|NCT02941523|38308453|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
17160796|NCT02941523|38308454|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
17160797|NCT02941523|38308453|FG000|Carboplatin Combination Therapy|Death|1|||
17160798|NCT02941523|38308454|FG001|Carboplatin Combination Therapy|Death|2|||
17160799|NCT02941523|38308453|FG000|Carboplatin Combination Therapy|Disease progression|2|||
17160800|NCT02941523|38308454|FG001|Carboplatin Combination Therapy|Disease progression|0|||
17160801|NCT02941523|38308453|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
17160802|NCT02941523|38308454|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
17160803|NCT02938585|38308472|FG000|Overall Study|Withdrawal by parent or guardian|0|||
17160804|NCT02938585|38308473|FG001|Overall Study|Withdrawal by parent or guardian|1|||
17160805|NCT02938585|38308474|FG002|Overall Study|Withdrawal by parent or guardian|0|||
17160806|NCT02938585|38308475|FG003|Overall Study|Withdrawal by parent or guardian|0|||
17160807|NCT02938585|38308472|FG000|Overall Study|Withdrawal by Subject|0|||
17081441|NCT00408434|38222404|FG002|Overall Study|Other|1|||
17081442|NCT00408434|38222405|FG003|Overall Study|Other|0|||
17160808|NCT02938585|38308473|FG001|Overall Study|Withdrawal by Subject|0|||
17081443|NCT00408434|38222406|FG004|Overall Study|Other|2|||
17081444|NCT00408434|38222407|FG005|Overall Study|Other|1|||
17081445|NCT00408434|38222408|FG006|Overall Study|Other|0|||
17081446|NCT00408434|38222402|FG000|Overall Study|Terminated by Investigator|0|||
17160809|NCT02938585|38308474|FG002|Overall Study|Withdrawal by Subject|0|||
17160810|NCT02938585|38308475|FG003|Overall Study|Withdrawal by Subject|5|||
17160811|NCT03229759|38308499|FG000|Overall Study|Screen Failure|30|||
17160812|NCT03228433|38308511|FG000|Overall Study|Lost to Follow-up|1|||
17160813|NCT03228433|38308512|FG001|Overall Study|Lost to Follow-up|0|||
17160814|NCT03228433|38308513|FG002|Overall Study|Lost to Follow-up|0|||
17160815|NCT03228433|38308514|FG003|Overall Study|Lost to Follow-up|0|||
17160816|NCT03228433|38308515|FG004|Overall Study|Lost to Follow-up|0|||
17160817|NCT03228433|38308516|FG005|Overall Study|Lost to Follow-up|0|||
17160818|NCT03228433|38308511|FG000|Overall Study|Positive alcohol test|0|||
17160819|NCT03228433|38308512|FG001|Overall Study|Positive alcohol test|0|||
17160820|NCT03228433|38308513|FG002|Overall Study|Positive alcohol test|0|||
17160821|NCT03228433|38308514|FG003|Overall Study|Positive alcohol test|1|||
17160822|NCT03228433|38308515|FG004|Overall Study|Positive alcohol test|0|||
17160823|NCT03228433|38308516|FG005|Overall Study|Positive alcohol test|0|||
17160824|NCT01496118|38308546|FG000|Overall Study|Disease progression|3|||
17160825|NCT01496118|38308547|FG001|Overall Study|Disease progression|2|||
17160826|NCT01496118|38308548|FG002|Overall Study|Disease progression|3|||
17160827|NCT01496118|38308549|FG003|Overall Study|Disease progression|1|||
17160828|NCT01496118|38308550|FG004|Overall Study|Disease progression|2|||
17160829|NCT01496118|38308551|FG005|Overall Study|Disease progression|2|||
17160830|NCT01496118|38308552|FG006|Overall Study|Disease progression|14|||
17160831|NCT01496118|38308553|FG007|Overall Study|Disease progression|10|||
17160832|NCT01496118|38308546|FG000|Overall Study|Physician Decision|0|||
17160833|NCT01496118|38308547|FG001|Overall Study|Physician Decision|0|||
17160834|NCT01496118|38308548|FG002|Overall Study|Physician Decision|0|||
17160835|NCT01496118|38308549|FG003|Overall Study|Physician Decision|0|||
17160836|NCT01496118|38308550|FG004|Overall Study|Physician Decision|1|||
16995468|NCT01572493|38139215|FG007|Overall Study|Adverse Event|0|||
16995469|NCT01572493|38139216|FG008|Overall Study|Adverse Event|0|||
16995470|NCT01018511|38139243|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
16995471|NCT01018511|38139244|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
16995472|NCT01018511|38139245|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
16995473|NCT01018511|38139246|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
16995474|NCT01018511|38139243|FG000|Overall Study|Adverse Event|5|||
16995475|NCT01018511|38139244|FG001|Overall Study|Adverse Event|9|||
16995476|NCT01018511|38139245|FG002|Overall Study|Adverse Event|13|||
16995477|NCT01018511|38139246|FG003|Overall Study|Adverse Event|10|||
16995478|NCT01018511|38139243|FG000|Overall Study|Lack of Efficacy|4|||
16995479|NCT01018511|38139244|FG001|Overall Study|Lack of Efficacy|1|||
16995480|NCT01018511|38139245|FG002|Overall Study|Lack of Efficacy|1|||
16995481|NCT01018511|38139246|FG003|Overall Study|Lack of Efficacy|2|||
16995482|NCT01018511|38139243|FG000|Overall Study|Withdrawal by Subject|6|||
16995483|NCT01018511|38139244|FG001|Overall Study|Withdrawal by Subject|5|||
16995484|NCT01018511|38139245|FG002|Overall Study|Withdrawal by Subject|11|||
16995485|NCT01018511|38139246|FG003|Overall Study|Withdrawal by Subject|9|||
16995486|NCT01018511|38139243|FG000|Overall Study|Lost to Follow-up|0|||
16995487|NCT01018511|38139244|FG001|Overall Study|Lost to Follow-up|0|||
16995488|NCT01018511|38139245|FG002|Overall Study|Lost to Follow-up|1|||
17081447|NCT00408434|38222403|FG001|Overall Study|Terminated by Investigator|0|||
17081448|NCT00408434|38222404|FG002|Overall Study|Terminated by Investigator|0|||
17081449|NCT00408434|38222405|FG003|Overall Study|Terminated by Investigator|0|||
17081450|NCT00408434|38222406|FG004|Overall Study|Terminated by Investigator|1|||
17081451|NCT00408434|38222407|FG005|Overall Study|Terminated by Investigator|1|||
16995489|NCT01018511|38139246|FG003|Overall Study|Lost to Follow-up|0|||
17081452|NCT00408434|38222408|FG006|Overall Study|Terminated by Investigator|0|||
17081453|NCT00418886|38222427|FG000|Overall Study|discontinue treatment survival follow up|90|||
17081454|NCT00418886|38222428|FG001|Overall Study|discontinue treatment survival follow up|91|||
17081455|NCT00418886|38222427|FG000|Overall Study|Death|122|||
17081456|NCT00418886|38222428|FG001|Overall Study|Death|147|||
17081457|NCT00418886|38222427|FG000|Overall Study|Withdrawal by Subject|9|||
17081458|NCT00418886|38222428|FG001|Overall Study|Withdrawal by Subject|10|||
17081459|NCT00418886|38222427|FG000|Overall Study|Lost to Follow-up|4|||
17081460|NCT00418886|38222428|FG001|Overall Study|Lost to Follow-up|6|||
17160837|NCT01496118|38308551|FG005|Overall Study|Physician Decision|0|||
16995490|NCT01018511|38139243|FG000|Overall Study|Protocol Violation|5|||
16995491|NCT01018511|38139244|FG001|Overall Study|Protocol Violation|8|||
17160838|NCT01496118|38308552|FG006|Overall Study|Physician Decision|3|||
17160839|NCT01496118|38308553|FG007|Overall Study|Physician Decision|6|||
17160840|NCT01496118|38308546|FG000|Overall Study|Adverse Event|1|||
17160841|NCT01496118|38308547|FG001|Overall Study|Adverse Event|1|||
17160842|NCT01496118|38308548|FG002|Overall Study|Adverse Event|0|||
17081461|NCT00418886|38222427|FG000|Overall Study|withdrawn due to other reason|1|||
17081462|NCT00418886|38222428|FG001|Overall Study|withdrawn due to other reason|0|||
17081463|NCT00418886|38222427|FG000|Overall Study|randomised but no treatment received|0|||
17081464|NCT00418886|38222428|FG001|Overall Study|randomised but no treatment received|1|||
17160843|NCT01496118|38308549|FG003|Overall Study|Adverse Event|0|||
17160844|NCT01496118|38308550|FG004|Overall Study|Adverse Event|0|||
17160845|NCT01496118|38308551|FG005|Overall Study|Adverse Event|0|||
17160846|NCT01496118|38308552|FG006|Overall Study|Adverse Event|6|||
17160847|NCT01496118|38308553|FG007|Overall Study|Adverse Event|10|||
17160848|NCT01496118|38308546|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
17160849|NCT01496118|38308547|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
17160850|NCT01496118|38308548|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
17160851|NCT01496118|38308549|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
17160852|NCT01496118|38308550|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
17160853|NCT01496118|38308551|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
17160854|NCT01496118|38308552|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
17160855|NCT01496118|38308553|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
17160856|NCT01496118|38308546|FG000|Overall Study|Death|0|||
17160857|NCT01496118|38308547|FG001|Overall Study|Death|0|||
17160858|NCT01496118|38308548|FG002|Overall Study|Death|0|||
17160859|NCT01496118|38308549|FG003|Overall Study|Death|0|||
17160860|NCT01496118|38308550|FG004|Overall Study|Death|0|||
17160861|NCT01496118|38308551|FG005|Overall Study|Death|0|||
17160862|NCT01496118|38308552|FG006|Overall Study|Death|1|||
17160863|NCT01496118|38308553|FG007|Overall Study|Death|1|||
17160864|NCT01496118|38308546|FG000|Overall Study|Withdrawal by Subject|0|||
17160865|NCT01496118|38308547|FG001|Overall Study|Withdrawal by Subject|0|||
17160866|NCT01496118|38308548|FG002|Overall Study|Withdrawal by Subject|0|||
17160867|NCT01496118|38308549|FG003|Overall Study|Withdrawal by Subject|2|||
17160868|NCT01496118|38308550|FG004|Overall Study|Withdrawal by Subject|0|||
17160869|NCT01496118|38308551|FG005|Overall Study|Withdrawal by Subject|1|||
17160870|NCT01496118|38308552|FG006|Overall Study|Withdrawal by Subject|6|||
17160871|NCT01496118|38308553|FG007|Overall Study|Withdrawal by Subject|3|||
17160872|NCT02936869|38308573|FG000|Overall Study|Lost to Follow-up|1|||
17160873|NCT02936869|38308574|FG001|Overall Study|Lost to Follow-up|3|||
17160874|NCT02936869|38308573|FG000|Overall Study|Death|0|||
17160875|NCT02936869|38308574|FG001|Overall Study|Death|1|||
17160876|NCT02936869|38308573|FG000|Overall Study|Legal Case|0|||
17160877|NCT02936869|38308574|FG001|Overall Study|Legal Case|1|||
17160878|NCT02936869|38308573|FG000|Overall Study|Protocol Violation|1|||
17160879|NCT02936869|38308574|FG001|Overall Study|Protocol Violation|0|||
17160880|NCT03309605|38308589|FG000|Overall Study|Adverse Event|0|||
17160881|NCT03309605|38308590|FG001|Overall Study|Adverse Event|0|||
17160882|NCT03309605|38308591|FG002|Overall Study|Adverse Event|0|||
17160883|NCT03309605|38308592|FG003|Overall Study|Adverse Event|1|||
17160884|NCT03309605|38308593|FG004|Overall Study|Adverse Event|0|||
17160885|NCT03309605|38308594|FG005|Overall Study|Adverse Event|0|||
17160886|NCT03309605|38308595|FG006|Overall Study|Adverse Event|2|||
17160887|NCT03309605|38308596|FG007|Overall Study|Adverse Event|1|||
17160888|NCT03309605|38308589|FG000|Overall Study|Withdrawal by Subject|0|||
17160889|NCT03309605|38308590|FG001|Overall Study|Withdrawal by Subject|0|||
17160890|NCT03309605|38308591|FG002|Overall Study|Withdrawal by Subject|0|||
17160891|NCT03309605|38308592|FG003|Overall Study|Withdrawal by Subject|0|||
17160892|NCT03309605|38308593|FG004|Overall Study|Withdrawal by Subject|1|||
17160893|NCT03309605|38308594|FG005|Overall Study|Withdrawal by Subject|0|||
17160894|NCT03309605|38308595|FG006|Overall Study|Withdrawal by Subject|1|||
17160895|NCT03309605|38308596|FG007|Overall Study|Withdrawal by Subject|1|||
17160896|NCT02936635|38308612|FG000|Overall Study|Adverse Event|43|||
17160897|NCT02936635|38308613|FG001|Overall Study|Adverse Event|25|||
17160898|NCT02936635|38308612|FG000|Overall Study|Progressive Disease|10|||
17160899|NCT02936635|38308613|FG001|Overall Study|Progressive Disease|18|||
17081465|NCT00418184|38222440|FG000|Double-blind Phase|Withdrawal by Subject|22|||
17081466|NCT00418184|38222441|FG001|Double-blind Phase|Withdrawal by Subject|9|||
17081467|NCT00418184|38222440|FG000|Double-blind Phase|Adverse Event|2|||
17081468|NCT00418184|38222441|FG001|Double-blind Phase|Adverse Event|1|||
17081469|NCT00418184|38222440|FG000|Double-blind Phase|Poor compliance|3|||
17081470|NCT00418184|38222441|FG001|Double-blind Phase|Poor compliance|1|||
17081471|NCT00407030|38222450|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
17081472|NCT00407030|38222451|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
17081473|NCT00407030|38222452|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
17081474|NCT00407030|38222450|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
17081475|NCT00407030|38222451|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
17081476|NCT00407030|38222452|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
17081477|NCT00407030|38222450|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
17081478|NCT00407030|38222451|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
17160900|NCT02936635|38308612|FG000|Overall Study|Sponsor Discretion|10|||
17160901|NCT02936635|38308613|FG001|Overall Study|Sponsor Discretion|16|||
17160902|NCT02936635|38308612|FG000|Overall Study|Death|9|||
17160903|NCT02936635|38308613|FG001|Overall Study|Death|15|||
17160904|NCT02936635|38308612|FG000|Overall Study|Withdrawal by Subject|8|||
17160905|NCT02936635|38308613|FG001|Overall Study|Withdrawal by Subject|15|||
17160906|NCT02936635|38308612|FG000|Overall Study|Physician Decision|2|||
17160907|NCT02936635|38308613|FG001|Overall Study|Physician Decision|9|||
17160908|NCT02936635|38308612|FG000|Overall Study|Lost to Follow-up|1|||
17160909|NCT02936635|38308613|FG001|Overall Study|Lost to Follow-up|2|||
17160910|NCT02936635|38308612|FG000|Overall Study|Protocol Violation|1|||
17160911|NCT02936635|38308613|FG001|Overall Study|Protocol Violation|0|||
17081479|NCT00407030|38222452|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
17081480|NCT00407030|38222450|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
17081481|NCT00407030|38222451|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
17081482|NCT00407030|38222452|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
17081483|NCT00407030|38222450|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
17081484|NCT00407030|38222451|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
17081485|NCT00407030|38222452|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
17081486|NCT00407030|38222450|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
17081487|NCT00407030|38222451|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
17081488|NCT00407030|38222452|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
17081489|NCT00407030|38222450|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
17081490|NCT00407030|38222451|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
17081491|NCT00407030|38222452|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
17081492|NCT00407030|38222450|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
17081493|NCT00407030|38222451|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
17081494|NCT00407030|38222452|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
17081495|NCT00407030|38222450|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
17081496|NCT00407030|38222451|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
17081497|NCT00407030|38222452|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
17081498|NCT00407030|38222450|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
17160912|NCT02936635|38308612|FG000|Overall Study|Lack of effect/Entry into other study|31|||
17160913|NCT02936635|38308613|FG001|Overall Study|Lack of effect/Entry into other study|65|||
17160914|NCT03227029|38308622|FG000|Overall Study|Child Wheezed (no treatment)|0|||
17160915|NCT03227029|38308623|FG001|Overall Study|Child Wheezed (no treatment)|1|||
17160916|NCT03227029|38308624|FG002|Overall Study|Child Wheezed (no treatment)|0|||
17160917|NCT03227029|38308622|FG000|Overall Study|No post RSV season visit due to COVID|3|||
17160918|NCT03227029|38308623|FG001|Overall Study|No post RSV season visit due to COVID|3|||
17160919|NCT03227029|38308624|FG002|Overall Study|No post RSV season visit due to COVID|2|||
17160920|NCT03227029|38308622|FG000|Overall Study|Not able to get to clinic|0|||
17160921|NCT03227029|38308623|FG001|Overall Study|Not able to get to clinic|0|||
17160922|NCT03227029|38308624|FG002|Overall Study|Not able to get to clinic|1|||
17160923|NCT03227029|38308622|FG000|Overall Study|Withdrawal by Subject|1|||
17160924|NCT03227029|38308623|FG001|Overall Study|Withdrawal by Subject|0|||
17160925|NCT03227029|38308624|FG002|Overall Study|Withdrawal by Subject|0|||
17160926|NCT03227029|38308622|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
17160927|NCT03227029|38308623|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
17160928|NCT03227029|38308624|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
17160929|NCT03329573|38308636|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
17160930|NCT03329573|38308637|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
17160931|NCT03329573|38308638|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
17160932|NCT03329573|38308639|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
17160933|NCT03329573|38308636|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
17160934|NCT03329573|38308637|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
17160935|NCT03329573|38308638|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17160936|NCT03329573|38308639|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
17160937|NCT03329573|38308636|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
17160938|NCT03329573|38308637|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
17160939|NCT03329573|38308638|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
17160940|NCT03329573|38308639|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
17160941|NCT03329573|38308636|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
17160942|NCT03329573|38308637|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
17160943|NCT03329573|38308638|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
17160944|NCT03329573|38308639|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
17160945|NCT03308825|38308670|FG000|Overall Study|Lost to Follow-up|2|||
17160946|NCT03308825|38308671|FG001|Overall Study|Lost to Follow-up|2|||
17160947|NCT03308825|38308672|FG002|Overall Study|Lost to Follow-up|1|||
17160948|NCT03308825|38308673|FG003|Overall Study|Lost to Follow-up|0|||
17160949|NCT03308825|38308670|FG000|Overall Study|Protocol Violation|0|||
17160950|NCT03308825|38308671|FG001|Overall Study|Protocol Violation|2|||
17160951|NCT03308825|38308672|FG002|Overall Study|Protocol Violation|0|||
17160952|NCT03308825|38308673|FG003|Overall Study|Protocol Violation|0|||
17160953|NCT03238417|38308689|FG000|Overall|non-response|955|||
17160954|NCT03238417|38308690|FG001|Overall|non-response|1920|||
16995492|NCT01018511|38139245|FG002|Overall Study|Protocol Violation|7|||
16995493|NCT01018511|38139246|FG003|Overall Study|Protocol Violation|9|||
16995494|NCT01018511|38139243|FG000|Overall Study|Miscellaneous|0|||
16995495|NCT01018511|38139244|FG001|Overall Study|Miscellaneous|2|||
16995496|NCT01018511|38139245|FG002|Overall Study|Miscellaneous|0|||
16995497|NCT01018511|38139246|FG003|Overall Study|Miscellaneous|0|||
16995498|NCT00996476|38139267|FG000|Overall Study|Withdrawal by Subject|1|||
16995499|NCT00996476|38139268|FG001|Overall Study|Withdrawal by Subject|2|||
16995500|NCT00996476|38139269|FG002|Overall Study|Withdrawal by Subject|1|||
16995501|NCT00996476|38139270|FG003|Overall Study|Withdrawal by Subject|0|||
16995502|NCT00996476|38139271|FG004|Overall Study|Withdrawal by Subject|1|||
16995503|NCT00996476|38139267|FG000|Overall Study|Adverse Event|0|||
16995504|NCT00996476|38139268|FG001|Overall Study|Adverse Event|1|||
16995505|NCT00996476|38139269|FG002|Overall Study|Adverse Event|0|||
16995506|NCT00996476|38139270|FG003|Overall Study|Adverse Event|0|||
16995507|NCT00996476|38139271|FG004|Overall Study|Adverse Event|1|||
16995508|NCT02269267|38139288|FG000|Overall Study|Death|5|||
16995509|NCT01017731|38139292|FG000|Overall Study|Lost to Follow-up|2|||
16995510|NCT01017731|38139292|FG000|Overall Study|Withdrawal by Subject|3|||
16995511|NCT01017731|38139292|FG000|Overall Study|Physician Decision|2|||
16995512|NCT01017731|38139292|FG000|Overall Study|Adverse Event|1|||
16995513|NCT01035905|38139299|FG000|Overall Study|Lack of Efficacy|1|||
16995514|NCT01035905|38139300|FG001|Overall Study|Lack of Efficacy|1|||
16995515|NCT00779584|38139324|FG000|Overall Study|Protocol Violation|0|||
16995516|NCT00779584|38139325|FG001|Overall Study|Protocol Violation|0|||
16995517|NCT00779584|38139326|FG002|Overall Study|Protocol Violation|0|||
16995518|NCT00779584|38139327|FG003|Overall Study|Protocol Violation|0|||
16995519|NCT00779584|38139328|FG004|Overall Study|Protocol Violation|0|||
16995520|NCT00779584|38139329|FG005|Overall Study|Protocol Violation|1|||
16995521|NCT00779584|38139330|FG006|Overall Study|Protocol Violation|0|||
16995522|NCT00779584|38139331|FG007|Overall Study|Protocol Violation|0|||
16995523|NCT00779584|38139332|FG008|Overall Study|Protocol Violation|0|||
16995524|NCT00779584|38139324|FG000|Overall Study|Withdrawal by Subject|1|||
16995525|NCT00779584|38139325|FG001|Overall Study|Withdrawal by Subject|1|||
16995526|NCT00779584|38139326|FG002|Overall Study|Withdrawal by Subject|2|||
16995527|NCT00779584|38139327|FG003|Overall Study|Withdrawal by Subject|0|||
16995528|NCT00779584|38139328|FG004|Overall Study|Withdrawal by Subject|0|||
16995529|NCT00779584|38139329|FG005|Overall Study|Withdrawal by Subject|2|||
16995530|NCT00779584|38139330|FG006|Overall Study|Withdrawal by Subject|1|||
16995531|NCT00779584|38139331|FG007|Overall Study|Withdrawal by Subject|0|||
16995532|NCT00779584|38139332|FG008|Overall Study|Withdrawal by Subject|0|||
16995533|NCT00779584|38139324|FG000|Overall Study|Lost to Follow-up|0|||
16995534|NCT00779584|38139325|FG001|Overall Study|Lost to Follow-up|0|||
16995535|NCT00779584|38139326|FG002|Overall Study|Lost to Follow-up|0|||
16995536|NCT00779584|38139327|FG003|Overall Study|Lost to Follow-up|0|||
16995537|NCT00779584|38139328|FG004|Overall Study|Lost to Follow-up|1|||
16995538|NCT00779584|38139329|FG005|Overall Study|Lost to Follow-up|0|||
16995539|NCT00779584|38139330|FG006|Overall Study|Lost to Follow-up|0|||
16995540|NCT00779584|38139331|FG007|Overall Study|Lost to Follow-up|0|||
16995541|NCT00779584|38139332|FG008|Overall Study|Lost to Follow-up|0|||
16995542|NCT00779584|38139324|FG000|Overall Study|Progression of Disease|0|||
16995543|NCT00779584|38139325|FG001|Overall Study|Progression of Disease|1|||
16995544|NCT00779584|38139326|FG002|Overall Study|Progression of Disease|2|||
16995545|NCT00779584|38139327|FG003|Overall Study|Progression of Disease|6|||
16995546|NCT00779584|38139328|FG004|Overall Study|Progression of Disease|5|||
16995547|NCT00779584|38139329|FG005|Overall Study|Progression of Disease|1|||
16995548|NCT00779584|38139330|FG006|Overall Study|Progression of Disease|4|||
17160955|NCT03238417|38308689|FG000|Overall|partial completion|48|||
17160956|NCT03238417|38308690|FG001|Overall|partial completion|68|||
17160957|NCT03238417|38308689|FG000|Baseline|Partial completion|17|||
16995549|NCT00779584|38139331|FG007|Overall Study|Progression of Disease|2|||
16995550|NCT00779584|38139332|FG008|Overall Study|Progression of Disease|1|||
16995551|NCT00779584|38139324|FG000|Overall Study|Adverse Event|1|||
16995552|NCT00779584|38139325|FG001|Overall Study|Adverse Event|0|||
16995553|NCT00779584|38139326|FG002|Overall Study|Adverse Event|2|||
16995554|NCT00779584|38139327|FG003|Overall Study|Adverse Event|0|||
16995555|NCT00779584|38139328|FG004|Overall Study|Adverse Event|0|||
16995556|NCT00779584|38139329|FG005|Overall Study|Adverse Event|0|||
16995557|NCT00779584|38139330|FG006|Overall Study|Adverse Event|2|||
16995558|NCT00779584|38139331|FG007|Overall Study|Adverse Event|1|||
16995559|NCT00779584|38139332|FG008|Overall Study|Adverse Event|1|||
16995560|NCT00779584|38139324|FG000|Overall Study|Symptomatic Deterioration|1|||
16995561|NCT00779584|38139325|FG001|Overall Study|Symptomatic Deterioration|1|||
16995562|NCT00779584|38139326|FG002|Overall Study|Symptomatic Deterioration|1|||
16995563|NCT00779584|38139327|FG003|Overall Study|Symptomatic Deterioration|0|||
16995564|NCT00779584|38139328|FG004|Overall Study|Symptomatic Deterioration|0|||
16995565|NCT00779584|38139329|FG005|Overall Study|Symptomatic Deterioration|1|||
16995566|NCT00779584|38139330|FG006|Overall Study|Symptomatic Deterioration|1|||
16995567|NCT00779584|38139331|FG007|Overall Study|Symptomatic Deterioration|0|||
16995568|NCT00779584|38139332|FG008|Overall Study|Symptomatic Deterioration|0|||
16995569|NCT00779584|38139324|FG000|Overall Study|Ongoing in Study|0|||
16995570|NCT00779584|38139325|FG001|Overall Study|Ongoing in Study|0|||
16995571|NCT00779584|38139326|FG002|Overall Study|Ongoing in Study|0|||
16995572|NCT00779584|38139327|FG003|Overall Study|Ongoing in Study|0|||
16995573|NCT00779584|38139328|FG004|Overall Study|Ongoing in Study|1|||
16995574|NCT00779584|38139329|FG005|Overall Study|Ongoing in Study|1|||
16995575|NCT00779584|38139330|FG006|Overall Study|Ongoing in Study|0|||
16995576|NCT00779584|38139331|FG007|Overall Study|Ongoing in Study|0|||
16995577|NCT00779584|38139332|FG008|Overall Study|Ongoing in Study|0|||
16995578|NCT00995930|38139354|FG000|Overall Study|Protocol deviation|2|||
16995579|NCT00995930|38139355|FG001|Overall Study|Protocol deviation|5|||
16995580|NCT00995930|38139354|FG000|Overall Study|Death|0|||
16995581|NCT00995930|38139355|FG001|Overall Study|Death|1|||
16995582|NCT00995930|38139354|FG000|Overall Study|Administrative problems|4|||
16995583|NCT00995930|38139355|FG001|Overall Study|Administrative problems|2|||
16995584|NCT00995930|38139354|FG000|Overall Study|Lost to Follow-up|1|||
16995585|NCT00995930|38139355|FG001|Overall Study|Lost to Follow-up|2|||
16995586|NCT00995930|38139354|FG000|Overall Study|Withdrawal by Subject|3|||
16995587|NCT00995930|38139355|FG001|Overall Study|Withdrawal by Subject|4|||
16995588|NCT00995930|38139354|FG000|Overall Study|Adverse Event|11|||
16995589|NCT00995930|38139355|FG001|Overall Study|Adverse Event|14|||
16995590|NCT00779506|38139362|FG000|Overall Study|Screening Failed|2|||
16995591|NCT00779506|38139362|FG000|Overall Study|Adverse Event|4|||
16995592|NCT00779506|38139362|FG000|Overall Study|Lack of Efficacy|11|||
16995593|NCT00779506|38139362|FG000|Overall Study|Protocol Violation|5|||
16995594|NCT00779506|38139362|FG000|Overall Study|Withdrawal by Subject|6|||
16995595|NCT00779506|38139362|FG000|Overall Study|Lost to Follow-up|1|||
16995596|NCT00995774|38139368|FG000|Training Period 2|Withdrawal by Subject|2|||
17160958|NCT03238417|38308690|FG001|Baseline|Partial completion|48|||
17160959|NCT03238417|38308689|FG000|Baseline|non-response|372|||
17160960|NCT03238417|38308690|FG001|Baseline|non-response|669|||
17160961|NCT03238417|38308689|FG000|12-month|non-response|296|||
17160962|NCT03238417|38308690|FG001|12-month|non-response|669|||
17160963|NCT03238417|38308689|FG000|12-month|partial completion|23|||
17160964|NCT03238417|38308690|FG001|12-month|partial completion|37|||
17160965|NCT03238417|38308689|FG000|24-month|non-response|287|||
17160966|NCT03238417|38308690|FG001|24-month|non-response|594|||
17160967|NCT03238417|38308689|FG000|24-month|partial completion|8|||
17160968|NCT03238417|38308690|FG001|24-month|partial completion|31|||
17160969|NCT03328325|38308696|FG000|Overall Study|Lost to Follow-up|4|||
17160970|NCT03328325|38308696|FG000|Overall Study|Physician Decision|1|||
17160971|NCT03328325|38308696|FG000|Overall Study|Withdrawal by Subject|3|||
17160972|NCT03328325|38308696|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
17160973|NCT03226249|38308704|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
17160974|NCT03226249|38308704|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
17160975|NCT03226249|38308704|FG000|Survival Follow-up|Patients still in follow-up.|30|||
17160976|NCT03305081|38308710|FG000|Overall Study|Lost to Follow-up|10|||
17160977|NCT03305081|38308711|FG001|Overall Study|Lost to Follow-up|15|||
17160978|NCT03325673|38308729|FG000|Overall Study|Adverse Event|4|||
17160979|NCT03325673|38308730|FG001|Overall Study|Adverse Event|0|||
17160980|NCT03223909|38308739|FG000|Overall Study|Protocol Violation|48|||
17160981|NCT03223909|38308740|FG001|Overall Study|Protocol Violation|45|||
17160982|NCT03223909|38308741|FG002|Overall Study|Protocol Violation|16|||
17160983|NCT03733925|38308749|FG000|Overall Study|Lost to Follow-up|1|||
17160984|NCT03733925|38308749|FG000|Overall Study|Withdrawal by Subject|2|||
17160985|NCT03733925|38308749|FG000|Overall Study|Adverse Event|2|||
17160986|NCT03733925|38308749|FG000|Overall Study|Non-Compliance with Study Drug|1|||
17160987|NCT03649711|38308756|FG000|Overall Study|Adverse Event|0|||
17160988|NCT03649711|38308757|FG001|Overall Study|Adverse Event|1|||
17160989|NCT03649711|38308758|FG002|Overall Study|Adverse Event|0|||
17160990|NCT03649711|38308756|FG000|Overall Study|Kidney Transplant|1|||
16995597|NCT00995774|38139369|FG001|Training Period 2|Withdrawal by Subject|0|||
16995598|NCT00765388|38139375|FG000|Period 1|Lack of Efficacy|1|||
16995599|NCT00765388|38139376|FG001|Period 1|Lack of Efficacy|2|||
16995600|NCT00765388|38139375|FG000|Period 1|Lost to Follow-up|0|||
16995601|NCT00765388|38139376|FG001|Period 1|Lost to Follow-up|1|||
16995602|NCT00765388|38139375|FG000|Period 1|Herpes Zoster|0|||
16995603|NCT00765388|38139376|FG001|Period 1|Herpes Zoster|1|||
16995604|NCT00765388|38139375|FG000|Period 1|Hip operation|0|||
17160991|NCT03649711|38308757|FG001|Overall Study|Kidney Transplant|0|||
16995605|NCT00765388|38139376|FG001|Period 1|Hip operation|1|||
16995606|NCT00769132|38139391|FG000|Period 1|Adverse Event|1|||
17160992|NCT03649711|38308758|FG002|Overall Study|Kidney Transplant|0|||
17160993|NCT03303521|38308768|FG000|Overall Study|Withdrawal by Subject|2|||
17160994|NCT03303521|38308769|FG001|Overall Study|Withdrawal by Subject|0|||
17160995|NCT03303521|38308768|FG000|Overall Study|Death|1|||
17160996|NCT03303521|38308769|FG001|Overall Study|Death|0|||
17160997|NCT03303521|38308768|FG000|Overall Study|Kidney transplantation|0|||
17160998|NCT03303521|38308769|FG001|Overall Study|Kidney transplantation|1|||
17160999|NCT03303521|38308768|FG000|Overall Study|Investigational product discontinuation|0|||
17161000|NCT03303521|38308769|FG001|Overall Study|Investigational product discontinuation|1|||
17161001|NCT03303521|38308768|FG000|Overall Study|Transferred to non-study dialysis center|1|||
17161002|NCT03303521|38308769|FG001|Overall Study|Transferred to non-study dialysis center|0|||
17161003|NCT03303521|38308768|FG000|Overall Study|Non-comliance to study protocol|0|||
17161004|NCT03303521|38308769|FG001|Overall Study|Non-comliance to study protocol|1|||
17081499|NCT00407030|38222451|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
17081500|NCT00407030|38222452|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
17081501|NCT00407030|38222450|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
17081502|NCT00407030|38222451|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
17081503|NCT00407030|38222452|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
17081504|NCT00407030|38222450|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
17081505|NCT00407030|38222451|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
17081506|NCT00407030|38222452|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
17161005|NCT03303521|38308768|FG000|Overall Study|Adverse Event|1|||
17161006|NCT03303521|38308769|FG001|Overall Study|Adverse Event|0|||
17081507|NCT00407030|38222450|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
17081508|NCT00407030|38222451|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
17081509|NCT00407030|38222452|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
17081510|NCT00406718|38222465|FG000|Overall Study|Withdrawal by Subject|2|||
17081511|NCT00406718|38222466|FG001|Overall Study|Withdrawal by Subject|9|||
17081512|NCT00406718|38222467|FG002|Overall Study|Withdrawal by Subject|4|||
17081513|NCT00406718|38222465|FG000|Overall Study|Lost to Follow-up|2|||
17081514|NCT00406718|38222466|FG001|Overall Study|Lost to Follow-up|5|||
17081515|NCT00406718|38222467|FG002|Overall Study|Lost to Follow-up|4|||
17081516|NCT00406640|38222479|FG000|Acute Phase|Adverse Event|18|||
17081517|NCT00406640|38222480|FG001|Acute Phase|Adverse Event|13|||
17081518|NCT00406640|38222479|FG000|Acute Phase|Failed to Return|5|||
17081519|NCT00406640|38222480|FG001|Acute Phase|Failed to Return|1|||
17081520|NCT00406640|38222479|FG000|Acute Phase|Physician Decision|0|||
17081521|NCT00406640|38222480|FG001|Acute Phase|Physician Decision|1|||
17081522|NCT00406640|38222479|FG000|Acute Phase|Lost to Follow-up|7|||
17081523|NCT00406640|38222480|FG001|Acute Phase|Lost to Follow-up|4|||
17081524|NCT00406640|38222479|FG000|Acute Phase|Protocol deviation|4|||
17081525|NCT00406640|38222480|FG001|Acute Phase|Protocol deviation|10|||
17081526|NCT00406640|38222479|FG000|Acute Phase|Protocol Violation|3|||
17081527|NCT00406640|38222480|FG001|Acute Phase|Protocol Violation|2|||
17081528|NCT00406640|38222479|FG000|Acute Phase|Withdrawal by Subject|11|||
17081529|NCT00406640|38222480|FG001|Acute Phase|Withdrawal by Subject|9|||
17081530|NCT00406640|38222479|FG000|Acute Phase|Lack of Efficacy|3|||
17081531|NCT00406640|38222480|FG001|Acute Phase|Lack of Efficacy|3|||
17081532|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
17081533|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
17081534|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|Death|1|||
17081535|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|Death|0|||
17081536|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
17081537|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
17081538|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
17081539|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
17081540|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
17081541|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
17081542|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|non-compliance|7|||
17081543|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|non-compliance|5|||
17081544|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
17081545|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
17081546|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
17081547|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
17081548|NCT00406640|38222479|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
17081549|NCT00406640|38222480|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
17081550|NCT00406640|38222479|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
17081551|NCT00406640|38222480|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
17081552|NCT00406640|38222479|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
17081553|NCT00406640|38222480|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
17081554|NCT00406640|38222479|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
17081555|NCT00406640|38222480|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
17081556|NCT00406640|38222479|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
17081557|NCT00406640|38222480|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
17081558|NCT00406640|38222479|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
17081559|NCT00406640|38222480|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
17081560|NCT00406640|38222479|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
17081561|NCT00406640|38222480|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
17081562|NCT00406640|38222479|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
17081563|NCT00406640|38222480|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
17081564|NCT00394706|38222500|FG000|Overall Study|Withdrawal by Subject|2|||
17081565|NCT00394706|38222501|FG001|Overall Study|Withdrawal by Subject|0|||
17081566|NCT00394706|38222502|FG002|Overall Study|Withdrawal by Subject|1|||
17081567|NCT00394706|38222503|FG003|Overall Study|Withdrawal by Subject|0|||
17081568|NCT00394706|38222504|FG004|Overall Study|Withdrawal by Subject|0|||
17081569|NCT00394706|38222505|FG005|Overall Study|Withdrawal by Subject|2|||
17081570|NCT00394706|38222506|FG006|Overall Study|Withdrawal by Subject|1|||
17081571|NCT00394706|38222507|FG007|Overall Study|Withdrawal by Subject|0|||
17081572|NCT00394706|38222500|FG000|Overall Study|Lost to Follow-up|2|||
17081573|NCT00394706|38222501|FG001|Overall Study|Lost to Follow-up|2|||
17081574|NCT00394706|38222502|FG002|Overall Study|Lost to Follow-up|8|||
17081575|NCT00394706|38222503|FG003|Overall Study|Lost to Follow-up|1|||
17081576|NCT00394706|38222504|FG004|Overall Study|Lost to Follow-up|2|||
17081577|NCT00394706|38222505|FG005|Overall Study|Lost to Follow-up|5|||
17081578|NCT00394706|38222506|FG006|Overall Study|Lost to Follow-up|2|||
17081579|NCT00394706|38222507|FG007|Overall Study|Lost to Follow-up|0|||
17081580|NCT00394472|38222523|FG000|Overall Study|Protocol Violation|1|||
17081581|NCT00394472|38222524|FG001|Overall Study|Protocol Violation|3|||
17081582|NCT00394472|38222523|FG000|Overall Study|incorrect enrolment|4|||
17081583|NCT00394472|38222524|FG001|Overall Study|incorrect enrolment|2|||
17081584|NCT00394472|38222523|FG000|Overall Study|Adverse Event|4|||
17081585|NCT00394472|38222524|FG001|Overall Study|Adverse Event|2|||
17081586|NCT00394472|38222523|FG000|Overall Study|Withdrawal by Subject|0|||
17081587|NCT00394472|38222524|FG001|Overall Study|Withdrawal by Subject|2|||
17081588|NCT00394472|38222523|FG000|Overall Study|Physician Decision|0|||
17081589|NCT00394472|38222524|FG001|Overall Study|Physician Decision|1|||
17081590|NCT00394472|38222523|FG000|Overall Study|Lost to Follow-up|0|||
17081591|NCT00394472|38222524|FG001|Overall Study|Lost to Follow-up|1|||
17081592|NCT00395642|38222530|FG000|Overall Study|Death|4|||
17081593|NCT00395642|38222530|FG000|Overall Study|Lost to Follow-up|1|||
17081594|NCT00395642|38222530|FG000|Overall Study|Physician Decision|7|||
17081595|NCT00395642|38222530|FG000|Overall Study|Withdrawal by Subject|1|||
17081596|NCT00395486|38222536|FG000|Overall Study|Adverse Event|1|||
17081597|NCT00395486|38222537|FG001|Overall Study|Adverse Event|2|||
17081598|NCT00395486|38222536|FG000|Overall Study|Withdrawal by Subject|5|||
17081599|NCT00395486|38222537|FG001|Overall Study|Withdrawal by Subject|2|||
17081600|NCT00395486|38222536|FG000|Overall Study|Lost to Follow-up|0|||
17081601|NCT00395486|38222537|FG001|Overall Study|Lost to Follow-up|1|||
17081602|NCT00395018|38222543|FG000|On-Treatment|Death|4|||
17081603|NCT00395018|38222543|FG000|On-Treatment|Other Reason|2|||
17081604|NCT00395018|38222543|FG000|On-Treatment|Poor/non-compliance|2|||
17081605|NCT00395018|38222543|FG000|On-Treatment|Subject no longer meets study criteria|2|||
17081606|NCT00395018|38222543|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
17081607|NCT00395018|38222543|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
17081608|NCT00395018|38222543|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
17081609|NCT00375518|38222549|FG000|Overall Study|Withdrawal by Subject|2|||
17081610|NCT00375518|38222550|FG001|Overall Study|Withdrawal by Subject|10|||
17081611|NCT00375518|38222549|FG000|Overall Study|Patient Not Treated|6|||
17081612|NCT00375518|38222550|FG001|Overall Study|Patient Not Treated|6|||
17081613|NCT00375518|38222549|FG000|Overall Study|Death|0|||
17081614|NCT00375518|38222550|FG001|Overall Study|Death|1|||
17081615|NCT00256750|38222559|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
17081616|NCT00256750|38222560|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
17081617|NCT00256750|38222561|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
17081618|NCT00256750|38222559|FG000|Transplanted Pre-Treatment|Other|2|||
17081619|NCT00256750|38222560|FG001|Transplanted Pre-Treatment|Other|0|||
17081620|NCT00256750|38222561|FG002|Transplanted Pre-Treatment|Other|0|||
17081621|NCT00256750|38222559|FG000|Transplanted Pre-Treatment|Death|1|||
17081622|NCT00256750|38222560|FG001|Transplanted Pre-Treatment|Death|0|||
17081623|NCT00256750|38222561|FG002|Transplanted Pre-Treatment|Death|0|||
17081624|NCT00256750|38222559|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
17081625|NCT00256750|38222560|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
17081626|NCT00256750|38222561|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
17081627|NCT00256750|38222559|FG000|Post-Transplant Treated (12 Months)|Death|3|||
17081628|NCT00256750|38222560|FG001|Post-Transplant Treated (12 Months)|Death|2|||
17081629|NCT00256750|38222561|FG002|Post-Transplant Treated (12 Months)|Death|4|||
17081630|NCT00256750|38222559|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
17081631|NCT00256750|38222560|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
17081632|NCT00256750|38222561|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
17081633|NCT00256750|38222559|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
17081634|NCT00256750|38222560|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
17081635|NCT00256750|38222561|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
17081636|NCT00256750|38222559|FG000|Post-Transplant Treated (12 Months)|Other|5|||
17081637|NCT00256750|38222560|FG001|Post-Transplant Treated (12 Months)|Other|4|||
17081638|NCT00256750|38222561|FG002|Post-Transplant Treated (12 Months)|Other|2|||
17081639|NCT00256750|38222559|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
17081640|NCT00256750|38222560|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
17081641|NCT00256750|38222561|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
17081642|NCT00256750|38222559|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
17081643|NCT00256750|38222560|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
17081644|NCT00256750|38222561|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
17081645|NCT00256750|38222559|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
17081646|NCT00256750|38222560|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
17081647|NCT00256750|38222561|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
17081648|NCT00256750|38222559|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
17081649|NCT00256750|38222560|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
17081650|NCT00256750|38222561|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
17081651|NCT00256750|38222559|FG000|Post-Transplant Treated (24 Months)|Death|3|||
17081652|NCT00256750|38222560|FG001|Post-Transplant Treated (24 Months)|Death|0|||
17081653|NCT00256750|38222561|FG002|Post-Transplant Treated (24 Months)|Death|0|||
17081654|NCT00256750|38222559|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
17081655|NCT00256750|38222560|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
17081656|NCT00256750|38222561|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
17081657|NCT00256750|38222559|FG000|Post-Transplant Treated (24 Months)|Other|2|||
17081658|NCT00256750|38222560|FG001|Post-Transplant Treated (24 Months)|Other|0|||
17081659|NCT00256750|38222561|FG002|Post-Transplant Treated (24 Months)|Other|1|||
17081660|NCT00256750|38222559|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
17081661|NCT00256750|38222560|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
17081662|NCT00256750|38222561|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
17081663|NCT00256750|38222559|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
17081664|NCT00256750|38222560|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
17081665|NCT00256750|38222561|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
17081666|NCT00256750|38222559|FG000|Post-Transplant Treated (36 Months)|Death|0|||
17081667|NCT00256750|38222560|FG001|Post-Transplant Treated (36 Months)|Death|2|||
17081668|NCT00256750|38222561|FG002|Post-Transplant Treated (36 Months)|Death|1|||
17081669|NCT00256750|38222559|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
17081670|NCT00256750|38222560|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
17081671|NCT00256750|38222561|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
17081672|NCT00256750|38222559|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
17081673|NCT00256750|38222560|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
17081674|NCT00256750|38222561|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
17081675|NCT00256750|38222559|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
17081676|NCT00256750|38222560|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
17081677|NCT00256750|38222561|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
17081678|NCT00256750|38222559|FG000|Post-Transplant Treated (36 Months)|Other|0|||
17081679|NCT00256750|38222560|FG001|Post-Transplant Treated (36 Months)|Other|1|||
17081680|NCT00256750|38222561|FG002|Post-Transplant Treated (36 Months)|Other|1|||
17081681|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
17081682|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
17081683|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
17081684|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
17081685|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
17081686|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
17081687|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
17081688|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
17081689|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
17081690|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
17081691|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
17081692|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
17081693|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
17081694|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
17081695|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
17081696|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
17081697|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
17081698|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
17081699|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
17081700|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
17081701|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
17081702|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
17081703|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
17081704|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
17081705|NCT00256750|38222559|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
17081706|NCT00256750|38222560|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
17081707|NCT00256750|38222561|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
17081708|NCT00279201|38222572|FG000|Initiation|Death|1|||
17081709|NCT00279201|38222573|FG001|Initiation|Death|5|||
17081710|NCT00279201|38222574|FG002|Initiation|Death|0|||
17081711|NCT00279201|38222575|FG003|Initiation|Death|0|||
17081712|NCT00279201|38222576|FG004|Initiation|Death|0|||
17081713|NCT00279201|38222577|FG005|Initiation|Death|0|||
17081714|NCT00279201|38222572|FG000|Initiation|Adverse Event|6|||
17081715|NCT00279201|38222573|FG001|Initiation|Adverse Event|15|||
17081716|NCT00279201|38222574|FG002|Initiation|Adverse Event|0|||
17081717|NCT00279201|38222575|FG003|Initiation|Adverse Event|0|||
17081718|NCT00279201|38222576|FG004|Initiation|Adverse Event|0|||
17081719|NCT00279201|38222577|FG005|Initiation|Adverse Event|0|||
17081720|NCT00279201|38222572|FG000|Initiation|Lost to Follow-up|42|||
17081721|NCT00279201|38222573|FG001|Initiation|Lost to Follow-up|41|||
17081722|NCT00279201|38222574|FG002|Initiation|Lost to Follow-up|0|||
17081723|NCT00279201|38222575|FG003|Initiation|Lost to Follow-up|0|||
17081724|NCT00279201|38222576|FG004|Initiation|Lost to Follow-up|0|||
17081725|NCT00279201|38222577|FG005|Initiation|Lost to Follow-up|0|||
17081726|NCT00279201|38222572|FG000|Initiation|Entry Criteria Exclusion|7|||
17081727|NCT00279201|38222573|FG001|Initiation|Entry Criteria Exclusion|9|||
17081728|NCT00279201|38222574|FG002|Initiation|Entry Criteria Exclusion|0|||
17081729|NCT00279201|38222575|FG003|Initiation|Entry Criteria Exclusion|0|||
17081730|NCT00279201|38222576|FG004|Initiation|Entry Criteria Exclusion|0|||
17081731|NCT00279201|38222577|FG005|Initiation|Entry Criteria Exclusion|0|||
17081732|NCT00279201|38222572|FG000|Initiation|Protocol Violation|9|||
17081733|NCT00279201|38222573|FG001|Initiation|Protocol Violation|10|||
17081734|NCT00279201|38222574|FG002|Initiation|Protocol Violation|0|||
17081735|NCT00279201|38222575|FG003|Initiation|Protocol Violation|0|||
16995607|NCT00769132|38139392|FG001|Period 1|Adverse Event|0|||
16995608|NCT00769132|38139393|FG002|Period 1|Adverse Event|0|||
16995609|NCT00769132|38139394|FG003|Period 1|Adverse Event|1|||
16995610|NCT00769132|38139391|FG000|Period 2|Withdrawal by Subject|0|||
16995611|NCT00769132|38139392|FG001|Period 2|Withdrawal by Subject|0|||
16995612|NCT00769132|38139393|FG002|Period 2|Withdrawal by Subject|0|||
16995613|NCT00769132|38139394|FG003|Period 2|Withdrawal by Subject|1|||
16995614|NCT00769132|38139391|FG000|Period 3|Withdrawal by Subject|1|||
16995615|NCT00769132|38139392|FG001|Period 3|Withdrawal by Subject|0|||
16995616|NCT00769132|38139393|FG002|Period 3|Withdrawal by Subject|0|||
16995617|NCT00769132|38139394|FG003|Period 3|Withdrawal by Subject|0|||
16995618|NCT00769132|38139391|FG000|Period 4|Withdrawal by Subject|0|||
16995619|NCT00769132|38139392|FG001|Period 4|Withdrawal by Subject|1|||
16995620|NCT00769132|38139393|FG002|Period 4|Withdrawal by Subject|0|||
16995621|NCT00769132|38139394|FG003|Period 4|Withdrawal by Subject|0|||
16995622|NCT00991952|38139406|FG000|Overall Study|Adverse Event|0|||
16995623|NCT00991952|38139407|FG001|Overall Study|Adverse Event|1|||
16995624|NCT00779038|38139413|FG000|Overall Study|Study Prematurely Terminated|13|||
16995625|NCT00765076|38139420|FG000|Overall Study|Adverse Event|1|||
16995626|NCT00765076|38139421|FG001|Overall Study|Adverse Event|0|||
16995627|NCT00765076|38139422|FG002|Overall Study|Adverse Event|0|||
16995628|NCT00765076|38139420|FG000|Overall Study|Withdrawal by Subject|0|||
16995629|NCT00765076|38139421|FG001|Overall Study|Withdrawal by Subject|0|||
16995630|NCT00765076|38139422|FG002|Overall Study|Withdrawal by Subject|1|||
16995631|NCT00994682|38139432|FG000|Double Bilnd|Withdrawal by Subject|5|||
16995632|NCT00994682|38139433|FG001|Double Bilnd|Withdrawal by Subject|6|||
16995633|NCT00994682|38139432|FG000|Double Bilnd|Lost to Follow-up|3|||
16995634|NCT00994682|38139433|FG001|Double Bilnd|Lost to Follow-up|3|||
16995635|NCT00994682|38139432|FG000|Double Bilnd|Adverse Event|1|||
16995636|NCT00994682|38139433|FG001|Double Bilnd|Adverse Event|0|||
16995637|NCT00994682|38139432|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
16995638|NCT00994682|38139433|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
16995639|NCT00994682|38139432|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
16995640|NCT00994682|38139433|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
16995641|NCT00994682|38139432|FG000|Pioglitazone Open Label|Physician Decision|6|||
16995642|NCT00994682|38139433|FG001|Pioglitazone Open Label|Physician Decision|1|||
16995643|NCT00768898|38139443|FG000|Overall Study|Unrelated injury|1|||
16995644|NCT00768898|38139443|FG000|Overall Study|Headache|1|||
16995645|NCT00994448|38139454|FG000|Overall Study|Adverse Event|1|||
16995646|NCT00994448|38139455|FG001|Overall Study|Adverse Event|0|||
16995647|NCT00994448|38139454|FG000|Overall Study|Lost to Follow-up|5|||
17081736|NCT00279201|38222576|FG004|Initiation|Protocol Violation|0|||
17081737|NCT00279201|38222577|FG005|Initiation|Protocol Violation|0|||
17081738|NCT00279201|38222572|FG000|Initiation|Withdrawal by Subject|35|||
17081739|NCT00279201|38222573|FG001|Initiation|Withdrawal by Subject|41|||
17081740|NCT00279201|38222574|FG002|Initiation|Withdrawal by Subject|0|||
17081741|NCT00279201|38222575|FG003|Initiation|Withdrawal by Subject|0|||
17081742|NCT00279201|38222576|FG004|Initiation|Withdrawal by Subject|0|||
17161007|NCT03214081|38308775|FG000|Overall Study|Case Report Forms Uncollected|9|||
17161008|NCT03214081|38308775|FG000|Overall Study|Protocol Deviation|54|||
17161009|NCT02888171|38308781|FG000|Overall Study|Lost to Follow-up|2|||
17161010|NCT02888171|38308782|FG001|Overall Study|Lost to Follow-up|1|||
17161011|NCT02888171|38308781|FG000|Overall Study|Withdrawal by Subject|3|||
17161012|NCT02888171|38308782|FG001|Overall Study|Withdrawal by Subject|2|||
17161013|NCT02888171|38308781|FG000|Overall Study|Adverse Event|0|||
17161014|NCT02888171|38308782|FG001|Overall Study|Adverse Event|1|||
17161015|NCT02932891|38308788|FG000|Overall Study|Lost to Follow-up|2|||
17161016|NCT02932891|38308788|FG000|Overall Study|HPA Suppress|2|||
17161017|NCT03302975|38308792|FG000|Overall Study|Lost to Follow-up|4|||
17161018|NCT03212521|38308796|FG000|Overall Study|Adverse Event|1|||
17161019|NCT03212521|38308796|FG000|Overall Study|Lost to Follow-up|4|||
17161020|NCT03212521|38308796|FG000|Overall Study|Withdrawal by Subject|1|||
17161021|NCT03212521|38308796|FG000|Overall Study|Other|1|||
17161022|NCT03212365|38308802|FG000|Overall Study|Discharged prior to Xa level|12|||
17161023|NCT03212365|38308803|FG001|Overall Study|Discharged prior to Xa level|8|||
17161024|NCT03212365|38308802|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
17161025|NCT03212365|38308803|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
17161026|NCT03212365|38308802|FG000|Overall Study|Refused study medication|3|||
17161027|NCT03212365|38308803|FG001|Overall Study|Refused study medication|0|||
17161028|NCT03212365|38308802|FG000|Overall Study|Initiated heparin infusion on floor|1|||
17161029|NCT03212365|38308803|FG001|Overall Study|Initiated heparin infusion on floor|1|||
17161030|NCT03212365|38308802|FG000|Overall Study|Unexpected return to OR|1|||
17161031|NCT03212365|38308803|FG001|Overall Study|Unexpected return to OR|1|||
17161032|NCT03212365|38308802|FG000|Overall Study|Medication distribution error|1|||
17161033|NCT03212365|38308803|FG001|Overall Study|Medication distribution error|0|||
17161034|NCT03212365|38308802|FG000|Overall Study|Required epidural placement|1|||
17161035|NCT03212365|38308803|FG001|Overall Study|Required epidural placement|0|||
17161036|NCT03212365|38308802|FG000|Overall Study|Withdrawal by Subject|0|||
17161037|NCT03212365|38308803|FG001|Overall Study|Withdrawal by Subject|1|||
17161038|NCT03212365|38308802|FG000|Overall Study|developed acute renal failure|0|||
17161039|NCT03212365|38308803|FG001|Overall Study|developed acute renal failure|1|||
17161040|NCT03273257|38308811|FG000|Overall Study|Death|0|||
17161041|NCT03273257|38308812|FG001|Overall Study|Death|1|||
17161042|NCT03273257|38308811|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
17161043|NCT03273257|38308812|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
17161044|NCT03273257|38308811|FG000|Overall Study|Study terminated|3|||
17161045|NCT03273257|38308812|FG001|Overall Study|Study terminated|2|||
17161046|NCT04316741|38308820|FG000|Baseline Enrollment|Lost to Follow-up|1|||
17161047|NCT04316741|38308821|FG001|Baseline Enrollment|Lost to Follow-up|1|||
17161048|NCT04316741|38308820|FG000|Immediate Post-Test|Lost to Follow-up|5|||
17161049|NCT04316741|38308821|FG001|Immediate Post-Test|Lost to Follow-up|1|||
17161050|NCT04316741|38308820|FG000|1-month Post-test|Lost to Follow-up|7|||
17161051|NCT04316741|38308821|FG001|1-month Post-test|Lost to Follow-up|2|||
17161052|NCT04316741|38308820|FG000|3-month Follow-up|Lost to Follow-up|10|||
17161053|NCT04316741|38308821|FG001|3-month Follow-up|Lost to Follow-up|2|||
17161054|NCT03271307|38308831|FG000|Overall Study|Lost to Follow-up|0|||
17161055|NCT03271307|38308832|FG001|Overall Study|Lost to Follow-up|0|||
17161056|NCT03271307|38308833|FG002|Overall Study|Lost to Follow-up|0|||
17161057|NCT03271307|38308834|FG003|Overall Study|Lost to Follow-up|28|||
17161058|NCT03271307|38308835|FG004|Overall Study|Lost to Follow-up|91|||
17161059|NCT03271151|38308852|FG000|Overall Study|Lost to Follow-up|1|||
17161060|NCT03271151|38308853|FG001|Overall Study|Lost to Follow-up|3|||
16995648|NCT00994448|38139455|FG001|Overall Study|Lost to Follow-up|1|||
16995649|NCT00994448|38139454|FG000|Overall Study|Withdrawal by Subject|1|||
16995650|NCT00994448|38139455|FG001|Overall Study|Withdrawal by Subject|1|||
16995651|NCT00994448|38139454|FG000|Overall Study|Physician Decision|1|||
16995652|NCT00994448|38139455|FG001|Overall Study|Physician Decision|0|||
17081743|NCT00279201|38222577|FG005|Initiation|Withdrawal by Subject|0|||
17081744|NCT00279201|38222572|FG000|Initiation|Physician Decision|15|||
17081745|NCT00279201|38222573|FG001|Initiation|Physician Decision|18|||
17081746|NCT00279201|38222574|FG002|Initiation|Physician Decision|0|||
17161061|NCT03271151|38308852|FG000|Overall Study|Withdrawal by Subject|1|||
17161062|NCT03271151|38308853|FG001|Overall Study|Withdrawal by Subject|0|||
17161063|NCT03245723|38308861|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
17161064|NCT03245723|38308862|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
17161065|NCT03245723|38308861|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
17161066|NCT03245723|38308862|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
17161067|NCT03245723|38308861|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
17161068|NCT03245723|38308862|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
17161069|NCT03245723|38308861|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
17161070|NCT03245723|38308862|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
17161071|NCT03301649|38308871|FG000|Overall Study|Need alternate therapy due to live lice|17|||
17161072|NCT03301649|38308872|FG001|Overall Study|Need alternate therapy due to live lice|25|||
17161073|NCT03301649|38308873|FG002|Overall Study|Need alternate therapy due to live lice|81|||
17161074|NCT03301649|38308871|FG000|Overall Study|Lost to Follow-up|11|||
17161075|NCT03301649|38308872|FG001|Overall Study|Lost to Follow-up|11|||
17161076|NCT03301649|38308873|FG002|Overall Study|Lost to Follow-up|3|||
17161077|NCT03301649|38308871|FG000|Overall Study|Protocol Violation|0|||
17081747|NCT00279201|38222575|FG003|Initiation|Physician Decision|0|||
17081748|NCT00279201|38222576|FG004|Initiation|Physician Decision|0|||
17081749|NCT00279201|38222577|FG005|Initiation|Physician Decision|0|||
17081750|NCT00279201|38222572|FG000|Initiation|Sponsor Decision|13|||
17081751|NCT00279201|38222573|FG001|Initiation|Sponsor Decision|5|||
17081752|NCT00279201|38222574|FG002|Initiation|Sponsor Decision|0|||
17081753|NCT00279201|38222575|FG003|Initiation|Sponsor Decision|0|||
17161078|NCT03301649|38308872|FG001|Overall Study|Protocol Violation|1|||
17161079|NCT03301649|38308873|FG002|Overall Study|Protocol Violation|1|||
17161080|NCT03301649|38308871|FG000|Overall Study|Withdrawal by Subject|10|||
17161081|NCT03301649|38308872|FG001|Overall Study|Withdrawal by Subject|4|||
17161082|NCT03301649|38308873|FG002|Overall Study|Withdrawal by Subject|0|||
17161083|NCT03301649|38308871|FG000|Overall Study|Other than specified|5|||
17161084|NCT03301649|38308872|FG001|Overall Study|Other than specified|3|||
17161085|NCT03301649|38308873|FG002|Overall Study|Other than specified|0|||
17161086|NCT03222973|38308883|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
17161087|NCT03222973|38308884|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
17161088|NCT03222973|38308885|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
17161089|NCT03222973|38308886|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
17161090|NCT03222973|38308883|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
17161091|NCT03222973|38308884|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
17161092|NCT03222973|38308885|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
17161093|NCT03222973|38308886|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
17161094|NCT03222973|38308883|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
17161095|NCT03222973|38308884|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
17161096|NCT03222973|38308885|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
17161097|NCT03222973|38308886|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
17161098|NCT03222973|38308883|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
17161099|NCT03222973|38308884|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
17161100|NCT03222973|38308885|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
17161101|NCT03222973|38308886|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
17161102|NCT03222973|38308883|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
17161103|NCT03222973|38308884|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
17161104|NCT03222973|38308885|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
17161105|NCT03222973|38308886|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
17161106|NCT03222973|38308883|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
17161107|NCT03222973|38308884|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
17161108|NCT03222973|38308885|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
17161109|NCT03222973|38308886|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
17161110|NCT03222973|38308883|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
17161111|NCT03222973|38308884|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
17161112|NCT03222973|38308885|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
17161113|NCT03222973|38308886|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
17161114|NCT03222973|38308883|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
17161115|NCT03222973|38308884|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
17161116|NCT03222973|38308885|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
17161117|NCT03222973|38308886|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
17161118|NCT03222973|38308883|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
17161119|NCT03222973|38308884|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
17161120|NCT03222973|38308885|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
17161121|NCT03222973|38308886|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
17161122|NCT03222973|38308883|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
17161123|NCT03222973|38308884|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
17161124|NCT03222973|38308885|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
17161125|NCT03222973|38308886|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
17161126|NCT03222973|38308883|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
17161127|NCT03222973|38308884|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
17081754|NCT00279201|38222576|FG004|Initiation|Sponsor Decision|0|||
17161128|NCT03222973|38308885|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
17161129|NCT03222973|38308886|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
17161130|NCT03222973|38308883|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
17161131|NCT03222973|38308884|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
17161132|NCT03222973|38308885|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
17161133|NCT03222973|38308886|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
17161134|NCT01144416|38308898|FG000|Intervention Period|Adverse Event|5|||
17161135|NCT01144416|38308899|FG001|Intervention Period|Adverse Event|6|||
17161136|NCT01144416|38308898|FG000|Intervention Period|Insufficient ovarian response|11|||
17161137|NCT01144416|38308899|FG001|Intervention Period|Insufficient ovarian response|17|||
17161138|NCT01144416|38308898|FG000|Intervention Period|Risk of OHSS|0|||
17081755|NCT00279201|38222577|FG005|Initiation|Sponsor Decision|0|||
17161139|NCT01144416|38308899|FG001|Intervention Period|Risk of OHSS|1|||
17161140|NCT01144416|38308898|FG000|Intervention Period|Too high ovarian response|4|||
17161141|NCT01144416|38308899|FG001|Intervention Period|Too high ovarian response|2|||
17161142|NCT01144416|38308898|FG000|Intervention Period|No/too few/bad oocytes|7|||
17161143|NCT01144416|38308899|FG001|Intervention Period|No/too few/bad oocytes|5|||
17161144|NCT01144416|38308898|FG000|Intervention Period|No or abnormal fertilization|25|||
17161145|NCT01144416|38308899|FG001|Intervention Period|No or abnormal fertilization|10|||
17161146|NCT01144416|38308898|FG000|Intervention Period|No/too few/bad quality embryos|3|||
17161147|NCT01144416|38308899|FG001|Intervention Period|No/too few/bad quality embryos|3|||
17161148|NCT01144416|38308898|FG000|Intervention Period|Other|7|||
17161149|NCT01144416|38308899|FG001|Intervention Period|Other|5|||
17161150|NCT00335777|38308909|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
17161151|NCT00335777|38308909|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
17161152|NCT00335777|38308909|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
17161153|NCT00335777|38308909|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
17161154|NCT00335777|38308909|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
17161155|NCT01140048|38308914|FG000|Overall Study|Physician Decision|1|||
17161156|NCT01140048|38308914|FG000|Overall Study|Withdrawal by Subject|13|||
17161157|NCT01140048|38308914|FG000|Overall Study|Lost to Follow-up|31|||
17161158|NCT02889809|38308920|FG000|Overall Study|Withdrawal by Subject|30|||
17161159|NCT02889809|38308921|FG001|Overall Study|Withdrawal by Subject|21|||
17161160|NCT02889809|38308920|FG000|Overall Study|Lost to Follow-up|1|||
17161161|NCT02889809|38308921|FG001|Overall Study|Lost to Follow-up|1|||
17161162|NCT02889809|38308920|FG000|Overall Study|Site Closed|12|||
17161163|NCT02889809|38308921|FG001|Overall Study|Site Closed|11|||
17161164|NCT00972738|38308934|FG000|Overall Study|Adverse Event|7|||
17161165|NCT00972738|38308935|FG001|Overall Study|Adverse Event|1|||
17161166|NCT00972738|38308936|FG002|Overall Study|Adverse Event|8|||
17161167|NCT00972738|38308934|FG000|Overall Study|Protocol Violation|2|||
17161168|NCT00972738|38308935|FG001|Overall Study|Protocol Violation|1|||
17081756|NCT00279201|38222572|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
17081757|NCT00279201|38222573|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
17081758|NCT00279201|38222574|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
17081759|NCT00279201|38222575|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
17081760|NCT00279201|38222576|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
17081761|NCT00279201|38222577|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
17081762|NCT00279201|38222572|FG000|Maintenance|Lack of Efficacy|32|||
17081763|NCT00279201|38222573|FG001|Maintenance|Lack of Efficacy|30|||
17081764|NCT00279201|38222574|FG002|Maintenance|Lack of Efficacy|0|||
17081765|NCT00279201|38222575|FG003|Maintenance|Lack of Efficacy|0|||
17081766|NCT00279201|38222576|FG004|Maintenance|Lack of Efficacy|0|||
17081767|NCT00279201|38222577|FG005|Maintenance|Lack of Efficacy|0|||
17081768|NCT00279201|38222572|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
17081769|NCT00279201|38222573|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
17081770|NCT00279201|38222574|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
17081771|NCT00279201|38222575|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
17081772|NCT00279201|38222576|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
17081773|NCT00279201|38222577|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
17161169|NCT00972738|38308936|FG002|Overall Study|Protocol Violation|3|||
17161170|NCT00972738|38308934|FG000|Overall Study|Lost to Follow-up|1|||
17161171|NCT00972738|38308935|FG001|Overall Study|Lost to Follow-up|0|||
17161172|NCT00972738|38308936|FG002|Overall Study|Lost to Follow-up|1|||
17161173|NCT00972738|38308934|FG000|Overall Study|Lack of Efficacy|5|||
17161174|NCT00972738|38308935|FG001|Overall Study|Lack of Efficacy|1|||
17161175|NCT00972738|38308936|FG002|Overall Study|Lack of Efficacy|11|||
17161176|NCT00972738|38308934|FG000|Overall Study|Withdrawal by Subject|5|||
17161177|NCT00972738|38308935|FG001|Overall Study|Withdrawal by Subject|1|||
17161178|NCT00972738|38308936|FG002|Overall Study|Withdrawal by Subject|4|||
17161179|NCT00972738|38308934|FG000|Overall Study|Moved|0|||
17161180|NCT00972738|38308935|FG001|Overall Study|Moved|0|||
17161181|NCT00972738|38308936|FG002|Overall Study|Moved|1|||
17161182|NCT00972738|38308934|FG000|Overall Study|Other|1|||
17081774|NCT00279201|38222572|FG000|Maintenance|Adverse Event|4|||
17161183|NCT00972738|38308935|FG001|Overall Study|Other|2|||
17161184|NCT00972738|38308936|FG002|Overall Study|Other|1|||
17161185|NCT03243305|38308944|FG000|Overall Study|Lost to Follow-up|250|||
17161186|NCT03243305|38308944|FG000|Overall Study|Withdrawal by Subject|170|||
17161187|NCT03243305|38308944|FG000|Overall Study|Pregnancy|104|||
17161188|NCT03243305|38308944|FG000|Overall Study|Non-Compliance with Study Drug|38|||
17161189|NCT03243305|38308944|FG000|Overall Study|Adverse Event|23|||
17161190|NCT03243305|38308944|FG000|Overall Study|No sexually active|26|||
17161191|NCT03243305|38308944|FG000|Overall Study|Physician Decision|22|||
17161192|NCT03243305|38308944|FG000|Overall Study|Protocol Violation|22|||
17161193|NCT03243305|38308944|FG000|Overall Study|Study method no longer primary method|12|||
17161194|NCT03243305|38308944|FG000|Overall Study|Study Terminated by Sponsor|1|||
17161195|NCT03243305|38308944|FG000|Overall Study|Early terminations|267|||
17161196|NCT03222583|38308950|FG000|Overall Study|Withdrawal by Subject|3|||
17161197|NCT03222583|38308951|FG001|Overall Study|Withdrawal by Subject|3|||
17161198|NCT03222583|38308950|FG000|Overall Study|Lost to Follow-up|1|||
17161199|NCT03222583|38308951|FG001|Overall Study|Lost to Follow-up|0|||
17161200|NCT03222583|38308950|FG000|Overall Study|Other|1|||
17161201|NCT03222583|38308951|FG001|Overall Study|Other|3|||
17081775|NCT00279201|38222573|FG001|Maintenance|Adverse Event|4|||
17081776|NCT00279201|38222574|FG002|Maintenance|Adverse Event|0|||
17081777|NCT00279201|38222575|FG003|Maintenance|Adverse Event|0|||
17081778|NCT00279201|38222576|FG004|Maintenance|Adverse Event|0|||
17081779|NCT00279201|38222577|FG005|Maintenance|Adverse Event|0|||
17081780|NCT00279201|38222572|FG000|Maintenance|Death|4|||
17081781|NCT00279201|38222573|FG001|Maintenance|Death|4|||
17081782|NCT00279201|38222574|FG002|Maintenance|Death|0|||
17081783|NCT00279201|38222575|FG003|Maintenance|Death|0|||
17081784|NCT00279201|38222576|FG004|Maintenance|Death|0|||
17081785|NCT00279201|38222577|FG005|Maintenance|Death|0|||
17081786|NCT00279201|38222572|FG000|Maintenance|Lost to Follow-up|17|||
17081787|NCT00279201|38222573|FG001|Maintenance|Lost to Follow-up|13|||
17081788|NCT00279201|38222574|FG002|Maintenance|Lost to Follow-up|0|||
17081789|NCT00279201|38222575|FG003|Maintenance|Lost to Follow-up|0|||
17081790|NCT00279201|38222576|FG004|Maintenance|Lost to Follow-up|0|||
17081791|NCT00279201|38222577|FG005|Maintenance|Lost to Follow-up|0|||
17081792|NCT00279201|38222572|FG000|Maintenance|Entry Criteria Exclusion|1|||
17081793|NCT00279201|38222573|FG001|Maintenance|Entry Criteria Exclusion|4|||
17081794|NCT00279201|38222574|FG002|Maintenance|Entry Criteria Exclusion|0|||
17081795|NCT00279201|38222575|FG003|Maintenance|Entry Criteria Exclusion|0|||
17081796|NCT00279201|38222576|FG004|Maintenance|Entry Criteria Exclusion|0|||
17081797|NCT00279201|38222577|FG005|Maintenance|Entry Criteria Exclusion|0|||
17081798|NCT00279201|38222572|FG000|Maintenance|Protocol Violation|16|||
17081799|NCT00279201|38222573|FG001|Maintenance|Protocol Violation|24|||
17081800|NCT00279201|38222574|FG002|Maintenance|Protocol Violation|0|||
17081801|NCT00279201|38222575|FG003|Maintenance|Protocol Violation|0|||
17081802|NCT00279201|38222576|FG004|Maintenance|Protocol Violation|0|||
17081803|NCT00279201|38222577|FG005|Maintenance|Protocol Violation|0|||
17081804|NCT00279201|38222572|FG000|Maintenance|Withdrawal by Subject|18|||
17081805|NCT00279201|38222573|FG001|Maintenance|Withdrawal by Subject|18|||
17081806|NCT00279201|38222574|FG002|Maintenance|Withdrawal by Subject|0|||
17081807|NCT00279201|38222575|FG003|Maintenance|Withdrawal by Subject|0|||
17081808|NCT00279201|38222576|FG004|Maintenance|Withdrawal by Subject|0|||
17081809|NCT00279201|38222577|FG005|Maintenance|Withdrawal by Subject|0|||
17081810|NCT00279201|38222572|FG000|Maintenance|Physician Decision|9|||
17081811|NCT00279201|38222573|FG001|Maintenance|Physician Decision|9|||
17081812|NCT00279201|38222574|FG002|Maintenance|Physician Decision|0|||
17081813|NCT00279201|38222575|FG003|Maintenance|Physician Decision|0|||
17081814|NCT00279201|38222576|FG004|Maintenance|Physician Decision|0|||
17081815|NCT00279201|38222577|FG005|Maintenance|Physician Decision|0|||
17081816|NCT00279201|38222572|FG000|Maintenance|Sponsor Decision|4|||
17081817|NCT00279201|38222573|FG001|Maintenance|Sponsor Decision|0|||
17081818|NCT00279201|38222574|FG002|Maintenance|Sponsor Decision|0|||
17081819|NCT00279201|38222575|FG003|Maintenance|Sponsor Decision|0|||
17081820|NCT00279201|38222576|FG004|Maintenance|Sponsor Decision|0|||
17081821|NCT00279201|38222577|FG005|Maintenance|Sponsor Decision|0|||
17081822|NCT00279201|38222572|FG000|Maintenance|HbA1c>7.5%|123|||
17081823|NCT00279201|38222573|FG001|Maintenance|HbA1c>7.5%|126|||
17081824|NCT00279201|38222574|FG002|Maintenance|HbA1c>7.5%|0|||
17081825|NCT00279201|38222575|FG003|Maintenance|HbA1c>7.5%|0|||
17081826|NCT00279201|38222576|FG004|Maintenance|HbA1c>7.5%|0|||
17081827|NCT00279201|38222577|FG005|Maintenance|HbA1c>7.5%|0|||
17081828|NCT00279201|38222572|FG000|Intensification Addendum|Withdrawal by Subject|0|||
17081829|NCT00279201|38222573|FG001|Intensification Addendum|Withdrawal by Subject|0|||
17081830|NCT00279201|38222574|FG002|Intensification Addendum|Withdrawal by Subject|12|||
17081831|NCT00279201|38222575|FG003|Intensification Addendum|Withdrawal by Subject|14|||
17081832|NCT00279201|38222576|FG004|Intensification Addendum|Withdrawal by Subject|9|||
17081833|NCT00279201|38222577|FG005|Intensification Addendum|Withdrawal by Subject|18|||
17081834|NCT00279201|38222572|FG000|Intensification Addendum|Lost to Follow-up|0|||
17081835|NCT00279201|38222573|FG001|Intensification Addendum|Lost to Follow-up|0|||
17081836|NCT00279201|38222574|FG002|Intensification Addendum|Lost to Follow-up|4|||
17081837|NCT00279201|38222575|FG003|Intensification Addendum|Lost to Follow-up|6|||
17081838|NCT00279201|38222576|FG004|Intensification Addendum|Lost to Follow-up|7|||
17081839|NCT00279201|38222577|FG005|Intensification Addendum|Lost to Follow-up|7|||
17081840|NCT00279201|38222572|FG000|Intensification Addendum|Protocol Violation|0|||
17081841|NCT00279201|38222573|FG001|Intensification Addendum|Protocol Violation|0|||
17081842|NCT00279201|38222574|FG002|Intensification Addendum|Protocol Violation|2|||
17081843|NCT00279201|38222575|FG003|Intensification Addendum|Protocol Violation|2|||
17081844|NCT00279201|38222576|FG004|Intensification Addendum|Protocol Violation|6|||
17081845|NCT00279201|38222577|FG005|Intensification Addendum|Protocol Violation|6|||
17081846|NCT00279201|38222572|FG000|Intensification Addendum|Adverse Event|0|||
17081847|NCT00279201|38222573|FG001|Intensification Addendum|Adverse Event|0|||
17081848|NCT00279201|38222574|FG002|Intensification Addendum|Adverse Event|0|||
17081849|NCT00279201|38222575|FG003|Intensification Addendum|Adverse Event|4|||
17081850|NCT00279201|38222576|FG004|Intensification Addendum|Adverse Event|1|||
17081851|NCT00279201|38222577|FG005|Intensification Addendum|Adverse Event|3|||
17081852|NCT00279201|38222572|FG000|Intensification Addendum|Physician Decision|0|||
17081853|NCT00279201|38222573|FG001|Intensification Addendum|Physician Decision|0|||
17081854|NCT00279201|38222574|FG002|Intensification Addendum|Physician Decision|4|||
17081855|NCT00279201|38222575|FG003|Intensification Addendum|Physician Decision|1|||
17081856|NCT00279201|38222576|FG004|Intensification Addendum|Physician Decision|3|||
17081857|NCT00279201|38222577|FG005|Intensification Addendum|Physician Decision|2|||
17081858|NCT00279201|38222572|FG000|Intensification Addendum|Sponsor Decision|0|||
17081859|NCT00279201|38222573|FG001|Intensification Addendum|Sponsor Decision|0|||
17081860|NCT00279201|38222574|FG002|Intensification Addendum|Sponsor Decision|0|||
17081861|NCT00279201|38222575|FG003|Intensification Addendum|Sponsor Decision|0|||
17081862|NCT00279201|38222576|FG004|Intensification Addendum|Sponsor Decision|1|||
17081863|NCT00279201|38222577|FG005|Intensification Addendum|Sponsor Decision|1|||
17081864|NCT00279201|38222572|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
17081865|NCT00279201|38222573|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
17081866|NCT00279201|38222574|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
17081867|NCT00279201|38222575|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
17081868|NCT00279201|38222576|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
17081869|NCT00279201|38222577|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
17081870|NCT00279201|38222572|FG000|Intensification Addendum|Lack of Efficacy|0|||
17081871|NCT00279201|38222573|FG001|Intensification Addendum|Lack of Efficacy|0|||
17081872|NCT00279201|38222574|FG002|Intensification Addendum|Lack of Efficacy|0|||
17081873|NCT00279201|38222575|FG003|Intensification Addendum|Lack of Efficacy|1|||
17081874|NCT00279201|38222576|FG004|Intensification Addendum|Lack of Efficacy|1|||
17081875|NCT00279201|38222577|FG005|Intensification Addendum|Lack of Efficacy|0|||
17081876|NCT00279201|38222572|FG000|Intensification Addendum|Death|0|||
17081877|NCT00279201|38222573|FG001|Intensification Addendum|Death|0|||
17081878|NCT00279201|38222574|FG002|Intensification Addendum|Death|0|||
17081879|NCT00279201|38222575|FG003|Intensification Addendum|Death|0|||
17081880|NCT00279201|38222576|FG004|Intensification Addendum|Death|1|||
17081881|NCT00279201|38222577|FG005|Intensification Addendum|Death|0|||
17081882|NCT00203476|38222613|FG000|Overall Study|Lost to Follow-up|1|||
17081883|NCT00203476|38222614|FG001|Overall Study|Lost to Follow-up|0|||
17081884|NCT00203476|38222615|FG002|Overall Study|Lost to Follow-up|0|||
17081885|NCT00203476|38222613|FG000|Overall Study|Withdrawal by Subject|0|||
17081886|NCT00203476|38222614|FG001|Overall Study|Withdrawal by Subject|1|||
17081887|NCT00203476|38222615|FG002|Overall Study|Withdrawal by Subject|0|||
17081888|NCT00203242|38222623|FG000|Overall Study|Lost to Follow-up|1|||
17081889|NCT00200356|38222629|FG000|Overall Study|Lack of Efficacy|3|||
17081890|NCT00200356|38222630|FG001|Overall Study|Lack of Efficacy|3|||
17081891|NCT00200356|38222629|FG000|Overall Study|Protocol Violation|4|||
17081892|NCT00200356|38222630|FG001|Overall Study|Protocol Violation|4|||
17081893|NCT00200356|38222629|FG000|Overall Study|Nontreatment|1|||
17081894|NCT00200356|38222630|FG001|Overall Study|Nontreatment|0|||
17081895|NCT00227344|38222638|FG000|Overall Study|study terminated early|12|||
17081896|NCT00227344|38222639|FG001|Overall Study|study terminated early|5|||
17081897|NCT00227266|38222648|FG000|Overall Study|Withdrawal by Subject|0|||
17081898|NCT00227266|38222649|FG001|Overall Study|Withdrawal by Subject|0|||
17081899|NCT00227266|38222650|FG002|Overall Study|Withdrawal by Subject|1|||
17081900|NCT00227266|38222648|FG000|Overall Study|Protocol Violation|1|||
17081901|NCT00227266|38222649|FG001|Overall Study|Protocol Violation|0|||
17161202|NCT03295721|38308960|FG000|Overall Study|Adverse Event|1|||
17161203|NCT03295721|38308961|FG001|Overall Study|Adverse Event|0|||
17161204|NCT03295721|38308962|FG002|Overall Study|Adverse Event|0|||
17161205|NCT03295721|38308960|FG000|Overall Study|Lost to Follow-up|1|||
17161206|NCT03295721|38308961|FG001|Overall Study|Lost to Follow-up|1|||
17161207|NCT03295721|38308962|FG002|Overall Study|Lost to Follow-up|1|||
17161208|NCT03295721|38308960|FG000|Overall Study|Withdrawal by Subject|1|||
17161209|NCT03295721|38308961|FG001|Overall Study|Withdrawal by Subject|0|||
17161210|NCT03295721|38308962|FG002|Overall Study|Withdrawal by Subject|1|||
17161211|NCT03295721|38308960|FG000|Overall Study|Death|0|||
17161212|NCT03295721|38308961|FG001|Overall Study|Death|0|||
17161213|NCT03295721|38308962|FG002|Overall Study|Death|1|||
17161214|NCT00803790|38308973|FG000|Period 1|Adverse Event|0|||
17161215|NCT00803790|38308974|FG001|Period 1|Adverse Event|1|||
17161216|NCT00803790|38308975|FG002|Period 1|Adverse Event|0|||
17161217|NCT00803790|38308976|FG003|Period 1|Adverse Event|0|||
17161218|NCT00803790|38308973|FG000|Period 1|Lost to Follow-up|1|||
17161219|NCT00803790|38308974|FG001|Period 1|Lost to Follow-up|2|||
17081902|NCT00227266|38222650|FG002|Overall Study|Protocol Violation|1|||
17081903|NCT00227266|38222648|FG000|Overall Study|Excessive weight gain|0|||
17081904|NCT00227266|38222649|FG001|Overall Study|Excessive weight gain|0|||
17081905|NCT00227266|38222650|FG002|Overall Study|Excessive weight gain|2|||
17081906|NCT00256282|38222661|FG000|Overall Study|Disease progression, relapse during acti|12|||
17081907|NCT00256282|38222661|FG000|Overall Study|Adverse Event|3|||
17081908|NCT00256282|38222661|FG000|Overall Study|Physician Decision|1|||
17161220|NCT00803790|38308975|FG002|Period 1|Lost to Follow-up|0|||
17161221|NCT00803790|38308976|FG003|Period 1|Lost to Follow-up|0|||
17161222|NCT00803790|38308973|FG000|Period 1|Withdrawal by Subject|8|||
17161223|NCT00803790|38308974|FG001|Period 1|Withdrawal by Subject|6|||
17161224|NCT00803790|38308975|FG002|Period 1|Withdrawal by Subject|0|||
17161225|NCT00803790|38308976|FG003|Period 1|Withdrawal by Subject|0|||
17161226|NCT00803790|38308973|FG000|Period 1|positive drug screen or personal reasons|0|||
17161227|NCT00803790|38308974|FG001|Period 1|positive drug screen or personal reasons|3|||
17161228|NCT00803790|38308975|FG002|Period 1|positive drug screen or personal reasons|0|||
17161229|NCT00803790|38308976|FG003|Period 1|positive drug screen or personal reasons|4|||
17161230|NCT00803790|38308973|FG000|Period 1|Protocol Violation|0|||
17161231|NCT00803790|38308974|FG001|Period 1|Protocol Violation|0|||
17161232|NCT00803790|38308975|FG002|Period 1|Protocol Violation|1|||
17161233|NCT00803790|38308976|FG003|Period 1|Protocol Violation|0|||
17161234|NCT00803790|38308973|FG000|Period 2|Adverse Event|0|||
17161235|NCT00803790|38308974|FG001|Period 2|Adverse Event|0|||
17161236|NCT00803790|38308975|FG002|Period 2|Adverse Event|1|||
17161237|NCT00803790|38308976|FG003|Period 2|Adverse Event|1|||
17161238|NCT00803790|38308973|FG000|Period 2|Withdrawal by Subject|1|||
17161239|NCT00803790|38308974|FG001|Period 2|Withdrawal by Subject|0|||
17161240|NCT00803790|38308975|FG002|Period 2|Withdrawal by Subject|0|||
17081909|NCT00266877|38222668|FG000|Overall Study|Death|1|||
17081910|NCT00266877|38222669|FG001|Overall Study|Death|1|||
17081911|NCT00266877|38222670|FG002|Overall Study|Death|1|||
17081912|NCT00266877|38222668|FG000|Overall Study|Adverse Event|6|||
17081913|NCT00266877|38222669|FG001|Overall Study|Adverse Event|4|||
17161241|NCT00803790|38308976|FG003|Period 2|Withdrawal by Subject|0|||
17161242|NCT00803790|38308973|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
17161243|NCT00803790|38308974|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
17081914|NCT00266877|38222670|FG002|Overall Study|Adverse Event|1|||
17081915|NCT00266877|38222668|FG000|Overall Study|Physician Decision|2|||
17081916|NCT00266877|38222669|FG001|Overall Study|Physician Decision|1|||
17081917|NCT00266877|38222670|FG002|Overall Study|Physician Decision|1|||
17081918|NCT00266877|38222668|FG000|Overall Study|Withdrawal by Subject|3|||
17081919|NCT00266877|38222669|FG001|Overall Study|Withdrawal by Subject|1|||
17081920|NCT00266877|38222670|FG002|Overall Study|Withdrawal by Subject|1|||
17081921|NCT00266877|38222668|FG000|Overall Study|Disease Progression|72|||
17081922|NCT00266877|38222669|FG001|Overall Study|Disease Progression|37|||
17081923|NCT00266877|38222670|FG002|Overall Study|Disease Progression|23|||
17081924|NCT00266877|38222668|FG000|Overall Study|Symptomatic Deterioration|6|||
17081925|NCT00266877|38222669|FG001|Overall Study|Symptomatic Deterioration|3|||
17081926|NCT00266877|38222670|FG002|Overall Study|Symptomatic Deterioration|1|||
17081927|NCT00266877|38222668|FG000|Overall Study|Hospitalization|1|||
17081928|NCT00266877|38222669|FG001|Overall Study|Hospitalization|0|||
17081929|NCT00266877|38222670|FG002|Overall Study|Hospitalization|0|||
17081930|NCT00266877|38222668|FG000|Overall Study|Concomitant Radiotherapy|0|||
17081931|NCT00266877|38222669|FG001|Overall Study|Concomitant Radiotherapy|1|||
17081932|NCT00266877|38222670|FG002|Overall Study|Concomitant Radiotherapy|0|||
17081933|NCT00256204|38222682|FG000|Overall Study|Adverse Event|10|||
17081934|NCT00256204|38222683|FG001|Overall Study|Adverse Event|14|||
17081935|NCT00256204|38222684|FG002|Overall Study|Adverse Event|16|||
17081936|NCT00256204|38222685|FG003|Overall Study|Adverse Event|14|||
17081937|NCT00256204|38222682|FG000|Overall Study|Death|0|||
17081938|NCT00256204|38222683|FG001|Overall Study|Death|1|||
17081939|NCT00256204|38222684|FG002|Overall Study|Death|0|||
17081940|NCT00256204|38222685|FG003|Overall Study|Death|0|||
17081941|NCT00256204|38222682|FG000|Overall Study|Lost to Follow-up|1|||
17081942|NCT00256204|38222683|FG001|Overall Study|Lost to Follow-up|1|||
17081943|NCT00256204|38222684|FG002|Overall Study|Lost to Follow-up|1|||
17081944|NCT00256204|38222685|FG003|Overall Study|Lost to Follow-up|2|||
17081945|NCT00256204|38222682|FG000|Overall Study|Protocol Violation|1|||
17081946|NCT00256204|38222683|FG001|Overall Study|Protocol Violation|0|||
17081947|NCT00256204|38222684|FG002|Overall Study|Protocol Violation|2|||
17081948|NCT00256204|38222685|FG003|Overall Study|Protocol Violation|1|||
17081949|NCT00256204|38222682|FG000|Overall Study|Physician Decision|0|||
17161244|NCT00803790|38308975|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
17161245|NCT00803790|38308976|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
17081950|NCT00256204|38222683|FG001|Overall Study|Physician Decision|0|||
17081951|NCT00256204|38222684|FG002|Overall Study|Physician Decision|1|||
17081952|NCT00256204|38222685|FG003|Overall Study|Physician Decision|2|||
17081953|NCT00256204|38222682|FG000|Overall Study|Withdrawal by Subject|17|||
17081954|NCT00256204|38222683|FG001|Overall Study|Withdrawal by Subject|6|||
17081955|NCT00256204|38222684|FG002|Overall Study|Withdrawal by Subject|7|||
17081956|NCT00256204|38222685|FG003|Overall Study|Withdrawal by Subject|5|||
17081957|NCT00256204|38222682|FG000|Overall Study|Need for additional prohibited treatment|38|||
17081958|NCT00256204|38222683|FG001|Overall Study|Need for additional prohibited treatment|28|||
17081959|NCT00256204|38222684|FG002|Overall Study|Need for additional prohibited treatment|27|||
17081960|NCT00256204|38222685|FG003|Overall Study|Need for additional prohibited treatment|25|||
17081961|NCT00256126|38222700|FG000|Overall Study|Adverse Event|1|||
17081962|NCT00256126|38222701|FG001|Overall Study|Adverse Event|0|||
17081963|NCT00256126|38222700|FG000|Overall Study|Other|1|||
17081964|NCT00256126|38222701|FG001|Overall Study|Other|2|||
17081965|NCT00278889|38222710|FG000|Overall Study|Withdrawal by Subject|0|||
17081966|NCT00278889|38222711|FG001|Overall Study|Withdrawal by Subject|5|||
17161246|NCT00250458|38309024|FG000|Overall Study|Lost to Follow-up|4|||
17161247|NCT00250458|38309025|FG001|Overall Study|Lost to Follow-up|2|||
17161248|NCT00250458|38309024|FG000|Overall Study|Protocol Violation|0|||
17161249|NCT00250458|38309025|FG001|Overall Study|Protocol Violation|1|||
17161250|NCT00250458|38309024|FG000|Overall Study|Withdrawal by Subject|4|||
17161251|NCT00250458|38309025|FG001|Overall Study|Withdrawal by Subject|2|||
17161252|NCT00250458|38309024|FG000|Overall Study|Lack of Migraine Attack|20|||
17161253|NCT00250458|38309025|FG001|Overall Study|Lack of Migraine Attack|9|||
17161254|NCT00250458|38309024|FG000|Overall Study|Qualifying migraine but did not treat|3|||
17161255|NCT00250458|38309025|FG001|Overall Study|Qualifying migraine but did not treat|3|||
17081967|NCT00278889|38222712|FG002|Overall Study|Withdrawal by Subject|3|||
17081968|NCT00278889|38222710|FG000|Overall Study|Lost to Follow-up|1|||
17081969|NCT00278889|38222711|FG001|Overall Study|Lost to Follow-up|1|||
17081970|NCT00278889|38222712|FG002|Overall Study|Lost to Follow-up|0|||
17081971|NCT00278889|38222710|FG000|Overall Study|Death|24|||
17081972|NCT00278889|38222711|FG001|Overall Study|Death|21|||
17081973|NCT00278889|38222712|FG002|Overall Study|Death|17|||
17081974|NCT00278109|38222720|FG000|Overall Study|Adverse Event|3|||
17081975|NCT00278109|38222720|FG000|Overall Study|social circumstances|1|||
17081976|NCT00296517|38222726|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
17081977|NCT00296517|38222727|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
17081978|NCT00296517|38222726|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
17081979|NCT00296517|38222727|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
17081980|NCT00296517|38222726|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
17081981|NCT00296517|38222727|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
17081982|NCT00296517|38222726|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
17081983|NCT00296517|38222727|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
17081984|NCT00296517|38222726|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
17081985|NCT00296517|38222727|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
17081986|NCT00296517|38222726|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
17081987|NCT00296517|38222727|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
17081988|NCT00296517|38222726|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
17081989|NCT00296517|38222727|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
17081990|NCT00296517|38222726|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
17081991|NCT00296517|38222727|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
17081992|NCT00296517|38222726|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
17081993|NCT00296517|38222727|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
17081994|NCT00224770|38222736|FG000|Overall Study|Lost to Follow-up|4|||
17081995|NCT00224770|38222737|FG001|Overall Study|Lost to Follow-up|2|||
17081996|NCT00224770|38222738|FG002|Overall Study|Lost to Follow-up|0|||
17161256|NCT00250458|38309024|FG000|Overall Study|Other|1|||
17161257|NCT00250458|38309025|FG001|Overall Study|Other|0|||
17161258|NCT01667133|38309043|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
17161259|NCT01667133|38309044|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
17161260|NCT01667133|38309045|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
17161261|NCT01667133|38309046|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
17161262|NCT01667133|38309047|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
17161263|NCT01667133|38309048|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
17081997|NCT00266409|38222751|FG000|Overall Study|Lack of Efficacy|2|||
17081998|NCT00266409|38222752|FG001|Overall Study|Lack of Efficacy|6|||
17081999|NCT00266409|38222753|FG002|Overall Study|Lack of Efficacy|1|||
17082000|NCT00266409|38222754|FG003|Overall Study|Lack of Efficacy|2|||
17082001|NCT00266409|38222751|FG000|Overall Study|Adverse Event|7|||
17082002|NCT00266409|38222752|FG001|Overall Study|Adverse Event|2|||
17082003|NCT00266409|38222753|FG002|Overall Study|Adverse Event|1|||
17082004|NCT00266409|38222754|FG003|Overall Study|Adverse Event|1|||
17161264|NCT01667133|38309049|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
17161265|NCT01667133|38309050|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
17161266|NCT01667133|38309051|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
17082005|NCT00266409|38222751|FG000|Overall Study|Lost to Follow-up|18|||
17082006|NCT00266409|38222752|FG001|Overall Study|Lost to Follow-up|21|||
17082007|NCT00266409|38222753|FG002|Overall Study|Lost to Follow-up|6|||
17082008|NCT00266409|38222754|FG003|Overall Study|Lost to Follow-up|8|||
17161267|NCT01667133|38309052|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
17161268|NCT01667133|38309053|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
17161269|NCT01667133|38309054|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
17161270|NCT01667133|38309043|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161271|NCT01667133|38309044|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161272|NCT01667133|38309045|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
17161273|NCT01667133|38309046|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161274|NCT01667133|38309047|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161275|NCT01667133|38309048|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161276|NCT01667133|38309049|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161277|NCT01667133|38309050|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17082009|NCT00266409|38222751|FG000|Overall Study|Withdrawal by Subject|6|||
17082010|NCT00266409|38222752|FG001|Overall Study|Withdrawal by Subject|10|||
17082011|NCT00266409|38222753|FG002|Overall Study|Withdrawal by Subject|3|||
17082012|NCT00266409|38222754|FG003|Overall Study|Withdrawal by Subject|9|||
17161278|NCT01667133|38309051|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161279|NCT01667133|38309052|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161280|NCT01667133|38309053|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161281|NCT01667133|38309054|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
17161282|NCT01667133|38309043|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
17161283|NCT01667133|38309044|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
17161284|NCT01667133|38309045|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
17161285|NCT01667133|38309046|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
17161286|NCT01667133|38309047|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
17161287|NCT01667133|38309048|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
17082013|NCT00266409|38222751|FG000|Overall Study|Protocol Violation|5|||
17082014|NCT00266409|38222752|FG001|Overall Study|Protocol Violation|3|||
17161288|NCT01667133|38309049|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
17161289|NCT01667133|38309050|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
17161290|NCT01667133|38309051|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
17161291|NCT01667133|38309052|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
17161292|NCT01667133|38309053|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
17161293|NCT01667133|38309054|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
17161294|NCT01667133|38309043|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161295|NCT01667133|38309044|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161296|NCT01667133|38309045|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161297|NCT01667133|38309046|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
17161298|NCT01667133|38309047|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161299|NCT01667133|38309048|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161300|NCT01667133|38309049|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161301|NCT01667133|38309050|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161302|NCT01667133|38309051|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161303|NCT01667133|38309052|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161304|NCT01667133|38309053|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161305|NCT01667133|38309054|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
17161306|NCT01667133|38309043|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
17161307|NCT01667133|38309044|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
17161308|NCT01667133|38309045|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
17161309|NCT01667133|38309046|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
17161310|NCT01667133|38309047|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
17161311|NCT01667133|38309048|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
17161312|NCT01667133|38309049|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
17161313|NCT01667133|38309050|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
17161314|NCT01667133|38309051|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
17161315|NCT01667133|38309052|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
17161316|NCT01667133|38309053|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
17161317|NCT01667133|38309054|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
17161318|NCT01667133|38309043|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161319|NCT01667133|38309044|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161320|NCT01667133|38309045|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161321|NCT01667133|38309046|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161322|NCT01667133|38309047|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161323|NCT01667133|38309048|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161324|NCT01667133|38309049|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161325|NCT01667133|38309050|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161326|NCT01667133|38309051|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161327|NCT01667133|38309052|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
16781289|NCT02105974|37720454|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
17082015|NCT00266409|38222753|FG002|Overall Study|Protocol Violation|4|||
17082016|NCT00266409|38222754|FG003|Overall Study|Protocol Violation|2|||
17082017|NCT00266409|38222751|FG000|Overall Study|Other|7|||
17082018|NCT00266409|38222752|FG001|Overall Study|Other|4|||
17082019|NCT00266409|38222753|FG002|Overall Study|Other|2|||
17082020|NCT00266409|38222754|FG003|Overall Study|Other|0|||
17082021|NCT00277095|38222764|FG000|Overall Study|Death|2|||
17082022|NCT00277095|38222764|FG000|Overall Study|Explanted|7|||
17082023|NCT00277095|38222764|FG000|Overall Study|Lost to Follow-up|2|||
17082024|NCT00277095|38222764|FG000|Overall Study|Missed Follow-up|9|||
17082025|NCT00277095|38222764|FG000|Overall Study|Physician Decision|1|||
17082026|NCT00265785|38222768|FG000|Overall Study|Adverse Event|4|||
17082027|NCT00265785|38222768|FG000|Overall Study|Withdrawal by Subject|3|||
17082028|NCT00265785|38222768|FG000|Overall Study|Progression/Relapse|15|||
17082029|NCT00265785|38222768|FG000|Overall Study|Not protocol specified|2|||
17082030|NCT00265785|38222768|FG000|Overall Study|Ineligible|1|||
17082031|NCT00265785|38222768|FG000|Overall Study|Did not receive protocol treatment|2|||
17082032|NCT00276159|38222772|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
17082033|NCT00265395|38222778|FG000|Overall Study|Adverse Event|3|||
17082034|NCT00265395|38222779|FG001|Overall Study|Adverse Event|6|||
17082035|NCT00265395|38222778|FG000|Overall Study|Lost to Follow-up|2|||
17082036|NCT00265395|38222779|FG001|Overall Study|Lost to Follow-up|1|||
17082037|NCT00265395|38222778|FG000|Overall Study|Withdrawal by Subject|1|||
17082038|NCT00265395|38222779|FG001|Overall Study|Withdrawal by Subject|6|||
17161328|NCT01667133|38309053|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161329|NCT01667133|38309054|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
17161330|NCT01667133|38309043|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
17161331|NCT01667133|38309044|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
17082039|NCT00265395|38222778|FG000|Overall Study|Protocol Violation|2|||
17082040|NCT00265395|38222779|FG001|Overall Study|Protocol Violation|2|||
17082041|NCT00265395|38222778|FG000|Overall Study|Lack of Efficacy|0|||
17082042|NCT00265395|38222779|FG001|Overall Study|Lack of Efficacy|1|||
17082043|NCT00265395|38222778|FG000|Overall Study|Administrative|0|||
17082044|NCT00265395|38222779|FG001|Overall Study|Administrative|1|||
17082045|NCT00195442|38222784|FG000|Overall Study|Less than expected therapeutic effect|38|||
17082046|NCT00195442|38222784|FG000|Overall Study|Lost to Follow-up|27|||
17082047|NCT00195442|38222784|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
17082048|NCT00195442|38222784|FG000|Overall Study|Intermittent product shortage|21|||
17082049|NCT00195442|38222784|FG000|Overall Study|Death|7|||
17082050|NCT00195442|38222784|FG000|Overall Study|No reason specified|4|||
17082051|NCT00195442|38222784|FG000|Overall Study|Poor cooperation|2|||
17082052|NCT00195442|38222784|FG000|Overall Study|Other|14|||
17082053|NCT00275301|38222788|FG000|Overall Study|Adverse Event|5|||
17082054|NCT00251745|38222795|FG000|Overall Study|Adverse Event|7|||
17082055|NCT00251745|38222796|FG001|Overall Study|Adverse Event|9|||
17082056|NCT00251745|38222797|FG002|Overall Study|Adverse Event|11|||
17082057|NCT00251745|38222795|FG000|Overall Study|Lost to Follow-up|4|||
17161332|NCT01667133|38309045|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
17161333|NCT01667133|38309046|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
17161334|NCT01667133|38309047|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
17161335|NCT01667133|38309048|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
17161336|NCT01667133|38309049|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
17161337|NCT01667133|38309050|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
17161338|NCT01667133|38309051|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
17161339|NCT01667133|38309052|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
17161340|NCT01667133|38309053|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
17161341|NCT01667133|38309054|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
17161342|NCT01667133|38309043|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161343|NCT01667133|38309044|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161344|NCT01667133|38309045|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161345|NCT01667133|38309046|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161346|NCT01667133|38309047|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161347|NCT01667133|38309048|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161348|NCT01667133|38309049|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161349|NCT01667133|38309050|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161350|NCT01667133|38309051|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16781290|NCT02105974|37720455|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
17082058|NCT00251745|38222796|FG001|Overall Study|Lost to Follow-up|2|||
17082059|NCT00251745|38222797|FG002|Overall Study|Lost to Follow-up|5|||
17082060|NCT00251745|38222795|FG000|Overall Study|Withdrawal by Subject|13|||
17082061|NCT00251745|38222796|FG001|Overall Study|Withdrawal by Subject|7|||
17161351|NCT01667133|38309052|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
17161352|NCT01667133|38309053|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161353|NCT01667133|38309054|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
17161354|NCT01667133|38309043|FG000|Phase 2: Dose-expansion|Death|0|||
17161355|NCT01667133|38309044|FG001|Phase 2: Dose-expansion|Death|0|||
17161356|NCT01667133|38309045|FG002|Phase 2: Dose-expansion|Death|0|||
17161357|NCT01667133|38309046|FG003|Phase 2: Dose-expansion|Death|0|||
17161358|NCT01667133|38309047|FG004|Phase 2: Dose-expansion|Death|0|||
17161359|NCT01667133|38309048|FG005|Phase 2: Dose-expansion|Death|0|||
17161360|NCT01667133|38309049|FG006|Phase 2: Dose-expansion|Death|0|||
17161361|NCT01667133|38309050|FG007|Phase 2: Dose-expansion|Death|0|||
17161362|NCT01667133|38309051|FG008|Phase 2: Dose-expansion|Death|0|||
17161363|NCT01667133|38309052|FG009|Phase 2: Dose-expansion|Death|1|||
17161364|NCT01667133|38309053|FG010|Phase 2: Dose-expansion|Death|0|||
17161365|NCT01667133|38309054|FG011|Phase 2: Dose-expansion|Death|0|||
17161366|NCT01667133|38309043|FG000|Phase 2: Dose-expansion|Other|0|||
17161367|NCT01667133|38309044|FG001|Phase 2: Dose-expansion|Other|0|||
17161368|NCT01667133|38309045|FG002|Phase 2: Dose-expansion|Other|0|||
17161369|NCT01667133|38309046|FG003|Phase 2: Dose-expansion|Other|0|||
17161370|NCT01667133|38309047|FG004|Phase 2: Dose-expansion|Other|0|||
17161371|NCT01667133|38309048|FG005|Phase 2: Dose-expansion|Other|0|||
17161372|NCT01667133|38309049|FG006|Phase 2: Dose-expansion|Other|0|||
17161373|NCT01667133|38309050|FG007|Phase 2: Dose-expansion|Other|0|||
17161374|NCT01667133|38309051|FG008|Phase 2: Dose-expansion|Other|0|||
17161375|NCT01667133|38309052|FG009|Phase 2: Dose-expansion|Other|0|||
17161376|NCT01667133|38309053|FG010|Phase 2: Dose-expansion|Other|0|||
17161377|NCT01667133|38309054|FG011|Phase 2: Dose-expansion|Other|1|||
17082062|NCT00251745|38222797|FG002|Overall Study|Withdrawal by Subject|3|||
17082063|NCT00251745|38222795|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
17082064|NCT00251745|38222796|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
17161378|NCT01891344|38309119|FG000|Overall Study|Ongoing|6|||
17161379|NCT01891344|38309120|FG001|Overall Study|Ongoing|2|||
17161380|NCT01891344|38309121|FG002|Overall Study|Ongoing|0|||
17161381|NCT01891344|38309122|FG003|Overall Study|Ongoing|1|||
17161382|NCT01891344|38309123|FG004|Overall Study|Ongoing|4|||
17161383|NCT01891344|38309124|FG005|Overall Study|Ongoing|1|||
17161384|NCT01891344|38309125|FG006|Overall Study|Ongoing|0|||
17161385|NCT01891344|38309126|FG007|Overall Study|Ongoing|0|||
17161386|NCT01181778|38309148|FG000|Overall Study|Physician Decision|48|||
17161387|NCT00092118|38309156|FG000|Overall Study|Adverse Event|35|||
17161388|NCT00092118|38309157|FG001|Overall Study|Adverse Event|32|||
17161389|NCT00092118|38309156|FG000|Overall Study|Lack of Efficacy|12|||
17161390|NCT00092118|38309157|FG001|Overall Study|Lack of Efficacy|14|||
17161391|NCT00092118|38309156|FG000|Overall Study|Lost to Follow-up|4|||
17161392|NCT00092118|38309157|FG001|Overall Study|Lost to Follow-up|3|||
17161393|NCT00092118|38309156|FG000|Overall Study|Protocol Violation|23|||
17161394|NCT00092118|38309157|FG001|Overall Study|Protocol Violation|25|||
17161395|NCT00092118|38309156|FG000|Overall Study|Withdrawal by Subject|4|||
17161396|NCT00092118|38309157|FG001|Overall Study|Withdrawal by Subject|10|||
17161397|NCT00092118|38309156|FG000|Overall Study|Other|6|||
17161398|NCT00092118|38309157|FG001|Overall Study|Other|5|||
17161399|NCT03261947|38309168|FG000|Overall Study|Death|10|||
17161400|NCT03261947|38309169|FG001|Overall Study|Death|13|||
16995653|NCT00991406|38139461|FG000|Overall Study|One participant did not respond to FES.|1|||
16995654|NCT01017575|38139470|FG000|Overall Study|Lack of Efficacy|0|||
16995655|NCT01017575|38139471|FG001|Overall Study|Lack of Efficacy|1|||
16995656|NCT01017575|38139472|FG002|Overall Study|Lack of Efficacy|0|||
16995657|NCT01017575|38139473|FG003|Overall Study|Lack of Efficacy|1|||
16995658|NCT01017575|38139474|FG004|Overall Study|Lack of Efficacy|1|||
16995659|NCT01017575|38139470|FG000|Overall Study|Adverse Event|0|||
16995660|NCT01017575|38139471|FG001|Overall Study|Adverse Event|1|||
17082065|NCT00251745|38222797|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
17082066|NCT00251745|38222795|FG000|Overall Study|Lack of Efficacy|3|||
17082067|NCT00251745|38222796|FG001|Overall Study|Lack of Efficacy|0|||
17082068|NCT00251745|38222797|FG002|Overall Study|Lack of Efficacy|0|||
17082069|NCT00251745|38222795|FG000|Overall Study|Noncompliant|0|||
17082070|NCT00251745|38222796|FG001|Overall Study|Noncompliant|2|||
17082071|NCT00251745|38222797|FG002|Overall Study|Noncompliant|2|||
17082072|NCT00251745|38222795|FG000|Overall Study|Pregnancy|0|||
17082073|NCT00251745|38222796|FG001|Overall Study|Pregnancy|1|||
17082074|NCT00251745|38222797|FG002|Overall Study|Pregnancy|0|||
17082075|NCT00251745|38222795|FG000|Overall Study|Per Subject Request|0|||
17082076|NCT00251745|38222796|FG001|Overall Study|Per Subject Request|0|||
17082077|NCT00251745|38222797|FG002|Overall Study|Per Subject Request|1|||
17082078|NCT00251745|38222795|FG000|Overall Study|Per Investigator Request|1|||
17082079|NCT00251745|38222796|FG001|Overall Study|Per Investigator Request|0|||
17082080|NCT00251745|38222797|FG002|Overall Study|Per Investigator Request|0|||
17082081|NCT00255346|38222810|FG000|Overall Study|Adverse Event|1|||
17082082|NCT00255346|38222811|FG001|Overall Study|Adverse Event|0|||
17082083|NCT00255346|38222812|FG002|Overall Study|Adverse Event|0|||
17082084|NCT00255346|38222813|FG003|Overall Study|Adverse Event|0|||
17082085|NCT00255346|38222814|FG004|Overall Study|Adverse Event|0|||
17082086|NCT00255190|38222824|FG000|Overall Study|Adverse Event|17|||
17082087|NCT00255190|38222825|FG001|Overall Study|Adverse Event|36|||
17161401|NCT03261947|38309170|FG002|Overall Study|Death|17|||
17082088|NCT00255190|38222824|FG000|Overall Study|Protocol Violation|2|||
17161402|NCT03261947|38309171|FG003|Overall Study|Death|12|||
17161403|NCT03261947|38309172|FG004|Overall Study|Death|8|||
17161404|NCT03261947|38309168|FG000|Overall Study|Lost to Follow-up|0|||
17161405|NCT03261947|38309169|FG001|Overall Study|Lost to Follow-up|0|||
17161406|NCT03261947|38309170|FG002|Overall Study|Lost to Follow-up|2|||
17161407|NCT03261947|38309171|FG003|Overall Study|Lost to Follow-up|1|||
17161408|NCT03261947|38309172|FG004|Overall Study|Lost to Follow-up|0|||
17161409|NCT03261947|38309168|FG000|Overall Study|Withdrawal by Subject|0|||
17161410|NCT03261947|38309169|FG001|Overall Study|Withdrawal by Subject|0|||
17161411|NCT03261947|38309170|FG002|Overall Study|Withdrawal by Subject|3|||
17161412|NCT03261947|38309171|FG003|Overall Study|Withdrawal by Subject|0|||
17161413|NCT03261947|38309172|FG004|Overall Study|Withdrawal by Subject|1|||
17161414|NCT03261947|38309168|FG000|Overall Study|Site Terminated by Sponsor|0|||
17161415|NCT03261947|38309169|FG001|Overall Study|Site Terminated by Sponsor|0|||
17161416|NCT03261947|38309170|FG002|Overall Study|Site Terminated by Sponsor|4|||
17161417|NCT03261947|38309171|FG003|Overall Study|Site Terminated by Sponsor|7|||
17161418|NCT03261947|38309172|FG004|Overall Study|Site Terminated by Sponsor|5|||
17161419|NCT03261947|38309168|FG000|Overall Study|Reason not Specified|2|||
17161420|NCT03261947|38309169|FG001|Overall Study|Reason not Specified|0|||
17161421|NCT03261947|38309170|FG002|Overall Study|Reason not Specified|4|||
17161422|NCT03261947|38309171|FG003|Overall Study|Reason not Specified|1|||
17161423|NCT03261947|38309172|FG004|Overall Study|Reason not Specified|3|||
17161424|NCT03034044|38309188|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
17161425|NCT03098979|38309198|FG000|Overall Study|Adverse Event|1|||
17161426|NCT03098979|38309199|FG001|Overall Study|Adverse Event|0|||
17161427|NCT03098979|38309200|FG002|Overall Study|Adverse Event|1|||
17161428|NCT03098979|38309201|FG003|Overall Study|Adverse Event|4|||
17161429|NCT03098979|38309202|FG004|Overall Study|Adverse Event|6|||
17161430|NCT03098979|38309203|FG005|Overall Study|Adverse Event|1|||
17161431|NCT03098979|38309198|FG000|Overall Study|Withdrawal by Subject|2|||
17082089|NCT00255190|38222825|FG001|Overall Study|Protocol Violation|2|||
17082090|NCT00255190|38222824|FG000|Overall Study|Lost to Follow-up|10|||
17082091|NCT00255190|38222825|FG001|Overall Study|Lost to Follow-up|27|||
17082092|NCT00255190|38222824|FG000|Overall Study|Withdrew Consent|17|||
17082093|NCT00255190|38222825|FG001|Overall Study|Withdrew Consent|48|||
17082094|NCT00255190|38222824|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
17082095|NCT00255190|38222825|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
17082096|NCT00255190|38222824|FG000|Overall Study|Erosive esophagitis not healed|0|||
17082097|NCT00255190|38222825|FG001|Overall Study|Erosive esophagitis not healed|20|||
17082098|NCT00255190|38222824|FG000|Overall Study|Various|4|||
17082099|NCT00255190|38222825|FG001|Overall Study|Various|23|||
17082100|NCT00359424|38222833|FG000|Overall Study|Death|99|||
17082101|NCT00359424|38222834|FG001|Overall Study|Death|58|||
17161432|NCT03098979|38309199|FG001|Overall Study|Withdrawal by Subject|1|||
17161433|NCT03098979|38309200|FG002|Overall Study|Withdrawal by Subject|1|||
17161434|NCT03098979|38309201|FG003|Overall Study|Withdrawal by Subject|1|||
17161435|NCT03098979|38309202|FG004|Overall Study|Withdrawal by Subject|2|||
17161436|NCT03098979|38309203|FG005|Overall Study|Withdrawal by Subject|1|||
17161437|NCT03098979|38309198|FG000|Overall Study|Death|1|||
17161438|NCT03098979|38309199|FG001|Overall Study|Death|0|||
17161439|NCT03098979|38309200|FG002|Overall Study|Death|2|||
17161440|NCT03098979|38309201|FG003|Overall Study|Death|0|||
17161441|NCT03098979|38309202|FG004|Overall Study|Death|1|||
17161442|NCT03098979|38309203|FG005|Overall Study|Death|0|||
17161443|NCT03098979|38309198|FG000|Overall Study|Physician Decision|2|||
17161444|NCT03098979|38309199|FG001|Overall Study|Physician Decision|1|||
17161445|NCT03098979|38309200|FG002|Overall Study|Physician Decision|0|||
17161446|NCT03098979|38309201|FG003|Overall Study|Physician Decision|0|||
17161447|NCT03098979|38309202|FG004|Overall Study|Physician Decision|0|||
17161448|NCT03098979|38309203|FG005|Overall Study|Physician Decision|0|||
17161449|NCT03098979|38309198|FG000|Overall Study|Non-compliance|0|||
17161450|NCT03098979|38309199|FG001|Overall Study|Non-compliance|0|||
17161451|NCT03098979|38309200|FG002|Overall Study|Non-compliance|0|||
17161452|NCT03098979|38309201|FG003|Overall Study|Non-compliance|0|||
17161453|NCT03098979|38309202|FG004|Overall Study|Non-compliance|0|||
17161454|NCT03098979|38309203|FG005|Overall Study|Non-compliance|1|||
17161455|NCT03098979|38309198|FG000|Overall Study|Protocol Violation|0|||
17082102|NCT00359424|38222833|FG000|Overall Study|Lost to Follow-up|19|||
17082103|NCT00359424|38222834|FG001|Overall Study|Lost to Follow-up|7|||
17082104|NCT00359424|38222833|FG000|Overall Study|Withdrawal by Subject|10|||
17082105|NCT00359424|38222834|FG001|Overall Study|Withdrawal by Subject|2|||
17082106|NCT00359424|38222833|FG000|Overall Study|follow up not conducted|2|||
17082107|NCT00359424|38222834|FG001|Overall Study|follow up not conducted|0|||
17161456|NCT03098979|38309199|FG001|Overall Study|Protocol Violation|0|||
17161457|NCT03098979|38309200|FG002|Overall Study|Protocol Violation|0|||
17161458|NCT03098979|38309201|FG003|Overall Study|Protocol Violation|0|||
17161459|NCT03098979|38309202|FG004|Overall Study|Protocol Violation|0|||
17161460|NCT03098979|38309203|FG005|Overall Study|Protocol Violation|1|||
17161461|NCT03261167|38309219|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
17161462|NCT03261167|38309220|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
17161463|NCT03261167|38309219|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
17161464|NCT03261167|38309220|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
17161465|NCT03261167|38309219|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
17161466|NCT03261167|38309220|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
17161467|NCT03261167|38309219|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
17161468|NCT03261167|38309220|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
17082108|NCT00255034|38222842|FG000|Overall Study|Withdrawal by Subject|15|||
17082109|NCT00255034|38222843|FG001|Overall Study|Withdrawal by Subject|38|||
17082110|NCT00254566|38222851|FG000|Overall Study|Death|1|||
17082111|NCT00254566|38222852|FG001|Overall Study|Death|0|||
17082112|NCT00254566|38222851|FG000|Overall Study|Adverse Event|5|||
17161469|NCT03261167|38309219|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
17161470|NCT03261167|38309220|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
17161471|NCT03294941|38309234|FG000|Overall Study|Withdrawal by Subject|0|||
17161472|NCT03294941|38309235|FG001|Overall Study|Withdrawal by Subject|2|||
17161473|NCT03098433|38309242|FG000|Overall Study|Withdrawal by Subject|10|||
17161474|NCT03294317|38309247|FG000|Overall Study|Physician Decision|1|||
17161475|NCT03294317|38309247|FG000|Overall Study|Withdrawal by Subject|6|||
17161476|NCT03294317|38309247|FG000|Overall Study|Lost to Follow-up|1|||
17082113|NCT00254566|38222852|FG001|Overall Study|Adverse Event|4|||
17082114|NCT00254566|38222851|FG000|Overall Study|Lack of Efficacy|12|||
17082115|NCT00254566|38222852|FG001|Overall Study|Lack of Efficacy|9|||
17082116|NCT00254566|38222851|FG000|Overall Study|Other|1|||
17082117|NCT00254566|38222852|FG001|Overall Study|Other|5|||
17082118|NCT00254566|38222851|FG000|Overall Study|Withdrawal by Subject|5|||
17082119|NCT00254566|38222852|FG001|Overall Study|Withdrawal by Subject|6|||
17082120|NCT00254566|38222851|FG000|Overall Study|Lost to Follow-up|7|||
17082121|NCT00254566|38222852|FG001|Overall Study|Lost to Follow-up|2|||
17082122|NCT00358956|38222858|FG000|Overall Study|Adverse Event|3|||
17082123|NCT00358956|38222858|FG000|Overall Study|condition under investigation worsened|4|||
17082124|NCT00358956|38222858|FG000|Overall Study|Withdrawal by Subject|1|||
17082125|NCT03830892|38222864|FG000|Overall Study|Physician Decision|2|||
17082126|NCT03830892|38222865|FG001|Overall Study|Physician Decision|3|||
17082127|NCT03830892|38222864|FG000|Overall Study|Study terminated due to COVID|4|||
17082128|NCT03830892|38222865|FG001|Overall Study|Study terminated due to COVID|0|||
17082129|NCT03830892|38222864|FG000|Overall Study|Protocol Violation|0|||
17082130|NCT03830892|38222865|FG001|Overall Study|Protocol Violation|1|||
17082131|NCT03830892|38222864|FG000|Overall Study|Withdrawal by Subject|0|||
17082132|NCT03830892|38222865|FG001|Overall Study|Withdrawal by Subject|2|||
17161477|NCT03294317|38309247|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
17161478|NCT03294317|38309247|FG000|Overall Study|Failed HB lead implant|8|||
17161479|NCT03294317|38309247|FG000|Overall Study|Received CRT instead|1|||
17161480|NCT03294317|38309247|FG000|Overall Study|Exited after lead revision|2|||
17161481|NCT03292913|38309253|FG000|Overall Study|Death|9|||
17161482|NCT03292913|38309254|FG001|Overall Study|Death|3|||
17161483|NCT03292913|38309253|FG000|Overall Study|Lost to Follow-up|49|||
17161484|NCT03292913|38309254|FG001|Overall Study|Lost to Follow-up|49|||
17161485|NCT03292913|38309253|FG000|Overall Study|Withdrawal by Subject|2|||
17161486|NCT03292913|38309254|FG001|Overall Study|Withdrawal by Subject|0|||
17161487|NCT03292913|38309253|FG000|Overall Study|Clinic closed due to COVID|22|||
17161488|NCT03292913|38309254|FG001|Overall Study|Clinic closed due to COVID|36|||
17161489|NCT03291587|38309266|FG000|Overall Study|Lost to Follow-up|62|||
17082133|NCT00253630|38222871|FG000|Overall Study|ineligible|2|||
17161490|NCT03291587|38309267|FG001|Overall Study|Lost to Follow-up|43|||
17161491|NCT03291587|38309266|FG000|Overall Study|Refused to Answer|5|||
17082134|NCT00358644|38222875|FG000|Overall Study|Progressive Disease|21|||
17082135|NCT00358644|38222875|FG000|Overall Study|Adverse Event|7|||
17082136|NCT00358644|38222875|FG000|Overall Study|Death|11|||
17082137|NCT00358644|38222875|FG000|Overall Study|Withdrawal by Subject|4|||
17082138|NCT00358644|38222875|FG000|Overall Study|Physician Decision|6|||
17082139|NCT00358644|38222875|FG000|Overall Study|Patient not eligible for study|1|||
17082140|NCT00364182|38222882|FG000|First Intervention|Secondary prophylaxis|1|||
17082141|NCT00364182|38222883|FG001|First Intervention|Secondary prophylaxis|0|||
17082142|NCT00364182|38222884|FG002|First Intervention|Secondary prophylaxis|0|||
17082143|NCT00364182|38222882|FG000|First Intervention|Withdrawal by Subject|2|||
17082144|NCT00364182|38222883|FG001|First Intervention|Withdrawal by Subject|0|||
17082145|NCT00364182|38222884|FG002|First Intervention|Withdrawal by Subject|0|||
17082146|NCT00364182|38222882|FG000|Second Intervention|non-compliance|0|||
17082147|NCT00364182|38222883|FG001|Second Intervention|non-compliance|1|||
17082148|NCT00364182|38222884|FG002|Second Intervention|non-compliance|1|||
17082149|NCT00364182|38222882|FG000|Second Intervention|Protocol Violation|0|||
17082150|NCT00364182|38222883|FG001|Second Intervention|Protocol Violation|1|||
17082151|NCT00364182|38222884|FG002|Second Intervention|Protocol Violation|0|||
17082152|NCT00364182|38222882|FG000|Second Intervention|Adverse Event|0|||
17082153|NCT00364182|38222883|FG001|Second Intervention|Adverse Event|0|||
17082154|NCT00364182|38222884|FG002|Second Intervention|Adverse Event|1|||
17082155|NCT00364182|38222882|FG000|Third Intervention|non-compliance|0|||
17082156|NCT00364182|38222883|FG001|Third Intervention|non-compliance|1|||
17082157|NCT00364182|38222884|FG002|Third Intervention|non-compliance|0|||
17082158|NCT00364182|38222882|FG000|Third Intervention|Lost to Follow-up|0|||
17161492|NCT03291587|38309267|FG001|Overall Study|Refused to Answer|2|||
17082159|NCT00364182|38222883|FG001|Third Intervention|Lost to Follow-up|0|||
17082160|NCT00364182|38222884|FG002|Third Intervention|Lost to Follow-up|1|||
17082161|NCT00369486|38222899|FG000|4-Week Visit|Missed visit|2|||
17082162|NCT00369486|38222900|FG001|4-Week Visit|Missed visit|2|||
17082163|NCT00369486|38222901|FG002|4-Week Visit|Missed visit|0|||
17082164|NCT00369486|38222902|FG003|4-Week Visit|Missed visit|2|||
17082165|NCT00369486|38222903|FG004|4-Week Visit|Missed visit|1|||
17082166|NCT00369486|38222899|FG000|4-Week Visit|Dropped|0|||
17082167|NCT00369486|38222900|FG001|4-Week Visit|Dropped|0|||
17082168|NCT00369486|38222901|FG002|4-Week Visit|Dropped|1|||
17082169|NCT00369486|38222902|FG003|4-Week Visit|Dropped|0|||
17082170|NCT00369486|38222903|FG004|4-Week Visit|Dropped|0|||
17082171|NCT00369486|38222899|FG000|8-Week Visit|Missed visit|0|||
17082172|NCT00369486|38222900|FG001|8-Week Visit|Missed visit|1|||
17082173|NCT00369486|38222901|FG002|8-Week Visit|Missed visit|0|||
17082174|NCT00369486|38222902|FG003|8-Week Visit|Missed visit|0|||
17082175|NCT00369486|38222903|FG004|8-Week Visit|Missed visit|1|||
17082176|NCT00369486|38222899|FG000|8-Week Visit|Dropped|0|||
17082177|NCT00369486|38222900|FG001|8-Week Visit|Dropped|0|||
17161493|NCT03291587|38309266|FG000|Overall Study|Death|2|||
16995661|NCT01017575|38139472|FG002|Overall Study|Adverse Event|0|||
16995662|NCT01017575|38139473|FG003|Overall Study|Adverse Event|0|||
16995663|NCT01017575|38139474|FG004|Overall Study|Adverse Event|2|||
16995664|NCT01017575|38139470|FG000|Overall Study|Withdrawal by Subject|1|||
16995665|NCT01017575|38139471|FG001|Overall Study|Withdrawal by Subject|0|||
16995666|NCT01017575|38139472|FG002|Overall Study|Withdrawal by Subject|0|||
16995667|NCT01017575|38139473|FG003|Overall Study|Withdrawal by Subject|0|||
16995668|NCT01017575|38139474|FG004|Overall Study|Withdrawal by Subject|0|||
16995669|NCT01017263|38139486|FG000|Overall Study|not eligible|12|||
16995670|NCT00768664|38139490|FG000|Overall Study|Death|57|||
16995671|NCT00768664|38139490|FG000|Overall Study|Lost to Follow-up|2|||
17082178|NCT00369486|38222901|FG002|8-Week Visit|Dropped|0|||
17082179|NCT00369486|38222902|FG003|8-Week Visit|Dropped|1|||
16995672|NCT00768664|38139490|FG000|Overall Study|Other|9|||
16995673|NCT00768664|38139490|FG000|Overall Study|Participant refused|1|||
16995674|NCT00778336|38139498|FG000|Index Procedure-Discharge|Death|6|||
17082180|NCT00369486|38222903|FG004|8-Week Visit|Dropped|0|||
17082181|NCT00369486|38222899|FG000|17-Week Visit|Missed visit|0|||
17082182|NCT00369486|38222900|FG001|17-Week Visit|Missed visit|0|||
17082183|NCT00369486|38222901|FG002|17-Week Visit|Missed visit|1|||
17082184|NCT00369486|38222902|FG003|17-Week Visit|Missed visit|1|||
17082185|NCT00369486|38222903|FG004|17-Week Visit|Missed visit|1|||
17082186|NCT00369486|38222899|FG000|34-Week Visit|Dropped|0|||
17082187|NCT00369486|38222900|FG001|34-Week Visit|Dropped|1|||
17082188|NCT00369486|38222901|FG002|34-Week Visit|Dropped|1|||
17082189|NCT00369486|38222902|FG003|34-Week Visit|Dropped|3|||
17082190|NCT00369486|38222903|FG004|34-Week Visit|Dropped|3|||
17082191|NCT00363480|38222915|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
17082192|NCT00363480|38222915|FG000|Overall Study|Adverse Event|4|||
17082193|NCT00363480|38222915|FG000|Overall Study|Lost to Follow-up|5|||
17082194|NCT00363480|38222915|FG000|Overall Study|Withdrawal by Subject|5|||
17082195|NCT00363480|38222915|FG000|Overall Study|Non-compliance of subject|1|||
17161494|NCT03291587|38309267|FG001|Overall Study|Death|4|||
17161495|NCT03291587|38309266|FG000|Overall Study|Not interested in participating|8|||
17161496|NCT03291587|38309267|FG001|Overall Study|Not interested in participating|6|||
17161497|NCT03291587|38309266|FG000|Overall Study|Too busy to participate|4|||
17161498|NCT03291587|38309267|FG001|Overall Study|Too busy to participate|2|||
17161499|NCT03210961|38309298|FG000|Overall Study|Adverse Event|0|||
17161500|NCT03210961|38309299|FG001|Overall Study|Adverse Event|0|||
17161501|NCT03210961|38309300|FG002|Overall Study|Adverse Event|0|||
17161502|NCT03210961|38309301|FG003|Overall Study|Adverse Event|0|||
17161503|NCT03210961|38309302|FG004|Overall Study|Adverse Event|0|||
17161504|NCT03210961|38309303|FG005|Overall Study|Adverse Event|0|||
17161505|NCT03210961|38309304|FG006|Overall Study|Adverse Event|0|||
17161506|NCT03210961|38309305|FG007|Overall Study|Adverse Event|0|||
17161507|NCT03210961|38309306|FG008|Overall Study|Adverse Event|0|||
17161508|NCT03210961|38309307|FG009|Overall Study|Adverse Event|0|||
17161509|NCT03210961|38309308|FG010|Overall Study|Adverse Event|0|||
17161510|NCT03210961|38309309|FG011|Overall Study|Adverse Event|0|||
17161511|NCT03210961|38309310|FG012|Overall Study|Adverse Event|0|||
17161512|NCT03210961|38309311|FG013|Overall Study|Adverse Event|1|||
17161513|NCT03210961|38309312|FG014|Overall Study|Adverse Event|0|||
17082196|NCT00363480|38222915|FG000|Overall Study|Participant discontinued on its own|1|||
17082197|NCT00363246|38222919|FG000|Overall Study|Death|40|||
17161514|NCT03210961|38309298|FG000|Overall Study|Lost to Follow-up|0|||
17161515|NCT03210961|38309299|FG001|Overall Study|Lost to Follow-up|0|||
17161516|NCT03210961|38309300|FG002|Overall Study|Lost to Follow-up|0|||
17161517|NCT03210961|38309301|FG003|Overall Study|Lost to Follow-up|0|||
17161518|NCT03210961|38309302|FG004|Overall Study|Lost to Follow-up|0|||
17161519|NCT03210961|38309303|FG005|Overall Study|Lost to Follow-up|0|||
17161520|NCT03210961|38309304|FG006|Overall Study|Lost to Follow-up|0|||
17161521|NCT03210961|38309305|FG007|Overall Study|Lost to Follow-up|0|||
17161522|NCT03210961|38309306|FG008|Overall Study|Lost to Follow-up|0|||
17161523|NCT03210961|38309307|FG009|Overall Study|Lost to Follow-up|0|||
17161524|NCT03210961|38309308|FG010|Overall Study|Lost to Follow-up|0|||
17161525|NCT03210961|38309309|FG011|Overall Study|Lost to Follow-up|0|||
17082198|NCT00363246|38222919|FG000|Overall Study|Withdrawal by Subject|19|||
17082199|NCT00363246|38222919|FG000|Overall Study|Lost to Follow-up|14|||
17082200|NCT00363246|38222919|FG000|Overall Study|Bad health|6|||
17082201|NCT00363246|38222919|FG000|Overall Study|Stopped using wheelchair|11|||
17082202|NCT00363246|38222919|FG000|Overall Study|Subject expressed security concerns|2|||
17082203|NCT00363246|38222919|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
17082204|NCT00223990|38222926|FG000|Overall Study|Moved from area|2|||
17082205|NCT00223990|38222927|FG001|Overall Study|Moved from area|1|||
17082206|NCT00223990|38222926|FG000|Overall Study|Withdrawal by Subject|4|||
17082207|NCT00223990|38222927|FG001|Overall Study|Withdrawal by Subject|8|||
17082208|NCT00223990|38222926|FG000|Overall Study|Lost to Follow-up|1|||
17082209|NCT00223990|38222927|FG001|Overall Study|Lost to Follow-up|0|||
17082210|NCT00221104|38222935|FG000|Overall Study|Adverse Event|1|||
17082211|NCT00221104|38222936|FG001|Overall Study|Adverse Event|0|||
17082212|NCT00221104|38222935|FG000|Overall Study|Physician Decision|1|||
17082213|NCT00221104|38222936|FG001|Overall Study|Physician Decision|0|||
17161526|NCT03210961|38309310|FG012|Overall Study|Lost to Follow-up|0|||
17161527|NCT03210961|38309311|FG013|Overall Study|Lost to Follow-up|0|||
17161528|NCT03210961|38309312|FG014|Overall Study|Lost to Follow-up|1|||
17161529|NCT03210961|38309298|FG000|Overall Study|Withdrawal by Subject|0|||
17161530|NCT03210961|38309299|FG001|Overall Study|Withdrawal by Subject|0|||
17161531|NCT03210961|38309300|FG002|Overall Study|Withdrawal by Subject|0|||
17082214|NCT00221104|38222935|FG000|Overall Study|Protocol Violation|2|||
17082215|NCT00221104|38222936|FG001|Overall Study|Protocol Violation|0|||
17161532|NCT03210961|38309301|FG003|Overall Study|Withdrawal by Subject|0|||
17161533|NCT03210961|38309302|FG004|Overall Study|Withdrawal by Subject|0|||
17161534|NCT03210961|38309303|FG005|Overall Study|Withdrawal by Subject|0|||
17161535|NCT03210961|38309304|FG006|Overall Study|Withdrawal by Subject|0|||
17161536|NCT03210961|38309305|FG007|Overall Study|Withdrawal by Subject|0|||
17161537|NCT03210961|38309306|FG008|Overall Study|Withdrawal by Subject|0|||
17161538|NCT03210961|38309307|FG009|Overall Study|Withdrawal by Subject|0|||
17161539|NCT03210961|38309308|FG010|Overall Study|Withdrawal by Subject|0|||
17161540|NCT03210961|38309309|FG011|Overall Study|Withdrawal by Subject|0|||
17161541|NCT03210961|38309310|FG012|Overall Study|Withdrawal by Subject|0|||
17161542|NCT03210961|38309311|FG013|Overall Study|Withdrawal by Subject|0|||
17161543|NCT03210961|38309312|FG014|Overall Study|Withdrawal by Subject|1|||
17082216|NCT00221104|38222935|FG000|Overall Study|Withdrawal by Subject|42|||
17082217|NCT00221104|38222936|FG001|Overall Study|Withdrawal by Subject|29|||
17082218|NCT00221104|38222935|FG000|Overall Study|Others|37|||
17161544|NCT03210961|38309298|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161545|NCT03210961|38309299|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161546|NCT03210961|38309300|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161547|NCT03210961|38309301|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161548|NCT03210961|38309302|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161549|NCT03210961|38309303|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161550|NCT03210961|38309304|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161551|NCT03210961|38309305|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
17082219|NCT00221104|38222936|FG001|Overall Study|Others|47|||
17082220|NCT00189202|38222944|FG000|Overall Study|Physician Decision|5|||
17082221|NCT00187486|38222948|FG000|Overall Study|Protocol Violation|1|||
17082222|NCT00220636|38222952|FG000|Overall Study|Withdrawal by Subject|4|||
17082223|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
17082224|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
17082225|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Death|1|||
17161552|NCT03210961|38309306|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161553|NCT03210961|38309307|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161554|NCT03210961|38309308|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161555|NCT03210961|38309309|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161556|NCT03210961|38309310|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161557|NCT03210961|38309311|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
17161558|NCT03210961|38309312|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
17161559|NCT03210961|38309298|FG000|Overall Study|Other|0|||
17161560|NCT03210961|38309299|FG001|Overall Study|Other|0|||
17161561|NCT03210961|38309300|FG002|Overall Study|Other|0|||
17161562|NCT03210961|38309301|FG003|Overall Study|Other|1|||
17161563|NCT03210961|38309302|FG004|Overall Study|Other|0|||
17161564|NCT03210961|38309303|FG005|Overall Study|Other|0|||
17161565|NCT03210961|38309304|FG006|Overall Study|Other|1|||
17161566|NCT03210961|38309305|FG007|Overall Study|Other|0|||
17161567|NCT03210961|38309306|FG008|Overall Study|Other|0|||
17161568|NCT03210961|38309307|FG009|Overall Study|Other|0|||
17161569|NCT03210961|38309308|FG010|Overall Study|Other|1|||
17161570|NCT03210961|38309309|FG011|Overall Study|Other|0|||
17161571|NCT03210961|38309310|FG012|Overall Study|Other|2|||
17161572|NCT03210961|38309311|FG013|Overall Study|Other|2|||
17161573|NCT03210961|38309312|FG014|Overall Study|Other|0|||
17161574|NCT03242759|38309365|FG000|Overall Study|Adverse Event|5|||
17161575|NCT03242759|38309366|FG001|Overall Study|Adverse Event|1|||
17161576|NCT03242759|38309365|FG000|Overall Study|Withdrawal by Subject|4|||
17161577|NCT03242759|38309366|FG001|Overall Study|Withdrawal by Subject|3|||
17161578|NCT03242759|38309365|FG000|Overall Study|Lost to Follow-up|3|||
17161579|NCT03242759|38309366|FG001|Overall Study|Lost to Follow-up|1|||
17161580|NCT03242759|38309365|FG000|Overall Study|Administrative problems|1|||
17161581|NCT03242759|38309366|FG001|Overall Study|Administrative problems|1|||
17161582|NCT03242759|38309365|FG000|Overall Study|Death|22|||
17161583|NCT03242759|38309366|FG001|Overall Study|Death|0|||
17161584|NCT03242759|38309365|FG000|Overall Study|Change visit schedule|0|||
17161585|NCT03242759|38309366|FG001|Overall Study|Change visit schedule|1|||
17161586|NCT03097029|38309372|FG000|Overall Study|Withdrawal by Subject|1|||
17161587|NCT03257813|38309378|FG000|Overall Study|Protocol Violation|6|||
17082226|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Death|3|||
17082227|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
17082228|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
17161588|NCT03257813|38309379|FG001|Overall Study|Protocol Violation|3|||
17161589|NCT03210259|38309390|FG000|12-Week Run-in Period|Adverse Event|1|||
17161590|NCT03210259|38309391|FG001|12-Week Run-in Period|Adverse Event|0|||
17161591|NCT03210259|38309392|FG002|12-Week Run-in Period|Adverse Event|0|||
17161592|NCT03210259|38309390|FG000|12-Week Run-in Period|Death|1|||
17161593|NCT03210259|38309391|FG001|12-Week Run-in Period|Death|0|||
17161594|NCT03210259|38309392|FG002|12-Week Run-in Period|Death|0|||
17161595|NCT03210259|38309390|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
17161596|NCT03210259|38309391|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
17161597|NCT03210259|38309392|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
17161598|NCT03210259|38309390|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
17161599|NCT03210259|38309391|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
17161600|NCT03210259|38309392|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
17161601|NCT03210259|38309390|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
17161602|NCT03210259|38309391|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
17082229|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
17082230|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
17082231|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
17082232|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
17082233|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
17082234|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
17082235|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
17082236|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
17082237|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
17161603|NCT03210259|38309392|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
17161604|NCT03210259|38309390|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
17161605|NCT03210259|38309391|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
17161606|NCT03210259|38309392|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
17161607|NCT03210259|38309390|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
17161608|NCT03210259|38309391|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
17161609|NCT03210259|38309392|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
17161610|NCT03210259|38309390|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
17161611|NCT03210259|38309391|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
17161612|NCT03210259|38309392|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
17161613|NCT03210259|38309390|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
17161614|NCT03210259|38309391|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
17161615|NCT03210259|38309392|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
17161616|NCT03210259|38309390|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
17161617|NCT03210259|38309391|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
17161618|NCT03210259|38309392|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
17161619|NCT03210259|38309390|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
17161620|NCT03210259|38309391|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
17161621|NCT03210259|38309392|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
17161622|NCT03257657|38309401|FG000|Overall Study|Lost to Follow-up|0|||
17161623|NCT03257657|38309402|FG001|Overall Study|Lost to Follow-up|3|||
17161624|NCT03257657|38309401|FG000|Overall Study|Withdrawn|0|||
17082238|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
17082239|NCT00362232|38222959|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
17082240|NCT00362232|38222960|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
17082241|NCT00362232|38222959|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
17082242|NCT00362232|38222960|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
17161625|NCT03257657|38309402|FG001|Overall Study|Withdrawn|1|||
17161626|NCT03257657|38309401|FG000|Overall Study|Noted not eligible right after enrolled|0|||
17161627|NCT03257657|38309402|FG001|Overall Study|Noted not eligible right after enrolled|1|||
17161628|NCT02496611|38309411|FG000|Overall Study|Lost to Follow-up|2|||
17161629|NCT02496611|38309412|FG001|Overall Study|Lost to Follow-up|1|||
17161630|NCT02496611|38309411|FG000|Overall Study|Withdrawal by Subject|5|||
17161631|NCT02496611|38309412|FG001|Overall Study|Withdrawal by Subject|2|||
17161632|NCT03237481|38309422|FG000|Overall Study|Lost to Follow-up|1|||
17161633|NCT03237481|38309423|FG001|Overall Study|Lost to Follow-up|0|||
17161634|NCT03237481|38309424|FG002|Overall Study|Lost to Follow-up|0|||
17161635|NCT03237481|38309422|FG000|Overall Study|Protocol Violation|1|||
17161636|NCT03237481|38309423|FG001|Overall Study|Protocol Violation|0|||
17161637|NCT03237481|38309424|FG002|Overall Study|Protocol Violation|0|||
17161638|NCT03237481|38309422|FG000|Overall Study|Withdrawal by Subject|3|||
17161639|NCT03237481|38309423|FG001|Overall Study|Withdrawal by Subject|2|||
17161640|NCT03237481|38309424|FG002|Overall Study|Withdrawal by Subject|1|||
17161641|NCT03222349|38309432|FG000|Overall Study|Treatment B not done|5|||
17161642|NCT03222349|38309433|FG001|Overall Study|Treatment B not done|0|||
17161643|NCT03222349|38309432|FG000|Overall Study|Lost to Follow-up|1|||
17161644|NCT03222349|38309433|FG001|Overall Study|Lost to Follow-up|2|||
17161645|NCT03222349|38309432|FG000|Overall Study|Withdrawal by Subject|1|||
17161646|NCT03222349|38309433|FG001|Overall Study|Withdrawal by Subject|0|||
17161647|NCT03222349|38309432|FG000|Overall Study|Treatment A not done|0|||
17161648|NCT03222349|38309433|FG001|Overall Study|Treatment A not done|5|||
17161649|NCT03222349|38309432|FG000|Overall Study|Study terminated by sponsor|1|||
17082243|NCT00362232|38222959|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
17082244|NCT00362232|38222960|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
17161650|NCT03222349|38309433|FG001|Overall Study|Study terminated by sponsor|0|||
17161651|NCT02927925|38309446|FG000|Overall Study|Death|16|||
17161652|NCT02927925|38309446|FG000|Overall Study|Physician Decision|1|||
17161653|NCT02927925|38309446|FG000|Overall Study|Withdrawal by Subject|11|||
17161654|NCT02927925|38309446|FG000|Overall Study|Other|3|||
17161655|NCT02927925|38309446|FG000|Overall Study|Disease progression at clinical cutoff|1|||
17082245|NCT00362232|38222959|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
17082246|NCT00362232|38222960|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
17082247|NCT00362232|38222959|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
17082248|NCT00362232|38222960|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
17082249|NCT00219544|38222966|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
17082250|NCT00219544|38222967|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
17161656|NCT03208933|38309450|FG000|Overall Study|Death|3|||
17161657|NCT03208933|38309450|FG000|Overall Study|Withdrawal by Subject|3|||
17161658|NCT03208933|38309450|FG000|Overall Study|Adverse Event|1|||
17161659|NCT03208933|38309450|FG000|Overall Study|Lost to Follow-up|2|||
17161660|NCT03208933|38309450|FG000|Overall Study|Physician Decision|3|||
17082251|NCT00219544|38222966|FG000|Single Blind Treatment Period|Adverse Event|9|||
17082252|NCT00219544|38222967|FG001|Single Blind Treatment Period|Adverse Event|0|||
17082253|NCT00219544|38222966|FG000|Single Blind Treatment Period|Protocol Violation|4|||
17082254|NCT00219544|38222967|FG001|Single Blind Treatment Period|Protocol Violation|0|||
17082255|NCT00219544|38222966|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
17082256|NCT00219544|38222967|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
17082257|NCT00219544|38222966|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
17082258|NCT00219544|38222967|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
17082259|NCT00219544|38222966|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
17082260|NCT00219544|38222967|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
17161661|NCT03208933|38309450|FG000|Overall Study|Protocol Violation|1|||
17161662|NCT02499120|38309456|FG000|Overall Study|Death|45|||
17161663|NCT02499120|38309457|FG001|Overall Study|Death|42|||
17161664|NCT02499120|38309456|FG000|Overall Study|Lost to Follow-up|1|||
17161665|NCT02499120|38309457|FG001|Overall Study|Lost to Follow-up|2|||
17161666|NCT02499120|38309456|FG000|Overall Study|Participant refused further follow-up|1|||
17161667|NCT02499120|38309457|FG001|Overall Study|Participant refused further follow-up|0|||
17161668|NCT02499120|38309456|FG000|Overall Study|Withdrawal by Subject|2|||
17161669|NCT02499120|38309457|FG001|Overall Study|Withdrawal by Subject|5|||
17161670|NCT02499120|38309456|FG000|Overall Study|Other|1|||
17161671|NCT02499120|38309457|FG001|Overall Study|Other|0|||
17161672|NCT02499120|38309456|FG000|Overall Study|Ongoing on study|15|||
17161673|NCT02499120|38309457|FG001|Overall Study|Ongoing on study|11|||
17161674|NCT03207763|38309465|FG000|Overall Study|Lost to Follow-up|1|||
17161675|NCT03207763|38309466|FG001|Overall Study|Lost to Follow-up|0|||
17161676|NCT04766034|38309485|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
17161677|NCT04766034|38309486|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
17161678|NCT04766034|38309487|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
17161679|NCT04766034|38309488|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
17161680|NCT04766034|38309489|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
17161681|NCT04766034|38309485|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
17082261|NCT00357552|38222975|FG000|Screening|Did not meet eligibility criteria|84|||
17082262|NCT00357552|38222975|FG000|Weeks 0 to 24|Death|1|||
17082263|NCT00357552|38222975|FG000|Weeks 24 to 104|Death|3|||
17082264|NCT00357552|38222975|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
17082265|NCT00187096|38222986|FG000|Overall Study|unacceptable toxicity|0|||
17082266|NCT00187096|38222987|FG001|Overall Study|unacceptable toxicity|0|||
17082267|NCT00187096|38222988|FG002|Overall Study|unacceptable toxicity|1|||
16995675|NCT00778336|38139499|FG001|Index Procedure-Discharge|Death|3|||
16995676|NCT00778336|38139500|FG002|Index Procedure-Discharge|Death|2|||
17082268|NCT00357396|38222998|FG000|Overall Study|Adverse Event|1|||
17082269|NCT00357396|38222999|FG001|Overall Study|Adverse Event|0|||
17082270|NCT00186628|38223004|FG000|Overall Study|Death|2|||
16995677|NCT00778336|38139501|FG003|Index Procedure-Discharge|Death|0|||
16995678|NCT00778336|38139498|FG000|3 Month Follow Up|Lost to Follow-up|15|||
16995679|NCT00778336|38139499|FG001|3 Month Follow Up|Lost to Follow-up|20|||
16995680|NCT00778336|38139500|FG002|3 Month Follow Up|Lost to Follow-up|3|||
16995681|NCT00778336|38139501|FG003|3 Month Follow Up|Lost to Follow-up|0|||
16995682|NCT00778336|38139498|FG000|3 Month Follow Up|Death|8|||
16995683|NCT00778336|38139499|FG001|3 Month Follow Up|Death|3|||
16995684|NCT00778336|38139500|FG002|3 Month Follow Up|Death|2|||
16995685|NCT00778336|38139501|FG003|3 Month Follow Up|Death|0|||
16995686|NCT01320085|38139514|FG000|Overall Study|Treatment Ongoing|0|||
17082271|NCT00186628|38223004|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
17082272|NCT00368550|38223012|FG000|Overall Study|Adverse Event|7|||
17082273|NCT00368550|38223013|FG001|Overall Study|Adverse Event|4|||
17082274|NCT00368550|38223012|FG000|Overall Study|Lack of Efficacy|4|||
16995687|NCT01320085|38139515|FG001|Overall Study|Treatment Ongoing|13|||
16995688|NCT01320085|38139516|FG002|Overall Study|Treatment Ongoing|2|||
16995689|NCT01320085|38139514|FG000|Overall Study|Disease Progression|26|||
17082275|NCT00368550|38223013|FG001|Overall Study|Lack of Efficacy|9|||
17082276|NCT00368550|38223012|FG000|Overall Study|Withdrawal by Subject|17|||
17161682|NCT04766034|38309486|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
17161683|NCT04766034|38309487|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
17161684|NCT04766034|38309488|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
17161685|NCT04766034|38309489|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
17161686|NCT04766034|38309485|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
17161687|NCT04766034|38309486|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
17161688|NCT04766034|38309487|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
17161689|NCT04766034|38309488|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
17161690|NCT04766034|38309489|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
17161691|NCT04766034|38309485|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
17161692|NCT04766034|38309486|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
17161693|NCT04766034|38309487|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
17082277|NCT00368550|38223013|FG001|Overall Study|Withdrawal by Subject|10|||
17082278|NCT00368472|38223019|FG000|Overall Study|Adverse Event|22|||
17082279|NCT00368472|38223019|FG000|Overall Study|Medication non-compliance|4|||
17082280|NCT00368472|38223019|FG000|Overall Study|Protocol Violation|2|||
17082281|NCT00368472|38223019|FG000|Overall Study|Request of Investigator or Sponsor|3|||
17082282|NCT00368472|38223019|FG000|Overall Study|Withdrawal by Subject|40|||
17082283|NCT00368472|38223019|FG000|Overall Study|Diary non-compliance|1|||
17082284|NCT00368472|38223019|FG000|Overall Study|Other|32|||
17082285|NCT00368472|38223019|FG000|Overall Study|Missing Final Disposition Date|1|||
17082286|NCT00357006|38223026|FG000|Overall Study|Lost to Follow-up|1|||
17082287|NCT00357006|38223027|FG001|Overall Study|Lost to Follow-up|2|||
17082288|NCT00357006|38223028|FG002|Overall Study|Lost to Follow-up|1|||
17082289|NCT00357006|38223026|FG000|Overall Study|Withdrawal by Subject|1|||
17161694|NCT04766034|38309488|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
17082290|NCT00357006|38223027|FG001|Overall Study|Withdrawal by Subject|3|||
17082291|NCT00357006|38223028|FG002|Overall Study|Withdrawal by Subject|2|||
17082292|NCT00165646|38223039|FG000|Overall Study|Adverse Event|1|||
17082293|NCT00165646|38223040|FG001|Overall Study|Adverse Event|1|||
17082294|NCT00165646|38223041|FG002|Overall Study|Adverse Event|1|||
17082295|NCT00165646|38223039|FG000|Overall Study|Lack of Efficacy|1|||
17082296|NCT00165646|38223040|FG001|Overall Study|Lack of Efficacy|2|||
17082297|NCT00165646|38223041|FG002|Overall Study|Lack of Efficacy|0|||
17082298|NCT00165646|38223039|FG000|Overall Study|Withdrawal by Subject|0|||
17082299|NCT00165646|38223040|FG001|Overall Study|Withdrawal by Subject|2|||
17082300|NCT00165646|38223041|FG002|Overall Study|Withdrawal by Subject|1|||
17082301|NCT00165646|38223039|FG000|Overall Study|Physician Decision|2|||
16781291|NCT02105974|37720453|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
17082302|NCT00165646|38223040|FG001|Overall Study|Physician Decision|0|||
17082303|NCT00165646|38223041|FG002|Overall Study|Physician Decision|2|||
17082304|NCT00165646|38223039|FG000|Overall Study|Protocol Violation|1|||
17082305|NCT00165646|38223040|FG001|Overall Study|Protocol Violation|0|||
17082306|NCT00165646|38223041|FG002|Overall Study|Protocol Violation|0|||
16781292|NCT02105974|37720454|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
17082307|NCT00367770|38223049|FG000|Overall Study|Adverse Event|1|||
17082308|NCT00367770|38223049|FG000|Overall Study|Withdrawal by Subject|1|||
16781293|NCT02105974|37720455|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
17082309|NCT00185614|38223053|FG000|Inter-treatment Period|Physician Decision|1|||
17082310|NCT00185614|38223053|FG000|Inter-treatment Period|Relapse|2|||
17082311|NCT00185614|38223053|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
17082312|NCT00162370|38223057|FG000|Efficacy Population|Lost to Follow-up|51|||
17082313|NCT00361842|38223066|FG000|Overall Study|Withdrawal by Subject|2|||
17082314|NCT00361842|38223067|FG001|Overall Study|Withdrawal by Subject|3|||
17082315|NCT00361842|38223066|FG000|Overall Study|Death|2|||
17082316|NCT00361842|38223067|FG001|Overall Study|Death|1|||
17161695|NCT04766034|38309489|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
17161696|NCT03237013|38309504|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
17161697|NCT03237013|38309505|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
17161698|NCT03237013|38309506|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
17161699|NCT03236779|38309516|FG000|Overall Study|Lost to Follow-up|13|||
17161700|NCT03236779|38309517|FG001|Overall Study|Lost to Follow-up|21|||
17161701|NCT03096483|38309525|FG000|Overall Study|Withdrawal by site|1|||
17161702|NCT03257267|38309531|FG000|Overall Study|Adverse Event|9|||
17161703|NCT03257267|38309532|FG001|Overall Study|Adverse Event|7|||
17161704|NCT03257267|38309531|FG000|Overall Study|Death|92|||
17161705|NCT03257267|38309532|FG001|Overall Study|Death|95|||
17161706|NCT03257267|38309531|FG000|Overall Study|Lost to Follow-up|2|||
17161707|NCT03257267|38309532|FG001|Overall Study|Lost to Follow-up|2|||
17161708|NCT03257267|38309531|FG000|Overall Study|Non-compliance with Study Drug|0|||
17161709|NCT03257267|38309532|FG001|Overall Study|Non-compliance with Study Drug|1|||
17161710|NCT03257267|38309531|FG000|Overall Study|Participant Decision|34|||
17161711|NCT03257267|38309532|FG001|Overall Study|Participant Decision|42|||
17161712|NCT03257267|38309531|FG000|Overall Study|Physician Decision|1|||
17161713|NCT03257267|38309532|FG001|Overall Study|Physician Decision|3|||
17161714|NCT03257267|38309531|FG000|Overall Study|Disease Progression|98|||
17161715|NCT03257267|38309532|FG001|Overall Study|Disease Progression|117|||
17161716|NCT03257267|38309531|FG000|Overall Study|Withdrawal of Consent|8|||
17161717|NCT03257267|38309532|FG001|Overall Study|Withdrawal of Consent|26|||
17161718|NCT03257267|38309531|FG000|Overall Study|Study Ongoing|53|||
17161719|NCT03257267|38309532|FG001|Overall Study|Study Ongoing|11|||
17161720|NCT02932579|38309540|FG000|Overall Study|Withdrawal by Subject|4|||
17161721|NCT02932579|38309541|FG001|Overall Study|Withdrawal by Subject|1|||
17161722|NCT03207451|38309551|FG000|Overall Study|scheduling conflict|1|||
17161723|NCT03207451|38309552|FG001|Overall Study|scheduling conflict|0|||
16995690|NCT01320085|38139515|FG001|Overall Study|Disease Progression|86|||
16995691|NCT01320085|38139516|FG002|Overall Study|Disease Progression|16|||
16995692|NCT01320085|38139514|FG000|Overall Study|Adverse Event|12|||
16995693|NCT01320085|38139515|FG001|Overall Study|Adverse Event|14|||
16995694|NCT01320085|38139516|FG002|Overall Study|Adverse Event|5|||
17082317|NCT00361842|38223066|FG000|Overall Study|Disease progression|19|||
17082318|NCT00361842|38223067|FG001|Overall Study|Disease progression|20|||
17082319|NCT00361842|38223066|FG000|Overall Study|Adverse Event|2|||
17082320|NCT00361842|38223067|FG001|Overall Study|Adverse Event|3|||
17082321|NCT00361842|38223066|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
17161724|NCT03207451|38309553|FG002|Overall Study|scheduling conflict|2|||
17161725|NCT03207451|38309554|FG003|Overall Study|scheduling conflict|2|||
16995695|NCT01320085|38139514|FG000|Overall Study|Withdrawal by Subject|2|||
16995696|NCT01320085|38139515|FG001|Overall Study|Withdrawal by Subject|4|||
16995697|NCT01320085|38139516|FG002|Overall Study|Withdrawal by Subject|1|||
16995698|NCT01320085|38139514|FG000|Overall Study|Protocol Deviation|1|||
16995699|NCT01320085|38139515|FG001|Overall Study|Protocol Deviation|0|||
17082322|NCT00361842|38223067|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
17161726|NCT03207451|38309551|FG000|Overall Study|Adverse Event|0|||
17161727|NCT03207451|38309552|FG001|Overall Study|Adverse Event|0|||
17161728|NCT03207451|38309553|FG002|Overall Study|Adverse Event|0|||
17161729|NCT03207451|38309554|FG003|Overall Study|Adverse Event|1|||
17161730|NCT03350503|38309581|FG000|Overall Study|Adverse Event|5|||
17161731|NCT03350503|38309581|FG000|Overall Study|Withdrawal by Subject|5|||
17161732|NCT03350503|38309581|FG000|Overall Study|Continuation impossible due to move|4|||
17161733|NCT03350503|38309581|FG000|Overall Study|Physician Decision|3|||
17161734|NCT03288779|38309604|FG000|Overall Study|Withdrawal by Subject|3|||
17161735|NCT03206749|38309611|FG000|Overall Study|Withdrawal of consent|5|||
17161736|NCT03206749|38309612|FG001|Overall Study|Withdrawal of consent|3|||
17161737|NCT03206749|38309613|FG002|Overall Study|Withdrawal of consent|6|||
17082323|NCT00361842|38223066|FG000|Overall Study|Other|1|||
17082324|NCT00361842|38223067|FG001|Overall Study|Other|0|||
17161738|NCT03206749|38309611|FG000|Overall Study|Lost to Follow-up|0|||
17161739|NCT03206749|38309612|FG001|Overall Study|Lost to Follow-up|0|||
17161740|NCT03206749|38309613|FG002|Overall Study|Lost to Follow-up|1|||
17161741|NCT03255941|38309633|FG000|Overall Study|Not eligible or refused injection|37|||
17161742|NCT03255941|38309634|FG001|Overall Study|Not eligible or refused injection|44|||
17161743|NCT03255941|38309635|FG002|Overall Study|Not eligible or refused injection|5|||
17082325|NCT00361842|38223066|FG000|Overall Study|Other|0|||
17082326|NCT00361842|38223067|FG001|Overall Study|Other|2|||
17082327|NCT00361296|38223075|FG000|Overall Study|Physician Decision|1|||
17082328|NCT00361296|38223075|FG000|Overall Study|Lack of Efficacy|2|||
17082329|NCT00356148|38223081|FG000|Overall Study|Reoperation within 30 days|2|||
17082330|NCT00356148|38223082|FG001|Overall Study|Reoperation within 30 days|1|||
17082331|NCT00361218|38223089|FG000|Overall Study|Lost to Follow-up|11|||
17082332|NCT00361218|38223089|FG000|Overall Study|Personal Reasons|7|||
17082333|NCT00361218|38223089|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
17082334|NCT00367458|38223095|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
17082335|NCT00367458|38223096|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
17082336|NCT00162136|38223108|FG000|Overall Study|Adverse Event|1|||
17082337|NCT00162136|38223108|FG000|Overall Study|Death|1|||
17082338|NCT00162136|38223108|FG000|Overall Study|Disease Progression/Relapse|23|||
17082339|NCT00162136|38223108|FG000|Overall Study|Investigator Request|5|||
17082340|NCT00162136|38223108|FG000|Overall Study|Study Drug Toxicity|4|||
17082341|NCT00162136|38223108|FG000|Overall Study|Withdrawal by Subject|1|||
17082342|NCT00252694|38223134|FG000|Overall Study|Withdrawal by Subject|83|||
17082343|NCT00252694|38223135|FG001|Overall Study|Withdrawal by Subject|91|||
17082344|NCT00252694|38223134|FG000|Overall Study|Death|36|||
17082345|NCT00252694|38223135|FG001|Overall Study|Death|34|||
17082346|NCT00252694|38223134|FG000|Overall Study|Mostly Lost to Follow Up|8|||
17082347|NCT00252694|38223135|FG001|Overall Study|Mostly Lost to Follow Up|13|||
17161744|NCT03255941|38309636|FG003|Overall Study|Not eligible or refused injection|6|||
17161745|NCT03255941|38309633|FG000|Overall Study|Did not complete exit interview|1|||
17161746|NCT03255941|38309634|FG001|Overall Study|Did not complete exit interview|2|||
17161747|NCT03255941|38309635|FG002|Overall Study|Did not complete exit interview|0|||
17082348|NCT00252694|38223134|FG000|Overall Study|Patient Moving|17|||
17082349|NCT00252694|38223135|FG001|Overall Study|Patient Moving|16|||
17082350|NCT00185458|38223141|FG000|Contraception Phase|Adverse Event|37|||
17082351|NCT00185458|38223141|FG000|Contraception Phase|Lost to Follow-up|10|||
17082352|NCT00185458|38223141|FG000|Contraception Phase|Protocol Violation|2|||
17082353|NCT00185458|38223141|FG000|Contraception Phase|Physician Decision|2|||
17082354|NCT00185458|38223141|FG000|Contraception Phase|Withdrawal by Subject|7|||
17082355|NCT00185458|38223141|FG000|HRT Phase|Adverse Event|18|||
17082356|NCT00185458|38223141|FG000|HRT Phase|Lost to Follow-up|4|||
17082357|NCT00185458|38223141|FG000|HRT Phase|Protocol Violation|2|||
17082358|NCT00185458|38223141|FG000|HRT Phase|Withdrawal by Subject|3|||
17082359|NCT00185380|38223156|FG000|Overall Study|Adverse Event|41|||
17082360|NCT00185380|38223157|FG001|Overall Study|Adverse Event|43|||
17082361|NCT00185380|38223158|FG002|Overall Study|Adverse Event|48|||
17082362|NCT00185380|38223156|FG000|Overall Study|Lost to Follow-up|0|||
17082363|NCT00185380|38223157|FG001|Overall Study|Lost to Follow-up|4|||
17082364|NCT00185380|38223158|FG002|Overall Study|Lost to Follow-up|3|||
17082365|NCT00185380|38223156|FG000|Overall Study|Pregnancy|1|||
17082366|NCT00185380|38223157|FG001|Overall Study|Pregnancy|4|||
17082367|NCT00185380|38223158|FG002|Overall Study|Pregnancy|0|||
17082368|NCT00185380|38223156|FG000|Overall Study|Protocol Violation|2|||
17161748|NCT03255941|38309636|FG003|Overall Study|Did not complete exit interview|0|||
17161749|NCT03255629|38309658|FG000|Overall Study|Adverse Event|1|||
17161750|NCT03255629|38309659|FG001|Overall Study|Adverse Event|0|||
17161751|NCT03255629|38309658|FG000|Overall Study|did not experience hypoglycemia|2|||
17161752|NCT03255629|38309659|FG001|Overall Study|did not experience hypoglycemia|1|||
17161753|NCT03031938|38309668|FG000|Overall Study|Death|1|||
17161754|NCT03031938|38309669|FG001|Overall Study|Death|0|||
17161755|NCT01137773|38309677|FG000|Overall Study|Death|3|||
17161756|NCT01137773|38309678|FG001|Overall Study|Death|3|||
17161757|NCT01137773|38309677|FG000|Overall Study|Lost to Follow-up|6|||
17161758|NCT01137773|38309678|FG001|Overall Study|Lost to Follow-up|0|||
16995700|NCT01320085|38139516|FG002|Overall Study|Protocol Deviation|1|||
16995701|NCT01253161|38139524|FG000|Overall Study|Adverse Event|1|||
16995702|NCT00581113|38139530|FG000|Overall Study|Withdrawal by Subject|0|||
16995703|NCT00581113|38139531|FG001|Overall Study|Withdrawal by Subject|1|||
16995704|NCT01017029|38139539|FG000|Overall Study|Lost to Follow-up|1|||
16995705|NCT01017029|38139540|FG001|Overall Study|Lost to Follow-up|0|||
16995706|NCT01017029|38139539|FG000|Overall Study|Administrative problem|0|||
16995707|NCT01017029|38139540|FG001|Overall Study|Administrative problem|1|||
16995708|NCT01017029|38139539|FG000|Overall Study|Death|3|||
16995709|NCT01017029|38139540|FG001|Overall Study|Death|1|||
16995710|NCT01016015|38139546|FG000|Overall Study|Not Treated|3|||
16995711|NCT01016015|38139546|FG000|Overall Study|Withdrawal by Subject|1|||
16995712|NCT01016015|38139546|FG000|Overall Study|Adverse Event|15|||
16995713|NCT01015703|38139555|FG000|Overall Study|Withdrawal by Subject|0|||
17082369|NCT00185380|38223157|FG001|Overall Study|Protocol Violation|2|||
17082370|NCT00185380|38223158|FG002|Overall Study|Protocol Violation|1|||
17161759|NCT03094611|38309686|FG000|Overall Study|Lack of Efficacy|1|||
17161760|NCT03094611|38309686|FG000|Overall Study|Stem Cell Transplant|1|||
16995714|NCT01015703|38139556|FG001|Overall Study|Withdrawal by Subject|1|||
17082371|NCT00185380|38223156|FG000|Overall Study|Withdrawal by Subject|1|||
17082372|NCT00185380|38223157|FG001|Overall Study|Withdrawal by Subject|2|||
17082373|NCT00185380|38223158|FG002|Overall Study|Withdrawal by Subject|0|||
17082374|NCT00185380|38223156|FG000|Overall Study|Failed insertion|1|||
17082375|NCT00185380|38223157|FG001|Overall Study|Failed insertion|1|||
17082376|NCT00185380|38223158|FG002|Overall Study|Failed insertion|2|||
17082377|NCT00185380|38223156|FG000|Overall Study|Planned pregnancy|9|||
17082378|NCT00185380|38223157|FG001|Overall Study|Planned pregnancy|12|||
17082379|NCT00185380|38223158|FG002|Overall Study|Planned pregnancy|12|||
17082380|NCT00185380|38223156|FG000|Overall Study|No need for contraception|3|||
17082381|NCT00185380|38223157|FG001|Overall Study|No need for contraception|3|||
17161761|NCT04105725|38309710|FG000|Primary Intervention|Lost to Follow-up|0|||
16995715|NCT01015703|38139557|FG002|Overall Study|Withdrawal by Subject|0|||
16995716|NCT01015703|38139558|FG003|Overall Study|Withdrawal by Subject|0|||
16995717|NCT01015703|38139559|FG004|Overall Study|Withdrawal by Subject|0|||
16995718|NCT01015703|38139555|FG000|Overall Study|Adverse Event|1|||
16995719|NCT01015703|38139556|FG001|Overall Study|Adverse Event|0|||
16995720|NCT01015703|38139557|FG002|Overall Study|Adverse Event|0|||
16995721|NCT01015703|38139558|FG003|Overall Study|Adverse Event|0|||
16995722|NCT01015703|38139559|FG004|Overall Study|Adverse Event|0|||
16995723|NCT01015703|38139555|FG000|Overall Study|Protocol Violation|1|||
16995724|NCT01015703|38139556|FG001|Overall Study|Protocol Violation|0|||
16995725|NCT01015703|38139557|FG002|Overall Study|Protocol Violation|0|||
16995726|NCT01015703|38139558|FG003|Overall Study|Protocol Violation|0|||
16995727|NCT01015703|38139559|FG004|Overall Study|Protocol Violation|0|||
16995728|NCT00994214|38139575|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
16995729|NCT00994214|38139576|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
16995730|NCT00994214|38139577|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
16995731|NCT00994214|38139578|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
16995732|NCT00994214|38139575|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
16995733|NCT00994214|38139576|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
16995734|NCT00994214|38139577|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
16995735|NCT00994214|38139578|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
16995736|NCT00994214|38139575|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
16995737|NCT00994214|38139576|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
16995738|NCT00994214|38139577|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
16995739|NCT00994214|38139578|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
16995740|NCT00994214|38139575|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
16995741|NCT00994214|38139576|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
16995742|NCT00994214|38139577|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
16995743|NCT00994214|38139578|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
17161762|NCT04105725|38309711|FG001|Primary Intervention|Lost to Follow-up|2|||
16995744|NCT00994214|38139575|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
16995745|NCT00994214|38139576|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
16995746|NCT00994214|38139577|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
16995747|NCT00994214|38139578|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
16995748|NCT00994214|38139575|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
16995749|NCT00994214|38139576|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
16995750|NCT00994214|38139577|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
16995751|NCT00994214|38139578|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
16995752|NCT01034657|38139606|FG000|Core Phase|Withdrawal by Subject|1|||
16995753|NCT01034657|38139607|FG001|Core Phase|Withdrawal by Subject|0|||
16995754|NCT01034657|38139608|FG002|Core Phase|Withdrawal by Subject|0|||
16995755|NCT01034657|38139606|FG000|Core Phase|Lack of Efficacy|2|||
16995756|NCT01034657|38139607|FG001|Core Phase|Lack of Efficacy|0|||
17161763|NCT04105725|38309710|FG000|Primary Intervention|Withdrawal by Subject|0|||
17161764|NCT04105725|38309711|FG001|Primary Intervention|Withdrawal by Subject|1|||
17161765|NCT04066023|38309720|FG000|Overall Study|Adverse Event|0|||
17161766|NCT04066023|38309721|FG001|Overall Study|Adverse Event|0|||
16995757|NCT01034657|38139608|FG002|Core Phase|Lack of Efficacy|0|||
16995758|NCT01034657|38139606|FG000|Core Phase|Abnormal laboratory value|1|||
16995759|NCT01034657|38139607|FG001|Core Phase|Abnormal laboratory value|0|||
16995760|NCT01034657|38139608|FG002|Core Phase|Abnormal laboratory value|0|||
16995761|NCT01034657|38139606|FG000|Core Phase|Adverse Event|8|||
16995762|NCT01034657|38139607|FG001|Core Phase|Adverse Event|0|||
16995763|NCT01034657|38139608|FG002|Core Phase|Adverse Event|0|||
16995764|NCT01034657|38139606|FG000|Core Phase|Protocol Violation|2|||
16995765|NCT01034657|38139607|FG001|Core Phase|Protocol Violation|0|||
16995766|NCT01034657|38139608|FG002|Core Phase|Protocol Violation|0|||
16995767|NCT01034657|38139606|FG000|Randomized Phase|Withdrawal by Subject|0|||
16995768|NCT01034657|38139607|FG001|Randomized Phase|Withdrawal by Subject|2|||
16995769|NCT01034657|38139608|FG002|Randomized Phase|Withdrawal by Subject|0|||
16995770|NCT01034657|38139606|FG000|Randomized Phase|Lack of Efficacy|5|||
16995771|NCT01034657|38139607|FG001|Randomized Phase|Lack of Efficacy|1|||
16995772|NCT01034657|38139608|FG002|Randomized Phase|Lack of Efficacy|0|||
16995773|NCT01034657|38139606|FG000|Randomized Phase|Abnormal laboratory value|0|||
16995774|NCT01034657|38139607|FG001|Randomized Phase|Abnormal laboratory value|1|||
16995775|NCT01034657|38139608|FG002|Randomized Phase|Abnormal laboratory value|0|||
16995776|NCT01034657|38139606|FG000|Randomized Phase|Adverse Event|0|||
16995777|NCT01034657|38139607|FG001|Randomized Phase|Adverse Event|2|||
16995778|NCT01034657|38139608|FG002|Randomized Phase|Adverse Event|1|||
16995779|NCT01014767|38139622|FG000|Overall Study|PI left institution, data unavailable|12|||
16995780|NCT01014767|38139623|FG001|Overall Study|PI left institution, data unavailable|1|||
16995781|NCT01014767|38139624|FG002|Overall Study|PI left institution, data unavailable|4|||
17082382|NCT00185380|38223158|FG002|Overall Study|No need for contraception|3|||
17082383|NCT00185380|38223156|FG000|Overall Study|Could not attend visits|2|||
17082384|NCT00185380|38223157|FG001|Overall Study|Could not attend visits|0|||
17082385|NCT00185380|38223158|FG002|Overall Study|Could not attend visits|4|||
17082386|NCT00185380|38223156|FG000|Overall Study|personal reason|6|||
17082387|NCT00185380|38223157|FG001|Overall Study|personal reason|1|||
17082388|NCT00185380|38223158|FG002|Overall Study|personal reason|1|||
17082389|NCT00160654|38223166|FG000|Overall Study|Adverse Event|14|||
17082390|NCT00160654|38223166|FG000|Overall Study|Lack of Efficacy|4|||
17161767|NCT04066023|38309722|FG002|Overall Study|Adverse Event|1|||
17161768|NCT04066023|38309720|FG000|Overall Study|Sponsor decision|3|||
17161769|NCT04066023|38309721|FG001|Overall Study|Sponsor decision|6|||
17161770|NCT04066023|38309722|FG002|Overall Study|Sponsor decision|2|||
17161771|NCT04066023|38309720|FG000|Overall Study|Physician Decision|0|||
17161772|NCT04066023|38309721|FG001|Overall Study|Physician Decision|0|||
17161773|NCT04066023|38309722|FG002|Overall Study|Physician Decision|1|||
17161774|NCT04066023|38309720|FG000|Overall Study|Lost to Follow-up|0|||
17161775|NCT04066023|38309721|FG001|Overall Study|Lost to Follow-up|1|||
17161776|NCT04066023|38309722|FG002|Overall Study|Lost to Follow-up|1|||
17161777|NCT04066023|38309720|FG000|Overall Study|Noncompliance|0|||
17161778|NCT04066023|38309721|FG001|Overall Study|Noncompliance|1|||
17161779|NCT04066023|38309722|FG002|Overall Study|Noncompliance|1|||
17161780|NCT03106987|38309734|FG000|Overall Study|Death|37|||
17161781|NCT03106987|38309735|FG001|Overall Study|Death|22|||
17161782|NCT03106987|38309736|FG002|Overall Study|Death|12|||
17161783|NCT03106987|38309737|FG003|Overall Study|Death|8|||
17161784|NCT03106987|38309734|FG000|Overall Study|Lost to Follow-up|2|||
17082391|NCT00160654|38223166|FG000|Overall Study|Lost to Follow-up|2|||
17082392|NCT00160654|38223166|FG000|Overall Study|Intake of expired drug|7|||
17082393|NCT00160654|38223166|FG000|Overall Study|Psychological trauma|1|||
17082394|NCT00160654|38223166|FG000|Overall Study|Sponsor decision|1|||
17082395|NCT00160654|38223166|FG000|Overall Study|Patient met exclusion criteria|1|||
17082396|NCT00160654|38223166|FG000|Overall Study|Patient decision|1|||
17082397|NCT00160654|38223166|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
17082398|NCT00160654|38223166|FG000|Overall Study|Met exclusion criteria|1|||
17082399|NCT00366678|38223172|FG000|Infant Series|Withdrawal by Subject|8|||
17082400|NCT00366678|38223173|FG001|Infant Series|Withdrawal by Subject|6|||
17161785|NCT03106987|38309735|FG001|Overall Study|Lost to Follow-up|0|||
17161786|NCT03106987|38309736|FG002|Overall Study|Lost to Follow-up|2|||
16995782|NCT01014767|38139625|FG003|Overall Study|PI left institution, data unavailable|1|||
17161787|NCT03106987|38309737|FG003|Overall Study|Lost to Follow-up|2|||
17082401|NCT00366678|38223174|FG002|Infant Series|Withdrawal by Subject|0|||
17082402|NCT00366678|38223172|FG000|Infant Series|Protocol Violation|4|||
17082403|NCT00366678|38223173|FG001|Infant Series|Protocol Violation|3|||
17082404|NCT00366678|38223174|FG002|Infant Series|Protocol Violation|0|||
17082405|NCT00366678|38223172|FG000|Infant Series|Failed to return|1|||
17082406|NCT00366678|38223173|FG001|Infant Series|Failed to return|1|||
17082407|NCT00366678|38223174|FG002|Infant Series|Failed to return|0|||
17082408|NCT00366678|38223172|FG000|Infant Series|Adverse Event|1|||
17082409|NCT00366678|38223173|FG001|Infant Series|Adverse Event|0|||
17082410|NCT00366678|38223174|FG002|Infant Series|Adverse Event|0|||
17161788|NCT03106987|38309734|FG000|Overall Study|Withdrawal by Subject|5|||
17161789|NCT03106987|38309735|FG001|Overall Study|Withdrawal by Subject|1|||
17161790|NCT03106987|38309736|FG002|Overall Study|Withdrawal by Subject|4|||
17161791|NCT03106987|38309737|FG003|Overall Study|Withdrawal by Subject|1|||
17161792|NCT02932267|38309747|FG000|Overall Study|Withdrawal by Subject|3|||
17082411|NCT00366678|38223172|FG000|After Infant|Withdrawal by Subject|8|||
17161793|NCT02932267|38309747|FG000|Overall Study|Lost to Follow-up|4|||
17161794|NCT02932267|38309747|FG000|Overall Study|Pregnancy|1|||
17161795|NCT03217591|38309754|FG000|Overall Study|Adverse Event|1|||
17161796|NCT03217591|38309755|FG001|Overall Study|Adverse Event|2|||
17161797|NCT03217591|38309756|FG002|Overall Study|Adverse Event|6|||
17161798|NCT03217591|38309754|FG000|Overall Study|Withdrawal by Subject|0|||
17161799|NCT03217591|38309755|FG001|Overall Study|Withdrawal by Subject|1|||
17161800|NCT03217591|38309756|FG002|Overall Study|Withdrawal by Subject|3|||
17161801|NCT03217591|38309754|FG000|Overall Study|Lost to Follow-up|1|||
17161802|NCT03217591|38309755|FG001|Overall Study|Lost to Follow-up|0|||
17161803|NCT03217591|38309756|FG002|Overall Study|Lost to Follow-up|0|||
17161804|NCT03217591|38309754|FG000|Overall Study|Protocol Violation|1|||
17161805|NCT03217591|38309755|FG001|Overall Study|Protocol Violation|0|||
17161806|NCT03217591|38309756|FG002|Overall Study|Protocol Violation|1|||
17161807|NCT03031782|38309765|FG000|Treatment Period 1|Lack of Efficacy|3|||
17161808|NCT03031782|38309766|FG001|Treatment Period 1|Lack of Efficacy|0|||
17082412|NCT00366678|38223173|FG001|After Infant|Withdrawal by Subject|4|||
17082413|NCT00366678|38223174|FG002|After Infant|Withdrawal by Subject|0|||
17082414|NCT00366678|38223172|FG000|After Infant|Lost to Follow-up|2|||
17082415|NCT00366678|38223173|FG001|After Infant|Lost to Follow-up|1|||
17082416|NCT00366678|38223174|FG002|After Infant|Lost to Follow-up|0|||
17082417|NCT00366678|38223172|FG000|After Infant|Failed to return|5|||
17082418|NCT00366678|38223173|FG001|After Infant|Failed to return|5|||
17082419|NCT00366678|38223174|FG002|After Infant|Failed to return|0|||
17082420|NCT00366678|38223172|FG000|After Infant|Adverse Event|1|||
17082421|NCT00366678|38223173|FG001|After Infant|Adverse Event|0|||
17082422|NCT00366678|38223174|FG002|After Infant|Adverse Event|0|||
17082423|NCT00366678|38223172|FG000|After Infant|Protocol Violation|1|||
17082424|NCT00366678|38223173|FG001|After Infant|Protocol Violation|0|||
17082425|NCT00366678|38223174|FG002|After Infant|Protocol Violation|0|||
17082426|NCT00366678|38223172|FG000|Toddler Dose|Protocol Violation|2|||
17082427|NCT00366678|38223173|FG001|Toddler Dose|Protocol Violation|1|||
17082428|NCT00366678|38223174|FG002|Toddler Dose|Protocol Violation|0|||
17082429|NCT00366678|38223172|FG000|Toddler Dose|Failed to return|1|||
17082430|NCT00366678|38223173|FG001|Toddler Dose|Failed to return|0|||
17082431|NCT00366678|38223174|FG002|Toddler Dose|Failed to return|0|||
17082432|NCT00366678|38223172|FG000|Toddler Dose|Withdrawal by Subject|1|||
17082433|NCT00366678|38223173|FG001|Toddler Dose|Withdrawal by Subject|0|||
17082434|NCT00366678|38223174|FG002|Toddler Dose|Withdrawal by Subject|0|||
17082435|NCT00366678|38223172|FG000|Toddler Dose|protocol deviation|1|||
17082436|NCT00366678|38223173|FG001|Toddler Dose|protocol deviation|0|||
17082437|NCT00366678|38223174|FG002|Toddler Dose|protocol deviation|0|||
17082438|NCT00355368|38223221|FG000|Overall Study|Protocol Violation|8|||
17082439|NCT00355368|38223222|FG001|Overall Study|Protocol Violation|7|||
17082440|NCT00355368|38223221|FG000|Overall Study|cardiac arrest prior to intubation|2|||
17082441|NCT00355368|38223222|FG001|Overall Study|cardiac arrest prior to intubation|2|||
17082442|NCT00360282|38223228|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
17082443|NCT00360282|38223229|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
17082444|NCT00360282|38223230|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
17082445|NCT00360282|38223231|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
17082446|NCT00360282|38223228|FG000|Second Intervention|Adverse Event|0|||
17082447|NCT00360282|38223229|FG001|Second Intervention|Adverse Event|1|||
17082448|NCT00360282|38223230|FG002|Second Intervention|Adverse Event|0|||
17082449|NCT00360282|38223231|FG003|Second Intervention|Adverse Event|0|||
17082450|NCT00373958|38223241|FG000|Infant Series|Withdrawal by Subject|13|||
17082451|NCT00373958|38223242|FG001|Infant Series|Withdrawal by Subject|15|||
17082452|NCT00373958|38223241|FG000|Infant Series|Failed to return|8|||
17082453|NCT00373958|38223242|FG001|Infant Series|Failed to return|13|||
17082454|NCT00373958|38223241|FG000|Infant Series|Lost to Follow-up|6|||
17082455|NCT00373958|38223242|FG001|Infant Series|Lost to Follow-up|5|||
17082456|NCT00373958|38223241|FG000|Infant Series|Protocol Violation|3|||
17082457|NCT00373958|38223242|FG001|Infant Series|Protocol Violation|7|||
17082458|NCT00373958|38223241|FG000|Infant Series|Lost Kaiser coverage|4|||
17082459|NCT00373958|38223242|FG001|Infant Series|Lost Kaiser coverage|0|||
17082460|NCT00373958|38223241|FG000|Infant Series|Child relocated|1|||
17082461|NCT00373958|38223242|FG001|Infant Series|Child relocated|0|||
17082462|NCT00373958|38223241|FG000|Infant Series|Consent was not received|1|||
17082463|NCT00373958|38223242|FG001|Infant Series|Consent was not received|0|||
17082464|NCT00373958|38223241|FG000|Infant Series|Adverse Event|3|||
17082465|NCT00373958|38223242|FG001|Infant Series|Adverse Event|1|||
17082466|NCT00373958|38223241|FG000|Infant Series|Physician Decision|1|||
17082467|NCT00373958|38223242|FG001|Infant Series|Physician Decision|1|||
17082468|NCT00373958|38223241|FG000|Toddler Dose|Lost to Follow-up|5|||
17082469|NCT00373958|38223242|FG001|Toddler Dose|Lost to Follow-up|8|||
17082470|NCT00373958|38223241|FG000|Toddler Dose|Withdrawal by Subject|2|||
17082471|NCT00373958|38223242|FG001|Toddler Dose|Withdrawal by Subject|2|||
17082472|NCT00373958|38223241|FG000|Toddler Dose|Failed to return|1|||
17082473|NCT00373958|38223242|FG001|Toddler Dose|Failed to return|2|||
17082474|NCT00373958|38223241|FG000|Toddler Dose|Protocol Violation|0|||
17082475|NCT00373958|38223242|FG001|Toddler Dose|Protocol Violation|1|||
17082476|NCT00373958|38223241|FG000|Toddler Dose|Withdrawn after infant series|22|||
17082477|NCT00373958|38223242|FG001|Toddler Dose|Withdrawn after infant series|25|||
17082478|NCT00373880|38223271|FG000|Overall Study|Physician Decision|3|||
17082479|NCT00373880|38223271|FG000|Overall Study|Arrested|1|||
17082480|NCT00373880|38223271|FG000|Overall Study|Protocol Violation|14|||
17082481|NCT00184600|38223286|FG000|Overall Study|Adverse Event|9|||
17082482|NCT00184600|38223287|FG001|Overall Study|Adverse Event|0|||
17082483|NCT00184600|38223288|FG002|Overall Study|Adverse Event|5|||
17082484|NCT00184600|38223286|FG000|Overall Study|Death|3|||
17082485|NCT00184600|38223287|FG001|Overall Study|Death|9|||
17082486|NCT00184600|38223288|FG002|Overall Study|Death|7|||
17082487|NCT00184600|38223286|FG000|Overall Study|Lack of Efficacy|3|||
17082488|NCT00184600|38223287|FG001|Overall Study|Lack of Efficacy|1|||
17082489|NCT00184600|38223288|FG002|Overall Study|Lack of Efficacy|3|||
17082490|NCT00184600|38223286|FG000|Overall Study|Lost to Follow-up|4|||
17082491|NCT00184600|38223287|FG001|Overall Study|Lost to Follow-up|6|||
17082492|NCT00184600|38223288|FG002|Overall Study|Lost to Follow-up|1|||
17082493|NCT00184600|38223286|FG000|Overall Study|Protocol Violation|2|||
17082494|NCT00184600|38223287|FG001|Overall Study|Protocol Violation|2|||
17082495|NCT00184600|38223288|FG002|Overall Study|Protocol Violation|3|||
17082496|NCT00184600|38223286|FG000|Overall Study|Withdrawal by Subject|20|||
17082497|NCT00184600|38223287|FG001|Overall Study|Withdrawal by Subject|28|||
17082498|NCT00184600|38223288|FG002|Overall Study|Withdrawal by Subject|12|||
17082499|NCT00184600|38223286|FG000|Overall Study|Unclassified|4|||
17082500|NCT00184600|38223287|FG001|Overall Study|Unclassified|5|||
17082501|NCT00184600|38223288|FG002|Overall Study|Unclassified|3|||
17082502|NCT00265317|38223300|FG000|Lead-In|Objective progression or relapse|6|||
17082503|NCT00265317|38223301|FG001|Lead-In|Objective progression or relapse|11|||
17082504|NCT00265317|38223302|FG002|Lead-In|Objective progression or relapse|0|||
17082505|NCT00265317|38223303|FG003|Lead-In|Objective progression or relapse|0|||
17082506|NCT00265317|38223300|FG000|Lead-In|Adverse Event|2|||
17082507|NCT00265317|38223301|FG001|Lead-In|Adverse Event|1|||
17082508|NCT00265317|38223302|FG002|Lead-In|Adverse Event|0|||
17082509|NCT00265317|38223303|FG003|Lead-In|Adverse Event|0|||
17082510|NCT00265317|38223300|FG000|Lead-In|Death|3|||
17082511|NCT00265317|38223301|FG001|Lead-In|Death|5|||
17082512|NCT00265317|38223302|FG002|Lead-In|Death|0|||
17082513|NCT00265317|38223303|FG003|Lead-In|Death|0|||
17082514|NCT00265317|38223300|FG000|Lead-In|Withdrawal/other than adverse event|1|||
17082515|NCT00265317|38223301|FG001|Lead-In|Withdrawal/other than adverse event|0|||
17082516|NCT00265317|38223302|FG002|Lead-In|Withdrawal/other than adverse event|0|||
17082517|NCT00265317|38223303|FG003|Lead-In|Withdrawal/other than adverse event|0|||
17082518|NCT00265317|38223300|FG000|Phase 2|Objective progression or relapse|0|||
17082519|NCT00265317|38223301|FG001|Phase 2|Objective progression or relapse|0|||
17082520|NCT00265317|38223302|FG002|Phase 2|Objective progression or relapse|37|||
17082521|NCT00265317|38223303|FG003|Phase 2|Objective progression or relapse|38|||
17161809|NCT03031782|38309767|FG002|Treatment Period 1|Lack of Efficacy|0|||
17161810|NCT03031782|38309768|FG003|Treatment Period 1|Lack of Efficacy|0|||
17161811|NCT03031782|38309769|FG004|Treatment Period 1|Lack of Efficacy|0|||
17161812|NCT03031782|38309765|FG000|Treatment Period 2|Physician Decision|0|||
17161813|NCT03031782|38309766|FG001|Treatment Period 2|Physician Decision|1|||
17161814|NCT03031782|38309767|FG002|Treatment Period 2|Physician Decision|0|||
17161815|NCT03031782|38309768|FG003|Treatment Period 2|Physician Decision|0|||
17161816|NCT03031782|38309769|FG004|Treatment Period 2|Physician Decision|3|||
17161817|NCT03031782|38309765|FG000|Treatment Period 2|Lack of Efficacy|0|||
17161818|NCT03031782|38309766|FG001|Treatment Period 2|Lack of Efficacy|1|||
17161819|NCT03031782|38309767|FG002|Treatment Period 2|Lack of Efficacy|0|||
17161820|NCT03031782|38309768|FG003|Treatment Period 2|Lack of Efficacy|0|||
17161821|NCT03031782|38309769|FG004|Treatment Period 2|Lack of Efficacy|1|||
17161822|NCT03031782|38309765|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17161823|NCT03031782|38309766|FG001|Treatment Period 2|Withdrawal by Subject|3|||
17161824|NCT03031782|38309767|FG002|Treatment Period 2|Withdrawal by Subject|0|||
17161825|NCT03031782|38309768|FG003|Treatment Period 2|Withdrawal by Subject|0|||
17161826|NCT03031782|38309769|FG004|Treatment Period 2|Withdrawal by Subject|1|||
17161827|NCT03031782|38309765|FG000|Treatment Period 2|Adverse Event|0|||
17161828|NCT03031782|38309766|FG001|Treatment Period 2|Adverse Event|1|||
17161829|NCT03031782|38309767|FG002|Treatment Period 2|Adverse Event|2|||
17161830|NCT03031782|38309768|FG003|Treatment Period 2|Adverse Event|0|||
17161831|NCT03031782|38309769|FG004|Treatment Period 2|Adverse Event|0|||
17161832|NCT03031782|38309765|FG000|Treatment Period 3|Withdrawal by Subject|0|||
17161833|NCT03031782|38309766|FG001|Treatment Period 3|Withdrawal by Subject|0|||
17161834|NCT03031782|38309767|FG002|Treatment Period 3|Withdrawal by Subject|0|||
17161835|NCT03031782|38309768|FG003|Treatment Period 3|Withdrawal by Subject|1|||
17161836|NCT03031782|38309769|FG004|Treatment Period 3|Withdrawal by Subject|0|||
17161837|NCT03216265|38309786|FG000|Overall Study|Adverse Event|2|||
17161838|NCT03216265|38309787|FG001|Overall Study|Adverse Event|0|||
17161839|NCT03216265|38309788|FG002|Overall Study|Adverse Event|2|||
17161840|NCT03216265|38309786|FG000|Overall Study|Lost to Follow-up|0|||
17161841|NCT03216265|38309787|FG001|Overall Study|Lost to Follow-up|1|||
17161842|NCT03216265|38309788|FG002|Overall Study|Lost to Follow-up|0|||
16995783|NCT02016781|38139637|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
16995784|NCT02016781|38139638|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
16995785|NCT02016781|38139637|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
16995786|NCT02016781|38139638|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
16995787|NCT02016781|38139637|FG000|Final Database Lock|Withdrawal by Subject|2|||
16995788|NCT02016781|38139638|FG001|Final Database Lock|Withdrawal by Subject|1|||
16995789|NCT02016781|38139637|FG000|Final Database Lock|Lost to Follow-up|11|||
16995790|NCT02016781|38139638|FG001|Final Database Lock|Lost to Follow-up|4|||
16995791|NCT02016781|38139637|FG000|Final Database Lock|Missing data|0|||
16995792|NCT02016781|38139638|FG001|Final Database Lock|Missing data|3|||
16995793|NCT01014689|38139646|FG000|Overall Study|Lack of Efficacy|0|||
16995794|NCT01014689|38139647|FG001|Overall Study|Lack of Efficacy|1|||
16995795|NCT01014689|38139646|FG000|Overall Study|Adverse Event|3|||
16995796|NCT01014689|38139647|FG001|Overall Study|Adverse Event|0|||
16995797|NCT01014689|38139646|FG000|Overall Study|Withdrawal by Subject|5|||
16995798|NCT01014689|38139647|FG001|Overall Study|Withdrawal by Subject|4|||
16995799|NCT01014689|38139646|FG000|Overall Study|Protocol Violation|1|||
16995800|NCT01014689|38139647|FG001|Overall Study|Protocol Violation|1|||
17161843|NCT03216265|38309786|FG000|Overall Study|Withdrawal by Subject|0|||
17161844|NCT03216265|38309787|FG001|Overall Study|Withdrawal by Subject|0|||
17161845|NCT03216265|38309788|FG002|Overall Study|Withdrawal by Subject|1|||
17161846|NCT04486950|38309810|FG000|Overall Study|Lost to Follow-up|0|||
17161847|NCT04486950|38309811|FG001|Overall Study|Lost to Follow-up|0|||
17161848|NCT04486950|38309812|FG002|Overall Study|Lost to Follow-up|0|||
17161849|NCT04486950|38309813|FG003|Overall Study|Lost to Follow-up|0|||
17161850|NCT04486950|38309814|FG004|Overall Study|Lost to Follow-up|0|||
17161851|NCT04486950|38309815|FG005|Overall Study|Lost to Follow-up|1|||
17161852|NCT04486950|38309816|FG006|Overall Study|Lost to Follow-up|0|||
17161853|NCT04693416|38309838|FG000|Overall Study|Lost to Follow-up|13|||
17161854|NCT04693416|38309839|FG001|Overall Study|Lost to Follow-up|0|||
17161855|NCT00265941|38309847|FG000|Overall Study|Protocol Violation|22|||
17161856|NCT00265941|38309848|FG001|Overall Study|Protocol Violation|25|||
17161857|NCT00265941|38309847|FG000|Overall Study|Lost to Follow-up|1|||
17161858|NCT00265941|38309848|FG001|Overall Study|Lost to Follow-up|1|||
17161859|NCT03203473|38309862|FG000|Induction Phase|Never started primary treatment|2|||
17161860|NCT03203473|38309863|FG001|Induction Phase|Never started primary treatment|0|||
17082522|NCT00265317|38223300|FG000|Phase 2|Global deterioration of health status|0|||
17082523|NCT00265317|38223301|FG001|Phase 2|Global deterioration of health status|0|||
17082524|NCT00265317|38223302|FG002|Phase 2|Global deterioration of health status|3|||
17082525|NCT00265317|38223303|FG003|Phase 2|Global deterioration of health status|0|||
17082526|NCT00265317|38223300|FG000|Phase 2|Adverse Event|0|||
17082527|NCT00265317|38223301|FG001|Phase 2|Adverse Event|0|||
17082528|NCT00265317|38223302|FG002|Phase 2|Adverse Event|7|||
17082529|NCT00265317|38223303|FG003|Phase 2|Adverse Event|5|||
17082530|NCT00265317|38223300|FG000|Phase 2|Death|0|||
17082531|NCT00265317|38223301|FG001|Phase 2|Death|0|||
17082532|NCT00265317|38223302|FG002|Phase 2|Death|12|||
17082533|NCT00265317|38223303|FG003|Phase 2|Death|15|||
17082534|NCT00265317|38223300|FG000|Phase 2|Protocol Violation|0|||
17082535|NCT00265317|38223301|FG001|Phase 2|Protocol Violation|0|||
17082536|NCT00265317|38223302|FG002|Phase 2|Protocol Violation|1|||
17082537|NCT00265317|38223303|FG003|Phase 2|Protocol Violation|4|||
17082538|NCT00265317|38223300|FG000|Phase 2|Lost to Follow-up|0|||
17082539|NCT00265317|38223301|FG001|Phase 2|Lost to Follow-up|0|||
17082540|NCT00265317|38223302|FG002|Phase 2|Lost to Follow-up|0|||
17082541|NCT00265317|38223303|FG003|Phase 2|Lost to Follow-up|1|||
17082542|NCT00265317|38223300|FG000|Phase 2|Withdrawal/other than adverse event|0|||
17082543|NCT00265317|38223301|FG001|Phase 2|Withdrawal/other than adverse event|0|||
17082544|NCT00265317|38223302|FG002|Phase 2|Withdrawal/other than adverse event|2|||
17082545|NCT00265317|38223303|FG003|Phase 2|Withdrawal/other than adverse event|1|||
17082546|NCT00265317|38223300|FG000|Phase 2|Study terminated by sponsor|0|||
17082547|NCT00265317|38223301|FG001|Phase 2|Study terminated by sponsor|0|||
17082548|NCT00265317|38223302|FG002|Phase 2|Study terminated by sponsor|1|||
17082549|NCT00265317|38223303|FG003|Phase 2|Study terminated by sponsor|0|||
17082550|NCT00265317|38223300|FG000|Phase 2|Other|0|||
17082551|NCT00265317|38223301|FG001|Phase 2|Other|0|||
17082552|NCT00265317|38223302|FG002|Phase 2|Other|1|||
17082553|NCT00265317|38223303|FG003|Phase 2|Other|1|||
17082554|NCT00373490|38223324|FG000|Overall Study|Adverse Event|0|||
17082555|NCT00373490|38223325|FG001|Overall Study|Adverse Event|1|||
17082556|NCT00373490|38223324|FG000|Overall Study|Lack of Efficacy|9|||
17082557|NCT00373490|38223325|FG001|Overall Study|Lack of Efficacy|4|||
17082558|NCT00373490|38223324|FG000|Overall Study|Withdrawal by Subject|0|||
17082559|NCT00373490|38223325|FG001|Overall Study|Withdrawal by Subject|1|||
17082560|NCT00251589|38223335|FG000|Overall Study|Adverse Event|5|||
17082561|NCT00251589|38223336|FG001|Overall Study|Adverse Event|1|||
17082562|NCT00251589|38223337|FG002|Overall Study|Adverse Event|2|||
17082563|NCT00251589|38223338|FG003|Overall Study|Adverse Event|1|||
17082564|NCT00251589|38223335|FG000|Overall Study|Withdrawal by Subject|1|||
17082565|NCT00251589|38223336|FG001|Overall Study|Withdrawal by Subject|1|||
17082566|NCT00251589|38223337|FG002|Overall Study|Withdrawal by Subject|0|||
17082567|NCT00251589|38223338|FG003|Overall Study|Withdrawal by Subject|0|||
17082568|NCT00251589|38223335|FG000|Overall Study|Discontinued due to progressive disease|9|||
17082569|NCT00251589|38223336|FG001|Overall Study|Discontinued due to progressive disease|1|||
17082570|NCT00251589|38223337|FG002|Overall Study|Discontinued due to progressive disease|0|||
17082571|NCT00251589|38223338|FG003|Overall Study|Discontinued due to progressive disease|1|||
17082572|NCT00265239|38223350|FG000|Overall Study|Adverse Event|2|||
17082573|NCT00265239|38223351|FG001|Overall Study|Adverse Event|1|||
17082574|NCT00350298|38223359|FG000|Overall Study|Death|7|||
17082575|NCT00350298|38223360|FG001|Overall Study|Death|8|||
17082576|NCT00350298|38223359|FG000|Overall Study|Lost to Follow-up|1|||
17082577|NCT00350298|38223360|FG001|Overall Study|Lost to Follow-up|2|||
17082578|NCT00350298|38223359|FG000|Overall Study|Withdrawal by Subject|1|||
17082579|NCT00350298|38223360|FG001|Overall Study|Withdrawal by Subject|3|||
17082580|NCT00159874|38223373|FG000|Overall Study|Adverse Event|2|||
17082581|NCT00159874|38223374|FG001|Overall Study|Adverse Event|2|||
17082582|NCT00159874|38223375|FG002|Overall Study|Adverse Event|5|||
17161861|NCT03203473|38309864|FG002|Induction Phase|Never started primary treatment|0|||
17161862|NCT03203473|38309862|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
17161863|NCT03203473|38309863|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
17161864|NCT03203473|38309864|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
17082583|NCT00159874|38223376|FG003|Overall Study|Adverse Event|1|||
17082584|NCT00159874|38223377|FG004|Overall Study|Adverse Event|1|||
17082585|NCT00159874|38223378|FG005|Overall Study|Adverse Event|2|||
17082586|NCT00159874|38223379|FG006|Overall Study|Adverse Event|0|||
17082587|NCT00159874|38223373|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
17082588|NCT00159874|38223374|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
17082589|NCT00159874|38223375|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
17082590|NCT00159874|38223376|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
17161865|NCT03203473|38309862|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
17161866|NCT03203473|38309863|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
17161867|NCT03203473|38309864|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
17161868|NCT03203473|38309862|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
17161869|NCT03203473|38309863|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
17161870|NCT03203473|38309864|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
17161871|NCT03203473|38309862|FG000|Arm Allocation Phase|started salvage therapy|0|||
17161872|NCT03203473|38309863|FG001|Arm Allocation Phase|started salvage therapy|5|||
17161873|NCT03203473|38309864|FG002|Arm Allocation Phase|started salvage therapy|0|||
17161874|NCT03203473|38309862|FG000|Arm Allocation Phase|Disease progression|0|||
17161875|NCT03203473|38309863|FG001|Arm Allocation Phase|Disease progression|0|||
17161876|NCT03203473|38309864|FG002|Arm Allocation Phase|Disease progression|37|||
17161877|NCT03203473|38309862|FG000|Arm Allocation Phase|Adverse Event|0|||
17161878|NCT03203473|38309863|FG001|Arm Allocation Phase|Adverse Event|0|||
17161879|NCT03203473|38309864|FG002|Arm Allocation Phase|Adverse Event|11|||
17161880|NCT03203473|38309862|FG000|Arm Allocation Phase|Physician Decision|0|||
17161881|NCT03203473|38309863|FG001|Arm Allocation Phase|Physician Decision|0|||
17161882|NCT03203473|38309864|FG002|Arm Allocation Phase|Physician Decision|3|||
17161883|NCT03203473|38309862|FG000|Arm Allocation Phase|Death|0|||
17161884|NCT03203473|38309863|FG001|Arm Allocation Phase|Death|0|||
17161885|NCT03203473|38309864|FG002|Arm Allocation Phase|Death|1|||
17161886|NCT03203473|38309862|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
17161887|NCT03203473|38309863|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
17161888|NCT03203473|38309864|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
17161889|NCT03203473|38309862|FG000|Arm Allocation Phase|Intercurrent illness|0|||
17161890|NCT03203473|38309863|FG001|Arm Allocation Phase|Intercurrent illness|0|||
17161891|NCT03203473|38309864|FG002|Arm Allocation Phase|Intercurrent illness|1|||
17161892|NCT03203473|38309862|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
17161893|NCT03203473|38309863|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
17161894|NCT03203473|38309864|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
17161895|NCT03882957|38309875|FG000|Overall Study|Did not complete all three arms|1|||
17161896|NCT03201211|38309887|FG000|Overall Study|Adverse Event|1|||
17161897|NCT03201211|38309888|FG001|Overall Study|Adverse Event|0|||
17161898|NCT03201211|38309889|FG002|Overall Study|Adverse Event|0|||
17161899|NCT03201211|38309887|FG000|Overall Study|Protocol Violation|1|||
17161900|NCT03201211|38309888|FG001|Overall Study|Protocol Violation|0|||
17161901|NCT03201211|38309889|FG002|Overall Study|Protocol Violation|0|||
17161902|NCT03201211|38309887|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
17161903|NCT03201211|38309888|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16995801|NCT01014689|38139646|FG000|Overall Study|Lost to Follow-up|3|||
16995802|NCT01014689|38139647|FG001|Overall Study|Lost to Follow-up|7|||
16995803|NCT01014689|38139646|FG000|Overall Study|Pregnancy|1|||
16995804|NCT01014689|38139647|FG001|Overall Study|Pregnancy|0|||
16995805|NCT01014533|38139655|FG000|Overall Study|Protocol Violation|3|||
16995806|NCT01014533|38139656|FG001|Overall Study|Protocol Violation|2|||
16995807|NCT01014533|38139655|FG000|Overall Study|Withdrawal by Subject|2|||
16995808|NCT01014533|38139656|FG001|Overall Study|Withdrawal by Subject|0|||
17082591|NCT00159874|38223377|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
17082592|NCT00159874|38223378|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
17082593|NCT00159874|38223379|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
17082594|NCT00159874|38223373|FG000|Overall Study|Lack of Efficacy|2|||
17082595|NCT00159874|38223374|FG001|Overall Study|Lack of Efficacy|0|||
17082596|NCT00159874|38223375|FG002|Overall Study|Lack of Efficacy|1|||
17082597|NCT00159874|38223376|FG003|Overall Study|Lack of Efficacy|1|||
17082598|NCT00159874|38223377|FG004|Overall Study|Lack of Efficacy|0|||
17082599|NCT00159874|38223378|FG005|Overall Study|Lack of Efficacy|3|||
17082600|NCT00159874|38223379|FG006|Overall Study|Lack of Efficacy|0|||
17082601|NCT00159874|38223373|FG000|Overall Study|Lost to Follow-up|1|||
17161904|NCT03201211|38309889|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
17161905|NCT03201211|38309887|FG000|Overall Study|OTHER unknown reasons|0|||
17161906|NCT03201211|38309888|FG001|Overall Study|OTHER unknown reasons|1|||
17161907|NCT03201211|38309889|FG002|Overall Study|OTHER unknown reasons|0|||
17082602|NCT00159874|38223374|FG001|Overall Study|Lost to Follow-up|0|||
17082603|NCT00159874|38223375|FG002|Overall Study|Lost to Follow-up|3|||
17082604|NCT00159874|38223376|FG003|Overall Study|Lost to Follow-up|0|||
17082605|NCT00159874|38223377|FG004|Overall Study|Lost to Follow-up|1|||
17082606|NCT00159874|38223378|FG005|Overall Study|Lost to Follow-up|2|||
17082607|NCT00159874|38223379|FG006|Overall Study|Lost to Follow-up|1|||
17082608|NCT00159874|38223373|FG000|Overall Study|Other|8|||
17082609|NCT00159874|38223374|FG001|Overall Study|Other|8|||
17082610|NCT00159874|38223375|FG002|Overall Study|Other|8|||
17082611|NCT00159874|38223376|FG003|Overall Study|Other|0|||
17082612|NCT00159874|38223377|FG004|Overall Study|Other|2|||
17082613|NCT00159874|38223378|FG005|Overall Study|Other|1|||
17082614|NCT00159874|38223379|FG006|Overall Study|Other|3|||
17082615|NCT00159874|38223373|FG000|Overall Study|Protocol Violation|0|||
17082616|NCT00159874|38223374|FG001|Overall Study|Protocol Violation|5|||
17082617|NCT00159874|38223375|FG002|Overall Study|Protocol Violation|2|||
17082618|NCT00159874|38223376|FG003|Overall Study|Protocol Violation|0|||
17082619|NCT00159874|38223377|FG004|Overall Study|Protocol Violation|0|||
17082620|NCT00159874|38223378|FG005|Overall Study|Protocol Violation|0|||
17082621|NCT00159874|38223379|FG006|Overall Study|Protocol Violation|0|||
17082622|NCT00159874|38223373|FG000|Overall Study|Death|3|||
17082623|NCT00159874|38223374|FG001|Overall Study|Death|8|||
17082624|NCT00159874|38223375|FG002|Overall Study|Death|15|||
17082625|NCT00159874|38223376|FG003|Overall Study|Death|0|||
17082626|NCT00159874|38223377|FG004|Overall Study|Death|1|||
17082627|NCT00159874|38223378|FG005|Overall Study|Death|2|||
17082628|NCT00159874|38223379|FG006|Overall Study|Death|0|||
17082629|NCT00159874|38223373|FG000|Overall Study|Withdrawal by Subject|2|||
17082630|NCT00159874|38223374|FG001|Overall Study|Withdrawal by Subject|6|||
17082631|NCT00159874|38223375|FG002|Overall Study|Withdrawal by Subject|8|||
17082632|NCT00159874|38223376|FG003|Overall Study|Withdrawal by Subject|4|||
17082633|NCT00159874|38223377|FG004|Overall Study|Withdrawal by Subject|3|||
17082634|NCT00159874|38223378|FG005|Overall Study|Withdrawal by Subject|2|||
17082635|NCT00159874|38223379|FG006|Overall Study|Withdrawal by Subject|1|||
17082636|NCT00159874|38223373|FG000|Overall Study|Pregnancy|1|||
17082637|NCT00159874|38223374|FG001|Overall Study|Pregnancy|1|||
17082638|NCT00159874|38223375|FG002|Overall Study|Pregnancy|0|||
17082639|NCT00159874|38223376|FG003|Overall Study|Pregnancy|0|||
17082640|NCT00159874|38223377|FG004|Overall Study|Pregnancy|0|||
17082641|NCT00159874|38223378|FG005|Overall Study|Pregnancy|0|||
17082642|NCT00159874|38223379|FG006|Overall Study|Pregnancy|0|||
17082643|NCT00349908|38223397|FG000|Overall Study|Withdrawal by Subject|0|||
17082644|NCT00349908|38223398|FG001|Overall Study|Withdrawal by Subject|4|||
17082645|NCT00184054|38223405|FG000|Overall Study|Adverse Event|1|||
17082646|NCT00183430|38223411|FG000|Overall Study|Adverse Event|1|||
17082647|NCT00183430|38223412|FG001|Overall Study|Adverse Event|0|||
17082648|NCT00183430|38223411|FG000|Overall Study|Lost to Follow-up|3|||
17082649|NCT00183430|38223412|FG001|Overall Study|Lost to Follow-up|0|||
17082650|NCT00183430|38223411|FG000|Overall Study|did not meet inclusion criteria|1|||
17082651|NCT00183430|38223412|FG001|Overall Study|did not meet inclusion criteria|0|||
17082652|NCT00183430|38223411|FG000|Overall Study|Withdrawal by Subject|1|||
17082653|NCT00183430|38223412|FG001|Overall Study|Withdrawal by Subject|0|||
17082654|NCT00183274|38223418|FG000|Phase 1: Open-Label|Adverse Event|31|||
17082655|NCT00183274|38223419|FG001|Phase 1: Open-Label|Adverse Event|0|||
17082656|NCT00183274|38223420|FG002|Phase 1: Open-Label|Adverse Event|0|||
16995809|NCT01014533|38139655|FG000|Overall Study|unable to come to appointment|0|||
16995810|NCT01014533|38139656|FG001|Overall Study|unable to come to appointment|3|||
16995811|NCT01014143|38139679|FG000|Second Intervention|Lost to Follow-up|2|||
16995812|NCT01014143|38139680|FG001|Second Intervention|Lost to Follow-up|0|||
16995813|NCT01014143|38139681|FG002|Second Intervention|Lost to Follow-up|0|||
16995814|NCT01013753|38139689|FG000|Overall Study|Adverse Event|8|||
16995815|NCT01013753|38139689|FG000|Overall Study|Protocol Violation|3|||
16995816|NCT01013753|38139689|FG000|Overall Study|Lost to Follow-up|1|||
16995817|NCT01013753|38139689|FG000|Overall Study|Withdrawal by Subject|2|||
16995818|NCT01013753|38139689|FG000|Overall Study|Other|2|||
16995819|NCT00757042|38139714|FG000|Overall Study|Lost to Follow-up|0|||
16995820|NCT00757042|38139715|FG001|Overall Study|Lost to Follow-up|0|||
16995821|NCT00757042|38139716|FG002|Overall Study|Lost to Follow-up|0|||
16995822|NCT00757042|38139717|FG003|Overall Study|Lost to Follow-up|0|||
16995823|NCT00757042|38139718|FG004|Overall Study|Lost to Follow-up|0|||
16995824|NCT00757042|38139719|FG005|Overall Study|Lost to Follow-up|0|||
16995825|NCT00757042|38139720|FG006|Overall Study|Lost to Follow-up|0|||
16995826|NCT00757042|38139721|FG007|Overall Study|Lost to Follow-up|0|||
16995827|NCT00757042|38139722|FG008|Overall Study|Lost to Follow-up|1|||
16995828|NCT00757042|38139723|FG009|Overall Study|Lost to Follow-up|0|||
16995829|NCT00757042|38139724|FG010|Overall Study|Lost to Follow-up|0|||
16995830|NCT00757042|38139714|FG000|Overall Study|Ineligibility Determined|0|||
16995831|NCT00757042|38139715|FG001|Overall Study|Ineligibility Determined|0|||
17082657|NCT00183274|38223421|FG003|Phase 1: Open-Label|Adverse Event|0|||
17082658|NCT00183274|38223422|FG004|Phase 1: Open-Label|Adverse Event|0|||
17082659|NCT00183274|38223423|FG005|Phase 1: Open-Label|Adverse Event|0|||
17082660|NCT00183274|38223418|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
17082661|NCT00183274|38223419|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
17082662|NCT00183274|38223420|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
17082663|NCT00183274|38223421|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
17082664|NCT00183274|38223422|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
17082665|NCT00183274|38223423|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
17082666|NCT00183274|38223418|FG000|Phase 1: Open-Label|Protocol Violation|11|||
17082667|NCT00183274|38223419|FG001|Phase 1: Open-Label|Protocol Violation|0|||
17082668|NCT00183274|38223420|FG002|Phase 1: Open-Label|Protocol Violation|0|||
17082669|NCT00183274|38223421|FG003|Phase 1: Open-Label|Protocol Violation|0|||
17082670|NCT00183274|38223422|FG004|Phase 1: Open-Label|Protocol Violation|0|||
17082671|NCT00183274|38223423|FG005|Phase 1: Open-Label|Protocol Violation|0|||
17082672|NCT00183274|38223418|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
17082673|NCT00183274|38223419|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
17082674|NCT00183274|38223420|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
17082675|NCT00183274|38223421|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
17082676|NCT00183274|38223422|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
17082677|NCT00183274|38223423|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
17082678|NCT00183274|38223418|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
16995832|NCT00757042|38139716|FG002|Overall Study|Ineligibility Determined|0|||
16995833|NCT00757042|38139717|FG003|Overall Study|Ineligibility Determined|0|||
16995834|NCT00757042|38139718|FG004|Overall Study|Ineligibility Determined|0|||
16995835|NCT00757042|38139719|FG005|Overall Study|Ineligibility Determined|0|||
16995836|NCT00757042|38139720|FG006|Overall Study|Ineligibility Determined|0|||
16995837|NCT00757042|38139721|FG007|Overall Study|Ineligibility Determined|0|||
16995838|NCT00757042|38139722|FG008|Overall Study|Ineligibility Determined|0|||
16995839|NCT00757042|38139723|FG009|Overall Study|Ineligibility Determined|0|||
16995840|NCT00757042|38139724|FG010|Overall Study|Ineligibility Determined|1|||
16995841|NCT00757042|38139714|FG000|Overall Study|Withdrawal by Subject|0|||
16995842|NCT00757042|38139715|FG001|Overall Study|Withdrawal by Subject|0|||
16995843|NCT00757042|38139716|FG002|Overall Study|Withdrawal by Subject|0|||
16995844|NCT00757042|38139717|FG003|Overall Study|Withdrawal by Subject|0|||
16995845|NCT00757042|38139718|FG004|Overall Study|Withdrawal by Subject|0|||
16995846|NCT00757042|38139719|FG005|Overall Study|Withdrawal by Subject|0|||
16995847|NCT00757042|38139720|FG006|Overall Study|Withdrawal by Subject|0|||
16995848|NCT00757042|38139721|FG007|Overall Study|Withdrawal by Subject|0|||
17082679|NCT00183274|38223419|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
16995849|NCT00757042|38139722|FG008|Overall Study|Withdrawal by Subject|0|||
17082680|NCT00183274|38223420|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
17082681|NCT00183274|38223421|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
17082682|NCT00183274|38223422|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
17082683|NCT00183274|38223423|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
17082684|NCT00183274|38223418|FG000|Phase 1: Open-Label|Other|9|||
16995850|NCT00757042|38139723|FG009|Overall Study|Withdrawal by Subject|1|||
16995851|NCT00757042|38139724|FG010|Overall Study|Withdrawal by Subject|0|||
16995852|NCT01013597|38139755|FG000|Overall Study|Withdrawal by Subject|1|||
16995853|NCT01013285|38139774|FG000|Overall Study|Death|48|||
16995854|NCT01013285|38139775|FG001|Overall Study|Death|89|||
16995855|NCT01033643|38139785|FG000|Overall Study|Withdrew Consent|0|||
16995856|NCT01033643|38139786|FG001|Overall Study|Withdrew Consent|3|||
16995857|NCT01033643|38139787|FG002|Overall Study|Withdrew Consent|0|||
16995858|NCT01033643|38139788|FG003|Overall Study|Withdrew Consent|0|||
16995859|NCT01033643|38139789|FG004|Overall Study|Withdrew Consent|0|||
16995860|NCT01033643|38139790|FG005|Overall Study|Withdrew Consent|1|||
16995861|NCT01013207|38139804|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
16995862|NCT01033487|38139808|FG000|Fourth Intervention Period|Adverse Event|0|||
16995863|NCT01033487|38139809|FG001|Fourth Intervention Period|Adverse Event|0|||
16995864|NCT01033487|38139810|FG002|Fourth Intervention Period|Adverse Event|0|||
17082685|NCT00183274|38223419|FG001|Phase 1: Open-Label|Other|0|||
17082686|NCT00183274|38223420|FG002|Phase 1: Open-Label|Other|0|||
17082687|NCT00183274|38223421|FG003|Phase 1: Open-Label|Other|0|||
17082688|NCT00183274|38223422|FG004|Phase 1: Open-Label|Other|0|||
17082689|NCT00183274|38223423|FG005|Phase 1: Open-Label|Other|0|||
17082690|NCT00183274|38223418|FG000|Phase 2: Double-Blind|Relapsed|0|||
16995865|NCT01033487|38139811|FG003|Fourth Intervention Period|Adverse Event|0|||
16995866|NCT01033487|38139812|FG004|Fourth Intervention Period|Adverse Event|0|||
17082691|NCT00183274|38223419|FG001|Phase 2: Double-Blind|Relapsed|8|||
17082692|NCT00183274|38223420|FG002|Phase 2: Double-Blind|Relapsed|29|||
17082693|NCT00183274|38223421|FG003|Phase 2: Double-Blind|Relapsed|0|||
17082694|NCT00183274|38223422|FG004|Phase 2: Double-Blind|Relapsed|0|||
17082695|NCT00183274|38223423|FG005|Phase 2: Double-Blind|Relapsed|0|||
17082696|NCT00183274|38223418|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
16995867|NCT01033487|38139813|FG005|Fourth Intervention Period|Adverse Event|0|||
16995868|NCT01033487|38139814|FG006|Fourth Intervention Period|Adverse Event|0|||
16995869|NCT01033487|38139815|FG007|Fourth Intervention Period|Adverse Event|0|||
16995870|NCT01033487|38139816|FG008|Fourth Intervention Period|Adverse Event|1|||
16995871|NCT01033487|38139817|FG009|Fourth Intervention Period|Adverse Event|0|||
16995872|NCT01033019|38139833|FG000|Overall Study|Withdrawal by Subject|1|||
17082697|NCT00183274|38223419|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
17082698|NCT00183274|38223420|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
17082699|NCT00183274|38223421|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
17082700|NCT00183274|38223422|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
16995873|NCT01033019|38139834|FG001|Overall Study|Withdrawal by Subject|0|||
16995874|NCT00603447|38139848|FG000|Overall Study|Adverse Event|0|||
17082701|NCT00183274|38223423|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
17082702|NCT00183274|38223418|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
17082703|NCT00183274|38223419|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
17082704|NCT00183274|38223420|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
17082705|NCT00183274|38223421|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
17082706|NCT00183274|38223422|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
17082707|NCT00183274|38223423|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
17082708|NCT00183274|38223418|FG000|Phase 3: Double-Blind|Relapsed|0|||
17082709|NCT00183274|38223419|FG001|Phase 3: Double-Blind|Relapsed|0|||
17082710|NCT00183274|38223420|FG002|Phase 3: Double-Blind|Relapsed|0|||
17082711|NCT00183274|38223421|FG003|Phase 3: Double-Blind|Relapsed|1|||
17082712|NCT00183274|38223422|FG004|Phase 3: Double-Blind|Relapsed|11|||
17082713|NCT00183274|38223423|FG005|Phase 3: Double-Blind|Relapsed|2|||
17082714|NCT00183196|38223441|FG000|Overall Study|Withdrawal by Subject|18|||
17082715|NCT00183196|38223442|FG001|Overall Study|Withdrawal by Subject|11|||
17082716|NCT00183196|38223443|FG002|Overall Study|Withdrawal by Subject|13|||
17082717|NCT00183196|38223441|FG000|Overall Study|Adverse Event|1|||
17082718|NCT00183196|38223442|FG001|Overall Study|Adverse Event|2|||
17082719|NCT00183196|38223443|FG002|Overall Study|Adverse Event|2|||
17082720|NCT00183196|38223441|FG000|Overall Study|Legal event|1|||
17082721|NCT00183196|38223442|FG001|Overall Study|Legal event|1|||
17082722|NCT00183196|38223443|FG002|Overall Study|Legal event|1|||
17082723|NCT00183196|38223441|FG000|Overall Study|Required more intensive care|0|||
17082724|NCT00183196|38223442|FG001|Overall Study|Required more intensive care|1|||
17082725|NCT00183196|38223443|FG002|Overall Study|Required more intensive care|2|||
17082726|NCT00349752|38223453|FG000|Overall Study|Adverse Event|8|||
17082727|NCT00349752|38223454|FG001|Overall Study|Adverse Event|12|||
17082728|NCT00349752|38223453|FG000|Overall Study|Lack of Efficacy|37|||
16995875|NCT00603447|38139849|FG001|Overall Study|Adverse Event|1|||
16995876|NCT00603447|38139850|FG002|Overall Study|Adverse Event|1|||
16995877|NCT00603447|38139851|FG003|Overall Study|Adverse Event|2|||
17082729|NCT00349752|38223454|FG001|Overall Study|Lack of Efficacy|42|||
17082730|NCT00349752|38223453|FG000|Overall Study|Lost to Follow-up|4|||
17082731|NCT00349752|38223454|FG001|Overall Study|Lost to Follow-up|2|||
17082732|NCT00349752|38223453|FG000|Overall Study|Personal reasons|6|||
17082733|NCT00349752|38223454|FG001|Overall Study|Personal reasons|5|||
17082734|NCT00349752|38223453|FG000|Overall Study|Other: Required exclusionary medication|0|||
17082735|NCT00349752|38223454|FG001|Overall Study|Other: Required exclusionary medication|1|||
17082736|NCT00349752|38223453|FG000|Overall Study|Other: Non compliance|0|||
17082737|NCT00349752|38223454|FG001|Overall Study|Other: Non compliance|1|||
17082738|NCT00349752|38223453|FG000|Overall Study|Other: Patient stopped steroids|0|||
17082739|NCT00349752|38223454|FG001|Overall Study|Other: Patient stopped steroids|1|||
17082740|NCT00349752|38223453|FG000|Overall Study|Other: Patient's steroid use|1|||
17082741|NCT00349752|38223454|FG001|Overall Study|Other: Patient's steroid use|0|||
17082742|NCT00349752|38223453|FG000|Overall Study|Other: Ineligible|1|||
17082743|NCT00349752|38223454|FG001|Overall Study|Other: Ineligible|0|||
17082744|NCT00349752|38223453|FG000|Overall Study|Other: Inadvertently unblinded|1|||
17082745|NCT00349752|38223454|FG001|Overall Study|Other: Inadvertently unblinded|0|||
17082746|NCT00349752|38223453|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
17082747|NCT00349752|38223454|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
17082748|NCT00174460|38223462|FG000|Overall Study|Withdrawal by Subject|0|||
17082749|NCT00174460|38223463|FG001|Overall Study|Withdrawal by Subject|1|||
17082750|NCT00348816|38223470|FG000|Overall Study|Noncompliance with radiation treatment|1|||
17082751|NCT00265083|38223479|FG000|Overall Study|Adverse Event|5|||
17082752|NCT00265083|38223480|FG001|Overall Study|Adverse Event|13|||
17082753|NCT00265083|38223481|FG002|Overall Study|Adverse Event|15|||
17082754|NCT00265083|38223479|FG000|Overall Study|Lost to Follow-up|3|||
17082755|NCT00265083|38223480|FG001|Overall Study|Lost to Follow-up|4|||
17082756|NCT00265083|38223481|FG002|Overall Study|Lost to Follow-up|4|||
17082757|NCT00265083|38223479|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
17082758|NCT00265083|38223480|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
17082759|NCT00265083|38223481|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
17082760|NCT00265083|38223479|FG000|Overall Study|Other|1|||
17082761|NCT00265083|38223480|FG001|Overall Study|Other|12|||
17082762|NCT00265083|38223481|FG002|Overall Study|Other|9|||
17082763|NCT00264849|38223492|FG000|Overall Study|Adverse Event|7|||
17082764|NCT00264849|38223493|FG001|Overall Study|Adverse Event|2|||
17082765|NCT00264849|38223492|FG000|Overall Study|Withdrawal by Subject|7|||
17082766|NCT00264849|38223493|FG001|Overall Study|Withdrawal by Subject|11|||
17082767|NCT00264849|38223492|FG000|Overall Study|Protocol Violation|5|||
17082768|NCT00264849|38223493|FG001|Overall Study|Protocol Violation|3|||
17082769|NCT00264849|38223492|FG000|Overall Study|Lack of Efficacy|1|||
17082770|NCT00264849|38223493|FG001|Overall Study|Lack of Efficacy|6|||
17082771|NCT00264849|38223492|FG000|Overall Study|Lost to Follow-up|0|||
17082772|NCT00264849|38223493|FG001|Overall Study|Lost to Follow-up|2|||
17082773|NCT00264849|38223492|FG000|Overall Study|Death|0|||
17082774|NCT00264849|38223493|FG001|Overall Study|Death|1|||
17082775|NCT00264849|38223492|FG000|Overall Study|Administrative Problems|2|||
17082776|NCT00264849|38223493|FG001|Overall Study|Administrative Problems|0|||
17082777|NCT00211809|38223499|FG000|Overall Study|Lack of Efficacy|1|||
17082778|NCT00211809|38223499|FG000|Overall Study|Lost to Follow-up|2|||
16995878|NCT00603447|38139852|FG004|Overall Study|Adverse Event|1|||
16995879|NCT00603447|38139853|FG005|Overall Study|Adverse Event|2|||
16995880|NCT00603447|38139854|FG006|Overall Study|Adverse Event|10|||
16995881|NCT00603447|38139848|FG000|Overall Study|Other|0|||
16995882|NCT00603447|38139849|FG001|Overall Study|Other|0|||
16995883|NCT00603447|38139850|FG002|Overall Study|Other|1|||
16995884|NCT00603447|38139851|FG003|Overall Study|Other|0|||
16995885|NCT00603447|38139852|FG004|Overall Study|Other|3|||
16995886|NCT00603447|38139853|FG005|Overall Study|Other|0|||
16995887|NCT00603447|38139854|FG006|Overall Study|Other|13|||
16995888|NCT00603447|38139848|FG000|Overall Study|Withdrew Consent|0|||
16995889|NCT00603447|38139849|FG001|Overall Study|Withdrew Consent|2|||
16995890|NCT00603447|38139850|FG002|Overall Study|Withdrew Consent|0|||
16995891|NCT00603447|38139851|FG003|Overall Study|Withdrew Consent|0|||
16995892|NCT00603447|38139852|FG004|Overall Study|Withdrew Consent|1|||
16995893|NCT00603447|38139853|FG005|Overall Study|Withdrew Consent|0|||
16995894|NCT00603447|38139854|FG006|Overall Study|Withdrew Consent|1|||
16995895|NCT00778258|38139879|FG000|Overall Study|Adverse Event|1|||
16995896|NCT00778258|38139880|FG001|Overall Study|Adverse Event|0|||
16995897|NCT00778258|38139881|FG002|Overall Study|Adverse Event|0|||
16995898|NCT00778258|38139882|FG003|Overall Study|Adverse Event|0|||
16995899|NCT00778258|38139883|FG004|Overall Study|Adverse Event|0|||
16995900|NCT00778258|38139884|FG005|Overall Study|Adverse Event|1|||
16995901|NCT00778258|38139885|FG006|Overall Study|Adverse Event|0|||
16995902|NCT00778258|38139886|FG007|Overall Study|Adverse Event|0|||
16995903|NCT00778258|38139887|FG008|Overall Study|Adverse Event|0|||
16995904|NCT00778258|38139879|FG000|Overall Study|Lost to Follow-up|0|||
16995905|NCT00778258|38139880|FG001|Overall Study|Lost to Follow-up|0|||
16995906|NCT00778258|38139881|FG002|Overall Study|Lost to Follow-up|2|||
16995907|NCT00778258|38139882|FG003|Overall Study|Lost to Follow-up|0|||
16995908|NCT00778258|38139883|FG004|Overall Study|Lost to Follow-up|0|||
16995909|NCT00778258|38139884|FG005|Overall Study|Lost to Follow-up|3|||
16995910|NCT00778258|38139885|FG006|Overall Study|Lost to Follow-up|2|||
16995911|NCT00778258|38139886|FG007|Overall Study|Lost to Follow-up|2|||
16995912|NCT00778258|38139887|FG008|Overall Study|Lost to Follow-up|0|||
16995913|NCT00778258|38139879|FG000|Overall Study|Withdrawal by Subject|6|||
16995914|NCT00778258|38139880|FG001|Overall Study|Withdrawal by Subject|2|||
16995915|NCT00778258|38139881|FG002|Overall Study|Withdrawal by Subject|8|||
16995916|NCT00778258|38139882|FG003|Overall Study|Withdrawal by Subject|2|||
16995917|NCT00778258|38139883|FG004|Overall Study|Withdrawal by Subject|0|||
16995918|NCT00778258|38139884|FG005|Overall Study|Withdrawal by Subject|6|||
16995919|NCT00778258|38139885|FG006|Overall Study|Withdrawal by Subject|12|||
16995920|NCT00778258|38139886|FG007|Overall Study|Withdrawal by Subject|12|||
16995921|NCT00778258|38139887|FG008|Overall Study|Withdrawal by Subject|4|||
16995922|NCT00778258|38139879|FG000|Overall Study|New Contraindication|0|||
16995923|NCT00778258|38139880|FG001|Overall Study|New Contraindication|0|||
16995924|NCT00778258|38139881|FG002|Overall Study|New Contraindication|0|||
16995925|NCT00778258|38139882|FG003|Overall Study|New Contraindication|0|||
16995926|NCT00778258|38139883|FG004|Overall Study|New Contraindication|0|||
16995927|NCT00778258|38139884|FG005|Overall Study|New Contraindication|0|||
16995928|NCT00778258|38139885|FG006|Overall Study|New Contraindication|0|||
16995929|NCT00778258|38139886|FG007|Overall Study|New Contraindication|1|||
16995930|NCT00778258|38139887|FG008|Overall Study|New Contraindication|0|||
16995931|NCT00778258|38139879|FG000|Overall Study|Non-compliance|0|||
16995932|NCT00778258|38139880|FG001|Overall Study|Non-compliance|0|||
16995933|NCT00778258|38139881|FG002|Overall Study|Non-compliance|0|||
16995934|NCT00778258|38139882|FG003|Overall Study|Non-compliance|1|||
16995935|NCT00778258|38139883|FG004|Overall Study|Non-compliance|0|||
16995936|NCT00778258|38139884|FG005|Overall Study|Non-compliance|0|||
16995937|NCT00778258|38139885|FG006|Overall Study|Non-compliance|0|||
16995938|NCT00778258|38139886|FG007|Overall Study|Non-compliance|0|||
17082779|NCT00211809|38223499|FG000|Overall Study|Pregnancy|1|||
17082780|NCT00211809|38223499|FG000|Overall Study|side effects|2|||
17082781|NCT00129766|38223507|FG000|Overall Study|Death|3|||
17082782|NCT00129766|38223508|FG001|Overall Study|Death|8|||
17082783|NCT00129766|38223507|FG000|Overall Study|Withdrawal of consent|31|||
17082784|NCT00129766|38223508|FG001|Overall Study|Withdrawal of consent|30|||
17082785|NCT00129766|38223507|FG000|Overall Study|Lost to Follow-up|26|||
17082786|NCT00129766|38223508|FG001|Overall Study|Lost to Follow-up|21|||
17082787|NCT00150592|38223517|FG000|Overall Study|Adverse Event|4|||
17082788|NCT00150592|38223518|FG001|Overall Study|Adverse Event|1|||
17082789|NCT00150592|38223517|FG000|Overall Study|Protocol Violation|1|||
17082790|NCT00150592|38223518|FG001|Overall Study|Protocol Violation|0|||
17082791|NCT00150592|38223517|FG000|Overall Study|Withdrawal by Subject|1|||
17082792|NCT00150592|38223518|FG001|Overall Study|Withdrawal by Subject|2|||
17082793|NCT00150592|38223517|FG000|Overall Study|Non-compliance|1|||
17082794|NCT00150592|38223518|FG001|Overall Study|Non-compliance|0|||
17082795|NCT00149890|38223526|FG000|Overall Study|Adverse Event|1|||
17082796|NCT00149890|38223527|FG001|Overall Study|Adverse Event|8|||
17082797|NCT00149890|38223526|FG000|Overall Study|Lack of Efficacy|8|||
17082798|NCT00149890|38223527|FG001|Overall Study|Lack of Efficacy|9|||
17082799|NCT00149890|38223526|FG000|Overall Study|Protocol Violation|1|||
17082800|NCT00149890|38223527|FG001|Overall Study|Protocol Violation|0|||
17082801|NCT00149890|38223526|FG000|Overall Study|Lost to Follow-up|1|||
17082802|NCT00149890|38223527|FG001|Overall Study|Lost to Follow-up|0|||
17082803|NCT00149890|38223526|FG000|Overall Study|Graft Loss|2|||
17082804|NCT00149890|38223527|FG001|Overall Study|Graft Loss|1|||
17082805|NCT00174382|38223533|FG000|Overall Study|Death|2|||
17082806|NCT00174382|38223533|FG000|Overall Study|Adverse Event|19|||
17082807|NCT00174382|38223533|FG000|Overall Study|Withdrawal by Subject|6|||
17082808|NCT00174382|38223533|FG000|Overall Study|Protocol Violation|3|||
17082809|NCT00174382|38223533|FG000|Overall Study|Arrived early for last visit in error|1|||
17082810|NCT00174382|38223533|FG000|Overall Study|Subject felt pill not effective enough|1|||
17161908|NCT04633837|38309899|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
17082811|NCT00174382|38223533|FG000|Overall Study|Lost to Follow-up|1|||
16995939|NCT00778258|38139887|FG008|Overall Study|Non-compliance|0|||
16995940|NCT00778258|38139879|FG000|Overall Study|Other|0|||
17082812|NCT00355134|38223542|FG000|Core Phase|Withdrawal by Subject|35|||
17082813|NCT00355134|38223543|FG001|Core Phase|Withdrawal by Subject|24|||
17082814|NCT00355134|38223544|FG002|Core Phase|Withdrawal by Subject|35|||
17082815|NCT00355134|38223545|FG003|Core Phase|Withdrawal by Subject|0|||
17082816|NCT00355134|38223546|FG004|Core Phase|Withdrawal by Subject|0|||
17082817|NCT00355134|38223542|FG000|Core Phase|Adverse Event|28|||
17082818|NCT00355134|38223543|FG001|Core Phase|Adverse Event|22|||
17082819|NCT00355134|38223544|FG002|Core Phase|Adverse Event|16|||
17082820|NCT00355134|38223545|FG003|Core Phase|Adverse Event|0|||
17082821|NCT00355134|38223546|FG004|Core Phase|Adverse Event|0|||
17082822|NCT00355134|38223542|FG000|Core Phase|Lost to Follow-up|17|||
17082823|NCT00355134|38223543|FG001|Core Phase|Lost to Follow-up|13|||
17082824|NCT00355134|38223544|FG002|Core Phase|Lost to Follow-up|21|||
17082825|NCT00355134|38223545|FG003|Core Phase|Lost to Follow-up|0|||
17082826|NCT00355134|38223546|FG004|Core Phase|Lost to Follow-up|0|||
17082827|NCT00355134|38223542|FG000|Core Phase|Abnormal laboratory value(s)|19|||
17082828|NCT00355134|38223543|FG001|Core Phase|Abnormal laboratory value(s)|14|||
17082829|NCT00355134|38223544|FG002|Core Phase|Abnormal laboratory value(s)|2|||
17082830|NCT00355134|38223545|FG003|Core Phase|Abnormal laboratory value(s)|0|||
17082831|NCT00355134|38223546|FG004|Core Phase|Abnormal laboratory value(s)|0|||
17082832|NCT00355134|38223542|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
17082833|NCT00355134|38223543|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
17082834|NCT00355134|38223544|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
17082835|NCT00355134|38223545|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
17082836|NCT00355134|38223546|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
17082837|NCT00355134|38223542|FG000|Core Phase|Administrative problems|5|||
17082838|NCT00355134|38223543|FG001|Core Phase|Administrative problems|3|||
17161909|NCT04633837|38309900|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
17161910|NCT03929913|38309906|FG000|Overall Study|Death|4|||
17161911|NCT03929913|38309906|FG000|Overall Study|Lost to Follow-up|1|||
17161912|NCT03929913|38309906|FG000|Overall Study|Failed Procedure|2|||
17082839|NCT00355134|38223544|FG002|Core Phase|Administrative problems|5|||
17082840|NCT00355134|38223545|FG003|Core Phase|Administrative problems|0|||
17082841|NCT00355134|38223546|FG004|Core Phase|Administrative problems|0|||
17161913|NCT03029832|38309912|FG000|Overall Study|Safety Follow-Up Completed|2|||
17161914|NCT03029832|38309913|FG001|Overall Study|Safety Follow-Up Completed|0|||
17161915|NCT03029832|38309912|FG000|Overall Study|Death due to Disease Progression|1|||
17161916|NCT03029832|38309913|FG001|Overall Study|Death due to Disease Progression|0|||
17082842|NCT00355134|38223542|FG000|Core Phase|Protocol Violation|3|||
17161917|NCT03029832|38309912|FG000|Overall Study|Study Terminated By Sponsor|1|||
17082843|NCT00355134|38223543|FG001|Core Phase|Protocol Violation|2|||
17082844|NCT00355134|38223544|FG002|Core Phase|Protocol Violation|2|||
17082845|NCT00355134|38223545|FG003|Core Phase|Protocol Violation|0|||
17082846|NCT00355134|38223546|FG004|Core Phase|Protocol Violation|0|||
17082847|NCT00355134|38223542|FG000|Core Phase|Abnormal test procedure result(s)|1|||
17082848|NCT00355134|38223543|FG001|Core Phase|Abnormal test procedure result(s)|2|||
17161918|NCT03029832|38309913|FG001|Overall Study|Study Terminated By Sponsor|1|||
17161919|NCT03089697|38309921|FG000|Overall Study|Adverse Event|1|||
17161920|NCT03089697|38309922|FG001|Overall Study|Adverse Event|2|||
17161921|NCT03089697|38309921|FG000|Overall Study|Withdrawal by Subject|1|||
17161922|NCT03089697|38309922|FG001|Overall Study|Withdrawal by Subject|0|||
17161923|NCT03199963|38309930|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
17161924|NCT03199963|38309931|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
17082849|NCT00355134|38223544|FG002|Core Phase|Abnormal test procedure result(s)|1|||
17082850|NCT00355134|38223545|FG003|Core Phase|Abnormal test procedure result(s)|0|||
17161925|NCT03199963|38309930|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
17161926|NCT03199963|38309931|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
17161927|NCT03199963|38309930|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
17161928|NCT03199963|38309931|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
17161929|NCT03199963|38309930|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
17161930|NCT03199963|38309931|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
17161931|NCT03199963|38309930|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
17161932|NCT03199963|38309931|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
17161933|NCT03199963|38309930|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
17161934|NCT03199963|38309931|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
17161935|NCT03257631|38309947|FG000|Overall Study|Death|8|||
17161936|NCT03257631|38309948|FG001|Overall Study|Death|5|||
17161937|NCT03257631|38309949|FG002|Overall Study|Death|13|||
17161938|NCT03257631|38309950|FG003|Overall Study|Death|5|||
17161939|NCT03257631|38309947|FG000|Overall Study|Progressive Disease|0|||
17161940|NCT03257631|38309948|FG001|Overall Study|Progressive Disease|0|||
17161941|NCT03257631|38309949|FG002|Overall Study|Progressive Disease|1|||
17161942|NCT03257631|38309950|FG003|Overall Study|Progressive Disease|0|||
17161943|NCT03257631|38309947|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
17161944|NCT03257631|38309948|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
17161945|NCT03257631|38309949|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
17161946|NCT03257631|38309950|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
17161947|NCT03257631|38309947|FG000|Overall Study|Lost to Follow-up|0|||
17161948|NCT03257631|38309948|FG001|Overall Study|Lost to Follow-up|0|||
17161949|NCT03257631|38309949|FG002|Overall Study|Lost to Follow-up|1|||
17161950|NCT03257631|38309950|FG003|Overall Study|Lost to Follow-up|0|||
17161951|NCT03257631|38309947|FG000|Overall Study|Still on Study|3|||
17161952|NCT03257631|38309948|FG001|Overall Study|Still on Study|2|||
17161953|NCT03257631|38309949|FG002|Overall Study|Still on Study|4|||
17161954|NCT03257631|38309950|FG003|Overall Study|Still on Study|4|||
17161955|NCT03883581|38309960|FG000|Overall Study|Withdrawal by Subject|4|||
17161956|NCT03029208|38309966|FG000|Overall Study|Withdrawal by Subject|2|||
17161957|NCT03029208|38309967|FG001|Overall Study|Withdrawal by Subject|3|||
17161958|NCT03029208|38309966|FG000|Overall Study|Lost to Follow-up|0|||
17161959|NCT03029208|38309967|FG001|Overall Study|Lost to Follow-up|1|||
17161960|NCT03198715|38309987|FG000|Overall Study|Death|0|||
17161961|NCT03198715|38309988|FG001|Overall Study|Death|0|||
17161962|NCT03198715|38309989|FG002|Overall Study|Death|1|||
17161963|NCT03198715|38309990|FG003|Overall Study|Death|0|||
17161964|NCT03198715|38309991|FG004|Overall Study|Death|2|||
17161965|NCT03198715|38309987|FG000|Overall Study|Other|0|||
17161966|NCT03198715|38309988|FG001|Overall Study|Other|1|||
17161967|NCT03198715|38309989|FG002|Overall Study|Other|1|||
17161968|NCT03198715|38309990|FG003|Overall Study|Other|0|||
17161969|NCT03198715|38309991|FG004|Overall Study|Other|0|||
17161970|NCT03197935|38310014|FG000|Overall Study|Death due to any cause|9|||
17161971|NCT03197935|38310015|FG001|Overall Study|Death due to any cause|7|||
17161972|NCT03197935|38310014|FG000|Overall Study|Lost to Follow-up|0|||
17161973|NCT03197935|38310015|FG001|Overall Study|Lost to Follow-up|3|||
17161974|NCT03197935|38310014|FG000|Overall Study|Physician Decision|0|||
17161975|NCT03197935|38310015|FG001|Overall Study|Physician Decision|1|||
17161976|NCT03197935|38310014|FG000|Overall Study|Withdrawal by Subject|11|||
17082851|NCT00355134|38223546|FG004|Core Phase|Abnormal test procedure result(s)|0|||
17082852|NCT00355134|38223542|FG000|Core Phase|Condition no longer requires study drug|1|||
17082853|NCT00355134|38223543|FG001|Core Phase|Condition no longer requires study drug|0|||
17082854|NCT00355134|38223544|FG002|Core Phase|Condition no longer requires study drug|1|||
17082855|NCT00355134|38223545|FG003|Core Phase|Condition no longer requires study drug|0|||
17082856|NCT00355134|38223546|FG004|Core Phase|Condition no longer requires study drug|0|||
17082857|NCT00355134|38223542|FG000|Extension Phase|Withdrawal by Subject|7|||
17082858|NCT00355134|38223543|FG001|Extension Phase|Withdrawal by Subject|11|||
17082859|NCT00355134|38223544|FG002|Extension Phase|Withdrawal by Subject|0|||
17082860|NCT00355134|38223545|FG003|Extension Phase|Withdrawal by Subject|7|||
17082861|NCT00355134|38223546|FG004|Extension Phase|Withdrawal by Subject|5|||
17082862|NCT00355134|38223542|FG000|Extension Phase|Adverse Event|13|||
17082863|NCT00355134|38223543|FG001|Extension Phase|Adverse Event|9|||
17082864|NCT00355134|38223544|FG002|Extension Phase|Adverse Event|0|||
17082865|NCT00355134|38223545|FG003|Extension Phase|Adverse Event|3|||
17082866|NCT00355134|38223546|FG004|Extension Phase|Adverse Event|5|||
17082867|NCT00355134|38223542|FG000|Extension Phase|Lost to Follow-up|2|||
17082868|NCT00355134|38223543|FG001|Extension Phase|Lost to Follow-up|6|||
17082869|NCT00355134|38223544|FG002|Extension Phase|Lost to Follow-up|0|||
17082870|NCT00355134|38223545|FG003|Extension Phase|Lost to Follow-up|2|||
17082871|NCT00355134|38223546|FG004|Extension Phase|Lost to Follow-up|4|||
17082872|NCT00355134|38223542|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
17082873|NCT00355134|38223543|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
17082874|NCT00355134|38223544|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
17082875|NCT00355134|38223545|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
17082876|NCT00355134|38223546|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
17082877|NCT00355134|38223542|FG000|Extension Phase|Administrative problems|2|||
17082878|NCT00355134|38223543|FG001|Extension Phase|Administrative problems|4|||
17082879|NCT00355134|38223544|FG002|Extension Phase|Administrative problems|0|||
17082880|NCT00355134|38223545|FG003|Extension Phase|Administrative problems|1|||
17082881|NCT00355134|38223546|FG004|Extension Phase|Administrative problems|1|||
17082882|NCT00355134|38223542|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
17082883|NCT00355134|38223543|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
17082884|NCT00355134|38223544|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
17082885|NCT00355134|38223545|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
17082886|NCT00355134|38223546|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
17082887|NCT00355134|38223542|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
17082888|NCT00355134|38223543|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
17082889|NCT00355134|38223544|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
17082890|NCT00355134|38223545|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
17082891|NCT00355134|38223546|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
17082892|NCT00355134|38223542|FG000|Extension Phase|Protocol Violation|0|||
17082893|NCT00355134|38223543|FG001|Extension Phase|Protocol Violation|0|||
17082894|NCT00355134|38223544|FG002|Extension Phase|Protocol Violation|0|||
17082895|NCT00355134|38223545|FG003|Extension Phase|Protocol Violation|1|||
17082896|NCT00355134|38223546|FG004|Extension Phase|Protocol Violation|0|||
17082897|NCT00171730|38223556|FG000|Overall Study|Adverse Event|3|||
17082898|NCT00171730|38223556|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
17082899|NCT00171730|38223556|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
17082900|NCT00171730|38223556|FG000|Overall Study|Withdrawal by Subject|3|||
17082901|NCT00355056|38223568|FG000|Randomization Period|Early Termination|4|||
17082902|NCT00355056|38223569|FG001|Randomization Period|Early Termination|6|||
17082903|NCT00348348|38223585|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
16995941|NCT00778258|38139880|FG001|Overall Study|Other|0|||
17161977|NCT03197935|38310015|FG001|Overall Study|Withdrawal by Subject|7|||
17161978|NCT03197935|38310014|FG000|Overall Study|On-Going in Study|147|||
17161979|NCT03197935|38310015|FG001|Overall Study|On-Going in Study|146|||
17161980|NCT03197935|38310014|FG000|Overall Study|Did not receive any study treatment|1|||
17161981|NCT03197935|38310015|FG001|Overall Study|Did not receive any study treatment|1|||
17161982|NCT03088917|38310022|FG000|Overall Study|In care/cured elsewhere|15|||
17161983|NCT03088917|38310022|FG000|Overall Study|Refuse re-evaluation|13|||
17161984|NCT03088917|38310022|FG000|Overall Study|Contact not established|13|||
17161985|NCT03088917|38310022|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
17161986|NCT03088917|38310022|FG000|Overall Study|Moved outside study region|50|||
17161987|NCT03087513|38310028|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
17161988|NCT02917629|38310043|FG000|Overall Study|Withdrawal by Subject|0|||
17161989|NCT02917629|38310044|FG001|Overall Study|Withdrawal by Subject|1|||
17161990|NCT02927847|38310053|FG000|Overall Study|Lost to Follow-up|1|||
17161991|NCT02927847|38310054|FG001|Overall Study|Lost to Follow-up|0|||
17161992|NCT02927847|38310053|FG000|Overall Study|Withdrawal by Subject|4|||
17161993|NCT02927847|38310054|FG001|Overall Study|Withdrawal by Subject|2|||
17161994|NCT02927847|38310053|FG000|Overall Study|PI withdrawn due to missed visits|1|||
17161995|NCT02927847|38310054|FG001|Overall Study|PI withdrawn due to missed visits|1|||
17161996|NCT02960438|38310064|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
17161997|NCT02960438|38310065|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
17161998|NCT02960438|38310066|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
17161999|NCT02960438|38310067|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
17162000|NCT02960438|38310064|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
17162001|NCT02960438|38310065|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
17162002|NCT02960438|38310066|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
17162003|NCT02960438|38310067|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
17162004|NCT02960438|38310064|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
17162005|NCT02960438|38310065|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
17162006|NCT02960438|38310066|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
17162007|NCT02960438|38310067|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
17162008|NCT02960438|38310064|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
17162009|NCT02960438|38310065|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
17162010|NCT02960438|38310066|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
17162011|NCT02960438|38310067|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
17082904|NCT00348348|38223586|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
17082905|NCT00348348|38223585|FG000|Overall Study|Lack of Efficacy|1|||
17082906|NCT00348348|38223586|FG001|Overall Study|Lack of Efficacy|1|||
17082907|NCT00348348|38223585|FG000|Overall Study|Lost to Follow-up|8|||
17082908|NCT00348348|38223586|FG001|Overall Study|Lost to Follow-up|10|||
17082909|NCT00348348|38223585|FG000|Overall Study|Withdrawal by Subject|4|||
17162012|NCT02960438|38310064|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
17162013|NCT02960438|38310065|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
17162014|NCT02960438|38310066|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
17162015|NCT02960438|38310067|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
17162016|NCT02960438|38310064|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
17162017|NCT02960438|38310065|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
17162018|NCT02960438|38310066|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
17162019|NCT02960438|38310067|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
17162020|NCT02960438|38310064|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
17082910|NCT00348348|38223586|FG001|Overall Study|Withdrawal by Subject|1|||
17082911|NCT00348348|38223585|FG000|Overall Study|Other|7|||
17082912|NCT00348348|38223586|FG001|Overall Study|Other|4|||
17082913|NCT00348348|38223585|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
17082914|NCT00348348|38223586|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
17082915|NCT00348348|38223585|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
17082916|NCT00348348|38223586|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
17082917|NCT00348348|38223585|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
17082918|NCT00348348|38223586|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
17082919|NCT00348348|38223585|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
17082920|NCT00348348|38223586|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
17082921|NCT00348348|38223585|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
17082922|NCT00348348|38223586|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
17082923|NCT00348348|38223585|FG000|Overall Study|Adverse event probably related to study|1|||
17082924|NCT00348348|38223586|FG001|Overall Study|Adverse event probably related to study|0|||
17082925|NCT00347958|38223592|FG000|Overall Study|Adverse Event|1|||
17082926|NCT00347958|38223592|FG000|Overall Study|Protocol Violation|2|||
17082927|NCT00347958|38223592|FG000|Overall Study|Withdrawal by Subject|1|||
17082928|NCT00354744|38223596|FG000|Overall Study|Adverse Event|2|||
17082929|NCT00354744|38223596|FG000|Overall Study|Death|2|||
17082930|NCT00354744|38223596|FG000|Overall Study|Lack of Efficacy|11|||
17082931|NCT00354744|38223596|FG000|Overall Study|Lost to Follow-up|2|||
17082932|NCT00354744|38223596|FG000|Overall Study|Physician Decision|11|||
17082933|NCT00354744|38223596|FG000|Overall Study|Withdrawal by Subject|14|||
17082934|NCT00373256|38223604|FG000|Overall Study|Adverse Event (AE)|1|||
17082935|NCT00373256|38223605|FG001|Overall Study|Adverse Event (AE)|5|||
17082936|NCT00373256|38223604|FG000|Overall Study|Lost to Follow-up|2|||
17082937|NCT00373256|38223605|FG001|Overall Study|Lost to Follow-up|1|||
17082938|NCT00373256|38223604|FG000|Overall Study|Death|9|||
17082939|NCT00373256|38223605|FG001|Overall Study|Death|8|||
17082940|NCT00373256|38223604|FG000|Overall Study|Objective Progression or Relapse|111|||
17082941|NCT00373256|38223605|FG001|Overall Study|Objective Progression or Relapse|104|||
17082942|NCT00373256|38223604|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
17082943|NCT00373256|38223605|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
16995942|NCT00778258|38139881|FG002|Overall Study|Other|0|||
17082944|NCT00373256|38223604|FG000|Overall Study|Other|73|||
17082945|NCT00373256|38223605|FG001|Overall Study|Other|107|||
17082946|NCT00373256|38223604|FG000|Overall Study|Protocol Violation|0|||
17082947|NCT00373256|38223605|FG001|Overall Study|Protocol Violation|2|||
17082948|NCT00373256|38223604|FG000|Overall Study|Study Terminated by Sponsor|41|||
17082949|NCT00373256|38223605|FG001|Overall Study|Study Terminated by Sponsor|13|||
17082950|NCT00394082|38223611|FG000|Overall Study|Unacceptable toxicity|15|||
17082951|NCT00394082|38223611|FG000|Overall Study|Adverse Event|4|||
17082952|NCT00394082|38223611|FG000|Overall Study|Physician Decision|4|||
17082953|NCT00394082|38223611|FG000|Overall Study|Withdrawal by Subject|2|||
17082954|NCT00394082|38223611|FG000|Overall Study|Other|1|||
17082955|NCT00393848|38223619|FG000|Overall Study|Surgical schedule|0|||
17082956|NCT00393848|38223620|FG001|Overall Study|Surgical schedule|0|||
16995943|NCT00778258|38139882|FG003|Overall Study|Other|0|||
17082957|NCT00393848|38223621|FG002|Overall Study|Surgical schedule|0|||
17082958|NCT00393848|38223622|FG003|Overall Study|Surgical schedule|1|||
17082959|NCT00393848|38223619|FG000|Overall Study|Personal reasons|0|||
17082960|NCT00393848|38223620|FG001|Overall Study|Personal reasons|0|||
17082961|NCT00393848|38223621|FG002|Overall Study|Personal reasons|2|||
17082962|NCT00393848|38223622|FG003|Overall Study|Personal reasons|0|||
17082963|NCT00393458|38223637|FG000|Overall Study|Adverse Event|35|||
17082964|NCT00393458|38223638|FG001|Overall Study|Adverse Event|24|||
17082965|NCT00393458|38223639|FG002|Overall Study|Adverse Event|40|||
17082966|NCT00393458|38223640|FG003|Overall Study|Adverse Event|35|||
17082967|NCT00393458|38223637|FG000|Overall Study|Subject withdrew consent|27|||
17082968|NCT00393458|38223638|FG001|Overall Study|Subject withdrew consent|40|||
17082969|NCT00393458|38223639|FG002|Overall Study|Subject withdrew consent|33|||
17082970|NCT00393458|38223640|FG003|Overall Study|Subject withdrew consent|50|||
16995944|NCT00778258|38139883|FG004|Overall Study|Other|0|||
17082971|NCT00393458|38223637|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
17082972|NCT00393458|38223638|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
17082973|NCT00393458|38223639|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
17082974|NCT00393458|38223640|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
17082975|NCT00393458|38223637|FG000|Overall Study|Protocol deviation|11|||
17082976|NCT00393458|38223638|FG001|Overall Study|Protocol deviation|11|||
17082977|NCT00393458|38223639|FG002|Overall Study|Protocol deviation|11|||
17162021|NCT02960438|38310065|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
17162022|NCT02960438|38310066|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
17162023|NCT02960438|38310067|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
17162024|NCT02960438|38310064|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
17162025|NCT02960438|38310065|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
17162026|NCT02960438|38310066|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
17162027|NCT02960438|38310067|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
17162028|NCT02960438|38310064|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
17162029|NCT02960438|38310065|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
17162030|NCT02960438|38310066|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
17162031|NCT02960438|38310067|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
17162032|NCT02960438|38310064|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
17162033|NCT02960438|38310065|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
17162034|NCT02960438|38310066|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
17162035|NCT02960438|38310067|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
17162036|NCT02960438|38310064|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
17162037|NCT02960438|38310065|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
17162038|NCT02960438|38310066|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
17082978|NCT00393458|38223640|FG003|Overall Study|Protocol deviation|10|||
17082979|NCT00393458|38223637|FG000|Overall Study|Administrative problems|7|||
17082980|NCT00393458|38223638|FG001|Overall Study|Administrative problems|8|||
17082981|NCT00393458|38223639|FG002|Overall Study|Administrative problems|5|||
17082982|NCT00393458|38223640|FG003|Overall Study|Administrative problems|2|||
17082983|NCT00393458|38223637|FG000|Overall Study|Lost to Follow-up|5|||
17082984|NCT00393458|38223638|FG001|Overall Study|Lost to Follow-up|6|||
17082985|NCT00393458|38223639|FG002|Overall Study|Lost to Follow-up|5|||
17082986|NCT00393458|38223640|FG003|Overall Study|Lost to Follow-up|3|||
17082987|NCT00393458|38223637|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16995945|NCT00778258|38139884|FG005|Overall Study|Other|0|||
16995946|NCT00778258|38139885|FG006|Overall Study|Other|1|||
16995947|NCT00778258|38139886|FG007|Overall Study|Other|0|||
16995948|NCT00778258|38139887|FG008|Overall Study|Other|0|||
16995949|NCT00988208|38139915|FG000|Overall Study|Adverse Event|71|||
16995950|NCT00988208|38139916|FG001|Overall Study|Adverse Event|122|||
16995951|NCT00988208|38139915|FG000|Overall Study|Disease Progression|103|||
16995952|NCT00988208|38139916|FG001|Overall Study|Disease Progression|89|||
16995953|NCT00988208|38139915|FG000|Overall Study|Withdrawal by Subject|50|||
16995954|NCT00988208|38139916|FG001|Overall Study|Withdrawal by Subject|57|||
17082988|NCT00393458|38223638|FG001|Overall Study|Abnormal laboratory value(s)|1|||
17082989|NCT00393458|38223639|FG002|Overall Study|Abnormal laboratory value(s)|0|||
17082990|NCT00393458|38223640|FG003|Overall Study|Abnormal laboratory value(s)|0|||
17082991|NCT00393458|38223637|FG000|Overall Study|Death|1|||
17082992|NCT00393458|38223638|FG001|Overall Study|Death|1|||
17082993|NCT00393458|38223639|FG002|Overall Study|Death|5|||
17082994|NCT00393458|38223640|FG003|Overall Study|Death|5|||
17082995|NCT00393458|38223637|FG000|Overall Study|Abnormal test procedure result(s)|0|||
17082996|NCT00393458|38223638|FG001|Overall Study|Abnormal test procedure result(s)|1|||
17082997|NCT00393458|38223639|FG002|Overall Study|Abnormal test procedure result(s)|1|||
17082998|NCT00393458|38223640|FG003|Overall Study|Abnormal test procedure result(s)|2|||
17082999|NCT00393458|38223637|FG000|Overall Study|Subject no longer requires study drug|0|||
17083000|NCT00393458|38223638|FG001|Overall Study|Subject no longer requires study drug|1|||
17083001|NCT00393458|38223639|FG002|Overall Study|Subject no longer requires study drug|0|||
17162039|NCT02960438|38310067|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
17162040|NCT02960438|38310064|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
17162041|NCT02960438|38310065|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
17162042|NCT02960438|38310066|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
17162043|NCT02960438|38310067|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
17162044|NCT02957942|38310087|FG000|Overall Study|Withdrawal by Subject|0|||
16995955|NCT00988208|38139915|FG000|Overall Study|Death|9|||
16995956|NCT00988208|38139916|FG001|Overall Study|Death|15|||
16995957|NCT00988208|38139915|FG000|Overall Study|Lost to Follow-up|2|||
17162045|NCT02957942|38310088|FG001|Overall Study|Withdrawal by Subject|1|||
17162046|NCT02957942|38310087|FG000|Overall Study|Practicing experiment protocol|0|||
17162047|NCT02957942|38310088|FG001|Overall Study|Practicing experiment protocol|6|||
17162048|NCT02959970|38310096|FG000|Overall Study|Adverse Event|1|||
17162049|NCT02959970|38310097|FG001|Overall Study|Adverse Event|0|||
17162050|NCT02959970|38310096|FG000|Overall Study|Withdrawal by Subject|0|||
17162051|NCT02959970|38310097|FG001|Overall Study|Withdrawal by Subject|2|||
17162052|NCT02959970|38310096|FG000|Overall Study|Lost to Follow-up|1|||
17162053|NCT02959970|38310097|FG001|Overall Study|Lost to Follow-up|5|||
17162054|NCT03580369|38310123|FG000|Overall Study|No treatment due to mis-randomization|1|||
17162055|NCT03580369|38310124|FG001|Overall Study|No treatment due to mis-randomization|0|||
17162056|NCT03580369|38310125|FG002|Overall Study|No treatment due to mis-randomization|0|||
17162057|NCT03580369|38310126|FG003|Overall Study|No treatment due to mis-randomization|0|||
17162058|NCT03580369|38310127|FG004|Overall Study|No treatment due to mis-randomization|3|||
17162059|NCT03580369|38310128|FG005|Overall Study|No treatment due to mis-randomization|0|||
17162060|NCT03580369|38310129|FG006|Overall Study|No treatment due to mis-randomization|0|||
17162061|NCT03580369|38310130|FG007|Overall Study|No treatment due to mis-randomization|0|||
17162062|NCT03580369|38310123|FG000|Overall Study|Reason unknown|0|||
17162063|NCT03580369|38310124|FG001|Overall Study|Reason unknown|0|||
17162064|NCT03580369|38310125|FG002|Overall Study|Reason unknown|1|||
17162065|NCT03580369|38310126|FG003|Overall Study|Reason unknown|0|||
17162066|NCT03580369|38310127|FG004|Overall Study|Reason unknown|0|||
17162067|NCT03580369|38310128|FG005|Overall Study|Reason unknown|0|||
17162068|NCT03580369|38310129|FG006|Overall Study|Reason unknown|0|||
17162069|NCT03580369|38310130|FG007|Overall Study|Reason unknown|0|||
17162070|NCT03580369|38310123|FG000|Overall Study|Technical problems|0|||
17162071|NCT03580369|38310124|FG001|Overall Study|Technical problems|0|||
17162072|NCT03580369|38310125|FG002|Overall Study|Technical problems|0|||
17162073|NCT03580369|38310126|FG003|Overall Study|Technical problems|0|||
17162074|NCT03580369|38310127|FG004|Overall Study|Technical problems|1|||
17162075|NCT03580369|38310128|FG005|Overall Study|Technical problems|0|||
17162076|NCT03580369|38310129|FG006|Overall Study|Technical problems|2|||
17162077|NCT03580369|38310130|FG007|Overall Study|Technical problems|0|||
17162078|NCT03580369|38310123|FG000|Overall Study|Pregnancy|2|||
17162079|NCT03580369|38310124|FG001|Overall Study|Pregnancy|0|||
17162080|NCT03580369|38310125|FG002|Overall Study|Pregnancy|3|||
17162081|NCT03580369|38310126|FG003|Overall Study|Pregnancy|0|||
17162082|NCT03580369|38310127|FG004|Overall Study|Pregnancy|2|||
17162083|NCT03580369|38310128|FG005|Overall Study|Pregnancy|0|||
17162084|NCT03580369|38310129|FG006|Overall Study|Pregnancy|0|||
17162085|NCT03580369|38310130|FG007|Overall Study|Pregnancy|0|||
17162086|NCT03580369|38310123|FG000|Overall Study|Lost to Follow-up|2|||
17162087|NCT03580369|38310124|FG001|Overall Study|Lost to Follow-up|0|||
17162088|NCT03580369|38310125|FG002|Overall Study|Lost to Follow-up|2|||
17162089|NCT03580369|38310126|FG003|Overall Study|Lost to Follow-up|0|||
17162090|NCT03580369|38310127|FG004|Overall Study|Lost to Follow-up|3|||
17162091|NCT03580369|38310128|FG005|Overall Study|Lost to Follow-up|0|||
17162092|NCT03580369|38310129|FG006|Overall Study|Lost to Follow-up|1|||
17162093|NCT03580369|38310130|FG007|Overall Study|Lost to Follow-up|0|||
17162094|NCT03580369|38310123|FG000|Overall Study|Physician Decision|4|||
17162095|NCT03580369|38310124|FG001|Overall Study|Physician Decision|0|||
17162096|NCT03580369|38310125|FG002|Overall Study|Physician Decision|4|||
17162097|NCT03580369|38310126|FG003|Overall Study|Physician Decision|1|||
17162098|NCT03580369|38310127|FG004|Overall Study|Physician Decision|1|||
17162099|NCT03580369|38310128|FG005|Overall Study|Physician Decision|0|||
17162100|NCT03580369|38310129|FG006|Overall Study|Physician Decision|0|||
17162101|NCT03580369|38310130|FG007|Overall Study|Physician Decision|0|||
17162102|NCT03580369|38310123|FG000|Overall Study|Lack of Efficacy|3|||
17162103|NCT03580369|38310124|FG001|Overall Study|Lack of Efficacy|0|||
17162104|NCT03580369|38310125|FG002|Overall Study|Lack of Efficacy|7|||
17162105|NCT03580369|38310126|FG003|Overall Study|Lack of Efficacy|0|||
17162106|NCT03580369|38310127|FG004|Overall Study|Lack of Efficacy|2|||
17162107|NCT03580369|38310128|FG005|Overall Study|Lack of Efficacy|0|||
17162108|NCT03580369|38310129|FG006|Overall Study|Lack of Efficacy|3|||
17162109|NCT03580369|38310130|FG007|Overall Study|Lack of Efficacy|0|||
17162110|NCT03580369|38310123|FG000|Overall Study|Protocol Violation|6|||
17162111|NCT03580369|38310124|FG001|Overall Study|Protocol Violation|0|||
17162112|NCT03580369|38310125|FG002|Overall Study|Protocol Violation|6|||
17162113|NCT03580369|38310126|FG003|Overall Study|Protocol Violation|1|||
17162114|NCT03580369|38310127|FG004|Overall Study|Protocol Violation|8|||
17162115|NCT03580369|38310128|FG005|Overall Study|Protocol Violation|2|||
17162116|NCT03580369|38310129|FG006|Overall Study|Protocol Violation|1|||
17162117|NCT03580369|38310130|FG007|Overall Study|Protocol Violation|0|||
17162118|NCT03580369|38310123|FG000|Overall Study|Adverse Event|7|||
17162119|NCT03580369|38310124|FG001|Overall Study|Adverse Event|0|||
17162120|NCT03580369|38310125|FG002|Overall Study|Adverse Event|14|||
17162121|NCT03580369|38310126|FG003|Overall Study|Adverse Event|1|||
17162122|NCT03580369|38310127|FG004|Overall Study|Adverse Event|6|||
17083002|NCT00393458|38223640|FG003|Overall Study|Subject no longer requires study drug|0|||
17083003|NCT00392990|38223652|FG000|Treatment on Study|Adverse Event|3|||
17083004|NCT00392990|38223653|FG001|Treatment on Study|Adverse Event|1|||
17083005|NCT00392990|38223652|FG000|Follow up for 2 Years|Death|4|||
17083006|NCT00392990|38223653|FG001|Follow up for 2 Years|Death|0|||
17083007|NCT00417482|38223662|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
17162123|NCT03580369|38310128|FG005|Overall Study|Adverse Event|0|||
17162124|NCT03580369|38310129|FG006|Overall Study|Adverse Event|1|||
17162125|NCT03580369|38310130|FG007|Overall Study|Adverse Event|0|||
17162126|NCT03580369|38310123|FG000|Overall Study|Withdrawal by Subject|19|||
17162127|NCT03580369|38310124|FG001|Overall Study|Withdrawal by Subject|0|||
17162128|NCT03580369|38310125|FG002|Overall Study|Withdrawal by Subject|17|||
17162129|NCT03580369|38310126|FG003|Overall Study|Withdrawal by Subject|0|||
17162130|NCT03580369|38310127|FG004|Overall Study|Withdrawal by Subject|16|||
17162131|NCT03580369|38310128|FG005|Overall Study|Withdrawal by Subject|1|||
17162132|NCT03580369|38310129|FG006|Overall Study|Withdrawal by Subject|7|||
17162133|NCT03580369|38310130|FG007|Overall Study|Withdrawal by Subject|0|||
17162134|NCT02925312|38310143|FG000|Overall Study|Lost to Follow-up|25|||
17162135|NCT02925312|38310144|FG001|Overall Study|Lost to Follow-up|0|||
17083008|NCT00417482|38223663|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
17083009|NCT00417482|38223664|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
17162136|NCT02925312|38310143|FG000|Overall Study|Adverse Event|2|||
17162137|NCT02925312|38310144|FG001|Overall Study|Adverse Event|0|||
17162138|NCT03196297|38310159|FG000|Main Period|Withdrawal by Subject|4|||
17162139|NCT03196297|38310159|FG000|Extension Period|Withdrawal by Subject|1|||
17162140|NCT03196297|38310159|FG000|Extension Period|Lack of Efficacy|2|||
17162141|NCT03192475|38310184|FG000|Overall Study|Death|0|||
17162142|NCT03192475|38310185|FG001|Overall Study|Death|1|||
17162143|NCT03192475|38310184|FG000|Overall Study|Lost to Follow-up|13|||
17083010|NCT00417482|38223662|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
17083011|NCT00417482|38223663|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
17083012|NCT00417482|38223664|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
17083013|NCT00417482|38223662|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
17083014|NCT00417482|38223663|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
17083015|NCT00417482|38223664|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
17083016|NCT00417482|38223662|FG000|Phase B 1st 16 Weeks|Death|1|||
17083017|NCT00417482|38223663|FG001|Phase B 1st 16 Weeks|Death|0|||
17083018|NCT00417482|38223664|FG002|Phase B 1st 16 Weeks|Death|0|||
17162144|NCT03192475|38310185|FG001|Overall Study|Lost to Follow-up|8|||
17162145|NCT03189745|38310194|FG000|Overall Study|Conflict in work schedule of participant|1|||
17083019|NCT00417482|38223662|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
17083020|NCT00417482|38223663|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
17083021|NCT00417482|38223664|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
17162146|NCT03189745|38310195|FG001|Overall Study|Conflict in work schedule of participant|1|||
17162147|NCT03188263|38310203|FG000|Overall Study|Withdrawal by Subject|3|||
17162148|NCT03188263|38310204|FG001|Overall Study|Withdrawal by Subject|0|||
17162149|NCT03188263|38310203|FG000|Overall Study|Physician Decision|1|||
17162150|NCT03188263|38310204|FG001|Overall Study|Physician Decision|0|||
17083022|NCT00417482|38223662|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
17162151|NCT03188185|38310212|FG000|Stage 1|Adverse Event|4|||
17162152|NCT03188185|38310213|FG001|Stage 1|Adverse Event|12|||
17162153|NCT03188185|38310214|FG002|Stage 1|Adverse Event|0|||
17162154|NCT03188185|38310215|FG003|Stage 1|Adverse Event|0|||
17162155|NCT03188185|38310212|FG000|Stage 1|Lack of Efficacy|0|||
17162156|NCT03188185|38310213|FG001|Stage 1|Lack of Efficacy|2|||
17162157|NCT03188185|38310214|FG002|Stage 1|Lack of Efficacy|0|||
17162158|NCT03188185|38310215|FG003|Stage 1|Lack of Efficacy|0|||
17162159|NCT03188185|38310212|FG000|Stage 1|Lost to Follow-up|6|||
17162160|NCT03188185|38310213|FG001|Stage 1|Lost to Follow-up|1|||
17162161|NCT03188185|38310214|FG002|Stage 1|Lost to Follow-up|0|||
17162162|NCT03188185|38310215|FG003|Stage 1|Lost to Follow-up|0|||
17162163|NCT03188185|38310212|FG000|Stage 1|Withdrawal by Subject|9|||
17162164|NCT03188185|38310213|FG001|Stage 1|Withdrawal by Subject|0|||
17162165|NCT03188185|38310214|FG002|Stage 1|Withdrawal by Subject|0|||
17162166|NCT03188185|38310215|FG003|Stage 1|Withdrawal by Subject|0|||
17162167|NCT03188185|38310212|FG000|Stage 1|Identified as a professional patient|0|||
17162168|NCT03188185|38310213|FG001|Stage 1|Identified as a professional patient|1|||
17162169|NCT03188185|38310214|FG002|Stage 1|Identified as a professional patient|0|||
17162170|NCT03188185|38310215|FG003|Stage 1|Identified as a professional patient|0|||
17162171|NCT03188185|38310212|FG000|Stage 2|Adverse Event|0|||
17162172|NCT03188185|38310213|FG001|Stage 2|Adverse Event|0|||
17162173|NCT03188185|38310214|FG002|Stage 2|Adverse Event|2|||
17162174|NCT03188185|38310215|FG003|Stage 2|Adverse Event|4|||
17162175|NCT03188185|38310212|FG000|Stage 2|Lack of Efficacy|0|||
17162176|NCT03188185|38310213|FG001|Stage 2|Lack of Efficacy|0|||
17162177|NCT03188185|38310214|FG002|Stage 2|Lack of Efficacy|3|||
17162178|NCT03188185|38310215|FG003|Stage 2|Lack of Efficacy|0|||
17162179|NCT03188185|38310212|FG000|Stage 2|Lost to Follow-up|0|||
17162180|NCT03188185|38310213|FG001|Stage 2|Lost to Follow-up|0|||
17162181|NCT03188185|38310214|FG002|Stage 2|Lost to Follow-up|1|||
17162182|NCT03188185|38310215|FG003|Stage 2|Lost to Follow-up|0|||
17162183|NCT03188185|38310212|FG000|Stage 2|Physician Decision|0|||
17162184|NCT03188185|38310213|FG001|Stage 2|Physician Decision|0|||
17162185|NCT03188185|38310214|FG002|Stage 2|Physician Decision|0|||
17162186|NCT03188185|38310215|FG003|Stage 2|Physician Decision|1|||
17162187|NCT03188185|38310212|FG000|Stage 2|Withdrawal by Subject|0|||
17162188|NCT03188185|38310213|FG001|Stage 2|Withdrawal by Subject|0|||
17162189|NCT03188185|38310214|FG002|Stage 2|Withdrawal by Subject|3|||
17162190|NCT03188185|38310215|FG003|Stage 2|Withdrawal by Subject|1|||
17162191|NCT03186781|38310231|FG000|Overall Study|Lost to Follow-up|0|||
17162192|NCT03186781|38310232|FG001|Overall Study|Lost to Follow-up|0|||
17162193|NCT03186781|38310233|FG002|Overall Study|Lost to Follow-up|1|||
17162194|NCT03186781|38310234|FG003|Overall Study|Lost to Follow-up|0|||
17162195|NCT03186781|38310235|FG004|Overall Study|Lost to Follow-up|1|||
17162196|NCT03186781|38310236|FG005|Overall Study|Lost to Follow-up|0|||
17162197|NCT03186781|38310231|FG000|Overall Study|Moved from Area|0|||
17162198|NCT03186781|38310232|FG001|Overall Study|Moved from Area|0|||
17162199|NCT03186781|38310233|FG002|Overall Study|Moved from Area|0|||
17162200|NCT03186781|38310234|FG003|Overall Study|Moved from Area|0|||
17162201|NCT03186781|38310235|FG004|Overall Study|Moved from Area|1|||
17162202|NCT03186781|38310236|FG005|Overall Study|Moved from Area|0|||
17162203|NCT03186781|38310231|FG000|Overall Study|Withdrawal by Subject|0|||
17162204|NCT03186781|38310232|FG001|Overall Study|Withdrawal by Subject|0|||
17162205|NCT03186781|38310233|FG002|Overall Study|Withdrawal by Subject|0|||
17162206|NCT03186781|38310234|FG003|Overall Study|Withdrawal by Subject|0|||
17162207|NCT03186781|38310235|FG004|Overall Study|Withdrawal by Subject|1|||
17162208|NCT03186781|38310236|FG005|Overall Study|Withdrawal by Subject|0|||
17162209|NCT03184987|38310263|FG000|Overall Study|Withdrawal by Subject|0|||
17162210|NCT03184987|38310264|FG001|Overall Study|Withdrawal by Subject|1|||
17162211|NCT03184987|38310265|FG002|Overall Study|Withdrawal by Subject|2|||
17162212|NCT03184987|38310263|FG000|Overall Study|Physician Decision|0|||
17162213|NCT03184987|38310264|FG001|Overall Study|Physician Decision|0|||
17162214|NCT03184987|38310265|FG002|Overall Study|Physician Decision|1|||
17162215|NCT03184987|38310263|FG000|Overall Study|Adverse Event|1|||
17162216|NCT03184987|38310264|FG001|Overall Study|Adverse Event|0|||
17162217|NCT03184987|38310265|FG002|Overall Study|Adverse Event|1|||
17162218|NCT03184519|38310273|FG000|Overall Study|Lost to Follow-up|6|||
17162219|NCT03184519|38310273|FG000|Overall Study|Physician Decision|21|||
17162220|NCT03184441|38310277|FG000|Overall Study|Withdrawal by Subject|1|||
17162221|NCT03026166|38310286|FG000|Overall Study|Death|22|||
17162222|NCT03026166|38310287|FG001|Overall Study|Death|7|||
17162223|NCT03026166|38310286|FG000|Overall Study|Physician Decision|2|||
17162224|NCT03026166|38310287|FG001|Overall Study|Physician Decision|0|||
17162225|NCT03026166|38310286|FG000|Overall Study|Withdrawal by Subject|1|||
17162226|NCT03026166|38310287|FG001|Overall Study|Withdrawal by Subject|2|||
17162227|NCT03026166|38310286|FG000|Overall Study|Lost to Follow-up|1|||
17162228|NCT03026166|38310287|FG001|Overall Study|Lost to Follow-up|0|||
17162229|NCT03026166|38310286|FG000|Overall Study|Study Terminated by Sponsor|3|||
17162230|NCT03026166|38310287|FG001|Overall Study|Study Terminated by Sponsor|3|||
17162231|NCT03026166|38310286|FG000|Overall Study|Other|1|||
16995958|NCT00988208|38139916|FG001|Overall Study|Lost to Follow-up|3|||
17162232|NCT03026166|38310287|FG001|Overall Study|Other|0|||
17162233|NCT03026088|38310293|FG000|Overall Study|Study termination|20|||
17162234|NCT03181789|38310301|FG000|Overall Study|Withdrawal by Subject|0|||
17162235|NCT03181789|38310302|FG001|Overall Study|Withdrawal by Subject|1|||
17162236|NCT03181789|38310303|FG002|Overall Study|Withdrawal by Subject|1|||
17162237|NCT03181789|38310304|FG003|Overall Study|Withdrawal by Subject|0|||
17162238|NCT03181789|38310301|FG000|Overall Study|Lost to Follow-up|7|||
17162239|NCT03181789|38310302|FG001|Overall Study|Lost to Follow-up|1|||
17162240|NCT03181789|38310303|FG002|Overall Study|Lost to Follow-up|0|||
17162241|NCT03181789|38310304|FG003|Overall Study|Lost to Follow-up|0|||
17162242|NCT03181789|38310301|FG000|Overall Study|Participant unable to adhere to visit|0|||
17162243|NCT03181789|38310302|FG001|Overall Study|Participant unable to adhere to visit|1|||
17162244|NCT03181789|38310303|FG002|Overall Study|Participant unable to adhere to visit|0|||
17083023|NCT00417482|38223663|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
17083024|NCT00417482|38223664|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
17083025|NCT00417482|38223662|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
17083026|NCT00417482|38223663|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
17162245|NCT03181789|38310304|FG003|Overall Study|Participant unable to adhere to visit|0|||
17162246|NCT03259074|38310317|FG000|Overall Study|Adverse Event|9|||
17162247|NCT03259074|38310318|FG001|Overall Study|Adverse Event|12|||
17162248|NCT03259074|38310319|FG002|Overall Study|Adverse Event|8|||
17162249|NCT03259074|38310317|FG000|Overall Study|Death|1|||
17162250|NCT03259074|38310318|FG001|Overall Study|Death|1|||
17083027|NCT00417482|38223664|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
17083028|NCT00417482|38223662|FG000|Phase B 2nd 16 Weeks|Death|1|||
17083029|NCT00417482|38223663|FG001|Phase B 2nd 16 Weeks|Death|1|||
17083030|NCT00417482|38223664|FG002|Phase B 2nd 16 Weeks|Death|0|||
17083031|NCT03832322|38223680|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
17083032|NCT03832322|38223681|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
17083033|NCT00417248|38223689|FG000|Overall Study|Study Terminated|6|||
17083034|NCT00417248|38223689|FG000|Overall Study|Death|1|||
17083035|NCT00417248|38223689|FG000|Overall Study|Lack of Efficacy|1|||
17083036|NCT00392288|38223697|FG000|Overall Study|Adverse Event|17|||
17083037|NCT00392288|38223698|FG001|Overall Study|Adverse Event|7|||
17083038|NCT00392288|38223699|FG002|Overall Study|Adverse Event|8|||
17083039|NCT00392288|38223697|FG000|Overall Study|Lack of Efficacy|8|||
17083040|NCT00392288|38223698|FG001|Overall Study|Lack of Efficacy|5|||
17083041|NCT00392288|38223699|FG002|Overall Study|Lack of Efficacy|3|||
17083042|NCT00392288|38223697|FG000|Overall Study|Protocol Violation|1|||
17083043|NCT00392288|38223698|FG001|Overall Study|Protocol Violation|3|||
17083044|NCT00392288|38223699|FG002|Overall Study|Protocol Violation|1|||
17162251|NCT03259074|38310319|FG002|Overall Study|Death|3|||
17162252|NCT03259074|38310317|FG000|Overall Study|Lost to Follow-up|2|||
17083045|NCT00392288|38223697|FG000|Overall Study|Lost to Follow-up|1|||
17083046|NCT00392288|38223698|FG001|Overall Study|Lost to Follow-up|1|||
17162253|NCT03259074|38310318|FG001|Overall Study|Lost to Follow-up|4|||
17162254|NCT03259074|38310319|FG002|Overall Study|Lost to Follow-up|3|||
17162255|NCT03259074|38310317|FG000|Overall Study|New Therapy For Study Indication|1|||
17162256|NCT03259074|38310318|FG001|Overall Study|New Therapy For Study Indication|2|||
17162257|NCT03259074|38310319|FG002|Overall Study|New Therapy For Study Indication|2|||
17162258|NCT03259074|38310317|FG000|Overall Study|Physician Decision|4|||
17162259|NCT03259074|38310318|FG001|Overall Study|Physician Decision|12|||
17162260|NCT03259074|38310319|FG002|Overall Study|Physician Decision|10|||
17162261|NCT03259074|38310317|FG000|Overall Study|Pregnancy|1|||
17162262|NCT03259074|38310318|FG001|Overall Study|Pregnancy|1|||
17162263|NCT03259074|38310319|FG002|Overall Study|Pregnancy|0|||
17162264|NCT03259074|38310317|FG000|Overall Study|Progressive Disease|1|||
17162265|NCT03259074|38310318|FG001|Overall Study|Progressive Disease|0|||
17162266|NCT03259074|38310319|FG002|Overall Study|Progressive Disease|0|||
17162267|NCT03259074|38310317|FG000|Overall Study|Protocol Deviation|1|||
17162268|NCT03259074|38310318|FG001|Overall Study|Protocol Deviation|1|||
17162269|NCT03259074|38310319|FG002|Overall Study|Protocol Deviation|3|||
17162270|NCT03259074|38310317|FG000|Overall Study|Subject/Guardian Decision|13|||
17162271|NCT03259074|38310318|FG001|Overall Study|Subject/Guardian Decision|16|||
17162272|NCT03259074|38310319|FG002|Overall Study|Subject/Guardian Decision|14|||
17162273|NCT03024606|38310329|FG000|Overall Study|Withdrawal by Subject|9|||
17162274|NCT03024606|38310330|FG001|Overall Study|Withdrawal by Subject|10|||
17162275|NCT03180619|38310339|FG000|Overall Study|Withdrew Consent|5|||
17162276|NCT03180619|38310340|FG001|Overall Study|Withdrew Consent|0|||
17162277|NCT03180619|38310341|FG002|Overall Study|Withdrew Consent|2|||
17162278|NCT03180619|38310339|FG000|Overall Study|Death|2|||
17162279|NCT03180619|38310340|FG001|Overall Study|Death|1|||
17162280|NCT03180619|38310341|FG002|Overall Study|Death|2|||
17083047|NCT00392288|38223699|FG002|Overall Study|Lost to Follow-up|1|||
17083048|NCT00392288|38223697|FG000|Overall Study|Withdrawal by Subject|1|||
17083049|NCT00392288|38223698|FG001|Overall Study|Withdrawal by Subject|0|||
17162281|NCT03180619|38310339|FG000|Overall Study|Adverse Event|2|||
17162282|NCT03180619|38310340|FG001|Overall Study|Adverse Event|0|||
17162283|NCT03180619|38310341|FG002|Overall Study|Adverse Event|1|||
17162284|NCT03180619|38310339|FG000|Overall Study|Investigator's discretion|2|||
17162285|NCT03180619|38310340|FG001|Overall Study|Investigator's discretion|0|||
17162286|NCT03180619|38310341|FG002|Overall Study|Investigator's discretion|1|||
17162287|NCT02915874|38310358|FG000|Overall Study|Lost to Follow-up|5|||
17162288|NCT02915874|38310359|FG001|Overall Study|Lost to Follow-up|4|||
17162289|NCT02915874|38310358|FG000|Overall Study|Withdrawal by Subject|1|||
17162290|NCT02915874|38310359|FG001|Overall Study|Withdrawal by Subject|1|||
17162291|NCT02915874|38310358|FG000|Overall Study|Started New Anxiety Medication|0|||
17162292|NCT02915874|38310359|FG001|Overall Study|Started New Anxiety Medication|1|||
17162293|NCT03022578|38310365|FG000|Overall Study|Adverse Event|1|||
17162294|NCT03022578|38310365|FG000|Overall Study|Lack of Efficacy|2|||
17162295|NCT03022578|38310365|FG000|Overall Study|Withdrawal by Subject|1|||
17162296|NCT03022422|38310375|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
17162297|NCT03022422|38310376|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
17162298|NCT03022422|38310377|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
17162299|NCT03022422|38310378|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
17162300|NCT03022422|38310379|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
17162301|NCT03022422|38310380|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
17162302|NCT03023826|38310396|FG000|Period 1|Withdrawal by Subject|0|||
17162303|NCT03023826|38310397|FG001|Period 1|Withdrawal by Subject|0|||
17162304|NCT03023826|38310398|FG002|Period 1|Withdrawal by Subject|0|||
17162305|NCT03023826|38310399|FG003|Period 1|Withdrawal by Subject|0|||
17162306|NCT03023826|38310400|FG004|Period 1|Withdrawal by Subject|1|||
17162307|NCT03023826|38310401|FG005|Period 1|Withdrawal by Subject|0|||
17162308|NCT03166735|38310414|FG000|Overall Study|Not Treated|1|||
17162309|NCT03166735|38310415|FG001|Overall Study|Not Treated|0|||
17162310|NCT03166735|38310416|FG002|Overall Study|Not Treated|0|||
17162311|NCT03166735|38310417|FG003|Overall Study|Not Treated|0|||
17162312|NCT03166735|38310418|FG004|Overall Study|Not Treated|0|||
17162313|NCT03166735|38310414|FG000|Overall Study|follow-up not completed as planned|0|||
17162314|NCT03166735|38310415|FG001|Overall Study|follow-up not completed as planned|1|||
17162315|NCT03166735|38310416|FG002|Overall Study|follow-up not completed as planned|1|||
17162316|NCT03166735|38310417|FG003|Overall Study|follow-up not completed as planned|0|||
17162317|NCT03166735|38310418|FG004|Overall Study|follow-up not completed as planned|1|||
17162318|NCT03166735|38310414|FG000|Overall Study|Withdrawal by Subject|0|||
17162319|NCT03166735|38310415|FG001|Overall Study|Withdrawal by Subject|0|||
17162320|NCT03166735|38310416|FG002|Overall Study|Withdrawal by Subject|1|||
17162321|NCT03166735|38310417|FG003|Overall Study|Withdrawal by Subject|1|||
17162322|NCT03166735|38310418|FG004|Overall Study|Withdrawal by Subject|2|||
17162323|NCT03166735|38310414|FG000|Overall Study|Lost to Follow-up|0|||
17162324|NCT03166735|38310415|FG001|Overall Study|Lost to Follow-up|2|||
17162325|NCT03166735|38310416|FG002|Overall Study|Lost to Follow-up|1|||
17162326|NCT03166735|38310417|FG003|Overall Study|Lost to Follow-up|0|||
17083050|NCT00392288|38223699|FG002|Overall Study|Withdrawal by Subject|2|||
17083051|NCT00392288|38223697|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
17083052|NCT00392288|38223698|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
17083053|NCT00392288|38223699|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
17162327|NCT03166735|38310418|FG004|Overall Study|Lost to Follow-up|1|||
17162328|NCT03165955|38310431|FG000|Treatment|Withdrawal by Subject|3|||
17162329|NCT03165955|38310431|FG000|Treatment|Death|1|||
17083054|NCT00392288|38223697|FG000|Overall Study|Other|3|||
17083055|NCT00392288|38223698|FG001|Overall Study|Other|4|||
17083056|NCT00392288|38223699|FG002|Overall Study|Other|1|||
17083057|NCT00417170|38223709|FG000|Overall Study|Adverse Event|1|||
17083058|NCT00417170|38223710|FG001|Overall Study|Adverse Event|1|||
17083059|NCT00417170|38223709|FG000|Overall Study|Withdrawal by Subject|1|||
17083060|NCT00417170|38223710|FG001|Overall Study|Withdrawal by Subject|1|||
17083061|NCT00417170|38223709|FG000|Overall Study|Lost to Follow-up|0|||
17083062|NCT00417170|38223710|FG001|Overall Study|Lost to Follow-up|1|||
17083063|NCT00249873|38223718|FG000|Overall Study|Not treated|7|||
17083064|NCT00249873|38223719|FG001|Overall Study|Not treated|8|||
17083065|NCT00249873|38223718|FG000|Overall Study|Significant thrombocytopenia|9|||
17083066|NCT00249873|38223719|FG001|Overall Study|Significant thrombocytopenia|8|||
17083067|NCT00249873|38223718|FG000|Overall Study|Severe allergic reaction|8|||
17083068|NCT00249873|38223719|FG001|Overall Study|Severe allergic reaction|1|||
17083069|NCT00249873|38223718|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
17083070|NCT00249873|38223719|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
17083071|NCT00249873|38223718|FG000|Overall Study|Other Serious Adverse Event|86|||
17083072|NCT00249873|38223719|FG001|Overall Study|Other Serious Adverse Event|97|||
17083073|NCT00249873|38223718|FG000|Overall Study|Qualifying condition not present|20|||
17083074|NCT00249873|38223719|FG001|Overall Study|Qualifying condition not present|23|||
17083075|NCT00249873|38223718|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
17083076|NCT00249873|38223719|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
17083077|NCT00249873|38223718|FG000|Overall Study|Withdrawal by Subject|504|||
17083078|NCT00249873|38223719|FG001|Overall Study|Withdrawal by Subject|466|||
17083079|NCT00249873|38223718|FG000|Overall Study|Lost to Follow-up|4|||
17083080|NCT00249873|38223719|FG001|Overall Study|Lost to Follow-up|7|||
16995959|NCT00988208|38139915|FG000|Overall Study|Protocol Violation|9|||
17162330|NCT03165955|38310431|FG000|Treatment|Adverse Event|1|||
17162331|NCT03165955|38310431|FG000|Treatment|Progressive disease|3|||
17162332|NCT03055494|38310437|FG000|Overall Study|Lost to Follow-up|6|||
17162333|NCT03055494|38310438|FG001|Overall Study|Lost to Follow-up|0|||
17162334|NCT03055494|38310437|FG000|Overall Study|Physician Decision|2|||
17162335|NCT03055494|38310438|FG001|Overall Study|Physician Decision|0|||
17162336|NCT03055494|38310437|FG000|Overall Study|Withdrawal by Subject|1|||
17162337|NCT03055494|38310438|FG001|Overall Study|Withdrawal by Subject|0|||
17162338|NCT03055494|38310437|FG000|Overall Study|Adverse Event|0|||
17162339|NCT03055494|38310438|FG001|Overall Study|Adverse Event|1|||
17162340|NCT03055494|38310437|FG000|Overall Study|Non-compliance with study treatment|1|||
17162341|NCT03055494|38310438|FG001|Overall Study|Non-compliance with study treatment|0|||
17162342|NCT02914548|38310448|FG000|Overall Study|Adverse Event|15|||
17162343|NCT02914548|38310449|FG001|Overall Study|Adverse Event|7|||
17162344|NCT02914548|38310450|FG002|Overall Study|Adverse Event|15|||
17162345|NCT02914548|38310448|FG000|Overall Study|Physician Decision|2|||
17162346|NCT02914548|38310449|FG001|Overall Study|Physician Decision|2|||
17162347|NCT02914548|38310450|FG002|Overall Study|Physician Decision|0|||
17162348|NCT02914548|38310448|FG000|Overall Study|Protocol Violation|1|||
17162349|NCT02914548|38310449|FG001|Overall Study|Protocol Violation|0|||
17162350|NCT02914548|38310450|FG002|Overall Study|Protocol Violation|0|||
17162351|NCT02914548|38310448|FG000|Overall Study|Withdrawal by Subject|3|||
17162352|NCT02914548|38310449|FG001|Overall Study|Withdrawal by Subject|4|||
17162353|NCT02914548|38310450|FG002|Overall Study|Withdrawal by Subject|4|||
17162354|NCT02914548|38310448|FG000|Overall Study|>40% of body surface area|0|||
17162355|NCT02914548|38310449|FG001|Overall Study|>40% of body surface area|1|||
17162356|NCT02914548|38310450|FG002|Overall Study|>40% of body surface area|1|||
17162357|NCT03165721|38310466|FG000|Overall Study|Refused further treatment|3|||
17162358|NCT03165721|38310467|FG001|Overall Study|Refused further treatment|0|||
17162359|NCT03165721|38310468|FG002|Overall Study|Refused further treatment|0|||
17162360|NCT03165721|38310466|FG000|Overall Study|Physician Decision|1|||
17162361|NCT03165721|38310467|FG001|Overall Study|Physician Decision|0|||
17162362|NCT03165721|38310468|FG002|Overall Study|Physician Decision|0|||
17162363|NCT02187198|38310484|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
17162364|NCT02187198|38310485|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
17162365|NCT02187198|38310484|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
17162366|NCT02187198|38310485|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
17162367|NCT02642029|38310491|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
17162368|NCT02642029|38310492|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
17162369|NCT02642029|38310493|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
17162370|NCT02642029|38310494|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
17162371|NCT02642029|38310495|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
16781294|NCT02105974|37720453|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
17162372|NCT02642029|38310496|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
17162373|NCT02642029|38310491|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
17162374|NCT02642029|38310492|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
17162375|NCT02642029|38310493|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
17162376|NCT02642029|38310494|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
17162377|NCT02642029|38310495|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
17162378|NCT02642029|38310496|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
17162379|NCT02642029|38310491|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
17162380|NCT02642029|38310492|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
17162381|NCT02642029|38310493|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
17162382|NCT02642029|38310494|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
17162383|NCT02642029|38310495|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
17162384|NCT02642029|38310496|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
17162385|NCT02642029|38310491|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
17162386|NCT02642029|38310492|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
17162387|NCT02642029|38310493|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
17162388|NCT02642029|38310494|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
17162389|NCT02642029|38310495|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
17162390|NCT02642029|38310496|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
17162391|NCT02642029|38310491|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
17162392|NCT02642029|38310492|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
17162393|NCT02642029|38310493|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
17162394|NCT02642029|38310494|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
17162395|NCT02642029|38310495|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
17162396|NCT02642029|38310496|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
17162397|NCT02642029|38310491|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
17162398|NCT02642029|38310492|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
17162399|NCT02642029|38310493|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
17162400|NCT02642029|38310494|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
17162401|NCT02642029|38310495|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
17162402|NCT02642029|38310496|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
17162403|NCT03178669|38310509|FG000|Overall Study|Adverse Event|4|||
17162404|NCT03178669|38310510|FG001|Overall Study|Adverse Event|1|||
17162405|NCT03178669|38310511|FG002|Overall Study|Adverse Event|4|||
17162406|NCT03178669|38310512|FG003|Overall Study|Adverse Event|2|||
17162407|NCT03178669|38310513|FG004|Overall Study|Adverse Event|2|||
17162408|NCT03178669|38310509|FG000|Overall Study|Lack of Efficacy|0|||
17162409|NCT03178669|38310510|FG001|Overall Study|Lack of Efficacy|0|||
17162410|NCT03178669|38310511|FG002|Overall Study|Lack of Efficacy|2|||
17162411|NCT03178669|38310512|FG003|Overall Study|Lack of Efficacy|0|||
17162412|NCT03178669|38310513|FG004|Overall Study|Lack of Efficacy|1|||
17162413|NCT03178669|38310509|FG000|Overall Study|Physician Decision|0|||
17162414|NCT03178669|38310510|FG001|Overall Study|Physician Decision|0|||
17162415|NCT03178669|38310511|FG002|Overall Study|Physician Decision|0|||
17162416|NCT03178669|38310512|FG003|Overall Study|Physician Decision|0|||
17162417|NCT03178669|38310513|FG004|Overall Study|Physician Decision|1|||
17162418|NCT03178669|38310509|FG000|Overall Study|Withdrawal by Subject|1|||
17162419|NCT03178669|38310510|FG001|Overall Study|Withdrawal by Subject|0|||
17162420|NCT03178669|38310511|FG002|Overall Study|Withdrawal by Subject|1|||
17162421|NCT03178669|38310512|FG003|Overall Study|Withdrawal by Subject|1|||
17162422|NCT03178669|38310513|FG004|Overall Study|Withdrawal by Subject|0|||
17162423|NCT03178669|38310509|FG000|Overall Study|Lost to Follow-up|0|||
17162424|NCT03178669|38310510|FG001|Overall Study|Lost to Follow-up|0|||
17162425|NCT03178669|38310511|FG002|Overall Study|Lost to Follow-up|0|||
17162426|NCT03178669|38310512|FG003|Overall Study|Lost to Follow-up|1|||
17162427|NCT03178669|38310513|FG004|Overall Study|Lost to Follow-up|0|||
17162428|NCT03178201|38310525|FG000|Overall Study|Off study|5|||
17162429|NCT02085408|38310531|FG000|Step 1: Induction|Disease Progression|19|||
17162430|NCT02085408|38310532|FG001|Step 1: Induction|Disease Progression|19|||
17162431|NCT02085408|38310531|FG000|Step 1: Induction|Adverse Event|18|||
17162432|NCT02085408|38310532|FG001|Step 1: Induction|Adverse Event|17|||
17162433|NCT02085408|38310531|FG000|Step 1: Induction|Death|33|||
17162434|NCT02085408|38310532|FG001|Step 1: Induction|Death|30|||
17162435|NCT02085408|38310531|FG000|Step 1: Induction|Withdrawal by Subject|16|||
17162436|NCT02085408|38310532|FG001|Step 1: Induction|Withdrawal by Subject|8|||
17162437|NCT02085408|38310531|FG000|Step 1: Induction|Alternative Therapy|15|||
17162438|NCT02085408|38310532|FG001|Step 1: Induction|Alternative Therapy|19|||
17162439|NCT02085408|38310531|FG000|Step 1: Induction|Complicating Disease|2|||
17162440|NCT02085408|38310532|FG001|Step 1: Induction|Complicating Disease|3|||
17162441|NCT02085408|38310531|FG000|Step 1: Induction|Other|27|||
17162442|NCT02085408|38310532|FG001|Step 1: Induction|Other|39|||
17162443|NCT02085408|38310531|FG000|Step 1: Induction|Never started treatment|6|||
17162444|NCT02085408|38310532|FG001|Step 1: Induction|Never started treatment|4|||
17162445|NCT02085408|38310531|FG000|Step 2: Consolidation|Disease Progression|5|||
17162446|NCT02085408|38310532|FG001|Step 2: Consolidation|Disease Progression|20|||
17162447|NCT02085408|38310531|FG000|Step 2: Consolidation|Adverse Event|9|||
17162448|NCT02085408|38310532|FG001|Step 2: Consolidation|Adverse Event|8|||
17162449|NCT02085408|38310531|FG000|Step 2: Consolidation|Death|4|||
17162450|NCT02085408|38310532|FG001|Step 2: Consolidation|Death|3|||
17162451|NCT02085408|38310531|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
17162452|NCT02085408|38310532|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
17162453|NCT02085408|38310531|FG000|Step 2: Consolidation|Alternative Therapy|9|||
17162454|NCT02085408|38310532|FG001|Step 2: Consolidation|Alternative Therapy|3|||
17162455|NCT02085408|38310531|FG000|Step 2: Consolidation|Complicating Disease|0|||
17162456|NCT02085408|38310532|FG001|Step 2: Consolidation|Complicating Disease|2|||
17162457|NCT02085408|38310531|FG000|Step 2: Consolidation|Other|6|||
17162458|NCT02085408|38310532|FG001|Step 2: Consolidation|Other|6|||
17162459|NCT02085408|38310531|FG000|Step 2: Consolidation|Never started treatment|4|||
17162460|NCT02085408|38310532|FG001|Step 2: Consolidation|Never started treatment|3|||
17162461|NCT02085408|38310531|FG000|Step 3: Maintenance|Disease Progression|13|||
17162462|NCT02085408|38310532|FG001|Step 3: Maintenance|Disease Progression|11|||
17162463|NCT02085408|38310531|FG000|Step 3: Maintenance|Adverse Event|2|||
17162464|NCT02085408|38310532|FG001|Step 3: Maintenance|Adverse Event|4|||
17162465|NCT02085408|38310531|FG000|Step 3: Maintenance|Death|1|||
17162466|NCT02085408|38310532|FG001|Step 3: Maintenance|Death|2|||
17162467|NCT02085408|38310531|FG000|Step 3: Maintenance|Alternative Therapy|1|||
17162468|NCT02085408|38310532|FG001|Step 3: Maintenance|Alternative Therapy|1|||
17162469|NCT02085408|38310531|FG000|Step 3: Maintenance|Complicating Disease|0|||
17162470|NCT02085408|38310532|FG001|Step 3: Maintenance|Complicating Disease|1|||
17162471|NCT02085408|38310531|FG000|Step 3: Maintenance|Other|3|||
17162472|NCT02085408|38310532|FG001|Step 3: Maintenance|Other|2|||
17083081|NCT00249873|38223718|FG000|Overall Study|Minor bleeding|99|||
17083082|NCT00249873|38223719|FG001|Overall Study|Minor bleeding|37|||
17083083|NCT00249873|38223718|FG000|Overall Study|Non-compliance|41|||
17083084|NCT00249873|38223719|FG001|Overall Study|Non-compliance|46|||
17083085|NCT00249873|38223718|FG000|Overall Study|Other non serious Adverse Event|112|||
17083086|NCT00249873|38223719|FG001|Overall Study|Other non serious Adverse Event|108|||
17083087|NCT00249873|38223718|FG000|Overall Study|Other contraindicated medication|1|||
17083088|NCT00249873|38223719|FG001|Overall Study|Other contraindicated medication|0|||
17083089|NCT00249873|38223718|FG000|Overall Study|Patient not wish to continue after May08|3|||
17083090|NCT00249873|38223719|FG001|Overall Study|Patient not wish to continue after May08|4|||
17083091|NCT00249873|38223718|FG000|Overall Study|Physician withdrew consent|59|||
17083092|NCT00249873|38223719|FG001|Overall Study|Physician withdrew consent|60|||
17083093|NCT00249873|38223718|FG000|Overall Study|Open label clopidogrel required|31|||
17083094|NCT00249873|38223719|FG001|Overall Study|Open label clopidogrel required|42|||
17083095|NCT00249873|38223718|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
17083096|NCT00249873|38223719|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
17083097|NCT00249873|38223718|FG000|Overall Study|Oral anticoagulant required|159|||
17083098|NCT00249873|38223719|FG001|Overall Study|Oral anticoagulant required|157|||
17083099|NCT00249873|38223718|FG000|Overall Study|Study drug intolerance|5|||
17083100|NCT00249873|38223719|FG001|Overall Study|Study drug intolerance|0|||
17083101|NCT00249873|38223718|FG000|Overall Study|Surgery/ procedure|9|||
17083102|NCT00249873|38223719|FG001|Overall Study|Surgery/ procedure|9|||
17083103|NCT00249873|38223718|FG000|Overall Study|Event related to cardiac condition|12|||
17083104|NCT00249873|38223719|FG001|Overall Study|Event related to cardiac condition|21|||
17083105|NCT00249873|38223718|FG000|Overall Study|Thromboembolic/outcome event|82|||
17083106|NCT00249873|38223719|FG001|Overall Study|Thromboembolic/outcome event|122|||
17083107|NCT00392210|38223727|FG000|First Voiding Trial|Physician Decision|2|||
17162473|NCT02085408|38310531|FG000|Step 3: Maintenance|Never started treatment|5|||
17162474|NCT02085408|38310532|FG001|Step 3: Maintenance|Never started treatment|1|||
17083108|NCT00392210|38223728|FG001|First Voiding Trial|Physician Decision|2|||
17083109|NCT00391976|38223737|FG000|Overall Study|Adverse Event|0|||
17083110|NCT00391976|38223738|FG001|Overall Study|Adverse Event|0|||
17083111|NCT00391976|38223739|FG002|Overall Study|Adverse Event|1|||
17083112|NCT00391976|38223737|FG000|Overall Study|Withdrawal of consent|0|||
17083113|NCT00391976|38223738|FG001|Overall Study|Withdrawal of consent|1|||
17083114|NCT00391976|38223739|FG002|Overall Study|Withdrawal of consent|1|||
17083115|NCT00391976|38223737|FG000|Overall Study|Lost to Follow-up|1|||
17083116|NCT00391976|38223738|FG001|Overall Study|Lost to Follow-up|2|||
17083117|NCT00391976|38223739|FG002|Overall Study|Lost to Follow-up|0|||
17083118|NCT00391976|38223737|FG000|Overall Study|Inappropriate enrollment|1|||
17083119|NCT00391976|38223738|FG001|Overall Study|Inappropriate enrollment|1|||
17083120|NCT00391976|38223739|FG002|Overall Study|Inappropriate enrollment|0|||
17083121|NCT00391976|38223737|FG000|Overall Study|Protocol deviation/violation|4|||
17083122|NCT00391976|38223738|FG001|Overall Study|Protocol deviation/violation|2|||
17083123|NCT00391976|38223739|FG002|Overall Study|Protocol deviation/violation|1|||
17083124|NCT00391976|38223737|FG000|Overall Study|Recurrence/no eradication of infection|21|||
17083125|NCT00391976|38223738|FG001|Overall Study|Recurrence/no eradication of infection|19|||
17083126|NCT00391976|38223739|FG002|Overall Study|Recurrence/no eradication of infection|0|||
17083127|NCT00391976|38223737|FG000|Overall Study|Unable to classify|0|||
17083128|NCT00391976|38223738|FG001|Overall Study|Unable to classify|0|||
17083129|NCT00391976|38223739|FG002|Overall Study|Unable to classify|1|||
17083130|NCT00391976|38223737|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
17083131|NCT00391976|38223738|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
17162475|NCT03021642|38310547|FG000|Washout Period (21 Days)|Adverse Event|1|||
17162476|NCT03021642|38310548|FG001|Washout Period (21 Days)|Adverse Event|1|||
17162477|NCT03021486|38310557|FG000|Overall Study|Withdrawal by Subject|1|||
17162478|NCT03021486|38310558|FG001|Overall Study|Withdrawal by Subject|1|||
17162479|NCT03021486|38310559|FG002|Overall Study|Withdrawal by Subject|3|||
17162480|NCT03021486|38310557|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
17162481|NCT03021486|38310558|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
17162482|NCT03021486|38310559|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
17162483|NCT03021564|38310570|FG000|Overall Study|Death|84|||
17162484|NCT03021564|38310571|FG001|Overall Study|Death|466|||
17162485|NCT03021564|38310570|FG000|Overall Study|Lost to Follow-up|0|||
17162486|NCT03021564|38310571|FG001|Overall Study|Lost to Follow-up|2|||
17162487|NCT03023046|38310581|FG000|Overall Study|Withdrawal by Subject|1|||
17162488|NCT03019458|38310589|FG000|Overall Study|Death|0|||
17162489|NCT03019458|38310590|FG001|Overall Study|Death|1|||
17162490|NCT02923830|38310600|FG000|Overall Study|Physician Decision|13|||
17162491|NCT02923830|38310601|FG001|Overall Study|Physician Decision|15|||
17162492|NCT03021018|38310610|FG000|Overall Study|Adverse Event|1|||
17162493|NCT03021018|38310611|FG001|Overall Study|Adverse Event|0|||
17162494|NCT03021018|38310612|FG002|Overall Study|Adverse Event|0|||
17162495|NCT03021018|38310610|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
17162496|NCT03021018|38310611|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
17162497|NCT03021018|38310612|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
17162498|NCT02509507|38310629|FG000|Overall Study|Death|21|||
17162499|NCT02509507|38310630|FG001|Overall Study|Death|3|||
17162500|NCT02509507|38310631|FG002|Overall Study|Death|22|||
17162501|NCT02509507|38310632|FG003|Overall Study|Death|13|||
17162502|NCT02509507|38310633|FG004|Overall Study|Death|6|||
17162503|NCT02509507|38310634|FG005|Overall Study|Death|9|||
17162504|NCT02509507|38310635|FG006|Overall Study|Death|4|||
17162505|NCT02509507|38310636|FG007|Overall Study|Death|3|||
17162506|NCT02509507|38310637|FG008|Overall Study|Death|7|||
17162507|NCT02509507|38310629|FG000|Overall Study|Lost to Follow-up|0|||
17162508|NCT02509507|38310630|FG001|Overall Study|Lost to Follow-up|1|||
17162509|NCT02509507|38310631|FG002|Overall Study|Lost to Follow-up|0|||
17162510|NCT02509507|38310632|FG003|Overall Study|Lost to Follow-up|0|||
17162511|NCT02509507|38310633|FG004|Overall Study|Lost to Follow-up|0|||
17162512|NCT02509507|38310634|FG005|Overall Study|Lost to Follow-up|1|||
17162513|NCT02509507|38310635|FG006|Overall Study|Lost to Follow-up|0|||
17162514|NCT02509507|38310636|FG007|Overall Study|Lost to Follow-up|0|||
17162515|NCT02509507|38310637|FG008|Overall Study|Lost to Follow-up|0|||
17162516|NCT02509507|38310629|FG000|Overall Study|Withdrawal by Subject|2|||
17162517|NCT02509507|38310630|FG001|Overall Study|Withdrawal by Subject|0|||
17162518|NCT02509507|38310631|FG002|Overall Study|Withdrawal by Subject|1|||
17162519|NCT02509507|38310632|FG003|Overall Study|Withdrawal by Subject|4|||
17162520|NCT02509507|38310633|FG004|Overall Study|Withdrawal by Subject|0|||
17162521|NCT02509507|38310634|FG005|Overall Study|Withdrawal by Subject|3|||
17162522|NCT02509507|38310635|FG006|Overall Study|Withdrawal by Subject|3|||
17162523|NCT02509507|38310636|FG007|Overall Study|Withdrawal by Subject|0|||
17162524|NCT02509507|38310637|FG008|Overall Study|Withdrawal by Subject|0|||
17162525|NCT02509507|38310629|FG000|Overall Study|Continuing Study|0|||
17162526|NCT02509507|38310630|FG001|Overall Study|Continuing Study|1|||
17162527|NCT02509507|38310631|FG002|Overall Study|Continuing Study|1|||
17162528|NCT02509507|38310632|FG003|Overall Study|Continuing Study|5|||
17162529|NCT02509507|38310633|FG004|Overall Study|Continuing Study|4|||
17162530|NCT02509507|38310634|FG005|Overall Study|Continuing Study|5|||
17083132|NCT00391976|38223739|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
17083133|NCT00391898|38223751|FG000|Overall Study|Adverse Event|3|||
17083134|NCT00391898|38223752|FG001|Overall Study|Adverse Event|0|||
17083135|NCT00391898|38223751|FG000|Overall Study|Other|8|||
17083136|NCT00391898|38223752|FG001|Overall Study|Other|10|||
17083137|NCT00391586|38223758|FG000|Overall Study|Progressive disease|13|||
17083138|NCT00391586|38223758|FG000|Overall Study|Adverse Event|5|||
17083139|NCT00391586|38223758|FG000|Overall Study|Physician Decision|2|||
17083140|NCT00391586|38223758|FG000|Overall Study|Death|4|||
17083141|NCT00391430|38223765|FG000|Overall Study|Withdrawal by Subject|3|||
17083142|NCT00391430|38223766|FG001|Overall Study|Withdrawal by Subject|0|||
17083143|NCT00391430|38223767|FG002|Overall Study|Withdrawal by Subject|12|||
17083144|NCT00391274|38223777|FG000|Overall Study|Death Due to Study Disease|55|||
17083145|NCT00391274|38223778|FG001|Overall Study|Death Due to Study Disease|45|||
17083146|NCT00391274|38223777|FG000|Overall Study|Lost to Follow-up|0|||
17083147|NCT00391274|38223778|FG001|Overall Study|Lost to Follow-up|3|||
17162531|NCT02509507|38310635|FG006|Overall Study|Continuing Study|3|||
17083148|NCT00391274|38223777|FG000|Overall Study|Physician Decision|4|||
17083149|NCT00391274|38223778|FG001|Overall Study|Physician Decision|2|||
17162532|NCT02509507|38310636|FG007|Overall Study|Continuing Study|2|||
17162533|NCT02509507|38310637|FG008|Overall Study|Continuing Study|3|||
17162534|NCT03178045|38310664|FG000|Overall Study|Withdrawal by Subject|5|||
17162535|NCT03178045|38310665|FG001|Overall Study|Withdrawal by Subject|7|||
17162536|NCT03178045|38310664|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
17162537|NCT03178045|38310665|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
17162538|NCT03178045|38310664|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
17162539|NCT03178045|38310665|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
17162540|NCT03176407|38310672|FG000|Overall Study|Protocol Violation|1|||
17162541|NCT03176407|38310672|FG000|Overall Study|human failure|1|||
17083150|NCT00391274|38223777|FG000|Overall Study|Withdrawal by Subject|0|||
17083151|NCT00391274|38223778|FG001|Overall Study|Withdrawal by Subject|3|||
17083152|NCT00391274|38223777|FG000|Overall Study|Death Due to Adverse Event|1|||
17083153|NCT00391274|38223778|FG001|Overall Study|Death Due to Adverse Event|3|||
17083154|NCT00391274|38223777|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
17083155|NCT00391274|38223778|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
17083156|NCT00391274|38223777|FG000|Overall Study|Death Not Study Related|0|||
17162542|NCT03176407|38310672|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
17162543|NCT03175549|38310680|FG000|Overall Study|Lost to Follow-up|2|||
17162544|NCT03175549|38310681|FG001|Overall Study|Lost to Follow-up|2|||
17162545|NCT03175549|38310680|FG000|Overall Study|Medication non-compliance|2|||
17162546|NCT03175549|38310681|FG001|Overall Study|Medication non-compliance|2|||
17162547|NCT03174925|38310689|FG000|Overall Study|Elastographic images not retrievable|2|||
17162548|NCT03174925|38310689|FG000|Overall Study|Elastography image not interpretable|1|||
17162549|NCT02924688|38310699|FG000|Overall Study|Adverse Event|9|||
17162550|NCT02924688|38310700|FG001|Overall Study|Adverse Event|3|||
17083157|NCT00391274|38223778|FG001|Overall Study|Death Not Study Related|1|||
17083158|NCT00391118|38223787|FG000|Overall Study|Adverse Event|3|||
17083159|NCT00391118|38223788|FG001|Overall Study|Adverse Event|10|||
17162551|NCT02924688|38310701|FG002|Overall Study|Adverse Event|2|||
17162552|NCT02924688|38310702|FG003|Overall Study|Adverse Event|2|||
17162553|NCT02924688|38310703|FG004|Overall Study|Adverse Event|3|||
17162554|NCT02924688|38310704|FG005|Overall Study|Adverse Event|2|||
17162555|NCT02924688|38310699|FG000|Overall Study|Lack of Efficacy|2|||
17162556|NCT02924688|38310700|FG001|Overall Study|Lack of Efficacy|3|||
17162557|NCT02924688|38310701|FG002|Overall Study|Lack of Efficacy|4|||
17162558|NCT02924688|38310702|FG003|Overall Study|Lack of Efficacy|2|||
17162559|NCT02924688|38310703|FG004|Overall Study|Lack of Efficacy|1|||
17162560|NCT02924688|38310704|FG005|Overall Study|Lack of Efficacy|1|||
17162561|NCT02924688|38310699|FG000|Overall Study|Protocol Violation|3|||
17162562|NCT02924688|38310700|FG001|Overall Study|Protocol Violation|7|||
17162563|NCT02924688|38310701|FG002|Overall Study|Protocol Violation|5|||
17162564|NCT02924688|38310702|FG003|Overall Study|Protocol Violation|6|||
17162565|NCT02924688|38310703|FG004|Overall Study|Protocol Violation|2|||
17162566|NCT02924688|38310704|FG005|Overall Study|Protocol Violation|2|||
17162567|NCT02924688|38310699|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
17162568|NCT02924688|38310700|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
17162569|NCT02924688|38310701|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
17162570|NCT02924688|38310702|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
17162571|NCT02924688|38310703|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
17162572|NCT02924688|38310704|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
17162573|NCT02924688|38310699|FG000|Overall Study|Lost to Follow-up|2|||
17162574|NCT02924688|38310700|FG001|Overall Study|Lost to Follow-up|4|||
17162575|NCT02924688|38310701|FG002|Overall Study|Lost to Follow-up|2|||
17162576|NCT02924688|38310702|FG003|Overall Study|Lost to Follow-up|4|||
17162577|NCT02924688|38310703|FG004|Overall Study|Lost to Follow-up|2|||
17162578|NCT02924688|38310704|FG005|Overall Study|Lost to Follow-up|4|||
17162579|NCT02924688|38310699|FG000|Overall Study|Physician Decision|2|||
17162580|NCT02924688|38310700|FG001|Overall Study|Physician Decision|1|||
17162581|NCT02924688|38310701|FG002|Overall Study|Physician Decision|0|||
17162582|NCT02924688|38310702|FG003|Overall Study|Physician Decision|1|||
17162583|NCT02924688|38310703|FG004|Overall Study|Physician Decision|1|||
17162584|NCT02924688|38310704|FG005|Overall Study|Physician Decision|1|||
17162585|NCT02924688|38310699|FG000|Overall Study|Withdrawal by Subject|14|||
17162586|NCT02924688|38310700|FG001|Overall Study|Withdrawal by Subject|13|||
17162587|NCT02924688|38310701|FG002|Overall Study|Withdrawal by Subject|9|||
17162588|NCT02924688|38310702|FG003|Overall Study|Withdrawal by Subject|12|||
17162589|NCT02924688|38310703|FG004|Overall Study|Withdrawal by Subject|13|||
17162590|NCT02924688|38310704|FG005|Overall Study|Withdrawal by Subject|14|||
17162591|NCT02177695|38310723|FG000|ITT Analysis|Ineligible|5|||
17162592|NCT02177695|38310724|FG001|ITT Analysis|Ineligible|5|||
17162593|NCT02177695|38310723|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
17162594|NCT02177695|38310724|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
17162595|NCT02177695|38310723|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
17162596|NCT02177695|38310724|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
17162597|NCT02177695|38310723|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
17083160|NCT00391118|38223789|FG002|Overall Study|Adverse Event|7|||
17083161|NCT00391118|38223787|FG000|Overall Study|Lost to Follow-up|0|||
17083162|NCT00391118|38223788|FG001|Overall Study|Lost to Follow-up|2|||
17083163|NCT00391118|38223789|FG002|Overall Study|Lost to Follow-up|3|||
17083164|NCT00391118|38223787|FG000|Overall Study|Withdrawal by Subject|0|||
17162598|NCT02177695|38310724|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
17162599|NCT03011892|38310738|FG000|Double Blind (DB) Period|Adverse Event|0|||
17162600|NCT03011892|38310739|FG001|Double Blind (DB) Period|Adverse Event|1|||
17162601|NCT03011892|38310740|FG002|Double Blind (DB) Period|Adverse Event|1|||
17083165|NCT00391118|38223788|FG001|Overall Study|Withdrawal by Subject|9|||
17083166|NCT00391118|38223789|FG002|Overall Study|Withdrawal by Subject|1|||
17083167|NCT00391118|38223787|FG000|Overall Study|Death|0|||
17083168|NCT00391118|38223788|FG001|Overall Study|Death|1|||
17162602|NCT03011892|38310741|FG003|Double Blind (DB) Period|Adverse Event|0|||
17083169|NCT00391118|38223789|FG002|Overall Study|Death|0|||
17083170|NCT00391118|38223787|FG000|Overall Study|Physician Decision|0|||
17162603|NCT03011892|38310742|FG004|Double Blind (DB) Period|Adverse Event|0|||
17162604|NCT03011892|38310743|FG005|Double Blind (DB) Period|Adverse Event|0|||
17162605|NCT03011892|38310744|FG006|Double Blind (DB) Period|Adverse Event|0|||
17162606|NCT03011892|38310745|FG007|Double Blind (DB) Period|Adverse Event|0|||
17162607|NCT03011892|38310746|FG008|Double Blind (DB) Period|Adverse Event|0|||
17162608|NCT03011892|38310747|FG009|Double Blind (DB) Period|Adverse Event|0|||
17083171|NCT00391118|38223788|FG001|Overall Study|Physician Decision|3|||
17083172|NCT00391118|38223789|FG002|Overall Study|Physician Decision|0|||
17083173|NCT00391118|38223787|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
17083174|NCT00391118|38223788|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
17083175|NCT00391118|38223789|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
17083176|NCT00391118|38223787|FG000|Overall Study|Progressive Disease|7|||
17083177|NCT00391118|38223788|FG001|Overall Study|Progressive Disease|26|||
17083178|NCT00391118|38223789|FG002|Overall Study|Progressive Disease|43|||
17083179|NCT00391118|38223787|FG000|Overall Study|Sponsor Decision|0|||
17083180|NCT00391118|38223788|FG001|Overall Study|Sponsor Decision|1|||
17083181|NCT00391118|38223789|FG002|Overall Study|Sponsor Decision|3|||
17083182|NCT00391118|38223787|FG000|Overall Study|Protocol Violation|1|||
17083183|NCT00391118|38223788|FG001|Overall Study|Protocol Violation|0|||
17162609|NCT03011892|38310748|FG010|Double Blind (DB) Period|Adverse Event|0|||
17162610|NCT03011892|38310749|FG011|Double Blind (DB) Period|Adverse Event|0|||
17162611|NCT03011892|38310738|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
17162612|NCT03011892|38310739|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
17162613|NCT03011892|38310740|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
17162614|NCT03011892|38310741|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
17162615|NCT03011892|38310742|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
17162616|NCT03011892|38310743|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
17162617|NCT03011892|38310744|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
17083184|NCT00391118|38223789|FG002|Overall Study|Protocol Violation|0|||
17083185|NCT00390884|38223802|FG000|Overall Study|Withdrawal by Subject|2|||
17083186|NCT00390884|38223803|FG001|Overall Study|Withdrawal by Subject|2|||
17083187|NCT00365846|38223809|FG000|Overall Study|Lost to Follow-up|1|||
17162618|NCT03011892|38310745|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
17083188|NCT00264537|38223819|FG000|Overall Study|Death|0|||
17162619|NCT03011892|38310746|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
17162620|NCT03011892|38310747|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
17162621|NCT03011892|38310748|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
17162622|NCT03011892|38310749|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
17162623|NCT03011892|38310738|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
17162624|NCT03011892|38310739|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
17162625|NCT03011892|38310740|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
17162626|NCT03011892|38310741|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
17162627|NCT03011892|38310742|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
17162628|NCT03011892|38310743|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
17162629|NCT03011892|38310744|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
17162630|NCT03011892|38310745|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
17162631|NCT03011892|38310746|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
17162632|NCT03011892|38310747|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
17162633|NCT03011892|38310748|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
17162634|NCT03011892|38310749|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
17083189|NCT00264537|38223820|FG001|Overall Study|Death|3|||
17083190|NCT00264537|38223821|FG002|Overall Study|Death|3|||
17083191|NCT00264537|38223822|FG003|Overall Study|Death|2|||
17083192|NCT00264537|38223819|FG000|Overall Study|Lost to Follow-up|3|||
17083193|NCT00264537|38223820|FG001|Overall Study|Lost to Follow-up|4|||
17083194|NCT00264537|38223821|FG002|Overall Study|Lost to Follow-up|7|||
17083195|NCT00264537|38223822|FG003|Overall Study|Lost to Follow-up|6|||
17083196|NCT00264537|38223819|FG000|Overall Study|Adverse Event|21|||
17083197|NCT00264537|38223820|FG001|Overall Study|Adverse Event|32|||
17083198|NCT00264537|38223821|FG002|Overall Study|Adverse Event|24|||
17083199|NCT00264537|38223822|FG003|Overall Study|Adverse Event|34|||
17083200|NCT00264537|38223819|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
17083201|NCT00264537|38223820|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
17083202|NCT00264537|38223821|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
17083203|NCT00264537|38223822|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
17083204|NCT00264537|38223819|FG000|Overall Study|Other|21|||
17083205|NCT00264537|38223820|FG001|Overall Study|Other|11|||
17083206|NCT00264537|38223821|FG002|Overall Study|Other|10|||
17083207|NCT00264537|38223822|FG003|Overall Study|Other|11|||
17083208|NCT00264537|38223819|FG000|Overall Study|Not treated|0|||
17083209|NCT00264537|38223820|FG001|Overall Study|Not treated|2|||
17083210|NCT00264537|38223821|FG002|Overall Study|Not treated|1|||
17083211|NCT00264537|38223822|FG003|Overall Study|Not treated|0|||
17083212|NCT00371462|38223836|FG000|Overall Study|Withdrawal by Subject|1|||
17083213|NCT00371462|38223837|FG001|Overall Study|Withdrawal by Subject|0|||
17083214|NCT00371462|38223836|FG000|Overall Study|Other|7|||
17083215|NCT00371462|38223837|FG001|Overall Study|Other|8|||
17083216|NCT00371150|38223845|FG000|Overall Study|Lost to Follow-up|3|||
17083217|NCT00371150|38223846|FG001|Overall Study|Lost to Follow-up|2|||
17083218|NCT00264303|38223858|FG000|Overall Study|Adverse Event|4|||
17162635|NCT03011892|38310738|FG000|Double Blind (DB) Period|Other|1|||
17162636|NCT03011892|38310739|FG001|Double Blind (DB) Period|Other|1|||
17083219|NCT00264303|38223859|FG001|Overall Study|Adverse Event|3|||
17083220|NCT00264303|38223858|FG000|Overall Study|Lack of Efficacy|10|||
17083221|NCT00264303|38223859|FG001|Overall Study|Lack of Efficacy|13|||
17162637|NCT03011892|38310740|FG002|Double Blind (DB) Period|Other|1|||
17162638|NCT03011892|38310741|FG003|Double Blind (DB) Period|Other|0|||
17083222|NCT00264303|38223858|FG000|Overall Study|Lost to Follow-up|3|||
17083223|NCT00264303|38223859|FG001|Overall Study|Lost to Follow-up|3|||
17083224|NCT00264303|38223858|FG000|Overall Study|Withdrawal by Subject|2|||
17162639|NCT03011892|38310742|FG004|Double Blind (DB) Period|Other|1|||
17162640|NCT03011892|38310743|FG005|Double Blind (DB) Period|Other|0|||
17162641|NCT03011892|38310744|FG006|Double Blind (DB) Period|Other|0|||
17162642|NCT03011892|38310745|FG007|Double Blind (DB) Period|Other|0|||
17162643|NCT03011892|38310746|FG008|Double Blind (DB) Period|Other|0|||
17162644|NCT03011892|38310747|FG009|Double Blind (DB) Period|Other|0|||
17162645|NCT03011892|38310748|FG010|Double Blind (DB) Period|Other|0|||
17162646|NCT03011892|38310749|FG011|Double Blind (DB) Period|Other|0|||
17162647|NCT03011892|38310738|FG000|Double Blind (DB) Period|Physician Decision|1|||
17162648|NCT03011892|38310739|FG001|Double Blind (DB) Period|Physician Decision|0|||
17162649|NCT03011892|38310740|FG002|Double Blind (DB) Period|Physician Decision|1|||
17162650|NCT03011892|38310741|FG003|Double Blind (DB) Period|Physician Decision|0|||
17162651|NCT03011892|38310742|FG004|Double Blind (DB) Period|Physician Decision|0|||
17162652|NCT03011892|38310743|FG005|Double Blind (DB) Period|Physician Decision|0|||
17162653|NCT03011892|38310744|FG006|Double Blind (DB) Period|Physician Decision|0|||
17083225|NCT00264303|38223859|FG001|Overall Study|Withdrawal by Subject|3|||
17083226|NCT00264303|38223858|FG000|Overall Study|Various reasons listed in study report|6|||
17083227|NCT00264303|38223859|FG001|Overall Study|Various reasons listed in study report|7|||
17083228|NCT00370682|38223868|FG000|Overall Study|Moved from area|0|||
17083229|NCT00370682|38223869|FG001|Overall Study|Moved from area|2|||
17083230|NCT00370682|38223870|FG002|Overall Study|Moved from area|0|||
17083231|NCT00370682|38223868|FG000|Overall Study|Lost to Follow-up|0|||
17083232|NCT00370682|38223869|FG001|Overall Study|Lost to Follow-up|1|||
17083233|NCT00370682|38223870|FG002|Overall Study|Lost to Follow-up|1|||
17083234|NCT00264147|38223887|FG000|Treatment I Period|Adverse Event|3|||
17083235|NCT00264147|38223888|FG001|Treatment I Period|Adverse Event|6|||
17083236|NCT00264147|38223889|FG002|Treatment I Period|Adverse Event|3|||
17083237|NCT00264147|38223890|FG003|Treatment I Period|Adverse Event|5|||
17162654|NCT03011892|38310745|FG007|Double Blind (DB) Period|Physician Decision|0|||
17162655|NCT03011892|38310746|FG008|Double Blind (DB) Period|Physician Decision|0|||
17162656|NCT03011892|38310747|FG009|Double Blind (DB) Period|Physician Decision|0|||
17162657|NCT03011892|38310748|FG010|Double Blind (DB) Period|Physician Decision|0|||
17162658|NCT03011892|38310749|FG011|Double Blind (DB) Period|Physician Decision|0|||
17162659|NCT03011892|38310738|FG000|Double Blind (DB) Period|Pregnancy|0|||
17162660|NCT03011892|38310739|FG001|Double Blind (DB) Period|Pregnancy|0|||
17162661|NCT03011892|38310740|FG002|Double Blind (DB) Period|Pregnancy|0|||
17162662|NCT03011892|38310741|FG003|Double Blind (DB) Period|Pregnancy|0|||
17162663|NCT03011892|38310742|FG004|Double Blind (DB) Period|Pregnancy|1|||
17083238|NCT00264147|38223891|FG004|Treatment I Period|Adverse Event|7|||
17083239|NCT00264147|38223892|FG005|Treatment I Period|Adverse Event|0|||
17083240|NCT00264147|38223887|FG000|Treatment I Period|Laboratory Adverse Event|0|||
17083241|NCT00264147|38223888|FG001|Treatment I Period|Laboratory Adverse Event|0|||
17083242|NCT00264147|38223889|FG002|Treatment I Period|Laboratory Adverse Event|0|||
17083243|NCT00264147|38223890|FG003|Treatment I Period|Laboratory Adverse Event|1|||
17083244|NCT00264147|38223891|FG004|Treatment I Period|Laboratory Adverse Event|0|||
17083245|NCT00264147|38223892|FG005|Treatment I Period|Laboratory Adverse Event|0|||
17083246|NCT00264147|38223887|FG000|Treatment I Period|Lack of Efficacy|6|||
17083247|NCT00264147|38223888|FG001|Treatment I Period|Lack of Efficacy|2|||
17083248|NCT00264147|38223889|FG002|Treatment I Period|Lack of Efficacy|8|||
17083249|NCT00264147|38223890|FG003|Treatment I Period|Lack of Efficacy|0|||
17083250|NCT00264147|38223891|FG004|Treatment I Period|Lack of Efficacy|1|||
17083251|NCT00264147|38223892|FG005|Treatment I Period|Lack of Efficacy|0|||
17083252|NCT00264147|38223887|FG000|Treatment I Period|Lost to Follow-up|1|||
17083253|NCT00264147|38223888|FG001|Treatment I Period|Lost to Follow-up|0|||
17083254|NCT00264147|38223889|FG002|Treatment I Period|Lost to Follow-up|0|||
17083255|NCT00264147|38223890|FG003|Treatment I Period|Lost to Follow-up|1|||
17083256|NCT00264147|38223891|FG004|Treatment I Period|Lost to Follow-up|1|||
17083257|NCT00264147|38223892|FG005|Treatment I Period|Lost to Follow-up|0|||
17083258|NCT00264147|38223887|FG000|Treatment I Period|Protocol Violation|2|||
17083259|NCT00264147|38223888|FG001|Treatment I Period|Protocol Violation|2|||
17083260|NCT00264147|38223889|FG002|Treatment I Period|Protocol Violation|0|||
17083261|NCT00264147|38223890|FG003|Treatment I Period|Protocol Violation|0|||
17083262|NCT00264147|38223891|FG004|Treatment I Period|Protocol Violation|0|||
17083263|NCT00264147|38223892|FG005|Treatment I Period|Protocol Violation|0|||
17083264|NCT00264147|38223887|FG000|Treatment I Period|Withdrawal by Subject|2|||
17083265|NCT00264147|38223888|FG001|Treatment I Period|Withdrawal by Subject|0|||
17083266|NCT00264147|38223889|FG002|Treatment I Period|Withdrawal by Subject|0|||
17083267|NCT00264147|38223890|FG003|Treatment I Period|Withdrawal by Subject|2|||
17083268|NCT00264147|38223891|FG004|Treatment I Period|Withdrawal by Subject|2|||
17083269|NCT00264147|38223892|FG005|Treatment I Period|Withdrawal by Subject|0|||
17083270|NCT00264147|38223887|FG000|Treatment I Period|Patient out of town for an extended time|0|||
17083271|NCT00264147|38223888|FG001|Treatment I Period|Patient out of town for an extended time|1|||
17083272|NCT00264147|38223889|FG002|Treatment I Period|Patient out of town for an extended time|0|||
17083273|NCT00264147|38223890|FG003|Treatment I Period|Patient out of town for an extended time|0|||
17083274|NCT00264147|38223891|FG004|Treatment I Period|Patient out of town for an extended time|0|||
17083275|NCT00264147|38223892|FG005|Treatment I Period|Patient out of town for an extended time|0|||
17083276|NCT00264147|38223887|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
17162664|NCT03011892|38310743|FG005|Double Blind (DB) Period|Pregnancy|0|||
17162665|NCT03011892|38310744|FG006|Double Blind (DB) Period|Pregnancy|0|||
17162666|NCT03011892|38310745|FG007|Double Blind (DB) Period|Pregnancy|0|||
17162667|NCT03011892|38310746|FG008|Double Blind (DB) Period|Pregnancy|0|||
17162668|NCT03011892|38310747|FG009|Double Blind (DB) Period|Pregnancy|0|||
17162669|NCT03011892|38310748|FG010|Double Blind (DB) Period|Pregnancy|0|||
17162670|NCT03011892|38310749|FG011|Double Blind (DB) Period|Pregnancy|0|||
17162671|NCT03011892|38310738|FG000|Double Blind (DB) Period|Protocol Violation|1|||
17083277|NCT00264147|38223888|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
17083278|NCT00264147|38223889|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
17083279|NCT00264147|38223890|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
17083280|NCT00264147|38223891|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
17083281|NCT00264147|38223892|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
17083282|NCT00264147|38223887|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
17083283|NCT00264147|38223888|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
17083284|NCT00264147|38223889|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
17083285|NCT00264147|38223890|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
17083286|NCT00264147|38223891|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
17162672|NCT03011892|38310739|FG001|Double Blind (DB) Period|Protocol Violation|0|||
17162673|NCT03011892|38310740|FG002|Double Blind (DB) Period|Protocol Violation|0|||
17162674|NCT03011892|38310741|FG003|Double Blind (DB) Period|Protocol Violation|0|||
17162675|NCT03011892|38310742|FG004|Double Blind (DB) Period|Protocol Violation|0|||
17162676|NCT03011892|38310743|FG005|Double Blind (DB) Period|Protocol Violation|0|||
17162677|NCT03011892|38310744|FG006|Double Blind (DB) Period|Protocol Violation|0|||
17162678|NCT03011892|38310745|FG007|Double Blind (DB) Period|Protocol Violation|0|||
17162679|NCT03011892|38310746|FG008|Double Blind (DB) Period|Protocol Violation|0|||
17162680|NCT03011892|38310747|FG009|Double Blind (DB) Period|Protocol Violation|0|||
17162681|NCT03011892|38310748|FG010|Double Blind (DB) Period|Protocol Violation|0|||
17162682|NCT03011892|38310749|FG011|Double Blind (DB) Period|Protocol Violation|0|||
17162683|NCT03011892|38310738|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
17162684|NCT03011892|38310739|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
17162685|NCT03011892|38310740|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
17162686|NCT03011892|38310741|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
17162687|NCT03011892|38310742|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
17162688|NCT03011892|38310743|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
17162689|NCT03011892|38310744|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
17162690|NCT03011892|38310745|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
17162691|NCT03011892|38310746|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
17162692|NCT03011892|38310747|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
17162693|NCT03011892|38310748|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
17162694|NCT03011892|38310749|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
17162695|NCT03011892|38310738|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
17162696|NCT03011892|38310739|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
17162697|NCT03011892|38310740|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
17162698|NCT03011892|38310741|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
17162699|NCT03011892|38310742|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
17162700|NCT03011892|38310743|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
17162701|NCT03011892|38310744|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
17162702|NCT03011892|38310745|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
17162703|NCT03011892|38310746|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
17162704|NCT03011892|38310747|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
17162705|NCT03011892|38310748|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
17162706|NCT03011892|38310749|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
17162707|NCT03011892|38310738|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
16995960|NCT00988208|38139916|FG001|Overall Study|Protocol Violation|2|||
16995961|NCT00988208|38139915|FG000|Overall Study|Sponsor Decision|102|||
17162708|NCT03011892|38310739|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
17162709|NCT03011892|38310740|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
16995962|NCT00988208|38139916|FG001|Overall Study|Sponsor Decision|78|||
16995963|NCT00988208|38139915|FG000|Overall Study|Clinical Progression|17|||
16995964|NCT00988208|38139916|FG001|Overall Study|Clinical Progression|16|||
16995965|NCT00988208|38139915|FG000|Overall Study|Biochemical Progression|21|||
16995966|NCT00988208|38139916|FG001|Overall Study|Biochemical Progression|7|||
16995967|NCT00988208|38139915|FG000|Overall Study|Clinical Deterioration|7|||
16995968|NCT00988208|38139916|FG001|Overall Study|Clinical Deterioration|14|||
17083287|NCT00264147|38223892|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
17083288|NCT00264147|38223887|FG000|Treatment II Period|Adverse Event|0|||
17083289|NCT00264147|38223888|FG001|Treatment II Period|Adverse Event|0|||
17083290|NCT00264147|38223889|FG002|Treatment II Period|Adverse Event|0|||
17083291|NCT00264147|38223890|FG003|Treatment II Period|Adverse Event|0|||
17083292|NCT00264147|38223891|FG004|Treatment II Period|Adverse Event|9|||
17083293|NCT00264147|38223892|FG005|Treatment II Period|Adverse Event|9|||
17083294|NCT00264147|38223887|FG000|Treatment II Period|Laboratory Adverse Event|0|||
17083295|NCT00264147|38223888|FG001|Treatment II Period|Laboratory Adverse Event|0|||
17083296|NCT00264147|38223889|FG002|Treatment II Period|Laboratory Adverse Event|0|||
17083297|NCT00264147|38223890|FG003|Treatment II Period|Laboratory Adverse Event|0|||
17083298|NCT00264147|38223891|FG004|Treatment II Period|Laboratory Adverse Event|0|||
17162710|NCT03011892|38310741|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
17162711|NCT03011892|38310742|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
17162712|NCT03011892|38310743|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
17162713|NCT03011892|38310744|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
17162714|NCT03011892|38310745|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
17162715|NCT03011892|38310746|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
17162716|NCT03011892|38310747|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
17162717|NCT03011892|38310748|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
17162718|NCT03011892|38310749|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
17162719|NCT03011892|38310738|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
17162720|NCT03011892|38310739|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
17162721|NCT03011892|38310740|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
17162722|NCT03011892|38310741|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
17162723|NCT03011892|38310742|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
17162724|NCT03011892|38310743|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
17162725|NCT03011892|38310744|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
17162726|NCT03011892|38310745|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
17162727|NCT03011892|38310746|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
17162728|NCT03011892|38310747|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
17162729|NCT03011892|38310748|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
17162730|NCT03011892|38310749|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
17162731|NCT03011892|38310738|FG000|Open Label (OL) Period|Reason not specified|0|||
17162732|NCT03011892|38310739|FG001|Open Label (OL) Period|Reason not specified|0|||
17162733|NCT03011892|38310740|FG002|Open Label (OL) Period|Reason not specified|0|||
17162734|NCT03011892|38310741|FG003|Open Label (OL) Period|Reason not specified|0|||
17162735|NCT03011892|38310742|FG004|Open Label (OL) Period|Reason not specified|0|||
17162736|NCT03011892|38310743|FG005|Open Label (OL) Period|Reason not specified|0|||
17162737|NCT03011892|38310744|FG006|Open Label (OL) Period|Reason not specified|0|||
17162738|NCT03011892|38310745|FG007|Open Label (OL) Period|Reason not specified|1|||
17162739|NCT03011892|38310746|FG008|Open Label (OL) Period|Reason not specified|0|||
17162740|NCT03011892|38310747|FG009|Open Label (OL) Period|Reason not specified|0|||
17162741|NCT03011892|38310748|FG010|Open Label (OL) Period|Reason not specified|0|||
17162742|NCT03011892|38310749|FG011|Open Label (OL) Period|Reason not specified|0|||
17083299|NCT00264147|38223892|FG005|Treatment II Period|Laboratory Adverse Event|1|||
17083300|NCT00264147|38223887|FG000|Treatment II Period|Lack of Efficacy|0|||
17083301|NCT00264147|38223888|FG001|Treatment II Period|Lack of Efficacy|0|||
17083302|NCT00264147|38223889|FG002|Treatment II Period|Lack of Efficacy|0|||
17083303|NCT00264147|38223890|FG003|Treatment II Period|Lack of Efficacy|0|||
16995969|NCT00988208|38139915|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
16995970|NCT00988208|38139916|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
16995971|NCT00988208|38139915|FG000|Overall Study|Other|8|||
16995972|NCT00988208|38139916|FG001|Overall Study|Other|3|||
16995973|NCT00990704|38139924|FG000|Overall Study|Adverse Event|1|||
16995974|NCT00990704|38139925|FG001|Overall Study|Adverse Event|1|||
16995975|NCT00990704|38139924|FG000|Overall Study|Physician Decision|0|||
16995976|NCT00990704|38139925|FG001|Overall Study|Physician Decision|1|||
16995977|NCT04089553|38139933|FG000|Overall Study|Death|12|||
16995978|NCT04089553|38139934|FG001|Overall Study|Death|11|||
16995979|NCT04089553|38139933|FG000|Overall Study|Lost to Follow-up|2|||
16995980|NCT04089553|38139934|FG001|Overall Study|Lost to Follow-up|2|||
16995981|NCT04089553|38139933|FG000|Overall Study|Progressive disease|0|||
16995982|NCT04089553|38139934|FG001|Overall Study|Progressive disease|1|||
16995983|NCT04089553|38139933|FG000|Overall Study|Withdrawal by Subject|5|||
16995984|NCT04089553|38139934|FG001|Overall Study|Withdrawal by Subject|2|||
16995985|NCT04089553|38139933|FG000|Overall Study|Other|6|||
16995986|NCT04089553|38139934|FG001|Overall Study|Other|2|||
16995987|NCT00993668|38139943|FG000|Single-Blind Period|Adverse Event|1|||
16995988|NCT00993668|38139944|FG001|Single-Blind Period|Adverse Event|1|||
16995989|NCT00993668|38139943|FG000|Single-Blind Period|Lack of Efficacy|0|||
16995990|NCT00993668|38139944|FG001|Single-Blind Period|Lack of Efficacy|1|||
17083304|NCT00264147|38223891|FG004|Treatment II Period|Lack of Efficacy|20|||
17083305|NCT00264147|38223892|FG005|Treatment II Period|Lack of Efficacy|19|||
17083306|NCT00264147|38223887|FG000|Treatment II Period|Lost to Follow-up|0|||
16995991|NCT00993668|38139943|FG000|Single-Blind Period|Lost to Follow-up|3|||
17083307|NCT00264147|38223888|FG001|Treatment II Period|Lost to Follow-up|0|||
16995992|NCT00993668|38139944|FG001|Single-Blind Period|Lost to Follow-up|1|||
16995993|NCT00993668|38139943|FG000|Open-Label Period|Adverse Event|9|||
17162743|NCT03017742|38310776|FG000|Overall Study|Protocol Violation|36|||
17162744|NCT03017742|38310776|FG000|Overall Study|Withdrawal by Subject|37|||
17162745|NCT03012828|38310786|FG000|Overall Study|Lost to Follow-up|1|||
17162746|NCT03012828|38310787|FG001|Overall Study|Lost to Follow-up|0|||
17162747|NCT03012828|38310788|FG002|Overall Study|Lost to Follow-up|1|||
17162748|NCT03012828|38310789|FG003|Overall Study|Lost to Follow-up|0|||
17162749|NCT03012828|38310790|FG004|Overall Study|Lost to Follow-up|1|||
17162750|NCT03012828|38310791|FG005|Overall Study|Lost to Follow-up|0|||
17162751|NCT03012828|38310786|FG000|Overall Study|Withdrawal by Subject|0|||
17162752|NCT03012828|38310787|FG001|Overall Study|Withdrawal by Subject|0|||
17162753|NCT03012828|38310788|FG002|Overall Study|Withdrawal by Subject|1|||
17162754|NCT03012828|38310789|FG003|Overall Study|Withdrawal by Subject|0|||
17162755|NCT03012828|38310790|FG004|Overall Study|Withdrawal by Subject|0|||
17162756|NCT03012828|38310791|FG005|Overall Study|Withdrawal by Subject|1|||
17162757|NCT03012828|38310786|FG000|Overall Study|Non-compliance with protocol|0|||
17162758|NCT03012828|38310787|FG001|Overall Study|Non-compliance with protocol|0|||
17162759|NCT03012828|38310788|FG002|Overall Study|Non-compliance with protocol|0|||
17162760|NCT03012828|38310789|FG003|Overall Study|Non-compliance with protocol|0|||
17162761|NCT03012828|38310790|FG004|Overall Study|Non-compliance with protocol|1|||
17162762|NCT03012828|38310791|FG005|Overall Study|Non-compliance with protocol|0|||
17162763|NCT03012828|38310786|FG000|Overall Study|Delay to last visit would delay DBL|0|||
17162764|NCT03012828|38310787|FG001|Overall Study|Delay to last visit would delay DBL|0|||
17162765|NCT03012828|38310788|FG002|Overall Study|Delay to last visit would delay DBL|0|||
17162766|NCT03012828|38310789|FG003|Overall Study|Delay to last visit would delay DBL|0|||
17162767|NCT03012828|38310790|FG004|Overall Study|Delay to last visit would delay DBL|0|||
17162768|NCT03012828|38310791|FG005|Overall Study|Delay to last visit would delay DBL|1|||
17162769|NCT03010254|38310809|FG000|Overall Study|Adverse Event|0|||
17162770|NCT03010254|38310810|FG001|Overall Study|Adverse Event|1|||
17162771|NCT03010254|38310809|FG000|Overall Study|Lost to Follow-up|4|||
17162772|NCT03010254|38310810|FG001|Overall Study|Lost to Follow-up|0|||
17162773|NCT03010254|38310809|FG000|Overall Study|Withdrawal by Subject|1|||
16995994|NCT00993668|38139944|FG001|Open-Label Period|Adverse Event|8|||
16995995|NCT00993668|38139943|FG000|Open-Label Period|Lack of Efficacy|4|||
16995996|NCT00993668|38139944|FG001|Open-Label Period|Lack of Efficacy|3|||
17083308|NCT00264147|38223889|FG002|Treatment II Period|Lost to Follow-up|0|||
17083309|NCT00264147|38223890|FG003|Treatment II Period|Lost to Follow-up|0|||
17083310|NCT00264147|38223891|FG004|Treatment II Period|Lost to Follow-up|1|||
17083311|NCT00264147|38223892|FG005|Treatment II Period|Lost to Follow-up|1|||
17083312|NCT00264147|38223887|FG000|Treatment II Period|Withdrawal by Subject|0|||
17083313|NCT00264147|38223888|FG001|Treatment II Period|Withdrawal by Subject|0|||
17083314|NCT00264147|38223889|FG002|Treatment II Period|Withdrawal by Subject|0|||
17083315|NCT00264147|38223890|FG003|Treatment II Period|Withdrawal by Subject|0|||
17083316|NCT00264147|38223891|FG004|Treatment II Period|Withdrawal by Subject|3|||
17083317|NCT00264147|38223892|FG005|Treatment II Period|Withdrawal by Subject|2|||
17083318|NCT00264147|38223887|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
17083319|NCT00264147|38223888|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
17083320|NCT00264147|38223889|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
17083321|NCT00264147|38223890|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
17083322|NCT00264147|38223891|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
17083323|NCT00264147|38223892|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
17083324|NCT00263757|38223908|FG000|Overall Study|Withdrawal by Subject|5|||
17083325|NCT00263757|38223909|FG001|Overall Study|Withdrawal by Subject|4|||
17083326|NCT00263757|38223908|FG000|Overall Study|Screen failure|0|||
16995997|NCT00993668|38139943|FG000|Open-Label Period|Withdrawal by Subject|4|||
16995998|NCT00993668|38139944|FG001|Open-Label Period|Withdrawal by Subject|3|||
16995999|NCT00993668|38139943|FG000|Open-Label Period|Lost to Follow-up|6|||
16996000|NCT00993668|38139944|FG001|Open-Label Period|Lost to Follow-up|1|||
16996001|NCT00778102|38139953|FG000|Overall Study|Adverse Event|8|||
16996002|NCT00778102|38139954|FG001|Overall Study|Adverse Event|5|||
16996003|NCT00778102|38139953|FG000|Overall Study|Death|1|||
16996004|NCT00778102|38139954|FG001|Overall Study|Death|1|||
16996005|NCT00778102|38139953|FG000|Overall Study|Lost to Follow-up|1|||
16996006|NCT00778102|38139954|FG001|Overall Study|Lost to Follow-up|0|||
16996007|NCT00778102|38139953|FG000|Overall Study|Violation of Selection Criteria|1|||
16996008|NCT00778102|38139954|FG001|Overall Study|Violation of Selection Criteria|1|||
16996009|NCT00778102|38139953|FG000|Overall Study|Protocol Violation|0|||
16996010|NCT00778102|38139954|FG001|Overall Study|Protocol Violation|1|||
16996011|NCT00778102|38139953|FG000|Overall Study|Refused Treatment|2|||
16996012|NCT00778102|38139954|FG001|Overall Study|Refused Treatment|3|||
16996013|NCT00778102|38139953|FG000|Overall Study|Withdrawal by Subject|1|||
16996014|NCT00778102|38139954|FG001|Overall Study|Withdrawal by Subject|1|||
16996015|NCT00778102|38139953|FG000|Overall Study|Administrative Reason|7|||
16996016|NCT00778102|38139954|FG001|Overall Study|Administrative Reason|10|||
16996017|NCT00756886|38139962|FG000|Overall Study|Lost to Follow-up|1|||
16996018|NCT00756886|38139963|FG001|Overall Study|Lost to Follow-up|0|||
16996019|NCT00756886|38139962|FG000|Overall Study|Adverse Event|0|||
16996020|NCT00756886|38139963|FG001|Overall Study|Adverse Event|3|||
16996021|NCT00756886|38139962|FG000|Overall Study|Lack of Efficacy|1|||
16996022|NCT00756886|38139963|FG001|Overall Study|Lack of Efficacy|0|||
16996023|NCT00756886|38139962|FG000|Overall Study|Ineligible|9|||
16996024|NCT00756886|38139963|FG001|Overall Study|Ineligible|4|||
16996025|NCT00756730|38139971|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
16996026|NCT00756730|38139972|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
16996027|NCT00756730|38139971|FG000|Overall Study|persistent low-level viremmia|0|||
16996028|NCT00756730|38139972|FG001|Overall Study|persistent low-level viremmia|1|||
17162774|NCT03010254|38310810|FG001|Overall Study|Withdrawal by Subject|1|||
17162775|NCT03010254|38310809|FG000|Overall Study|Other|2|||
17162776|NCT03010254|38310810|FG001|Overall Study|Other|3|||
17162777|NCT03008460|38310825|FG000|Overall Study|Protocol deviation|0|||
17162778|NCT03008460|38310826|FG001|Overall Study|Protocol deviation|2|||
17162779|NCT03008460|38310825|FG000|Overall Study|Study drug not dispensed|0|||
17162780|NCT03008460|38310826|FG001|Overall Study|Study drug not dispensed|1|||
17162781|NCT03008460|38310825|FG000|Overall Study|Adverse Event|0|||
17162782|NCT03008460|38310826|FG001|Overall Study|Adverse Event|1|||
17162783|NCT03008460|38310825|FG000|Overall Study|Withdrawal by Subject|5|||
17083327|NCT00263757|38223909|FG001|Overall Study|Screen failure|1|||
17083328|NCT00263757|38223908|FG000|Overall Study|Adverse Event|3|||
17083329|NCT00263757|38223909|FG001|Overall Study|Adverse Event|3|||
17083330|NCT00263211|38223917|FG000|Overall Study|Death|1|||
17083331|NCT00263211|38223918|FG001|Overall Study|Death|0|||
17083332|NCT00263211|38223917|FG000|Overall Study|Withdrawal by Subject|3|||
17083333|NCT00263211|38223918|FG001|Overall Study|Withdrawal by Subject|0|||
17083334|NCT00263211|38223917|FG000|Overall Study|Protocol Violation|1|||
17083335|NCT00263211|38223918|FG001|Overall Study|Protocol Violation|0|||
17083336|NCT00263211|38223917|FG000|Overall Study|Disease Progression|0|||
17083337|NCT00263211|38223918|FG001|Overall Study|Disease Progression|1|||
17083338|NCT00248625|38223929|FG000|Overall Study|Withdrawal by Subject|0|||
17083339|NCT00248625|38223930|FG001|Overall Study|Withdrawal by Subject|2|||
17083340|NCT00262821|38223938|FG000|Overall Study|Ineligible - wrong stage|0|||
17083341|NCT00262821|38223939|FG001|Overall Study|Ineligible - wrong stage|3|||
17083342|NCT00262821|38223938|FG000|Overall Study|Ineligible - wrong cell type|2|||
17083343|NCT00262821|38223939|FG001|Overall Study|Ineligible - wrong cell type|2|||
17083344|NCT00262821|38223938|FG000|Overall Study|Ineligible - wrong primary|0|||
17083345|NCT00262821|38223939|FG001|Overall Study|Ineligible - wrong primary|1|||
17083346|NCT00262821|38223938|FG000|Overall Study|Ineligible - inadequate pathology|1|||
17083347|NCT00262821|38223939|FG001|Overall Study|Ineligible - inadequate pathology|3|||
17083348|NCT00262821|38223938|FG000|Overall Study|Ineligible - elevated creatinine|0|||
17083349|NCT00262821|38223939|FG001|Overall Study|Ineligible - elevated creatinine|2|||
17083350|NCT00262821|38223938|FG000|Overall Study|Ineligible - required test not done|1|||
17083351|NCT00262821|38223939|FG001|Overall Study|Ineligible - required test not done|4|||
17083352|NCT00262821|38223938|FG000|Overall Study|Inevaluable - inadequate data|0|||
17083353|NCT00262821|38223939|FG001|Overall Study|Inevaluable - inadequate data|4|||
17083354|NCT00262743|38223947|FG000|Overall Study|Adverse Event|0|||
17083355|NCT00262743|38223948|FG001|Overall Study|Adverse Event|9|||
17083356|NCT00262743|38223947|FG000|Overall Study|Disease progression|0|||
17083357|NCT00262743|38223948|FG001|Overall Study|Disease progression|3|||
17162784|NCT03008460|38310826|FG001|Overall Study|Withdrawal by Subject|6|||
17162785|NCT03008460|38310825|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
17162786|NCT03008460|38310826|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
17162787|NCT03008460|38310825|FG000|Overall Study|End of study visit outside permitted time window|0|||
17162788|NCT03008460|38310826|FG001|Overall Study|End of study visit outside permitted time window|1|||
17162789|NCT03008460|38310825|FG000|Overall Study|Lost to Follow-up|1|||
17083358|NCT00262119|38223955|FG000|Overall Study|Lost to Follow-up|38|||
17083359|NCT00262119|38223956|FG001|Overall Study|Lost to Follow-up|51|||
17083360|NCT00262119|38223957|FG002|Overall Study|Lost to Follow-up|42|||
17083361|NCT00262119|38223955|FG000|Overall Study|Death|20|||
17083362|NCT00262119|38223956|FG001|Overall Study|Death|19|||
17083363|NCT00262119|38223957|FG002|Overall Study|Death|16|||
17162790|NCT03008460|38310826|FG001|Overall Study|Lost to Follow-up|3|||
17162791|NCT03008070|38310835|FG000|Overall Study|Adverse Event|3|||
17162792|NCT03008070|38310836|FG001|Overall Study|Adverse Event|3|||
17162793|NCT03008070|38310837|FG002|Overall Study|Adverse Event|3|||
17083364|NCT00170950|38223967|FG000|Overall Study|Death|236|||
17083365|NCT00170950|38223968|FG001|Overall Study|Death|274|||
17083366|NCT00170950|38223967|FG000|Overall Study|Withdrawal by Subject|496|||
17083367|NCT00170950|38223968|FG001|Overall Study|Withdrawal by Subject|498|||
17162794|NCT03008070|38310835|FG000|Overall Study|Lost to Follow-up|1|||
17162795|NCT03008070|38310836|FG001|Overall Study|Lost to Follow-up|1|||
17162796|NCT03008070|38310837|FG002|Overall Study|Lost to Follow-up|0|||
17162797|NCT03008070|38310835|FG000|Overall Study|Non compliance|0|||
17162798|NCT03008070|38310836|FG001|Overall Study|Non compliance|1|||
17162799|NCT03008070|38310837|FG002|Overall Study|Non compliance|1|||
17162800|NCT03008070|38310835|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
17162801|NCT03008070|38310836|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
17162802|NCT03008070|38310837|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
17162803|NCT03008070|38310835|FG000|Overall Study|Withdrawal by Subject|2|||
17162804|NCT03008070|38310836|FG001|Overall Study|Withdrawal by Subject|0|||
17162805|NCT03008070|38310837|FG002|Overall Study|Withdrawal by Subject|1|||
17162806|NCT03008070|38310835|FG000|Overall Study|Use of prohibited drug|0|||
17162807|NCT03008070|38310836|FG001|Overall Study|Use of prohibited drug|0|||
17162808|NCT03008070|38310837|FG002|Overall Study|Use of prohibited drug|2|||
17162809|NCT02914236|38310847|FG000|Overall Study|Lost to Follow-up|1|||
17162810|NCT03003390|38310853|FG000|Overall Study|Physician Decision|2|||
17162811|NCT03003390|38310854|FG001|Overall Study|Physician Decision|0|||
17162812|NCT03003390|38310853|FG000|Overall Study|Parent refused intervention|2|||
17162813|NCT03003390|38310854|FG001|Overall Study|Parent refused intervention|0|||
17162814|NCT03003000|38310868|FG000|Overall Study|Adverse Event|1|||
17162815|NCT03003000|38310869|FG001|Overall Study|Adverse Event|2|||
17162816|NCT03003000|38310870|FG002|Overall Study|Adverse Event|3|||
17162817|NCT03003000|38310868|FG000|Overall Study|Lack of Efficacy|1|||
17162818|NCT03003000|38310869|FG001|Overall Study|Lack of Efficacy|0|||
17162819|NCT03003000|38310870|FG002|Overall Study|Lack of Efficacy|0|||
16996029|NCT00984620|38139980|FG000|Overall Study|Adverse Event|5|||
16996030|NCT00984620|38139981|FG001|Overall Study|Adverse Event|5|||
16996031|NCT00984620|38139980|FG000|Overall Study|Lost to Follow-up|1|||
16996032|NCT00984620|38139981|FG001|Overall Study|Lost to Follow-up|1|||
16996033|NCT00984620|38139980|FG000|Overall Study|Withdrawal by Subject|0|||
16996034|NCT00984620|38139981|FG001|Overall Study|Withdrawal by Subject|2|||
16996035|NCT00984620|38139980|FG000|Overall Study|reason other than listed above|0|||
16996036|NCT00984620|38139981|FG001|Overall Study|reason other than listed above|4|||
16996037|NCT00777946|38139992|FG000|Overall Study|Adverse Event|11|||
16996038|NCT00777946|38139993|FG001|Overall Study|Adverse Event|1|||
16996039|NCT00777946|38139994|FG002|Overall Study|Adverse Event|3|||
16996040|NCT00777946|38139992|FG000|Overall Study|Lack of Efficacy|0|||
16996041|NCT00777946|38139993|FG001|Overall Study|Lack of Efficacy|0|||
16996042|NCT00777946|38139994|FG002|Overall Study|Lack of Efficacy|9|||
16996043|NCT00777946|38139992|FG000|Overall Study|Condition no longer required study drug|1|||
16996044|NCT00777946|38139993|FG001|Overall Study|Condition no longer required study drug|0|||
16996045|NCT00777946|38139994|FG002|Overall Study|Condition no longer required study drug|0|||
16996046|NCT00777946|38139992|FG000|Overall Study|Patient withdrew consent|3|||
16996047|NCT00777946|38139993|FG001|Overall Study|Patient withdrew consent|2|||
16996048|NCT00777946|38139994|FG002|Overall Study|Patient withdrew consent|3|||
16996049|NCT00777946|38139992|FG000|Overall Study|Lost to Follow-up|3|||
16996050|NCT00777946|38139993|FG001|Overall Study|Lost to Follow-up|1|||
16996051|NCT00777946|38139994|FG002|Overall Study|Lost to Follow-up|0|||
16996052|NCT00777946|38139992|FG000|Overall Study|Protocol deviation|2|||
16996053|NCT00777946|38139993|FG001|Overall Study|Protocol deviation|1|||
16996054|NCT00777946|38139994|FG002|Overall Study|Protocol deviation|1|||
16996055|NCT00777946|38139992|FG000|Overall Study|Randomized in error|1|||
17162820|NCT03003000|38310868|FG000|Overall Study|Non-compliant with protocol|0|||
17162821|NCT03003000|38310869|FG001|Overall Study|Non-compliant with protocol|1|||
17162822|NCT03003000|38310870|FG002|Overall Study|Non-compliant with protocol|1|||
17162823|NCT03003000|38310868|FG000|Overall Study|Refused to continue medication|2|||
17162824|NCT03003000|38310869|FG001|Overall Study|Refused to continue medication|0|||
17162825|NCT03003000|38310870|FG002|Overall Study|Refused to continue medication|0|||
17162826|NCT03003000|38310868|FG000|Overall Study|Other than listed|1|||
17162827|NCT03003000|38310869|FG001|Overall Study|Other than listed|1|||
17162828|NCT03003000|38310870|FG002|Overall Study|Other than listed|1|||
17162829|NCT03002610|38310881|FG000|Overall Study|Withdrawal by Subject|6|||
17162830|NCT03002610|38310882|FG001|Overall Study|Withdrawal by Subject|25|||
17162831|NCT03002610|38310883|FG002|Overall Study|Withdrawal by Subject|13|||
17162832|NCT03005106|38310891|FG000|Overall Study|Lost to Follow-up|16|||
17162833|NCT03005106|38310891|FG000|Overall Study|Adverse Event|1|||
17162834|NCT03005106|38310891|FG000|Overall Study|Physician Decision|1|||
17162835|NCT03005106|38310891|FG000|Overall Study|Death|2|||
17162836|NCT01004861|38310908|FG000|Overall Study|Disease progression|3|||
17162837|NCT01004861|38310909|FG001|Overall Study|Disease progression|4|||
17162838|NCT01004861|38310910|FG002|Overall Study|Disease progression|5|||
17162839|NCT01004861|38310911|FG003|Overall Study|Disease progression|4|||
17162840|NCT01004861|38310912|FG004|Overall Study|Disease progression|4|||
17162841|NCT01004861|38310913|FG005|Overall Study|Disease progression|4|||
17162842|NCT01004861|38310914|FG006|Overall Study|Disease progression|5|||
17162843|NCT01004861|38310915|FG007|Overall Study|Disease progression|1|||
17162844|NCT01004861|38310916|FG008|Overall Study|Disease progression|4|||
17162845|NCT01004861|38310917|FG009|Overall Study|Disease progression|7|||
17162846|NCT01004861|38310918|FG010|Overall Study|Disease progression|6|||
17162847|NCT01004861|38310919|FG011|Overall Study|Disease progression|3|||
17162848|NCT01004861|38310920|FG012|Overall Study|Disease progression|8|||
17162849|NCT01004861|38310908|FG000|Overall Study|Physician Decision|0|||
16781295|NCT02105974|37720454|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
16781296|NCT02105974|37720455|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
16996056|NCT00777946|38139993|FG001|Overall Study|Randomized in error|1|||
16996057|NCT00777946|38139994|FG002|Overall Study|Randomized in error|0|||
16996058|NCT00990314|38140002|FG000|Overall Study|Death|2|||
16996059|NCT00990314|38140002|FG000|Overall Study|Adverse Event|2|||
16996060|NCT00990314|38140002|FG000|Overall Study|Withdrawal by Subject|3|||
16996061|NCT00990314|38140002|FG000|Overall Study|Non-Compliance|1|||
16996062|NCT00990314|38140002|FG000|Overall Study|Physician Decision|3|||
16996063|NCT00990314|38140002|FG000|Overall Study|Lack of Efficacy|1|||
16996064|NCT00756652|38140008|FG000|Original Phase|Withdrawal by Subject|864|||
16996065|NCT00756652|38140009|FG001|Original Phase|Withdrawal by Subject|23|||
16996066|NCT00756652|38140008|FG000|Original Phase|Lost to Follow-up|601|||
16996067|NCT00756652|38140009|FG001|Original Phase|Lost to Follow-up|0|||
16996068|NCT00756652|38140008|FG000|Original Phase|Other Discontinuation|797|||
16996069|NCT00756652|38140009|FG001|Original Phase|Other Discontinuation|5|||
16996070|NCT00756652|38140008|FG000|Original Phase|Participant Noncompliance|18622|||
16996071|NCT00756652|38140009|FG001|Original Phase|Participant Noncompliance|424|||
16996072|NCT00756652|38140008|FG000|Original Phase|Unknown Discontinuation Reason|2|||
16996073|NCT00756652|38140009|FG001|Original Phase|Unknown Discontinuation Reason|0|||
16996074|NCT00756652|38140008|FG000|Original Phase|Participants without data|3259|||
16996075|NCT00756652|38140009|FG001|Original Phase|Participants without data|466|||
16996076|NCT00756652|38140008|FG000|Original Phase|Death|168|||
16996077|NCT00756652|38140009|FG001|Original Phase|Death|1|||
16996078|NCT00756652|38140008|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
16996079|NCT00756652|38140009|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
16996080|NCT00756652|38140008|FG000|Re-Op Phase|Withdrawal by Subject|62|||
16996081|NCT00756652|38140009|FG001|Re-Op Phase|Withdrawal by Subject|0|||
16996082|NCT00756652|38140008|FG000|Re-Op Phase|Death|6|||
16996083|NCT00756652|38140009|FG001|Re-Op Phase|Death|0|||
16996084|NCT00756652|38140008|FG000|Re-Op Phase|Lost to Follow-up|340|||
16996085|NCT00756652|38140009|FG001|Re-Op Phase|Lost to Follow-up|0|||
16996086|NCT00756652|38140008|FG000|Re-Op Phase|Site Closed|2454|||
16996087|NCT00756652|38140009|FG001|Re-Op Phase|Site Closed|0|||
16996088|NCT00756652|38140008|FG000|Re-Op Phase|Withdrawn after explant|14|||
16996089|NCT00756652|38140009|FG001|Re-Op Phase|Withdrawn after explant|0|||
16996090|NCT00777556|38140013|FG000|Overall Study|Inappropriate self-selection|34|||
16996091|NCT00777556|38140013|FG000|Overall Study|Dispensed but did not use product|12|||
16996092|NCT00777556|38140013|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
16996093|NCT00602979|38140022|FG000|Overall Study|Lost to Follow-up|3|||
16996094|NCT00602979|38140023|FG001|Overall Study|Lost to Follow-up|2|||
16996095|NCT00602979|38140024|FG002|Overall Study|Lost to Follow-up|3|||
16996096|NCT00602979|38140025|FG003|Overall Study|Lost to Follow-up|2|||
16996097|NCT00602979|38140026|FG004|Overall Study|Lost to Follow-up|3|||
16996098|NCT00602979|38140022|FG000|Overall Study|Failed Intubation|0|||
16996099|NCT00602979|38140023|FG001|Overall Study|Failed Intubation|1|||
16781297|NCT02105974|37720453|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
16996100|NCT00602979|38140024|FG002|Overall Study|Failed Intubation|0|||
16996101|NCT00602979|38140025|FG003|Overall Study|Failed Intubation|1|||
16996102|NCT00602979|38140026|FG004|Overall Study|Failed Intubation|0|||
16996103|NCT04081363|38140040|FG000|Overall Study|Withdrawal by Subject|1|||
16996104|NCT04081363|38140041|FG001|Overall Study|Withdrawal by Subject|0|||
16996105|NCT00993044|38140047|FG000|Irinotecan 50 mg|Physician Decision|1|||
16996106|NCT00777088|38140061|FG000|Overall Study|PED Treatment not attempted|1|||
16996107|NCT00763282|38140077|FG000|Overall Study|Withdrawal by Subject|6|||
16996108|NCT00763282|38140078|FG001|Overall Study|Withdrawal by Subject|5|||
16996109|NCT00763282|38140077|FG000|Overall Study|Death|4|||
17162850|NCT01004861|38310909|FG001|Overall Study|Physician Decision|2|||
17162851|NCT01004861|38310910|FG002|Overall Study|Physician Decision|1|||
17162852|NCT01004861|38310911|FG003|Overall Study|Physician Decision|1|||
17162853|NCT01004861|38310912|FG004|Overall Study|Physician Decision|1|||
17162854|NCT01004861|38310913|FG005|Overall Study|Physician Decision|0|||
17162855|NCT01004861|38310914|FG006|Overall Study|Physician Decision|0|||
17162856|NCT01004861|38310915|FG007|Overall Study|Physician Decision|1|||
17083368|NCT00170950|38223967|FG000|Overall Study|Lost to Follow-up|134|||
17083369|NCT00170950|38223968|FG001|Overall Study|Lost to Follow-up|115|||
17083370|NCT00170950|38223967|FG000|Overall Study|Missing|2|||
17083371|NCT00170950|38223968|FG001|Overall Study|Missing|1|||
17083372|NCT00170950|38223967|FG000|Overall Study|Termination Data Not Recorded|17|||
17083373|NCT00170950|38223968|FG001|Overall Study|Termination Data Not Recorded|22|||
17083374|NCT00239577|38223978|FG000|Primary Phase|Adverse Event|0|||
17083375|NCT00239577|38223979|FG001|Primary Phase|Adverse Event|0|||
17083376|NCT00239577|38223980|FG002|Primary Phase|Adverse Event|1|||
17083377|NCT00239577|38223981|FG003|Primary Phase|Adverse Event|0|||
17083378|NCT00239577|38223978|FG000|Primary Phase|Other|5|||
17083379|NCT00239577|38223979|FG001|Primary Phase|Other|3|||
17083380|NCT00239577|38223980|FG002|Primary Phase|Other|2|||
17083381|NCT00239577|38223981|FG003|Primary Phase|Other|0|||
17083382|NCT00262041|38223997|FG000|Overall Study|Withdrawal by Subject|0|||
17162857|NCT01004861|38310916|FG008|Overall Study|Physician Decision|0|||
17162858|NCT01004861|38310917|FG009|Overall Study|Physician Decision|0|||
17083383|NCT00262041|38223998|FG001|Overall Study|Withdrawal by Subject|3|||
17083384|NCT00262041|38223999|FG002|Overall Study|Withdrawal by Subject|1|||
17083385|NCT00262041|38223997|FG000|Overall Study|Lost to Follow-up|1|||
17083386|NCT00262041|38223998|FG001|Overall Study|Lost to Follow-up|1|||
17083387|NCT00262041|38223999|FG002|Overall Study|Lost to Follow-up|5|||
17083388|NCT00262041|38223997|FG000|Overall Study|Unable to classify|1|||
17083389|NCT00262041|38223998|FG001|Overall Study|Unable to classify|0|||
17083390|NCT00262041|38223999|FG002|Overall Study|Unable to classify|0|||
17083391|NCT00208767|38224015|FG000|Overall Study|Adverse Event|9|||
17083392|NCT00208767|38224016|FG001|Overall Study|Adverse Event|1|||
17083393|NCT00208767|38224015|FG000|Overall Study|Withdrawal by Subject|14|||
17083394|NCT00208767|38224016|FG001|Overall Study|Withdrawal by Subject|3|||
17083395|NCT00208767|38224015|FG000|Overall Study|Death|1|||
17083396|NCT00208767|38224016|FG001|Overall Study|Death|0|||
17083397|NCT00208767|38224015|FG000|Overall Study|Lost to Follow-up|3|||
17083398|NCT00208767|38224016|FG001|Overall Study|Lost to Follow-up|3|||
17083399|NCT00390806|38224024|FG000|Overall Study|Lost to Follow-up|7|||
17083400|NCT00390806|38224025|FG001|Overall Study|Lost to Follow-up|6|||
17083401|NCT00390806|38224024|FG000|Overall Study|Protocol Violation|2|||
17083402|NCT00390806|38224025|FG001|Overall Study|Protocol Violation|2|||
17083403|NCT00390806|38224024|FG000|Overall Study|Withdrawal by Subject|12|||
17162859|NCT01004861|38310918|FG010|Overall Study|Physician Decision|0|||
16996110|NCT00763282|38140078|FG001|Overall Study|Death|3|||
16996111|NCT00763282|38140077|FG000|Overall Study|Lost to Follow-up|22|||
16996112|NCT00763282|38140078|FG001|Overall Study|Lost to Follow-up|26|||
16996113|NCT00988598|38140088|FG000|Overall Study|Withdrawal by Subject|2|||
16996114|NCT00988598|38140089|FG001|Overall Study|Withdrawal by Subject|0|||
16996115|NCT00979628|38140098|FG000|Overall Study|received regimen < 24 hours|7|||
16996116|NCT00979628|38140099|FG001|Overall Study|received regimen < 24 hours|6|||
16996117|NCT00979628|38140100|FG002|Overall Study|received regimen < 24 hours|5|||
16996118|NCT00979628|38140098|FG000|Overall Study|received steroids|1|||
16996119|NCT00979628|38140099|FG001|Overall Study|received steroids|1|||
16996120|NCT00979628|38140100|FG002|Overall Study|received steroids|0|||
16996121|NCT00979628|38140098|FG000|Overall Study|transferred to ICU|1|||
16996122|NCT00979628|38140099|FG001|Overall Study|transferred to ICU|2|||
16996123|NCT00979628|38140100|FG002|Overall Study|transferred to ICU|1|||
16996124|NCT00762970|38140114|FG000|Overall Study|Withdrawal by Subject|7|||
16996125|NCT00762970|38140115|FG001|Overall Study|Withdrawal by Subject|4|||
16996126|NCT00762970|38140116|FG002|Overall Study|Withdrawal by Subject|0|||
16996127|NCT00762970|38140114|FG000|Overall Study|Protocol Violation|3|||
16996128|NCT00762970|38140115|FG001|Overall Study|Protocol Violation|1|||
16996129|NCT00762970|38140116|FG002|Overall Study|Protocol Violation|1|||
16996130|NCT00762970|38140114|FG000|Overall Study|Lost to Follow-up|1|||
16996131|NCT00762970|38140115|FG001|Overall Study|Lost to Follow-up|2|||
16996132|NCT00762970|38140116|FG002|Overall Study|Lost to Follow-up|0|||
16996133|NCT00762970|38140114|FG000|Overall Study|Difficulty of handling lens|1|||
16996134|NCT00762970|38140115|FG001|Overall Study|Difficulty of handling lens|2|||
16996135|NCT00762970|38140116|FG002|Overall Study|Difficulty of handling lens|0|||
16996136|NCT00988442|38140126|FG000|Overall Study|Death|1|||
16996137|NCT00988442|38140127|FG001|Overall Study|Death|2|||
16996138|NCT00988442|38140126|FG000|Overall Study|Lost to Follow-up|0|||
16996139|NCT00988442|38140127|FG001|Overall Study|Lost to Follow-up|1|||
16996140|NCT00988442|38140126|FG000|Overall Study|Early Study Closure|29|||
16996141|NCT00988442|38140127|FG001|Overall Study|Early Study Closure|25|||
16996142|NCT03258723|38140136|FG000|Overall Study|COVID Interruption of study|54|||
16996143|NCT03258723|38140136|FG000|Overall Study|Lost to Follow-up|8|||
16996144|NCT00992186|38140140|FG000|Overall Study|Withdrawal by Subject|2|||
16996145|NCT00992186|38140140|FG000|Overall Study|Protocol Violation|1|||
16996146|NCT00992186|38140140|FG000|Overall Study|Physician Decision|1|||
16996147|NCT00992186|38140140|FG000|Overall Study|Adverse Event|9|||
16996148|NCT00992186|38140140|FG000|Overall Study|Progressive Disease|30|||
16996149|NCT00992186|38140140|FG000|Overall Study|Refusal To Receive Study Agent|3|||
16996150|NCT00992108|38140147|FG000|Overall Study|Lost to Follow-up|0|||
16996151|NCT00992108|38140148|FG001|Overall Study|Lost to Follow-up|1|||
16996152|NCT00752986|38140157|FG000|Overall Study|Withdrawal by Subject|2|||
16996153|NCT00752986|38140158|FG001|Overall Study|Withdrawal by Subject|1|||
17083404|NCT00390806|38224025|FG001|Overall Study|Withdrawal by Subject|15|||
17083405|NCT00390806|38224024|FG000|Overall Study|Investigator Decision|4|||
17083406|NCT00390806|38224025|FG001|Overall Study|Investigator Decision|6|||
16996154|NCT00752986|38140159|FG002|Overall Study|Withdrawal by Subject|2|||
16996155|NCT00752986|38140157|FG000|Overall Study|Protocol Violation|3|||
16996156|NCT00752986|38140158|FG001|Overall Study|Protocol Violation|0|||
16996157|NCT00752986|38140159|FG002|Overall Study|Protocol Violation|0|||
16996158|NCT03483103|38140167|FG000|Pre-Treatment Phase|Other reasons|1|||
16996159|NCT03483103|38140167|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
16996160|NCT03483103|38140167|FG000|Pre-Treatment Phase|Disease-related complications|1|||
16996161|NCT03483103|38140167|FG000|Pre-Treatment Phase|Death|5|||
16996162|NCT03483103|38140167|FG000|Treatment Phase|Withdrawal by Subject|6|||
16996163|NCT03483103|38140167|FG000|Treatment Phase|Other reasons|2|||
16996164|NCT03483103|38140167|FG000|Treatment Phase|Death|20|||
16996165|NCT03483103|38140167|FG000|Treatment Phase|Ongoing in study|26|||
16996166|NCT03483103|38140167|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
16996167|NCT03483103|38140167|FG000|Treatment Phase|Received nonconforming product|1|||
16996168|NCT00762892|38140173|FG000|Overall Study|Lost to Follow-up|2|||
16996169|NCT00762892|38140174|FG001|Overall Study|Lost to Follow-up|5|||
17162860|NCT01004861|38310919|FG011|Overall Study|Physician Decision|0|||
17162861|NCT01004861|38310920|FG012|Overall Study|Physician Decision|3|||
17162862|NCT01004861|38310908|FG000|Overall Study|Adverse Event|0|||
17162863|NCT01004861|38310909|FG001|Overall Study|Adverse Event|0|||
17162864|NCT01004861|38310910|FG002|Overall Study|Adverse Event|0|||
17162865|NCT01004861|38310911|FG003|Overall Study|Adverse Event|1|||
17162866|NCT01004861|38310912|FG004|Overall Study|Adverse Event|0|||
17162867|NCT01004861|38310913|FG005|Overall Study|Adverse Event|2|||
17162868|NCT01004861|38310914|FG006|Overall Study|Adverse Event|1|||
17162869|NCT01004861|38310915|FG007|Overall Study|Adverse Event|1|||
17162870|NCT01004861|38310916|FG008|Overall Study|Adverse Event|13|||
17162871|NCT01004861|38310917|FG009|Overall Study|Adverse Event|1|||
17162872|NCT01004861|38310918|FG010|Overall Study|Adverse Event|1|||
17162873|NCT01004861|38310919|FG011|Overall Study|Adverse Event|0|||
17162874|NCT01004861|38310920|FG012|Overall Study|Adverse Event|2|||
17162875|NCT01004861|38310908|FG000|Overall Study|Protocol Violation|0|||
17162876|NCT01004861|38310909|FG001|Overall Study|Protocol Violation|0|||
17162877|NCT01004861|38310910|FG002|Overall Study|Protocol Violation|0|||
17162878|NCT01004861|38310911|FG003|Overall Study|Protocol Violation|0|||
17162879|NCT01004861|38310912|FG004|Overall Study|Protocol Violation|1|||
17083407|NCT00390806|38224024|FG000|Overall Study|Death|1|||
17162880|NCT01004861|38310913|FG005|Overall Study|Protocol Violation|0|||
17162881|NCT01004861|38310914|FG006|Overall Study|Protocol Violation|0|||
17162882|NCT01004861|38310915|FG007|Overall Study|Protocol Violation|0|||
17162883|NCT01004861|38310916|FG008|Overall Study|Protocol Violation|0|||
17162884|NCT01004861|38310917|FG009|Overall Study|Protocol Violation|0|||
17162885|NCT01004861|38310918|FG010|Overall Study|Protocol Violation|0|||
17162886|NCT01004861|38310919|FG011|Overall Study|Protocol Violation|0|||
17162887|NCT01004861|38310920|FG012|Overall Study|Protocol Violation|0|||
17162888|NCT01004861|38310908|FG000|Overall Study|Lost to Follow-up|0|||
17162889|NCT01004861|38310909|FG001|Overall Study|Lost to Follow-up|0|||
17162890|NCT01004861|38310910|FG002|Overall Study|Lost to Follow-up|0|||
17162891|NCT01004861|38310911|FG003|Overall Study|Lost to Follow-up|0|||
17162892|NCT01004861|38310912|FG004|Overall Study|Lost to Follow-up|0|||
17162893|NCT01004861|38310913|FG005|Overall Study|Lost to Follow-up|0|||
17162894|NCT01004861|38310914|FG006|Overall Study|Lost to Follow-up|0|||
17162895|NCT01004861|38310915|FG007|Overall Study|Lost to Follow-up|1|||
17162896|NCT01004861|38310916|FG008|Overall Study|Lost to Follow-up|3|||
17162897|NCT01004861|38310917|FG009|Overall Study|Lost to Follow-up|0|||
17162898|NCT01004861|38310918|FG010|Overall Study|Lost to Follow-up|0|||
17162899|NCT01004861|38310919|FG011|Overall Study|Lost to Follow-up|1|||
17162900|NCT01004861|38310920|FG012|Overall Study|Lost to Follow-up|0|||
17162901|NCT01004861|38310908|FG000|Overall Study|Non-compliance|0|||
17162902|NCT01004861|38310909|FG001|Overall Study|Non-compliance|0|||
17162903|NCT01004861|38310910|FG002|Overall Study|Non-compliance|0|||
17162904|NCT01004861|38310911|FG003|Overall Study|Non-compliance|0|||
17162905|NCT01004861|38310912|FG004|Overall Study|Non-compliance|0|||
17162906|NCT01004861|38310913|FG005|Overall Study|Non-compliance|0|||
17162907|NCT01004861|38310914|FG006|Overall Study|Non-compliance|0|||
17162908|NCT01004861|38310915|FG007|Overall Study|Non-compliance|0|||
17162909|NCT01004861|38310916|FG008|Overall Study|Non-compliance|5|||
17162910|NCT01004861|38310917|FG009|Overall Study|Non-compliance|0|||
17162911|NCT01004861|38310918|FG010|Overall Study|Non-compliance|0|||
17162912|NCT01004861|38310919|FG011|Overall Study|Non-compliance|0|||
17162913|NCT01004861|38310920|FG012|Overall Study|Non-compliance|1|||
17162914|NCT01004861|38310908|FG000|Overall Study|Other|0|||
16782562|NCT01663623|37722164|FG001|Overall Study|Withdrawal by Subject|1|||
16996170|NCT00762892|38140173|FG000|Overall Study|Withdrawal by Subject|0|||
16996171|NCT00762892|38140174|FG001|Overall Study|Withdrawal by Subject|1|||
16996172|NCT00762892|38140173|FG000|Overall Study|Death|1|||
16996173|NCT00762892|38140174|FG001|Overall Study|Death|0|||
16996174|NCT00762892|38140173|FG000|Overall Study|Pregnancy|1|||
16996175|NCT00762892|38140174|FG001|Overall Study|Pregnancy|0|||
16996176|NCT00762892|38140173|FG000|Overall Study|Incarceration|1|||
16996177|NCT00762892|38140174|FG001|Overall Study|Incarceration|0|||
16996178|NCT00755716|38140183|FG000|Overall Study|Adverse Event|1|||
16996179|NCT00755716|38140184|FG001|Overall Study|Adverse Event|4|||
16996180|NCT00755716|38140185|FG002|Overall Study|Adverse Event|1|||
16996181|NCT00755716|38140183|FG000|Overall Study|Lack of Efficacy|2|||
16996182|NCT00755716|38140184|FG001|Overall Study|Lack of Efficacy|0|||
16996183|NCT00755716|38140185|FG002|Overall Study|Lack of Efficacy|0|||
16996184|NCT00755716|38140183|FG000|Overall Study|Lost to Follow-up|5|||
16996185|NCT00755716|38140184|FG001|Overall Study|Lost to Follow-up|3|||
16996186|NCT00755716|38140185|FG002|Overall Study|Lost to Follow-up|1|||
16996187|NCT00755716|38140183|FG000|Overall Study|work schedule issues|0|||
16996188|NCT00755716|38140184|FG001|Overall Study|work schedule issues|1|||
16996189|NCT00755716|38140185|FG002|Overall Study|work schedule issues|1|||
17162915|NCT01004861|38310909|FG001|Overall Study|Other|0|||
17162916|NCT01004861|38310910|FG002|Overall Study|Other|0|||
17162917|NCT01004861|38310911|FG003|Overall Study|Other|0|||
16996190|NCT00755326|38140195|FG000|Overall Study|Lost to Follow-up|2|||
17162918|NCT01004861|38310912|FG004|Overall Study|Other|0|||
17162919|NCT01004861|38310913|FG005|Overall Study|Other|0|||
17083408|NCT00390806|38224025|FG001|Overall Study|Death|0|||
17083409|NCT00390806|38224024|FG000|Overall Study|Physician Decision|0|||
17083410|NCT00390806|38224025|FG001|Overall Study|Physician Decision|1|||
17083411|NCT00390806|38224024|FG000|Overall Study|Ongoing|4|||
17083412|NCT00390806|38224025|FG001|Overall Study|Ongoing|2|||
17083413|NCT00390572|38224033|FG000|Overall Study|Lost to Follow-up|8|||
17083414|NCT00390572|38224034|FG001|Overall Study|Lost to Follow-up|4|||
17083415|NCT00390572|38224033|FG000|Overall Study|health condition|0|||
17083416|NCT00390572|38224034|FG001|Overall Study|health condition|1|||
17083417|NCT00390416|38224044|FG000|Overall Study|Withdrawal by Subject|1|||
17083418|NCT00390416|38224044|FG000|Overall Study|Not treated|3|||
17083419|NCT00261495|38224050|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
17083420|NCT00261495|38224051|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
17162920|NCT01004861|38310914|FG006|Overall Study|Other|0|||
17162921|NCT01004861|38310915|FG007|Overall Study|Other|0|||
17162922|NCT01004861|38310916|FG008|Overall Study|Other|0|||
17162923|NCT01004861|38310917|FG009|Overall Study|Other|2|||
17162924|NCT01004861|38310918|FG010|Overall Study|Other|1|||
17162925|NCT01004861|38310919|FG011|Overall Study|Other|2|||
17162926|NCT01004861|38310920|FG012|Overall Study|Other|3|||
17162927|NCT01004861|38310908|FG000|Overall Study|Patient decision|0|||
17162928|NCT01004861|38310909|FG001|Overall Study|Patient decision|0|||
17162929|NCT01004861|38310910|FG002|Overall Study|Patient decision|0|||
17162930|NCT01004861|38310911|FG003|Overall Study|Patient decision|0|||
17162931|NCT01004861|38310912|FG004|Overall Study|Patient decision|1|||
17162932|NCT01004861|38310913|FG005|Overall Study|Patient decision|0|||
17162933|NCT01004861|38310914|FG006|Overall Study|Patient decision|1|||
17162934|NCT01004861|38310915|FG007|Overall Study|Patient decision|0|||
17162935|NCT01004861|38310916|FG008|Overall Study|Patient decision|7|||
17162936|NCT01004861|38310917|FG009|Overall Study|Patient decision|1|||
17162937|NCT01004861|38310918|FG010|Overall Study|Patient decision|1|||
17162938|NCT01004861|38310919|FG011|Overall Study|Patient decision|2|||
17162939|NCT01004861|38310920|FG012|Overall Study|Patient decision|3|||
17162940|NCT01004861|38310908|FG000|Overall Study|Transitioned to Phase 4 study|0|||
17162941|NCT01004861|38310909|FG001|Overall Study|Transitioned to Phase 4 study|0|||
17162942|NCT01004861|38310910|FG002|Overall Study|Transitioned to Phase 4 study|0|||
17162943|NCT01004861|38310911|FG003|Overall Study|Transitioned to Phase 4 study|0|||
17083421|NCT00261495|38224050|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
17083422|NCT00261495|38224051|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
17162944|NCT01004861|38310912|FG004|Overall Study|Transitioned to Phase 4 study|0|||
17162945|NCT01004861|38310913|FG005|Overall Study|Transitioned to Phase 4 study|0|||
17162946|NCT01004861|38310914|FG006|Overall Study|Transitioned to Phase 4 study|0|||
17083423|NCT00261495|38224050|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
17083424|NCT00261495|38224051|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
17083425|NCT00261495|38224050|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
17083426|NCT00261495|38224051|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
17083427|NCT00261495|38224050|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
17162947|NCT01004861|38310915|FG007|Overall Study|Transitioned to Phase 4 study|0|||
17162948|NCT01004861|38310916|FG008|Overall Study|Transitioned to Phase 4 study|2|||
17162949|NCT01004861|38310917|FG009|Overall Study|Transitioned to Phase 4 study|0|||
17162950|NCT01004861|38310918|FG010|Overall Study|Transitioned to Phase 4 study|0|||
17162951|NCT01004861|38310919|FG011|Overall Study|Transitioned to Phase 4 study|0|||
17162952|NCT01004861|38310920|FG012|Overall Study|Transitioned to Phase 4 study|0|||
17162953|NCT01004861|38310908|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162954|NCT01004861|38310909|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162955|NCT01004861|38310910|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162956|NCT01004861|38310911|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162957|NCT01004861|38310912|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162958|NCT01004861|38310913|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162959|NCT01004861|38310914|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162960|NCT01004861|38310915|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162961|NCT01004861|38310916|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
17162962|NCT01004861|38310917|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162963|NCT01004861|38310918|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162964|NCT01004861|38310919|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162965|NCT01004861|38310920|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
17162966|NCT01004861|38310908|FG000|Overall Study|Patient withdrew|0|||
17162967|NCT01004861|38310909|FG001|Overall Study|Patient withdrew|0|||
17162968|NCT01004861|38310910|FG002|Overall Study|Patient withdrew|0|||
17162969|NCT01004861|38310911|FG003|Overall Study|Patient withdrew|0|||
17162970|NCT01004861|38310912|FG004|Overall Study|Patient withdrew|0|||
17162971|NCT01004861|38310913|FG005|Overall Study|Patient withdrew|0|||
17162972|NCT01004861|38310914|FG006|Overall Study|Patient withdrew|0|||
17162973|NCT01004861|38310915|FG007|Overall Study|Patient withdrew|0|||
17162974|NCT01004861|38310916|FG008|Overall Study|Patient withdrew|1|||
17162975|NCT01004861|38310917|FG009|Overall Study|Patient withdrew|0|||
17162976|NCT01004861|38310918|FG010|Overall Study|Patient withdrew|0|||
17162977|NCT01004861|38310919|FG011|Overall Study|Patient withdrew|0|||
17162978|NCT01004861|38310920|FG012|Overall Study|Patient withdrew|0|||
17162979|NCT01004861|38310908|FG000|Overall Study|Surgical resection|0|||
17162980|NCT01004861|38310909|FG001|Overall Study|Surgical resection|0|||
17083428|NCT00261495|38224051|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
17162981|NCT01004861|38310910|FG002|Overall Study|Surgical resection|0|||
17162982|NCT01004861|38310911|FG003|Overall Study|Surgical resection|0|||
17162983|NCT01004861|38310912|FG004|Overall Study|Surgical resection|0|||
17162984|NCT01004861|38310913|FG005|Overall Study|Surgical resection|0|||
17162985|NCT01004861|38310914|FG006|Overall Study|Surgical resection|0|||
17162986|NCT01004861|38310915|FG007|Overall Study|Surgical resection|0|||
17162987|NCT01004861|38310916|FG008|Overall Study|Surgical resection|1|||
17162988|NCT01004861|38310917|FG009|Overall Study|Surgical resection|0|||
17162989|NCT01004861|38310918|FG010|Overall Study|Surgical resection|0|||
17162990|NCT01004861|38310919|FG011|Overall Study|Surgical resection|0|||
17162991|NCT01004861|38310920|FG012|Overall Study|Surgical resection|0|||
17162992|NCT01004861|38310908|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17162993|NCT01004861|38310909|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17162994|NCT01004861|38310910|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17162995|NCT01004861|38310911|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17162996|NCT01004861|38310912|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16996191|NCT00755326|38140196|FG001|Overall Study|Lost to Follow-up|3|||
17083429|NCT00261495|38224050|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
17083430|NCT00261495|38224051|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
17083431|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
17083432|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
17083433|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
17083434|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
17083435|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
17083436|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
17083437|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
17083438|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
17083439|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
17083440|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
17083441|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
17162997|NCT01004861|38310913|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17162998|NCT01004861|38310914|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17162999|NCT01004861|38310915|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17163000|NCT01004861|38310916|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
17163001|NCT01004861|38310917|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17163002|NCT01004861|38310918|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17163003|NCT01004861|38310919|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17163004|NCT01004861|38310920|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
17163005|NCT01004861|38310908|FG000|Overall Study|Study termination by Sponsor|0|||
17163006|NCT01004861|38310909|FG001|Overall Study|Study termination by Sponsor|0|||
17163007|NCT01004861|38310910|FG002|Overall Study|Study termination by Sponsor|0|||
17163008|NCT01004861|38310911|FG003|Overall Study|Study termination by Sponsor|0|||
17163009|NCT01004861|38310912|FG004|Overall Study|Study termination by Sponsor|0|||
17163010|NCT01004861|38310913|FG005|Overall Study|Study termination by Sponsor|0|||
17163011|NCT01004861|38310914|FG006|Overall Study|Study termination by Sponsor|0|||
17163012|NCT01004861|38310915|FG007|Overall Study|Study termination by Sponsor|0|||
17163013|NCT01004861|38310916|FG008|Overall Study|Study termination by Sponsor|1|||
17163014|NCT01004861|38310917|FG009|Overall Study|Study termination by Sponsor|0|||
17163015|NCT01004861|38310918|FG010|Overall Study|Study termination by Sponsor|0|||
17163016|NCT01004861|38310919|FG011|Overall Study|Study termination by Sponsor|0|||
17163017|NCT01004861|38310920|FG012|Overall Study|Study termination by Sponsor|0|||
17163018|NCT03254459|38310967|FG000|Overall Study|Adverse Event|7|||
17163019|NCT03254459|38310968|FG001|Overall Study|Adverse Event|20|||
17163020|NCT03254459|38310967|FG000|Overall Study|Withdrawal by Subject Consent|3|||
17163021|NCT03254459|38310968|FG001|Overall Study|Withdrawal by Subject Consent|1|||
16781298|NCT02105974|37720454|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
16996192|NCT03084471|38140203|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
16996193|NCT03084471|38140203|FG000|Overall Study|Condition under investigation worsened|84|||
16996194|NCT03084471|38140203|FG000|Overall Study|Lack of therapeutic response|2|||
16996195|NCT03084471|38140203|FG000|Overall Study|Protocol Violation|1|||
16996196|NCT03084471|38140203|FG000|Overall Study|Adverse Event|73|||
16996197|NCT03084471|38140203|FG000|Overall Study|Withdrawal by Subject|12|||
16996198|NCT03084471|38140203|FG000|Overall Study|Disease relapse|181|||
16996199|NCT03084471|38140203|FG000|Overall Study|Subjective disease progression|359|||
16996200|NCT03084471|38140203|FG000|Overall Study|Other (as recorded)|33|||
16996201|NCT03084471|38140203|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
16996202|NCT00754936|38140210|FG000|Overall Study|Lost to Follow-up|3|||
16996203|NCT00754936|38140210|FG000|Overall Study|Physician Decision|1|||
16996204|NCT00754936|38140210|FG000|Overall Study|Withdrawal by Subject|2|||
16996205|NCT00754936|38140210|FG000|Overall Study|Side Effects|3|||
16996206|NCT00754936|38140210|FG000|Overall Study|Inter-current medical events|3|||
16996207|NCT00762502|38140217|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
16996208|NCT00762502|38140218|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
16996209|NCT00762502|38140219|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
17083442|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
17083443|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
17083444|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
17083445|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
17083446|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
17083447|NCT00261495|38224050|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
17083448|NCT00261495|38224051|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
17083449|NCT00261495|38224050|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
17083450|NCT00261495|38224051|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
17083451|NCT00261495|38224050|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
17083452|NCT00261495|38224051|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
17083453|NCT00261495|38224050|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
17083454|NCT00261495|38224051|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
17083455|NCT00261495|38224050|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
17083456|NCT00261495|38224051|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
17163022|NCT03254459|38310967|FG000|Overall Study|Lost to Follow-up|0|||
17163023|NCT03254459|38310968|FG001|Overall Study|Lost to Follow-up|1|||
17163024|NCT03254459|38310967|FG000|Overall Study|Miscellaneous|0|||
17163025|NCT03254459|38310968|FG001|Overall Study|Miscellaneous|1|||
17163026|NCT02736617|38310974|FG000|Treatment|Adverse Event|1|||
17163027|NCT02736617|38310974|FG000|Treatment|Lack of Efficacy|1|||
17163028|NCT02736617|38310974|FG000|Treatment|Withdrawal by Subject|1|||
17163029|NCT02736617|38310974|FG000|Maintenance|Lack of Efficacy|4|||
17163030|NCT02736617|38310974|FG000|Maintenance|Physician Decision|1|||
17163031|NCT03251963|38310981|FG000|Overall Study|inappropriate Xa level timing|6|||
17163032|NCT03251963|38310982|FG001|Overall Study|inappropriate Xa level timing|3|||
17083457|NCT00261495|38224050|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
17083458|NCT00261495|38224051|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
17083459|NCT00261495|38224050|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
17083460|NCT00261495|38224051|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
17083461|NCT00168844|38224060|FG000|Overall Study|Adverse Event|31|||
17083462|NCT00168844|38224061|FG001|Overall Study|Adverse Event|32|||
17163033|NCT03251963|38310981|FG000|Overall Study|no peak Xa level drawn|2|||
17163034|NCT03251963|38310982|FG001|Overall Study|no peak Xa level drawn|0|||
17163035|NCT03251963|38310981|FG000|Overall Study|bled prior to Xa level|1|||
17163036|NCT03251963|38310982|FG001|Overall Study|bled prior to Xa level|2|||
17163037|NCT03287219|38310990|FG000|Overall Study|Protocol Violation|0|||
17163038|NCT03287219|38310991|FG001|Overall Study|Protocol Violation|2|||
17163039|NCT03286751|38311030|FG000|Washout Period 1|Withdrawal by Subject|0|||
17163040|NCT03286751|38311031|FG001|Washout Period 1|Withdrawal by Subject|0|||
17163041|NCT03286751|38311032|FG002|Washout Period 1|Withdrawal by Subject|0|||
17163042|NCT03286751|38311033|FG003|Washout Period 1|Withdrawal by Subject|0|||
17163043|NCT03286751|38311034|FG004|Washout Period 1|Withdrawal by Subject|1|||
17163044|NCT03286751|38311035|FG005|Washout Period 1|Withdrawal by Subject|0|||
17163045|NCT03286751|38311030|FG000|Washout Period 2|Personal Reasons|0|||
17163046|NCT03286751|38311031|FG001|Washout Period 2|Personal Reasons|1|||
17163047|NCT03286751|38311032|FG002|Washout Period 2|Personal Reasons|0|||
17163048|NCT03286751|38311033|FG003|Washout Period 2|Personal Reasons|0|||
17163049|NCT03286751|38311034|FG004|Washout Period 2|Personal Reasons|0|||
17163050|NCT03286751|38311035|FG005|Washout Period 2|Personal Reasons|0|||
17163051|NCT03286751|38311030|FG000|Washout Period 5|Adverse Event|0|||
16781299|NCT02105974|37720455|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
17163052|NCT03286751|38311031|FG001|Washout Period 5|Adverse Event|0|||
16781300|NCT02105974|37720453|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
17083463|NCT00168844|38224062|FG002|Overall Study|Adverse Event|48|||
17083464|NCT00168844|38224060|FG000|Overall Study|Lost to Follow-up|4|||
17083465|NCT00168844|38224061|FG001|Overall Study|Lost to Follow-up|5|||
17083466|NCT00168844|38224062|FG002|Overall Study|Lost to Follow-up|11|||
17083467|NCT00168844|38224060|FG000|Overall Study|Withdrawal by Subject|12|||
17163053|NCT03286751|38311032|FG002|Washout Period 5|Adverse Event|0|||
17163054|NCT03286751|38311033|FG003|Washout Period 5|Adverse Event|0|||
17163055|NCT03286751|38311034|FG004|Washout Period 5|Adverse Event|1|||
17163056|NCT03286751|38311035|FG005|Washout Period 5|Adverse Event|0|||
17163057|NCT03249935|38311049|FG000|Overall Study|Discharged from facility early|36|||
17163058|NCT03249935|38311049|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
17163059|NCT03249935|38311049|FG000|Overall Study|Protocol Violation|5|||
17163060|NCT03285113|38311055|FG000|Overall Study|Unable to implant leads|2|||
17163061|NCT03000348|38311065|FG000|Overall Study|Adverse Event|1|||
17163062|NCT03000348|38311066|FG001|Overall Study|Adverse Event|1|||
17163063|NCT03000348|38311067|FG002|Overall Study|Adverse Event|1|||
17163064|NCT03000348|38311068|FG003|Overall Study|Adverse Event|1|||
17163065|NCT03000348|38311069|FG004|Overall Study|Adverse Event|1|||
17163066|NCT03000348|38311070|FG005|Overall Study|Adverse Event|1|||
17163067|NCT03000348|38311065|FG000|Overall Study|Lost to Follow-up|0|||
17163068|NCT03000348|38311066|FG001|Overall Study|Lost to Follow-up|0|||
17163069|NCT03000348|38311067|FG002|Overall Study|Lost to Follow-up|1|||
17163070|NCT03000348|38311068|FG003|Overall Study|Lost to Follow-up|0|||
17163071|NCT03000348|38311069|FG004|Overall Study|Lost to Follow-up|0|||
17163072|NCT03000348|38311070|FG005|Overall Study|Lost to Follow-up|0|||
17163073|NCT03000348|38311065|FG000|Overall Study|Withdrawal by Subject|0|||
17163074|NCT03000348|38311066|FG001|Overall Study|Withdrawal by Subject|1|||
17163075|NCT03000348|38311067|FG002|Overall Study|Withdrawal by Subject|0|||
17163076|NCT03000348|38311068|FG003|Overall Study|Withdrawal by Subject|0|||
17163077|NCT03000348|38311069|FG004|Overall Study|Withdrawal by Subject|0|||
17163078|NCT03000348|38311070|FG005|Overall Study|Withdrawal by Subject|0|||
17163079|NCT03000348|38311065|FG000|Overall Study|Consent|0|||
17083468|NCT00168844|38224061|FG001|Overall Study|Withdrawal by Subject|9|||
17083469|NCT00168844|38224062|FG002|Overall Study|Withdrawal by Subject|19|||
17163080|NCT03000348|38311066|FG001|Overall Study|Consent|0|||
17163081|NCT03000348|38311067|FG002|Overall Study|Consent|0|||
17163082|NCT03000348|38311068|FG003|Overall Study|Consent|0|||
17163083|NCT03000348|38311069|FG004|Overall Study|Consent|1|||
17163084|NCT03000348|38311070|FG005|Overall Study|Consent|0|||
17163085|NCT03000348|38311065|FG000|Overall Study|Failure to expectorate sputum|1|||
17163086|NCT03000348|38311066|FG001|Overall Study|Failure to expectorate sputum|0|||
17163087|NCT03000348|38311067|FG002|Overall Study|Failure to expectorate sputum|1|||
17163088|NCT03000348|38311068|FG003|Overall Study|Failure to expectorate sputum|0|||
17163089|NCT03000348|38311069|FG004|Overall Study|Failure to expectorate sputum|1|||
17163090|NCT03000348|38311070|FG005|Overall Study|Failure to expectorate sputum|0|||
17163091|NCT03000348|38311065|FG000|Overall Study|No gram negative|1|||
17163092|NCT03000348|38311066|FG001|Overall Study|No gram negative|2|||
17163093|NCT03000348|38311067|FG002|Overall Study|No gram negative|1|||
17163094|NCT03000348|38311068|FG003|Overall Study|No gram negative|1|||
17163095|NCT03000348|38311069|FG004|Overall Study|No gram negative|1|||
17163096|NCT03000348|38311070|FG005|Overall Study|No gram negative|1|||
17163097|NCT03000348|38311065|FG000|Overall Study|Patient had no transport|0|||
17163098|NCT03000348|38311066|FG001|Overall Study|Patient had no transport|0|||
17163099|NCT03000348|38311067|FG002|Overall Study|Patient had no transport|0|||
17163100|NCT03000348|38311068|FG003|Overall Study|Patient had no transport|1|||
17163101|NCT03000348|38311069|FG004|Overall Study|Patient had no transport|0|||
17163102|NCT03000348|38311070|FG005|Overall Study|Patient had no transport|0|||
17163103|NCT03000348|38311065|FG000|Overall Study|Dosing|0|||
17163104|NCT03000348|38311066|FG001|Overall Study|Dosing|0|||
17163105|NCT03000348|38311067|FG002|Overall Study|Dosing|0|||
17163106|NCT03000348|38311068|FG003|Overall Study|Dosing|0|||
17163107|NCT03000348|38311069|FG004|Overall Study|Dosing|1|||
17163108|NCT03000348|38311070|FG005|Overall Study|Dosing|0|||
17163109|NCT03283709|38311089|FG000|Overall Study|trial terminated|0|||
17163110|NCT03283709|38311090|FG001|Overall Study|trial terminated|1|||
17163111|NCT03247673|38311099|FG000|Overall Study|Withdrawal by Subject|1|||
17163112|NCT03247673|38311100|FG001|Overall Study|Withdrawal by Subject|0|||
17163113|NCT03247673|38311101|FG002|Overall Study|Withdrawal by Subject|3|||
17163114|NCT03247673|38311099|FG000|Overall Study|Lost to Follow-up|0|||
17163115|NCT03247673|38311100|FG001|Overall Study|Lost to Follow-up|0|||
17163116|NCT03247673|38311101|FG002|Overall Study|Lost to Follow-up|1|||
17083470|NCT00168844|38224060|FG000|Overall Study|Protocol Violation|2|||
17083471|NCT00168844|38224061|FG001|Overall Study|Protocol Violation|2|||
17083472|NCT00168844|38224062|FG002|Overall Study|Protocol Violation|4|||
17083473|NCT00168844|38224060|FG000|Overall Study|Other|6|||
17163117|NCT03247517|38311112|FG000|Overall Study|Adverse Event|0|||
17163118|NCT03247517|38311113|FG001|Overall Study|Adverse Event|4|||
17163119|NCT03247517|38311114|FG002|Overall Study|Adverse Event|2|||
17163120|NCT03247517|38311112|FG000|Overall Study|Lost to Follow-up|2|||
17163121|NCT03247517|38311113|FG001|Overall Study|Lost to Follow-up|6|||
17083474|NCT00168844|38224061|FG001|Overall Study|Other|7|||
17083475|NCT00168844|38224062|FG002|Overall Study|Other|9|||
17083476|NCT00365456|38224070|FG000|Trial Period I (12 Months)|Adverse Event|84|||
17083477|NCT00365456|38224071|FG001|Trial Period I (12 Months)|Adverse Event|0|||
17163122|NCT03247517|38311114|FG002|Overall Study|Lost to Follow-up|4|||
17163123|NCT03247517|38311112|FG000|Overall Study|Consent withdrawn by caregiver|1|||
17163124|NCT03247517|38311113|FG001|Overall Study|Consent withdrawn by caregiver|4|||
17163125|NCT03247517|38311114|FG002|Overall Study|Consent withdrawn by caregiver|7|||
17163126|NCT03247517|38311112|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
17163127|NCT03247517|38311113|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
17163128|NCT03247517|38311114|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
17163129|NCT03247517|38311112|FG000|Overall Study|Protocol Violation|0|||
17163130|NCT03247517|38311113|FG001|Overall Study|Protocol Violation|2|||
17163131|NCT03247517|38311114|FG002|Overall Study|Protocol Violation|0|||
17163132|NCT03247517|38311112|FG000|Overall Study|Multiple reasons|3|||
17163133|NCT03247517|38311113|FG001|Overall Study|Multiple reasons|1|||
17163134|NCT03247517|38311114|FG002|Overall Study|Multiple reasons|0|||
17163135|NCT03283553|38311124|FG000|Patient Participant Flow|Death|5|||
17083478|NCT00365456|38224070|FG000|Trial Period I (12 Months)|Non-compliance|3|||
17083479|NCT00365456|38224071|FG001|Trial Period I (12 Months)|Non-compliance|0|||
17083480|NCT00365456|38224070|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
17083481|NCT00365456|38224071|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
17083482|NCT00365456|38224070|FG000|Trial Period I (12 Months)|Other|11|||
17083483|NCT00365456|38224071|FG001|Trial Period I (12 Months)|Other|0|||
17083484|NCT00365456|38224070|FG000|Trial Period II (12 Months)|Adverse Event|0|||
17083485|NCT00365456|38224071|FG001|Trial Period II (12 Months)|Adverse Event|6|||
17083486|NCT00365456|38224070|FG000|Trial Period II (12 Months)|Non-compliance|0|||
17083487|NCT00365456|38224071|FG001|Trial Period II (12 Months)|Non-compliance|2|||
17083488|NCT00365456|38224070|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
17083489|NCT00365456|38224071|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
17083490|NCT00365456|38224070|FG000|Trial Period II (12 Months)|Other|0|||
17083491|NCT00365456|38224071|FG001|Trial Period II (12 Months)|Other|1|||
17083492|NCT00365456|38224070|FG000|Trial Period III (12 Months)|Adverse Event|13|||
17083493|NCT00365456|38224071|FG001|Trial Period III (12 Months)|Adverse Event|3|||
17083494|NCT00365456|38224070|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
17083495|NCT00365456|38224071|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
17083496|NCT00365456|38224070|FG000|Trial Period III (12 Months)|Other|1|||
17083497|NCT00365456|38224071|FG001|Trial Period III (12 Months)|Other|1|||
17083498|NCT00147238|38224077|FG000|Overall Study|Inevaluable|8|||
17083499|NCT00206427|38224081|FG000|Overall Study|Adverse Event|2|||
17083500|NCT00146848|38224088|FG000|Pre-randomization|Death|19|||
17083501|NCT00146848|38224089|FG001|Pre-randomization|Death|0|||
17083502|NCT00146848|38224090|FG002|Pre-randomization|Death|0|||
17083503|NCT00146848|38224088|FG000|Pre-randomization|Lost to Follow-up|70|||
17083504|NCT00146848|38224089|FG001|Pre-randomization|Lost to Follow-up|0|||
17083505|NCT00146848|38224090|FG002|Pre-randomization|Lost to Follow-up|0|||
17083506|NCT00146848|38224088|FG000|Pre-randomization|Physician Decision|8|||
17083507|NCT00146848|38224089|FG001|Pre-randomization|Physician Decision|0|||
17083508|NCT00146848|38224090|FG002|Pre-randomization|Physician Decision|0|||
17083509|NCT00146848|38224088|FG000|Pre-randomization|Protocol Violation|172|||
17083510|NCT00146848|38224089|FG001|Pre-randomization|Protocol Violation|0|||
17083511|NCT00146848|38224090|FG002|Pre-randomization|Protocol Violation|0|||
17083512|NCT00146848|38224088|FG000|Pre-randomization|Withdrawal by Subject|40|||
17083513|NCT00146848|38224089|FG001|Pre-randomization|Withdrawal by Subject|0|||
17083514|NCT00146848|38224090|FG002|Pre-randomization|Withdrawal by Subject|0|||
17083515|NCT00146848|38224088|FG000|Post-randomization|Lost to Follow-up|12|||
17083516|NCT00146848|38224089|FG001|Post-randomization|Lost to Follow-up|15|||
17083517|NCT00146848|38224090|FG002|Post-randomization|Lost to Follow-up|12|||
17083518|NCT00146848|38224088|FG000|Post-randomization|Withdrawn|26|||
17083519|NCT00146848|38224089|FG001|Post-randomization|Withdrawn|32|||
17083520|NCT00146848|38224090|FG002|Post-randomization|Withdrawn|27|||
17083521|NCT00205881|38224098|FG000|Overall Study|Withdrawal by Subject|16|||
17083522|NCT00365378|38224105|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
17083523|NCT00365378|38224106|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
17083524|NCT00365378|38224107|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
17083525|NCT00365378|38224105|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
17083526|NCT00365378|38224106|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
17083527|NCT00365378|38224107|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
17083528|NCT00365378|38224105|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
17083529|NCT00365378|38224106|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
17083530|NCT00365378|38224107|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
17083531|NCT00365378|38224105|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
17083532|NCT00365378|38224106|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
17083533|NCT00365378|38224107|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
17083534|NCT00365378|38224105|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
17083535|NCT00365378|38224106|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
17083536|NCT00365378|38224107|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
17083537|NCT00365378|38224105|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
17083538|NCT00365378|38224106|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
17083539|NCT00365378|38224107|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
17163136|NCT03283553|38311125|FG001|Patient Participant Flow|Death|10|||
17083540|NCT00365378|38224105|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
17083541|NCT00365378|38224106|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
17083542|NCT00365378|38224107|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
17083543|NCT00365378|38224105|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
17083544|NCT00365378|38224106|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
17083545|NCT00365378|38224107|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
17083546|NCT00365378|38224105|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
17083547|NCT00365378|38224106|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
17083548|NCT00365378|38224107|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
17083549|NCT00365378|38224105|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
17083550|NCT00365378|38224106|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
17083551|NCT00365378|38224107|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
17083552|NCT00365378|38224105|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
17083553|NCT00365378|38224106|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
17083554|NCT00365378|38224107|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
17083555|NCT00365378|38224105|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
17083556|NCT00365378|38224106|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
17083557|NCT00365378|38224107|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
17083558|NCT00365378|38224105|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
17083559|NCT00365378|38224106|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
17083560|NCT00365378|38224107|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
17083561|NCT00365378|38224105|FG000|Extension|Adverse Event|0|||
17083562|NCT00365378|38224106|FG001|Extension|Adverse Event|0|||
17083563|NCT00365378|38224107|FG002|Extension|Adverse Event|1|||
17083564|NCT00365378|38224105|FG000|Extension|Moved|0|||
17083565|NCT00365378|38224106|FG001|Extension|Moved|0|||
17083566|NCT00365378|38224107|FG002|Extension|Moved|8|||
17083567|NCT00365378|38224105|FG000|Extension|Lost to Follow-up|0|||
17083568|NCT00365378|38224106|FG001|Extension|Lost to Follow-up|0|||
17083569|NCT00365378|38224107|FG002|Extension|Lost to Follow-up|57|||
17083570|NCT00365378|38224105|FG000|Extension|Protocol Violation|0|||
17083571|NCT00365378|38224106|FG001|Extension|Protocol Violation|0|||
17083572|NCT00365378|38224107|FG002|Extension|Protocol Violation|2|||
17083573|NCT00365378|38224105|FG000|Extension|Withdrawal by Subject|0|||
17083574|NCT00365378|38224106|FG001|Extension|Withdrawal by Subject|0|||
17083575|NCT00365378|38224107|FG002|Extension|Withdrawal by Subject|98|||
17083576|NCT00365378|38224105|FG000|Extension|Other|0|||
17083577|NCT00365378|38224106|FG001|Extension|Other|0|||
17083578|NCT00365378|38224107|FG002|Extension|Other|31|||
17083579|NCT00389324|38224114|FG000|Run-In Phase|Adverse Event|1|||
17083580|NCT00389324|38224114|FG000|Run-In Phase|Lost to Follow-up|1|||
17083581|NCT00389324|38224114|FG000|Run-In Phase|Withdrawal by Subject|1|||
17083582|NCT00389324|38224114|FG000|Subcutaneous Phase|Adverse Event|2|||
17083583|NCT00389324|38224114|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
17083584|NCT00389324|38224114|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
17083585|NCT00389324|38224114|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
17083586|NCT00365300|38224123|FG000|Open-label Phase|Adverse Event|4|||
17083587|NCT00365300|38224124|FG001|Open-label Phase|Adverse Event|0|||
17163137|NCT03283553|38311124|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
17163138|NCT03283553|38311125|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
17163139|NCT03283553|38311124|FG000|Patient Participant Flow|Lost to Follow-up|1|||
17163140|NCT03283553|38311125|FG001|Patient Participant Flow|Lost to Follow-up|1|||
17163141|NCT03283553|38311124|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
17163142|NCT03283553|38311125|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
17163143|NCT03283553|38311124|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
17163144|NCT03283553|38311125|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
17163145|NCT03283553|38311124|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
17163146|NCT03283553|38311125|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
17163147|NCT03283319|38311139|FG000|Overall Study|Lost to Follow-up|5|||
17163148|NCT03283319|38311140|FG001|Overall Study|Lost to Follow-up|4|||
17163149|NCT03283319|38311141|FG002|Overall Study|Lost to Follow-up|5|||
17163150|NCT03283319|38311142|FG003|Overall Study|Lost to Follow-up|5|||
17163151|NCT03283319|38311143|FG004|Overall Study|Lost to Follow-up|4|||
17083588|NCT00365300|38224123|FG000|Open-label Phase|Failed to Return|1|||
17083589|NCT00365300|38224124|FG001|Open-label Phase|Failed to Return|0|||
17163152|NCT03283319|38311144|FG005|Overall Study|Lost to Follow-up|3|||
17163153|NCT03283319|38311139|FG000|Overall Study|Withdrawal by Subject|2|||
17163154|NCT03283319|38311140|FG001|Overall Study|Withdrawal by Subject|2|||
17163155|NCT03283319|38311141|FG002|Overall Study|Withdrawal by Subject|2|||
17163156|NCT03283319|38311142|FG003|Overall Study|Withdrawal by Subject|1|||
17083590|NCT00365300|38224123|FG000|Open-label Phase|Physician Decision|1|||
17083591|NCT00365300|38224124|FG001|Open-label Phase|Physician Decision|0|||
17083592|NCT00365300|38224123|FG000|Open-label Phase|Noncompliance|9|||
17083593|NCT00365300|38224124|FG001|Open-label Phase|Noncompliance|0|||
17083594|NCT00365300|38224123|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
17083595|NCT00365300|38224124|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
17163157|NCT03283319|38311143|FG004|Overall Study|Withdrawal by Subject|0|||
17163158|NCT03283319|38311144|FG005|Overall Study|Withdrawal by Subject|1|||
17163159|NCT03283319|38311139|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
17163160|NCT03283319|38311140|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
17163161|NCT03283319|38311141|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
17163162|NCT03283319|38311142|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
17163163|NCT03283319|38311143|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
17163164|NCT03283319|38311144|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
17163165|NCT03282227|38311158|FG000|Overall Study|Exposure Goals Achieved|60|||
17163166|NCT03282227|38311158|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
17163167|NCT03282227|38311158|FG000|Overall Study|Adverse Event|15|||
17163168|NCT03282227|38311158|FG000|Overall Study|Lost to Follow-up|21|||
17163169|NCT03282227|38311158|FG000|Overall Study|Withdrawal by Subject|20|||
17163170|NCT03282227|38311158|FG000|Overall Study|Lack of Efficacy|12|||
17163171|NCT03282227|38311158|FG000|Overall Study|Sponsor decision|3|||
17163172|NCT03282227|38311158|FG000|Overall Study|Physician Decision|2|||
17163173|NCT03282227|38311158|FG000|Overall Study|Pregnancy|2|||
17163174|NCT03282227|38311158|FG000|Overall Study|Other|1|||
17163175|NCT03240575|38311166|FG000|Overall Study|Adverse Event|0|||
17083596|NCT00365300|38224123|FG000|Open-label Phase|Protocol Violation|1|||
17083597|NCT00365300|38224124|FG001|Open-label Phase|Protocol Violation|0|||
17083598|NCT00365300|38224123|FG000|Open-label Phase|Lack of Efficacy|1|||
17083599|NCT00365300|38224124|FG001|Open-label Phase|Lack of Efficacy|0|||
17083600|NCT00365300|38224123|FG000|Open-label Phase|Patient skipped open label phase|1|||
17083601|NCT00365300|38224124|FG001|Open-label Phase|Patient skipped open label phase|0|||
17083602|NCT00365300|38224123|FG000|Double-blind Phase|Failed to return|1|||
17083603|NCT00365300|38224124|FG001|Double-blind Phase|Failed to return|0|||
17083604|NCT00365300|38224123|FG000|Double-blind Phase|Noncompliance|1|||
17083605|NCT00365300|38224124|FG001|Double-blind Phase|Noncompliance|1|||
17163176|NCT03240575|38311167|FG001|Overall Study|Adverse Event|2|||
17163177|NCT03240575|38311168|FG002|Overall Study|Adverse Event|0|||
17163178|NCT03240575|38311169|FG003|Overall Study|Adverse Event|1|||
17163179|NCT03240575|38311166|FG000|Overall Study|Withdrawal by Subject|2|||
17163180|NCT03240575|38311167|FG001|Overall Study|Withdrawal by Subject|11|||
17163181|NCT03240575|38311168|FG002|Overall Study|Withdrawal by Subject|0|||
17163182|NCT03240575|38311169|FG003|Overall Study|Withdrawal by Subject|1|||
17163183|NCT03240575|38311166|FG000|Overall Study|Other|0|||
17163184|NCT03240575|38311167|FG001|Overall Study|Other|1|||
17163185|NCT03240575|38311168|FG002|Overall Study|Other|0|||
17163186|NCT03240575|38311169|FG003|Overall Study|Other|0|||
17163187|NCT03385265|38311181|FG000|Overall Study|Withdrawal by Subject|5|||
17163188|NCT03385265|38311182|FG001|Overall Study|Withdrawal by Subject|2|||
17163189|NCT03385265|38311183|FG002|Overall Study|Withdrawal by Subject|5|||
17163190|NCT03385265|38311184|FG003|Overall Study|Withdrawal by Subject|2|||
17163191|NCT03280121|38311196|FG000|Overall Study|Physician Decision|1|||
17163192|NCT03280121|38311196|FG000|Overall Study|Lost to Follow-up|1|||
17163193|NCT03280121|38311196|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
17163194|NCT03233009|38311200|FG000|Overall Study|Lost to Follow-up|1|||
17163195|NCT04034225|38311215|FG000|Overall Study|Death|3|||
17163196|NCT04034225|38311215|FG000|Overall Study|Withdrawal by Subject|2|||
17163197|NCT04034225|38311215|FG000|Overall Study|Study termination by Sponsor|18|||
17163198|NCT04034225|38311215|FG000|Overall Study|Physician Decision|1|||
17163199|NCT04034225|38311215|FG000|Overall Study|Lack of Efficacy|1|||
17163200|NCT02999178|38311223|FG000|Overall Study|Adverse Event|85|||
17163201|NCT02999178|38311224|FG001|Overall Study|Adverse Event|62|||
17163202|NCT02999178|38311223|FG000|Overall Study|Protocol Violation|1|||
17163203|NCT02999178|38311224|FG001|Overall Study|Protocol Violation|2|||
17163204|NCT02999178|38311223|FG000|Overall Study|Lost to Follow-up|0|||
17163205|NCT02999178|38311224|FG001|Overall Study|Lost to Follow-up|2|||
17163206|NCT02999178|38311223|FG000|Overall Study|Withdrawal by Subject|21|||
17163207|NCT02999178|38311224|FG001|Overall Study|Withdrawal by Subject|21|||
17163208|NCT02999178|38311223|FG000|Overall Study|Other reason not defined above|7|||
17163209|NCT02999178|38311224|FG001|Overall Study|Other reason not defined above|13|||
17163210|NCT02959190|38311236|FG000|Open Label|Adverse Event|5|||
17163211|NCT02959190|38311237|FG001|Open Label|Adverse Event|7|||
17163212|NCT02959190|38311238|FG002|Open Label|Adverse Event|3|||
17163213|NCT02959190|38311239|FG003|Open Label|Adverse Event|4|||
17083606|NCT00365300|38224123|FG000|Double-blind Phase|Withdrawal by Subject|0|||
17163214|NCT02959190|38311236|FG000|Open Label|Pregnancy|0|||
17163215|NCT02959190|38311237|FG001|Open Label|Pregnancy|1|||
17163216|NCT02959190|38311238|FG002|Open Label|Pregnancy|0|||
17163217|NCT02959190|38311239|FG003|Open Label|Pregnancy|0|||
17163218|NCT02959190|38311236|FG000|Open Label|Withdrawal by Subject|2|||
17163219|NCT02959190|38311237|FG001|Open Label|Withdrawal by Subject|8|||
17163220|NCT02959190|38311238|FG002|Open Label|Withdrawal by Subject|0|||
17163221|NCT02959190|38311239|FG003|Open Label|Withdrawal by Subject|0|||
17163222|NCT02959190|38311236|FG000|Open Label|Physician Decision|0|||
17163223|NCT02959190|38311237|FG001|Open Label|Physician Decision|0|||
17163224|NCT02959190|38311238|FG002|Open Label|Physician Decision|1|||
17163225|NCT02959190|38311239|FG003|Open Label|Physician Decision|0|||
17163226|NCT02959190|38311236|FG000|Open Label|Protocol Violation|0|||
17163227|NCT02959190|38311237|FG001|Open Label|Protocol Violation|0|||
17163228|NCT02959190|38311238|FG002|Open Label|Protocol Violation|0|||
17163229|NCT02959190|38311239|FG003|Open Label|Protocol Violation|2|||
17163230|NCT02959190|38311236|FG000|Post Treatment Follow Up|Adverse Event|1|||
17163231|NCT02959190|38311237|FG001|Post Treatment Follow Up|Adverse Event|1|||
17083607|NCT00365300|38224124|FG001|Double-blind Phase|Withdrawal by Subject|1|||
17083608|NCT00365300|38224123|FG000|Double-blind Phase|Protocol Violation|3|||
17083609|NCT00365300|38224124|FG001|Double-blind Phase|Protocol Violation|1|||
17083610|NCT00365300|38224123|FG000|Double-blind Phase|Lack of Efficacy|6|||
17083611|NCT00365300|38224124|FG001|Double-blind Phase|Lack of Efficacy|6|||
17083612|NCT00370292|38224135|FG000|Overall Study|Disease Progression|4|||
17083613|NCT00370292|38224135|FG000|Overall Study|Adverse Event|7|||
17083614|NCT00370292|38224135|FG000|Overall Study|Physician Decision|2|||
17083615|NCT00369824|38224152|FG000|Overall Study|Adverse Event|0|||
17083616|NCT00369824|38224153|FG001|Overall Study|Adverse Event|2|||
17083617|NCT00369824|38224154|FG002|Overall Study|Adverse Event|0|||
17083618|NCT00369824|38224155|FG003|Overall Study|Adverse Event|0|||
17083619|NCT00369824|38224156|FG004|Overall Study|Adverse Event|1|||
17083620|NCT00369824|38224157|FG005|Overall Study|Adverse Event|0|||
17163232|NCT02959190|38311238|FG002|Post Treatment Follow Up|Adverse Event|0|||
17163233|NCT02959190|38311239|FG003|Post Treatment Follow Up|Adverse Event|0|||
17163234|NCT02959190|38311236|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
17163235|NCT02959190|38311237|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
17163236|NCT02959190|38311238|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
17163237|NCT02959190|38311239|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
17163238|NCT01344356|38311260|FG000|Overall Study|Physician Decision|0|||
17163239|NCT01344356|38311261|FG001|Overall Study|Physician Decision|3|||
17163240|NCT01344356|38311260|FG000|Overall Study|Lost to Follow-up|0|||
17163241|NCT01344356|38311261|FG001|Overall Study|Lost to Follow-up|6|||
17163242|NCT02956460|38311287|FG000|Lens 1|Lost to Follow-up|1|||
17163243|NCT02956460|38311288|FG001|Lens 1|Lost to Follow-up|0|||
17163244|NCT02999100|38311300|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
17163245|NCT02999100|38311301|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
17163246|NCT02999100|38311302|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
17163247|NCT02999100|38311303|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
17163248|NCT02999100|38311304|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
17163249|NCT02999100|38311305|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
17163250|NCT02999100|38311300|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
17163251|NCT02999100|38311301|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
17163252|NCT02999100|38311302|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
17163253|NCT02999100|38311303|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
17163254|NCT02999100|38311304|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
17163255|NCT02999100|38311305|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
17163256|NCT02999100|38311300|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
17163257|NCT02999100|38311301|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
17163258|NCT02999100|38311302|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
17163259|NCT02999100|38311303|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
17163260|NCT02999100|38311304|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
17163261|NCT02999100|38311305|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
17163262|NCT02749370|38311327|FG000|Overall Study|Withdrawal by Subject|11|||
17163263|NCT02749370|38311327|FG000|Overall Study|Lost to Follow-up|3|||
17163264|NCT04516746|38311333|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
17163265|NCT04516746|38311334|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
17163266|NCT04516746|38311333|FG000|Overall Study|Withdrawal by Subject|362|||
17163267|NCT04516746|38311334|FG001|Overall Study|Withdrawal by Subject|408|||
17163268|NCT04516746|38311333|FG000|Overall Study|Lost to Follow-up|157|||
17163269|NCT04516746|38311334|FG001|Overall Study|Lost to Follow-up|86|||
17163270|NCT04516746|38311333|FG000|Overall Study|Protocol deviation|18|||
17163271|NCT04516746|38311334|FG001|Overall Study|Protocol deviation|7|||
17163272|NCT04516746|38311333|FG000|Overall Study|Death|8|||
17163273|NCT04516746|38311334|FG001|Overall Study|Death|7|||
17163274|NCT04516746|38311333|FG000|Overall Study|Physician Decision|0|||
17163275|NCT04516746|38311334|FG001|Overall Study|Physician Decision|2|||
17163276|NCT04516746|38311333|FG000|Overall Study|Other|0|||
17163277|NCT04516746|38311334|FG001|Overall Study|Other|1|||
17163278|NCT03607994|38311342|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
17083621|NCT00369824|38224152|FG000|Overall Study|Protocol Violation|0|||
17163279|NCT03607994|38311343|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
17163280|NCT02996682|38311351|FG000|Overall Study|Death|0|||
17163281|NCT02996682|38311352|FG001|Overall Study|Death|3|||
17163282|NCT02873702|38311360|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
17163283|NCT02873702|38311361|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
17163284|NCT02873702|38311362|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
17163285|NCT02873702|38311363|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
17163286|NCT02873702|38311360|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
17163287|NCT02873702|38311361|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
17163288|NCT02873702|38311362|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
17163289|NCT02873702|38311363|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
17163290|NCT02873702|38311360|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
17163291|NCT02873702|38311361|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
17163292|NCT02873702|38311362|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
17163293|NCT02873702|38311363|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
17163294|NCT02873702|38311360|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
17163295|NCT02873702|38311361|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
17163296|NCT02873702|38311362|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
17163297|NCT02873702|38311363|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
17163298|NCT02873702|38311360|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
17163299|NCT02873702|38311361|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
17163300|NCT02873702|38311362|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
17163301|NCT02873702|38311363|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
17163302|NCT02911116|38311375|FG000|Overall Study|Insufficient Therapeutic Response|1|||
17163303|NCT02911116|38311376|FG001|Overall Study|Insufficient Therapeutic Response|0|||
17163304|NCT02911116|38311375|FG000|Overall Study|Lost to Follow-up|0|||
17163305|NCT02911116|38311376|FG001|Overall Study|Lost to Follow-up|1|||
17163306|NCT02998554|38311384|FG000|Overall Study|Adverse Event|8|||
17163307|NCT02998554|38311385|FG001|Overall Study|Adverse Event|3|||
17163308|NCT02998554|38311384|FG000|Overall Study|Protocol deviation|1|||
17163309|NCT02998554|38311385|FG001|Overall Study|Protocol deviation|0|||
17163310|NCT02998554|38311384|FG000|Overall Study|Withdrawal by Subject|2|||
17163311|NCT02998554|38311385|FG001|Overall Study|Withdrawal by Subject|6|||
17163312|NCT02998554|38311384|FG000|Overall Study|Lost to Follow-up|0|||
17083622|NCT00369824|38224153|FG001|Overall Study|Protocol Violation|1|||
17083623|NCT00369824|38224154|FG002|Overall Study|Protocol Violation|0|||
17083624|NCT00369824|38224155|FG003|Overall Study|Protocol Violation|1|||
17083625|NCT00369824|38224156|FG004|Overall Study|Protocol Violation|1|||
17083626|NCT00369824|38224157|FG005|Overall Study|Protocol Violation|0|||
17083627|NCT00369824|38224152|FG000|Overall Study|Withdrawal by Subject|9|||
17083628|NCT00369824|38224153|FG001|Overall Study|Withdrawal by Subject|5|||
17083629|NCT00369824|38224154|FG002|Overall Study|Withdrawal by Subject|5|||
17083630|NCT00369824|38224155|FG003|Overall Study|Withdrawal by Subject|4|||
17083631|NCT00369824|38224156|FG004|Overall Study|Withdrawal by Subject|6|||
17083632|NCT00369824|38224157|FG005|Overall Study|Withdrawal by Subject|2|||
17083633|NCT00369824|38224152|FG000|Overall Study|Lost to Follow-up|6|||
17083634|NCT00369824|38224153|FG001|Overall Study|Lost to Follow-up|11|||
17083635|NCT00369824|38224154|FG002|Overall Study|Lost to Follow-up|7|||
17083636|NCT00369824|38224155|FG003|Overall Study|Lost to Follow-up|8|||
17083637|NCT00369824|38224156|FG004|Overall Study|Lost to Follow-up|9|||
17083638|NCT00369824|38224157|FG005|Overall Study|Lost to Follow-up|6|||
17083639|NCT00369824|38224152|FG000|Overall Study|Other|0|||
17083640|NCT00369824|38224153|FG001|Overall Study|Other|0|||
17083641|NCT00369824|38224154|FG002|Overall Study|Other|0|||
17083642|NCT00369824|38224155|FG003|Overall Study|Other|2|||
17083643|NCT00369824|38224156|FG004|Overall Study|Other|1|||
17083644|NCT00369824|38224157|FG005|Overall Study|Other|3|||
17083645|NCT00369668|38224174|FG000|Overall Study|Lack of Efficacy|4|||
17083646|NCT00369668|38224175|FG001|Overall Study|Lack of Efficacy|5|||
17083647|NCT00369668|38224176|FG002|Overall Study|Lack of Efficacy|7|||
17083648|NCT00388154|38224187|FG000|Overall Study|Withdrawal by Subject|1|||
17083649|NCT00387764|38224191|FG000|Overall Study|Adverse Event|12|||
17083650|NCT00387764|38224191|FG000|Overall Study|Withdrawal by Subject|8|||
17083651|NCT00387764|38224191|FG000|Overall Study|Sponsor Terminated Study|1|||
17083652|NCT00387764|38224191|FG000|Overall Study|Physician Decision|1|||
17083653|NCT00387764|38224191|FG000|Overall Study|Other|2|||
17083654|NCT00387764|38224191|FG000|Overall Study|Death|7|||
17083655|NCT00386360|38224197|FG000|Overall Study|Adverse Event|4|||
17083656|NCT00386360|38224198|FG001|Overall Study|Adverse Event|2|||
17083657|NCT00386360|38224197|FG000|Overall Study|Physician Decision|2|||
17083658|NCT00386360|38224198|FG001|Overall Study|Physician Decision|2|||
17083659|NCT00386360|38224197|FG000|Overall Study|Lost to Follow-up|0|||
17083660|NCT00386360|38224198|FG001|Overall Study|Lost to Follow-up|2|||
17083661|NCT00386360|38224197|FG000|Overall Study|Protocol Violation|0|||
17083662|NCT00386360|38224198|FG001|Overall Study|Protocol Violation|3|||
17083663|NCT00386360|38224197|FG000|Overall Study|Withdrawal by Subject|3|||
17083664|NCT00386360|38224198|FG001|Overall Study|Withdrawal by Subject|6|||
17083665|NCT00386360|38224197|FG000|Overall Study|Did not take any study medication|0|||
17083666|NCT00386360|38224198|FG001|Overall Study|Did not take any study medication|2|||
17083667|NCT00369278|38224206|FG000|Overall Study|Adverse Event|14|||
17163313|NCT02998554|38311385|FG001|Overall Study|Lost to Follow-up|1|||
17163314|NCT02998554|38311384|FG000|Overall Study|Lack of Efficacy|0|||
17163315|NCT02998554|38311385|FG001|Overall Study|Lack of Efficacy|1|||
17163316|NCT02996448|38311393|FG000|Overall Study|Study terminated due to adverse effects|3|||
17163317|NCT02995980|38311398|FG000|Overall Study|Lost to Follow-up|14|||
17163318|NCT02872142|38311403|FG000|Overall Study|Adverse Event|2|||
17163319|NCT02872142|38311403|FG000|Overall Study|Death|1|||
17163320|NCT02872142|38311403|FG000|Overall Study|Participant Decision|3|||
17163321|NCT02994654|38311407|FG000|Overall Study|Lost to Follow-up|1|||
17163322|NCT02870972|38311417|FG000|Overall Study|Adverse Event|1|||
17163323|NCT02870972|38311418|FG001|Overall Study|Adverse Event|0|||
17163324|NCT02870972|38311419|FG002|Overall Study|Adverse Event|0|||
17163325|NCT02870972|38311420|FG003|Overall Study|Adverse Event|0|||
17163326|NCT02870972|38311421|FG004|Overall Study|Adverse Event|0|||
17163327|NCT03214367|38311441|FG000|Lead-in Period|Withdrawal by Subject|50|||
17163328|NCT03214367|38311442|FG001|Lead-in Period|Withdrawal by Subject|0|||
17163329|NCT03214367|38311443|FG002|Lead-in Period|Withdrawal by Subject|0|||
17163330|NCT03214367|38311444|FG003|Lead-in Period|Withdrawal by Subject|0|||
17163331|NCT03214367|38311445|FG004|Lead-in Period|Withdrawal by Subject|2|||
17163332|NCT03214367|38311446|FG005|Lead-in Period|Withdrawal by Subject|0|||
17163333|NCT03214367|38311447|FG006|Lead-in Period|Withdrawal by Subject|0|||
17163334|NCT03214367|38311448|FG007|Lead-in Period|Withdrawal by Subject|0|||
17163335|NCT03214367|38311441|FG000|Lead-in Period|Adverse Event|3|||
17163336|NCT03214367|38311442|FG001|Lead-in Period|Adverse Event|0|||
17163337|NCT03214367|38311443|FG002|Lead-in Period|Adverse Event|0|||
17163338|NCT03214367|38311444|FG003|Lead-in Period|Adverse Event|0|||
17163339|NCT03214367|38311445|FG004|Lead-in Period|Adverse Event|0|||
17163340|NCT03214367|38311446|FG005|Lead-in Period|Adverse Event|0|||
17163341|NCT03214367|38311447|FG006|Lead-in Period|Adverse Event|0|||
17163342|NCT03214367|38311448|FG007|Lead-in Period|Adverse Event|0|||
17163343|NCT03214367|38311441|FG000|Lead-in Period|Lost to Follow-up|12|||
17163344|NCT03214367|38311442|FG001|Lead-in Period|Lost to Follow-up|0|||
17163345|NCT03214367|38311443|FG002|Lead-in Period|Lost to Follow-up|0|||
17163346|NCT03214367|38311444|FG003|Lead-in Period|Lost to Follow-up|0|||
17163347|NCT03214367|38311445|FG004|Lead-in Period|Lost to Follow-up|0|||
17163348|NCT03214367|38311446|FG005|Lead-in Period|Lost to Follow-up|0|||
17163349|NCT03214367|38311447|FG006|Lead-in Period|Lost to Follow-up|0|||
17163350|NCT03214367|38311448|FG007|Lead-in Period|Lost to Follow-up|0|||
17163351|NCT03214367|38311441|FG000|Lead-in Period|Sponsor Decision|11|||
17163352|NCT03214367|38311442|FG001|Lead-in Period|Sponsor Decision|0|||
17163353|NCT03214367|38311443|FG002|Lead-in Period|Sponsor Decision|0|||
17163354|NCT03214367|38311444|FG003|Lead-in Period|Sponsor Decision|0|||
17163355|NCT03214367|38311445|FG004|Lead-in Period|Sponsor Decision|0|||
17163356|NCT03214367|38311446|FG005|Lead-in Period|Sponsor Decision|0|||
17163357|NCT03214367|38311447|FG006|Lead-in Period|Sponsor Decision|0|||
17163358|NCT03214367|38311448|FG007|Lead-in Period|Sponsor Decision|0|||
17163359|NCT03214367|38311441|FG000|Lead-in Period|Physician Decision|12|||
17163360|NCT03214367|38311442|FG001|Lead-in Period|Physician Decision|0|||
17163361|NCT03214367|38311443|FG002|Lead-in Period|Physician Decision|0|||
17163362|NCT03214367|38311444|FG003|Lead-in Period|Physician Decision|0|||
17163363|NCT03214367|38311445|FG004|Lead-in Period|Physician Decision|0|||
17163364|NCT03214367|38311446|FG005|Lead-in Period|Physician Decision|0|||
17163365|NCT03214367|38311447|FG006|Lead-in Period|Physician Decision|0|||
17163366|NCT03214367|38311448|FG007|Lead-in Period|Physician Decision|0|||
17163367|NCT03214367|38311441|FG000|Lead-in Period|Protocol Violation|5|||
17163368|NCT03214367|38311442|FG001|Lead-in Period|Protocol Violation|0|||
17163369|NCT03214367|38311443|FG002|Lead-in Period|Protocol Violation|0|||
17163370|NCT03214367|38311444|FG003|Lead-in Period|Protocol Violation|0|||
17163371|NCT03214367|38311445|FG004|Lead-in Period|Protocol Violation|0|||
17163372|NCT03214367|38311446|FG005|Lead-in Period|Protocol Violation|0|||
17163373|NCT03214367|38311447|FG006|Lead-in Period|Protocol Violation|0|||
17163374|NCT03214367|38311448|FG007|Lead-in Period|Protocol Violation|0|||
17163375|NCT03214367|38311441|FG000|Lead-in Period|Treatment Interruption|1|||
17163376|NCT03214367|38311442|FG001|Lead-in Period|Treatment Interruption|0|||
17163377|NCT03214367|38311443|FG002|Lead-in Period|Treatment Interruption|0|||
17163378|NCT03214367|38311444|FG003|Lead-in Period|Treatment Interruption|0|||
17163379|NCT03214367|38311445|FG004|Lead-in Period|Treatment Interruption|0|||
17163380|NCT03214367|38311446|FG005|Lead-in Period|Treatment Interruption|0|||
17163381|NCT03214367|38311447|FG006|Lead-in Period|Treatment Interruption|0|||
17163382|NCT03214367|38311448|FG007|Lead-in Period|Treatment Interruption|0|||
17163383|NCT03214367|38311441|FG000|Treatment Period|Adverse Event|0|||
17163384|NCT03214367|38311442|FG001|Treatment Period|Adverse Event|1|||
17163385|NCT03214367|38311443|FG002|Treatment Period|Adverse Event|4|||
17163386|NCT03214367|38311444|FG003|Treatment Period|Adverse Event|2|||
17163387|NCT03214367|38311445|FG004|Treatment Period|Adverse Event|0|||
17163388|NCT03214367|38311446|FG005|Treatment Period|Adverse Event|0|||
17163389|NCT03214367|38311447|FG006|Treatment Period|Adverse Event|0|||
17163390|NCT03214367|38311448|FG007|Treatment Period|Adverse Event|0|||
17163391|NCT03214367|38311441|FG000|Treatment Period|Death|0|||
17163392|NCT03214367|38311442|FG001|Treatment Period|Death|1|||
17163393|NCT03214367|38311443|FG002|Treatment Period|Death|1|||
17163394|NCT03214367|38311444|FG003|Treatment Period|Death|1|||
17163395|NCT03214367|38311445|FG004|Treatment Period|Death|0|||
17163396|NCT03214367|38311446|FG005|Treatment Period|Death|0|||
17163397|NCT03214367|38311447|FG006|Treatment Period|Death|0|||
17163398|NCT03214367|38311448|FG007|Treatment Period|Death|0|||
17163399|NCT03214367|38311441|FG000|Treatment Period|Lost to Follow-up|0|||
17163400|NCT03214367|38311442|FG001|Treatment Period|Lost to Follow-up|5|||
17163401|NCT03214367|38311443|FG002|Treatment Period|Lost to Follow-up|3|||
17163402|NCT03214367|38311444|FG003|Treatment Period|Lost to Follow-up|2|||
17163403|NCT03214367|38311445|FG004|Treatment Period|Lost to Follow-up|0|||
17163404|NCT03214367|38311446|FG005|Treatment Period|Lost to Follow-up|2|||
17163405|NCT03214367|38311447|FG006|Treatment Period|Lost to Follow-up|1|||
17163406|NCT03214367|38311448|FG007|Treatment Period|Lost to Follow-up|0|||
17163407|NCT03214367|38311441|FG000|Treatment Period|Sponsor Decision|0|||
17163408|NCT03214367|38311442|FG001|Treatment Period|Sponsor Decision|3|||
17163409|NCT03214367|38311443|FG002|Treatment Period|Sponsor Decision|0|||
17163410|NCT03214367|38311444|FG003|Treatment Period|Sponsor Decision|0|||
17163411|NCT03214367|38311445|FG004|Treatment Period|Sponsor Decision|0|||
17163412|NCT03214367|38311446|FG005|Treatment Period|Sponsor Decision|0|||
17163413|NCT03214367|38311447|FG006|Treatment Period|Sponsor Decision|0|||
17163414|NCT03214367|38311448|FG007|Treatment Period|Sponsor Decision|0|||
17163415|NCT03214367|38311441|FG000|Treatment Period|Physician Decision|0|||
17163416|NCT03214367|38311442|FG001|Treatment Period|Physician Decision|1|||
17163417|NCT03214367|38311443|FG002|Treatment Period|Physician Decision|2|||
17163418|NCT03214367|38311444|FG003|Treatment Period|Physician Decision|0|||
17163419|NCT03214367|38311445|FG004|Treatment Period|Physician Decision|0|||
17163420|NCT03214367|38311446|FG005|Treatment Period|Physician Decision|0|||
17163421|NCT03214367|38311447|FG006|Treatment Period|Physician Decision|0|||
17163422|NCT03214367|38311448|FG007|Treatment Period|Physician Decision|0|||
17163423|NCT03214367|38311441|FG000|Treatment Period|Protocol Violation|0|||
17163424|NCT03214367|38311442|FG001|Treatment Period|Protocol Violation|3|||
17163425|NCT03214367|38311443|FG002|Treatment Period|Protocol Violation|0|||
17163426|NCT03214367|38311444|FG003|Treatment Period|Protocol Violation|0|||
17163427|NCT03214367|38311445|FG004|Treatment Period|Protocol Violation|0|||
17163428|NCT03214367|38311446|FG005|Treatment Period|Protocol Violation|0|||
17163429|NCT03214367|38311447|FG006|Treatment Period|Protocol Violation|0|||
17163430|NCT03214367|38311448|FG007|Treatment Period|Protocol Violation|0|||
17163431|NCT03214367|38311441|FG000|Treatment Period|Withdrawal by Subject|0|||
17163432|NCT03214367|38311442|FG001|Treatment Period|Withdrawal by Subject|20|||
17163433|NCT03214367|38311443|FG002|Treatment Period|Withdrawal by Subject|23|||
17163434|NCT03214367|38311444|FG003|Treatment Period|Withdrawal by Subject|14|||
17163435|NCT03214367|38311445|FG004|Treatment Period|Withdrawal by Subject|0|||
17163436|NCT03214367|38311446|FG005|Treatment Period|Withdrawal by Subject|1|||
17163437|NCT03214367|38311447|FG006|Treatment Period|Withdrawal by Subject|1|||
17163438|NCT03214367|38311448|FG007|Treatment Period|Withdrawal by Subject|1|||
17163439|NCT02994108|38311464|FG000|Intervention Messages|Withdrawal by Subject|2|||
17163440|NCT02994108|38311465|FG001|Intervention Messages|Withdrawal by Subject|0|||
17163441|NCT02994108|38311464|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
17163442|NCT02994108|38311465|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
17163443|NCT02994108|38311464|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
17163444|NCT02994108|38311465|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
17163445|NCT02994108|38311464|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
17163446|NCT02994108|38311465|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
17163447|NCT03231371|38311472|FG000|Overall Study|Withdrawal by Subject|1|||
17083668|NCT00369278|38224207|FG001|Overall Study|Adverse Event|11|||
17083669|NCT00369278|38224206|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
17083670|NCT00369278|38224207|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
17083671|NCT00369278|38224206|FG000|Overall Study|Protocol Violation|2|||
17083672|NCT00369278|38224207|FG001|Overall Study|Protocol Violation|1|||
17083673|NCT00369278|38224206|FG000|Overall Study|Withdrawal by Subject|2|||
17083674|NCT00369278|38224207|FG001|Overall Study|Withdrawal by Subject|2|||
17163448|NCT03231371|38311472|FG000|Overall Study|chose or were ineligible to have MRI|12|||
17163449|NCT02870348|38311476|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
17163450|NCT03239873|38311482|FG000|Overall Study|Lost to Follow-up|15|||
17163451|NCT03239873|38311483|FG001|Overall Study|Lost to Follow-up|16|||
17163452|NCT03239873|38311482|FG000|Overall Study|Physician Decision|1|||
17163453|NCT03239873|38311483|FG001|Overall Study|Physician Decision|0|||
17163454|NCT03239873|38311482|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
17163455|NCT03239873|38311483|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
17163456|NCT03239873|38311482|FG000|Overall Study|Withdrawal by Subject|2|||
17163457|NCT03239873|38311483|FG001|Overall Study|Withdrawal by Subject|0|||
17083675|NCT00369278|38224206|FG000|Overall Study|Lost to Follow-up|1|||
17163458|NCT03239873|38311482|FG000|Overall Study|Contraindication to study medication|1|||
17163459|NCT03239873|38311483|FG001|Overall Study|Contraindication to study medication|0|||
17163460|NCT03239873|38311482|FG000|Overall Study|Protocol Violation|1|||
17163461|NCT03239873|38311483|FG001|Overall Study|Protocol Violation|0|||
17083676|NCT00369278|38224207|FG001|Overall Study|Lost to Follow-up|0|||
17083677|NCT00369278|38224206|FG000|Overall Study|Graft loss|1|||
17083678|NCT00369278|38224207|FG001|Overall Study|Graft loss|2|||
17083679|NCT00529373|38224215|FG000|Base Study|Adverse Event|525|||
17083680|NCT00529373|38224216|FG001|Base Study|Adverse Event|470|||
17083681|NCT00529373|38224215|FG000|Base Study|Lack of Efficacy|16|||
17083682|NCT00529373|38224216|FG001|Base Study|Lack of Efficacy|75|||
17083683|NCT00529373|38224215|FG000|Base Study|Lost to Follow-up|221|||
17083684|NCT00529373|38224216|FG001|Base Study|Lost to Follow-up|208|||
17083685|NCT00529373|38224215|FG000|Base Study|Other Protocol Specified Criteria|19|||
17163462|NCT03213509|38311491|FG000|Overall Study|Did not consent for verbal autopsy|4|||
17163463|NCT03213509|38311492|FG001|Overall Study|Did not consent for verbal autopsy|5|||
17163464|NCT03239483|38311501|FG000|Overall Study|Lost to Follow-up|1|||
17163465|NCT03239483|38311502|FG001|Overall Study|Lost to Follow-up|0|||
17163466|NCT03239483|38311501|FG000|Overall Study|Withdrawal by Subject|1|||
17163467|NCT03239483|38311502|FG001|Overall Study|Withdrawal by Subject|0|||
17163468|NCT02868554|38311511|FG000|Overall Study|Lost to Follow-up|3|||
17163469|NCT02868554|38311512|FG001|Overall Study|Lost to Follow-up|0|||
17163470|NCT02868554|38311513|FG002|Overall Study|Lost to Follow-up|1|||
17163471|NCT01068912|38311524|FG000|Overall Study|Adverse Event|2|||
17163472|NCT01068912|38311525|FG001|Overall Study|Adverse Event|3|||
17163473|NCT01068912|38311526|FG002|Overall Study|Adverse Event|2|||
17163474|NCT01068912|38311524|FG000|Overall Study|Withdrawal by Subject|5|||
17163475|NCT01068912|38311525|FG001|Overall Study|Withdrawal by Subject|6|||
17163476|NCT01068912|38311526|FG002|Overall Study|Withdrawal by Subject|6|||
17163477|NCT01068912|38311524|FG000|Overall Study|Lost to Follow-up|3|||
17163478|NCT01068912|38311525|FG001|Overall Study|Lost to Follow-up|7|||
17163479|NCT01068912|38311526|FG002|Overall Study|Lost to Follow-up|3|||
17163480|NCT01068912|38311524|FG000|Overall Study|Protocol Violation|0|||
17163481|NCT01068912|38311525|FG001|Overall Study|Protocol Violation|2|||
17163482|NCT01068912|38311526|FG002|Overall Study|Protocol Violation|0|||
17163483|NCT01068912|38311524|FG000|Overall Study|aggravation influenza|1|||
17163484|NCT01068912|38311525|FG001|Overall Study|aggravation influenza|1|||
17163485|NCT01068912|38311526|FG002|Overall Study|aggravation influenza|1|||
17163486|NCT01068912|38311524|FG000|Overall Study|other underlying illness|0|||
17163487|NCT01068912|38311525|FG001|Overall Study|other underlying illness|3|||
17163488|NCT01068912|38311526|FG002|Overall Study|other underlying illness|3|||
17163489|NCT03229109|38311538|FG000|Overall Study|Withdrawal by Subject|0|||
17163490|NCT03229109|38311539|FG001|Overall Study|Withdrawal by Subject|0|||
17163491|NCT03229109|38311540|FG002|Overall Study|Withdrawal by Subject|0|||
17163492|NCT03229109|38311541|FG003|Overall Study|Withdrawal by Subject|1|||
17163493|NCT03212261|38311551|FG000|Overall Study|Became ineligible d/t tech|2|||
17163494|NCT03212261|38311551|FG000|Overall Study|Tech Trouble- No first study visit|1|||
17163495|NCT03212261|38311551|FG000|Overall Study|Lost to Follow-up|7|||
17163496|NCT03212261|38311551|FG000|Overall Study|Family Emergency|1|||
17163497|NCT03212261|38311551|FG000|Overall Study|Too busy/ No time|5|||
17163498|NCT02993250|38311558|FG000|Overall Study|Lost to Follow-up|0|||
17083686|NCT00529373|38224216|FG001|Base Study|Other Protocol Specified Criteria|20|||
17083687|NCT00529373|38224215|FG000|Base Study|Physician Decision|60|||
17083688|NCT00529373|38224216|FG001|Base Study|Physician Decision|52|||
17083689|NCT00529373|38224215|FG000|Base Study|Protocol Violation|48|||
17083690|NCT00529373|38224216|FG001|Base Study|Protocol Violation|38|||
17083691|NCT00529373|38224215|FG000|Base Study|Withdrawal by Subject|1062|||
17083692|NCT00529373|38224216|FG001|Base Study|Withdrawal by Subject|967|||
17083693|NCT00529373|38224215|FG000|Base Study|Did not continue into Extension|1795|||
17083694|NCT00529373|38224216|FG001|Base Study|Did not continue into Extension|2238|||
17083695|NCT00529373|38224215|FG000|First Extension Study|Adverse Event|162|||
17083696|NCT00529373|38224216|FG001|First Extension Study|Adverse Event|142|||
17083697|NCT00529373|38224215|FG000|First Extension Study|Lack of Efficacy|65|||
17083698|NCT00529373|38224216|FG001|First Extension Study|Lack of Efficacy|427|||
17083699|NCT00529373|38224215|FG000|First Extension Study|Lost to Follow-up|41|||
17083700|NCT00529373|38224216|FG001|First Extension Study|Lost to Follow-up|37|||
17083701|NCT00529373|38224215|FG000|First Extension Study|Other|27|||
17083702|NCT00529373|38224216|FG001|First Extension Study|Other|47|||
17083703|NCT00529373|38224215|FG000|First Extension Study|Physician Decision|50|||
17163499|NCT02993250|38311559|FG001|Overall Study|Lost to Follow-up|1|||
17163500|NCT02989194|38311568|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
17163501|NCT02989194|38311569|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
17163502|NCT02989194|38311570|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
17163503|NCT02989194|38311568|FG000|Overall Study|Lost to Follow-up|0|||
17163504|NCT02989194|38311569|FG001|Overall Study|Lost to Follow-up|1|||
17163505|NCT02989194|38311570|FG002|Overall Study|Lost to Follow-up|0|||
17083704|NCT00529373|38224216|FG001|First Extension Study|Physician Decision|45|||
17083705|NCT00529373|38224215|FG000|First Extension Study|Protocol Violation|16|||
17083706|NCT00529373|38224216|FG001|First Extension Study|Protocol Violation|13|||
17083707|NCT00529373|38224215|FG000|First Extension Study|Withdrawal by Subject|296|||
17163506|NCT02989194|38311568|FG000|Overall Study|Withdrawal by Subject|0|||
17163507|NCT02989194|38311569|FG001|Overall Study|Withdrawal by Subject|1|||
17163508|NCT02989194|38311570|FG002|Overall Study|Withdrawal by Subject|0|||
17163509|NCT02990910|38311591|FG000|Overall Study|Lack of Efficacy|6|||
17163510|NCT02990910|38311592|FG001|Overall Study|Lack of Efficacy|10|||
17163511|NCT03227861|38311598|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
17163512|NCT03227861|38311598|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
17083708|NCT00529373|38224216|FG001|First Extension Study|Withdrawal by Subject|287|||
17083709|NCT00529373|38224215|FG000|First Extension Study|Disposition record non-existing|0|||
17083710|NCT00529373|38224216|FG001|First Extension Study|Disposition record non-existing|1|||
17083711|NCT00529373|38224215|FG000|First Extension Study|Discontinued after 5 years completion|208|||
17083712|NCT00529373|38224216|FG001|First Extension Study|Discontinued after 5 years completion|346|||
17083713|NCT00529373|38224215|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
17163513|NCT03227861|38311598|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
17163514|NCT03227861|38311598|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
17163515|NCT03227861|38311598|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
17163516|NCT03227861|38311598|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
17163517|NCT03227861|38311598|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
17163518|NCT03227861|38311598|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
17163519|NCT03227861|38311598|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
17163520|NCT03227861|38311598|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
17163521|NCT01336712|38311604|FG000|Overall Study|Death|2|||
17163522|NCT01336712|38311604|FG000|Overall Study|Lack of Efficacy|1|||
17163523|NCT03208127|38311608|FG000|Overall Study|Death|1|||
17163524|NCT02865122|38311615|FG000|Overall Study|Adverse Event|1|||
17163525|NCT02865122|38311616|FG001|Overall Study|Adverse Event|0|||
17163526|NCT02865122|38311617|FG002|Overall Study|Adverse Event|0|||
17163527|NCT02864498|38311628|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
17163528|NCT02864498|38311629|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
17163529|NCT02864498|38311630|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
17163530|NCT02864498|38311628|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
17163531|NCT02864498|38311629|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
17163532|NCT02864498|38311630|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
17163533|NCT02864498|38311628|FG000|Overall Study|Investigator Discretion|0|||
17163534|NCT02864498|38311629|FG001|Overall Study|Investigator Discretion|2|||
17163535|NCT02864498|38311630|FG002|Overall Study|Investigator Discretion|1|||
17163536|NCT02864498|38311628|FG000|Overall Study|Lost to Follow-up|8|||
17163537|NCT02864498|38311629|FG001|Overall Study|Lost to Follow-up|6|||
17163538|NCT02864498|38311630|FG002|Overall Study|Lost to Follow-up|3|||
17163539|NCT02864498|38311628|FG000|Overall Study|Lack of Efficacy|5|||
17163540|NCT02864498|38311629|FG001|Overall Study|Lack of Efficacy|3|||
17163541|NCT02864498|38311630|FG002|Overall Study|Lack of Efficacy|3|||
17163542|NCT02864498|38311628|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
17163543|NCT02864498|38311629|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
17163544|NCT02864498|38311630|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
17163545|NCT02864498|38311628|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
17163546|NCT02864498|38311629|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
17163547|NCT02864498|38311630|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
17163548|NCT02864498|38311628|FG000|Overall Study|Subject moved out of the country.|0|||
17163549|NCT02864498|38311629|FG001|Overall Study|Subject moved out of the country.|0|||
17163550|NCT02864498|38311630|FG002|Overall Study|Subject moved out of the country.|1|||
17163551|NCT03238781|38311641|FG000|Overall Study|Adverse Event|1|||
17163552|NCT03238781|38311642|FG001|Overall Study|Adverse Event|1|||
17163553|NCT03238781|38311643|FG002|Overall Study|Adverse Event|2|||
17163554|NCT03238781|38311641|FG000|Overall Study|Lost to Follow-up|2|||
17163555|NCT03238781|38311642|FG001|Overall Study|Lost to Follow-up|1|||
17163556|NCT03238781|38311643|FG002|Overall Study|Lost to Follow-up|2|||
17163557|NCT03238781|38311641|FG000|Overall Study|Withdrawal by Subject|23|||
17163558|NCT03238781|38311642|FG001|Overall Study|Withdrawal by Subject|14|||
17163559|NCT03238781|38311643|FG002|Overall Study|Withdrawal by Subject|16|||
17163560|NCT03238781|38311641|FG000|Overall Study|Decision by sponsor|0|||
17163561|NCT03238781|38311642|FG001|Overall Study|Decision by sponsor|1|||
17163562|NCT03238781|38311643|FG002|Overall Study|Decision by sponsor|0|||
17163563|NCT02097121|38311654|FG000|Overall Study|Other, not specified|4|||
16781301|NCT02105974|37720454|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
17083714|NCT00529373|38224216|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
17083715|NCT00529373|38224215|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
17083716|NCT00529373|38224216|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
17083717|NCT00529373|38224215|FG000|Second Extension Study|Adverse Event|101|||
17163564|NCT02097121|38311655|FG001|Overall Study|Other, not specified|2|||
17163565|NCT02097121|38311656|FG002|Overall Study|Other, not specified|3|||
17163566|NCT02097121|38311654|FG000|Overall Study|Lack of Efficacy|2|||
17163567|NCT02097121|38311655|FG001|Overall Study|Lack of Efficacy|1|||
17163568|NCT02097121|38311656|FG002|Overall Study|Lack of Efficacy|3|||
17163569|NCT02097121|38311654|FG000|Overall Study|Withdrawal by Subject|0|||
17163570|NCT02097121|38311655|FG001|Overall Study|Withdrawal by Subject|1|||
17163571|NCT02097121|38311656|FG002|Overall Study|Withdrawal by Subject|2|||
17163572|NCT02097121|38311654|FG000|Overall Study|Adverse Event|0|||
17163573|NCT02097121|38311655|FG001|Overall Study|Adverse Event|1|||
17163574|NCT02097121|38311656|FG002|Overall Study|Adverse Event|0|||
17163575|NCT02097121|38311654|FG000|Overall Study|Lost to Follow-up|1|||
17163576|NCT02097121|38311655|FG001|Overall Study|Lost to Follow-up|1|||
17163577|NCT02097121|38311656|FG002|Overall Study|Lost to Follow-up|2|||
17163578|NCT02747420|38311685|FG000|Overall Study|Lost to Follow-up|4|||
17163579|NCT02747420|38311686|FG001|Overall Study|Lost to Follow-up|2|||
17163580|NCT02747420|38311685|FG000|Overall Study|Withdrawal by Subject|3|||
17163581|NCT02747420|38311686|FG001|Overall Study|Withdrawal by Subject|2|||
17163582|NCT03238001|38311692|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
17163583|NCT03238001|38311692|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
17163584|NCT03238001|38311692|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
17163585|NCT03238001|38311692|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
17163586|NCT03238001|38311692|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
17163587|NCT03238001|38311692|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
17163588|NCT03238001|38311692|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
17163589|NCT03238001|38311692|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
17163590|NCT02747108|38311706|FG000|Overall Study|Death|2|||
17163591|NCT02747108|38311707|FG001|Overall Study|Death|2|||
17163592|NCT02747108|38311706|FG000|Overall Study|Withdrawal by Subject|1|||
17163593|NCT02747108|38311707|FG001|Overall Study|Withdrawal by Subject|0|||
17163594|NCT02747108|38311706|FG000|Overall Study|Protocol Violation|2|||
17163595|NCT02747108|38311707|FG001|Overall Study|Protocol Violation|0|||
17163596|NCT03226769|38311735|FG000|Overall Study|Withdrawal by Subject|0|||
17163597|NCT03226769|38311736|FG001|Overall Study|Withdrawal by Subject|1|||
17163598|NCT02864342|38311744|FG000|Overall Study|Eligibility Criteria Deviation|2|||
17163599|NCT02864342|38311745|FG001|Overall Study|Eligibility Criteria Deviation|3|||
17163600|NCT02864342|38311744|FG000|Overall Study|Withdrawal by Subject|4|||
17163601|NCT02864342|38311745|FG001|Overall Study|Withdrawal by Subject|2|||
17163602|NCT02864342|38311744|FG000|Overall Study|Device Technology Issue|6|||
17163603|NCT02864342|38311745|FG001|Overall Study|Device Technology Issue|7|||
17163604|NCT02864342|38311744|FG000|Overall Study|Death|0|||
17163605|NCT02864342|38311745|FG001|Overall Study|Death|1|||
17163606|NCT02864342|38311744|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
17163607|NCT02864342|38311745|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
17163608|NCT02864342|38311744|FG000|Overall Study|Lost to Follow-up|1|||
17163609|NCT02864342|38311745|FG001|Overall Study|Lost to Follow-up|5|||
17163610|NCT02864342|38311744|FG000|Overall Study|Lost Device|1|||
17163611|NCT02864342|38311745|FG001|Overall Study|Lost Device|0|||
17163612|NCT02864342|38311744|FG000|Overall Study|Adverse Event|1|||
17163613|NCT02864342|38311745|FG001|Overall Study|Adverse Event|0|||
17163614|NCT03237065|38311754|FG000|Overall Study|Adverse Event|0|||
17163615|NCT03237065|38311755|FG001|Overall Study|Adverse Event|2|||
17163616|NCT03237065|38311754|FG000|Overall Study|Protocol Violation|0|||
17163617|NCT03237065|38311755|FG001|Overall Study|Protocol Violation|1|||
17163618|NCT03237065|38311754|FG000|Overall Study|Withdrawal by Subject|3|||
17163619|NCT03237065|38311755|FG001|Overall Study|Withdrawal by Subject|0|||
17163620|NCT03237065|38311754|FG000|Overall Study|Lost to Follow-up|1|||
17163621|NCT03237065|38311755|FG001|Overall Study|Lost to Follow-up|0|||
17163622|NCT03237065|38311754|FG000|Overall Study|Unable to obtain venous access|0|||
17163623|NCT03237065|38311755|FG001|Overall Study|Unable to obtain venous access|1|||
17163624|NCT03171415|38311766|FG000|Overall Study|Lost to Follow-up|0|||
17163625|NCT03171415|38311767|FG001|Overall Study|Lost to Follow-up|0|||
17163626|NCT03171415|38311768|FG002|Overall Study|Lost to Follow-up|0|||
17163627|NCT03171415|38311769|FG003|Overall Study|Lost to Follow-up|0|||
17163628|NCT03171415|38311770|FG004|Overall Study|Lost to Follow-up|2|||
17163629|NCT03829241|38311795|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
17163630|NCT03829241|38311796|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
17163631|NCT03829241|38311795|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
17163632|NCT03829241|38311796|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
17163633|NCT03829241|38311795|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
17163634|NCT03829241|38311796|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
17163635|NCT03829241|38311795|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
17163636|NCT03829241|38311796|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
17163637|NCT03829241|38311795|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
17163638|NCT03829241|38311796|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
17163639|NCT03829241|38311795|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
17163640|NCT03829241|38311796|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
17163641|NCT03829241|38311795|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
17163642|NCT03829241|38311796|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
17163643|NCT03829241|38311795|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
17163644|NCT03829241|38311796|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
17163645|NCT03829241|38311795|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
17163646|NCT03829241|38311796|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
17163647|NCT03829241|38311795|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
17163648|NCT03829241|38311796|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
17163649|NCT03829241|38311795|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
17163650|NCT03829241|38311796|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
17163651|NCT03829241|38311795|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
17163652|NCT03829241|38311796|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
17163653|NCT03829241|38311795|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
17163654|NCT03829241|38311796|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
17163655|NCT03829241|38311795|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
17163656|NCT03829241|38311796|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
17163657|NCT03164551|38311808|FG000|Overall Study|Imaging discontinued prior completion|8|||
17163658|NCT03164551|38311809|FG001|Overall Study|Imaging discontinued prior completion|0|||
17163659|NCT03164551|38311808|FG000|Overall Study|Participant was non-compliant|1|||
17163660|NCT03164551|38311809|FG001|Overall Study|Participant was non-compliant|0|||
17163661|NCT03164551|38311808|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
17163662|NCT03164551|38311809|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
17163663|NCT03164551|38311808|FG000|Overall Study|Other|8|||
17163664|NCT03164551|38311809|FG001|Overall Study|Other|2|||
17163665|NCT02863328|38311817|FG000|Overall Study|Lost to Follow-up|4|||
17163666|NCT02863328|38311818|FG001|Overall Study|Lost to Follow-up|10|||
17163667|NCT02863328|38311817|FG000|Overall Study|Withdrawal by Subject|7|||
17163668|NCT02863328|38311818|FG001|Overall Study|Withdrawal by Subject|12|||
17163669|NCT02863328|38311817|FG000|Overall Study|Died|0|||
17163670|NCT02863328|38311818|FG001|Overall Study|Died|1|||
17163671|NCT03040141|38311827|FG000|Overall Study|Death|1|||
17163672|NCT03040141|38311828|FG001|Overall Study|Death|2|||
17163673|NCT03040141|38311829|FG002|Overall Study|Death|3|||
17163674|NCT03040141|38311827|FG000|Overall Study|Withdrawal by Subject|3|||
17163675|NCT03040141|38311828|FG001|Overall Study|Withdrawal by Subject|1|||
17163676|NCT03040141|38311829|FG002|Overall Study|Withdrawal by Subject|1|||
17163677|NCT03040141|38311827|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
17163678|NCT03040141|38311828|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
17163679|NCT03040141|38311829|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
17163680|NCT03040141|38311827|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
17163681|NCT03040141|38311828|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
17163682|NCT03040141|38311829|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
17163683|NCT02937701|38311843|FG000|Day 1 to Week 22|Adverse Event|11|||
17163684|NCT02937701|38311844|FG001|Day 1 to Week 22|Adverse Event|14|||
17163685|NCT02937701|38311845|FG002|Day 1 to Week 22|Adverse Event|0|||
17163686|NCT02937701|38311846|FG003|Day 1 to Week 22|Adverse Event|0|||
17163687|NCT02937701|38311847|FG004|Day 1 to Week 22|Adverse Event|0|||
17163688|NCT02937701|38311843|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
17163689|NCT02937701|38311844|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
17163690|NCT02937701|38311845|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
17163691|NCT02937701|38311846|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
17163692|NCT02937701|38311847|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
17163693|NCT02937701|38311843|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
17163694|NCT02937701|38311844|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
17163695|NCT02937701|38311845|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
17163696|NCT02937701|38311846|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
16781302|NCT02105974|37720455|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
17083718|NCT00529373|38224216|FG001|Second Extension Study|Adverse Event|51|||
17083719|NCT00529373|38224215|FG000|Second Extension Study|Lack of Efficacy|7|||
17083720|NCT00529373|38224216|FG001|Second Extension Study|Lack of Efficacy|15|||
17083721|NCT00529373|38224215|FG000|Second Extension Study|Lost to Follow-up|18|||
17083722|NCT00529373|38224216|FG001|Second Extension Study|Lost to Follow-up|12|||
17083723|NCT00529373|38224215|FG000|Second Extension Study|Other|7|||
17083724|NCT00529373|38224216|FG001|Second Extension Study|Other|12|||
17083725|NCT00529373|38224215|FG000|Second Extension Study|Physician Decision|63|||
17083726|NCT00529373|38224216|FG001|Second Extension Study|Physician Decision|26|||
17083727|NCT00529373|38224215|FG000|Second Extension Study|Protocol Violation|2|||
17163697|NCT02937701|38311847|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
17163698|NCT02937701|38311843|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
17163699|NCT02937701|38311844|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
17163700|NCT02937701|38311845|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
17163701|NCT02937701|38311846|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
17163702|NCT02937701|38311847|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
17163703|NCT02937701|38311843|FG000|Day 1 to Week 22|Death|1|||
17163704|NCT02937701|38311844|FG001|Day 1 to Week 22|Death|1|||
17163705|NCT02937701|38311845|FG002|Day 1 to Week 22|Death|0|||
17163706|NCT02937701|38311846|FG003|Day 1 to Week 22|Death|0|||
17163707|NCT02937701|38311847|FG004|Day 1 to Week 22|Death|0|||
17163708|NCT02937701|38311843|FG000|Day 1 to Week 22|Protocol Violation|1|||
17163709|NCT02937701|38311844|FG001|Day 1 to Week 22|Protocol Violation|1|||
17163710|NCT02937701|38311845|FG002|Day 1 to Week 22|Protocol Violation|0|||
17163711|NCT02937701|38311846|FG003|Day 1 to Week 22|Protocol Violation|0|||
17163712|NCT02937701|38311847|FG004|Day 1 to Week 22|Protocol Violation|0|||
17163713|NCT02937701|38311843|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
17163714|NCT02937701|38311844|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
17163715|NCT02937701|38311845|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
17163716|NCT02937701|38311846|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
17163717|NCT02937701|38311847|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
17163718|NCT02937701|38311843|FG000|Day 1 to Week 22|Physician Decision|2|||
17163719|NCT02937701|38311844|FG001|Day 1 to Week 22|Physician Decision|0|||
17163720|NCT02937701|38311845|FG002|Day 1 to Week 22|Physician Decision|0|||
17163721|NCT02937701|38311846|FG003|Day 1 to Week 22|Physician Decision|0|||
17163722|NCT02937701|38311847|FG004|Day 1 to Week 22|Physician Decision|0|||
17163723|NCT02937701|38311843|FG000|Day 1 to Week 22|Other|1|||
17163724|NCT02937701|38311844|FG001|Day 1 to Week 22|Other|0|||
17163725|NCT02937701|38311845|FG002|Day 1 to Week 22|Other|0|||
17163726|NCT02937701|38311846|FG003|Day 1 to Week 22|Other|0|||
17163727|NCT02937701|38311847|FG004|Day 1 to Week 22|Other|0|||
17163728|NCT02937701|38311843|FG000|Week 22 to Week 50|Adverse Event|0|||
17163729|NCT02937701|38311844|FG001|Week 22 to Week 50|Adverse Event|0|||
17163730|NCT02937701|38311845|FG002|Week 22 to Week 50|Adverse Event|10|||
17163731|NCT02937701|38311846|FG003|Week 22 to Week 50|Adverse Event|3|||
17163732|NCT02937701|38311847|FG004|Week 22 to Week 50|Adverse Event|3|||
17163733|NCT02937701|38311843|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
17163734|NCT02937701|38311844|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
17163735|NCT02937701|38311845|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
17163736|NCT02937701|38311846|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
17163737|NCT02937701|38311847|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
17163738|NCT02937701|38311843|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
17163739|NCT02937701|38311844|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
17163740|NCT02937701|38311845|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
17163741|NCT02937701|38311846|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
17163742|NCT02937701|38311847|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
17163743|NCT02937701|38311843|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
17163744|NCT02937701|38311844|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
17163745|NCT02937701|38311845|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
17163746|NCT02937701|38311846|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
17163747|NCT02937701|38311847|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
17163748|NCT02937701|38311843|FG000|Week 22 to Week 50|Physician Decision|0|||
17163749|NCT02937701|38311844|FG001|Week 22 to Week 50|Physician Decision|0|||
17163750|NCT02937701|38311845|FG002|Week 22 to Week 50|Physician Decision|2|||
17163751|NCT02937701|38311846|FG003|Week 22 to Week 50|Physician Decision|0|||
17163752|NCT02937701|38311847|FG004|Week 22 to Week 50|Physician Decision|1|||
17163753|NCT02937701|38311843|FG000|Week 22 to Week 50|Other|0|||
17163754|NCT02937701|38311844|FG001|Week 22 to Week 50|Other|0|||
17163755|NCT02937701|38311845|FG002|Week 22 to Week 50|Other|0|||
17163756|NCT02937701|38311846|FG003|Week 22 to Week 50|Other|0|||
17163757|NCT02937701|38311847|FG004|Week 22 to Week 50|Other|1|||
17163758|NCT03169153|38311859|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
17163759|NCT03169153|38311860|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
17163760|NCT03169153|38311859|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
17163761|NCT03169153|38311860|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
17163762|NCT03169153|38311859|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
17163763|NCT03169153|38311860|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
17163764|NCT03169153|38311859|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
17163765|NCT03169153|38311860|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
17163766|NCT03168919|38311866|FG000|Overall Study|Withdrawal by Subject|2|||
17163767|NCT03205163|38311876|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
17163768|NCT03205163|38311877|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
17163769|NCT01759537|38311892|FG000|Overall Study|Death|1|||
17163770|NCT01759537|38311893|FG001|Overall Study|Death|1|||
17163771|NCT01759537|38311892|FG000|Overall Study|Pregnancy|1|||
17163772|NCT01759537|38311893|FG001|Overall Study|Pregnancy|1|||
17163773|NCT01759537|38311892|FG000|Overall Study|Lost to Follow-up|9|||
17163774|NCT01759537|38311893|FG001|Overall Study|Lost to Follow-up|9|||
17163775|NCT01759537|38311892|FG000|Overall Study|Accident involving jaw fracture|1|||
17163776|NCT01759537|38311893|FG001|Overall Study|Accident involving jaw fracture|1|||
17163777|NCT01759537|38311892|FG000|Overall Study|Subcrestal implant too coronal|1|||
17163778|NCT01759537|38311893|FG001|Overall Study|Subcrestal implant too coronal|1|||
17163779|NCT03204539|38311901|FG000|Overall Study|Loss of funding|0|||
17163780|NCT03204539|38311902|FG001|Overall Study|Loss of funding|1|||
17163781|NCT03502681|38311919|FG000|Overall Study|Adverse Event|1|||
17163782|NCT03502681|38311920|FG001|Overall Study|Adverse Event|1|||
17163783|NCT03502681|38311919|FG000|Overall Study|Disease Progression|2|||
17163784|NCT03502681|38311920|FG001|Overall Study|Disease Progression|1|||
17163785|NCT02860130|38311927|FG000|Overall Study|Adverse Event|2|||
17163786|NCT02860130|38311928|FG001|Overall Study|Adverse Event|3|||
17163787|NCT02860130|38311927|FG000|Overall Study|Protocol Violation|1|||
17163788|NCT02860130|38311928|FG001|Overall Study|Protocol Violation|1|||
17163789|NCT02860130|38311927|FG000|Overall Study|Withdrawal by Subject|0|||
17163790|NCT02860130|38311928|FG001|Overall Study|Withdrawal by Subject|2|||
17163791|NCT02860130|38311927|FG000|Overall Study|Physician Decision|2|||
17163792|NCT02860130|38311928|FG001|Overall Study|Physician Decision|2|||
17163793|NCT02860130|38311927|FG000|Overall Study|Other|2|||
17163794|NCT02860130|38311928|FG001|Overall Study|Other|1|||
17163795|NCT00788671|38311934|FG000|Overall Study|Death|2|||
17163796|NCT00788671|38311934|FG000|Overall Study|Unable to biopsy|1|||
17163797|NCT00788671|38311934|FG000|Overall Study|Withdrawal by Subject|4|||
17163798|NCT00788671|38311934|FG000|Overall Study|IUD expulsed|1|||
17163799|NCT00788671|38311934|FG000|Overall Study|Lost to follow up|2|||
17163800|NCT02986854|38311941|FG000|Overall Study|Withdrawal by Subject|0|||
17163801|NCT02986854|38311942|FG001|Overall Study|Withdrawal by Subject|1|||
17163802|NCT02986854|38311943|FG002|Overall Study|Withdrawal by Subject|1|||
17163803|NCT02986854|38311941|FG000|Overall Study|Lost to Follow-up|3|||
17163804|NCT02986854|38311942|FG001|Overall Study|Lost to Follow-up|11|||
17163805|NCT02986854|38311943|FG002|Overall Study|Lost to Follow-up|2|||
17163806|NCT02887183|38311953|FG000|Overall Study|Adverse Event|44|||
17163807|NCT02887183|38311953|FG000|Overall Study|Death|30|||
17163808|NCT02887183|38311953|FG000|Overall Study|Pregnancy|1|||
17163809|NCT02887183|38311953|FG000|Overall Study|Protocol Violation|6|||
17163810|NCT02887183|38311953|FG000|Overall Study|Technical Problems|2|||
17163811|NCT02887183|38311953|FG000|Overall Study|Lost to Follow-up|13|||
17163812|NCT02887183|38311953|FG000|Overall Study|Physician Decision|10|||
17163813|NCT02887183|38311953|FG000|Overall Study|Withdrawal by Subject|35|||
17163814|NCT03167359|38311961|FG000|Overall Study|Physician Decision|1|||
17083728|NCT00529373|38224216|FG001|Second Extension Study|Protocol Violation|1|||
17083729|NCT00529373|38224215|FG000|Second Extension Study|Withdrawal by Subject|97|||
17083730|NCT00529373|38224216|FG001|Second Extension Study|Withdrawal by Subject|75|||
17163815|NCT03167359|38311961|FG000|Overall Study|Lost to Follow-up|1|||
17163816|NCT01068600|38311967|FG000|Overall Study|Withdrawal by Subject|5|||
17163817|NCT01068600|38311968|FG001|Overall Study|Withdrawal by Subject|6|||
17163818|NCT01068600|38311967|FG000|Overall Study|Adverse Event|3|||
17163819|NCT01068600|38311968|FG001|Overall Study|Adverse Event|3|||
17163820|NCT01068600|38311967|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17163821|NCT01068600|38311968|FG001|Overall Study|Abnormal laboratory value(s)|0|||
17163822|NCT01068600|38311967|FG000|Overall Study|Lost to Follow-up|1|||
17163823|NCT01068600|38311968|FG001|Overall Study|Lost to Follow-up|2|||
17163824|NCT01068600|38311967|FG000|Overall Study|Protocol deviation|1|||
17083731|NCT00529373|38224215|FG000|Second Extension Study|Status Missing|5|||
17083732|NCT00529373|38224216|FG001|Second Extension Study|Status Missing|5|||
17083733|NCT00369122|38224230|FG000|Overall Study|Ineligible|10|||
17083734|NCT00369122|38224230|FG000|Overall Study|No protocol treatment|1|||
17083735|NCT03687125|38224236|FG000|Overall Study|Progressive Disease|2|||
17083736|NCT03687125|38224237|FG001|Overall Study|Progressive Disease|1|||
17083737|NCT03687125|38224236|FG000|Overall Study|Protocol Violation|1|||
17083738|NCT03687125|38224237|FG001|Overall Study|Protocol Violation|0|||
17083739|NCT03872843|38224247|FG000|Overall Study|Lost to Follow-up|5|||
17083740|NCT03872843|38224248|FG001|Overall Study|Lost to Follow-up|7|||
17083741|NCT00146770|38224256|FG000|Overall Study|Adverse Event|2|||
17083742|NCT00146770|38224257|FG001|Overall Study|Adverse Event|0|||
17083743|NCT00146770|38224256|FG000|Overall Study|Pregnancy|1|||
17083744|NCT00146770|38224257|FG001|Overall Study|Pregnancy|0|||
17083745|NCT00146770|38224256|FG000|Overall Study|Withdrawal by Subject|2|||
17083746|NCT00146770|38224257|FG001|Overall Study|Withdrawal by Subject|0|||
17083747|NCT03874013|38224265|FG000|Overall Study|Adverse Event|0|||
17083748|NCT03874013|38224266|FG001|Overall Study|Adverse Event|1|||
17083749|NCT00168064|38224274|FG000|Overall Study|Adverse Event|26|||
17083750|NCT00168064|38224275|FG001|Overall Study|Adverse Event|22|||
17083751|NCT00168064|38224274|FG000|Overall Study|Withdrawal by Subject|3|||
17083752|NCT00168064|38224275|FG001|Overall Study|Withdrawal by Subject|4|||
17083753|NCT00168064|38224274|FG000|Overall Study|Lack of Efficacy|4|||
17163825|NCT01068600|38311968|FG001|Overall Study|Protocol deviation|1|||
17163826|NCT01068600|38311967|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
17163827|NCT01068600|38311968|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
17163828|NCT01068600|38311967|FG000|Overall Study|Administrative problems|0|||
17163829|NCT01068600|38311968|FG001|Overall Study|Administrative problems|1|||
17163830|NCT01067976|38311974|FG000|Overall Study|Study drug never administered|20|||
17163831|NCT01067976|38311974|FG000|Overall Study|Study prematurely discontinued|2|||
17163832|NCT02858492|38311996|FG000|Overall Study|Withdrawal by Subject|0|||
17163833|NCT02858492|38311997|FG001|Overall Study|Withdrawal by Subject|1|||
17163834|NCT02858492|38311998|FG002|Overall Study|Withdrawal by Subject|0|||
17163835|NCT02858492|38311999|FG003|Overall Study|Withdrawal by Subject|1|||
17163836|NCT02858492|38311996|FG000|Overall Study|Adverse Event|0|||
17163837|NCT02858492|38311997|FG001|Overall Study|Adverse Event|0|||
17163838|NCT02858492|38311998|FG002|Overall Study|Adverse Event|0|||
17163839|NCT02858492|38311999|FG003|Overall Study|Adverse Event|3|||
17163840|NCT02858492|38311996|FG000|Overall Study|Lack of Efficacy|0|||
17163841|NCT02858492|38311997|FG001|Overall Study|Lack of Efficacy|0|||
17163842|NCT02858492|38311998|FG002|Overall Study|Lack of Efficacy|0|||
17163843|NCT02858492|38311999|FG003|Overall Study|Lack of Efficacy|1|||
17163844|NCT02858492|38311996|FG000|Overall Study|Protocol defined stopping criteria|0|||
17163845|NCT02858492|38311997|FG001|Overall Study|Protocol defined stopping criteria|0|||
17163846|NCT02858492|38311998|FG002|Overall Study|Protocol defined stopping criteria|0|||
17163847|NCT02858492|38311999|FG003|Overall Study|Protocol defined stopping criteria|1|||
17163848|NCT01067508|38312013|FG000|Overall Study|Physician Decision|0|||
17163849|NCT01067508|38312014|FG001|Overall Study|Physician Decision|1|||
17163850|NCT01067508|38312013|FG000|Overall Study|Withdrawal by Subject|0|||
17163851|NCT01067508|38312014|FG001|Overall Study|Withdrawal by Subject|1|||
17163852|NCT01067352|38312023|FG000|Overall Study|Withdrawal by Subject|1|||
17163853|NCT01067352|38312024|FG001|Overall Study|Withdrawal by Subject|2|||
17163854|NCT01067352|38312025|FG002|Overall Study|Withdrawal by Subject|1|||
17163855|NCT01067352|38312023|FG000|Overall Study|Physician Decision|0|||
17163856|NCT01067352|38312024|FG001|Overall Study|Physician Decision|1|||
17163857|NCT01067352|38312025|FG002|Overall Study|Physician Decision|0|||
17163858|NCT02986074|38312033|FG000|First Trial Period|Adverse Event|1|||
17163859|NCT02986074|38312034|FG001|First Trial Period|Adverse Event|0|||
17163860|NCT02986074|38312035|FG002|First Trial Period|Adverse Event|0|||
17163861|NCT02986074|38312036|FG003|First Trial Period|Adverse Event|0|||
17163862|NCT02986074|38312033|FG000|Follow up Period|system explant|0|||
17163863|NCT02986074|38312034|FG001|Follow up Period|system explant|0|||
17163864|NCT02986074|38312035|FG002|Follow up Period|system explant|1|||
17163865|NCT02986074|38312036|FG003|Follow up Period|system explant|2|||
17163866|NCT02986074|38312033|FG000|Follow up Period|Physician Decision|0|||
17163867|NCT02986074|38312034|FG001|Follow up Period|Physician Decision|0|||
17163868|NCT02986074|38312035|FG002|Follow up Period|Physician Decision|0|||
17163869|NCT02986074|38312036|FG003|Follow up Period|Physician Decision|1|||
17163870|NCT02920242|38312044|FG000|Overall Study|Withdrawal by Subject|1|||
17163871|NCT02920242|38312045|FG001|Overall Study|Withdrawal by Subject|0|||
17163872|NCT02920242|38312046|FG002|Overall Study|Withdrawal by Subject|1|||
17163873|NCT02920242|38312044|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
17163874|NCT02920242|38312045|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
17163875|NCT02920242|38312046|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
17163876|NCT02985996|38312059|FG000|Overall Study|Withdrawal by Subject|0|||
17163877|NCT02985996|38312060|FG001|Overall Study|Withdrawal by Subject|0|||
17163878|NCT02985996|38312061|FG002|Overall Study|Withdrawal by Subject|1|||
17163879|NCT02985996|38312062|FG003|Overall Study|Withdrawal by Subject|0|||
17163880|NCT02985996|38312063|FG004|Overall Study|Withdrawal by Subject|0|||
17163881|NCT02985996|38312059|FG000|Overall Study|Protocol Violation|0|||
17163882|NCT02985996|38312060|FG001|Overall Study|Protocol Violation|1|||
17083754|NCT00168064|38224275|FG001|Overall Study|Lack of Efficacy|4|||
17083755|NCT00168064|38224274|FG000|Overall Study|Lost to Follow-up|4|||
17083756|NCT00168064|38224275|FG001|Overall Study|Lost to Follow-up|3|||
17083757|NCT00168064|38224274|FG000|Overall Study|Non-compliance|2|||
17083758|NCT00168064|38224275|FG001|Overall Study|Non-compliance|3|||
17083759|NCT00168064|38224274|FG000|Overall Study|Concurrent Illness|4|||
17163883|NCT02985996|38312061|FG002|Overall Study|Protocol Violation|0|||
17163884|NCT02985996|38312062|FG003|Overall Study|Protocol Violation|0|||
17163885|NCT02985996|38312063|FG004|Overall Study|Protocol Violation|0|||
16996210|NCT00762502|38140217|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
16996211|NCT00762502|38140218|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
16996212|NCT00762502|38140219|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
17083760|NCT00168064|38224275|FG001|Overall Study|Concurrent Illness|3|||
17083761|NCT00168064|38224274|FG000|Overall Study|Subject's Best interest|2|||
17163886|NCT03225833|38312085|FG000|Overall Study|Adverse Event|0|||
17163887|NCT03225833|38312086|FG001|Overall Study|Adverse Event|1|||
17163888|NCT03225833|38312087|FG002|Overall Study|Adverse Event|2|||
17163889|NCT03225833|38312088|FG003|Overall Study|Adverse Event|0|||
17163890|NCT03225833|38312089|FG004|Overall Study|Adverse Event|0|||
17083762|NCT00168064|38224275|FG001|Overall Study|Subject's Best interest|2|||
17163891|NCT03225833|38312090|FG005|Overall Study|Adverse Event|2|||
17163892|NCT03225833|38312085|FG000|Overall Study|Withdrawal by Subject|1|||
17163893|NCT03225833|38312086|FG001|Overall Study|Withdrawal by Subject|0|||
17163894|NCT03225833|38312087|FG002|Overall Study|Withdrawal by Subject|0|||
17163895|NCT03225833|38312088|FG003|Overall Study|Withdrawal by Subject|0|||
17163896|NCT03225833|38312089|FG004|Overall Study|Withdrawal by Subject|1|||
17163897|NCT03225833|38312090|FG005|Overall Study|Withdrawal by Subject|0|||
17163898|NCT03225833|38312085|FG000|Overall Study|Termination of Study by Sponsor|4|||
17163899|NCT03225833|38312086|FG001|Overall Study|Termination of Study by Sponsor|0|||
17163900|NCT03225833|38312087|FG002|Overall Study|Termination of Study by Sponsor|0|||
17163901|NCT03225833|38312088|FG003|Overall Study|Termination of Study by Sponsor|0|||
17163902|NCT03225833|38312089|FG004|Overall Study|Termination of Study by Sponsor|0|||
17163903|NCT03225833|38312090|FG005|Overall Study|Termination of Study by Sponsor|7|||
17163904|NCT03225833|38312085|FG000|Overall Study|Sponsor Decision|0|||
17163905|NCT03225833|38312086|FG001|Overall Study|Sponsor Decision|0|||
17163906|NCT03225833|38312087|FG002|Overall Study|Sponsor Decision|0|||
17163907|NCT03225833|38312088|FG003|Overall Study|Sponsor Decision|0|||
17163908|NCT03225833|38312089|FG004|Overall Study|Sponsor Decision|0|||
17163909|NCT03225833|38312090|FG005|Overall Study|Sponsor Decision|1|||
17163910|NCT03203447|38312111|FG000|Overall Study|Withdrawal by Subject|2|||
17163911|NCT03203447|38312112|FG001|Overall Study|Withdrawal by Subject|1|||
17163912|NCT03203447|38312111|FG000|Overall Study|Lost to Follow-up|1|||
17163913|NCT03203447|38312112|FG001|Overall Study|Lost to Follow-up|10|||
17163914|NCT03203447|38312111|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
17163915|NCT03203447|38312112|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
17163916|NCT02858726|38312122|FG000|Overall Study|Adverse Event|4|||
17163917|NCT02858726|38312123|FG001|Overall Study|Adverse Event|4|||
17163918|NCT02858726|38312124|FG002|Overall Study|Adverse Event|9|||
17163919|NCT02858726|38312125|FG003|Overall Study|Adverse Event|1|||
17163920|NCT02858726|38312122|FG000|Overall Study|Physician Decision|0|||
17163921|NCT02858726|38312123|FG001|Overall Study|Physician Decision|0|||
17163922|NCT02858726|38312124|FG002|Overall Study|Physician Decision|1|||
17163923|NCT02858726|38312125|FG003|Overall Study|Physician Decision|0|||
17083763|NCT00168064|38224274|FG000|Overall Study|Various|4|||
17083764|NCT00168064|38224275|FG001|Overall Study|Various|3|||
17083765|NCT00166114|38224285|FG000|Overall Study|Protocol Violation|2|||
17083766|NCT00166114|38224286|FG001|Overall Study|Protocol Violation|1|||
17083767|NCT00166114|38224285|FG000|Overall Study|Withdrawal by Subject|10|||
17083768|NCT00166114|38224286|FG001|Overall Study|Withdrawal by Subject|4|||
17083769|NCT00166114|38224285|FG000|Overall Study|Adverse Event|2|||
17083770|NCT00166114|38224286|FG001|Overall Study|Adverse Event|1|||
17083771|NCT03686969|38224294|FG000|Overall Study|Study terminated|1|||
17083772|NCT03686969|38224295|FG001|Overall Study|Study terminated|0|||
17083773|NCT00145600|38224305|FG000|Overall Study|Death|1|||
17083774|NCT00145600|38224306|FG001|Overall Study|Death|2|||
17083775|NCT00145600|38224307|FG002|Overall Study|Death|2|||
17083776|NCT00145600|38224308|FG003|Overall Study|Death|6|||
17083777|NCT00145600|38224305|FG000|Overall Study|Ineligible|3|||
17083778|NCT00145600|38224306|FG001|Overall Study|Ineligible|0|||
17083779|NCT00145600|38224307|FG002|Overall Study|Ineligible|1|||
17083780|NCT00145600|38224308|FG003|Overall Study|Ineligible|5|||
17083781|NCT00145600|38224305|FG000|Overall Study|Lost to Follow-up|2|||
17083782|NCT00145600|38224306|FG001|Overall Study|Lost to Follow-up|6|||
17083783|NCT00145600|38224307|FG002|Overall Study|Lost to Follow-up|2|||
17083784|NCT00145600|38224308|FG003|Overall Study|Lost to Follow-up|4|||
17083785|NCT00145600|38224305|FG000|Overall Study|Noncompliance|1|||
17083786|NCT00145600|38224306|FG001|Overall Study|Noncompliance|0|||
17083787|NCT00145600|38224307|FG002|Overall Study|Noncompliance|0|||
17083788|NCT00145600|38224308|FG003|Overall Study|Noncompliance|0|||
17083789|NCT00145600|38224305|FG000|Overall Study|Withdrawal by Subject|1|||
17083790|NCT00145600|38224306|FG001|Overall Study|Withdrawal by Subject|2|||
17083791|NCT00145600|38224307|FG002|Overall Study|Withdrawal by Subject|0|||
17083792|NCT00145600|38224308|FG003|Overall Study|Withdrawal by Subject|1|||
17083793|NCT00129376|38224332|FG000|Overall Study|Adverse Event|1|||
17083794|NCT00129376|38224332|FG000|Overall Study|Lack of Efficacy|1|||
17083795|NCT00129220|38224339|FG000|Study Period II|Adverse Event|9|||
17083796|NCT00129220|38224340|FG001|Study Period II|Adverse Event|5|||
17083797|NCT00129220|38224341|FG002|Study Period II|Adverse Event|7|||
17083798|NCT00129220|38224339|FG000|Study Period II|Lack of Efficacy|15|||
17083799|NCT00129220|38224340|FG001|Study Period II|Lack of Efficacy|1|||
17083800|NCT00129220|38224341|FG002|Study Period II|Lack of Efficacy|28|||
17083801|NCT00129220|38224339|FG000|Study Period II|Entry Criteria Not Met|2|||
17083802|NCT00129220|38224340|FG001|Study Period II|Entry Criteria Not Met|0|||
17083803|NCT00129220|38224341|FG002|Study Period II|Entry Criteria Not Met|2|||
17083804|NCT00129220|38224339|FG000|Study Period II|Protocol Violation|4|||
17083805|NCT00129220|38224340|FG001|Study Period II|Protocol Violation|2|||
17083806|NCT00129220|38224341|FG002|Study Period II|Protocol Violation|1|||
17163924|NCT02858726|38312122|FG000|Overall Study|Protocol Violation|0|||
17083807|NCT00129220|38224339|FG000|Study Period II|Physician Decision|0|||
17083808|NCT00129220|38224340|FG001|Study Period II|Physician Decision|1|||
17083809|NCT00129220|38224341|FG002|Study Period II|Physician Decision|0|||
17083810|NCT00129220|38224339|FG000|Study Period II|Withdrawal by Subject|1|||
17083811|NCT00129220|38224340|FG001|Study Period II|Withdrawal by Subject|3|||
17083812|NCT00129220|38224341|FG002|Study Period II|Withdrawal by Subject|4|||
17083813|NCT00129220|38224339|FG000|Study Period II|Reason Not Specified|2|||
17083814|NCT00129220|38224340|FG001|Study Period II|Reason Not Specified|0|||
17083815|NCT00129220|38224341|FG002|Study Period II|Reason Not Specified|5|||
17083816|NCT00129220|38224339|FG000|Study Period III|Adverse Event|1|||
17083817|NCT00129220|38224340|FG001|Study Period III|Adverse Event|0|||
17083818|NCT00129220|38224341|FG002|Study Period III|Adverse Event|3|||
17083819|NCT00129220|38224339|FG000|Study Period III|Protocol Violation|1|||
17083820|NCT00129220|38224340|FG001|Study Period III|Protocol Violation|1|||
17083821|NCT00129220|38224341|FG002|Study Period III|Protocol Violation|2|||
17083822|NCT00129220|38224339|FG000|Study Period III|Withdrawal by Subject|1|||
17083823|NCT00129220|38224340|FG001|Study Period III|Withdrawal by Subject|0|||
17083824|NCT00129220|38224341|FG002|Study Period III|Withdrawal by Subject|3|||
17083825|NCT00129220|38224339|FG000|Study Period III|Sponsor Decision|1|||
17083826|NCT00129220|38224340|FG001|Study Period III|Sponsor Decision|0|||
17083827|NCT00129220|38224341|FG002|Study Period III|Sponsor Decision|0|||
17083828|NCT00129220|38224339|FG000|Study Period III|Reason Not Specified|9|||
17083829|NCT00129220|38224340|FG001|Study Period III|Reason Not Specified|0|||
17083830|NCT00129220|38224341|FG002|Study Period III|Reason Not Specified|2|||
17083831|NCT00128830|38224361|FG000|Overall Study|Adverse Event|10|||
17083832|NCT00128830|38224361|FG000|Overall Study|Withdrawal by Subject|14|||
17083833|NCT00128830|38224361|FG000|Overall Study|Lost to Follow-up|4|||
17083834|NCT00128830|38224361|FG000|Overall Study|Reached a virologic endpoint|29|||
17083835|NCT00128830|38224361|FG000|Overall Study|Non-compliant|4|||
17083836|NCT00128830|38224361|FG000|Overall Study|Discontinued or ineligible for study|2|||
17083837|NCT00128830|38224361|FG000|Overall Study|Other|9|||
17083838|NCT03686033|38224367|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
17083839|NCT03686033|38224368|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
17083840|NCT03686033|38224369|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
17083841|NCT03686033|38224370|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
17083842|NCT03686033|38224371|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
17083843|NCT03686033|38224372|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
17083844|NCT00128206|38224388|FG000|Overall Study|Lost to Follow-up|137|||
17083845|NCT00128206|38224389|FG001|Overall Study|Lost to Follow-up|118|||
17083846|NCT00128206|38224388|FG000|Overall Study|Adverse Event|0|||
17083847|NCT00128206|38224389|FG001|Overall Study|Adverse Event|2|||
17083848|NCT03685643|38224397|FG000|Overall Study|Lost to Follow-up|14|||
17083849|NCT03685643|38224398|FG001|Overall Study|Lost to Follow-up|22|||
17083850|NCT03823378|38224410|FG000|Overall Study|Adverse Event|2|||
17083851|NCT03823378|38224411|FG001|Overall Study|Adverse Event|2|||
17083852|NCT03823378|38224412|FG002|Overall Study|Adverse Event|0|||
17083853|NCT03823378|38224413|FG003|Overall Study|Adverse Event|0|||
17083854|NCT03823378|38224414|FG004|Overall Study|Adverse Event|0|||
17083855|NCT03823378|38224415|FG005|Overall Study|Adverse Event|0|||
17083856|NCT03823378|38224410|FG000|Overall Study|Lost to Follow-up|0|||
17083857|NCT03823378|38224411|FG001|Overall Study|Lost to Follow-up|1|||
17083858|NCT03823378|38224412|FG002|Overall Study|Lost to Follow-up|0|||
17083859|NCT03823378|38224413|FG003|Overall Study|Lost to Follow-up|0|||
17083860|NCT03823378|38224414|FG004|Overall Study|Lost to Follow-up|1|||
17083861|NCT03823378|38224415|FG005|Overall Study|Lost to Follow-up|0|||
17083862|NCT03823378|38224410|FG000|Overall Study|Withdrawal by Subject|0|||
17163925|NCT02858726|38312123|FG001|Overall Study|Protocol Violation|0|||
17163926|NCT02858726|38312124|FG002|Overall Study|Protocol Violation|0|||
17163927|NCT02858726|38312125|FG003|Overall Study|Protocol Violation|1|||
17163928|NCT02858726|38312122|FG000|Overall Study|Study Terminated by Sponsor|0|||
17163929|NCT02858726|38312123|FG001|Overall Study|Study Terminated by Sponsor|0|||
17163930|NCT02858726|38312124|FG002|Overall Study|Study Terminated by Sponsor|0|||
17163931|NCT02858726|38312125|FG003|Overall Study|Study Terminated by Sponsor|1|||
17163932|NCT02858726|38312122|FG000|Overall Study|Withdrawal by Subject|1|||
17163933|NCT02858726|38312123|FG001|Overall Study|Withdrawal by Subject|2|||
17163934|NCT02858726|38312124|FG002|Overall Study|Withdrawal by Subject|1|||
17163935|NCT02858726|38312125|FG003|Overall Study|Withdrawal by Subject|0|||
17163936|NCT02858726|38312122|FG000|Overall Study|Noncompliance|0|||
16781303|NCT02105974|37720453|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
17083863|NCT03823378|38224411|FG001|Overall Study|Withdrawal by Subject|1|||
17083864|NCT03823378|38224412|FG002|Overall Study|Withdrawal by Subject|4|||
17083865|NCT03823378|38224413|FG003|Overall Study|Withdrawal by Subject|2|||
17163937|NCT02858726|38312123|FG001|Overall Study|Noncompliance|1|||
17083866|NCT03823378|38224414|FG004|Overall Study|Withdrawal by Subject|0|||
17083867|NCT03823378|38224415|FG005|Overall Study|Withdrawal by Subject|1|||
17083868|NCT03823378|38224410|FG000|Overall Study|Other, not specified|19|||
17083869|NCT03823378|38224411|FG001|Overall Study|Other, not specified|12|||
17163938|NCT02858726|38312124|FG002|Overall Study|Noncompliance|0|||
17163939|NCT02858726|38312125|FG003|Overall Study|Noncompliance|0|||
17163940|NCT03203291|38312139|FG000|Overall Study|Withdrawal by Subject|1|||
17163941|NCT01068678|38312145|FG000|Overall Study|Lack of Efficacy|3|||
17163942|NCT01068678|38312146|FG001|Overall Study|Lack of Efficacy|2|||
17163943|NCT01068678|38312145|FG000|Overall Study|Protocol Violation|5|||
17163944|NCT01068678|38312146|FG001|Overall Study|Protocol Violation|1|||
17163945|NCT01068678|38312145|FG000|Overall Study|Withdrawal criteria|12|||
17163946|NCT01068678|38312146|FG001|Overall Study|Withdrawal criteria|6|||
17163947|NCT01068678|38312145|FG000|Overall Study|Unclassified|18|||
17163948|NCT01068678|38312146|FG001|Overall Study|Unclassified|15|||
17163949|NCT03202511|38312152|FG000|Overall Study|Withdrawal by Subject|1|||
17163950|NCT03202511|38312153|FG001|Overall Study|Withdrawal by Subject|0|||
17163951|NCT03334435|38312164|FG000|Overall Study|Ongoing as of Week 52|70|||
17163952|NCT03334435|38312165|FG001|Overall Study|Ongoing as of Week 52|32|||
17163953|NCT03334435|38312166|FG002|Overall Study|Ongoing as of Week 52|379|||
17163954|NCT03334435|38312167|FG003|Overall Study|Ongoing as of Week 52|519|||
17163955|NCT03334435|38312168|FG004|Overall Study|Ongoing as of Week 52|146|||
17163956|NCT03334435|38312164|FG000|Overall Study|Lack of Efficacy|3|||
17163957|NCT03334435|38312165|FG001|Overall Study|Lack of Efficacy|5|||
17163958|NCT03334435|38312166|FG002|Overall Study|Lack of Efficacy|76|||
17163959|NCT03334435|38312167|FG003|Overall Study|Lack of Efficacy|140|||
17163960|NCT03334435|38312168|FG004|Overall Study|Lack of Efficacy|61|||
17163961|NCT03334435|38312164|FG000|Overall Study|Adverse Event|2|||
17163962|NCT03334435|38312165|FG001|Overall Study|Adverse Event|1|||
17163963|NCT03334435|38312166|FG002|Overall Study|Adverse Event|9|||
17163964|NCT03334435|38312167|FG003|Overall Study|Adverse Event|23|||
17163965|NCT03334435|38312168|FG004|Overall Study|Adverse Event|13|||
17163966|NCT03334435|38312164|FG000|Overall Study|Withdrawal by Subject|11|||
17163967|NCT03334435|38312165|FG001|Overall Study|Withdrawal by Subject|4|||
17163968|NCT03334435|38312166|FG002|Overall Study|Withdrawal by Subject|38|||
17163969|NCT03334435|38312167|FG003|Overall Study|Withdrawal by Subject|42|||
17163970|NCT03334435|38312168|FG004|Overall Study|Withdrawal by Subject|20|||
17163971|NCT03334435|38312164|FG000|Overall Study|Lost to Follow-up|3|||
17163972|NCT03334435|38312165|FG001|Overall Study|Lost to Follow-up|0|||
17163973|NCT03334435|38312166|FG002|Overall Study|Lost to Follow-up|2|||
17163974|NCT03334435|38312167|FG003|Overall Study|Lost to Follow-up|1|||
17163975|NCT03334435|38312168|FG004|Overall Study|Lost to Follow-up|1|||
17163976|NCT03334435|38312164|FG000|Overall Study|Death|0|||
17163977|NCT03334435|38312165|FG001|Overall Study|Death|0|||
17163978|NCT03334435|38312166|FG002|Overall Study|Death|0|||
17163979|NCT03334435|38312167|FG003|Overall Study|Death|1|||
17163980|NCT03334435|38312168|FG004|Overall Study|Death|0|||
17163981|NCT03334435|38312164|FG000|Overall Study|Other|0|||
17163982|NCT03334435|38312165|FG001|Overall Study|Other|1|||
17163983|NCT03334435|38312166|FG002|Overall Study|Other|3|||
17163984|NCT03334435|38312167|FG003|Overall Study|Other|2|||
17163985|NCT03334435|38312168|FG004|Overall Study|Other|1|||
17163986|NCT02919696|38312213|FG000|Overall Study|Adverse Event|1|||
17163987|NCT02919696|38312214|FG001|Overall Study|Adverse Event|2|||
17163988|NCT02919696|38312213|FG000|Overall Study|Withdrawal by Subject|2|||
17163989|NCT02919696|38312214|FG001|Overall Study|Withdrawal by Subject|1|||
17163990|NCT02919696|38312213|FG000|Overall Study|Sponsor Decision|1|||
17163991|NCT02919696|38312214|FG001|Overall Study|Sponsor Decision|1|||
17163992|NCT02919696|38312213|FG000|Overall Study|Never Treated|0|||
17163993|NCT02919696|38312214|FG001|Overall Study|Never Treated|1|||
17163994|NCT02935673|38312229|FG000|Overall Study|Adverse Event|0|||
17163995|NCT02935673|38312230|FG001|Overall Study|Adverse Event|1|||
17163996|NCT02935673|38312231|FG002|Overall Study|Adverse Event|0|||
17163997|NCT02935673|38312229|FG000|Overall Study|Withdrawal by Subject|1|||
17163998|NCT02935673|38312230|FG001|Overall Study|Withdrawal by Subject|2|||
17163999|NCT02935673|38312231|FG002|Overall Study|Withdrawal by Subject|0|||
17164000|NCT03201809|38312243|FG000|Overall Study|Lost to Follow-up|2|||
17164001|NCT03201809|38312244|FG001|Overall Study|Lost to Follow-up|0|||
17164002|NCT02919618|38312250|FG000|Overall Study|Death|1|||
17164003|NCT02985684|38312270|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
17164004|NCT02985684|38312270|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
17164005|NCT02985684|38312270|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
17164006|NCT02985450|38312274|FG000|Overall Study|Lost to Follow-up|7|||
17164007|NCT02908464|38312283|FG000|Overall Study|Withdrawal by Subject|2|||
17164008|NCT02908464|38312284|FG001|Overall Study|Withdrawal by Subject|1|||
17164009|NCT02908464|38312283|FG000|Overall Study|Found ineligible after randomization|0|||
17164010|NCT02908464|38312284|FG001|Overall Study|Found ineligible after randomization|2|||
17164011|NCT02907216|38312293|FG000|Overall Study|No benefit to be obtained by continuing|0|||
17164012|NCT02907216|38312294|FG001|Overall Study|No benefit to be obtained by continuing|1|||
17164013|NCT02907216|38312293|FG000|Overall Study|Withdrawal by Subject|1|||
17164014|NCT02907216|38312294|FG001|Overall Study|Withdrawal by Subject|0|||
17164015|NCT02984982|38312302|FG000|Overall Study|Adverse Event|2|||
17164016|NCT02984982|38312303|FG001|Overall Study|Adverse Event|5|||
17164017|NCT02984982|38312302|FG000|Overall Study|Poor Compliance to Protocol|4|||
17164018|NCT02984982|38312303|FG001|Overall Study|Poor Compliance to Protocol|4|||
17164019|NCT02984982|38312302|FG000|Overall Study|Withdrawal by Subject|2|||
17164020|NCT02984982|38312303|FG001|Overall Study|Withdrawal by Subject|0|||
17164021|NCT02984982|38312302|FG000|Overall Study|Randomized but not treated|0|||
17164022|NCT02984982|38312303|FG001|Overall Study|Randomized but not treated|1|||
17164023|NCT02981472|38312312|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
17164024|NCT02981472|38312313|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
17164025|NCT02981472|38312312|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
17164026|NCT02981472|38312313|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
17164027|NCT02981472|38312312|FG000|Treatment Period|Adverse Event|6|||
17164028|NCT02981472|38312313|FG001|Treatment Period|Adverse Event|1|||
17164029|NCT02981472|38312312|FG000|Treatment Period|Participant withdrew consent|1|||
17164030|NCT02981472|38312313|FG001|Treatment Period|Participant withdrew consent|0|||
17164031|NCT02981472|38312312|FG000|Treatment Period|Lost to Follow-up|0|||
17164032|NCT02981472|38312313|FG001|Treatment Period|Lost to Follow-up|1|||
17164033|NCT02982720|38312325|FG000|Overall Study|Adverse Event|3|||
17164034|NCT02982720|38312325|FG000|Overall Study|Death|1|||
17164035|NCT00849667|38312332|FG000|Overall Study|Withdrawal by Subject|16|||
17164036|NCT00849667|38312333|FG001|Overall Study|Withdrawal by Subject|33|||
17164037|NCT00849667|38312334|FG002|Overall Study|Withdrawal by Subject|35|||
17164038|NCT00849667|38312332|FG000|Overall Study|Lost to Follow-up|8|||
17164039|NCT00849667|38312333|FG001|Overall Study|Lost to Follow-up|8|||
17164040|NCT00849667|38312334|FG002|Overall Study|Lost to Follow-up|8|||
17164041|NCT00849667|38312332|FG000|Overall Study|Adverse Event|1|||
17164042|NCT00849667|38312333|FG001|Overall Study|Adverse Event|2|||
17164043|NCT00849667|38312334|FG002|Overall Study|Adverse Event|0|||
17164044|NCT00849667|38312332|FG000|Overall Study|Other|18|||
17164045|NCT00849667|38312333|FG001|Overall Study|Other|19|||
17164046|NCT00849667|38312334|FG002|Overall Study|Other|18|||
17164047|NCT00849667|38312332|FG000|Overall Study|Progressive disease|119|||
17164048|NCT00849667|38312333|FG001|Overall Study|Progressive disease|100|||
17164049|NCT00849667|38312334|FG002|Overall Study|Progressive disease|112|||
17164050|NCT00849667|38312332|FG000|Overall Study|Sponsor decision|208|||
17164051|NCT00849667|38312333|FG001|Overall Study|Sponsor decision|204|||
17164052|NCT00849667|38312334|FG002|Overall Study|Sponsor decision|190|||
17164053|NCT00849667|38312332|FG000|Overall Study|Investigator discretion|0|||
17164054|NCT00849667|38312333|FG001|Overall Study|Investigator discretion|0|||
17164055|NCT00849667|38312334|FG002|Overall Study|Investigator discretion|1|||
17164056|NCT03201419|38312353|FG000|Overall Study|Adverse Event|3|||
17164057|NCT03201419|38312354|FG001|Overall Study|Adverse Event|1|||
17164058|NCT03201419|38312355|FG002|Overall Study|Adverse Event|0|||
17164059|NCT03201419|38312356|FG003|Overall Study|Adverse Event|0|||
17164060|NCT03201419|38312357|FG004|Overall Study|Adverse Event|1|||
17164061|NCT03201419|38312358|FG005|Overall Study|Adverse Event|1|||
17164062|NCT03201419|38312359|FG006|Overall Study|Adverse Event|5|||
17164063|NCT03201419|38312360|FG007|Overall Study|Adverse Event|0|||
17164064|NCT03201419|38312361|FG008|Overall Study|Adverse Event|0|||
17164065|NCT03201419|38312353|FG000|Overall Study|Lost to Follow-up|1|||
17164066|NCT03201419|38312354|FG001|Overall Study|Lost to Follow-up|0|||
17164067|NCT03201419|38312355|FG002|Overall Study|Lost to Follow-up|0|||
17164068|NCT03201419|38312356|FG003|Overall Study|Lost to Follow-up|0|||
17164069|NCT03201419|38312357|FG004|Overall Study|Lost to Follow-up|0|||
17164070|NCT03201419|38312358|FG005|Overall Study|Lost to Follow-up|0|||
17164071|NCT03201419|38312359|FG006|Overall Study|Lost to Follow-up|0|||
17164072|NCT03201419|38312360|FG007|Overall Study|Lost to Follow-up|0|||
17164073|NCT03201419|38312361|FG008|Overall Study|Lost to Follow-up|0|||
17164074|NCT03201419|38312353|FG000|Overall Study|Protocol Deviation|0|||
17164075|NCT03201419|38312354|FG001|Overall Study|Protocol Deviation|0|||
17164076|NCT03201419|38312355|FG002|Overall Study|Protocol Deviation|0|||
17164077|NCT03201419|38312356|FG003|Overall Study|Protocol Deviation|0|||
17164078|NCT03201419|38312357|FG004|Overall Study|Protocol Deviation|0|||
17164079|NCT03201419|38312358|FG005|Overall Study|Protocol Deviation|0|||
17164080|NCT03201419|38312359|FG006|Overall Study|Protocol Deviation|1|||
17164081|NCT03201419|38312360|FG007|Overall Study|Protocol Deviation|0|||
17164082|NCT03201419|38312361|FG008|Overall Study|Protocol Deviation|0|||
17164083|NCT03201419|38312353|FG000|Overall Study|Withdrawal by Subject|4|||
17164084|NCT03201419|38312354|FG001|Overall Study|Withdrawal by Subject|2|||
17164085|NCT03201419|38312355|FG002|Overall Study|Withdrawal by Subject|1|||
17164086|NCT03201419|38312356|FG003|Overall Study|Withdrawal by Subject|0|||
17164087|NCT03201419|38312357|FG004|Overall Study|Withdrawal by Subject|0|||
17164088|NCT03201419|38312358|FG005|Overall Study|Withdrawal by Subject|0|||
17164089|NCT03201419|38312359|FG006|Overall Study|Withdrawal by Subject|0|||
17164090|NCT03201419|38312360|FG007|Overall Study|Withdrawal by Subject|1|||
17164091|NCT03201419|38312361|FG008|Overall Study|Withdrawal by Subject|2|||
17164092|NCT03201419|38312353|FG000|Overall Study|Other|0|||
17164093|NCT03201419|38312354|FG001|Overall Study|Other|0|||
17164094|NCT03201419|38312355|FG002|Overall Study|Other|1|||
17164095|NCT03201419|38312356|FG003|Overall Study|Other|0|||
17164096|NCT03201419|38312357|FG004|Overall Study|Other|0|||
17164097|NCT03201419|38312358|FG005|Overall Study|Other|0|||
17164098|NCT03201419|38312359|FG006|Overall Study|Other|0|||
17164099|NCT03201419|38312360|FG007|Overall Study|Other|0|||
17164100|NCT03201419|38312361|FG008|Overall Study|Other|0|||
17164101|NCT01764633|38312397|FG000|Overall Study|Withdrawal by Subject|105|||
17164102|NCT01764633|38312398|FG001|Overall Study|Withdrawal by Subject|88|||
17164103|NCT01764633|38312397|FG000|Overall Study|Lost to Follow-up|13|||
17164104|NCT01764633|38312398|FG001|Overall Study|Lost to Follow-up|5|||
17164105|NCT02924389|38312406|FG000|Overall Study|Lost to Follow-up|1|||
17164106|NCT02924389|38312407|FG001|Overall Study|Lost to Follow-up|0|||
17164107|NCT02924389|38312406|FG000|Overall Study|Physician Decision|2|||
17164108|NCT02924389|38312407|FG001|Overall Study|Physician Decision|0|||
17164109|NCT02924389|38312406|FG000|Overall Study|Withdrawal by Subject|3|||
17164110|NCT02924389|38312407|FG001|Overall Study|Withdrawal by Subject|0|||
17164111|NCT02924389|38312406|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
17164112|NCT02924389|38312407|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
17164113|NCT03235349|38312414|FG000|Overall Study|Adverse Event|1|||
17164114|NCT03235349|38312414|FG000|Overall Study|Other|1|||
17164115|NCT03235115|38312418|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
17164116|NCT03235115|38312419|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
17164117|NCT03235115|38312420|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
17164118|NCT03235115|38312421|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
17164119|NCT03235115|38312422|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
17164120|NCT03235115|38312423|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
17164121|NCT02923531|38312431|FG000|Overall Study|Adverse Event|4|||
17164122|NCT02923531|38312431|FG000|Overall Study|Clinical Deterioration|1|||
17164123|NCT02923531|38312431|FG000|Overall Study|Disease Progression|3|||
17164124|NCT02923531|38312431|FG000|Overall Study|Study Termination|1|||
17164125|NCT02934503|38312436|FG000|Overall Study|progression of disease|3|||
17164126|NCT02934503|38312436|FG000|Overall Study|Withdrawal by Subject|1|||
17164127|NCT02937545|38312442|FG000|Overall Study|Withdrawal by Subject|1|||
17164128|NCT02937545|38312443|FG001|Overall Study|Withdrawal by Subject|2|||
17164129|NCT02937545|38312444|FG002|Overall Study|Withdrawal by Subject|6|||
17164130|NCT02937545|38312445|FG003|Overall Study|Withdrawal by Subject|7|||
17164131|NCT02937545|38312442|FG000|Overall Study|Lost to Follow-up|1|||
17164132|NCT02937545|38312443|FG001|Overall Study|Lost to Follow-up|0|||
17164133|NCT02937545|38312444|FG002|Overall Study|Lost to Follow-up|0|||
17164134|NCT02937545|38312445|FG003|Overall Study|Lost to Follow-up|0|||
17164135|NCT03199391|38312456|FG000|Overall Study|Death|1|||
17164136|NCT03199391|38312456|FG000|Overall Study|Lost to Follow-up|3|||
17164137|NCT03199391|38312456|FG000|Overall Study|Adverse Event|2|||
17164138|NCT03199391|38312456|FG000|Overall Study|Withdrawal by Subject|10|||
17164139|NCT03198767|38312467|FG000|Overall Study|Protocol Violation|0|||
17164140|NCT03198767|38312468|FG001|Overall Study|Protocol Violation|0|||
17164141|NCT03198767|38312469|FG002|Overall Study|Protocol Violation|0|||
17164142|NCT03198767|38312470|FG003|Overall Study|Protocol Violation|6|||
17164143|NCT03198767|38312471|FG004|Overall Study|Protocol Violation|0|||
17164144|NCT03198767|38312472|FG005|Overall Study|Protocol Violation|0|||
17164145|NCT03198767|38312473|FG006|Overall Study|Protocol Violation|0|||
17164146|NCT03162055|38312490|FG000|Overall Study|Adverse Event|6|||
17164147|NCT03162055|38312491|FG001|Overall Study|Adverse Event|5|||
17164148|NCT03162055|38312490|FG000|Overall Study|Death|3|||
17164149|NCT03162055|38312491|FG001|Overall Study|Death|3|||
17164150|NCT03162055|38312490|FG000|Overall Study|Lost to Follow-up|0|||
17164151|NCT03162055|38312491|FG001|Overall Study|Lost to Follow-up|1|||
17164152|NCT03162055|38312490|FG000|Overall Study|Study-specific withdrawal criteria|22|||
17164153|NCT03162055|38312491|FG001|Overall Study|Study-specific withdrawal criteria|14|||
17164154|NCT03162055|38312490|FG000|Overall Study|Withdrawal by Subject|17|||
17164155|NCT03162055|38312491|FG001|Overall Study|Withdrawal by Subject|2|||
17164156|NCT03162055|38312490|FG000|Overall Study|Did not receive treatment|2|||
17164157|NCT03162055|38312491|FG001|Overall Study|Did not receive treatment|0|||
17164158|NCT03162055|38312490|FG000|Overall Study|Incorrect randomization|4|||
17164159|NCT03162055|38312491|FG001|Overall Study|Incorrect randomization|3|||
17164160|NCT03162055|38312490|FG000|Overall Study|Other|8|||
17164161|NCT03162055|38312491|FG001|Overall Study|Other|15|||
17164162|NCT02927145|38312504|FG000|Initial Recruitment|Withdrawal by Subject|0|||
17164163|NCT02927145|38312505|FG001|Initial Recruitment|Withdrawal by Subject|1|||
17164164|NCT02927145|38312506|FG002|Initial Recruitment|Withdrawal by Subject|1|||
17164165|NCT02927145|38312507|FG003|Initial Recruitment|Withdrawal by Subject|4|||
17164166|NCT02927145|38312508|FG004|Initial Recruitment|Withdrawal by Subject|1|||
17164167|NCT02927145|38312509|FG005|Initial Recruitment|Withdrawal by Subject|1|||
17164168|NCT02927145|38312510|FG006|Initial Recruitment|Withdrawal by Subject|0|||
17164169|NCT02927145|38312511|FG007|Initial Recruitment|Withdrawal by Subject|0|||
17164170|NCT02927145|38312512|FG008|Initial Recruitment|Withdrawal by Subject|2|||
17164171|NCT02927145|38312504|FG000|Initial Recruitment|Adverse Event|0|||
17164172|NCT02927145|38312505|FG001|Initial Recruitment|Adverse Event|0|||
17164173|NCT02927145|38312506|FG002|Initial Recruitment|Adverse Event|0|||
17164174|NCT02927145|38312507|FG003|Initial Recruitment|Adverse Event|0|||
17164175|NCT02927145|38312508|FG004|Initial Recruitment|Adverse Event|2|||
17164176|NCT02927145|38312509|FG005|Initial Recruitment|Adverse Event|0|||
17164177|NCT02927145|38312510|FG006|Initial Recruitment|Adverse Event|0|||
17164178|NCT02927145|38312511|FG007|Initial Recruitment|Adverse Event|0|||
17164179|NCT02927145|38312512|FG008|Initial Recruitment|Adverse Event|0|||
17164180|NCT02927145|38312504|FG000|Invitation for Additional Challenge|Pregnancy|0|||
17164181|NCT02927145|38312505|FG001|Invitation for Additional Challenge|Pregnancy|0|||
17164182|NCT02927145|38312506|FG002|Invitation for Additional Challenge|Pregnancy|0|||
17164183|NCT02927145|38312507|FG003|Invitation for Additional Challenge|Pregnancy|0|||
17164184|NCT02927145|38312508|FG004|Invitation for Additional Challenge|Pregnancy|0|||
17164185|NCT02927145|38312509|FG005|Invitation for Additional Challenge|Pregnancy|0|||
17164186|NCT02927145|38312510|FG006|Invitation for Additional Challenge|Pregnancy|1|||
17164187|NCT02927145|38312511|FG007|Invitation for Additional Challenge|Pregnancy|0|||
17164188|NCT02927145|38312512|FG008|Invitation for Additional Challenge|Pregnancy|0|||
17164189|NCT03688919|38312535|FG000|Overall Study|Lost to Follow-up|2|||
17164190|NCT03688919|38312536|FG001|Overall Study|Lost to Follow-up|1|||
17164191|NCT03688919|38312535|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
17164192|NCT03688919|38312536|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
17164193|NCT02888119|38312559|FG000|Overall Study|Lost to Follow-up|5|||
17164194|NCT02888119|38312560|FG001|Overall Study|Lost to Follow-up|4|||
17164195|NCT02888119|38312561|FG002|Overall Study|Lost to Follow-up|0|||
17164196|NCT03197129|38312570|FG000|Overall Study|did not answer the VPT: shyness|4|||
17164197|NCT03197129|38312571|FG001|Overall Study|did not answer the VPT: shyness|5|||
17164198|NCT03196973|38312580|FG000|Overall Study|Adverse Event|1|||
17164199|NCT03196973|38312581|FG001|Overall Study|Adverse Event|1|||
17164200|NCT03196973|38312582|FG002|Overall Study|Adverse Event|2|||
17164201|NCT03196973|38312580|FG000|Overall Study|Lack of Efficacy|2|||
17164202|NCT03196973|38312581|FG001|Overall Study|Lack of Efficacy|6|||
17164203|NCT03196973|38312582|FG002|Overall Study|Lack of Efficacy|1|||
17164204|NCT03196973|38312580|FG000|Overall Study|Lost to Follow-up|4|||
17164205|NCT03196973|38312581|FG001|Overall Study|Lost to Follow-up|3|||
17164206|NCT03196973|38312582|FG002|Overall Study|Lost to Follow-up|2|||
17164207|NCT03196973|38312580|FG000|Overall Study|Consent withdrawn|2|||
17164208|NCT03196973|38312581|FG001|Overall Study|Consent withdrawn|1|||
17164209|NCT03196973|38312582|FG002|Overall Study|Consent withdrawn|0|||
17164210|NCT03196973|38312580|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
17164211|NCT03196973|38312581|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
17164212|NCT03196973|38312582|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
17164213|NCT03196505|38312592|FG000|Overall Study|Physician Decision|26|||
17164214|NCT03196505|38312593|FG001|Overall Study|Physician Decision|26|||
17164215|NCT03196349|38312602|FG000|Overall Study|Did not receive study drug|0|||
17164216|NCT03196349|38312603|FG001|Overall Study|Did not receive study drug|1|||
17164217|NCT03196349|38312604|FG002|Overall Study|Did not receive study drug|2|||
17083870|NCT03823378|38224412|FG002|Overall Study|Other, not specified|6|||
17083871|NCT03823378|38224413|FG003|Overall Study|Other, not specified|8|||
17164218|NCT03196349|38312602|FG000|Overall Study|No data entered|2|||
17164219|NCT03196349|38312603|FG001|Overall Study|No data entered|4|||
17164220|NCT03196349|38312604|FG002|Overall Study|No data entered|0|||
17083872|NCT03823378|38224414|FG004|Overall Study|Other, not specified|17|||
17083873|NCT03823378|38224415|FG005|Overall Study|Other, not specified|7|||
17083874|NCT00142792|38224432|FG000|Overall Study|Death|0|||
17083875|NCT00142792|38224433|FG001|Overall Study|Death|0|||
17083876|NCT00142792|38224434|FG002|Overall Study|Death|1|||
17083877|NCT00142792|38224432|FG000|Overall Study|Withdrawal by Subject|3|||
17083878|NCT00142792|38224433|FG001|Overall Study|Withdrawal by Subject|2|||
17083879|NCT00142792|38224434|FG002|Overall Study|Withdrawal by Subject|3|||
17083880|NCT00142792|38224432|FG000|Overall Study|Lost to Follow-up|8|||
17083881|NCT00142792|38224433|FG001|Overall Study|Lost to Follow-up|11|||
17083882|NCT00142792|38224434|FG002|Overall Study|Lost to Follow-up|7|||
17083883|NCT00142792|38224432|FG000|Overall Study|No category|1|||
17083884|NCT00142792|38224433|FG001|Overall Study|No category|2|||
17083885|NCT00142792|38224434|FG002|Overall Study|No category|1|||
17083886|NCT00141778|38224445|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
17083887|NCT00141778|38224446|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
17083888|NCT00141778|38224447|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
17083889|NCT00141778|38224445|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
17083890|NCT00141778|38224446|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
17083891|NCT00141778|38224447|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
17083892|NCT00141778|38224445|FG000|Started Study Medication|Withdrawal by Subject|0|||
17083893|NCT00141778|38224446|FG001|Started Study Medication|Withdrawal by Subject|2|||
17164221|NCT03196349|38312602|FG000|Overall Study|Study Terminated early|15|||
17164222|NCT03196349|38312603|FG001|Overall Study|Study Terminated early|9|||
17164223|NCT03196349|38312604|FG002|Overall Study|Study Terminated early|11|||
17164224|NCT02886715|38312615|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17164225|NCT02886715|38312616|FG001|Overall Study|Non-Compliance With Study Drug|2|||
17164226|NCT02886715|38312617|FG002|Overall Study|Non-Compliance With Study Drug|0|||
17164227|NCT02886715|38312615|FG000|Overall Study|Adverse Event|4|||
17164228|NCT02886715|38312616|FG001|Overall Study|Adverse Event|2|||
17164229|NCT02886715|38312617|FG002|Overall Study|Adverse Event|0|||
17164230|NCT02886715|38312615|FG000|Overall Study|Lack of Efficacy|0|||
17164231|NCT02886715|38312616|FG001|Overall Study|Lack of Efficacy|2|||
17164232|NCT02886715|38312617|FG002|Overall Study|Lack of Efficacy|1|||
17164233|NCT02886715|38312615|FG000|Overall Study|Lost to Follow-up|29|||
17164234|NCT02886715|38312616|FG001|Overall Study|Lost to Follow-up|26|||
17164235|NCT02886715|38312617|FG002|Overall Study|Lost to Follow-up|10|||
17164236|NCT02886715|38312615|FG000|Overall Study|Pregnancy|1|||
17164237|NCT02886715|38312616|FG001|Overall Study|Pregnancy|1|||
17164238|NCT02886715|38312617|FG002|Overall Study|Pregnancy|1|||
17164239|NCT02886715|38312615|FG000|Overall Study|Protocol Violation|3|||
17164240|NCT02886715|38312616|FG001|Overall Study|Protocol Violation|2|||
17164241|NCT02886715|38312617|FG002|Overall Study|Protocol Violation|1|||
17164242|NCT02886715|38312615|FG000|Overall Study|Withdrawal by Subject|20|||
17164243|NCT02886715|38312616|FG001|Overall Study|Withdrawal by Subject|18|||
17164244|NCT02886715|38312617|FG002|Overall Study|Withdrawal by Subject|5|||
17164245|NCT02886715|38312615|FG000|Overall Study|missing|7|||
17164246|NCT02886715|38312616|FG001|Overall Study|missing|2|||
17164247|NCT02886715|38312617|FG002|Overall Study|missing|2|||
17164248|NCT03085797|38312627|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
17164249|NCT03085797|38312628|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
17164250|NCT03085797|38312627|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
17164251|NCT03085797|38312628|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
17164252|NCT03085797|38312627|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
17164253|NCT03085797|38312628|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
17164254|NCT03157531|38312636|FG000|Overall Study|Death|2|||
17164255|NCT03157531|38312636|FG000|Overall Study|Lost to Follow-up|4|||
17164256|NCT03633617|38312645|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
17164257|NCT03633617|38312646|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
17164258|NCT03633617|38312647|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
17164259|NCT03633617|38312648|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
17164260|NCT03633617|38312649|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
17083894|NCT00141778|38224447|FG002|Started Study Medication|Withdrawal by Subject|0|||
17083895|NCT00141778|38224445|FG000|Started Study Medication|Difficulty Swallowing|0|||
17083896|NCT00141778|38224446|FG001|Started Study Medication|Difficulty Swallowing|1|||
17083897|NCT00141778|38224447|FG002|Started Study Medication|Difficulty Swallowing|0|||
17083898|NCT00141778|38224445|FG000|Started Study Medication|Chest Discomfort|0|||
17083899|NCT00141778|38224446|FG001|Started Study Medication|Chest Discomfort|0|||
17083900|NCT00141778|38224447|FG002|Started Study Medication|Chest Discomfort|1|||
17083901|NCT00127660|38224459|FG000|Overall Study|Protocol Violation|3|||
17083902|NCT00127660|38224460|FG001|Overall Study|Protocol Violation|3|||
17083903|NCT00127660|38224461|FG002|Overall Study|Protocol Violation|5|||
17083904|NCT00127660|38224462|FG003|Overall Study|Protocol Violation|0|||
17083905|NCT03817528|38224472|FG000|Overall Study|Withdrawal by Subject|1|||
17083906|NCT03817528|38224472|FG000|Overall Study|Adverse Event|2|||
17083907|NCT00115336|38224478|FG000|Overall Study|Hospital discharge before study drug|0|||
17083908|NCT00115336|38224479|FG001|Overall Study|Hospital discharge before study drug|1|||
17083909|NCT00205803|38224489|FG000|Infant Series|Lost to Follow-up|10|||
17083910|NCT00205803|38224490|FG001|Infant Series|Lost to Follow-up|4|||
17083911|NCT00205803|38224489|FG000|Infant Series|Withdrawal by Subject|2|||
17083912|NCT00205803|38224490|FG001|Infant Series|Withdrawal by Subject|5|||
17083913|NCT00205803|38224489|FG000|Infant Series|Physician Decision|3|||
17083914|NCT00205803|38224490|FG001|Infant Series|Physician Decision|1|||
17083915|NCT00205803|38224489|FG000|Infant Series|Protocol Violation|1|||
17083916|NCT00205803|38224490|FG001|Infant Series|Protocol Violation|0|||
17083917|NCT00205803|38224489|FG000|Infant Series|Lost Kaiser coverage|0|||
17083918|NCT00205803|38224490|FG001|Infant Series|Lost Kaiser coverage|1|||
17083919|NCT00205803|38224489|FG000|Infant Series|Non-compliant|1|||
17083920|NCT00205803|38224490|FG001|Infant Series|Non-compliant|0|||
17083921|NCT00205803|38224489|FG000|Infant Series|Sponsor request|1|||
17083922|NCT00205803|38224490|FG001|Infant Series|Sponsor request|0|||
17083923|NCT00205803|38224489|FG000|After Infant Series|Adverse Event|1|||
17083924|NCT00205803|38224490|FG001|After Infant Series|Adverse Event|1|||
17083925|NCT00205803|38224489|FG000|After Infant Series|Protocol Violation|1|||
17083926|NCT00205803|38224490|FG001|After Infant Series|Protocol Violation|1|||
17083927|NCT00205803|38224489|FG000|After Infant Series|Lost to Follow-up|2|||
17083928|NCT00205803|38224490|FG001|After Infant Series|Lost to Follow-up|1|||
17083929|NCT00205803|38224489|FG000|After Infant Series|Physician Decision|3|||
17164261|NCT03633617|38312645|FG000|Part A|Unconfirmed early termination visit|1|||
17164262|NCT03633617|38312646|FG001|Part A|Unconfirmed early termination visit|0|||
17164263|NCT03633617|38312647|FG002|Part A|Unconfirmed early termination visit|0|||
17164264|NCT03633617|38312648|FG003|Part A|Unconfirmed early termination visit|0|||
17164265|NCT03633617|38312649|FG004|Part A|Unconfirmed early termination visit|0|||
17164266|NCT03633617|38312645|FG000|Part A|Adverse Event|0|||
17164267|NCT03633617|38312646|FG001|Part A|Adverse Event|1|||
17164268|NCT03633617|38312647|FG002|Part A|Adverse Event|0|||
17164269|NCT03633617|38312648|FG003|Part A|Adverse Event|0|||
17164270|NCT03633617|38312649|FG004|Part A|Adverse Event|0|||
17164271|NCT03633617|38312645|FG000|Part A|Pregnancy|1|||
17164272|NCT03633617|38312646|FG001|Part A|Pregnancy|0|||
17164273|NCT03633617|38312647|FG002|Part A|Pregnancy|0|||
17164274|NCT03633617|38312648|FG003|Part A|Pregnancy|0|||
17164275|NCT03633617|38312649|FG004|Part A|Pregnancy|0|||
17164276|NCT03633617|38312645|FG000|Part A|Withdrawal by Subject|0|||
17164277|NCT03633617|38312646|FG001|Part A|Withdrawal by Subject|1|||
17164278|NCT03633617|38312647|FG002|Part A|Withdrawal by Subject|0|||
17164279|NCT03633617|38312648|FG003|Part A|Withdrawal by Subject|0|||
17164280|NCT03633617|38312649|FG004|Part A|Withdrawal by Subject|0|||
17164281|NCT03633617|38312645|FG000|Part B|Adverse Event|0|||
17164282|NCT03633617|38312646|FG001|Part B|Adverse Event|0|||
17164283|NCT03633617|38312647|FG002|Part B|Adverse Event|2|||
17164284|NCT03633617|38312648|FG003|Part B|Adverse Event|2|||
17164285|NCT03633617|38312649|FG004|Part B|Adverse Event|1|||
17164286|NCT03633617|38312645|FG000|Part B|Withdrawal by Subject|0|||
17164287|NCT03633617|38312646|FG001|Part B|Withdrawal by Subject|0|||
17164288|NCT03633617|38312647|FG002|Part B|Withdrawal by Subject|1|||
17164289|NCT03633617|38312648|FG003|Part B|Withdrawal by Subject|0|||
17164290|NCT03633617|38312649|FG004|Part B|Withdrawal by Subject|2|||
17164291|NCT03633617|38312645|FG000|Part B|Lost to Follow-up|0|||
17164292|NCT03633617|38312646|FG001|Part B|Lost to Follow-up|0|||
17164293|NCT03633617|38312647|FG002|Part B|Lost to Follow-up|0|||
17164294|NCT03633617|38312648|FG003|Part B|Lost to Follow-up|0|||
17164295|NCT03633617|38312649|FG004|Part B|Lost to Follow-up|1|||
17164296|NCT03633617|38312645|FG000|Part B|Physician Decision|0|||
17164297|NCT03633617|38312646|FG001|Part B|Physician Decision|0|||
17164298|NCT03633617|38312647|FG002|Part B|Physician Decision|0|||
17164299|NCT03633617|38312648|FG003|Part B|Physician Decision|0|||
17164300|NCT03633617|38312649|FG004|Part B|Physician Decision|1|||
17164301|NCT03633617|38312645|FG000|Part B|COVID-19 Restrictions|0|||
17164302|NCT03633617|38312646|FG001|Part B|COVID-19 Restrictions|0|||
17164303|NCT03633617|38312647|FG002|Part B|COVID-19 Restrictions|1|||
17164304|NCT03633617|38312648|FG003|Part B|COVID-19 Restrictions|0|||
17164305|NCT03633617|38312649|FG004|Part B|COVID-19 Restrictions|0|||
17164306|NCT03633617|38312645|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
17164307|NCT03633617|38312646|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
17164308|NCT03633617|38312647|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
17164309|NCT03633617|38312648|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
17164310|NCT03633617|38312649|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
17164311|NCT03159091|38312663|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
17164312|NCT03159091|38312664|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
17164313|NCT03159091|38312663|FG000|Overall Study|Patient has taken no dose of study drug|0|||
17164314|NCT03159091|38312664|FG001|Overall Study|Patient has taken no dose of study drug|1|||
17164315|NCT03196193|38312672|FG000|Overall Study|Adverse Event|1|||
17164316|NCT03196193|38312673|FG001|Overall Study|Adverse Event|0|||
17164317|NCT03196193|38312672|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
17164318|NCT03196193|38312673|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
17164319|NCT03621761|38312682|FG000|Overall Study|Lost to Follow-up|1|||
17164320|NCT03621761|38312683|FG001|Overall Study|Lost to Follow-up|1|||
17164321|NCT03621761|38312684|FG002|Overall Study|Lost to Follow-up|2|||
17164322|NCT03621761|38312682|FG000|Overall Study|Withdrawal by Subject|2|||
17164323|NCT03621761|38312683|FG001|Overall Study|Withdrawal by Subject|1|||
17164324|NCT03621761|38312684|FG002|Overall Study|Withdrawal by Subject|1|||
17164325|NCT03621761|38312682|FG000|Overall Study|Became Ineligible|0|||
17083930|NCT00205803|38224490|FG001|After Infant Series|Physician Decision|2|||
17083931|NCT00205803|38224489|FG000|After Infant Series|Withdrawal by Subject|1|||
17083932|NCT00205803|38224490|FG001|After Infant Series|Withdrawal by Subject|4|||
17083933|NCT00205803|38224489|FG000|After Infant Series|Other|10|||
17083934|NCT00205803|38224490|FG001|After Infant Series|Other|4|||
17083935|NCT00205803|38224489|FG000|Toddler Dose|Lost to Follow-up|2|||
17083936|NCT00205803|38224490|FG001|Toddler Dose|Lost to Follow-up|3|||
17083937|NCT00127192|38224519|FG000|Overall Study|Adverse Event|0|||
17083938|NCT00127192|38224520|FG001|Overall Study|Adverse Event|1|||
17164326|NCT03621761|38312683|FG001|Overall Study|Became Ineligible|2|||
17164327|NCT03621761|38312684|FG002|Overall Study|Became Ineligible|0|||
17164328|NCT03221387|38312692|FG000|Overall Study|Lost to Follow-up|1|||
17164329|NCT03221387|38312692|FG000|Overall Study|Lung transplant|1|||
17083939|NCT00127192|38224521|FG002|Overall Study|Adverse Event|1|||
17164330|NCT03318861|38312701|FG000|Overall Study|Death|1|||
17164331|NCT03318861|38312702|FG001|Overall Study|Death|2|||
17164332|NCT03318861|38312703|FG002|Overall Study|Death|2|||
17164333|NCT03318861|38312704|FG003|Overall Study|Death|1|||
17164334|NCT03318861|38312705|FG004|Overall Study|Death|1|||
17164335|NCT03318861|38312701|FG000|Overall Study|Still on Study|2|||
17164336|NCT03318861|38312702|FG001|Overall Study|Still on Study|1|||
17164337|NCT03318861|38312703|FG002|Overall Study|Still on Study|1|||
17164338|NCT03318861|38312704|FG003|Overall Study|Still on Study|2|||
17164339|NCT03318861|38312705|FG004|Overall Study|Still on Study|1|||
17164340|NCT03318861|38312701|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
17164341|NCT03318861|38312702|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
17164342|NCT03318861|38312703|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
17164343|NCT03318861|38312704|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
17164344|NCT03318861|38312705|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
17164345|NCT03084315|38312719|FG000|Overall Study|Lost to Follow-up|8|||
17164346|NCT03084315|38312720|FG001|Overall Study|Lost to Follow-up|7|||
17164347|NCT03084315|38312719|FG000|Overall Study|Withdrawal by Subject|2|||
17164348|NCT03084315|38312720|FG001|Overall Study|Withdrawal by Subject|2|||
17164349|NCT03187301|38312726|FG000|Titration Period|Adverse Event|0|||
17164350|NCT03187301|38312727|FG001|Titration Period|Adverse Event|0|||
17164351|NCT03187301|38312728|FG002|Titration Period|Adverse Event|0|||
17164352|NCT03187301|38312729|FG003|Titration Period|Adverse Event|0|||
17164353|NCT03187301|38312730|FG004|Titration Period|Adverse Event|0|||
17164354|NCT03187301|38312731|FG005|Titration Period|Adverse Event|0|||
17164355|NCT03187301|38312732|FG006|Titration Period|Adverse Event|5|||
17164356|NCT03187301|38312726|FG000|Titration Period|Withdrawal by Subject|0|||
17164357|NCT03187301|38312727|FG001|Titration Period|Withdrawal by Subject|0|||
17164358|NCT03187301|38312728|FG002|Titration Period|Withdrawal by Subject|0|||
17164359|NCT03187301|38312729|FG003|Titration Period|Withdrawal by Subject|0|||
17164360|NCT03187301|38312730|FG004|Titration Period|Withdrawal by Subject|0|||
17164361|NCT03187301|38312731|FG005|Titration Period|Withdrawal by Subject|0|||
17164362|NCT03187301|38312732|FG006|Titration Period|Withdrawal by Subject|1|||
17164363|NCT03187301|38312726|FG000|Titration Period|Exclusion Criteria Met|0|||
17164364|NCT03187301|38312727|FG001|Titration Period|Exclusion Criteria Met|0|||
17164365|NCT03187301|38312728|FG002|Titration Period|Exclusion Criteria Met|0|||
17164366|NCT03187301|38312729|FG003|Titration Period|Exclusion Criteria Met|0|||
17164367|NCT03187301|38312730|FG004|Titration Period|Exclusion Criteria Met|0|||
17164368|NCT03187301|38312731|FG005|Titration Period|Exclusion Criteria Met|0|||
17083940|NCT00127192|38224522|FG003|Overall Study|Adverse Event|1|||
17164369|NCT03187301|38312732|FG006|Titration Period|Exclusion Criteria Met|1|||
17164370|NCT03187301|38312726|FG000|Pre-Intervention|Withdrawal by Subject|1|||
17164371|NCT03187301|38312727|FG001|Pre-Intervention|Withdrawal by Subject|0|||
17164372|NCT03187301|38312728|FG002|Pre-Intervention|Withdrawal by Subject|0|||
17164373|NCT03187301|38312729|FG003|Pre-Intervention|Withdrawal by Subject|0|||
17164374|NCT03187301|38312730|FG004|Pre-Intervention|Withdrawal by Subject|0|||
17164375|NCT03187301|38312731|FG005|Pre-Intervention|Withdrawal by Subject|0|||
17164376|NCT03187301|38312732|FG006|Pre-Intervention|Withdrawal by Subject|0|||
17164377|NCT02946047|38312757|FG000|Overall Study|Adverse Event|1|||
17083941|NCT00127192|38224523|FG004|Overall Study|Adverse Event|0|||
17083942|NCT00127192|38224519|FG000|Overall Study|Lack of Efficacy|2|||
17083943|NCT00127192|38224520|FG001|Overall Study|Lack of Efficacy|0|||
17083944|NCT00127192|38224521|FG002|Overall Study|Lack of Efficacy|0|||
17083945|NCT00127192|38224522|FG003|Overall Study|Lack of Efficacy|0|||
17083946|NCT00127192|38224523|FG004|Overall Study|Lack of Efficacy|2|||
17164378|NCT02946047|38312758|FG001|Overall Study|Adverse Event|0|||
17164379|NCT02946047|38312759|FG002|Overall Study|Adverse Event|0|||
17164380|NCT02946047|38312760|FG003|Overall Study|Adverse Event|0|||
17164381|NCT03077919|38312772|FG000|Overall Study|Lost to Follow-up|4|||
17164382|NCT03077919|38312773|FG001|Overall Study|Lost to Follow-up|1|||
17164383|NCT03220217|38312782|FG000|Overall Study|Withdrawal by Subject|0|||
17164384|NCT03220217|38312783|FG001|Overall Study|Withdrawal by Subject|1|||
17164385|NCT03220217|38312784|FG002|Overall Study|Withdrawal by Subject|0|||
17164386|NCT03220217|38312782|FG000|Overall Study|Subject Missed Procedure|0|||
17164387|NCT03220217|38312783|FG001|Overall Study|Subject Missed Procedure|0|||
17164388|NCT03220217|38312784|FG002|Overall Study|Subject Missed Procedure|1|||
17164389|NCT03192137|38312815|FG000|Overall Study|Adverse Event|10|||
17164390|NCT03192137|38312816|FG001|Overall Study|Adverse Event|11|||
17164391|NCT03192137|38312815|FG000|Overall Study|Physician Decision|1|||
17164392|NCT03192137|38312816|FG001|Overall Study|Physician Decision|0|||
17164393|NCT03192137|38312815|FG000|Overall Study|Lack of Efficacy|20|||
17164394|NCT03192137|38312816|FG001|Overall Study|Lack of Efficacy|37|||
17164395|NCT03192137|38312815|FG000|Overall Study|Withdrawal by Subject|3|||
17083947|NCT00127192|38224519|FG000|Overall Study|Withdrawal by Subject|0|||
17083948|NCT00127192|38224520|FG001|Overall Study|Withdrawal by Subject|0|||
17083949|NCT00127192|38224521|FG002|Overall Study|Withdrawal by Subject|1|||
17164396|NCT03192137|38312816|FG001|Overall Study|Withdrawal by Subject|3|||
17083950|NCT00127192|38224522|FG003|Overall Study|Withdrawal by Subject|0|||
17164397|NCT03192137|38312815|FG000|Overall Study|Protocol Violation|4|||
17164398|NCT03192137|38312816|FG001|Overall Study|Protocol Violation|3|||
17164399|NCT03192137|38312815|FG000|Overall Study|Surgery Cancelled|4|||
17164400|NCT03192137|38312816|FG001|Overall Study|Surgery Cancelled|1|||
17164401|NCT03192137|38312815|FG000|Overall Study|Other - Various Administrative Reasons|8|||
17164402|NCT03192137|38312816|FG001|Overall Study|Other - Various Administrative Reasons|3|||
17164403|NCT03881059|38312836|FG000|Treatment Period - Part A|Adverse Event|1|||
17164404|NCT03881059|38312837|FG001|Treatment Period - Part A|Adverse Event|3|||
17164405|NCT03881059|38312838|FG002|Treatment Period - Part A|Adverse Event|4|||
17164406|NCT03881059|38312836|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
17164407|NCT03881059|38312837|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
17164408|NCT03881059|38312838|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
17083951|NCT00127192|38224523|FG004|Overall Study|Withdrawal by Subject|3|||
17083952|NCT00127192|38224519|FG000|Overall Study|Adverse event in pre-treatment period|1|||
17083953|NCT00127192|38224520|FG001|Overall Study|Adverse event in pre-treatment period|0|||
17083954|NCT00127192|38224521|FG002|Overall Study|Adverse event in pre-treatment period|0|||
17083955|NCT00127192|38224522|FG003|Overall Study|Adverse event in pre-treatment period|0|||
17083956|NCT00127192|38224523|FG004|Overall Study|Adverse event in pre-treatment period|0|||
17083957|NCT00205179|38224537|FG000|Overall Study|Death|0|||
17083958|NCT00205179|38224538|FG001|Overall Study|Death|2|||
17083959|NCT00205179|38224537|FG000|Overall Study|Physician Decision|1|||
17083960|NCT00205179|38224538|FG001|Overall Study|Physician Decision|1|||
17083961|NCT00205179|38224537|FG000|Overall Study|Adverse Event|1|||
17083962|NCT00205179|38224538|FG001|Overall Study|Adverse Event|1|||
17083963|NCT00127036|38224547|FG000|Overall Study|Insufficient Data for Analysis|6|||
17083964|NCT00127036|38224548|FG001|Overall Study|Insufficient Data for Analysis|11|||
17083965|NCT00127036|38224547|FG000|Overall Study|Screen Failure|2|||
17083966|NCT00127036|38224548|FG001|Overall Study|Screen Failure|0|||
17083967|NCT00259857|38224556|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
17083968|NCT00259857|38224557|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
17083969|NCT00259857|38224556|FG000|24 Months Treatment|Lost to Follow-up|0|||
17083970|NCT00259857|38224557|FG001|24 Months Treatment|Lost to Follow-up|3|||
17083971|NCT00203307|38224565|FG000|First Intervention|Adverse Event|2|||
17083972|NCT00203307|38224566|FG001|First Intervention|Adverse Event|0|||
17083973|NCT00126568|38224572|FG000|Overall Study|Death|2|||
17083974|NCT00114634|38224577|FG000|Overall Study|failure to return forms|3|||
16996213|NCT00762502|38140217|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
16996214|NCT00762502|38140218|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
16996215|NCT00762502|38140219|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
16996216|NCT00762268|38140227|FG000|Overall Study|Withdrawal by Subject|3|||
16996217|NCT00762268|38140228|FG001|Overall Study|Withdrawal by Subject|3|||
16996218|NCT00975884|38140236|FG000|Overall Study|Adverse Event|1|||
16996219|NCT00975884|38140237|FG001|Overall Study|Adverse Event|0|||
16996220|NCT00975884|38140236|FG000|Overall Study|Lost to Follow-up|5|||
16996221|NCT00975884|38140237|FG001|Overall Study|Lost to Follow-up|3|||
16996222|NCT00975884|38140236|FG000|Overall Study|Withdrawal by Subject|9|||
16996223|NCT00975884|38140237|FG001|Overall Study|Withdrawal by Subject|9|||
16996224|NCT00975884|38140236|FG000|Overall Study|Other|1|||
16996225|NCT00975884|38140237|FG001|Overall Study|Other|3|||
16996226|NCT00578227|38140256|FG000|Overall Study|Lost to Follow-up|0|||
16996227|NCT00578227|38140257|FG001|Overall Study|Lost to Follow-up|1|||
16996228|NCT00578227|38140258|FG002|Overall Study|Lost to Follow-up|1|||
16996229|NCT00578227|38140256|FG000|Overall Study|Withdrawal by Subject|5|||
16996230|NCT00578227|38140257|FG001|Overall Study|Withdrawal by Subject|1|||
16996231|NCT00578227|38140258|FG002|Overall Study|Withdrawal by Subject|3|||
16996232|NCT00978380|38140268|FG000|Overall Study|Protocol Violation|2|||
16996233|NCT00978380|38140268|FG000|Overall Study|Withdrawal criteria|9|||
16996234|NCT00978380|38140268|FG000|Overall Study|Unclassified|8|||
16996235|NCT00577993|38140276|FG000|Overall Study|Adverse Event|1|||
16996236|NCT00577993|38140277|FG001|Overall Study|Adverse Event|0|||
16996237|NCT00577993|38140278|FG002|Overall Study|Adverse Event|0|||
16996238|NCT00577993|38140276|FG000|Overall Study|Death|0|||
16996239|NCT00577993|38140277|FG001|Overall Study|Death|1|||
16996240|NCT00577993|38140278|FG002|Overall Study|Death|1|||
16996241|NCT00577993|38140276|FG000|Overall Study|Lack of Efficacy|0|||
16996242|NCT00577993|38140277|FG001|Overall Study|Lack of Efficacy|1|||
16996243|NCT00577993|38140278|FG002|Overall Study|Lack of Efficacy|0|||
16996244|NCT00577993|38140276|FG000|Overall Study|Protocol Violation|2|||
16996245|NCT00577993|38140277|FG001|Overall Study|Protocol Violation|3|||
16996246|NCT00577993|38140278|FG002|Overall Study|Protocol Violation|0|||
16996247|NCT00577993|38140276|FG000|Overall Study|Withdrawal by Subject|1|||
16996248|NCT00577993|38140277|FG001|Overall Study|Withdrawal by Subject|0|||
16996249|NCT00577993|38140278|FG002|Overall Study|Withdrawal by Subject|2|||
16996250|NCT00577993|38140276|FG000|Overall Study|Conversion|2|||
17083975|NCT00202839|38224585|FG000|Overall Study|Adverse Event|1|||
17083976|NCT00202839|38224586|FG001|Overall Study|Adverse Event|5|||
17083977|NCT00202839|38224585|FG000|Overall Study|Physician Decision|12|||
17083978|NCT00202839|38224586|FG001|Overall Study|Physician Decision|0|||
17083979|NCT00202839|38224585|FG000|Overall Study|Withdrawal by Subject|6|||
17083980|NCT00202839|38224586|FG001|Overall Study|Withdrawal by Subject|2|||
17164409|NCT03881059|38312836|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
17164410|NCT03881059|38312837|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
17164411|NCT03881059|38312838|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
17164412|NCT03881059|38312836|FG000|Treatment Period - Part A|Other reasons|2|||
17164413|NCT03881059|38312837|FG001|Treatment Period - Part A|Other reasons|1|||
17164414|NCT03881059|38312838|FG002|Treatment Period - Part A|Other reasons|0|||
17164415|NCT03881059|38312836|FG000|Treatment Period - Part B|Adverse Event|0|||
17164416|NCT03881059|38312837|FG001|Treatment Period - Part B|Adverse Event|0|||
17164417|NCT03881059|38312838|FG002|Treatment Period - Part B|Adverse Event|3|||
17164418|NCT03881059|38312836|FG000|Treatment Period - Part B|Death|0|||
17164419|NCT03881059|38312837|FG001|Treatment Period - Part B|Death|1|||
17164420|NCT03881059|38312838|FG002|Treatment Period - Part B|Death|1|||
17164421|NCT03881059|38312836|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
17164422|NCT03881059|38312837|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
17164423|NCT03881059|38312838|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
17164424|NCT03881059|38312836|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
17164425|NCT03881059|38312837|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
17164426|NCT03881059|38312838|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
17083981|NCT00202839|38224585|FG000|Overall Study|Protocol Violation|2|||
17083982|NCT00202839|38224586|FG001|Overall Study|Protocol Violation|1|||
17083983|NCT00202839|38224585|FG000|Overall Study|Lost to Follow-up|3|||
17083984|NCT00202839|38224586|FG001|Overall Study|Lost to Follow-up|2|||
17083985|NCT00201201|38224594|FG000|Overall Study|Death|0|||
17083986|NCT00201201|38224595|FG001|Overall Study|Death|2|||
17164427|NCT03881059|38312836|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
17164428|NCT03881059|38312837|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
17164429|NCT03881059|38312838|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
17164430|NCT03881059|38312836|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
17164431|NCT03881059|38312837|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
17164432|NCT03881059|38312838|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
17164433|NCT03881059|38312836|FG000|Treatment Period - Part B|Other reasons|4|||
17164434|NCT03881059|38312837|FG001|Treatment Period - Part B|Other reasons|3|||
17164435|NCT03881059|38312838|FG002|Treatment Period - Part B|Other reasons|3|||
17164436|NCT02861534|38312853|FG000|Overall Study|Death|541|||
17164437|NCT02861534|38312854|FG001|Overall Study|Death|552|||
17164438|NCT02861534|38312853|FG000|Overall Study|Lost to Follow-up|14|||
17164439|NCT02861534|38312854|FG001|Overall Study|Lost to Follow-up|14|||
17164440|NCT02861534|38312853|FG000|Overall Study|Site Terminated by Sponsor|4|||
17164441|NCT02861534|38312854|FG001|Overall Study|Site Terminated by Sponsor|3|||
17164442|NCT02861534|38312853|FG000|Overall Study|Withdrawal by Subject|15|||
17164443|NCT02861534|38312854|FG001|Overall Study|Withdrawal by Subject|18|||
17164444|NCT03083847|38312895|FG000|Main|Physician Decision|0|||
17164445|NCT03083847|38312896|FG001|Main|Physician Decision|0|||
17164446|NCT03083847|38312897|FG002|Main|Physician Decision|0|||
17164447|NCT03083847|38312898|FG003|Main|Physician Decision|0|||
17164448|NCT03083847|38312899|FG004|Main|Physician Decision|0|||
17164449|NCT03083847|38312900|FG005|Main|Physician Decision|1|||
17164450|NCT03083847|38312901|FG006|Main|Physician Decision|0|||
17164451|NCT03083847|38312902|FG007|Main|Physician Decision|0|||
17164452|NCT03083847|38312903|FG008|Main|Physician Decision|0|||
17164453|NCT03083847|38312904|FG009|Main|Physician Decision|0|||
17164454|NCT03083847|38312895|FG000|Main|Pregnancy|0|||
17164455|NCT03083847|38312896|FG001|Main|Pregnancy|0|||
17164456|NCT03083847|38312897|FG002|Main|Pregnancy|0|||
17164457|NCT03083847|38312898|FG003|Main|Pregnancy|0|||
17164458|NCT03083847|38312899|FG004|Main|Pregnancy|0|||
17164459|NCT03083847|38312900|FG005|Main|Pregnancy|0|||
17164460|NCT03083847|38312901|FG006|Main|Pregnancy|0|||
17164461|NCT03083847|38312902|FG007|Main|Pregnancy|1|||
17164462|NCT03083847|38312903|FG008|Main|Pregnancy|0|||
17164463|NCT03083847|38312904|FG009|Main|Pregnancy|0|||
17164464|NCT03083847|38312895|FG000|Main|Adverse Event|0|||
17164465|NCT03083847|38312896|FG001|Main|Adverse Event|0|||
17164466|NCT03083847|38312897|FG002|Main|Adverse Event|0|||
17164467|NCT03083847|38312898|FG003|Main|Adverse Event|0|||
17164468|NCT03083847|38312899|FG004|Main|Adverse Event|0|||
17164469|NCT03083847|38312900|FG005|Main|Adverse Event|0|||
17164470|NCT03083847|38312901|FG006|Main|Adverse Event|0|||
17164471|NCT03083847|38312902|FG007|Main|Adverse Event|2|||
17164472|NCT03083847|38312903|FG008|Main|Adverse Event|0|||
17164473|NCT03083847|38312904|FG009|Main|Adverse Event|0|||
17164474|NCT03083847|38312895|FG000|Main|Withdrawal by Subject|0|||
17164475|NCT03083847|38312896|FG001|Main|Withdrawal by Subject|0|||
17083987|NCT00201201|38224594|FG000|Overall Study|Withdrawal by Subject|5|||
17083988|NCT00201201|38224595|FG001|Overall Study|Withdrawal by Subject|5|||
17164476|NCT03083847|38312897|FG002|Main|Withdrawal by Subject|0|||
17164477|NCT03083847|38312898|FG003|Main|Withdrawal by Subject|0|||
17083989|NCT00126490|38224601|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
17083990|NCT00346632|38224607|FG000|Overall Study|Progressive Disease|2|||
17083991|NCT00346632|38224608|FG001|Overall Study|Progressive Disease|2|||
17083992|NCT00346632|38224609|FG002|Overall Study|Progressive Disease|4|||
17083993|NCT00346632|38224610|FG003|Overall Study|Progressive Disease|3|||
17083994|NCT00346632|38224611|FG004|Overall Study|Progressive Disease|3|||
17083995|NCT00346632|38224612|FG005|Overall Study|Progressive Disease|1|||
17083996|NCT00346632|38224613|FG006|Overall Study|Progressive Disease|2|||
17083997|NCT00346632|38224614|FG007|Overall Study|Progressive Disease|2|||
17083998|NCT00346632|38224615|FG008|Overall Study|Progressive Disease|2|||
17083999|NCT00346632|38224616|FG009|Overall Study|Progressive Disease|2|||
17084000|NCT00346632|38224607|FG000|Overall Study|Adverse Event|0|||
17084001|NCT00346632|38224608|FG001|Overall Study|Adverse Event|0|||
17084002|NCT00346632|38224609|FG002|Overall Study|Adverse Event|0|||
17084003|NCT00346632|38224610|FG003|Overall Study|Adverse Event|0|||
17084004|NCT00346632|38224611|FG004|Overall Study|Adverse Event|1|||
17084005|NCT00346632|38224612|FG005|Overall Study|Adverse Event|1|||
17084006|NCT00346632|38224613|FG006|Overall Study|Adverse Event|1|||
17084007|NCT00346632|38224614|FG007|Overall Study|Adverse Event|0|||
17084008|NCT00346632|38224615|FG008|Overall Study|Adverse Event|0|||
17084009|NCT00346632|38224616|FG009|Overall Study|Adverse Event|0|||
17084010|NCT00346632|38224607|FG000|Overall Study|Death|0|||
17084011|NCT00346632|38224608|FG001|Overall Study|Death|0|||
17084012|NCT00346632|38224609|FG002|Overall Study|Death|1|||
17084013|NCT00346632|38224610|FG003|Overall Study|Death|0|||
17084014|NCT00346632|38224611|FG004|Overall Study|Death|0|||
17084015|NCT00346632|38224612|FG005|Overall Study|Death|0|||
17084016|NCT00346632|38224613|FG006|Overall Study|Death|0|||
17084017|NCT00346632|38224614|FG007|Overall Study|Death|0|||
17084018|NCT00346632|38224615|FG008|Overall Study|Death|0|||
17084019|NCT00346632|38224616|FG009|Overall Study|Death|0|||
17084020|NCT00346632|38224607|FG000|Overall Study|Protocol Violation|0|||
17084021|NCT00346632|38224608|FG001|Overall Study|Protocol Violation|0|||
17084022|NCT00346632|38224609|FG002|Overall Study|Protocol Violation|0|||
17084023|NCT00346632|38224610|FG003|Overall Study|Protocol Violation|0|||
17084024|NCT00346632|38224611|FG004|Overall Study|Protocol Violation|0|||
17084025|NCT00346632|38224612|FG005|Overall Study|Protocol Violation|0|||
17084026|NCT00346632|38224613|FG006|Overall Study|Protocol Violation|1|||
17084027|NCT00346632|38224614|FG007|Overall Study|Protocol Violation|0|||
17084028|NCT00346632|38224615|FG008|Overall Study|Protocol Violation|0|||
17084029|NCT00346632|38224616|FG009|Overall Study|Protocol Violation|0|||
17084030|NCT00346632|38224607|FG000|Overall Study|Withdrawal by Subject|0|||
17084031|NCT00346632|38224608|FG001|Overall Study|Withdrawal by Subject|0|||
17084032|NCT00346632|38224609|FG002|Overall Study|Withdrawal by Subject|0|||
17084033|NCT00346632|38224610|FG003|Overall Study|Withdrawal by Subject|0|||
17084034|NCT00346632|38224611|FG004|Overall Study|Withdrawal by Subject|0|||
17084035|NCT00346632|38224612|FG005|Overall Study|Withdrawal by Subject|0|||
17084036|NCT00346632|38224613|FG006|Overall Study|Withdrawal by Subject|1|||
17084037|NCT00346632|38224614|FG007|Overall Study|Withdrawal by Subject|0|||
17084038|NCT00346632|38224615|FG008|Overall Study|Withdrawal by Subject|0|||
17084039|NCT00346632|38224616|FG009|Overall Study|Withdrawal by Subject|0|||
17084040|NCT00346632|38224607|FG000|Overall Study|Switched to alternative treatment|0|||
17084041|NCT00346632|38224608|FG001|Overall Study|Switched to alternative treatment|0|||
17084042|NCT00346632|38224609|FG002|Overall Study|Switched to alternative treatment|1|||
17084043|NCT00346632|38224610|FG003|Overall Study|Switched to alternative treatment|0|||
17084044|NCT00346632|38224611|FG004|Overall Study|Switched to alternative treatment|0|||
17084045|NCT00346632|38224612|FG005|Overall Study|Switched to alternative treatment|0|||
17084046|NCT00346632|38224613|FG006|Overall Study|Switched to alternative treatment|0|||
17084047|NCT00346632|38224614|FG007|Overall Study|Switched to alternative treatment|0|||
17084048|NCT00346632|38224615|FG008|Overall Study|Switched to alternative treatment|0|||
17084049|NCT00346632|38224616|FG009|Overall Study|Switched to alternative treatment|0|||
17084050|NCT00346632|38224607|FG000|Overall Study|Not Stated|1|||
17084051|NCT00346632|38224608|FG001|Overall Study|Not Stated|1|||
17084052|NCT00346632|38224609|FG002|Overall Study|Not Stated|0|||
17084053|NCT00346632|38224610|FG003|Overall Study|Not Stated|0|||
17084054|NCT00346632|38224611|FG004|Overall Study|Not Stated|0|||
17084055|NCT00346632|38224612|FG005|Overall Study|Not Stated|0|||
17084056|NCT00346632|38224613|FG006|Overall Study|Not Stated|0|||
17084057|NCT00346632|38224614|FG007|Overall Study|Not Stated|2|||
17084058|NCT00346632|38224615|FG008|Overall Study|Not Stated|2|||
17084059|NCT00346632|38224616|FG009|Overall Study|Not Stated|1|||
17084060|NCT00200967|38224680|FG000|First Treatment Period|Withdrawal by Subject|5|||
17084061|NCT00200967|38224681|FG001|First Treatment Period|Withdrawal by Subject|1|||
17084062|NCT00200967|38224680|FG000|First Treatment Period|Pregnancy|1|||
17084063|NCT00200967|38224681|FG001|First Treatment Period|Pregnancy|0|||
17084064|NCT00200967|38224680|FG000|Wash-out Period|Lost to Follow-up|0|||
17084065|NCT00200967|38224681|FG001|Wash-out Period|Lost to Follow-up|1|||
17084066|NCT00200967|38224680|FG000|Second Treatment Period|Withdrawal by Subject|1|||
17084067|NCT00200967|38224681|FG001|Second Treatment Period|Withdrawal by Subject|2|||
17084068|NCT00200967|38224680|FG000|Run-out Period|Lost to Follow-up|1|||
17164478|NCT03083847|38312899|FG004|Main|Withdrawal by Subject|0|||
17164479|NCT03083847|38312900|FG005|Main|Withdrawal by Subject|0|||
17164480|NCT03083847|38312901|FG006|Main|Withdrawal by Subject|1|||
17164481|NCT03083847|38312902|FG007|Main|Withdrawal by Subject|1|||
17164482|NCT03083847|38312903|FG008|Main|Withdrawal by Subject|0|||
17164483|NCT03083847|38312904|FG009|Main|Withdrawal by Subject|0|||
17164484|NCT03082677|38312932|FG000|Overall Study|Not Treated|2|||
17164485|NCT02858180|38312947|FG000|Overall Study|Lost to Follow-up|0|||
17164486|NCT02858180|38312948|FG001|Overall Study|Lost to Follow-up|2|||
17164487|NCT03082599|38312956|FG000|Overall Study|Lost to Follow-up|1|||
17164488|NCT03082599|38312957|FG001|Overall Study|Lost to Follow-up|0|||
17164489|NCT01346501|38312965|FG000|Overall Study|Initiated Other Biological Agents|3|||
17164490|NCT01346501|38312966|FG001|Overall Study|Initiated Other Biological Agents|1|||
17164491|NCT01346501|38312965|FG000|Overall Study|Other|8|||
17164492|NCT01346501|38312966|FG001|Overall Study|Other|12|||
17164493|NCT03160885|38312976|FG000|Initial Treatment Period|Not dosed|2|||
17164494|NCT03160885|38312977|FG001|Initial Treatment Period|Not dosed|0|||
17164495|NCT03160885|38312978|FG002|Initial Treatment Period|Not dosed|0|||
17164496|NCT03160885|38312979|FG003|Initial Treatment Period|Not dosed|0|||
17164497|NCT03160885|38312980|FG004|Initial Treatment Period|Not dosed|0|||
17164498|NCT03160885|38312981|FG005|Initial Treatment Period|Not dosed|0|||
17164499|NCT03160885|38312982|FG006|Initial Treatment Period|Not dosed|0|||
17164500|NCT03160885|38312976|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
17164501|NCT03160885|38312977|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
17164502|NCT03160885|38312978|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17164503|NCT03160885|38312979|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17164504|NCT03160885|38312980|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17164505|NCT03160885|38312981|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17164506|NCT03160885|38312982|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
17164507|NCT03160885|38312976|FG000|Open-label Treatment|Not dosed|0|||
17164508|NCT03160885|38312977|FG001|Open-label Treatment|Not dosed|0|||
17164509|NCT03160885|38312978|FG002|Open-label Treatment|Not dosed|0|||
17164510|NCT03160885|38312979|FG003|Open-label Treatment|Not dosed|0|||
17164511|NCT03160885|38312980|FG004|Open-label Treatment|Not dosed|0|||
17164512|NCT03160885|38312981|FG005|Open-label Treatment|Not dosed|0|||
17164513|NCT03160885|38312982|FG006|Open-label Treatment|Not dosed|2|||
17164514|NCT03160885|38312976|FG000|Open-label Treatment|Discontinued IMP|0|||
17164515|NCT03160885|38312977|FG001|Open-label Treatment|Discontinued IMP|0|||
17164516|NCT03160885|38312978|FG002|Open-label Treatment|Discontinued IMP|0|||
17164517|NCT03160885|38312979|FG003|Open-label Treatment|Discontinued IMP|0|||
17164518|NCT03160885|38312980|FG004|Open-label Treatment|Discontinued IMP|0|||
17164519|NCT03160885|38312981|FG005|Open-label Treatment|Discontinued IMP|0|||
17164520|NCT03160885|38312982|FG006|Open-label Treatment|Discontinued IMP|131|||
17164521|NCT03160885|38312976|FG000|Open-label Treatment|Completed Week 50|0|||
17164522|NCT03160885|38312977|FG001|Open-label Treatment|Completed Week 50|0|||
17164523|NCT03160885|38312978|FG002|Open-label Treatment|Completed Week 50|0|||
17164524|NCT03160885|38312979|FG003|Open-label Treatment|Completed Week 50|0|||
17164525|NCT03160885|38312980|FG004|Open-label Treatment|Completed Week 50|0|||
17164526|NCT03160885|38312981|FG005|Open-label Treatment|Completed Week 50|0|||
17164527|NCT03160885|38312982|FG006|Open-label Treatment|Completed Week 50|4|||
17164528|NCT03160885|38312976|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
17164529|NCT03160885|38312977|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
17164530|NCT03160885|38312978|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
17164531|NCT03160885|38312979|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
17164532|NCT03160885|38312980|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
17164533|NCT03160885|38312981|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
17164534|NCT03160885|38312982|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
17164535|NCT03160885|38312976|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
17164536|NCT03160885|38312977|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
17164537|NCT03160885|38312978|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
17164538|NCT03160885|38312979|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
17084069|NCT00200967|38224681|FG001|Run-out Period|Lost to Follow-up|0|||
17084070|NCT00354432|38224691|FG000|Overall Study|Adverse Event|3|||
17084071|NCT00354432|38224692|FG001|Overall Study|Adverse Event|1|||
17084072|NCT00354432|38224693|FG002|Overall Study|Adverse Event|5|||
17084073|NCT00354432|38224694|FG003|Overall Study|Adverse Event|5|||
17084074|NCT00354432|38224691|FG000|Overall Study|Off/Toxicity|3|||
17084075|NCT00354432|38224692|FG001|Overall Study|Off/Toxicity|7|||
17084076|NCT00354432|38224693|FG002|Overall Study|Off/Toxicity|5|||
17084077|NCT00354432|38224694|FG003|Overall Study|Off/Toxicity|5|||
17164539|NCT03160885|38312980|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
17084078|NCT00140140|38224707|FG000|Overall Study|Unacceptable toxicity|1|||
17084079|NCT00140140|38224708|FG001|Overall Study|Unacceptable toxicity|1|||
17084080|NCT00140140|38224709|FG002|Overall Study|Unacceptable toxicity|2|||
17164540|NCT03160885|38312981|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
17164541|NCT03160885|38312982|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
17164542|NCT03160885|38312976|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
17164543|NCT03160885|38312977|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
17164544|NCT03160885|38312978|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
17164545|NCT03160885|38312979|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
17164546|NCT03160885|38312980|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
17164547|NCT03160885|38312981|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
17164548|NCT03160885|38312982|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
17084081|NCT00140140|38224707|FG000|Overall Study|Physician Decision|1|||
17084082|NCT00140140|38224708|FG001|Overall Study|Physician Decision|1|||
17084083|NCT00140140|38224709|FG002|Overall Study|Physician Decision|0|||
17084084|NCT00346398|38224718|FG000|Overall Study|Lost to Follow-up|3|||
17164549|NCT03160885|38312976|FG000|Maintenance Treatment Period|Completed Week 50|0|||
17164550|NCT03160885|38312977|FG001|Maintenance Treatment Period|Completed Week 50|0|||
17164551|NCT03160885|38312978|FG002|Maintenance Treatment Period|Completed Week 50|1|||
17164552|NCT03160885|38312979|FG003|Maintenance Treatment Period|Completed Week 50|0|||
17164553|NCT03160885|38312980|FG004|Maintenance Treatment Period|Completed Week 50|0|||
17164554|NCT03160885|38312981|FG005|Maintenance Treatment Period|Completed Week 50|0|||
17164555|NCT03160885|38312982|FG006|Maintenance Treatment Period|Completed Week 50|0|||
17164556|NCT03181451|38313002|FG000|Overall Study|Adverse Event|0|||
17084085|NCT00346398|38224719|FG001|Overall Study|Lost to Follow-up|0|||
17084086|NCT00346398|38224718|FG000|Overall Study|Withdrawal by Subject|0|||
17164557|NCT03181451|38313003|FG001|Overall Study|Adverse Event|1|||
17164558|NCT03181451|38313004|FG002|Overall Study|Adverse Event|0|||
17164559|NCT03181451|38313002|FG000|Overall Study|Withdrawal by Subject|0|||
17164560|NCT03181451|38313003|FG001|Overall Study|Withdrawal by Subject|1|||
17164561|NCT03181451|38313004|FG002|Overall Study|Withdrawal by Subject|0|||
17164562|NCT00406783|38313016|FG000|Overall Study|Adverse Event|4|||
17164563|NCT00406783|38313017|FG001|Overall Study|Adverse Event|4|||
17164564|NCT00406783|38313016|FG000|Overall Study|Treatment Failure|2|||
17164565|NCT00406783|38313017|FG001|Overall Study|Treatment Failure|3|||
17164566|NCT00406783|38313016|FG000|Overall Study|Lost to Follow-up|3|||
17164567|NCT00406783|38313017|FG001|Overall Study|Lost to Follow-up|0|||
17164568|NCT00406783|38313016|FG000|Overall Study|Withdrawal by Subject|1|||
17164569|NCT00406783|38313017|FG001|Overall Study|Withdrawal by Subject|4|||
17164570|NCT00406783|38313016|FG000|Overall Study|Protocol Violation|4|||
17164571|NCT00406783|38313017|FG001|Overall Study|Protocol Violation|4|||
17164572|NCT03179891|38313023|FG000|First Intervention|Withdrawal by Subject|1|||
17164573|NCT03179891|38313024|FG001|First Intervention|Withdrawal by Subject|1|||
17164574|NCT03179891|38313023|FG000|First Intervention|Unspecified reason|1|||
17164575|NCT03179891|38313024|FG001|First Intervention|Unspecified reason|0|||
17164576|NCT03179891|38313023|FG000|First Intervention|Protocol Violation|0|||
17164577|NCT03179891|38313024|FG001|First Intervention|Protocol Violation|1|||
17164578|NCT02973815|38313035|FG000|Post Intervention|Death|1|||
17164579|NCT02973815|38313036|FG001|Post Intervention|Death|0|||
17164580|NCT02973815|38313035|FG000|Post Intervention|Lost to Follow-up|7|||
17164581|NCT02973815|38313036|FG001|Post Intervention|Lost to Follow-up|24|||
17164582|NCT02973815|38313035|FG000|Follow-up|Lost to Follow-up|2|||
17164583|NCT02973815|38313036|FG001|Follow-up|Lost to Follow-up|0|||
17164584|NCT03160573|38313046|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
17164585|NCT03160573|38313047|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
17164586|NCT03160573|38313048|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
17164587|NCT03160573|38313049|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
17164588|NCT02736227|38313062|FG000|Overall Study|Withdrawal by Subject|0|||
17084087|NCT00346398|38224719|FG001|Overall Study|Withdrawal by Subject|2|||
17084088|NCT00346164|38224729|FG000|Overall Study|Adverse Event|0|||
17084089|NCT00346164|38224730|FG001|Overall Study|Adverse Event|0|||
17084090|NCT00346164|38224731|FG002|Overall Study|Adverse Event|0|||
17084091|NCT00346164|38224732|FG003|Overall Study|Adverse Event|1|||
17164589|NCT02736227|38313063|FG001|Overall Study|Withdrawal by Subject|0|||
17164590|NCT02736227|38313064|FG002|Overall Study|Withdrawal by Subject|1|||
17164591|NCT02736227|38313062|FG000|Overall Study|Physician Decision|0|||
17164592|NCT02736227|38313063|FG001|Overall Study|Physician Decision|0|||
17164593|NCT02736227|38313064|FG002|Overall Study|Physician Decision|5|||
17164594|NCT02736227|38313062|FG000|Overall Study|Non Compliant|0|||
17164595|NCT02736227|38313063|FG001|Overall Study|Non Compliant|0|||
17164596|NCT02736227|38313064|FG002|Overall Study|Non Compliant|2|||
17164597|NCT03176459|38313073|FG000|Overall Study|Lost to Follow-up|5|||
17164598|NCT03176459|38313074|FG001|Overall Study|Lost to Follow-up|7|||
17164599|NCT03155269|38313082|FG000|Overall Study|Withdrawal by Subject|4|||
17164600|NCT03155269|38313083|FG001|Overall Study|Withdrawal by Subject|5|||
17084092|NCT00346164|38224729|FG000|Overall Study|Lack of Efficacy|0|||
17084093|NCT00346164|38224730|FG001|Overall Study|Lack of Efficacy|1|||
17084094|NCT00346164|38224731|FG002|Overall Study|Lack of Efficacy|7|||
17164601|NCT03155269|38313082|FG000|Overall Study|Lost to Follow-up|1|||
17164602|NCT03155269|38313083|FG001|Overall Study|Lost to Follow-up|2|||
17164603|NCT02906670|38313099|FG000|Cohort 1, QW|Radiological Progression|1|||
17164604|NCT02906670|38313100|FG001|Cohort 1, QW|Radiological Progression|0|||
17164605|NCT02906670|38313101|FG002|Cohort 1, QW|Radiological Progression|0|||
17164606|NCT02906670|38313102|FG003|Cohort 1, QW|Radiological Progression|0|||
17164607|NCT02906670|38313103|FG004|Cohort 1, QW|Radiological Progression|0|||
17164608|NCT02906670|38313104|FG005|Cohort 1, QW|Radiological Progression|0|||
17164609|NCT02906670|38313105|FG006|Cohort 1, QW|Radiological Progression|0|||
17164610|NCT02906670|38313106|FG007|Cohort 1, QW|Radiological Progression|0|||
17164611|NCT02906670|38313107|FG008|Cohort 1, QW|Radiological Progression|0|||
17164612|NCT02906670|38313108|FG009|Cohort 1, QW|Radiological Progression|0|||
17164613|NCT02906670|38313099|FG000|Cohort 2, QW|Radiological Progression|0|||
17164614|NCT02906670|38313100|FG001|Cohort 2, QW|Radiological Progression|1|||
17164615|NCT02906670|38313101|FG002|Cohort 2, QW|Radiological Progression|0|||
17164616|NCT02906670|38313102|FG003|Cohort 2, QW|Radiological Progression|0|||
17164617|NCT02906670|38313103|FG004|Cohort 2, QW|Radiological Progression|0|||
17164618|NCT02906670|38313104|FG005|Cohort 2, QW|Radiological Progression|0|||
17164619|NCT02906670|38313105|FG006|Cohort 2, QW|Radiological Progression|0|||
17164620|NCT02906670|38313106|FG007|Cohort 2, QW|Radiological Progression|0|||
17164621|NCT02906670|38313107|FG008|Cohort 2, QW|Radiological Progression|0|||
17164622|NCT02906670|38313108|FG009|Cohort 2, QW|Radiological Progression|0|||
17164623|NCT02906670|38313099|FG000|Cohort 3, QW|Radiological Progression|0|||
17164624|NCT02906670|38313100|FG001|Cohort 3, QW|Radiological Progression|0|||
17164625|NCT02906670|38313101|FG002|Cohort 3, QW|Radiological Progression|2|||
17164626|NCT02906670|38313102|FG003|Cohort 3, QW|Radiological Progression|0|||
17164627|NCT02906670|38313103|FG004|Cohort 3, QW|Radiological Progression|0|||
17164628|NCT02906670|38313104|FG005|Cohort 3, QW|Radiological Progression|0|||
17164629|NCT02906670|38313105|FG006|Cohort 3, QW|Radiological Progression|0|||
17164630|NCT02906670|38313106|FG007|Cohort 3, QW|Radiological Progression|0|||
17164631|NCT02906670|38313107|FG008|Cohort 3, QW|Radiological Progression|0|||
17164632|NCT02906670|38313108|FG009|Cohort 3, QW|Radiological Progression|0|||
17164633|NCT02906670|38313099|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
17084095|NCT00346164|38224732|FG003|Overall Study|Lack of Efficacy|25|||
17084096|NCT00346164|38224729|FG000|Overall Study|Physician Decision|0|||
17084097|NCT00346164|38224730|FG001|Overall Study|Physician Decision|1|||
17084098|NCT00346164|38224731|FG002|Overall Study|Physician Decision|2|||
17084099|NCT00346164|38224732|FG003|Overall Study|Physician Decision|27|||
17084100|NCT00346164|38224729|FG000|Overall Study|Protocol Violation|6|||
17164634|NCT02906670|38313100|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
17164635|NCT02906670|38313101|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
17164636|NCT02906670|38313102|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
17164637|NCT02906670|38313103|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
17164638|NCT02906670|38313104|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
17164639|NCT02906670|38313105|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
17164640|NCT02906670|38313106|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
17164641|NCT02906670|38313107|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
17164642|NCT02906670|38313108|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
17164643|NCT02906670|38313099|FG000|Cohort 4, Q2W|Radiological Progression|0|||
17164644|NCT02906670|38313100|FG001|Cohort 4, Q2W|Radiological Progression|0|||
17164645|NCT02906670|38313101|FG002|Cohort 4, Q2W|Radiological Progression|0|||
17164646|NCT02906670|38313102|FG003|Cohort 4, Q2W|Radiological Progression|0|||
17164647|NCT02906670|38313103|FG004|Cohort 4, Q2W|Radiological Progression|0|||
17084101|NCT00346164|38224730|FG001|Overall Study|Protocol Violation|2|||
17084102|NCT00346164|38224731|FG002|Overall Study|Protocol Violation|10|||
17084103|NCT00346164|38224732|FG003|Overall Study|Protocol Violation|4|||
17084104|NCT00346164|38224729|FG000|Overall Study|Withdrawal by Subject|0|||
17084105|NCT00346164|38224730|FG001|Overall Study|Withdrawal by Subject|0|||
17084106|NCT00346164|38224731|FG002|Overall Study|Withdrawal by Subject|2|||
17084107|NCT00346164|38224732|FG003|Overall Study|Withdrawal by Subject|0|||
17084108|NCT00346164|38224729|FG000|Overall Study|Ineligible|11|||
17084109|NCT00346164|38224730|FG001|Overall Study|Ineligible|2|||
17084110|NCT00346164|38224731|FG002|Overall Study|Ineligible|2|||
17084111|NCT00346164|38224732|FG003|Overall Study|Ineligible|23|||
17164648|NCT02906670|38313104|FG005|Cohort 4, Q2W|Radiological Progression|1|||
17164649|NCT02906670|38313105|FG006|Cohort 4, Q2W|Radiological Progression|0|||
17164650|NCT02906670|38313106|FG007|Cohort 4, Q2W|Radiological Progression|0|||
17164651|NCT02906670|38313107|FG008|Cohort 4, Q2W|Radiological Progression|0|||
17164652|NCT02906670|38313108|FG009|Cohort 4, Q2W|Radiological Progression|0|||
17164653|NCT02906670|38313099|FG000|Cohort 4, Q2W|Clinical Progression|0|||
17164654|NCT02906670|38313100|FG001|Cohort 4, Q2W|Clinical Progression|0|||
17164655|NCT02906670|38313101|FG002|Cohort 4, Q2W|Clinical Progression|0|||
17084112|NCT00346164|38224729|FG000|Overall Study|Refusal of further protocol therapy|0|||
17084113|NCT00346164|38224730|FG001|Overall Study|Refusal of further protocol therapy|1|||
17084114|NCT00346164|38224731|FG002|Overall Study|Refusal of further protocol therapy|3|||
17084115|NCT00346164|38224732|FG003|Overall Study|Refusal of further protocol therapy|15|||
17164656|NCT02906670|38313102|FG003|Cohort 4, Q2W|Clinical Progression|0|||
17164657|NCT02906670|38313103|FG004|Cohort 4, Q2W|Clinical Progression|0|||
17164658|NCT02906670|38313104|FG005|Cohort 4, Q2W|Clinical Progression|2|||
17164659|NCT02906670|38313105|FG006|Cohort 4, Q2W|Clinical Progression|0|||
17164660|NCT02906670|38313106|FG007|Cohort 4, Q2W|Clinical Progression|0|||
17164661|NCT02906670|38313107|FG008|Cohort 4, Q2W|Clinical Progression|0|||
17164662|NCT02906670|38313108|FG009|Cohort 4, Q2W|Clinical Progression|0|||
17164663|NCT02906670|38313099|FG000|Cohort 5, Q2W|Radiological Progression|0|||
17164664|NCT02906670|38313100|FG001|Cohort 5, Q2W|Radiological Progression|0|||
17164665|NCT02906670|38313101|FG002|Cohort 5, Q2W|Radiological Progression|0|||
17164666|NCT02906670|38313102|FG003|Cohort 5, Q2W|Radiological Progression|0|||
17164667|NCT02906670|38313103|FG004|Cohort 5, Q2W|Radiological Progression|0|||
17164668|NCT02906670|38313104|FG005|Cohort 5, Q2W|Radiological Progression|0|||
17164669|NCT02906670|38313105|FG006|Cohort 5, Q2W|Radiological Progression|4|||
17164670|NCT02906670|38313106|FG007|Cohort 5, Q2W|Radiological Progression|0|||
17164671|NCT02906670|38313107|FG008|Cohort 5, Q2W|Radiological Progression|0|||
17164672|NCT02906670|38313108|FG009|Cohort 5, Q2W|Radiological Progression|0|||
17164673|NCT02906670|38313099|FG000|Cohort 5, Q2W|Clinical Progression|0|||
17164674|NCT02906670|38313100|FG001|Cohort 5, Q2W|Clinical Progression|0|||
17164675|NCT02906670|38313101|FG002|Cohort 5, Q2W|Clinical Progression|0|||
17164676|NCT02906670|38313102|FG003|Cohort 5, Q2W|Clinical Progression|0|||
17164677|NCT02906670|38313103|FG004|Cohort 5, Q2W|Clinical Progression|0|||
17164678|NCT02906670|38313104|FG005|Cohort 5, Q2W|Clinical Progression|0|||
17164679|NCT02906670|38313105|FG006|Cohort 5, Q2W|Clinical Progression|1|||
17164680|NCT02906670|38313106|FG007|Cohort 5, Q2W|Clinical Progression|0|||
17164681|NCT02906670|38313107|FG008|Cohort 5, Q2W|Clinical Progression|0|||
17164682|NCT02906670|38313108|FG009|Cohort 5, Q2W|Clinical Progression|0|||
17164683|NCT02906670|38313099|FG000|Cohort 5, Q2W|Adverse Event|0|||
17164684|NCT02906670|38313100|FG001|Cohort 5, Q2W|Adverse Event|0|||
17164685|NCT02906670|38313101|FG002|Cohort 5, Q2W|Adverse Event|0|||
17164686|NCT02906670|38313102|FG003|Cohort 5, Q2W|Adverse Event|0|||
17164687|NCT02906670|38313103|FG004|Cohort 5, Q2W|Adverse Event|0|||
17084116|NCT00346164|38224729|FG000|Overall Study|Inability to start week 16 tx on time|0|||
17084117|NCT00346164|38224730|FG001|Overall Study|Inability to start week 16 tx on time|0|||
17084118|NCT00346164|38224731|FG002|Overall Study|Inability to start week 16 tx on time|0|||
17084119|NCT00346164|38224732|FG003|Overall Study|Inability to start week 16 tx on time|11|||
17084120|NCT00114244|38224760|FG000|Overall Study|Adverse Event|2|||
17084121|NCT00114244|38224761|FG001|Overall Study|Adverse Event|5|||
17084122|NCT00114244|38224760|FG000|Overall Study|Withdrawal by Subject|0|||
17084123|NCT00114244|38224761|FG001|Overall Study|Withdrawal by Subject|2|||
17164688|NCT02906670|38313104|FG005|Cohort 5, Q2W|Adverse Event|0|||
17164689|NCT02906670|38313105|FG006|Cohort 5, Q2W|Adverse Event|1|||
17164690|NCT02906670|38313106|FG007|Cohort 5, Q2W|Adverse Event|0|||
17164691|NCT02906670|38313107|FG008|Cohort 5, Q2W|Adverse Event|0|||
17164692|NCT02906670|38313108|FG009|Cohort 5, Q2W|Adverse Event|0|||
17164693|NCT02906670|38313099|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164694|NCT02906670|38313100|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164695|NCT02906670|38313101|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164696|NCT02906670|38313102|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164697|NCT02906670|38313103|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164698|NCT02906670|38313104|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164699|NCT02906670|38313105|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
17164700|NCT02906670|38313106|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164701|NCT02906670|38313107|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164702|NCT02906670|38313108|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
17164703|NCT02906670|38313099|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
17164704|NCT02906670|38313100|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
17164705|NCT02906670|38313101|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
17164706|NCT02906670|38313102|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
17164707|NCT02906670|38313103|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
17164708|NCT02906670|38313104|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
17164709|NCT02906670|38313105|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
17164710|NCT02906670|38313106|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
17164711|NCT02906670|38313107|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
17164712|NCT02906670|38313108|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
17164713|NCT02906670|38313099|FG000|Cohort 5P, Q2W|Adverse Event|0|||
17164714|NCT02906670|38313100|FG001|Cohort 5P, Q2W|Adverse Event|0|||
17164715|NCT02906670|38313101|FG002|Cohort 5P, Q2W|Adverse Event|0|||
17164716|NCT02906670|38313102|FG003|Cohort 5P, Q2W|Adverse Event|0|||
17164717|NCT02906670|38313103|FG004|Cohort 5P, Q2W|Adverse Event|0|||
17164718|NCT02906670|38313104|FG005|Cohort 5P, Q2W|Adverse Event|0|||
17164719|NCT02906670|38313105|FG006|Cohort 5P, Q2W|Adverse Event|0|||
17164720|NCT02906670|38313106|FG007|Cohort 5P, Q2W|Adverse Event|1|||
17164721|NCT02906670|38313107|FG008|Cohort 5P, Q2W|Adverse Event|0|||
17164722|NCT02906670|38313108|FG009|Cohort 5P, Q2W|Adverse Event|0|||
17164723|NCT02906670|38313099|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
17164724|NCT02906670|38313100|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
17164725|NCT02906670|38313101|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
17164726|NCT02906670|38313102|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
17164727|NCT02906670|38313103|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
17164728|NCT02906670|38313104|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
17164729|NCT02906670|38313105|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
17164730|NCT02906670|38313106|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
17164731|NCT02906670|38313107|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
17164732|NCT02906670|38313108|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
17164733|NCT02906670|38313099|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
17164734|NCT02906670|38313100|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
17164735|NCT02906670|38313101|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
17164736|NCT02906670|38313102|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
17164737|NCT02906670|38313103|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
17164738|NCT02906670|38313104|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
17164739|NCT02906670|38313105|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
17164740|NCT02906670|38313106|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
17164741|NCT02906670|38313107|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
17164742|NCT02906670|38313108|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
17164743|NCT02906670|38313099|FG000|Cohort 4P, QW|Radiological Progression|0|||
17164744|NCT02906670|38313100|FG001|Cohort 4P, QW|Radiological Progression|0|||
17164745|NCT02906670|38313101|FG002|Cohort 4P, QW|Radiological Progression|0|||
17164746|NCT02906670|38313102|FG003|Cohort 4P, QW|Radiological Progression|3|||
17164747|NCT02906670|38313103|FG004|Cohort 4P, QW|Radiological Progression|0|||
17164748|NCT02906670|38313104|FG005|Cohort 4P, QW|Radiological Progression|0|||
17164749|NCT02906670|38313105|FG006|Cohort 4P, QW|Radiological Progression|0|||
17164750|NCT02906670|38313106|FG007|Cohort 4P, QW|Radiological Progression|0|||
17164751|NCT02906670|38313107|FG008|Cohort 4P, QW|Radiological Progression|0|||
17164752|NCT02906670|38313108|FG009|Cohort 4P, QW|Radiological Progression|0|||
17164753|NCT02906670|38313099|FG000|Cohort 7P, Q2W|Adverse Event|0|||
17164754|NCT02906670|38313100|FG001|Cohort 7P, Q2W|Adverse Event|0|||
17164755|NCT02906670|38313101|FG002|Cohort 7P, Q2W|Adverse Event|0|||
17164756|NCT02906670|38313102|FG003|Cohort 7P, Q2W|Adverse Event|0|||
17164757|NCT02906670|38313103|FG004|Cohort 7P, Q2W|Adverse Event|0|||
17164758|NCT02906670|38313104|FG005|Cohort 7P, Q2W|Adverse Event|0|||
17164759|NCT02906670|38313105|FG006|Cohort 7P, Q2W|Adverse Event|0|||
17164760|NCT02906670|38313106|FG007|Cohort 7P, Q2W|Adverse Event|0|||
17164761|NCT02906670|38313107|FG008|Cohort 7P, Q2W|Adverse Event|0|||
17164762|NCT02906670|38313108|FG009|Cohort 7P, Q2W|Adverse Event|1|||
17164763|NCT02906670|38313099|FG000|Cohort 7P, Q2W|Physician Decision|0|||
17164764|NCT02906670|38313100|FG001|Cohort 7P, Q2W|Physician Decision|0|||
17164765|NCT02906670|38313101|FG002|Cohort 7P, Q2W|Physician Decision|0|||
17164766|NCT02906670|38313102|FG003|Cohort 7P, Q2W|Physician Decision|0|||
17164767|NCT02906670|38313103|FG004|Cohort 7P, Q2W|Physician Decision|0|||
17164768|NCT02906670|38313104|FG005|Cohort 7P, Q2W|Physician Decision|0|||
17164769|NCT02906670|38313105|FG006|Cohort 7P, Q2W|Physician Decision|0|||
17164770|NCT02906670|38313106|FG007|Cohort 7P, Q2W|Physician Decision|0|||
17164771|NCT02906670|38313107|FG008|Cohort 7P, Q2W|Physician Decision|0|||
17164772|NCT02906670|38313108|FG009|Cohort 7P, Q2W|Physician Decision|1|||
17164773|NCT02906670|38313099|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17164774|NCT02906670|38313100|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17084124|NCT00138658|38224767|FG000|Overall Study|Adverse Event|23|||
17084125|NCT00138658|38224767|FG000|Overall Study|Death|1|||
17084126|NCT00138658|38224767|FG000|Overall Study|Disease Progression|21|||
17084127|NCT00138658|38224767|FG000|Overall Study|Physician Decision|11|||
17084128|NCT00138658|38224767|FG000|Overall Study|Withdrawal by Subject|5|||
17084129|NCT00337662|38224776|FG000|Study Period II|Lost to Follow-up|0|||
17084130|NCT00337662|38224777|FG001|Study Period II|Lost to Follow-up|0|||
17084131|NCT00337662|38224778|FG002|Study Period II|Lost to Follow-up|0|||
17084132|NCT00337662|38224779|FG003|Study Period II|Lost to Follow-up|35|||
17084133|NCT00337662|38224776|FG000|Study Period II|Withdrawal by Subject|0|||
17084134|NCT00337662|38224777|FG001|Study Period II|Withdrawal by Subject|0|||
17084135|NCT00337662|38224778|FG002|Study Period II|Withdrawal by Subject|0|||
17164775|NCT02906670|38313101|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17164776|NCT02906670|38313102|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17164777|NCT02906670|38313103|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17164778|NCT02906670|38313104|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17164779|NCT02906670|38313105|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17164780|NCT02906670|38313106|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17164781|NCT02906670|38313107|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
17164782|NCT02906670|38313108|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
17164783|NCT02906670|38313099|FG000|Cohort 5P, QW|Radiological Progression|0|||
17164784|NCT02906670|38313100|FG001|Cohort 5P, QW|Radiological Progression|0|||
17164785|NCT02906670|38313101|FG002|Cohort 5P, QW|Radiological Progression|0|||
17084136|NCT00337662|38224779|FG003|Study Period II|Withdrawal by Subject|20|||
17084137|NCT00337662|38224776|FG000|Study Period II|Adverse Event|0|||
17164786|NCT02906670|38313102|FG003|Cohort 5P, QW|Radiological Progression|0|||
17164787|NCT02906670|38313103|FG004|Cohort 5P, QW|Radiological Progression|3|||
17164788|NCT02906670|38313104|FG005|Cohort 5P, QW|Radiological Progression|0|||
17164789|NCT02906670|38313105|FG006|Cohort 5P, QW|Radiological Progression|0|||
17164790|NCT02906670|38313106|FG007|Cohort 5P, QW|Radiological Progression|0|||
17164791|NCT02906670|38313107|FG008|Cohort 5P, QW|Radiological Progression|0|||
17164792|NCT02906670|38313108|FG009|Cohort 5P, QW|Radiological Progression|0|||
17084138|NCT00337662|38224777|FG001|Study Period II|Adverse Event|0|||
17084139|NCT00337662|38224778|FG002|Study Period II|Adverse Event|0|||
17084140|NCT00337662|38224779|FG003|Study Period II|Adverse Event|16|||
17084141|NCT00337662|38224776|FG000|Study Period II|Physician Decision|0|||
17084142|NCT00337662|38224777|FG001|Study Period II|Physician Decision|0|||
17084143|NCT00337662|38224778|FG002|Study Period II|Physician Decision|0|||
17084144|NCT00337662|38224779|FG003|Study Period II|Physician Decision|13|||
17084145|NCT00337662|38224776|FG000|Study Period II|Entry Criteria Not Met|0|||
17084146|NCT00337662|38224777|FG001|Study Period II|Entry Criteria Not Met|0|||
17084147|NCT00337662|38224778|FG002|Study Period II|Entry Criteria Not Met|0|||
17084148|NCT00337662|38224779|FG003|Study Period II|Entry Criteria Not Met|6|||
17084149|NCT00337662|38224776|FG000|Study Period II|Protocol Violation|0|||
17164793|NCT02906358|38313160|FG000|Overall Study|Withdrawal by Subject|10|||
17164794|NCT02906358|38313161|FG001|Overall Study|Withdrawal by Subject|7|||
17164795|NCT02906358|38313160|FG000|Overall Study|Lost to Follow-up|12|||
17164796|NCT02906358|38313161|FG001|Overall Study|Lost to Follow-up|15|||
17164797|NCT02186834|38313167|FG000|Dose Escalation|Death|0|||
17164798|NCT02186834|38313168|FG001|Dose Escalation|Death|0|||
17164799|NCT02186834|38313169|FG002|Dose Escalation|Death|0|||
17164800|NCT02186834|38313170|FG003|Dose Escalation|Death|1|||
17164801|NCT02186834|38313171|FG004|Dose Escalation|Death|0|||
17164802|NCT02186834|38313172|FG005|Dose Escalation|Death|0|||
17164803|NCT02186834|38313167|FG000|Treatment at RP2D|Died prior to treatment|0|||
17164804|NCT02186834|38313168|FG001|Treatment at RP2D|Died prior to treatment|0|||
17164805|NCT02186834|38313169|FG002|Treatment at RP2D|Died prior to treatment|0|||
17164806|NCT02186834|38313170|FG003|Treatment at RP2D|Died prior to treatment|0|||
17164807|NCT02186834|38313171|FG004|Treatment at RP2D|Died prior to treatment|0|||
17164808|NCT02186834|38313172|FG005|Treatment at RP2D|Died prior to treatment|1|||
17164809|NCT03144687|38313183|FG000|Overall Study|Death|0|||
17164810|NCT03144687|38313184|FG001|Overall Study|Death|2|||
17164811|NCT03144687|38313183|FG000|Overall Study|Lost to Follow-up|0|||
17164812|NCT03144687|38313184|FG001|Overall Study|Lost to Follow-up|1|||
17164813|NCT03144687|38313183|FG000|Overall Study|Physician Decision|0|||
17164814|NCT03144687|38313184|FG001|Overall Study|Physician Decision|1|||
17164815|NCT03144687|38313183|FG000|Overall Study|Withdrawal by Subject|1|||
17164816|NCT03144687|38313184|FG001|Overall Study|Withdrawal by Subject|3|||
17164817|NCT03144687|38313183|FG000|Overall Study|Not Reported|2|||
17164818|NCT03144687|38313184|FG001|Overall Study|Not Reported|0|||
17164819|NCT03080961|38313194|FG000|Overall Study|Withdrawal by Subject|3|||
17164820|NCT02905266|38313218|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
17164821|NCT02905266|38313219|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
17164822|NCT02905266|38313218|FG000|Treatment Phase Part 1|Disease Progression|6|||
17164823|NCT02905266|38313219|FG001|Treatment Phase Part 1|Disease Progression|7|||
17164824|NCT02905266|38313218|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
17164825|NCT02905266|38313219|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
17164826|NCT02905266|38313218|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
17164827|NCT02905266|38313219|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
17164828|NCT02905266|38313218|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
17164829|NCT02905266|38313219|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
17164830|NCT02905266|38313218|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
17164831|NCT02905266|38313219|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
17164832|NCT02905266|38313218|FG000|Transition From Part 1 to Part 2|Death|0|||
17164833|NCT02905266|38313219|FG001|Transition From Part 1 to Part 2|Death|1|||
17164834|NCT02905266|38313218|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
17164835|NCT02905266|38313219|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
17164836|NCT02905266|38313218|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
17164837|NCT02905266|38313219|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
17164838|NCT02905266|38313218|FG000|Maintenance Phase Part 2|Disease Progression|9|||
17164839|NCT02905266|38313219|FG001|Maintenance Phase Part 2|Disease Progression|2|||
17164840|NCT02905266|38313218|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
17164841|NCT02905266|38313219|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
17164842|NCT02905266|38313218|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
17164843|NCT02905266|38313219|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
17164844|NCT02982018|38313227|FG000|Overall Study|Incorrect Lens Dispensed|1|||
17164845|NCT02982018|38313228|FG001|Overall Study|Incorrect Lens Dispensed|0|||
17164846|NCT02982018|38313227|FG000|Overall Study|Protocol Violation|1|||
17164847|NCT02982018|38313228|FG001|Overall Study|Protocol Violation|1|||
17164848|NCT02982018|38313227|FG000|Overall Study|Adverse Event|1|||
17164849|NCT02982018|38313228|FG001|Overall Study|Adverse Event|1|||
17164850|NCT02982018|38313227|FG000|Overall Study|Lens Discomfort|2|||
17164851|NCT02982018|38313228|FG001|Overall Study|Lens Discomfort|0|||
17164852|NCT02982018|38313227|FG000|Overall Study|Withdrawal by Subject|0|||
17164853|NCT02982018|38313228|FG001|Overall Study|Withdrawal by Subject|1|||
17164854|NCT03080493|38313236|FG000|Overall Study|Did not provide NRS pain results|1|||
17164855|NCT03080493|38313237|FG001|Overall Study|Did not provide NRS pain results|0|||
17164856|NCT03080493|38313236|FG000|Overall Study|Adverse Event|0|||
17164857|NCT03080493|38313237|FG001|Overall Study|Adverse Event|1|||
17164858|NCT03080493|38313236|FG000|Overall Study|Randomization error (parity group)|0|||
17164859|NCT03080493|38313237|FG001|Overall Study|Randomization error (parity group)|1|||
17164860|NCT01339910|38313245|FG000|Overall Study|Withdrawal by Subject|1|||
17164861|NCT01339910|38313246|FG001|Overall Study|Withdrawal by Subject|0|||
17164862|NCT01339910|38313245|FG000|Overall Study|Physician Decision|1|||
17164863|NCT01339910|38313246|FG001|Overall Study|Physician Decision|0|||
17164864|NCT01339910|38313245|FG000|Overall Study|Disease relapse|1|||
17164865|NCT01339910|38313246|FG001|Overall Study|Disease relapse|4|||
17164866|NCT02981082|38313254|FG000|Overall Study|Withdrawal by Subject|2|||
17164867|NCT02981082|38313255|FG001|Overall Study|Withdrawal by Subject|0|||
17164868|NCT02981082|38313254|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
17164869|NCT02981082|38313255|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
17164870|NCT02981082|38313254|FG000|Overall Study|Adverse Event|0|||
17164871|NCT02981082|38313255|FG001|Overall Study|Adverse Event|1|||
17164872|NCT02975700|38313261|FG000|Overall Study|Adverse Event|1|||
17164873|NCT02975700|38313261|FG000|Overall Study|Progressive disease|3|||
17164874|NCT02975700|38313261|FG000|Overall Study|Failed screening criteria|2|||
17164875|NCT01066104|38313267|FG000|Overall Study|Adverse Event|1|||
17164876|NCT01066104|38313268|FG001|Overall Study|Adverse Event|1|||
17164877|NCT01066104|38313267|FG000|Overall Study|Protocol Violation|1|||
17164878|NCT01066104|38313268|FG001|Overall Study|Protocol Violation|0|||
17164879|NCT02736968|38313279|FG000|Overall Study|Lost to Follow-up|0|||
17164880|NCT02736968|38313280|FG001|Overall Study|Lost to Follow-up|0|||
17164881|NCT02736968|38313281|FG002|Overall Study|Lost to Follow-up|0|||
17164882|NCT02736968|38313282|FG003|Overall Study|Lost to Follow-up|0|||
17164883|NCT02736968|38313283|FG004|Overall Study|Lost to Follow-up|0|||
17164884|NCT02736968|38313284|FG005|Overall Study|Lost to Follow-up|0|||
17164885|NCT02736968|38313285|FG006|Overall Study|Lost to Follow-up|5|||
17164886|NCT02736968|38313286|FG007|Overall Study|Lost to Follow-up|2|||
17164887|NCT02736968|38313279|FG000|Overall Study|COVID-19 Pandemic|0|||
17164888|NCT02736968|38313280|FG001|Overall Study|COVID-19 Pandemic|0|||
17164889|NCT02736968|38313281|FG002|Overall Study|COVID-19 Pandemic|0|||
17164890|NCT02736968|38313282|FG003|Overall Study|COVID-19 Pandemic|0|||
17164891|NCT02736968|38313283|FG004|Overall Study|COVID-19 Pandemic|0|||
17164892|NCT02736968|38313284|FG005|Overall Study|COVID-19 Pandemic|0|||
17164893|NCT02736968|38313285|FG006|Overall Study|COVID-19 Pandemic|2|||
17164894|NCT02736968|38313286|FG007|Overall Study|COVID-19 Pandemic|0|||
17164895|NCT02736968|38313279|FG000|Overall Study|Withdrawal by Subject|0|||
17164896|NCT02736968|38313280|FG001|Overall Study|Withdrawal by Subject|0|||
17164897|NCT02736968|38313281|FG002|Overall Study|Withdrawal by Subject|0|||
17164898|NCT02736968|38313282|FG003|Overall Study|Withdrawal by Subject|0|||
17164899|NCT02736968|38313283|FG004|Overall Study|Withdrawal by Subject|0|||
17164900|NCT02736968|38313284|FG005|Overall Study|Withdrawal by Subject|0|||
17164901|NCT02736968|38313285|FG006|Overall Study|Withdrawal by Subject|1|||
16781304|NCT02105974|37720454|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
16868022|NCT01536145|37841042|FG009|Overall Study|Withdrawal by Subject|0|||
17084150|NCT00337662|38224777|FG001|Study Period II|Protocol Violation|0|||
17084151|NCT00337662|38224778|FG002|Study Period II|Protocol Violation|0|||
17084152|NCT00337662|38224779|FG003|Study Period II|Protocol Violation|6|||
17084153|NCT00337662|38224776|FG000|Study Period II|Lack of Efficacy|0|||
17084154|NCT00337662|38224777|FG001|Study Period II|Lack of Efficacy|0|||
17084155|NCT00337662|38224778|FG002|Study Period II|Lack of Efficacy|0|||
17084156|NCT00337662|38224779|FG003|Study Period II|Lack of Efficacy|7|||
17084157|NCT00337662|38224776|FG000|Study Period II|Sponsor Decision|0|||
17084158|NCT00337662|38224777|FG001|Study Period II|Sponsor Decision|0|||
17084159|NCT00337662|38224778|FG002|Study Period II|Sponsor Decision|0|||
17084160|NCT00337662|38224779|FG003|Study Period II|Sponsor Decision|2|||
17084161|NCT00337662|38224776|FG000|Study Period II|Parent/Caregiver Decision|0|||
17084162|NCT00337662|38224777|FG001|Study Period II|Parent/Caregiver Decision|0|||
17084163|NCT00337662|38224778|FG002|Study Period II|Parent/Caregiver Decision|0|||
17084164|NCT00337662|38224779|FG003|Study Period II|Parent/Caregiver Decision|1|||
17084165|NCT00337662|38224776|FG000|Study Period III|Lost to Follow-up|14|||
17084166|NCT00337662|38224777|FG001|Study Period III|Lost to Follow-up|16|||
17084167|NCT00337662|38224778|FG002|Study Period III|Lost to Follow-up|14|||
17084168|NCT00337662|38224779|FG003|Study Period III|Lost to Follow-up|0|||
17084169|NCT00337662|38224776|FG000|Study Period III|Withdrawal by Subject|18|||
17164902|NCT02736968|38313286|FG007|Overall Study|Withdrawal by Subject|0|||
17164903|NCT02980224|38313299|FG000|Overall Study|Adverse Event|4|||
17164904|NCT02980224|38313300|FG001|Overall Study|Adverse Event|1|||
17164905|NCT02980224|38313299|FG000|Overall Study|Withdrawal by Subject|0|||
17164906|NCT02980224|38313300|FG001|Overall Study|Withdrawal by Subject|2|||
17164907|NCT02591615|38313310|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
17164908|NCT02591615|38313311|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
17164909|NCT02591615|38313312|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
17164910|NCT02591615|38313313|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
17164911|NCT02591615|38313310|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
17164912|NCT02591615|38313311|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
17084170|NCT00337662|38224777|FG001|Study Period III|Withdrawal by Subject|14|||
17084171|NCT00337662|38224778|FG002|Study Period III|Withdrawal by Subject|12|||
17084172|NCT00337662|38224779|FG003|Study Period III|Withdrawal by Subject|0|||
17084173|NCT00337662|38224776|FG000|Study Period III|Adverse Event|9|||
17084174|NCT00337662|38224777|FG001|Study Period III|Adverse Event|10|||
17084175|NCT00337662|38224778|FG002|Study Period III|Adverse Event|8|||
17084176|NCT00337662|38224779|FG003|Study Period III|Adverse Event|0|||
17084177|NCT00337662|38224776|FG000|Study Period III|Protocol Violation|3|||
17084178|NCT00337662|38224777|FG001|Study Period III|Protocol Violation|8|||
17084179|NCT00337662|38224778|FG002|Study Period III|Protocol Violation|2|||
17084180|NCT00337662|38224779|FG003|Study Period III|Protocol Violation|0|||
17084181|NCT00337662|38224776|FG000|Study Period III|Physician Decision|6|||
17084182|NCT00337662|38224777|FG001|Study Period III|Physician Decision|5|||
17084183|NCT00337662|38224778|FG002|Study Period III|Physician Decision|0|||
17084184|NCT00337662|38224779|FG003|Study Period III|Physician Decision|0|||
17084185|NCT00337662|38224776|FG000|Study Period III|Entry Criteria Not Met|4|||
17084186|NCT00337662|38224777|FG001|Study Period III|Entry Criteria Not Met|1|||
17084187|NCT00337662|38224778|FG002|Study Period III|Entry Criteria Not Met|3|||
17084188|NCT00337662|38224779|FG003|Study Period III|Entry Criteria Not Met|0|||
17084189|NCT00337662|38224776|FG000|Study Period III|Lack of Efficacy|4|||
17084190|NCT00337662|38224777|FG001|Study Period III|Lack of Efficacy|4|||
17084191|NCT00337662|38224778|FG002|Study Period III|Lack of Efficacy|2|||
17084192|NCT00337662|38224779|FG003|Study Period III|Lack of Efficacy|0|||
17084193|NCT00337662|38224776|FG000|Study Period III|Parent/Caregiver Decision|0|||
17164913|NCT02591615|38313312|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
17164914|NCT02591615|38313313|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
17164915|NCT02591615|38313310|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
17164916|NCT02591615|38313311|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
17164917|NCT02591615|38313312|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
17164918|NCT02591615|38313313|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
17164919|NCT02591615|38313310|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
17164920|NCT02591615|38313311|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
17164921|NCT02591615|38313312|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
17164922|NCT02591615|38313313|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
17164923|NCT02591615|38313310|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
17164924|NCT02591615|38313311|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
17164925|NCT02591615|38313312|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
17164926|NCT02591615|38313313|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
17164927|NCT02591615|38313310|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
17164928|NCT02591615|38313311|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
17164929|NCT02591615|38313312|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
17164930|NCT02591615|38313313|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
17164931|NCT02591615|38313310|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
17164932|NCT02591615|38313311|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
17164933|NCT02591615|38313312|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
17164934|NCT02591615|38313313|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
17164935|NCT02591615|38313310|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
17164936|NCT02591615|38313311|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
17164937|NCT02591615|38313312|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
17164938|NCT02591615|38313313|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
17164939|NCT02591615|38313310|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
17164940|NCT02591615|38313311|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
17164941|NCT02591615|38313312|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
17164942|NCT02591615|38313313|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
17164943|NCT02591615|38313310|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
17164944|NCT02591615|38313311|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
17164945|NCT02591615|38313312|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
17164946|NCT02591615|38313313|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
17164947|NCT02591615|38313310|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
16781305|NCT02105974|37720455|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
17084194|NCT00337662|38224777|FG001|Study Period III|Parent/Caregiver Decision|0|||
17084195|NCT00337662|38224778|FG002|Study Period III|Parent/Caregiver Decision|2|||
17084196|NCT00337662|38224779|FG003|Study Period III|Parent/Caregiver Decision|0|||
17084197|NCT00337662|38224776|FG000|Study Period III|Sponsor Decision|1|||
17084198|NCT00337662|38224777|FG001|Study Period III|Sponsor Decision|0|||
17084199|NCT00337662|38224778|FG002|Study Period III|Sponsor Decision|1|||
17084200|NCT00337662|38224779|FG003|Study Period III|Sponsor Decision|0|||
17084201|NCT00337662|38224776|FG000|Study Period III|Clinical Relapse|1|||
17084202|NCT00337662|38224777|FG001|Study Period III|Clinical Relapse|0|||
17164948|NCT02591615|38313311|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
17164949|NCT02591615|38313312|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
17164950|NCT02591615|38313313|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
17164951|NCT02591615|38313310|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
17164952|NCT02591615|38313311|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
17084203|NCT00337662|38224778|FG002|Study Period III|Clinical Relapse|0|||
17084204|NCT00337662|38224779|FG003|Study Period III|Clinical Relapse|0|||
17084205|NCT00138424|38224794|FG000|Overall Study|Physician Decision|0|||
17084206|NCT00138424|38224795|FG001|Overall Study|Physician Decision|1|||
17084207|NCT00138424|38224796|FG002|Overall Study|Physician Decision|0|||
17084208|NCT00138424|38224797|FG003|Overall Study|Physician Decision|0|||
17084209|NCT00368966|38224811|FG000|Infant Series|Withdrawal by Subject|11|||
17084210|NCT00368966|38224812|FG001|Infant Series|Withdrawal by Subject|6|||
17084211|NCT00368966|38224811|FG000|Infant Series|Protocol Violation|2|||
17084212|NCT00368966|38224812|FG001|Infant Series|Protocol Violation|1|||
17084213|NCT00368966|38224811|FG000|Infant Series|Lost to Follow-up|2|||
17084214|NCT00368966|38224812|FG001|Infant Series|Lost to Follow-up|0|||
17084215|NCT00368966|38224811|FG000|Infant Series|Randomization error|0|||
17084216|NCT00368966|38224812|FG001|Infant Series|Randomization error|1|||
17084217|NCT00368966|38224811|FG000|Infant Series|Failed to meet eligibility criteria|0|||
17084218|NCT00368966|38224812|FG001|Infant Series|Failed to meet eligibility criteria|1|||
17084219|NCT00368966|38224811|FG000|Infant Series|Adverse Event|0|||
17084220|NCT00368966|38224812|FG001|Infant Series|Adverse Event|1|||
17084221|NCT00368966|38224811|FG000|Infant Series|Failed to return|1|||
17084222|NCT00368966|38224812|FG001|Infant Series|Failed to return|0|||
17084223|NCT00368966|38224811|FG000|After Infant|Failed to return|3|||
17084224|NCT00368966|38224812|FG001|After Infant|Failed to return|1|||
17084225|NCT00368966|38224811|FG000|After Infant|Adverse Event|1|||
17084226|NCT00368966|38224812|FG001|After Infant|Adverse Event|2|||
17084227|NCT00368966|38224811|FG000|After Infant|Withdrawal by Subject|1|||
17084228|NCT00368966|38224812|FG001|After Infant|Withdrawal by Subject|1|||
17084229|NCT00368966|38224811|FG000|After Infant|Death|1|||
17084230|NCT00368966|38224812|FG001|After Infant|Death|0|||
17084231|NCT00368966|38224811|FG000|After Infant|Lost to Follow-up|0|||
17084232|NCT00368966|38224812|FG001|After Infant|Lost to Follow-up|1|||
17084233|NCT00368966|38224811|FG000|Toddler Dose|Withdrawal by Subject|1|||
17084234|NCT00368966|38224812|FG001|Toddler Dose|Withdrawal by Subject|1|||
17084235|NCT00368966|38224811|FG000|Toddler Dose|Lost to Follow-up|0|||
17084236|NCT00368966|38224812|FG001|Toddler Dose|Lost to Follow-up|2|||
17084237|NCT00114166|38224845|FG000|Overall Study|Wrong primary|0|||
17084238|NCT00114166|38224846|FG001|Overall Study|Wrong primary|1|||
17084239|NCT00125242|38224856|FG000|Overall Study|did not qualify|7|||
17084240|NCT00125242|38224857|FG001|Overall Study|did not qualify|2|||
17084241|NCT00337428|38224864|FG000|Overall Study|Withdrawal by Subject|1|||
17084242|NCT00337428|38224865|FG001|Overall Study|Withdrawal by Subject|2|||
17084243|NCT00337428|38224864|FG000|Overall Study|Lack of Time|1|||
17084244|NCT00337428|38224865|FG001|Overall Study|Lack of Time|1|||
17084245|NCT00337428|38224864|FG000|Overall Study|Unwilling to Continue|1|||
17084246|NCT00337428|38224865|FG001|Overall Study|Unwilling to Continue|0|||
17084247|NCT00337428|38224864|FG000|Overall Study|Anorexia|1|||
17084248|NCT00337428|38224865|FG001|Overall Study|Anorexia|0|||
17084249|NCT00235989|38224875|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
17084250|NCT00235989|38224876|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
17084251|NCT00235989|38224877|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
17084252|NCT00235989|38224878|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
17084253|NCT00235989|38224879|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
17084254|NCT00235989|38224880|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
17084255|NCT00235989|38224875|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
17084256|NCT00235989|38224876|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
17084257|NCT00235989|38224877|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
17084258|NCT00235989|38224878|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
17084259|NCT00235989|38224879|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
17084260|NCT00235989|38224880|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
17084261|NCT00235989|38224875|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
17084262|NCT00235989|38224876|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
17084263|NCT00235989|38224877|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
17084264|NCT00235989|38224878|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
17164953|NCT02591615|38313312|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
17164954|NCT02591615|38313313|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
17164955|NCT02591615|38313310|FG000|Maintenance MK-3475|Adverse Event|0|||
17164956|NCT02591615|38313311|FG001|Maintenance MK-3475|Adverse Event|3|||
17164957|NCT02591615|38313312|FG002|Maintenance MK-3475|Adverse Event|1|||
17164958|NCT02591615|38313313|FG003|Maintenance MK-3475|Adverse Event|2|||
17164959|NCT02591615|38313310|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
17164960|NCT02591615|38313311|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
17164961|NCT02591615|38313312|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
17164962|NCT02591615|38313313|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
17164963|NCT02591615|38313310|FG000|Maintenance MK-3475|Death|0|||
17164964|NCT02591615|38313311|FG001|Maintenance MK-3475|Death|1|||
17164965|NCT02591615|38313312|FG002|Maintenance MK-3475|Death|1|||
17164966|NCT02591615|38313313|FG003|Maintenance MK-3475|Death|0|||
17164967|NCT02591615|38313310|FG000|Maintenance MK-3475|Physician discretion|0|||
17164968|NCT02591615|38313311|FG001|Maintenance MK-3475|Physician discretion|0|||
17164969|NCT02591615|38313312|FG002|Maintenance MK-3475|Physician discretion|1|||
17164970|NCT02591615|38313313|FG003|Maintenance MK-3475|Physician discretion|0|||
17164971|NCT02591615|38313310|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
17164972|NCT02591615|38313311|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
17164973|NCT02591615|38313312|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
17164974|NCT02591615|38313313|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
17164975|NCT02591615|38313310|FG000|Maintenance MK-3475|In active treatment|2|||
17164976|NCT02591615|38313311|FG001|Maintenance MK-3475|In active treatment|0|||
17164977|NCT02591615|38313312|FG002|Maintenance MK-3475|In active treatment|0|||
17164978|NCT02591615|38313313|FG003|Maintenance MK-3475|In active treatment|1|||
17164979|NCT03077607|38313328|FG000|Period 1 (15 Days)|Adverse Event|1|||
17164980|NCT03077607|38313329|FG001|Period 1 (15 Days)|Adverse Event|0|||
17164981|NCT03077607|38313328|FG000|Period 1 (15 Days)|Death|1|||
17164982|NCT03077607|38313329|FG001|Period 1 (15 Days)|Death|0|||
17164983|NCT03077607|38313328|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
17164984|NCT03077607|38313329|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
17164985|NCT03077607|38313328|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
17164986|NCT03077607|38313329|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
17164987|NCT02977572|38313348|FG000|Overall Study|Exclusion criterion|2|||
17164988|NCT02977572|38313349|FG001|Overall Study|Exclusion criterion|2|||
17164989|NCT02746874|38313361|FG000|Overall Study|Withdrawal by Subject|0|||
17164990|NCT02746874|38313362|FG001|Overall Study|Withdrawal by Subject|1|||
17164991|NCT02746874|38313361|FG000|Overall Study|Surgery Date Changed|0|||
17164992|NCT02746874|38313362|FG001|Overall Study|Surgery Date Changed|2|||
17164993|NCT03217175|38313368|FG000|Overall Study|Physician Decision|4|||
17164994|NCT03217175|38313369|FG001|Overall Study|Physician Decision|1|||
17164995|NCT01062126|38313375|FG000|Overall Study|Death|209|||
17164996|NCT01062126|38313375|FG000|Overall Study|All Withdrawals|324|||
17164997|NCT02522429|38313379|FG000|Overall Study|Lost to Follow-up|8|||
17164998|NCT02522429|38313379|FG000|Overall Study|Adverse Event|2|||
17164999|NCT02522429|38313379|FG000|Overall Study|Death|1|||
17165000|NCT02522429|38313379|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
17165001|NCT02974140|38313383|FG000|Overall Study|Adverse Event|2|||
17165002|NCT02974140|38313383|FG000|Overall Study|Lost to Follow-up|1|||
17165003|NCT02974140|38313383|FG000|Overall Study|Study Terminated by Sponsor|36|||
17165004|NCT02974842|38313390|FG000|Overall Study|Withdrawal by Subject|4|||
17165005|NCT02974842|38313390|FG000|Overall Study|Screen failures|4|||
17165006|NCT03172481|38313396|FG000|Double-blind|Withdrawal by Subject|1|||
17165007|NCT03172481|38313397|FG001|Double-blind|Withdrawal by Subject|0|||
17165008|NCT02855450|38313405|FG000|Overall Study|Adverse Event|1|||
17165009|NCT02855450|38313406|FG001|Overall Study|Adverse Event|0|||
17165010|NCT02855450|38313405|FG000|Overall Study|Lost to Follow-up|4|||
17165011|NCT02855450|38313406|FG001|Overall Study|Lost to Follow-up|0|||
17165012|NCT03172325|38313414|FG000|Overall Study|Adverse Event|2|||
17165013|NCT03172325|38313415|FG001|Overall Study|Adverse Event|3|||
17165014|NCT03172325|38313414|FG000|Overall Study|Positive PPD|1|||
17165015|NCT03172325|38313415|FG001|Overall Study|Positive PPD|0|||
17165016|NCT03172325|38313414|FG000|Overall Study|Poor Compliance|1|||
17165017|NCT03172325|38313415|FG001|Overall Study|Poor Compliance|1|||
17165018|NCT03085017|38313423|FG000|Overall Study|Death|0|||
17165019|NCT03085017|38313424|FG001|Overall Study|Death|3|||
17165020|NCT03215771|38313430|FG000|Overall Study|Withdrawal by Subject|2|||
17165021|NCT03215771|38313430|FG000|Overall Study|Physician Decision|1|||
17165022|NCT02745392|38313439|FG000|Overall Study|Lost to Follow-up|0|||
17165023|NCT02745392|38313440|FG001|Overall Study|Lost to Follow-up|1|||
17165024|NCT02745392|38313441|FG002|Overall Study|Lost to Follow-up|0|||
17165025|NCT02745392|38313442|FG003|Overall Study|Lost to Follow-up|0|||
17165026|NCT03076515|38313454|FG000|Overall Study|DMC decision based on interim analysis|25|||
17165027|NCT03076515|38313455|FG001|Overall Study|DMC decision based on interim analysis|29|||
17165028|NCT03170609|38313468|FG000|Overall Study|Death|0|||
17165029|NCT03170609|38313469|FG001|Overall Study|Death|0|||
17165030|NCT03170609|38313470|FG002|Overall Study|Death|1|||
17165031|NCT03170609|38313471|FG003|Overall Study|Death|0|||
17165032|NCT03170609|38313472|FG004|Overall Study|Death|0|||
17165033|NCT03170609|38313473|FG005|Overall Study|Death|0|||
17084265|NCT00235989|38224879|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
17084266|NCT00235989|38224880|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
17165034|NCT03170609|38313474|FG006|Overall Study|Death|0|||
17165035|NCT03170609|38313468|FG000|Overall Study|Withdrawal by Subject|1|||
17165036|NCT03170609|38313469|FG001|Overall Study|Withdrawal by Subject|2|||
17165037|NCT03170609|38313470|FG002|Overall Study|Withdrawal by Subject|0|||
17165038|NCT03170609|38313471|FG003|Overall Study|Withdrawal by Subject|0|||
17165039|NCT03170609|38313472|FG004|Overall Study|Withdrawal by Subject|0|||
17165040|NCT03170609|38313473|FG005|Overall Study|Withdrawal by Subject|0|||
17165041|NCT03170609|38313474|FG006|Overall Study|Withdrawal by Subject|1|||
17165042|NCT03170609|38313468|FG000|Overall Study|Lost to Follow-up|1|||
16996251|NCT00577993|38140277|FG001|Overall Study|Conversion|5|||
16996252|NCT00577993|38140278|FG002|Overall Study|Conversion|0|||
16996253|NCT00577993|38140276|FG000|Overall Study|Uninsured|1|||
16996254|NCT00577993|38140277|FG001|Overall Study|Uninsured|0|||
16996255|NCT00577993|38140278|FG002|Overall Study|Uninsured|0|||
16996256|NCT00975806|38140287|FG000|Overall Study|Adverse Event|2|||
16996257|NCT00975806|38140288|FG001|Overall Study|Adverse Event|1|||
16996258|NCT00975806|38140289|FG002|Overall Study|Adverse Event|2|||
16996259|NCT00975806|38140287|FG000|Overall Study|Disease Progression|1|||
16996260|NCT00975806|38140288|FG001|Overall Study|Disease Progression|5|||
16996261|NCT00975806|38140289|FG002|Overall Study|Disease Progression|1|||
16996262|NCT00975806|38140287|FG000|Overall Study|Withdrawal by Subject|1|||
16996263|NCT00975806|38140288|FG001|Overall Study|Withdrawal by Subject|0|||
17084267|NCT00235989|38224875|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
17084268|NCT00235989|38224876|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
17084269|NCT00235989|38224877|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
17084270|NCT00235989|38224878|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
17084271|NCT00235989|38224879|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
17084272|NCT00235989|38224880|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
17084273|NCT00235989|38224875|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
17084274|NCT00235989|38224876|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
17084275|NCT00235989|38224877|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
17084276|NCT00235989|38224878|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
17084277|NCT00235989|38224879|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
17084278|NCT00235989|38224880|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
17084279|NCT00113386|38224892|FG000|Overall Study|Withdrawal by Subject|1|||
17084280|NCT00113386|38224893|FG001|Overall Study|Withdrawal by Subject|0|||
17084281|NCT00113386|38224892|FG000|Overall Study|Physician Decision|0|||
17084282|NCT00113386|38224893|FG001|Overall Study|Physician Decision|1|||
17084283|NCT00113386|38224892|FG000|Overall Study|Toxicity|3|||
17084284|NCT00113386|38224893|FG001|Overall Study|Toxicity|0|||
17084285|NCT00113386|38224892|FG000|Overall Study|Ineligible|1|||
17084286|NCT00113386|38224893|FG001|Overall Study|Ineligible|2|||
17084287|NCT00113386|38224892|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
17084288|NCT00113386|38224893|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
17084289|NCT00353262|38224899|FG000|Overall Study|Adverse Event|8|||
17084290|NCT00353262|38224899|FG000|Overall Study|Withdrawal by Subject|2|||
17084291|NCT00353262|38224899|FG000|Overall Study|Insufficient Therapeutic Response|13|||
17084292|NCT00353262|38224899|FG000|Overall Study|Progression|1|||
17084293|NCT00353262|38224899|FG000|Overall Study|Surgery|4|||
17084294|NCT00353262|38224899|FG000|Overall Study|Break from Chemotherapy|1|||
17084295|NCT00337272|38224905|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
17084296|NCT00337272|38224906|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
17084297|NCT00337272|38224905|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
17084298|NCT00337272|38224906|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
17084299|NCT00337272|38224905|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
17084300|NCT00337272|38224906|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
17084301|NCT00337272|38224905|FG000|Treatment Period|Non-compliance|1|||
17084302|NCT00337272|38224906|FG001|Treatment Period|Non-compliance|1|||
17084303|NCT00337272|38224905|FG000|Treatment Period|Withdrawal by Subject|0|||
17084304|NCT00337272|38224906|FG001|Treatment Period|Withdrawal by Subject|1|||
17084305|NCT00337272|38224905|FG000|Withdrawal Period|Non-compliance|0|||
17084306|NCT00337272|38224906|FG001|Withdrawal Period|Non-compliance|1|||
17084307|NCT00125164|38224916|FG000|Overall Study|Adverse Event|0|||
17084308|NCT00125164|38224917|FG001|Overall Study|Adverse Event|0|||
17084309|NCT00125164|38224918|FG002|Overall Study|Adverse Event|2|||
17084310|NCT00125164|38224919|FG003|Overall Study|Adverse Event|4|||
17084311|NCT00125164|38224916|FG000|Overall Study|Lost to Follow-up|0|||
17165043|NCT03170609|38313469|FG001|Overall Study|Lost to Follow-up|0|||
17165044|NCT03170609|38313470|FG002|Overall Study|Lost to Follow-up|5|||
16996264|NCT00975806|38140289|FG002|Overall Study|Withdrawal by Subject|0|||
17084312|NCT00125164|38224917|FG001|Overall Study|Lost to Follow-up|0|||
17084313|NCT00125164|38224918|FG002|Overall Study|Lost to Follow-up|1|||
17084314|NCT00125164|38224919|FG003|Overall Study|Lost to Follow-up|1|||
17084315|NCT00125164|38224916|FG000|Overall Study|Withdrawal by Subject|2|||
17165045|NCT03170609|38313471|FG003|Overall Study|Lost to Follow-up|2|||
17165046|NCT03170609|38313472|FG004|Overall Study|Lost to Follow-up|1|||
17165047|NCT03170609|38313473|FG005|Overall Study|Lost to Follow-up|1|||
17165048|NCT03170609|38313474|FG006|Overall Study|Lost to Follow-up|0|||
17165049|NCT03170609|38313468|FG000|Overall Study|Other|1|||
17165050|NCT03170609|38313469|FG001|Overall Study|Other|0|||
17165051|NCT03170609|38313470|FG002|Overall Study|Other|0|||
17165052|NCT03170609|38313471|FG003|Overall Study|Other|0|||
17165053|NCT03170609|38313472|FG004|Overall Study|Other|0|||
17165054|NCT03170609|38313473|FG005|Overall Study|Other|1|||
17165055|NCT03170609|38313474|FG006|Overall Study|Other|0|||
17165056|NCT01141712|38313490|FG000|Overall Study|Disease progression|3|||
17165057|NCT00004445|38313498|FG000|Overall Study|Physician Decision|2|||
17165058|NCT00004445|38313498|FG000|Overall Study|Withdrawal by Subject|1|||
17165059|NCT03219333|38313504|FG000|Overall Study|Withdrawal by Subject|8|||
17165060|NCT03219333|38313505|FG001|Overall Study|Withdrawal by Subject|3|||
17165061|NCT03219333|38313504|FG000|Overall Study|Lost to Follow-up|1|||
17165062|NCT03219333|38313505|FG001|Overall Study|Lost to Follow-up|0|||
17165063|NCT03219333|38313504|FG000|Overall Study|Death|94|||
17165064|NCT03219333|38313505|FG001|Overall Study|Death|44|||
17165065|NCT03219333|38313504|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
17165066|NCT03219333|38313505|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
17165067|NCT01064622|38313514|FG000|Randomized Phase II|Withdrawal by Subject|2|||
17165068|NCT01064622|38313515|FG001|Randomized Phase II|Withdrawal by Subject|2|||
17165069|NCT01064622|38313514|FG000|Randomized Phase II|Protocol Violation|0|||
17165070|NCT01064622|38313515|FG001|Randomized Phase II|Protocol Violation|1|||
17165071|NCT04163718|38313524|FG000|Overall Study|Study terminated|12|||
17165072|NCT01063764|38313528|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
17165073|NCT01063764|38313528|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
17165074|NCT01063764|38313528|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
17165075|NCT01063764|38313528|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
17165076|NCT01063764|38313528|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
17165077|NCT01063764|38313528|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
17165078|NCT01063764|38313528|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
17165079|NCT03075891|38313538|FG000|Overall Study|Withdrawal by Subject|3|||
17165080|NCT03075891|38313539|FG001|Overall Study|Withdrawal by Subject|6|||
17165081|NCT03075891|38313538|FG000|Overall Study|Lost to Follow-up|1|||
17165082|NCT03075891|38313539|FG001|Overall Study|Lost to Follow-up|0|||
17165083|NCT03075891|38313538|FG000|Overall Study|Pregnancy|3|||
17165084|NCT03075891|38313539|FG001|Overall Study|Pregnancy|1|||
17165085|NCT03075891|38313538|FG000|Overall Study|visits not performed (no time)|1|||
17165086|NCT03075891|38313539|FG001|Overall Study|visits not performed (no time)|0|||
17165087|NCT03075891|38313538|FG000|Overall Study|Drug abuse relapse issue|0|||
17165088|NCT03075891|38313539|FG001|Overall Study|Drug abuse relapse issue|1|||
17165089|NCT03075891|38313538|FG000|Overall Study|Participant requiring study withdrawal|0|||
17165090|NCT03075891|38313539|FG001|Overall Study|Participant requiring study withdrawal|1|||
17165091|NCT03075891|38313538|FG000|Overall Study|Adverse event, non-fatal|1|||
17084316|NCT00125164|38224917|FG001|Overall Study|Withdrawal by Subject|0|||
17084317|NCT00125164|38224918|FG002|Overall Study|Withdrawal by Subject|1|||
17084318|NCT00125164|38224919|FG003|Overall Study|Withdrawal by Subject|1|||
17084319|NCT00136318|38224931|FG000|Overall Study|Adverse Event|5|||
17084320|NCT00136318|38224932|FG001|Overall Study|Adverse Event|5|||
17165092|NCT03075891|38313539|FG001|Overall Study|Adverse event, non-fatal|4|||
17165093|NCT02013167|38313549|FG000|Overall Study|Withdrawal by Subject|15|||
17165094|NCT02013167|38313550|FG001|Overall Study|Withdrawal by Subject|14|||
17165095|NCT02013167|38313549|FG000|Overall Study|Sponsor Decision|1|||
17165096|NCT02013167|38313550|FG001|Overall Study|Sponsor Decision|3|||
17165097|NCT02013167|38313549|FG000|Overall Study|Lost to Follow-up|0|||
17165098|NCT02013167|38313550|FG001|Overall Study|Lost to Follow-up|1|||
17165099|NCT02013167|38313549|FG000|Overall Study|Death|85|||
16996265|NCT00975806|38140287|FG000|Overall Study|Death|0|||
16996266|NCT00975806|38140288|FG001|Overall Study|Death|1|||
16996267|NCT00975806|38140289|FG002|Overall Study|Death|0|||
16996268|NCT00975806|38140287|FG000|Overall Study|Physician decision and disease related|1|||
16996269|NCT00975806|38140288|FG001|Overall Study|Physician decision and disease related|0|||
17165100|NCT02013167|38313550|FG001|Overall Study|Death|160|||
17165101|NCT01063062|38313559|FG000|Overall Study|Patient withdrew consent|0|||
17165102|NCT01063062|38313560|FG001|Overall Study|Patient withdrew consent|1|||
17165103|NCT01063062|38313559|FG000|Overall Study|Adverse Event|2|||
17165104|NCT01063062|38313560|FG001|Overall Study|Adverse Event|4|||
17165105|NCT01063062|38313559|FG000|Overall Study|Protocol Violation|5|||
17165106|NCT01063062|38313560|FG001|Overall Study|Protocol Violation|4|||
17165107|NCT01063062|38313559|FG000|Overall Study|Investigator's request|1|||
17165108|NCT01063062|38313560|FG001|Overall Study|Investigator's request|0|||
17165109|NCT01063062|38313559|FG000|Overall Study|Lost to Follow-up|0|||
17165110|NCT01063062|38313560|FG001|Overall Study|Lost to Follow-up|2|||
17165111|NCT01063062|38313559|FG000|Overall Study|Miscellaneous reason|0|||
17165112|NCT01063062|38313560|FG001|Overall Study|Miscellaneous reason|1|||
17165113|NCT02973048|38313569|FG000|Overall Study|Epidural catheter insertion failure|1|||
17165114|NCT02973048|38313570|FG001|Overall Study|Epidural catheter insertion failure|0|||
17165115|NCT02973048|38313569|FG000|Overall Study|Withdrawal by Subject|0|||
17165116|NCT02973048|38313570|FG001|Overall Study|Withdrawal by Subject|3|||
17165117|NCT02853344|38313578|FG000|Overall Study|Death|23|||
17165118|NCT02853344|38313579|FG001|Overall Study|Death|84|||
17165119|NCT02853344|38313578|FG000|Overall Study|Withdrawal by Subject|1|||
17165120|NCT02853344|38313579|FG001|Overall Study|Withdrawal by Subject|3|||
17165121|NCT02853344|38313578|FG000|Overall Study|Ongoing|86|||
17165122|NCT02853344|38313579|FG001|Overall Study|Ongoing|78|||
17165123|NCT02932943|38313589|FG000|Overall Study|Lost to Follow-up|0|||
17165124|NCT02932943|38313590|FG001|Overall Study|Lost to Follow-up|2|||
17165125|NCT02932943|38313589|FG000|Overall Study|Adverse Event|2|||
17165126|NCT02932943|38313590|FG001|Overall Study|Adverse Event|2|||
17165127|NCT02932943|38313589|FG000|Overall Study|Withdrawal by Subject|3|||
17165128|NCT02932943|38313590|FG001|Overall Study|Withdrawal by Subject|3|||
17165129|NCT02972658|38313615|FG000|Overall Study|Adverse Event|0|||
17165130|NCT02972658|38313616|FG001|Overall Study|Adverse Event|3|||
17165131|NCT02972658|38313617|FG002|Overall Study|Adverse Event|0|||
17165132|NCT02972658|38313618|FG003|Overall Study|Adverse Event|2|||
17165133|NCT02972658|38313615|FG000|Overall Study|Other-determined by Investigator|1|||
17165134|NCT02972658|38313616|FG001|Overall Study|Other-determined by Investigator|1|||
17165135|NCT02972658|38313617|FG002|Overall Study|Other-determined by Investigator|0|||
17165136|NCT02972658|38313618|FG003|Overall Study|Other-determined by Investigator|0|||
17165137|NCT02972658|38313615|FG000|Overall Study|Death|0|||
17165138|NCT02972658|38313616|FG001|Overall Study|Death|0|||
17165139|NCT02972658|38313617|FG002|Overall Study|Death|0|||
17165140|NCT02972658|38313618|FG003|Overall Study|Death|1|||
17165141|NCT02972658|38313615|FG000|Overall Study|Lost to Follow-up|0|||
17165142|NCT02972658|38313616|FG001|Overall Study|Lost to Follow-up|1|||
17165143|NCT02972658|38313617|FG002|Overall Study|Lost to Follow-up|1|||
17165144|NCT02972658|38313618|FG003|Overall Study|Lost to Follow-up|2|||
17165145|NCT02972658|38313615|FG000|Overall Study|Progressive Disease|0|||
17165146|NCT02972658|38313616|FG001|Overall Study|Progressive Disease|1|||
17165147|NCT02972658|38313617|FG002|Overall Study|Progressive Disease|0|||
17165148|NCT02972658|38313618|FG003|Overall Study|Progressive Disease|1|||
17165149|NCT02972658|38313615|FG000|Overall Study|Withdrawal by Subject|4|||
17165150|NCT02972658|38313616|FG001|Overall Study|Withdrawal by Subject|4|||
17165151|NCT02972658|38313617|FG002|Overall Study|Withdrawal by Subject|1|||
17165152|NCT02972658|38313618|FG003|Overall Study|Withdrawal by Subject|6|||
17165153|NCT02972658|38313615|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
17165154|NCT02972658|38313616|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
17165155|NCT02972658|38313617|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
17165156|NCT02972658|38313618|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
17165157|NCT02972658|38313615|FG000|Overall Study|Sponsor Decision|70|||
17165158|NCT02972658|38313616|FG001|Overall Study|Sponsor Decision|127|||
17165159|NCT02972658|38313617|FG002|Overall Study|Sponsor Decision|72|||
17165160|NCT02972658|38313618|FG003|Overall Study|Sponsor Decision|119|||
17165161|NCT02853032|38313630|FG000|Overall Study|Adverse Event|4|||
17165162|NCT02853032|38313631|FG001|Overall Study|Adverse Event|0|||
17165163|NCT02853032|38313630|FG000|Overall Study|Withdrawal by Subject|3|||
17165164|NCT02853032|38313631|FG001|Overall Study|Withdrawal by Subject|1|||
17165165|NCT02853032|38313630|FG000|Overall Study|Requested to withdraw from all treatment|2|||
17165166|NCT02853032|38313631|FG001|Overall Study|Requested to withdraw from all treatment|2|||
17165167|NCT02232087|38313639|FG000|Overall Study|Withdrawal by Subject|2|||
17165168|NCT02232087|38313640|FG001|Overall Study|Withdrawal by Subject|0|||
17165169|NCT02232087|38313641|FG002|Overall Study|Withdrawal by Subject|0|||
17165170|NCT02232087|38313642|FG003|Overall Study|Withdrawal by Subject|0|||
17165171|NCT02232087|38313643|FG004|Overall Study|Withdrawal by Subject|0|||
17165172|NCT02232087|38313644|FG005|Overall Study|Withdrawal by Subject|1|||
17165173|NCT02232087|38313639|FG000|Overall Study|poor inhalation technique|0|||
17165174|NCT02232087|38313640|FG001|Overall Study|poor inhalation technique|1|||
17165175|NCT02232087|38313641|FG002|Overall Study|poor inhalation technique|0|||
17165176|NCT02232087|38313642|FG003|Overall Study|poor inhalation technique|0|||
17165177|NCT02232087|38313643|FG004|Overall Study|poor inhalation technique|0|||
17165178|NCT02232087|38313644|FG005|Overall Study|poor inhalation technique|2|||
17165179|NCT02232087|38313639|FG000|Overall Study|protocol stop criteria|0|||
17165180|NCT02232087|38313640|FG001|Overall Study|protocol stop criteria|1|||
17165181|NCT02232087|38313641|FG002|Overall Study|protocol stop criteria|0|||
17165182|NCT02232087|38313642|FG003|Overall Study|protocol stop criteria|1|||
17165183|NCT02232087|38313643|FG004|Overall Study|protocol stop criteria|0|||
17165184|NCT02232087|38313644|FG005|Overall Study|protocol stop criteria|0|||
17165185|NCT02232087|38313639|FG000|Overall Study|Adverse Event|0|||
17165186|NCT02232087|38313640|FG001|Overall Study|Adverse Event|0|||
17165187|NCT02232087|38313641|FG002|Overall Study|Adverse Event|0|||
17165188|NCT02232087|38313642|FG003|Overall Study|Adverse Event|0|||
17165189|NCT02232087|38313643|FG004|Overall Study|Adverse Event|1|||
17165190|NCT02232087|38313644|FG005|Overall Study|Adverse Event|0|||
17165191|NCT03168425|38313665|FG000|Overall Study|Lost to Follow-up|5|||
17165192|NCT03168425|38313666|FG001|Overall Study|Lost to Follow-up|8|||
17165193|NCT03168425|38313665|FG000|Overall Study|unable to confirm post op opioids|2|||
17165194|NCT03168425|38313666|FG001|Overall Study|unable to confirm post op opioids|3|||
17165195|NCT02972502|38313679|FG000|Overall Study|Lost to Follow-up|3|||
17084321|NCT00136318|38224931|FG000|Overall Study|Withdrawal by Subject|2|||
17084322|NCT00136318|38224932|FG001|Overall Study|Withdrawal by Subject|2|||
17084323|NCT00136084|38224941|FG000|Overall Study|Death|12|||
17084324|NCT00136084|38224942|FG001|Overall Study|Death|5|||
17084325|NCT00136084|38224941|FG000|Overall Study|Unacceptable toxicity|8|||
17084326|NCT00136084|38224942|FG001|Overall Study|Unacceptable toxicity|11|||
17084327|NCT00136084|38224941|FG000|Overall Study|Relapse|20|||
17084328|NCT00136084|38224942|FG001|Overall Study|Relapse|23|||
17084329|NCT00136084|38224941|FG000|Overall Study|Lost to Follow-up|2|||
17084330|NCT00136084|38224942|FG001|Overall Study|Lost to Follow-up|0|||
17084331|NCT00136084|38224941|FG000|Overall Study|No Response|1|||
17084332|NCT00136084|38224942|FG001|Overall Study|No Response|2|||
17084333|NCT00136084|38224941|FG000|Overall Study|Withdrawal by Subject|5|||
17084334|NCT00136084|38224942|FG001|Overall Study|Withdrawal by Subject|1|||
17165196|NCT02972502|38313680|FG001|Overall Study|Lost to Follow-up|1|||
17165197|NCT02972502|38313679|FG000|Overall Study|Withdrawal by Subject|1|||
17165198|NCT02972502|38313680|FG001|Overall Study|Withdrawal by Subject|1|||
17165199|NCT02971800|38313686|FG000|Overall Study|Protocol Violation|1|||
17165200|NCT02971800|38313686|FG000|Overall Study|Withdrawal by Subject|1|||
17165201|NCT02971800|38313686|FG000|Overall Study|Exclusion criteria prior intervention|1|||
17165202|NCT02971800|38313686|FG000|Overall Study|Number evaluable participant already reached|4|||
17165203|NCT03163667|38313692|FG000|Overall Study|Death|15|||
17165204|NCT03163667|38313693|FG001|Overall Study|Death|27|||
17165205|NCT03163667|38313692|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
17165206|NCT03163667|38313693|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
17165207|NCT03167411|38313701|FG000|Overall Study|Adverse Event|0|||
17165208|NCT03167411|38313702|FG001|Overall Study|Adverse Event|1|||
17165209|NCT01952847|38313712|FG000|Overall Study|Ineligible|1|||
17165210|NCT01952847|38313713|FG001|Overall Study|Ineligible|0|||
17165211|NCT01952847|38313714|FG002|Overall Study|Ineligible|0|||
17165212|NCT01952847|38313715|FG003|Overall Study|Ineligible|0|||
17165213|NCT01952847|38313712|FG000|Overall Study|Lack of Insurance Coverage|0|||
17165214|NCT01952847|38313713|FG001|Overall Study|Lack of Insurance Coverage|1|||
17165215|NCT01952847|38313714|FG002|Overall Study|Lack of Insurance Coverage|0|||
17084335|NCT00364832|38224963|FG000|Core Period|Early Withdrawals|2|||
17165216|NCT01952847|38313715|FG003|Overall Study|Lack of Insurance Coverage|0|||
17165217|NCT01952847|38313712|FG000|Overall Study|Withdrawal by Subject|1|||
17165218|NCT01952847|38313713|FG001|Overall Study|Withdrawal by Subject|1|||
17165219|NCT01952847|38313714|FG002|Overall Study|Withdrawal by Subject|0|||
17165220|NCT01952847|38313715|FG003|Overall Study|Withdrawal by Subject|1|||
17165221|NCT01560585|38313727|FG000|Overall Study|Physician Decision|3|||
17165222|NCT03075501|38313734|FG000|Overall Study|Scheduling difficulties|15|||
17165223|NCT03075501|38313735|FG001|Overall Study|Scheduling difficulties|9|||
17165224|NCT02317991|38313742|FG000|Overall Study|Adverse Event|12|||
17165225|NCT02317991|38313742|FG000|Overall Study|Death|4|||
17165226|NCT02317991|38313742|FG000|Overall Study|Withdrawal by Subject|8|||
17165227|NCT02317991|38313742|FG000|Overall Study|Progressive Disease|41|||
17165228|NCT03075267|38313749|FG000|Overall Study|Protocol Violation|1|||
17165229|NCT03075267|38313750|FG001|Overall Study|Protocol Violation|0|||
17165230|NCT03075267|38313751|FG002|Overall Study|Protocol Violation|0|||
17165231|NCT03074331|38313759|FG000|Overall Study|Enrolled but Not Treated|1|||
17165232|NCT03074331|38313759|FG000|Overall Study|Lost to Follow-up|5|||
17165233|NCT03074331|38313759|FG000|Overall Study|Withdrew Consent|1|||
17165234|NCT02260193|38313766|FG000|Overall Study|Lack of Efficacy|0|||
17165235|NCT02260193|38313767|FG001|Overall Study|Lack of Efficacy|1|||
17165236|NCT02260193|38313768|FG002|Overall Study|Lack of Efficacy|6|||
17165237|NCT02260193|38313766|FG000|Overall Study|Adverse Event|3|||
17165238|NCT02260193|38313767|FG001|Overall Study|Adverse Event|4|||
17165239|NCT02260193|38313768|FG002|Overall Study|Adverse Event|1|||
17165240|NCT02260193|38313766|FG000|Overall Study|Protocol Violation|0|||
17165241|NCT02260193|38313767|FG001|Overall Study|Protocol Violation|4|||
17165242|NCT02260193|38313768|FG002|Overall Study|Protocol Violation|0|||
17165243|NCT02260193|38313766|FG000|Overall Study|Withdrawal by Subject|3|||
17165244|NCT02260193|38313767|FG001|Overall Study|Withdrawal by Subject|0|||
17084336|NCT00364832|38224964|FG001|Core Period|Early Withdrawals|2|||
17084337|NCT00364832|38224965|FG002|Core Period|Early Withdrawals|1|||
17165245|NCT02260193|38313768|FG002|Overall Study|Withdrawal by Subject|2|||
17165246|NCT02260193|38313766|FG000|Overall Study|Kidney Transplantation|0|||
17165247|NCT02260193|38313767|FG001|Overall Study|Kidney Transplantation|0|||
17165248|NCT02260193|38313768|FG002|Overall Study|Kidney Transplantation|1|||
17165249|NCT02849678|38313778|FG000|Overall Study|Protocol Violation|3|||
17165250|NCT02849678|38313779|FG001|Overall Study|Protocol Violation|6|||
17165251|NCT01596257|38313787|FG000|Overall Study|Inadequate Collection|23|||
17165252|NCT01596257|38313788|FG001|Overall Study|Inadequate Collection|19|||
17165253|NCT04577781|38313798|FG000|Overall Study|Adverse Event|2|||
17165254|NCT04577781|38313799|FG001|Overall Study|Adverse Event|2|||
17165255|NCT04577781|38313798|FG000|Overall Study|Physician Decision|1|||
17165256|NCT04577781|38313799|FG001|Overall Study|Physician Decision|0|||
17165257|NCT02737826|38313806|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
17165258|NCT02737826|38313807|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
17165259|NCT02737826|38313808|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
17165260|NCT03070431|38313835|FG000|Overall Study|Withdrawal by Subject|2|||
17165261|NCT03070431|38313835|FG000|Overall Study|Lost to Follow-up|2|||
17165262|NCT01071395|38313846|FG000|Overall Study|Withdrawal by Subject|2|||
17165263|NCT01071395|38313847|FG001|Overall Study|Withdrawal by Subject|1|||
17165264|NCT01071395|38313846|FG000|Overall Study|Adverse Event|3|||
17165265|NCT01071395|38313847|FG001|Overall Study|Adverse Event|1|||
17165266|NCT02970942|38313857|FG000|Overall Study|Death|0|||
17165267|NCT02970942|38313858|FG001|Overall Study|Death|1|||
17084338|NCT00364832|38224966|FG003|Core Period|Early Withdrawals|1|||
17084339|NCT00364832|38224967|FG004|Core Period|Early Withdrawals|0|||
17084340|NCT00364832|38224968|FG005|Core Period|Early Withdrawals|0|||
17084341|NCT00364832|38224969|FG006|Core Period|Early Withdrawals|4|||
17084342|NCT00364832|38224970|FG007|Core Period|Early Withdrawals|1|||
17084343|NCT00364832|38224971|FG008|Core Period|Early Withdrawals|0|||
17084344|NCT00364832|38224972|FG009|Core Period|Early Withdrawals|0|||
17084345|NCT00364832|38224973|FG010|Core Period|Early Withdrawals|0|||
17084346|NCT00364832|38224974|FG011|Core Period|Early Withdrawals|0|||
17165268|NCT02970942|38313859|FG002|Overall Study|Death|0|||
17165269|NCT02970942|38313860|FG003|Overall Study|Death|0|||
17165270|NCT02970942|38313857|FG000|Overall Study|Lost to Follow-up|1|||
17165271|NCT02970942|38313858|FG001|Overall Study|Lost to Follow-up|0|||
17165272|NCT02970942|38313859|FG002|Overall Study|Lost to Follow-up|2|||
17165273|NCT02970942|38313860|FG003|Overall Study|Lost to Follow-up|1|||
17165274|NCT02970942|38313857|FG000|Overall Study|Withdrawal by Subject|3|||
17165275|NCT02970942|38313858|FG001|Overall Study|Withdrawal by Subject|5|||
17165276|NCT02970942|38313859|FG002|Overall Study|Withdrawal by Subject|3|||
17165277|NCT02970942|38313860|FG003|Overall Study|Withdrawal by Subject|2|||
17165278|NCT03073005|38313874|FG000|Overall Study|Death|6|||
17165279|NCT03073005|38313875|FG001|Overall Study|Death|0|||
17084347|NCT00364832|38224963|FG000|Extension Year 1|Early Withdrawals|0|||
17165280|NCT03073005|38313876|FG002|Overall Study|Death|7|||
17165281|NCT03073005|38313877|FG003|Overall Study|Death|0|||
17165282|NCT03073005|38313874|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
17165283|NCT03073005|38313875|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
17165284|NCT03073005|38313876|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
17165285|NCT03073005|38313877|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
17165286|NCT03073005|38313874|FG000|Overall Study|Lost to Follow-up|2|||
17165287|NCT03073005|38313875|FG001|Overall Study|Lost to Follow-up|2|||
17165288|NCT03073005|38313876|FG002|Overall Study|Lost to Follow-up|1|||
17165289|NCT03073005|38313877|FG003|Overall Study|Lost to Follow-up|2|||
17165290|NCT03073005|38313874|FG000|Overall Study|Withdrawal by Subject|0|||
17165291|NCT03073005|38313875|FG001|Overall Study|Withdrawal by Subject|4|||
17165292|NCT03073005|38313876|FG002|Overall Study|Withdrawal by Subject|4|||
17165293|NCT03073005|38313877|FG003|Overall Study|Withdrawal by Subject|4|||
17165294|NCT02849171|38313890|FG000|Overall Study|Withdrawal by Subject|1|||
17165295|NCT02849171|38313890|FG000|Overall Study|Not treated|1|||
17165296|NCT02848664|38313903|FG000|Overall Study|Withdrawal by Subject|2|||
17165297|NCT02848664|38313903|FG000|Overall Study|Adverse Event|1|||
17165298|NCT02848664|38313903|FG000|Overall Study|no assistance for device training|1|||
17165299|NCT02969382|38313913|FG000|Overall Study|Adverse Event|8|||
17165300|NCT02969382|38313914|FG001|Overall Study|Adverse Event|10|||
17165301|NCT02969382|38313913|FG000|Overall Study|Lack of Efficacy|4|||
17165302|NCT02969382|38313914|FG001|Overall Study|Lack of Efficacy|5|||
17165303|NCT02969382|38313913|FG000|Overall Study|Death|0|||
17165304|NCT02969382|38313914|FG001|Overall Study|Death|1|||
17165305|NCT02969382|38313913|FG000|Overall Study|PROTOCOL DEVIATION|0|||
17165306|NCT02969382|38313914|FG001|Overall Study|PROTOCOL DEVIATION|1|||
17165307|NCT02969382|38313913|FG000|Overall Study|Withdrawal by Subject|14|||
17165308|NCT02969382|38313914|FG001|Overall Study|Withdrawal by Subject|9|||
17165309|NCT01989104|38313925|FG000|Overall Study|Withdrawal by Subject|3|||
17165310|NCT01989104|38313926|FG001|Overall Study|Withdrawal by Subject|0|||
17165311|NCT01989104|38313927|FG002|Overall Study|Withdrawal by Subject|0|||
17084348|NCT00364832|38224964|FG001|Extension Year 1|Early Withdrawals|0|||
17165312|NCT01989104|38313928|FG003|Overall Study|Withdrawal by Subject|0|||
17165313|NCT01989104|38313929|FG004|Overall Study|Withdrawal by Subject|0|||
17165314|NCT02903238|38313941|FG000|Overall Study|Lost to Follow-up|4|||
17165315|NCT02847260|38313946|FG000|Overall Study|Adverse Event|3|||
17165316|NCT02847260|38313946|FG000|Overall Study|Withdrawal by Subject|2|||
17165317|NCT02847260|38313946|FG000|Overall Study|Clinical Deterioration|1|||
17165318|NCT02847260|38313946|FG000|Overall Study|Physician Decision|1|||
17084349|NCT00364832|38224965|FG002|Extension Year 1|Early Withdrawals|0|||
17084350|NCT00364832|38224966|FG003|Extension Year 1|Early Withdrawals|0|||
17084351|NCT00364832|38224967|FG004|Extension Year 1|Early Withdrawals|0|||
17165319|NCT02968563|38313952|FG000|Overall Study|Adverse Event|0|||
17165320|NCT02968563|38313953|FG001|Overall Study|Adverse Event|6|||
17165321|NCT02968563|38313952|FG000|Overall Study|Death|1|||
17165322|NCT02968563|38313953|FG001|Overall Study|Death|1|||
17165323|NCT02968563|38313952|FG000|Overall Study|Lost to Follow-up|0|||
17165324|NCT02968563|38313953|FG001|Overall Study|Lost to Follow-up|1|||
17165325|NCT02904096|38313961|FG000|Overall Study|Adverse Event|1|||
17165326|NCT02904096|38313962|FG001|Overall Study|Adverse Event|0|||
17165327|NCT02904096|38313961|FG000|Overall Study|Withdrawal by Subject|4|||
17165328|NCT02904096|38313962|FG001|Overall Study|Withdrawal by Subject|3|||
17165329|NCT02904096|38313961|FG000|Overall Study|Lost to Follow-up|10|||
17165330|NCT02904096|38313962|FG001|Overall Study|Lost to Follow-up|17|||
17084352|NCT00364832|38224968|FG005|Extension Year 1|Early Withdrawals|0|||
17084353|NCT00364832|38224969|FG006|Extension Year 1|Early Withdrawals|0|||
17165331|NCT02904096|38313961|FG000|Overall Study|Non-compliant|3|||
17165332|NCT02904096|38313962|FG001|Overall Study|Non-compliant|1|||
17165333|NCT02904096|38313961|FG000|Overall Study|Sponsor instructed|1|||
17165334|NCT02904096|38313962|FG001|Overall Study|Sponsor instructed|0|||
17165335|NCT03161483|38313972|FG000|Overall Study|Death|1|||
17165336|NCT03161483|38313973|FG001|Overall Study|Death|0|||
17165337|NCT03161483|38313974|FG002|Overall Study|Death|0|||
17165338|NCT03161483|38313975|FG003|Overall Study|Death|0|||
17165339|NCT03161483|38313972|FG000|Overall Study|Adverse Event|5|||
17165340|NCT03161483|38313973|FG001|Overall Study|Adverse Event|1|||
17165341|NCT03161483|38313974|FG002|Overall Study|Adverse Event|11|||
17165342|NCT03161483|38313975|FG003|Overall Study|Adverse Event|2|||
17165343|NCT03161483|38313972|FG000|Overall Study|Pregnancy|1|||
17165344|NCT03161483|38313973|FG001|Overall Study|Pregnancy|0|||
17165345|NCT03161483|38313974|FG002|Overall Study|Pregnancy|0|||
17165346|NCT03161483|38313975|FG003|Overall Study|Pregnancy|0|||
17165347|NCT03161483|38313972|FG000|Overall Study|Lack of Efficacy|0|||
17165348|NCT03161483|38313973|FG001|Overall Study|Lack of Efficacy|0|||
17165349|NCT03161483|38313974|FG002|Overall Study|Lack of Efficacy|1|||
17165350|NCT03161483|38313975|FG003|Overall Study|Lack of Efficacy|0|||
17165351|NCT03161483|38313972|FG000|Overall Study|Withdrawal by Subject|2|||
17165352|NCT03161483|38313973|FG001|Overall Study|Withdrawal by Subject|2|||
17165353|NCT03161483|38313974|FG002|Overall Study|Withdrawal by Subject|6|||
17165354|NCT03161483|38313975|FG003|Overall Study|Withdrawal by Subject|5|||
17165355|NCT03161483|38313972|FG000|Overall Study|Lost to Follow-up|0|||
17165356|NCT03161483|38313973|FG001|Overall Study|Lost to Follow-up|0|||
17165357|NCT03161483|38313974|FG002|Overall Study|Lost to Follow-up|1|||
17165358|NCT03161483|38313975|FG003|Overall Study|Lost to Follow-up|0|||
17165359|NCT03161483|38313972|FG000|Overall Study|Protocol Violation|0|||
17165360|NCT03161483|38313973|FG001|Overall Study|Protocol Violation|0|||
17165361|NCT03161483|38313974|FG002|Overall Study|Protocol Violation|1|||
17165362|NCT03161483|38313975|FG003|Overall Study|Protocol Violation|0|||
17165363|NCT03161483|38313972|FG000|Overall Study|Other reasons|1|||
17165364|NCT03161483|38313973|FG001|Overall Study|Other reasons|0|||
17165365|NCT03161483|38313974|FG002|Overall Study|Other reasons|0|||
17165366|NCT03161483|38313975|FG003|Overall Study|Other reasons|1|||
17165367|NCT03161405|38313989|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
17165368|NCT01813929|38313998|FG000|Overall Study|Withdrawal by Subject|0|||
17165369|NCT01813929|38313999|FG001|Overall Study|Withdrawal by Subject|1|||
17165370|NCT02901054|38314009|FG000|Overall Study|Physician Decision|1|||
17165371|NCT02901054|38314009|FG000|Overall Study|Withdrawal by Subject|3|||
17084354|NCT00364832|38224970|FG007|Extension Year 1|Early Withdrawals|0|||
17084355|NCT00364832|38224971|FG008|Extension Year 1|Early Withdrawals|0|||
17084356|NCT00364832|38224972|FG009|Extension Year 1|Early Withdrawals|4|||
17084357|NCT00364832|38224973|FG010|Extension Year 1|Early Withdrawals|2|||
17084358|NCT00364832|38224974|FG011|Extension Year 1|Early Withdrawals|10|||
17084359|NCT00364832|38224963|FG000|Extension Year 2|Early Withdrawals|0|||
17084360|NCT00364832|38224964|FG001|Extension Year 2|Early Withdrawals|0|||
17084361|NCT00364832|38224965|FG002|Extension Year 2|Early Withdrawals|0|||
17084362|NCT00364832|38224966|FG003|Extension Year 2|Early Withdrawals|0|||
17084363|NCT00364832|38224967|FG004|Extension Year 2|Early Withdrawals|0|||
17084364|NCT00364832|38224968|FG005|Extension Year 2|Early Withdrawals|0|||
17084365|NCT00364832|38224969|FG006|Extension Year 2|Early Withdrawals|0|||
17165372|NCT03068715|38314015|FG000|Overall Study|No longer met inclusion criteria|1|||
17165373|NCT03068715|38314016|FG001|Overall Study|No longer met inclusion criteria|0|||
17165374|NCT02966340|38314024|FG000|Overall Study|Adverse Event|0|||
17165375|NCT02966340|38314025|FG001|Overall Study|Adverse Event|1|||
17165376|NCT02966340|38314024|FG000|Overall Study|Lost to Follow-up|0|||
17165377|NCT02966340|38314025|FG001|Overall Study|Lost to Follow-up|1|||
17165378|NCT02966340|38314024|FG000|Overall Study|Withdrawal by Subject|1|||
17165379|NCT02966340|38314025|FG001|Overall Study|Withdrawal by Subject|0|||
17165380|NCT02966340|38314024|FG000|Overall Study|data acquisition error|1|||
17165381|NCT02966340|38314025|FG001|Overall Study|data acquisition error|0|||
17165382|NCT02966340|38314024|FG000|Overall Study|startle non-responder|1|||
17165383|NCT02966340|38314025|FG001|Overall Study|startle non-responder|1|||
17165384|NCT03067311|38314033|FG000|Overall Study|Lost to Follow-up|1|||
17165385|NCT03067311|38314034|FG001|Overall Study|Lost to Follow-up|1|||
17165386|NCT03067311|38314033|FG000|Overall Study|Moved away|1|||
17165387|NCT03067311|38314034|FG001|Overall Study|Moved away|1|||
17165388|NCT04380519|38314043|FG000|Overall Study|Withdrawal by Subject|4|||
17165389|NCT04380519|38314044|FG001|Overall Study|Withdrawal by Subject|0|||
17165390|NCT04380519|38314045|FG002|Overall Study|Withdrawal by Subject|1|||
17165391|NCT04380519|38314043|FG000|Overall Study|Death|14|||
17165392|NCT04380519|38314044|FG001|Overall Study|Death|9|||
17165393|NCT04380519|38314045|FG002|Overall Study|Death|6|||
17165394|NCT04380519|38314043|FG000|Overall Study|Adverse Event|0|||
17165395|NCT04380519|38314044|FG001|Overall Study|Adverse Event|1|||
17165396|NCT04380519|38314045|FG002|Overall Study|Adverse Event|0|||
17165397|NCT04380519|38314043|FG000|Overall Study|relatives' decision|0|||
17165398|NCT04380519|38314044|FG001|Overall Study|relatives' decision|1|||
17165399|NCT04380519|38314045|FG002|Overall Study|relatives' decision|0|||
17165400|NCT02847182|38314055|FG000|Overall Study|Withdrawal by Subject|0|||
17165401|NCT02847182|38314056|FG001|Overall Study|Withdrawal by Subject|1|||
17165402|NCT02846558|38314072|FG000|Overall Study|Adverse Event|1|||
17165403|NCT02846558|38314073|FG001|Overall Study|Adverse Event|0|||
17165404|NCT02846558|38314074|FG002|Overall Study|Adverse Event|0|||
17165405|NCT02846558|38314075|FG003|Overall Study|Adverse Event|0|||
17165406|NCT02846558|38314072|FG000|Overall Study|Withdrawal by Subject|5|||
17165407|NCT02846558|38314073|FG001|Overall Study|Withdrawal by Subject|4|||
17165408|NCT02846558|38314074|FG002|Overall Study|Withdrawal by Subject|2|||
17165409|NCT02846558|38314075|FG003|Overall Study|Withdrawal by Subject|2|||
17165410|NCT02846558|38314072|FG000|Overall Study|Lost to Follow-up|2|||
17165411|NCT02846558|38314073|FG001|Overall Study|Lost to Follow-up|0|||
17165412|NCT02846558|38314074|FG002|Overall Study|Lost to Follow-up|0|||
17165413|NCT02846558|38314075|FG003|Overall Study|Lost to Follow-up|0|||
17165414|NCT04362813|38314094|FG000|Overall Study|Death|12|||
17165415|NCT04362813|38314095|FG001|Overall Study|Death|16|||
17165416|NCT04362813|38314094|FG000|Overall Study|Withdrawal by Subject|3|||
17165417|NCT04362813|38314095|FG001|Overall Study|Withdrawal by Subject|1|||
17165418|NCT04362813|38314094|FG000|Overall Study|Protocol Violation|0|||
17165419|NCT04362813|38314095|FG001|Overall Study|Protocol Violation|3|||
17165420|NCT04362813|38314094|FG000|Overall Study|Lost to Follow-up|1|||
17165421|NCT04362813|38314095|FG001|Overall Study|Lost to Follow-up|1|||
17165422|NCT04362813|38314094|FG000|Overall Study|Enrolled but did not receive treatment|2|||
17165423|NCT04362813|38314095|FG001|Overall Study|Enrolled but did not receive treatment|4|||
17165424|NCT02966028|38314104|FG000|Overall Study|Adverse Event|7|||
17165425|NCT02966028|38314105|FG001|Overall Study|Adverse Event|13|||
17165426|NCT02966028|38314106|FG002|Overall Study|Adverse Event|10|||
17165427|NCT02966028|38314104|FG000|Overall Study|Physician Decision|1|||
17165428|NCT02966028|38314105|FG001|Overall Study|Physician Decision|0|||
17165429|NCT02966028|38314106|FG002|Overall Study|Physician Decision|2|||
17165430|NCT02966028|38314104|FG000|Overall Study|Withdrawal by Subject|7|||
17165431|NCT02966028|38314105|FG001|Overall Study|Withdrawal by Subject|5|||
17165432|NCT02966028|38314106|FG002|Overall Study|Withdrawal by Subject|5|||
17165433|NCT02966028|38314104|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
17165434|NCT02966028|38314105|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
17165435|NCT02966028|38314106|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
17165436|NCT02925741|38314120|FG000|Overall Study|Withdrawal by Subject|11|||
17165437|NCT02925741|38314121|FG001|Overall Study|Withdrawal by Subject|0|||
17165438|NCT02964312|38314130|FG000|Overall Study|Lost to Follow-up|28|||
17165439|NCT02964312|38314130|FG000|Overall Study|Withdrawal by Subject|11|||
17165440|NCT02964312|38314130|FG000|Overall Study|Lack of Efficacy|10|||
17165441|NCT02964312|38314130|FG000|Overall Study|Did not consent to long-term FU|14|||
17165442|NCT02964312|38314130|FG000|Overall Study|Death|1|||
17165443|NCT02899962|38314154|FG000|Open-label Phase|Adverse Event|2|||
17165444|NCT02899962|38314155|FG001|Open-label Phase|Adverse Event|0|||
17165445|NCT02899962|38314156|FG002|Open-label Phase|Adverse Event|0|||
17165446|NCT02899962|38314154|FG000|Open-label Phase|Lost to Follow-up|9|||
17165447|NCT02899962|38314155|FG001|Open-label Phase|Lost to Follow-up|0|||
17165448|NCT02899962|38314156|FG002|Open-label Phase|Lost to Follow-up|0|||
17165449|NCT02899962|38314154|FG000|Open-label Phase|Other reasons|9|||
17165450|NCT02899962|38314155|FG001|Open-label Phase|Other reasons|0|||
17165451|NCT02899962|38314156|FG002|Open-label Phase|Other reasons|0|||
17165452|NCT02899962|38314154|FG000|Open-label Phase|Withdrawal by Subject|7|||
17165453|NCT02899962|38314155|FG001|Open-label Phase|Withdrawal by Subject|0|||
17165454|NCT02899962|38314156|FG002|Open-label Phase|Withdrawal by Subject|0|||
17165455|NCT02899962|38314154|FG000|Maintenance Phase|Adverse Event|0|||
17165456|NCT02899962|38314155|FG001|Maintenance Phase|Adverse Event|2|||
17165457|NCT02899962|38314156|FG002|Maintenance Phase|Adverse Event|1|||
17165458|NCT02899962|38314154|FG000|Maintenance Phase|Death|0|||
17165459|NCT02899962|38314155|FG001|Maintenance Phase|Death|0|||
17165460|NCT02899962|38314156|FG002|Maintenance Phase|Death|1|||
17165461|NCT02899962|38314154|FG000|Maintenance Phase|Lack of Efficacy|0|||
17165462|NCT02899962|38314155|FG001|Maintenance Phase|Lack of Efficacy|20|||
17165463|NCT02899962|38314156|FG002|Maintenance Phase|Lack of Efficacy|16|||
17165464|NCT02899962|38314154|FG000|Maintenance Phase|Lost to Follow-up|0|||
17165465|NCT02899962|38314155|FG001|Maintenance Phase|Lost to Follow-up|12|||
17165466|NCT02899962|38314156|FG002|Maintenance Phase|Lost to Follow-up|14|||
17165467|NCT02899962|38314154|FG000|Maintenance Phase|Other reasons|0|||
17165468|NCT02899962|38314155|FG001|Maintenance Phase|Other reasons|9|||
17165469|NCT02899962|38314156|FG002|Maintenance Phase|Other reasons|13|||
17165470|NCT02899962|38314154|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
17165471|NCT02899962|38314155|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
17165472|NCT02899962|38314156|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
17165473|NCT02899962|38314154|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
17165474|NCT02899962|38314155|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
17165475|NCT02899962|38314156|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
17165476|NCT02899962|38314154|FG000|Maintenance Phase|Withdrawal by Subject|0|||
17165477|NCT02899962|38314155|FG001|Maintenance Phase|Withdrawal by Subject|30|||
17165478|NCT02899962|38314156|FG002|Maintenance Phase|Withdrawal by Subject|36|||
17165479|NCT02899728|38314165|FG000|Overall Study|Withdrawal by Subject|1|||
17165480|NCT02899728|38314166|FG001|Overall Study|Withdrawal by Subject|1|||
17165481|NCT02899338|38314174|FG000|Overall Study|Adverse Event|1|||
17165482|NCT02899338|38314175|FG001|Overall Study|Adverse Event|2|||
17165483|NCT02899338|38314174|FG000|Overall Study|Withdrawal by Subject|2|||
17165484|NCT02899338|38314175|FG001|Overall Study|Withdrawal by Subject|0|||
17165485|NCT03066609|38314184|FG000|INDUCTION|Pregnancy|0|||
17165486|NCT03066609|38314185|FG001|INDUCTION|Pregnancy|0|||
17165487|NCT03066609|38314186|FG002|INDUCTION|Pregnancy|1|||
17165488|NCT03066609|38314187|FG003|INDUCTION|Pregnancy|0|||
17165489|NCT03066609|38314184|FG000|INDUCTION|Lack of Efficacy|0|||
17165490|NCT03066609|38314185|FG001|INDUCTION|Lack of Efficacy|0|||
17165491|NCT03066609|38314186|FG002|INDUCTION|Lack of Efficacy|1|||
17165492|NCT03066609|38314187|FG003|INDUCTION|Lack of Efficacy|0|||
17165493|NCT03066609|38314184|FG000|INDUCTION|Adverse Event|2|||
17165494|NCT03066609|38314185|FG001|INDUCTION|Adverse Event|2|||
17165495|NCT03066609|38314186|FG002|INDUCTION|Adverse Event|0|||
17165496|NCT03066609|38314187|FG003|INDUCTION|Adverse Event|0|||
17165497|NCT03066609|38314184|FG000|MAINTENANCE|Adverse Event|0|||
17165498|NCT03066609|38314185|FG001|MAINTENANCE|Adverse Event|0|||
17165499|NCT03066609|38314186|FG002|MAINTENANCE|Adverse Event|0|||
17165500|NCT03066609|38314187|FG003|MAINTENANCE|Adverse Event|1|||
17165501|NCT03066609|38314184|FG000|MAINTENANCE|Withdrawal by Subject|4|||
17165502|NCT03066609|38314185|FG001|MAINTENANCE|Withdrawal by Subject|2|||
17165503|NCT03066609|38314186|FG002|MAINTENANCE|Withdrawal by Subject|1|||
17165504|NCT03066609|38314187|FG003|MAINTENANCE|Withdrawal by Subject|1|||
17165505|NCT03066609|38314184|FG000|MAINTENANCE|Lost to Follow-up|0|||
17165506|NCT03066609|38314185|FG001|MAINTENANCE|Lost to Follow-up|1|||
17165507|NCT03066609|38314186|FG002|MAINTENANCE|Lost to Follow-up|1|||
17165508|NCT03066609|38314187|FG003|MAINTENANCE|Lost to Follow-up|0|||
17165509|NCT03066609|38314184|FG000|MAINTENANCE|Pregnancy|1|||
17165510|NCT03066609|38314185|FG001|MAINTENANCE|Pregnancy|0|||
17165511|NCT03066609|38314186|FG002|MAINTENANCE|Pregnancy|0|||
17165512|NCT03066609|38314187|FG003|MAINTENANCE|Pregnancy|0|||
17165513|NCT03066609|38314184|FG000|MAINTENANCE|Lack of Efficacy|2|||
17165514|NCT03066609|38314185|FG001|MAINTENANCE|Lack of Efficacy|1|||
17165515|NCT03066609|38314186|FG002|MAINTENANCE|Lack of Efficacy|0|||
17165516|NCT03066609|38314187|FG003|MAINTENANCE|Lack of Efficacy|1|||
17165517|NCT03066609|38314184|FG000|OVERALL STUDY|Adverse Event|2|||
17165518|NCT03066609|38314185|FG001|OVERALL STUDY|Adverse Event|2|||
17165519|NCT03066609|38314186|FG002|OVERALL STUDY|Adverse Event|0|||
17165520|NCT03066609|38314187|FG003|OVERALL STUDY|Adverse Event|1|||
17165521|NCT03066609|38314184|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
17165522|NCT03066609|38314185|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
17165523|NCT03066609|38314186|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
17165524|NCT03066609|38314187|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
17165525|NCT03066609|38314184|FG000|OVERALL STUDY|Lost to Follow-up|1|||
17165526|NCT03066609|38314185|FG001|OVERALL STUDY|Lost to Follow-up|1|||
17165527|NCT03066609|38314186|FG002|OVERALL STUDY|Lost to Follow-up|1|||
17165528|NCT03066609|38314187|FG003|OVERALL STUDY|Lost to Follow-up|1|||
17165529|NCT03066609|38314184|FG000|OVERALL STUDY|Pregnancy|1|||
17165530|NCT03066609|38314185|FG001|OVERALL STUDY|Pregnancy|0|||
17165531|NCT03066609|38314186|FG002|OVERALL STUDY|Pregnancy|1|||
17165532|NCT03066609|38314187|FG003|OVERALL STUDY|Pregnancy|0|||
17165533|NCT03066609|38314184|FG000|OVERALL STUDY|Lack of Efficacy|2|||
17165534|NCT03066609|38314185|FG001|OVERALL STUDY|Lack of Efficacy|1|||
17165535|NCT03066609|38314186|FG002|OVERALL STUDY|Lack of Efficacy|1|||
17165536|NCT03066609|38314187|FG003|OVERALL STUDY|Lack of Efficacy|1|||
17165537|NCT03066609|38314184|FG000|OVERALL STUDY|discontinued follow up|0|||
17165538|NCT03066609|38314185|FG001|OVERALL STUDY|discontinued follow up|2|||
17165539|NCT03066609|38314186|FG002|OVERALL STUDY|discontinued follow up|0|||
17165540|NCT03066609|38314187|FG003|OVERALL STUDY|discontinued follow up|0|||
17165541|NCT02964234|38314204|FG000|Overall Study|Lost to Follow-up|22|||
17165542|NCT02964234|38314205|FG001|Overall Study|Lost to Follow-up|13|||
17165543|NCT01345188|38314211|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
17165544|NCT01345188|38314211|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
17165545|NCT03852459|38314220|FG000|Overall Study|Adverse Event|2|||
17165546|NCT03852459|38314221|FG001|Overall Study|Adverse Event|2|||
17165547|NCT03852459|38314220|FG000|Overall Study|Withdrawal by Subject|1|||
17165548|NCT03852459|38314221|FG001|Overall Study|Withdrawal by Subject|1|||
17165549|NCT02896296|38314227|FG000|Overall Study|Adverse Event|1|||
17165550|NCT02896296|38314227|FG000|Overall Study|Lost to Follow-up|19|||
17165551|NCT02896296|38314227|FG000|Overall Study|Pregnancy|1|||
17165552|NCT02896296|38314227|FG000|Overall Study|Physician Decision|2|||
17165553|NCT02896296|38314227|FG000|Overall Study|Withdrawal by Subject|10|||
17165554|NCT02896296|38314227|FG000|Overall Study|Site closing|7|||
17165555|NCT02896296|38314227|FG000|Overall Study|Incarceration|1|||
17165556|NCT02896296|38314227|FG000|Overall Study|Relocation|1|||
17165557|NCT03740919|38314234|FG000|Lead-in Period|Lost to Follow-up|1|||
17165558|NCT03740919|38314235|FG001|Lead-in Period|Lost to Follow-up|0|||
17165559|NCT03740919|38314236|FG002|Lead-in Period|Lost to Follow-up|0|||
17165560|NCT03740919|38314237|FG003|Lead-in Period|Lost to Follow-up|0|||
17165561|NCT03740919|38314234|FG000|Lead-in Period|Physician Decision|2|||
17165562|NCT03740919|38314235|FG001|Lead-in Period|Physician Decision|0|||
17165563|NCT03740919|38314236|FG002|Lead-in Period|Physician Decision|0|||
17165564|NCT03740919|38314237|FG003|Lead-in Period|Physician Decision|0|||
17165565|NCT03740919|38314234|FG000|Lead-in Period|Protocol Violation|1|||
16996270|NCT00975806|38140289|FG002|Overall Study|Physician decision and disease related|1|||
16996271|NCT00978068|38140301|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
17165566|NCT03740919|38314235|FG001|Lead-in Period|Protocol Violation|0|||
17165567|NCT03740919|38314236|FG002|Lead-in Period|Protocol Violation|0|||
17165568|NCT03740919|38314237|FG003|Lead-in Period|Protocol Violation|0|||
17165569|NCT03740919|38314234|FG000|Lead-in Period|Withdrawal by Subject|10|||
17165570|NCT03740919|38314235|FG001|Lead-in Period|Withdrawal by Subject|0|||
17165571|NCT03740919|38314236|FG002|Lead-in Period|Withdrawal by Subject|0|||
17165572|NCT03740919|38314237|FG003|Lead-in Period|Withdrawal by Subject|0|||
17165573|NCT03740919|38314234|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
17165574|NCT03740919|38314235|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
17165575|NCT03740919|38314236|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
17165576|NCT03740919|38314237|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
17165577|NCT03740919|38314234|FG000|Lead-in Period|Study Task Too Burdensome|1|||
17165578|NCT03740919|38314235|FG001|Lead-in Period|Study Task Too Burdensome|0|||
17165579|NCT03740919|38314236|FG002|Lead-in Period|Study Task Too Burdensome|0|||
17165580|NCT03740919|38314237|FG003|Lead-in Period|Study Task Too Burdensome|0|||
17165581|NCT03740919|38314234|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
17165582|NCT03740919|38314235|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
17165583|NCT03740919|38314236|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
17165584|NCT03740919|38314237|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
17165585|NCT03740919|38314234|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
17165586|NCT03740919|38314235|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
17165587|NCT03740919|38314236|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
17165588|NCT03740919|38314237|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
17165589|NCT03740919|38314234|FG000|Treatment Period|Adverse Event|0|||
17165590|NCT03740919|38314235|FG001|Treatment Period|Adverse Event|0|||
17165591|NCT03740919|38314236|FG002|Treatment Period|Adverse Event|2|||
17165592|NCT03740919|38314237|FG003|Treatment Period|Adverse Event|0|||
17165593|NCT03740919|38314234|FG000|Treatment Period|Protocol Violation|0|||
17165594|NCT03740919|38314235|FG001|Treatment Period|Protocol Violation|1|||
17165595|NCT03740919|38314236|FG002|Treatment Period|Protocol Violation|0|||
17165596|NCT03740919|38314237|FG003|Treatment Period|Protocol Violation|0|||
17165597|NCT03740919|38314234|FG000|Treatment Period|Withdrawal by Subject|0|||
17165598|NCT03740919|38314235|FG001|Treatment Period|Withdrawal by Subject|7|||
17165599|NCT03740919|38314236|FG002|Treatment Period|Withdrawal by Subject|6|||
17165600|NCT03740919|38314237|FG003|Treatment Period|Withdrawal by Subject|2|||
17165601|NCT03740919|38314234|FG000|Treatment Period|Terminated by Sponsor|0|||
17165602|NCT03740919|38314235|FG001|Treatment Period|Terminated by Sponsor|1|||
17165603|NCT03740919|38314236|FG002|Treatment Period|Terminated by Sponsor|0|||
17165604|NCT03740919|38314237|FG003|Treatment Period|Terminated by Sponsor|0|||
17165605|NCT03740919|38314234|FG000|Treatment Period|Issue with Insulin Pump|0|||
17165606|NCT03740919|38314235|FG001|Treatment Period|Issue with Insulin Pump|1|||
17165607|NCT03740919|38314236|FG002|Treatment Period|Issue with Insulin Pump|0|||
17165608|NCT03740919|38314237|FG003|Treatment Period|Issue with Insulin Pump|0|||
17165609|NCT03740919|38314234|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
17165610|NCT03740919|38314235|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
17165611|NCT03740919|38314236|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
17165612|NCT03740919|38314237|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
17165613|NCT03740919|38314234|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
17165614|NCT03740919|38314235|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
17165615|NCT03740919|38314236|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
17165616|NCT03740919|38314237|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
17165617|NCT03740919|38314234|FG000|Treatment Period|Not Completing Diary|0|||
17165618|NCT03740919|38314235|FG001|Treatment Period|Not Completing Diary|0|||
17165619|NCT03740919|38314236|FG002|Treatment Period|Not Completing Diary|1|||
17165620|NCT03740919|38314237|FG003|Treatment Period|Not Completing Diary|0|||
17165621|NCT03740919|38314234|FG000|Treatment Period|Insulin Painful to Participant|0|||
17165622|NCT03740919|38314235|FG001|Treatment Period|Insulin Painful to Participant|0|||
17165623|NCT03740919|38314236|FG002|Treatment Period|Insulin Painful to Participant|1|||
17165624|NCT03740919|38314237|FG003|Treatment Period|Insulin Painful to Participant|0|||
17165625|NCT01335685|38314252|FG000|Overall Study|Study Terminated by Sponsor|2|||
17165626|NCT01335685|38314253|FG001|Overall Study|Study Terminated by Sponsor|1|||
17165627|NCT01335685|38314254|FG002|Overall Study|Study Terminated by Sponsor|1|||
17165628|NCT01335685|38314255|FG003|Overall Study|Study Terminated by Sponsor|10|||
17165629|NCT01335685|38314256|FG004|Overall Study|Study Terminated by Sponsor|0|||
17165630|NCT01335685|38314257|FG005|Overall Study|Study Terminated by Sponsor|4|||
17165631|NCT01335685|38314258|FG006|Overall Study|Study Terminated by Sponsor|2|||
17165632|NCT01335685|38314259|FG007|Overall Study|Study Terminated by Sponsor|3|||
17165633|NCT01335685|38314252|FG000|Overall Study|Withdrawal by Subject|1|||
17165634|NCT01335685|38314253|FG001|Overall Study|Withdrawal by Subject|0|||
17165635|NCT01335685|38314254|FG002|Overall Study|Withdrawal by Subject|0|||
17165636|NCT01335685|38314255|FG003|Overall Study|Withdrawal by Subject|1|||
17165637|NCT01335685|38314256|FG004|Overall Study|Withdrawal by Subject|0|||
17165638|NCT01335685|38314257|FG005|Overall Study|Withdrawal by Subject|0|||
17165639|NCT01335685|38314258|FG006|Overall Study|Withdrawal by Subject|0|||
17165640|NCT01335685|38314259|FG007|Overall Study|Withdrawal by Subject|0|||
17165641|NCT01335685|38314252|FG000|Overall Study|Reason not Specified|0|||
17165642|NCT01335685|38314253|FG001|Overall Study|Reason not Specified|0|||
17165643|NCT01335685|38314254|FG002|Overall Study|Reason not Specified|1|||
17165644|NCT01335685|38314255|FG003|Overall Study|Reason not Specified|0|||
17165645|NCT01335685|38314256|FG004|Overall Study|Reason not Specified|0|||
17165646|NCT01335685|38314257|FG005|Overall Study|Reason not Specified|1|||
17165647|NCT01335685|38314258|FG006|Overall Study|Reason not Specified|0|||
17165648|NCT01335685|38314259|FG007|Overall Study|Reason not Specified|0|||
17165649|NCT02926209|38314282|FG000|Study Cohort|Poor Bowel Preparation|1|||
17165650|NCT02926209|38314283|FG001|Study Cohort|Poor Bowel Preparation|0|||
17165651|NCT03066999|38314292|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
17165652|NCT03066999|38314293|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
17165653|NCT02963922|38314307|FG000|Overall Study|Adverse Event|15|||
17165654|NCT02963922|38314308|FG001|Overall Study|Adverse Event|6|||
17165655|NCT02963922|38314307|FG000|Overall Study|Protocol deviation|6|||
17165656|NCT02963922|38314308|FG001|Overall Study|Protocol deviation|6|||
17165657|NCT02963922|38314307|FG000|Overall Study|Lack of Efficacy|1|||
17165658|NCT02963922|38314308|FG001|Overall Study|Lack of Efficacy|1|||
17165659|NCT02963922|38314307|FG000|Overall Study|Lost to Follow-up|2|||
17165660|NCT02963922|38314308|FG001|Overall Study|Lost to Follow-up|3|||
17165661|NCT02963922|38314307|FG000|Overall Study|Other|8|||
17165662|NCT02963922|38314308|FG001|Overall Study|Other|14|||
17165663|NCT02881567|38314314|FG000|Overall Study|Adverse Event|1|||
17165664|NCT02881567|38314314|FG000|Overall Study|Lost to Follow-up|3|||
17165665|NCT02881567|38314314|FG000|Overall Study|Consent withdrawn|1|||
17165666|NCT02881567|38314314|FG000|Overall Study|Investigator decision|1|||
17165667|NCT02881567|38314314|FG000|Overall Study|Study terminated by sponsor|9|||
17165668|NCT02881567|38314314|FG000|Overall Study|Reason not Specified|3|||
17165669|NCT02962674|38314318|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
17165670|NCT02962908|38314328|FG000|Overall Study|Lost to Follow-up|0|||
17165671|NCT02962908|38314329|FG001|Overall Study|Lost to Follow-up|3|||
17165672|NCT02962908|38314330|FG002|Overall Study|Lost to Follow-up|0|||
17165673|NCT02962908|38314331|FG003|Overall Study|Lost to Follow-up|1|||
17165674|NCT02962908|38314328|FG000|Overall Study|Withdrawal by Subject|0|||
17165675|NCT02962908|38314329|FG001|Overall Study|Withdrawal by Subject|3|||
17165676|NCT02962908|38314330|FG002|Overall Study|Withdrawal by Subject|0|||
17165677|NCT02962908|38314331|FG003|Overall Study|Withdrawal by Subject|2|||
17165678|NCT02962908|38314328|FG000|Overall Study|Protocol Violation|0|||
17165679|NCT02962908|38314329|FG001|Overall Study|Protocol Violation|1|||
17165680|NCT02962908|38314330|FG002|Overall Study|Protocol Violation|0|||
17165681|NCT02962908|38314331|FG003|Overall Study|Protocol Violation|0|||
17165682|NCT02962908|38314328|FG000|Overall Study|Physician Decision|0|||
17165683|NCT02962908|38314329|FG001|Overall Study|Physician Decision|1|||
17165684|NCT02962908|38314330|FG002|Overall Study|Physician Decision|0|||
17165685|NCT02962908|38314331|FG003|Overall Study|Physician Decision|0|||
17165686|NCT02962284|38314349|FG000|Overall Study|Death|2|||
17165687|NCT02962284|38314350|FG001|Overall Study|Death|0|||
17165688|NCT02962284|38314349|FG000|Overall Study|Progressive disease|2|||
17165689|NCT02962284|38314350|FG001|Overall Study|Progressive disease|3|||
17165690|NCT02962284|38314349|FG000|Overall Study|Withdrawal by Subject|1|||
17165691|NCT02962284|38314350|FG001|Overall Study|Withdrawal by Subject|0|||
17165692|NCT01344876|38314358|FG000|Overall Study|Adverse Event|0|||
17165693|NCT01344876|38314359|FG001|Overall Study|Adverse Event|0|||
17165694|NCT01344876|38314360|FG002|Overall Study|Adverse Event|0|||
17165695|NCT01344876|38314361|FG003|Overall Study|Adverse Event|0|||
17165696|NCT01344876|38314362|FG004|Overall Study|Adverse Event|1|||
17165697|NCT01344876|38314358|FG000|Overall Study|Withdrawal by Subject|0|||
17165698|NCT01344876|38314359|FG001|Overall Study|Withdrawal by Subject|0|||
17084366|NCT00364832|38224970|FG007|Extension Year 2|Early Withdrawals|0|||
17084367|NCT00364832|38224971|FG008|Extension Year 2|Early Withdrawals|0|||
17084368|NCT00364832|38224972|FG009|Extension Year 2|Early Withdrawals|5|||
17084369|NCT00364832|38224973|FG010|Extension Year 2|Early Withdrawals|5|||
17084370|NCT00364832|38224974|FG011|Extension Year 2|Early Withdrawals|3|||
17084371|NCT00235755|38224994|FG000|4-Week Titration Phase|Adverse Event|6|||
17084372|NCT00235755|38224995|FG001|4-Week Titration Phase|Adverse Event|14|||
17084373|NCT00235755|38224996|FG002|4-Week Titration Phase|Adverse Event|20|||
17084374|NCT00235755|38224994|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
17165699|NCT01344876|38314360|FG002|Overall Study|Withdrawal by Subject|1|||
17165700|NCT01344876|38314361|FG003|Overall Study|Withdrawal by Subject|0|||
17165701|NCT01344876|38314362|FG004|Overall Study|Withdrawal by Subject|0|||
17165702|NCT01344876|38314358|FG000|Overall Study|Definite progression of primary disease|1|||
17165703|NCT01344876|38314359|FG001|Overall Study|Definite progression of primary disease|0|||
17165704|NCT01344876|38314360|FG002|Overall Study|Definite progression of primary disease|0|||
17165705|NCT01344876|38314361|FG003|Overall Study|Definite progression of primary disease|3|||
17165706|NCT01344876|38314362|FG004|Overall Study|Definite progression of primary disease|0|||
17165707|NCT00026312|38314377|FG000|Overall Study|Adverse Event|0|||
17165708|NCT00026312|38314378|FG001|Overall Study|Adverse Event|32|||
17165709|NCT00026312|38314377|FG000|Overall Study|Death|1|||
17165710|NCT00026312|38314378|FG001|Overall Study|Death|7|||
17165711|NCT00026312|38314377|FG000|Overall Study|Lack of Efficacy|19|||
17165712|NCT00026312|38314378|FG001|Overall Study|Lack of Efficacy|114|||
17165713|NCT00026312|38314377|FG000|Overall Study|Lost to Follow-up|0|||
17165714|NCT00026312|38314378|FG001|Overall Study|Lost to Follow-up|5|||
17165715|NCT00026312|38314377|FG000|Overall Study|Physician Decision|1|||
17165716|NCT00026312|38314378|FG001|Overall Study|Physician Decision|37|||
17165717|NCT00026312|38314377|FG000|Overall Study|Protocol Violation|0|||
17165718|NCT00026312|38314378|FG001|Overall Study|Protocol Violation|3|||
17165719|NCT00026312|38314377|FG000|Overall Study|Withdrawal by Subject|1|||
17165720|NCT00026312|38314378|FG001|Overall Study|Withdrawal by Subject|6|||
17165721|NCT00026312|38314377|FG000|Overall Study|Ineligible|4|||
17165722|NCT00026312|38314378|FG001|Overall Study|Ineligible|5|||
17165723|NCT00026312|38314377|FG000|Overall Study|Entry onto another COG study|0|||
17165724|NCT00026312|38314378|FG001|Overall Study|Entry onto another COG study|1|||
17165725|NCT00026312|38314377|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
17165726|NCT00026312|38314378|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
17165727|NCT02846324|38314392|FG000|Overall Study|Other|1|||
17165728|NCT02846324|38314393|FG001|Overall Study|Other|0|||
17165729|NCT02846324|38314394|FG002|Overall Study|Other|0|||
17165730|NCT02846324|38314395|FG003|Overall Study|Other|0|||
17165731|NCT02846324|38314392|FG000|Overall Study|Withdrawal by Subject|1|||
17165732|NCT02846324|38314393|FG001|Overall Study|Withdrawal by Subject|0|||
17165733|NCT02846324|38314394|FG002|Overall Study|Withdrawal by Subject|4|||
17165734|NCT02846324|38314395|FG003|Overall Study|Withdrawal by Subject|0|||
17165735|NCT03161093|38314420|FG000|Overall Study|Protocol Violation|11|||
17165736|NCT03161093|38314421|FG001|Overall Study|Protocol Violation|14|||
17165737|NCT03161093|38314422|FG002|Overall Study|Protocol Violation|6|||
17165738|NCT03161093|38314423|FG003|Overall Study|Protocol Violation|13|||
17165739|NCT03161093|38314424|FG004|Overall Study|Protocol Violation|1|||
17165740|NCT03161093|38314425|FG005|Overall Study|Protocol Violation|0|||
17165741|NCT03161093|38314420|FG000|Overall Study|Adverse Event|5|||
17165742|NCT03161093|38314421|FG001|Overall Study|Adverse Event|21|||
17165743|NCT03161093|38314422|FG002|Overall Study|Adverse Event|16|||
17165744|NCT03161093|38314423|FG003|Overall Study|Adverse Event|35|||
17084375|NCT00235755|38224995|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
17165745|NCT03161093|38314424|FG004|Overall Study|Adverse Event|2|||
17165746|NCT03161093|38314425|FG005|Overall Study|Adverse Event|1|||
17165747|NCT03161093|38314420|FG000|Overall Study|Lack of Efficacy|9|||
17165748|NCT03161093|38314421|FG001|Overall Study|Lack of Efficacy|13|||
17165749|NCT03161093|38314422|FG002|Overall Study|Lack of Efficacy|9|||
17165750|NCT03161093|38314423|FG003|Overall Study|Lack of Efficacy|24|||
17165751|NCT03161093|38314424|FG004|Overall Study|Lack of Efficacy|4|||
17165752|NCT03161093|38314425|FG005|Overall Study|Lack of Efficacy|1|||
17165753|NCT03161093|38314420|FG000|Overall Study|Physician Decision|0|||
17165754|NCT03161093|38314421|FG001|Overall Study|Physician Decision|1|||
17165755|NCT03161093|38314422|FG002|Overall Study|Physician Decision|0|||
17165756|NCT03161093|38314423|FG003|Overall Study|Physician Decision|2|||
17165757|NCT03161093|38314424|FG004|Overall Study|Physician Decision|17|||
17165758|NCT03161093|38314425|FG005|Overall Study|Physician Decision|15|||
17165759|NCT03161093|38314420|FG000|Overall Study|Withdrawal by Subject|24|||
17165760|NCT03161093|38314421|FG001|Overall Study|Withdrawal by Subject|73|||
17165761|NCT03161093|38314422|FG002|Overall Study|Withdrawal by Subject|44|||
17165762|NCT03161093|38314423|FG003|Overall Study|Withdrawal by Subject|97|||
17165763|NCT03161093|38314424|FG004|Overall Study|Withdrawal by Subject|11|||
17165764|NCT03161093|38314425|FG005|Overall Study|Withdrawal by Subject|10|||
17165765|NCT03161093|38314420|FG000|Overall Study|Lost to Follow-up|3|||
17165766|NCT03161093|38314421|FG001|Overall Study|Lost to Follow-up|12|||
17165767|NCT03161093|38314422|FG002|Overall Study|Lost to Follow-up|4|||
17165768|NCT03161093|38314423|FG003|Overall Study|Lost to Follow-up|7|||
17165769|NCT03161093|38314424|FG004|Overall Study|Lost to Follow-up|8|||
17165770|NCT03161093|38314425|FG005|Overall Study|Lost to Follow-up|13|||
17165771|NCT03161093|38314420|FG000|Overall Study|Death|3|||
17165772|NCT03161093|38314421|FG001|Overall Study|Death|9|||
17165773|NCT03161093|38314422|FG002|Overall Study|Death|7|||
17165774|NCT03161093|38314423|FG003|Overall Study|Death|9|||
17165775|NCT03161093|38314424|FG004|Overall Study|Death|0|||
17165776|NCT03161093|38314425|FG005|Overall Study|Death|0|||
17165777|NCT03161093|38314420|FG000|Overall Study|Unknown - Not reported|0|||
17165778|NCT03161093|38314421|FG001|Overall Study|Unknown - Not reported|1|||
17165779|NCT03161093|38314422|FG002|Overall Study|Unknown - Not reported|0|||
17165780|NCT03161093|38314423|FG003|Overall Study|Unknown - Not reported|0|||
17165781|NCT03161093|38314424|FG004|Overall Study|Unknown - Not reported|0|||
17165782|NCT03161093|38314425|FG005|Overall Study|Unknown - Not reported|1|||
17165783|NCT02847650|38314446|FG000|Overall Study|Adverse Event|2|||
17165784|NCT02847650|38314447|FG001|Overall Study|Adverse Event|4|||
17165785|NCT02847650|38314446|FG000|Overall Study|Lost to Follow-up|1|||
17165786|NCT02847650|38314447|FG001|Overall Study|Lost to Follow-up|0|||
17165787|NCT02847650|38314446|FG000|Overall Study|Protocol Violation|0|||
17165788|NCT02847650|38314447|FG001|Overall Study|Protocol Violation|1|||
17165789|NCT02847650|38314446|FG000|Overall Study|Withdrawal by Subject|1|||
17165790|NCT02847650|38314447|FG001|Overall Study|Withdrawal by Subject|1|||
17165791|NCT02847494|38314455|FG000|Overall Study|Lost to Follow-up|8|||
17165792|NCT02847494|38314456|FG001|Overall Study|Lost to Follow-up|5|||
17165793|NCT02554253|38314464|FG000|Overall Study|ineligible after enrollment|1|||
17165794|NCT02554253|38314465|FG001|Overall Study|ineligible after enrollment|0|||
17165795|NCT02554253|38314464|FG000|Overall Study|converted to transcatheter procedure|0|||
17165796|NCT02554253|38314465|FG001|Overall Study|converted to transcatheter procedure|1|||
17165797|NCT02554253|38314464|FG000|Overall Study|received both drugs|0|||
17165798|NCT02554253|38314465|FG001|Overall Study|received both drugs|1|||
17165799|NCT03157583|38314472|FG000|Overall Study|Other (did not meet study criteria)|1|||
17165800|NCT02842736|38314490|FG000|Overall Study|Lost to Follow-up|13|||
17165801|NCT02842736|38314490|FG000|Overall Study|Intervention for menstrual bleeding|17|||
17165802|NCT02842736|38314490|FG000|Overall Study|Withdrawal by Subject|4|||
17165803|NCT02842736|38314490|FG000|Overall Study|Pregnancy|3|||
17165804|NCT02842736|38314490|FG000|Overall Study|Hysterectomy for fibroids|2|||
17165805|NCT02842736|38314490|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
17165806|NCT02842736|38314490|FG000|Overall Study|IUD: Mirena|1|||
17165807|NCT01307033|38314496|FG000|8-week Double-blind Period|Adverse Event|2|||
17165808|NCT01307033|38314497|FG001|8-week Double-blind Period|Adverse Event|0|||
17165809|NCT01307033|38314498|FG002|8-week Double-blind Period|Adverse Event|0|||
17165810|NCT01307033|38314499|FG003|8-week Double-blind Period|Adverse Event|0|||
17165811|NCT01307033|38314496|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
17165812|NCT01307033|38314497|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
17165813|NCT01307033|38314498|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
17165814|NCT01307033|38314499|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
17165815|NCT01307033|38314496|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
17165816|NCT01307033|38314497|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
17165817|NCT01307033|38314498|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
17165818|NCT01307033|38314499|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
17165819|NCT01307033|38314496|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
17165820|NCT01307033|38314497|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
17165821|NCT01307033|38314498|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
17165822|NCT01307033|38314499|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
17165823|NCT01307033|38314496|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
17165824|NCT01307033|38314497|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
17165825|NCT01307033|38314498|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
17165826|NCT01307033|38314499|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
17165827|NCT01307033|38314496|FG000|44-week Open-label Extension|Adverse Event|0|||
17165828|NCT01307033|38314497|FG001|44-week Open-label Extension|Adverse Event|0|||
17165829|NCT01307033|38314498|FG002|44-week Open-label Extension|Adverse Event|2|||
17165830|NCT01307033|38314499|FG003|44-week Open-label Extension|Adverse Event|1|||
17165831|NCT01307033|38314496|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
17165832|NCT01307033|38314497|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
17165833|NCT01307033|38314498|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
17165834|NCT01307033|38314499|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
17165835|NCT01307033|38314496|FG000|44-week Open-label Extension|Physician Decision|0|||
17165836|NCT01307033|38314497|FG001|44-week Open-label Extension|Physician Decision|0|||
17165837|NCT01307033|38314498|FG002|44-week Open-label Extension|Physician Decision|1|||
17165838|NCT01307033|38314499|FG003|44-week Open-label Extension|Physician Decision|0|||
17165839|NCT01307033|38314496|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
17165840|NCT01307033|38314497|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
17165841|NCT01307033|38314498|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
17165842|NCT01307033|38314499|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
17165843|NCT01307033|38314496|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
17165844|NCT01307033|38314497|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
17165845|NCT01307033|38314498|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
17165846|NCT01307033|38314499|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
17165847|NCT01307033|38314496|FG000|44-week Open-label Extension|Death|0|||
17165848|NCT01307033|38314497|FG001|44-week Open-label Extension|Death|0|||
17165849|NCT01307033|38314498|FG002|44-week Open-label Extension|Death|0|||
17165850|NCT01307033|38314499|FG003|44-week Open-label Extension|Death|1|||
17165851|NCT02844920|38314511|FG000|Overall Study|Lost to Follow-up|2|||
17165852|NCT03158311|38314518|FG000|Overall Study|Subject/Guardian Decision|10|||
17165853|NCT03158311|38314519|FG001|Overall Study|Subject/Guardian Decision|6|||
17165854|NCT03158311|38314520|FG002|Overall Study|Subject/Guardian Decision|11|||
17165855|NCT03158311|38314518|FG000|Overall Study|Adverse Event|5|||
17165856|NCT03158311|38314519|FG001|Overall Study|Adverse Event|3|||
17165857|NCT03158311|38314520|FG002|Overall Study|Adverse Event|3|||
17165858|NCT03158311|38314518|FG000|Overall Study|Techinical Problems|3|||
17165859|NCT03158311|38314519|FG001|Overall Study|Techinical Problems|1|||
17165860|NCT03158311|38314520|FG002|Overall Study|Techinical Problems|5|||
17165861|NCT03158311|38314518|FG000|Overall Study|Physician Decision|2|||
17165862|NCT03158311|38314519|FG001|Overall Study|Physician Decision|3|||
17165863|NCT03158311|38314520|FG002|Overall Study|Physician Decision|7|||
17165864|NCT03158311|38314518|FG000|Overall Study|Lost to Follow-up|1|||
17165865|NCT03158311|38314519|FG001|Overall Study|Lost to Follow-up|1|||
17084376|NCT00235755|38224996|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
17084377|NCT00235755|38224994|FG000|4-Week Titration Phase|Protocol Violation|2|||
17084378|NCT00235755|38224995|FG001|4-Week Titration Phase|Protocol Violation|2|||
17084379|NCT00235755|38224996|FG002|4-Week Titration Phase|Protocol Violation|1|||
17084380|NCT00235755|38224994|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
17084381|NCT00235755|38224995|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
17165866|NCT03158311|38314520|FG002|Overall Study|Lost to Follow-up|1|||
17165867|NCT03158311|38314518|FG000|Overall Study|Sponsor decision|1|||
17165868|NCT03158311|38314519|FG001|Overall Study|Sponsor decision|0|||
17165869|NCT03158311|38314520|FG002|Overall Study|Sponsor decision|0|||
17165870|NCT03158311|38314518|FG000|Overall Study|Pregnancy|0|||
17165871|NCT03158311|38314519|FG001|Overall Study|Pregnancy|2|||
17165872|NCT03158311|38314520|FG002|Overall Study|Pregnancy|0|||
17165873|NCT03158311|38314518|FG000|Overall Study|Randomized in error|0|||
17165874|NCT03158311|38314519|FG001|Overall Study|Randomized in error|0|||
17165875|NCT03158311|38314520|FG002|Overall Study|Randomized in error|1|||
17165876|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
17165877|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
17165878|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
17165879|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
17165880|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
17084382|NCT00235755|38224996|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
17165881|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
17165882|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
17165883|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
17165884|NCT01336621|38314532|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
17165885|NCT01336621|38314532|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
17165886|NCT01336621|38314532|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
17165887|NCT01336621|38314532|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
17165888|NCT01336621|38314532|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
17165889|NCT01336621|38314532|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
17165890|NCT00383435|38314544|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
17165891|NCT00383435|38314545|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
17165892|NCT00383435|38314546|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
17165893|NCT00383435|38314547|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
17165894|NCT00383435|38314548|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
17165895|NCT00383435|38314544|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
17165896|NCT00383435|38314545|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
17165897|NCT00383435|38314546|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
17165898|NCT00383435|38314547|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
17165899|NCT00383435|38314548|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
17165900|NCT00383435|38314544|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
17165901|NCT00383435|38314545|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
17165902|NCT00383435|38314546|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
17165903|NCT00383435|38314547|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
17165904|NCT00383435|38314548|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
17165905|NCT00383435|38314544|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
17165906|NCT00383435|38314545|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
17165907|NCT00383435|38314546|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
17165908|NCT00383435|38314547|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
17165909|NCT00383435|38314548|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
17165910|NCT00383435|38314544|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
17165911|NCT00383435|38314545|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
17165912|NCT00383435|38314546|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
17165913|NCT00383435|38314547|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
17165914|NCT00383435|38314548|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
17165915|NCT00383435|38314544|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
17165916|NCT00383435|38314545|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
17165917|NCT00383435|38314546|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
17165918|NCT00383435|38314547|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
17165919|NCT00383435|38314548|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
17165920|NCT00383435|38314544|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
17165921|NCT00383435|38314545|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
17165922|NCT00383435|38314546|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
17165923|NCT00383435|38314547|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
17165924|NCT00383435|38314548|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
17165925|NCT00383435|38314544|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
17165926|NCT00383435|38314545|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
17165927|NCT00383435|38314546|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
17165928|NCT00383435|38314547|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
17165929|NCT00383435|38314548|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
17165930|NCT00383435|38314544|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
17165931|NCT00383435|38314545|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
17165932|NCT00383435|38314546|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
17165933|NCT00383435|38314547|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
17165934|NCT00383435|38314548|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
17165935|NCT00383435|38314544|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
17165936|NCT00383435|38314545|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
17165937|NCT00383435|38314546|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
17084383|NCT00235755|38224994|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
17084384|NCT00235755|38224995|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
17084385|NCT00235755|38224996|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
17084386|NCT00235755|38224994|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
17084387|NCT00235755|38224995|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
17084388|NCT00235755|38224996|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
17084389|NCT00235755|38224994|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
17084390|NCT00235755|38224995|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
17084391|NCT00235755|38224996|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
17084392|NCT00235755|38224994|FG000|12-Week Maintenance Phase|Adverse Event|8|||
17084393|NCT00235755|38224995|FG001|12-Week Maintenance Phase|Adverse Event|12|||
17084394|NCT00235755|38224996|FG002|12-Week Maintenance Phase|Adverse Event|26|||
17084395|NCT00235755|38224994|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
17165938|NCT00383435|38314547|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
17165939|NCT00383435|38314548|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
17165940|NCT00383435|38314544|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
17165941|NCT00383435|38314545|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
17165942|NCT00383435|38314546|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
17165943|NCT00383435|38314547|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
17165944|NCT00383435|38314548|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
17165945|NCT00383435|38314544|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
17165946|NCT00383435|38314545|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
17165947|NCT00383435|38314546|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
17165948|NCT00383435|38314547|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
17165949|NCT00383435|38314548|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
17165950|NCT00383435|38314544|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
17165951|NCT00383435|38314545|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
17165952|NCT00383435|38314546|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
17165953|NCT00383435|38314547|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
17165954|NCT00383435|38314548|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
17165955|NCT00383435|38314544|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
17165956|NCT00383435|38314545|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
17165957|NCT00383435|38314546|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
17165958|NCT00383435|38314547|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
17165959|NCT00383435|38314548|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
17165960|NCT00383435|38314544|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
17165961|NCT00383435|38314545|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
17165962|NCT00383435|38314546|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
17165963|NCT00383435|38314547|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
17165964|NCT00383435|38314548|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
17165965|NCT00383435|38314544|FG000|26-Week Treatment Safety Extension|Administrative|1|||
17165966|NCT00383435|38314545|FG001|26-Week Treatment Safety Extension|Administrative|1|||
17165967|NCT00383435|38314546|FG002|26-Week Treatment Safety Extension|Administrative|0|||
17165968|NCT00383435|38314547|FG003|26-Week Treatment Safety Extension|Administrative|1|||
17165969|NCT00383435|38314548|FG004|26-Week Treatment Safety Extension|Administrative|0|||
17165970|NCT03157037|38314560|FG000|Overall Study|Death|1|||
17165971|NCT00381485|38314582|FG000|Open-Label Run-In Period|Adverse Event|9|||
17165972|NCT00381485|38314583|FG001|Open-Label Run-In Period|Adverse Event|0|||
17165973|NCT00381485|38314584|FG002|Open-Label Run-In Period|Adverse Event|0|||
17165974|NCT00381485|38314585|FG003|Open-Label Run-In Period|Adverse Event|0|||
17165975|NCT00381485|38314582|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
17165976|NCT00381485|38314583|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
17165977|NCT00381485|38314584|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
17165978|NCT00381485|38314585|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
17165979|NCT00381485|38314582|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
17165980|NCT00381485|38314583|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
17165981|NCT00381485|38314584|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
17165982|NCT00381485|38314585|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
17165983|NCT00381485|38314582|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
17165984|NCT00381485|38314583|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
17165985|NCT00381485|38314584|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
17165986|NCT00381485|38314585|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
17165987|NCT00381485|38314582|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
17165988|NCT00381485|38314583|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
17165989|NCT00381485|38314584|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
17165990|NCT00381485|38314585|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
17165991|NCT00381485|38314582|FG000|Open-Label Run-In Period|Treatment failure|1|||
17165992|NCT00381485|38314583|FG001|Open-Label Run-In Period|Treatment failure|0|||
17165993|NCT00381485|38314584|FG002|Open-Label Run-In Period|Treatment failure|0|||
17165994|NCT00381485|38314585|FG003|Open-Label Run-In Period|Treatment failure|0|||
17165995|NCT00381485|38314582|FG000|Double-Blind Treatment Period|Adverse Event|0|||
17165996|NCT00381485|38314583|FG001|Double-Blind Treatment Period|Adverse Event|2|||
17165997|NCT00381485|38314584|FG002|Double-Blind Treatment Period|Adverse Event|2|||
17165998|NCT00381485|38314585|FG003|Double-Blind Treatment Period|Adverse Event|5|||
17165999|NCT00381485|38314582|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
17166000|NCT00381485|38314583|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
17166001|NCT00381485|38314584|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
16782563|NCT02042950|37722170|FG000|Overall Study|Progressive Disease|4|||
17166002|NCT00381485|38314585|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
17166003|NCT00381485|38314582|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
17166004|NCT00381485|38314583|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
17166005|NCT00381485|38314584|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
17166006|NCT00381485|38314585|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
17166007|NCT00381485|38314582|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
17166008|NCT00381485|38314583|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
17166009|NCT00381485|38314584|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
17166010|NCT00381485|38314585|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
17166011|NCT00381485|38314582|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
17166012|NCT00381485|38314583|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
17166013|NCT00381485|38314584|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
17166014|NCT00381485|38314585|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
17166015|NCT00381485|38314582|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
17166016|NCT00381485|38314583|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
17166017|NCT00381485|38314584|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
17166018|NCT00381485|38314585|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
17166019|NCT00381485|38314582|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
17166020|NCT00381485|38314583|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
17166021|NCT00381485|38314584|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
17166022|NCT00381485|38314585|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
17166023|NCT00381485|38314582|FG000|Double-Blind Treatment Period|Administrative|0|||
17166024|NCT00381485|38314583|FG001|Double-Blind Treatment Period|Administrative|1|||
17166025|NCT00381485|38314584|FG002|Double-Blind Treatment Period|Administrative|0|||
17166026|NCT00381485|38314585|FG003|Double-Blind Treatment Period|Administrative|1|||
17166027|NCT02840474|38314596|FG000|Overall Study|Lost to Follow-up|1|||
17166028|NCT02840474|38314597|FG001|Overall Study|Lost to Follow-up|0|||
17166029|NCT03155945|38314605|FG000|Overall Study|Lost to Follow-up|0|||
17166030|NCT03155945|38314606|FG001|Overall Study|Lost to Follow-up|1|||
17166031|NCT03155945|38314605|FG000|Overall Study|Withdrawal by Subject|0|||
17084396|NCT00235755|38224995|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
17084397|NCT00235755|38224996|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
17166032|NCT03155945|38314606|FG001|Overall Study|Withdrawal by Subject|1|||
17166033|NCT03155945|38314605|FG000|Overall Study|Other Reason|0|||
17166034|NCT03155945|38314606|FG001|Overall Study|Other Reason|1|||
17166035|NCT03160703|38314616|FG000|Overall Study|Withdrawal by Subject|0|||
17166036|NCT03160703|38314617|FG001|Overall Study|Withdrawal by Subject|0|||
17166037|NCT03160703|38314618|FG002|Overall Study|Withdrawal by Subject|0|||
17166038|NCT03160703|38314619|FG003|Overall Study|Withdrawal by Subject|1|||
17166039|NCT03159611|38314631|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
17166040|NCT03159611|38314632|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
17166041|NCT03159611|38314631|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
17166042|NCT03159611|38314632|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
17166043|NCT03159611|38314631|FG000|Overall Study|Protocol Violation|7|||
17166044|NCT03159611|38314632|FG001|Overall Study|Protocol Violation|4|||
17166045|NCT03159611|38314631|FG000|Overall Study|Adverse Event|1|||
17166046|NCT03159611|38314632|FG001|Overall Study|Adverse Event|0|||
17166047|NCT03159611|38314631|FG000|Overall Study|Withdrawal by Subject|1|||
17166048|NCT03159611|38314632|FG001|Overall Study|Withdrawal by Subject|1|||
17166049|NCT03159611|38314631|FG000|Overall Study|Non-compliance with protocol requirement|3|||
17166050|NCT03159611|38314632|FG001|Overall Study|Non-compliance with protocol requirement|2|||
17166051|NCT03159611|38314631|FG000|Overall Study|Inability to perform procedures|1|||
17166052|NCT03159611|38314632|FG001|Overall Study|Inability to perform procedures|0|||
17166053|NCT03159455|38314644|FG000|Overall Study|Adverse Event|0|||
17166054|NCT03159455|38314645|FG001|Overall Study|Adverse Event|0|||
17166055|NCT03159455|38314646|FG002|Overall Study|Adverse Event|0|||
17166056|NCT03159455|38314647|FG003|Overall Study|Adverse Event|0|||
17166057|NCT03159455|38314648|FG004|Overall Study|Adverse Event|0|||
17166058|NCT03159455|38314649|FG005|Overall Study|Adverse Event|1|||
17166059|NCT02838134|38314669|FG000|Overall Study|Lost to Follow-up|1|||
17166060|NCT02838134|38314670|FG001|Overall Study|Lost to Follow-up|2|||
16996272|NCT00978068|38140302|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
17084398|NCT00235755|38224994|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
17084399|NCT00235755|38224995|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
17084400|NCT00235755|38224996|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
17084401|NCT00235755|38224994|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
17084402|NCT00235755|38224995|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
17084403|NCT00235755|38224996|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
17166061|NCT02838134|38314669|FG000|Overall Study|logistic problems|1|||
17166062|NCT02838134|38314670|FG001|Overall Study|logistic problems|1|||
17166063|NCT03150589|38314678|FG000|Overall Study|Withdrawal by Subject|16|||
17166064|NCT03150589|38314679|FG001|Overall Study|Withdrawal by Subject|9|||
16996273|NCT00978068|38140301|FG000|Overall Study|Death|1|||
16996274|NCT00978068|38140302|FG001|Overall Study|Death|2|||
16996275|NCT00978068|38140301|FG000|Overall Study|Lost to Follow-up|1|||
16996276|NCT00978068|38140302|FG001|Overall Study|Lost to Follow-up|2|||
16996277|NCT00978068|38140301|FG000|Overall Study|Physician Decision|0|||
16996278|NCT00978068|38140302|FG001|Overall Study|Physician Decision|1|||
16996279|NCT00978068|38140301|FG000|Overall Study|Unable to Comply with Study|0|||
16996280|NCT00978068|38140302|FG001|Overall Study|Unable to Comply with Study|2|||
16996281|NCT00603525|38140314|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
16996282|NCT00603525|38140315|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
16996283|NCT00603525|38140316|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16996284|NCT00603525|38140314|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
16996285|NCT00603525|38140315|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16996286|NCT00603525|38140316|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16996287|NCT00603525|38140314|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
16996288|NCT00603525|38140315|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
16996289|NCT00603525|38140316|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16996290|NCT00603525|38140314|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
16996291|NCT00603525|38140315|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
16996292|NCT00603525|38140316|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16996293|NCT00603525|38140314|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
16996294|NCT00603525|38140315|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
16996295|NCT00603525|38140316|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16996296|NCT00603525|38140314|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
16996297|NCT00603525|38140315|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
16996298|NCT00603525|38140316|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
16996299|NCT00603525|38140314|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
16996300|NCT00603525|38140315|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
16996301|NCT00603525|38140316|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
16996302|NCT00603525|38140314|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
16996303|NCT00603525|38140315|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
16996304|NCT00603525|38140316|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
16996305|NCT00603525|38140314|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
16996306|NCT00603525|38140315|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
16996307|NCT00603525|38140316|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
16996308|NCT00603525|38140314|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
16996309|NCT00603525|38140315|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
16996310|NCT00603525|38140316|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
16996311|NCT00603525|38140314|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
16996312|NCT00603525|38140315|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
16996313|NCT00603525|38140316|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
16996314|NCT00603525|38140314|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
16996315|NCT00603525|38140315|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
16996316|NCT00603525|38140316|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
16996317|NCT00603525|38140314|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
16996318|NCT00603525|38140315|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
16996319|NCT00603525|38140316|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
16996320|NCT00603525|38140314|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
16996321|NCT00603525|38140315|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
16996322|NCT00603525|38140316|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
16996323|NCT00603525|38140314|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
16996324|NCT00603525|38140315|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
16996325|NCT00603525|38140316|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
16996326|NCT00762034|38140329|FG000|Induction Period|Protocol Violation|1|||
16996327|NCT00762034|38140330|FG001|Induction Period|Protocol Violation|2|||
16996328|NCT00762034|38140329|FG000|Induction Period|Entry Criterion Not Met|12|||
16996329|NCT00762034|38140330|FG001|Induction Period|Entry Criterion Not Met|11|||
16996330|NCT00762034|38140329|FG000|Induction Period|Adverse Event|27|||
16996331|NCT00762034|38140330|FG001|Induction Period|Adverse Event|38|||
16996332|NCT00762034|38140329|FG000|Induction Period|Lost to Follow-up|1|||
16996333|NCT00762034|38140330|FG001|Induction Period|Lost to Follow-up|1|||
16996334|NCT00762034|38140329|FG000|Induction Period|Progressive Disease|73|||
16996335|NCT00762034|38140330|FG001|Induction Period|Progressive Disease|55|||
16996336|NCT00762034|38140329|FG000|Induction Period|Physician Decision|21|||
16996337|NCT00762034|38140330|FG001|Induction Period|Physician Decision|20|||
16996338|NCT00762034|38140329|FG000|Induction Period|Withdrawal by Subject|15|||
17084404|NCT00235755|38224994|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
17084405|NCT00235755|38224995|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
17084406|NCT00235755|38224996|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
17084407|NCT00235755|38224994|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
17084408|NCT00235755|38224995|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
17084409|NCT00235755|38224996|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
17084410|NCT00337194|38225021|FG000|Overall Study|Adverse Event|5|||
17084411|NCT00337194|38225022|FG001|Overall Study|Adverse Event|1|||
17084412|NCT00337194|38225021|FG000|Overall Study|Death|2|||
17084413|NCT00337194|38225022|FG001|Overall Study|Death|0|||
17084414|NCT00337194|38225021|FG000|Overall Study|Withdrawal by Subject|1|||
17084415|NCT00337194|38225022|FG001|Overall Study|Withdrawal by Subject|0|||
17084416|NCT00337194|38225021|FG000|Overall Study|Disease progression|1|||
17084417|NCT00337194|38225022|FG001|Overall Study|Disease progression|2|||
17084418|NCT00337194|38225021|FG000|Overall Study|Subsequent non-protocol therapy|3|||
17084419|NCT00337194|38225022|FG001|Overall Study|Subsequent non-protocol therapy|1|||
17084420|NCT03826914|38225032|FG000|Overall Study|Withdrawal by Subject|1|||
17084421|NCT03826914|38225033|FG001|Overall Study|Withdrawal by Subject|1|||
17084422|NCT00385736|38225044|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
17084423|NCT00385736|38225045|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
17084424|NCT00385736|38225046|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
17084425|NCT00385736|38225044|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
17084426|NCT00385736|38225045|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
17084427|NCT00385736|38225046|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
17084428|NCT00385736|38225044|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
17084429|NCT00385736|38225045|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
17084430|NCT00385736|38225046|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
17084431|NCT00385736|38225044|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
17084432|NCT00385736|38225045|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
17084433|NCT00385736|38225046|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
17084434|NCT00385736|38225044|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
17084435|NCT00385736|38225045|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
17084436|NCT00385736|38225046|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
17084437|NCT00385736|38225044|FG000|Efficacy Analysis Set - Induction|Other|0|||
17084438|NCT00385736|38225045|FG001|Efficacy Analysis Set - Induction|Other|0|||
17084439|NCT00385736|38225046|FG002|Efficacy Analysis Set - Induction|Other|1|||
17084440|NCT00385736|38225044|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
17084441|NCT00385736|38225045|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
17084442|NCT00385736|38225046|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
17084443|NCT00385736|38225044|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
17084444|NCT00385736|38225045|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
17084445|NCT00385736|38225046|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
17084446|NCT00385736|38225044|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
17084447|NCT00385736|38225045|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
17084448|NCT00385736|38225046|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
17084449|NCT00385736|38225044|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
17084450|NCT00385736|38225045|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
17084451|NCT00385736|38225046|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
17084452|NCT00385736|38225044|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
17084453|NCT00385736|38225045|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
17084454|NCT00385736|38225046|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
17084455|NCT00385736|38225044|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
17084456|NCT00385736|38225045|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
17084457|NCT00385736|38225046|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
17084458|NCT00385736|38225044|FG000|Safety Analysis Set|Adverse Event|23|||
17084459|NCT00385736|38225045|FG001|Safety Analysis Set|Adverse Event|15|||
17084460|NCT00385736|38225046|FG002|Safety Analysis Set|Adverse Event|23|||
17084461|NCT00385736|38225044|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
17084462|NCT00385736|38225045|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
17084463|NCT00385736|38225046|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
17084464|NCT00385736|38225044|FG000|Safety Analysis Set|Lost to Follow-up|0|||
17084465|NCT00385736|38225045|FG001|Safety Analysis Set|Lost to Follow-up|2|||
17084466|NCT00385736|38225046|FG002|Safety Analysis Set|Lost to Follow-up|2|||
17084467|NCT00385736|38225044|FG000|Safety Analysis Set|Lack of Efficacy|38|||
17084468|NCT00385736|38225045|FG001|Safety Analysis Set|Lack of Efficacy|16|||
17084469|NCT00385736|38225046|FG002|Safety Analysis Set|Lack of Efficacy|31|||
17084470|NCT00385736|38225044|FG000|Safety Analysis Set|Protocol Violation|2|||
17084471|NCT00385736|38225045|FG001|Safety Analysis Set|Protocol Violation|1|||
17084472|NCT00385736|38225046|FG002|Safety Analysis Set|Protocol Violation|6|||
17084473|NCT00385736|38225044|FG000|Safety Analysis Set|Other|1|||
17084474|NCT00385736|38225045|FG001|Safety Analysis Set|Other|4|||
17166065|NCT03150589|38314678|FG000|Overall Study|Adverse Event|7|||
17166066|NCT03150589|38314679|FG001|Overall Study|Adverse Event|6|||
17166067|NCT03150589|38314678|FG000|Overall Study|Protocol Violation|4|||
17166068|NCT03150589|38314679|FG001|Overall Study|Protocol Violation|3|||
17166069|NCT03150589|38314678|FG000|Overall Study|Lost to Follow-up|3|||
17166070|NCT03150589|38314679|FG001|Overall Study|Lost to Follow-up|3|||
17166071|NCT03150589|38314678|FG000|Overall Study|Death|2|||
17166072|NCT03150589|38314679|FG001|Overall Study|Death|3|||
17166073|NCT03150589|38314678|FG000|Overall Study|IP non-compliance and other reasons|12|||
17166074|NCT03150589|38314679|FG001|Overall Study|IP non-compliance and other reasons|3|||
17166075|NCT02835092|38314688|FG000|Overall Study|Withdrawal by Subject|3|||
17166076|NCT02835092|38314689|FG001|Overall Study|Withdrawal by Subject|6|||
17166077|NCT02835092|38314690|FG002|Overall Study|Withdrawal by Subject|3|||
17166078|NCT02835092|38314688|FG000|Overall Study|Lost to Follow-up|0|||
17166079|NCT02835092|38314689|FG001|Overall Study|Lost to Follow-up|2|||
17166080|NCT02835092|38314690|FG002|Overall Study|Lost to Follow-up|0|||
17166081|NCT03145207|38314698|FG000|Overall Study|volunteer started taking allergy shots|1|||
17166082|NCT03145207|38314698|FG000|Overall Study|baseline blood pressure high|1|||
17166083|NCT02836652|38314715|FG000|Overall Study|Death|3|||
17166084|NCT02836652|38314716|FG001|Overall Study|Death|3|||
17166085|NCT02836652|38314715|FG000|Overall Study|Transplant/Explant|3|||
17166086|NCT02836652|38314716|FG001|Overall Study|Transplant/Explant|4|||
17166087|NCT02836652|38314715|FG000|Overall Study|Withdrawn|9|||
17166088|NCT02836652|38314716|FG001|Overall Study|Withdrawn|9|||
17166089|NCT02836652|38314715|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
17166090|NCT02836652|38314716|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
17166091|NCT02836496|38314724|FG000|Overall Study|Adverse Event|2|||
17166092|NCT02836496|38314725|FG001|Overall Study|Adverse Event|1|||
17166093|NCT02836496|38314724|FG000|Overall Study|Withdrawal by Subject|0|||
17166094|NCT02836496|38314725|FG001|Overall Study|Withdrawal by Subject|1|||
17166095|NCT04213807|38314734|FG000|Overall Study|Physician Decision|0|||
17166096|NCT04213807|38314735|FG001|Overall Study|Physician Decision|0|||
17166097|NCT04213807|38314736|FG002|Overall Study|Physician Decision|1|||
17166098|NCT00577577|38314755|FG000|Overall Study|Adverse Event|3|||
17166099|NCT00577577|38314756|FG001|Overall Study|Adverse Event|2|||
17166100|NCT00577577|38314755|FG000|Overall Study|Lost to Follow-up|1|||
17166101|NCT00577577|38314756|FG001|Overall Study|Lost to Follow-up|0|||
17166102|NCT00577577|38314755|FG000|Overall Study|Protocol Violation|0|||
17166103|NCT00577577|38314756|FG001|Overall Study|Protocol Violation|3|||
17166104|NCT00577577|38314755|FG000|Overall Study|Transportation|1|||
17166105|NCT00577577|38314756|FG001|Overall Study|Transportation|0|||
17166106|NCT02833844|38314764|FG000|Double-Blind Period|Withdrawal by Subject|2|||
17166107|NCT02833844|38314765|FG001|Double-Blind Period|Withdrawal by Subject|3|||
17166108|NCT02833844|38314764|FG000|Double-Blind Period|Protocol Violation|0|||
17166109|NCT02833844|38314765|FG001|Double-Blind Period|Protocol Violation|4|||
17166110|NCT02833844|38314764|FG000|Open-Label Period|Death|0|||
17166111|NCT02833844|38314765|FG001|Open-Label Period|Death|2|||
17166112|NCT02833844|38314764|FG000|Open-Label Period|Lost to Follow-up|1|||
17166113|NCT02833844|38314765|FG001|Open-Label Period|Lost to Follow-up|0|||
17166114|NCT02833844|38314764|FG000|Open-Label Period|Withdrawal by Subject|1|||
17166115|NCT02833844|38314765|FG001|Open-Label Period|Withdrawal by Subject|0|||
17166116|NCT01341782|38314775|FG000|Overall Study|Adverse Event|1|||
17166117|NCT01341782|38314776|FG001|Overall Study|Adverse Event|1|||
17166118|NCT01341782|38314775|FG000|Overall Study|Withdrawal by Subject|6|||
17166119|NCT01341782|38314776|FG001|Overall Study|Withdrawal by Subject|5|||
17166120|NCT01341782|38314775|FG000|Overall Study|Missed 3 consecutive doses|0|||
17166121|NCT01341782|38314776|FG001|Overall Study|Missed 3 consecutive doses|4|||
17166122|NCT01341782|38314775|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
17166123|NCT01341782|38314776|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
17166124|NCT01341782|38314775|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
17166125|NCT01341782|38314776|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
17166126|NCT01341782|38314775|FG000|Overall Study|Other|5|||
17166127|NCT01341782|38314776|FG001|Overall Study|Other|0|||
17166128|NCT01341470|38314788|FG000|Overall Study|Sponsor decision|0|||
17166129|NCT01341470|38314789|FG001|Overall Study|Sponsor decision|0|||
17166130|NCT01341470|38314790|FG002|Overall Study|Sponsor decision|1|||
17166131|NCT01341470|38314791|FG003|Overall Study|Sponsor decision|1|||
17166132|NCT01341470|38314792|FG004|Overall Study|Sponsor decision|0|||
17166133|NCT01341470|38314793|FG005|Overall Study|Sponsor decision|1|||
17166134|NCT03143101|38314812|FG000|Overall Study|Withdrawal by Subject|0|||
17166135|NCT03143101|38314813|FG001|Overall Study|Withdrawal by Subject|1|||
17166136|NCT03143101|38314814|FG002|Overall Study|Withdrawal by Subject|0|||
17166137|NCT03143101|38314812|FG000|Overall Study|Lost to Follow-up|2|||
17166138|NCT03143101|38314813|FG001|Overall Study|Lost to Follow-up|2|||
17166139|NCT03143101|38314814|FG002|Overall Study|Lost to Follow-up|0|||
17166140|NCT00871351|38314825|FG000|Overall Study|Withdrawal by Subject|1|||
17166141|NCT00871351|38314826|FG001|Overall Study|Withdrawal by Subject|0|||
17166142|NCT00871351|38314827|FG002|Overall Study|Withdrawal by Subject|0|||
17166143|NCT00871351|38314825|FG000|Overall Study|Adverse Event|3|||
17166144|NCT00871351|38314826|FG001|Overall Study|Adverse Event|1|||
17166145|NCT00871351|38314827|FG002|Overall Study|Adverse Event|0|||
17166146|NCT02745080|38314837|FG000|Overall Study|Adverse Event|13|||
17166147|NCT02745080|38314838|FG001|Overall Study|Adverse Event|21|||
17166148|NCT02745080|38314837|FG000|Overall Study|Lack of Efficacy|11|||
17166149|NCT02745080|38314838|FG001|Overall Study|Lack of Efficacy|23|||
17166150|NCT02745080|38314837|FG000|Overall Study|Lost to Follow-up|3|||
17166151|NCT02745080|38314838|FG001|Overall Study|Lost to Follow-up|3|||
17166152|NCT02745080|38314837|FG000|Overall Study|Physician Decision|3|||
17166153|NCT02745080|38314838|FG001|Overall Study|Physician Decision|0|||
17166154|NCT02745080|38314837|FG000|Overall Study|Protocol Violation|3|||
17166155|NCT02745080|38314838|FG001|Overall Study|Protocol Violation|1|||
17166156|NCT02745080|38314837|FG000|Overall Study|Withdrawal by Subject|22|||
17166157|NCT02745080|38314838|FG001|Overall Study|Withdrawal by Subject|41|||
17166158|NCT00521599|38314848|FG000|Overall Study|Adverse Event|5|||
17166159|NCT00521599|38314849|FG001|Overall Study|Adverse Event|7|||
17166160|NCT00521599|38314850|FG002|Overall Study|Adverse Event|6|||
17166161|NCT00521599|38314848|FG000|Overall Study|Treatment Failure|8|||
17166162|NCT00521599|38314849|FG001|Overall Study|Treatment Failure|9|||
17166163|NCT00521599|38314850|FG002|Overall Study|Treatment Failure|22|||
17166164|NCT00521599|38314848|FG000|Overall Study|Lost to Follow-up|2|||
17166165|NCT00521599|38314849|FG001|Overall Study|Lost to Follow-up|1|||
17166166|NCT00521599|38314850|FG002|Overall Study|Lost to Follow-up|2|||
17166167|NCT00521599|38314848|FG000|Overall Study|Withdrawal by Subject|3|||
17166168|NCT00521599|38314849|FG001|Overall Study|Withdrawal by Subject|5|||
17166169|NCT00521599|38314850|FG002|Overall Study|Withdrawal by Subject|1|||
17166170|NCT00521599|38314848|FG000|Overall Study|Withdrawal by subject treatment related|3|||
17166171|NCT00521599|38314849|FG001|Overall Study|Withdrawal by subject treatment related|1|||
17166172|NCT00521599|38314850|FG002|Overall Study|Withdrawal by subject treatment related|2|||
17166173|NCT00521599|38314848|FG000|Overall Study|Protocol Violation|2|||
17166174|NCT00521599|38314849|FG001|Overall Study|Protocol Violation|4|||
17166175|NCT00521599|38314850|FG002|Overall Study|Protocol Violation|2|||
17166176|NCT00521599|38314848|FG000|Overall Study|Did not meet protocol eligibility|2|||
17166177|NCT00521599|38314849|FG001|Overall Study|Did not meet protocol eligibility|2|||
17166178|NCT00521599|38314850|FG002|Overall Study|Did not meet protocol eligibility|1|||
17166179|NCT00442897|38314861|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
17166180|NCT00442897|38314862|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
17084475|NCT00385736|38225046|FG002|Safety Analysis Set|Other|4|||
17084476|NCT00195819|38225057|FG000|Double-Blind|Withdrawal by Subject|1|||
17084477|NCT00195819|38225058|FG001|Double-Blind|Withdrawal by Subject|0|||
17084478|NCT00195819|38225057|FG000|Double-Blind|Moved|1|||
17084479|NCT00195819|38225058|FG001|Double-Blind|Moved|0|||
17084480|NCT00195819|38225057|FG000|Open-label|Adverse Event|0|||
17166181|NCT00442897|38314861|FG000|Base Study (12 Week Follow-up)|Death|0|||
17166182|NCT00442897|38314862|FG001|Base Study (12 Week Follow-up)|Death|1|||
17166183|NCT00442897|38314861|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
17166184|NCT00442897|38314862|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
17166185|NCT00442897|38314861|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
17166186|NCT00442897|38314862|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
17166187|NCT00442897|38314861|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
17166188|NCT00442897|38314862|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
17166189|NCT00442897|38314861|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
17166190|NCT00442897|38314862|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
17166191|NCT00442897|38314861|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
17084481|NCT00195819|38225058|FG001|Open-label|Adverse Event|9|||
17084482|NCT00195819|38225057|FG000|Open-label|Lack of Efficacy|0|||
17084483|NCT00195819|38225058|FG001|Open-label|Lack of Efficacy|2|||
17084484|NCT00195819|38225057|FG000|Open-label|Pregnancy|0|||
17084485|NCT00195819|38225058|FG001|Open-label|Pregnancy|1|||
17084486|NCT00195819|38225057|FG000|Open-label|Protocol Violation|0|||
17084487|NCT00195819|38225058|FG001|Open-label|Protocol Violation|2|||
17084488|NCT00195819|38225057|FG000|Open-label|Moved|0|||
17084489|NCT00195819|38225058|FG001|Open-label|Moved|1|||
17084490|NCT00195819|38225057|FG000|Open-label|Withdrawal by Subject|0|||
17084491|NCT00195819|38225058|FG001|Open-label|Withdrawal by Subject|5|||
17084492|NCT00527735|38225073|FG000|Overall Study|Disease progression|47|||
17084493|NCT00527735|38225074|FG001|Overall Study|Disease progression|61|||
17084494|NCT00527735|38225075|FG002|Overall Study|Disease progression|53|||
17166192|NCT00442897|38314862|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
17166193|NCT00442897|38314861|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
17166194|NCT00442897|38314862|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
17166195|NCT02834390|38314870|FG000|Induction Phase|Progressive disease|0|||
17166196|NCT02834390|38314871|FG001|Induction Phase|Progressive disease|1|||
17166197|NCT02834390|38314870|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
17166198|NCT02834390|38314871|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
17166199|NCT02834390|38314870|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
17084495|NCT00527735|38225073|FG000|Overall Study|Death|23|||
17166200|NCT02834390|38314871|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
17166201|NCT02834390|38314870|FG000|Consolidation Phase|Physician Decision|1|||
17166202|NCT02834390|38314871|FG001|Consolidation Phase|Physician Decision|1|||
17166203|NCT03141151|38314879|FG000|Overall Study|Lost to Follow-up|3|||
17166204|NCT03141151|38314880|FG001|Overall Study|Lost to Follow-up|2|||
17166205|NCT03141151|38314879|FG000|Overall Study|Withdrawal by Subject|3|||
17166206|NCT03141151|38314880|FG001|Overall Study|Withdrawal by Subject|2|||
17166207|NCT01358708|38314888|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
17166208|NCT01358708|38314889|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
17166209|NCT01358708|38314888|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
17166210|NCT01358708|38314889|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
17166211|NCT01356602|38314902|FG000|Overall Study|Protocol Deviation|0|||
17166212|NCT01356602|38314903|FG001|Overall Study|Protocol Deviation|1|||
17166213|NCT01356602|38314904|FG002|Overall Study|Protocol Deviation|1|||
17166214|NCT01356602|38314902|FG000|Overall Study|Administrative Problems|1|||
17166215|NCT01356602|38314903|FG001|Overall Study|Administrative Problems|4|||
17166216|NCT01356602|38314904|FG002|Overall Study|Administrative Problems|5|||
17166217|NCT01356602|38314902|FG000|Overall Study|Lost to Follow-up|4|||
17166218|NCT01356602|38314903|FG001|Overall Study|Lost to Follow-up|5|||
17166219|NCT01356602|38314904|FG002|Overall Study|Lost to Follow-up|6|||
17166220|NCT01356602|38314902|FG000|Overall Study|Withdrawal by Subject|4|||
17166221|NCT01356602|38314903|FG001|Overall Study|Withdrawal by Subject|3|||
17166222|NCT01356602|38314904|FG002|Overall Study|Withdrawal by Subject|7|||
17166223|NCT01356602|38314902|FG000|Overall Study|Lack of Efficacy|0|||
17166224|NCT01356602|38314903|FG001|Overall Study|Lack of Efficacy|1|||
17166225|NCT01356602|38314904|FG002|Overall Study|Lack of Efficacy|4|||
17166226|NCT01356602|38314902|FG000|Overall Study|Adverse Event|0|||
17166227|NCT01356602|38314903|FG001|Overall Study|Adverse Event|1|||
17166228|NCT01356602|38314904|FG002|Overall Study|Adverse Event|1|||
17166229|NCT02830880|38314912|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
17166230|NCT02830880|38314912|FG000|Overall Study|Death|1|||
17166231|NCT02830880|38314912|FG000|Overall Study|Physician Decision|1|||
17166232|NCT03141307|38314918|FG000|In-Hospital|Withdrawal by Subject|0|||
17166233|NCT03141307|38314919|FG001|In-Hospital|Withdrawal by Subject|2|||
17166234|NCT03141307|38314918|FG000|In-Hospital|Protocol Violation|4|||
17166235|NCT03141307|38314919|FG001|In-Hospital|Protocol Violation|0|||
17166236|NCT03141307|38314918|FG000|Follow-Up|Lost to Follow-up|97|||
17166237|NCT03141307|38314919|FG001|Follow-Up|Lost to Follow-up|54|||
17166238|NCT02825420|38314927|FG000|Overall Study|Death|30|||
17166239|NCT02825420|38314928|FG001|Overall Study|Death|12|||
17166240|NCT02825420|38314927|FG000|Overall Study|Progressive disease|6|||
17166241|NCT02825420|38314928|FG001|Overall Study|Progressive disease|1|||
17166242|NCT02825420|38314927|FG000|Overall Study|Lost to Follow-up|2|||
17166243|NCT02825420|38314928|FG001|Overall Study|Lost to Follow-up|2|||
17166244|NCT02825420|38314927|FG000|Overall Study|Withdrawal by Subject|1|||
17166245|NCT02825420|38314928|FG001|Overall Study|Withdrawal by Subject|1|||
17166246|NCT02825420|38314927|FG000|Overall Study|Protocol amendment not signed|1|||
17166247|NCT02825420|38314928|FG001|Overall Study|Protocol amendment not signed|1|||
17166248|NCT02825420|38314927|FG000|Overall Study|Physician Decision|1|||
17084496|NCT00527735|38225074|FG001|Overall Study|Death|13|||
17084497|NCT00527735|38225075|FG002|Overall Study|Death|15|||
17084498|NCT00527735|38225073|FG000|Overall Study|Completed treatment in treatment phase|14|||
17084499|NCT00527735|38225074|FG001|Overall Study|Completed treatment in treatment phase|13|||
17084500|NCT00527735|38225075|FG002|Overall Study|Completed treatment in treatment phase|18|||
17084501|NCT00527735|38225073|FG000|Overall Study|Adverse Event|10|||
17084502|NCT00527735|38225074|FG001|Overall Study|Adverse Event|6|||
17084503|NCT00527735|38225075|FG002|Overall Study|Adverse Event|7|||
17084504|NCT00527735|38225073|FG000|Overall Study|Not identified|5|||
17084505|NCT00527735|38225074|FG001|Overall Study|Not identified|5|||
17084506|NCT00527735|38225075|FG002|Overall Study|Not identified|5|||
17084507|NCT00527735|38225073|FG000|Overall Study|Withdrawal by Subject|5|||
17084508|NCT00527735|38225074|FG001|Overall Study|Withdrawal by Subject|4|||
17084509|NCT00527735|38225075|FG002|Overall Study|Withdrawal by Subject|3|||
17084510|NCT00527735|38225073|FG000|Overall Study|No longer met study criteria|2|||
17084511|NCT00527735|38225074|FG001|Overall Study|No longer met study criteria|2|||
17166249|NCT02825420|38314928|FG001|Overall Study|Physician Decision|0|||
17166250|NCT02825420|38314927|FG000|Overall Study|Did not receive PLD|2|||
17166251|NCT02825420|38314928|FG001|Overall Study|Did not receive PLD|0|||
17166252|NCT02829944|38314941|FG000|Overall Study|Physician Decision|0|||
17166253|NCT02829944|38314942|FG001|Overall Study|Physician Decision|1|||
17166254|NCT02829944|38314941|FG000|Overall Study|Screen Failure|2|||
17166255|NCT02829944|38314942|FG001|Overall Study|Screen Failure|2|||
17166256|NCT02829944|38314941|FG000|Overall Study|Inadequate Neuraxial Block|1|||
17166257|NCT02829944|38314942|FG001|Overall Study|Inadequate Neuraxial Block|1|||
17166258|NCT02829944|38314941|FG000|Overall Study|Withdrawal by Subject|2|||
17166259|NCT02829944|38314942|FG001|Overall Study|Withdrawal by Subject|1|||
17166260|NCT02829944|38314941|FG000|Overall Study|Catheter Displacement|1|||
17166261|NCT02829944|38314942|FG001|Overall Study|Catheter Displacement|0|||
17166262|NCT02829944|38314941|FG000|Overall Study|Catheter broke|0|||
17166263|NCT02829944|38314942|FG001|Overall Study|Catheter broke|1|||
17166264|NCT02829944|38314941|FG000|Overall Study|Staff unavailable|0|||
17166265|NCT02829944|38314942|FG001|Overall Study|Staff unavailable|1|||
17166266|NCT02824562|38314950|FG000|Overall Study|Lost to Follow-up|3|||
17166267|NCT02824562|38314951|FG001|Overall Study|Lost to Follow-up|4|||
17166268|NCT02824562|38314950|FG000|Overall Study|Death|0|||
17166269|NCT02824562|38314951|FG001|Overall Study|Death|1|||
17166270|NCT02744066|38314959|FG000|Overall Study|Withdrawal by parent|0|||
17166271|NCT02744066|38314960|FG001|Overall Study|Withdrawal by parent|1|||
17166272|NCT02744066|38314959|FG000|Overall Study|Discharged from NICU prior to completion|0|||
17166273|NCT02744066|38314960|FG001|Overall Study|Discharged from NICU prior to completion|4|||
17166274|NCT01338818|38314968|FG000|Overall Study|Adverse Event|8|||
17166275|NCT01338818|38314968|FG000|Overall Study|Lack of Efficacy|5|||
17166276|NCT01338818|38314968|FG000|Overall Study|no longer require study drug|1|||
17166277|NCT01338818|38314968|FG000|Overall Study|Withdrawal by Subject|11|||
17166278|NCT01338818|38314968|FG000|Overall Study|Lost to Follow-up|4|||
17166279|NCT01338818|38314968|FG000|Overall Study|Administrative problems|3|||
17166280|NCT01338818|38314968|FG000|Overall Study|Protocol Deviation|4|||
17166281|NCT02823470|38314974|FG000|Overall Study|Adverse Event|1|||
17166282|NCT02823470|38314975|FG001|Overall Study|Adverse Event|0|||
17166283|NCT02823470|38314974|FG000|Overall Study|Study terminated by sponsor|8|||
17166284|NCT02823470|38314975|FG001|Overall Study|Study terminated by sponsor|15|||
17166285|NCT01371656|38314986|FG000|Overall Study|Death|7|||
17166286|NCT01371656|38314987|FG001|Overall Study|Death|4|||
17166287|NCT01371656|38314986|FG000|Overall Study|Physician Decision|46|||
17166288|NCT01371656|38314987|FG001|Overall Study|Physician Decision|7|||
17166289|NCT01371656|38314986|FG000|Overall Study|Withdrawal by Subject|7|||
17166290|NCT01371656|38314987|FG001|Overall Study|Withdrawal by Subject|0|||
17166291|NCT01371656|38314986|FG000|Overall Study|Ineligible|4|||
17166292|NCT01371656|38314987|FG001|Overall Study|Ineligible|3|||
17166293|NCT01354106|38314993|FG000|Overall Study|Withdrawal by Subject|2|||
17166294|NCT01354028|38314999|FG000|Overall Study|Physician Decision|0|||
17166295|NCT01354028|38315000|FG001|Overall Study|Physician Decision|2|||
17166296|NCT01354028|38314999|FG000|Overall Study|Discharged before study start|2|||
17166297|NCT01354028|38315000|FG001|Overall Study|Discharged before study start|2|||
17166298|NCT01354028|38314999|FG000|Overall Study|No quiet alert state|0|||
17166299|NCT01354028|38315000|FG001|Overall Study|No quiet alert state|1|||
17166300|NCT01354964|38315014|FG000|Overall Study|Lost to Follow-up|2|||
17166301|NCT01354964|38315015|FG001|Overall Study|Lost to Follow-up|0|||
17166302|NCT01354964|38315014|FG000|Overall Study|IV access issues|1|||
17166303|NCT01354964|38315015|FG001|Overall Study|IV access issues|1|||
17166304|NCT01354964|38315014|FG000|Overall Study|Physician Decision|1|||
17166305|NCT01354964|38315015|FG001|Overall Study|Physician Decision|0|||
17166306|NCT01354496|38315025|FG000|Period 1|Adverse Event|0|||
17166307|NCT01354496|38315026|FG001|Period 1|Adverse Event|0|||
17166308|NCT01354496|38315027|FG002|Period 1|Adverse Event|1|||
17166309|NCT01354496|38315028|FG003|Period 1|Adverse Event|0|||
17166310|NCT01354496|38315029|FG004|Period 1|Adverse Event|0|||
17166311|NCT01354496|38315030|FG005|Period 1|Adverse Event|0|||
17166312|NCT01354496|38315025|FG000|Period 1|Physician Decision|0|||
17166313|NCT01354496|38315026|FG001|Period 1|Physician Decision|0|||
17166314|NCT01354496|38315027|FG002|Period 1|Physician Decision|1|||
17166315|NCT01354496|38315028|FG003|Period 1|Physician Decision|0|||
17166316|NCT01354496|38315029|FG004|Period 1|Physician Decision|0|||
17166317|NCT01354496|38315030|FG005|Period 1|Physician Decision|0|||
17166318|NCT01354496|38315025|FG000|Period 2|Adverse Event|0|||
17166319|NCT01354496|38315026|FG001|Period 2|Adverse Event|0|||
17166320|NCT01354496|38315027|FG002|Period 2|Adverse Event|0|||
17166321|NCT01354496|38315028|FG003|Period 2|Adverse Event|1|||
17166322|NCT01354496|38315029|FG004|Period 2|Adverse Event|0|||
17166323|NCT01354496|38315030|FG005|Period 2|Adverse Event|0|||
17166324|NCT01354496|38315025|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
17166325|NCT01354496|38315026|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
17166326|NCT01354496|38315027|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
17166327|NCT01354496|38315028|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
17166328|NCT01354496|38315029|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
17166329|NCT01354496|38315030|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
17166330|NCT02822222|38315053|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
17166331|NCT02822222|38315054|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
17166332|NCT02821910|38315066|FG000|Overall Study|Withdrawal by Subject|0|||
17166333|NCT02821910|38315067|FG001|Overall Study|Withdrawal by Subject|0|||
17166334|NCT02821910|38315068|FG002|Overall Study|Withdrawal by Subject|1|||
17166335|NCT02821910|38315069|FG003|Overall Study|Withdrawal by Subject|0|||
17166336|NCT02821910|38315070|FG004|Overall Study|Withdrawal by Subject|0|||
17166337|NCT02821910|38315071|FG005|Overall Study|Withdrawal by Subject|1|||
17166338|NCT02821910|38315066|FG000|Overall Study|Other than specified|1|||
17166339|NCT02821910|38315067|FG001|Overall Study|Other than specified|0|||
17166340|NCT02821910|38315068|FG002|Overall Study|Other than specified|1|||
17166341|NCT02821910|38315069|FG003|Overall Study|Other than specified|0|||
17166342|NCT02821910|38315070|FG004|Overall Study|Other than specified|0|||
17166343|NCT02821910|38315071|FG005|Overall Study|Other than specified|0|||
17166344|NCT02817776|38315085|FG000|Overall Study|Excluded|33|||
17166345|NCT02817776|38315085|FG000|Overall Study|Lost to Follow-up|20|||
17166346|NCT02817776|38315085|FG000|Overall Study|Withdrawal by Subject|33|||
17166347|NCT02817776|38315085|FG000|Overall Study|Death|2|||
17166348|NCT03138655|38315097|FG000|Overall Study|Adverse Event|2|||
17166349|NCT03138655|38315098|FG001|Overall Study|Adverse Event|1|||
17166350|NCT03138655|38315099|FG002|Overall Study|Adverse Event|2|||
17166351|NCT03138655|38315100|FG003|Overall Study|Adverse Event|1|||
17166352|NCT03138655|38315101|FG004|Overall Study|Adverse Event|1|||
17166353|NCT03138655|38315102|FG005|Overall Study|Adverse Event|4|||
17166354|NCT03138655|38315103|FG006|Overall Study|Adverse Event|2|||
17166355|NCT03138655|38315104|FG007|Overall Study|Adverse Event|2|||
17166356|NCT03138655|38315097|FG000|Overall Study|Withdrawal by Subject|0|||
17166357|NCT03138655|38315098|FG001|Overall Study|Withdrawal by Subject|1|||
17166358|NCT03138655|38315099|FG002|Overall Study|Withdrawal by Subject|0|||
17166359|NCT03138655|38315100|FG003|Overall Study|Withdrawal by Subject|0|||
17166360|NCT03138655|38315101|FG004|Overall Study|Withdrawal by Subject|0|||
17166361|NCT03138655|38315102|FG005|Overall Study|Withdrawal by Subject|0|||
17166362|NCT03138655|38315103|FG006|Overall Study|Withdrawal by Subject|1|||
17166363|NCT03138655|38315104|FG007|Overall Study|Withdrawal by Subject|0|||
17166364|NCT03138655|38315097|FG000|Overall Study|Reason not Specified|1|||
17166365|NCT03138655|38315098|FG001|Overall Study|Reason not Specified|0|||
17166366|NCT03138655|38315099|FG002|Overall Study|Reason not Specified|0|||
17166367|NCT03138655|38315100|FG003|Overall Study|Reason not Specified|2|||
17166368|NCT03138655|38315101|FG004|Overall Study|Reason not Specified|1|||
17166369|NCT03138655|38315102|FG005|Overall Study|Reason not Specified|1|||
17166370|NCT03138655|38315103|FG006|Overall Study|Reason not Specified|0|||
17166371|NCT03138655|38315104|FG007|Overall Study|Reason not Specified|0|||
17166372|NCT02820038|38315130|FG000|Overall Study|Lost to Follow-up|7|||
17166373|NCT02820038|38315131|FG001|Overall Study|Lost to Follow-up|11|||
17166374|NCT02820038|38315132|FG002|Overall Study|Lost to Follow-up|2|||
17166375|NCT02820038|38315133|FG003|Overall Study|Lost to Follow-up|9|||
17166376|NCT02820038|38315130|FG000|Overall Study|Withdrawal by Subject|3|||
17166377|NCT02820038|38315131|FG001|Overall Study|Withdrawal by Subject|14|||
17166378|NCT02820038|38315132|FG002|Overall Study|Withdrawal by Subject|3|||
17166379|NCT02820038|38315133|FG003|Overall Study|Withdrawal by Subject|13|||
17166380|NCT02819804|38315144|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
17166381|NCT02819726|38315151|FG000|Part A (All Participants)|Lost to Follow-up|0|||
17166382|NCT02819726|38315152|FG001|Part A (All Participants)|Lost to Follow-up|1|||
17166383|NCT02819726|38315153|FG002|Part A (All Participants)|Lost to Follow-up|0|||
17166384|NCT02819726|38315154|FG003|Part A (All Participants)|Lost to Follow-up|0|||
17166385|NCT02819726|38315151|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
17166386|NCT02819726|38315152|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
17166387|NCT02819726|38315153|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
17166388|NCT02819726|38315154|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
17166389|NCT02819726|38315151|FG000|Part A (All Participants)|Protocol non-compliance|3|||
17166390|NCT02819726|38315152|FG001|Part A (All Participants)|Protocol non-compliance|4|||
17084512|NCT00527735|38225075|FG002|Overall Study|No longer met study criteria|1|||
17084513|NCT00527735|38225073|FG000|Overall Study|Lost to Follow-up|0|||
17084514|NCT00527735|38225074|FG001|Overall Study|Lost to Follow-up|0|||
17084515|NCT00527735|38225075|FG002|Overall Study|Lost to Follow-up|3|||
17084516|NCT00527735|38225073|FG000|Overall Study|Poor compliance or noncompliance|0|||
17084517|NCT00527735|38225074|FG001|Overall Study|Poor compliance or noncompliance|1|||
17084518|NCT00527735|38225075|FG002|Overall Study|Poor compliance or noncompliance|1|||
17084519|NCT00527735|38225073|FG000|Overall Study|Completed treatment during maintenance|2|||
17084520|NCT00527735|38225074|FG001|Overall Study|Completed treatment during maintenance|2|||
17084521|NCT00527735|38225075|FG002|Overall Study|Completed treatment during maintenance|1|||
17084522|NCT00364286|38225095|FG000|Overall Study|Withdrawal by Subject|1|||
17084523|NCT00364286|38225095|FG000|Overall Study|Adverse Event|2|||
17084524|NCT00336492|38225102|FG000|Overall Study|Adverse Event|4|||
17084525|NCT00336492|38225103|FG001|Overall Study|Adverse Event|3|||
17084526|NCT00336492|38225104|FG002|Overall Study|Adverse Event|6|||
17084527|NCT00336492|38225102|FG000|Overall Study|Lack of Efficacy|6|||
17084528|NCT00336492|38225103|FG001|Overall Study|Lack of Efficacy|1|||
17084529|NCT00336492|38225104|FG002|Overall Study|Lack of Efficacy|4|||
17166391|NCT02819726|38315153|FG002|Part A (All Participants)|Protocol non-compliance|5|||
17166392|NCT02819726|38315154|FG003|Part A (All Participants)|Protocol non-compliance|0|||
17166393|NCT02819726|38315151|FG000|Part B (All Participants)|Lost to Follow-up|1|||
17166394|NCT02819726|38315152|FG001|Part B (All Participants)|Lost to Follow-up|1|||
17166395|NCT02819726|38315153|FG002|Part B (All Participants)|Lost to Follow-up|2|||
17166396|NCT02819726|38315154|FG003|Part B (All Participants)|Lost to Follow-up|2|||
17166397|NCT02819726|38315151|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
17166398|NCT02819726|38315152|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
17166399|NCT02819726|38315153|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
17166400|NCT02819726|38315154|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
17166401|NCT02819726|38315151|FG000|Part B (All Participants)|Protocol non-compliance|0|||
17166402|NCT02819726|38315152|FG001|Part B (All Participants)|Protocol non-compliance|0|||
17166403|NCT02819726|38315153|FG002|Part B (All Participants)|Protocol non-compliance|1|||
17166404|NCT02819726|38315154|FG003|Part B (All Participants)|Protocol non-compliance|0|||
17166405|NCT02816138|38315162|FG000|Overall Study|Adverse Event|1|||
17166406|NCT02815670|38315166|FG000|Overall Study|Prematurely discontinued of the trial|1|||
17166407|NCT02809976|38315170|FG000|Overall Study|Lost to Follow-up|1|||
17166408|NCT02809976|38315170|FG000|Overall Study|Withdrawal by Subject|1|||
17166409|NCT02880865|38315176|FG000|Overall Study|Adverse Event|1|||
17166410|NCT02880865|38315177|FG001|Overall Study|Adverse Event|0|||
17166411|NCT02880865|38315176|FG000|Overall Study|Withdrawal by Subject|0|||
17166412|NCT02880865|38315177|FG001|Overall Study|Withdrawal by Subject|2|||
17166413|NCT02880865|38315176|FG000|Overall Study|Physician Decision|0|||
17166414|NCT02880865|38315177|FG001|Overall Study|Physician Decision|1|||
17166415|NCT01854385|38315204|FG000|Pre-Treatment|Withdrawal by Subject|4|||
17166416|NCT01854385|38315204|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
17166417|NCT01854385|38315204|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
17166418|NCT01854385|38315204|FG000|Pre-Treatment|Unable to come for study visits|1|||
17166419|NCT01854385|38315204|FG000|Treatment|Lost to Follow-up|1|||
17166420|NCT02809118|38315211|FG000|Overall Study|Withdrawal by Subject|0|||
17166421|NCT02809118|38315212|FG001|Overall Study|Withdrawal by Subject|1|||
17166422|NCT02809118|38315213|FG002|Overall Study|Withdrawal by Subject|1|||
17166423|NCT03604159|38315223|FG000|Overall Study|Lost to Follow-up|6|||
17166424|NCT03604159|38315224|FG001|Overall Study|Lost to Follow-up|7|||
17166425|NCT02808338|38315230|FG000|Screening|Screen Failure|10|||
17166426|NCT02808338|38315230|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
17166427|NCT02808338|38315230|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
17166428|NCT02807948|38315241|FG000|Overall Study|Physician Decision|1|||
17166429|NCT02807948|38315242|FG001|Overall Study|Physician Decision|0|||
17166430|NCT02879383|38315251|FG000|First 24 Weeks|Physician Decision|0|||
17166431|NCT02879383|38315252|FG001|First 24 Weeks|Physician Decision|1|||
17166432|NCT02879383|38315253|FG002|First 24 Weeks|Physician Decision|0|||
17166433|NCT02879383|38315254|FG003|First 24 Weeks|Physician Decision|0|||
17166434|NCT02049710|38315268|FG000|Overall Study|Lost to Follow-up|319|||
17166435|NCT02049710|38315269|FG001|Overall Study|Lost to Follow-up|324|||
17166436|NCT02806232|38315297|FG000|Overall Study|Lost to Follow-up|1|||
17166437|NCT02806232|38315298|FG001|Overall Study|Lost to Follow-up|2|||
17166438|NCT02806232|38315299|FG002|Overall Study|Lost to Follow-up|1|||
17166439|NCT02806232|38315300|FG003|Overall Study|Lost to Follow-up|0|||
17166440|NCT02806232|38315301|FG004|Overall Study|Lost to Follow-up|0|||
17166441|NCT02806232|38315302|FG005|Overall Study|Lost to Follow-up|1|||
17166442|NCT02806232|38315303|FG006|Overall Study|Lost to Follow-up|0|||
17166443|NCT02806232|38315304|FG007|Overall Study|Lost to Follow-up|0|||
17166444|NCT02806232|38315305|FG008|Overall Study|Lost to Follow-up|0|||
17166445|NCT02806232|38315297|FG000|Overall Study|Withdrawal by Subject|0|||
17166446|NCT02806232|38315298|FG001|Overall Study|Withdrawal by Subject|2|||
17166447|NCT02806232|38315299|FG002|Overall Study|Withdrawal by Subject|0|||
17166448|NCT02806232|38315300|FG003|Overall Study|Withdrawal by Subject|0|||
17166449|NCT02806232|38315301|FG004|Overall Study|Withdrawal by Subject|2|||
17166450|NCT02806232|38315302|FG005|Overall Study|Withdrawal by Subject|1|||
17166451|NCT02806232|38315303|FG006|Overall Study|Withdrawal by Subject|0|||
17166452|NCT02806232|38315304|FG007|Overall Study|Withdrawal by Subject|0|||
17166453|NCT02806232|38315305|FG008|Overall Study|Withdrawal by Subject|0|||
17166454|NCT02807402|38315325|FG000|Overall Study|Failure to Return|1|||
17166455|NCT02807402|38315325|FG000|Overall Study|Death|3|||
17166456|NCT02807402|38315325|FG000|Overall Study|Other|2|||
17166457|NCT00392327|38315345|FG000|Overall Study|Death|1|||
17166458|NCT00392327|38315346|FG001|Overall Study|Death|0|||
17166459|NCT00392327|38315347|FG002|Overall Study|Death|1|||
17166460|NCT00392327|38315348|FG003|Overall Study|Death|0|||
17166461|NCT00392327|38315349|FG004|Overall Study|Death|0|||
17166462|NCT00392327|38315350|FG005|Overall Study|Death|0|||
17166463|NCT00392327|38315351|FG006|Overall Study|Death|0|||
17166464|NCT00392327|38315352|FG007|Overall Study|Death|0|||
17166465|NCT00392327|38315345|FG000|Overall Study|Lack of Efficacy|8|||
17166466|NCT00392327|38315346|FG001|Overall Study|Lack of Efficacy|8|||
17166467|NCT00392327|38315347|FG002|Overall Study|Lack of Efficacy|9|||
17166468|NCT00392327|38315348|FG003|Overall Study|Lack of Efficacy|6|||
17166469|NCT00392327|38315349|FG004|Overall Study|Lack of Efficacy|3|||
17166470|NCT00392327|38315350|FG005|Overall Study|Lack of Efficacy|3|||
17166471|NCT00392327|38315351|FG006|Overall Study|Lack of Efficacy|3|||
17166472|NCT00392327|38315352|FG007|Overall Study|Lack of Efficacy|3|||
17166473|NCT00392327|38315345|FG000|Overall Study|Physician Decision|3|||
17166474|NCT00392327|38315346|FG001|Overall Study|Physician Decision|5|||
17166475|NCT00392327|38315347|FG002|Overall Study|Physician Decision|2|||
17166476|NCT00392327|38315348|FG003|Overall Study|Physician Decision|2|||
17166477|NCT00392327|38315349|FG004|Overall Study|Physician Decision|0|||
17166478|NCT00392327|38315350|FG005|Overall Study|Physician Decision|1|||
17166479|NCT00392327|38315351|FG006|Overall Study|Physician Decision|5|||
17166480|NCT00392327|38315352|FG007|Overall Study|Physician Decision|3|||
17166481|NCT00392327|38315345|FG000|Overall Study|Protocol Violation|0|||
17166482|NCT00392327|38315346|FG001|Overall Study|Protocol Violation|0|||
17166483|NCT00392327|38315347|FG002|Overall Study|Protocol Violation|1|||
17166484|NCT00392327|38315348|FG003|Overall Study|Protocol Violation|0|||
17166485|NCT00392327|38315349|FG004|Overall Study|Protocol Violation|0|||
17166486|NCT00392327|38315350|FG005|Overall Study|Protocol Violation|0|||
17166487|NCT00392327|38315351|FG006|Overall Study|Protocol Violation|0|||
17166488|NCT00392327|38315352|FG007|Overall Study|Protocol Violation|0|||
17166489|NCT00392327|38315345|FG000|Overall Study|Withdrawal by Subject|3|||
17166490|NCT00392327|38315346|FG001|Overall Study|Withdrawal by Subject|2|||
17166491|NCT00392327|38315347|FG002|Overall Study|Withdrawal by Subject|4|||
17166492|NCT00392327|38315348|FG003|Overall Study|Withdrawal by Subject|6|||
17166493|NCT00392327|38315349|FG004|Overall Study|Withdrawal by Subject|0|||
17166494|NCT00392327|38315350|FG005|Overall Study|Withdrawal by Subject|1|||
17166495|NCT00392327|38315351|FG006|Overall Study|Withdrawal by Subject|1|||
17166496|NCT00392327|38315352|FG007|Overall Study|Withdrawal by Subject|5|||
17166497|NCT00392327|38315345|FG000|Overall Study|Ineligible|0|||
17166498|NCT00392327|38315346|FG001|Overall Study|Ineligible|4|||
17166499|NCT00392327|38315347|FG002|Overall Study|Ineligible|3|||
17166500|NCT00392327|38315348|FG003|Overall Study|Ineligible|2|||
17166501|NCT00392327|38315349|FG004|Overall Study|Ineligible|0|||
17166502|NCT00392327|38315350|FG005|Overall Study|Ineligible|0|||
17166503|NCT00392327|38315351|FG006|Overall Study|Ineligible|0|||
17166504|NCT00392327|38315352|FG007|Overall Study|Ineligible|0|||
17166505|NCT02960490|38315372|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
17166506|NCT02960490|38315373|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
17166507|NCT02960490|38315374|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
17166508|NCT02960490|38315375|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
17166509|NCT02960490|38315376|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
17166510|NCT02960490|38315377|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
17166511|NCT02960490|38315378|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
17166512|NCT02960490|38315379|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
17166513|NCT02960490|38315380|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
17166514|NCT02960490|38315381|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
17166515|NCT02960490|38315372|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
17166516|NCT02960490|38315373|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
17166517|NCT02960490|38315374|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
17166518|NCT02960490|38315375|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
17166519|NCT02960490|38315376|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
17166520|NCT02960490|38315377|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16996339|NCT00762034|38140330|FG001|Induction Period|Withdrawal by Subject|19|||
17084530|NCT00336492|38225102|FG000|Overall Study|Other|5|||
17084531|NCT00336492|38225103|FG001|Overall Study|Other|0|||
17084532|NCT00336492|38225104|FG002|Overall Study|Other|1|||
17084533|NCT00194025|38225112|FG000|Overall Study|Adverse Event|1|||
17084534|NCT00194025|38225112|FG000|Overall Study|non-adherence with study medication|4|||
17084535|NCT00368108|38225119|FG000|Overall Study|Adverse Event|38|||
17084536|NCT00368108|38225120|FG001|Overall Study|Adverse Event|26|||
17084537|NCT00368108|38225121|FG002|Overall Study|Adverse Event|44|||
17084538|NCT00368108|38225119|FG000|Overall Study|Abnormal Laboratory Value|0|||
17084539|NCT00368108|38225120|FG001|Overall Study|Abnormal Laboratory Value|0|||
17084540|NCT00368108|38225121|FG002|Overall Study|Abnormal Laboratory Value|3|||
17084541|NCT00368108|38225119|FG000|Overall Study|Protocol Violation|5|||
17084542|NCT00368108|38225120|FG001|Overall Study|Protocol Violation|9|||
17084543|NCT00368108|38225121|FG002|Overall Study|Protocol Violation|9|||
17084544|NCT00368108|38225119|FG000|Overall Study|Withdrawal by Subject|9|||
17084545|NCT00368108|38225120|FG001|Overall Study|Withdrawal by Subject|3|||
17084546|NCT00368108|38225121|FG002|Overall Study|Withdrawal by Subject|5|||
17084547|NCT00368108|38225119|FG000|Overall Study|Lack of Efficacy|7|||
17084548|NCT00368108|38225120|FG001|Overall Study|Lack of Efficacy|8|||
17084549|NCT00368108|38225121|FG002|Overall Study|Lack of Efficacy|5|||
17084550|NCT00368108|38225119|FG000|Overall Study|Physician Decision|2|||
17084551|NCT00368108|38225120|FG001|Overall Study|Physician Decision|0|||
17084552|NCT00368108|38225121|FG002|Overall Study|Physician Decision|1|||
17084553|NCT00368108|38225119|FG000|Overall Study|Other|3|||
17084554|NCT00368108|38225120|FG001|Overall Study|Other|7|||
17084555|NCT00368108|38225121|FG002|Overall Study|Other|1|||
17084556|NCT00364130|38225131|FG000|Intervention Period|Lost to Follow-up|4|||
17084557|NCT00364130|38225132|FG001|Intervention Period|Lost to Follow-up|3|||
17166521|NCT02960490|38315378|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
17166522|NCT02960490|38315379|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
17166523|NCT02960490|38315380|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
17166524|NCT02960490|38315381|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
17166525|NCT02960490|38315372|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
17166526|NCT02960490|38315373|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
17166527|NCT02960490|38315374|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
17166528|NCT02960490|38315375|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
17166529|NCT02960490|38315376|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
17166530|NCT02960490|38315377|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
17166531|NCT02960490|38315378|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
17166532|NCT02960490|38315379|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
17166533|NCT02960490|38315380|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
17166534|NCT02960490|38315381|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
17166535|NCT02960490|38315372|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
17166536|NCT02960490|38315373|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
17166537|NCT02960490|38315374|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
17166538|NCT02960490|38315375|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
17166539|NCT02960490|38315376|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
17166540|NCT02960490|38315377|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
17166541|NCT02960490|38315378|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
17166542|NCT02960490|38315379|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
17166543|NCT02960490|38315380|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
17166544|NCT02960490|38315381|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
17166545|NCT02960490|38315372|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
17166546|NCT02960490|38315373|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
17166547|NCT02960490|38315374|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
17166548|NCT02960490|38315375|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
17166549|NCT02960490|38315376|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
17166550|NCT02960490|38315377|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
17166551|NCT02960490|38315378|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
17166552|NCT02960490|38315379|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
17166553|NCT02960490|38315380|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
17166554|NCT02960490|38315381|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
17166555|NCT02960490|38315372|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
17166556|NCT02960490|38315373|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
17166557|NCT02960490|38315374|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
17166558|NCT02960490|38315375|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
17166559|NCT02960490|38315376|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
17166560|NCT02960490|38315377|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
17166561|NCT02960490|38315378|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
17166562|NCT02960490|38315379|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
17166563|NCT02960490|38315380|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
17166564|NCT02960490|38315381|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
17166565|NCT02960490|38315372|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
17166566|NCT02960490|38315373|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
17166567|NCT02960490|38315374|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
17166568|NCT02960490|38315375|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
17166569|NCT02960490|38315376|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
17166570|NCT02960490|38315377|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
17166571|NCT02960490|38315378|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
17166572|NCT02960490|38315379|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
16996340|NCT00762034|38140329|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
17084558|NCT00364130|38225131|FG000|Intervention Period|Pregnancy|1|||
17084559|NCT00364130|38225132|FG001|Intervention Period|Pregnancy|0|||
17084560|NCT00364130|38225131|FG000|Intervention Period|Withdrawal by Subject|4|||
17084561|NCT00364130|38225132|FG001|Intervention Period|Withdrawal by Subject|5|||
17084562|NCT00364130|38225131|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
17084563|NCT00364130|38225132|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
17084564|NCT00521339|38225140|FG000|Treatment Phase|Adverse Event|2|||
17084565|NCT00521339|38225141|FG001|Treatment Phase|Adverse Event|0|||
17084566|NCT00521339|38225142|FG002|Treatment Phase|Adverse Event|0|||
17084567|NCT00521339|38225140|FG000|Treatment Phase|Intolerability to study drug|2|||
17084568|NCT00521339|38225141|FG001|Treatment Phase|Intolerability to study drug|0|||
17084569|NCT00521339|38225142|FG002|Treatment Phase|Intolerability to study drug|0|||
17084570|NCT00521339|38225140|FG000|Treatment Phase|Lack of Efficacy|3|||
16996341|NCT00762034|38140330|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
17084571|NCT00521339|38225141|FG001|Treatment Phase|Lack of Efficacy|0|||
17084572|NCT00521339|38225142|FG002|Treatment Phase|Lack of Efficacy|0|||
17084573|NCT00521339|38225140|FG000|Treatment Phase|Withdrawal by Subject|3|||
17084574|NCT00521339|38225141|FG001|Treatment Phase|Withdrawal by Subject|0|||
17084575|NCT00521339|38225142|FG002|Treatment Phase|Withdrawal by Subject|0|||
17084576|NCT00521339|38225140|FG000|Treatment Phase|Lost to Follow-up|1|||
17084577|NCT00521339|38225141|FG001|Treatment Phase|Lost to Follow-up|0|||
17084578|NCT00521339|38225142|FG002|Treatment Phase|Lost to Follow-up|0|||
17084579|NCT00521339|38225140|FG000|Treatment Phase|Protocol Violation|1|||
17084580|NCT00521339|38225141|FG001|Treatment Phase|Protocol Violation|0|||
17084581|NCT00521339|38225142|FG002|Treatment Phase|Protocol Violation|0|||
17084582|NCT00521339|38225140|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
17084583|NCT00521339|38225141|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
17084584|NCT00521339|38225142|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
17084585|NCT00521339|38225140|FG000|Treatment Extension Phase|Death|0|||
17084586|NCT00521339|38225141|FG001|Treatment Extension Phase|Death|0|||
17084587|NCT00521339|38225142|FG002|Treatment Extension Phase|Death|1|||
17084588|NCT00363896|38225165|FG000|Overall Study|Withdrawal by Subject|29|||
17084589|NCT00363896|38225166|FG001|Overall Study|Withdrawal by Subject|16|||
17084590|NCT00363896|38225165|FG000|Overall Study|Adverse Event|24|||
17084591|NCT00363896|38225166|FG001|Overall Study|Adverse Event|13|||
17084592|NCT00363896|38225165|FG000|Overall Study|COPD exacerbation|13|||
17084593|NCT00363896|38225166|FG001|Overall Study|COPD exacerbation|7|||
17084594|NCT00363896|38225165|FG000|Overall Study|Lack of Efficacy|12|||
17084595|NCT00363896|38225166|FG001|Overall Study|Lack of Efficacy|8|||
17084596|NCT00363896|38225165|FG000|Overall Study|Protocol Violation|6|||
17084597|NCT00363896|38225166|FG001|Overall Study|Protocol Violation|1|||
17084598|NCT00363896|38225165|FG000|Overall Study|Lost to Follow-up|3|||
17084599|NCT00363896|38225166|FG001|Overall Study|Lost to Follow-up|0|||
17084600|NCT00363896|38225165|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
17084601|NCT00363896|38225166|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
17084602|NCT00363896|38225165|FG000|Overall Study|Other|1|||
17084603|NCT00363896|38225166|FG001|Overall Study|Other|2|||
17084604|NCT00527423|38225175|FG000|Overall Study|Protocol Violation|1|||
17084605|NCT00527423|38225175|FG000|Overall Study|Adverse Event|5|||
17084606|NCT00527423|38225175|FG000|Overall Study|Physician Decision|4|||
17084607|NCT00527423|38225175|FG000|Overall Study|Withdrawal by Subject|10|||
17084608|NCT00527423|38225175|FG000|Overall Study|Lost to Follow-up|4|||
17084609|NCT00527423|38225175|FG000|Overall Study|OTHER|4|||
17084610|NCT00527423|38225175|FG000|Overall Study|Death|9|||
17084611|NCT00527111|38225183|FG000|Overall Study|Adverse Event|14|||
17084612|NCT00527111|38225184|FG001|Overall Study|Adverse Event|13|||
17084613|NCT00527111|38225183|FG000|Overall Study|Death|0|||
17084614|NCT00527111|38225184|FG001|Overall Study|Death|1|||
17084615|NCT00527111|38225183|FG000|Overall Study|Investigator Request|2|||
17084616|NCT00527111|38225184|FG001|Overall Study|Investigator Request|1|||
17084617|NCT00527111|38225183|FG000|Overall Study|Patient Request|2|||
17084618|NCT00527111|38225184|FG001|Overall Study|Patient Request|5|||
17084619|NCT00527111|38225183|FG000|Overall Study|Other|2|||
17084620|NCT00527111|38225184|FG001|Overall Study|Other|2|||
17084621|NCT00336024|38225192|FG000|Overall Study|Death|2|||
17084622|NCT00336024|38225193|FG001|Overall Study|Death|1|||
17084623|NCT00336024|38225192|FG000|Overall Study|Physician Decision|4|||
17084624|NCT00336024|38225193|FG001|Overall Study|Physician Decision|1|||
17084625|NCT00336024|38225192|FG000|Overall Study|Protocol Violation|1|||
17084626|NCT00336024|38225193|FG001|Overall Study|Protocol Violation|0|||
17084627|NCT00336024|38225192|FG000|Overall Study|Withdrawal by Subject|1|||
17084628|NCT00336024|38225193|FG001|Overall Study|Withdrawal by Subject|2|||
17084629|NCT00336024|38225192|FG000|Overall Study|Failure to fulfill consolidation|1|||
17084630|NCT00336024|38225193|FG001|Overall Study|Failure to fulfill consolidation|1|||
17084631|NCT00336024|38225192|FG000|Overall Study|Progressive Disease|4|||
17084632|NCT00336024|38225193|FG001|Overall Study|Progressive Disease|7|||
17084633|NCT00336024|38225192|FG000|Overall Study|Ineligible|7|||
17084634|NCT00336024|38225193|FG001|Overall Study|Ineligible|7|||
17084635|NCT00384956|38225199|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
17084636|NCT00367640|38225207|FG000|Overall Study|Adverse Event|3|||
17084637|NCT00367640|38225208|FG001|Overall Study|Adverse Event|6|||
17084638|NCT00367640|38225209|FG002|Overall Study|Adverse Event|8|||
17084639|NCT00367640|38225210|FG003|Overall Study|Adverse Event|0|||
17084640|NCT00367640|38225207|FG000|Overall Study|Withdrawal by Subject|8|||
17084641|NCT00367640|38225208|FG001|Overall Study|Withdrawal by Subject|11|||
17084642|NCT00367640|38225209|FG002|Overall Study|Withdrawal by Subject|8|||
17084643|NCT00367640|38225210|FG003|Overall Study|Withdrawal by Subject|6|||
17084644|NCT00367640|38225207|FG000|Overall Study|Any other reason not above-mentioned|7|||
17084645|NCT00367640|38225208|FG001|Overall Study|Any other reason not above-mentioned|5|||
17084646|NCT00367640|38225209|FG002|Overall Study|Any other reason not above-mentioned|3|||
17084647|NCT00367640|38225210|FG003|Overall Study|Any other reason not above-mentioned|4|||
17166573|NCT02960490|38315380|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
17166574|NCT02960490|38315381|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
17166575|NCT02960490|38315372|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
17166576|NCT02960490|38315373|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
17166577|NCT02960490|38315374|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
17166578|NCT02960490|38315375|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
17166579|NCT02960490|38315376|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
17166580|NCT02960490|38315377|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
17166581|NCT02960490|38315378|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
17166582|NCT02960490|38315379|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
17166583|NCT02960490|38315380|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
17166584|NCT02960490|38315381|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
17166585|NCT02960490|38315372|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166586|NCT02960490|38315373|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166587|NCT02960490|38315374|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166588|NCT02960490|38315375|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166589|NCT02960490|38315376|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166590|NCT02960490|38315377|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166591|NCT02960490|38315378|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166592|NCT02960490|38315379|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
17166593|NCT02960490|38315380|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166594|NCT02960490|38315381|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
17166595|NCT02960490|38315372|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
17166596|NCT02960490|38315373|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
17166597|NCT02960490|38315374|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
17166598|NCT02960490|38315375|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
17166599|NCT02960490|38315376|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
17166600|NCT02960490|38315377|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
17166601|NCT02960490|38315378|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
17166602|NCT02960490|38315379|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
17166603|NCT02960490|38315380|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
17166604|NCT02960490|38315381|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
17166605|NCT02960490|38315372|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166606|NCT02960490|38315373|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166607|NCT02960490|38315374|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166608|NCT02960490|38315375|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166609|NCT02960490|38315376|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166610|NCT02960490|38315377|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166611|NCT02960490|38315378|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
17166612|NCT02960490|38315379|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166613|NCT02960490|38315380|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166614|NCT02960490|38315381|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
17166615|NCT02960490|38315372|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166616|NCT02960490|38315373|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166617|NCT02960490|38315374|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166618|NCT02960490|38315375|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166619|NCT02960490|38315376|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166620|NCT02960490|38315377|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166621|NCT02960490|38315378|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166622|NCT02960490|38315379|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
17166623|NCT02960490|38315380|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166624|NCT02960490|38315381|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
17166625|NCT02804750|38315405|FG000|Period 1|Adverse Event|0|||
17166626|NCT02804750|38315406|FG001|Period 1|Adverse Event|2|||
17166627|NCT02804750|38315405|FG000|Period 1|Withdrawal by Subject|0|||
17166628|NCT02804750|38315406|FG001|Period 1|Withdrawal by Subject|1|||
17166629|NCT02804750|38315405|FG000|Period 2|Adverse Event|1|||
17166630|NCT02804750|38315406|FG001|Period 2|Adverse Event|0|||
17166631|NCT02804750|38315405|FG000|Period 3|Adverse Event|0|||
17166632|NCT02804750|38315406|FG001|Period 3|Adverse Event|2|||
17166633|NCT02804750|38315405|FG000|Period 4|Adverse Event|0|||
17166634|NCT02804750|38315406|FG001|Period 4|Adverse Event|5|||
17166635|NCT02959866|38315414|FG000|Overall Study|Withdrawal by Subject|1|||
17166636|NCT02748512|38315421|FG000|Overall Study|Lost to Follow-up|1|||
16996342|NCT00762034|38140329|FG000|Induction Period|Deaths Due to Study Disease|9|||
17166637|NCT02748512|38315422|FG001|Overall Study|Lost to Follow-up|1|||
17166638|NCT02748356|38315428|FG000|Overall Study|Withdrawal by Subject|1|||
17166639|NCT03439657|38315434|FG000|Overall Study|Adverse Event|2|||
17166640|NCT03439657|38315435|FG001|Overall Study|Adverse Event|3|||
17166641|NCT03439657|38315434|FG000|Overall Study|Lost to Follow-up|1|||
17166642|NCT03439657|38315435|FG001|Overall Study|Lost to Follow-up|0|||
17166643|NCT03439657|38315434|FG000|Overall Study|Protocol Violation|1|||
17166644|NCT03439657|38315435|FG001|Overall Study|Protocol Violation|1|||
17084648|NCT00367484|38225220|FG000|Overall Study|Adverse Event|7|||
17084649|NCT00367484|38225220|FG000|Overall Study|Withdrew informed consent|5|||
17084650|NCT00367484|38225220|FG000|Overall Study|Travel to USA|1|||
17084651|NCT00367484|38225220|FG000|Overall Study|Lost to Follow-up|1|||
17084652|NCT00367484|38225220|FG000|Overall Study|Protocol Violation|1|||
17084653|NCT00367484|38225220|FG000|Overall Study|The choice of the patient|1|||
17084654|NCT00367484|38225220|FG000|Overall Study|Lack of Efficacy|1|||
17084655|NCT00526799|38225226|FG000|Overall Study|Withdrawal by Subject|1|||
17084656|NCT00526799|38225227|FG001|Overall Study|Withdrawal by Subject|0|||
17084657|NCT00526799|38225226|FG000|Overall Study|Intercurrent Complicating Disease|0|||
17084658|NCT00526799|38225227|FG001|Overall Study|Intercurrent Complicating Disease|1|||
17084659|NCT00526331|38225233|FG000|Overall Study|Sponsor Termination|55|||
17084660|NCT00520481|38225239|FG000|Overall Study|Adverse Event|4|||
17084661|NCT00520481|38225240|FG001|Overall Study|Adverse Event|1|||
17166645|NCT03439657|38315434|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
17166646|NCT03439657|38315435|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
17166647|NCT02803580|38315443|FG000|Overall Study|Death|13|||
17166648|NCT02803580|38315443|FG000|Overall Study|Lost to Follow-up|19|||
17166649|NCT02803580|38315443|FG000|Overall Study|Withdrawal by Subject|3|||
17166650|NCT02803580|38315443|FG000|Overall Study|Inclusion in clinical trial|1|||
17166651|NCT02878213|38315447|FG000|Overall Study|Withdrawal by Subject|2|||
17166652|NCT02878213|38315447|FG000|Overall Study|Adverse Event|1|||
17166653|NCT02802878|38315454|FG000|Overall Study|Withdrawal by Subject|3|||
17166654|NCT02802878|38315455|FG001|Overall Study|Withdrawal by Subject|3|||
17166655|NCT02802878|38315454|FG000|Overall Study|Protocol Violation|1|||
17166656|NCT02802878|38315455|FG001|Overall Study|Protocol Violation|0|||
17166657|NCT02801396|38315461|FG000|Period 1|Withdrawal by Subject|0|||
17166658|NCT02801396|38315462|FG001|Period 1|Withdrawal by Subject|0|||
17166659|NCT02801396|38315463|FG002|Period 1|Withdrawal by Subject|0|||
17166660|NCT02801396|38315464|FG003|Period 1|Withdrawal by Subject|0|||
17166661|NCT02801396|38315465|FG004|Period 1|Withdrawal by Subject|1|||
17166662|NCT02801396|38315466|FG005|Period 1|Withdrawal by Subject|0|||
17166663|NCT02800928|38315474|FG000|Overall Study|Withdrawal by Subject|1|||
17166664|NCT02800928|38315475|FG001|Overall Study|Withdrawal by Subject|1|||
17166665|NCT02800928|38315474|FG000|Overall Study|Protocol Violation|1|||
17166666|NCT02800928|38315475|FG001|Overall Study|Protocol Violation|1|||
17166667|NCT03148691|38315484|FG000|Overall Study|Protocol Violation|1|||
17166668|NCT03148691|38315485|FG001|Overall Study|Protocol Violation|2|||
17166669|NCT03148691|38315486|FG002|Overall Study|Protocol Violation|7|||
17166670|NCT03148691|38315484|FG000|Overall Study|Lost to Follow-up|0|||
17166671|NCT03148691|38315485|FG001|Overall Study|Lost to Follow-up|0|||
17166672|NCT03148691|38315486|FG002|Overall Study|Lost to Follow-up|1|||
17166673|NCT03148691|38315484|FG000|Overall Study|Other|1|||
17166674|NCT03148691|38315485|FG001|Overall Study|Other|0|||
17166675|NCT03148691|38315486|FG002|Overall Study|Other|0|||
17166676|NCT03148691|38315484|FG000|Overall Study|Withdrawal by Subject|1|||
17166677|NCT03148691|38315485|FG001|Overall Study|Withdrawal by Subject|0|||
17166678|NCT03148691|38315486|FG002|Overall Study|Withdrawal by Subject|0|||
17166679|NCT03148067|38315494|FG000|Overall Study|Lost to Follow-up|3|||
17166680|NCT03148067|38315494|FG000|Overall Study|Death|1|||
17166681|NCT03146741|38315508|FG000|Overall Study|Txp with non-HCV+ heart|4|||
17166682|NCT03146741|38315508|FG000|Overall Study|Listeted for MOT|2|||
17166683|NCT03146741|38315508|FG000|Overall Study|Physician Decision|2|||
17166684|NCT03146741|38315508|FG000|Overall Study|Awaiting txp|2|||
17166685|NCT03150719|38315514|FG000|Overall Study|Adverse Event|0|||
17166686|NCT03150719|38315515|FG001|Overall Study|Adverse Event|1|||
17166687|NCT03150719|38315514|FG000|Overall Study|Death|0|||
17166688|NCT03150719|38315515|FG001|Overall Study|Death|1|||
17166689|NCT03150719|38315514|FG000|Overall Study|Other|1|||
17166690|NCT03150719|38315515|FG001|Overall Study|Other|0|||
17166691|NCT04039217|38315521|FG000|Overall Study|Lost to Follow-up|1|||
17166692|NCT00982111|38315531|FG000|Overall Study|Adverse Event|1|||
17166693|NCT00982111|38315532|FG001|Overall Study|Adverse Event|1|||
16996343|NCT00762034|38140330|FG001|Induction Period|Deaths Due to Study Disease|9|||
17084662|NCT00520481|38225239|FG000|Overall Study|Withdrawal by Subject|3|||
17166694|NCT00982111|38315531|FG000|Overall Study|Progressive Disease|46|||
17166695|NCT00982111|38315532|FG001|Overall Study|Progressive Disease|39|||
17166696|NCT00982111|38315531|FG000|Overall Study|Lost to Follow-up|9|||
17166697|NCT00982111|38315532|FG001|Overall Study|Lost to Follow-up|6|||
17166698|NCT00982111|38315531|FG000|Overall Study|New Anti-Cancer Therapy|5|||
17166699|NCT00982111|38315532|FG001|Overall Study|New Anti-Cancer Therapy|5|||
17166700|NCT00982111|38315531|FG000|Overall Study|Medical Decision|1|||
17166701|NCT00982111|38315532|FG001|Overall Study|Medical Decision|0|||
17166702|NCT00982111|38315531|FG000|Overall Study|Withdrawal by Subject|17|||
17166703|NCT00982111|38315532|FG001|Overall Study|Withdrawal by Subject|19|||
17166704|NCT00982111|38315531|FG000|Overall Study|Global Study End|0|||
17166705|NCT00982111|38315532|FG001|Overall Study|Global Study End|1|||
17166706|NCT00982111|38315531|FG000|Overall Study|Sponsor's Decision|0|||
17166707|NCT00982111|38315532|FG001|Overall Study|Sponsor's Decision|1|||
17166708|NCT02957682|38315541|FG000|Overall Study|Adverse Event|64|||
17166709|NCT02957682|38315542|FG001|Overall Study|Adverse Event|67|||
17166710|NCT02957682|38315541|FG000|Overall Study|Poor Compliance to Protocol|30|||
17166711|NCT02957682|38315542|FG001|Overall Study|Poor Compliance to Protocol|26|||
17166712|NCT02957682|38315541|FG000|Overall Study|Physician Decision|4|||
17166713|NCT02957682|38315542|FG001|Overall Study|Physician Decision|4|||
17166714|NCT02957682|38315541|FG000|Overall Study|Study Terminated by Sponsor|4|||
17166715|NCT02957682|38315542|FG001|Overall Study|Study Terminated by Sponsor|3|||
17166716|NCT02957682|38315541|FG000|Overall Study|Subject Moved|10|||
17166717|NCT02957682|38315542|FG001|Overall Study|Subject Moved|16|||
17166718|NCT02957682|38315541|FG000|Overall Study|Withdrawal by Subject|64|||
17166719|NCT02957682|38315542|FG001|Overall Study|Withdrawal by Subject|33|||
17166720|NCT02957682|38315541|FG000|Overall Study|Related to IMP Administration|3|||
17166721|NCT02957682|38315542|FG001|Overall Study|Related to IMP Administration|6|||
17166722|NCT02957682|38315541|FG000|Overall Study|Non-disclosed|16|||
17166723|NCT02957682|38315542|FG001|Overall Study|Non-disclosed|12|||
17166724|NCT02957682|38315541|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
17166725|NCT02957682|38315542|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
17166726|NCT03057951|38315550|FG000|Overall Study|Adverse Event|553|||
17166727|NCT03057951|38315551|FG001|Overall Study|Adverse Event|575|||
17166728|NCT03057951|38315550|FG000|Overall Study|Protocol Violation|30|||
17166729|NCT03057951|38315551|FG001|Overall Study|Protocol Violation|24|||
17166730|NCT03057951|38315550|FG000|Overall Study|Lost to Follow-up|6|||
17166731|NCT03057951|38315551|FG001|Overall Study|Lost to Follow-up|16|||
17166732|NCT03057951|38315550|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
17166733|NCT03057951|38315551|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
17166734|NCT03057951|38315550|FG000|Overall Study|Study drug stopped, reason missing|6|||
17166735|NCT03057951|38315551|FG001|Overall Study|Study drug stopped, reason missing|1|||
17166736|NCT03057951|38315550|FG000|Overall Study|Medical advice|6|||
17166737|NCT03057951|38315551|FG001|Overall Study|Medical advice|2|||
17166738|NCT03057951|38315550|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
17166739|NCT03057951|38315551|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
17166740|NCT03057951|38315550|FG000|Overall Study|Investigator decision|2|||
17166741|NCT03057951|38315551|FG001|Overall Study|Investigator decision|0|||
17166742|NCT03057951|38315550|FG000|Overall Study|Patient decision|5|||
17166743|NCT03057951|38315551|FG001|Overall Study|Patient decision|2|||
17166744|NCT03057951|38315550|FG000|Overall Study|Not attending study visits|3|||
17166745|NCT03057951|38315551|FG001|Overall Study|Not attending study visits|0|||
17166746|NCT03057951|38315550|FG000|Overall Study|Patient moved away|3|||
17166747|NCT03057951|38315551|FG001|Overall Study|Patient moved away|4|||
17166748|NCT03057951|38315550|FG000|Overall Study|Other reason than stated above|23|||
17166749|NCT03057951|38315551|FG001|Overall Study|Other reason than stated above|29|||
17166750|NCT03057951|38315550|FG000|Overall Study|Not treated|2|||
17166751|NCT03057951|38315551|FG001|Overall Study|Not treated|1|||
17166752|NCT03146663|38315559|FG000|Overall Study|Did not receive study treatment|1|||
17166753|NCT03146663|38315560|FG001|Overall Study|Did not receive study treatment|1|||
17166754|NCT02956278|38315570|FG000|Overall Study|Withdrawal by Subject|6|||
17166755|NCT02956278|38315571|FG001|Overall Study|Withdrawal by Subject|2|||
17166756|NCT02956278|38315572|FG002|Overall Study|Withdrawal by Subject|0|||
17166757|NCT02957136|38315582|FG000|Overall Study|Withdrawal by Subject|2|||
17166758|NCT02957136|38315583|FG001|Overall Study|Withdrawal by Subject|1|||
17166759|NCT03150485|38315589|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
17166760|NCT03150485|38315590|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
17166761|NCT03150485|38315591|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
17166762|NCT03150485|38315592|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
17166763|NCT03150485|38315593|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
16996344|NCT00762034|38140329|FG000|Maintenance Period|Protocol Violation|1|||
17166764|NCT03150485|38315594|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
17166765|NCT03134911|38315601|FG000|Overall Study|Screen failure|31|||
17166766|NCT03134911|38315601|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
17166767|NCT03488472|38315609|FG000|Overall Study|disease progression additional mets|1|||
17166768|NCT03134599|38315624|FG000|Week 1|Lost to Follow-up|0|||
17166769|NCT03134599|38315625|FG001|Week 1|Lost to Follow-up|0|||
17166770|NCT03134599|38315626|FG002|Week 1|Lost to Follow-up|0|||
17166771|NCT03134599|38315627|FG003|Week 1|Lost to Follow-up|0|||
17166772|NCT03134599|38315628|FG004|Week 1|Lost to Follow-up|1|||
17166773|NCT03134599|38315629|FG005|Week 1|Lost to Follow-up|0|||
17166774|NCT03134599|38315624|FG000|Week 2|Lost to Follow-up|1|||
17166775|NCT03134599|38315625|FG001|Week 2|Lost to Follow-up|0|||
17166776|NCT03134599|38315626|FG002|Week 2|Lost to Follow-up|0|||
17166777|NCT03134599|38315627|FG003|Week 2|Lost to Follow-up|1|||
17166778|NCT03134599|38315628|FG004|Week 2|Lost to Follow-up|1|||
17166779|NCT03134599|38315629|FG005|Week 2|Lost to Follow-up|0|||
17166780|NCT03134599|38315624|FG000|Week 3|Lost to Follow-up|0|||
17166781|NCT03134599|38315625|FG001|Week 3|Lost to Follow-up|0|||
17166782|NCT03134599|38315626|FG002|Week 3|Lost to Follow-up|0|||
17166783|NCT03134599|38315627|FG003|Week 3|Lost to Follow-up|1|||
17166784|NCT03134599|38315628|FG004|Week 3|Lost to Follow-up|0|||
17166785|NCT03134599|38315629|FG005|Week 3|Lost to Follow-up|1|||
17166786|NCT03153137|38315639|FG000|Overall Study|Lost to Follow-up|1|||
17166787|NCT03153137|38315640|FG001|Overall Study|Lost to Follow-up|0|||
17166788|NCT03153137|38315639|FG000|Overall Study|Withdrawal by Subject|2|||
17166789|NCT03153137|38315640|FG001|Overall Study|Withdrawal by Subject|1|||
17166790|NCT03153137|38315639|FG000|Overall Study|Physician Decision|0|||
17166791|NCT03153137|38315640|FG001|Overall Study|Physician Decision|3|||
17166792|NCT03136861|38315653|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
17166793|NCT03136861|38315654|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
17166794|NCT03136861|38315655|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
17166795|NCT03136861|38315656|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
17166796|NCT03136861|38315657|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
17166797|NCT03136861|38315658|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
17166798|NCT03136861|38315659|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
17166799|NCT03136861|38315653|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
17166800|NCT03136861|38315654|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
17166801|NCT03136861|38315655|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
17166802|NCT03136861|38315656|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
17166803|NCT03136861|38315657|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
17166804|NCT03136861|38315658|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
17166805|NCT03136861|38315659|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
17166806|NCT03136861|38315653|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
17084663|NCT00520481|38225240|FG001|Overall Study|Withdrawal by Subject|0|||
17084664|NCT00520403|38225248|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
17084665|NCT00520403|38225248|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
17084666|NCT00520403|38225248|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
17084667|NCT00520403|38225248|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
17084668|NCT00520403|38225248|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
17084669|NCT00520403|38225248|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
17084670|NCT00520403|38225248|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
17166807|NCT03136861|38315654|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
17166808|NCT03136861|38315655|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
17166809|NCT03136861|38315656|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
17166810|NCT03136861|38315657|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
17166811|NCT03136861|38315658|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
17166812|NCT03136861|38315659|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
17166813|NCT03136861|38315653|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
17166814|NCT03136861|38315654|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
17166815|NCT03136861|38315655|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
17166816|NCT03136861|38315656|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
17166817|NCT03136861|38315657|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
17084671|NCT00520403|38225248|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
17084672|NCT00520013|38225255|FG000|Overall Study|Withdrawal by Subject|0|||
17084673|NCT00520013|38225256|FG001|Overall Study|Withdrawal by Subject|0|||
17166818|NCT03136861|38315658|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
17166819|NCT03136861|38315659|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
17166820|NCT03136861|38315653|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
17166821|NCT03136861|38315654|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
17166822|NCT03136861|38315655|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
17166823|NCT03136861|38315656|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
17166824|NCT03136861|38315657|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
17166825|NCT03136861|38315658|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
17166826|NCT03136861|38315659|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
17166827|NCT03136861|38315653|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
17166828|NCT03136861|38315654|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
17166829|NCT03136861|38315655|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
17166830|NCT03136861|38315656|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
17166831|NCT03136861|38315657|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
17166832|NCT03136861|38315658|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
17166833|NCT03136861|38315659|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
17166834|NCT03136861|38315653|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
17166835|NCT03136861|38315654|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
17166836|NCT03136861|38315655|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
17166837|NCT03136861|38315656|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
17166838|NCT03136861|38315657|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
17166839|NCT03136861|38315658|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
17166840|NCT03136861|38315659|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
17166841|NCT03136861|38315653|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
17166842|NCT03136861|38315654|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
17166843|NCT03136861|38315655|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
17166844|NCT03136861|38315656|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
17166845|NCT03136861|38315657|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
17166846|NCT03136861|38315658|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
17166847|NCT03136861|38315659|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
17166848|NCT03316950|38315687|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
17166849|NCT03316950|38315688|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
17166850|NCT03316950|38315689|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
17166851|NCT03316950|38315690|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
17166852|NCT03316950|38315687|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
17166853|NCT03316950|38315688|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
17166854|NCT03316950|38315689|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
17166855|NCT03316950|38315690|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
17166856|NCT03316950|38315687|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
17166857|NCT03316950|38315688|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
17166858|NCT03316950|38315689|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
17166859|NCT03316950|38315690|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
17166860|NCT03139279|38315704|FG000|Overall Study|Physician Decision|2|||
17166861|NCT03139279|38315705|FG001|Overall Study|Physician Decision|0|||
17166862|NCT03139279|38315704|FG000|Overall Study|Protocol Violation|5|||
17084674|NCT00520013|38225257|FG002|Overall Study|Withdrawal by Subject|1|||
17084675|NCT00520013|38225255|FG000|Overall Study|Adverse Event|2|||
17084676|NCT00520013|38225256|FG001|Overall Study|Adverse Event|10|||
17084677|NCT00520013|38225257|FG002|Overall Study|Adverse Event|7|||
17084678|NCT00520013|38225255|FG000|Overall Study|Progressive Disease|7|||
17084679|NCT00520013|38225256|FG001|Overall Study|Progressive Disease|3|||
17084680|NCT00520013|38225257|FG002|Overall Study|Progressive Disease|0|||
17084681|NCT00520013|38225255|FG000|Overall Study|Clinical Progression|3|||
17166863|NCT03139279|38315705|FG001|Overall Study|Protocol Violation|4|||
17166864|NCT03139279|38315704|FG000|Overall Study|Withdrawal by Subject|0|||
17166865|NCT03139279|38315705|FG001|Overall Study|Withdrawal by Subject|2|||
17166866|NCT01370642|38315714|FG000|Overall Study|Adverse Event|2|||
17166867|NCT01370642|38315715|FG001|Overall Study|Adverse Event|1|||
17166868|NCT01370642|38315716|FG002|Overall Study|Adverse Event|1|||
17166869|NCT01370642|38315714|FG000|Overall Study|Detectable HCV RNA|0|||
17166870|NCT01370642|38315715|FG001|Overall Study|Detectable HCV RNA|0|||
17166871|NCT01370642|38315716|FG002|Overall Study|Detectable HCV RNA|22|||
17166872|NCT01370642|38315714|FG000|Overall Study|Lost to Follow-up|0|||
17166873|NCT01370642|38315715|FG001|Overall Study|Lost to Follow-up|0|||
17166874|NCT01370642|38315716|FG002|Overall Study|Lost to Follow-up|1|||
17166875|NCT01370642|38315714|FG000|Overall Study|Physician Decision|4|||
17166876|NCT01370642|38315715|FG001|Overall Study|Physician Decision|1|||
17166877|NCT01370642|38315716|FG002|Overall Study|Physician Decision|2|||
17166878|NCT01370642|38315714|FG000|Overall Study|Withdrawal by Subject|2|||
17166879|NCT01370642|38315715|FG001|Overall Study|Withdrawal by Subject|4|||
17166880|NCT01370642|38315716|FG002|Overall Study|Withdrawal by Subject|3|||
17084682|NCT00520013|38225256|FG001|Overall Study|Clinical Progression|1|||
17084683|NCT00520013|38225257|FG002|Overall Study|Clinical Progression|0|||
17084684|NCT00520013|38225255|FG000|Overall Study|Death|0|||
17166881|NCT02873208|38315724|FG000|Overall Study|Withdrawal by Subject|36|||
17166882|NCT02873208|38315724|FG000|Overall Study|Lost to Follow-up|22|||
17166883|NCT02873208|38315724|FG000|Overall Study|Adverse Event|15|||
17166884|NCT02873208|38315724|FG000|Overall Study|Non-compliance with study drug|12|||
17166885|NCT02873208|38315724|FG000|Overall Study|Protocol Violation|8|||
17166886|NCT02873208|38315724|FG000|Overall Study|Pregnancy|2|||
17166887|NCT02873208|38315724|FG000|Overall Study|Incarceration|1|||
17166888|NCT02873208|38315724|FG000|Overall Study|Lack of Efficacy|1|||
17166889|NCT02873208|38315724|FG000|Overall Study|Physician Decision|1|||
17166890|NCT03138967|38315730|FG000|Overall Study|Death|0|||
17166891|NCT03138967|38315731|FG001|Overall Study|Death|1|||
17166892|NCT03138967|38315730|FG000|Overall Study|Physician Decision|1|||
17166893|NCT03138967|38315731|FG001|Overall Study|Physician Decision|3|||
17166894|NCT01547117|38315741|FG000|Overall Study|Physician Decision|0|||
17166895|NCT01547117|38315742|FG001|Overall Study|Physician Decision|1|||
17166896|NCT01547117|38315743|FG002|Overall Study|Physician Decision|1|||
17166897|NCT01547117|38315744|FG003|Overall Study|Physician Decision|3|||
17166898|NCT01547117|38315741|FG000|Overall Study|Withdrawal by Subject|1|||
17166899|NCT01547117|38315742|FG001|Overall Study|Withdrawal by Subject|2|||
17166900|NCT01547117|38315743|FG002|Overall Study|Withdrawal by Subject|1|||
17166901|NCT01547117|38315744|FG003|Overall Study|Withdrawal by Subject|2|||
17166902|NCT03136159|38315772|FG000|Overall Study|chorioamnionitis|2|||
17166903|NCT03136159|38315773|FG001|Overall Study|chorioamnionitis|0|||
17166904|NCT03136159|38315772|FG000|Overall Study|vertical skin incision|1|||
16996345|NCT00762034|38140330|FG001|Maintenance Period|Protocol Violation|3|||
16996346|NCT00762034|38140329|FG000|Maintenance Period|Entry Criterion Not Met|0|||
16996347|NCT00762034|38140330|FG001|Maintenance Period|Entry Criterion Not Met|2|||
16996348|NCT00762034|38140329|FG000|Maintenance Period|Adverse Event|42|||
16996349|NCT00762034|38140330|FG001|Maintenance Period|Adverse Event|26|||
16996350|NCT00762034|38140329|FG000|Maintenance Period|Progressive Disease|186|||
16996351|NCT00762034|38140330|FG001|Maintenance Period|Progressive Disease|224|||
16996352|NCT00762034|38140329|FG000|Maintenance Period|Physician Decision|25|||
16996353|NCT00762034|38140330|FG001|Maintenance Period|Physician Decision|20|||
16996354|NCT00762034|38140329|FG000|Maintenance Period|Withdrawal by Subject|34|||
16996355|NCT00762034|38140330|FG001|Maintenance Period|Withdrawal by Subject|14|||
16996356|NCT00762034|38140329|FG000|Maintenance Period|Death not due to study disease|2|||
16996357|NCT00762034|38140330|FG001|Maintenance Period|Death not due to study disease|5|||
16996358|NCT00762034|38140329|FG000|Maintenance Period|Death due to study disease|3|||
16996359|NCT00762034|38140330|FG001|Maintenance Period|Death due to study disease|3|||
16996360|NCT00762034|38140329|FG000|Maintenance Period|Other|1|||
16996361|NCT00762034|38140330|FG001|Maintenance Period|Other|1|||
16996362|NCT00761956|38140362|FG000|Overall Study|Lost to Follow-up|6|||
16996363|NCT00761956|38140363|FG001|Overall Study|Lost to Follow-up|11|||
16996364|NCT00761956|38140362|FG000|Overall Study|Withdrawal by Subject|3|||
16996365|NCT00761956|38140363|FG001|Overall Study|Withdrawal by Subject|8|||
16996366|NCT00761956|38140362|FG000|Overall Study|Death|0|||
16996367|NCT00761956|38140363|FG001|Overall Study|Death|1|||
16996368|NCT00761956|38140362|FG000|Overall Study|Adverse Event|26|||
16996369|NCT00761956|38140363|FG001|Overall Study|Adverse Event|34|||
16996370|NCT00754624|38140369|FG000|Overall Study|Adverse Event|16|||
16996371|NCT00754624|38140369|FG000|Overall Study|Death|1|||
16996372|NCT00754624|38140369|FG000|Overall Study|Physician Decision|8|||
16996373|NCT00754624|38140369|FG000|Overall Study|Protocol Violation|1|||
16996374|NCT00754624|38140369|FG000|Overall Study|Withdrawal by Subject|28|||
16996375|NCT00754624|38140369|FG000|Overall Study|Various|12|||
16996376|NCT00754624|38140369|FG000|Overall Study|Lost to Follow-up|3|||
16996377|NCT00586846|38140382|FG000|Overall Study|Physician Decision|1|||
16996378|NCT00586846|38140382|FG000|Overall Study|Death|1|||
16996379|NCT00586846|38140382|FG000|Overall Study|Evaluable for Toxicity Only|4|||
16996380|NCT00973700|38140391|FG000|Overall Study|Withdrawal by Subject|2|||
16996381|NCT00973700|38140392|FG001|Overall Study|Withdrawal by Subject|2|||
16996382|NCT00973700|38140393|FG002|Overall Study|Withdrawal by Subject|8|||
16996383|NCT00973700|38140394|FG003|Overall Study|Withdrawal by Subject|4|||
16996384|NCT00973700|38140395|FG004|Overall Study|Withdrawal by Subject|4|||
16996385|NCT00973700|38140391|FG000|Overall Study|Lost to Follow-up|5|||
16996386|NCT00973700|38140392|FG001|Overall Study|Lost to Follow-up|0|||
16996387|NCT00973700|38140393|FG002|Overall Study|Lost to Follow-up|1|||
16996388|NCT00973700|38140394|FG003|Overall Study|Lost to Follow-up|8|||
16996389|NCT00973700|38140395|FG004|Overall Study|Lost to Follow-up|5|||
16996390|NCT00973700|38140391|FG000|Overall Study|Inappropriate enrolment|0|||
16996391|NCT00973700|38140392|FG001|Overall Study|Inappropriate enrolment|0|||
16996392|NCT00973700|38140393|FG002|Overall Study|Inappropriate enrolment|0|||
16996393|NCT00973700|38140394|FG003|Overall Study|Inappropriate enrolment|4|||
16996394|NCT00973700|38140395|FG004|Overall Study|Inappropriate enrolment|0|||
16996395|NCT00973700|38140391|FG000|Overall Study|Unable to Classify|0|||
16996396|NCT00973700|38140392|FG001|Overall Study|Unable to Classify|0|||
16996397|NCT00973700|38140393|FG002|Overall Study|Unable to Classify|1|||
16996398|NCT00973700|38140394|FG003|Overall Study|Unable to Classify|2|||
16996399|NCT00973700|38140395|FG004|Overall Study|Unable to Classify|1|||
16996400|NCT00754390|38140422|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
16996401|NCT00754390|38140422|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
16996402|NCT00754390|38140422|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
16996403|NCT00754390|38140422|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
16996404|NCT00754234|38140429|FG000|Overall Study|Withdrawal by Subject|3|||
16996405|NCT00753922|38140437|FG000|Overall Study|Lost to Follow-up|155|||
16996406|NCT00753922|38140438|FG001|Overall Study|Lost to Follow-up|24|||
16996407|NCT00753922|38140439|FG002|Overall Study|Lost to Follow-up|28|||
16996408|NCT00753922|38140440|FG003|Overall Study|Lost to Follow-up|5|||
16996409|NCT00753922|38140437|FG000|Overall Study|Withdrawal by Subject|9|||
16996410|NCT00753922|38140438|FG001|Overall Study|Withdrawal by Subject|11|||
16996411|NCT00753922|38140439|FG002|Overall Study|Withdrawal by Subject|4|||
16996412|NCT00753922|38140440|FG003|Overall Study|Withdrawal by Subject|2|||
16996413|NCT00753922|38140437|FG000|Overall Study|Patient Non-compliance|55|||
16996414|NCT00753922|38140438|FG001|Overall Study|Patient Non-compliance|22|||
17166905|NCT03136159|38315773|FG001|Overall Study|vertical skin incision|0|||
17166906|NCT03136159|38315772|FG000|Overall Study|additional dressing|1|||
17166907|NCT03136159|38315773|FG001|Overall Study|additional dressing|0|||
17166908|NCT03136159|38315772|FG000|Overall Study|never got dressing placed|1|||
17166909|NCT03136159|38315773|FG001|Overall Study|never got dressing placed|0|||
17166910|NCT01986933|38315784|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
17166911|NCT01986933|38315785|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
17166912|NCT01986933|38315786|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
17166913|NCT01986933|38315787|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
17166914|NCT01986933|38315788|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
17166915|NCT01986933|38315784|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
17166916|NCT01986933|38315785|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
17166917|NCT01986933|38315786|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
17166918|NCT01986933|38315787|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
17166919|NCT01986933|38315788|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
17166920|NCT01986933|38315784|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
17166921|NCT01986933|38315785|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
17166922|NCT01986933|38315786|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
17166923|NCT01986933|38315787|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
17166924|NCT01986933|38315788|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
17166925|NCT01986933|38315784|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
17166926|NCT01986933|38315785|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
17166927|NCT01986933|38315786|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
17166928|NCT01986933|38315787|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
17166929|NCT01986933|38315788|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
17166930|NCT01986933|38315784|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
17166931|NCT01986933|38315785|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
17166932|NCT01986933|38315786|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
17166933|NCT01986933|38315787|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
17166934|NCT01986933|38315788|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
17166935|NCT01986933|38315784|FG000|Active-to-active (Part B)|Adverse Event|0|||
17166936|NCT01986933|38315785|FG001|Active-to-active (Part B)|Adverse Event|2|||
17166937|NCT01986933|38315786|FG002|Active-to-active (Part B)|Adverse Event|0|||
17166938|NCT01986933|38315787|FG003|Active-to-active (Part B)|Adverse Event|1|||
17084685|NCT00520013|38225256|FG001|Overall Study|Death|1|||
17084686|NCT00520013|38225257|FG002|Overall Study|Death|0|||
17166939|NCT01986933|38315788|FG004|Active-to-active (Part B)|Adverse Event|3|||
17166940|NCT01986933|38315784|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
17166941|NCT01986933|38315785|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
17166942|NCT01986933|38315786|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
17166943|NCT01986933|38315787|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
17166944|NCT01986933|38315788|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
17166945|NCT01986933|38315784|FG000|Active-to-active (Part B)|Pregnancy|0|||
17166946|NCT01986933|38315785|FG001|Active-to-active (Part B)|Pregnancy|0|||
17166947|NCT01986933|38315786|FG002|Active-to-active (Part B)|Pregnancy|0|||
17166948|NCT01986933|38315787|FG003|Active-to-active (Part B)|Pregnancy|0|||
17166949|NCT01986933|38315788|FG004|Active-to-active (Part B)|Pregnancy|1|||
17166950|NCT01986933|38315784|FG000|Active-to-active (Part B)|Physician Decision|0|||
17166951|NCT01986933|38315785|FG001|Active-to-active (Part B)|Physician Decision|0|||
17166952|NCT01986933|38315786|FG002|Active-to-active (Part B)|Physician Decision|1|||
17166953|NCT01986933|38315787|FG003|Active-to-active (Part B)|Physician Decision|1|||
17166954|NCT01986933|38315788|FG004|Active-to-active (Part B)|Physician Decision|0|||
17166955|NCT01986933|38315784|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
17166956|NCT01986933|38315785|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
17166957|NCT01986933|38315786|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
17166958|NCT01986933|38315787|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
17166959|NCT01986933|38315788|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
17166960|NCT01986933|38315784|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
17166961|NCT01986933|38315785|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
17166962|NCT01986933|38315786|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
17166963|NCT01986933|38315787|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
17166964|NCT01986933|38315788|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
17166965|NCT01986933|38315784|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
17166966|NCT01986933|38315785|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
17084687|NCT00520013|38225255|FG000|Overall Study|Physician Decision|0|||
17084688|NCT00520013|38225256|FG001|Overall Study|Physician Decision|0|||
17084689|NCT00520013|38225257|FG002|Overall Study|Physician Decision|3|||
17084690|NCT00519779|38225265|FG000|Overall Study|Withdrawal by Subject|0|||
17084691|NCT00519779|38225266|FG001|Overall Study|Withdrawal by Subject|1|||
17084692|NCT00526097|38225274|FG000|Overall Study|Adverse Event|6|||
17084693|NCT00526097|38225275|FG001|Overall Study|Adverse Event|44|||
17084694|NCT00526097|38225274|FG000|Overall Study|Protocol Violation|4|||
17166967|NCT01986933|38315786|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
17166968|NCT01986933|38315787|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
17166969|NCT01986933|38315788|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
17166970|NCT01986933|38315784|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
17166971|NCT01986933|38315785|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
17166972|NCT01986933|38315786|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
17166973|NCT01986933|38315787|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
17166974|NCT01986933|38315788|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
17166975|NCT01986933|38315784|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
17166976|NCT01986933|38315785|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
17166977|NCT01986933|38315786|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
17166978|NCT01986933|38315787|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
17166979|NCT01986933|38315788|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
17166980|NCT01986933|38315784|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
17166981|NCT01986933|38315785|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
17166982|NCT01986933|38315786|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
17166983|NCT01986933|38315787|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
17166984|NCT01986933|38315788|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
17166985|NCT01986933|38315784|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
17166986|NCT01986933|38315785|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
17166987|NCT01986933|38315786|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
17166988|NCT01986933|38315787|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
17166989|NCT01986933|38315788|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
17166990|NCT01986933|38315784|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
17166991|NCT01986933|38315785|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
17166992|NCT01986933|38315786|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
17084695|NCT00526097|38225275|FG001|Overall Study|Protocol Violation|10|||
17084696|NCT00526097|38225274|FG000|Overall Study|Withdrawal by Subject|3|||
17166993|NCT01986933|38315787|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
17166994|NCT01986933|38315788|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
17166995|NCT00394355|38315832|FG000|Overall Study|Adverse Event|10|||
17166996|NCT00394355|38315833|FG001|Overall Study|Adverse Event|6|||
17166997|NCT00394355|38315834|FG002|Overall Study|Adverse Event|7|||
17166998|NCT00394355|38315835|FG003|Overall Study|Adverse Event|8|||
17166999|NCT00394355|38315832|FG000|Overall Study|Did not meet protocol eligibility|1|||
17167000|NCT00394355|38315833|FG001|Overall Study|Did not meet protocol eligibility|5|||
17167001|NCT00394355|38315834|FG002|Overall Study|Did not meet protocol eligibility|4|||
17167002|NCT00394355|38315835|FG003|Overall Study|Did not meet protocol eligibility|2|||
17167003|NCT00394355|38315832|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
17167004|NCT00394355|38315833|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
17167005|NCT00394355|38315834|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
17167006|NCT00394355|38315835|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
17167007|NCT00394355|38315832|FG000|Overall Study|Subject withdrawal - related to drug|1|||
17167008|NCT00394355|38315833|FG001|Overall Study|Subject withdrawal - related to drug|0|||
17167009|NCT00394355|38315834|FG002|Overall Study|Subject withdrawal - related to drug|0|||
17167010|NCT00394355|38315835|FG003|Overall Study|Subject withdrawal - related to drug|0|||
17167011|NCT00394355|38315832|FG000|Overall Study|Lost to Follow-up|7|||
17167012|NCT00394355|38315833|FG001|Overall Study|Lost to Follow-up|5|||
17167013|NCT00394355|38315834|FG002|Overall Study|Lost to Follow-up|4|||
17167014|NCT00394355|38315835|FG003|Overall Study|Lost to Follow-up|3|||
17167015|NCT00394355|38315832|FG000|Overall Study|Noncompliance with protocol|4|||
17167016|NCT00394355|38315833|FG001|Overall Study|Noncompliance with protocol|3|||
17167017|NCT00394355|38315834|FG002|Overall Study|Noncompliance with protocol|10|||
17167018|NCT00394355|38315835|FG003|Overall Study|Noncompliance with protocol|8|||
17167019|NCT00394355|38315832|FG000|Overall Study|Administrative|0|||
17167020|NCT00394355|38315833|FG001|Overall Study|Administrative|1|||
17167021|NCT00394355|38315834|FG002|Overall Study|Administrative|1|||
17167022|NCT00394355|38315835|FG003|Overall Study|Administrative|1|||
17167023|NCT00394355|38315832|FG000|Overall Study|Lack of Efficacy|0|||
17084697|NCT00526097|38225275|FG001|Overall Study|Withdrawal by Subject|1|||
17084698|NCT00526097|38225274|FG000|Overall Study|Other|2|||
17084699|NCT00526097|38225275|FG001|Overall Study|Other|1|||
17084700|NCT00525785|38225281|FG000|Overall Study|Withdrawal by Subject|1|||
17084701|NCT00525785|38225281|FG000|Overall Study|Lack of Efficacy|1|||
17084702|NCT00525785|38225281|FG000|Overall Study|Physician Decision|1|||
17084703|NCT00525161|38225285|FG000|Overall Study|Adverse Event|1|||
17084704|NCT00524771|38225291|FG000|Overall Study|Protocol Violation|220|||
17084705|NCT00524771|38225292|FG001|Overall Study|Protocol Violation|585|||
17084706|NCT00135694|38225302|FG000|Overall Study|Adverse Event|17|||
17167024|NCT00394355|38315833|FG001|Overall Study|Lack of Efficacy|0|||
17167025|NCT00394355|38315834|FG002|Overall Study|Lack of Efficacy|2|||
17084707|NCT00135694|38225303|FG001|Overall Study|Adverse Event|4|||
17084708|NCT00135694|38225304|FG002|Overall Study|Adverse Event|0|||
17167026|NCT00394355|38315835|FG003|Overall Study|Lack of Efficacy|3|||
17167027|NCT02797808|38315847|FG000|Overall Study|Withdrawal by Subject|1|||
17167028|NCT02797808|38315848|FG001|Overall Study|Withdrawal by Subject|1|||
17167029|NCT02797808|38315847|FG000|Overall Study|Physician Decision|6|||
17167030|NCT02797808|38315848|FG001|Overall Study|Physician Decision|2|||
17167031|NCT02796560|38315856|FG000|Overall Study|Adverse Event|2|||
17167032|NCT02796560|38315857|FG001|Overall Study|Adverse Event|0|||
17167033|NCT02796560|38315856|FG000|Overall Study|Withdrawal by Subject|2|||
17167034|NCT02796560|38315857|FG001|Overall Study|Withdrawal by Subject|2|||
17167035|NCT00344487|38315863|FG000|Overall Study|immunologic failure|1|||
17167036|NCT02871492|38315872|FG000|Overall Study|Lost to Follow-up|6|||
17167037|NCT02871492|38315873|FG001|Overall Study|Lost to Follow-up|3|||
17167038|NCT02871492|38315874|FG002|Overall Study|Lost to Follow-up|5|||
17167039|NCT02871492|38315872|FG000|Overall Study|Withdrawal by Subject|0|||
17167040|NCT02871492|38315873|FG001|Overall Study|Withdrawal by Subject|0|||
17167041|NCT02871492|38315874|FG002|Overall Study|Withdrawal by Subject|1|||
17167042|NCT03143855|38315884|FG000|Overall Study|Withdrawal by Subject|4|||
17167043|NCT03143855|38315885|FG001|Overall Study|Withdrawal by Subject|3|||
17167044|NCT03143855|38315884|FG000|Overall Study|Protocol Violation|1|||
17167045|NCT03143855|38315885|FG001|Overall Study|Protocol Violation|0|||
17167046|NCT03143855|38315884|FG000|Overall Study|Participant experienced withdrawal|0|||
17167047|NCT03143855|38315885|FG001|Overall Study|Participant experienced withdrawal|1|||
17167048|NCT02878603|38315893|FG000|Overall Study|Lost to Follow-up|4|||
17167049|NCT02878603|38315894|FG001|Overall Study|Lost to Follow-up|1|||
17167050|NCT02878603|38315893|FG000|Overall Study|Withdrawal by Subject|1|||
17167051|NCT02878603|38315894|FG001|Overall Study|Withdrawal by Subject|1|||
17167052|NCT02878603|38315893|FG000|Overall Study|Death|1|||
17167053|NCT02878603|38315894|FG001|Overall Study|Death|0|||
17167054|NCT02878603|38315893|FG000|Overall Study|Physician Decision|0|||
17167055|NCT02878603|38315894|FG001|Overall Study|Physician Decision|3|||
17167056|NCT01370408|38315900|FG000|Overall Study|treatment failure|9|||
17084709|NCT00135694|38225302|FG000|Overall Study|Death|14|||
17084710|NCT00135694|38225303|FG001|Overall Study|Death|1|||
17084711|NCT00135694|38225304|FG002|Overall Study|Death|2|||
17167057|NCT03294109|38315906|FG000|Overall Study|Withdrawal by Subject|6|||
17167058|NCT03294109|38315907|FG001|Overall Study|Withdrawal by Subject|5|||
17167059|NCT02868216|38315925|FG000|Overall Study|Death|0|||
17167060|NCT02868216|38315926|FG001|Overall Study|Death|1|||
17167061|NCT02868216|38315925|FG000|Overall Study|coronary artery bypass|1|||
17167062|NCT02868216|38315926|FG001|Overall Study|coronary artery bypass|0|||
17167063|NCT02868216|38315925|FG000|Overall Study|Withdrawal by Subject|7|||
17167064|NCT02868216|38315926|FG001|Overall Study|Withdrawal by Subject|5|||
17167065|NCT03132805|38315935|FG000|Overall Study|Lost to Follow-up|142|||
17167066|NCT03132805|38315936|FG001|Overall Study|Lost to Follow-up|141|||
17167067|NCT03132805|38315937|FG002|Overall Study|Lost to Follow-up|113|||
17167068|NCT02793128|38315945|FG000|Overall Study|Death|4|||
17167069|NCT02793128|38315945|FG000|Overall Study|Withdrawal by Subject|2|||
17167070|NCT02793128|38315945|FG000|Overall Study|Physician Decision|1|||
17167071|NCT02793128|38315945|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
17167072|NCT02793128|38315945|FG000|Overall Study|Patient elected nephroureterectomy|1|||
17167073|NCT02524171|38315959|FG000|6-month Follow-up|Lost to Follow-up|53|||
17167074|NCT02524171|38315960|FG001|6-month Follow-up|Lost to Follow-up|45|||
17167075|NCT02524171|38315959|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
17167076|NCT02524171|38315960|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
17167077|NCT03142451|38315968|FG000|Overall Study|Adverse Event|5|||
17167078|NCT03142451|38315969|FG001|Overall Study|Adverse Event|2|||
17167079|NCT03142451|38315968|FG000|Overall Study|Lost to Follow-up|25|||
17084712|NCT00135694|38225302|FG000|Overall Study|Lost to Follow-up|8|||
17084713|NCT00135694|38225303|FG001|Overall Study|Lost to Follow-up|7|||
17084714|NCT00135694|38225304|FG002|Overall Study|Lost to Follow-up|1|||
17084715|NCT00135694|38225302|FG000|Overall Study|Withdrawal by Subject|41|||
17084716|NCT00135694|38225303|FG001|Overall Study|Withdrawal by Subject|7|||
17084717|NCT00135694|38225304|FG002|Overall Study|Withdrawal by Subject|4|||
17084718|NCT00135694|38225302|FG000|Overall Study|Protocol Violation|19|||
17084719|NCT00135694|38225303|FG001|Overall Study|Protocol Violation|1|||
17167080|NCT03142451|38315969|FG001|Overall Study|Lost to Follow-up|8|||
17167081|NCT03142451|38315968|FG000|Overall Study|Participant request|24|||
17167082|NCT03142451|38315969|FG001|Overall Study|Participant request|12|||
17167083|NCT03142451|38315968|FG000|Overall Study|Protocol Violation|3|||
17167084|NCT03142451|38315969|FG001|Overall Study|Protocol Violation|1|||
17167085|NCT03142451|38315968|FG000|Overall Study|Other|1|||
17167086|NCT03142451|38315969|FG001|Overall Study|Other|1|||
17167087|NCT03141905|38315977|FG000|Overall Study|Death|3|||
17167088|NCT03141905|38315978|FG001|Overall Study|Death|2|||
17084720|NCT00135694|38225304|FG002|Overall Study|Protocol Violation|0|||
17084721|NCT00135694|38225302|FG000|Overall Study|Hepatitis C related reasons|39|||
17167089|NCT03141905|38315977|FG000|Overall Study|Withdrawal by Subject|1|||
17167090|NCT03141905|38315978|FG001|Overall Study|Withdrawal by Subject|0|||
17167091|NCT03141905|38315977|FG000|Overall Study|Lost to Follow-up|3|||
17167092|NCT03141905|38315978|FG001|Overall Study|Lost to Follow-up|7|||
17167093|NCT03141905|38315977|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
17167094|NCT03141905|38315978|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
17167095|NCT01370018|38315985|FG000|Overall Study|Did not meet criteria for analysis|1|||
17167096|NCT04034355|38315991|FG000|Overall Study|Study terminated by Sponsor|10|||
17167097|NCT04034355|38315992|FG001|Overall Study|Study terminated by Sponsor|17|||
17167098|NCT04034355|38315991|FG000|Overall Study|Withdrawal by Subject|12|||
17167099|NCT04034355|38315992|FG001|Overall Study|Withdrawal by Subject|11|||
17167100|NCT04034355|38315991|FG000|Overall Study|Site terminated by Sponsor|4|||
17167101|NCT04034355|38315992|FG001|Overall Study|Site terminated by Sponsor|5|||
17167102|NCT04034355|38315991|FG000|Overall Study|Adverse Event|2|||
17167103|NCT04034355|38315992|FG001|Overall Study|Adverse Event|0|||
17167104|NCT04034355|38315991|FG000|Overall Study|Death|1|||
17167105|NCT04034355|38315992|FG001|Overall Study|Death|1|||
17167106|NCT04034355|38315991|FG000|Overall Study|Not reported|2|||
17167107|NCT04034355|38315992|FG001|Overall Study|Not reported|0|||
17167108|NCT04034355|38315991|FG000|Overall Study|Lost to Follow-up|1|||
17167109|NCT04034355|38315992|FG001|Overall Study|Lost to Follow-up|0|||
17167110|NCT04034355|38315991|FG000|Overall Study|Physician Decision|1|||
17167111|NCT04034355|38315992|FG001|Overall Study|Physician Decision|0|||
17167112|NCT04034355|38315991|FG000|Overall Study|Protocol Violation|0|||
17167113|NCT04034355|38315992|FG001|Overall Study|Protocol Violation|1|||
17167114|NCT04034355|38315991|FG000|Overall Study|Progressive disease|1|||
17167115|NCT04034355|38315992|FG001|Overall Study|Progressive disease|0|||
17167116|NCT01336764|38316009|FG000|Overall Study|Withdrawal by Subject|5|||
17167117|NCT01336764|38316010|FG001|Overall Study|Withdrawal by Subject|5|||
17167118|NCT01336608|38316019|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
17167119|NCT01336608|38316020|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
17167120|NCT01336608|38316021|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
17167121|NCT01336608|38316022|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
17167122|NCT01336608|38316019|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
17167123|NCT01336608|38316020|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
17167124|NCT01336608|38316021|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
17167125|NCT01336608|38316022|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
17167126|NCT01336608|38316019|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
17167127|NCT01336608|38316020|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
17167128|NCT01336608|38316021|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
17167129|NCT01336608|38316022|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
17167130|NCT01336608|38316019|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
17167131|NCT01336608|38316020|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
17167132|NCT01336608|38316021|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
17167133|NCT01336608|38316022|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
17167134|NCT01336608|38316019|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
17167135|NCT01336608|38316020|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
17167136|NCT01336608|38316021|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
17167137|NCT01336608|38316022|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
17167138|NCT01336608|38316019|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
17167139|NCT01336608|38316020|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
17167140|NCT01336608|38316021|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
17167141|NCT01336608|38316022|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
17167142|NCT01336608|38316019|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
17167143|NCT01336608|38316020|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
17167144|NCT01336608|38316021|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
17167145|NCT01336608|38316022|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
17167146|NCT01336608|38316019|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
17167147|NCT01336608|38316020|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
17167148|NCT01336608|38316021|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
17167149|NCT01336608|38316022|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
17167150|NCT01336608|38316019|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
17167151|NCT01336608|38316020|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
17167152|NCT01336608|38316021|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
17167153|NCT01336608|38316022|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
17167154|NCT01336608|38316019|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
17167155|NCT01336608|38316020|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
17167156|NCT01336608|38316021|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
17167157|NCT01336608|38316022|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
17167158|NCT01336608|38316019|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
17167159|NCT01336608|38316020|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
17167160|NCT01336608|38316021|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
17167161|NCT01336608|38316022|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
17167162|NCT01336608|38316019|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
17167163|NCT01336608|38316020|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
17167164|NCT01336608|38316021|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
17167165|NCT01336608|38316022|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
17167166|NCT01336608|38316019|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
17167167|NCT01336608|38316020|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
17167168|NCT01336608|38316021|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
17167169|NCT01336608|38316022|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
17167170|NCT01346371|38316041|FG000|Overall Study|Lost to Follow-up|2|||
17167171|NCT01346371|38316042|FG001|Overall Study|Lost to Follow-up|0|||
17167172|NCT03644849|38316060|FG000|Overall Study|Lost to Follow-up|1|||
17167173|NCT03644849|38316061|FG001|Overall Study|Lost to Follow-up|3|||
17167174|NCT03131479|38316072|FG000|Overall Study|Adverse Event|0|||
17167175|NCT03131479|38316073|FG001|Overall Study|Adverse Event|0|||
17167176|NCT03131479|38316074|FG002|Overall Study|Adverse Event|1|||
17167177|NCT03131479|38316075|FG003|Overall Study|Adverse Event|1|||
17167178|NCT03131479|38316076|FG004|Overall Study|Adverse Event|0|||
17167179|NCT03131479|38316072|FG000|Overall Study|Subject/Guardian Decision|0|||
17167180|NCT03131479|38316073|FG001|Overall Study|Subject/Guardian Decision|0|||
17167181|NCT03131479|38316074|FG002|Overall Study|Subject/Guardian Decision|0|||
17167182|NCT03131479|38316075|FG003|Overall Study|Subject/Guardian Decision|1|||
17167183|NCT03131479|38316076|FG004|Overall Study|Subject/Guardian Decision|0|||
17167184|NCT03602885|38316090|FG000|Overall Study|Lost to Follow-up|3|||
17167185|NCT03602885|38316091|FG001|Overall Study|Lost to Follow-up|0|||
17167186|NCT02880761|38316099|FG000|Overall Study|Death|6|||
17167187|NCT02880761|38316100|FG001|Overall Study|Death|8|||
17167188|NCT02880761|38316099|FG000|Overall Study|Withdrawal by Subject|3|||
17167189|NCT02880761|38316100|FG001|Overall Study|Withdrawal by Subject|6|||
17167190|NCT02880761|38316099|FG000|Overall Study|Protocol Violation|4|||
17167191|NCT02880761|38316100|FG001|Overall Study|Protocol Violation|3|||
17167192|NCT02880761|38316099|FG000|Overall Study|Lost to Follow-up|3|||
17167193|NCT02880761|38316100|FG001|Overall Study|Lost to Follow-up|4|||
17167194|NCT02930941|38316108|FG000|Overall Study|Lost to Follow-up|1|||
17167195|NCT02930941|38316109|FG001|Overall Study|Lost to Follow-up|2|||
17167196|NCT03137537|38316121|FG000|Overall Study|Adverse Event|0|||
17167197|NCT03137537|38316122|FG001|Overall Study|Adverse Event|1|||
17167198|NCT03137459|38316130|FG000|2-month Assessment|Withdrawal by Subject|13|||
17167199|NCT03137459|38316131|FG001|2-month Assessment|Withdrawal by Subject|3|||
17167200|NCT03137459|38316130|FG000|2-month Assessment|Unable to reach|42|||
17167201|NCT03137459|38316131|FG001|2-month Assessment|Unable to reach|32|||
17167202|NCT03137459|38316130|FG000|2-month Assessment|Refused assessment|7|||
17167203|NCT03137459|38316131|FG001|2-month Assessment|Refused assessment|5|||
17167204|NCT03137459|38316130|FG000|2-month Assessment|Acutely ill|6|||
17167205|NCT03137459|38316131|FG001|2-month Assessment|Acutely ill|2|||
17167206|NCT03137459|38316130|FG000|4-month Assessment|Death|4|||
17167207|NCT03137459|38316131|FG001|4-month Assessment|Death|2|||
17167208|NCT03137459|38316130|FG000|4-month Assessment|Withdrawal by Subject|4|||
17167209|NCT03137459|38316131|FG001|4-month Assessment|Withdrawal by Subject|2|||
16996415|NCT00753922|38140439|FG002|Overall Study|Patient Non-compliance|14|||
17084722|NCT00135694|38225303|FG001|Overall Study|Hepatitis C related reasons|1|||
17084723|NCT00135694|38225304|FG002|Overall Study|Hepatitis C related reasons|0|||
17084724|NCT00135694|38225302|FG000|Overall Study|Ineligible for Random assignment|42|||
17084725|NCT00135694|38225303|FG001|Overall Study|Ineligible for Random assignment|0|||
17084726|NCT00135694|38225304|FG002|Overall Study|Ineligible for Random assignment|0|||
17084727|NCT00524459|38225312|FG000|Overall Study|Withdrawal by Subject|1|||
17084728|NCT00524459|38225312|FG000|Overall Study|Other|1|||
17084729|NCT00519623|38225316|FG000|Overall Study|Adverse Event|1|||
17084730|NCT00519077|38225320|FG000|Overall Study|Death|6|||
17084731|NCT00519077|38225320|FG000|Overall Study|Other|2|||
17084732|NCT00124618|38225324|FG000|Overall Study|Ineligible|1|||
17084733|NCT00124462|38225330|FG000|Overall Study|Lost to Follow-up|3|||
17084734|NCT00124462|38225331|FG001|Overall Study|Lost to Follow-up|3|||
17084735|NCT00124462|38225330|FG000|Overall Study|Physician Decision|3|||
17084736|NCT00124462|38225331|FG001|Overall Study|Physician Decision|4|||
17167210|NCT03137459|38316130|FG000|4-month Assessment|Unable to reach|44|||
17167211|NCT03137459|38316131|FG001|4-month Assessment|Unable to reach|29|||
17167212|NCT03137459|38316130|FG000|4-month Assessment|Refused assessment|24|||
17167213|NCT03137459|38316131|FG001|4-month Assessment|Refused assessment|10|||
17167214|NCT03137459|38316130|FG000|4-month Assessment|Acutely ill|2|||
17084737|NCT00124462|38225330|FG000|Overall Study|Withdrawal by Subject|4|||
17084738|NCT00124462|38225331|FG001|Overall Study|Withdrawal by Subject|5|||
17084739|NCT00124462|38225330|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
17084740|NCT00124462|38225331|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
17084741|NCT00124072|38225341|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
17084742|NCT00124072|38225342|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
17084743|NCT00124072|38225343|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
17084744|NCT00124072|38225344|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
17084745|NCT00124072|38225341|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
17084746|NCT00124072|38225342|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
17084747|NCT00124072|38225343|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
17084748|NCT00124072|38225344|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
17084749|NCT00124072|38225341|FG000|Overall Study|Death|499|||
17084750|NCT00124072|38225342|FG001|Overall Study|Death|484|||
17084751|NCT00124072|38225343|FG002|Overall Study|Death|471|||
17084752|NCT00124072|38225344|FG003|Overall Study|Death|480|||
17084753|NCT00362648|38225358|FG000|Overall Study|Adverse Event|12|||
17084754|NCT00362648|38225359|FG001|Overall Study|Adverse Event|21|||
17084755|NCT00362648|38225360|FG002|Overall Study|Adverse Event|1|||
17084756|NCT00362648|38225361|FG003|Overall Study|Adverse Event|0|||
17084757|NCT00362648|38225358|FG000|Overall Study|Lost to Follow-up|62|||
17084758|NCT00362648|38225359|FG001|Overall Study|Lost to Follow-up|69|||
17084759|NCT00362648|38225360|FG002|Overall Study|Lost to Follow-up|4|||
17084760|NCT00362648|38225361|FG003|Overall Study|Lost to Follow-up|3|||
17084761|NCT00362648|38225358|FG000|Overall Study|Protocol Violation|4|||
17084762|NCT00362648|38225359|FG001|Overall Study|Protocol Violation|2|||
17084763|NCT00362648|38225360|FG002|Overall Study|Protocol Violation|2|||
17084764|NCT00362648|38225361|FG003|Overall Study|Protocol Violation|2|||
17084765|NCT00362648|38225358|FG000|Overall Study|Withdrawal by Subject|48|||
17084766|NCT00362648|38225359|FG001|Overall Study|Withdrawal by Subject|42|||
17167215|NCT03137459|38316131|FG001|4-month Assessment|Acutely ill|3|||
17167216|NCT03137459|38316130|FG000|6-months|Lost to Follow-up|14|||
17167217|NCT03137459|38316131|FG001|6-months|Lost to Follow-up|11|||
17167218|NCT03137459|38316130|FG000|6-months|Death|0|||
17167219|NCT03137459|38316131|FG001|6-months|Death|2|||
17167220|NCT03137459|38316130|FG000|6-months|Refused assessment|6|||
17167221|NCT03137459|38316131|FG001|6-months|Refused assessment|3|||
17167222|NCT03137459|38316130|FG000|6-months|Acutely ill|1|||
17167223|NCT03137459|38316131|FG001|6-months|Acutely ill|1|||
17167224|NCT03131713|38316140|FG000|Overall Study|Lost to Follow-up|5|||
17167225|NCT03131713|38316141|FG001|Overall Study|Lost to Follow-up|0|||
17167226|NCT02930005|38316149|FG000|Overall Study|Lost to Follow-up|1|||
17167227|NCT02930005|38316150|FG001|Overall Study|Lost to Follow-up|5|||
17167228|NCT03637491|38316160|FG000|Overall Study|Death|9|||
17167229|NCT03637491|38316161|FG001|Overall Study|Death|9|||
17167230|NCT03637491|38316162|FG002|Overall Study|Death|5|||
17167231|NCT03637491|38316163|FG003|Overall Study|Death|3|||
17167232|NCT03637491|38316160|FG000|Overall Study|Lost to Follow-up|0|||
17167233|NCT03637491|38316161|FG001|Overall Study|Lost to Follow-up|1|||
17167234|NCT03637491|38316162|FG002|Overall Study|Lost to Follow-up|0|||
17167235|NCT03637491|38316163|FG003|Overall Study|Lost to Follow-up|1|||
17167236|NCT03637491|38316160|FG000|Overall Study|Study Terminated By Sponsor|0|||
17167237|NCT03637491|38316161|FG001|Overall Study|Study Terminated By Sponsor|2|||
17167238|NCT03637491|38316162|FG002|Overall Study|Study Terminated By Sponsor|1|||
17167239|NCT03637491|38316163|FG003|Overall Study|Study Terminated By Sponsor|0|||
17167240|NCT03637491|38316160|FG000|Overall Study|Withdrawal by Subject|1|||
17167241|NCT03637491|38316161|FG001|Overall Study|Withdrawal by Subject|0|||
17167242|NCT03637491|38316162|FG002|Overall Study|Withdrawal by Subject|1|||
17167243|NCT03637491|38316163|FG003|Overall Study|Withdrawal by Subject|2|||
17167244|NCT03334539|38316197|FG000|Overall Study|Adverse Event|3|||
17167245|NCT03334539|38316198|FG001|Overall Study|Adverse Event|5|||
17167246|NCT03334539|38316199|FG002|Overall Study|Adverse Event|0|||
17167247|NCT03334539|38316197|FG000|Overall Study|Withdrawal by Subject|0|||
17167248|NCT03334539|38316198|FG001|Overall Study|Withdrawal by Subject|1|||
17167249|NCT03334539|38316199|FG002|Overall Study|Withdrawal by Subject|1|||
17167250|NCT03334539|38316197|FG000|Overall Study|Administrative Reasons|1|||
17167251|NCT03334539|38316198|FG001|Overall Study|Administrative Reasons|0|||
17167252|NCT03334539|38316199|FG002|Overall Study|Administrative Reasons|0|||
17167253|NCT03334539|38316197|FG000|Overall Study|Hypertension Not Controlled|0|||
17167254|NCT03334539|38316198|FG001|Overall Study|Hypertension Not Controlled|1|||
17167255|NCT03334539|38316199|FG002|Overall Study|Hypertension Not Controlled|0|||
17167256|NCT03137303|38316214|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
17167257|NCT03137303|38316215|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
17167258|NCT03137303|38316214|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
17167259|NCT03137303|38316215|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
17167260|NCT03137303|38316214|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
17167261|NCT03137303|38316215|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
17167262|NCT03137303|38316214|FG000|T3: 9-month Follow-up|Death|1|||
17167263|NCT03137303|38316215|FG001|T3: 9-month Follow-up|Death|0|||
17167264|NCT03137303|38316214|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
17167265|NCT03137303|38316215|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
17167266|NCT03137303|38316214|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
17167267|NCT03137303|38316215|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
17167268|NCT03137303|38316214|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
17167269|NCT03137303|38316215|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
17167270|NCT03296553|38316223|FG000|Overall Study|Withdrawal by Subject|1|||
17167271|NCT03296553|38316224|FG001|Overall Study|Withdrawal by Subject|1|||
17167272|NCT03296553|38316223|FG000|Overall Study|Death|1|||
17167273|NCT03296553|38316224|FG001|Overall Study|Death|0|||
17167274|NCT03131167|38316243|FG000|Overall Study|Other (Unspecified)|0|||
17167275|NCT03131167|38316244|FG001|Overall Study|Other (Unspecified)|0|||
17167276|NCT03131167|38316245|FG002|Overall Study|Other (Unspecified)|0|||
17167277|NCT03131167|38316246|FG003|Overall Study|Other (Unspecified)|0|||
17167278|NCT03131167|38316247|FG004|Overall Study|Other (Unspecified)|0|||
17167279|NCT03131167|38316248|FG005|Overall Study|Other (Unspecified)|1|||
17167280|NCT03131167|38316249|FG006|Overall Study|Other (Unspecified)|0|||
17167281|NCT03131167|38316250|FG007|Overall Study|Other (Unspecified)|0|||
17167282|NCT03131167|38316251|FG008|Overall Study|Other (Unspecified)|0|||
17167283|NCT03131167|38316252|FG009|Overall Study|Other (Unspecified)|0|||
17167284|NCT03131167|38316253|FG010|Overall Study|Other (Unspecified)|0|||
17167285|NCT03131167|38316254|FG011|Overall Study|Other (Unspecified)|0|||
17167286|NCT03131167|38316255|FG012|Overall Study|Other (Unspecified)|0|||
17167287|NCT03060447|38316286|FG000|Overall Study|Withdrawal by Subject|2|||
17167288|NCT03060447|38316287|FG001|Overall Study|Withdrawal by Subject|0|||
17167289|NCT01712789|38316299|FG000|Overall Study|Lack of Efficacy|2|||
17167290|NCT01712789|38316299|FG000|Overall Study|Lost to Follow-up|1|||
17167291|NCT01712789|38316299|FG000|Overall Study|Progressive Disease|504|||
17167292|NCT01712789|38316299|FG000|Overall Study|Death|57|||
17167293|NCT01712789|38316299|FG000|Overall Study|Adverse Event|52|||
17167294|NCT01712789|38316299|FG000|Overall Study|Miscellaneous|31|||
17167295|NCT01712789|38316299|FG000|Overall Study|Withdrawal by Subject|21|||
17167296|NCT01712789|38316299|FG000|Overall Study|Transition to Commercial Treatment|8|||
17167297|NCT01712789|38316299|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
17167298|NCT02978781|38316306|FG000|Part A|Adverse Event|1|||
17167299|NCT02978781|38316307|FG001|Part A|Adverse Event|1|||
17167300|NCT02978781|38316308|FG002|Part A|Adverse Event|0|||
17167301|NCT02978781|38316309|FG003|Part A|Adverse Event|0|||
17167302|NCT02978781|38316310|FG004|Part A|Adverse Event|0|||
17084767|NCT00362648|38225360|FG002|Overall Study|Withdrawal by Subject|2|||
17084768|NCT00362648|38225361|FG003|Overall Study|Withdrawal by Subject|6|||
17167303|NCT02978781|38316306|FG000|Part A|Withdrawal by Subject|0|||
17167304|NCT02978781|38316307|FG001|Part A|Withdrawal by Subject|1|||
17167305|NCT02978781|38316308|FG002|Part A|Withdrawal by Subject|0|||
17167306|NCT02978781|38316309|FG003|Part A|Withdrawal by Subject|0|||
17167307|NCT02978781|38316310|FG004|Part A|Withdrawal by Subject|0|||
17167308|NCT02978781|38316306|FG000|Part B|Withdrawal by Subject|0|||
17167309|NCT02978781|38316307|FG001|Part B|Withdrawal by Subject|0|||
17167310|NCT02978781|38316308|FG002|Part B|Withdrawal by Subject|0|||
17167311|NCT02978781|38316309|FG003|Part B|Withdrawal by Subject|1|||
17167312|NCT02978781|38316310|FG004|Part B|Withdrawal by Subject|0|||
16868023|NCT01536145|37841043|FG010|Overall Study|Withdrawal by Subject|2|||
17084769|NCT00524303|38225378|FG000|Overall Study|Lost to Follow-up|6|||
17084770|NCT00524303|38225379|FG001|Overall Study|Lost to Follow-up|0|||
17084771|NCT00524303|38225380|FG002|Overall Study|Lost to Follow-up|3|||
17084772|NCT00524303|38225378|FG000|Overall Study|Protocol Violation|0|||
17084773|NCT00524303|38225379|FG001|Overall Study|Protocol Violation|1|||
17084774|NCT00524303|38225380|FG002|Overall Study|Protocol Violation|1|||
17084775|NCT00524303|38225378|FG000|Overall Study|Withdrawal by Subject|3|||
17084776|NCT00524303|38225379|FG001|Overall Study|Withdrawal by Subject|0|||
17084777|NCT00524303|38225380|FG002|Overall Study|Withdrawal by Subject|4|||
17084778|NCT00524303|38225378|FG000|Overall Study|Death|0|||
17084779|NCT00524303|38225379|FG001|Overall Study|Death|2|||
17084780|NCT00524303|38225380|FG002|Overall Study|Death|3|||
17084781|NCT00524303|38225378|FG000|Overall Study|Adverse Event|1|||
17084782|NCT00524303|38225379|FG001|Overall Study|Adverse Event|2|||
17084783|NCT00524303|38225380|FG002|Overall Study|Adverse Event|3|||
17084784|NCT00524303|38225378|FG000|Overall Study|Did not Complete Study Dosing|1|||
17084785|NCT00524303|38225379|FG001|Overall Study|Did not Complete Study Dosing|0|||
17084786|NCT00524303|38225380|FG002|Overall Study|Did not Complete Study Dosing|0|||
17084787|NCT00524303|38225378|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
17084788|NCT00524303|38225379|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
17084789|NCT00524303|38225380|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
17167313|NCT02978781|38316306|FG000|Part C|Adverse Event|0|||
17167314|NCT02978781|38316307|FG001|Part C|Adverse Event|0|||
17167315|NCT02978781|38316308|FG002|Part C|Adverse Event|0|||
17167316|NCT02978781|38316309|FG003|Part C|Adverse Event|0|||
17167317|NCT02978781|38316310|FG004|Part C|Adverse Event|2|||
17167318|NCT02978781|38316306|FG000|Part C|Withdrawal by Subject|0|||
17167319|NCT02978781|38316307|FG001|Part C|Withdrawal by Subject|0|||
17167320|NCT02978781|38316308|FG002|Part C|Withdrawal by Subject|0|||
17084790|NCT00524303|38225378|FG000|Overall Study|Disease Progression|0|||
17084791|NCT00524303|38225379|FG001|Overall Study|Disease Progression|4|||
17084792|NCT00524303|38225380|FG002|Overall Study|Disease Progression|1|||
17084793|NCT00524303|38225378|FG000|Overall Study|Disease Recurrence|0|||
17084794|NCT00524303|38225379|FG001|Overall Study|Disease Recurrence|1|||
17084795|NCT00524303|38225380|FG002|Overall Study|Disease Recurrence|0|||
17084796|NCT00524303|38225378|FG000|Overall Study|Sponsor Request|0|||
17084797|NCT00524303|38225379|FG001|Overall Study|Sponsor Request|0|||
17084798|NCT00524303|38225380|FG002|Overall Study|Sponsor Request|1|||
17084799|NCT00524303|38225378|FG000|Overall Study|Physician Decision|0|||
17084800|NCT00524303|38225379|FG001|Overall Study|Physician Decision|0|||
17167321|NCT02978781|38316309|FG003|Part C|Withdrawal by Subject|0|||
17167322|NCT02978781|38316310|FG004|Part C|Withdrawal by Subject|1|||
17167323|NCT02978781|38316306|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
17167324|NCT02978781|38316307|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
17167325|NCT02978781|38316308|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
17167326|NCT02978781|38316309|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
17167327|NCT02978781|38316310|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
17167328|NCT03074318|38316340|FG000|Overall Study|Adverse Event|0|||
17167329|NCT03074318|38316341|FG001|Overall Study|Adverse Event|1|||
17167330|NCT03074318|38316342|FG002|Overall Study|Adverse Event|1|||
17167331|NCT03074318|38316343|FG003|Overall Study|Adverse Event|1|||
17167332|NCT03074318|38316340|FG000|Overall Study|Death|1|||
17167333|NCT03074318|38316341|FG001|Overall Study|Death|0|||
17167334|NCT03074318|38316342|FG002|Overall Study|Death|0|||
17084801|NCT00524303|38225380|FG002|Overall Study|Physician Decision|1|||
17084802|NCT00524303|38225378|FG000|Overall Study|Completed 5 years|0|||
17084803|NCT00524303|38225379|FG001|Overall Study|Completed 5 years|0|||
17084804|NCT00524303|38225380|FG002|Overall Study|Completed 5 years|1|||
17084805|NCT00335556|38225397|FG000|Overall Study|Death|0|||
17084806|NCT00335556|38225398|FG001|Overall Study|Death|5|||
17084807|NCT00335556|38225399|FG002|Overall Study|Death|0|||
17084808|NCT00335556|38225400|FG003|Overall Study|Death|0|||
17084809|NCT00335556|38225401|FG004|Overall Study|Death|1|||
17084810|NCT00335556|38225402|FG005|Overall Study|Death|0|||
17084811|NCT00335556|38225397|FG000|Overall Study|Lack of Efficacy|0|||
17084812|NCT00335556|38225398|FG001|Overall Study|Lack of Efficacy|19|||
17167335|NCT03074318|38316343|FG003|Overall Study|Death|0|||
17167336|NCT03074318|38316340|FG000|Overall Study|Withdrawal by Subject|1|||
17167337|NCT03074318|38316341|FG001|Overall Study|Withdrawal by Subject|2|||
17167338|NCT03074318|38316342|FG002|Overall Study|Withdrawal by Subject|2|||
17167339|NCT03074318|38316343|FG003|Overall Study|Withdrawal by Subject|4|||
17167340|NCT03074318|38316340|FG000|Overall Study|Trial Closure|2|||
17167341|NCT03074318|38316341|FG001|Overall Study|Trial Closure|2|||
17167342|NCT03074318|38316342|FG002|Overall Study|Trial Closure|3|||
17167343|NCT03074318|38316343|FG003|Overall Study|Trial Closure|11|||
17167344|NCT03135119|38316364|FG000|Overall Study|Lost to Follow-up|2|||
17167345|NCT03135119|38316365|FG001|Overall Study|Lost to Follow-up|0|||
17167346|NCT03135119|38316364|FG000|Overall Study|Physician Decision|1|||
17167347|NCT03135119|38316365|FG001|Overall Study|Physician Decision|1|||
17167348|NCT03135119|38316364|FG000|Overall Study|COVID-19 Shutdown|2|||
17167349|NCT03135119|38316365|FG001|Overall Study|COVID-19 Shutdown|2|||
17167350|NCT01369784|38316371|FG000|Overall Study|Protocol Violation|12|||
17167351|NCT03353675|38316375|FG000|Overall Study|Adverse Event|4|||
17167352|NCT03137069|38316385|FG000|Overall Study|Withdrawal by Subject|1|||
17167353|NCT03137069|38316386|FG001|Overall Study|Withdrawal by Subject|2|||
17167354|NCT03137069|38316387|FG002|Overall Study|Withdrawal by Subject|2|||
17167355|NCT03137069|38316388|FG003|Overall Study|Withdrawal by Subject|2|||
17167356|NCT03137069|38316389|FG004|Overall Study|Withdrawal by Subject|0|||
17167357|NCT03137069|38316390|FG005|Overall Study|Withdrawal by Subject|0|||
17167358|NCT03137069|38316385|FG000|Overall Study|Adverse Event|0|||
17167359|NCT03137069|38316386|FG001|Overall Study|Adverse Event|3|||
17167360|NCT03137069|38316387|FG002|Overall Study|Adverse Event|1|||
17167361|NCT03137069|38316388|FG003|Overall Study|Adverse Event|1|||
17167362|NCT03137069|38316389|FG004|Overall Study|Adverse Event|0|||
17167363|NCT03137069|38316390|FG005|Overall Study|Adverse Event|1|||
17167364|NCT03137069|38316385|FG000|Overall Study|Protocol Violation|0|||
17167365|NCT03137069|38316386|FG001|Overall Study|Protocol Violation|1|||
17167366|NCT03137069|38316387|FG002|Overall Study|Protocol Violation|0|||
17167367|NCT03137069|38316388|FG003|Overall Study|Protocol Violation|1|||
17167368|NCT03137069|38316389|FG004|Overall Study|Protocol Violation|1|||
17167369|NCT03137069|38316390|FG005|Overall Study|Protocol Violation|1|||
17167370|NCT03137069|38316385|FG000|Overall Study|Physician Decision|0|||
17167371|NCT03137069|38316386|FG001|Overall Study|Physician Decision|0|||
17084813|NCT00335556|38225399|FG002|Overall Study|Lack of Efficacy|3|||
17084814|NCT00335556|38225400|FG003|Overall Study|Lack of Efficacy|3|||
17084815|NCT00335556|38225401|FG004|Overall Study|Lack of Efficacy|0|||
17084816|NCT00335556|38225402|FG005|Overall Study|Lack of Efficacy|1|||
17084817|NCT00335556|38225397|FG000|Overall Study|Physician Decision|0|||
17084818|NCT00335556|38225398|FG001|Overall Study|Physician Decision|6|||
17167372|NCT03137069|38316387|FG002|Overall Study|Physician Decision|0|||
17167373|NCT03137069|38316388|FG003|Overall Study|Physician Decision|1|||
17167374|NCT03137069|38316389|FG004|Overall Study|Physician Decision|0|||
17167375|NCT03137069|38316390|FG005|Overall Study|Physician Decision|0|||
17167376|NCT03137069|38316385|FG000|Overall Study|Study Terminated by Sponsor|0|||
17167377|NCT03137069|38316386|FG001|Overall Study|Study Terminated by Sponsor|0|||
17167378|NCT03137069|38316387|FG002|Overall Study|Study Terminated by Sponsor|0|||
17167379|NCT03137069|38316388|FG003|Overall Study|Study Terminated by Sponsor|0|||
17167380|NCT03137069|38316389|FG004|Overall Study|Study Terminated by Sponsor|1|||
17167381|NCT03137069|38316390|FG005|Overall Study|Study Terminated by Sponsor|0|||
17167382|NCT03137069|38316385|FG000|Overall Study|Data Entry Error|0|||
17167383|NCT03137069|38316386|FG001|Overall Study|Data Entry Error|0|||
17167384|NCT03137069|38316387|FG002|Overall Study|Data Entry Error|0|||
17167385|NCT03137069|38316388|FG003|Overall Study|Data Entry Error|1|||
17167386|NCT03137069|38316389|FG004|Overall Study|Data Entry Error|0|||
17167387|NCT03137069|38316390|FG005|Overall Study|Data Entry Error|0|||
17167388|NCT02792504|38316408|FG000|Overall Study|Lost to Follow-up|24|||
17167389|NCT02792504|38316408|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
17167390|NCT03124459|38316418|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
17167391|NCT03124459|38316419|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
17167392|NCT03124459|38316420|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
17167393|NCT03124459|38316421|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
17167394|NCT03124459|38316422|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
17167395|NCT03124459|38316423|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
17167396|NCT03124459|38316418|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
17167397|NCT03124459|38316419|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
17167398|NCT03124459|38316420|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
17167399|NCT03124459|38316421|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
17167400|NCT03124459|38316422|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
17167401|NCT03124459|38316423|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
17167402|NCT03124459|38316418|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
17167403|NCT03124459|38316419|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
17167404|NCT03124459|38316420|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
17167405|NCT03124459|38316421|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
17167406|NCT03124459|38316422|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
17167407|NCT03124459|38316423|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
17167408|NCT03124459|38316418|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
17167409|NCT03124459|38316419|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
17167410|NCT03124459|38316420|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
17167411|NCT03124459|38316421|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
17167412|NCT03124459|38316422|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
17084819|NCT00335556|38225399|FG002|Overall Study|Physician Decision|2|||
17084820|NCT00335556|38225400|FG003|Overall Study|Physician Decision|1|||
17084821|NCT00335556|38225401|FG004|Overall Study|Physician Decision|0|||
17084822|NCT00335556|38225402|FG005|Overall Study|Physician Decision|0|||
17084823|NCT00335556|38225397|FG000|Overall Study|Ineligible|2|||
17084824|NCT00335556|38225398|FG001|Overall Study|Ineligible|0|||
17084825|NCT00335556|38225399|FG002|Overall Study|Ineligible|0|||
17084826|NCT00335556|38225400|FG003|Overall Study|Ineligible|0|||
17084827|NCT00335556|38225401|FG004|Overall Study|Ineligible|0|||
17084828|NCT00335556|38225402|FG005|Overall Study|Ineligible|0|||
17084829|NCT00335556|38225397|FG000|Overall Study|Refusal of further protocol therapy|0|||
17084830|NCT00335556|38225398|FG001|Overall Study|Refusal of further protocol therapy|4|||
17167413|NCT03124459|38316423|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
17167414|NCT03124459|38316418|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
17167415|NCT03124459|38316419|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
17167416|NCT03124459|38316420|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
17167417|NCT03124459|38316421|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
16781306|NCT02105974|37720453|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
16781307|NCT02105974|37720454|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
17167418|NCT03124459|38316422|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
17167419|NCT03124459|38316423|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
17167420|NCT03124459|38316418|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
17167421|NCT03124459|38316419|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
17167422|NCT03124459|38316420|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
17167423|NCT03124459|38316421|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
17167424|NCT03124459|38316422|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
17084831|NCT00335556|38225399|FG002|Overall Study|Refusal of further protocol therapy|0|||
17084832|NCT00335556|38225400|FG003|Overall Study|Refusal of further protocol therapy|1|||
17084833|NCT00335556|38225401|FG004|Overall Study|Refusal of further protocol therapy|0|||
17084834|NCT00335556|38225402|FG005|Overall Study|Refusal of further protocol therapy|0|||
17167425|NCT03124459|38316423|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
17167426|NCT03134183|38316438|FG000|Overall Study|Withdrawal by Subject|1|||
17167427|NCT03134183|38316439|FG001|Overall Study|Withdrawal by Subject|1|||
17167428|NCT03136367|38316448|FG000|T1 Consultation|discontinued mistakenly included|2|||
17167429|NCT03136367|38316449|FG001|T1 Consultation|discontinued mistakenly included|6|||
17167430|NCT03136367|38316450|FG002|T1 Consultation|discontinued mistakenly included|1|||
17167431|NCT03136367|38316448|FG000|T1 Consultation|Discontinued other|0|||
17167432|NCT03136367|38316449|FG001|T1 Consultation|Discontinued other|1|||
17167433|NCT03136367|38316450|FG002|T1 Consultation|Discontinued other|0|||
17167434|NCT03136367|38316448|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
17167435|NCT03136367|38316449|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
17167436|NCT03136367|38316450|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
17167437|NCT03136367|38316448|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
17167438|NCT03136367|38316449|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
17167439|NCT03136367|38316450|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
17167440|NCT03136367|38316448|FG000|T2 Post-consultation|Discontinued other|0|||
17167441|NCT03136367|38316449|FG001|T2 Post-consultation|Discontinued other|2|||
17167442|NCT03136367|38316450|FG002|T2 Post-consultation|Discontinued other|6|||
17167443|NCT03136367|38316448|FG000|T2 Post-consultation|Discontinued transferred care|0|||
17167444|NCT03136367|38316449|FG001|T2 Post-consultation|Discontinued transferred care|0|||
17167445|NCT03136367|38316450|FG002|T2 Post-consultation|Discontinued transferred care|3|||
17167446|NCT03136367|38316448|FG000|T2 Post-consultation|Discontinued lost contact|0|||
17167447|NCT03136367|38316449|FG001|T2 Post-consultation|Discontinued lost contact|1|||
17167448|NCT03136367|38316450|FG002|T2 Post-consultation|Discontinued lost contact|0|||
17167449|NCT03136367|38316448|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
17167450|NCT03136367|38316449|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
17167451|NCT03136367|38316450|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
17167452|NCT03136367|38316448|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
17167453|NCT03136367|38316449|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
17167454|NCT03136367|38316450|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
17167455|NCT03136367|38316448|FG000|T3 1 Week After Surgery|other discontinued|2|||
17167456|NCT03136367|38316449|FG001|T3 1 Week After Surgery|other discontinued|4|||
17167457|NCT03136367|38316450|FG002|T3 1 Week After Surgery|other discontinued|3|||
17167458|NCT03136367|38316448|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
17167459|NCT03136367|38316449|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
17167460|NCT03136367|38316450|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
17167461|NCT03136367|38316448|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
17167462|NCT03136367|38316449|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
17167463|NCT03136367|38316450|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
17167464|NCT03136367|38316448|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
17167465|NCT03136367|38316449|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
17167466|NCT03136367|38316450|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
17167467|NCT03136367|38316448|FG000|T4 12 Weeks After Surgery|Death|0|||
17167468|NCT03136367|38316449|FG001|T4 12 Weeks After Surgery|Death|1|||
17167469|NCT03136367|38316450|FG002|T4 12 Weeks After Surgery|Death|3|||
17167470|NCT03136367|38316448|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
17167471|NCT03136367|38316449|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
17167472|NCT03136367|38316450|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
17167473|NCT03136367|38316448|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
17167474|NCT03136367|38316449|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
17167475|NCT03136367|38316450|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
17167476|NCT03136367|38316448|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
17167477|NCT03136367|38316449|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
17167478|NCT03136367|38316450|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
17167479|NCT03136367|38316448|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
17167480|NCT03136367|38316449|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
17167481|NCT03136367|38316450|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
17167482|NCT03136367|38316448|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
17167483|NCT03136367|38316449|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
17084835|NCT00518687|38225423|FG000|Overall Study|Adverse Event|201|||
17084836|NCT00518687|38225424|FG001|Overall Study|Adverse Event|177|||
17084837|NCT00518687|38225423|FG000|Overall Study|Lost to Follow-up|144|||
17084838|NCT00518687|38225424|FG001|Overall Study|Lost to Follow-up|155|||
17084839|NCT00518687|38225423|FG000|Overall Study|Physician Decision|42|||
17084840|NCT00518687|38225424|FG001|Overall Study|Physician Decision|48|||
17084841|NCT00518687|38225423|FG000|Overall Study|Progressive disease|2|||
17084842|NCT00518687|38225424|FG001|Overall Study|Progressive disease|2|||
17084843|NCT00518687|38225423|FG000|Overall Study|Protocol Violation|8|||
17084844|NCT00518687|38225424|FG001|Overall Study|Protocol Violation|10|||
17084845|NCT00518687|38225423|FG000|Overall Study|Study terminated by sponsor|930|||
17084846|NCT00518687|38225424|FG001|Overall Study|Study terminated by sponsor|918|||
17084847|NCT00518687|38225423|FG000|Overall Study|Withdrawal by Subject|110|||
16996416|NCT00753922|38140440|FG003|Overall Study|Patient Non-compliance|11|||
16996417|NCT00753922|38140437|FG000|Overall Study|Patients Not Completing Visit|11|||
16996418|NCT00753922|38140438|FG001|Overall Study|Patients Not Completing Visit|0|||
16996419|NCT00753922|38140439|FG002|Overall Study|Patients Not Completing Visit|1|||
16996420|NCT00753922|38140440|FG003|Overall Study|Patients Not Completing Visit|0|||
17084848|NCT00518687|38225424|FG001|Overall Study|Withdrawal by Subject|110|||
17084849|NCT00134056|38225432|FG000|Randomization|Not eligible for assigned treatment|22|||
17084850|NCT00134056|38225433|FG001|Randomization|Not eligible for assigned treatment|20|||
17084851|NCT00134056|38225432|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
17167484|NCT03136367|38316450|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
17167485|NCT03136367|38316448|FG000|T5 1 Year After Surgery|Death|0|||
17167486|NCT03136367|38316449|FG001|T5 1 Year After Surgery|Death|0|||
17167487|NCT03136367|38316450|FG002|T5 1 Year After Surgery|Death|1|||
17167488|NCT03136367|38316448|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
17167489|NCT03136367|38316449|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
17167490|NCT03136367|38316450|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
17167491|NCT03136367|38316448|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
17167492|NCT03136367|38316449|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
17167493|NCT03136367|38316450|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
17167494|NCT03136367|38316448|FG000|T5 1 Year After Surgery|study ended before due|31|||
17167495|NCT03136367|38316449|FG001|T5 1 Year After Surgery|study ended before due|103|||
17167496|NCT03136367|38316450|FG002|T5 1 Year After Surgery|study ended before due|110|||
17167497|NCT03136367|38316448|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
17167498|NCT03136367|38316449|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
17167499|NCT03136367|38316450|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
17167500|NCT03124381|38316463|FG000|Overall Study|Lost to Follow-up|1|||
17167501|NCT03124381|38316464|FG001|Overall Study|Lost to Follow-up|1|||
17167502|NCT03124381|38316463|FG000|Overall Study|Withdrawal by Subject|6|||
17167503|NCT03124381|38316464|FG001|Overall Study|Withdrawal by Subject|3|||
17167504|NCT03124381|38316463|FG000|Overall Study|Protocol Violation|0|||
17167505|NCT03124381|38316464|FG001|Overall Study|Protocol Violation|1|||
17167506|NCT03124381|38316463|FG000|Overall Study|Adverse Event|1|||
17167507|NCT03124381|38316464|FG001|Overall Study|Adverse Event|1|||
17167508|NCT03124381|38316463|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
17167509|NCT03124381|38316464|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
17167510|NCT02576574|38316473|FG000|Overall Study|still ongoing|65|||
17167511|NCT02576574|38316474|FG001|Overall Study|still ongoing|66|||
17167512|NCT02576574|38316475|FG002|Overall Study|still ongoing|73|||
17167513|NCT02576574|38316473|FG000|Overall Study|Randomized, not treated|5|||
17167514|NCT02576574|38316474|FG001|Overall Study|Randomized, not treated|4|||
17167515|NCT02576574|38316475|FG002|Overall Study|Randomized, not treated|26|||
17167516|NCT03133793|38316489|FG000|Overall Study|Withdrawal by Subject|0|||
17167517|NCT03133793|38316490|FG001|Overall Study|Withdrawal by Subject|4|||
17167518|NCT03133793|38316491|FG002|Overall Study|Withdrawal by Subject|2|||
17167519|NCT03133793|38316492|FG003|Overall Study|Withdrawal by Subject|4|||
17167520|NCT03133793|38316489|FG000|Overall Study|Lost to Follow-up|1|||
17167521|NCT03133793|38316490|FG001|Overall Study|Lost to Follow-up|0|||
17167522|NCT03133793|38316491|FG002|Overall Study|Lost to Follow-up|2|||
17167523|NCT03133793|38316492|FG003|Overall Study|Lost to Follow-up|0|||
17167524|NCT03133793|38316489|FG000|Overall Study|Death|0|||
17167525|NCT03133793|38316490|FG001|Overall Study|Death|0|||
17167526|NCT03133793|38316491|FG002|Overall Study|Death|0|||
17167527|NCT03133793|38316492|FG003|Overall Study|Death|1|||
17167528|NCT02747238|38316508|FG000|Overall Study|Lack of Efficacy|0|||
17167529|NCT02747238|38316509|FG001|Overall Study|Lack of Efficacy|1|||
17167530|NCT02747238|38316508|FG000|Overall Study|Data lost|3|||
17167531|NCT02747238|38316509|FG001|Overall Study|Data lost|5|||
17167532|NCT03133481|38316517|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
17167533|NCT03133481|38316518|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
17167534|NCT02864316|38316526|FG000|Overall Study|Progressive Disease|2|||
17167535|NCT02864316|38316527|FG001|Overall Study|Progressive Disease|1|||
17167536|NCT02864316|38316526|FG000|Overall Study|Adverse Event|0|||
17167537|NCT02864316|38316527|FG001|Overall Study|Adverse Event|1|||
17167538|NCT02862600|38316533|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
16782564|NCT02042404|37722174|FG000|Overall Study|Death|1|||
16996421|NCT00753922|38140437|FG000|Overall Study|Death|2|||
16996422|NCT00753922|38140438|FG001|Overall Study|Death|23|||
16996423|NCT00753922|38140439|FG002|Overall Study|Death|2|||
16996424|NCT00753922|38140440|FG003|Overall Study|Death|1|||
16996425|NCT00753922|38140437|FG000|Overall Study|Discontinuation Due to Explantation|14|||
16996426|NCT00753922|38140438|FG001|Overall Study|Discontinuation Due to Explantation|14|||
16996427|NCT00753922|38140439|FG002|Overall Study|Discontinuation Due to Explantation|14|||
17084852|NCT00134056|38225433|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
17167539|NCT02862600|38316533|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
17167540|NCT02862600|38316533|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
16996428|NCT00753922|38140440|FG003|Overall Study|Discontinuation Due to Explantation|4|||
16996429|NCT00761176|38140452|FG000|Overall Study|Death|1|||
16996430|NCT00761176|38140453|FG001|Overall Study|Death|0|||
17167541|NCT02862600|38316533|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
17167542|NCT02864082|38316541|FG000|Overall Study|Adverse Event|1|||
17167543|NCT02864082|38316542|FG001|Overall Study|Adverse Event|1|||
17167544|NCT02864082|38316541|FG000|Overall Study|Lost to Follow-up|0|||
17167545|NCT02864082|38316542|FG001|Overall Study|Lost to Follow-up|1|||
17167546|NCT02864082|38316541|FG000|Overall Study|Withdrawal by Subject|2|||
17167547|NCT02864082|38316542|FG001|Overall Study|Withdrawal by Subject|2|||
17167548|NCT02792192|38316566|FG000|Overall Study|Death|1|||
17167549|NCT02792192|38316567|FG001|Overall Study|Death|0|||
17167550|NCT02792192|38316568|FG002|Overall Study|Death|0|||
17167551|NCT02792192|38316569|FG003|Overall Study|Death|0|||
17167552|NCT02792192|38316566|FG000|Overall Study|Informed Consent Withdrawn|4|||
17167553|NCT02792192|38316567|FG001|Overall Study|Informed Consent Withdrawn|0|||
17167554|NCT02792192|38316568|FG002|Overall Study|Informed Consent Withdrawn|0|||
17167555|NCT02792192|38316569|FG003|Overall Study|Informed Consent Withdrawn|0|||
17167556|NCT02792192|38316566|FG000|Overall Study|Physician Decision|1|||
17167557|NCT02792192|38316567|FG001|Overall Study|Physician Decision|0|||
17167558|NCT02792192|38316568|FG002|Overall Study|Physician Decision|0|||
17167559|NCT02792192|38316569|FG003|Overall Study|Physician Decision|0|||
17167560|NCT02792192|38316566|FG000|Overall Study|Progressive Disease|0|||
17167561|NCT02792192|38316567|FG001|Overall Study|Progressive Disease|1|||
17167562|NCT02792192|38316568|FG002|Overall Study|Progressive Disease|0|||
17167563|NCT02792192|38316569|FG003|Overall Study|Progressive Disease|0|||
17167564|NCT02792192|38316566|FG000|Overall Study|Study Terminated By Sponsor|6|||
17167565|NCT02792192|38316567|FG001|Overall Study|Study Terminated By Sponsor|10|||
17167566|NCT02792192|38316568|FG002|Overall Study|Study Terminated By Sponsor|0|||
17167567|NCT02792192|38316569|FG003|Overall Study|Study Terminated By Sponsor|0|||
17167568|NCT02964507|38316588|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
17167569|NCT02964507|38316589|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
17167570|NCT02964507|38316590|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
17167571|NCT02964507|38316591|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
17167572|NCT02964507|38316592|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
17167573|NCT02964507|38316593|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
17167574|NCT02964507|38316594|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
17167575|NCT02964507|38316595|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
17167576|NCT02964507|38316588|FG000|Overall Study|Ongoing at the time of analysis|1|||
17167577|NCT02964507|38316589|FG001|Overall Study|Ongoing at the time of analysis|0|||
17167578|NCT02964507|38316590|FG002|Overall Study|Ongoing at the time of analysis|2|||
17167579|NCT02964507|38316591|FG003|Overall Study|Ongoing at the time of analysis|0|||
17167580|NCT02964507|38316592|FG004|Overall Study|Ongoing at the time of analysis|0|||
17167581|NCT02964507|38316593|FG005|Overall Study|Ongoing at the time of analysis|0|||
17167582|NCT02964507|38316594|FG006|Overall Study|Ongoing at the time of analysis|0|||
17167583|NCT02964507|38316595|FG007|Overall Study|Ongoing at the time of analysis|0|||
17167584|NCT02964507|38316588|FG000|Overall Study|Study terminated by Sponsor|9|||
17167585|NCT02964507|38316589|FG001|Overall Study|Study terminated by Sponsor|1|||
17167586|NCT02964507|38316590|FG002|Overall Study|Study terminated by Sponsor|9|||
17167587|NCT02964507|38316591|FG003|Overall Study|Study terminated by Sponsor|3|||
17167588|NCT02964507|38316592|FG004|Overall Study|Study terminated by Sponsor|3|||
17167589|NCT02964507|38316593|FG005|Overall Study|Study terminated by Sponsor|2|||
17167590|NCT02964507|38316594|FG006|Overall Study|Study terminated by Sponsor|0|||
17167591|NCT02964507|38316595|FG007|Overall Study|Study terminated by Sponsor|0|||
17167592|NCT02964507|38316588|FG000|Overall Study|Other|3|||
17167593|NCT02964507|38316589|FG001|Overall Study|Other|0|||
17167594|NCT02964507|38316590|FG002|Overall Study|Other|0|||
17167595|NCT02964507|38316591|FG003|Overall Study|Other|0|||
17167596|NCT02964507|38316592|FG004|Overall Study|Other|1|||
17167597|NCT02964507|38316593|FG005|Overall Study|Other|0|||
17167598|NCT02964507|38316594|FG006|Overall Study|Other|0|||
17167599|NCT02964507|38316595|FG007|Overall Study|Other|0|||
17167600|NCT02964507|38316588|FG000|Overall Study|Death|11|||
17167601|NCT02964507|38316589|FG001|Overall Study|Death|9|||
17167602|NCT02964507|38316590|FG002|Overall Study|Death|12|||
17167603|NCT02964507|38316591|FG003|Overall Study|Death|2|||
17167604|NCT02964507|38316592|FG004|Overall Study|Death|10|||
17167605|NCT02964507|38316593|FG005|Overall Study|Death|5|||
17167606|NCT02964507|38316594|FG006|Overall Study|Death|0|||
17167607|NCT02964507|38316595|FG007|Overall Study|Death|0|||
17167608|NCT02964507|38316588|FG000|Overall Study|Withdrawal by Subject|1|||
16996431|NCT00761176|38140452|FG000|Overall Study|Withdrawal by Subject|1|||
16996432|NCT00761176|38140453|FG001|Overall Study|Withdrawal by Subject|1|||
17167609|NCT02964507|38316589|FG001|Overall Study|Withdrawal by Subject|0|||
17167610|NCT02964507|38316590|FG002|Overall Study|Withdrawal by Subject|1|||
17167611|NCT02964507|38316591|FG003|Overall Study|Withdrawal by Subject|1|||
17167612|NCT02964507|38316592|FG004|Overall Study|Withdrawal by Subject|0|||
17167613|NCT02964507|38316593|FG005|Overall Study|Withdrawal by Subject|1|||
17167614|NCT02964507|38316594|FG006|Overall Study|Withdrawal by Subject|0|||
17167615|NCT02964507|38316595|FG007|Overall Study|Withdrawal by Subject|0|||
17084853|NCT00134056|38225432|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
17084854|NCT00134056|38225433|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
17084855|NCT00134056|38225432|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
17084856|NCT00134056|38225433|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
17084857|NCT00134056|38225432|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
17084858|NCT00134056|38225433|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
17084859|NCT00518531|38225444|FG000|Treatment Period 1|Adverse Event|5|||
17084860|NCT00518531|38225445|FG001|Treatment Period 1|Adverse Event|0|||
17084861|NCT00518531|38225444|FG000|Treatment Period 1|Lost to Follow-up|5|||
17084862|NCT00518531|38225445|FG001|Treatment Period 1|Lost to Follow-up|3|||
17084863|NCT00518531|38225444|FG000|Treatment Period 1|Physician Decision|1|||
17084864|NCT00518531|38225445|FG001|Treatment Period 1|Physician Decision|0|||
17084865|NCT00518531|38225444|FG000|Treatment Period 1|Protocol Violation|2|||
17084866|NCT00518531|38225445|FG001|Treatment Period 1|Protocol Violation|0|||
17084867|NCT00518531|38225444|FG000|Treatment Period 1|Withdrawal by Subject|4|||
17084868|NCT00518531|38225445|FG001|Treatment Period 1|Withdrawal by Subject|6|||
17084869|NCT00518531|38225444|FG000|Treatment Period 1|Early crossover|1|||
17084870|NCT00518531|38225445|FG001|Treatment Period 1|Early crossover|3|||
17084871|NCT00518531|38225444|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17084872|NCT00518531|38225445|FG001|Treatment Period 2|Withdrawal by Subject|8|||
17167616|NCT02964507|38316588|FG000|Overall Study|Physician Decision|1|||
17167617|NCT02964507|38316589|FG001|Overall Study|Physician Decision|0|||
17167618|NCT02964507|38316590|FG002|Overall Study|Physician Decision|1|||
17167619|NCT02964507|38316591|FG003|Overall Study|Physician Decision|0|||
17167620|NCT02964507|38316592|FG004|Overall Study|Physician Decision|1|||
17167621|NCT02964507|38316593|FG005|Overall Study|Physician Decision|0|||
17167622|NCT02964507|38316594|FG006|Overall Study|Physician Decision|0|||
17167623|NCT02964507|38316595|FG007|Overall Study|Physician Decision|0|||
17167624|NCT03170869|38316614|FG000|Overall Study|Protocol Violation|5|||
17167625|NCT03170869|38316614|FG000|Overall Study|Early study termination|3|||
17167626|NCT02440464|38316621|FG000|Overall Study|Withdrawal by Subject|3|||
17167627|NCT02440464|38316622|FG001|Overall Study|Withdrawal by Subject|2|||
17167628|NCT03103321|38316633|FG000|Overall Study|Protocol Violation|1|||
17167629|NCT03103321|38316634|FG001|Overall Study|Protocol Violation|1|||
17167630|NCT03103321|38316635|FG002|Overall Study|Protocol Violation|1|||
17167631|NCT03103321|38316636|FG003|Overall Study|Protocol Violation|0|||
17167632|NCT03131453|38316649|FG000|Overall Study|Study terminated by Sponsor|424|||
17167633|NCT03131453|38316650|FG001|Overall Study|Study terminated by Sponsor|222|||
17167634|NCT03131453|38316651|FG002|Overall Study|Study terminated by Sponsor|438|||
17167635|NCT03131453|38316649|FG000|Overall Study|Withdrawal by Subject|18|||
17167636|NCT03131453|38316650|FG001|Overall Study|Withdrawal by Subject|7|||
17167637|NCT03131453|38316651|FG002|Overall Study|Withdrawal by Subject|13|||
17167638|NCT03131453|38316649|FG000|Overall Study|Adverse Event|10|||
17167639|NCT03131453|38316650|FG001|Overall Study|Adverse Event|3|||
17167640|NCT03131453|38316651|FG002|Overall Study|Adverse Event|3|||
17167641|NCT03131453|38316649|FG000|Overall Study|Lost to Follow-up|1|||
17167642|NCT03131453|38316650|FG001|Overall Study|Lost to Follow-up|0|||
17167643|NCT03131453|38316651|FG002|Overall Study|Lost to Follow-up|1|||
17167644|NCT03131453|38316649|FG000|Overall Study|Physician Decision|1|||
17167645|NCT03131453|38316650|FG001|Overall Study|Physician Decision|0|||
17167646|NCT03131453|38316651|FG002|Overall Study|Physician Decision|1|||
17167647|NCT03131453|38316649|FG000|Overall Study|Non-compliance with study treatment|1|||
17167648|NCT03131453|38316650|FG001|Overall Study|Non-compliance with study treatment|0|||
17167649|NCT03131453|38316651|FG002|Overall Study|Non-compliance with study treatment|0|||
17167650|NCT03131453|38316649|FG000|Overall Study|Technical problems|1|||
17167651|NCT03131453|38316650|FG001|Overall Study|Technical problems|0|||
17167652|NCT03131453|38316651|FG002|Overall Study|Technical problems|0|||
17167653|NCT03131453|38316649|FG000|Overall Study|Protocol deviation|0|||
17167654|NCT03131453|38316650|FG001|Overall Study|Protocol deviation|1|||
17167655|NCT03131453|38316651|FG002|Overall Study|Protocol deviation|0|||
17167656|NCT02942277|38316679|FG000|Year 1|Withdrawal by Subject|0|||
17167657|NCT02942277|38316680|FG001|Year 1|Withdrawal by Subject|0|||
17167658|NCT02942277|38316681|FG002|Year 1|Withdrawal by Subject|0|||
17167659|NCT02942277|38316682|FG003|Year 1|Withdrawal by Subject|0|||
17167660|NCT02942277|38316683|FG004|Year 1|Withdrawal by Subject|1|||
17167661|NCT02942277|38316684|FG005|Year 1|Withdrawal by Subject|3|||
17167662|NCT02942277|38316685|FG006|Year 1|Withdrawal by Subject|0|||
17167663|NCT02942277|38316686|FG007|Year 1|Withdrawal by Subject|1|||
17167664|NCT02942277|38316687|FG008|Year 1|Withdrawal by Subject|0|||
17084873|NCT00518531|38225444|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
17167665|NCT02942277|38316688|FG009|Year 1|Withdrawal by Subject|0|||
17167666|NCT02942277|38316689|FG010|Year 1|Withdrawal by Subject|3|||
17167667|NCT02942277|38316679|FG000|Year 1|Travel|0|||
17167668|NCT02942277|38316680|FG001|Year 1|Travel|1|||
17167669|NCT02942277|38316681|FG002|Year 1|Travel|0|||
17167670|NCT02942277|38316682|FG003|Year 1|Travel|0|||
17167671|NCT02942277|38316683|FG004|Year 1|Travel|4|||
17167672|NCT02942277|38316684|FG005|Year 1|Travel|5|||
17167673|NCT02942277|38316685|FG006|Year 1|Travel|0|||
17167674|NCT02942277|38316686|FG007|Year 1|Travel|0|||
17167675|NCT02942277|38316687|FG008|Year 1|Travel|0|||
17084874|NCT00518531|38225445|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
17084875|NCT00518531|38225444|FG000|Treatment Period 2|Adverse Event|1|||
17084876|NCT00518531|38225445|FG001|Treatment Period 2|Adverse Event|7|||
17084877|NCT00518531|38225444|FG000|Treatment Period 2|Protocol-specified criteria|0|||
17084878|NCT00518531|38225445|FG001|Treatment Period 2|Protocol-specified criteria|1|||
17084879|NCT00518531|38225444|FG000|Treatment Period 2|Non-compliance|1|||
17084880|NCT00518531|38225445|FG001|Treatment Period 2|Non-compliance|2|||
17084881|NCT00351468|38225453|FG000|Overall Study|Adverse Event|42|||
17084882|NCT00351468|38225453|FG000|Overall Study|Withdrawal by Subject|39|||
17084883|NCT00351468|38225453|FG000|Overall Study|Various -follow up w clinical team|39|||
17167676|NCT02942277|38316688|FG009|Year 1|Travel|0|||
17167677|NCT02942277|38316689|FG010|Year 1|Travel|8|||
17167678|NCT02942277|38316679|FG000|Year 1|Joined Army|0|||
17167679|NCT02942277|38316680|FG001|Year 1|Joined Army|1|||
17167680|NCT02942277|38316681|FG002|Year 1|Joined Army|0|||
17167681|NCT02942277|38316682|FG003|Year 1|Joined Army|0|||
17167682|NCT02942277|38316683|FG004|Year 1|Joined Army|0|||
17167683|NCT02942277|38316684|FG005|Year 1|Joined Army|0|||
17167684|NCT02942277|38316685|FG006|Year 1|Joined Army|0|||
17167685|NCT02942277|38316686|FG007|Year 1|Joined Army|0|||
17167686|NCT02942277|38316687|FG008|Year 1|Joined Army|0|||
17167687|NCT02942277|38316688|FG009|Year 1|Joined Army|0|||
17167688|NCT02942277|38316689|FG010|Year 1|Joined Army|0|||
17167689|NCT02942277|38316679|FG000|Year 1|Subject met withdrawal criteria|0|||
17167690|NCT02942277|38316680|FG001|Year 1|Subject met withdrawal criteria|0|||
17167691|NCT02942277|38316681|FG002|Year 1|Subject met withdrawal criteria|0|||
17167692|NCT02942277|38316682|FG003|Year 1|Subject met withdrawal criteria|1|||
17167693|NCT02942277|38316683|FG004|Year 1|Subject met withdrawal criteria|0|||
17167694|NCT02942277|38316684|FG005|Year 1|Subject met withdrawal criteria|0|||
17167695|NCT02942277|38316685|FG006|Year 1|Subject met withdrawal criteria|0|||
17167696|NCT02942277|38316686|FG007|Year 1|Subject met withdrawal criteria|0|||
17167697|NCT02942277|38316687|FG008|Year 1|Subject met withdrawal criteria|0|||
17167698|NCT02942277|38316688|FG009|Year 1|Subject met withdrawal criteria|0|||
17167699|NCT02942277|38316689|FG010|Year 1|Subject met withdrawal criteria|0|||
17167700|NCT02942277|38316679|FG000|Year 1|Lost to Follow-up|0|||
17167701|NCT02942277|38316680|FG001|Year 1|Lost to Follow-up|0|||
17167702|NCT02942277|38316681|FG002|Year 1|Lost to Follow-up|0|||
17167703|NCT02942277|38316682|FG003|Year 1|Lost to Follow-up|0|||
17167704|NCT02942277|38316683|FG004|Year 1|Lost to Follow-up|1|||
17167705|NCT02942277|38316684|FG005|Year 1|Lost to Follow-up|0|||
17167706|NCT02942277|38316685|FG006|Year 1|Lost to Follow-up|0|||
17167707|NCT02942277|38316686|FG007|Year 1|Lost to Follow-up|0|||
17167708|NCT02942277|38316687|FG008|Year 1|Lost to Follow-up|0|||
17167709|NCT02942277|38316688|FG009|Year 1|Lost to Follow-up|0|||
17167710|NCT02942277|38316689|FG010|Year 1|Lost to Follow-up|2|||
17167711|NCT02942277|38316679|FG000|Year 1|Protocol Violation|0|||
17167712|NCT02942277|38316680|FG001|Year 1|Protocol Violation|0|||
17167713|NCT02942277|38316681|FG002|Year 1|Protocol Violation|0|||
17167714|NCT02942277|38316682|FG003|Year 1|Protocol Violation|0|||
16996433|NCT00760552|38140461|FG000|Overall Study|Death|2|||
16996434|NCT00760552|38140462|FG001|Overall Study|Death|0|||
16996435|NCT00760552|38140461|FG000|Overall Study|Lost to Follow-up|11|||
16996436|NCT00760552|38140462|FG001|Overall Study|Lost to Follow-up|10|||
16996437|NCT01924533|38140470|FG000|Overall Study|Death|181|||
16996438|NCT01924533|38140471|FG001|Overall Study|Death|200|||
16996439|NCT01924533|38140470|FG000|Overall Study|Lost to Follow-up|0|||
16996440|NCT01924533|38140471|FG001|Overall Study|Lost to Follow-up|1|||
16996441|NCT01924533|38140470|FG000|Overall Study|Withdrawal by Subject|7|||
16996442|NCT01924533|38140471|FG001|Overall Study|Withdrawal by Subject|3|||
16996443|NCT01924533|38140470|FG000|Overall Study|Other Eligibility criteria|1|||
16996444|NCT01924533|38140471|FG001|Overall Study|Other Eligibility criteria|1|||
16996445|NCT00753766|38140479|FG000|Overall Study|Physician Decision|1|||
16996446|NCT00753766|38140480|FG001|Overall Study|Physician Decision|0|||
17167715|NCT02942277|38316683|FG004|Year 1|Protocol Violation|1|||
17167716|NCT02942277|38316684|FG005|Year 1|Protocol Violation|1|||
16996447|NCT00976898|38140487|FG000|Overall Study|Protocol Violation|1|||
16996448|NCT00976898|38140487|FG000|Overall Study|Adverse Event|1|||
17084884|NCT00351468|38225453|FG000|Overall Study|Lack of Efficacy|32|||
17084885|NCT00351468|38225453|FG000|Overall Study|Non-compliance|8|||
17167717|NCT02942277|38316685|FG006|Year 1|Protocol Violation|0|||
17167718|NCT02942277|38316686|FG007|Year 1|Protocol Violation|0|||
17167719|NCT02942277|38316687|FG008|Year 1|Protocol Violation|0|||
17167720|NCT02942277|38316688|FG009|Year 1|Protocol Violation|0|||
17167721|NCT02942277|38316689|FG010|Year 1|Protocol Violation|2|||
17084886|NCT00351468|38225453|FG000|Overall Study|Lost to Follow-up|4|||
17084887|NCT00351468|38225453|FG000|Overall Study|Protocol Violation|3|||
17084888|NCT00523991|38225460|FG000|Overall Study|Adverse Event|6|||
17084889|NCT00523991|38225461|FG001|Overall Study|Adverse Event|5|||
17084890|NCT00523991|38225460|FG000|Overall Study|Protocol Violation|1|||
17084891|NCT00523991|38225461|FG001|Overall Study|Protocol Violation|4|||
17084892|NCT00523991|38225460|FG000|Overall Study|Lost to Follow-up|4|||
17084893|NCT00523991|38225461|FG001|Overall Study|Lost to Follow-up|1|||
17084894|NCT00523991|38225460|FG000|Overall Study|Withdrawal by Subject|7|||
17084895|NCT00523991|38225461|FG001|Overall Study|Withdrawal by Subject|17|||
17084896|NCT00523991|38225460|FG000|Overall Study|Other reason (not specified)|3|||
17084897|NCT00523991|38225461|FG001|Overall Study|Other reason (not specified)|0|||
17167722|NCT02942277|38316679|FG000|Year 1|Pregnancy|0|||
17167723|NCT02942277|38316680|FG001|Year 1|Pregnancy|0|||
17167724|NCT02942277|38316681|FG002|Year 1|Pregnancy|0|||
17167725|NCT02942277|38316682|FG003|Year 1|Pregnancy|0|||
17167726|NCT02942277|38316683|FG004|Year 1|Pregnancy|0|||
17167727|NCT02942277|38316684|FG005|Year 1|Pregnancy|1|||
17167728|NCT02942277|38316685|FG006|Year 1|Pregnancy|0|||
17167729|NCT02942277|38316686|FG007|Year 1|Pregnancy|0|||
17167730|NCT02942277|38316687|FG008|Year 1|Pregnancy|0|||
17167731|NCT02942277|38316688|FG009|Year 1|Pregnancy|0|||
17167732|NCT02942277|38316689|FG010|Year 1|Pregnancy|0|||
17167733|NCT02942277|38316679|FG000|Year 2|Lost to Follow-up|0|||
17167734|NCT02942277|38316680|FG001|Year 2|Lost to Follow-up|0|||
17167735|NCT02942277|38316681|FG002|Year 2|Lost to Follow-up|0|||
17167736|NCT02942277|38316682|FG003|Year 2|Lost to Follow-up|0|||
17167737|NCT02942277|38316683|FG004|Year 2|Lost to Follow-up|2|||
17167738|NCT02942277|38316684|FG005|Year 2|Lost to Follow-up|1|||
17167739|NCT02942277|38316685|FG006|Year 2|Lost to Follow-up|0|||
17167740|NCT02942277|38316686|FG007|Year 2|Lost to Follow-up|0|||
17167741|NCT02942277|38316687|FG008|Year 2|Lost to Follow-up|0|||
17167742|NCT02942277|38316688|FG009|Year 2|Lost to Follow-up|0|||
17167743|NCT02942277|38316689|FG010|Year 2|Lost to Follow-up|0|||
17167744|NCT02942277|38316679|FG000|Year 2|Did not rescreen|0|||
17167745|NCT02942277|38316680|FG001|Year 2|Did not rescreen|0|||
17167746|NCT02942277|38316681|FG002|Year 2|Did not rescreen|1|||
17167747|NCT02942277|38316682|FG003|Year 2|Did not rescreen|1|||
17167748|NCT02942277|38316683|FG004|Year 2|Did not rescreen|9|||
17167749|NCT02942277|38316684|FG005|Year 2|Did not rescreen|6|||
17167750|NCT02942277|38316685|FG006|Year 2|Did not rescreen|0|||
17167751|NCT02942277|38316686|FG007|Year 2|Did not rescreen|1|||
17167752|NCT02942277|38316687|FG008|Year 2|Did not rescreen|0|||
17167753|NCT02942277|38316688|FG009|Year 2|Did not rescreen|0|||
17167754|NCT02942277|38316689|FG010|Year 2|Did not rescreen|21|||
17167755|NCT02942277|38316679|FG000|Year 2|Met withdrawal criteria|0|||
17167756|NCT02942277|38316680|FG001|Year 2|Met withdrawal criteria|0|||
17167757|NCT02942277|38316681|FG002|Year 2|Met withdrawal criteria|0|||
17167758|NCT02942277|38316682|FG003|Year 2|Met withdrawal criteria|0|||
17167759|NCT02942277|38316683|FG004|Year 2|Met withdrawal criteria|1|||
17167760|NCT02942277|38316684|FG005|Year 2|Met withdrawal criteria|2|||
17167761|NCT02942277|38316685|FG006|Year 2|Met withdrawal criteria|0|||
17167762|NCT02942277|38316686|FG007|Year 2|Met withdrawal criteria|0|||
17167763|NCT02942277|38316687|FG008|Year 2|Met withdrawal criteria|0|||
17167764|NCT02942277|38316688|FG009|Year 2|Met withdrawal criteria|0|||
17167765|NCT02942277|38316689|FG010|Year 2|Met withdrawal criteria|1|||
17167766|NCT02942277|38316679|FG000|Year 2|Travel|0|||
17167767|NCT02942277|38316680|FG001|Year 2|Travel|1|||
17167768|NCT02942277|38316681|FG002|Year 2|Travel|0|||
17167769|NCT02942277|38316682|FG003|Year 2|Travel|0|||
17167770|NCT02942277|38316683|FG004|Year 2|Travel|0|||
17167771|NCT02942277|38316684|FG005|Year 2|Travel|1|||
17167772|NCT02942277|38316685|FG006|Year 2|Travel|0|||
17167773|NCT02942277|38316686|FG007|Year 2|Travel|0|||
17167774|NCT02942277|38316687|FG008|Year 2|Travel|0|||
17167775|NCT02942277|38316688|FG009|Year 2|Travel|1|||
17167776|NCT02942277|38316689|FG010|Year 2|Travel|3|||
17167777|NCT02942277|38316679|FG000|Year 2|Non-compliant|0|||
17167778|NCT02942277|38316680|FG001|Year 2|Non-compliant|0|||
17167779|NCT02942277|38316681|FG002|Year 2|Non-compliant|0|||
17167780|NCT02942277|38316682|FG003|Year 2|Non-compliant|0|||
17167781|NCT02942277|38316683|FG004|Year 2|Non-compliant|1|||
17167782|NCT02942277|38316684|FG005|Year 2|Non-compliant|1|||
16996449|NCT00976898|38140487|FG000|Overall Study|Physician Decision|1|||
16782565|NCT02042404|37722175|FG001|Overall Study|Death|0|||
17084898|NCT00350844|38225467|FG000|Overall Study|Lost to Follow-up|1|||
17084899|NCT00345540|38225471|FG000|Overall Study|Withdrawal by Subject|1|||
17084900|NCT00335322|38225478|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
17167783|NCT02942277|38316685|FG006|Year 2|Non-compliant|0|||
17167784|NCT02942277|38316686|FG007|Year 2|Non-compliant|0|||
17167785|NCT02942277|38316687|FG008|Year 2|Non-compliant|0|||
17167786|NCT02942277|38316688|FG009|Year 2|Non-compliant|0|||
17167787|NCT02942277|38316689|FG010|Year 2|Non-compliant|0|||
17167788|NCT02942277|38316679|FG000|Year 2|Withdrawal by Subject|0|||
17167789|NCT02942277|38316680|FG001|Year 2|Withdrawal by Subject|0|||
17167790|NCT02942277|38316681|FG002|Year 2|Withdrawal by Subject|0|||
17167791|NCT02942277|38316682|FG003|Year 2|Withdrawal by Subject|0|||
17167792|NCT02942277|38316683|FG004|Year 2|Withdrawal by Subject|0|||
17167793|NCT02942277|38316684|FG005|Year 2|Withdrawal by Subject|0|||
17167794|NCT02942277|38316685|FG006|Year 2|Withdrawal by Subject|1|||
17167795|NCT02942277|38316686|FG007|Year 2|Withdrawal by Subject|0|||
17167796|NCT02942277|38316687|FG008|Year 2|Withdrawal by Subject|0|||
17167797|NCT02942277|38316688|FG009|Year 2|Withdrawal by Subject|0|||
17167798|NCT02942277|38316689|FG010|Year 2|Withdrawal by Subject|0|||
17167799|NCT03131219|38316718|FG000|Initial Evaluation Period|Adverse Event|1|||
17167800|NCT03131219|38316719|FG001|Initial Evaluation Period|Adverse Event|0|||
17167801|NCT03131219|38316718|FG000|Initial Evaluation Period|Protocol Violation|1|||
17167802|NCT03131219|38316719|FG001|Initial Evaluation Period|Protocol Violation|0|||
17167803|NCT03131219|38316718|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
17167804|NCT03131219|38316719|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
17167805|NCT02859324|38316749|FG000|Overall Study|Death|4|||
17167806|NCT02859324|38316750|FG001|Overall Study|Death|6|||
17167807|NCT02859324|38316751|FG002|Overall Study|Death|5|||
17167808|NCT02859324|38316749|FG000|Overall Study|Other reasons|3|||
17167809|NCT02859324|38316750|FG001|Overall Study|Other reasons|3|||
17167810|NCT02859324|38316751|FG002|Overall Study|Other reasons|0|||
17167811|NCT02143063|38316762|FG000|Overall Study|Lost to Follow-up|16|||
17167812|NCT02143063|38316763|FG001|Overall Study|Lost to Follow-up|28|||
17167813|NCT02143063|38316764|FG002|Overall Study|Lost to Follow-up|29|||
17167814|NCT02143063|38316762|FG000|Overall Study|Withdrawal by Subject|0|||
17167815|NCT02143063|38316763|FG001|Overall Study|Withdrawal by Subject|1|||
17167816|NCT02143063|38316764|FG002|Overall Study|Withdrawal by Subject|0|||
17167817|NCT02143063|38316762|FG000|Overall Study|Death|0|||
17167818|NCT02143063|38316763|FG001|Overall Study|Death|1|||
17167819|NCT02143063|38316764|FG002|Overall Study|Death|1|||
17167820|NCT02859246|38316772|FG000|Overall Study|Screen fails|3|||
17167821|NCT02859246|38316772|FG000|Overall Study|Adverse Event|1|||
17167822|NCT02859246|38316772|FG000|Overall Study|Withdrawal by Subject|1|||
17167823|NCT01083433|38316795|FG000|Overall Study|Lost to Follow-up|2|||
17167824|NCT01083433|38316796|FG001|Overall Study|Lost to Follow-up|1|||
17167825|NCT01083433|38316797|FG002|Overall Study|Lost to Follow-up|1|||
17167826|NCT01083433|38316795|FG000|Overall Study|Withdrawal by Subject|0|||
17167827|NCT01083433|38316796|FG001|Overall Study|Withdrawal by Subject|5|||
17167828|NCT01083433|38316797|FG002|Overall Study|Withdrawal by Subject|3|||
17167829|NCT01083433|38316795|FG000|Overall Study|Pregnancy|0|||
17167830|NCT01083433|38316796|FG001|Overall Study|Pregnancy|0|||
17167831|NCT01083433|38316797|FG002|Overall Study|Pregnancy|1|||
17167832|NCT02791490|38316811|FG000|Overall Study|Lost to Follow-up|1|||
17167833|NCT02791490|38316812|FG001|Overall Study|Lost to Follow-up|2|||
17167834|NCT02791490|38316811|FG000|Overall Study|Withdrawal by Subject|2|||
17167835|NCT02791490|38316812|FG001|Overall Study|Withdrawal by Subject|6|||
17167836|NCT02507973|38316827|FG000|Overall Study|Adverse Event|1|||
17167837|NCT02425644|38316835|FG000|Overall Study|Lost to Follow-up|2|||
17167838|NCT02425644|38316836|FG001|Overall Study|Lost to Follow-up|3|||
17167839|NCT02425644|38316835|FG000|Overall Study|Withdrawal by Subject|41|||
17167840|NCT02425644|38316836|FG001|Overall Study|Withdrawal by Subject|36|||
17167841|NCT02425644|38316835|FG000|Overall Study|Lack of Efficacy|3|||
17167842|NCT02425644|38316836|FG001|Overall Study|Lack of Efficacy|10|||
17167843|NCT02425644|38316835|FG000|Overall Study|Adverse Event|13|||
17167844|NCT02425644|38316836|FG001|Overall Study|Adverse Event|3|||
17167845|NCT02425644|38316835|FG000|Overall Study|Death|0|||
17167846|NCT02425644|38316836|FG001|Overall Study|Death|2|||
17084901|NCT00335322|38225479|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
17084902|NCT00335322|38225480|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
17084903|NCT00523367|38225491|FG000|Overall Study|19 screen failures|19|||
17084904|NCT00523367|38225491|FG000|Overall Study|4 Withdrawn by PI|4|||
17167847|NCT02425644|38316835|FG000|Overall Study|Other|18|||
17167848|NCT02425644|38316836|FG001|Overall Study|Other|17|||
17167849|NCT02861664|38316848|FG000|Overall Study|Withdrawal of Consent|0|||
17167850|NCT02861664|38316849|FG001|Overall Study|Withdrawal of Consent|1|||
17167851|NCT01307787|38316857|FG000|Overall Study|Withdrawal by Subject|2|||
17084905|NCT03755765|38225498|FG000|Overall Study|Withdrawal by Subject|2|||
17084906|NCT03755765|38225499|FG001|Overall Study|Withdrawal by Subject|4|||
17084907|NCT03755765|38225500|FG002|Overall Study|Withdrawal by Subject|4|||
17084908|NCT00344448|38225508|FG000|Screening|Withdrawal by Subject|0|||
17084909|NCT00344448|38225509|FG001|Screening|Withdrawal by Subject|1|||
17084910|NCT00344448|38225508|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
17084911|NCT00344448|38225509|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
17084912|NCT00344448|38225508|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
17084913|NCT00344448|38225509|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
17084914|NCT00344448|38225508|FG000|Open Label|Withdrawal by Subject|1|||
17084915|NCT00344448|38225509|FG001|Open Label|Withdrawal by Subject|1|||
17084916|NCT00344448|38225508|FG000|Open Label|Study terminated|1|||
17084917|NCT00344448|38225509|FG001|Open Label|Study terminated|0|||
17084918|NCT00324168|38225517|FG000|Overall Study|Lost to Follow-up|19|||
17167852|NCT01307787|38316858|FG001|Overall Study|Withdrawal by Subject|0|||
17167853|NCT03284853|38316871|FG000|Overall Study|Adverse Event|40|||
17167854|NCT03284853|38316872|FG001|Overall Study|Adverse Event|4|||
17167855|NCT03284853|38316871|FG000|Overall Study|Withdrawal by Subject|5|||
17167856|NCT03284853|38316872|FG001|Overall Study|Withdrawal by Subject|1|||
17167857|NCT03284853|38316871|FG000|Overall Study|Lost to Follow-up|1|||
17167858|NCT03284853|38316872|FG001|Overall Study|Lost to Follow-up|0|||
17167859|NCT03284853|38316871|FG000|Overall Study|Lack of Efficacy|1|||
17167860|NCT03284853|38316872|FG001|Overall Study|Lack of Efficacy|0|||
17167861|NCT03284853|38316871|FG000|Overall Study|Disallowed Concurrent Medication|1|||
17167862|NCT03284853|38316872|FG001|Overall Study|Disallowed Concurrent Medication|1|||
17167863|NCT03284853|38316871|FG000|Overall Study|Protocol Violation|3|||
17167864|NCT03284853|38316872|FG001|Overall Study|Protocol Violation|3|||
17167865|NCT03284853|38316871|FG000|Overall Study|Death|0|||
17167866|NCT03284853|38316872|FG001|Overall Study|Death|1|||
17167867|NCT03284853|38316871|FG000|Overall Study|Other - Reason not reported in CSR|4|||
17167868|NCT03284853|38316872|FG001|Overall Study|Other - Reason not reported in CSR|3|||
17167869|NCT03126019|38316880|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
17167870|NCT03126019|38316881|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
17167871|NCT03126019|38316880|FG000|Overall Study|Death|2|||
17167872|NCT03126019|38316881|FG001|Overall Study|Death|7|||
17167873|NCT03126019|38316880|FG000|Overall Study|Lost to Follow-up|2|||
17167874|NCT03126019|38316881|FG001|Overall Study|Lost to Follow-up|3|||
17167875|NCT03126019|38316880|FG000|Overall Study|Withdrawal by Participant|1|||
17167876|NCT03126019|38316881|FG001|Overall Study|Withdrawal by Participant|3|||
17167877|NCT03126019|38316880|FG000|Overall Study|Reason not Specified|1|||
17084919|NCT00324168|38225518|FG001|Overall Study|Lost to Follow-up|18|||
17084920|NCT00324168|38225517|FG000|Overall Study|Death|3|||
17084921|NCT00324168|38225518|FG001|Overall Study|Death|3|||
17084922|NCT00324168|38225517|FG000|Overall Study|Patient did not visit in f/u window|6|||
17084923|NCT00324168|38225518|FG001|Overall Study|Patient did not visit in f/u window|9|||
17084924|NCT00517829|38225526|FG000|Overall Study|Adverse Event|22|||
17084925|NCT00517829|38225527|FG001|Overall Study|Adverse Event|34|||
17084926|NCT00517829|38225526|FG000|Overall Study|Disease Progression|39|||
17084927|NCT00517829|38225527|FG001|Overall Study|Disease Progression|32|||
17084928|NCT00517829|38225526|FG000|Overall Study|Patient Request|6|||
17084929|NCT00517829|38225527|FG001|Overall Study|Patient Request|5|||
17084930|NCT00517829|38225526|FG000|Overall Study|Investigator Request|5|||
17084931|NCT00517829|38225527|FG001|Overall Study|Investigator Request|3|||
17084932|NCT00517829|38225526|FG000|Overall Study|Other|3|||
17084933|NCT00517829|38225527|FG001|Overall Study|Other|1|||
17084934|NCT00343512|38225533|FG000|Overall Study|Withdrawal by Subject|2|||
17084935|NCT00334542|38225538|FG000|Overall Study|Adverse Event|3|||
17084936|NCT00334542|38225538|FG000|Overall Study|Withdrawal by Subject|1|||
17084937|NCT00334542|38225538|FG000|Overall Study|New cancer diagnosis|1|||
17084938|NCT00112294|38225545|FG000|Overall Study|Still on study|5|||
17084939|NCT00112294|38225546|FG001|Overall Study|Still on study|0|||
17084940|NCT00235443|38225558|FG000|Overall Study|Adverse Event|4|||
17084941|NCT00235443|38225559|FG001|Overall Study|Adverse Event|12|||
17084942|NCT00235443|38225560|FG002|Overall Study|Adverse Event|17|||
17084943|NCT00235443|38225561|FG003|Overall Study|Adverse Event|44|||
17084944|NCT00235443|38225562|FG004|Overall Study|Adverse Event|10|||
17084945|NCT00235443|38225563|FG005|Overall Study|Adverse Event|15|||
17084946|NCT00235443|38225558|FG000|Overall Study|Lack of Efficacy|0|||
17084947|NCT00235443|38225559|FG001|Overall Study|Lack of Efficacy|1|||
17084948|NCT00235443|38225560|FG002|Overall Study|Lack of Efficacy|5|||
17084949|NCT00235443|38225561|FG003|Overall Study|Lack of Efficacy|12|||
17084950|NCT00235443|38225562|FG004|Overall Study|Lack of Efficacy|2|||
17084951|NCT00235443|38225563|FG005|Overall Study|Lack of Efficacy|9|||
17084952|NCT00235443|38225558|FG000|Overall Study|Withdrawal by Subject|3|||
17084953|NCT00235443|38225559|FG001|Overall Study|Withdrawal by Subject|9|||
17084954|NCT00235443|38225560|FG002|Overall Study|Withdrawal by Subject|25|||
17084955|NCT00235443|38225561|FG003|Overall Study|Withdrawal by Subject|24|||
17084956|NCT00235443|38225562|FG004|Overall Study|Withdrawal by Subject|10|||
17084957|NCT00235443|38225563|FG005|Overall Study|Withdrawal by Subject|12|||
17084958|NCT00235443|38225558|FG000|Overall Study|Lost to Follow-up|0|||
17084959|NCT00235443|38225559|FG001|Overall Study|Lost to Follow-up|8|||
17084960|NCT00235443|38225560|FG002|Overall Study|Lost to Follow-up|6|||
17084961|NCT00235443|38225561|FG003|Overall Study|Lost to Follow-up|6|||
17084962|NCT00235443|38225562|FG004|Overall Study|Lost to Follow-up|4|||
17084963|NCT00235443|38225563|FG005|Overall Study|Lost to Follow-up|3|||
17084964|NCT00235443|38225558|FG000|Overall Study|Unsatisfactory compliance|0|||
17084965|NCT00235443|38225559|FG001|Overall Study|Unsatisfactory compliance|2|||
17084966|NCT00235443|38225560|FG002|Overall Study|Unsatisfactory compliance|3|||
17084967|NCT00235443|38225561|FG003|Overall Study|Unsatisfactory compliance|4|||
17084968|NCT00235443|38225562|FG004|Overall Study|Unsatisfactory compliance|1|||
17084969|NCT00235443|38225563|FG005|Overall Study|Unsatisfactory compliance|0|||
17167878|NCT03126019|38316881|FG001|Overall Study|Reason not Specified|3|||
17167879|NCT03055221|38316888|FG000|Overall Study|Adverse Event|2|||
17167880|NCT03055221|38316888|FG000|Overall Study|Withdrawal by Subject|4|||
17167881|NCT03055221|38316888|FG000|Overall Study|Death|6|||
17167882|NCT03055221|38316888|FG000|Overall Study|Physician Decision|1|||
17167883|NCT03055221|38316888|FG000|Overall Study|Study terminated by Sponsor|3|||
17167884|NCT04497415|38316914|FG000|Overall Study|Lost to Follow-up|43|||
17167885|NCT04497415|38316915|FG001|Overall Study|Lost to Follow-up|27|||
17167886|NCT03125941|38316923|FG000|Overall Study|did not receive intervention|1|||
17167887|NCT03125941|38316924|FG001|Overall Study|did not receive intervention|2|||
17167888|NCT02774889|38316932|FG000|Overall Study|Lost to Follow-up|2|||
17167889|NCT02774889|38316933|FG001|Overall Study|Lost to Follow-up|1|||
17167890|NCT03125629|38316941|FG000|Overall Study|Withdrawal by Subject|2|||
17167891|NCT03125629|38316941|FG000|Overall Study|Equipment malfunction|1|||
17167892|NCT03125395|38316953|FG000|Overall Study|Adverse Event|2|||
17167893|NCT03125395|38316953|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
17167894|NCT03125395|38316953|FG000|Overall Study|Physician Decision|2|||
17167895|NCT03125395|38316953|FG000|Overall Study|Commercial drug is available|5|||
17167896|NCT00261807|38316967|FG000|Overall Study|Lost to Follow-up|2|||
17167897|NCT00261807|38316967|FG000|Overall Study|Adverse Event|2|||
17167898|NCT00261807|38316967|FG000|Overall Study|Death|1|||
17167899|NCT00261807|38316967|FG000|Overall Study|Protocol Violation|2|||
17167900|NCT02820753|38316974|FG000|2 Month|Withdrawal by Subject|3|||
17167901|NCT02820753|38316975|FG001|2 Month|Withdrawal by Subject|3|||
17167902|NCT02820753|38316974|FG000|2 Month|Lost to Follow-up|24|||
17167903|NCT02820753|38316975|FG001|2 Month|Lost to Follow-up|26|||
17167904|NCT02820753|38316974|FG000|2 Month|Stopped per NIH Hold|51|||
17167905|NCT02820753|38316975|FG001|2 Month|Stopped per NIH Hold|13|||
17167906|NCT02820753|38316974|FG000|6 Month|Withdrawal by Subject|2|||
17167907|NCT02820753|38316975|FG001|6 Month|Withdrawal by Subject|2|||
17167908|NCT02820753|38316974|FG000|6 Month|Lost to Follow-up|20|||
17167909|NCT02820753|38316975|FG001|6 Month|Lost to Follow-up|27|||
17167910|NCT02820753|38316974|FG000|6 Month|Stopped per NIH Hold|81|||
17167911|NCT02820753|38316975|FG001|6 Month|Stopped per NIH Hold|81|||
17167912|NCT02820753|38316974|FG000|6 Month|Death|0|||
17167913|NCT02820753|38316975|FG001|6 Month|Death|1|||
17167914|NCT02861586|38316989|FG000|Overall Study|Withdrawal by Subject|1|||
17167915|NCT02861586|38316990|FG001|Overall Study|Withdrawal by Subject|2|||
17167916|NCT02861586|38316991|FG002|Overall Study|Withdrawal by Subject|0|||
17167917|NCT02861586|38316992|FG003|Overall Study|Withdrawal by Subject|0|||
17167918|NCT02861586|38316993|FG004|Overall Study|Withdrawal by Subject|0|||
17167919|NCT02861586|38316994|FG005|Overall Study|Withdrawal by Subject|1|||
17167920|NCT02861586|38316995|FG006|Overall Study|Withdrawal by Subject|1|||
17167921|NCT02861586|38316996|FG007|Overall Study|Withdrawal by Subject|0|||
17167922|NCT02861586|38316989|FG000|Overall Study|Lost to Follow-up|3|||
17167923|NCT02861586|38316990|FG001|Overall Study|Lost to Follow-up|1|||
17167924|NCT02861586|38316991|FG002|Overall Study|Lost to Follow-up|1|||
17167925|NCT02861586|38316992|FG003|Overall Study|Lost to Follow-up|0|||
17167926|NCT02861586|38316993|FG004|Overall Study|Lost to Follow-up|0|||
17167927|NCT02861586|38316994|FG005|Overall Study|Lost to Follow-up|3|||
17167928|NCT02861586|38316995|FG006|Overall Study|Lost to Follow-up|0|||
17167929|NCT02861586|38316996|FG007|Overall Study|Lost to Follow-up|0|||
17167930|NCT02861586|38316989|FG000|Overall Study|Adverse Event|0|||
17167931|NCT02861586|38316990|FG001|Overall Study|Adverse Event|0|||
17167932|NCT02861586|38316991|FG002|Overall Study|Adverse Event|0|||
17167933|NCT02861586|38316992|FG003|Overall Study|Adverse Event|0|||
17167934|NCT02861586|38316993|FG004|Overall Study|Adverse Event|0|||
17167935|NCT02861586|38316994|FG005|Overall Study|Adverse Event|1|||
17167936|NCT02861586|38316995|FG006|Overall Study|Adverse Event|0|||
17167937|NCT02861586|38316996|FG007|Overall Study|Adverse Event|0|||
17167938|NCT03120949|38317032|FG000|Overall Study|randomized in error|1|||
17167939|NCT03120949|38317033|FG001|Overall Study|randomized in error|0|||
17167940|NCT03120949|38317032|FG000|Overall Study|Death|13|||
17167941|NCT03120949|38317033|FG001|Overall Study|Death|13|||
17167942|NCT03120949|38317032|FG000|Overall Study|Lost to Follow-up|23|||
17167943|NCT03120949|38317033|FG001|Overall Study|Lost to Follow-up|13|||
17167944|NCT03120949|38317032|FG000|Overall Study|Withdrawal by Subject|139|||
17167945|NCT03120949|38317033|FG001|Overall Study|Withdrawal by Subject|124|||
17167946|NCT03120949|38317032|FG000|Overall Study|Covid-19|43|||
17167947|NCT03120949|38317033|FG001|Overall Study|Covid-19|34|||
17167948|NCT03120949|38317032|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
17167949|NCT03120949|38317033|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
17167950|NCT03120949|38317032|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
17167951|NCT03120949|38317033|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
17167952|NCT03120949|38317032|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
16996450|NCT00976898|38140487|FG000|Overall Study|Liver Transplant|1|||
16996451|NCT00976898|38140487|FG000|Overall Study|Progressive Disease|1|||
17167953|NCT03120949|38317033|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
17167954|NCT03120949|38317032|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
17167955|NCT03120949|38317033|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
17167956|NCT03120949|38317032|FG000|Overall Study|Site was closed|2|||
17167957|NCT03120949|38317033|FG001|Overall Study|Site was closed|3|||
17167958|NCT03120949|38317032|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
17167959|NCT03120949|38317033|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
17167960|NCT03120949|38317032|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
17167961|NCT03120949|38317033|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
17167962|NCT03120949|38317032|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
17167963|NCT03120949|38317033|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
17167964|NCT03120949|38317032|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
17167965|NCT03120949|38317033|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
17167966|NCT03120949|38317032|FG000|Overall Study|Other: Adverse Event|0|||
17167967|NCT03120949|38317033|FG001|Overall Study|Other: Adverse Event|1|||
17167968|NCT03120949|38317032|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
17167969|NCT03120949|38317033|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
17167970|NCT03120949|38317032|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
17167971|NCT03120949|38317033|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
17167972|NCT03120949|38317032|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
17167973|NCT03120949|38317033|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
17167974|NCT03120949|38317032|FG000|Overall Study|Personal Reasons|0|||
17167975|NCT03120949|38317033|FG001|Overall Study|Personal Reasons|1|||
17167976|NCT03120949|38317032|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
17167977|NCT03120949|38317033|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
17167978|NCT03120949|38317032|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
17167979|NCT03120949|38317033|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
17167980|NCT03120949|38317032|FG000|Overall Study|Compliance With Medication|0|||
17167981|NCT03120949|38317033|FG001|Overall Study|Compliance With Medication|1|||
17167982|NCT03120949|38317032|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
17167983|NCT03120949|38317033|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
17167984|NCT03120949|38317032|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
17167985|NCT03120949|38317033|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
17167986|NCT03120949|38317032|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
17167987|NCT03120949|38317033|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
17167988|NCT03124537|38317052|FG000|Overall Study|Lost to Follow-up|3|||
17167989|NCT03124537|38317053|FG001|Overall Study|Lost to Follow-up|5|||
17167990|NCT03124537|38317052|FG000|Overall Study|App Crash, Incomplete Data|7|||
17167991|NCT03124537|38317053|FG001|Overall Study|App Crash, Incomplete Data|8|||
17084970|NCT00235443|38225558|FG000|Overall Study|Other reasons for premature termination|1|||
17084971|NCT00235443|38225559|FG001|Overall Study|Other reasons for premature termination|6|||
17084972|NCT00235443|38225560|FG002|Overall Study|Other reasons for premature termination|6|||
17084973|NCT00235443|38225561|FG003|Overall Study|Other reasons for premature termination|7|||
17084974|NCT00235443|38225562|FG004|Overall Study|Other reasons for premature termination|3|||
17084975|NCT00235443|38225563|FG005|Overall Study|Other reasons for premature termination|6|||
17084976|NCT00234039|38225579|FG000|Overall Study|Adverse Event|2|||
17084977|NCT00234039|38225579|FG000|Overall Study|Progression/relapse|34|||
17084978|NCT00234039|38225579|FG000|Overall Study|Other - Not Protocol Specified|3|||
17084979|NCT00234039|38225579|FG000|Overall Study|Ineligible|9|||
17084980|NCT00234039|38225579|FG000|Overall Study|No Protocol Treatment Received|2|||
17084981|NCT00323622|38225591|FG000|Overall Study|Other|30|||
17084982|NCT00323622|38225592|FG001|Overall Study|Other|91|||
17084983|NCT00323622|38225593|FG002|Overall Study|Other|4|||
17084984|NCT00323622|38225594|FG003|Overall Study|Other|12|||
17084985|NCT00323622|38225595|FG004|Overall Study|Other|32|||
17084986|NCT00323622|38225596|FG005|Overall Study|Other|74|||
17084987|NCT00323622|38225597|FG006|Overall Study|Other|5|||
17084988|NCT00323622|38225598|FG007|Overall Study|Other|13|||
17084989|NCT00323622|38225591|FG000|Overall Study|Death|1|||
17084990|NCT00323622|38225592|FG001|Overall Study|Death|1|||
17084991|NCT00323622|38225593|FG002|Overall Study|Death|0|||
17084992|NCT00323622|38225594|FG003|Overall Study|Death|0|||
17084993|NCT00323622|38225595|FG004|Overall Study|Death|7|||
17084994|NCT00323622|38225596|FG005|Overall Study|Death|0|||
17167992|NCT03118297|38317061|FG000|Overall Study|Lost to Follow-up|0|||
17167993|NCT03118297|38317062|FG001|Overall Study|Lost to Follow-up|2|||
17167994|NCT03117361|38317068|FG000|Overall Study|Progressive disease|5|||
17167995|NCT03117361|38317068|FG000|Overall Study|Death|1|||
17167996|NCT03117361|38317068|FG000|Overall Study|Physician Decision|2|||
17167997|NCT03117361|38317068|FG000|Overall Study|On study treatment at the end of study|1|||
17167998|NCT03117361|38317068|FG000|Overall Study|Treatment-related adverse event|1|||
17167999|NCT01368614|38317072|FG000|Screening Period|Screen Failure|58|||
17168000|NCT01368614|38317073|FG001|Screening Period|Screen Failure|0|||
17168001|NCT01368614|38317074|FG002|Screening Period|Screen Failure|0|||
17168002|NCT01368614|38317075|FG003|Screening Period|Screen Failure|0|||
17168003|NCT01368614|38317072|FG000|Study Period|Withdrawal by Subject|0|||
17084995|NCT00323622|38225597|FG006|Overall Study|Death|0|||
17168004|NCT01368614|38317073|FG001|Study Period|Withdrawal by Subject|1|||
17168005|NCT01368614|38317074|FG002|Study Period|Withdrawal by Subject|1|||
17168006|NCT01368614|38317075|FG003|Study Period|Withdrawal by Subject|3|||
17168007|NCT01368614|38317072|FG000|Study Period|Lost to Follow-up|0|||
17168008|NCT01368614|38317073|FG001|Study Period|Lost to Follow-up|0|||
17168009|NCT01368614|38317074|FG002|Study Period|Lost to Follow-up|1|||
17084996|NCT00323622|38225598|FG007|Overall Study|Death|2|||
17084997|NCT00189423|38225626|FG000|Overall Study|Death|746|||
17084998|NCT00189423|38225627|FG001|Overall Study|Death|747|||
17084999|NCT00189423|38225626|FG000|Overall Study|Withdrawal by Subject|9|||
17085000|NCT00189423|38225627|FG001|Overall Study|Withdrawal by Subject|9|||
17085001|NCT00189423|38225626|FG000|Overall Study|Lost to Follow-up|10|||
17085002|NCT00189423|38225627|FG001|Overall Study|Lost to Follow-up|10|||
17085003|NCT00323310|38225633|FG000|Overall Study|Withdrawal by Subject|1|||
17168010|NCT01368614|38317075|FG003|Study Period|Lost to Follow-up|0|||
17085004|NCT00323310|38225633|FG000|Overall Study|a parent refused blood draw|1|||
17085005|NCT00323310|38225633|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
17085006|NCT00186537|38225640|FG000|Overall Study|Withdrawal by Subject|4|||
17085007|NCT00186537|38225641|FG001|Overall Study|Withdrawal by Subject|0|||
17085008|NCT00186537|38225642|FG002|Overall Study|Withdrawal by Subject|3|||
17085009|NCT00186537|38225640|FG000|Overall Study|ALT > 1.5 x ULN|3|||
17085010|NCT00186537|38225641|FG001|Overall Study|ALT > 1.5 x ULN|0|||
17085011|NCT00186537|38225642|FG002|Overall Study|ALT > 1.5 x ULN|0|||
17085012|NCT00517751|38225650|FG000|Overall Study|Death|3|||
17085013|NCT00517751|38225650|FG000|Overall Study|Withdrawal by Subject|37|||
17085014|NCT00517751|38225650|FG000|Overall Study|Lost to Follow-up|4|||
17085015|NCT00517751|38225650|FG000|Overall Study|patient not over due|6|||
17085016|NCT00517751|38225650|FG000|Overall Study|Patient not due for visit|76|||
17085017|NCT00517751|38225650|FG000|Overall Study|Missing|3|||
17085018|NCT00322842|38225656|FG000|Overall Study|Withdrawal by Subject|0|||
17085019|NCT00322842|38225657|FG001|Overall Study|Withdrawal by Subject|1|||
17085020|NCT00322842|38225656|FG000|Overall Study|Lost to Follow-up|0|||
17085021|NCT00322842|38225657|FG001|Overall Study|Lost to Follow-up|1|||
17085022|NCT00322842|38225656|FG000|Overall Study|Refused transplant|1|||
17085023|NCT00322842|38225657|FG001|Overall Study|Refused transplant|0|||
17085024|NCT00322842|38225656|FG000|Overall Study|Death|1|||
17085025|NCT00322842|38225657|FG001|Overall Study|Death|0|||
17085026|NCT00255723|38225666|FG000|Overall Study|Adverse Event|1|||
17085027|NCT00255723|38225667|FG001|Overall Study|Adverse Event|1|||
17085028|NCT00255723|38225666|FG000|Overall Study|Death|0|||
17085029|NCT00255723|38225667|FG001|Overall Study|Death|1|||
17085030|NCT00255723|38225666|FG000|Overall Study|Response Data Not Available|1|||
17085031|NCT00255723|38225667|FG001|Overall Study|Response Data Not Available|0|||
17085032|NCT00132808|38225676|FG000|Stratum I|Adverse Event|2|||
17085033|NCT00132808|38225677|FG001|Stratum I|Adverse Event|1|||
17085034|NCT00132808|38225678|FG002|Stratum I|Adverse Event|0|||
17085035|NCT00132808|38225676|FG000|Stratum I|Lost to Follow-up|3|||
17085036|NCT00132808|38225677|FG001|Stratum I|Lost to Follow-up|4|||
17085037|NCT00132808|38225678|FG002|Stratum I|Lost to Follow-up|1|||
17085038|NCT00132808|38225676|FG000|Stratum I|Withdrawal by Subject|4|||
17085039|NCT00132808|38225677|FG001|Stratum I|Withdrawal by Subject|7|||
17085040|NCT00132808|38225678|FG002|Stratum I|Withdrawal by Subject|3|||
17085041|NCT00132808|38225676|FG000|Stratum I|Abnormal test procedure result (s)|0|||
17085042|NCT00132808|38225677|FG001|Stratum I|Abnormal test procedure result (s)|0|||
17085043|NCT00132808|38225678|FG002|Stratum I|Abnormal test procedure result (s)|1|||
17085044|NCT00132808|38225676|FG000|Stratum II|Adverse Event|1|||
17168011|NCT03053427|38317085|FG000|Overall Study|Adverse Event|4|||
17168012|NCT03053427|38317086|FG001|Overall Study|Adverse Event|4|||
17168013|NCT03053427|38317085|FG000|Overall Study|Lack of Efficacy|1|||
17168014|NCT03053427|38317086|FG001|Overall Study|Lack of Efficacy|3|||
17168015|NCT03053427|38317085|FG000|Overall Study|Lost to Follow-up|2|||
17168016|NCT03053427|38317086|FG001|Overall Study|Lost to Follow-up|2|||
17168017|NCT03053427|38317085|FG000|Overall Study|Worsening of the target disease|0|||
17085045|NCT00132808|38225677|FG001|Stratum II|Adverse Event|2|||
17085046|NCT00132808|38225678|FG002|Stratum II|Adverse Event|1|||
17168018|NCT03053427|38317086|FG001|Overall Study|Worsening of the target disease|1|||
17168019|NCT03053427|38317085|FG000|Overall Study|Protocol Deviation|3|||
17168020|NCT03053427|38317086|FG001|Overall Study|Protocol Deviation|3|||
17168021|NCT03053427|38317085|FG000|Overall Study|Withdrawal by Subject|3|||
17168022|NCT03053427|38317086|FG001|Overall Study|Withdrawal by Subject|2|||
17168023|NCT03053427|38317085|FG000|Overall Study|Miscellaneous|0|||
17168024|NCT03053427|38317086|FG001|Overall Study|Miscellaneous|1|||
17168025|NCT03052959|38317103|FG000|Overall Study|Lost to Follow-up|4|||
17168026|NCT03052959|38317104|FG001|Overall Study|Lost to Follow-up|5|||
17168027|NCT03120013|38317111|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
17168028|NCT03120013|38317112|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
17168029|NCT01845649|38317120|FG000|Overall Study|Adverse Event|7|||
17168030|NCT01845649|38317121|FG001|Overall Study|Adverse Event|10|||
17168031|NCT01845649|38317120|FG000|Overall Study|Lack of Efficacy|1|||
17168032|NCT01845649|38317121|FG001|Overall Study|Lack of Efficacy|1|||
17168033|NCT01845649|38317120|FG000|Overall Study|Lost to Follow-up|2|||
17168034|NCT01845649|38317121|FG001|Overall Study|Lost to Follow-up|2|||
17168035|NCT01845649|38317120|FG000|Overall Study|Withdrew Consent|12|||
17168036|NCT01845649|38317121|FG001|Overall Study|Withdrew Consent|4|||
17168037|NCT01845649|38317120|FG000|Overall Study|Protocol Deviation|7|||
17168038|NCT01845649|38317121|FG001|Overall Study|Protocol Deviation|4|||
17168039|NCT01845649|38317120|FG000|Overall Study|Reason not Specified|2|||
17168040|NCT01845649|38317121|FG001|Overall Study|Reason not Specified|1|||
17168041|NCT01345929|38317129|FG000|Overall Study|Withdrawal by Subject|9|||
17168042|NCT01345929|38317130|FG001|Overall Study|Withdrawal by Subject|8|||
17168043|NCT01345929|38317129|FG000|Overall Study|Lost to Follow-up|9|||
17168044|NCT01345929|38317130|FG001|Overall Study|Lost to Follow-up|9|||
17168045|NCT01345929|38317129|FG000|Overall Study|Adverse Event|0|||
17168046|NCT01345929|38317130|FG001|Overall Study|Adverse Event|1|||
17168047|NCT01345929|38317129|FG000|Overall Study|Didn't meet eligibility criteria|2|||
17168048|NCT01345929|38317130|FG001|Overall Study|Didn't meet eligibility criteria|0|||
17168049|NCT01345929|38317129|FG000|Overall Study|40,000 CFU/ML|1|||
17168050|NCT01345929|38317130|FG001|Overall Study|40,000 CFU/ML|0|||
17168051|NCT01345929|38317129|FG000|Overall Study|Patient withdrawal|0|||
17168052|NCT01345929|38317130|FG001|Overall Study|Patient withdrawal|1|||
17168053|NCT01343901|38317136|FG000|Overall Study|Death|85|||
17168054|NCT01343901|38317136|FG000|Overall Study|Physician Decision|4|||
17168055|NCT01343901|38317136|FG000|Overall Study|Lost to Follow-up|12|||
17168056|NCT01343901|38317136|FG000|Overall Study|Management by another medical team|11|||
17168057|NCT01343901|38317136|FG000|Overall Study|Participant decision|1|||
17168058|NCT03053271|38317140|FG000|Overall Study|Did not meet randomization criteria|3|||
17168059|NCT03053271|38317140|FG000|Overall Study|Withdrawal by Subject|1|||
17085047|NCT00132808|38225676|FG000|Stratum II|Death|1|||
17085048|NCT00132808|38225677|FG001|Stratum II|Death|0|||
17085049|NCT00132808|38225678|FG002|Stratum II|Death|0|||
17085050|NCT00132808|38225676|FG000|Stratum II|Lost to Follow-up|2|||
17085051|NCT00132808|38225677|FG001|Stratum II|Lost to Follow-up|2|||
17085052|NCT00132808|38225678|FG002|Stratum II|Lost to Follow-up|1|||
17085053|NCT00132808|38225676|FG000|Stratum II|Protocol Violation|0|||
17085054|NCT00132808|38225677|FG001|Stratum II|Protocol Violation|2|||
17085055|NCT00132808|38225678|FG002|Stratum II|Protocol Violation|1|||
17085056|NCT00132808|38225676|FG000|Stratum II|Withdrawal by Subject|4|||
17085057|NCT00132808|38225677|FG001|Stratum II|Withdrawal by Subject|9|||
17085058|NCT00132808|38225678|FG002|Stratum II|Withdrawal by Subject|6|||
17085059|NCT00517361|38225686|FG000|Overall Study|Death|6|||
17085060|NCT00517361|38225686|FG000|Overall Study|The study was terminated|5|||
17085061|NCT00516893|38225690|FG000|Overall Study|Lost to Follow-up|4|||
17085062|NCT00516893|38225690|FG000|Overall Study|Adverse Event|3|||
17085063|NCT00516893|38225690|FG000|Overall Study|Withdrawal by Subject|2|||
17085064|NCT00516893|38225690|FG000|Overall Study|Noncompliance|2|||
17085065|NCT00516893|38225690|FG000|Overall Study|Death|1|||
17085066|NCT00516893|38225690|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
17085067|NCT00516893|38225690|FG000|Overall Study|Relocated|1|||
17085068|NCT00516893|38225690|FG000|Overall Study|Pregnancy|1|||
17085069|NCT00516893|38225690|FG000|Overall Study|Received Medication From Another Study|1|||
17085070|NCT00522431|38225694|FG000|Overall Study|Adverse Event|5|||
17085071|NCT00522431|38225694|FG000|Overall Study|Protocol Violation|2|||
17085072|NCT00522431|38225694|FG000|Overall Study|Withdrawal by Subject|2|||
17085073|NCT00522431|38225694|FG000|Overall Study|Subject non-compliance|1|||
17085074|NCT00522431|38225694|FG000|Overall Study|Other/unknown|1|||
17085075|NCT00185211|38225700|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
17085076|NCT00185211|38225701|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
17085077|NCT00185211|38225700|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
17085078|NCT00185211|38225701|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
17085079|NCT00185211|38225700|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
17085080|NCT00185211|38225701|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
17085081|NCT00185211|38225700|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
17085082|NCT00185211|38225701|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
17168060|NCT01343823|38317148|FG000|Overall Study|Study Terminated|1|||
17168061|NCT01343823|38317149|FG001|Overall Study|Study Terminated|0|||
17168062|NCT01343823|38317150|FG002|Overall Study|Study Terminated|0|||
17168063|NCT01343823|38317151|FG003|Overall Study|Study Terminated|1|||
17168064|NCT01343823|38317148|FG000|Overall Study|Withdrawal by Subject|1|||
17168065|NCT01343823|38317149|FG001|Overall Study|Withdrawal by Subject|0|||
17168066|NCT01343823|38317150|FG002|Overall Study|Withdrawal by Subject|0|||
17168067|NCT01343823|38317151|FG003|Overall Study|Withdrawal by Subject|0|||
17168068|NCT01318083|38317164|FG000|Overall Study|Adverse Event|4|||
17168069|NCT01318083|38317165|FG001|Overall Study|Adverse Event|1|||
17168070|NCT01318083|38317166|FG002|Overall Study|Adverse Event|2|||
17168071|NCT01318083|38317164|FG000|Overall Study|Withdrawal by Subject|1|||
17168072|NCT01318083|38317165|FG001|Overall Study|Withdrawal by Subject|0|||
17168073|NCT01318083|38317166|FG002|Overall Study|Withdrawal by Subject|2|||
17168074|NCT01318083|38317164|FG000|Overall Study|Lack of Efficacy|0|||
17168075|NCT01318083|38317165|FG001|Overall Study|Lack of Efficacy|0|||
17168076|NCT01318083|38317166|FG002|Overall Study|Lack of Efficacy|1|||
17168077|NCT01318083|38317164|FG000|Overall Study|Treatment Complications|1|||
17168078|NCT01318083|38317165|FG001|Overall Study|Treatment Complications|0|||
17168079|NCT01318083|38317166|FG002|Overall Study|Treatment Complications|0|||
17168080|NCT01318083|38317164|FG000|Overall Study|Lack of Study Medication Compliance|0|||
17168081|NCT01318083|38317165|FG001|Overall Study|Lack of Study Medication Compliance|1|||
17168082|NCT01318083|38317166|FG002|Overall Study|Lack of Study Medication Compliance|0|||
17168083|NCT01376323|38317179|FG000|Overall Study|Adverse Event|1|||
17168084|NCT01376323|38317180|FG001|Overall Study|Adverse Event|0|||
17168085|NCT01376323|38317181|FG002|Overall Study|Adverse Event|0|||
17168086|NCT01376323|38317182|FG003|Overall Study|Adverse Event|2|||
17168087|NCT01376323|38317183|FG004|Overall Study|Adverse Event|0|||
17168088|NCT01376323|38317179|FG000|Overall Study|Lost to Follow-up|0|||
17168089|NCT01376323|38317180|FG001|Overall Study|Lost to Follow-up|0|||
17168090|NCT01376323|38317181|FG002|Overall Study|Lost to Follow-up|0|||
17168091|NCT01376323|38317182|FG003|Overall Study|Lost to Follow-up|2|||
17168092|NCT01376323|38317183|FG004|Overall Study|Lost to Follow-up|0|||
17168093|NCT01376323|38317179|FG000|Overall Study|Physician Decision|1|||
17168094|NCT01376323|38317180|FG001|Overall Study|Physician Decision|0|||
17168095|NCT01376323|38317181|FG002|Overall Study|Physician Decision|2|||
17168096|NCT01376323|38317182|FG003|Overall Study|Physician Decision|1|||
17168097|NCT01376323|38317183|FG004|Overall Study|Physician Decision|1|||
17168098|NCT01376323|38317179|FG000|Overall Study|Withdrawal by Subject|0|||
17168099|NCT01376323|38317180|FG001|Overall Study|Withdrawal by Subject|1|||
17168100|NCT01376323|38317181|FG002|Overall Study|Withdrawal by Subject|1|||
17168101|NCT01376323|38317182|FG003|Overall Study|Withdrawal by Subject|0|||
17168102|NCT01376323|38317183|FG004|Overall Study|Withdrawal by Subject|0|||
17168103|NCT03725293|38317220|FG000|Overall Study|Physician Decision|9|||
17168104|NCT03725293|38317221|FG001|Overall Study|Physician Decision|6|||
17168105|NCT03725293|38317220|FG000|Overall Study|alternative vascular access needs|1|||
17168106|NCT03725293|38317221|FG001|Overall Study|alternative vascular access needs|2|||
17168107|NCT03725293|38317220|FG000|Overall Study|venous anatomy screen failures|2|||
17168108|NCT03725293|38317221|FG001|Overall Study|venous anatomy screen failures|1|||
17168109|NCT01368536|38317230|FG000|Overall Study|Adverse Event|5|||
17168110|NCT01368536|38317231|FG001|Overall Study|Adverse Event|6|||
17168111|NCT01368536|38317232|FG002|Overall Study|Adverse Event|8|||
17168112|NCT01368536|38317230|FG000|Overall Study|Abnormal laboratory value(s)|0|||
17168113|NCT01368536|38317231|FG001|Overall Study|Abnormal laboratory value(s)|1|||
17168114|NCT01368536|38317232|FG002|Overall Study|Abnormal laboratory value(s)|2|||
17168115|NCT01368536|38317230|FG000|Overall Study|Abnormal test procedure result(s)|0|||
17168116|NCT01368536|38317231|FG001|Overall Study|Abnormal test procedure result(s)|0|||
17168117|NCT01368536|38317232|FG002|Overall Study|Abnormal test procedure result(s)|1|||
17168118|NCT01368536|38317230|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
17168119|NCT01368536|38317231|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
17168120|NCT01368536|38317232|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
17168121|NCT01368536|38317230|FG000|Overall Study|No longer required study medication|0|||
17168122|NCT01368536|38317231|FG001|Overall Study|No longer required study medication|0|||
16996452|NCT02620579|38140499|FG000|Overall Study|Physician Decision|0|||
17168123|NCT01368536|38317232|FG002|Overall Study|No longer required study medication|1|||
17168124|NCT01368536|38317230|FG000|Overall Study|Withdrawal by Subject|2|||
17168125|NCT01368536|38317231|FG001|Overall Study|Withdrawal by Subject|5|||
17168126|NCT01368536|38317232|FG002|Overall Study|Withdrawal by Subject|4|||
17168127|NCT01368536|38317230|FG000|Overall Study|Lost to Follow-up|3|||
17168128|NCT01368536|38317231|FG001|Overall Study|Lost to Follow-up|3|||
17168129|NCT01368536|38317232|FG002|Overall Study|Lost to Follow-up|5|||
17168130|NCT01368536|38317230|FG000|Overall Study|Administrative problems|34|||
17168131|NCT01368536|38317231|FG001|Overall Study|Administrative problems|39|||
17168132|NCT01368536|38317232|FG002|Overall Study|Administrative problems|35|||
17168133|NCT01368536|38317230|FG000|Overall Study|Protocol deviation|0|||
17168134|NCT01368536|38317231|FG001|Overall Study|Protocol deviation|3|||
17168135|NCT01368536|38317232|FG002|Overall Study|Protocol deviation|1|||
17168136|NCT03051165|38317241|FG000|Overall Study|Withdrawal by Subject|1|||
17168137|NCT03051165|38317241|FG000|Overall Study|Early termination of study|12|||
17168138|NCT01319929|38317247|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
17168139|NCT01319929|38317248|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
17168140|NCT01319929|38317247|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
17168141|NCT01319929|38317248|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
17168142|NCT01319929|38317247|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
17168143|NCT01319929|38317248|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
17168144|NCT01319929|38317247|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
17168145|NCT01319929|38317248|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
17168146|NCT01319929|38317247|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
17168147|NCT01319929|38317248|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
17168148|NCT03110185|38317257|FG000|Overall Study|Death|0|||
17168149|NCT03110185|38317258|FG001|Overall Study|Death|1|||
17168150|NCT03110185|38317257|FG000|Overall Study|Withdrawal by Subject|2|||
17168151|NCT03110185|38317258|FG001|Overall Study|Withdrawal by Subject|7|||
17168152|NCT03110185|38317257|FG000|Overall Study|Time Constraints|0|||
17168153|NCT03110185|38317258|FG001|Overall Study|Time Constraints|6|||
17168154|NCT03110185|38317257|FG000|Overall Study|Conflict with care|5|||
17168155|NCT03110185|38317258|FG001|Overall Study|Conflict with care|12|||
17168156|NCT03110185|38317257|FG000|Overall Study|Protocol Violation|1|||
17168157|NCT03110185|38317258|FG001|Overall Study|Protocol Violation|4|||
17168158|NCT03110185|38317257|FG000|Overall Study|MRI Incompatible|2|||
17168159|NCT03110185|38317258|FG001|Overall Study|MRI Incompatible|0|||
17168160|NCT03110185|38317257|FG000|Overall Study|Patient Refusal|0|||
17168161|NCT03110185|38317258|FG001|Overall Study|Patient Refusal|1|||
17168162|NCT02858076|38317269|FG000|Overall Study|Death|6|||
17168163|NCT02858076|38317270|FG001|Overall Study|Death|3|||
17168164|NCT02858076|38317269|FG000|Overall Study|Withdrawal by Subject|1|||
17168165|NCT02858076|38317270|FG001|Overall Study|Withdrawal by Subject|5|||
17168166|NCT02858076|38317269|FG000|Overall Study|Lost to Follow-up|2|||
17168167|NCT02858076|38317270|FG001|Overall Study|Lost to Follow-up|7|||
17168168|NCT02858076|38317269|FG000|Overall Study|Completed Out of Window|1|||
17168169|NCT02858076|38317270|FG001|Overall Study|Completed Out of Window|3|||
17168170|NCT04594759|38317278|FG000|Overall Study|Lost to Follow-up|3|||
17168171|NCT02856282|38317282|FG000|Overall Study|Withdrawal by Subject|1|||
17168172|NCT02063724|38317286|FG000|Overall Study|Disease progression|1|||
17168173|NCT03833817|38317292|FG000|Overall Study|Withdrawal by Subject|3|||
17168174|NCT03833817|38317293|FG001|Overall Study|Withdrawal by Subject|3|||
17085083|NCT00185211|38225700|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
17085084|NCT00185211|38225701|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
17168175|NCT03833817|38317292|FG000|Overall Study|Lost to Follow-up|3|||
17168176|NCT03833817|38317293|FG001|Overall Study|Lost to Follow-up|3|||
17168177|NCT03119701|38317301|FG000|6-day Dosing|Death|4|||
17168178|NCT03119701|38317302|FG001|6-day Dosing|Death|1|||
17168179|NCT03119701|38317301|FG000|6-day Dosing|Adverse Event|3|||
17168180|NCT03119701|38317302|FG001|6-day Dosing|Adverse Event|0|||
17168181|NCT03119701|38317301|FG000|6-day Dosing|Physician Decision|0|||
17168182|NCT03119701|38317302|FG001|6-day Dosing|Physician Decision|1|||
17168183|NCT03119701|38317301|FG000|6-day Dosing|Withdrawal by Subject|0|||
17168184|NCT03119701|38317302|FG001|6-day Dosing|Withdrawal by Subject|1|||
17168185|NCT03119701|38317301|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
17168186|NCT03119701|38317302|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
17168187|NCT02679781|38317316|FG000|Overall Study|Lost to Follow-up|1|||
17168188|NCT02679781|38317317|FG001|Overall Study|Lost to Follow-up|2|||
17168189|NCT02679781|38317316|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
17168190|NCT02679781|38317317|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
17168191|NCT02624869|38317326|FG000|Overall Study|Lost to Follow-up|0|||
17168192|NCT02624869|38317327|FG001|Overall Study|Lost to Follow-up|0|||
17168193|NCT02624869|38317328|FG002|Overall Study|Lost to Follow-up|1|||
17168194|NCT02624869|38317326|FG000|Overall Study|Withdrawal by Subject|1|||
17168195|NCT02624869|38317327|FG001|Overall Study|Withdrawal by Subject|3|||
17168196|NCT02624869|38317328|FG002|Overall Study|Withdrawal by Subject|1|||
17168197|NCT03110029|38317348|FG000|Overall Study|Withdrawal by Subject|1|||
16996453|NCT02620579|38140500|FG001|Overall Study|Physician Decision|0|||
17085085|NCT00185211|38225700|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
17085086|NCT00185211|38225701|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
17085087|NCT00185211|38225700|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
17085088|NCT00185211|38225701|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
17085089|NCT00185211|38225700|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
17085090|NCT00185211|38225701|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
17085091|NCT00185211|38225700|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
17085092|NCT00185211|38225701|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
17085093|NCT00185211|38225700|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
17085094|NCT00185211|38225701|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
17085095|NCT00185211|38225700|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
17085096|NCT00185211|38225701|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
17085097|NCT00185211|38225700|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
17085098|NCT00185211|38225701|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
17085099|NCT00516737|38225710|FG000|Overall Study|Lost to Follow-up|2|||
17085100|NCT00516737|38225711|FG001|Overall Study|Lost to Follow-up|0|||
17085101|NCT00516737|38225710|FG000|Overall Study|Physician Decision|0|||
17085102|NCT00516737|38225711|FG001|Overall Study|Physician Decision|1|||
17085103|NCT00516737|38225710|FG000|Overall Study|Withdrawal by Subject|0|||
17085104|NCT00516737|38225711|FG001|Overall Study|Withdrawal by Subject|1|||
17085105|NCT00516737|38225710|FG000|Overall Study|Lack of Qualifying Event|9|||
17085106|NCT00516737|38225711|FG001|Overall Study|Lack of Qualifying Event|6|||
17085107|NCT00132730|38225721|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
17085108|NCT00132730|38225722|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
17168198|NCT03110029|38317349|FG001|Overall Study|Withdrawal by Subject|1|||
17168199|NCT02747004|38317358|FG000|Overall Study|Withdrawal by Subject|8|||
17168200|NCT02747004|38317359|FG001|Overall Study|Withdrawal by Subject|5|||
17168201|NCT02747004|38317360|FG002|Overall Study|Withdrawal by Subject|4|||
17168202|NCT02747004|38317358|FG000|Overall Study|Lost to Follow-up|1|||
17168203|NCT02747004|38317359|FG001|Overall Study|Lost to Follow-up|2|||
17168204|NCT02747004|38317360|FG002|Overall Study|Lost to Follow-up|2|||
17168205|NCT02747004|38317358|FG000|Overall Study|on study treatment/follow-up|48|||
17168206|NCT02747004|38317359|FG001|Overall Study|on study treatment/follow-up|42|||
17168207|NCT02747004|38317360|FG002|Overall Study|on study treatment/follow-up|41|||
17168208|NCT04207749|38317370|FG000|Overall Study|Lost to Follow-up|0|||
17168209|NCT04207749|38317371|FG001|Overall Study|Lost to Follow-up|2|||
17168210|NCT04207749|38317370|FG000|Overall Study|Protocol Violation|0|||
17168211|NCT04207749|38317371|FG001|Overall Study|Protocol Violation|1|||
17168212|NCT04207749|38317370|FG000|Overall Study|Withdrawal by Subject|3|||
17168213|NCT04207749|38317371|FG001|Overall Study|Withdrawal by Subject|0|||
17168214|NCT04207749|38317370|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
17168215|NCT04207749|38317371|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
17168216|NCT03043365|38317382|FG000|Weeks 0 to Week 8|Adverse Event|1|||
17168217|NCT03043365|38317383|FG001|Weeks 0 to Week 8|Adverse Event|3|||
17168218|NCT03043365|38317382|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
17168219|NCT03043365|38317383|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
17168220|NCT03043365|38317382|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
17168221|NCT03043365|38317383|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
17168222|NCT03108157|38317393|FG000|Overall Study|Protocol Violation|15|||
17168223|NCT03108157|38317394|FG001|Overall Study|Protocol Violation|4|||
17168224|NCT04421131|38317401|FG000|Overall Study|Lost to Follow-up|1|||
17168225|NCT04421131|38317401|FG000|Overall Study|Protocol Violation|2|||
17168226|NCT04421131|38317401|FG000|Overall Study|App crashed|5|||
17168227|NCT04167345|38317410|FG000|Overall Study|Other|1|||
17168228|NCT04167345|38317411|FG001|Overall Study|Other|1|||
17168229|NCT04167345|38317412|FG002|Overall Study|Other|0|||
17168230|NCT04167345|38317413|FG003|Overall Study|Other|0|||
17168231|NCT04167345|38317414|FG004|Overall Study|Other|0|||
17168232|NCT02854800|38317433|FG000|Overall Study|Protocol Violation|16|||
17168233|NCT02854800|38317434|FG001|Overall Study|Protocol Violation|11|||
17168234|NCT02854800|38317435|FG002|Overall Study|Protocol Violation|3|||
17168235|NCT02854800|38317433|FG000|Overall Study|Withdrawal by Subject|4|||
17168236|NCT02854800|38317434|FG001|Overall Study|Withdrawal by Subject|2|||
17168237|NCT02854800|38317435|FG002|Overall Study|Withdrawal by Subject|3|||
17168238|NCT02931539|38317448|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
17168239|NCT02931539|38317449|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
17168240|NCT02931539|38317450|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
17168241|NCT02931539|38317448|FG000|Period 1: Treatment Phase|Adverse Event|5|||
17168242|NCT02931539|38317449|FG001|Period 1: Treatment Phase|Adverse Event|1|||
17168243|NCT02931539|38317450|FG002|Period 1: Treatment Phase|Adverse Event|0|||
17168244|NCT02931539|38317448|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
17168245|NCT02931539|38317449|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
17168246|NCT02931539|38317450|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
17168247|NCT02931539|38317448|FG000|Period 1: Treatment Phase|Death|8|||
17168248|NCT02931539|38317449|FG001|Period 1: Treatment Phase|Death|24|||
17085109|NCT00132730|38225723|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
17168249|NCT02931539|38317450|FG002|Period 1: Treatment Phase|Death|0|||
17168250|NCT02931539|38317448|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
17168251|NCT02931539|38317449|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
17168252|NCT02931539|38317450|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
17168253|NCT02931539|38317448|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
17168254|NCT02931539|38317449|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
17168255|NCT02931539|38317450|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
17168256|NCT02931539|38317448|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
17168257|NCT02931539|38317449|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
17168258|NCT02931539|38317450|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
17168259|NCT02931539|38317448|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
17168260|NCT02931539|38317449|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
17168261|NCT02931539|38317450|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
17168262|NCT04042077|38317467|FG000|Overall Study|Adverse Event|0|||
17168263|NCT04042077|38317468|FG001|Overall Study|Adverse Event|1|||
17168264|NCT04042077|38317467|FG000|Overall Study|Death|2|||
17168265|NCT04042077|38317468|FG001|Overall Study|Death|1|||
17168266|NCT04042077|38317467|FG000|Overall Study|Physician Decision|2|||
17168267|NCT04042077|38317468|FG001|Overall Study|Physician Decision|0|||
17168268|NCT04042077|38317467|FG000|Overall Study|Withdrawal by Subject|3|||
17168269|NCT04042077|38317468|FG001|Overall Study|Withdrawal by Subject|2|||
17168270|NCT04042077|38317467|FG000|Overall Study|Lack of Efficacy|0|||
17168271|NCT04042077|38317468|FG001|Overall Study|Lack of Efficacy|1|||
17168272|NCT02853318|38317489|FG000|Overall Study|Withdrawal by Subject|1|||
17168273|NCT03113071|38317499|FG000|Overall Study|Withdrawal by Subject|1|||
17168274|NCT03113071|38317500|FG001|Overall Study|Withdrawal by Subject|0|||
17168275|NCT03050307|38317508|FG000|Overall Study|Adverse Event|4|||
17168276|NCT03050307|38317509|FG001|Overall Study|Adverse Event|2|||
17085110|NCT00132730|38225724|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
17085111|NCT00132730|38225725|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
17085112|NCT00132730|38225726|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
17085113|NCT00132730|38225721|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
17085114|NCT00132730|38225722|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
17085115|NCT00132730|38225723|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
17085116|NCT00132730|38225724|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
17168277|NCT03050307|38317508|FG000|Overall Study|Significant Protocol Deviation|0|||
17168278|NCT03050307|38317509|FG001|Overall Study|Significant Protocol Deviation|1|||
17168279|NCT03050307|38317508|FG000|Overall Study|Lost to Follow-up|0|||
17168280|NCT03050307|38317509|FG001|Overall Study|Lost to Follow-up|1|||
17168281|NCT03050307|38317508|FG000|Overall Study|Voluntary Withdrawal|3|||
17168282|NCT03050307|38317509|FG001|Overall Study|Voluntary Withdrawal|4|||
17168283|NCT03050307|38317508|FG000|Overall Study|Reason not Specified|1|||
17168284|NCT03050307|38317509|FG001|Overall Study|Reason not Specified|1|||
17168285|NCT03118765|38317535|FG000|Overall Study|Withdrawal by Subject|0|||
17168286|NCT03118765|38317536|FG001|Overall Study|Withdrawal by Subject|0|||
17168287|NCT03118765|38317537|FG002|Overall Study|Withdrawal by Subject|1|||
17168288|NCT03118765|38317538|FG003|Overall Study|Withdrawal by Subject|0|||
17168289|NCT03118765|38317539|FG004|Overall Study|Withdrawal by Subject|0|||
17168290|NCT03118765|38317535|FG000|Overall Study|Adverse Event|1|||
17168291|NCT03118765|38317536|FG001|Overall Study|Adverse Event|1|||
17168292|NCT03118765|38317537|FG002|Overall Study|Adverse Event|1|||
17168293|NCT03118765|38317538|FG003|Overall Study|Adverse Event|1|||
17168294|NCT03118765|38317539|FG004|Overall Study|Adverse Event|1|||
17168295|NCT03118765|38317535|FG000|Overall Study|Non compliance with Study Procedures|0|||
17168296|NCT03118765|38317536|FG001|Overall Study|Non compliance with Study Procedures|0|||
17085117|NCT00132730|38225725|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
17085118|NCT00132730|38225726|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
17085119|NCT00132730|38225721|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
17085120|NCT00132730|38225722|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
17085121|NCT00132730|38225723|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
17085122|NCT00132730|38225724|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
17085123|NCT00132730|38225725|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
17085124|NCT00132730|38225726|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
17085125|NCT00132730|38225721|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
17168297|NCT03118765|38317537|FG002|Overall Study|Non compliance with Study Procedures|0|||
17168298|NCT03118765|38317538|FG003|Overall Study|Non compliance with Study Procedures|1|||
17168299|NCT03118765|38317539|FG004|Overall Study|Non compliance with Study Procedures|0|||
17168300|NCT03118765|38317535|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
17168301|NCT03118765|38317536|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
17168302|NCT03118765|38317537|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
17168303|NCT03118765|38317538|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
17168304|NCT03118765|38317539|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
17168305|NCT03118765|38317535|FG000|Overall Study|COPD Exacerbation|1|||
17168306|NCT03118765|38317536|FG001|Overall Study|COPD Exacerbation|0|||
17168307|NCT03118765|38317537|FG002|Overall Study|COPD Exacerbation|0|||
17168308|NCT03118765|38317538|FG003|Overall Study|COPD Exacerbation|1|||
17168309|NCT03118765|38317539|FG004|Overall Study|COPD Exacerbation|0|||
17168310|NCT03118765|38317535|FG000|Overall Study|Lost to Follow-up|1|||
17168311|NCT03118765|38317536|FG001|Overall Study|Lost to Follow-up|0|||
17168312|NCT03118765|38317537|FG002|Overall Study|Lost to Follow-up|1|||
17168313|NCT03118765|38317538|FG003|Overall Study|Lost to Follow-up|0|||
17168314|NCT03118765|38317539|FG004|Overall Study|Lost to Follow-up|0|||
17168315|NCT03118765|38317535|FG000|Overall Study|Sponsor Decision|1|||
17085126|NCT00132730|38225722|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
17085127|NCT00132730|38225723|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
17085128|NCT00132730|38225724|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
17085129|NCT00132730|38225725|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
17085130|NCT00132730|38225726|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
17085131|NCT00132730|38225721|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
17085132|NCT00132730|38225722|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
17085133|NCT00132730|38225723|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
17085134|NCT00132730|38225724|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
17085135|NCT00132730|38225725|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
17085136|NCT00132730|38225726|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
17085137|NCT00132730|38225721|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
17085138|NCT00132730|38225722|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
17085139|NCT00132730|38225723|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
17085140|NCT00132730|38225724|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
17085141|NCT00132730|38225725|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
17085142|NCT00132730|38225726|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
17085143|NCT00132730|38225721|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
17085144|NCT00132730|38225722|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
17085145|NCT00132730|38225723|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
17085146|NCT00132730|38225724|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
17085147|NCT00132730|38225725|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
17085148|NCT00132730|38225726|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
17085149|NCT00132730|38225721|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
17085150|NCT00132730|38225722|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
17085151|NCT00132730|38225723|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
17085152|NCT00132730|38225724|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
17085153|NCT00132730|38225725|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
17085154|NCT00132730|38225726|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
17085155|NCT00132730|38225721|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
17085156|NCT00132730|38225722|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
17085157|NCT00132730|38225723|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
17085158|NCT00132730|38225724|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
17085159|NCT00132730|38225725|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
17085160|NCT00132730|38225726|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
17085161|NCT00132730|38225721|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
17085162|NCT00132730|38225722|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
17085163|NCT00132730|38225723|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
17085164|NCT00132730|38225724|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
17085165|NCT00132730|38225725|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
17085166|NCT00132730|38225726|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
17085167|NCT00132730|38225721|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
17085168|NCT00132730|38225722|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
17085169|NCT00132730|38225723|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
17085170|NCT00132730|38225724|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
17085171|NCT00132730|38225725|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
17085172|NCT00132730|38225726|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
17085173|NCT00132730|38225721|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
17085174|NCT00132730|38225722|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
17085175|NCT00132730|38225723|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
17085176|NCT00132730|38225724|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
17085177|NCT00132730|38225725|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
17085178|NCT00132730|38225726|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
17085179|NCT00232557|38225742|FG000|Overall Study|Lost to Follow-up|3|||
17085180|NCT00232557|38225743|FG001|Overall Study|Lost to Follow-up|5|||
17085181|NCT00522275|38225749|FG000|Overall Study|Adverse Event|35|||
17085182|NCT00522275|38225749|FG000|Overall Study|Lack of Efficacy|80|||
17085183|NCT00522275|38225749|FG000|Overall Study|Subject withdrew consent|16|||
17168316|NCT03118765|38317536|FG001|Overall Study|Sponsor Decision|0|||
17168317|NCT03118765|38317537|FG002|Overall Study|Sponsor Decision|1|||
17168318|NCT03118765|38317538|FG003|Overall Study|Sponsor Decision|0|||
17085184|NCT00522275|38225749|FG000|Overall Study|Protocol deviation|1|||
17085185|NCT00522275|38225749|FG000|Overall Study|Unsatisfactory compliance|11|||
17085186|NCT00522275|38225749|FG000|Overall Study|Lost to Follow-up|8|||
17085187|NCT00522275|38225749|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
17085188|NCT00522275|38225749|FG000|Overall Study|Other: Subject is pregnant|2|||
17085189|NCT00522275|38225749|FG000|Overall Study|Other: Subject relocated|2|||
17085190|NCT00522275|38225749|FG000|Overall Study|Other: Subject arrested|1|||
17085191|NCT00522275|38225749|FG000|Overall Study|Other: Site / clinic closed|4|||
17085192|NCT00522275|38225749|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
17085193|NCT00522275|38225749|FG000|Overall Study|Other: Sponsor request|2|||
17085194|NCT00522275|38225749|FG000|Overall Study|Other: Subject ran out of medication|1|||
17085195|NCT00522275|38225749|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
17085196|NCT00522041|38225755|FG000|Overall Study|Adverse Event|9|||
17085197|NCT00522041|38225756|FG001|Overall Study|Adverse Event|3|||
17085198|NCT00522041|38225755|FG000|Overall Study|Protocol Violation|2|||
17085199|NCT00522041|38225756|FG001|Overall Study|Protocol Violation|0|||
17085200|NCT00522041|38225755|FG000|Overall Study|Lost to Follow-up|1|||
17085201|NCT00522041|38225756|FG001|Overall Study|Lost to Follow-up|4|||
17085202|NCT00522041|38225755|FG000|Overall Study|Voluntary withdrawal|5|||
17085203|NCT00522041|38225756|FG001|Overall Study|Voluntary withdrawal|4|||
17085204|NCT00522041|38225755|FG000|Overall Study|Did not receive treatment|0|||
17085205|NCT00522041|38225756|FG001|Overall Study|Did not receive treatment|1|||
17085206|NCT00122980|38225765|FG000|Overall Study|Death|0|||
17085207|NCT00122980|38225766|FG001|Overall Study|Death|1|||
17085208|NCT00122980|38225765|FG000|Overall Study|Physician Decision|2|||
17085209|NCT00122980|38225766|FG001|Overall Study|Physician Decision|0|||
17085210|NCT00122980|38225765|FG000|Overall Study|Protocol Violation|5|||
17085211|NCT00122980|38225766|FG001|Overall Study|Protocol Violation|1|||
17085212|NCT00122980|38225765|FG000|Overall Study|Withdrawal by Subject|2|||
17085213|NCT00122980|38225766|FG001|Overall Study|Withdrawal by Subject|3|||
17085214|NCT00122980|38225765|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
17085215|NCT00122980|38225766|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
17085216|NCT00122980|38225765|FG000|Overall Study|Study termination|27|||
17085217|NCT00122980|38225766|FG001|Overall Study|Study termination|35|||
17085218|NCT03868631|38225774|FG000|Baseline to Week 6|Adverse Event|0|||
17085219|NCT03868631|38225775|FG001|Baseline to Week 6|Adverse Event|3|||
17085220|NCT03868631|38225774|FG000|Baseline to Week 6|Protocol Violation|1|||
17085221|NCT03868631|38225775|FG001|Baseline to Week 6|Protocol Violation|1|||
17085222|NCT03868631|38225774|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
17085223|NCT03868631|38225775|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
17085224|NCT03868631|38225774|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
17085225|NCT03868631|38225775|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
17085226|NCT03868631|38225774|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
17085227|NCT03868631|38225775|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
17085228|NCT03868631|38225774|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
17085229|NCT03868631|38225775|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
17085230|NCT00340704|38225790|FG000|PK Study|Adverse Event|0|||
17085231|NCT00340704|38225791|FG001|PK Study|Adverse Event|1|||
17085232|NCT00340704|38225792|FG002|PK Study|Adverse Event|0|||
17085233|NCT00340704|38225793|FG003|PK Study|Adverse Event|0|||
17085234|NCT00340704|38225794|FG004|PK Study|Adverse Event|0|||
17085235|NCT00340704|38225795|FG005|PK Study|Adverse Event|0|||
17085236|NCT00340704|38225796|FG006|PK Study|Adverse Event|0|||
17085237|NCT00340704|38225797|FG007|PK Study|Adverse Event|0|||
17085238|NCT00340704|38225798|FG008|PK Study|Adverse Event|0|||
17085239|NCT00340704|38225790|FG000|PK Study|Not treated|0|||
17085240|NCT00340704|38225791|FG001|PK Study|Not treated|0|||
17085241|NCT00340704|38225792|FG002|PK Study|Not treated|1|||
17085242|NCT00340704|38225793|FG003|PK Study|Not treated|0|||
17085243|NCT00340704|38225794|FG004|PK Study|Not treated|0|||
17085244|NCT00340704|38225795|FG005|PK Study|Not treated|0|||
17085245|NCT00340704|38225796|FG006|PK Study|Not treated|0|||
17085246|NCT00340704|38225797|FG007|PK Study|Not treated|0|||
17085247|NCT00340704|38225798|FG008|PK Study|Not treated|0|||
17085248|NCT00340704|38225790|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
17085249|NCT00340704|38225791|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
17085250|NCT00340704|38225792|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
17085251|NCT00340704|38225793|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
17085252|NCT00340704|38225794|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
17085253|NCT00340704|38225795|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
17085254|NCT00340704|38225796|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
17085255|NCT00340704|38225797|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
17085256|NCT00340704|38225798|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
17085257|NCT00340704|38225790|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
17085258|NCT00340704|38225791|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
17085259|NCT00340704|38225792|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
17085260|NCT00340704|38225793|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
17085261|NCT00340704|38225794|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
17085262|NCT00340704|38225795|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
17085263|NCT00340704|38225796|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
17085264|NCT00340704|38225797|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
17085265|NCT00340704|38225798|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
17085266|NCT00340704|38225790|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
17085267|NCT00340704|38225791|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
17085268|NCT00340704|38225792|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
17085269|NCT00340704|38225793|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
17085270|NCT00340704|38225794|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
17085271|NCT00340704|38225795|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
17085272|NCT00340704|38225796|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
17085273|NCT00340704|38225797|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
17085274|NCT00340704|38225798|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
17085275|NCT00340704|38225790|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
17085276|NCT00340704|38225791|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
17085277|NCT00340704|38225792|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
17085278|NCT00340704|38225793|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
17085279|NCT00340704|38225794|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
17085280|NCT00340704|38225795|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
17085281|NCT00340704|38225796|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
17085282|NCT00340704|38225797|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
17085283|NCT00340704|38225798|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
17085284|NCT00132496|38225826|FG000|Overall Study|Withdrawal by Subject|1|||
17085285|NCT00132496|38225827|FG001|Overall Study|Withdrawal by Subject|2|||
17085286|NCT00132496|38225826|FG000|Overall Study|Physician Decision|1|||
17085287|NCT00132496|38225827|FG001|Overall Study|Physician Decision|0|||
17085288|NCT00231777|38225835|FG000|Overall Study|Lost to Follow-up|3|||
17085289|NCT00231777|38225836|FG001|Overall Study|Lost to Follow-up|0|||
17085290|NCT00231777|38225835|FG000|Overall Study|Other|3|||
17085291|NCT00231777|38225836|FG001|Overall Study|Other|2|||
17085292|NCT00231465|38225842|FG000|Overall Study|Completed only one cycle|1|||
17085293|NCT00231465|38225842|FG000|Overall Study|Did not have follow up CT scans|1|||
17085294|NCT00254397|38225850|FG000|Overall Study|Disease Progression|4|||
17085295|NCT00254397|38225851|FG001|Overall Study|Disease Progression|1|||
17085296|NCT00254397|38225852|FG002|Overall Study|Disease Progression|16|||
17085297|NCT00254397|38225853|FG003|Overall Study|Disease Progression|23|||
17085298|NCT00254397|38225850|FG000|Overall Study|Non-Compliant|0|||
17085299|NCT00254397|38225851|FG001|Overall Study|Non-Compliant|0|||
17085300|NCT00254397|38225852|FG002|Overall Study|Non-Compliant|0|||
17085301|NCT00254397|38225853|FG003|Overall Study|Non-Compliant|1|||
17085302|NCT00254397|38225850|FG000|Overall Study|Adverse Event|2|||
17085303|NCT00254397|38225851|FG001|Overall Study|Adverse Event|0|||
17085304|NCT00254397|38225852|FG002|Overall Study|Adverse Event|3|||
17085305|NCT00254397|38225853|FG003|Overall Study|Adverse Event|1|||
17085306|NCT00254163|38225864|FG000|Overall Study|Adverse Event|29|||
17085307|NCT00254163|38225865|FG001|Overall Study|Adverse Event|26|||
17085308|NCT00254163|38225864|FG000|Overall Study|Patient request/withdrew consent|6|||
17085309|NCT00254163|38225865|FG001|Overall Study|Patient request/withdrew consent|4|||
17085310|NCT00254163|38225864|FG000|Overall Study|Investigator request|1|||
17085311|NCT00254163|38225865|FG001|Overall Study|Investigator request|3|||
17085312|NCT00254163|38225864|FG000|Overall Study|Failed entry|1|||
17085313|NCT00254163|38225865|FG001|Overall Study|Failed entry|3|||
17085314|NCT00254163|38225864|FG000|Overall Study|Progressive disease|0|||
17085315|NCT00254163|38225865|FG001|Overall Study|Progressive disease|1|||
17085316|NCT00254163|38225864|FG000|Overall Study|Death|0|||
17085317|NCT00254163|38225865|FG001|Overall Study|Death|1|||
17085318|NCT00254163|38225864|FG000|Overall Study|Other|8|||
17085319|NCT00254163|38225865|FG001|Overall Study|Other|8|||
17085320|NCT03869333|38225875|FG000|Overall Study|Lost to Follow-up|1|||
17085321|NCT03869333|38225876|FG001|Overall Study|Lost to Follow-up|0|||
17085322|NCT03869333|38225877|FG002|Overall Study|Lost to Follow-up|0|||
17085323|NCT03869333|38225878|FG003|Overall Study|Lost to Follow-up|0|||
17085324|NCT03869333|38225875|FG000|Overall Study|Pregnancy|1|||
17085325|NCT03869333|38225876|FG001|Overall Study|Pregnancy|0|||
17085326|NCT03869333|38225877|FG002|Overall Study|Pregnancy|0|||
17085327|NCT03869333|38225878|FG003|Overall Study|Pregnancy|0|||
17085328|NCT03869333|38225875|FG000|Overall Study|Physician Decision|0|||
17085329|NCT03869333|38225876|FG001|Overall Study|Physician Decision|1|||
17085330|NCT03869333|38225877|FG002|Overall Study|Physician Decision|0|||
17085331|NCT03869333|38225878|FG003|Overall Study|Physician Decision|0|||
17085332|NCT00110890|38225890|FG000|Overall Study|Adverse Event|30|||
17085333|NCT00110890|38225891|FG001|Overall Study|Adverse Event|7|||
17085334|NCT00110890|38225890|FG000|Overall Study|Death|16|||
17085335|NCT00110890|38225891|FG001|Overall Study|Death|9|||
17085336|NCT00110890|38225890|FG000|Overall Study|Lost to Follow-up|3|||
17085337|NCT00110890|38225891|FG001|Overall Study|Lost to Follow-up|1|||
17085338|NCT00110890|38225890|FG000|Overall Study|Physician Decision|4|||
17085339|NCT00110890|38225891|FG001|Overall Study|Physician Decision|5|||
17085340|NCT00110890|38225890|FG000|Overall Study|Withdrawal by Subject|17|||
17085341|NCT00110890|38225891|FG001|Overall Study|Withdrawal by Subject|5|||
17085342|NCT00110890|38225890|FG000|Overall Study|Protocol Deviation|1|||
17085343|NCT00110890|38225891|FG001|Overall Study|Protocol Deviation|0|||
17085344|NCT00110890|38225890|FG000|Overall Study|Noncompliance|10|||
17085345|NCT00110890|38225891|FG001|Overall Study|Noncompliance|0|||
17085346|NCT00110890|38225890|FG000|Overall Study|Kidney Transplant|16|||
17085347|NCT00110890|38225891|FG001|Overall Study|Kidney Transplant|12|||
17085348|NCT00110890|38225890|FG000|Overall Study|Invest. Product Commercially Available|217|||
17085349|NCT00110890|38225891|FG001|Overall Study|Invest. Product Commercially Available|110|||
17085350|NCT00110890|38225890|FG000|Overall Study|Other|34|||
17085351|NCT00110890|38225891|FG001|Overall Study|Other|23|||
17085352|NCT00110890|38225890|FG000|Overall Study|Ineligibility determined|3|||
17085353|NCT00110890|38225891|FG001|Overall Study|Ineligibility determined|0|||
17085354|NCT00110890|38225890|FG000|Overall Study|Requirement for alternative therapy|0|||
17085355|NCT00110890|38225891|FG001|Overall Study|Requirement for alternative therapy|1|||
17085356|NCT00110890|38225890|FG000|Overall Study|Disease progression|0|||
17085357|NCT00110890|38225891|FG001|Overall Study|Disease progression|1|||
17085358|NCT00110890|38225890|FG000|Overall Study|Parathyroidectomy|0|||
17085359|NCT00110890|38225891|FG001|Overall Study|Parathyroidectomy|1|||
17085360|NCT00110890|38225890|FG000|Overall Study|Did not enter follow-up phase|10|||
17085361|NCT00110890|38225891|FG001|Overall Study|Did not enter follow-up phase|4|||
17085362|NCT00182637|38225897|FG000|Overall Study|Adverse Event|2|||
17085363|NCT00182637|38225897|FG000|Overall Study|Disease Progression|1|||
17085364|NCT00182325|38225904|FG000|Overall Study|Lost to Follow-up|7|||
17085365|NCT00182325|38225905|FG001|Overall Study|Lost to Follow-up|7|||
17085366|NCT00182325|38225904|FG000|Overall Study|Miscarriage|5|||
17085367|NCT00182325|38225905|FG001|Overall Study|Miscarriage|3|||
17085368|NCT00182325|38225904|FG000|Overall Study|Did not complete survey|22|||
17085369|NCT00182325|38225905|FG001|Overall Study|Did not complete survey|43|||
17085370|NCT00122278|38225913|FG000|Overall Study|Lost to Follow-up|2|||
17085371|NCT00122278|38225914|FG001|Overall Study|Lost to Follow-up|0|||
17085372|NCT00182091|38225924|FG000|Overall Study|Withdrawal by Subject|1|||
17085373|NCT00182091|38225925|FG001|Overall Study|Withdrawal by Subject|0|||
17085374|NCT00182091|38225926|FG002|Overall Study|Withdrawal by Subject|0|||
17085375|NCT00182091|38225927|FG003|Overall Study|Withdrawal by Subject|0|||
17085376|NCT00181155|38225935|FG000|Overall Study|Physician Decision|1|||
17085377|NCT00181155|38225936|FG001|Overall Study|Physician Decision|0|||
17085378|NCT00181155|38225935|FG000|Overall Study|Withdrawal by Subject|1|||
17085379|NCT00181155|38225936|FG001|Overall Study|Withdrawal by Subject|0|||
17085380|NCT00322452|38225945|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
17085381|NCT00322452|38225946|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
17085382|NCT00322452|38225945|FG000|Overall Study|Lost to Follow-up|5|||
17085383|NCT00322452|38225946|FG001|Overall Study|Lost to Follow-up|2|||
17085384|NCT00322452|38225945|FG000|Overall Study|Withdrawal by Subject|19|||
17085385|NCT00322452|38225946|FG001|Overall Study|Withdrawal by Subject|46|||
17085386|NCT00322452|38225945|FG000|Overall Study|Death|223|||
17085387|NCT00322452|38225946|FG001|Overall Study|Death|227|||
17085388|NCT00110812|38225955|FG000|Main Study|Death|0|||
17085389|NCT00110812|38225956|FG001|Main Study|Death|0|||
17085390|NCT00110812|38225957|FG002|Main Study|Death|2|||
17085391|NCT00110812|38225955|FG000|Main Study|Withdrawal by Subject|0|||
17085392|NCT00110812|38225956|FG001|Main Study|Withdrawal by Subject|0|||
17085393|NCT00110812|38225957|FG002|Main Study|Withdrawal by Subject|1|||
17085394|NCT00110812|38225955|FG000|Main Study|Lost to Follow-up|8|||
17085395|NCT00110812|38225956|FG001|Main Study|Lost to Follow-up|11|||
17085396|NCT00110812|38225957|FG002|Main Study|Lost to Follow-up|10|||
17085397|NCT00110812|38225955|FG000|Extended Follow-up|Death|1|||
17085398|NCT00110812|38225956|FG001|Extended Follow-up|Death|0|||
17085399|NCT00110812|38225957|FG002|Extended Follow-up|Death|3|||
17085400|NCT00110812|38225955|FG000|Extended Follow-up|Withdrawal by Subject|0|||
17085401|NCT00110812|38225956|FG001|Extended Follow-up|Withdrawal by Subject|1|||
17085402|NCT00110812|38225957|FG002|Extended Follow-up|Withdrawal by Subject|0|||
17085403|NCT00110812|38225955|FG000|Extended Follow-up|Lost to Follow-up|1|||
17085404|NCT00110812|38225956|FG001|Extended Follow-up|Lost to Follow-up|3|||
17085405|NCT00110812|38225957|FG002|Extended Follow-up|Lost to Follow-up|1|||
17085406|NCT00516269|38225972|FG000|Overall Study|Adverse Event|2|||
17085407|NCT00516269|38225973|FG001|Overall Study|Adverse Event|1|||
17085408|NCT00516269|38225972|FG000|Overall Study|Lost to Follow-up|0|||
17085409|NCT00516269|38225973|FG001|Overall Study|Lost to Follow-up|1|||
17085410|NCT00516269|38225972|FG000|Overall Study|Protocol Violation|0|||
17085411|NCT00516269|38225973|FG001|Overall Study|Protocol Violation|1|||
17085412|NCT00229203|38225981|FG000|Overall Study|Progressive disease|18|||
17085413|NCT00229203|38225982|FG001|Overall Study|Progressive disease|9|||
17085414|NCT00229203|38225981|FG000|Overall Study|Toxicity|6|||
17085415|NCT00229203|38225982|FG001|Overall Study|Toxicity|1|||
17085416|NCT00229203|38225981|FG000|Overall Study|Death|4|||
17085417|NCT00229203|38225982|FG001|Overall Study|Death|2|||
17085418|NCT00229203|38225981|FG000|Overall Study|Other|3|||
17085419|NCT00229203|38225982|FG001|Overall Study|Other|3|||
17085420|NCT00229203|38225981|FG000|Overall Study|Withdrawal by Subject|1|||
17085421|NCT00229203|38225982|FG001|Overall Study|Withdrawal by Subject|4|||
17085422|NCT00228813|38225988|FG000|Overall Study|Death|4|||
17085423|NCT00322374|38225995|FG000|Starting Dose|Physician Decision|2|||
17085424|NCT00322374|38225996|FG001|Starting Dose|Physician Decision|0|||
17085425|NCT00322374|38225997|FG002|Starting Dose|Physician Decision|0|||
17085426|NCT00322374|38225998|FG003|Starting Dose|Physician Decision|0|||
17085427|NCT00322374|38225995|FG000|Starting Dose|Study Drug Toxicity|4|||
17085428|NCT00322374|38225996|FG001|Starting Dose|Study Drug Toxicity|0|||
17085429|NCT00322374|38225997|FG002|Starting Dose|Study Drug Toxicity|0|||
17085430|NCT00322374|38225998|FG003|Starting Dose|Study Drug Toxicity|0|||
17085431|NCT00322374|38225995|FG000|First Escalation|Documented Disease Progression|0|||
17085432|NCT00322374|38225996|FG001|First Escalation|Documented Disease Progression|6|||
17085433|NCT00322374|38225997|FG002|First Escalation|Documented Disease Progression|0|||
17085434|NCT00322374|38225998|FG003|First Escalation|Documented Disease Progression|0|||
17085435|NCT00322374|38225995|FG000|First Escalation|Physician Decision|0|||
17085436|NCT00322374|38225996|FG001|First Escalation|Physician Decision|12|||
17085437|NCT00322374|38225997|FG002|First Escalation|Physician Decision|0|||
17085438|NCT00322374|38225998|FG003|First Escalation|Physician Decision|0|||
17085439|NCT00322374|38225995|FG000|First Escalation|Study Drug Toxicity|0|||
17085440|NCT00322374|38225996|FG001|First Escalation|Study Drug Toxicity|11|||
17085441|NCT00322374|38225997|FG002|First Escalation|Study Drug Toxicity|0|||
17085442|NCT00322374|38225998|FG003|First Escalation|Study Drug Toxicity|0|||
17085443|NCT00322374|38225995|FG000|First Escalation|Participant Request|0|||
17085444|NCT00322374|38225996|FG001|First Escalation|Participant Request|1|||
17085445|NCT00322374|38225997|FG002|First Escalation|Participant Request|0|||
17085446|NCT00322374|38225998|FG003|First Escalation|Participant Request|0|||
17085447|NCT00322374|38225995|FG000|Second Escalation|Physician Decision|0|||
17085448|NCT00322374|38225996|FG001|Second Escalation|Physician Decision|0|||
17085449|NCT00322374|38225997|FG002|Second Escalation|Physician Decision|5|||
17085450|NCT00322374|38225998|FG003|Second Escalation|Physician Decision|0|||
17085451|NCT00322374|38225995|FG000|Second Escalation|Study Drug Toxicity|0|||
17085452|NCT00322374|38225996|FG001|Second Escalation|Study Drug Toxicity|0|||
17085453|NCT00322374|38225997|FG002|Second Escalation|Study Drug Toxicity|1|||
17085454|NCT00322374|38225998|FG003|Second Escalation|Study Drug Toxicity|0|||
17085455|NCT00174447|38226011|FG000|Overall Study|Adverse Event|19|||
17085456|NCT00174447|38226011|FG000|Overall Study|Withdrawal by Subject|15|||
17085457|NCT00174447|38226011|FG000|Overall Study|Protocol Violation|1|||
17085458|NCT00174447|38226011|FG000|Overall Study|Lack of Efficacy|1|||
17085459|NCT00174447|38226011|FG000|Overall Study|Administrative reason/Other|2|||
17085460|NCT00321984|38226018|FG000|Overall Study|Adverse Event|9|||
17085461|NCT00321984|38226019|FG001|Overall Study|Adverse Event|6|||
17085462|NCT00321984|38226020|FG002|Overall Study|Adverse Event|8|||
17085463|NCT00321984|38226018|FG000|Overall Study|Protocol Violation|0|||
17085464|NCT00321984|38226019|FG001|Overall Study|Protocol Violation|1|||
17085465|NCT00321984|38226020|FG002|Overall Study|Protocol Violation|1|||
17085466|NCT00321984|38226018|FG000|Overall Study|Lost to Follow-up|2|||
17085467|NCT00321984|38226019|FG001|Overall Study|Lost to Follow-up|4|||
17085468|NCT00321984|38226020|FG002|Overall Study|Lost to Follow-up|2|||
17085469|NCT00321984|38226018|FG000|Overall Study|Withdrawal by Subject|8|||
17085470|NCT00321984|38226019|FG001|Overall Study|Withdrawal by Subject|6|||
17085471|NCT00321984|38226020|FG002|Overall Study|Withdrawal by Subject|5|||
17085472|NCT00321984|38226018|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
17085473|NCT00321984|38226019|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
17085474|NCT00321984|38226020|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
17085475|NCT00321984|38226018|FG000|Overall Study|Lack of Efficacy|3|||
17085476|NCT00321984|38226019|FG001|Overall Study|Lack of Efficacy|1|||
17085477|NCT00321984|38226020|FG002|Overall Study|Lack of Efficacy|3|||
17085478|NCT00321984|38226018|FG000|Overall Study|Noncompliant|0|||
17085479|NCT00321984|38226019|FG001|Overall Study|Noncompliant|0|||
17085480|NCT00321984|38226020|FG002|Overall Study|Noncompliant|2|||
17085481|NCT00321984|38226018|FG000|Overall Study|Pregnancy|0|||
17085482|NCT00321984|38226019|FG001|Overall Study|Pregnancy|1|||
17085483|NCT00321984|38226020|FG002|Overall Study|Pregnancy|0|||
17085484|NCT00321984|38226018|FG000|Overall Study|Per Subject Request|1|||
17085485|NCT00321984|38226019|FG001|Overall Study|Per Subject Request|0|||
17085486|NCT00321984|38226020|FG002|Overall Study|Per Subject Request|0|||
17085487|NCT00321984|38226018|FG000|Overall Study|Per Investigator Request|1|||
17085488|NCT00321984|38226019|FG001|Overall Study|Per Investigator Request|0|||
17085489|NCT00321984|38226020|FG002|Overall Study|Per Investigator Request|0|||
17085490|NCT00321984|38226018|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
17085491|NCT00321984|38226019|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
17085492|NCT00321984|38226020|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
17085493|NCT00515099|38226030|FG000|Overall Study|Lost to Follow-up|0|||
17085494|NCT00515099|38226031|FG001|Overall Study|Lost to Follow-up|4|||
17085495|NCT00515099|38226030|FG000|Overall Study|Withdrawal by Subject|2|||
17085496|NCT00515099|38226031|FG001|Overall Study|Withdrawal by Subject|0|||
17085497|NCT00515099|38226030|FG000|Overall Study|IRB Recommendation|1|||
17085498|NCT00515099|38226031|FG001|Overall Study|IRB Recommendation|0|||
17085499|NCT00110266|38226037|FG000|Overall Study|Adverse Event|27|||
17085500|NCT00110266|38226037|FG000|Overall Study|Abnormal laboratory value|15|||
17085501|NCT00110266|38226037|FG000|Overall Study|Withdrawal by Subject|16|||
17085502|NCT00110266|38226037|FG000|Overall Study|Death|17|||
17085503|NCT00110266|38226037|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
17085504|NCT00110266|38226037|FG000|Overall Study|Participant condition no longer requires study drug|1|||
17085505|NCT00174291|38226044|FG000|Overall Study|Lost to Follow-up|1|||
17085506|NCT00174291|38226045|FG001|Overall Study|Lost to Follow-up|1|||
17085507|NCT00174291|38226044|FG000|Overall Study|Protocol Violation|0|||
17085508|NCT00174291|38226045|FG001|Overall Study|Protocol Violation|2|||
17085509|NCT00174291|38226044|FG000|Overall Study|Study terminated by sponsor|1|||
17085510|NCT00174291|38226045|FG001|Overall Study|Study terminated by sponsor|0|||
17085511|NCT00174291|38226044|FG000|Overall Study|Withdrawal by Subject|3|||
17085512|NCT00174291|38226045|FG001|Overall Study|Withdrawal by Subject|3|||
17085513|NCT00366548|38226053|FG000|Infant Series|Adverse Event|1|||
17085514|NCT00366548|38226054|FG001|Infant Series|Adverse Event|3|||
17085515|NCT00366548|38226053|FG000|Infant Series|Protocol Violation|0|||
17085516|NCT00366548|38226054|FG001|Infant Series|Protocol Violation|1|||
17085517|NCT00366548|38226053|FG000|Infant Series|Withdrawal by Subject|3|||
17085518|NCT00366548|38226054|FG001|Infant Series|Withdrawal by Subject|1|||
17085519|NCT00366548|38226053|FG000|After Infant Series|Withdrawal by Subject|3|||
17085520|NCT00366548|38226054|FG001|After Infant Series|Withdrawal by Subject|1|||
17085521|NCT00366548|38226053|FG000|After Infant Series|Adverse Event|2|||
17085522|NCT00366548|38226054|FG001|After Infant Series|Adverse Event|0|||
17085523|NCT00366548|38226053|FG000|After Infant Series|Lost to Follow-up|1|||
17085524|NCT00366548|38226054|FG001|After Infant Series|Lost to Follow-up|0|||
17085525|NCT00252057|38226080|FG000|Overall Study|Withdrawal by Subject|2|||
17085526|NCT00252057|38226081|FG001|Overall Study|Withdrawal by Subject|5|||
17085527|NCT00252057|38226080|FG000|Overall Study|Death|1|||
17085528|NCT00252057|38226081|FG001|Overall Study|Death|2|||
17085529|NCT00252057|38226080|FG000|Overall Study|Participant previously enrolled|0|||
17085530|NCT00252057|38226081|FG001|Overall Study|Participant previously enrolled|1|||
17085531|NCT00132028|38226087|FG000|Overall Study|Adverse Event|7|||
17085532|NCT00132028|38226087|FG000|Overall Study|Death|2|||
17085533|NCT00132028|38226087|FG000|Overall Study|Lack of Efficacy|11|||
17085534|NCT00132028|38226087|FG000|Overall Study|Withdrawal by Subject|2|||
17085535|NCT00132028|38226087|FG000|Overall Study|not eligible|2|||
17085536|NCT00132028|38226087|FG000|Overall Study|Physician Decision|3|||
17085537|NCT00131248|38226091|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
17085538|NCT00131248|38226092|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
17085539|NCT00362414|38226098|FG000|Overall Study|Death|2|||
17085540|NCT00362414|38226098|FG000|Overall Study|Adverse Event|1|||
17085541|NCT00096382|38226107|FG000|Overall Study|Not treated|1|||
17085542|NCT00096382|38226108|FG001|Overall Study|Not treated|0|||
17085543|NCT00096382|38226107|FG000|Overall Study|Death during treatment|1|||
17085544|NCT00096382|38226108|FG001|Overall Study|Death during treatment|0|||
17085545|NCT00359294|38226119|FG000|Overall Study|Progressive disease|1|||
17085546|NCT00359294|38226120|FG001|Overall Study|Progressive disease|1|||
17085547|NCT00359294|38226121|FG002|Overall Study|Progressive disease|2|||
17085548|NCT00359294|38226122|FG003|Overall Study|Progressive disease|3|||
17085549|NCT00359294|38226123|FG004|Overall Study|Progressive disease|2|||
17085550|NCT00359294|38226119|FG000|Overall Study|Withdrawal by Subject|0|||
17085551|NCT00359294|38226120|FG001|Overall Study|Withdrawal by Subject|0|||
17085552|NCT00359294|38226121|FG002|Overall Study|Withdrawal by Subject|0|||
17085553|NCT00359294|38226122|FG003|Overall Study|Withdrawal by Subject|0|||
17085554|NCT00359294|38226123|FG004|Overall Study|Withdrawal by Subject|1|||
17085555|NCT00359294|38226119|FG000|Overall Study|Not treated|0|||
17085556|NCT00359294|38226120|FG001|Overall Study|Not treated|0|||
17085557|NCT00359294|38226121|FG002|Overall Study|Not treated|0|||
17085558|NCT00359294|38226122|FG003|Overall Study|Not treated|1|||
17085559|NCT00359294|38226123|FG004|Overall Study|Not treated|0|||
17085560|NCT00359294|38226119|FG000|Overall Study|Physician Decision|0|||
17085561|NCT00359294|38226120|FG001|Overall Study|Physician Decision|0|||
17085562|NCT00359294|38226121|FG002|Overall Study|Physician Decision|1|||
17085563|NCT00359294|38226122|FG003|Overall Study|Physician Decision|0|||
17085564|NCT00359294|38226123|FG004|Overall Study|Physician Decision|0|||
17085565|NCT00384332|38226133|FG000|Overall Study|Lost to Follow-up|4|||
17085566|NCT00384332|38226134|FG001|Overall Study|Lost to Follow-up|0|||
17085567|NCT00096226|38226142|FG000|Overall Study|Ineligible|2|||
17085568|NCT00096226|38226142|FG000|Overall Study|Protocol treatment not started|1|||
17085569|NCT00105508|38226148|FG000|Overall Study|Prephase Dropout|1|||
17085570|NCT00105508|38226149|FG001|Overall Study|Prephase Dropout|0|||
17085571|NCT00105508|38226148|FG000|Overall Study|Adverse Event|16|||
17085572|NCT00105508|38226149|FG001|Overall Study|Adverse Event|19|||
17085573|NCT00105508|38226148|FG000|Overall Study|Insufficient Efficacy|1|||
17085574|NCT00105508|38226149|FG001|Overall Study|Insufficient Efficacy|0|||
17085575|NCT00105508|38226148|FG000|Overall Study|Withdrawal by Subject|10|||
17085576|NCT00105508|38226149|FG001|Overall Study|Withdrawal by Subject|6|||
17085577|NCT00105508|38226148|FG000|Overall Study|Lost to Follow-up|3|||
17085578|NCT00105508|38226149|FG001|Overall Study|Lost to Follow-up|0|||
17085579|NCT00105508|38226148|FG000|Overall Study|Protocol Violation|1|||
17085580|NCT00105508|38226149|FG001|Overall Study|Protocol Violation|2|||
17085581|NCT00105508|38226148|FG000|Overall Study|Other|8|||
17085582|NCT00105508|38226149|FG001|Overall Study|Other|9|||
17085583|NCT00105196|38226157|FG000|Overall Study|Lack of Efficacy|2|||
17085584|NCT00105196|38226158|FG001|Overall Study|Lack of Efficacy|3|||
17085585|NCT00105196|38226157|FG000|Overall Study|Adverse Event|11|||
17085586|NCT00105196|38226158|FG001|Overall Study|Adverse Event|3|||
17085587|NCT00105196|38226157|FG000|Overall Study|Withdrawal by Subject|6|||
17085588|NCT00105196|38226158|FG001|Overall Study|Withdrawal by Subject|6|||
17085589|NCT00105196|38226157|FG000|Overall Study|Lost to Follow-up|3|||
17085590|NCT00105196|38226158|FG001|Overall Study|Lost to Follow-up|2|||
17085591|NCT00105196|38226157|FG000|Overall Study|Poor/noncompliance|3|||
17085592|NCT00105196|38226158|FG001|Overall Study|Poor/noncompliance|4|||
17085593|NCT00105196|38226157|FG000|Overall Study|Protocol Violation|5|||
17085594|NCT00105196|38226158|FG001|Overall Study|Protocol Violation|2|||
17085595|NCT00105196|38226157|FG000|Overall Study|pending surgery|0|||
17085596|NCT00105196|38226158|FG001|Overall Study|pending surgery|1|||
17085597|NCT00105196|38226157|FG000|Overall Study|marijuana use|0|||
17085598|NCT00105196|38226158|FG001|Overall Study|marijuana use|1|||
17085599|NCT00105196|38226157|FG000|Overall Study|Subject became unblinded|0|||
17085600|NCT00105196|38226158|FG001|Overall Study|Subject became unblinded|1|||
17085601|NCT03820024|38226166|FG000|Overall Study|Physician Decision|1|||
17085602|NCT03820024|38226167|FG001|Overall Study|Physician Decision|2|||
17085603|NCT03819634|38226173|FG000|Overall Study|Physician Decision|2|||
17085604|NCT00104572|38226180|FG000|Overall Study|Withdrawal by Subject|3|||
17085605|NCT00104572|38226181|FG001|Overall Study|Withdrawal by Subject|3|||
17085606|NCT00104572|38226182|FG002|Overall Study|Withdrawal by Subject|0|||
17085607|NCT00514943|38226192|FG000|Stage 1|Progressive disease|4|||
17085608|NCT00514943|38226193|FG001|Stage 1|Progressive disease|8|||
17085609|NCT00514943|38226192|FG000|Stage 1|Other Adverse Event|16|||
17085610|NCT00514943|38226193|FG001|Stage 1|Other Adverse Event|6|||
17085611|NCT00514943|38226192|FG000|Stage 1|Not treated|1|||
17085612|NCT00514943|38226193|FG001|Stage 1|Not treated|2|||
17085613|NCT00514943|38226192|FG000|Stage 1|Patient refused to continue study meds|8|||
17085614|NCT00514943|38226193|FG001|Stage 1|Patient refused to continue study meds|3|||
17085615|NCT00514943|38226192|FG000|Stage 1|Other than stated above|1|||
17085616|NCT00514943|38226193|FG001|Stage 1|Other than stated above|7|||
17085617|NCT00514943|38226192|FG000|Stage 2|Progressive disease|27|||
17085618|NCT00514943|38226193|FG001|Stage 2|Progressive disease|24|||
17085619|NCT00514943|38226192|FG000|Stage 2|Other Adverse Event|3|||
17085620|NCT00514943|38226193|FG001|Stage 2|Other Adverse Event|10|||
17085621|NCT00514943|38226192|FG000|Stage 2|Patient refused to continue study meds|2|||
17085622|NCT00514943|38226193|FG001|Stage 2|Patient refused to continue study meds|0|||
17085623|NCT00514943|38226192|FG000|Stage 2|Other than stated above|0|||
17085624|NCT00514943|38226193|FG001|Stage 2|Other than stated above|2|||
17085625|NCT03864653|38226214|FG000|Overall Study|Withdrawal by Subject|1|||
17085626|NCT00103402|38226220|FG000|Overall Study|Adverse Event|3|||
17085627|NCT00103402|38226221|FG001|Overall Study|Adverse Event|4|||
17085628|NCT00103402|38226220|FG000|Overall Study|Lost to Follow-up|8|||
17085629|NCT00103402|38226221|FG001|Overall Study|Lost to Follow-up|7|||
17085630|NCT00103402|38226220|FG000|Overall Study|Dissatisfied/No longer interested|6|||
17085631|NCT00103402|38226221|FG001|Overall Study|Dissatisfied/No longer interested|6|||
17085632|NCT00103402|38226220|FG000|Overall Study|Personal constraints/Other|5|||
17085633|NCT00103402|38226221|FG001|Overall Study|Personal constraints/Other|0|||
17085634|NCT03864341|38226227|FG000|Overall Study|Withdrawal by Subject|1|||
17085635|NCT01739309|38226231|FG000|Overall Study|On study treatment|3|||
17085636|NCT00095836|38226237|FG000|Overall Study|Lost to Follow-up|1|||
17085637|NCT00095836|38226237|FG000|Overall Study|Adverse Event|1|||
17085638|NCT00095836|38226237|FG000|Overall Study|Death|2|||
17085639|NCT00168831|38226244|FG000|Overall Study|Adverse Event|36|||
17085640|NCT00168831|38226245|FG001|Overall Study|Adverse Event|47|||
17085641|NCT00168831|38226246|FG002|Overall Study|Adverse Event|74|||
17085642|NCT00168831|38226244|FG000|Overall Study|Lost to Follow-up|5|||
17085643|NCT00168831|38226245|FG001|Overall Study|Lost to Follow-up|6|||
17085644|NCT00168831|38226246|FG002|Overall Study|Lost to Follow-up|4|||
17085645|NCT00168831|38226244|FG000|Overall Study|Withdrawal by Subject|7|||
17085646|NCT00168831|38226245|FG001|Overall Study|Withdrawal by Subject|14|||
17085647|NCT00168831|38226246|FG002|Overall Study|Withdrawal by Subject|19|||
17085648|NCT00168831|38226244|FG000|Overall Study|Protocol Violation|6|||
17085649|NCT00168831|38226245|FG001|Overall Study|Protocol Violation|11|||
17085650|NCT00168831|38226246|FG002|Overall Study|Protocol Violation|11|||
17085651|NCT00168831|38226244|FG000|Overall Study|Other|6|||
17085652|NCT00168831|38226245|FG001|Overall Study|Other|3|||
17085653|NCT00168831|38226246|FG002|Overall Study|Other|6|||
17085654|NCT00103012|38226257|FG000|Overall Study|Withdrawal by Subject|2|||
17085655|NCT00103012|38226258|FG001|Overall Study|Withdrawal by Subject|1|||
17085656|NCT00103012|38226259|FG002|Overall Study|Withdrawal by Subject|2|||
17085657|NCT00103012|38226257|FG000|Overall Study|Pregnancy|1|||
17085658|NCT00103012|38226258|FG001|Overall Study|Pregnancy|0|||
17085659|NCT00103012|38226259|FG002|Overall Study|Pregnancy|0|||
17085660|NCT00103012|38226257|FG000|Overall Study|Adverse Event|0|||
17085661|NCT00103012|38226258|FG001|Overall Study|Adverse Event|0|||
17085662|NCT00103012|38226259|FG002|Overall Study|Adverse Event|1|||
17085663|NCT00103012|38226257|FG000|Overall Study|Subject non-compliant with medications|0|||
17085664|NCT00103012|38226258|FG001|Overall Study|Subject non-compliant with medications|0|||
17085665|NCT00103012|38226259|FG002|Overall Study|Subject non-compliant with medications|1|||
17085666|NCT00512135|38226267|FG000|Overall Study|Not Treated|5|||
17085667|NCT00512135|38226267|FG000|Overall Study|Lack of Efficacy|2|||
17085668|NCT00512135|38226267|FG000|Overall Study|Adverse Event|6|||
17085669|NCT00512135|38226267|FG000|Overall Study|Withdrawal by Subject|22|||
17085670|NCT00512135|38226267|FG000|Overall Study|Lost to Follow-up|27|||
17085671|NCT00512135|38226267|FG000|Overall Study|Other|22|||
17085672|NCT00251979|38226274|FG000|Overall Study|Protocol Violation|3|||
17085673|NCT00251979|38226275|FG001|Overall Study|Protocol Violation|5|||
17085674|NCT00251979|38226274|FG000|Overall Study|Adverse Event|11|||
17085675|NCT00251979|38226275|FG001|Overall Study|Adverse Event|17|||
17085676|NCT00251979|38226274|FG000|Overall Study|Withdrawal by Subject|13|||
17085677|NCT00251979|38226275|FG001|Overall Study|Withdrawal by Subject|7|||
17085678|NCT00251979|38226274|FG000|Overall Study|Lost to Follow-up|8|||
17085679|NCT00251979|38226275|FG001|Overall Study|Lost to Follow-up|6|||
17085680|NCT00251979|38226274|FG000|Overall Study|Death|3|||
17085681|NCT00251979|38226275|FG001|Overall Study|Death|5|||
17085682|NCT00511901|38226283|FG000|Overall Study|Withdrawal by Subject|1|||
17085683|NCT00511901|38226284|FG001|Overall Study|Withdrawal by Subject|3|||
17085684|NCT03862625|38226292|FG000|Overall Study|Lost to Follow-up|0|||
17085685|NCT03862625|38226293|FG001|Overall Study|Lost to Follow-up|1|||
17085686|NCT00163215|38226299|FG000|Overall Study|Lack of Efficacy|3|||
17085687|NCT00163215|38226299|FG000|Overall Study|Withdrawal by Subject|5|||
17168319|NCT03118765|38317539|FG004|Overall Study|Sponsor Decision|1|||
17168320|NCT01367834|38317554|FG000|Overall Study|Withdrawal by Subject|2|||
17168321|NCT01367834|38317555|FG001|Overall Study|Withdrawal by Subject|2|||
17168322|NCT01367834|38317554|FG000|Overall Study|Study was ended.|0|||
17168323|NCT01367834|38317555|FG001|Overall Study|Study was ended.|1|||
17168324|NCT03106753|38317563|FG000|Overall Study|Withdrawal by Subject|0|||
17168325|NCT03106753|38317564|FG001|Overall Study|Withdrawal by Subject|1|||
17168326|NCT02125461|38317574|FG000|Overall Study|Withdrawal by Subject|30|||
17168327|NCT02125461|38317575|FG001|Overall Study|Withdrawal by Subject|16|||
17168328|NCT02125461|38317574|FG000|Overall Study|Lost to Follow-up|8|||
17168329|NCT02125461|38317575|FG001|Overall Study|Lost to Follow-up|3|||
17168330|NCT02125461|38317574|FG000|Overall Study|Death|260|||
17168331|NCT02125461|38317575|FG001|Overall Study|Death|149|||
17168332|NCT02125461|38317574|FG000|Overall Study|Missing Termination Reason|0|||
17168333|NCT02125461|38317575|FG001|Overall Study|Missing Termination Reason|1|||
17168334|NCT03045081|38317583|FG000|Overall Study|Withdrawal by Subject|6|||
17168335|NCT03045081|38317584|FG001|Overall Study|Withdrawal by Subject|11|||
17168336|NCT03107377|38317592|FG000|Overall Study|Adverse Event|3|||
17168337|NCT03107377|38317593|FG001|Overall Study|Adverse Event|3|||
17168338|NCT03107377|38317592|FG000|Overall Study|Protocol Violation|9|||
17168339|NCT03107377|38317593|FG001|Overall Study|Protocol Violation|12|||
17168340|NCT03107377|38317592|FG000|Overall Study|Physician Decision|3|||
17168341|NCT03107377|38317593|FG001|Overall Study|Physician Decision|6|||
17168342|NCT03107377|38317592|FG000|Overall Study|Pregnancy|7|||
17168343|NCT03107377|38317593|FG001|Overall Study|Pregnancy|7|||
17168344|NCT03107377|38317592|FG000|Overall Study|Withdrawal by Subject|16|||
17168345|NCT03107377|38317593|FG001|Overall Study|Withdrawal by Subject|22|||
17168346|NCT03107377|38317592|FG000|Overall Study|Lost to Follow-up|37|||
17168347|NCT03107377|38317593|FG001|Overall Study|Lost to Follow-up|34|||
17168348|NCT03107377|38317592|FG000|Overall Study|Other reason not specified|16|||
17168349|NCT03107377|38317593|FG001|Overall Study|Other reason not specified|15|||
17085688|NCT00163215|38226299|FG000|Overall Study|Other|7|||
17085689|NCT00228423|38226305|FG000|Overall Study|Adverse Event|2|||
17085690|NCT00228423|38226306|FG001|Overall Study|Adverse Event|5|||
17085691|NCT00228423|38226305|FG000|Overall Study|Withdrawal by Subject|7|||
17085692|NCT00228423|38226306|FG001|Overall Study|Withdrawal by Subject|3|||
17085693|NCT00228423|38226305|FG000|Overall Study|Protocol Violation|1|||
17168350|NCT02545283|38317601|FG000|Overall Study|Lost to Follow-up|2|||
17168351|NCT02545283|38317602|FG001|Overall Study|Lost to Follow-up|4|||
17168352|NCT02545283|38317601|FG000|Overall Study|Withdrawal by Subject|5|||
17168353|NCT02545283|38317602|FG001|Overall Study|Withdrawal by Subject|9|||
17168354|NCT02545283|38317601|FG000|Overall Study|Death|109|||
17168355|NCT02545283|38317602|FG001|Overall Study|Death|211|||
17168356|NCT02545283|38317601|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
17168357|NCT02545283|38317602|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
17168358|NCT02545283|38317601|FG000|Overall Study|Study Terminated By Sponsor|33|||
17168359|NCT02545283|38317602|FG001|Overall Study|Study Terminated By Sponsor|71|||
17168360|NCT03282565|38317613|FG000|Overall Study|COVID-19 Research Shutdown|0|||
17168361|NCT03282565|38317614|FG001|Overall Study|COVID-19 Research Shutdown|2|||
17168362|NCT03282565|38317615|FG002|Overall Study|COVID-19 Research Shutdown|2|||
17168363|NCT02875613|38317623|FG000|Overall Study|Withdrawal by Subject|1|||
17168364|NCT02815267|38317633|FG000|Double-Blind Phase|Adverse Event|0|||
17168365|NCT02815267|38317634|FG001|Double-Blind Phase|Adverse Event|3|||
17168366|NCT02815267|38317633|FG000|Double-Blind Phase|Lost to Follow-up|17|||
17168367|NCT02815267|38317634|FG001|Double-Blind Phase|Lost to Follow-up|9|||
17168368|NCT02815267|38317633|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
16996454|NCT02620579|38140501|FG002|Overall Study|Physician Decision|0|||
17085694|NCT00228423|38226306|FG001|Overall Study|Protocol Violation|3|||
17085695|NCT00228423|38226305|FG000|Overall Study|Physician Decision|0|||
17085696|NCT00228423|38226306|FG001|Overall Study|Physician Decision|1|||
17085697|NCT00511667|38226314|FG000|Overall Study|Adverse Event|1|||
17085698|NCT00511667|38226315|FG001|Overall Study|Adverse Event|0|||
17085699|NCT00511667|38226314|FG000|Overall Study|Protocol Violation|1|||
17085700|NCT00511667|38226315|FG001|Overall Study|Protocol Violation|1|||
17085701|NCT00511667|38226314|FG000|Overall Study|Withdrawal by Subject|2|||
17085702|NCT00511667|38226315|FG001|Overall Study|Withdrawal by Subject|0|||
17085703|NCT00511667|38226314|FG000|Overall Study|Site terminated|6|||
17085704|NCT00511667|38226315|FG001|Overall Study|Site terminated|1|||
17085705|NCT00511667|38226314|FG000|Overall Study|Other|2|||
17085706|NCT00511667|38226315|FG001|Overall Study|Other|1|||
17085707|NCT00227877|38226331|FG000|Pre-visit Assessment|Technical difficulties|7|||
17085708|NCT00227877|38226332|FG001|Pre-visit Assessment|Technical difficulties|3|||
17085709|NCT00227877|38226333|FG002|Pre-visit Assessment|Technical difficulties|0|||
17085710|NCT00227877|38226334|FG003|Pre-visit Assessment|Technical difficulties|0|||
17085711|NCT00227877|38226331|FG000|Post-visit Checklist|Lost to Follow-up|24|||
17085712|NCT00227877|38226332|FG001|Post-visit Checklist|Lost to Follow-up|13|||
17085713|NCT00227877|38226333|FG002|Post-visit Checklist|Lost to Follow-up|1|||
17085714|NCT00227877|38226334|FG003|Post-visit Checklist|Lost to Follow-up|0|||
17085715|NCT00227877|38226331|FG000|3-months Follow-up|Completed late|135|||
17085716|NCT00227877|38226332|FG001|3-months Follow-up|Completed late|128|||
17085717|NCT00227877|38226333|FG002|3-months Follow-up|Completed late|34|||
17085718|NCT00227877|38226334|FG003|3-months Follow-up|Completed late|8|||
17085719|NCT00227877|38226331|FG000|3-months Follow-up|Lost to Follow-up|178|||
17085720|NCT00227877|38226332|FG001|3-months Follow-up|Lost to Follow-up|139|||
17085721|NCT00227877|38226333|FG002|3-months Follow-up|Lost to Follow-up|18|||
17085722|NCT00227877|38226334|FG003|3-months Follow-up|Lost to Follow-up|13|||
17085723|NCT00227877|38226331|FG000|12-months Follow-up|Completed late|78|||
17085724|NCT00227877|38226332|FG001|12-months Follow-up|Completed late|74|||
17085725|NCT00227877|38226333|FG002|12-months Follow-up|Completed late|1|||
17085726|NCT00227877|38226334|FG003|12-months Follow-up|Completed late|0|||
17085727|NCT00227877|38226331|FG000|12-months Follow-up|Lost to Follow-up|232|||
17085728|NCT00227877|38226332|FG001|12-months Follow-up|Lost to Follow-up|189|||
17085729|NCT00227877|38226333|FG002|12-months Follow-up|Lost to Follow-up|30|||
17085730|NCT00227877|38226334|FG003|12-months Follow-up|Lost to Follow-up|26|||
17085731|NCT00513695|38226346|FG000|Overall Study|Discontinued therapy|2|||
17085732|NCT00513695|38226346|FG000|Overall Study|Progression prior to surgery|3|||
17085733|NCT00162981|38226352|FG000|Overall Study|Adverse Event|2|||
17085734|NCT00162981|38226353|FG001|Overall Study|Adverse Event|5|||
17085735|NCT00162981|38226352|FG000|Overall Study|Withdrawal by Subject|1|||
17085736|NCT00162981|38226353|FG001|Overall Study|Withdrawal by Subject|1|||
17085737|NCT00162981|38226352|FG000|Overall Study|Physician Decision|1|||
17085738|NCT00162981|38226353|FG001|Overall Study|Physician Decision|0|||
17085739|NCT00511433|38226361|FG000|Overall Study|Adverse Event|5|||
17085740|NCT00511433|38226362|FG001|Overall Study|Adverse Event|0|||
17085741|NCT00511433|38226361|FG000|Overall Study|Other Reason|1|||
17085742|NCT00511433|38226362|FG001|Overall Study|Other Reason|1|||
17085743|NCT00099268|38226372|FG000|Overall Study|Withdrawal by Subject|46|||
17085744|NCT00099268|38226373|FG001|Overall Study|Withdrawal by Subject|28|||
17085745|NCT00099268|38226372|FG000|Overall Study|Adverse Event|19|||
17085746|NCT00099268|38226373|FG001|Overall Study|Adverse Event|19|||
17085747|NCT00099268|38226372|FG000|Overall Study|Protocol Violation|9|||
17085748|NCT00099268|38226373|FG001|Overall Study|Protocol Violation|8|||
17085749|NCT00099268|38226372|FG000|Overall Study|Lost to Follow-up|6|||
17085750|NCT00099268|38226373|FG001|Overall Study|Lost to Follow-up|4|||
17085751|NCT00099268|38226372|FG000|Overall Study|Lack of Efficacy|5|||
17085752|NCT00099268|38226373|FG001|Overall Study|Lack of Efficacy|18|||
17085753|NCT00099268|38226372|FG000|Overall Study|Administrative problems|4|||
17085754|NCT00099268|38226373|FG001|Overall Study|Administrative problems|4|||
17085755|NCT00099268|38226372|FG000|Overall Study|Death|3|||
17085756|NCT00099268|38226373|FG001|Overall Study|Death|1|||
17085757|NCT00511355|38226381|FG000|Overall Study|Adverse Event|4|||
17085758|NCT00511355|38226382|FG001|Overall Study|Adverse Event|4|||
17085759|NCT00511355|38226381|FG000|Overall Study|Pregnancy Wish|1|||
17085760|NCT00511355|38226382|FG001|Overall Study|Pregnancy Wish|0|||
17085761|NCT00511355|38226381|FG000|Overall Study|Lost to Follow-up|2|||
17085762|NCT00511355|38226382|FG001|Overall Study|Lost to Follow-up|1|||
17085763|NCT00511355|38226381|FG000|Overall Study|Other Reason|0|||
17085764|NCT00511355|38226382|FG001|Overall Study|Other Reason|1|||
17085765|NCT00511355|38226381|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
17085766|NCT00511355|38226382|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
17085767|NCT00511355|38226381|FG000|Overall Study|Withdrawal of informed consent|0|||
17085768|NCT00511355|38226382|FG001|Overall Study|Withdrawal of informed consent|1|||
17085769|NCT00511355|38226381|FG000|Overall Study|Other reason pre-treatment|0|||
17085770|NCT00511355|38226382|FG001|Overall Study|Other reason pre-treatment|1|||
17085771|NCT00095212|38226392|FG000|Overall Study|Withdrawal by Subject|1|||
17085772|NCT00095212|38226393|FG001|Overall Study|Withdrawal by Subject|3|||
17085773|NCT00120874|38226401|FG000|Overall Study|Death|0|||
17085774|NCT00120874|38226402|FG001|Overall Study|Death|1|||
17085775|NCT00120406|38226410|FG000|Overall Study|Death|9|||
17085776|NCT00120406|38226411|FG001|Overall Study|Death|4|||
17085777|NCT00120406|38226410|FG000|Overall Study|Withdrawal by Subject|5|||
17085778|NCT00120406|38226411|FG001|Overall Study|Withdrawal by Subject|7|||
17085779|NCT00120406|38226410|FG000|Overall Study|Lost to Follow-up|5|||
17085780|NCT00120406|38226411|FG001|Overall Study|Lost to Follow-up|2|||
17085781|NCT00120406|38226410|FG000|Overall Study|received non-study stent|0|||
17085782|NCT00120406|38226411|FG001|Overall Study|received non-study stent|2|||
17085783|NCT00120406|38226410|FG000|Overall Study|patient moved but has not withdrawn|0|||
17085784|NCT00120406|38226411|FG001|Overall Study|patient moved but has not withdrawn|1|||
17085785|NCT00120250|38226417|FG000|Overall Study|Lost to Follow-up|1|||
17085786|NCT00120250|38226418|FG001|Overall Study|Lost to Follow-up|1|||
17085787|NCT00120250|38226417|FG000|Overall Study|Protocol Violation|0|||
17085788|NCT00120250|38226418|FG001|Overall Study|Protocol Violation|1|||
17085789|NCT00511199|38226427|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
17085790|NCT00511199|38226428|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
17085791|NCT00511199|38226427|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
17085792|NCT00511199|38226428|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
17085793|NCT00511199|38226427|FG000|Overall Study|Withdrawal of Informed Consent|19|||
17085794|NCT00511199|38226428|FG001|Overall Study|Withdrawal of Informed Consent|4|||
17085795|NCT00511199|38226427|FG000|Overall Study|Pregnancy|6|||
17085796|NCT00511199|38226428|FG001|Overall Study|Pregnancy|3|||
17085797|NCT00511199|38226427|FG000|Overall Study|Pregnancy Wish|16|||
17085798|NCT00511199|38226428|FG001|Overall Study|Pregnancy Wish|8|||
17168369|NCT02815267|38317634|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
17168370|NCT02815267|38317633|FG000|Double-Blind Phase|Protocol Violation|3|||
17168371|NCT02815267|38317634|FG001|Double-Blind Phase|Protocol Violation|2|||
17168372|NCT02815267|38317633|FG000|Double-Blind Phase|Site withdrawal|1|||
17168373|NCT02815267|38317634|FG001|Double-Blind Phase|Site withdrawal|6|||
17168374|NCT02815267|38317633|FG000|Double-Blind Phase|Received a disallowed medication|1|||
17168375|NCT02815267|38317634|FG001|Double-Blind Phase|Received a disallowed medication|1|||
17168376|NCT02815267|38317633|FG000|Open-Label Phase|Adverse Event|1|||
17168377|NCT02815267|38317634|FG001|Open-Label Phase|Adverse Event|1|||
17168378|NCT02815267|38317633|FG000|Open-Label Phase|Lost to Follow-up|23|||
17168379|NCT02815267|38317634|FG001|Open-Label Phase|Lost to Follow-up|9|||
17168380|NCT02815267|38317633|FG000|Open-Label Phase|Withdrawal by Subject|24|||
17168381|NCT02815267|38317634|FG001|Open-Label Phase|Withdrawal by Subject|13|||
17168382|NCT02815267|38317633|FG000|Open-Label Phase|Protocol Violation|0|||
17168383|NCT02815267|38317634|FG001|Open-Label Phase|Protocol Violation|1|||
17168384|NCT02815267|38317633|FG000|Open-Label Phase|Administrative|21|||
17168385|NCT02815267|38317634|FG001|Open-Label Phase|Administrative|12|||
17168386|NCT02815267|38317633|FG000|Open-Label Phase|Other|2|||
17168387|NCT02815267|38317634|FG001|Open-Label Phase|Other|5|||
17168388|NCT02930837|38317644|FG000|Overall Study|Adverse Event|6|||
17168389|NCT02930837|38317644|FG000|Overall Study|Lost to Follow-up|5|||
17168390|NCT02930837|38317644|FG000|Overall Study|Withdrawal by Subject|1|||
17168391|NCT01343277|38317650|FG000|Overall Study|Other|3|||
17168392|NCT01343277|38317651|FG001|Overall Study|Other|3|||
17168393|NCT01343277|38317650|FG000|Overall Study|Withdrawal by Subject|18|||
17168394|NCT01343277|38317651|FG001|Overall Study|Withdrawal by Subject|13|||
17168395|NCT01343277|38317650|FG000|Overall Study|Physician Decision|1|||
17168396|NCT01343277|38317651|FG001|Overall Study|Physician Decision|2|||
17168397|NCT01343277|38317650|FG000|Overall Study|Death|10|||
17085799|NCT00511199|38226427|FG000|Overall Study|Lost to Follow-up|40|||
17168398|NCT01343277|38317651|FG001|Overall Study|Death|1|||
17168399|NCT01343277|38317650|FG000|Overall Study|Adverse Event|67|||
17168400|NCT01343277|38317651|FG001|Overall Study|Adverse Event|13|||
17168401|NCT01343277|38317650|FG000|Overall Study|Disease progression|270|||
17168402|NCT01343277|38317651|FG001|Overall Study|Disease progression|138|||
17168403|NCT01343277|38317650|FG000|Overall Study|Randomized not treated|6|||
17168404|NCT01343277|38317651|FG001|Overall Study|Randomized not treated|21|||
17168405|NCT01343277|38317650|FG000|Overall Study|Treatment ongoing|8|||
17168406|NCT01343277|38317651|FG001|Overall Study|Treatment ongoing|2|||
17168407|NCT01343277|38317650|FG000|Overall Study|Subsequent anticancer therapy|1|||
17168408|NCT01343277|38317651|FG001|Overall Study|Subsequent anticancer therapy|0|||
17168409|NCT03135899|38317665|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
17168410|NCT03135899|38317666|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
17168411|NCT03135899|38317667|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
17168412|NCT03135899|38317668|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
17168413|NCT03135899|38317669|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
17168414|NCT03135899|38317670|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
17168415|NCT03135899|38317671|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
17168416|NCT03135899|38317672|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
17168417|NCT03135899|38317665|FG000|Overall Study|Withdrawal by Subject|0|||
17168418|NCT03135899|38317666|FG001|Overall Study|Withdrawal by Subject|0|||
17168419|NCT03135899|38317667|FG002|Overall Study|Withdrawal by Subject|0|||
17168420|NCT03135899|38317668|FG003|Overall Study|Withdrawal by Subject|0|||
17168421|NCT03135899|38317669|FG004|Overall Study|Withdrawal by Subject|0|||
17168422|NCT03135899|38317670|FG005|Overall Study|Withdrawal by Subject|2|||
17168423|NCT03135899|38317671|FG006|Overall Study|Withdrawal by Subject|0|||
17168424|NCT03135899|38317672|FG007|Overall Study|Withdrawal by Subject|0|||
17168425|NCT02487979|38317686|FG000|Overall Study|Physician Decision|2|||
17168426|NCT02487979|38317686|FG000|Overall Study|Withdrawal by Subject|2|||
16781308|NCT02105974|37720455|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
17168427|NCT02487979|38317686|FG000|Overall Study|Progressive Disease|17|||
17168428|NCT03103087|38317697|FG000|Overall Study|Did not receive any study drug|1|||
17168429|NCT03103087|38317698|FG001|Overall Study|Did not receive any study drug|0|||
17168430|NCT03103087|38317699|FG002|Overall Study|Did not receive any study drug|0|||
17168431|NCT03103087|38317697|FG000|Overall Study|Protocol Violation|1|||
17168432|NCT03103087|38317698|FG001|Overall Study|Protocol Violation|2|||
17168433|NCT03103087|38317699|FG002|Overall Study|Protocol Violation|1|||
17168434|NCT03103087|38317697|FG000|Overall Study|Lack of Efficacy|2|||
17168435|NCT03103087|38317698|FG001|Overall Study|Lack of Efficacy|1|||
17168436|NCT03103087|38317699|FG002|Overall Study|Lack of Efficacy|1|||
17168437|NCT03103087|38317697|FG000|Overall Study|Pregnancy|0|||
17168438|NCT03103087|38317698|FG001|Overall Study|Pregnancy|0|||
17168439|NCT03103087|38317699|FG002|Overall Study|Pregnancy|1|||
17168440|NCT03103087|38317697|FG000|Overall Study|Adverse Event|2|||
17168441|NCT03103087|38317698|FG001|Overall Study|Adverse Event|15|||
17168442|NCT03103087|38317699|FG002|Overall Study|Adverse Event|6|||
17168443|NCT03103087|38317697|FG000|Overall Study|Withdrawal by Subject|13|||
17168444|NCT03103087|38317698|FG001|Overall Study|Withdrawal by Subject|6|||
17168445|NCT03103087|38317699|FG002|Overall Study|Withdrawal by Subject|6|||
17168446|NCT03103087|38317697|FG000|Overall Study|Lost to Follow-up|4|||
17168447|NCT03103087|38317698|FG001|Overall Study|Lost to Follow-up|2|||
17168448|NCT03103087|38317699|FG002|Overall Study|Lost to Follow-up|7|||
17168449|NCT03103087|38317697|FG000|Overall Study|Other reason not reported|1|||
17168450|NCT03103087|38317698|FG001|Overall Study|Other reason not reported|3|||
17168451|NCT03103087|38317699|FG002|Overall Study|Other reason not reported|5|||
17168452|NCT03132467|38317709|FG000|Overall Study|Adverse Event|2|||
17168453|NCT03132467|38317709|FG000|Overall Study|Withdrawal by Subject|2|||
17168454|NCT03131999|38317716|FG000|Overall Study|Withdrawal by Subject|0|||
17168455|NCT03131999|38317717|FG001|Overall Study|Withdrawal by Subject|1|||
17168456|NCT02263885|38317732|FG000|Overall Study|Withdrawal by Subject|7|||
17168457|NCT02263885|38317732|FG000|Overall Study|Alternative Treatment|3|||
17168458|NCT02895360|38317743|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
17168459|NCT02895360|38317744|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
17168460|NCT02895360|38317745|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
17168461|NCT02895360|38317746|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
17168462|NCT02895360|38317747|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
17168463|NCT02895360|38317748|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
17168464|NCT02895360|38317743|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
17168465|NCT02895360|38317744|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
17168466|NCT02895360|38317745|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
17168467|NCT02895360|38317746|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
17168468|NCT02895360|38317747|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
17168469|NCT02895360|38317748|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
17168470|NCT02895360|38317743|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
17168471|NCT02895360|38317744|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
17168472|NCT02895360|38317745|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
17168473|NCT02895360|38317746|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
17168474|NCT02895360|38317747|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
17168475|NCT02895360|38317748|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
17168476|NCT02895360|38317743|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
17168477|NCT02895360|38317744|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
17168478|NCT02895360|38317745|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
17168479|NCT02895360|38317746|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
17168480|NCT02895360|38317747|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
17168481|NCT02895360|38317748|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
17168482|NCT02895360|38317743|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
17168483|NCT02895360|38317744|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
17168484|NCT02895360|38317745|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
17168485|NCT02895360|38317746|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
17085800|NCT00511199|38226428|FG001|Overall Study|Lost to Follow-up|17|||
17085801|NCT00511199|38226427|FG000|Overall Study|Other Reason|78|||
17168486|NCT02895360|38317747|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
17168487|NCT02895360|38317748|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
17168488|NCT02895360|38317743|FG000|Phase 2a|Adverse Event|0|||
17168489|NCT02895360|38317744|FG001|Phase 2a|Adverse Event|0|||
17085802|NCT00511199|38226428|FG001|Overall Study|Other Reason|37|||
17085803|NCT00384176|38226439|FG000|Overall Study|Death|239|||
17085804|NCT00384176|38226440|FG001|Overall Study|Death|247|||
17085805|NCT00384176|38226441|FG002|Overall Study|Death|105|||
17085806|NCT00384176|38226439|FG000|Overall Study|Withdrawal by Subject|52|||
17085807|NCT00384176|38226440|FG001|Overall Study|Withdrawal by Subject|48|||
17085808|NCT00384176|38226441|FG002|Overall Study|Withdrawal by Subject|22|||
17085809|NCT00384176|38226439|FG000|Overall Study|Lost to Follow-up|16|||
17085810|NCT00384176|38226440|FG001|Overall Study|Lost to Follow-up|18|||
17085811|NCT00384176|38226441|FG002|Overall Study|Lost to Follow-up|4|||
17085812|NCT00384176|38226439|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
16996455|NCT02620579|38140502|FG003|Overall Study|Physician Decision|1|||
16996456|NCT02620579|38140499|FG000|Overall Study|Withdrawal by Subject|0|||
16996457|NCT02620579|38140500|FG001|Overall Study|Withdrawal by Subject|1|||
16996458|NCT02620579|38140501|FG002|Overall Study|Withdrawal by Subject|1|||
16996459|NCT02620579|38140502|FG003|Overall Study|Withdrawal by Subject|0|||
16996460|NCT00753688|38140518|FG000|Overall Study|Death|102|||
16996461|NCT00753688|38140519|FG001|Overall Study|Death|203|||
16996462|NCT00753688|38140518|FG000|Overall Study|Missing|4|||
16996463|NCT00753688|38140519|FG001|Overall Study|Missing|9|||
16996464|NCT00753688|38140518|FG000|Overall Study|Participant Withdrew Consent|2|||
16996465|NCT00753688|38140519|FG001|Overall Study|Participant Withdrew Consent|2|||
16996466|NCT00753688|38140518|FG000|Overall Study|Ongoing - in Follow-up|15|||
16996467|NCT00753688|38140519|FG001|Overall Study|Ongoing - in Follow-up|31|||
16996468|NCT00753688|38140518|FG000|Overall Study|Adverse Event|0|||
17168490|NCT02895360|38317745|FG002|Phase 2a|Adverse Event|0|||
17168491|NCT02895360|38317746|FG003|Phase 2a|Adverse Event|0|||
17168492|NCT02895360|38317747|FG004|Phase 2a|Adverse Event|0|||
17168493|NCT02895360|38317748|FG005|Phase 2a|Adverse Event|1|||
17168494|NCT02895360|38317743|FG000|Phase 2a|Progressive disease|0|||
17168495|NCT02895360|38317744|FG001|Phase 2a|Progressive disease|0|||
17168496|NCT02895360|38317745|FG002|Phase 2a|Progressive disease|0|||
17168497|NCT02895360|38317746|FG003|Phase 2a|Progressive disease|0|||
17168498|NCT02895360|38317747|FG004|Phase 2a|Progressive disease|11|||
17168499|NCT02895360|38317748|FG005|Phase 2a|Progressive disease|11|||
17168500|NCT02000219|38317780|FG000|14-Week Study Period|Physician Decision|1|||
17168501|NCT02000219|38317780|FG000|14-Week Study Period|Adverse Event|1|||
17168502|NCT02000219|38317780|FG000|14-Week Study Period|Underwent transplantation|1|||
17168503|NCT02000219|38317780|FG000|Continuation Period|Withdrawal by Subject|1|||
17168504|NCT02000219|38317780|FG000|Continuation Period|Had liver transplant|2|||
17168505|NCT02000219|38317780|FG000|Continuation Period|Non-compliance with study drug|2|||
17168506|NCT03101371|38317786|FG000|Overall Study|Physician Decision|0|||
17168507|NCT03101371|38317787|FG001|Overall Study|Physician Decision|1|||
17168508|NCT03101371|38317786|FG000|Overall Study|Lost to Follow-up|1|||
17168509|NCT03101371|38317787|FG001|Overall Study|Lost to Follow-up|4|||
17168510|NCT03101371|38317786|FG000|Overall Study|Did not meet eligibility criteria|2|||
17168511|NCT03101371|38317787|FG001|Overall Study|Did not meet eligibility criteria|1|||
17168512|NCT02850276|38317793|FG000|Overall Study|screen failure|43|||
17168513|NCT02850276|38317793|FG000|Overall Study|Withdrawal by Subject|14|||
17085813|NCT00384176|38226440|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
17085814|NCT00384176|38226441|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
17085815|NCT00384176|38226439|FG000|Overall Study|Longer QTC as Visit 1|1|||
17085816|NCT00384176|38226440|FG001|Overall Study|Longer QTC as Visit 1|0|||
17168514|NCT02850276|38317793|FG000|Overall Study|Physician Decision|2|||
17168515|NCT02850276|38317793|FG000|Overall Study|Lost to Follow-up|2|||
17168516|NCT02783768|38317798|FG000|Overall Study|Lost to Follow-up|1|||
17168517|NCT02783768|38317799|FG001|Overall Study|Lost to Follow-up|0|||
17168518|NCT03131687|38317811|FG000|Overall Study|Adverse Event|0|||
17168519|NCT03131687|38317812|FG001|Overall Study|Adverse Event|1|||
17168520|NCT03131687|38317813|FG002|Overall Study|Adverse Event|0|||
17168521|NCT03131687|38317814|FG003|Overall Study|Adverse Event|1|||
17168522|NCT03131687|38317815|FG004|Overall Study|Adverse Event|2|||
17168523|NCT03131687|38317816|FG005|Overall Study|Adverse Event|2|||
17168524|NCT03131687|38317811|FG000|Overall Study|Death|1|||
17168525|NCT03131687|38317812|FG001|Overall Study|Death|0|||
17085817|NCT00384176|38226441|FG002|Overall Study|Longer QTC as Visit 1|0|||
17085818|NCT00384176|38226439|FG000|Overall Study|Toxicity of treatment|1|||
17085819|NCT00384176|38226440|FG001|Overall Study|Toxicity of treatment|0|||
17085820|NCT00384176|38226441|FG002|Overall Study|Toxicity of treatment|0|||
17168526|NCT03131687|38317813|FG002|Overall Study|Death|0|||
17168527|NCT03131687|38317814|FG003|Overall Study|Death|0|||
17168528|NCT03131687|38317815|FG004|Overall Study|Death|0|||
17168529|NCT03131687|38317816|FG005|Overall Study|Death|0|||
17168530|NCT03131687|38317811|FG000|Overall Study|Withdrawal by Subject|3|||
17168531|NCT03131687|38317812|FG001|Overall Study|Withdrawal by Subject|3|||
17168532|NCT03131687|38317813|FG002|Overall Study|Withdrawal by Subject|3|||
17168533|NCT03131687|38317814|FG003|Overall Study|Withdrawal by Subject|1|||
17168534|NCT03131687|38317815|FG004|Overall Study|Withdrawal by Subject|2|||
17168535|NCT03131687|38317816|FG005|Overall Study|Withdrawal by Subject|1|||
17168536|NCT03131687|38317811|FG000|Overall Study|Lost to Follow-up|1|||
17168537|NCT03131687|38317812|FG001|Overall Study|Lost to Follow-up|4|||
17168538|NCT03131687|38317813|FG002|Overall Study|Lost to Follow-up|0|||
17168539|NCT03131687|38317814|FG003|Overall Study|Lost to Follow-up|1|||
17168540|NCT03131687|38317815|FG004|Overall Study|Lost to Follow-up|4|||
17168541|NCT03131687|38317816|FG005|Overall Study|Lost to Follow-up|2|||
17168542|NCT03131687|38317811|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
17168543|NCT03131687|38317812|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
17168544|NCT03131687|38317813|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
17168545|NCT03131687|38317814|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
17168546|NCT03131687|38317815|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
17168547|NCT03131687|38317816|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
17168548|NCT03131687|38317811|FG000|Overall Study|Principle Investigator Decision|0|||
17168549|NCT03131687|38317812|FG001|Overall Study|Principle Investigator Decision|1|||
17168550|NCT03131687|38317813|FG002|Overall Study|Principle Investigator Decision|0|||
17168551|NCT03131687|38317814|FG003|Overall Study|Principle Investigator Decision|0|||
17168552|NCT03131687|38317815|FG004|Overall Study|Principle Investigator Decision|0|||
17168553|NCT03131687|38317816|FG005|Overall Study|Principle Investigator Decision|0|||
17168554|NCT03131687|38317811|FG000|Overall Study|Inadvertent Enrollment|0|||
17168555|NCT03131687|38317812|FG001|Overall Study|Inadvertent Enrollment|0|||
17168556|NCT03131687|38317813|FG002|Overall Study|Inadvertent Enrollment|0|||
16996469|NCT00753688|38140519|FG001|Overall Study|Adverse Event|1|||
17085821|NCT00384176|38226439|FG000|Overall Study|Did not receive study treatment|0|||
17168557|NCT03131687|38317814|FG003|Overall Study|Inadvertent Enrollment|1|||
17168558|NCT03131687|38317815|FG004|Overall Study|Inadvertent Enrollment|0|||
17168559|NCT03131687|38317816|FG005|Overall Study|Inadvertent Enrollment|0|||
17168560|NCT03101293|38317845|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
17168561|NCT03101293|38317846|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
17168562|NCT02850978|38317852|FG000|Overall Study|Uncollectable CRF|27|||
17168563|NCT02850978|38317852|FG000|Overall Study|No visit since the first visit|35|||
17168564|NCT02850978|38317852|FG000|Overall Study|Adverse Event|81|||
17168565|NCT02850978|38317852|FG000|Overall Study|Lack of Efficacy|40|||
17168566|NCT02850978|38317852|FG000|Overall Study|Improvement in condition|34|||
17168567|NCT02850978|38317852|FG000|Overall Study|Lost to Follow-up|121|||
17168568|NCT02850978|38317852|FG000|Overall Study|Reason not listed|88|||
17168569|NCT03135431|38317858|FG000|Overall Study|Study Surgeon not available|2|||
17168570|NCT03135431|38317859|FG001|Overall Study|Study Surgeon not available|0|||
17168571|NCT04534517|38317881|FG000|Overall Study|Adverse Event|1|||
17168572|NCT04534517|38317881|FG000|Overall Study|Withdrawal by Subject|1|||
17168573|NCT04534517|38317881|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
17168574|NCT04534517|38317881|FG000|Overall Study|COVID-19 Related|1|||
17168575|NCT02831257|38317885|FG000|Overall Study|Lack of Efficacy|3|||
17168576|NCT02831257|38317885|FG000|Overall Study|Adverse Event|2|||
17168577|NCT02831257|38317885|FG000|Overall Study|Physician Decision|1|||
17168578|NCT02831257|38317885|FG000|Overall Study|Withdrawal by Subject|6|||
17168579|NCT03100825|38317889|FG000|Overall Study|Participant/Guardian Decision|7|||
17168580|NCT03100825|38317889|FG000|Overall Study|Physician Decision|1|||
17168581|NCT02250534|38317896|FG000|Overall Study|Lost to Follow-up|18|||
17168582|NCT02250534|38317897|FG001|Overall Study|Lost to Follow-up|28|||
17168583|NCT02250534|38317898|FG002|Overall Study|Lost to Follow-up|33|||
17168584|NCT02250534|38317896|FG000|Overall Study|Personal reasons|7|||
17168585|NCT02250534|38317897|FG001|Overall Study|Personal reasons|8|||
17168586|NCT02250534|38317898|FG002|Overall Study|Personal reasons|14|||
17168587|NCT02250534|38317896|FG000|Overall Study|Adverse Event|6|||
17168588|NCT02250534|38317897|FG001|Overall Study|Adverse Event|3|||
17168589|NCT02250534|38317898|FG002|Overall Study|Adverse Event|8|||
17168590|NCT02250534|38317896|FG000|Overall Study|incarcerated|2|||
17168591|NCT02250534|38317897|FG001|Overall Study|incarcerated|1|||
17085822|NCT00384176|38226440|FG001|Overall Study|Did not receive study treatment|1|||
17085823|NCT00384176|38226441|FG002|Overall Study|Did not receive study treatment|1|||
17085824|NCT00384176|38226439|FG000|Overall Study|Physician Decision|0|||
17085825|NCT00384176|38226440|FG001|Overall Study|Physician Decision|2|||
17085826|NCT00384176|38226441|FG002|Overall Study|Physician Decision|0|||
17085827|NCT00384176|38226439|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
17085828|NCT00384176|38226440|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
17085829|NCT00384176|38226441|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
17085830|NCT00513305|38226451|FG000|Overall Study|Adverse Event|6|||
17085831|NCT00513305|38226452|FG001|Overall Study|Adverse Event|2|||
17085832|NCT00513305|38226451|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
17085833|NCT00513305|38226452|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
17085834|NCT00513305|38226451|FG000|Overall Study|Lack of Efficacy|8|||
17168592|NCT02250534|38317898|FG002|Overall Study|incarcerated|2|||
17168593|NCT02250534|38317896|FG000|Overall Study|Withdrawal by Subject|0|||
17168594|NCT02250534|38317897|FG001|Overall Study|Withdrawal by Subject|1|||
17168595|NCT02250534|38317898|FG002|Overall Study|Withdrawal by Subject|2|||
17168596|NCT02250534|38317896|FG000|Overall Study|Death|0|||
17168597|NCT02250534|38317897|FG001|Overall Study|Death|1|||
17168598|NCT02250534|38317898|FG002|Overall Study|Death|1|||
17168599|NCT02250534|38317896|FG000|Overall Study|Physician Decision|1|||
17168600|NCT02250534|38317897|FG001|Overall Study|Physician Decision|3|||
17168601|NCT02250534|38317898|FG002|Overall Study|Physician Decision|1|||
17168602|NCT02250534|38317896|FG000|Overall Study|Protocol Violation|1|||
17168603|NCT02250534|38317897|FG001|Overall Study|Protocol Violation|0|||
17168604|NCT02250534|38317898|FG002|Overall Study|Protocol Violation|1|||
17168605|NCT02250534|38317896|FG000|Overall Study|Reason unknown|1|||
17168606|NCT02250534|38317897|FG001|Overall Study|Reason unknown|0|||
17168607|NCT02250534|38317898|FG002|Overall Study|Reason unknown|0|||
17168608|NCT02848326|38317912|FG000|Treatment Period|Adverse Event|5|||
17168609|NCT02848326|38317913|FG001|Treatment Period|Adverse Event|4|||
17168610|NCT02848326|38317914|FG002|Treatment Period|Adverse Event|11|||
17168611|NCT02848326|38317915|FG003|Treatment Period|Adverse Event|6|||
17168612|NCT02848326|38317916|FG004|Treatment Period|Adverse Event|5|||
17168613|NCT02848326|38317917|FG005|Treatment Period|Adverse Event|7|||
17168614|NCT02848326|38317912|FG000|Treatment Period|Withdrawal of Consent|20|||
16781309|NCT02105662|37720461|FG000|Overall Study|Lost to Follow-up|5|||
17085835|NCT00513305|38226452|FG001|Overall Study|Lack of Efficacy|13|||
17085836|NCT00513305|38226451|FG000|Overall Study|Withdrawal by Subject|1|||
17168615|NCT02848326|38317913|FG001|Treatment Period|Withdrawal of Consent|6|||
17168616|NCT02848326|38317914|FG002|Treatment Period|Withdrawal of Consent|9|||
17168617|NCT02848326|38317915|FG003|Treatment Period|Withdrawal of Consent|6|||
17168618|NCT02848326|38317916|FG004|Treatment Period|Withdrawal of Consent|9|||
17168619|NCT02848326|38317917|FG005|Treatment Period|Withdrawal of Consent|6|||
17168620|NCT02848326|38317912|FG000|Treatment Period|Lost to Follow-up|5|||
17168621|NCT02848326|38317913|FG001|Treatment Period|Lost to Follow-up|1|||
17168622|NCT02848326|38317914|FG002|Treatment Period|Lost to Follow-up|11|||
17168623|NCT02848326|38317915|FG003|Treatment Period|Lost to Follow-up|7|||
17168624|NCT02848326|38317916|FG004|Treatment Period|Lost to Follow-up|2|||
17168625|NCT02848326|38317917|FG005|Treatment Period|Lost to Follow-up|3|||
17168626|NCT02848326|38317912|FG000|Treatment Period|Pregnancy|0|||
17168627|NCT02848326|38317913|FG001|Treatment Period|Pregnancy|0|||
17168628|NCT02848326|38317914|FG002|Treatment Period|Pregnancy|1|||
17168629|NCT02848326|38317915|FG003|Treatment Period|Pregnancy|1|||
17168630|NCT02848326|38317916|FG004|Treatment Period|Pregnancy|0|||
17168631|NCT02848326|38317917|FG005|Treatment Period|Pregnancy|1|||
17168632|NCT02848326|38317912|FG000|Treatment Period|Protocol Violation|4|||
17168633|NCT02848326|38317913|FG001|Treatment Period|Protocol Violation|3|||
17168634|NCT02848326|38317914|FG002|Treatment Period|Protocol Violation|4|||
17085837|NCT00513305|38226452|FG001|Overall Study|Withdrawal by Subject|2|||
17085838|NCT00513305|38226451|FG000|Overall Study|Disease progression|8|||
17085839|NCT00513305|38226452|FG001|Overall Study|Disease progression|5|||
17085840|NCT00513305|38226451|FG000|Overall Study|Eligible for stem cell transplant|1|||
17085841|NCT00513305|38226452|FG001|Overall Study|Eligible for stem cell transplant|0|||
17085842|NCT00513305|38226451|FG000|Overall Study|Hematologic counts did not recover|1|||
17085843|NCT00513305|38226452|FG001|Overall Study|Hematologic counts did not recover|0|||
17085844|NCT00513305|38226451|FG000|Overall Study|Physician Decision|1|||
17085845|NCT00513305|38226452|FG001|Overall Study|Physician Decision|0|||
17085846|NCT00513305|38226451|FG000|Overall Study|Persistent hypocellularity|0|||
17085847|NCT00513305|38226452|FG001|Overall Study|Persistent hypocellularity|1|||
17085848|NCT00513305|38226451|FG000|Overall Study|Sponsor Decision|0|||
17085849|NCT00513305|38226452|FG001|Overall Study|Sponsor Decision|2|||
17085850|NCT00513071|38226458|FG000|Overall Study|Adverse Event|1|||
17085851|NCT00513071|38226458|FG000|Overall Study|Withdrawal by Subject|1|||
17085852|NCT00513071|38226458|FG000|Overall Study|Physician Decision|3|||
17085853|NCT00510887|38226462|FG000|Overall Study|Lost to Follow-up|1|||
17085854|NCT00358826|38226470|FG000|Core Study|Adverse Event|1|||
17085855|NCT00358826|38226471|FG001|Core Study|Adverse Event|3|||
17085856|NCT00358826|38226472|FG002|Core Study|Adverse Event|1|||
17085857|NCT00358826|38226473|FG003|Core Study|Adverse Event|1|||
17085858|NCT00358826|38226474|FG004|Core Study|Adverse Event|0|||
17085859|NCT00358826|38226475|FG005|Core Study|Adverse Event|0|||
17085860|NCT00358826|38226476|FG006|Core Study|Adverse Event|0|||
17085861|NCT00358826|38226477|FG007|Core Study|Adverse Event|0|||
17085862|NCT00358826|38226470|FG000|Core Study|Withdrawal by Subject|2|||
17085863|NCT00358826|38226471|FG001|Core Study|Withdrawal by Subject|2|||
17085864|NCT00358826|38226472|FG002|Core Study|Withdrawal by Subject|0|||
17085865|NCT00358826|38226473|FG003|Core Study|Withdrawal by Subject|0|||
17085866|NCT00358826|38226474|FG004|Core Study|Withdrawal by Subject|0|||
17085867|NCT00358826|38226475|FG005|Core Study|Withdrawal by Subject|0|||
17085868|NCT00358826|38226476|FG006|Core Study|Withdrawal by Subject|0|||
17085869|NCT00358826|38226477|FG007|Core Study|Withdrawal by Subject|0|||
17085870|NCT00358826|38226470|FG000|Core Study|Lost to Follow-up|0|||
17085871|NCT00358826|38226471|FG001|Core Study|Lost to Follow-up|0|||
17085872|NCT00358826|38226472|FG002|Core Study|Lost to Follow-up|0|||
17085873|NCT00358826|38226473|FG003|Core Study|Lost to Follow-up|1|||
17085874|NCT00358826|38226474|FG004|Core Study|Lost to Follow-up|0|||
17085875|NCT00358826|38226475|FG005|Core Study|Lost to Follow-up|0|||
17085876|NCT00358826|38226476|FG006|Core Study|Lost to Follow-up|0|||
17085877|NCT00358826|38226477|FG007|Core Study|Lost to Follow-up|0|||
17085878|NCT00358826|38226470|FG000|Core Study|Physician Decision|0|||
17168635|NCT02848326|38317915|FG003|Treatment Period|Protocol Violation|2|||
17085879|NCT00358826|38226471|FG001|Core Study|Physician Decision|0|||
17085880|NCT00358826|38226472|FG002|Core Study|Physician Decision|1|||
17085881|NCT00358826|38226473|FG003|Core Study|Physician Decision|0|||
17085882|NCT00358826|38226474|FG004|Core Study|Physician Decision|0|||
17085883|NCT00358826|38226475|FG005|Core Study|Physician Decision|0|||
17085884|NCT00358826|38226476|FG006|Core Study|Physician Decision|0|||
17085885|NCT00358826|38226477|FG007|Core Study|Physician Decision|0|||
17085886|NCT00358826|38226470|FG000|MDCT Substudy|Adverse Event|0|||
17168636|NCT02848326|38317916|FG004|Treatment Period|Protocol Violation|3|||
17168637|NCT02848326|38317917|FG005|Treatment Period|Protocol Violation|3|||
17168638|NCT02848326|38317912|FG000|Treatment Period|Non-compliance with Study Drug|4|||
17168639|NCT02848326|38317913|FG001|Treatment Period|Non-compliance with Study Drug|0|||
17168640|NCT02848326|38317914|FG002|Treatment Period|Non-compliance with Study Drug|0|||
17168641|NCT02848326|38317915|FG003|Treatment Period|Non-compliance with Study Drug|1|||
17168642|NCT02848326|38317916|FG004|Treatment Period|Non-compliance with Study Drug|0|||
17168643|NCT02848326|38317917|FG005|Treatment Period|Non-compliance with Study Drug|0|||
17168644|NCT02848326|38317912|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
17085887|NCT00358826|38226471|FG001|MDCT Substudy|Adverse Event|0|||
17168645|NCT02848326|38317913|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
17168646|NCT02848326|38317914|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
17085888|NCT00358826|38226472|FG002|MDCT Substudy|Adverse Event|0|||
17085889|NCT00358826|38226473|FG003|MDCT Substudy|Adverse Event|0|||
17085890|NCT00358826|38226474|FG004|MDCT Substudy|Adverse Event|1|||
17168647|NCT02848326|38317915|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
17168648|NCT02848326|38317916|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
17168649|NCT02848326|38317917|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
17168650|NCT02848326|38317912|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
17168651|NCT02848326|38317913|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
17168652|NCT02848326|38317914|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
17168653|NCT02848326|38317915|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
17168654|NCT02848326|38317916|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
17168655|NCT02848326|38317917|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
17168656|NCT03128723|38317931|FG000|Overall Study|Withdrawal by Subject|2|||
17168657|NCT03128411|38317935|FG000|Treatment Phase|Adverse Event|21|||
17168658|NCT03128411|38317935|FG000|Treatment Phase|Physician Decision|1|||
17168659|NCT03128411|38317935|FG000|Treatment Phase|Other|2|||
17168660|NCT03128411|38317935|FG000|Long Term Follow-up Phase|Death|2|||
17168661|NCT02847858|38317941|FG000|Overall Study|Lost to Follow-up|401|||
17168662|NCT02847858|38317942|FG001|Overall Study|Lost to Follow-up|269|||
17168663|NCT03124199|38317953|FG000|Overall Study|Lost to Follow-up|4|||
17168664|NCT04465916|38317959|FG000|Overall Study|Withdrawal by Subject|0|||
17168665|NCT04465916|38317960|FG001|Overall Study|Withdrawal by Subject|1|||
17168666|NCT05090852|38317966|FG000|Overall Study|Physician Decision|5|||
17168667|NCT00075816|38317972|FG000|Overall Study|Did not undergo transplantation|14|||
17168668|NCT00075816|38317973|FG001|Overall Study|Did not undergo transplantation|11|||
17168669|NCT00109772|38317987|FG000|Double-blind Treatment|Adverse Event|14|||
17168670|NCT00109772|38317988|FG001|Double-blind Treatment|Adverse Event|5|||
17168671|NCT00109772|38317987|FG000|Double-blind Treatment|Lack of Efficacy|1|||
17168672|NCT00109772|38317988|FG001|Double-blind Treatment|Lack of Efficacy|0|||
17168673|NCT00109772|38317987|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
17168674|NCT00109772|38317988|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
17168675|NCT00109772|38317987|FG000|Double-blind Treatment|Lost to Follow-up|2|||
17168676|NCT00109772|38317988|FG001|Double-blind Treatment|Lost to Follow-up|3|||
17168677|NCT00109772|38317987|FG000|Double-blind Treatment|Protocol Violation|0|||
17168678|NCT00109772|38317988|FG001|Double-blind Treatment|Protocol Violation|1|||
17168679|NCT00109772|38317987|FG000|Double-blind Treatment|Other|0|||
17168680|NCT00109772|38317988|FG001|Double-blind Treatment|Other|4|||
17168681|NCT00109772|38317987|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
17168682|NCT00109772|38317988|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
17168683|NCT00109772|38317987|FG000|Open-label Extension|Adverse Event|10|||
17168684|NCT00109772|38317988|FG001|Open-label Extension|Adverse Event|19|||
17168685|NCT00109772|38317987|FG000|Open-label Extension|Lack of Efficacy|19|||
17168686|NCT00109772|38317988|FG001|Open-label Extension|Lack of Efficacy|11|||
17168687|NCT00109772|38317987|FG000|Open-label Extension|Withdrawal by Subject|9|||
17168688|NCT00109772|38317988|FG001|Open-label Extension|Withdrawal by Subject|6|||
17168689|NCT00109772|38317987|FG000|Open-label Extension|Lost to Follow-up|1|||
17168690|NCT00109772|38317988|FG001|Open-label Extension|Lost to Follow-up|0|||
17168691|NCT00109772|38317987|FG000|Open-label Extension|Death|0|||
17168692|NCT00109772|38317988|FG001|Open-label Extension|Death|1|||
17168693|NCT00109772|38317987|FG000|Open-label Extension|Protocol Violation|2|||
17168694|NCT00109772|38317988|FG001|Open-label Extension|Protocol Violation|2|||
17168695|NCT00109772|38317987|FG000|Open-label Extension|Other|4|||
17168696|NCT00109772|38317988|FG001|Open-label Extension|Other|10|||
17168697|NCT02783066|38317994|FG000|Overall Study|Withdrawal by Subject|13|||
17168698|NCT01371305|38318005|FG000|Overall Study|Adverse Event|0|||
17168699|NCT01371305|38318006|FG001|Overall Study|Adverse Event|0|||
17168700|NCT01371305|38318007|FG002|Overall Study|Adverse Event|0|||
17168701|NCT01371305|38318008|FG003|Overall Study|Adverse Event|2|||
17168702|NCT01371305|38318009|FG004|Overall Study|Adverse Event|1|||
17168703|NCT01371305|38318010|FG005|Overall Study|Adverse Event|0|||
17168704|NCT01371305|38318005|FG000|Overall Study|Study terminated by sponsor|0|||
17168705|NCT01371305|38318006|FG001|Overall Study|Study terminated by sponsor|0|||
17168706|NCT01371305|38318007|FG002|Overall Study|Study terminated by sponsor|0|||
17168707|NCT01371305|38318008|FG003|Overall Study|Study terminated by sponsor|0|||
17168708|NCT01371305|38318009|FG004|Overall Study|Study terminated by sponsor|3|||
17168709|NCT01371305|38318010|FG005|Overall Study|Study terminated by sponsor|1|||
17168710|NCT01371305|38318005|FG000|Overall Study|Subject request|0|||
17085891|NCT00358826|38226475|FG005|MDCT Substudy|Adverse Event|0|||
17085892|NCT00358826|38226476|FG006|MDCT Substudy|Adverse Event|0|||
17085893|NCT00358826|38226477|FG007|MDCT Substudy|Adverse Event|0|||
17085894|NCT00358826|38226470|FG000|MDCT Substudy|Lost to Follow-up|0|||
17085895|NCT00358826|38226471|FG001|MDCT Substudy|Lost to Follow-up|0|||
17085896|NCT00358826|38226472|FG002|MDCT Substudy|Lost to Follow-up|0|||
17085897|NCT00358826|38226473|FG003|MDCT Substudy|Lost to Follow-up|0|||
17168711|NCT01371305|38318006|FG001|Overall Study|Subject request|0|||
17168712|NCT01371305|38318007|FG002|Overall Study|Subject request|0|||
17168713|NCT01371305|38318008|FG003|Overall Study|Subject request|0|||
17168714|NCT01371305|38318009|FG004|Overall Study|Subject request|0|||
17168715|NCT01371305|38318010|FG005|Overall Study|Subject request|1|||
17168716|NCT00109928|38318025|FG000|Overall Study|Adverse Event|2|||
17168717|NCT00109928|38318025|FG000|Overall Study|Progression|6|||
17168718|NCT00109928|38318025|FG000|Overall Study|Death|2|||
17168719|NCT00109928|38318025|FG000|Overall Study|not protocol specified|2|||
17168720|NCT00109928|38318025|FG000|Overall Study|not eligible|1|||
17168721|NCT01358877|38318032|FG000|Overall Study|Death|80|||
17168722|NCT01358877|38318033|FG001|Overall Study|Death|89|||
17168723|NCT01358877|38318032|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
17168724|NCT01358877|38318033|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
17168725|NCT01358877|38318032|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
17168726|NCT01358877|38318033|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
17168727|NCT01358877|38318032|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
17168728|NCT01358877|38318033|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
17168729|NCT01358877|38318032|FG000|Overall Study|Other|142|||
17168730|NCT01358877|38318033|FG001|Overall Study|Other|129|||
17168731|NCT00109850|38318039|FG000|Overall Study|Adverse Event|1|||
17168732|NCT00109850|38318039|FG000|Overall Study|Death|2|||
17168733|NCT00109850|38318039|FG000|Overall Study|Ineligible|1|||
17168734|NCT01342926|38318047|FG000|Overall Study|Adverse Event|5|||
17168735|NCT01342926|38318048|FG001|Overall Study|Adverse Event|8|||
17168736|NCT01342926|38318049|FG002|Overall Study|Adverse Event|10|||
17168737|NCT01342926|38318050|FG003|Overall Study|Adverse Event|7|||
17168738|NCT01342926|38318047|FG000|Overall Study|Lost to Follow-up|0|||
17168739|NCT01342926|38318048|FG001|Overall Study|Lost to Follow-up|1|||
17168740|NCT01342926|38318049|FG002|Overall Study|Lost to Follow-up|1|||
17168741|NCT01342926|38318050|FG003|Overall Study|Lost to Follow-up|0|||
17168742|NCT01342926|38318047|FG000|Overall Study|Investigator Discretion|2|||
17168743|NCT01342926|38318048|FG001|Overall Study|Investigator Discretion|2|||
17168744|NCT01342926|38318049|FG002|Overall Study|Investigator Discretion|0|||
17168745|NCT01342926|38318050|FG003|Overall Study|Investigator Discretion|0|||
17168746|NCT01342926|38318047|FG000|Overall Study|Withdrawal by Subject|2|||
17168747|NCT01342926|38318048|FG001|Overall Study|Withdrawal by Subject|4|||
17168748|NCT01342926|38318049|FG002|Overall Study|Withdrawal by Subject|3|||
17168749|NCT01342926|38318050|FG003|Overall Study|Withdrawal by Subject|5|||
17168750|NCT01810016|38318063|FG000|Overall Study|Progressive disease|1|||
17168751|NCT01810016|38318064|FG001|Overall Study|Progressive disease|1|||
17168752|NCT01810016|38318065|FG002|Overall Study|Progressive disease|0|||
17168753|NCT01810016|38318063|FG000|Overall Study|Death|0|||
17168754|NCT01810016|38318064|FG001|Overall Study|Death|0|||
17168755|NCT01810016|38318065|FG002|Overall Study|Death|1|||
17168756|NCT02843178|38318077|FG000|Overall Study|Lost to Follow-up|8|||
17168757|NCT02843178|38318078|FG001|Overall Study|Lost to Follow-up|8|||
17168758|NCT02843178|38318079|FG002|Overall Study|Lost to Follow-up|6|||
17168759|NCT02843178|38318080|FG003|Overall Study|Lost to Follow-up|3|||
17168760|NCT02843178|38318077|FG000|Overall Study|Withdrawal by Subject|0|||
17085898|NCT00358826|38226474|FG004|MDCT Substudy|Lost to Follow-up|0|||
17085899|NCT00358826|38226475|FG005|MDCT Substudy|Lost to Follow-up|1|||
17085900|NCT00358826|38226476|FG006|MDCT Substudy|Lost to Follow-up|0|||
17085901|NCT00358826|38226477|FG007|MDCT Substudy|Lost to Follow-up|0|||
17085902|NCT00358826|38226470|FG000|MDCT Substudy|Withdrawal by Subject|0|||
17085903|NCT00358826|38226471|FG001|MDCT Substudy|Withdrawal by Subject|0|||
17085904|NCT00358826|38226472|FG002|MDCT Substudy|Withdrawal by Subject|0|||
17085905|NCT00358826|38226473|FG003|MDCT Substudy|Withdrawal by Subject|0|||
17085906|NCT00358826|38226474|FG004|MDCT Substudy|Withdrawal by Subject|0|||
17085907|NCT00358826|38226475|FG005|MDCT Substudy|Withdrawal by Subject|1|||
17085908|NCT00358826|38226476|FG006|MDCT Substudy|Withdrawal by Subject|0|||
17085909|NCT00358826|38226477|FG007|MDCT Substudy|Withdrawal by Subject|0|||
17085910|NCT00510653|38226491|FG000|Overall Study|Withdrawal by Subject|8|||
17085911|NCT00510653|38226491|FG000|Overall Study|Monetary|3|||
17085912|NCT00362336|38226498|FG000|Overall Study|Serious Adverse Event|1|||
17085913|NCT00362336|38226499|FG001|Overall Study|Serious Adverse Event|0|||
17085914|NCT00362336|38226500|FG002|Overall Study|Serious Adverse Event|1|||
17085915|NCT00362336|38226498|FG000|Overall Study|Protocol Violation|0|||
17085916|NCT00362336|38226499|FG001|Overall Study|Protocol Violation|0|||
17085917|NCT00362336|38226500|FG002|Overall Study|Protocol Violation|1|||
17168761|NCT02843178|38318078|FG001|Overall Study|Withdrawal by Subject|0|||
17085918|NCT00362336|38226498|FG000|Overall Study|Lost to Follow-up|6|||
17085919|NCT00362336|38226499|FG001|Overall Study|Lost to Follow-up|4|||
17085920|NCT00362336|38226500|FG002|Overall Study|Lost to Follow-up|0|||
17085921|NCT00362336|38226498|FG000|Overall Study|Withdrawal by Subject|3|||
17085922|NCT00362336|38226499|FG001|Overall Study|Withdrawal by Subject|3|||
17168762|NCT02843178|38318079|FG002|Overall Study|Withdrawal by Subject|1|||
17168763|NCT02843178|38318080|FG003|Overall Study|Withdrawal by Subject|1|||
17168764|NCT01722266|38318094|FG000|Overall Study|Withdrawal by Subject|1|||
17085923|NCT00362336|38226500|FG002|Overall Study|Withdrawal by Subject|1|||
17085924|NCT00506285|38226517|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
17168765|NCT01722266|38318095|FG001|Overall Study|Withdrawal by Subject|2|||
17168766|NCT01722266|38318096|FG002|Overall Study|Withdrawal by Subject|0|||
17168767|NCT01722266|38318097|FG003|Overall Study|Withdrawal by Subject|0|||
17168768|NCT01722266|38318094|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
17168769|NCT01722266|38318095|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
17168770|NCT01722266|38318096|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
17168771|NCT01722266|38318097|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
17168772|NCT01722266|38318094|FG000|Overall Study|Dropped out due to Nausea|0|||
17168773|NCT01722266|38318095|FG001|Overall Study|Dropped out due to Nausea|0|||
17168774|NCT01722266|38318096|FG002|Overall Study|Dropped out due to Nausea|2|||
17168775|NCT01722266|38318097|FG003|Overall Study|Dropped out due to Nausea|0|||
17085925|NCT00506285|38226518|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
17085926|NCT00506285|38226517|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
17085927|NCT00506285|38226518|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
17085928|NCT00506285|38226517|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
17085929|NCT00506285|38226518|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
17085930|NCT00506285|38226517|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
17085931|NCT00506285|38226518|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
17085932|NCT00506285|38226517|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
17085933|NCT00506285|38226518|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
17085934|NCT00506129|38226526|FG000|Overall Study|Disease Progression/Relapse|15|||
17085935|NCT00506129|38226526|FG000|Overall Study|Death|7|||
17085936|NCT00358670|38226532|FG000|Overall Study|Adverse Event|26|||
17085937|NCT00358670|38226533|FG001|Overall Study|Adverse Event|29|||
17085938|NCT00358670|38226532|FG000|Overall Study|Lack of Efficacy|20|||
17085939|NCT00358670|38226533|FG001|Overall Study|Lack of Efficacy|23|||
17085940|NCT00358670|38226532|FG000|Overall Study|Protocol Violation|6|||
17085941|NCT00358670|38226533|FG001|Overall Study|Protocol Violation|9|||
17085942|NCT00358670|38226532|FG000|Overall Study|Lost to Follow-up|4|||
17085943|NCT00358670|38226533|FG001|Overall Study|Lost to Follow-up|5|||
17085944|NCT00358670|38226532|FG000|Overall Study|Withdrawal by Subject|13|||
17085945|NCT00358670|38226533|FG001|Overall Study|Withdrawal by Subject|24|||
17085946|NCT00358670|38226532|FG000|Overall Study|Protocol Defined Clinical Event|0|||
17085947|NCT00358670|38226533|FG001|Overall Study|Protocol Defined Clinical Event|1|||
17085948|NCT00358670|38226532|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
17085949|NCT00358670|38226533|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
17085950|NCT00358670|38226532|FG000|Overall Study|Administrative|153|||
17085951|NCT00358670|38226533|FG001|Overall Study|Administrative|125|||
17085952|NCT00505661|38226539|FG000|Overall Study|Not Eligible|4|||
17085953|NCT00383786|38226545|FG000|Overall Study|Protocol Violation|2|||
17085954|NCT00383786|38226546|FG001|Overall Study|Protocol Violation|6|||
17085955|NCT00383786|38226545|FG000|Overall Study|Withdrawal by Subject|2|||
17085956|NCT00383786|38226546|FG001|Overall Study|Withdrawal by Subject|5|||
17085957|NCT00383786|38226545|FG000|Overall Study|Physician Decision|0|||
17085958|NCT00383786|38226546|FG001|Overall Study|Physician Decision|1|||
17085959|NCT00383708|38226552|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
17085960|NCT00383708|38226552|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
17085961|NCT00383708|38226552|FG000|Run-in Period|Protocol Violation|4|||
17085962|NCT00383708|38226552|FG000|Run-in Period|Adverse Event|2|||
17085963|NCT00383708|38226552|FG000|Run-in Period|Claustrophobia|1|||
17085964|NCT00383708|38226552|FG000|Co-administration Period|Adverse Event|5|||
17085965|NCT00504881|38226559|FG000|Overall Study|Lack of Efficacy|1|||
17085966|NCT00504881|38226560|FG001|Overall Study|Lack of Efficacy|5|||
17085967|NCT00504881|38226559|FG000|Overall Study|Lost to Follow-up|0|||
17085968|NCT00504881|38226560|FG001|Overall Study|Lost to Follow-up|2|||
17085969|NCT00504881|38226559|FG000|Overall Study|Withdrawal by Subject|1|||
17085970|NCT00504881|38226560|FG001|Overall Study|Withdrawal by Subject|4|||
17085971|NCT00504881|38226559|FG000|Overall Study|Non-Compliance|1|||
17085972|NCT00504881|38226560|FG001|Overall Study|Non-Compliance|0|||
17085973|NCT00504881|38226559|FG000|Overall Study|No Birth Control|0|||
17085974|NCT00504881|38226560|FG001|Overall Study|No Birth Control|1|||
17085975|NCT00504881|38226559|FG000|Overall Study|Safety Visit not performed|0|||
17085976|NCT00504881|38226560|FG001|Overall Study|Safety Visit not performed|1|||
17085977|NCT00504881|38226559|FG000|Overall Study|AE, serious fatal|0|||
17085978|NCT00504881|38226560|FG001|Overall Study|AE, serious fatal|1|||
17085979|NCT00504881|38226559|FG000|Overall Study|SAE, non-fatal|2|||
17085980|NCT00504881|38226560|FG001|Overall Study|SAE, non-fatal|6|||
17085981|NCT00504881|38226559|FG000|Overall Study|AE, non-serious non-fatal|4|||
17085982|NCT00504881|38226560|FG001|Overall Study|AE, non-serious non-fatal|14|||
17085983|NCT00504881|38226559|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
17085984|NCT00504881|38226560|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
17085985|NCT00504881|38226559|FG000|Overall Study|AE of unknown type|1|||
17085986|NCT00504881|38226560|FG001|Overall Study|AE of unknown type|0|||
17085987|NCT00504725|38226570|FG000|Overall Study|Protocol Violation|1|||
17168776|NCT03123185|38318121|FG000|Overall Study|Withdrawal by Subject|0|||
17168777|NCT03123185|38318122|FG001|Overall Study|Withdrawal by Subject|0|||
17168778|NCT03123185|38318123|FG002|Overall Study|Withdrawal by Subject|0|||
17168779|NCT03123185|38318124|FG003|Overall Study|Withdrawal by Subject|0|||
17168780|NCT03123185|38318125|FG004|Overall Study|Withdrawal by Subject|0|||
17168781|NCT03123185|38318126|FG005|Overall Study|Withdrawal by Subject|0|||
17168782|NCT03123185|38318127|FG006|Overall Study|Withdrawal by Subject|0|||
17168783|NCT03123185|38318128|FG007|Overall Study|Withdrawal by Subject|0|||
17168784|NCT03123185|38318129|FG008|Overall Study|Withdrawal by Subject|0|||
17168785|NCT03123185|38318130|FG009|Overall Study|Withdrawal by Subject|0|||
17168786|NCT03123185|38318131|FG010|Overall Study|Withdrawal by Subject|0|||
17168787|NCT03123185|38318132|FG011|Overall Study|Withdrawal by Subject|0|||
17168788|NCT03123185|38318133|FG012|Overall Study|Withdrawal by Subject|1|||
17168789|NCT03123185|38318134|FG013|Overall Study|Withdrawal by Subject|0|||
17168790|NCT02842866|38318193|FG000|Overall Study|Serious Adverse Event|0|||
17168791|NCT02842866|38318194|FG001|Overall Study|Serious Adverse Event|1|||
17168792|NCT02842866|38318193|FG000|Overall Study|Protocol Violation|4|||
17168793|NCT02842866|38318194|FG001|Overall Study|Protocol Violation|2|||
17168794|NCT02842866|38318193|FG000|Overall Study|Lost to Follow-up|2|||
17168795|NCT02842866|38318194|FG001|Overall Study|Lost to Follow-up|0|||
17168796|NCT02842866|38318193|FG000|Overall Study|Withdrawal by Subject|1|||
17168797|NCT02842866|38318194|FG001|Overall Study|Withdrawal by Subject|0|||
17168798|NCT01316913|38318204|FG000|Overall Study|Adverse Event|17|||
17168799|NCT01316913|38318205|FG001|Overall Study|Adverse Event|20|||
17168800|NCT01316913|38318206|FG002|Overall Study|Adverse Event|15|||
17168801|NCT01316913|38318207|FG003|Overall Study|Adverse Event|11|||
17168802|NCT01316913|38318204|FG000|Overall Study|Lack of Efficacy|22|||
17168803|NCT01316913|38318205|FG001|Overall Study|Lack of Efficacy|12|||
17168804|NCT01316913|38318206|FG002|Overall Study|Lack of Efficacy|9|||
17168805|NCT01316913|38318207|FG003|Overall Study|Lack of Efficacy|13|||
17168806|NCT01316913|38318204|FG000|Overall Study|Protocol Violation|1|||
17168807|NCT01316913|38318205|FG001|Overall Study|Protocol Violation|4|||
17168808|NCT01316913|38318206|FG002|Overall Study|Protocol Violation|4|||
17168809|NCT01316913|38318207|FG003|Overall Study|Protocol Violation|1|||
17168810|NCT01316913|38318204|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
17168811|NCT01316913|38318205|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
17168812|NCT01316913|38318206|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
17168813|NCT01316913|38318207|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
17168814|NCT01316913|38318204|FG000|Overall Study|Lost to Follow-up|0|||
17168815|NCT01316913|38318205|FG001|Overall Study|Lost to Follow-up|1|||
17168816|NCT01316913|38318206|FG002|Overall Study|Lost to Follow-up|0|||
17168817|NCT01316913|38318207|FG003|Overall Study|Lost to Follow-up|2|||
17168818|NCT01316913|38318204|FG000|Overall Study|Withdrawal by Subject|10|||
17168819|NCT01316913|38318205|FG001|Overall Study|Withdrawal by Subject|9|||
17168820|NCT01316913|38318206|FG002|Overall Study|Withdrawal by Subject|10|||
17168821|NCT01316913|38318207|FG003|Overall Study|Withdrawal by Subject|6|||
17168822|NCT02875067|38318218|FG000|Overall Study|Withdrawal by Subject|1|||
17168823|NCT02875067|38318218|FG000|Overall Study|Withdrawal by Termination of Study|5|||
17168824|NCT02781506|38318222|FG000|Overall Study|Adverse Event|5|||
17168825|NCT03132753|38318228|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
17168826|NCT03132753|38318229|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
17168827|NCT03132753|38318228|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
17168828|NCT03132753|38318229|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
17168829|NCT01468454|38318235|FG000|Overall Study|Did not have surgery after PET|9|||
17168830|NCT03067077|38318240|FG000|Overall Study|Did not receive surgery|4|||
17168831|NCT03067077|38318241|FG001|Overall Study|Did not receive surgery|5|||
17168832|NCT03067077|38318240|FG000|Overall Study|Lost to Follow-up|3|||
17168833|NCT03067077|38318241|FG001|Overall Study|Lost to Follow-up|2|||
17168834|NCT03096847|38318250|FG000|Overall Study|Other|2|||
17168835|NCT03096847|38318251|FG001|Overall Study|Other|1|||
17168836|NCT03096847|38318252|FG002|Overall Study|Other|2|||
17168837|NCT03096847|38318250|FG000|Overall Study|Lost to Follow-up|1|||
17168838|NCT03096847|38318251|FG001|Overall Study|Lost to Follow-up|0|||
17168839|NCT03096847|38318252|FG002|Overall Study|Lost to Follow-up|1|||
17168840|NCT03096847|38318250|FG000|Overall Study|Death|6|||
17168841|NCT03096847|38318251|FG001|Overall Study|Death|0|||
17168842|NCT03096847|38318252|FG002|Overall Study|Death|2|||
17168843|NCT03096847|38318250|FG000|Overall Study|Protocol Violation|3|||
17168844|NCT03096847|38318251|FG001|Overall Study|Protocol Violation|0|||
17168845|NCT03096847|38318252|FG002|Overall Study|Protocol Violation|6|||
17168846|NCT03096847|38318250|FG000|Overall Study|Physician Decision|12|||
17168847|NCT03096847|38318251|FG001|Overall Study|Physician Decision|2|||
17168848|NCT03096847|38318252|FG002|Overall Study|Physician Decision|8|||
17168849|NCT03096847|38318250|FG000|Overall Study|Withdrawal by Subject|24|||
17168850|NCT03096847|38318251|FG001|Overall Study|Withdrawal by Subject|1|||
17168851|NCT03096847|38318252|FG002|Overall Study|Withdrawal by Subject|12|||
17168852|NCT03096847|38318250|FG000|Overall Study|Adverse Event|72|||
17168853|NCT03096847|38318251|FG001|Overall Study|Adverse Event|6|||
17168854|NCT03096847|38318252|FG002|Overall Study|Adverse Event|28|||
17168855|NCT03096847|38318250|FG000|Overall Study|Progressive disease|97|||
17168856|NCT03096847|38318251|FG001|Overall Study|Progressive disease|10|||
17168857|NCT03096847|38318252|FG002|Overall Study|Progressive disease|78|||
17168858|NCT03096847|38318250|FG000|Overall Study|Non-compliance with study medication|1|||
17168859|NCT03096847|38318251|FG001|Overall Study|Non-compliance with study medication|0|||
17168860|NCT03096847|38318252|FG002|Overall Study|Non-compliance with study medication|0|||
17168861|NCT03096847|38318250|FG000|Overall Study|New therapy for study indication|1|||
17168862|NCT03096847|38318251|FG001|Overall Study|New therapy for study indication|0|||
17168863|NCT03096847|38318252|FG002|Overall Study|New therapy for study indication|1|||
17168864|NCT01365182|38318271|FG000|Overall Study|Withdrawal by Subject|10|||
17168865|NCT01365182|38318272|FG001|Overall Study|Withdrawal by Subject|13|||
17168866|NCT01365182|38318273|FG002|Overall Study|Withdrawal by Subject|12|||
17168867|NCT03128099|38318291|FG000|Overall Study|High dose task was too long|0|||
17168868|NCT03128099|38318292|FG001|Overall Study|High dose task was too long|4|||
17168869|NCT03128099|38318293|FG002|Overall Study|High dose task was too long|0|||
17168870|NCT03128099|38318291|FG000|Overall Study|Participant got a full time job.|1|||
17168871|NCT03128099|38318292|FG001|Overall Study|Participant got a full time job.|0|||
17168872|NCT03128099|38318293|FG002|Overall Study|Participant got a full time job.|0|||
17168873|NCT03128099|38318291|FG000|Overall Study|Became homeless and lost contact|1|||
17168874|NCT03128099|38318292|FG001|Overall Study|Became homeless and lost contact|0|||
17168875|NCT03128099|38318293|FG002|Overall Study|Became homeless and lost contact|0|||
17168876|NCT03128099|38318291|FG000|Overall Study|Did not complete all the assessments|0|||
17168877|NCT03128099|38318292|FG001|Overall Study|Did not complete all the assessments|0|||
17168878|NCT03128099|38318293|FG002|Overall Study|Did not complete all the assessments|1|||
17168879|NCT02886494|38318301|FG000|Overall Study|Adverse Event|1|||
17168880|NCT02886494|38318302|FG001|Overall Study|Adverse Event|0|||
17168881|NCT02886494|38318301|FG000|Overall Study|Withdrawal by Subject|12|||
17168882|NCT02886494|38318302|FG001|Overall Study|Withdrawal by Subject|3|||
17168883|NCT02886494|38318301|FG000|Overall Study|Protocol Violation|4|||
17168884|NCT02886494|38318302|FG001|Overall Study|Protocol Violation|1|||
17168885|NCT02846532|38318314|FG000|Overall Study|Lost to Follow-up|0|||
17168886|NCT02846532|38318315|FG001|Overall Study|Lost to Follow-up|1|||
17168887|NCT02846532|38318316|FG002|Overall Study|Lost to Follow-up|1|||
17168888|NCT02846532|38318314|FG000|Overall Study|Withdrawal by Subject|1|||
17168889|NCT02846532|38318315|FG001|Overall Study|Withdrawal by Subject|2|||
17168890|NCT02846532|38318316|FG002|Overall Study|Withdrawal by Subject|0|||
17168891|NCT00842348|38318335|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
17168892|NCT00842348|38318336|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
17168893|NCT00842348|38318335|FG000|Study 729|Disease progression/death|19|||
17168894|NCT00842348|38318336|FG001|Study 729|Disease progression/death|30|||
17085988|NCT00504725|38226571|FG001|Overall Study|Protocol Violation|0|||
17085989|NCT00383240|38226581|FG000|Overall Study|Adverse Event|4|||
17085990|NCT00383240|38226582|FG001|Overall Study|Adverse Event|6|||
17085991|NCT00383240|38226583|FG002|Overall Study|Adverse Event|9|||
17085992|NCT00383240|38226584|FG003|Overall Study|Adverse Event|7|||
17085993|NCT00383240|38226581|FG000|Overall Study|Treatment Failure|8|||
17085994|NCT00383240|38226582|FG001|Overall Study|Treatment Failure|13|||
17085995|NCT00383240|38226583|FG002|Overall Study|Treatment Failure|47|||
17085996|NCT00383240|38226584|FG003|Overall Study|Treatment Failure|46|||
17085997|NCT00383240|38226581|FG000|Overall Study|Lost to Follow-up|3|||
17085998|NCT00383240|38226582|FG001|Overall Study|Lost to Follow-up|0|||
17085999|NCT00383240|38226583|FG002|Overall Study|Lost to Follow-up|0|||
17086000|NCT00383240|38226584|FG003|Overall Study|Lost to Follow-up|2|||
17086001|NCT00383240|38226581|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
17168895|NCT00842348|38318335|FG000|Study 729|Adverse Event|1|||
17168896|NCT00842348|38318336|FG001|Study 729|Adverse Event|1|||
17168897|NCT00842348|38318335|FG000|Study 729|Protocol Violation|1|||
17168898|NCT00842348|38318336|FG001|Study 729|Protocol Violation|1|||
17168899|NCT00842348|38318335|FG000|Study 729|Withdrawal by Subject|2|||
17168900|NCT00842348|38318336|FG001|Study 729|Withdrawal by Subject|4|||
17168901|NCT00842348|38318335|FG000|Study 729|Due to Sponsor stopping the study|1|||
17168902|NCT00842348|38318336|FG001|Study 729|Due to Sponsor stopping the study|1|||
17168903|NCT00842348|38318335|FG000|Study 729|Due to non-availability of IP|0|||
17168904|NCT00842348|38318336|FG001|Study 729|Due to non-availability of IP|1|||
17168905|NCT00842348|38318335|FG000|Study 729|Sponsor's decision|1|||
17168906|NCT00842348|38318336|FG001|Study 729|Sponsor's decision|0|||
17168907|NCT00842348|38318335|FG000|Study 729|Surgical resection|1|||
17168908|NCT00842348|38318336|FG001|Study 729|Surgical resection|0|||
17168909|NCT03095599|38318348|FG000|Overall Study|Withdrawal by Subject|1|||
17168910|NCT03095599|38318349|FG001|Overall Study|Withdrawal by Subject|0|||
17168911|NCT03095599|38318348|FG000|Overall Study|Lost to Follow-up|1|||
17168912|NCT03095599|38318349|FG001|Overall Study|Lost to Follow-up|0|||
17168913|NCT03095599|38318348|FG000|Overall Study|Withdrawal prior to vaccination|1|||
17086002|NCT00383240|38226582|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
17168914|NCT03095599|38318349|FG001|Overall Study|Withdrawal prior to vaccination|0|||
17168915|NCT03095521|38318359|FG000|Overall Study|Withdrawal by Subject|0|||
17168916|NCT03095521|38318360|FG001|Overall Study|Withdrawal by Subject|1|||
17168917|NCT03095521|38318359|FG000|Overall Study|Lost to Follow-up|0|||
17168918|NCT03095521|38318360|FG001|Overall Study|Lost to Follow-up|1|||
17168919|NCT03033875|38318369|FG000|Overall Study|Withdrawal by Subject|5|||
17168920|NCT03033875|38318370|FG001|Overall Study|Withdrawal by Subject|9|||
17168921|NCT03033875|38318371|FG002|Overall Study|Withdrawal by Subject|4|||
17168922|NCT03033875|38318369|FG000|Overall Study|Other|14|||
17168923|NCT03033875|38318370|FG001|Overall Study|Other|15|||
17168924|NCT03033875|38318371|FG002|Overall Study|Other|8|||
17086003|NCT00383240|38226583|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
17086004|NCT00383240|38226584|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
17086005|NCT00383240|38226581|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
17086006|NCT00383240|38226582|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
17086007|NCT00383240|38226583|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
17086008|NCT00383240|38226584|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
17086009|NCT00383240|38226581|FG000|Overall Study|Protocol Violation|4|||
17086010|NCT00383240|38226582|FG001|Overall Study|Protocol Violation|5|||
17086011|NCT00383240|38226583|FG002|Overall Study|Protocol Violation|9|||
17086012|NCT00383240|38226584|FG003|Overall Study|Protocol Violation|6|||
17168925|NCT01968785|38318389|FG000|Overall Study|Withdrawal by Subject|1|||
17168926|NCT01968785|38318390|FG001|Overall Study|Withdrawal by Subject|0|||
17168927|NCT03095287|38318396|FG000|Overall Study|Treatment Failure|1|||
17168928|NCT03095287|38318396|FG000|Overall Study|Adverse Event|1|||
17168929|NCT02839746|38318414|FG000|Overall Study|Not met selection criteria|12|||
17168930|NCT00033293|38318420|FG000|Overall Study|Death|0|||
17168931|NCT00033293|38318421|FG001|Overall Study|Death|1|||
17168932|NCT00033293|38318420|FG000|Overall Study|Lack of Efficacy|5|||
17168933|NCT00033293|38318421|FG001|Overall Study|Lack of Efficacy|8|||
17168934|NCT00033293|38318420|FG000|Overall Study|Lost to Follow-up|0|||
17168935|NCT00033293|38318421|FG001|Overall Study|Lost to Follow-up|1|||
17168936|NCT00033293|38318420|FG000|Overall Study|Physician Decision|3|||
17168937|NCT00033293|38318421|FG001|Overall Study|Physician Decision|1|||
17168938|NCT00033293|38318420|FG000|Overall Study|Withdrawal by Subject|1|||
17168939|NCT00033293|38318421|FG001|Overall Study|Withdrawal by Subject|0|||
17168940|NCT00033293|38318420|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
17168941|NCT00033293|38318421|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
17168942|NCT00033293|38318420|FG000|Overall Study|Treatment refused|0|||
17168943|NCT00033293|38318421|FG001|Overall Study|Treatment refused|6|||
17168944|NCT02836236|38318431|FG000|Overall Study|Randomized but Never Treated|1|||
17168945|NCT02836236|38318432|FG001|Overall Study|Randomized but Never Treated|0|||
17168946|NCT02836236|38318431|FG000|Overall Study|Withdrew Consent|2|||
17168947|NCT02836236|38318432|FG001|Overall Study|Withdrew Consent|0|||
17168948|NCT02836236|38318431|FG000|Overall Study|Adverse Event|0|||
17168949|NCT02836236|38318432|FG001|Overall Study|Adverse Event|1|||
17168950|NCT02836236|38318431|FG000|Overall Study|Investigator's Discretion|1|||
17168951|NCT02836236|38318432|FG001|Overall Study|Investigator's Discretion|0|||
17168952|NCT02836236|38318431|FG000|Overall Study|Still on Study|101|||
17168953|NCT02836236|38318432|FG001|Overall Study|Still on Study|49|||
17168954|NCT02039674|38318452|FG000|Overall Study|Adverse Event|0|||
17168955|NCT02039674|38318453|FG001|Overall Study|Adverse Event|0|||
17086013|NCT00383240|38226581|FG000|Overall Study|Did not meet protocol eligibility|9|||
17086014|NCT00383240|38226582|FG001|Overall Study|Did not meet protocol eligibility|4|||
17086015|NCT00383240|38226583|FG002|Overall Study|Did not meet protocol eligibility|9|||
17086016|NCT00383240|38226584|FG003|Overall Study|Did not meet protocol eligibility|3|||
17086017|NCT00383240|38226581|FG000|Overall Study|Administrative|1|||
17168956|NCT02039674|38318454|FG002|Overall Study|Adverse Event|0|||
17168957|NCT02039674|38318455|FG003|Overall Study|Adverse Event|1|||
17168958|NCT02039674|38318456|FG004|Overall Study|Adverse Event|0|||
17168959|NCT02039674|38318457|FG005|Overall Study|Adverse Event|0|||
17168960|NCT02039674|38318458|FG006|Overall Study|Adverse Event|0|||
17168961|NCT02039674|38318459|FG007|Overall Study|Adverse Event|0|||
17168962|NCT02039674|38318460|FG008|Overall Study|Adverse Event|2|||
17168963|NCT02039674|38318461|FG009|Overall Study|Adverse Event|1|||
17168964|NCT02039674|38318462|FG010|Overall Study|Adverse Event|0|||
17168965|NCT02039674|38318463|FG011|Overall Study|Adverse Event|2|||
17168966|NCT02039674|38318464|FG012|Overall Study|Adverse Event|3|||
17168967|NCT02039674|38318465|FG013|Overall Study|Adverse Event|1|||
17168968|NCT02039674|38318452|FG000|Overall Study|Death|2|||
17168969|NCT02039674|38318453|FG001|Overall Study|Death|0|||
17168970|NCT02039674|38318454|FG002|Overall Study|Death|2|||
17168971|NCT02039674|38318455|FG003|Overall Study|Death|3|||
17168972|NCT02039674|38318456|FG004|Overall Study|Death|0|||
17168973|NCT02039674|38318457|FG005|Overall Study|Death|0|||
17168974|NCT02039674|38318458|FG006|Overall Study|Death|1|||
17168975|NCT02039674|38318459|FG007|Overall Study|Death|0|||
16868024|NCT01536145|37841033|FG000|Overall Study|Other|0|||
17168976|NCT02039674|38318460|FG008|Overall Study|Death|2|||
17168977|NCT02039674|38318461|FG009|Overall Study|Death|0|||
17168978|NCT02039674|38318462|FG010|Overall Study|Death|1|||
17168979|NCT02039674|38318463|FG011|Overall Study|Death|3|||
17168980|NCT02039674|38318464|FG012|Overall Study|Death|2|||
17168981|NCT02039674|38318465|FG013|Overall Study|Death|8|||
17168982|NCT02039674|38318452|FG000|Overall Study|Excluded Medication|1|||
17168983|NCT02039674|38318453|FG001|Overall Study|Excluded Medication|1|||
17168984|NCT02039674|38318454|FG002|Overall Study|Excluded Medication|0|||
17168985|NCT02039674|38318455|FG003|Overall Study|Excluded Medication|1|||
17168986|NCT02039674|38318456|FG004|Overall Study|Excluded Medication|0|||
17168987|NCT02039674|38318457|FG005|Overall Study|Excluded Medication|1|||
17168988|NCT02039674|38318458|FG006|Overall Study|Excluded Medication|0|||
17168989|NCT02039674|38318459|FG007|Overall Study|Excluded Medication|0|||
17168990|NCT02039674|38318460|FG008|Overall Study|Excluded Medication|2|||
17168991|NCT02039674|38318461|FG009|Overall Study|Excluded Medication|3|||
17168992|NCT02039674|38318462|FG010|Overall Study|Excluded Medication|5|||
17168993|NCT02039674|38318463|FG011|Overall Study|Excluded Medication|6|||
17168994|NCT02039674|38318464|FG012|Overall Study|Excluded Medication|8|||
17168995|NCT02039674|38318465|FG013|Overall Study|Excluded Medication|3|||
17168996|NCT02039674|38318452|FG000|Overall Study|Lost to Follow-up|0|||
17168997|NCT02039674|38318453|FG001|Overall Study|Lost to Follow-up|0|||
17168998|NCT02039674|38318454|FG002|Overall Study|Lost to Follow-up|0|||
17086018|NCT00383240|38226582|FG001|Overall Study|Administrative|1|||
17168999|NCT02039674|38318455|FG003|Overall Study|Lost to Follow-up|0|||
17169000|NCT02039674|38318456|FG004|Overall Study|Lost to Follow-up|1|||
17169001|NCT02039674|38318457|FG005|Overall Study|Lost to Follow-up|1|||
17169002|NCT02039674|38318458|FG006|Overall Study|Lost to Follow-up|0|||
17169003|NCT02039674|38318459|FG007|Overall Study|Lost to Follow-up|0|||
17169004|NCT02039674|38318460|FG008|Overall Study|Lost to Follow-up|0|||
17169005|NCT02039674|38318461|FG009|Overall Study|Lost to Follow-up|0|||
17169006|NCT02039674|38318462|FG010|Overall Study|Lost to Follow-up|0|||
17169007|NCT02039674|38318463|FG011|Overall Study|Lost to Follow-up|2|||
17169008|NCT02039674|38318464|FG012|Overall Study|Lost to Follow-up|2|||
17169009|NCT02039674|38318465|FG013|Overall Study|Lost to Follow-up|1|||
17169010|NCT02039674|38318452|FG000|Overall Study|Physician Decision|0|||
17169011|NCT02039674|38318453|FG001|Overall Study|Physician Decision|0|||
17086019|NCT00383240|38226583|FG002|Overall Study|Administrative|0|||
17086020|NCT00383240|38226584|FG003|Overall Study|Administrative|0|||
17086021|NCT00362180|38226604|FG000|Treated Period|Withdrawal by Subject|1|||
17086022|NCT00362180|38226605|FG001|Treated Period|Withdrawal by Subject|0|||
17086023|NCT00362180|38226606|FG002|Treated Period|Withdrawal by Subject|0|||
17086024|NCT00362180|38226607|FG003|Treated Period|Withdrawal by Subject|0|||
17086025|NCT00362180|38226608|FG004|Treated Period|Withdrawal by Subject|0|||
17086026|NCT00362180|38226609|FG005|Treated Period|Withdrawal by Subject|0|||
17086027|NCT00362180|38226610|FG006|Treated Period|Withdrawal by Subject|0|||
17086028|NCT00362180|38226611|FG007|Treated Period|Withdrawal by Subject|0|||
17086029|NCT00362180|38226612|FG008|Treated Period|Withdrawal by Subject|0|||
17086030|NCT00362180|38226604|FG000|Treated Period|Adverse Event|0|||
17086031|NCT00362180|38226605|FG001|Treated Period|Adverse Event|0|||
17086032|NCT00362180|38226606|FG002|Treated Period|Adverse Event|0|||
17086033|NCT00362180|38226607|FG003|Treated Period|Adverse Event|0|||
17086034|NCT00362180|38226608|FG004|Treated Period|Adverse Event|0|||
17086035|NCT00362180|38226609|FG005|Treated Period|Adverse Event|1|||
17086036|NCT00362180|38226610|FG006|Treated Period|Adverse Event|0|||
17086037|NCT00362180|38226611|FG007|Treated Period|Adverse Event|1|||
17086038|NCT00362180|38226612|FG008|Treated Period|Adverse Event|0|||
17086039|NCT00383162|38226630|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
17086040|NCT00383162|38226631|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
17086041|NCT00383162|38226630|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
17086042|NCT00383162|38226631|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
17086043|NCT00383162|38226630|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
17086044|NCT00383162|38226631|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
17086045|NCT00383162|38226630|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
17086046|NCT00383162|38226631|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
17086047|NCT00383162|38226630|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
17086048|NCT00383162|38226631|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
17086049|NCT00383162|38226630|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
17086050|NCT00383162|38226631|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
17086051|NCT00383162|38226630|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
17086052|NCT00383162|38226631|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
17086053|NCT00383162|38226630|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
17169012|NCT02039674|38318454|FG002|Overall Study|Physician Decision|0|||
17169013|NCT02039674|38318455|FG003|Overall Study|Physician Decision|0|||
17169014|NCT02039674|38318456|FG004|Overall Study|Physician Decision|0|||
17169015|NCT02039674|38318457|FG005|Overall Study|Physician Decision|0|||
17169016|NCT02039674|38318458|FG006|Overall Study|Physician Decision|0|||
17086054|NCT00383162|38226631|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
17086055|NCT00383162|38226630|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
17086056|NCT00383162|38226631|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
17086057|NCT00358436|38226639|FG000|Overall Study|Adverse Event|29|||
17086058|NCT00358436|38226640|FG001|Overall Study|Adverse Event|13|||
17086059|NCT00358436|38226639|FG000|Overall Study|Lack of Efficacy|34|||
17086060|NCT00358436|38226640|FG001|Overall Study|Lack of Efficacy|36|||
17086061|NCT00358436|38226639|FG000|Overall Study|Lost to Follow-up|11|||
17086062|NCT00358436|38226640|FG001|Overall Study|Lost to Follow-up|6|||
17086063|NCT00358436|38226639|FG000|Overall Study|Protocol Violation|8|||
17086064|NCT00358436|38226640|FG001|Overall Study|Protocol Violation|3|||
17086065|NCT00358436|38226639|FG000|Overall Study|Withdrawal by Subject|40|||
17086066|NCT00358436|38226640|FG001|Overall Study|Withdrawal by Subject|17|||
17086067|NCT00358436|38226639|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
17086068|NCT00358436|38226640|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
17086069|NCT00358436|38226639|FG000|Overall Study|COPD exacerbation|22|||
17086070|NCT00358436|38226640|FG001|Overall Study|COPD exacerbation|10|||
17169017|NCT02039674|38318459|FG007|Overall Study|Physician Decision|0|||
17169018|NCT02039674|38318460|FG008|Overall Study|Physician Decision|0|||
17169019|NCT02039674|38318461|FG009|Overall Study|Physician Decision|0|||
17169020|NCT02039674|38318462|FG010|Overall Study|Physician Decision|0|||
17169021|NCT02039674|38318463|FG011|Overall Study|Physician Decision|1|||
17169022|NCT02039674|38318464|FG012|Overall Study|Physician Decision|1|||
17169023|NCT02039674|38318465|FG013|Overall Study|Physician Decision|0|||
17169024|NCT02039674|38318452|FG000|Overall Study|Progressive Disease|8|||
17169025|NCT02039674|38318453|FG001|Overall Study|Progressive Disease|8|||
17169026|NCT02039674|38318454|FG002|Overall Study|Progressive Disease|6|||
17169027|NCT02039674|38318455|FG003|Overall Study|Progressive Disease|7|||
17169028|NCT02039674|38318456|FG004|Overall Study|Progressive Disease|9|||
17169029|NCT02039674|38318457|FG005|Overall Study|Progressive Disease|10|||
17169030|NCT02039674|38318458|FG006|Overall Study|Progressive Disease|1|||
17169031|NCT02039674|38318459|FG007|Overall Study|Progressive Disease|3|||
17169032|NCT02039674|38318460|FG008|Overall Study|Progressive Disease|6|||
17169033|NCT02039674|38318461|FG009|Overall Study|Progressive Disease|4|||
17086071|NCT00358436|38226639|FG000|Overall Study|Other|6|||
17086072|NCT00358436|38226640|FG001|Overall Study|Other|1|||
17086073|NCT00383084|38226650|FG000|Overall Study|Withdrawal by Subject|12|||
17086074|NCT00383084|38226651|FG001|Overall Study|Withdrawal by Subject|10|||
17086075|NCT00361634|38226657|FG000|Overall Study|Lost to Follow-up|1|||
17086076|NCT00361634|38226657|FG000|Overall Study|Withdrawal by Subject|1|||
17086077|NCT00357968|38226663|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
17086078|NCT00357968|38226664|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
17086079|NCT00357968|38226663|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
17086080|NCT00357968|38226664|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
17086081|NCT00357656|38226687|FG000|Overall Study|Other, No surgery performed|0|||
17086082|NCT00357656|38226688|FG001|Overall Study|Other, No surgery performed|3|||
17086083|NCT00357500|38226706|FG000|Overall Study|Adverse Event|3|||
17086084|NCT00357500|38226706|FG000|Overall Study|Withdrawal by Subject|5|||
17086085|NCT00357500|38226706|FG000|Overall Study|Progressive Disease|65|||
17086086|NCT00357500|38226706|FG000|Overall Study|Not Started Protocol Therapy|4|||
17086087|NCT00357110|38226712|FG000|Overall Study|Early study termination|5|||
17086088|NCT00357110|38226713|FG001|Overall Study|Early study termination|5|||
17169034|NCT02039674|38318462|FG010|Overall Study|Progressive Disease|0|||
17169035|NCT02039674|38318463|FG011|Overall Study|Progressive Disease|34|||
17169036|NCT02039674|38318464|FG012|Overall Study|Progressive Disease|34|||
17169037|NCT02039674|38318465|FG013|Overall Study|Progressive Disease|18|||
17169038|NCT02039674|38318452|FG000|Overall Study|Withdrawal by Subject|1|||
17169039|NCT02039674|38318453|FG001|Overall Study|Withdrawal by Subject|2|||
17169040|NCT02039674|38318454|FG002|Overall Study|Withdrawal by Subject|3|||
17169041|NCT02039674|38318455|FG003|Overall Study|Withdrawal by Subject|0|||
17169042|NCT02039674|38318456|FG004|Overall Study|Withdrawal by Subject|1|||
17169043|NCT02039674|38318457|FG005|Overall Study|Withdrawal by Subject|0|||
17169044|NCT02039674|38318458|FG006|Overall Study|Withdrawal by Subject|0|||
17169045|NCT02039674|38318459|FG007|Overall Study|Withdrawal by Subject|0|||
17169046|NCT02039674|38318460|FG008|Overall Study|Withdrawal by Subject|0|||
17169047|NCT02039674|38318461|FG009|Overall Study|Withdrawal by Subject|1|||
17169048|NCT02039674|38318462|FG010|Overall Study|Withdrawal by Subject|1|||
17086089|NCT00098722|38226722|FG000|Double Blind Phase|Adverse Event|7|||
17086090|NCT00098722|38226723|FG001|Double Blind Phase|Adverse Event|7|||
17086091|NCT00098722|38226724|FG002|Double Blind Phase|Adverse Event|3|||
17086092|NCT00098722|38226725|FG003|Double Blind Phase|Adverse Event|0|||
17169049|NCT02039674|38318463|FG011|Overall Study|Withdrawal by Subject|4|||
17169050|NCT02039674|38318464|FG012|Overall Study|Withdrawal by Subject|6|||
17169051|NCT02039674|38318465|FG013|Overall Study|Withdrawal by Subject|2|||
17086093|NCT00098722|38226726|FG004|Double Blind Phase|Adverse Event|0|||
17169052|NCT02039674|38318452|FG000|Overall Study|Clinical Progression|0|||
17169053|NCT02039674|38318453|FG001|Overall Study|Clinical Progression|0|||
17169054|NCT02039674|38318454|FG002|Overall Study|Clinical Progression|0|||
17169055|NCT02039674|38318455|FG003|Overall Study|Clinical Progression|0|||
17169056|NCT02039674|38318456|FG004|Overall Study|Clinical Progression|0|||
17169057|NCT02039674|38318457|FG005|Overall Study|Clinical Progression|0|||
17169058|NCT02039674|38318458|FG006|Overall Study|Clinical Progression|1|||
17169059|NCT02039674|38318459|FG007|Overall Study|Clinical Progression|0|||
17169060|NCT02039674|38318460|FG008|Overall Study|Clinical Progression|0|||
17169061|NCT02039674|38318461|FG009|Overall Study|Clinical Progression|0|||
17169062|NCT02039674|38318462|FG010|Overall Study|Clinical Progression|0|||
17169063|NCT02039674|38318463|FG011|Overall Study|Clinical Progression|0|||
17169064|NCT02039674|38318464|FG012|Overall Study|Clinical Progression|1|||
17169065|NCT02039674|38318465|FG013|Overall Study|Clinical Progression|0|||
17169066|NCT02039674|38318452|FG000|Overall Study|Sponsor Decision|1|||
17169067|NCT02039674|38318453|FG001|Overall Study|Sponsor Decision|1|||
17169068|NCT02039674|38318454|FG002|Overall Study|Sponsor Decision|1|||
17169069|NCT02039674|38318455|FG003|Overall Study|Sponsor Decision|1|||
17169070|NCT02039674|38318456|FG004|Overall Study|Sponsor Decision|1|||
17169071|NCT02039674|38318457|FG005|Overall Study|Sponsor Decision|0|||
17169072|NCT02039674|38318458|FG006|Overall Study|Sponsor Decision|0|||
17169073|NCT02039674|38318459|FG007|Overall Study|Sponsor Decision|0|||
17169074|NCT02039674|38318460|FG008|Overall Study|Sponsor Decision|0|||
17169075|NCT02039674|38318461|FG009|Overall Study|Sponsor Decision|3|||
17169076|NCT02039674|38318462|FG010|Overall Study|Sponsor Decision|0|||
17169077|NCT02039674|38318463|FG011|Overall Study|Sponsor Decision|8|||
17169078|NCT02039674|38318464|FG012|Overall Study|Sponsor Decision|5|||
17169079|NCT02039674|38318465|FG013|Overall Study|Sponsor Decision|0|||
17169080|NCT02039674|38318452|FG000|Overall Study|Other|0|||
17169081|NCT02039674|38318453|FG001|Overall Study|Other|0|||
17169082|NCT02039674|38318454|FG002|Overall Study|Other|0|||
17169083|NCT02039674|38318455|FG003|Overall Study|Other|0|||
17169084|NCT02039674|38318456|FG004|Overall Study|Other|0|||
17169085|NCT02039674|38318457|FG005|Overall Study|Other|0|||
17169086|NCT02039674|38318458|FG006|Overall Study|Other|0|||
17169087|NCT02039674|38318459|FG007|Overall Study|Other|0|||
17169088|NCT02039674|38318460|FG008|Overall Study|Other|0|||
17169089|NCT02039674|38318461|FG009|Overall Study|Other|0|||
17169090|NCT02039674|38318462|FG010|Overall Study|Other|0|||
17169091|NCT02039674|38318463|FG011|Overall Study|Other|0|||
17169092|NCT02039674|38318464|FG012|Overall Study|Other|1|||
17169093|NCT02039674|38318465|FG013|Overall Study|Other|0|||
17169094|NCT03126227|38318505|FG000|Overall Study|Adverse Event|43|||
17169095|NCT03126227|38318506|FG001|Overall Study|Adverse Event|4|||
17169096|NCT03126227|38318505|FG000|Overall Study|Death|0|||
17169097|NCT03126227|38318506|FG001|Overall Study|Death|1|||
17169098|NCT03126227|38318505|FG000|Overall Study|Lost to Follow-up|0|||
17169099|NCT03126227|38318506|FG001|Overall Study|Lost to Follow-up|1|||
17169100|NCT03126227|38318505|FG000|Overall Study|Physician Decision|2|||
17169101|NCT03126227|38318506|FG001|Overall Study|Physician Decision|0|||
17169102|NCT03126227|38318505|FG000|Overall Study|Protocol Violation|1|||
17169103|NCT03126227|38318506|FG001|Overall Study|Protocol Violation|0|||
17169104|NCT03126227|38318505|FG000|Overall Study|Withdrawal by Subject|19|||
17169105|NCT03126227|38318506|FG001|Overall Study|Withdrawal by Subject|3|||
17169106|NCT03126227|38318505|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
17169107|NCT03126227|38318506|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
17169108|NCT03126227|38318505|FG000|Overall Study|Lack of dosing compliance|2|||
17169109|NCT03126227|38318506|FG001|Overall Study|Lack of dosing compliance|0|||
17169110|NCT03126227|38318505|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
17169111|NCT03126227|38318506|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
17169112|NCT03126227|38318505|FG000|Overall Study|Scheduling conflict|1|||
17169113|NCT03126227|38318506|FG001|Overall Study|Scheduling conflict|0|||
17169114|NCT03099187|38318514|FG000|Double-blind Treatment|Adverse Event|19|||
17169115|NCT03099187|38318515|FG001|Double-blind Treatment|Adverse Event|1|||
17169116|NCT03099187|38318516|FG002|Double-blind Treatment|Adverse Event|0|||
17169117|NCT03099187|38318517|FG003|Double-blind Treatment|Adverse Event|0|||
17169118|NCT03099187|38318514|FG000|Double-blind Treatment|Death|1|||
17169119|NCT03099187|38318515|FG001|Double-blind Treatment|Death|3|||
17169120|NCT03099187|38318516|FG002|Double-blind Treatment|Death|0|||
17169121|NCT03099187|38318517|FG003|Double-blind Treatment|Death|0|||
17169122|NCT03099187|38318514|FG000|Double-blind Treatment|Lack of Efficacy|1|||
17169123|NCT03099187|38318515|FG001|Double-blind Treatment|Lack of Efficacy|0|||
17169124|NCT03099187|38318516|FG002|Double-blind Treatment|Lack of Efficacy|0|||
17169125|NCT03099187|38318517|FG003|Double-blind Treatment|Lack of Efficacy|0|||
17169126|NCT03099187|38318514|FG000|Double-blind Treatment|Physician Decision|2|||
17169127|NCT03099187|38318515|FG001|Double-blind Treatment|Physician Decision|1|||
17169128|NCT03099187|38318516|FG002|Double-blind Treatment|Physician Decision|0|||
17169129|NCT03099187|38318517|FG003|Double-blind Treatment|Physician Decision|0|||
16781310|NCT02105662|37720461|FG000|Overall Study|Withdrawal by Subject|1|||
17169130|NCT03099187|38318514|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
17169131|NCT03099187|38318515|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
17169132|NCT03099187|38318516|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
17169133|NCT03099187|38318517|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
17169134|NCT03099187|38318514|FG000|Double-blind Treatment|Lung transplantation|0|||
17169135|NCT03099187|38318515|FG001|Double-blind Treatment|Lung transplantation|1|||
17169136|NCT03099187|38318516|FG002|Double-blind Treatment|Lung transplantation|0|||
17169137|NCT03099187|38318517|FG003|Double-blind Treatment|Lung transplantation|0|||
16996470|NCT00586612|38140527|FG000|Primary Phase|Protocol Violation|1|||
16996471|NCT00586612|38140528|FG001|Primary Phase|Protocol Violation|0|||
16996472|NCT00586612|38140527|FG000|Primary Phase|Lost to Follow-up|0|||
16996473|NCT00586612|38140528|FG001|Primary Phase|Lost to Follow-up|1|||
16996474|NCT00586612|38140527|FG000|Primary Phase|Withdrawal by Subject|0|||
16996475|NCT00586612|38140528|FG001|Primary Phase|Withdrawal by Subject|2|||
16996476|NCT00586612|38140527|FG000|Booster Phase|Lost to Follow-up|3|||
16996477|NCT00586612|38140528|FG001|Booster Phase|Lost to Follow-up|1|||
16996478|NCT00586690|38140536|FG000|Overall Study|Death|2|||
16996479|NCT00586690|38140537|FG001|Overall Study|Death|0|||
16996480|NCT00586690|38140536|FG000|Overall Study|Disease Progression|10|||
16996481|NCT00586690|38140537|FG001|Overall Study|Disease Progression|0|||
16996482|NCT00586690|38140536|FG000|Overall Study|Adverse Event|1|||
16996483|NCT00586690|38140537|FG001|Overall Study|Adverse Event|0|||
16996484|NCT00586690|38140536|FG000|Overall Study|Lack of Efficacy|2|||
16996485|NCT00586690|38140537|FG001|Overall Study|Lack of Efficacy|0|||
16996486|NCT00586690|38140536|FG000|Overall Study|Lab can't accommodate|1|||
16996487|NCT00586690|38140537|FG001|Overall Study|Lab can't accommodate|0|||
16996488|NCT00976820|38140546|FG000|Overall Study|Lost to Follow-up|5|||
16996489|NCT00976820|38140547|FG001|Overall Study|Lost to Follow-up|16|||
16996490|NCT00976820|38140548|FG002|Overall Study|Lost to Follow-up|2|||
16996491|NCT00976820|38140549|FG003|Overall Study|Lost to Follow-up|3|||
16996492|NCT00976820|38140546|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
16996493|NCT00976820|38140547|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
16996494|NCT00976820|38140548|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
16996495|NCT00976820|38140549|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
16996496|NCT00976820|38140546|FG000|Overall Study|Withdrawal by Subject|2|||
16996497|NCT00976820|38140547|FG001|Overall Study|Withdrawal by Subject|4|||
16996498|NCT00976820|38140548|FG002|Overall Study|Withdrawal by Subject|1|||
16996499|NCT00976820|38140549|FG003|Overall Study|Withdrawal by Subject|4|||
16996500|NCT00760474|38140600|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
17169138|NCT03099187|38318514|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
17169139|NCT03099187|38318515|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
17169140|NCT03099187|38318516|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
17169141|NCT03099187|38318517|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
17169142|NCT03099187|38318514|FG000|Double-blind Treatment|Disease progression|0|||
17169143|NCT03099187|38318515|FG001|Double-blind Treatment|Disease progression|1|||
17169144|NCT03099187|38318516|FG002|Double-blind Treatment|Disease progression|0|||
17169145|NCT03099187|38318517|FG003|Double-blind Treatment|Disease progression|0|||
17169146|NCT03099187|38318514|FG000|Double-blind Treatment|Randomization error|0|||
17169147|NCT03099187|38318515|FG001|Double-blind Treatment|Randomization error|2|||
17169148|NCT03099187|38318516|FG002|Double-blind Treatment|Randomization error|0|||
17169149|NCT03099187|38318517|FG003|Double-blind Treatment|Randomization error|0|||
17169150|NCT03099187|38318514|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
17169151|NCT03099187|38318515|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
17169152|NCT03099187|38318516|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
17169153|NCT03099187|38318517|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
17169154|NCT03099187|38318514|FG000|12-month Safety Follow-up|Adverse Event|0|||
17169155|NCT03099187|38318515|FG001|12-month Safety Follow-up|Adverse Event|0|||
17169156|NCT03099187|38318516|FG002|12-month Safety Follow-up|Adverse Event|5|||
17169157|NCT03099187|38318517|FG003|12-month Safety Follow-up|Adverse Event|12|||
16996501|NCT00760474|38140601|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
17169158|NCT03099187|38318514|FG000|12-month Safety Follow-up|Death|0|||
16781311|NCT02143102|37720467|FG000|Overall Study|Lost to Follow-up|11|||
16996502|NCT00760474|38140600|FG000|Placebo Washout Period|Other|0|||
16996503|NCT00760474|38140601|FG001|Placebo Washout Period|Other|1|||
17169159|NCT03099187|38318515|FG001|12-month Safety Follow-up|Death|0|||
17169160|NCT03099187|38318516|FG002|12-month Safety Follow-up|Death|7|||
17169161|NCT03099187|38318517|FG003|12-month Safety Follow-up|Death|9|||
17169162|NCT03099187|38318514|FG000|12-month Safety Follow-up|Lung transplantation|0|||
17169163|NCT03099187|38318515|FG001|12-month Safety Follow-up|Lung transplantation|0|||
17169164|NCT03099187|38318516|FG002|12-month Safety Follow-up|Lung transplantation|2|||
17169165|NCT03099187|38318517|FG003|12-month Safety Follow-up|Lung transplantation|1|||
17169166|NCT03099187|38318514|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
17169167|NCT03099187|38318515|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
17169168|NCT03099187|38318516|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
17169169|NCT03099187|38318517|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
17169170|NCT03099187|38318514|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
17169171|NCT03099187|38318515|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
17169172|NCT03099187|38318516|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
17169173|NCT03099187|38318517|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
17169174|NCT03099187|38318514|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
17169175|NCT03099187|38318515|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
17169176|NCT03099187|38318516|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
17169177|NCT03099187|38318517|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
17169178|NCT03099187|38318514|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
17169179|NCT03099187|38318515|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
17169180|NCT03099187|38318516|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
17169181|NCT03099187|38318517|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
17169182|NCT04463069|38318529|FG000|Overall Study|Withdrawal by Subject|2|||
17169183|NCT04463069|38318530|FG001|Overall Study|Withdrawal by Subject|10|||
17169184|NCT04463069|38318529|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
17169185|NCT04463069|38318530|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
17169186|NCT03521687|38318536|FG000|Overall Study|Adverse Event|4|||
17169187|NCT03521687|38318536|FG000|Overall Study|Physician Decision|1|||
17169188|NCT03125915|38318544|FG000|1 Month Follow up|Lost to Follow-up|3|||
17169189|NCT03125915|38318545|FG001|1 Month Follow up|Lost to Follow-up|3|||
17169190|NCT03125915|38318546|FG002|1 Month Follow up|Lost to Follow-up|2|||
17169191|NCT03125915|38318547|FG003|1 Month Follow up|Lost to Follow-up|3|||
17169192|NCT03125915|38318544|FG000|3 Month Follow-up|Lost to Follow-up|6|||
17169193|NCT03125915|38318545|FG001|3 Month Follow-up|Lost to Follow-up|4|||
17169194|NCT03125915|38318546|FG002|3 Month Follow-up|Lost to Follow-up|4|||
17169195|NCT03125915|38318547|FG003|3 Month Follow-up|Lost to Follow-up|2|||
17169196|NCT03125915|38318544|FG000|6 Month Follow-up|Lost to Follow-up|7|||
17169197|NCT03125915|38318545|FG001|6 Month Follow-up|Lost to Follow-up|3|||
17169198|NCT03125915|38318546|FG002|6 Month Follow-up|Lost to Follow-up|6|||
17169199|NCT03125915|38318547|FG003|6 Month Follow-up|Lost to Follow-up|3|||
16781312|NCT02143102|37720468|FG001|Overall Study|Lost to Follow-up|0|||
17086094|NCT00098722|38226727|FG005|Double Blind Phase|Adverse Event|0|||
17086095|NCT00098722|38226728|FG006|Double Blind Phase|Adverse Event|0|||
17086096|NCT00098722|38226722|FG000|Double Blind Phase|Death|2|||
17086097|NCT00098722|38226723|FG001|Double Blind Phase|Death|5|||
17086098|NCT00098722|38226724|FG002|Double Blind Phase|Death|0|||
17086099|NCT00098722|38226725|FG003|Double Blind Phase|Death|0|||
17086100|NCT00098722|38226726|FG004|Double Blind Phase|Death|0|||
17086101|NCT00098722|38226727|FG005|Double Blind Phase|Death|0|||
17086102|NCT00098722|38226728|FG006|Double Blind Phase|Death|0|||
17086103|NCT00098722|38226722|FG000|Double Blind Phase|Lack of Efficacy|21|||
17086104|NCT00098722|38226723|FG001|Double Blind Phase|Lack of Efficacy|23|||
17086105|NCT00098722|38226724|FG002|Double Blind Phase|Lack of Efficacy|15|||
17086106|NCT00098722|38226725|FG003|Double Blind Phase|Lack of Efficacy|0|||
17086107|NCT00098722|38226726|FG004|Double Blind Phase|Lack of Efficacy|0|||
17169200|NCT03122171|38318557|FG000|Overall Study|Withdrawal by Subject|1|||
17169201|NCT01427725|38318561|FG000|Overall Study|Lost to Follow-up|17|||
17169202|NCT01427725|38318561|FG000|Overall Study|Protocol Violation|1|||
17086108|NCT00098722|38226727|FG005|Double Blind Phase|Lack of Efficacy|0|||
17169203|NCT01427725|38318561|FG000|Overall Study|Drug not administered|1|||
17169204|NCT01427725|38318561|FG000|Overall Study|Failure to visit|7|||
17169205|NCT01427725|38318561|FG000|Overall Study|Adverse Event|46|||
17169206|NCT01427725|38318561|FG000|Overall Study|Failure to visit after administration|40|||
17169207|NCT01427725|38318561|FG000|Overall Study|Patient's rejection|27|||
17169208|NCT01427725|38318561|FG000|Overall Study|Transfer to a different hospital|17|||
17169209|NCT01427725|38318561|FG000|Overall Study|Lack of Efficacy|8|||
17169210|NCT01427725|38318561|FG000|Overall Study|Death|7|||
17169211|NCT01427725|38318561|FG000|Overall Study|Symptom improvement|6|||
17169212|NCT01427725|38318561|FG000|Overall Study|AE and Patient's rejection|5|||
17169213|NCT01427725|38318561|FG000|Overall Study|Physician Decision|5|||
17169214|NCT01427725|38318561|FG000|Overall Study|Exacerbation of underlying disease|5|||
17169215|NCT01427725|38318561|FG000|Overall Study|Oral feeding difficulty|5|||
17169216|NCT01427725|38318561|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
17169217|NCT01427725|38318561|FG000|Overall Study|Forgetting prescription|1|||
17169218|NCT01427725|38318561|FG000|Overall Study|Other|2|||
17169219|NCT02839200|38318572|FG000|Overall Study|Withdrawal by Subject|2|||
17169220|NCT02839200|38318573|FG001|Overall Study|Withdrawal by Subject|0|||
17169221|NCT02839200|38318574|FG002|Overall Study|Withdrawal by Subject|1|||
17169222|NCT02839200|38318575|FG003|Overall Study|Withdrawal by Subject|0|||
17169223|NCT02839200|38318576|FG004|Overall Study|Withdrawal by Subject|0|||
17169224|NCT02839200|38318577|FG005|Overall Study|Withdrawal by Subject|1|||
17169225|NCT02839200|38318572|FG000|Overall Study|Lost to Follow-up|2|||
17169226|NCT02839200|38318573|FG001|Overall Study|Lost to Follow-up|0|||
17169227|NCT02839200|38318574|FG002|Overall Study|Lost to Follow-up|0|||
17169228|NCT02839200|38318575|FG003|Overall Study|Lost to Follow-up|0|||
17169229|NCT02839200|38318576|FG004|Overall Study|Lost to Follow-up|1|||
17169230|NCT02839200|38318577|FG005|Overall Study|Lost to Follow-up|0|||
17169231|NCT02839200|38318572|FG000|Overall Study|Adverse Event|0|||
17169232|NCT02839200|38318573|FG001|Overall Study|Adverse Event|0|||
17169233|NCT02839200|38318574|FG002|Overall Study|Adverse Event|0|||
17169234|NCT02839200|38318575|FG003|Overall Study|Adverse Event|0|||
17169235|NCT02839200|38318576|FG004|Overall Study|Adverse Event|1|||
17169236|NCT02839200|38318577|FG005|Overall Study|Adverse Event|0|||
17169237|NCT02839200|38318572|FG000|Overall Study|Randomized in error|0|||
17169238|NCT02839200|38318573|FG001|Overall Study|Randomized in error|1|||
17169239|NCT02839200|38318574|FG002|Overall Study|Randomized in error|0|||
17169240|NCT02839200|38318575|FG003|Overall Study|Randomized in error|0|||
17169241|NCT02839200|38318576|FG004|Overall Study|Randomized in error|0|||
17169242|NCT02839200|38318577|FG005|Overall Study|Randomized in error|0|||
17169243|NCT03118739|38318593|FG000|Overall Study|Physician Decision|0|||
17169244|NCT03118739|38318594|FG001|Overall Study|Physician Decision|1|||
17169245|NCT03118739|38318593|FG000|Overall Study|Withdrawal by Subject|5|||
17169246|NCT03118739|38318594|FG001|Overall Study|Withdrawal by Subject|3|||
17086109|NCT00098722|38226728|FG006|Double Blind Phase|Lack of Efficacy|0|||
17169247|NCT03118739|38318593|FG000|Overall Study|Lost to Follow-up|2|||
17169248|NCT03118739|38318594|FG001|Overall Study|Lost to Follow-up|0|||
17169249|NCT03094195|38318603|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
17169250|NCT03094195|38318604|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
17169251|NCT03094195|38318605|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
17169252|NCT03094195|38318606|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
17169253|NCT03094195|38318607|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
17169254|NCT03094195|38318608|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
17169255|NCT03094195|38318609|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
17086110|NCT00098722|38226722|FG000|Double Blind Phase|Participant defaulted|16|||
17086111|NCT00098722|38226723|FG001|Double Blind Phase|Participant defaulted|11|||
17086112|NCT00098722|38226724|FG002|Double Blind Phase|Participant defaulted|9|||
17086113|NCT00098722|38226725|FG003|Double Blind Phase|Participant defaulted|0|||
17086114|NCT00098722|38226726|FG004|Double Blind Phase|Participant defaulted|0|||
17086115|NCT00098722|38226727|FG005|Double Blind Phase|Participant defaulted|0|||
17086116|NCT00098722|38226728|FG006|Double Blind Phase|Participant defaulted|0|||
17086117|NCT00098722|38226722|FG000|Double Blind Phase|Pregnancy|1|||
17086118|NCT00098722|38226723|FG001|Double Blind Phase|Pregnancy|0|||
17086119|NCT00098722|38226724|FG002|Double Blind Phase|Pregnancy|0|||
17086120|NCT00098722|38226725|FG003|Double Blind Phase|Pregnancy|0|||
17086121|NCT00098722|38226726|FG004|Double Blind Phase|Pregnancy|0|||
17086122|NCT00098722|38226727|FG005|Double Blind Phase|Pregnancy|0|||
17086123|NCT00098722|38226728|FG006|Double Blind Phase|Pregnancy|0|||
17169256|NCT03094195|38318610|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
17169257|NCT03094195|38318603|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
17169258|NCT03094195|38318604|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
17169259|NCT03094195|38318605|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
17169260|NCT03094195|38318606|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
17169261|NCT03094195|38318607|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
17169262|NCT03094195|38318608|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
17169263|NCT03094195|38318609|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
17169264|NCT03094195|38318610|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
17169265|NCT03094195|38318603|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17169266|NCT03094195|38318604|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17169267|NCT03094195|38318605|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
17169268|NCT03094195|38318606|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17169269|NCT03094195|38318607|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17169270|NCT03094195|38318608|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17169271|NCT03094195|38318609|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17169272|NCT03094195|38318610|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
17169273|NCT03094195|38318603|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17169274|NCT03094195|38318604|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
17169275|NCT03094195|38318605|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
17169276|NCT03094195|38318606|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17169277|NCT03094195|38318607|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17169278|NCT03094195|38318608|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17169279|NCT03094195|38318609|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17169280|NCT03094195|38318610|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
17169281|NCT02835690|38318631|FG000|Overall Study|Death|12|||
17169282|NCT02835690|38318632|FG001|Overall Study|Death|11|||
17169283|NCT02835690|38318633|FG002|Overall Study|Death|13|||
17169284|NCT02835690|38318631|FG000|Overall Study|Transferred to Extension Study|2|||
17169285|NCT02835690|38318632|FG001|Overall Study|Transferred to Extension Study|2|||
17169286|NCT02835690|38318633|FG002|Overall Study|Transferred to Extension Study|1|||
17169287|NCT02835690|38318631|FG000|Overall Study|Did Not Continue on Extension Study|0|||
17169288|NCT02835690|38318632|FG001|Overall Study|Did Not Continue on Extension Study|0|||
17169289|NCT02835690|38318633|FG002|Overall Study|Did Not Continue on Extension Study|1|||
17169290|NCT02835690|38318631|FG000|Overall Study|Not Treated|0|||
17169291|NCT02835690|38318632|FG001|Overall Study|Not Treated|2|||
17169292|NCT02835690|38318633|FG002|Overall Study|Not Treated|0|||
17169293|NCT02837952|38318648|FG000|Overall Study|Adverse Event|0|||
17169294|NCT02837952|38318649|FG001|Overall Study|Adverse Event|1|||
17169295|NCT02837952|38318648|FG000|Overall Study|Withdrawal by Subject|4|||
17169296|NCT02837952|38318649|FG001|Overall Study|Withdrawal by Subject|5|||
17169297|NCT02837952|38318648|FG000|Overall Study|Medication Error|1|||
17169298|NCT02837952|38318649|FG001|Overall Study|Medication Error|0|||
17169299|NCT02832167|38318655|FG000|Treatment Period 1|Disease progression|90|||
17169300|NCT02832167|38318655|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
17169301|NCT02832167|38318655|FG000|Treatment Period 1|Death|2|||
17169302|NCT02832167|38318655|FG000|Treatment Period 1|Study Drug Toxicity|6|||
17169303|NCT02832167|38318655|FG000|Treatment Period 1|Participant request to discontinue|9|||
17169304|NCT02832167|38318655|FG000|Treatment Period 1|No longer meet study criteria|1|||
17169305|NCT02832167|38318655|FG000|Treatment Period 1|Participant withdrew consent|3|||
17169306|NCT02832167|38318655|FG000|Treatment Period 1|Other reasons|6|||
17169307|NCT02832167|38318655|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
17169308|NCT02832167|38318655|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
17169309|NCT02832167|38318655|FG000|Transition From Period 1 to Period 2|Death|2|||
16996504|NCT00760474|38140600|FG000|Period 2 (P2)|Lost to Follow-up|1|||
16996505|NCT00760474|38140601|FG001|Period 2 (P2)|Lost to Follow-up|0|||
16996506|NCT00760474|38140600|FG000|Period 2 (P2)|Adverse Event|0|||
16996507|NCT00760474|38140601|FG001|Period 2 (P2)|Adverse Event|1|||
16996508|NCT00975416|38140610|FG000|Overall Study|early discharge from tx|3|||
16996509|NCT00975416|38140611|FG001|Overall Study|early discharge from tx|5|||
16996510|NCT00760084|38140618|FG000|Overall Study|Physician Decision|5|||
16996511|NCT00760084|38140618|FG000|Overall Study|Withdrawal by Subject|2|||
16996512|NCT00760084|38140618|FG000|Overall Study|Progressive Disease|3|||
16996513|NCT00752206|38140624|FG000|Overall Study|Disease progression|8|||
16996514|NCT00752206|38140625|FG001|Overall Study|Disease progression|11|||
16996515|NCT00752206|38140624|FG000|Overall Study|Pregnancy|1|||
16996516|NCT00752206|38140625|FG001|Overall Study|Pregnancy|0|||
16996517|NCT00752128|38140631|FG000|Overall Study|Withdrawal by Subject|4|||
16996518|NCT00976508|38140638|FG000|Overall Study|Death|7|||
16996519|NCT00976508|38140639|FG001|Overall Study|Death|1|||
16996520|NCT00976508|38140638|FG000|Overall Study|Lost to Follow-up|1|||
16996521|NCT00976508|38140639|FG001|Overall Study|Lost to Follow-up|0|||
16996522|NCT00976508|38140638|FG000|Overall Study|Withdrawal by Subject|1|||
16996523|NCT00976508|38140639|FG001|Overall Study|Withdrawal by Subject|0|||
16996524|NCT00976508|38140638|FG000|Overall Study|Disease Progression|4|||
16996525|NCT00976508|38140639|FG001|Overall Study|Disease Progression|4|||
16996526|NCT00976508|38140638|FG000|Overall Study|Subject Enrolled in Hospice|1|||
16996527|NCT00976508|38140639|FG001|Overall Study|Subject Enrolled in Hospice|0|||
16996528|NCT00976508|38140638|FG000|Overall Study|Terminated by the Sponsor|0|||
16996529|NCT00976508|38140639|FG001|Overall Study|Terminated by the Sponsor|1|||
16996530|NCT00973622|38140650|FG000|Overall Study|did not attend MRI|14|||
16996531|NCT00973622|38140651|FG001|Overall Study|did not attend MRI|3|||
17169310|NCT02832167|38318655|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
17169311|NCT02832167|38318655|FG000|Treatment Period 2|Disease progression|69|||
17169312|NCT02832167|38318655|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
17169313|NCT02832167|38318655|FG000|Treatment Period 2|Maximum clinical benefit|1|||
17169314|NCT02832167|38318655|FG000|Treatment Period 2|Study Drug Toxicity|5|||
17169315|NCT02832167|38318655|FG000|Treatment Period 2|Participant request to discontinue|2|||
17169316|NCT02832167|38318655|FG000|Treatment Period 2|Participant withdrew consent|3|||
17169317|NCT02832167|38318655|FG000|Treatment Period 2|Other reasons|3|||
17169318|NCT02674529|38318661|FG000|Overall Study|Lost to Follow-up|1|||
17169319|NCT02674529|38318662|FG001|Overall Study|Lost to Follow-up|2|||
17169320|NCT02674529|38318661|FG000|Overall Study|Withdrawal by Subject|2|||
17169321|NCT02674529|38318662|FG001|Overall Study|Withdrawal by Subject|1|||
17169322|NCT02674529|38318661|FG000|Overall Study|Physician Decision|0|||
17169323|NCT02674529|38318662|FG001|Overall Study|Physician Decision|1|||
17169324|NCT02674529|38318661|FG000|Overall Study|Protocol Violation|0|||
17169325|NCT02674529|38318662|FG001|Overall Study|Protocol Violation|1|||
17169326|NCT02626949|38318673|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
17169327|NCT02626949|38318674|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
17169328|NCT02626949|38318673|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
17169329|NCT02626949|38318674|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
17169330|NCT02626949|38318673|FG000|Enrolled|Lost to Follow-up|7|||
17169331|NCT02626949|38318674|FG001|Enrolled|Lost to Follow-up|6|||
17169332|NCT02626949|38318673|FG000|Enrolled|Withdrawal by Subject|3|||
17169333|NCT02626949|38318674|FG001|Enrolled|Withdrawal by Subject|2|||
17169334|NCT02838420|38318682|FG000|Overall Study|Ongoing in Study|113|||
17169335|NCT02838420|38318683|FG001|Overall Study|Ongoing in Study|45|||
17169336|NCT02838420|38318682|FG000|Overall Study|Lost to Follow-up|1|||
17169337|NCT02838420|38318683|FG001|Overall Study|Lost to Follow-up|0|||
17169338|NCT02838420|38318682|FG000|Overall Study|Withdrawal by Subject|3|||
17169339|NCT02838420|38318683|FG001|Overall Study|Withdrawal by Subject|4|||
17169340|NCT02838420|38318682|FG000|Overall Study|Death|8|||
17169341|NCT02838420|38318683|FG001|Overall Study|Death|13|||
17169342|NCT03116399|38318691|FG000|Overall Study|Death|8|||
17169343|NCT03116399|38318692|FG001|Overall Study|Death|3|||
17169344|NCT03116399|38318691|FG000|Overall Study|Lost to Follow-up|7|||
17169345|NCT03116399|38318692|FG001|Overall Study|Lost to Follow-up|11|||
17169346|NCT03116399|38318691|FG000|Overall Study|Investigator Decision|1|||
17169347|NCT03116399|38318692|FG001|Overall Study|Investigator Decision|1|||
17169348|NCT03116399|38318691|FG000|Overall Study|Withdrawal by Subject|24|||
17169349|NCT03116399|38318692|FG001|Overall Study|Withdrawal by Subject|9|||
17169350|NCT03097861|38318701|FG000|Overall Study|Adverse Event|3|||
17169351|NCT03097861|38318702|FG001|Overall Study|Adverse Event|8|||
17169352|NCT03097861|38318703|FG002|Overall Study|Adverse Event|4|||
17169353|NCT03097861|38318701|FG000|Overall Study|Investigator Decision|0|||
17169354|NCT03097861|38318702|FG001|Overall Study|Investigator Decision|1|||
17169355|NCT03097861|38318703|FG002|Overall Study|Investigator Decision|0|||
17169356|NCT03097861|38318701|FG000|Overall Study|Lost to Follow-up|0|||
17169357|NCT03097861|38318702|FG001|Overall Study|Lost to Follow-up|7|||
17169358|NCT03097861|38318703|FG002|Overall Study|Lost to Follow-up|1|||
17169359|NCT03097861|38318701|FG000|Overall Study|Withdrawal by Subject|1|||
17169360|NCT03097861|38318702|FG001|Overall Study|Withdrawal by Subject|5|||
17169361|NCT03097861|38318703|FG002|Overall Study|Withdrawal by Subject|3|||
17169362|NCT03097861|38318701|FG000|Overall Study|Reason not provided|3|||
17169363|NCT03097861|38318702|FG001|Overall Study|Reason not provided|1|||
17169364|NCT03097861|38318703|FG002|Overall Study|Reason not provided|1|||
17169365|NCT03910673|38318718|FG000|Overall Study|Adverse Event|0|||
17169366|NCT03910673|38318719|FG001|Overall Study|Adverse Event|0|||
17169367|NCT03910673|38318720|FG002|Overall Study|Adverse Event|0|||
17169368|NCT03910673|38318721|FG003|Overall Study|Adverse Event|2|||
17169369|NCT03910673|38318722|FG004|Overall Study|Adverse Event|0|||
17169370|NCT01816139|38318728|FG000|Overall Study|Adverse Event|6|||
17169371|NCT01816139|38318729|FG001|Overall Study|Adverse Event|8|||
17169372|NCT01816139|38318728|FG000|Overall Study|Lack of Efficacy|1|||
17169373|NCT01816139|38318729|FG001|Overall Study|Lack of Efficacy|2|||
17169374|NCT01816139|38318728|FG000|Overall Study|Lost to Follow-up|5|||
17169375|NCT01816139|38318729|FG001|Overall Study|Lost to Follow-up|3|||
17086124|NCT00098722|38226722|FG000|Double Blind Phase|Randomized, not treated|4|||
17086125|NCT00098722|38226723|FG001|Double Blind Phase|Randomized, not treated|3|||
17086126|NCT00098722|38226724|FG002|Double Blind Phase|Randomized, not treated|3|||
17086127|NCT00098722|38226725|FG003|Double Blind Phase|Randomized, not treated|0|||
17086128|NCT00098722|38226726|FG004|Double Blind Phase|Randomized, not treated|0|||
17086129|NCT00098722|38226727|FG005|Double Blind Phase|Randomized, not treated|0|||
17086130|NCT00098722|38226728|FG006|Double Blind Phase|Randomized, not treated|0|||
17169376|NCT01816139|38318728|FG000|Overall Study|Withdrew Consent|6|||
17169377|NCT01816139|38318729|FG001|Overall Study|Withdrew Consent|4|||
17169378|NCT01816139|38318728|FG000|Overall Study|Protocol Violation|6|||
17169379|NCT01816139|38318729|FG001|Overall Study|Protocol Violation|3|||
17169380|NCT01816139|38318728|FG000|Overall Study|Reason not Specified|4|||
17169381|NCT01816139|38318729|FG001|Overall Study|Reason not Specified|2|||
17169382|NCT02833350|38318772|FG000|Overall Study|Adverse Event|0|||
17169383|NCT02833350|38318773|FG001|Overall Study|Adverse Event|3|||
17169384|NCT02833350|38318774|FG002|Overall Study|Adverse Event|4|||
17169385|NCT02833350|38318775|FG003|Overall Study|Adverse Event|4|||
17169386|NCT02833350|38318776|FG004|Overall Study|Adverse Event|1|||
17169387|NCT02833350|38318777|FG005|Overall Study|Adverse Event|0|||
17169388|NCT02833350|38318778|FG006|Overall Study|Adverse Event|1|||
17169389|NCT02833350|38318772|FG000|Overall Study|Death|0|||
17169390|NCT02833350|38318773|FG001|Overall Study|Death|0|||
17169391|NCT02833350|38318774|FG002|Overall Study|Death|1|||
17169392|NCT02833350|38318775|FG003|Overall Study|Death|0|||
17169393|NCT02833350|38318776|FG004|Overall Study|Death|0|||
17169394|NCT02833350|38318777|FG005|Overall Study|Death|0|||
17169395|NCT02833350|38318778|FG006|Overall Study|Death|0|||
17169396|NCT02833350|38318772|FG000|Overall Study|Lack of Efficacy|0|||
17169397|NCT02833350|38318773|FG001|Overall Study|Lack of Efficacy|2|||
17169398|NCT02833350|38318774|FG002|Overall Study|Lack of Efficacy|1|||
17169399|NCT02833350|38318775|FG003|Overall Study|Lack of Efficacy|4|||
17169400|NCT02833350|38318776|FG004|Overall Study|Lack of Efficacy|0|||
17169401|NCT02833350|38318777|FG005|Overall Study|Lack of Efficacy|1|||
17169402|NCT02833350|38318778|FG006|Overall Study|Lack of Efficacy|1|||
17169403|NCT02833350|38318772|FG000|Overall Study|Lost to Follow-up|0|||
17169404|NCT02833350|38318773|FG001|Overall Study|Lost to Follow-up|1|||
17169405|NCT02833350|38318774|FG002|Overall Study|Lost to Follow-up|0|||
17169406|NCT02833350|38318775|FG003|Overall Study|Lost to Follow-up|0|||
17169407|NCT02833350|38318776|FG004|Overall Study|Lost to Follow-up|0|||
17169408|NCT02833350|38318777|FG005|Overall Study|Lost to Follow-up|0|||
17169409|NCT02833350|38318778|FG006|Overall Study|Lost to Follow-up|1|||
17169410|NCT02833350|38318772|FG000|Overall Study|Withdrawal by Subject|3|||
17169411|NCT02833350|38318773|FG001|Overall Study|Withdrawal by Subject|3|||
17169412|NCT02833350|38318774|FG002|Overall Study|Withdrawal by Subject|2|||
17169413|NCT02833350|38318775|FG003|Overall Study|Withdrawal by Subject|0|||
17169414|NCT02833350|38318776|FG004|Overall Study|Withdrawal by Subject|2|||
17169415|NCT02833350|38318777|FG005|Overall Study|Withdrawal by Subject|0|||
17169416|NCT02833350|38318778|FG006|Overall Study|Withdrawal by Subject|2|||
17169417|NCT01343043|38318801|FG000|Overall Study|Disease progression before treatment|1|||
17169418|NCT01343043|38318802|FG001|Overall Study|Disease progression before treatment|0|||
17169419|NCT01343043|38318803|FG002|Overall Study|Disease progression before treatment|0|||
17169420|NCT01343043|38318804|FG003|Overall Study|Disease progression before treatment|0|||
17169421|NCT01343043|38318801|FG000|Overall Study|Withdrawal by Subject|1|||
17169422|NCT01343043|38318802|FG001|Overall Study|Withdrawal by Subject|0|||
17086131|NCT00098722|38226722|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
17086132|NCT00098722|38226723|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
17086133|NCT00098722|38226724|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
17086134|NCT00098722|38226725|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
17086135|NCT00098722|38226726|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
17086136|NCT00098722|38226727|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
17086137|NCT00098722|38226728|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
17086138|NCT00098722|38226722|FG000|Double Blind Phase|Other|7|||
17086139|NCT00098722|38226723|FG001|Double Blind Phase|Other|8|||
17086140|NCT00098722|38226724|FG002|Double Blind Phase|Other|7|||
17086141|NCT00098722|38226725|FG003|Double Blind Phase|Other|0|||
17086142|NCT00098722|38226726|FG004|Double Blind Phase|Other|0|||
17086143|NCT00098722|38226727|FG005|Double Blind Phase|Other|0|||
17086144|NCT00098722|38226728|FG006|Double Blind Phase|Other|0|||
17086145|NCT00098722|38226722|FG000|Open Label Phase|Adverse Event|0|||
17086146|NCT00098722|38226723|FG001|Open Label Phase|Adverse Event|0|||
17086147|NCT00098722|38226724|FG002|Open Label Phase|Adverse Event|0|||
17086148|NCT00098722|38226725|FG003|Open Label Phase|Adverse Event|5|||
17086149|NCT00098722|38226726|FG004|Open Label Phase|Adverse Event|0|||
17086150|NCT00098722|38226727|FG005|Open Label Phase|Adverse Event|0|||
17086151|NCT00098722|38226728|FG006|Open Label Phase|Adverse Event|0|||
17086152|NCT00098722|38226722|FG000|Open Label Phase|Death|0|||
17086153|NCT00098722|38226723|FG001|Open Label Phase|Death|0|||
17086154|NCT00098722|38226724|FG002|Open Label Phase|Death|0|||
17086155|NCT00098722|38226725|FG003|Open Label Phase|Death|2|||
17086156|NCT00098722|38226726|FG004|Open Label Phase|Death|0|||
17086157|NCT00098722|38226727|FG005|Open Label Phase|Death|0|||
17169423|NCT01343043|38318803|FG002|Overall Study|Withdrawal by Subject|0|||
17169424|NCT01343043|38318804|FG003|Overall Study|Withdrawal by Subject|0|||
17169425|NCT01343043|38318801|FG000|Overall Study|Death|1|||
17169426|NCT01343043|38318802|FG001|Overall Study|Death|1|||
17169427|NCT01343043|38318803|FG002|Overall Study|Death|0|||
17169428|NCT01343043|38318804|FG003|Overall Study|Death|1|||
17086158|NCT00098722|38226728|FG006|Open Label Phase|Death|0|||
17169429|NCT03548987|38318819|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
17169430|NCT03548987|38318820|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
17169431|NCT03548987|38318819|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
17169432|NCT03548987|38318820|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
17169433|NCT03548987|38318819|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
17169434|NCT03548987|38318820|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
17169435|NCT03548987|38318819|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
17169436|NCT03548987|38318820|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
17169437|NCT03548987|38318819|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
17169438|NCT03548987|38318820|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
17169439|NCT03548987|38318819|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
17169440|NCT03548987|38318820|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
17169441|NCT03548987|38318819|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
17169442|NCT03548987|38318820|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
17169443|NCT03548987|38318819|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
17169444|NCT03548987|38318820|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
17169445|NCT03548987|38318819|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
17169446|NCT03548987|38318820|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
17169447|NCT03548987|38318819|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
17169448|NCT03548987|38318820|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
17169449|NCT03548987|38318819|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
17169450|NCT03548987|38318820|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
17169451|NCT03548987|38318819|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
17169452|NCT03548987|38318820|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
17169453|NCT03548987|38318819|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
17169454|NCT03548987|38318820|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
17169455|NCT03548987|38318819|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
17169456|NCT03548987|38318820|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
17169457|NCT01358760|38318830|FG000|Overall Study|Adverse Event|3|||
17169458|NCT01358760|38318831|FG001|Overall Study|Adverse Event|4|||
17169459|NCT01358760|38318832|FG002|Overall Study|Adverse Event|3|||
17169460|NCT01358760|38318830|FG000|Overall Study|Lost to Follow-up|1|||
17169461|NCT01358760|38318831|FG001|Overall Study|Lost to Follow-up|1|||
17169462|NCT01358760|38318832|FG002|Overall Study|Lost to Follow-up|3|||
17169463|NCT01358760|38318830|FG000|Overall Study|Withdrawal by Subject|5|||
17169464|NCT01358760|38318831|FG001|Overall Study|Withdrawal by Subject|3|||
17169465|NCT01358760|38318832|FG002|Overall Study|Withdrawal by Subject|2|||
17169466|NCT01358760|38318830|FG000|Overall Study|Physician Decision|1|||
17169467|NCT01358760|38318831|FG001|Overall Study|Physician Decision|0|||
17169468|NCT01358760|38318832|FG002|Overall Study|Physician Decision|1|||
17169469|NCT01358760|38318830|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
17169470|NCT01358760|38318831|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
17169471|NCT01358760|38318832|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
17169472|NCT01341990|38318842|FG000|Overall Study|Adverse Event|0|||
17169473|NCT01341990|38318843|FG001|Overall Study|Adverse Event|1|||
17169474|NCT01341990|38318842|FG000|Overall Study|Torn Study Lens|1|||
17169475|NCT01341990|38318843|FG001|Overall Study|Torn Study Lens|0|||
17169476|NCT01341990|38318842|FG000|Overall Study|Withdrawal by Subject|2|||
17169477|NCT01341990|38318843|FG001|Overall Study|Withdrawal by Subject|0|||
17169478|NCT03048747|38318849|FG000|Overall Study|Adverse Event|2|||
17169479|NCT03048747|38318849|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
17169480|NCT03048747|38318849|FG000|Overall Study|Physician Decision|1|||
17169481|NCT01991067|38318911|FG000|Overall Study|Lost to Follow-up|6|||
17169482|NCT01991067|38318912|FG001|Overall Study|Lost to Follow-up|5|||
17169483|NCT01709331|38318918|FG000|Overall Study|Adverse Event|1|||
17169484|NCT03255083|38318926|FG000|Overall Study|Clinical progression|1|||
17169485|NCT03255083|38318927|FG001|Overall Study|Clinical progression|0|||
17169486|NCT03255083|38318928|FG002|Overall Study|Clinical progression|0|||
17169487|NCT03255083|38318929|FG003|Overall Study|Clinical progression|0|||
17169488|NCT03255083|38318926|FG000|Overall Study|Adverse Event|0|||
17169489|NCT03255083|38318927|FG001|Overall Study|Adverse Event|1|||
17169490|NCT03255083|38318928|FG002|Overall Study|Adverse Event|0|||
17169491|NCT03255083|38318929|FG003|Overall Study|Adverse Event|0|||
17169492|NCT03255083|38318926|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
17169493|NCT03255083|38318927|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
17169494|NCT03255083|38318928|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
17169495|NCT03255083|38318929|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
17169496|NCT03255083|38318926|FG000|Overall Study|Withdrawal by Subject|1|||
17169497|NCT03255083|38318927|FG001|Overall Study|Withdrawal by Subject|1|||
17169498|NCT03255083|38318928|FG002|Overall Study|Withdrawal by Subject|1|||
17169499|NCT03255083|38318929|FG003|Overall Study|Withdrawal by Subject|0|||
17169500|NCT04552587|38318945|FG000|Overall Study|Lost to Follow-up|4|||
17169501|NCT01316055|38318961|FG000|Overall Study|Lost to Follow-up|1|||
17169502|NCT01316055|38318962|FG001|Overall Study|Lost to Follow-up|0|||
17169503|NCT01316055|38318963|FG002|Overall Study|Lost to Follow-up|0|||
17169504|NCT01340976|38318980|FG000|Overall Study|Physician Decision|2|||
17169505|NCT01340976|38318981|FG001|Overall Study|Physician Decision|0|||
17169506|NCT01340976|38318982|FG002|Overall Study|Physician Decision|1|||
17169507|NCT01340976|38318983|FG003|Overall Study|Physician Decision|1|||
17169508|NCT01340976|38318984|FG004|Overall Study|Physician Decision|1|||
17169509|NCT01340976|38318985|FG005|Overall Study|Physician Decision|0|||
17169510|NCT01340976|38318980|FG000|Overall Study|Death|0|||
17169511|NCT01340976|38318981|FG001|Overall Study|Death|1|||
17169512|NCT01340976|38318982|FG002|Overall Study|Death|0|||
17169513|NCT01340976|38318983|FG003|Overall Study|Death|0|||
17169514|NCT01340976|38318984|FG004|Overall Study|Death|0|||
17169515|NCT01340976|38318985|FG005|Overall Study|Death|0|||
17169516|NCT01340976|38318980|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
17169517|NCT01340976|38318981|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
17169518|NCT01340976|38318982|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
17169519|NCT01340976|38318983|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
17169520|NCT01340976|38318984|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
17169521|NCT01340976|38318985|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
17169522|NCT01340976|38318980|FG000|Overall Study|Withdrawal by Subject|0|||
17169523|NCT01340976|38318981|FG001|Overall Study|Withdrawal by Subject|0|||
17169524|NCT01340976|38318982|FG002|Overall Study|Withdrawal by Subject|0|||
17169525|NCT01340976|38318983|FG003|Overall Study|Withdrawal by Subject|1|||
17169526|NCT01340976|38318984|FG004|Overall Study|Withdrawal by Subject|1|||
17169527|NCT01340976|38318985|FG005|Overall Study|Withdrawal by Subject|0|||
17169528|NCT01340976|38318980|FG000|Overall Study|Other anemia treatment|1|||
17169529|NCT01340976|38318981|FG001|Overall Study|Other anemia treatment|0|||
17169530|NCT01340976|38318982|FG002|Overall Study|Other anemia treatment|2|||
17169531|NCT01340976|38318983|FG003|Overall Study|Other anemia treatment|1|||
17169532|NCT01340976|38318984|FG004|Overall Study|Other anemia treatment|0|||
17169533|NCT01340976|38318985|FG005|Overall Study|Other anemia treatment|1|||
17169534|NCT01340976|38318980|FG000|Overall Study|Adverse Event|0|||
17169535|NCT01340976|38318981|FG001|Overall Study|Adverse Event|1|||
17169536|NCT01340976|38318982|FG002|Overall Study|Adverse Event|0|||
17169537|NCT01340976|38318983|FG003|Overall Study|Adverse Event|0|||
17169538|NCT01340976|38318984|FG004|Overall Study|Adverse Event|0|||
17169539|NCT01340976|38318985|FG005|Overall Study|Adverse Event|0|||
17169540|NCT01680016|38319007|FG000|Overall Study|Adverse Event|0|||
17169541|NCT01680016|38319008|FG001|Overall Study|Adverse Event|0|||
17169542|NCT01680016|38319009|FG002|Overall Study|Adverse Event|1|||
17169543|NCT01680016|38319010|FG003|Overall Study|Adverse Event|4|||
17169544|NCT01680016|38319007|FG000|Overall Study|The Subject went out of The Trial|1|||
17086159|NCT00098722|38226722|FG000|Open Label Phase|Lack of Efficacy|0|||
17086160|NCT00098722|38226723|FG001|Open Label Phase|Lack of Efficacy|0|||
17086161|NCT00098722|38226724|FG002|Open Label Phase|Lack of Efficacy|0|||
17086162|NCT00098722|38226725|FG003|Open Label Phase|Lack of Efficacy|8|||
17086163|NCT00098722|38226726|FG004|Open Label Phase|Lack of Efficacy|0|||
17086164|NCT00098722|38226727|FG005|Open Label Phase|Lack of Efficacy|0|||
17086165|NCT00098722|38226728|FG006|Open Label Phase|Lack of Efficacy|0|||
17086166|NCT00098722|38226722|FG000|Open Label Phase|Pregnancy|0|||
17086167|NCT00098722|38226723|FG001|Open Label Phase|Pregnancy|0|||
17086168|NCT00098722|38226724|FG002|Open Label Phase|Pregnancy|0|||
17086169|NCT00098722|38226725|FG003|Open Label Phase|Pregnancy|1|||
17086170|NCT00098722|38226726|FG004|Open Label Phase|Pregnancy|0|||
17086171|NCT00098722|38226727|FG005|Open Label Phase|Pregnancy|0|||
17086172|NCT00098722|38226728|FG006|Open Label Phase|Pregnancy|0|||
17086173|NCT00098722|38226722|FG000|Open Label Phase|Participant defaulted|0|||
17169545|NCT01680016|38319008|FG001|Overall Study|The Subject went out of The Trial|0|||
17169546|NCT01680016|38319009|FG002|Overall Study|The Subject went out of The Trial|3|||
17169547|NCT01680016|38319010|FG003|Overall Study|The Subject went out of The Trial|0|||
17169548|NCT01680016|38319007|FG000|Overall Study|Protocol Violation|0|||
17169549|NCT01680016|38319008|FG001|Overall Study|Protocol Violation|1|||
17169550|NCT01680016|38319009|FG002|Overall Study|Protocol Violation|0|||
17169551|NCT01680016|38319010|FG003|Overall Study|Protocol Violation|0|||
17169552|NCT01680016|38319007|FG000|Overall Study|Withdrawal by Subject|5|||
17169553|NCT01680016|38319008|FG001|Overall Study|Withdrawal by Subject|7|||
17169554|NCT01680016|38319009|FG002|Overall Study|Withdrawal by Subject|1|||
17169555|NCT01680016|38319010|FG003|Overall Study|Withdrawal by Subject|1|||
17169556|NCT01340898|38319035|FG000|Primary Phase|Serious Adverse Events|0|||
17169557|NCT01340898|38319036|FG001|Primary Phase|Serious Adverse Events|0|||
17169558|NCT01340898|38319037|FG002|Primary Phase|Serious Adverse Events|1|||
17169559|NCT01340898|38319035|FG000|Primary Phase|Withdrawal by Subject|8|||
17169560|NCT01340898|38319036|FG001|Primary Phase|Withdrawal by Subject|7|||
17169561|NCT01340898|38319037|FG002|Primary Phase|Withdrawal by Subject|5|||
17086174|NCT00098722|38226723|FG001|Open Label Phase|Participant defaulted|0|||
17086175|NCT00098722|38226724|FG002|Open Label Phase|Participant defaulted|0|||
17169562|NCT01340898|38319035|FG000|Primary Phase|Migrated/moved from study area|4|||
17169563|NCT01340898|38319036|FG001|Primary Phase|Migrated/moved from study area|1|||
17169564|NCT01340898|38319037|FG002|Primary Phase|Migrated/moved from study area|0|||
17169565|NCT01340898|38319035|FG000|Primary Phase|Lost to Follow-up|4|||
17169566|NCT01340898|38319036|FG001|Primary Phase|Lost to Follow-up|1|||
17169567|NCT01340898|38319037|FG002|Primary Phase|Lost to Follow-up|0|||
17169568|NCT01340898|38319035|FG000|Booster Phase|Withdrawal by Subject|3|||
17169569|NCT01340898|38319036|FG001|Booster Phase|Withdrawal by Subject|0|||
17169570|NCT01340898|38319037|FG002|Booster Phase|Withdrawal by Subject|4|||
17169571|NCT01340898|38319035|FG000|Booster Phase|Migrated/moved from study area|3|||
17169572|NCT01340898|38319036|FG001|Booster Phase|Migrated/moved from study area|0|||
17169573|NCT01340898|38319037|FG002|Booster Phase|Migrated/moved from study area|0|||
17169574|NCT01340898|38319035|FG000|Booster Phase|Lost to Follow-up|4|||
17169575|NCT01340898|38319036|FG001|Booster Phase|Lost to Follow-up|2|||
17169576|NCT01340898|38319037|FG002|Booster Phase|Lost to Follow-up|3|||
17169577|NCT02470585|38319050|FG000|Overall Study|Death|82|||
17169578|NCT02470585|38319051|FG001|Overall Study|Death|87|||
17169579|NCT02470585|38319052|FG002|Overall Study|Death|86|||
17169580|NCT02470585|38319050|FG000|Overall Study|Withdrawal by Subject|19|||
17169581|NCT02470585|38319051|FG001|Overall Study|Withdrawal by Subject|21|||
17169582|NCT02470585|38319052|FG002|Overall Study|Withdrawal by Subject|29|||
17169583|NCT02470585|38319050|FG000|Overall Study|Lost to Follow-up|2|||
17169584|NCT02470585|38319051|FG001|Overall Study|Lost to Follow-up|5|||
17169585|NCT02470585|38319052|FG002|Overall Study|Lost to Follow-up|4|||
17169586|NCT02470585|38319050|FG000|Overall Study|Other|4|||
17169587|NCT02470585|38319051|FG001|Overall Study|Other|4|||
17169588|NCT02470585|38319052|FG002|Overall Study|Other|6|||
17169589|NCT02744898|38319071|FG000|Overall Study|Progressive Disease|2|||
17169590|NCT02744898|38319071|FG000|Overall Study|Physician Decision|1|||
17169591|NCT02744898|38319071|FG000|Overall Study|Toxicity|1|||
17169592|NCT03036813|38319078|FG000|Overall Study|Adverse Event|6|||
17169593|NCT03036813|38319079|FG001|Overall Study|Adverse Event|11|||
17169594|NCT03036813|38319080|FG002|Overall Study|Adverse Event|6|||
17169595|NCT03036813|38319078|FG000|Overall Study|Withdrawal by Subject|12|||
17086176|NCT00098722|38226725|FG003|Open Label Phase|Participant defaulted|18|||
17086177|NCT00098722|38226726|FG004|Open Label Phase|Participant defaulted|0|||
17086178|NCT00098722|38226727|FG005|Open Label Phase|Participant defaulted|0|||
17086179|NCT00098722|38226728|FG006|Open Label Phase|Participant defaulted|0|||
17086180|NCT00098722|38226722|FG000|Open Label Phase|Ongoing at cut-off date|0|||
17086181|NCT00098722|38226723|FG001|Open Label Phase|Ongoing at cut-off date|0|||
17086182|NCT00098722|38226724|FG002|Open Label Phase|Ongoing at cut-off date|0|||
17086183|NCT00098722|38226725|FG003|Open Label Phase|Ongoing at cut-off date|220|||
17086184|NCT00098722|38226726|FG004|Open Label Phase|Ongoing at cut-off date|50|||
17086185|NCT00098722|38226727|FG005|Open Label Phase|Ongoing at cut-off date|0|||
17086186|NCT00098722|38226728|FG006|Open Label Phase|Ongoing at cut-off date|0|||
17086187|NCT00098722|38226722|FG000|Open Label Phase|Other|0|||
17169596|NCT03036813|38319079|FG001|Overall Study|Withdrawal by Subject|6|||
17169597|NCT03036813|38319080|FG002|Overall Study|Withdrawal by Subject|10|||
17169598|NCT03036813|38319078|FG000|Overall Study|Lost to Follow-up|1|||
17169599|NCT03036813|38319079|FG001|Overall Study|Lost to Follow-up|1|||
17169600|NCT03036813|38319080|FG002|Overall Study|Lost to Follow-up|0|||
17169601|NCT03036813|38319078|FG000|Overall Study|Physician Decision|2|||
17169602|NCT03036813|38319079|FG001|Overall Study|Physician Decision|1|||
17169603|NCT03036813|38319080|FG002|Overall Study|Physician Decision|1|||
17169604|NCT03036813|38319078|FG000|Overall Study|Non-Compliance|1|||
17169605|NCT03036813|38319079|FG001|Overall Study|Non-Compliance|5|||
17169606|NCT03036813|38319080|FG002|Overall Study|Non-Compliance|3|||
17169607|NCT03036813|38319078|FG000|Overall Study|Pregnancy|0|||
17169608|NCT03036813|38319079|FG001|Overall Study|Pregnancy|0|||
17169609|NCT03036813|38319080|FG002|Overall Study|Pregnancy|1|||
17169610|NCT03036813|38319078|FG000|Overall Study|Other|0|||
17169611|NCT03036813|38319079|FG001|Overall Study|Other|3|||
17169612|NCT03036813|38319080|FG002|Overall Study|Other|5|||
17169613|NCT03097315|38319091|FG000|Overall Study|Withdrawal by Subject|1|||
17169614|NCT03039699|38319097|FG000|Overall Study|Incorrect inclusion|5|||
17169615|NCT03039699|38319098|FG001|Overall Study|Incorrect inclusion|4|||
17169616|NCT03039699|38319097|FG000|Overall Study|Lack of data to assess study endpoint|5|||
17169617|NCT03039699|38319098|FG001|Overall Study|Lack of data to assess study endpoint|3|||
17169618|NCT03039699|38319097|FG000|Overall Study|Bacterial infection|12|||
17169619|NCT03039699|38319098|FG001|Overall Study|Bacterial infection|28|||
17169620|NCT02833974|38319106|FG000|Overall Study|Lost to Follow-up|1|||
17086188|NCT00098722|38226723|FG001|Open Label Phase|Other|0|||
17086189|NCT00098722|38226724|FG002|Open Label Phase|Other|0|||
17169621|NCT02833974|38319107|FG001|Overall Study|Lost to Follow-up|0|||
17169622|NCT02833974|38319106|FG000|Overall Study|Adverse Event|0|||
17086190|NCT00098722|38226725|FG003|Open Label Phase|Other|18|||
17086191|NCT00098722|38226726|FG004|Open Label Phase|Other|0|||
17169623|NCT02833974|38319107|FG001|Overall Study|Adverse Event|3|||
17169624|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
17169625|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
17169626|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
17169627|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
17169628|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
17169629|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
17169630|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
17169631|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
17169632|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
17169633|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
17169634|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
17169635|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
17169636|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
17169637|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
17169638|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
17169639|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
17169640|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
17169641|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
17169642|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
17169643|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
17169644|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
17169645|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
17169646|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
17169647|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
17169648|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
17169649|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
17169650|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
17169651|NCT03093415|38319116|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
17169652|NCT03093415|38319117|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
17169653|NCT03093415|38319118|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
17169654|NCT03093415|38319116|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
17169655|NCT03093415|38319117|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
17169656|NCT03093415|38319118|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
17169657|NCT01358526|38319128|FG000|Open-label Titration Period|Adverse Event|95|||
17169658|NCT01358526|38319129|FG001|Open-label Titration Period|Adverse Event|0|||
17169659|NCT01358526|38319130|FG002|Open-label Titration Period|Adverse Event|0|||
17169660|NCT01358526|38319128|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
17169661|NCT01358526|38319129|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
17169662|NCT01358526|38319130|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
17169663|NCT01358526|38319128|FG000|Open-label Titration Period|Lost to Follow-up|25|||
17169664|NCT01358526|38319129|FG001|Open-label Titration Period|Lost to Follow-up|0|||
17169665|NCT01358526|38319130|FG002|Open-label Titration Period|Lost to Follow-up|0|||
17169666|NCT01358526|38319128|FG000|Open-label Titration Period|Lack of Efficacy|107|||
17169667|NCT01358526|38319129|FG001|Open-label Titration Period|Lack of Efficacy|0|||
17169668|NCT01358526|38319130|FG002|Open-label Titration Period|Lack of Efficacy|0|||
17169669|NCT01358526|38319128|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
17169670|NCT01358526|38319129|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
17169671|NCT01358526|38319130|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
17169672|NCT01358526|38319128|FG000|Open-label Titration Period|Administrative|8|||
17169673|NCT01358526|38319129|FG001|Open-label Titration Period|Administrative|0|||
17169674|NCT01358526|38319130|FG002|Open-label Titration Period|Administrative|0|||
17169675|NCT01358526|38319128|FG000|Open-label Titration Period|Did not qualify|178|||
17169676|NCT01358526|38319129|FG001|Open-label Titration Period|Did not qualify|0|||
17169677|NCT01358526|38319130|FG002|Open-label Titration Period|Did not qualify|0|||
17169678|NCT01358526|38319128|FG000|Double-blind Phase|Adverse Event|0|||
17169679|NCT01358526|38319129|FG001|Double-blind Phase|Adverse Event|24|||
17169680|NCT01358526|38319130|FG002|Double-blind Phase|Adverse Event|23|||
17169681|NCT01358526|38319128|FG000|Double-blind Phase|Withdrawal by Subject|0|||
17169682|NCT01358526|38319129|FG001|Double-blind Phase|Withdrawal by Subject|10|||
17169683|NCT01358526|38319130|FG002|Double-blind Phase|Withdrawal by Subject|8|||
17169684|NCT01358526|38319128|FG000|Double-blind Phase|Lost to Follow-up|0|||
17169685|NCT01358526|38319129|FG001|Double-blind Phase|Lost to Follow-up|4|||
17169686|NCT01358526|38319130|FG002|Double-blind Phase|Lost to Follow-up|1|||
17169687|NCT01358526|38319128|FG000|Double-blind Phase|Lack of Efficacy|0|||
17169688|NCT01358526|38319129|FG001|Double-blind Phase|Lack of Efficacy|31|||
17169689|NCT01358526|38319130|FG002|Double-blind Phase|Lack of Efficacy|73|||
17169690|NCT01358526|38319128|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
17169691|NCT01358526|38319129|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
17169692|NCT01358526|38319130|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
17169693|NCT01358526|38319128|FG000|Double-blind Phase|Administrative|0|||
17169694|NCT01358526|38319129|FG001|Double-blind Phase|Administrative|6|||
17169695|NCT01358526|38319130|FG002|Double-blind Phase|Administrative|10|||
17169696|NCT02830776|38319137|FG000|Overall Study|Lost to Follow-up|1|||
17169697|NCT03039621|38319144|FG000|Overall Study|Violation of inclusion criteria|3|||
17169698|NCT03039621|38319145|FG001|Overall Study|Violation of inclusion criteria|2|||
17169699|NCT03039621|38319144|FG000|Overall Study|Non-compliance with protocol requirement|4|||
17169700|NCT03039621|38319145|FG001|Overall Study|Non-compliance with protocol requirement|5|||
17169701|NCT03039621|38319144|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
17169702|NCT03039621|38319145|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
17169703|NCT03039621|38319144|FG000|Overall Study|Violation of non-inclusion criteria|1|||
17169704|NCT03039621|38319145|FG001|Overall Study|Violation of non-inclusion criteria|2|||
17169705|NCT03041181|38319153|FG000|Overall Study|Disease Progression|1|||
17169706|NCT03041181|38319154|FG001|Overall Study|Disease Progression|2|||
17169707|NCT02828436|38319160|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
17169708|NCT02828436|38319161|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
17169709|NCT02828436|38319160|FG000|Period 1|Lost to Follow-up|0|||
17169710|NCT02828436|38319161|FG001|Period 1|Lost to Follow-up|1|||
17169711|NCT02828436|38319160|FG000|Period 2|Withdrawal by Subject|4|||
17169712|NCT02828436|38319161|FG001|Period 2|Withdrawal by Subject|0|||
17169713|NCT02828436|38319160|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
17169714|NCT02828436|38319161|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
17169715|NCT02828436|38319160|FG000|Period 2|Lost to Follow-up|1|||
17169716|NCT02828436|38319161|FG001|Period 2|Lost to Follow-up|0|||
17169717|NCT02828124|38319175|FG000|Overall Study|Disease Progression|1|||
17169718|NCT02828124|38319176|FG001|Overall Study|Disease Progression|2|||
17169719|NCT02828124|38319177|FG002|Overall Study|Disease Progression|1|||
17169720|NCT02828124|38319178|FG003|Overall Study|Disease Progression|4|||
17169721|NCT02828124|38319175|FG000|Overall Study|AE Unrelated to Study Drug|0|||
17169722|NCT02828124|38319176|FG001|Overall Study|AE Unrelated to Study Drug|0|||
17169723|NCT02828124|38319177|FG002|Overall Study|AE Unrelated to Study Drug|0|||
17169724|NCT02828124|38319178|FG003|Overall Study|AE Unrelated to Study Drug|1|||
17169725|NCT02828124|38319175|FG000|Overall Study|Subject Withdrew Consent|0|||
17169726|NCT02828124|38319176|FG001|Overall Study|Subject Withdrew Consent|0|||
17169727|NCT02828124|38319177|FG002|Overall Study|Subject Withdrew Consent|0|||
17169728|NCT02828124|38319178|FG003|Overall Study|Subject Withdrew Consent|1|||
17169729|NCT02829996|38319193|FG000|Overall Study|Withdrawal by Subject|1|||
17169730|NCT02829996|38319194|FG001|Overall Study|Withdrawal by Subject|0|||
17169731|NCT02829996|38319195|FG002|Overall Study|Withdrawal by Subject|0|||
17169732|NCT02829996|38319196|FG003|Overall Study|Withdrawal by Subject|0|||
17169733|NCT02829996|38319197|FG004|Overall Study|Withdrawal by Subject|0|||
17169734|NCT02827500|38319211|FG000|Overall Study|Death|7|||
17169735|NCT02827500|38319212|FG001|Overall Study|Death|3|||
17169736|NCT02827500|38319211|FG000|Overall Study|Lost to Follow-up|1|||
17169737|NCT02827500|38319212|FG001|Overall Study|Lost to Follow-up|1|||
17169738|NCT02827500|38319211|FG000|Overall Study|Withdrawal by Subject|3|||
17169739|NCT02827500|38319212|FG001|Overall Study|Withdrawal by Subject|1|||
17169740|NCT02827500|38319211|FG000|Overall Study|Missing primary endpoint data|3|||
17169741|NCT02827500|38319212|FG001|Overall Study|Missing primary endpoint data|1|||
17169742|NCT02827500|38319211|FG000|Overall Study|Other|5|||
17169743|NCT02827500|38319212|FG001|Overall Study|Other|1|||
17169744|NCT02826798|38319223|FG000|Overall Study|Withdrawal by Subject|0|||
17169745|NCT02826798|38319224|FG001|Overall Study|Withdrawal by Subject|1|||
17169746|NCT02826798|38319225|FG002|Overall Study|Withdrawal by Subject|0|||
17169747|NCT02826798|38319226|FG003|Overall Study|Withdrawal by Subject|1|||
17169748|NCT02826798|38319227|FG004|Overall Study|Withdrawal by Subject|0|||
17169749|NCT02829138|38319241|FG000|Overall Study|Withdrawal by Subject|1|||
17169750|NCT02829138|38319242|FG001|Overall Study|Withdrawal by Subject|0|||
17169751|NCT02825550|38319248|FG000|Overall Study|Physician Decision|1|||
17169752|NCT02744040|38319257|FG000|Overall Study|Withdrawal by Subject|3|||
17169753|NCT02744040|38319258|FG001|Overall Study|Withdrawal by Subject|2|||
17169754|NCT02744040|38319259|FG002|Overall Study|Withdrawal by Subject|2|||
17169755|NCT02744040|38319257|FG000|Overall Study|Physician Decision|0|||
17169756|NCT02744040|38319258|FG001|Overall Study|Physician Decision|8|||
17169757|NCT02744040|38319259|FG002|Overall Study|Physician Decision|13|||
17169758|NCT02744040|38319257|FG000|Overall Study|Lost to Follow-up|3|||
17169759|NCT02744040|38319258|FG001|Overall Study|Lost to Follow-up|1|||
17169760|NCT02744040|38319259|FG002|Overall Study|Lost to Follow-up|7|||
17169761|NCT02743962|38319269|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
17169762|NCT02743962|38319270|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
17169763|NCT03094416|38319279|FG000|Run-in|Screening failure|8|||
17169764|NCT03094416|38319279|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
16996532|NCT00973622|38140650|FG000|Overall Study|did not pass MRI screen|6|||
17169765|NCT03094416|38319279|FG000|Run-in|Withdrawal by Subject|3|||
17169766|NCT03094416|38319279|FG000|Treatment Period|Withdrawal by Subject|2|||
17169767|NCT03041025|38319287|FG000|Overall Study|Adverse Event|0|||
17169768|NCT03041025|38319288|FG001|Overall Study|Adverse Event|0|||
17169769|NCT03041025|38319289|FG002|Overall Study|Adverse Event|1|||
17169770|NCT03041025|38319287|FG000|Overall Study|Lost to Follow-up|1|||
17169771|NCT03041025|38319288|FG001|Overall Study|Lost to Follow-up|0|||
17169772|NCT03041025|38319289|FG002|Overall Study|Lost to Follow-up|0|||
17169773|NCT03041025|38319287|FG000|Overall Study|Withdrawal by Subject|0|||
17169774|NCT03041025|38319288|FG001|Overall Study|Withdrawal by Subject|0|||
17169775|NCT03041025|38319289|FG002|Overall Study|Withdrawal by Subject|1|||
17169776|NCT01338870|38319306|FG000|Overall Study|Lost to Follow-up|0|||
17169777|NCT01338870|38319307|FG001|Overall Study|Lost to Follow-up|0|||
17169778|NCT01338870|38319308|FG002|Overall Study|Lost to Follow-up|1|||
17169779|NCT01338870|38319309|FG003|Overall Study|Lost to Follow-up|0|||
17169780|NCT01338870|38319310|FG004|Overall Study|Lost to Follow-up|1|||
17169781|NCT01338870|38319311|FG005|Overall Study|Lost to Follow-up|0|||
17169782|NCT01338870|38319306|FG000|Overall Study|Withdrawal by Subject|2|||
17169783|NCT01338870|38319307|FG001|Overall Study|Withdrawal by Subject|3|||
17169784|NCT01338870|38319308|FG002|Overall Study|Withdrawal by Subject|4|||
17169785|NCT01338870|38319309|FG003|Overall Study|Withdrawal by Subject|0|||
17169786|NCT01338870|38319310|FG004|Overall Study|Withdrawal by Subject|0|||
17169787|NCT01338870|38319311|FG005|Overall Study|Withdrawal by Subject|2|||
17169788|NCT01338870|38319306|FG000|Overall Study|Other|3|||
17169789|NCT01338870|38319307|FG001|Overall Study|Other|3|||
17169790|NCT01338870|38319308|FG002|Overall Study|Other|3|||
17169791|NCT01338870|38319309|FG003|Overall Study|Other|2|||
17169792|NCT01338870|38319310|FG004|Overall Study|Other|0|||
17169793|NCT01338870|38319311|FG005|Overall Study|Other|2|||
17169794|NCT01338870|38319306|FG000|Overall Study|Protocol Violation|0|||
17169795|NCT01338870|38319307|FG001|Overall Study|Protocol Violation|2|||
17169796|NCT01338870|38319308|FG002|Overall Study|Protocol Violation|2|||
17169797|NCT01338870|38319309|FG003|Overall Study|Protocol Violation|2|||
17169798|NCT01338870|38319310|FG004|Overall Study|Protocol Violation|1|||
17169799|NCT01338870|38319311|FG005|Overall Study|Protocol Violation|1|||
17169800|NCT01338870|38319306|FG000|Overall Study|Adverse Event|4|||
17169801|NCT01338870|38319307|FG001|Overall Study|Adverse Event|4|||
17169802|NCT01338870|38319308|FG002|Overall Study|Adverse Event|1|||
17169803|NCT01338870|38319309|FG003|Overall Study|Adverse Event|5|||
17169804|NCT01338870|38319310|FG004|Overall Study|Adverse Event|4|||
17169805|NCT01338870|38319311|FG005|Overall Study|Adverse Event|1|||
17169806|NCT02824224|38319327|FG000|Overall Study|Discontinued, IUS expulsion|0|||
17169807|NCT02824224|38319328|FG001|Overall Study|Discontinued, IUS expulsion|1|||
17169808|NCT02824224|38319327|FG000|Overall Study|Did not show up for allocation visit|2|||
16996533|NCT00973622|38140651|FG001|Overall Study|did not pass MRI screen|0|||
16996534|NCT00973622|38140650|FG000|Overall Study|did not complete rTMS sessions|11|||
16996535|NCT00973622|38140651|FG001|Overall Study|did not complete rTMS sessions|2|||
16996536|NCT04044716|38140659|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
16996537|NCT04044716|38140660|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
16996538|NCT04044716|38140661|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
16996539|NCT04044716|38140659|FG000|Overall Study|Lost to Follow-up|2|||
16996540|NCT04044716|38140660|FG001|Overall Study|Lost to Follow-up|3|||
16996541|NCT04044716|38140661|FG002|Overall Study|Lost to Follow-up|0|||
17169809|NCT02824224|38319328|FG001|Overall Study|Did not show up for allocation visit|0|||
17169810|NCT01338792|38319334|FG000|Overall Study|Adverse Event|2|||
17169811|NCT01338792|38319334|FG000|Overall Study|Death|1|||
17169812|NCT01338792|38319334|FG000|Overall Study|Withdrawal by Subject|1|||
17169813|NCT01314105|38319340|FG000|Overall Study|Progressive Disease|6|||
17169814|NCT01314105|38319341|FG001|Overall Study|Progressive Disease|10|||
17169815|NCT01314105|38319340|FG000|Overall Study|Refused to continue taking medication|0|||
17169816|NCT01314105|38319341|FG001|Overall Study|Refused to continue taking medication|1|||
17169817|NCT01314105|38319340|FG000|Overall Study|Other Adverse Event|1|||
17169818|NCT01314105|38319341|FG001|Overall Study|Other Adverse Event|1|||
17169819|NCT03040713|38319349|FG000|Overall Study|Positive amyloid scan|3|||
17169820|NCT01966471|38319355|FG000|Overall Study|Death|44|||
17169821|NCT01966471|38319356|FG001|Overall Study|Death|56|||
17169822|NCT01966471|38319355|FG000|Overall Study|Lost to Follow-up|46|||
17169823|NCT01966471|38319356|FG001|Overall Study|Lost to Follow-up|39|||
17169824|NCT01966471|38319355|FG000|Overall Study|Various reasons|4|||
17169825|NCT01966471|38319356|FG001|Overall Study|Various reasons|4|||
17169826|NCT01966471|38319355|FG000|Overall Study|Physician Decision|7|||
17169827|NCT01966471|38319356|FG001|Overall Study|Physician Decision|5|||
17169828|NCT01966471|38319355|FG000|Overall Study|Study Terminated By Sponsor|758|||
17169829|NCT01966471|38319356|FG001|Overall Study|Study Terminated By Sponsor|773|||
17169830|NCT01966471|38319355|FG000|Overall Study|Withdrawal by Subject|59|||
17169831|NCT01966471|38319356|FG001|Overall Study|Withdrawal by Subject|51|||
17169832|NCT03227471|38319377|FG000|Overall Study|Withdrawal by Subject|0|||
17169833|NCT03227471|38319378|FG001|Overall Study|Withdrawal by Subject|0|||
17169834|NCT03227471|38319379|FG002|Overall Study|Withdrawal by Subject|0|||
17169835|NCT03227471|38319380|FG003|Overall Study|Withdrawal by Subject|0|||
17169836|NCT03227471|38319381|FG004|Overall Study|Withdrawal by Subject|1|||
17169837|NCT03227471|38319382|FG005|Overall Study|Withdrawal by Subject|0|||
17169838|NCT03227471|38319383|FG006|Overall Study|Withdrawal by Subject|0|||
17169839|NCT03227471|38319384|FG007|Overall Study|Withdrawal by Subject|0|||
17169840|NCT03227471|38319385|FG008|Overall Study|Withdrawal by Subject|0|||
17169841|NCT03227471|38319386|FG009|Overall Study|Withdrawal by Subject|0|||
17169842|NCT03227471|38319387|FG010|Overall Study|Withdrawal by Subject|0|||
17169843|NCT03227471|38319388|FG011|Overall Study|Withdrawal by Subject|0|||
17169844|NCT03227471|38319389|FG012|Overall Study|Withdrawal by Subject|1|||
17169845|NCT03227471|38319390|FG013|Overall Study|Withdrawal by Subject|0|||
17169846|NCT03227471|38319391|FG014|Overall Study|Withdrawal by Subject|0|||
17169847|NCT03227471|38319377|FG000|Overall Study|Randomized, Never Dosed|0|||
17169848|NCT03227471|38319378|FG001|Overall Study|Randomized, Never Dosed|0|||
17169849|NCT03227471|38319379|FG002|Overall Study|Randomized, Never Dosed|0|||
17169850|NCT03227471|38319380|FG003|Overall Study|Randomized, Never Dosed|0|||
17169851|NCT03227471|38319381|FG004|Overall Study|Randomized, Never Dosed|0|||
17169852|NCT03227471|38319382|FG005|Overall Study|Randomized, Never Dosed|0|||
17169853|NCT03227471|38319383|FG006|Overall Study|Randomized, Never Dosed|0|||
17169854|NCT03227471|38319384|FG007|Overall Study|Randomized, Never Dosed|0|||
17169855|NCT03227471|38319385|FG008|Overall Study|Randomized, Never Dosed|0|||
17169856|NCT03227471|38319386|FG009|Overall Study|Randomized, Never Dosed|0|||
17169857|NCT03227471|38319387|FG010|Overall Study|Randomized, Never Dosed|0|||
17169858|NCT03227471|38319388|FG011|Overall Study|Randomized, Never Dosed|0|||
17169859|NCT03227471|38319389|FG012|Overall Study|Randomized, Never Dosed|0|||
17169860|NCT03227471|38319390|FG013|Overall Study|Randomized, Never Dosed|0|||
17169861|NCT03227471|38319391|FG014|Overall Study|Randomized, Never Dosed|1|||
17169862|NCT01354314|38319456|FG000|Overall Study|Lost to Follow-up|1|||
17169863|NCT01354314|38319457|FG001|Overall Study|Lost to Follow-up|0|||
17169864|NCT01354314|38319458|FG002|Overall Study|Lost to Follow-up|1|||
17169865|NCT01354314|38319459|FG003|Overall Study|Lost to Follow-up|1|||
17169866|NCT01354314|38319456|FG000|Overall Study|Withdrawal by Subject|0|||
17169867|NCT01354314|38319457|FG001|Overall Study|Withdrawal by Subject|0|||
17169868|NCT01354314|38319458|FG002|Overall Study|Withdrawal by Subject|1|||
17169869|NCT01354314|38319459|FG003|Overall Study|Withdrawal by Subject|0|||
17169870|NCT01354314|38319456|FG000|Overall Study|Adverse Event|0|||
17169871|NCT01354314|38319457|FG001|Overall Study|Adverse Event|0|||
17169872|NCT01354314|38319458|FG002|Overall Study|Adverse Event|0|||
17169873|NCT01354314|38319459|FG003|Overall Study|Adverse Event|1|||
17169874|NCT01354314|38319456|FG000|Overall Study|Protocol Violation|1|||
17169875|NCT01354314|38319457|FG001|Overall Study|Protocol Violation|1|||
17169876|NCT01354314|38319458|FG002|Overall Study|Protocol Violation|0|||
17169877|NCT01354314|38319459|FG003|Overall Study|Protocol Violation|0|||
17169878|NCT01354314|38319456|FG000|Overall Study|Less than 90% Adherence|4|||
17169879|NCT01354314|38319457|FG001|Overall Study|Less than 90% Adherence|2|||
17169880|NCT01354314|38319458|FG002|Overall Study|Less than 90% Adherence|6|||
17169881|NCT01354314|38319459|FG003|Overall Study|Less than 90% Adherence|4|||
17169882|NCT03194321|38319471|FG000|Overall Study|Withdrawal by Subject|1|||
17169883|NCT03194321|38319471|FG000|Overall Study|Lost to Follow-up|1|||
17169884|NCT03194321|38319471|FG000|Overall Study|Travel for Follow-up|1|||
17169885|NCT01354938|38319475|FG000|Overall Study|Lost to Follow-up|1|||
17169886|NCT03092791|38319498|FG000|Overall Study|Lost to Follow-up|0|||
17169887|NCT03092791|38319499|FG001|Overall Study|Lost to Follow-up|0|||
17169888|NCT03092791|38319500|FG002|Overall Study|Lost to Follow-up|0|||
17169889|NCT03092791|38319501|FG003|Overall Study|Lost to Follow-up|0|||
17169890|NCT03092791|38319502|FG004|Overall Study|Lost to Follow-up|0|||
17169891|NCT03092791|38319503|FG005|Overall Study|Lost to Follow-up|0|||
17169892|NCT03092791|38319504|FG006|Overall Study|Lost to Follow-up|1|||
17169893|NCT03092791|38319505|FG007|Overall Study|Lost to Follow-up|0|||
17169894|NCT03092791|38319498|FG000|Overall Study|Withdrawal of Consent|0|||
17169895|NCT03092791|38319499|FG001|Overall Study|Withdrawal of Consent|0|||
17169896|NCT03092791|38319500|FG002|Overall Study|Withdrawal of Consent|0|||
17169897|NCT03092791|38319501|FG003|Overall Study|Withdrawal of Consent|0|||
17169898|NCT03092791|38319502|FG004|Overall Study|Withdrawal of Consent|4|||
17169899|NCT03092791|38319503|FG005|Overall Study|Withdrawal of Consent|12|||
17169900|NCT03092791|38319504|FG006|Overall Study|Withdrawal of Consent|6|||
17169901|NCT03092791|38319505|FG007|Overall Study|Withdrawal of Consent|4|||
17169902|NCT03092791|38319498|FG000|Overall Study|Study Termination|0|||
17169903|NCT03092791|38319499|FG001|Overall Study|Study Termination|0|||
17169904|NCT03092791|38319500|FG002|Overall Study|Study Termination|0|||
17169905|NCT03092791|38319501|FG003|Overall Study|Study Termination|0|||
17169906|NCT03092791|38319502|FG004|Overall Study|Study Termination|55|||
17169907|NCT03092791|38319503|FG005|Overall Study|Study Termination|46|||
17169908|NCT03092791|38319504|FG006|Overall Study|Study Termination|53|||
17169909|NCT03092791|38319505|FG007|Overall Study|Study Termination|55|||
17169910|NCT03092791|38319498|FG000|Overall Study|Death|0|||
17169911|NCT03092791|38319499|FG001|Overall Study|Death|0|||
17169912|NCT03092791|38319500|FG002|Overall Study|Death|0|||
17169913|NCT03092791|38319501|FG003|Overall Study|Death|0|||
17169914|NCT03092791|38319502|FG004|Overall Study|Death|0|||
17169915|NCT03092791|38319503|FG005|Overall Study|Death|1|||
17169916|NCT03092791|38319504|FG006|Overall Study|Death|0|||
17169917|NCT03092791|38319505|FG007|Overall Study|Death|1|||
17169918|NCT03092791|38319498|FG000|Overall Study|Reason Not Specified|0|||
17169919|NCT03092791|38319499|FG001|Overall Study|Reason Not Specified|0|||
17169920|NCT03092791|38319500|FG002|Overall Study|Reason Not Specified|0|||
17169921|NCT03092791|38319501|FG003|Overall Study|Reason Not Specified|0|||
17169922|NCT03092791|38319502|FG004|Overall Study|Reason Not Specified|1|||
17169923|NCT03092791|38319503|FG005|Overall Study|Reason Not Specified|1|||
17169924|NCT03092791|38319504|FG006|Overall Study|Reason Not Specified|0|||
17169925|NCT03092791|38319505|FG007|Overall Study|Reason Not Specified|0|||
17169926|NCT02505425|38319532|FG000|Overall Study|Lost to Follow-up|41|||
17169927|NCT02505425|38319533|FG001|Overall Study|Lost to Follow-up|61|||
17169928|NCT02505425|38319534|FG002|Overall Study|Lost to Follow-up|31|||
17169929|NCT02505425|38319535|FG003|Overall Study|Lost to Follow-up|19|||
17169930|NCT02505425|38319532|FG000|Overall Study|Withdrawal by Subject|39|||
17169931|NCT02505425|38319533|FG001|Overall Study|Withdrawal by Subject|9|||
17169932|NCT02505425|38319534|FG002|Overall Study|Withdrawal by Subject|19|||
17169933|NCT02505425|38319535|FG003|Overall Study|Withdrawal by Subject|7|||
17169934|NCT02505425|38319532|FG000|Overall Study|Death|8|||
17169935|NCT02505425|38319533|FG001|Overall Study|Death|12|||
17169936|NCT02505425|38319534|FG002|Overall Study|Death|0|||
17169937|NCT02505425|38319535|FG003|Overall Study|Death|0|||
17169938|NCT03089047|38319547|FG000|Overall Study|Lost to Follow-up|1|||
17169939|NCT03089047|38319548|FG001|Overall Study|Lost to Follow-up|0|||
17169940|NCT01371006|38319556|FG000|Overall Study|Adverse Event|1|||
17169941|NCT01371006|38319557|FG001|Overall Study|Adverse Event|0|||
17169942|NCT01371552|38319592|FG000|Part 1, First 3 Days|Inconvenience|0|||
17169943|NCT01371552|38319593|FG001|Part 1, First 3 Days|Inconvenience|0|||
17169944|NCT01371552|38319594|FG002|Part 1, First 3 Days|Inconvenience|1|||
17169945|NCT01371552|38319595|FG003|Part 1, First 3 Days|Inconvenience|0|||
17169946|NCT01371552|38319596|FG004|Part 1, First 3 Days|Inconvenience|0|||
17169947|NCT01371552|38319597|FG005|Part 1, First 3 Days|Inconvenience|0|||
17169948|NCT02819310|38319606|FG000|Overall Study|Withdrawal by Subject|37|||
17169949|NCT02819310|38319606|FG000|Overall Study|Lost to Follow-up|16|||
17169950|NCT02819310|38319606|FG000|Overall Study|Adverse Event|13|||
17169951|NCT02819310|38319606|FG000|Overall Study|Lack of Efficacy|5|||
17169952|NCT02819310|38319606|FG000|Overall Study|Physician Decision|8|||
17169953|NCT02819310|38319606|FG000|Overall Study|Protocol Violation|30|||
17169954|NCT03087643|38319612|FG000|Overall Study|Withdrawal by Subject|2|||
17169955|NCT03087643|38319613|FG001|Overall Study|Withdrawal by Subject|4|||
17169956|NCT03087643|38319612|FG000|Overall Study|Death|2|||
17169957|NCT03087643|38319613|FG001|Overall Study|Death|2|||
17169958|NCT02821962|38319621|FG000|Overall Study|Lost to Follow-up|2|||
17169959|NCT02821962|38319622|FG001|Overall Study|Lost to Follow-up|0|||
17169960|NCT03092479|38319630|FG000|Overall Study|Lost to Follow-up|3|||
17169961|NCT03092479|38319631|FG001|Overall Study|Lost to Follow-up|2|||
17169962|NCT03092479|38319630|FG000|Overall Study|Withdrawal by Subject|4|||
17169963|NCT03092479|38319631|FG001|Overall Study|Withdrawal by Subject|0|||
17169964|NCT03086551|38319639|FG000|First Intervention|Failure to meet inclusion criterion|1|||
17169965|NCT03086551|38319640|FG001|First Intervention|Failure to meet inclusion criterion|0|||
17169966|NCT03086551|38319639|FG000|First Intervention|Lost to Follow-up|0|||
17169967|NCT03086551|38319640|FG001|First Intervention|Lost to Follow-up|1|||
17169968|NCT03086551|38319639|FG000|Washout|Lost to Follow-up|1|||
17169969|NCT03086551|38319640|FG001|Washout|Lost to Follow-up|2|||
17169970|NCT03086551|38319639|FG000|Washout|Withdrawal by Subject|2|||
17169971|NCT03086551|38319640|FG001|Washout|Withdrawal by Subject|1|||
16996542|NCT00753454|38140668|FG000|Overall Study|Adverse Event|4|||
16996543|NCT00753454|38140668|FG000|Overall Study|Lack of Efficacy|1|||
17169972|NCT03265249|38319648|FG000|Overall Study|Withdrawal by Subject|0|||
17169973|NCT03265249|38319649|FG001|Overall Study|Withdrawal by Subject|1|||
17169974|NCT02951767|38319655|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
17169975|NCT02951767|38319655|FG000|Overall Study|Withdrawal by Subject|5|||
17169976|NCT02951767|38319655|FG000|Overall Study|Death|59|||
17169977|NCT02951767|38319655|FG000|Overall Study|Lost to Follow-up|1|||
17169978|NCT03093181|38319662|FG000|Overall Study|Withdrawal by Subject|2|||
17169979|NCT03093181|38319663|FG001|Overall Study|Withdrawal by Subject|1|||
17169980|NCT03093181|38319664|FG002|Overall Study|Withdrawal by Subject|2|||
17169981|NCT03093181|38319662|FG000|Overall Study|Other (Not specified)|1|||
17169982|NCT03093181|38319663|FG001|Overall Study|Other (Not specified)|0|||
17169983|NCT03093181|38319664|FG002|Overall Study|Other (Not specified)|0|||
17169984|NCT03093181|38319662|FG000|Overall Study|Adverse Event|0|||
17169985|NCT03093181|38319663|FG001|Overall Study|Adverse Event|1|||
17169986|NCT03093181|38319664|FG002|Overall Study|Adverse Event|0|||
17169987|NCT03093181|38319662|FG000|Overall Study|Other (Protocol violation)|0|||
17169988|NCT03093181|38319663|FG001|Overall Study|Other (Protocol violation)|0|||
17169989|NCT03093181|38319664|FG002|Overall Study|Other (Protocol violation)|1|||
17169990|NCT03091777|38319675|FG000|Overall Study|Pregnancy|2|||
17169991|NCT03091777|38319676|FG001|Overall Study|Pregnancy|1|||
17169992|NCT03091777|38319677|FG002|Overall Study|Pregnancy|0|||
17169993|NCT03091777|38319675|FG000|Overall Study|Adverse Event|2|||
17169994|NCT03091777|38319676|FG001|Overall Study|Adverse Event|1|||
17169995|NCT03091777|38319677|FG002|Overall Study|Adverse Event|4|||
17169996|NCT03091777|38319675|FG000|Overall Study|Withdrawal by Subject|4|||
17169997|NCT03091777|38319676|FG001|Overall Study|Withdrawal by Subject|2|||
17169998|NCT03091777|38319677|FG002|Overall Study|Withdrawal by Subject|6|||
17169999|NCT03091777|38319675|FG000|Overall Study|Protocol Violation|2|||
17170000|NCT03091777|38319676|FG001|Overall Study|Protocol Violation|1|||
17170001|NCT03091777|38319677|FG002|Overall Study|Protocol Violation|1|||
17170002|NCT03091777|38319675|FG000|Overall Study|Lost to Follow-up|12|||
17170003|NCT03091777|38319676|FG001|Overall Study|Lost to Follow-up|14|||
17170004|NCT03091777|38319677|FG002|Overall Study|Lost to Follow-up|7|||
17170005|NCT03091777|38319675|FG000|Overall Study|Lack of Efficacy|0|||
17170006|NCT03091777|38319676|FG001|Overall Study|Lack of Efficacy|0|||
17170007|NCT03091777|38319677|FG002|Overall Study|Lack of Efficacy|5|||
17170008|NCT03091777|38319675|FG000|Overall Study|Noncompliance with study drug|2|||
17170009|NCT03091777|38319676|FG001|Overall Study|Noncompliance with study drug|3|||
17170010|NCT03091777|38319677|FG002|Overall Study|Noncompliance with study drug|1|||
17170011|NCT03091777|38319675|FG000|Overall Study|Physician Decision|1|||
17170012|NCT03091777|38319676|FG001|Overall Study|Physician Decision|0|||
17170013|NCT03091777|38319677|FG002|Overall Study|Physician Decision|1|||
17170014|NCT03091777|38319675|FG000|Overall Study|Abnormal Laboratory Value|7|||
17170015|NCT03091777|38319676|FG001|Overall Study|Abnormal Laboratory Value|11|||
17170016|NCT03091777|38319677|FG002|Overall Study|Abnormal Laboratory Value|12|||
17170017|NCT02818998|38319688|FG000|Overall Study|Adverse Event|3|||
17170018|NCT02818998|38319689|FG001|Overall Study|Adverse Event|2|||
17170019|NCT02818998|38319690|FG002|Overall Study|Adverse Event|1|||
17170020|NCT02818998|38319688|FG000|Overall Study|Lost to Follow-up|4|||
17170021|NCT02818998|38319689|FG001|Overall Study|Lost to Follow-up|1|||
17170022|NCT02818998|38319690|FG002|Overall Study|Lost to Follow-up|2|||
17170023|NCT02818998|38319688|FG000|Overall Study|Withdrawal by sponsor|0|||
17170024|NCT02818998|38319689|FG001|Overall Study|Withdrawal by sponsor|1|||
17170025|NCT02818998|38319690|FG002|Overall Study|Withdrawal by sponsor|1|||
17170026|NCT02818998|38319688|FG000|Overall Study|Death|3|||
17170027|NCT02818998|38319689|FG001|Overall Study|Death|6|||
17170028|NCT02818998|38319690|FG002|Overall Study|Death|8|||
17170029|NCT02818998|38319688|FG000|Overall Study|Withdrawal by Subject|7|||
17170030|NCT02818998|38319689|FG001|Overall Study|Withdrawal by Subject|6|||
17170031|NCT02818998|38319690|FG002|Overall Study|Withdrawal by Subject|6|||
17170032|NCT02818998|38319688|FG000|Overall Study|Physician Decision|1|||
17170033|NCT02818998|38319689|FG001|Overall Study|Physician Decision|0|||
17170034|NCT02818998|38319690|FG002|Overall Study|Physician Decision|0|||
17170035|NCT02821416|38319700|FG000|Overall Study|Adverse Event|0|||
17170036|NCT02821416|38319701|FG001|Overall Study|Adverse Event|1|||
17170037|NCT02821416|38319700|FG000|Overall Study|Withdrawal by Subject|2|||
17170038|NCT02821416|38319701|FG001|Overall Study|Withdrawal by Subject|0|||
17170039|NCT02821416|38319700|FG000|Overall Study|Lost to Follow-up|1|||
17170040|NCT02821416|38319701|FG001|Overall Study|Lost to Follow-up|0|||
17170041|NCT03108521|38319710|FG000|Overall Study|Lost to Follow-up|3|||
17170042|NCT03108521|38319711|FG001|Overall Study|Lost to Follow-up|0|||
17086192|NCT00098722|38226727|FG005|Open Label Phase|Other|0|||
17086193|NCT00098722|38226728|FG006|Open Label Phase|Other|0|||
17086194|NCT00098722|38226722|FG000|Observation Phase|Death|0|||
17086195|NCT00098722|38226723|FG001|Observation Phase|Death|0|||
17086196|NCT00098722|38226724|FG002|Observation Phase|Death|0|||
17086197|NCT00098722|38226725|FG003|Observation Phase|Death|0|||
17086198|NCT00098722|38226726|FG004|Observation Phase|Death|0|||
17086199|NCT00098722|38226727|FG005|Observation Phase|Death|5|||
17086200|NCT00098722|38226728|FG006|Observation Phase|Death|3|||
17086201|NCT00098722|38226722|FG000|Observation Phase|Lack of Efficacy|0|||
17086202|NCT00098722|38226723|FG001|Observation Phase|Lack of Efficacy|0|||
17086203|NCT00098722|38226724|FG002|Observation Phase|Lack of Efficacy|0|||
17086204|NCT00098722|38226725|FG003|Observation Phase|Lack of Efficacy|0|||
17170043|NCT03108521|38319710|FG000|Overall Study|Lack of Efficacy|2|||
17170044|NCT03108521|38319711|FG001|Overall Study|Lack of Efficacy|0|||
17170045|NCT03108521|38319710|FG000|Overall Study|Physician Decision|4|||
17170046|NCT03108521|38319711|FG001|Overall Study|Physician Decision|0|||
17170047|NCT03108521|38319710|FG000|Overall Study|Adverse Event|3|||
17170048|NCT03108521|38319711|FG001|Overall Study|Adverse Event|0|||
17170049|NCT02818920|38319721|FG000|Overall Study|Unresectable|4|||
17170050|NCT02818920|38319721|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
17170051|NCT02818920|38319721|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
17170052|NCT02818920|38319721|FG000|Overall Study|Adverse Event|3|||
17170053|NCT02818920|38319721|FG000|Overall Study|Developed Other Disease|1|||
17170054|NCT02818920|38319721|FG000|Overall Study|Refused Further Treatment|1|||
17170055|NCT02817828|38319738|FG000|Overall Study|Lost to Follow-up|41|||
17170056|NCT02817828|38319738|FG000|Overall Study|Adverse event not related to bleeding|104|||
17170057|NCT02817828|38319738|FG000|Overall Study|Adverse event related to bleeding|53|||
17170058|NCT02817828|38319738|FG000|Overall Study|Protocol Violation|11|||
17170059|NCT02817828|38319738|FG000|Overall Study|Pregnancy|7|||
17170060|NCT02817828|38319738|FG000|Overall Study|Pregnancy wish|15|||
17170061|NCT02817828|38319738|FG000|Overall Study|Withdrawal by Subject|78|||
17170062|NCT02817828|38319738|FG000|Overall Study|Other|26|||
17170063|NCT02817906|38319749|FG000|Overall Study|Adverse Event|3|||
17170064|NCT02817906|38319750|FG001|Overall Study|Adverse Event|0|||
17170065|NCT02817906|38319749|FG000|Overall Study|Lack of Efficacy|1|||
17170066|NCT02817906|38319750|FG001|Overall Study|Lack of Efficacy|0|||
17170067|NCT02817906|38319749|FG000|Overall Study|Protocol Violation|1|||
17170068|NCT02817906|38319750|FG001|Overall Study|Protocol Violation|1|||
17170069|NCT02817906|38319749|FG000|Overall Study|Study Terminated by Sponsor|2|||
17170070|NCT02817906|38319750|FG001|Overall Study|Study Terminated by Sponsor|2|||
17170071|NCT02817906|38319749|FG000|Overall Study|Withdrawal by Subject|7|||
17170072|NCT02817906|38319750|FG001|Overall Study|Withdrawal by Subject|0|||
17170073|NCT02817906|38319749|FG000|Overall Study|Other|2|||
17170074|NCT02817906|38319750|FG001|Overall Study|Other|2|||
17170075|NCT02817594|38319761|FG000|Overall Study|Withdrawal by Subject|1|||
17170076|NCT02817594|38319761|FG000|Overall Study|Other|1|||
17170077|NCT02817594|38319761|FG000|Overall Study|Did Not Receive Treatment|1|||
17170078|NCT02813694|38319771|FG000|Overall Study|Physician Decision|0|||
17170079|NCT02813694|38319772|FG001|Overall Study|Physician Decision|1|||
17170080|NCT02813694|38319771|FG000|Overall Study|Withdrawal by Subject|10|||
17170081|NCT02813694|38319772|FG001|Overall Study|Withdrawal by Subject|9|||
17170082|NCT02813694|38319771|FG000|Overall Study|Lost to Follow-up|1|||
17170083|NCT02813694|38319772|FG001|Overall Study|Lost to Follow-up|1|||
17170084|NCT02813694|38319771|FG000|Overall Study|Death|3|||
17170085|NCT02813694|38319772|FG001|Overall Study|Death|3|||
17170086|NCT02813694|38319771|FG000|Overall Study|Randomized- did not receive study drug|2|||
17170087|NCT02813694|38319772|FG001|Overall Study|Randomized- did not receive study drug|0|||
17170088|NCT02813694|38319771|FG000|Overall Study|Patient hospitalized|1|||
17170089|NCT02813694|38319772|FG001|Overall Study|Patient hospitalized|0|||
17170090|NCT03103919|38319780|FG000|Overall Study|Adverse Event|2|||
17170091|NCT03103919|38319781|FG001|Overall Study|Adverse Event|2|||
17170092|NCT02810964|38319791|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
17170093|NCT02810964|38319792|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
17170094|NCT02810964|38319791|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
17170095|NCT02810964|38319792|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
17170096|NCT02810964|38319791|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
17170097|NCT02810964|38319792|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
17170098|NCT02810964|38319791|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
17170099|NCT02810964|38319792|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
17170100|NCT03103763|38319801|FG000|Overall Study|Death|15|||
17170101|NCT03103763|38319802|FG001|Overall Study|Death|5|||
17170102|NCT03103763|38319803|FG002|Overall Study|Death|5|||
17170103|NCT03103763|38319801|FG000|Overall Study|Withdrawal by Subject|0|||
17170104|NCT03103763|38319802|FG001|Overall Study|Withdrawal by Subject|3|||
17170105|NCT03103763|38319803|FG002|Overall Study|Withdrawal by Subject|2|||
17170106|NCT03101267|38319827|FG000|Primary Study Period|Withdrawal by Subject|1|||
17170107|NCT03101267|38319828|FG001|Primary Study Period|Withdrawal by Subject|2|||
17170108|NCT03101267|38319829|FG002|Primary Study Period|Withdrawal by Subject|3|||
17170109|NCT03101267|38319827|FG000|Primary Study Period|Miscellaneous|2|||
17170110|NCT03101267|38319828|FG001|Primary Study Period|Miscellaneous|0|||
17170111|NCT03101267|38319829|FG002|Primary Study Period|Miscellaneous|0|||
17170112|NCT02810418|38319844|FG000|Arm A Dose Escalation|Adverse Event|2|||
17170113|NCT02810418|38319845|FG001|Arm A Dose Escalation|Adverse Event|1|||
17170114|NCT02810418|38319846|FG002|Arm A Dose Escalation|Adverse Event|0|||
17170115|NCT02810418|38319847|FG003|Arm A Dose Escalation|Adverse Event|0|||
17170116|NCT02810418|38319848|FG004|Arm A Dose Escalation|Adverse Event|0|||
17170117|NCT02810418|38319849|FG005|Arm A Dose Escalation|Adverse Event|0|||
17170118|NCT02810418|38319850|FG006|Arm A Dose Escalation|Adverse Event|0|||
17170119|NCT02810418|38319844|FG000|Dose Expansion|Adverse Event|0|||
17170120|NCT02810418|38319845|FG001|Dose Expansion|Adverse Event|1|||
17170121|NCT02810418|38319846|FG002|Dose Expansion|Adverse Event|1|||
17170122|NCT02810418|38319847|FG003|Dose Expansion|Adverse Event|0|||
17170123|NCT02810418|38319848|FG004|Dose Expansion|Adverse Event|0|||
17170124|NCT02810418|38319849|FG005|Dose Expansion|Adverse Event|0|||
17170125|NCT02810418|38319850|FG006|Dose Expansion|Adverse Event|0|||
17170126|NCT02810418|38319844|FG000|Dose Expansion|Physician Decision|0|||
17170127|NCT02810418|38319845|FG001|Dose Expansion|Physician Decision|0|||
17170128|NCT02810418|38319846|FG002|Dose Expansion|Physician Decision|2|||
17170129|NCT02810418|38319847|FG003|Dose Expansion|Physician Decision|0|||
17170130|NCT02810418|38319848|FG004|Dose Expansion|Physician Decision|0|||
17170131|NCT02810418|38319849|FG005|Dose Expansion|Physician Decision|0|||
17170132|NCT02810418|38319850|FG006|Dose Expansion|Physician Decision|0|||
17170133|NCT02810418|38319844|FG000|Arm B Dose Escalation|Adverse Event|0|||
17170134|NCT02810418|38319845|FG001|Arm B Dose Escalation|Adverse Event|0|||
17170135|NCT02810418|38319846|FG002|Arm B Dose Escalation|Adverse Event|0|||
17170136|NCT02810418|38319847|FG003|Arm B Dose Escalation|Adverse Event|0|||
17170137|NCT02810418|38319848|FG004|Arm B Dose Escalation|Adverse Event|1|||
17170138|NCT02810418|38319849|FG005|Arm B Dose Escalation|Adverse Event|2|||
17170139|NCT02810418|38319850|FG006|Arm B Dose Escalation|Adverse Event|0|||
17170140|NCT02810340|38319916|FG000|Overall Study|Withdrawal by Subject|1|||
17170141|NCT02810340|38319917|FG001|Overall Study|Withdrawal by Subject|0|||
17170142|NCT02810340|38319918|FG002|Overall Study|Withdrawal by Subject|0|||
17170143|NCT02810340|38319916|FG000|Overall Study|Incarceration|0|||
17170144|NCT02810340|38319917|FG001|Overall Study|Incarceration|1|||
17170145|NCT02810340|38319918|FG002|Overall Study|Incarceration|0|||
17170146|NCT02810340|38319916|FG000|Overall Study|Lost to Follow-up|0|||
17170147|NCT02810340|38319917|FG001|Overall Study|Lost to Follow-up|0|||
17170148|NCT02810340|38319918|FG002|Overall Study|Lost to Follow-up|1|||
17170149|NCT02817516|38319930|FG000|Overall Study|Other|0|||
17170150|NCT02817516|38319931|FG001|Overall Study|Other|0|||
17170151|NCT02817516|38319932|FG002|Overall Study|Other|1|||
17170152|NCT02817516|38319933|FG003|Overall Study|Other|0|||
17170153|NCT02928029|38319948|FG000|Overall Study|Withdrawal by Subject|0|||
17170154|NCT02928029|38319949|FG001|Overall Study|Withdrawal by Subject|1|||
17170155|NCT02928029|38319948|FG000|Overall Study|Radiological progression|1|||
17170156|NCT02928029|38319949|FG001|Overall Study|Radiological progression|0|||
17170157|NCT02928029|38319948|FG000|Overall Study|Clinical progression|1|||
17170158|NCT02928029|38319949|FG001|Overall Study|Clinical progression|2|||
17170159|NCT02928029|38319948|FG000|Overall Study|AE not related to clinical progression|1|||
17170160|NCT02928029|38319949|FG001|Overall Study|AE not related to clinical progression|1|||
17170161|NCT02806986|38319955|FG000|Treatment Stage 1|Adverse Event|1|||
17170162|NCT02806986|38319955|FG000|Treatment Stage 2|Adverse Event|3|||
17170163|NCT02806986|38319955|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
17170164|NCT03095651|38319971|FG000|Overall Study|Lost to Follow-up|1|||
17170165|NCT03095651|38319972|FG001|Overall Study|Lost to Follow-up|1|||
17170166|NCT03095651|38319973|FG002|Overall Study|Lost to Follow-up|0|||
17170167|NCT03095651|38319974|FG003|Overall Study|Lost to Follow-up|1|||
17170168|NCT03095651|38319975|FG004|Overall Study|Lost to Follow-up|0|||
17170169|NCT03095651|38319976|FG005|Overall Study|Lost to Follow-up|0|||
17170170|NCT03095651|38319977|FG006|Overall Study|Lost to Follow-up|0|||
17170171|NCT03095651|38319978|FG007|Overall Study|Lost to Follow-up|0|||
17170172|NCT03095651|38319971|FG000|Overall Study|Withdrawal by Subject|0|||
17170173|NCT03095651|38319972|FG001|Overall Study|Withdrawal by Subject|0|||
17170174|NCT03095651|38319973|FG002|Overall Study|Withdrawal by Subject|0|||
17170175|NCT03095651|38319974|FG003|Overall Study|Withdrawal by Subject|0|||
17170176|NCT03095651|38319975|FG004|Overall Study|Withdrawal by Subject|0|||
17170177|NCT03095651|38319976|FG005|Overall Study|Withdrawal by Subject|1|||
17170178|NCT03095651|38319977|FG006|Overall Study|Withdrawal by Subject|0|||
17170179|NCT03095651|38319978|FG007|Overall Study|Withdrawal by Subject|0|||
17170180|NCT02808312|38320001|FG000|Overall Study|Enrolled but Never Treated|0|||
17170181|NCT02808312|38320002|FG001|Overall Study|Enrolled but Never Treated|0|||
17170182|NCT02808312|38320003|FG002|Overall Study|Enrolled but Never Treated|1|||
17170183|NCT02808312|38320004|FG003|Overall Study|Enrolled but Never Treated|0|||
17170184|NCT02808312|38320005|FG004|Overall Study|Enrolled but Never Treated|0|||
17170185|NCT03099161|38320025|FG000|Overall Study|Adverse Event|0|||
17170186|NCT03099161|38320026|FG001|Overall Study|Adverse Event|0|||
17170187|NCT03099161|38320027|FG002|Overall Study|Adverse Event|2|||
17170188|NCT03099161|38320025|FG000|Overall Study|Physician Decision|2|||
17170189|NCT03099161|38320026|FG001|Overall Study|Physician Decision|0|||
17170190|NCT03099161|38320027|FG002|Overall Study|Physician Decision|0|||
17170191|NCT03099161|38320025|FG000|Overall Study|Progressive Disease|1|||
17170192|NCT03099161|38320026|FG001|Overall Study|Progressive Disease|4|||
16996544|NCT00753454|38140668|FG000|Overall Study|Lost to Follow-up|3|||
16996545|NCT00753454|38140668|FG000|Overall Study|Withdrawal by Subject|5|||
17170193|NCT03099161|38320027|FG002|Overall Study|Progressive Disease|1|||
17170194|NCT03095027|38320035|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
17170195|NCT03095027|38320036|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
17170196|NCT04227197|38320044|FG000|Randomization|Protocol Violation|1|||
17170197|NCT04227197|38320045|FG001|Randomization|Protocol Violation|0|||
17170198|NCT04227197|38320044|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
17170199|NCT04227197|38320045|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
17170200|NCT04227197|38320044|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
17170201|NCT04227197|38320045|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
17170202|NCT04227197|38320044|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
17170203|NCT04227197|38320045|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
17170204|NCT04227197|38320044|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
17170205|NCT04227197|38320045|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
17170206|NCT04227197|38320044|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
17170207|NCT04227197|38320045|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
17170208|NCT04227197|38320044|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
17170209|NCT04227197|38320045|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
17170210|NCT03080935|38320056|FG000|Overall Study|Death|34|||
17170211|NCT03080935|38320057|FG001|Overall Study|Death|50|||
17170212|NCT03080935|38320056|FG000|Overall Study|Lost to Follow-up|5|||
17170213|NCT03080935|38320057|FG001|Overall Study|Lost to Follow-up|4|||
17170214|NCT03080935|38320056|FG000|Overall Study|Withdrawal by Subject|11|||
17170215|NCT03080935|38320057|FG001|Overall Study|Withdrawal by Subject|15|||
17170216|NCT03148795|38320067|FG000|Overall Study|Death|6|||
17170217|NCT03148795|38320067|FG000|Overall Study|Adverse Event|5|||
17170218|NCT03148795|38320067|FG000|Overall Study|Other|15|||
17170219|NCT03148795|38320067|FG000|Overall Study|No Longer Clinically Benefitting|2|||
17170220|NCT03148795|38320067|FG000|Overall Study|Global Deterioration Of Health Status|6|||
17170221|NCT03148795|38320067|FG000|Overall Study|Withdrawal by Subject|2|||
17170222|NCT03148795|38320067|FG000|Overall Study|Progressive Disease|62|||
17170223|NCT03148795|38320067|FG000|Overall Study|Ongoing|30|||
17170224|NCT02921789|38320073|FG000|Overall Study|Adverse Event|0|||
17170225|NCT02921789|38320074|FG001|Overall Study|Adverse Event|1|||
17170226|NCT02921789|38320073|FG000|Overall Study|Lost to Follow-up|1|||
17170227|NCT02921789|38320074|FG001|Overall Study|Lost to Follow-up|0|||
17170228|NCT02921789|38320073|FG000|Overall Study|Protocol Deviation|2|||
17170229|NCT02921789|38320074|FG001|Overall Study|Protocol Deviation|0|||
17170230|NCT02921789|38320073|FG000|Overall Study|Withdrawal by Subject|2|||
17170231|NCT02921789|38320074|FG001|Overall Study|Withdrawal by Subject|1|||
17170232|NCT02921789|38320073|FG000|Overall Study|Miscellaneous|3|||
17170233|NCT02921789|38320074|FG001|Overall Study|Miscellaneous|2|||
17170234|NCT02564900|38320095|FG000|Dose Escalation|Progressive disease per RECIST|2|||
17170235|NCT02564900|38320096|FG001|Dose Escalation|Progressive disease per RECIST|3|||
17170236|NCT02564900|38320097|FG002|Dose Escalation|Progressive disease per RECIST|3|||
17170237|NCT02564900|38320098|FG003|Dose Escalation|Progressive disease per RECIST|3|||
17170238|NCT02564900|38320099|FG004|Dose Escalation|Progressive disease per RECIST|3|||
17170239|NCT02564900|38320100|FG005|Dose Escalation|Progressive disease per RECIST|1|||
17170240|NCT02564900|38320101|FG006|Dose Escalation|Progressive disease per RECIST|0|||
17170241|NCT02564900|38320102|FG007|Dose Escalation|Progressive disease per RECIST|0|||
17170242|NCT02564900|38320103|FG008|Dose Escalation|Progressive disease per RECIST|0|||
17170243|NCT02564900|38320104|FG009|Dose Escalation|Progressive disease per RECIST|0|||
17170244|NCT02564900|38320105|FG010|Dose Escalation|Progressive disease per RECIST|0|||
17170245|NCT02564900|38320106|FG011|Dose Escalation|Progressive disease per RECIST|0|||
17170246|NCT02564900|38320107|FG012|Dose Escalation|Progressive disease per RECIST|0|||
17170247|NCT02564900|38320108|FG013|Dose Escalation|Progressive disease per RECIST|0|||
17170248|NCT02564900|38320109|FG014|Dose Escalation|Progressive disease per RECIST|0|||
17170249|NCT02564900|38320095|FG000|Dose Escalation|Ongoing|1|||
17170250|NCT02564900|38320096|FG001|Dose Escalation|Ongoing|0|||
17170251|NCT02564900|38320097|FG002|Dose Escalation|Ongoing|0|||
17170252|NCT02564900|38320098|FG003|Dose Escalation|Ongoing|2|||
17170253|NCT02564900|38320099|FG004|Dose Escalation|Ongoing|2|||
17170254|NCT02564900|38320100|FG005|Dose Escalation|Ongoing|2|||
17170255|NCT02564900|38320101|FG006|Dose Escalation|Ongoing|0|||
17170256|NCT02564900|38320102|FG007|Dose Escalation|Ongoing|0|||
17170257|NCT02564900|38320103|FG008|Dose Escalation|Ongoing|0|||
17170258|NCT02564900|38320104|FG009|Dose Escalation|Ongoing|0|||
17170259|NCT02564900|38320105|FG010|Dose Escalation|Ongoing|0|||
17170260|NCT02564900|38320106|FG011|Dose Escalation|Ongoing|0|||
17170261|NCT02564900|38320107|FG012|Dose Escalation|Ongoing|0|||
17170262|NCT02564900|38320108|FG013|Dose Escalation|Ongoing|0|||
17170263|NCT02564900|38320109|FG014|Dose Escalation|Ongoing|0|||
17170264|NCT02564900|38320095|FG000|Dose Escalation|Adverse Event|0|||
17170265|NCT02564900|38320096|FG001|Dose Escalation|Adverse Event|0|||
17170266|NCT02564900|38320097|FG002|Dose Escalation|Adverse Event|0|||
17170267|NCT02564900|38320098|FG003|Dose Escalation|Adverse Event|1|||
17170268|NCT02564900|38320099|FG004|Dose Escalation|Adverse Event|1|||
17170269|NCT02564900|38320100|FG005|Dose Escalation|Adverse Event|3|||
17170270|NCT02564900|38320101|FG006|Dose Escalation|Adverse Event|0|||
17170271|NCT02564900|38320102|FG007|Dose Escalation|Adverse Event|0|||
17170272|NCT02564900|38320103|FG008|Dose Escalation|Adverse Event|0|||
17170273|NCT02564900|38320104|FG009|Dose Escalation|Adverse Event|0|||
17170274|NCT02564900|38320105|FG010|Dose Escalation|Adverse Event|0|||
17170275|NCT02564900|38320106|FG011|Dose Escalation|Adverse Event|0|||
17170276|NCT02564900|38320107|FG012|Dose Escalation|Adverse Event|0|||
17170277|NCT02564900|38320108|FG013|Dose Escalation|Adverse Event|0|||
17170278|NCT02564900|38320109|FG014|Dose Escalation|Adverse Event|0|||
17170279|NCT02564900|38320095|FG000|Dose Expansion|Progressive disease per RECIST|0|||
17170280|NCT02564900|38320096|FG001|Dose Expansion|Progressive disease per RECIST|0|||
17170281|NCT02564900|38320097|FG002|Dose Expansion|Progressive disease per RECIST|0|||
17170282|NCT02564900|38320098|FG003|Dose Expansion|Progressive disease per RECIST|0|||
17170283|NCT02564900|38320099|FG004|Dose Expansion|Progressive disease per RECIST|0|||
17170284|NCT02564900|38320100|FG005|Dose Expansion|Progressive disease per RECIST|0|||
17086205|NCT00098722|38226726|FG004|Observation Phase|Lack of Efficacy|0|||
17086206|NCT00098722|38226727|FG005|Observation Phase|Lack of Efficacy|2|||
17086207|NCT00098722|38226728|FG006|Observation Phase|Lack of Efficacy|0|||
17170285|NCT02564900|38320101|FG006|Dose Expansion|Progressive disease per RECIST|19|||
17170286|NCT02564900|38320102|FG007|Dose Expansion|Progressive disease per RECIST|17|||
17170287|NCT02564900|38320103|FG008|Dose Expansion|Progressive disease per RECIST|8|||
17170288|NCT02564900|38320104|FG009|Dose Expansion|Progressive disease per RECIST|16|||
17170289|NCT02564900|38320105|FG010|Dose Expansion|Progressive disease per RECIST|13|||
17170290|NCT02564900|38320106|FG011|Dose Expansion|Progressive disease per RECIST|19|||
17170291|NCT02564900|38320107|FG012|Dose Expansion|Progressive disease per RECIST|10|||
17170292|NCT02564900|38320108|FG013|Dose Expansion|Progressive disease per RECIST|13|||
17170293|NCT02564900|38320109|FG014|Dose Expansion|Progressive disease per RECIST|11|||
17170294|NCT02564900|38320095|FG000|Dose Expansion|Clinical progression|0|||
17170295|NCT02564900|38320096|FG001|Dose Expansion|Clinical progression|0|||
17170296|NCT02564900|38320097|FG002|Dose Expansion|Clinical progression|0|||
17170297|NCT02564900|38320098|FG003|Dose Expansion|Clinical progression|0|||
17170298|NCT02564900|38320099|FG004|Dose Expansion|Clinical progression|0|||
17170299|NCT02564900|38320100|FG005|Dose Expansion|Clinical progression|0|||
17170300|NCT02564900|38320101|FG006|Dose Expansion|Clinical progression|5|||
17170301|NCT02564900|38320102|FG007|Dose Expansion|Clinical progression|12|||
17170302|NCT02564900|38320103|FG008|Dose Expansion|Clinical progression|0|||
17170303|NCT02564900|38320104|FG009|Dose Expansion|Clinical progression|3|||
17170304|NCT02564900|38320105|FG010|Dose Expansion|Clinical progression|2|||
17170305|NCT02564900|38320106|FG011|Dose Expansion|Clinical progression|0|||
17170306|NCT02564900|38320107|FG012|Dose Expansion|Clinical progression|1|||
17170307|NCT02564900|38320108|FG013|Dose Expansion|Clinical progression|3|||
17170308|NCT02564900|38320109|FG014|Dose Expansion|Clinical progression|1|||
17170309|NCT02564900|38320095|FG000|Dose Expansion|Adverse Event|0|||
17170310|NCT02564900|38320096|FG001|Dose Expansion|Adverse Event|0|||
17170311|NCT02564900|38320097|FG002|Dose Expansion|Adverse Event|0|||
17170312|NCT02564900|38320098|FG003|Dose Expansion|Adverse Event|0|||
17170313|NCT02564900|38320099|FG004|Dose Expansion|Adverse Event|0|||
17170314|NCT02564900|38320100|FG005|Dose Expansion|Adverse Event|0|||
17170315|NCT02564900|38320101|FG006|Dose Expansion|Adverse Event|9|||
17170316|NCT02564900|38320102|FG007|Dose Expansion|Adverse Event|22|||
17170317|NCT02564900|38320103|FG008|Dose Expansion|Adverse Event|0|||
17086208|NCT00098722|38226722|FG000|Observation Phase|Participant defaulted|0|||
17086209|NCT00098722|38226723|FG001|Observation Phase|Participant defaulted|0|||
17086210|NCT00098722|38226724|FG002|Observation Phase|Participant defaulted|0|||
17086211|NCT00098722|38226725|FG003|Observation Phase|Participant defaulted|0|||
17170318|NCT02564900|38320104|FG009|Dose Expansion|Adverse Event|11|||
17170319|NCT02564900|38320105|FG010|Dose Expansion|Adverse Event|0|||
17170320|NCT02564900|38320106|FG011|Dose Expansion|Adverse Event|5|||
17170321|NCT02564900|38320107|FG012|Dose Expansion|Adverse Event|2|||
17170322|NCT02564900|38320108|FG013|Dose Expansion|Adverse Event|2|||
17086212|NCT00098722|38226726|FG004|Observation Phase|Participant defaulted|0|||
17086213|NCT00098722|38226727|FG005|Observation Phase|Participant defaulted|17|||
17086214|NCT00098722|38226728|FG006|Observation Phase|Participant defaulted|4|||
17086215|NCT00098722|38226722|FG000|Observation Phase|Other|0|||
17086216|NCT00098722|38226723|FG001|Observation Phase|Other|0|||
17086217|NCT00098722|38226724|FG002|Observation Phase|Other|0|||
17086218|NCT00098722|38226725|FG003|Observation Phase|Other|0|||
17086219|NCT00098722|38226726|FG004|Observation Phase|Other|0|||
17086220|NCT00098722|38226727|FG005|Observation Phase|Other|21|||
17086221|NCT00098722|38226728|FG006|Observation Phase|Other|10|||
17086222|NCT00098254|38226740|FG000|Overall Study|Adverse Event|2|||
17170323|NCT02564900|38320109|FG014|Dose Expansion|Adverse Event|1|||
17086223|NCT00098254|38226740|FG000|Overall Study|Death|1|||
17086224|NCT00095056|38226746|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
17170324|NCT02564900|38320095|FG000|Dose Expansion|Ongoing|0|||
17170325|NCT02564900|38320096|FG001|Dose Expansion|Ongoing|0|||
17170326|NCT02564900|38320097|FG002|Dose Expansion|Ongoing|0|||
17170327|NCT02564900|38320098|FG003|Dose Expansion|Ongoing|0|||
17170328|NCT02564900|38320099|FG004|Dose Expansion|Ongoing|0|||
17170329|NCT02564900|38320100|FG005|Dose Expansion|Ongoing|0|||
17170330|NCT02564900|38320101|FG006|Dose Expansion|Ongoing|9|||
17170331|NCT02564900|38320102|FG007|Dose Expansion|Ongoing|10|||
17170332|NCT02564900|38320103|FG008|Dose Expansion|Ongoing|11|||
16781313|NCT02143024|37720476|FG000|Overall Study|Lost to Follow-up|1|||
17170333|NCT02564900|38320104|FG009|Dose Expansion|Ongoing|3|||
17170334|NCT02564900|38320105|FG010|Dose Expansion|Ongoing|0|||
17170335|NCT02564900|38320106|FG011|Dose Expansion|Ongoing|0|||
17170336|NCT02564900|38320107|FG012|Dose Expansion|Ongoing|4|||
17170337|NCT02564900|38320108|FG013|Dose Expansion|Ongoing|0|||
17170338|NCT02564900|38320109|FG014|Dose Expansion|Ongoing|6|||
17170339|NCT02564900|38320095|FG000|Dose Expansion|Death|0|||
17170340|NCT02564900|38320096|FG001|Dose Expansion|Death|0|||
17170341|NCT02564900|38320097|FG002|Dose Expansion|Death|0|||
17170342|NCT02564900|38320098|FG003|Dose Expansion|Death|0|||
17170343|NCT02564900|38320099|FG004|Dose Expansion|Death|0|||
17170344|NCT02564900|38320100|FG005|Dose Expansion|Death|0|||
17170345|NCT02564900|38320101|FG006|Dose Expansion|Death|1|||
17170346|NCT02564900|38320102|FG007|Dose Expansion|Death|0|||
17170347|NCT02564900|38320103|FG008|Dose Expansion|Death|0|||
17170348|NCT02564900|38320104|FG009|Dose Expansion|Death|0|||
17170349|NCT02564900|38320105|FG010|Dose Expansion|Death|1|||
17170350|NCT02564900|38320106|FG011|Dose Expansion|Death|0|||
17170351|NCT02564900|38320107|FG012|Dose Expansion|Death|1|||
17170352|NCT02564900|38320108|FG013|Dose Expansion|Death|1|||
17170353|NCT02564900|38320109|FG014|Dose Expansion|Death|0|||
17170354|NCT02564900|38320095|FG000|Dose Expansion|Withdrawal by Subject|0|||
17170355|NCT02564900|38320096|FG001|Dose Expansion|Withdrawal by Subject|0|||
17170356|NCT02564900|38320097|FG002|Dose Expansion|Withdrawal by Subject|0|||
17170357|NCT02564900|38320098|FG003|Dose Expansion|Withdrawal by Subject|0|||
17170358|NCT02564900|38320099|FG004|Dose Expansion|Withdrawal by Subject|0|||
17170359|NCT02564900|38320100|FG005|Dose Expansion|Withdrawal by Subject|0|||
17170360|NCT02564900|38320101|FG006|Dose Expansion|Withdrawal by Subject|4|||
17170361|NCT02564900|38320102|FG007|Dose Expansion|Withdrawal by Subject|0|||
17170362|NCT02564900|38320103|FG008|Dose Expansion|Withdrawal by Subject|0|||
17170363|NCT02564900|38320104|FG009|Dose Expansion|Withdrawal by Subject|0|||
17170364|NCT02564900|38320105|FG010|Dose Expansion|Withdrawal by Subject|1|||
17170365|NCT02564900|38320106|FG011|Dose Expansion|Withdrawal by Subject|0|||
17170366|NCT02564900|38320107|FG012|Dose Expansion|Withdrawal by Subject|0|||
17170367|NCT02564900|38320108|FG013|Dose Expansion|Withdrawal by Subject|1|||
17170368|NCT02564900|38320109|FG014|Dose Expansion|Withdrawal by Subject|1|||
17170369|NCT02564900|38320095|FG000|Dose Expansion|Other|0|||
17170370|NCT02564900|38320096|FG001|Dose Expansion|Other|0|||
17170371|NCT02564900|38320097|FG002|Dose Expansion|Other|0|||
17170372|NCT02564900|38320098|FG003|Dose Expansion|Other|0|||
17170373|NCT02564900|38320099|FG004|Dose Expansion|Other|0|||
17170374|NCT02564900|38320100|FG005|Dose Expansion|Other|0|||
17170375|NCT02564900|38320101|FG006|Dose Expansion|Other|1|||
17170376|NCT02564900|38320102|FG007|Dose Expansion|Other|0|||
17170377|NCT02564900|38320103|FG008|Dose Expansion|Other|1|||
17170378|NCT02564900|38320104|FG009|Dose Expansion|Other|0|||
17170379|NCT02564900|38320105|FG010|Dose Expansion|Other|0|||
17170380|NCT02564900|38320106|FG011|Dose Expansion|Other|0|||
17170381|NCT02564900|38320107|FG012|Dose Expansion|Other|0|||
17170382|NCT02564900|38320108|FG013|Dose Expansion|Other|0|||
17170383|NCT02564900|38320109|FG014|Dose Expansion|Other|1|||
17170384|NCT02564900|38320095|FG000|Dose Expansion|Did not receive treatment|0|||
17170385|NCT02564900|38320096|FG001|Dose Expansion|Did not receive treatment|0|||
17170386|NCT02564900|38320097|FG002|Dose Expansion|Did not receive treatment|0|||
17170387|NCT02564900|38320098|FG003|Dose Expansion|Did not receive treatment|0|||
17170388|NCT02564900|38320099|FG004|Dose Expansion|Did not receive treatment|0|||
17170389|NCT02564900|38320100|FG005|Dose Expansion|Did not receive treatment|0|||
17170390|NCT02564900|38320101|FG006|Dose Expansion|Did not receive treatment|1|||
17170391|NCT02564900|38320102|FG007|Dose Expansion|Did not receive treatment|1|||
17170392|NCT02564900|38320103|FG008|Dose Expansion|Did not receive treatment|0|||
17170393|NCT02564900|38320104|FG009|Dose Expansion|Did not receive treatment|0|||
17170394|NCT02564900|38320105|FG010|Dose Expansion|Did not receive treatment|0|||
17170395|NCT02564900|38320106|FG011|Dose Expansion|Did not receive treatment|0|||
17170396|NCT02564900|38320107|FG012|Dose Expansion|Did not receive treatment|0|||
17170397|NCT02564900|38320108|FG013|Dose Expansion|Did not receive treatment|0|||
17170398|NCT02564900|38320109|FG014|Dose Expansion|Did not receive treatment|1|||
17170399|NCT03364673|38320159|FG000|Overall Study|Withdrawal by Subject|2|||
17170400|NCT03364673|38320159|FG000|Overall Study|Injury unrelated to study|3|||
17170401|NCT03097289|38320163|FG000|Overall Study|Adverse Event|1|||
17170402|NCT03097289|38320163|FG000|Overall Study|Equipment failure|2|||
17170403|NCT03097289|38320163|FG000|Overall Study|Collected platelet product unusable|3|||
17170404|NCT02419742|38320185|FG000|Overall Study|Adverse Event|2|||
17170405|NCT02419742|38320186|FG001|Overall Study|Adverse Event|0|||
17170406|NCT02419742|38320185|FG000|Overall Study|Disease Progression|0|||
17170407|NCT02419742|38320186|FG001|Overall Study|Disease Progression|1|||
17170408|NCT02419742|38320185|FG000|Overall Study|Withdrew Consent|2|||
16781314|NCT02143024|37720477|FG001|Overall Study|Lost to Follow-up|1|||
17170409|NCT02419742|38320186|FG001|Overall Study|Withdrew Consent|1|||
17170410|NCT02419742|38320185|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
17170411|NCT02419742|38320186|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
17170412|NCT02898077|38320194|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
17170413|NCT02898077|38320195|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
17170414|NCT02898077|38320194|FG000|Overall Study|Lost to Follow-up|4|||
17170415|NCT02898077|38320195|FG001|Overall Study|Lost to Follow-up|3|||
17170416|NCT02898077|38320194|FG000|Overall Study|Physician Decision|0|||
17170417|NCT02898077|38320195|FG001|Overall Study|Physician Decision|2|||
17170418|NCT02898077|38320194|FG000|Overall Study|Sponsor Decision|32|||
17170419|NCT02898077|38320195|FG001|Overall Study|Sponsor Decision|13|||
17170420|NCT02898077|38320194|FG000|Overall Study|Withdrawal by Subject|6|||
17170421|NCT02898077|38320195|FG001|Overall Study|Withdrawal by Subject|3|||
17170422|NCT02898077|38320194|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
17170423|NCT02898077|38320195|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
17170424|NCT02898077|38320194|FG000|Overall Study|Ended extension period|3|||
17170425|NCT02898077|38320195|FG001|Overall Study|Ended extension period|0|||
17170426|NCT03097133|38320203|FG000|Overall Study|Lost to Follow-up|3|||
17170427|NCT03097133|38320204|FG001|Overall Study|Lost to Follow-up|2|||
17170428|NCT03097133|38320203|FG000|Overall Study|Withdrawal by Subject|2|||
17170429|NCT03097133|38320204|FG001|Overall Study|Withdrawal by Subject|5|||
17170430|NCT03097133|38320203|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
17170431|NCT03097133|38320204|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
17170432|NCT03097133|38320203|FG000|Overall Study|Other|3|||
17170433|NCT03097133|38320204|FG001|Overall Study|Other|2|||
17170434|NCT03097133|38320203|FG000|Overall Study|Adverse Event|1|||
17170435|NCT03097133|38320204|FG001|Overall Study|Adverse Event|0|||
17170436|NCT03889639|38320218|FG000|Overall Study|Withdrawal by Subject|0|||
17170437|NCT03889639|38320219|FG001|Overall Study|Withdrawal by Subject|0|||
17170438|NCT03889639|38320220|FG002|Overall Study|Withdrawal by Subject|0|||
17170439|NCT03889639|38320221|FG003|Overall Study|Withdrawal by Subject|0|||
17170440|NCT03889639|38320222|FG004|Overall Study|Withdrawal by Subject|0|||
17170441|NCT03889639|38320223|FG005|Overall Study|Withdrawal by Subject|0|||
17170442|NCT03889639|38320224|FG006|Overall Study|Withdrawal by Subject|0|||
17170443|NCT03889639|38320225|FG007|Overall Study|Withdrawal by Subject|1|||
17170444|NCT03265145|38320248|FG000|Overall Study|Protocol Violation|2|||
17170445|NCT03265145|38320249|FG001|Overall Study|Protocol Violation|0|||
17170446|NCT03265145|38320248|FG000|Overall Study|Adverse Event|1|||
17170447|NCT03265145|38320249|FG001|Overall Study|Adverse Event|0|||
17170448|NCT03265145|38320248|FG000|Overall Study|Withdrawal by Subject|23|||
17170449|NCT03265145|38320249|FG001|Overall Study|Withdrawal by Subject|19|||
17170450|NCT03265145|38320248|FG000|Overall Study|Death|12|||
17170451|NCT03265145|38320249|FG001|Overall Study|Death|12|||
17170452|NCT03265145|38320248|FG000|Overall Study|Lost to Follow-up|13|||
17170453|NCT03265145|38320249|FG001|Overall Study|Lost to Follow-up|9|||
17170454|NCT03265145|38320248|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
17170455|NCT03265145|38320249|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
17170456|NCT03265145|38320248|FG000|Overall Study|Switched back to previous medication|1|||
17170457|NCT03265145|38320249|FG001|Overall Study|Switched back to previous medication|0|||
17086225|NCT00095056|38226747|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
17086226|NCT00095056|38226746|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
17086227|NCT00095056|38226747|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
17086228|NCT00095056|38226746|FG000|Phase A (Weeks 0-12)|Death|1|||
17086229|NCT00095056|38226747|FG001|Phase A (Weeks 0-12)|Death|0|||
17086230|NCT00095056|38226746|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
17086231|NCT00095056|38226747|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
17086232|NCT00095056|38226746|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
17086233|NCT00095056|38226747|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
17086234|NCT00095056|38226746|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
17086235|NCT00095056|38226747|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
17086236|NCT00095056|38226746|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
17086237|NCT00095056|38226747|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
17086238|NCT00095056|38226746|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
17086239|NCT00095056|38226747|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
17086240|NCT00095056|38226746|FG000|Phase B (Weeks 12-54)|Death|3|||
17086241|NCT00095056|38226747|FG001|Phase B (Weeks 12-54)|Death|1|||
17086242|NCT00095056|38226746|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
17086243|NCT00095056|38226747|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
17086244|NCT00095056|38226746|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
17086245|NCT00095056|38226747|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
17086246|NCT00098020|38226753|FG000|Overall Study|Adverse Event|2|||
17086247|NCT00098020|38226753|FG000|Overall Study|Lost to Follow-up|1|||
17086248|NCT00098020|38226753|FG000|Overall Study|elevated liver enzymes|1|||
17086249|NCT00098020|38226753|FG000|Overall Study|Low urine PCR|1|||
17086250|NCT00098020|38226753|FG000|Overall Study|Low epidermal growth factor receptor|1|||
17170458|NCT03265145|38320248|FG000|Overall Study|Did not want to take medication|1|||
16868025|NCT01536145|37841034|FG001|Overall Study|Other|0|||
17170459|NCT03265145|38320249|FG001|Overall Study|Did not want to take medication|0|||
17170460|NCT03265145|38320248|FG000|Overall Study|Subject could not afford medication|0|||
17170461|NCT03265145|38320249|FG001|Overall Study|Subject could not afford medication|1|||
17170462|NCT03265145|38320248|FG000|Overall Study|Site closed|2|||
17170463|NCT03265145|38320249|FG001|Overall Study|Site closed|3|||
17170464|NCT03265145|38320248|FG000|Overall Study|Incorrectly randomized|16|||
17170465|NCT03265145|38320249|FG001|Overall Study|Incorrectly randomized|6|||
17170466|NCT03265145|38320248|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
17170467|NCT03265145|38320249|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
17170468|NCT03265145|38320248|FG000|Overall Study|Physician Decision|0|||
17170469|NCT03265145|38320249|FG001|Overall Study|Physician Decision|3|||
17170470|NCT03265145|38320248|FG000|Overall Study|Subject transferred to another facility|0|||
17170471|NCT03265145|38320249|FG001|Overall Study|Subject transferred to another facility|1|||
17170472|NCT03064763|38320256|FG000|Overall Study|Ongoing in study|10|||
17170473|NCT03064763|38320256|FG000|Overall Study|Death|8|||
17170474|NCT02782676|38320260|FG000|Overall Study|Lost to Follow-up|0|||
17170475|NCT02782676|38320261|FG001|Overall Study|Lost to Follow-up|1|||
17170476|NCT02471339|38320269|FG000|Overall Study|Did not provide follow-up data|2|||
17170477|NCT02471339|38320270|FG001|Overall Study|Did not provide follow-up data|0|||
17170478|NCT00107978|38320278|FG000|Overall Study|Adverse Event|1|||
17170479|NCT00107978|38320279|FG001|Overall Study|Adverse Event|5|||
17170480|NCT00107978|38320278|FG000|Overall Study|Death|3|||
17170481|NCT00107978|38320279|FG001|Overall Study|Death|3|||
17170482|NCT00107978|38320278|FG000|Overall Study|Lost to Follow-up|20|||
17170483|NCT00107978|38320279|FG001|Overall Study|Lost to Follow-up|28|||
17170484|NCT00107978|38320278|FG000|Overall Study|Withdrawal by Subject|4|||
17170485|NCT00107978|38320279|FG001|Overall Study|Withdrawal by Subject|9|||
17170486|NCT00107978|38320278|FG000|Overall Study|Protocol Violation|0|||
17170487|NCT00107978|38320279|FG001|Overall Study|Protocol Violation|1|||
17170488|NCT00107978|38320278|FG000|Overall Study|Other|5|||
17170489|NCT00107978|38320279|FG001|Overall Study|Other|4|||
17086251|NCT00381680|38226759|FG000|Overall Study|Adverse Event|9|||
17086252|NCT00381680|38226760|FG001|Overall Study|Adverse Event|3|||
17086253|NCT00381680|38226759|FG000|Overall Study|Death|10|||
17086254|NCT00381680|38226760|FG001|Overall Study|Death|7|||
17086255|NCT00381680|38226759|FG000|Overall Study|Lost to Follow-up|3|||
17086256|NCT00381680|38226760|FG001|Overall Study|Lost to Follow-up|2|||
17086257|NCT00381680|38226759|FG000|Overall Study|Physician Decision|25|||
17086258|NCT00381680|38226760|FG001|Overall Study|Physician Decision|6|||
17086259|NCT00381680|38226759|FG000|Overall Study|Withdrawal by Subject|3|||
17170490|NCT02781818|38320288|FG000|Overall Study|Lost to Follow-up|4|||
17170491|NCT02781818|38320289|FG001|Overall Study|Lost to Follow-up|2|||
17170492|NCT02781818|38320290|FG002|Overall Study|Lost to Follow-up|1|||
17170493|NCT02927873|38320304|FG000|Overall Study|Lost to Follow-up|0|||
17170494|NCT02927873|38320305|FG001|Overall Study|Lost to Follow-up|1|||
17170495|NCT02927873|38320306|FG002|Overall Study|Lost to Follow-up|0|||
17170496|NCT02927873|38320307|FG003|Overall Study|Lost to Follow-up|0|||
17170497|NCT02927873|38320308|FG004|Overall Study|Lost to Follow-up|0|||
17170498|NCT02927873|38320309|FG005|Overall Study|Lost to Follow-up|0|||
17170499|NCT02927873|38320304|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
17170500|NCT02927873|38320305|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
17170501|NCT02927873|38320306|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
17170502|NCT02927873|38320307|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
17170503|NCT02927873|38320308|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
17170504|NCT02927873|38320309|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
17170505|NCT02927873|38320304|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17170506|NCT02927873|38320305|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17170507|NCT02927873|38320306|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17170508|NCT02927873|38320307|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17170509|NCT02927873|38320308|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17170510|NCT02927873|38320309|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
17170511|NCT02927873|38320304|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
17170512|NCT02927873|38320305|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
17170513|NCT02927873|38320306|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
17170514|NCT02927873|38320307|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
17170515|NCT02927873|38320308|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
17170516|NCT02927873|38320309|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
17170517|NCT02927873|38320304|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
17170518|NCT02927873|38320305|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
17170519|NCT02927873|38320306|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
17170520|NCT02927873|38320307|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
17170521|NCT02927873|38320308|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
17170522|NCT02927873|38320309|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
17170523|NCT02927873|38320304|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
17170524|NCT02927873|38320305|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
17170525|NCT02927873|38320306|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
17170526|NCT02927873|38320307|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
17170527|NCT02927873|38320308|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
17170528|NCT02927873|38320309|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
17170529|NCT01220999|38320328|FG000|Overall Study|Progressive disease|0|||
17170530|NCT01220999|38320329|FG001|Overall Study|Progressive disease|0|||
17170531|NCT01220999|38320330|FG002|Overall Study|Progressive disease|1|||
17170532|NCT01220999|38320331|FG003|Overall Study|Progressive disease|0|||
17170533|NCT01220999|38320332|FG004|Overall Study|Progressive disease|0|||
17170534|NCT00142415|38320350|FG000|Overall Study|Physician Decision|0|||
17170535|NCT00142415|38320351|FG001|Overall Study|Physician Decision|0|||
17170536|NCT00142415|38320352|FG002|Overall Study|Physician Decision|0|||
17170537|NCT00142415|38320353|FG003|Overall Study|Physician Decision|0|||
17170538|NCT00142415|38320354|FG004|Overall Study|Physician Decision|1|||
17170539|NCT00142415|38320355|FG005|Overall Study|Physician Decision|2|||
17170540|NCT02781584|38320397|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
17170541|NCT02781584|38320398|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
17170542|NCT02781584|38320399|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
17170543|NCT02781584|38320400|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
17170544|NCT02781584|38320401|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
17170545|NCT02781584|38320402|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
17170546|NCT02781584|38320403|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
17170547|NCT02781584|38320404|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
17170548|NCT02781584|38320405|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
17170549|NCT02781584|38320406|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
17170550|NCT02781584|38320407|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
17170551|NCT02781584|38320408|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
17170552|NCT02781584|38320409|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
17170553|NCT02781584|38320397|FG000|Pre-treatment Phase|Adverse Event|0|||
17170554|NCT02781584|38320398|FG001|Pre-treatment Phase|Adverse Event|0|||
17170555|NCT02781584|38320399|FG002|Pre-treatment Phase|Adverse Event|0|||
17170556|NCT02781584|38320400|FG003|Pre-treatment Phase|Adverse Event|0|||
17170557|NCT02781584|38320401|FG004|Pre-treatment Phase|Adverse Event|0|||
17170558|NCT02781584|38320402|FG005|Pre-treatment Phase|Adverse Event|0|||
17170559|NCT02781584|38320403|FG006|Pre-treatment Phase|Adverse Event|0|||
17170560|NCT02781584|38320404|FG007|Pre-treatment Phase|Adverse Event|0|||
17170561|NCT02781584|38320405|FG008|Pre-treatment Phase|Adverse Event|0|||
17170562|NCT02781584|38320406|FG009|Pre-treatment Phase|Adverse Event|0|||
17170563|NCT02781584|38320407|FG010|Pre-treatment Phase|Adverse Event|0|||
17170564|NCT02781584|38320408|FG011|Pre-treatment Phase|Adverse Event|1|||
17170565|NCT02781584|38320409|FG012|Pre-treatment Phase|Adverse Event|0|||
17170566|NCT02781584|38320397|FG000|Treatment Phase|Withdrew Consent|0|||
17170567|NCT02781584|38320398|FG001|Treatment Phase|Withdrew Consent|0|||
17086260|NCT00381680|38226760|FG001|Overall Study|Withdrawal by Subject|1|||
17086261|NCT00381680|38226759|FG000|Overall Study|Entry onto another COG Trial|1|||
17170568|NCT02781584|38320399|FG002|Treatment Phase|Withdrew Consent|0|||
17170569|NCT02781584|38320400|FG003|Treatment Phase|Withdrew Consent|0|||
17170570|NCT02781584|38320401|FG004|Treatment Phase|Withdrew Consent|0|||
17170571|NCT02781584|38320402|FG005|Treatment Phase|Withdrew Consent|1|||
17170572|NCT02781584|38320403|FG006|Treatment Phase|Withdrew Consent|0|||
17170573|NCT02781584|38320404|FG007|Treatment Phase|Withdrew Consent|0|||
17086262|NCT00381680|38226760|FG001|Overall Study|Entry onto another COG Trial|2|||
17086263|NCT00381680|38226759|FG000|Overall Study|Alternative Therapy|11|||
17086264|NCT00381680|38226760|FG001|Overall Study|Alternative Therapy|5|||
17086265|NCT00381680|38226759|FG000|Overall Study|Secondary Malignancy|3|||
17086266|NCT00381680|38226760|FG001|Overall Study|Secondary Malignancy|0|||
17086267|NCT00381680|38226759|FG000|Overall Study|Delay initiation|1|||
17086268|NCT00381680|38226760|FG001|Overall Study|Delay initiation|0|||
17086269|NCT00381680|38226759|FG000|Overall Study|Stem Cell Transplant|26|||
17086270|NCT00381680|38226760|FG001|Overall Study|Stem Cell Transplant|10|||
17086271|NCT00381680|38226759|FG000|Overall Study|Relapse|18|||
17086272|NCT00381680|38226760|FG001|Overall Study|Relapse|9|||
17086273|NCT00381680|38226759|FG000|Overall Study|Induction Failure|4|||
17086274|NCT00381680|38226760|FG001|Overall Study|Induction Failure|1|||
17086275|NCT00381680|38226759|FG000|Overall Study|Progression|1|||
17086276|NCT00381680|38226760|FG001|Overall Study|Progression|1|||
17086277|NCT00381680|38226759|FG000|Overall Study|Other not otherwise specified|7|||
17086278|NCT00381680|38226760|FG001|Overall Study|Other not otherwise specified|2|||
17086279|NCT00381680|38226759|FG000|Overall Study|Ineligible|3|||
17086280|NCT00381680|38226760|FG001|Overall Study|Ineligible|1|||
17086281|NCT00360698|38226772|FG000|Run-In|Physician Decision|0|||
17086282|NCT00360698|38226773|FG001|Run-In|Physician Decision|1|||
17086283|NCT00360698|38226772|FG000|Run-In|Withdrawal by Subject|0|||
17086284|NCT00360698|38226773|FG001|Run-In|Withdrawal by Subject|2|||
17170574|NCT02781584|38320405|FG008|Treatment Phase|Withdrew Consent|0|||
17170575|NCT02781584|38320406|FG009|Treatment Phase|Withdrew Consent|0|||
17170576|NCT02781584|38320407|FG010|Treatment Phase|Withdrew Consent|1|||
17170577|NCT02781584|38320408|FG011|Treatment Phase|Withdrew Consent|2|||
17170578|NCT02781584|38320409|FG012|Treatment Phase|Withdrew Consent|0|||
17170579|NCT02781584|38320397|FG000|Treatment Phase|Adverse Event|0|||
17170580|NCT02781584|38320398|FG001|Treatment Phase|Adverse Event|0|||
17170581|NCT02781584|38320399|FG002|Treatment Phase|Adverse Event|0|||
17170582|NCT02781584|38320400|FG003|Treatment Phase|Adverse Event|0|||
17170583|NCT02781584|38320401|FG004|Treatment Phase|Adverse Event|0|||
17170584|NCT02781584|38320402|FG005|Treatment Phase|Adverse Event|0|||
17170585|NCT02781584|38320403|FG006|Treatment Phase|Adverse Event|0|||
17170586|NCT02781584|38320404|FG007|Treatment Phase|Adverse Event|1|||
17170587|NCT02781584|38320405|FG008|Treatment Phase|Adverse Event|0|||
17170588|NCT02781584|38320406|FG009|Treatment Phase|Adverse Event|0|||
17170589|NCT02781584|38320407|FG010|Treatment Phase|Adverse Event|0|||
17170590|NCT02781584|38320408|FG011|Treatment Phase|Adverse Event|0|||
17170591|NCT02781584|38320409|FG012|Treatment Phase|Adverse Event|0|||
17170592|NCT02776670|38320439|FG000|Overall Study|Adverse Event|0|||
17170593|NCT02776670|38320440|FG001|Overall Study|Adverse Event|2|||
17170594|NCT02776670|38320439|FG000|Overall Study|Protocol Violation|0|||
17170595|NCT02776670|38320440|FG001|Overall Study|Protocol Violation|2|||
17170596|NCT02776670|38320439|FG000|Overall Study|Withdrawal by Subject|0|||
17170597|NCT02776670|38320440|FG001|Overall Study|Withdrawal by Subject|1|||
17170598|NCT02776670|38320439|FG000|Overall Study|Other - Reason not given|0|||
17170599|NCT02776670|38320440|FG001|Overall Study|Other - Reason not given|1|||
17170600|NCT01307423|38320449|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
17170601|NCT01307423|38320450|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
17170602|NCT01307423|38320451|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
17170603|NCT01307423|38320452|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
17170604|NCT01307423|38320453|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
17170605|NCT01307423|38320454|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
17170606|NCT01307423|38320455|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
17170607|NCT01307423|38320456|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
17170608|NCT01307423|38320457|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
17170609|NCT01307423|38320449|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
17170610|NCT01307423|38320450|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
17170611|NCT01307423|38320451|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
17170612|NCT01307423|38320452|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
17170613|NCT01307423|38320453|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
17170614|NCT01307423|38320454|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
17170615|NCT01307423|38320455|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
17170616|NCT01307423|38320456|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
17170617|NCT01307423|38320457|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
17170618|NCT01307423|38320449|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
17170619|NCT01307423|38320450|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
17170620|NCT01307423|38320451|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
17170621|NCT01307423|38320452|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
17170622|NCT01307423|38320453|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
17170623|NCT01307423|38320454|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
17170624|NCT01307423|38320455|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
17170625|NCT01307423|38320456|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
17170626|NCT01307423|38320457|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
17170627|NCT01307423|38320449|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
17170628|NCT01307423|38320450|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
17170629|NCT01307423|38320451|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
17170630|NCT01307423|38320452|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
17170631|NCT01307423|38320453|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
17170632|NCT01307423|38320454|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
17170633|NCT01307423|38320455|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
17170634|NCT01307423|38320456|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
17170635|NCT01307423|38320457|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
17170636|NCT01307423|38320449|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
17170637|NCT01307423|38320450|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
17170638|NCT01307423|38320451|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
17170639|NCT01307423|38320452|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
17170640|NCT01307423|38320453|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
17170641|NCT01307423|38320454|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
17170642|NCT01307423|38320455|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
17170643|NCT01307423|38320456|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
17170644|NCT01307423|38320457|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
17170645|NCT01307423|38320449|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
17170646|NCT01307423|38320450|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
17170647|NCT01307423|38320451|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
17170648|NCT01307423|38320452|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
17170649|NCT01307423|38320453|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
17170650|NCT01307423|38320454|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
17170651|NCT01307423|38320455|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
17170652|NCT01307423|38320456|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
17170653|NCT01307423|38320457|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
17170654|NCT01307423|38320449|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
17170655|NCT01307423|38320450|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
17170656|NCT01307423|38320451|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17170657|NCT01307423|38320452|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17170658|NCT01307423|38320453|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17170659|NCT01307423|38320454|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17170660|NCT01307423|38320455|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17170661|NCT01307423|38320456|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17170662|NCT01307423|38320457|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17170663|NCT01307423|38320449|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
17170664|NCT01307423|38320450|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
17170665|NCT01307423|38320451|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
17170666|NCT01307423|38320452|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
17170667|NCT01307423|38320453|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
17170668|NCT01307423|38320454|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
17170669|NCT01307423|38320455|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
17170670|NCT01307423|38320456|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
17170671|NCT01307423|38320457|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
17170672|NCT01307423|38320449|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
17170673|NCT01307423|38320450|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
17170674|NCT01307423|38320451|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
17170675|NCT01307423|38320452|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
17170676|NCT01307423|38320453|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
17170677|NCT01307423|38320454|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
17170678|NCT01307423|38320455|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
17170679|NCT01307423|38320456|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
17170680|NCT01307423|38320457|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
17170681|NCT01307423|38320449|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
17170682|NCT01307423|38320450|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
17170683|NCT01307423|38320451|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
17170684|NCT01307423|38320452|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
17170685|NCT01307423|38320453|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
17170686|NCT01307423|38320454|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
17170687|NCT01307423|38320455|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
17170688|NCT01307423|38320456|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
17170689|NCT01307423|38320457|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
17170690|NCT01307423|38320449|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
17170691|NCT01307423|38320450|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
17170692|NCT01307423|38320451|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
17170693|NCT01307423|38320452|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
17170694|NCT01307423|38320453|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
17170695|NCT01307423|38320454|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
17170696|NCT01307423|38320455|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
17170697|NCT01307423|38320456|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
17086285|NCT00360698|38226772|FG000|Run-In|Non compliance with treatment procedure|0|||
17086286|NCT00360698|38226773|FG001|Run-In|Non compliance with treatment procedure|1|||
17086287|NCT00360698|38226772|FG000|Run-In|Sponsor request|0|||
17086288|NCT00360698|38226773|FG001|Run-In|Sponsor request|2|||
17086289|NCT00360698|38226772|FG000|Run-In|Patient did not meet inclusion criteria|0|||
17086290|NCT00360698|38226773|FG001|Run-In|Patient did not meet inclusion criteria|1|||
17086291|NCT00360698|38226772|FG000|Run-In|Patient personal reasons|0|||
17086292|NCT00360698|38226773|FG001|Run-In|Patient personal reasons|2|||
17086293|NCT00360698|38226772|FG000|Run-In|Need of insulin with meals|0|||
17086294|NCT00360698|38226773|FG001|Run-In|Need of insulin with meals|1|||
17170698|NCT01307423|38320457|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
17170699|NCT01307423|38320449|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
17170700|NCT01307423|38320450|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
17170701|NCT01307423|38320451|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
17170702|NCT01307423|38320452|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
17170703|NCT01307423|38320453|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
17170704|NCT01307423|38320454|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
17170705|NCT01307423|38320455|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
17170706|NCT01307423|38320456|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
17170707|NCT01307423|38320457|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
17170708|NCT01307423|38320449|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
17170709|NCT01307423|38320450|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
17170710|NCT01307423|38320451|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
17170711|NCT01307423|38320452|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
17170712|NCT01307423|38320453|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
17170713|NCT01307423|38320454|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
17170714|NCT01307423|38320455|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
17170715|NCT01307423|38320456|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
17170716|NCT01307423|38320457|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
17170717|NCT01307423|38320449|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
17170718|NCT01307423|38320450|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
17170719|NCT01307423|38320451|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
17170720|NCT01307423|38320452|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
17170721|NCT01307423|38320453|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
17170722|NCT01307423|38320454|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
17170723|NCT01307423|38320455|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
17170724|NCT01307423|38320456|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
17170725|NCT01307423|38320457|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
17170726|NCT01307423|38320449|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
17086295|NCT00360698|38226772|FG000|Treatment Period|Non compliance with treatment procedure|1|||
17086296|NCT00360698|38226773|FG001|Treatment Period|Non compliance with treatment procedure|0|||
17170727|NCT01307423|38320450|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
17170728|NCT01307423|38320451|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
17170729|NCT01307423|38320452|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
17170730|NCT01307423|38320453|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
17170731|NCT01307423|38320454|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
17170732|NCT01307423|38320455|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
17170733|NCT01307423|38320456|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
17170734|NCT01307423|38320457|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
17170735|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
17170736|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
17170737|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
17170738|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
17170739|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
17170740|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
17170741|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
17170742|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
17170743|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
17170744|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
17170745|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
17170746|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
17170747|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
17170748|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
17170749|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
17170750|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
17170751|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
17170752|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
17170753|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
17170754|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
17170755|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
17086297|NCT00360698|38226772|FG000|Treatment Period|Early termination by error|0|||
17086298|NCT00360698|38226773|FG001|Treatment Period|Early termination by error|1|||
17086299|NCT00380978|38226781|FG000|Overall Study|Refused allocated intervention|0|||
17086300|NCT00380978|38226782|FG001|Overall Study|Refused allocated intervention|6|||
17086301|NCT00380978|38226781|FG000|Overall Study|Wrong study envelope|0|||
17086302|NCT00380978|38226782|FG001|Overall Study|Wrong study envelope|2|||
17170756|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
17170757|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
17170758|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
17170759|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
17170760|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
17170761|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
17170762|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
17170763|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
17170764|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
17170765|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
17170766|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
17170767|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
17170768|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
17170769|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
17170770|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
17170771|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
17170772|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
17170773|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
17170774|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
17170775|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
17170776|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
17170777|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
17170778|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
17170779|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
17170780|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
17170781|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
17170782|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
17170783|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
17170784|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
17170785|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
17170786|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
17170787|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
17170788|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
17170789|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
17170790|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
17170791|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
17170792|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
17170793|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
17170794|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
17170795|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
17170796|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
17170797|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
17170798|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
17170799|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
17170800|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
17086303|NCT00380978|38226781|FG000|Overall Study|Allocation prior to analgesia request|1|||
17086304|NCT00380978|38226782|FG001|Overall Study|Allocation prior to analgesia request|2|||
17086305|NCT00380978|38226781|FG000|Overall Study|Parous patient|1|||
17086306|NCT00380978|38226782|FG001|Overall Study|Parous patient|0|||
17086307|NCT00162123|38226796|FG000|Overall Study|Disease progression|27|||
17086308|NCT00162123|38226797|FG001|Overall Study|Disease progression|19|||
17086309|NCT00162123|38226798|FG002|Overall Study|Disease progression|10|||
17086310|NCT00162123|38226799|FG003|Overall Study|Disease progression|4|||
17086311|NCT00162123|38226800|FG004|Overall Study|Disease progression|8|||
17086312|NCT00162123|38226801|FG005|Overall Study|Disease progression|3|||
17086313|NCT00162123|38226802|FG006|Overall Study|Disease progression|1|||
17086314|NCT00162123|38226803|FG007|Overall Study|Disease progression|0|||
17086315|NCT00162123|38226796|FG000|Overall Study|Study drug toxicity|6|||
17086316|NCT00162123|38226797|FG001|Overall Study|Study drug toxicity|1|||
17086317|NCT00162123|38226798|FG002|Overall Study|Study drug toxicity|5|||
17086318|NCT00162123|38226799|FG003|Overall Study|Study drug toxicity|0|||
17086319|NCT00162123|38226800|FG004|Overall Study|Study drug toxicity|4|||
17086320|NCT00162123|38226801|FG005|Overall Study|Study drug toxicity|1|||
17086321|NCT00162123|38226802|FG006|Overall Study|Study drug toxicity|1|||
17086322|NCT00162123|38226803|FG007|Overall Study|Study drug toxicity|0|||
17086323|NCT00162123|38226796|FG000|Overall Study|Death|3|||
17086324|NCT00162123|38226797|FG001|Overall Study|Death|3|||
17086325|NCT00162123|38226798|FG002|Overall Study|Death|1|||
17086326|NCT00162123|38226799|FG003|Overall Study|Death|1|||
17086327|NCT00162123|38226800|FG004|Overall Study|Death|1|||
17170801|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
17170802|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
17170803|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
17170804|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
17170805|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
17170806|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
17170807|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
17170808|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
17170809|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
17170810|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
17086328|NCT00162123|38226801|FG005|Overall Study|Death|1|||
17086329|NCT00162123|38226802|FG006|Overall Study|Death|0|||
17086330|NCT00162123|38226803|FG007|Overall Study|Death|0|||
17086331|NCT00162123|38226796|FG000|Overall Study|Withdrawal by Subject|2|||
17086332|NCT00162123|38226797|FG001|Overall Study|Withdrawal by Subject|0|||
17086333|NCT00162123|38226798|FG002|Overall Study|Withdrawal by Subject|2|||
17086334|NCT00162123|38226799|FG003|Overall Study|Withdrawal by Subject|1|||
17086335|NCT00162123|38226800|FG004|Overall Study|Withdrawal by Subject|1|||
17086336|NCT00162123|38226801|FG005|Overall Study|Withdrawal by Subject|2|||
17086337|NCT00162123|38226802|FG006|Overall Study|Withdrawal by Subject|1|||
17170811|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
17170812|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
17170813|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
17170814|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
17170815|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
17170816|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
17170817|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
17170818|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
17170819|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
17170820|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
17170821|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
17170822|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
17170823|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
17170824|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
17170825|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
17170826|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
17170827|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
17170828|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
17170829|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
17170830|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
17170831|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
17170832|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
17170833|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
17170834|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
17086338|NCT00162123|38226803|FG007|Overall Study|Withdrawal by Subject|0|||
17086339|NCT00162123|38226796|FG000|Overall Study|Deterioration without progression|2|||
17086340|NCT00162123|38226797|FG001|Overall Study|Deterioration without progression|2|||
17086341|NCT00162123|38226798|FG002|Overall Study|Deterioration without progression|3|||
17086342|NCT00162123|38226799|FG003|Overall Study|Deterioration without progression|0|||
17086343|NCT00162123|38226800|FG004|Overall Study|Deterioration without progression|1|||
17086344|NCT00162123|38226801|FG005|Overall Study|Deterioration without progression|0|||
17086345|NCT00162123|38226802|FG006|Overall Study|Deterioration without progression|0|||
17086346|NCT00162123|38226803|FG007|Overall Study|Deterioration without progression|0|||
17086347|NCT00162123|38226796|FG000|Overall Study|Adverse Event|1|||
17086348|NCT00162123|38226797|FG001|Overall Study|Adverse Event|2|||
17086349|NCT00162123|38226798|FG002|Overall Study|Adverse Event|0|||
17086350|NCT00162123|38226799|FG003|Overall Study|Adverse Event|2|||
17086351|NCT00162123|38226800|FG004|Overall Study|Adverse Event|1|||
17086352|NCT00162123|38226801|FG005|Overall Study|Adverse Event|0|||
17086353|NCT00162123|38226802|FG006|Overall Study|Adverse Event|0|||
17086354|NCT00162123|38226803|FG007|Overall Study|Adverse Event|0|||
17086355|NCT00162123|38226796|FG000|Overall Study|Not specified (before treatment)|2|||
17086356|NCT00162123|38226797|FG001|Overall Study|Not specified (before treatment)|0|||
17086357|NCT00162123|38226798|FG002|Overall Study|Not specified (before treatment)|0|||
17086358|NCT00162123|38226799|FG003|Overall Study|Not specified (before treatment)|0|||
17086359|NCT00162123|38226800|FG004|Overall Study|Not specified (before treatment)|12|||
17086360|NCT00162123|38226801|FG005|Overall Study|Not specified (before treatment)|1|||
17086361|NCT00162123|38226802|FG006|Overall Study|Not specified (before treatment)|0|||
17086362|NCT00162123|38226803|FG007|Overall Study|Not specified (before treatment)|0|||
17086363|NCT00162123|38226796|FG000|Overall Study|Not specified (after start of treatment)|0|||
17170835|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
17170836|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
17170837|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
17170838|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
17170839|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
17170840|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
17170841|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
17170842|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
17170843|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
17170844|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
17170845|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
17170846|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
17170847|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
17170848|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
17170849|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
17170850|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
17170851|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
17170852|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
17170853|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
17170854|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
17170855|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
17170856|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
17170857|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
17170858|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
17170859|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
17170860|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
17170861|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
17170862|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
17170863|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
17170864|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
17170865|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
17170866|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
17170867|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
17170868|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
17170869|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
17170870|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
17170871|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
17170872|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
17170873|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
17170874|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
17170875|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
17170876|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
17170877|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
17170878|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
17170879|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
17170880|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
17170881|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
17170882|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
17170883|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
17170884|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
17170885|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
17170886|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
17170887|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
17170888|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
17170889|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
17170890|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
17170891|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
17170892|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
17170893|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
17170894|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
17170895|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
17170896|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
17170897|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
17170898|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
17170899|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
17170900|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
17170901|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
17170902|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
17170903|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
17170904|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
17170905|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
17170906|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
17170907|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
17170908|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
17170909|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
17170910|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
17170911|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
17170912|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
17170913|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
17170914|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
17170915|NCT01307423|38320449|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
17170916|NCT01307423|38320450|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
17170917|NCT01307423|38320451|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
17170918|NCT01307423|38320452|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
17170919|NCT01307423|38320453|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
17170920|NCT01307423|38320454|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
17170921|NCT01307423|38320455|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
17170922|NCT01307423|38320456|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
17170923|NCT01307423|38320457|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
17170924|NCT02778074|38320491|FG000|Overall Study|Lost to Follow-up|7|||
17170925|NCT02778074|38320492|FG001|Overall Study|Lost to Follow-up|10|||
17170926|NCT02768792|38320507|FG000|Overall Study|Adverse Event|1|||
17170927|NCT02775344|38320513|FG000|Overall Study|No ovarian cyst identified|3|||
17170928|NCT02775344|38320514|FG001|Overall Study|No ovarian cyst identified|2|||
17170929|NCT02777918|38320522|FG000|Overall Study|Medical reasons|1|||
17170930|NCT02777918|38320523|FG001|Overall Study|Medical reasons|2|||
17170931|NCT02777918|38320522|FG000|Overall Study|Too busy / stressed|1|||
17170932|NCT02777918|38320523|FG001|Overall Study|Too busy / stressed|1|||
17170933|NCT02777918|38320522|FG000|Overall Study|Withdrawal by Subject|1|||
17170934|NCT02777918|38320523|FG001|Overall Study|Withdrawal by Subject|1|||
17170935|NCT02927795|38320529|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
17170936|NCT02927795|38320529|FG000|Overall Study|Not Treated|4|||
17170937|NCT02767856|38320535|FG000|Overall Study|Lost to Follow-up|9|||
17170938|NCT02767856|38320536|FG001|Overall Study|Lost to Follow-up|1|||
17170939|NCT02767856|38320535|FG000|Overall Study|Withdrawal by Subject|2|||
17170940|NCT02767856|38320536|FG001|Overall Study|Withdrawal by Subject|1|||
17170941|NCT03087851|38320545|FG000|Overall Study|Withdraw on medical grounds|0|||
17170942|NCT03087851|38320546|FG001|Overall Study|Withdraw on medical grounds|1|||
17170943|NCT03087851|38320547|FG002|Overall Study|Withdraw on medical grounds|2|||
17170944|NCT03092375|38320559|FG000|Overall Study|Lack of Efficacy|0|||
17170945|NCT03092375|38320560|FG001|Overall Study|Lack of Efficacy|1|||
17170946|NCT03092375|38320561|FG002|Overall Study|Lack of Efficacy|1|||
17170947|NCT03092375|38320562|FG003|Overall Study|Lack of Efficacy|0|||
17170948|NCT01995513|38320579|FG000|Open Label Treatment Period|Other|9|||
17170949|NCT01995513|38320580|FG001|Open Label Treatment Period|Other|0|||
17170950|NCT01995513|38320581|FG002|Open Label Treatment Period|Other|0|||
17170951|NCT01995513|38320579|FG000|Open Label Treatment Period|Withdrawal by Subject|14|||
17170952|NCT01995513|38320580|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
17170953|NCT01995513|38320581|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
17170954|NCT01995513|38320579|FG000|Open Label Treatment Period|Protocol Violation|1|||
17170955|NCT01995513|38320580|FG001|Open Label Treatment Period|Protocol Violation|0|||
17170956|NCT01995513|38320581|FG002|Open Label Treatment Period|Protocol Violation|0|||
17170957|NCT01995513|38320579|FG000|Open Label Treatment Period|Disease Progression|64|||
17170958|NCT01995513|38320580|FG001|Open Label Treatment Period|Disease Progression|0|||
17170959|NCT01995513|38320581|FG002|Open Label Treatment Period|Disease Progression|0|||
17170960|NCT01995513|38320579|FG000|Open Label Treatment Period|No PSA response at week 13|43|||
17170961|NCT01995513|38320580|FG001|Open Label Treatment Period|No PSA response at week 13|0|||
17170962|NCT01995513|38320581|FG002|Open Label Treatment Period|No PSA response at week 13|0|||
17170963|NCT01995513|38320579|FG000|Open Label Treatment Period|Adverse Event|35|||
17170964|NCT01995513|38320580|FG001|Open Label Treatment Period|Adverse Event|0|||
17170965|NCT01995513|38320581|FG002|Open Label Treatment Period|Adverse Event|0|||
17170966|NCT01995513|38320579|FG000|Open Label Treatment Period|Death|8|||
17170967|NCT01995513|38320580|FG001|Open Label Treatment Period|Death|0|||
17170968|NCT01995513|38320581|FG002|Open Label Treatment Period|Death|0|||
17170969|NCT01995513|38320579|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84|||
17170970|NCT01995513|38320580|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
17170971|NCT01995513|38320581|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
17170972|NCT01995513|38320579|FG000|Double Blind Treatment Period|Adverse Event|0|||
17170973|NCT01995513|38320580|FG001|Double Blind Treatment Period|Adverse Event|12|||
17170974|NCT01995513|38320581|FG002|Double Blind Treatment Period|Adverse Event|5|||
17170975|NCT01995513|38320579|FG000|Double Blind Treatment Period|Other|0|||
17170976|NCT01995513|38320580|FG001|Double Blind Treatment Period|Other|1|||
17170977|NCT01995513|38320581|FG002|Double Blind Treatment Period|Other|2|||
17170978|NCT01995513|38320579|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
17170979|NCT01995513|38320580|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
17170980|NCT01995513|38320581|FG002|Double Blind Treatment Period|Withdrawal by Subject|6|||
17170981|NCT01995513|38320579|FG000|Double Blind Treatment Period|Death|0|||
17170982|NCT01995513|38320580|FG001|Double Blind Treatment Period|Death|0|||
17170983|NCT01995513|38320581|FG002|Double Blind Treatment Period|Death|1|||
17170984|NCT01995513|38320579|FG000|Double Blind Treatment Period|Disease Progression|0|||
17170985|NCT01995513|38320580|FG001|Double Blind Treatment Period|Disease Progression|82|||
17170986|NCT01995513|38320581|FG002|Double Blind Treatment Period|Disease Progression|93|||
17170987|NCT01995513|38320579|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
17170988|NCT01995513|38320580|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27|||
17170989|NCT01995513|38320581|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18|||
17170990|NCT02927171|38320593|FG000|Overall Study|Lost to Follow-up|0|||
17170991|NCT02927171|38320594|FG001|Overall Study|Lost to Follow-up|1|||
17170992|NCT03035409|38320600|FG000|Overall Study|Adverse Event|5|||
17170993|NCT03035409|38320600|FG000|Overall Study|Death|2|||
17170994|NCT03035409|38320600|FG000|Overall Study|Withdrawal by Subject|2|||
17170995|NCT03035409|38320600|FG000|Overall Study|Non compliance|4|||
17170996|NCT03035409|38320600|FG000|Overall Study|Patient was jittery|1|||
17170997|NCT03035409|38320600|FG000|Overall Study|Did not like Questionnaire|1|||
17170998|NCT03035409|38320600|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
17170999|NCT03035409|38320600|FG000|Overall Study|Did not like taking drugs|1|||
17171000|NCT03087617|38320608|FG000|Overall Study|Lost to Follow-up|32|||
17171001|NCT03087617|38320609|FG001|Overall Study|Lost to Follow-up|30|||
17171002|NCT03087617|38320610|FG002|Overall Study|Lost to Follow-up|30|||
17171003|NCT03087617|38320611|FG003|Overall Study|Lost to Follow-up|39|||
17171004|NCT00103610|38320623|FG000|Overall Study|Entered Rescue Procedure|10|||
17171005|NCT00103610|38320624|FG001|Overall Study|Entered Rescue Procedure|52|||
17171006|NCT00103610|38320623|FG000|Overall Study|Death|16|||
17171007|NCT00103610|38320624|FG001|Overall Study|Death|12|||
17171008|NCT00103610|38320623|FG000|Overall Study|Elective Withdrawal|4|||
17171009|NCT00103610|38320624|FG001|Overall Study|Elective Withdrawal|0|||
17171010|NCT00103610|38320623|FG000|Overall Study|Lost to Follow-up|3|||
17171011|NCT00103610|38320624|FG001|Overall Study|Lost to Follow-up|1|||
17171012|NCT00103610|38320623|FG000|Overall Study|Adverse Event|2|||
17171013|NCT00103610|38320624|FG001|Overall Study|Adverse Event|2|||
17171014|NCT00103610|38320623|FG000|Overall Study|Other|2|||
17171015|NCT00103610|38320624|FG001|Overall Study|Other|7|||
17171016|NCT00103610|38320623|FG000|Overall Study|Failed mobilization|1|||
17171017|NCT00103610|38320624|FG001|Overall Study|Failed mobilization|5|||
17171018|NCT00103610|38320623|FG000|Overall Study|Noncompliance|0|||
17171019|NCT00103610|38320624|FG001|Overall Study|Noncompliance|1|||
17171020|NCT03091439|38320633|FG000|Overall Study|Study Terminated by the Sponsor|1|||
17171021|NCT03091439|38320634|FG001|Overall Study|Study Terminated by the Sponsor|0|||
17171022|NCT03086447|38320642|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
17171023|NCT03086447|38320643|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
17171024|NCT03086447|38320642|FG000|Overall Study|Lost Lens|2|||
17171025|NCT03086447|38320643|FG001|Overall Study|Lost Lens|5|||
17171026|NCT03086447|38320642|FG000|Overall Study|Product quality complaint|0|||
17171027|NCT03086447|38320643|FG001|Overall Study|Product quality complaint|1|||
17171028|NCT03086447|38320642|FG000|Overall Study|Lens Damage|1|||
17171029|NCT03086447|38320643|FG001|Overall Study|Lens Damage|6|||
17171030|NCT03086447|38320642|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
17171031|NCT03086447|38320643|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
17171032|NCT03086447|38320642|FG000|Overall Study|Test Article No Longer Available|1|||
17171033|NCT03086447|38320643|FG001|Overall Study|Test Article No Longer Available|0|||
17171034|NCT03086447|38320642|FG000|Overall Study|Protocol Violation|2|||
17171035|NCT03086447|38320643|FG001|Overall Study|Protocol Violation|4|||
17171036|NCT03086447|38320642|FG000|Overall Study|Lost to Follow-up|0|||
17171037|NCT03086447|38320643|FG001|Overall Study|Lost to Follow-up|1|||
17171038|NCT03086447|38320642|FG000|Overall Study|Adverse Event|3|||
17171039|NCT03086447|38320643|FG001|Overall Study|Adverse Event|0|||
17171040|NCT03086447|38320642|FG000|Overall Study|Lens Discomfort|2|||
17171041|NCT03086447|38320643|FG001|Overall Study|Lens Discomfort|1|||
17171042|NCT03083639|38320674|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
17171043|NCT03083639|38320675|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
17171044|NCT03083639|38320674|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
17171045|NCT03083639|38320675|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
17171046|NCT02927431|38320684|FG000|Overall Study|Withdrawal by Subject|0|||
17171047|NCT02927431|38320685|FG001|Overall Study|Withdrawal by Subject|0|||
17171048|NCT02927431|38320686|FG002|Overall Study|Withdrawal by Subject|1|||
17171049|NCT03083483|38320699|FG000|Overall Study|Adverse Event|1|||
17171050|NCT03083483|38320700|FG001|Overall Study|Adverse Event|1|||
17171051|NCT03083483|38320701|FG002|Overall Study|Adverse Event|1|||
17171052|NCT03083483|38320699|FG000|Overall Study|Lost to Follow-up|2|||
17171053|NCT03083483|38320700|FG001|Overall Study|Lost to Follow-up|1|||
17171054|NCT03083483|38320701|FG002|Overall Study|Lost to Follow-up|1|||
17171055|NCT03083483|38320699|FG000|Overall Study|technological issues|1|||
17171056|NCT03083483|38320700|FG001|Overall Study|technological issues|0|||
17171057|NCT03083483|38320701|FG002|Overall Study|technological issues|1|||
17171058|NCT03085927|38320713|FG000|Overall Study|Withdrawal by Subject|1|||
17171059|NCT03085927|38320714|FG001|Overall Study|Withdrawal by Subject|4|||
17171060|NCT03085927|38320713|FG000|Overall Study|Lost to Follow-up|3|||
17171061|NCT03085927|38320714|FG001|Overall Study|Lost to Follow-up|1|||
17171062|NCT03085927|38320713|FG000|Overall Study|Death|1|||
17171063|NCT03085927|38320714|FG001|Overall Study|Death|0|||
17171064|NCT03085927|38320713|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
17171065|NCT03085927|38320714|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
17171066|NCT03085927|38320713|FG000|Overall Study|Dyad Became Ineligible|0|||
17171067|NCT03085927|38320714|FG001|Overall Study|Dyad Became Ineligible|1|||
17171068|NCT04392583|38320722|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
17171069|NCT04497987|38320728|FG000|Overall Study|Adverse Event|1|||
17171070|NCT04497987|38320729|FG001|Overall Study|Adverse Event|0|||
17171071|NCT04497987|38320728|FG000|Overall Study|Death|21|||
17171072|NCT04497987|38320729|FG001|Overall Study|Death|13|||
17171073|NCT04497987|38320728|FG000|Overall Study|Lost to Follow-up|19|||
17171074|NCT04497987|38320729|FG001|Overall Study|Lost to Follow-up|17|||
17171075|NCT04497987|38320728|FG000|Overall Study|Other - as reported by the investigator|22|||
17171076|NCT04497987|38320729|FG001|Overall Study|Other - as reported by the investigator|16|||
17171077|NCT04497987|38320728|FG000|Overall Study|Physician Decision|1|||
17171078|NCT04497987|38320729|FG001|Overall Study|Physician Decision|0|||
17171079|NCT04497987|38320728|FG000|Overall Study|Withdrawal by Subject|35|||
17171080|NCT04497987|38320729|FG001|Overall Study|Withdrawal by Subject|21|||
17171081|NCT00974571|38320739|FG000|Overall Study|Adverse Event|31|||
17171082|NCT00974571|38320740|FG001|Overall Study|Adverse Event|4|||
17171083|NCT00974571|38320741|FG002|Overall Study|Adverse Event|27|||
17171084|NCT00974571|38320739|FG000|Overall Study|Lack of Efficacy|3|||
17171085|NCT00974571|38320740|FG001|Overall Study|Lack of Efficacy|2|||
17171086|NCT00974571|38320741|FG002|Overall Study|Lack of Efficacy|9|||
17171087|NCT00974571|38320739|FG000|Overall Study|Lost to Follow-up|2|||
17171088|NCT00974571|38320740|FG001|Overall Study|Lost to Follow-up|1|||
17171089|NCT00974571|38320741|FG002|Overall Study|Lost to Follow-up|2|||
17171090|NCT00974571|38320739|FG000|Overall Study|Protocol Violation|13|||
17171091|NCT00974571|38320740|FG001|Overall Study|Protocol Violation|4|||
17171092|NCT00974571|38320741|FG002|Overall Study|Protocol Violation|18|||
17171093|NCT00974571|38320739|FG000|Overall Study|Withdrawal by Subject|14|||
17171094|NCT00974571|38320740|FG001|Overall Study|Withdrawal by Subject|5|||
17171095|NCT00974571|38320741|FG002|Overall Study|Withdrawal by Subject|16|||
17171096|NCT00974571|38320739|FG000|Overall Study|Patient Moved|1|||
17171097|NCT00974571|38320740|FG001|Overall Study|Patient Moved|0|||
17171098|NCT00974571|38320741|FG002|Overall Study|Patient Moved|1|||
17171099|NCT00974571|38320739|FG000|Overall Study|Other|4|||
17171100|NCT00974571|38320740|FG001|Overall Study|Other|0|||
17171101|NCT00974571|38320741|FG002|Overall Study|Other|10|||
17171102|NCT02766608|38320754|FG000|Overall Study|Adverse Event|27|||
17171103|NCT02766608|38320755|FG001|Overall Study|Adverse Event|22|||
17171104|NCT02766608|38320756|FG002|Overall Study|Adverse Event|17|||
17171105|NCT02766608|38320757|FG003|Overall Study|Adverse Event|13|||
17171106|NCT02766608|38320758|FG004|Overall Study|Adverse Event|12|||
17171107|NCT02766608|38320754|FG000|Overall Study|Withdrawal by Subject|21|||
17171108|NCT02766608|38320755|FG001|Overall Study|Withdrawal by Subject|20|||
17171109|NCT02766608|38320756|FG002|Overall Study|Withdrawal by Subject|24|||
17171110|NCT02766608|38320757|FG003|Overall Study|Withdrawal by Subject|13|||
17171111|NCT02766608|38320758|FG004|Overall Study|Withdrawal by Subject|10|||
17171112|NCT02766608|38320754|FG000|Overall Study|Lack of Efficacy|16|||
17171113|NCT02766608|38320755|FG001|Overall Study|Lack of Efficacy|15|||
17171114|NCT02766608|38320756|FG002|Overall Study|Lack of Efficacy|32|||
17171115|NCT02766608|38320757|FG003|Overall Study|Lack of Efficacy|8|||
17171116|NCT02766608|38320758|FG004|Overall Study|Lack of Efficacy|2|||
17171117|NCT02766608|38320754|FG000|Overall Study|Lost to Follow-up|6|||
17171118|NCT02766608|38320755|FG001|Overall Study|Lost to Follow-up|3|||
17171119|NCT02766608|38320756|FG002|Overall Study|Lost to Follow-up|5|||
17171120|NCT02766608|38320757|FG003|Overall Study|Lost to Follow-up|2|||
17171121|NCT02766608|38320758|FG004|Overall Study|Lost to Follow-up|2|||
17171122|NCT02766608|38320754|FG000|Overall Study|Physician Decision|3|||
17171123|NCT02766608|38320755|FG001|Overall Study|Physician Decision|2|||
17171124|NCT02766608|38320756|FG002|Overall Study|Physician Decision|3|||
17171125|NCT02766608|38320757|FG003|Overall Study|Physician Decision|1|||
17171126|NCT02766608|38320758|FG004|Overall Study|Physician Decision|2|||
17171127|NCT02766608|38320754|FG000|Overall Study|Protocol disc criteria|3|||
17171128|NCT02766608|38320755|FG001|Overall Study|Protocol disc criteria|3|||
17171129|NCT02766608|38320756|FG002|Overall Study|Protocol disc criteria|4|||
17171130|NCT02766608|38320757|FG003|Overall Study|Protocol disc criteria|0|||
17171131|NCT02766608|38320758|FG004|Overall Study|Protocol disc criteria|0|||
17171132|NCT02766608|38320754|FG000|Overall Study|Protocol Violation|0|||
17171133|NCT02766608|38320755|FG001|Overall Study|Protocol Violation|4|||
17171134|NCT02766608|38320756|FG002|Overall Study|Protocol Violation|4|||
17171135|NCT02766608|38320757|FG003|Overall Study|Protocol Violation|0|||
17171136|NCT02766608|38320758|FG004|Overall Study|Protocol Violation|1|||
17171137|NCT02766608|38320754|FG000|Overall Study|Administrative Reasons|3|||
17171138|NCT02766608|38320755|FG001|Overall Study|Administrative Reasons|1|||
17171139|NCT02766608|38320756|FG002|Overall Study|Administrative Reasons|1|||
17171140|NCT02766608|38320757|FG003|Overall Study|Administrative Reasons|0|||
17171141|NCT02766608|38320758|FG004|Overall Study|Administrative Reasons|0|||
17171142|NCT00960141|38320776|FG000|Overall Study|Adverse Event|4|||
17171143|NCT00960141|38320777|FG001|Overall Study|Adverse Event|8|||
17171144|NCT00960141|38320778|FG002|Overall Study|Adverse Event|2|||
17171145|NCT00960141|38320776|FG000|Overall Study|Lack of Efficacy|3|||
17171146|NCT00960141|38320777|FG001|Overall Study|Lack of Efficacy|4|||
17171147|NCT00960141|38320778|FG002|Overall Study|Lack of Efficacy|2|||
17171148|NCT00960141|38320776|FG000|Overall Study|Lost to Follow-up|1|||
17171149|NCT00960141|38320777|FG001|Overall Study|Lost to Follow-up|0|||
17171150|NCT00960141|38320778|FG002|Overall Study|Lost to Follow-up|0|||
17171151|NCT00960141|38320776|FG000|Overall Study|Protocol Violation|1|||
17171152|NCT00960141|38320777|FG001|Overall Study|Protocol Violation|3|||
17171153|NCT00960141|38320778|FG002|Overall Study|Protocol Violation|2|||
17171154|NCT00960141|38320776|FG000|Overall Study|Withdrawal by Subject|1|||
17171155|NCT00960141|38320777|FG001|Overall Study|Withdrawal by Subject|2|||
17171156|NCT00960141|38320778|FG002|Overall Study|Withdrawal by Subject|1|||
17171157|NCT02771522|38320786|FG000|Overall Study|Lost to Follow-up|3|||
17171158|NCT02771522|38320786|FG000|Overall Study|Withdrawal by Subject|2|||
17171159|NCT02771522|38320786|FG000|Overall Study|No white spot lesions|3|||
17171160|NCT00759655|38320795|FG000|Overall Study|Termination of the study by sponsor|1|||
17171161|NCT02771366|38320801|FG000|Period 1|Withdrawal by Subject|0|||
17171162|NCT02771366|38320802|FG001|Period 1|Withdrawal by Subject|2|||
17171163|NCT02771366|38320801|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
17171164|NCT02771366|38320802|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
17171165|NCT03396471|38320809|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
17171166|NCT03396471|38320809|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
17171167|NCT03396471|38320809|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
17171168|NCT03396471|38320809|FG000|Study Treatment - Up to 22 Months|Death|2|||
17171169|NCT03396471|38320809|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
17171170|NCT03396471|38320809|FG000|Follow up - Up to 2 Years|Death|9|||
17171171|NCT03396471|38320809|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
17171172|NCT03396471|38320809|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
17171173|NCT03396471|38320809|FG000|Follow up - Up to 2 Years|study terminated|1|||
17171174|NCT03396471|38320809|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
17171175|NCT03396471|38320809|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
17171176|NCT00103142|38320815|FG000|Overall Study|Adverse Event|1|||
17171177|NCT00103142|38320816|FG001|Overall Study|Adverse Event|0|||
17171178|NCT00103142|38320815|FG000|Overall Study|Progression of disease|2|||
17171179|NCT00103142|38320816|FG001|Overall Study|Progression of disease|1|||
17171180|NCT00943683|38320826|FG000|Overall Study|Adverse Event|3|||
17171181|NCT00943683|38320827|FG001|Overall Study|Adverse Event|3|||
17171182|NCT00943683|38320826|FG000|Overall Study|Lost to Follow-up|1|||
17171183|NCT00943683|38320827|FG001|Overall Study|Lost to Follow-up|1|||
17086364|NCT00162123|38226797|FG001|Overall Study|Not specified (after start of treatment)|0|||
17086365|NCT00162123|38226798|FG002|Overall Study|Not specified (after start of treatment)|0|||
17086366|NCT00162123|38226799|FG003|Overall Study|Not specified (after start of treatment)|0|||
17086367|NCT00162123|38226800|FG004|Overall Study|Not specified (after start of treatment)|3|||
17086368|NCT00162123|38226801|FG005|Overall Study|Not specified (after start of treatment)|0|||
17086369|NCT00162123|38226802|FG006|Overall Study|Not specified (after start of treatment)|0|||
17086370|NCT00162123|38226803|FG007|Overall Study|Not specified (after start of treatment)|0|||
17171184|NCT00943683|38320826|FG000|Overall Study|Protocol Violation|1|||
17171185|NCT00943683|38320827|FG001|Overall Study|Protocol Violation|2|||
17171186|NCT00943683|38320826|FG000|Overall Study|Withdrawal by Subject|1|||
17171187|NCT00943683|38320827|FG001|Overall Study|Withdrawal by Subject|0|||
17171188|NCT00943683|38320826|FG000|Overall Study|Patient Moved|1|||
17171189|NCT00943683|38320827|FG001|Overall Study|Patient Moved|0|||
17171190|NCT00911547|38320837|FG000|Overall Study|Adverse Event|8|||
17171191|NCT00911547|38320838|FG001|Overall Study|Adverse Event|27|||
17171192|NCT00911547|38320839|FG002|Overall Study|Adverse Event|11|||
17171193|NCT00911547|38320840|FG003|Overall Study|Adverse Event|6|||
17171194|NCT00911547|38320837|FG000|Overall Study|Lost to Follow-up|0|||
17171195|NCT00911547|38320838|FG001|Overall Study|Lost to Follow-up|0|||
17171196|NCT00911547|38320839|FG002|Overall Study|Lost to Follow-up|2|||
17086371|NCT00162123|38226796|FG000|Overall Study|Physician Decision|1|||
17086372|NCT00162123|38226797|FG001|Overall Study|Physician Decision|2|||
17086373|NCT00162123|38226798|FG002|Overall Study|Physician Decision|0|||
17086374|NCT00162123|38226799|FG003|Overall Study|Physician Decision|0|||
17086375|NCT00162123|38226800|FG004|Overall Study|Physician Decision|0|||
17171197|NCT00911547|38320840|FG003|Overall Study|Lost to Follow-up|1|||
17171198|NCT00911547|38320837|FG000|Overall Study|Protocol Violation|0|||
17171199|NCT00911547|38320838|FG001|Overall Study|Protocol Violation|5|||
17171200|NCT00911547|38320839|FG002|Overall Study|Protocol Violation|5|||
17171201|NCT00911547|38320840|FG003|Overall Study|Protocol Violation|1|||
17171202|NCT00911547|38320837|FG000|Overall Study|Withdrawal by Subject|3|||
17171203|NCT00911547|38320838|FG001|Overall Study|Withdrawal by Subject|10|||
17171204|NCT00911547|38320839|FG002|Overall Study|Withdrawal by Subject|4|||
17171205|NCT00911547|38320840|FG003|Overall Study|Withdrawal by Subject|8|||
17171206|NCT00899379|38320855|FG000|Overall Study|Adverse Event|2|||
17171207|NCT00899379|38320856|FG001|Overall Study|Adverse Event|2|||
17171208|NCT00899379|38320857|FG002|Overall Study|Adverse Event|1|||
17171209|NCT00899379|38320858|FG003|Overall Study|Adverse Event|1|||
17171210|NCT00899379|38320859|FG004|Overall Study|Adverse Event|2|||
17171211|NCT00899379|38320855|FG000|Overall Study|Lack of Efficacy|0|||
17171212|NCT00899379|38320856|FG001|Overall Study|Lack of Efficacy|4|||
17171213|NCT00899379|38320857|FG002|Overall Study|Lack of Efficacy|3|||
17171214|NCT00899379|38320858|FG003|Overall Study|Lack of Efficacy|0|||
17171215|NCT00899379|38320859|FG004|Overall Study|Lack of Efficacy|1|||
17171216|NCT00899379|38320855|FG000|Overall Study|Lost to Follow-up|9|||
17171217|NCT00899379|38320856|FG001|Overall Study|Lost to Follow-up|3|||
17171218|NCT00899379|38320857|FG002|Overall Study|Lost to Follow-up|0|||
17171219|NCT00899379|38320858|FG003|Overall Study|Lost to Follow-up|6|||
17171220|NCT00899379|38320859|FG004|Overall Study|Lost to Follow-up|2|||
17171221|NCT00899379|38320855|FG000|Overall Study|Protocol Violation|0|||
17171222|NCT00899379|38320856|FG001|Overall Study|Protocol Violation|0|||
17171223|NCT00899379|38320857|FG002|Overall Study|Protocol Violation|1|||
17171224|NCT00899379|38320858|FG003|Overall Study|Protocol Violation|1|||
16996546|NCT00753454|38140668|FG000|Overall Study|Investigator Decision|1|||
16996547|NCT00976274|38140674|FG000|Overall Study|Lost to Follow-up|5|||
16996548|NCT00976274|38140675|FG001|Overall Study|Lost to Follow-up|5|||
16996549|NCT00976274|38140674|FG000|Overall Study|Withdrawal by Subject|1|||
16996550|NCT00976274|38140675|FG001|Overall Study|Withdrawal by Subject|1|||
16996551|NCT00976274|38140674|FG000|Overall Study|Physician Decision|1|||
16996552|NCT00976274|38140675|FG001|Overall Study|Physician Decision|2|||
16996553|NCT00759148|38140683|FG000|Overall Study|Adverse Event|1|||
16996554|NCT00759148|38140684|FG001|Overall Study|Adverse Event|6|||
16996555|NCT00759148|38140683|FG000|Overall Study|Withdrawal by Subject|3|||
16996556|NCT00759148|38140684|FG001|Overall Study|Withdrawal by Subject|7|||
16996557|NCT00759148|38140683|FG000|Overall Study|Lost to Follow-up|3|||
16996558|NCT00759148|38140684|FG001|Overall Study|Lost to Follow-up|9|||
16996559|NCT00759148|38140683|FG000|Overall Study|Treatment Failure|6|||
16996560|NCT00759148|38140684|FG001|Overall Study|Treatment Failure|10|||
16996561|NCT00759148|38140683|FG000|Overall Study|Reason not given|1|||
16996562|NCT00759148|38140684|FG001|Overall Study|Reason not given|0|||
16996563|NCT02794285|38140694|FG000|Overall Study|Adverse Event|11|||
16996564|NCT02794285|38140695|FG001|Overall Study|Adverse Event|4|||
16996565|NCT02794285|38140696|FG002|Overall Study|Adverse Event|5|||
16996566|NCT02794285|38140697|FG003|Overall Study|Adverse Event|8|||
16996567|NCT02794285|38140694|FG000|Overall Study|Condition Under Investigation Improved|1|||
16996568|NCT02794285|38140695|FG001|Overall Study|Condition Under Investigation Improved|0|||
16996569|NCT02794285|38140696|FG002|Overall Study|Condition Under Investigation Improved|0|||
16996570|NCT02794285|38140697|FG003|Overall Study|Condition Under Investigation Improved|0|||
16996571|NCT02794285|38140694|FG000|Overall Study|Condition Under Investigation Worsened|0|||
16996572|NCT02794285|38140695|FG001|Overall Study|Condition Under Investigation Worsened|2|||
16996573|NCT02794285|38140696|FG002|Overall Study|Condition Under Investigation Worsened|1|||
16996574|NCT02794285|38140697|FG003|Overall Study|Condition Under Investigation Worsened|0|||
16996575|NCT02794285|38140694|FG000|Overall Study|Death|2|||
16996576|NCT02794285|38140695|FG001|Overall Study|Death|1|||
16996577|NCT02794285|38140696|FG002|Overall Study|Death|2|||
16996578|NCT02794285|38140697|FG003|Overall Study|Death|0|||
16996579|NCT02794285|38140694|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
16996580|NCT02794285|38140695|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
16996581|NCT02794285|38140696|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
16996582|NCT02794285|38140697|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
16996583|NCT02794285|38140694|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
16996584|NCT02794285|38140695|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
16996585|NCT02794285|38140696|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
16996586|NCT02794285|38140697|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
16996587|NCT02794285|38140694|FG000|Overall Study|Lack of Efficacy|10|||
16996588|NCT02794285|38140695|FG001|Overall Study|Lack of Efficacy|6|||
16996589|NCT02794285|38140696|FG002|Overall Study|Lack of Efficacy|3|||
16996590|NCT02794285|38140697|FG003|Overall Study|Lack of Efficacy|3|||
16996591|NCT02794285|38140694|FG000|Overall Study|Lost to Follow-up|5|||
16996592|NCT02794285|38140695|FG001|Overall Study|Lost to Follow-up|6|||
16996593|NCT02794285|38140696|FG002|Overall Study|Lost to Follow-up|3|||
17171225|NCT00899379|38320859|FG004|Overall Study|Protocol Violation|0|||
17086376|NCT00162123|38226801|FG005|Overall Study|Physician Decision|1|||
17086377|NCT00162123|38226802|FG006|Overall Study|Physician Decision|1|||
17086378|NCT00162123|38226803|FG007|Overall Study|Physician Decision|0|||
17086379|NCT00162123|38226796|FG000|Overall Study|Tumor assessment only (not treated)|0|||
17086380|NCT00162123|38226797|FG001|Overall Study|Tumor assessment only (not treated)|0|||
17086381|NCT00162123|38226798|FG002|Overall Study|Tumor assessment only (not treated)|0|||
17086382|NCT00162123|38226799|FG003|Overall Study|Tumor assessment only (not treated)|0|||
17086383|NCT00162123|38226800|FG004|Overall Study|Tumor assessment only (not treated)|0|||
17086384|NCT00162123|38226801|FG005|Overall Study|Tumor assessment only (not treated)|0|||
17086385|NCT00162123|38226802|FG006|Overall Study|Tumor assessment only (not treated)|0|||
17086386|NCT00162123|38226803|FG007|Overall Study|Tumor assessment only (not treated)|1|||
17086387|NCT00162123|38226796|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
17086388|NCT00162123|38226797|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
17086389|NCT00162123|38226798|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
16996594|NCT02794285|38140697|FG003|Overall Study|Lost to Follow-up|1|||
17171226|NCT00899379|38320855|FG000|Overall Study|Withdrawal by Subject|2|||
17171227|NCT00899379|38320856|FG001|Overall Study|Withdrawal by Subject|4|||
17171228|NCT00899379|38320857|FG002|Overall Study|Withdrawal by Subject|2|||
17171229|NCT00899379|38320858|FG003|Overall Study|Withdrawal by Subject|3|||
17171230|NCT00899379|38320859|FG004|Overall Study|Withdrawal by Subject|6|||
17171231|NCT00899379|38320855|FG000|Overall Study|Pregnancy|0|||
17171232|NCT00899379|38320856|FG001|Overall Study|Pregnancy|0|||
17171233|NCT00899379|38320857|FG002|Overall Study|Pregnancy|1|||
17171234|NCT00899379|38320858|FG003|Overall Study|Pregnancy|0|||
17171235|NCT00899379|38320859|FG004|Overall Study|Pregnancy|1|||
17171236|NCT00899379|38320855|FG000|Overall Study|Patient Uncooperative|0|||
17171237|NCT00899379|38320856|FG001|Overall Study|Patient Uncooperative|1|||
17171238|NCT00899379|38320857|FG002|Overall Study|Patient Uncooperative|0|||
17171239|NCT00899379|38320858|FG003|Overall Study|Patient Uncooperative|1|||
17171240|NCT00899379|38320859|FG004|Overall Study|Patient Uncooperative|2|||
17171241|NCT00899379|38320855|FG000|Overall Study|Abnormal Baseline ECG|0|||
17086390|NCT00162123|38226799|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
17086391|NCT00162123|38226800|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
17086392|NCT00162123|38226801|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
17086393|NCT00162123|38226802|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
17086394|NCT00162123|38226803|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
17086395|NCT00227721|38226822|FG000|Overall Study|On study, but never treated.|1|||
17086396|NCT00226941|38226830|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
17086397|NCT00226941|38226831|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
17086398|NCT00226941|38226832|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
17086399|NCT00226941|38226833|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
17086400|NCT00226941|38226830|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
17086401|NCT00226941|38226831|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
17171242|NCT00899379|38320856|FG001|Overall Study|Abnormal Baseline ECG|0|||
17086402|NCT00226941|38226832|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
17086403|NCT00226941|38226833|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
17086404|NCT00356408|38226853|FG000|Overall Study|Adverse Event|9|||
17086405|NCT00356408|38226853|FG000|Overall Study|Lack of Efficacy|36|||
16996595|NCT02794285|38140694|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
16996596|NCT02794285|38140695|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
16996597|NCT02794285|38140696|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
16996598|NCT02794285|38140697|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
16996599|NCT02794285|38140694|FG000|Overall Study|Withdrawal by Subject|38|||
16996600|NCT02794285|38140695|FG001|Overall Study|Withdrawal by Subject|29|||
16996601|NCT02794285|38140696|FG002|Overall Study|Withdrawal by Subject|20|||
16996602|NCT02794285|38140697|FG003|Overall Study|Withdrawal by Subject|12|||
16996603|NCT02794285|38140694|FG000|Overall Study|Missing|1|||
16996604|NCT02794285|38140695|FG001|Overall Study|Missing|0|||
16996605|NCT02794285|38140696|FG002|Overall Study|Missing|0|||
16996606|NCT02794285|38140697|FG003|Overall Study|Missing|0|||
16996607|NCT02794285|38140694|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
17086406|NCT00356408|38226853|FG000|Overall Study|Lost to Follow-up|2|||
17086407|NCT00356408|38226853|FG000|Overall Study|Withdrawal by Subject|6|||
17086408|NCT00356408|38226853|FG000|Overall Study|Other: Principal investigator discretion|3|||
17086409|NCT00356408|38226853|FG000|Overall Study|Other: Sponsor request|1|||
17086410|NCT00356408|38226853|FG000|Overall Study|Other: Azathioprine stopped|1|||
17086411|NCT00356408|38226853|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
17086412|NCT00356408|38226853|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
17086413|NCT00509795|38226868|FG000|Overall Study|Adverse Event|4|||
17086414|NCT00509795|38226869|FG001|Overall Study|Adverse Event|3|||
17086415|NCT00509795|38226870|FG002|Overall Study|Adverse Event|5|||
17086416|NCT00509795|38226871|FG003|Overall Study|Adverse Event|4|||
17086417|NCT00509795|38226868|FG000|Overall Study|Death|3|||
17086418|NCT00509795|38226869|FG001|Overall Study|Death|1|||
17086419|NCT00509795|38226870|FG002|Overall Study|Death|2|||
17086420|NCT00509795|38226871|FG003|Overall Study|Death|7|||
17086421|NCT00509795|38226868|FG000|Overall Study|Lack of Efficacy|0|||
17086422|NCT00509795|38226869|FG001|Overall Study|Lack of Efficacy|0|||
16996608|NCT02794285|38140695|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
16996609|NCT02794285|38140696|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
17086423|NCT00509795|38226870|FG002|Overall Study|Lack of Efficacy|2|||
17086424|NCT00509795|38226871|FG003|Overall Study|Lack of Efficacy|2|||
17086425|NCT00509795|38226868|FG000|Overall Study|Lost to Follow-up|1|||
17086426|NCT00509795|38226869|FG001|Overall Study|Lost to Follow-up|2|||
17086427|NCT00509795|38226870|FG002|Overall Study|Lost to Follow-up|4|||
17086428|NCT00509795|38226871|FG003|Overall Study|Lost to Follow-up|4|||
17086429|NCT00509795|38226868|FG000|Overall Study|OTHER|1|||
17086430|NCT00509795|38226869|FG001|Overall Study|OTHER|0|||
17086431|NCT00509795|38226870|FG002|Overall Study|OTHER|4|||
17086432|NCT00509795|38226871|FG003|Overall Study|OTHER|1|||
17086433|NCT00509795|38226868|FG000|Overall Study|Protocol Violation|3|||
17171243|NCT00899379|38320857|FG002|Overall Study|Abnormal Baseline ECG|0|||
17171244|NCT00899379|38320858|FG003|Overall Study|Abnormal Baseline ECG|1|||
17171245|NCT00899379|38320859|FG004|Overall Study|Abnormal Baseline ECG|0|||
17171246|NCT00899379|38320855|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
17171247|NCT00899379|38320856|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
17171248|NCT00899379|38320857|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
17171249|NCT00899379|38320858|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
17171250|NCT00899379|38320859|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
17171251|NCT00899379|38320855|FG000|Overall Study|Not Completed/Entered Extn|5|||
17171252|NCT00899379|38320856|FG001|Overall Study|Not Completed/Entered Extn|1|||
17171253|NCT00899379|38320857|FG002|Overall Study|Not Completed/Entered Extn|6|||
17171254|NCT00899379|38320858|FG003|Overall Study|Not Completed/Entered Extn|4|||
17171255|NCT00899379|38320859|FG004|Overall Study|Not Completed/Entered Extn|3|||
17171256|NCT00899379|38320855|FG000|Overall Study|Study Terminated|3|||
17171257|NCT00899379|38320856|FG001|Overall Study|Study Terminated|0|||
17171258|NCT00899379|38320857|FG002|Overall Study|Study Terminated|3|||
17171259|NCT00899379|38320858|FG003|Overall Study|Study Terminated|3|||
17171260|NCT00899379|38320859|FG004|Overall Study|Study Terminated|1|||
16996610|NCT02794285|38140697|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
16996611|NCT02794285|38140694|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
16996612|NCT02794285|38140695|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
16996613|NCT02794285|38140696|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
16996614|NCT02794285|38140697|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
16996615|NCT00970268|38140709|FG000|Overall Study|Withdrawal by Subject|12|||
16996616|NCT00970268|38140710|FG001|Overall Study|Withdrawal by Subject|19|||
16996617|NCT00970268|38140709|FG000|Overall Study|Adverse Event|15|||
16996618|NCT00970268|38140710|FG001|Overall Study|Adverse Event|12|||
16996619|NCT00970268|38140709|FG000|Overall Study|Lack of Efficacy|3|||
16996620|NCT00970268|38140710|FG001|Overall Study|Lack of Efficacy|6|||
16996621|NCT00970268|38140709|FG000|Overall Study|Protocol Violation|4|||
16996622|NCT00970268|38140710|FG001|Overall Study|Protocol Violation|7|||
16996623|NCT00970268|38140709|FG000|Overall Study|Other Reason|3|||
16996624|NCT00970268|38140710|FG001|Overall Study|Other Reason|1|||
17086434|NCT00509795|38226869|FG001|Overall Study|Protocol Violation|0|||
17171261|NCT00899379|38320855|FG000|Overall Study|Lost to Follow-up|3|||
17171262|NCT00899379|38320856|FG001|Overall Study|Lost to Follow-up|1|||
17171263|NCT00899379|38320857|FG002|Overall Study|Lost to Follow-up|0|||
17171264|NCT00899379|38320858|FG003|Overall Study|Lost to Follow-up|2|||
17171265|NCT00899379|38320859|FG004|Overall Study|Lost to Follow-up|5|||
17171266|NCT00899379|38320855|FG000|Overall Study|Withdrawal by Subject|4|||
17171267|NCT00899379|38320856|FG001|Overall Study|Withdrawal by Subject|7|||
17171268|NCT00899379|38320857|FG002|Overall Study|Withdrawal by Subject|4|||
17171269|NCT00899379|38320858|FG003|Overall Study|Withdrawal by Subject|7|||
17171270|NCT00899379|38320859|FG004|Overall Study|Withdrawal by Subject|2|||
17171271|NCT00899379|38320855|FG000|Overall Study|Pregnancy|1|||
17171272|NCT00899379|38320856|FG001|Overall Study|Pregnancy|0|||
17171273|NCT00899379|38320857|FG002|Overall Study|Pregnancy|0|||
17171274|NCT00899379|38320858|FG003|Overall Study|Pregnancy|0|||
17171275|NCT00899379|38320859|FG004|Overall Study|Pregnancy|0|||
17171276|NCT00899379|38320855|FG000|Overall Study|Patient Uncooperative|0|||
17171277|NCT00899379|38320856|FG001|Overall Study|Patient Uncooperative|0|||
17171278|NCT00899379|38320857|FG002|Overall Study|Patient Uncooperative|0|||
17171279|NCT00899379|38320858|FG003|Overall Study|Patient Uncooperative|1|||
17171280|NCT00899379|38320859|FG004|Overall Study|Patient Uncooperative|0|||
17171281|NCT00899379|38320855|FG000|Overall Study|Abnormal Prestudy Labs|0|||
17171282|NCT00899379|38320856|FG001|Overall Study|Abnormal Prestudy Labs|0|||
17171283|NCT00899379|38320857|FG002|Overall Study|Abnormal Prestudy Labs|0|||
17171284|NCT00899379|38320858|FG003|Overall Study|Abnormal Prestudy Labs|0|||
17171285|NCT00899379|38320859|FG004|Overall Study|Abnormal Prestudy Labs|2|||
17171286|NCT00899379|38320855|FG000|Overall Study|Abnormal Baseline ECG|0|||
17171287|NCT00899379|38320856|FG001|Overall Study|Abnormal Baseline ECG|0|||
17171288|NCT00899379|38320857|FG002|Overall Study|Abnormal Baseline ECG|1|||
17171289|NCT00899379|38320858|FG003|Overall Study|Abnormal Baseline ECG|1|||
17171290|NCT00899379|38320859|FG004|Overall Study|Abnormal Baseline ECG|0|||
17171291|NCT00899379|38320855|FG000|Overall Study|No Attack Pretreatment|3|||
17171292|NCT00899379|38320856|FG001|Overall Study|No Attack Pretreatment|5|||
17171293|NCT00899379|38320857|FG002|Overall Study|No Attack Pretreatment|5|||
17171294|NCT00899379|38320858|FG003|Overall Study|No Attack Pretreatment|6|||
17171295|NCT00899379|38320859|FG004|Overall Study|No Attack Pretreatment|4|||
17086435|NCT00509795|38226870|FG002|Overall Study|Protocol Violation|3|||
17086436|NCT00509795|38226871|FG003|Overall Study|Protocol Violation|1|||
17086437|NCT00509795|38226868|FG000|Overall Study|Withdrawal by Subject|10|||
17086438|NCT00509795|38226869|FG001|Overall Study|Withdrawal by Subject|5|||
17086439|NCT00509795|38226870|FG002|Overall Study|Withdrawal by Subject|7|||
17086440|NCT00509795|38226871|FG003|Overall Study|Withdrawal by Subject|8|||
17086441|NCT00165789|38226886|FG000|Overall Study|Adverse Event|0|||
17086442|NCT00165789|38226887|FG001|Overall Study|Adverse Event|3|||
17086443|NCT00165789|38226888|FG002|Overall Study|Adverse Event|0|||
17086444|NCT00165789|38226889|FG003|Overall Study|Adverse Event|12|||
17086445|NCT00165789|38226886|FG000|Overall Study|Withdrawal by Subject|0|||
17086446|NCT00165789|38226887|FG001|Overall Study|Withdrawal by Subject|1|||
17086447|NCT00165789|38226888|FG002|Overall Study|Withdrawal by Subject|1|||
17086448|NCT00165789|38226889|FG003|Overall Study|Withdrawal by Subject|2|||
17086449|NCT00504257|38226899|FG000|Overall Study|Withdrawal by Subject|2|||
17086450|NCT00504257|38226899|FG000|Overall Study|ineligible histology|2|||
17086451|NCT00509093|38226903|FG000|Overall Study|Adverse Event|10|||
17171296|NCT00899379|38320855|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
17171297|NCT00899379|38320856|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
17171298|NCT00899379|38320857|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
17171299|NCT00899379|38320858|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
17171300|NCT00899379|38320859|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
17171301|NCT00899379|38320855|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
17171302|NCT00899379|38320856|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
17171303|NCT00899379|38320857|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
17171304|NCT00899379|38320858|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
17171305|NCT00899379|38320859|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
17171306|NCT04326439|38320867|FG000|Overall Study|Withdrawal by Subject|1|||
17171307|NCT04326439|38320868|FG001|Overall Study|Withdrawal by Subject|0|||
17171308|NCT04326439|38320867|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
17171309|NCT04326439|38320868|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
17171310|NCT04326439|38320867|FG000|Overall Study|Relapse after Induction 2|0|||
17171311|NCT04326439|38320868|FG001|Overall Study|Relapse after Induction 2|1|||
17171312|NCT04326439|38320867|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
17171313|NCT04326439|38320868|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
17171314|NCT00145795|38320882|FG000|Overall Study|Adverse Event|1|||
17171315|NCT00145795|38320883|FG001|Overall Study|Adverse Event|0|||
17171316|NCT02771210|38320891|FG000|Period 1|Adverse Event|5|||
17086452|NCT00509093|38226903|FG000|Overall Study|Disease Progression|9|||
17086453|NCT00509093|38226903|FG000|Overall Study|Transformed into MDS|1|||
17086454|NCT00509093|38226903|FG000|Overall Study|Withdrawal by Subject|3|||
17171317|NCT02771210|38320892|FG001|Period 1|Adverse Event|3|||
17171318|NCT02771210|38320891|FG000|Period 1|Lack of Efficacy|3|||
17171319|NCT02771210|38320892|FG001|Period 1|Lack of Efficacy|6|||
17171320|NCT02771210|38320891|FG000|Period 1|Lost to Follow-up|2|||
17171321|NCT02771210|38320892|FG001|Period 1|Lost to Follow-up|0|||
17171322|NCT02771210|38320891|FG000|Period 1|Physician Decision|0|||
17171323|NCT02771210|38320892|FG001|Period 1|Physician Decision|1|||
17171324|NCT02771210|38320891|FG000|Period 1|Withdrawal by Subject|0|||
17171325|NCT02771210|38320892|FG001|Period 1|Withdrawal by Subject|3|||
17171326|NCT02771210|38320891|FG000|Period 1|Withdrawal of informed consent|1|||
17171327|NCT02771210|38320892|FG001|Period 1|Withdrawal of informed consent|5|||
17171328|NCT02771210|38320891|FG000|Period 2|Adverse Event|1|||
17171329|NCT02771210|38320892|FG001|Period 2|Adverse Event|0|||
17171330|NCT02771210|38320891|FG000|Period 2|Lack of Efficacy|0|||
17171331|NCT02771210|38320892|FG001|Period 2|Lack of Efficacy|1|||
17171332|NCT02771210|38320891|FG000|Period 2|Withdrawal by Subject|1|||
17171333|NCT02771210|38320892|FG001|Period 2|Withdrawal by Subject|0|||
17171334|NCT02771210|38320891|FG000|Period 2|Withdrawal of informed consent|0|||
17171335|NCT02771210|38320892|FG001|Period 2|Withdrawal of informed consent|2|||
17171336|NCT00898677|38320902|FG000|Overall Study|Adverse Event|0|||
17171337|NCT00898677|38320903|FG001|Overall Study|Adverse Event|0|||
17171338|NCT00898677|38320904|FG002|Overall Study|Adverse Event|1|||
17171339|NCT00898677|38320905|FG003|Overall Study|Adverse Event|0|||
17171340|NCT00898677|38320902|FG000|Overall Study|Lost to Follow-up|0|||
17171341|NCT00898677|38320903|FG001|Overall Study|Lost to Follow-up|0|||
17171342|NCT00898677|38320904|FG002|Overall Study|Lost to Follow-up|2|||
17171343|NCT00898677|38320905|FG003|Overall Study|Lost to Follow-up|0|||
17171344|NCT00898677|38320902|FG000|Overall Study|Protocol Violation|1|||
17171345|NCT00898677|38320903|FG001|Overall Study|Protocol Violation|1|||
17171346|NCT00898677|38320904|FG002|Overall Study|Protocol Violation|2|||
17171347|NCT00898677|38320905|FG003|Overall Study|Protocol Violation|0|||
17171348|NCT00898677|38320902|FG000|Overall Study|Withdrawal by Subject|0|||
17171349|NCT00898677|38320903|FG001|Overall Study|Withdrawal by Subject|0|||
17171350|NCT00898677|38320904|FG002|Overall Study|Withdrawal by Subject|0|||
17171351|NCT00898677|38320905|FG003|Overall Study|Withdrawal by Subject|1|||
17171352|NCT00898677|38320902|FG000|Overall Study|Not Treated: Adverse Event|0|||
17171353|NCT00898677|38320903|FG001|Overall Study|Not Treated: Adverse Event|2|||
17171354|NCT00898677|38320904|FG002|Overall Study|Not Treated: Adverse Event|1|||
17171355|NCT00898677|38320905|FG003|Overall Study|Not Treated: Adverse Event|0|||
17171356|NCT00898677|38320902|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
17171357|NCT00898677|38320903|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
17171358|NCT00898677|38320904|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
17171359|NCT00898677|38320905|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
17171360|NCT00898677|38320902|FG000|Overall Study|Not Treated: Pregnancy|0|||
17171361|NCT00898677|38320903|FG001|Overall Study|Not Treated: Pregnancy|0|||
17171362|NCT00898677|38320904|FG002|Overall Study|Not Treated: Pregnancy|1|||
17171363|NCT00898677|38320905|FG003|Overall Study|Not Treated: Pregnancy|0|||
17171364|NCT00898677|38320902|FG000|Overall Study|Not Treated: Protocol Violation|2|||
17171365|NCT00898677|38320903|FG001|Overall Study|Not Treated: Protocol Violation|0|||
17171366|NCT00898677|38320904|FG002|Overall Study|Not Treated: Protocol Violation|2|||
17171367|NCT00898677|38320905|FG003|Overall Study|Not Treated: Protocol Violation|0|||
17171368|NCT00898677|38320902|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
17171369|NCT00898677|38320903|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
17171370|NCT00898677|38320904|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
17171371|NCT00898677|38320905|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
17171372|NCT00898677|38320902|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
17171373|NCT00898677|38320903|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
17171374|NCT00898677|38320904|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
17171375|NCT00898677|38320905|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
17171376|NCT00898677|38320902|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
17171377|NCT00898677|38320903|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
17171378|NCT00898677|38320904|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
17171379|NCT00898677|38320905|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
17171380|NCT00898677|38320902|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
17171381|NCT00898677|38320903|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
17171382|NCT00898677|38320904|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
17171383|NCT00898677|38320905|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
17171384|NCT00898677|38320902|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
17171385|NCT00898677|38320903|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
17171386|NCT00898677|38320904|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
17171387|NCT00898677|38320905|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
17171388|NCT00898677|38320902|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
17171389|NCT00898677|38320903|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
17171390|NCT00898677|38320904|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
17171391|NCT00898677|38320905|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
17171392|NCT00898677|38320902|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
17171393|NCT00898677|38320903|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
17171394|NCT00898677|38320904|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
17171395|NCT00898677|38320905|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
17171396|NCT02770820|38320915|FG000|Overall Study|Death|1|||
17171397|NCT02770820|38320915|FG000|Overall Study|Physician Decision|2|||
17171398|NCT03082729|38320919|FG000|Overall Study|Lost to Follow-up|7|||
17171399|NCT03082729|38320919|FG000|Overall Study|Physician Decision|2|||
17171400|NCT03082729|38320919|FG000|Overall Study|Withdrawal by Subject|1|||
17171401|NCT03082729|38320919|FG000|Overall Study|Lack of Efficacy|9|||
17171402|NCT03082729|38320919|FG000|Overall Study|Adverse Event|4|||
17171403|NCT03082729|38320919|FG000|Overall Study|Protocol Violation|6|||
17171404|NCT03082729|38320919|FG000|Overall Study|Fear of study procedure|1|||
17171405|NCT03082729|38320919|FG000|Overall Study|Scheduling conflict|1|||
17171406|NCT02764190|38320931|FG000|Overall Study|Lost to Follow-up|17|||
17171407|NCT02764190|38320932|FG001|Overall Study|Lost to Follow-up|13|||
17171408|NCT03077659|38320941|FG000|Overall Study|Withdrawal by Subject|0|||
17171409|NCT03077659|38320942|FG001|Overall Study|Withdrawal by Subject|0|||
17171410|NCT03077659|38320943|FG002|Overall Study|Withdrawal by Subject|1|||
17171411|NCT02807883|38320954|FG000|Overall Study|Withdrawal by Subject|2|||
17171412|NCT03082261|38320958|FG000|Overall Study|Death|4|||
17171413|NCT03082261|38320958|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
17171414|NCT03082261|38320958|FG000|Overall Study|Insurance denial|1|||
17171415|NCT03082261|38320958|FG000|Overall Study|Peripheral lead added|1|||
17171416|NCT03082261|38320958|FG000|Overall Study|Withdrawal by Subject|40|||
17171417|NCT03082261|38320958|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
17171418|NCT03082261|38320958|FG000|Overall Study|Subject implanted with device other than study device|1|||
17171419|NCT03082261|38320958|FG000|Overall Study|Lost to Follow-up|14|||
17171420|NCT03082261|38320958|FG000|Overall Study|Subject moved to a different state|1|||
17171421|NCT03082261|38320958|FG000|Overall Study|Subject non-compliance|2|||
17171422|NCT03082261|38320958|FG000|Overall Study|Subject participation terminated by investigator|9|||
17171423|NCT03082261|38320958|FG000|Overall Study|Subject participation terminated by sponsor|4|||
17171424|NCT03082261|38320958|FG000|Overall Study|System explant|19|||
17171425|NCT03082261|38320958|FG000|Overall Study|Unable to place lead(s)|2|||
17171426|NCT03082261|38320958|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
17171427|NCT00102440|38320965|FG000|Overall Study|Lost to Follow-up|25|||
17086455|NCT00509093|38226903|FG000|Overall Study|Physician Decision|1|||
17086456|NCT00160641|38226907|FG000|Overall Study|Adverse Event|102|||
17171428|NCT00102440|38320966|FG001|Overall Study|Lost to Follow-up|18|||
17171429|NCT00102440|38320967|FG002|Overall Study|Lost to Follow-up|21|||
17171430|NCT00102440|38320965|FG000|Overall Study|Adverse Event|16|||
17171431|NCT00102440|38320966|FG001|Overall Study|Adverse Event|23|||
17171432|NCT00102440|38320967|FG002|Overall Study|Adverse Event|8|||
17171433|NCT00102440|38320965|FG000|Overall Study|Gout Flare|10|||
17171434|NCT00102440|38320966|FG001|Overall Study|Gout Flare|28|||
17171435|NCT00102440|38320967|FG002|Overall Study|Gout Flare|9|||
17171436|NCT00102440|38320965|FG000|Overall Study|Personal Reason(s)|19|||
17171437|NCT00102440|38320966|FG001|Overall Study|Personal Reason(s)|13|||
17171438|NCT00102440|38320967|FG002|Overall Study|Personal Reason(s)|13|||
17171439|NCT00102440|38320965|FG000|Overall Study|Other|11|||
17171440|NCT00102440|38320966|FG001|Overall Study|Other|14|||
17171441|NCT00102440|38320967|FG002|Overall Study|Other|14|||
17171442|NCT00102440|38320965|FG000|Overall Study|Protocol Violation|7|||
17171443|NCT00102440|38320966|FG001|Overall Study|Protocol Violation|2|||
17171444|NCT00102440|38320967|FG002|Overall Study|Protocol Violation|1|||
17171445|NCT02762084|38320991|FG000|Overall Study|Withdrawal by Subject|1|||
17171446|NCT02762084|38320992|FG001|Overall Study|Withdrawal by Subject|0|||
17171447|NCT02762084|38320993|FG002|Overall Study|Withdrawal by Subject|0|||
16996625|NCT00970268|38140709|FG000|Overall Study|COPD Exacerbation|4|||
17086457|NCT00160641|38226907|FG000|Overall Study|Withdrawal by Subject|87|||
17086458|NCT00160641|38226907|FG000|Overall Study|Lost to Follow-up|8|||
17086459|NCT00160641|38226907|FG000|Overall Study|Lack of Efficacy|12|||
17086460|NCT00160641|38226907|FG000|Overall Study|Protocol Violation|3|||
17086461|NCT00160641|38226907|FG000|Overall Study|Other|9|||
17086462|NCT00493025|38226911|FG000|Overall Study|Physician Decision|19|||
17086463|NCT00160563|38226919|FG000|Overall Study|Adverse Event|1|||
17086464|NCT00160563|38226920|FG001|Overall Study|Adverse Event|1|||
17086465|NCT00160563|38226921|FG002|Overall Study|Adverse Event|1|||
17086466|NCT00160563|38226919|FG000|Overall Study|Lost to Follow-up|1|||
17086467|NCT00160563|38226920|FG001|Overall Study|Lost to Follow-up|1|||
17086468|NCT00160563|38226921|FG002|Overall Study|Lost to Follow-up|2|||
17086469|NCT00160563|38226919|FG000|Overall Study|Protocol Violation|0|||
17086470|NCT00160563|38226920|FG001|Overall Study|Protocol Violation|0|||
17086471|NCT00160563|38226921|FG002|Overall Study|Protocol Violation|3|||
17086472|NCT00160563|38226919|FG000|Overall Study|Withdrawal by Subject|1|||
17086473|NCT00160563|38226920|FG001|Overall Study|Withdrawal by Subject|2|||
17086474|NCT00160563|38226921|FG002|Overall Study|Withdrawal by Subject|3|||
17086475|NCT00160563|38226919|FG000|Overall Study|Other (listed in the study report)|48|||
17171448|NCT02762084|38320991|FG000|Overall Study|Adverse Event|0|||
17171449|NCT02762084|38320992|FG001|Overall Study|Adverse Event|0|||
17171450|NCT02762084|38320993|FG002|Overall Study|Adverse Event|1|||
17171451|NCT02763644|38321005|FG000|Overall Study|Patient/guardian decision|1|||
17171452|NCT02763644|38321006|FG001|Overall Study|Patient/guardian decision|0|||
17171453|NCT02763644|38321005|FG000|Overall Study|Death|1|||
17171454|NCT02763644|38321006|FG001|Overall Study|Death|1|||
17171455|NCT02763644|38321005|FG000|Overall Study|Adverse Event|1|||
17171456|NCT02763644|38321006|FG001|Overall Study|Adverse Event|1|||
17171457|NCT04576455|38321016|FG000|Overall Study|Ongoing in the Study|122|||
17171458|NCT04576455|38321017|FG001|Overall Study|Ongoing in the Study|135|||
17171459|NCT04576455|38321016|FG000|Overall Study|Death|18|||
17171460|NCT04576455|38321017|FG001|Overall Study|Death|12|||
17171461|NCT04576455|38321016|FG000|Overall Study|Lost to Follow-up|1|||
17171462|NCT04576455|38321017|FG001|Overall Study|Lost to Follow-up|0|||
17171463|NCT04576455|38321016|FG000|Overall Study|Withdrawal by Subject|10|||
17171464|NCT04576455|38321017|FG001|Overall Study|Withdrawal by Subject|5|||
17171465|NCT02807844|38321034|FG000|Overall Study|Physician Decision|0|||
17171466|NCT02807844|38321035|FG001|Overall Study|Physician Decision|0|||
17171467|NCT02807844|38321036|FG002|Overall Study|Physician Decision|0|||
17171468|NCT02807844|38321037|FG003|Overall Study|Physician Decision|0|||
17171469|NCT02807844|38321038|FG004|Overall Study|Physician Decision|0|||
17171470|NCT02807844|38321039|FG005|Overall Study|Physician Decision|0|||
17171471|NCT02807844|38321040|FG006|Overall Study|Physician Decision|3|||
17171472|NCT02807844|38321041|FG007|Overall Study|Physician Decision|0|||
17171473|NCT02807844|38321042|FG008|Overall Study|Physician Decision|1|||
17171474|NCT02807844|38321043|FG009|Overall Study|Physician Decision|2|||
17171475|NCT02807844|38321034|FG000|Overall Study|Death|0|||
17171476|NCT02807844|38321035|FG001|Overall Study|Death|0|||
17171477|NCT02807844|38321036|FG002|Overall Study|Death|2|||
17171478|NCT02807844|38321037|FG003|Overall Study|Death|4|||
17171479|NCT02807844|38321038|FG004|Overall Study|Death|1|||
17171480|NCT02807844|38321039|FG005|Overall Study|Death|2|||
17171481|NCT02807844|38321040|FG006|Overall Study|Death|1|||
17171482|NCT02807844|38321041|FG007|Overall Study|Death|2|||
17171483|NCT02807844|38321042|FG008|Overall Study|Death|0|||
17171484|NCT02807844|38321043|FG009|Overall Study|Death|1|||
17171485|NCT02807844|38321034|FG000|Overall Study|Withdrawal by Subject|0|||
17171486|NCT02807844|38321035|FG001|Overall Study|Withdrawal by Subject|0|||
17171487|NCT02807844|38321036|FG002|Overall Study|Withdrawal by Subject|2|||
17171488|NCT02807844|38321037|FG003|Overall Study|Withdrawal by Subject|1|||
17171489|NCT02807844|38321038|FG004|Overall Study|Withdrawal by Subject|1|||
17171490|NCT02807844|38321039|FG005|Overall Study|Withdrawal by Subject|0|||
17171491|NCT02807844|38321040|FG006|Overall Study|Withdrawal by Subject|1|||
17171492|NCT02807844|38321041|FG007|Overall Study|Withdrawal by Subject|0|||
17171493|NCT02807844|38321042|FG008|Overall Study|Withdrawal by Subject|0|||
17171494|NCT02807844|38321043|FG009|Overall Study|Withdrawal by Subject|0|||
17171495|NCT02807844|38321034|FG000|Overall Study|Progressive disease|5|||
17171496|NCT02807844|38321035|FG001|Overall Study|Progressive disease|12|||
17171497|NCT02807844|38321036|FG002|Overall Study|Progressive disease|8|||
17171498|NCT02807844|38321037|FG003|Overall Study|Progressive disease|8|||
17171499|NCT02807844|38321038|FG004|Overall Study|Progressive disease|3|||
17171500|NCT02807844|38321039|FG005|Overall Study|Progressive disease|8|||
17171501|NCT02807844|38321040|FG006|Overall Study|Progressive disease|14|||
17171502|NCT02807844|38321041|FG007|Overall Study|Progressive disease|17|||
17171503|NCT02807844|38321042|FG008|Overall Study|Progressive disease|19|||
17171504|NCT02807844|38321043|FG009|Overall Study|Progressive disease|15|||
17171505|NCT02807844|38321034|FG000|Overall Study|Adverse Event|1|||
17171506|NCT02807844|38321035|FG001|Overall Study|Adverse Event|0|||
17171507|NCT02807844|38321036|FG002|Overall Study|Adverse Event|0|||
17171508|NCT02807844|38321037|FG003|Overall Study|Adverse Event|0|||
17171509|NCT02807844|38321038|FG004|Overall Study|Adverse Event|1|||
17171510|NCT02807844|38321039|FG005|Overall Study|Adverse Event|1|||
17171511|NCT02807844|38321040|FG006|Overall Study|Adverse Event|1|||
17171512|NCT02807844|38321041|FG007|Overall Study|Adverse Event|1|||
17171513|NCT02807844|38321042|FG008|Overall Study|Adverse Event|1|||
17171514|NCT02807844|38321043|FG009|Overall Study|Adverse Event|2|||
17171515|NCT02763566|38321073|FG000|Overall Study|Lost to Follow-up|1|||
17171516|NCT02763566|38321074|FG001|Overall Study|Lost to Follow-up|4|||
17171517|NCT02763566|38321075|FG002|Overall Study|Lost to Follow-up|0|||
17171518|NCT02763566|38321076|FG003|Overall Study|Lost to Follow-up|1|||
17171519|NCT02763566|38321073|FG000|Overall Study|On study treatment at study conclusion|114|||
17171520|NCT02763566|38321074|FG001|Overall Study|On study treatment at study conclusion|34|||
17171521|NCT02763566|38321075|FG002|Overall Study|On study treatment at study conclusion|54|||
17171522|NCT02763566|38321076|FG003|Overall Study|On study treatment at study conclusion|13|||
17171523|NCT02763566|38321073|FG000|Overall Study|Withdrawal by Subject|3|||
17171524|NCT02763566|38321074|FG001|Overall Study|Withdrawal by Subject|1|||
17171525|NCT02763566|38321075|FG002|Overall Study|Withdrawal by Subject|0|||
17171526|NCT02763566|38321076|FG003|Overall Study|Withdrawal by Subject|0|||
17171527|NCT02763254|38321090|FG000|Overall Study|Adverse Event|1|||
17171528|NCT02805972|38321096|FG000|Washout Period|Lost to Follow-up|3|||
17171529|NCT02805972|38321097|FG001|Washout Period|Lost to Follow-up|0|||
17171530|NCT03032523|38321115|FG000|Overall Study|Withdrawal by Subject|2|||
17171531|NCT03032523|38321116|FG001|Overall Study|Withdrawal by Subject|2|||
17171532|NCT03032523|38321115|FG000|Overall Study|Physician Decision|1|||
17171533|NCT03032523|38321116|FG001|Overall Study|Physician Decision|0|||
17171534|NCT03031899|38321123|FG000|Overall Study|Protocol Violation|1|||
17171535|NCT03031899|38321123|FG000|Overall Study|lesion disappeared after stopping habit|1|||
17171536|NCT03086369|38321136|FG000|Overall Study|Lost to Follow-up|1|||
17171537|NCT03086369|38321137|FG001|Overall Study|Lost to Follow-up|0|||
17171538|NCT03086369|38321138|FG002|Overall Study|Lost to Follow-up|0|||
17171539|NCT03086369|38321139|FG003|Overall Study|Lost to Follow-up|2|||
17171540|NCT03086369|38321140|FG004|Overall Study|Lost to Follow-up|1|||
17171541|NCT03086369|38321136|FG000|Overall Study|Physician Decision|0|||
17171542|NCT03086369|38321137|FG001|Overall Study|Physician Decision|0|||
17171543|NCT03086369|38321138|FG002|Overall Study|Physician Decision|0|||
17171544|NCT03086369|38321139|FG003|Overall Study|Physician Decision|1|||
17171545|NCT03086369|38321140|FG004|Overall Study|Physician Decision|2|||
17171546|NCT03086369|38321136|FG000|Overall Study|Withdrawal by Subject|0|||
17171547|NCT03086369|38321137|FG001|Overall Study|Withdrawal by Subject|0|||
17171548|NCT03086369|38321138|FG002|Overall Study|Withdrawal by Subject|0|||
17171549|NCT03086369|38321139|FG003|Overall Study|Withdrawal by Subject|5|||
17171550|NCT03086369|38321140|FG004|Overall Study|Withdrawal by Subject|3|||
17171551|NCT03086369|38321136|FG000|Overall Study|Progressive Disease|0|||
17171552|NCT03086369|38321137|FG001|Overall Study|Progressive Disease|0|||
17171553|NCT03086369|38321138|FG002|Overall Study|Progressive Disease|0|||
17171554|NCT03086369|38321139|FG003|Overall Study|Progressive Disease|1|||
17171555|NCT03086369|38321140|FG004|Overall Study|Progressive Disease|1|||
17171556|NCT00101582|38321156|FG000|Overall Study|Ineligibility determined|0|||
17171557|NCT00101582|38321157|FG001|Overall Study|Ineligibility determined|1|||
17171558|NCT00101582|38321156|FG000|Overall Study|Adverse Event|1|||
17171559|NCT00101582|38321157|FG001|Overall Study|Adverse Event|4|||
17171560|NCT00101582|38321156|FG000|Overall Study|Withdrawal by Subject|6|||
17086476|NCT00160563|38226920|FG001|Overall Study|Other (listed in the study report)|40|||
17086477|NCT00160563|38226921|FG002|Overall Study|Other (listed in the study report)|81|||
17086478|NCT00160563|38226919|FG000|Overall Study|Missing reason|0|||
17086479|NCT00160563|38226920|FG001|Overall Study|Missing reason|1|||
17086480|NCT00160563|38226921|FG002|Overall Study|Missing reason|0|||
17086481|NCT00380744|38226937|FG000|Overall Study|Death|0|||
17086482|NCT00380744|38226938|FG001|Overall Study|Death|0|||
17086483|NCT00380744|38226939|FG002|Overall Study|Death|0|||
17086484|NCT00380744|38226940|FG003|Overall Study|Death|0|||
17086485|NCT00380744|38226941|FG004|Overall Study|Death|0|||
17086486|NCT00380744|38226942|FG005|Overall Study|Death|0|||
17086487|NCT00380744|38226943|FG006|Overall Study|Death|1|||
17086488|NCT00380744|38226937|FG000|Overall Study|Withdrawal by Subject|1|||
17086489|NCT00380744|38226938|FG001|Overall Study|Withdrawal by Subject|0|||
17086490|NCT00380744|38226939|FG002|Overall Study|Withdrawal by Subject|0|||
17086491|NCT00380744|38226940|FG003|Overall Study|Withdrawal by Subject|0|||
17086492|NCT00380744|38226941|FG004|Overall Study|Withdrawal by Subject|0|||
17086493|NCT00380744|38226942|FG005|Overall Study|Withdrawal by Subject|0|||
17086494|NCT00380744|38226943|FG006|Overall Study|Withdrawal by Subject|0|||
17086495|NCT00380588|38226962|FG000|Overall Study|Unequivocal Disease Progression|25|||
17086496|NCT00380588|38226963|FG001|Overall Study|Unequivocal Disease Progression|34|||
17086497|NCT00380588|38226962|FG000|Overall Study|Next Cycle Not Started|4|||
17086498|NCT00380588|38226963|FG001|Overall Study|Next Cycle Not Started|0|||
17086499|NCT00380588|38226962|FG000|Overall Study|Adverse Event|7|||
17086500|NCT00380588|38226963|FG001|Overall Study|Adverse Event|3|||
17086501|NCT00380588|38226962|FG000|Overall Study|Withdrawal by Subject|1|||
17086502|NCT00380588|38226963|FG001|Overall Study|Withdrawal by Subject|3|||
17086503|NCT00380588|38226962|FG000|Overall Study|Physician Decision|2|||
17086504|NCT00380588|38226963|FG001|Overall Study|Physician Decision|0|||
17086505|NCT00379808|38226969|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
17086506|NCT00379808|38226970|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
17086507|NCT00355784|38226979|FG000|Overall Study|Withdrawal by Subject|0|||
17086508|NCT00355784|38226980|FG001|Overall Study|Withdrawal by Subject|0|||
17086509|NCT00355784|38226981|FG002|Overall Study|Withdrawal by Subject|2|||
17086510|NCT00355472|38226990|FG000|Overall Study|Physician Decision|1|||
17086511|NCT00492557|38227004|FG000|Overall Study|Subject request|12|||
17086512|NCT00492557|38227005|FG001|Overall Study|Subject request|11|||
17086513|NCT00492557|38227004|FG000|Overall Study|Protocol Violation|7|||
17086514|NCT00492557|38227005|FG001|Overall Study|Protocol Violation|8|||
17086515|NCT00492557|38227004|FG000|Overall Study|Other|2|||
17086516|NCT00492557|38227005|FG001|Overall Study|Other|2|||
17086517|NCT00492557|38227004|FG000|Overall Study|Death|1|||
17086518|NCT00492557|38227005|FG001|Overall Study|Death|1|||
17086519|NCT00492557|38227004|FG000|Overall Study|Adverse Event|1|||
17086520|NCT00492557|38227005|FG001|Overall Study|Adverse Event|0|||
17086521|NCT00492557|38227004|FG000|Overall Study|Failed to return|1|||
17171561|NCT00101582|38321157|FG001|Overall Study|Withdrawal by Subject|4|||
17171562|NCT00101582|38321156|FG000|Overall Study|Physician Decision|1|||
17171563|NCT00101582|38321157|FG001|Overall Study|Physician Decision|0|||
17171564|NCT00101582|38321156|FG000|Overall Study|Death|3|||
17171565|NCT00101582|38321157|FG001|Overall Study|Death|5|||
17171566|NCT00101582|38321156|FG000|Overall Study|Other|0|||
17171567|NCT00101582|38321157|FG001|Overall Study|Other|1|||
17171568|NCT03086135|38321163|FG000|Overall Study|Adverse Event|1|||
17171569|NCT03086135|38321163|FG000|Overall Study|Lost to Follow-up|2|||
17171570|NCT02762708|38321180|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
17171571|NCT02762708|38321181|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
17171572|NCT02762708|38321182|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
17171573|NCT02762708|38321183|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
17171574|NCT02760602|38321195|FG000|Overall Study|Withdrawal by Subject|1|||
17171575|NCT02760602|38321196|FG001|Overall Study|Withdrawal by Subject|0|||
17171576|NCT02760602|38321195|FG000|Overall Study|Terminated by sponsor|12|||
17171577|NCT02760602|38321196|FG001|Overall Study|Terminated by sponsor|13|||
17171578|NCT03852719|38321205|FG000|Overall Study|Still on study|50|||
17171579|NCT03852719|38321206|FG001|Overall Study|Still on study|48|||
17086522|NCT00492557|38227005|FG001|Overall Study|Failed to return|0|||
17086523|NCT00492557|38227004|FG000|Overall Study|Lost to Follow-up|0|||
17086524|NCT00492557|38227005|FG001|Overall Study|Lost to Follow-up|1|||
17086525|NCT00508391|38227016|FG000|First Treatment|Withdrawal by Subject|6|||
17086526|NCT00508391|38227017|FG001|First Treatment|Withdrawal by Subject|3|||
17171580|NCT03852719|38321207|FG002|Overall Study|Still on study|47|||
17171581|NCT03852719|38321205|FG000|Overall Study|Withdrawal of consent|0|||
17171582|NCT03852719|38321206|FG001|Overall Study|Withdrawal of consent|1|||
17171583|NCT03852719|38321207|FG002|Overall Study|Withdrawal of consent|2|||
17171584|NCT03852719|38321205|FG000|Overall Study|Physician Decision|0|||
17171585|NCT03852719|38321206|FG001|Overall Study|Physician Decision|0|||
17171586|NCT03852719|38321207|FG002|Overall Study|Physician Decision|1|||
17171587|NCT03852719|38321205|FG000|Overall Study|Pregnancy|1|||
17171588|NCT03852719|38321206|FG001|Overall Study|Pregnancy|0|||
17171589|NCT03852719|38321207|FG002|Overall Study|Pregnancy|0|||
17171590|NCT00210249|38321215|FG000|Overall Study|Lost to Follow-up|5|||
17171591|NCT00210249|38321215|FG000|Overall Study|Protocol Violation|11|||
17171592|NCT03086057|38321223|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
17171593|NCT03086057|38321224|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
17171594|NCT03086057|38321225|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
17171595|NCT03086057|38321226|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
17171596|NCT03086057|38321223|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
17171597|NCT03086057|38321224|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
17171598|NCT03086057|38321225|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
17171599|NCT03086057|38321226|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
17171600|NCT03086057|38321223|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
17171601|NCT03086057|38321224|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
17171602|NCT03086057|38321225|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
17171603|NCT03086057|38321226|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
17171604|NCT03086057|38321223|FG000|Stage 1: PrEP Uptake|Death|1|||
17171605|NCT03086057|38321224|FG001|Stage 1: PrEP Uptake|Death|0|||
17171606|NCT03086057|38321225|FG002|Stage 1: PrEP Uptake|Death|0|||
17171607|NCT03086057|38321226|FG003|Stage 1: PrEP Uptake|Death|0|||
17171608|NCT03086057|38321223|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
17171609|NCT03086057|38321224|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
17171610|NCT03086057|38321225|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
17171611|NCT03086057|38321226|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
17171612|NCT03086057|38321223|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
17171613|NCT03086057|38321224|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
17171614|NCT03086057|38321225|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
17171615|NCT03086057|38321226|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
17171616|NCT03086057|38321223|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
17171617|NCT03086057|38321224|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
17171618|NCT03086057|38321225|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
17171619|NCT03086057|38321226|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
17171620|NCT02759120|38321238|FG000|Overall Study|Death|34|||
17171621|NCT02759120|38321239|FG001|Overall Study|Death|36|||
17171622|NCT02759120|38321238|FG000|Overall Study|Lost to Follow-up|4|||
17086527|NCT00508391|38227016|FG000|Second Treatment|Withdrawal by Subject|2|||
17086528|NCT00508391|38227017|FG001|Second Treatment|Withdrawal by Subject|0|||
17171623|NCT02759120|38321239|FG001|Overall Study|Lost to Follow-up|7|||
17171624|NCT02759120|38321238|FG000|Overall Study|Physician Decision|3|||
17086529|NCT00508157|38227027|FG000|Overall Study|Adverse Event|0|||
17086530|NCT00508157|38227028|FG001|Overall Study|Adverse Event|1|||
17086531|NCT00508157|38227027|FG000|Overall Study|Subject Withdrew Consent|1|||
17171625|NCT02759120|38321239|FG001|Overall Study|Physician Decision|0|||
17086532|NCT00508157|38227028|FG001|Overall Study|Subject Withdrew Consent|0|||
17086533|NCT00508157|38227027|FG000|Overall Study|Lost to Follow-up|1|||
17171626|NCT02759120|38321238|FG000|Overall Study|Withdrawal by Subject|28|||
17171627|NCT02759120|38321239|FG001|Overall Study|Withdrawal by Subject|15|||
17171628|NCT02759120|38321238|FG000|Overall Study|Moved out of area|3|||
17171629|NCT02759120|38321239|FG001|Overall Study|Moved out of area|4|||
17171630|NCT02759120|38321238|FG000|Overall Study|Lung transplant|3|||
17171631|NCT02759120|38321239|FG001|Overall Study|Lung transplant|5|||
17171632|NCT02759120|38321238|FG000|Overall Study|Other reason not completed|10|||
17171633|NCT02759120|38321239|FG001|Overall Study|Other reason not completed|12|||
17171634|NCT00101192|38321245|FG000|Overall Study|Ineligible|6|||
17171635|NCT00101192|38321245|FG000|Overall Study|Inevaluable|1|||
17171636|NCT03031431|38321249|FG000|Overall Study|Infant removed by maternal request|1|||
17171637|NCT03029247|38321255|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
17171638|NCT03029247|38321256|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
17171639|NCT03029247|38321255|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
17171640|NCT03029247|38321256|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
17171641|NCT03029247|38321255|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
17171642|NCT03029247|38321256|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
17171643|NCT03029247|38321255|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
17171644|NCT03029247|38321256|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
17171645|NCT04313283|38321262|FG000|Overall Study|did not complete intervention|4|||
17171646|NCT02760368|38321269|FG000|Overall Study|Withdrawal by Subject|12|||
17171647|NCT02760368|38321270|FG001|Overall Study|Withdrawal by Subject|8|||
17171648|NCT02760368|38321271|FG002|Overall Study|Withdrawal by Subject|9|||
17171649|NCT02760368|38321269|FG000|Overall Study|Screen Failure|0|||
17171650|NCT02760368|38321270|FG001|Overall Study|Screen Failure|0|||
17171651|NCT02760368|38321271|FG002|Overall Study|Screen Failure|1|||
17171652|NCT02760368|38321269|FG000|Overall Study|Death|1|||
17171653|NCT02760368|38321270|FG001|Overall Study|Death|0|||
17171654|NCT02760368|38321271|FG002|Overall Study|Death|0|||
17171655|NCT02760368|38321269|FG000|Overall Study|Withdrawal by Sponsor|0|||
17171656|NCT02760368|38321270|FG001|Overall Study|Withdrawal by Sponsor|0|||
17171657|NCT02760368|38321271|FG002|Overall Study|Withdrawal by Sponsor|1|||
17171658|NCT03026283|38321279|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
17171659|NCT03026283|38321280|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
17171660|NCT03026283|38321281|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
17171661|NCT03026283|38321282|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
17171662|NCT03026283|38321283|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
17171663|NCT03026283|38321284|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
17171664|NCT03026283|38321285|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
17171665|NCT03026283|38321286|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
17171666|NCT03026283|38321279|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
17171667|NCT03026283|38321280|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
17171668|NCT03026283|38321281|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
17171669|NCT03026283|38321282|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
17171670|NCT03026283|38321283|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
17171671|NCT03026283|38321284|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
17171672|NCT03026283|38321285|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
17171673|NCT03026283|38321286|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
17171674|NCT03026283|38321279|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
17171675|NCT03026283|38321280|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
17171676|NCT03026283|38321281|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
17171677|NCT03026283|38321282|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
17171678|NCT03026283|38321283|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
17171679|NCT03026283|38321284|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
17171680|NCT03026283|38321285|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
17171681|NCT03026283|38321286|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
17171682|NCT03026283|38321279|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
17171683|NCT03026283|38321280|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
17171684|NCT03026283|38321281|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
17171685|NCT03026283|38321282|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
17171686|NCT03026283|38321283|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
17171687|NCT03026283|38321284|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
17171688|NCT03026283|38321285|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
17171689|NCT03026283|38321286|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
17171690|NCT03026283|38321279|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
17171691|NCT03026283|38321280|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
17171692|NCT03026283|38321281|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
17171693|NCT03026283|38321282|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
17171694|NCT03026283|38321283|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
17171695|NCT03026283|38321284|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
17171696|NCT03026283|38321285|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
17171697|NCT03026283|38321286|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
17171698|NCT03026283|38321279|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
17171699|NCT03026283|38321280|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
17171700|NCT03026283|38321281|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
17171701|NCT03026283|38321282|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
17171702|NCT03026283|38321283|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
17171703|NCT03026283|38321284|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
17171704|NCT03026283|38321285|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
17171705|NCT03026283|38321286|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
17171706|NCT03026283|38321279|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
17171707|NCT03026283|38321280|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
17171708|NCT03026283|38321281|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
17171709|NCT03026283|38321282|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
17171710|NCT03026283|38321283|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
17171711|NCT03026283|38321284|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
17171712|NCT03026283|38321285|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
17171713|NCT03026283|38321286|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
17086534|NCT00508157|38227028|FG001|Overall Study|Lost to Follow-up|0|||
17086535|NCT00508157|38227027|FG000|Overall Study|Subject no longer met study criteria|0|||
17086536|NCT00508157|38227028|FG001|Overall Study|Subject no longer met study criteria|1|||
17086537|NCT00508157|38227027|FG000|Overall Study|Other known cause|0|||
17086538|NCT00508157|38227028|FG001|Overall Study|Other known cause|1|||
17086539|NCT00378560|38227036|FG000|Overall Study|Adverse Event|1|||
17086540|NCT00378560|38227037|FG001|Overall Study|Adverse Event|0|||
17086541|NCT00378560|38227036|FG000|Overall Study|Lost to Follow-up|24|||
17086542|NCT00378560|38227037|FG001|Overall Study|Lost to Follow-up|29|||
17086543|NCT00378560|38227036|FG000|Overall Study|Protocol Violation|2|||
17086544|NCT00378560|38227037|FG001|Overall Study|Protocol Violation|0|||
17086545|NCT00378560|38227036|FG000|Overall Study|Withdrawal by Subject|17|||
17086546|NCT00378560|38227037|FG001|Overall Study|Withdrawal by Subject|21|||
17086547|NCT00378560|38227036|FG000|Overall Study|Moved|4|||
17086548|NCT00378560|38227037|FG001|Overall Study|Moved|3|||
17086549|NCT00378560|38227036|FG000|Overall Study|Pregnancy|7|||
17086550|NCT00378560|38227037|FG001|Overall Study|Pregnancy|5|||
17086551|NCT00378560|38227036|FG000|Overall Study|Laboratory test values abnormal|1|||
17086552|NCT00378560|38227037|FG001|Overall Study|Laboratory test values abnormal|0|||
17086553|NCT00508001|38227046|FG000|Overall Study|Adverse Event|2|||
17086554|NCT00508001|38227047|FG001|Overall Study|Adverse Event|0|||
17086555|NCT00508001|38227048|FG002|Overall Study|Adverse Event|4|||
17086556|NCT00508001|38227046|FG000|Overall Study|condition under investigation worsened|13|||
17086557|NCT00508001|38227047|FG001|Overall Study|condition under investigation worsened|7|||
17086558|NCT00508001|38227048|FG002|Overall Study|condition under investigation worsened|1|||
17086559|NCT00508001|38227046|FG000|Overall Study|Death|0|||
17086560|NCT00508001|38227047|FG001|Overall Study|Death|1|||
17086561|NCT00508001|38227048|FG002|Overall Study|Death|1|||
17086562|NCT00508001|38227046|FG000|Overall Study|Withdrawal by Subject|4|||
17086563|NCT00508001|38227047|FG001|Overall Study|Withdrawal by Subject|4|||
17086564|NCT00508001|38227048|FG002|Overall Study|Withdrawal by Subject|1|||
17086565|NCT00507689|38227059|FG000|Pre-Randomization Period|Adverse Event|1|||
17086566|NCT00507689|38227060|FG001|Pre-Randomization Period|Adverse Event|0|||
17086567|NCT00507689|38227059|FG000|Pre-Randomization Period|Physician Decision|1|||
17086568|NCT00507689|38227060|FG001|Pre-Randomization Period|Physician Decision|0|||
17086569|NCT00507689|38227059|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
17086570|NCT00507689|38227060|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
17086571|NCT00507689|38227059|FG000|Randomized Period|Adverse Event|1|||
17086572|NCT00507689|38227060|FG001|Randomized Period|Adverse Event|1|||
17086573|NCT00507689|38227059|FG000|Randomized Period|Withdrawal by Subject|0|||
17086574|NCT00507689|38227060|FG001|Randomized Period|Withdrawal by Subject|1|||
17086575|NCT00491387|38227067|FG000|Overall Study|study terminated|20|||
17086576|NCT00491075|38227071|FG000|Overall Study|Withdrawal by Subject|1|||
17086577|NCT00491075|38227071|FG000|Overall Study|Physician Decision|1|||
17086578|NCT00507455|38227078|FG000|Overall Study|Adverse Event|3|||
17086579|NCT00507455|38227079|FG001|Overall Study|Adverse Event|3|||
17086580|NCT00507455|38227080|FG002|Overall Study|Adverse Event|6|||
17086581|NCT00507455|38227078|FG000|Overall Study|Withdrawal by Subject|2|||
17086582|NCT00507455|38227079|FG001|Overall Study|Withdrawal by Subject|1|||
17086583|NCT00507455|38227080|FG002|Overall Study|Withdrawal by Subject|2|||
17086584|NCT00507455|38227078|FG000|Overall Study|Protocol Violation|4|||
17086585|NCT00507455|38227079|FG001|Overall Study|Protocol Violation|1|||
17086586|NCT00507455|38227080|FG002|Overall Study|Protocol Violation|1|||
17086587|NCT00507455|38227078|FG000|Overall Study|Lost to Follow-up|2|||
17086588|NCT00507455|38227079|FG001|Overall Study|Lost to Follow-up|0|||
17086589|NCT00507455|38227080|FG002|Overall Study|Lost to Follow-up|2|||
17086590|NCT00507455|38227078|FG000|Overall Study|Lack of Efficacy|0|||
17086591|NCT00507455|38227079|FG001|Overall Study|Lack of Efficacy|1|||
17086592|NCT00507455|38227080|FG002|Overall Study|Lack of Efficacy|0|||
17086593|NCT00507455|38227078|FG000|Overall Study|Other - miscellaneous reason|1|||
17086594|NCT00507455|38227079|FG001|Overall Study|Other - miscellaneous reason|0|||
17086595|NCT00507455|38227080|FG002|Overall Study|Other - miscellaneous reason|1|||
17086596|NCT00506831|38227088|FG000|Overall Study|Death|1|||
17086597|NCT00506831|38227088|FG000|Overall Study|Withdrawal by Subject|1|||
17086598|NCT00506753|38227094|FG000|Overall Study|Lost to Follow-up|21|||
17086599|NCT00506753|38227095|FG001|Overall Study|Lost to Follow-up|15|||
17086600|NCT00490919|38227103|FG000|Open-label Run-in Period|Adverse Event|239|||
17086601|NCT00490919|38227104|FG001|Open-label Run-in Period|Adverse Event|0|||
17086602|NCT00490919|38227105|FG002|Open-label Run-in Period|Adverse Event|0|||
17086603|NCT00490919|38227103|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
17086604|NCT00490919|38227104|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
17086605|NCT00490919|38227105|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
17086606|NCT00490919|38227103|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
17086607|NCT00490919|38227104|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
17171714|NCT03026283|38321279|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
17171715|NCT03026283|38321280|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
17171716|NCT03026283|38321281|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
17171717|NCT03026283|38321282|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
17171718|NCT03026283|38321283|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
17171719|NCT03026283|38321284|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
17171720|NCT03026283|38321285|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
17171721|NCT03026283|38321286|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
17171722|NCT03026283|38321279|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
17171723|NCT03026283|38321280|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
17171724|NCT03026283|38321281|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
17171725|NCT03026283|38321282|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
17171726|NCT03026283|38321283|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
17171727|NCT03026283|38321284|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
17171728|NCT03026283|38321285|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
17171729|NCT03026283|38321286|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
17171730|NCT02754440|38321303|FG000|Overall Study|Protocol Violation|3|||
17171731|NCT02754440|38321304|FG001|Overall Study|Protocol Violation|2|||
17171732|NCT02754440|38321305|FG002|Overall Study|Protocol Violation|2|||
17171733|NCT02754440|38321306|FG003|Overall Study|Protocol Violation|6|||
17171734|NCT02754440|38321303|FG000|Overall Study|Adverse Event|3|||
17086608|NCT00490919|38227105|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
17086609|NCT00490919|38227103|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
17086610|NCT00490919|38227104|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
17171735|NCT02754440|38321304|FG001|Overall Study|Adverse Event|1|||
17171736|NCT02754440|38321305|FG002|Overall Study|Adverse Event|0|||
17171737|NCT02754440|38321306|FG003|Overall Study|Adverse Event|9|||
17171738|NCT02754440|38321303|FG000|Overall Study|Withdrawal by Subject|0|||
17171739|NCT02754440|38321304|FG001|Overall Study|Withdrawal by Subject|0|||
17171740|NCT02754440|38321305|FG002|Overall Study|Withdrawal by Subject|0|||
17171741|NCT02754440|38321306|FG003|Overall Study|Withdrawal by Subject|1|||
17171742|NCT02754440|38321303|FG000|Overall Study|Equipment failure|0|||
17171743|NCT02754440|38321304|FG001|Overall Study|Equipment failure|5|||
17171744|NCT02754440|38321305|FG002|Overall Study|Equipment failure|5|||
17171745|NCT02754440|38321306|FG003|Overall Study|Equipment failure|7|||
17171746|NCT02754440|38321303|FG000|Overall Study|Subject issues not resulting in AE|0|||
17171747|NCT02754440|38321304|FG001|Overall Study|Subject issues not resulting in AE|0|||
17171748|NCT02754440|38321305|FG002|Overall Study|Subject issues not resulting in AE|0|||
17171749|NCT02754440|38321306|FG003|Overall Study|Subject issues not resulting in AE|12|||
17171750|NCT02753816|38321318|FG000|Overall Study|Protocol Violation|0|||
17171751|NCT02753816|38321319|FG001|Overall Study|Protocol Violation|1|||
17171752|NCT02753816|38321320|FG002|Overall Study|Protocol Violation|0|||
17171753|NCT02752802|38321328|FG000|Overall Study|Contrast Volume Not Collected|1|||
17171754|NCT02752802|38321329|FG001|Overall Study|Contrast Volume Not Collected|0|||
17171755|NCT02756078|38321337|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
17171756|NCT02756078|38321338|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
17171757|NCT02756078|38321337|FG000|Period 1|Lost to Follow-up|0|||
17171758|NCT02756078|38321338|FG001|Period 1|Lost to Follow-up|2|||
17171759|NCT02756078|38321337|FG000|Period 1|Protocol Violation|0|||
17171760|NCT02756078|38321338|FG001|Period 1|Protocol Violation|1|||
17171761|NCT02756078|38321337|FG000|Period 1|Adverse Event|1|||
17171762|NCT02756078|38321338|FG001|Period 1|Adverse Event|10|||
17171763|NCT02756078|38321337|FG000|Period 1|Withdrawal by Subject|6|||
17171764|NCT02756078|38321338|FG001|Period 1|Withdrawal by Subject|6|||
17171765|NCT02756078|38321337|FG000|Period 1|Lens Discomfort|2|||
17171766|NCT02756078|38321338|FG001|Period 1|Lens Discomfort|2|||
17171767|NCT02756078|38321337|FG000|Period 2|Adverse Event|3|||
17171768|NCT02756078|38321338|FG001|Period 2|Adverse Event|5|||
17171769|NCT02756078|38321337|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
17171770|NCT02756078|38321338|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
17171771|NCT02756078|38321337|FG000|Period 2|Withdrawal by Subject|3|||
17171772|NCT02756078|38321338|FG001|Period 2|Withdrawal by Subject|1|||
17171773|NCT03813147|38321346|FG000|Overall Study|Lack of Efficacy|4|||
17171774|NCT03813147|38321347|FG001|Overall Study|Lack of Efficacy|4|||
17171775|NCT03813147|38321346|FG000|Overall Study|Physician Decision|2|||
17086611|NCT00490919|38227105|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
17086612|NCT00490919|38227103|FG000|Open-label Run-in Period|Administrative|40|||
17086613|NCT00490919|38227104|FG001|Open-label Run-in Period|Administrative|0|||
17086614|NCT00490919|38227105|FG002|Open-label Run-in Period|Administrative|0|||
17086615|NCT00490919|38227103|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
17086616|NCT00490919|38227104|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
17086617|NCT00490919|38227105|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
17086618|NCT00490919|38227103|FG000|Double-blind Phase|Adverse Event|0|||
17086619|NCT00490919|38227104|FG001|Double-blind Phase|Adverse Event|40|||
17086620|NCT00490919|38227105|FG002|Double-blind Phase|Adverse Event|20|||
17086621|NCT00490919|38227103|FG000|Double-blind Phase|Withdrawal by Subject|0|||
17086622|NCT00490919|38227104|FG001|Double-blind Phase|Withdrawal by Subject|10|||
17086623|NCT00490919|38227105|FG002|Double-blind Phase|Withdrawal by Subject|11|||
17086624|NCT00490919|38227103|FG000|Double-blind Phase|Lost to Follow-up|0|||
17086625|NCT00490919|38227104|FG001|Double-blind Phase|Lost to Follow-up|8|||
17086626|NCT00490919|38227105|FG002|Double-blind Phase|Lost to Follow-up|11|||
17086627|NCT00490919|38227103|FG000|Double-blind Phase|Lack of Efficacy|0|||
17086628|NCT00490919|38227104|FG001|Double-blind Phase|Lack of Efficacy|22|||
17086629|NCT00490919|38227105|FG002|Double-blind Phase|Lack of Efficacy|36|||
17086630|NCT00490919|38227103|FG000|Double-blind Phase|Administrative|0|||
17086631|NCT00490919|38227104|FG001|Double-blind Phase|Administrative|6|||
17086632|NCT00490919|38227105|FG002|Double-blind Phase|Administrative|6|||
17086633|NCT00503867|38227112|FG000|Overall Study|Lost to Follow-up|1|||
17086634|NCT00503867|38227112|FG000|Overall Study|Adverse Event|1|||
17086635|NCT00503399|38227118|FG000|Overall Study|Death|2|||
17086636|NCT00503399|38227119|FG001|Overall Study|Death|1|||
17086637|NCT00503399|38227118|FG000|Overall Study|Protocol Violation|1|||
17171776|NCT03813147|38321347|FG001|Overall Study|Physician Decision|1|||
17171777|NCT02752958|38321353|FG000|Overall Study|Adverse Event|3|||
17171778|NCT02752958|38321353|FG000|Overall Study|Lost to Follow-up|1|||
17171779|NCT02752958|38321353|FG000|Overall Study|Protocol Violation|1|||
17171780|NCT02752958|38321353|FG000|Overall Study|Withdrawal by Subject|2|||
17171781|NCT02752958|38321353|FG000|Overall Study|Other (Reason not specified)|2|||
17171782|NCT02805660|38321366|FG000|Overall Study|Death|5|||
17171783|NCT02805660|38321367|FG001|Overall Study|Death|2|||
17171784|NCT02805660|38321368|FG002|Overall Study|Death|9|||
17171785|NCT02805660|38321369|FG003|Overall Study|Death|5|||
17171786|NCT02805660|38321370|FG004|Overall Study|Death|0|||
17171787|NCT02805660|38321371|FG005|Overall Study|Death|14|||
17171788|NCT02805660|38321372|FG006|Overall Study|Death|12|||
17171789|NCT02805660|38321366|FG000|Overall Study|Lost to Follow-up|0|||
17171790|NCT02805660|38321367|FG001|Overall Study|Lost to Follow-up|1|||
17171791|NCT02805660|38321368|FG002|Overall Study|Lost to Follow-up|1|||
17171792|NCT02805660|38321369|FG003|Overall Study|Lost to Follow-up|2|||
17171793|NCT02805660|38321370|FG004|Overall Study|Lost to Follow-up|0|||
17171794|NCT02805660|38321371|FG005|Overall Study|Lost to Follow-up|0|||
17171795|NCT02805660|38321372|FG006|Overall Study|Lost to Follow-up|0|||
17171796|NCT02805660|38321366|FG000|Overall Study|Withdrawal by Subject|0|||
17171797|NCT02805660|38321367|FG001|Overall Study|Withdrawal by Subject|0|||
17171798|NCT02805660|38321368|FG002|Overall Study|Withdrawal by Subject|0|||
17171799|NCT02805660|38321369|FG003|Overall Study|Withdrawal by Subject|3|||
17171800|NCT02805660|38321370|FG004|Overall Study|Withdrawal by Subject|1|||
17171801|NCT02805660|38321371|FG005|Overall Study|Withdrawal by Subject|0|||
17171802|NCT02805660|38321372|FG006|Overall Study|Withdrawal by Subject|2|||
17086638|NCT00503399|38227119|FG001|Overall Study|Protocol Violation|0|||
17086639|NCT00503399|38227118|FG000|Overall Study|Withdrawal by Subject|4|||
17086640|NCT00503399|38227119|FG001|Overall Study|Withdrawal by Subject|2|||
17086641|NCT00503399|38227118|FG000|Overall Study|Adverse Event|0|||
17086642|NCT00503399|38227119|FG001|Overall Study|Adverse Event|3|||
17086643|NCT00503399|38227118|FG000|Overall Study|Lost to Follow-up|0|||
17086644|NCT00503399|38227119|FG001|Overall Study|Lost to Follow-up|2|||
17171803|NCT02805660|38321366|FG000|Overall Study|Study terminated by Sponsor|0|||
17171804|NCT02805660|38321367|FG001|Overall Study|Study terminated by Sponsor|0|||
17171805|NCT02805660|38321368|FG002|Overall Study|Study terminated by Sponsor|1|||
17171806|NCT02805660|38321369|FG003|Overall Study|Study terminated by Sponsor|4|||
17171807|NCT02805660|38321370|FG004|Overall Study|Study terminated by Sponsor|2|||
17171808|NCT02805660|38321371|FG005|Overall Study|Study terminated by Sponsor|3|||
17171809|NCT02805660|38321372|FG006|Overall Study|Study terminated by Sponsor|1|||
17171810|NCT02805660|38321366|FG000|Overall Study|Miscellaneous|0|||
17171811|NCT02805660|38321367|FG001|Overall Study|Miscellaneous|1|||
17171812|NCT02805660|38321368|FG002|Overall Study|Miscellaneous|0|||
17171813|NCT02805660|38321369|FG003|Overall Study|Miscellaneous|4|||
17171814|NCT02805660|38321370|FG004|Overall Study|Miscellaneous|0|||
17171815|NCT02805660|38321371|FG005|Overall Study|Miscellaneous|6|||
17171816|NCT02805660|38321372|FG006|Overall Study|Miscellaneous|4|||
17171817|NCT02807376|38321403|FG000|Overall Study|Intra-operative exclusion criteria|3|||
17171818|NCT02807376|38321404|FG001|Overall Study|Intra-operative exclusion criteria|0|||
17171819|NCT02807376|38321403|FG000|Overall Study|Lost to Follow-up|0|||
17171820|NCT02807376|38321404|FG001|Overall Study|Lost to Follow-up|1|||
17171821|NCT02804178|38321410|FG000|Overall Study|Adverse Event|1|||
17171822|NCT02917941|38321414|FG000|Treatment Period|Adverse Event|11|||
17171823|NCT02917941|38321414|FG000|Treatment Period|Progressive Disease|11|||
17171824|NCT02917941|38321414|FG000|Treatment Period|Reason not Specified|2|||
17171825|NCT02917941|38321414|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
17171826|NCT02917941|38321414|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
17171827|NCT01333956|38321422|FG000|Overall Study|Lost to Follow-up|1|||
17171828|NCT01333956|38321423|FG001|Overall Study|Lost to Follow-up|2|||
17171829|NCT01333956|38321424|FG002|Overall Study|Lost to Follow-up|0|||
17171830|NCT01333956|38321425|FG003|Overall Study|Lost to Follow-up|1|||
17171831|NCT01333956|38321422|FG000|Overall Study|Unable to complete study procedure|1|||
17171832|NCT01333956|38321423|FG001|Overall Study|Unable to complete study procedure|0|||
17171833|NCT01333956|38321424|FG002|Overall Study|Unable to complete study procedure|0|||
17171834|NCT01333956|38321425|FG003|Overall Study|Unable to complete study procedure|1|||
17171835|NCT01333956|38321422|FG000|Overall Study|Withdrawal by Subject|0|||
17171836|NCT01333956|38321423|FG001|Overall Study|Withdrawal by Subject|2|||
17171837|NCT01333956|38321424|FG002|Overall Study|Withdrawal by Subject|1|||
17171838|NCT01333956|38321425|FG003|Overall Study|Withdrawal by Subject|0|||
17171839|NCT01333722|38321438|FG000|Overall Study|Lack of Efficacy|0|||
17171840|NCT01333722|38321439|FG001|Overall Study|Lack of Efficacy|2|||
17171841|NCT01333722|38321438|FG000|Overall Study|Withdrawal by Subject|0|||
17171842|NCT01333722|38321439|FG001|Overall Study|Withdrawal by Subject|1|||
17171843|NCT01370694|38321447|FG000|Overall Study|Switched to rituximab|4|||
17171844|NCT01370694|38321447|FG000|Overall Study|Progressive disease|2|||
17171845|NCT03315143|38321453|FG000|Overall Study|Death|240|||
17171846|NCT03315143|38321454|FG001|Overall Study|Death|246|||
17171847|NCT03315143|38321453|FG000|Overall Study|Withdrawal by Subject|57|||
17171848|NCT03315143|38321454|FG001|Overall Study|Withdrawal by Subject|68|||
17171849|NCT03315143|38321453|FG000|Overall Study|Site Terminated by Sponsor|256|||
17171850|NCT03315143|38321454|FG001|Overall Study|Site Terminated by Sponsor|282|||
17171851|NCT03315143|38321453|FG000|Overall Study|Study Terminated by Sponsor|4723|||
17086645|NCT00506519|38227128|FG000|Overall Study|Death|4|||
17086646|NCT00506519|38227129|FG001|Overall Study|Death|6|||
17086647|NCT00506519|38227130|FG002|Overall Study|Death|0|||
17086648|NCT00506519|38227128|FG000|Overall Study|Adverse Event|1|||
17086649|NCT00506519|38227129|FG001|Overall Study|Adverse Event|0|||
17086650|NCT00506519|38227130|FG002|Overall Study|Adverse Event|0|||
17086651|NCT00503009|38227144|FG000|Overall Study|Protocol Violation|1|||
17086652|NCT00503009|38227145|FG001|Overall Study|Protocol Violation|0|||
17086653|NCT00503009|38227146|FG002|Overall Study|Protocol Violation|1|||
17086654|NCT00503009|38227144|FG000|Overall Study|Withdrawal by Subject|0|||
17086655|NCT00503009|38227145|FG001|Overall Study|Withdrawal by Subject|1|||
17086656|NCT00503009|38227146|FG002|Overall Study|Withdrawal by Subject|1|||
17086657|NCT00503009|38227144|FG000|Overall Study|Physician Decision|0|||
17086658|NCT00503009|38227145|FG001|Overall Study|Physician Decision|1|||
17086659|NCT00503009|38227146|FG002|Overall Study|Physician Decision|1|||
17086660|NCT00160251|38227160|FG000|Prior to Amendment 2|Adverse Event|2|||
17086661|NCT00160251|38227161|FG001|Prior to Amendment 2|Adverse Event|1|||
17086662|NCT00160251|38227162|FG002|Prior to Amendment 2|Adverse Event|3|||
17086663|NCT00160251|38227163|FG003|Prior to Amendment 2|Adverse Event|1|||
17086664|NCT00160251|38227164|FG004|Prior to Amendment 2|Adverse Event|1|||
17086665|NCT00160251|38227165|FG005|Prior to Amendment 2|Adverse Event|1|||
17086666|NCT00160251|38227166|FG006|Prior to Amendment 2|Adverse Event|1|||
17086667|NCT00160251|38227167|FG007|Prior to Amendment 2|Adverse Event|0|||
17086668|NCT00160251|38227160|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
17086669|NCT00160251|38227161|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
17086670|NCT00160251|38227162|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
17086671|NCT00160251|38227163|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
17086672|NCT00160251|38227164|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
17086673|NCT00160251|38227165|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
17086674|NCT00160251|38227166|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
17171852|NCT03315143|38321454|FG001|Overall Study|Study Terminated by Sponsor|4664|||
17171853|NCT03315143|38321453|FG000|Overall Study|Reason not Specified|16|||
17171854|NCT03315143|38321454|FG001|Overall Study|Reason not Specified|32|||
17086675|NCT00160251|38227167|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
17086676|NCT00160251|38227160|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
17086677|NCT00160251|38227161|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
17086678|NCT00160251|38227162|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
17086679|NCT00160251|38227163|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
17086680|NCT00160251|38227164|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
17086681|NCT00160251|38227165|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
17086682|NCT00160251|38227166|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
17086683|NCT00160251|38227167|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
17086684|NCT00160251|38227160|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
17086685|NCT00160251|38227161|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
17086686|NCT00160251|38227162|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
17086687|NCT00160251|38227163|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
17086688|NCT00160251|38227164|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
17086689|NCT00160251|38227165|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
17086690|NCT00160251|38227166|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
17086691|NCT00160251|38227167|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
17086692|NCT00160251|38227160|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
17086693|NCT00160251|38227161|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
17086694|NCT00160251|38227162|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
17086695|NCT00160251|38227163|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
17086696|NCT00160251|38227164|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
17086697|NCT00160251|38227165|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
17086698|NCT00160251|38227166|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
17086699|NCT00160251|38227167|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
17086700|NCT00160251|38227160|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
17086701|NCT00160251|38227161|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
17086702|NCT00160251|38227162|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
17086703|NCT00160251|38227163|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
17086704|NCT00160251|38227164|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
17086705|NCT00160251|38227165|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
17086706|NCT00160251|38227166|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
17086707|NCT00160251|38227167|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
17086708|NCT00160251|38227160|FG000|Post-amendment 2|Adverse Event|0|||
17086709|NCT00160251|38227161|FG001|Post-amendment 2|Adverse Event|0|||
17086710|NCT00160251|38227162|FG002|Post-amendment 2|Adverse Event|0|||
17086711|NCT00160251|38227163|FG003|Post-amendment 2|Adverse Event|0|||
17086712|NCT00160251|38227164|FG004|Post-amendment 2|Adverse Event|0|||
17086713|NCT00160251|38227165|FG005|Post-amendment 2|Adverse Event|0|||
17086714|NCT00160251|38227166|FG006|Post-amendment 2|Adverse Event|0|||
17086715|NCT00160251|38227167|FG007|Post-amendment 2|Adverse Event|20|||
17086716|NCT00160251|38227160|FG000|Post-amendment 2|Lack of Efficacy|0|||
17086717|NCT00160251|38227161|FG001|Post-amendment 2|Lack of Efficacy|0|||
17086718|NCT00160251|38227162|FG002|Post-amendment 2|Lack of Efficacy|0|||
17086719|NCT00160251|38227163|FG003|Post-amendment 2|Lack of Efficacy|0|||
17086720|NCT00160251|38227164|FG004|Post-amendment 2|Lack of Efficacy|0|||
17086721|NCT00160251|38227165|FG005|Post-amendment 2|Lack of Efficacy|0|||
17086722|NCT00160251|38227166|FG006|Post-amendment 2|Lack of Efficacy|0|||
17086723|NCT00160251|38227167|FG007|Post-amendment 2|Lack of Efficacy|24|||
17086724|NCT00160251|38227160|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
17086725|NCT00160251|38227161|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
17086726|NCT00160251|38227162|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
17086727|NCT00160251|38227163|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
17086728|NCT00160251|38227164|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
17086729|NCT00160251|38227165|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
17086730|NCT00160251|38227166|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
17086731|NCT00160251|38227167|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
17086732|NCT00506441|38227224|FG000|Period 1; Open-label Period|Adverse Event|21|||
17086733|NCT00506441|38227225|FG001|Period 1; Open-label Period|Adverse Event|0|||
17086734|NCT00506441|38227224|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
17086735|NCT00506441|38227225|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
17086736|NCT00506441|38227224|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
17086737|NCT00506441|38227225|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
17086738|NCT00506441|38227224|FG000|Period 1; Open-label Period|Physician Decision|5|||
17086739|NCT00506441|38227225|FG001|Period 1; Open-label Period|Physician Decision|0|||
17086740|NCT00506441|38227224|FG000|Period 1; Open-label Period|Protocol Violation|9|||
17086741|NCT00506441|38227225|FG001|Period 1; Open-label Period|Protocol Violation|0|||
17086742|NCT00506441|38227224|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
17086743|NCT00506441|38227225|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
17086744|NCT00506441|38227224|FG000|Period 1; Open-label Period|Other Reasons|13|||
17086745|NCT00506441|38227225|FG001|Period 1; Open-label Period|Other Reasons|0|||
17086746|NCT00506441|38227224|FG000|Period 2; Double-blind Period|Adverse Event|0|||
17086747|NCT00506441|38227225|FG001|Period 2; Double-blind Period|Adverse Event|1|||
17086748|NCT00506441|38227224|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
17086749|NCT00506441|38227225|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
17086750|NCT00506441|38227224|FG000|Period 2; Double-blind Period|Physician Decision|1|||
17086751|NCT00506441|38227225|FG001|Period 2; Double-blind Period|Physician Decision|1|||
17086752|NCT00506441|38227224|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
17086753|NCT00506441|38227225|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
17086754|NCT00506441|38227224|FG000|Period 2; Double-blind Period|Other Reason|1|||
17086755|NCT00506441|38227225|FG001|Period 2; Double-blind Period|Other Reason|1|||
17086756|NCT00378014|38227252|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
17086757|NCT00378014|38227253|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
17086758|NCT00378014|38227252|FG000|Core (Randomization to Month 11)|Graft loss|1|||
17086759|NCT00378014|38227253|FG001|Core (Randomization to Month 11)|Graft loss|2|||
17086760|NCT00378014|38227252|FG000|Core (Randomization to Month 11)|Death|5|||
17086761|NCT00378014|38227253|FG001|Core (Randomization to Month 11)|Death|3|||
17086762|NCT00378014|38227252|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
17086763|NCT00378014|38227253|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
17086764|NCT00378014|38227252|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
17086765|NCT00378014|38227253|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
17086766|NCT00378014|38227252|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
17086767|NCT00378014|38227253|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
17086768|NCT00378014|38227252|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
17086769|NCT00378014|38227253|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
17086770|NCT00378014|38227252|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
17086771|NCT00378014|38227253|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
17086772|NCT00378014|38227252|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
17086773|NCT00378014|38227253|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
17171855|NCT02797080|38321460|FG000|Overall Study|Lost to Follow-up|1|||
17171856|NCT02797080|38321460|FG000|Overall Study|Withdrawal by Subject|1|||
17171857|NCT02915835|38321466|FG000|Overall Study|Physician Decision|1|||
17171858|NCT02915835|38321467|FG001|Overall Study|Physician Decision|0|||
17171859|NCT02915835|38321466|FG000|Overall Study|Withdrawal by Subject|0|||
17171860|NCT02915835|38321467|FG001|Overall Study|Withdrawal by Subject|1|||
17171861|NCT01370616|38321475|FG000|Overall Study|Adverse Event|11|||
17171862|NCT01370616|38321476|FG001|Overall Study|Adverse Event|16|||
17171863|NCT01370616|38321475|FG000|Overall Study|Death|1|||
17171864|NCT01370616|38321476|FG001|Overall Study|Death|0|||
17171865|NCT01370616|38321475|FG000|Overall Study|Lack of Efficacy|6|||
17086774|NCT00378014|38227252|FG000|Extension (Month 12 to Month 59)|Death|1|||
17086775|NCT00378014|38227253|FG001|Extension (Month 12 to Month 59)|Death|2|||
17086776|NCT00378014|38227252|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
17086777|NCT00378014|38227253|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
17086778|NCT00378014|38227252|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
17086779|NCT00378014|38227253|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
17086780|NCT00378014|38227252|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
17171866|NCT01370616|38321476|FG001|Overall Study|Lack of Efficacy|2|||
17171867|NCT01370616|38321475|FG000|Overall Study|Lost to Follow-up|0|||
17171868|NCT01370616|38321476|FG001|Overall Study|Lost to Follow-up|3|||
17171869|NCT01370616|38321475|FG000|Overall Study|Physician Decision|6|||
17171870|NCT01370616|38321476|FG001|Overall Study|Physician Decision|6|||
17171871|NCT01370616|38321475|FG000|Overall Study|Progressive Disease|0|||
17171872|NCT01370616|38321476|FG001|Overall Study|Progressive Disease|1|||
17171873|NCT01370616|38321475|FG000|Overall Study|Recovery|1|||
17171874|NCT01370616|38321476|FG001|Overall Study|Recovery|0|||
17171875|NCT01370616|38321475|FG000|Overall Study|Technical Problems|3|||
17171876|NCT01370616|38321476|FG001|Overall Study|Technical Problems|5|||
17171877|NCT01370616|38321475|FG000|Overall Study|Withdrawal by Subject|34|||
17171878|NCT01370616|38321476|FG001|Overall Study|Withdrawal by Subject|34|||
17171879|NCT02916927|38321489|FG000|Overall Study|Discharged prior to study drug receipt|0|||
17171880|NCT02916927|38321490|FG001|Overall Study|Discharged prior to study drug receipt|2|||
17171881|NCT02916927|38321489|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
16868026|NCT01536145|37841035|FG002|Overall Study|Other|0|||
17171882|NCT02916927|38321490|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
17171883|NCT02916927|38321489|FG000|Overall Study|Withdrawal before first time point|1|||
17171884|NCT02916927|38321490|FG001|Overall Study|Withdrawal before first time point|0|||
17171885|NCT02916693|38321496|FG000|Overall Study|Lost to Follow-up|7|||
17171886|NCT02574455|38321506|FG000|Overall Study|Death|197|||
17171887|NCT02574455|38321507|FG001|Overall Study|Death|210|||
17171888|NCT02574455|38321506|FG000|Overall Study|Withdrawal of Consent|11|||
17171889|NCT02574455|38321507|FG001|Overall Study|Withdrawal of Consent|28|||
17171890|NCT02574455|38321506|FG000|Overall Study|Lost to Follow-up|4|||
17171891|NCT02574455|38321507|FG001|Overall Study|Lost to Follow-up|4|||
17171892|NCT02574455|38321506|FG000|Overall Study|Sponsor's Decision|55|||
17171893|NCT02574455|38321507|FG001|Overall Study|Sponsor's Decision|20|||
17171894|NCT02795832|38321519|FG000|Overall Study|Adverse Event|0|||
17171895|NCT02795832|38321520|FG001|Overall Study|Adverse Event|0|||
17171896|NCT02795832|38321521|FG002|Overall Study|Adverse Event|0|||
17171897|NCT02795832|38321522|FG003|Overall Study|Adverse Event|0|||
17171898|NCT02795832|38321523|FG004|Overall Study|Adverse Event|0|||
17171899|NCT02795832|38321524|FG005|Overall Study|Adverse Event|3|||
17171900|NCT02794974|38321548|FG000|Overall Study|Physician Decision|0|||
17171901|NCT02794974|38321549|FG001|Overall Study|Physician Decision|1|||
17171902|NCT02419417|38321566|FG000|Overall Study|Disease progression|5|||
17171903|NCT02419417|38321567|FG001|Overall Study|Disease progression|4|||
17171904|NCT02419417|38321568|FG002|Overall Study|Disease progression|13|||
17171905|NCT02419417|38321569|FG003|Overall Study|Disease progression|10|||
17171906|NCT02419417|38321570|FG004|Overall Study|Disease progression|10|||
16996626|NCT00970268|38140710|FG001|Overall Study|COPD Exacerbation|2|||
16996627|NCT00970268|38140709|FG000|Overall Study|Lost to Follow-up|1|||
17086781|NCT00378014|38227253|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
17171907|NCT02419417|38321571|FG005|Overall Study|Disease progression|3|||
17171908|NCT02419417|38321572|FG006|Overall Study|Disease progression|4|||
17171909|NCT02419417|38321573|FG007|Overall Study|Disease progression|5|||
17171910|NCT02419417|38321574|FG008|Overall Study|Disease progression|13|||
17171911|NCT02419417|38321575|FG009|Overall Study|Disease progression|9|||
17171912|NCT02419417|38321576|FG010|Overall Study|Disease progression|0|||
17171913|NCT02419417|38321566|FG000|Overall Study|Study drug toxicity|0|||
17171914|NCT02419417|38321567|FG001|Overall Study|Study drug toxicity|0|||
17171915|NCT02419417|38321568|FG002|Overall Study|Study drug toxicity|0|||
17171916|NCT02419417|38321569|FG003|Overall Study|Study drug toxicity|0|||
17086782|NCT00378014|38227252|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
17086783|NCT00378014|38227253|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
17086784|NCT00485303|38227261|FG000|Overall Study|Adverse Event|5|||
16996628|NCT00970268|38140710|FG001|Overall Study|Lost to Follow-up|2|||
16996629|NCT00970268|38140709|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
17086785|NCT00485303|38227261|FG000|Overall Study|Progressive Disease|44|||
17086786|NCT00485303|38227261|FG000|Overall Study|Other|3|||
17086787|NCT00485303|38227261|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
17086788|NCT00485303|38227261|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
17086789|NCT00490841|38227265|FG000|Overall Study|Death|5|||
17086790|NCT00490841|38227265|FG000|Overall Study|Withdrawal by Subject|4|||
17086791|NCT00490841|38227265|FG000|Overall Study|Lost to Follow-up|1|||
17086792|NCT00490841|38227265|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
17086793|NCT00377858|38227272|FG000|Overall Study|Withdrawal by Subject|12|||
17086794|NCT00377858|38227273|FG001|Overall Study|Withdrawal by Subject|11|||
17086795|NCT00377858|38227272|FG000|Overall Study|Lost to Follow-up|6|||
17086796|NCT00377858|38227273|FG001|Overall Study|Lost to Follow-up|1|||
17086797|NCT00377858|38227272|FG000|Overall Study|Physician Decision|5|||
17086798|NCT00377858|38227273|FG001|Overall Study|Physician Decision|5|||
17086799|NCT00377858|38227272|FG000|Overall Study|Protocol Violation|3|||
17086800|NCT00377858|38227273|FG001|Overall Study|Protocol Violation|4|||
17086801|NCT00377858|38227272|FG000|Overall Study|Adverse Event|2|||
17086802|NCT00377858|38227273|FG001|Overall Study|Adverse Event|1|||
17086803|NCT00377858|38227272|FG000|Overall Study|Entry Criteria Not Met|2|||
17086804|NCT00377858|38227273|FG001|Overall Study|Entry Criteria Not Met|0|||
17086805|NCT00377858|38227272|FG000|Overall Study|Sponsor Decision|1|||
17086806|NCT00377858|38227273|FG001|Overall Study|Sponsor Decision|2|||
17086807|NCT00377858|38227272|FG000|Overall Study|Death|0|||
17086808|NCT00377858|38227273|FG001|Overall Study|Death|3|||
16996630|NCT00970268|38140710|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
16996631|NCT00969332|38140722|FG000|Overall Study|Physician Decision|8|||
16996632|NCT00969332|38140722|FG000|Overall Study|Withdrawal by Subject|3|||
16996633|NCT00968864|38140727|FG000|Overall Study|Protocol exception/ not evaluable|1|||
17171917|NCT02419417|38321570|FG004|Overall Study|Study drug toxicity|1|||
17086809|NCT00502775|38227282|FG000|Overall Study|Adverse Event|1|||
17086810|NCT00502775|38227283|FG001|Overall Study|Adverse Event|2|||
17086811|NCT00502775|38227284|FG002|Overall Study|Adverse Event|1|||
17086812|NCT00502775|38227282|FG000|Overall Study|Protocol Violation|1|||
17086813|NCT00502775|38227283|FG001|Overall Study|Protocol Violation|5|||
17171918|NCT02419417|38321571|FG005|Overall Study|Study drug toxicity|0|||
17171919|NCT02419417|38321572|FG006|Overall Study|Study drug toxicity|0|||
17171920|NCT02419417|38321573|FG007|Overall Study|Study drug toxicity|0|||
17171921|NCT02419417|38321574|FG008|Overall Study|Study drug toxicity|0|||
17086814|NCT00502775|38227284|FG002|Overall Study|Protocol Violation|2|||
17086815|NCT00502775|38227282|FG000|Overall Study|Withdrawal by Subject|1|||
17086816|NCT00502775|38227283|FG001|Overall Study|Withdrawal by Subject|1|||
17086817|NCT00502775|38227284|FG002|Overall Study|Withdrawal by Subject|2|||
17086818|NCT00502775|38227282|FG000|Overall Study|Sponsor Terminated Study|1|||
17086819|NCT00502775|38227283|FG001|Overall Study|Sponsor Terminated Study|0|||
17086820|NCT00502775|38227284|FG002|Overall Study|Sponsor Terminated Study|1|||
17086821|NCT00502775|38227282|FG000|Overall Study|Non-compliance with eDiary|4|||
17086822|NCT00502775|38227283|FG001|Overall Study|Non-compliance with eDiary|1|||
17086823|NCT00502775|38227284|FG002|Overall Study|Non-compliance with eDiary|1|||
17086824|NCT00502775|38227282|FG000|Overall Study|Subject unable to swallow capsule|1|||
17086825|NCT00502775|38227283|FG001|Overall Study|Subject unable to swallow capsule|0|||
17086826|NCT00502775|38227284|FG002|Overall Study|Subject unable to swallow capsule|1|||
17086827|NCT00502775|38227282|FG000|Overall Study|Logpad compliance <80%|1|||
17086828|NCT00502775|38227283|FG001|Overall Study|Logpad compliance <80%|0|||
17086829|NCT00502775|38227284|FG002|Overall Study|Logpad compliance <80%|0|||
17086830|NCT00502775|38227282|FG000|Overall Study|Randomized in error|0|||
17086831|NCT00502775|38227283|FG001|Overall Study|Randomized in error|1|||
17086832|NCT00502775|38227284|FG002|Overall Study|Randomized in error|1|||
17086833|NCT00502775|38227282|FG000|Overall Study|Non-compliance|0|||
17086834|NCT00502775|38227283|FG001|Overall Study|Non-compliance|2|||
17086835|NCT00502775|38227284|FG002|Overall Study|Non-compliance|2|||
17086836|NCT00502775|38227282|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
17086837|NCT00502775|38227283|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
17086838|NCT00502775|38227284|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
17086839|NCT00502775|38227282|FG000|Overall Study|Declining pollen counts|0|||
17086840|NCT00502775|38227283|FG001|Overall Study|Declining pollen counts|1|||
17086841|NCT00502775|38227284|FG002|Overall Study|Declining pollen counts|1|||
17086842|NCT00502775|38227282|FG000|Overall Study|Subject in jail|0|||
17086843|NCT00502775|38227283|FG001|Overall Study|Subject in jail|1|||
17086844|NCT00502775|38227284|FG002|Overall Study|Subject in jail|0|||
17086845|NCT00502775|38227282|FG000|Overall Study|Subject took disallowed drug|0|||
17086846|NCT00502775|38227283|FG001|Overall Study|Subject took disallowed drug|0|||
17086847|NCT00502775|38227284|FG002|Overall Study|Subject took disallowed drug|1|||
17086848|NCT00502697|38227294|FG000|Overall Study|Withdrawal by Subject|3|||
17171922|NCT02419417|38321575|FG009|Overall Study|Study drug toxicity|0|||
17171923|NCT02419417|38321576|FG010|Overall Study|Study drug toxicity|0|||
17171924|NCT02419417|38321566|FG000|Overall Study|Adverse event unrelated to study drug|0|||
17171925|NCT02419417|38321567|FG001|Overall Study|Adverse event unrelated to study drug|0|||
17171926|NCT02419417|38321568|FG002|Overall Study|Adverse event unrelated to study drug|0|||
17171927|NCT02419417|38321569|FG003|Overall Study|Adverse event unrelated to study drug|0|||
17171928|NCT02419417|38321570|FG004|Overall Study|Adverse event unrelated to study drug|2|||
17171929|NCT02419417|38321571|FG005|Overall Study|Adverse event unrelated to study drug|1|||
17171930|NCT02419417|38321572|FG006|Overall Study|Adverse event unrelated to study drug|0|||
17171931|NCT02419417|38321573|FG007|Overall Study|Adverse event unrelated to study drug|1|||
17171932|NCT02419417|38321574|FG008|Overall Study|Adverse event unrelated to study drug|0|||
17171933|NCT02419417|38321575|FG009|Overall Study|Adverse event unrelated to study drug|0|||
17086849|NCT00502697|38227295|FG001|Overall Study|Withdrawal by Subject|1|||
17086850|NCT00502697|38227294|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
17171934|NCT02419417|38321576|FG010|Overall Study|Adverse event unrelated to study drug|0|||
17171935|NCT02419417|38321566|FG000|Overall Study|Participant request to discontinue|0|||
17171936|NCT02419417|38321567|FG001|Overall Study|Participant request to discontinue|0|||
17171937|NCT02419417|38321568|FG002|Overall Study|Participant request to discontinue|0|||
17171938|NCT02419417|38321569|FG003|Overall Study|Participant request to discontinue|0|||
17171939|NCT02419417|38321570|FG004|Overall Study|Participant request to discontinue|0|||
17171940|NCT02419417|38321571|FG005|Overall Study|Participant request to discontinue|0|||
17171941|NCT02419417|38321572|FG006|Overall Study|Participant request to discontinue|0|||
17171942|NCT02419417|38321573|FG007|Overall Study|Participant request to discontinue|0|||
17171943|NCT02419417|38321574|FG008|Overall Study|Participant request to discontinue|0|||
17086851|NCT00502697|38227295|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
17086852|NCT00502697|38227294|FG000|Overall Study|found not to meet eligibility criteria|3|||
17086853|NCT00502697|38227295|FG001|Overall Study|found not to meet eligibility criteria|4|||
17086854|NCT00502697|38227294|FG000|Overall Study|did not meet assignment criteria|4|||
16996634|NCT00758680|38140745|FG000|Overall Study|Adverse Event|0|||
16996635|NCT00758680|38140746|FG001|Overall Study|Adverse Event|0|||
16996636|NCT00758680|38140747|FG002|Overall Study|Adverse Event|0|||
16996637|NCT00758680|38140748|FG003|Overall Study|Adverse Event|0|||
17086855|NCT00502697|38227295|FG001|Overall Study|did not meet assignment criteria|2|||
17086856|NCT00485069|38227303|FG000|Overall Study|Adverse Event|10|||
17086857|NCT00485069|38227304|FG001|Overall Study|Adverse Event|4|||
17086858|NCT00485069|38227303|FG000|Overall Study|Lack of Efficacy|2|||
17086859|NCT00485069|38227304|FG001|Overall Study|Lack of Efficacy|1|||
17086860|NCT00485069|38227303|FG000|Overall Study|Protocol Violation|0|||
17086861|NCT00485069|38227304|FG001|Overall Study|Protocol Violation|1|||
17086862|NCT00485069|38227303|FG000|Overall Study|Withdrawal by Subject|6|||
17086863|NCT00485069|38227304|FG001|Overall Study|Withdrawal by Subject|6|||
17086864|NCT00355082|38227319|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
17086865|NCT00355082|38227320|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
17086866|NCT00355082|38227321|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
17086867|NCT00355082|38227319|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
17086868|NCT00355082|38227320|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
17086869|NCT00355082|38227321|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
17086870|NCT00355082|38227319|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
17086871|NCT00355082|38227320|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
17086872|NCT00355082|38227321|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
17086873|NCT00355082|38227319|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
17086874|NCT00355082|38227320|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
17086875|NCT00355082|38227321|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
17086876|NCT00355082|38227319|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
17086877|NCT00355082|38227320|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
17086878|NCT00355082|38227321|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
17086879|NCT00355082|38227319|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
17086880|NCT00355082|38227320|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
17086881|NCT00355082|38227321|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
17086882|NCT00355082|38227319|FG000|Continuation Phase|Adverse Event|2|||
17086883|NCT00355082|38227320|FG001|Continuation Phase|Adverse Event|0|||
17086884|NCT00355082|38227321|FG002|Continuation Phase|Adverse Event|1|||
17086885|NCT00355082|38227319|FG000|Continuation Phase|Lost to Follow-up|2|||
17086886|NCT00355082|38227320|FG001|Continuation Phase|Lost to Follow-up|0|||
17086887|NCT00355082|38227321|FG002|Continuation Phase|Lost to Follow-up|1|||
17086888|NCT00355082|38227319|FG000|Continuation Phase|Protocol Violation|1|||
17086889|NCT00355082|38227320|FG001|Continuation Phase|Protocol Violation|0|||
17086890|NCT00355082|38227321|FG002|Continuation Phase|Protocol Violation|1|||
17086891|NCT00355082|38227319|FG000|Continuation Phase|Withdrawal by Subject|4|||
17086892|NCT00355082|38227320|FG001|Continuation Phase|Withdrawal by Subject|0|||
17086893|NCT00355082|38227321|FG002|Continuation Phase|Withdrawal by Subject|0|||
17086894|NCT00355082|38227319|FG000|Continuation Phase|Lack of Efficacy|5|||
17086895|NCT00355082|38227320|FG001|Continuation Phase|Lack of Efficacy|0|||
17086896|NCT00355082|38227321|FG002|Continuation Phase|Lack of Efficacy|0|||
17086897|NCT00355082|38227319|FG000|Continuation Phase|Site Closed by Sponsor|8|||
17086898|NCT00355082|38227320|FG001|Continuation Phase|Site Closed by Sponsor|0|||
17086899|NCT00355082|38227321|FG002|Continuation Phase|Site Closed by Sponsor|0|||
17086900|NCT00355082|38227319|FG000|Continuation Phase|Scheduling Error|1|||
17086901|NCT00355082|38227320|FG001|Continuation Phase|Scheduling Error|0|||
17086902|NCT00355082|38227321|FG002|Continuation Phase|Scheduling Error|0|||
17086903|NCT00355082|38227319|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
17086904|NCT00355082|38227320|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
17086905|NCT00355082|38227321|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
17086906|NCT00502307|38227332|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
17086907|NCT00502307|38227333|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
17086908|NCT00502307|38227334|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
17086909|NCT00502307|38227332|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
17086910|NCT00502307|38227333|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
17086911|NCT00502307|38227334|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
17086912|NCT00502307|38227332|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
17086913|NCT00502307|38227333|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
17086914|NCT00502307|38227334|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
17086915|NCT00502307|38227332|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
17086916|NCT00502307|38227333|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
17086917|NCT00502307|38227334|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
17086918|NCT00502307|38227332|FG000|Maintenance Period|Progressive disease|80|||
17086919|NCT00502307|38227333|FG001|Maintenance Period|Progressive disease|0|||
17086920|NCT00502307|38227334|FG002|Maintenance Period|Progressive disease|0|||
17086921|NCT00502307|38227332|FG000|Maintenance Period|Discontinued due to other reasons|68|||
17086922|NCT00502307|38227333|FG001|Maintenance Period|Discontinued due to other reasons|0|||
17086923|NCT00502307|38227334|FG002|Maintenance Period|Discontinued due to other reasons|0|||
17171944|NCT02419417|38321575|FG009|Overall Study|Participant request to discontinue|1|||
17171945|NCT02419417|38321576|FG010|Overall Study|Participant request to discontinue|0|||
17171946|NCT02419417|38321566|FG000|Overall Study|Withdrawal by Subject|0|||
17171947|NCT02419417|38321567|FG001|Overall Study|Withdrawal by Subject|0|||
17171948|NCT02419417|38321568|FG002|Overall Study|Withdrawal by Subject|0|||
17171949|NCT02419417|38321569|FG003|Overall Study|Withdrawal by Subject|0|||
17171950|NCT02419417|38321570|FG004|Overall Study|Withdrawal by Subject|0|||
17171951|NCT02419417|38321571|FG005|Overall Study|Withdrawal by Subject|0|||
17171952|NCT02419417|38321572|FG006|Overall Study|Withdrawal by Subject|0|||
17171953|NCT02419417|38321573|FG007|Overall Study|Withdrawal by Subject|0|||
17171954|NCT02419417|38321574|FG008|Overall Study|Withdrawal by Subject|0|||
17171955|NCT02419417|38321575|FG009|Overall Study|Withdrawal by Subject|0|||
17171956|NCT02419417|38321576|FG010|Overall Study|Withdrawal by Subject|1|||
17171957|NCT00777491|38321617|FG000|Overall Study|Protocol Violation|0|||
17171958|NCT00777491|38321618|FG001|Overall Study|Protocol Violation|2|||
17171959|NCT00777491|38321617|FG000|Overall Study|Did not receive any protocol treatment|2|||
17171960|NCT00777491|38321618|FG001|Overall Study|Did not receive any protocol treatment|0|||
17171961|NCT03077711|38321630|FG000|Overall Study|Lost to Follow-up|2|||
17171962|NCT03077711|38321631|FG001|Overall Study|Lost to Follow-up|2|||
17171963|NCT03077711|38321630|FG000|Overall Study|noncompliant taking medication|2|||
17171964|NCT03077711|38321631|FG001|Overall Study|noncompliant taking medication|0|||
17171965|NCT04311463|38321658|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
17171966|NCT04311463|38321659|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
17171967|NCT04311463|38321658|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
17171968|NCT04311463|38321659|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
17171969|NCT04311463|38321658|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
17171970|NCT04311463|38321659|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
17171971|NCT01370538|38321672|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
17171972|NCT01370538|38321673|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
17171973|NCT01370538|38321672|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
17086924|NCT00484679|38227351|FG000|Overall Study|Withdrawal by Subject|3|||
17086925|NCT00377312|38227357|FG000|Overall Study|Adverse Event|1|||
17086926|NCT00377312|38227358|FG001|Overall Study|Adverse Event|1|||
17086927|NCT00377234|38227366|FG000|Overall Study|Adverse Event|14|||
17086928|NCT00377234|38227367|FG001|Overall Study|Adverse Event|17|||
17086929|NCT00377234|38227366|FG000|Overall Study|Withdrawal by Subject|11|||
17086930|NCT00377234|38227367|FG001|Overall Study|Withdrawal by Subject|9|||
17086931|NCT00377234|38227366|FG000|Overall Study|Lost to Follow-up|4|||
17086932|NCT00377234|38227367|FG001|Overall Study|Lost to Follow-up|2|||
17086933|NCT00377234|38227366|FG000|Overall Study|Administrative|2|||
17086934|NCT00377234|38227367|FG001|Overall Study|Administrative|1|||
17086935|NCT00377234|38227366|FG000|Overall Study|Not assigned|3|||
17086936|NCT00377234|38227367|FG001|Overall Study|Not assigned|2|||
17086937|NCT00377156|38227381|FG000|Overall Study|Death|23|||
17086938|NCT00377156|38227382|FG001|Overall Study|Death|19|||
17086939|NCT00377156|38227381|FG000|Overall Study|Withdrawal by Subject|16|||
17086940|NCT00377156|38227382|FG001|Overall Study|Withdrawal by Subject|24|||
17086941|NCT00377156|38227381|FG000|Overall Study|Had follow-up <90 d|3|||
17086942|NCT00377156|38227382|FG001|Overall Study|Had follow-up <90 d|6|||
17171974|NCT01370538|38321673|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
17171975|NCT01370538|38321672|FG000|Overall Study|Adverse Event|1|||
17171976|NCT01370538|38321673|FG001|Overall Study|Adverse Event|0|||
17171977|NCT01370538|38321672|FG000|Overall Study|Protocol Violation|8|||
17171978|NCT01370538|38321673|FG001|Overall Study|Protocol Violation|5|||
17171979|NCT01370538|38321672|FG000|Overall Study|Development of study specific withdrawal|1|||
17171980|NCT01370538|38321673|FG001|Overall Study|Development of study specific withdrawal|1|||
17171981|NCT01370538|38321672|FG000|Overall Study|Lost to follow up|6|||
17171982|NCT01370538|38321673|FG001|Overall Study|Lost to follow up|10|||
17171983|NCT03402841|38321692|FG000|Overall Study|Withdrawal by Subject|3|||
17171984|NCT03402841|38321692|FG000|Overall Study|Lost to Follow-up|2|||
17171985|NCT03402841|38321692|FG000|Overall Study|Death|146|||
17171986|NCT02881957|38321707|FG000|Overall Study|Comfort care|0|||
17171987|NCT02881957|38321708|FG001|Overall Study|Comfort care|1|||
17171988|NCT02881957|38321707|FG000|Overall Study|Concurrent trial enrollment|0|||
17171989|NCT02881957|38321708|FG001|Overall Study|Concurrent trial enrollment|1|||
17171990|NCT02881957|38321707|FG000|Overall Study|Discharged within 48 hours|0|||
17171991|NCT02881957|38321708|FG001|Overall Study|Discharged within 48 hours|1|||
17171992|NCT02881957|38321707|FG000|Overall Study|Withdrawal by Subject|2|||
17086943|NCT00377156|38227381|FG000|Overall Study|Cancellation|1|||
17086944|NCT00377156|38227382|FG001|Overall Study|Cancellation|0|||
17086945|NCT00377156|38227381|FG000|Overall Study|Refused testing|0|||
17086946|NCT00377156|38227382|FG001|Overall Study|Refused testing|1|||
17171993|NCT02881957|38321708|FG001|Overall Study|Withdrawal by Subject|1|||
17171994|NCT02881957|38321707|FG000|Overall Study|Protocol Violation|1|||
17171995|NCT02881957|38321708|FG001|Overall Study|Protocol Violation|0|||
17171996|NCT03022461|38321714|FG000|Overall Study|Death|3|||
17171997|NCT02750930|38321719|FG000|Overall Study|Study closed/terminated|8|||
17171998|NCT03078907|38321725|FG000|Overall Study|Adverse Event|2|||
17171999|NCT03078907|38321726|FG001|Overall Study|Adverse Event|0|||
17172000|NCT03078907|38321725|FG000|Overall Study|Other|1|||
17172001|NCT03078907|38321726|FG001|Overall Study|Other|0|||
17172002|NCT03078907|38321725|FG000|Overall Study|Protocol Violation|0|||
17172003|NCT03078907|38321726|FG001|Overall Study|Protocol Violation|1|||
17172004|NCT03249714|38321734|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
17172005|NCT03249714|38321735|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
17172006|NCT03249714|38321734|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
17172007|NCT03249714|38321735|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
17172008|NCT03249714|38321734|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
17172009|NCT03249714|38321735|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
17172010|NCT03249714|38321734|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
17172011|NCT03249714|38321735|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
17172012|NCT02925117|38321761|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
17172013|NCT02925117|38321762|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
17172014|NCT02925117|38321763|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
17172015|NCT02925117|38321764|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
17172016|NCT02925117|38321765|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
17172017|NCT02925117|38321766|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
17172018|NCT02925117|38321767|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
17172019|NCT02925117|38321768|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
17172020|NCT02925117|38321769|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
17172021|NCT02925117|38321770|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
17172022|NCT02925117|38321771|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
17172023|NCT02925117|38321772|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
17172024|NCT02925117|38321761|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
17172025|NCT02925117|38321762|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
17172026|NCT02925117|38321763|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
17172027|NCT02925117|38321764|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172028|NCT02925117|38321765|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172029|NCT02925117|38321766|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172030|NCT02925117|38321767|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172031|NCT02925117|38321768|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172032|NCT02925117|38321769|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172033|NCT02925117|38321770|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172034|NCT02925117|38321771|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172035|NCT02925117|38321772|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
17172036|NCT02925117|38321761|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
17172037|NCT02925117|38321762|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
17172038|NCT02925117|38321763|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17172039|NCT02925117|38321764|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17172040|NCT02925117|38321765|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17172041|NCT02925117|38321766|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17172042|NCT02925117|38321767|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17086947|NCT00377156|38227381|FG000|Overall Study|Ineligible|0|||
17086948|NCT00377156|38227382|FG001|Overall Study|Ineligible|1|||
17086949|NCT00377156|38227381|FG000|Overall Study|Disability or language problem|0|||
17086950|NCT00377156|38227382|FG001|Overall Study|Disability or language problem|1|||
17086951|NCT00377156|38227381|FG000|Overall Study|Other|5|||
17086952|NCT00377156|38227382|FG001|Overall Study|Other|2|||
17086953|NCT00376688|38227390|FG000|Overall Study|Adverse Event|3|||
17086954|NCT00376688|38227390|FG000|Overall Study|Death|1|||
17086955|NCT00376532|38227396|FG000|Overall Study|Lack sufficient blood sample|6|||
17086956|NCT00376532|38227397|FG001|Overall Study|Lack sufficient blood sample|6|||
17086957|NCT00376220|38227405|FG000|Overall Study|Lost to Follow-up|7|||
17086958|NCT00376220|38227406|FG001|Overall Study|Lost to Follow-up|10|||
17086959|NCT00376220|38227405|FG000|Overall Study|Withdrawal by Subject|3|||
17086960|NCT00376220|38227406|FG001|Overall Study|Withdrawal by Subject|2|||
17086961|NCT00375752|38227414|FG000|Overall Study|Lack of Efficacy|4|||
17086962|NCT00375752|38227415|FG001|Overall Study|Lack of Efficacy|4|||
17086963|NCT00375752|38227414|FG000|Overall Study|Adverse Event|1|||
17086964|NCT00375752|38227415|FG001|Overall Study|Adverse Event|6|||
17086965|NCT00375752|38227414|FG000|Overall Study|Withdrawal by Subject|6|||
17086966|NCT00375752|38227415|FG001|Overall Study|Withdrawal by Subject|1|||
17086967|NCT00375752|38227414|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
17086968|NCT00375752|38227415|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
17086969|NCT00375752|38227414|FG000|Overall Study|Protocol Violation|0|||
17086970|NCT00375752|38227415|FG001|Overall Study|Protocol Violation|2|||
17172043|NCT02925117|38321768|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17086971|NCT00375752|38227414|FG000|Overall Study|Administrative Problems|0|||
17086972|NCT00375752|38227415|FG001|Overall Study|Administrative Problems|1|||
17086973|NCT00484289|38227424|FG000|Long Term Phase|Adverse Event|1|||
17086974|NCT00484289|38227425|FG001|Long Term Phase|Adverse Event|17|||
17086975|NCT00484289|38227426|FG002|Long Term Phase|Adverse Event|5|||
17086976|NCT00484289|38227424|FG000|Long Term Phase|Withdrawal by Subject|0|||
17086977|NCT00484289|38227425|FG001|Long Term Phase|Withdrawal by Subject|7|||
17086978|NCT00484289|38227426|FG002|Long Term Phase|Withdrawal by Subject|6|||
17172044|NCT02925117|38321769|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17172045|NCT02925117|38321770|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17172046|NCT02925117|38321771|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17172047|NCT02925117|38321772|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
17172048|NCT02925117|38321761|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
17172049|NCT02925117|38321762|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
17172050|NCT02925117|38321763|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
17172051|NCT02925117|38321764|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
17172052|NCT02925117|38321765|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
17172053|NCT02925117|38321766|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
17172054|NCT02925117|38321767|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
17172055|NCT02925117|38321768|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
17172056|NCT02925117|38321769|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
17172057|NCT02925117|38321770|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
17172058|NCT02925117|38321771|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
17172059|NCT02925117|38321772|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
17172060|NCT02925117|38321761|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172061|NCT02925117|38321762|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172062|NCT02925117|38321763|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172063|NCT02925117|38321764|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172064|NCT02925117|38321765|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172065|NCT02925117|38321766|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
17172066|NCT02925117|38321767|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172067|NCT02925117|38321768|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172068|NCT02925117|38321769|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172069|NCT02925117|38321770|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
17172070|NCT02925117|38321771|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
17172071|NCT02925117|38321772|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
17172072|NCT02925117|38321761|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
17172073|NCT02925117|38321762|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
17172074|NCT02925117|38321763|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
17172075|NCT02925117|38321764|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
17172076|NCT02925117|38321765|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
17172077|NCT02925117|38321766|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
17172078|NCT02925117|38321767|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
17172079|NCT02925117|38321768|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
17172080|NCT02925117|38321769|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
17172081|NCT02925117|38321770|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
17172082|NCT02925117|38321771|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
17172083|NCT02925117|38321772|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
17172084|NCT02925117|38321761|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
17172085|NCT02925117|38321762|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
17172086|NCT02925117|38321763|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
17172087|NCT02925117|38321764|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
17172088|NCT02925117|38321765|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
17172089|NCT02925117|38321766|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
17172090|NCT02925117|38321767|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
17172091|NCT02925117|38321768|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
17172092|NCT02925117|38321769|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
17172093|NCT02925117|38321770|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
17172094|NCT02925117|38321771|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
17172095|NCT02925117|38321772|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
17172096|NCT02925117|38321761|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
17172097|NCT02925117|38321762|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
17172098|NCT02925117|38321763|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
17172099|NCT02925117|38321764|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
17172100|NCT02925117|38321765|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
17172101|NCT02925117|38321766|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
17172102|NCT02925117|38321767|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
17172103|NCT02925117|38321768|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
17172104|NCT02925117|38321769|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
17172105|NCT02925117|38321770|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
17172106|NCT02925117|38321771|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
17172107|NCT02925117|38321772|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
17172108|NCT03075163|38321796|FG000|Overall Study|not eligible for treatment limb|138|||
17086979|NCT00484289|38227424|FG000|Long Term Phase|Inadequate response|2|||
17086980|NCT00484289|38227425|FG001|Long Term Phase|Inadequate response|7|||
17172109|NCT03075163|38321797|FG001|Overall Study|not eligible for treatment limb|138|||
17172110|NCT03078751|38321805|FG000|Overall Study|Adverse Event|4|||
17172111|NCT03078751|38321806|FG001|Overall Study|Adverse Event|0|||
17172112|NCT03078751|38321805|FG000|Overall Study|Physician Decision|1|||
17172113|NCT03078751|38321806|FG001|Overall Study|Physician Decision|0|||
17172114|NCT03078751|38321805|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
17172115|NCT03078751|38321806|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
17172116|NCT03078751|38321805|FG000|Overall Study|Subject/guardian decision|8|||
17172117|NCT03078751|38321806|FG001|Overall Study|Subject/guardian decision|1|||
17172118|NCT03078751|38321805|FG000|Overall Study|Untreated|0|||
17172119|NCT03078751|38321806|FG001|Overall Study|Untreated|4|||
17172120|NCT02924883|38321814|FG000|Overall Study|Death|39|||
17172121|NCT02924883|38321815|FG001|Overall Study|Death|20|||
17172122|NCT02924883|38321814|FG000|Overall Study|Lost to Follow-up|1|||
17172123|NCT02924883|38321815|FG001|Overall Study|Lost to Follow-up|0|||
17172124|NCT02924883|38321814|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
17172125|NCT02924883|38321815|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
17172126|NCT02924883|38321814|FG000|Overall Study|Protocol Violation|1|||
17172127|NCT02924883|38321815|FG001|Overall Study|Protocol Violation|0|||
17172128|NCT02924883|38321814|FG000|Overall Study|Withdrawal by Subject|22|||
17172129|NCT02924883|38321815|FG001|Overall Study|Withdrawal by Subject|16|||
17172130|NCT02924883|38321814|FG000|Overall Study|Progressive Disease|1|||
17172131|NCT02924883|38321815|FG001|Overall Study|Progressive Disease|0|||
17172132|NCT02924883|38321814|FG000|Overall Study|Study Terminated by Sponsor|69|||
17172133|NCT02924883|38321815|FG001|Overall Study|Study Terminated by Sponsor|32|||
17172134|NCT01369680|38321838|FG000|Overall Study|Lost to Follow-up|0|||
17172135|NCT01369680|38321839|FG001|Overall Study|Lost to Follow-up|0|||
17172136|NCT01369680|38321840|FG002|Overall Study|Lost to Follow-up|1|||
17172137|NCT01369680|38321841|FG003|Overall Study|Lost to Follow-up|2|||
17172138|NCT03074149|38321873|FG000|Overall Study|Reason unknown|22|||
17172139|NCT03074149|38321874|FG001|Overall Study|Reason unknown|35|||
17172140|NCT03074149|38321873|FG000|Overall Study|Death|10|||
17172141|NCT03074149|38321874|FG001|Overall Study|Death|45|||
17172142|NCT02751320|38321882|FG000|Overall Study|Adverse Event|2|||
17172143|NCT02751320|38321882|FG000|Overall Study|Withdrawal by Subject|1|||
17172144|NCT02206035|38321910|FG000|Overall Study|Physician Decision|10|||
17172145|NCT02206035|38321911|FG001|Overall Study|Physician Decision|0|||
17172146|NCT02206035|38321912|FG002|Overall Study|Physician Decision|175|||
17172147|NCT02746471|38321919|FG000|Overall Study|Death|43|||
17172148|NCT02746471|38321919|FG000|Overall Study|Exited before 36 months|1119|||
17172149|NCT02591953|38321926|FG000|Overall Study|Lost to Follow-up|6|||
17172150|NCT02591953|38321927|FG001|Overall Study|Lost to Follow-up|6|||
17172151|NCT03073213|38321935|FG000|Multiple Dose Period|Protocol Violation|0|||
17172152|NCT03073213|38321936|FG001|Multiple Dose Period|Protocol Violation|0|||
17172153|NCT03073213|38321937|FG002|Multiple Dose Period|Protocol Violation|1|||
17172154|NCT03070483|38321946|FG000|Overall Study|Lost to Follow-up|2|||
17172155|NCT01757535|38321953|FG000|Overall Study|Disease Relapse|143|||
17172156|NCT01757535|38321954|FG001|Overall Study|Disease Relapse|180|||
17172157|NCT01757535|38321953|FG000|Overall Study|Adverse Event|29|||
17172158|NCT01757535|38321954|FG001|Overall Study|Adverse Event|11|||
17172159|NCT01757535|38321953|FG000|Overall Study|Withdrawal by Subject|9|||
17172160|NCT01757535|38321954|FG001|Overall Study|Withdrawal by Subject|13|||
17172161|NCT01757535|38321953|FG000|Overall Study|Miscellaneous|5|||
17172162|NCT01757535|38321954|FG001|Overall Study|Miscellaneous|2|||
17172163|NCT01757535|38321953|FG000|Overall Study|Physician Decision|6|||
17172164|NCT01757535|38321954|FG001|Overall Study|Physician Decision|0|||
17172165|NCT01757535|38321953|FG000|Overall Study|Death|1|||
17172166|NCT01757535|38321954|FG001|Overall Study|Death|2|||
17172167|NCT02231762|38321960|FG000|Combination Phase|Adverse Event|10|||
17172168|NCT02231762|38321961|FG001|Combination Phase|Adverse Event|0|||
17172169|NCT02231762|38321962|FG002|Combination Phase|Adverse Event|0|||
17172170|NCT02231762|38321963|FG003|Combination Phase|Adverse Event|0|||
17172171|NCT02231762|38321960|FG000|Combination Phase|Withdrawal by Subject|2|||
17172172|NCT02231762|38321961|FG001|Combination Phase|Withdrawal by Subject|0|||
17172173|NCT02231762|38321962|FG002|Combination Phase|Withdrawal by Subject|0|||
17172174|NCT02231762|38321963|FG003|Combination Phase|Withdrawal by Subject|0|||
17172175|NCT02231762|38321960|FG000|Combination Phase|Disease Progression|6|||
17172176|NCT02231762|38321961|FG001|Combination Phase|Disease Progression|0|||
17172177|NCT02231762|38321962|FG002|Combination Phase|Disease Progression|0|||
17172178|NCT02231762|38321963|FG003|Combination Phase|Disease Progression|0|||
17172179|NCT02231762|38321960|FG000|Combination Phase|Did not meet inclusion criteria|1|||
17172180|NCT02231762|38321961|FG001|Combination Phase|Did not meet inclusion criteria|0|||
17172181|NCT02231762|38321962|FG002|Combination Phase|Did not meet inclusion criteria|0|||
17172182|NCT02231762|38321963|FG003|Combination Phase|Did not meet inclusion criteria|0|||
17172183|NCT02231762|38321960|FG000|Combination Phase|Protocol Violation|1|||
17172184|NCT02231762|38321961|FG001|Combination Phase|Protocol Violation|0|||
17172185|NCT02231762|38321962|FG002|Combination Phase|Protocol Violation|0|||
17172186|NCT02231762|38321963|FG003|Combination Phase|Protocol Violation|0|||
17172187|NCT02231762|38321960|FG000|Maintenance Phase|Disease progression|0|||
17172188|NCT02231762|38321961|FG001|Maintenance Phase|Disease progression|3|||
17172189|NCT02231762|38321962|FG002|Maintenance Phase|Disease progression|4|||
17172190|NCT02231762|38321963|FG003|Maintenance Phase|Disease progression|3|||
17172191|NCT02231762|38321960|FG000|Maintenance Phase|Adverse Event|0|||
17172192|NCT02231762|38321961|FG001|Maintenance Phase|Adverse Event|0|||
17172193|NCT02231762|38321962|FG002|Maintenance Phase|Adverse Event|1|||
17172194|NCT02231762|38321963|FG003|Maintenance Phase|Adverse Event|2|||
17172195|NCT02750618|38321977|FG000|Overall Study|Withdrawal by Subject|1|||
17172196|NCT03023397|38321984|FG000|Run-In|Failed screening allergen challenge|1|||
17172197|NCT03023397|38321985|FG001|Run-In|Failed screening allergen challenge|0|||
17172198|NCT03023397|38321986|FG002|Run-In|Failed screening allergen challenge|0|||
17172199|NCT03023397|38321984|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
17172200|NCT03023397|38321985|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
17086981|NCT00484289|38227426|FG002|Long Term Phase|Inadequate response|4|||
17086982|NCT00484289|38227424|FG000|Long Term Phase|Other Reason|0|||
17086983|NCT00484289|38227425|FG001|Long Term Phase|Other Reason|5|||
17086984|NCT00484289|38227426|FG002|Long Term Phase|Other Reason|1|||
17086985|NCT00484289|38227424|FG000|Post Marketing Phase|Adverse Event|0|||
17086986|NCT00484289|38227425|FG001|Post Marketing Phase|Adverse Event|1|||
17086987|NCT00484289|38227426|FG002|Post Marketing Phase|Adverse Event|0|||
17086988|NCT00490529|38227435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
17172201|NCT03023397|38321986|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
17172202|NCT04325906|38321997|FG000|Overall Study|Withdrawal by Subject|2|||
17172203|NCT04325906|38321998|FG001|Overall Study|Withdrawal by Subject|0|||
17172204|NCT03068455|38322006|FG000|Pre-treatment Period|Disease progression|0|||
17172205|NCT03068455|38322007|FG001|Pre-treatment Period|Disease progression|1|||
17172206|NCT03068455|38322006|FG000|Pre-treatment Period|Participant withdrew consent|1|||
17172207|NCT03068455|38322007|FG001|Pre-treatment Period|Participant withdrew consent|1|||
17172208|NCT03068455|38322006|FG000|Pre-treatment Period|Poor/non-compliance|0|||
17172209|NCT03068455|38322007|FG001|Pre-treatment Period|Poor/non-compliance|1|||
17172210|NCT03068455|38322006|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
17172211|NCT03068455|38322007|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
17172212|NCT03068455|38322006|FG000|Pre-treatment Period|Not reported|2|||
17172213|NCT03068455|38322007|FG001|Pre-treatment Period|Not reported|1|||
17172214|NCT03068455|38322006|FG000|Treatment Period|Disease progression|166|||
17172215|NCT03068455|38322007|FG001|Treatment Period|Disease progression|208|||
17086989|NCT00490529|38227435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
17086990|NCT00490529|38227435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
17086991|NCT00490529|38227435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
17086992|NCT00490529|38227435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
17086993|NCT00490529|38227435|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
17086994|NCT00333840|38227441|FG000|First-line Treatment Period|Adverse Event|38|||
17086995|NCT00333840|38227442|FG001|First-line Treatment Period|Adverse Event|37|||
17086996|NCT00333840|38227443|FG002|First-line Treatment Period|Adverse Event|0|||
17086997|NCT00333840|38227444|FG003|First-line Treatment Period|Adverse Event|0|||
17086998|NCT00333840|38227441|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
17086999|NCT00333840|38227442|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
17087000|NCT00333840|38227443|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
17087001|NCT00333840|38227444|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
17087002|NCT00333840|38227441|FG000|First-line Treatment Period|Abnormal procedure|2|||
17087003|NCT00333840|38227442|FG001|First-line Treatment Period|Abnormal procedure|0|||
17087004|NCT00333840|38227443|FG002|First-line Treatment Period|Abnormal procedure|0|||
17087005|NCT00333840|38227444|FG003|First-line Treatment Period|Abnormal procedure|0|||
17087006|NCT00333840|38227441|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
16868027|NCT01536145|37841036|FG003|Overall Study|Other|0|||
17087007|NCT00333840|38227442|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
17087008|NCT00333840|38227443|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
17087009|NCT00333840|38227444|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
17087010|NCT00333840|38227441|FG000|First-line Treatment Period|No longer required study drug|21|||
17087011|NCT00333840|38227442|FG001|First-line Treatment Period|No longer required study drug|8|||
17087012|NCT00333840|38227443|FG002|First-line Treatment Period|No longer required study drug|0|||
17087013|NCT00333840|38227444|FG003|First-line Treatment Period|No longer required study drug|0|||
17087014|NCT00333840|38227441|FG000|First-line Treatment Period|Protocol Violation|17|||
17087015|NCT00333840|38227442|FG001|First-line Treatment Period|Protocol Violation|17|||
17087016|NCT00333840|38227443|FG002|First-line Treatment Period|Protocol Violation|0|||
17087017|NCT00333840|38227444|FG003|First-line Treatment Period|Protocol Violation|0|||
17087018|NCT00333840|38227441|FG000|First-line Treatment Period|Subject withdrew consent|57|||
17172216|NCT03068455|38322006|FG000|Treatment Period|Study drug toxicity|317|||
17087019|NCT00333840|38227442|FG001|First-line Treatment Period|Subject withdrew consent|77|||
17087020|NCT00333840|38227443|FG002|First-line Treatment Period|Subject withdrew consent|0|||
17087021|NCT00333840|38227444|FG003|First-line Treatment Period|Subject withdrew consent|0|||
17087022|NCT00333840|38227441|FG000|First-line Treatment Period|Lost to Follow-up|15|||
17087023|NCT00333840|38227442|FG001|First-line Treatment Period|Lost to Follow-up|6|||
17087024|NCT00333840|38227443|FG002|First-line Treatment Period|Lost to Follow-up|0|||
17087025|NCT00333840|38227444|FG003|First-line Treatment Period|Lost to Follow-up|0|||
17087026|NCT00333840|38227441|FG000|First-line Treatment Period|Administrative problems|12|||
16996638|NCT00758680|38140749|FG004|Overall Study|Adverse Event|0|||
16996639|NCT00758680|38140750|FG005|Overall Study|Adverse Event|0|||
16996640|NCT00758680|38140751|FG006|Overall Study|Adverse Event|0|||
16996641|NCT00758680|38140752|FG007|Overall Study|Adverse Event|1|||
16996642|NCT00758680|38140753|FG008|Overall Study|Adverse Event|0|||
16996643|NCT00758680|38140754|FG009|Overall Study|Adverse Event|1|||
16996644|NCT00758680|38140745|FG000|Overall Study|Laboratory Adverse Event|0|||
17087027|NCT00333840|38227442|FG001|First-line Treatment Period|Administrative problems|6|||
17087028|NCT00333840|38227443|FG002|First-line Treatment Period|Administrative problems|0|||
17087029|NCT00333840|38227444|FG003|First-line Treatment Period|Administrative problems|0|||
17087030|NCT00333840|38227441|FG000|First-line Treatment Period|Death|19|||
17087031|NCT00333840|38227442|FG001|First-line Treatment Period|Death|2|||
17087032|NCT00333840|38227443|FG002|First-line Treatment Period|Death|0|||
17087033|NCT00333840|38227444|FG003|First-line Treatment Period|Death|0|||
17172217|NCT03068455|38322007|FG001|Treatment Period|Study drug toxicity|104|||
17172218|NCT03068455|38322006|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
17172219|NCT03068455|38322007|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
17172220|NCT03068455|38322006|FG000|Treatment Period|Participant request to stop therapy|33|||
17172221|NCT03068455|38322007|FG001|Treatment Period|Participant request to stop therapy|20|||
17172222|NCT03068455|38322006|FG000|Treatment Period|Participant withdrew consent|5|||
17172223|NCT03068455|38322007|FG001|Treatment Period|Participant withdrew consent|10|||
17172224|NCT03068455|38322006|FG000|Treatment Period|Poor/non-compliance|3|||
17172225|NCT03068455|38322007|FG001|Treatment Period|Poor/non-compliance|0|||
17172226|NCT03068455|38322006|FG000|Treatment Period|Participant no longer meets study criteria|1|||
17087034|NCT00333840|38227441|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
17087035|NCT00333840|38227442|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
17087036|NCT00333840|38227443|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
17172227|NCT03068455|38322007|FG001|Treatment Period|Participant no longer meets study criteria|3|||
17172228|NCT03068455|38322006|FG000|Treatment Period|Other reasons|12|||
17172229|NCT03068455|38322007|FG001|Treatment Period|Other reasons|4|||
17172230|NCT03067987|38322015|FG000|Overall Study|Lost to Follow-up|7|||
17172231|NCT03067987|38322016|FG001|Overall Study|Lost to Follow-up|10|||
17172232|NCT03067987|38322015|FG000|Overall Study|Protocol Violation|1|||
17172233|NCT03067987|38322016|FG001|Overall Study|Protocol Violation|2|||
17172234|NCT03067987|38322015|FG000|Overall Study|Withdrawal by Subject|2|||
17172235|NCT03067987|38322016|FG001|Overall Study|Withdrawal by Subject|1|||
17172236|NCT04889222|38322022|FG000|Overall Study|Did not meet eligibility criteria|8|||
17172237|NCT04889222|38322022|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
16996645|NCT00758680|38140746|FG001|Overall Study|Laboratory Adverse Event|0|||
17087037|NCT00333840|38227444|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
17087038|NCT00333840|38227441|FG000|Second-line Treatment Period|Adverse Event|0|||
17087039|NCT00333840|38227442|FG001|Second-line Treatment Period|Adverse Event|0|||
17087040|NCT00333840|38227443|FG002|Second-line Treatment Period|Adverse Event|3|||
17172238|NCT04889222|38322022|FG000|Overall Study|Did not proceed due to time constraints|5|||
17172239|NCT03067441|38322028|FG000|Overall Study|Withdrawal by Subject|16|||
17172240|NCT03067441|38322029|FG001|Overall Study|Withdrawal by Subject|34|||
17172241|NCT03067441|38322028|FG000|Overall Study|Lost to Follow-up|7|||
17172242|NCT03067441|38322029|FG001|Overall Study|Lost to Follow-up|5|||
16996646|NCT00758680|38140747|FG002|Overall Study|Laboratory Adverse Event|0|||
16996647|NCT00758680|38140748|FG003|Overall Study|Laboratory Adverse Event|0|||
16996648|NCT00758680|38140749|FG004|Overall Study|Laboratory Adverse Event|0|||
16996649|NCT00758680|38140750|FG005|Overall Study|Laboratory Adverse Event|0|||
17172243|NCT03067441|38322028|FG000|Overall Study|Adverse Event|7|||
17172244|NCT03067441|38322029|FG001|Overall Study|Adverse Event|14|||
17172245|NCT03067441|38322028|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
17172246|NCT03067441|38322029|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
17172247|NCT03067441|38322028|FG000|Overall Study|Physician Decision|1|||
17172248|NCT03067441|38322029|FG001|Overall Study|Physician Decision|3|||
17172249|NCT03067441|38322028|FG000|Overall Study|Other|1|||
17172250|NCT03067441|38322029|FG001|Overall Study|Other|1|||
17172251|NCT02600923|38322038|FG000|Overall Study|Death|10|||
17172252|NCT02600923|38322038|FG000|Overall Study|Adverse Event|3|||
17172253|NCT02600923|38322038|FG000|Overall Study|Global deterioration of health status|2|||
17172254|NCT02600923|38322038|FG000|Overall Study|Insufficient clinical response|6|||
17172255|NCT02600923|38322038|FG000|Overall Study|Lost to Follow-up|1|||
17172256|NCT02600923|38322038|FG000|Overall Study|Withdrawal by Subject|5|||
17172257|NCT02600923|38322038|FG000|Overall Study|Objective progression or relapse|50|||
17172258|NCT02600923|38322038|FG000|Overall Study|Study terminated by Sponsor|53|||
17172259|NCT02600923|38322038|FG000|Overall Study|Not treated|1|||
17172260|NCT03070171|38322044|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
17172261|NCT03070171|38322045|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
17172262|NCT03070171|38322044|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
17172263|NCT03070171|38322045|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
17172264|NCT01084252|38322065|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
17172265|NCT01084252|38322066|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
17172266|NCT01084252|38322067|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
17172267|NCT01084252|38322068|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
17172268|NCT01084252|38322069|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
17172269|NCT01084252|38322070|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
17172270|NCT01084252|38322071|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
17172271|NCT01084252|38322072|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
17172272|NCT01084252|38322073|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
17172273|NCT01084252|38322074|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
17172274|NCT01084252|38322075|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
17172275|NCT01084252|38322076|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
17172276|NCT01084252|38322077|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
17172277|NCT01084252|38322078|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
17172278|NCT01084252|38322065|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
17172279|NCT01084252|38322066|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
17172280|NCT01084252|38322067|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
17172281|NCT01084252|38322068|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
17172282|NCT01084252|38322069|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
17172283|NCT01084252|38322070|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
17172284|NCT01084252|38322071|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
17172285|NCT01084252|38322072|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
17172286|NCT01084252|38322073|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
17172287|NCT01084252|38322074|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
17172288|NCT01084252|38322075|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
17172289|NCT01084252|38322076|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
17172290|NCT01084252|38322077|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
17172291|NCT01084252|38322078|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
17172292|NCT01084252|38322065|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
17172293|NCT01084252|38322066|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
17172294|NCT01084252|38322067|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
17172295|NCT01084252|38322068|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
17172296|NCT01084252|38322069|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
17172297|NCT01084252|38322070|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
17172298|NCT01084252|38322071|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
17172299|NCT01084252|38322072|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
17172300|NCT01084252|38322073|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
17172301|NCT01084252|38322074|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
17172302|NCT01084252|38322075|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
17172303|NCT01084252|38322076|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
17172304|NCT01084252|38322077|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
17172305|NCT01084252|38322078|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
17172306|NCT01084252|38322065|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172307|NCT01084252|38322066|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172308|NCT01084252|38322067|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172309|NCT01084252|38322068|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172310|NCT01084252|38322069|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172311|NCT01084252|38322070|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172312|NCT01084252|38322071|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172313|NCT01084252|38322072|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172314|NCT01084252|38322073|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172315|NCT01084252|38322074|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
17172316|NCT01084252|38322075|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
17172317|NCT01084252|38322076|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
17172318|NCT01084252|38322077|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172319|NCT01084252|38322078|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
17172320|NCT01084252|38322065|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172321|NCT01084252|38322066|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172322|NCT01084252|38322067|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172323|NCT01084252|38322068|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172324|NCT01084252|38322069|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172325|NCT01084252|38322070|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172326|NCT01084252|38322071|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172327|NCT01084252|38322072|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172328|NCT01084252|38322073|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
17172329|NCT01084252|38322074|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
17172330|NCT01084252|38322075|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
17172331|NCT01084252|38322076|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
17172332|NCT01084252|38322077|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172333|NCT01084252|38322078|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
17172334|NCT01084252|38322065|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172335|NCT01084252|38322066|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172336|NCT01084252|38322067|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172337|NCT01084252|38322068|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172338|NCT01084252|38322069|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172339|NCT01084252|38322070|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17087041|NCT00333840|38227444|FG003|Second-line Treatment Period|Adverse Event|34|||
17087042|NCT00333840|38227441|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
17087043|NCT00333840|38227442|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
17087044|NCT00333840|38227443|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
17087045|NCT00333840|38227444|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
17087046|NCT00333840|38227441|FG000|Second-line Treatment Period|Abnormal procedure|0|||
17087047|NCT00333840|38227442|FG001|Second-line Treatment Period|Abnormal procedure|0|||
17087048|NCT00333840|38227443|FG002|Second-line Treatment Period|Abnormal procedure|0|||
17087049|NCT00333840|38227444|FG003|Second-line Treatment Period|Abnormal procedure|1|||
17087050|NCT00333840|38227441|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
17087051|NCT00333840|38227442|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
17087052|NCT00333840|38227443|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
17087053|NCT00333840|38227444|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
17087054|NCT00333840|38227441|FG000|Second-line Treatment Period|No longer required study drug|0|||
17087055|NCT00333840|38227442|FG001|Second-line Treatment Period|No longer required study drug|0|||
17087056|NCT00333840|38227443|FG002|Second-line Treatment Period|No longer required study drug|1|||
17087057|NCT00333840|38227444|FG003|Second-line Treatment Period|No longer required study drug|14|||
17087058|NCT00333840|38227441|FG000|Second-line Treatment Period|Protocol Violation|0|||
17087059|NCT00333840|38227442|FG001|Second-line Treatment Period|Protocol Violation|0|||
17087060|NCT00333840|38227443|FG002|Second-line Treatment Period|Protocol Violation|1|||
17087061|NCT00333840|38227444|FG003|Second-line Treatment Period|Protocol Violation|10|||
17087062|NCT00333840|38227441|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
17087063|NCT00333840|38227442|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
17087064|NCT00333840|38227443|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
17087065|NCT00333840|38227444|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
17087066|NCT00333840|38227441|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
17087067|NCT00333840|38227442|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
17087068|NCT00333840|38227443|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
17087069|NCT00333840|38227444|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
17087070|NCT00333840|38227441|FG000|Second-line Treatment Period|Administrative problems|0|||
17087071|NCT00333840|38227442|FG001|Second-line Treatment Period|Administrative problems|0|||
17087072|NCT00333840|38227443|FG002|Second-line Treatment Period|Administrative problems|0|||
17087073|NCT00333840|38227444|FG003|Second-line Treatment Period|Administrative problems|7|||
17087074|NCT00333840|38227441|FG000|Second-line Treatment Period|Death|0|||
17087075|NCT00333840|38227442|FG001|Second-line Treatment Period|Death|0|||
17087076|NCT00333840|38227443|FG002|Second-line Treatment Period|Death|0|||
17087077|NCT00333840|38227444|FG003|Second-line Treatment Period|Death|9|||
17087078|NCT00490451|38227460|FG000|Overall Study|Adverse Event|3|||
17087079|NCT00490451|38227461|FG001|Overall Study|Adverse Event|3|||
17087080|NCT00490451|38227460|FG000|Overall Study|Death|3|||
17087081|NCT00490451|38227461|FG001|Overall Study|Death|1|||
17087082|NCT00490451|38227460|FG000|Overall Study|Withdrawal by Subject|2|||
17087083|NCT00490451|38227461|FG001|Overall Study|Withdrawal by Subject|0|||
17172340|NCT01084252|38322071|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172341|NCT01084252|38322072|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172342|NCT01084252|38322073|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
17172343|NCT01084252|38322074|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172344|NCT01084252|38322075|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
17172345|NCT01084252|38322076|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
17172346|NCT01084252|38322077|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172347|NCT01084252|38322078|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
17172348|NCT01084252|38322065|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172349|NCT01084252|38322066|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172350|NCT01084252|38322067|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172351|NCT01084252|38322068|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172352|NCT01084252|38322069|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172353|NCT01084252|38322070|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172354|NCT01084252|38322071|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172355|NCT01084252|38322072|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172356|NCT01084252|38322073|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
17172357|NCT01084252|38322074|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
17172358|NCT01084252|38322075|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
17172359|NCT01084252|38322076|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
17172360|NCT01084252|38322077|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172361|NCT01084252|38322078|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
17172362|NCT01084252|38322065|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172363|NCT01084252|38322066|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172364|NCT01084252|38322067|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172365|NCT01084252|38322068|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172366|NCT01084252|38322069|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172367|NCT01084252|38322070|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172368|NCT01084252|38322071|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172369|NCT01084252|38322072|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172370|NCT01084252|38322073|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172371|NCT01084252|38322074|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172372|NCT01084252|38322075|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17087084|NCT00490451|38227460|FG000|Overall Study|Investigator Decision|1|||
17087085|NCT00490451|38227461|FG001|Overall Study|Investigator Decision|0|||
17087086|NCT00490451|38227460|FG000|Overall Study|Protocol Violation|1|||
17087087|NCT00490451|38227461|FG001|Overall Study|Protocol Violation|0|||
17087088|NCT00490451|38227460|FG000|Overall Study|Progressive Disease|53|||
17087089|NCT00490451|38227461|FG001|Overall Study|Progressive Disease|34|||
17087090|NCT00321906|38227469|FG000|Overall Study|Adverse Event|36|||
17087091|NCT00321906|38227470|FG001|Overall Study|Adverse Event|44|||
17087092|NCT00321906|38227469|FG000|Overall Study|Death|9|||
17087093|NCT00321906|38227470|FG001|Overall Study|Death|6|||
17172373|NCT01084252|38322076|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
17172374|NCT01084252|38322077|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
17172375|NCT01084252|38322078|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
17172376|NCT01084252|38322065|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172377|NCT01084252|38322066|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172378|NCT01084252|38322067|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172379|NCT01084252|38322068|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172380|NCT01084252|38322069|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172381|NCT01084252|38322070|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172382|NCT01084252|38322071|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172383|NCT01084252|38322072|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172384|NCT01084252|38322073|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172385|NCT01084252|38322074|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172386|NCT01084252|38322075|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17172387|NCT01084252|38322076|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
17087094|NCT00321906|38227469|FG000|Overall Study|Lost to Follow-up|1|||
17087095|NCT00321906|38227470|FG001|Overall Study|Lost to Follow-up|2|||
17087096|NCT00321906|38227469|FG000|Overall Study|Withdrawal by Subject|0|||
17087097|NCT00321906|38227470|FG001|Overall Study|Withdrawal by Subject|4|||
17087098|NCT00339144|38227479|FG000|Overall Study|Disease progression|5|||
17087099|NCT00339144|38227480|FG001|Overall Study|Disease progression|2|||
17087100|NCT00339144|38227481|FG002|Overall Study|Disease progression|2|||
17087101|NCT00339144|38227479|FG000|Overall Study|Study drug toxicity|3|||
17087102|NCT00339144|38227480|FG001|Overall Study|Study drug toxicity|1|||
17087103|NCT00339144|38227481|FG002|Overall Study|Study drug toxicity|1|||
17087104|NCT00339144|38227479|FG000|Overall Study|Participant's request to discontinuation|1|||
17087105|NCT00339144|38227480|FG001|Overall Study|Participant's request to discontinuation|0|||
17172388|NCT01084252|38322077|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
17172389|NCT01084252|38322078|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
17172390|NCT01084252|38322065|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172391|NCT01084252|38322066|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17087106|NCT00339144|38227481|FG002|Overall Study|Participant's request to discontinuation|1|||
17087107|NCT00321828|38227490|FG000|Overall Study|Ineligible|3|||
17087108|NCT00321828|38227490|FG000|Overall Study|No follow up data|1|||
17087109|NCT00333138|38227497|FG000|Core Study (6 Months)|Adverse Event|4|||
17087110|NCT00333138|38227498|FG001|Core Study (6 Months)|Adverse Event|5|||
17087111|NCT00333138|38227499|FG002|Core Study (6 Months)|Adverse Event|8|||
17087112|NCT00333138|38227497|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
17087113|NCT00333138|38227498|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
17087114|NCT00333138|38227499|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
17087115|NCT00333138|38227497|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
17087116|NCT00333138|38227498|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
17087117|NCT00333138|38227499|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
17087118|NCT00333138|38227497|FG000|Core Study (6 Months)|Protocol Violation|1|||
17087119|NCT00333138|38227498|FG001|Core Study (6 Months)|Protocol Violation|0|||
17087120|NCT00333138|38227499|FG002|Core Study (6 Months)|Protocol Violation|1|||
17087121|NCT00333138|38227497|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
17087122|NCT00333138|38227498|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
17087123|NCT00333138|38227499|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
17087124|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
17087125|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
17087126|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
17087127|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
17087128|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
17087129|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
17087130|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
17087131|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
17087132|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
17087133|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
17087134|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
17087135|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
17087136|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
17087137|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
17087138|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
17087139|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
17087140|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
17087141|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
17087142|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
17087143|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
17087144|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
17087145|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
17087146|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
17087147|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
17087148|NCT00333138|38227497|FG000|Extension Study (Month6 to End of Study)|Death|0|||
17087149|NCT00333138|38227498|FG001|Extension Study (Month6 to End of Study)|Death|1|||
17087150|NCT00333138|38227499|FG002|Extension Study (Month6 to End of Study)|Death|0|||
17087151|NCT00332202|38227511|FG000|Overall Study|Adverse Event|72|||
17087152|NCT00332202|38227512|FG001|Overall Study|Adverse Event|28|||
17087153|NCT00332202|38227511|FG000|Overall Study|Lost to Follow-up|2|||
17087154|NCT00332202|38227512|FG001|Overall Study|Lost to Follow-up|1|||
17087155|NCT00332202|38227511|FG000|Overall Study|Physician Decision|6|||
17087156|NCT00332202|38227512|FG001|Overall Study|Physician Decision|8|||
17087157|NCT00332202|38227511|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
17087158|NCT00332202|38227512|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
17087159|NCT00332202|38227511|FG000|Overall Study|Protocol Violation|7|||
17087160|NCT00332202|38227512|FG001|Overall Study|Protocol Violation|2|||
17087161|NCT00332202|38227511|FG000|Overall Study|Sponsor Decision|1|||
17087162|NCT00332202|38227512|FG001|Overall Study|Sponsor Decision|2|||
17087163|NCT00332202|38227511|FG000|Overall Study|Withdrawal by Subject|36|||
17087164|NCT00332202|38227512|FG001|Overall Study|Withdrawal by Subject|17|||
17087165|NCT00332202|38227511|FG000|Overall Study|Progressive Disease|106|||
17087166|NCT00332202|38227512|FG001|Overall Study|Progressive Disease|60|||
17087167|NCT00332202|38227511|FG000|Overall Study|Death|5|||
17087168|NCT00332202|38227512|FG001|Overall Study|Death|2|||
17087169|NCT00331422|38227527|FG000|Overall Study|Did not receive entire study regimen|5|||
17087170|NCT00331344|38227532|FG000|Phase I|Adverse Event|0|||
17172392|NCT01084252|38322067|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172393|NCT01084252|38322068|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172394|NCT01084252|38322069|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172395|NCT01084252|38322070|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172396|NCT01084252|38322071|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172397|NCT01084252|38322072|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172398|NCT01084252|38322073|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172399|NCT01084252|38322074|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172400|NCT01084252|38322075|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172401|NCT01084252|38322076|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172402|NCT01084252|38322077|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
17172403|NCT01084252|38322078|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
17172404|NCT01084252|38322065|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172405|NCT01084252|38322066|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172406|NCT01084252|38322067|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172407|NCT01084252|38322068|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172408|NCT01084252|38322069|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172409|NCT01084252|38322070|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172410|NCT01084252|38322071|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172411|NCT01084252|38322072|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172412|NCT01084252|38322073|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172413|NCT01084252|38322074|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172414|NCT01084252|38322075|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172415|NCT01084252|38322076|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
17172416|NCT01084252|38322077|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
17172417|NCT01084252|38322078|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
17172418|NCT01084252|38322065|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172419|NCT01084252|38322066|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172420|NCT01084252|38322067|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172421|NCT01084252|38322068|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172422|NCT01084252|38322069|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172423|NCT01084252|38322070|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172424|NCT01084252|38322071|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172425|NCT01084252|38322072|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172426|NCT01084252|38322073|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172427|NCT01084252|38322074|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17087171|NCT00331344|38227533|FG001|Phase I|Adverse Event|0|||
17087172|NCT00331344|38227534|FG002|Phase I|Adverse Event|0|||
17087173|NCT00331344|38227535|FG003|Phase I|Adverse Event|1|||
17087174|NCT00331344|38227536|FG004|Phase I|Adverse Event|2|||
17087175|NCT00331344|38227537|FG005|Phase I|Adverse Event|2|||
17087176|NCT00331344|38227538|FG006|Phase I|Adverse Event|0|||
17087177|NCT00331344|38227539|FG007|Phase I|Adverse Event|1|||
17087178|NCT00331344|38227540|FG008|Phase I|Adverse Event|0|||
17087179|NCT00331344|38227532|FG000|Phase II|Death|0|||
17172428|NCT01084252|38322075|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172429|NCT01084252|38322076|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
17172430|NCT01084252|38322077|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
17172431|NCT01084252|38322078|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
17172432|NCT01084252|38322065|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172433|NCT01084252|38322066|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172434|NCT01084252|38322067|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172435|NCT01084252|38322068|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172436|NCT01084252|38322069|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172437|NCT01084252|38322070|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172438|NCT01084252|38322071|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172439|NCT01084252|38322072|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172440|NCT01084252|38322073|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172441|NCT01084252|38322074|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172442|NCT01084252|38322075|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172443|NCT01084252|38322076|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172444|NCT01084252|38322077|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
17172445|NCT01084252|38322078|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
17172446|NCT03644017|38322142|FG000|Overall Study|Access Abandonment|5|||
17172447|NCT03644017|38322142|FG000|Overall Study|Kidney Transplant|2|||
17172448|NCT00158054|38322148|FG000|Overall Study|Refused to continue|3|||
17172449|NCT00158054|38322149|FG001|Overall Study|Refused to continue|0|||
17172450|NCT00158054|38322148|FG000|Overall Study|Unavailable for follow up|7|||
17172451|NCT00158054|38322149|FG001|Overall Study|Unavailable for follow up|3|||
17087180|NCT00331344|38227533|FG001|Phase II|Death|0|||
17172452|NCT01337960|38322158|FG000|Overall Study|Lost to Follow-up|1|||
17172453|NCT01337960|38322159|FG001|Overall Study|Lost to Follow-up|0|||
17172454|NCT01337960|38322160|FG002|Overall Study|Lost to Follow-up|0|||
17172455|NCT01337960|38322158|FG000|Overall Study|Withdrawal by Subject|1|||
17172456|NCT01337960|38322159|FG001|Overall Study|Withdrawal by Subject|0|||
17172457|NCT01337960|38322160|FG002|Overall Study|Withdrawal by Subject|0|||
17172458|NCT04016714|38322179|FG000|Overall Study|Death|1|||
17172459|NCT04016714|38322180|FG001|Overall Study|Death|0|||
17172460|NCT04016714|38322179|FG000|Overall Study|Lost to Follow-up|3|||
17087181|NCT00331344|38227534|FG002|Phase II|Death|0|||
17087182|NCT00331344|38227535|FG003|Phase II|Death|0|||
17087183|NCT00331344|38227536|FG004|Phase II|Death|0|||
17172461|NCT04016714|38322180|FG001|Overall Study|Lost to Follow-up|1|||
17172462|NCT04016714|38322179|FG000|Overall Study|Physician Decision|3|||
17172463|NCT04016714|38322180|FG001|Overall Study|Physician Decision|3|||
17172464|NCT04016714|38322179|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
17172465|NCT04016714|38322180|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
17172466|NCT02750306|38322188|FG000|Overall Study|Withdrawal by Subject|5|||
17172467|NCT02750306|38322189|FG001|Overall Study|Withdrawal by Subject|2|||
17172468|NCT02750306|38322188|FG000|Overall Study|Protocol Violation|1|||
17172469|NCT02750306|38322189|FG001|Overall Study|Protocol Violation|0|||
17172470|NCT01816165|38322197|FG000|Overall Study|Adverse Event|1|||
17172471|NCT01816165|38322198|FG001|Overall Study|Adverse Event|0|||
17172472|NCT01816165|38322199|FG002|Overall Study|Adverse Event|0|||
17172473|NCT01816165|38322200|FG003|Overall Study|Adverse Event|0|||
17172474|NCT01677988|38322229|FG000|Overall Study|Lack of Efficacy|2|||
17172475|NCT02926573|38322236|FG000|Overall Study|Nausea|1|||
17172476|NCT02926573|38322237|FG001|Overall Study|Nausea|0|||
17172477|NCT02926573|38322236|FG000|Overall Study|Remain intubated|2|||
17172478|NCT02926573|38322237|FG001|Overall Study|Remain intubated|2|||
17172479|NCT02926573|38322236|FG000|Overall Study|Change in surgery plan|3|||
17172480|NCT02926573|38322237|FG001|Overall Study|Change in surgery plan|1|||
17172481|NCT02926573|38322236|FG000|Overall Study|Change to outpatient status|5|||
17172482|NCT02926573|38322237|FG001|Overall Study|Change to outpatient status|1|||
17172483|NCT02926573|38322236|FG000|Overall Study|Withdrawal by Subject|0|||
17172484|NCT02926573|38322237|FG001|Overall Study|Withdrawal by Subject|2|||
17172485|NCT02926573|38322236|FG000|Overall Study|Return to operating room|0|||
17172486|NCT02926573|38322237|FG001|Overall Study|Return to operating room|2|||
17172487|NCT02926573|38322236|FG000|Overall Study|Delirium|0|||
17172488|NCT02926573|38322237|FG001|Overall Study|Delirium|1|||
17172489|NCT00158860|38322245|FG000|Overall Study|Adverse Event|3|||
17172490|NCT00158860|38322246|FG001|Overall Study|Adverse Event|6|||
17172491|NCT00158860|38322245|FG000|Overall Study|Lost to Follow-up|11|||
17172492|NCT00158860|38322246|FG001|Overall Study|Lost to Follow-up|17|||
17172493|NCT00158860|38322245|FG000|Overall Study|Protocol Violation|8|||
17172494|NCT00158860|38322246|FG001|Overall Study|Protocol Violation|23|||
17172495|NCT00158860|38322245|FG000|Overall Study|Withdrawal by Subject|7|||
17172496|NCT00158860|38322246|FG001|Overall Study|Withdrawal by Subject|17|||
17172497|NCT00158860|38322245|FG000|Overall Study|MOVING OUT OF STATE|1|||
17172498|NCT00158860|38322246|FG001|Overall Study|MOVING OUT OF STATE|0|||
17172499|NCT00158860|38322245|FG000|Overall Study|Pregnancy|3|||
17172500|NCT00158860|38322246|FG001|Overall Study|Pregnancy|3|||
17172501|NCT00158860|38322245|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
17172502|NCT00158860|38322246|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
17172503|NCT00158860|38322245|FG000|Overall Study|SPONSOR REQUEST|0|||
17172504|NCT00158860|38322246|FG001|Overall Study|SPONSOR REQUEST|1|||
17172505|NCT00158860|38322245|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
17172506|NCT00158860|38322246|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
17172507|NCT00158860|38322245|FG000|Overall Study|Closed per sponsor|0|||
17172508|NCT00158860|38322246|FG001|Overall Study|Closed per sponsor|1|||
17172509|NCT03067129|38322257|FG000|Overall Study|Ongoing|45|||
17172510|NCT03067129|38322258|FG001|Overall Study|Ongoing|28|||
17172511|NCT03067129|38322259|FG002|Overall Study|Ongoing|27|||
17172512|NCT03067129|38322260|FG003|Overall Study|Ongoing|23|||
17172513|NCT03067129|38322257|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0|||
17172514|NCT03067129|38322258|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0|||
17172515|NCT03067129|38322259|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0|||
17172516|NCT03067129|38322260|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1|||
17087184|NCT00331344|38227537|FG005|Phase II|Death|0|||
17087185|NCT00331344|38227538|FG006|Phase II|Death|0|||
17087186|NCT00331344|38227539|FG007|Phase II|Death|0|||
17087187|NCT00331344|38227540|FG008|Phase II|Death|4|||
17087188|NCT00321672|38227557|FG000|Overall Study|Withdrawal by Subject|5|||
17087189|NCT00321672|38227558|FG001|Overall Study|Withdrawal by Subject|1|||
17172517|NCT01679236|38322280|FG000|Overall Study|Lost to Follow-up|15|||
17172518|NCT01679236|38322281|FG001|Overall Study|Lost to Follow-up|15|||
17172519|NCT01679002|38322290|FG000|Overall Study|Adverse Event|1|||
17172520|NCT01679002|38322291|FG001|Overall Study|Adverse Event|1|||
17172521|NCT01679002|38322292|FG002|Overall Study|Adverse Event|0|||
17172522|NCT04409509|38322302|FG000|Overall Study|Failure to meet randomization requirement|1|||
17172523|NCT04409509|38322303|FG001|Overall Study|Failure to meet randomization requirement|0|||
17172524|NCT04409509|38322302|FG000|Overall Study|Adverse Event|0|||
17172525|NCT04409509|38322303|FG001|Overall Study|Adverse Event|1|||
17172526|NCT04409509|38322302|FG000|Overall Study|Death|11|||
17172527|NCT04409509|38322303|FG001|Overall Study|Death|10|||
17172528|NCT04409509|38322302|FG000|Overall Study|Non-compliance with study drug|0|||
17172529|NCT04409509|38322303|FG001|Overall Study|Non-compliance with study drug|1|||
17172530|NCT04409509|38322302|FG000|Overall Study|Lost to Follow-up|0|||
17172531|NCT04409509|38322303|FG001|Overall Study|Lost to Follow-up|3|||
17172532|NCT04409509|38322302|FG000|Overall Study|Withdrawal by Subject|0|||
17172533|NCT04409509|38322303|FG001|Overall Study|Withdrawal by Subject|3|||
17172534|NCT04409509|38322302|FG000|Overall Study|Randomized by mistake|0|||
17172535|NCT04409509|38322303|FG001|Overall Study|Randomized by mistake|1|||
17172536|NCT04409509|38322302|FG000|Overall Study|Other|1|||
17172537|NCT04409509|38322303|FG001|Overall Study|Other|1|||
17172538|NCT01678924|38322314|FG000|Overall Study|Adverse Event|1|||
17172539|NCT01678924|38322315|FG001|Overall Study|Adverse Event|1|||
17087190|NCT00321672|38227559|FG002|Overall Study|Withdrawal by Subject|2|||
17087191|NCT00321672|38227560|FG003|Overall Study|Withdrawal by Subject|0|||
17087192|NCT00321672|38227557|FG000|Overall Study|Noncompliance|1|||
17087193|NCT00321672|38227558|FG001|Overall Study|Noncompliance|2|||
17087194|NCT00321672|38227559|FG002|Overall Study|Noncompliance|1|||
17087195|NCT00321672|38227560|FG003|Overall Study|Noncompliance|0|||
17087196|NCT00321672|38227557|FG000|Overall Study|Adverse Event|1|||
17087197|NCT00321672|38227558|FG001|Overall Study|Adverse Event|1|||
17087198|NCT00321672|38227559|FG002|Overall Study|Adverse Event|0|||
17087199|NCT00321672|38227560|FG003|Overall Study|Adverse Event|0|||
17087200|NCT00321672|38227557|FG000|Overall Study|Lack of Efficacy|1|||
17172540|NCT01678924|38322316|FG002|Overall Study|Adverse Event|0|||
17172541|NCT01678924|38322317|FG003|Overall Study|Adverse Event|1|||
17172542|NCT01678924|38322314|FG000|Overall Study|Lack of Efficacy|7|||
17172543|NCT01678924|38322315|FG001|Overall Study|Lack of Efficacy|2|||
17172544|NCT01678924|38322316|FG002|Overall Study|Lack of Efficacy|0|||
17172545|NCT01678924|38322317|FG003|Overall Study|Lack of Efficacy|5|||
17172546|NCT01678924|38322314|FG000|Overall Study|Lost to Follow-up|0|||
17172547|NCT01678924|38322315|FG001|Overall Study|Lost to Follow-up|4|||
17172548|NCT01678924|38322316|FG002|Overall Study|Lost to Follow-up|0|||
17172549|NCT01678924|38322317|FG003|Overall Study|Lost to Follow-up|2|||
17172550|NCT01678924|38322314|FG000|Overall Study|Personal Reasons|2|||
17172551|NCT01678924|38322315|FG001|Overall Study|Personal Reasons|2|||
17172552|NCT01678924|38322316|FG002|Overall Study|Personal Reasons|2|||
17172553|NCT01678924|38322317|FG003|Overall Study|Personal Reasons|7|||
17172554|NCT01678924|38322314|FG000|Overall Study|Withdrawal by Subject|0|||
17172555|NCT01678924|38322315|FG001|Overall Study|Withdrawal by Subject|3|||
17172556|NCT01678924|38322316|FG002|Overall Study|Withdrawal by Subject|0|||
17172557|NCT01678924|38322317|FG003|Overall Study|Withdrawal by Subject|2|||
17172558|NCT01678924|38322314|FG000|Overall Study|Unable to attend scheduled visits|0|||
17172559|NCT01678924|38322315|FG001|Overall Study|Unable to attend scheduled visits|0|||
17172560|NCT01678924|38322316|FG002|Overall Study|Unable to attend scheduled visits|0|||
17172561|NCT01678924|38322317|FG003|Overall Study|Unable to attend scheduled visits|1|||
17172562|NCT02925793|38322331|FG000|Overall Study|Adverse Event|3|||
17172563|NCT02925793|38322332|FG001|Overall Study|Adverse Event|3|||
17172564|NCT02925793|38322333|FG002|Overall Study|Adverse Event|6|||
17172565|NCT02925793|38322331|FG000|Overall Study|Withdrawal by Subject|16|||
17172566|NCT02925793|38322332|FG001|Overall Study|Withdrawal by Subject|15|||
17172567|NCT02925793|38322333|FG002|Overall Study|Withdrawal by Subject|13|||
17172568|NCT02925793|38322331|FG000|Overall Study|Investigator Discretion|0|||
17172569|NCT02925793|38322332|FG001|Overall Study|Investigator Discretion|1|||
17172570|NCT02925793|38322333|FG002|Overall Study|Investigator Discretion|1|||
17172571|NCT02925793|38322331|FG000|Overall Study|Lost to Follow-up|2|||
17172572|NCT02925793|38322332|FG001|Overall Study|Lost to Follow-up|3|||
17172573|NCT02925793|38322333|FG002|Overall Study|Lost to Follow-up|1|||
17172574|NCT02925793|38322331|FG000|Overall Study|Lack of Efficacy|2|||
17172575|NCT02925793|38322332|FG001|Overall Study|Lack of Efficacy|6|||
17172576|NCT02925793|38322333|FG002|Overall Study|Lack of Efficacy|4|||
17172577|NCT02925793|38322331|FG000|Overall Study|Other:|2|||
17172578|NCT02925793|38322332|FG001|Overall Study|Other:|1|||
17172579|NCT02925793|38322333|FG002|Overall Study|Other:|3|||
17172580|NCT03071263|38322343|FG000|Overall Study|Adverse Event|1|||
17172581|NCT03071263|38322344|FG001|Overall Study|Adverse Event|3|||
17172582|NCT03071263|38322343|FG000|Overall Study|Withdrawal by Subject|1|||
17172583|NCT03071263|38322344|FG001|Overall Study|Withdrawal by Subject|3|||
17172584|NCT03071263|38322343|FG000|Overall Study|Physician Decision|1|||
17172585|NCT03071263|38322344|FG001|Overall Study|Physician Decision|0|||
17172586|NCT03071263|38322343|FG000|Overall Study|Participant moved to another city|0|||
17172587|NCT03071263|38322344|FG001|Overall Study|Participant moved to another city|1|||
17172588|NCT00157196|38322356|FG000|Overall Study|Ongoing at data cut-off|9|||
17172589|NCT03066193|38322360|FG000|Overall Study|Withdrawal by Subject|1|||
17172590|NCT03922321|38322364|FG000|Overall Study|Participant Moved|1|||
17172591|NCT03922321|38322364|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
17172592|NCT01677910|38322371|FG000|Double-Blind Treatment Period|Adverse Event|6|||
17172593|NCT01677910|38322372|FG001|Double-Blind Treatment Period|Adverse Event|2|||
17172594|NCT01677910|38322373|FG002|Double-Blind Treatment Period|Adverse Event|3|||
17172595|NCT01677910|38322374|FG003|Double-Blind Treatment Period|Adverse Event|0|||
17172596|NCT01677910|38322371|FG000|Double-Blind Treatment Period|Physician Decision|0|||
17172597|NCT01677910|38322372|FG001|Double-Blind Treatment Period|Physician Decision|0|||
17172598|NCT01677910|38322373|FG002|Double-Blind Treatment Period|Physician Decision|1|||
17172599|NCT01677910|38322374|FG003|Double-Blind Treatment Period|Physician Decision|0|||
17172600|NCT01677910|38322371|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
17172601|NCT01677910|38322372|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
17172602|NCT01677910|38322373|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
17172603|NCT01677910|38322374|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
17172604|NCT01677910|38322371|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
17172605|NCT01677910|38322372|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
17172606|NCT01677910|38322373|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
17172607|NCT01677910|38322374|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
17172608|NCT01677910|38322371|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
17172609|NCT01677910|38322372|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
17172610|NCT01677910|38322373|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
17172611|NCT01677910|38322374|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
17087201|NCT00321672|38227558|FG001|Overall Study|Lack of Efficacy|1|||
17087202|NCT00321672|38227559|FG002|Overall Study|Lack of Efficacy|0|||
17172612|NCT01677910|38322371|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
17172613|NCT01677910|38322372|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
17172614|NCT01677910|38322373|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
17172615|NCT01677910|38322374|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
17172616|NCT01677910|38322371|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
17172617|NCT01677910|38322372|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
17172618|NCT01677910|38322373|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
17172619|NCT01677910|38322374|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
17172620|NCT01677910|38322371|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
17172621|NCT01677910|38322372|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
17172622|NCT01677910|38322373|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
17172623|NCT01677910|38322374|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
17172624|NCT01677910|38322371|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
17172625|NCT01677910|38322372|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
17172626|NCT01677910|38322373|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
17172627|NCT01677910|38322374|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
17172628|NCT01677910|38322371|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
17172629|NCT01677910|38322372|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
17172630|NCT01677910|38322373|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
17172631|NCT01677910|38322374|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
17172632|NCT03911713|38322389|FG000|Overall Study|Lost to Follow-up|0|||
17172633|NCT03911713|38322390|FG001|Overall Study|Lost to Follow-up|2|||
17172634|NCT03911713|38322391|FG002|Overall Study|Lost to Follow-up|0|||
17172635|NCT03911713|38322392|FG003|Overall Study|Lost to Follow-up|0|||
17172636|NCT03911713|38322393|FG004|Overall Study|Lost to Follow-up|0|||
17172637|NCT03911713|38322389|FG000|Overall Study|Other|0|||
17172638|NCT03911713|38322390|FG001|Overall Study|Other|0|||
17172639|NCT03911713|38322391|FG002|Overall Study|Other|0|||
17172640|NCT03911713|38322392|FG003|Overall Study|Other|1|||
17172641|NCT03911713|38322393|FG004|Overall Study|Other|0|||
17172642|NCT03911713|38322389|FG000|Overall Study|Randomized, Never Dosed|1|||
17172643|NCT03911713|38322390|FG001|Overall Study|Randomized, Never Dosed|0|||
17172644|NCT03911713|38322391|FG002|Overall Study|Randomized, Never Dosed|0|||
17087203|NCT00321672|38227560|FG003|Overall Study|Lack of Efficacy|0|||
17087204|NCT00321672|38227557|FG000|Overall Study|Lost to Follow-up|2|||
17087205|NCT00321672|38227558|FG001|Overall Study|Lost to Follow-up|0|||
17087206|NCT00321672|38227559|FG002|Overall Study|Lost to Follow-up|4|||
17087207|NCT00321672|38227560|FG003|Overall Study|Lost to Follow-up|2|||
17087208|NCT00321672|38227557|FG000|Overall Study|Death|1|||
17087209|NCT00321672|38227558|FG001|Overall Study|Death|0|||
17087210|NCT00321672|38227559|FG002|Overall Study|Death|0|||
17087211|NCT00321672|38227560|FG003|Overall Study|Death|0|||
17087212|NCT00321672|38227557|FG000|Overall Study|Too far to travel for visits|1|||
17087213|NCT00321672|38227558|FG001|Overall Study|Too far to travel for visits|0|||
17087214|NCT00321672|38227559|FG002|Overall Study|Too far to travel for visits|0|||
17087215|NCT00321672|38227560|FG003|Overall Study|Too far to travel for visits|0|||
17087216|NCT00321672|38227557|FG000|Overall Study|Incarcerated|0|||
17172645|NCT03911713|38322392|FG003|Overall Study|Randomized, Never Dosed|1|||
17172646|NCT03911713|38322393|FG004|Overall Study|Randomized, Never Dosed|0|||
17172647|NCT03065023|38322411|FG000|Overall Study|Progressive Disease|0|||
17172648|NCT03065023|38322412|FG001|Overall Study|Progressive Disease|1|||
17172649|NCT03065023|38322413|FG002|Overall Study|Progressive Disease|0|||
17172650|NCT03065023|38322414|FG003|Overall Study|Progressive Disease|0|||
17172651|NCT03065023|38322415|FG004|Overall Study|Progressive Disease|0|||
17172652|NCT03065023|38322411|FG000|Overall Study|Death|2|||
17172653|NCT03065023|38322412|FG001|Overall Study|Death|0|||
17172654|NCT03065023|38322413|FG002|Overall Study|Death|1|||
17172655|NCT03065023|38322414|FG003|Overall Study|Death|1|||
17172656|NCT03065023|38322415|FG004|Overall Study|Death|0|||
17172657|NCT03065023|38322411|FG000|Overall Study|Lost to Follow-up|0|||
17172658|NCT03065023|38322412|FG001|Overall Study|Lost to Follow-up|1|||
17172659|NCT03065023|38322413|FG002|Overall Study|Lost to Follow-up|0|||
17172660|NCT03065023|38322414|FG003|Overall Study|Lost to Follow-up|0|||
17172661|NCT03065023|38322415|FG004|Overall Study|Lost to Follow-up|0|||
17172662|NCT03065023|38322411|FG000|Overall Study|Participant Decision|0|||
17172663|NCT03065023|38322412|FG001|Overall Study|Participant Decision|0|||
17172664|NCT03065023|38322413|FG002|Overall Study|Participant Decision|0|||
17172665|NCT03065023|38322414|FG003|Overall Study|Participant Decision|1|||
17172666|NCT03065023|38322415|FG004|Overall Study|Participant Decision|0|||
17172667|NCT03065023|38322411|FG000|Overall Study|Withdrawal by Subject|0|||
17172668|NCT03065023|38322412|FG001|Overall Study|Withdrawal by Subject|0|||
17172669|NCT03065023|38322413|FG002|Overall Study|Withdrawal by Subject|0|||
17172670|NCT03065023|38322414|FG003|Overall Study|Withdrawal by Subject|1|||
17172671|NCT03065023|38322415|FG004|Overall Study|Withdrawal by Subject|0|||
17172672|NCT03614923|38322428|FG000|Overall Study|Withdrawal by Subject|2|||
17172673|NCT03614923|38322429|FG001|Overall Study|Withdrawal by Subject|1|||
17172674|NCT03614923|38322430|FG002|Overall Study|Withdrawal by Subject|1|||
17172675|NCT03614923|38322428|FG000|Overall Study|Adverse Event|0|||
17172676|NCT03614923|38322429|FG001|Overall Study|Adverse Event|2|||
17172677|NCT03614923|38322430|FG002|Overall Study|Adverse Event|1|||
17172678|NCT03614923|38322428|FG000|Overall Study|Lost to Follow-up|1|||
17172679|NCT03614923|38322429|FG001|Overall Study|Lost to Follow-up|0|||
17172680|NCT03614923|38322430|FG002|Overall Study|Lost to Follow-up|1|||
17172681|NCT03614923|38322428|FG000|Overall Study|Lack of Efficacy|2|||
17172682|NCT03614923|38322429|FG001|Overall Study|Lack of Efficacy|0|||
17172683|NCT03614923|38322430|FG002|Overall Study|Lack of Efficacy|1|||
17172684|NCT03614923|38322428|FG000|Overall Study|Non-compliance|0|||
17172685|NCT03614923|38322429|FG001|Overall Study|Non-compliance|1|||
17172686|NCT03614923|38322430|FG002|Overall Study|Non-compliance|0|||
17172687|NCT03614923|38322428|FG000|Overall Study|Other|0|||
17172688|NCT03614923|38322429|FG001|Overall Study|Other|1|||
17172689|NCT03614923|38322430|FG002|Overall Study|Other|1|||
17172690|NCT02915016|38322446|FG000|Overall Study|Lost to Follow-up|4|||
17172691|NCT02915016|38322447|FG001|Overall Study|Lost to Follow-up|2|||
17172692|NCT02915016|38322448|FG002|Overall Study|Lost to Follow-up|5|||
17087217|NCT00321672|38227558|FG001|Overall Study|Incarcerated|0|||
17087218|NCT00321672|38227559|FG002|Overall Study|Incarcerated|2|||
17087219|NCT00321672|38227560|FG003|Overall Study|Incarcerated|0|||
17087220|NCT00321672|38227557|FG000|Overall Study|Moved out of state|0|||
17087221|NCT00321672|38227558|FG001|Overall Study|Moved out of state|1|||
17087222|NCT00321672|38227559|FG002|Overall Study|Moved out of state|1|||
17087223|NCT00321672|38227560|FG003|Overall Study|Moved out of state|0|||
17087224|NCT00321672|38227557|FG000|Overall Study|Protocol Violation|0|||
17087225|NCT00321672|38227558|FG001|Overall Study|Protocol Violation|0|||
17087226|NCT00321672|38227559|FG002|Overall Study|Protocol Violation|1|||
17087227|NCT00321672|38227560|FG003|Overall Study|Protocol Violation|0|||
17087228|NCT00321672|38227557|FG000|Overall Study|Diagnosis of testicular cancer|0|||
17087229|NCT00321672|38227558|FG001|Overall Study|Diagnosis of testicular cancer|1|||
17087230|NCT00321672|38227559|FG002|Overall Study|Diagnosis of testicular cancer|0|||
17087231|NCT00321672|38227560|FG003|Overall Study|Diagnosis of testicular cancer|0|||
17087232|NCT00321672|38227557|FG000|Overall Study|Extensive travel required for new job|0|||
17087233|NCT00321672|38227558|FG001|Overall Study|Extensive travel required for new job|1|||
17087234|NCT00321672|38227559|FG002|Overall Study|Extensive travel required for new job|0|||
17087235|NCT00321672|38227560|FG003|Overall Study|Extensive travel required for new job|0|||
17172693|NCT02915016|38322449|FG003|Overall Study|Lost to Follow-up|3|||
17172694|NCT02915016|38322450|FG004|Overall Study|Lost to Follow-up|5|||
17172695|NCT02915016|38322451|FG005|Overall Study|Lost to Follow-up|2|||
17172696|NCT02915016|38322452|FG006|Overall Study|Lost to Follow-up|8|||
17172697|NCT02915016|38322453|FG007|Overall Study|Lost to Follow-up|2|||
17172698|NCT02915016|38322446|FG000|Overall Study|Physician Decision|0|||
17172699|NCT02915016|38322447|FG001|Overall Study|Physician Decision|0|||
17172700|NCT02915016|38322448|FG002|Overall Study|Physician Decision|1|||
17172701|NCT02915016|38322449|FG003|Overall Study|Physician Decision|0|||
17172702|NCT02915016|38322450|FG004|Overall Study|Physician Decision|0|||
17172703|NCT02915016|38322451|FG005|Overall Study|Physician Decision|1|||
17172704|NCT02915016|38322452|FG006|Overall Study|Physician Decision|2|||
17172705|NCT02915016|38322453|FG007|Overall Study|Physician Decision|0|||
17172706|NCT02915016|38322446|FG000|Overall Study|Withdrawal by Subject|2|||
17172707|NCT02915016|38322447|FG001|Overall Study|Withdrawal by Subject|0|||
17172708|NCT02915016|38322448|FG002|Overall Study|Withdrawal by Subject|1|||
17172709|NCT02915016|38322449|FG003|Overall Study|Withdrawal by Subject|0|||
17172710|NCT02915016|38322450|FG004|Overall Study|Withdrawal by Subject|1|||
17172711|NCT02915016|38322451|FG005|Overall Study|Withdrawal by Subject|3|||
17172712|NCT02915016|38322452|FG006|Overall Study|Withdrawal by Subject|1|||
17172713|NCT02915016|38322453|FG007|Overall Study|Withdrawal by Subject|1|||
17172714|NCT02915016|38322446|FG000|Overall Study|Elected not to continue|0|||
17172715|NCT02915016|38322447|FG001|Overall Study|Elected not to continue|0|||
17172716|NCT02915016|38322448|FG002|Overall Study|Elected not to continue|0|||
17172717|NCT02915016|38322449|FG003|Overall Study|Elected not to continue|1|||
17172718|NCT02915016|38322450|FG004|Overall Study|Elected not to continue|0|||
17172719|NCT02915016|38322451|FG005|Overall Study|Elected not to continue|0|||
17087236|NCT00321048|38227576|FG000|Overall Study|Withdrawal by Subject|6|||
17087237|NCT00321048|38227577|FG001|Overall Study|Withdrawal by Subject|8|||
17087238|NCT00330174|38227585|FG000|Overall Study|Withdrawal by Subject|7|||
17087239|NCT00330174|38227586|FG001|Overall Study|Withdrawal by Subject|7|||
17087240|NCT00330174|38227585|FG000|Overall Study|Lost to Follow-up|4|||
17087241|NCT00330174|38227586|FG001|Overall Study|Lost to Follow-up|1|||
17087242|NCT00330174|38227585|FG000|Overall Study|Clinical deterioration|1|||
17087243|NCT00330174|38227586|FG001|Overall Study|Clinical deterioration|2|||
17087244|NCT00330174|38227585|FG000|Overall Study|Excessive missed visits|3|||
17087245|NCT00330174|38227586|FG001|Overall Study|Excessive missed visits|8|||
17087246|NCT00330174|38227585|FG000|Overall Study|Miscellaneous reasons|7|||
17087247|NCT00330174|38227586|FG001|Overall Study|Miscellaneous reasons|1|||
17087248|NCT00320424|38227592|FG000|Overall Study|Adverse Event|3|||
17087249|NCT00320424|38227592|FG000|Overall Study|Other|3|||
17087250|NCT00338286|38227598|FG000|Overall Study|Withdrawal by Subject|50|||
17087251|NCT00338286|38227599|FG001|Overall Study|Withdrawal by Subject|54|||
17087252|NCT00338286|38227598|FG000|Overall Study|Lost to Follow-up|80|||
17087253|NCT00338286|38227599|FG001|Overall Study|Lost to Follow-up|66|||
17087254|NCT00338286|38227598|FG000|Overall Study|Other|103|||
17087255|NCT00338286|38227599|FG001|Overall Study|Other|93|||
17087256|NCT00329784|38227609|FG000|Overall Study|Lost to Follow-up|0|||
17087257|NCT00329784|38227610|FG001|Overall Study|Lost to Follow-up|1|||
17172720|NCT02915016|38322452|FG006|Overall Study|Elected not to continue|1|||
17172721|NCT02915016|38322453|FG007|Overall Study|Elected not to continue|0|||
17172722|NCT02915016|38322446|FG000|Overall Study|HIV infection|1|||
17172723|NCT02915016|38322447|FG001|Overall Study|HIV infection|1|||
17172724|NCT02915016|38322448|FG002|Overall Study|HIV infection|1|||
17172725|NCT02915016|38322449|FG003|Overall Study|HIV infection|0|||
17172726|NCT02915016|38322450|FG004|Overall Study|HIV infection|1|||
17172727|NCT02915016|38322451|FG005|Overall Study|HIV infection|0|||
17172728|NCT02915016|38322452|FG006|Overall Study|HIV infection|0|||
17172729|NCT02915016|38322453|FG007|Overall Study|HIV infection|0|||
17172730|NCT02915016|38322446|FG000|Overall Study|Participant unable to adhere|0|||
17172731|NCT02915016|38322447|FG001|Overall Study|Participant unable to adhere|0|||
17172732|NCT02915016|38322448|FG002|Overall Study|Participant unable to adhere|0|||
17172733|NCT02915016|38322449|FG003|Overall Study|Participant unable to adhere|0|||
17172734|NCT02915016|38322450|FG004|Overall Study|Participant unable to adhere|0|||
17172735|NCT02915016|38322451|FG005|Overall Study|Participant unable to adhere|0|||
17172736|NCT02915016|38322452|FG006|Overall Study|Participant unable to adhere|0|||
17172737|NCT02915016|38322453|FG007|Overall Study|Participant unable to adhere|1|||
17172738|NCT03323749|38322473|FG000|Double-blind Period|Lost to Follow-up|4|||
17172739|NCT03323749|38322474|FG001|Double-blind Period|Lost to Follow-up|5|||
17172740|NCT03323749|38322473|FG000|Double-blind Period|Adverse Event|3|||
17172741|NCT03323749|38322474|FG001|Double-blind Period|Adverse Event|1|||
17172742|NCT03323749|38322473|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
17172743|NCT03323749|38322474|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
17172744|NCT03323749|38322473|FG000|Open-Label Period|Adverse Event|3|||
17172745|NCT03323749|38322474|FG001|Open-Label Period|Adverse Event|10|||
17172746|NCT03323749|38322473|FG000|Open-Label Period|Withdrawal by Subject|7|||
17172747|NCT03323749|38322474|FG001|Open-Label Period|Withdrawal by Subject|5|||
17172748|NCT02208024|38322493|FG000|Overall Study|Withdrawal by Subject|1|||
17172749|NCT02660086|38322499|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
17172750|NCT02660086|38322500|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
17172751|NCT02660086|38322499|FG000|Overall Study- 12-month|Left full-time employment|12|||
17172752|NCT02660086|38322500|FG001|Overall Study- 12-month|Left full-time employment|20|||
17172753|NCT02660086|38322499|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
17172754|NCT02660086|38322500|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
17172755|NCT02660086|38322499|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
16868028|NCT01536145|37841037|FG004|Overall Study|Other|1|||
17172756|NCT02660086|38322500|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
17172757|NCT02660086|38322499|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
17172758|NCT02660086|38322500|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
17172759|NCT02660086|38322499|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
17172760|NCT02660086|38322500|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
17172761|NCT01678144|38322506|FG000|Stage 1: MAR Classic|Adverse Event|1|||
17172762|NCT00153920|38322510|FG000|Overall Study|Adverse Event|9|||
17172763|NCT00153920|38322510|FG000|Overall Study|Progressive Disease|9|||
17172764|NCT00153920|38322510|FG000|Overall Study|Physician Decision|3|||
17172765|NCT00153920|38322510|FG000|Overall Study|Lack of Response|3|||
17172766|NCT00153920|38322510|FG000|Overall Study|Death|2|||
17172767|NCT00153920|38322510|FG000|Overall Study|Withdrawal by Subject|1|||
17172768|NCT00153920|38322510|FG000|Overall Study|Non-Protocol Therapy|1|||
17172769|NCT00153920|38322510|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
17172770|NCT00153920|38322510|FG000|Overall Study|Progressive Disease before Trt|1|||
17172771|NCT02660242|38322514|FG000|Glucose Tabs|Lost to Follow-up|1|||
17172772|NCT02660242|38322514|FG000|Glucagon Injection|Lost to Follow-up|1|||
17172773|NCT03072043|38322530|FG000|Overall Study|Death|0|||
17172774|NCT03072043|38322531|FG001|Overall Study|Death|0|||
17172775|NCT03072043|38322532|FG002|Overall Study|Death|3|||
17172776|NCT03072043|38322530|FG000|Overall Study|Adverse Event|0|||
17172777|NCT03072043|38322531|FG001|Overall Study|Adverse Event|0|||
17172778|NCT03072043|38322532|FG002|Overall Study|Adverse Event|2|||
17172779|NCT03072043|38322530|FG000|Overall Study|Withdrawal by Subject|0|||
17172780|NCT03072043|38322531|FG001|Overall Study|Withdrawal by Subject|0|||
17087258|NCT00329784|38227611|FG002|Overall Study|Lost to Follow-up|0|||
17087259|NCT00329784|38227612|FG003|Overall Study|Lost to Follow-up|0|||
17087260|NCT00329784|38227609|FG000|Overall Study|Withdrawal by Subject|4|||
17087261|NCT00329784|38227610|FG001|Overall Study|Withdrawal by Subject|2|||
17087262|NCT00329784|38227611|FG002|Overall Study|Withdrawal by Subject|0|||
17087263|NCT00329784|38227612|FG003|Overall Study|Withdrawal by Subject|0|||
17087264|NCT00329784|38227609|FG000|Overall Study|Other|1|||
17087265|NCT00329784|38227610|FG001|Overall Study|Other|2|||
17087266|NCT00329784|38227611|FG002|Overall Study|Other|0|||
17087267|NCT00329784|38227612|FG003|Overall Study|Other|0|||
17087268|NCT00337818|38227627|FG000|Overall Study|Lost to Follow-up|289|||
17087269|NCT00337818|38227628|FG001|Overall Study|Lost to Follow-up|91|||
16996650|NCT00758680|38140751|FG006|Overall Study|Laboratory Adverse Event|0|||
17087270|NCT00337818|38227629|FG002|Overall Study|Lost to Follow-up|107|||
17087271|NCT00329550|38227640|FG000|Overall Study|Adverse Event|3|||
17087272|NCT00329550|38227641|FG001|Overall Study|Adverse Event|4|||
17087273|NCT00329550|38227642|FG002|Overall Study|Adverse Event|2|||
17087274|NCT00329550|38227640|FG000|Overall Study|Withdrawal of Consent|1|||
17087275|NCT00329550|38227641|FG001|Overall Study|Withdrawal of Consent|0|||
17172781|NCT03072043|38322532|FG002|Overall Study|Withdrawal by Subject|4|||
16996651|NCT00758680|38140752|FG007|Overall Study|Laboratory Adverse Event|0|||
16996652|NCT00758680|38140753|FG008|Overall Study|Laboratory Adverse Event|1|||
16996653|NCT00758680|38140754|FG009|Overall Study|Laboratory Adverse Event|0|||
16996654|NCT00758680|38140745|FG000|Overall Study|Withdrawal by Subject|0|||
16996655|NCT00758680|38140746|FG001|Overall Study|Withdrawal by Subject|0|||
16996656|NCT00758680|38140747|FG002|Overall Study|Withdrawal by Subject|0|||
16996657|NCT00758680|38140748|FG003|Overall Study|Withdrawal by Subject|0|||
16996658|NCT00758680|38140749|FG004|Overall Study|Withdrawal by Subject|0|||
16996659|NCT00758680|38140750|FG005|Overall Study|Withdrawal by Subject|0|||
16996660|NCT00758680|38140751|FG006|Overall Study|Withdrawal by Subject|1|||
16996661|NCT00758680|38140752|FG007|Overall Study|Withdrawal by Subject|0|||
16996662|NCT00758680|38140753|FG008|Overall Study|Withdrawal by Subject|1|||
16996663|NCT00758680|38140754|FG009|Overall Study|Withdrawal by Subject|0|||
16996664|NCT00758602|38140779|FG000|Overall Study|Adverse Event|11|||
16996665|NCT00758602|38140780|FG001|Overall Study|Adverse Event|10|||
16996666|NCT00758602|38140779|FG000|Overall Study|Lost to Follow-up|4|||
16996667|NCT00758602|38140780|FG001|Overall Study|Lost to Follow-up|3|||
16996668|NCT00758602|38140779|FG000|Overall Study|Withdrawal by Subject|1|||
16996669|NCT00758602|38140780|FG001|Overall Study|Withdrawal by Subject|3|||
16996670|NCT00758602|38140779|FG000|Overall Study|Protocol Violation|0|||
16996671|NCT00758602|38140780|FG001|Overall Study|Protocol Violation|2|||
16996672|NCT00758602|38140779|FG000|Overall Study|Death|0|||
16996673|NCT00758602|38140780|FG001|Overall Study|Death|1|||
16996674|NCT00758602|38140779|FG000|Overall Study|Reason not specified|3|||
16996675|NCT00758602|38140780|FG001|Overall Study|Reason not specified|3|||
16996676|NCT00713323|38140787|FG000|Overall Study|Adverse Event|75|||
16996677|NCT00713323|38140787|FG000|Overall Study|Withdrawal by Subject|15|||
17087276|NCT00329550|38227642|FG002|Overall Study|Withdrawal of Consent|1|||
17172782|NCT03069313|38322544|FG000|Overall Study|Adverse Event|5|||
17172783|NCT03068767|38322550|FG000|Overall Study|Lost to Follow-up|7|||
17172784|NCT03068767|38322551|FG001|Overall Study|Lost to Follow-up|3|||
17172785|NCT03068767|38322550|FG000|Overall Study|Protocol Violation|3|||
17172786|NCT03068767|38322551|FG001|Overall Study|Protocol Violation|0|||
17172787|NCT03020745|38322565|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
17172788|NCT03020745|38322566|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
17172789|NCT03020745|38322567|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
17172790|NCT03020745|38322568|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
17087277|NCT00329550|38227640|FG000|Overall Study|Due to Relocation|0|||
17087278|NCT00329550|38227641|FG001|Overall Study|Due to Relocation|0|||
17087279|NCT00329550|38227642|FG002|Overall Study|Due to Relocation|1|||
17087280|NCT00375674|38227654|FG000|Overall Study|Other|26|||
17172791|NCT03020745|38322569|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
17172792|NCT03020745|38322570|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
17172793|NCT03020745|38322571|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
17172794|NCT03020745|38322572|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
17172795|NCT03020745|38322573|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
17172796|NCT03020745|38322574|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
17172797|NCT03020745|38322565|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172798|NCT03020745|38322566|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172799|NCT03020745|38322567|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172800|NCT03020745|38322568|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172801|NCT03020745|38322569|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172802|NCT03020745|38322570|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172803|NCT03020745|38322571|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172804|NCT03020745|38322572|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
17172805|NCT03020745|38322573|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172806|NCT03020745|38322574|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
17172807|NCT03020745|38322565|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
17172808|NCT03020745|38322566|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
17172809|NCT03020745|38322567|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
17172810|NCT03020745|38322568|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
17172811|NCT03020745|38322569|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
17172812|NCT03020745|38322570|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
17172813|NCT03020745|38322571|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
17172814|NCT03020745|38322572|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
17172815|NCT03020745|38322573|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
17172816|NCT03020745|38322574|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
17172817|NCT03020745|38322565|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172818|NCT03020745|38322566|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172819|NCT03020745|38322567|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172820|NCT03020745|38322568|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172821|NCT03020745|38322569|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172822|NCT03020745|38322570|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172823|NCT03020745|38322571|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172824|NCT03020745|38322572|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172825|NCT03020745|38322573|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
17172826|NCT03020745|38322574|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
17172827|NCT03019965|38322609|FG000|Overall Study|Withdrawal by Subject|1|||
17172828|NCT03019965|38322610|FG001|Overall Study|Withdrawal by Subject|0|||
17172829|NCT03019965|38322609|FG000|Overall Study|Protocol Violation|1|||
17172830|NCT03019965|38322610|FG001|Overall Study|Protocol Violation|3|||
17172831|NCT03019965|38322609|FG000|Overall Study|viral or fungal infection|3|||
17172832|NCT03019965|38322610|FG001|Overall Study|viral or fungal infection|4|||
17172833|NCT03019965|38322609|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
17172834|NCT03019965|38322610|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
17172835|NCT03019965|38322609|FG000|Overall Study|Physician Decision|1|||
17172836|NCT03019965|38322610|FG001|Overall Study|Physician Decision|1|||
17172837|NCT01675882|38322629|FG000|Overall Study|Adverse Event|0|||
17172838|NCT01675882|38322630|FG001|Overall Study|Adverse Event|2|||
17172839|NCT01675882|38322631|FG002|Overall Study|Adverse Event|1|||
17172840|NCT01675882|38322632|FG003|Overall Study|Adverse Event|0|||
17172841|NCT01675882|38322629|FG000|Overall Study|Participant unwilling to continue|2|||
17172842|NCT01675882|38322630|FG001|Overall Study|Participant unwilling to continue|4|||
17172843|NCT01675882|38322631|FG002|Overall Study|Participant unwilling to continue|2|||
17087281|NCT00375674|38227655|FG001|Overall Study|Other|18|||
17087282|NCT00375674|38227654|FG000|Overall Study|Death|67|||
17087283|NCT00375674|38227655|FG001|Overall Study|Death|76|||
17087284|NCT00375674|38227654|FG000|Overall Study|Participants refused further follow-up|31|||
17087285|NCT00375674|38227655|FG001|Overall Study|Participants refused further follow-up|30|||
17087286|NCT00375674|38227654|FG000|Overall Study|Lost to Follow-up|17|||
17087287|NCT00375674|38227655|FG001|Overall Study|Lost to Follow-up|15|||
17087288|NCT00375674|38227654|FG000|Overall Study|Enrolled but not treated|3|||
17087289|NCT00375674|38227655|FG001|Overall Study|Enrolled but not treated|2|||
17087290|NCT00350402|38227663|FG000|Overall Study|Lost to Follow-up|1|||
17172844|NCT01675882|38322632|FG003|Overall Study|Participant unwilling to continue|1|||
17172845|NCT01675882|38322629|FG000|Overall Study|Lost to Follow-up|0|||
17172846|NCT01675882|38322630|FG001|Overall Study|Lost to Follow-up|1|||
17172847|NCT01675882|38322631|FG002|Overall Study|Lost to Follow-up|0|||
17172848|NCT01675882|38322632|FG003|Overall Study|Lost to Follow-up|0|||
17172849|NCT01675882|38322629|FG000|Overall Study|Non-compliance|0|||
17172850|NCT01675882|38322630|FG001|Overall Study|Non-compliance|0|||
17172851|NCT01675882|38322631|FG002|Overall Study|Non-compliance|0|||
17172852|NCT01675882|38322632|FG003|Overall Study|Non-compliance|1|||
17172853|NCT03018249|38322644|FG000|Overall Study|Withdrawal by Subject|2|||
17172854|NCT03018249|38322645|FG001|Overall Study|Withdrawal by Subject|2|||
17172855|NCT02923245|38322663|FG000|Overall Study|ultrasound order was cancelled|2|||
17087291|NCT00350402|38227664|FG001|Overall Study|Lost to Follow-up|1|||
17087292|NCT00320190|38227678|FG000|First 12 Months|Completed but did not enter extension|5|||
17087293|NCT00320190|38227679|FG001|First 12 Months|Completed but did not enter extension|3|||
17087294|NCT00320190|38227678|FG000|First 12 Months|Sponsor terminated study|2|||
17172856|NCT02923245|38322664|FG001|Overall Study|ultrasound order was cancelled|1|||
17172857|NCT00905606|38322680|FG000|Period 1|Adverse Event|0|||
17172858|NCT00905606|38322681|FG001|Period 1|Adverse Event|1|||
17172859|NCT00905606|38322680|FG000|Washout|Withdrawal by Subject|1|||
17172860|NCT00905606|38322681|FG001|Washout|Withdrawal by Subject|0|||
17172861|NCT01676896|38322688|FG000|Overall Study|Withdrawal by Subject|12|||
17172862|NCT01676896|38322689|FG001|Overall Study|Withdrawal by Subject|7|||
17172863|NCT01676896|38322690|FG002|Overall Study|Withdrawal by Subject|19|||
17172864|NCT03017235|38322700|FG000|Overall Study|Withdrawal by Subject|4|||
17172865|NCT03017235|38322701|FG001|Overall Study|Withdrawal by Subject|3|||
17172866|NCT03017235|38322700|FG000|Overall Study|Lost to Follow-up|2|||
17172867|NCT03017235|38322701|FG001|Overall Study|Lost to Follow-up|7|||
17172868|NCT03017235|38322700|FG000|Overall Study|Adverse Event|0|||
17172869|NCT03017235|38322701|FG001|Overall Study|Adverse Event|1|||
17172870|NCT03017235|38322700|FG000|Overall Study|Protocol Violation|2|||
17172871|NCT03017235|38322701|FG001|Overall Study|Protocol Violation|1|||
17172872|NCT03017235|38322700|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
17172873|NCT03017235|38322701|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
17172874|NCT03017079|38322709|FG000|Overall Study|Physician Decision|1|||
17172875|NCT03017079|38322710|FG001|Overall Study|Physician Decision|1|||
17172876|NCT03017079|38322709|FG000|Overall Study|Death|3|||
17172877|NCT03017079|38322710|FG001|Overall Study|Death|2|||
17172878|NCT03017079|38322709|FG000|Overall Study|Lack of Efficacy|2|||
17172879|NCT03017079|38322710|FG001|Overall Study|Lack of Efficacy|2|||
17172880|NCT03017079|38322709|FG000|Overall Study|Protocol Violation|0|||
17172881|NCT03017079|38322710|FG001|Overall Study|Protocol Violation|1|||
17172882|NCT03015363|38322723|FG000|Overall Study|Physician Decision|14|||
17172883|NCT03015363|38322723|FG000|Overall Study|Withdrawal by Subject|3|||
17172884|NCT02880371|38322735|FG000|Phase 1b|Lost to Follow-up|1|||
17087295|NCT00320190|38227679|FG001|First 12 Months|Sponsor terminated study|2|||
17087296|NCT00320190|38227678|FG000|First 12 Months|Lost to Follow-up|0|||
17087297|NCT00320190|38227679|FG001|First 12 Months|Lost to Follow-up|1|||
17087298|NCT00320190|38227678|FG000|First 12 Months|Enrollment failure|0|||
17087299|NCT00320190|38227679|FG001|First 12 Months|Enrollment failure|1|||
17087300|NCT00320190|38227678|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
17087301|NCT00320190|38227679|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
17087302|NCT00320190|38227678|FG000|First 12 Months|Investigator request|0|||
17087303|NCT00320190|38227679|FG001|First 12 Months|Investigator request|1|||
17172885|NCT02880371|38322736|FG001|Phase 1b|Lost to Follow-up|0|||
17172886|NCT02880371|38322737|FG002|Phase 1b|Lost to Follow-up|0|||
17172887|NCT02880371|38322738|FG003|Phase 1b|Lost to Follow-up|0|||
17172888|NCT02880371|38322739|FG004|Phase 1b|Lost to Follow-up|0|||
17172889|NCT02880371|38322740|FG005|Phase 1b|Lost to Follow-up|0|||
17172890|NCT02880371|38322741|FG006|Phase 1b|Lost to Follow-up|0|||
16996678|NCT00713323|38140787|FG000|Overall Study|Lost to Follow-up|11|||
16996679|NCT00713323|38140787|FG000|Overall Study|Lack of Efficacy|36|||
16996680|NCT00713323|38140787|FG000|Overall Study|Low creatine clearance at screening|1|||
16996681|NCT00713323|38140787|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
16996682|NCT00713323|38140787|FG000|Overall Study|Surgery cured allodynic pain|1|||
16996683|NCT00713323|38140787|FG000|Overall Study|Pain free|1|||
16996684|NCT00713323|38140787|FG000|Overall Study|Non-compliance|1|||
16996685|NCT00713323|38140787|FG000|Overall Study|Pain resolved|1|||
16996686|NCT00713323|38140787|FG000|Overall Study|Subject travelling to USA|1|||
17172891|NCT02880371|38322742|FG007|Phase 1b|Lost to Follow-up|0|||
17172892|NCT02880371|38322735|FG000|Phase 1b|Participants terminated by Sponsor|1|||
17172893|NCT02880371|38322736|FG001|Phase 1b|Participants terminated by Sponsor|0|||
17172894|NCT02880371|38322737|FG002|Phase 1b|Participants terminated by Sponsor|0|||
17172895|NCT02880371|38322738|FG003|Phase 1b|Participants terminated by Sponsor|0|||
17172896|NCT02880371|38322739|FG004|Phase 1b|Participants terminated by Sponsor|0|||
17172897|NCT02880371|38322740|FG005|Phase 1b|Participants terminated by Sponsor|0|||
17172898|NCT02880371|38322741|FG006|Phase 1b|Participants terminated by Sponsor|0|||
17172899|NCT02880371|38322742|FG007|Phase 1b|Participants terminated by Sponsor|0|||
17172900|NCT02880371|38322735|FG000|Phase 1b|Withdrawal by Subject|0|||
17172901|NCT02880371|38322736|FG001|Phase 1b|Withdrawal by Subject|0|||
17172902|NCT02880371|38322737|FG002|Phase 1b|Withdrawal by Subject|1|||
17172903|NCT02880371|38322738|FG003|Phase 1b|Withdrawal by Subject|0|||
17172904|NCT02880371|38322739|FG004|Phase 1b|Withdrawal by Subject|0|||
17172905|NCT02880371|38322740|FG005|Phase 1b|Withdrawal by Subject|0|||
17172906|NCT02880371|38322741|FG006|Phase 1b|Withdrawal by Subject|0|||
17172907|NCT02880371|38322742|FG007|Phase 1b|Withdrawal by Subject|0|||
17172908|NCT02880371|38322735|FG000|Phase 1b|Death|4|||
17172909|NCT02880371|38322736|FG001|Phase 1b|Death|6|||
17172910|NCT02880371|38322737|FG002|Phase 1b|Death|5|||
17172911|NCT02880371|38322738|FG003|Phase 1b|Death|1|||
17172912|NCT02880371|38322739|FG004|Phase 1b|Death|0|||
17172913|NCT02880371|38322740|FG005|Phase 1b|Death|0|||
17172914|NCT02880371|38322741|FG006|Phase 1b|Death|0|||
17172915|NCT02880371|38322742|FG007|Phase 1b|Death|0|||
17172916|NCT02880371|38322735|FG000|Phase 1b|Enrolled but not Treated|0|||
17172917|NCT02880371|38322736|FG001|Phase 1b|Enrolled but not Treated|1|||
17172918|NCT02880371|38322737|FG002|Phase 1b|Enrolled but not Treated|0|||
17172919|NCT02880371|38322738|FG003|Phase 1b|Enrolled but not Treated|0|||
17172920|NCT02880371|38322739|FG004|Phase 1b|Enrolled but not Treated|0|||
17172921|NCT02880371|38322740|FG005|Phase 1b|Enrolled but not Treated|0|||
17172922|NCT02880371|38322741|FG006|Phase 1b|Enrolled but not Treated|0|||
17172923|NCT02880371|38322742|FG007|Phase 1b|Enrolled but not Treated|0|||
17172924|NCT02880371|38322735|FG000|Phase 2|Enrolled but not Treated|0|||
17172925|NCT02880371|38322736|FG001|Phase 2|Enrolled but not Treated|0|||
17172926|NCT02880371|38322737|FG002|Phase 2|Enrolled but not Treated|0|||
17172927|NCT02880371|38322738|FG003|Phase 2|Enrolled but not Treated|0|||
17172928|NCT02880371|38322739|FG004|Phase 2|Enrolled but not Treated|0|||
17172929|NCT02880371|38322740|FG005|Phase 2|Enrolled but not Treated|1|||
17172930|NCT02880371|38322741|FG006|Phase 2|Enrolled but not Treated|1|||
17172931|NCT02880371|38322742|FG007|Phase 2|Enrolled but not Treated|0|||
17172932|NCT02880371|38322735|FG000|Phase 2|Other|0|||
17172933|NCT02880371|38322736|FG001|Phase 2|Other|0|||
17172934|NCT02880371|38322737|FG002|Phase 2|Other|0|||
17172935|NCT02880371|38322738|FG003|Phase 2|Other|0|||
17087304|NCT00320190|38227678|FG000|First 12 Months|Study drug toxicity|0|||
17087305|NCT00320190|38227679|FG001|First 12 Months|Study drug toxicity|1|||
17087306|NCT00320190|38227678|FG000|First 12 Months|Withdrawal by Subject|0|||
17087307|NCT00320190|38227679|FG001|First 12 Months|Withdrawal by Subject|1|||
17087308|NCT00320190|38227678|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
17087309|NCT00320190|38227679|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
17087310|NCT00320190|38227678|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
17087311|NCT00320190|38227679|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
17087312|NCT00320190|38227678|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
17087313|NCT00320190|38227679|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
17087314|NCT00320112|38227687|FG000|Overall Study|Lost to Follow-up|3|||
17087315|NCT00320112|38227688|FG001|Overall Study|Lost to Follow-up|4|||
17087316|NCT00320112|38227687|FG000|Overall Study|Withdrawal by Subject|3|||
17087317|NCT00320112|38227688|FG001|Overall Study|Withdrawal by Subject|0|||
17087318|NCT00320112|38227687|FG000|Overall Study|Death|2|||
17087319|NCT00320112|38227688|FG001|Overall Study|Death|1|||
17087320|NCT00319956|38227702|FG000|Overall Study|Death|20|||
17087321|NCT00319956|38227703|FG001|Overall Study|Death|24|||
17087322|NCT00349622|38227711|FG000|Overall Study|Death|168|||
17087323|NCT00349622|38227712|FG001|Overall Study|Death|86|||
17087324|NCT00349622|38227711|FG000|Overall Study|Lost to Follow-up|5|||
17087325|NCT00349622|38227712|FG001|Overall Study|Lost to Follow-up|1|||
17087326|NCT00349622|38227711|FG000|Overall Study|Withdrawal by Subject|5|||
17087327|NCT00349622|38227712|FG001|Overall Study|Withdrawal by Subject|9|||
17087328|NCT00354614|38227718|FG000|Overall Study|Lack of Efficacy|28|||
17087329|NCT00360308|38227725|FG000|Overall Study|Adverse Event|15|||
17172936|NCT02880371|38322739|FG004|Phase 2|Other|0|||
17172937|NCT02880371|38322740|FG005|Phase 2|Other|1|||
17087330|NCT00360308|38227726|FG001|Overall Study|Adverse Event|14|||
17087331|NCT00360308|38227727|FG002|Overall Study|Adverse Event|25|||
17172938|NCT02880371|38322741|FG006|Phase 2|Other|2|||
17172939|NCT02880371|38322742|FG007|Phase 2|Other|1|||
17087332|NCT00360308|38227725|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
17087333|NCT00360308|38227726|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
17087334|NCT00360308|38227727|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
17087335|NCT00360308|38227725|FG000|Overall Study|Protocol Violation|2|||
17087336|NCT00360308|38227726|FG001|Overall Study|Protocol Violation|1|||
17087337|NCT00360308|38227727|FG002|Overall Study|Protocol Violation|2|||
17087338|NCT00360308|38227725|FG000|Overall Study|Withdrawal by Subject|11|||
17087339|NCT00360308|38227726|FG001|Overall Study|Withdrawal by Subject|7|||
17087340|NCT00360308|38227727|FG002|Overall Study|Withdrawal by Subject|14|||
17087341|NCT00360308|38227725|FG000|Overall Study|Lack of Efficacy|3|||
17087342|NCT00360308|38227726|FG001|Overall Study|Lack of Efficacy|0|||
17087343|NCT00360308|38227727|FG002|Overall Study|Lack of Efficacy|2|||
17087344|NCT00360308|38227725|FG000|Overall Study|Other|2|||
17087345|NCT00360308|38227726|FG001|Overall Study|Other|1|||
17087346|NCT00360308|38227727|FG002|Overall Study|Other|1|||
17087347|NCT00360308|38227725|FG000|Overall Study|Study termination by sponsor|43|||
17087348|NCT00360308|38227726|FG001|Overall Study|Study termination by sponsor|55|||
17087349|NCT00360308|38227727|FG002|Overall Study|Study termination by sponsor|44|||
17087350|NCT00348686|38227739|FG000|Overall Study|Withdrawal by Subject|45|||
17087351|NCT00348686|38227739|FG000|Overall Study|Adverse Event|5|||
17087352|NCT00348686|38227739|FG000|Overall Study|Protocol Violation|6|||
17087353|NCT00348686|38227739|FG000|Overall Study|Lost to Follow-up|2|||
17087354|NCT00348686|38227739|FG000|Overall Study|Multiple Reasons|8|||
17087355|NCT00360230|38227750|FG000|Overall Study|Withdrawal by Subject|1|||
17087356|NCT00360230|38227751|FG001|Overall Study|Withdrawal by Subject|1|||
17087357|NCT00360230|38227752|FG002|Overall Study|Withdrawal by Subject|0|||
17087358|NCT00360230|38227753|FG003|Overall Study|Withdrawal by Subject|1|||
17087359|NCT00360230|38227754|FG004|Overall Study|Withdrawal by Subject|1|||
17087360|NCT00360230|38227755|FG005|Overall Study|Withdrawal by Subject|1|||
17087361|NCT00360230|38227756|FG006|Overall Study|Withdrawal by Subject|0|||
17087362|NCT00360230|38227750|FG000|Overall Study|Migrated|4|||
17087363|NCT00360230|38227751|FG001|Overall Study|Migrated|1|||
17087364|NCT00360230|38227752|FG002|Overall Study|Migrated|3|||
17087365|NCT00360230|38227753|FG003|Overall Study|Migrated|1|||
17087366|NCT00360230|38227754|FG004|Overall Study|Migrated|4|||
17087367|NCT00360230|38227755|FG005|Overall Study|Migrated|1|||
17087368|NCT00360230|38227756|FG006|Overall Study|Migrated|1|||
17087369|NCT00360230|38227750|FG000|Overall Study|Other|1|||
17087370|NCT00360230|38227751|FG001|Overall Study|Other|0|||
17087371|NCT00360230|38227752|FG002|Overall Study|Other|0|||
17087372|NCT00360230|38227753|FG003|Overall Study|Other|0|||
17087373|NCT00360230|38227754|FG004|Overall Study|Other|0|||
17087374|NCT00360230|38227755|FG005|Overall Study|Other|0|||
17087375|NCT00360230|38227756|FG006|Overall Study|Other|0|||
17087376|NCT00360230|38227750|FG000|Overall Study|Protocol Violation|0|||
17087377|NCT00360230|38227751|FG001|Overall Study|Protocol Violation|0|||
17087378|NCT00360230|38227752|FG002|Overall Study|Protocol Violation|0|||
17087379|NCT00360230|38227753|FG003|Overall Study|Protocol Violation|0|||
17087380|NCT00360230|38227754|FG004|Overall Study|Protocol Violation|0|||
17087381|NCT00360230|38227755|FG005|Overall Study|Protocol Violation|1|||
17087382|NCT00360230|38227756|FG006|Overall Study|Protocol Violation|0|||
17087383|NCT00360230|38227750|FG000|Overall Study|Death|0|||
17087384|NCT00360230|38227751|FG001|Overall Study|Death|1|||
17087385|NCT00360230|38227752|FG002|Overall Study|Death|0|||
17087386|NCT00360230|38227753|FG003|Overall Study|Death|0|||
17087387|NCT00360230|38227754|FG004|Overall Study|Death|0|||
17087388|NCT00360230|38227755|FG005|Overall Study|Death|1|||
17087389|NCT00360230|38227756|FG006|Overall Study|Death|1|||
17087390|NCT00348374|38227776|FG000|Overall Study|Adverse Event|1|||
17087391|NCT00348374|38227777|FG001|Overall Study|Adverse Event|4|||
17087392|NCT00348374|38227776|FG000|Overall Study|Lost to Follow-up|1|||
17087393|NCT00348374|38227777|FG001|Overall Study|Lost to Follow-up|3|||
17087394|NCT00348374|38227776|FG000|Overall Study|Withdrawal by Subject|5|||
17087395|NCT00348374|38227777|FG001|Overall Study|Withdrawal by Subject|5|||
17087396|NCT00348374|38227776|FG000|Overall Study|Other|11|||
17087397|NCT00348374|38227777|FG001|Overall Study|Other|12|||
17087398|NCT00348374|38227776|FG000|Overall Study|ongoing at date of cutoff|1|||
17087399|NCT00348374|38227777|FG001|Overall Study|ongoing at date of cutoff|1|||
17087400|NCT00348374|38227776|FG000|Overall Study|randomized but did not receive treatment|0|||
17087401|NCT00348374|38227777|FG001|Overall Study|randomized but did not receive treatment|7|||
17087402|NCT00353366|38227784|FG000|Overall Study|Adverse Event|8|||
17087403|NCT00353366|38227784|FG000|Overall Study|Protocol Violation|12|||
17087404|NCT00353366|38227784|FG000|Overall Study|Withdrawal by Subject|12|||
17087405|NCT00353366|38227784|FG000|Overall Study|Lost to Follow-up|92|||
17087406|NCT00353366|38227784|FG000|Overall Study|Other|19|||
17087407|NCT00352664|38227790|FG000|Overall Study|Withdrawal by Subject|7|||
17087408|NCT00352664|38227791|FG001|Overall Study|Withdrawal by Subject|0|||
17087409|NCT00490139|38227801|FG000|Overall Study|Death|106|||
17087410|NCT00490139|38227802|FG001|Overall Study|Death|119|||
17087411|NCT00490139|38227803|FG002|Overall Study|Death|168|||
17087412|NCT00490139|38227804|FG003|Overall Study|Death|135|||
17087413|NCT00490139|38227801|FG000|Overall Study|Lost to Follow-up|56|||
17087414|NCT00490139|38227802|FG001|Overall Study|Lost to Follow-up|46|||
17087415|NCT00490139|38227803|FG002|Overall Study|Lost to Follow-up|58|||
17087416|NCT00490139|38227804|FG003|Overall Study|Lost to Follow-up|56|||
17087417|NCT00490139|38227801|FG000|Overall Study|Participant Withdrew Consent|146|||
17087418|NCT00490139|38227802|FG001|Overall Study|Participant Withdrew Consent|110|||
17087419|NCT00490139|38227803|FG002|Overall Study|Participant Withdrew Consent|208|||
17087420|NCT00490139|38227804|FG003|Overall Study|Participant Withdrew Consent|116|||
17087421|NCT00348140|38227819|FG000|Overall Study|Adverse Event|46|||
17087422|NCT00348140|38227820|FG001|Overall Study|Adverse Event|49|||
17087423|NCT00348140|38227821|FG002|Overall Study|Adverse Event|78|||
17087424|NCT00348140|38227819|FG000|Overall Study|Lost to Follow-up|4|||
17087425|NCT00348140|38227820|FG001|Overall Study|Lost to Follow-up|4|||
17087426|NCT00348140|38227821|FG002|Overall Study|Lost to Follow-up|4|||
17087427|NCT00348140|38227819|FG000|Overall Study|Protocol Violation|12|||
17087428|NCT00348140|38227820|FG001|Overall Study|Protocol Violation|13|||
17087429|NCT00348140|38227821|FG002|Overall Study|Protocol Violation|14|||
17087430|NCT00348140|38227819|FG000|Overall Study|Withdrawal by Subject|32|||
17087431|NCT00348140|38227820|FG001|Overall Study|Withdrawal by Subject|40|||
17087432|NCT00348140|38227821|FG002|Overall Study|Withdrawal by Subject|40|||
17087433|NCT00348140|38227819|FG000|Overall Study|Non-compliance|8|||
17087434|NCT00348140|38227820|FG001|Overall Study|Non-compliance|13|||
17087435|NCT00348140|38227821|FG002|Overall Study|Non-compliance|5|||
17087436|NCT00348140|38227819|FG000|Overall Study|Participant at risk due to study drug|2|||
17087437|NCT00348140|38227820|FG001|Overall Study|Participant at risk due to study drug|0|||
17087438|NCT00348140|38227821|FG002|Overall Study|Participant at risk due to study drug|0|||
17087439|NCT00348140|38227819|FG000|Overall Study|Conditional medication increased dose|1|||
17087440|NCT00348140|38227820|FG001|Overall Study|Conditional medication increased dose|0|||
17087441|NCT00348140|38227821|FG002|Overall Study|Conditional medication increased dose|0|||
17087442|NCT00348140|38227819|FG000|Overall Study|Caregiver related|4|||
17087443|NCT00348140|38227820|FG001|Overall Study|Caregiver related|7|||
17087444|NCT00348140|38227821|FG002|Overall Study|Caregiver related|3|||
17087445|NCT00348140|38227819|FG000|Overall Study|Participant hospitalised|3|||
17087446|NCT00348140|38227820|FG001|Overall Study|Participant hospitalised|0|||
17087447|NCT00348140|38227821|FG002|Overall Study|Participant hospitalised|0|||
17087448|NCT00348140|38227819|FG000|Overall Study|Efficacy related|1|||
17087449|NCT00348140|38227820|FG001|Overall Study|Efficacy related|1|||
17087450|NCT00348140|38227821|FG002|Overall Study|Efficacy related|0|||
17087451|NCT00348140|38227819|FG000|Overall Study|Administration related|3|||
17087452|NCT00348140|38227820|FG001|Overall Study|Administration related|1|||
17087453|NCT00348140|38227821|FG002|Overall Study|Administration related|1|||
17087454|NCT00348140|38227819|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
17087455|NCT00348140|38227820|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
17087456|NCT00348140|38227821|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
17087457|NCT00348140|38227819|FG000|Overall Study|Participant unwell|1|||
17087458|NCT00348140|38227820|FG001|Overall Study|Participant unwell|0|||
17087459|NCT00348140|38227821|FG002|Overall Study|Participant unwell|0|||
17087460|NCT00348140|38227819|FG000|Overall Study|Screen failure|1|||
17087461|NCT00348140|38227820|FG001|Overall Study|Screen failure|0|||
17087462|NCT00348140|38227821|FG002|Overall Study|Screen failure|0|||
17087463|NCT00348140|38227819|FG000|Overall Study|Investigator decided to discontinue|4|||
17087464|NCT00348140|38227820|FG001|Overall Study|Investigator decided to discontinue|1|||
17087465|NCT00348140|38227821|FG002|Overall Study|Investigator decided to discontinue|4|||
17087466|NCT00348140|38227819|FG000|Overall Study|Decided to discontinue on their own|1|||
17087467|NCT00348140|38227820|FG001|Overall Study|Decided to discontinue on their own|4|||
17087468|NCT00348140|38227821|FG002|Overall Study|Decided to discontinue on their own|1|||
17087469|NCT00348140|38227819|FG000|Overall Study|Use of prohibited drug|1|||
17087470|NCT00348140|38227820|FG001|Overall Study|Use of prohibited drug|0|||
17172940|NCT02880371|38322735|FG000|Phase 2|Participants terminated by Sponsor|0|||
17172941|NCT02880371|38322736|FG001|Phase 2|Participants terminated by Sponsor|0|||
17172942|NCT02880371|38322737|FG002|Phase 2|Participants terminated by Sponsor|0|||
17172943|NCT02880371|38322738|FG003|Phase 2|Participants terminated by Sponsor|0|||
17172944|NCT02880371|38322739|FG004|Phase 2|Participants terminated by Sponsor|1|||
17172945|NCT02880371|38322740|FG005|Phase 2|Participants terminated by Sponsor|6|||
17172946|NCT02880371|38322741|FG006|Phase 2|Participants terminated by Sponsor|1|||
17172947|NCT02880371|38322742|FG007|Phase 2|Participants terminated by Sponsor|5|||
17172948|NCT02880371|38322735|FG000|Phase 2|Death|0|||
17172949|NCT02880371|38322736|FG001|Phase 2|Death|0|||
17087471|NCT00348140|38227821|FG002|Overall Study|Use of prohibited drug|2|||
17087472|NCT00348140|38227819|FG000|Overall Study|Disease progression|1|||
17087473|NCT00348140|38227820|FG001|Overall Study|Disease progression|2|||
17172950|NCT02880371|38322737|FG002|Phase 2|Death|0|||
17172951|NCT02880371|38322738|FG003|Phase 2|Death|0|||
17172952|NCT02880371|38322739|FG004|Phase 2|Death|1|||
17087474|NCT00348140|38227821|FG002|Overall Study|Disease progression|5|||
17087475|NCT00348140|38227819|FG000|Overall Study|Increased risk of cardiac infarction|0|||
17087476|NCT00348140|38227820|FG001|Overall Study|Increased risk of cardiac infarction|1|||
17087477|NCT00348140|38227821|FG002|Overall Study|Increased risk of cardiac infarction|0|||
17087478|NCT00348140|38227819|FG000|Overall Study|Serious adverse event|0|||
17087479|NCT00348140|38227820|FG001|Overall Study|Serious adverse event|1|||
17087480|NCT00348140|38227821|FG002|Overall Study|Serious adverse event|0|||
17087481|NCT00348140|38227819|FG000|Overall Study|Abnormal ECG|0|||
17087482|NCT00348140|38227820|FG001|Overall Study|Abnormal ECG|1|||
17087483|NCT00348140|38227821|FG002|Overall Study|Abnormal ECG|3|||
17087484|NCT00348140|38227819|FG000|Overall Study|Participant died|0|||
17087485|NCT00348140|38227820|FG001|Overall Study|Participant died|1|||
17087486|NCT00348140|38227821|FG002|Overall Study|Participant died|0|||
17087487|NCT00348140|38227819|FG000|Overall Study|Exclusion criteria met|0|||
17087488|NCT00348140|38227820|FG001|Overall Study|Exclusion criteria met|0|||
17087489|NCT00348140|38227821|FG002|Overall Study|Exclusion criteria met|1|||
17087490|NCT00348140|38227819|FG000|Overall Study|Memory declined|0|||
17087491|NCT00348140|38227820|FG001|Overall Study|Memory declined|0|||
17087492|NCT00348140|38227821|FG002|Overall Study|Memory declined|1|||
17087493|NCT00490061|38227830|FG000|Overall Study|Physician Decision|1|||
17087494|NCT00483119|38227836|FG000|Overall Study|Adverse Event|0|||
17087495|NCT00483119|38227837|FG001|Overall Study|Adverse Event|1|||
17087496|NCT00483119|38227836|FG000|Overall Study|Physician Decision|1|||
17087497|NCT00483119|38227837|FG001|Overall Study|Physician Decision|0|||
17087498|NCT00483041|38227845|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
17087499|NCT00483041|38227846|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
17087500|NCT00501293|38227854|FG000|Optimization Period|Enrolled in error|1|||
17087501|NCT00501293|38227855|FG001|Optimization Period|Enrolled in error|0|||
17087502|NCT00501293|38227854|FG000|Maintenance Period|Withdrawal by Subject|14|||
17087503|NCT00501293|38227855|FG001|Maintenance Period|Withdrawal by Subject|13|||
17087504|NCT00501293|38227854|FG000|Maintenance Period|Lost to Follow-up|12|||
17087505|NCT00501293|38227855|FG001|Maintenance Period|Lost to Follow-up|7|||
17087506|NCT00501293|38227854|FG000|Maintenance Period|Adverse Event|6|||
17087507|NCT00501293|38227855|FG001|Maintenance Period|Adverse Event|6|||
17087508|NCT00501293|38227854|FG000|Maintenance Period|Protocol Violation|2|||
17087509|NCT00501293|38227855|FG001|Maintenance Period|Protocol Violation|1|||
17087510|NCT00501293|38227854|FG000|Maintenance Period|Lack of Efficacy|4|||
17087511|NCT00501293|38227855|FG001|Maintenance Period|Lack of Efficacy|1|||
17087512|NCT00501293|38227854|FG000|Maintenance Period|Noncompliant with study medication|5|||
17087513|NCT00501293|38227855|FG001|Maintenance Period|Noncompliant with study medication|0|||
17087514|NCT00501293|38227854|FG000|Maintenance Period|Went into rehabilitation|1|||
17087515|NCT00501293|38227855|FG001|Maintenance Period|Went into rehabilitation|0|||
17087516|NCT00501293|38227854|FG000|Maintenance Period|Would not wear patch|1|||
17087517|NCT00501293|38227855|FG001|Maintenance Period|Would not wear patch|0|||
17087518|NCT00501293|38227854|FG000|Maintenance Period|Application site reaction|1|||
17087519|NCT00501293|38227855|FG001|Maintenance Period|Application site reaction|0|||
17087520|NCT00482729|38227864|FG000|Overall Study|Adverse Event|29|||
17087521|NCT00482729|38227865|FG001|Overall Study|Adverse Event|33|||
17087522|NCT00482729|38227864|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
17087523|NCT00482729|38227865|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
17087524|NCT00482729|38227864|FG000|Overall Study|Hyperglycemia Criteria|7|||
17087525|NCT00482729|38227865|FG001|Overall Study|Hyperglycemia Criteria|5|||
17087526|NCT00482729|38227864|FG000|Overall Study|Lack of Efficacy|4|||
17087527|NCT00482729|38227865|FG001|Overall Study|Lack of Efficacy|16|||
17087528|NCT00482729|38227864|FG000|Overall Study|Lost to Follow-up|86|||
17087529|NCT00482729|38227865|FG001|Overall Study|Lost to Follow-up|66|||
17087530|NCT00482729|38227864|FG000|Overall Study|Physician Decision|10|||
17087531|NCT00482729|38227865|FG001|Overall Study|Physician Decision|7|||
17087532|NCT00482729|38227864|FG000|Overall Study|Pregnancy|4|||
17087533|NCT00482729|38227865|FG001|Overall Study|Pregnancy|2|||
17087534|NCT00482729|38227864|FG000|Overall Study|Protocol Violation|10|||
17087535|NCT00482729|38227865|FG001|Overall Study|Protocol Violation|18|||
17087536|NCT00482729|38227864|FG000|Overall Study|Withdrawal by Subject|67|||
17087537|NCT00482729|38227865|FG001|Overall Study|Withdrawal by Subject|69|||
17087538|NCT00359762|38227873|FG000|Period II|Adverse Event|17|||
17087539|NCT00359762|38227874|FG001|Period II|Adverse Event|0|||
17087540|NCT00359762|38227875|FG002|Period II|Adverse Event|0|||
17087541|NCT00359762|38227876|FG003|Period II|Adverse Event|0|||
17087542|NCT00359762|38227877|FG004|Period II|Adverse Event|49|||
17087543|NCT00359762|38227873|FG000|Period II|Protocol Violation|18|||
17087544|NCT00359762|38227874|FG001|Period II|Protocol Violation|0|||
17087545|NCT00359762|38227875|FG002|Period II|Protocol Violation|0|||
17087546|NCT00359762|38227876|FG003|Period II|Protocol Violation|0|||
17172953|NCT02880371|38322740|FG005|Phase 2|Death|10|||
17172954|NCT02880371|38322741|FG006|Phase 2|Death|20|||
17087547|NCT00359762|38227877|FG004|Period II|Protocol Violation|11|||
17087548|NCT00359762|38227873|FG000|Period II|Physician Decision|17|||
17172955|NCT02880371|38322742|FG007|Phase 2|Death|5|||
17172956|NCT02880371|38322735|FG000|Phase 2|Lost to Follow-up|0|||
17172957|NCT02880371|38322736|FG001|Phase 2|Lost to Follow-up|0|||
17172958|NCT02880371|38322737|FG002|Phase 2|Lost to Follow-up|0|||
17172959|NCT02880371|38322738|FG003|Phase 2|Lost to Follow-up|0|||
17172960|NCT02880371|38322739|FG004|Phase 2|Lost to Follow-up|0|||
17172961|NCT02880371|38322740|FG005|Phase 2|Lost to Follow-up|0|||
17172962|NCT02880371|38322741|FG006|Phase 2|Lost to Follow-up|3|||
17172963|NCT02880371|38322742|FG007|Phase 2|Lost to Follow-up|0|||
17172964|NCT02880371|38322735|FG000|Phase 2|Withdrawal by Subject|0|||
17172965|NCT02880371|38322736|FG001|Phase 2|Withdrawal by Subject|0|||
17172966|NCT02880371|38322737|FG002|Phase 2|Withdrawal by Subject|0|||
17172967|NCT02880371|38322738|FG003|Phase 2|Withdrawal by Subject|0|||
17172968|NCT02880371|38322739|FG004|Phase 2|Withdrawal by Subject|0|||
17172969|NCT02880371|38322740|FG005|Phase 2|Withdrawal by Subject|1|||
17172970|NCT02880371|38322741|FG006|Phase 2|Withdrawal by Subject|1|||
17172971|NCT02880371|38322742|FG007|Phase 2|Withdrawal by Subject|0|||
17172972|NCT02880371|38322735|FG000|Phase 2|End of Study page not completed by error|0|||
17172973|NCT02880371|38322736|FG001|Phase 2|End of Study page not completed by error|0|||
17172974|NCT02880371|38322737|FG002|Phase 2|End of Study page not completed by error|0|||
17172975|NCT02880371|38322738|FG003|Phase 2|End of Study page not completed by error|0|||
17172976|NCT02880371|38322739|FG004|Phase 2|End of Study page not completed by error|0|||
17087549|NCT00359762|38227874|FG001|Period II|Physician Decision|0|||
17087550|NCT00359762|38227875|FG002|Period II|Physician Decision|0|||
17087551|NCT00359762|38227876|FG003|Period II|Physician Decision|0|||
17087552|NCT00359762|38227877|FG004|Period II|Physician Decision|23|||
17087553|NCT00359762|38227873|FG000|Period II|Death|2|||
17087554|NCT00359762|38227874|FG001|Period II|Death|0|||
17087555|NCT00359762|38227875|FG002|Period II|Death|0|||
17087556|NCT00359762|38227876|FG003|Period II|Death|0|||
17087557|NCT00359762|38227877|FG004|Period II|Death|4|||
17087558|NCT00359762|38227873|FG000|Period II|Lack of Efficacy|11|||
17087559|NCT00359762|38227874|FG001|Period II|Lack of Efficacy|0|||
17087560|NCT00359762|38227875|FG002|Period II|Lack of Efficacy|0|||
17087561|NCT00359762|38227876|FG003|Period II|Lack of Efficacy|0|||
17087562|NCT00359762|38227877|FG004|Period II|Lack of Efficacy|8|||
17087563|NCT00359762|38227873|FG000|Period II|Lost to follow up|5|||
17087564|NCT00359762|38227874|FG001|Period II|Lost to follow up|0|||
17087565|NCT00359762|38227875|FG002|Period II|Lost to follow up|0|||
17087566|NCT00359762|38227876|FG003|Period II|Lost to follow up|0|||
17087567|NCT00359762|38227877|FG004|Period II|Lost to follow up|5|||
17087568|NCT00359762|38227873|FG000|Period II|Entry Criteria Not Met|8|||
17172977|NCT02880371|38322740|FG005|Phase 2|End of Study page not completed by error|1|||
17172978|NCT02880371|38322741|FG006|Phase 2|End of Study page not completed by error|0|||
17172979|NCT02880371|38322742|FG007|Phase 2|End of Study page not completed by error|0|||
17172980|NCT02837029|38322765|FG000|Screening|Failed to meet screening requirements.|7|||
17172981|NCT02837029|38322766|FG001|Screening|Failed to meet screening requirements.|3|||
17172982|NCT02837029|38322767|FG002|Screening|Failed to meet screening requirements.|0|||
17172983|NCT02837029|38322765|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
17172984|NCT02837029|38322766|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
17172985|NCT02837029|38322767|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
17087569|NCT00359762|38227874|FG001|Period II|Entry Criteria Not Met|0|||
17087570|NCT00359762|38227875|FG002|Period II|Entry Criteria Not Met|0|||
17087571|NCT00359762|38227876|FG003|Period II|Entry Criteria Not Met|0|||
17087572|NCT00359762|38227877|FG004|Period II|Entry Criteria Not Met|4|||
17087573|NCT00359762|38227873|FG000|Period II|Subject Decision|50|||
17087574|NCT00359762|38227874|FG001|Period II|Subject Decision|0|||
17172986|NCT02837029|38322765|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
17172987|NCT02837029|38322766|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
17172988|NCT02837029|38322767|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
17172989|NCT02837029|38322765|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
17172990|NCT02837029|38322766|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
17172991|NCT02837029|38322767|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
17172992|NCT02837029|38322765|FG000|Cycle 2 and Beyond|Adverse Event|1|||
17172993|NCT02837029|38322766|FG001|Cycle 2 and Beyond|Adverse Event|0|||
17172994|NCT02837029|38322767|FG002|Cycle 2 and Beyond|Adverse Event|0|||
17172995|NCT02837029|38322765|FG000|2 Year Follow-up|Death|6|||
17172996|NCT02837029|38322766|FG001|2 Year Follow-up|Death|7|||
17172997|NCT02837029|38322767|FG002|2 Year Follow-up|Death|0|||
17172998|NCT02642965|38322776|FG000|Overall Study|Lack of Efficacy|4|||
17172999|NCT02642965|38322776|FG000|Overall Study|Physician Decision|9|||
17173000|NCT03010527|38322783|FG000|Overall Study|Death|0|||
17087575|NCT00359762|38227875|FG002|Period II|Subject Decision|0|||
17087576|NCT00359762|38227876|FG003|Period II|Subject Decision|0|||
17173001|NCT03010527|38322784|FG001|Overall Study|Death|0|||
17173002|NCT03010527|38322785|FG002|Overall Study|Death|1|||
17087577|NCT00359762|38227877|FG004|Period II|Subject Decision|70|||
17087578|NCT00359762|38227873|FG000|Period III|Protocol Violation|0|||
17173003|NCT03010527|38322783|FG000|Overall Study|Adverse Event|0|||
17173004|NCT03010527|38322784|FG001|Overall Study|Adverse Event|4|||
17173005|NCT03010527|38322785|FG002|Overall Study|Adverse Event|2|||
17173006|NCT03010527|38322783|FG000|Overall Study|Protocol Violation|0|||
17173007|NCT03010527|38322784|FG001|Overall Study|Protocol Violation|1|||
17173008|NCT03010527|38322785|FG002|Overall Study|Protocol Violation|0|||
17173009|NCT03010527|38322783|FG000|Overall Study|Lost to Follow-up|0|||
17173010|NCT03010527|38322784|FG001|Overall Study|Lost to Follow-up|2|||
17173011|NCT03010527|38322785|FG002|Overall Study|Lost to Follow-up|1|||
17173012|NCT03010527|38322783|FG000|Overall Study|Withdrawal by Subject|0|||
17173013|NCT03010527|38322784|FG001|Overall Study|Withdrawal by Subject|3|||
17173014|NCT03010527|38322785|FG002|Overall Study|Withdrawal by Subject|4|||
17173015|NCT03010527|38322783|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
17173016|NCT03010527|38322784|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
17173017|NCT03010527|38322785|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
17173018|NCT03010527|38322783|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
17173019|NCT03010527|38322784|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
17173020|NCT03010527|38322785|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
17173021|NCT03010527|38322783|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
17173022|NCT03010527|38322784|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
17173023|NCT03010527|38322785|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
17173024|NCT00794924|38322818|FG000|Overall Study|Lost to Follow-up|6|||
17173025|NCT00794924|38322819|FG001|Overall Study|Lost to Follow-up|8|||
17173026|NCT00794924|38322818|FG000|Overall Study|Withdrawal by Subject|48|||
17173027|NCT00794924|38322819|FG001|Overall Study|Withdrawal by Subject|60|||
17173028|NCT00794924|38322818|FG000|Overall Study|Adverse Event|6|||
17173029|NCT00794924|38322819|FG001|Overall Study|Adverse Event|2|||
17173030|NCT02914275|38322825|FG000|Overall Study|Lost to Follow-up|84|||
17173031|NCT02914275|38322826|FG001|Overall Study|Lost to Follow-up|29|||
17173032|NCT02914275|38322825|FG000|Overall Study|Withdrawal by Subject|26|||
17173033|NCT02914275|38322826|FG001|Overall Study|Withdrawal by Subject|10|||
17173034|NCT02914275|38322825|FG000|Overall Study|Protocol Violation|1|||
17173035|NCT02914275|38322826|FG001|Overall Study|Protocol Violation|1|||
17173036|NCT02914275|38322825|FG000|Overall Study|Physician Decision|3|||
17173037|NCT02914275|38322826|FG001|Overall Study|Physician Decision|1|||
17173038|NCT02914275|38322825|FG000|Overall Study|Other|4|||
17173039|NCT02914275|38322826|FG001|Overall Study|Other|1|||
17087579|NCT00359762|38227874|FG001|Period III|Protocol Violation|5|||
17087580|NCT00359762|38227875|FG002|Period III|Protocol Violation|3|||
17087581|NCT00359762|38227876|FG003|Period III|Protocol Violation|8|||
17087582|NCT00359762|38227877|FG004|Period III|Protocol Violation|0|||
17087583|NCT00359762|38227873|FG000|Period III|Adverse Event|0|||
17087584|NCT00359762|38227874|FG001|Period III|Adverse Event|3|||
17087585|NCT00359762|38227875|FG002|Period III|Adverse Event|4|||
17087586|NCT00359762|38227876|FG003|Period III|Adverse Event|10|||
17087587|NCT00359762|38227877|FG004|Period III|Adverse Event|0|||
17087588|NCT00359762|38227873|FG000|Period III|Physician Decision|0|||
17087589|NCT00359762|38227874|FG001|Period III|Physician Decision|5|||
17087590|NCT00359762|38227875|FG002|Period III|Physician Decision|9|||
17173040|NCT02914275|38322825|FG000|Overall Study|Excluded due to invalid informed consent|3|||
17173041|NCT02914275|38322826|FG001|Overall Study|Excluded due to invalid informed consent|0|||
17173042|NCT00792116|38322838|FG000|Overall Study|Lost to Follow-up|0|||
17173043|NCT00792116|38322839|FG001|Overall Study|Lost to Follow-up|1|||
17173044|NCT00792116|38322838|FG000|Overall Study|Discontnued intervention|1|||
17173045|NCT00792116|38322839|FG001|Overall Study|Discontnued intervention|0|||
17173046|NCT00489827|38322854|FG000|Overall Study|Intraoperative exclusion criteria|1|||
17173047|NCT00489827|38322855|FG001|Overall Study|Intraoperative exclusion criteria|1|||
17173048|NCT00489827|38322854|FG000|Overall Study|Intraoperative exclusion criteria|1|||
17173049|NCT00489827|38322855|FG001|Overall Study|Intraoperative exclusion criteria|1|||
17173050|NCT03007953|38322863|FG000|Overall Study|Withdrawal by Subject|5|||
17173051|NCT03007953|38322864|FG001|Overall Study|Withdrawal by Subject|2|||
17173052|NCT03007953|38322863|FG000|Overall Study|Death|5|||
17173053|NCT03007953|38322864|FG001|Overall Study|Death|7|||
17173054|NCT03007953|38322863|FG000|Overall Study|Lost to Follow-up|3|||
17173055|NCT03007953|38322864|FG001|Overall Study|Lost to Follow-up|2|||
17173056|NCT03007953|38322863|FG000|Overall Study|Enrolled in Hospice|3|||
17173057|NCT03007953|38322864|FG001|Overall Study|Enrolled in Hospice|2|||
17173058|NCT02604433|38322872|FG000|Overall Study|Withdrawal by Subject|37|||
17173059|NCT02604433|38322873|FG001|Overall Study|Withdrawal by Subject|16|||
17173060|NCT02604433|38322872|FG000|Overall Study|Adverse Event|4|||
17173061|NCT02604433|38322873|FG001|Overall Study|Adverse Event|0|||
17173062|NCT02604433|38322872|FG000|Overall Study|Other reasons|3|||
17173063|NCT02604433|38322873|FG001|Overall Study|Other reasons|5|||
17087591|NCT00359762|38227876|FG003|Period III|Physician Decision|15|||
17173064|NCT02604433|38322872|FG000|Overall Study|Death|4|||
17173065|NCT02604433|38322873|FG001|Overall Study|Death|1|||
17087592|NCT00359762|38227877|FG004|Period III|Physician Decision|0|||
17087593|NCT00359762|38227873|FG000|Period III|Lack of Efficacy|0|||
17087594|NCT00359762|38227874|FG001|Period III|Lack of Efficacy|7|||
17087595|NCT00359762|38227875|FG002|Period III|Lack of Efficacy|5|||
17087596|NCT00359762|38227876|FG003|Period III|Lack of Efficacy|9|||
17087597|NCT00359762|38227877|FG004|Period III|Lack of Efficacy|0|||
17087598|NCT00359762|38227873|FG000|Period III|Lost to follow up|0|||
17087599|NCT00359762|38227874|FG001|Period III|Lost to follow up|1|||
17087600|NCT00359762|38227875|FG002|Period III|Lost to follow up|1|||
17087601|NCT00359762|38227876|FG003|Period III|Lost to follow up|2|||
17087602|NCT00359762|38227877|FG004|Period III|Lost to follow up|0|||
17087603|NCT00359762|38227873|FG000|Period III|Entry Criteria Not Met|0|||
17087604|NCT00359762|38227874|FG001|Period III|Entry Criteria Not Met|1|||
17087605|NCT00359762|38227875|FG002|Period III|Entry Criteria Not Met|0|||
17087606|NCT00359762|38227876|FG003|Period III|Entry Criteria Not Met|1|||
17173066|NCT02604433|38322872|FG000|Overall Study|Transition to Rollover Protocol|169|||
17173067|NCT02604433|38322873|FG001|Overall Study|Transition to Rollover Protocol|82|||
17173068|NCT02604433|38322872|FG000|Overall Study|Physician Decision|1|||
17173069|NCT02604433|38322873|FG001|Overall Study|Physician Decision|1|||
17173070|NCT02604433|38322872|FG000|Overall Study|Lack of Efficacy|0|||
17173071|NCT02604433|38322873|FG001|Overall Study|Lack of Efficacy|1|||
17087607|NCT00359762|38227877|FG004|Period III|Entry Criteria Not Met|0|||
17087608|NCT00359762|38227873|FG000|Period III|Subject Decision|0|||
17173072|NCT02659150|38322879|FG000|Subject Enrollment|Physician Decision|3|||
17173073|NCT02659150|38322879|FG000|Subject Enrollment|Withdrawal by Subject|2|||
17173074|NCT02659150|38322879|FG000|Baseline Imaging|Withdrawal by Subject|1|||
17173075|NCT02659150|38322879|FG000|Baseline Imaging|Physician Decision|1|||
17173076|NCT02659150|38322879|FG000|Study Drug Dosing|Adverse Event|1|||
17173077|NCT03006393|38322886|FG000|Overall Study|Withdrawal by Subject|1|||
17173078|NCT03006393|38322887|FG001|Overall Study|Withdrawal by Subject|1|||
17173079|NCT03006393|38322886|FG000|Overall Study|Pregnancy|0|||
17173080|NCT03006393|38322887|FG001|Overall Study|Pregnancy|1|||
17173081|NCT03006393|38322886|FG000|Overall Study|Lost to Follow-up|0|||
17173082|NCT03006393|38322887|FG001|Overall Study|Lost to Follow-up|1|||
17173083|NCT00882440|38322904|FG000|Overall Study|Adverse Event|2|||
17173084|NCT00882440|38322905|FG001|Overall Study|Adverse Event|2|||
17173085|NCT00882440|38322906|FG002|Overall Study|Adverse Event|2|||
17173086|NCT00882440|38322907|FG003|Overall Study|Adverse Event|1|||
17173087|NCT00882440|38322908|FG004|Overall Study|Adverse Event|1|||
17173088|NCT00882440|38322909|FG005|Overall Study|Adverse Event|4|||
17173089|NCT00882440|38322910|FG006|Overall Study|Adverse Event|2|||
17173090|NCT00882440|38322904|FG000|Overall Study|Lack of Efficacy|3|||
17173091|NCT00882440|38322905|FG001|Overall Study|Lack of Efficacy|5|||
17173092|NCT00882440|38322906|FG002|Overall Study|Lack of Efficacy|2|||
17173093|NCT00882440|38322907|FG003|Overall Study|Lack of Efficacy|0|||
17173094|NCT00882440|38322908|FG004|Overall Study|Lack of Efficacy|0|||
17173095|NCT00882440|38322909|FG005|Overall Study|Lack of Efficacy|3|||
17173096|NCT00882440|38322910|FG006|Overall Study|Lack of Efficacy|0|||
17173097|NCT00882440|38322904|FG000|Overall Study|Lost to Follow-up|2|||
17173098|NCT00882440|38322905|FG001|Overall Study|Lost to Follow-up|0|||
17173099|NCT00882440|38322906|FG002|Overall Study|Lost to Follow-up|1|||
17173100|NCT00882440|38322907|FG003|Overall Study|Lost to Follow-up|1|||
17173101|NCT00882440|38322908|FG004|Overall Study|Lost to Follow-up|1|||
17173102|NCT00882440|38322909|FG005|Overall Study|Lost to Follow-up|0|||
17173103|NCT00882440|38322910|FG006|Overall Study|Lost to Follow-up|1|||
17173104|NCT00882440|38322904|FG000|Overall Study|Protocol Violation|0|||
17173105|NCT00882440|38322905|FG001|Overall Study|Protocol Violation|0|||
17173106|NCT00882440|38322906|FG002|Overall Study|Protocol Violation|1|||
17173107|NCT00882440|38322907|FG003|Overall Study|Protocol Violation|1|||
17173108|NCT00882440|38322908|FG004|Overall Study|Protocol Violation|1|||
17173109|NCT00882440|38322909|FG005|Overall Study|Protocol Violation|0|||
17173110|NCT00882440|38322910|FG006|Overall Study|Protocol Violation|0|||
17173111|NCT00882440|38322904|FG000|Overall Study|Withdrawal by Subject|2|||
17173112|NCT00882440|38322905|FG001|Overall Study|Withdrawal by Subject|1|||
17173113|NCT00882440|38322906|FG002|Overall Study|Withdrawal by Subject|1|||
17173114|NCT00882440|38322907|FG003|Overall Study|Withdrawal by Subject|0|||
17173115|NCT00882440|38322908|FG004|Overall Study|Withdrawal by Subject|6|||
17173116|NCT00882440|38322909|FG005|Overall Study|Withdrawal by Subject|0|||
17173117|NCT00882440|38322910|FG006|Overall Study|Withdrawal by Subject|1|||
17173118|NCT00882440|38322904|FG000|Overall Study|Patient Uncooperative|2|||
17173119|NCT00882440|38322905|FG001|Overall Study|Patient Uncooperative|0|||
17173120|NCT00882440|38322906|FG002|Overall Study|Patient Uncooperative|0|||
17173121|NCT00882440|38322907|FG003|Overall Study|Patient Uncooperative|0|||
17173122|NCT00882440|38322908|FG004|Overall Study|Patient Uncooperative|1|||
17173123|NCT00882440|38322909|FG005|Overall Study|Patient Uncooperative|0|||
17173124|NCT00882440|38322910|FG006|Overall Study|Patient Uncooperative|0|||
17173125|NCT03005067|38322921|FG000|Overall Study|Withdrawal by Subject|3|||
17087609|NCT00359762|38227874|FG001|Period III|Subject Decision|7|||
17087610|NCT00359762|38227875|FG002|Period III|Subject Decision|8|||
17173126|NCT03005067|38322922|FG001|Overall Study|Withdrawal by Subject|2|||
17173127|NCT03005067|38322921|FG000|Overall Study|Adverse Event|4|||
17173128|NCT03005067|38322922|FG001|Overall Study|Adverse Event|3|||
17173129|NCT03005067|38322921|FG000|Overall Study|Other (reason not specified)|3|||
17173130|NCT03005067|38322922|FG001|Overall Study|Other (reason not specified)|1|||
17173131|NCT03005067|38322921|FG000|Overall Study|Protocol Violation|0|||
17173132|NCT03005067|38322922|FG001|Overall Study|Protocol Violation|1|||
17173133|NCT02658448|38322928|FG000|Overall Study|Lost to Follow-up|1|||
17173134|NCT03075761|38322934|FG000|Overall Study|Lost to Follow-up|1|||
17173135|NCT03075761|38322935|FG001|Overall Study|Lost to Follow-up|6|||
17173136|NCT03000075|38322949|FG000|Part A|Adverse Event|4|||
17173137|NCT03000075|38322950|FG001|Part A|Adverse Event|0|||
17173138|NCT03000075|38322951|FG002|Part A|Adverse Event|0|||
17173139|NCT03000075|38322952|FG003|Part A|Adverse Event|0|||
17173140|NCT03000075|38322953|FG004|Part A|Adverse Event|0|||
17173141|NCT03000075|38322954|FG005|Part A|Adverse Event|0|||
17173142|NCT03000075|38322955|FG006|Part A|Adverse Event|0|||
17173143|NCT03000075|38322949|FG000|Part B|Not dosed due to AE|0|||
17173144|NCT03000075|38322950|FG001|Part B|Not dosed due to AE|0|||
17173145|NCT03000075|38322951|FG002|Part B|Not dosed due to AE|0|||
17173146|NCT03000075|38322952|FG003|Part B|Not dosed due to AE|0|||
17173147|NCT03000075|38322953|FG004|Part B|Not dosed due to AE|0|||
17173148|NCT03000075|38322954|FG005|Part B|Not dosed due to AE|2|||
17173149|NCT03000075|38322955|FG006|Part B|Not dosed due to AE|1|||
17173150|NCT03000075|38322949|FG000|Part B|Adverse Event|0|||
17173151|NCT03000075|38322950|FG001|Part B|Adverse Event|0|||
17173152|NCT03000075|38322951|FG002|Part B|Adverse Event|0|||
17173153|NCT03000075|38322952|FG003|Part B|Adverse Event|0|||
17173154|NCT03000075|38322953|FG004|Part B|Adverse Event|1|||
17173155|NCT03000075|38322954|FG005|Part B|Adverse Event|0|||
17173156|NCT03000075|38322955|FG006|Part B|Adverse Event|0|||
17173157|NCT03073109|38322973|FG000|Overall Study|Adverse Event|0|||
17173158|NCT03073109|38322974|FG001|Overall Study|Adverse Event|1|||
17173159|NCT03073109|38322973|FG000|Overall Study|Other|2|||
17173160|NCT03073109|38322974|FG001|Overall Study|Other|0|||
17173161|NCT03073109|38322973|FG000|Overall Study|Lost to Follow-up|8|||
17173162|NCT03073109|38322974|FG001|Overall Study|Lost to Follow-up|1|||
17173163|NCT02371889|38322996|FG000|Overall Study|Adverse medication effect|11|||
17173164|NCT02371889|38322997|FG001|Overall Study|Adverse medication effect|2|||
17173165|NCT02371889|38322996|FG000|Overall Study|Lost to Follow-up|6|||
17173166|NCT02371889|38322997|FG001|Overall Study|Lost to Follow-up|5|||
17173167|NCT02371889|38322996|FG000|Overall Study|Personal time constraints|2|||
17173168|NCT02371889|38322997|FG001|Overall Study|Personal time constraints|4|||
17173169|NCT02371889|38322996|FG000|Overall Study|Lack of Efficacy|0|||
17173170|NCT02371889|38322997|FG001|Overall Study|Lack of Efficacy|2|||
17173171|NCT02371889|38322996|FG000|Overall Study|Relapse|0|||
17173172|NCT02371889|38322997|FG001|Overall Study|Relapse|1|||
17173173|NCT03072875|38323007|FG000|Overall Study|Lost to Follow-up|1|||
17173174|NCT04250077|38323015|FG000|Overall Study|Withdrawal by Subject|0|||
17173175|NCT04250077|38323016|FG001|Overall Study|Withdrawal by Subject|1|||
17173176|NCT04250077|38323017|FG002|Overall Study|Withdrawal by Subject|0|||
17173177|NCT04250077|38323015|FG000|Overall Study|Lost to Follow-up|2|||
17173178|NCT04250077|38323016|FG001|Overall Study|Lost to Follow-up|3|||
17173179|NCT04250077|38323017|FG002|Overall Study|Lost to Follow-up|0|||
16996687|NCT00713323|38140787|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
16996688|NCT00713323|38140787|FG000|Overall Study|Treatment that may interact with Sativex|1|||
16996689|NCT00711529|38140793|FG000|Overall Study|Protocol Violation|2|||
16996690|NCT00711529|38140794|FG001|Overall Study|Protocol Violation|0|||
16996691|NCT00711529|38140793|FG000|Overall Study|Withdrawal by Subject|2|||
17087611|NCT00359762|38227876|FG003|Period III|Subject Decision|20|||
17087612|NCT00359762|38227877|FG004|Period III|Subject Decision|0|||
17087613|NCT00347438|38227891|FG000|Overall Study|Withdrawal by Subject|1|||
17087614|NCT00347438|38227891|FG000|Overall Study|Physician Decision|1|||
17087615|NCT00329238|38227897|FG000|Overall Study|Adverse Event|147|||
17087616|NCT00329238|38227898|FG001|Overall Study|Adverse Event|129|||
17087617|NCT00329238|38227897|FG000|Overall Study|Protocol Violation|23|||
17087618|NCT00329238|38227898|FG001|Overall Study|Protocol Violation|34|||
17087619|NCT00329238|38227897|FG000|Overall Study|Lost to Follow-up|2|||
17173180|NCT00859430|38323029|FG000|First Intervention|Withdrawal by Subject|0|||
17173181|NCT00859430|38323030|FG001|First Intervention|Withdrawal by Subject|1|||
17173182|NCT02913105|38323047|FG000|Overall Study|Adverse Event|11|||
17173183|NCT02913105|38323048|FG001|Overall Study|Adverse Event|0|||
17173184|NCT02913105|38323049|FG002|Overall Study|Adverse Event|4|||
17173185|NCT02913105|38323047|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17173186|NCT02913105|38323048|FG001|Overall Study|Non-Compliance With Study Drug|0|||
17173187|NCT02913105|38323049|FG002|Overall Study|Non-Compliance With Study Drug|1|||
17173188|NCT02913105|38323047|FG000|Overall Study|Reason Not Specified|3|||
17173189|NCT02913105|38323048|FG001|Overall Study|Reason Not Specified|1|||
17173190|NCT02913105|38323049|FG002|Overall Study|Reason Not Specified|1|||
17173191|NCT02913105|38323047|FG000|Overall Study|Physician Decision|1|||
17173192|NCT02913105|38323048|FG001|Overall Study|Physician Decision|1|||
17173193|NCT02913105|38323049|FG002|Overall Study|Physician Decision|0|||
17173194|NCT02913105|38323047|FG000|Overall Study|Withdrawal by Subject|0|||
17173195|NCT02913105|38323048|FG001|Overall Study|Withdrawal by Subject|3|||
17173196|NCT02913105|38323049|FG002|Overall Study|Withdrawal by Subject|1|||
17173197|NCT00840632|38323067|FG000|First Intervention|Withdrawal by Subject|0|||
17173198|NCT00840632|38323068|FG001|First Intervention|Withdrawal by Subject|1|||
17173199|NCT00840632|38323067|FG000|Washout|Withdrawal by Subject|1|||
17173200|NCT00840632|38323068|FG001|Washout|Withdrawal by Subject|1|||
17173201|NCT01602562|38323085|FG000|Overall Study|Adverse Event|3|||
17173202|NCT01602562|38323086|FG001|Overall Study|Adverse Event|1|||
17173203|NCT01602562|38323085|FG000|Overall Study|Physician Decision|1|||
17173204|NCT01602562|38323086|FG001|Overall Study|Physician Decision|1|||
17173205|NCT01602562|38323085|FG000|Overall Study|Withdrawal by Subject|1|||
17173206|NCT01602562|38323086|FG001|Overall Study|Withdrawal by Subject|1|||
17173207|NCT01945775|38323095|FG000|Overall Study|Death|214|||
17173208|NCT01945775|38323096|FG001|Overall Study|Death|98|||
17173209|NCT01945775|38323095|FG000|Overall Study|Lost to Follow-up|12|||
17173210|NCT01945775|38323096|FG001|Overall Study|Lost to Follow-up|7|||
17173211|NCT01945775|38323095|FG000|Overall Study|Withdrawal by Subject|11|||
17173212|NCT01945775|38323096|FG001|Overall Study|Withdrawal by Subject|21|||
17173213|NCT01945775|38323095|FG000|Overall Study|Other|50|||
17173214|NCT01945775|38323096|FG001|Overall Study|Other|18|||
17173215|NCT03072719|38323124|FG000|Overall Study|Adverse Event|1|||
17173216|NCT03072719|38323125|FG001|Overall Study|Adverse Event|1|||
17173217|NCT00835796|38323133|FG000|First Intervention|Withdrawal by Subject|0|||
17173218|NCT00835796|38323134|FG001|First Intervention|Withdrawal by Subject|1|||
17087620|NCT00329238|38227898|FG001|Overall Study|Lost to Follow-up|6|||
17087621|NCT00329238|38227897|FG000|Overall Study|Withdrawal by Subject|64|||
17087622|NCT00329238|38227898|FG001|Overall Study|Withdrawal by Subject|58|||
17087623|NCT00329238|38227897|FG000|Overall Study|Other reason (not specified)|40|||
17087624|NCT00329238|38227898|FG001|Overall Study|Other reason (not specified)|54|||
17087625|NCT00329160|38227906|FG000|Overall Study|Adverse Event|27|||
17087626|NCT00329160|38227906|FG000|Overall Study|Withdrawal by Subject|13|||
17087627|NCT00329160|38227906|FG000|Overall Study|Protocol Violation|2|||
17087628|NCT00329160|38227906|FG000|Overall Study|Did not Receive Study Drug|1|||
17087629|NCT00329160|38227906|FG000|Overall Study|Incomplete IVUS|45|||
17087630|NCT00328926|38227913|FG000|Overall Study|Pregnancy|2|||
17087631|NCT00328926|38227914|FG001|Overall Study|Pregnancy|1|||
17087632|NCT00328926|38227915|FG002|Overall Study|Pregnancy|0|||
17087633|NCT00328926|38227913|FG000|Overall Study|Lost to Follow-up|0|||
17087634|NCT00328926|38227914|FG001|Overall Study|Lost to Follow-up|1|||
17087635|NCT00328926|38227915|FG002|Overall Study|Lost to Follow-up|0|||
17087636|NCT00328926|38227913|FG000|Overall Study|Death|0|||
17087637|NCT00328926|38227914|FG001|Overall Study|Death|0|||
17087638|NCT00328926|38227915|FG002|Overall Study|Death|1|||
17087639|NCT00328926|38227913|FG000|Overall Study|In vitro fertilization treatment|0|||
17087640|NCT00328926|38227914|FG001|Overall Study|In vitro fertilization treatment|0|||
17087641|NCT00328926|38227915|FG002|Overall Study|In vitro fertilization treatment|1|||
17087642|NCT00328926|38227913|FG000|Overall Study|Lack of ovarian response|0|||
17087643|NCT00328926|38227914|FG001|Overall Study|Lack of ovarian response|1|||
17087644|NCT00328926|38227915|FG002|Overall Study|Lack of ovarian response|0|||
17087645|NCT00319254|38227923|FG000|Overall Study|Withdrawal by Subject|4|||
17087646|NCT00319254|38227923|FG000|Overall Study|Death|46|||
17087647|NCT00319254|38227923|FG000|Overall Study|Lost to Follow-up|2|||
17087648|NCT00319254|38227923|FG000|Overall Study|Enrolled, Not Treated|2|||
17087649|NCT00319098|38227931|FG000|Overall Study|Serious adverse event|3|||
17087650|NCT00319098|38227932|FG001|Overall Study|Serious adverse event|0|||
17087651|NCT00319098|38227931|FG000|Overall Study|Adverse Event|20|||
17087652|NCT00319098|38227932|FG001|Overall Study|Adverse Event|1|||
17087653|NCT00319098|38227931|FG000|Overall Study|Withdrawal by Subject|37|||
17173219|NCT00835640|38323140|FG000|Second Intervention|Protocol Violation|1|||
17173220|NCT00835640|38323141|FG001|Second Intervention|Protocol Violation|0|||
17173221|NCT02942017|38323147|FG000|Overall Study|Adverse Event|0|||
17173222|NCT02942017|38323148|FG001|Overall Study|Adverse Event|1|||
17173223|NCT02942017|38323147|FG000|Overall Study|Withdrawal by Subject|0|||
17173224|NCT02942017|38323148|FG001|Overall Study|Withdrawal by Subject|1|||
17173225|NCT02942017|38323147|FG000|Overall Study|Lost to Follow-up|1|||
17173226|NCT02942017|38323148|FG001|Overall Study|Lost to Follow-up|1|||
17173227|NCT02942017|38323147|FG000|Overall Study|Randomized but not dosed|1|||
17087654|NCT00319098|38227932|FG001|Overall Study|Withdrawal by Subject|8|||
17087655|NCT00319098|38227931|FG000|Overall Study|Migrated/moved from study area|2|||
17087656|NCT00319098|38227932|FG001|Overall Study|Migrated/moved from study area|1|||
17087657|NCT00319098|38227931|FG000|Overall Study|Lost to Follow-up|37|||
17173228|NCT02942017|38323148|FG001|Overall Study|Randomized but not dosed|3|||
17173229|NCT00835406|38323163|FG000|Period: First Intervention|Adverse Event|0|||
17173230|NCT00835406|38323164|FG001|Period: First Intervention|Adverse Event|1|||
17173231|NCT00835406|38323163|FG000|Period: First Intervention|Withdrawal by Subject|2|||
17173232|NCT00835406|38323164|FG001|Period: First Intervention|Withdrawal by Subject|0|||
17173233|NCT00835406|38323163|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
17173234|NCT00835406|38323164|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
17087658|NCT00319098|38227932|FG001|Overall Study|Lost to Follow-up|13|||
17087659|NCT00319098|38227931|FG000|Overall Study|Others|33|||
17087660|NCT00319098|38227932|FG001|Overall Study|Others|8|||
17087661|NCT00319098|38227931|FG000|Overall Study|Protocol Violation|3|||
17087662|NCT00319098|38227932|FG001|Overall Study|Protocol Violation|1|||
17173235|NCT00835172|38323170|FG000|Washout|Protocol Violation|0|||
17173236|NCT00835172|38323171|FG001|Washout|Protocol Violation|1|||
17173237|NCT01676116|38323177|FG000|Overall Study|Withdrawal criteria|2|||
17173238|NCT01676116|38323178|FG001|Overall Study|Withdrawal criteria|14|||
17173239|NCT01676116|38323177|FG000|Overall Study|Adverse Event|1|||
17173240|NCT01676116|38323178|FG001|Overall Study|Adverse Event|2|||
17173241|NCT01676116|38323177|FG000|Overall Study|Unclassified|4|||
17173242|NCT01676116|38323178|FG001|Overall Study|Unclassified|10|||
17173243|NCT01676116|38323177|FG000|Overall Study|Protocol Violation|9|||
17173244|NCT01676116|38323178|FG001|Overall Study|Protocol Violation|3|||
17173245|NCT00740480|38323184|FG000|Overall Study|Adverse Event|1|||
17173246|NCT00740480|38323184|FG000|Overall Study|Physician Decision|1|||
17173247|NCT02743520|38323187|FG000|Overall Study|Withdrawal by Subject|1|||
17087663|NCT00347360|38227957|FG000|Overall Study|Adverse Event|1|||
17087664|NCT00347360|38227958|FG001|Overall Study|Adverse Event|2|||
17087665|NCT00347360|38227959|FG002|Overall Study|Adverse Event|0|||
17087666|NCT00347360|38227960|FG003|Overall Study|Adverse Event|4|||
17087667|NCT00347360|38227961|FG004|Overall Study|Adverse Event|1|||
17087668|NCT00347360|38227962|FG005|Overall Study|Adverse Event|2|||
17087669|NCT00347360|38227963|FG006|Overall Study|Adverse Event|2|||
17173248|NCT03001557|38323206|FG000|Core Phase|Randomized but not treated|0|||
17173249|NCT03001557|38323207|FG001|Core Phase|Randomized but not treated|0|||
17173250|NCT03001557|38323208|FG002|Core Phase|Randomized but not treated|1|||
17173251|NCT03001557|38323209|FG003|Core Phase|Randomized but not treated|0|||
17173252|NCT03001557|38323210|FG004|Core Phase|Randomized but not treated|0|||
17173253|NCT03001557|38323211|FG005|Core Phase|Randomized but not treated|0|||
17173254|NCT03001557|38323212|FG006|Core Phase|Randomized but not treated|0|||
17173255|NCT03001557|38323213|FG007|Core Phase|Randomized but not treated|0|||
17173256|NCT03001557|38323206|FG000|Extension Phase|Adverse Event|0|||
17173257|NCT03001557|38323207|FG001|Extension Phase|Adverse Event|0|||
17173258|NCT03001557|38323208|FG002|Extension Phase|Adverse Event|0|||
17173259|NCT03001557|38323209|FG003|Extension Phase|Adverse Event|0|||
17173260|NCT03001557|38323210|FG004|Extension Phase|Adverse Event|0|||
17173261|NCT03001557|38323211|FG005|Extension Phase|Adverse Event|2|||
17173262|NCT03001557|38323212|FG006|Extension Phase|Adverse Event|0|||
16996692|NCT00711529|38140794|FG001|Overall Study|Withdrawal by Subject|6|||
17087670|NCT00347360|38227964|FG007|Overall Study|Adverse Event|0|||
17087671|NCT00347360|38227965|FG008|Overall Study|Adverse Event|2|||
17087672|NCT00347360|38227966|FG009|Overall Study|Adverse Event|3|||
17087673|NCT00347360|38227967|FG010|Overall Study|Adverse Event|3|||
17087674|NCT00347360|38227968|FG011|Overall Study|Adverse Event|1|||
17087675|NCT00347360|38227969|FG012|Overall Study|Adverse Event|3|||
17087676|NCT00347360|38227970|FG013|Overall Study|Adverse Event|2|||
17087677|NCT00347360|38227971|FG014|Overall Study|Adverse Event|2|||
17087678|NCT00347360|38227957|FG000|Overall Study|Lost to Follow-up|0|||
17087679|NCT00347360|38227958|FG001|Overall Study|Lost to Follow-up|0|||
17087680|NCT00347360|38227959|FG002|Overall Study|Lost to Follow-up|0|||
17087681|NCT00347360|38227960|FG003|Overall Study|Lost to Follow-up|2|||
17087682|NCT00347360|38227961|FG004|Overall Study|Lost to Follow-up|1|||
17087683|NCT00347360|38227962|FG005|Overall Study|Lost to Follow-up|1|||
17087684|NCT00347360|38227963|FG006|Overall Study|Lost to Follow-up|0|||
17087685|NCT00347360|38227964|FG007|Overall Study|Lost to Follow-up|1|||
17087686|NCT00347360|38227965|FG008|Overall Study|Lost to Follow-up|1|||
17087687|NCT00347360|38227966|FG009|Overall Study|Lost to Follow-up|2|||
17173263|NCT03001557|38323213|FG007|Extension Phase|Adverse Event|0|||
17173264|NCT03001557|38323206|FG000|Extension Phase|Withdrawal by Subject|0|||
17087688|NCT00347360|38227967|FG010|Overall Study|Lost to Follow-up|0|||
17173265|NCT03001557|38323207|FG001|Extension Phase|Withdrawal by Subject|0|||
17173266|NCT03001557|38323208|FG002|Extension Phase|Withdrawal by Subject|0|||
16996693|NCT00601419|38140800|FG000|Overall Study|Lost to Follow-up|3|||
16996694|NCT00601419|38140800|FG000|Overall Study|Missed Visits|1|||
16996695|NCT00712933|38140820|FG000|Overall Study|Adverse Event|69|||
16996696|NCT00712933|38140820|FG000|Overall Study|Lack of Efficacy|6|||
16996697|NCT00712933|38140820|FG000|Overall Study|Lost to Follow-up|22|||
16996698|NCT00712933|38140820|FG000|Overall Study|Non-compliance with study drug|13|||
16996699|NCT00712933|38140820|FG000|Overall Study|Other Pregnancy|37|||
16996700|NCT00712933|38140820|FG000|Overall Study|Sponsor decision|14|||
16996701|NCT00712933|38140820|FG000|Overall Study|Withdrew consent|4|||
16996702|NCT00712933|38140820|FG000|Overall Study|Hip replacement surgery|1|||
17087689|NCT00347360|38227968|FG011|Overall Study|Lost to Follow-up|0|||
17087690|NCT00347360|38227969|FG012|Overall Study|Lost to Follow-up|1|||
17087691|NCT00347360|38227970|FG013|Overall Study|Lost to Follow-up|0|||
17173267|NCT03001557|38323209|FG003|Extension Phase|Withdrawal by Subject|0|||
17173268|NCT03001557|38323210|FG004|Extension Phase|Withdrawal by Subject|0|||
17173269|NCT03001557|38323211|FG005|Extension Phase|Withdrawal by Subject|1|||
17173270|NCT03001557|38323212|FG006|Extension Phase|Withdrawal by Subject|5|||
17173271|NCT03001557|38323213|FG007|Extension Phase|Withdrawal by Subject|2|||
17173272|NCT03001557|38323206|FG000|Extension Phase|Lost to Follow-up|0|||
17173273|NCT03001557|38323207|FG001|Extension Phase|Lost to Follow-up|0|||
17173274|NCT03001557|38323208|FG002|Extension Phase|Lost to Follow-up|0|||
17173275|NCT03001557|38323209|FG003|Extension Phase|Lost to Follow-up|0|||
17173276|NCT03001557|38323210|FG004|Extension Phase|Lost to Follow-up|0|||
17173277|NCT03001557|38323211|FG005|Extension Phase|Lost to Follow-up|0|||
17173278|NCT03001557|38323212|FG006|Extension Phase|Lost to Follow-up|2|||
17173279|NCT03001557|38323213|FG007|Extension Phase|Lost to Follow-up|1|||
17173280|NCT03001557|38323206|FG000|Extension Phase|Administrative Reason|0|||
17173281|NCT03001557|38323207|FG001|Extension Phase|Administrative Reason|0|||
17173282|NCT03001557|38323208|FG002|Extension Phase|Administrative Reason|0|||
17173283|NCT03001557|38323209|FG003|Extension Phase|Administrative Reason|0|||
17173284|NCT03001557|38323210|FG004|Extension Phase|Administrative Reason|0|||
17173285|NCT03001557|38323211|FG005|Extension Phase|Administrative Reason|1|||
17173286|NCT03001557|38323212|FG006|Extension Phase|Administrative Reason|3|||
17173287|NCT03001557|38323213|FG007|Extension Phase|Administrative Reason|3|||
17173288|NCT03001557|38323206|FG000|Extension Phase|Loss of caregiver|0|||
17173289|NCT03001557|38323207|FG001|Extension Phase|Loss of caregiver|0|||
17173290|NCT03001557|38323208|FG002|Extension Phase|Loss of caregiver|0|||
17173291|NCT03001557|38323209|FG003|Extension Phase|Loss of caregiver|0|||
17173292|NCT03001557|38323210|FG004|Extension Phase|Loss of caregiver|0|||
17173293|NCT03001557|38323211|FG005|Extension Phase|Loss of caregiver|0|||
17173294|NCT03001557|38323212|FG006|Extension Phase|Loss of caregiver|1|||
17173295|NCT03001557|38323213|FG007|Extension Phase|Loss of caregiver|0|||
17173296|NCT03001557|38323206|FG000|Extension Phase|Others|0|||
17173297|NCT03001557|38323207|FG001|Extension Phase|Others|0|||
17173298|NCT03001557|38323208|FG002|Extension Phase|Others|0|||
17173299|NCT03001557|38323209|FG003|Extension Phase|Others|0|||
17173300|NCT03001557|38323210|FG004|Extension Phase|Others|0|||
17173301|NCT03001557|38323211|FG005|Extension Phase|Others|1|||
17173302|NCT03001557|38323212|FG006|Extension Phase|Others|3|||
17173303|NCT03001557|38323213|FG007|Extension Phase|Others|0|||
17173304|NCT00830336|38323250|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
17173305|NCT00830336|38323251|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
17173306|NCT00830258|38323257|FG000|First Intervention|Adverse Event|1|||
17087692|NCT00347360|38227971|FG014|Overall Study|Lost to Follow-up|0|||
17087693|NCT00347360|38227957|FG000|Overall Study|Protocol Violation|2|||
17087694|NCT00347360|38227958|FG001|Overall Study|Protocol Violation|3|||
17087695|NCT00347360|38227959|FG002|Overall Study|Protocol Violation|1|||
17087696|NCT00347360|38227960|FG003|Overall Study|Protocol Violation|2|||
17087697|NCT00347360|38227961|FG004|Overall Study|Protocol Violation|1|||
17087698|NCT00347360|38227962|FG005|Overall Study|Protocol Violation|2|||
17087699|NCT00347360|38227963|FG006|Overall Study|Protocol Violation|0|||
17087700|NCT00347360|38227964|FG007|Overall Study|Protocol Violation|0|||
17087701|NCT00347360|38227965|FG008|Overall Study|Protocol Violation|1|||
17087702|NCT00347360|38227966|FG009|Overall Study|Protocol Violation|2|||
17087703|NCT00347360|38227967|FG010|Overall Study|Protocol Violation|0|||
17087704|NCT00347360|38227968|FG011|Overall Study|Protocol Violation|0|||
17087705|NCT00347360|38227969|FG012|Overall Study|Protocol Violation|0|||
17087706|NCT00347360|38227970|FG013|Overall Study|Protocol Violation|1|||
17087707|NCT00347360|38227971|FG014|Overall Study|Protocol Violation|0|||
17087708|NCT00347360|38227957|FG000|Overall Study|Withdrawal by Subject|0|||
17087709|NCT00347360|38227958|FG001|Overall Study|Withdrawal by Subject|1|||
17087710|NCT00347360|38227959|FG002|Overall Study|Withdrawal by Subject|2|||
17087711|NCT00347360|38227960|FG003|Overall Study|Withdrawal by Subject|4|||
17087712|NCT00347360|38227961|FG004|Overall Study|Withdrawal by Subject|1|||
17087713|NCT00347360|38227962|FG005|Overall Study|Withdrawal by Subject|2|||
17087714|NCT00347360|38227963|FG006|Overall Study|Withdrawal by Subject|1|||
17087715|NCT00347360|38227964|FG007|Overall Study|Withdrawal by Subject|1|||
17087716|NCT00347360|38227965|FG008|Overall Study|Withdrawal by Subject|1|||
17087717|NCT00347360|38227966|FG009|Overall Study|Withdrawal by Subject|1|||
17087718|NCT00347360|38227967|FG010|Overall Study|Withdrawal by Subject|0|||
17087719|NCT00347360|38227968|FG011|Overall Study|Withdrawal by Subject|3|||
17087720|NCT00347360|38227969|FG012|Overall Study|Withdrawal by Subject|4|||
17087721|NCT00347360|38227970|FG013|Overall Study|Withdrawal by Subject|2|||
17087722|NCT00347360|38227971|FG014|Overall Study|Withdrawal by Subject|1|||
17087723|NCT00347360|38227957|FG000|Overall Study|Lack of Efficacy|1|||
17087724|NCT00347360|38227958|FG001|Overall Study|Lack of Efficacy|1|||
17087725|NCT00347360|38227959|FG002|Overall Study|Lack of Efficacy|3|||
17087726|NCT00347360|38227960|FG003|Overall Study|Lack of Efficacy|1|||
17087727|NCT00347360|38227961|FG004|Overall Study|Lack of Efficacy|0|||
17087728|NCT00347360|38227962|FG005|Overall Study|Lack of Efficacy|1|||
17087729|NCT00347360|38227963|FG006|Overall Study|Lack of Efficacy|0|||
17087730|NCT00347360|38227964|FG007|Overall Study|Lack of Efficacy|1|||
17087731|NCT00347360|38227965|FG008|Overall Study|Lack of Efficacy|1|||
17173307|NCT00830258|38323258|FG001|First Intervention|Adverse Event|0|||
17173308|NCT00830258|38323257|FG000|Washout: 7 Days|Protocol Violation|1|||
17173309|NCT00830258|38323258|FG001|Washout: 7 Days|Protocol Violation|0|||
17087732|NCT00347360|38227966|FG009|Overall Study|Lack of Efficacy|0|||
17087733|NCT00347360|38227967|FG010|Overall Study|Lack of Efficacy|0|||
17087734|NCT00347360|38227968|FG011|Overall Study|Lack of Efficacy|0|||
17173310|NCT03349775|38323264|FG000|Overall Study|Side Effects|1|||
17173311|NCT03349775|38323265|FG001|Overall Study|Side Effects|2|||
17173312|NCT03349775|38323264|FG000|Overall Study|Withdrawal by Subject|1|||
17173313|NCT03349775|38323265|FG001|Overall Study|Withdrawal by Subject|1|||
17173314|NCT03349775|38323264|FG000|Overall Study|No primary outcome measurements|0|||
17173315|NCT03349775|38323265|FG001|Overall Study|No primary outcome measurements|1|||
17173316|NCT00830024|38323273|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
17173317|NCT00830024|38323274|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
17173318|NCT00829868|38323280|FG000|Washout|Physician Decision|1|||
17173319|NCT00829868|38323281|FG001|Washout|Physician Decision|0|||
17173320|NCT00829790|38323287|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
17173321|NCT00829790|38323288|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
17173322|NCT03207815|38323294|FG000|Overall Study|Protocol Violation|3|||
17173323|NCT03207815|38323295|FG001|Overall Study|Protocol Violation|1|||
17173324|NCT03207815|38323294|FG000|Overall Study|Adverse Event|1|||
17173325|NCT03207815|38323295|FG001|Overall Study|Adverse Event|2|||
17173326|NCT03207815|38323294|FG000|Overall Study|Lost to Follow-up|1|||
17173327|NCT03207815|38323295|FG001|Overall Study|Lost to Follow-up|2|||
17173328|NCT03207815|38323294|FG000|Overall Study|Investigator's Discretion|1|||
16996703|NCT00712933|38140820|FG000|Overall Study|Involved in Clinical research|3|||
16996704|NCT00712933|38140820|FG000|Overall Study|Participant hospitalized|1|||
16996705|NCT00712933|38140820|FG000|Overall Study|Participant travelled overseas|2|||
16996706|NCT00712933|38140820|FG000|Overall Study|Death of patient|1|||
16996707|NCT00712933|38140820|FG000|Overall Study|Other Physician decision|1|||
16996708|NCT00712933|38140820|FG000|Overall Study|Not committed to contraception|1|||
16996709|NCT00712933|38140820|FG000|Overall Study|Participant received medication|1|||
17087735|NCT00347360|38227969|FG012|Overall Study|Lack of Efficacy|0|||
17087736|NCT00347360|38227970|FG013|Overall Study|Lack of Efficacy|0|||
17087737|NCT00347360|38227971|FG014|Overall Study|Lack of Efficacy|0|||
17087738|NCT00347360|38227957|FG000|Overall Study|Reason not listed/blank|1|||
17087739|NCT00347360|38227958|FG001|Overall Study|Reason not listed/blank|0|||
17087740|NCT00347360|38227959|FG002|Overall Study|Reason not listed/blank|0|||
17087741|NCT00347360|38227960|FG003|Overall Study|Reason not listed/blank|0|||
17087742|NCT00347360|38227961|FG004|Overall Study|Reason not listed/blank|0|||
17087743|NCT00347360|38227962|FG005|Overall Study|Reason not listed/blank|0|||
17087744|NCT00347360|38227963|FG006|Overall Study|Reason not listed/blank|1|||
17087745|NCT00347360|38227964|FG007|Overall Study|Reason not listed/blank|0|||
17087746|NCT00347360|38227965|FG008|Overall Study|Reason not listed/blank|0|||
17087747|NCT00347360|38227966|FG009|Overall Study|Reason not listed/blank|0|||
17087748|NCT00347360|38227967|FG010|Overall Study|Reason not listed/blank|0|||
17087749|NCT00347360|38227968|FG011|Overall Study|Reason not listed/blank|0|||
17087750|NCT00347360|38227969|FG012|Overall Study|Reason not listed/blank|0|||
17087751|NCT00347360|38227970|FG013|Overall Study|Reason not listed/blank|1|||
17087752|NCT00347360|38227971|FG014|Overall Study|Reason not listed/blank|0|||
17087753|NCT00347360|38227957|FG000|Overall Study|Per sponsors instruction|0|||
17087754|NCT00347360|38227958|FG001|Overall Study|Per sponsors instruction|1|||
17087755|NCT00347360|38227959|FG002|Overall Study|Per sponsors instruction|0|||
17087756|NCT00347360|38227960|FG003|Overall Study|Per sponsors instruction|0|||
17087757|NCT00347360|38227961|FG004|Overall Study|Per sponsors instruction|0|||
17087758|NCT00347360|38227962|FG005|Overall Study|Per sponsors instruction|0|||
17173329|NCT03207815|38323295|FG001|Overall Study|Investigator's Discretion|1|||
17173330|NCT03207815|38323294|FG000|Overall Study|Lack of Efficacy|0|||
17173331|NCT03207815|38323295|FG001|Overall Study|Lack of Efficacy|1|||
17173332|NCT03207815|38323294|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
17173333|NCT03207815|38323295|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
17173334|NCT03207815|38323294|FG000|Overall Study|Withdrew Consent|1|||
17173335|NCT03207815|38323295|FG001|Overall Study|Withdrew Consent|0|||
17173336|NCT02911935|38323303|FG000|Overall Study|Lost to Follow-up|5|||
17173337|NCT02911935|38323304|FG001|Overall Study|Lost to Follow-up|7|||
17173338|NCT00829712|38323312|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
17173339|NCT00829712|38323313|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
17173340|NCT03069989|38323328|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
17173341|NCT03069989|38323329|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
17173342|NCT02698163|38323356|FG000|Overall Study|Lost to Follow-up|0|||
17173343|NCT02698163|38323357|FG001|Overall Study|Lost to Follow-up|1|||
17173344|NCT03817190|38323365|FG000|Overall Study|Early Termination|13|||
17173345|NCT03817190|38323366|FG001|Overall Study|Early Termination|20|||
17173346|NCT03817190|38323365|FG000|Overall Study|Adverse Event|10|||
17173347|NCT03817190|38323366|FG001|Overall Study|Adverse Event|17|||
17173348|NCT03817190|38323365|FG000|Overall Study|Withdrawal by Subject|12|||
17173349|NCT03817190|38323366|FG001|Overall Study|Withdrawal by Subject|8|||
16996710|NCT00712933|38140820|FG000|Overall Study|Physician Decision|36|||
17087759|NCT00347360|38227963|FG006|Overall Study|Per sponsors instruction|0|||
17173350|NCT03817190|38323365|FG000|Overall Study|Lost to Follow-up|11|||
17173351|NCT03817190|38323366|FG001|Overall Study|Lost to Follow-up|7|||
17173352|NCT03817190|38323365|FG000|Overall Study|Lack of Efficacy|7|||
17173353|NCT03817190|38323366|FG001|Overall Study|Lack of Efficacy|5|||
17173354|NCT03817190|38323365|FG000|Overall Study|Investigator Decision|5|||
17173355|NCT03817190|38323366|FG001|Overall Study|Investigator Decision|1|||
17173356|NCT03817190|38323365|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
17173357|NCT03817190|38323366|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
17173358|NCT03817190|38323365|FG000|Overall Study|Lack of Contact|1|||
17173359|NCT03817190|38323366|FG001|Overall Study|Lack of Contact|0|||
17173360|NCT03817190|38323365|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
17173361|NCT03817190|38323366|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
17173362|NCT03797222|38323385|FG000|Overall Study|Withdrawal by Subject|1|||
17173363|NCT02742818|38323395|FG000|Overall Study|Adverse Event|0|||
17173364|NCT02742818|38323396|FG001|Overall Study|Adverse Event|1|||
17173365|NCT02742818|38323395|FG000|Overall Study|Protocol Violation|0|||
17173366|NCT02742818|38323396|FG001|Overall Study|Protocol Violation|1|||
17173367|NCT03069365|38323404|FG000|Overall Study|Adverse Event|1|||
17173368|NCT03065933|38323408|FG000|Overall Study|study terminated|5|||
17173369|NCT04256629|38323418|FG000|Overall Study|Adverse Event|0|||
17173370|NCT04256629|38323419|FG001|Overall Study|Adverse Event|0|||
17173371|NCT04256629|38323420|FG002|Overall Study|Adverse Event|0|||
17173372|NCT04256629|38323421|FG003|Overall Study|Adverse Event|0|||
17173373|NCT04256629|38323422|FG004|Overall Study|Adverse Event|0|||
17173374|NCT04256629|38323423|FG005|Overall Study|Adverse Event|1|||
17173375|NCT04256629|38323418|FG000|Overall Study|Protocol Violation|0|||
17173376|NCT04256629|38323419|FG001|Overall Study|Protocol Violation|1|||
17173377|NCT04256629|38323420|FG002|Overall Study|Protocol Violation|0|||
17173378|NCT04256629|38323421|FG003|Overall Study|Protocol Violation|0|||
17173379|NCT04256629|38323422|FG004|Overall Study|Protocol Violation|0|||
17173380|NCT04256629|38323423|FG005|Overall Study|Protocol Violation|0|||
17173381|NCT01346293|38323433|FG000|Overall Study|Protocol Violation|30|||
17173382|NCT01346293|38323434|FG001|Overall Study|Protocol Violation|9|||
17173383|NCT01346293|38323433|FG000|Overall Study|Lost to Follow-up|21|||
17173384|NCT01346293|38323434|FG001|Overall Study|Lost to Follow-up|8|||
17173385|NCT01346293|38323433|FG000|Overall Study|Withdrawal by Subject|15|||
17173386|NCT01346293|38323434|FG001|Overall Study|Withdrawal by Subject|4|||
17173387|NCT01346293|38323433|FG000|Overall Study|Other|1|||
17173388|NCT01346293|38323434|FG001|Overall Study|Other|0|||
17173389|NCT03502187|38323445|FG000|Overall Study|Withdrawal by Subject|4|||
17173390|NCT03502187|38323446|FG001|Overall Study|Withdrawal by Subject|3|||
17173391|NCT03502187|38323447|FG002|Overall Study|Withdrawal by Subject|3|||
17173392|NCT03502187|38323445|FG000|Overall Study|Lost to Follow-up|5|||
17173393|NCT03502187|38323446|FG001|Overall Study|Lost to Follow-up|4|||
17173394|NCT03502187|38323447|FG002|Overall Study|Lost to Follow-up|5|||
17173395|NCT03058705|38323455|FG000|Overall Study|Withdrawal by Subject|2|||
17173396|NCT03058705|38323455|FG000|Overall Study|Physician Decision|2|||
17173397|NCT02998671|38323464|FG000|Period 1|Study Terminated By Sponsor|2|||
17173398|NCT02998671|38323465|FG001|Period 1|Study Terminated By Sponsor|1|||
17173399|NCT02998671|38323466|FG002|Period 1|Study Terminated By Sponsor|0|||
17173400|NCT02998671|38323467|FG003|Period 1|Study Terminated By Sponsor|0|||
17173401|NCT02998671|38323468|FG004|Period 1|Study Terminated By Sponsor|1|||
17173402|NCT02998671|38323464|FG000|Period 1|Withdrawal by Subject|1|||
17173403|NCT02998671|38323465|FG001|Period 1|Withdrawal by Subject|2|||
17173404|NCT02998671|38323466|FG002|Period 1|Withdrawal by Subject|0|||
17173405|NCT02998671|38323467|FG003|Period 1|Withdrawal by Subject|0|||
17173406|NCT02998671|38323468|FG004|Period 1|Withdrawal by Subject|2|||
17173407|NCT02998671|38323464|FG000|Period 1|Pregnancy|1|||
17173408|NCT02998671|38323465|FG001|Period 1|Pregnancy|0|||
17173409|NCT02998671|38323466|FG002|Period 1|Pregnancy|0|||
17173410|NCT02998671|38323467|FG003|Period 1|Pregnancy|0|||
17173411|NCT02998671|38323468|FG004|Period 1|Pregnancy|0|||
17173412|NCT02998671|38323464|FG000|Period 1|Adverse Event|0|||
17173413|NCT02998671|38323465|FG001|Period 1|Adverse Event|0|||
17173414|NCT02998671|38323466|FG002|Period 1|Adverse Event|0|||
17173415|NCT02998671|38323467|FG003|Period 1|Adverse Event|0|||
17173416|NCT02998671|38323468|FG004|Period 1|Adverse Event|1|||
17173417|NCT02998671|38323464|FG000|Period 2|Adverse Event|0|||
17173418|NCT02998671|38323465|FG001|Period 2|Adverse Event|1|||
17173419|NCT02998671|38323466|FG002|Period 2|Adverse Event|0|||
17173420|NCT02998671|38323467|FG003|Period 2|Adverse Event|0|||
17173421|NCT02998671|38323468|FG004|Period 2|Adverse Event|0|||
17173422|NCT02998671|38323464|FG000|Period 2|Study Terminated By Sponsor|3|||
17173423|NCT02998671|38323465|FG001|Period 2|Study Terminated By Sponsor|5|||
17173424|NCT02998671|38323466|FG002|Period 2|Study Terminated By Sponsor|1|||
17173425|NCT02998671|38323467|FG003|Period 2|Study Terminated By Sponsor|3|||
17173426|NCT02998671|38323468|FG004|Period 2|Study Terminated By Sponsor|0|||
17173427|NCT02998671|38323464|FG000|Period 2|Withdrawal by Subject|0|||
17173428|NCT02998671|38323465|FG001|Period 2|Withdrawal by Subject|1|||
17173429|NCT02998671|38323466|FG002|Period 2|Withdrawal by Subject|0|||
17173430|NCT02998671|38323467|FG003|Period 2|Withdrawal by Subject|0|||
17173431|NCT02998671|38323468|FG004|Period 2|Withdrawal by Subject|0|||
17173432|NCT02998671|38323464|FG000|Period 2|Lost to Follow-up|0|||
17173433|NCT02998671|38323465|FG001|Period 2|Lost to Follow-up|0|||
17173434|NCT02998671|38323466|FG002|Period 2|Lost to Follow-up|0|||
17173435|NCT02998671|38323467|FG003|Period 2|Lost to Follow-up|1|||
17087760|NCT00347360|38227964|FG007|Overall Study|Per sponsors instruction|0|||
17087761|NCT00347360|38227965|FG008|Overall Study|Per sponsors instruction|0|||
17087762|NCT00347360|38227966|FG009|Overall Study|Per sponsors instruction|0|||
17087763|NCT00347360|38227967|FG010|Overall Study|Per sponsors instruction|0|||
17087764|NCT00347360|38227968|FG011|Overall Study|Per sponsors instruction|0|||
17087765|NCT00347360|38227969|FG012|Overall Study|Per sponsors instruction|0|||
17087766|NCT00347360|38227970|FG013|Overall Study|Per sponsors instruction|0|||
17087767|NCT00347360|38227971|FG014|Overall Study|Per sponsors instruction|0|||
17087768|NCT00347360|38227957|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
17087769|NCT00347360|38227958|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
17087770|NCT00347360|38227959|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
17087771|NCT00347360|38227960|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
17087772|NCT00347360|38227961|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
17087773|NCT00347360|38227962|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
17087774|NCT00347360|38227963|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
17087775|NCT00347360|38227964|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
17173436|NCT02998671|38323468|FG004|Period 2|Lost to Follow-up|0|||
17173437|NCT02660827|38323488|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
17173438|NCT02660827|38323488|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
17173439|NCT02660827|38323488|FG000|From Study to End of Continued Access|Adverse Event|3|||
17173440|NCT02660827|38323488|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
17173441|NCT02660827|38323488|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
17173442|NCT02660827|38323488|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
17173443|NCT02660827|38323488|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
17173444|NCT02660827|38323488|FG000|Period 2: Continued Access Period|Adverse Event|3|||
17173445|NCT01069419|38323509|FG000|Overall Study|Adverse Event|233|||
17173446|NCT01069419|38323509|FG000|Overall Study|Lack of Efficacy|332|||
17173447|NCT01069419|38323509|FG000|Overall Study|Lost to Follow-up|49|||
17087776|NCT00347360|38227965|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
17087777|NCT00347360|38227966|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
17087778|NCT00347360|38227967|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
17087779|NCT00347360|38227968|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
17087780|NCT00347360|38227969|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
17087781|NCT00347360|38227970|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
17173448|NCT01069419|38323509|FG000|Overall Study|Remission of disease|11|||
17173449|NCT01069419|38323509|FG000|Overall Study|Withdrawal by Subject|34|||
17173450|NCT01069419|38323509|FG000|Overall Study|Other Reason|43|||
17173451|NCT01069419|38323509|FG000|Overall Study|Missing termination information|13|||
17173452|NCT01069341|38323513|FG000|Overall Study|Lost to Follow-up|1|||
17173453|NCT02996097|38323517|FG000|Overall Study|Lost to Follow-up|11|||
17173454|NCT02996097|38323518|FG001|Overall Study|Lost to Follow-up|11|||
17173455|NCT02992899|38323525|FG000|Overall Study|Withdrawal by Subject|1|||
17173456|NCT02992899|38323526|FG001|Overall Study|Withdrawal by Subject|0|||
17173457|NCT02992899|38323525|FG000|Overall Study|Lost to Follow-up|1|||
17173458|NCT02992899|38323526|FG001|Overall Study|Lost to Follow-up|3|||
17173459|NCT01602484|38323534|FG000|Overall Study|Airway issues unrelated to study|0|||
17173460|NCT01602484|38323535|FG001|Overall Study|Airway issues unrelated to study|1|||
17173461|NCT02989389|38323551|FG000|Period 1|Lost to Follow-up|0|||
17173462|NCT02989389|38323552|FG001|Period 1|Lost to Follow-up|1|||
17173463|NCT02989389|38323553|FG002|Period 1|Lost to Follow-up|0|||
17173464|NCT02989389|38323554|FG003|Period 1|Lost to Follow-up|0|||
17173465|NCT02989389|38323555|FG004|Period 1|Lost to Follow-up|0|||
17173466|NCT02989389|38323556|FG005|Period 1|Lost to Follow-up|0|||
17173467|NCT02989389|38323557|FG006|Period 1|Lost to Follow-up|0|||
17173468|NCT02989389|38323558|FG007|Period 1|Lost to Follow-up|0|||
17173469|NCT02989389|38323559|FG008|Period 1|Lost to Follow-up|0|||
17173470|NCT02989389|38323560|FG009|Period 1|Lost to Follow-up|0|||
17173471|NCT02989389|38323551|FG000|Period 1|Physician Decision|0|||
17173472|NCT02989389|38323552|FG001|Period 1|Physician Decision|0|||
17173473|NCT02989389|38323553|FG002|Period 1|Physician Decision|0|||
17173474|NCT02989389|38323554|FG003|Period 1|Physician Decision|0|||
17173475|NCT02989389|38323555|FG004|Period 1|Physician Decision|0|||
17173476|NCT02989389|38323556|FG005|Period 1|Physician Decision|0|||
17173477|NCT02989389|38323557|FG006|Period 1|Physician Decision|0|||
17173478|NCT02989389|38323558|FG007|Period 1|Physician Decision|0|||
17173479|NCT02989389|38323559|FG008|Period 1|Physician Decision|1|||
17173480|NCT02989389|38323560|FG009|Period 1|Physician Decision|0|||
17173481|NCT02653300|38323600|FG000|Overall Study|Withdrawal by Subject|2|||
17173482|NCT01757665|38323606|FG000|Overall Study|Still on Study - Visit Completed|240|||
17173483|NCT01757665|38323607|FG001|Overall Study|Still on Study - Visit Completed|30|||
17173484|NCT01757665|38323606|FG000|Overall Study|Still on Study - Visit Pending|398|||
17173485|NCT01757665|38323607|FG001|Overall Study|Still on Study - Visit Pending|40|||
17173486|NCT01757665|38323606|FG000|Overall Study|Still on Study - Missed Visit|14|||
17173487|NCT01757665|38323607|FG001|Overall Study|Still on Study - Missed Visit|1|||
17173488|NCT01757665|38323606|FG000|Overall Study|Death|25|||
17173489|NCT01757665|38323607|FG001|Overall Study|Death|8|||
17173490|NCT01757665|38323606|FG000|Overall Study|Explant|1|||
17173491|NCT01757665|38323607|FG001|Overall Study|Explant|2|||
17173492|NCT01757665|38323606|FG000|Overall Study|Withdrawal by Subject|10|||
17173493|NCT01757665|38323607|FG001|Overall Study|Withdrawal by Subject|0|||
17173494|NCT01757665|38323606|FG000|Overall Study|Lost to Follow-up|1|||
17173495|NCT01757665|38323607|FG001|Overall Study|Lost to Follow-up|1|||
17173496|NCT01757665|38323606|FG000|Overall Study|Not Implanted with Device|5|||
17173497|NCT01757665|38323607|FG001|Overall Study|Not Implanted with Device|1|||
17173498|NCT00430508|38323632|FG000|Overall Study|Adverse Event|2|||
17173499|NCT00430508|38323633|FG001|Overall Study|Adverse Event|3|||
17173500|NCT00430508|38323634|FG002|Overall Study|Adverse Event|5|||
17173501|NCT00430508|38323635|FG003|Overall Study|Adverse Event|3|||
17173502|NCT00430508|38323632|FG000|Overall Study|Withdrawal by Subject|0|||
17173503|NCT00430508|38323633|FG001|Overall Study|Withdrawal by Subject|1|||
17173504|NCT00430508|38323634|FG002|Overall Study|Withdrawal by Subject|1|||
17173505|NCT00430508|38323635|FG003|Overall Study|Withdrawal by Subject|1|||
17173506|NCT00430508|38323632|FG000|Overall Study|responder at visit 4|0|||
17173507|NCT00430508|38323633|FG001|Overall Study|responder at visit 4|0|||
17173508|NCT00430508|38323634|FG002|Overall Study|responder at visit 4|2|||
17173509|NCT00430508|38323635|FG003|Overall Study|responder at visit 4|0|||
17173510|NCT00430508|38323632|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
17173511|NCT00430508|38323633|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
17173512|NCT00430508|38323634|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
17173513|NCT00430508|38323635|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
17173514|NCT00430508|38323632|FG000|Overall Study|Other|1|||
17173515|NCT00430508|38323633|FG001|Overall Study|Other|1|||
17173516|NCT00430508|38323634|FG002|Overall Study|Other|3|||
17173517|NCT00430508|38323635|FG003|Overall Study|Other|0|||
17173518|NCT02988219|38323643|FG000|Overall Study|Lack of Efficacy|1|||
17173519|NCT02988219|38323644|FG001|Overall Study|Lack of Efficacy|1|||
17173520|NCT02988219|38323643|FG000|Overall Study|Withdrawal by Subject|0|||
17173521|NCT02988219|38323644|FG001|Overall Study|Withdrawal by Subject|2|||
17173522|NCT01346059|38323652|FG000|Overall Study|Withdrawal by Subject|1|||
17173523|NCT01346059|38323653|FG001|Overall Study|Withdrawal by Subject|0|||
17173524|NCT01318915|38323659|FG000|Overall Study|Lost to Follow-up|1|||
17173525|NCT02987205|38323665|FG000|Overall Study|Adverse Event|1|||
17173526|NCT02987205|38323665|FG000|Overall Study|Withdrawal by Subject|3|||
17173527|NCT02926937|38323687|FG000|Overall Study|Adverse Event|0|||
17173528|NCT02926937|38323688|FG001|Overall Study|Adverse Event|1|||
17173529|NCT02926937|38323689|FG002|Overall Study|Adverse Event|1|||
17173530|NCT02926937|38323687|FG000|Overall Study|Poor Compliance to Protocol|1|||
17173531|NCT02926937|38323688|FG001|Overall Study|Poor Compliance to Protocol|0|||
17173532|NCT02926937|38323689|FG002|Overall Study|Poor Compliance to Protocol|0|||
17173533|NCT02926937|38323687|FG000|Overall Study|Lost to Follow-up|4|||
17173534|NCT02926937|38323688|FG001|Overall Study|Lost to Follow-up|5|||
17173535|NCT02926937|38323689|FG002|Overall Study|Lost to Follow-up|0|||
17173536|NCT02926937|38323687|FG000|Overall Study|At the Participant's own Request|11|||
17173537|NCT02926937|38323688|FG001|Overall Study|At the Participant's own Request|5|||
17173538|NCT02926937|38323689|FG002|Overall Study|At the Participant's own Request|8|||
17173539|NCT02926937|38323687|FG000|Overall Study|Reason not Specified|3|||
17173540|NCT02926937|38323688|FG001|Overall Study|Reason not Specified|4|||
17173541|NCT02926937|38323689|FG002|Overall Study|Reason not Specified|2|||
17173542|NCT04189588|38323700|FG000|Overall Study|Death|0|||
17173543|NCT04189588|38323701|FG001|Overall Study|Death|1|||
17173544|NCT04189588|38323700|FG000|Overall Study|Lost to Follow-up|0|||
17173545|NCT04189588|38323701|FG001|Overall Study|Lost to Follow-up|1|||
17173546|NCT00151892|38323709|FG000|Overall Study|Lack of Efficacy|50|||
17173547|NCT00151892|38323710|FG001|Overall Study|Lack of Efficacy|57|||
17173548|NCT00151892|38323709|FG000|Overall Study|Patient request|10|||
17087782|NCT00347360|38227971|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
17087783|NCT00347360|38227957|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
17087784|NCT00347360|38227958|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
17173549|NCT00151892|38323710|FG001|Overall Study|Patient request|7|||
17173550|NCT00151892|38323709|FG000|Overall Study|Lost to Follow-up|5|||
17173551|NCT00151892|38323710|FG001|Overall Study|Lost to Follow-up|10|||
17173552|NCT00151892|38323709|FG000|Overall Study|Adverse Event|6|||
17173553|NCT00151892|38323710|FG001|Overall Study|Adverse Event|3|||
17173554|NCT00151892|38323709|FG000|Overall Study|Protocol Violation|3|||
17087785|NCT00347360|38227959|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
17087786|NCT00347360|38227960|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
17087787|NCT00347360|38227961|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
17087788|NCT00347360|38227962|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
17087789|NCT00347360|38227963|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
17087790|NCT00347360|38227964|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
17087791|NCT00347360|38227965|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
17087792|NCT00347360|38227966|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
17087793|NCT00347360|38227967|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
17173555|NCT00151892|38323710|FG001|Overall Study|Protocol Violation|3|||
17173556|NCT00151892|38323709|FG000|Overall Study|Non-compliance|0|||
17173557|NCT00151892|38323710|FG001|Overall Study|Non-compliance|1|||
17173558|NCT00151892|38323709|FG000|Overall Study|Pregnancy|0|||
17087794|NCT00347360|38227968|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
17087795|NCT00347360|38227969|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
17087796|NCT00347360|38227970|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
17087797|NCT00347360|38227971|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
17173559|NCT00151892|38323710|FG001|Overall Study|Pregnancy|1|||
17173560|NCT00151892|38323709|FG000|Overall Study|Did not return for a visit|1|||
17173561|NCT00151892|38323710|FG001|Overall Study|Did not return for a visit|0|||
17173562|NCT00151892|38323709|FG000|Overall Study|Used prohibited corticosteroids|1|||
17173563|NCT00151892|38323710|FG001|Overall Study|Used prohibited corticosteroids|0|||
16996711|NCT00712933|38140820|FG000|Overall Study|Protocol Violation|4|||
16996712|NCT00712933|38140820|FG000|Overall Study|Withdrawal by Subject|151|||
16996713|NCT00712543|38140830|FG000|Day 8-14|Lost to Follow-up|0|||
16996714|NCT00712543|38140831|FG001|Day 8-14|Lost to Follow-up|2|||
16996715|NCT00709111|38140837|FG000|Overall Study|Withdrawal by Subject|1|||
16996716|NCT00709111|38140837|FG000|Overall Study|Unable to attend clinic visits|1|||
16996717|NCT00710749|38140841|FG000|First Intervention|Withdrawal by Subject|1|||
16996718|NCT00710749|38140842|FG001|First Intervention|Withdrawal by Subject|0|||
16996719|NCT00699907|38140862|FG000|Overall Study|Withdrawal by Subject|2|||
16996720|NCT00699907|38140863|FG001|Overall Study|Withdrawal by Subject|1|||
16996721|NCT00699907|38140864|FG002|Overall Study|Withdrawal by Subject|0|||
16996722|NCT00699907|38140862|FG000|Overall Study|No usable sample|0|||
16996723|NCT00699907|38140863|FG001|Overall Study|No usable sample|9|||
16996724|NCT00699907|38140864|FG002|Overall Study|No usable sample|8|||
16996725|NCT00710593|38140874|FG000|Overall Study|Incarceration|1|||
16996726|NCT00710593|38140875|FG001|Overall Study|Incarceration|0|||
16996727|NCT00710593|38140874|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
16996728|NCT00710593|38140875|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
16996729|NCT00710593|38140874|FG000|Overall Study|Lost to Follow-up|3|||
16996730|NCT00710593|38140875|FG001|Overall Study|Lost to Follow-up|1|||
16996731|NCT00710593|38140874|FG000|Overall Study|Moved out of area|1|||
16996732|NCT00710593|38140875|FG001|Overall Study|Moved out of area|0|||
16996733|NCT00710593|38140874|FG000|Overall Study|Failure to adhere or complete study eval|1|||
16996734|NCT00710593|38140875|FG001|Overall Study|Failure to adhere or complete study eval|1|||
16996735|NCT00710593|38140874|FG000|Overall Study|Protocol Violation|1|||
16996736|NCT00710593|38140875|FG001|Overall Study|Protocol Violation|1|||
16996737|NCT00710593|38140874|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
16996738|NCT00710593|38140875|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
16996739|NCT00599313|38140897|FG000|Overall Study|Adverse Event|19|||
16996740|NCT00599313|38140897|FG000|Overall Study|Disease Progression|12|||
16996741|NCT00599313|38140897|FG000|Overall Study|Patient Request|4|||
16996742|NCT00599313|38140897|FG000|Overall Study|Ineligible|1|||
16996743|NCT00708175|38140903|FG000|Overall Study|Adverse Event|4|||
16996744|NCT00708175|38140904|FG001|Overall Study|Adverse Event|5|||
16996745|NCT00708175|38140903|FG000|Overall Study|Protocol Violation|2|||
16996746|NCT00708175|38140904|FG001|Overall Study|Protocol Violation|3|||
16996747|NCT00708175|38140903|FG000|Overall Study|Lost to Follow-up|5|||
16996748|NCT00708175|38140904|FG001|Overall Study|Lost to Follow-up|3|||
16996749|NCT00708175|38140903|FG000|Overall Study|Withdrawal by Subject|5|||
16996750|NCT00708175|38140904|FG001|Overall Study|Withdrawal by Subject|7|||
16996751|NCT00708175|38140903|FG000|Overall Study|BMD loss >7%|2|||
16996752|NCT00708175|38140904|FG001|Overall Study|BMD loss >7%|3|||
16996753|NCT00707239|38140913|FG000|Overall Study|Adverse Event|5|||
16996754|NCT00707239|38140914|FG001|Overall Study|Adverse Event|3|||
16996755|NCT00707239|38140915|FG002|Overall Study|Adverse Event|2|||
16996756|NCT00707239|38140913|FG000|Overall Study|Death|3|||
17087798|NCT00347360|38227957|FG000|Overall Study|Abnormal lab values|0|||
17087799|NCT00347360|38227958|FG001|Overall Study|Abnormal lab values|0|||
17087800|NCT00347360|38227959|FG002|Overall Study|Abnormal lab values|0|||
17087801|NCT00347360|38227960|FG003|Overall Study|Abnormal lab values|0|||
17087802|NCT00347360|38227961|FG004|Overall Study|Abnormal lab values|0|||
17087803|NCT00347360|38227962|FG005|Overall Study|Abnormal lab values|0|||
17173564|NCT00151892|38323709|FG000|Overall Study|Lack of study medication at center|0|||
17173565|NCT00151892|38323710|FG001|Overall Study|Lack of study medication at center|1|||
17173566|NCT03055195|38323734|FG000|Overall Study|Lack of Efficacy|1|||
17173567|NCT03055195|38323735|FG001|Overall Study|Lack of Efficacy|0|||
17173568|NCT03055195|38323734|FG000|Overall Study|Withdrawal by Subject|6|||
17173569|NCT03055195|38323735|FG001|Overall Study|Withdrawal by Subject|7|||
17173570|NCT03055195|38323734|FG000|Overall Study|Study Terminated by Sponsor|2|||
17173571|NCT03055195|38323735|FG001|Overall Study|Study Terminated by Sponsor|6|||
17173572|NCT03055195|38323734|FG000|Overall Study|Protocol Violation|2|||
17173573|NCT03055195|38323735|FG001|Overall Study|Protocol Violation|1|||
17173574|NCT03055195|38323734|FG000|Overall Study|Physician Decision|1|||
17173575|NCT03055195|38323735|FG001|Overall Study|Physician Decision|0|||
17173576|NCT02921919|38323743|FG000|Overall Study|Other|5|||
17173577|NCT02921919|38323744|FG001|Overall Study|Other|6|||
17173578|NCT02921919|38323743|FG000|Overall Study|Lost to Follow-up|0|||
17173579|NCT02921919|38323744|FG001|Overall Study|Lost to Follow-up|1|||
17173580|NCT02921919|38323743|FG000|Overall Study|Withdrawal by Subject|5|||
17173581|NCT02921919|38323744|FG001|Overall Study|Withdrawal by Subject|1|||
17173582|NCT02921919|38323743|FG000|Overall Study|Disease Progression|47|||
17173583|NCT02921919|38323744|FG001|Overall Study|Disease Progression|38|||
17173584|NCT02921919|38323743|FG000|Overall Study|Physician Decision|3|||
17173585|NCT02921919|38323744|FG001|Overall Study|Physician Decision|2|||
17173586|NCT02921919|38323743|FG000|Overall Study|Adverse Event|6|||
17173587|NCT02921919|38323744|FG001|Overall Study|Adverse Event|4|||
17173588|NCT01586910|38323766|FG000|Overall Study|Death|4|||
17173589|NCT01586910|38323767|FG001|Overall Study|Death|4|||
17173590|NCT01586910|38323766|FG000|Overall Study|Withdrawal by Subject|6|||
17173591|NCT01586910|38323767|FG001|Overall Study|Withdrawal by Subject|43|||
17173592|NCT01586910|38323766|FG000|Overall Study|Physician withdrew Subject|5|||
17173593|NCT01586910|38323767|FG001|Overall Study|Physician withdrew Subject|24|||
17173594|NCT02910219|38323777|FG000|Overall Study|Withdrawal by Subject|1|||
17173595|NCT02910219|38323778|FG001|Overall Study|Withdrawal by Subject|1|||
17173596|NCT01068717|38323784|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
17173597|NCT01068717|38323785|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
17173598|NCT01068717|38323786|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
17173599|NCT01068717|38323787|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
17173600|NCT02921763|38323801|FG000|Overall Study|Adverse Event|4|||
17173601|NCT02921763|38323801|FG000|Overall Study|Lost to Follow-up|4|||
17173602|NCT02921763|38323801|FG000|Overall Study|Lack of Efficacy|3|||
17173603|NCT02921763|38323801|FG000|Overall Study|Protocol Violation|2|||
17173604|NCT02921763|38323801|FG000|Overall Study|Withdrawal by Subject|2|||
17173605|NCT02921763|38323801|FG000|Overall Study|Physician Decision|1|||
17173606|NCT02921763|38323801|FG000|Overall Study|No data obtained|2|||
17173607|NCT01318135|38323823|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
17173608|NCT01318135|38323824|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17173609|NCT01318135|38323825|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17173610|NCT01318135|38323826|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17173611|NCT01318135|38323827|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17173612|NCT01318135|38323828|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17173613|NCT01318135|38323829|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17173614|NCT01318135|38323830|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17173615|NCT01318135|38323823|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
17173616|NCT01318135|38323824|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
17173617|NCT01318135|38323825|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
17173618|NCT01318135|38323826|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
17173619|NCT01318135|38323827|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
17173620|NCT01318135|38323828|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
17173621|NCT01318135|38323829|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
17173622|NCT01318135|38323830|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
17173623|NCT01318135|38323823|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
17173624|NCT01318135|38323824|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
17173625|NCT01318135|38323825|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
17173626|NCT01318135|38323826|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
17173627|NCT01318135|38323827|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
17173628|NCT01318135|38323828|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
17173629|NCT01318135|38323829|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
17173630|NCT01318135|38323830|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
17173631|NCT01318135|38323823|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
17173632|NCT01318135|38323824|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
17173633|NCT01318135|38323825|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
17173634|NCT01318135|38323826|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
17173635|NCT01318135|38323827|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
17173636|NCT01318135|38323828|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
17173637|NCT01318135|38323829|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
17173638|NCT01318135|38323830|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
17173639|NCT01318135|38323823|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
17173640|NCT01318135|38323824|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
17173641|NCT01318135|38323825|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
17173642|NCT01318135|38323826|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
17173643|NCT01318135|38323827|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
17173644|NCT01318135|38323828|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
17173645|NCT01318135|38323829|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
17173646|NCT01318135|38323830|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
17173647|NCT01318135|38323823|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
17173648|NCT01318135|38323824|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
17173649|NCT01318135|38323825|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
17087804|NCT00347360|38227963|FG006|Overall Study|Abnormal lab values|1|||
17087805|NCT00347360|38227964|FG007|Overall Study|Abnormal lab values|0|||
17087806|NCT00347360|38227965|FG008|Overall Study|Abnormal lab values|0|||
17087807|NCT00347360|38227966|FG009|Overall Study|Abnormal lab values|0|||
17087808|NCT00347360|38227967|FG010|Overall Study|Abnormal lab values|0|||
17087809|NCT00347360|38227968|FG011|Overall Study|Abnormal lab values|0|||
17087810|NCT00347360|38227969|FG012|Overall Study|Abnormal lab values|0|||
17087811|NCT00347360|38227970|FG013|Overall Study|Abnormal lab values|0|||
17087812|NCT00347360|38227971|FG014|Overall Study|Abnormal lab values|0|||
17087813|NCT00347360|38227957|FG000|Overall Study|PI recommended early withdrawal|0|||
17087814|NCT00347360|38227958|FG001|Overall Study|PI recommended early withdrawal|0|||
17087815|NCT00347360|38227959|FG002|Overall Study|PI recommended early withdrawal|0|||
17173650|NCT01318135|38323826|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
17173651|NCT01318135|38323827|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
17173652|NCT01318135|38323828|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
17173653|NCT01318135|38323829|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
17173654|NCT01318135|38323830|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
17173655|NCT01318135|38323823|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
17173656|NCT01318135|38323824|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
17173657|NCT01318135|38323825|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
17173658|NCT01318135|38323826|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
17173659|NCT01318135|38323827|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
17173660|NCT01318135|38323828|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
17173661|NCT01318135|38323829|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
17173662|NCT01318135|38323830|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
17173663|NCT02922153|38323842|FG000|Overall Study|Death|8|||
17173664|NCT02922153|38323843|FG001|Overall Study|Death|1|||
17173665|NCT02922153|38323842|FG000|Overall Study|Lost to Follow-up|1|||
17173666|NCT02922153|38323843|FG001|Overall Study|Lost to Follow-up|0|||
17173667|NCT02922153|38323842|FG000|Overall Study|Physician Decision|1|||
17173668|NCT02922153|38323843|FG001|Overall Study|Physician Decision|1|||
17173669|NCT02920983|38323849|FG000|Dispense 1|Unacceptable Lens Fit|0|||
17173670|NCT02920983|38323850|FG001|Dispense 1|Unacceptable Lens Fit|0|||
17173671|NCT02920983|38323851|FG002|Dispense 1|Unacceptable Lens Fit|0|||
17173672|NCT02920983|38323852|FG003|Dispense 1|Unacceptable Lens Fit|0|||
17173673|NCT02920983|38323853|FG004|Dispense 1|Unacceptable Lens Fit|1|||
17173674|NCT02920983|38323854|FG005|Dispense 1|Unacceptable Lens Fit|0|||
17173675|NCT02920983|38323849|FG000|Dispense 2|Unscceptable lens fit|1|||
17173676|NCT02920983|38323850|FG001|Dispense 2|Unscceptable lens fit|0|||
17173677|NCT02920983|38323851|FG002|Dispense 2|Unscceptable lens fit|0|||
17173678|NCT02920983|38323852|FG003|Dispense 2|Unscceptable lens fit|0|||
17173679|NCT02920983|38323853|FG004|Dispense 2|Unscceptable lens fit|1|||
17173680|NCT02920983|38323854|FG005|Dispense 2|Unscceptable lens fit|0|||
17173681|NCT02920983|38323849|FG000|Dispense 3|Unacceptable Lens Fit|1|||
17173682|NCT02920983|38323850|FG001|Dispense 3|Unacceptable Lens Fit|1|||
17173683|NCT02920983|38323851|FG002|Dispense 3|Unacceptable Lens Fit|0|||
17173684|NCT02920983|38323852|FG003|Dispense 3|Unacceptable Lens Fit|0|||
17173685|NCT02920983|38323853|FG004|Dispense 3|Unacceptable Lens Fit|1|||
17173686|NCT02920983|38323854|FG005|Dispense 3|Unacceptable Lens Fit|0|||
17173687|NCT02654002|38323871|FG000|Overall Study|Adverse Event|0|||
17173688|NCT02654002|38323872|FG001|Overall Study|Adverse Event|0|||
17173689|NCT02654002|38323873|FG002|Overall Study|Adverse Event|0|||
17173690|NCT02654002|38323874|FG003|Overall Study|Adverse Event|0|||
17173691|NCT02654002|38323875|FG004|Overall Study|Adverse Event|0|||
17173692|NCT02654002|38323876|FG005|Overall Study|Adverse Event|0|||
17173693|NCT02654002|38323877|FG006|Overall Study|Adverse Event|1|||
16996757|NCT00707239|38140914|FG001|Overall Study|Death|1|||
17087816|NCT00347360|38227960|FG003|Overall Study|PI recommended early withdrawal|0|||
17173694|NCT02654002|38323878|FG007|Overall Study|Adverse Event|0|||
17173695|NCT02654002|38323879|FG008|Overall Study|Adverse Event|0|||
17173696|NCT02654002|38323871|FG000|Overall Study|Withdrew Consent|0|||
17173697|NCT02654002|38323872|FG001|Overall Study|Withdrew Consent|0|||
17173698|NCT02654002|38323873|FG002|Overall Study|Withdrew Consent|0|||
17173699|NCT02654002|38323874|FG003|Overall Study|Withdrew Consent|0|||
17173700|NCT02654002|38323875|FG004|Overall Study|Withdrew Consent|0|||
17173701|NCT02654002|38323876|FG005|Overall Study|Withdrew Consent|1|||
17173702|NCT02654002|38323877|FG006|Overall Study|Withdrew Consent|0|||
17173703|NCT02654002|38323878|FG007|Overall Study|Withdrew Consent|1|||
17173704|NCT02654002|38323879|FG008|Overall Study|Withdrew Consent|0|||
17173705|NCT01675492|38323914|FG000|Overall Study|study completed early - product approval|42|||
17173706|NCT03924622|38323925|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
17173707|NCT03924622|38323926|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
17173708|NCT03924622|38323927|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
17173709|NCT03924622|38323928|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
17173710|NCT03924622|38323929|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
17173711|NCT03924622|38323930|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
17173712|NCT04044664|38323947|FG000|Stage 1|Adverse Event|3|||
17173713|NCT04044664|38323948|FG001|Stage 1|Adverse Event|3|||
17173714|NCT04044664|38323949|FG002|Stage 1|Adverse Event|1|||
17173715|NCT04044664|38323947|FG000|Stage 1|Lost to Follow-up|3|||
17173716|NCT04044664|38323948|FG001|Stage 1|Lost to Follow-up|2|||
17173717|NCT04044664|38323949|FG002|Stage 1|Lost to Follow-up|2|||
17173718|NCT04044664|38323947|FG000|Stage 1|Withdrawal by Subject|9|||
17173719|NCT04044664|38323948|FG001|Stage 1|Withdrawal by Subject|1|||
17173720|NCT04044664|38323949|FG002|Stage 1|Withdrawal by Subject|0|||
17173721|NCT04044664|38323947|FG000|Stage 1|noncompliance, personal reason|2|||
17173722|NCT04044664|38323948|FG001|Stage 1|noncompliance, personal reason|0|||
17173723|NCT04044664|38323949|FG002|Stage 1|noncompliance, personal reason|0|||
17173724|NCT04044664|38323947|FG000|Stage 1|randomization error|0|||
17173725|NCT04044664|38323948|FG001|Stage 1|randomization error|1|||
17173726|NCT04044664|38323949|FG002|Stage 1|randomization error|0|||
17173727|NCT04044664|38323947|FG000|Stage 2|Adverse Event|2|||
17173728|NCT04044664|38323948|FG001|Stage 2|Adverse Event|0|||
17173729|NCT04044664|38323949|FG002|Stage 2|Adverse Event|0|||
17173730|NCT04044664|38323947|FG000|Stage 2|Lost to Follow-up|3|||
17173731|NCT04044664|38323948|FG001|Stage 2|Lost to Follow-up|2|||
17173732|NCT04044664|38323949|FG002|Stage 2|Lost to Follow-up|1|||
17173733|NCT04044664|38323947|FG000|Stage 2|Withdrawal by Subject|3|||
17173734|NCT04044664|38323948|FG001|Stage 2|Withdrawal by Subject|0|||
17173735|NCT04044664|38323949|FG002|Stage 2|Withdrawal by Subject|0|||
17173736|NCT04044664|38323947|FG000|Stage 2|protocol deviation|1|||
17173737|NCT04044664|38323948|FG001|Stage 2|protocol deviation|0|||
17173738|NCT04044664|38323949|FG002|Stage 2|protocol deviation|0|||
17173739|NCT00150176|38323959|FG000|Overall Study|Adverse Event|16|||
17173740|NCT00150176|38323960|FG001|Overall Study|Adverse Event|53|||
17173741|NCT00150176|38323959|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
17173742|NCT00150176|38323960|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
17173743|NCT00150176|38323959|FG000|Overall Study|Withdrawal by Subject|19|||
17173744|NCT00150176|38323960|FG001|Overall Study|Withdrawal by Subject|12|||
17173745|NCT00150176|38323959|FG000|Overall Study|Lost to Follow-up|3|||
17173746|NCT00150176|38323960|FG001|Overall Study|Lost to Follow-up|3|||
17173747|NCT00150176|38323959|FG000|Overall Study|OTHER|11|||
17173748|NCT00150176|38323960|FG001|Overall Study|OTHER|13|||
17173749|NCT02985879|38323970|FG000|Overall Study|Adverse Event|7|||
17173750|NCT02985879|38323971|FG001|Overall Study|Adverse Event|9|||
17173751|NCT02985879|38323972|FG002|Overall Study|Adverse Event|7|||
17173752|NCT02985879|38323970|FG000|Overall Study|Withdrew consent|6|||
17173753|NCT02985879|38323971|FG001|Overall Study|Withdrew consent|8|||
17173754|NCT02985879|38323972|FG002|Overall Study|Withdrew consent|10|||
17173755|NCT02985879|38323970|FG000|Overall Study|Lost to Follow-up|1|||
17173756|NCT02985879|38323971|FG001|Overall Study|Lost to Follow-up|0|||
17173757|NCT02985879|38323972|FG002|Overall Study|Lost to Follow-up|2|||
17173758|NCT02985879|38323970|FG000|Overall Study|Other, not specified|62|||
17173759|NCT02985879|38323971|FG001|Overall Study|Other, not specified|58|||
17173760|NCT02985879|38323972|FG002|Overall Study|Other, not specified|58|||
17173761|NCT01067469|38323988|FG000|Overall Study|Withdrawal by Subject|0|||
17173762|NCT01067469|38323989|FG001|Overall Study|Withdrawal by Subject|1|||
17173763|NCT01067469|38323988|FG000|Overall Study|Disease Progression|0|||
17173764|NCT01067469|38323989|FG001|Overall Study|Disease Progression|1|||
17173765|NCT02985021|38323995|FG000|Overall Study|Inability to comply with study procedures|1|||
17173766|NCT01066923|38324003|FG000|Overall Study|Withdrawal by Subject|3|||
17173767|NCT01066923|38324004|FG001|Overall Study|Withdrawal by Subject|3|||
17173768|NCT01066923|38324005|FG002|Overall Study|Withdrawal by Subject|8|||
17173769|NCT01066923|38324006|FG003|Overall Study|Withdrawal by Subject|8|||
17173770|NCT02919267|38324031|FG000|Overall Study|Protocol Violation|0|||
17173771|NCT02919267|38324032|FG001|Overall Study|Protocol Violation|3|||
17173772|NCT02919267|38324033|FG002|Overall Study|Protocol Violation|3|||
17173773|NCT02919267|38324034|FG003|Overall Study|Protocol Violation|4|||
17173774|NCT01368900|38324044|FG000|Overall Study|Lost to Follow-up|7|||
17173775|NCT02910063|38324050|FG000|Phase 2|Withdrawal by Subject|3|||
17087817|NCT00347360|38227961|FG004|Overall Study|PI recommended early withdrawal|0|||
17087818|NCT00347360|38227962|FG005|Overall Study|PI recommended early withdrawal|0|||
17087819|NCT00347360|38227963|FG006|Overall Study|PI recommended early withdrawal|0|||
17087820|NCT00347360|38227964|FG007|Overall Study|PI recommended early withdrawal|0|||
17087821|NCT00347360|38227965|FG008|Overall Study|PI recommended early withdrawal|0|||
17087822|NCT00347360|38227966|FG009|Overall Study|PI recommended early withdrawal|1|||
17087823|NCT00347360|38227967|FG010|Overall Study|PI recommended early withdrawal|0|||
17087824|NCT00347360|38227968|FG011|Overall Study|PI recommended early withdrawal|0|||
17173776|NCT02910063|38324051|FG001|Phase 2|Withdrawal by Subject|0|||
17173777|NCT02910063|38324052|FG002|Phase 2|Withdrawal by Subject|0|||
17173778|NCT02910063|38324050|FG000|Phase 2|Lost to Follow-up|1|||
17173779|NCT02910063|38324051|FG001|Phase 2|Lost to Follow-up|0|||
17173780|NCT02910063|38324052|FG002|Phase 2|Lost to Follow-up|0|||
17173781|NCT02910063|38324050|FG000|Phase 2|Death|24|||
17087825|NCT00347360|38227969|FG012|Overall Study|PI recommended early withdrawal|0|||
17087826|NCT00347360|38227970|FG013|Overall Study|PI recommended early withdrawal|0|||
17087827|NCT00347360|38227971|FG014|Overall Study|PI recommended early withdrawal|0|||
17173782|NCT02910063|38324051|FG001|Phase 2|Death|0|||
17173783|NCT02910063|38324052|FG002|Phase 2|Death|0|||
17173784|NCT02909907|38324063|FG000|Overall Study|Withdrawal by Subject|0|||
17173785|NCT02909907|38324064|FG001|Overall Study|Withdrawal by Subject|1|||
17173786|NCT02651194|38324070|FG000|Overall Study|Lost to Follow-up|3|||
17087828|NCT00347360|38227957|FG000|Overall Study|Did not meet criteria before ABPM|0|||
17087829|NCT00347360|38227958|FG001|Overall Study|Did not meet criteria before ABPM|0|||
17087830|NCT00347360|38227959|FG002|Overall Study|Did not meet criteria before ABPM|0|||
17087831|NCT00347360|38227960|FG003|Overall Study|Did not meet criteria before ABPM|0|||
17087832|NCT00347360|38227961|FG004|Overall Study|Did not meet criteria before ABPM|0|||
17087833|NCT00347360|38227962|FG005|Overall Study|Did not meet criteria before ABPM|0|||
17087834|NCT00347360|38227963|FG006|Overall Study|Did not meet criteria before ABPM|0|||
17087835|NCT00347360|38227964|FG007|Overall Study|Did not meet criteria before ABPM|0|||
17087836|NCT00347360|38227965|FG008|Overall Study|Did not meet criteria before ABPM|0|||
17087837|NCT00347360|38227966|FG009|Overall Study|Did not meet criteria before ABPM|0|||
17087838|NCT00347360|38227967|FG010|Overall Study|Did not meet criteria before ABPM|1|||
17087839|NCT00347360|38227968|FG011|Overall Study|Did not meet criteria before ABPM|0|||
17087840|NCT00347360|38227969|FG012|Overall Study|Did not meet criteria before ABPM|0|||
17087841|NCT00347360|38227970|FG013|Overall Study|Did not meet criteria before ABPM|0|||
17087842|NCT00347360|38227971|FG014|Overall Study|Did not meet criteria before ABPM|0|||
17087843|NCT00347360|38227957|FG000|Overall Study|Randomized in error|0|||
17087844|NCT00347360|38227958|FG001|Overall Study|Randomized in error|0|||
17087845|NCT00347360|38227959|FG002|Overall Study|Randomized in error|0|||
17087846|NCT00347360|38227960|FG003|Overall Study|Randomized in error|0|||
17173787|NCT02651194|38324070|FG000|Overall Study|Other|2|||
17173788|NCT02907177|38324076|FG000|Overall Study|Death|0|||
17173789|NCT02907177|38324077|FG001|Overall Study|Death|1|||
17173790|NCT02907177|38324076|FG000|Overall Study|Physician Decision|3|||
17173791|NCT02907177|38324077|FG001|Overall Study|Physician Decision|3|||
17173792|NCT02907177|38324076|FG000|Overall Study|Withdrawal by Subject|15|||
17173793|NCT02907177|38324077|FG001|Overall Study|Withdrawal by Subject|7|||
17173794|NCT02907177|38324076|FG000|Overall Study|Sponsor's Decision|50|||
17173795|NCT02907177|38324077|FG001|Overall Study|Sponsor's Decision|57|||
17173796|NCT02652442|38324083|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
17173797|NCT02906709|38324097|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
17173798|NCT02906709|38324098|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
17173799|NCT02906709|38324097|FG000|Phase A (Week 0 to Week 16)|Death|0|||
17173800|NCT02906709|38324098|FG001|Phase A (Week 0 to Week 16)|Death|1|||
17173801|NCT02906709|38324097|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
17173802|NCT02906709|38324098|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
17173803|NCT02906709|38324097|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
17173804|NCT02906709|38324098|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
17173805|NCT00318656|38324112|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
17173806|NCT00318656|38324113|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
17173807|NCT00318656|38324112|FG000|Overall Study|Did not receive any treatment|0|||
17173808|NCT00318656|38324113|FG001|Overall Study|Did not receive any treatment|1|||
17173809|NCT02908347|38324119|FG000|Overall Study|Adverse Event|0|||
17173810|NCT02908347|38324120|FG001|Overall Study|Adverse Event|1|||
17173811|NCT02908347|38324119|FG000|Overall Study|Lost to Follow-up|1|||
17173812|NCT02908347|38324120|FG001|Overall Study|Lost to Follow-up|0|||
17173813|NCT02983305|38324142|FG000|Overall Study|incomplete data|2|||
17173814|NCT02983305|38324143|FG001|Overall Study|incomplete data|0|||
17173815|NCT03663166|38324149|FG000|Overall Study|Withdrawal by Subject|1|||
17173816|NCT02983227|38324156|FG000|Overall Study|Adverse Event|21|||
17173817|NCT02983227|38324157|FG001|Overall Study|Adverse Event|3|||
17173818|NCT02983227|38324156|FG000|Overall Study|Death|3|||
17173819|NCT02983227|38324157|FG001|Overall Study|Death|0|||
17173820|NCT02983227|38324156|FG000|Overall Study|Lack of Efficacy|8|||
17173821|NCT02983227|38324157|FG001|Overall Study|Lack of Efficacy|1|||
17173822|NCT02983227|38324156|FG000|Overall Study|Lost to Follow-up|3|||
17173823|NCT02983227|38324157|FG001|Overall Study|Lost to Follow-up|0|||
17173824|NCT02983227|38324156|FG000|Overall Study|Multiple Reasons|2|||
17173825|NCT02983227|38324157|FG001|Overall Study|Multiple Reasons|1|||
17173826|NCT02983227|38324156|FG000|Overall Study|Physician Decision|3|||
17173827|NCT02983227|38324157|FG001|Overall Study|Physician Decision|1|||
17173828|NCT02983227|38324156|FG000|Overall Study|Withdrawal by Subject|19|||
17173829|NCT02983227|38324157|FG001|Overall Study|Withdrawal by Subject|8|||
17173830|NCT00301262|38324165|FG000|Double Blind Phase (DB)|Adverse Event|1|||
17173831|NCT00301262|38324166|FG001|Double Blind Phase (DB)|Adverse Event|0|||
17173832|NCT00301262|38324165|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
17173833|NCT00301262|38324166|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
17173834|NCT00301262|38324165|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
17173835|NCT00301262|38324166|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
17173836|NCT00301262|38324165|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
17173837|NCT00301262|38324166|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
17173838|NCT00301262|38324165|FG000|Double Blind Phase (DB)|Other|1|||
17173839|NCT00301262|38324166|FG001|Double Blind Phase (DB)|Other|4|||
17173840|NCT00301262|38324165|FG000|Open Label Phase (OL)|Adverse Event|1|||
17173841|NCT00301262|38324166|FG001|Open Label Phase (OL)|Adverse Event|0|||
17173842|NCT00301262|38324165|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
17173843|NCT00301262|38324166|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
17173844|NCT00301262|38324165|FG000|Open Label Phase (OL)|Other|2|||
17173845|NCT00301262|38324166|FG001|Open Label Phase (OL)|Other|0|||
17173846|NCT02905149|38324193|FG000|Overall Study|Lost to Follow-up|2|||
17173847|NCT02905149|38324194|FG001|Overall Study|Lost to Follow-up|0|||
17173848|NCT02790606|38324200|FG000|Overall Study|Death|27|||
17173849|NCT02790606|38324200|FG000|Overall Study|Lost to Follow-up|4|||
17173850|NCT02790606|38324200|FG000|Overall Study|Physician Decision|3|||
17173851|NCT02790606|38324200|FG000|Overall Study|Withdrawal by Subject|1|||
17173852|NCT03077620|38324208|FG000|Overall Study|Unable to place lumbar catheter|1|||
17173853|NCT03077620|38324209|FG001|Overall Study|Unable to place lumbar catheter|0|||
17173854|NCT03077620|38324210|FG002|Overall Study|Unable to place lumbar catheter|1|||
17173855|NCT03077620|38324211|FG003|Overall Study|Unable to place lumbar catheter|0|||
17173856|NCT03077620|38324208|FG000|Overall Study|Withdrawal by Subject|0|||
17173857|NCT03077620|38324209|FG001|Overall Study|Withdrawal by Subject|1|||
17087847|NCT00347360|38227961|FG004|Overall Study|Randomized in error|0|||
17087848|NCT00347360|38227962|FG005|Overall Study|Randomized in error|0|||
17173858|NCT03077620|38324210|FG002|Overall Study|Withdrawal by Subject|0|||
17173859|NCT03077620|38324211|FG003|Overall Study|Withdrawal by Subject|0|||
17173860|NCT03077620|38324208|FG000|Overall Study|Physician Decision|0|||
17087849|NCT00347360|38227963|FG006|Overall Study|Randomized in error|0|||
17087850|NCT00347360|38227964|FG007|Overall Study|Randomized in error|0|||
17087851|NCT00347360|38227965|FG008|Overall Study|Randomized in error|0|||
17173861|NCT03077620|38324209|FG001|Overall Study|Physician Decision|0|||
17173862|NCT03077620|38324210|FG002|Overall Study|Physician Decision|1|||
17173863|NCT03077620|38324211|FG003|Overall Study|Physician Decision|0|||
17173864|NCT02982213|38324232|FG000|Overall Study|Did not complete follow up questionnaire|5|||
17173865|NCT02982213|38324233|FG001|Overall Study|Did not complete follow up questionnaire|1|||
17173866|NCT02649634|38324241|FG000|Overall Study|Withdrawal by Subject|3|||
17173867|NCT02649634|38324242|FG001|Overall Study|Withdrawal by Subject|5|||
17173868|NCT02649634|38324241|FG000|Overall Study|Lost to Follow-up|0|||
17173869|NCT02649634|38324242|FG001|Overall Study|Lost to Follow-up|1|||
17173870|NCT01066143|38324248|FG000|Overall Study|ineligible for the study|8|||
17173871|NCT02980107|38324254|FG000|Overall Study|Withdrawal by Subject|51|||
17173872|NCT02980107|38324255|FG001|Overall Study|Withdrawal by Subject|62|||
17173873|NCT02652130|38324261|FG000|Overall Study|Death|1|||
17173874|NCT02979639|38324265|FG000|Overall Study|Withdrawal based on medical judgement|1|||
17173875|NCT02979639|38324265|FG000|Overall Study|Lost to Follow-up|8|||
17173876|NCT02979639|38324265|FG000|Overall Study|Withdrawal by Subject|3|||
17173877|NCT02979639|38324265|FG000|Overall Study|Adverse Event|2|||
17173878|NCT03416179|38324273|FG000|Overall Study|Death|67|||
17173879|NCT03416179|38324274|FG001|Overall Study|Death|60|||
17173880|NCT03416179|38324275|FG002|Overall Study|Death|96|||
17173881|NCT03416179|38324276|FG003|Overall Study|Death|88|||
17173882|NCT03416179|38324273|FG000|Overall Study|Withdrawal by Subject|13|||
17087852|NCT00347360|38227966|FG009|Overall Study|Randomized in error|0|||
17087853|NCT00347360|38227967|FG010|Overall Study|Randomized in error|0|||
17087854|NCT00347360|38227968|FG011|Overall Study|Randomized in error|1|||
17087855|NCT00347360|38227969|FG012|Overall Study|Randomized in error|0|||
17087856|NCT00347360|38227970|FG013|Overall Study|Randomized in error|0|||
17087857|NCT00347360|38227971|FG014|Overall Study|Randomized in error|0|||
17173883|NCT03416179|38324274|FG001|Overall Study|Withdrawal by Subject|19|||
17087858|NCT00347360|38227957|FG000|Overall Study|Failed inclusion criteria #4|0|||
17087859|NCT00347360|38227958|FG001|Overall Study|Failed inclusion criteria #4|0|||
17087860|NCT00347360|38227959|FG002|Overall Study|Failed inclusion criteria #4|0|||
17087861|NCT00347360|38227960|FG003|Overall Study|Failed inclusion criteria #4|0|||
17087862|NCT00347360|38227961|FG004|Overall Study|Failed inclusion criteria #4|0|||
17087863|NCT00347360|38227962|FG005|Overall Study|Failed inclusion criteria #4|0|||
17087864|NCT00347360|38227963|FG006|Overall Study|Failed inclusion criteria #4|0|||
17087865|NCT00347360|38227964|FG007|Overall Study|Failed inclusion criteria #4|0|||
17087866|NCT00347360|38227965|FG008|Overall Study|Failed inclusion criteria #4|0|||
17087867|NCT00347360|38227966|FG009|Overall Study|Failed inclusion criteria #4|0|||
17087868|NCT00347360|38227967|FG010|Overall Study|Failed inclusion criteria #4|0|||
17087869|NCT00347360|38227968|FG011|Overall Study|Failed inclusion criteria #4|1|||
17087870|NCT00347360|38227969|FG012|Overall Study|Failed inclusion criteria #4|0|||
17087871|NCT00347360|38227970|FG013|Overall Study|Failed inclusion criteria #4|0|||
17087872|NCT00347360|38227971|FG014|Overall Study|Failed inclusion criteria #4|0|||
17087873|NCT00347360|38227957|FG000|Overall Study|Prolonged duration between visits|0|||
17087874|NCT00347360|38227958|FG001|Overall Study|Prolonged duration between visits|0|||
17087875|NCT00347360|38227959|FG002|Overall Study|Prolonged duration between visits|0|||
17087876|NCT00347360|38227960|FG003|Overall Study|Prolonged duration between visits|0|||
17087877|NCT00347360|38227961|FG004|Overall Study|Prolonged duration between visits|0|||
17087878|NCT00347360|38227962|FG005|Overall Study|Prolonged duration between visits|0|||
17087879|NCT00347360|38227963|FG006|Overall Study|Prolonged duration between visits|0|||
17087880|NCT00347360|38227964|FG007|Overall Study|Prolonged duration between visits|0|||
17087881|NCT00347360|38227965|FG008|Overall Study|Prolonged duration between visits|0|||
17087882|NCT00347360|38227966|FG009|Overall Study|Prolonged duration between visits|0|||
17087883|NCT00347360|38227967|FG010|Overall Study|Prolonged duration between visits|0|||
17087884|NCT00347360|38227968|FG011|Overall Study|Prolonged duration between visits|0|||
17087885|NCT00347360|38227969|FG012|Overall Study|Prolonged duration between visits|1|||
17087886|NCT00347360|38227970|FG013|Overall Study|Prolonged duration between visits|0|||
17087887|NCT00347360|38227971|FG014|Overall Study|Prolonged duration between visits|0|||
17087888|NCT00347360|38227957|FG000|Overall Study|Subject left town, ran out of study drug|0|||
17087889|NCT00347360|38227958|FG001|Overall Study|Subject left town, ran out of study drug|0|||
17087890|NCT00347360|38227959|FG002|Overall Study|Subject left town, ran out of study drug|0|||
17173884|NCT03416179|38324275|FG002|Overall Study|Withdrawal by Subject|5|||
17173885|NCT03416179|38324276|FG003|Overall Study|Withdrawal by Subject|6|||
17173886|NCT03416179|38324273|FG000|Overall Study|Ongoing|121|||
17173887|NCT03416179|38324274|FG001|Overall Study|Ongoing|123|||
17173888|NCT03416179|38324275|FG002|Overall Study|Ongoing|62|||
17173889|NCT03416179|38324276|FG003|Overall Study|Ongoing|66|||
17173890|NCT03416179|38324273|FG000|Overall Study|Lost to Follow-up|0|||
17173891|NCT03416179|38324274|FG001|Overall Study|Lost to Follow-up|0|||
17173892|NCT03416179|38324275|FG002|Overall Study|Lost to Follow-up|0|||
17173893|NCT03416179|38324276|FG003|Overall Study|Lost to Follow-up|2|||
17173894|NCT03416179|38324273|FG000|Overall Study|Other|0|||
17173895|NCT03416179|38324274|FG001|Overall Study|Other|1|||
17173896|NCT03416179|38324275|FG002|Overall Study|Other|0|||
17173897|NCT03416179|38324276|FG003|Overall Study|Other|0|||
17173898|NCT01674634|38324286|FG000|Overall Study|Withdrawal by Subject|3|||
17173899|NCT01674634|38324286|FG000|Overall Study|Lost to Follow-up|3|||
17173900|NCT02979249|38324294|FG000|Overall Study|Lost to Follow-up|2|||
17173901|NCT02979249|38324294|FG000|Overall Study|Withdrawal by Subject|4|||
17173902|NCT02976519|38324305|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
17173903|NCT02976519|38324306|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
17173904|NCT02976519|38324307|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
17173905|NCT02976519|38324308|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
17173906|NCT02976519|38324309|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
17173907|NCT02976519|38324310|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
17173908|NCT02976519|38324311|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
17173909|NCT02976519|38324305|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
17173910|NCT02976519|38324306|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
17173911|NCT02976519|38324307|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
17173912|NCT02976519|38324308|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
17173913|NCT02976519|38324309|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
17173914|NCT02976519|38324310|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
17173915|NCT02976519|38324311|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
17173916|NCT02976519|38324305|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
17173917|NCT02976519|38324306|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
17173918|NCT02976519|38324307|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
17173919|NCT02976519|38324308|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
17173920|NCT02976519|38324309|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
17173921|NCT02976519|38324310|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
17087891|NCT00347360|38227960|FG003|Overall Study|Subject left town, ran out of study drug|0|||
17173922|NCT02976519|38324311|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
17173923|NCT02976519|38324305|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
17173924|NCT02976519|38324306|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
17173925|NCT02976519|38324307|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
17173926|NCT02976519|38324308|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
17173927|NCT02976519|38324309|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
17173928|NCT02976519|38324310|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
17173929|NCT02976519|38324311|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
17173930|NCT02976519|38324305|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
17173931|NCT02976519|38324306|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
17173932|NCT02976519|38324307|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
17173933|NCT02976519|38324308|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
17173934|NCT02976519|38324309|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
17173935|NCT02976519|38324310|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
17173936|NCT02976519|38324311|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
17173937|NCT02975973|38324416|FG000|Overall Study|Adverse Event|1|||
17173938|NCT02975973|38324417|FG001|Overall Study|Adverse Event|1|||
17173939|NCT02975973|38324418|FG002|Overall Study|Adverse Event|1|||
17173940|NCT02975973|38324419|FG003|Overall Study|Adverse Event|0|||
17173941|NCT01362322|38324431|FG000|Overall Study|Withdrawal by Subject|3|||
17173942|NCT01362322|38324432|FG001|Overall Study|Withdrawal by Subject|1|||
17173943|NCT01362322|38324431|FG000|Overall Study|Lost to Follow-up|2|||
17173944|NCT01362322|38324432|FG001|Overall Study|Lost to Follow-up|6|||
17173945|NCT02975349|38324443|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17173946|NCT02975349|38324444|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17173947|NCT02975349|38324445|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
17173948|NCT02975349|38324446|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
17173949|NCT02975349|38324447|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17173950|NCT02975349|38324448|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17173951|NCT02975349|38324443|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
17173952|NCT02975349|38324444|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17173953|NCT02975349|38324445|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17173954|NCT02975349|38324446|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17173955|NCT02975349|38324447|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17173956|NCT02975349|38324448|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17173957|NCT02975349|38324443|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
17173958|NCT02975349|38324444|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
17173959|NCT02975349|38324445|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
17173960|NCT02975349|38324446|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
17173961|NCT02975349|38324447|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
17173962|NCT02975349|38324448|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
17173963|NCT02975349|38324443|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
17173964|NCT02975349|38324444|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
17173965|NCT02975349|38324445|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
17173966|NCT02975349|38324446|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
17173967|NCT02975349|38324447|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
17173968|NCT02975349|38324448|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
17173969|NCT02975349|38324443|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
17173970|NCT02975349|38324444|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
17173971|NCT02975349|38324445|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
17173972|NCT02975349|38324446|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
17173973|NCT02975349|38324447|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
17173974|NCT02975349|38324448|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
17173975|NCT02975349|38324443|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
17173976|NCT02975349|38324444|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
17173977|NCT02975349|38324445|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
17173978|NCT02975349|38324446|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
17173979|NCT02975349|38324447|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
17173980|NCT02975349|38324448|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
17173981|NCT02975349|38324443|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
17173982|NCT02975349|38324444|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
17173983|NCT02975349|38324445|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
17173984|NCT02975349|38324446|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
17173985|NCT02975349|38324447|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
17173986|NCT02975349|38324448|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
17173987|NCT02975349|38324443|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
17173988|NCT02975349|38324444|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
17173989|NCT02975349|38324445|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
17173990|NCT02975349|38324446|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
17173991|NCT02975349|38324447|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
17173992|NCT02975349|38324448|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
17173993|NCT02975349|38324443|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
17087892|NCT00347360|38227961|FG004|Overall Study|Subject left town, ran out of study drug|0|||
17087893|NCT00347360|38227962|FG005|Overall Study|Subject left town, ran out of study drug|0|||
17087894|NCT00347360|38227963|FG006|Overall Study|Subject left town, ran out of study drug|0|||
17087895|NCT00347360|38227964|FG007|Overall Study|Subject left town, ran out of study drug|0|||
17087896|NCT00347360|38227965|FG008|Overall Study|Subject left town, ran out of study drug|0|||
17087897|NCT00347360|38227966|FG009|Overall Study|Subject left town, ran out of study drug|0|||
17087898|NCT00347360|38227967|FG010|Overall Study|Subject left town, ran out of study drug|0|||
17087899|NCT00347360|38227968|FG011|Overall Study|Subject left town, ran out of study drug|0|||
17087900|NCT00347360|38227969|FG012|Overall Study|Subject left town, ran out of study drug|0|||
17087901|NCT00347360|38227970|FG013|Overall Study|Subject left town, ran out of study drug|1|||
17087902|NCT00347360|38227971|FG014|Overall Study|Subject left town, ran out of study drug|0|||
17087903|NCT00347360|38227957|FG000|Overall Study|Subject refuse to sign updated consent|0|||
17087904|NCT00347360|38227958|FG001|Overall Study|Subject refuse to sign updated consent|0|||
17087905|NCT00347360|38227959|FG002|Overall Study|Subject refuse to sign updated consent|0|||
17087906|NCT00347360|38227960|FG003|Overall Study|Subject refuse to sign updated consent|0|||
17087907|NCT00347360|38227961|FG004|Overall Study|Subject refuse to sign updated consent|0|||
17087908|NCT00347360|38227962|FG005|Overall Study|Subject refuse to sign updated consent|0|||
17087909|NCT00347360|38227963|FG006|Overall Study|Subject refuse to sign updated consent|0|||
17087910|NCT00347360|38227964|FG007|Overall Study|Subject refuse to sign updated consent|0|||
17087911|NCT00347360|38227965|FG008|Overall Study|Subject refuse to sign updated consent|0|||
17087912|NCT00347360|38227966|FG009|Overall Study|Subject refuse to sign updated consent|0|||
17087913|NCT00347360|38227967|FG010|Overall Study|Subject refuse to sign updated consent|0|||
17087914|NCT00347360|38227968|FG011|Overall Study|Subject refuse to sign updated consent|0|||
17087915|NCT00347360|38227969|FG012|Overall Study|Subject refuse to sign updated consent|0|||
17087916|NCT00347360|38227970|FG013|Overall Study|Subject refuse to sign updated consent|0|||
17087917|NCT00347360|38227971|FG014|Overall Study|Subject refuse to sign updated consent|1|||
17087918|NCT00347360|38227957|FG000|Overall Study|Visits conflicted with new job|0|||
17087919|NCT00347360|38227958|FG001|Overall Study|Visits conflicted with new job|0|||
17087920|NCT00347360|38227959|FG002|Overall Study|Visits conflicted with new job|0|||
17087921|NCT00347360|38227960|FG003|Overall Study|Visits conflicted with new job|0|||
17087922|NCT00347360|38227961|FG004|Overall Study|Visits conflicted with new job|0|||
17087923|NCT00347360|38227962|FG005|Overall Study|Visits conflicted with new job|0|||
17173994|NCT02975349|38324444|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
17173995|NCT02975349|38324445|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
17173996|NCT02975349|38324446|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
17173997|NCT02975349|38324447|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
17173998|NCT02975349|38324448|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
17173999|NCT02918877|38324469|FG000|Overall Study|Withdrawal by Subject|2|||
17174000|NCT02918877|38324470|FG001|Overall Study|Withdrawal by Subject|2|||
17174001|NCT02918877|38324469|FG000|Overall Study|Surgery cancelled|1|||
17174002|NCT02918877|38324470|FG001|Overall Study|Surgery cancelled|0|||
17174003|NCT02918877|38324469|FG000|Overall Study|Physician Decision|1|||
17174004|NCT02918877|38324470|FG001|Overall Study|Physician Decision|0|||
17174005|NCT02918877|38324469|FG000|Overall Study|Received intraoperative steroids|1|||
17174006|NCT02918877|38324470|FG001|Overall Study|Received intraoperative steroids|0|||
17174007|NCT02918877|38324469|FG000|Overall Study|Unable to obtain lab samples|1|||
17174008|NCT02918877|38324470|FG001|Overall Study|Unable to obtain lab samples|0|||
17174009|NCT02918877|38324469|FG000|Overall Study|Unsafe to perform BAL|0|||
17174010|NCT02918877|38324470|FG001|Overall Study|Unsafe to perform BAL|1|||
17174011|NCT01674712|38324481|FG000|Overall Study|Adverse Event|5|||
17174012|NCT01674712|38324482|FG001|Overall Study|Adverse Event|6|||
17174013|NCT01674712|38324483|FG002|Overall Study|Adverse Event|3|||
17174014|NCT01674712|38324484|FG003|Overall Study|Adverse Event|4|||
17174015|NCT01674712|38324485|FG004|Overall Study|Adverse Event|6|||
17174016|NCT01674712|38324481|FG000|Overall Study|Lost to Follow-up|1|||
17174017|NCT01674712|38324482|FG001|Overall Study|Lost to Follow-up|0|||
17174018|NCT01674712|38324483|FG002|Overall Study|Lost to Follow-up|0|||
17174019|NCT01674712|38324484|FG003|Overall Study|Lost to Follow-up|0|||
17174020|NCT01674712|38324485|FG004|Overall Study|Lost to Follow-up|0|||
17174021|NCT01674712|38324481|FG000|Overall Study|Protocol Violation|2|||
17174022|NCT01674712|38324482|FG001|Overall Study|Protocol Violation|0|||
17174023|NCT01674712|38324483|FG002|Overall Study|Protocol Violation|0|||
17174024|NCT01674712|38324484|FG003|Overall Study|Protocol Violation|0|||
17174025|NCT01674712|38324485|FG004|Overall Study|Protocol Violation|0|||
17174026|NCT01674712|38324481|FG000|Overall Study|Withdrawal by Subject|2|||
17174027|NCT01674712|38324482|FG001|Overall Study|Withdrawal by Subject|2|||
17087924|NCT00347360|38227963|FG006|Overall Study|Visits conflicted with new job|1|||
17174028|NCT01674712|38324483|FG002|Overall Study|Withdrawal by Subject|5|||
17174029|NCT01674712|38324484|FG003|Overall Study|Withdrawal by Subject|4|||
17174030|NCT01674712|38324485|FG004|Overall Study|Withdrawal by Subject|3|||
17174031|NCT01674712|38324481|FG000|Overall Study|Administrative|0|||
17174032|NCT01674712|38324482|FG001|Overall Study|Administrative|1|||
17174033|NCT01674712|38324483|FG002|Overall Study|Administrative|0|||
17174034|NCT01674712|38324484|FG003|Overall Study|Administrative|0|||
17174035|NCT01674712|38324485|FG004|Overall Study|Administrative|1|||
17174036|NCT01674712|38324481|FG000|Overall Study|Lack of Efficacy|0|||
17174037|NCT01674712|38324482|FG001|Overall Study|Lack of Efficacy|0|||
17174038|NCT01674712|38324483|FG002|Overall Study|Lack of Efficacy|1|||
17174039|NCT01674712|38324484|FG003|Overall Study|Lack of Efficacy|0|||
17174040|NCT01674712|38324485|FG004|Overall Study|Lack of Efficacy|1|||
17174041|NCT01368432|38324499|FG000|Overall Study|Lost to Follow-up|0|||
17174042|NCT01368432|38324500|FG001|Overall Study|Lost to Follow-up|1|||
17174043|NCT01063881|38324523|FG000|Overall Study|Adverse Event|12|||
17174044|NCT01063881|38324524|FG001|Overall Study|Adverse Event|2|||
17174045|NCT01063881|38324525|FG002|Overall Study|Adverse Event|0|||
17174046|NCT01063881|38324523|FG000|Overall Study|Lost to Follow-up|13|||
17174047|NCT01063881|38324524|FG001|Overall Study|Lost to Follow-up|7|||
17174048|NCT01063881|38324525|FG002|Overall Study|Lost to Follow-up|1|||
17174049|NCT01063881|38324523|FG000|Overall Study|Withdrawal by Subject|25|||
17174050|NCT01063881|38324524|FG001|Overall Study|Withdrawal by Subject|1|||
17174051|NCT01063881|38324525|FG002|Overall Study|Withdrawal by Subject|0|||
17174052|NCT01063881|38324523|FG000|Overall Study|Reason for not completed not specified|5|||
17174053|NCT01063881|38324524|FG001|Overall Study|Reason for not completed not specified|1|||
17174054|NCT01063881|38324525|FG002|Overall Study|Reason for not completed not specified|0|||
17174055|NCT01065597|38324540|FG000|Overall Study|Adverse Event|1|||
17174056|NCT01062555|38324546|FG000|Phase 1|Death|10|||
17174057|NCT01062555|38324547|FG001|Phase 1|Death|17|||
17174058|NCT01062555|38324548|FG002|Phase 1|Death|0|||
17174059|NCT01062555|38324549|FG003|Phase 1|Death|0|||
17174060|NCT01062555|38324546|FG000|Phase 1|Graft Failure|12|||
17174061|NCT01062555|38324547|FG001|Phase 1|Graft Failure|8|||
17174062|NCT01062555|38324548|FG002|Phase 1|Graft Failure|0|||
17174063|NCT01062555|38324549|FG003|Phase 1|Graft Failure|0|||
17174064|NCT01062555|38324546|FG000|Phase 1|Withdrawal by Subject|1|||
17174065|NCT01062555|38324547|FG001|Phase 1|Withdrawal by Subject|1|||
17174066|NCT01062555|38324548|FG002|Phase 1|Withdrawal by Subject|0|||
17174067|NCT01062555|38324549|FG003|Phase 1|Withdrawal by Subject|0|||
17174068|NCT01062555|38324546|FG000|Phase 2|Death|0|||
17174069|NCT01062555|38324547|FG001|Phase 2|Death|0|||
17174070|NCT01062555|38324548|FG002|Phase 2|Death|8|||
17174071|NCT01062555|38324549|FG003|Phase 2|Death|3|||
17174072|NCT01062555|38324546|FG000|Phase 2|Graft failure|0|||
17174073|NCT01062555|38324547|FG001|Phase 2|Graft failure|0|||
17174074|NCT01062555|38324548|FG002|Phase 2|Graft failure|7|||
17174075|NCT01062555|38324549|FG003|Phase 2|Graft failure|4|||
17174076|NCT01062555|38324546|FG000|Phase 2|Withdrawal by Subject|0|||
17174077|NCT01062555|38324547|FG001|Phase 2|Withdrawal by Subject|0|||
17174078|NCT01062555|38324548|FG002|Phase 2|Withdrawal by Subject|0|||
17174079|NCT01062555|38324549|FG003|Phase 2|Withdrawal by Subject|7|||
17174080|NCT01062555|38324546|FG000|Phase 2|Protocol Violation|0|||
17174081|NCT01062555|38324547|FG001|Phase 2|Protocol Violation|0|||
17174082|NCT01062555|38324548|FG002|Phase 2|Protocol Violation|0|||
17174083|NCT01062555|38324549|FG003|Phase 2|Protocol Violation|3|||
17174084|NCT01062555|38324546|FG000|Phase 2|Physician Decision|0|||
17174085|NCT01062555|38324547|FG001|Phase 2|Physician Decision|0|||
17174086|NCT01062555|38324548|FG002|Phase 2|Physician Decision|0|||
17174087|NCT01062555|38324549|FG003|Phase 2|Physician Decision|17|||
17174088|NCT01064817|38324561|FG000|Study Completion|Physician Decision|1|||
17174089|NCT01064817|38324562|FG001|Study Completion|Physician Decision|0|||
17174090|NCT01064817|38324561|FG000|Study Completion|Withdrawal by Subject|1|||
17174091|NCT01064817|38324562|FG001|Study Completion|Withdrawal by Subject|0|||
17174092|NCT01368276|38324570|FG000|Overall Study|Death|1|||
17174093|NCT01368276|38324571|FG001|Overall Study|Death|10|||
17174094|NCT01064739|38324577|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
17174095|NCT02741570|38324589|FG000|Pre-Treatment Period|Other reasons|0|||
17174096|NCT02741570|38324590|FG001|Pre-Treatment Period|Other reasons|3|||
17174097|NCT02741570|38324589|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
17174098|NCT02741570|38324590|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
17174099|NCT02741570|38324589|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
17174100|NCT02741570|38324590|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
17174101|NCT02741570|38324589|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
17174102|NCT02741570|38324590|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
17174103|NCT02741570|38324589|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
17174104|NCT02741570|38324590|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
17174105|NCT02741570|38324589|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
17174106|NCT02741570|38324590|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
17174107|NCT02741570|38324589|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
17174108|NCT02741570|38324590|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
17174109|NCT02741570|38324589|FG000|Pre-Treatment Period|Death|0|||
17174110|NCT02741570|38324590|FG001|Pre-Treatment Period|Death|1|||
17174111|NCT02741570|38324589|FG000|Pre-Treatment Period|Disease progression|0|||
17174112|NCT02741570|38324590|FG001|Pre-Treatment Period|Disease progression|1|||
17174113|NCT02741570|38324589|FG000|Treatment Period|Other reasons|47|||
17174114|NCT02741570|38324590|FG001|Treatment Period|Other reasons|8|||
17174115|NCT02741570|38324589|FG000|Treatment Period|Poor/non-compliance|0|||
17174116|NCT02741570|38324590|FG001|Treatment Period|Poor/non-compliance|1|||
17174117|NCT02741570|38324589|FG000|Treatment Period|Maximum clinical benefit|3|||
17174118|NCT02741570|38324590|FG001|Treatment Period|Maximum clinical benefit|5|||
17174119|NCT02741570|38324589|FG000|Treatment Period|Lost to Follow-up|1|||
17174120|NCT02741570|38324590|FG001|Treatment Period|Lost to Follow-up|3|||
17174121|NCT02741570|38324589|FG000|Treatment Period|Participant withdrew consent|9|||
17174122|NCT02741570|38324590|FG001|Treatment Period|Participant withdrew consent|13|||
17087925|NCT00347360|38227964|FG007|Overall Study|Visits conflicted with new job|0|||
17087926|NCT00347360|38227965|FG008|Overall Study|Visits conflicted with new job|0|||
17087927|NCT00347360|38227966|FG009|Overall Study|Visits conflicted with new job|0|||
17087928|NCT00347360|38227967|FG010|Overall Study|Visits conflicted with new job|0|||
17087929|NCT00347360|38227968|FG011|Overall Study|Visits conflicted with new job|0|||
17087930|NCT00347360|38227969|FG012|Overall Study|Visits conflicted with new job|0|||
17087931|NCT00347360|38227970|FG013|Overall Study|Visits conflicted with new job|0|||
17087932|NCT00347360|38227971|FG014|Overall Study|Visits conflicted with new job|0|||
17087933|NCT00319020|38228005|FG000|Overall Study|Death|2|||
17087934|NCT00319020|38228006|FG001|Overall Study|Death|2|||
17087935|NCT00319020|38228005|FG000|Overall Study|Withdrawal by Subject|4|||
17087936|NCT00319020|38228006|FG001|Overall Study|Withdrawal by Subject|1|||
17087937|NCT00319020|38228005|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
17087938|NCT00319020|38228006|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
17087939|NCT00319020|38228005|FG000|Overall Study|Administrative reason|0|||
17087940|NCT00319020|38228006|FG001|Overall Study|Administrative reason|5|||
17174123|NCT02741570|38324589|FG000|Treatment Period|Participant request to discontinue treatment|8|||
17174124|NCT02741570|38324590|FG001|Treatment Period|Participant request to discontinue treatment|23|||
17174125|NCT02741570|38324589|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
17174126|NCT02741570|38324590|FG001|Treatment Period|Adverse event unrelated to study drug|25|||
17174127|NCT02741570|38324589|FG000|Treatment Period|Death|9|||
17174128|NCT02741570|38324590|FG001|Treatment Period|Death|7|||
17174129|NCT02741570|38324589|FG000|Treatment Period|Study drug toxicity|55|||
17174130|NCT02741570|38324590|FG001|Treatment Period|Study drug toxicity|45|||
17174131|NCT02741570|38324589|FG000|Treatment Period|Disease progression|295|||
17174132|NCT02741570|38324590|FG001|Treatment Period|Disease progression|304|||
17174133|NCT01061775|38324596|FG000|Overall Study|Physician Decision|2|||
17174134|NCT01061775|38324596|FG000|Overall Study|Lost to Follow-up|1|||
17174135|NCT02651116|38324603|FG000|Overall Study|Adverse Event|0|||
17174136|NCT02651116|38324604|FG001|Overall Study|Adverse Event|1|||
17174137|NCT02651116|38324603|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
17174138|NCT02651116|38324604|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
17174139|NCT01061385|38324612|FG000|Overall Study|Lost to Follow-up|1|||
17174140|NCT01061385|38324613|FG001|Overall Study|Lost to Follow-up|0|||
17174141|NCT01061385|38324612|FG000|Overall Study|subject decision not related to AE|0|||
17174142|NCT01061385|38324613|FG001|Overall Study|subject decision not related to AE|1|||
17174143|NCT02973477|38324622|FG000|First Intervention|Lost to Follow-up|0|||
17174144|NCT02973477|38324623|FG001|First Intervention|Lost to Follow-up|2|||
17174145|NCT02973477|38324622|FG000|Washout|Withdrawal by Subject|1|||
17174146|NCT02973477|38324623|FG001|Washout|Withdrawal by Subject|0|||
17174147|NCT02973477|38324622|FG000|Second Intervention|Lost to Follow-up|1|||
17174148|NCT02973477|38324623|FG001|Second Intervention|Lost to Follow-up|0|||
17174149|NCT02788656|38324637|FG000|Overall Study|Withdrawal by Subject|1|||
17174150|NCT02788656|38324638|FG001|Overall Study|Withdrawal by Subject|0|||
17174151|NCT00283868|38324646|FG000|Overall Study|Lost to Follow-up|7|||
17174152|NCT00283868|38324647|FG001|Overall Study|Lost to Follow-up|8|||
17174153|NCT02973087|38324653|FG000|Overall Study|Withdrawal by Subject|2|||
17174154|NCT02973087|38324654|FG001|Overall Study|Withdrawal by Subject|1|||
17174155|NCT02973087|38324653|FG000|Overall Study|Adverse Event|1|||
17174156|NCT02973087|38324654|FG001|Overall Study|Adverse Event|0|||
17174157|NCT02973087|38324653|FG000|Overall Study|other|1|||
17174158|NCT02973087|38324654|FG001|Overall Study|other|1|||
17174159|NCT00271544|38324674|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
17174160|NCT00271544|38324674|FG000|Overall Study|Model 4196 lead not attempted|9|||
17174161|NCT00271544|38324674|FG000|Overall Study|Implant not attempted|4|||
17174162|NCT05342532|38324697|FG000|Overall Study|Adverse Event|5|||
17087941|NCT00319020|38228005|FG000|Overall Study|Disease progression|0|||
17087942|NCT00319020|38228006|FG001|Overall Study|Disease progression|2|||
17087943|NCT00319020|38228005|FG000|Overall Study|Transplant|0|||
17174163|NCT05342532|38324698|FG001|Overall Study|Adverse Event|20|||
17174164|NCT05342532|38324697|FG000|Overall Study|Lost to Follow-up|10|||
17174165|NCT05342532|38324698|FG001|Overall Study|Lost to Follow-up|15|||
17174166|NCT02971683|38324706|FG000|Overall Study|Other reasons|0|||
17174167|NCT02971683|38324707|FG001|Overall Study|Other reasons|1|||
17174168|NCT02971683|38324706|FG000|Overall Study|Poor/Non-Compliance|0|||
17174169|NCT02971683|38324707|FG001|Overall Study|Poor/Non-Compliance|1|||
17174170|NCT02971683|38324706|FG000|Overall Study|Lost to Follow-up|1|||
17174171|NCT02971683|38324707|FG001|Overall Study|Lost to Follow-up|0|||
17174172|NCT02971683|38324706|FG000|Overall Study|Participant withdrew consent|1|||
17174173|NCT02971683|38324707|FG001|Overall Study|Participant withdrew consent|1|||
17174174|NCT02971683|38324706|FG000|Overall Study|Participant request to discontinue study treatment|1|||
17174175|NCT02971683|38324707|FG001|Overall Study|Participant request to discontinue study treatment|1|||
17087944|NCT00319020|38228006|FG001|Overall Study|Transplant|1|||
17087945|NCT00319020|38228005|FG000|Overall Study|Treatment failure|0|||
17087946|NCT00319020|38228006|FG001|Overall Study|Treatment failure|1|||
17087947|NCT00319020|38228005|FG000|Overall Study|Adverse Event|0|||
17087948|NCT00319020|38228006|FG001|Overall Study|Adverse Event|1|||
17087949|NCT00352118|38228014|FG000|Overall Study|Physician Decision|4|||
17174176|NCT02971683|38324706|FG000|Overall Study|Adverse Event|1|||
17174177|NCT02971683|38324707|FG001|Overall Study|Adverse Event|2|||
17174178|NCT02971683|38324706|FG000|Overall Study|Lack of Efficacy|2|||
17174179|NCT02971683|38324707|FG001|Overall Study|Lack of Efficacy|2|||
17174180|NCT02984943|38324713|FG000|Overall Study|Withdrawal by Subject|3|||
17174181|NCT02984943|38324713|FG000|Overall Study|Physician Decision|1|||
17174182|NCT02787408|38324717|FG000|Overall Study|Death|16|||
17174183|NCT02787408|38324717|FG000|Overall Study|Withdrawal by Subject|1|||
17174184|NCT02787408|38324717|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
17174185|NCT02971605|38324721|FG000|Overall Study|Withdrawal by Subject|1|||
17174186|NCT03054337|38324733|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
17174187|NCT03054337|38324734|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
17174188|NCT03054337|38324735|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
17174189|NCT03054337|38324736|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
17174190|NCT03054337|38324737|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
17174191|NCT03054337|38324738|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
17174192|NCT01060059|38324771|FG000|Overall Study|Adverse Event|1|||
17174193|NCT01060059|38324772|FG001|Overall Study|Adverse Event|1|||
17174194|NCT01060059|38324771|FG000|Overall Study|Death|2|||
17174195|NCT01060059|38324772|FG001|Overall Study|Death|3|||
17174196|NCT01060059|38324771|FG000|Overall Study|Lost to Follow-up|18|||
17174197|NCT01060059|38324772|FG001|Overall Study|Lost to Follow-up|34|||
17174198|NCT01060059|38324771|FG000|Overall Study|entry criteria not met|4|||
17174199|NCT01060059|38324772|FG001|Overall Study|entry criteria not met|3|||
17174200|NCT01060059|38324771|FG000|Overall Study|Withdrawal by Subject|35|||
17174201|NCT01060059|38324772|FG001|Overall Study|Withdrawal by Subject|23|||
17174202|NCT01060059|38324771|FG000|Overall Study|lack of glycemic control|2|||
17174203|NCT01060059|38324772|FG001|Overall Study|lack of glycemic control|1|||
17174204|NCT01060059|38324771|FG000|Overall Study|lack of compliance|5|||
17174205|NCT01060059|38324772|FG001|Overall Study|lack of compliance|2|||
17174206|NCT02648932|38324786|FG000|Overall Study|No transplant|3|||
17174207|NCT02648932|38324787|FG001|Overall Study|No transplant|1|||
17174208|NCT02903511|38324795|FG000|Overall Study|Withdrawal by Subject|1|||
17174209|NCT02903511|38324796|FG001|Overall Study|Withdrawal by Subject|0|||
17174210|NCT02903511|38324795|FG000|Overall Study|Lost to Follow-up|3|||
17174211|NCT02903511|38324796|FG001|Overall Study|Lost to Follow-up|2|||
17174212|NCT01368042|38324813|FG000|Overall Study|Death|14|||
17174213|NCT01368042|38324813|FG000|Overall Study|Protocol Violation|11|||
17174214|NCT01368042|38324813|FG000|Overall Study|Lost to Follow-up|4|||
17174215|NCT01368042|38324813|FG000|Overall Study|Transplanted|1|||
17174216|NCT00126776|38324819|FG000|Overall Study|follow up complete on all patients|0|||
17174217|NCT00126776|38324820|FG001|Overall Study|follow up complete on all patients|0|||
17174218|NCT01674010|38324824|FG000|Open Treatment Phase 1|Adverse Event|10|||
17174219|NCT01674010|38324825|FG001|Open Treatment Phase 1|Adverse Event|0|||
17174220|NCT01674010|38324826|FG002|Open Treatment Phase 1|Adverse Event|0|||
17174221|NCT01674010|38324824|FG000|Open Treatment Phase 1|Death|1|||
17174222|NCT01674010|38324825|FG001|Open Treatment Phase 1|Death|0|||
17174223|NCT01674010|38324826|FG002|Open Treatment Phase 1|Death|0|||
17174224|NCT01674010|38324824|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
17174225|NCT01674010|38324825|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
17174226|NCT01674010|38324826|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
17174227|NCT01674010|38324824|FG000|Open Treatment Phase 1|Physician Decision|9|||
17174228|NCT01674010|38324825|FG001|Open Treatment Phase 1|Physician Decision|0|||
17174229|NCT01674010|38324826|FG002|Open Treatment Phase 1|Physician Decision|0|||
17174230|NCT01674010|38324824|FG000|Open Treatment Phase 1|Protocol Violation|7|||
17087950|NCT00318474|38228020|FG000|Overall Study|Adverse Event|1|||
17087951|NCT00318474|38228021|FG001|Overall Study|Adverse Event|1|||
17174231|NCT01674010|38324825|FG001|Open Treatment Phase 1|Protocol Violation|0|||
17174232|NCT01674010|38324826|FG002|Open Treatment Phase 1|Protocol Violation|0|||
17174233|NCT01674010|38324824|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
17174234|NCT01674010|38324825|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
17174235|NCT01674010|38324826|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
17174236|NCT01674010|38324824|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
17174237|NCT01674010|38324825|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
17174238|NCT01674010|38324826|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
17174239|NCT01674010|38324824|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
17174240|NCT01674010|38324825|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
17174241|NCT01674010|38324826|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
17174242|NCT01674010|38324824|FG000|Randomization Phase 2|Adverse Event|0|||
17174243|NCT01674010|38324825|FG001|Randomization Phase 2|Adverse Event|1|||
17174244|NCT01674010|38324826|FG002|Randomization Phase 2|Adverse Event|1|||
17174245|NCT01674010|38324824|FG000|Randomization Phase 2|Lost to Follow-up|0|||
17174246|NCT01674010|38324825|FG001|Randomization Phase 2|Lost to Follow-up|1|||
17174247|NCT01674010|38324826|FG002|Randomization Phase 2|Lost to Follow-up|2|||
17174248|NCT01674010|38324824|FG000|Randomization Phase 2|Mood episode recurrence|0|||
17174249|NCT01674010|38324825|FG001|Randomization Phase 2|Mood episode recurrence|8|||
17174250|NCT01674010|38324826|FG002|Randomization Phase 2|Mood episode recurrence|2|||
17174251|NCT01674010|38324824|FG000|Randomization Phase 2|Physician Decision|0|||
17174252|NCT01674010|38324825|FG001|Randomization Phase 2|Physician Decision|0|||
17174253|NCT01674010|38324826|FG002|Randomization Phase 2|Physician Decision|2|||
17174254|NCT01674010|38324824|FG000|Randomization Phase 2|Pregnancy|0|||
17174255|NCT01674010|38324825|FG001|Randomization Phase 2|Pregnancy|1|||
17174256|NCT01674010|38324826|FG002|Randomization Phase 2|Pregnancy|1|||
17174257|NCT01674010|38324824|FG000|Randomization Phase 2|Protocol Violation|0|||
17174258|NCT01674010|38324825|FG001|Randomization Phase 2|Protocol Violation|1|||
17174259|NCT01674010|38324826|FG002|Randomization Phase 2|Protocol Violation|1|||
17174260|NCT01674010|38324824|FG000|Randomization Phase 2|Sponsor Decision|0|||
17174261|NCT01674010|38324825|FG001|Randomization Phase 2|Sponsor Decision|42|||
17174262|NCT01674010|38324826|FG002|Randomization Phase 2|Sponsor Decision|45|||
17174263|NCT01674010|38324824|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
17174264|NCT01674010|38324825|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
17174265|NCT01674010|38324826|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
17174266|NCT01345669|38324836|FG000|Overall Study|Primary tumour recurrence|53|||
17174267|NCT01345669|38324837|FG001|Overall Study|Primary tumour recurrence|32|||
17174268|NCT01345669|38324836|FG000|Overall Study|Second primary tumour|4|||
17174269|NCT01345669|38324837|FG001|Overall Study|Second primary tumour|3|||
17174270|NCT01345669|38324836|FG000|Overall Study|Adverse Event|63|||
17174271|NCT01345669|38324837|FG001|Overall Study|Adverse Event|9|||
17174272|NCT01345669|38324836|FG000|Overall Study|Protocol Violation|3|||
17174273|NCT01345669|38324837|FG001|Overall Study|Protocol Violation|1|||
17174274|NCT01345669|38324836|FG000|Overall Study|Lost to Follow-up|1|||
17174275|NCT01345669|38324837|FG001|Overall Study|Lost to Follow-up|1|||
17174276|NCT01345669|38324836|FG000|Overall Study|Withdrawal by Subject|52|||
17174277|NCT01345669|38324837|FG001|Overall Study|Withdrawal by Subject|13|||
17174278|NCT01345669|38324836|FG000|Overall Study|Other Reasons|111|||
17174279|NCT01345669|38324837|FG001|Overall Study|Other Reasons|60|||
17174280|NCT05334212|38324843|FG000|Overall Study|Study terminated prematurely|7|||
17174281|NCT01673854|38324847|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
17174282|NCT01673854|38324847|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
17174283|NCT01673854|38324847|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
17174284|NCT01673854|38324847|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
17174285|NCT01673854|38324847|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
17174286|NCT01673854|38324847|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
17174287|NCT01673854|38324847|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
17174288|NCT01673854|38324847|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
17174289|NCT01673854|38324847|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
17174290|NCT01673854|38324847|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
17174291|NCT01673854|38324847|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
17174292|NCT01673854|38324847|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
17174293|NCT01343407|38324851|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
17174294|NCT01343407|38324852|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
17174295|NCT01343407|38324853|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
17174296|NCT01343407|38324854|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
17174297|NCT01343407|38324855|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
17174298|NCT01343407|38324856|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
17174299|NCT01343407|38324851|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
17174300|NCT01343407|38324852|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
17174301|NCT01343407|38324853|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
17174302|NCT01343407|38324854|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
17174303|NCT01343407|38324855|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
17174304|NCT01343407|38324856|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
17174305|NCT01367886|38324864|FG000|Overall Study|Lost to Follow-up|4|||
17174306|NCT01367886|38324864|FG000|Overall Study|Lack of Efficacy|2|||
17174307|NCT01367886|38324864|FG000|Overall Study|Death|1|||
17174308|NCT01673698|38324871|FG000|Overall Study|Lost to Follow-up|51|||
17174309|NCT01673698|38324872|FG001|Overall Study|Lost to Follow-up|13|||
17174310|NCT02786004|38324881|FG000|Overall Study|Withdrawal by Subject|0|||
17174311|NCT02786004|38324882|FG001|Overall Study|Withdrawal by Subject|1|||
17174312|NCT03051607|38324890|FG000|Overall Study|Adverse Event|66|||
17174313|NCT01062399|38324899|FG000|Overall Study|Protocol Violation|0|||
17174314|NCT01062399|38324900|FG001|Overall Study|Protocol Violation|1|||
17174315|NCT01062399|38324901|FG002|Overall Study|Protocol Violation|0|||
17174316|NCT01062399|38324902|FG003|Overall Study|Protocol Violation|6|||
17174317|NCT01062399|38324903|FG004|Overall Study|Protocol Violation|4|||
17174318|NCT01317277|38324917|FG000|Overall Study|Lost to Follow-up|3|||
17174319|NCT01317277|38324918|FG001|Overall Study|Lost to Follow-up|1|||
17174320|NCT01317277|38324917|FG000|Overall Study|Lost MEMS|1|||
17174321|NCT01317277|38324918|FG001|Overall Study|Lost MEMS|1|||
17174322|NCT01317277|38324917|FG000|Overall Study|Unable to comply with intervention|1|||
17174323|NCT01317277|38324918|FG001|Overall Study|Unable to comply with intervention|0|||
17174324|NCT01317277|38324917|FG000|Overall Study|Withdrawal by Subject|1|||
17174325|NCT01317277|38324918|FG001|Overall Study|Withdrawal by Subject|0|||
17174326|NCT01317277|38324917|FG000|Overall Study|Adverse Event|1|||
17174327|NCT01317277|38324918|FG001|Overall Study|Adverse Event|0|||
17174328|NCT02740478|38324924|FG000|Overall Study|Withdrawal by Subject|1|||
17174329|NCT02969655|38324930|FG000|Overall Study|Withdrawal by Subject|3|||
17174330|NCT02969655|38324931|FG001|Overall Study|Withdrawal by Subject|2|||
17174331|NCT02969655|38324930|FG000|Overall Study|Physician Decision|4|||
17174332|NCT02969655|38324931|FG001|Overall Study|Physician Decision|3|||
17174333|NCT02969655|38324930|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
17174334|NCT02969655|38324931|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
17174335|NCT02969655|38324930|FG000|Overall Study|Adverse Event|10|||
17174336|NCT02969655|38324931|FG001|Overall Study|Adverse Event|8|||
17174337|NCT01317199|38324942|FG000|Dose-escalation Phase 1|Physician Decision|5|||
17174338|NCT01317199|38324943|FG001|Dose-escalation Phase 1|Physician Decision|0|||
17174339|NCT01317199|38324944|FG002|Dose-escalation Phase 1|Physician Decision|0|||
17174340|NCT01317199|38324945|FG003|Dose-escalation Phase 1|Physician Decision|0|||
17174341|NCT01317199|38324942|FG000|Dose-escalation Phase 1|Disease progression|1|||
17174342|NCT01317199|38324943|FG001|Dose-escalation Phase 1|Disease progression|0|||
17174343|NCT01317199|38324944|FG002|Dose-escalation Phase 1|Disease progression|0|||
17174344|NCT01317199|38324945|FG003|Dose-escalation Phase 1|Disease progression|0|||
17174345|NCT01317199|38324942|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
17174346|NCT01317199|38324943|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
17174347|NCT01317199|38324944|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
17174348|NCT01317199|38324945|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
17174349|NCT01317199|38324942|FG000|Randomized Phase 2|Disease progression|0|||
17174350|NCT01317199|38324943|FG001|Randomized Phase 2|Disease progression|3|||
17174351|NCT01317199|38324944|FG002|Randomized Phase 2|Disease progression|7|||
17174352|NCT01317199|38324945|FG003|Randomized Phase 2|Disease progression|5|||
17174353|NCT01317199|38324942|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
17174354|NCT01317199|38324943|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
17174355|NCT01317199|38324944|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
17174356|NCT01317199|38324945|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
17174357|NCT01317199|38324942|FG000|Randomized Phase 2|Adverse Event|0|||
17174358|NCT01317199|38324943|FG001|Randomized Phase 2|Adverse Event|0|||
17174359|NCT01317199|38324944|FG002|Randomized Phase 2|Adverse Event|0|||
17174360|NCT01317199|38324945|FG003|Randomized Phase 2|Adverse Event|1|||
17174361|NCT01317199|38324942|FG000|Randomized Phase 2|Comorbidities|0|||
17174362|NCT01317199|38324943|FG001|Randomized Phase 2|Comorbidities|2|||
16781315|NCT02143024|37720476|FG000|Overall Study|Withdrawal by Subject|1|||
17087952|NCT00318474|38228020|FG000|Overall Study|Lost to Follow-up|0|||
17087953|NCT00318474|38228021|FG001|Overall Study|Lost to Follow-up|1|||
17087954|NCT00318474|38228020|FG000|Overall Study|Pregnancy|0|||
17087955|NCT00318474|38228021|FG001|Overall Study|Pregnancy|2|||
17087956|NCT00318474|38228020|FG000|Overall Study|Protocol Violation|1|||
17087957|NCT00318474|38228021|FG001|Overall Study|Protocol Violation|0|||
17087958|NCT00318474|38228020|FG000|Overall Study|Withdrawal by Subject|3|||
17087959|NCT00318474|38228021|FG001|Overall Study|Withdrawal by Subject|2|||
17087960|NCT00318474|38228020|FG000|Overall Study|Fall in GFR|3|||
17087961|NCT00318474|38228021|FG001|Overall Study|Fall in GFR|3|||
17174363|NCT01317199|38324944|FG002|Randomized Phase 2|Comorbidities|2|||
17174364|NCT01317199|38324945|FG003|Randomized Phase 2|Comorbidities|2|||
17087962|NCT00318474|38228020|FG000|Overall Study|Post-therapy hyperflycemia|0|||
17087963|NCT00318474|38228021|FG001|Overall Study|Post-therapy hyperflycemia|1|||
17087964|NCT00318474|38228020|FG000|Overall Study|Trial terminated|10|||
17087965|NCT00318474|38228021|FG001|Overall Study|Trial terminated|7|||
17087966|NCT00350870|38228031|FG000|Overall Study|Withdrawal by Subject|21|||
17087967|NCT00350870|38228032|FG001|Overall Study|Withdrawal by Subject|17|||
17087968|NCT00350870|38228033|FG002|Overall Study|Withdrawal by Subject|15|||
17087969|NCT00350870|38228034|FG003|Overall Study|Withdrawal by Subject|14|||
17087970|NCT00350870|38228031|FG000|Overall Study|Physician Decision|1|||
17087971|NCT00350870|38228032|FG001|Overall Study|Physician Decision|0|||
17087972|NCT00350870|38228033|FG002|Overall Study|Physician Decision|1|||
17087973|NCT00350870|38228034|FG003|Overall Study|Physician Decision|1|||
17087974|NCT00350792|38228044|FG000|Overall Study|Adverse Event|11|||
17087975|NCT00350792|38228044|FG000|Overall Study|Death from Study Disease|1|||
17087976|NCT00350792|38228044|FG000|Overall Study|Death from Study Drug Toxicity|1|||
17174365|NCT01317199|38324942|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
17174366|NCT01317199|38324943|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
17174367|NCT01317199|38324944|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
17174368|NCT01317199|38324945|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
17174369|NCT01317199|38324942|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
17174370|NCT01317199|38324943|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
17174371|NCT01317199|38324944|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
17174372|NCT01317199|38324945|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
17174373|NCT01317199|38324942|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
17174374|NCT01317199|38324943|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
17174375|NCT01317199|38324944|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
17174376|NCT01317199|38324945|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
17174377|NCT01317199|38324942|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
17174378|NCT01317199|38324943|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
17174379|NCT01317199|38324944|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
17174380|NCT01317199|38324945|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
17174381|NCT02648698|38324964|FG000|Overall Study|Protocol Violation|1|||
17174382|NCT02648698|38324965|FG001|Overall Study|Protocol Violation|5|||
17174383|NCT02970669|38324973|FG000|Double-blind Period|Adverse Event|4|||
17174384|NCT02970669|38324974|FG001|Double-blind Period|Adverse Event|0|||
17174385|NCT02970669|38324973|FG000|Double-blind Period|Death|1|||
17174386|NCT02970669|38324974|FG001|Double-blind Period|Death|0|||
17174387|NCT02970669|38324973|FG000|Double-blind Period|Study terminated by sponsor|1|||
17174388|NCT02970669|38324974|FG001|Double-blind Period|Study terminated by sponsor|2|||
17174389|NCT02970669|38324973|FG000|Double-blind Period|Physician Decision|0|||
17174390|NCT02970669|38324974|FG001|Double-blind Period|Physician Decision|2|||
17174391|NCT02970669|38324973|FG000|Double-blind Period|Withdrawal by Subject|2|||
17174392|NCT02970669|38324974|FG001|Double-blind Period|Withdrawal by Subject|2|||
17174393|NCT02970669|38324973|FG000|Open-label Period|Withdrawal by Subject|2|||
17174394|NCT02970669|38324974|FG001|Open-label Period|Withdrawal by Subject|2|||
17174395|NCT02970669|38324973|FG000|Open-label Period|Adverse Event|1|||
17174396|NCT02970669|38324974|FG001|Open-label Period|Adverse Event|0|||
17174397|NCT02970669|38324973|FG000|Open-label Period|Physician Decision|1|||
17174398|NCT02970669|38324974|FG001|Open-label Period|Physician Decision|0|||
17174399|NCT02902965|38324982|FG000|Overall Study|Withdrawal by Subject|10|||
17174400|NCT02642042|38324987|FG000|Overall Study|Adverse Event|22|||
17174401|NCT02642042|38324987|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
17174402|NCT02642042|38324987|FG000|Overall Study|Progression/Relapse|28|||
17174403|NCT02642042|38324987|FG000|Overall Study|Death|1|||
17174404|NCT02642042|38324987|FG000|Overall Study|Not Protocol Specified|2|||
17174405|NCT02902809|38324991|FG000|Overall Study|Discontinuation of asthma program|28|||
17174406|NCT01362244|38324997|FG000|Overall Study|Adverse Event|3|||
17174407|NCT01362244|38324998|FG001|Overall Study|Adverse Event|5|||
17174408|NCT01362244|38324997|FG000|Overall Study|Lack of Efficacy|5|||
17174409|NCT01362244|38324998|FG001|Overall Study|Lack of Efficacy|11|||
17174410|NCT01362244|38324997|FG000|Overall Study|Lost to Follow-up|0|||
17174411|NCT01362244|38324998|FG001|Overall Study|Lost to Follow-up|2|||
17174412|NCT01362244|38324997|FG000|Overall Study|Protocol Violation|5|||
17174413|NCT01362244|38324998|FG001|Overall Study|Protocol Violation|1|||
17174414|NCT01362244|38324997|FG000|Overall Study|Withdrawal by Subject|2|||
16996758|NCT00707239|38140915|FG002|Overall Study|Death|3|||
16996759|NCT00707239|38140913|FG000|Overall Study|Physician Decision|1|||
17174415|NCT01362244|38324998|FG001|Overall Study|Withdrawal by Subject|1|||
17174416|NCT01362244|38324997|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
17174417|NCT01362244|38324998|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
17174418|NCT01362244|38324997|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
17174419|NCT01362244|38324998|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
17174420|NCT02969187|38325006|FG000|Overall Study|Physician Decision|12|||
17174421|NCT02969187|38325007|FG001|Overall Study|Physician Decision|13|||
17174422|NCT03050359|38325017|FG000|Overall Study|Randomized But Not Treated|2|||
17174423|NCT03050359|38325018|FG001|Overall Study|Randomized But Not Treated|0|||
17087977|NCT00350792|38228044|FG000|Overall Study|Death Not Study Drug Related|2|||
17087978|NCT00350792|38228044|FG000|Overall Study|Protocol Violation|1|||
17174424|NCT03050359|38325017|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
17174425|NCT03050359|38325018|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
17174426|NCT03050359|38325017|FG000|Overall Study|Significant Protocol Deviation|2|||
17174427|NCT03050359|38325018|FG001|Overall Study|Significant Protocol Deviation|3|||
17174428|NCT03050359|38325017|FG000|Overall Study|Lost to Follow-up|2|||
17174429|NCT03050359|38325018|FG001|Overall Study|Lost to Follow-up|1|||
17174430|NCT03050359|38325017|FG000|Overall Study|Voluntary Withdrawal|4|||
17174431|NCT03050359|38325018|FG001|Overall Study|Voluntary Withdrawal|6|||
17174432|NCT03050359|38325017|FG000|Overall Study|Pregnancy|1|||
17174433|NCT03050359|38325018|FG001|Overall Study|Pregnancy|0|||
17174434|NCT03050359|38325017|FG000|Overall Study|Reason Not Specified|1|||
17174435|NCT03050359|38325018|FG001|Overall Study|Reason Not Specified|0|||
17174436|NCT02785770|38325026|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
17174437|NCT02785770|38325027|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
17174438|NCT02785770|38325028|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
17174439|NCT02785770|38325029|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
17174440|NCT02785770|38325026|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
17174441|NCT02785770|38325027|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
17174442|NCT02785770|38325028|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
17174443|NCT02785770|38325029|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
17174444|NCT02785770|38325026|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
17174445|NCT02785770|38325027|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
17174446|NCT02785770|38325028|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
17174447|NCT02785770|38325029|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
17174448|NCT02965833|38325042|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
17174449|NCT02965833|38325043|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
17174450|NCT02965833|38325042|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
17174451|NCT02965833|38325043|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
17174452|NCT02965833|38325042|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
17174453|NCT02965833|38325043|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
17174454|NCT02965833|38325042|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
17174455|NCT02965833|38325043|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
17174456|NCT02965833|38325042|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
17174457|NCT02965833|38325043|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
17174458|NCT02968173|38325049|FG000|Overall Study|Withdrawal by Subject|1|||
17174459|NCT02785458|38325056|FG000|1 Month|Withdrawal by Subject|2|||
17174460|NCT02785458|38325057|FG001|1 Month|Withdrawal by Subject|1|||
17174461|NCT02785458|38325056|FG000|1 Month|Lost to Follow-up|38|||
17174462|NCT02785458|38325057|FG001|1 Month|Lost to Follow-up|31|||
17174463|NCT02785458|38325056|FG000|1 Month|Deemed Ineligible|1|||
17174464|NCT02785458|38325057|FG001|1 Month|Deemed Ineligible|0|||
17174465|NCT02785458|38325056|FG000|1 Month|Completed Evaluation by Baseline|42|||
17174466|NCT02785458|38325057|FG001|1 Month|Completed Evaluation by Baseline|39|||
17174467|NCT02785458|38325056|FG000|1 Month|Partial Interview|0|||
17174468|NCT02785458|38325057|FG001|1 Month|Partial Interview|4|||
17174469|NCT02785458|38325056|FG000|3 Months|Withdrawal by Subject|3|||
17174470|NCT02785458|38325057|FG001|3 Months|Withdrawal by Subject|1|||
17174471|NCT02785458|38325056|FG000|3 Months|Lost to Follow-up|25|||
17174472|NCT02785458|38325057|FG001|3 Months|Lost to Follow-up|21|||
17174473|NCT02785458|38325056|FG000|3 Months|Completed Evaluation at 1 Month|100|||
17174474|NCT02785458|38325057|FG001|3 Months|Completed Evaluation at 1 Month|89|||
17174475|NCT02784834|38325063|FG000|Overall Study|Lack of Efficacy|1|||
17174476|NCT02966223|38325080|FG000|Overall Study|Physician Decision|3|||
17174477|NCT02966223|38325080|FG000|Overall Study|Withdrawal by Subject|11|||
17174478|NCT02966223|38325080|FG000|Overall Study|Lost to Follow-up|1|||
17174479|NCT03049735|38325087|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
17174480|NCT03049735|38325088|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
17174481|NCT03049735|38325089|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
17174482|NCT03049735|38325087|FG000|Overall Study|Other|5|||
17174483|NCT03049735|38325088|FG001|Overall Study|Other|3|||
17174484|NCT03049735|38325089|FG002|Overall Study|Other|1|||
17174485|NCT03049735|38325087|FG000|Overall Study|Lack of Efficacy|4|||
17174486|NCT03049735|38325088|FG001|Overall Study|Lack of Efficacy|0|||
17174487|NCT03049735|38325089|FG002|Overall Study|Lack of Efficacy|3|||
17174488|NCT03049735|38325087|FG000|Overall Study|Protocol deviation|1|||
17174489|NCT03049735|38325088|FG001|Overall Study|Protocol deviation|0|||
17174490|NCT03049735|38325089|FG002|Overall Study|Protocol deviation|0|||
17174491|NCT03049735|38325087|FG000|Overall Study|Pregnancy|0|||
17174492|NCT03049735|38325088|FG001|Overall Study|Pregnancy|0|||
17174493|NCT03049735|38325089|FG002|Overall Study|Pregnancy|1|||
17174494|NCT03049735|38325087|FG000|Overall Study|Adverse Event|7|||
17174495|NCT03049735|38325088|FG001|Overall Study|Adverse Event|18|||
17174496|NCT03049735|38325089|FG002|Overall Study|Adverse Event|5|||
17174497|NCT03049735|38325087|FG000|Overall Study|Withdrawal by Subject|10|||
17174498|NCT03049735|38325088|FG001|Overall Study|Withdrawal by Subject|3|||
17174499|NCT03049735|38325089|FG002|Overall Study|Withdrawal by Subject|7|||
17087979|NCT00350792|38228044|FG000|Overall Study|Withdrawal by Subject|4|||
17087980|NCT00350792|38228044|FG000|Overall Study|Physician Decision|2|||
17087981|NCT00350792|38228044|FG000|Overall Study|Lack of Efficacy|11|||
17087982|NCT00317772|38228052|FG000|Overall Study|Adverse Event|0|||
17174500|NCT03049735|38325087|FG000|Overall Study|Lost to Follow-up|1|||
17174501|NCT03049735|38325088|FG001|Overall Study|Lost to Follow-up|5|||
17174502|NCT03049735|38325089|FG002|Overall Study|Lost to Follow-up|5|||
17174503|NCT01295944|38325097|FG000|Overall Study|Switched to alternative treatment|1|||
17174504|NCT01295944|38325097|FG000|Overall Study|Ineligible|9|||
17174505|NCT01295944|38325097|FG000|Overall Study|Withdrawal by Subject|4|||
17174506|NCT01295944|38325097|FG000|Overall Study|Participant chose to be treated in Peru|1|||
17174507|NCT01295944|38325097|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
17087983|NCT00317772|38228053|FG001|Overall Study|Adverse Event|0|||
17087984|NCT00317772|38228054|FG002|Overall Study|Adverse Event|0|||
17087985|NCT00317772|38228055|FG003|Overall Study|Adverse Event|2|||
17174508|NCT01295944|38325097|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
17174509|NCT01295944|38325097|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
16996760|NCT00707239|38140914|FG001|Overall Study|Physician Decision|1|||
16996761|NCT00707239|38140915|FG002|Overall Study|Physician Decision|2|||
16996762|NCT00707239|38140913|FG000|Overall Study|Protocol Violation|0|||
16996763|NCT00707239|38140914|FG001|Overall Study|Protocol Violation|0|||
16996764|NCT00707239|38140915|FG002|Overall Study|Protocol Violation|1|||
16996765|NCT00707239|38140913|FG000|Overall Study|Lack of Efficacy|1|||
17087986|NCT00317772|38228052|FG000|Overall Study|Disease Progression|2|||
17087987|NCT00317772|38228053|FG001|Overall Study|Disease Progression|2|||
17087988|NCT00317772|38228054|FG002|Overall Study|Disease Progression|1|||
17087989|NCT00317772|38228055|FG003|Overall Study|Disease Progression|7|||
17087990|NCT00350636|38228068|FG000|Overall Study|Adverse Event|19|||
17087991|NCT00350636|38228069|FG001|Overall Study|Adverse Event|13|||
17087992|NCT00350636|38228068|FG000|Overall Study|Protocol Violation|1|||
17087993|NCT00350636|38228069|FG001|Overall Study|Protocol Violation|3|||
17087994|NCT00350636|38228068|FG000|Overall Study|Withdrawal by Subject|13|||
16996766|NCT00707239|38140914|FG001|Overall Study|Lack of Efficacy|2|||
16996767|NCT00707239|38140915|FG002|Overall Study|Lack of Efficacy|0|||
16996768|NCT00707239|38140913|FG000|Overall Study|Randomized, but not treated|1|||
16996769|NCT00707239|38140914|FG001|Overall Study|Randomized, but not treated|1|||
16996770|NCT00707239|38140915|FG002|Overall Study|Randomized, but not treated|1|||
16996771|NCT00707239|38140913|FG000|Overall Study|Other|8|||
16996772|NCT00707239|38140914|FG001|Overall Study|Other|3|||
16996773|NCT00707239|38140915|FG002|Overall Study|Other|5|||
16996774|NCT00968708|38140928|FG000|Overall Study|Adverse Event|169|||
16996775|NCT00968708|38140929|FG001|Overall Study|Adverse Event|150|||
16996776|NCT00968708|38140928|FG000|Overall Study|Major Protocol Deviation|0|||
16996777|NCT00968708|38140929|FG001|Overall Study|Major Protocol Deviation|1|||
16996778|NCT00968708|38140928|FG000|Overall Study|Lost to Follow-up|19|||
16996779|NCT00968708|38140929|FG001|Overall Study|Lost to Follow-up|11|||
16996780|NCT00968708|38140928|FG000|Overall Study|Voluntary Withdrawal|104|||
16996781|NCT00968708|38140929|FG001|Overall Study|Voluntary Withdrawal|101|||
16996782|NCT00968708|38140928|FG000|Overall Study|Investigator Discretion|0|||
16996783|NCT00968708|38140929|FG001|Overall Study|Investigator Discretion|1|||
16996784|NCT00968708|38140928|FG000|Overall Study|Other|26|||
16996785|NCT00968708|38140929|FG001|Overall Study|Other|34|||
16996786|NCT00967694|38140935|FG000|Overall Study|Withdrawal by Subject|6|||
17174510|NCT02965599|38325103|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
17174511|NCT02965599|38325104|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
17174512|NCT02898597|38325113|FG000|Overall Study|Protocol Violation|4|||
17174513|NCT02898597|38325114|FG001|Overall Study|Protocol Violation|2|||
17174514|NCT02898597|38325113|FG000|Overall Study|Lost to Follow-up|0|||
17174515|NCT02898597|38325114|FG001|Overall Study|Lost to Follow-up|9|||
16996787|NCT00967616|38140941|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
16996788|NCT00967616|38140942|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
16996789|NCT00967616|38140941|FG000|Overall Study|Death|0|||
17087995|NCT00350636|38228069|FG001|Overall Study|Withdrawal by Subject|17|||
17087996|NCT00350636|38228068|FG000|Overall Study|Lost to Follow-up|9|||
17087997|NCT00350636|38228069|FG001|Overall Study|Lost to Follow-up|8|||
17087998|NCT00350636|38228068|FG000|Overall Study|Physician Decision|0|||
17087999|NCT00350636|38228069|FG001|Overall Study|Physician Decision|2|||
17088000|NCT00350636|38228068|FG000|Overall Study|Other|1|||
17088001|NCT00350636|38228069|FG001|Overall Study|Other|2|||
17088002|NCT00346268|38228077|FG000|Overall Study|Adverse Event|1|||
17088003|NCT00346268|38228078|FG001|Overall Study|Adverse Event|0|||
17088004|NCT00346268|38228077|FG000|Overall Study|Protocol Violation|1|||
16996790|NCT00967616|38140942|FG001|Overall Study|Death|3|||
16996791|NCT00967616|38140941|FG000|Overall Study|Withdrawal by Subject|8|||
17088005|NCT00346268|38228078|FG001|Overall Study|Protocol Violation|0|||
17088006|NCT00346268|38228077|FG000|Overall Study|Participant refused|0|||
17088007|NCT00346268|38228078|FG001|Overall Study|Participant refused|3|||
17174516|NCT02898597|38325113|FG000|Overall Study|Death|0|||
17174517|NCT02898597|38325114|FG001|Overall Study|Death|1|||
17174518|NCT02899377|38325122|FG000|Overall Study|Adverse Event|1|||
17174519|NCT02899377|38325123|FG001|Overall Study|Adverse Event|0|||
17174520|NCT01316887|38325134|FG000|Overall Study|Adverse Event|13|||
17174521|NCT01316887|38325135|FG001|Overall Study|Adverse Event|21|||
17174522|NCT01316887|38325136|FG002|Overall Study|Adverse Event|17|||
17174523|NCT01316887|38325134|FG000|Overall Study|Lack of Efficacy|9|||
17174524|NCT01316887|38325135|FG001|Overall Study|Lack of Efficacy|3|||
17174525|NCT01316887|38325136|FG002|Overall Study|Lack of Efficacy|1|||
17174526|NCT01316887|38325134|FG000|Overall Study|Protocol Violation|2|||
17174527|NCT01316887|38325135|FG001|Overall Study|Protocol Violation|6|||
17174528|NCT01316887|38325136|FG002|Overall Study|Protocol Violation|6|||
17174529|NCT01316887|38325134|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
17174530|NCT01316887|38325135|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
17174531|NCT01316887|38325136|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
17174532|NCT01316887|38325134|FG000|Overall Study|Study Closed/Terminated|2|||
17174533|NCT01316887|38325135|FG001|Overall Study|Study Closed/Terminated|4|||
17174534|NCT01316887|38325136|FG002|Overall Study|Study Closed/Terminated|3|||
17174535|NCT01316887|38325134|FG000|Overall Study|Lost to Follow-up|1|||
17088008|NCT00327444|38228086|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
17088009|NCT00327444|38228087|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
17088010|NCT00327444|38228086|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
17088011|NCT00327444|38228087|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
17088012|NCT00327444|38228086|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
17088013|NCT00327444|38228087|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
17088014|NCT00327444|38228086|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
17088015|NCT00327444|38228087|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
17088016|NCT00327444|38228086|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
17088017|NCT00327444|38228087|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
17088018|NCT00327444|38228086|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
17088019|NCT00327444|38228087|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
17088020|NCT00327444|38228086|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
17088021|NCT00327444|38228087|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
17088022|NCT00327444|38228086|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
17088023|NCT00327444|38228087|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
17088024|NCT00337610|38228097|FG000|Overall Study|Adverse Event|2|||
17088025|NCT00337610|38228098|FG001|Overall Study|Adverse Event|2|||
17088026|NCT00337610|38228097|FG000|Overall Study|Death|0|||
17088027|NCT00337610|38228098|FG001|Overall Study|Death|1|||
17088028|NCT00337610|38228097|FG000|Overall Study|Lack of Efficacy|6|||
17088029|NCT00337610|38228098|FG001|Overall Study|Lack of Efficacy|3|||
17088030|NCT00337610|38228097|FG000|Overall Study|Lost to Follow-up|3|||
17088031|NCT00337610|38228098|FG001|Overall Study|Lost to Follow-up|3|||
17088032|NCT00337610|38228097|FG000|Overall Study|Withdrawal by Subject|6|||
17088033|NCT00337610|38228098|FG001|Overall Study|Withdrawal by Subject|5|||
17088034|NCT00316914|38228106|FG000|Overall Study|Withdrawal by Subject|5|||
17088035|NCT00316914|38228107|FG001|Overall Study|Withdrawal by Subject|3|||
17088036|NCT00316914|38228106|FG000|Overall Study|Adverse Event|8|||
17088037|NCT00316914|38228107|FG001|Overall Study|Adverse Event|7|||
17088038|NCT00316914|38228106|FG000|Overall Study|Other Problems|6|||
17088039|NCT00316914|38228107|FG001|Overall Study|Other Problems|11|||
17088040|NCT00316914|38228106|FG000|Overall Study|Missing end of treatment documentation|14|||
17088041|NCT00316914|38228107|FG001|Overall Study|Missing end of treatment documentation|15|||
17088042|NCT00336284|38228115|FG000|Overall Study|Death|52|||
17088043|NCT00336284|38228116|FG001|Overall Study|Death|26|||
17088044|NCT00336284|38228115|FG000|Overall Study|Lost to Follow-up|82|||
17088045|NCT00336284|38228116|FG001|Overall Study|Lost to Follow-up|61|||
17088046|NCT00336284|38228115|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
17088047|NCT00336284|38228116|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
17088048|NCT00316602|38228124|FG000|Overall Study|Withdrawal by Subject|3|||
17088049|NCT00316602|38228125|FG001|Overall Study|Withdrawal by Subject|2|||
17088050|NCT00316602|38228124|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
17088051|NCT00316602|38228125|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
17088052|NCT00316602|38228124|FG000|Overall Study|Adverse Event|1|||
17088053|NCT00316602|38228125|FG001|Overall Study|Adverse Event|0|||
17088054|NCT00316602|38228124|FG000|Overall Study|Other|3|||
17088055|NCT00316602|38228125|FG001|Overall Study|Other|6|||
17088056|NCT00335972|38228133|FG000|Overall Study|not given treatments|0|||
17088057|NCT00335972|38228134|FG001|Overall Study|not given treatments|3|||
17088058|NCT00346034|38228140|FG000|Overall Study|Adverse Event|34|||
17088059|NCT00346034|38228140|FG000|Overall Study|Lack of Efficacy|8|||
17088060|NCT00346034|38228140|FG000|Overall Study|Withdrawal by Subject|13|||
17088061|NCT00346034|38228140|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
17174536|NCT01316887|38325135|FG001|Overall Study|Lost to Follow-up|7|||
17174537|NCT01316887|38325136|FG002|Overall Study|Lost to Follow-up|5|||
17088062|NCT00346034|38228140|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
17088063|NCT00345878|38228146|FG000|Overall Study|Adverse Event|1|||
17088064|NCT00345878|38228147|FG001|Overall Study|Adverse Event|0|||
17088065|NCT00345878|38228146|FG000|Overall Study|Lost to Follow-up|2|||
17088066|NCT00345878|38228147|FG001|Overall Study|Lost to Follow-up|1|||
17088067|NCT00345878|38228146|FG000|Overall Study|Other|1|||
17088068|NCT00345878|38228147|FG001|Overall Study|Other|0|||
17088069|NCT00335738|38228155|FG000|Overall Study|Physician Decision|6|||
17088070|NCT00335738|38228156|FG001|Overall Study|Physician Decision|0|||
17088071|NCT00335738|38228155|FG000|Overall Study|Withdrawal by Subject|2|||
17088072|NCT00335738|38228156|FG001|Overall Study|Withdrawal by Subject|0|||
17088073|NCT00335738|38228155|FG000|Overall Study|Ineligible|3|||
17088074|NCT00335738|38228156|FG001|Overall Study|Ineligible|4|||
17088075|NCT00334958|38228174|FG000|Overall Study|Medication Noncompliance|0|||
17088076|NCT00334958|38228175|FG001|Overall Study|Medication Noncompliance|3|||
17088077|NCT00334958|38228174|FG000|Overall Study|Protocol Violation|2|||
17174538|NCT01316887|38325134|FG000|Overall Study|Withdrawal by Subject|8|||
17174539|NCT01316887|38325135|FG001|Overall Study|Withdrawal by Subject|16|||
17174540|NCT01316887|38325136|FG002|Overall Study|Withdrawal by Subject|15|||
17174541|NCT02897349|38325147|FG000|Overall Study|Lost to Follow-up|2|||
17174542|NCT02897349|38325148|FG001|Overall Study|Lost to Follow-up|2|||
17174543|NCT02897349|38325147|FG000|Overall Study|Adverse Event|3|||
17174544|NCT02897349|38325148|FG001|Overall Study|Adverse Event|3|||
17174545|NCT02897349|38325147|FG000|Overall Study|Other than listed above|0|||
17174546|NCT02897349|38325148|FG001|Overall Study|Other than listed above|1|||
17174547|NCT03047551|38325156|FG000|Overall Study|Did not receive TAS|1|||
17174548|NCT03047551|38325157|FG001|Overall Study|Did not receive TAS|0|||
17174549|NCT03047551|38325156|FG000|Overall Study|Physician Decision|1|||
17174550|NCT03047551|38325157|FG001|Overall Study|Physician Decision|0|||
17174551|NCT03047551|38325156|FG000|Overall Study|Withdrawal by Subject|0|||
17174552|NCT03047551|38325157|FG001|Overall Study|Withdrawal by Subject|1|||
17174553|NCT03047551|38325156|FG000|Overall Study|Probe malfunction|0|||
17174554|NCT03047551|38325157|FG001|Overall Study|Probe malfunction|1|||
17174555|NCT03047551|38325156|FG000|Overall Study|Ineligible|0|||
17174556|NCT03047551|38325157|FG001|Overall Study|Ineligible|1|||
17174557|NCT02964741|38325166|FG000|Overall Study|Protocol Violation|1|||
17174558|NCT02964741|38325167|FG001|Overall Study|Protocol Violation|0|||
17174559|NCT02964741|38325168|FG002|Overall Study|Protocol Violation|0|||
17174560|NCT02964741|38325166|FG000|Overall Study|Withdrawal by Subject|0|||
17174561|NCT02964741|38325167|FG001|Overall Study|Withdrawal by Subject|1|||
17174562|NCT02964741|38325168|FG002|Overall Study|Withdrawal by Subject|0|||
17174563|NCT02964741|38325166|FG000|Overall Study|claustrophobia|1|||
17174564|NCT02964741|38325167|FG001|Overall Study|claustrophobia|0|||
17174565|NCT02964741|38325168|FG002|Overall Study|claustrophobia|0|||
17174566|NCT01316419|38325174|FG000|Overall Study|Not treated|103|||
17174567|NCT01316419|38325174|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
17174568|NCT01316419|38325174|FG000|Overall Study|Lost to Follow-up|19|||
17174569|NCT02964039|38325181|FG000|Overall Study|Medical reason unrelated to study participation|1|||
17174570|NCT02964039|38325182|FG001|Overall Study|Medical reason unrelated to study participation|0|||
17174571|NCT02964039|38325183|FG002|Overall Study|Medical reason unrelated to study participation|3|||
17174572|NCT02964039|38325181|FG000|Overall Study|Research shutdown due to pandemic|2|||
17174573|NCT02964039|38325182|FG001|Overall Study|Research shutdown due to pandemic|0|||
17174574|NCT02964039|38325183|FG002|Overall Study|Research shutdown due to pandemic|1|||
17174575|NCT02964039|38325181|FG000|Overall Study|Withdrawal by Subject|0|||
17174576|NCT02964039|38325182|FG001|Overall Study|Withdrawal by Subject|1|||
17174577|NCT02964039|38325183|FG002|Overall Study|Withdrawal by Subject|0|||
17174578|NCT02964039|38325181|FG000|Overall Study|Lost to Follow-up|1|||
17174579|NCT02964039|38325182|FG001|Overall Study|Lost to Follow-up|0|||
17174580|NCT02964039|38325183|FG002|Overall Study|Lost to Follow-up|1|||
17174581|NCT02897115|38325193|FG000|Overall Study|Early termination of study by sponsor|11|||
17174582|NCT02897115|38325194|FG001|Overall Study|Early termination of study by sponsor|8|||
17174583|NCT02896569|38325202|FG000|Overall Study|Lost to Follow-up|2|||
17174584|NCT02896569|38325203|FG001|Overall Study|Lost to Follow-up|1|||
17174585|NCT02896569|38325202|FG000|Overall Study|Physician Decision|1|||
17174586|NCT02896569|38325203|FG001|Overall Study|Physician Decision|3|||
17174587|NCT02896569|38325202|FG000|Overall Study|Adverse Event|0|||
17174588|NCT02896569|38325203|FG001|Overall Study|Adverse Event|1|||
17174589|NCT02896569|38325202|FG000|Overall Study|Withdrawal by Subject|1|||
17174590|NCT02896569|38325203|FG001|Overall Study|Withdrawal by Subject|0|||
17174591|NCT04030195|38325212|FG000|Overall Study|Withdrawal by Subject|2|||
17174592|NCT04030195|38325213|FG001|Overall Study|Withdrawal by Subject|0|||
17174593|NCT04030195|38325214|FG002|Overall Study|Withdrawal by Subject|0|||
17174594|NCT01673620|38325225|FG000|Overall Study|Adverse Event|1|||
17174595|NCT01673620|38325226|FG001|Overall Study|Adverse Event|0|||
17088078|NCT00334958|38228175|FG001|Overall Study|Protocol Violation|2|||
17174596|NCT03044197|38325240|FG000|Overall Study|Withdrawal by Subject|3|||
17174597|NCT03044197|38325241|FG001|Overall Study|Withdrawal by Subject|1|||
17174598|NCT03575325|38325260|FG000|Overall Study|Death|1|||
17174599|NCT03043651|38325275|FG000|Overall Study|Death|1|||
17174600|NCT03043651|38325275|FG000|Overall Study|Progressive Disease|2|||
17174601|NCT03043651|38325275|FG000|Overall Study|Adverse Event|2|||
17174602|NCT03043651|38325275|FG000|Overall Study|Withdrawal by Subject|4|||
17174603|NCT03043651|38325275|FG000|Overall Study|Study Terminated by Sponsor|39|||
17174604|NCT03536143|38325279|FG000|Overall Study|Early termination, Sponsor decision|1|||
17174605|NCT01344759|38325289|FG000|Overall Study|Patients failed to reach sedation level|0|||
17174606|NCT01344759|38325290|FG001|Overall Study|Patients failed to reach sedation level|2|||
17174607|NCT04001803|38325306|FG000|Overall Study|Ongoing at the time of analysis|103|||
17174608|NCT04001803|38325306|FG000|Overall Study|Adverse Event|2|||
17088079|NCT00334958|38228174|FG000|Overall Study|Request of the investigator or sponsor|0|||
17088080|NCT00334958|38228175|FG001|Overall Study|Request of the investigator or sponsor|1|||
17088081|NCT00334958|38228174|FG000|Overall Study|Withdrawal by Subject|7|||
17088082|NCT00334958|38228175|FG001|Overall Study|Withdrawal by Subject|4|||
17088083|NCT00334958|38228174|FG000|Overall Study|Adverse Event|27|||
17174609|NCT04001803|38325306|FG000|Overall Study|Protocol Violation|2|||
17174610|NCT04001803|38325306|FG000|Overall Study|Lost to Follow-up|2|||
17174611|NCT04001803|38325306|FG000|Overall Study|Physician Decision|1|||
17174612|NCT04001803|38325306|FG000|Overall Study|Withdrawal by Subject|4|||
17174613|NCT02988661|38325324|FG000|Overall Study|Death|2|||
17174614|NCT02988661|38325325|FG001|Overall Study|Death|18|||
17174615|NCT02988661|38325324|FG000|Overall Study|Lost to Follow-up|0|||
17174616|NCT02988661|38325325|FG001|Overall Study|Lost to Follow-up|33|||
17174617|NCT02988661|38325324|FG000|Overall Study|Withdrawal by Subject|0|||
17174618|NCT02988661|38325325|FG001|Overall Study|Withdrawal by Subject|6|||
17174619|NCT02988661|38325324|FG000|Overall Study|Unable to complete the 18-month survey|1|||
17174620|NCT02988661|38325325|FG001|Overall Study|Unable to complete the 18-month survey|27|||
17174621|NCT03738397|38325333|FG000|Overall Study|Adverse Event|3|||
17174622|NCT03738397|38325334|FG001|Overall Study|Adverse Event|7|||
17174623|NCT03738397|38325333|FG000|Overall Study|Withdrawal by Subject|8|||
17174624|NCT03738397|38325334|FG001|Overall Study|Withdrawal by Subject|11|||
17174625|NCT03738397|38325333|FG000|Overall Study|Lost to Follow-up|8|||
17174626|NCT03738397|38325334|FG001|Overall Study|Lost to Follow-up|5|||
17174627|NCT03738397|38325333|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
17174628|NCT03738397|38325334|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
17174629|NCT03738397|38325333|FG000|Overall Study|Other|4|||
17174630|NCT03738397|38325334|FG001|Overall Study|Other|6|||
17174631|NCT02960217|38325342|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
17174632|NCT02960217|38325343|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
17174633|NCT02960217|38325342|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
17174634|NCT02960217|38325343|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
17174635|NCT02960217|38325342|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
17174636|NCT02960217|38325343|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
17174637|NCT02960217|38325342|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
17174638|NCT02960217|38325343|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
17174639|NCT02960217|38325342|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
17174640|NCT02960217|38325343|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
17174641|NCT02960217|38325342|FG000|Open-Label Extension Phase|Adverse Event|1|||
17174642|NCT02960217|38325343|FG001|Open-Label Extension Phase|Adverse Event|0|||
17174643|NCT02960217|38325342|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
17174644|NCT02960217|38325343|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
17174645|NCT02960217|38325342|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
17174646|NCT02960217|38325343|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
17174647|NCT02960217|38325342|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
17174648|NCT02960217|38325343|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
17174649|NCT02959983|38325355|FG000|Overall Study|Protocol Violation|0|||
17174650|NCT02959983|38325356|FG001|Overall Study|Protocol Violation|1|||
17174651|NCT02959983|38325355|FG000|Overall Study|Lack of Efficacy|0|||
17174652|NCT02959983|38325356|FG001|Overall Study|Lack of Efficacy|1|||
17174653|NCT02959983|38325355|FG000|Overall Study|Lost to Follow-up|12|||
17174654|NCT02959983|38325356|FG001|Overall Study|Lost to Follow-up|9|||
17174655|NCT02959983|38325355|FG000|Overall Study|Other|1|||
17174656|NCT02959983|38325356|FG001|Overall Study|Other|1|||
17174657|NCT02959983|38325355|FG000|Overall Study|Physician Decision|1|||
16781316|NCT02143024|37720477|FG001|Overall Study|Withdrawal by Subject|0|||
17088084|NCT00334958|38228175|FG001|Overall Study|Adverse Event|12|||
17088085|NCT00334958|38228174|FG000|Overall Study|Other|1|||
17088086|NCT00334958|38228175|FG001|Overall Study|Other|2|||
17174658|NCT02959983|38325356|FG001|Overall Study|Physician Decision|0|||
17174659|NCT02959983|38325355|FG000|Overall Study|Adverse Event|5|||
17174660|NCT02959983|38325356|FG001|Overall Study|Adverse Event|1|||
17174661|NCT02959983|38325355|FG000|Overall Study|Withdrawal by Subject|7|||
17088087|NCT00326898|38228184|FG000|Overall Study|Disease progression|52|||
17088088|NCT00326898|38228185|FG001|Overall Study|Disease progression|54|||
17088089|NCT00326898|38228186|FG002|Overall Study|Disease progression|102|||
17174662|NCT02959983|38325356|FG001|Overall Study|Withdrawal by Subject|12|||
17174663|NCT01344447|38325362|FG000|Overall Study|Adverse Event|1|||
17174664|NCT01344447|38325362|FG000|Overall Study|Protocol Violation|1|||
17174665|NCT01344447|38325362|FG000|Overall Study|Withdrawal by Subject|1|||
17174666|NCT01344447|38325362|FG000|Overall Study|The contrast was not seen|1|||
17174667|NCT01344447|38325362|FG000|Overall Study|Physician Decision|1|||
17174668|NCT01344447|38325362|FG000|Overall Study|MRA unsuccessful|1|||
17174669|NCT01344447|38325362|FG000|Overall Study|Bolus tracking failed|1|||
17174670|NCT01344447|38325362|FG000|Overall Study|Error of power injector|1|||
17174671|NCT03513068|38325372|FG000|Overall Study|Death|1|||
17174672|NCT03513068|38325373|FG001|Overall Study|Death|0|||
17174673|NCT03513068|38325372|FG000|Overall Study|Withdrawal by Subject|4|||
17174674|NCT03513068|38325373|FG001|Overall Study|Withdrawal by Subject|6|||
17174675|NCT01344057|38325379|FG000|Overall Study|Premature Withdrawal|1|||
17174676|NCT01348425|38325385|FG000|Overall Study|Imaging was not taken.|1|||
17174677|NCT01348425|38325386|FG001|Overall Study|Imaging was not taken.|1|||
17174678|NCT03041701|38325394|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
17174679|NCT03041701|38325395|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
17174680|NCT03041701|38325396|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
17174681|NCT03041701|38325394|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
17174682|NCT03041701|38325395|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
17174683|NCT03041701|38325396|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
17174684|NCT02956629|38325413|FG000|Overall Study|Adverse Event|0|||
17174685|NCT02956629|38325414|FG001|Overall Study|Adverse Event|0|||
17174686|NCT02956629|38325415|FG002|Overall Study|Adverse Event|1|||
17174687|NCT02956629|38325416|FG003|Overall Study|Adverse Event|0|||
17174688|NCT02956629|38325417|FG004|Overall Study|Adverse Event|0|||
17174689|NCT02956629|38325418|FG005|Overall Study|Adverse Event|0|||
17174690|NCT02956629|38325413|FG000|Overall Study|Lost to Follow-up|2|||
17174691|NCT02956629|38325414|FG001|Overall Study|Lost to Follow-up|5|||
17174692|NCT02956629|38325415|FG002|Overall Study|Lost to Follow-up|3|||
17174693|NCT02956629|38325416|FG003|Overall Study|Lost to Follow-up|1|||
17174694|NCT02956629|38325417|FG004|Overall Study|Lost to Follow-up|0|||
17174695|NCT02956629|38325418|FG005|Overall Study|Lost to Follow-up|1|||
17174696|NCT02956629|38325413|FG000|Overall Study|Withdrawal by Subject|3|||
17174697|NCT02956629|38325414|FG001|Overall Study|Withdrawal by Subject|1|||
17174698|NCT02956629|38325415|FG002|Overall Study|Withdrawal by Subject|0|||
17174699|NCT02956629|38325416|FG003|Overall Study|Withdrawal by Subject|0|||
17174700|NCT02956629|38325417|FG004|Overall Study|Withdrawal by Subject|0|||
17088090|NCT00326898|38228184|FG000|Overall Study|Adverse Event|124|||
17088091|NCT00326898|38228185|FG001|Overall Study|Adverse Event|128|||
17088092|NCT00326898|38228186|FG002|Overall Study|Adverse Event|33|||
17088093|NCT00326898|38228184|FG000|Overall Study|Death|2|||
17088094|NCT00326898|38228185|FG001|Overall Study|Death|0|||
17088095|NCT00326898|38228186|FG002|Overall Study|Death|0|||
17088096|NCT00326898|38228184|FG000|Overall Study|Withdrawal by Subject|134|||
17088097|NCT00326898|38228185|FG001|Overall Study|Withdrawal by Subject|128|||
17088098|NCT00326898|38228186|FG002|Overall Study|Withdrawal by Subject|32|||
17088099|NCT00326898|38228184|FG000|Overall Study|Alternative therapy|1|||
17088100|NCT00326898|38228185|FG001|Overall Study|Alternative therapy|0|||
17088101|NCT00326898|38228186|FG002|Overall Study|Alternative therapy|0|||
17088102|NCT00326898|38228184|FG000|Overall Study|Other complicating disease|5|||
17088103|NCT00326898|38228185|FG001|Overall Study|Other complicating disease|5|||
17088104|NCT00326898|38228186|FG002|Overall Study|Other complicating disease|4|||
17088105|NCT00326898|38228184|FG000|Overall Study|Other/Missing/Unknown|33|||
17088106|NCT00326898|38228185|FG001|Overall Study|Other/Missing/Unknown|28|||
17088107|NCT00326898|38228186|FG002|Overall Study|Other/Missing/Unknown|32|||
17088108|NCT00326118|38228196|FG000|Active Phase|Withdrawal by Subject|4|||
17088109|NCT00326118|38228197|FG001|Active Phase|Withdrawal by Subject|1|||
17088110|NCT00334802|38228206|FG000|Overall Study|Progressive Disease|2|||
17088111|NCT00334802|38228207|FG001|Overall Study|Progressive Disease|24|||
17088112|NCT00334802|38228206|FG000|Overall Study|Toxicity|1|||
17088113|NCT00334802|38228207|FG001|Overall Study|Toxicity|5|||
17088114|NCT00334802|38228206|FG000|Overall Study|Lack of Efficacy|1|||
17088115|NCT00334802|38228207|FG001|Overall Study|Lack of Efficacy|3|||
17088116|NCT00334802|38228206|FG000|Overall Study|Patient Condition Aggrevated|1|||
17174701|NCT02956629|38325418|FG005|Overall Study|Withdrawal by Subject|0|||
17174702|NCT01348347|38325435|FG000|Overall Study|Withdrawal by Subject|1|||
17174703|NCT01348347|38325436|FG001|Overall Study|Withdrawal by Subject|1|||
17174704|NCT01348347|38325437|FG002|Overall Study|Withdrawal by Subject|1|||
17174705|NCT01348347|38325435|FG000|Overall Study|Progressive disease|2|||
17174706|NCT01348347|38325436|FG001|Overall Study|Progressive disease|5|||
17174707|NCT01348347|38325437|FG002|Overall Study|Progressive disease|5|||
17174708|NCT02959671|38325446|FG000|Overall Study|Adverse Event|2|||
17174709|NCT02959671|38325446|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
17174710|NCT01597258|38325450|FG000|Overall Study|No Drug Administration|1|||
17174711|NCT02958267|38325456|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
17174712|NCT02958267|38325457|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
17174713|NCT02958267|38325456|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
17174714|NCT02958267|38325457|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
17174715|NCT02958267|38325456|FG000|Follow-up Visits|Additional treatment pursued|2|||
17174716|NCT02958267|38325457|FG001|Follow-up Visits|Additional treatment pursued|1|||
17174717|NCT01952574|38325467|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
17174718|NCT01952574|38325468|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
17174719|NCT01952574|38325469|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
17174720|NCT01952574|38325470|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
17174721|NCT01952574|38325471|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
17174722|NCT01952574|38325472|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
17174723|NCT01952574|38325473|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
17174724|NCT01952574|38325467|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
17174725|NCT01952574|38325468|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
17174726|NCT01952574|38325469|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
17174727|NCT01952574|38325470|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
17174728|NCT01952574|38325471|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
17174729|NCT01952574|38325472|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
17174730|NCT01952574|38325473|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
17174731|NCT01952574|38325467|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
17174732|NCT01952574|38325468|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
17174733|NCT01952574|38325469|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
17174734|NCT01952574|38325470|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
17174735|NCT01952574|38325471|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
17174736|NCT01952574|38325472|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
17174737|NCT01952574|38325473|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
17174738|NCT01952574|38325467|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
17174739|NCT01952574|38325468|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
17174740|NCT01952574|38325469|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
17174741|NCT01952574|38325470|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
17174742|NCT01952574|38325471|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
17174743|NCT01952574|38325472|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
17174744|NCT01952574|38325473|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
17174745|NCT01952574|38325467|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
17174746|NCT01952574|38325468|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
17174747|NCT01952574|38325469|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
17174748|NCT01952574|38325470|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
17174749|NCT01952574|38325471|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
17174750|NCT01952574|38325472|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
17174751|NCT01952574|38325473|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
17174752|NCT01952574|38325467|FG000|Open-label Treatment Phase|Missing|0|||
17174753|NCT01952574|38325468|FG001|Open-label Treatment Phase|Missing|0|||
17174754|NCT01952574|38325469|FG002|Open-label Treatment Phase|Missing|0|||
17174755|NCT01952574|38325470|FG003|Open-label Treatment Phase|Missing|0|||
17174756|NCT01952574|38325471|FG004|Open-label Treatment Phase|Missing|4|||
17174757|NCT01952574|38325472|FG005|Open-label Treatment Phase|Missing|0|||
17174758|NCT01952574|38325473|FG006|Open-label Treatment Phase|Missing|0|||
17174759|NCT01952574|38325467|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
17174760|NCT01952574|38325468|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
17174761|NCT01952574|38325469|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
17088117|NCT00334802|38228207|FG001|Overall Study|Patient Condition Aggrevated|0|||
17088118|NCT00334802|38228206|FG000|Overall Study|Physician Decision|1|||
17088119|NCT00334802|38228207|FG001|Overall Study|Physician Decision|0|||
17088120|NCT00334802|38228206|FG000|Overall Study|Withdrawal by Subject|0|||
17088121|NCT00334802|38228207|FG001|Overall Study|Withdrawal by Subject|4|||
17088122|NCT00334802|38228206|FG000|Overall Study|Adverse Event|0|||
17088123|NCT00334802|38228207|FG001|Overall Study|Adverse Event|3|||
17088124|NCT00334802|38228206|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
17088125|NCT00334802|38228207|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
17088126|NCT00307164|38228218|FG000|Overall Study|Death|1|||
17174762|NCT01952574|38325470|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
17174763|NCT01952574|38325471|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
17174764|NCT01952574|38325472|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
17174765|NCT01952574|38325473|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
17174766|NCT01952574|38325467|FG000|Open-label Treatment Phase|Death|0|||
17174767|NCT01952574|38325468|FG001|Open-label Treatment Phase|Death|0|||
17174768|NCT01952574|38325469|FG002|Open-label Treatment Phase|Death|0|||
17174769|NCT01952574|38325470|FG003|Open-label Treatment Phase|Death|0|||
17174770|NCT01952574|38325471|FG004|Open-label Treatment Phase|Death|1|||
17174771|NCT01952574|38325472|FG005|Open-label Treatment Phase|Death|0|||
17174772|NCT01952574|38325473|FG006|Open-label Treatment Phase|Death|0|||
17174773|NCT01952574|38325467|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
17174774|NCT01952574|38325468|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
17174775|NCT01952574|38325469|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
17174776|NCT01952574|38325470|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
17174777|NCT01952574|38325471|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
17174778|NCT01952574|38325472|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
17174779|NCT01952574|38325473|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
17174780|NCT01952574|38325467|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
17174781|NCT01952574|38325468|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
17174782|NCT01952574|38325469|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
17174783|NCT01952574|38325470|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
17174784|NCT01952574|38325471|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
17174785|NCT01952574|38325472|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
17174786|NCT01952574|38325473|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
17174787|NCT02959437|38325502|FG000|Overall Study|Death|33|||
17174788|NCT02959437|38325503|FG001|Overall Study|Death|3|||
17174789|NCT02959437|38325504|FG002|Overall Study|Death|0|||
17174790|NCT02959437|38325505|FG003|Overall Study|Death|0|||
17174791|NCT02959437|38325502|FG000|Overall Study|Lost to Follow-up|3|||
17174792|NCT02959437|38325503|FG001|Overall Study|Lost to Follow-up|1|||
17174793|NCT02959437|38325504|FG002|Overall Study|Lost to Follow-up|0|||
17174794|NCT02959437|38325505|FG003|Overall Study|Lost to Follow-up|0|||
17174795|NCT02959437|38325502|FG000|Overall Study|Withdrawal by Subject|11|||
17174796|NCT02959437|38325503|FG001|Overall Study|Withdrawal by Subject|3|||
17174797|NCT02959437|38325504|FG002|Overall Study|Withdrawal by Subject|0|||
17174798|NCT02959437|38325505|FG003|Overall Study|Withdrawal by Subject|0|||
17174799|NCT02959437|38325502|FG000|Overall Study|Progressive Disease|9|||
17174800|NCT02959437|38325503|FG001|Overall Study|Progressive Disease|1|||
17174801|NCT02959437|38325504|FG002|Overall Study|Progressive Disease|0|||
17174802|NCT02959437|38325505|FG003|Overall Study|Progressive Disease|0|||
17174803|NCT02959437|38325502|FG000|Overall Study|Study Terminated by Sponsor|4|||
17174804|NCT02959437|38325503|FG001|Overall Study|Study Terminated by Sponsor|0|||
17174805|NCT02959437|38325504|FG002|Overall Study|Study Terminated by Sponsor|0|||
17174806|NCT02959437|38325505|FG003|Overall Study|Study Terminated by Sponsor|0|||
17174807|NCT02959437|38325502|FG000|Overall Study|Other Unspecified|2|||
17174808|NCT02959437|38325503|FG001|Overall Study|Other Unspecified|0|||
17174809|NCT02959437|38325504|FG002|Overall Study|Other Unspecified|0|||
17174810|NCT02959437|38325505|FG003|Overall Study|Other Unspecified|0|||
17174811|NCT02957331|38325518|FG000|Overall Study|Protocol Violation|1|||
17174812|NCT02957331|38325519|FG001|Overall Study|Protocol Violation|0|||
17174813|NCT02646124|38325527|FG000|Overall Study|Lost to Follow-up|0|||
17174814|NCT02646124|38325528|FG001|Overall Study|Lost to Follow-up|2|||
17174815|NCT03041467|38325536|FG000|Overall Study|Death|36|||
17174816|NCT03041467|38325537|FG001|Overall Study|Death|32|||
17174817|NCT03041467|38325536|FG000|Overall Study|Withdrawal by Subject|26|||
17174818|NCT03041467|38325537|FG001|Overall Study|Withdrawal by Subject|28|||
17174819|NCT03041467|38325536|FG000|Overall Study|Lost to Follow-up|6|||
17174820|NCT03041467|38325537|FG001|Overall Study|Lost to Follow-up|7|||
17088127|NCT00307164|38228219|FG001|Overall Study|Death|0|||
17088128|NCT00307164|38228218|FG000|Overall Study|Severe debilitation, unable to continue|1|||
17088129|NCT00307164|38228219|FG001|Overall Study|Severe debilitation, unable to continue|0|||
17088130|NCT00307164|38228218|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
17088131|NCT00307164|38228219|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
17088132|NCT00307164|38228218|FG000|Overall Study|Withdrawal by Subject|1|||
17088133|NCT00307164|38228219|FG001|Overall Study|Withdrawal by Subject|8|||
17088134|NCT00307164|38228218|FG000|Overall Study|Not compliant with requirements|4|||
17088135|NCT00307164|38228219|FG001|Overall Study|Not compliant with requirements|4|||
17088136|NCT00307164|38228218|FG000|Overall Study|Lost to Follow-up|6|||
17088137|NCT00307164|38228219|FG001|Overall Study|Lost to Follow-up|1|||
17088138|NCT03827564|38228227|FG000|Overall Study|Discontinued due to Study Termination|1|||
17088139|NCT03827564|38228228|FG001|Overall Study|Discontinued due to Study Termination|0|||
17174821|NCT03041467|38325536|FG000|Overall Study|Declined consent for study extension|21|||
17174822|NCT03041467|38325537|FG001|Overall Study|Declined consent for study extension|33|||
17174823|NCT03041467|38325536|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
17174824|NCT03041467|38325537|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
17174825|NCT03041467|38325536|FG000|Overall Study|36 Month visit not completed|2|||
17174826|NCT03041467|38325537|FG001|Overall Study|36 Month visit not completed|0|||
17174827|NCT01597492|38325547|FG000|Overall Study|Withdrawal by Subject|1|||
17174828|NCT01597492|38325548|FG001|Overall Study|Withdrawal by Subject|2|||
17174829|NCT01597492|38325547|FG000|Overall Study|Adverse Event|3|||
17174830|NCT01597492|38325548|FG001|Overall Study|Adverse Event|0|||
17174831|NCT01597492|38325547|FG000|Overall Study|Lost to Follow-up|0|||
17174832|NCT01597492|38325548|FG001|Overall Study|Lost to Follow-up|2|||
17174833|NCT01597492|38325547|FG000|Overall Study|Other Reason|2|||
17174834|NCT01597492|38325548|FG001|Overall Study|Other Reason|0|||
17174835|NCT03423602|38325554|FG000|Overall Study|Death|1|||
17174836|NCT03423602|38325554|FG000|Overall Study|Lost to Follow-up|6|||
17174837|NCT03423602|38325554|FG000|Overall Study|Protocol Violation|1|||
17174838|NCT03423602|38325554|FG000|Overall Study|Withdrawal by Subject|4|||
17174839|NCT00109590|38325561|FG000|Overall Study|Lost to Follow-up|1|||
17174840|NCT00109590|38325562|FG001|Overall Study|Lost to Follow-up|0|||
17174841|NCT00109590|38325563|FG002|Overall Study|Lost to Follow-up|1|||
17174842|NCT00109590|38325561|FG000|Overall Study|Never Started Treatment|1|||
17174843|NCT00109590|38325562|FG001|Overall Study|Never Started Treatment|2|||
17174844|NCT00109590|38325563|FG002|Overall Study|Never Started Treatment|3|||
17174845|NCT02781558|38325587|FG000|Overall Study|Lost to Follow-up|2|||
17174846|NCT02781558|38325588|FG001|Overall Study|Lost to Follow-up|2|||
17174847|NCT02781558|38325587|FG000|Overall Study|Adverse Event|1|||
17174848|NCT02781558|38325588|FG001|Overall Study|Adverse Event|0|||
17174849|NCT03041311|38325597|FG000|Overall Study|Death|39|||
17174850|NCT03041311|38325598|FG001|Overall Study|Death|42|||
17174851|NCT03041311|38325597|FG000|Overall Study|Lost to Follow-up|0|||
17174852|NCT03041311|38325598|FG001|Overall Study|Lost to Follow-up|1|||
17174853|NCT03041311|38325597|FG000|Overall Study|Withdrawal by Subject|8|||
17174854|NCT03041311|38325598|FG001|Overall Study|Withdrawal by Subject|5|||
17174855|NCT03041311|38325597|FG000|Overall Study|Sponsor Terminated Study|2|||
17174856|NCT03041311|38325598|FG001|Overall Study|Sponsor Terminated Study|4|||
17174857|NCT03041311|38325597|FG000|Overall Study|Disease Progression|3|||
17174858|NCT03041311|38325598|FG001|Overall Study|Disease Progression|1|||
17174859|NCT03041311|38325597|FG000|Overall Study|Randomized in error, did not receive drug|2|||
17174860|NCT03041311|38325598|FG001|Overall Study|Randomized in error, did not receive drug|0|||
17174861|NCT02644096|38325614|FG000|Overall Study|Withdrawal by Subject|28|||
17174862|NCT02644096|38325615|FG001|Overall Study|Withdrawal by Subject|25|||
17174863|NCT02643628|38325623|FG000|Overall Study|Lost to Follow-up|1|||
17174864|NCT02643628|38325624|FG001|Overall Study|Lost to Follow-up|4|||
17174865|NCT02643628|38325623|FG000|Overall Study|Withdrawal by Subject|0|||
17174866|NCT02643628|38325624|FG001|Overall Study|Withdrawal by Subject|1|||
17174867|NCT02643628|38325623|FG000|Overall Study|Relocated out of state|0|||
17174868|NCT02643628|38325624|FG001|Overall Study|Relocated out of state|1|||
17174869|NCT02643472|38325634|FG000|Overall Study|Death|2|||
17174870|NCT02643472|38325635|FG001|Overall Study|Death|5|||
17174871|NCT02643472|38325634|FG000|Overall Study|Withdrawal by Subject|3|||
17174872|NCT02643472|38325635|FG001|Overall Study|Withdrawal by Subject|2|||
17174873|NCT02643472|38325634|FG000|Overall Study|Protocol Violation|0|||
17174874|NCT02643472|38325635|FG001|Overall Study|Protocol Violation|1|||
17174875|NCT02643472|38325634|FG000|Overall Study|Lost to Follow-up|22|||
17174876|NCT02643472|38325635|FG001|Overall Study|Lost to Follow-up|26|||
17088140|NCT00307086|38228234|FG000|Overall Study|ineligible|5|||
17088141|NCT00325416|38228240|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
17174877|NCT02738840|38325643|FG000|Overall Study|MRI Scan not Performed|5|||
17174878|NCT02738840|38325643|FG000|Overall Study|Lost to Follow-up|1|||
17174879|NCT02738840|38325643|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
17174880|NCT02738840|38325643|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
17174881|NCT03569293|38325653|FG000|Overall Study|Adverse Event|4|||
17174882|NCT03569293|38325654|FG001|Overall Study|Adverse Event|1|||
17174883|NCT03569293|38325655|FG002|Overall Study|Adverse Event|5|||
17174884|NCT03569293|38325656|FG003|Overall Study|Adverse Event|1|||
17174885|NCT03569293|38325657|FG004|Overall Study|Adverse Event|0|||
17174886|NCT03569293|38325658|FG005|Overall Study|Adverse Event|0|||
17174887|NCT03569293|38325653|FG000|Overall Study|Withdrawal by Subject|16|||
17088142|NCT00325416|38228241|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
17088143|NCT00325416|38228240|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
17088144|NCT00325416|38228241|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
17088145|NCT00325416|38228240|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
17088146|NCT00325416|38228241|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
17088147|NCT00325416|38228240|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
17174888|NCT03569293|38325654|FG001|Overall Study|Withdrawal by Subject|2|||
17174889|NCT03569293|38325655|FG002|Overall Study|Withdrawal by Subject|4|||
17174890|NCT03569293|38325656|FG003|Overall Study|Withdrawal by Subject|1|||
17174891|NCT03569293|38325657|FG004|Overall Study|Withdrawal by Subject|0|||
17174892|NCT03569293|38325658|FG005|Overall Study|Withdrawal by Subject|0|||
17174893|NCT03569293|38325653|FG000|Overall Study|Lost to Follow-up|1|||
17174894|NCT03569293|38325654|FG001|Overall Study|Lost to Follow-up|3|||
17174895|NCT03569293|38325655|FG002|Overall Study|Lost to Follow-up|1|||
17174896|NCT03569293|38325656|FG003|Overall Study|Lost to Follow-up|1|||
17174897|NCT03569293|38325657|FG004|Overall Study|Lost to Follow-up|0|||
17174898|NCT03569293|38325658|FG005|Overall Study|Lost to Follow-up|0|||
17174899|NCT03569293|38325653|FG000|Overall Study|Other|8|||
17174900|NCT03569293|38325654|FG001|Overall Study|Other|2|||
17174901|NCT03569293|38325655|FG002|Overall Study|Other|1|||
17174902|NCT03569293|38325656|FG003|Overall Study|Other|1|||
17174903|NCT03569293|38325657|FG004|Overall Study|Other|0|||
17174904|NCT03569293|38325658|FG005|Overall Study|Other|0|||
17174905|NCT03569293|38325653|FG000|Overall Study|Ongoing at Time of Analysis|8|||
17174906|NCT03569293|38325654|FG001|Overall Study|Ongoing at Time of Analysis|1|||
17174907|NCT03569293|38325655|FG002|Overall Study|Ongoing at Time of Analysis|3|||
17174908|NCT03569293|38325656|FG003|Overall Study|Ongoing at Time of Analysis|0|||
17174909|NCT03569293|38325657|FG004|Overall Study|Ongoing at Time of Analysis|0|||
17174910|NCT03569293|38325658|FG005|Overall Study|Ongoing at Time of Analysis|0|||
17174911|NCT02643394|38325683|FG000|Overall Study|Protocol Violation|4|||
17174912|NCT02643394|38325684|FG001|Overall Study|Protocol Violation|5|||
17174913|NCT03538158|38325692|FG000|Overall Study|Lost to Follow-up|13|||
17174914|NCT03538158|38325693|FG001|Overall Study|Lost to Follow-up|7|||
17174915|NCT03538158|38325692|FG000|Overall Study|Withdrawal by Subject|2|||
17174916|NCT03538158|38325693|FG001|Overall Study|Withdrawal by Subject|1|||
17174917|NCT02643082|38325699|FG000|Period 1|Adverse Event|1|||
17174918|NCT02643082|38325700|FG001|Period 1|Adverse Event|0|||
17174919|NCT00353496|38325709|FG000|Overall Study|Adverse Event|1|||
17174920|NCT00353496|38325710|FG001|Overall Study|Adverse Event|0|||
17174921|NCT00353496|38325709|FG000|Overall Study|Protocol Violation|2|||
17174922|NCT00353496|38325710|FG001|Overall Study|Protocol Violation|2|||
17174923|NCT00353496|38325709|FG000|Overall Study|Withdrawal by Subject|3|||
17174924|NCT00353496|38325710|FG001|Overall Study|Withdrawal by Subject|4|||
17088148|NCT00325416|38228241|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
17088149|NCT00325416|38228240|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
17088150|NCT00325416|38228241|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
17088151|NCT00325416|38228240|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
17088152|NCT00325416|38228241|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
17088153|NCT00314808|38228247|FG000|Overall Study|Disease Progression without AE|4|||
17088154|NCT00314808|38228247|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
17088155|NCT00314574|38228253|FG000|Overall Study|Death|3|||
17174925|NCT00353496|38325709|FG000|Overall Study|Physician Decision|6|||
17174926|NCT00353496|38325710|FG001|Overall Study|Physician Decision|9|||
17174927|NCT00353496|38325709|FG000|Overall Study|Not otherwise specified|4|||
17174928|NCT00353496|38325710|FG001|Overall Study|Not otherwise specified|2|||
17174929|NCT01361464|38325726|FG000|Overall Study|Death|1|||
17174930|NCT01361464|38325726|FG000|Overall Study|Withdrawal by Subject|2|||
17174931|NCT03486912|38325734|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
17174932|NCT03486912|38325735|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
17174933|NCT03486912|38325736|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
17174934|NCT03486912|38325737|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
17174935|NCT03486912|38325734|FG000|Treatment Period|Withdrawal by Subject|3|||
17174936|NCT03486912|38325735|FG001|Treatment Period|Withdrawal by Subject|3|||
17174937|NCT03486912|38325736|FG002|Treatment Period|Withdrawal by Subject|3|||
17174938|NCT03486912|38325737|FG003|Treatment Period|Withdrawal by Subject|2|||
17174939|NCT03486912|38325734|FG000|Treatment Period|Other Reasons|0|||
17174940|NCT03486912|38325735|FG001|Treatment Period|Other Reasons|2|||
17174941|NCT03486912|38325736|FG002|Treatment Period|Other Reasons|1|||
17174942|NCT03486912|38325737|FG003|Treatment Period|Other Reasons|1|||
17174943|NCT03486912|38325734|FG000|Treatment Period|Adverse Event|0|||
17174944|NCT03486912|38325735|FG001|Treatment Period|Adverse Event|1|||
17174945|NCT03486912|38325736|FG002|Treatment Period|Adverse Event|1|||
17174946|NCT03486912|38325737|FG003|Treatment Period|Adverse Event|0|||
17174947|NCT03486912|38325734|FG000|Treatment Period|Lost to Follow-up|1|||
17174948|NCT03486912|38325735|FG001|Treatment Period|Lost to Follow-up|0|||
17174949|NCT03486912|38325736|FG002|Treatment Period|Lost to Follow-up|0|||
17174950|NCT03486912|38325737|FG003|Treatment Period|Lost to Follow-up|2|||
17174951|NCT03345342|38325747|FG000|Open-Label Phase|Adverse Event|30|||
17174952|NCT03345342|38325748|FG001|Open-Label Phase|Adverse Event|0|||
17174953|NCT03345342|38325749|FG002|Open-Label Phase|Adverse Event|0|||
17174954|NCT03345342|38325750|FG003|Open-Label Phase|Adverse Event|0|||
17174955|NCT03345342|38325751|FG004|Open-Label Phase|Adverse Event|0|||
17174956|NCT03345342|38325747|FG000|Open-Label Phase|Death|1|||
17174957|NCT03345342|38325748|FG001|Open-Label Phase|Death|0|||
17174958|NCT03345342|38325749|FG002|Open-Label Phase|Death|0|||
17174959|NCT03345342|38325750|FG003|Open-Label Phase|Death|0|||
17174960|NCT03345342|38325751|FG004|Open-Label Phase|Death|0|||
17174961|NCT03345342|38325747|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
17174962|NCT03345342|38325748|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
17174963|NCT03345342|38325749|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
17174964|NCT03345342|38325750|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
17174965|NCT03345342|38325751|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
17174966|NCT03345342|38325747|FG000|Open-Label Phase|Lack of Efficacy|6|||
17174967|NCT03345342|38325748|FG001|Open-Label Phase|Lack of Efficacy|0|||
17174968|NCT03345342|38325749|FG002|Open-Label Phase|Lack of Efficacy|0|||
17174969|NCT03345342|38325750|FG003|Open-Label Phase|Lack of Efficacy|0|||
17174970|NCT03345342|38325751|FG004|Open-Label Phase|Lack of Efficacy|0|||
17088156|NCT00314574|38228254|FG001|Overall Study|Death|0|||
17088157|NCT00314574|38228253|FG000|Overall Study|Adverse Event|11|||
17088158|NCT00314574|38228254|FG001|Overall Study|Adverse Event|16|||
17088159|NCT00314574|38228253|FG000|Overall Study|Lost to Follow-up|19|||
17088160|NCT00314574|38228254|FG001|Overall Study|Lost to Follow-up|25|||
17088161|NCT00314574|38228253|FG000|Overall Study|Withdrawal by Subject|33|||
17088162|NCT00314574|38228254|FG001|Overall Study|Withdrawal by Subject|22|||
17088163|NCT00314574|38228253|FG000|Overall Study|Physician Decision|22|||
17174971|NCT03345342|38325747|FG000|Open-Label Phase|Lost to Follow-up|9|||
17174972|NCT03345342|38325748|FG001|Open-Label Phase|Lost to Follow-up|0|||
17174973|NCT03345342|38325749|FG002|Open-Label Phase|Lost to Follow-up|0|||
17174974|NCT03345342|38325750|FG003|Open-Label Phase|Lost to Follow-up|0|||
17174975|NCT03345342|38325751|FG004|Open-Label Phase|Lost to Follow-up|0|||
17174976|NCT03345342|38325747|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
17174977|NCT03345342|38325748|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
17174978|NCT03345342|38325749|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
17174979|NCT03345342|38325750|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
17174980|NCT03345342|38325751|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
17174981|NCT03345342|38325747|FG000|Open-Label Phase|Physician Decision|4|||
17174982|NCT03345342|38325748|FG001|Open-Label Phase|Physician Decision|0|||
17174983|NCT03345342|38325749|FG002|Open-Label Phase|Physician Decision|0|||
17174984|NCT03345342|38325750|FG003|Open-Label Phase|Physician Decision|0|||
17174985|NCT03345342|38325751|FG004|Open-Label Phase|Physician Decision|0|||
17174986|NCT03345342|38325747|FG000|Open-Label Phase|Protocol Violation|8|||
17174987|NCT03345342|38325748|FG001|Open-Label Phase|Protocol Violation|0|||
17174988|NCT03345342|38325749|FG002|Open-Label Phase|Protocol Violation|0|||
17174989|NCT03345342|38325750|FG003|Open-Label Phase|Protocol Violation|0|||
17174990|NCT03345342|38325751|FG004|Open-Label Phase|Protocol Violation|0|||
17174991|NCT03345342|38325747|FG000|Open-Label Phase|Withdrawal by Subject|57|||
17174992|NCT03345342|38325748|FG001|Open-Label Phase|Withdrawal by Subject|0|||
17174993|NCT03345342|38325749|FG002|Open-Label Phase|Withdrawal by Subject|0|||
17174994|NCT03345342|38325750|FG003|Open-Label Phase|Withdrawal by Subject|0|||
17174995|NCT03345342|38325751|FG004|Open-Label Phase|Withdrawal by Subject|0|||
17174996|NCT03345342|38325747|FG000|Open-Label Phase|Other|15|||
17174997|NCT03345342|38325748|FG001|Open-Label Phase|Other|0|||
17174998|NCT03345342|38325749|FG002|Open-Label Phase|Other|0|||
17174999|NCT03345342|38325750|FG003|Open-Label Phase|Other|0|||
17175000|NCT03345342|38325751|FG004|Open-Label Phase|Other|0|||
17175001|NCT03345342|38325747|FG000|Double-Blind Phase|Adverse Event|0|||
17175002|NCT03345342|38325748|FG001|Double-Blind Phase|Adverse Event|1|||
17175003|NCT03345342|38325749|FG002|Double-Blind Phase|Adverse Event|6|||
17175004|NCT03345342|38325750|FG003|Double-Blind Phase|Adverse Event|0|||
17175005|NCT03345342|38325751|FG004|Double-Blind Phase|Adverse Event|0|||
17175006|NCT03345342|38325747|FG000|Double-Blind Phase|Death|0|||
17175007|NCT03345342|38325748|FG001|Double-Blind Phase|Death|2|||
17175008|NCT03345342|38325749|FG002|Double-Blind Phase|Death|1|||
17175009|NCT03345342|38325750|FG003|Double-Blind Phase|Death|0|||
17175010|NCT03345342|38325751|FG004|Double-Blind Phase|Death|0|||
17175011|NCT03345342|38325747|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
17175012|NCT03345342|38325748|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
17175013|NCT03345342|38325749|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
17175014|NCT03345342|38325750|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
17175015|NCT03345342|38325751|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
17175016|NCT03345342|38325747|FG000|Double-Blind Phase|Lost to Follow-up|0|||
17175017|NCT03345342|38325748|FG001|Double-Blind Phase|Lost to Follow-up|1|||
17175018|NCT03345342|38325749|FG002|Double-Blind Phase|Lost to Follow-up|7|||
17175019|NCT03345342|38325750|FG003|Double-Blind Phase|Lost to Follow-up|0|||
17175020|NCT03345342|38325751|FG004|Double-Blind Phase|Lost to Follow-up|0|||
17175021|NCT03345342|38325747|FG000|Double-Blind Phase|Physician Decision|0|||
17175022|NCT03345342|38325748|FG001|Double-Blind Phase|Physician Decision|1|||
17175023|NCT03345342|38325749|FG002|Double-Blind Phase|Physician Decision|4|||
17175024|NCT03345342|38325750|FG003|Double-Blind Phase|Physician Decision|0|||
17175025|NCT03345342|38325751|FG004|Double-Blind Phase|Physician Decision|0|||
17175026|NCT03345342|38325747|FG000|Double-Blind Phase|Protocol Violation|0|||
17175027|NCT03345342|38325748|FG001|Double-Blind Phase|Protocol Violation|0|||
17175028|NCT03345342|38325749|FG002|Double-Blind Phase|Protocol Violation|1|||
17175029|NCT03345342|38325750|FG003|Double-Blind Phase|Protocol Violation|0|||
17175030|NCT03345342|38325751|FG004|Double-Blind Phase|Protocol Violation|0|||
17175031|NCT03345342|38325747|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
17175032|NCT03345342|38325748|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
17175033|NCT03345342|38325749|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
17175034|NCT03345342|38325750|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
17175035|NCT03345342|38325751|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
17175036|NCT03345342|38325747|FG000|Double-Blind Phase|Other|0|||
17175037|NCT03345342|38325748|FG001|Double-Blind Phase|Other|1|||
17175038|NCT03345342|38325749|FG002|Double-Blind Phase|Other|3|||
17175039|NCT03345342|38325750|FG003|Double-Blind Phase|Other|0|||
17175040|NCT03345342|38325751|FG004|Double-Blind Phase|Other|0|||
17175041|NCT03345342|38325747|FG000|Follow-Up Phase|Adverse Event|0|||
17175042|NCT03345342|38325748|FG001|Follow-Up Phase|Adverse Event|0|||
17175043|NCT03345342|38325749|FG002|Follow-Up Phase|Adverse Event|0|||
17175044|NCT03345342|38325750|FG003|Follow-Up Phase|Adverse Event|0|||
17175045|NCT03345342|38325751|FG004|Follow-Up Phase|Adverse Event|4|||
17175046|NCT03345342|38325747|FG000|Follow-Up Phase|Lost to Follow-up|0|||
17175047|NCT03345342|38325748|FG001|Follow-Up Phase|Lost to Follow-up|0|||
17175048|NCT03345342|38325749|FG002|Follow-Up Phase|Lost to Follow-up|0|||
17175049|NCT03345342|38325750|FG003|Follow-Up Phase|Lost to Follow-up|0|||
17175050|NCT03345342|38325751|FG004|Follow-Up Phase|Lost to Follow-up|6|||
17175051|NCT03345342|38325747|FG000|Follow-Up Phase|Physician Decision|0|||
17175052|NCT03345342|38325748|FG001|Follow-Up Phase|Physician Decision|0|||
17175053|NCT03345342|38325749|FG002|Follow-Up Phase|Physician Decision|0|||
17175054|NCT03345342|38325750|FG003|Follow-Up Phase|Physician Decision|0|||
17175055|NCT03345342|38325751|FG004|Follow-Up Phase|Physician Decision|5|||
17175056|NCT03345342|38325747|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
17175057|NCT03345342|38325748|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
17175058|NCT03345342|38325749|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
17175059|NCT03345342|38325750|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
17175060|NCT03345342|38325751|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
17175061|NCT03345342|38325747|FG000|Follow-Up Phase|Other|0|||
17175062|NCT03345342|38325748|FG001|Follow-Up Phase|Other|0|||
17175063|NCT03345342|38325749|FG002|Follow-Up Phase|Other|0|||
17175064|NCT03345342|38325750|FG003|Follow-Up Phase|Other|3|||
17175065|NCT03345342|38325751|FG004|Follow-Up Phase|Other|1|||
17175066|NCT02642614|38325767|FG000|Overall Study|Adverse Event|1|||
17175067|NCT02642614|38325768|FG001|Overall Study|Adverse Event|1|||
17175068|NCT02642614|38325769|FG002|Overall Study|Adverse Event|2|||
17175069|NCT02642614|38325770|FG003|Overall Study|Adverse Event|2|||
17175070|NCT02642614|38325767|FG000|Overall Study|Lost to Follow-up|1|||
17175071|NCT02642614|38325768|FG001|Overall Study|Lost to Follow-up|0|||
17175072|NCT02642614|38325769|FG002|Overall Study|Lost to Follow-up|0|||
17175073|NCT02642614|38325770|FG003|Overall Study|Lost to Follow-up|0|||
17175074|NCT02642614|38325767|FG000|Overall Study|Withdrawal by Subject|1|||
17175075|NCT02642614|38325768|FG001|Overall Study|Withdrawal by Subject|1|||
17175076|NCT02642614|38325769|FG002|Overall Study|Withdrawal by Subject|0|||
17175077|NCT02642614|38325770|FG003|Overall Study|Withdrawal by Subject|0|||
17175078|NCT02781324|38325785|FG000|Overall Study|Withdrawal by Subject|1|||
17175079|NCT02781324|38325786|FG001|Overall Study|Withdrawal by Subject|0|||
17175080|NCT02781324|38325785|FG000|Overall Study|Physician Decision|1|||
17175081|NCT02781324|38325786|FG001|Overall Study|Physician Decision|2|||
17175082|NCT03292146|38325796|FG000|Baseline to 12 Months|Relocation|1|||
17175083|NCT03292146|38325797|FG001|Baseline to 12 Months|Relocation|0|||
17175084|NCT03292146|38325796|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
17175085|NCT03292146|38325797|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
17175086|NCT03292146|38325796|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
17175087|NCT03292146|38325797|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
17175088|NCT03292146|38325796|FG000|12 Months to 24 Months|Planning pregnancy|2|||
17175089|NCT03292146|38325797|FG001|12 Months to 24 Months|Planning pregnancy|2|||
17175090|NCT03292146|38325796|FG000|12 Months to 24 Months|Personal reasons|1|||
17175091|NCT03292146|38325797|FG001|12 Months to 24 Months|Personal reasons|0|||
17175092|NCT03292146|38325796|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
17175093|NCT03292146|38325797|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
17175094|NCT01360996|38325806|FG000|Overall Study|Withdrawal by Subject|4|||
17175095|NCT01360996|38325807|FG001|Overall Study|Withdrawal by Subject|3|||
17175096|NCT01360996|38325808|FG002|Overall Study|Withdrawal by Subject|2|||
17175097|NCT01360996|38325806|FG000|Overall Study|Noncompliant|2|||
17175098|NCT01360996|38325807|FG001|Overall Study|Noncompliant|0|||
17175099|NCT01360996|38325808|FG002|Overall Study|Noncompliant|0|||
17175100|NCT01951885|38325817|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
17175101|NCT01951885|38325818|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
17175102|NCT01951885|38325817|FG000|Overall Study|Adverse Event|1|||
17175103|NCT01951885|38325818|FG001|Overall Study|Adverse Event|0|||
17175104|NCT01951885|38325817|FG000|Overall Study|Withdrawal by Subject|0|||
17175105|NCT01951885|38325818|FG001|Overall Study|Withdrawal by Subject|1|||
17175106|NCT01951885|38325817|FG000|Overall Study|ineligible due to a change in donor|0|||
17175107|NCT01951885|38325818|FG001|Overall Study|ineligible due to a change in donor|1|||
17175108|NCT01951885|38325817|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
17175109|NCT01951885|38325818|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
17175110|NCT02639338|38325826|FG000|Overall Study|Lost to Follow-up|2|||
17175111|NCT02639338|38325827|FG001|Overall Study|Lost to Follow-up|2|||
17175112|NCT02639338|38325826|FG000|Overall Study|Withdrew Consent|1|||
17175113|NCT02639338|38325827|FG001|Overall Study|Withdrew Consent|2|||
17175114|NCT02639338|38325826|FG000|Overall Study|Death|1|||
17175115|NCT02639338|38325827|FG001|Overall Study|Death|0|||
17175116|NCT02639338|38325826|FG000|Overall Study|Randomized but Not Treated|0|||
17175117|NCT02639338|38325827|FG001|Overall Study|Randomized but Not Treated|1|||
17175118|NCT02900352|38325835|FG000|Overall Study|Lost to Follow-up|28|||
17175119|NCT02900352|38325836|FG001|Overall Study|Lost to Follow-up|17|||
17175120|NCT03040687|38325845|FG000|Overall Study|Withdrawal by Subject|1|||
17175121|NCT03040687|38325846|FG001|Overall Study|Withdrawal by Subject|0|||
17175122|NCT03040687|38325847|FG002|Overall Study|Withdrawal by Subject|0|||
17175123|NCT03042559|38325857|FG000|Overall Study|drop out|1|||
17175124|NCT03042559|38325858|FG001|Overall Study|drop out|1|||
17175125|NCT02780856|38325864|FG000|Overall Study|Lost to Follow-up|1|||
17088164|NCT00314574|38228254|FG001|Overall Study|Physician Decision|15|||
17088165|NCT00314574|38228253|FG000|Overall Study|Pregnancy|6|||
17088166|NCT00314574|38228254|FG001|Overall Study|Pregnancy|4|||
17088167|NCT00314574|38228253|FG000|Overall Study|Data unknown at database lock|0|||
17088168|NCT00314574|38228254|FG001|Overall Study|Data unknown at database lock|1|||
17088169|NCT00314340|38228260|FG000|Overall Study|lost interest|1|||
17088170|NCT00306852|38228268|FG000|Overall Study|Death|14|||
17088171|NCT00306852|38228269|FG001|Overall Study|Death|14|||
17088172|NCT00306852|38228268|FG000|Overall Study|Lost to Follow-up|15|||
17088173|NCT00306852|38228269|FG001|Overall Study|Lost to Follow-up|24|||
17088174|NCT00314262|38228275|FG000|Overall Study|Adverse Event|2|||
17088175|NCT00314262|38228275|FG000|Overall Study|Withdrawal by Subject|2|||
17088176|NCT00314262|38228275|FG000|Overall Study|Physician Decision|1|||
17088177|NCT00333866|38228283|FG000|Overall Study|Adverse Event|23|||
17088178|NCT00333866|38228284|FG001|Overall Study|Adverse Event|37|||
17088179|NCT00333866|38228285|FG002|Overall Study|Adverse Event|38|||
17088180|NCT00333866|38228286|FG003|Overall Study|Adverse Event|47|||
17088181|NCT00333866|38228283|FG000|Overall Study|Other|3|||
17088182|NCT00333866|38228284|FG001|Overall Study|Other|2|||
17088183|NCT00333866|38228285|FG002|Overall Study|Other|2|||
17088184|NCT00333866|38228286|FG003|Overall Study|Other|2|||
17088185|NCT00333866|38228283|FG000|Overall Study|Lack of Efficacy|8|||
17088186|NCT00333866|38228284|FG001|Overall Study|Lack of Efficacy|6|||
17088187|NCT00333866|38228285|FG002|Overall Study|Lack of Efficacy|3|||
17088188|NCT00333866|38228286|FG003|Overall Study|Lack of Efficacy|5|||
17088189|NCT00333866|38228283|FG000|Overall Study|Lost to Follow-up|1|||
17088190|NCT00333866|38228284|FG001|Overall Study|Lost to Follow-up|2|||
17088191|NCT00333866|38228285|FG002|Overall Study|Lost to Follow-up|2|||
17088192|NCT00333866|38228286|FG003|Overall Study|Lost to Follow-up|2|||
17088193|NCT00333866|38228283|FG000|Overall Study|Withdrawal by Subject|8|||
17088194|NCT00333866|38228284|FG001|Overall Study|Withdrawal by Subject|14|||
17088195|NCT00333866|38228285|FG002|Overall Study|Withdrawal by Subject|4|||
17088196|NCT00333866|38228286|FG003|Overall Study|Withdrawal by Subject|9|||
17088197|NCT00333866|38228283|FG000|Overall Study|Randomized but not Treated|5|||
17088198|NCT00333866|38228284|FG001|Overall Study|Randomized but not Treated|3|||
17088199|NCT00333866|38228285|FG002|Overall Study|Randomized but not Treated|2|||
17088200|NCT00333866|38228286|FG003|Overall Study|Randomized but not Treated|1|||
17088201|NCT00324740|38228296|FG000|Overall Study|Withdrawal by Subject|1|||
17088202|NCT00324740|38228297|FG001|Overall Study|Withdrawal by Subject|0|||
17088203|NCT00324740|38228298|FG002|Overall Study|Withdrawal by Subject|1|||
17088204|NCT00333788|38228305|FG000|Overall Study|Adverse Event|44|||
17088205|NCT00333788|38228305|FG000|Overall Study|Lack of Efficacy|80|||
17088206|NCT00333788|38228305|FG000|Overall Study|Lost to Follow-up|2|||
17088207|NCT00333788|38228305|FG000|Overall Study|Withdrawal by Subject|24|||
17088208|NCT00333788|38228305|FG000|Overall Study|Other: Non-compliance|2|||
17088209|NCT00333788|38228305|FG000|Overall Study|Other: Moved|2|||
17088210|NCT00333788|38228305|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
17088211|NCT00333788|38228305|FG000|Overall Study|Other: Investigator decision|1|||
17175126|NCT00108732|38325893|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
17175127|NCT00108732|38325893|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
17175128|NCT00108732|38325893|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
17175129|NCT00108732|38325893|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
17175130|NCT00108732|38325893|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
17175131|NCT00108732|38325893|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
17175132|NCT00108732|38325893|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
17175133|NCT00107952|38325899|FG000|Overall Study|Death|75|||
17175134|NCT00107952|38325900|FG001|Overall Study|Death|61|||
17175135|NCT00107952|38325899|FG000|Overall Study|Lost to Follow-up|0|||
17175136|NCT00107952|38325900|FG001|Overall Study|Lost to Follow-up|3|||
17175137|NCT00107952|38325899|FG000|Overall Study|Withdrawal by Subject|9|||
17175138|NCT00107952|38325900|FG001|Overall Study|Withdrawal by Subject|6|||
17175139|NCT00107952|38325899|FG000|Overall Study|Other|2|||
17175140|NCT00107952|38325900|FG001|Overall Study|Other|5|||
17175141|NCT00107952|38325899|FG000|Overall Study|Never received study treatment|9|||
17175142|NCT00107952|38325900|FG001|Overall Study|Never received study treatment|6|||
17175143|NCT01366638|38325918|FG000|Overall Study|Withdrawal by Subject|0|||
17175144|NCT01366638|38325919|FG001|Overall Study|Withdrawal by Subject|0|||
17175145|NCT01366638|38325920|FG002|Overall Study|Withdrawal by Subject|6|||
17175146|NCT01366638|38325918|FG000|Overall Study|Other|1|||
17175147|NCT01366638|38325919|FG001|Overall Study|Other|0|||
17175148|NCT01366638|38325920|FG002|Overall Study|Other|0|||
17175149|NCT02780700|38325928|FG000|Overall Study|Progressive disease|1|||
17175150|NCT04230122|38325966|FG000|Overall Study|Lost to Follow-up|1|||
17175151|NCT04230122|38325967|FG001|Overall Study|Lost to Follow-up|0|||
17175152|NCT02780388|38325978|FG000|Overall Study|Lost to Follow-up|0|||
17175153|NCT02780388|38325979|FG001|Overall Study|Lost to Follow-up|1|||
17175154|NCT02780388|38325980|FG002|Overall Study|Lost to Follow-up|0|||
17175155|NCT02780388|38325981|FG003|Overall Study|Lost to Follow-up|0|||
17175156|NCT02780388|38325982|FG004|Overall Study|Lost to Follow-up|0|||
17175157|NCT02780388|38325978|FG000|Overall Study|Withdrawal by Subject|1|||
17175158|NCT02780388|38325979|FG001|Overall Study|Withdrawal by Subject|1|||
17175159|NCT02780388|38325980|FG002|Overall Study|Withdrawal by Subject|0|||
17175160|NCT02780388|38325981|FG003|Overall Study|Withdrawal by Subject|0|||
17175161|NCT02780388|38325982|FG004|Overall Study|Withdrawal by Subject|0|||
17175162|NCT02224573|38326000|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
17175163|NCT02224573|38326001|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
17175164|NCT02224573|38326000|FG000|Treatment Phase|Started on Other IMP|1|||
17175165|NCT02224573|38326001|FG001|Treatment Phase|Started on Other IMP|0|||
17175166|NCT02224573|38326000|FG000|Treatment Phase|Participant Discontinued IMP|0|||
17175167|NCT02224573|38326001|FG001|Treatment Phase|Participant Discontinued IMP|1|||
17175168|NCT02224573|38326000|FG000|Treatment Phase|Lack of Efficacy|15|||
17175169|NCT02224573|38326001|FG001|Treatment Phase|Lack of Efficacy|8|||
17175170|NCT02224573|38326000|FG000|Treatment Phase|Began Commercial Product|1|||
17175171|NCT02224573|38326001|FG001|Treatment Phase|Began Commercial Product|0|||
17175172|NCT02224573|38326000|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
17175173|NCT02224573|38326001|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
17175174|NCT02224573|38326000|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
17175175|NCT02224573|38326001|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
17175176|NCT02224573|38326000|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
17175177|NCT02224573|38326001|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
17175178|NCT02224573|38326000|FG000|Treatment Phase|Continued Compassionate Use|1|||
17175179|NCT02224573|38326001|FG001|Treatment Phase|Continued Compassionate Use|0|||
17175180|NCT02224573|38326000|FG000|Treatment Phase|Lack of Efficiency|2|||
17175181|NCT02224573|38326001|FG001|Treatment Phase|Lack of Efficiency|1|||
17175182|NCT02224573|38326000|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
17175183|NCT02224573|38326001|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
17175184|NCT02224573|38326000|FG000|Treatment Phase|Participant Moved|2|||
17175185|NCT02224573|38326001|FG001|Treatment Phase|Participant Moved|0|||
17175186|NCT02224573|38326000|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
17175187|NCT02224573|38326001|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
17175188|NCT02224573|38326000|FG000|Treatment Phase|Refused Medication|1|||
17175189|NCT02224573|38326001|FG001|Treatment Phase|Refused Medication|1|||
17175190|NCT02224573|38326000|FG000|Treatment Phase|Adverse Event|26|||
17175191|NCT02224573|38326001|FG001|Treatment Phase|Adverse Event|38|||
17175192|NCT02224573|38326000|FG000|Treatment Phase|Placed in Group Home|0|||
17175193|NCT02224573|38326001|FG001|Treatment Phase|Placed in Group Home|1|||
17175194|NCT02224573|38326000|FG000|Treatment Phase|Pursued Other Trials|1|||
17175195|NCT02224573|38326001|FG001|Treatment Phase|Pursued Other Trials|0|||
17175196|NCT02224573|38326000|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
17175197|NCT02224573|38326001|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
17175198|NCT02224573|38326000|FG000|Treatment Phase|Lost to Follow-up|2|||
17175199|NCT02224573|38326001|FG001|Treatment Phase|Lost to Follow-up|1|||
17175200|NCT02224573|38326000|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
17175201|NCT02224573|38326001|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
17175202|NCT02224573|38326000|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
17175203|NCT02224573|38326001|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
17175204|NCT02224573|38326000|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
17175205|NCT02224573|38326001|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
17175206|NCT02224573|38326000|FG000|Taper Phase|Adverse Event|1|||
17175207|NCT02224573|38326001|FG001|Taper Phase|Adverse Event|1|||
17175208|NCT01360840|38326011|FG000|Overall Study|Ongoing at data cut-off|10|||
17175209|NCT01360840|38326012|FG001|Overall Study|Ongoing at data cut-off|10|||
17175210|NCT01360840|38326013|FG002|Overall Study|Ongoing at data cut-off|9|||
17175211|NCT03350984|38326025|FG000|Overall Study|Death|1|||
17175212|NCT03350984|38326026|FG001|Overall Study|Death|0|||
17175213|NCT03350984|38326025|FG000|Overall Study|Lost to Follow-up|5|||
17175214|NCT03350984|38326026|FG001|Overall Study|Lost to Follow-up|6|||
17175215|NCT03350984|38326025|FG000|Overall Study|Protocol Violation|1|||
17175216|NCT03350984|38326026|FG001|Overall Study|Protocol Violation|2|||
17175217|NCT03350984|38326025|FG000|Overall Study|Physician Decision|1|||
17175218|NCT03350984|38326026|FG001|Overall Study|Physician Decision|0|||
17175219|NCT05176717|38326044|FG000|Overall Study|Sponsor Decision|1|||
17175220|NCT05176717|38326045|FG001|Overall Study|Sponsor Decision|2|||
17175221|NCT05176717|38326046|FG002|Overall Study|Sponsor Decision|2|||
17175222|NCT02770248|38326056|FG000|Overall Study|Adverse Event|0|||
17175223|NCT02770248|38326057|FG001|Overall Study|Adverse Event|1|||
17175224|NCT02770248|38326056|FG000|Overall Study|Randomized in error, prior to treatment|0|||
17175225|NCT02770248|38326057|FG001|Overall Study|Randomized in error, prior to treatment|1|||
17175226|NCT01344369|38326065|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
17175227|NCT01344369|38326066|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
17175228|NCT01344369|38326065|FG000|Washout of 28 Days|Physician Decision|0|||
17175229|NCT01344369|38326066|FG001|Washout of 28 Days|Physician Decision|1|||
17175230|NCT01344369|38326065|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
17175231|NCT01344369|38326066|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
17175232|NCT03179462|38326075|FG000|Overall Study|screening failure|1|||
17175233|NCT03179462|38326076|FG001|Overall Study|screening failure|2|||
17175234|NCT03179462|38326077|FG002|Overall Study|screening failure|0|||
17175235|NCT01314703|38326085|FG000|Overall Study|screen failure and closed enrollment|8|||
17175236|NCT01360762|38326090|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
17175237|NCT01360762|38326090|FG000|Main Study Period (12-month Treatment)|Death|5|||
17175238|NCT01360762|38326090|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
17175239|NCT01360762|38326090|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
17175240|NCT01360762|38326090|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
17175241|NCT01360762|38326090|FG000|Whole Study Period|Lost to Follow-up|10|||
17175242|NCT01360762|38326090|FG000|Whole Study Period|Death|7|||
17175243|NCT01360762|38326090|FG000|Whole Study Period|Patient relapsed|18|||
17175244|NCT01360762|38326090|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
17175245|NCT04382924|38326097|FG000|Overall Study|Death|2|||
17175246|NCT04382924|38326098|FG001|Overall Study|Death|5|||
17175247|NCT04382924|38326099|FG002|Overall Study|Death|4|||
17175248|NCT04382924|38326097|FG000|Overall Study|Protocol Violation|0|||
17175249|NCT04382924|38326098|FG001|Overall Study|Protocol Violation|1|||
17175250|NCT04382924|38326099|FG002|Overall Study|Protocol Violation|1|||
17175251|NCT04382924|38326097|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
17175252|NCT04382924|38326098|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
17175253|NCT04382924|38326099|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
17175254|NCT04382924|38326097|FG000|Overall Study|Withdrawal by Subject|6|||
17175255|NCT04382924|38326098|FG001|Overall Study|Withdrawal by Subject|3|||
17175256|NCT04382924|38326099|FG002|Overall Study|Withdrawal by Subject|6|||
17175257|NCT03044431|38326113|FG000|Overall Study|Lost to Follow-up|59|||
17175258|NCT02770170|38326121|FG000|Overall Study|Withdrawal by Subject|0|||
17175259|NCT02770170|38326122|FG001|Overall Study|Withdrawal by Subject|0|||
17175260|NCT02770170|38326123|FG002|Overall Study|Withdrawal by Subject|0|||
17175261|NCT02770170|38326124|FG003|Overall Study|Withdrawal by Subject|2|||
17175262|NCT02770170|38326121|FG000|Overall Study|due to pregnancy|1|||
17088212|NCT00333788|38228305|FG000|Overall Study|Other: Quality of life concern|1|||
17088213|NCT00333788|38228305|FG000|Overall Study|Other: Sponsor decision|1|||
17088214|NCT00333788|38228305|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
17088215|NCT00333788|38228305|FG000|Overall Study|Other: Medical monitor decision|1|||
17088216|NCT00333788|38228305|FG000|Overall Study|Other: Physician decision|1|||
17088217|NCT00333788|38228305|FG000|Overall Study|Other: Signed consent for another study|1|||
17088218|NCT00324116|38228309|FG000|Overall Study|Adverse Event|5|||
17088219|NCT00324116|38228309|FG000|Overall Study|Lack of Efficacy|17|||
17088220|NCT00324116|38228309|FG000|Overall Study|Withdrawal by Subject|5|||
17088221|NCT00324116|38228309|FG000|Overall Study|Other|5|||
17088222|NCT00332696|38228315|FG000|Overall Study|Death|24|||
17175263|NCT02770170|38326122|FG001|Overall Study|due to pregnancy|0|||
17175264|NCT02770170|38326123|FG002|Overall Study|due to pregnancy|0|||
17175265|NCT02770170|38326124|FG003|Overall Study|due to pregnancy|0|||
17175266|NCT02770170|38326121|FG000|Overall Study|Lack of Efficacy|2|||
17175267|NCT02770170|38326122|FG001|Overall Study|Lack of Efficacy|0|||
17175268|NCT02770170|38326123|FG002|Overall Study|Lack of Efficacy|0|||
17175269|NCT02770170|38326124|FG003|Overall Study|Lack of Efficacy|1|||
17175270|NCT02770170|38326121|FG000|Overall Study|Adverse Event|4|||
17175271|NCT02770170|38326122|FG001|Overall Study|Adverse Event|3|||
17175272|NCT02770170|38326123|FG002|Overall Study|Adverse Event|5|||
17175273|NCT02770170|38326124|FG003|Overall Study|Adverse Event|3|||
17175274|NCT02770170|38326121|FG000|Overall Study|due to disease worsening|0|||
17175275|NCT02770170|38326122|FG001|Overall Study|due to disease worsening|0|||
17175276|NCT02770170|38326123|FG002|Overall Study|due to disease worsening|0|||
17175277|NCT02770170|38326124|FG003|Overall Study|due to disease worsening|1|||
17175278|NCT02769858|38326134|FG000|Overall Study|Withdrawal by Subject|2|||
17175279|NCT02769624|38326138|FG000|Overall Study|Lost to Follow-up|0|||
17175280|NCT02769624|38326139|FG001|Overall Study|Lost to Follow-up|1|||
17175281|NCT03446768|38326147|FG000|Overall Study|Withdrawal by Subject|0|||
17175282|NCT03446768|38326148|FG001|Overall Study|Withdrawal by Subject|1|||
17175283|NCT02676284|38326154|FG000|Overall Study|Withdrawal by Subject|1|||
17175284|NCT02769312|38326160|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
17175285|NCT02769312|38326161|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
17175286|NCT02769312|38326160|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
17175287|NCT02769312|38326161|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
17175288|NCT02769312|38326160|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
17175289|NCT02769312|38326161|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
17175290|NCT02769312|38326160|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
17175291|NCT02769312|38326161|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
17175292|NCT02769312|38326160|FG000|Follow-up|Lost to Follow-up|1|||
17175293|NCT02769312|38326161|FG001|Follow-up|Lost to Follow-up|1|||
17175294|NCT01673386|38326168|FG000|Overall Study|Study terminated by sponsor|16|||
17175295|NCT01673386|38326169|FG001|Overall Study|Study terminated by sponsor|22|||
17175296|NCT01673386|38326168|FG000|Overall Study|Adverse Event|5|||
17175297|NCT01673386|38326169|FG001|Overall Study|Adverse Event|2|||
17175298|NCT01673386|38326168|FG000|Overall Study|Progressive disease|4|||
17175299|NCT01673386|38326169|FG001|Overall Study|Progressive disease|1|||
17175300|NCT01673386|38326168|FG000|Overall Study|Withdrawal by Subject|0|||
17175301|NCT01673386|38326169|FG001|Overall Study|Withdrawal by Subject|2|||
17175302|NCT00103740|38326177|FG000|Period 1 - Core|Adverse Event|1|||
17175303|NCT00103740|38326178|FG001|Period 1 - Core|Adverse Event|0|||
17175304|NCT00103740|38326177|FG000|Period 1 - Core|Protocol Violation|3|||
17175305|NCT00103740|38326178|FG001|Period 1 - Core|Protocol Violation|2|||
17175306|NCT00103740|38326177|FG000|Period 1 - Core|Patient withdrew consent|3|||
17175307|NCT00103740|38326178|FG001|Period 1 - Core|Patient withdrew consent|2|||
17175308|NCT00103740|38326177|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
17175309|NCT00103740|38326178|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
17175310|NCT00103740|38326177|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
17175311|NCT00103740|38326178|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
17175312|NCT00103740|38326177|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
17175313|NCT00103740|38326178|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
17175314|NCT00103740|38326177|FG000|Period 2 - Extended Observation Period|Death|6|||
17175315|NCT00103740|38326178|FG001|Period 2 - Extended Observation Period|Death|2|||
17175316|NCT00103740|38326177|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
17175317|NCT00103740|38326178|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
17175318|NCT01281644|38326184|FG000|Overall Study|Lost to Follow-up|3|||
17175319|NCT01281644|38326184|FG000|Overall Study|Withdrawal by Subject|2|||
17175320|NCT02869893|38326190|FG000|Overall Study|participant aversion to IV|5|||
17175321|NCT02869893|38326190|FG000|Overall Study|participant fear of MRI scanner|2|||
17175322|NCT02872935|38326220|FG000|Overall Study|Other|0|||
17175323|NCT02872935|38326221|FG001|Overall Study|Other|1|||
17175324|NCT02872311|38326236|FG000|Overall Study|Death|2|||
17175325|NCT02872311|38326237|FG001|Overall Study|Death|0|||
17175326|NCT02872311|38326238|FG002|Overall Study|Death|0|||
17175327|NCT02872311|38326239|FG003|Overall Study|Death|0|||
17175328|NCT02872311|38326240|FG004|Overall Study|Death|0|||
17175329|NCT02872311|38326236|FG000|Overall Study|Lost to Follow-up|2|||
17175330|NCT02872311|38326237|FG001|Overall Study|Lost to Follow-up|0|||
17175331|NCT02872311|38326238|FG002|Overall Study|Lost to Follow-up|0|||
17175332|NCT02872311|38326239|FG003|Overall Study|Lost to Follow-up|0|||
17175333|NCT02872311|38326240|FG004|Overall Study|Lost to Follow-up|0|||
17175334|NCT02872311|38326236|FG000|Overall Study|Protocol Violation|0|||
17175335|NCT02872311|38326237|FG001|Overall Study|Protocol Violation|2|||
17175336|NCT02872311|38326238|FG002|Overall Study|Protocol Violation|1|||
17175337|NCT02872311|38326239|FG003|Overall Study|Protocol Violation|0|||
17175338|NCT02872311|38326240|FG004|Overall Study|Protocol Violation|0|||
17175339|NCT02871375|38326268|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
17175340|NCT02871375|38326269|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
17175341|NCT02867709|38326280|FG000|Treatment Period|Adverse Event|1|||
17175342|NCT02867709|38326281|FG001|Treatment Period|Adverse Event|1|||
17175343|NCT02867709|38326282|FG002|Treatment Period|Adverse Event|2|||
17175344|NCT02867709|38326280|FG000|Treatment Period|Withdrawal of Consent|7|||
17175345|NCT02867709|38326281|FG001|Treatment Period|Withdrawal of Consent|9|||
17175346|NCT02867709|38326282|FG002|Treatment Period|Withdrawal of Consent|8|||
17175347|NCT02867709|38326280|FG000|Treatment Period|Lost to Follow-up|17|||
17175348|NCT02867709|38326281|FG001|Treatment Period|Lost to Follow-up|20|||
17175349|NCT02867709|38326282|FG002|Treatment Period|Lost to Follow-up|20|||
17175350|NCT02867709|38326280|FG000|Treatment Period|Lack of Qualifying Event|42|||
17175351|NCT02867709|38326281|FG001|Treatment Period|Lack of Qualifying Event|55|||
17175352|NCT02867709|38326282|FG002|Treatment Period|Lack of Qualifying Event|42|||
17175353|NCT02867709|38326280|FG000|Treatment Period|Protocol Violation|3|||
17175354|NCT02867709|38326281|FG001|Treatment Period|Protocol Violation|2|||
17175355|NCT02867709|38326282|FG002|Treatment Period|Protocol Violation|3|||
17175356|NCT02867709|38326280|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
17175357|NCT02867709|38326281|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
17175358|NCT02867709|38326282|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
17175359|NCT02867709|38326280|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
17175360|NCT02867709|38326281|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
17175361|NCT02867709|38326282|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
17175362|NCT02867709|38326280|FG000|Safety Follow-up Period|Pregnancy|0|||
17175363|NCT02867709|38326281|FG001|Safety Follow-up Period|Pregnancy|1|||
17175364|NCT02867709|38326282|FG002|Safety Follow-up Period|Pregnancy|0|||
17175365|NCT02867709|38326280|FG000|Safety Follow-up Period|Protocol Violation|0|||
17175366|NCT02867709|38326281|FG001|Safety Follow-up Period|Protocol Violation|1|||
17175367|NCT02867709|38326282|FG002|Safety Follow-up Period|Protocol Violation|1|||
17175368|NCT03044353|38326293|FG000|Overall Study|Adverse Event|0|||
17175369|NCT03044353|38326294|FG001|Overall Study|Adverse Event|1|||
17175370|NCT03044353|38326295|FG002|Overall Study|Adverse Event|0|||
17175371|NCT01361308|38326304|FG000|Overall Study|Withdrawal by Subject|9|||
17175372|NCT01361308|38326305|FG001|Overall Study|Withdrawal by Subject|13|||
17175373|NCT01361308|38326304|FG000|Overall Study|Physician Decision|3|||
17088223|NCT00332696|38228316|FG001|Overall Study|Death|14|||
17088224|NCT00332696|38228315|FG000|Overall Study|Insufficient therapeutic effect|4|||
17088225|NCT00332696|38228316|FG001|Overall Study|Insufficient therapeutic effect|11|||
17088226|NCT00332696|38228315|FG000|Overall Study|Adverse Event|1|||
17088227|NCT00332696|38228316|FG001|Overall Study|Adverse Event|2|||
17088228|NCT00332696|38228315|FG000|Overall Study|Condition does not justify treatment|0|||
17088229|NCT00332696|38228316|FG001|Overall Study|Condition does not justify treatment|2|||
17088230|NCT00332696|38228315|FG000|Overall Study|Lost to Follow-up|0|||
17088231|NCT00332696|38228316|FG001|Overall Study|Lost to Follow-up|1|||
17088232|NCT00332696|38228315|FG000|Overall Study|Withdrawal by Subject|1|||
17088233|NCT00332696|38228316|FG001|Overall Study|Withdrawal by Subject|0|||
17088234|NCT00313716|38228328|FG000|Overall Study|Death|3|||
17088235|NCT00313716|38228329|FG001|Overall Study|Death|2|||
17088236|NCT00313716|38228330|FG002|Overall Study|Death|9|||
17088237|NCT00313716|38228331|FG003|Overall Study|Death|3|||
17088238|NCT00313716|38228332|FG004|Overall Study|Death|5|||
17088239|NCT00313716|38228333|FG005|Overall Study|Death|9|||
17088240|NCT00313716|38228328|FG000|Overall Study|Lost to Follow-up|2|||
17088241|NCT00313716|38228329|FG001|Overall Study|Lost to Follow-up|5|||
17088242|NCT00313716|38228330|FG002|Overall Study|Lost to Follow-up|2|||
17088243|NCT00313716|38228331|FG003|Overall Study|Lost to Follow-up|1|||
17088244|NCT00313716|38228332|FG004|Overall Study|Lost to Follow-up|0|||
17088245|NCT00313716|38228333|FG005|Overall Study|Lost to Follow-up|4|||
17088246|NCT00313716|38228328|FG000|Overall Study|Withdrawal by Subject|0|||
17088247|NCT00313716|38228329|FG001|Overall Study|Withdrawal by Subject|1|||
17088248|NCT00313716|38228330|FG002|Overall Study|Withdrawal by Subject|1|||
17088249|NCT00313716|38228331|FG003|Overall Study|Withdrawal by Subject|0|||
17088250|NCT00313716|38228332|FG004|Overall Study|Withdrawal by Subject|1|||
17088251|NCT00313716|38228333|FG005|Overall Study|Withdrawal by Subject|0|||
17088252|NCT00313170|38228354|FG000|Overall Study|Death|2|||
17088253|NCT00313170|38228355|FG001|Overall Study|Death|4|||
17088254|NCT00313170|38228356|FG002|Overall Study|Death|2|||
17088255|NCT00313170|38228354|FG000|Overall Study|Adverse Event|1|||
17088256|NCT00313170|38228355|FG001|Overall Study|Adverse Event|2|||
17088257|NCT00313170|38228356|FG002|Overall Study|Adverse Event|0|||
17088258|NCT00313170|38228354|FG000|Overall Study|Disease progression|31|||
17088259|NCT00313170|38228355|FG001|Overall Study|Disease progression|26|||
17175374|NCT01361308|38326305|FG001|Overall Study|Physician Decision|3|||
17175375|NCT01361308|38326304|FG000|Overall Study|Lack of Efficacy|2|||
17088260|NCT00313170|38228356|FG002|Overall Study|Disease progression|27|||
17088261|NCT00313170|38228354|FG000|Overall Study|Withdrawal by Subject|1|||
17175376|NCT01361308|38326305|FG001|Overall Study|Lack of Efficacy|0|||
17175377|NCT01361308|38326304|FG000|Overall Study|Protocol Violation|1|||
17175378|NCT01361308|38326305|FG001|Overall Study|Protocol Violation|0|||
17175379|NCT01361308|38326304|FG000|Overall Study|Lost to Follow-up|5|||
17175380|NCT01361308|38326305|FG001|Overall Study|Lost to Follow-up|4|||
17175381|NCT01361308|38326304|FG000|Overall Study|Adverse Event|8|||
17175382|NCT01361308|38326305|FG001|Overall Study|Adverse Event|4|||
17175383|NCT01361308|38326304|FG000|Overall Study|Eligibility Criteria Not Met|2|||
17175384|NCT01361308|38326305|FG001|Overall Study|Eligibility Criteria Not Met|3|||
17175385|NCT01361308|38326304|FG000|Overall Study|Failed C-SSRS|5|||
17175386|NCT01361308|38326305|FG001|Overall Study|Failed C-SSRS|2|||
17175387|NCT01361308|38326304|FG000|Overall Study|Other|0|||
17175388|NCT01361308|38326305|FG001|Overall Study|Other|1|||
17175389|NCT00103662|38326317|FG000|Overall Study|Entered Rescue Procedure|0|||
17175390|NCT00103662|38326318|FG001|Overall Study|Entered Rescue Procedure|7|||
17175391|NCT00103662|38326317|FG000|Overall Study|Death|7|||
17175392|NCT00103662|38326318|FG001|Overall Study|Death|7|||
17175393|NCT00103662|38326317|FG000|Overall Study|Elective Withdrawal|5|||
17175394|NCT00103662|38326318|FG001|Overall Study|Elective Withdrawal|5|||
17175395|NCT00103662|38326317|FG000|Overall Study|Lost to Follow-up|0|||
17175396|NCT00103662|38326318|FG001|Overall Study|Lost to Follow-up|1|||
17175397|NCT00103662|38326317|FG000|Overall Study|Other|6|||
17175398|NCT00103662|38326318|FG001|Overall Study|Other|9|||
17175399|NCT00103662|38326317|FG000|Overall Study|Failed mobilization|0|||
17175400|NCT00103662|38326318|FG001|Overall Study|Failed mobilization|4|||
17175401|NCT00103662|38326317|FG000|Overall Study|Intercurrent illness|1|||
17175402|NCT00103662|38326318|FG001|Overall Study|Intercurrent illness|0|||
17175403|NCT02865915|38326326|FG000|Overall Study|Pregnancy|1|||
17175404|NCT02865915|38326327|FG001|Overall Study|Pregnancy|0|||
17175405|NCT02865915|38326326|FG000|Overall Study|Withdrawal by Subject|1|||
17175406|NCT02865915|38326327|FG001|Overall Study|Withdrawal by Subject|1|||
17175407|NCT02865915|38326326|FG000|Overall Study|Adverse Event|0|||
17175408|NCT02865915|38326327|FG001|Overall Study|Adverse Event|4|||
17175409|NCT02865915|38326326|FG000|Overall Study|Lost to Follow-up|0|||
17175410|NCT02865915|38326327|FG001|Overall Study|Lost to Follow-up|1|||
17175411|NCT02865915|38326326|FG000|Overall Study|Protocol Violation|0|||
17175412|NCT02865915|38326327|FG001|Overall Study|Protocol Violation|1|||
17175413|NCT02865915|38326326|FG000|Overall Study|Study terminated by sponsor|23|||
17175414|NCT02865915|38326327|FG001|Overall Study|Study terminated by sponsor|18|||
17175415|NCT02865915|38326326|FG000|Overall Study|Dosing group discontinued|0|||
17175416|NCT02865915|38326327|FG001|Overall Study|Dosing group discontinued|5|||
17175417|NCT00104676|38326335|FG000|Overall Study|Death|3|||
17175418|NCT00104676|38326336|FG001|Overall Study|Death|2|||
17175419|NCT00104676|38326335|FG000|Overall Study|Withdrawal by Subject|0|||
17175420|NCT00104676|38326336|FG001|Overall Study|Withdrawal by Subject|2|||
17175421|NCT00104676|38326335|FG000|Overall Study|treatment interruption|4|||
17175422|NCT00104676|38326336|FG001|Overall Study|treatment interruption|10|||
17175423|NCT00354835|38326344|FG000|Overall Study|Death|1|||
17175424|NCT00354835|38326345|FG001|Overall Study|Death|1|||
17175425|NCT00354835|38326344|FG000|Overall Study|Physician Decision|8|||
17175426|NCT00354835|38326345|FG001|Overall Study|Physician Decision|13|||
17175427|NCT00354835|38326344|FG000|Overall Study|Withdrawal by Subject|2|||
17175428|NCT00354835|38326345|FG001|Overall Study|Withdrawal by Subject|1|||
17175429|NCT00354835|38326344|FG000|Overall Study|Ineligible|17|||
17175430|NCT00354835|38326345|FG001|Overall Study|Ineligible|16|||
17175431|NCT00354835|38326344|FG000|Overall Study|Disease progression or relapse|15|||
17175432|NCT00354835|38326345|FG001|Overall Study|Disease progression or relapse|22|||
17175433|NCT00354835|38326344|FG000|Overall Study|Adverse Event|6|||
17175434|NCT00354835|38326345|FG001|Overall Study|Adverse Event|0|||
17175435|NCT00354835|38326344|FG000|Overall Study|Refusal of further therapy|3|||
17175436|NCT00354835|38326345|FG001|Overall Study|Refusal of further therapy|8|||
17175437|NCT02768298|38326368|FG000|Overall Study|Adverse Event|1|||
17175438|NCT02768298|38326369|FG001|Overall Study|Adverse Event|4|||
17175439|NCT02768298|38326368|FG000|Overall Study|Death|2|||
17175440|NCT02768298|38326369|FG001|Overall Study|Death|1|||
16996792|NCT00967616|38140942|FG001|Overall Study|Withdrawal by Subject|4|||
17088262|NCT00313170|38228355|FG001|Overall Study|Withdrawal by Subject|0|||
17088263|NCT00313170|38228356|FG002|Overall Study|Withdrawal by Subject|1|||
17088264|NCT00313170|38228354|FG000|Overall Study|Incorrect enrollment|0|||
17088265|NCT00313170|38228355|FG001|Overall Study|Incorrect enrollment|2|||
17088266|NCT00313170|38228356|FG002|Overall Study|Incorrect enrollment|1|||
17088267|NCT00313170|38228354|FG000|Overall Study|Lost to Follow-up|0|||
17088268|NCT00313170|38228355|FG001|Overall Study|Lost to Follow-up|0|||
17088269|NCT00313170|38228356|FG002|Overall Study|Lost to Follow-up|1|||
17088270|NCT00313170|38228354|FG000|Overall Study|Progression (investigators opinion)|1|||
17088271|NCT00313170|38228355|FG001|Overall Study|Progression (investigators opinion)|0|||
17175441|NCT02768298|38326368|FG000|Overall Study|Non-compliance with study treatment|0|||
17175442|NCT02768298|38326369|FG001|Overall Study|Non-compliance with study treatment|1|||
17088272|NCT00313170|38228356|FG002|Overall Study|Progression (investigators opinion)|0|||
17175443|NCT02768298|38326368|FG000|Overall Study|Subject/guardian decision|1|||
17175444|NCT02768298|38326369|FG001|Overall Study|Subject/guardian decision|0|||
17175445|NCT02768298|38326368|FG000|Overall Study|Withdrawal of informed consent|0|||
17175446|NCT02768298|38326369|FG001|Overall Study|Withdrawal of informed consent|1|||
17175447|NCT02775864|38326379|FG000|Overall Study|Data ended end of 2010|1764|||
17175448|NCT02775864|38326380|FG001|Overall Study|Data ended end of 2010|2880|||
17175449|NCT02775864|38326381|FG002|Overall Study|Data ended end of 2010|1140|||
17175450|NCT02775864|38326382|FG003|Overall Study|Data ended end of 2010|1194|||
17175451|NCT02775864|38326379|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
17175452|NCT02775864|38326380|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
17175453|NCT02775864|38326381|FG002|Overall Study|Medicaid eligibility discontinued|720|||
17175454|NCT02775864|38326382|FG003|Overall Study|Medicaid eligibility discontinued|890|||
17175455|NCT00324805|38326395|FG000|Overall Study|Adverse Event|62|||
17175456|NCT00324805|38326396|FG001|Overall Study|Adverse Event|203|||
17175457|NCT00324805|38326395|FG000|Overall Study|Progression|7|||
17175458|NCT00324805|38326396|FG001|Overall Study|Progression|35|||
17175459|NCT00324805|38326395|FG000|Overall Study|Withdrawal by Subject|51|||
17175460|NCT00324805|38326396|FG001|Overall Study|Withdrawal by Subject|174|||
17175461|NCT00324805|38326395|FG000|Overall Study|Death|6|||
17175462|NCT00324805|38326396|FG001|Overall Study|Death|9|||
17175463|NCT00324805|38326395|FG000|Overall Study|Alternative therapy|4|||
17175464|NCT00324805|38326396|FG001|Overall Study|Alternative therapy|8|||
17175465|NCT00324805|38326395|FG000|Overall Study|Other complicating disease|1|||
17175466|NCT00324805|38326396|FG001|Overall Study|Other complicating disease|9|||
17175467|NCT00324805|38326395|FG000|Overall Study|Other reasons|7|||
17175468|NCT00324805|38326396|FG001|Overall Study|Other reasons|26|||
17175469|NCT00324805|38326395|FG000|Overall Study|Other|0|||
17175470|NCT00324805|38326396|FG001|Overall Study|Other|2|||
17175471|NCT00324805|38326395|FG000|Overall Study|Did not start therapy|12|||
17175472|NCT00324805|38326396|FG001|Overall Study|Did not start therapy|17|||
17175473|NCT02964273|38326404|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
17175474|NCT02964273|38326405|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
17175475|NCT02964273|38326406|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
17175476|NCT02964273|38326407|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
17175477|NCT02964273|38326404|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
17175478|NCT02964273|38326405|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
17175479|NCT02964273|38326406|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
17175480|NCT02964273|38326407|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
17175481|NCT02964273|38326404|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
17175482|NCT02964273|38326405|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
17175483|NCT02964273|38326406|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
17175484|NCT02964273|38326407|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
17175485|NCT02964273|38326404|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
17175486|NCT02964273|38326405|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
17175487|NCT02964273|38326406|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
17175488|NCT02964273|38326407|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
17175489|NCT02964273|38326404|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
17175490|NCT02964273|38326405|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
17175491|NCT02964273|38326406|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
17175492|NCT02964273|38326407|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
17175493|NCT02964273|38326404|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
17175494|NCT02964273|38326405|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
17175495|NCT02964273|38326406|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
17175496|NCT02964273|38326407|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
17175497|NCT02773446|38326426|FG000|First Admission|Withdrawal by Subject|0|||
17175498|NCT02773446|38326427|FG001|First Admission|Withdrawal by Subject|0|||
17175499|NCT02773446|38326428|FG002|First Admission|Withdrawal by Subject|0|||
17175500|NCT02773446|38326429|FG003|First Admission|Withdrawal by Subject|1|||
17175501|NCT02773446|38326430|FG004|First Admission|Withdrawal by Subject|0|||
17175502|NCT02773446|38326431|FG005|First Admission|Withdrawal by Subject|0|||
17175503|NCT02773446|38326426|FG000|First Admission|Lost to Follow-up|1|||
17175504|NCT02773446|38326427|FG001|First Admission|Lost to Follow-up|0|||
17175505|NCT02773446|38326428|FG002|First Admission|Lost to Follow-up|0|||
17175506|NCT02773446|38326429|FG003|First Admission|Lost to Follow-up|0|||
17175507|NCT02773446|38326430|FG004|First Admission|Lost to Follow-up|0|||
17175508|NCT02773446|38326431|FG005|First Admission|Lost to Follow-up|0|||
17175509|NCT02773368|38326450|FG000|Overall Study|Lost to Follow-up|4|||
17175510|NCT02773368|38326451|FG001|Overall Study|Lost to Follow-up|1|||
17175511|NCT02773368|38326450|FG000|Overall Study|Withdrawal by Subject|5|||
17175512|NCT02773368|38326451|FG001|Overall Study|Withdrawal by Subject|1|||
17175513|NCT02773368|38326450|FG000|Overall Study|Unclassified|1|||
17175514|NCT02773368|38326451|FG001|Overall Study|Unclassified|1|||
17175515|NCT02773368|38326450|FG000|Overall Study|Missing|0|||
17175516|NCT02773368|38326451|FG001|Overall Study|Missing|1|||
17175517|NCT01336647|38326460|FG000|Overall Study|Lost to Follow-up|4|||
17175518|NCT01336647|38326461|FG001|Overall Study|Lost to Follow-up|1|||
17175519|NCT01336647|38326462|FG002|Overall Study|Lost to Follow-up|3|||
17175520|NCT01336569|38326472|FG000|Overall Study|Lost to Follow-up|4|||
17175521|NCT02772978|38326476|FG000|Overall Study|Withdrawal by Subject|1|||
17175522|NCT02772978|38326477|FG001|Overall Study|Withdrawal by Subject|1|||
17175523|NCT00104052|38326482|FG000|Overall Study|Adverse Event|1|||
17175524|NCT00104052|38326482|FG000|Overall Study|Lack of Efficacy|26|||
17175525|NCT00104052|38326482|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
17175526|NCT02777970|38326489|FG000|Overall Study|Lost to Follow-up|0|||
17175527|NCT02777970|38326490|FG001|Overall Study|Lost to Follow-up|1|||
17175528|NCT02777970|38326491|FG002|Overall Study|Lost to Follow-up|0|||
17175529|NCT02777970|38326489|FG000|Overall Study|Protocol Violation|1|||
17175530|NCT02777970|38326490|FG001|Overall Study|Protocol Violation|0|||
17175531|NCT02777970|38326491|FG002|Overall Study|Protocol Violation|0|||
17175532|NCT03037489|38326503|FG000|Overall Study|Adverse Event|4|||
17175533|NCT03037489|38326504|FG001|Overall Study|Adverse Event|0|||
17175534|NCT03037489|38326503|FG000|Overall Study|Withdrawal by Subject|3|||
17175535|NCT03037489|38326504|FG001|Overall Study|Withdrawal by Subject|0|||
17175536|NCT01336023|38326513|FG000|Week 0 to Week 26|Adverse Event|8|||
17175537|NCT01336023|38326514|FG001|Week 0 to Week 26|Adverse Event|10|||
17175538|NCT01336023|38326515|FG002|Week 0 to Week 26|Adverse Event|24|||
17175539|NCT01336023|38326513|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
17175540|NCT01336023|38326514|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
17175541|NCT01336023|38326515|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
17175542|NCT01336023|38326513|FG000|Week 0 to Week 26|Protocol Violation|1|||
17175543|NCT01336023|38326514|FG001|Week 0 to Week 26|Protocol Violation|2|||
17175544|NCT01336023|38326515|FG002|Week 0 to Week 26|Protocol Violation|0|||
17175545|NCT01336023|38326513|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
17175546|NCT01336023|38326514|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
17175547|NCT01336023|38326515|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
17175548|NCT01336023|38326513|FG000|Week 0 to Week 26|Unclassified|5|||
17175549|NCT01336023|38326514|FG001|Week 0 to Week 26|Unclassified|16|||
17175550|NCT01336023|38326515|FG002|Week 0 to Week 26|Unclassified|9|||
17175551|NCT01336023|38326513|FG000|Week 27 to 52|Adverse Event|1|||
17175552|NCT01336023|38326514|FG001|Week 27 to 52|Adverse Event|5|||
17175553|NCT01336023|38326515|FG002|Week 27 to 52|Adverse Event|2|||
17175554|NCT01336023|38326513|FG000|Week 27 to 52|Protocol Violation|0|||
17175555|NCT01336023|38326514|FG001|Week 27 to 52|Protocol Violation|2|||
17175556|NCT01336023|38326515|FG002|Week 27 to 52|Protocol Violation|1|||
17175557|NCT01336023|38326513|FG000|Week 27 to 52|Withdrawal Criteria|14|||
17175558|NCT01336023|38326514|FG001|Week 27 to 52|Withdrawal Criteria|19|||
17175559|NCT01336023|38326515|FG002|Week 27 to 52|Withdrawal Criteria|16|||
17175560|NCT01336023|38326513|FG000|Week 27 to 52|Unclassified|13|||
17175561|NCT01336023|38326514|FG001|Week 27 to 52|Unclassified|18|||
17175562|NCT01336023|38326515|FG002|Week 27 to 52|Unclassified|9|||
17175563|NCT03039283|38326523|FG000|Overall Study|Protocol Violation|2|||
17175564|NCT02863575|38326545|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
17175565|NCT02863575|38326546|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
17175566|NCT02863575|38326547|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
17175567|NCT02863575|38326545|FG000|Overall Study|Withdrawal by Subject|0|||
17175568|NCT02863575|38326546|FG001|Overall Study|Withdrawal by Subject|1|||
17175569|NCT02863575|38326547|FG002|Overall Study|Withdrawal by Subject|1|||
17175570|NCT02863575|38326545|FG000|Overall Study|Adverse Event|0|||
17175571|NCT02863575|38326546|FG001|Overall Study|Adverse Event|1|||
17175572|NCT02863575|38326547|FG002|Overall Study|Adverse Event|0|||
17175573|NCT01227187|38326559|FG000|Overall Study|Physician Decision|0|||
17175574|NCT01227187|38326560|FG001|Overall Study|Physician Decision|0|||
17175575|NCT01227187|38326561|FG002|Overall Study|Physician Decision|0|||
17175576|NCT01227187|38326562|FG003|Overall Study|Physician Decision|1|||
17175577|NCT02638012|38326583|FG000|Overall Study|Lost to Follow-up|1|||
17175578|NCT00103506|38326589|FG000|Overall Study|Study closed by sponsor|34|||
17175579|NCT00103506|38326590|FG001|Overall Study|Study closed by sponsor|37|||
17175580|NCT00103506|38326589|FG000|Overall Study|Death|257|||
17175581|NCT00103506|38326590|FG001|Overall Study|Death|253|||
17175582|NCT00103506|38326589|FG000|Overall Study|Lost to Follow-up|13|||
17175583|NCT00103506|38326590|FG001|Overall Study|Lost to Follow-up|13|||
17175584|NCT00103506|38326589|FG000|Overall Study|Withdrawal by Subject|18|||
17175585|NCT00103506|38326590|FG001|Overall Study|Withdrawal by Subject|21|||
16996793|NCT00967616|38140941|FG000|Overall Study|Progressive Disease|31|||
17175586|NCT02765490|38326598|FG000|Overall Study|Lost to Follow-up|1|||
17175587|NCT02765490|38326599|FG001|Overall Study|Lost to Follow-up|1|||
17175588|NCT02765490|38326598|FG000|Overall Study|Other|0|||
16996794|NCT00967616|38140942|FG001|Overall Study|Progressive Disease|18|||
17175589|NCT02765490|38326599|FG001|Overall Study|Other|1|||
17175590|NCT02765490|38326598|FG000|Overall Study|Death|0|||
17175591|NCT02765490|38326599|FG001|Overall Study|Death|1|||
17175592|NCT02762370|38326607|FG000|Overall Study|Protocol Violation|1|||
17175593|NCT02762370|38326608|FG001|Overall Study|Protocol Violation|0|||
17175594|NCT02639182|38326618|FG000|Overall Study|Disease Progression|50|||
17175595|NCT02639182|38326619|FG001|Overall Study|Disease Progression|49|||
17175596|NCT02639182|38326618|FG000|Overall Study|Adverse Event|7|||
17175597|NCT02639182|38326619|FG001|Overall Study|Adverse Event|5|||
17175598|NCT02639182|38326618|FG000|Overall Study|Physician Decision|3|||
17175599|NCT02639182|38326619|FG001|Overall Study|Physician Decision|3|||
17175600|NCT02639182|38326618|FG000|Overall Study|Withdrew Consent|5|||
17175601|NCT02639182|38326619|FG001|Overall Study|Withdrew Consent|4|||
17175602|NCT02639182|38326618|FG000|Overall Study|Lost to Follow-up|0|||
17175603|NCT02639182|38326619|FG001|Overall Study|Lost to Follow-up|1|||
17175604|NCT02639182|38326618|FG000|Overall Study|Study Closure|1|||
17175605|NCT02639182|38326619|FG001|Overall Study|Study Closure|2|||
17175606|NCT02639182|38326618|FG000|Overall Study|Sponsor Ended Study|0|||
17175607|NCT02639182|38326619|FG001|Overall Study|Sponsor Ended Study|1|||
17175608|NCT02639182|38326618|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
17175609|NCT02639182|38326619|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
17175610|NCT02863419|38326628|FG000|Overall Study|Lost to Follow-up|0|||
17175611|NCT02863419|38326629|FG001|Overall Study|Lost to Follow-up|1|||
17175612|NCT02863419|38326630|FG002|Overall Study|Lost to Follow-up|4|||
17175613|NCT02863419|38326628|FG000|Overall Study|Withdrawal by Subject|5|||
17175614|NCT02863419|38326629|FG001|Overall Study|Withdrawal by Subject|5|||
17175615|NCT02863419|38326630|FG002|Overall Study|Withdrawal by Subject|3|||
17175616|NCT02863419|38326628|FG000|Overall Study|Died|3|||
17175617|NCT02863419|38326629|FG001|Overall Study|Died|4|||
17175618|NCT02863419|38326630|FG002|Overall Study|Died|1|||
17175619|NCT02765100|38326640|FG000|Overall Study|subject found ineligible after baseline|1|||
17175620|NCT02765100|38326641|FG001|Overall Study|subject found ineligible after baseline|1|||
17175621|NCT02765100|38326640|FG000|Overall Study|Lost to Follow-up|0|||
17175622|NCT02765100|38326641|FG001|Overall Study|Lost to Follow-up|1|||
17175623|NCT02761980|38326651|FG000|Overall Study|Adverse Event|4|||
17175624|NCT02761980|38326652|FG001|Overall Study|Adverse Event|6|||
17175625|NCT02761980|38326653|FG002|Overall Study|Adverse Event|5|||
17175626|NCT02761980|38326654|FG003|Overall Study|Adverse Event|6|||
17175627|NCT02761980|38326651|FG000|Overall Study|Withdrawal by Subject|0|||
17175628|NCT02761980|38326652|FG001|Overall Study|Withdrawal by Subject|1|||
17175629|NCT02761980|38326653|FG002|Overall Study|Withdrawal by Subject|0|||
17175630|NCT02761980|38326654|FG003|Overall Study|Withdrawal by Subject|0|||
17175631|NCT02761980|38326651|FG000|Overall Study|Other|0|||
17175632|NCT02761980|38326652|FG001|Overall Study|Other|0|||
17175633|NCT02761980|38326653|FG002|Overall Study|Other|1|||
17175634|NCT02761980|38326654|FG003|Overall Study|Other|0|||
17175635|NCT02862171|38326673|FG000|Overall Study|Death|1|||
17175636|NCT02862171|38326673|FG000|Overall Study|Lost to Follow-up|13|||
17175637|NCT02862171|38326673|FG000|Overall Study|Withdrawal by Subject|57|||
17175638|NCT02862171|38326673|FG000|Overall Study|Non-compliance|4|||
17175639|NCT02862171|38326673|FG000|Overall Study|HIV-1 seroconversion|18|||
17175640|NCT02638948|38326681|FG000|Overall Study|Withdrawal by Subject|4|||
17175641|NCT02638948|38326682|FG001|Overall Study|Withdrawal by Subject|5|||
17175642|NCT02638948|38326683|FG002|Overall Study|Withdrawal by Subject|3|||
17175643|NCT02638948|38326684|FG003|Overall Study|Withdrawal by Subject|1|||
17175644|NCT02638948|38326681|FG000|Overall Study|Administrative Reason by Sponsor|0|||
17175645|NCT02638948|38326682|FG001|Overall Study|Administrative Reason by Sponsor|1|||
17175646|NCT02638948|38326683|FG002|Overall Study|Administrative Reason by Sponsor|0|||
17175647|NCT02638948|38326684|FG003|Overall Study|Administrative Reason by Sponsor|4|||
17175648|NCT02638948|38326681|FG000|Overall Study|Adverse Event|0|||
17175649|NCT02638948|38326682|FG001|Overall Study|Adverse Event|0|||
17175650|NCT02638948|38326683|FG002|Overall Study|Adverse Event|1|||
17175651|NCT02638948|38326684|FG003|Overall Study|Adverse Event|1|||
17175652|NCT02638948|38326681|FG000|Overall Study|Lack of Efficacy|1|||
17175653|NCT02638948|38326682|FG001|Overall Study|Lack of Efficacy|1|||
17175654|NCT02638948|38326683|FG002|Overall Study|Lack of Efficacy|0|||
17175655|NCT02638948|38326684|FG003|Overall Study|Lack of Efficacy|0|||
17175656|NCT02638948|38326681|FG000|Overall Study|Lost to Follow-up|0|||
17175657|NCT02638948|38326682|FG001|Overall Study|Lost to Follow-up|0|||
17175658|NCT02638948|38326683|FG002|Overall Study|Lost to Follow-up|1|||
17175659|NCT02638948|38326684|FG003|Overall Study|Lost to Follow-up|1|||
17175660|NCT02638948|38326681|FG000|Overall Study|Poor/Non-Compliance|0|||
17175661|NCT02638948|38326682|FG001|Overall Study|Poor/Non-Compliance|2|||
17175662|NCT02638948|38326683|FG002|Overall Study|Poor/Non-Compliance|1|||
17175663|NCT02638948|38326684|FG003|Overall Study|Poor/Non-Compliance|0|||
17175664|NCT02638948|38326681|FG000|Overall Study|Participant no longer met study criteria|0|||
17175665|NCT02638948|38326682|FG001|Overall Study|Participant no longer met study criteria|1|||
17175666|NCT02638948|38326683|FG002|Overall Study|Participant no longer met study criteria|0|||
17175667|NCT02638948|38326684|FG003|Overall Study|Participant no longer met study criteria|0|||
17175668|NCT02638948|38326681|FG000|Overall Study|Other than specified above|4|||
17175669|NCT02638948|38326682|FG001|Overall Study|Other than specified above|1|||
17175670|NCT02638948|38326683|FG002|Overall Study|Other than specified above|1|||
17175671|NCT02638948|38326684|FG003|Overall Study|Other than specified above|1|||
17175672|NCT00102960|38326700|FG000|Overall Study|Death|23|||
17175673|NCT00102960|38326701|FG001|Overall Study|Death|11|||
17175674|NCT00102960|38326702|FG002|Overall Study|Death|11|||
17175675|NCT00102960|38326700|FG000|Overall Study|Lost to Follow-up|6|||
17175676|NCT00102960|38326701|FG001|Overall Study|Lost to Follow-up|12|||
17175677|NCT00102960|38326702|FG002|Overall Study|Lost to Follow-up|16|||
17175678|NCT00102960|38326700|FG000|Overall Study|Withdrawal by Subject|1|||
17175679|NCT00102960|38326701|FG001|Overall Study|Withdrawal by Subject|0|||
17175680|NCT00102960|38326702|FG002|Overall Study|Withdrawal by Subject|1|||
17175681|NCT02858895|38326714|FG000|Overall Study|Disease progression|31|||
17175682|NCT02858895|38326714|FG000|Overall Study|Death|2|||
17175683|NCT02858895|38326714|FG000|Overall Study|Adverse Event|1|||
17175684|NCT02858895|38326714|FG000|Overall Study|Withdrawal by Subject|3|||
17175685|NCT02858895|38326714|FG000|Overall Study|hospice,|1|||
17175686|NCT02858895|38326714|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
17175687|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
17175688|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
17175689|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
17175690|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
17175691|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
17175692|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
17175693|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
17175694|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
17175695|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
17175696|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
17175697|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
17175698|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
17175699|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
17175700|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
17175701|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
17175702|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
17175703|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
17175704|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
17175705|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
17175706|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
17175707|NCT02637856|38326725|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
17175708|NCT02637856|38326726|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
17175709|NCT02637856|38326725|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
17175710|NCT02637856|38326726|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
17175711|NCT02637856|38326725|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
17175712|NCT02637856|38326726|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
17175713|NCT02858037|38326732|FG000|Overall Study|Death|1|||
17175714|NCT02858037|38326732|FG000|Overall Study|Withdrawal by Subject|18|||
17175715|NCT02858037|38326732|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
17175716|NCT02858037|38326732|FG000|Overall Study|Lost to Follow-up|3|||
17175717|NCT02858037|38326732|FG000|Overall Study|Other|4|||
17175718|NCT02065869|38326736|FG000|Overall Study|Death|7|||
17175719|NCT02065869|38326736|FG000|Overall Study|Disease relapse|16|||
17175720|NCT02065869|38326736|FG000|Overall Study|Lost to Follow-up|4|||
17175721|NCT02065869|38326736|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
17175722|NCT02065869|38326736|FG000|Overall Study|Withdrawal by Subject|1|||
17175723|NCT02856555|38326744|FG000|Overall Study|Adverse Event|1|||
17175724|NCT02856555|38326745|FG001|Overall Study|Adverse Event|0|||
17175725|NCT02856555|38326746|FG002|Overall Study|Adverse Event|0|||
17175726|NCT02856555|38326744|FG000|Overall Study|Lost to Follow-up|1|||
17175727|NCT02856555|38326745|FG001|Overall Study|Lost to Follow-up|3|||
17175728|NCT02856555|38326746|FG002|Overall Study|Lost to Follow-up|0|||
17175729|NCT02856555|38326744|FG000|Overall Study|Withdrawal by Subject|3|||
17175730|NCT02856555|38326745|FG001|Overall Study|Withdrawal by Subject|0|||
17175731|NCT02856555|38326746|FG002|Overall Study|Withdrawal by Subject|0|||
17175732|NCT02856555|38326744|FG000|Overall Study|Randomized but Never Treated|0|||
17175733|NCT02856555|38326745|FG001|Overall Study|Randomized but Never Treated|1|||
17175734|NCT02856555|38326746|FG002|Overall Study|Randomized but Never Treated|0|||
17175735|NCT02637232|38326784|FG000|Overall Study|Lost to Follow-up|42|||
17175736|NCT02637232|38326784|FG000|Overall Study|Adverse Event|11|||
17175737|NCT02637232|38326784|FG000|Overall Study|patient 's decision|2|||
17175738|NCT02855541|38326788|FG000|Overall Study|Change in health status|2|||
17175739|NCT02855541|38326788|FG000|Overall Study|Withdrawal by Subject|2|||
17175740|NCT02635984|38326794|FG000|Overall Study|Lost to Follow-up|2|||
17175741|NCT02635984|38326795|FG001|Overall Study|Lost to Follow-up|4|||
17175742|NCT02635984|38326794|FG000|Overall Study|Study Arm Closed|1|||
17175743|NCT02635984|38326795|FG001|Overall Study|Study Arm Closed|0|||
17175744|NCT01147653|38326803|FG000|Year 2|Withdrawal by Subject|2|||
17175745|NCT01147653|38326804|FG001|Year 2|Withdrawal by Subject|3|||
17175746|NCT02747043|38326825|FG000|Overall Study|Other|1|||
17175747|NCT02747043|38326826|FG001|Overall Study|Other|1|||
17175748|NCT02747043|38326825|FG000|Overall Study|Adverse Event|3|||
17175749|NCT02747043|38326826|FG001|Overall Study|Adverse Event|1|||
17175750|NCT02747043|38326825|FG000|Overall Study|Withdrawal by Subject|1|||
17175751|NCT02747043|38326826|FG001|Overall Study|Withdrawal by Subject|1|||
17175752|NCT02747043|38326825|FG000|Overall Study|Physician Decision|1|||
17175753|NCT02747043|38326826|FG001|Overall Study|Physician Decision|1|||
17175754|NCT02747043|38326825|FG000|Overall Study|Protocol Violation|0|||
17175755|NCT02747043|38326826|FG001|Overall Study|Protocol Violation|1|||
17175756|NCT02747043|38326825|FG000|Overall Study|Disease progression|4|||
17175757|NCT02747043|38326826|FG001|Overall Study|Disease progression|0|||
17175758|NCT02637076|38326834|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
17175759|NCT02637076|38326835|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
17175760|NCT02637076|38326834|FG000|Overall Study|Withdrawal by Subject|0|||
17175761|NCT02637076|38326835|FG001|Overall Study|Withdrawal by Subject|4|||
17175762|NCT02854605|38326844|FG000|Overall Study|Adverse Event|1|||
17175763|NCT02854605|38326845|FG001|Overall Study|Adverse Event|5|||
17175764|NCT02854605|38326846|FG002|Overall Study|Adverse Event|2|||
17175765|NCT02854605|38326844|FG000|Overall Study|Lost to Follow-up|0|||
17175766|NCT02854605|38326845|FG001|Overall Study|Lost to Follow-up|2|||
17175767|NCT02854605|38326846|FG002|Overall Study|Lost to Follow-up|0|||
17175768|NCT02854605|38326844|FG000|Overall Study|Withdrew Consent|1|||
17175769|NCT02854605|38326845|FG001|Overall Study|Withdrew Consent|0|||
17175770|NCT02854605|38326846|FG002|Overall Study|Withdrew Consent|1|||
17175771|NCT02854605|38326844|FG000|Overall Study|Investigator's Discretion|1|||
17175772|NCT02854605|38326845|FG001|Overall Study|Investigator's Discretion|0|||
17175773|NCT02854605|38326846|FG002|Overall Study|Investigator's Discretion|0|||
17175774|NCT02854605|38326844|FG000|Overall Study|Protocol Violation|0|||
17175775|NCT02854605|38326845|FG001|Overall Study|Protocol Violation|0|||
17175776|NCT02854605|38326846|FG002|Overall Study|Protocol Violation|1|||
17175777|NCT02854527|38326864|FG000|Overall Study|Adverse Event|0|||
17175778|NCT02854527|38326865|FG001|Overall Study|Adverse Event|0|||
17175779|NCT02854527|38326866|FG002|Overall Study|Adverse Event|0|||
17175780|NCT02854527|38326867|FG003|Overall Study|Adverse Event|0|||
17175781|NCT02854527|38326868|FG004|Overall Study|Adverse Event|1|||
17175782|NCT02854527|38326869|FG005|Overall Study|Adverse Event|0|||
17175783|NCT02854527|38326870|FG006|Overall Study|Adverse Event|0|||
17175784|NCT02854527|38326871|FG007|Overall Study|Adverse Event|0|||
17175785|NCT02854527|38326872|FG008|Overall Study|Adverse Event|0|||
17175786|NCT02854527|38326873|FG009|Overall Study|Adverse Event|0|||
17175787|NCT02854527|38326864|FG000|Overall Study|Lost to Follow-up|0|||
17175788|NCT02854527|38326865|FG001|Overall Study|Lost to Follow-up|0|||
17175789|NCT02854527|38326866|FG002|Overall Study|Lost to Follow-up|0|||
17175790|NCT02854527|38326867|FG003|Overall Study|Lost to Follow-up|1|||
17175791|NCT02854527|38326868|FG004|Overall Study|Lost to Follow-up|0|||
17175792|NCT02854527|38326869|FG005|Overall Study|Lost to Follow-up|0|||
17175793|NCT02854527|38326870|FG006|Overall Study|Lost to Follow-up|0|||
17175794|NCT02854527|38326871|FG007|Overall Study|Lost to Follow-up|0|||
17175795|NCT02854527|38326872|FG008|Overall Study|Lost to Follow-up|0|||
17175796|NCT02854527|38326873|FG009|Overall Study|Lost to Follow-up|0|||
17175797|NCT02853435|38326900|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
17175798|NCT02853435|38326901|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
17175799|NCT02853435|38326902|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
17175800|NCT02853435|38326903|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
17175801|NCT02853435|38326904|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
17175802|NCT02853435|38326905|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
17175803|NCT02635204|38326937|FG000|Overall Study|Adverse Event|1|||
17175804|NCT02635204|38326938|FG001|Overall Study|Adverse Event|0|||
17175805|NCT02635204|38326937|FG000|Overall Study|Lost to Follow-up|1|||
17175806|NCT02635204|38326938|FG001|Overall Study|Lost to Follow-up|1|||
17175807|NCT00102804|38326946|FG000|Overall Study|Progressive Disease (PD)|307|||
17175808|NCT00102804|38326947|FG001|Overall Study|Progressive Disease (PD)|196|||
17175809|NCT00102804|38326946|FG000|Overall Study|Withdrawal by Subject|46|||
17175810|NCT00102804|38326947|FG001|Overall Study|Withdrawal by Subject|7|||
17175811|NCT00102804|38326946|FG000|Overall Study|Adverse Event|37|||
17175812|NCT00102804|38326947|FG001|Overall Study|Adverse Event|3|||
17175813|NCT00102804|38326946|FG000|Overall Study|Physician Decision|24|||
17175814|NCT00102804|38326947|FG001|Overall Study|Physician Decision|6|||
17175815|NCT00102804|38326946|FG000|Overall Study|Death|5|||
17175816|NCT00102804|38326947|FG001|Overall Study|Death|6|||
17175817|NCT00102804|38326946|FG000|Overall Study|Enrollment Criteria Not Met|6|||
17175818|NCT00102804|38326947|FG001|Overall Study|Enrollment Criteria Not Met|0|||
17175819|NCT00102804|38326946|FG000|Overall Study|Lost to Follow-up|4|||
17175820|NCT00102804|38326947|FG001|Overall Study|Lost to Follow-up|1|||
17175821|NCT00102804|38326946|FG000|Overall Study|Protocol Violation|2|||
17175822|NCT00102804|38326947|FG001|Overall Study|Protocol Violation|1|||
17175823|NCT00102804|38326946|FG000|Overall Study|Satisfactory Response|2|||
17175824|NCT00102804|38326947|FG001|Overall Study|Satisfactory Response|0|||
17175825|NCT00102804|38326946|FG000|Overall Study|Sponsor Decision|1|||
17175826|NCT00102804|38326947|FG001|Overall Study|Sponsor Decision|0|||
17175827|NCT00102804|38326946|FG000|Overall Study|Alive, Receiving Treatment|7|||
17175828|NCT00102804|38326947|FG001|Overall Study|Alive, Receiving Treatment|2|||
17175829|NCT01814072|38326985|FG000|Overall Study|Lost to Follow-up|2|||
17175830|NCT01814072|38326986|FG001|Overall Study|Lost to Follow-up|2|||
17175831|NCT01814072|38326987|FG002|Overall Study|Lost to Follow-up|2|||
17175832|NCT01814072|38326988|FG003|Overall Study|Lost to Follow-up|0|||
17175833|NCT01814072|38326989|FG004|Overall Study|Lost to Follow-up|2|||
17175834|NCT01814072|38326990|FG005|Overall Study|Lost to Follow-up|3|||
17175835|NCT01814072|38326991|FG006|Overall Study|Lost to Follow-up|3|||
17175836|NCT01814072|38326992|FG007|Overall Study|Lost to Follow-up|1|||
17175837|NCT01814072|38326993|FG008|Overall Study|Lost to Follow-up|2|||
17175838|NCT01814072|38326994|FG009|Overall Study|Lost to Follow-up|3|||
17175839|NCT01814072|38326995|FG010|Overall Study|Lost to Follow-up|1|||
17175840|NCT01814072|38326996|FG011|Overall Study|Lost to Follow-up|2|||
17175841|NCT01814072|38326997|FG012|Overall Study|Lost to Follow-up|2|||
17175842|NCT01814072|38326998|FG013|Overall Study|Lost to Follow-up|1|||
17175843|NCT01814072|38326999|FG014|Overall Study|Lost to Follow-up|2|||
17175844|NCT01814072|38327000|FG015|Overall Study|Lost to Follow-up|1|||
17175845|NCT01814072|38327001|FG016|Overall Study|Lost to Follow-up|3|||
17175846|NCT01814072|38327002|FG017|Overall Study|Lost to Follow-up|1|||
17175847|NCT01814072|38327003|FG018|Overall Study|Lost to Follow-up|3|||
17175848|NCT01814072|38327004|FG019|Overall Study|Lost to Follow-up|3|||
17175849|NCT01814072|38327005|FG020|Overall Study|Lost to Follow-up|2|||
17175850|NCT01814072|38327006|FG021|Overall Study|Lost to Follow-up|1|||
17175851|NCT01814072|38327007|FG022|Overall Study|Lost to Follow-up|3|||
17175852|NCT01814072|38327008|FG023|Overall Study|Lost to Follow-up|1|||
17175853|NCT01814072|38327009|FG024|Overall Study|Lost to Follow-up|4|||
17175854|NCT01814072|38327010|FG025|Overall Study|Lost to Follow-up|1|||
17175855|NCT01814072|38327011|FG026|Overall Study|Lost to Follow-up|1|||
17175856|NCT01814072|38327012|FG027|Overall Study|Lost to Follow-up|2|||
17175857|NCT01814072|38327013|FG028|Overall Study|Lost to Follow-up|3|||
17175858|NCT01814072|38327014|FG029|Overall Study|Lost to Follow-up|3|||
17175859|NCT01814072|38327015|FG030|Overall Study|Lost to Follow-up|2|||
17175860|NCT01814072|38327016|FG031|Overall Study|Lost to Follow-up|0|||
17175861|NCT01814072|38326985|FG000|Overall Study|Withdrawal by Subject|2|||
17175862|NCT01814072|38326986|FG001|Overall Study|Withdrawal by Subject|0|||
17175863|NCT01814072|38326987|FG002|Overall Study|Withdrawal by Subject|1|||
17175864|NCT01814072|38326988|FG003|Overall Study|Withdrawal by Subject|0|||
17175865|NCT01814072|38326989|FG004|Overall Study|Withdrawal by Subject|2|||
17175866|NCT01814072|38326990|FG005|Overall Study|Withdrawal by Subject|3|||
17175867|NCT01814072|38326991|FG006|Overall Study|Withdrawal by Subject|1|||
17175868|NCT01814072|38326992|FG007|Overall Study|Withdrawal by Subject|0|||
17175869|NCT01814072|38326993|FG008|Overall Study|Withdrawal by Subject|1|||
17175870|NCT01814072|38326994|FG009|Overall Study|Withdrawal by Subject|2|||
17175871|NCT01814072|38326995|FG010|Overall Study|Withdrawal by Subject|0|||
17175872|NCT01814072|38326996|FG011|Overall Study|Withdrawal by Subject|0|||
17175873|NCT01814072|38326997|FG012|Overall Study|Withdrawal by Subject|1|||
17175874|NCT01814072|38326998|FG013|Overall Study|Withdrawal by Subject|1|||
17088273|NCT00332462|38228365|FG000|Overall Study|Adverse Event|5|||
17088274|NCT00332462|38228365|FG000|Overall Study|Abnormal Lab Value|1|||
17088275|NCT00332462|38228365|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
17088276|NCT00332462|38228365|FG000|Overall Study|no longer requires study drug|1|||
17088277|NCT00332462|38228365|FG000|Overall Study|Death|3|||
17088278|NCT00332462|38228365|FG000|Overall Study|Graft Loss|2|||
17088279|NCT00324038|38228374|FG000|Overall Study|Adverse Event|38|||
17088280|NCT00324038|38228375|FG001|Overall Study|Adverse Event|23|||
17088281|NCT00324038|38228374|FG000|Overall Study|Lack of Efficacy|5|||
17175875|NCT01814072|38326999|FG014|Overall Study|Withdrawal by Subject|1|||
17175876|NCT01814072|38327000|FG015|Overall Study|Withdrawal by Subject|1|||
17175877|NCT01814072|38327001|FG016|Overall Study|Withdrawal by Subject|0|||
17175878|NCT01814072|38327002|FG017|Overall Study|Withdrawal by Subject|0|||
17175879|NCT01814072|38327003|FG018|Overall Study|Withdrawal by Subject|0|||
17175880|NCT01814072|38327004|FG019|Overall Study|Withdrawal by Subject|2|||
17175881|NCT01814072|38327005|FG020|Overall Study|Withdrawal by Subject|0|||
17175882|NCT01814072|38327006|FG021|Overall Study|Withdrawal by Subject|0|||
17175883|NCT01814072|38327007|FG022|Overall Study|Withdrawal by Subject|1|||
17175884|NCT01814072|38327008|FG023|Overall Study|Withdrawal by Subject|0|||
17175885|NCT01814072|38327009|FG024|Overall Study|Withdrawal by Subject|2|||
17175886|NCT01814072|38327010|FG025|Overall Study|Withdrawal by Subject|1|||
17175887|NCT01814072|38327011|FG026|Overall Study|Withdrawal by Subject|1|||
17175888|NCT01814072|38327012|FG027|Overall Study|Withdrawal by Subject|2|||
17175889|NCT01814072|38327013|FG028|Overall Study|Withdrawal by Subject|1|||
17175890|NCT01814072|38327014|FG029|Overall Study|Withdrawal by Subject|0|||
17175891|NCT01814072|38327015|FG030|Overall Study|Withdrawal by Subject|0|||
17175892|NCT01814072|38327016|FG031|Overall Study|Withdrawal by Subject|0|||
17175893|NCT03038113|38327071|FG000|Overall Study|Withdrawal by Subject|0|||
17175894|NCT03038113|38327072|FG001|Overall Study|Withdrawal by Subject|0|||
17175895|NCT03038113|38327073|FG002|Overall Study|Withdrawal by Subject|1|||
17175896|NCT03038113|38327074|FG003|Overall Study|Withdrawal by Subject|0|||
17175897|NCT03038113|38327075|FG004|Overall Study|Withdrawal by Subject|0|||
17175898|NCT03038113|38327076|FG005|Overall Study|Withdrawal by Subject|0|||
17175899|NCT03038113|38327077|FG006|Overall Study|Withdrawal by Subject|0|||
17175900|NCT03038113|38327078|FG007|Overall Study|Withdrawal by Subject|0|||
17175901|NCT03038113|38327079|FG008|Overall Study|Withdrawal by Subject|0|||
17175902|NCT03038113|38327080|FG009|Overall Study|Withdrawal by Subject|0|||
17175903|NCT03038113|38327081|FG010|Overall Study|Withdrawal by Subject|0|||
17175904|NCT03038113|38327082|FG011|Overall Study|Withdrawal by Subject|0|||
17175905|NCT03038113|38327083|FG012|Overall Study|Withdrawal by Subject|0|||
17175906|NCT03038113|38327084|FG013|Overall Study|Withdrawal by Subject|1|||
17175907|NCT03038113|38327071|FG000|Overall Study|Lost to Follow-up|0|||
17175908|NCT03038113|38327072|FG001|Overall Study|Lost to Follow-up|0|||
17175909|NCT03038113|38327073|FG002|Overall Study|Lost to Follow-up|0|||
17175910|NCT03038113|38327074|FG003|Overall Study|Lost to Follow-up|0|||
17175911|NCT03038113|38327075|FG004|Overall Study|Lost to Follow-up|0|||
17175912|NCT03038113|38327076|FG005|Overall Study|Lost to Follow-up|0|||
17175913|NCT03038113|38327077|FG006|Overall Study|Lost to Follow-up|1|||
17175914|NCT03038113|38327078|FG007|Overall Study|Lost to Follow-up|0|||
17175915|NCT03038113|38327079|FG008|Overall Study|Lost to Follow-up|0|||
17175916|NCT03038113|38327080|FG009|Overall Study|Lost to Follow-up|0|||
17175917|NCT03038113|38327081|FG010|Overall Study|Lost to Follow-up|0|||
17175918|NCT03038113|38327082|FG011|Overall Study|Lost to Follow-up|0|||
17175919|NCT03038113|38327083|FG012|Overall Study|Lost to Follow-up|0|||
17175920|NCT03038113|38327084|FG013|Overall Study|Lost to Follow-up|0|||
17175921|NCT00968149|38327133|FG000|Overall Study|Adverse Event|5|||
17175922|NCT00968149|38327134|FG001|Overall Study|Adverse Event|1|||
17175923|NCT00968149|38327133|FG000|Overall Study|Lack of Efficacy|0|||
17175924|NCT00968149|38327134|FG001|Overall Study|Lack of Efficacy|4|||
17175925|NCT00968149|38327133|FG000|Overall Study|Lost to Follow-up|0|||
17175926|NCT00968149|38327134|FG001|Overall Study|Lost to Follow-up|1|||
17175927|NCT00968149|38327133|FG000|Overall Study|Protocol Violation|4|||
17175928|NCT00968149|38327134|FG001|Overall Study|Protocol Violation|0|||
17175929|NCT00968149|38327133|FG000|Overall Study|Withdrawal by Subject|2|||
17175930|NCT00968149|38327134|FG001|Overall Study|Withdrawal by Subject|0|||
17175931|NCT00963469|38327143|FG000|Overall Study|Adverse Event|15|||
17175932|NCT00963469|38327144|FG001|Overall Study|Adverse Event|11|||
17175933|NCT00963469|38327145|FG002|Overall Study|Adverse Event|1|||
17175934|NCT00963469|38327143|FG000|Overall Study|Lack of Efficacy|10|||
17175935|NCT00963469|38327144|FG001|Overall Study|Lack of Efficacy|7|||
17175936|NCT00963469|38327145|FG002|Overall Study|Lack of Efficacy|2|||
17175937|NCT00963469|38327143|FG000|Overall Study|Lost to Follow-up|1|||
17088282|NCT00324038|38228375|FG001|Overall Study|Lack of Efficacy|13|||
17088283|NCT00324038|38228374|FG000|Overall Study|Lost to Follow-up|0|||
17088284|NCT00324038|38228375|FG001|Overall Study|Lost to Follow-up|2|||
17088285|NCT00324038|38228374|FG000|Overall Study|Other|6|||
17088286|NCT00324038|38228375|FG001|Overall Study|Other|13|||
17088287|NCT00159861|38228383|FG000|Core Study - 16 Weeks|Death|3|||
17088288|NCT00159861|38228384|FG001|Core Study - 16 Weeks|Death|0|||
17088289|NCT00159861|38228383|FG000|Core Study - 16 Weeks|Adverse Event|12|||
17088290|NCT00159861|38228384|FG001|Core Study - 16 Weeks|Adverse Event|6|||
17088291|NCT00159861|38228383|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
17088292|NCT00159861|38228384|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
17088293|NCT00159861|38228383|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
17088294|NCT00159861|38228384|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
17175938|NCT00963469|38327144|FG001|Overall Study|Lost to Follow-up|1|||
17175939|NCT00963469|38327145|FG002|Overall Study|Lost to Follow-up|0|||
17175940|NCT00963469|38327143|FG000|Overall Study|Protocol Violation|5|||
17175941|NCT00963469|38327144|FG001|Overall Study|Protocol Violation|5|||
17175942|NCT00963469|38327145|FG002|Overall Study|Protocol Violation|3|||
17175943|NCT00963469|38327143|FG000|Overall Study|Withdrawal by Subject|4|||
17175944|NCT00963469|38327144|FG001|Overall Study|Withdrawal by Subject|1|||
17175945|NCT00963469|38327145|FG002|Overall Study|Withdrawal by Subject|1|||
17175946|NCT00963469|38327143|FG000|Overall Study|Pre-randomization Adverse Event|1|||
17175947|NCT00963469|38327144|FG001|Overall Study|Pre-randomization Adverse Event|2|||
17175948|NCT00963469|38327145|FG002|Overall Study|Pre-randomization Adverse Event|0|||
17088295|NCT00159861|38228383|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
17175949|NCT00963469|38327143|FG000|Overall Study|Moved|1|||
17175950|NCT00963469|38327144|FG001|Overall Study|Moved|0|||
17175951|NCT00963469|38327145|FG002|Overall Study|Moved|0|||
17175952|NCT00963469|38327143|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
17175953|NCT00963469|38327144|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
17175954|NCT00963469|38327145|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
17175955|NCT00897949|38327156|FG000|Overall Study|Adverse Event|1|||
17175956|NCT00897949|38327157|FG001|Overall Study|Adverse Event|1|||
17175957|NCT00897949|38327158|FG002|Overall Study|Adverse Event|0|||
17175958|NCT00897949|38327156|FG000|Overall Study|Lost to Follow-up|0|||
17175959|NCT00897949|38327157|FG001|Overall Study|Lost to Follow-up|2|||
17175960|NCT00897949|38327158|FG002|Overall Study|Lost to Follow-up|1|||
17175961|NCT00897949|38327156|FG000|Overall Study|Protocol Violation|6|||
17175962|NCT00897949|38327157|FG001|Overall Study|Protocol Violation|3|||
17175963|NCT00897949|38327158|FG002|Overall Study|Protocol Violation|1|||
17175964|NCT00897949|38327156|FG000|Overall Study|Withdrawal by Subject|1|||
17175965|NCT00897949|38327157|FG001|Overall Study|Withdrawal by Subject|2|||
17175966|NCT00897949|38327158|FG002|Overall Study|Withdrawal by Subject|0|||
17175967|NCT00897949|38327156|FG000|Overall Study|Patient Uncoorperative|0|||
17175968|NCT00897949|38327157|FG001|Overall Study|Patient Uncoorperative|2|||
17175969|NCT00897949|38327158|FG002|Overall Study|Patient Uncoorperative|1|||
17175970|NCT00897949|38327156|FG000|Overall Study|Lost to Follow-up|30|||
17175971|NCT00897949|38327157|FG001|Overall Study|Lost to Follow-up|23|||
17175972|NCT00897949|38327158|FG002|Overall Study|Lost to Follow-up|17|||
17175973|NCT00897949|38327156|FG000|Overall Study|Withdrawal by Subject|24|||
17175974|NCT00897949|38327157|FG001|Overall Study|Withdrawal by Subject|31|||
17175975|NCT00897949|38327158|FG002|Overall Study|Withdrawal by Subject|17|||
17175976|NCT00897949|38327156|FG000|Overall Study|Abnormal Prestudy Labs|2|||
17175977|NCT00897949|38327157|FG001|Overall Study|Abnormal Prestudy Labs|3|||
17175978|NCT00897949|38327158|FG002|Overall Study|Abnormal Prestudy Labs|4|||
17175979|NCT00897949|38327156|FG000|Overall Study|Abnormal Baseline ECG|2|||
17175980|NCT00897949|38327157|FG001|Overall Study|Abnormal Baseline ECG|2|||
17175981|NCT00897949|38327158|FG002|Overall Study|Abnormal Baseline ECG|4|||
17175982|NCT00897949|38327156|FG000|Overall Study|Need for Concom. Med.|0|||
17175983|NCT00897949|38327157|FG001|Overall Study|Need for Concom. Med.|1|||
17175984|NCT00897949|38327158|FG002|Overall Study|Need for Concom. Med.|1|||
17175985|NCT00897949|38327156|FG000|Overall Study|Lack of Migraine Attack|29|||
17175986|NCT00897949|38327157|FG001|Overall Study|Lack of Migraine Attack|30|||
17175987|NCT00897949|38327158|FG002|Overall Study|Lack of Migraine Attack|19|||
17175988|NCT00897949|38327156|FG000|Overall Study|Did not take study drug|9|||
17175989|NCT00897949|38327157|FG001|Overall Study|Did not take study drug|3|||
17175990|NCT00897949|38327158|FG002|Overall Study|Did not take study drug|4|||
17175991|NCT02760810|38327172|FG000|Overall Study|Protocol Violation|1|||
17175992|NCT02760654|38327178|FG000|Overall Study|Lost to Follow-up|3|||
17175993|NCT02760654|38327179|FG001|Overall Study|Lost to Follow-up|3|||
17175994|NCT02760654|38327178|FG000|Overall Study|Withdrawal by Subject|4|||
17175995|NCT02760654|38327179|FG001|Overall Study|Withdrawal by Subject|3|||
17175996|NCT00725491|38327187|FG000|Overall Study|Adverse Event|3|||
17175997|NCT00725491|38327188|FG001|Overall Study|Adverse Event|2|||
17175998|NCT00725491|38327187|FG000|Overall Study|Pregnancy|0|||
17175999|NCT00725491|38327188|FG001|Overall Study|Pregnancy|3|||
16996795|NCT00967616|38140941|FG000|Overall Study|Other|8|||
16996796|NCT00967616|38140942|FG001|Overall Study|Other|8|||
16996797|NCT00967616|38140941|FG000|Overall Study|Protocol Violation|1|||
16996798|NCT00967616|38140942|FG001|Overall Study|Protocol Violation|0|||
16996799|NCT00971204|38140952|FG000|Overall Study|Did not meet all criteria-not treated|14|||
17176000|NCT00725491|38327187|FG000|Overall Study|Risk for hyperstimulation|2|||
16996800|NCT00971204|38140952|FG000|Overall Study|Lost to Follow-up|10|||
17088296|NCT00159861|38228384|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
17088297|NCT00159861|38228383|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
17088298|NCT00159861|38228384|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
17088299|NCT00159861|38228383|FG000|Extension Study - up to 3 Years|Death|24|||
17088300|NCT00159861|38228384|FG001|Extension Study - up to 3 Years|Death|28|||
17088301|NCT00159861|38228383|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
17088302|NCT00159861|38228384|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
17088303|NCT00159861|38228383|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
17088304|NCT00159861|38228384|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
17088305|NCT00159861|38228383|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
17088306|NCT00159861|38228384|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
17176001|NCT00725491|38327188|FG001|Overall Study|Risk for hyperstimulation|9|||
17176002|NCT00725491|38327187|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
17176003|NCT00725491|38327188|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
17176004|NCT00725491|38327187|FG000|Overall Study|Fertilization failure|0|||
17176005|NCT00725491|38327188|FG001|Overall Study|Fertilization failure|1|||
17176006|NCT00725491|38327187|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
17176007|NCT00725491|38327188|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
17176008|NCT02634580|38327198|FG000|Double-blind Treatment Period|Subject Request|1|||
16996801|NCT03107793|38140956|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
17088307|NCT00159861|38228383|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
17088308|NCT00159861|38228384|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
17088309|NCT00331760|38228397|FG000|Overall Study|Ineligible / no protocol treatment|15|||
17088310|NCT00331760|38228398|FG001|Overall Study|Ineligible / no protocol treatment|8|||
17088311|NCT00225147|38228409|FG000|Open-label Phase|Lost to Follow-up|0|||
17088312|NCT00225147|38228410|FG001|Open-label Phase|Lost to Follow-up|0|||
17088313|NCT00225147|38228411|FG002|Open-label Phase|Lost to Follow-up|0|||
17176009|NCT02634580|38327199|FG001|Double-blind Treatment Period|Subject Request|0|||
17176010|NCT02634580|38327200|FG002|Double-blind Treatment Period|Subject Request|1|||
17176011|NCT02634580|38327201|FG003|Double-blind Treatment Period|Subject Request|1|||
17176012|NCT02634580|38327198|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
17088314|NCT00225147|38228412|FG003|Open-label Phase|Lost to Follow-up|4|||
17088315|NCT00225147|38228409|FG000|Open-label Phase|Withdrawal by Subject|0|||
17088316|NCT00225147|38228410|FG001|Open-label Phase|Withdrawal by Subject|0|||
17088317|NCT00225147|38228411|FG002|Open-label Phase|Withdrawal by Subject|0|||
17088318|NCT00225147|38228412|FG003|Open-label Phase|Withdrawal by Subject|6|||
17088319|NCT00313014|38228427|FG000|Overall Study|Withdrawal by Subject|11|||
17088320|NCT00313014|38228428|FG001|Overall Study|Withdrawal by Subject|7|||
17176013|NCT02634580|38327199|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
17176014|NCT02634580|38327200|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
17176015|NCT02634580|38327201|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
17176016|NCT02225366|38327212|FG000|Overall Study|Lack of Efficacy|1|||
17176017|NCT02225366|38327213|FG001|Overall Study|Lack of Efficacy|0|||
17176018|NCT00697255|38327221|FG000|Stage 1a|Insufficient ovarian response|1|||
17176019|NCT00697255|38327222|FG001|Stage 1a|Insufficient ovarian response|0|||
17176020|NCT00697255|38327221|FG000|Stage 1a|Multifollicular growth|1|||
17176021|NCT00697255|38327222|FG001|Stage 1a|Multifollicular growth|0|||
17176022|NCT00697255|38327221|FG000|Stage 1a|Not growing of dominant follicle|1|||
17176023|NCT00697255|38327222|FG001|Stage 1a|Not growing of dominant follicle|0|||
17176024|NCT00697255|38327221|FG000|Stage 1b|Not growing of dominant follicle|0|||
17176025|NCT00697255|38327222|FG001|Stage 1b|Not growing of dominant follicle|1|||
17176026|NCT00697255|38327221|FG000|Stage 1b|Insufficient ovarian response|0|||
17176027|NCT00697255|38327222|FG001|Stage 1b|Insufficient ovarian response|1|||
17176028|NCT02764320|38327230|FG000|Overall Study|Withdrawal by Subject|35|||
17176029|NCT02764320|38327231|FG001|Overall Study|Withdrawal by Subject|38|||
17176030|NCT02764320|38327230|FG000|Overall Study|Protocol Violation|11|||
17176031|NCT02764320|38327231|FG001|Overall Study|Protocol Violation|6|||
17176032|NCT02764320|38327230|FG000|Overall Study|Adverse Event|2|||
17176033|NCT02764320|38327231|FG001|Overall Study|Adverse Event|0|||
17176034|NCT02764320|38327230|FG000|Overall Study|Health Issues unable to continue|2|||
17176035|NCT02764320|38327231|FG001|Overall Study|Health Issues unable to continue|0|||
17176036|NCT02764320|38327230|FG000|Overall Study|Did not meet inclusion criteria|1|||
17176037|NCT02764320|38327231|FG001|Overall Study|Did not meet inclusion criteria|0|||
17176038|NCT02764320|38327230|FG000|Overall Study|Subject moved|0|||
17176039|NCT02764320|38327231|FG001|Overall Study|Subject moved|2|||
17176040|NCT02764320|38327230|FG000|Overall Study|Overused medication unavailable|0|||
17176041|NCT02764320|38327231|FG001|Overall Study|Overused medication unavailable|1|||
17176042|NCT02764320|38327230|FG000|Overall Study|Seeking care outside site|0|||
17176043|NCT02764320|38327231|FG001|Overall Study|Seeking care outside site|1|||
17176044|NCT02764320|38327230|FG000|Overall Study|Technology barriers|0|||
17176045|NCT02764320|38327231|FG001|Overall Study|Technology barriers|1|||
17176046|NCT02851407|38327239|FG000|Overall Study|Withdrawal by parent/guardian|2|||
17176047|NCT02851407|38327240|FG001|Overall Study|Withdrawal by parent/guardian|7|||
17176048|NCT02851407|38327239|FG000|Overall Study|Protocol deviation|0|||
17176049|NCT02851407|38327240|FG001|Overall Study|Protocol deviation|1|||
17176050|NCT02851407|38327239|FG000|Overall Study|Transferred to another hospital to continue|1|||
17176051|NCT02851407|38327240|FG001|Overall Study|Transferred to another hospital to continue|0|||
17176052|NCT02851407|38327239|FG000|Overall Study|Other Death|30|||
17176053|NCT02851407|38327240|FG001|Overall Study|Other Death|20|||
17176054|NCT02851407|38327239|FG000|Overall Study|Adverse event, serious fatal|6|||
17176055|NCT02851407|38327240|FG001|Overall Study|Adverse event, serious fatal|8|||
16781317|NCT02142712|37720486|FG000|Overall Study|Lost to Follow-up|1|||
17088321|NCT00313014|38228429|FG002|Overall Study|Withdrawal by Subject|5|||
17088322|NCT00313014|38228427|FG000|Overall Study|Adverse Event|14|||
17088323|NCT00313014|38228428|FG001|Overall Study|Adverse Event|29|||
17088324|NCT00313014|38228429|FG002|Overall Study|Adverse Event|16|||
17088325|NCT00313014|38228427|FG000|Overall Study|Lost to Follow-up|7|||
17176056|NCT02851407|38327239|FG000|Overall Study|Consent withdrawn by participant|5|||
17176057|NCT02851407|38327240|FG001|Overall Study|Consent withdrawn by participant|3|||
17176058|NCT02851407|38327239|FG000|Overall Study|Screen failure|2|||
17176059|NCT02851407|38327240|FG001|Overall Study|Screen failure|1|||
17176060|NCT02851407|38327239|FG000|Overall Study|Disease relapse|9|||
17176061|NCT02851407|38327240|FG001|Overall Study|Disease relapse|6|||
17176062|NCT02851407|38327239|FG000|Overall Study|Physician Decision|7|||
17176063|NCT02851407|38327240|FG001|Overall Study|Physician Decision|6|||
17176064|NCT02851407|38327239|FG000|Overall Study|Transferred to hospital closer to home|0|||
17176065|NCT02851407|38327240|FG001|Overall Study|Transferred to hospital closer to home|1|||
17176066|NCT02851407|38327239|FG000|Overall Study|Enrolled in an investigational study|0|||
17176067|NCT02851407|38327240|FG001|Overall Study|Enrolled in an investigational study|1|||
17176068|NCT02851407|38327239|FG000|Overall Study|Early recovery|1|||
17176069|NCT02851407|38327240|FG001|Overall Study|Early recovery|0|||
17176070|NCT02851407|38327239|FG000|Overall Study|Adverse event, non-fatal|7|||
17176071|NCT02851407|38327240|FG001|Overall Study|Adverse event, non-fatal|5|||
17176072|NCT02851407|38327239|FG000|Overall Study|Lost to Follow-up|0|||
17176073|NCT02851407|38327240|FG001|Overall Study|Lost to Follow-up|2|||
17176074|NCT02636608|38327246|FG000|Overall Study|Failure to Return|4|||
17176075|NCT02636608|38327246|FG000|Overall Study|Insufficient Virological Response|1|||
17176076|NCT02636608|38327246|FG000|Overall Study|Death|3|||
17176077|NCT02636608|38327246|FG000|Overall Study|Other|2|||
17088326|NCT00313014|38228428|FG001|Overall Study|Lost to Follow-up|6|||
17088327|NCT00313014|38228429|FG002|Overall Study|Lost to Follow-up|10|||
17088328|NCT00313014|38228427|FG000|Overall Study|Administrative|9|||
17088329|NCT00313014|38228428|FG001|Overall Study|Administrative|6|||
17088330|NCT00313014|38228429|FG002|Overall Study|Administrative|14|||
17088331|NCT00313014|38228427|FG000|Overall Study|Lack of Efficacy|52|||
17088332|NCT00313014|38228428|FG001|Overall Study|Lack of Efficacy|25|||
17088333|NCT00313014|38228429|FG002|Overall Study|Lack of Efficacy|16|||
17088334|NCT00157209|38228440|FG000|Overall Study|Ongoing at data cut-off|10|||
17088335|NCT00157209|38228441|FG001|Overall Study|Ongoing at data cut-off|0|||
17088336|NCT00312858|38228449|FG000|Overall Study|Adverse Event|0|||
17088337|NCT00312858|38228450|FG001|Overall Study|Adverse Event|1|||
17088338|NCT00312858|38228449|FG000|Overall Study|Lost to Follow-up|25|||
17088339|NCT00312858|38228450|FG001|Overall Study|Lost to Follow-up|42|||
17088340|NCT00312858|38228449|FG000|Overall Study|Protocol Violation|3|||
17088341|NCT00312858|38228450|FG001|Overall Study|Protocol Violation|8|||
17088342|NCT00312858|38228449|FG000|Overall Study|Withdraw by Participant|20|||
17088343|NCT00312858|38228450|FG001|Overall Study|Withdraw by Participant|20|||
17088344|NCT00312858|38228449|FG000|Overall Study|Participant Moved|11|||
17088345|NCT00312858|38228450|FG001|Overall Study|Participant Moved|10|||
17088346|NCT00312858|38228449|FG000|Overall Study|Other|9|||
17176078|NCT02636608|38327246|FG000|Overall Study|Did Not Receive Treatment|1|||
17176079|NCT02759562|38327255|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
17176080|NCT02759562|38327256|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
17176081|NCT02759562|38327255|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
17176082|NCT02759562|38327256|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
17088347|NCT00312858|38228450|FG001|Overall Study|Other|12|||
17088348|NCT00130533|38228458|FG000|Overall Study|Withdrawal by Subject|33|||
17088349|NCT00130533|38228459|FG001|Overall Study|Withdrawal by Subject|6|||
17088350|NCT00130533|38228458|FG000|Overall Study|Adverse Event|34|||
17088351|NCT00130533|38228459|FG001|Overall Study|Adverse Event|1|||
17088352|NCT00130533|38228458|FG000|Overall Study|Disease relapse|9|||
17088353|NCT00130533|38228459|FG001|Overall Study|Disease relapse|13|||
17088354|NCT00130533|38228458|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
17088355|NCT00130533|38228459|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
17088356|NCT00130533|38228458|FG000|Overall Study|Death|4|||
17088357|NCT00130533|38228459|FG001|Overall Study|Death|2|||
17088358|NCT00130533|38228458|FG000|Overall Study|Protocol Violation|5|||
17088359|NCT00130533|38228459|FG001|Overall Study|Protocol Violation|1|||
17088360|NCT00130533|38228458|FG000|Overall Study|Lost to Follow-up|1|||
17088361|NCT00130533|38228459|FG001|Overall Study|Lost to Follow-up|1|||
17088362|NCT00130533|38228458|FG000|Overall Study|Sponsor´s decision|2|||
17088363|NCT00130533|38228459|FG001|Overall Study|Sponsor´s decision|0|||
17088364|NCT00130533|38228458|FG000|Overall Study|Second Primary Malignancy|0|||
17088365|NCT00130533|38228459|FG001|Overall Study|Second Primary Malignancy|1|||
17088366|NCT00130533|38228458|FG000|Overall Study|Other|12|||
17088367|NCT00130533|38228459|FG001|Overall Study|Other|5|||
17088368|NCT00312702|38228468|FG000|Immunization Phase|Lost to Follow-up|0|||
17088369|NCT00312702|38228469|FG001|Immunization Phase|Lost to Follow-up|1|||
17088370|NCT00312702|38228470|FG002|Immunization Phase|Lost to Follow-up|0|||
17088371|NCT00156819|38228481|FG000|Overall Study|Lost to Follow-up|1|||
17088372|NCT00156819|38228482|FG001|Overall Study|Lost to Follow-up|1|||
17088373|NCT00156819|38228483|FG002|Overall Study|Lost to Follow-up|3|||
17088374|NCT03825042|38228493|FG000|Overall Study|Adverse Event|1|||
17088375|NCT03825042|38228494|FG001|Overall Study|Adverse Event|0|||
17088376|NCT03825042|38228493|FG000|Overall Study|Withdrawal by Subject|1|||
17088377|NCT03825042|38228494|FG001|Overall Study|Withdrawal by Subject|0|||
17176083|NCT02746575|38327263|FG000|Overall Study|Surgery cancelled or time chaned|13|||
17176084|NCT02746575|38327263|FG000|Overall Study|Received epidural|10|||
17176085|NCT02746575|38327263|FG000|Overall Study|Withdrawal by Subject|3|||
17088378|NCT00129987|38228502|FG000|1st Educational Session|Withdrawal by Subject|141|||
17088379|NCT00129987|38228503|FG001|1st Educational Session|Withdrawal by Subject|109|||
17088380|NCT00129987|38228502|FG000|1 Year|Withdrawal by Subject|32|||
17088381|NCT00129987|38228503|FG001|1 Year|Withdrawal by Subject|21|||
17088382|NCT00224133|38228509|FG000|Overall Study|Adverse Event|93|||
17176086|NCT02746575|38327263|FG000|Overall Study|Bradycardia/hypotension|9|||
17176087|NCT02746575|38327263|FG000|Overall Study|Study paused|8|||
17176088|NCT02746575|38327263|FG000|Overall Study|put on beta-blocker|3|||
17176089|NCT02746575|38327263|FG000|Overall Study|type of surgery|1|||
17176090|NCT02746575|38327263|FG000|Overall Study|typ of surgery|1|||
17176091|NCT02746575|38327263|FG000|Overall Study|PI unavailable|1|||
17176092|NCT02746575|38327263|FG000|Overall Study|Unknown history of CVA|1|||
17176093|NCT03625466|38327269|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
17176094|NCT03625466|38327270|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
17176095|NCT03625466|38327271|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
17176096|NCT03625466|38327269|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
17176097|NCT03625466|38327270|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
17176098|NCT03625466|38327271|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
17176099|NCT03625466|38327269|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
17176100|NCT03625466|38327270|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
17176101|NCT03625466|38327271|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
17176102|NCT02853123|38327278|FG000|Treatment Period 1|Adverse Event|0|||
17176103|NCT02853123|38327279|FG001|Treatment Period 1|Adverse Event|3|||
17176104|NCT02853123|38327278|FG000|Washout Period|Worsening of COPD|0|||
17176105|NCT02853123|38327279|FG001|Washout Period|Worsening of COPD|3|||
17176106|NCT02853123|38327278|FG000|Washout Period|Adverse Event|1|||
17176107|NCT02853123|38327279|FG001|Washout Period|Adverse Event|0|||
17176108|NCT02634346|38327289|FG000|Overall Study|Withdrawal by Subject|8|||
17176109|NCT02634346|38327290|FG001|Overall Study|Withdrawal by Subject|9|||
17088383|NCT00224133|38228509|FG000|Overall Study|Protocol Violation|6|||
17088384|NCT00224133|38228509|FG000|Overall Study|Withdrawal by Subject|33|||
17088385|NCT00224133|38228509|FG000|Overall Study|Lack of Efficacy|58|||
17176110|NCT02634346|38327291|FG002|Overall Study|Withdrawal by Subject|8|||
17176111|NCT02634346|38327289|FG000|Overall Study|Adverse Event|2|||
17176112|NCT02634346|38327290|FG001|Overall Study|Adverse Event|2|||
17176113|NCT02634346|38327291|FG002|Overall Study|Adverse Event|7|||
17176114|NCT02634346|38327289|FG000|Overall Study|Lack of Efficacy|1|||
17176115|NCT02634346|38327290|FG001|Overall Study|Lack of Efficacy|2|||
17176116|NCT02634346|38327291|FG002|Overall Study|Lack of Efficacy|8|||
17176117|NCT02634346|38327289|FG000|Overall Study|Lost to Follow-up|1|||
17176118|NCT02634346|38327290|FG001|Overall Study|Lost to Follow-up|0|||
17176119|NCT02634346|38327291|FG002|Overall Study|Lost to Follow-up|0|||
17176120|NCT02634346|38327289|FG000|Overall Study|Protocol Violation|0|||
17176121|NCT02634346|38327290|FG001|Overall Study|Protocol Violation|1|||
17176122|NCT02634346|38327291|FG002|Overall Study|Protocol Violation|0|||
17176123|NCT00849147|38327299|FG000|Overall Study|Withdrawal by Subject|1|||
17176124|NCT00849147|38327299|FG000|Overall Study|Protocol Violation|2|||
17176125|NCT00849147|38327299|FG000|Overall Study|Disease Relapse/Progression|2|||
17088386|NCT00224133|38228509|FG000|Overall Study|Lost to Follow-up|21|||
17088387|NCT00224133|38228509|FG000|Overall Study|Physician Decision|1|||
17176126|NCT00101166|38327303|FG000|Overall Study|progressive disease|10|||
17176127|NCT02759016|38327309|FG000|Overall Study|Not treated with BI 836826|1|||
17176128|NCT02759016|38327310|FG001|Overall Study|Not treated with BI 836826|0|||
17176129|NCT02759016|38327309|FG000|Overall Study|Progressive disease|1|||
17176130|NCT02759016|38327310|FG001|Overall Study|Progressive disease|0|||
17176131|NCT02759016|38327309|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
17176132|NCT02759016|38327310|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
17176133|NCT02759016|38327309|FG000|Overall Study|Other not defined above|2|||
17176134|NCT02759016|38327310|FG001|Overall Study|Other not defined above|1|||
17176135|NCT02852967|38327322|FG000|Overall Study|Adverse Event|3|||
17176136|NCT02852967|38327323|FG001|Overall Study|Adverse Event|1|||
17176137|NCT02852967|38327324|FG002|Overall Study|Adverse Event|0|||
17176138|NCT02852967|38327325|FG003|Overall Study|Adverse Event|1|||
17176139|NCT02852967|38327326|FG004|Overall Study|Adverse Event|0|||
17176140|NCT02852967|38327322|FG000|Overall Study|Death|1|||
17176141|NCT02852967|38327323|FG001|Overall Study|Death|0|||
17176142|NCT02852967|38327324|FG002|Overall Study|Death|0|||
17176143|NCT02852967|38327325|FG003|Overall Study|Death|0|||
17176144|NCT02852967|38327326|FG004|Overall Study|Death|0|||
17176145|NCT02852967|38327322|FG000|Overall Study|Lost to Follow-up|1|||
17176146|NCT02852967|38327323|FG001|Overall Study|Lost to Follow-up|2|||
17088388|NCT00224133|38228509|FG000|Overall Study|Other|14|||
17176147|NCT02852967|38327324|FG002|Overall Study|Lost to Follow-up|3|||
17176148|NCT02852967|38327325|FG003|Overall Study|Lost to Follow-up|4|||
17176149|NCT02852967|38327326|FG004|Overall Study|Lost to Follow-up|4|||
17176150|NCT02852967|38327322|FG000|Overall Study|Withdrawal by Subject|6|||
17176151|NCT02852967|38327323|FG001|Overall Study|Withdrawal by Subject|12|||
17176152|NCT02852967|38327324|FG002|Overall Study|Withdrawal by Subject|7|||
17088389|NCT00224055|38228515|FG000|Overall Study|Adverse Event|9|||
17088390|NCT00224055|38228516|FG001|Overall Study|Adverse Event|3|||
17088391|NCT00224055|38228515|FG000|Overall Study|Lost to Follow-up|1|||
17088392|NCT00224055|38228516|FG001|Overall Study|Lost to Follow-up|2|||
17176153|NCT02852967|38327325|FG003|Overall Study|Withdrawal by Subject|10|||
17176154|NCT02852967|38327326|FG004|Overall Study|Withdrawal by Subject|10|||
17176155|NCT02852967|38327322|FG000|Overall Study|SAE|0|||
17176156|NCT02852967|38327323|FG001|Overall Study|SAE|0|||
17176157|NCT02852967|38327324|FG002|Overall Study|SAE|0|||
17176158|NCT02852967|38327325|FG003|Overall Study|SAE|3|||
17176159|NCT02852967|38327326|FG004|Overall Study|SAE|0|||
17176160|NCT02852967|38327322|FG000|Overall Study|Elevated Liver Enzymes|2|||
17176161|NCT02852967|38327323|FG001|Overall Study|Elevated Liver Enzymes|0|||
17176162|NCT02852967|38327324|FG002|Overall Study|Elevated Liver Enzymes|0|||
17176163|NCT02852967|38327325|FG003|Overall Study|Elevated Liver Enzymes|2|||
17088393|NCT00224055|38228515|FG000|Overall Study|Protocol Violation|1|||
17088394|NCT00224055|38228516|FG001|Overall Study|Protocol Violation|1|||
17088395|NCT00224055|38228515|FG000|Overall Study|Inclusion Violation|3|||
17088396|NCT00224055|38228516|FG001|Overall Study|Inclusion Violation|6|||
17088397|NCT00224055|38228515|FG000|Overall Study|Withdrawal by Subject|0|||
17088398|NCT00224055|38228516|FG001|Overall Study|Withdrawal by Subject|2|||
17088399|NCT00224055|38228515|FG000|Overall Study|Other|1|||
17088400|NCT00224055|38228516|FG001|Overall Study|Other|0|||
17088401|NCT00150969|38228524|FG000|24 Month Main Study|Adverse Event|3|||
17088402|NCT00150969|38228525|FG001|24 Month Main Study|Adverse Event|4|||
17088403|NCT00150969|38228524|FG000|24 Month Main Study|Death|1|||
17088404|NCT00150969|38228525|FG001|24 Month Main Study|Death|1|||
17088405|NCT00150969|38228524|FG000|24 Month Main Study|Lack of Efficacy|1|||
17088406|NCT00150969|38228525|FG001|24 Month Main Study|Lack of Efficacy|8|||
17088407|NCT00150969|38228524|FG000|24 Month Main Study|Lost to Follow-up|3|||
17088408|NCT00150969|38228525|FG001|24 Month Main Study|Lost to Follow-up|2|||
17088409|NCT00150969|38228524|FG000|24 Month Main Study|Protocol Violation|4|||
17088410|NCT00150969|38228525|FG001|24 Month Main Study|Protocol Violation|2|||
17088411|NCT00150969|38228524|FG000|24 Month Main Study|Withdrawal by Subject|7|||
17088412|NCT00150969|38228525|FG001|24 Month Main Study|Withdrawal by Subject|4|||
17088413|NCT00150969|38228524|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
17088414|NCT00150969|38228525|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
17088415|NCT00150969|38228524|FG000|24-48 Month Extension|Lack of Efficacy|0|||
17088416|NCT00150969|38228525|FG001|24-48 Month Extension|Lack of Efficacy|1|||
17088417|NCT00150969|38228524|FG000|24-48 Month Extension|Adverse Event|1|||
17088418|NCT00150969|38228525|FG001|24-48 Month Extension|Adverse Event|3|||
17088419|NCT00150969|38228524|FG000|24-48 Month Extension|Other Reason|81|||
17088420|NCT00150969|38228525|FG001|24-48 Month Extension|Other Reason|91|||
17088421|NCT00150345|38228534|FG000|Overall Study|Death|5|||
17088422|NCT00150345|38228535|FG001|Overall Study|Death|2|||
17088423|NCT00150345|38228534|FG000|Overall Study|Adverse Event|8|||
17088424|NCT00150345|38228535|FG001|Overall Study|Adverse Event|6|||
17088425|NCT00150345|38228534|FG000|Overall Study|Lack of Efficacy|5|||
17088426|NCT00150345|38228535|FG001|Overall Study|Lack of Efficacy|4|||
17088427|NCT00150345|38228534|FG000|Overall Study|Withdrawal by Subject|3|||
17088428|NCT00150345|38228535|FG001|Overall Study|Withdrawal by Subject|4|||
17088429|NCT00150345|38228534|FG000|Overall Study|Laboratory abnormality|1|||
17088430|NCT00150345|38228535|FG001|Overall Study|Laboratory abnormality|2|||
17088431|NCT00150345|38228534|FG000|Overall Study|Other|12|||
17088432|NCT00150345|38228535|FG001|Overall Study|Other|14|||
17088433|NCT00223977|38228545|FG000|Overall Study|Adverse Event|7|||
17088434|NCT00223977|38228546|FG001|Overall Study|Adverse Event|10|||
17088435|NCT00223977|38228547|FG002|Overall Study|Adverse Event|0|||
17088436|NCT00223977|38228545|FG000|Overall Study|Protocol Violation|0|||
17088437|NCT00223977|38228546|FG001|Overall Study|Protocol Violation|0|||
17088438|NCT00223977|38228547|FG002|Overall Study|Protocol Violation|1|||
17088439|NCT00223977|38228545|FG000|Overall Study|Withdrawal by Subject|1|||
17088440|NCT00223977|38228546|FG001|Overall Study|Withdrawal by Subject|1|||
17088441|NCT00223977|38228547|FG002|Overall Study|Withdrawal by Subject|2|||
17088442|NCT00223977|38228545|FG000|Overall Study|Other|1|||
17088443|NCT00223977|38228546|FG001|Overall Study|Other|0|||
17088444|NCT00223977|38228547|FG002|Overall Study|Other|0|||
17088445|NCT00148941|38228559|FG000|Overall Study|Lost to Follow-up|17|||
17088446|NCT00148941|38228560|FG001|Overall Study|Lost to Follow-up|24|||
17088447|NCT00148941|38228561|FG002|Overall Study|Lost to Follow-up|18|||
17088448|NCT00148941|38228562|FG003|Overall Study|Lost to Follow-up|22|||
17088449|NCT00148941|38228559|FG000|Overall Study|Withdrawal by Subject|1|||
17088450|NCT00148941|38228560|FG001|Overall Study|Withdrawal by Subject|0|||
17088451|NCT00148941|38228561|FG002|Overall Study|Withdrawal by Subject|1|||
17176164|NCT02852967|38327326|FG004|Overall Study|Elevated Liver Enzymes|2|||
17176165|NCT02852967|38327322|FG000|Overall Study|Physician Decision|0|||
17176166|NCT02852967|38327323|FG001|Overall Study|Physician Decision|0|||
17176167|NCT02852967|38327324|FG002|Overall Study|Physician Decision|0|||
17176168|NCT02852967|38327325|FG003|Overall Study|Physician Decision|1|||
17088452|NCT00148941|38228562|FG003|Overall Study|Withdrawal by Subject|0|||
17088453|NCT00148941|38228559|FG000|Overall Study|Other|0|||
17088454|NCT00148941|38228560|FG001|Overall Study|Other|0|||
17088455|NCT00148941|38228561|FG002|Overall Study|Other|1|||
17088456|NCT00148941|38228562|FG003|Overall Study|Other|2|||
17088457|NCT00148317|38228572|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
17088458|NCT00148317|38228572|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
17088459|NCT00148317|38228572|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
17088460|NCT00323882|38228584|FG000|Overall Study|Adverse Event|2|||
17088461|NCT00323882|38228585|FG001|Overall Study|Adverse Event|1|||
17088462|NCT00323882|38228586|FG002|Overall Study|Adverse Event|1|||
17088463|NCT00323882|38228587|FG003|Overall Study|Adverse Event|1|||
17088464|NCT00323882|38228588|FG004|Overall Study|Adverse Event|3|||
17088465|NCT00323882|38228584|FG000|Overall Study|Disease Progression|6|||
17088466|NCT00323882|38228585|FG001|Overall Study|Disease Progression|4|||
17088467|NCT00323882|38228586|FG002|Overall Study|Disease Progression|10|||
17088468|NCT00323882|38228587|FG003|Overall Study|Disease Progression|5|||
17088469|NCT00323882|38228588|FG004|Overall Study|Disease Progression|22|||
17088470|NCT00323882|38228584|FG000|Overall Study|Death|0|||
17088471|NCT00323882|38228585|FG001|Overall Study|Death|1|||
17088472|NCT00323882|38228586|FG002|Overall Study|Death|1|||
17088473|NCT00323882|38228587|FG003|Overall Study|Death|0|||
17088474|NCT00323882|38228588|FG004|Overall Study|Death|5|||
17088475|NCT00323882|38228584|FG000|Overall Study|Lost to Follow-up|0|||
17088476|NCT00323882|38228585|FG001|Overall Study|Lost to Follow-up|0|||
17088477|NCT00323882|38228586|FG002|Overall Study|Lost to Follow-up|1|||
17088478|NCT00323882|38228587|FG003|Overall Study|Lost to Follow-up|0|||
17088479|NCT00323882|38228588|FG004|Overall Study|Lost to Follow-up|1|||
17088480|NCT00323882|38228584|FG000|Overall Study|Other|0|||
17088481|NCT00323882|38228585|FG001|Overall Study|Other|0|||
17088482|NCT00323882|38228586|FG002|Overall Study|Other|0|||
17088483|NCT00323882|38228587|FG003|Overall Study|Other|1|||
17088484|NCT00323882|38228588|FG004|Overall Study|Other|1|||
17088485|NCT00331682|38228609|FG000|Overall Study|Adverse Event|1|||
17088486|NCT00323492|38228615|FG000|Study Phase 1|Adverse Event|2|||
17088487|NCT00323492|38228616|FG001|Study Phase 1|Adverse Event|0|||
17088488|NCT00323492|38228617|FG002|Study Phase 1|Adverse Event|0|||
17088489|NCT00323492|38228615|FG000|Study Phase 2|Adverse Event|1|||
17088490|NCT00323492|38228616|FG001|Study Phase 2|Adverse Event|0|||
17088491|NCT00323492|38228617|FG002|Study Phase 2|Adverse Event|0|||
17088492|NCT00323492|38228615|FG000|Study Phase 2|Physician Decision|1|||
17088493|NCT00323492|38228616|FG001|Study Phase 2|Physician Decision|0|||
17088494|NCT00323492|38228617|FG002|Study Phase 2|Physician Decision|0|||
17176169|NCT02852967|38327326|FG004|Overall Study|Physician Decision|0|||
17176170|NCT02852967|38327322|FG000|Overall Study|Lack of Efficacy|0|||
17176171|NCT02852967|38327323|FG001|Overall Study|Lack of Efficacy|1|||
17176172|NCT02852967|38327324|FG002|Overall Study|Lack of Efficacy|0|||
17176173|NCT02852967|38327325|FG003|Overall Study|Lack of Efficacy|0|||
17176174|NCT02852967|38327326|FG004|Overall Study|Lack of Efficacy|0|||
17176175|NCT02852967|38327322|FG000|Overall Study|Non-compliance|0|||
17176176|NCT02852967|38327323|FG001|Overall Study|Non-compliance|0|||
17176177|NCT02852967|38327324|FG002|Overall Study|Non-compliance|1|||
17176178|NCT02852967|38327325|FG003|Overall Study|Non-compliance|1|||
17176179|NCT02852967|38327326|FG004|Overall Study|Non-compliance|0|||
17176180|NCT02852967|38327322|FG000|Overall Study|Dispensing Drug Violation|0|||
17176181|NCT02852967|38327323|FG001|Overall Study|Dispensing Drug Violation|0|||
17176182|NCT02852967|38327324|FG002|Overall Study|Dispensing Drug Violation|1|||
17176183|NCT02852967|38327325|FG003|Overall Study|Dispensing Drug Violation|0|||
17176184|NCT02852967|38327326|FG004|Overall Study|Dispensing Drug Violation|0|||
17176185|NCT02852967|38327322|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
17176186|NCT02852967|38327323|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
17176187|NCT02852967|38327324|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
17176188|NCT02852967|38327325|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
17176189|NCT02852967|38327326|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
17176190|NCT02762994|38327354|FG000|Overall Study|Withdrawal by Subject|0|||
17176191|NCT02762994|38327355|FG001|Overall Study|Withdrawal by Subject|1|||
17176192|NCT02762994|38327356|FG002|Overall Study|Withdrawal by Subject|2|||
17176193|NCT02762994|38327357|FG003|Overall Study|Withdrawal by Subject|0|||
17176194|NCT02762994|38327354|FG000|Overall Study|Protocol Violation|1|||
17088495|NCT00323492|38228615|FG000|Study Phase 2|Lost to Follow-up|1|||
17088496|NCT00323492|38228616|FG001|Study Phase 2|Lost to Follow-up|0|||
17088497|NCT00323492|38228617|FG002|Study Phase 2|Lost to Follow-up|0|||
17176195|NCT02762994|38327355|FG001|Overall Study|Protocol Violation|0|||
17176196|NCT02762994|38327356|FG002|Overall Study|Protocol Violation|0|||
17088498|NCT00323492|38228615|FG000|Study Phase 2|Withdrawal by Subject|0|||
17088499|NCT00323492|38228616|FG001|Study Phase 2|Withdrawal by Subject|1|||
17088500|NCT00323492|38228617|FG002|Study Phase 2|Withdrawal by Subject|0|||
17176197|NCT02762994|38327357|FG003|Overall Study|Protocol Violation|2|||
17176198|NCT02852265|38327373|FG000|3-month Follow-up|Lost to Follow-up|1|||
17176199|NCT02852265|38327374|FG001|3-month Follow-up|Lost to Follow-up|1|||
17176200|NCT02633800|38327386|FG000|Overall Study|Death|3|||
17176201|NCT02633800|38327387|FG001|Overall Study|Death|3|||
17176202|NCT02633800|38327386|FG000|Overall Study|Reason not provided|1|||
17176203|NCT02633800|38327387|FG001|Overall Study|Reason not provided|0|||
17176204|NCT02633800|38327386|FG000|Overall Study|Radiologic(al) progression|23|||
17176205|NCT02633800|38327387|FG001|Overall Study|Radiologic(al) progression|23|||
17176206|NCT02633800|38327386|FG000|Overall Study|Clinical progression|3|||
17176207|NCT02633800|38327387|FG001|Overall Study|Clinical progression|6|||
17176208|NCT02633800|38327386|FG000|Overall Study|Study terminated by sponsor|6|||
17176209|NCT02633800|38327387|FG001|Overall Study|Study terminated by sponsor|5|||
17176210|NCT02633800|38327386|FG000|Overall Study|Adverse event, non-fatal|7|||
17176211|NCT02633800|38327387|FG001|Overall Study|Adverse event, non-fatal|2|||
17176212|NCT02633800|38327386|FG000|Overall Study|Withdrawal by Subject|0|||
17176213|NCT02633800|38327387|FG001|Overall Study|Withdrawal by Subject|3|||
17176214|NCT02633800|38327386|FG000|Overall Study|Patient Request|1|||
17176215|NCT02633800|38327387|FG001|Overall Study|Patient Request|1|||
17176216|NCT03829657|38327396|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
17176217|NCT03829657|38327397|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
17176218|NCT03829657|38327398|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
17176219|NCT03829657|38327399|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
17176220|NCT03829657|38327400|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
17176221|NCT03829657|38327396|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
17176222|NCT03829657|38327397|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
17176223|NCT03829657|38327398|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
17176224|NCT03829657|38327399|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
17176225|NCT03829657|38327400|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
17176226|NCT03829657|38327396|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
17176227|NCT03829657|38327397|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
17176228|NCT03829657|38327398|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
17176229|NCT03829657|38327399|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
17176230|NCT03829657|38327400|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
17176231|NCT03829657|38327396|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
17176232|NCT03829657|38327397|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
17176233|NCT03829657|38327398|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
17176234|NCT03829657|38327399|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
17176235|NCT03829657|38327400|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
17176236|NCT03829657|38327396|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
17176237|NCT03829657|38327397|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
17176238|NCT03829657|38327398|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
17176239|NCT03829657|38327399|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
17176240|NCT03829657|38327400|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
17176241|NCT03829657|38327396|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
17176242|NCT03829657|38327397|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
17176243|NCT03829657|38327398|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
17176244|NCT03829657|38327399|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
17176245|NCT03829657|38327400|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
17176246|NCT03829657|38327396|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
17176247|NCT03829657|38327397|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
17176248|NCT03829657|38327398|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
17176249|NCT03829657|38327399|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
17176250|NCT03829657|38327400|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
17176251|NCT03829657|38327396|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
17176252|NCT03829657|38327397|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
17176253|NCT03829657|38327398|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
17176254|NCT03829657|38327399|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
17176255|NCT03829657|38327400|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
17176256|NCT03829657|38327396|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
17176257|NCT03829657|38327397|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
17176258|NCT03829657|38327398|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
17176259|NCT03829657|38327399|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
17176260|NCT03829657|38327400|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
17176261|NCT03829657|38327396|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
17176262|NCT03829657|38327397|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
17176263|NCT03829657|38327398|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
17176264|NCT03829657|38327399|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
17176265|NCT03829657|38327400|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
17176266|NCT03035227|38327411|FG000|Overall Study|study stopped due to PI leaving institut|1|||
17176267|NCT03035227|38327412|FG001|Overall Study|study stopped due to PI leaving institut|1|||
17176268|NCT00100932|38327422|FG000|Overall Study|Adverse Event|11|||
17176269|NCT00100932|38327423|FG001|Overall Study|Adverse Event|2|||
17176270|NCT00100932|38327422|FG000|Overall Study|Withdrawal by Subject|6|||
17176271|NCT00100932|38327423|FG001|Overall Study|Withdrawal by Subject|0|||
17176272|NCT00100932|38327422|FG000|Overall Study|Progressive Disease|44|||
17176273|NCT00100932|38327423|FG001|Overall Study|Progressive Disease|18|||
17176274|NCT00100932|38327422|FG000|Overall Study|Physician Decision|7|||
17176275|NCT00100932|38327423|FG001|Overall Study|Physician Decision|5|||
17176276|NCT00100932|38327422|FG000|Overall Study|Other|5|||
17176277|NCT00100932|38327423|FG001|Overall Study|Other|2|||
17176278|NCT03180307|38327431|FG000|Overall Study|Lost to Follow-up|2|||
17176279|NCT03180307|38327432|FG001|Overall Study|Lost to Follow-up|0|||
17176280|NCT03180307|38327431|FG000|Overall Study|Death|1|||
17176281|NCT03180307|38327432|FG001|Overall Study|Death|0|||
17176282|NCT03180307|38327431|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
17176283|NCT03180307|38327432|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
17176284|NCT02848833|38327436|FG000|Overall Study|subject who are duplicated|1|||
17176285|NCT02848833|38327436|FG000|Overall Study|have not taken the study drug|11|||
17176286|NCT02848833|38327436|FG000|Overall Study|follow-up failure|6|||
17176287|NCT02848833|38327436|FG000|Overall Study|Protocol Violation|119|||
17176288|NCT03361189|38327442|FG000|Overall Study|Received heart transplant|1|||
17176289|NCT03361189|38327443|FG001|Overall Study|Received heart transplant|0|||
17176290|NCT03361189|38327442|FG000|Overall Study|Pacemake replacement|0|||
17176291|NCT03361189|38327443|FG001|Overall Study|Pacemake replacement|1|||
17176292|NCT00092131|38327451|FG000|Treatment Period I|Adverse Event|1|||
17176293|NCT00092131|38327452|FG001|Treatment Period I|Adverse Event|0|||
17176294|NCT00092131|38327451|FG000|Treatment Period II|Adverse Event|0|||
17176295|NCT00092131|38327452|FG001|Treatment Period II|Adverse Event|1|||
17176296|NCT02668783|38327460|FG000|Overall Study|Pregnancy|0|||
17176297|NCT02668783|38327461|FG001|Overall Study|Pregnancy|1|||
17176298|NCT02668783|38327460|FG000|Overall Study|Protocol Violation|2|||
17176299|NCT02668783|38327461|FG001|Overall Study|Protocol Violation|1|||
17176300|NCT02668783|38327460|FG000|Overall Study|Study terminated by sponsor|9|||
17176301|NCT02668783|38327461|FG001|Overall Study|Study terminated by sponsor|10|||
17176302|NCT02668783|38327460|FG000|Overall Study|Subject moved|1|||
17176303|NCT02668783|38327461|FG001|Overall Study|Subject moved|0|||
17176304|NCT02668783|38327460|FG000|Overall Study|Withdrawal by Subject|1|||
17176305|NCT02668783|38327461|FG001|Overall Study|Withdrawal by Subject|0|||
17176306|NCT00101010|38327467|FG000|Overall Study|Physician Decision|1|||
17176307|NCT02848599|38327473|FG000|Overall Study|Protocol Violation|7|||
17176308|NCT02848599|38327474|FG001|Overall Study|Protocol Violation|9|||
17088501|NCT00323492|38228615|FG000|Study Phase 2|Noncompliance with study schedule|0|||
17088502|NCT00323492|38228616|FG001|Study Phase 2|Noncompliance with study schedule|0|||
17088503|NCT00323492|38228617|FG002|Study Phase 2|Noncompliance with study schedule|1|||
17088504|NCT00323492|38228615|FG000|Study Phase 2|Protocol Violation|1|||
17088505|NCT00323492|38228616|FG001|Study Phase 2|Protocol Violation|0|||
17088506|NCT00323492|38228617|FG002|Study Phase 2|Protocol Violation|0|||
17088507|NCT00331136|38228628|FG000|Overall Study|Adverse Event|3|||
17088508|NCT00331136|38228629|FG001|Overall Study|Adverse Event|5|||
17088509|NCT00331136|38228630|FG002|Overall Study|Adverse Event|0|||
17088510|NCT00331136|38228631|FG003|Overall Study|Adverse Event|1|||
17088511|NCT00331136|38228628|FG000|Overall Study|Withdrawal by Subject|0|||
17088512|NCT00331136|38228629|FG001|Overall Study|Withdrawal by Subject|1|||
17088513|NCT00331136|38228630|FG002|Overall Study|Withdrawal by Subject|0|||
17088514|NCT00331136|38228631|FG003|Overall Study|Withdrawal by Subject|0|||
17088515|NCT00331136|38228628|FG000|Overall Study|Lost to Follow-up|0|||
17088516|NCT00331136|38228629|FG001|Overall Study|Lost to Follow-up|1|||
17088517|NCT00331136|38228630|FG002|Overall Study|Lost to Follow-up|0|||
17088518|NCT00331136|38228631|FG003|Overall Study|Lost to Follow-up|0|||
17088519|NCT00331136|38228628|FG000|Overall Study|Protocol Violation|1|||
17088520|NCT00331136|38228629|FG001|Overall Study|Protocol Violation|0|||
17088521|NCT00331136|38228630|FG002|Overall Study|Protocol Violation|0|||
17088522|NCT00331136|38228631|FG003|Overall Study|Protocol Violation|0|||
17088523|NCT00331136|38228628|FG000|Overall Study|Not treated|1|||
17088524|NCT00331136|38228629|FG001|Overall Study|Not treated|0|||
17176309|NCT00778999|38327505|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
17176310|NCT00778999|38327506|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
16781318|NCT02142712|37720487|FG001|Overall Study|Lost to Follow-up|1|||
17176311|NCT00778999|38327505|FG000|Overall Study|Did not receive recFSH|14|||
17176312|NCT00778999|38327506|FG001|Overall Study|Did not receive recFSH|20|||
17176313|NCT02631850|38327516|FG000|Treatment Period|Lost to Follow-up|0|||
17176314|NCT02631850|38327517|FG001|Treatment Period|Lost to Follow-up|1|||
17176315|NCT02631850|38327518|FG002|Treatment Period|Lost to Follow-up|0|||
17176316|NCT02631850|38327519|FG003|Treatment Period|Lost to Follow-up|0|||
17176317|NCT02631850|38327516|FG000|Treatment Period|Protocol Violation|1|||
17176318|NCT02631850|38327517|FG001|Treatment Period|Protocol Violation|0|||
17176319|NCT02631850|38327518|FG002|Treatment Period|Protocol Violation|0|||
17176320|NCT02631850|38327519|FG003|Treatment Period|Protocol Violation|0|||
17176321|NCT02631850|38327516|FG000|Treatment Period|Withdrawal by Subject|0|||
17088525|NCT00331136|38228630|FG002|Overall Study|Not treated|0|||
17088526|NCT00331136|38228631|FG003|Overall Study|Not treated|0|||
17088527|NCT00323414|38228643|FG000|Overall Study|Withdrawal by Subject|0|||
17088528|NCT00323414|38228644|FG001|Overall Study|Withdrawal by Subject|1|||
17088529|NCT00330668|38228650|FG000|BID Dosing Period|Adverse Event|1|||
17088530|NCT00330668|38228650|FG000|BID Dosing Period|Lost to Follow-up|7|||
17088531|NCT00330668|38228650|FG000|BID Dosing Period|Non-Compliance|5|||
17088532|NCT00330668|38228650|FG000|BID Dosing Period|Withdrawal by Subject|19|||
17088533|NCT00330668|38228650|FG000|BID Dosing Period|Sponsor's decision|1|||
17088534|NCT00330668|38228650|FG000|BID Dosing Period|Other|3|||
17088535|NCT00330668|38228650|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
17088536|NCT00330668|38228650|FG000|QD Dosing Period|Other|1|||
17088537|NCT00330668|38228650|FG000|QD Dosing Period|Withdrawal by Subject|1|||
17088538|NCT00330668|38228650|FG000|QD Dosing Period|Lost to Follow-up|2|||
17088539|NCT00306384|38228657|FG000|Overall Study|Adverse Event|103|||
17088540|NCT00306384|38228658|FG001|Overall Study|Adverse Event|87|||
17088541|NCT00306384|38228659|FG002|Overall Study|Adverse Event|40|||
17088542|NCT00306384|38228657|FG000|Overall Study|Major protocol deviation|43|||
17088543|NCT00306384|38228658|FG001|Overall Study|Major protocol deviation|51|||
17088544|NCT00306384|38228659|FG002|Overall Study|Major protocol deviation|18|||
17088545|NCT00306384|38228657|FG000|Overall Study|Lost to Follow-up|57|||
17088546|NCT00306384|38228658|FG001|Overall Study|Lost to Follow-up|41|||
17088547|NCT00306384|38228659|FG002|Overall Study|Lost to Follow-up|35|||
17088548|NCT00306384|38228657|FG000|Overall Study|Voluntary withdrawal|199|||
17088549|NCT00306384|38228658|FG001|Overall Study|Voluntary withdrawal|187|||
17088550|NCT00306384|38228659|FG002|Overall Study|Voluntary withdrawal|91|||
17088551|NCT00306384|38228657|FG000|Overall Study|Study termination|1|||
17088552|NCT00306384|38228658|FG001|Overall Study|Study termination|0|||
17088553|NCT00306384|38228659|FG002|Overall Study|Study termination|1|||
17088554|NCT00306384|38228657|FG000|Overall Study|Pregnancy|3|||
17088555|NCT00306384|38228658|FG001|Overall Study|Pregnancy|1|||
17088556|NCT00306384|38228659|FG002|Overall Study|Pregnancy|1|||
17176322|NCT02631850|38327517|FG001|Treatment Period|Withdrawal by Subject|5|||
17176323|NCT02631850|38327518|FG002|Treatment Period|Withdrawal by Subject|2|||
17088557|NCT00306384|38228657|FG000|Overall Study|Lack of Efficacy|26|||
17088558|NCT00306384|38228658|FG001|Overall Study|Lack of Efficacy|40|||
17176324|NCT02631850|38327519|FG003|Treatment Period|Withdrawal by Subject|2|||
17088559|NCT00306384|38228659|FG002|Overall Study|Lack of Efficacy|38|||
17088560|NCT00306384|38228657|FG000|Overall Study|Investigator discretion|28|||
17088561|NCT00306384|38228658|FG001|Overall Study|Investigator discretion|31|||
17088562|NCT00306384|38228659|FG002|Overall Study|Investigator discretion|21|||
17088563|NCT00306384|38228657|FG000|Overall Study|Other|80|||
17088564|NCT00306384|38228658|FG001|Overall Study|Other|70|||
17176325|NCT02631850|38327516|FG000|Treatment Period|Adverse Event|1|||
17176326|NCT02631850|38327517|FG001|Treatment Period|Adverse Event|0|||
17176327|NCT02631850|38327518|FG002|Treatment Period|Adverse Event|2|||
17176328|NCT02631850|38327519|FG003|Treatment Period|Adverse Event|3|||
17176329|NCT02631850|38327516|FG000|Treatment Period|Family medical issue|1|||
17176330|NCT02631850|38327517|FG001|Treatment Period|Family medical issue|0|||
17176331|NCT02631850|38327518|FG002|Treatment Period|Family medical issue|0|||
17176332|NCT02631850|38327519|FG003|Treatment Period|Family medical issue|0|||
17176333|NCT02631850|38327516|FG000|6 Month Follow up|Lost to Follow-up|5|||
17176334|NCT02631850|38327517|FG001|6 Month Follow up|Lost to Follow-up|8|||
17176335|NCT02631850|38327518|FG002|6 Month Follow up|Lost to Follow-up|3|||
17176336|NCT02631850|38327519|FG003|6 Month Follow up|Lost to Follow-up|5|||
17176337|NCT02631850|38327516|FG000|6 Month Follow up|Withdrawal by Subject|1|||
17176338|NCT02631850|38327517|FG001|6 Month Follow up|Withdrawal by Subject|0|||
17176339|NCT02631850|38327518|FG002|6 Month Follow up|Withdrawal by Subject|0|||
17176340|NCT02631850|38327519|FG003|6 Month Follow up|Withdrawal by Subject|2|||
17176341|NCT02631850|38327516|FG000|6 Month Follow up|Adverse Event|1|||
17176342|NCT02631850|38327517|FG001|6 Month Follow up|Adverse Event|4|||
17176343|NCT02631850|38327518|FG002|6 Month Follow up|Adverse Event|1|||
17176344|NCT02631850|38327519|FG003|6 Month Follow up|Adverse Event|3|||
17176345|NCT02631850|38327516|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
17088565|NCT00306384|38228659|FG002|Overall Study|Other|32|||
17088566|NCT00306384|38228657|FG000|Overall Study|Site closure|2|||
17088567|NCT00306384|38228658|FG001|Overall Study|Site closure|0|||
17088568|NCT00306384|38228659|FG002|Overall Study|Site closure|0|||
17088569|NCT00305604|38228669|FG000|Overall Study|Adverse Event|6|||
17176346|NCT02631850|38327517|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
17088570|NCT00305604|38228670|FG001|Overall Study|Adverse Event|3|||
17088571|NCT00305604|38228669|FG000|Overall Study|Lack of Efficacy|11|||
17176347|NCT02631850|38327518|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
17088572|NCT00305604|38228670|FG001|Overall Study|Lack of Efficacy|18|||
17088573|NCT00305604|38228669|FG000|Overall Study|Lost to Follow-up|0|||
17088574|NCT00305604|38228670|FG001|Overall Study|Lost to Follow-up|4|||
17088575|NCT00305604|38228669|FG000|Overall Study|Protocol Violation|2|||
17088576|NCT00305604|38228670|FG001|Overall Study|Protocol Violation|1|||
17088577|NCT00305604|38228669|FG000|Overall Study|Withdrawal by Subject|12|||
17176348|NCT02631850|38327519|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
17176349|NCT00103038|38327530|FG000|Overall Study|Withdrawal by Subject|8|||
17088578|NCT00305604|38228670|FG001|Overall Study|Withdrawal by Subject|21|||
17088579|NCT00305604|38228669|FG000|Overall Study|Patient moved|1|||
17088580|NCT00305604|38228670|FG001|Overall Study|Patient moved|0|||
17088581|NCT00501059|38228678|FG000|Overall Study|Protocol Violation|80|||
17088582|NCT00501059|38228679|FG001|Overall Study|Protocol Violation|69|||
17088583|NCT00501059|38228678|FG000|Overall Study|Death|140|||
17088584|NCT00501059|38228679|FG001|Overall Study|Death|137|||
17088585|NCT00501059|38228678|FG000|Overall Study|Other|236|||
17088586|NCT00501059|38228679|FG001|Overall Study|Other|239|||
17088587|NCT00501059|38228678|FG000|Overall Study|Missing end-of-study page|91|||
17088588|NCT00501059|38228679|FG001|Overall Study|Missing end-of-study page|92|||
17088589|NCT00501059|38228678|FG000|Overall Study|Clinical endpoint reached|110|||
17176350|NCT00103038|38327530|FG000|Overall Study|Screen failure|3|||
17176351|NCT00103038|38327530|FG000|Overall Study|Death|1|||
17176352|NCT00103038|38327530|FG000|Overall Study|Physician Decision|1|||
17176353|NCT00620035|38327537|FG000|Overall Study|Adverse Event|106|||
17176354|NCT00620035|38327537|FG000|Overall Study|Withdrawal of Informed Consent|1|||
17176355|NCT00620035|38327537|FG000|Overall Study|Other Reason|38|||
17176356|NCT02763579|38327543|FG000|Overall Study|Death|101|||
17176357|NCT02763579|38327544|FG001|Overall Study|Death|132|||
17176358|NCT02763579|38327543|FG000|Overall Study|Lost to Follow-up|3|||
17176359|NCT02763579|38327544|FG001|Overall Study|Lost to Follow-up|1|||
17176360|NCT02763579|38327543|FG000|Overall Study|Withdrawal by Subject|18|||
17176361|NCT02763579|38327544|FG001|Overall Study|Withdrawal by Subject|9|||
17176362|NCT02763579|38327543|FG000|Overall Study|Physician Decision|2|||
17176363|NCT02763579|38327544|FG001|Overall Study|Physician Decision|0|||
17176364|NCT02763579|38327543|FG000|Overall Study|On-going in study|77|||
17176365|NCT02763579|38327544|FG001|Overall Study|On-going in study|60|||
17176366|NCT02869633|38327552|FG000|Overall Study|Death|2|||
17176367|NCT02869633|38327553|FG001|Overall Study|Death|1|||
17176368|NCT02869633|38327552|FG000|Overall Study|Patient refused follow-up|1|||
17176369|NCT02869633|38327553|FG001|Overall Study|Patient refused follow-up|0|||
17176370|NCT02869633|38327552|FG000|Overall Study|Provider discretion|1|||
17176371|NCT02869633|38327553|FG001|Overall Study|Provider discretion|0|||
17176372|NCT02869633|38327552|FG000|Overall Study|Investigator decision|1|||
17176373|NCT02869633|38327553|FG001|Overall Study|Investigator decision|0|||
17176374|NCT02869633|38327552|FG000|Overall Study|Lost to Follow-up|0|||
17176375|NCT02869633|38327553|FG001|Overall Study|Lost to Follow-up|1|||
17176376|NCT02869633|38327552|FG000|Overall Study|Not eligible|6|||
17176377|NCT02869633|38327553|FG001|Overall Study|Not eligible|1|||
17176378|NCT02869633|38327552|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
17176379|NCT02869633|38327553|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
17176380|NCT02869633|38327552|FG000|Overall Study|Withdrawal by Subject|0|||
17176381|NCT02869633|38327553|FG001|Overall Study|Withdrawal by Subject|1|||
17176382|NCT03034057|38327558|FG000|Overall Study|Withdrawal by Subject|10|||
17176383|NCT03034057|38327558|FG000|Overall Study|Protocol Violation|1|||
17176384|NCT03034057|38327558|FG000|Overall Study|Not defined|2|||
17176385|NCT03034057|38327558|FG000|Overall Study|Lost to Follow-up|19|||
17176386|NCT03034057|38327558|FG000|Overall Study|Adverse Event|22|||
17176387|NCT03034057|38327558|FG000|Overall Study|Medication error without associated AE|1|||
17176388|NCT02757768|38327564|FG000|Overall Study|Randomized Never Received Study Drug|3|||
17176389|NCT02757768|38327565|FG001|Overall Study|Randomized Never Received Study Drug|4|||
17176390|NCT02757768|38327564|FG000|Overall Study|Adverse Event|5|||
17176391|NCT02757768|38327565|FG001|Overall Study|Adverse Event|3|||
17176392|NCT02757768|38327564|FG000|Overall Study|Lack of Efficacy|2|||
17176393|NCT02757768|38327565|FG001|Overall Study|Lack of Efficacy|1|||
17176394|NCT02757768|38327564|FG000|Overall Study|Lost to Follow-up|1|||
17176395|NCT02757768|38327565|FG001|Overall Study|Lost to Follow-up|0|||
17176396|NCT02757768|38327564|FG000|Overall Study|Protocol Deviation|2|||
17176397|NCT02757768|38327565|FG001|Overall Study|Protocol Deviation|9|||
17176398|NCT02757768|38327564|FG000|Overall Study|Withdrawal by Subject|16|||
17176399|NCT02757768|38327565|FG001|Overall Study|Withdrawal by Subject|9|||
17176400|NCT02757768|38327564|FG000|Overall Study|Miscellaneous|4|||
17176401|NCT02757768|38327565|FG001|Overall Study|Miscellaneous|2|||
17176402|NCT02753946|38327575|FG000|Overall Study|Adverse Event|7|||
17088590|NCT00501059|38228679|FG001|Overall Study|Clinical endpoint reached|123|||
17088591|NCT00501059|38228678|FG000|Overall Study|Insufficient therapeutic effect|4|||
17176403|NCT02753946|38327576|FG001|Overall Study|Adverse Event|6|||
17176404|NCT02753946|38327575|FG000|Overall Study|Withdrawal by Subject|6|||
17176405|NCT02753946|38327576|FG001|Overall Study|Withdrawal by Subject|1|||
17176406|NCT02753946|38327575|FG000|Overall Study|Lack of Efficacy|1|||
17176407|NCT02753946|38327576|FG001|Overall Study|Lack of Efficacy|0|||
17176408|NCT02753946|38327575|FG000|Overall Study|Physician Decision|0|||
17176409|NCT02753946|38327576|FG001|Overall Study|Physician Decision|2|||
17176410|NCT02756832|38327582|FG000|Overall Study|Lost for Observation after Baseline|6|||
17176411|NCT02756832|38327582|FG000|Overall Study|Lost for Observation|13|||
17088592|NCT00501059|38228679|FG001|Overall Study|Insufficient therapeutic effect|5|||
17176412|NCT02756832|38327582|FG000|Overall Study|Patient's Unwillingness|12|||
17176413|NCT02756832|38327582|FG000|Overall Study|Insufficient Efficacy|2|||
17176414|NCT02756832|38327582|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
17176415|NCT02756832|38327582|FG000|Overall Study|Reason not Specified|9|||
17176416|NCT02756832|38327582|FG000|Overall Study|Protocol Deviation|10|||
17176417|NCT00106080|38327588|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
17176418|NCT00106080|38327589|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
17176419|NCT02633020|38327597|FG000|Overall Study|Adverse Event|1|||
17176420|NCT02633020|38327598|FG001|Overall Study|Adverse Event|0|||
17176421|NCT00106626|38327608|FG000|Overall Study|Adverse Event|5|||
17176422|NCT00106626|38327609|FG001|Overall Study|Adverse Event|4|||
17176423|NCT00106626|38327610|FG002|Overall Study|Adverse Event|3|||
17176424|NCT00106626|38327611|FG003|Overall Study|Adverse Event|3|||
17176425|NCT00106626|38327608|FG000|Overall Study|Progressive Disease|4|||
17176426|NCT00106626|38327609|FG001|Overall Study|Progressive Disease|1|||
17176427|NCT00106626|38327610|FG002|Overall Study|Progressive Disease|9|||
17176428|NCT00106626|38327611|FG003|Overall Study|Progressive Disease|10|||
17176429|NCT00106626|38327608|FG000|Overall Study|Received radiation on new therapy|1|||
17176430|NCT00106626|38327609|FG001|Overall Study|Received radiation on new therapy|0|||
17176431|NCT00106626|38327610|FG002|Overall Study|Received radiation on new therapy|0|||
17176432|NCT00106626|38327611|FG003|Overall Study|Received radiation on new therapy|0|||
17176433|NCT00106626|38327608|FG000|Overall Study|> 14 day delay in therapy start|0|||
17176434|NCT00106626|38327609|FG001|Overall Study|> 14 day delay in therapy start|1|||
17176435|NCT00106626|38327610|FG002|Overall Study|> 14 day delay in therapy start|0|||
17176436|NCT00106626|38327611|FG003|Overall Study|> 14 day delay in therapy start|0|||
17176437|NCT02632786|38327628|FG000|Overall Study|Adverse Event|2|||
17176438|NCT02632786|38327629|FG001|Overall Study|Adverse Event|1|||
17176439|NCT02632786|38327628|FG000|Overall Study|Death|3|||
17176440|NCT02632786|38327629|FG001|Overall Study|Death|2|||
17176441|NCT02632786|38327628|FG000|Overall Study|Physician Decision|5|||
17176442|NCT02632786|38327629|FG001|Overall Study|Physician Decision|4|||
17088593|NCT00501059|38228678|FG000|Overall Study|Consent withdrawn by subject|817|||
17088594|NCT00501059|38228679|FG001|Overall Study|Consent withdrawn by subject|873|||
17088595|NCT00501059|38228678|FG000|Overall Study|Non-compliant with study treatment|23|||
17088596|NCT00501059|38228679|FG001|Overall Study|Non-compliant with study treatment|16|||
17088597|NCT00501059|38228678|FG000|Overall Study|Reason not given|3|||
17088598|NCT00501059|38228679|FG001|Overall Study|Reason not given|1|||
17088599|NCT00501059|38228678|FG000|Overall Study|Adverse Event|129|||
17088600|NCT00501059|38228679|FG001|Overall Study|Adverse Event|122|||
17088601|NCT00501059|38228678|FG000|Overall Study|Lost to Follow-up|210|||
17088602|NCT00501059|38228679|FG001|Overall Study|Lost to Follow-up|198|||
17088603|NCT00501059|38228678|FG000|Overall Study|Not treated|25|||
17088604|NCT00501059|38228679|FG001|Overall Study|Not treated|17|||
17088605|NCT00344318|38228691|FG000|Overall Study|Adverse Event|0|||
17088606|NCT00344318|38228692|FG001|Overall Study|Adverse Event|3|||
17088607|NCT00344318|38228693|FG002|Overall Study|Adverse Event|0|||
17088608|NCT00344318|38228694|FG003|Overall Study|Adverse Event|1|||
17088609|NCT00344318|38228691|FG000|Overall Study|Withdrawal by Subject|2|||
17088610|NCT00344318|38228692|FG001|Overall Study|Withdrawal by Subject|2|||
17088611|NCT00344318|38228693|FG002|Overall Study|Withdrawal by Subject|0|||
17088612|NCT00344318|38228694|FG003|Overall Study|Withdrawal by Subject|2|||
17088613|NCT00344318|38228691|FG000|Overall Study|Lost to Follow-up|2|||
17088614|NCT00344318|38228692|FG001|Overall Study|Lost to Follow-up|0|||
17088615|NCT00344318|38228693|FG002|Overall Study|Lost to Follow-up|1|||
17088616|NCT00344318|38228694|FG003|Overall Study|Lost to Follow-up|0|||
17088617|NCT00323258|38228708|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
17088618|NCT00323258|38228709|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
17088619|NCT00323258|38228708|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
17088620|NCT00323258|38228709|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
17088621|NCT00323258|38228708|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
17088622|NCT00323258|38228709|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
17088623|NCT00323258|38228708|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
17088624|NCT00323258|38228709|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
17088625|NCT00323258|38228708|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
17088626|NCT00323258|38228709|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
17088627|NCT00323258|38228708|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
17176443|NCT02632786|38327628|FG000|Overall Study|Withdrawal by Subject|1|||
17088628|NCT00323258|38228709|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
17088629|NCT00323258|38228708|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
17088630|NCT00323258|38228709|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
17088631|NCT00322868|38228715|FG000|Overall Study|disease progression|1|||
17088632|NCT00322712|38228720|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
17088633|NCT00343382|38228727|FG000|Overall Study|Adverse Event|2|||
17088634|NCT00343382|38228728|FG001|Overall Study|Adverse Event|10|||
17088635|NCT00343382|38228729|FG002|Overall Study|Adverse Event|7|||
17088636|NCT00343382|38228727|FG000|Overall Study|Withdrawal by Subject|1|||
17088637|NCT00343382|38228728|FG001|Overall Study|Withdrawal by Subject|2|||
17176444|NCT02632786|38327629|FG001|Overall Study|Withdrawal by Subject|0|||
17176445|NCT02755818|38327640|FG000|Overall Study|Withdrawal by Subject|0|||
17176446|NCT02755818|38327641|FG001|Overall Study|Withdrawal by Subject|0|||
17176447|NCT02755818|38327642|FG002|Overall Study|Withdrawal by Subject|0|||
17176448|NCT02755818|38327643|FG003|Overall Study|Withdrawal by Subject|2|||
17176449|NCT02755818|38327640|FG000|Overall Study|withdrawal by PI|0|||
17176450|NCT02755818|38327641|FG001|Overall Study|withdrawal by PI|0|||
17176451|NCT02755818|38327642|FG002|Overall Study|withdrawal by PI|1|||
17088638|NCT00343382|38228729|FG002|Overall Study|Withdrawal by Subject|6|||
17088639|NCT00343382|38228727|FG000|Overall Study|Other Reason Not Specified|1|||
17088640|NCT00343382|38228728|FG001|Overall Study|Other Reason Not Specified|2|||
17088641|NCT00343382|38228729|FG002|Overall Study|Other Reason Not Specified|4|||
17088642|NCT00481871|38228742|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
17088643|NCT00481871|38228743|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
17088644|NCT00481871|38228744|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
17088645|NCT00481871|38228745|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
17088646|NCT00481871|38228746|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
17088647|NCT00329420|38228757|FG000|Re-induction Phase|Lack of Efficacy|0|||
17088648|NCT00329420|38228758|FG001|Re-induction Phase|Lack of Efficacy|1|||
17088649|NCT00329420|38228759|FG002|Re-induction Phase|Lack of Efficacy|0|||
17088650|NCT00329420|38228757|FG000|Re-induction Phase|Withdrawal of Consent|0|||
17088651|NCT00329420|38228758|FG001|Re-induction Phase|Withdrawal of Consent|0|||
17088652|NCT00329420|38228759|FG002|Re-induction Phase|Withdrawal of Consent|1|||
17088653|NCT00329420|38228757|FG000|Re-induction Phase|Did not respond to re-induction|6|||
17088654|NCT00329420|38228758|FG001|Re-induction Phase|Did not respond to re-induction|5|||
17088655|NCT00329420|38228759|FG002|Re-induction Phase|Did not respond to re-induction|7|||
17088656|NCT00329420|38228757|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
17088657|NCT00329420|38228758|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
17088658|NCT00329420|38228759|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
17088659|NCT00329420|38228757|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
17088660|NCT00329420|38228758|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
17088661|NCT00329420|38228759|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
17088662|NCT00329420|38228757|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
17088663|NCT00329420|38228758|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
17088664|NCT00329420|38228759|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
17088665|NCT00329108|38228771|FG000|Overall Study|Adverse Event|2|||
17176452|NCT02755818|38327643|FG003|Overall Study|withdrawal by PI|1|||
17176453|NCT03033745|38327658|FG000|Overall Study|Protocol Violation|0|||
17176454|NCT03033745|38327659|FG001|Overall Study|Protocol Violation|0|||
17176455|NCT03033745|38327660|FG002|Overall Study|Protocol Violation|1|||
17176456|NCT03033745|38327658|FG000|Overall Study|Adverse Event|1|||
17176457|NCT03033745|38327659|FG001|Overall Study|Adverse Event|0|||
17176458|NCT03033745|38327660|FG002|Overall Study|Adverse Event|1|||
17176459|NCT03033745|38327658|FG000|Overall Study|Withdrawal by Subject|0|||
17176460|NCT03033745|38327659|FG001|Overall Study|Withdrawal by Subject|1|||
17176461|NCT03033745|38327660|FG002|Overall Study|Withdrawal by Subject|0|||
17176462|NCT01672294|38327679|FG000|Overall Study|Withdrawal by Subject|4|||
17176463|NCT01672294|38327680|FG001|Overall Study|Withdrawal by Subject|4|||
17176464|NCT01672294|38327681|FG002|Overall Study|Withdrawal by Subject|4|||
17176465|NCT01672294|38327682|FG003|Overall Study|Withdrawal by Subject|4|||
17176466|NCT01672294|38327679|FG000|Overall Study|Excluded by study|1|||
17176467|NCT01672294|38327680|FG001|Overall Study|Excluded by study|1|||
17176468|NCT01672294|38327681|FG002|Overall Study|Excluded by study|0|||
17176469|NCT01672294|38327682|FG003|Overall Study|Excluded by study|0|||
17176470|NCT01672294|38327679|FG000|Overall Study|Lost to Follow-up|1|||
17176471|NCT01672294|38327680|FG001|Overall Study|Lost to Follow-up|16|||
17176472|NCT01672294|38327681|FG002|Overall Study|Lost to Follow-up|7|||
17176473|NCT01672294|38327682|FG003|Overall Study|Lost to Follow-up|9|||
17176474|NCT02755116|38327694|FG000|Overall Study|surgery converted to open, pt admitted|3|||
17176475|NCT02755116|38327695|FG001|Overall Study|surgery converted to open, pt admitted|1|||
17176476|NCT02754492|38327705|FG000|Overall Study|Protocol Violation|2|||
17176477|NCT02754492|38327706|FG001|Overall Study|Protocol Violation|2|||
17176478|NCT02754492|38327707|FG002|Overall Study|Protocol Violation|0|||
17176479|NCT02754492|38327708|FG003|Overall Study|Protocol Violation|1|||
17176480|NCT02754492|38327705|FG000|Overall Study|Withdrawal by Subject|2|||
17176481|NCT02754492|38327706|FG001|Overall Study|Withdrawal by Subject|0|||
17176482|NCT02754492|38327707|FG002|Overall Study|Withdrawal by Subject|0|||
17176483|NCT02754492|38327708|FG003|Overall Study|Withdrawal by Subject|0|||
17176484|NCT02754492|38327705|FG000|Overall Study|Equipment malfuntion|0|||
17088666|NCT00329108|38228772|FG001|Overall Study|Adverse Event|2|||
17088667|NCT00329108|38228771|FG000|Overall Study|Lack of Efficacy|3|||
17088668|NCT00329108|38228772|FG001|Overall Study|Lack of Efficacy|3|||
17088669|NCT00329108|38228771|FG000|Overall Study|Withdrawal by Subject|0|||
17088670|NCT00329108|38228772|FG001|Overall Study|Withdrawal by Subject|2|||
17088671|NCT00329108|38228771|FG000|Overall Study|symptomatic deterioration|1|||
17088672|NCT00329108|38228772|FG001|Overall Study|symptomatic deterioration|1|||
17088673|NCT00329108|38228771|FG000|Overall Study|Subject no longer willing to participate|2|||
17088674|NCT00329108|38228772|FG001|Overall Study|Subject no longer willing to participate|2|||
17088675|NCT00329108|38228771|FG000|Overall Study|study terminated by sponsor|1|||
17088676|NCT00329108|38228772|FG001|Overall Study|study terminated by sponsor|0|||
17088677|NCT00329108|38228771|FG000|Overall Study|withdrew patient after SAE resolved|1|||
17088678|NCT00329108|38228772|FG001|Overall Study|withdrew patient after SAE resolved|0|||
17088679|NCT00329108|38228771|FG000|Overall Study|Protocol Violation|0|||
17088680|NCT00329108|38228772|FG001|Overall Study|Protocol Violation|2|||
17088681|NCT00329030|38228780|FG000|Overall Study|Withdrawal by Subject|1|||
17088682|NCT00329030|38228781|FG001|Overall Study|Withdrawal by Subject|3|||
17088683|NCT00329030|38228780|FG000|Overall Study|Progressive Disease|6|||
17088684|NCT00329030|38228781|FG001|Overall Study|Progressive Disease|2|||
17088685|NCT00329030|38228780|FG000|Overall Study|Ineligible Pathology|1|||
17088686|NCT00329030|38228781|FG001|Overall Study|Ineligible Pathology|1|||
17088687|NCT00328562|38228787|FG000|Overall Study|Disease progression|1|||
17088688|NCT00328172|38228796|FG000|Overall Study|Adverse Event|3|||
17088689|NCT00328172|38228797|FG001|Overall Study|Adverse Event|2|||
17088690|NCT00328172|38228798|FG002|Overall Study|Adverse Event|1|||
17088691|NCT00328172|38228799|FG003|Overall Study|Adverse Event|2|||
17088692|NCT00328172|38228800|FG004|Overall Study|Adverse Event|1|||
17088693|NCT00328172|38228796|FG000|Overall Study|Protocol Violation|0|||
17176485|NCT02754492|38327706|FG001|Overall Study|Equipment malfuntion|0|||
17176486|NCT02754492|38327707|FG002|Overall Study|Equipment malfuntion|2|||
17176487|NCT02754492|38327708|FG003|Overall Study|Equipment malfuntion|5|||
17176488|NCT02754492|38327705|FG000|Overall Study|Adverse Event|0|||
17176489|NCT02754492|38327706|FG001|Overall Study|Adverse Event|0|||
17176490|NCT02754492|38327707|FG002|Overall Study|Adverse Event|0|||
17176491|NCT02754492|38327708|FG003|Overall Study|Adverse Event|13|||
17176492|NCT02754492|38327705|FG000|Overall Study|Venous access issues not resulting in AE|0|||
17176493|NCT02754492|38327706|FG001|Overall Study|Venous access issues not resulting in AE|0|||
17176494|NCT02754492|38327707|FG002|Overall Study|Venous access issues not resulting in AE|0|||
17176495|NCT02754492|38327708|FG003|Overall Study|Venous access issues not resulting in AE|4|||
17176496|NCT04068688|38327727|FG000|Overall Study|Lost to Follow-up|1|||
17176497|NCT04068688|38327728|FG001|Overall Study|Lost to Follow-up|1|||
17176498|NCT04068688|38327729|FG002|Overall Study|Lost to Follow-up|0|||
17176499|NCT04068688|38327730|FG003|Overall Study|Lost to Follow-up|0|||
17176500|NCT04068688|38327731|FG004|Overall Study|Lost to Follow-up|5|||
17176501|NCT04068688|38327732|FG005|Overall Study|Lost to Follow-up|5|||
17176502|NCT04068688|38327733|FG006|Overall Study|Lost to Follow-up|0|||
17176503|NCT04068688|38327734|FG007|Overall Study|Lost to Follow-up|0|||
17176504|NCT04068688|38327735|FG008|Overall Study|Lost to Follow-up|1|||
17176505|NCT04068688|38327736|FG009|Overall Study|Lost to Follow-up|0|||
17088694|NCT00328172|38228797|FG001|Overall Study|Protocol Violation|1|||
17088695|NCT00328172|38228798|FG002|Overall Study|Protocol Violation|1|||
17088696|NCT00328172|38228799|FG003|Overall Study|Protocol Violation|0|||
17088697|NCT00328172|38228800|FG004|Overall Study|Protocol Violation|0|||
17088698|NCT00328172|38228796|FG000|Overall Study|Lost to Follow-up|1|||
17088699|NCT00328172|38228797|FG001|Overall Study|Lost to Follow-up|1|||
17088700|NCT00328172|38228798|FG002|Overall Study|Lost to Follow-up|2|||
17088701|NCT00328172|38228799|FG003|Overall Study|Lost to Follow-up|1|||
17088702|NCT00328172|38228800|FG004|Overall Study|Lost to Follow-up|1|||
17088703|NCT00328172|38228796|FG000|Overall Study|Withdrawal by Subject|1|||
17088704|NCT00328172|38228797|FG001|Overall Study|Withdrawal by Subject|1|||
17088705|NCT00328172|38228798|FG002|Overall Study|Withdrawal by Subject|1|||
17088706|NCT00328172|38228799|FG003|Overall Study|Withdrawal by Subject|6|||
17176506|NCT04068688|38327727|FG000|Overall Study|Withdrawal by Subject|1|||
17088707|NCT00328172|38228800|FG004|Overall Study|Withdrawal by Subject|0|||
17088708|NCT00328172|38228796|FG000|Overall Study|Lack of Efficacy|14|||
17088709|NCT00328172|38228797|FG001|Overall Study|Lack of Efficacy|9|||
17088710|NCT00328172|38228798|FG002|Overall Study|Lack of Efficacy|4|||
17088711|NCT00328172|38228799|FG003|Overall Study|Lack of Efficacy|4|||
17088712|NCT00328172|38228800|FG004|Overall Study|Lack of Efficacy|3|||
17088713|NCT00328172|38228796|FG000|Overall Study|Other reason (not specified)|3|||
17088714|NCT00328172|38228797|FG001|Overall Study|Other reason (not specified)|0|||
17088715|NCT00328172|38228798|FG002|Overall Study|Other reason (not specified)|1|||
17088716|NCT00328172|38228799|FG003|Overall Study|Other reason (not specified)|0|||
17088717|NCT00328172|38228800|FG004|Overall Study|Other reason (not specified)|0|||
17088718|NCT00328094|38228814|FG000|Overall Study|Physician Decision|3|||
17088719|NCT00328094|38228815|FG001|Overall Study|Physician Decision|3|||
17088720|NCT00500903|38228824|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
17088721|NCT00500903|38228825|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
17088722|NCT00500903|38228826|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
17088723|NCT00500903|38228824|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
17088724|NCT00500903|38228825|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
17088725|NCT00500903|38228826|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
17088726|NCT00500903|38228824|FG000|Overall Study|Progressive Disease|41|||
17088727|NCT00500903|38228825|FG001|Overall Study|Progressive Disease|2|||
17088728|NCT00500903|38228826|FG002|Overall Study|Progressive Disease|15|||
17088729|NCT00500903|38228824|FG000|Overall Study|Patient Declined Further Treatment|0|||
17088730|NCT00500903|38228825|FG001|Overall Study|Patient Declined Further Treatment|0|||
17088731|NCT00500903|38228826|FG002|Overall Study|Patient Declined Further Treatment|3|||
17088732|NCT00500903|38228824|FG000|Overall Study|Symptomatic Deterioration|2|||
17088733|NCT00500903|38228825|FG001|Overall Study|Symptomatic Deterioration|0|||
17088734|NCT00500903|38228826|FG002|Overall Study|Symptomatic Deterioration|0|||
17088735|NCT00500903|38228824|FG000|Overall Study|Reason Not Specified|10|||
17088736|NCT00500903|38228825|FG001|Overall Study|Reason Not Specified|0|||
17088737|NCT00500903|38228826|FG002|Overall Study|Reason Not Specified|2|||
17088738|NCT00295932|38228875|FG000|Overall Study|Not Treated|0|||
17088739|NCT00295932|38228876|FG001|Overall Study|Not Treated|0|||
17088740|NCT00295932|38228877|FG002|Overall Study|Not Treated|0|||
17088741|NCT00295932|38228878|FG003|Overall Study|Not Treated|0|||
17088742|NCT00295932|38228879|FG004|Overall Study|Not Treated|0|||
17088743|NCT00295932|38228880|FG005|Overall Study|Not Treated|0|||
17088744|NCT00295932|38228881|FG006|Overall Study|Not Treated|0|||
17088745|NCT00295932|38228882|FG007|Overall Study|Not Treated|0|||
17088746|NCT00295932|38228883|FG008|Overall Study|Not Treated|0|||
17088747|NCT00295932|38228884|FG009|Overall Study|Not Treated|0|||
17088748|NCT00295932|38228885|FG010|Overall Study|Not Treated|1|||
17088749|NCT00305448|38228914|FG000|Overall Study|Protocol Violation|0|||
17088750|NCT00305448|38228915|FG001|Overall Study|Protocol Violation|1|||
17088751|NCT00305448|38228916|FG002|Overall Study|Protocol Violation|0|||
17088752|NCT00305448|38228914|FG000|Overall Study|Withdrawal by Subject|2|||
17088753|NCT00305448|38228915|FG001|Overall Study|Withdrawal by Subject|0|||
17088754|NCT00305448|38228916|FG002|Overall Study|Withdrawal by Subject|1|||
17088755|NCT00305448|38228914|FG000|Overall Study|Adverse Event|1|||
17088756|NCT00305448|38228915|FG001|Overall Study|Adverse Event|0|||
17088757|NCT00305448|38228916|FG002|Overall Study|Adverse Event|1|||
17088758|NCT00305448|38228914|FG000|Overall Study|Disease Progression|27|||
17088759|NCT00305448|38228915|FG001|Overall Study|Disease Progression|31|||
17088760|NCT00305448|38228916|FG002|Overall Study|Disease Progression|28|||
17088761|NCT00305448|38228914|FG000|Overall Study|Subjective Disease Progression|1|||
17088762|NCT00305448|38228915|FG001|Overall Study|Subjective Disease Progression|2|||
17088763|NCT00305448|38228916|FG002|Overall Study|Subjective Disease Progression|2|||
17088764|NCT00305448|38228914|FG000|Overall Study|Tumor Marker Elevation|0|||
17088765|NCT00305448|38228915|FG001|Overall Study|Tumor Marker Elevation|0|||
17088766|NCT00305448|38228916|FG002|Overall Study|Tumor Marker Elevation|1|||
17088767|NCT00305058|38228927|FG000|Overall Study|Participant too young|1|||
17088768|NCT00305058|38228928|FG001|Overall Study|Participant too young|0|||
17088769|NCT00305058|38228927|FG000|Overall Study|Missing data collection instrument|3|||
17088770|NCT00305058|38228928|FG001|Overall Study|Missing data collection instrument|2|||
17088771|NCT00305058|38228927|FG000|Overall Study|Missing outcome data|3|||
17088772|NCT00305058|38228928|FG001|Overall Study|Missing outcome data|2|||
17088773|NCT00295854|38228937|FG000|Overall Study|Adverse Event|7|||
17088774|NCT00295854|38228938|FG001|Overall Study|Adverse Event|7|||
17088775|NCT00295854|38228939|FG002|Overall Study|Adverse Event|6|||
17088776|NCT00295854|38228937|FG000|Overall Study|Protocol Violation|1|||
17088777|NCT00295854|38228938|FG001|Overall Study|Protocol Violation|1|||
17088778|NCT00295854|38228939|FG002|Overall Study|Protocol Violation|1|||
17088779|NCT00295854|38228937|FG000|Overall Study|Lost to Follow-up|2|||
17088780|NCT00295854|38228938|FG001|Overall Study|Lost to Follow-up|0|||
17088781|NCT00295854|38228939|FG002|Overall Study|Lost to Follow-up|1|||
17088782|NCT00295854|38228937|FG000|Overall Study|Withdrawal by Subject|3|||
17088783|NCT00295854|38228938|FG001|Overall Study|Withdrawal by Subject|7|||
17088784|NCT00295854|38228939|FG002|Overall Study|Withdrawal by Subject|4|||
17088785|NCT00295854|38228937|FG000|Overall Study|did not continue to meet criteria|1|||
17088786|NCT00295854|38228938|FG001|Overall Study|did not continue to meet criteria|1|||
17088787|NCT00295854|38228939|FG002|Overall Study|did not continue to meet criteria|2|||
17088788|NCT00295854|38228937|FG000|Overall Study|required a prohibited medication|1|||
17088789|NCT00295854|38228938|FG001|Overall Study|required a prohibited medication|0|||
17088790|NCT00295854|38228939|FG002|Overall Study|required a prohibited medication|0|||
17088791|NCT00295854|38228937|FG000|Overall Study|Other|3|||
17088792|NCT00295854|38228938|FG001|Overall Study|Other|5|||
17088793|NCT00295854|38228939|FG002|Overall Study|Other|1|||
17088794|NCT00327470|38228949|FG000|Overall Study|Randomized, but not treated|0|||
17088795|NCT00327470|38228950|FG001|Overall Study|Randomized, but not treated|2|||
17088796|NCT00327470|38228949|FG000|Overall Study|Adverse Event|9|||
17088797|NCT00327470|38228950|FG001|Overall Study|Adverse Event|14|||
17088798|NCT00327470|38228949|FG000|Overall Study|Lack of Efficacy|7|||
17176507|NCT04068688|38327728|FG001|Overall Study|Withdrawal by Subject|1|||
17176508|NCT04068688|38327729|FG002|Overall Study|Withdrawal by Subject|0|||
17176509|NCT04068688|38327730|FG003|Overall Study|Withdrawal by Subject|0|||
17176510|NCT04068688|38327731|FG004|Overall Study|Withdrawal by Subject|0|||
17176511|NCT04068688|38327732|FG005|Overall Study|Withdrawal by Subject|0|||
17176512|NCT04068688|38327733|FG006|Overall Study|Withdrawal by Subject|0|||
17176513|NCT04068688|38327734|FG007|Overall Study|Withdrawal by Subject|0|||
17176514|NCT04068688|38327735|FG008|Overall Study|Withdrawal by Subject|0|||
17176515|NCT04068688|38327736|FG009|Overall Study|Withdrawal by Subject|0|||
17176516|NCT04068688|38327727|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
17176517|NCT04068688|38327728|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
17176518|NCT04068688|38327729|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
17176519|NCT04068688|38327730|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
17176520|NCT04068688|38327731|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
17176521|NCT04068688|38327732|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
17176522|NCT04068688|38327733|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
17088799|NCT00327470|38228950|FG001|Overall Study|Lack of Efficacy|19|||
17088800|NCT00327470|38228949|FG000|Overall Study|Other|5|||
17088801|NCT00327470|38228950|FG001|Overall Study|Other|9|||
17088802|NCT00327470|38228949|FG000|Overall Study|Lost to Follow-up|1|||
17088803|NCT00327470|38228950|FG001|Overall Study|Lost to Follow-up|3|||
17088804|NCT00327470|38228949|FG000|Overall Study|Withdrawal by Subject|6|||
17088805|NCT00327470|38228950|FG001|Overall Study|Withdrawal by Subject|12|||
17088806|NCT00327470|38228949|FG000|Overall Study|Death|1|||
17088807|NCT00327470|38228950|FG001|Overall Study|Death|4|||
17088808|NCT00322556|38228956|FG000|Overall Study|Adverse Event|1|||
17088809|NCT00322556|38228956|FG000|Overall Study|Withdrawal by Subject|1|||
17088810|NCT00322556|38228956|FG000|Overall Study|Lost to Follow-up|3|||
17088811|NCT00322556|38228956|FG000|Overall Study|Other Reason|7|||
17088812|NCT00321932|38228965|FG000|Overall Study|Death|3|||
17088813|NCT00321932|38228966|FG001|Overall Study|Death|6|||
17088814|NCT00321932|38228965|FG000|Overall Study|Withdrawal by Subject|3|||
17088815|NCT00321932|38228966|FG001|Overall Study|Withdrawal by Subject|6|||
17088816|NCT00321932|38228965|FG000|Overall Study|Early relapse|2|||
17088817|NCT00321932|38228966|FG001|Overall Study|Early relapse|8|||
17088818|NCT00321932|38228965|FG000|Overall Study|Missing data|2|||
17088819|NCT00321932|38228966|FG001|Overall Study|Missing data|1|||
17088820|NCT00326612|38228975|FG000|Overall Study|They did not have a seizure requiring tx|129|||
17088821|NCT00326612|38228976|FG001|Overall Study|They did not have a seizure requiring tx|137|||
17088822|NCT00325754|38228988|FG000|Overall Study|Adverse Event|4|||
17088823|NCT00325754|38228989|FG001|Overall Study|Adverse Event|1|||
17088824|NCT00325130|38228997|FG000|Overall Study|Lost to Follow-up|6|||
17088825|NCT00325130|38228998|FG001|Overall Study|Lost to Follow-up|14|||
17088826|NCT00325130|38228997|FG000|Overall Study|Withdrawal by Subject|12|||
17088827|NCT00325130|38228998|FG001|Overall Study|Withdrawal by Subject|14|||
17088828|NCT00325130|38228997|FG000|Overall Study|Protocol Deviation|0|||
17088829|NCT00325130|38228998|FG001|Overall Study|Protocol Deviation|1|||
17088830|NCT00325130|38228997|FG000|Overall Study|Moved|0|||
17088831|NCT00325130|38228998|FG001|Overall Study|Moved|1|||
17088832|NCT00325130|38228997|FG000|Overall Study|Patient Discontinued for Other|1|||
17088833|NCT00325130|38228998|FG001|Overall Study|Patient Discontinued for Other|0|||
17088834|NCT00321854|38229006|FG000|Overall Study|Adverse Event|41|||
17088835|NCT00321854|38229007|FG001|Overall Study|Adverse Event|43|||
17088836|NCT00321854|38229006|FG000|Overall Study|Lack of Efficacy|9|||
17088837|NCT00321854|38229007|FG001|Overall Study|Lack of Efficacy|14|||
17088838|NCT00321854|38229006|FG000|Overall Study|Protocol Violation|6|||
17088839|NCT00321854|38229007|FG001|Overall Study|Protocol Violation|5|||
17088840|NCT00321854|38229006|FG000|Overall Study|Lost to Follow-up|0|||
17088841|NCT00321854|38229007|FG001|Overall Study|Lost to Follow-up|2|||
17088842|NCT00321854|38229006|FG000|Overall Study|Withdrawal by Subject|6|||
17088843|NCT00321854|38229007|FG001|Overall Study|Withdrawal by Subject|17|||
17088844|NCT00321854|38229006|FG000|Overall Study|Other|1|||
17088845|NCT00321854|38229007|FG001|Overall Study|Other|1|||
17176523|NCT04068688|38327734|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
17176524|NCT04068688|38327735|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
17176525|NCT04068688|38327736|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
17176526|NCT01671748|38327764|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
17176527|NCT01671748|38327765|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
17176528|NCT01671748|38327764|FG000|4 Week run-in Phase|Adverse Event|1|||
17176529|NCT01671748|38327765|FG001|4 Week run-in Phase|Adverse Event|0|||
17176530|NCT01671748|38327764|FG000|4 Week run-in Phase|Not eligible|9|||
17176531|NCT01671748|38327765|FG001|4 Week run-in Phase|Not eligible|0|||
17176532|NCT02657889|38327775|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
17176533|NCT02657889|38327776|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
17176534|NCT02657889|38327777|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
17176535|NCT02657889|38327778|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
17176536|NCT02657889|38327775|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
17176537|NCT02657889|38327776|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
17176538|NCT02657889|38327777|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
17176539|NCT02657889|38327778|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
17176540|NCT02657889|38327775|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
17176541|NCT02657889|38327776|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
17176542|NCT02657889|38327777|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
17176543|NCT02657889|38327778|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
17176544|NCT02657889|38327775|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
17176545|NCT02657889|38327776|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
17176546|NCT02657889|38327777|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
17176547|NCT02657889|38327778|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
17176548|NCT02657889|38327775|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
17176549|NCT02657889|38327776|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
17176550|NCT02657889|38327777|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
17176551|NCT02657889|38327778|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
17176552|NCT02657889|38327775|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
17176553|NCT02657889|38327776|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
17176554|NCT02657889|38327777|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
17176555|NCT02657889|38327778|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
17176556|NCT02657889|38327775|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
17176557|NCT02657889|38327776|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
17176558|NCT02657889|38327777|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
17176559|NCT02657889|38327778|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
17176560|NCT02657889|38327775|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
17176561|NCT02657889|38327776|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
17176562|NCT02657889|38327777|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
17176563|NCT02657889|38327778|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
17176564|NCT02657889|38327775|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
17176565|NCT02657889|38327776|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
17176566|NCT02657889|38327777|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
17176567|NCT02657889|38327778|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
17176568|NCT02657889|38327775|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
17176569|NCT02657889|38327776|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
17176570|NCT02657889|38327777|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
17176571|NCT02657889|38327778|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
17176572|NCT02657889|38327775|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
17176573|NCT02657889|38327776|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
16996802|NCT03107793|38140957|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
16996803|NCT03107793|38140958|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
17088846|NCT00310388|38229015|FG000|Primary Reporting Phase|Adverse Event|101|||
17088847|NCT00310388|38229016|FG001|Primary Reporting Phase|Adverse Event|0|||
17088848|NCT00310388|38229015|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
17088849|NCT00310388|38229016|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
17088850|NCT00310388|38229015|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
17088851|NCT00310388|38229016|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
17088852|NCT00310388|38229015|FG000|Primary Reporting Phase|Protocol Violation|10|||
17088853|NCT00310388|38229016|FG001|Primary Reporting Phase|Protocol Violation|0|||
17088854|NCT00310388|38229015|FG000|Primary Reporting Phase|Pregnancy|3|||
17088855|NCT00310388|38229016|FG001|Primary Reporting Phase|Pregnancy|0|||
17088856|NCT00310388|38229015|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
17088857|NCT00310388|38229016|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
17088858|NCT00310388|38229015|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
17176574|NCT02657889|38327777|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
17176575|NCT02657889|38327778|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
17176576|NCT02657889|38327775|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
17176577|NCT02657889|38327776|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
17176578|NCT02657889|38327777|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
17176579|NCT02657889|38327778|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
17176580|NCT03034915|38327793|FG000|Overall Study|Adverse Event|29|||
17176581|NCT03034915|38327794|FG001|Overall Study|Adverse Event|32|||
17176582|NCT03034915|38327795|FG002|Overall Study|Adverse Event|22|||
17176583|NCT03034915|38327793|FG000|Overall Study|Lost to Follow-up|5|||
17176584|NCT03034915|38327794|FG001|Overall Study|Lost to Follow-up|13|||
17176585|NCT03034915|38327795|FG002|Overall Study|Lost to Follow-up|3|||
17176586|NCT03034915|38327793|FG000|Overall Study|Withdrawal by Subject|29|||
17176587|NCT03034915|38327794|FG001|Overall Study|Withdrawal by Subject|46|||
17176588|NCT03034915|38327795|FG002|Overall Study|Withdrawal by Subject|41|||
17176589|NCT03034915|38327793|FG000|Overall Study|Protocol Deviation|2|||
17176590|NCT03034915|38327794|FG001|Overall Study|Protocol Deviation|14|||
17176591|NCT03034915|38327795|FG002|Overall Study|Protocol Deviation|7|||
17176592|NCT03034915|38327793|FG000|Overall Study|Lack of Efficacy|8|||
17176593|NCT03034915|38327794|FG001|Overall Study|Lack of Efficacy|16|||
17176594|NCT03034915|38327795|FG002|Overall Study|Lack of Efficacy|18|||
17176595|NCT03034915|38327793|FG000|Overall Study|Site closed|2|||
17176596|NCT03034915|38327794|FG001|Overall Study|Site closed|2|||
17176597|NCT03034915|38327795|FG002|Overall Study|Site closed|4|||
17176598|NCT03034915|38327793|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
17176599|NCT03034915|38327794|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
17176600|NCT03034915|38327795|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
17176601|NCT03034915|38327793|FG000|Overall Study|Physician Decision|1|||
17176602|NCT03034915|38327794|FG001|Overall Study|Physician Decision|5|||
17176603|NCT03034915|38327795|FG002|Overall Study|Physician Decision|2|||
17176604|NCT02631538|38327807|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
17176605|NCT02631538|38327808|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
17176606|NCT02631538|38327809|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
17176607|NCT02631538|38327810|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
17176608|NCT02631538|38327807|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
17176609|NCT02631538|38327808|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
17176610|NCT02631538|38327809|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
17176611|NCT02631538|38327810|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
17176612|NCT02631538|38327807|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
17176613|NCT02631538|38327808|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
17176614|NCT02631538|38327809|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
17176615|NCT02631538|38327810|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
17176616|NCT02631538|38327807|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
17176617|NCT02631538|38327808|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
17176618|NCT02631538|38327809|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
17176619|NCT02631538|38327810|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
17176620|NCT02631538|38327807|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
17176621|NCT02631538|38327808|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
17176622|NCT02631538|38327809|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
17176623|NCT02631538|38327810|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
17176624|NCT02631538|38327807|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
17176625|NCT02631538|38327808|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
17176626|NCT02631538|38327809|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
17176627|NCT02631538|38327810|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
17176628|NCT02631148|38327833|FG000|Overall Study|8 were ineligible|8|||
17176629|NCT02631148|38327834|FG001|Overall Study|8 were ineligible|0|||
17176630|NCT02631148|38327833|FG000|Overall Study|Withdrawal by Subject|1|||
17176631|NCT02631148|38327834|FG001|Overall Study|Withdrawal by Subject|0|||
17176632|NCT02631148|38327833|FG000|Overall Study|PAH not available to study participant|1|||
17176633|NCT02631148|38327834|FG001|Overall Study|PAH not available to study participant|0|||
17176634|NCT02753400|38327842|FG000|Overall Study|Adverse Event|3|||
17176635|NCT02753400|38327843|FG001|Overall Study|Adverse Event|0|||
17176636|NCT02753400|38327842|FG000|Overall Study|Withdrawal by Subject|2|||
17176637|NCT02753400|38327843|FG001|Overall Study|Withdrawal by Subject|1|||
17176638|NCT03943147|38327860|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
17176639|NCT03943147|38327861|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
17176640|NCT03943147|38327860|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
17176641|NCT03943147|38327861|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
17176642|NCT03943147|38327860|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
17176643|NCT03943147|38327861|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
17176644|NCT03943147|38327860|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
17176645|NCT03943147|38327861|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
17176646|NCT03943147|38327860|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
17176647|NCT03943147|38327861|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
17176648|NCT03943147|38327860|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
17176649|NCT03943147|38327861|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
17176650|NCT03730987|38327879|FG000|Overall Study|Lost to Follow-up|2|||
17176651|NCT03730987|38327880|FG001|Overall Study|Lost to Follow-up|0|||
17176652|NCT03730987|38327881|FG002|Overall Study|Lost to Follow-up|2|||
16996804|NCT03107793|38140959|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
16996805|NCT03107793|38140960|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
16996806|NCT03107793|38140956|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
16996807|NCT03107793|38140957|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
16996808|NCT03107793|38140958|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
16996809|NCT03107793|38140959|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
16996810|NCT03107793|38140960|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
16996811|NCT03107793|38140956|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
16996812|NCT03107793|38140957|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
16996813|NCT03107793|38140958|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
16996814|NCT03107793|38140959|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
16996815|NCT03107793|38140960|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
16996816|NCT03107793|38140956|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
17176653|NCT03730987|38327882|FG003|Overall Study|Lost to Follow-up|0|||
17176654|NCT03556891|38327893|FG000|Overall Study|Adverse Event|4|||
17176655|NCT03556891|38327893|FG000|Overall Study|MRI Need|3|||
17176656|NCT03556891|38327893|FG000|Overall Study|Device Failure|1|||
17176657|NCT03556891|38327893|FG000|Overall Study|Death|1|||
17176658|NCT03556891|38327893|FG000|Overall Study|Lost to Follow-up|1|||
17176659|NCT03556891|38327893|FG000|Overall Study|Missing at random|1|||
17176660|NCT03556891|38327893|FG000|Overall Study|Missing due to COVID|1|||
17176661|NCT03556891|38327893|FG000|Overall Study|Protocol Violation|1|||
17176662|NCT02844543|38327897|FG000|Overall Study|Withdrawal by Subject|4|||
17176663|NCT02844543|38327897|FG000|Overall Study|Did not meet eligibility criteria|1|||
17176664|NCT03034135|38327901|FG000|Overall Study|Withdrawal by Subject|2|||
17176665|NCT01671280|38327905|FG000|Overall Study|Withdrawal by Subject|2|||
17176666|NCT01405963|38327911|FG000|Overall Study|Moved Away|2|||
17176667|NCT01405963|38327912|FG001|Overall Study|Moved Away|0|||
17176668|NCT01405963|38327911|FG000|Overall Study|Adverse Event|0|||
17176669|NCT01405963|38327912|FG001|Overall Study|Adverse Event|1|||
17176670|NCT01405963|38327911|FG000|Overall Study|Lost to Follow-up|0|||
17176671|NCT01405963|38327912|FG001|Overall Study|Lost to Follow-up|1|||
17176672|NCT02846415|38327921|FG000|Overall Study|Lost to Follow-up|2|||
17176673|NCT02846415|38327922|FG001|Overall Study|Lost to Follow-up|0|||
17176674|NCT02846415|38327921|FG000|Overall Study|Withdrawal by Subject|1|||
17176675|NCT02846415|38327922|FG001|Overall Study|Withdrawal by Subject|1|||
17176676|NCT02628418|38327941|FG000|Overall Study|Lost to Follow-up|1|||
17176677|NCT02628418|38327942|FG001|Overall Study|Lost to Follow-up|2|||
17176678|NCT02752776|38327970|FG000|Overall Study|Adverse Event|15|||
17176679|NCT02752776|38327971|FG001|Overall Study|Adverse Event|23|||
17176680|NCT02752776|38327972|FG002|Overall Study|Adverse Event|11|||
17176681|NCT02752776|38327970|FG000|Overall Study|Lack of Efficacy|2|||
17176682|NCT02752776|38327971|FG001|Overall Study|Lack of Efficacy|6|||
17176683|NCT02752776|38327972|FG002|Overall Study|Lack of Efficacy|14|||
17176684|NCT02752776|38327970|FG000|Overall Study|Lost to Follow-up|11|||
17176685|NCT02752776|38327971|FG001|Overall Study|Lost to Follow-up|12|||
17176686|NCT02752776|38327972|FG002|Overall Study|Lost to Follow-up|4|||
17176687|NCT02752776|38327970|FG000|Overall Study|Non-compliance with study treatment|0|||
17176688|NCT02752776|38327971|FG001|Overall Study|Non-compliance with study treatment|0|||
17176689|NCT02752776|38327972|FG002|Overall Study|Non-compliance with study treatment|1|||
17176690|NCT02752776|38327970|FG000|Overall Study|Physician Decision|2|||
17176691|NCT02752776|38327971|FG001|Overall Study|Physician Decision|6|||
17176692|NCT02752776|38327972|FG002|Overall Study|Physician Decision|2|||
17176693|NCT02752776|38327970|FG000|Overall Study|Pregnancy|1|||
17176694|NCT02752776|38327971|FG001|Overall Study|Pregnancy|6|||
17176695|NCT02752776|38327972|FG002|Overall Study|Pregnancy|3|||
17176696|NCT02752776|38327970|FG000|Overall Study|Protocol Violation|10|||
17176697|NCT02752776|38327971|FG001|Overall Study|Protocol Violation|13|||
17176698|NCT02752776|38327972|FG002|Overall Study|Protocol Violation|6|||
17176699|NCT02752776|38327970|FG000|Overall Study|Subject/guardian decision|8|||
16996817|NCT03107793|38140957|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17176700|NCT02752776|38327971|FG001|Overall Study|Subject/guardian decision|6|||
17176701|NCT02752776|38327972|FG002|Overall Study|Subject/guardian decision|4|||
17176702|NCT02752776|38327970|FG000|Overall Study|Death|0|||
17176703|NCT02752776|38327971|FG001|Overall Study|Death|0|||
17176704|NCT02752776|38327972|FG002|Overall Study|Death|1|||
17176705|NCT02752776|38327970|FG000|Overall Study|Withdrawal by Subject|3|||
17176706|NCT02752776|38327971|FG001|Overall Study|Withdrawal by Subject|4|||
17176707|NCT02752776|38327972|FG002|Overall Study|Withdrawal by Subject|2|||
17176708|NCT01342965|38327984|FG000|Overall Study|Death|58|||
17176709|NCT01342965|38327985|FG001|Overall Study|Death|57|||
17176710|NCT01342965|38327984|FG000|Overall Study|Lost to Follow-up|5|||
17176711|NCT01342965|38327985|FG001|Overall Study|Lost to Follow-up|3|||
17176712|NCT01342965|38327984|FG000|Overall Study|Other Reasons- Unspecified|44|||
17176713|NCT01342965|38327985|FG001|Overall Study|Other Reasons- Unspecified|38|||
17176714|NCT01342965|38327984|FG000|Overall Study|Withdrawal by Subject|2|||
17176715|NCT01342965|38327985|FG001|Overall Study|Withdrawal by Subject|9|||
17176716|NCT02629822|38327991|FG000|Base Study|Lost to Follow-up|2|||
17176717|NCT02629822|38327991|FG000|Base Study|Non-Compliance With Study Drug|1|||
17176718|NCT02629822|38327991|FG000|Extension Study|Adverse Event|1|||
17176719|NCT02629822|38327991|FG000|Extension Study|Lost to Follow-up|1|||
17176720|NCT02840721|38327996|FG000|Treatment Period|Adverse Event|1|||
17176721|NCT02840721|38327996|FG000|Follow-Up|Lack of Efficacy|1|||
17176722|NCT02840721|38327996|FG000|Follow-Up|Withdrawal by Subject|4|||
17176723|NCT02840721|38327996|FG000|Follow-Up|Withdrawal of Consent|2|||
17176724|NCT03462706|38328004|FG000|Overall Study|Polyp was pedunculated|1|||
17176725|NCT03462706|38328005|FG001|Overall Study|Polyp was pedunculated|0|||
17176726|NCT03462706|38328006|FG002|Overall Study|Polyp was pedunculated|1|||
17176727|NCT03462706|38328007|FG003|Overall Study|Polyp was pedunculated|0|||
17176728|NCT03462706|38328004|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
17176729|NCT03462706|38328005|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
17176730|NCT03462706|38328006|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
17176731|NCT03462706|38328007|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
17176732|NCT02840253|38328017|FG000|Overall Study|Unsuccessful block|4|||
17176733|NCT02752074|38328023|FG000|Overall Study|Lost to Follow-up|1|||
17176734|NCT02752074|38328024|FG001|Overall Study|Lost to Follow-up|4|||
17176735|NCT02752074|38328023|FG000|Overall Study|Death|146|||
17176736|NCT02752074|38328024|FG001|Overall Study|Death|129|||
17176737|NCT02752074|38328023|FG000|Overall Study|Withdrawal by Subject|9|||
17176738|NCT02752074|38328024|FG001|Overall Study|Withdrawal by Subject|10|||
17176739|NCT02835495|38328032|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
17176740|NCT02835495|38328033|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
17176741|NCT02835495|38328032|FG000|Overall Study|Declined in-person follow-up visit|4|||
17176742|NCT02835495|38328033|FG001|Overall Study|Declined in-person follow-up visit|2|||
17176743|NCT02835339|38328043|FG000|Overall Study|Did not receive allocated intervention|13|||
17176744|NCT02835339|38328044|FG001|Overall Study|Did not receive allocated intervention|16|||
17176745|NCT02832063|38328052|FG000|Overall Study|Adverse Event|2|||
17176746|NCT02832063|38328053|FG001|Overall Study|Adverse Event|1|||
17176747|NCT02832063|38328052|FG000|Overall Study|Physician Decision|5|||
17176748|NCT02832063|38328053|FG001|Overall Study|Physician Decision|7|||
17176749|NCT02832063|38328052|FG000|Overall Study|Lost to Follow-up|15|||
17176750|NCT02832063|38328053|FG001|Overall Study|Lost to Follow-up|8|||
17176751|NCT02832063|38328052|FG000|Overall Study|Withdrawal by Subject|10|||
17176752|NCT02832063|38328053|FG001|Overall Study|Withdrawal by Subject|21|||
17176753|NCT02832063|38328052|FG000|Overall Study|Other|2|||
17176754|NCT02832063|38328053|FG001|Overall Study|Other|1|||
17176755|NCT03125902|38328061|FG000|Overall Study|Death|52|||
17176756|NCT03125902|38328062|FG001|Overall Study|Death|123|||
17176757|NCT03125902|38328061|FG000|Overall Study|Lost to Follow-up|1|||
17176758|NCT03125902|38328062|FG001|Overall Study|Lost to Follow-up|0|||
17176759|NCT03125902|38328061|FG000|Overall Study|Mastectomy|0|||
17176760|NCT03125902|38328062|FG001|Overall Study|Mastectomy|1|||
17176761|NCT03125902|38328061|FG000|Overall Study|Physician Decision|1|||
17176762|NCT03125902|38328062|FG001|Overall Study|Physician Decision|0|||
17176763|NCT03125902|38328061|FG000|Overall Study|Withdrawal by Subject|13|||
17176764|NCT03125902|38328062|FG001|Overall Study|Withdrawal by Subject|25|||
17176765|NCT03125902|38328061|FG000|Overall Study|Study is ongoing|153|||
17176766|NCT03125902|38328062|FG001|Overall Study|Study is ongoing|282|||
17176767|NCT04412707|38328071|FG000|Cycle 1|Death|0|||
17176768|NCT04412707|38328072|FG001|Cycle 1|Death|3|||
17176769|NCT04412707|38328071|FG000|Cycle 1|Disease progression|1|||
17176770|NCT04412707|38328072|FG001|Cycle 1|Disease progression|2|||
17176771|NCT04412707|38328071|FG000|Cycle 2|Death|0|||
17176772|NCT04412707|38328072|FG001|Cycle 2|Death|1|||
17176773|NCT04412707|38328071|FG000|Cycle 2|Disease progression|3|||
17176774|NCT04412707|38328072|FG001|Cycle 2|Disease progression|0|||
17176775|NCT04412707|38328071|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
17176776|NCT04412707|38328072|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
17176777|NCT04412707|38328071|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
17176778|NCT04412707|38328072|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
17176779|NCT04412707|38328071|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
17176780|NCT04412707|38328072|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
17176781|NCT04412707|38328071|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
17176782|NCT04412707|38328072|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
17176783|NCT01358721|38328091|FG000|Overall Study|Withdrawal by Subject|0|||
17176784|NCT01358721|38328092|FG001|Overall Study|Withdrawal by Subject|0|||
17176785|NCT01358721|38328093|FG002|Overall Study|Withdrawal by Subject|0|||
17176786|NCT01358721|38328094|FG003|Overall Study|Withdrawal by Subject|1|||
17176787|NCT01358721|38328091|FG000|Overall Study|Death|0|||
17176788|NCT01358721|38328092|FG001|Overall Study|Death|2|||
17176789|NCT01358721|38328093|FG002|Overall Study|Death|0|||
17176790|NCT01358721|38328094|FG003|Overall Study|Death|0|||
17176791|NCT01358721|38328091|FG000|Overall Study|Study Drug Toxicity|1|||
17176792|NCT01358721|38328092|FG001|Overall Study|Study Drug Toxicity|3|||
17176793|NCT01358721|38328093|FG002|Overall Study|Study Drug Toxicity|4|||
17176794|NCT01358721|38328094|FG003|Overall Study|Study Drug Toxicity|5|||
17176795|NCT01358721|38328091|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
17176796|NCT01358721|38328092|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
17176797|NCT01358721|38328093|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
17176798|NCT01358721|38328094|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
17176799|NCT01358721|38328091|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
17176800|NCT01358721|38328092|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
17176801|NCT01358721|38328093|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
17176802|NCT01358721|38328094|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
17176803|NCT01358721|38328091|FG000|Overall Study|Adverse Event related to study drug|1|||
17176804|NCT01358721|38328092|FG001|Overall Study|Adverse Event related to study drug|0|||
17176805|NCT01358721|38328093|FG002|Overall Study|Adverse Event related to study drug|0|||
17176806|NCT01358721|38328094|FG003|Overall Study|Adverse Event related to study drug|1|||
17176807|NCT01358721|38328091|FG000|Overall Study|Disease Progression|19|||
17176808|NCT01358721|38328092|FG001|Overall Study|Disease Progression|15|||
17176809|NCT01358721|38328093|FG002|Overall Study|Disease Progression|17|||
17176810|NCT01358721|38328094|FG003|Overall Study|Disease Progression|15|||
17176811|NCT01358721|38328091|FG000|Overall Study|Out of State/Unmet Criteria|0|||
17176812|NCT01358721|38328092|FG001|Overall Study|Out of State/Unmet Criteria|0|||
17176813|NCT01358721|38328093|FG002|Overall Study|Out of State/Unmet Criteria|1|||
17176814|NCT01358721|38328094|FG003|Overall Study|Out of State/Unmet Criteria|0|||
17176815|NCT01341639|38328106|FG000|Infant Series|Protocol Violation|1|||
17176816|NCT01341639|38328107|FG001|Infant Series|Protocol Violation|0|||
17176817|NCT01341639|38328106|FG000|Infant Series|Not Vaccinated|0|||
17176818|NCT01341639|38328107|FG001|Infant Series|Not Vaccinated|1|||
17176819|NCT01341639|38328106|FG000|Infant Series|Adverse Event|0|||
17176820|NCT01341639|38328107|FG001|Infant Series|Adverse Event|5|||
17176821|NCT01341639|38328106|FG000|Infant Series|Withdrawal by Subject|11|||
17176822|NCT01341639|38328107|FG001|Infant Series|Withdrawal by Subject|8|||
17176823|NCT01341639|38328106|FG000|Infant Series|Lost to Follow-up|0|||
17176824|NCT01341639|38328107|FG001|Infant Series|Lost to Follow-up|2|||
17176825|NCT01341639|38328106|FG000|Infant Series|Site 0048 Participants|17|||
17176826|NCT01341639|38328107|FG001|Infant Series|Site 0048 Participants|16|||
17176827|NCT01341639|38328106|FG000|Interim Period|Withdrawal by Subject|6|||
17176828|NCT01341639|38328107|FG001|Interim Period|Withdrawal by Subject|7|||
17176829|NCT01341639|38328106|FG000|Interim Period|Lost to Follow-up|2|||
17176830|NCT01341639|38328107|FG001|Interim Period|Lost to Follow-up|0|||
17176831|NCT01341639|38328106|FG000|Interim Period|Physician Decision|0|||
17176832|NCT01341639|38328107|FG001|Interim Period|Physician Decision|1|||
17176833|NCT01341639|38328106|FG000|Interim Period|Protocol Violation|0|||
17176834|NCT01341639|38328107|FG001|Interim Period|Protocol Violation|1|||
17176835|NCT01341639|38328106|FG000|Post-Treatment|Withdrawal by Subject|0|||
17176836|NCT01341639|38328107|FG001|Post-Treatment|Withdrawal by Subject|1|||
17176837|NCT01341639|38328106|FG000|Post-Treatment|Adverse Event|0|||
17176838|NCT01341639|38328107|FG001|Post-Treatment|Adverse Event|2|||
17176839|NCT02628028|38328121|FG000|Dosing Period|Withdrawal by Subject|0|||
17176840|NCT02628028|38328122|FG001|Dosing Period|Withdrawal by Subject|0|||
17176841|NCT02628028|38328123|FG002|Dosing Period|Withdrawal by Subject|1|||
17176842|NCT02628028|38328124|FG003|Dosing Period|Withdrawal by Subject|0|||
17176843|NCT02628028|38328125|FG004|Dosing Period|Withdrawal by Subject|2|||
17176844|NCT02628028|38328126|FG005|Dosing Period|Withdrawal by Subject|4|||
17176845|NCT02628028|38328127|FG006|Dosing Period|Withdrawal by Subject|1|||
17176846|NCT02628028|38328128|FG007|Dosing Period|Withdrawal by Subject|1|||
17176847|NCT02628028|38328121|FG000|Dosing Period|Adverse Event|0|||
17176848|NCT02628028|38328122|FG001|Dosing Period|Adverse Event|0|||
17176849|NCT02628028|38328123|FG002|Dosing Period|Adverse Event|0|||
17176850|NCT02628028|38328124|FG003|Dosing Period|Adverse Event|0|||
17176851|NCT02628028|38328125|FG004|Dosing Period|Adverse Event|2|||
17176852|NCT02628028|38328126|FG005|Dosing Period|Adverse Event|1|||
17176853|NCT02628028|38328127|FG006|Dosing Period|Adverse Event|3|||
17176854|NCT02628028|38328128|FG007|Dosing Period|Adverse Event|2|||
17176855|NCT02628028|38328121|FG000|Dosing Period|Death|0|||
17088859|NCT00310388|38229016|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
17088860|NCT00310388|38229015|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
17088861|NCT00310388|38229016|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
17088862|NCT00310388|38229015|FG000|Primary Reporting Phase|Physician Decision|2|||
17088863|NCT00310388|38229016|FG001|Primary Reporting Phase|Physician Decision|0|||
17088864|NCT00310388|38229015|FG000|Primary Reporting Phase|Request of the sponsor|19|||
17088865|NCT00310388|38229016|FG001|Primary Reporting Phase|Request of the sponsor|0|||
17088866|NCT00310388|38229015|FG000|Primary Reporting Phase|Failed to return|8|||
17088867|NCT00310388|38229016|FG001|Primary Reporting Phase|Failed to return|0|||
17088868|NCT00310388|38229015|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
17088869|NCT00310388|38229016|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
17088870|NCT00310388|38229015|FG000|Primary Reporting Phase|Participant request|2|||
17088871|NCT00310388|38229016|FG001|Primary Reporting Phase|Participant request|0|||
17088872|NCT00310388|38229015|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
17088873|NCT00310388|38229016|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
17088874|NCT00310388|38229015|FG000|Primary Reporting Phase|Discontinuation of study|1|||
17088875|NCT00310388|38229016|FG001|Primary Reporting Phase|Discontinuation of study|0|||
17088876|NCT00310388|38229015|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
17088877|NCT00310388|38229016|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
17088878|NCT00310388|38229015|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
17088879|NCT00310388|38229016|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
17088880|NCT00310388|38229015|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
17088881|NCT00310388|38229016|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
17088882|NCT00310388|38229015|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
17088883|NCT00310388|38229016|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
17088884|NCT00310388|38229015|FG000|Primary Reporting Phase|Participant passed away|1|||
17088885|NCT00310388|38229016|FG001|Primary Reporting Phase|Participant passed away|0|||
17088886|NCT00310388|38229015|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
17088887|NCT00310388|38229016|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
17088888|NCT00310388|38229015|FG000|Primary Reporting Phase|Missing|1|||
17088889|NCT00310388|38229016|FG001|Primary Reporting Phase|Missing|0|||
17088890|NCT00310388|38229015|FG000|Primary Reporting Phase|Other|1|||
17088891|NCT00310388|38229016|FG001|Primary Reporting Phase|Other|0|||
17088892|NCT00310388|38229015|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
17088893|NCT00310388|38229016|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
17088894|NCT00310388|38229015|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
17088895|NCT00310388|38229016|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
17088896|NCT00310388|38229015|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
17088897|NCT00310388|38229016|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
17088898|NCT00310388|38229015|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
17088899|NCT00310388|38229016|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
17088900|NCT00500357|38229021|FG000|Overall Study|Death|1|||
17088901|NCT00309842|38229036|FG000|Overall Study|Lost to Follow-up|1|||
17088902|NCT00499889|38229040|FG000|Overall Study|Infection prior to treatment|1|||
17088903|NCT00309608|38229049|FG000|Overall Study|Adverse Event|1|||
17088904|NCT00309608|38229050|FG001|Overall Study|Adverse Event|5|||
17088905|NCT00309608|38229051|FG002|Overall Study|Adverse Event|3|||
17088906|NCT00309608|38229052|FG003|Overall Study|Adverse Event|2|||
17088907|NCT00309608|38229053|FG004|Overall Study|Adverse Event|3|||
17088908|NCT00309608|38229049|FG000|Overall Study|Protocol Violation|2|||
17088909|NCT00309608|38229050|FG001|Overall Study|Protocol Violation|0|||
17088910|NCT00309608|38229051|FG002|Overall Study|Protocol Violation|0|||
17088911|NCT00309608|38229052|FG003|Overall Study|Protocol Violation|0|||
17088912|NCT00309608|38229053|FG004|Overall Study|Protocol Violation|0|||
17088913|NCT00309608|38229049|FG000|Overall Study|Lost to Follow-up|0|||
17088914|NCT00309608|38229050|FG001|Overall Study|Lost to Follow-up|0|||
17088915|NCT00309608|38229051|FG002|Overall Study|Lost to Follow-up|2|||
17088916|NCT00309608|38229052|FG003|Overall Study|Lost to Follow-up|0|||
17088917|NCT00309608|38229053|FG004|Overall Study|Lost to Follow-up|1|||
17088918|NCT00309608|38229049|FG000|Overall Study|Withdrawal by Subject|1|||
17088919|NCT00309608|38229050|FG001|Overall Study|Withdrawal by Subject|4|||
17088920|NCT00309608|38229051|FG002|Overall Study|Withdrawal by Subject|2|||
17088921|NCT00309608|38229052|FG003|Overall Study|Withdrawal by Subject|0|||
17088922|NCT00309608|38229053|FG004|Overall Study|Withdrawal by Subject|0|||
17088923|NCT00309608|38229049|FG000|Overall Study|Other incl. Lack of efficacy|10|||
17088924|NCT00309608|38229050|FG001|Overall Study|Other incl. Lack of efficacy|4|||
17088925|NCT00309608|38229051|FG002|Overall Study|Other incl. Lack of efficacy|3|||
17088926|NCT00309608|38229052|FG003|Overall Study|Other incl. Lack of efficacy|4|||
17088927|NCT00309608|38229053|FG004|Overall Study|Other incl. Lack of efficacy|0|||
17088928|NCT00309452|38229067|FG000|Overall Study|Withdrawal by Subject|3|||
17088929|NCT00309452|38229068|FG001|Overall Study|Withdrawal by Subject|0|||
17176856|NCT02628028|38328122|FG001|Dosing Period|Death|0|||
17176857|NCT02628028|38328123|FG002|Dosing Period|Death|0|||
17176858|NCT02628028|38328124|FG003|Dosing Period|Death|0|||
17176859|NCT02628028|38328125|FG004|Dosing Period|Death|0|||
17176860|NCT02628028|38328126|FG005|Dosing Period|Death|0|||
17176861|NCT02628028|38328127|FG006|Dosing Period|Death|0|||
17176862|NCT02628028|38328128|FG007|Dosing Period|Death|1|||
17176863|NCT02628028|38328121|FG000|Dosing Period|Lack of Efficacy|0|||
17176864|NCT02628028|38328122|FG001|Dosing Period|Lack of Efficacy|0|||
17176865|NCT02628028|38328123|FG002|Dosing Period|Lack of Efficacy|0|||
17176866|NCT02628028|38328124|FG003|Dosing Period|Lack of Efficacy|0|||
17176867|NCT02628028|38328125|FG004|Dosing Period|Lack of Efficacy|3|||
17176868|NCT02628028|38328126|FG005|Dosing Period|Lack of Efficacy|0|||
17176869|NCT02628028|38328127|FG006|Dosing Period|Lack of Efficacy|1|||
17176870|NCT02628028|38328128|FG007|Dosing Period|Lack of Efficacy|0|||
17176871|NCT02628028|38328121|FG000|Dosing Period|Study Terminated by Sponsor|0|||
17176872|NCT02628028|38328122|FG001|Dosing Period|Study Terminated by Sponsor|0|||
17176873|NCT02628028|38328123|FG002|Dosing Period|Study Terminated by Sponsor|0|||
17176874|NCT02628028|38328124|FG003|Dosing Period|Study Terminated by Sponsor|0|||
17176875|NCT02628028|38328125|FG004|Dosing Period|Study Terminated by Sponsor|7|||
17176876|NCT02628028|38328126|FG005|Dosing Period|Study Terminated by Sponsor|6|||
17176877|NCT02628028|38328127|FG006|Dosing Period|Study Terminated by Sponsor|7|||
17176878|NCT02628028|38328128|FG007|Dosing Period|Study Terminated by Sponsor|7|||
17176879|NCT02628028|38328121|FG000|Dosing Period|Physician Decision|0|||
17176880|NCT02628028|38328122|FG001|Dosing Period|Physician Decision|0|||
17176881|NCT02628028|38328123|FG002|Dosing Period|Physician Decision|0|||
17176882|NCT02628028|38328124|FG003|Dosing Period|Physician Decision|0|||
17176883|NCT02628028|38328125|FG004|Dosing Period|Physician Decision|0|||
17176884|NCT02628028|38328126|FG005|Dosing Period|Physician Decision|1|||
17176885|NCT02628028|38328127|FG006|Dosing Period|Physician Decision|0|||
17176886|NCT02628028|38328128|FG007|Dosing Period|Physician Decision|0|||
17176887|NCT02628028|38328121|FG000|Dosing Period|Site Terminated by Sponsor|0|||
17176888|NCT02628028|38328122|FG001|Dosing Period|Site Terminated by Sponsor|0|||
17176889|NCT02628028|38328123|FG002|Dosing Period|Site Terminated by Sponsor|0|||
17176890|NCT02628028|38328124|FG003|Dosing Period|Site Terminated by Sponsor|0|||
17176891|NCT02628028|38328125|FG004|Dosing Period|Site Terminated by Sponsor|0|||
17176892|NCT02628028|38328126|FG005|Dosing Period|Site Terminated by Sponsor|1|||
17176893|NCT02628028|38328127|FG006|Dosing Period|Site Terminated by Sponsor|1|||
17176894|NCT02628028|38328128|FG007|Dosing Period|Site Terminated by Sponsor|0|||
17176895|NCT02628028|38328121|FG000|Dosing Period|Lost to Follow-up|0|||
17176896|NCT02628028|38328122|FG001|Dosing Period|Lost to Follow-up|0|||
17176897|NCT02628028|38328123|FG002|Dosing Period|Lost to Follow-up|0|||
17176898|NCT02628028|38328124|FG003|Dosing Period|Lost to Follow-up|0|||
17176899|NCT02628028|38328125|FG004|Dosing Period|Lost to Follow-up|0|||
17176900|NCT02628028|38328126|FG005|Dosing Period|Lost to Follow-up|0|||
17176901|NCT02628028|38328127|FG006|Dosing Period|Lost to Follow-up|1|||
17176902|NCT02628028|38328128|FG007|Dosing Period|Lost to Follow-up|0|||
17176903|NCT02628028|38328121|FG000|Dosing Period|Other|0|||
17176904|NCT02628028|38328122|FG001|Dosing Period|Other|0|||
17176905|NCT02628028|38328123|FG002|Dosing Period|Other|0|||
17176906|NCT02628028|38328124|FG003|Dosing Period|Other|0|||
17176907|NCT02628028|38328125|FG004|Dosing Period|Other|2|||
17176908|NCT02628028|38328126|FG005|Dosing Period|Other|1|||
17176909|NCT02628028|38328127|FG006|Dosing Period|Other|2|||
17176910|NCT02628028|38328128|FG007|Dosing Period|Other|4|||
17176911|NCT02628028|38328121|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
17176912|NCT02628028|38328122|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
17176913|NCT02628028|38328123|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
17176914|NCT02628028|38328124|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
17176915|NCT02628028|38328125|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
17176916|NCT02628028|38328126|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
17176917|NCT02628028|38328127|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
17176918|NCT02628028|38328128|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
17176919|NCT02628028|38328121|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
17176920|NCT02628028|38328122|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
17176921|NCT02628028|38328123|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
17176922|NCT02628028|38328124|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
17176923|NCT02628028|38328125|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
17176924|NCT02628028|38328126|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
17176925|NCT02628028|38328127|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
17176926|NCT02628028|38328128|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
17176927|NCT02628028|38328121|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
17176928|NCT02628028|38328122|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
17176929|NCT02628028|38328123|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
17176930|NCT02628028|38328124|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
17176931|NCT02628028|38328125|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
17176932|NCT02628028|38328126|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
17176933|NCT02628028|38328127|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
17176934|NCT02628028|38328128|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
17176935|NCT02628028|38328121|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
17176936|NCT02628028|38328122|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
17176937|NCT02628028|38328123|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
17176938|NCT02628028|38328124|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
17176939|NCT02628028|38328125|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
17176940|NCT02628028|38328126|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
17176941|NCT02628028|38328127|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
17176942|NCT02628028|38328128|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
17176943|NCT02628028|38328121|FG000|Long-term Extension (LTE) Period|Other|0|||
17176944|NCT02628028|38328122|FG001|Long-term Extension (LTE) Period|Other|0|||
17176945|NCT02628028|38328123|FG002|Long-term Extension (LTE) Period|Other|0|||
17176946|NCT02628028|38328124|FG003|Long-term Extension (LTE) Period|Other|0|||
17176947|NCT02628028|38328125|FG004|Long-term Extension (LTE) Period|Other|0|||
17176948|NCT02628028|38328126|FG005|Long-term Extension (LTE) Period|Other|3|||
17176949|NCT02628028|38328127|FG006|Long-term Extension (LTE) Period|Other|4|||
17176950|NCT02628028|38328128|FG007|Long-term Extension (LTE) Period|Other|3|||
17176951|NCT03977701|38328160|FG000|Overall Study|COVID-19 pandemic|0|||
17176952|NCT03977701|38328161|FG001|Overall Study|COVID-19 pandemic|0|||
17176953|NCT03977701|38328162|FG002|Overall Study|COVID-19 pandemic|0|||
17176954|NCT03977701|38328163|FG003|Overall Study|COVID-19 pandemic|0|||
17176955|NCT03977701|38328164|FG004|Overall Study|COVID-19 pandemic|0|||
17176956|NCT03977701|38328165|FG005|Overall Study|COVID-19 pandemic|1|||
17176957|NCT03977701|38328166|FG006|Overall Study|COVID-19 pandemic|0|||
17176958|NCT03977701|38328167|FG007|Overall Study|COVID-19 pandemic|1|||
17176959|NCT03977701|38328168|FG008|Overall Study|COVID-19 pandemic|0|||
17176960|NCT03977701|38328169|FG009|Overall Study|COVID-19 pandemic|0|||
17176961|NCT02814526|38328208|FG000|Overall Study|Adverse Event|4|||
17176962|NCT02814526|38328209|FG001|Overall Study|Adverse Event|3|||
17176963|NCT02814526|38328208|FG000|Overall Study|Death|1|||
17176964|NCT02814526|38328209|FG001|Overall Study|Death|1|||
17176965|NCT02814526|38328208|FG000|Overall Study|Lost to Follow-up|3|||
17176966|NCT02814526|38328209|FG001|Overall Study|Lost to Follow-up|4|||
17176967|NCT02814526|38328208|FG000|Overall Study|non site physician decision|1|||
17176968|NCT02814526|38328209|FG001|Overall Study|non site physician decision|0|||
17176969|NCT02814526|38328208|FG000|Overall Study|participant noncompliance|1|||
17176970|NCT02814526|38328209|FG001|Overall Study|participant noncompliance|1|||
17176971|NCT02814526|38328208|FG000|Overall Study|Withdrawal by Subject|20|||
17176972|NCT02814526|38328209|FG001|Overall Study|Withdrawal by Subject|14|||
17176973|NCT02814526|38328208|FG000|Overall Study|safety risk|2|||
17176974|NCT02814526|38328209|FG001|Overall Study|safety risk|1|||
17176975|NCT02814526|38328208|FG000|Overall Study|early termination-study terminated|1|||
17176976|NCT02814526|38328209|FG001|Overall Study|early termination-study terminated|2|||
17176977|NCT02814526|38328208|FG000|Overall Study|Other|0|||
17176978|NCT02814526|38328209|FG001|Overall Study|Other|4|||
17176979|NCT02329834|38328217|FG000|Overall Study|Physician Decision|1|||
17176980|NCT02329834|38328218|FG001|Overall Study|Physician Decision|0|||
17176981|NCT01340937|38328229|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
17176982|NCT01340937|38328230|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
17176983|NCT01340937|38328231|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
17176984|NCT01340937|38328232|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
17176985|NCT01340937|38328229|FG000|Period 1: Infant Series|Adverse Event|0|||
17176986|NCT01340937|38328230|FG001|Period 1: Infant Series|Adverse Event|1|||
17176987|NCT01340937|38328231|FG002|Period 1: Infant Series|Adverse Event|4|||
17176988|NCT01340937|38328232|FG003|Period 1: Infant Series|Adverse Event|0|||
17176989|NCT01340937|38328229|FG000|Period 1: Infant Series|Death|2|||
17176990|NCT01340937|38328230|FG001|Period 1: Infant Series|Death|0|||
17176991|NCT01340937|38328231|FG002|Period 1: Infant Series|Death|2|||
17176992|NCT01340937|38328232|FG003|Period 1: Infant Series|Death|0|||
17176993|NCT01340937|38328229|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
17176994|NCT01340937|38328230|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
17176995|NCT01340937|38328231|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
17176996|NCT01340937|38328232|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
17176997|NCT01340937|38328229|FG000|Period 1: Infant Series|Physician Decision|2|||
17176998|NCT01340937|38328230|FG001|Period 1: Infant Series|Physician Decision|3|||
17176999|NCT01340937|38328231|FG002|Period 1: Infant Series|Physician Decision|1|||
17177000|NCT01340937|38328232|FG003|Period 1: Infant Series|Physician Decision|0|||
17177001|NCT01340937|38328229|FG000|Period 1: Infant Series|Protocol Violation|1|||
17177002|NCT01340937|38328230|FG001|Period 1: Infant Series|Protocol Violation|4|||
17177003|NCT01340937|38328231|FG002|Period 1: Infant Series|Protocol Violation|4|||
17177004|NCT01340937|38328232|FG003|Period 1: Infant Series|Protocol Violation|3|||
16996818|NCT03107793|38140958|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16996819|NCT03107793|38140959|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17177005|NCT01340937|38328229|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
17177006|NCT01340937|38328230|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
17177007|NCT01340937|38328231|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
17177008|NCT01340937|38328232|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
17177009|NCT01340937|38328229|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
17177010|NCT01340937|38328230|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
17177011|NCT01340937|38328231|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
17177012|NCT01340937|38328232|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
17177013|NCT01340937|38328229|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
17177014|NCT01340937|38328230|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
17177015|NCT01340937|38328231|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
17177016|NCT01340937|38328232|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
17177017|NCT01340937|38328229|FG000|Period 2: Interim Period|Adverse Event|1|||
17177018|NCT01340937|38328230|FG001|Period 2: Interim Period|Adverse Event|0|||
17177019|NCT01340937|38328231|FG002|Period 2: Interim Period|Adverse Event|1|||
17177020|NCT01340937|38328232|FG003|Period 2: Interim Period|Adverse Event|0|||
17177021|NCT01340937|38328229|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
17177022|NCT01340937|38328230|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
17177023|NCT01340937|38328231|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
17177024|NCT01340937|38328232|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
17177025|NCT01340937|38328229|FG000|Period 2: Interim Period|Physician Decision|0|||
17177026|NCT01340937|38328230|FG001|Period 2: Interim Period|Physician Decision|1|||
17177027|NCT01340937|38328231|FG002|Period 2: Interim Period|Physician Decision|1|||
17177028|NCT01340937|38328232|FG003|Period 2: Interim Period|Physician Decision|0|||
17177029|NCT01340937|38328229|FG000|Period 2: Interim Period|Protocol Violation|5|||
17177030|NCT01340937|38328230|FG001|Period 2: Interim Period|Protocol Violation|3|||
17177031|NCT01340937|38328231|FG002|Period 2: Interim Period|Protocol Violation|6|||
17177032|NCT01340937|38328232|FG003|Period 2: Interim Period|Protocol Violation|3|||
17177033|NCT01340937|38328229|FG000|Period 2: Interim Period|Technical problems|4|||
17177034|NCT01340937|38328230|FG001|Period 2: Interim Period|Technical problems|4|||
17177035|NCT01340937|38328231|FG002|Period 2: Interim Period|Technical problems|6|||
17177036|NCT01340937|38328232|FG003|Period 2: Interim Period|Technical problems|3|||
17177037|NCT01340937|38328229|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
17177038|NCT01340937|38328230|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
17177039|NCT01340937|38328231|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
17177040|NCT01340937|38328232|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
17177041|NCT01340937|38328229|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
17177042|NCT01340937|38328230|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
17177043|NCT01340937|38328231|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
17177044|NCT01340937|38328232|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
17177045|NCT01340937|38328229|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
17177046|NCT01340937|38328230|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
17177047|NCT01340937|38328231|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
17177048|NCT01340937|38328232|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
17177049|NCT01340937|38328229|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
17177050|NCT01340937|38328230|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
17177051|NCT01340937|38328231|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
17177052|NCT01340937|38328232|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
17177053|NCT03029143|38328248|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
17177054|NCT03029143|38328249|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
17177055|NCT03029143|38328250|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
17177056|NCT03029143|38328248|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
17177057|NCT03029143|38328249|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
17177058|NCT03029143|38328250|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
17177059|NCT03029143|38328248|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
17177060|NCT03029143|38328249|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
17177061|NCT03029143|38328250|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
17177062|NCT03029143|38328248|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
17177063|NCT03029143|38328249|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
17177064|NCT03029143|38328250|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
17177065|NCT03029143|38328248|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
17177066|NCT03029143|38328249|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
17177067|NCT03029143|38328250|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
17177068|NCT03029143|38328248|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
17177069|NCT03029143|38328249|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
17177070|NCT03029143|38328250|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
17177071|NCT03029143|38328248|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
17177072|NCT03029143|38328249|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
17177073|NCT03029143|38328250|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
17177074|NCT03029143|38328248|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
17177075|NCT03029143|38328249|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
17177076|NCT03029143|38328250|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
17177077|NCT03029143|38328248|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
17177078|NCT03029143|38328249|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
17177079|NCT03029143|38328250|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
17177080|NCT03029143|38328248|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
17177081|NCT03029143|38328249|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
17177082|NCT03029143|38328250|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
17177083|NCT03029143|38328248|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
17177084|NCT03029143|38328249|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
17177085|NCT03029143|38328250|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
17177086|NCT03028129|38328261|FG000|Overall Study|Adverse Event|13|||
17177087|NCT03028129|38328262|FG001|Overall Study|Adverse Event|2|||
17177088|NCT03028129|38328261|FG000|Overall Study|Lost to Follow-up|50|||
17177089|NCT03028129|38328262|FG001|Overall Study|Lost to Follow-up|38|||
17177090|NCT03028129|38328261|FG000|Overall Study|Physician Decision|0|||
17177091|NCT03028129|38328262|FG001|Overall Study|Physician Decision|1|||
17177092|NCT03028129|38328261|FG000|Overall Study|Protocol Violation|1|||
17177093|NCT03028129|38328262|FG001|Overall Study|Protocol Violation|1|||
17177094|NCT03028129|38328261|FG000|Overall Study|Withdrawal by Subject|62|||
17177095|NCT03028129|38328262|FG001|Overall Study|Withdrawal by Subject|45|||
17177096|NCT01309672|38328277|FG000|Overall Study|Lack of Efficacy|20|||
17177097|NCT01309672|38328277|FG000|Overall Study|Other|9|||
17177098|NCT01309672|38328277|FG000|Overall Study|Adverse Event|5|||
17177099|NCT01309672|38328277|FG000|Overall Study|Withdrawal by Subject|3|||
17177100|NCT03026257|38328288|FG000|Overall Study|Adverse Event|3|||
17177101|NCT03026257|38328289|FG001|Overall Study|Adverse Event|0|||
17177102|NCT03026257|38328290|FG002|Overall Study|Adverse Event|0|||
17177103|NCT03026257|38328291|FG003|Overall Study|Adverse Event|0|||
17177104|NCT03026257|38328292|FG004|Overall Study|Adverse Event|0|||
17177105|NCT03026257|38328293|FG005|Overall Study|Adverse Event|0|||
17177106|NCT03026257|38328288|FG000|Overall Study|Lost to Follow-up|1|||
17177107|NCT03026257|38328289|FG001|Overall Study|Lost to Follow-up|0|||
17177108|NCT03026257|38328290|FG002|Overall Study|Lost to Follow-up|0|||
17177109|NCT03026257|38328291|FG003|Overall Study|Lost to Follow-up|0|||
17177110|NCT03026257|38328292|FG004|Overall Study|Lost to Follow-up|0|||
17177111|NCT03026257|38328293|FG005|Overall Study|Lost to Follow-up|0|||
17177112|NCT03026257|38328288|FG000|Overall Study|Protocol Violation|1|||
17177113|NCT03026257|38328289|FG001|Overall Study|Protocol Violation|0|||
17177114|NCT03026257|38328290|FG002|Overall Study|Protocol Violation|0|||
17177115|NCT03026257|38328291|FG003|Overall Study|Protocol Violation|1|||
17177116|NCT03026257|38328292|FG004|Overall Study|Protocol Violation|1|||
17177117|NCT03026257|38328293|FG005|Overall Study|Protocol Violation|0|||
17177118|NCT03026257|38328288|FG000|Overall Study|Withdrawal by Subject|1|||
17177119|NCT03026257|38328289|FG001|Overall Study|Withdrawal by Subject|1|||
17177120|NCT03026257|38328290|FG002|Overall Study|Withdrawal by Subject|0|||
17177121|NCT03026257|38328291|FG003|Overall Study|Withdrawal by Subject|0|||
17177122|NCT03026257|38328292|FG004|Overall Study|Withdrawal by Subject|0|||
17177123|NCT03026257|38328293|FG005|Overall Study|Withdrawal by Subject|0|||
17177124|NCT01670188|38328309|FG000|Overall Study|Death|0|||
17177125|NCT01670188|38328310|FG001|Overall Study|Death|1|||
17177126|NCT01933048|38328318|FG000|Overall Study|Lost to Follow-up|15|||
17177127|NCT01933048|38328319|FG001|Overall Study|Lost to Follow-up|18|||
17177128|NCT01933048|38328318|FG000|Overall Study|personal reasons|1|||
17177129|NCT01933048|38328319|FG001|Overall Study|personal reasons|1|||
17177130|NCT01933048|38328318|FG000|Overall Study|Protocol Violation|7|||
17177131|NCT01933048|38328319|FG001|Overall Study|Protocol Violation|8|||
17177132|NCT01933048|38328318|FG000|Overall Study|Physician Decision|1|||
17177133|NCT01933048|38328319|FG001|Overall Study|Physician Decision|0|||
17177134|NCT01933048|38328318|FG000|Overall Study|unknown reasons|1|||
17177135|NCT01933048|38328319|FG001|Overall Study|unknown reasons|1|||
17177136|NCT02751450|38328330|FG000|Overall Study|Adverse Event|1|||
17177137|NCT02751450|38328331|FG001|Overall Study|Adverse Event|0|||
17177138|NCT01515748|38328341|FG000|Overall Study|Withdrawal by Subject|32|||
17177139|NCT01515748|38328342|FG001|Overall Study|Withdrawal by Subject|41|||
17177140|NCT01515748|38328341|FG000|Overall Study|Lost to Follow-up|2|||
17177141|NCT01515748|38328342|FG001|Overall Study|Lost to Follow-up|4|||
17177142|NCT01515748|38328341|FG000|Overall Study|Ongoing|86|||
17177143|NCT01515748|38328342|FG001|Overall Study|Ongoing|90|||
17177144|NCT01358175|38328352|FG000|Overall Study|Death|1|||
17177145|NCT01358175|38328353|FG001|Overall Study|Death|0|||
17177146|NCT01358175|38328354|FG002|Overall Study|Death|1|||
17177147|NCT01358175|38328352|FG000|Overall Study|Withdrawal by Subject|9|||
17177148|NCT01358175|38328353|FG001|Overall Study|Withdrawal by Subject|5|||
17177149|NCT01358175|38328354|FG002|Overall Study|Withdrawal by Subject|10|||
17177150|NCT01358175|38328352|FG000|Overall Study|Technical issues|0|||
17177151|NCT01358175|38328353|FG001|Overall Study|Technical issues|1|||
17177152|NCT01358175|38328354|FG002|Overall Study|Technical issues|0|||
17177153|NCT01358175|38328352|FG000|Overall Study|Pregnancy|0|||
17177154|NCT01358175|38328353|FG001|Overall Study|Pregnancy|1|||
17177155|NCT01358175|38328354|FG002|Overall Study|Pregnancy|0|||
17177156|NCT01358175|38328352|FG000|Overall Study|Physician Decision|1|||
17177157|NCT01358175|38328353|FG001|Overall Study|Physician Decision|0|||
17177158|NCT01358175|38328354|FG002|Overall Study|Physician Decision|0|||
17177159|NCT01358175|38328352|FG000|Overall Study|Non Compliance with Study Treatment|0|||
17177160|NCT01358175|38328353|FG001|Overall Study|Non Compliance with Study Treatment|1|||
17177161|NCT01358175|38328354|FG002|Overall Study|Non Compliance with Study Treatment|1|||
17177162|NCT01358175|38328352|FG000|Overall Study|Lost to Follow-up|1|||
17177163|NCT01358175|38328353|FG001|Overall Study|Lost to Follow-up|1|||
17177164|NCT01358175|38328354|FG002|Overall Study|Lost to Follow-up|3|||
17177165|NCT01358175|38328352|FG000|Overall Study|Lack of Efficacy|3|||
17177166|NCT01358175|38328353|FG001|Overall Study|Lack of Efficacy|8|||
17177167|NCT01358175|38328354|FG002|Overall Study|Lack of Efficacy|6|||
17177168|NCT01358175|38328352|FG000|Overall Study|Adverse Event|6|||
17177169|NCT01358175|38328353|FG001|Overall Study|Adverse Event|11|||
17177170|NCT01358175|38328354|FG002|Overall Study|Adverse Event|11|||
17177171|NCT04116229|38328368|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
17177172|NCT04116229|38328369|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
17177173|NCT04116229|38328368|FG000|Overall Study|Scheduling not possible.|0|||
17177174|NCT04116229|38328369|FG001|Overall Study|Scheduling not possible.|1|||
17177175|NCT02833077|38328377|FG000|Overall Study|Adverse Event|1|||
17177176|NCT02833077|38328378|FG001|Overall Study|Adverse Event|2|||
17177177|NCT02833077|38328377|FG000|Overall Study|Lost to Follow-up|10|||
17177178|NCT02833077|38328378|FG001|Overall Study|Lost to Follow-up|1|||
17177179|NCT02833077|38328377|FG000|Overall Study|Personal Reasons|6|||
17177180|NCT02833077|38328378|FG001|Overall Study|Personal Reasons|4|||
17177181|NCT02833077|38328377|FG000|Overall Study|Protocol Deviation|0|||
17177182|NCT02833077|38328378|FG001|Overall Study|Protocol Deviation|1|||
17177183|NCT01355679|38328385|FG000|Overall Study|benign tumor types found at biopsy|2|||
17177184|NCT02832375|38328392|FG000|Overall Study|Lost to Follow-up|1|||
17177185|NCT02832375|38328393|FG001|Overall Study|Lost to Follow-up|0|||
17177186|NCT02832375|38328392|FG000|Overall Study|Withdrawal of Consent|1|||
17177187|NCT02832375|38328393|FG001|Overall Study|Withdrawal of Consent|0|||
17177188|NCT02925403|38328402|FG000|Overall Study|Lost to Follow-up|0|||
17177189|NCT02925403|38328403|FG001|Overall Study|Lost to Follow-up|1|||
17177190|NCT02626780|38328409|FG000|Overall Study|Withdrawal by Subject|3|||
17177191|NCT02831673|38328424|FG000|Overall Study|Adverse Event|6|||
17177192|NCT02831673|38328425|FG001|Overall Study|Adverse Event|4|||
17177193|NCT02831673|38328424|FG000|Overall Study|Lack of Efficacy|3|||
17177194|NCT02831673|38328425|FG001|Overall Study|Lack of Efficacy|1|||
17177195|NCT02831673|38328424|FG000|Overall Study|Protocol Violation|5|||
17177196|NCT02831673|38328425|FG001|Overall Study|Protocol Violation|4|||
17177197|NCT02831673|38328424|FG000|Overall Study|Protocol Withdrawal Criterion Met|1|||
17177198|NCT02831673|38328425|FG001|Overall Study|Protocol Withdrawal Criterion Met|6|||
17177199|NCT02831673|38328424|FG000|Overall Study|Lost to Follow-up|9|||
17177200|NCT02831673|38328425|FG001|Overall Study|Lost to Follow-up|6|||
17177201|NCT02831673|38328424|FG000|Overall Study|Physician Decision|6|||
17177202|NCT02831673|38328425|FG001|Overall Study|Physician Decision|3|||
17177203|NCT02831673|38328424|FG000|Overall Study|Withdrawal by Subject|6|||
17177204|NCT02831673|38328425|FG001|Overall Study|Withdrawal by Subject|4|||
17177205|NCT02831673|38328424|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320|||
17177206|NCT02831673|38328425|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330|||
17177207|NCT02830893|38328433|FG000|Overall Study|Relocation to out of the country|1|||
17177208|NCT02830893|38328434|FG001|Overall Study|Relocation to out of the country|0|||
17177209|NCT02830893|38328433|FG000|Overall Study|Lost to Follow-up|0|||
17177210|NCT02830893|38328434|FG001|Overall Study|Lost to Follow-up|2|||
17177211|NCT02830893|38328433|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
17177212|NCT02830893|38328434|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
17177213|NCT02625922|38328442|FG000|Overall Study|Non-availability of IMP|1|||
17177214|NCT02625922|38328443|FG001|Overall Study|Non-availability of IMP|1|||
17177215|NCT02625922|38328442|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
17177216|NCT02625922|38328443|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
17177217|NCT03350035|38328455|FG000|Overall Study|Lack of Efficacy|2|||
17177218|NCT03350035|38328456|FG001|Overall Study|Lack of Efficacy|0|||
17177219|NCT03350035|38328457|FG002|Overall Study|Lack of Efficacy|0|||
17177220|NCT03350035|38328455|FG000|Overall Study|Subject discharged to hospice|0|||
17177221|NCT03350035|38328456|FG001|Overall Study|Subject discharged to hospice|0|||
17177222|NCT03350035|38328457|FG002|Overall Study|Subject discharged to hospice|1|||
17177223|NCT01358331|38328491|FG000|Overall Study|Lost to Follow-up|0|||
17177224|NCT01358331|38328492|FG001|Overall Study|Lost to Follow-up|0|||
17177225|NCT01358331|38328493|FG002|Overall Study|Lost to Follow-up|0|||
17177226|NCT01358331|38328494|FG003|Overall Study|Lost to Follow-up|1|||
17177227|NCT01358331|38328495|FG004|Overall Study|Lost to Follow-up|0|||
17177228|NCT01358331|38328496|FG005|Overall Study|Lost to Follow-up|0|||
17177229|NCT01358331|38328491|FG000|Overall Study|Withdrawal by Subject|0|||
17177230|NCT01358331|38328492|FG001|Overall Study|Withdrawal by Subject|0|||
17177231|NCT01358331|38328493|FG002|Overall Study|Withdrawal by Subject|0|||
17177232|NCT01358331|38328494|FG003|Overall Study|Withdrawal by Subject|1|||
17177233|NCT01358331|38328495|FG004|Overall Study|Withdrawal by Subject|1|||
17177234|NCT01358331|38328496|FG005|Overall Study|Withdrawal by Subject|1|||
17177235|NCT01358331|38328491|FG000|Overall Study|Adverse Events|1|||
17177236|NCT01358331|38328492|FG001|Overall Study|Adverse Events|1|||
17177237|NCT01358331|38328493|FG002|Overall Study|Adverse Events|1|||
17177238|NCT01358331|38328494|FG003|Overall Study|Adverse Events|0|||
17177239|NCT01358331|38328495|FG004|Overall Study|Adverse Events|1|||
17177240|NCT01358331|38328496|FG005|Overall Study|Adverse Events|5|||
17177241|NCT01358331|38328491|FG000|Overall Study|Symptomatic Deterioration|0|||
17177242|NCT01358331|38328492|FG001|Overall Study|Symptomatic Deterioration|0|||
17177243|NCT01358331|38328493|FG002|Overall Study|Symptomatic Deterioration|0|||
17177244|NCT01358331|38328494|FG003|Overall Study|Symptomatic Deterioration|0|||
17177245|NCT01358331|38328495|FG004|Overall Study|Symptomatic Deterioration|1|||
17177246|NCT01358331|38328496|FG005|Overall Study|Symptomatic Deterioration|0|||
17177247|NCT01358331|38328491|FG000|Overall Study|Participants did not wish to continue|0|||
17177248|NCT01358331|38328492|FG001|Overall Study|Participants did not wish to continue|0|||
17177249|NCT01358331|38328493|FG002|Overall Study|Participants did not wish to continue|0|||
17177250|NCT01358331|38328494|FG003|Overall Study|Participants did not wish to continue|0|||
17177251|NCT01358331|38328495|FG004|Overall Study|Participants did not wish to continue|1|||
17177252|NCT01358331|38328496|FG005|Overall Study|Participants did not wish to continue|0|||
17177253|NCT01358331|38328491|FG000|Overall Study|Progress of disease under investigation|1|||
17177254|NCT01358331|38328492|FG001|Overall Study|Progress of disease under investigation|2|||
17177255|NCT01358331|38328493|FG002|Overall Study|Progress of disease under investigation|3|||
17177256|NCT01358331|38328494|FG003|Overall Study|Progress of disease under investigation|1|||
17177257|NCT01358331|38328495|FG004|Overall Study|Progress of disease under investigation|3|||
17177258|NCT01358331|38328496|FG005|Overall Study|Progress of disease under investigation|0|||
17177259|NCT02828241|38328512|FG000|Overall Study|Adverse Event|7|||
17177260|NCT02828241|38328513|FG001|Overall Study|Adverse Event|2|||
17177261|NCT02828241|38328512|FG000|Overall Study|Protocol Violation|1|||
17177262|NCT02828241|38328513|FG001|Overall Study|Protocol Violation|0|||
17177263|NCT01355523|38328522|FG000|Overall Study|Withdrawal by Subject|1|||
17177264|NCT01355523|38328523|FG001|Overall Study|Withdrawal by Subject|4|||
17177265|NCT01355523|38328522|FG000|Overall Study|Lost to Follow-up|0|||
17177266|NCT01355523|38328523|FG001|Overall Study|Lost to Follow-up|2|||
17177267|NCT01355523|38328522|FG000|Overall Study|Protocol Violation|0|||
17177268|NCT01355523|38328523|FG001|Overall Study|Protocol Violation|2|||
17177269|NCT01355523|38328522|FG000|Overall Study|Adverse Event|0|||
17177270|NCT01355523|38328523|FG001|Overall Study|Adverse Event|2|||
17177271|NCT02625220|38328529|FG000|Overall Study|Adverse Event|2|||
17177272|NCT02625220|38328529|FG000|Overall Study|Lost to Follow-up|2|||
17177273|NCT02625220|38328529|FG000|Overall Study|Protocol Violation|1|||
17177274|NCT02625220|38328529|FG000|Overall Study|Study discontinued at site|2|||
17177275|NCT02826603|38328535|FG000|Overall Study|Adverse Event|17|||
17177276|NCT02826603|38328536|FG001|Overall Study|Adverse Event|9|||
17177277|NCT02826603|38328535|FG000|Overall Study|Lack of Efficacy|4|||
17177278|NCT02826603|38328536|FG001|Overall Study|Lack of Efficacy|9|||
17177279|NCT02826603|38328535|FG000|Overall Study|Lost to Follow-up|13|||
17177280|NCT02826603|38328536|FG001|Overall Study|Lost to Follow-up|12|||
17177281|NCT02826603|38328535|FG000|Overall Study|Noncompliance with treatment|0|||
17177282|NCT02826603|38328536|FG001|Overall Study|Noncompliance with treatment|2|||
17177283|NCT02826603|38328535|FG000|Overall Study|Physician Decision|1|||
17177284|NCT02826603|38328536|FG001|Overall Study|Physician Decision|7|||
17177285|NCT02826603|38328535|FG000|Overall Study|Pregnancy|1|||
17177286|NCT02826603|38328536|FG001|Overall Study|Pregnancy|2|||
17177287|NCT02826603|38328535|FG000|Overall Study|Protocol Violation|3|||
17177288|NCT02826603|38328536|FG001|Overall Study|Protocol Violation|3|||
17177289|NCT02826603|38328535|FG000|Overall Study|Withdrawal by Subject|20|||
17177290|NCT02826603|38328536|FG001|Overall Study|Withdrawal by Subject|19|||
17177291|NCT02826603|38328535|FG000|Overall Study|Death|2|||
17177292|NCT02826603|38328536|FG001|Overall Study|Death|0|||
17177293|NCT02826603|38328535|FG000|Overall Study|New therapy for study indication|0|||
17177294|NCT02826603|38328536|FG001|Overall Study|New therapy for study indication|1|||
17177295|NCT01329900|38328543|FG000|Overall Study|Elevated creatinine/renal function|1|||
17177296|NCT02825043|38328547|FG000|Overall Study|Lost to Follow-up|4|||
17177297|NCT02744391|38328551|FG000|Overall Study|Lost to Follow-up|9|||
17177298|NCT02744391|38328551|FG000|Overall Study|Physician Decision|2|||
17177299|NCT02744391|38328551|FG000|Overall Study|Withdrawal by Subject|3|||
17177300|NCT02750592|38328566|FG000|Overall Study|Adverse Event|3|||
17177301|NCT02750592|38328566|FG000|Overall Study|Lack of Efficacy|2|||
17177302|NCT02624986|38328578|FG000|Overall Study|Death|0|||
17177303|NCT02624986|38328579|FG001|Overall Study|Death|1|||
17177304|NCT02624986|38328580|FG002|Overall Study|Death|2|||
17177305|NCT02624986|38328581|FG003|Overall Study|Death|2|||
17177306|NCT02624986|38328582|FG004|Overall Study|Death|2|||
17177307|NCT02624986|38328583|FG005|Overall Study|Death|0|||
17177308|NCT02624986|38328584|FG006|Overall Study|Death|0|||
17177309|NCT02624986|38328585|FG007|Overall Study|Death|1|||
17177310|NCT02624986|38328578|FG000|Overall Study|Study Terminated by Sponsor|1|||
17177311|NCT02624986|38328579|FG001|Overall Study|Study Terminated by Sponsor|1|||
17177312|NCT02624986|38328580|FG002|Overall Study|Study Terminated by Sponsor|0|||
17177313|NCT02624986|38328581|FG003|Overall Study|Study Terminated by Sponsor|1|||
17177314|NCT02624986|38328582|FG004|Overall Study|Study Terminated by Sponsor|2|||
17177315|NCT02624986|38328583|FG005|Overall Study|Study Terminated by Sponsor|2|||
17177316|NCT02624986|38328584|FG006|Overall Study|Study Terminated by Sponsor|4|||
17177317|NCT02624986|38328585|FG007|Overall Study|Study Terminated by Sponsor|3|||
17177318|NCT02624986|38328578|FG000|Overall Study|Progressive Disease|0|||
17177319|NCT02624986|38328579|FG001|Overall Study|Progressive Disease|1|||
17177320|NCT02624986|38328580|FG002|Overall Study|Progressive Disease|0|||
17177321|NCT02624986|38328581|FG003|Overall Study|Progressive Disease|0|||
17177322|NCT02624986|38328582|FG004|Overall Study|Progressive Disease|0|||
17177323|NCT02624986|38328583|FG005|Overall Study|Progressive Disease|0|||
17177324|NCT02624986|38328584|FG006|Overall Study|Progressive Disease|0|||
17177325|NCT02624986|38328585|FG007|Overall Study|Progressive Disease|0|||
17177326|NCT02624986|38328578|FG000|Overall Study|Protocol Violation|1|||
17177327|NCT02624986|38328579|FG001|Overall Study|Protocol Violation|0|||
17177328|NCT02624986|38328580|FG002|Overall Study|Protocol Violation|0|||
17177329|NCT02624986|38328581|FG003|Overall Study|Protocol Violation|0|||
17177330|NCT02624986|38328582|FG004|Overall Study|Protocol Violation|0|||
17177331|NCT02624986|38328583|FG005|Overall Study|Protocol Violation|0|||
17177332|NCT02624986|38328584|FG006|Overall Study|Protocol Violation|0|||
17177333|NCT02624986|38328585|FG007|Overall Study|Protocol Violation|0|||
17177334|NCT02624986|38328578|FG000|Overall Study|Withdrawal by Subject|0|||
17177335|NCT02624986|38328579|FG001|Overall Study|Withdrawal by Subject|0|||
17177336|NCT02624986|38328580|FG002|Overall Study|Withdrawal by Subject|0|||
17177337|NCT02624986|38328581|FG003|Overall Study|Withdrawal by Subject|0|||
17177338|NCT02624986|38328582|FG004|Overall Study|Withdrawal by Subject|0|||
17177339|NCT02624986|38328583|FG005|Overall Study|Withdrawal by Subject|0|||
17177340|NCT02624986|38328584|FG006|Overall Study|Withdrawal by Subject|0|||
17177341|NCT02624986|38328585|FG007|Overall Study|Withdrawal by Subject|1|||
17177342|NCT02587598|38328618|FG000|Overall Study|Death|4|||
17177343|NCT02587598|38328619|FG001|Overall Study|Death|8|||
17177344|NCT02587598|38328620|FG002|Overall Study|Death|4|||
17177345|NCT02587598|38328621|FG003|Overall Study|Death|16|||
17177346|NCT02587598|38328622|FG004|Overall Study|Death|9|||
17177347|NCT02587598|38328623|FG005|Overall Study|Death|4|||
17177348|NCT02587598|38328624|FG006|Overall Study|Death|6|||
17177349|NCT02587598|38328625|FG007|Overall Study|Death|7|||
17177350|NCT02587598|38328626|FG008|Overall Study|Death|9|||
17177351|NCT02587598|38328627|FG009|Overall Study|Death|1|||
17177352|NCT02587598|38328628|FG010|Overall Study|Death|3|||
17177353|NCT02587598|38328618|FG000|Overall Study|Study Terminated by the Sponsor|0|||
17177354|NCT02587598|38328619|FG001|Overall Study|Study Terminated by the Sponsor|1|||
17177355|NCT02587598|38328620|FG002|Overall Study|Study Terminated by the Sponsor|0|||
17177356|NCT02587598|38328621|FG003|Overall Study|Study Terminated by the Sponsor|3|||
17177357|NCT02587598|38328622|FG004|Overall Study|Study Terminated by the Sponsor|0|||
17177358|NCT02587598|38328623|FG005|Overall Study|Study Terminated by the Sponsor|1|||
17177359|NCT02587598|38328624|FG006|Overall Study|Study Terminated by the Sponsor|0|||
17177360|NCT02587598|38328625|FG007|Overall Study|Study Terminated by the Sponsor|0|||
17177361|NCT02587598|38328626|FG008|Overall Study|Study Terminated by the Sponsor|0|||
17177362|NCT02587598|38328627|FG009|Overall Study|Study Terminated by the Sponsor|1|||
17177363|NCT02587598|38328628|FG010|Overall Study|Study Terminated by the Sponsor|6|||
17177364|NCT02587598|38328618|FG000|Overall Study|Reason for study withdrawal not specified|0|||
17177365|NCT02587598|38328619|FG001|Overall Study|Reason for study withdrawal not specified|1|||
17177366|NCT02587598|38328620|FG002|Overall Study|Reason for study withdrawal not specified|0|||
17177367|NCT02587598|38328621|FG003|Overall Study|Reason for study withdrawal not specified|0|||
17177368|NCT02587598|38328622|FG004|Overall Study|Reason for study withdrawal not specified|0|||
17177369|NCT02587598|38328623|FG005|Overall Study|Reason for study withdrawal not specified|0|||
17177370|NCT02587598|38328624|FG006|Overall Study|Reason for study withdrawal not specified|0|||
17177371|NCT02587598|38328625|FG007|Overall Study|Reason for study withdrawal not specified|0|||
17177372|NCT02587598|38328626|FG008|Overall Study|Reason for study withdrawal not specified|0|||
17177373|NCT02587598|38328627|FG009|Overall Study|Reason for study withdrawal not specified|0|||
17177374|NCT02587598|38328628|FG010|Overall Study|Reason for study withdrawal not specified|0|||
17177375|NCT02587598|38328618|FG000|Overall Study|Withdrawal by Subject|0|||
17177376|NCT02587598|38328619|FG001|Overall Study|Withdrawal by Subject|1|||
17177377|NCT02587598|38328620|FG002|Overall Study|Withdrawal by Subject|0|||
17177378|NCT02587598|38328621|FG003|Overall Study|Withdrawal by Subject|2|||
17177379|NCT02587598|38328622|FG004|Overall Study|Withdrawal by Subject|3|||
17177380|NCT02587598|38328623|FG005|Overall Study|Withdrawal by Subject|1|||
17177381|NCT02587598|38328624|FG006|Overall Study|Withdrawal by Subject|0|||
17177382|NCT02587598|38328625|FG007|Overall Study|Withdrawal by Subject|0|||
17177383|NCT02587598|38328626|FG008|Overall Study|Withdrawal by Subject|0|||
17177384|NCT02587598|38328627|FG009|Overall Study|Withdrawal by Subject|1|||
17177385|NCT02587598|38328628|FG010|Overall Study|Withdrawal by Subject|2|||
17177386|NCT02587598|38328618|FG000|Overall Study|Physician Decision|0|||
17177387|NCT02587598|38328619|FG001|Overall Study|Physician Decision|0|||
17177388|NCT02587598|38328620|FG002|Overall Study|Physician Decision|0|||
17177389|NCT02587598|38328621|FG003|Overall Study|Physician Decision|0|||
17177390|NCT02587598|38328622|FG004|Overall Study|Physician Decision|0|||
17177391|NCT02587598|38328623|FG005|Overall Study|Physician Decision|0|||
17177392|NCT02587598|38328624|FG006|Overall Study|Physician Decision|0|||
17177393|NCT02587598|38328625|FG007|Overall Study|Physician Decision|0|||
17177394|NCT02587598|38328626|FG008|Overall Study|Physician Decision|0|||
17177395|NCT02587598|38328627|FG009|Overall Study|Physician Decision|0|||
17177396|NCT02587598|38328628|FG010|Overall Study|Physician Decision|3|||
17177397|NCT02485574|38328664|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
17177398|NCT02624284|38328676|FG000|Overall Study|Withdrawal by Subject|3|||
17177399|NCT02624284|38328677|FG001|Overall Study|Withdrawal by Subject|6|||
17177400|NCT02624284|38328678|FG002|Overall Study|Withdrawal by Subject|3|||
17177401|NCT02624284|38328676|FG000|Overall Study|Protocol Violation|9|||
17177402|NCT02624284|38328677|FG001|Overall Study|Protocol Violation|10|||
17177403|NCT02624284|38328678|FG002|Overall Study|Protocol Violation|7|||
17177404|NCT02624284|38328676|FG000|Overall Study|Revealed exclusionary condition|2|||
17177405|NCT02624284|38328677|FG001|Overall Study|Revealed exclusionary condition|2|||
17177406|NCT02624284|38328678|FG002|Overall Study|Revealed exclusionary condition|0|||
17177407|NCT02624284|38328676|FG000|Overall Study|Adverse Event|0|||
17177408|NCT02624284|38328677|FG001|Overall Study|Adverse Event|0|||
17177409|NCT02624284|38328678|FG002|Overall Study|Adverse Event|1|||
17177410|NCT02738450|38328690|FG000|Overall Study|Withdrawal by Subject|0|||
17177411|NCT02738450|38328691|FG001|Overall Study|Withdrawal by Subject|2|||
17177412|NCT02738450|38328692|FG002|Overall Study|Withdrawal by Subject|0|||
17177413|NCT02624050|38328703|FG000|Overall Study|Physician Decision|4|||
17177414|NCT02624050|38328704|FG001|Overall Study|Physician Decision|0|||
17177415|NCT02624050|38328703|FG000|Overall Study|Protocol Violation|2|||
17177416|NCT02624050|38328704|FG001|Overall Study|Protocol Violation|0|||
17177417|NCT01338987|38328720|FG000|Overall Study|enrolled on new protocol|0|||
17177418|NCT01338987|38328721|FG001|Overall Study|enrolled on new protocol|0|||
17177419|NCT01338987|38328722|FG002|Overall Study|enrolled on new protocol|1|||
17177420|NCT01338987|38328723|FG003|Overall Study|enrolled on new protocol|0|||
17177421|NCT01338987|38328724|FG004|Overall Study|enrolled on new protocol|0|||
17177422|NCT01338987|38328720|FG000|Overall Study|Disease progression on study|2|||
17177423|NCT01338987|38328721|FG001|Overall Study|Disease progression on study|1|||
17177424|NCT01338987|38328722|FG002|Overall Study|Disease progression on study|1|||
17177425|NCT01338987|38328723|FG003|Overall Study|Disease progression on study|0|||
17177426|NCT01338987|38328724|FG004|Overall Study|Disease progression on study|0|||
17177427|NCT02738138|38328756|FG000|Overall Study|Adverse Event|0|||
17177428|NCT02738138|38328757|FG001|Overall Study|Adverse Event|1|||
17177429|NCT02738138|38328756|FG000|Overall Study|Lost to Follow-up|2|||
17177430|NCT02738138|38328757|FG001|Overall Study|Lost to Follow-up|0|||
17177431|NCT02738138|38328756|FG000|Overall Study|Other - not further specified|1|||
17177432|NCT02738138|38328757|FG001|Overall Study|Other - not further specified|0|||
17177433|NCT01355289|38328766|FG000|Core Study|Adverse Event, Non-Fatal|1|||
17177434|NCT01355289|38328767|FG001|Core Study|Adverse Event, Non-Fatal|0|||
17177435|NCT01355289|38328768|FG002|Core Study|Adverse Event, Non-Fatal|0|||
17177436|NCT01355289|38328769|FG003|Core Study|Adverse Event, Non-Fatal|0|||
17177437|NCT01355289|38328770|FG004|Core Study|Adverse Event, Non-Fatal|0|||
17177438|NCT01355289|38328766|FG000|Core Study|Inadequate Therapeutic Effect|0|||
17177439|NCT01355289|38328767|FG001|Core Study|Inadequate Therapeutic Effect|0|||
17177440|NCT01355289|38328768|FG002|Core Study|Inadequate Therapeutic Effect|0|||
17177441|NCT01355289|38328769|FG003|Core Study|Inadequate Therapeutic Effect|1|||
17177442|NCT01355289|38328770|FG004|Core Study|Inadequate Therapeutic Effect|0|||
17177443|NCT01355289|38328766|FG000|Core Study|Other|0|||
17177444|NCT01355289|38328767|FG001|Core Study|Other|0|||
17177445|NCT01355289|38328768|FG002|Core Study|Other|0|||
17177446|NCT01355289|38328769|FG003|Core Study|Other|1|||
17177447|NCT01355289|38328770|FG004|Core Study|Other|0|||
17177448|NCT01355289|38328766|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
17177449|NCT01355289|38328767|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
17177450|NCT01355289|38328768|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
17177451|NCT01355289|38328769|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
17177452|NCT01355289|38328770|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
17177453|NCT01355289|38328766|FG000|Open Label Extension|Lost to Follow-up|0|||
17177454|NCT01355289|38328767|FG001|Open Label Extension|Lost to Follow-up|0|||
16781319|NCT02142712|37720488|FG002|Overall Study|Lost to Follow-up|1|||
17177455|NCT01355289|38328768|FG002|Open Label Extension|Lost to Follow-up|0|||
17177456|NCT01355289|38328769|FG003|Open Label Extension|Lost to Follow-up|0|||
17177457|NCT01355289|38328770|FG004|Open Label Extension|Lost to Follow-up|1|||
17177458|NCT01355289|38328766|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
17177459|NCT01355289|38328767|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
17177460|NCT01355289|38328768|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
17177461|NCT01355289|38328769|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
17177462|NCT01355289|38328770|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
17177463|NCT01355289|38328766|FG000|Open Label Extension|Other|0|||
17177464|NCT01355289|38328767|FG001|Open Label Extension|Other|0|||
17177465|NCT01355289|38328768|FG002|Open Label Extension|Other|0|||
17177466|NCT01355289|38328769|FG003|Open Label Extension|Other|0|||
17177467|NCT01355289|38328770|FG004|Open Label Extension|Other|3|||
17177468|NCT02737592|38328783|FG000|Overall Study|Withdrawal by Subject|1|||
17177469|NCT02737358|38328810|FG000|Overall Study|Withdrawal by Subject|7|||
17177470|NCT02737358|38328811|FG001|Overall Study|Withdrawal by Subject|12|||
17177471|NCT02737358|38328810|FG000|Overall Study|Lost to Follow-up|2|||
17177472|NCT02737358|38328811|FG001|Overall Study|Lost to Follow-up|3|||
17177473|NCT01354431|38328820|FG000|Pre-Treatment Period|Not reported|1|||
17177474|NCT01354431|38328821|FG001|Pre-Treatment Period|Not reported|0|||
17177475|NCT01354431|38328822|FG002|Pre-Treatment Period|Not reported|0|||
17177476|NCT01354431|38328820|FG000|Treatment Period|Disease Progression|50|||
17177477|NCT01354431|38328821|FG001|Treatment Period|Disease Progression|40|||
17177478|NCT01354431|38328822|FG002|Treatment Period|Disease Progression|44|||
17177479|NCT01354431|38328820|FG000|Treatment Period|Study Drug Toxicity|5|||
17177480|NCT01354431|38328821|FG001|Treatment Period|Study Drug Toxicity|8|||
17177481|NCT01354431|38328822|FG002|Treatment Period|Study Drug Toxicity|4|||
17177482|NCT01354431|38328820|FG000|Treatment Period|Death|0|||
17177483|NCT01354431|38328821|FG001|Treatment Period|Death|1|||
17177484|NCT01354431|38328822|FG002|Treatment Period|Death|0|||
17177485|NCT01354431|38328820|FG000|Treatment Period|AE unrelated to study drug|1|||
17177486|NCT01354431|38328821|FG001|Treatment Period|AE unrelated to study drug|2|||
17177487|NCT01354431|38328822|FG002|Treatment Period|AE unrelated to study drug|5|||
17177488|NCT01354431|38328820|FG000|Treatment Period|Participant request to discontinue|2|||
17177489|NCT01354431|38328821|FG001|Treatment Period|Participant request to discontinue|2|||
17177490|NCT01354431|38328822|FG002|Treatment Period|Participant request to discontinue|1|||
17177491|NCT01354431|38328820|FG000|Treatment Period|Participant withdrew consent|0|||
17177492|NCT01354431|38328821|FG001|Treatment Period|Participant withdrew consent|1|||
17177493|NCT01354431|38328822|FG002|Treatment Period|Participant withdrew consent|0|||
17177494|NCT01354431|38328820|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
17177495|NCT01354431|38328821|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
17177496|NCT01354431|38328822|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
17177497|NCT02736578|38328832|FG000|Overall Study|Adverse Event|1|||
17177498|NCT02736578|38328833|FG001|Overall Study|Adverse Event|0|||
17177499|NCT02622724|38328845|FG000|Overall Study|Death|51|||
17177500|NCT02622724|38328846|FG001|Overall Study|Death|53|||
17177501|NCT02622724|38328845|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
17177502|NCT02622724|38328846|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
17177503|NCT02622724|38328845|FG000|Overall Study|Early termination of study|38|||
17177504|NCT02622724|38328846|FG001|Overall Study|Early termination of study|43|||
17177505|NCT01354353|38328864|FG000|Overall Study|Adverse Event|1|||
17177506|NCT01354353|38328865|FG001|Overall Study|Adverse Event|0|||
17177507|NCT01354353|38328866|FG002|Overall Study|Adverse Event|0|||
17177508|NCT01354353|38328867|FG003|Overall Study|Adverse Event|4|||
17177509|NCT01354353|38328868|FG004|Overall Study|Adverse Event|0|||
17177510|NCT01354353|38328869|FG005|Overall Study|Adverse Event|5|||
17177511|NCT01354353|38328864|FG000|Overall Study|Entry Criteria Not Met|0|||
17177512|NCT01354353|38328865|FG001|Overall Study|Entry Criteria Not Met|0|||
17177513|NCT01354353|38328866|FG002|Overall Study|Entry Criteria Not Met|0|||
17177514|NCT01354353|38328867|FG003|Overall Study|Entry Criteria Not Met|1|||
17177515|NCT01354353|38328868|FG004|Overall Study|Entry Criteria Not Met|1|||
17177516|NCT01354353|38328869|FG005|Overall Study|Entry Criteria Not Met|0|||
17177517|NCT01354353|38328864|FG000|Overall Study|Physician Decision|0|||
17177518|NCT01354353|38328865|FG001|Overall Study|Physician Decision|1|||
17177519|NCT01354353|38328866|FG002|Overall Study|Physician Decision|1|||
17177520|NCT01354353|38328867|FG003|Overall Study|Physician Decision|0|||
17177521|NCT01354353|38328868|FG004|Overall Study|Physician Decision|0|||
17177522|NCT01354353|38328869|FG005|Overall Study|Physician Decision|0|||
17177523|NCT01354353|38328864|FG000|Overall Study|Withdrawal by Subject|2|||
17177524|NCT01354353|38328865|FG001|Overall Study|Withdrawal by Subject|0|||
17177525|NCT01354353|38328866|FG002|Overall Study|Withdrawal by Subject|1|||
17177526|NCT01354353|38328867|FG003|Overall Study|Withdrawal by Subject|0|||
17177527|NCT01354353|38328868|FG004|Overall Study|Withdrawal by Subject|0|||
17177528|NCT01354353|38328869|FG005|Overall Study|Withdrawal by Subject|1|||
17177529|NCT02622568|38328892|FG000|Overall Study|Lost to Follow-up|5|||
17177530|NCT02622568|38328893|FG001|Overall Study|Lost to Follow-up|5|||
17177531|NCT01354899|38328899|FG000|Overall Study|discharge from the hospital|2|||
17177532|NCT01354899|38328899|FG000|Overall Study|Protocol Violation|1|||
17177533|NCT01353963|38328903|FG000|Overall Study|Adverse Event|2|||
17177534|NCT02820597|38328912|FG000|Overall Study|Lost to Follow-up|12|||
17177535|NCT02822235|38328918|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
17177536|NCT02822235|38328919|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
17177537|NCT02822235|38328918|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
17177538|NCT02822235|38328919|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
17177539|NCT02822235|38328918|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
17177540|NCT02822235|38328919|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
17177541|NCT02822235|38328918|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
17177542|NCT02822235|38328919|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
17177543|NCT02822235|38328918|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
17177544|NCT02822235|38328919|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
17177545|NCT02822235|38328918|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
17177546|NCT02822235|38328919|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
17177547|NCT02817555|38328934|FG000|Overall Study|Death|1|||
17177548|NCT02817555|38328935|FG001|Overall Study|Death|3|||
17177549|NCT02817555|38328934|FG000|Overall Study|moved away|1|||
17177550|NCT02817555|38328935|FG001|Overall Study|moved away|0|||
17177551|NCT02817555|38328934|FG000|Overall Study|transplant|1|||
17177552|NCT02817555|38328935|FG001|Overall Study|transplant|1|||
17177553|NCT02817555|38328934|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
17177554|NCT02817555|38328935|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
17177555|NCT02817087|38328943|FG000|Overall Study|Withdrawal by Subject|2|||
17177556|NCT02817087|38328944|FG001|Overall Study|Withdrawal by Subject|0|||
17177557|NCT02813577|38328950|FG000|Overall Study|Study terminated|4|||
17177558|NCT02815293|38328957|FG000|Overall Study|Study termination by sponsor|10|||
17177559|NCT02815293|38328958|FG001|Overall Study|Study termination by sponsor|7|||
17177560|NCT02815293|38328959|FG002|Overall Study|Study termination by sponsor|0|||
17177561|NCT02815293|38328957|FG000|Overall Study|Participants not randomized|0|||
17177562|NCT02815293|38328958|FG001|Overall Study|Participants not randomized|0|||
17177563|NCT02815293|38328959|FG002|Overall Study|Participants not randomized|18|||
17177564|NCT02815293|38328957|FG000|Overall Study|Adverse Event|0|||
17177565|NCT02815293|38328958|FG001|Overall Study|Adverse Event|1|||
17177566|NCT02815293|38328959|FG002|Overall Study|Adverse Event|0|||
17177567|NCT02813421|38328967|FG000|Overall Study|Withdrawal by Subject|1|||
17177568|NCT02813421|38328968|FG001|Overall Study|Withdrawal by Subject|2|||
17177569|NCT02813421|38328967|FG000|Overall Study|Lost to Follow-up|1|||
17177570|NCT02813421|38328968|FG001|Overall Study|Lost to Follow-up|1|||
17177571|NCT03672188|38328989|FG000|Overall Study|Withdrawal by Subject|0|||
17177572|NCT03672188|38328990|FG001|Overall Study|Withdrawal by Subject|0|||
17177573|NCT03672188|38328991|FG002|Overall Study|Withdrawal by Subject|0|||
17177574|NCT03672188|38328992|FG003|Overall Study|Withdrawal by Subject|3|||
17177575|NCT03672188|38328993|FG004|Overall Study|Withdrawal by Subject|0|||
17177576|NCT03672188|38328994|FG005|Overall Study|Withdrawal by Subject|0|||
17177577|NCT03672188|38328995|FG006|Overall Study|Withdrawal by Subject|0|||
17177578|NCT03672188|38328996|FG007|Overall Study|Withdrawal by Subject|0|||
17177579|NCT03672188|38328997|FG008|Overall Study|Withdrawal by Subject|0|||
17177580|NCT03672188|38328998|FG009|Overall Study|Withdrawal by Subject|0|||
17177581|NCT03672188|38328999|FG010|Overall Study|Withdrawal by Subject|0|||
17177582|NCT03672188|38329000|FG011|Overall Study|Withdrawal by Subject|0|||
17177583|NCT03672188|38329001|FG012|Overall Study|Withdrawal by Subject|0|||
17177584|NCT03672188|38329002|FG013|Overall Study|Withdrawal by Subject|0|||
17177585|NCT03672188|38329003|FG014|Overall Study|Withdrawal by Subject|0|||
17177586|NCT03672188|38328989|FG000|Overall Study|Death|0|||
17177587|NCT03672188|38328990|FG001|Overall Study|Death|0|||
17177588|NCT03672188|38328991|FG002|Overall Study|Death|0|||
17177589|NCT03672188|38328992|FG003|Overall Study|Death|0|||
17177590|NCT03672188|38328993|FG004|Overall Study|Death|0|||
17177591|NCT03672188|38328994|FG005|Overall Study|Death|0|||
17177592|NCT03672188|38328995|FG006|Overall Study|Death|0|||
17177593|NCT03672188|38328996|FG007|Overall Study|Death|0|||
17177594|NCT03672188|38328997|FG008|Overall Study|Death|0|||
17177595|NCT03672188|38328998|FG009|Overall Study|Death|0|||
17177596|NCT03672188|38328999|FG010|Overall Study|Death|0|||
17177597|NCT03672188|38329000|FG011|Overall Study|Death|0|||
17177598|NCT03672188|38329001|FG012|Overall Study|Death|1|||
17177599|NCT03672188|38329002|FG013|Overall Study|Death|0|||
17177600|NCT03672188|38329003|FG014|Overall Study|Death|0|||
17177601|NCT03672188|38328989|FG000|Overall Study|Lost to Follow-up|0|||
17177602|NCT03672188|38328990|FG001|Overall Study|Lost to Follow-up|0|||
17177603|NCT03672188|38328991|FG002|Overall Study|Lost to Follow-up|1|||
17177604|NCT03672188|38328992|FG003|Overall Study|Lost to Follow-up|0|||
17088930|NCT00308750|38229077|FG000|Overall Study|Adverse Event|9|||
17177605|NCT03672188|38328993|FG004|Overall Study|Lost to Follow-up|0|||
17177606|NCT03672188|38328994|FG005|Overall Study|Lost to Follow-up|0|||
17177607|NCT03672188|38328995|FG006|Overall Study|Lost to Follow-up|0|||
17177608|NCT03672188|38328996|FG007|Overall Study|Lost to Follow-up|0|||
17177609|NCT03672188|38328997|FG008|Overall Study|Lost to Follow-up|0|||
17177610|NCT03672188|38328998|FG009|Overall Study|Lost to Follow-up|0|||
17177611|NCT03672188|38328999|FG010|Overall Study|Lost to Follow-up|0|||
17177612|NCT03672188|38329000|FG011|Overall Study|Lost to Follow-up|0|||
17177613|NCT03672188|38329001|FG012|Overall Study|Lost to Follow-up|0|||
17177614|NCT03672188|38329002|FG013|Overall Study|Lost to Follow-up|0|||
17177615|NCT03672188|38329003|FG014|Overall Study|Lost to Follow-up|0|||
17177616|NCT02620384|38329071|FG000|Overall Study|Adverse Event|2|||
17177617|NCT02620384|38329072|FG001|Overall Study|Adverse Event|1|||
17177618|NCT02620384|38329071|FG000|Overall Study|Discharged prior to 2nd dose|2|||
17177619|NCT02620384|38329072|FG001|Overall Study|Discharged prior to 2nd dose|5|||
17177620|NCT02620384|38329071|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
17177621|NCT02620384|38329072|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
17177622|NCT03915860|38329078|FG000|Overall Study|Adverse Event|3|||
17177623|NCT03915860|38329078|FG000|Overall Study|Withdrawal by Subject|6|||
17177624|NCT03915860|38329078|FG000|Overall Study|Lost to Follow-up|2|||
17177625|NCT03915860|38329078|FG000|Overall Study|Other than specified|3|||
17177626|NCT03786380|38329087|FG000|Overall Study|Adverse Event|1|||
17177627|NCT03786380|38329088|FG001|Overall Study|Adverse Event|0|||
17177628|NCT03786380|38329089|FG002|Overall Study|Adverse Event|0|||
17177629|NCT03786380|38329090|FG003|Overall Study|Adverse Event|3|||
17177630|NCT03786380|38329091|FG004|Overall Study|Adverse Event|1|||
17177631|NCT03786380|38329087|FG000|Overall Study|Lack of Efficacy|0|||
17177632|NCT03786380|38329088|FG001|Overall Study|Lack of Efficacy|0|||
17177633|NCT03786380|38329089|FG002|Overall Study|Lack of Efficacy|0|||
17177634|NCT03786380|38329090|FG003|Overall Study|Lack of Efficacy|0|||
17177635|NCT03786380|38329091|FG004|Overall Study|Lack of Efficacy|1|||
17177636|NCT03786380|38329087|FG000|Overall Study|Withdrawal by Subject|1|||
17177637|NCT03786380|38329088|FG001|Overall Study|Withdrawal by Subject|2|||
17177638|NCT03786380|38329089|FG002|Overall Study|Withdrawal by Subject|2|||
17177639|NCT03786380|38329090|FG003|Overall Study|Withdrawal by Subject|1|||
17177640|NCT03786380|38329091|FG004|Overall Study|Withdrawal by Subject|2|||
17177641|NCT03786380|38329087|FG000|Overall Study|Lost to Follow-up|3|||
17177642|NCT03786380|38329088|FG001|Overall Study|Lost to Follow-up|0|||
17177643|NCT03786380|38329089|FG002|Overall Study|Lost to Follow-up|1|||
17177644|NCT03786380|38329090|FG003|Overall Study|Lost to Follow-up|2|||
17177645|NCT03786380|38329091|FG004|Overall Study|Lost to Follow-up|0|||
17177646|NCT03786380|38329087|FG000|Overall Study|Physician Decision|0|||
17177647|NCT03786380|38329088|FG001|Overall Study|Physician Decision|0|||
17177648|NCT03786380|38329089|FG002|Overall Study|Physician Decision|1|||
17177649|NCT03786380|38329090|FG003|Overall Study|Physician Decision|0|||
17177650|NCT03786380|38329091|FG004|Overall Study|Physician Decision|0|||
17177651|NCT03786380|38329087|FG000|Overall Study|Study Terminated by the Sponsor|30|||
17177652|NCT03786380|38329088|FG001|Overall Study|Study Terminated by the Sponsor|20|||
17177653|NCT03786380|38329089|FG002|Overall Study|Study Terminated by the Sponsor|50|||
17177654|NCT03786380|38329090|FG003|Overall Study|Study Terminated by the Sponsor|57|||
17177655|NCT03786380|38329091|FG004|Overall Study|Study Terminated by the Sponsor|23|||
17177656|NCT03786380|38329087|FG000|Overall Study|Reason Not Specified|0|||
17177657|NCT03786380|38329088|FG001|Overall Study|Reason Not Specified|0|||
17177658|NCT03786380|38329089|FG002|Overall Study|Reason Not Specified|0|||
17177659|NCT03786380|38329090|FG003|Overall Study|Reason Not Specified|0|||
17177660|NCT03786380|38329091|FG004|Overall Study|Reason Not Specified|1|||
17177661|NCT02626000|38329103|FG000|Overall Study|Decision by Sponsor|1|||
17177662|NCT02626000|38329103|FG000|Overall Study|Death|29|||
17177663|NCT02736890|38329119|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
17177664|NCT02736890|38329120|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
17177665|NCT02736890|38329119|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
17177666|NCT02736890|38329120|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
17177667|NCT02779556|38329128|FG000|Baseline|Partial baseline interview completed|1|||
17177668|NCT02779556|38329129|FG001|Baseline|Partial baseline interview completed|0|||
17177669|NCT02779556|38329128|FG000|3 Months|Lost to Follow-up|40|||
17177670|NCT02779556|38329129|FG001|3 Months|Lost to Follow-up|29|||
17177671|NCT02779556|38329128|FG000|3 Months|Missed 3 month clinic visit|27|||
17177672|NCT02779556|38329129|FG001|3 Months|Missed 3 month clinic visit|19|||
17177673|NCT02779556|38329128|FG000|6 Month|Lost to Follow-up|33|||
17177674|NCT02779556|38329129|FG001|6 Month|Lost to Follow-up|39|||
17177675|NCT02779556|38329128|FG000|6 Month HbA1c|No value collected during window|69|||
17177676|NCT02779556|38329129|FG001|6 Month HbA1c|No value collected during window|50|||
17177677|NCT02779556|38329128|FG000|12 Month HbA1c|No value collected during window|138|||
17177678|NCT02779556|38329129|FG001|12 Month HbA1c|No value collected during window|102|||
17177679|NCT01669798|38329135|FG000|Overall Study|Physician Decision|5|||
17177680|NCT02334722|38329141|FG000|Overall Study|Lost to Follow-up|4|||
17177681|NCT02334722|38329142|FG001|Overall Study|Lost to Follow-up|0|||
17177682|NCT02334722|38329141|FG000|Overall Study|6 week questionnaire not completed|2|||
17177683|NCT02334722|38329142|FG001|Overall Study|6 week questionnaire not completed|0|||
17177684|NCT02334722|38329141|FG000|Overall Study|Unable to obtain medication|1|||
17177685|NCT02334722|38329142|FG001|Overall Study|Unable to obtain medication|1|||
17177686|NCT02334722|38329141|FG000|Overall Study|Withdrawal by Subject|0|||
17177687|NCT02334722|38329142|FG001|Overall Study|Withdrawal by Subject|3|||
17177688|NCT02334722|38329141|FG000|Overall Study|Adverse Event|0|||
17177689|NCT02334722|38329142|FG001|Overall Study|Adverse Event|2|||
17177690|NCT02334722|38329141|FG000|Overall Study|Physician Decision|0|||
17177691|NCT02334722|38329142|FG001|Overall Study|Physician Decision|1|||
17177692|NCT00812708|38329157|FG000|Overall Study|Device could not be implanted|2|||
17177693|NCT00812708|38329157|FG000|Overall Study|Lack of medical insurance|1|||
17177694|NCT00812708|38329157|FG000|Overall Study|Switched to another study|1|||
17177695|NCT00812708|38329157|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
17177696|NCT00812708|38329157|FG000|Overall Study|Signed consent but later withdrew|3|||
17177697|NCT03761810|38329173|FG000|Overall Study|Adverse Event|12|||
17177698|NCT03761810|38329174|FG001|Overall Study|Adverse Event|0|||
17177699|NCT03761810|38329173|FG000|Overall Study|Lost to Follow-up|15|||
17177700|NCT03761810|38329174|FG001|Overall Study|Lost to Follow-up|7|||
17177701|NCT03761810|38329173|FG000|Overall Study|Pregnancy|1|||
17177702|NCT03761810|38329174|FG001|Overall Study|Pregnancy|0|||
17177703|NCT03761810|38329173|FG000|Overall Study|Withdrawal by Subject|14|||
17177704|NCT03761810|38329174|FG001|Overall Study|Withdrawal by Subject|5|||
17177705|NCT03761810|38329173|FG000|Overall Study|Physician Decision|1|||
17177706|NCT03761810|38329174|FG001|Overall Study|Physician Decision|0|||
17177707|NCT03761810|38329173|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
17177708|NCT03761810|38329174|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
17177709|NCT03761810|38329173|FG000|Overall Study|Other Than Specified|1|||
17177710|NCT03761810|38329174|FG001|Overall Study|Other Than Specified|0|||
17177711|NCT02811861|38329188|FG000|Overall Study|Radiological Disease Progression|123|||
17177712|NCT02811861|38329189|FG001|Overall Study|Radiological Disease Progression|97|||
17177713|NCT02811861|38329190|FG002|Overall Study|Radiological Disease Progression|174|||
17177714|NCT02811861|38329188|FG000|Overall Study|Clinical Disease Progression|20|||
17177715|NCT02811861|38329189|FG001|Overall Study|Clinical Disease Progression|19|||
17177716|NCT02811861|38329190|FG002|Overall Study|Clinical Disease Progression|22|||
17177717|NCT02811861|38329188|FG000|Overall Study|Adverse Event|63|||
17177718|NCT02811861|38329189|FG001|Overall Study|Adverse Event|60|||
17177719|NCT02811861|38329190|FG002|Overall Study|Adverse Event|41|||
17177720|NCT02811861|38329188|FG000|Overall Study|Lost to Follow-up|0|||
17177721|NCT02811861|38329189|FG001|Overall Study|Lost to Follow-up|0|||
17177722|NCT02811861|38329190|FG002|Overall Study|Lost to Follow-up|1|||
17177723|NCT02811861|38329188|FG000|Overall Study|Subject Choice|29|||
17177724|NCT02811861|38329189|FG001|Overall Study|Subject Choice|17|||
17177725|NCT02811861|38329190|FG002|Overall Study|Subject Choice|23|||
17177726|NCT02811861|38329188|FG000|Overall Study|Withdrawal by Subject|4|||
17177727|NCT02811861|38329189|FG001|Overall Study|Withdrawal by Subject|4|||
17177728|NCT02811861|38329190|FG002|Overall Study|Withdrawal by Subject|9|||
17177729|NCT02811861|38329188|FG000|Overall Study|Other|4|||
17177730|NCT02811861|38329189|FG001|Overall Study|Other|13|||
17177731|NCT02811861|38329190|FG002|Overall Study|Other|3|||
17177732|NCT02811861|38329188|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
17177733|NCT02811861|38329189|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
17177734|NCT02811861|38329190|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
17177735|NCT02811861|38329188|FG000|Overall Study|Randomized but not treated|2|||
17177736|NCT02811861|38329189|FG001|Overall Study|Randomized but not treated|3|||
17177737|NCT02811861|38329190|FG002|Overall Study|Randomized but not treated|17|||
17177738|NCT02811159|38329198|FG000|Treatment Course 1|Lost to Follow-up|1|||
17177739|NCT01889186|38329204|FG000|Overall Study|Adverse event- not related to progression|18|||
17177740|NCT01889186|38329205|FG001|Overall Study|Adverse event- not related to progression|5|||
17177741|NCT01889186|38329204|FG000|Overall Study|Adverse event- related to progression|7|||
17177742|NCT01889186|38329205|FG001|Overall Study|Adverse event- related to progression|2|||
17177743|NCT01889186|38329204|FG000|Overall Study|COVID-19 logistical restrictions|1|||
17177744|NCT01889186|38329205|FG001|Overall Study|COVID-19 logistical restrictions|0|||
17177745|NCT01889186|38329204|FG000|Overall Study|Investigator request|1|||
17177746|NCT01889186|38329205|FG001|Overall Study|Investigator request|1|||
17177747|NCT01889186|38329204|FG000|Overall Study|Progressive disease- Richter's|12|||
17177748|NCT01889186|38329205|FG001|Overall Study|Progressive disease- Richter's|7|||
17177749|NCT01889186|38329204|FG000|Overall Study|Progressive disease per protocol|46|||
17177750|NCT01889186|38329205|FG001|Overall Study|Progressive disease per protocol|17|||
17177751|NCT01889186|38329204|FG000|Overall Study|Stem cell transplant|2|||
17177752|NCT01889186|38329205|FG001|Overall Study|Stem cell transplant|1|||
17177753|NCT01889186|38329204|FG000|Overall Study|Withdrew consent|2|||
17177754|NCT01889186|38329205|FG001|Overall Study|Withdrew consent|3|||
17177755|NCT01889186|38329204|FG000|Overall Study|Other, not specified|18|||
17177756|NCT01889186|38329205|FG001|Overall Study|Other, not specified|15|||
17177757|NCT01510184|38329215|FG000|Overall Study|Sponsor discretion|28|||
17177758|NCT01510184|38329216|FG001|Overall Study|Sponsor discretion|28|||
17177759|NCT01510184|38329215|FG000|Overall Study|Death|1|||
17177760|NCT01510184|38329216|FG001|Overall Study|Death|2|||
17177761|NCT01510184|38329215|FG000|Overall Study|Withdrawal by Subject|1|||
17177762|NCT01510184|38329216|FG001|Overall Study|Withdrawal by Subject|4|||
17177763|NCT01510184|38329215|FG000|Overall Study|Other|0|||
17177764|NCT01510184|38329216|FG001|Overall Study|Other|1|||
17177765|NCT02809833|38329241|FG000|Overall Study|Death|3|||
17177766|NCT02809833|38329241|FG000|Overall Study|Intolerance|54|||
17177767|NCT02809833|38329241|FG000|Overall Study|Lack of Efficacy|89|||
17177768|NCT02809833|38329241|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
17177769|NCT02809833|38329241|FG000|Overall Study|Noncompliance|1|||
17177770|NCT02809833|38329241|FG000|Overall Study|Withdrawal by Subject|34|||
17177771|NCT02809833|38329241|FG000|Overall Study|Lost to Follow-up|35|||
17177772|NCT02809833|38329241|FG000|Overall Study|Adverse Event (AE)|24|||
17177773|NCT02809833|38329241|FG000|Overall Study|Other|5|||
17177774|NCT02809833|38329241|FG000|Overall Study|Missing Information|52|||
17177775|NCT02797262|38329247|FG000|Overall Study|Withdrawal by Subject|5|||
17177776|NCT02797262|38329248|FG001|Overall Study|Withdrawal by Subject|1|||
17177777|NCT02797262|38329247|FG000|Overall Study|Lost to Follow-up|10|||
17177778|NCT02797262|38329248|FG001|Overall Study|Lost to Follow-up|7|||
17177779|NCT02797262|38329247|FG000|Overall Study|Death|1|||
17177780|NCT02797262|38329248|FG001|Overall Study|Death|2|||
17177781|NCT02797262|38329247|FG000|Overall Study|Adverse Event|1|||
17177782|NCT02797262|38329248|FG001|Overall Study|Adverse Event|0|||
17177783|NCT02797262|38329247|FG000|Overall Study|COVID-19|2|||
17177784|NCT02797262|38329248|FG001|Overall Study|COVID-19|1|||
17177785|NCT02797262|38329247|FG000|Overall Study|Out-of-country|1|||
17177786|NCT02797262|38329248|FG001|Overall Study|Out-of-country|0|||
17177787|NCT02809053|38329256|FG000|Overall Study|Death|0|||
17177788|NCT02809053|38329257|FG001|Overall Study|Death|1|||
17177789|NCT02809053|38329256|FG000|Overall Study|Lost to Follow-up|3|||
17177790|NCT02809053|38329257|FG001|Overall Study|Lost to Follow-up|1|||
17177791|NCT02809053|38329256|FG000|Overall Study|Withdrawal by Subject|2|||
17177792|NCT02809053|38329257|FG001|Overall Study|Withdrawal by Subject|3|||
17177793|NCT02809053|38329256|FG000|Overall Study|Disease Progression|2|||
17177794|NCT02809053|38329257|FG001|Overall Study|Disease Progression|1|||
17177795|NCT02808975|38329265|FG000|Overall Study|Adverse Event|3|||
17177796|NCT02808975|38329266|FG001|Overall Study|Adverse Event|4|||
17177797|NCT02808975|38329265|FG000|Overall Study|Withdrew consent|9|||
17177798|NCT02808975|38329266|FG001|Overall Study|Withdrew consent|8|||
17177799|NCT02808975|38329265|FG000|Overall Study|Lost to Follow-up|4|||
17177800|NCT02808975|38329266|FG001|Overall Study|Lost to Follow-up|6|||
17177801|NCT02808975|38329265|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
17177802|NCT02808975|38329266|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
17177803|NCT02808975|38329265|FG000|Overall Study|Other, not specified|5|||
17177804|NCT02808975|38329266|FG001|Overall Study|Other, not specified|1|||
17177805|NCT02976038|38329272|FG000|Overall Study|Physician Decision|22|||
17177806|NCT02976038|38329272|FG000|Overall Study|Withdrawal by Subject|3|||
17177807|NCT02976038|38329272|FG000|Overall Study|Lost to Follow-up|2|||
17177808|NCT02976038|38329272|FG000|Overall Study|Adverse Event|1|||
17177809|NCT02808819|38329297|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
17177810|NCT02808819|38329298|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
17177811|NCT02808819|38329297|FG000|Overall Study|Withdrawal by Subject|10|||
17177812|NCT02808819|38329298|FG001|Overall Study|Withdrawal by Subject|13|||
17177813|NCT02808819|38329297|FG000|Overall Study|Site terminated by sponsor|2|||
17177814|NCT02808819|38329298|FG001|Overall Study|Site terminated by sponsor|0|||
17177815|NCT02808819|38329297|FG000|Overall Study|Pregnancy|1|||
17177816|NCT02808819|38329298|FG001|Overall Study|Pregnancy|0|||
17177817|NCT02808819|38329297|FG000|Overall Study|Lost to Follow-up|1|||
17177818|NCT02808819|38329298|FG001|Overall Study|Lost to Follow-up|6|||
17177819|NCT02808819|38329297|FG000|Overall Study|Protocol Violation|0|||
17177820|NCT02808819|38329298|FG001|Overall Study|Protocol Violation|1|||
17177821|NCT02808819|38329297|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
17177822|NCT02808819|38329298|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
17177823|NCT02808819|38329297|FG000|Overall Study|Death|1|||
17177824|NCT02808819|38329298|FG001|Overall Study|Death|0|||
17177825|NCT02808819|38329297|FG000|Overall Study|Adverse Event|3|||
17177826|NCT02808819|38329298|FG001|Overall Study|Adverse Event|4|||
17177827|NCT02808429|38329308|FG000|Overall Study|Lost to Follow-up|1|||
17177828|NCT02808429|38329309|FG001|Overall Study|Lost to Follow-up|0|||
17177829|NCT02808429|38329310|FG002|Overall Study|Lost to Follow-up|0|||
17177830|NCT02808429|38329308|FG000|Overall Study|Protocol Violation|0|||
17177831|NCT02808429|38329309|FG001|Overall Study|Protocol Violation|1|||
17177832|NCT02808429|38329310|FG002|Overall Study|Protocol Violation|0|||
17177833|NCT02808429|38329308|FG000|Overall Study|Premature study termination by sponsor|2|||
17177834|NCT02808429|38329309|FG001|Overall Study|Premature study termination by sponsor|0|||
17177835|NCT02808429|38329310|FG002|Overall Study|Premature study termination by sponsor|1|||
17177836|NCT02808429|38329308|FG000|Overall Study|Relocation|0|||
17177837|NCT02808429|38329309|FG001|Overall Study|Relocation|0|||
17177838|NCT02808429|38329310|FG002|Overall Study|Relocation|1|||
17177839|NCT01594762|38329320|FG000|Overall Study|Withdrawal by Subject|1|||
17177840|NCT01594762|38329321|FG001|Overall Study|Withdrawal by Subject|0|||
17177841|NCT01594762|38329320|FG000|Overall Study|Lost to Follow-up|10|||
17177842|NCT01594762|38329321|FG001|Overall Study|Lost to Follow-up|10|||
17177843|NCT02615470|38329329|FG000|Overall Study|Lost to Follow-up|21|||
17177844|NCT02615470|38329330|FG001|Overall Study|Lost to Follow-up|32|||
17177845|NCT02806947|38329338|FG000|Overall Study|Withdrawal by Subject|5|||
17177846|NCT02806947|38329339|FG001|Overall Study|Withdrawal by Subject|1|||
17177847|NCT02806713|38329347|FG000|Overall Study|Urethral injury during procedure|1|||
17177848|NCT02806713|38329348|FG001|Overall Study|Urethral injury during procedure|0|||
17177849|NCT02806713|38329347|FG000|Overall Study|cancelled surgery|1|||
17177850|NCT02806713|38329348|FG001|Overall Study|cancelled surgery|2|||
17177851|NCT02807493|38329356|FG000|Overall Study|Adverse Event|5|||
17177852|NCT02807493|38329357|FG001|Overall Study|Adverse Event|2|||
17177853|NCT02807493|38329356|FG000|Overall Study|Lost to Follow-up|6|||
17177854|NCT02807493|38329357|FG001|Overall Study|Lost to Follow-up|0|||
17177855|NCT02807493|38329356|FG000|Overall Study|Physician Decision|4|||
17177856|NCT02807493|38329357|FG001|Overall Study|Physician Decision|1|||
17177857|NCT02807493|38329356|FG000|Overall Study|Protocol Violation|7|||
17177858|NCT02807493|38329357|FG001|Overall Study|Protocol Violation|0|||
17177859|NCT02807493|38329356|FG000|Overall Study|Withdrawal by Subject|17|||
17177860|NCT02807493|38329357|FG001|Overall Study|Withdrawal by Subject|10|||
17177861|NCT02807493|38329356|FG000|Overall Study|Other withdrawal|17|||
17177862|NCT02807493|38329357|FG001|Overall Study|Other withdrawal|0|||
17177863|NCT02807493|38329356|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
17177864|NCT02807493|38329357|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
17177865|NCT02807259|38329365|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
17177866|NCT02807259|38329366|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
17177867|NCT02807259|38329365|FG000|Midline (3 Months)|migration, refusal, not available|30|||
17177868|NCT02807259|38329366|FG001|Midline (3 Months)|migration, refusal, not available|34|||
17177869|NCT02807259|38329365|FG000|Endline (3 Months)|migration, refusal, not available|35|||
17177870|NCT02807259|38329366|FG001|Endline (3 Months)|migration, refusal, not available|87|||
17177871|NCT02802345|38329376|FG000|Overall Study|Not Treated|0|||
17177872|NCT02802345|38329377|FG001|Overall Study|Not Treated|1|||
17177873|NCT02802345|38329376|FG000|Overall Study|Adverse Event|28|||
17177874|NCT02802345|38329377|FG001|Overall Study|Adverse Event|20|||
17177875|NCT02802345|38329376|FG000|Overall Study|Withdrawal by Subject|3|||
17177876|NCT02802345|38329377|FG001|Overall Study|Withdrawal by Subject|3|||
17177877|NCT02802345|38329376|FG000|Overall Study|Protocol Violation|0|||
17177878|NCT02802345|38329377|FG001|Overall Study|Protocol Violation|1|||
17177879|NCT02802345|38329376|FG000|Overall Study|Other than listed|1|||
17177880|NCT02802345|38329377|FG001|Overall Study|Other than listed|5|||
17177881|NCT02801877|38329387|FG000|Overall Study|Lost to Follow-up|1|||
17177882|NCT02801877|38329388|FG001|Overall Study|Lost to Follow-up|1|||
17177883|NCT02801877|38329389|FG002|Overall Study|Lost to Follow-up|2|||
17177884|NCT02801877|38329390|FG003|Overall Study|Lost to Follow-up|0|||
17177885|NCT02801877|38329387|FG000|Overall Study|Never Started Treatment|2|||
17177886|NCT02801877|38329388|FG001|Overall Study|Never Started Treatment|0|||
17177887|NCT02801877|38329389|FG002|Overall Study|Never Started Treatment|4|||
17177888|NCT02801877|38329390|FG003|Overall Study|Never Started Treatment|0|||
17177889|NCT02805309|38329403|FG000|Overall Study|Lost to Follow-up|2|||
17177890|NCT02805309|38329404|FG001|Overall Study|Lost to Follow-up|2|||
17177891|NCT02805309|38329405|FG002|Overall Study|Lost to Follow-up|2|||
17177892|NCT02805309|38329403|FG000|Overall Study|Post-Randomization Exclusion|0|||
17177893|NCT02805309|38329404|FG001|Overall Study|Post-Randomization Exclusion|2|||
17177894|NCT02805309|38329405|FG002|Overall Study|Post-Randomization Exclusion|1|||
17177895|NCT02804763|38329417|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
17177896|NCT02804763|38329418|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
17177897|NCT02804763|38329419|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
17177898|NCT02804763|38329420|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
17177899|NCT02804763|38329417|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
17177900|NCT02804763|38329418|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
17177901|NCT02804763|38329419|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
17177902|NCT02804763|38329420|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
17177903|NCT02804763|38329417|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
17177904|NCT02804763|38329418|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
17177905|NCT02804763|38329419|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
17177906|NCT02804763|38329420|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
17177907|NCT02804763|38329417|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
17177908|NCT02804763|38329418|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
17177909|NCT02804763|38329419|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
17177910|NCT02804763|38329420|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
17177911|NCT02804763|38329417|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
17177912|NCT02804763|38329418|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
17177913|NCT02804763|38329419|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
17177914|NCT02804763|38329420|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
17177915|NCT02804763|38329417|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
17177916|NCT02804763|38329418|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
17177917|NCT02804763|38329419|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
17177918|NCT02804763|38329420|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
17177919|NCT02748057|38329436|FG000|Overall Study|Adverse Event|1|||
17177920|NCT02748057|38329437|FG001|Overall Study|Adverse Event|0|||
17177921|NCT02748057|38329436|FG000|Overall Study|Physician Decision|0|||
17177922|NCT02748057|38329437|FG001|Overall Study|Physician Decision|1|||
17177923|NCT02748057|38329436|FG000|Overall Study|Protocol Violation|2|||
17177924|NCT02748057|38329437|FG001|Overall Study|Protocol Violation|1|||
17177925|NCT02748057|38329436|FG000|Overall Study|Participant Moved|1|||
17177926|NCT02748057|38329437|FG001|Overall Study|Participant Moved|0|||
17177927|NCT02748057|38329436|FG000|Overall Study|Withdrawal by Subject|1|||
17177928|NCT02748057|38329437|FG001|Overall Study|Withdrawal by Subject|0|||
17177929|NCT02748213|38329445|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
17177930|NCT02748213|38329446|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
17177931|NCT02748213|38329445|FG000|Overall Study|Abnormal Laboratory Test|1|||
17177932|NCT02748213|38329446|FG001|Overall Study|Abnormal Laboratory Test|0|||
17177933|NCT02748213|38329445|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
17177934|NCT02748213|38329446|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
17177935|NCT02748213|38329445|FG000|Overall Study|Death|5|||
17177936|NCT02748213|38329446|FG001|Overall Study|Death|3|||
17177937|NCT02748213|38329445|FG000|Overall Study|Insufficient Therapeutic Response|56|||
17177938|NCT02748213|38329446|FG001|Overall Study|Insufficient Therapeutic Response|57|||
17177939|NCT02748213|38329445|FG000|Overall Study|Violation of Selection Criteria|2|||
17177940|NCT02748213|38329446|FG001|Overall Study|Violation of Selection Criteria|0|||
17177941|NCT02748213|38329445|FG000|Overall Study|Protocol Violation|6|||
17177942|NCT02748213|38329446|FG001|Overall Study|Protocol Violation|4|||
17177943|NCT02748213|38329445|FG000|Overall Study|Refused Treatment*|6|||
17177944|NCT02748213|38329446|FG001|Overall Study|Refused Treatment*|6|||
17177945|NCT02748213|38329445|FG000|Overall Study|Failure to Return|1|||
17177946|NCT02748213|38329446|FG001|Overall Study|Failure to Return|0|||
17088931|NCT00308750|38229078|FG001|Overall Study|Adverse Event|9|||
17088932|NCT00308750|38229079|FG002|Overall Study|Adverse Event|13|||
17088933|NCT00308750|38229077|FG000|Overall Study|Withdrawal by Subject|6|||
17088934|NCT00308750|38229078|FG001|Overall Study|Withdrawal by Subject|2|||
17088935|NCT00308750|38229079|FG002|Overall Study|Withdrawal by Subject|3|||
17088936|NCT00308750|38229077|FG000|Overall Study|Physician Decision|3|||
17088937|NCT00308750|38229078|FG001|Overall Study|Physician Decision|4|||
17088938|NCT00308750|38229079|FG002|Overall Study|Physician Decision|3|||
17088939|NCT00308750|38229077|FG000|Overall Study|Sponsor Decision|1|||
17088940|NCT00308750|38229078|FG001|Overall Study|Sponsor Decision|0|||
17088941|NCT00308750|38229079|FG002|Overall Study|Sponsor Decision|0|||
17088942|NCT00308750|38229077|FG000|Overall Study|Disease Progression|47|||
17088943|NCT00308750|38229078|FG001|Overall Study|Disease Progression|24|||
17088944|NCT00308750|38229079|FG002|Overall Study|Disease Progression|28|||
17088945|NCT00308750|38229077|FG000|Overall Study|Unrelated Complication|3|||
17088946|NCT00308750|38229078|FG001|Overall Study|Unrelated Complication|0|||
17088947|NCT00308750|38229079|FG002|Overall Study|Unrelated Complication|1|||
17088948|NCT00308750|38229077|FG000|Overall Study|Death|1|||
17088949|NCT00308750|38229078|FG001|Overall Study|Death|0|||
17088950|NCT00308750|38229079|FG002|Overall Study|Death|1|||
17088951|NCT00308750|38229077|FG000|Overall Study|Protocol Violation|1|||
17088952|NCT00308750|38229078|FG001|Overall Study|Protocol Violation|0|||
17088953|NCT00308750|38229079|FG002|Overall Study|Protocol Violation|0|||
17088954|NCT00308750|38229077|FG000|Overall Study|New Primary Disease Identified|1|||
17088955|NCT00308750|38229078|FG001|Overall Study|New Primary Disease Identified|1|||
17088956|NCT00308750|38229079|FG002|Overall Study|New Primary Disease Identified|0|||
17088957|NCT00489359|38229090|FG000|Overall Study|Death|0|||
17088958|NCT00489359|38229091|FG001|Overall Study|Death|2|||
17088959|NCT00489359|38229090|FG000|Overall Study|Progressive Disease|5|||
17088960|NCT00489359|38229091|FG001|Overall Study|Progressive Disease|6|||
17088961|NCT00489359|38229090|FG000|Overall Study|Lost to Follow-up|1|||
17088962|NCT00489359|38229091|FG001|Overall Study|Lost to Follow-up|0|||
17088963|NCT00489359|38229090|FG000|Overall Study|Withdrawal by Subject|1|||
17088964|NCT00489359|38229091|FG001|Overall Study|Withdrawal by Subject|5|||
17177947|NCT02748213|38329445|FG000|Overall Study|Other|30|||
17177948|NCT02748213|38329446|FG001|Overall Study|Other|29|||
17177949|NCT02613910|38329452|FG000|Overall Study|Termination of study|1|||
17177950|NCT02802735|38329459|FG000|Overall Study|Withdrawal by Subject|0|||
17177951|NCT02802735|38329460|FG001|Overall Study|Withdrawal by Subject|1|||
17177952|NCT02802735|38329461|FG002|Overall Study|Withdrawal by Subject|0|||
17177953|NCT02802735|38329462|FG003|Overall Study|Withdrawal by Subject|0|||
17177954|NCT02802735|38329463|FG004|Overall Study|Withdrawal by Subject|0|||
17177955|NCT02799381|38329493|FG000|Overall Study|Withdrew consent|3|||
17177956|NCT02799381|38329494|FG001|Overall Study|Withdrew consent|2|||
17177957|NCT02799381|38329493|FG000|Overall Study|Adverse Event|0|||
17177958|NCT02799381|38329494|FG001|Overall Study|Adverse Event|1|||
17177959|NCT02799381|38329493|FG000|Overall Study|Participant did not take any study drug|1|||
17177960|NCT02799381|38329494|FG001|Overall Study|Participant did not take any study drug|0|||
17177961|NCT01333059|38329502|FG000|Overall Study|Physician Decision|3|||
17177962|NCT01333059|38329503|FG001|Overall Study|Physician Decision|3|||
17177963|NCT01333059|38329502|FG000|Overall Study|Protocol Violation|3|||
17177964|NCT01333059|38329503|FG001|Overall Study|Protocol Violation|0|||
17177965|NCT01370733|38329513|FG000|Overall Study|Withdrawal by Subject|8|||
17177966|NCT01370733|38329514|FG001|Overall Study|Withdrawal by Subject|8|||
17177967|NCT01370733|38329513|FG000|Overall Study|Lost to Follow-up|3|||
17177968|NCT01370733|38329514|FG001|Overall Study|Lost to Follow-up|0|||
17177969|NCT01370733|38329513|FG000|Overall Study|Adverse Event|2|||
17177970|NCT01370733|38329514|FG001|Overall Study|Adverse Event|4|||
17177971|NCT01370733|38329513|FG000|Overall Study|Lack of Efficacy|3|||
17177972|NCT01370733|38329514|FG001|Overall Study|Lack of Efficacy|5|||
17177973|NCT01370733|38329513|FG000|Overall Study|Physician Decision|0|||
17177974|NCT01370733|38329514|FG001|Overall Study|Physician Decision|2|||
17177975|NCT01370733|38329513|FG000|Overall Study|Protocol Violation|1|||
17177976|NCT01370733|38329514|FG001|Overall Study|Protocol Violation|3|||
17177977|NCT02613364|38329523|FG000|Overall Study|Other|19|||
17177978|NCT02613364|38329524|FG001|Overall Study|Other|29|||
17177979|NCT02613364|38329525|FG002|Overall Study|Other|17|||
17177980|NCT02613364|38329523|FG000|Overall Study|Too time consuming|21|||
17177981|NCT02613364|38329524|FG001|Overall Study|Too time consuming|26|||
17177982|NCT02613364|38329525|FG002|Overall Study|Too time consuming|26|||
17177983|NCT02613364|38329523|FG000|Overall Study|Withdrawal by Subject|13|||
17177984|NCT02613364|38329524|FG001|Overall Study|Withdrawal by Subject|18|||
17088965|NCT00489359|38229090|FG000|Overall Study|Adverse Event|0|||
17088966|NCT00489359|38229091|FG001|Overall Study|Adverse Event|16|||
17088967|NCT00481247|38229104|FG000|Overall Study|Death|0|||
17088968|NCT00481247|38229105|FG001|Overall Study|Death|1|||
17088969|NCT00481247|38229104|FG000|Overall Study|Disease progression|18|||
17088970|NCT00481247|38229105|FG001|Overall Study|Disease progression|22|||
17088971|NCT00481247|38229104|FG000|Overall Study|Intolerance|42|||
17088972|NCT00481247|38229105|FG001|Overall Study|Intolerance|17|||
17088973|NCT00481247|38229104|FG000|Overall Study|Treatment failure|10|||
17088974|NCT00481247|38229105|FG001|Overall Study|Treatment failure|14|||
17177985|NCT02613364|38329525|FG002|Overall Study|Withdrawal by Subject|17|||
17177986|NCT02613364|38329523|FG000|Overall Study|Medical|12|||
17177987|NCT02613364|38329524|FG001|Overall Study|Medical|13|||
17177988|NCT02613364|38329525|FG002|Overall Study|Medical|9|||
17177989|NCT02613364|38329523|FG000|Overall Study|Disliked Study Procedure|1|||
17177990|NCT02613364|38329524|FG001|Overall Study|Disliked Study Procedure|1|||
17177991|NCT02613364|38329525|FG002|Overall Study|Disliked Study Procedure|4|||
17177992|NCT02613364|38329523|FG000|Overall Study|Disliked Intervention|0|||
17177993|NCT02613364|38329524|FG001|Overall Study|Disliked Intervention|3|||
17177994|NCT02613364|38329525|FG002|Overall Study|Disliked Intervention|3|||
17177995|NCT01370655|38329545|FG000|Period 1|Adverse Event|2|||
17177996|NCT01370655|38329546|FG001|Period 1|Adverse Event|0|||
17177997|NCT01370655|38329547|FG002|Period 1|Adverse Event|0|||
17177998|NCT01370655|38329548|FG003|Period 1|Adverse Event|0|||
17177999|NCT01370655|38329549|FG004|Period 1|Adverse Event|0|||
17178000|NCT01370655|38329550|FG005|Period 1|Adverse Event|0|||
17178001|NCT01370655|38329551|FG006|Period 1|Adverse Event|1|||
17178002|NCT01370655|38329552|FG007|Period 1|Adverse Event|0|||
17088975|NCT00481247|38229104|FG000|Overall Study|AE unrelated to study drug|13|||
17088976|NCT00481247|38229105|FG001|Overall Study|AE unrelated to study drug|4|||
17088977|NCT00481247|38229104|FG000|Overall Study|Withdrawal by Subject|8|||
17178003|NCT01370655|38329553|FG008|Period 1|Adverse Event|0|||
17178004|NCT01370655|38329554|FG009|Period 1|Adverse Event|0|||
17178005|NCT01370655|38329555|FG010|Period 1|Adverse Event|0|||
17178006|NCT01370655|38329556|FG011|Period 1|Adverse Event|0|||
17178007|NCT01370655|38329545|FG000|Period 2|Adverse Event|0|||
17178008|NCT01370655|38329546|FG001|Period 2|Adverse Event|0|||
17178009|NCT01370655|38329547|FG002|Period 2|Adverse Event|1|||
17178010|NCT01370655|38329548|FG003|Period 2|Adverse Event|0|||
17178011|NCT01370655|38329549|FG004|Period 2|Adverse Event|1|||
17178012|NCT01370655|38329550|FG005|Period 2|Adverse Event|0|||
17178013|NCT01370655|38329551|FG006|Period 2|Adverse Event|0|||
17178014|NCT01370655|38329552|FG007|Period 2|Adverse Event|1|||
17178015|NCT01370655|38329553|FG008|Period 2|Adverse Event|0|||
17178016|NCT01370655|38329554|FG009|Period 2|Adverse Event|0|||
17178017|NCT01370655|38329555|FG010|Period 2|Adverse Event|0|||
17178018|NCT01370655|38329556|FG011|Period 2|Adverse Event|0|||
17178019|NCT01370655|38329545|FG000|Period 2|met protocol specified stopping criteria|0|||
17178020|NCT01370655|38329546|FG001|Period 2|met protocol specified stopping criteria|0|||
17178021|NCT01370655|38329547|FG002|Period 2|met protocol specified stopping criteria|1|||
17178022|NCT01370655|38329548|FG003|Period 2|met protocol specified stopping criteria|0|||
17178023|NCT01370655|38329549|FG004|Period 2|met protocol specified stopping criteria|0|||
17178024|NCT01370655|38329550|FG005|Period 2|met protocol specified stopping criteria|0|||
17178025|NCT01370655|38329551|FG006|Period 2|met protocol specified stopping criteria|1|||
17178026|NCT01370655|38329552|FG007|Period 2|met protocol specified stopping criteria|0|||
17178027|NCT01370655|38329553|FG008|Period 2|met protocol specified stopping criteria|1|||
17178028|NCT01370655|38329554|FG009|Period 2|met protocol specified stopping criteria|0|||
17178029|NCT01370655|38329555|FG010|Period 2|met protocol specified stopping criteria|1|||
17178030|NCT01370655|38329556|FG011|Period 2|met protocol specified stopping criteria|0|||
17178031|NCT01370655|38329545|FG000|Period 2|Withdrawal by Subject|0|||
17178032|NCT01370655|38329546|FG001|Period 2|Withdrawal by Subject|0|||
17178033|NCT01370655|38329547|FG002|Period 2|Withdrawal by Subject|0|||
17178034|NCT01370655|38329548|FG003|Period 2|Withdrawal by Subject|0|||
17178035|NCT01370655|38329549|FG004|Period 2|Withdrawal by Subject|0|||
17178036|NCT01370655|38329550|FG005|Period 2|Withdrawal by Subject|0|||
17178037|NCT01370655|38329551|FG006|Period 2|Withdrawal by Subject|0|||
17178038|NCT01370655|38329552|FG007|Period 2|Withdrawal by Subject|0|||
17178039|NCT01370655|38329553|FG008|Period 2|Withdrawal by Subject|1|||
17178040|NCT01370655|38329554|FG009|Period 2|Withdrawal by Subject|0|||
17178041|NCT01370655|38329555|FG010|Period 2|Withdrawal by Subject|0|||
17178042|NCT01370655|38329556|FG011|Period 2|Withdrawal by Subject|0|||
17178043|NCT02612194|38329569|FG000|Overall Study|Death|5|||
17178044|NCT02612194|38329570|FG001|Overall Study|Death|0|||
17178045|NCT02612194|38329571|FG002|Overall Study|Death|2|||
17178046|NCT02612194|38329569|FG000|Overall Study|Early Study Termination|1|||
17178047|NCT02612194|38329570|FG001|Overall Study|Early Study Termination|0|||
17178048|NCT02612194|38329571|FG002|Overall Study|Early Study Termination|0|||
17178049|NCT02798211|38329581|FG000|Period 1|Adverse Event|1|||
17178050|NCT02798211|38329582|FG001|Period 1|Adverse Event|1|||
17178051|NCT02798211|38329583|FG002|Period 1|Adverse Event|0|||
17178052|NCT02798211|38329584|FG003|Period 1|Adverse Event|0|||
17178053|NCT02798211|38329585|FG004|Period 1|Adverse Event|0|||
17178054|NCT02798211|38329586|FG005|Period 1|Adverse Event|0|||
17178055|NCT02798211|38329581|FG000|Period 1|Lost to Follow-up|2|||
17178056|NCT02798211|38329582|FG001|Period 1|Lost to Follow-up|1|||
17178057|NCT02798211|38329583|FG002|Period 1|Lost to Follow-up|0|||
17178058|NCT02798211|38329584|FG003|Period 1|Lost to Follow-up|0|||
17178059|NCT02798211|38329585|FG004|Period 1|Lost to Follow-up|0|||
17178060|NCT02798211|38329586|FG005|Period 1|Lost to Follow-up|0|||
17178061|NCT02798211|38329581|FG000|Period 1|Protocol Violation|0|||
17178062|NCT02798211|38329582|FG001|Period 1|Protocol Violation|0|||
17178063|NCT02798211|38329583|FG002|Period 1|Protocol Violation|2|||
17178064|NCT02798211|38329584|FG003|Period 1|Protocol Violation|0|||
17178065|NCT02798211|38329585|FG004|Period 1|Protocol Violation|0|||
17178066|NCT02798211|38329586|FG005|Period 1|Protocol Violation|0|||
17178067|NCT02798211|38329581|FG000|Period 1|Withdrawal by Subject|1|||
17178068|NCT02798211|38329582|FG001|Period 1|Withdrawal by Subject|1|||
17178069|NCT02798211|38329583|FG002|Period 1|Withdrawal by Subject|0|||
17178070|NCT02798211|38329584|FG003|Period 1|Withdrawal by Subject|0|||
17178071|NCT02798211|38329585|FG004|Period 1|Withdrawal by Subject|0|||
17178072|NCT02798211|38329586|FG005|Period 1|Withdrawal by Subject|0|||
17178073|NCT02798211|38329581|FG000|Period 1|Death|0|||
17178074|NCT02798211|38329582|FG001|Period 1|Death|0|||
17178075|NCT02798211|38329583|FG002|Period 1|Death|1|||
17178076|NCT02798211|38329584|FG003|Period 1|Death|0|||
17178077|NCT02798211|38329585|FG004|Period 1|Death|0|||
17178078|NCT02798211|38329586|FG005|Period 1|Death|0|||
17178079|NCT02798211|38329581|FG000|Period 1|Withdrawal of Informed Consent|2|||
17178080|NCT02798211|38329582|FG001|Period 1|Withdrawal of Informed Consent|7|||
17178081|NCT02798211|38329583|FG002|Period 1|Withdrawal of Informed Consent|3|||
17178082|NCT02798211|38329584|FG003|Period 1|Withdrawal of Informed Consent|0|||
17178083|NCT02798211|38329585|FG004|Period 1|Withdrawal of Informed Consent|0|||
17178084|NCT02798211|38329586|FG005|Period 1|Withdrawal of Informed Consent|0|||
17178085|NCT02798211|38329581|FG000|Period 2|Withdrawal by Subject|2|||
17178086|NCT02798211|38329582|FG001|Period 2|Withdrawal by Subject|0|||
17178087|NCT02798211|38329583|FG002|Period 2|Withdrawal by Subject|0|||
17178088|NCT02798211|38329584|FG003|Period 2|Withdrawal by Subject|0|||
17178089|NCT02798211|38329585|FG004|Period 2|Withdrawal by Subject|2|||
17178090|NCT02798211|38329586|FG005|Period 2|Withdrawal by Subject|2|||
17178091|NCT02798211|38329581|FG000|Period 2|Adverse Event|5|||
17178092|NCT02798211|38329582|FG001|Period 2|Adverse Event|0|||
17178093|NCT02798211|38329583|FG002|Period 2|Adverse Event|0|||
17178094|NCT02798211|38329584|FG003|Period 2|Adverse Event|0|||
17178095|NCT02798211|38329585|FG004|Period 2|Adverse Event|1|||
17178096|NCT02798211|38329586|FG005|Period 2|Adverse Event|0|||
17178097|NCT02798211|38329581|FG000|Period 2|Lack of Efficacy|1|||
17178098|NCT02798211|38329582|FG001|Period 2|Lack of Efficacy|0|||
17178099|NCT02798211|38329583|FG002|Period 2|Lack of Efficacy|0|||
17178100|NCT02798211|38329584|FG003|Period 2|Lack of Efficacy|1|||
17178101|NCT02798211|38329585|FG004|Period 2|Lack of Efficacy|0|||
17178102|NCT02798211|38329586|FG005|Period 2|Lack of Efficacy|1|||
17178103|NCT02798211|38329581|FG000|Period 2|Lost to Follow-up|3|||
17178104|NCT02798211|38329582|FG001|Period 2|Lost to Follow-up|0|||
17178105|NCT02798211|38329583|FG002|Period 2|Lost to Follow-up|0|||
17178106|NCT02798211|38329584|FG003|Period 2|Lost to Follow-up|0|||
17178107|NCT02798211|38329585|FG004|Period 2|Lost to Follow-up|2|||
17178108|NCT02798211|38329586|FG005|Period 2|Lost to Follow-up|0|||
17178109|NCT02798211|38329581|FG000|Period 2|Physician Decision|1|||
17178110|NCT02798211|38329582|FG001|Period 2|Physician Decision|0|||
17178111|NCT02798211|38329583|FG002|Period 2|Physician Decision|0|||
17178112|NCT02798211|38329584|FG003|Period 2|Physician Decision|1|||
17178113|NCT02798211|38329585|FG004|Period 2|Physician Decision|1|||
17178114|NCT02798211|38329586|FG005|Period 2|Physician Decision|0|||
17178115|NCT02798211|38329581|FG000|Period 2|Pregnancy|0|||
17178116|NCT02798211|38329582|FG001|Period 2|Pregnancy|0|||
17178117|NCT02798211|38329583|FG002|Period 2|Pregnancy|0|||
17178118|NCT02798211|38329584|FG003|Period 2|Pregnancy|2|||
17178119|NCT02798211|38329585|FG004|Period 2|Pregnancy|0|||
17178120|NCT02798211|38329586|FG005|Period 2|Pregnancy|0|||
17178121|NCT02798211|38329581|FG000|Period 2|Technical problems|1|||
17178122|NCT02798211|38329582|FG001|Period 2|Technical problems|0|||
17178123|NCT02798211|38329583|FG002|Period 2|Technical problems|0|||
17178124|NCT02798211|38329584|FG003|Period 2|Technical problems|1|||
17178125|NCT02798211|38329585|FG004|Period 2|Technical problems|0|||
17178126|NCT02798211|38329586|FG005|Period 2|Technical problems|0|||
17178127|NCT02798211|38329581|FG000|Period 2|Withdrawal of Informed Consent|1|||
17178128|NCT02798211|38329582|FG001|Period 2|Withdrawal of Informed Consent|0|||
17178129|NCT02798211|38329583|FG002|Period 2|Withdrawal of Informed Consent|0|||
17178130|NCT02798211|38329584|FG003|Period 2|Withdrawal of Informed Consent|2|||
17178131|NCT02798211|38329585|FG004|Period 2|Withdrawal of Informed Consent|2|||
17178132|NCT02798211|38329586|FG005|Period 2|Withdrawal of Informed Consent|3|||
17178133|NCT02799069|38329601|FG000|Overall Study|Adverse Event|0|||
17178134|NCT02799069|38329602|FG001|Overall Study|Adverse Event|2|||
17178135|NCT02799069|38329603|FG002|Overall Study|Adverse Event|2|||
17178136|NCT02799069|38329601|FG000|Overall Study|Lack of Efficacy|2|||
17178137|NCT02799069|38329602|FG001|Overall Study|Lack of Efficacy|0|||
17178138|NCT02799069|38329603|FG002|Overall Study|Lack of Efficacy|0|||
17178139|NCT02799069|38329601|FG000|Overall Study|Lost to Follow-up|1|||
17178140|NCT02799069|38329602|FG001|Overall Study|Lost to Follow-up|1|||
17178141|NCT02799069|38329603|FG002|Overall Study|Lost to Follow-up|0|||
17178142|NCT02799069|38329601|FG000|Overall Study|Withdrawal by Subject|4|||
17178143|NCT02799069|38329602|FG001|Overall Study|Withdrawal by Subject|4|||
17178144|NCT02799069|38329603|FG002|Overall Study|Withdrawal by Subject|3|||
17178145|NCT02799069|38329601|FG000|Overall Study|Protocol Violation|1|||
17178146|NCT02799069|38329602|FG001|Overall Study|Protocol Violation|0|||
17178147|NCT02799069|38329603|FG002|Overall Study|Protocol Violation|2|||
17178148|NCT01669174|38329613|FG000|Overall Study|Subject withdrew consent|2|||
17178149|NCT01669174|38329614|FG001|Overall Study|Subject withdrew consent|2|||
17178150|NCT01669174|38329613|FG000|Overall Study|Lost to Follow-up|1|||
17178151|NCT01669174|38329614|FG001|Overall Study|Lost to Follow-up|0|||
17178152|NCT01669174|38329613|FG000|Overall Study|Adverse Event|2|||
17178153|NCT01669174|38329614|FG001|Overall Study|Adverse Event|2|||
17178154|NCT01669174|38329613|FG000|Overall Study|Administrative problems|1|||
17178155|NCT01669174|38329614|FG001|Overall Study|Administrative problems|2|||
17178156|NCT02798835|38329623|FG000|Overall Study|Protocol Violation|0|||
17178157|NCT02798835|38329624|FG001|Overall Study|Protocol Violation|0|||
17178158|NCT02798835|38329625|FG002|Overall Study|Protocol Violation|3|||
17178159|NCT02611882|38329636|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
17178160|NCT02611882|38329637|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
17178161|NCT02611882|38329638|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
17178162|NCT02796963|38329649|FG000|Overall Study|Lost to Follow-up|89|||
17178163|NCT02796963|38329650|FG001|Overall Study|Lost to Follow-up|76|||
17178164|NCT02796963|38329651|FG002|Overall Study|Lost to Follow-up|69|||
17178165|NCT02796963|38329652|FG003|Overall Study|Lost to Follow-up|72|||
17178166|NCT02796651|38329662|FG000|Overall Study|Adverse Event|6|||
17178167|NCT02796651|38329662|FG000|Overall Study|Lost to Follow-up|1|||
17178168|NCT02796651|38329662|FG000|Overall Study|Withdrawal by Subject|4|||
17178169|NCT02796651|38329662|FG000|Overall Study|Protocol Violation|4|||
17178170|NCT02796651|38329662|FG000|Overall Study|Lack of Efficacy|1|||
17178171|NCT02796651|38329662|FG000|Overall Study|Other|10|||
17178172|NCT02613208|38329677|FG000|Overall Study|Withdrawal by Subject|1|||
17178173|NCT02613208|38329677|FG000|Overall Study|Change of address|2|||
17178174|NCT02613208|38329677|FG000|Overall Study|Physician Decision|2|||
17178175|NCT02613208|38329677|FG000|Overall Study|Lost to Follow-up|5|||
17178176|NCT02613208|38329677|FG000|Overall Study|Death|37|||
17178177|NCT01668784|38329683|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
17178178|NCT01668784|38329684|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
17178179|NCT01668784|38329683|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
17178180|NCT01668784|38329684|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
17178181|NCT01668784|38329683|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
17178182|NCT01668784|38329684|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
17178183|NCT01668784|38329683|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
17178184|NCT01668784|38329684|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
17178185|NCT01668784|38329683|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
17178186|NCT01668784|38329684|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
17178187|NCT01668784|38329683|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
17088978|NCT00481247|38229105|FG001|Overall Study|Withdrawal by Subject|13|||
17088979|NCT00481247|38229104|FG000|Overall Study|Pregnancy|2|||
17088980|NCT00481247|38229105|FG001|Overall Study|Pregnancy|1|||
17088981|NCT00481247|38229104|FG000|Overall Study|Lost to Follow-up|1|||
17088982|NCT00481247|38229105|FG001|Overall Study|Lost to Follow-up|2|||
17088983|NCT00481247|38229104|FG000|Overall Study|Poor compliance/noncompliance|1|||
17088984|NCT00481247|38229105|FG001|Overall Study|Poor compliance/noncompliance|7|||
17088985|NCT00481247|38229104|FG000|Overall Study|Administrative reason by sponsor|157|||
17088986|NCT00481247|38229105|FG001|Overall Study|Administrative reason by sponsor|162|||
17088987|NCT00481247|38229104|FG000|Overall Study|Varied|6|||
17178188|NCT01668784|38329684|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
17178189|NCT01668784|38329683|FG000|Treatment Period|Disease Progression|316|||
17178190|NCT01668784|38329684|FG001|Treatment Period|Disease Progression|293|||
17178191|NCT01668784|38329683|FG000|Treatment Period|Study Drug Toxicity|46|||
17178192|NCT01668784|38329684|FG001|Treatment Period|Study Drug Toxicity|53|||
17178193|NCT01668784|38329683|FG000|Treatment Period|Death|1|||
17178194|NCT01668784|38329684|FG001|Treatment Period|Death|1|||
17178195|NCT01668784|38329683|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
17178196|NCT01668784|38329684|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
17178197|NCT01668784|38329683|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
17178198|NCT01668784|38329684|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
17178199|NCT01668784|38329683|FG000|Treatment Period|Withdrawal by Subject|5|||
17178200|NCT01668784|38329684|FG001|Treatment Period|Withdrawal by Subject|3|||
17178201|NCT01668784|38329683|FG000|Treatment Period|Maximal Clinical Benefit|3|||
17178202|NCT01668784|38329684|FG001|Treatment Period|Maximal Clinical Benefit|3|||
17178203|NCT01668784|38329683|FG000|Treatment Period|Other|2|||
17178204|NCT01668784|38329684|FG001|Treatment Period|Other|8|||
17178205|NCT01668784|38329683|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
17178206|NCT01668784|38329684|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
17178207|NCT02750514|38329695|FG000|Track 1|Disease progression|20|||
17178208|NCT02750514|38329696|FG001|Track 1|Disease progression|1|||
17178209|NCT02750514|38329697|FG002|Track 1|Disease progression|0|||
17178210|NCT02750514|38329698|FG003|Track 1|Disease progression|1|||
17178211|NCT02750514|38329699|FG004|Track 1|Disease progression|0|||
17178212|NCT02750514|38329695|FG000|Track 1|Adverse event unrelated to study drug|1|||
17178213|NCT02750514|38329696|FG001|Track 1|Adverse event unrelated to study drug|0|||
17178214|NCT02750514|38329697|FG002|Track 1|Adverse event unrelated to study drug|0|||
17178215|NCT02750514|38329698|FG003|Track 1|Adverse event unrelated to study drug|0|||
17178216|NCT02750514|38329699|FG004|Track 1|Adverse event unrelated to study drug|0|||
17178217|NCT02750514|38329695|FG000|Track 1|Study drug toxicity|4|||
17178218|NCT02750514|38329696|FG001|Track 1|Study drug toxicity|1|||
17178219|NCT02750514|38329697|FG002|Track 1|Study drug toxicity|0|||
17178220|NCT02750514|38329698|FG003|Track 1|Study drug toxicity|1|||
17178221|NCT02750514|38329699|FG004|Track 1|Study drug toxicity|0|||
17178222|NCT02750514|38329695|FG000|Track 1|Participant request to discontinue|1|||
17178223|NCT02750514|38329696|FG001|Track 1|Participant request to discontinue|0|||
17178224|NCT02750514|38329697|FG002|Track 1|Participant request to discontinue|0|||
17178225|NCT02750514|38329698|FG003|Track 1|Participant request to discontinue|0|||
17178226|NCT02750514|38329699|FG004|Track 1|Participant request to discontinue|0|||
17178227|NCT02750514|38329695|FG000|Track 1|Other reasons|1|||
17178228|NCT02750514|38329696|FG001|Track 1|Other reasons|0|||
17088988|NCT00481247|38229105|FG001|Overall Study|Varied|15|||
17178229|NCT02750514|38329697|FG002|Track 1|Other reasons|0|||
17178230|NCT02750514|38329698|FG003|Track 1|Other reasons|0|||
17178231|NCT02750514|38329699|FG004|Track 1|Other reasons|0|||
17178232|NCT02750514|38329695|FG000|Track 2|Disease progression|4|||
17178233|NCT02750514|38329696|FG001|Track 2|Disease progression|5|||
17178234|NCT02750514|38329697|FG002|Track 2|Disease progression|2|||
17178235|NCT02750514|38329698|FG003|Track 2|Disease progression|5|||
17178236|NCT02750514|38329699|FG004|Track 2|Disease progression|0|||
17178237|NCT02750514|38329695|FG000|Track 2|Adverse event unrelated to study drug|1|||
17178238|NCT02750514|38329696|FG001|Track 2|Adverse event unrelated to study drug|0|||
17178239|NCT02750514|38329697|FG002|Track 2|Adverse event unrelated to study drug|0|||
17178240|NCT02750514|38329698|FG003|Track 2|Adverse event unrelated to study drug|0|||
17178241|NCT02750514|38329699|FG004|Track 2|Adverse event unrelated to study drug|0|||
17178242|NCT02750514|38329695|FG000|Track 2|Study drug toxicity|1|||
17178243|NCT02750514|38329696|FG001|Track 2|Study drug toxicity|2|||
17178244|NCT02750514|38329697|FG002|Track 2|Study drug toxicity|0|||
17178245|NCT02750514|38329698|FG003|Track 2|Study drug toxicity|2|||
17178246|NCT02750514|38329699|FG004|Track 2|Study drug toxicity|0|||
17178247|NCT02750514|38329695|FG000|Track 2|Participant withdrew consent|0|||
17178248|NCT02750514|38329696|FG001|Track 2|Participant withdrew consent|1|||
17178249|NCT02750514|38329697|FG002|Track 2|Participant withdrew consent|0|||
17178250|NCT02750514|38329698|FG003|Track 2|Participant withdrew consent|0|||
17178251|NCT02750514|38329699|FG004|Track 2|Participant withdrew consent|0|||
17178252|NCT02750514|38329695|FG000|Track 3|Disease progression|0|||
17178253|NCT02750514|38329696|FG001|Track 3|Disease progression|24|||
17178254|NCT02750514|38329697|FG002|Track 3|Disease progression|13|||
17178255|NCT02750514|38329698|FG003|Track 3|Disease progression|14|||
17178256|NCT02750514|38329699|FG004|Track 3|Disease progression|0|||
17178257|NCT02750514|38329695|FG000|Track 3|Adverse event unrelated to study drug|0|||
17178258|NCT02750514|38329696|FG001|Track 3|Adverse event unrelated to study drug|1|||
17178259|NCT02750514|38329697|FG002|Track 3|Adverse event unrelated to study drug|1|||
17178260|NCT02750514|38329698|FG003|Track 3|Adverse event unrelated to study drug|1|||
17178261|NCT02750514|38329699|FG004|Track 3|Adverse event unrelated to study drug|0|||
17178262|NCT02750514|38329695|FG000|Track 3|Study drug toxicity|0|||
17178263|NCT02750514|38329696|FG001|Track 3|Study drug toxicity|3|||
17178264|NCT02750514|38329697|FG002|Track 3|Study drug toxicity|0|||
17088989|NCT00481247|38229104|FG000|Overall Study|Did not receive treatment|1|||
17088990|NCT00481247|38229105|FG001|Overall Study|Did not receive treatment|2|||
17178265|NCT02750514|38329698|FG003|Track 3|Study drug toxicity|1|||
17178266|NCT02750514|38329699|FG004|Track 3|Study drug toxicity|0|||
17178267|NCT02750514|38329695|FG000|Track 3|Participant request to discontinue|0|||
17178268|NCT02750514|38329696|FG001|Track 3|Participant request to discontinue|2|||
17178269|NCT02750514|38329697|FG002|Track 3|Participant request to discontinue|0|||
17088991|NCT00480857|38229111|FG000|Overall Study|Lack of Efficacy|2|||
17088992|NCT00480779|38229117|FG000|Overall Study|Other|2|||
17088993|NCT00480779|38229118|FG001|Overall Study|Other|0|||
17088994|NCT00480779|38229117|FG000|Overall Study|Job and Health-related|0|||
17088995|NCT00480779|38229118|FG001|Overall Study|Job and Health-related|3|||
17088996|NCT00499031|38229124|FG000|Overall Study|Improper pre-protocol treatment|1|||
17088997|NCT00499031|38229124|FG000|Overall Study|Required test not done|1|||
17088998|NCT00499031|38229124|FG000|Overall Study|Never treated|1|||
17088999|NCT00498797|38229130|FG000|Overall Study|Withdrawal by Subject|4|||
17089000|NCT00498797|38229131|FG001|Overall Study|Withdrawal by Subject|2|||
17089001|NCT00498797|38229130|FG000|Overall Study|Adverse Event|12|||
17089002|NCT00498797|38229131|FG001|Overall Study|Adverse Event|5|||
17089003|NCT00498797|38229130|FG000|Overall Study|Condition under investigation worsened|19|||
17089004|NCT00498797|38229131|FG001|Overall Study|Condition under investigation worsened|21|||
17089005|NCT00498797|38229130|FG000|Overall Study|Other|3|||
17089006|NCT00498797|38229131|FG001|Overall Study|Other|1|||
17089007|NCT00498485|38229139|FG000|Overall Study|Adverse Event|1|||
17089008|NCT00498485|38229140|FG001|Overall Study|Adverse Event|5|||
17089009|NCT00480077|38229150|FG000|Overall Study|Death|19|||
17089010|NCT00480077|38229151|FG001|Overall Study|Death|15|||
17089011|NCT00480077|38229150|FG000|Overall Study|early exit|12|||
17089012|NCT00480077|38229151|FG001|Overall Study|early exit|11|||
17089013|NCT00498173|38229159|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
17089014|NCT00498173|38229160|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
17089015|NCT00498173|38229161|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
17089016|NCT00295620|38229171|FG000|Overall Study|Lost to Follow-up|9|||
17089017|NCT00295620|38229172|FG001|Overall Study|Lost to Follow-up|5|||
17089018|NCT00295620|38229171|FG000|Overall Study|Withdrawal by Subject|37|||
17178270|NCT02750514|38329698|FG003|Track 3|Participant request to discontinue|0|||
17178271|NCT02750514|38329699|FG004|Track 3|Participant request to discontinue|0|||
17178272|NCT02750514|38329695|FG000|Track 3|Participant withdrew consent|0|||
17178273|NCT02750514|38329696|FG001|Track 3|Participant withdrew consent|3|||
17178274|NCT02750514|38329697|FG002|Track 3|Participant withdrew consent|1|||
17178275|NCT02750514|38329698|FG003|Track 3|Participant withdrew consent|0|||
17178276|NCT02750514|38329699|FG004|Track 3|Participant withdrew consent|0|||
17178277|NCT02750514|38329695|FG000|Track 3|Other reasons|0|||
17178278|NCT02750514|38329696|FG001|Track 3|Other reasons|3|||
17178279|NCT02750514|38329697|FG002|Track 3|Other reasons|0|||
17178280|NCT02750514|38329698|FG003|Track 3|Other reasons|0|||
17178281|NCT02750514|38329699|FG004|Track 3|Other reasons|0|||
17178282|NCT02750514|38329695|FG000|Track 4|Study drug toxicity|0|||
17178283|NCT02750514|38329696|FG001|Track 4|Study drug toxicity|6|||
17178284|NCT02750514|38329697|FG002|Track 4|Study drug toxicity|0|||
17178285|NCT02750514|38329698|FG003|Track 4|Study drug toxicity|5|||
17178286|NCT02750514|38329699|FG004|Track 4|Study drug toxicity|0|||
17178287|NCT02750514|38329695|FG000|Track 4|Participant request to discontinue|0|||
17178288|NCT02750514|38329696|FG001|Track 4|Participant request to discontinue|1|||
17178289|NCT02750514|38329697|FG002|Track 4|Participant request to discontinue|0|||
17178290|NCT02750514|38329698|FG003|Track 4|Participant request to discontinue|1|||
17178291|NCT02750514|38329699|FG004|Track 4|Participant request to discontinue|0|||
17178292|NCT02750514|38329695|FG000|Track 4|Participant withdrew consent|0|||
17178293|NCT02750514|38329696|FG001|Track 4|Participant withdrew consent|1|||
17178294|NCT02750514|38329697|FG002|Track 4|Participant withdrew consent|0|||
17178295|NCT02750514|38329698|FG003|Track 4|Participant withdrew consent|0|||
17178296|NCT02750514|38329699|FG004|Track 4|Participant withdrew consent|0|||
17178297|NCT02750514|38329695|FG000|Track 4|Other reasons|0|||
17178298|NCT02750514|38329696|FG001|Track 4|Other reasons|5|||
17178299|NCT02750514|38329697|FG002|Track 4|Other reasons|0|||
17178300|NCT02750514|38329698|FG003|Track 4|Other reasons|3|||
17178301|NCT02750514|38329699|FG004|Track 4|Other reasons|0|||
17178302|NCT02750514|38329695|FG000|Track 4|Disease progression|0|||
17178303|NCT02750514|38329696|FG001|Track 4|Disease progression|33|||
17178304|NCT02750514|38329697|FG002|Track 4|Disease progression|0|||
17178305|NCT02750514|38329698|FG003|Track 4|Disease progression|32|||
17178306|NCT02750514|38329699|FG004|Track 4|Disease progression|0|||
17178307|NCT02750514|38329695|FG000|Track 4|Adverse event unrelated to study drug|0|||
17178308|NCT02750514|38329696|FG001|Track 4|Adverse event unrelated to study drug|5|||
17178309|NCT02750514|38329697|FG002|Track 4|Adverse event unrelated to study drug|0|||
17178310|NCT02750514|38329698|FG003|Track 4|Adverse event unrelated to study drug|0|||
17178311|NCT02750514|38329699|FG004|Track 4|Adverse event unrelated to study drug|0|||
17178312|NCT02750514|38329695|FG000|Track 4|Death|0|||
17178313|NCT02750514|38329696|FG001|Track 4|Death|0|||
17178314|NCT02750514|38329697|FG002|Track 4|Death|0|||
17178315|NCT02750514|38329698|FG003|Track 4|Death|1|||
17178316|NCT02750514|38329699|FG004|Track 4|Death|0|||
17178317|NCT02750514|38329695|FG000|Track 5|Disease progression|0|||
17178318|NCT02750514|38329696|FG001|Track 5|Disease progression|0|||
17178319|NCT02750514|38329697|FG002|Track 5|Disease progression|0|||
17178320|NCT02750514|38329698|FG003|Track 5|Disease progression|0|||
17178321|NCT02750514|38329699|FG004|Track 5|Disease progression|34|||
17178322|NCT02750514|38329695|FG000|Track 5|Adverse event unrelated to study drug|0|||
17178323|NCT02750514|38329696|FG001|Track 5|Adverse event unrelated to study drug|0|||
17178324|NCT02750514|38329697|FG002|Track 5|Adverse event unrelated to study drug|0|||
17178325|NCT02750514|38329698|FG003|Track 5|Adverse event unrelated to study drug|0|||
17178326|NCT02750514|38329699|FG004|Track 5|Adverse event unrelated to study drug|2|||
17178327|NCT02750514|38329695|FG000|Track 5|Study drug toxicity|0|||
17178328|NCT02750514|38329696|FG001|Track 5|Study drug toxicity|0|||
17178329|NCT02750514|38329697|FG002|Track 5|Study drug toxicity|0|||
17178330|NCT02750514|38329698|FG003|Track 5|Study drug toxicity|0|||
17178331|NCT02750514|38329699|FG004|Track 5|Study drug toxicity|2|||
17178332|NCT02750514|38329695|FG000|Track 5|Participant request to discontinue|0|||
17178333|NCT02750514|38329696|FG001|Track 5|Participant request to discontinue|0|||
17178334|NCT02750514|38329697|FG002|Track 5|Participant request to discontinue|0|||
17178335|NCT02750514|38329698|FG003|Track 5|Participant request to discontinue|0|||
17178336|NCT02750514|38329699|FG004|Track 5|Participant request to discontinue|3|||
17178337|NCT02750514|38329695|FG000|Track 5|Other reasons|0|||
17178338|NCT02750514|38329696|FG001|Track 5|Other reasons|0|||
17178339|NCT02750514|38329697|FG002|Track 5|Other reasons|0|||
17178340|NCT02750514|38329698|FG003|Track 5|Other reasons|0|||
17178341|NCT02750514|38329699|FG004|Track 5|Other reasons|2|||
17178342|NCT02612428|38329721|FG000|VTL-308|Death|14|||
17178343|NCT02612428|38329722|FG001|VTL-308|Death|16|||
17178344|NCT02612428|38329721|FG000|VTL-308|Withdrawal by Subject|0|||
17178345|NCT02612428|38329722|FG001|VTL-308|Withdrawal by Subject|1|||
17178346|NCT02612428|38329721|FG000|VTL-308E|Death|9|||
17178347|NCT02612428|38329722|FG001|VTL-308E|Death|7|||
17178348|NCT02612428|38329721|FG000|VTL-308E|Lost to Follow-up|2|||
17178349|NCT02612428|38329722|FG001|VTL-308E|Lost to Follow-up|0|||
17178350|NCT03679884|38329733|FG000|Overall Study|Other|12|||
17178351|NCT03679884|38329734|FG001|Overall Study|Other|12|||
17178352|NCT03679884|38329735|FG002|Overall Study|Other|12|||
17178353|NCT03679884|38329736|FG003|Overall Study|Other|7|||
17178354|NCT03679884|38329737|FG004|Overall Study|Other|8|||
17178355|NCT03679884|38329733|FG000|Overall Study|Lack of Efficacy|15|||
17178356|NCT03679884|38329734|FG001|Overall Study|Lack of Efficacy|29|||
17178357|NCT03679884|38329735|FG002|Overall Study|Lack of Efficacy|13|||
17178358|NCT03679884|38329736|FG003|Overall Study|Lack of Efficacy|29|||
17178359|NCT03679884|38329737|FG004|Overall Study|Lack of Efficacy|10|||
17178360|NCT03679884|38329733|FG000|Overall Study|Death|1|||
17178361|NCT03679884|38329734|FG001|Overall Study|Death|0|||
17178362|NCT03679884|38329735|FG002|Overall Study|Death|0|||
17178363|NCT03679884|38329736|FG003|Overall Study|Death|0|||
17178364|NCT03679884|38329737|FG004|Overall Study|Death|0|||
17178365|NCT03679884|38329733|FG000|Overall Study|Adverse Event|2|||
17178366|NCT03679884|38329734|FG001|Overall Study|Adverse Event|10|||
17178367|NCT03679884|38329735|FG002|Overall Study|Adverse Event|9|||
17178368|NCT03679884|38329736|FG003|Overall Study|Adverse Event|6|||
17178369|NCT03679884|38329737|FG004|Overall Study|Adverse Event|6|||
17178370|NCT03679884|38329733|FG000|Overall Study|Withdrawal by Subject|12|||
17178371|NCT03679884|38329734|FG001|Overall Study|Withdrawal by Subject|23|||
17178372|NCT03679884|38329735|FG002|Overall Study|Withdrawal by Subject|8|||
17178373|NCT03679884|38329736|FG003|Overall Study|Withdrawal by Subject|8|||
17178374|NCT03679884|38329737|FG004|Overall Study|Withdrawal by Subject|9|||
17178375|NCT03679884|38329733|FG000|Overall Study|Lost to Follow-up|1|||
17178376|NCT03679884|38329734|FG001|Overall Study|Lost to Follow-up|4|||
17178377|NCT03679884|38329735|FG002|Overall Study|Lost to Follow-up|2|||
17178378|NCT03679884|38329736|FG003|Overall Study|Lost to Follow-up|0|||
17178379|NCT03679884|38329737|FG004|Overall Study|Lost to Follow-up|3|||
17178380|NCT01329978|38329752|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
17178381|NCT01329978|38329753|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
17178382|NCT01329978|38329754|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
17178383|NCT01329978|38329755|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
17178384|NCT01329978|38329756|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
17178385|NCT01329978|38329752|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
17178386|NCT01329978|38329753|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
17178387|NCT01329978|38329754|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
17178388|NCT01329978|38329755|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
17178389|NCT01329978|38329756|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
17178390|NCT01329978|38329752|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
17178391|NCT01329978|38329753|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
17178392|NCT01329978|38329754|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
17178393|NCT01329978|38329755|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
17178394|NCT01329978|38329756|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
17178395|NCT01329978|38329752|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
17178396|NCT01329978|38329753|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
17178397|NCT01329978|38329754|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
17178398|NCT01329978|38329755|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
17178399|NCT01329978|38329756|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
17178400|NCT01329978|38329752|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
17178401|NCT01329978|38329753|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
17178402|NCT01329978|38329754|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
17178403|NCT01329978|38329755|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
17178404|NCT01329978|38329756|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
17178405|NCT01329978|38329752|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
17178406|NCT01329978|38329753|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
17178407|NCT01329978|38329754|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
17178408|NCT01329978|38329755|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
17178409|NCT01329978|38329756|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
17178410|NCT01329978|38329752|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
17178411|NCT01329978|38329753|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
17178412|NCT01329978|38329754|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
17178413|NCT01329978|38329755|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
17178414|NCT01329978|38329756|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
17178415|NCT01338012|38329768|FG000|Overall Study|Death|4|||
17178416|NCT01338012|38329768|FG000|Overall Study|Study terminated|4|||
17178417|NCT04905498|38329774|FG000|Overall Study|Lost to Follow-up|0|||
17178418|NCT04905498|38329775|FG001|Overall Study|Lost to Follow-up|2|||
17178419|NCT04905498|38329774|FG000|Overall Study|COVID lockdown|1|||
17178420|NCT04905498|38329775|FG001|Overall Study|COVID lockdown|0|||
17178421|NCT02607280|38329783|FG000|Overall Study|Adverse Event|4|||
17178422|NCT02607280|38329784|FG001|Overall Study|Adverse Event|0|||
17178423|NCT02607280|38329783|FG000|Overall Study|Decrease in CrCl <15|0|||
17178424|NCT02607280|38329784|FG001|Overall Study|Decrease in CrCl <15|1|||
17178425|NCT02202434|38329794|FG000|Overall Study|Death|70|||
17178426|NCT02202434|38329795|FG001|Overall Study|Death|39|||
17178427|NCT02202434|38329796|FG002|Overall Study|Death|13|||
17178428|NCT02202434|38329797|FG003|Overall Study|Death|27|||
17178429|NCT02202434|38329794|FG000|Overall Study|Lost to Follow-up|1|||
17178430|NCT02202434|38329795|FG001|Overall Study|Lost to Follow-up|1|||
17178431|NCT02202434|38329796|FG002|Overall Study|Lost to Follow-up|1|||
17178432|NCT02202434|38329797|FG003|Overall Study|Lost to Follow-up|0|||
17178433|NCT02202434|38329794|FG000|Overall Study|Physician Decision|2|||
17178434|NCT02202434|38329795|FG001|Overall Study|Physician Decision|3|||
17178435|NCT02202434|38329796|FG002|Overall Study|Physician Decision|0|||
17178436|NCT02202434|38329797|FG003|Overall Study|Physician Decision|0|||
17178437|NCT02202434|38329794|FG000|Overall Study|Withdrawal by Subject|13|||
17178438|NCT02202434|38329795|FG001|Overall Study|Withdrawal by Subject|14|||
17178439|NCT02202434|38329796|FG002|Overall Study|Withdrawal by Subject|1|||
17178440|NCT02202434|38329797|FG003|Overall Study|Withdrawal by Subject|4|||
17178441|NCT02202434|38329794|FG000|Overall Study|Completed Study|1|||
17178442|NCT02202434|38329795|FG001|Overall Study|Completed Study|0|||
17178443|NCT02202434|38329796|FG002|Overall Study|Completed Study|0|||
17178444|NCT02202434|38329797|FG003|Overall Study|Completed Study|0|||
17178445|NCT02202434|38329794|FG000|Overall Study|Visit Missed|21|||
17178446|NCT02202434|38329795|FG001|Overall Study|Visit Missed|12|||
17178447|NCT02202434|38329796|FG002|Overall Study|Visit Missed|0|||
17178448|NCT02202434|38329797|FG003|Overall Study|Visit Missed|5|||
17178449|NCT02202434|38329794|FG000|Overall Study|Other|1|||
17178450|NCT02202434|38329795|FG001|Overall Study|Other|0|||
17178451|NCT02202434|38329796|FG002|Overall Study|Other|0|||
17178452|NCT02202434|38329797|FG003|Overall Study|Other|1|||
17178453|NCT01230242|38329807|FG000|Overall Study|Physician Decision|2|||
17178454|NCT01230242|38329807|FG000|Overall Study|Withdrawal by Subject|1|||
17178455|NCT02608450|38329813|FG000|Overall Study|Lost to Follow-up|39|||
17178456|NCT02608450|38329814|FG001|Overall Study|Lost to Follow-up|32|||
17178457|NCT02608450|38329813|FG000|Overall Study|Withdrawal by Subject|21|||
17178458|NCT02608450|38329814|FG001|Overall Study|Withdrawal by Subject|15|||
17178459|NCT02608450|38329813|FG000|Overall Study|Adverse Event|3|||
17178460|NCT02608450|38329814|FG001|Overall Study|Adverse Event|6|||
17178461|NCT02608450|38329813|FG000|Overall Study|Withdrawal by parent|2|||
17178462|NCT02608450|38329814|FG001|Overall Study|Withdrawal by parent|3|||
17178463|NCT02608450|38329813|FG000|Overall Study|Lack of Efficacy|0|||
17178464|NCT02608450|38329814|FG001|Overall Study|Lack of Efficacy|3|||
17178465|NCT02608450|38329813|FG000|Overall Study|Noncompliance with study drug|0|||
17178466|NCT02608450|38329814|FG001|Overall Study|Noncompliance with study drug|2|||
17178467|NCT02608450|38329813|FG000|Overall Study|Physician Decision|0|||
17178468|NCT02608450|38329814|FG001|Overall Study|Physician Decision|1|||
17178469|NCT02608450|38329813|FG000|Overall Study|Pregnancy|0|||
17178470|NCT02608450|38329814|FG001|Overall Study|Pregnancy|1|||
17178471|NCT02608450|38329813|FG000|Overall Study|Progressive disease|1|||
17178472|NCT02608450|38329814|FG001|Overall Study|Progressive disease|0|||
17178473|NCT02608450|38329813|FG000|Overall Study|Multiple reasons|0|||
17178474|NCT02608450|38329814|FG001|Overall Study|Multiple reasons|2|||
17178475|NCT01668004|38329820|FG000|Overall Study|Adverse Event|7|||
17178476|NCT01668004|38329820|FG000|Overall Study|Withdrawal by Subject|2|||
17178477|NCT01668004|38329820|FG000|Overall Study|Lost to Follow-up|5|||
17178478|NCT01668004|38329820|FG000|Overall Study|Lack of Efficacy|9|||
17178479|NCT01668004|38329820|FG000|Overall Study|Non-compliance with treatment|2|||
17178480|NCT01667926|38329828|FG000|Overall Study|Withdrawal by Subject|1|||
17178481|NCT01667926|38329829|FG001|Overall Study|Withdrawal by Subject|2|||
17178482|NCT01667926|38329830|FG002|Overall Study|Withdrawal by Subject|2|||
17178483|NCT01667926|38329828|FG000|Overall Study|Physician Decision|0|||
17178484|NCT01667926|38329829|FG001|Overall Study|Physician Decision|0|||
17178485|NCT01667926|38329830|FG002|Overall Study|Physician Decision|1|||
17178486|NCT01667926|38329828|FG000|Overall Study|Time committment|0|||
17178487|NCT01667926|38329829|FG001|Overall Study|Time committment|0|||
17178488|NCT01667926|38329830|FG002|Overall Study|Time committment|2|||
17178489|NCT01667926|38329828|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
17178490|NCT01667926|38329829|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
17178491|NCT01667926|38329830|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
17178492|NCT01667926|38329828|FG000|Overall Study|Lost to Follow-up|1|||
17178493|NCT01667926|38329829|FG001|Overall Study|Lost to Follow-up|2|||
17178494|NCT01667926|38329830|FG002|Overall Study|Lost to Follow-up|1|||
17178495|NCT01667926|38329828|FG000|Overall Study|Side effects|3|||
17178496|NCT01667926|38329829|FG001|Overall Study|Side effects|0|||
17178497|NCT01667926|38329830|FG002|Overall Study|Side effects|0|||
17178498|NCT02604160|38329838|FG000|Overall Study|Protocol Violation|0|||
17178499|NCT02604160|38329839|FG001|Overall Study|Protocol Violation|1|||
17178500|NCT02604160|38329838|FG000|Overall Study|Physician Decision|0|||
17178501|NCT02604160|38329839|FG001|Overall Study|Physician Decision|1|||
17178502|NCT01359904|38329849|FG000|Overall Study|Withdrawal by Subject|1|||
17178503|NCT01359904|38329850|FG001|Overall Study|Withdrawal by Subject|0|||
17178504|NCT02328014|38329860|FG000|Overall Study|Adverse Event|1|||
17178505|NCT02328014|38329861|FG001|Overall Study|Adverse Event|0|||
17178506|NCT02328014|38329862|FG002|Overall Study|Adverse Event|0|||
17178507|NCT02328014|38329863|FG003|Overall Study|Adverse Event|1|||
17178508|NCT02328014|38329860|FG000|Overall Study|Death|0|||
17178509|NCT02328014|38329861|FG001|Overall Study|Death|0|||
17178510|NCT02328014|38329862|FG002|Overall Study|Death|0|||
17178511|NCT02328014|38329863|FG003|Overall Study|Death|4|||
17178512|NCT02328014|38329860|FG000|Overall Study|Physician Decision|0|||
17178513|NCT02328014|38329861|FG001|Overall Study|Physician Decision|0|||
17178514|NCT02328014|38329862|FG002|Overall Study|Physician Decision|0|||
17178515|NCT02328014|38329863|FG003|Overall Study|Physician Decision|1|||
17178516|NCT02328014|38329860|FG000|Overall Study|Disease Progression|1|||
17178517|NCT02328014|38329861|FG001|Overall Study|Disease Progression|0|||
17178518|NCT02328014|38329862|FG002|Overall Study|Disease Progression|1|||
17178519|NCT02328014|38329863|FG003|Overall Study|Disease Progression|3|||
17178520|NCT02328014|38329860|FG000|Overall Study|Study Terminated by Sponsor|4|||
17178521|NCT02328014|38329861|FG001|Overall Study|Study Terminated by Sponsor|1|||
17178522|NCT02328014|38329862|FG002|Overall Study|Study Terminated by Sponsor|1|||
17178523|NCT02328014|38329863|FG003|Overall Study|Study Terminated by Sponsor|0|||
17178524|NCT02328014|38329860|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
17178525|NCT02328014|38329861|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
17178526|NCT02328014|38329862|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
17178527|NCT02328014|38329863|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
17178528|NCT02328014|38329860|FG000|Overall Study|Withdrawal by Subject|0|||
17178529|NCT02328014|38329861|FG001|Overall Study|Withdrawal by Subject|0|||
17178530|NCT02328014|38329862|FG002|Overall Study|Withdrawal by Subject|0|||
17178531|NCT02328014|38329863|FG003|Overall Study|Withdrawal by Subject|1|||
17178532|NCT00157248|38329896|FG000|Overall Study|Adverse Event|36|||
17178533|NCT00157248|38329897|FG001|Overall Study|Adverse Event|25|||
17178534|NCT00157248|38329898|FG002|Overall Study|Adverse Event|13|||
17178535|NCT00157248|38329899|FG003|Overall Study|Adverse Event|33|||
17178536|NCT00157248|38329896|FG000|Overall Study|Protocol Violation|4|||
17178537|NCT00157248|38329897|FG001|Overall Study|Protocol Violation|0|||
17178538|NCT00157248|38329898|FG002|Overall Study|Protocol Violation|2|||
17178539|NCT00157248|38329899|FG003|Overall Study|Protocol Violation|2|||
17178540|NCT00157248|38329896|FG000|Overall Study|Lost to Follow-up|0|||
17178541|NCT00157248|38329897|FG001|Overall Study|Lost to Follow-up|1|||
17178542|NCT00157248|38329898|FG002|Overall Study|Lost to Follow-up|0|||
17178543|NCT00157248|38329899|FG003|Overall Study|Lost to Follow-up|0|||
17178544|NCT00157248|38329896|FG000|Overall Study|Withdrawal by Subject|1|||
17178545|NCT00157248|38329897|FG001|Overall Study|Withdrawal by Subject|4|||
17178546|NCT00157248|38329898|FG002|Overall Study|Withdrawal by Subject|3|||
17178547|NCT00157248|38329899|FG003|Overall Study|Withdrawal by Subject|3|||
17178548|NCT00157248|38329896|FG000|Overall Study|site closures, subject moving|7|||
17178549|NCT00157248|38329897|FG001|Overall Study|site closures, subject moving|7|||
17178550|NCT00157248|38329898|FG002|Overall Study|site closures, subject moving|3|||
17178551|NCT00157248|38329899|FG003|Overall Study|site closures, subject moving|9|||
17178552|NCT03019406|38329917|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
17178553|NCT03019406|38329918|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
17178554|NCT03019406|38329919|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
17178555|NCT03019406|38329920|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
17178556|NCT01328756|38329933|FG000|Overall Study|Protocol Violation|4|||
17178557|NCT01328756|38329933|FG000|Overall Study|Adverse Event|39|||
17178558|NCT01328756|38329933|FG000|Overall Study|Lack of Efficacy|5|||
17178559|NCT01328756|38329933|FG000|Overall Study|Withdrawal by Subject|41|||
17178560|NCT01328756|38329933|FG000|Overall Study|Lost to Follow-up|5|||
17178561|NCT01328756|38329933|FG000|Overall Study|Other|29|||
17178562|NCT03922308|38329940|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
17178563|NCT03922308|38329941|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
17178564|NCT03922308|38329942|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
17178565|NCT03922308|38329940|FG000|Overall Study|Lost to Follow-up|1|||
17178566|NCT03922308|38329941|FG001|Overall Study|Lost to Follow-up|0|||
17178567|NCT03922308|38329942|FG002|Overall Study|Lost to Follow-up|0|||
17178568|NCT03922308|38329940|FG000|Overall Study|Reason not Specified|0|||
17178569|NCT03922308|38329941|FG001|Overall Study|Reason not Specified|2|||
17178570|NCT03922308|38329942|FG002|Overall Study|Reason not Specified|1|||
17178571|NCT02607930|38329959|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
17178572|NCT02607930|38329960|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
17178573|NCT02607930|38329961|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
17178574|NCT02607930|38329962|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
17178575|NCT02607930|38329959|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
17178576|NCT02607930|38329960|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
17178577|NCT02607930|38329961|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
17178578|NCT02607930|38329962|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
17178579|NCT02607930|38329959|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
17178580|NCT02607930|38329960|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
17178581|NCT02607930|38329961|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
17178582|NCT02607930|38329962|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
17178583|NCT02607930|38329959|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
17178584|NCT02607930|38329960|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
17178585|NCT02607930|38329961|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
17178586|NCT02607930|38329962|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
17178587|NCT02607930|38329959|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
17178588|NCT02607930|38329960|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
17178589|NCT02607930|38329961|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
17178590|NCT02607930|38329962|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
17178591|NCT02607930|38329959|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
17178592|NCT02607930|38329960|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
17178593|NCT02607930|38329961|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
17178594|NCT02607930|38329962|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
17178595|NCT02607930|38329959|FG000|Double-Blinded Treatment Phase|Death|2|||
17178596|NCT02607930|38329960|FG001|Double-Blinded Treatment Phase|Death|1|||
17178597|NCT02607930|38329961|FG002|Double-Blinded Treatment Phase|Death|0|||
17178598|NCT02607930|38329962|FG003|Double-Blinded Treatment Phase|Death|0|||
17178599|NCT02607930|38329959|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
17178600|NCT02607930|38329960|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
17178601|NCT02607930|38329961|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
17178602|NCT02607930|38329962|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
17178603|NCT02607930|38329959|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
17178604|NCT02607930|38329960|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
17178605|NCT02607930|38329961|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
17178606|NCT02607930|38329962|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
17178607|NCT02607930|38329959|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
17178608|NCT02607930|38329960|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
17178609|NCT02607930|38329961|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
17178610|NCT02607930|38329962|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
17178611|NCT02607930|38329959|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
17178612|NCT02607930|38329960|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
17178613|NCT02607930|38329961|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
17178614|NCT02607930|38329962|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
17178615|NCT02607930|38329959|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
17178616|NCT02607930|38329960|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
17178617|NCT02607930|38329961|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
17178618|NCT02607930|38329962|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
17178619|NCT02607930|38329959|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
17178620|NCT02607930|38329960|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
17178621|NCT02607930|38329961|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
17178622|NCT02607930|38329962|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
17178623|NCT02607930|38329959|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
17178624|NCT02607930|38329960|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
17178625|NCT02607930|38329961|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
17178626|NCT02607930|38329962|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
17178627|NCT02607930|38329959|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
17178628|NCT02607930|38329960|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
17178629|NCT02607930|38329961|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
17178630|NCT02607930|38329962|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
17178631|NCT02607930|38329959|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
17178632|NCT02607930|38329960|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
17178633|NCT02607930|38329961|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
17178634|NCT02607930|38329962|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
17178635|NCT02101034|38329977|FG000|Overall Study|Enrolled but did not start treatment|0|||
17178636|NCT02101034|38329978|FG001|Overall Study|Enrolled but did not start treatment|0|||
17178637|NCT02101034|38329979|FG002|Overall Study|Enrolled but did not start treatment|1|||
17178638|NCT02101034|38329980|FG003|Overall Study|Enrolled but did not start treatment|0|||
17178639|NCT02101034|38329981|FG004|Overall Study|Enrolled but did not start treatment|0|||
17178640|NCT02736188|38330016|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
17178641|NCT02736188|38330016|FG000|Overall Study|Adverse Event|1|||
17178642|NCT02736188|38330016|FG000|Overall Study|Withdrawal by Subject|1|||
17178643|NCT02736188|38330016|FG000|Overall Study|Other|6|||
17178644|NCT00154284|38330024|FG000|Overall Study|Adverse Event|6|||
17178645|NCT00154284|38330025|FG001|Overall Study|Adverse Event|9|||
17178646|NCT00154284|38330024|FG000|Overall Study|Abnormal laboratory value(s)|0|||
17178647|NCT00154284|38330025|FG001|Overall Study|Abnormal laboratory value(s)|1|||
17178648|NCT00154284|38330024|FG000|Overall Study|Lack of Efficacy|1|||
17178649|NCT00154284|38330025|FG001|Overall Study|Lack of Efficacy|2|||
17178650|NCT00154284|38330024|FG000|Overall Study|Protocol Violation|0|||
17178651|NCT00154284|38330025|FG001|Overall Study|Protocol Violation|1|||
17178652|NCT02735096|38330033|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
17178653|NCT00905346|38330046|FG000|Period 1|Withdrawal by Subject|1|||
17178654|NCT00905346|38330047|FG001|Period 1|Withdrawal by Subject|0|||
17178655|NCT01328444|38330060|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
17178656|NCT01328444|38330061|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
17178657|NCT01328444|38330062|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
17178658|NCT01328444|38330063|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
17178659|NCT01328444|38330064|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
17178660|NCT01328444|38330065|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
17178661|NCT01328444|38330060|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
17178662|NCT01328444|38330061|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
17178663|NCT01328444|38330062|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
17178664|NCT01328444|38330063|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
17178665|NCT01328444|38330064|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
17178666|NCT01328444|38330065|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
17178667|NCT01328444|38330060|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
17178668|NCT01328444|38330061|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
17178669|NCT01328444|38330062|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
17178670|NCT01328444|38330063|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
17178671|NCT01328444|38330064|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
17178672|NCT01328444|38330065|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
17178673|NCT01328444|38330060|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
17178674|NCT01328444|38330061|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
17178675|NCT01328444|38330062|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
17178676|NCT01328444|38330063|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
17178677|NCT01328444|38330064|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
17178678|NCT01328444|38330065|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
17178679|NCT01328444|38330060|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
17178680|NCT01328444|38330061|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
17178681|NCT01328444|38330062|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
17178682|NCT01328444|38330063|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
17178683|NCT01328444|38330064|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
17178684|NCT01328444|38330065|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
17178685|NCT01328444|38330060|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
17178686|NCT01328444|38330061|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
17178687|NCT01328444|38330062|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
17178688|NCT01328444|38330063|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
17178689|NCT01328444|38330064|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
17178690|NCT01328444|38330065|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
17178691|NCT01328444|38330060|FG000|Washout Period (14 Days)|Adverse Event|1|||
17178692|NCT01328444|38330061|FG001|Washout Period (14 Days)|Adverse Event|1|||
17178693|NCT01328444|38330062|FG002|Washout Period (14 Days)|Adverse Event|0|||
17178694|NCT01328444|38330063|FG003|Washout Period (14 Days)|Adverse Event|1|||
17178695|NCT01328444|38330064|FG004|Washout Period (14 Days)|Adverse Event|1|||
17178696|NCT01328444|38330065|FG005|Washout Period (14 Days)|Adverse Event|2|||
17178697|NCT01328444|38330060|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
17178698|NCT01328444|38330061|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
17178699|NCT01328444|38330062|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
17178700|NCT01328444|38330063|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
17178701|NCT01328444|38330064|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
17178702|NCT01328444|38330065|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
17178703|NCT01328444|38330060|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
17178704|NCT01328444|38330061|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
17178705|NCT01328444|38330062|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
17178706|NCT01328444|38330063|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
17178707|NCT01328444|38330064|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
17178708|NCT01328444|38330065|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
17178709|NCT01328444|38330060|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
17178710|NCT01328444|38330061|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
17178711|NCT01328444|38330062|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
17178712|NCT01328444|38330063|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
17178713|NCT01328444|38330064|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
17178714|NCT01328444|38330065|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
17178715|NCT01328444|38330060|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
17178716|NCT01328444|38330061|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
17178717|NCT01328444|38330062|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
17178718|NCT01328444|38330063|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
17178719|NCT01328444|38330064|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
17178720|NCT01328444|38330065|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
17178721|NCT01328444|38330060|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
17178722|NCT01328444|38330061|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
17178723|NCT01328444|38330062|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
17178724|NCT01328444|38330063|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
17178725|NCT01328444|38330064|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
17178726|NCT01328444|38330065|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
17178727|NCT01328444|38330060|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
17178728|NCT01328444|38330061|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
17178729|NCT01328444|38330062|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
17178730|NCT01328444|38330063|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
17178731|NCT01328444|38330064|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
17178732|NCT01328444|38330065|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
17178733|NCT01328444|38330060|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
17178734|NCT01328444|38330061|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
17178735|NCT01328444|38330062|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
17178736|NCT01328444|38330063|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
17178737|NCT01328444|38330064|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
17178738|NCT01328444|38330065|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
17178739|NCT01328444|38330060|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
17178740|NCT01328444|38330061|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
17178741|NCT01328444|38330062|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
17178742|NCT01328444|38330063|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
17178743|NCT01328444|38330064|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
17178744|NCT01328444|38330065|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
17178745|NCT00887250|38330082|FG000|Overall Study|Adverse Event|3|||
17178746|NCT00887250|38330083|FG001|Overall Study|Adverse Event|0|||
17178747|NCT00887250|38330084|FG002|Overall Study|Adverse Event|7|||
17178748|NCT00887250|38330082|FG000|Overall Study|Lack of Efficacy|9|||
17178749|NCT00887250|38330083|FG001|Overall Study|Lack of Efficacy|6|||
17178750|NCT00887250|38330084|FG002|Overall Study|Lack of Efficacy|1|||
17178751|NCT00887250|38330082|FG000|Overall Study|Lost to Follow-up|2|||
17178752|NCT00887250|38330083|FG001|Overall Study|Lost to Follow-up|3|||
17178753|NCT00887250|38330084|FG002|Overall Study|Lost to Follow-up|1|||
17178754|NCT00887250|38330082|FG000|Overall Study|Protocol Violation|2|||
17178755|NCT00887250|38330083|FG001|Overall Study|Protocol Violation|2|||
17178756|NCT00887250|38330084|FG002|Overall Study|Protocol Violation|1|||
17178757|NCT00887250|38330082|FG000|Overall Study|Withdrawal by Subject|2|||
17178758|NCT00887250|38330083|FG001|Overall Study|Withdrawal by Subject|1|||
17178759|NCT00887250|38330084|FG002|Overall Study|Withdrawal by Subject|2|||
17178760|NCT00887250|38330082|FG000|Overall Study|Patient uncooperative|0|||
17178761|NCT00887250|38330083|FG001|Overall Study|Patient uncooperative|0|||
17178762|NCT00887250|38330084|FG002|Overall Study|Patient uncooperative|1|||
17178763|NCT02599402|38330089|FG000|Overall Study|Disease progression|153|||
17178764|NCT02599402|38330089|FG000|Overall Study|Study drug toxicity|201|||
17178765|NCT02599402|38330089|FG000|Overall Study|Death|26|||
17178766|NCT02599402|38330089|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
17178767|NCT02599402|38330089|FG000|Overall Study|Participant request to discontinue study treatment|13|||
17178768|NCT02599402|38330089|FG000|Overall Study|Participant withdrew consent|5|||
17178769|NCT02599402|38330089|FG000|Overall Study|Lost to Follow-up|1|||
17178770|NCT02599402|38330089|FG000|Overall Study|Maximum Clinical Benefit|7|||
17178771|NCT02599402|38330089|FG000|Overall Study|Poor/non-compliance|1|||
17178772|NCT02599402|38330089|FG000|Overall Study|Pregnancy|1|||
17178773|NCT02599402|38330089|FG000|Overall Study|Participant no longer met study criteria|7|||
17178774|NCT02599402|38330089|FG000|Overall Study|Other Reasons|95|||
17178775|NCT02734862|38330129|FG000|Part A|Death|3|||
17178776|NCT02734862|38330130|FG001|Part A|Death|4|||
17178777|NCT02734862|38330131|FG002|Part A|Death|6|||
17178778|NCT02734862|38330129|FG000|Part A|Lost to Follow-up|2|||
17178779|NCT02734862|38330130|FG001|Part A|Lost to Follow-up|1|||
17178780|NCT02734862|38330131|FG002|Part A|Lost to Follow-up|1|||
17178781|NCT02734862|38330129|FG000|Part A|Withdrawal by Subject|1|||
17178782|NCT02734862|38330130|FG001|Part A|Withdrawal by Subject|1|||
17178783|NCT02734862|38330131|FG002|Part A|Withdrawal by Subject|2|||
17178784|NCT02734862|38330129|FG000|Part A|Physician Decision|2|||
17178785|NCT02734862|38330130|FG001|Part A|Physician Decision|0|||
17178786|NCT02734862|38330131|FG002|Part A|Physician Decision|1|||
17178787|NCT02734862|38330129|FG000|Part A|Adverse Event|2|||
17178788|NCT02734862|38330130|FG001|Part A|Adverse Event|0|||
17178789|NCT02734862|38330131|FG002|Part A|Adverse Event|1|||
17178790|NCT02734862|38330129|FG000|Part A|Noncompliance|1|||
17178791|NCT02734862|38330130|FG001|Part A|Noncompliance|1|||
17178792|NCT02734862|38330131|FG002|Part A|Noncompliance|0|||
17178793|NCT02734862|38330129|FG000|Part A|Other|1|||
17178794|NCT02734862|38330130|FG001|Part A|Other|1|||
17178795|NCT02734862|38330131|FG002|Part A|Other|3|||
17178796|NCT02734862|38330129|FG000|Part B|Death|8|||
17178797|NCT02734862|38330130|FG001|Part B|Death|3|||
17178798|NCT02734862|38330131|FG002|Part B|Death|5|||
17178799|NCT02734862|38330129|FG000|Part B|Lost to Follow-up|2|||
17178800|NCT02734862|38330130|FG001|Part B|Lost to Follow-up|2|||
17178801|NCT02734862|38330131|FG002|Part B|Lost to Follow-up|0|||
17178802|NCT02734862|38330129|FG000|Part B|Withdrawal by Subject|3|||
17178803|NCT02734862|38330130|FG001|Part B|Withdrawal by Subject|1|||
17178804|NCT02734862|38330131|FG002|Part B|Withdrawal by Subject|0|||
17178805|NCT02734862|38330129|FG000|Part B|Other|0|||
17178806|NCT02734862|38330130|FG001|Part B|Other|1|||
17178807|NCT02734862|38330131|FG002|Part B|Other|0|||
17178808|NCT00858702|38330142|FG000|Overall Study|Lack of Efficacy|1|||
17178809|NCT00858702|38330143|FG001|Overall Study|Lack of Efficacy|0|||
17178810|NCT00858702|38330142|FG000|Overall Study|Protocol Violation|1|||
17178811|NCT00858702|38330143|FG001|Overall Study|Protocol Violation|1|||
17178812|NCT00858702|38330142|FG000|Overall Study|Other|2|||
17178813|NCT00858702|38330143|FG001|Overall Study|Other|1|||
17178814|NCT00858702|38330142|FG000|Overall Study|Withdrawal by Subject|1|||
17178815|NCT00858702|38330143|FG001|Overall Study|Withdrawal by Subject|0|||
17178816|NCT02598934|38330151|FG000|Overall Study|Adverse Event|11|||
17178817|NCT02598934|38330152|FG001|Overall Study|Adverse Event|13|||
17178818|NCT02598934|38330151|FG000|Overall Study|Failure to Return|3|||
17178819|NCT02598934|38330152|FG001|Overall Study|Failure to Return|3|||
17178820|NCT02598934|38330151|FG000|Overall Study|Withdrawal by Subject|2|||
17178821|NCT02598934|38330152|FG001|Overall Study|Withdrawal by Subject|3|||
17178822|NCT02598934|38330151|FG000|Overall Study|Administrative|2|||
17178823|NCT02598934|38330152|FG001|Overall Study|Administrative|1|||
17178824|NCT02598934|38330151|FG000|Overall Study|Protocol Violation|1|||
17178825|NCT02598934|38330152|FG001|Overall Study|Protocol Violation|2|||
17178826|NCT02598622|38330160|FG000|Overall Study|Withdrawal by Subject|3|||
17178827|NCT02598622|38330161|FG001|Overall Study|Withdrawal by Subject|0|||
17178828|NCT02598622|38330160|FG000|Overall Study|Physician Decision|3|||
17178829|NCT02598622|38330161|FG001|Overall Study|Physician Decision|0|||
17178830|NCT00841698|38330169|FG000|First Intervention|Withdrawal by Subject|1|||
17178831|NCT00841698|38330170|FG001|First Intervention|Withdrawal by Subject|0|||
17178832|NCT00841542|38330176|FG000|Period 1|Adverse Event|1|||
17178833|NCT00841542|38330177|FG001|Period 1|Adverse Event|0|||
17178834|NCT00840216|38330199|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
17178835|NCT00840216|38330200|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
17178836|NCT00836706|38330210|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
17178837|NCT00836706|38330211|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
17178838|NCT00836472|38330217|FG000|Washout|Adverse Event|1|||
17178839|NCT00836472|38330218|FG001|Washout|Adverse Event|2|||
17178840|NCT00836472|38330217|FG000|Washout|Withdrawal by Subject|1|||
17178841|NCT00836472|38330218|FG001|Washout|Withdrawal by Subject|1|||
17178842|NCT02598388|38330234|FG000|Overall Study|Lost to Follow-up|1|||
17178843|NCT02598388|38330235|FG001|Overall Study|Lost to Follow-up|0|||
17178844|NCT02598388|38330236|FG002|Overall Study|Lost to Follow-up|1|||
17178845|NCT02598388|38330237|FG003|Overall Study|Lost to Follow-up|0|||
17178846|NCT02598388|38330238|FG004|Overall Study|Lost to Follow-up|5|||
17178847|NCT02598388|38330239|FG005|Overall Study|Lost to Follow-up|1|||
17178848|NCT02598388|38330240|FG006|Overall Study|Lost to Follow-up|2|||
17178849|NCT02598388|38330241|FG007|Overall Study|Lost to Follow-up|1|||
17178850|NCT02598388|38330242|FG008|Overall Study|Lost to Follow-up|0|||
17178851|NCT02598388|38330243|FG009|Overall Study|Lost to Follow-up|0|||
17178852|NCT02598388|38330244|FG010|Overall Study|Lost to Follow-up|1|||
17178853|NCT02598388|38330245|FG011|Overall Study|Lost to Follow-up|0|||
17178854|NCT02598388|38330234|FG000|Overall Study|Withdrawal by Subject|0|||
17178855|NCT02598388|38330235|FG001|Overall Study|Withdrawal by Subject|0|||
17178856|NCT02598388|38330236|FG002|Overall Study|Withdrawal by Subject|0|||
17178857|NCT02598388|38330237|FG003|Overall Study|Withdrawal by Subject|0|||
17178858|NCT02598388|38330238|FG004|Overall Study|Withdrawal by Subject|2|||
17178859|NCT02598388|38330239|FG005|Overall Study|Withdrawal by Subject|0|||
17178860|NCT02598388|38330240|FG006|Overall Study|Withdrawal by Subject|2|||
17178861|NCT02598388|38330241|FG007|Overall Study|Withdrawal by Subject|0|||
17178862|NCT02598388|38330242|FG008|Overall Study|Withdrawal by Subject|0|||
17178863|NCT02598388|38330243|FG009|Overall Study|Withdrawal by Subject|1|||
17178864|NCT02598388|38330244|FG010|Overall Study|Withdrawal by Subject|0|||
17178865|NCT02598388|38330245|FG011|Overall Study|Withdrawal by Subject|0|||
17178866|NCT02598388|38330234|FG000|Overall Study|Other|0|||
17178867|NCT02598388|38330235|FG001|Overall Study|Other|0|||
17178868|NCT02598388|38330236|FG002|Overall Study|Other|1|||
17178869|NCT02598388|38330237|FG003|Overall Study|Other|0|||
17178870|NCT02598388|38330238|FG004|Overall Study|Other|3|||
17178871|NCT02598388|38330239|FG005|Overall Study|Other|0|||
17178872|NCT02598388|38330240|FG006|Overall Study|Other|1|||
17178873|NCT02598388|38330241|FG007|Overall Study|Other|0|||
17178874|NCT02598388|38330242|FG008|Overall Study|Other|0|||
17178875|NCT02598388|38330243|FG009|Overall Study|Other|0|||
17178876|NCT02598388|38330244|FG010|Overall Study|Other|0|||
17178877|NCT02598388|38330245|FG011|Overall Study|Other|0|||
17178878|NCT00835692|38330285|FG000|First Intervention|Withdrawal by Subject|1|||
17178879|NCT00835692|38330286|FG001|First Intervention|Withdrawal by Subject|0|||
17178880|NCT00835536|38330299|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
17178881|NCT00835536|38330300|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
17178882|NCT03865316|38330304|FG000|Overall Study|Procedure Cancelled|4|||
17178883|NCT03865316|38330304|FG000|Overall Study|Equipment failure|4|||
17178884|NCT02598076|38330310|FG000|Overall Study|Lost to Follow-up|2|||
17178885|NCT02598076|38330311|FG001|Overall Study|Lost to Follow-up|3|||
17178886|NCT02602288|38330319|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
17178887|NCT02602288|38330320|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
17178888|NCT02602288|38330319|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
17178889|NCT02602288|38330320|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
17178890|NCT02602288|38330319|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
17178891|NCT02602288|38330320|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
17178892|NCT02602288|38330319|FG000|12 Month Follow-up|Lost to Follow-up|0|||
17178893|NCT02602288|38330320|FG001|12 Month Follow-up|Lost to Follow-up|4|||
17178894|NCT02602288|38330319|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
17178895|NCT02602288|38330320|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
17178896|NCT02601820|38330326|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
17178897|NCT02601820|38330326|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
17178898|NCT02601820|38330326|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
17178899|NCT02601820|38330326|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
17178900|NCT02807454|38330345|FG000|Overall Study|Adverse Event|1|||
17178901|NCT02807454|38330346|FG001|Overall Study|Adverse Event|0|||
17178902|NCT02807454|38330345|FG000|Overall Study|Withdrawal by Subject|0|||
17178903|NCT02807454|38330346|FG001|Overall Study|Withdrawal by Subject|1|||
17178904|NCT02807454|38330345|FG000|Overall Study|Progressive Disease|30|||
17178905|NCT02807454|38330346|FG001|Overall Study|Progressive Disease|3|||
17178906|NCT02807454|38330345|FG000|Overall Study|Other Reasons|1|||
17178907|NCT02807454|38330346|FG001|Overall Study|Other Reasons|1|||
17178908|NCT02597920|38330361|FG000|Overall Study|Worsening of other pre-existing disease|0|||
17178909|NCT02597920|38330362|FG001|Overall Study|Worsening of other pre-existing disease|1|||
17178910|NCT02597920|38330363|FG002|Overall Study|Worsening of other pre-existing disease|0|||
17178911|NCT02597920|38330361|FG000|Overall Study|Other adverse event|20|||
17178912|NCT02597920|38330362|FG001|Overall Study|Other adverse event|30|||
17178913|NCT02597920|38330363|FG002|Overall Study|Other adverse event|0|||
17178914|NCT02597920|38330361|FG000|Overall Study|Lost to Follow-up|7|||
17178915|NCT02597920|38330362|FG001|Overall Study|Lost to Follow-up|9|||
17178916|NCT02597920|38330363|FG002|Overall Study|Lost to Follow-up|0|||
17178917|NCT02597920|38330361|FG000|Overall Study|Refuse to continue in the study|3|||
17178918|NCT02597920|38330362|FG001|Overall Study|Refuse to continue in the study|13|||
17178919|NCT02597920|38330363|FG002|Overall Study|Refuse to continue in the study|1|||
17178920|NCT02597920|38330361|FG000|Overall Study|Other than specified|10|||
17178921|NCT02597920|38330362|FG001|Overall Study|Other than specified|31|||
17178922|NCT02597920|38330363|FG002|Overall Study|Other than specified|5|||
17178923|NCT02597920|38330361|FG000|Overall Study|Other|1|||
17178924|NCT02597920|38330362|FG001|Overall Study|Other|0|||
17178925|NCT02597920|38330363|FG002|Overall Study|Other|0|||
17178926|NCT01235234|38330383|FG000|Overall Study|Adverse Event|2|||
17178927|NCT01235234|38330384|FG001|Overall Study|Adverse Event|2|||
17178928|NCT01235234|38330385|FG002|Overall Study|Adverse Event|1|||
17178929|NCT02597452|38330400|FG000|Overall Study|testing incomplete|30|||
17178930|NCT02597062|38330404|FG000|Overall Study|Ineligible|1|||
17178931|NCT00834756|38330410|FG000|First Intervention|Adverse Event|1|||
17178932|NCT00834756|38330411|FG001|First Intervention|Adverse Event|0|||
17178933|NCT00834756|38330410|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
17178934|NCT00834756|38330411|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
17178935|NCT00828854|38330415|FG000|Overall Study|Disease Progression|17|||
17178936|NCT00828854|38330415|FG000|Overall Study|Adverse Event|9|||
17178937|NCT00828854|38330415|FG000|Overall Study|Reason not Specified|1|||
17178938|NCT00834522|38330421|FG000|Washout|Adverse Event|1|||
17178939|NCT00834522|38330422|FG001|Washout|Adverse Event|0|||
17178940|NCT00834522|38330421|FG000|Washout|Withdrawal by Subject|2|||
17178941|NCT00834522|38330422|FG001|Washout|Withdrawal by Subject|1|||
17178942|NCT00834444|38330428|FG000|First Intervention|Adverse Event|1|||
17178943|NCT00834444|38330429|FG001|First Intervention|Adverse Event|0|||
17178944|NCT00834444|38330428|FG000|First Intervention|Intolerance to Venopuncture|0|||
17089019|NCT00295620|38229172|FG001|Overall Study|Withdrawal by Subject|50|||
17178945|NCT00834444|38330429|FG001|First Intervention|Intolerance to Venopuncture|1|||
17178946|NCT00834444|38330428|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
17178947|NCT00834444|38330429|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
17178948|NCT00834444|38330428|FG000|Second Intervention|Adverse Event|1|||
17178949|NCT00834444|38330429|FG001|Second Intervention|Adverse Event|0|||
17178950|NCT02605954|38330456|FG000|Overall Study|Adverse Event|5|||
17178951|NCT02605954|38330457|FG001|Overall Study|Adverse Event|1|||
17178952|NCT02605954|38330456|FG000|Overall Study|Investigator's Discretion|1|||
17178953|NCT02605954|38330457|FG001|Overall Study|Investigator's Discretion|0|||
17178954|NCT02605954|38330456|FG000|Overall Study|Non-Compliance with Study Drug|1|||
17178955|NCT02605954|38330457|FG001|Overall Study|Non-Compliance with Study Drug|0|||
17178956|NCT02605954|38330456|FG000|Overall Study|Withdrew Consent|2|||
17178957|NCT02605954|38330457|FG001|Overall Study|Withdrew Consent|2|||
17178958|NCT02605954|38330456|FG000|Overall Study|Lost to Follow-up|3|||
17178959|NCT02605954|38330457|FG001|Overall Study|Lost to Follow-up|0|||
17178960|NCT02605954|38330456|FG000|Overall Study|Randomized but not treated|0|||
17178961|NCT02605954|38330457|FG001|Overall Study|Randomized but not treated|1|||
17178962|NCT00724698|38330466|FG000|Overall Study|Adverse Event|9|||
17178963|NCT00724698|38330466|FG000|Overall Study|Failure of Therapy|4|||
17178964|NCT00724698|38330466|FG000|Overall Study|Poor Compliance|16|||
17178965|NCT00724698|38330466|FG000|Overall Study|Lost to Follow-up|36|||
17178966|NCT00724698|38330466|FG000|Overall Study|No Info|25|||
17178967|NCT00829998|38330471|FG000|Washout|Adverse Event|0|||
17178968|NCT00829998|38330472|FG001|Washout|Adverse Event|1|||
17178969|NCT00829764|38330483|FG000|First Intervention|Adverse Event|1|||
17178970|NCT00829764|38330484|FG001|First Intervention|Adverse Event|0|||
17178971|NCT00829764|38330483|FG000|First Intervention|Withdrawal by Subject|1|||
17178972|NCT00829764|38330484|FG001|First Intervention|Withdrawal by Subject|1|||
17178973|NCT00829530|38330506|FG000|First Intervention|Adverse Event|0|||
17178974|NCT00829530|38330507|FG001|First Intervention|Adverse Event|1|||
17178975|NCT00829530|38330506|FG000|First Intervention|Intolerance to Venopuncture|0|||
17178976|NCT00829530|38330507|FG001|First Intervention|Intolerance to Venopuncture|1|||
17178977|NCT00829530|38330506|FG000|Second Intervention|Intolerance to Venopuncture|1|||
17178978|NCT00829530|38330507|FG001|Second Intervention|Intolerance to Venopuncture|0|||
17178979|NCT01377194|38330514|FG000|Overall Study|Adverse Event|3|||
17178980|NCT01377194|38330515|FG001|Overall Study|Adverse Event|12|||
17178981|NCT01377194|38330516|FG002|Overall Study|Adverse Event|19|||
17178982|NCT01377194|38330514|FG000|Overall Study|Lack of Efficacy|3|||
17178983|NCT01377194|38330515|FG001|Overall Study|Lack of Efficacy|3|||
17178984|NCT01377194|38330516|FG002|Overall Study|Lack of Efficacy|3|||
17178985|NCT01377194|38330514|FG000|Overall Study|Protocol Violation|4|||
17178986|NCT01377194|38330515|FG001|Overall Study|Protocol Violation|10|||
17178987|NCT01377194|38330516|FG002|Overall Study|Protocol Violation|6|||
17178988|NCT01377194|38330514|FG000|Overall Study|Withdrawal by Subject|8|||
17178989|NCT01377194|38330515|FG001|Overall Study|Withdrawal by Subject|10|||
17178990|NCT01377194|38330516|FG002|Overall Study|Withdrawal by Subject|7|||
17178991|NCT01377194|38330514|FG000|Overall Study|Lost to Follow-up|14|||
17178992|NCT01377194|38330515|FG001|Overall Study|Lost to Follow-up|8|||
17178993|NCT01377194|38330516|FG002|Overall Study|Lost to Follow-up|11|||
17178994|NCT00829452|38330529|FG000|First Intervention|Withdrawal by Subject|0|||
17178995|NCT00829452|38330530|FG001|First Intervention|Withdrawal by Subject|1|||
17178996|NCT00829452|38330529|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
17178997|NCT00829452|38330530|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
17178998|NCT00829452|38330529|FG000|Second Intervention|Physician Decision|0|||
17178999|NCT00829452|38330530|FG001|Second Intervention|Physician Decision|1|||
17179000|NCT04600076|38330534|FG000|Overall Study|Lost to Follow-up|3|||
17179001|NCT02064387|38330550|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179002|NCT02064387|38330551|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179003|NCT02064387|38330552|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179004|NCT02064387|38330553|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179005|NCT02064387|38330554|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179006|NCT02064387|38330555|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179007|NCT02064387|38330556|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179008|NCT02064387|38330557|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
17179009|NCT02064387|38330558|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179010|NCT02064387|38330559|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
17179011|NCT02064387|38330560|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179012|NCT02064387|38330561|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
17179013|NCT02064387|38330550|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179014|NCT02064387|38330551|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179015|NCT02064387|38330552|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179016|NCT02064387|38330553|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179017|NCT02064387|38330554|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179018|NCT02064387|38330555|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179019|NCT02064387|38330556|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179020|NCT02064387|38330557|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
17179021|NCT02064387|38330558|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179022|NCT02064387|38330559|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179023|NCT02064387|38330560|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179024|NCT02064387|38330561|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
17179025|NCT02064387|38330550|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179026|NCT02064387|38330551|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179027|NCT02064387|38330552|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179028|NCT02064387|38330553|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179029|NCT02064387|38330554|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179030|NCT02064387|38330555|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179031|NCT02064387|38330556|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179032|NCT02064387|38330557|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179033|NCT02064387|38330558|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
17179034|NCT02064387|38330559|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179035|NCT02064387|38330560|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179036|NCT02064387|38330561|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
17179037|NCT02064387|38330550|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
17179038|NCT02064387|38330551|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
17179039|NCT02064387|38330552|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
17179040|NCT02064387|38330553|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
17179041|NCT02064387|38330554|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
17179042|NCT02064387|38330555|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
17179043|NCT02064387|38330556|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
17179044|NCT02064387|38330557|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
17179045|NCT02064387|38330558|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
17179046|NCT02064387|38330559|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
17179047|NCT02064387|38330560|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
17179048|NCT02064387|38330561|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
17179049|NCT02064387|38330550|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179050|NCT02064387|38330551|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179051|NCT02064387|38330552|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179052|NCT02064387|38330553|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179053|NCT02064387|38330554|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179054|NCT02064387|38330555|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179055|NCT02064387|38330556|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179056|NCT02064387|38330557|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179057|NCT02064387|38330558|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179058|NCT02064387|38330559|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179059|NCT02064387|38330560|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
17179060|NCT02064387|38330561|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
17179061|NCT01328366|38330600|FG000|Overall Study|Death|1|||
17179062|NCT01328366|38330600|FG000|Overall Study|Withdrawal by Subject|2|||
17179063|NCT01328366|38330600|FG000|Overall Study|Lost to Follow-up|7|||
17179064|NCT03256344|38330606|FG000|Overall Study|Death|6|||
17179065|NCT03256344|38330607|FG001|Overall Study|Death|22|||
17179066|NCT03256344|38330606|FG000|Overall Study|Withdrawal by Subject|3|||
17179067|NCT03256344|38330607|FG001|Overall Study|Withdrawal by Subject|3|||
17179068|NCT03256344|38330606|FG000|Overall Study|Sponsor Decision|1|||
17179069|NCT03256344|38330607|FG001|Overall Study|Sponsor Decision|0|||
17179070|NCT01370499|38330615|FG000|Overall Study|Adverse Event|38|||
17179071|NCT01370499|38330616|FG001|Overall Study|Adverse Event|12|||
17179072|NCT01370499|38330615|FG000|Overall Study|Lack of Efficacy|4|||
17179073|NCT01370499|38330616|FG001|Overall Study|Lack of Efficacy|2|||
17179074|NCT01370499|38330615|FG000|Overall Study|Lost to Follow-up|2|||
17179075|NCT01370499|38330616|FG001|Overall Study|Lost to Follow-up|1|||
17179076|NCT01370499|38330615|FG000|Overall Study|Physician Decision|3|||
17179077|NCT01370499|38330616|FG001|Overall Study|Physician Decision|3|||
17179078|NCT01370499|38330615|FG000|Overall Study|Protocol Violation|5|||
17179079|NCT01370499|38330616|FG001|Overall Study|Protocol Violation|4|||
17179080|NCT01370499|38330615|FG000|Overall Study|Withdrawal by Subject|18|||
17179081|NCT01370499|38330616|FG001|Overall Study|Withdrawal by Subject|7|||
17179082|NCT01370499|38330615|FG000|Overall Study|Sponsor Decision|41|||
17179083|NCT01370499|38330616|FG001|Overall Study|Sponsor Decision|15|||
17179084|NCT01370265|38330624|FG000|First Intervention|Adverse Event|1|||
17179085|NCT01370265|38330625|FG001|First Intervention|Adverse Event|1|||
17089020|NCT00295620|38229171|FG000|Overall Study|Death|206|||
17089021|NCT00295620|38229172|FG001|Overall Study|Death|207|||
17089022|NCT00295620|38229171|FG000|Overall Study|Other reasons|10|||
17089023|NCT00295620|38229172|FG001|Overall Study|Other reasons|9|||
17089024|NCT00295620|38229171|FG000|Overall Study|Discontinuation by sponsor|580|||
17089025|NCT00295620|38229172|FG001|Overall Study|Discontinuation by sponsor|593|||
17089026|NCT00295620|38229171|FG000|Overall Study|Protocol Violation|30|||
17089027|NCT00295620|38229172|FG001|Overall Study|Protocol Violation|32|||
17089028|NCT00310440|38229180|FG000|Overall Study|Lost to Follow-up|17|||
17179086|NCT01359592|38330638|FG000|Initial Registration|Adverse Event|1|||
17179087|NCT01359592|38330639|FG001|Initial Registration|Adverse Event|0|||
17179088|NCT01359592|38330640|FG002|Initial Registration|Adverse Event|0|||
17179089|NCT01359592|38330641|FG003|Initial Registration|Adverse Event|0|||
17179090|NCT01359592|38330638|FG000|Initial Registration|Death|1|||
17179091|NCT01359592|38330639|FG001|Initial Registration|Death|0|||
17179092|NCT01359592|38330640|FG002|Initial Registration|Death|0|||
17179093|NCT01359592|38330641|FG003|Initial Registration|Death|0|||
17179094|NCT01359592|38330638|FG000|Initial Registration|Other reason not protocol specified|1|||
17179095|NCT01359592|38330639|FG001|Initial Registration|Other reason not protocol specified|0|||
17179096|NCT01359592|38330640|FG002|Initial Registration|Other reason not protocol specified|0|||
17179097|NCT01359592|38330641|FG003|Initial Registration|Other reason not protocol specified|0|||
17179098|NCT01359592|38330638|FG000|Initial Registration|Ineligible|26|||
17179099|NCT01359592|38330639|FG001|Initial Registration|Ineligible|0|||
17179100|NCT01359592|38330640|FG002|Initial Registration|Ineligible|0|||
17179101|NCT01359592|38330641|FG003|Initial Registration|Ineligible|0|||
17179102|NCT01359592|38330638|FG000|PET-Directed Therapy|Adverse Event|0|||
17179103|NCT01359592|38330639|FG001|PET-Directed Therapy|Adverse Event|0|||
17179104|NCT01359592|38330640|FG002|PET-Directed Therapy|Adverse Event|1|||
17179105|NCT01359592|38330641|FG003|PET-Directed Therapy|Adverse Event|0|||
17179106|NCT01359592|38330638|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
17179107|NCT01359592|38330639|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
17179108|NCT01359592|38330640|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
17179109|NCT01359592|38330641|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
17179110|NCT01359592|38330638|FG000|PET-Directed Therapy|Ineligible|0|||
17179111|NCT01359592|38330639|FG001|PET-Directed Therapy|Ineligible|0|||
17179112|NCT01359592|38330640|FG002|PET-Directed Therapy|Ineligible|24|||
17179113|NCT01359592|38330641|FG003|PET-Directed Therapy|Ineligible|0|||
17179114|NCT02792829|38330664|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
17179115|NCT02792829|38330665|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
17179116|NCT02792829|38330666|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
17179117|NCT02792829|38330667|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
17179118|NCT02792829|38330668|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
17179119|NCT02792829|38330669|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
17179120|NCT02792829|38330670|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
17179121|NCT02792829|38330671|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
17179122|NCT02792829|38330664|FG000|Treatment Period 2|Adverse Event|0|||
17179123|NCT02792829|38330665|FG001|Treatment Period 2|Adverse Event|0|||
17179124|NCT02792829|38330666|FG002|Treatment Period 2|Adverse Event|0|||
17179125|NCT02792829|38330667|FG003|Treatment Period 2|Adverse Event|0|||
17179126|NCT02792829|38330668|FG004|Treatment Period 2|Adverse Event|1|||
17179127|NCT02792829|38330669|FG005|Treatment Period 2|Adverse Event|0|||
17179128|NCT02792829|38330670|FG006|Treatment Period 2|Adverse Event|1|||
17179129|NCT02792829|38330671|FG007|Treatment Period 2|Adverse Event|1|||
17179130|NCT02792829|38330664|FG000|Treatment Period 2|Use of proscribed medications|0|||
17179131|NCT02792829|38330665|FG001|Treatment Period 2|Use of proscribed medications|0|||
17179132|NCT02792829|38330666|FG002|Treatment Period 2|Use of proscribed medications|0|||
17179133|NCT02792829|38330667|FG003|Treatment Period 2|Use of proscribed medications|0|||
17179134|NCT02792829|38330668|FG004|Treatment Period 2|Use of proscribed medications|0|||
17179135|NCT02792829|38330669|FG005|Treatment Period 2|Use of proscribed medications|0|||
17179136|NCT02792829|38330670|FG006|Treatment Period 2|Use of proscribed medications|0|||
17179137|NCT02792829|38330671|FG007|Treatment Period 2|Use of proscribed medications|1|||
17179138|NCT02867592|38330703|FG000|Overall Study|Adverse Event|3|||
17179139|NCT02867592|38330704|FG001|Overall Study|Adverse Event|0|||
17179140|NCT02867592|38330705|FG002|Overall Study|Adverse Event|2|||
17179141|NCT02867592|38330706|FG003|Overall Study|Adverse Event|1|||
17179142|NCT02867592|38330707|FG004|Overall Study|Adverse Event|1|||
17179143|NCT02867592|38330708|FG005|Overall Study|Adverse Event|5|||
17179144|NCT02867592|38330703|FG000|Overall Study|Death|0|||
17179145|NCT02867592|38330704|FG001|Overall Study|Death|0|||
17179146|NCT02867592|38330705|FG002|Overall Study|Death|0|||
17179147|NCT02867592|38330706|FG003|Overall Study|Death|1|||
17179148|NCT02867592|38330707|FG004|Overall Study|Death|0|||
17089029|NCT00310440|38229181|FG001|Overall Study|Lost to Follow-up|8|||
17089030|NCT00310440|38229180|FG000|Overall Study|Withdrawal by Subject|2|||
17089031|NCT00310440|38229181|FG001|Overall Study|Withdrawal by Subject|1|||
17089032|NCT00310440|38229180|FG000|Overall Study|Missed 12 Month Visit|7|||
17089033|NCT00310440|38229181|FG001|Overall Study|Missed 12 Month Visit|4|||
17089034|NCT00304356|38229187|FG000|Nitazoxanide|Physician Decision|5|||
17089035|NCT00304356|38229187|FG000|Nitazoxanide|Physician Decision|1|||
17089036|NCT00304356|38229187|FG000|Nitazoxanide|number is 0|1|||
17089037|NCT00304356|38229187|FG000|Nitazoxanide|Physician Decision|1|||
17089038|NCT00304356|38229187|FG000|Nitazoxanide|Physician Decision|1|||
17089039|NCT00304356|38229187|FG000|Nitazoxanide|Physician Decision|1|||
17089040|NCT00321620|38229193|FG000|Overall Study|Death|269|||
17179149|NCT02867592|38330708|FG005|Overall Study|Death|1|||
17179150|NCT02867592|38330703|FG000|Overall Study|Lack of Efficacy|8|||
17179151|NCT02867592|38330704|FG001|Overall Study|Lack of Efficacy|10|||
17179152|NCT02867592|38330705|FG002|Overall Study|Lack of Efficacy|8|||
17179153|NCT02867592|38330706|FG003|Overall Study|Lack of Efficacy|8|||
17179154|NCT02867592|38330707|FG004|Overall Study|Lack of Efficacy|12|||
17179155|NCT02867592|38330708|FG005|Overall Study|Lack of Efficacy|17|||
17179156|NCT02867592|38330703|FG000|Overall Study|Physician Decision|1|||
17179157|NCT02867592|38330704|FG001|Overall Study|Physician Decision|2|||
17179158|NCT02867592|38330705|FG002|Overall Study|Physician Decision|2|||
17179159|NCT02867592|38330706|FG003|Overall Study|Physician Decision|0|||
17179160|NCT02867592|38330707|FG004|Overall Study|Physician Decision|5|||
17179161|NCT02867592|38330708|FG005|Overall Study|Physician Decision|1|||
17179162|NCT02867592|38330703|FG000|Overall Study|Protocol Violation|0|||
17179163|NCT02867592|38330704|FG001|Overall Study|Protocol Violation|0|||
17179164|NCT02867592|38330705|FG002|Overall Study|Protocol Violation|0|||
17179165|NCT02867592|38330706|FG003|Overall Study|Protocol Violation|0|||
17179166|NCT02867592|38330707|FG004|Overall Study|Protocol Violation|1|||
17089041|NCT00321620|38229194|FG001|Overall Study|Death|294|||
17089042|NCT00321620|38229193|FG000|Overall Study|Withdrawal by Subject|164|||
17089043|NCT00321620|38229194|FG001|Overall Study|Withdrawal by Subject|147|||
17089044|NCT00321620|38229193|FG000|Overall Study|Disease progression|113|||
17089045|NCT00321620|38229194|FG001|Overall Study|Disease progression|117|||
17089046|NCT00321620|38229193|FG000|Overall Study|Adverse Event|43|||
17089047|NCT00321620|38229194|FG001|Overall Study|Adverse Event|56|||
17089048|NCT00321620|38229193|FG000|Overall Study|Lost to Follow-up|13|||
17089049|NCT00321620|38229194|FG001|Overall Study|Lost to Follow-up|9|||
17089050|NCT00321620|38229193|FG000|Overall Study|Physician Decision|4|||
17089051|NCT00321620|38229194|FG001|Overall Study|Physician Decision|1|||
17089052|NCT00321620|38229193|FG000|Overall Study|Noncompliance|14|||
17089053|NCT00321620|38229194|FG001|Overall Study|Noncompliance|7|||
17089054|NCT00321620|38229193|FG000|Overall Study|Protocol deviation|4|||
17089055|NCT00321620|38229194|FG001|Overall Study|Protocol deviation|3|||
17089056|NCT00321620|38229193|FG000|Overall Study|Ineligibility determined|2|||
17089057|NCT00321620|38229194|FG001|Overall Study|Ineligibility determined|3|||
17089058|NCT00321620|38229193|FG000|Overall Study|Participant request|75|||
17089059|NCT00321620|38229194|FG001|Overall Study|Participant request|52|||
17089060|NCT00321620|38229193|FG000|Overall Study|Other|42|||
17089061|NCT00321620|38229194|FG001|Overall Study|Other|33|||
17089062|NCT00304278|38229200|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
17089063|NCT00304278|38229200|FG000|Overall Study|PT had medical condition preventing TX|1|||
17089064|NCT00291018|38229207|FG000|Overall Study|Not Consented or Declined PAS|12|||
17089065|NCT00291018|38229208|FG001|Overall Study|Not Consented or Declined PAS|15|||
17089066|NCT00291018|38229209|FG002|Overall Study|Not Consented or Declined PAS|15|||
17089067|NCT00291018|38229207|FG000|Overall Study|Death|3|||
17089068|NCT00291018|38229208|FG001|Overall Study|Death|3|||
17089069|NCT00291018|38229209|FG002|Overall Study|Death|4|||
17089070|NCT00291018|38229207|FG000|Overall Study|Withdrawal by Subject|2|||
17089071|NCT00291018|38229208|FG001|Overall Study|Withdrawal by Subject|8|||
17089072|NCT00291018|38229209|FG002|Overall Study|Withdrawal by Subject|1|||
17089073|NCT00291018|38229207|FG000|Overall Study|Failures|5|||
17089074|NCT00291018|38229208|FG001|Overall Study|Failures|12|||
17089075|NCT00291018|38229209|FG002|Overall Study|Failures|5|||
17089076|NCT00291018|38229207|FG000|Overall Study|Lost to Follow-up|3|||
17089077|NCT00291018|38229208|FG001|Overall Study|Lost to Follow-up|4|||
17089078|NCT00291018|38229209|FG002|Overall Study|Lost to Follow-up|18|||
17089079|NCT00320606|38229220|FG000|Overall Study|Adverse Event|1|||
17089080|NCT00320606|38229220|FG000|Overall Study|Protocol Violation|1|||
17089081|NCT00320606|38229220|FG000|Overall Study|Withdrawal by Subject|1|||
17089082|NCT00307736|38229225|FG000|Overall Study|Adverse Event|0|||
17089083|NCT00307736|38229226|FG001|Overall Study|Adverse Event|0|||
17089084|NCT00307736|38229227|FG002|Overall Study|Adverse Event|1|||
17179167|NCT02867592|38330708|FG005|Overall Study|Protocol Violation|1|||
17179168|NCT02867592|38330703|FG000|Overall Study|Withdrawal by Subject|0|||
17179169|NCT02867592|38330704|FG001|Overall Study|Withdrawal by Subject|1|||
17179170|NCT02867592|38330705|FG002|Overall Study|Withdrawal by Subject|0|||
17179171|NCT02867592|38330706|FG003|Overall Study|Withdrawal by Subject|1|||
17179172|NCT02867592|38330707|FG004|Overall Study|Withdrawal by Subject|3|||
17179173|NCT02867592|38330708|FG005|Overall Study|Withdrawal by Subject|3|||
17179174|NCT02867592|38330703|FG000|Overall Study|Ineligible|1|||
17179175|NCT02867592|38330704|FG001|Overall Study|Ineligible|1|||
17179176|NCT02867592|38330705|FG002|Overall Study|Ineligible|0|||
17179177|NCT02867592|38330706|FG003|Overall Study|Ineligible|0|||
17179178|NCT02867592|38330707|FG004|Overall Study|Ineligible|2|||
17179179|NCT02867592|38330708|FG005|Overall Study|Ineligible|0|||
17089085|NCT00307736|38229228|FG003|Overall Study|Adverse Event|3|||
17089086|NCT00307736|38229225|FG000|Overall Study|Withdrawal by Subject|0|||
17179180|NCT02867592|38330703|FG000|Overall Study|No Treatment|1|||
17179181|NCT02867592|38330704|FG001|Overall Study|No Treatment|0|||
17179182|NCT02867592|38330705|FG002|Overall Study|No Treatment|0|||
17179183|NCT02867592|38330706|FG003|Overall Study|No Treatment|0|||
17179184|NCT02867592|38330707|FG004|Overall Study|No Treatment|0|||
17179185|NCT02867592|38330708|FG005|Overall Study|No Treatment|0|||
17179186|NCT02867592|38330703|FG000|Overall Study|Still on Therapy|0|||
17179187|NCT02867592|38330704|FG001|Overall Study|Still on Therapy|0|||
17179188|NCT02867592|38330705|FG002|Overall Study|Still on Therapy|0|||
17179189|NCT02867592|38330706|FG003|Overall Study|Still on Therapy|0|||
17179190|NCT02867592|38330707|FG004|Overall Study|Still on Therapy|1|||
17179191|NCT02867592|38330708|FG005|Overall Study|Still on Therapy|0|||
17179192|NCT02867592|38330703|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
17179193|NCT02867592|38330704|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
17179194|NCT02867592|38330705|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
17179195|NCT02867592|38330706|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
17179196|NCT02867592|38330707|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
17179197|NCT02867592|38330708|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
17179198|NCT02867592|38330703|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
17179199|NCT02867592|38330704|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
17179200|NCT02867592|38330705|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
17179201|NCT02867592|38330706|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
17179202|NCT02867592|38330707|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
17179203|NCT02867592|38330708|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
17179204|NCT00676494|38330724|FG000|Overall Study|Missed Visit|8|||
17179205|NCT00676494|38330724|FG000|Overall Study|Withdrawal by Subject|6|||
17179206|NCT02605642|38330729|FG000|Overall Study|Other|11|||
17179207|NCT02605642|38330730|FG001|Overall Study|Other|1|||
17179208|NCT02605642|38330729|FG000|Overall Study|Participant non-compliance|2|||
17179209|NCT02605642|38330730|FG001|Overall Study|Participant non-compliance|4|||
17179210|NCT02605642|38330729|FG000|Overall Study|Physician Decision|10|||
17179211|NCT02605642|38330730|FG001|Overall Study|Physician Decision|0|||
17179212|NCT02605642|38330729|FG000|Overall Study|Lost to Follow-up|12|||
17179213|NCT02605642|38330730|FG001|Overall Study|Lost to Follow-up|1|||
17179214|NCT02605642|38330729|FG000|Overall Study|Adverse Event|14|||
17179215|NCT02605642|38330730|FG001|Overall Study|Adverse Event|2|||
17179216|NCT02605642|38330729|FG000|Overall Study|Withdrawal by Subject|23|||
17179217|NCT02605642|38330730|FG001|Overall Study|Withdrawal by Subject|2|||
17179218|NCT02605642|38330729|FG000|Overall Study|Lack of response|24|||
17179219|NCT02605642|38330730|FG001|Overall Study|Lack of response|11|||
17179220|NCT02253810|38330738|FG000|Overall Study|Withdrawal by Subject|2|||
17179221|NCT02253810|38330739|FG001|Overall Study|Withdrawal by Subject|1|||
17179222|NCT02253810|38330738|FG000|Overall Study|Unknown concomitant procedure|3|||
17179223|NCT02253810|38330739|FG001|Overall Study|Unknown concomitant procedure|2|||
17179224|NCT03915470|38330760|FG000|Overall Study|Death|3|||
17179225|NCT03915470|38330761|FG001|Overall Study|Death|1|||
17179226|NCT03915470|38330760|FG000|Overall Study|Adverse Event|1|||
17179227|NCT03915470|38330761|FG001|Overall Study|Adverse Event|0|||
17179228|NCT03915470|38330760|FG000|Overall Study|Physician Decision|1|||
17179229|NCT03915470|38330761|FG001|Overall Study|Physician Decision|0|||
17179230|NCT03915470|38330760|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
17179231|NCT03915470|38330761|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
17179232|NCT02732912|38330772|FG000|Overall Study|Discharged before night|2|||
17179233|NCT02732912|38330773|FG001|Overall Study|Discharged before night|6|||
17179234|NCT02732912|38330772|FG000|Overall Study|Incomplete completion of questionnaire|2|||
17179235|NCT02732912|38330773|FG001|Overall Study|Incomplete completion of questionnaire|3|||
17179236|NCT02732912|38330772|FG000|Overall Study|No outcome; discharged or refused|6|||
17179237|NCT02732912|38330773|FG001|Overall Study|No outcome; discharged or refused|9|||
17179238|NCT02792517|38330779|FG000|Overall Study|Withdrawal by Subject|10|||
17179239|NCT02792517|38330779|FG000|Overall Study|Decision by Sponsor|7|||
17179240|NCT02792517|38330779|FG000|Overall Study|Lost to Follow-up|3|||
17179241|NCT03126435|38330785|FG000|Overall Study|Death|90|||
17179242|NCT03126435|38330786|FG001|Overall Study|Death|84|||
17179243|NCT03126435|38330785|FG000|Overall Study|Lost to Follow-up|4|||
17179244|NCT03126435|38330786|FG001|Overall Study|Lost to Follow-up|3|||
17179245|NCT03126435|38330785|FG000|Overall Study|Physician Decision|0|||
17179246|NCT03126435|38330786|FG001|Overall Study|Physician Decision|1|||
17179247|NCT03126435|38330785|FG000|Overall Study|Withdrawal by Subject|6|||
17179248|NCT03126435|38330786|FG001|Overall Study|Withdrawal by Subject|12|||
17179249|NCT03126435|38330785|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
17179250|NCT03126435|38330786|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
17179251|NCT01369485|38330825|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
17179252|NCT01369485|38330826|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
17179253|NCT01369485|38330825|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
17179254|NCT01369485|38330826|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
17179255|NCT01369485|38330825|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
17179256|NCT01369485|38330826|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
17179257|NCT01369485|38330825|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
17179258|NCT01369485|38330826|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
17179259|NCT01369485|38330825|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
17179260|NCT01369485|38330826|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
17179261|NCT01369485|38330825|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
17179262|NCT01369485|38330826|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
17179263|NCT01369485|38330825|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
17179264|NCT01369485|38330826|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
17179265|NCT01369485|38330825|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
17179266|NCT01369485|38330826|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
17179267|NCT01369485|38330825|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
17179268|NCT01369485|38330826|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
17179269|NCT01369485|38330825|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
17179270|NCT01369485|38330826|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
17179271|NCT02886572|38330853|FG000|Overall Study|Death|8|||
17179272|NCT02741700|38330866|FG000|Overall Study|Lost to Follow-up|17|||
17179273|NCT02741700|38330867|FG001|Overall Study|Lost to Follow-up|8|||
17179274|NCT02741700|38330866|FG000|Overall Study|Withdrawal by Subject|2|||
17179275|NCT02741700|38330867|FG001|Overall Study|Withdrawal by Subject|5|||
17179276|NCT02741700|38330866|FG000|Overall Study|Physician Decision|3|||
17179277|NCT02741700|38330867|FG001|Overall Study|Physician Decision|0|||
17179278|NCT02741700|38330866|FG000|Overall Study|Moved out of State|0|||
17179279|NCT02741700|38330867|FG001|Overall Study|Moved out of State|1|||
17179280|NCT02741700|38330866|FG000|Overall Study|Death|4|||
17179281|NCT02741700|38330867|FG001|Overall Study|Death|5|||
17179282|NCT00430950|38330875|FG000|Overall Study|Adverse Event|7|||
17179283|NCT00430950|38330876|FG001|Overall Study|Adverse Event|6|||
17179284|NCT00430950|38330875|FG000|Overall Study|Withdrawal by Subject|1|||
17179285|NCT00430950|38330876|FG001|Overall Study|Withdrawal by Subject|0|||
17179286|NCT00430950|38330875|FG000|Overall Study|concomitant medication,etc.|5|||
17179287|NCT00430950|38330876|FG001|Overall Study|concomitant medication,etc.|7|||
17179288|NCT02081391|38330884|FG000|12-hour Treatment|Withdrawal by Subject|3|||
17179289|NCT02081391|38330885|FG001|12-hour Treatment|Withdrawal by Subject|2|||
17179290|NCT02081391|38330886|FG002|12-hour Treatment|Withdrawal by Subject|0|||
17179291|NCT02081391|38330887|FG003|12-hour Treatment|Withdrawal by Subject|0|||
17179292|NCT02081391|38330884|FG000|12-hour Treatment|Physician Decision|4|||
17179293|NCT02081391|38330885|FG001|12-hour Treatment|Physician Decision|1|||
17179294|NCT02081391|38330886|FG002|12-hour Treatment|Physician Decision|0|||
17179295|NCT02081391|38330887|FG003|12-hour Treatment|Physician Decision|0|||
17179296|NCT02081391|38330884|FG000|12-hour Treatment|Lack of Efficacy|3|||
17179297|NCT02081391|38330885|FG001|12-hour Treatment|Lack of Efficacy|0|||
17179298|NCT02081391|38330886|FG002|12-hour Treatment|Lack of Efficacy|0|||
17179299|NCT02081391|38330887|FG003|12-hour Treatment|Lack of Efficacy|0|||
17179300|NCT02081391|38330884|FG000|12-hour Treatment|Adverse Event|4|||
17179301|NCT02081391|38330885|FG001|12-hour Treatment|Adverse Event|2|||
17179302|NCT02081391|38330886|FG002|12-hour Treatment|Adverse Event|0|||
17179303|NCT02081391|38330887|FG003|12-hour Treatment|Adverse Event|0|||
17179304|NCT02081391|38330884|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
17179305|NCT02081391|38330885|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
17179306|NCT02081391|38330886|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
17179307|NCT02081391|38330887|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
17179308|NCT02081391|38330884|FG000|12-hour Treatment|Further reasons|2|||
17179309|NCT02081391|38330885|FG001|12-hour Treatment|Further reasons|1|||
17179310|NCT02081391|38330886|FG002|12-hour Treatment|Further reasons|0|||
17179311|NCT02081391|38330887|FG003|12-hour Treatment|Further reasons|0|||
17179312|NCT02081391|38330884|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
17179313|NCT02081391|38330885|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
17179314|NCT02081391|38330886|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
17179315|NCT02081391|38330887|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
17179316|NCT02081391|38330884|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
17179317|NCT02081391|38330885|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
17179318|NCT02081391|38330886|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
17179319|NCT02081391|38330887|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
17179320|NCT02081391|38330884|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
17179321|NCT02081391|38330885|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
17179322|NCT02081391|38330886|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
17179323|NCT02081391|38330887|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
17179324|NCT02081391|38330884|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
17179325|NCT02081391|38330885|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
17179326|NCT02081391|38330886|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
17179327|NCT02081391|38330887|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
17179328|NCT02081391|38330884|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
17179329|NCT02081391|38330885|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
17179330|NCT02081391|38330886|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
17179331|NCT02081391|38330887|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
17179332|NCT02081391|38330884|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
17179333|NCT02081391|38330885|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
17179334|NCT02081391|38330886|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
17179335|NCT02081391|38330887|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
17179336|NCT00430092|38330910|FG000|Overall Study|Adverse Event|0|||
17179337|NCT00430092|38330911|FG001|Overall Study|Adverse Event|0|||
17179338|NCT00430092|38330912|FG002|Overall Study|Adverse Event|1|||
17179339|NCT00430092|38330910|FG000|Overall Study|Lack of Efficacy|5|||
17179340|NCT00430092|38330911|FG001|Overall Study|Lack of Efficacy|2|||
17179341|NCT00430092|38330912|FG002|Overall Study|Lack of Efficacy|54|||
17179342|NCT00430092|38330910|FG000|Overall Study|Lost to Follow-up|1|||
17179343|NCT00430092|38330911|FG001|Overall Study|Lost to Follow-up|0|||
17179344|NCT00430092|38330912|FG002|Overall Study|Lost to Follow-up|0|||
17179345|NCT00430092|38330910|FG000|Overall Study|Protocol Violation|0|||
17179346|NCT00430092|38330911|FG001|Overall Study|Protocol Violation|1|||
17179347|NCT00430092|38330912|FG002|Overall Study|Protocol Violation|1|||
17179348|NCT00430092|38330910|FG000|Overall Study|Withdrawal by Subject|0|||
17179349|NCT00430092|38330911|FG001|Overall Study|Withdrawal by Subject|1|||
17179350|NCT00430092|38330912|FG002|Overall Study|Withdrawal by Subject|1|||
17179351|NCT00425100|38330917|FG000|Overall Study|Adverse Event|36|||
17179352|NCT00425100|38330917|FG000|Overall Study|Lack of Efficacy|4|||
17179353|NCT00425100|38330917|FG000|Overall Study|Lost to Follow-up|2|||
17179354|NCT00425100|38330917|FG000|Overall Study|Protocol Violation|4|||
17179355|NCT00425100|38330917|FG000|Overall Study|Withdrawal by Subject|7|||
17179356|NCT00412932|38330922|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
17179357|NCT00412932|38330922|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
17179358|NCT00412932|38330922|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
17179359|NCT00412932|38330922|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
17179360|NCT00412932|38330922|FG000|Olmesartan (Olm) 20 mg|Other|1|||
17179361|NCT00412932|38330922|FG000|Olmesartan 40 mg|Adverse Event|4|||
17179362|NCT00412932|38330922|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
17179363|NCT00412932|38330922|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
17179364|NCT00412932|38330922|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
17179365|NCT00412932|38330922|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
17179366|NCT00412932|38330922|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
17179367|NCT00412932|38330922|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
17179368|NCT02696031|38330928|FG000|Up to Week 24|Adverse Event|2|||
17179369|NCT02696031|38330929|FG001|Up to Week 24|Adverse Event|4|||
17179370|NCT02696031|38330930|FG002|Up to Week 24|Adverse Event|2|||
17179371|NCT02696031|38330931|FG003|Up to Week 24|Adverse Event|0|||
17179372|NCT02696031|38330932|FG004|Up to Week 24|Adverse Event|0|||
17179373|NCT02696031|38330933|FG005|Up to Week 24|Adverse Event|0|||
17179374|NCT02696031|38330928|FG000|Up to Week 24|Lack of Efficacy|2|||
17179375|NCT02696031|38330929|FG001|Up to Week 24|Lack of Efficacy|1|||
17179376|NCT02696031|38330930|FG002|Up to Week 24|Lack of Efficacy|2|||
17179377|NCT02696031|38330931|FG003|Up to Week 24|Lack of Efficacy|0|||
17179378|NCT02696031|38330932|FG004|Up to Week 24|Lack of Efficacy|0|||
17179379|NCT02696031|38330933|FG005|Up to Week 24|Lack of Efficacy|0|||
17179380|NCT02696031|38330928|FG000|Up to Week 24|Lost to Follow-up|0|||
17179381|NCT02696031|38330929|FG001|Up to Week 24|Lost to Follow-up|1|||
17179382|NCT02696031|38330930|FG002|Up to Week 24|Lost to Follow-up|1|||
17179383|NCT02696031|38330931|FG003|Up to Week 24|Lost to Follow-up|0|||
17179384|NCT02696031|38330932|FG004|Up to Week 24|Lost to Follow-up|0|||
17179385|NCT02696031|38330933|FG005|Up to Week 24|Lost to Follow-up|0|||
17179386|NCT02696031|38330928|FG000|Up to Week 24|Physician Decision|1|||
17179387|NCT02696031|38330929|FG001|Up to Week 24|Physician Decision|0|||
17179388|NCT02696031|38330930|FG002|Up to Week 24|Physician Decision|1|||
17179389|NCT02696031|38330931|FG003|Up to Week 24|Physician Decision|0|||
17179390|NCT02696031|38330932|FG004|Up to Week 24|Physician Decision|0|||
17179391|NCT02696031|38330933|FG005|Up to Week 24|Physician Decision|0|||
17179392|NCT02696031|38330928|FG000|Up to Week 24|Protocol Violation|1|||
17179393|NCT02696031|38330929|FG001|Up to Week 24|Protocol Violation|0|||
17179394|NCT02696031|38330930|FG002|Up to Week 24|Protocol Violation|0|||
17179395|NCT02696031|38330931|FG003|Up to Week 24|Protocol Violation|0|||
17179396|NCT02696031|38330932|FG004|Up to Week 24|Protocol Violation|0|||
17179397|NCT02696031|38330933|FG005|Up to Week 24|Protocol Violation|0|||
17179398|NCT02696031|38330928|FG000|Up to Week 24|Withdrawal by Subject|4|||
17179399|NCT02696031|38330929|FG001|Up to Week 24|Withdrawal by Subject|1|||
17179400|NCT02696031|38330930|FG002|Up to Week 24|Withdrawal by Subject|5|||
17179401|NCT02696031|38330931|FG003|Up to Week 24|Withdrawal by Subject|0|||
17179402|NCT02696031|38330932|FG004|Up to Week 24|Withdrawal by Subject|0|||
17179403|NCT02696031|38330933|FG005|Up to Week 24|Withdrawal by Subject|0|||
17179404|NCT02696031|38330928|FG000|Up to Week 52|Adverse Event|4|||
17179405|NCT02696031|38330929|FG001|Up to Week 52|Adverse Event|5|||
17179406|NCT02696031|38330930|FG002|Up to Week 52|Adverse Event|3|||
17179407|NCT02696031|38330931|FG003|Up to Week 52|Adverse Event|0|||
17179408|NCT02696031|38330932|FG004|Up to Week 52|Adverse Event|0|||
17179409|NCT02696031|38330933|FG005|Up to Week 52|Adverse Event|0|||
17179410|NCT02696031|38330928|FG000|Up to Week 52|Lack of Efficacy|10|||
17179411|NCT02696031|38330929|FG001|Up to Week 52|Lack of Efficacy|7|||
17179412|NCT02696031|38330930|FG002|Up to Week 52|Lack of Efficacy|11|||
17179413|NCT02696031|38330931|FG003|Up to Week 52|Lack of Efficacy|0|||
17179414|NCT02696031|38330932|FG004|Up to Week 52|Lack of Efficacy|0|||
17179415|NCT02696031|38330933|FG005|Up to Week 52|Lack of Efficacy|0|||
17179416|NCT02696031|38330928|FG000|Up to Week 52|Lost to Follow-up|1|||
17179417|NCT02696031|38330929|FG001|Up to Week 52|Lost to Follow-up|1|||
17179418|NCT02696031|38330930|FG002|Up to Week 52|Lost to Follow-up|1|||
17179419|NCT02696031|38330931|FG003|Up to Week 52|Lost to Follow-up|0|||
17179420|NCT02696031|38330932|FG004|Up to Week 52|Lost to Follow-up|0|||
17179421|NCT02696031|38330933|FG005|Up to Week 52|Lost to Follow-up|0|||
17179422|NCT02696031|38330928|FG000|Up to Week 52|Physician Decision|1|||
17179423|NCT02696031|38330929|FG001|Up to Week 52|Physician Decision|1|||
17179424|NCT02696031|38330930|FG002|Up to Week 52|Physician Decision|2|||
17179425|NCT02696031|38330931|FG003|Up to Week 52|Physician Decision|0|||
17179426|NCT02696031|38330932|FG004|Up to Week 52|Physician Decision|0|||
17179427|NCT02696031|38330933|FG005|Up to Week 52|Physician Decision|0|||
17179428|NCT02696031|38330928|FG000|Up to Week 52|Pregnancy|0|||
17179429|NCT02696031|38330929|FG001|Up to Week 52|Pregnancy|2|||
17179430|NCT02696031|38330930|FG002|Up to Week 52|Pregnancy|0|||
17179431|NCT02696031|38330931|FG003|Up to Week 52|Pregnancy|0|||
17179432|NCT02696031|38330932|FG004|Up to Week 52|Pregnancy|0|||
17179433|NCT02696031|38330933|FG005|Up to Week 52|Pregnancy|0|||
17179434|NCT02696031|38330928|FG000|Up to Week 52|Protocol Violation|1|||
17179435|NCT02696031|38330929|FG001|Up to Week 52|Protocol Violation|0|||
17179436|NCT02696031|38330930|FG002|Up to Week 52|Protocol Violation|0|||
17179437|NCT02696031|38330931|FG003|Up to Week 52|Protocol Violation|0|||
17179438|NCT02696031|38330932|FG004|Up to Week 52|Protocol Violation|0|||
17179439|NCT02696031|38330933|FG005|Up to Week 52|Protocol Violation|0|||
17179440|NCT02696031|38330928|FG000|Up to Week 52|Withdrawal by Subject|12|||
17179441|NCT02696031|38330929|FG001|Up to Week 52|Withdrawal by Subject|3|||
17179442|NCT02696031|38330930|FG002|Up to Week 52|Withdrawal by Subject|9|||
17179443|NCT02696031|38330931|FG003|Up to Week 52|Withdrawal by Subject|0|||
17179444|NCT02696031|38330932|FG004|Up to Week 52|Withdrawal by Subject|0|||
17179445|NCT02696031|38330933|FG005|Up to Week 52|Withdrawal by Subject|0|||
17179446|NCT02696031|38330928|FG000|Up to Week 104|Pregnancy|0|||
17179447|NCT02696031|38330929|FG001|Up to Week 104|Pregnancy|2|||
17179448|NCT02696031|38330930|FG002|Up to Week 104|Pregnancy|1|||
17179449|NCT02696031|38330931|FG003|Up to Week 104|Pregnancy|0|||
17179450|NCT02696031|38330932|FG004|Up to Week 104|Pregnancy|0|||
17179451|NCT02696031|38330933|FG005|Up to Week 104|Pregnancy|0|||
17179452|NCT02696031|38330928|FG000|Up to Week 104|Withdrawal by Subject|15|||
17179453|NCT02696031|38330929|FG001|Up to Week 104|Withdrawal by Subject|10|||
17179454|NCT02696031|38330930|FG002|Up to Week 104|Withdrawal by Subject|16|||
17179455|NCT02696031|38330931|FG003|Up to Week 104|Withdrawal by Subject|0|||
17179456|NCT02696031|38330932|FG004|Up to Week 104|Withdrawal by Subject|0|||
17179457|NCT02696031|38330933|FG005|Up to Week 104|Withdrawal by Subject|0|||
17179458|NCT02696031|38330928|FG000|Up to Week 104|Protocol Violation|1|||
17179459|NCT02696031|38330929|FG001|Up to Week 104|Protocol Violation|0|||
17179460|NCT02696031|38330930|FG002|Up to Week 104|Protocol Violation|0|||
17179461|NCT02696031|38330931|FG003|Up to Week 104|Protocol Violation|0|||
17179462|NCT02696031|38330932|FG004|Up to Week 104|Protocol Violation|0|||
17179463|NCT02696031|38330933|FG005|Up to Week 104|Protocol Violation|0|||
17179464|NCT02696031|38330928|FG000|Up to Week 104|Physician Decision|1|||
17179465|NCT02696031|38330929|FG001|Up to Week 104|Physician Decision|2|||
17179466|NCT02696031|38330930|FG002|Up to Week 104|Physician Decision|3|||
17179467|NCT02696031|38330931|FG003|Up to Week 104|Physician Decision|0|||
17179468|NCT02696031|38330932|FG004|Up to Week 104|Physician Decision|0|||
17179469|NCT02696031|38330933|FG005|Up to Week 104|Physician Decision|0|||
17179470|NCT02696031|38330928|FG000|Up to Week 104|Lost to Follow-up|2|||
17179471|NCT02696031|38330929|FG001|Up to Week 104|Lost to Follow-up|3|||
17179472|NCT02696031|38330930|FG002|Up to Week 104|Lost to Follow-up|1|||
17179473|NCT02696031|38330931|FG003|Up to Week 104|Lost to Follow-up|0|||
17179474|NCT02696031|38330932|FG004|Up to Week 104|Lost to Follow-up|0|||
17179475|NCT02696031|38330933|FG005|Up to Week 104|Lost to Follow-up|0|||
17179476|NCT02696031|38330928|FG000|Up to Week 104|Lack of Efficacy|13|||
17179477|NCT02696031|38330929|FG001|Up to Week 104|Lack of Efficacy|12|||
17179478|NCT02696031|38330930|FG002|Up to Week 104|Lack of Efficacy|11|||
17179479|NCT02696031|38330931|FG003|Up to Week 104|Lack of Efficacy|0|||
17179480|NCT02696031|38330932|FG004|Up to Week 104|Lack of Efficacy|0|||
17179481|NCT02696031|38330933|FG005|Up to Week 104|Lack of Efficacy|0|||
17179482|NCT02696031|38330928|FG000|Up to Week 104|Adverse Event|7|||
17179483|NCT02696031|38330929|FG001|Up to Week 104|Adverse Event|11|||
17179484|NCT02696031|38330930|FG002|Up to Week 104|Adverse Event|5|||
17179485|NCT02696031|38330931|FG003|Up to Week 104|Adverse Event|0|||
17179486|NCT02696031|38330932|FG004|Up to Week 104|Adverse Event|0|||
17179487|NCT02696031|38330933|FG005|Up to Week 104|Adverse Event|0|||
17179488|NCT02696031|38330928|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
17179489|NCT02696031|38330929|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
17179490|NCT02696031|38330930|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
17179491|NCT02696031|38330931|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
17179492|NCT02696031|38330932|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
17179493|NCT02696031|38330933|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
17179494|NCT02696031|38330928|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
17179495|NCT02696031|38330929|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
17179496|NCT02696031|38330930|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
17179497|NCT02696031|38330931|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
17179498|NCT02696031|38330932|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
17179499|NCT02696031|38330933|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
17179500|NCT02696031|38330928|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
17179501|NCT02696031|38330929|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
17179502|NCT02696031|38330930|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
17179503|NCT02696031|38330931|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
17179504|NCT02696031|38330932|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
17179505|NCT02696031|38330933|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
17179506|NCT02696031|38330928|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
17179507|NCT02696031|38330929|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
17179508|NCT02696031|38330930|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
17179509|NCT02696031|38330931|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
17179510|NCT02696031|38330932|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
17179511|NCT02696031|38330933|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
17179512|NCT02696031|38330928|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
17179513|NCT02696031|38330929|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
17179514|NCT02696031|38330930|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
17179515|NCT02696031|38330931|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
17179516|NCT02696031|38330932|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
17179517|NCT02696031|38330933|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
17179518|NCT02696031|38330928|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
17179519|NCT02696031|38330929|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
17179520|NCT02696031|38330930|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
17179521|NCT02696031|38330931|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
17179522|NCT02696031|38330932|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
17179523|NCT02696031|38330933|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
17179524|NCT02696031|38330928|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
17179525|NCT02696031|38330929|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
17179526|NCT02696031|38330930|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
17179527|NCT02696031|38330931|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
17179528|NCT02696031|38330932|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
17179529|NCT02696031|38330933|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
17179530|NCT00397254|38330942|FG000|Overall Study|Lost to Follow-up|2|||
17179531|NCT00397254|38330943|FG001|Overall Study|Lost to Follow-up|2|||
17179532|NCT01369641|38330947|FG000|Overall Study|Withdrawal by Subject|1|||
17179533|NCT00529152|38330951|FG000|Overall Study|Adverse Event|2|||
17179534|NCT00529152|38330951|FG000|Overall Study|Withdrawal by Subject|2|||
17179535|NCT00529152|38330951|FG000|Overall Study|Lost to Follow-up|1|||
17179536|NCT02605174|38330958|FG000|Overall Study|Adverse Event|0|||
17179537|NCT02605174|38330959|FG001|Overall Study|Adverse Event|0|||
17179538|NCT02605174|38330960|FG002|Overall Study|Adverse Event|1|||
17179539|NCT02605174|38330961|FG003|Overall Study|Adverse Event|0|||
17179540|NCT02605174|38330962|FG004|Overall Study|Adverse Event|4|||
17179541|NCT02605174|38330963|FG005|Overall Study|Adverse Event|0|||
17179542|NCT02605174|38330964|FG006|Overall Study|Adverse Event|0|||
17179543|NCT02605174|38330958|FG000|Overall Study|Lost to Follow-up|20|||
17179544|NCT02605174|38330959|FG001|Overall Study|Lost to Follow-up|7|||
17179545|NCT02605174|38330960|FG002|Overall Study|Lost to Follow-up|27|||
17179546|NCT02605174|38330961|FG003|Overall Study|Lost to Follow-up|10|||
17179547|NCT02605174|38330962|FG004|Overall Study|Lost to Follow-up|20|||
17179548|NCT02605174|38330963|FG005|Overall Study|Lost to Follow-up|10|||
17179549|NCT02605174|38330964|FG006|Overall Study|Lost to Follow-up|29|||
17179550|NCT02605174|38330958|FG000|Overall Study|Protocol Violation|10|||
17179551|NCT02605174|38330959|FG001|Overall Study|Protocol Violation|4|||
17179552|NCT02605174|38330960|FG002|Overall Study|Protocol Violation|14|||
17179553|NCT02605174|38330961|FG003|Overall Study|Protocol Violation|6|||
17179554|NCT02605174|38330962|FG004|Overall Study|Protocol Violation|7|||
17179555|NCT02605174|38330963|FG005|Overall Study|Protocol Violation|7|||
17179556|NCT02605174|38330964|FG006|Overall Study|Protocol Violation|12|||
17179557|NCT02605174|38330958|FG000|Overall Study|Pregnancy|1|||
17179558|NCT02605174|38330959|FG001|Overall Study|Pregnancy|0|||
17179559|NCT02605174|38330960|FG002|Overall Study|Pregnancy|0|||
17179560|NCT02605174|38330961|FG003|Overall Study|Pregnancy|2|||
17179561|NCT02605174|38330962|FG004|Overall Study|Pregnancy|0|||
17179562|NCT02605174|38330963|FG005|Overall Study|Pregnancy|0|||
17179563|NCT02605174|38330964|FG006|Overall Study|Pregnancy|0|||
17179564|NCT02605174|38330958|FG000|Overall Study|Withdrawal by Subject|9|||
17179565|NCT02605174|38330959|FG001|Overall Study|Withdrawal by Subject|6|||
17179566|NCT02605174|38330960|FG002|Overall Study|Withdrawal by Subject|14|||
17179567|NCT02605174|38330961|FG003|Overall Study|Withdrawal by Subject|11|||
17179568|NCT02605174|38330962|FG004|Overall Study|Withdrawal by Subject|6|||
17179569|NCT02605174|38330963|FG005|Overall Study|Withdrawal by Subject|4|||
17179570|NCT02605174|38330964|FG006|Overall Study|Withdrawal by Subject|15|||
17179571|NCT02605174|38330958|FG000|Overall Study|Physician Decision|2|||
17179572|NCT02605174|38330959|FG001|Overall Study|Physician Decision|0|||
17179573|NCT02605174|38330960|FG002|Overall Study|Physician Decision|0|||
17179574|NCT02605174|38330961|FG003|Overall Study|Physician Decision|0|||
17179575|NCT02605174|38330962|FG004|Overall Study|Physician Decision|0|||
17179576|NCT02605174|38330963|FG005|Overall Study|Physician Decision|0|||
17179577|NCT02605174|38330964|FG006|Overall Study|Physician Decision|3|||
17179578|NCT02605174|38330958|FG000|Overall Study|Randomization Failure|22|||
17179579|NCT02605174|38330959|FG001|Overall Study|Randomization Failure|6|||
17179580|NCT02605174|38330960|FG002|Overall Study|Randomization Failure|20|||
17179581|NCT02605174|38330961|FG003|Overall Study|Randomization Failure|7|||
17179582|NCT02605174|38330962|FG004|Overall Study|Randomization Failure|16|||
17179583|NCT02605174|38330963|FG005|Overall Study|Randomization Failure|11|||
17179584|NCT02605174|38330964|FG006|Overall Study|Randomization Failure|30|||
17179585|NCT02604550|38330992|FG000|Overall Study|Lost to Follow-up|7|||
17179586|NCT02604550|38330993|FG001|Overall Study|Lost to Follow-up|6|||
17179587|NCT02604550|38330992|FG000|Overall Study|Withdrawal by Subject|0|||
17179588|NCT02604550|38330993|FG001|Overall Study|Withdrawal by Subject|1|||
17179589|NCT02604550|38330992|FG000|Overall Study|Incomplete data using paper journal|18|||
17179590|NCT02604550|38330993|FG001|Overall Study|Incomplete data using paper journal|19|||
17179591|NCT02591290|38330999|FG000|Overall Study|Withdrawal by Subject|2|||
17179592|NCT02791893|38331005|FG000|Blinded Phase|Lost to Follow-up|2|||
17179593|NCT02791893|38331006|FG001|Blinded Phase|Lost to Follow-up|2|||
17179594|NCT02791893|38331005|FG000|Blinded Phase|Withdrawal by Subject|1|||
17179595|NCT02791893|38331006|FG001|Blinded Phase|Withdrawal by Subject|2|||
17179596|NCT02791893|38331005|FG000|Open Label Phase|Lost to Follow-up|3|||
17179597|NCT02791893|38331006|FG001|Open Label Phase|Lost to Follow-up|0|||
17179598|NCT02791893|38331005|FG000|Open Label Phase|Withdrawal by Subject|0|||
17179599|NCT02791893|38331006|FG001|Open Label Phase|Withdrawal by Subject|2|||
17179600|NCT00120042|38331015|FG000|Overall Study|all completed protocl|0|||
17179601|NCT00120042|38331016|FG001|Overall Study|all completed protocl|0|||
17179602|NCT00120042|38331017|FG002|Overall Study|all completed protocl|0|||
17179603|NCT02476851|38331024|FG000|Overall Study|Protocol Violation|1|||
17179604|NCT02476851|38331025|FG001|Overall Study|Protocol Violation|1|||
17179605|NCT02595970|38331031|FG000|Overall Study|Withdrawal by Subject|2|||
17179606|NCT02595970|38331031|FG000|Overall Study|Physician Decision|2|||
17179607|NCT02595970|38331031|FG000|Overall Study|Protocol Violation|4|||
17179608|NCT02595970|38331031|FG000|Overall Study|Adverse Event|5|||
17179609|NCT02595970|38331031|FG000|Overall Study|Lack of Efficacy|7|||
17179610|NCT01866111|38331039|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
17179611|NCT01866111|38331040|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
17179612|NCT01866111|38331041|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
17179613|NCT01866111|38331042|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
17179614|NCT01866111|38331039|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
17179615|NCT01866111|38331040|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
17179616|NCT01866111|38331041|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
17179617|NCT01866111|38331042|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
17179618|NCT02595502|38331052|FG000|Period 1|Adverse Event|0|||
17179619|NCT02595502|38331053|FG001|Period 1|Adverse Event|1|||
17179620|NCT02595502|38331052|FG000|Period 1|Withdrawal by Subject|1|||
17179621|NCT02595502|38331053|FG001|Period 1|Withdrawal by Subject|0|||
17179622|NCT02595502|38331052|FG000|Period 1|Lost to Follow-up|0|||
17179623|NCT02595502|38331053|FG001|Period 1|Lost to Follow-up|1|||
17179624|NCT02595502|38331052|FG000|Period 2|Adverse Event|1|||
17179625|NCT02595502|38331053|FG001|Period 2|Adverse Event|1|||
17179626|NCT02595502|38331052|FG000|Period 2|Received incorrect lens at Period 1|0|||
17179627|NCT02595502|38331053|FG001|Period 2|Received incorrect lens at Period 1|1|||
17179628|NCT02595502|38331052|FG000|Period 3|Protocol Violation|0|||
17179629|NCT02595502|38331053|FG001|Period 3|Protocol Violation|1|||
17179630|NCT02595502|38331052|FG000|Period 3|Lost to Follow-up|1|||
17179631|NCT02595502|38331053|FG001|Period 3|Lost to Follow-up|0|||
17179632|NCT02595502|38331052|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
17179633|NCT02595502|38331053|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
17179634|NCT01369329|38331062|FG000|Overall Study|Withdrawal by Subject|8|||
17179635|NCT01369329|38331063|FG001|Overall Study|Withdrawal by Subject|6|||
17179636|NCT01369329|38331064|FG002|Overall Study|Withdrawal by Subject|10|||
17179637|NCT01369329|38331062|FG000|Overall Study|Lost to Follow-up|2|||
17179638|NCT01369329|38331063|FG001|Overall Study|Lost to Follow-up|2|||
17179639|NCT01369329|38331064|FG002|Overall Study|Lost to Follow-up|2|||
17179640|NCT01369329|38331062|FG000|Overall Study|Other|2|||
17179641|NCT01369329|38331063|FG001|Overall Study|Other|3|||
17179642|NCT01369329|38331064|FG002|Overall Study|Other|2|||
17179643|NCT02791659|38331074|FG000|Overall Study|Protocol Violation|0|||
17179644|NCT02791659|38331075|FG001|Overall Study|Protocol Violation|1|||
17179645|NCT02594098|38331083|FG000|Overall Study|Lack of Efficacy|17|||
17179646|NCT02594098|38331084|FG001|Overall Study|Lack of Efficacy|6|||
17179647|NCT02594098|38331083|FG000|Overall Study|Withdrawal by Subject|1|||
17179648|NCT02594098|38331084|FG001|Overall Study|Withdrawal by Subject|3|||
17179649|NCT02594098|38331083|FG000|Overall Study|Terminated participation|6|||
17179650|NCT02594098|38331084|FG001|Overall Study|Terminated participation|2|||
17179651|NCT02594098|38331083|FG000|Overall Study|Seek alternative treatment|2|||
17179652|NCT02594098|38331084|FG001|Overall Study|Seek alternative treatment|1|||
17179653|NCT02594098|38331083|FG000|Overall Study|Other|0|||
17179654|NCT02594098|38331084|FG001|Overall Study|Other|1|||
17179655|NCT02593864|38331092|FG000|Overall Study|Withdrawal by Subject|3|||
17179656|NCT02593864|38331092|FG000|Overall Study|Lost to Follow-up|3|||
17179657|NCT02590588|38331096|FG000|Overall Study|Adverse Event|1|||
17179658|NCT01434602|38331105|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
17179659|NCT01434602|38331106|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
17179660|NCT01434602|38331107|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
17179661|NCT01434602|38331108|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
17179662|NCT01434602|38331109|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
17179663|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
17179664|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
17179665|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
17179666|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
17179667|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
17179668|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
17179669|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
17179670|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
17179671|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
17179672|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
17179673|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
17179674|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
17179675|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
17179676|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
17179677|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
17179678|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
17179679|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
17179680|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
17179681|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
17179682|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
17179683|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
17179684|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
17179685|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
17179686|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
17179687|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
17179688|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
17179689|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
17179690|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
17179691|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
17179692|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
17179693|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
17179694|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
17179695|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
17179696|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
17179697|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
17179698|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
17179699|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
17179700|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
17179701|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
17179702|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
17179703|NCT01434602|38331105|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
17179704|NCT01434602|38331106|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
17179705|NCT01434602|38331107|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
17179706|NCT01434602|38331108|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
17179707|NCT01434602|38331109|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
17179708|NCT01767129|38331131|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
17179709|NCT01767129|38331132|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
17179710|NCT02791269|38331141|FG000|Overall Study|Lost to Follow-up|0|||
17179711|NCT02791269|38331142|FG001|Overall Study|Lost to Follow-up|1|||
17179712|NCT02696564|38331152|FG000|Overall Study|Death|1|||
17179713|NCT02696564|38331153|FG001|Overall Study|Death|2|||
17179714|NCT02696564|38331152|FG000|Overall Study|Withdrawal by Subject|3|||
17179715|NCT02696564|38331153|FG001|Overall Study|Withdrawal by Subject|2|||
17179716|NCT02696564|38331152|FG000|Overall Study|Lost to Follow-up|3|||
17179717|NCT02696564|38331153|FG001|Overall Study|Lost to Follow-up|3|||
17179718|NCT02696564|38331152|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
17179719|NCT02696564|38331153|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
17179720|NCT02696564|38331152|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
17179721|NCT02696564|38331153|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
17179722|NCT02696564|38331152|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
17179723|NCT02696564|38331153|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
17179724|NCT02696564|38331152|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
17179725|NCT02696564|38331153|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
17179726|NCT02696564|38331152|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
17179727|NCT02696564|38331153|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
17179728|NCT02640950|38331159|FG000|Overall Study|Adverse Event|1|||
17179729|NCT02640950|38331159|FG000|Overall Study|Withdrawal by Subject|1|||
17179730|NCT02593786|38331167|FG000|Overall Study|Disease progression|12|||
17179731|NCT02593786|38331168|FG001|Overall Study|Disease progression|16|||
17179732|NCT02593786|38331169|FG002|Overall Study|Disease progression|10|||
17179733|NCT02593786|38331170|FG003|Overall Study|Disease progression|7|||
17179734|NCT02593786|38331167|FG000|Overall Study|Study drug toxicity|1|||
17179735|NCT02593786|38331168|FG001|Overall Study|Study drug toxicity|0|||
17179736|NCT02593786|38331169|FG002|Overall Study|Study drug toxicity|0|||
17179737|NCT02593786|38331170|FG003|Overall Study|Study drug toxicity|0|||
17179738|NCT02593786|38331167|FG000|Overall Study|Adverse event unrelated to study drug|1|||
17179739|NCT02593786|38331168|FG001|Overall Study|Adverse event unrelated to study drug|1|||
17179740|NCT02593786|38331169|FG002|Overall Study|Adverse event unrelated to study drug|1|||
17179741|NCT02593786|38331170|FG003|Overall Study|Adverse event unrelated to study drug|0|||
17179742|NCT02593786|38331167|FG000|Overall Study|Participant request to discontinue study therapy|0|||
17179743|NCT02593786|38331168|FG001|Overall Study|Participant request to discontinue study therapy|2|||
17179744|NCT02593786|38331169|FG002|Overall Study|Participant request to discontinue study therapy|0|||
17179745|NCT02593786|38331170|FG003|Overall Study|Participant request to discontinue study therapy|0|||
17179746|NCT02593786|38331167|FG000|Overall Study|Other reasons|1|||
17179747|NCT02593786|38331168|FG001|Overall Study|Other reasons|1|||
17179748|NCT02593786|38331169|FG002|Overall Study|Other reasons|0|||
17179749|NCT02593786|38331170|FG003|Overall Study|Other reasons|5|||
17179750|NCT02593318|38331205|FG000|Overall Study|Withdrawal by Subject|1|||
17179751|NCT02593318|38331206|FG001|Overall Study|Withdrawal by Subject|1|||
17179752|NCT02343302|38331220|FG000|Overall Study|Physician Decision|1|||
17179753|NCT02343302|38331221|FG001|Overall Study|Physician Decision|1|||
17179754|NCT02590432|38331229|FG000|Open-label Treatment Period|Adverse Event|97|||
17179755|NCT02590432|38331230|FG001|Open-label Treatment Period|Adverse Event|79|||
17179756|NCT02590432|38331231|FG002|Open-label Treatment Period|Adverse Event|0|||
17179757|NCT02590432|38331232|FG003|Open-label Treatment Period|Adverse Event|0|||
17179758|NCT02590432|38331233|FG004|Open-label Treatment Period|Adverse Event|0|||
17179759|NCT02590432|38331234|FG005|Open-label Treatment Period|Adverse Event|0|||
17179760|NCT02590432|38331235|FG006|Open-label Treatment Period|Adverse Event|0|||
17179761|NCT02590432|38331236|FG007|Open-label Treatment Period|Adverse Event|0|||
17179762|NCT02590432|38331237|FG008|Open-label Treatment Period|Adverse Event|0|||
17179763|NCT02590432|38331229|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
17179764|NCT02590432|38331230|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
17179765|NCT02590432|38331231|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
17179766|NCT02590432|38331232|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
17179767|NCT02590432|38331233|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
17179768|NCT02590432|38331234|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
17179769|NCT02590432|38331235|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
17179770|NCT02590432|38331236|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
17179771|NCT02590432|38331237|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
17179772|NCT02590432|38331229|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
17179773|NCT02590432|38331230|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
17179774|NCT02590432|38331231|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
17179775|NCT02590432|38331232|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
17179776|NCT02590432|38331233|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
17179777|NCT02590432|38331234|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
17179778|NCT02590432|38331235|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
17179779|NCT02590432|38331236|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
17179780|NCT02590432|38331237|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
17179781|NCT02590432|38331229|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
17179782|NCT02590432|38331230|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
17179783|NCT02590432|38331231|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
17179784|NCT02590432|38331232|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
17179785|NCT02590432|38331233|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
17179786|NCT02590432|38331234|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
17179787|NCT02590432|38331235|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
17179788|NCT02590432|38331236|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
17179789|NCT02590432|38331237|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
17179790|NCT02590432|38331229|FG000|Open-label Treatment Period|Protocol Violation|10|||
17179791|NCT02590432|38331230|FG001|Open-label Treatment Period|Protocol Violation|4|||
17179792|NCT02590432|38331231|FG002|Open-label Treatment Period|Protocol Violation|0|||
17179793|NCT02590432|38331232|FG003|Open-label Treatment Period|Protocol Violation|0|||
17179794|NCT02590432|38331233|FG004|Open-label Treatment Period|Protocol Violation|0|||
17179795|NCT02590432|38331234|FG005|Open-label Treatment Period|Protocol Violation|0|||
16996820|NCT03107793|38140960|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16996821|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16996822|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
16996823|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
16996824|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16996825|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16996826|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16996827|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
16996828|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
16996829|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16996830|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16996831|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
16996832|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
16996833|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
16996834|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
16996835|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
16996836|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16996837|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
16996838|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
16996839|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16996840|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16996841|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
17179796|NCT02590432|38331235|FG006|Open-label Treatment Period|Protocol Violation|0|||
17179797|NCT02590432|38331236|FG007|Open-label Treatment Period|Protocol Violation|0|||
17179798|NCT02590432|38331237|FG008|Open-label Treatment Period|Protocol Violation|0|||
17179799|NCT02590432|38331229|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
17179800|NCT02590432|38331230|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
17179801|NCT02590432|38331231|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
17179802|NCT02590432|38331232|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
17179803|NCT02590432|38331233|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
17179804|NCT02590432|38331234|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
17179805|NCT02590432|38331235|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
17179806|NCT02590432|38331236|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
17179807|NCT02590432|38331237|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
17179808|NCT02590432|38331229|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
17179809|NCT02590432|38331230|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
17179810|NCT02590432|38331231|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
17179811|NCT02590432|38331232|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
17179812|NCT02590432|38331233|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
17179813|NCT02590432|38331234|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
17179814|NCT02590432|38331235|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
17179815|NCT02590432|38331236|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
17179816|NCT02590432|38331237|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
17179817|NCT02590432|38331229|FG000|Double-blind Treatment Period|Adverse Event|0|||
17179818|NCT02590432|38331230|FG001|Double-blind Treatment Period|Adverse Event|0|||
17179819|NCT02590432|38331231|FG002|Double-blind Treatment Period|Adverse Event|14|||
17179820|NCT02590432|38331232|FG003|Double-blind Treatment Period|Adverse Event|12|||
17179821|NCT02590432|38331233|FG004|Double-blind Treatment Period|Adverse Event|6|||
17179822|NCT02590432|38331234|FG005|Double-blind Treatment Period|Adverse Event|22|||
17179823|NCT02590432|38331235|FG006|Double-blind Treatment Period|Adverse Event|20|||
17179824|NCT02590432|38331236|FG007|Double-blind Treatment Period|Adverse Event|0|||
17179825|NCT02590432|38331237|FG008|Double-blind Treatment Period|Adverse Event|0|||
17179826|NCT02590432|38331229|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
17179827|NCT02590432|38331230|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
17179828|NCT02590432|38331231|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
17179829|NCT02590432|38331232|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
17179830|NCT02590432|38331233|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
17179831|NCT02590432|38331234|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
17179832|NCT02590432|38331235|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
17179833|NCT02590432|38331236|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
17179834|NCT02590432|38331237|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
17179835|NCT02590432|38331229|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
17179836|NCT02590432|38331230|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
17179837|NCT02590432|38331231|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
17179838|NCT02590432|38331232|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
17179839|NCT02590432|38331233|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
17179840|NCT02590432|38331234|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
17179841|NCT02590432|38331235|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
17179842|NCT02590432|38331236|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
17179843|NCT02590432|38331237|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
17179844|NCT02590432|38331229|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
17179845|NCT02590432|38331230|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
17179846|NCT02590432|38331231|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
17179847|NCT02590432|38331232|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
17179848|NCT02590432|38331233|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
17179849|NCT02590432|38331234|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
17179850|NCT02590432|38331235|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
17179851|NCT02590432|38331236|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
17179852|NCT02590432|38331237|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
17179853|NCT02590432|38331229|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
17179854|NCT02590432|38331230|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
17179855|NCT02590432|38331231|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
17179856|NCT02590432|38331232|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
17179857|NCT02590432|38331233|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
17179858|NCT02590432|38331234|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
17179859|NCT02590432|38331235|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
17179860|NCT02590432|38331236|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
17179861|NCT02590432|38331237|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
17179862|NCT02590432|38331229|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
17179863|NCT02590432|38331230|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
17179864|NCT02590432|38331231|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
17179865|NCT02590432|38331232|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
17179866|NCT02590432|38331233|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
17179867|NCT02590432|38331234|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
17179868|NCT02590432|38331235|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
17179869|NCT02590432|38331236|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
17179870|NCT02590432|38331237|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
17179871|NCT02590432|38331229|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
17179872|NCT02590432|38331230|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
17179873|NCT02590432|38331231|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
17179874|NCT02590432|38331232|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
17179875|NCT02590432|38331233|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
17179876|NCT02590432|38331234|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
17179877|NCT02590432|38331235|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
17179878|NCT02590432|38331236|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
17179879|NCT02590432|38331237|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
17179880|NCT02590432|38331229|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
17179881|NCT02590432|38331230|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
17179882|NCT02590432|38331231|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
17179883|NCT02590432|38331232|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
17179884|NCT02590432|38331233|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
17179885|NCT02590432|38331234|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
17179886|NCT02590432|38331235|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
17179887|NCT02590432|38331236|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
17179888|NCT02590432|38331237|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
17179889|NCT02590432|38331229|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
17179890|NCT02590432|38331230|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
17179891|NCT02590432|38331231|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
17179892|NCT02590432|38331232|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
17179893|NCT02590432|38331233|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
17179894|NCT02590432|38331234|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
17179895|NCT02590432|38331235|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
17179896|NCT02590432|38331236|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
17179897|NCT02590432|38331237|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
17179898|NCT02590432|38331229|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
17179899|NCT02590432|38331230|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
17179900|NCT02590432|38331231|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
17179901|NCT02590432|38331232|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
17179902|NCT02590432|38331233|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
17179903|NCT02590432|38331234|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
17179904|NCT02590432|38331235|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
17179905|NCT02590432|38331236|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
17179906|NCT02590432|38331237|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
17179907|NCT02590432|38331229|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
17179908|NCT02590432|38331230|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
17179909|NCT02590432|38331231|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
17179910|NCT02590432|38331232|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
17179911|NCT02590432|38331233|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
17179912|NCT02590432|38331234|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
17179913|NCT02590432|38331235|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
17179914|NCT02590432|38331236|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
17179915|NCT02590432|38331237|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
17179916|NCT02590432|38331229|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
17179917|NCT02590432|38331230|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
17179918|NCT02590432|38331231|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
17179919|NCT02590432|38331232|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
17179920|NCT02590432|38331233|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
17179921|NCT02590432|38331234|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
17179922|NCT02590432|38331235|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
17179923|NCT02590432|38331236|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
17179924|NCT02590432|38331237|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
17179925|NCT02590354|38331249|FG000|Phase 1|Active hepatitis B or C infection|1|||
17179926|NCT02590354|38331249|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
17179927|NCT02590354|38331249|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
17179928|NCT02590354|38331249|FG000|Phase 1|Subject does not want to participate|20|||
17179929|NCT02590354|38331249|FG000|Phase 1|Lost to Follow-up|1|||
17179930|NCT02590354|38331249|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
17179931|NCT01667224|38331256|FG000|Overall Study|Withdrawal by Subject|3|||
17179932|NCT01667224|38331257|FG001|Overall Study|Withdrawal by Subject|1|||
17179933|NCT01667224|38331256|FG000|Overall Study|Protocol Violation|1|||
17179934|NCT01667224|38331257|FG001|Overall Study|Protocol Violation|1|||
17179935|NCT03923738|38331265|FG000|Period 1|Adverse Event|1|||
17179936|NCT03923738|38331265|FG000|Period 1|Withdrawal by Subject|1|||
17179937|NCT02588248|38331273|FG000|Overall Study|Physician Decision|4|||
17179938|NCT02588248|38331274|FG001|Overall Study|Physician Decision|3|||
17179939|NCT01328054|38331285|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
17179940|NCT01328054|38331286|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
17179941|NCT01328054|38331285|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
17179942|NCT01328054|38331286|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
17179943|NCT01328054|38331285|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
17179944|NCT01328054|38331286|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
17179945|NCT01849250|38331309|FG000|Overall Study|Withdrawal by Subject|1|||
17179946|NCT01849250|38331310|FG001|Overall Study|Withdrawal by Subject|0|||
17179947|NCT01849250|38331309|FG000|Overall Study|Not Evaluable|5|||
17179948|NCT01849250|38331310|FG001|Overall Study|Not Evaluable|3|||
17179949|NCT01849250|38331309|FG000|Overall Study|Screen Failure|1|||
17179950|NCT01849250|38331310|FG001|Overall Study|Screen Failure|0|||
17179951|NCT02791191|38331320|FG000|Overall Study|Adverse Event|2|||
17179952|NCT02791191|38331321|FG001|Overall Study|Adverse Event|4|||
17179953|NCT02791191|38331322|FG002|Overall Study|Adverse Event|5|||
17179954|NCT02791191|38331320|FG000|Overall Study|Lack of Efficacy|0|||
17179955|NCT02791191|38331321|FG001|Overall Study|Lack of Efficacy|1|||
17179956|NCT02791191|38331322|FG002|Overall Study|Lack of Efficacy|0|||
17179957|NCT02791191|38331320|FG000|Overall Study|Study Drug Non-Compliance|0|||
17179958|NCT02791191|38331321|FG001|Overall Study|Study Drug Non-Compliance|2|||
17179959|NCT02791191|38331322|FG002|Overall Study|Study Drug Non-Compliance|0|||
17179960|NCT02791191|38331320|FG000|Overall Study|Site Closed by Sponsor|1|||
17179961|NCT02791191|38331321|FG001|Overall Study|Site Closed by Sponsor|1|||
17179962|NCT02791191|38331322|FG002|Overall Study|Site Closed by Sponsor|3|||
17179963|NCT02791191|38331320|FG000|Overall Study|Progressive Disease|1|||
17179964|NCT02791191|38331321|FG001|Overall Study|Progressive Disease|0|||
17179965|NCT02791191|38331322|FG002|Overall Study|Progressive Disease|0|||
17179966|NCT02791191|38331320|FG000|Overall Study|Study Terminated by Sponsor|29|||
17179967|NCT02791191|38331321|FG001|Overall Study|Study Terminated by Sponsor|101|||
17179968|NCT02791191|38331322|FG002|Overall Study|Study Terminated by Sponsor|109|||
17179969|NCT02791191|38331320|FG000|Overall Study|Withdrawal by Subject|3|||
17179970|NCT02791191|38331321|FG001|Overall Study|Withdrawal by Subject|1|||
17179971|NCT02791191|38331322|FG002|Overall Study|Withdrawal by Subject|3|||
17179972|NCT02791191|38331320|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
17179973|NCT02791191|38331321|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
17179974|NCT02791191|38331322|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
17179975|NCT02114697|38331345|FG000|Overall Study|Study terminated|5|||
17179976|NCT02114697|38331346|FG001|Overall Study|Study terminated|4|||
17179977|NCT01330017|38331357|FG000|Overall Study|Adverse Event|0|||
17179978|NCT01330017|38331358|FG001|Overall Study|Adverse Event|1|||
17179979|NCT01330017|38331359|FG002|Overall Study|Adverse Event|1|||
17179980|NCT01330017|38331360|FG003|Overall Study|Adverse Event|4|||
17179981|NCT01330017|38331361|FG004|Overall Study|Adverse Event|0|||
17179982|NCT01330017|38331357|FG000|Overall Study|Withdrawal by Subject|0|||
17179983|NCT01330017|38331358|FG001|Overall Study|Withdrawal by Subject|0|||
17179984|NCT01330017|38331359|FG002|Overall Study|Withdrawal by Subject|1|||
17179985|NCT01330017|38331360|FG003|Overall Study|Withdrawal by Subject|0|||
17179986|NCT01330017|38331361|FG004|Overall Study|Withdrawal by Subject|1|||
17179987|NCT01330017|38331357|FG000|Overall Study|Lost to Follow-up|0|||
17179988|NCT01330017|38331358|FG001|Overall Study|Lost to Follow-up|0|||
17179989|NCT01330017|38331359|FG002|Overall Study|Lost to Follow-up|1|||
17179990|NCT01330017|38331360|FG003|Overall Study|Lost to Follow-up|0|||
17179991|NCT01330017|38331361|FG004|Overall Study|Lost to Follow-up|0|||
17179992|NCT01330017|38331357|FG000|Overall Study|Protocol Violation|0|||
17179993|NCT01330017|38331358|FG001|Overall Study|Protocol Violation|0|||
17179994|NCT01330017|38331359|FG002|Overall Study|Protocol Violation|0|||
17179995|NCT01330017|38331360|FG003|Overall Study|Protocol Violation|1|||
17179996|NCT01330017|38331361|FG004|Overall Study|Protocol Violation|0|||
17179997|NCT01330017|38331357|FG000|Overall Study|Unknown Reason|5|||
17179998|NCT01330017|38331358|FG001|Overall Study|Unknown Reason|3|||
17179999|NCT01330017|38331359|FG002|Overall Study|Unknown Reason|5|||
17180000|NCT01330017|38331360|FG003|Overall Study|Unknown Reason|7|||
17180001|NCT01330017|38331361|FG004|Overall Study|Unknown Reason|2|||
17180002|NCT00150462|38331384|FG000|Overall Study|Disease Progression or Relapse|3|||
17180003|NCT00150462|38331385|FG001|Overall Study|Disease Progression or Relapse|1|||
17180004|NCT00150462|38331386|FG002|Overall Study|Disease Progression or Relapse|2|||
17180005|NCT00150462|38331387|FG003|Overall Study|Disease Progression or Relapse|1|||
17180006|NCT00150462|38331388|FG004|Overall Study|Disease Progression or Relapse|2|||
17180007|NCT00150462|38331389|FG005|Overall Study|Disease Progression or Relapse|2|||
17180008|NCT00150462|38331390|FG006|Overall Study|Disease Progression or Relapse|3|||
17180009|NCT00150462|38331391|FG007|Overall Study|Disease Progression or Relapse|5|||
17180010|NCT00150462|38331392|FG008|Overall Study|Disease Progression or Relapse|5|||
17180011|NCT00150462|38331393|FG009|Overall Study|Disease Progression or Relapse|3|||
17180012|NCT00150462|38331394|FG010|Overall Study|Disease Progression or Relapse|2|||
17180013|NCT00150462|38331384|FG000|Overall Study|Withdrawal by Subject|0|||
17180014|NCT00150462|38331385|FG001|Overall Study|Withdrawal by Subject|1|||
17180015|NCT00150462|38331386|FG002|Overall Study|Withdrawal by Subject|1|||
17180016|NCT00150462|38331387|FG003|Overall Study|Withdrawal by Subject|0|||
17180017|NCT00150462|38331388|FG004|Overall Study|Withdrawal by Subject|1|||
17180018|NCT00150462|38331389|FG005|Overall Study|Withdrawal by Subject|2|||
17180019|NCT00150462|38331390|FG006|Overall Study|Withdrawal by Subject|0|||
17180020|NCT00150462|38331391|FG007|Overall Study|Withdrawal by Subject|1|||
17180021|NCT00150462|38331392|FG008|Overall Study|Withdrawal by Subject|0|||
17180022|NCT00150462|38331393|FG009|Overall Study|Withdrawal by Subject|1|||
17180023|NCT00150462|38331394|FG010|Overall Study|Withdrawal by Subject|0|||
17180024|NCT00150462|38331384|FG000|Overall Study|Death|0|||
17180025|NCT00150462|38331385|FG001|Overall Study|Death|1|||
17180026|NCT00150462|38331386|FG002|Overall Study|Death|0|||
17180027|NCT00150462|38331387|FG003|Overall Study|Death|0|||
17180028|NCT00150462|38331388|FG004|Overall Study|Death|0|||
17180029|NCT00150462|38331389|FG005|Overall Study|Death|0|||
17180030|NCT00150462|38331390|FG006|Overall Study|Death|0|||
17180031|NCT00150462|38331391|FG007|Overall Study|Death|0|||
17180032|NCT00150462|38331392|FG008|Overall Study|Death|1|||
17180033|NCT00150462|38331393|FG009|Overall Study|Death|0|||
17180034|NCT00150462|38331394|FG010|Overall Study|Death|0|||
17180035|NCT00150462|38331384|FG000|Overall Study|Adverse Event|0|||
17180036|NCT00150462|38331385|FG001|Overall Study|Adverse Event|0|||
17180037|NCT00150462|38331386|FG002|Overall Study|Adverse Event|0|||
17180038|NCT00150462|38331387|FG003|Overall Study|Adverse Event|1|||
17180039|NCT00150462|38331388|FG004|Overall Study|Adverse Event|0|||
17180040|NCT00150462|38331389|FG005|Overall Study|Adverse Event|0|||
17180041|NCT00150462|38331390|FG006|Overall Study|Adverse Event|0|||
17180042|NCT00150462|38331391|FG007|Overall Study|Adverse Event|2|||
17180043|NCT00150462|38331392|FG008|Overall Study|Adverse Event|0|||
17180044|NCT00150462|38331393|FG009|Overall Study|Adverse Event|1|||
17180045|NCT00150462|38331394|FG010|Overall Study|Adverse Event|0|||
17180046|NCT00150462|38331384|FG000|Overall Study|Physician Decision|0|||
17180047|NCT00150462|38331385|FG001|Overall Study|Physician Decision|0|||
17180048|NCT00150462|38331386|FG002|Overall Study|Physician Decision|1|||
17180049|NCT00150462|38331387|FG003|Overall Study|Physician Decision|1|||
17180050|NCT00150462|38331388|FG004|Overall Study|Physician Decision|0|||
17180051|NCT00150462|38331389|FG005|Overall Study|Physician Decision|0|||
17180052|NCT00150462|38331390|FG006|Overall Study|Physician Decision|0|||
17180053|NCT00150462|38331391|FG007|Overall Study|Physician Decision|0|||
17180054|NCT00150462|38331392|FG008|Overall Study|Physician Decision|0|||
17180055|NCT00150462|38331393|FG009|Overall Study|Physician Decision|0|||
17180056|NCT00150462|38331394|FG010|Overall Study|Physician Decision|0|||
17180057|NCT00150462|38331384|FG000|Overall Study|Other|0|||
17180058|NCT00150462|38331385|FG001|Overall Study|Other|0|||
17180059|NCT00150462|38331386|FG002|Overall Study|Other|0|||
17180060|NCT00150462|38331387|FG003|Overall Study|Other|0|||
17180061|NCT00150462|38331388|FG004|Overall Study|Other|0|||
17180062|NCT00150462|38331389|FG005|Overall Study|Other|0|||
17180063|NCT00150462|38331390|FG006|Overall Study|Other|0|||
17180064|NCT00150462|38331391|FG007|Overall Study|Other|0|||
17180065|NCT00150462|38331392|FG008|Overall Study|Other|0|||
17180066|NCT00150462|38331393|FG009|Overall Study|Other|1|||
17180067|NCT00150462|38331394|FG010|Overall Study|Other|1|||
17180068|NCT01368081|38331434|FG000|Overall Study|Adverse Event|4|||
17180069|NCT01368081|38331435|FG001|Overall Study|Adverse Event|4|||
17180070|NCT01368081|38331436|FG002|Overall Study|Adverse Event|3|||
17180071|NCT01368081|38331437|FG003|Overall Study|Adverse Event|2|||
17180072|NCT01368081|38331438|FG004|Overall Study|Adverse Event|2|||
17180073|NCT01368081|38331439|FG005|Overall Study|Adverse Event|5|||
17180074|NCT01368081|38331440|FG006|Overall Study|Adverse Event|6|||
17180075|NCT01368081|38331441|FG007|Overall Study|Adverse Event|2|||
17180076|NCT01368081|38331442|FG008|Overall Study|Adverse Event|3|||
17180077|NCT01368081|38331443|FG009|Overall Study|Adverse Event|5|||
17180078|NCT01368081|38331444|FG010|Overall Study|Adverse Event|6|||
17180079|NCT01368081|38331445|FG011|Overall Study|Adverse Event|1|||
17180080|NCT01368081|38331446|FG012|Overall Study|Adverse Event|3|||
17180081|NCT01368081|38331434|FG000|Overall Study|Lack of Efficacy|0|||
17180082|NCT01368081|38331435|FG001|Overall Study|Lack of Efficacy|1|||
17180083|NCT01368081|38331436|FG002|Overall Study|Lack of Efficacy|0|||
17180084|NCT01368081|38331437|FG003|Overall Study|Lack of Efficacy|1|||
17180085|NCT01368081|38331438|FG004|Overall Study|Lack of Efficacy|0|||
17180086|NCT01368081|38331439|FG005|Overall Study|Lack of Efficacy|0|||
17180087|NCT01368081|38331440|FG006|Overall Study|Lack of Efficacy|0|||
17180088|NCT01368081|38331441|FG007|Overall Study|Lack of Efficacy|2|||
17180089|NCT01368081|38331442|FG008|Overall Study|Lack of Efficacy|0|||
17180090|NCT01368081|38331443|FG009|Overall Study|Lack of Efficacy|0|||
17180091|NCT01368081|38331444|FG010|Overall Study|Lack of Efficacy|0|||
17180092|NCT01368081|38331445|FG011|Overall Study|Lack of Efficacy|0|||
17180093|NCT01368081|38331446|FG012|Overall Study|Lack of Efficacy|0|||
17180094|NCT01368081|38331434|FG000|Overall Study|Protocol Violation|0|||
17180095|NCT01368081|38331435|FG001|Overall Study|Protocol Violation|0|||
17180096|NCT01368081|38331436|FG002|Overall Study|Protocol Violation|0|||
16996842|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
16996843|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
16996844|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
16996845|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
16996846|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
16996847|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
16996848|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
16996849|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
16996850|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
16996851|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16996852|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
16996853|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16996854|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16996855|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16996856|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
16996857|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
16996858|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
16996859|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
16996860|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
16996861|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
16996862|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
16996863|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
16996864|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
16996865|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
16996866|NCT03107793|38140956|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
16996867|NCT03107793|38140957|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
16996868|NCT03107793|38140958|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
16996869|NCT03107793|38140959|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
16996870|NCT03107793|38140960|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
16996871|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
16996872|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
16996873|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
16996874|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
16996875|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
16996876|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
16996877|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
16996878|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
16996879|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
16996880|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
16996881|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
16996882|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
16996883|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
16996884|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
16996885|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
16996886|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Death|0|||
16996887|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Death|0|||
16996888|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Death|0|||
16996889|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Death|0|||
16996890|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Death|1|||
16996891|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
16996892|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
16996893|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
16996894|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
17180097|NCT01368081|38331437|FG003|Overall Study|Protocol Violation|0|||
17180098|NCT01368081|38331438|FG004|Overall Study|Protocol Violation|0|||
17180099|NCT01368081|38331439|FG005|Overall Study|Protocol Violation|1|||
17180100|NCT01368081|38331440|FG006|Overall Study|Protocol Violation|0|||
17180101|NCT01368081|38331441|FG007|Overall Study|Protocol Violation|1|||
17180102|NCT01368081|38331442|FG008|Overall Study|Protocol Violation|0|||
17180103|NCT01368081|38331443|FG009|Overall Study|Protocol Violation|0|||
17180104|NCT01368081|38331444|FG010|Overall Study|Protocol Violation|0|||
17180105|NCT01368081|38331445|FG011|Overall Study|Protocol Violation|0|||
17180106|NCT01368081|38331446|FG012|Overall Study|Protocol Violation|0|||
17180107|NCT01368081|38331434|FG000|Overall Study|Lost to Follow-up|0|||
17180108|NCT01368081|38331435|FG001|Overall Study|Lost to Follow-up|0|||
17180109|NCT01368081|38331436|FG002|Overall Study|Lost to Follow-up|0|||
17180110|NCT01368081|38331437|FG003|Overall Study|Lost to Follow-up|0|||
17180111|NCT01368081|38331438|FG004|Overall Study|Lost to Follow-up|0|||
17180112|NCT01368081|38331439|FG005|Overall Study|Lost to Follow-up|0|||
17180113|NCT01368081|38331440|FG006|Overall Study|Lost to Follow-up|0|||
17180114|NCT01368081|38331441|FG007|Overall Study|Lost to Follow-up|0|||
17180115|NCT01368081|38331442|FG008|Overall Study|Lost to Follow-up|0|||
17180116|NCT01368081|38331443|FG009|Overall Study|Lost to Follow-up|0|||
17180117|NCT01368081|38331444|FG010|Overall Study|Lost to Follow-up|0|||
17180118|NCT01368081|38331445|FG011|Overall Study|Lost to Follow-up|0|||
17180119|NCT01368081|38331446|FG012|Overall Study|Lost to Follow-up|1|||
17180120|NCT01368081|38331434|FG000|Overall Study|Withdrawal by Subject|4|||
17180121|NCT01368081|38331435|FG001|Overall Study|Withdrawal by Subject|4|||
17180122|NCT01368081|38331436|FG002|Overall Study|Withdrawal by Subject|1|||
17180123|NCT01368081|38331437|FG003|Overall Study|Withdrawal by Subject|1|||
17180124|NCT01368081|38331438|FG004|Overall Study|Withdrawal by Subject|0|||
17180125|NCT01368081|38331439|FG005|Overall Study|Withdrawal by Subject|3|||
17180126|NCT01368081|38331440|FG006|Overall Study|Withdrawal by Subject|4|||
17180127|NCT01368081|38331441|FG007|Overall Study|Withdrawal by Subject|2|||
17180128|NCT01368081|38331442|FG008|Overall Study|Withdrawal by Subject|5|||
17180129|NCT01368081|38331443|FG009|Overall Study|Withdrawal by Subject|4|||
17180130|NCT01368081|38331444|FG010|Overall Study|Withdrawal by Subject|3|||
17180131|NCT01368081|38331445|FG011|Overall Study|Withdrawal by Subject|2|||
17180132|NCT01368081|38331446|FG012|Overall Study|Withdrawal by Subject|0|||
17180133|NCT01368081|38331434|FG000|Overall Study|Other reason not defined above|2|||
17180134|NCT01368081|38331435|FG001|Overall Study|Other reason not defined above|0|||
17180135|NCT01368081|38331436|FG002|Overall Study|Other reason not defined above|0|||
17180136|NCT01368081|38331437|FG003|Overall Study|Other reason not defined above|1|||
17180137|NCT01368081|38331438|FG004|Overall Study|Other reason not defined above|0|||
17180138|NCT01368081|38331439|FG005|Overall Study|Other reason not defined above|1|||
17180139|NCT01368081|38331440|FG006|Overall Study|Other reason not defined above|2|||
17180140|NCT01368081|38331441|FG007|Overall Study|Other reason not defined above|0|||
17180141|NCT01368081|38331442|FG008|Overall Study|Other reason not defined above|0|||
17180142|NCT01368081|38331443|FG009|Overall Study|Other reason not defined above|1|||
17180143|NCT01368081|38331444|FG010|Overall Study|Other reason not defined above|0|||
17180144|NCT01368081|38331445|FG011|Overall Study|Other reason not defined above|0|||
17180145|NCT01368081|38331446|FG012|Overall Study|Other reason not defined above|3|||
17180146|NCT00303498|38331476|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
17180147|NCT00303498|38331477|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
17180148|NCT00303498|38331476|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
17180149|NCT00303498|38331477|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
17180150|NCT00303498|38331476|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
17180151|NCT00303498|38331477|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
17180152|NCT00303498|38331476|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
17180153|NCT00303498|38331477|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
17180154|NCT00303498|38331476|FG000|Run-In-Phase (10 Weeks)|Other|4|||
17180155|NCT00303498|38331477|FG001|Run-In-Phase (10 Weeks)|Other|1|||
17180156|NCT00303498|38331476|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
17180157|NCT00303498|38331477|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
17180158|NCT00303498|38331476|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
17180159|NCT00303498|38331477|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
17180160|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
17180161|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
17180162|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Death|1|||
17180163|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Death|0|||
17180164|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
17180165|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
17180166|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
17180167|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
17180168|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
17180169|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
17180170|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
17180171|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
17180172|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Other|1|||
17180173|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Other|0|||
17180174|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
17180175|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
17180176|NCT00303498|38331476|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
17180177|NCT00303498|38331477|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
17180178|NCT02588092|38331493|FG000|Overall Study|Death|4|||
17180179|NCT02588092|38331494|FG001|Overall Study|Death|3|||
17180180|NCT02588092|38331495|FG002|Overall Study|Death|3|||
17180181|NCT02588092|38331496|FG003|Overall Study|Death|3|||
17180182|NCT02588092|38331497|FG004|Overall Study|Death|2|||
17180183|NCT02588092|38331498|FG005|Overall Study|Death|2|||
17180184|NCT02588092|38331499|FG006|Overall Study|Death|2|||
17180185|NCT02588092|38331500|FG007|Overall Study|Death|1|||
17180186|NCT02588092|38331501|FG008|Overall Study|Death|5|||
17180187|NCT02588092|38331502|FG009|Overall Study|Death|2|||
17180188|NCT02588092|38331493|FG000|Overall Study|Withdrawal by Subject|0|||
17180189|NCT02588092|38331494|FG001|Overall Study|Withdrawal by Subject|0|||
17180190|NCT02588092|38331495|FG002|Overall Study|Withdrawal by Subject|0|||
17180191|NCT02588092|38331496|FG003|Overall Study|Withdrawal by Subject|0|||
17180192|NCT02588092|38331497|FG004|Overall Study|Withdrawal by Subject|0|||
17180193|NCT02588092|38331498|FG005|Overall Study|Withdrawal by Subject|1|||
17180194|NCT02588092|38331499|FG006|Overall Study|Withdrawal by Subject|1|||
17180195|NCT02588092|38331500|FG007|Overall Study|Withdrawal by Subject|2|||
17180196|NCT02588092|38331501|FG008|Overall Study|Withdrawal by Subject|0|||
17180197|NCT02588092|38331502|FG009|Overall Study|Withdrawal by Subject|0|||
17180198|NCT02588092|38331493|FG000|Overall Study|Started Another Treatment|0|||
17180199|NCT02588092|38331494|FG001|Overall Study|Started Another Treatment|0|||
17180200|NCT02588092|38331495|FG002|Overall Study|Started Another Treatment|0|||
17180201|NCT02588092|38331496|FG003|Overall Study|Started Another Treatment|0|||
17180202|NCT02588092|38331497|FG004|Overall Study|Started Another Treatment|1|||
17180203|NCT02588092|38331498|FG005|Overall Study|Started Another Treatment|0|||
17180204|NCT02588092|38331499|FG006|Overall Study|Started Another Treatment|0|||
17180205|NCT02588092|38331500|FG007|Overall Study|Started Another Treatment|1|||
17180206|NCT02588092|38331501|FG008|Overall Study|Started Another Treatment|0|||
17180207|NCT02588092|38331502|FG009|Overall Study|Started Another Treatment|0|||
17180208|NCT02588092|38331493|FG000|Overall Study|Sponsor Decision|0|||
17180209|NCT02588092|38331494|FG001|Overall Study|Sponsor Decision|0|||
17180210|NCT02588092|38331495|FG002|Overall Study|Sponsor Decision|0|||
17180211|NCT02588092|38331496|FG003|Overall Study|Sponsor Decision|0|||
17180212|NCT02588092|38331497|FG004|Overall Study|Sponsor Decision|0|||
17180213|NCT02588092|38331498|FG005|Overall Study|Sponsor Decision|0|||
17180214|NCT02588092|38331499|FG006|Overall Study|Sponsor Decision|0|||
17180215|NCT02588092|38331500|FG007|Overall Study|Sponsor Decision|0|||
17180216|NCT02588092|38331501|FG008|Overall Study|Sponsor Decision|1|||
16996895|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
16996896|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
16996897|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
16996898|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
16996899|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
16996900|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
16996901|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
16996902|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
16996903|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
16996904|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
16996905|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
16996906|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
16996907|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
16996908|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
16996909|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
16996910|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
16996911|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
16996912|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
16996913|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
16996914|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
16996915|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
16996916|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Other|0|||
17180217|NCT02588092|38331502|FG009|Overall Study|Sponsor Decision|1|||
17180218|NCT01367847|38331530|FG000|Overall Study|Withdrawal by Subject|2|||
17180219|NCT01367847|38331531|FG001|Overall Study|Withdrawal by Subject|2|||
17180220|NCT00150618|38331543|FG000|Overall Study|Adverse Event|2|||
17180221|NCT00150618|38331544|FG001|Overall Study|Adverse Event|2|||
17180222|NCT00150618|38331545|FG002|Overall Study|Adverse Event|6|||
17180223|NCT00150618|38331546|FG003|Overall Study|Adverse Event|9|||
17180224|NCT00150618|38331547|FG004|Overall Study|Adverse Event|5|||
17180225|NCT00150618|38331543|FG000|Overall Study|Withdrawal by Subject|6|||
17180226|NCT00150618|38331544|FG001|Overall Study|Withdrawal by Subject|8|||
17180227|NCT00150618|38331545|FG002|Overall Study|Withdrawal by Subject|8|||
17180228|NCT00150618|38331546|FG003|Overall Study|Withdrawal by Subject|4|||
17180229|NCT00150618|38331547|FG004|Overall Study|Withdrawal by Subject|5|||
17180230|NCT00150618|38331543|FG000|Overall Study|Lost to Follow-up|4|||
17180231|NCT00150618|38331544|FG001|Overall Study|Lost to Follow-up|1|||
17180232|NCT00150618|38331545|FG002|Overall Study|Lost to Follow-up|5|||
17180233|NCT00150618|38331546|FG003|Overall Study|Lost to Follow-up|8|||
17180234|NCT00150618|38331547|FG004|Overall Study|Lost to Follow-up|4|||
17180235|NCT00150618|38331543|FG000|Overall Study|Protocol Violation|1|||
17180236|NCT00150618|38331544|FG001|Overall Study|Protocol Violation|0|||
17180237|NCT00150618|38331545|FG002|Overall Study|Protocol Violation|0|||
17180238|NCT00150618|38331546|FG003|Overall Study|Protocol Violation|0|||
17180239|NCT00150618|38331547|FG004|Overall Study|Protocol Violation|1|||
17180240|NCT00150618|38331543|FG000|Overall Study|Lack of Efficacy|1|||
17180241|NCT00150618|38331544|FG001|Overall Study|Lack of Efficacy|4|||
17180242|NCT00150618|38331545|FG002|Overall Study|Lack of Efficacy|7|||
17180243|NCT00150618|38331546|FG003|Overall Study|Lack of Efficacy|4|||
17180244|NCT00150618|38331547|FG004|Overall Study|Lack of Efficacy|6|||
17180245|NCT00150618|38331543|FG000|Overall Study|No study meds|0|||
17180246|NCT00150618|38331544|FG001|Overall Study|No study meds|0|||
17180247|NCT00150618|38331545|FG002|Overall Study|No study meds|0|||
17180248|NCT00150618|38331546|FG003|Overall Study|No study meds|0|||
17180249|NCT00150618|38331547|FG004|Overall Study|No study meds|2|||
17180250|NCT00150618|38331543|FG000|Overall Study|Physician Decision|0|||
17180251|NCT00150618|38331544|FG001|Overall Study|Physician Decision|2|||
17180252|NCT00150618|38331545|FG002|Overall Study|Physician Decision|0|||
17180253|NCT00150618|38331546|FG003|Overall Study|Physician Decision|0|||
17180254|NCT00150618|38331547|FG004|Overall Study|Physician Decision|1|||
17180255|NCT00150618|38331543|FG000|Overall Study|Lack of compliance|2|||
17180256|NCT00150618|38331544|FG001|Overall Study|Lack of compliance|1|||
17180257|NCT00150618|38331545|FG002|Overall Study|Lack of compliance|1|||
17180258|NCT00150618|38331546|FG003|Overall Study|Lack of compliance|0|||
17180259|NCT00150618|38331547|FG004|Overall Study|Lack of compliance|1|||
17180260|NCT00150618|38331543|FG000|Overall Study|Abnormal ECG|1|||
17180261|NCT00150618|38331544|FG001|Overall Study|Abnormal ECG|0|||
17180262|NCT00150618|38331545|FG002|Overall Study|Abnormal ECG|0|||
17180263|NCT00150618|38331546|FG003|Overall Study|Abnormal ECG|0|||
17180264|NCT00150618|38331547|FG004|Overall Study|Abnormal ECG|0|||
17180265|NCT00150618|38331543|FG000|Overall Study|Sponsor's decision|0|||
17180266|NCT00150618|38331544|FG001|Overall Study|Sponsor's decision|0|||
17180267|NCT00150618|38331545|FG002|Overall Study|Sponsor's decision|0|||
17180268|NCT00150618|38331546|FG003|Overall Study|Sponsor's decision|1|||
17180269|NCT00150618|38331547|FG004|Overall Study|Sponsor's decision|0|||
17180270|NCT02587234|38331561|FG000|Overall Study|Withdrawal by Subject|1|||
17180271|NCT02587234|38331562|FG001|Overall Study|Withdrawal by Subject|1|||
17180272|NCT02587234|38331561|FG000|Overall Study|Lost to Follow-up|0|||
17180273|NCT02587234|38331562|FG001|Overall Study|Lost to Follow-up|2|||
17180274|NCT01359046|38331570|FG000|Overall Study|Did not receive allocated intervention|6|||
17180275|NCT01359046|38331571|FG001|Overall Study|Did not receive allocated intervention|6|||
17180276|NCT01359046|38331570|FG000|Overall Study|Physician Decision|1|||
17180277|NCT01359046|38331571|FG001|Overall Study|Physician Decision|11|||
17180278|NCT02741310|38331579|FG000|Overall Study|Sponsor Decision|2|||
17180279|NCT02741310|38331580|FG001|Overall Study|Sponsor Decision|2|||
17180280|NCT01367457|38331597|FG000|Overall Study|Death|2|||
17180281|NCT01367457|38331598|FG001|Overall Study|Death|0|||
17180282|NCT01367457|38331599|FG002|Overall Study|Death|0|||
17180283|NCT01367457|38331597|FG000|Overall Study|Investigator's decision|2|||
17180284|NCT01367457|38331598|FG001|Overall Study|Investigator's decision|0|||
17180285|NCT01367457|38331599|FG002|Overall Study|Investigator's decision|0|||
17180286|NCT01367457|38331597|FG000|Overall Study|Clinical decline (CD)|2|||
17180287|NCT01367457|38331598|FG001|Overall Study|Clinical decline (CD)|0|||
17180288|NCT01367457|38331599|FG002|Overall Study|Clinical decline (CD)|0|||
17180289|NCT01367457|38331597|FG000|Overall Study|Progression and death|8|||
17180290|NCT01367457|38331598|FG001|Overall Study|Progression and death|0|||
17180291|NCT01367457|38331599|FG002|Overall Study|Progression and death|0|||
17180292|NCT01367457|38331597|FG000|Overall Study|Toxicity|16|||
17180293|NCT01367457|38331598|FG001|Overall Study|Toxicity|0|||
17180294|NCT01367457|38331599|FG002|Overall Study|Toxicity|0|||
17180295|NCT01367457|38331597|FG000|Overall Study|Progression|137|||
17180296|NCT01367457|38331598|FG001|Overall Study|Progression|0|||
17180297|NCT01367457|38331599|FG002|Overall Study|Progression|0|||
17180298|NCT01367457|38331597|FG000|Overall Study|Patient asks for rest + slow progression|1|||
17180299|NCT01367457|38331598|FG001|Overall Study|Patient asks for rest + slow progression|0|||
17180300|NCT01367457|38331599|FG002|Overall Study|Patient asks for rest + slow progression|0|||
17180301|NCT01367457|38331597|FG000|Overall Study|Investigator's opinion, stable disease|1|||
17180302|NCT01367457|38331598|FG001|Overall Study|Investigator's opinion, stable disease|0|||
17180303|NCT01367457|38331599|FG002|Overall Study|Investigator's opinion, stable disease|0|||
17180304|NCT01367457|38331597|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
17180305|NCT01367457|38331598|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
17180306|NCT01367457|38331599|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
17180307|NCT01367457|38331597|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
17180308|NCT01367457|38331598|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
17180309|NCT01367457|38331599|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
17180310|NCT01367457|38331597|FG000|Overall Study|low grade toxicities + stable disease|1|||
17180311|NCT01367457|38331598|FG001|Overall Study|low grade toxicities + stable disease|0|||
17180312|NCT01367457|38331599|FG002|Overall Study|low grade toxicities + stable disease|0|||
17180313|NCT01367457|38331597|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
17180314|NCT01367457|38331598|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
17180315|NCT01367457|38331599|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
17180316|NCT01367457|38331597|FG000|Overall Study|Withdrawal by Subject|1|||
17180317|NCT01367457|38331598|FG001|Overall Study|Withdrawal by Subject|0|||
17180318|NCT01367457|38331599|FG002|Overall Study|Withdrawal by Subject|0|||
17180319|NCT01367457|38331597|FG000|Overall Study|CD, associated leukaemia|1|||
17180320|NCT01367457|38331598|FG001|Overall Study|CD, associated leukaemia|0|||
17180321|NCT01367457|38331599|FG002|Overall Study|CD, associated leukaemia|0|||
17180322|NCT01367457|38331597|FG000|Overall Study|Uncontrolled pain|1|||
17180323|NCT01367457|38331598|FG001|Overall Study|Uncontrolled pain|0|||
17180324|NCT01367457|38331599|FG002|Overall Study|Uncontrolled pain|0|||
17180325|NCT01367457|38331597|FG000|Overall Study|Overall status worsens to grade 4|1|||
17180326|NCT01367457|38331598|FG001|Overall Study|Overall status worsens to grade 4|0|||
17180327|NCT01367457|38331599|FG002|Overall Study|Overall status worsens to grade 4|0|||
17180328|NCT01367457|38331597|FG000|Overall Study|Stabilisation + frequent infections|1|||
17180329|NCT01367457|38331598|FG001|Overall Study|Stabilisation + frequent infections|0|||
17180330|NCT01367457|38331599|FG002|Overall Study|Stabilisation + frequent infections|0|||
17180331|NCT01367457|38331597|FG000|Overall Study|No clinical benefit|1|||
17180332|NCT01367457|38331598|FG001|Overall Study|No clinical benefit|0|||
17180333|NCT01367457|38331599|FG002|Overall Study|No clinical benefit|0|||
17180334|NCT01367457|38331597|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
17180335|NCT01367457|38331598|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
17180336|NCT01367457|38331599|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
17180337|NCT01367457|38331597|FG000|Overall Study|Overall decline|1|||
17180338|NCT01367457|38331598|FG001|Overall Study|Overall decline|0|||
17180339|NCT01367457|38331599|FG002|Overall Study|Overall decline|0|||
17180340|NCT01367457|38331597|FG000|Overall Study|Rejection of treatment|1|||
17180341|NCT01367457|38331598|FG001|Overall Study|Rejection of treatment|0|||
17180342|NCT01367457|38331599|FG002|Overall Study|Rejection of treatment|0|||
17180343|NCT01367457|38331597|FG000|Overall Study|Lost to Follow-up|1|||
17180344|NCT01367457|38331598|FG001|Overall Study|Lost to Follow-up|0|||
17180345|NCT01367457|38331599|FG002|Overall Study|Lost to Follow-up|0|||
17180346|NCT01367457|38331597|FG000|Overall Study|Death from septic shock|1|||
17180347|NCT01367457|38331598|FG001|Overall Study|Death from septic shock|0|||
17180348|NCT01367457|38331599|FG002|Overall Study|Death from septic shock|0|||
17180349|NCT01367457|38331597|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
17180350|NCT01367457|38331598|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
17180351|NCT01367457|38331599|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
17180352|NCT01367457|38331597|FG000|Overall Study|Patient's Wish|1|||
17180353|NCT01367457|38331598|FG001|Overall Study|Patient's Wish|0|||
17180354|NCT01367457|38331599|FG002|Overall Study|Patient's Wish|0|||
17180355|NCT01367457|38331597|FG000|Overall Study|Palliative. Overall decline|1|||
17180356|NCT01367457|38331598|FG001|Overall Study|Palliative. Overall decline|0|||
17180357|NCT01367457|38331599|FG002|Overall Study|Palliative. Overall decline|0|||
17180358|NCT01367457|38331597|FG000|Overall Study|Suspected DP/suspected active infection|1|||
17180359|NCT01367457|38331598|FG001|Overall Study|Suspected DP/suspected active infection|0|||
17180360|NCT01367457|38331599|FG002|Overall Study|Suspected DP/suspected active infection|0|||
17180361|NCT00235326|38331609|FG000|Overall Study|Lost to Follow-up|746|||
17180362|NCT00235326|38331610|FG001|Overall Study|Lost to Follow-up|1400|||
17189072|NCT01060111|38342040|FG000|Overall Study|Inappropriate participant|5|||
17189073|NCT01060111|38342041|FG001|Overall Study|Inappropriate participant|4|||
17189074|NCT01060111|38342042|FG002|Overall Study|Inappropriate participant|5|||
17189075|NCT01060111|38342040|FG000|Overall Study|Participants' evasion for hospital visit|0|||
17189076|NCT01060111|38342041|FG001|Overall Study|Participants' evasion for hospital visit|3|||
17189077|NCT01060111|38342042|FG002|Overall Study|Participants' evasion for hospital visit|2|||
17189078|NCT01060111|38342040|FG000|Overall Study|Participants' non-cooperation|8|||
17189079|NCT01060111|38342041|FG001|Overall Study|Participants' non-cooperation|6|||
17189080|NCT01060111|38342042|FG002|Overall Study|Participants' non-cooperation|6|||
17189081|NCT01060111|38342040|FG000|Overall Study|Adverse event and insufficient effect|0|||
17189082|NCT01060111|38342041|FG001|Overall Study|Adverse event and insufficient effect|1|||
17180363|NCT00162942|38331620|FG000|Overall Study|Adverse Event|10|||
17180364|NCT00162942|38331621|FG001|Overall Study|Adverse Event|6|||
17180365|NCT00162942|38331620|FG000|Overall Study|Death|1|||
17180366|NCT00162942|38331621|FG001|Overall Study|Death|0|||
17180367|NCT00162942|38331620|FG000|Overall Study|Withdrawal by Subject|3|||
17180368|NCT00162942|38331621|FG001|Overall Study|Withdrawal by Subject|6|||
17180369|NCT00162942|38331620|FG000|Overall Study|Physician Decision|1|||
17180370|NCT00162942|38331621|FG001|Overall Study|Physician Decision|0|||
17180371|NCT00162942|38331620|FG000|Overall Study|Enter Open-Label Study|76|||
17180372|NCT00162942|38331621|FG001|Overall Study|Enter Open-Label Study|35|||
17180373|NCT00162942|38331620|FG000|Overall Study|Alternate Therapy|6|||
17180374|NCT00162942|38331621|FG001|Overall Study|Alternate Therapy|2|||
17180375|NCT00162942|38331620|FG000|Overall Study|Lack of Efficacy|1|||
17180376|NCT00162942|38331621|FG001|Overall Study|Lack of Efficacy|0|||
17180377|NCT00162942|38331620|FG000|Overall Study|Flare During Active Treatment|7|||
17180378|NCT00162942|38331621|FG001|Overall Study|Flare During Active Treatment|3|||
17180379|NCT00162942|38331620|FG000|Overall Study|2 or more consecutive treatments missed|1|||
17180380|NCT00162942|38331621|FG001|Overall Study|2 or more consecutive treatments missed|0|||
17180381|NCT02786901|38331651|FG000|Overall Study|Adverse Event|1|||
17180382|NCT02786901|38331652|FG001|Overall Study|Adverse Event|1|||
17180383|NCT02786901|38331653|FG002|Overall Study|Adverse Event|2|||
17180384|NCT02786901|38331651|FG000|Overall Study|Physician Decision|1|||
17180385|NCT02786901|38331652|FG001|Overall Study|Physician Decision|0|||
17180386|NCT02786901|38331653|FG002|Overall Study|Physician Decision|0|||
17180387|NCT02786901|38331651|FG000|Overall Study|Rescue Therapy Use|71|||
17180388|NCT02786901|38331652|FG001|Overall Study|Rescue Therapy Use|49|||
17180389|NCT02786901|38331653|FG002|Overall Study|Rescue Therapy Use|33|||
17180390|NCT02786901|38331651|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
17180391|NCT02786901|38331652|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
17180392|NCT02786901|38331653|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
17180393|NCT02786901|38331651|FG000|Overall Study|Disallowed medication|1|||
17180394|NCT02786901|38331652|FG001|Overall Study|Disallowed medication|1|||
17180395|NCT02786901|38331653|FG002|Overall Study|Disallowed medication|0|||
17180396|NCT02786901|38331651|FG000|Overall Study|Randomized in error|2|||
17180397|NCT02786901|38331652|FG001|Overall Study|Randomized in error|0|||
17180398|NCT02786901|38331653|FG002|Overall Study|Randomized in error|1|||
17180399|NCT02137239|38331663|FG000|Overall Study|Discontinued Study Treatment|0|||
17180400|NCT02137239|38331664|FG001|Overall Study|Discontinued Study Treatment|3|||
17180401|NCT02137239|38331663|FG000|Overall Study|Withdrew Consent|1|||
17180402|NCT02137239|38331664|FG001|Overall Study|Withdrew Consent|1|||
17180403|NCT02137239|38331663|FG000|Overall Study|Adverse Event|2|||
17180404|NCT02137239|38331664|FG001|Overall Study|Adverse Event|2|||
17180405|NCT02741076|38331683|FG000|Overall Study|Adverse Event|0|||
17180406|NCT02741076|38331684|FG001|Overall Study|Adverse Event|1|||
17180407|NCT02741076|38331685|FG002|Overall Study|Adverse Event|1|||
17180408|NCT02741076|38331686|FG003|Overall Study|Adverse Event|0|||
17180409|NCT02741076|38331683|FG000|Overall Study|Lack of Efficacy|1|||
17180410|NCT02741076|38331684|FG001|Overall Study|Lack of Efficacy|0|||
17180411|NCT02741076|38331685|FG002|Overall Study|Lack of Efficacy|0|||
17180412|NCT02741076|38331686|FG003|Overall Study|Lack of Efficacy|0|||
17180413|NCT02741076|38331683|FG000|Overall Study|Withdrawal by Subject|0|||
17180414|NCT02741076|38331684|FG001|Overall Study|Withdrawal by Subject|1|||
17180415|NCT02741076|38331685|FG002|Overall Study|Withdrawal by Subject|0|||
17180416|NCT02741076|38331686|FG003|Overall Study|Withdrawal by Subject|0|||
17180417|NCT02741076|38331683|FG000|Overall Study|Sponsor Request|2|||
17180418|NCT02741076|38331684|FG001|Overall Study|Sponsor Request|3|||
17180419|NCT02741076|38331685|FG002|Overall Study|Sponsor Request|0|||
17180420|NCT02741076|38331686|FG003|Overall Study|Sponsor Request|1|||
17180421|NCT02741076|38331683|FG000|Overall Study|No additional information available|0|||
17180422|NCT02741076|38331684|FG001|Overall Study|No additional information available|0|||
17180423|NCT02741076|38331685|FG002|Overall Study|No additional information available|1|||
17180424|NCT02741076|38331686|FG003|Overall Study|No additional information available|1|||
17180425|NCT01666444|38331699|FG000|Overall Study|Did not initiate treatment|2|||
17180426|NCT01666444|38331700|FG001|Overall Study|Did not initiate treatment|1|||
17180427|NCT05159622|38331708|FG000|Overall Study|Lost to Follow-up|4|||
17180428|NCT05159622|38331709|FG001|Overall Study|Lost to Follow-up|5|||
17180429|NCT01665430|38331721|FG000|Overall Study|Adverse Event|1|||
17180430|NCT01665430|38331721|FG000|Overall Study|Withdrawal by Subject|6|||
17180431|NCT01665430|38331721|FG000|Overall Study|Other Unspecified|2|||
17180432|NCT02739594|38331727|FG000|Overall Study|Undesired Event|3|||
17180433|NCT02739594|38331728|FG001|Overall Study|Undesired Event|4|||
17180434|NCT02739594|38331727|FG000|Overall Study|Violation of Eligibility Criteria|1|||
17180435|NCT02739594|38331728|FG001|Overall Study|Violation of Eligibility Criteria|2|||
17180436|NCT02739594|38331727|FG000|Overall Study|Protocol Violation|5|||
17180437|NCT02739594|38331728|FG001|Overall Study|Protocol Violation|6|||
17180438|NCT02739594|38331727|FG000|Overall Study|Death|4|||
17180439|NCT02739594|38331728|FG001|Overall Study|Death|2|||
17180440|NCT02739594|38331727|FG000|Overall Study|Renal Insufficiency|4|||
17180441|NCT02739594|38331728|FG001|Overall Study|Renal Insufficiency|6|||
17180442|NCT02739594|38331727|FG000|Overall Study|Administrative Reasons|1|||
17180443|NCT02739594|38331728|FG001|Overall Study|Administrative Reasons|3|||
17180444|NCT02739594|38331727|FG000|Overall Study|Withdrawal by Subject|1|||
17180445|NCT02739594|38331728|FG001|Overall Study|Withdrawal by Subject|1|||
17180446|NCT02739594|38331727|FG000|Overall Study|Lost to Follow-up|0|||
17180447|NCT02739594|38331728|FG001|Overall Study|Lost to Follow-up|1|||
17180448|NCT02739594|38331727|FG000|Overall Study|Elevated Serum Creatinine|0|||
17180449|NCT02739594|38331728|FG001|Overall Study|Elevated Serum Creatinine|1|||
17180450|NCT02739594|38331727|FG000|Overall Study|Other|6|||
17180451|NCT02739594|38331728|FG001|Overall Study|Other|2|||
17180452|NCT03989232|38331737|FG000|Overall Study|Lost to Follow-up|3|||
17180453|NCT03989232|38331738|FG001|Overall Study|Lost to Follow-up|10|||
17180454|NCT03989232|38331737|FG000|Overall Study|Withdrawal by Subject|6|||
17180455|NCT03989232|38331738|FG001|Overall Study|Withdrawal by Subject|6|||
17180456|NCT03989232|38331737|FG000|Overall Study|Death|1|||
17180457|NCT03989232|38331738|FG001|Overall Study|Death|2|||
17180458|NCT02585830|38331744|FG000|Overall Study|Withdrawal by Subject|3|||
17180459|NCT02584504|38331751|FG000|Double-blind Treatment|Participant withdrew consent|0|||
17180460|NCT02584504|38331752|FG001|Double-blind Treatment|Participant withdrew consent|0|||
17180461|NCT02584504|38331753|FG002|Double-blind Treatment|Participant withdrew consent|1|||
17180462|NCT02584504|38331751|FG000|Double-blind Treatment|Adverse Event|0|||
17180463|NCT02584504|38331752|FG001|Double-blind Treatment|Adverse Event|1|||
17180464|NCT02584504|38331753|FG002|Double-blind Treatment|Adverse Event|0|||
17180465|NCT02584504|38331751|FG000|Double-blind Treatment|Family Matter|0|||
17180466|NCT02584504|38331752|FG001|Double-blind Treatment|Family Matter|1|||
17180467|NCT02584504|38331753|FG002|Double-blind Treatment|Family Matter|0|||
17180468|NCT02584504|38331751|FG000|Open-label Treatment|Participant withdrew consent|0|||
17180469|NCT02584504|38331752|FG001|Open-label Treatment|Participant withdrew consent|0|||
17180470|NCT02584504|38331753|FG002|Open-label Treatment|Participant withdrew consent|4|||
17180471|NCT02584504|38331751|FG000|Open-label Treatment|Adverse Event|2|||
17180472|NCT02584504|38331752|FG001|Open-label Treatment|Adverse Event|2|||
17180473|NCT02584504|38331753|FG002|Open-label Treatment|Adverse Event|3|||
17180474|NCT02584504|38331751|FG000|Open-label Treatment|Physician Decision|0|||
17180475|NCT02584504|38331752|FG001|Open-label Treatment|Physician Decision|1|||
17180476|NCT02584504|38331753|FG002|Open-label Treatment|Physician Decision|0|||
17180477|NCT02584504|38331751|FG000|Open-label Treatment|Entered but not treated|0|||
17089087|NCT00307736|38229226|FG001|Overall Study|Withdrawal by Subject|0|||
17089088|NCT00307736|38229227|FG002|Overall Study|Withdrawal by Subject|2|||
17089089|NCT00307736|38229228|FG003|Overall Study|Withdrawal by Subject|0|||
17089090|NCT00320528|38229242|FG000|Study Period II|Adverse Event|3|||
17089091|NCT00320528|38229243|FG001|Study Period II|Adverse Event|4|||
17089092|NCT00320528|38229244|FG002|Study Period II|Adverse Event|8|||
17089093|NCT00320528|38229242|FG000|Study Period II|Parent/Caregiver Decision|8|||
17089094|NCT00320528|38229243|FG001|Study Period II|Parent/Caregiver Decision|3|||
17089095|NCT00320528|38229244|FG002|Study Period II|Parent/Caregiver Decision|11|||
17089096|NCT00320528|38229242|FG000|Study Period II|Withdrawal by Subject|0|||
17089097|NCT00320528|38229243|FG001|Study Period II|Withdrawal by Subject|1|||
17089098|NCT00320528|38229244|FG002|Study Period II|Withdrawal by Subject|1|||
17089099|NCT00320528|38229242|FG000|Study Period II|Entry Criteria Exclusion|0|||
17089100|NCT00320528|38229243|FG001|Study Period II|Entry Criteria Exclusion|2|||
17089101|NCT00320528|38229244|FG002|Study Period II|Entry Criteria Exclusion|2|||
17089102|NCT00320528|38229242|FG000|Study Period III|Adverse Event|1|||
17089103|NCT00320528|38229243|FG001|Study Period III|Adverse Event|0|||
17089104|NCT00320528|38229244|FG002|Study Period III|Adverse Event|0|||
17089105|NCT00320528|38229242|FG000|Study Period III|Lost to Follow-up|1|||
17089106|NCT00320528|38229243|FG001|Study Period III|Lost to Follow-up|0|||
17089107|NCT00320528|38229244|FG002|Study Period III|Lost to Follow-up|0|||
17089108|NCT00320528|38229242|FG000|Study Period III|Withdrawal by Subject|1|||
17089109|NCT00320528|38229243|FG001|Study Period III|Withdrawal by Subject|1|||
17089110|NCT00320528|38229244|FG002|Study Period III|Withdrawal by Subject|2|||
17089111|NCT00320528|38229242|FG000|Study Period III|Lack of Efficacy|2|||
17089112|NCT00320528|38229243|FG001|Study Period III|Lack of Efficacy|0|||
17089113|NCT00320528|38229244|FG002|Study Period III|Lack of Efficacy|0|||
17089114|NCT00320528|38229242|FG000|Study Period III|Parent/Caregiver Decision|14|||
17089115|NCT00320528|38229243|FG001|Study Period III|Parent/Caregiver Decision|3|||
17089116|NCT00320528|38229244|FG002|Study Period III|Parent/Caregiver Decision|11|||
17089117|NCT00320528|38229242|FG000|Study Period III|Protocol Violation|0|||
17089118|NCT00320528|38229243|FG001|Study Period III|Protocol Violation|1|||
17089119|NCT00320528|38229244|FG002|Study Period III|Protocol Violation|0|||
17089120|NCT00320528|38229242|FG000|Study Period III|Physician Decision|0|||
17180478|NCT02584504|38331752|FG001|Open-label Treatment|Entered but not treated|1|||
17180479|NCT02584504|38331753|FG002|Open-label Treatment|Entered but not treated|1|||
17180480|NCT04354155|38331778|FG000|Overall Study|Withdrawal by Subject|1|||
17180481|NCT04354155|38331778|FG000|Overall Study|Did not meet criteria for study intervention|1|||
17180482|NCT02586064|38331784|FG000|Overall Study|Other Obligations|6|||
17180483|NCT02586064|38331785|FG001|Overall Study|Other Obligations|6|||
17180484|NCT02586064|38331784|FG000|Overall Study|Other|3|||
17180485|NCT02586064|38331785|FG001|Overall Study|Other|7|||
17180486|NCT02586064|38331784|FG000|Overall Study|Never Started|3|||
17180487|NCT02586064|38331785|FG001|Overall Study|Never Started|3|||
17180488|NCT02586064|38331784|FG000|Overall Study|Lost Interest|1|||
17180489|NCT02586064|38331785|FG001|Overall Study|Lost Interest|4|||
17180490|NCT02586064|38331784|FG000|Overall Study|Miscellaneous Life Issues|0|||
17180491|NCT02586064|38331785|FG001|Overall Study|Miscellaneous Life Issues|5|||
17180492|NCT02586064|38331784|FG000|Overall Study|Infrequent Attendance|2|||
17180493|NCT02586064|38331785|FG001|Overall Study|Infrequent Attendance|1|||
17180494|NCT02586064|38331784|FG000|Overall Study|Timed Out|2|||
17180495|NCT02586064|38331785|FG001|Overall Study|Timed Out|0|||
17180496|NCT02586064|38331784|FG000|Overall Study|AUD relapse|0|||
17180497|NCT02586064|38331785|FG001|Overall Study|AUD relapse|2|||
17180498|NCT02586064|38331784|FG000|Overall Study|Legal Issue|1|||
17180499|NCT02586064|38331785|FG001|Overall Study|Legal Issue|0|||
17180500|NCT03810495|38331794|FG000|Overall Study|Lost to Follow-up|2|||
17180501|NCT03810495|38331794|FG000|Overall Study|Withdrawal by Subject|1|||
17180502|NCT02782923|38331798|FG000|Overall Study|Lost to Follow-up|15|||
17180503|NCT03760458|38331807|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
17180504|NCT03760458|38331808|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
17180505|NCT03760458|38331809|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
17180506|NCT03760458|38331810|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
17180507|NCT03760458|38331811|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
17180508|NCT02066415|38331826|FG000|Overall Study|Decision by Sponsor|5|||
17180509|NCT02066415|38331827|FG001|Overall Study|Decision by Sponsor|4|||
17180510|NCT02066415|38331828|FG002|Overall Study|Decision by Sponsor|2|||
17180511|NCT02066415|38331826|FG000|Overall Study|Withdrawal by Subject|9|||
17180512|NCT02066415|38331827|FG001|Overall Study|Withdrawal by Subject|1|||
17180513|NCT02066415|38331828|FG002|Overall Study|Withdrawal by Subject|4|||
17180514|NCT02066415|38331826|FG000|Overall Study|Lost to Follow-up|7|||
17180515|NCT02066415|38331827|FG001|Overall Study|Lost to Follow-up|2|||
17180516|NCT02066415|38331828|FG002|Overall Study|Lost to Follow-up|2|||
17180517|NCT02583256|38331840|FG000|Overall Study|Withdrawal by Subject|0|||
17180518|NCT02583256|38331841|FG001|Overall Study|Withdrawal by Subject|1|||
17180519|NCT02583256|38331842|FG002|Overall Study|Withdrawal by Subject|1|||
17180520|NCT02583256|38331843|FG003|Overall Study|Withdrawal by Subject|0|||
17180521|NCT02583256|38331840|FG000|Overall Study|Lost to Follow-up|1|||
17180522|NCT02583256|38331841|FG001|Overall Study|Lost to Follow-up|1|||
17180523|NCT02583256|38331842|FG002|Overall Study|Lost to Follow-up|0|||
17180524|NCT02583256|38331843|FG003|Overall Study|Lost to Follow-up|1|||
17180525|NCT02583256|38331840|FG000|Overall Study|Administrative/Other|2|||
17180526|NCT02583256|38331841|FG001|Overall Study|Administrative/Other|0|||
17180527|NCT02583256|38331842|FG002|Overall Study|Administrative/Other|1|||
17180528|NCT02583256|38331843|FG003|Overall Study|Administrative/Other|2|||
17180529|NCT02582866|38331864|FG000|Overall Study|Death|1|||
17180530|NCT02582866|38331864|FG000|Overall Study|Lack of Efficacy|2|||
17180531|NCT02582866|38331864|FG000|Overall Study|Lost to Follow-up|2|||
17180532|NCT02582866|38331864|FG000|Overall Study|Withdrawal by Subject|7|||
17180533|NCT02582866|38331864|FG000|Overall Study|Investigator decision|5|||
17180534|NCT02582866|38331864|FG000|Overall Study|Participant wants to get pregnant|1|||
17180535|NCT02582866|38331864|FG000|Overall Study|Pregnancy|2|||
17180536|NCT02582866|38331864|FG000|Overall Study|Sponsor decision|1|||
17180537|NCT02582866|38331864|FG000|Overall Study|Withdrawal due to personal reasons|1|||
17180538|NCT01981551|38331868|FG000|Overall Study|Refused further treatment|8|||
17180539|NCT01981551|38331868|FG000|Overall Study|Adverse Event|1|||
17180540|NCT02584660|38331874|FG000|Overall Study|Adverse Event|4|||
17180541|NCT02584660|38331875|FG001|Overall Study|Adverse Event|0|||
17180542|NCT02584660|38331874|FG000|Overall Study|Lost to Follow-up|3|||
17180543|NCT02584660|38331875|FG001|Overall Study|Lost to Follow-up|4|||
17180544|NCT02584660|38331874|FG000|Overall Study|Protocol Violation|0|||
17180545|NCT02584660|38331875|FG001|Overall Study|Protocol Violation|1|||
17180546|NCT02584660|38331874|FG000|Overall Study|Withdrawal by Subject|0|||
17180547|NCT02584660|38331875|FG001|Overall Study|Withdrawal by Subject|2|||
17180548|NCT02584660|38331874|FG000|Overall Study|Other|0|||
17180549|NCT02584660|38331875|FG001|Overall Study|Other|1|||
17180550|NCT02582632|38331906|FG000|Overall Study|Other|1|||
17180551|NCT02178722|38331915|FG000|Overall Study|Withdrawal by Subject|0|||
17180552|NCT02178722|38331916|FG001|Overall Study|Withdrawal by Subject|0|||
17180553|NCT02178722|38331917|FG002|Overall Study|Withdrawal by Subject|0|||
17180554|NCT02178722|38331918|FG003|Overall Study|Withdrawal by Subject|2|||
17180555|NCT02178722|38331919|FG004|Overall Study|Withdrawal by Subject|33|||
17180556|NCT02178722|38331915|FG000|Overall Study|Death|2|||
17180557|NCT02178722|38331916|FG001|Overall Study|Death|13|||
17180558|NCT02178722|38331917|FG002|Overall Study|Death|12|||
17180559|NCT02178722|38331918|FG003|Overall Study|Death|12|||
17180560|NCT02178722|38331919|FG004|Overall Study|Death|205|||
17180561|NCT02178722|38331915|FG000|Overall Study|Lost to Follow-up|0|||
17180562|NCT02178722|38331916|FG001|Overall Study|Lost to Follow-up|0|||
17180563|NCT02178722|38331917|FG002|Overall Study|Lost to Follow-up|0|||
17180564|NCT02178722|38331918|FG003|Overall Study|Lost to Follow-up|2|||
17180565|NCT02178722|38331919|FG004|Overall Study|Lost to Follow-up|11|||
17180566|NCT02178722|38331915|FG000|Overall Study|Study terminated by Sponsor|2|||
17180567|NCT02178722|38331916|FG001|Overall Study|Study terminated by Sponsor|7|||
17180568|NCT02178722|38331917|FG002|Overall Study|Study terminated by Sponsor|6|||
17180569|NCT02178722|38331918|FG003|Overall Study|Study terminated by Sponsor|4|||
17180570|NCT02178722|38331919|FG004|Overall Study|Study terminated by Sponsor|128|||
17180571|NCT02178722|38331915|FG000|Overall Study|Physician Decision|0|||
17180572|NCT02178722|38331916|FG001|Overall Study|Physician Decision|0|||
17180573|NCT02178722|38331917|FG002|Overall Study|Physician Decision|0|||
17180574|NCT02178722|38331918|FG003|Overall Study|Physician Decision|0|||
17180575|NCT02178722|38331919|FG004|Overall Study|Physician Decision|3|||
17180576|NCT02178722|38331915|FG000|Overall Study|Other|0|||
17180577|NCT02178722|38331916|FG001|Overall Study|Other|0|||
17180578|NCT02178722|38331917|FG002|Overall Study|Other|0|||
17180579|NCT02178722|38331918|FG003|Overall Study|Other|0|||
17180580|NCT02178722|38331919|FG004|Overall Study|Other|2|||
17180581|NCT00972309|38331936|FG000|Overall Study|Switched to alternative treatment|0|||
17180582|NCT00972309|38331937|FG001|Overall Study|Switched to alternative treatment|2|||
17180583|NCT00972309|38331936|FG000|Overall Study|Refused further treatment|0|||
17180584|NCT00972309|38331937|FG001|Overall Study|Refused further treatment|1|||
17180585|NCT00972309|38331936|FG000|Overall Study|Late determination of ineligibility|0|||
17180586|NCT00972309|38331937|FG001|Overall Study|Late determination of ineligibility|1|||
17180587|NCT00972309|38331936|FG000|Overall Study|Second malignancy|1|||
17180588|NCT00972309|38331937|FG001|Overall Study|Second malignancy|1|||
17180589|NCT00972309|38331936|FG000|Overall Study|Visa issues|0|||
17180590|NCT00972309|38331937|FG001|Overall Study|Visa issues|1|||
17180591|NCT00972309|38331936|FG000|Overall Study|Secondary cancer (SCC)|0|||
17180592|NCT00972309|38331937|FG001|Overall Study|Secondary cancer (SCC)|1|||
17180593|NCT00972309|38331936|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
17180594|NCT00972309|38331937|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
17180595|NCT00972309|38331936|FG000|Overall Study|Lost to Follow-up|1|||
17180596|NCT00972309|38331937|FG001|Overall Study|Lost to Follow-up|1|||
17180597|NCT00972309|38331936|FG000|Overall Study|Disease progression on study|10|||
17180598|NCT00972309|38331937|FG001|Overall Study|Disease progression on study|4|||
17180599|NCT02582242|38331956|FG000|Overall Study|Adverse Event|4|||
17180600|NCT02582242|38331957|FG001|Overall Study|Adverse Event|3|||
17180601|NCT02582242|38331956|FG000|Overall Study|Protocol Violation|3|||
17180602|NCT02582242|38331957|FG001|Overall Study|Protocol Violation|1|||
17180603|NCT02582242|38331956|FG000|Overall Study|Lost to Follow-up|0|||
17180604|NCT02582242|38331957|FG001|Overall Study|Lost to Follow-up|1|||
17180605|NCT02582242|38331956|FG000|Overall Study|Withdrawal by Subject|11|||
17180606|NCT02582242|38331957|FG001|Overall Study|Withdrawal by Subject|11|||
17180607|NCT02582242|38331956|FG000|Overall Study|Unclassified|2|||
17180608|NCT02582242|38331957|FG001|Overall Study|Unclassified|1|||
17180609|NCT00663351|38331965|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
17180610|NCT00663351|38331966|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
17180611|NCT00663351|38331965|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
17180612|NCT00663351|38331966|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
17180613|NCT00663351|38331965|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
17180614|NCT00663351|38331966|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
17180615|NCT00663351|38331965|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
17180616|NCT00663351|38331966|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
17180617|NCT00663351|38331965|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
17180618|NCT00663351|38331966|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
17180619|NCT00663351|38331965|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
17180620|NCT00663351|38331966|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
17180621|NCT00616941|38331975|FG000|Overall Study|Progressive Disease|1|||
17180622|NCT00616941|38331976|FG001|Overall Study|Progressive Disease|2|||
17180623|NCT00616941|38331977|FG002|Overall Study|Progressive Disease|1|||
17180624|NCT00616941|38331975|FG000|Overall Study|Adverse Event|0|||
17180625|NCT00616941|38331976|FG001|Overall Study|Adverse Event|1|||
17180626|NCT00616941|38331977|FG002|Overall Study|Adverse Event|1|||
17180627|NCT00616941|38331975|FG000|Overall Study|Subject Non-compliance|0|||
17180628|NCT00616941|38331976|FG001|Overall Study|Subject Non-compliance|0|||
17180629|NCT00616941|38331977|FG002|Overall Study|Subject Non-compliance|1|||
17180630|NCT00616941|38331975|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
17180631|NCT00616941|38331976|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
17180632|NCT00616941|38331977|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
17180633|NCT00616941|38331975|FG000|Overall Study|Vaccination Suspended|0|||
17180634|NCT00616941|38331976|FG001|Overall Study|Vaccination Suspended|0|||
17180635|NCT00616941|38331977|FG002|Overall Study|Vaccination Suspended|3|||
17180636|NCT02581930|38331985|FG000|Overall Study|Withdrawal by Subject|1|||
17180637|NCT02581930|38331985|FG000|Overall Study|patient declined further treatment|1|||
17180638|NCT00105560|38331989|FG000|Overall Study|Lost to Follow-up|1|||
17180639|NCT02577718|38332002|FG000|Overall Study|Death|6|||
17180640|NCT02577718|38332002|FG000|Overall Study|Withdrawal by Subject|2|||
17180641|NCT00520533|38332008|FG000|Overall Study|Death|1|||
17180642|NCT00520533|38332008|FG000|Overall Study|Suspension of the study for safety reasons|1|||
17180643|NCT00520533|38332008|FG000|Overall Study|Withdrawal by Subject|1|||
17180644|NCT00520533|38332008|FG000|Overall Study|Physician Decision|1|||
17180645|NCT01664104|38332017|FG000|Overall Study|Adverse Event|6|||
17180646|NCT01664104|38332017|FG000|Overall Study|Lack of Efficacy|2|||
17180647|NCT01664104|38332017|FG000|Overall Study|Withdrawal by Subject|1|||
17180648|NCT01664104|38332017|FG000|Overall Study|Lost to Follow-up|4|||
17180649|NCT01664104|38332017|FG000|Overall Study|Other|1|||
17180650|NCT01664104|38332017|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
17180651|NCT02739984|38332025|FG000|Overall Study|Sponsor Decision|1|||
17180652|NCT02739984|38332026|FG001|Overall Study|Sponsor Decision|0|||
17180653|NCT02739984|38332025|FG000|Overall Study|Withdrawal by Subject|1|||
17180654|NCT02739984|38332026|FG001|Overall Study|Withdrawal by Subject|1|||
17180655|NCT02739984|38332025|FG000|Overall Study|Death|0|||
17180656|NCT02739984|38332026|FG001|Overall Study|Death|1|||
17180657|NCT02739984|38332025|FG000|Overall Study|Lost to Follow-up|3|||
17180658|NCT02739984|38332026|FG001|Overall Study|Lost to Follow-up|0|||
17180659|NCT00496730|38332034|FG000|Overall Study|Lost to Follow-up|4|||
17180660|NCT00496730|38332035|FG001|Overall Study|Lost to Follow-up|3|||
17180661|NCT00496730|38332034|FG000|Overall Study|Withdrawal by Subject|2|||
17180662|NCT00496730|38332035|FG001|Overall Study|Withdrawal by Subject|2|||
17180663|NCT02739828|38332041|FG000|Overall Study|Adverse Event|1|||
17180664|NCT02739828|38332041|FG000|Overall Study|Lost to Follow-up|4|||
17180665|NCT04435808|38332047|FG000|Overall Study|Study stopped by DSMB|0|||
17180666|NCT04435808|38332048|FG001|Overall Study|Study stopped by DSMB|1|||
17180667|NCT01664494|38332071|FG000|Overall Study|Withdrawal by Subject|27|||
17180668|NCT01664494|38332071|FG000|Overall Study|Death|18|||
17180669|NCT01664494|38332071|FG000|Overall Study|Other|49|||
17180670|NCT01664494|38332071|FG000|Overall Study|Lost to Follow-up|99|||
17180671|NCT02577016|38332077|FG000|Overall Study|Adverse Event|2|||
17180672|NCT02577016|38332078|FG001|Overall Study|Adverse Event|1|||
17180673|NCT02577016|38332077|FG000|Overall Study|Physician Decision|0|||
17180674|NCT02577016|38332078|FG001|Overall Study|Physician Decision|1|||
17180675|NCT05101252|38332086|FG000|Overall Study|Unsatisfactory Test Article|1|||
17180676|NCT05101252|38332087|FG001|Overall Study|Unsatisfactory Test Article|0|||
17180677|NCT05101252|38332086|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
17180678|NCT05101252|38332087|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
17180679|NCT05101252|38332086|FG000|Overall Study|Withdrew Consent during study|0|||
17180680|NCT05101252|38332087|FG001|Overall Study|Withdrew Consent during study|1|||
17180681|NCT05101252|38332086|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
17180682|NCT05101252|38332087|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
17180683|NCT03316586|38332093|FG000|Overall Study|Adverse Event|2|||
17180684|NCT03316586|38332093|FG000|Overall Study|Physician Decision|3|||
17180685|NCT03316586|38332093|FG000|Overall Study|Lack of Efficacy|10|||
17180686|NCT03316586|38332093|FG000|Overall Study|still on treatment|1|||
17180687|NCT03316586|38332093|FG000|Overall Study|Patient needed radiation therapy|1|||
17180688|NCT03316586|38332093|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
17180689|NCT02994927|38332099|FG000|Overall Study|Withdrawal by parent/guardian|0|||
17180690|NCT02994927|38332100|FG001|Overall Study|Withdrawal by parent/guardian|1|||
17180691|NCT02994927|38332099|FG000|Overall Study|Did not meet eligibility criteria|0|||
17180692|NCT02994927|38332100|FG001|Overall Study|Did not meet eligibility criteria|1|||
17180693|NCT02994927|38332099|FG000|Overall Study|Physician Decision|4|||
17180694|NCT02994927|38332100|FG001|Overall Study|Physician Decision|3|||
17180695|NCT02994927|38332099|FG000|Overall Study|Death|4|||
17180696|NCT02994927|38332100|FG001|Overall Study|Death|2|||
17180697|NCT02994927|38332099|FG000|Overall Study|Adverse Event|2|||
17180698|NCT02994927|38332100|FG001|Overall Study|Adverse Event|1|||
17180699|NCT02994927|38332099|FG000|Overall Study|Withdrawal by Subject|3|||
17180700|NCT02994927|38332100|FG001|Overall Study|Withdrawal by Subject|6|||
17180701|NCT02994927|38332099|FG000|Overall Study|Lost to Follow-up|2|||
17180702|NCT02994927|38332100|FG001|Overall Study|Lost to Follow-up|1|||
17180703|NCT00107991|38332106|FG000|Eligibility Assessment|Disease not severe enough|7|||
17180704|NCT00107991|38332106|FG000|Eligibility Assessment|Unwilling to participate|7|||
17180705|NCT00107991|38332106|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
17180706|NCT00107991|38332106|FG000|Eligibility Assessment|Abnormal labs|2|||
17180707|NCT00107991|38332106|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
17180708|NCT00107991|38332106|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
17180709|NCT00107991|38332106|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
17180710|NCT00107991|38332106|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
17180711|NCT00107991|38332106|FG000|12 Week Treatment Period|Adverse Event|1|||
17180712|NCT00107991|38332106|FG000|12 Week Treatment Period|Protocol Violation|1|||
17180713|NCT00107991|38332106|FG000|12 Week Treatment Period|Incarcerated|1|||
17180714|NCT00107991|38332106|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
17180715|NCT03142334|38332112|FG000|Overall Study|Death|18|||
17180716|NCT03142334|38332113|FG001|Overall Study|Death|33|||
17180717|NCT03142334|38332112|FG000|Overall Study|Withdrawal by Subject|15|||
17180718|NCT03142334|38332113|FG001|Overall Study|Withdrawal by Subject|11|||
17180719|NCT03142334|38332112|FG000|Overall Study|Ongoing on trial follow up|463|||
17180720|NCT03142334|38332113|FG001|Overall Study|Ongoing on trial follow up|454|||
17180721|NCT00492856|38332119|FG000|Induction|Adverse Event|2|||
17180722|NCT00492856|38332120|FG001|Induction|Adverse Event|0|||
17180723|NCT00492856|38332121|FG002|Induction|Adverse Event|0|||
17180724|NCT00492856|38332122|FG003|Induction|Adverse Event|0|||
17180725|NCT00492856|38332119|FG000|Induction|Withdrawal by Subject|1|||
17180726|NCT00492856|38332120|FG001|Induction|Withdrawal by Subject|0|||
17180727|NCT00492856|38332121|FG002|Induction|Withdrawal by Subject|0|||
17180728|NCT00492856|38332122|FG003|Induction|Withdrawal by Subject|0|||
17180729|NCT00492856|38332119|FG000|Induction|Death|3|||
17180730|NCT00492856|38332120|FG001|Induction|Death|0|||
17180731|NCT00492856|38332121|FG002|Induction|Death|0|||
17180732|NCT00492856|38332122|FG003|Induction|Death|0|||
17180733|NCT00492856|38332119|FG000|Consolidation|Adverse Event|6|||
17180734|NCT00492856|38332120|FG001|Consolidation|Adverse Event|0|||
17180735|NCT00492856|38332121|FG002|Consolidation|Adverse Event|0|||
17180736|NCT00492856|38332122|FG003|Consolidation|Adverse Event|0|||
17180737|NCT00492856|38332119|FG000|Consolidation|Not protocol specified|2|||
17180738|NCT00492856|38332120|FG001|Consolidation|Not protocol specified|0|||
17180739|NCT00492856|38332121|FG002|Consolidation|Not protocol specified|0|||
17180740|NCT00492856|38332122|FG003|Consolidation|Not protocol specified|0|||
17180741|NCT00492856|38332119|FG000|Consolidation|Lost to Follow-up|1|||
17180742|NCT00492856|38332120|FG001|Consolidation|Lost to Follow-up|0|||
17180743|NCT00492856|38332121|FG002|Consolidation|Lost to Follow-up|0|||
17180744|NCT00492856|38332122|FG003|Consolidation|Lost to Follow-up|0|||
17180745|NCT00492856|38332119|FG000|Post-consolidation|Adverse Event|0|||
17180746|NCT00492856|38332120|FG001|Post-consolidation|Adverse Event|4|||
17180747|NCT00492856|38332121|FG002|Post-consolidation|Adverse Event|0|||
17180748|NCT00492856|38332122|FG003|Post-consolidation|Adverse Event|1|||
17180749|NCT00492856|38332119|FG000|Post-consolidation|Withdrawal by Subject|0|||
17180750|NCT00492856|38332120|FG001|Post-consolidation|Withdrawal by Subject|4|||
17180751|NCT00492856|38332121|FG002|Post-consolidation|Withdrawal by Subject|0|||
17180752|NCT00492856|38332122|FG003|Post-consolidation|Withdrawal by Subject|0|||
17180753|NCT00492856|38332119|FG000|Post-consolidation|Death|0|||
17180754|NCT00492856|38332120|FG001|Post-consolidation|Death|1|||
17180755|NCT00492856|38332121|FG002|Post-consolidation|Death|0|||
17180756|NCT00492856|38332122|FG003|Post-consolidation|Death|0|||
17180757|NCT00492856|38332119|FG000|Post-consolidation|Not protocol specified|0|||
17180758|NCT00492856|38332120|FG001|Post-consolidation|Not protocol specified|1|||
17180759|NCT00492856|38332121|FG002|Post-consolidation|Not protocol specified|0|||
17180760|NCT00492856|38332122|FG003|Post-consolidation|Not protocol specified|0|||
17180761|NCT00492856|38332119|FG000|Post-consolidation|Lost to Follow-up|0|||
17180762|NCT00492856|38332120|FG001|Post-consolidation|Lost to Follow-up|2|||
17180763|NCT00492856|38332121|FG002|Post-consolidation|Lost to Follow-up|0|||
17180764|NCT00492856|38332122|FG003|Post-consolidation|Lost to Follow-up|0|||
17180765|NCT00492856|38332119|FG000|Post-consolidation|Observation Arm|0|||
17180766|NCT00492856|38332120|FG001|Post-consolidation|Observation Arm|0|||
17180767|NCT00492856|38332121|FG002|Post-consolidation|Observation Arm|27|||
17180768|NCT00492856|38332122|FG003|Post-consolidation|Observation Arm|0|||
17180769|NCT02782377|38332134|FG000|Overall Study|Physician Decision|5|||
17180770|NCT02410629|38332141|FG000|Overall Study|Family cannot commit to the study|2|||
17180771|NCT02410629|38332142|FG001|Overall Study|Family cannot commit to the study|1|||
17180772|NCT02410629|38332141|FG000|Overall Study|Subject returned to work|1|||
17180773|NCT02410629|38332142|FG001|Overall Study|Subject returned to work|0|||
17180774|NCT02410629|38332141|FG000|Overall Study|Subject moved back to home country|0|||
17180775|NCT02410629|38332142|FG001|Overall Study|Subject moved back to home country|1|||
17180776|NCT02410629|38332141|FG000|Overall Study|Subject underwent heart surgery|0|||
17180777|NCT02410629|38332142|FG001|Overall Study|Subject underwent heart surgery|1|||
17180778|NCT02252211|38332150|FG000|Overall Study|Adverse Event|0|||
17180779|NCT02252211|38332151|FG001|Overall Study|Adverse Event|1|||
17180780|NCT02252211|38332152|FG002|Overall Study|Adverse Event|0|||
17180781|NCT02252211|38332150|FG000|Overall Study|Progressive disease|3|||
17180782|NCT02252211|38332151|FG001|Overall Study|Progressive disease|2|||
17180783|NCT02252211|38332152|FG002|Overall Study|Progressive disease|0|||
17180784|NCT02252211|38332150|FG000|Overall Study|Withdrawal by Subject|1|||
17180785|NCT02252211|38332151|FG001|Overall Study|Withdrawal by Subject|0|||
17180786|NCT02252211|38332152|FG002|Overall Study|Withdrawal by Subject|0|||
17180787|NCT02252211|38332150|FG000|Overall Study|Serious Adverse Event During Screening|1|||
17180788|NCT02252211|38332151|FG001|Overall Study|Serious Adverse Event During Screening|0|||
17180789|NCT02252211|38332152|FG002|Overall Study|Serious Adverse Event During Screening|1|||
17180790|NCT02776683|38332159|FG000|Pre-switch Period|Protocol Violation|1|||
17180791|NCT02776683|38332160|FG001|Pre-switch Period|Protocol Violation|0|||
17180792|NCT02776683|38332159|FG000|Pre-switch Period|Adverse Event|21|||
17180793|NCT02776683|38332160|FG001|Pre-switch Period|Adverse Event|0|||
17180794|NCT02776683|38332159|FG000|Pre-switch Period|Withdrawal by Subject|9|||
17180795|NCT02776683|38332160|FG001|Pre-switch Period|Withdrawal by Subject|0|||
17180796|NCT02776683|38332159|FG000|Pre-switch Period|Physician Decision|7|||
17180797|NCT02776683|38332160|FG001|Pre-switch Period|Physician Decision|0|||
17180798|NCT02776683|38332159|FG000|Pre-switch Period|Progressive disease|39|||
17180799|NCT02776683|38332160|FG001|Pre-switch Period|Progressive disease|0|||
17180800|NCT02776683|38332159|FG000|Pre-switch Period|Other than listed|3|||
17180801|NCT02776683|38332160|FG001|Pre-switch Period|Other than listed|0|||
17180802|NCT02776683|38332159|FG000|Post-switch Period|Adverse Event|0|||
17180803|NCT02776683|38332160|FG001|Post-switch Period|Adverse Event|3|||
17180804|NCT02776683|38332159|FG000|Post-switch Period|Withdrawal by Subject|0|||
17180805|NCT02776683|38332160|FG001|Post-switch Period|Withdrawal by Subject|2|||
17180806|NCT02776683|38332159|FG000|Post-switch Period|Physician Decision|0|||
17180807|NCT02776683|38332160|FG001|Post-switch Period|Physician Decision|3|||
17180808|NCT02776683|38332159|FG000|Post-switch Period|Progressive disease|0|||
17180809|NCT02776683|38332160|FG001|Post-switch Period|Progressive disease|20|||
17180810|NCT02776683|38332159|FG000|Post-switch Period|Other than listed|0|||
17180811|NCT02776683|38332160|FG001|Post-switch Period|Other than listed|15|||
17180812|NCT02731742|38332168|FG000|Overall Study|Death|1|||
17180813|NCT02731742|38332169|FG001|Overall Study|Death|2|||
17180814|NCT02731742|38332170|FG002|Overall Study|Death|5|||
17180815|NCT02731742|38332171|FG003|Overall Study|Death|0|||
17180816|NCT02731742|38332168|FG000|Overall Study|Physician Decision|0|||
17180817|NCT02731742|38332169|FG001|Overall Study|Physician Decision|0|||
17180818|NCT02731742|38332170|FG002|Overall Study|Physician Decision|0|||
17180819|NCT02731742|38332171|FG003|Overall Study|Physician Decision|1|||
17180820|NCT02731742|38332168|FG000|Overall Study|Study Terminated by Sponsor|2|||
17180821|NCT02731742|38332169|FG001|Overall Study|Study Terminated by Sponsor|1|||
17180822|NCT02731742|38332170|FG002|Overall Study|Study Terminated by Sponsor|1|||
17180823|NCT02731742|38332171|FG003|Overall Study|Study Terminated by Sponsor|1|||
17180824|NCT00104871|38332194|FG000|Overall Study|Not evaluable|1|||
17180825|NCT03487796|38332202|FG000|Overall Study|Lost to Follow-up|18|||
17180826|NCT03487796|38332203|FG001|Overall Study|Lost to Follow-up|6|||
17180827|NCT03446612|38332217|FG000|Overall Study|Protocol defined stopping criteria|0|||
17180828|NCT03446612|38332218|FG001|Overall Study|Protocol defined stopping criteria|1|||
17180829|NCT02730728|38332229|FG000|Overall Study|Withdrawal by Subject|0|||
17180830|NCT02730728|38332230|FG001|Overall Study|Withdrawal by Subject|1|||
17180831|NCT02730728|38332231|FG002|Overall Study|Withdrawal by Subject|0|||
17180832|NCT02730728|38332229|FG000|Overall Study|Lack of Efficacy|0|||
17180833|NCT02730728|38332230|FG001|Overall Study|Lack of Efficacy|1|||
17180834|NCT02730728|38332231|FG002|Overall Study|Lack of Efficacy|1|||
17180835|NCT02580058|38332242|FG000|Overall Study|Lost to Follow-up|4|||
17180836|NCT02580058|38332243|FG001|Overall Study|Lost to Follow-up|5|||
17180837|NCT02580058|38332244|FG002|Overall Study|Lost to Follow-up|4|||
17180838|NCT02580058|38332242|FG000|Overall Study|Ongoing|51|||
17180839|NCT02580058|38332243|FG001|Overall Study|Ongoing|55|||
17180840|NCT02580058|38332244|FG002|Overall Study|Ongoing|46|||
17180841|NCT02580058|38332242|FG000|Overall Study|Withdrawal by Subject|24|||
17180842|NCT02580058|38332243|FG001|Overall Study|Withdrawal by Subject|26|||
17180843|NCT02580058|38332244|FG002|Overall Study|Withdrawal by Subject|36|||
17180844|NCT00104637|38332252|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
17180845|NCT00104637|38332253|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
17180846|NCT02768103|38332262|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
17180847|NCT02767323|38332271|FG000|Overall Study|Withdrawal by Subject|17|||
17180848|NCT02767323|38332272|FG001|Overall Study|Withdrawal by Subject|5|||
17180849|NCT02767323|38332273|FG002|Overall Study|Withdrawal by Subject|13|||
17180850|NCT02767323|38332274|FG003|Overall Study|Withdrawal by Subject|0|||
17180851|NCT02767323|38332271|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
17180852|NCT02767323|38332272|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
17180853|NCT02767323|38332273|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
17180854|NCT02767323|38332274|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
17180855|NCT02780115|38332292|FG000|Overall Study|Withdrawal by Subject|0|||
17180856|NCT02780115|38332293|FG001|Overall Study|Withdrawal by Subject|1|||
17180857|NCT02780115|38332294|FG002|Overall Study|Withdrawal by Subject|1|||
17180858|NCT02780115|38332295|FG003|Overall Study|Withdrawal by Subject|0|||
17180859|NCT02780115|38332296|FG004|Overall Study|Withdrawal by Subject|0|||
17180860|NCT02780115|38332292|FG000|Overall Study|Adverse Event|0|||
17180861|NCT02780115|38332293|FG001|Overall Study|Adverse Event|0|||
17180862|NCT02780115|38332294|FG002|Overall Study|Adverse Event|0|||
17180863|NCT02780115|38332295|FG003|Overall Study|Adverse Event|1|||
17180864|NCT02780115|38332296|FG004|Overall Study|Adverse Event|1|||
17180865|NCT02766777|38332308|FG000|Overall Study|Adverse Event|12|||
17180866|NCT02766777|38332308|FG000|Overall Study|Lost to Follow-up|16|||
17180867|NCT02766777|38332308|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17180868|NCT02766777|38332308|FG000|Overall Study|Protocol Violation|1|||
17180869|NCT02766777|38332308|FG000|Overall Study|Withdrawal by Subject|4|||
17180870|NCT00157014|38332316|FG000|Overall Study|Death|4|||
17180871|NCT00157014|38332317|FG001|Overall Study|Death|2|||
17180872|NCT00157014|38332318|FG002|Overall Study|Death|1|||
17180873|NCT00157014|38332319|FG003|Overall Study|Death|1|||
17180874|NCT00157014|38332316|FG000|Overall Study|Physician Decision|0|||
17180875|NCT00157014|38332317|FG001|Overall Study|Physician Decision|1|||
17180876|NCT00157014|38332318|FG002|Overall Study|Physician Decision|0|||
17180877|NCT00157014|38332319|FG003|Overall Study|Physician Decision|0|||
17180878|NCT00157014|38332316|FG000|Overall Study|Medications withdrawn on family request|0|||
17180879|NCT00157014|38332317|FG001|Overall Study|Medications withdrawn on family request|1|||
17180880|NCT00157014|38332318|FG002|Overall Study|Medications withdrawn on family request|0|||
17180881|NCT00157014|38332319|FG003|Overall Study|Medications withdrawn on family request|0|||
17180882|NCT00157014|38332316|FG000|Overall Study|Patient withdrawn by investigator|1|||
17180883|NCT00157014|38332317|FG001|Overall Study|Patient withdrawn by investigator|0|||
17180884|NCT00157014|38332318|FG002|Overall Study|Patient withdrawn by investigator|0|||
17180885|NCT00157014|38332319|FG003|Overall Study|Patient withdrawn by investigator|0|||
17180886|NCT00157014|38332316|FG000|Overall Study|Patient unable to return in nursing home|1|||
17180887|NCT00157014|38332317|FG001|Overall Study|Patient unable to return in nursing home|0|||
17180888|NCT00157014|38332318|FG002|Overall Study|Patient unable to return in nursing home|0|||
17180889|NCT00157014|38332319|FG003|Overall Study|Patient unable to return in nursing home|0|||
17180890|NCT00157014|38332316|FG000|Overall Study|Patient would not receive transplant|0|||
17180891|NCT00157014|38332317|FG001|Overall Study|Patient would not receive transplant|1|||
17180892|NCT00157014|38332318|FG002|Overall Study|Patient would not receive transplant|0|||
17180893|NCT00157014|38332319|FG003|Overall Study|Patient would not receive transplant|0|||
17180894|NCT00157014|38332316|FG000|Overall Study|Withdrawal by Subject|1|||
17180895|NCT00157014|38332317|FG001|Overall Study|Withdrawal by Subject|0|||
17180896|NCT00157014|38332318|FG002|Overall Study|Withdrawal by Subject|0|||
17180897|NCT00157014|38332319|FG003|Overall Study|Withdrawal by Subject|0|||
17180898|NCT02778867|38332331|FG000|Phase 1|Withdrawal by Subject|2|||
17180899|NCT02778867|38332332|FG001|Phase 1|Withdrawal by Subject|3|||
17180900|NCT02778867|38332333|FG002|Phase 1|Withdrawal by Subject|0|||
17180901|NCT02778867|38332334|FG003|Phase 1|Withdrawal by Subject|0|||
17180902|NCT02778867|38332331|FG000|Phase 2|Withdrawal by Subject|0|||
17180903|NCT02778867|38332332|FG001|Phase 2|Withdrawal by Subject|0|||
17180904|NCT02778867|38332333|FG002|Phase 2|Withdrawal by Subject|1|||
17180905|NCT02778867|38332334|FG003|Phase 2|Withdrawal by Subject|0|||
17180906|NCT02778867|38332331|FG000|Phase 2|Physician Decision|0|||
17180907|NCT02778867|38332332|FG001|Phase 2|Physician Decision|0|||
17180908|NCT02778867|38332333|FG002|Phase 2|Physician Decision|0|||
17180909|NCT02778867|38332334|FG003|Phase 2|Physician Decision|1|||
17180910|NCT02778867|38332331|FG000|Phase 2|Adverse Event|0|||
17180911|NCT02778867|38332332|FG001|Phase 2|Adverse Event|0|||
17180912|NCT02778867|38332333|FG002|Phase 2|Adverse Event|0|||
17180913|NCT02778867|38332334|FG003|Phase 2|Adverse Event|1|||
17180914|NCT02778555|38332347|FG000|Overall Study|Withdrawal by Subject|55|||
17180915|NCT02778555|38332348|FG001|Overall Study|Withdrawal by Subject|32|||
17180916|NCT02778555|38332349|FG002|Overall Study|Withdrawal by Subject|107|||
17180917|NCT02778399|38332363|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
17180918|NCT02778399|38332364|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
17180919|NCT02778399|38332365|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
17180920|NCT02778399|38332366|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
17180921|NCT02778399|38332367|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
17180922|NCT02778399|38332368|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
17180923|NCT02778399|38332363|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
17180924|NCT02778399|38332364|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
17180925|NCT02778399|38332365|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
17180926|NCT02778399|38332366|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
17180927|NCT02778399|38332367|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
17180928|NCT02778399|38332368|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
17180929|NCT02778399|38332363|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
17180930|NCT02778399|38332364|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
17180931|NCT02778399|38332365|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
17180932|NCT02778399|38332366|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
17180933|NCT02778399|38332367|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
17180934|NCT02778399|38332368|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
17180935|NCT02778399|38332363|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
17180936|NCT02778399|38332364|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
17180937|NCT02778399|38332365|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
17180938|NCT02778399|38332366|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
17180939|NCT02778399|38332367|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
17180940|NCT02778399|38332368|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
17180941|NCT02778399|38332363|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
17180942|NCT02778399|38332364|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
17180943|NCT02778399|38332365|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
17180944|NCT02778399|38332366|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
17180945|NCT02778399|38332367|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
17180946|NCT02778399|38332368|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
17180947|NCT02778399|38332363|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
17180948|NCT02778399|38332364|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
17180949|NCT02778399|38332365|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
17180950|NCT02778399|38332366|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
17180951|NCT02778399|38332367|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
17180952|NCT02778399|38332368|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
17180953|NCT02778399|38332363|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
17180954|NCT02778399|38332364|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
17180955|NCT02778399|38332365|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
17180956|NCT02778399|38332366|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
17180957|NCT02778399|38332367|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
17180958|NCT02778399|38332368|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
17180959|NCT02778399|38332363|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
17180960|NCT02778399|38332364|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
17180961|NCT02778399|38332365|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
17180962|NCT02778399|38332366|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
17180963|NCT02778399|38332367|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
17180964|NCT02778399|38332368|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
17180965|NCT02778399|38332363|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
17180966|NCT02778399|38332364|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
17180967|NCT02778399|38332365|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
17180968|NCT02778399|38332366|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
17180969|NCT02778399|38332367|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
17180970|NCT02778399|38332368|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
17180971|NCT02778399|38332363|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
17180972|NCT02778399|38332364|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
17180973|NCT02778399|38332365|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
17180974|NCT02778399|38332366|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
17180975|NCT02778399|38332367|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
16996917|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Other|0|||
16996918|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Other|0|||
16996919|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Other|1|||
16996920|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Other|3|||
16996921|NCT03107793|38140956|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
16996922|NCT03107793|38140957|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
16996923|NCT03107793|38140958|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
16996924|NCT03107793|38140959|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
16996925|NCT03107793|38140960|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
16996926|NCT00974090|38140971|FG000|Period 1: Double Blind Period|Adverse Event|2|||
16996927|NCT00974090|38140972|FG001|Period 1: Double Blind Period|Adverse Event|1|||
16996928|NCT00974090|38140971|FG000|Period 1: Double Blind Period|Physician Decision|1|||
17089121|NCT00320528|38229243|FG001|Study Period III|Physician Decision|1|||
17089122|NCT00320528|38229244|FG002|Study Period III|Physician Decision|2|||
17089123|NCT00320528|38229242|FG000|Study Period III|Sponsor Decision|0|||
17089124|NCT00320528|38229243|FG001|Study Period III|Sponsor Decision|0|||
17089125|NCT00320528|38229244|FG002|Study Period III|Sponsor Decision|1|||
17089126|NCT00320528|38229242|FG000|Study Period III|Atomoxetine Commercially Available|68|||
17089127|NCT00320528|38229243|FG001|Study Period III|Atomoxetine Commercially Available|25|||
17089128|NCT00320528|38229244|FG002|Study Period III|Atomoxetine Commercially Available|90|||
17089129|NCT00320372|38229255|FG000|Overall Study|Physician Decision|4|||
17089130|NCT00320372|38229256|FG001|Overall Study|Physician Decision|7|||
17089131|NCT00320372|38229255|FG000|Overall Study|Death|7|||
17089132|NCT00320372|38229256|FG001|Overall Study|Death|8|||
17089133|NCT00320372|38229255|FG000|Overall Study|Withdrawal by Subject|55|||
17089134|NCT00320372|38229256|FG001|Overall Study|Withdrawal by Subject|37|||
17089135|NCT00320372|38229255|FG000|Overall Study|Non-Compliance|40|||
17089136|NCT00320372|38229256|FG001|Overall Study|Non-Compliance|39|||
17089137|NCT00320372|38229255|FG000|Overall Study|Did not Meet (I/E)|3|||
17089138|NCT00320372|38229256|FG001|Overall Study|Did not Meet (I/E)|1|||
17180976|NCT02778399|38332368|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
17180977|NCT02778399|38332363|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
17180978|NCT02778399|38332364|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
17180979|NCT02778399|38332365|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
17180980|NCT02778399|38332366|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
17180981|NCT02778399|38332367|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
17180982|NCT02778399|38332368|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
17180983|NCT03656744|38332417|FG000|Overall Study|Adverse Event|1|||
17180984|NCT03656744|38332418|FG001|Overall Study|Adverse Event|4|||
17180985|NCT03656744|38332419|FG002|Overall Study|Adverse Event|1|||
17180986|NCT03656744|38332417|FG000|Overall Study|Protocol Violation|1|||
17180987|NCT03656744|38332418|FG001|Overall Study|Protocol Violation|0|||
17180988|NCT03656744|38332419|FG002|Overall Study|Protocol Violation|0|||
17180989|NCT03656744|38332417|FG000|Overall Study|Lost to Follow-up|2|||
17180990|NCT03656744|38332418|FG001|Overall Study|Lost to Follow-up|2|||
17180991|NCT03656744|38332419|FG002|Overall Study|Lost to Follow-up|0|||
17180992|NCT03656744|38332417|FG000|Overall Study|Withdrawal by Subject|0|||
17180993|NCT03656744|38332418|FG001|Overall Study|Withdrawal by Subject|1|||
17180994|NCT03656744|38332419|FG002|Overall Study|Withdrawal by Subject|0|||
17180995|NCT03656744|38332417|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
17180996|NCT03656744|38332418|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
17180997|NCT03656744|38332419|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
17180998|NCT02739360|38332427|FG000|Overall Study|Adverse Event|1|||
17180999|NCT02739360|38332427|FG000|Overall Study|Study terminated by Sponsor|2|||
17181000|NCT01822522|38332437|FG000|Overall Study|Adverse Event|1|||
17181001|NCT01822522|38332438|FG001|Overall Study|Adverse Event|1|||
17181002|NCT01822522|38332439|FG002|Overall Study|Adverse Event|1|||
17181003|NCT01822522|38332440|FG003|Overall Study|Adverse Event|0|||
17181004|NCT01822522|38332441|FG004|Overall Study|Adverse Event|0|||
17181005|NCT01822522|38332442|FG005|Overall Study|Adverse Event|1|||
17181006|NCT01822522|38332437|FG000|Overall Study|Death|3|||
17181007|NCT01822522|38332438|FG001|Overall Study|Death|0|||
17181008|NCT01822522|38332439|FG002|Overall Study|Death|2|||
17181009|NCT01822522|38332440|FG003|Overall Study|Death|0|||
17181010|NCT01822522|38332441|FG004|Overall Study|Death|0|||
17181011|NCT01822522|38332442|FG005|Overall Study|Death|0|||
17181012|NCT01822522|38332437|FG000|Overall Study|Lost to Follow-up|0|||
17181013|NCT01822522|38332438|FG001|Overall Study|Lost to Follow-up|0|||
17181014|NCT01822522|38332439|FG002|Overall Study|Lost to Follow-up|1|||
17181015|NCT01822522|38332440|FG003|Overall Study|Lost to Follow-up|1|||
17181016|NCT01822522|38332441|FG004|Overall Study|Lost to Follow-up|0|||
17181017|NCT01822522|38332442|FG005|Overall Study|Lost to Follow-up|1|||
17181018|NCT01822522|38332437|FG000|Overall Study|Withdrawal by Subject|0|||
17181019|NCT01822522|38332438|FG001|Overall Study|Withdrawal by Subject|0|||
17181020|NCT01822522|38332439|FG002|Overall Study|Withdrawal by Subject|0|||
17181021|NCT01822522|38332440|FG003|Overall Study|Withdrawal by Subject|1|||
17181022|NCT01822522|38332441|FG004|Overall Study|Withdrawal by Subject|0|||
17181023|NCT01822522|38332442|FG005|Overall Study|Withdrawal by Subject|0|||
17181024|NCT01822522|38332437|FG000|Overall Study|Lack of Efficacy|0|||
17181025|NCT01822522|38332438|FG001|Overall Study|Lack of Efficacy|0|||
17181026|NCT01822522|38332439|FG002|Overall Study|Lack of Efficacy|0|||
17181027|NCT01822522|38332440|FG003|Overall Study|Lack of Efficacy|0|||
17181028|NCT01822522|38332441|FG004|Overall Study|Lack of Efficacy|0|||
17181029|NCT01822522|38332442|FG005|Overall Study|Lack of Efficacy|2|||
17181030|NCT00102687|38332486|FG000|Initial Period|Withdrawal by Subject|6|||
17181031|NCT00102687|38332487|FG001|Initial Period|Withdrawal by Subject|3|||
17181032|NCT00102687|38332488|FG002|Initial Period|Withdrawal by Subject|5|||
17181033|NCT00102687|38332489|FG003|Initial Period|Withdrawal by Subject|0|||
17181034|NCT00102687|38332490|FG004|Initial Period|Withdrawal by Subject|0|||
17181035|NCT00102687|38332486|FG000|Initial Period|Adverse Event|4|||
17181036|NCT00102687|38332487|FG001|Initial Period|Adverse Event|7|||
17181037|NCT00102687|38332488|FG002|Initial Period|Adverse Event|9|||
17181038|NCT00102687|38332489|FG003|Initial Period|Adverse Event|0|||
17181039|NCT00102687|38332490|FG004|Initial Period|Adverse Event|0|||
17181040|NCT00102687|38332486|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
17181041|NCT00102687|38332487|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
17181042|NCT00102687|38332488|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
17181043|NCT00102687|38332489|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
17181044|NCT00102687|38332490|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
17181045|NCT00102687|38332486|FG000|Initial Period|Protocol Violation|0|||
17181046|NCT00102687|38332487|FG001|Initial Period|Protocol Violation|0|||
17181047|NCT00102687|38332488|FG002|Initial Period|Protocol Violation|2|||
17181048|NCT00102687|38332489|FG003|Initial Period|Protocol Violation|0|||
17181049|NCT00102687|38332490|FG004|Initial Period|Protocol Violation|0|||
17181050|NCT00102687|38332486|FG000|Initial Period|Physician Decision|2|||
17181051|NCT00102687|38332487|FG001|Initial Period|Physician Decision|9|||
17181052|NCT00102687|38332488|FG002|Initial Period|Physician Decision|6|||
17181053|NCT00102687|38332489|FG003|Initial Period|Physician Decision|0|||
17181054|NCT00102687|38332490|FG004|Initial Period|Physician Decision|0|||
17181055|NCT00102687|38332486|FG000|Initial Period|Sponsor's decision|0|||
17181056|NCT00102687|38332487|FG001|Initial Period|Sponsor's decision|1|||
17181057|NCT00102687|38332488|FG002|Initial Period|Sponsor's decision|1|||
17181058|NCT00102687|38332489|FG003|Initial Period|Sponsor's decision|0|||
17181059|NCT00102687|38332490|FG004|Initial Period|Sponsor's decision|0|||
17181060|NCT00102687|38332486|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
17181061|NCT00102687|38332487|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
17181062|NCT00102687|38332488|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
17181063|NCT00102687|38332489|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
17181064|NCT00102687|38332490|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
17181065|NCT00102687|38332486|FG000|Initial Period|Death|1|||
17181066|NCT00102687|38332487|FG001|Initial Period|Death|1|||
17181067|NCT00102687|38332488|FG002|Initial Period|Death|1|||
17181068|NCT00102687|38332489|FG003|Initial Period|Death|0|||
17181069|NCT00102687|38332490|FG004|Initial Period|Death|0|||
17181070|NCT00102687|38332486|FG000|Maintenance Period|Withdrawal by Subject|4|||
17181071|NCT00102687|38332487|FG001|Maintenance Period|Withdrawal by Subject|0|||
17181072|NCT00102687|38332488|FG002|Maintenance Period|Withdrawal by Subject|2|||
17181073|NCT00102687|38332489|FG003|Maintenance Period|Withdrawal by Subject|3|||
17181074|NCT00102687|38332490|FG004|Maintenance Period|Withdrawal by Subject|1|||
16996929|NCT00974090|38140972|FG001|Period 1: Double Blind Period|Physician Decision|0|||
16996930|NCT00974090|38140971|FG000|Period 2: Open-label Period|Adverse Event|4|||
16996931|NCT00974090|38140972|FG001|Period 2: Open-label Period|Adverse Event|6|||
16996932|NCT00974090|38140971|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
16996933|NCT00974090|38140972|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
16996934|NCT00974090|38140971|FG000|Period 2: Open-label Period|Physician Decision|0|||
16996935|NCT00974090|38140972|FG001|Period 2: Open-label Period|Physician Decision|3|||
16996936|NCT00974090|38140971|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
16996937|NCT00974090|38140972|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
16996938|NCT00971048|38140984|FG000|Overall Study|Protocol Violation|1|||
16996939|NCT00971048|38140985|FG001|Overall Study|Protocol Violation|2|||
16996940|NCT00971048|38140986|FG002|Overall Study|Protocol Violation|0|||
16996941|NCT00971048|38140987|FG003|Overall Study|Protocol Violation|1|||
16996942|NCT00971048|38140984|FG000|Overall Study|Adverse Event|0|||
16996943|NCT00971048|38140985|FG001|Overall Study|Adverse Event|0|||
16996944|NCT00971048|38140986|FG002|Overall Study|Adverse Event|1|||
16996945|NCT00971048|38140987|FG003|Overall Study|Adverse Event|0|||
16996946|NCT00971048|38140984|FG000|Overall Study|Physician Decision|0|||
16996947|NCT00971048|38140985|FG001|Overall Study|Physician Decision|0|||
16996948|NCT00971048|38140986|FG002|Overall Study|Physician Decision|0|||
17089139|NCT00320372|38229255|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
17089140|NCT00320372|38229256|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
17089141|NCT00294762|38229272|FG000|Overall Study|Did not receive study treatment|3|||
17089142|NCT00294762|38229273|FG001|Overall Study|Did not receive study treatment|3|||
17089143|NCT00294684|38229281|FG000|Overall Study|Lost to Follow-up|5|||
17089144|NCT00294684|38229282|FG001|Overall Study|Lost to Follow-up|8|||
17089145|NCT00307034|38229290|FG000|Overall Study|Adverse Event|1|||
17089146|NCT00307034|38229291|FG001|Overall Study|Adverse Event|2|||
17089147|NCT00307034|38229290|FG000|Overall Study|Withdrawal by Subject|1|||
17089148|NCT00307034|38229291|FG001|Overall Study|Withdrawal by Subject|2|||
17089149|NCT00307034|38229290|FG000|Overall Study|Lost to Follow-up|0|||
17089150|NCT00307034|38229291|FG001|Overall Study|Lost to Follow-up|3|||
17089151|NCT00320216|38229302|FG000|Overall Study|Adverse Event|0|||
17089152|NCT00320216|38229303|FG001|Overall Study|Adverse Event|6|||
17089153|NCT00320216|38229304|FG002|Overall Study|Adverse Event|0|||
17089154|NCT00320216|38229305|FG003|Overall Study|Adverse Event|2|||
17089155|NCT00320216|38229306|FG004|Overall Study|Adverse Event|2|||
17181075|NCT00102687|38332486|FG000|Maintenance Period|Adverse Event|1|||
17181076|NCT00102687|38332487|FG001|Maintenance Period|Adverse Event|0|||
16996949|NCT00971048|38140987|FG003|Overall Study|Physician Decision|1|||
16996950|NCT00699751|38141001|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
16996951|NCT00699751|38141002|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
16996952|NCT00699751|38141001|FG000|Period 1: Without/Before Drug Switch|Death|28|||
16996953|NCT00699751|38141002|FG001|Period 1: Without/Before Drug Switch|Death|29|||
17089156|NCT00320216|38229302|FG000|Overall Study|Lack of Efficacy|6|||
17089157|NCT00320216|38229303|FG001|Overall Study|Lack of Efficacy|2|||
17089158|NCT00320216|38229304|FG002|Overall Study|Lack of Efficacy|1|||
17089159|NCT00320216|38229305|FG003|Overall Study|Lack of Efficacy|0|||
17089160|NCT00320216|38229306|FG004|Overall Study|Lack of Efficacy|1|||
17181077|NCT00102687|38332488|FG002|Maintenance Period|Adverse Event|0|||
17181078|NCT00102687|38332489|FG003|Maintenance Period|Adverse Event|1|||
17181079|NCT00102687|38332490|FG004|Maintenance Period|Adverse Event|3|||
17181080|NCT00102687|38332486|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
17181081|NCT00102687|38332487|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
17181082|NCT00102687|38332488|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
17181083|NCT00102687|38332489|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
17181084|NCT00102687|38332490|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
17181085|NCT00102687|38332486|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
17181086|NCT00102687|38332487|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
17181087|NCT00102687|38332488|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
17181088|NCT00102687|38332489|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
17181089|NCT00102687|38332490|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
17181090|NCT00102687|38332486|FG000|Maintenance Period|Death|0|||
17181091|NCT00102687|38332487|FG001|Maintenance Period|Death|0|||
17181092|NCT00102687|38332488|FG002|Maintenance Period|Death|0|||
17181093|NCT00102687|38332489|FG003|Maintenance Period|Death|1|||
17181094|NCT00102687|38332490|FG004|Maintenance Period|Death|1|||
17181095|NCT00102687|38332486|FG000|Maintenance Period|Physician Decision|1|||
17181096|NCT00102687|38332487|FG001|Maintenance Period|Physician Decision|2|||
17181097|NCT00102687|38332488|FG002|Maintenance Period|Physician Decision|3|||
17181098|NCT00102687|38332489|FG003|Maintenance Period|Physician Decision|0|||
17181099|NCT00102687|38332490|FG004|Maintenance Period|Physician Decision|4|||
17181100|NCT00102531|38332508|FG000|Overall Study|Adverse Event|0|||
17181101|NCT00102531|38332509|FG001|Overall Study|Adverse Event|1|||
17181102|NCT00102531|38332508|FG000|Overall Study|Disease Progression|5|||
17181103|NCT00102531|38332509|FG001|Overall Study|Disease Progression|9|||
17181104|NCT00102531|38332508|FG000|Overall Study|Physician Decision|0|||
17181105|NCT00102531|38332509|FG001|Overall Study|Physician Decision|1|||
17181106|NCT02771145|38332515|FG000|Overall Study|Adverse Event|3|||
17181107|NCT02771145|38332515|FG000|Overall Study|Lost to Follow-up|1|||
17181108|NCT02578186|38332535|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
17181109|NCT02578186|38332536|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
17181110|NCT02578186|38332535|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
17181111|NCT02578186|38332536|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
17181112|NCT00103311|38332544|FG000|Overall Study|Lost to Follow-up|1|||
17181113|NCT00103311|38332545|FG001|Overall Study|Lost to Follow-up|0|||
17181114|NCT00103311|38332544|FG000|Overall Study|Withdrawal by Subject|2|||
17181115|NCT00103311|38332545|FG001|Overall Study|Withdrawal by Subject|1|||
17181116|NCT00103311|38332544|FG000|Overall Study|Adverse Event|1|||
17181117|NCT00103311|38332545|FG001|Overall Study|Adverse Event|0|||
17181118|NCT02576938|38332558|FG000|Overall Study|Adverse Event|5|||
17181119|NCT02576938|38332559|FG001|Overall Study|Adverse Event|3|||
17181120|NCT02576938|38332560|FG002|Overall Study|Adverse Event|6|||
17181121|NCT02576938|38332558|FG000|Overall Study|Protocol Violation|1|||
17181122|NCT02576938|38332559|FG001|Overall Study|Protocol Violation|1|||
17181123|NCT02576938|38332560|FG002|Overall Study|Protocol Violation|1|||
17181124|NCT02576938|38332558|FG000|Overall Study|Withdrawal by Subject|3|||
17181125|NCT02576938|38332559|FG001|Overall Study|Withdrawal by Subject|2|||
17181126|NCT02576938|38332560|FG002|Overall Study|Withdrawal by Subject|4|||
17181127|NCT02576938|38332558|FG000|Overall Study|Lack of Efficacy|9|||
17181128|NCT02576938|38332559|FG001|Overall Study|Lack of Efficacy|4|||
17181129|NCT02576938|38332560|FG002|Overall Study|Lack of Efficacy|0|||
17181130|NCT02576938|38332558|FG000|Overall Study|Lost to Follow-up|2|||
17181131|NCT02576938|38332559|FG001|Overall Study|Lost to Follow-up|0|||
17181132|NCT02576938|38332560|FG002|Overall Study|Lost to Follow-up|1|||
17181133|NCT02576938|38332558|FG000|Overall Study|Physician Decision|0|||
17181134|NCT02576938|38332559|FG001|Overall Study|Physician Decision|1|||
17181135|NCT02576938|38332560|FG002|Overall Study|Physician Decision|0|||
17181136|NCT02576938|38332558|FG000|Overall Study|Met Exclusion Criteria|0|||
17181137|NCT02576938|38332559|FG001|Overall Study|Met Exclusion Criteria|1|||
17181138|NCT02576938|38332560|FG002|Overall Study|Met Exclusion Criteria|0|||
17181139|NCT02576860|38332572|FG000|Overall Study|Adverse Event|6|||
17181140|NCT02576860|38332573|FG001|Overall Study|Adverse Event|6|||
17181141|NCT02576860|38332572|FG000|Overall Study|Lost to Follow-up|5|||
17181142|NCT02576860|38332573|FG001|Overall Study|Lost to Follow-up|7|||
17181143|NCT02576860|38332572|FG000|Overall Study|Physician Decision|0|||
17181144|NCT02576860|38332573|FG001|Overall Study|Physician Decision|1|||
17181145|NCT02576860|38332572|FG000|Overall Study|Protocol Violation|0|||
17089161|NCT00320216|38229302|FG000|Overall Study|Lost to Follow-up|3|||
17089162|NCT00320216|38229303|FG001|Overall Study|Lost to Follow-up|0|||
17089163|NCT00320216|38229304|FG002|Overall Study|Lost to Follow-up|0|||
17089164|NCT00320216|38229305|FG003|Overall Study|Lost to Follow-up|0|||
17089165|NCT00320216|38229306|FG004|Overall Study|Lost to Follow-up|0|||
17089166|NCT00320216|38229302|FG000|Overall Study|Other|7|||
17089167|NCT00320216|38229303|FG001|Overall Study|Other|2|||
17089168|NCT00320216|38229304|FG002|Overall Study|Other|5|||
17089169|NCT00320216|38229305|FG003|Overall Study|Other|1|||
17089170|NCT00320216|38229306|FG004|Overall Study|Other|3|||
17089171|NCT00290706|38229327|FG000|Overall Study|Withdrawal by Subject|2|||
17181146|NCT02576860|38332573|FG001|Overall Study|Protocol Violation|2|||
17181147|NCT02576860|38332572|FG000|Overall Study|Withdrawal by Subject|13|||
17181148|NCT02576860|38332573|FG001|Overall Study|Withdrawal by Subject|8|||
17181149|NCT02576860|38332572|FG000|Overall Study|Disallowed medication|1|||
17181150|NCT02576860|38332573|FG001|Overall Study|Disallowed medication|0|||
17181151|NCT02572570|38332580|FG000|Overall Study|Study Terminated|27|||
17181152|NCT00709202|38332589|FG000|Overall Study|Withdrawal by Subject|6|||
17181153|NCT00709202|38332590|FG001|Overall Study|Withdrawal by Subject|6|||
17181154|NCT00709124|38332599|FG000|Overall Study|Death|3|||
17181155|NCT00709124|38332600|FG001|Overall Study|Death|1|||
17181156|NCT00709124|38332599|FG000|Overall Study|encephalopathy; can't do assessment|1|||
17181157|NCT00709124|38332600|FG001|Overall Study|encephalopathy; can't do assessment|0|||
17181158|NCT02738580|38332612|FG000|Overall Study|Adverse Event|1|||
17181159|NCT02738580|38332613|FG001|Overall Study|Adverse Event|0|||
16996954|NCT00699751|38141001|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
16996955|NCT00699751|38141002|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
16996956|NCT00699751|38141001|FG000|Period 1: Without/Before Drug Switch|Other|30|||
16996957|NCT00699751|38141002|FG001|Period 1: Without/Before Drug Switch|Other|20|||
16996958|NCT00699751|38141001|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
16996959|NCT00699751|38141002|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
16996960|NCT00699751|38141001|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
16996961|NCT00699751|38141002|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
16996962|NCT00699751|38141001|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
16996963|NCT00699751|38141002|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
16996964|NCT00699751|38141001|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
16996965|NCT00699751|38141002|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
16996966|NCT00970502|38141009|FG000|Overall Study|Withdrawal by Subject|1|||
16996967|NCT00967226|38141019|FG000|Overall Study|Adverse Event|0|||
16996968|NCT00967226|38141020|FG001|Overall Study|Adverse Event|5|||
16996969|NCT00967226|38141019|FG000|Overall Study|Protocol Violation|2|||
16996970|NCT00967226|38141020|FG001|Overall Study|Protocol Violation|0|||
16996971|NCT00967226|38141019|FG000|Overall Study|Physician Decision|0|||
16996972|NCT00967226|38141020|FG001|Overall Study|Physician Decision|1|||
16996973|NCT00706381|38141054|FG000|Overall Study|Lost to Follow-up|0|||
16996974|NCT00706381|38141055|FG001|Overall Study|Lost to Follow-up|1|||
16996975|NCT00706381|38141056|FG002|Overall Study|Lost to Follow-up|1|||
16996976|NCT00706381|38141057|FG003|Overall Study|Lost to Follow-up|0|||
16996977|NCT00964886|38141074|FG000|Overall Study|Lost to Follow-up|2|||
16996978|NCT00964886|38141075|FG001|Overall Study|Lost to Follow-up|2|||
16996979|NCT00964886|38141076|FG002|Overall Study|Lost to Follow-up|6|||
16996980|NCT00964886|38141077|FG003|Overall Study|Lost to Follow-up|4|||
16996981|NCT00964886|38141074|FG000|Overall Study|Withdrawal by Subject|6|||
16996982|NCT00964886|38141075|FG001|Overall Study|Withdrawal by Subject|2|||
16996983|NCT00964886|38141076|FG002|Overall Study|Withdrawal by Subject|5|||
16996984|NCT00964886|38141077|FG003|Overall Study|Withdrawal by Subject|3|||
16996985|NCT00964886|38141074|FG000|Overall Study|Adverse Event|3|||
16996986|NCT00964886|38141075|FG001|Overall Study|Adverse Event|1|||
16996987|NCT00964886|38141076|FG002|Overall Study|Adverse Event|5|||
16996988|NCT00964886|38141077|FG003|Overall Study|Adverse Event|2|||
16996989|NCT00964886|38141074|FG000|Overall Study|Protocol Violation|0|||
16996990|NCT00964886|38141075|FG001|Overall Study|Protocol Violation|2|||
16996991|NCT00964886|38141076|FG002|Overall Study|Protocol Violation|0|||
16996992|NCT00964886|38141077|FG003|Overall Study|Protocol Violation|0|||
16996993|NCT00705757|38141094|FG000|Overall Study|Lack of Efficacy|5|||
16996994|NCT00705757|38141095|FG001|Overall Study|Lack of Efficacy|1|||
16996995|NCT00705757|38141096|FG002|Overall Study|Lack of Efficacy|3|||
16996996|NCT00705757|38141094|FG000|Overall Study|Lost to Follow-up|7|||
16996997|NCT00705757|38141095|FG001|Overall Study|Lost to Follow-up|6|||
16996998|NCT00705757|38141096|FG002|Overall Study|Lost to Follow-up|6|||
16996999|NCT00705757|38141094|FG000|Overall Study|Withdrawal by Subject|1|||
16997000|NCT00705757|38141095|FG001|Overall Study|Withdrawal by Subject|1|||
16997001|NCT00705757|38141096|FG002|Overall Study|Withdrawal by Subject|2|||
16997002|NCT00960752|38141124|FG000|Overall Study|Adverse Event|0|||
16997003|NCT00960752|38141125|FG001|Overall Study|Adverse Event|0|||
16997004|NCT00960752|38141126|FG002|Overall Study|Adverse Event|1|||
16997005|NCT00960752|38141124|FG000|Overall Study|Progression|0|||
16997006|NCT00960752|38141125|FG001|Overall Study|Progression|0|||
16997007|NCT00960752|38141126|FG002|Overall Study|Progression|1|||
16997008|NCT00758524|38141140|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
16997009|NCT00758524|38141141|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
16997010|NCT00758524|38141142|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
16997011|NCT00758524|38141143|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16997012|NCT00758524|38141144|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
17181160|NCT02738580|38332612|FG000|Overall Study|Lack of Efficacy|3|||
17181161|NCT02738580|38332613|FG001|Overall Study|Lack of Efficacy|2|||
17181162|NCT02738580|38332612|FG000|Overall Study|Withdrawal by Subject|0|||
17181163|NCT02738580|38332613|FG001|Overall Study|Withdrawal by Subject|1|||
17181164|NCT02738580|38332612|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
17181165|NCT02738580|38332613|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
17181166|NCT02571244|38332621|FG000|Overall Study|Lost to Follow-up|0|||
17181167|NCT02571244|38332622|FG001|Overall Study|Lost to Follow-up|1|||
17181168|NCT02571244|38332621|FG000|Overall Study|Unable to reach out post discharge|3|||
17181169|NCT02571244|38332622|FG001|Overall Study|Unable to reach out post discharge|0|||
17181170|NCT02573350|38332633|FG000|Overall Study|Lost to Follow-up|2|||
17181171|NCT02573350|38332634|FG001|Overall Study|Lost to Follow-up|1|||
17181172|NCT02573350|38332633|FG000|Overall Study|Adverse Event|3|||
17181173|NCT02573350|38332634|FG001|Overall Study|Adverse Event|4|||
17181174|NCT02573350|38332633|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
17181175|NCT02573350|38332634|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
17181176|NCT02573350|38332633|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
17181177|NCT02573350|38332634|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
17181178|NCT02573350|38332633|FG000|Overall Study|Subject withdrew consent to participate|6|||
17181179|NCT02573350|38332634|FG001|Overall Study|Subject withdrew consent to participate|1|||
17181180|NCT02573350|38332633|FG000|Overall Study|Protocol Deviation|1|||
17181181|NCT02573350|38332634|FG001|Overall Study|Protocol Deviation|1|||
17181182|NCT01376804|38332643|FG000|Treatment Period|Withdrawal by Subject|1|||
17181183|NCT01376804|38332643|FG000|Treatment Period|Adverse Event|6|||
17181184|NCT01376804|38332643|FG000|Treatment Period|Patient did not receive study drug|1|||
17181185|NCT02574520|38332651|FG000|Overall Study|Not dosed|2|||
17181186|NCT02574520|38332652|FG001|Overall Study|Not dosed|0|||
17181187|NCT02574520|38332653|FG002|Overall Study|Not dosed|5|||
17181188|NCT02574520|38332654|FG003|Overall Study|Not dosed|4|||
17181189|NCT02574520|38332651|FG000|Overall Study|Adverse Event|0|||
17181190|NCT02574520|38332652|FG001|Overall Study|Adverse Event|0|||
17181191|NCT02574520|38332653|FG002|Overall Study|Adverse Event|0|||
17181192|NCT02574520|38332654|FG003|Overall Study|Adverse Event|1|||
17181193|NCT02574520|38332651|FG000|Overall Study|Withdrawal by Subject|0|||
17181194|NCT02574520|38332652|FG001|Overall Study|Withdrawal by Subject|0|||
17181195|NCT02574520|38332653|FG002|Overall Study|Withdrawal by Subject|0|||
17181196|NCT02574520|38332654|FG003|Overall Study|Withdrawal by Subject|1|||
17181197|NCT02574520|38332651|FG000|Overall Study|Other|0|||
17181198|NCT02574520|38332652|FG001|Overall Study|Other|0|||
17181199|NCT02574520|38332653|FG002|Overall Study|Other|0|||
17181200|NCT02574520|38332654|FG003|Overall Study|Other|2|||
17181201|NCT00709592|38332666|FG000|Overall Study|Unable to proceed to transplant|0|||
17181202|NCT00709592|38332667|FG001|Overall Study|Unable to proceed to transplant|1|||
17181203|NCT02570152|38332673|FG000|Overall Study|Protocol Violation|2|||
17181204|NCT02570152|38332673|FG000|Overall Study|Migrated/moved from study area|13|||
17181205|NCT02570074|38332679|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
17181206|NCT02570074|38332680|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
17181207|NCT02569996|38332698|FG000|Overall Study|Adverse Event|6|||
16997013|NCT00758524|38141145|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
16997014|NCT00758524|38141146|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
17181208|NCT02569996|38332698|FG000|Overall Study|Physician Decision|3|||
17181209|NCT02569996|38332698|FG000|Overall Study|Progression of the disease|18|||
17181210|NCT02569996|38332698|FG000|Overall Study|New anti-lymphoma treatment|1|||
17181211|NCT02569996|38332698|FG000|Overall Study|Non-compliance|9|||
17181212|NCT02569996|38332698|FG000|Overall Study|Withdrawal by Subject|5|||
17181213|NCT02569996|38332698|FG000|Overall Study|Lost to Follow-up|5|||
17181214|NCT02569996|38332698|FG000|Overall Study|Complete remission|7|||
17181215|NCT02569996|38332698|FG000|Overall Study|Unknown reason|1|||
17181216|NCT02572882|38332702|FG000|Overall Study|Withdrawal by Subject|1|||
17181217|NCT02572882|38332702|FG000|Overall Study|Participant received kidney transplant|1|||
17181218|NCT00708500|38332732|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
17181219|NCT00708500|38332733|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
16997015|NCT00758524|38141147|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16997016|NCT00758524|38141148|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16997017|NCT00758524|38141149|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
17181220|NCT00708500|38332734|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
17181221|NCT00708500|38332732|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
17181222|NCT00708500|38332733|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
16997018|NCT00758524|38141150|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
17181223|NCT00708500|38332734|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
17181224|NCT00708500|38332732|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
17181225|NCT00708500|38332733|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
17181226|NCT00708500|38332734|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
17181227|NCT00708500|38332732|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
17181228|NCT00708500|38332733|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
17089172|NCT00290706|38229328|FG001|Overall Study|Withdrawal by Subject|0|||
17089173|NCT00290706|38229329|FG002|Overall Study|Withdrawal by Subject|0|||
17089174|NCT00290706|38229330|FG003|Overall Study|Withdrawal by Subject|0|||
17089175|NCT00290706|38229327|FG000|Overall Study|Progressive Disease|3|||
16997019|NCT00758524|38141151|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16997020|NCT00758524|38141152|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16997021|NCT00758524|38141153|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16997022|NCT00758524|38141154|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16997023|NCT00758524|38141155|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
17089176|NCT00290706|38229328|FG001|Overall Study|Progressive Disease|5|||
17089177|NCT00290706|38229329|FG002|Overall Study|Progressive Disease|4|||
17089178|NCT00290706|38229330|FG003|Overall Study|Progressive Disease|10|||
17089179|NCT00290706|38229327|FG000|Overall Study|Adverse Event|0|||
17089180|NCT00290706|38229328|FG001|Overall Study|Adverse Event|1|||
17089181|NCT00290706|38229329|FG002|Overall Study|Adverse Event|2|||
17089182|NCT00290706|38229330|FG003|Overall Study|Adverse Event|0|||
17089183|NCT00290706|38229327|FG000|Overall Study|Receive auto transplant or radiation|0|||
17089184|NCT00290706|38229328|FG001|Overall Study|Receive auto transplant or radiation|0|||
17089185|NCT00290706|38229329|FG002|Overall Study|Receive auto transplant or radiation|0|||
17089186|NCT00290706|38229330|FG003|Overall Study|Receive auto transplant or radiation|1|||
17089187|NCT00290706|38229327|FG000|Overall Study|Physician Decision|0|||
17089188|NCT00290706|38229328|FG001|Overall Study|Physician Decision|0|||
17089189|NCT00290706|38229329|FG002|Overall Study|Physician Decision|0|||
17089190|NCT00290706|38229330|FG003|Overall Study|Physician Decision|1|||
17089191|NCT00303186|38229341|FG000|Overall Study|Other|52|||
17089192|NCT00294060|38229345|FG000|Overall Study|Death|225|||
17089193|NCT00294060|38229345|FG000|Overall Study|Other|59|||
17089194|NCT00294060|38229345|FG000|Overall Study|Lost to Follow-up|55|||
17089195|NCT00294060|38229345|FG000|Overall Study|Withdrawal by Subject|11|||
17089196|NCT00294060|38229345|FG000|Overall Study|Physician Decision|797|||
17089197|NCT00294060|38229345|FG000|Overall Study|Medical condition|3|||
17089198|NCT00294060|38229345|FG000|Overall Study|Device explanted/not replaced|23|||
17089199|NCT00303108|38229352|FG000|Overall Study|Adverse Event|5|||
17089200|NCT00303108|38229353|FG001|Overall Study|Adverse Event|6|||
17089201|NCT00303108|38229354|FG002|Overall Study|Adverse Event|7|||
17089202|NCT00303108|38229352|FG000|Overall Study|Patient Request|4|||
17089203|NCT00303108|38229353|FG001|Overall Study|Patient Request|2|||
17089204|NCT00303108|38229354|FG002|Overall Study|Patient Request|8|||
17089205|NCT00303108|38229352|FG000|Overall Study|Failed Entry|1|||
17089206|NCT00303108|38229353|FG001|Overall Study|Failed Entry|0|||
17089207|NCT00303108|38229354|FG002|Overall Study|Failed Entry|1|||
17089208|NCT00303108|38229352|FG000|Overall Study|ineligible|2|||
17089209|NCT00303108|38229353|FG001|Overall Study|ineligible|1|||
17089210|NCT00303108|38229354|FG002|Overall Study|ineligible|0|||
17089211|NCT00302952|38229363|FG000|Overall Study|Physician Decision|1|||
17089212|NCT00302952|38229364|FG001|Overall Study|Physician Decision|1|||
17181229|NCT00708500|38332734|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
17181230|NCT00708500|38332732|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
17181231|NCT00708500|38332733|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
17181232|NCT00708500|38332734|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
17181233|NCT00708500|38332732|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
17181234|NCT00708500|38332733|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
17181235|NCT00708500|38332734|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
17181236|NCT00708500|38332732|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
17181237|NCT00708500|38332733|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
17181238|NCT00708500|38332734|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
17181239|NCT00708500|38332732|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
17181240|NCT00708500|38332733|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
17181241|NCT00708500|38332734|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
17181242|NCT00708500|38332732|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
17181243|NCT00708500|38332733|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
17181244|NCT00708500|38332734|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
17181245|NCT00708500|38332732|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
17181246|NCT00708500|38332733|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
17181247|NCT00708500|38332734|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
17181248|NCT00708500|38332732|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
17181249|NCT00708500|38332733|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
17181250|NCT00708500|38332734|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
17181251|NCT00708500|38332732|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
17181252|NCT00708500|38332733|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
17181253|NCT00708500|38332734|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
17181254|NCT00708500|38332732|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
17181255|NCT00708500|38332733|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
17181256|NCT00708500|38332734|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
17181257|NCT00708500|38332732|FG000|FOLLOWUP|Adverse Event|0|||
17181258|NCT00708500|38332733|FG001|FOLLOWUP|Adverse Event|1|||
17181259|NCT00708500|38332734|FG002|FOLLOWUP|Adverse Event|0|||
17181260|NCT00708500|38332732|FG000|FOLLOWUP|Lost to Follow-up|1|||
17181261|NCT00708500|38332733|FG001|FOLLOWUP|Lost to Follow-up|6|||
17181262|NCT00708500|38332734|FG002|FOLLOWUP|Lost to Follow-up|4|||
17181263|NCT00708500|38332732|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
17181264|NCT00708500|38332733|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
17181265|NCT00708500|38332734|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
17181266|NCT00708500|38332732|FG000|FOLLOWUP|Subject withdrew consent|31|||
17181267|NCT00708500|38332733|FG001|FOLLOWUP|Subject withdrew consent|4|||
17181268|NCT00708500|38332734|FG002|FOLLOWUP|Subject withdrew consent|5|||
17181269|NCT00708500|38332732|FG000|FOLLOWUP|Non-compliance with protocol|5|||
17181270|NCT00708500|38332733|FG001|FOLLOWUP|Non-compliance with protocol|0|||
17181271|NCT00708500|38332734|FG002|FOLLOWUP|Non-compliance with protocol|1|||
17181272|NCT00708734|38332751|FG000|Overall Study|scheduling conflict|2|||
17181273|NCT00708734|38332751|FG000|Overall Study|moved|1|||
17181274|NCT00708734|38332751|FG000|Overall Study|leg injury|1|||
17181275|NCT00708734|38332751|FG000|Overall Study|knee replacement|1|||
17181276|NCT00708734|38332751|FG000|Overall Study|vertigo|1|||
17181277|NCT00708734|38332751|FG000|Overall Study|leg fracture|1|||
17181278|NCT04834362|38332757|FG000|Overall Study|Death|1|||
17181279|NCT04834362|38332758|FG001|Overall Study|Death|2|||
17181280|NCT00101907|38332787|FG000|Overall Study|Adverse Event|1|||
17181281|NCT00101907|38332788|FG001|Overall Study|Adverse Event|0|||
17181282|NCT00101907|38332789|FG002|Overall Study|Adverse Event|0|||
17181283|NCT00101907|38332790|FG003|Overall Study|Adverse Event|0|||
17181284|NCT00101907|38332791|FG004|Overall Study|Adverse Event|0|||
17181285|NCT00101907|38332792|FG005|Overall Study|Adverse Event|0|||
17181286|NCT00101907|38332787|FG000|Overall Study|Death|0|||
17181287|NCT00101907|38332788|FG001|Overall Study|Death|1|||
17181288|NCT00101907|38332789|FG002|Overall Study|Death|0|||
17181289|NCT00101907|38332790|FG003|Overall Study|Death|0|||
17181290|NCT00101907|38332791|FG004|Overall Study|Death|3|||
17181291|NCT00101907|38332792|FG005|Overall Study|Death|0|||
17181292|NCT00101907|38332787|FG000|Overall Study|Physician Decision|0|||
17181293|NCT00101907|38332788|FG001|Overall Study|Physician Decision|0|||
17181294|NCT00101907|38332789|FG002|Overall Study|Physician Decision|0|||
17181295|NCT00101907|38332790|FG003|Overall Study|Physician Decision|1|||
17181296|NCT00101907|38332791|FG004|Overall Study|Physician Decision|1|||
17181297|NCT00101907|38332792|FG005|Overall Study|Physician Decision|0|||
17181298|NCT00101907|38332787|FG000|Overall Study|Withdrawal by Subject|1|||
17181299|NCT00101907|38332788|FG001|Overall Study|Withdrawal by Subject|0|||
17181300|NCT00101907|38332789|FG002|Overall Study|Withdrawal by Subject|1|||
17181301|NCT00101907|38332790|FG003|Overall Study|Withdrawal by Subject|0|||
17181302|NCT00101907|38332791|FG004|Overall Study|Withdrawal by Subject|1|||
17181303|NCT00101907|38332792|FG005|Overall Study|Withdrawal by Subject|0|||
17181304|NCT02565784|38332813|FG000|First Treatment|Adverse Event|1|||
17181305|NCT02565784|38332813|FG000|First Treatment|Withdrawal by Subject|1|||
17181306|NCT02565784|38332813|FG000|Second Treatment|Withdrawal by Subject|2|||
17181307|NCT02761629|38332847|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
17181308|NCT02761629|38332848|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
17181309|NCT02761629|38332847|FG000|Overall Study|Insufficient Therapeutic Response|2|||
17181310|NCT02761629|38332848|FG001|Overall Study|Insufficient Therapeutic Response|7|||
17181311|NCT02761629|38332847|FG000|Overall Study|Failure to Return|2|||
17181312|NCT02761629|38332848|FG001|Overall Study|Failure to Return|4|||
17181313|NCT02761629|38332847|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
17181314|NCT02761629|38332848|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
17181315|NCT02761629|38332847|FG000|Overall Study|Protocol Violation|2|||
17181316|NCT02761629|38332848|FG001|Overall Study|Protocol Violation|2|||
17181317|NCT02761629|38332847|FG000|Overall Study|Withdrawal by Subject|0|||
17181318|NCT02761629|38332848|FG001|Overall Study|Withdrawal by Subject|3|||
17181319|NCT02761629|38332847|FG000|Overall Study|Other|0|||
17181320|NCT02761629|38332848|FG001|Overall Study|Other|2|||
17181321|NCT02761629|38332847|FG000|Overall Study|Lost to Follow-up|4|||
17181322|NCT02761629|38332848|FG001|Overall Study|Lost to Follow-up|1|||
17181323|NCT02761629|38332847|FG000|Overall Study|Randomized But Not Treated|8|||
17181324|NCT02761629|38332848|FG001|Overall Study|Randomized But Not Treated|4|||
17181325|NCT02760927|38332854|FG000|Overall Study|Tube Slippage from Device|1|||
17181326|NCT00101439|38332860|FG000|Period 2|Withdrawal by Subject|0|||
17181327|NCT00101439|38332861|FG001|Period 2|Withdrawal by Subject|2|||
17181328|NCT04033068|38332871|FG000|Overall Study|Withdrawal by Subject|0|||
17181329|NCT04033068|38332872|FG001|Overall Study|Withdrawal by Subject|0|||
17181330|NCT04033068|38332873|FG002|Overall Study|Withdrawal by Subject|1|||
17181331|NCT04033068|38332874|FG003|Overall Study|Withdrawal by Subject|0|||
17181332|NCT04033068|38332871|FG000|Overall Study|Lost to Follow-up|0|||
17181333|NCT04033068|38332872|FG001|Overall Study|Lost to Follow-up|1|||
17181334|NCT04033068|38332873|FG002|Overall Study|Lost to Follow-up|0|||
17181335|NCT04033068|38332874|FG003|Overall Study|Lost to Follow-up|0|||
17181336|NCT04033068|38332871|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
17181337|NCT04033068|38332872|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
17181338|NCT04033068|38332873|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
17181339|NCT04033068|38332874|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
17181340|NCT00101283|38332886|FG000|Overall Study|Withdrawal by Subject|0|||
17181341|NCT00101283|38332887|FG001|Overall Study|Withdrawal by Subject|1|||
17181342|NCT00101283|38332886|FG000|Overall Study|Insurance Refusal|0|||
17181343|NCT00101283|38332887|FG001|Overall Study|Insurance Refusal|1|||
17181344|NCT00101283|38332886|FG000|Overall Study|Prostate Cancer Recurrence|0|||
17181345|NCT00101283|38332887|FG001|Overall Study|Prostate Cancer Recurrence|1|||
17181346|NCT02762565|38332893|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
17181347|NCT02757963|38332906|FG000|Overall Study|Adverse Event|3|||
17181348|NCT02757963|38332906|FG000|Overall Study|Reached Stopping Criteria|1054|||
17181349|NCT02757963|38332906|FG000|Overall Study|Lost to Follow-up|5|||
17181350|NCT02757963|38332906|FG000|Overall Study|Physician Decision|1|||
17181351|NCT02757963|38332906|FG000|Overall Study|Withdrawal by Subject|34|||
17181352|NCT03111732|38332921|FG000|Overall Study|Enrolled in different study|1|||
17181353|NCT03111732|38332921|FG000|Overall Study|Progressive disease|3|||
17181354|NCT03111732|38332921|FG000|Overall Study|Withdrawal by Subject|1|||
17181355|NCT01663714|38332930|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
17181356|NCT01663714|38332930|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
17181357|NCT01663714|38332930|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
17181358|NCT01663714|38332930|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
17181359|NCT01663714|38332930|FG000|Long-Term Follow-Up|Death|4|||
17181360|NCT01663714|38332930|FG000|Long-Term Follow-Up|Non-compliance|1|||
17181361|NCT01663636|38332952|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
17181362|NCT01663636|38332953|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
17181363|NCT03065244|38332961|FG000|Overall Study|Lost to Follow-up|1|||
17181364|NCT03065244|38332962|FG001|Overall Study|Lost to Follow-up|1|||
17181365|NCT03065244|38332961|FG000|Overall Study|Diagnosed with a different disease|1|||
17181366|NCT03065244|38332962|FG001|Overall Study|Diagnosed with a different disease|1|||
17181367|NCT03065244|38332961|FG000|Overall Study|Protocol Violation|0|||
17181368|NCT03065244|38332962|FG001|Overall Study|Protocol Violation|1|||
17181369|NCT03065244|38332961|FG000|Overall Study|Withdrawal by Subject|1|||
17181370|NCT03065244|38332962|FG001|Overall Study|Withdrawal by Subject|1|||
17181371|NCT00100815|38332968|FG000|Overall Study|Progression|24|||
17181372|NCT00100815|38332968|FG000|Overall Study|Adverse Event|18|||
17181373|NCT00100815|38332968|FG000|Overall Study|Death|4|||
17181374|NCT00100815|38332968|FG000|Overall Study|Other|3|||
17181375|NCT00708422|38332974|FG000|Overall Study|Adverse Event|3|||
17181376|NCT00708422|38332975|FG001|Overall Study|Adverse Event|1|||
17181377|NCT00708422|38332974|FG000|Overall Study|Withdrawal by Subject|1|||
17181378|NCT00708422|38332975|FG001|Overall Study|Withdrawal by Subject|0|||
17181379|NCT02760069|38332984|FG000|Overall Study|Withdrawal by Subject|0|||
17181380|NCT02760069|38332985|FG001|Overall Study|Withdrawal by Subject|1|||
17181381|NCT02760069|38332986|FG002|Overall Study|Withdrawal by Subject|1|||
17181382|NCT00707486|38332994|FG000|Overall Study|Withdrawal by Subject|1|||
17181383|NCT02759055|38333002|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
17181384|NCT02759055|38333003|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
17181385|NCT04634253|38333012|FG000|Overall Study|Adverse Event|1|||
17181386|NCT04634253|38333013|FG001|Overall Study|Adverse Event|1|||
17181387|NCT04634253|38333014|FG002|Overall Study|Adverse Event|0|||
17181388|NCT04634253|38333012|FG000|Overall Study|Physician Decision|0|||
17181389|NCT04634253|38333013|FG001|Overall Study|Physician Decision|1|||
17181390|NCT04634253|38333014|FG002|Overall Study|Physician Decision|0|||
17181391|NCT04634253|38333012|FG000|Overall Study|Withdrawal by Subject|1|||
17181392|NCT04634253|38333013|FG001|Overall Study|Withdrawal by Subject|0|||
17181393|NCT04634253|38333014|FG002|Overall Study|Withdrawal by Subject|3|||
17181394|NCT02756637|38333026|FG000|Overall Study|Not eligible for initial SWOG study|10|||
17181395|NCT02756637|38333027|FG001|Overall Study|Not eligible for initial SWOG study|10|||
17181396|NCT02756637|38333026|FG000|Overall Study|No available NLR value|44|||
17181397|NCT02756637|38333027|FG001|Overall Study|No available NLR value|44|||
17181398|NCT02756637|38333026|FG000|Overall Study|Did not complete curative therapy|33|||
17181399|NCT02756637|38333027|FG001|Overall Study|Did not complete curative therapy|0|||
17181400|NCT00708032|38333035|FG000|Overall Study|Adverse Event|0|||
17181401|NCT00708032|38333036|FG001|Overall Study|Adverse Event|2|||
17181402|NCT00708032|38333035|FG000|Overall Study|Lost to Follow-up|1|||
17181403|NCT00708032|38333036|FG001|Overall Study|Lost to Follow-up|2|||
17181404|NCT00708032|38333035|FG000|Overall Study|Pregnancy|0|||
17181405|NCT00708032|38333036|FG001|Overall Study|Pregnancy|1|||
17181406|NCT00708032|38333035|FG000|Overall Study|Poor vision|0|||
17181407|NCT00708032|38333036|FG001|Overall Study|Poor vision|6|||
17181408|NCT00708032|38333035|FG000|Overall Study|Visit out of range at month 12|4|||
17181409|NCT00708032|38333036|FG001|Overall Study|Visit out of range at month 12|1|||
17181410|NCT00708032|38333035|FG000|Overall Study|Did not meet protocol criteria|1|||
17181411|NCT00708032|38333036|FG001|Overall Study|Did not meet protocol criteria|2|||
17181412|NCT00708032|38333035|FG000|Overall Study|Protocol Violation|4|||
17181413|NCT00708032|38333036|FG001|Overall Study|Protocol Violation|1|||
17181414|NCT00708032|38333035|FG000|Overall Study|Withdrawal by Subject|0|||
17181415|NCT00708032|38333036|FG001|Overall Study|Withdrawal by Subject|1|||
17181416|NCT00707174|38333044|FG000|Overall Study|Adverse Event|1|||
17181417|NCT00707174|38333045|FG001|Overall Study|Adverse Event|6|||
17181418|NCT00707174|38333044|FG000|Overall Study|Withdrawal by Subject|4|||
17181419|NCT00707174|38333045|FG001|Overall Study|Withdrawal by Subject|1|||
17181420|NCT02756403|38333055|FG000|Overall Study|Unable to swallow medication|0|||
17181421|NCT02756403|38333056|FG001|Overall Study|Unable to swallow medication|1|||
17181422|NCT02756403|38333057|FG002|Overall Study|Unable to swallow medication|1|||
17181423|NCT02756403|38333058|FG003|Overall Study|Unable to swallow medication|1|||
17181424|NCT02756403|38333055|FG000|Overall Study|Did not complete Procedure|0|||
17181425|NCT02756403|38333056|FG001|Overall Study|Did not complete Procedure|1|||
17181426|NCT02756403|38333057|FG002|Overall Study|Did not complete Procedure|0|||
17181427|NCT02756403|38333058|FG003|Overall Study|Did not complete Procedure|0|||
17181428|NCT02756403|38333055|FG000|Overall Study|Changed Mind About Procedure|0|||
17181429|NCT02756403|38333056|FG001|Overall Study|Changed Mind About Procedure|0|||
17181430|NCT02756403|38333057|FG002|Overall Study|Changed Mind About Procedure|1|||
17181431|NCT02756403|38333058|FG003|Overall Study|Changed Mind About Procedure|0|||
17181432|NCT02756403|38333055|FG000|Overall Study|Protocol Violation|0|||
17181433|NCT02756403|38333056|FG001|Overall Study|Protocol Violation|1|||
17181434|NCT02756403|38333057|FG002|Overall Study|Protocol Violation|0|||
17181435|NCT02756403|38333058|FG003|Overall Study|Protocol Violation|1|||
17181436|NCT02753595|38333070|FG000|Overall Study|Sponsor termination|2|||
17181437|NCT02753595|38333071|FG001|Overall Study|Sponsor termination|2|||
17181438|NCT00707954|38333094|FG000|Overall Study|Physician Decision|0|||
17181439|NCT00707954|38333095|FG001|Overall Study|Physician Decision|0|||
17181440|NCT00707954|38333096|FG002|Overall Study|Physician Decision|0|||
17181441|NCT00707954|38333097|FG003|Overall Study|Physician Decision|0|||
17181442|NCT00707954|38333098|FG004|Overall Study|Physician Decision|1|||
17181443|NCT02561962|38333119|FG000|Overall Study|Ongoing in study|1|||
17181444|NCT02561962|38333120|FG001|Overall Study|Ongoing in study|0|||
17181445|NCT02561962|38333121|FG002|Overall Study|Ongoing in study|0|||
17181446|NCT02561962|38333122|FG003|Overall Study|Ongoing in study|1|||
17181447|NCT02561962|38333123|FG004|Overall Study|Ongoing in study|0|||
17181448|NCT02561962|38333124|FG005|Overall Study|Ongoing in study|1|||
17181449|NCT02561962|38333125|FG006|Overall Study|Ongoing in study|0|||
17181450|NCT02561962|38333126|FG007|Overall Study|Ongoing in study|4|||
17181451|NCT02561962|38333127|FG008|Overall Study|Ongoing in study|1|||
17181452|NCT02561962|38333119|FG000|Overall Study|Withdrawal by Subject|1|||
17181453|NCT02561962|38333120|FG001|Overall Study|Withdrawal by Subject|0|||
17181454|NCT02561962|38333121|FG002|Overall Study|Withdrawal by Subject|0|||
17181455|NCT02561962|38333122|FG003|Overall Study|Withdrawal by Subject|0|||
17181456|NCT02561962|38333123|FG004|Overall Study|Withdrawal by Subject|1|||
17181457|NCT02561962|38333124|FG005|Overall Study|Withdrawal by Subject|1|||
17181458|NCT02561962|38333125|FG006|Overall Study|Withdrawal by Subject|2|||
17181459|NCT02561962|38333126|FG007|Overall Study|Withdrawal by Subject|1|||
17181460|NCT02561962|38333127|FG008|Overall Study|Withdrawal by Subject|0|||
17181461|NCT02561962|38333119|FG000|Overall Study|Decision by sponsor|0|||
17181462|NCT02561962|38333120|FG001|Overall Study|Decision by sponsor|0|||
17181463|NCT02561962|38333121|FG002|Overall Study|Decision by sponsor|0|||
17181464|NCT02561962|38333122|FG003|Overall Study|Decision by sponsor|0|||
17181465|NCT02561962|38333123|FG004|Overall Study|Decision by sponsor|1|||
17181466|NCT02561962|38333124|FG005|Overall Study|Decision by sponsor|1|||
17181467|NCT02561962|38333125|FG006|Overall Study|Decision by sponsor|0|||
17181468|NCT02561962|38333126|FG007|Overall Study|Decision by sponsor|3|||
17181469|NCT02561962|38333127|FG008|Overall Study|Decision by sponsor|0|||
17181470|NCT02561962|38333119|FG000|Overall Study|Lost to Follow-up|0|||
17181471|NCT02561962|38333120|FG001|Overall Study|Lost to Follow-up|0|||
17181472|NCT02561962|38333121|FG002|Overall Study|Lost to Follow-up|0|||
17181473|NCT02561962|38333122|FG003|Overall Study|Lost to Follow-up|0|||
17181474|NCT02561962|38333123|FG004|Overall Study|Lost to Follow-up|0|||
17181475|NCT02561962|38333124|FG005|Overall Study|Lost to Follow-up|1|||
17181476|NCT02561962|38333125|FG006|Overall Study|Lost to Follow-up|0|||
17181477|NCT02561962|38333126|FG007|Overall Study|Lost to Follow-up|0|||
17181478|NCT02561962|38333127|FG008|Overall Study|Lost to Follow-up|0|||
17181479|NCT02565706|38333151|FG000|Overall Study|Withdrawal by Subject|5|||
17181480|NCT02565706|38333152|FG001|Overall Study|Withdrawal by Subject|7|||
17181481|NCT02565706|38333153|FG002|Overall Study|Withdrawal by Subject|7|||
17181482|NCT02565706|38333154|FG003|Overall Study|Withdrawal by Subject|11|||
17181483|NCT02565706|38333151|FG000|Overall Study|Lost to Follow-up|72|||
17181484|NCT02565706|38333152|FG001|Overall Study|Lost to Follow-up|75|||
17181485|NCT02565706|38333153|FG002|Overall Study|Lost to Follow-up|82|||
17181486|NCT02565706|38333154|FG003|Overall Study|Lost to Follow-up|74|||
17181487|NCT00706628|38333173|FG000|Overall Study|Other Adverse Event|16|||
17181488|NCT00706628|38333174|FG001|Overall Study|Other Adverse Event|5|||
17181489|NCT00706628|38333175|FG002|Overall Study|Other Adverse Event|5|||
17181490|NCT00706628|38333176|FG003|Overall Study|Other Adverse Event|2|||
17181491|NCT00706628|38333173|FG000|Overall Study|Non compliant with protocol|0|||
17181492|NCT00706628|38333174|FG001|Overall Study|Non compliant with protocol|1|||
17181493|NCT00706628|38333175|FG002|Overall Study|Non compliant with protocol|0|||
17181494|NCT00706628|38333176|FG003|Overall Study|Non compliant with protocol|0|||
17181495|NCT00706628|38333173|FG000|Overall Study|Consent withdrawn|6|||
17181496|NCT00706628|38333174|FG001|Overall Study|Consent withdrawn|1|||
17181497|NCT00706628|38333175|FG002|Overall Study|Consent withdrawn|3|||
17181498|NCT00706628|38333176|FG003|Overall Study|Consent withdrawn|0|||
17181499|NCT00706628|38333173|FG000|Overall Study|Progressive disease|20|||
17181500|NCT00706628|38333174|FG001|Overall Study|Progressive disease|13|||
17181501|NCT00706628|38333175|FG002|Overall Study|Progressive disease|8|||
17181502|NCT00706628|38333176|FG003|Overall Study|Progressive disease|1|||
17181503|NCT00706628|38333173|FG000|Overall Study|Other than those stated above|4|||
17181504|NCT00706628|38333174|FG001|Overall Study|Other than those stated above|0|||
17181505|NCT00706628|38333175|FG002|Overall Study|Other than those stated above|0|||
17181506|NCT00706628|38333176|FG003|Overall Study|Other than those stated above|0|||
17181507|NCT00706628|38333173|FG000|Overall Study|Not treated|1|||
17181508|NCT00706628|38333174|FG001|Overall Study|Not treated|1|||
17181509|NCT00706628|38333175|FG002|Overall Study|Not treated|0|||
17181510|NCT00706628|38333176|FG003|Overall Study|Not treated|0|||
17181511|NCT02561806|38333191|FG000|Induction Period|Adverse Event|0|||
17181512|NCT02561806|38333192|FG001|Induction Period|Adverse Event|2|||
17181513|NCT02561806|38333191|FG000|Induction Period|Lack of Efficacy|1|||
17181514|NCT02561806|38333192|FG001|Induction Period|Lack of Efficacy|0|||
17181515|NCT02561806|38333191|FG000|Induction Period|Withdrawal by Subject|0|||
17181516|NCT02561806|38333192|FG001|Induction Period|Withdrawal by Subject|2|||
17181517|NCT02561806|38333191|FG000|Induction Period|Site staff became unblinded|1|||
17181518|NCT02561806|38333192|FG001|Induction Period|Site staff became unblinded|0|||
17181519|NCT02561806|38333191|FG000|Induction Period|Randomized but not treated|0|||
17181520|NCT02561806|38333192|FG001|Induction Period|Randomized but not treated|1|||
17181521|NCT02561806|38333191|FG000|Maintenance Period|Adverse Event|2|||
17181522|NCT02561806|38333192|FG001|Maintenance Period|Adverse Event|1|||
17181523|NCT02561806|38333191|FG000|Maintenance Period|Lack of Efficacy|3|||
17181524|NCT02561806|38333192|FG001|Maintenance Period|Lack of Efficacy|1|||
17181525|NCT02561806|38333191|FG000|Maintenance Period|Lost to Follow-up|2|||
17181526|NCT02561806|38333192|FG001|Maintenance Period|Lost to Follow-up|2|||
17181527|NCT02561806|38333191|FG000|Maintenance Period|Protocol Violation|1|||
17181528|NCT02561806|38333192|FG001|Maintenance Period|Protocol Violation|0|||
17181529|NCT02561806|38333191|FG000|Maintenance Period|Withdrawal by Subject|5|||
17181530|NCT02561806|38333192|FG001|Maintenance Period|Withdrawal by Subject|3|||
17181531|NCT02561806|38333191|FG000|Maintenance Period|Site staff became unblinded|0|||
17181532|NCT02561806|38333192|FG001|Maintenance Period|Site staff became unblinded|1|||
17181533|NCT02561806|38333191|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
17181534|NCT02561806|38333192|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
17181535|NCT02561806|38333191|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
17181536|NCT02561806|38333192|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
17181537|NCT02561572|38333215|FG000|Overall Study|Inadequate time before surgery|2|||
17181538|NCT02561572|38333216|FG001|Overall Study|Inadequate time before surgery|1|||
17181539|NCT02561572|38333215|FG000|Overall Study|Protocol Violation|0|||
17181540|NCT02561572|38333216|FG001|Overall Study|Protocol Violation|1|||
17181541|NCT02180217|38333225|FG000|Overall Study|Adverse Event|3|||
17181542|NCT02180217|38333226|FG001|Overall Study|Adverse Event|2|||
17181543|NCT02180217|38333227|FG002|Overall Study|Adverse Event|22|||
17181544|NCT02180217|38333225|FG000|Overall Study|Death|1|||
17181545|NCT02180217|38333226|FG001|Overall Study|Death|1|||
17181546|NCT02180217|38333227|FG002|Overall Study|Death|0|||
17181547|NCT02180217|38333225|FG000|Overall Study|Withdrawal by Subject|1|||
17181548|NCT02180217|38333226|FG001|Overall Study|Withdrawal by Subject|1|||
17181549|NCT02180217|38333227|FG002|Overall Study|Withdrawal by Subject|4|||
17181550|NCT02180217|38333225|FG000|Overall Study|Subject/Guardian decision|5|||
17181551|NCT02180217|38333226|FG001|Overall Study|Subject/Guardian decision|3|||
17181552|NCT02180217|38333227|FG002|Overall Study|Subject/Guardian decision|6|||
17181553|NCT02180217|38333225|FG000|Overall Study|Physician Decision|1|||
17181554|NCT02180217|38333226|FG001|Overall Study|Physician Decision|1|||
17181555|NCT02180217|38333227|FG002|Overall Study|Physician Decision|6|||
17181556|NCT02180217|38333225|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17181557|NCT02180217|38333226|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17181558|NCT02180217|38333227|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
17181559|NCT02560558|38333244|FG000|Overall Study|Adverse Event|1|||
17181560|NCT02560558|38333245|FG001|Overall Study|Adverse Event|0|||
17181561|NCT02560558|38333244|FG000|Overall Study|Death|0|||
17181562|NCT02560558|38333245|FG001|Overall Study|Death|2|||
17181563|NCT02560558|38333244|FG000|Overall Study|Lost to Follow-up|0|||
17181564|NCT02560558|38333245|FG001|Overall Study|Lost to Follow-up|4|||
17181565|NCT02560558|38333244|FG000|Overall Study|Protocol Violation|3|||
17181566|NCT02560558|38333245|FG001|Overall Study|Protocol Violation|0|||
17181567|NCT02560558|38333244|FG000|Overall Study|Withdrawal by Subject|3|||
17181568|NCT02560558|38333245|FG001|Overall Study|Withdrawal by Subject|0|||
17181569|NCT02568046|38333253|FG000|Overall Study|Adverse Event|0|||
17181570|NCT02568046|38333254|FG001|Overall Study|Adverse Event|1|||
17181571|NCT02568046|38333253|FG000|Overall Study|Death|2|||
17181572|NCT02568046|38333254|FG001|Overall Study|Death|0|||
17181573|NCT02568046|38333253|FG000|Overall Study|Progressive Disease|1|||
17181574|NCT02568046|38333254|FG001|Overall Study|Progressive Disease|0|||
17181575|NCT02568046|38333253|FG000|Overall Study|Withdrawal by Subject|2|||
17181576|NCT02568046|38333254|FG001|Overall Study|Withdrawal by Subject|1|||
17181577|NCT02568046|38333253|FG000|Overall Study|Other Events|0|||
17181578|NCT02568046|38333254|FG001|Overall Study|Other Events|1|||
17181579|NCT02567656|38333266|FG000|Overall Study|Premature discontinuation due to PD|1|||
17181580|NCT02567656|38333267|FG001|Overall Study|Premature discontinuation due to PD|1|||
17181581|NCT02567656|38333268|FG002|Overall Study|Premature discontinuation due to PD|2|||
17181582|NCT02567656|38333269|FG003|Overall Study|Premature discontinuation due to PD|0|||
17181583|NCT02567656|38333270|FG004|Overall Study|Premature discontinuation due to PD|0|||
17181584|NCT02567656|38333271|FG005|Overall Study|Premature discontinuation due to PD|0|||
17181585|NCT02560012|38333285|FG000|Overall Study|Study Terminated|2|||
17181586|NCT02567266|38333292|FG000|Overall Study|Withdrawal by Subject|10|||
17181587|NCT02567266|38333293|FG001|Overall Study|Withdrawal by Subject|7|||
17181588|NCT02567266|38333294|FG002|Overall Study|Withdrawal by Subject|6|||
17181589|NCT02567266|38333292|FG000|Overall Study|Lost to Follow-up|13|||
17181590|NCT02567266|38333293|FG001|Overall Study|Lost to Follow-up|8|||
17181591|NCT02567266|38333294|FG002|Overall Study|Lost to Follow-up|10|||
17181592|NCT02567188|38333302|FG000|Overall Study|Death|10|||
17181593|NCT02567188|38333302|FG000|Overall Study|Terminated Mircera Treatment|9|||
17181594|NCT02567188|38333302|FG000|Overall Study|Lost to Follow-up|5|||
17181595|NCT02567188|38333302|FG000|Overall Study|Adverse Event|1|||
17181596|NCT02567188|38333302|FG000|Overall Study|Withdrawal by Subject|1|||
17181597|NCT02567188|38333302|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
17181598|NCT02567188|38333302|FG000|Overall Study|Moved and Changed Clinic|1|||
17181599|NCT02567188|38333302|FG000|Overall Study|Started Hemodialysis|2|||
17181600|NCT02567188|38333302|FG000|Overall Study|Protocol Violation|5|||
17181601|NCT00706238|38333307|FG000|Overall Study|Disease progression|4|||
17181602|NCT00706238|38333307|FG000|Overall Study|Other|1|||
17181603|NCT04649164|38333314|FG000|Overall Study|Withdrawal by Subject|1|||
17181604|NCT04649164|38333315|FG001|Overall Study|Withdrawal by Subject|1|||
17181605|NCT04649164|38333316|FG002|Overall Study|Withdrawal by Subject|2|||
17181606|NCT04649164|38333314|FG000|Overall Study|Participant's care recipient expired|0|||
17181607|NCT04649164|38333315|FG001|Overall Study|Participant's care recipient expired|0|||
17181608|NCT04649164|38333316|FG002|Overall Study|Participant's care recipient expired|2|||
17181609|NCT02753127|38333326|FG000|Overall Study|Lost to Follow-up|13|||
17181610|NCT02753127|38333327|FG001|Overall Study|Lost to Follow-up|11|||
17181611|NCT02753127|38333326|FG000|Overall Study|Withdrawal by Subject|37|||
17181612|NCT02753127|38333327|FG001|Overall Study|Withdrawal by Subject|47|||
17181613|NCT02753127|38333326|FG000|Overall Study|Other|3|||
17181614|NCT02753127|38333327|FG001|Overall Study|Other|8|||
17181615|NCT02753127|38333326|FG000|Overall Study|Hospice|0|||
17181616|NCT02753127|38333327|FG001|Overall Study|Hospice|2|||
17181617|NCT00706004|38333359|FG000|Overall Study|Did not meet eligibility criteria|2|||
17181618|NCT02724644|38333366|FG000|Overall Study|Adverse Event|7|||
17181619|NCT02724644|38333367|FG001|Overall Study|Adverse Event|1|||
17181620|NCT02724644|38333366|FG000|Overall Study|Lost to Follow-up|6|||
17181621|NCT02724644|38333367|FG001|Overall Study|Lost to Follow-up|2|||
17181622|NCT02724644|38333366|FG000|Overall Study|Withdrawal by Subject|7|||
17181623|NCT02724644|38333367|FG001|Overall Study|Withdrawal by Subject|1|||
17181624|NCT02724644|38333366|FG000|Overall Study|Administrative|1|||
17181625|NCT02724644|38333367|FG001|Overall Study|Administrative|0|||
17181626|NCT02725268|38333377|FG000|Overall Study|Death|58|||
17181627|NCT02725268|38333378|FG001|Overall Study|Death|59|||
17181628|NCT02725268|38333379|FG002|Overall Study|Death|30|||
17181629|NCT02725268|38333380|FG003|Overall Study|Death|16|||
17181630|NCT02725268|38333377|FG000|Overall Study|Lost to Follow-up|4|||
17181631|NCT02725268|38333378|FG001|Overall Study|Lost to Follow-up|3|||
17181632|NCT02725268|38333379|FG002|Overall Study|Lost to Follow-up|0|||
17181633|NCT02725268|38333380|FG003|Overall Study|Lost to Follow-up|1|||
17181634|NCT02725268|38333377|FG000|Overall Study|Site Terminated by Sponsor|0|||
17181635|NCT02725268|38333378|FG001|Overall Study|Site Terminated by Sponsor|1|||
17181636|NCT02725268|38333379|FG002|Overall Study|Site Terminated by Sponsor|0|||
17181637|NCT02725268|38333380|FG003|Overall Study|Site Terminated by Sponsor|0|||
17089213|NCT00302952|38229363|FG000|Overall Study|Withdrawal by Subject|2|||
17089214|NCT00302952|38229364|FG001|Overall Study|Withdrawal by Subject|3|||
17089215|NCT00302952|38229363|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
17089216|NCT00302952|38229364|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
17089217|NCT00302718|38229374|FG000|Overall Study|Participant left the hospital|1|||
17089218|NCT00302718|38229375|FG001|Overall Study|Participant left the hospital|0|||
17089219|NCT00302718|38229376|FG002|Overall Study|Participant left the hospital|0|||
17089220|NCT00302718|38229377|FG003|Overall Study|Participant left the hospital|1|||
17089221|NCT00302718|38229374|FG000|Overall Study|Withdrawal by Subject|0|||
17089222|NCT00302718|38229375|FG001|Overall Study|Withdrawal by Subject|1|||
17089223|NCT00302718|38229376|FG002|Overall Study|Withdrawal by Subject|0|||
17089224|NCT00302718|38229377|FG003|Overall Study|Withdrawal by Subject|0|||
17089225|NCT00302718|38229374|FG000|Overall Study|Participant left primary care setting|0|||
17089226|NCT00302718|38229375|FG001|Overall Study|Participant left primary care setting|0|||
17089227|NCT00302718|38229376|FG002|Overall Study|Participant left primary care setting|2|||
17089228|NCT00302718|38229377|FG003|Overall Study|Participant left primary care setting|1|||
17089229|NCT00302328|38229395|FG000|Overall Study|Physician Decision|0|||
17089230|NCT00302328|38229396|FG001|Overall Study|Physician Decision|1|||
17089231|NCT00302328|38229397|FG002|Overall Study|Physician Decision|0|||
17089232|NCT00301080|38229408|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
17089233|NCT00301080|38229409|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
17089234|NCT00301080|38229410|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
17089235|NCT00301080|38229411|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
17089236|NCT00301080|38229412|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
17089237|NCT00290238|38229423|FG000|Overall Study|Study terminated|27|||
17089238|NCT00290238|38229424|FG001|Overall Study|Study terminated|27|||
17089239|NCT00290238|38229423|FG000|Overall Study|Lost to Follow-up|0|||
17089240|NCT00290238|38229424|FG001|Overall Study|Lost to Follow-up|1|||
17089241|NCT00290238|38229423|FG000|Overall Study|Withdrawal by Subject|15|||
17089242|NCT00290238|38229424|FG001|Overall Study|Withdrawal by Subject|13|||
17089243|NCT00289848|38229432|FG000|Overall Study|Adverse Event|6|||
17089244|NCT00289848|38229433|FG001|Overall Study|Adverse Event|4|||
17089245|NCT00289848|38229432|FG000|Overall Study|Death|1|||
17089246|NCT00289848|38229433|FG001|Overall Study|Death|0|||
17089247|NCT00289848|38229432|FG000|Overall Study|Lack of Efficacy|20|||
17089248|NCT00289848|38229433|FG001|Overall Study|Lack of Efficacy|24|||
17089249|NCT00289848|38229432|FG000|Overall Study|Lost to Follow-up|3|||
17089250|NCT00289848|38229433|FG001|Overall Study|Lost to Follow-up|1|||
17089251|NCT00289848|38229432|FG000|Overall Study|Protocol Violation|5|||
17089252|NCT00289848|38229433|FG001|Overall Study|Protocol Violation|2|||
17089253|NCT00289848|38229432|FG000|Overall Study|Withdrawal by Subject|5|||
17181638|NCT02725268|38333377|FG000|Overall Study|Withdrawal by Subject|8|||
17181639|NCT02725268|38333378|FG001|Overall Study|Withdrawal by Subject|6|||
17181640|NCT02725268|38333379|FG002|Overall Study|Withdrawal by Subject|8|||
17181641|NCT02725268|38333380|FG003|Overall Study|Withdrawal by Subject|1|||
17181642|NCT02725268|38333377|FG000|Overall Study|Reason not Specified|2|||
17181643|NCT02725268|38333378|FG001|Overall Study|Reason not Specified|1|||
17181644|NCT02725268|38333379|FG002|Overall Study|Reason not Specified|0|||
17181645|NCT02725268|38333380|FG003|Overall Study|Reason not Specified|0|||
17181646|NCT02724956|38333392|FG000|Overall Study|Physician Decision|1|||
17181647|NCT02724956|38333393|FG001|Overall Study|Physician Decision|0|||
17181648|NCT02724956|38333392|FG000|Overall Study|Lack of Efficacy|0|||
17181649|NCT02724956|38333393|FG001|Overall Study|Lack of Efficacy|1|||
17181650|NCT02724956|38333392|FG000|Overall Study|Withdrawal by Subject|0|||
17181651|NCT02724956|38333393|FG001|Overall Study|Withdrawal by Subject|1|||
17181652|NCT00705536|38333401|FG000|Start Period 1|Withdrawal by Subject|0|||
17181653|NCT00705536|38333402|FG001|Start Period 1|Withdrawal by Subject|0|||
17181654|NCT00705536|38333403|FG002|Start Period 1|Withdrawal by Subject|0|||
17181655|NCT00705536|38333404|FG003|Start Period 1|Withdrawal by Subject|1|||
17181656|NCT02724878|38333423|FG000|Overall Study|Still on Active Therapy|15|||
17181657|NCT02724878|38333423|FG000|Overall Study|Disease Progression|31|||
17181658|NCT02724878|38333423|FG000|Overall Study|Toxicity|5|||
17181659|NCT02724878|38333423|FG000|Overall Study|Death|1|||
17181660|NCT02724878|38333423|FG000|Overall Study|Withdrawal by Subject|4|||
17181661|NCT02724878|38333423|FG000|Overall Study|Lost to Follow-up|2|||
17181662|NCT02724878|38333423|FG000|Overall Study|Protocol Violation|1|||
17181663|NCT02724878|38333423|FG000|Overall Study|Ineligible for Study Drug|5|||
17181664|NCT02724878|38333423|FG000|Overall Study|not started|1|||
17181665|NCT02660034|38333441|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
17181666|NCT02660034|38333442|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
17181667|NCT02660034|38333443|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
17181668|NCT02660034|38333444|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
17181669|NCT02660034|38333445|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
17181670|NCT02660034|38333446|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
17181671|NCT02660034|38333447|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
17181672|NCT02660034|38333448|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
17181673|NCT02660034|38333449|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
17181674|NCT02660034|38333450|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
17181675|NCT02660034|38333451|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
17181676|NCT02660034|38333452|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
17181677|NCT02660034|38333453|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
17181678|NCT02660034|38333454|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
17181679|NCT02660034|38333441|FG000|Overall Study|Progressive Disease (Clinical)|7|||
17181680|NCT02660034|38333442|FG001|Overall Study|Progressive Disease (Clinical)|8|||
17181681|NCT02660034|38333443|FG002|Overall Study|Progressive Disease (Clinical)|3|||
17181682|NCT02660034|38333444|FG003|Overall Study|Progressive Disease (Clinical)|9|||
17181683|NCT02660034|38333445|FG004|Overall Study|Progressive Disease (Clinical)|3|||
17181684|NCT02660034|38333446|FG005|Overall Study|Progressive Disease (Clinical)|0|||
17181685|NCT02660034|38333447|FG006|Overall Study|Progressive Disease (Clinical)|0|||
17181686|NCT02660034|38333448|FG007|Overall Study|Progressive Disease (Clinical)|0|||
17181687|NCT02660034|38333449|FG008|Overall Study|Progressive Disease (Clinical)|0|||
17181688|NCT02660034|38333450|FG009|Overall Study|Progressive Disease (Clinical)|0|||
17181689|NCT02660034|38333451|FG010|Overall Study|Progressive Disease (Clinical)|0|||
17181690|NCT02660034|38333452|FG011|Overall Study|Progressive Disease (Clinical)|0|||
17181691|NCT02660034|38333453|FG012|Overall Study|Progressive Disease (Clinical)|0|||
17181692|NCT02660034|38333454|FG013|Overall Study|Progressive Disease (Clinical)|0|||
17181693|NCT02660034|38333441|FG000|Overall Study|Lost to Follow-up|0|||
17181694|NCT02660034|38333442|FG001|Overall Study|Lost to Follow-up|0|||
17181695|NCT02660034|38333443|FG002|Overall Study|Lost to Follow-up|1|||
17181696|NCT02660034|38333444|FG003|Overall Study|Lost to Follow-up|1|||
17181697|NCT02660034|38333445|FG004|Overall Study|Lost to Follow-up|0|||
17181698|NCT02660034|38333446|FG005|Overall Study|Lost to Follow-up|0|||
17181699|NCT02660034|38333447|FG006|Overall Study|Lost to Follow-up|0|||
17181700|NCT02660034|38333448|FG007|Overall Study|Lost to Follow-up|0|||
17181701|NCT02660034|38333449|FG008|Overall Study|Lost to Follow-up|0|||
17181702|NCT02660034|38333450|FG009|Overall Study|Lost to Follow-up|1|||
17181703|NCT02660034|38333451|FG010|Overall Study|Lost to Follow-up|1|||
17089254|NCT00289848|38229433|FG001|Overall Study|Withdrawal by Subject|11|||
17089255|NCT00289848|38229432|FG000|Overall Study|Patient Moved|6|||
17089256|NCT00289848|38229433|FG001|Overall Study|Patient Moved|2|||
17089257|NCT00289848|38229432|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
17089258|NCT00289848|38229433|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
17089259|NCT00289770|38229439|FG000|Year 15|Withdrawal by Subject|1|||
17089260|NCT00289536|38229443|FG000|Period 3|Lost to Follow-up|0|||
17089261|NCT00289536|38229444|FG001|Period 3|Lost to Follow-up|0|||
17089262|NCT00289536|38229445|FG002|Period 3|Lost to Follow-up|1|||
17181704|NCT02660034|38333452|FG011|Overall Study|Lost to Follow-up|1|||
17181705|NCT02660034|38333453|FG012|Overall Study|Lost to Follow-up|0|||
17181706|NCT02660034|38333454|FG013|Overall Study|Lost to Follow-up|0|||
17181707|NCT02660034|38333441|FG000|Overall Study|Participant moved into special access scheme|1|||
17181708|NCT02660034|38333442|FG001|Overall Study|Participant moved into special access scheme|2|||
17181709|NCT02660034|38333443|FG002|Overall Study|Participant moved into special access scheme|0|||
17181710|NCT02660034|38333444|FG003|Overall Study|Participant moved into special access scheme|0|||
17181711|NCT02660034|38333445|FG004|Overall Study|Participant moved into special access scheme|0|||
17181712|NCT02660034|38333446|FG005|Overall Study|Participant moved into special access scheme|0|||
17181713|NCT02660034|38333447|FG006|Overall Study|Participant moved into special access scheme|0|||
17181714|NCT02660034|38333448|FG007|Overall Study|Participant moved into special access scheme|0|||
17181715|NCT02660034|38333449|FG008|Overall Study|Participant moved into special access scheme|0|||
17181716|NCT02660034|38333450|FG009|Overall Study|Participant moved into special access scheme|0|||
17181717|NCT02660034|38333451|FG010|Overall Study|Participant moved into special access scheme|0|||
17181718|NCT02660034|38333452|FG011|Overall Study|Participant moved into special access scheme|0|||
17181719|NCT02660034|38333453|FG012|Overall Study|Participant moved into special access scheme|0|||
17181720|NCT02660034|38333454|FG013|Overall Study|Participant moved into special access scheme|0|||
17181721|NCT02660034|38333441|FG000|Overall Study|Adverse Event|1|||
17181722|NCT02660034|38333442|FG001|Overall Study|Adverse Event|0|||
17181723|NCT02660034|38333443|FG002|Overall Study|Adverse Event|0|||
17181724|NCT02660034|38333444|FG003|Overall Study|Adverse Event|0|||
17181725|NCT02660034|38333445|FG004|Overall Study|Adverse Event|0|||
17181726|NCT02660034|38333446|FG005|Overall Study|Adverse Event|0|||
17181727|NCT02660034|38333447|FG006|Overall Study|Adverse Event|0|||
17181728|NCT02660034|38333448|FG007|Overall Study|Adverse Event|0|||
17181729|NCT02660034|38333449|FG008|Overall Study|Adverse Event|0|||
17181730|NCT02660034|38333450|FG009|Overall Study|Adverse Event|0|||
17181731|NCT02660034|38333451|FG010|Overall Study|Adverse Event|0|||
17181732|NCT02660034|38333452|FG011|Overall Study|Adverse Event|0|||
17181733|NCT02660034|38333453|FG012|Overall Study|Adverse Event|0|||
17181734|NCT02660034|38333454|FG013|Overall Study|Adverse Event|0|||
17181735|NCT02660034|38333441|FG000|Overall Study|Sponsor Decision|0|||
17181736|NCT02660034|38333442|FG001|Overall Study|Sponsor Decision|1|||
17181737|NCT02660034|38333443|FG002|Overall Study|Sponsor Decision|2|||
17181738|NCT02660034|38333444|FG003|Overall Study|Sponsor Decision|2|||
17181739|NCT02660034|38333445|FG004|Overall Study|Sponsor Decision|3|||
17181740|NCT02660034|38333446|FG005|Overall Study|Sponsor Decision|0|||
17181741|NCT02660034|38333447|FG006|Overall Study|Sponsor Decision|0|||
17181742|NCT02660034|38333448|FG007|Overall Study|Sponsor Decision|0|||
17181743|NCT02660034|38333449|FG008|Overall Study|Sponsor Decision|0|||
17181744|NCT02660034|38333450|FG009|Overall Study|Sponsor Decision|0|||
17181745|NCT02660034|38333451|FG010|Overall Study|Sponsor Decision|0|||
17181746|NCT02660034|38333452|FG011|Overall Study|Sponsor Decision|0|||
17181747|NCT02660034|38333453|FG012|Overall Study|Sponsor Decision|0|||
17181748|NCT02660034|38333454|FG013|Overall Study|Sponsor Decision|1|||
17181749|NCT02660034|38333441|FG000|Overall Study|Withdrawal by Subject|0|||
17181750|NCT02660034|38333442|FG001|Overall Study|Withdrawal by Subject|0|||
17181751|NCT02660034|38333443|FG002|Overall Study|Withdrawal by Subject|0|||
17181752|NCT02660034|38333444|FG003|Overall Study|Withdrawal by Subject|0|||
17181753|NCT02660034|38333445|FG004|Overall Study|Withdrawal by Subject|0|||
17181754|NCT02660034|38333446|FG005|Overall Study|Withdrawal by Subject|0|||
17181755|NCT02660034|38333447|FG006|Overall Study|Withdrawal by Subject|1|||
17181756|NCT02660034|38333448|FG007|Overall Study|Withdrawal by Subject|1|||
17181757|NCT02660034|38333449|FG008|Overall Study|Withdrawal by Subject|1|||
17181758|NCT02660034|38333450|FG009|Overall Study|Withdrawal by Subject|0|||
17181759|NCT02660034|38333451|FG010|Overall Study|Withdrawal by Subject|0|||
17181760|NCT02660034|38333452|FG011|Overall Study|Withdrawal by Subject|1|||
17181761|NCT02660034|38333453|FG012|Overall Study|Withdrawal by Subject|2|||
17181762|NCT02660034|38333454|FG013|Overall Study|Withdrawal by Subject|0|||
17181763|NCT02660034|38333441|FG000|Overall Study|Death|0|||
17089263|NCT00289458|38229454|FG000|Overall Study|Death|1|||
17089264|NCT00289458|38229455|FG001|Overall Study|Death|0|||
17089265|NCT00289458|38229456|FG002|Overall Study|Death|0|||
17089266|NCT00289458|38229454|FG000|Overall Study|Physician Decision|3|||
17089267|NCT00289458|38229455|FG001|Overall Study|Physician Decision|4|||
17089268|NCT00289458|38229456|FG002|Overall Study|Physician Decision|2|||
17089269|NCT00289458|38229454|FG000|Overall Study|Withdrawal by Subject|2|||
17089270|NCT00289458|38229455|FG001|Overall Study|Withdrawal by Subject|2|||
17089271|NCT00289458|38229456|FG002|Overall Study|Withdrawal by Subject|4|||
17181764|NCT02660034|38333442|FG001|Overall Study|Death|0|||
17181765|NCT02660034|38333443|FG002|Overall Study|Death|0|||
17181766|NCT02660034|38333444|FG003|Overall Study|Death|0|||
17181767|NCT02660034|38333445|FG004|Overall Study|Death|0|||
17181768|NCT02660034|38333446|FG005|Overall Study|Death|13|||
17181769|NCT02660034|38333447|FG006|Overall Study|Death|14|||
17181770|NCT02660034|38333448|FG007|Overall Study|Death|10|||
17181771|NCT02660034|38333449|FG008|Overall Study|Death|9|||
17181772|NCT02660034|38333450|FG009|Overall Study|Death|21|||
17181773|NCT02660034|38333451|FG010|Overall Study|Death|17|||
17181774|NCT02660034|38333452|FG011|Overall Study|Death|15|||
17181775|NCT02660034|38333453|FG012|Overall Study|Death|18|||
17181776|NCT02660034|38333454|FG013|Overall Study|Death|7|||
17181777|NCT02660034|38333441|FG000|Overall Study|Physician Decision|0|||
17181778|NCT02660034|38333442|FG001|Overall Study|Physician Decision|0|||
17181779|NCT02660034|38333443|FG002|Overall Study|Physician Decision|0|||
17181780|NCT02660034|38333444|FG003|Overall Study|Physician Decision|0|||
17181781|NCT02660034|38333445|FG004|Overall Study|Physician Decision|0|||
17181782|NCT02660034|38333446|FG005|Overall Study|Physician Decision|0|||
17181783|NCT02660034|38333447|FG006|Overall Study|Physician Decision|0|||
17181784|NCT02660034|38333448|FG007|Overall Study|Physician Decision|0|||
17181785|NCT02660034|38333449|FG008|Overall Study|Physician Decision|0|||
17181786|NCT02660034|38333450|FG009|Overall Study|Physician Decision|0|||
17181787|NCT02660034|38333451|FG010|Overall Study|Physician Decision|0|||
17181788|NCT02660034|38333452|FG011|Overall Study|Physician Decision|0|||
17181789|NCT02660034|38333453|FG012|Overall Study|Physician Decision|0|||
17181790|NCT02660034|38333454|FG013|Overall Study|Physician Decision|1|||
17181791|NCT02660034|38333441|FG000|Overall Study|Participants transferred to LTE|0|||
17181792|NCT02660034|38333442|FG001|Overall Study|Participants transferred to LTE|0|||
17181793|NCT02660034|38333443|FG002|Overall Study|Participants transferred to LTE|0|||
17181794|NCT02660034|38333444|FG003|Overall Study|Participants transferred to LTE|0|||
17181795|NCT02660034|38333445|FG004|Overall Study|Participants transferred to LTE|0|||
17181796|NCT02660034|38333446|FG005|Overall Study|Participants transferred to LTE|10|||
17181797|NCT02660034|38333447|FG006|Overall Study|Participants transferred to LTE|8|||
17181798|NCT02660034|38333448|FG007|Overall Study|Participants transferred to LTE|8|||
17181799|NCT02660034|38333449|FG008|Overall Study|Participants transferred to LTE|10|||
17181800|NCT02660034|38333450|FG009|Overall Study|Participants transferred to LTE|1|||
17181801|NCT02660034|38333451|FG010|Overall Study|Participants transferred to LTE|2|||
17181802|NCT02660034|38333452|FG011|Overall Study|Participants transferred to LTE|4|||
17181803|NCT02660034|38333453|FG012|Overall Study|Participants transferred to LTE|1|||
17181804|NCT02660034|38333454|FG013|Overall Study|Participants transferred to LTE|1|||
17181805|NCT02724020|38333491|FG000|Overall Study|Death|16|||
17181806|NCT02724020|38333492|FG001|Overall Study|Death|18|||
17181807|NCT02724020|38333493|FG002|Overall Study|Death|19|||
17181808|NCT02724020|38333491|FG000|Overall Study|Lost to Follow-up|0|||
17181809|NCT02724020|38333492|FG001|Overall Study|Lost to Follow-up|3|||
17181810|NCT02724020|38333493|FG002|Overall Study|Lost to Follow-up|0|||
17181811|NCT02724020|38333491|FG000|Overall Study|Site Terminated by Sponsor|15|||
17181812|NCT02724020|38333492|FG001|Overall Study|Site Terminated by Sponsor|8|||
17181813|NCT02724020|38333493|FG002|Overall Study|Site Terminated by Sponsor|8|||
17181814|NCT02724020|38333491|FG000|Overall Study|Withdrawal by Subject|1|||
17181815|NCT02724020|38333492|FG001|Overall Study|Withdrawal by Subject|3|||
17181816|NCT02724020|38333493|FG002|Overall Study|Withdrawal by Subject|5|||
17181817|NCT02193867|38333510|FG000|Overall Study|Death|2|||
17181818|NCT02193867|38333510|FG000|Overall Study|Sponsor Study Termination|2|||
17181819|NCT02200770|38333538|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
17181820|NCT02200770|38333539|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
17181821|NCT02200770|38333538|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
17181822|NCT02200770|38333539|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
17181823|NCT02200770|38333538|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
17181824|NCT02200770|38333539|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
17181825|NCT02200770|38333538|FG000|Randomized-controlled Period (RCP)|Other|1|||
17181826|NCT02200770|38333539|FG001|Randomized-controlled Period (RCP)|Other|2|||
17181827|NCT02200770|38333538|FG000|Open-label Period (OLP)|Adverse Event|1|||
17181828|NCT02200770|38333539|FG001|Open-label Period (OLP)|Adverse Event|2|||
17181829|NCT02200770|38333538|FG000|Open-label Period (OLP)|Death|1|||
17181830|NCT02200770|38333539|FG001|Open-label Period (OLP)|Death|2|||
17181831|NCT02200770|38333538|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
17181832|NCT02200770|38333539|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
17181833|NCT02200770|38333538|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
17181834|NCT02200770|38333539|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
17181835|NCT02200770|38333538|FG000|Open-label Period (OLP)|Other|6|||
17181836|NCT02200770|38333539|FG001|Open-label Period (OLP)|Other|15|||
17181837|NCT01186848|38333547|FG000|Overall Study|Lost to Follow-up|4|||
17181838|NCT01186848|38333547|FG000|Overall Study|Withdrawal by Subject|2|||
17181839|NCT01186848|38333547|FG000|Overall Study|Adverse Event|2|||
17181840|NCT01024608|38333555|FG000|Overall Study|Adverse Event|1|||
17181841|NCT01024608|38333556|FG001|Overall Study|Adverse Event|0|||
17181842|NCT01024608|38333555|FG000|Overall Study|Withdrawal by Subject|1|||
16997024|NCT00758524|38141156|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
17181843|NCT01024608|38333556|FG001|Overall Study|Withdrawal by Subject|0|||
17181844|NCT01024608|38333555|FG000|Overall Study|Lost to Follow-up|0|||
17181845|NCT01024608|38333556|FG001|Overall Study|Lost to Follow-up|1|||
17181846|NCT01024608|38333555|FG000|Overall Study|Protocol Violation|0|||
17181847|NCT01024608|38333556|FG001|Overall Study|Protocol Violation|3|||
17181848|NCT01024608|38333555|FG000|Overall Study|Never received study treatment|2|||
17181849|NCT01024608|38333556|FG001|Overall Study|Never received study treatment|0|||
17181850|NCT00910650|38333562|FG000|Overall Study|Death|2|||
17181851|NCT03996876|38333597|FG000|Overall Study|Incomplete Data|2|||
17181852|NCT03996876|38333598|FG001|Overall Study|Incomplete Data|4|||
17181853|NCT01460160|38333605|FG000|Treatment Phase|Lack of Efficacy|3|||
17181854|NCT01460160|38333605|FG000|Treatment Phase|Study Drug Toxicity|2|||
17181855|NCT01460160|38333605|FG000|Treatment Phase|Adverse Event|8|||
17181856|NCT01460160|38333605|FG000|Treatment Phase|Withdrawal by Subject|4|||
17181857|NCT01460160|38333605|FG000|Treatment Phase|Death|2|||
17181858|NCT01460160|38333605|FG000|Treatment Phase|Other reasons|9|||
17181859|NCT01460160|38333605|FG000|Follow-up Phase|Withdrawal by Subject|4|||
17181860|NCT01460160|38333605|FG000|Follow-up Phase|Death|14|||
17181861|NCT01460160|38333605|FG000|Follow-up Phase|Lost to Follow-up|7|||
17181862|NCT01460160|38333605|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
17181863|NCT01460160|38333605|FG000|Follow-up Phase|Other and not reported reasons|5|||
17181864|NCT01170702|38333613|FG000|Overall Study|Exclusion criteria met after consent|1|||
17181865|NCT01170702|38333614|FG001|Overall Study|Exclusion criteria met after consent|2|||
17181866|NCT01170702|38333615|FG002|Overall Study|Exclusion criteria met after consent|0|||
17181867|NCT01170702|38333616|FG003|Overall Study|Exclusion criteria met after consent|2|||
17181868|NCT02723864|38333655|FG000|Overall Study|Refused further treatment|1|||
17181869|NCT02723864|38333656|FG001|Overall Study|Refused further treatment|0|||
17181870|NCT02723864|38333657|FG002|Overall Study|Refused further treatment|0|||
17181871|NCT02723864|38333658|FG003|Overall Study|Refused further treatment|0|||
17181872|NCT02723864|38333659|FG004|Overall Study|Refused further treatment|1|||
17181873|NCT02723864|38333660|FG005|Overall Study|Refused further treatment|2|||
17181874|NCT02723864|38333661|FG006|Overall Study|Refused further treatment|0|||
17181875|NCT02723864|38333655|FG000|Overall Study|Exceed treatment hold time|0|||
17181876|NCT02723864|38333656|FG001|Overall Study|Exceed treatment hold time|1|||
17181877|NCT02723864|38333657|FG002|Overall Study|Exceed treatment hold time|0|||
17181878|NCT02723864|38333658|FG003|Overall Study|Exceed treatment hold time|0|||
17181879|NCT02723864|38333659|FG004|Overall Study|Exceed treatment hold time|0|||
17181880|NCT02723864|38333660|FG005|Overall Study|Exceed treatment hold time|0|||
17181881|NCT02723864|38333661|FG006|Overall Study|Exceed treatment hold time|0|||
17181882|NCT02723864|38333655|FG000|Overall Study|Clinical progression|0|||
17181883|NCT02723864|38333656|FG001|Overall Study|Clinical progression|0|||
17181884|NCT02723864|38333657|FG002|Overall Study|Clinical progression|1|||
17181885|NCT02723864|38333658|FG003|Overall Study|Clinical progression|0|||
17181886|NCT02723864|38333659|FG004|Overall Study|Clinical progression|0|||
17181887|NCT02723864|38333660|FG005|Overall Study|Clinical progression|3|||
17181888|NCT02723864|38333661|FG006|Overall Study|Clinical progression|1|||
17181889|NCT02723864|38333655|FG000|Overall Study|Physician Decision|0|||
17181890|NCT02723864|38333656|FG001|Overall Study|Physician Decision|0|||
17181891|NCT02723864|38333657|FG002|Overall Study|Physician Decision|0|||
17181892|NCT02723864|38333658|FG003|Overall Study|Physician Decision|0|||
17181893|NCT02723864|38333659|FG004|Overall Study|Physician Decision|0|||
17181894|NCT02723864|38333660|FG005|Overall Study|Physician Decision|0|||
17181895|NCT02723864|38333661|FG006|Overall Study|Physician Decision|1|||
17181896|NCT02723864|38333655|FG000|Overall Study|Changes in patient condition|0|||
17181897|NCT02723864|38333656|FG001|Overall Study|Changes in patient condition|0|||
17181898|NCT02723864|38333657|FG002|Overall Study|Changes in patient condition|0|||
17181899|NCT02723864|38333658|FG003|Overall Study|Changes in patient condition|0|||
17181900|NCT02723864|38333659|FG004|Overall Study|Changes in patient condition|0|||
17181901|NCT02723864|38333660|FG005|Overall Study|Changes in patient condition|1|||
17181902|NCT02723864|38333661|FG006|Overall Study|Changes in patient condition|0|||
17181903|NCT02723864|38333655|FG000|Overall Study|Patient choice|0|||
17181904|NCT02723864|38333656|FG001|Overall Study|Patient choice|0|||
17181905|NCT02723864|38333657|FG002|Overall Study|Patient choice|0|||
17181906|NCT02723864|38333658|FG003|Overall Study|Patient choice|0|||
17181907|NCT02723864|38333659|FG004|Overall Study|Patient choice|0|||
17181908|NCT02723864|38333660|FG005|Overall Study|Patient choice|1|||
17181909|NCT02723864|38333661|FG006|Overall Study|Patient choice|0|||
17181910|NCT02723864|38333655|FG000|Overall Study|Adverse Event|0|||
17181911|NCT02723864|38333656|FG001|Overall Study|Adverse Event|0|||
17181912|NCT02723864|38333657|FG002|Overall Study|Adverse Event|0|||
17181913|NCT02723864|38333658|FG003|Overall Study|Adverse Event|0|||
17181914|NCT02723864|38333659|FG004|Overall Study|Adverse Event|0|||
17181915|NCT02723864|38333660|FG005|Overall Study|Adverse Event|1|||
17181916|NCT02723864|38333661|FG006|Overall Study|Adverse Event|0|||
17181917|NCT02723864|38333655|FG000|Overall Study|Started new treatment|0|||
17181918|NCT02723864|38333656|FG001|Overall Study|Started new treatment|0|||
17181919|NCT02723864|38333657|FG002|Overall Study|Started new treatment|0|||
17181920|NCT02723864|38333658|FG003|Overall Study|Started new treatment|0|||
17181921|NCT02723864|38333659|FG004|Overall Study|Started new treatment|0|||
17181922|NCT02723864|38333660|FG005|Overall Study|Started new treatment|1|||
17181923|NCT02723864|38333661|FG006|Overall Study|Started new treatment|0|||
17181924|NCT02723864|38333655|FG000|Overall Study|Switched to alternative treatment|0|||
17181925|NCT02723864|38333656|FG001|Overall Study|Switched to alternative treatment|0|||
17181926|NCT02723864|38333657|FG002|Overall Study|Switched to alternative treatment|0|||
17181927|NCT02723864|38333658|FG003|Overall Study|Switched to alternative treatment|0|||
17181928|NCT02723864|38333659|FG004|Overall Study|Switched to alternative treatment|0|||
17181929|NCT02723864|38333660|FG005|Overall Study|Switched to alternative treatment|1|||
17181930|NCT02723864|38333661|FG006|Overall Study|Switched to alternative treatment|0|||
17181931|NCT02723864|38333655|FG000|Overall Study|Late determination of ineligibility|0|||
17181932|NCT02723864|38333656|FG001|Overall Study|Late determination of ineligibility|0|||
17181933|NCT02723864|38333657|FG002|Overall Study|Late determination of ineligibility|0|||
17181934|NCT02723864|38333658|FG003|Overall Study|Late determination of ineligibility|0|||
17181935|NCT02723864|38333659|FG004|Overall Study|Late determination of ineligibility|0|||
17181936|NCT02723864|38333660|FG005|Overall Study|Late determination of ineligibility|1|||
17181937|NCT02723864|38333661|FG006|Overall Study|Late determination of ineligibility|0|||
17181938|NCT00705146|38333700|FG000|Overall Study|Lost to Follow-up|1|||
17181939|NCT00705146|38333701|FG001|Overall Study|Lost to Follow-up|1|||
17181940|NCT03203642|38333709|FG000|Overall Study|Adverse Event|3|||
17181941|NCT03203642|38333710|FG001|Overall Study|Adverse Event|1|||
17181942|NCT03203642|38333709|FG000|Overall Study|Withdrawal by Subject|6|||
17181943|NCT03203642|38333710|FG001|Overall Study|Withdrawal by Subject|6|||
17181944|NCT03203642|38333709|FG000|Overall Study|Lost to Follow-up|2|||
17181945|NCT03203642|38333710|FG001|Overall Study|Lost to Follow-up|1|||
17181946|NCT03203642|38333709|FG000|Overall Study|Termination of the study by sponsor|1|||
17181947|NCT03203642|38333710|FG001|Overall Study|Termination of the study by sponsor|1|||
17181948|NCT03203642|38333709|FG000|Overall Study|Participant moved|0|||
17181949|NCT03203642|38333710|FG001|Overall Study|Participant moved|1|||
17181950|NCT03203642|38333709|FG000|Overall Study|Investigator's decision|3|||
17181951|NCT03203642|38333710|FG001|Overall Study|Investigator's decision|0|||
17181952|NCT03203642|38333709|FG000|Overall Study|Other than above specified|0|||
17181953|NCT03203642|38333710|FG001|Overall Study|Other than above specified|1|||
17181954|NCT02737722|38333720|FG000|Overall Study|Physician Decision|0|||
17181955|NCT02737722|38333721|FG001|Overall Study|Physician Decision|0|||
17181956|NCT02737722|38333722|FG002|Overall Study|Physician Decision|1|||
17181957|NCT02737722|38333723|FG003|Overall Study|Physician Decision|0|||
17181958|NCT03792750|38333733|FG000|Overall Study|Death|3|||
17181959|NCT02750709|38333738|FG000|Treatment Period 1|Adverse Event|0|||
17181960|NCT02750709|38333739|FG001|Treatment Period 1|Adverse Event|0|||
17181961|NCT02750709|38333740|FG002|Treatment Period 1|Adverse Event|0|||
17181962|NCT02750709|38333741|FG003|Treatment Period 1|Adverse Event|0|||
17181963|NCT02750709|38333742|FG004|Treatment Period 1|Adverse Event|0|||
17181964|NCT02750709|38333743|FG005|Treatment Period 1|Adverse Event|1|||
17181965|NCT02723786|38333751|FG000|Overall Study|Lost to Follow-up|1|||
17181966|NCT02723084|38333770|FG000|Overall Study|Withdrawal by Subject|1|||
17181967|NCT02723084|38333771|FG001|Overall Study|Withdrawal by Subject|1|||
17181968|NCT02723084|38333770|FG000|Overall Study|Lost to Follow-up|3|||
17181969|NCT02723084|38333771|FG001|Overall Study|Lost to Follow-up|0|||
17181970|NCT02750943|38333779|FG000|Overall Study|Lost to Follow-up|1|||
17181971|NCT02750943|38333780|FG001|Overall Study|Lost to Follow-up|2|||
17181972|NCT02750943|38333779|FG000|Overall Study|Withdrawal by Subject|5|||
17181973|NCT02750943|38333780|FG001|Overall Study|Withdrawal by Subject|7|||
17181974|NCT04730349|38333797|FG000|Overall Study|Participant withdrew consent|1|||
17181975|NCT04730349|38333798|FG001|Overall Study|Participant withdrew consent|0|||
17181976|NCT04730349|38333797|FG000|Overall Study|Disease progression|6|||
17181977|NCT04730349|38333798|FG001|Overall Study|Disease progression|4|||
17181978|NCT04730349|38333797|FG000|Overall Study|Study drug toxicity|0|||
17181979|NCT04730349|38333798|FG001|Overall Study|Study drug toxicity|1|||
17181980|NCT04307394|38333817|FG000|Overall Study|Lost to Follow-up|3|||
17181981|NCT04307394|38333817|FG000|Overall Study|Withdrawal by Subject|2|||
17181982|NCT04050670|38333861|FG000|Period 3|Physician Decision|0|||
17181983|NCT04050670|38333862|FG001|Period 3|Physician Decision|1|||
17181984|NCT04050670|38333863|FG002|Period 3|Physician Decision|0|||
17181985|NCT03940742|38333875|FG000|Overall Study|Lost to Follow-up|0|||
17181986|NCT03940742|38333876|FG001|Overall Study|Lost to Follow-up|0|||
17181987|NCT03940742|38333877|FG002|Overall Study|Lost to Follow-up|0|||
17181988|NCT03940742|38333878|FG003|Overall Study|Lost to Follow-up|1|||
17181989|NCT03917654|38333900|FG000|Year 1|Withdrawal by Subject|1|||
17181990|NCT03917654|38333901|FG001|Year 1|Withdrawal by Subject|0|||
17181991|NCT03917654|38333902|FG002|Year 1|Withdrawal by Subject|0|||
17181992|NCT03917654|38333903|FG003|Year 1|Withdrawal by Subject|0|||
17181993|NCT03917654|38333904|FG004|Year 1|Withdrawal by Subject|0|||
17181994|NCT03917654|38333905|FG005|Year 1|Withdrawal by Subject|1|||
17181995|NCT03917654|38333906|FG006|Year 1|Withdrawal by Subject|6|||
17181996|NCT03917654|38333907|FG007|Year 1|Withdrawal by Subject|2|||
17181997|NCT03917654|38333908|FG008|Year 1|Withdrawal by Subject|5|||
17181998|NCT03917654|38333909|FG009|Year 1|Withdrawal by Subject|3|||
17181999|NCT03917654|38333910|FG010|Year 1|Withdrawal by Subject|1|||
17182000|NCT03917654|38333911|FG011|Year 1|Withdrawal by Subject|0|||
17182001|NCT03917654|38333900|FG000|Year 1|Travel|0|||
17182002|NCT03917654|38333901|FG001|Year 1|Travel|1|||
17182003|NCT03917654|38333902|FG002|Year 1|Travel|1|||
17182004|NCT03917654|38333903|FG003|Year 1|Travel|0|||
17182005|NCT03917654|38333904|FG004|Year 1|Travel|4|||
17182006|NCT03917654|38333905|FG005|Year 1|Travel|4|||
17182007|NCT03917654|38333906|FG006|Year 1|Travel|10|||
17182008|NCT03917654|38333907|FG007|Year 1|Travel|8|||
17182009|NCT03917654|38333908|FG008|Year 1|Travel|2|||
17182010|NCT03917654|38333909|FG009|Year 1|Travel|5|||
17182011|NCT03917654|38333910|FG010|Year 1|Travel|3|||
17182012|NCT03917654|38333911|FG011|Year 1|Travel|3|||
17182013|NCT03917654|38333900|FG000|Year 1|Subject moved away from site|0|||
17182014|NCT03917654|38333901|FG001|Year 1|Subject moved away from site|1|||
17182015|NCT03917654|38333902|FG002|Year 1|Subject moved away from site|0|||
17182016|NCT03917654|38333903|FG003|Year 1|Subject moved away from site|0|||
17182017|NCT03917654|38333904|FG004|Year 1|Subject moved away from site|0|||
17182018|NCT03917654|38333905|FG005|Year 1|Subject moved away from site|0|||
17182019|NCT03917654|38333906|FG006|Year 1|Subject moved away from site|1|||
17182020|NCT03917654|38333907|FG007|Year 1|Subject moved away from site|2|||
17182021|NCT03917654|38333908|FG008|Year 1|Subject moved away from site|1|||
17182022|NCT03917654|38333909|FG009|Year 1|Subject moved away from site|0|||
17182023|NCT03917654|38333910|FG010|Year 1|Subject moved away from site|0|||
17182024|NCT03917654|38333911|FG011|Year 1|Subject moved away from site|3|||
17182025|NCT03917654|38333900|FG000|Year 1|Spouse/Family member request|0|||
17182026|NCT03917654|38333901|FG001|Year 1|Spouse/Family member request|0|||
17182027|NCT03917654|38333902|FG002|Year 1|Spouse/Family member request|1|||
17182028|NCT03917654|38333903|FG003|Year 1|Spouse/Family member request|0|||
17182029|NCT03917654|38333904|FG004|Year 1|Spouse/Family member request|1|||
17182030|NCT03917654|38333905|FG005|Year 1|Spouse/Family member request|0|||
17182031|NCT03917654|38333906|FG006|Year 1|Spouse/Family member request|0|||
17182032|NCT03917654|38333907|FG007|Year 1|Spouse/Family member request|2|||
17182033|NCT03917654|38333908|FG008|Year 1|Spouse/Family member request|0|||
17182034|NCT03917654|38333909|FG009|Year 1|Spouse/Family member request|0|||
17182035|NCT03917654|38333910|FG010|Year 1|Spouse/Family member request|0|||
17182036|NCT03917654|38333911|FG011|Year 1|Spouse/Family member request|1|||
17182037|NCT03917654|38333900|FG000|Year 1|Death|0|||
17182038|NCT03917654|38333901|FG001|Year 1|Death|0|||
17182039|NCT03917654|38333902|FG002|Year 1|Death|0|||
17182040|NCT03917654|38333903|FG003|Year 1|Death|0|||
17182041|NCT03917654|38333904|FG004|Year 1|Death|0|||
17182042|NCT03917654|38333905|FG005|Year 1|Death|0|||
17182043|NCT03917654|38333906|FG006|Year 1|Death|0|||
17182044|NCT03917654|38333907|FG007|Year 1|Death|0|||
17182045|NCT03917654|38333908|FG008|Year 1|Death|1|||
17182046|NCT03917654|38333909|FG009|Year 1|Death|1|||
17182047|NCT03917654|38333910|FG010|Year 1|Death|0|||
17182048|NCT03917654|38333911|FG011|Year 1|Death|0|||
17182049|NCT03917654|38333900|FG000|Year 1|Lost to Follow-up|0|||
17182050|NCT03917654|38333901|FG001|Year 1|Lost to Follow-up|0|||
17182051|NCT03917654|38333902|FG002|Year 1|Lost to Follow-up|0|||
17182052|NCT03917654|38333903|FG003|Year 1|Lost to Follow-up|0|||
17182053|NCT03917654|38333904|FG004|Year 1|Lost to Follow-up|0|||
17182054|NCT03917654|38333905|FG005|Year 1|Lost to Follow-up|0|||
17182055|NCT03917654|38333906|FG006|Year 1|Lost to Follow-up|2|||
17182056|NCT03917654|38333907|FG007|Year 1|Lost to Follow-up|0|||
17182057|NCT03917654|38333908|FG008|Year 1|Lost to Follow-up|0|||
17089272|NCT00288912|38229467|FG000|Overall Study|Developed exclusion criterion|4|||
17089273|NCT00288912|38229468|FG001|Overall Study|Developed exclusion criterion|6|||
17089274|NCT00288912|38229469|FG002|Overall Study|Developed exclusion criterion|7|||
17089275|NCT00288912|38229467|FG000|Overall Study|Lost to Follow-up|9|||
17089276|NCT00288912|38229468|FG001|Overall Study|Lost to Follow-up|6|||
17089277|NCT00288912|38229469|FG002|Overall Study|Lost to Follow-up|9|||
17182058|NCT03917654|38333909|FG009|Year 1|Lost to Follow-up|0|||
17182059|NCT03917654|38333910|FG010|Year 1|Lost to Follow-up|0|||
17182060|NCT03917654|38333911|FG011|Year 1|Lost to Follow-up|0|||
17182061|NCT03917654|38333900|FG000|Year 1|Missed visits|0|||
17182062|NCT03917654|38333901|FG001|Year 1|Missed visits|0|||
17182063|NCT03917654|38333902|FG002|Year 1|Missed visits|0|||
17182064|NCT03917654|38333903|FG003|Year 1|Missed visits|0|||
17182065|NCT03917654|38333904|FG004|Year 1|Missed visits|0|||
17182066|NCT03917654|38333905|FG005|Year 1|Missed visits|0|||
17182067|NCT03917654|38333906|FG006|Year 1|Missed visits|0|||
17182068|NCT03917654|38333907|FG007|Year 1|Missed visits|0|||
17182069|NCT03917654|38333908|FG008|Year 1|Missed visits|0|||
17182070|NCT03917654|38333909|FG009|Year 1|Missed visits|0|||
17182071|NCT03917654|38333910|FG010|Year 1|Missed visits|1|||
17182072|NCT03917654|38333911|FG011|Year 1|Missed visits|1|||
17182073|NCT03917654|38333900|FG000|Year 1|Pregnancy|0|||
17182074|NCT03917654|38333901|FG001|Year 1|Pregnancy|0|||
17182075|NCT03917654|38333902|FG002|Year 1|Pregnancy|0|||
17182076|NCT03917654|38333903|FG003|Year 1|Pregnancy|0|||
17182077|NCT03917654|38333904|FG004|Year 1|Pregnancy|0|||
17182078|NCT03917654|38333905|FG005|Year 1|Pregnancy|0|||
17182079|NCT03917654|38333906|FG006|Year 1|Pregnancy|0|||
17182080|NCT03917654|38333907|FG007|Year 1|Pregnancy|1|||
17182081|NCT03917654|38333908|FG008|Year 1|Pregnancy|0|||
17182082|NCT03917654|38333909|FG009|Year 1|Pregnancy|1|||
17182083|NCT03917654|38333910|FG010|Year 1|Pregnancy|0|||
17182084|NCT03917654|38333911|FG011|Year 1|Pregnancy|0|||
17182085|NCT03917654|38333900|FG000|Year 2|Travel|1|||
17182086|NCT03917654|38333901|FG001|Year 2|Travel|0|||
17182087|NCT03917654|38333902|FG002|Year 2|Travel|0|||
17182088|NCT03917654|38333903|FG003|Year 2|Travel|0|||
17182089|NCT03917654|38333904|FG004|Year 2|Travel|1|||
17182090|NCT03917654|38333905|FG005|Year 2|Travel|1|||
17182091|NCT03917654|38333906|FG006|Year 2|Travel|2|||
17182092|NCT03917654|38333907|FG007|Year 2|Travel|1|||
17182093|NCT03917654|38333908|FG008|Year 2|Travel|0|||
17182094|NCT03917654|38333909|FG009|Year 2|Travel|1|||
17182095|NCT03917654|38333910|FG010|Year 2|Travel|0|||
17182096|NCT03917654|38333911|FG011|Year 2|Travel|1|||
17182097|NCT03917654|38333900|FG000|Year 2|Married|1|||
17182098|NCT03917654|38333901|FG001|Year 2|Married|0|||
17182099|NCT03917654|38333902|FG002|Year 2|Married|0|||
17182100|NCT03917654|38333903|FG003|Year 2|Married|0|||
17182101|NCT03917654|38333904|FG004|Year 2|Married|0|||
17182102|NCT03917654|38333905|FG005|Year 2|Married|0|||
17182103|NCT03917654|38333906|FG006|Year 2|Married|1|||
17182104|NCT03917654|38333907|FG007|Year 2|Married|1|||
17182105|NCT03917654|38333908|FG008|Year 2|Married|0|||
17182106|NCT03917654|38333909|FG009|Year 2|Married|0|||
17182107|NCT03917654|38333910|FG010|Year 2|Married|0|||
17182108|NCT03917654|38333911|FG011|Year 2|Married|0|||
17182109|NCT03917654|38333900|FG000|Year 2|Subject moved away from site|1|||
17182110|NCT03917654|38333901|FG001|Year 2|Subject moved away from site|0|||
17182111|NCT03917654|38333902|FG002|Year 2|Subject moved away from site|0|||
17182112|NCT03917654|38333903|FG003|Year 2|Subject moved away from site|0|||
17182113|NCT03917654|38333904|FG004|Year 2|Subject moved away from site|1|||
17182114|NCT03917654|38333905|FG005|Year 2|Subject moved away from site|0|||
17182115|NCT03917654|38333906|FG006|Year 2|Subject moved away from site|2|||
17182116|NCT03917654|38333907|FG007|Year 2|Subject moved away from site|3|||
17182117|NCT03917654|38333908|FG008|Year 2|Subject moved away from site|0|||
17182118|NCT03917654|38333909|FG009|Year 2|Subject moved away from site|2|||
17182119|NCT03917654|38333910|FG010|Year 2|Subject moved away from site|0|||
17182120|NCT03917654|38333911|FG011|Year 2|Subject moved away from site|1|||
17182121|NCT03917654|38333900|FG000|Year 2|Year 2 Screening failure|0|||
17182122|NCT03917654|38333901|FG001|Year 2|Year 2 Screening failure|1|||
17182123|NCT03917654|38333902|FG002|Year 2|Year 2 Screening failure|0|||
17182124|NCT03917654|38333903|FG003|Year 2|Year 2 Screening failure|0|||
17182125|NCT03917654|38333904|FG004|Year 2|Year 2 Screening failure|2|||
17182126|NCT03917654|38333905|FG005|Year 2|Year 2 Screening failure|0|||
17182127|NCT03917654|38333906|FG006|Year 2|Year 2 Screening failure|4|||
17182128|NCT03917654|38333907|FG007|Year 2|Year 2 Screening failure|3|||
17182129|NCT03917654|38333908|FG008|Year 2|Year 2 Screening failure|10|||
17182130|NCT03917654|38333909|FG009|Year 2|Year 2 Screening failure|2|||
17182131|NCT03917654|38333910|FG010|Year 2|Year 2 Screening failure|1|||
17182132|NCT03917654|38333911|FG011|Year 2|Year 2 Screening failure|1|||
17182133|NCT03917654|38333900|FG000|Year 2|Death|0|||
17182134|NCT03917654|38333901|FG001|Year 2|Death|0|||
17182135|NCT03917654|38333902|FG002|Year 2|Death|0|||
17182136|NCT03917654|38333903|FG003|Year 2|Death|0|||
17182137|NCT03917654|38333904|FG004|Year 2|Death|0|||
17182138|NCT03917654|38333905|FG005|Year 2|Death|1|||
17182139|NCT03917654|38333906|FG006|Year 2|Death|0|||
17182140|NCT03917654|38333907|FG007|Year 2|Death|0|||
17182141|NCT03917654|38333908|FG008|Year 2|Death|1|||
17182142|NCT03917654|38333909|FG009|Year 2|Death|1|||
17182143|NCT03917654|38333910|FG010|Year 2|Death|0|||
17182144|NCT03917654|38333911|FG011|Year 2|Death|0|||
17182145|NCT03917654|38333900|FG000|Year 2|Withdrawal by Subject|0|||
17182146|NCT03917654|38333901|FG001|Year 2|Withdrawal by Subject|0|||
17182147|NCT03917654|38333902|FG002|Year 2|Withdrawal by Subject|0|||
17182148|NCT03917654|38333903|FG003|Year 2|Withdrawal by Subject|0|||
17182149|NCT03917654|38333904|FG004|Year 2|Withdrawal by Subject|0|||
17182150|NCT03917654|38333905|FG005|Year 2|Withdrawal by Subject|0|||
17182151|NCT03917654|38333906|FG006|Year 2|Withdrawal by Subject|3|||
17182152|NCT03917654|38333907|FG007|Year 2|Withdrawal by Subject|0|||
17182153|NCT03917654|38333908|FG008|Year 2|Withdrawal by Subject|2|||
17182154|NCT03917654|38333909|FG009|Year 2|Withdrawal by Subject|5|||
17182155|NCT03917654|38333910|FG010|Year 2|Withdrawal by Subject|0|||
17182156|NCT03917654|38333911|FG011|Year 2|Withdrawal by Subject|0|||
17182157|NCT03917654|38333900|FG000|Year 2|Spouse/family member request|0|||
17182158|NCT03917654|38333901|FG001|Year 2|Spouse/family member request|0|||
17182159|NCT03917654|38333902|FG002|Year 2|Spouse/family member request|0|||
17182160|NCT03917654|38333903|FG003|Year 2|Spouse/family member request|0|||
17182161|NCT03917654|38333904|FG004|Year 2|Spouse/family member request|0|||
17182162|NCT03917654|38333905|FG005|Year 2|Spouse/family member request|0|||
17182163|NCT03917654|38333906|FG006|Year 2|Spouse/family member request|1|||
17182164|NCT03917654|38333907|FG007|Year 2|Spouse/family member request|0|||
17182165|NCT03917654|38333908|FG008|Year 2|Spouse/family member request|0|||
17182166|NCT03917654|38333909|FG009|Year 2|Spouse/family member request|0|||
17182167|NCT03917654|38333910|FG010|Year 2|Spouse/family member request|0|||
17182168|NCT03917654|38333911|FG011|Year 2|Spouse/family member request|0|||
17182169|NCT03917654|38333900|FG000|Year 2|Lost to Follow-up|0|||
17182170|NCT03917654|38333901|FG001|Year 2|Lost to Follow-up|0|||
17182171|NCT03917654|38333902|FG002|Year 2|Lost to Follow-up|0|||
17182172|NCT03917654|38333903|FG003|Year 2|Lost to Follow-up|0|||
17182173|NCT03917654|38333904|FG004|Year 2|Lost to Follow-up|0|||
17182174|NCT03917654|38333905|FG005|Year 2|Lost to Follow-up|0|||
17182175|NCT03917654|38333906|FG006|Year 2|Lost to Follow-up|1|||
17182176|NCT03917654|38333907|FG007|Year 2|Lost to Follow-up|0|||
17182177|NCT03917654|38333908|FG008|Year 2|Lost to Follow-up|1|||
17182178|NCT03917654|38333909|FG009|Year 2|Lost to Follow-up|0|||
17182179|NCT03917654|38333910|FG010|Year 2|Lost to Follow-up|0|||
17182180|NCT03917654|38333911|FG011|Year 2|Lost to Follow-up|1|||
17182181|NCT03917654|38333900|FG000|Year 2|Adverse Event|0|||
17182182|NCT03917654|38333901|FG001|Year 2|Adverse Event|0|||
17182183|NCT03917654|38333902|FG002|Year 2|Adverse Event|0|||
17182184|NCT03917654|38333903|FG003|Year 2|Adverse Event|0|||
17182185|NCT03917654|38333904|FG004|Year 2|Adverse Event|0|||
17182186|NCT03917654|38333905|FG005|Year 2|Adverse Event|0|||
17182187|NCT03917654|38333906|FG006|Year 2|Adverse Event|0|||
17182188|NCT03917654|38333907|FG007|Year 2|Adverse Event|0|||
17182189|NCT03917654|38333908|FG008|Year 2|Adverse Event|0|||
17182190|NCT03917654|38333909|FG009|Year 2|Adverse Event|1|||
17182191|NCT03917654|38333910|FG010|Year 2|Adverse Event|0|||
17182192|NCT03917654|38333911|FG011|Year 2|Adverse Event|0|||
17182193|NCT03692052|38333946|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
17182194|NCT03692052|38333946|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
17182195|NCT03692052|38333946|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
17182196|NCT03692052|38333946|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
17182197|NCT03474107|38333952|FG000|Overall Study|Adverse Event|42|||
17182198|NCT03474107|38333953|FG001|Overall Study|Adverse Event|46|||
17182199|NCT03474107|38333952|FG000|Overall Study|Death|2|||
17182200|NCT03474107|38333953|FG001|Overall Study|Death|2|||
17182201|NCT03474107|38333952|FG000|Overall Study|Lost to Follow-up|0|||
17182202|NCT03474107|38333953|FG001|Overall Study|Lost to Follow-up|1|||
17182203|NCT03474107|38333952|FG000|Overall Study|Progressive Disease|177|||
17182204|NCT03474107|38333953|FG001|Overall Study|Progressive Disease|180|||
17182205|NCT03474107|38333952|FG000|Overall Study|Protocol Violation|1|||
17182206|NCT03474107|38333953|FG001|Overall Study|Protocol Violation|1|||
17182207|NCT03474107|38333952|FG000|Overall Study|Withdrawal by Subject|15|||
17182208|NCT03474107|38333953|FG001|Overall Study|Withdrawal by Subject|27|||
17182209|NCT03474107|38333952|FG000|Overall Study|Physician Decision|7|||
17182210|NCT03474107|38333953|FG001|Overall Study|Physician Decision|22|||
17182211|NCT03474107|38333952|FG000|Overall Study|Miscellaneous|1|||
17182212|NCT03474107|38333953|FG001|Overall Study|Miscellaneous|6|||
17182213|NCT03064126|38333972|FG000|Overall Study|Death|6|||
17182214|NCT03064126|38333973|FG001|Overall Study|Death|2|||
17182215|NCT03064126|38333974|FG002|Overall Study|Death|2|||
17182216|NCT03064126|38333975|FG003|Overall Study|Death|1|||
17182217|NCT03064126|38333972|FG000|Overall Study|Investigator Discretion|1|||
17182218|NCT03064126|38333973|FG001|Overall Study|Investigator Discretion|0|||
17182219|NCT03064126|38333974|FG002|Overall Study|Investigator Discretion|0|||
17182220|NCT03064126|38333975|FG003|Overall Study|Investigator Discretion|0|||
17182221|NCT03064126|38333972|FG000|Overall Study|Withdrawal by Subject|7|||
17182222|NCT03064126|38333973|FG001|Overall Study|Withdrawal by Subject|4|||
17182223|NCT03064126|38333974|FG002|Overall Study|Withdrawal by Subject|0|||
17182224|NCT03064126|38333975|FG003|Overall Study|Withdrawal by Subject|0|||
17182225|NCT03064126|38333972|FG000|Overall Study|Subject moved|1|||
17182226|NCT03064126|38333973|FG001|Overall Study|Subject moved|0|||
17182227|NCT03064126|38333974|FG002|Overall Study|Subject moved|0|||
17182228|NCT03064126|38333975|FG003|Overall Study|Subject moved|0|||
17182229|NCT03064126|38333972|FG000|Overall Study|Protocol Violation|11|||
17182230|NCT03064126|38333973|FG001|Overall Study|Protocol Violation|1|||
17182231|NCT03064126|38333974|FG002|Overall Study|Protocol Violation|1|||
17182232|NCT03064126|38333975|FG003|Overall Study|Protocol Violation|0|||
17182233|NCT03060577|38333988|FG000|Overall Study|Withdrawal by Subject|25|||
17182234|NCT03060577|38333989|FG001|Overall Study|Withdrawal by Subject|5|||
17182235|NCT03060577|38333988|FG000|Overall Study|Physician Decision|4|||
17182236|NCT03060577|38333989|FG001|Overall Study|Physician Decision|3|||
17182237|NCT03060577|38333988|FG000|Overall Study|Lost to Follow-up|3|||
17182238|NCT03060577|38333989|FG001|Overall Study|Lost to Follow-up|0|||
17182239|NCT03060577|38333988|FG000|Overall Study|Death|7|||
17182240|NCT03060577|38333989|FG001|Overall Study|Death|1|||
17182241|NCT03060577|38333988|FG000|Overall Study|Adverse Event|9|||
17182242|NCT03060577|38333989|FG001|Overall Study|Adverse Event|1|||
17182243|NCT03060577|38333988|FG000|Overall Study|Inclusion/Exclusion|1|||
17182244|NCT03060577|38333989|FG001|Overall Study|Inclusion/Exclusion|0|||
17182245|NCT03060577|38333988|FG000|Overall Study|Other|8|||
17182246|NCT03060577|38333989|FG001|Overall Study|Other|2|||
17182247|NCT02872714|38334000|FG000|Overall Study|Progressive Disease|1|||
17182248|NCT02872714|38334001|FG001|Overall Study|Progressive Disease|2|||
17182249|NCT02872714|38334002|FG002|Overall Study|Progressive Disease|0|||
17182250|NCT02872714|38334003|FG003|Overall Study|Progressive Disease|0|||
17182251|NCT02872714|38334004|FG004|Overall Study|Progressive Disease|0|||
17182252|NCT02872714|38334000|FG000|Overall Study|Death|87|||
17182253|NCT02872714|38334001|FG001|Overall Study|Death|36|||
17182254|NCT02872714|38334002|FG002|Overall Study|Death|8|||
17182255|NCT02872714|38334003|FG003|Overall Study|Death|81|||
17182256|NCT02872714|38334004|FG004|Overall Study|Death|2|||
17182257|NCT02872714|38334000|FG000|Overall Study|Lost to Follow-up|2|||
17182258|NCT02872714|38334001|FG001|Overall Study|Lost to Follow-up|1|||
17182259|NCT02872714|38334002|FG002|Overall Study|Lost to Follow-up|0|||
17182260|NCT02872714|38334003|FG003|Overall Study|Lost to Follow-up|3|||
17182261|NCT02872714|38334004|FG004|Overall Study|Lost to Follow-up|0|||
17182262|NCT02872714|38334000|FG000|Overall Study|Physician Decision|0|||
17182263|NCT02872714|38334001|FG001|Overall Study|Physician Decision|0|||
17182264|NCT02872714|38334002|FG002|Overall Study|Physician Decision|0|||
17182265|NCT02872714|38334003|FG003|Overall Study|Physician Decision|1|||
17182266|NCT02872714|38334004|FG004|Overall Study|Physician Decision|0|||
17182267|NCT02872714|38334000|FG000|Overall Study|Withdrawal by Subject|1|||
17182268|NCT02872714|38334001|FG001|Overall Study|Withdrawal by Subject|3|||
17182269|NCT02872714|38334002|FG002|Overall Study|Withdrawal by Subject|0|||
17182270|NCT02872714|38334003|FG003|Overall Study|Withdrawal by Subject|2|||
17182271|NCT02872714|38334004|FG004|Overall Study|Withdrawal by Subject|0|||
17182272|NCT02872714|38334000|FG000|Overall Study|Captured as Other|2|||
17182273|NCT02872714|38334001|FG001|Overall Study|Captured as Other|0|||
17182274|NCT02872714|38334002|FG002|Overall Study|Captured as Other|0|||
17182275|NCT02872714|38334003|FG003|Overall Study|Captured as Other|1|||
17182276|NCT02872714|38334004|FG004|Overall Study|Captured as Other|0|||
17182277|NCT02787005|38334024|FG000|Overall Study|Adverse Event|24|||
17182278|NCT02787005|38334025|FG001|Overall Study|Adverse Event|9|||
17182279|NCT02787005|38334026|FG002|Overall Study|Adverse Event|9|||
17182280|NCT02787005|38334027|FG003|Overall Study|Adverse Event|7|||
17182281|NCT02787005|38334028|FG004|Overall Study|Adverse Event|2|||
17182282|NCT02787005|38334024|FG000|Overall Study|Death|100|||
17182283|NCT02787005|38334025|FG001|Overall Study|Death|53|||
17182284|NCT02787005|38334026|FG002|Overall Study|Death|48|||
17182285|NCT02787005|38334027|FG003|Overall Study|Death|69|||
17182286|NCT02787005|38334028|FG004|Overall Study|Death|38|||
17182287|NCT02787005|38334024|FG000|Overall Study|Sponsor Decision|7|||
17182288|NCT02787005|38334025|FG001|Overall Study|Sponsor Decision|4|||
17182289|NCT02787005|38334026|FG002|Overall Study|Sponsor Decision|0|||
17182290|NCT02787005|38334027|FG003|Overall Study|Sponsor Decision|4|||
17182291|NCT02787005|38334028|FG004|Overall Study|Sponsor Decision|5|||
17182292|NCT02787005|38334024|FG000|Overall Study|Withdrawal by Subject|2|||
17182293|NCT02787005|38334025|FG001|Overall Study|Withdrawal by Subject|1|||
17182294|NCT02787005|38334026|FG002|Overall Study|Withdrawal by Subject|1|||
17182295|NCT02787005|38334027|FG003|Overall Study|Withdrawal by Subject|0|||
17182296|NCT02787005|38334028|FG004|Overall Study|Withdrawal by Subject|1|||
17182297|NCT02787005|38334024|FG000|Overall Study|Screen Failure|0|||
17182298|NCT02787005|38334025|FG001|Overall Study|Screen Failure|2|||
17182299|NCT02787005|38334026|FG002|Overall Study|Screen Failure|0|||
17182300|NCT02787005|38334027|FG003|Overall Study|Screen Failure|0|||
17182301|NCT02787005|38334028|FG004|Overall Study|Screen Failure|1|||
17182302|NCT02787005|38334024|FG000|Overall Study|Lost to Follow-up|0|||
17182303|NCT02787005|38334025|FG001|Overall Study|Lost to Follow-up|0|||
17182304|NCT02787005|38334026|FG002|Overall Study|Lost to Follow-up|0|||
17182305|NCT02787005|38334027|FG003|Overall Study|Lost to Follow-up|1|||
17182306|NCT02787005|38334028|FG004|Overall Study|Lost to Follow-up|0|||
17182307|NCT02601313|38334062|FG000|Overall Study|Death|2|||
17182308|NCT02601313|38334063|FG001|Overall Study|Death|16|||
17182309|NCT02601313|38334064|FG002|Overall Study|Death|4|||
17182310|NCT02601313|38334062|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
17182311|NCT02601313|38334063|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
17182312|NCT02601313|38334064|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
17182313|NCT02601313|38334062|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
17182314|NCT02601313|38334063|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
16997025|NCT00758524|38141140|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
16997026|NCT00758524|38141141|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997027|NCT00758524|38141142|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
16997028|NCT00758524|38141143|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
16997029|NCT00758524|38141144|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
16997030|NCT00758524|38141145|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
16997031|NCT00758524|38141146|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
17182315|NCT02601313|38334064|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
17182316|NCT02601313|38334062|FG000|Overall Study|Still on study|0|||
17182317|NCT02601313|38334063|FG001|Overall Study|Still on study|52|||
17182318|NCT02601313|38334064|FG002|Overall Study|Still on study|10|||
17182319|NCT02601313|38334062|FG000|Overall Study|Enrolled, did not initiate AC|4|||
17182320|NCT02601313|38334063|FG001|Overall Study|Enrolled, did not initiate AC|0|||
17182321|NCT02601313|38334064|FG002|Overall Study|Enrolled, did not initiate AC|0|||
17182322|NCT02514083|38334072|FG000|Overall Study|Adverse Event|1|||
17182323|NCT02453282|38334079|FG000|Overall Study|Death|275|||
17182324|NCT02453282|38334080|FG001|Overall Study|Death|277|||
17182325|NCT02453282|38334081|FG002|Overall Study|Death|296|||
17182326|NCT02453282|38334079|FG000|Overall Study|Lost to Follow-up|1|||
17182327|NCT02453282|38334080|FG001|Overall Study|Lost to Follow-up|0|||
17182328|NCT02453282|38334081|FG002|Overall Study|Lost to Follow-up|2|||
17182329|NCT02453282|38334079|FG000|Overall Study|Withdrawal by Subject|12|||
17182330|NCT02453282|38334080|FG001|Overall Study|Withdrawal by Subject|10|||
17182331|NCT02453282|38334081|FG002|Overall Study|Withdrawal by Subject|11|||
17182332|NCT02453282|38334079|FG000|Overall Study|Participants ongoing at data cut-off|85|||
17182333|NCT02453282|38334080|FG001|Overall Study|Participants ongoing at data cut-off|84|||
17182334|NCT02453282|38334081|FG002|Overall Study|Participants ongoing at data cut-off|62|||
17182335|NCT02453282|38334079|FG000|Overall Study|Other|1|||
17182336|NCT02453282|38334080|FG001|Overall Study|Other|1|||
17182337|NCT02453282|38334081|FG002|Overall Study|Other|1|||
17182338|NCT02395848|38334091|FG000|Overall Study|Lost to Follow-up|2|||
17182339|NCT02061761|38334108|FG000|Overall Study|Disease progression|2|||
17182340|NCT02061761|38334109|FG001|Overall Study|Disease progression|8|||
17182341|NCT02061761|38334110|FG002|Overall Study|Disease progression|4|||
17182342|NCT02061761|38334111|FG003|Overall Study|Disease progression|5|||
17182343|NCT02061761|38334112|FG004|Overall Study|Disease progression|9|||
17182344|NCT02061761|38334113|FG005|Overall Study|Disease progression|3|||
17182345|NCT02061761|38334114|FG006|Overall Study|Disease progression|1|||
17182346|NCT02061761|38334115|FG007|Overall Study|Disease progression|2|||
17182347|NCT02061761|38334116|FG008|Overall Study|Disease progression|28|||
17182348|NCT02061761|38334108|FG000|Overall Study|Study Drug toxicity|0|||
17182349|NCT02061761|38334109|FG001|Overall Study|Study Drug toxicity|0|||
17182350|NCT02061761|38334110|FG002|Overall Study|Study Drug toxicity|0|||
17182351|NCT02061761|38334111|FG003|Overall Study|Study Drug toxicity|0|||
17182352|NCT02061761|38334112|FG004|Overall Study|Study Drug toxicity|0|||
17182353|NCT02061761|38334113|FG005|Overall Study|Study Drug toxicity|1|||
17182354|NCT02061761|38334114|FG006|Overall Study|Study Drug toxicity|0|||
17182355|NCT02061761|38334115|FG007|Overall Study|Study Drug toxicity|2|||
16997032|NCT00758524|38141147|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997033|NCT00758524|38141148|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997034|NCT00758524|38141149|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997035|NCT00758524|38141150|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997036|NCT00758524|38141151|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997037|NCT00758524|38141152|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997038|NCT00758524|38141153|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997039|NCT00758524|38141154|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997040|NCT00758524|38141155|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997041|NCT00758524|38141156|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16997042|NCT00758524|38141140|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
16997043|NCT00758524|38141141|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
16997044|NCT00758524|38141142|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
16997045|NCT00758524|38141143|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
16997046|NCT00758524|38141144|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
16997047|NCT00758524|38141145|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
16997048|NCT00758524|38141146|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997049|NCT00758524|38141147|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997050|NCT00758524|38141148|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997051|NCT00758524|38141149|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
17182356|NCT02061761|38334116|FG008|Overall Study|Study Drug toxicity|6|||
17182357|NCT02061761|38334108|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
17182358|NCT02061761|38334109|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
17182359|NCT02061761|38334110|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
17182360|NCT02061761|38334111|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
17182361|NCT02061761|38334112|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
17182362|NCT02061761|38334113|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
17182363|NCT02061761|38334114|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
17182364|NCT02061761|38334115|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
17182365|NCT02061761|38334116|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
17182366|NCT02061761|38334108|FG000|Overall Study|Participant request to discontinue study treatment|0|||
17182367|NCT02061761|38334109|FG001|Overall Study|Participant request to discontinue study treatment|0|||
17182368|NCT02061761|38334110|FG002|Overall Study|Participant request to discontinue study treatment|2|||
17182369|NCT02061761|38334111|FG003|Overall Study|Participant request to discontinue study treatment|2|||
17182370|NCT02061761|38334112|FG004|Overall Study|Participant request to discontinue study treatment|0|||
17182371|NCT02061761|38334113|FG005|Overall Study|Participant request to discontinue study treatment|1|||
17182372|NCT02061761|38334114|FG006|Overall Study|Participant request to discontinue study treatment|0|||
17182373|NCT02061761|38334115|FG007|Overall Study|Participant request to discontinue study treatment|0|||
17182374|NCT02061761|38334116|FG008|Overall Study|Participant request to discontinue study treatment|2|||
17182375|NCT02061761|38334108|FG000|Overall Study|Withdrawal by Subject|0|||
17182376|NCT02061761|38334109|FG001|Overall Study|Withdrawal by Subject|0|||
17182377|NCT02061761|38334110|FG002|Overall Study|Withdrawal by Subject|0|||
17182378|NCT02061761|38334111|FG003|Overall Study|Withdrawal by Subject|0|||
17182379|NCT02061761|38334112|FG004|Overall Study|Withdrawal by Subject|0|||
17182380|NCT02061761|38334113|FG005|Overall Study|Withdrawal by Subject|0|||
17182381|NCT02061761|38334114|FG006|Overall Study|Withdrawal by Subject|0|||
17182382|NCT02061761|38334115|FG007|Overall Study|Withdrawal by Subject|0|||
17182383|NCT02061761|38334116|FG008|Overall Study|Withdrawal by Subject|2|||
17182384|NCT02061761|38334108|FG000|Overall Study|Maximum clinical benefit|0|||
17182385|NCT02061761|38334109|FG001|Overall Study|Maximum clinical benefit|0|||
17182386|NCT02061761|38334110|FG002|Overall Study|Maximum clinical benefit|0|||
17182387|NCT02061761|38334111|FG003|Overall Study|Maximum clinical benefit|1|||
17182388|NCT02061761|38334112|FG004|Overall Study|Maximum clinical benefit|0|||
17182389|NCT02061761|38334113|FG005|Overall Study|Maximum clinical benefit|0|||
17182390|NCT02061761|38334114|FG006|Overall Study|Maximum clinical benefit|0|||
17182391|NCT02061761|38334115|FG007|Overall Study|Maximum clinical benefit|0|||
17182392|NCT02061761|38334116|FG008|Overall Study|Maximum clinical benefit|6|||
17182393|NCT02061761|38334108|FG000|Overall Study|Participant no longer meets study criteria|0|||
17182394|NCT02061761|38334109|FG001|Overall Study|Participant no longer meets study criteria|0|||
17182395|NCT02061761|38334110|FG002|Overall Study|Participant no longer meets study criteria|0|||
17182396|NCT02061761|38334111|FG003|Overall Study|Participant no longer meets study criteria|0|||
17182397|NCT02061761|38334112|FG004|Overall Study|Participant no longer meets study criteria|0|||
17182398|NCT02061761|38334113|FG005|Overall Study|Participant no longer meets study criteria|0|||
17182399|NCT02061761|38334114|FG006|Overall Study|Participant no longer meets study criteria|0|||
17182400|NCT02061761|38334115|FG007|Overall Study|Participant no longer meets study criteria|0|||
17182401|NCT02061761|38334116|FG008|Overall Study|Participant no longer meets study criteria|1|||
17182402|NCT02061761|38334108|FG000|Overall Study|Other reasons|0|||
17182403|NCT02061761|38334109|FG001|Overall Study|Other reasons|0|||
17182404|NCT02061761|38334110|FG002|Overall Study|Other reasons|0|||
17182405|NCT02061761|38334111|FG003|Overall Study|Other reasons|0|||
17182406|NCT02061761|38334112|FG004|Overall Study|Other reasons|2|||
17182407|NCT02061761|38334113|FG005|Overall Study|Other reasons|0|||
17182408|NCT02061761|38334114|FG006|Overall Study|Other reasons|0|||
17182409|NCT02061761|38334115|FG007|Overall Study|Other reasons|0|||
17182410|NCT02061761|38334116|FG008|Overall Study|Other reasons|6|||
17182411|NCT01927068|38334144|FG000|Overall Study|Death|37|||
17182412|NCT01927068|38334145|FG001|Overall Study|Death|3|||
17182413|NCT01927068|38334144|FG000|Overall Study|Withdrawal by Subject|50|||
17182414|NCT01927068|38334145|FG001|Overall Study|Withdrawal by Subject|3|||
17182415|NCT01927068|38334144|FG000|Overall Study|Lost to Follow-up|10|||
17182416|NCT01927068|38334145|FG001|Overall Study|Lost to Follow-up|2|||
17182417|NCT01927068|38334144|FG000|Overall Study|Physician Decision|9|||
17182418|NCT01927068|38334145|FG001|Overall Study|Physician Decision|0|||
17182419|NCT01927068|38334144|FG000|Overall Study|Missed last follow-up visit|2|||
17182420|NCT01927068|38334145|FG001|Overall Study|Missed last follow-up visit|0|||
17182421|NCT01309230|38334154|FG000|Overall Study|Withdrawal by Subject|0|||
17182422|NCT01309230|38334155|FG001|Overall Study|Withdrawal by Subject|2|||
17182423|NCT01309230|38334154|FG000|Overall Study|Observation arm closed|0|||
17182424|NCT01309230|38334155|FG001|Overall Study|Observation arm closed|2|||
17182425|NCT00819832|38334167|FG000|Overall Study|Sponsor Termination of Study|3|||
17182426|NCT00819832|38334168|FG001|Overall Study|Sponsor Termination of Study|0|||
17182427|NCT00819832|38334169|FG002|Overall Study|Sponsor Termination of Study|0|||
17182428|NCT00819832|38334170|FG003|Overall Study|Sponsor Termination of Study|0|||
17182429|NCT00819832|38334171|FG004|Overall Study|Sponsor Termination of Study|0|||
17182430|NCT00819832|38334172|FG005|Overall Study|Sponsor Termination of Study|0|||
17182431|NCT00704522|38334188|FG000|Overall Study|Lack of Efficacy|65|||
17182432|NCT00704522|38334189|FG001|Overall Study|Lack of Efficacy|17|||
17182433|NCT00704522|38334188|FG000|Overall Study|Failure to appear again at hospital|56|||
17182434|NCT00704522|38334189|FG001|Overall Study|Failure to appear again at hospital|10|||
17182435|NCT00704522|38334188|FG000|Overall Study|Withdrawal by Subject|17|||
17182436|NCT00704522|38334189|FG001|Overall Study|Withdrawal by Subject|8|||
17182437|NCT00704522|38334188|FG000|Overall Study|Adverse Event|9|||
17182438|NCT00704522|38334189|FG001|Overall Study|Adverse Event|1|||
17182439|NCT00704522|38334188|FG000|Overall Study|Undefined causes|9|||
17182440|NCT00704522|38334189|FG001|Overall Study|Undefined causes|7|||
17182441|NCT00704522|38334188|FG000|Overall Study|No information on therapy end|27|||
17182442|NCT00704522|38334189|FG001|Overall Study|No information on therapy end|2|||
17182443|NCT02723630|38334200|FG000|Intervention Period 1|Adverse Event|1|||
17182444|NCT02723630|38334201|FG001|Intervention Period 1|Adverse Event|0|||
17182445|NCT02723630|38334202|FG002|Intervention Period 1|Adverse Event|0|||
17182446|NCT02723630|38334203|FG003|Intervention Period 1|Adverse Event|0|||
17182447|NCT02723630|38334204|FG004|Intervention Period 1|Adverse Event|0|||
17182448|NCT02723630|38334205|FG005|Intervention Period 1|Adverse Event|0|||
17182449|NCT02723630|38334200|FG000|Intervention Period 3|consumption of restricted item|0|||
17182450|NCT02723630|38334201|FG001|Intervention Period 3|consumption of restricted item|1|||
17182451|NCT02723630|38334202|FG002|Intervention Period 3|consumption of restricted item|0|||
17182452|NCT02723630|38334203|FG003|Intervention Period 3|consumption of restricted item|0|||
17182453|NCT02723630|38334204|FG004|Intervention Period 3|consumption of restricted item|0|||
17182454|NCT02723630|38334205|FG005|Intervention Period 3|consumption of restricted item|0|||
17182455|NCT01984346|38334235|FG000|Overall Study|Physician Decision|4|||
17182456|NCT01984346|38334236|FG001|Overall Study|Physician Decision|2|||
17182457|NCT01984346|38334235|FG000|Overall Study|Withdrawal by Subject|2|||
17182458|NCT01984346|38334236|FG001|Overall Study|Withdrawal by Subject|2|||
17182459|NCT01984346|38334235|FG000|Overall Study|Enrollment Closed|8|||
17182460|NCT01984346|38334236|FG001|Overall Study|Enrollment Closed|1|||
17182461|NCT01984346|38334235|FG000|Overall Study|Insurance Coverage|1|||
17182462|NCT01984346|38334236|FG001|Overall Study|Insurance Coverage|0|||
17182463|NCT01984346|38334235|FG000|Overall Study|Intra-operative Exclusion|2|||
17182464|NCT01984346|38334236|FG001|Overall Study|Intra-operative Exclusion|0|||
17182465|NCT01876784|38334253|FG000|Overall Study|Withdrawal by Subject|17|||
17182466|NCT01876784|38334254|FG001|Overall Study|Withdrawal by Subject|2|||
17182467|NCT01876784|38334253|FG000|Overall Study|Adverse Event|15|||
17182468|NCT01876784|38334254|FG001|Overall Study|Adverse Event|2|||
17182469|NCT01876784|38334253|FG000|Overall Study|Protocol Violation|1|||
17182470|NCT01876784|38334254|FG001|Overall Study|Protocol Violation|0|||
17182471|NCT01876784|38334253|FG000|Overall Study|Disease progression|37|||
17182472|NCT01876784|38334254|FG001|Overall Study|Disease progression|67|||
17182473|NCT01876784|38334253|FG000|Overall Study|Lost to Follow-up|0|||
17182474|NCT01876784|38334254|FG001|Overall Study|Lost to Follow-up|1|||
17182475|NCT01876784|38334253|FG000|Overall Study|Death|1|||
17182476|NCT01876784|38334254|FG001|Overall Study|Death|0|||
17182477|NCT01876784|38334253|FG000|Overall Study|Randomized but not treated|2|||
17182478|NCT01876784|38334254|FG001|Overall Study|Randomized but not treated|1|||
17182479|NCT01876784|38334253|FG000|Overall Study|Other than specified above|5|||
17182480|NCT01876784|38334254|FG001|Overall Study|Other than specified above|6|||
17182481|NCT01876784|38334253|FG000|Overall Study|Ongoing|41|||
17182482|NCT01876784|38334254|FG001|Overall Study|Ongoing|40|||
17182483|NCT04205162|38334262|FG000|Overall Study|Lost to Follow-up|1|||
17182484|NCT04205162|38334263|FG001|Overall Study|Lost to Follow-up|0|||
17182485|NCT04205162|38334262|FG000|Overall Study|Withdrawal by Subject|2|||
17182486|NCT04205162|38334263|FG001|Overall Study|Withdrawal by Subject|0|||
17182487|NCT04205162|38334262|FG000|Overall Study|University closure due to COVID-19|1|||
17182488|NCT04205162|38334263|FG001|Overall Study|University closure due to COVID-19|0|||
17182489|NCT01329939|38334274|FG000|Overall Study|Lost to Follow-up|3|||
17182490|NCT01329939|38334275|FG001|Overall Study|Lost to Follow-up|0|||
17182491|NCT01329939|38334276|FG002|Overall Study|Lost to Follow-up|1|||
17182492|NCT01329939|38334277|FG003|Overall Study|Lost to Follow-up|2|||
17182493|NCT01329939|38334274|FG000|Overall Study|Withdrawal by Subject|0|||
17182494|NCT01329939|38334275|FG001|Overall Study|Withdrawal by Subject|1|||
17182495|NCT01329939|38334276|FG002|Overall Study|Withdrawal by Subject|0|||
17182496|NCT01329939|38334277|FG003|Overall Study|Withdrawal by Subject|0|||
17182497|NCT01329939|38334274|FG000|Overall Study|Adverse Event|0|||
17182498|NCT01329939|38334275|FG001|Overall Study|Adverse Event|0|||
17182499|NCT01329939|38334276|FG002|Overall Study|Adverse Event|0|||
17182500|NCT01329939|38334277|FG003|Overall Study|Adverse Event|3|||
17182501|NCT02499900|38334289|FG000|Core Study Period|Other|1|||
17182502|NCT02499900|38334290|FG001|Core Study Period|Other|4|||
17182503|NCT02499900|38334289|FG000|Core Study Period|Lost to Follow-up|1|||
17182504|NCT02499900|38334290|FG001|Core Study Period|Lost to Follow-up|2|||
17182505|NCT02499900|38334289|FG000|Core Study Period|Per sponsor request|0|||
17182506|NCT02499900|38334290|FG001|Core Study Period|Per sponsor request|1|||
17182507|NCT02499900|38334289|FG000|Core Study Period|Pregnancy|1|||
17182508|NCT02499900|38334290|FG001|Core Study Period|Pregnancy|0|||
17182509|NCT02499900|38334289|FG000|Core Study Period|Protocol Violation|3|||
17182510|NCT02499900|38334290|FG001|Core Study Period|Protocol Violation|0|||
17182511|NCT02499900|38334289|FG000|Core Study Period|Withdrawal by Subject|11|||
17182512|NCT02499900|38334290|FG001|Core Study Period|Withdrawal by Subject|10|||
17182513|NCT02499900|38334289|FG000|Core Study Period|Adverse Event|18|||
17182514|NCT02499900|38334290|FG001|Core Study Period|Adverse Event|14|||
17182515|NCT02499900|38334289|FG000|Core Study Period|Death|0|||
17182516|NCT02499900|38334290|FG001|Core Study Period|Death|1|||
17182517|NCT02499900|38334289|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
17182518|NCT02499900|38334290|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
17182519|NCT02499900|38334289|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
17182520|NCT02499900|38334290|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
17182521|NCT02499900|38334289|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
17182522|NCT02499900|38334290|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
17182523|NCT02499900|38334289|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
17182524|NCT02499900|38334290|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
17182525|NCT02499900|38334289|FG000|Extension Study Period|Adverse Event|2|||
17182526|NCT02499900|38334290|FG001|Extension Study Period|Adverse Event|4|||
17182527|NCT02499900|38334289|FG000|Extension Study Period|Withdrawal by Subject|5|||
17182528|NCT02499900|38334290|FG001|Extension Study Period|Withdrawal by Subject|2|||
17182529|NCT02499900|38334289|FG000|Extension Study Period|Physician Decision|2|||
17182530|NCT02499900|38334290|FG001|Extension Study Period|Physician Decision|5|||
17182531|NCT02499900|38334289|FG000|Extension Study Period|Pregnancy|1|||
17182532|NCT02499900|38334290|FG001|Extension Study Period|Pregnancy|2|||
17182533|NCT02499900|38334289|FG000|Extension Study Period|Lost to Follow-up|2|||
17182534|NCT02499900|38334290|FG001|Extension Study Period|Lost to Follow-up|5|||
17182535|NCT02499900|38334289|FG000|Extension Study Period|Other|0|||
17182536|NCT02499900|38334290|FG001|Extension Study Period|Other|2|||
17182537|NCT03505749|38334304|FG000|Overall Study|Lost to Follow-up|7|||
17182538|NCT03505749|38334305|FG001|Overall Study|Lost to Follow-up|11|||
17182539|NCT03505749|38334304|FG000|Overall Study|Withdrawal by Subject|6|||
17182540|NCT03505749|38334305|FG001|Overall Study|Withdrawal by Subject|0|||
17182541|NCT03505749|38334304|FG000|Overall Study|Discharged from treatment|3|||
17182542|NCT03505749|38334305|FG001|Overall Study|Discharged from treatment|6|||
17182543|NCT03710642|38334329|FG000|Overall Study|Adverse Event|5|||
17182544|NCT03710642|38334330|FG001|Overall Study|Adverse Event|1|||
17182545|NCT03710642|38334329|FG000|Overall Study|non-site physician recommendation|1|||
17182546|NCT03710642|38334330|FG001|Overall Study|non-site physician recommendation|0|||
17182547|NCT03710642|38334329|FG000|Overall Study|Participant unwilling or unable to participate|1|||
17182548|NCT03710642|38334330|FG001|Overall Study|Participant unwilling or unable to participate|1|||
17182549|NCT03710642|38334329|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
17182550|NCT03710642|38334330|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
17182551|NCT03710642|38334329|FG000|Overall Study|NA-no code provided|1|||
17182552|NCT03710642|38334330|FG001|Overall Study|NA-no code provided|0|||
17182553|NCT03710642|38334329|FG000|Overall Study|Withdrawal by Subject|1|||
17182554|NCT03710642|38334330|FG001|Overall Study|Withdrawal by Subject|0|||
17182555|NCT00705224|38334336|FG000|Overall Study|Adverse Event|1|||
17182556|NCT00705224|38334336|FG000|Overall Study|Lack of Efficacy|2|||
17182557|NCT00705224|38334336|FG000|Overall Study|Withdrawal by Subject|3|||
17182558|NCT00705224|38334336|FG000|Overall Study|Lost to Follow-up|5|||
17182559|NCT02722148|38334343|FG000|Overall Study|Lost to Follow-up|2|||
17182560|NCT02722148|38334343|FG000|Overall Study|Non compliant with treatment regimen|3|||
17182561|NCT00704132|38334349|FG000|Overall Study|Clinical Adverse Experience|1|||
17182562|NCT00704132|38334350|FG001|Overall Study|Clinical Adverse Experience|0|||
17182563|NCT00704132|38334349|FG000|Overall Study|Lack of Efficacy|0|||
17182564|NCT00704132|38334350|FG001|Overall Study|Lack of Efficacy|1|||
17182565|NCT00704132|38334349|FG000|Overall Study|Withdrawal by Subject|0|||
17182566|NCT00704132|38334350|FG001|Overall Study|Withdrawal by Subject|1|||
17182567|NCT01329549|38334365|FG000|Overall Study|Withdrawal by Subject|1|||
17182568|NCT01329549|38334365|FG000|Overall Study|Adverse Event|1|||
17182569|NCT02736474|38334371|FG000|Overall Study|Lost to Follow-up|0|||
17182570|NCT02736474|38334372|FG001|Overall Study|Lost to Follow-up|1|||
17182571|NCT00702650|38334394|FG000|Overall Study|Withdrawal by Subject|9|||
17182572|NCT00702650|38334394|FG000|Overall Study|Non-Compliance of Study Drug|3|||
17182573|NCT00702650|38334394|FG000|Overall Study|Lost to Follow-up|2|||
17182574|NCT00702650|38334394|FG000|Overall Study|Non-Compliance with Site Directives|1|||
17182575|NCT00702650|38334394|FG000|Overall Study|Sponsor Request|1|||
17182576|NCT00702650|38334394|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
17182577|NCT00702650|38334394|FG000|Overall Study|Adverse Event|3|||
17182578|NCT03230916|38334409|FG000|Overall Study|Withdrawal by Subject|0|||
17182579|NCT03230916|38334410|FG001|Overall Study|Withdrawal by Subject|0|||
17182580|NCT03230916|38334411|FG002|Overall Study|Withdrawal by Subject|0|||
17182581|NCT03230916|38334412|FG003|Overall Study|Withdrawal by Subject|0|||
17182582|NCT03230916|38334413|FG004|Overall Study|Withdrawal by Subject|0|||
17182583|NCT03230916|38334414|FG005|Overall Study|Withdrawal by Subject|1|||
17182584|NCT03230916|38334415|FG006|Overall Study|Withdrawal by Subject|0|||
17182585|NCT03230916|38334416|FG007|Overall Study|Withdrawal by Subject|0|||
17182586|NCT03230916|38334417|FG008|Overall Study|Withdrawal by Subject|0|||
17182587|NCT03230916|38334418|FG009|Overall Study|Withdrawal by Subject|0|||
17182588|NCT03230916|38334419|FG010|Overall Study|Withdrawal by Subject|0|||
17182589|NCT01337115|38334462|FG000|Overall Study|Protocol Violation|2|||
17182590|NCT01337115|38334463|FG001|Overall Study|Protocol Violation|0|||
17182591|NCT03761784|38334473|FG000|Overall Study|Adverse Event|4|||
17182592|NCT03761784|38334474|FG001|Overall Study|Adverse Event|0|||
17182593|NCT03761784|38334473|FG000|Overall Study|Lost to Follow-up|10|||
17182594|NCT03761784|38334474|FG001|Overall Study|Lost to Follow-up|7|||
17182595|NCT03761784|38334473|FG000|Overall Study|Pregnancy|1|||
17182596|NCT03761784|38334474|FG001|Overall Study|Pregnancy|0|||
17182597|NCT03761784|38334473|FG000|Overall Study|Protocol Violation|2|||
17182598|NCT03761784|38334474|FG001|Overall Study|Protocol Violation|0|||
17182599|NCT03761784|38334473|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
17182600|NCT03761784|38334474|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
17182601|NCT03761784|38334473|FG000|Overall Study|Withdrawal by Subject|9|||
17182602|NCT03761784|38334474|FG001|Overall Study|Withdrawal by Subject|4|||
17182603|NCT03761784|38334473|FG000|Overall Study|Physician Decision|1|||
17182604|NCT03761784|38334474|FG001|Overall Study|Physician Decision|0|||
17182605|NCT03761784|38334473|FG000|Overall Study|Other Than Specified|1|||
17182606|NCT03761784|38334474|FG001|Overall Study|Other Than Specified|0|||
17182607|NCT03195894|38334482|FG000|Overall Study|"An example is Started other treatment."|4|||
17182608|NCT03195894|38334483|FG001|Overall Study|"An example is Started other treatment."|5|||
17182609|NCT03195894|38334482|FG000|Overall Study|Withdrawal by Subject|15|||
17182610|NCT03195894|38334483|FG001|Overall Study|Withdrawal by Subject|4|||
17182611|NCT03195894|38334482|FG000|Overall Study|Lost to Follow-up|14|||
17182612|NCT03195894|38334483|FG001|Overall Study|Lost to Follow-up|19|||
17182613|NCT01337973|38334495|FG000|Overall Study|Lost to Follow-up|2|||
17182614|NCT01337973|38334496|FG001|Overall Study|Lost to Follow-up|4|||
17182615|NCT01337973|38334497|FG002|Overall Study|Lost to Follow-up|3|||
17182616|NCT01337973|38334495|FG000|Overall Study|Death|1|||
17182617|NCT01337973|38334496|FG001|Overall Study|Death|2|||
17182618|NCT01337973|38334497|FG002|Overall Study|Death|1|||
17182619|NCT01337973|38334495|FG000|Overall Study|Withdrawal by Subject|10|||
17182620|NCT01337973|38334496|FG001|Overall Study|Withdrawal by Subject|8|||
17182621|NCT01337973|38334497|FG002|Overall Study|Withdrawal by Subject|4|||
17182622|NCT01337973|38334495|FG000|Overall Study|missing data on primary outcome|3|||
17182623|NCT01337973|38334496|FG001|Overall Study|missing data on primary outcome|1|||
17182624|NCT01337973|38334497|FG002|Overall Study|missing data on primary outcome|3|||
17182625|NCT02929056|38334507|FG000|Overall Study|Lost to Follow-up|0|||
17182626|NCT02929056|38334508|FG001|Overall Study|Lost to Follow-up|1|||
17182627|NCT00157755|38334527|FG000|Overall Study|Death|2|||
17182628|NCT00157755|38334528|FG001|Overall Study|Death|3|||
17182629|NCT00157755|38334529|FG002|Overall Study|Death|3|||
17182630|NCT00157755|38334530|FG003|Overall Study|Death|2|||
17182631|NCT00157755|38334531|FG004|Overall Study|Death|0|||
17182632|NCT00157755|38334532|FG005|Overall Study|Death|0|||
17182633|NCT00157755|38334527|FG000|Overall Study|Lost to Follow-up|0|||
17182634|NCT00157755|38334528|FG001|Overall Study|Lost to Follow-up|0|||
17182635|NCT00157755|38334529|FG002|Overall Study|Lost to Follow-up|1|||
17182636|NCT00157755|38334530|FG003|Overall Study|Lost to Follow-up|0|||
17182637|NCT00157755|38334531|FG004|Overall Study|Lost to Follow-up|0|||
17182638|NCT00157755|38334532|FG005|Overall Study|Lost to Follow-up|0|||
17182639|NCT00157755|38334527|FG000|Overall Study|Withdrawal by Subject|0|||
17182640|NCT00157755|38334528|FG001|Overall Study|Withdrawal by Subject|0|||
17182641|NCT00157755|38334529|FG002|Overall Study|Withdrawal by Subject|1|||
17182642|NCT00157755|38334530|FG003|Overall Study|Withdrawal by Subject|1|||
17182643|NCT00157755|38334531|FG004|Overall Study|Withdrawal by Subject|1|||
17182644|NCT00157755|38334532|FG005|Overall Study|Withdrawal by Subject|2|||
17182645|NCT00157755|38334527|FG000|Overall Study|Explant due to infection|0|||
17182646|NCT00157755|38334528|FG001|Overall Study|Explant due to infection|0|||
17182647|NCT00157755|38334529|FG002|Overall Study|Explant due to infection|1|||
17182648|NCT00157755|38334530|FG003|Overall Study|Explant due to infection|0|||
17182649|NCT00157755|38334531|FG004|Overall Study|Explant due to infection|0|||
17182650|NCT00157755|38334532|FG005|Overall Study|Explant due to infection|0|||
17182651|NCT00157755|38334527|FG000|Overall Study|Medical reason|0|||
17182652|NCT00157755|38334528|FG001|Overall Study|Medical reason|0|||
17182653|NCT00157755|38334529|FG002|Overall Study|Medical reason|1|||
17182654|NCT00157755|38334530|FG003|Overall Study|Medical reason|1|||
17182655|NCT00157755|38334531|FG004|Overall Study|Medical reason|0|||
17182656|NCT00157755|38334532|FG005|Overall Study|Medical reason|0|||
17182657|NCT00157755|38334527|FG000|Overall Study|Study site closure|0|||
17182658|NCT00157755|38334528|FG001|Overall Study|Study site closure|1|||
17182659|NCT00157755|38334529|FG002|Overall Study|Study site closure|0|||
17182660|NCT00157755|38334530|FG003|Overall Study|Study site closure|0|||
17182661|NCT00157755|38334531|FG004|Overall Study|Study site closure|0|||
17182662|NCT00157755|38334532|FG005|Overall Study|Study site closure|0|||
17182663|NCT00157755|38334527|FG000|Overall Study|Subject non-compliance|0|||
17182664|NCT00157755|38334528|FG001|Overall Study|Subject non-compliance|0|||
17182665|NCT00157755|38334529|FG002|Overall Study|Subject non-compliance|0|||
17182666|NCT00157755|38334530|FG003|Overall Study|Subject non-compliance|0|||
17182667|NCT00157755|38334531|FG004|Overall Study|Subject non-compliance|0|||
17182668|NCT00157755|38334532|FG005|Overall Study|Subject non-compliance|1|||
17182669|NCT00157755|38334527|FG000|Overall Study|Study completion|0|||
17182670|NCT00157755|38334528|FG001|Overall Study|Study completion|0|||
17182671|NCT00157755|38334529|FG002|Overall Study|Study completion|0|||
17182672|NCT00157755|38334530|FG003|Overall Study|Study completion|0|||
17182673|NCT00157755|38334531|FG004|Overall Study|Study completion|1|||
17182674|NCT00157755|38334532|FG005|Overall Study|Study completion|2|||
17182675|NCT02723006|38334541|FG000|Overall Study|Withdrawal by Subject|0|||
17182676|NCT02723006|38334542|FG001|Overall Study|Withdrawal by Subject|1|||
17182677|NCT02723006|38334543|FG002|Overall Study|Withdrawal by Subject|1|||
17182678|NCT02723006|38334541|FG000|Overall Study|Study Terminated by Sponsor|1|||
17182679|NCT02723006|38334542|FG001|Overall Study|Study Terminated by Sponsor|6|||
17182680|NCT02723006|38334543|FG002|Overall Study|Study Terminated by Sponsor|6|||
17182681|NCT04003389|38334554|FG000|Overall Study|Adverse Event|27|||
17182682|NCT04003389|38334555|FG001|Overall Study|Adverse Event|34|||
17182683|NCT04003389|38334556|FG002|Overall Study|Adverse Event|28|||
17182684|NCT04003389|38334554|FG000|Overall Study|Lost to Follow-up|39|||
17182685|NCT04003389|38334555|FG001|Overall Study|Lost to Follow-up|30|||
17182686|NCT04003389|38334556|FG002|Overall Study|Lost to Follow-up|33|||
17182687|NCT04003389|38334554|FG000|Overall Study|Protocol Violation|1|||
17182688|NCT04003389|38334555|FG001|Overall Study|Protocol Violation|6|||
17182689|NCT04003389|38334556|FG002|Overall Study|Protocol Violation|5|||
17182690|NCT04003389|38334554|FG000|Overall Study|Withdrawal by Subject|119|||
17182691|NCT04003389|38334555|FG001|Overall Study|Withdrawal by Subject|79|||
17182692|NCT04003389|38334556|FG002|Overall Study|Withdrawal by Subject|85|||
17182693|NCT04003389|38334554|FG000|Overall Study|Miscellaneous|14|||
17182694|NCT04003389|38334555|FG001|Overall Study|Miscellaneous|11|||
17182695|NCT04003389|38334556|FG002|Overall Study|Miscellaneous|14|||
17182696|NCT04003389|38334554|FG000|Overall Study|Participant did not receive study drug|1|||
17182697|NCT04003389|38334555|FG001|Overall Study|Participant did not receive study drug|0|||
17182698|NCT04003389|38334556|FG002|Overall Study|Participant did not receive study drug|0|||
17182699|NCT00702962|38334566|FG000|Overall Study|Progressive disease|0|||
17182700|NCT00702962|38334567|FG001|Overall Study|Progressive disease|1|||
17182701|NCT00702962|38334566|FG000|Overall Study|Hospitalized for other health disorder|1|||
17182702|NCT00702962|38334567|FG001|Overall Study|Hospitalized for other health disorder|0|||
17182703|NCT01379508|38334579|FG000|Treatment to Week 104|Adverse Event|2|||
17182704|NCT01379508|38334580|FG001|Treatment to Week 104|Adverse Event|0|||
17182705|NCT01379508|38334581|FG002|Treatment to Week 104|Adverse Event|5|||
17182706|NCT01379508|38334582|FG003|Treatment to Week 104|Adverse Event|0|||
17182707|NCT01379508|38334579|FG000|Treatment to Week 104|Abnormal lab value|1|||
17182708|NCT01379508|38334580|FG001|Treatment to Week 104|Abnormal lab value|0|||
17182709|NCT01379508|38334581|FG002|Treatment to Week 104|Abnormal lab value|0|||
17182710|NCT01379508|38334582|FG003|Treatment to Week 104|Abnormal lab value|0|||
17182711|NCT01379508|38334579|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
17182712|NCT01379508|38334580|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
17182713|NCT01379508|38334581|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
17182714|NCT01379508|38334582|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
17182715|NCT01379508|38334579|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
17182716|NCT01379508|38334580|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
17182717|NCT01379508|38334581|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
17182718|NCT01379508|38334582|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
17182719|NCT01379508|38334579|FG000|Treatment to Week 104|Lost to Follow-up|5|||
17182720|NCT01379508|38334580|FG001|Treatment to Week 104|Lost to Follow-up|0|||
17182721|NCT01379508|38334581|FG002|Treatment to Week 104|Lost to Follow-up|3|||
17182722|NCT01379508|38334582|FG003|Treatment to Week 104|Lost to Follow-up|0|||
17182723|NCT01379508|38334579|FG000|Treatment to Week 104|Administrative problems|3|||
17182724|NCT01379508|38334580|FG001|Treatment to Week 104|Administrative problems|1|||
17182725|NCT01379508|38334581|FG002|Treatment to Week 104|Administrative problems|0|||
17182726|NCT01379508|38334582|FG003|Treatment to Week 104|Administrative problems|0|||
17182727|NCT01379508|38334579|FG000|Treatment to Week 104|Protocol Violation|1|||
17182728|NCT01379508|38334580|FG001|Treatment to Week 104|Protocol Violation|1|||
17182729|NCT01379508|38334581|FG002|Treatment to Week 104|Protocol Violation|1|||
17182730|NCT01379508|38334582|FG003|Treatment to Week 104|Protocol Violation|0|||
17182731|NCT01379508|38334579|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
17182732|NCT01379508|38334580|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
17182733|NCT01379508|38334581|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
17182734|NCT01379508|38334582|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
17182735|NCT01379508|38334579|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
17182736|NCT01379508|38334580|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
17182737|NCT01379508|38334581|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
17182738|NCT01379508|38334582|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
16997052|NCT00758524|38141150|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
17089278|NCT00288912|38229467|FG000|Overall Study|Withdrawal by Subject|4|||
17089279|NCT00288912|38229468|FG001|Overall Study|Withdrawal by Subject|5|||
17089280|NCT00288912|38229469|FG002|Overall Study|Withdrawal by Subject|12|||
17089281|NCT00305864|38229481|FG000|Overall Study|Ineligible / No protocol treatment|0|||
17089282|NCT00305864|38229482|FG001|Overall Study|Ineligible / No protocol treatment|1|||
17089283|NCT00305864|38229483|FG002|Overall Study|Ineligible / No protocol treatment|1|||
17089284|NCT00305864|38229484|FG003|Overall Study|Ineligible / No protocol treatment|13|||
17089285|NCT00295880|38229494|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
17089286|NCT00295880|38229494|FG000|Overall Study|Unit randomization did not occur|1|||
17089287|NCT00319982|38229500|FG000|Overall Study|Withdrawal by Subject|1|||
16997053|NCT00758524|38141151|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997054|NCT00758524|38141152|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997055|NCT00758524|38141153|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997056|NCT00758524|38141154|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997057|NCT00758524|38141155|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997058|NCT00758524|38141156|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16997059|NCT00758524|38141140|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997060|NCT00758524|38141141|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
16997061|NCT00758524|38141142|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
17089288|NCT00319982|38229501|FG001|Overall Study|Withdrawal by Subject|0|||
17089289|NCT00319592|38229509|FG000|Overall Study|Protocol Violation|1|||
17089290|NCT00319592|38229510|FG001|Overall Study|Protocol Violation|0|||
17089291|NCT00319592|38229509|FG000|Overall Study|Physician Decision|0|||
16997062|NCT00758524|38141143|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
17089292|NCT00319592|38229510|FG001|Overall Study|Physician Decision|1|||
17089293|NCT00295490|38229520|FG000|Overall Study|Protocol Violation|0|||
16997063|NCT00758524|38141144|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
16997064|NCT00758524|38141145|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
16997065|NCT00758524|38141146|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997066|NCT00758524|38141147|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997067|NCT00758524|38141148|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997068|NCT00758524|38141149|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997069|NCT00758524|38141150|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997070|NCT00758524|38141151|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
17089294|NCT00295490|38229521|FG001|Overall Study|Protocol Violation|0|||
17089295|NCT00295490|38229522|FG002|Overall Study|Protocol Violation|3|||
17089296|NCT00295490|38229523|FG003|Overall Study|Protocol Violation|3|||
17089297|NCT00295490|38229520|FG000|Overall Study|Withdrawal by Subject|0|||
17089298|NCT00295490|38229521|FG001|Overall Study|Withdrawal by Subject|2|||
17089299|NCT00295490|38229522|FG002|Overall Study|Withdrawal by Subject|0|||
17089300|NCT00295490|38229523|FG003|Overall Study|Withdrawal by Subject|1|||
17089301|NCT00295490|38229520|FG000|Overall Study|Lost to Follow-up|0|||
17089302|NCT00295490|38229521|FG001|Overall Study|Lost to Follow-up|0|||
17089303|NCT00295490|38229522|FG002|Overall Study|Lost to Follow-up|1|||
17089304|NCT00295490|38229523|FG003|Overall Study|Lost to Follow-up|0|||
16997071|NCT00758524|38141152|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997072|NCT00758524|38141153|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997073|NCT00758524|38141154|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997074|NCT00758524|38141155|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997075|NCT00758524|38141156|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16997076|NCT00758524|38141140|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
17089305|NCT00295490|38229520|FG000|Overall Study|Adverse Event|1|||
17089306|NCT00295490|38229521|FG001|Overall Study|Adverse Event|0|||
17089307|NCT00295490|38229522|FG002|Overall Study|Adverse Event|0|||
17089308|NCT00295490|38229523|FG003|Overall Study|Adverse Event|0|||
17089309|NCT00295490|38229520|FG000|Overall Study|Other|0|||
17089310|NCT00295490|38229521|FG001|Overall Study|Other|2|||
17089311|NCT00295490|38229522|FG002|Overall Study|Other|0|||
17089312|NCT00295490|38229523|FG003|Overall Study|Other|1|||
17089313|NCT00305006|38229535|FG000|Overall Study|Withdrawal by Subject|1|||
17089314|NCT00305006|38229536|FG001|Overall Study|Withdrawal by Subject|0|||
17089315|NCT00305006|38229535|FG000|Overall Study|Failure to complete pretest|0|||
17089316|NCT00305006|38229536|FG001|Overall Study|Failure to complete pretest|1|||
17089317|NCT00319436|38229544|FG000|Overall Study|Withdrawal by Subject|6|||
17089318|NCT00319436|38229545|FG001|Overall Study|Withdrawal by Subject|7|||
17089319|NCT00319046|38229551|FG000|Overall Study|withdrawal of subject's consent|7|||
17089320|NCT00319046|38229551|FG000|Overall Study|administrative reason|1|||
17089321|NCT00303602|38229557|FG000|Overall Study|Adverse Event|2|||
17089322|NCT00303602|38229558|FG001|Overall Study|Adverse Event|2|||
17089323|NCT00303602|38229557|FG000|Overall Study|Withdrawal by Subject|5|||
17089324|NCT00303602|38229558|FG001|Overall Study|Withdrawal by Subject|6|||
17089325|NCT00303602|38229557|FG000|Overall Study|Lost to Follow-up|5|||
17182739|NCT01379508|38334579|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
17182740|NCT01379508|38334580|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
17182741|NCT01379508|38334581|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
17182742|NCT01379508|38334582|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
17182743|NCT01379508|38334579|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
17182744|NCT01379508|38334580|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
17182745|NCT01379508|38334581|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
17182746|NCT01379508|38334582|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
17182747|NCT02722928|38334598|FG000|Overall Study|Standard CT was not as required per prot|5|||
17182748|NCT02722928|38334599|FG001|Overall Study|Standard CT was not as required per prot|13|||
17182749|NCT02722928|38334598|FG000|Overall Study|Required Intraoperative MRI|5|||
17182750|NCT02722928|38334599|FG001|Overall Study|Required Intraoperative MRI|7|||
17182751|NCT02519439|38334609|FG000|Overall Study|Study Termination|19|||
17182752|NCT02519439|38334609|FG000|Overall Study|Withdrawal by Subject|1|||
17182753|NCT02519439|38334609|FG000|Overall Study|Adverse Event|1|||
17182754|NCT02722304|38334618|FG000|Overall Study|Study Terminated by Sponsor|1|||
17182755|NCT02722304|38334619|FG001|Overall Study|Study Terminated by Sponsor|0|||
17182756|NCT02722304|38334620|FG002|Overall Study|Study Terminated by Sponsor|2|||
17182757|NCT02722304|38334621|FG003|Overall Study|Study Terminated by Sponsor|1|||
17182758|NCT02722304|38334622|FG004|Overall Study|Study Terminated by Sponsor|1|||
17182759|NCT02722304|38334618|FG000|Overall Study|Other|0|||
17182760|NCT02722304|38334619|FG001|Overall Study|Other|0|||
17182761|NCT02722304|38334620|FG002|Overall Study|Other|0|||
17182762|NCT02722304|38334621|FG003|Overall Study|Other|1|||
17182763|NCT02722304|38334622|FG004|Overall Study|Other|1|||
17182764|NCT00709956|38334638|FG000|Overall Study|Withdrawal by Subject|1|||
17182765|NCT00709956|38334639|FG001|Overall Study|Withdrawal by Subject|1|||
17182766|NCT00709956|38334638|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
17182767|NCT00709956|38334639|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
17182768|NCT02719028|38334669|FG000|Overall Study|Adverse Event|2|||
17182769|NCT02719028|38334670|FG001|Overall Study|Adverse Event|1|||
17182770|NCT02719028|38334671|FG002|Overall Study|Adverse Event|4|||
17182771|NCT02719028|38334672|FG003|Overall Study|Adverse Event|8|||
17182772|NCT02719028|38334669|FG000|Overall Study|Physician Decision|0|||
17182773|NCT02719028|38334670|FG001|Overall Study|Physician Decision|1|||
17182774|NCT02719028|38334671|FG002|Overall Study|Physician Decision|1|||
17182775|NCT02719028|38334672|FG003|Overall Study|Physician Decision|1|||
17182776|NCT02719028|38334669|FG000|Overall Study|Use of prohibited medication|0|||
17182777|NCT02719028|38334670|FG001|Overall Study|Use of prohibited medication|0|||
17182778|NCT02719028|38334671|FG002|Overall Study|Use of prohibited medication|1|||
17182779|NCT02719028|38334672|FG003|Overall Study|Use of prohibited medication|0|||
17182780|NCT02719028|38334669|FG000|Overall Study|Protocol Violation|0|||
17182781|NCT02719028|38334670|FG001|Overall Study|Protocol Violation|0|||
17182782|NCT02719028|38334671|FG002|Overall Study|Protocol Violation|0|||
17182783|NCT02719028|38334672|FG003|Overall Study|Protocol Violation|1|||
17182784|NCT02720510|38334684|FG000|Overall Study|Study Terminated by the sponsor|2|||
17182785|NCT02720510|38334685|FG001|Overall Study|Study Terminated by the sponsor|0|||
17182786|NCT02720510|38334684|FG000|Overall Study|Adverse Event|0|||
17182787|NCT02720510|38334685|FG001|Overall Study|Adverse Event|1|||
17182788|NCT02720510|38334684|FG000|Overall Study|Physician Decision|1|||
17182789|NCT02720510|38334685|FG001|Overall Study|Physician Decision|2|||
17182790|NCT02720198|38334693|FG000|Overall Study|Withdrawal by Subject|0|||
17182791|NCT02720198|38334694|FG001|Overall Study|Withdrawal by Subject|1|||
17182792|NCT00703118|38334716|FG000|Overall Study|Adverse Event|1|||
17182793|NCT00703118|38334717|FG001|Overall Study|Adverse Event|2|||
17182794|NCT00703118|38334718|FG002|Overall Study|Adverse Event|2|||
17182795|NCT00703118|38334716|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
17182796|NCT00703118|38334717|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
17182797|NCT00703118|38334718|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
17182798|NCT00703118|38334716|FG000|Overall Study|Lost to Follow-up|6|||
17182799|NCT00703118|38334717|FG001|Overall Study|Lost to Follow-up|4|||
17182800|NCT00703118|38334718|FG002|Overall Study|Lost to Follow-up|4|||
17182801|NCT00703118|38334716|FG000|Overall Study|Withdrawal by Subject|8|||
17182802|NCT00703118|38334717|FG001|Overall Study|Withdrawal by Subject|7|||
17182803|NCT00703118|38334718|FG002|Overall Study|Withdrawal by Subject|13|||
17182804|NCT00703118|38334716|FG000|Overall Study|Other|0|||
17182805|NCT00703118|38334717|FG001|Overall Study|Other|0|||
17182806|NCT00703118|38334718|FG002|Overall Study|Other|1|||
17182807|NCT00909753|38334740|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
17182808|NCT00909753|38334741|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
17182809|NCT00909753|38334740|FG000|Period: Second Intervention|Protocol Violation|1|||
17182810|NCT00909753|38334741|FG001|Period: Second Intervention|Protocol Violation|0|||
17182811|NCT03745638|38334748|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
17182812|NCT03745638|38334749|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
17182813|NCT03745638|38334750|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
17182814|NCT03745638|38334751|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
17182815|NCT03745638|38334752|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
17182816|NCT03745638|38334753|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
17182817|NCT03745638|38334754|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
17182818|NCT03745638|38334748|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
17182819|NCT03745638|38334749|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17182820|NCT03745638|38334750|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17182821|NCT03745638|38334751|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17182822|NCT03745638|38334752|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17182823|NCT03745638|38334753|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17182824|NCT03745638|38334754|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17182825|NCT03745638|38334748|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
17182826|NCT03745638|38334749|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
17182827|NCT03745638|38334750|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
17182828|NCT03745638|38334751|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17182829|NCT03745638|38334752|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17182830|NCT03745638|38334753|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17182831|NCT03745638|38334754|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17182832|NCT03745638|38334748|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
17182833|NCT03745638|38334749|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
17182834|NCT03745638|38334750|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
17182835|NCT03745638|38334751|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
17182836|NCT03745638|38334752|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
17182837|NCT03745638|38334753|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
17182838|NCT03745638|38334754|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
17182839|NCT03745638|38334748|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
17182840|NCT03745638|38334749|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
17182841|NCT03745638|38334750|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
17182842|NCT03745638|38334751|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
17182843|NCT03745638|38334752|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
17182844|NCT03745638|38334753|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
17182845|NCT03745638|38334754|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
17182846|NCT03745638|38334748|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
17182847|NCT03745638|38334749|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
17182848|NCT03745638|38334750|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
17182849|NCT03745638|38334751|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
17182850|NCT03745638|38334752|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
17182851|NCT03745638|38334753|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
17182852|NCT03745638|38334754|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
17182853|NCT03745638|38334748|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
17182854|NCT03745638|38334749|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
17182855|NCT03745638|38334750|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
17182856|NCT03745638|38334751|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17182857|NCT03745638|38334752|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17182858|NCT03745638|38334753|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17182859|NCT03745638|38334754|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17182860|NCT03745638|38334748|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
17182861|NCT03745638|38334749|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
17182862|NCT03745638|38334750|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
17182863|NCT03745638|38334751|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
17182864|NCT03745638|38334752|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
17182865|NCT03745638|38334753|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
17089326|NCT00303602|38229558|FG001|Overall Study|Lost to Follow-up|2|||
17089327|NCT00303602|38229557|FG000|Overall Study|Protocol entry criteria not met|2|||
17089328|NCT00303602|38229558|FG001|Overall Study|Protocol entry criteria not met|2|||
17089329|NCT00303602|38229557|FG000|Overall Study|Physician Decision|2|||
17089330|NCT00303602|38229558|FG001|Overall Study|Physician Decision|1|||
17089331|NCT00303602|38229557|FG000|Overall Study|Noncompliance|2|||
17089332|NCT00303602|38229558|FG001|Overall Study|Noncompliance|2|||
17089333|NCT00303602|38229557|FG000|Overall Study|Protocol Violation|1|||
17089334|NCT00303602|38229558|FG001|Overall Study|Protocol Violation|0|||
17089335|NCT00299130|38229567|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
17089336|NCT00299130|38229568|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
17089337|NCT00299130|38229569|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
17089338|NCT00299130|38229567|FG000|Treatment Period (up to 5 Years)|Death|1|||
17182866|NCT03745638|38334754|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
17182867|NCT03745638|38334748|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
17182868|NCT03745638|38334749|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
17182869|NCT03745638|38334750|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
17182870|NCT03745638|38334751|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
17182871|NCT03745638|38334752|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
17182872|NCT03745638|38334753|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
17182873|NCT03745638|38334754|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
17182874|NCT03745638|38334748|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
17182875|NCT03745638|38334749|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
17182876|NCT03745638|38334750|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
17182877|NCT03745638|38334751|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
17182878|NCT03745638|38334752|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
17182879|NCT03745638|38334753|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
17182880|NCT03745638|38334754|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
17182881|NCT03745638|38334748|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
17182882|NCT03745638|38334749|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
17182883|NCT03745638|38334750|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
17182884|NCT03745638|38334751|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
17182885|NCT03745638|38334752|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
17182886|NCT03745638|38334753|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
17182887|NCT03745638|38334754|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
17182888|NCT03745638|38334748|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
17182889|NCT03745638|38334749|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
17182890|NCT03745638|38334750|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
17182891|NCT03745638|38334751|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
17182892|NCT03745638|38334752|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
17182893|NCT03745638|38334753|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
17182894|NCT03745638|38334754|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
17182895|NCT03745638|38334748|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17182896|NCT03745638|38334749|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17182897|NCT03745638|38334750|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17182898|NCT03745638|38334751|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17182899|NCT03745638|38334752|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17182900|NCT03745638|38334753|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
17182901|NCT03745638|38334754|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
17182902|NCT03745638|38334748|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
17182903|NCT03745638|38334749|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
17182904|NCT03745638|38334750|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
17182905|NCT03745638|38334751|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
17182906|NCT03745638|38334752|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
17182907|NCT03745638|38334753|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
17182908|NCT03745638|38334754|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
17182909|NCT03745638|38334748|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
17182910|NCT03745638|38334749|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
17182911|NCT03745638|38334750|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
17182912|NCT03745638|38334751|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
17182913|NCT03745638|38334752|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
17182914|NCT03745638|38334753|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
17182915|NCT03745638|38334754|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
17182916|NCT03715764|38334773|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
17182917|NCT03715764|38334774|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
17182918|NCT03715764|38334773|FG000|3 Month Follow-up|Lost to Follow-up|2|||
17182919|NCT03715764|38334774|FG001|3 Month Follow-up|Lost to Follow-up|2|||
17182920|NCT03715764|38334773|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
17182921|NCT03715764|38334774|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
17182922|NCT03715764|38334773|FG000|6 Month Follow-up|Lost to Follow-up|3|||
17182923|NCT03715764|38334774|FG001|6 Month Follow-up|Lost to Follow-up|0|||
17182924|NCT03715764|38334773|FG000|12 Month Follow-up|Lost to Follow-up|2|||
17182925|NCT03715764|38334774|FG001|12 Month Follow-up|Lost to Follow-up|3|||
17182926|NCT03715764|38334773|FG000|12 Month Follow-up|Pregnancy|0|||
17182927|NCT03715764|38334774|FG001|12 Month Follow-up|Pregnancy|1|||
17182928|NCT03715764|38334773|FG000|12 Month Follow-up|Surgery|2|||
17182929|NCT03715764|38334774|FG001|12 Month Follow-up|Surgery|0|||
17182930|NCT03715764|38334773|FG000|12 Month Follow-up|Wrong address|1|||
17182931|NCT03715764|38334774|FG001|12 Month Follow-up|Wrong address|0|||
17182932|NCT03715764|38334773|FG000|12 Month Follow-up|No symptoms|1|||
17182933|NCT03715764|38334774|FG001|12 Month Follow-up|No symptoms|0|||
17182934|NCT03715764|38334773|FG000|12 Month Follow-up|Changed primary care centre|0|||
17182935|NCT03715764|38334774|FG001|12 Month Follow-up|Changed primary care centre|1|||
17182936|NCT02718326|38334783|FG000|Overall Study|Adverse Event|4|||
17182937|NCT02718326|38334784|FG001|Overall Study|Adverse Event|9|||
17182938|NCT02718326|38334785|FG002|Overall Study|Adverse Event|0|||
17182939|NCT02718326|38334783|FG000|Overall Study|Death|8|||
17182940|NCT02718326|38334784|FG001|Overall Study|Death|1|||
17182941|NCT02718326|38334785|FG002|Overall Study|Death|2|||
17182942|NCT02718326|38334783|FG000|Overall Study|Withdrawal by Subject|4|||
17182943|NCT02718326|38334784|FG001|Overall Study|Withdrawal by Subject|9|||
17182944|NCT02718326|38334785|FG002|Overall Study|Withdrawal by Subject|6|||
17182945|NCT02718326|38334783|FG000|Overall Study|Lost to Follow-up|18|||
17182946|NCT02718326|38334784|FG001|Overall Study|Lost to Follow-up|5|||
17182947|NCT02718326|38334785|FG002|Overall Study|Lost to Follow-up|14|||
17182948|NCT02718326|38334783|FG000|Overall Study|Protocol Deviation|1|||
17182949|NCT02718326|38334784|FG001|Overall Study|Protocol Deviation|0|||
17182950|NCT02718326|38334785|FG002|Overall Study|Protocol Deviation|0|||
17182951|NCT02718326|38334783|FG000|Overall Study|Pregnancy|1|||
17182952|NCT02718326|38334784|FG001|Overall Study|Pregnancy|0|||
17182953|NCT02718326|38334785|FG002|Overall Study|Pregnancy|0|||
17182954|NCT03600714|38334795|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
17182955|NCT02720042|38334834|FG000|Overall Study|Death|3|||
17182956|NCT02720042|38334834|FG000|Overall Study|Lost to Follow-up|4|||
17182957|NCT02720042|38334834|FG000|Overall Study|Withdrawal by Subject|1|||
17182958|NCT02720042|38334834|FG000|Overall Study|Physician Decision|3|||
17182959|NCT02720042|38334834|FG000|Overall Study|Phasix Mesh explanted|1|||
17182960|NCT02720042|38334834|FG000|Overall Study|unable due to non-study-related illness|3|||
17182961|NCT01352793|38334840|FG000|Overall Study|Lost to Follow-up|289|||
17182962|NCT01352793|38334841|FG001|Overall Study|Lost to Follow-up|125|||
17182963|NCT01352793|38334840|FG000|Overall Study|Withdrawal by Subject|120|||
17182964|NCT01352793|38334841|FG001|Overall Study|Withdrawal by Subject|55|||
17182965|NCT01352793|38334840|FG000|Overall Study|Protocol Violation|44|||
17182966|NCT01352793|38334841|FG001|Overall Study|Protocol Violation|23|||
17182967|NCT01352793|38334840|FG000|Overall Study|Adverse Event|44|||
17182968|NCT01352793|38334841|FG001|Overall Study|Adverse Event|10|||
17182969|NCT01352793|38334840|FG000|Overall Study|Physician Decision|1|||
17182970|NCT01352793|38334841|FG001|Overall Study|Physician Decision|0|||
17182971|NCT01352793|38334840|FG000|Overall Study|Pregnancy|26|||
17182972|NCT01352793|38334841|FG001|Overall Study|Pregnancy|8|||
17182973|NCT01352793|38334840|FG000|Overall Study|Other|25|||
17182974|NCT01352793|38334841|FG001|Overall Study|Other|7|||
17182975|NCT01352793|38334840|FG000|Overall Study|Medication error|2|||
17182976|NCT01352793|38334841|FG001|Overall Study|Medication error|2|||
17182977|NCT01352793|38334840|FG000|Overall Study|Death|1|||
17182978|NCT01352793|38334841|FG001|Overall Study|Death|0|||
17182979|NCT01352793|38334840|FG000|Overall Study|Randomized but not vaccinated|8|||
17182980|NCT01352793|38334841|FG001|Overall Study|Randomized but not vaccinated|0|||
17182981|NCT01352793|38334840|FG000|Overall Study|No longer meets eligibility criteria|25|||
17182982|NCT01352793|38334841|FG001|Overall Study|No longer meets eligibility criteria|15|||
17182983|NCT02717546|38334847|FG000|Overall Study|Lost to Follow-up|12|||
17182984|NCT01378962|38334851|FG000|Overall Study|Death|14|||
17182985|NCT01378962|38334851|FG000|Overall Study|Lost to Follow-up|1|||
17182986|NCT01378962|38334851|FG000|Overall Study|Other|2|||
17182987|NCT00890409|38334857|FG000|Overall Study|Lost to Follow-up|20|||
17182988|NCT00890409|38334858|FG001|Overall Study|Lost to Follow-up|21|||
17182989|NCT04495478|38334869|FG000|Overall Study|Withdrawal by Subject|0|||
17182990|NCT04495478|38334870|FG001|Overall Study|Withdrawal by Subject|0|||
17182991|NCT04495478|38334871|FG002|Overall Study|Withdrawal by Subject|0|||
17182992|NCT04495478|38334872|FG003|Overall Study|Withdrawal by Subject|1|||
17182993|NCT04495478|38334873|FG004|Overall Study|Withdrawal by Subject|0|||
17182994|NCT04495478|38334874|FG005|Overall Study|Withdrawal by Subject|0|||
17182995|NCT04495478|38334875|FG006|Overall Study|Withdrawal by Subject|0|||
17182996|NCT04495478|38334869|FG000|Overall Study|Physician Decision|0|||
17182997|NCT04495478|38334870|FG001|Overall Study|Physician Decision|1|||
17182998|NCT04495478|38334871|FG002|Overall Study|Physician Decision|0|||
17182999|NCT04495478|38334872|FG003|Overall Study|Physician Decision|0|||
17183000|NCT04495478|38334873|FG004|Overall Study|Physician Decision|1|||
17183001|NCT04495478|38334874|FG005|Overall Study|Physician Decision|0|||
17183002|NCT04495478|38334875|FG006|Overall Study|Physician Decision|0|||
17183003|NCT00152763|38334901|FG000|Overall Study|Death|4|||
17183004|NCT00152763|38334902|FG001|Overall Study|Death|1|||
17183005|NCT00152763|38334903|FG002|Overall Study|Death|2|||
17183006|NCT00152763|38334904|FG003|Overall Study|Death|1|||
17183007|NCT00152763|38334901|FG000|Overall Study|Lost to Follow-up|6|||
17183008|NCT00152763|38334902|FG001|Overall Study|Lost to Follow-up|4|||
17183009|NCT00152763|38334903|FG002|Overall Study|Lost to Follow-up|2|||
17183010|NCT00152763|38334904|FG003|Overall Study|Lost to Follow-up|13|||
17183011|NCT03181542|38334918|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
17183012|NCT03181542|38334919|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
17183013|NCT00806403|38334927|FG000|Overall Study|Death|4|||
17183014|NCT00806403|38334928|FG001|Overall Study|Death|3|||
17183015|NCT00701558|38334945|FG000|Overall Study|Death|7|||
17183016|NCT00701558|38334945|FG000|Overall Study|Lost to Follow-up|8|||
17183017|NCT01663402|38334951|FG000|Overall Study|Randomized but not treated|19|||
17183018|NCT01663402|38334952|FG001|Overall Study|Randomized but not treated|11|||
17183019|NCT01663402|38334951|FG000|Overall Study|Adverse Event|347|||
17183020|NCT01663402|38334952|FG001|Overall Study|Adverse Event|362|||
17183021|NCT01663402|38334951|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
17183022|NCT01663402|38334952|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
17183023|NCT01663402|38334951|FG000|Overall Study|Poor compliance to protocol|529|||
17183024|NCT01663402|38334952|FG001|Overall Study|Poor compliance to protocol|454|||
17183025|NCT01663402|38334951|FG000|Overall Study|Physician Decision|77|||
17183026|NCT01663402|38334952|FG001|Overall Study|Physician Decision|62|||
17183027|NCT01663402|38334951|FG000|Overall Study|Site terminated by sponsor|1|||
17183028|NCT01663402|38334952|FG001|Overall Study|Site terminated by sponsor|3|||
17183029|NCT01663402|38334951|FG000|Overall Study|Participant moved|139|||
17183030|NCT01663402|38334952|FG001|Overall Study|Participant moved|104|||
17183031|NCT01663402|38334951|FG000|Overall Study|Withdrawal by Subject|118|||
17183032|NCT01663402|38334952|FG001|Overall Study|Withdrawal by Subject|91|||
17183033|NCT01663402|38334951|FG000|Overall Study|Related to study drug administration|96|||
17183034|NCT01663402|38334952|FG001|Overall Study|Related to study drug administration|105|||
17183035|NCT01663402|38334951|FG000|Overall Study|Lost to Follow-up|17|||
17183036|NCT01663402|38334952|FG001|Overall Study|Lost to Follow-up|15|||
17183037|NCT01663402|38334951|FG000|Overall Study|Other than specified above|172|||
17183038|NCT01663402|38334952|FG001|Overall Study|Other than specified above|147|||
17183039|NCT00859521|38334969|FG000|Washout|Withdrawal by Subject|0|||
17183040|NCT00859521|38334970|FG001|Washout|Withdrawal by Subject|1|||
17183041|NCT00841815|38334985|FG000|Washout|Withdrawal by Subject|0|||
17183042|NCT00841815|38334986|FG001|Washout|Withdrawal by Subject|1|||
17183043|NCT00841659|38334993|FG000|Washout: 2 Weeks|Protocol Violation|1|||
17183044|NCT00841659|38334994|FG001|Washout: 2 Weeks|Protocol Violation|0|||
17183045|NCT02716298|38334998|FG000|First Intervention (1 Month)|Lens discomfort|1|||
17183046|NCT02716298|38334999|FG001|First Intervention (1 Month)|Lens discomfort|1|||
17183047|NCT00840879|38335012|FG000|Second Intervention|Withdrawal by Subject|1|||
17183048|NCT00840879|38335013|FG001|Second Intervention|Withdrawal by Subject|0|||
17183049|NCT00840411|38335028|FG000|First Intervention|Adverse Event|1|||
17183050|NCT00840411|38335029|FG001|First Intervention|Adverse Event|0|||
17183051|NCT00840411|38335028|FG000|Washout|Withdrawal by Subject|1|||
17183052|NCT00840411|38335029|FG001|Washout|Withdrawal by Subject|0|||
17183053|NCT00836901|38335042|FG000|First Intervention|Withdrawal by Subject|1|||
17183054|NCT00836901|38335043|FG001|First Intervention|Withdrawal by Subject|0|||
17183055|NCT04466384|38335047|FG000|First Phase|Protocol Violation|1|||
17183056|NCT04466384|38335048|FG001|First Phase|Protocol Violation|0|||
17183057|NCT04466384|38335047|FG000|First Phase|Missing data|1|||
17183058|NCT04466384|38335048|FG001|First Phase|Missing data|0|||
17183059|NCT04466384|38335047|FG000|Cross Over Phase|Physician Decision|1|||
17183060|NCT04466384|38335048|FG001|Cross Over Phase|Physician Decision|0|||
17183061|NCT04466384|38335047|FG000|Cross Over Phase|Withdrawal by Subject|0|||
17183062|NCT04466384|38335048|FG001|Cross Over Phase|Withdrawal by Subject|1|||
17183063|NCT03050814|38335059|FG000|Overall Study|Screen failures|0|||
17183064|NCT03050814|38335060|FG001|Overall Study|Screen failures|0|||
17183065|NCT03050814|38335061|FG002|Overall Study|Screen failures|4|||
17183066|NCT00835575|38335069|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
17183067|NCT00835575|38335070|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
17183068|NCT04601194|38335074|FG000|Overall Study|Lost to Follow-up|7|||
17183069|NCT00835263|38335087|FG000|Second Intervention|Adverse Event|1|||
17183070|NCT00835263|38335088|FG001|Second Intervention|Adverse Event|0|||
17183071|NCT01963208|38335126|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
17183072|NCT01963208|38335127|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
17183073|NCT01963208|38335128|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
17183074|NCT01963208|38335129|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
17183075|NCT01963208|38335130|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
17183076|NCT01963208|38335131|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
17183077|NCT01963208|38335126|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
17183078|NCT01963208|38335127|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
17183079|NCT01963208|38335128|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
17183080|NCT01963208|38335129|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
17183081|NCT01963208|38335130|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
17183082|NCT01963208|38335131|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
17183083|NCT01963208|38335126|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
17183084|NCT01963208|38335127|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
17183085|NCT01963208|38335128|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
17183086|NCT01963208|38335129|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
17183087|NCT01963208|38335130|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
17183088|NCT01963208|38335131|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
17183089|NCT01963208|38335126|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
17183090|NCT01963208|38335127|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
17183091|NCT01963208|38335128|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
17183092|NCT01963208|38335129|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
17183093|NCT01963208|38335130|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
17183094|NCT01963208|38335131|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
17183095|NCT01963208|38335126|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
17183096|NCT01963208|38335127|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
17183097|NCT01963208|38335128|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
17183098|NCT01963208|38335129|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
17183099|NCT01963208|38335130|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
17183100|NCT01963208|38335131|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
17183101|NCT01963208|38335126|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
17183102|NCT01963208|38335127|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
17183103|NCT01963208|38335128|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
17183104|NCT01963208|38335129|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
17089339|NCT00299130|38229568|FG001|Treatment Period (up to 5 Years)|Death|3|||
17089340|NCT00299130|38229569|FG002|Treatment Period (up to 5 Years)|Death|1|||
17089341|NCT00299130|38229567|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
17089342|NCT00299130|38229568|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
17089343|NCT00299130|38229569|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
17089344|NCT00299130|38229567|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
17089345|NCT00299130|38229568|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
17089346|NCT00299130|38229569|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
17089347|NCT00299130|38229567|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
17089348|NCT00299130|38229568|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
17089349|NCT00299130|38229569|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
17089350|NCT00299130|38229567|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
17089351|NCT00299130|38229568|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
17089352|NCT00299130|38229569|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
17089353|NCT00299130|38229567|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
17089354|NCT00299130|38229568|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
17089355|NCT00299130|38229569|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
17089356|NCT00299130|38229567|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
16997077|NCT00758524|38141141|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997078|NCT00758524|38141142|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
16997079|NCT00758524|38141143|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
16997080|NCT00758524|38141144|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997081|NCT00758524|38141145|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997082|NCT00758524|38141146|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997083|NCT00758524|38141147|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997084|NCT00758524|38141148|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997085|NCT00758524|38141149|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997086|NCT00758524|38141150|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997087|NCT00758524|38141151|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997088|NCT00758524|38141152|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997089|NCT00758524|38141153|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997090|NCT00758524|38141154|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997091|NCT00758524|38141155|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997092|NCT00758524|38141156|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16997093|NCT00758524|38141140|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997094|NCT00758524|38141141|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997095|NCT00758524|38141142|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997096|NCT00758524|38141143|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997097|NCT00758524|38141144|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
16997098|NCT00758524|38141145|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997099|NCT00758524|38141146|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997100|NCT00758524|38141147|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997101|NCT00758524|38141148|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997102|NCT00758524|38141149|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997103|NCT00758524|38141150|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997104|NCT00758524|38141151|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997105|NCT00758524|38141152|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
17183105|NCT01963208|38335130|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
17183106|NCT01963208|38335131|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
17183107|NCT01963208|38335126|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
17183108|NCT01963208|38335127|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
17183109|NCT01963208|38335128|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
17183110|NCT01963208|38335129|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
17183111|NCT01963208|38335130|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
17183112|NCT01963208|38335131|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
17183113|NCT01963208|38335126|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
17183114|NCT01963208|38335127|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
17183115|NCT01963208|38335128|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
17183116|NCT01963208|38335129|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
17183117|NCT01963208|38335130|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
17183118|NCT01963208|38335131|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
17183119|NCT01963208|38335126|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
17183120|NCT01963208|38335127|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
17183121|NCT01963208|38335128|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
17183122|NCT01963208|38335129|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
17183123|NCT01963208|38335130|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
17183124|NCT01963208|38335131|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
17183125|NCT01963208|38335126|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
17183126|NCT01963208|38335127|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
17183127|NCT01963208|38335128|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
17183128|NCT01963208|38335129|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
17183129|NCT01963208|38335130|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
17183130|NCT01963208|38335131|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
17183131|NCT01963208|38335126|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
17183132|NCT01963208|38335127|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
17183133|NCT01963208|38335128|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
17183134|NCT01963208|38335129|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
17183135|NCT01963208|38335130|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
17183136|NCT01963208|38335131|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
17183137|NCT01963208|38335126|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
17183138|NCT01963208|38335127|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
17183139|NCT01963208|38335128|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
17183140|NCT01963208|38335129|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
17183141|NCT01963208|38335130|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
17183142|NCT01963208|38335131|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
17183143|NCT01963208|38335126|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
17183144|NCT01963208|38335127|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
17183145|NCT01963208|38335128|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
17183146|NCT01963208|38335129|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
17183147|NCT01963208|38335130|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
17183148|NCT01963208|38335131|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
17183149|NCT01963208|38335126|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
17183150|NCT01963208|38335127|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
17183151|NCT01963208|38335128|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
17183152|NCT01963208|38335129|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
17183153|NCT01963208|38335130|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
17183154|NCT01963208|38335131|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
17183155|NCT00834873|38335143|FG000|First Intervention|Adverse Event|0|||
17183156|NCT00834873|38335144|FG001|First Intervention|Adverse Event|1|||
17183157|NCT01377480|38335152|FG000|Overall Study|Protocol Violation|0|||
17183158|NCT01377480|38335153|FG001|Overall Study|Protocol Violation|0|||
17183159|NCT01377480|38335154|FG002|Overall Study|Protocol Violation|0|||
17183160|NCT01377480|38335155|FG003|Overall Study|Protocol Violation|4|||
17183161|NCT01377480|38335152|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
17183162|NCT01377480|38335153|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
17183163|NCT01377480|38335154|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
17183164|NCT01377480|38335155|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
17183165|NCT01377480|38335152|FG000|Overall Study|Withdrawal by Subject|0|||
17183166|NCT01377480|38335153|FG001|Overall Study|Withdrawal by Subject|0|||
17183167|NCT01377480|38335154|FG002|Overall Study|Withdrawal by Subject|1|||
17183168|NCT01377480|38335155|FG003|Overall Study|Withdrawal by Subject|0|||
17183169|NCT01377480|38335152|FG000|Overall Study|Serious adverse event|0|||
17183170|NCT01377480|38335153|FG001|Overall Study|Serious adverse event|0|||
17183171|NCT01377480|38335154|FG002|Overall Study|Serious adverse event|1|||
17183172|NCT01377480|38335155|FG003|Overall Study|Serious adverse event|1|||
17183173|NCT01377480|38335152|FG000|Overall Study|Other|0|||
17183174|NCT01377480|38335153|FG001|Overall Study|Other|0|||
17183175|NCT01377480|38335154|FG002|Overall Study|Other|7|||
17183176|NCT01377480|38335155|FG003|Overall Study|Other|6|||
17183177|NCT00834795|38335167|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
17183178|NCT00834795|38335168|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
17183179|NCT00834795|38335167|FG000|Second Intervention|Adverse Event|1|||
17183180|NCT00834795|38335168|FG001|Second Intervention|Adverse Event|0|||
17183181|NCT00834717|38335174|FG000|First Intervention|Adverse Event|1|||
17183182|NCT00834717|38335175|FG001|First Intervention|Adverse Event|0|||
17183183|NCT00834717|38335174|FG000|First Intervention|Withdrawal by Subject|0|||
17183184|NCT00834717|38335175|FG001|First Intervention|Withdrawal by Subject|1|||
17183185|NCT00834639|38335181|FG000|Second Intervention|Physician Decision|0|||
17183186|NCT00834639|38335182|FG001|Second Intervention|Physician Decision|2|||
17183187|NCT00834249|38335202|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
17183188|NCT00834249|38335203|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
17183189|NCT00834249|38335202|FG000|Second Intervention|Adverse Event|1|||
17183190|NCT00834249|38335203|FG001|Second Intervention|Adverse Event|0|||
17183191|NCT00833937|38335209|FG000|Washout|Withdrawal by Subject|1|||
17183192|NCT00833937|38335210|FG001|Washout|Withdrawal by Subject|0|||
17183193|NCT00924170|38335216|FG000|Overall Study|Refused further treatment|0|||
17183194|NCT00924170|38335217|FG001|Overall Study|Refused further treatment|1|||
17183195|NCT00924170|38335216|FG000|Overall Study|Physician Decision|0|||
17183196|NCT00924170|38335217|FG001|Overall Study|Physician Decision|1|||
17183197|NCT00924170|38335216|FG000|Overall Study|Progressive disease|3|||
17183198|NCT00924170|38335217|FG001|Overall Study|Progressive disease|6|||
17183199|NCT00924170|38335216|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
17183200|NCT00924170|38335217|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
17183201|NCT00924170|38335216|FG000|Overall Study|Death|1|||
17183202|NCT00924170|38335217|FG001|Overall Study|Death|0|||
17183203|NCT00828321|38335231|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
17183204|NCT00828321|38335232|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
17183205|NCT00828321|38335231|FG000|Second Intervention|Protocol Violation|0|||
17183206|NCT00828321|38335232|FG001|Second Intervention|Protocol Violation|1|||
17183207|NCT01352715|38335238|FG000|Overall Study|Death|3|||
17183208|NCT01352715|38335239|FG001|Overall Study|Death|3|||
17183209|NCT01352715|38335238|FG000|Overall Study|Lost to Follow-up|5|||
17183210|NCT01352715|38335239|FG001|Overall Study|Lost to Follow-up|7|||
17183211|NCT01352715|38335238|FG000|Overall Study|Withdrawal by Subject|4|||
17183212|NCT01352715|38335239|FG001|Overall Study|Withdrawal by Subject|8|||
17183213|NCT01352715|38335238|FG000|Overall Study|site closure|16|||
17183214|NCT01352715|38335239|FG001|Overall Study|site closure|15|||
17183215|NCT01352715|38335238|FG000|Overall Study|no final visit in closeout period|15|||
17183216|NCT01352715|38335239|FG001|Overall Study|no final visit in closeout period|12|||
17183217|NCT01352715|38335238|FG000|Overall Study|major ineligibility|2|||
17183218|NCT01352715|38335239|FG001|Overall Study|major ineligibility|1|||
17183219|NCT00919893|38335250|FG000|Overall Study|Protocol Violation|19|||
17183220|NCT00919893|38335251|FG001|Overall Study|Protocol Violation|9|||
17183221|NCT02559622|38335259|FG000|Overall Study|Progressive disease|0|||
17183222|NCT02559622|38335260|FG001|Overall Study|Progressive disease|1|||
17183223|NCT02559622|38335261|FG002|Overall Study|Progressive disease|0|||
17183224|NCT02559622|38335262|FG003|Overall Study|Progressive disease|0|||
17183225|NCT02559622|38335259|FG000|Overall Study|Adverse Event|0|||
17183226|NCT02559622|38335260|FG001|Overall Study|Adverse Event|2|||
17183227|NCT02559622|38335261|FG002|Overall Study|Adverse Event|2|||
17183228|NCT02559622|38335262|FG003|Overall Study|Adverse Event|2|||
17183229|NCT02559622|38335259|FG000|Overall Study|Patient/guardian decision|1|||
17183230|NCT02559622|38335260|FG001|Overall Study|Patient/guardian decision|2|||
17183231|NCT02559622|38335261|FG002|Overall Study|Patient/guardian decision|0|||
17183232|NCT02559622|38335262|FG003|Overall Study|Patient/guardian decision|1|||
17183233|NCT02559310|38335278|FG000|Overall Study|Death|4|||
17183234|NCT02559310|38335279|FG001|Overall Study|Death|3|||
17183235|NCT02559310|38335278|FG000|Overall Study|Lost to Follow-up|5|||
17183236|NCT02559310|38335279|FG001|Overall Study|Lost to Follow-up|3|||
17183237|NCT02559310|38335278|FG000|Overall Study|Physician Decision|2|||
17183238|NCT02559310|38335279|FG001|Overall Study|Physician Decision|1|||
17183239|NCT02559310|38335278|FG000|Overall Study|Withdrawal by Subject|13|||
17183240|NCT02559310|38335279|FG001|Overall Study|Withdrawal by Subject|9|||
17183241|NCT02559310|38335278|FG000|Overall Study|Sponsor Decision|0|||
17183242|NCT02559310|38335279|FG001|Overall Study|Sponsor Decision|1|||
17183243|NCT02559310|38335278|FG000|Overall Study|Randomized but not treated|3|||
17183244|NCT02559310|38335279|FG001|Overall Study|Randomized but not treated|2|||
17183245|NCT03517449|38335287|FG000|Overall Study|Death|184|||
17183246|NCT03517449|38335288|FG001|Overall Study|Death|236|||
17183247|NCT03517449|38335287|FG000|Overall Study|Lost to Follow-up|0|||
17183248|NCT03517449|38335288|FG001|Overall Study|Lost to Follow-up|2|||
17183249|NCT03517449|38335287|FG000|Overall Study|Withdrawal by Subject|7|||
17183250|NCT03517449|38335288|FG001|Overall Study|Withdrawal by Subject|26|||
17183251|NCT03517449|38335287|FG000|Overall Study|Participants Ongoing|220|||
17183252|NCT03517449|38335288|FG001|Overall Study|Participants Ongoing|152|||
17183253|NCT02555878|38335320|FG000|Overall Study|Lost to Follow-up|2|||
17183254|NCT02555878|38335321|FG001|Overall Study|Lost to Follow-up|3|||
17183255|NCT02555878|38335320|FG000|Overall Study|Withdrawal by Subject|48|||
17183256|NCT02555878|38335321|FG001|Overall Study|Withdrawal by Subject|48|||
17183257|NCT02555878|38335320|FG000|Overall Study|Adverse Event|12|||
17183258|NCT02555878|38335321|FG001|Overall Study|Adverse Event|8|||
17183259|NCT02555878|38335320|FG000|Overall Study|Death|74|||
17183260|NCT02555878|38335321|FG001|Overall Study|Death|59|||
17183261|NCT02555878|38335320|FG000|Overall Study|Protocol Violation|1|||
17183262|NCT02555878|38335321|FG001|Overall Study|Protocol Violation|2|||
17183263|NCT02555878|38335320|FG000|Overall Study|Physician Decision|12|||
17183264|NCT02555878|38335321|FG001|Overall Study|Physician Decision|13|||
17183265|NCT02555878|38335320|FG000|Overall Study|Other|17|||
17183266|NCT02555878|38335321|FG001|Overall Study|Other|17|||
17183267|NCT02555722|38335329|FG000|Week 2|Adverse Event|0|||
17183268|NCT02555722|38335330|FG001|Week 2|Adverse Event|1|||
17183269|NCT02555722|38335329|FG000|Week 2|Withdrawal by Subject|1|||
17183270|NCT02555722|38335330|FG001|Week 2|Withdrawal by Subject|0|||
17183271|NCT02555722|38335329|FG000|Month 1|Lens Discomfort|1|||
17183272|NCT02555722|38335330|FG001|Month 1|Lens Discomfort|0|||
17183273|NCT02555722|38335329|FG000|Month 2|Withdrawal by Subject|3|||
17183274|NCT02555722|38335330|FG001|Month 2|Withdrawal by Subject|0|||
17183275|NCT02555722|38335329|FG000|Month 2|Lost to Follow-up|1|||
17183276|NCT02555722|38335330|FG001|Month 2|Lost to Follow-up|0|||
17183277|NCT02558296|38335384|FG000|Completed the Study Through Week 24|Adverse Event|9|||
17183278|NCT02558296|38335385|FG001|Completed the Study Through Week 24|Adverse Event|3|||
17183279|NCT02558296|38335384|FG000|Completed the Study Through Week 24|Death|7|||
17183280|NCT02558296|38335385|FG001|Completed the Study Through Week 24|Death|7|||
17183281|NCT02558296|38335384|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
17183282|NCT02558296|38335385|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
17183283|NCT02558296|38335384|FG000|Completed the Study Through Week 24|Physician Decision|1|||
17183284|NCT02558296|38335385|FG001|Completed the Study Through Week 24|Physician Decision|0|||
17183285|NCT02558296|38335384|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
17183286|NCT02558296|38335385|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
17183287|NCT02558296|38335384|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
17183288|NCT02558296|38335385|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
17183289|NCT02558296|38335384|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
17183290|NCT02558296|38335385|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
17183291|NCT02558296|38335384|FG000|Completed the Study|Adverse Event|14|||
17183292|NCT02558296|38335385|FG001|Completed the Study|Adverse Event|5|||
17183293|NCT02558296|38335384|FG000|Completed the Study|Death|39|||
17183294|NCT02558296|38335385|FG001|Completed the Study|Death|25|||
17183295|NCT02558296|38335384|FG000|Completed the Study|Lost to Follow-up|31|||
17183296|NCT02558296|38335385|FG001|Completed the Study|Lost to Follow-up|23|||
17183297|NCT02558296|38335384|FG000|Completed the Study|Physician Decision|6|||
17183298|NCT02558296|38335385|FG001|Completed the Study|Physician Decision|0|||
17183299|NCT02558296|38335384|FG000|Completed the Study|Protocol Violation|2|||
17183300|NCT02558296|38335385|FG001|Completed the Study|Protocol Violation|1|||
17183301|NCT02558296|38335384|FG000|Completed the Study|Withdrawal by Subject|53|||
17183302|NCT02558296|38335385|FG001|Completed the Study|Withdrawal by Subject|31|||
17183303|NCT02558296|38335384|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
17183304|NCT02558296|38335385|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
17183305|NCT02737475|38335422|FG000|Overall Study|Other reasons|0|||
17183306|NCT02737475|38335423|FG001|Overall Study|Other reasons|0|||
17183307|NCT02737475|38335424|FG002|Overall Study|Other reasons|0|||
17183308|NCT02737475|38335425|FG003|Overall Study|Other reasons|0|||
17183309|NCT02737475|38335426|FG004|Overall Study|Other reasons|1|||
17183310|NCT02737475|38335427|FG005|Overall Study|Other reasons|1|||
17183311|NCT02737475|38335428|FG006|Overall Study|Other reasons|0|||
17183312|NCT02737475|38335429|FG007|Overall Study|Other reasons|0|||
17183313|NCT02737475|38335430|FG008|Overall Study|Other reasons|1|||
17183314|NCT02737475|38335431|FG009|Overall Study|Other reasons|0|||
17183315|NCT02737475|38335432|FG010|Overall Study|Other reasons|1|||
17183316|NCT02737475|38335433|FG011|Overall Study|Other reasons|0|||
17183317|NCT02737475|38335434|FG012|Overall Study|Other reasons|0|||
17183318|NCT02737475|38335435|FG013|Overall Study|Other reasons|0|||
17183319|NCT02737475|38335436|FG014|Overall Study|Other reasons|0|||
17183320|NCT02737475|38335437|FG015|Overall Study|Other reasons|0|||
17183321|NCT02737475|38335438|FG016|Overall Study|Other reasons|0|||
17183322|NCT02737475|38335439|FG017|Overall Study|Other reasons|0|||
17183323|NCT02737475|38335440|FG018|Overall Study|Other reasons|0|||
17183324|NCT02737475|38335441|FG019|Overall Study|Other reasons|0|||
17183325|NCT02737475|38335442|FG020|Overall Study|Other reasons|0|||
17183326|NCT02737475|38335443|FG021|Overall Study|Other reasons|1|||
17183327|NCT02737475|38335444|FG022|Overall Study|Other reasons|0|||
17183328|NCT02737475|38335445|FG023|Overall Study|Other reasons|1|||
17183329|NCT02737475|38335446|FG024|Overall Study|Other reasons|1|||
17183330|NCT02737475|38335447|FG025|Overall Study|Other reasons|1|||
17183331|NCT02737475|38335448|FG026|Overall Study|Other reasons|0|||
17183332|NCT02737475|38335422|FG000|Overall Study|Death|1|||
17183333|NCT02737475|38335423|FG001|Overall Study|Death|0|||
17183334|NCT02737475|38335424|FG002|Overall Study|Death|0|||
17183335|NCT02737475|38335425|FG003|Overall Study|Death|1|||
17183336|NCT02737475|38335426|FG004|Overall Study|Death|0|||
17183337|NCT02737475|38335427|FG005|Overall Study|Death|0|||
17183338|NCT02737475|38335428|FG006|Overall Study|Death|0|||
17183339|NCT02737475|38335429|FG007|Overall Study|Death|2|||
17183340|NCT02737475|38335430|FG008|Overall Study|Death|0|||
17183341|NCT02737475|38335431|FG009|Overall Study|Death|0|||
17183342|NCT02737475|38335432|FG010|Overall Study|Death|0|||
17183343|NCT02737475|38335433|FG011|Overall Study|Death|4|||
17183344|NCT02737475|38335434|FG012|Overall Study|Death|2|||
17183345|NCT02737475|38335435|FG013|Overall Study|Death|2|||
17183346|NCT02737475|38335436|FG014|Overall Study|Death|0|||
17183347|NCT02737475|38335437|FG015|Overall Study|Death|2|||
17183348|NCT02737475|38335438|FG016|Overall Study|Death|2|||
17183349|NCT02737475|38335439|FG017|Overall Study|Death|2|||
17183350|NCT02737475|38335440|FG018|Overall Study|Death|1|||
17183351|NCT02737475|38335441|FG019|Overall Study|Death|0|||
17183352|NCT02737475|38335442|FG020|Overall Study|Death|0|||
17183353|NCT02737475|38335443|FG021|Overall Study|Death|0|||
17183354|NCT02737475|38335444|FG022|Overall Study|Death|0|||
17183355|NCT02737475|38335445|FG023|Overall Study|Death|0|||
17183356|NCT02737475|38335446|FG024|Overall Study|Death|0|||
17183357|NCT02737475|38335447|FG025|Overall Study|Death|0|||
17183358|NCT02737475|38335448|FG026|Overall Study|Death|0|||
17183359|NCT02737475|38335422|FG000|Overall Study|Participant withdrew consent|0|||
17183360|NCT02737475|38335423|FG001|Overall Study|Participant withdrew consent|0|||
17183361|NCT02737475|38335424|FG002|Overall Study|Participant withdrew consent|0|||
17183362|NCT02737475|38335425|FG003|Overall Study|Participant withdrew consent|0|||
17183363|NCT02737475|38335426|FG004|Overall Study|Participant withdrew consent|0|||
17183364|NCT02737475|38335427|FG005|Overall Study|Participant withdrew consent|2|||
17183365|NCT02737475|38335428|FG006|Overall Study|Participant withdrew consent|0|||
17183366|NCT02737475|38335429|FG007|Overall Study|Participant withdrew consent|0|||
17183367|NCT02737475|38335430|FG008|Overall Study|Participant withdrew consent|0|||
17183368|NCT02737475|38335431|FG009|Overall Study|Participant withdrew consent|0|||
17183369|NCT02737475|38335432|FG010|Overall Study|Participant withdrew consent|0|||
17183370|NCT02737475|38335433|FG011|Overall Study|Participant withdrew consent|0|||
17183371|NCT02737475|38335434|FG012|Overall Study|Participant withdrew consent|0|||
17183372|NCT02737475|38335435|FG013|Overall Study|Participant withdrew consent|0|||
17183373|NCT02737475|38335436|FG014|Overall Study|Participant withdrew consent|1|||
17183374|NCT02737475|38335437|FG015|Overall Study|Participant withdrew consent|0|||
17183375|NCT02737475|38335438|FG016|Overall Study|Participant withdrew consent|0|||
17183376|NCT02737475|38335439|FG017|Overall Study|Participant withdrew consent|2|||
17183377|NCT02737475|38335440|FG018|Overall Study|Participant withdrew consent|1|||
17183378|NCT02737475|38335441|FG019|Overall Study|Participant withdrew consent|0|||
17183379|NCT02737475|38335442|FG020|Overall Study|Participant withdrew consent|2|||
17183380|NCT02737475|38335443|FG021|Overall Study|Participant withdrew consent|0|||
17183381|NCT02737475|38335444|FG022|Overall Study|Participant withdrew consent|0|||
17183382|NCT02737475|38335445|FG023|Overall Study|Participant withdrew consent|0|||
17183383|NCT02737475|38335446|FG024|Overall Study|Participant withdrew consent|0|||
17183384|NCT02737475|38335447|FG025|Overall Study|Participant withdrew consent|0|||
17183385|NCT02737475|38335448|FG026|Overall Study|Participant withdrew consent|0|||
17183386|NCT02737475|38335422|FG000|Overall Study|Lost to Follow-up|0|||
17183387|NCT02737475|38335423|FG001|Overall Study|Lost to Follow-up|0|||
17183388|NCT02737475|38335424|FG002|Overall Study|Lost to Follow-up|0|||
17183389|NCT02737475|38335425|FG003|Overall Study|Lost to Follow-up|0|||
17183390|NCT02737475|38335426|FG004|Overall Study|Lost to Follow-up|0|||
17183391|NCT02737475|38335427|FG005|Overall Study|Lost to Follow-up|0|||
17183392|NCT02737475|38335428|FG006|Overall Study|Lost to Follow-up|0|||
17183393|NCT02737475|38335429|FG007|Overall Study|Lost to Follow-up|0|||
17183394|NCT02737475|38335430|FG008|Overall Study|Lost to Follow-up|0|||
17183395|NCT02737475|38335431|FG009|Overall Study|Lost to Follow-up|0|||
17183396|NCT02737475|38335432|FG010|Overall Study|Lost to Follow-up|0|||
17183397|NCT02737475|38335433|FG011|Overall Study|Lost to Follow-up|0|||
17183398|NCT02737475|38335434|FG012|Overall Study|Lost to Follow-up|0|||
17183399|NCT02737475|38335435|FG013|Overall Study|Lost to Follow-up|0|||
17183400|NCT02737475|38335436|FG014|Overall Study|Lost to Follow-up|0|||
17183401|NCT02737475|38335437|FG015|Overall Study|Lost to Follow-up|1|||
17183402|NCT02737475|38335438|FG016|Overall Study|Lost to Follow-up|0|||
17183403|NCT02737475|38335439|FG017|Overall Study|Lost to Follow-up|0|||
17183404|NCT02737475|38335440|FG018|Overall Study|Lost to Follow-up|0|||
17183405|NCT02737475|38335441|FG019|Overall Study|Lost to Follow-up|0|||
17183406|NCT02737475|38335442|FG020|Overall Study|Lost to Follow-up|0|||
17183407|NCT02737475|38335443|FG021|Overall Study|Lost to Follow-up|0|||
17183408|NCT02737475|38335444|FG022|Overall Study|Lost to Follow-up|0|||
17183409|NCT02737475|38335445|FG023|Overall Study|Lost to Follow-up|0|||
17183410|NCT02737475|38335446|FG024|Overall Study|Lost to Follow-up|0|||
17183411|NCT02737475|38335447|FG025|Overall Study|Lost to Follow-up|0|||
17183412|NCT02737475|38335448|FG026|Overall Study|Lost to Follow-up|0|||
17183413|NCT02737475|38335422|FG000|Overall Study|Disease Progression|0|||
17183414|NCT02737475|38335423|FG001|Overall Study|Disease Progression|0|||
17183415|NCT02737475|38335424|FG002|Overall Study|Disease Progression|0|||
17183416|NCT02737475|38335425|FG003|Overall Study|Disease Progression|0|||
17183417|NCT02737475|38335426|FG004|Overall Study|Disease Progression|0|||
17183418|NCT02737475|38335427|FG005|Overall Study|Disease Progression|0|||
17183419|NCT02737475|38335428|FG006|Overall Study|Disease Progression|0|||
17183420|NCT02737475|38335429|FG007|Overall Study|Disease Progression|0|||
17183421|NCT02737475|38335430|FG008|Overall Study|Disease Progression|0|||
17183422|NCT02737475|38335431|FG009|Overall Study|Disease Progression|0|||
17183423|NCT02737475|38335432|FG010|Overall Study|Disease Progression|0|||
17183424|NCT02737475|38335433|FG011|Overall Study|Disease Progression|0|||
17183425|NCT02737475|38335434|FG012|Overall Study|Disease Progression|0|||
17183426|NCT02737475|38335435|FG013|Overall Study|Disease Progression|0|||
17183427|NCT02737475|38335436|FG014|Overall Study|Disease Progression|0|||
17183428|NCT02737475|38335437|FG015|Overall Study|Disease Progression|0|||
17183429|NCT02737475|38335438|FG016|Overall Study|Disease Progression|0|||
17183430|NCT02737475|38335439|FG017|Overall Study|Disease Progression|0|||
17183431|NCT02737475|38335440|FG018|Overall Study|Disease Progression|0|||
17183432|NCT02737475|38335441|FG019|Overall Study|Disease Progression|0|||
17183433|NCT02737475|38335442|FG020|Overall Study|Disease Progression|0|||
17183434|NCT02737475|38335443|FG021|Overall Study|Disease Progression|0|||
17183435|NCT02737475|38335444|FG022|Overall Study|Disease Progression|0|||
17183436|NCT02737475|38335445|FG023|Overall Study|Disease Progression|0|||
17183437|NCT02737475|38335446|FG024|Overall Study|Disease Progression|0|||
17183438|NCT02737475|38335447|FG025|Overall Study|Disease Progression|0|||
17183439|NCT02737475|38335448|FG026|Overall Study|Disease Progression|1|||
17183440|NCT02557672|38335538|FG000|Overall Study|Withdrawal by Subject|4|||
17183441|NCT02557672|38335539|FG001|Overall Study|Withdrawal by Subject|2|||
17183442|NCT02714426|38335551|FG000|Overall Study|Withdrawal by Subject|2|||
17183443|NCT02714426|38335552|FG001|Overall Study|Withdrawal by Subject|2|||
17183444|NCT02925923|38335565|FG000|Overall Study|blood samples hemolyzed|0|||
17183445|NCT02925923|38335566|FG001|Overall Study|blood samples hemolyzed|2|||
17183446|NCT02410343|38335574|FG000|Core Period (24 Weeks)|Adverse Event|1|||
17183447|NCT02410343|38335575|FG001|Core Period (24 Weeks)|Adverse Event|0|||
17183448|NCT02410343|38335574|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
17183449|NCT02410343|38335575|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
17183450|NCT02410343|38335574|FG000|Extension Period (12 Months)|Adverse Event|1|||
17183451|NCT02410343|38335575|FG001|Extension Period (12 Months)|Adverse Event|0|||
17183452|NCT02410343|38335574|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
17183453|NCT02410343|38335575|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
17183454|NCT03064841|38335582|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
17183455|NCT03064841|38335582|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
17183456|NCT03064841|38335582|FG000|Overall Study|Screen failure|2|||
17183457|NCT02045303|38335588|FG000|Overall Study|Protocol Violation|2|||
17183458|NCT02045303|38335589|FG001|Overall Study|Protocol Violation|1|||
17183459|NCT02045303|38335590|FG002|Overall Study|Protocol Violation|0|||
17183460|NCT02045303|38335588|FG000|Overall Study|Withdrawal by Subject|0|||
17183461|NCT02045303|38335589|FG001|Overall Study|Withdrawal by Subject|2|||
17183462|NCT02045303|38335590|FG002|Overall Study|Withdrawal by Subject|0|||
17183463|NCT03434379|38335601|FG000|Global Period|Lost to Follow-up|3|||
17183464|NCT03434379|38335602|FG001|Global Period|Lost to Follow-up|1|||
17183465|NCT03434379|38335603|FG002|Global Period|Lost to Follow-up|0|||
17183466|NCT03434379|38335604|FG003|Global Period|Lost to Follow-up|0|||
17183467|NCT03434379|38335601|FG000|Global Period|Death|99|||
17183468|NCT03434379|38335602|FG001|Global Period|Death|179|||
17183469|NCT03434379|38335603|FG002|Global Period|Death|0|||
17183470|NCT03434379|38335604|FG003|Global Period|Death|0|||
17183471|NCT03434379|38335601|FG000|Global Period|Withdrawal by Subject|20|||
17183472|NCT03434379|38335602|FG001|Global Period|Withdrawal by Subject|20|||
17183473|NCT03434379|38335603|FG002|Global Period|Withdrawal by Subject|0|||
17183474|NCT03434379|38335604|FG003|Global Period|Withdrawal by Subject|0|||
16997106|NCT00758524|38141153|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
17089357|NCT00299130|38229568|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
17089358|NCT00299130|38229569|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
17089359|NCT00299130|38229567|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
17089360|NCT00299130|38229568|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
17089361|NCT00299130|38229569|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
17089362|NCT00299130|38229567|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
17089363|NCT00299130|38229568|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
17089364|NCT00299130|38229569|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
17183475|NCT03434379|38335601|FG000|Global Period|On Study|43|||
17183476|NCT03434379|38335602|FG001|Global Period|On Study|136|||
17183477|NCT03434379|38335603|FG002|Global Period|On Study|0|||
17183478|NCT03434379|38335604|FG003|Global Period|On Study|0|||
17183479|NCT03434379|38335601|FG000|China Extension Period|Lost to Follow-up|0|||
17183480|NCT03434379|38335602|FG001|China Extension Period|Lost to Follow-up|0|||
17183481|NCT03434379|38335603|FG002|China Extension Period|Lost to Follow-up|1|||
17183482|NCT03434379|38335604|FG003|China Extension Period|Lost to Follow-up|0|||
17183483|NCT03434379|38335601|FG000|China Extension Period|Death|0|||
17183484|NCT03434379|38335602|FG001|China Extension Period|Death|0|||
17183485|NCT03434379|38335603|FG002|China Extension Period|Death|38|||
17183486|NCT03434379|38335604|FG003|China Extension Period|Death|61|||
17183487|NCT03434379|38335601|FG000|China Extension Period|Withdrawal by Subject|0|||
17183488|NCT03434379|38335602|FG001|China Extension Period|Withdrawal by Subject|0|||
17183489|NCT03434379|38335603|FG002|China Extension Period|Withdrawal by Subject|7|||
17183490|NCT03434379|38335604|FG003|China Extension Period|Withdrawal by Subject|6|||
17183491|NCT03434379|38335601|FG000|China Extension Period|On Study|0|||
17183492|NCT03434379|38335602|FG001|China Extension Period|On Study|0|||
17183493|NCT03434379|38335603|FG002|China Extension Period|On Study|15|||
17183494|NCT03434379|38335604|FG003|China Extension Period|On Study|66|||
17183495|NCT03064451|38335620|FG000|Overall Study|Lost to Follow-up|1|||
17183496|NCT03064451|38335620|FG000|Overall Study|Mapping Failure|4|||
17183497|NCT03064451|38335620|FG000|Overall Study|Exited prior to procedure|8|||
17183498|NCT03064451|38335620|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
17183499|NCT03058679|38335626|FG000|Baseline to Week 6|Lost to Follow-up|3|||
17183500|NCT03058679|38335627|FG001|Baseline to Week 6|Lost to Follow-up|2|||
17183501|NCT03058679|38335626|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
17183502|NCT03058679|38335627|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
17183503|NCT03058679|38335626|FG000|Baseline to Week 6|Adverse Event|6|||
17183504|NCT03058679|38335627|FG001|Baseline to Week 6|Adverse Event|6|||
17183505|NCT03058679|38335626|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
17183506|NCT03058679|38335627|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
17183507|NCT03058679|38335626|FG000|Baseline to Week 6|Difficulty following the diet|0|||
17183508|NCT03058679|38335627|FG001|Baseline to Week 6|Difficulty following the diet|2|||
17183509|NCT03058679|38335626|FG000|Baseline to Week 6|Physician Decision|1|||
17183510|NCT03058679|38335627|FG001|Baseline to Week 6|Physician Decision|0|||
17183511|NCT03058679|38335626|FG000|Week 6 to Week 12|Change in medication|5|||
17183512|NCT03058679|38335627|FG001|Week 6 to Week 12|Change in medication|7|||
17183513|NCT03058679|38335626|FG000|Week 6 to Week 12|Adverse Event|4|||
17183514|NCT03058679|38335627|FG001|Week 6 to Week 12|Adverse Event|3|||
17183515|NCT03058679|38335626|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
17183516|NCT03058679|38335627|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
17183517|NCT03058679|38335626|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
17183518|NCT03058679|38335627|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
17183519|NCT03382821|38335635|FG000|Overall Study|Did not receive allocated intervention.|0|||
17183520|NCT03382821|38335636|FG001|Overall Study|Did not receive allocated intervention.|3|||
17183521|NCT02557516|38335647|FG000|Overall Study|Adverse Event|1|||
17183522|NCT02557516|38335648|FG001|Overall Study|Adverse Event|0|||
17183523|NCT02557516|38335649|FG002|Overall Study|Adverse Event|2|||
17183524|NCT02557516|38335650|FG003|Overall Study|Adverse Event|1|||
17183525|NCT02557516|38335647|FG000|Overall Study|Disease progression|0|||
17183526|NCT02557516|38335648|FG001|Overall Study|Disease progression|2|||
17183527|NCT02557516|38335649|FG002|Overall Study|Disease progression|0|||
17183528|NCT02557516|38335650|FG003|Overall Study|Disease progression|0|||
17183529|NCT02557516|38335647|FG000|Overall Study|Physician Decision|0|||
17183530|NCT02557516|38335648|FG001|Overall Study|Physician Decision|2|||
17183531|NCT02557516|38335649|FG002|Overall Study|Physician Decision|0|||
17183532|NCT02557516|38335650|FG003|Overall Study|Physician Decision|0|||
17183533|NCT02557516|38335647|FG000|Overall Study|Sponsor decision|0|||
17183534|NCT02557516|38335648|FG001|Overall Study|Sponsor decision|1|||
17183535|NCT02557516|38335649|FG002|Overall Study|Sponsor decision|2|||
17183536|NCT02557516|38335650|FG003|Overall Study|Sponsor decision|8|||
17183537|NCT00711555|38335669|FG000|Overall Study|Adverse Event|3|||
17183538|NCT02713490|38335674|FG000|Overall Study|Withdrawal by Subject|2|||
17183539|NCT02713490|38335675|FG001|Overall Study|Withdrawal by Subject|1|||
17183540|NCT02713490|38335674|FG000|Overall Study|Did not receive study drug|1|||
17183541|NCT02713490|38335675|FG001|Overall Study|Did not receive study drug|0|||
17183542|NCT02713490|38335674|FG000|Overall Study|Met exclusion criteria|0|||
17183543|NCT02713490|38335675|FG001|Overall Study|Met exclusion criteria|1|||
17183544|NCT03772574|38335684|FG000|Overall Study|Protocol Violation|2|||
17183545|NCT03772574|38335685|FG001|Overall Study|Protocol Violation|0|||
17183546|NCT03772574|38335686|FG002|Overall Study|Protocol Violation|0|||
17183547|NCT03772574|38335684|FG000|Overall Study|Discomfort|0|||
17183548|NCT03772574|38335685|FG001|Overall Study|Discomfort|5|||
17183549|NCT03772574|38335686|FG002|Overall Study|Discomfort|4|||
17183550|NCT02743221|38335696|FG000|Overall Study|Progressive disease|29|||
17183551|NCT02743221|38335697|FG001|Overall Study|Progressive disease|38|||
17183552|NCT02743221|38335696|FG000|Overall Study|Adverse Event|17|||
17183553|NCT02743221|38335697|FG001|Overall Study|Adverse Event|14|||
17183554|NCT02743221|38335696|FG000|Overall Study|non medical reason|8|||
17183555|NCT02743221|38335697|FG001|Overall Study|non medical reason|2|||
17183556|NCT02743221|38335696|FG000|Overall Study|Physician Decision|2|||
17183557|NCT02743221|38335697|FG001|Overall Study|Physician Decision|5|||
17183558|NCT02743221|38335696|FG000|Overall Study|Patient not eligible, not treated|0|||
17183559|NCT02743221|38335697|FG001|Overall Study|Patient not eligible, not treated|1|||
17183560|NCT03836625|38335705|FG000|Overall Study|Lost to Follow-up|9|||
17183561|NCT03836625|38335706|FG001|Overall Study|Lost to Follow-up|9|||
17183562|NCT03836625|38335705|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
17183563|NCT03836625|38335706|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
17183564|NCT03836625|38335705|FG000|Overall Study|Death|0|||
17183565|NCT03836625|38335706|FG001|Overall Study|Death|1|||
17183566|NCT03836625|38335705|FG000|Overall Study|Refused follow-up|0|||
17183567|NCT03836625|38335706|FG001|Overall Study|Refused follow-up|1|||
17183568|NCT01358968|38335712|FG000|Period 2|Adverse Event|0|||
17183569|NCT01358968|38335713|FG001|Period 2|Adverse Event|1|||
17183570|NCT01358968|38335714|FG002|Period 2|Adverse Event|0|||
17183571|NCT01358968|38335715|FG003|Period 2|Adverse Event|0|||
17183572|NCT01358968|38335712|FG000|Continued Access Phase|Progression of Disease|0|||
17183573|NCT01358968|38335713|FG001|Continued Access Phase|Progression of Disease|0|||
17183574|NCT01358968|38335714|FG002|Continued Access Phase|Progression of Disease|8|||
17183575|NCT01358968|38335715|FG003|Continued Access Phase|Progression of Disease|4|||
17183576|NCT01358968|38335712|FG000|Continued Access Phase|Protocol Violation|0|||
17183577|NCT01358968|38335713|FG001|Continued Access Phase|Protocol Violation|0|||
17183578|NCT01358968|38335714|FG002|Continued Access Phase|Protocol Violation|0|||
17183579|NCT01358968|38335715|FG003|Continued Access Phase|Protocol Violation|2|||
17183580|NCT01358968|38335712|FG000|Continued Access Phase|Withdrawal by Subject|0|||
17183581|NCT01358968|38335713|FG001|Continued Access Phase|Withdrawal by Subject|0|||
17183582|NCT01358968|38335714|FG002|Continued Access Phase|Withdrawal by Subject|3|||
17183583|NCT01358968|38335715|FG003|Continued Access Phase|Withdrawal by Subject|0|||
17183584|NCT01358968|38335712|FG000|Continued Access Phase|Death|0|||
17183585|NCT01358968|38335713|FG001|Continued Access Phase|Death|0|||
17183586|NCT01358968|38335714|FG002|Continued Access Phase|Death|1|||
17183587|NCT01358968|38335715|FG003|Continued Access Phase|Death|1|||
17183588|NCT00701090|38335727|FG000|Overall Study|Adverse Event|11|||
17183589|NCT00701090|38335728|FG001|Overall Study|Adverse Event|2|||
17183590|NCT00701090|38335727|FG000|Overall Study|Death|0|||
17183591|NCT00701090|38335728|FG001|Overall Study|Death|1|||
17183592|NCT00701090|38335727|FG000|Overall Study|Lack of Efficacy|5|||
17183593|NCT00701090|38335728|FG001|Overall Study|Lack of Efficacy|4|||
17183594|NCT00701090|38335727|FG000|Overall Study|Lost to Follow-up|9|||
17183595|NCT00701090|38335728|FG001|Overall Study|Lost to Follow-up|9|||
17183596|NCT00701090|38335727|FG000|Overall Study|Physician Decision|3|||
17183597|NCT00701090|38335728|FG001|Overall Study|Physician Decision|4|||
17183598|NCT00701090|38335727|FG000|Overall Study|Protocol Violation|2|||
17183599|NCT00701090|38335728|FG001|Overall Study|Protocol Violation|3|||
17183600|NCT00701090|38335727|FG000|Overall Study|Withdrawal by Subject|11|||
17183601|NCT00701090|38335728|FG001|Overall Study|Withdrawal by Subject|16|||
17183602|NCT00701090|38335727|FG000|Overall Study|Other|7|||
17183603|NCT00701090|38335728|FG001|Overall Study|Other|12|||
17183604|NCT03950674|38335736|FG000|Overall Study|Death|3|||
17183605|NCT03950674|38335737|FG001|Overall Study|Death|7|||
17183606|NCT03950674|38335736|FG000|Overall Study|Ongoing in Study|22|||
17183607|NCT03950674|38335737|FG001|Overall Study|Ongoing in Study|8|||
17183608|NCT03057977|38335746|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
17183609|NCT03057977|38335747|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
17183610|NCT03057977|38335746|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
17183611|NCT03057977|38335747|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
17183612|NCT03057977|38335746|FG000|Discontinuation From Treatment|Protocol Violation|6|||
17183613|NCT03057977|38335747|FG001|Discontinuation From Treatment|Protocol Violation|5|||
17183614|NCT03057977|38335746|FG000|Discontinuation From Treatment|Not treated|4|||
17183615|NCT03057977|38335747|FG001|Discontinuation From Treatment|Not treated|0|||
17183616|NCT03057977|38335746|FG000|Discontinuation From Treatment|Adverse Event|343|||
17183617|NCT03057977|38335747|FG001|Discontinuation From Treatment|Adverse Event|337|||
17183618|NCT03057977|38335746|FG000|Discontinuation From Treatment|Reason Unknown|0|||
17183619|NCT03057977|38335747|FG001|Discontinuation From Treatment|Reason Unknown|1|||
17183620|NCT03057977|38335746|FG000|Discontinuation From Treatment|Personal Reasons|1|||
17183621|NCT03057977|38335747|FG001|Discontinuation From Treatment|Personal Reasons|1|||
17183622|NCT03057977|38335746|FG000|Discontinuation From Treatment|Unblinded medication|1|||
17183623|NCT03057977|38335747|FG001|Discontinuation From Treatment|Unblinded medication|0|||
17183624|NCT03057977|38335746|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
17183625|NCT03057977|38335747|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
17183626|NCT03057977|38335746|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
17183627|NCT03057977|38335747|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
17183628|NCT03057977|38335746|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
17183629|NCT03057977|38335747|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
17183630|NCT03057977|38335746|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
17183631|NCT03057977|38335747|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
17183632|NCT03057977|38335746|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
17183633|NCT03057977|38335747|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
17183634|NCT03057977|38335746|FG000|Discontinuation From Treatment|Not attending study visit|3|||
17183635|NCT03057977|38335747|FG001|Discontinuation From Treatment|Not attending study visit|10|||
17183636|NCT03057977|38335746|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
17183637|NCT03057977|38335747|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
17183638|NCT03057977|38335746|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
17183639|NCT03057977|38335747|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
17183640|NCT03057977|38335746|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
17183641|NCT03057977|38335747|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
17183642|NCT03057977|38335746|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
17183643|NCT03057977|38335747|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
17183644|NCT03057977|38335746|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
17183645|NCT03057977|38335747|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
17183646|NCT03062891|38335759|FG000|Overall Study|Withdrawal by Subject|2|||
17183647|NCT03062891|38335760|FG001|Overall Study|Withdrawal by Subject|0|||
17183648|NCT03062891|38335759|FG000|Overall Study|Lost to Follow-up|50|||
17183649|NCT03062891|38335760|FG001|Overall Study|Lost to Follow-up|38|||
17183650|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
17183651|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
17183652|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
17183653|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
17183654|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
17183655|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
17183656|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
17183657|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
17183658|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
17183659|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
17183660|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
17183661|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
17183662|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
17183663|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
17183664|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
17183665|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
17183666|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
17183667|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
17183668|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
17183669|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
17183670|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
17183671|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
17183672|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
17183673|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
17183674|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
17183675|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
17183676|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
17183677|NCT02552212|38335769|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
17183678|NCT02552212|38335770|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
17183679|NCT02552212|38335771|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
17183680|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
17183681|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
17183682|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
17183683|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
17183684|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
17183685|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
17183686|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
17183687|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
17183688|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
17183689|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
17183690|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
17183691|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
17183692|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
17183693|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
17183694|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
17183695|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
17183696|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
17183697|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
17183698|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
17183699|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
17183700|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
17183701|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
17183702|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
17183703|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
17183704|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
17183705|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
17183706|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
17183707|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
17183708|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
17183709|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
17183710|NCT02552212|38335769|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
17183711|NCT02552212|38335770|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
17183712|NCT02552212|38335771|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
17183713|NCT00685919|38335791|FG000|Overall Study|Withdrawal by Subject|0|||
17183714|NCT00685919|38335792|FG001|Overall Study|Withdrawal by Subject|0|||
17183715|NCT00685919|38335793|FG002|Overall Study|Withdrawal by Subject|1|||
17183716|NCT00685919|38335794|FG003|Overall Study|Withdrawal by Subject|0|||
17183717|NCT00685919|38335791|FG000|Overall Study|Physician Decision|1|||
17183718|NCT00685919|38335792|FG001|Overall Study|Physician Decision|0|||
17183719|NCT00685919|38335793|FG002|Overall Study|Physician Decision|0|||
17183720|NCT00685919|38335794|FG003|Overall Study|Physician Decision|0|||
17183721|NCT03061331|38335806|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
16997107|NCT00758524|38141154|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997108|NCT00758524|38141155|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997109|NCT00758524|38141156|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16997110|NCT00758524|38141140|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
17089365|NCT00299130|38229567|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
17089366|NCT00299130|38229568|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
17089367|NCT00299130|38229569|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
17089368|NCT00299130|38229567|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
17089369|NCT00299130|38229568|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
17089370|NCT00299130|38229569|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
17089371|NCT00299130|38229567|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
17089372|NCT00299130|38229568|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
17089373|NCT00299130|38229569|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
17089374|NCT00299130|38229567|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
17089375|NCT00299130|38229568|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
17089376|NCT00299130|38229569|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
17089377|NCT00299130|38229567|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
17089378|NCT00299130|38229568|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
17089379|NCT00299130|38229569|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
17089380|NCT00299130|38229567|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
17089381|NCT00299130|38229568|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
17089382|NCT00299130|38229569|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
17089383|NCT00299130|38229567|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
17089384|NCT00299130|38229568|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
17089385|NCT00299130|38229569|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
17089386|NCT00288054|38229584|FG000|Overall Study|Protocol Violation|2|||
17089387|NCT00288054|38229584|FG000|Overall Study|Lack of Efficacy|16|||
17089388|NCT00288054|38229584|FG000|Overall Study|Adverse Event|3|||
17089389|NCT00288054|38229584|FG000|Overall Study|Withdrawal by Subject|1|||
16997111|NCT00758524|38141141|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
16997112|NCT00758524|38141142|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997113|NCT00758524|38141143|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997114|NCT00758524|38141144|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997115|NCT00758524|38141145|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997116|NCT00758524|38141146|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997117|NCT00758524|38141147|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997118|NCT00758524|38141148|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997119|NCT00758524|38141149|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997120|NCT00758524|38141150|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997121|NCT00758524|38141151|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997122|NCT00758524|38141152|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997123|NCT00758524|38141153|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997124|NCT00758524|38141154|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997125|NCT00758524|38141155|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
17089390|NCT00288054|38229584|FG000|Overall Study|Not protocol specified|2|||
17089391|NCT00287586|38229592|FG000|Overall Study|Withdrew Consent|19|||
17089392|NCT00287586|38229593|FG001|Overall Study|Withdrew Consent|30|||
17089393|NCT00287586|38229592|FG000|Overall Study|Lost to Follow-up|5|||
17089394|NCT00287586|38229593|FG001|Overall Study|Lost to Follow-up|4|||
17089395|NCT00287586|38229592|FG000|Overall Study|Death|2|||
17089396|NCT00287586|38229593|FG001|Overall Study|Death|3|||
17089397|NCT00287586|38229592|FG000|Overall Study|Elevated Hematocrit|3|||
17089398|NCT00287586|38229593|FG001|Overall Study|Elevated Hematocrit|0|||
17089399|NCT00287586|38229592|FG000|Overall Study|Rash|3|||
17089400|NCT00287586|38229593|FG001|Overall Study|Rash|0|||
17089401|NCT00287586|38229592|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
17089402|NCT00287586|38229593|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
17089403|NCT00287586|38229592|FG000|Overall Study|Stroke|2|||
17089404|NCT00287586|38229593|FG001|Overall Study|Stroke|0|||
17089405|NCT00287586|38229592|FG000|Overall Study|Myocardial Infarction|1|||
17089406|NCT00287586|38229593|FG001|Overall Study|Myocardial Infarction|0|||
17089407|NCT00287586|38229592|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
17089408|NCT00287586|38229593|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
17089409|NCT00287586|38229592|FG000|Overall Study|Cognitive Impairment|1|||
17089410|NCT00287586|38229593|FG001|Overall Study|Cognitive Impairment|0|||
17089411|NCT00287586|38229592|FG000|Overall Study|Pancreatic Cancer|1|||
17089412|NCT00287586|38229593|FG001|Overall Study|Pancreatic Cancer|3|||
17089413|NCT00287586|38229592|FG000|Overall Study|Sleep Apnea|1|||
17089414|NCT00287586|38229593|FG001|Overall Study|Sleep Apnea|0|||
17089415|NCT00287586|38229592|FG000|Overall Study|Shoulder Pain|1|||
17089416|NCT00287586|38229593|FG001|Overall Study|Shoulder Pain|0|||
17089417|NCT00287586|38229592|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
16997126|NCT00758524|38141156|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16997127|NCT00758524|38141140|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997128|NCT00758524|38141141|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
16997129|NCT00758524|38141142|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997130|NCT00758524|38141143|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997131|NCT00758524|38141144|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997132|NCT00758524|38141145|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997133|NCT00758524|38141146|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997134|NCT00758524|38141147|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997135|NCT00758524|38141148|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997136|NCT00758524|38141149|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997137|NCT00758524|38141150|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997138|NCT00758524|38141151|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997139|NCT00758524|38141152|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997140|NCT00758524|38141153|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997141|NCT00758524|38141154|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997142|NCT00758524|38141155|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997143|NCT00758524|38141156|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16997144|NCT00758524|38141140|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997145|NCT00758524|38141141|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
17089418|NCT00287586|38229593|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
17089419|NCT00287586|38229592|FG000|Overall Study|Nonadherence|1|||
17089420|NCT00287586|38229593|FG001|Overall Study|Nonadherence|1|||
17089421|NCT00287586|38229592|FG000|Overall Study|Enrolled in Another Study|1|||
17089422|NCT00287586|38229593|FG001|Overall Study|Enrolled in Another Study|0|||
17089423|NCT00287586|38229592|FG000|Overall Study|Major Depression|0|||
17089424|NCT00287586|38229593|FG001|Overall Study|Major Depression|2|||
17089425|NCT00287586|38229592|FG000|Overall Study|Lung Cancer|0|||
17089426|NCT00287586|38229593|FG001|Overall Study|Lung Cancer|2|||
17089427|NCT00287586|38229592|FG000|Overall Study|Elevated IPSS Score|0|||
17089428|NCT00287586|38229593|FG001|Overall Study|Elevated IPSS Score|1|||
17089429|NCT00287586|38229592|FG000|Overall Study|Retroperitoneal Cancer|0|||
17089430|NCT00287586|38229593|FG001|Overall Study|Retroperitoneal Cancer|1|||
17089431|NCT00287586|38229592|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
17089432|NCT00287586|38229593|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
17183722|NCT03061331|38335807|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
17183723|NCT00700778|38335813|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
17183724|NCT03908476|38335819|FG000|Overall Study|Death|3|||
17183725|NCT03908476|38335820|FG001|Overall Study|Death|0|||
17183726|NCT03908476|38335819|FG000|Overall Study|Lost to Follow-up|3|||
17183727|NCT03908476|38335820|FG001|Overall Study|Lost to Follow-up|1|||
17183728|NCT03908476|38335819|FG000|Overall Study|Withdrawal by Subject|7|||
17183729|NCT03908476|38335820|FG001|Overall Study|Withdrawal by Subject|1|||
17183730|NCT03908476|38335819|FG000|Overall Study|Physician Decision|2|||
17183731|NCT03908476|38335820|FG001|Overall Study|Physician Decision|0|||
17183732|NCT03908476|38335819|FG000|Overall Study|System Explanted and not Replaced|4|||
17183733|NCT03908476|38335820|FG001|Overall Study|System Explanted and not Replaced|0|||
17183734|NCT03908476|38335819|FG000|Overall Study|Intrathecal Pump|1|||
17183735|NCT03908476|38335820|FG001|Overall Study|Intrathecal Pump|0|||
17183736|NCT03908476|38335819|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
17183737|NCT03908476|38335820|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
17183738|NCT02551666|38335828|FG000|Overall Study|Withdrawal by Subject|1|||
17183739|NCT02551666|38335829|FG001|Overall Study|Withdrawal by Subject|3|||
17183740|NCT03061175|38335841|FG000|Baseline|Participant was deemed ineligible|1|||
17183741|NCT03061175|38335842|FG001|Baseline|Participant was deemed ineligible|0|||
17183742|NCT03061175|38335841|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
17183743|NCT03061175|38335842|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
17183744|NCT03061175|38335841|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
17183745|NCT03061175|38335842|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
17183746|NCT03061175|38335841|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
17183747|NCT03061175|38335842|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
17183748|NCT02554474|38335859|FG000|Overall Study|Protocol Violation|1|||
17183749|NCT02554474|38335860|FG001|Overall Study|Protocol Violation|1|||
17183750|NCT02554474|38335859|FG000|Overall Study|Health issue not related to the study|1|||
17183751|NCT02554474|38335860|FG001|Overall Study|Health issue not related to the study|0|||
17183752|NCT02554474|38335859|FG000|Overall Study|Withdrawal by Subject|1|||
17183753|NCT02554474|38335860|FG001|Overall Study|Withdrawal by Subject|1|||
17183754|NCT03061097|38335868|FG000|Overall Study|Withdrawal by Subject|0|||
17183755|NCT03061097|38335869|FG001|Overall Study|Withdrawal by Subject|3|||
17183756|NCT02554318|38335877|FG000|Overall Study|Withdrawal by Subject|10|||
17183757|NCT02554318|38335878|FG001|Overall Study|Withdrawal by Subject|8|||
17183758|NCT02550106|38335884|FG000|Overall Study|Adverse Event|1|||
17183759|NCT02550106|38335884|FG000|Overall Study|Lack of Efficacy|3|||
17183760|NCT02550106|38335884|FG000|Overall Study|Protocol Violation|6|||
17183761|NCT02550106|38335884|FG000|Overall Study|Withdrawal by Subject|2|||
17183762|NCT03060551|38335890|FG000|Overall Study|Withdrawal by Subject|1|||
17183763|NCT03060551|38335890|FG000|Overall Study|Adverse Event|1|||
17183764|NCT01662310|38335894|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
17183765|NCT01662310|38335895|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
17183766|NCT01662310|38335896|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
17183767|NCT01662310|38335897|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
17183768|NCT01662310|38335898|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
17183769|NCT01662310|38335894|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
17183770|NCT01662310|38335895|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
17183771|NCT01662310|38335896|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
17183772|NCT01662310|38335897|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
17183773|NCT01662310|38335898|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
17183774|NCT01662310|38335894|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
17183775|NCT01662310|38335895|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
17183776|NCT01662310|38335896|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
17183777|NCT01662310|38335897|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
17183778|NCT01662310|38335898|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
17183779|NCT01662310|38335894|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
17183780|NCT01662310|38335895|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
17183781|NCT01662310|38335896|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
17183782|NCT01662310|38335897|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
17183783|NCT01662310|38335898|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
17183784|NCT01662310|38335894|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
17183785|NCT01662310|38335895|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
17183786|NCT01662310|38335896|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
17183787|NCT01662310|38335897|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
17183788|NCT01662310|38335898|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
17183789|NCT01662310|38335894|FG000|Run-In or Stabilization Phase|Other|1|||
17183790|NCT01662310|38335895|FG001|Run-In or Stabilization Phase|Other|0|||
17183791|NCT01662310|38335896|FG002|Run-In or Stabilization Phase|Other|0|||
17183792|NCT01662310|38335897|FG003|Run-In or Stabilization Phase|Other|0|||
17183793|NCT01662310|38335898|FG004|Run-In or Stabilization Phase|Other|0|||
17183794|NCT01662310|38335894|FG000|Double-Blind Phase|Adverse Event|0|||
17183795|NCT01662310|38335895|FG001|Double-Blind Phase|Adverse Event|0|||
17183796|NCT01662310|38335896|FG002|Double-Blind Phase|Adverse Event|1|||
17183797|NCT01662310|38335897|FG003|Double-Blind Phase|Adverse Event|0|||
17183798|NCT01662310|38335898|FG004|Double-Blind Phase|Adverse Event|0|||
17183799|NCT01662310|38335894|FG000|Double-Blind Phase|Lost to Follow-up|0|||
17183800|NCT01662310|38335895|FG001|Double-Blind Phase|Lost to Follow-up|3|||
17183801|NCT01662310|38335896|FG002|Double-Blind Phase|Lost to Follow-up|0|||
17183802|NCT01662310|38335897|FG003|Double-Blind Phase|Lost to Follow-up|0|||
17183803|NCT01662310|38335898|FG004|Double-Blind Phase|Lost to Follow-up|0|||
17183804|NCT01662310|38335894|FG000|Double-Blind Phase|Pregnancy|0|||
17183805|NCT01662310|38335895|FG001|Double-Blind Phase|Pregnancy|2|||
17183806|NCT01662310|38335896|FG002|Double-Blind Phase|Pregnancy|0|||
17183807|NCT01662310|38335897|FG003|Double-Blind Phase|Pregnancy|0|||
17183808|NCT01662310|38335898|FG004|Double-Blind Phase|Pregnancy|0|||
17183809|NCT01662310|38335894|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
17183810|NCT01662310|38335895|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
17183811|NCT01662310|38335896|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
17183812|NCT01662310|38335897|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
17183813|NCT01662310|38335898|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
17183814|NCT01662310|38335894|FG000|Double-Blind Phase|Other|0|||
17183815|NCT01662310|38335895|FG001|Double-Blind Phase|Other|0|||
17183816|NCT01662310|38335896|FG002|Double-Blind Phase|Other|1|||
17183817|NCT01662310|38335897|FG003|Double-Blind Phase|Other|0|||
17183818|NCT01662310|38335898|FG004|Double-Blind Phase|Other|0|||
17183819|NCT01662310|38335894|FG000|Double-Blind Phase|Randomized but not treated|0|||
17183820|NCT01662310|38335895|FG001|Double-Blind Phase|Randomized but not treated|1|||
17183821|NCT01662310|38335896|FG002|Double-Blind Phase|Randomized but not treated|0|||
17183822|NCT01662310|38335897|FG003|Double-Blind Phase|Randomized but not treated|0|||
17183823|NCT01662310|38335898|FG004|Double-Blind Phase|Randomized but not treated|0|||
17183824|NCT01662310|38335894|FG000|Open-Label Extension Phase|Adverse Event|0|||
17183825|NCT01662310|38335895|FG001|Open-Label Extension Phase|Adverse Event|0|||
17183826|NCT01662310|38335896|FG002|Open-Label Extension Phase|Adverse Event|0|||
17183827|NCT01662310|38335897|FG003|Open-Label Extension Phase|Adverse Event|3|||
17183828|NCT01662310|38335898|FG004|Open-Label Extension Phase|Adverse Event|0|||
17183829|NCT01662310|38335894|FG000|Open-Label Extension Phase|Death|0|||
17183830|NCT01662310|38335895|FG001|Open-Label Extension Phase|Death|0|||
17183831|NCT01662310|38335896|FG002|Open-Label Extension Phase|Death|0|||
17183832|NCT01662310|38335897|FG003|Open-Label Extension Phase|Death|1|||
17089433|NCT00287586|38229592|FG000|Overall Study|Mood Swings and Irritability|0|||
17089434|NCT00287586|38229593|FG001|Overall Study|Mood Swings and Irritability|1|||
17089435|NCT00287586|38229592|FG000|Overall Study|Bradycardia|0|||
17089436|NCT00287586|38229593|FG001|Overall Study|Bradycardia|1|||
17089437|NCT00287586|38229592|FG000|Overall Study|Itchy Swollen Eyes|0|||
17089438|NCT00287586|38229593|FG001|Overall Study|Itchy Swollen Eyes|1|||
17089439|NCT00287586|38229592|FG000|Overall Study|Recurrent Melanoma|0|||
17089440|NCT00287586|38229593|FG001|Overall Study|Recurrent Melanoma|1|||
17089441|NCT00287118|38229599|FG000|Overall Study|Adverse Event|30|||
17089442|NCT00287118|38229599|FG000|Overall Study|Death|1|||
17089443|NCT00287118|38229599|FG000|Overall Study|Lack of Efficacy|11|||
17089444|NCT00287118|38229599|FG000|Overall Study|Lost to Follow-up|1|||
17089445|NCT00287118|38229599|FG000|Overall Study|Protocol Violation|2|||
17089446|NCT00287118|38229599|FG000|Overall Study|Other|7|||
17089447|NCT00293202|38229605|FG000|Overall Study|Withdrawal by Subject|1|||
17089448|NCT00293202|38229606|FG001|Overall Study|Withdrawal by Subject|2|||
17089449|NCT00293202|38229605|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
17089450|NCT00293202|38229606|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
17089451|NCT00293202|38229605|FG000|Overall Study|on-hold due to fistula maturation time|1|||
17089452|NCT00293202|38229606|FG001|Overall Study|on-hold due to fistula maturation time|0|||
17089453|NCT00298896|38229616|FG000|Overall Study|Death|3|||
17089454|NCT00298896|38229616|FG000|Overall Study|Physician Decision|2|||
17089455|NCT00298896|38229616|FG000|Overall Study|Intercurrent Illness|1|||
17089456|NCT00298896|38229616|FG000|Overall Study|Disease Progression|41|||
17089457|NCT00298896|38229616|FG000|Overall Study|Withdrawal by Subject|2|||
17089458|NCT00298896|38229616|FG000|Overall Study|Assigned to treatment in error|1|||
17089459|NCT00286494|38229623|FG000|Overall Study|Hyperglycemic rescue|12|||
17089460|NCT00286494|38229624|FG001|Overall Study|Hyperglycemic rescue|19|||
17089461|NCT00286494|38229625|FG002|Overall Study|Hyperglycemic rescue|18|||
17089462|NCT00286494|38229623|FG000|Overall Study|Withdrawal by Subject|2|||
17089463|NCT00286494|38229624|FG001|Overall Study|Withdrawal by Subject|10|||
17089464|NCT00286494|38229625|FG002|Overall Study|Withdrawal by Subject|9|||
17089465|NCT00286494|38229623|FG000|Overall Study|Adverse Event|3|||
17089466|NCT00286494|38229624|FG001|Overall Study|Adverse Event|8|||
17089467|NCT00286494|38229625|FG002|Overall Study|Adverse Event|6|||
17183833|NCT01662310|38335898|FG004|Open-Label Extension Phase|Death|0|||
17089468|NCT00286494|38229623|FG000|Overall Study|Physician Decision|5|||
17183834|NCT01662310|38335894|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
17183835|NCT01662310|38335895|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
17183836|NCT01662310|38335896|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
17183837|NCT01662310|38335897|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
17183838|NCT01662310|38335898|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
17183839|NCT01662310|38335894|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
17183840|NCT01662310|38335895|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
17183841|NCT01662310|38335896|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
17183842|NCT01662310|38335897|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
17183843|NCT01662310|38335898|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
17183844|NCT01662310|38335894|FG000|Open-Label Extension Phase|Pregnancy|0|||
17183845|NCT01662310|38335895|FG001|Open-Label Extension Phase|Pregnancy|0|||
17183846|NCT01662310|38335896|FG002|Open-Label Extension Phase|Pregnancy|0|||
17183847|NCT01662310|38335897|FG003|Open-Label Extension Phase|Pregnancy|1|||
17183848|NCT01662310|38335898|FG004|Open-Label Extension Phase|Pregnancy|0|||
17183849|NCT01662310|38335894|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
17183850|NCT01662310|38335895|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
17183851|NCT01662310|38335896|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
17183852|NCT01662310|38335897|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
17183853|NCT01662310|38335898|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
17183854|NCT00700622|38335912|FG000|Overall Study|Adverse Event|4|||
17183855|NCT00700622|38335913|FG001|Overall Study|Adverse Event|0|||
17183856|NCT00700622|38335912|FG000|Overall Study|Lost to Follow-up|0|||
17183857|NCT00700622|38335913|FG001|Overall Study|Lost to Follow-up|1|||
17183858|NCT00700622|38335912|FG000|Overall Study|Physician Decision|2|||
17183859|NCT00700622|38335913|FG001|Overall Study|Physician Decision|1|||
17183860|NCT00700622|38335912|FG000|Overall Study|Protocol Violation|0|||
17183861|NCT00700622|38335913|FG001|Overall Study|Protocol Violation|1|||
17183862|NCT00700622|38335912|FG000|Overall Study|Withdrawal by Subject|4|||
17183863|NCT00700622|38335913|FG001|Overall Study|Withdrawal by Subject|1|||
17183864|NCT00700622|38335912|FG000|Overall Study|Other|3|||
17183865|NCT00700622|38335913|FG001|Overall Study|Other|1|||
17183866|NCT02553928|38335921|FG000|Overall Study|Adverse Event|2|||
17183867|NCT02553928|38335922|FG001|Overall Study|Adverse Event|1|||
17183868|NCT02553928|38335921|FG000|Overall Study|Lost to Follow-up|0|||
17183869|NCT02553928|38335922|FG001|Overall Study|Lost to Follow-up|1|||
17183870|NCT02553928|38335921|FG000|Overall Study|Administrative reason(s)|0|||
17183871|NCT02553928|38335922|FG001|Overall Study|Administrative reason(s)|1|||
17183872|NCT03076775|38335931|FG000|Overall Study|Lost to Follow-up|1|||
17183873|NCT03076775|38335932|FG001|Overall Study|Lost to Follow-up|0|||
17183874|NCT03058991|38335949|FG000|Overall Study|Lost to Follow-up|17|||
17183875|NCT03058991|38335950|FG001|Overall Study|Lost to Follow-up|12|||
17183876|NCT03058991|38335951|FG002|Overall Study|Lost to Follow-up|12|||
17183877|NCT03058991|38335949|FG000|Overall Study|Withdrawal by Subject|1|||
17183878|NCT03058991|38335950|FG001|Overall Study|Withdrawal by Subject|0|||
17183879|NCT03058991|38335951|FG002|Overall Study|Withdrawal by Subject|0|||
17183880|NCT00700310|38335963|FG000|Overall Study|Adverse Event|6|||
17183881|NCT00700310|38335964|FG001|Overall Study|Adverse Event|10|||
17183882|NCT00700310|38335965|FG002|Overall Study|Adverse Event|5|||
17183883|NCT00700310|38335966|FG003|Overall Study|Adverse Event|11|||
17183884|NCT00700310|38335963|FG000|Overall Study|Lost to Follow-up|4|||
17183885|NCT00700310|38335964|FG001|Overall Study|Lost to Follow-up|1|||
17183886|NCT00700310|38335965|FG002|Overall Study|Lost to Follow-up|0|||
17183887|NCT00700310|38335966|FG003|Overall Study|Lost to Follow-up|1|||
17183888|NCT00700310|38335963|FG000|Overall Study|Withdrawal by Subject|8|||
17183889|NCT00700310|38335964|FG001|Overall Study|Withdrawal by Subject|9|||
17183890|NCT00700310|38335965|FG002|Overall Study|Withdrawal by Subject|8|||
17183891|NCT00700310|38335966|FG003|Overall Study|Withdrawal by Subject|8|||
17183892|NCT00700310|38335963|FG000|Overall Study|Lack of Efficacy|0|||
17183893|NCT00700310|38335964|FG001|Overall Study|Lack of Efficacy|3|||
17183894|NCT00700310|38335965|FG002|Overall Study|Lack of Efficacy|0|||
17183895|NCT00700310|38335966|FG003|Overall Study|Lack of Efficacy|1|||
17183896|NCT00700310|38335963|FG000|Overall Study|Administrative/Other|1|||
17183897|NCT00700310|38335964|FG001|Overall Study|Administrative/Other|3|||
17183898|NCT00700310|38335965|FG002|Overall Study|Administrative/Other|1|||
17183899|NCT00700310|38335966|FG003|Overall Study|Administrative/Other|3|||
17183900|NCT00700310|38335963|FG000|Overall Study|Randomized, Not Treated|2|||
17183901|NCT00700310|38335964|FG001|Overall Study|Randomized, Not Treated|0|||
17183902|NCT00700310|38335965|FG002|Overall Study|Randomized, Not Treated|2|||
17183903|NCT00700310|38335966|FG003|Overall Study|Randomized, Not Treated|2|||
17183904|NCT01575548|38335996|FG000|Overall Study|Adverse Event|15|||
17183905|NCT01575548|38335997|FG001|Overall Study|Adverse Event|2|||
17183906|NCT01575548|38335996|FG000|Overall Study|Disease progression|12|||
17183907|NCT01575548|38335997|FG001|Overall Study|Disease progression|25|||
17183908|NCT01575548|38335996|FG000|Overall Study|Death|1|||
17183909|NCT01575548|38335997|FG001|Overall Study|Death|0|||
17183910|NCT01575548|38335996|FG000|Overall Study|Other complicating disease|1|||
17183911|NCT01575548|38335997|FG001|Overall Study|Other complicating disease|0|||
17183912|NCT01575548|38335996|FG000|Overall Study|Withdrawal by Subject|7|||
17183913|NCT01575548|38335997|FG001|Overall Study|Withdrawal by Subject|3|||
17183914|NCT01575548|38335996|FG000|Overall Study|Noncompliance|1|||
17183915|NCT01575548|38335997|FG001|Overall Study|Noncompliance|0|||
17183916|NCT01575548|38335996|FG000|Overall Study|Anticipated surgery|0|||
17183917|NCT01575548|38335997|FG001|Overall Study|Anticipated surgery|1|||
17183918|NCT01575548|38335996|FG000|Overall Study|Never started protocol therapy|3|||
17183919|NCT01575548|38335997|FG001|Overall Study|Never started protocol therapy|2|||
17183920|NCT01750281|38336006|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
17183921|NCT01750281|38336007|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
17183922|NCT01750281|38336008|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
17183923|NCT01750281|38336006|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
17183924|NCT01750281|38336007|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
17183925|NCT01750281|38336008|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
17183926|NCT01750281|38336006|FG000|Overall Study|Did not receive treatment|0|||
17089469|NCT00286494|38229624|FG001|Overall Study|Physician Decision|5|||
17089470|NCT00286494|38229625|FG002|Overall Study|Physician Decision|1|||
17089471|NCT00286494|38229623|FG000|Overall Study|Lost to Follow-up|3|||
17089472|NCT00286494|38229624|FG001|Overall Study|Lost to Follow-up|1|||
17089473|NCT00286494|38229625|FG002|Overall Study|Lost to Follow-up|3|||
17089474|NCT00286494|38229623|FG000|Overall Study|Protocol Violation|1|||
17089475|NCT00286494|38229624|FG001|Overall Study|Protocol Violation|1|||
17089476|NCT00286494|38229625|FG002|Overall Study|Protocol Violation|2|||
17089477|NCT00298740|38229633|FG000|Overall Study|Lack of Efficacy|6|||
17089478|NCT00298740|38229633|FG000|Overall Study|Withdrawal by Subject|3|||
17089479|NCT00285012|38229639|FG000|Assigned to Study Treatment (Tx)|Other|2|||
17089480|NCT00285012|38229640|FG001|Assigned to Study Treatment (Tx)|Other|3|||
17089481|NCT00285012|38229639|FG000|Received Study Tx|Death|2|||
17089482|NCT00285012|38229640|FG001|Received Study Tx|Death|1|||
17089483|NCT00285012|38229639|FG000|Received Study Tx|Adverse Event|5|||
17089484|NCT00285012|38229640|FG001|Received Study Tx|Adverse Event|11|||
17089485|NCT00285012|38229639|FG000|Received Study Tx|Lack of Efficacy|0|||
17089486|NCT00285012|38229640|FG001|Received Study Tx|Lack of Efficacy|3|||
17089487|NCT00285012|38229639|FG000|Received Study Tx|Lost to Follow-up|29|||
17089488|NCT00285012|38229640|FG001|Received Study Tx|Lost to Follow-up|31|||
17089489|NCT00285012|38229639|FG000|Received Study Tx|Withdrawal by Subject|31|||
17089490|NCT00285012|38229640|FG001|Received Study Tx|Withdrawal by Subject|43|||
17089491|NCT00285012|38229639|FG000|Received Study Tx|Other|5|||
17089492|NCT00285012|38229640|FG001|Received Study Tx|Other|5|||
17089493|NCT00284934|38229648|FG000|Overall Study|Adverse Event|1|||
17089494|NCT00284934|38229649|FG001|Overall Study|Adverse Event|2|||
17089495|NCT00284934|38229648|FG000|Overall Study|Other reasons|3|||
17089496|NCT00284934|38229649|FG001|Overall Study|Other reasons|1|||
17089497|NCT00284856|38229658|FG000|Overall Study|Adverse Event|3|||
17089498|NCT00284856|38229659|FG001|Overall Study|Adverse Event|3|||
17089499|NCT00284856|38229660|FG002|Overall Study|Adverse Event|3|||
17089500|NCT00284856|38229658|FG000|Overall Study|Lack of Efficacy|2|||
17089501|NCT00284856|38229659|FG001|Overall Study|Lack of Efficacy|1|||
17089502|NCT00284856|38229660|FG002|Overall Study|Lack of Efficacy|8|||
17089503|NCT00284856|38229658|FG000|Overall Study|Lost to Follow-up|25|||
17089504|NCT00284856|38229659|FG001|Overall Study|Lost to Follow-up|21|||
17089505|NCT00284856|38229660|FG002|Overall Study|Lost to Follow-up|22|||
17089506|NCT00284856|38229658|FG000|Overall Study|Protocol Violation|5|||
17089507|NCT00284856|38229659|FG001|Overall Study|Protocol Violation|4|||
17089508|NCT00284856|38229660|FG002|Overall Study|Protocol Violation|5|||
17089509|NCT00284856|38229658|FG000|Overall Study|Withdrawal by Subject|12|||
17089510|NCT00284856|38229659|FG001|Overall Study|Withdrawal by Subject|16|||
17089511|NCT00284856|38229660|FG002|Overall Study|Withdrawal by Subject|18|||
17089512|NCT00284856|38229658|FG000|Overall Study|Other|4|||
17089513|NCT00284856|38229659|FG001|Overall Study|Other|5|||
17089514|NCT00284856|38229660|FG002|Overall Study|Other|4|||
17089515|NCT00298272|38229670|FG000|Double-blind Phase|Adverse Event|2|||
17089516|NCT00298272|38229671|FG001|Double-blind Phase|Adverse Event|0|||
17089517|NCT00298272|38229670|FG000|Double-blind Phase|Failure to Return|2|||
17089518|NCT00298272|38229671|FG001|Double-blind Phase|Failure to Return|0|||
17089519|NCT00298272|38229670|FG000|Double-blind Phase|Protocol Violation|2|||
17089520|NCT00298272|38229671|FG001|Double-blind Phase|Protocol Violation|0|||
17089521|NCT00298272|38229670|FG000|Double-blind Phase|Withdrawal by Subject|2|||
17089522|NCT00298272|38229671|FG001|Double-blind Phase|Withdrawal by Subject|0|||
17089523|NCT00298272|38229670|FG000|Open Label Retreatment Phase|Adverse Event|1|||
17089524|NCT00298272|38229671|FG001|Open Label Retreatment Phase|Adverse Event|2|||
17089525|NCT00298272|38229670|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
17089526|NCT00298272|38229671|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
17089527|NCT00298272|38229670|FG000|Open Label Retreatment Phase|Failure to Return|1|||
17089528|NCT00298272|38229671|FG001|Open Label Retreatment Phase|Failure to Return|0|||
17089529|NCT00298272|38229670|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
17183927|NCT01750281|38336007|FG001|Overall Study|Did not receive treatment|1|||
17183928|NCT01750281|38336008|FG002|Overall Study|Did not receive treatment|0|||
17183929|NCT03000569|38336035|FG000|Overall Study|Withdrawal by Subject|1|||
17183930|NCT03000569|38336036|FG001|Overall Study|Withdrawal by Subject|0|||
17183931|NCT02554786|38336055|FG000|Overall Study|Subject/guardian decision|29|||
17183932|NCT02554786|38336056|FG001|Overall Study|Subject/guardian decision|17|||
17183933|NCT02554786|38336057|FG002|Overall Study|Subject/guardian decision|18|||
17183934|NCT02554786|38336058|FG003|Overall Study|Subject/guardian decision|30|||
17183935|NCT02554786|38336059|FG004|Overall Study|Subject/guardian decision|20|||
17183936|NCT02554786|38336055|FG000|Overall Study|Lost to Follow-up|4|||
17183937|NCT02554786|38336056|FG001|Overall Study|Lost to Follow-up|3|||
17183938|NCT02554786|38336057|FG002|Overall Study|Lost to Follow-up|4|||
17183939|NCT02554786|38336058|FG003|Overall Study|Lost to Follow-up|2|||
17183940|NCT02554786|38336059|FG004|Overall Study|Lost to Follow-up|2|||
17183941|NCT02554786|38336055|FG000|Overall Study|Protocol deviation|1|||
17183942|NCT02554786|38336056|FG001|Overall Study|Protocol deviation|3|||
17183943|NCT02554786|38336057|FG002|Overall Study|Protocol deviation|3|||
17183944|NCT02554786|38336058|FG003|Overall Study|Protocol deviation|4|||
17183945|NCT02554786|38336059|FG004|Overall Study|Protocol deviation|2|||
17183946|NCT02554786|38336055|FG000|Overall Study|Technical problems|1|||
17183947|NCT02554786|38336056|FG001|Overall Study|Technical problems|1|||
17183948|NCT02554786|38336057|FG002|Overall Study|Technical problems|0|||
17183949|NCT02554786|38336058|FG003|Overall Study|Technical problems|2|||
17183950|NCT02554786|38336059|FG004|Overall Study|Technical problems|1|||
17183951|NCT02554786|38336055|FG000|Overall Study|Adverse Event|0|||
17183952|NCT02554786|38336056|FG001|Overall Study|Adverse Event|0|||
17183953|NCT02554786|38336057|FG002|Overall Study|Adverse Event|0|||
17183954|NCT02554786|38336058|FG003|Overall Study|Adverse Event|0|||
17183955|NCT02554786|38336059|FG004|Overall Study|Adverse Event|2|||
17183956|NCT02554786|38336055|FG000|Overall Study|Death|0|||
17183957|NCT02554786|38336056|FG001|Overall Study|Death|0|||
17183958|NCT02554786|38336057|FG002|Overall Study|Death|0|||
17183959|NCT02554786|38336058|FG003|Overall Study|Death|1|||
17183960|NCT02554786|38336059|FG004|Overall Study|Death|0|||
17183961|NCT02554786|38336055|FG000|Overall Study|Non-compliance with study treatment|0|||
17183962|NCT02554786|38336056|FG001|Overall Study|Non-compliance with study treatment|1|||
17183963|NCT02554786|38336057|FG002|Overall Study|Non-compliance with study treatment|1|||
17183964|NCT02554786|38336058|FG003|Overall Study|Non-compliance with study treatment|0|||
17183965|NCT02554786|38336059|FG004|Overall Study|Non-compliance with study treatment|1|||
17183966|NCT02554786|38336055|FG000|Overall Study|Physician Decision|0|||
17183967|NCT02554786|38336056|FG001|Overall Study|Physician Decision|1|||
17183968|NCT02554786|38336057|FG002|Overall Study|Physician Decision|4|||
17183969|NCT02554786|38336058|FG003|Overall Study|Physician Decision|1|||
17183970|NCT02554786|38336059|FG004|Overall Study|Physician Decision|1|||
17183971|NCT02554786|38336055|FG000|Overall Study|Pregnancy|0|||
17183972|NCT02554786|38336056|FG001|Overall Study|Pregnancy|0|||
17183973|NCT02554786|38336057|FG002|Overall Study|Pregnancy|0|||
17183974|NCT02554786|38336058|FG003|Overall Study|Pregnancy|1|||
17183975|NCT02554786|38336059|FG004|Overall Study|Pregnancy|1|||
17183976|NCT02893930|38336075|FG000|Overall Study|Adverse Event|3|||
17183977|NCT02893930|38336075|FG000|Overall Study|Death|1|||
17183978|NCT02893930|38336075|FG000|Overall Study|Disease progression|5|||
17183979|NCT02893930|38336075|FG000|Overall Study|Withdrawal by Subject|2|||
17183980|NCT02893930|38336075|FG000|Overall Study|Physician Decision|1|||
17183981|NCT02893930|38336075|FG000|Overall Study|Ineligible|1|||
17183982|NCT01347645|38336084|FG000|Overall Study|Death|1|||
17183983|NCT01347645|38336085|FG001|Overall Study|Death|5|||
17183984|NCT01347645|38336086|FG002|Overall Study|Death|2|||
17183985|NCT01347645|38336087|FG003|Overall Study|Death|7|||
17183986|NCT01347645|38336088|FG004|Overall Study|Death|7|||
17183987|NCT01347645|38336084|FG000|Overall Study|Lost to Follow-up|1|||
17183988|NCT01347645|38336085|FG001|Overall Study|Lost to Follow-up|1|||
17183989|NCT01347645|38336086|FG002|Overall Study|Lost to Follow-up|0|||
17183990|NCT01347645|38336087|FG003|Overall Study|Lost to Follow-up|1|||
17183991|NCT01347645|38336088|FG004|Overall Study|Lost to Follow-up|1|||
17183992|NCT01347645|38336084|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
17183993|NCT01347645|38336085|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
17183994|NCT01347645|38336086|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
17183995|NCT01347645|38336087|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
17183996|NCT01347645|38336088|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
17183997|NCT01347645|38336084|FG000|Overall Study|Other|1|||
17183998|NCT01347645|38336085|FG001|Overall Study|Other|0|||
17183999|NCT01347645|38336086|FG002|Overall Study|Other|0|||
17184000|NCT01347645|38336087|FG003|Overall Study|Other|0|||
17184001|NCT01347645|38336088|FG004|Overall Study|Other|1|||
17184002|NCT01347645|38336084|FG000|Overall Study|Withdrawal by Subject|0|||
17184003|NCT01347645|38336085|FG001|Overall Study|Withdrawal by Subject|0|||
17184004|NCT01347645|38336086|FG002|Overall Study|Withdrawal by Subject|0|||
17184005|NCT01347645|38336087|FG003|Overall Study|Withdrawal by Subject|3|||
17184006|NCT01347645|38336088|FG004|Overall Study|Withdrawal by Subject|3|||
17184007|NCT01347645|38336084|FG000|Overall Study|Physician Decision|0|||
17184008|NCT01347645|38336085|FG001|Overall Study|Physician Decision|0|||
17184009|NCT01347645|38336086|FG002|Overall Study|Physician Decision|0|||
17184010|NCT01347645|38336087|FG003|Overall Study|Physician Decision|0|||
17184011|NCT01347645|38336088|FG004|Overall Study|Physician Decision|1|||
17184012|NCT01347645|38336084|FG000|Overall Study|Adverse Event|0|||
17184013|NCT01347645|38336085|FG001|Overall Study|Adverse Event|0|||
17184014|NCT01347645|38336086|FG002|Overall Study|Adverse Event|0|||
17184015|NCT01347645|38336087|FG003|Overall Study|Adverse Event|1|||
17184016|NCT01347645|38336088|FG004|Overall Study|Adverse Event|1|||
17184017|NCT00484419|38336126|FG000|Overall Study|Adverse Event|3|||
17184018|NCT00484419|38336127|FG001|Overall Study|Adverse Event|0|||
17184019|NCT00484419|38336128|FG002|Overall Study|Adverse Event|0|||
17184020|NCT00484419|38336126|FG000|Overall Study|Lost to Follow-up|1|||
17184021|NCT00484419|38336127|FG001|Overall Study|Lost to Follow-up|0|||
17184022|NCT00484419|38336128|FG002|Overall Study|Lost to Follow-up|2|||
17184023|NCT00484419|38336126|FG000|Overall Study|Withdrawal by Subject|3|||
17184024|NCT00484419|38336127|FG001|Overall Study|Withdrawal by Subject|1|||
17184025|NCT00484419|38336128|FG002|Overall Study|Withdrawal by Subject|1|||
17184026|NCT00484419|38336126|FG000|Overall Study|subject met discontinuation criteria|2|||
17184027|NCT00484419|38336127|FG001|Overall Study|subject met discontinuation criteria|2|||
17184028|NCT00484419|38336128|FG002|Overall Study|subject met discontinuation criteria|4|||
17184029|NCT00484419|38336126|FG000|Overall Study|required restricted medication|1|||
17184030|NCT00484419|38336127|FG001|Overall Study|required restricted medication|0|||
17184031|NCT00484419|38336128|FG002|Overall Study|required restricted medication|1|||
17184032|NCT00484419|38336126|FG000|Overall Study|Physician Decision|1|||
17184033|NCT00484419|38336127|FG001|Overall Study|Physician Decision|1|||
17184034|NCT00484419|38336128|FG002|Overall Study|Physician Decision|1|||
17184035|NCT00484419|38336126|FG000|Overall Study|subject unable to receive medication|1|||
17184036|NCT00484419|38336127|FG001|Overall Study|subject unable to receive medication|0|||
17184037|NCT00484419|38336128|FG002|Overall Study|subject unable to receive medication|0|||
17184038|NCT00484419|38336126|FG000|Overall Study|subject relocated|0|||
17184039|NCT00484419|38336127|FG001|Overall Study|subject relocated|1|||
17184040|NCT00484419|38336128|FG002|Overall Study|subject relocated|0|||
17184041|NCT00484419|38336126|FG000|Overall Study|sponsor decision, randomized in error|0|||
17184042|NCT00484419|38336127|FG001|Overall Study|sponsor decision, randomized in error|0|||
17184043|NCT00484419|38336128|FG002|Overall Study|sponsor decision, randomized in error|2|||
17184044|NCT03220724|38336137|FG000|Overall Study|Lost to Follow-up|2|||
17184045|NCT03220724|38336138|FG001|Overall Study|Lost to Follow-up|1|||
17184046|NCT03220724|38336139|FG002|Overall Study|Lost to Follow-up|0|||
17184047|NCT03220724|38336140|FG003|Overall Study|Lost to Follow-up|3|||
17184048|NCT03220724|38336137|FG000|Overall Study|Withdrawal by Subject|1|||
17184049|NCT03220724|38336138|FG001|Overall Study|Withdrawal by Subject|1|||
17184050|NCT03220724|38336139|FG002|Overall Study|Withdrawal by Subject|1|||
17184051|NCT03220724|38336140|FG003|Overall Study|Withdrawal by Subject|0|||
17184052|NCT02549092|38336152|FG000|Treatment Period|Adverse Event|2|||
17184053|NCT02549092|38336153|FG001|Treatment Period|Adverse Event|2|||
17184054|NCT02549092|38336152|FG000|Treatment Period|Withdrawal by Subject|1|||
17184055|NCT02549092|38336153|FG001|Treatment Period|Withdrawal by Subject|3|||
17184056|NCT02549092|38336152|FG000|Treatment Period|Lack of Efficacy|0|||
17184057|NCT02549092|38336153|FG001|Treatment Period|Lack of Efficacy|2|||
17184058|NCT02549092|38336152|FG000|Extension/Transition Period|Still in Extension/Transition Period|4|||
17184059|NCT02549092|38336153|FG001|Extension/Transition Period|Still in Extension/Transition Period|8|||
17184060|NCT02549092|38336152|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
17184061|NCT02549092|38336153|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
17184062|NCT03056573|38336164|FG000|Overall Study|Death|2|||
17184063|NCT03056573|38336165|FG001|Overall Study|Death|4|||
17089530|NCT00298272|38229671|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
17089531|NCT00298272|38229670|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
17089532|NCT00298272|38229671|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
17089533|NCT00298272|38229670|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
17089534|NCT00298272|38229671|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
17089535|NCT00298272|38229670|FG000|Safety Follow-up Phase|Failure to Return|1|||
17089536|NCT00298272|38229671|FG001|Safety Follow-up Phase|Failure to Return|1|||
17089537|NCT00298272|38229670|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
17184064|NCT03056573|38336164|FG000|Overall Study|Withdrawal by Subject|2|||
17184065|NCT03056573|38336165|FG001|Overall Study|Withdrawal by Subject|0|||
17184066|NCT03056573|38336164|FG000|Overall Study|Lost to Follow-up|1|||
17184067|NCT03056573|38336165|FG001|Overall Study|Lost to Follow-up|1|||
17184068|NCT02553772|38336173|FG000|Overall Study|Adverse Event|2|||
17184069|NCT02553772|38336174|FG001|Overall Study|Adverse Event|3|||
17184070|NCT02553772|38336173|FG000|Overall Study|Lost to Follow-up|2|||
17184071|NCT02553772|38336174|FG001|Overall Study|Lost to Follow-up|1|||
17184072|NCT02553772|38336173|FG000|Overall Study|Withdrawal of Consent|1|||
17184073|NCT02553772|38336174|FG001|Overall Study|Withdrawal of Consent|1|||
17184074|NCT02553772|38336173|FG000|Overall Study|Lack of Efficacy|1|||
17184075|NCT02553772|38336174|FG001|Overall Study|Lack of Efficacy|0|||
17184076|NCT02553772|38336173|FG000|Overall Study|Other Miscellaneous Reasons|0|||
17184077|NCT02553772|38336174|FG001|Overall Study|Other Miscellaneous Reasons|1|||
17184078|NCT02553538|38336182|FG000|Overall Study|Could Not Reach by Telephone|133|||
17184079|NCT02553538|38336183|FG001|Overall Study|Could Not Reach by Telephone|0|||
17184080|NCT02553538|38336182|FG000|Overall Study|Died or Left Network|54|||
17184081|NCT02553538|38336183|FG001|Overall Study|Died or Left Network|56|||
17184082|NCT02548156|38336189|FG000|Washout Period 1|Lost to Follow-up|0|||
17184083|NCT02548156|38336190|FG001|Washout Period 1|Lost to Follow-up|0|||
17184084|NCT02548156|38336191|FG002|Washout Period 1|Lost to Follow-up|0|||
17184085|NCT02548156|38336192|FG003|Washout Period 1|Lost to Follow-up|0|||
17184086|NCT02548156|38336193|FG004|Washout Period 1|Lost to Follow-up|1|||
17184087|NCT02548156|38336194|FG005|Washout Period 1|Lost to Follow-up|0|||
17184088|NCT01503515|38336204|FG000|Overall Study|Adverse Event|4|||
17184089|NCT01503515|38336205|FG001|Overall Study|Adverse Event|5|||
17184090|NCT01503515|38336204|FG000|Overall Study|Death|0|||
17184091|NCT01503515|38336205|FG001|Overall Study|Death|1|||
17184092|NCT01503515|38336204|FG000|Overall Study|Physician Decision|14|||
17184093|NCT01503515|38336205|FG001|Overall Study|Physician Decision|23|||
17184094|NCT01503515|38336204|FG000|Overall Study|Withdrawal by Subject|0|||
17184095|NCT01503515|38336205|FG001|Overall Study|Withdrawal by Subject|1|||
17184096|NCT01503515|38336204|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
17184097|NCT01503515|38336205|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
17184098|NCT01503515|38336204|FG000|Overall Study|Ineligible|1|||
17184099|NCT01503515|38336205|FG001|Overall Study|Ineligible|1|||
17184100|NCT02742519|38336213|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
17184101|NCT02742519|38336214|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
17184102|NCT02742519|38336215|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
17184103|NCT02742519|38336213|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
17184104|NCT02742519|38336214|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
17184105|NCT02742519|38336215|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
17184106|NCT02742519|38336213|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
17184107|NCT02742519|38336214|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
17184108|NCT02742519|38336215|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
17184109|NCT01375010|38336225|FG000|Overall Study|Lost to Follow-up|8|||
17184110|NCT01375010|38336226|FG001|Overall Study|Lost to Follow-up|2|||
17184111|NCT01375010|38336225|FG000|Overall Study|Withdrawal by Subject|4|||
17184112|NCT01375010|38336226|FG001|Overall Study|Withdrawal by Subject|2|||
17184113|NCT00659061|38336250|FG000|Overall Study|Migration due to political unrest|21|||
17184114|NCT00659061|38336251|FG001|Overall Study|Migration due to political unrest|15|||
17184115|NCT02548078|38336268|FG000|Overall Study|Serious adverse event/Adverse event|1|||
17184116|NCT02548078|38336269|FG001|Overall Study|Serious adverse event/Adverse event|0|||
17184117|NCT02548078|38336268|FG000|Overall Study|Moved from study area|3|||
17184118|NCT02548078|38336269|FG001|Overall Study|Moved from study area|3|||
17184119|NCT02548078|38336268|FG000|Overall Study|Lost to Follow-up|1|||
17184120|NCT02548078|38336269|FG001|Overall Study|Lost to Follow-up|3|||
17184121|NCT02671435|38336297|FG000|Overall Study|Death|1|||
17184122|NCT02671435|38336298|FG001|Overall Study|Death|3|||
17184123|NCT02671435|38336299|FG002|Overall Study|Death|0|||
17184124|NCT02671435|38336300|FG003|Overall Study|Death|16|||
17184125|NCT02671435|38336301|FG004|Overall Study|Death|14|||
17184126|NCT02671435|38336302|FG005|Overall Study|Death|29|||
17184127|NCT02671435|38336303|FG006|Overall Study|Death|34|||
17184128|NCT02671435|38336304|FG007|Overall Study|Death|28|||
17184129|NCT02671435|38336305|FG008|Overall Study|Death|19|||
17184130|NCT02671435|38336306|FG009|Overall Study|Death|10|||
17184131|NCT02671435|38336307|FG010|Overall Study|Death|8|||
17184132|NCT02671435|38336308|FG011|Overall Study|Death|29|||
17184133|NCT02671435|38336309|FG012|Overall Study|Death|29|||
17184134|NCT02671435|38336310|FG013|Overall Study|Death|29|||
17184135|NCT02671435|38336311|FG014|Overall Study|Death|27|||
17184136|NCT02671435|38336297|FG000|Overall Study|Lost to Follow-up|0|||
17184137|NCT02671435|38336298|FG001|Overall Study|Lost to Follow-up|0|||
17184138|NCT02671435|38336299|FG002|Overall Study|Lost to Follow-up|1|||
17184139|NCT02671435|38336300|FG003|Overall Study|Lost to Follow-up|0|||
17184140|NCT02671435|38336301|FG004|Overall Study|Lost to Follow-up|1|||
17184141|NCT02671435|38336302|FG005|Overall Study|Lost to Follow-up|1|||
17184142|NCT02671435|38336303|FG006|Overall Study|Lost to Follow-up|2|||
17184143|NCT02671435|38336304|FG007|Overall Study|Lost to Follow-up|2|||
17184144|NCT02671435|38336305|FG008|Overall Study|Lost to Follow-up|0|||
17184145|NCT02671435|38336306|FG009|Overall Study|Lost to Follow-up|2|||
17184146|NCT02671435|38336307|FG010|Overall Study|Lost to Follow-up|0|||
17184147|NCT02671435|38336308|FG011|Overall Study|Lost to Follow-up|3|||
17184148|NCT02671435|38336309|FG012|Overall Study|Lost to Follow-up|3|||
17184149|NCT02671435|38336310|FG013|Overall Study|Lost to Follow-up|2|||
17184150|NCT02671435|38336311|FG014|Overall Study|Lost to Follow-up|0|||
17184151|NCT02671435|38336297|FG000|Overall Study|Withdrawal by Subject|2|||
17184152|NCT02671435|38336298|FG001|Overall Study|Withdrawal by Subject|0|||
17184153|NCT02671435|38336299|FG002|Overall Study|Withdrawal by Subject|2|||
17184154|NCT02671435|38336300|FG003|Overall Study|Withdrawal by Subject|2|||
17184155|NCT02671435|38336301|FG004|Overall Study|Withdrawal by Subject|2|||
17184156|NCT02671435|38336302|FG005|Overall Study|Withdrawal by Subject|7|||
17184157|NCT02671435|38336303|FG006|Overall Study|Withdrawal by Subject|2|||
17184158|NCT02671435|38336304|FG007|Overall Study|Withdrawal by Subject|7|||
17184159|NCT02671435|38336305|FG008|Overall Study|Withdrawal by Subject|1|||
17184160|NCT02671435|38336306|FG009|Overall Study|Withdrawal by Subject|1|||
17184161|NCT02671435|38336307|FG010|Overall Study|Withdrawal by Subject|2|||
17184162|NCT02671435|38336308|FG011|Overall Study|Withdrawal by Subject|4|||
17184163|NCT02671435|38336309|FG012|Overall Study|Withdrawal by Subject|4|||
17184164|NCT02671435|38336310|FG013|Overall Study|Withdrawal by Subject|4|||
17184165|NCT02671435|38336311|FG014|Overall Study|Withdrawal by Subject|2|||
17184166|NCT02671435|38336297|FG000|Overall Study|Un-specified|0|||
17184167|NCT02671435|38336298|FG001|Overall Study|Un-specified|0|||
17184168|NCT02671435|38336299|FG002|Overall Study|Un-specified|0|||
17184169|NCT02671435|38336300|FG003|Overall Study|Un-specified|0|||
17184170|NCT02671435|38336301|FG004|Overall Study|Un-specified|1|||
17184171|NCT02671435|38336302|FG005|Overall Study|Un-specified|3|||
17184172|NCT02671435|38336303|FG006|Overall Study|Un-specified|2|||
17184173|NCT02671435|38336304|FG007|Overall Study|Un-specified|3|||
17184174|NCT02671435|38336305|FG008|Overall Study|Un-specified|0|||
17184175|NCT02671435|38336306|FG009|Overall Study|Un-specified|5|||
17184176|NCT02671435|38336307|FG010|Overall Study|Un-specified|8|||
17184177|NCT02671435|38336308|FG011|Overall Study|Un-specified|4|||
17184178|NCT02671435|38336309|FG012|Overall Study|Un-specified|5|||
17184179|NCT02671435|38336310|FG013|Overall Study|Un-specified|9|||
17184180|NCT02671435|38336311|FG014|Overall Study|Un-specified|8|||
17184181|NCT02916433|38336366|FG000|Overall Study|Withdrawal by Subject|1|||
17184182|NCT02916433|38336367|FG001|Overall Study|Withdrawal by Subject|0|||
17184183|NCT02916433|38336366|FG000|Overall Study|Physician Decision|1|||
17184184|NCT02916433|38336367|FG001|Overall Study|Physician Decision|0|||
17184185|NCT00526227|38336376|FG000|Overall Study|Device not implanted|1|||
17184186|NCT00526227|38336376|FG000|Overall Study|Death|1|||
17184187|NCT02547922|38336384|FG000|Overall Study|Withdrawal by Subject|9|||
17184188|NCT02547922|38336385|FG001|Overall Study|Withdrawal by Subject|6|||
17184189|NCT02547922|38336386|FG002|Overall Study|Withdrawal by Subject|10|||
17184190|NCT02547922|38336384|FG000|Overall Study|Adverse Event|3|||
17184191|NCT02547922|38336385|FG001|Overall Study|Adverse Event|1|||
17184192|NCT02547922|38336386|FG002|Overall Study|Adverse Event|2|||
17184193|NCT02547922|38336384|FG000|Overall Study|Lost to Follow-up|1|||
17184194|NCT02547922|38336385|FG001|Overall Study|Lost to Follow-up|0|||
17184195|NCT02547922|38336386|FG002|Overall Study|Lost to Follow-up|0|||
17184196|NCT02547922|38336384|FG000|Overall Study|Lack of Efficacy|5|||
17184197|NCT02547922|38336385|FG001|Overall Study|Lack of Efficacy|7|||
17184198|NCT02547922|38336386|FG002|Overall Study|Lack of Efficacy|4|||
17184199|NCT02547922|38336384|FG000|Overall Study|Death|1|||
17184200|NCT02547922|38336385|FG001|Overall Study|Death|0|||
17184201|NCT02547922|38336386|FG002|Overall Study|Death|0|||
17184202|NCT02547922|38336384|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
17184203|NCT02547922|38336385|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
17184204|NCT02547922|38336386|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
17184205|NCT02547922|38336384|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
17184206|NCT02547922|38336385|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
17184207|NCT02547922|38336386|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
17184208|NCT02547922|38336384|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
17184209|NCT02547922|38336385|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
17184210|NCT02547922|38336386|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
17184211|NCT02547922|38336384|FG000|Overall Study|Physician Decision|2|||
17184212|NCT02547922|38336385|FG001|Overall Study|Physician Decision|1|||
17184213|NCT02547922|38336386|FG002|Overall Study|Physician Decision|2|||
17184214|NCT02547922|38336384|FG000|Overall Study|Patients did not receive IP|1|||
17184215|NCT02547922|38336385|FG001|Overall Study|Patients did not receive IP|1|||
17184216|NCT02547922|38336386|FG002|Overall Study|Patients did not receive IP|0|||
17184217|NCT02547766|38336400|FG000|Overall Study|Withdrawal by Subject|1|||
17184218|NCT02547454|38336404|FG000|Overall Study|Due to hemodialysis|53|||
17184219|NCT02547454|38336404|FG000|Overall Study|Due to transplantation|1|||
17184220|NCT02547454|38336404|FG000|Overall Study|Due to no further need to treat|4|||
17184221|NCT02547454|38336404|FG000|Overall Study|Death|38|||
17184222|NCT02547454|38336404|FG000|Overall Study|Lost to Follow-up|26|||
17184223|NCT02547454|38336404|FG000|Overall Study|Other|39|||
17184224|NCT02547454|38336404|FG000|Overall Study|No data|11|||
17184225|NCT02742441|38336417|FG000|Overall Study|Lost to Follow-up|4|||
17184226|NCT02742441|38336418|FG001|Overall Study|Lost to Follow-up|4|||
17184227|NCT02742441|38336417|FG000|Overall Study|Withdrawal by Subject|2|||
17184228|NCT02742441|38336418|FG001|Overall Study|Withdrawal by Subject|2|||
17184229|NCT02742441|38336417|FG000|Overall Study|Adverse Event|0|||
17184230|NCT02742441|38336418|FG001|Overall Study|Adverse Event|2|||
17184231|NCT02547220|38336435|FG000|Overall Study|Withdrawal by Subject|1|||
17184232|NCT02547220|38336436|FG001|Overall Study|Withdrawal by Subject|0|||
17184233|NCT02547220|38336435|FG000|Overall Study|Study terminated by sponsor|18|||
17184234|NCT02547220|38336436|FG001|Overall Study|Study terminated by sponsor|20|||
17184235|NCT02542072|38336444|FG000|First Intervention (1 Month)|Adverse Event|1|||
17184236|NCT02542072|38336445|FG001|First Intervention (1 Month)|Adverse Event|1|||
17184237|NCT02542072|38336444|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
17184238|NCT02542072|38336445|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
17184239|NCT02542072|38336444|FG000|First Intervention (1 Month)|Lens discomfort|1|||
17184240|NCT02542072|38336445|FG001|First Intervention (1 Month)|Lens discomfort|2|||
17184241|NCT02542072|38336444|FG000|First Intervention (1 Month)|Protocol Violation|1|||
17184242|NCT02542072|38336445|FG001|First Intervention (1 Month)|Protocol Violation|0|||
17184243|NCT02542072|38336444|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
17184244|NCT02542072|38336445|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
17184245|NCT02542072|38336444|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
17184246|NCT02542072|38336445|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
17184247|NCT00415623|38336498|FG000|Overall Study|Adverse Event|3|||
17184248|NCT00415623|38336499|FG001|Overall Study|Adverse Event|4|||
17184249|NCT00415623|38336498|FG000|Overall Study|Death|1|||
17184250|NCT00415623|38336499|FG001|Overall Study|Death|0|||
17184251|NCT00415623|38336498|FG000|Overall Study|Withdrawal by Subject|1|||
17184252|NCT00415623|38336499|FG001|Overall Study|Withdrawal by Subject|1|||
17184253|NCT01969409|38336508|FG000|Overall Study|Death|2|||
17184254|NCT01969409|38336509|FG001|Overall Study|Death|2|||
17184255|NCT01969409|38336508|FG000|Overall Study|Transplant|1|||
17184256|NCT01969409|38336509|FG001|Overall Study|Transplant|1|||
17184257|NCT01969409|38336508|FG000|Overall Study|Withdrawal by Subject|0|||
17184258|NCT01969409|38336509|FG001|Overall Study|Withdrawal by Subject|1|||
17184259|NCT00150813|38336515|FG000|Overall Study|Adverse Event|1|||
17184260|NCT00150813|38336515|FG000|Overall Study|Lack of Efficacy|1|||
17184261|NCT00150813|38336515|FG000|Overall Study|Lost to Follow-up|5|||
17184262|NCT00150813|38336515|FG000|Overall Study|Withdrawal by Subject|5|||
17184263|NCT00150813|38336515|FG000|Overall Study|Remission|3|||
17184264|NCT00150813|38336515|FG000|Overall Study|Planned pregancy|1|||
17184265|NCT00150813|38336515|FG000|Overall Study|Switch to commercially available LEV|2|||
17184266|NCT02712788|38336521|FG000|Overall Study|Physician Decision|1|||
17184267|NCT02712788|38336522|FG001|Overall Study|Physician Decision|0|||
17184268|NCT02712788|38336521|FG000|Overall Study|Protocol Violation|1|||
17184269|NCT02712788|38336522|FG001|Overall Study|Protocol Violation|0|||
17184270|NCT02308111|38336530|FG000|Overall Study|Adverse Event|31|||
17184271|NCT02308111|38336531|FG001|Overall Study|Adverse Event|19|||
17184272|NCT02308111|38336530|FG000|Overall Study|Death|9|||
17184273|NCT02308111|38336531|FG001|Overall Study|Death|6|||
17184274|NCT02308111|38336530|FG000|Overall Study|Lost to Follow-up|2|||
17184275|NCT02308111|38336531|FG001|Overall Study|Lost to Follow-up|7|||
17184276|NCT02308111|38336530|FG000|Overall Study|Physician Decision|6|||
17184277|NCT02308111|38336531|FG001|Overall Study|Physician Decision|17|||
17184278|NCT02308111|38336530|FG000|Overall Study|Protocol Violation|0|||
17184279|NCT02308111|38336531|FG001|Overall Study|Protocol Violation|1|||
17184280|NCT02308111|38336530|FG000|Overall Study|Withdrawal by Subject|28|||
17184281|NCT02308111|38336531|FG001|Overall Study|Withdrawal by Subject|38|||
17184282|NCT02308111|38336530|FG000|Overall Study|Study Terminated by Sponsor|72|||
17184283|NCT02308111|38336531|FG001|Overall Study|Study Terminated by Sponsor|61|||
17184284|NCT02308111|38336530|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
17184285|NCT02308111|38336531|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
17184286|NCT02308111|38336530|FG000|Overall Study|Site Closure|3|||
17184287|NCT02308111|38336531|FG001|Overall Study|Site Closure|3|||
17184288|NCT02308111|38336530|FG000|Overall Study|Non-compliance with Study Drug|3|||
17184289|NCT02308111|38336531|FG001|Overall Study|Non-compliance with Study Drug|1|||
17184290|NCT02308111|38336530|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
17184291|NCT02308111|38336531|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
17184292|NCT02308111|38336530|FG000|Overall Study|Liver Transplant|3|||
17184293|NCT02308111|38336531|FG001|Overall Study|Liver Transplant|3|||
17184294|NCT02308111|38336530|FG000|Overall Study|Liver Transplant Waitlist|2|||
17184295|NCT02308111|38336531|FG001|Overall Study|Liver Transplant Waitlist|2|||
17184296|NCT02308111|38336530|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
17184297|NCT02308111|38336531|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
17184298|NCT01346189|38336542|FG000|Overall Study|Withdrawal by Subject|7|||
17184299|NCT01346189|38336543|FG001|Overall Study|Withdrawal by Subject|5|||
17184300|NCT01346189|38336544|FG002|Overall Study|Withdrawal by Subject|3|||
17184301|NCT01346189|38336545|FG003|Overall Study|Withdrawal by Subject|5|||
17184302|NCT01346189|38336542|FG000|Overall Study|Physician Decision|4|||
17184303|NCT01346189|38336543|FG001|Overall Study|Physician Decision|0|||
17184304|NCT01346189|38336544|FG002|Overall Study|Physician Decision|0|||
17184305|NCT01346189|38336545|FG003|Overall Study|Physician Decision|0|||
17184306|NCT01346189|38336542|FG000|Overall Study|Moved|3|||
17184307|NCT01346189|38336543|FG001|Overall Study|Moved|0|||
17184308|NCT01346189|38336544|FG002|Overall Study|Moved|4|||
17184309|NCT01346189|38336545|FG003|Overall Study|Moved|0|||
17184310|NCT01346189|38336542|FG000|Overall Study|Other|2|||
17184311|NCT01346189|38336543|FG001|Overall Study|Other|4|||
17184312|NCT01346189|38336544|FG002|Overall Study|Other|7|||
17184313|NCT01346189|38336545|FG003|Overall Study|Other|3|||
17184314|NCT01346189|38336542|FG000|Overall Study|Death|0|||
17184315|NCT01346189|38336543|FG001|Overall Study|Death|3|||
17184316|NCT01346189|38336544|FG002|Overall Study|Death|0|||
17184317|NCT01346189|38336545|FG003|Overall Study|Death|0|||
17184318|NCT01346189|38336542|FG000|Overall Study|Non-health system primary care physician|0|||
17184319|NCT01346189|38336543|FG001|Overall Study|Non-health system primary care physician|5|||
17184320|NCT01346189|38336544|FG002|Overall Study|Non-health system primary care physician|0|||
17184321|NCT01346189|38336545|FG003|Overall Study|Non-health system primary care physician|0|||
17184322|NCT01346189|38336542|FG000|Overall Study|Travel|0|||
17184323|NCT01346189|38336543|FG001|Overall Study|Travel|0|||
17184324|NCT01346189|38336544|FG002|Overall Study|Travel|0|||
17184325|NCT01346189|38336545|FG003|Overall Study|Travel|3|||
17184326|NCT00369317|38336555|FG000|Overall Study|Adverse Event|3|||
17184327|NCT00369317|38336555|FG000|Overall Study|Death|1|||
17184328|NCT00369317|38336555|FG000|Overall Study|Lack of Efficacy|5|||
17184329|NCT00369317|38336555|FG000|Overall Study|Physician Decision|2|||
17184330|NCT00369317|38336555|FG000|Overall Study|Withdrawal by Subject|8|||
17184331|NCT00369317|38336555|FG000|Overall Study|Ineligible|1|||
17184332|NCT03193021|38336562|FG000|Overall Study|Lost to Follow-up|1|||
17184333|NCT03193021|38336563|FG001|Overall Study|Lost to Follow-up|1|||
17184334|NCT03913091|38336571|FG000|Overall Study|Lost to Follow-up|18|||
17184335|NCT03913091|38336572|FG001|Overall Study|Lost to Follow-up|11|||
17184336|NCT03913091|38336571|FG000|Overall Study|Required additional meds/surgery|1|||
17184337|NCT03913091|38336572|FG001|Overall Study|Required additional meds/surgery|2|||
17184338|NCT03913091|38336571|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
17184339|NCT03913091|38336572|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
17184340|NCT01318499|38336596|FG000|Overall Study|Adverse Event|16|||
17184341|NCT01318499|38336597|FG001|Overall Study|Adverse Event|11|||
17184342|NCT01318499|38336598|FG002|Overall Study|Adverse Event|6|||
17184343|NCT01318499|38336596|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
17184344|NCT01318499|38336597|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
17184345|NCT01318499|38336598|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
17184346|NCT01318499|38336596|FG000|Overall Study|Noncompliance|2|||
17184347|NCT01318499|38336597|FG001|Overall Study|Noncompliance|3|||
17184348|NCT01318499|38336598|FG002|Overall Study|Noncompliance|0|||
17184349|NCT01318499|38336596|FG000|Overall Study|Treatment Failure|19|||
17184350|NCT01318499|38336597|FG001|Overall Study|Treatment Failure|19|||
17184351|NCT01318499|38336598|FG002|Overall Study|Treatment Failure|101|||
17184352|NCT01318499|38336596|FG000|Overall Study|Protocol Violation|2|||
17184353|NCT01318499|38336597|FG001|Overall Study|Protocol Violation|4|||
17184354|NCT01318499|38336598|FG002|Overall Study|Protocol Violation|2|||
17184355|NCT01318499|38336596|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
17184356|NCT01318499|38336597|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
17184357|NCT01318499|38336598|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
17184358|NCT01318499|38336596|FG000|Overall Study|Other|7|||
17184359|NCT01318499|38336597|FG001|Overall Study|Other|10|||
17184360|NCT01318499|38336598|FG002|Overall Study|Other|22|||
17184361|NCT02285595|38336632|FG000|Overall Study|Lost to Follow-up|14|||
17184362|NCT02285595|38336632|FG000|Overall Study|Withdrawal by Subject|1|||
17184363|NCT02712398|38336655|FG000|Overall Study|Withdrawal by Subject|6|||
17184364|NCT02712398|38336655|FG000|Overall Study|Lost to Follow-up|6|||
17184365|NCT02712398|38336655|FG000|Overall Study|Sponsor Decision|1|||
17184366|NCT02712398|38336655|FG000|Overall Study|Physician Decision|1|||
17184367|NCT02712398|38336655|FG000|Overall Study|Death|2|||
17184368|NCT02712398|38336655|FG000|Overall Study|Re-operation|21|||
17184369|NCT00282867|38336662|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
17184370|NCT00282867|38336663|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
17184371|NCT00282867|38336664|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
17184372|NCT00151281|38336669|FG000|Overall Study|Not evaluable|3|||
17184373|NCT01318109|38336684|FG000|Overall Study|Adverse Event|0|||
17184374|NCT01318109|38336685|FG001|Overall Study|Adverse Event|2|||
17184375|NCT01318109|38336686|FG002|Overall Study|Adverse Event|0|||
17184376|NCT01318109|38336684|FG000|Overall Study|Withdrawal by Subject|1|||
17184377|NCT01318109|38336685|FG001|Overall Study|Withdrawal by Subject|0|||
17184378|NCT01318109|38336686|FG002|Overall Study|Withdrawal by Subject|0|||
17184379|NCT01318109|38336684|FG000|Overall Study|Schedule Conflict|0|||
17184380|NCT01318109|38336685|FG001|Overall Study|Schedule Conflict|1|||
17184381|NCT01318109|38336686|FG002|Overall Study|Schedule Conflict|0|||
17184382|NCT02712554|38336696|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
17184383|NCT02712554|38336697|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
17184384|NCT02712554|38336696|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
17184385|NCT02712554|38336697|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
17184386|NCT02712554|38336696|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
17184387|NCT02712554|38336697|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
17184388|NCT02712554|38336696|FG000|Part B: Qualification Phase|Adverse Event|0|||
17184389|NCT02712554|38336697|FG001|Part B: Qualification Phase|Adverse Event|1|||
17184390|NCT02712554|38336696|FG000|Part B: Treatment Phase|Adverse Event|0|||
17184391|NCT02712554|38336697|FG001|Part B: Treatment Phase|Adverse Event|1|||
17184392|NCT02712554|38336696|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
17184393|NCT02712554|38336697|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
17184394|NCT02712554|38336696|FG000|Part B: Treatment Phase|Other|0|||
17184395|NCT02712554|38336697|FG001|Part B: Treatment Phase|Other|1|||
17184396|NCT02712320|38336720|FG000|Overall Study|Lost to Follow-up|1|||
17184397|NCT02712320|38336720|FG000|Overall Study|Withdrawal by Subject|1|||
17184398|NCT02712320|38336720|FG000|Overall Study|Transferred to another facility|1|||
17184399|NCT02712320|38336720|FG000|Overall Study|Treating with the prohibited medications|2|||
17184400|NCT03052751|38336726|FG000|Dosing Period 1|Adverse Event|0|||
17184401|NCT03052751|38336727|FG001|Dosing Period 1|Adverse Event|1|||
17184402|NCT03052751|38336728|FG002|Dosing Period 1|Adverse Event|0|||
17184403|NCT03052751|38336729|FG003|Dosing Period 1|Adverse Event|0|||
17184404|NCT03052751|38336730|FG004|Dosing Period 1|Adverse Event|0|||
17184405|NCT03052751|38336731|FG005|Dosing Period 1|Adverse Event|0|||
17184406|NCT03052751|38336726|FG000|Dosing Period 2|Adverse Event|0|||
17184407|NCT03052751|38336727|FG001|Dosing Period 2|Adverse Event|0|||
17184408|NCT03052751|38336728|FG002|Dosing Period 2|Adverse Event|3|||
17184409|NCT03052751|38336729|FG003|Dosing Period 2|Adverse Event|0|||
17184410|NCT03052751|38336730|FG004|Dosing Period 2|Adverse Event|0|||
17184411|NCT03052751|38336731|FG005|Dosing Period 2|Adverse Event|0|||
17184412|NCT03052751|38336726|FG000|Observation Period|Adverse Event|0|||
17184413|NCT03052751|38336727|FG001|Observation Period|Adverse Event|0|||
17184414|NCT03052751|38336728|FG002|Observation Period|Adverse Event|0|||
17184415|NCT03052751|38336729|FG003|Observation Period|Adverse Event|0|||
17184416|NCT03052751|38336730|FG004|Observation Period|Adverse Event|1|||
17184417|NCT03052751|38336731|FG005|Observation Period|Adverse Event|0|||
17184418|NCT01317797|38336744|FG000|Overall Study|Other|0|||
17184419|NCT01317797|38336745|FG001|Overall Study|Other|1|||
17184420|NCT01317797|38336746|FG002|Overall Study|Other|0|||
17184421|NCT01317797|38336744|FG000|Overall Study|Withdrawal of Patient|0|||
17184422|NCT01317797|38336745|FG001|Overall Study|Withdrawal of Patient|0|||
17184423|NCT01317797|38336746|FG002|Overall Study|Withdrawal of Patient|1|||
17184424|NCT01343693|38336754|FG000|Overall Study|Lost to Follow-up|9|||
17184425|NCT02712008|38336761|FG000|Baseline (Day 1) up to Week 12|Death|3|||
17184426|NCT02712008|38336762|FG001|Baseline (Day 1) up to Week 12|Death|0|||
17184427|NCT02712008|38336763|FG002|Baseline (Day 1) up to Week 12|Death|0|||
17184428|NCT02712008|38336764|FG003|Baseline (Day 1) up to Week 12|Death|0|||
17184429|NCT02712008|38336765|FG004|Baseline (Day 1) up to Week 12|Death|0|||
17184430|NCT02712008|38336766|FG005|Baseline (Day 1) up to Week 12|Death|0|||
17184431|NCT02712008|38336767|FG006|Baseline (Day 1) up to Week 12|Death|0|||
17184432|NCT02712008|38336768|FG007|Baseline (Day 1) up to Week 12|Death|0|||
17184433|NCT02712008|38336761|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17184434|NCT02712008|38336762|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
17184435|NCT02712008|38336763|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
17184436|NCT02712008|38336764|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17184437|NCT02712008|38336765|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17184438|NCT02712008|38336766|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17184439|NCT02712008|38336767|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17184440|NCT02712008|38336768|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
17184441|NCT02712008|38336761|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
17184442|NCT02712008|38336762|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17184443|NCT02712008|38336763|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
17184444|NCT02712008|38336764|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17184445|NCT02712008|38336765|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17184446|NCT02712008|38336766|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17184447|NCT02712008|38336767|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17184448|NCT02712008|38336768|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
17184449|NCT02712008|38336761|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
17184450|NCT02712008|38336762|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
17184451|NCT02712008|38336763|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
17184452|NCT02712008|38336764|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
17184453|NCT02712008|38336765|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
17184454|NCT02712008|38336766|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
17184455|NCT02712008|38336767|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
17184456|NCT02712008|38336768|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
17184457|NCT02712008|38336761|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
17184458|NCT02712008|38336762|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
17184459|NCT02712008|38336763|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
17184460|NCT02712008|38336764|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
17184461|NCT02712008|38336765|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
17184462|NCT02712008|38336766|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
17184463|NCT02712008|38336767|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
17184464|NCT02712008|38336768|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
17184465|NCT02712008|38336761|FG000|From Week 12 up to Week 36|Adverse Event|0|||
17184466|NCT02712008|38336762|FG001|From Week 12 up to Week 36|Adverse Event|0|||
17184467|NCT02712008|38336763|FG002|From Week 12 up to Week 36|Adverse Event|0|||
17184468|NCT02712008|38336764|FG003|From Week 12 up to Week 36|Adverse Event|0|||
17184469|NCT02712008|38336765|FG004|From Week 12 up to Week 36|Adverse Event|1|||
17184470|NCT02712008|38336766|FG005|From Week 12 up to Week 36|Adverse Event|0|||
17184471|NCT02712008|38336767|FG006|From Week 12 up to Week 36|Adverse Event|0|||
17184472|NCT02712008|38336768|FG007|From Week 12 up to Week 36|Adverse Event|2|||
17184473|NCT02712008|38336761|FG000|From Week 12 up to Week 36|Death|1|||
17184474|NCT02712008|38336762|FG001|From Week 12 up to Week 36|Death|0|||
17184475|NCT02712008|38336763|FG002|From Week 12 up to Week 36|Death|0|||
17184476|NCT02712008|38336764|FG003|From Week 12 up to Week 36|Death|0|||
17184477|NCT02712008|38336765|FG004|From Week 12 up to Week 36|Death|0|||
17184478|NCT02712008|38336766|FG005|From Week 12 up to Week 36|Death|0|||
17184479|NCT02712008|38336767|FG006|From Week 12 up to Week 36|Death|1|||
17184480|NCT02712008|38336768|FG007|From Week 12 up to Week 36|Death|0|||
17184481|NCT02712008|38336761|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
17184482|NCT02712008|38336762|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
17184483|NCT02712008|38336763|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
17184484|NCT02712008|38336764|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
17184485|NCT02712008|38336765|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
17184486|NCT02712008|38336766|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
17184487|NCT02712008|38336767|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
17184488|NCT02712008|38336768|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
17184489|NCT02712008|38336761|FG000|From Week 12 up to Week 36|Physician Decision|0|||
17184490|NCT02712008|38336762|FG001|From Week 12 up to Week 36|Physician Decision|0|||
17184491|NCT02712008|38336763|FG002|From Week 12 up to Week 36|Physician Decision|0|||
17184492|NCT02712008|38336764|FG003|From Week 12 up to Week 36|Physician Decision|1|||
17184493|NCT02712008|38336765|FG004|From Week 12 up to Week 36|Physician Decision|1|||
17184494|NCT02712008|38336766|FG005|From Week 12 up to Week 36|Physician Decision|0|||
17184495|NCT02712008|38336767|FG006|From Week 12 up to Week 36|Physician Decision|0|||
17184496|NCT02712008|38336768|FG007|From Week 12 up to Week 36|Physician Decision|0|||
17184497|NCT02712008|38336761|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
17184498|NCT02712008|38336762|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
17184499|NCT02712008|38336763|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
17184500|NCT02712008|38336764|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
17184501|NCT02712008|38336765|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
17184502|NCT02712008|38336766|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
17184503|NCT02712008|38336767|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
17184504|NCT02712008|38336768|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
17184505|NCT04238481|38336786|FG000|Overall Study|Miscellaneous|0|||
17184506|NCT04238481|38336787|FG001|Overall Study|Miscellaneous|1|||
17184507|NCT04238481|38336788|FG002|Overall Study|Miscellaneous|0|||
17184508|NCT04238481|38336789|FG003|Overall Study|Miscellaneous|0|||
17184509|NCT02711306|38336805|FG000|Overall Study|Withdrawal by Subject|2|||
17184510|NCT02711306|38336806|FG001|Overall Study|Withdrawal by Subject|2|||
17184511|NCT05012163|38336816|FG000|Overall Study|Protocol Violation|0|||
17184512|NCT05012163|38336817|FG001|Overall Study|Protocol Violation|0|||
17184513|NCT05012163|38336818|FG002|Overall Study|Protocol Violation|1|||
17184514|NCT05012163|38336819|FG003|Overall Study|Protocol Violation|1|||
17184515|NCT02710292|38336829|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
17184516|NCT02710292|38336830|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
17184517|NCT02710292|38336829|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
17184518|NCT02710292|38336830|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
17184519|NCT02710214|38336839|FG000|Overall Study|Lost to Follow-up|1|||
17184520|NCT02710214|38336840|FG001|Overall Study|Lost to Follow-up|0|||
17184521|NCT02710214|38336839|FG000|Overall Study|Lack of Efficacy|0|||
17184522|NCT02710214|38336840|FG001|Overall Study|Lack of Efficacy|1|||
17184523|NCT02710214|38336839|FG000|Overall Study|Death|0|||
17184524|NCT02710214|38336840|FG001|Overall Study|Death|1|||
17184525|NCT03052517|38336849|FG000|Overall Study|Study Terminated By Sponsor|928|||
17184526|NCT03052517|38336850|FG001|Overall Study|Study Terminated By Sponsor|938|||
17184527|NCT03052517|38336851|FG002|Overall Study|Study Terminated By Sponsor|296|||
17184528|NCT03052517|38336849|FG000|Overall Study|Subject/Guardian Decision|50|||
17184529|NCT03052517|38336850|FG001|Overall Study|Subject/Guardian Decision|45|||
17184530|NCT03052517|38336851|FG002|Overall Study|Subject/Guardian Decision|22|||
17184531|NCT03052517|38336849|FG000|Overall Study|Lack of Efficacy|23|||
17184532|NCT03052517|38336850|FG001|Overall Study|Lack of Efficacy|14|||
17184533|NCT03052517|38336851|FG002|Overall Study|Lack of Efficacy|7|||
17184534|NCT03052517|38336849|FG000|Overall Study|Adverse Event|6|||
17184535|NCT03052517|38336850|FG001|Overall Study|Adverse Event|5|||
17184536|NCT03052517|38336851|FG002|Overall Study|Adverse Event|0|||
17184537|NCT03052517|38336849|FG000|Overall Study|Physician Decision|4|||
17184538|NCT03052517|38336850|FG001|Overall Study|Physician Decision|5|||
17184539|NCT03052517|38336851|FG002|Overall Study|Physician Decision|1|||
17184540|NCT03052517|38336849|FG000|Overall Study|Death|3|||
17184541|NCT03052517|38336850|FG001|Overall Study|Death|0|||
17184542|NCT03052517|38336851|FG002|Overall Study|Death|1|||
17184543|NCT03052517|38336849|FG000|Overall Study|Lost to Follow-up|2|||
17184544|NCT03052517|38336850|FG001|Overall Study|Lost to Follow-up|4|||
17184545|NCT03052517|38336851|FG002|Overall Study|Lost to Follow-up|0|||
17184546|NCT03052517|38336849|FG000|Overall Study|Pregnancy|1|||
17184547|NCT03052517|38336850|FG001|Overall Study|Pregnancy|0|||
17184548|NCT03052517|38336851|FG002|Overall Study|Pregnancy|1|||
17184549|NCT03052517|38336849|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
17184550|NCT03052517|38336850|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
17184551|NCT03052517|38336851|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
17184552|NCT03052517|38336849|FG000|Overall Study|Technical Problems|0|||
17184553|NCT03052517|38336850|FG001|Overall Study|Technical Problems|1|||
17184554|NCT03052517|38336851|FG002|Overall Study|Technical Problems|0|||
17184555|NCT02708498|38336867|FG000|Overall Study|Death|20|||
17184556|NCT02708498|38336868|FG001|Overall Study|Death|19|||
17184557|NCT02708498|38336869|FG002|Overall Study|Death|0|||
17184558|NCT02708498|38336870|FG003|Overall Study|Death|0|||
17184559|NCT02708498|38336871|FG004|Overall Study|Death|1|||
17184560|NCT02708498|38336872|FG005|Overall Study|Death|0|||
17184561|NCT02708498|38336873|FG006|Overall Study|Death|0|||
17184562|NCT02708498|38336874|FG007|Overall Study|Death|0|||
17184563|NCT02708498|38336867|FG000|Overall Study|Unknown reason, missing data|0|||
17184564|NCT02708498|38336868|FG001|Overall Study|Unknown reason, missing data|0|||
17184565|NCT02708498|38336869|FG002|Overall Study|Unknown reason, missing data|62|||
17184566|NCT02708498|38336870|FG003|Overall Study|Unknown reason, missing data|51|||
17184567|NCT02708498|38336871|FG004|Overall Study|Unknown reason, missing data|195|||
17184568|NCT02708498|38336872|FG005|Overall Study|Unknown reason, missing data|132|||
17184569|NCT02708498|38336873|FG006|Overall Study|Unknown reason, missing data|0|||
17184570|NCT02708498|38336874|FG007|Overall Study|Unknown reason, missing data|0|||
17184571|NCT02710136|38336892|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
17184572|NCT02710136|38336893|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
17184573|NCT03702231|38336903|FG000|Overall Study|Withdrawal by Subject|1|||
17184574|NCT03702231|38336904|FG001|Overall Study|Withdrawal by Subject|0|||
17184575|NCT03702231|38336905|FG002|Overall Study|Withdrawal by Subject|0|||
17184576|NCT03702231|38336903|FG000|Overall Study|Protocol Violation|0|||
17184577|NCT03702231|38336904|FG001|Overall Study|Protocol Violation|0|||
17184578|NCT03702231|38336905|FG002|Overall Study|Protocol Violation|1|||
17184579|NCT03702231|38336903|FG000|Overall Study|COVID Pandemic|3|||
17184580|NCT03702231|38336904|FG001|Overall Study|COVID Pandemic|4|||
17184581|NCT03702231|38336905|FG002|Overall Study|COVID Pandemic|1|||
17184582|NCT02741271|38336915|FG000|Overall Study|Lost to Follow-up|2|||
17184583|NCT02741271|38336916|FG001|Overall Study|Lost to Follow-up|0|||
17184584|NCT02741271|38336915|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
17184585|NCT02741271|38336916|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
17184586|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
17184587|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
17184588|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
17184589|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
17184590|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
17184591|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
17184592|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
17184593|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
17184594|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
17184595|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
17184596|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
17184597|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
17184598|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
17184599|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
17184600|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
17184601|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
17184602|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
17184603|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
17184604|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
17184605|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
17184606|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
17184607|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
17184608|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
17184609|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
17184610|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
17184611|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
17184612|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
17184613|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
17184614|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
17184615|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
17184616|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
17184617|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
17184618|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
17184619|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
17184620|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
17184621|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
17184622|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
17184623|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
17184624|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
17184625|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
17184626|NCT02709746|38336929|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
17184627|NCT02709746|38336930|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
17184628|NCT02709746|38336931|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
17184629|NCT02709746|38336932|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
17184630|NCT02709746|38336933|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
17184631|NCT02709746|38336929|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
17184632|NCT02709746|38336930|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
17184633|NCT02709746|38336931|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
17184634|NCT02709746|38336932|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
17184635|NCT02709746|38336933|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
17184636|NCT02709746|38336929|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
17184637|NCT02709746|38336930|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
17184638|NCT02709746|38336931|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
17184639|NCT02709746|38336932|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
17184640|NCT02709746|38336933|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
17184641|NCT02709746|38336929|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
17184642|NCT02709746|38336930|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
17184643|NCT02709746|38336931|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
17184644|NCT02709746|38336932|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
17184645|NCT02709746|38336933|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
17184646|NCT02709746|38336929|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
17184647|NCT02709746|38336930|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
17184648|NCT02709746|38336931|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
17184649|NCT02709746|38336932|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
17184650|NCT02709746|38336933|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
17184651|NCT02709746|38336929|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
17184652|NCT02709746|38336930|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
17184653|NCT02709746|38336931|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
17184654|NCT02709746|38336932|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
17184655|NCT02709746|38336933|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
17184656|NCT02709746|38336929|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
17184657|NCT02709746|38336930|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
17184658|NCT02709746|38336931|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
17184659|NCT02709746|38336932|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
17184660|NCT02709746|38336933|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
17184661|NCT02709746|38336929|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
17184662|NCT02709746|38336930|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
17184663|NCT02709746|38336931|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
17184664|NCT02709746|38336932|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
17184665|NCT02709746|38336933|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
17184666|NCT02709746|38336929|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
17184667|NCT02709746|38336930|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
17184668|NCT02709746|38336931|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
17184669|NCT02709746|38336932|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
17184670|NCT02709746|38336933|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
17184671|NCT01317641|38336954|FG000|Overall Study|Not treated|0|||
17184672|NCT01317641|38336955|FG001|Overall Study|Not treated|0|||
17184673|NCT01317641|38336956|FG002|Overall Study|Not treated|0|||
17184674|NCT01317641|38336957|FG003|Overall Study|Not treated|0|||
17184675|NCT01317641|38336958|FG004|Overall Study|Not treated|0|||
17184676|NCT01317641|38336959|FG005|Overall Study|Not treated|0|||
17184677|NCT01317641|38336960|FG006|Overall Study|Not treated|0|||
17184678|NCT01317641|38336961|FG007|Overall Study|Not treated|1|||
17184679|NCT01317641|38336962|FG008|Overall Study|Not treated|1|||
17184680|NCT01317641|38336954|FG000|Overall Study|Adverse Event|0|||
17184681|NCT01317641|38336955|FG001|Overall Study|Adverse Event|1|||
17184682|NCT01317641|38336956|FG002|Overall Study|Adverse Event|0|||
17184683|NCT01317641|38336957|FG003|Overall Study|Adverse Event|1|||
17184684|NCT01317641|38336958|FG004|Overall Study|Adverse Event|0|||
17184685|NCT01317641|38336959|FG005|Overall Study|Adverse Event|0|||
17184686|NCT01317641|38336960|FG006|Overall Study|Adverse Event|2|||
17184687|NCT01317641|38336961|FG007|Overall Study|Adverse Event|1|||
17184688|NCT01317641|38336962|FG008|Overall Study|Adverse Event|0|||
17184689|NCT01317641|38336954|FG000|Overall Study|Protocol Violation|1|||
17184690|NCT01317641|38336955|FG001|Overall Study|Protocol Violation|0|||
17184691|NCT01317641|38336956|FG002|Overall Study|Protocol Violation|0|||
17184692|NCT01317641|38336957|FG003|Overall Study|Protocol Violation|0|||
17184693|NCT01317641|38336958|FG004|Overall Study|Protocol Violation|0|||
17184694|NCT01317641|38336959|FG005|Overall Study|Protocol Violation|0|||
17184695|NCT01317641|38336960|FG006|Overall Study|Protocol Violation|0|||
17184696|NCT01317641|38336961|FG007|Overall Study|Protocol Violation|0|||
17184697|NCT01317641|38336962|FG008|Overall Study|Protocol Violation|0|||
17184698|NCT01317641|38336954|FG000|Overall Study|Disease progression|0|||
17184699|NCT01317641|38336955|FG001|Overall Study|Disease progression|0|||
17184700|NCT01317641|38336956|FG002|Overall Study|Disease progression|0|||
17184701|NCT01317641|38336957|FG003|Overall Study|Disease progression|0|||
17184702|NCT01317641|38336958|FG004|Overall Study|Disease progression|0|||
17184703|NCT01317641|38336959|FG005|Overall Study|Disease progression|0|||
17184704|NCT01317641|38336960|FG006|Overall Study|Disease progression|0|||
17184705|NCT01317641|38336961|FG007|Overall Study|Disease progression|3|||
17184706|NCT01317641|38336962|FG008|Overall Study|Disease progression|4|||
17184707|NCT01317641|38336954|FG000|Overall Study|Withdrawal by Subject|0|||
17184708|NCT01317641|38336955|FG001|Overall Study|Withdrawal by Subject|0|||
17184709|NCT01317641|38336956|FG002|Overall Study|Withdrawal by Subject|0|||
17184710|NCT01317641|38336957|FG003|Overall Study|Withdrawal by Subject|0|||
17184711|NCT01317641|38336958|FG004|Overall Study|Withdrawal by Subject|0|||
17184712|NCT01317641|38336959|FG005|Overall Study|Withdrawal by Subject|0|||
17184713|NCT01317641|38336960|FG006|Overall Study|Withdrawal by Subject|1|||
17184714|NCT01317641|38336961|FG007|Overall Study|Withdrawal by Subject|0|||
17184715|NCT01317641|38336962|FG008|Overall Study|Withdrawal by Subject|0|||
17184716|NCT03186794|38336998|FG000|Overall Study|Physician Decision|2|||
17184717|NCT03186794|38336998|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
17184718|NCT02290431|38337003|FG000|Overall Study|Adverse Event|20|||
17184719|NCT02290431|38337003|FG000|Overall Study|Progressive disease|4|||
17184720|NCT02290431|38337003|FG000|Overall Study|Study terminated by Sponsor|1|||
17184721|NCT02290431|38337003|FG000|Overall Study|Physician Decision|2|||
17184722|NCT03051659|38337009|FG000|Treatment Period|Withdrawal by Subject|0|||
17184723|NCT03051659|38337010|FG001|Treatment Period|Withdrawal by Subject|2|||
17184724|NCT03051659|38337009|FG000|Survival Follow-up|Lost to Follow-up|23|||
17184725|NCT03051659|38337010|FG001|Survival Follow-up|Lost to Follow-up|22|||
17184726|NCT02707952|38337020|FG000|Overall Study|Adverse Event|1|||
17184727|NCT02707952|38337021|FG001|Overall Study|Adverse Event|0|||
17184728|NCT02707952|38337022|FG002|Overall Study|Adverse Event|0|||
17184729|NCT02707952|38337023|FG003|Overall Study|Adverse Event|0|||
17184730|NCT02707952|38337020|FG000|Overall Study|Lost to Follow-up|1|||
17184731|NCT02707952|38337021|FG001|Overall Study|Lost to Follow-up|0|||
17184732|NCT02707952|38337022|FG002|Overall Study|Lost to Follow-up|0|||
17184733|NCT02707952|38337023|FG003|Overall Study|Lost to Follow-up|0|||
17184734|NCT02707952|38337020|FG000|Overall Study|Withdrawal by Subject|0|||
17184735|NCT02707952|38337021|FG001|Overall Study|Withdrawal by Subject|1|||
17184736|NCT02707952|38337022|FG002|Overall Study|Withdrawal by Subject|2|||
17184737|NCT02707952|38337023|FG003|Overall Study|Withdrawal by Subject|0|||
17184738|NCT03050801|38337041|FG000|Experiment 1|Lost to Follow-up|0|||
17184739|NCT03050801|38337042|FG001|Experiment 1|Lost to Follow-up|1|||
17184740|NCT03050801|38337043|FG002|Experiment 1|Lost to Follow-up|0|||
17184741|NCT03050801|38337044|FG003|Experiment 1|Lost to Follow-up|0|||
17184742|NCT03050801|38337045|FG004|Experiment 1|Lost to Follow-up|0|||
17184743|NCT03050801|38337046|FG005|Experiment 1|Lost to Follow-up|0|||
17184744|NCT03050801|38337041|FG000|Experiment 1|Physician Decision|0|||
17184745|NCT03050801|38337042|FG001|Experiment 1|Physician Decision|3|||
17184746|NCT03050801|38337043|FG002|Experiment 1|Physician Decision|0|||
17184747|NCT03050801|38337044|FG003|Experiment 1|Physician Decision|0|||
17184748|NCT03050801|38337045|FG004|Experiment 1|Physician Decision|0|||
17184749|NCT03050801|38337046|FG005|Experiment 1|Physician Decision|0|||
17184750|NCT03050801|38337041|FG000|Experiment 1|Change of experimental design|0|||
17184751|NCT03050801|38337042|FG001|Experiment 1|Change of experimental design|3|||
17184752|NCT03050801|38337043|FG002|Experiment 1|Change of experimental design|0|||
17184753|NCT03050801|38337044|FG003|Experiment 1|Change of experimental design|0|||
17184754|NCT03050801|38337045|FG004|Experiment 1|Change of experimental design|0|||
17184755|NCT03050801|38337046|FG005|Experiment 1|Change of experimental design|0|||
17184756|NCT03050801|38337041|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
17184757|NCT03050801|38337042|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
17184758|NCT03050801|38337043|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
17184759|NCT03050801|38337044|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
17184760|NCT03050801|38337045|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
17184761|NCT03050801|38337046|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
17184762|NCT03050801|38337041|FG000|Experiment 2|Lost to Follow-up|0|||
17184763|NCT03050801|38337042|FG001|Experiment 2|Lost to Follow-up|0|||
17184764|NCT03050801|38337043|FG002|Experiment 2|Lost to Follow-up|0|||
17184765|NCT03050801|38337044|FG003|Experiment 2|Lost to Follow-up|1|||
17184766|NCT03050801|38337045|FG004|Experiment 2|Lost to Follow-up|1|||
17184767|NCT03050801|38337046|FG005|Experiment 2|Lost to Follow-up|0|||
17184768|NCT03050801|38337041|FG000|Experiment 2|Physician Decision|0|||
17184769|NCT03050801|38337042|FG001|Experiment 2|Physician Decision|0|||
17184770|NCT03050801|38337043|FG002|Experiment 2|Physician Decision|0|||
17184771|NCT03050801|38337044|FG003|Experiment 2|Physician Decision|0|||
17184772|NCT03050801|38337045|FG004|Experiment 2|Physician Decision|1|||
17184773|NCT03050801|38337046|FG005|Experiment 2|Physician Decision|0|||
17184774|NCT03050801|38337041|FG000|Experiment 2|Pregnancy|0|||
17184775|NCT03050801|38337042|FG001|Experiment 2|Pregnancy|0|||
17184776|NCT03050801|38337043|FG002|Experiment 2|Pregnancy|0|||
17184777|NCT03050801|38337044|FG003|Experiment 2|Pregnancy|0|||
17184778|NCT03050801|38337045|FG004|Experiment 2|Pregnancy|1|||
17184779|NCT03050801|38337046|FG005|Experiment 2|Pregnancy|0|||
17184780|NCT03050801|38337041|FG000|Experiment 2|Withdrawal by Subject|0|||
17184781|NCT03050801|38337042|FG001|Experiment 2|Withdrawal by Subject|0|||
17184782|NCT03050801|38337043|FG002|Experiment 2|Withdrawal by Subject|0|||
17184783|NCT03050801|38337044|FG003|Experiment 2|Withdrawal by Subject|1|||
17184784|NCT03050801|38337045|FG004|Experiment 2|Withdrawal by Subject|0|||
17184785|NCT03050801|38337046|FG005|Experiment 2|Withdrawal by Subject|0|||
17184786|NCT03050801|38337041|FG000|Experiment 2|Poor data quality|0|||
17184787|NCT03050801|38337042|FG001|Experiment 2|Poor data quality|0|||
17184788|NCT03050801|38337043|FG002|Experiment 2|Poor data quality|0|||
17184789|NCT03050801|38337044|FG003|Experiment 2|Poor data quality|4|||
17184790|NCT03050801|38337045|FG004|Experiment 2|Poor data quality|1|||
17184791|NCT03050801|38337046|FG005|Experiment 2|Poor data quality|0|||
17184792|NCT03050801|38337041|FG000|Experiment 2|Discomfort during stimulation|0|||
17184793|NCT03050801|38337042|FG001|Experiment 2|Discomfort during stimulation|0|||
17184794|NCT03050801|38337043|FG002|Experiment 2|Discomfort during stimulation|0|||
17184795|NCT03050801|38337044|FG003|Experiment 2|Discomfort during stimulation|0|||
17184796|NCT03050801|38337045|FG004|Experiment 2|Discomfort during stimulation|0|||
17184797|NCT03050801|38337046|FG005|Experiment 2|Discomfort during stimulation|2|||
17184798|NCT02707640|38337065|FG000|Overall Study|Adverse Event|4|||
17184799|NCT02707640|38337066|FG001|Overall Study|Adverse Event|2|||
17184800|NCT02707640|38337065|FG000|Overall Study|Death|1|||
17184801|NCT02707640|38337066|FG001|Overall Study|Death|2|||
17184802|NCT02707640|38337065|FG000|Overall Study|Physician Decision|2|||
17184803|NCT02707640|38337066|FG001|Overall Study|Physician Decision|0|||
17184804|NCT02707640|38337065|FG000|Overall Study|Withdrawal by Subject|0|||
17184805|NCT02707640|38337066|FG001|Overall Study|Withdrawal by Subject|1|||
17184806|NCT02707640|38337065|FG000|Overall Study|Participant's Personal Decision|1|||
17184807|NCT02707640|38337066|FG001|Overall Study|Participant's Personal Decision|2|||
17184808|NCT02707640|38337065|FG000|Overall Study|Sponsor Discretion|1|||
17184809|NCT02707640|38337066|FG001|Overall Study|Sponsor Discretion|0|||
17184810|NCT02708966|38337074|FG000|Overall Study|Lost to Follow-up|2|||
17184811|NCT02708966|38337075|FG001|Overall Study|Lost to Follow-up|2|||
17184812|NCT02706938|38337083|FG000|First Period, 6 Weeks|Adverse Event|8|||
17184813|NCT02706938|38337084|FG001|First Period, 6 Weeks|Adverse Event|0|||
17184814|NCT02706938|38337083|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
17184815|NCT02706938|38337084|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
17184816|NCT02706938|38337083|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
17184817|NCT02706938|38337084|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
17184818|NCT02706938|38337083|FG000|Second Period, 6 Weeks|Adverse Event|0|||
17184819|NCT02706938|38337084|FG001|Second Period, 6 Weeks|Adverse Event|7|||
17184820|NCT02706938|38337083|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
17184821|NCT02706938|38337084|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
17184822|NCT03053063|38337094|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
17184823|NCT03053063|38337095|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
17184824|NCT03053063|38337096|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
17184825|NCT03053063|38337097|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
17184826|NCT03053063|38337094|FG000|Randomized Phase|Withdrew consent|8|||
17184827|NCT03053063|38337095|FG001|Randomized Phase|Withdrew consent|11|||
17184828|NCT03053063|38337096|FG002|Randomized Phase|Withdrew consent|5|||
17184829|NCT03053063|38337097|FG003|Randomized Phase|Withdrew consent|0|||
17184830|NCT03053063|38337094|FG000|Randomized Phase|Investigator's Discretion|8|||
17184831|NCT03053063|38337095|FG001|Randomized Phase|Investigator's Discretion|6|||
17184832|NCT03053063|38337096|FG002|Randomized Phase|Investigator's Discretion|2|||
17184833|NCT03053063|38337097|FG003|Randomized Phase|Investigator's Discretion|0|||
17184834|NCT03053063|38337094|FG000|Randomized Phase|Lost to Follow-up|3|||
17184835|NCT03053063|38337095|FG001|Randomized Phase|Lost to Follow-up|5|||
17184836|NCT03053063|38337096|FG002|Randomized Phase|Lost to Follow-up|1|||
17184837|NCT03053063|38337097|FG003|Randomized Phase|Lost to Follow-up|0|||
17184838|NCT03053063|38337094|FG000|Randomized Phase|Adverse Event|0|||
17184839|NCT03053063|38337095|FG001|Randomized Phase|Adverse Event|1|||
17184840|NCT03053063|38337096|FG002|Randomized Phase|Adverse Event|0|||
17184841|NCT03053063|38337097|FG003|Randomized Phase|Adverse Event|0|||
17184842|NCT03053063|38337094|FG000|Randomized Phase|Randomized but Never Treated|1|||
17184843|NCT03053063|38337095|FG001|Randomized Phase|Randomized but Never Treated|3|||
17184844|NCT03053063|38337096|FG002|Randomized Phase|Randomized but Never Treated|2|||
17184845|NCT03053063|38337097|FG003|Randomized Phase|Randomized but Never Treated|0|||
17184846|NCT03053063|38337094|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
17184847|NCT03053063|38337095|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
17184848|NCT03053063|38337096|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
17184849|NCT03053063|38337097|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
17184850|NCT03053063|38337094|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
17184851|NCT03053063|38337095|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
17184852|NCT03053063|38337096|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
17184853|NCT03053063|38337097|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
17184854|NCT03053063|38337094|FG000|Open-Label Phase|Death|0|||
17184855|NCT03053063|38337095|FG001|Open-Label Phase|Death|0|||
17184856|NCT03053063|38337096|FG002|Open-Label Phase|Death|0|||
17184857|NCT03053063|38337097|FG003|Open-Label Phase|Death|2|||
17184858|NCT03053063|38337094|FG000|Open-Label Phase|Investigator's discretion|0|||
17184859|NCT03053063|38337095|FG001|Open-Label Phase|Investigator's discretion|0|||
17184860|NCT03053063|38337096|FG002|Open-Label Phase|Investigator's discretion|0|||
17184861|NCT03053063|38337097|FG003|Open-Label Phase|Investigator's discretion|2|||
17184862|NCT01316939|38337119|FG000|Overall Study|Study closed/terminated|26|||
17184863|NCT01316939|38337120|FG001|Overall Study|Study closed/terminated|25|||
17184864|NCT01316939|38337121|FG002|Overall Study|Study closed/terminated|23|||
17184865|NCT01316939|38337119|FG000|Overall Study|Lack of Efficacy|24|||
17184866|NCT01316939|38337120|FG001|Overall Study|Lack of Efficacy|25|||
17184867|NCT01316939|38337121|FG002|Overall Study|Lack of Efficacy|25|||
17184868|NCT01316939|38337119|FG000|Overall Study|Adverse Event|9|||
17184869|NCT01316939|38337120|FG001|Overall Study|Adverse Event|12|||
17184870|NCT01316939|38337121|FG002|Overall Study|Adverse Event|11|||
17184871|NCT01316939|38337119|FG000|Overall Study|Withdrawal by Subject|1|||
17184872|NCT01316939|38337120|FG001|Overall Study|Withdrawal by Subject|3|||
17184873|NCT01316939|38337121|FG002|Overall Study|Withdrawal by Subject|6|||
17184874|NCT01316939|38337119|FG000|Overall Study|Physician Decision|2|||
17184875|NCT01316939|38337120|FG001|Overall Study|Physician Decision|2|||
17184876|NCT01316939|38337121|FG002|Overall Study|Physician Decision|1|||
17184877|NCT01316939|38337119|FG000|Overall Study|Lost to Follow-up|0|||
17184878|NCT01316939|38337120|FG001|Overall Study|Lost to Follow-up|0|||
17184879|NCT01316939|38337121|FG002|Overall Study|Lost to Follow-up|2|||
17184880|NCT01316939|38337119|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
17184881|NCT01316939|38337120|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
17184882|NCT01316939|38337121|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
17184883|NCT01316939|38337119|FG000|Overall Study|Protocol Violation|0|||
17184884|NCT01316939|38337120|FG001|Overall Study|Protocol Violation|1|||
17184885|NCT01316939|38337121|FG002|Overall Study|Protocol Violation|0|||
17184886|NCT03044249|38337131|FG000|Overall Study|Adverse Event|4|||
17184887|NCT03044249|38337132|FG001|Overall Study|Adverse Event|9|||
17089538|NCT00298272|38229671|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
17089539|NCT00298272|38229670|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
17089540|NCT00298272|38229671|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
17089541|NCT00283842|38229685|FG000|Overall Study|Adverse Event|8|||
17089542|NCT00283842|38229686|FG001|Overall Study|Adverse Event|7|||
17089543|NCT00283842|38229687|FG002|Overall Study|Adverse Event|21|||
17089544|NCT00283842|38229688|FG003|Overall Study|Adverse Event|21|||
17089545|NCT00283842|38229689|FG004|Overall Study|Adverse Event|5|||
17089546|NCT00283842|38229685|FG000|Overall Study|Protocol Violation|1|||
17089547|NCT00283842|38229686|FG001|Overall Study|Protocol Violation|5|||
17089548|NCT00283842|38229687|FG002|Overall Study|Protocol Violation|4|||
17089549|NCT00283842|38229688|FG003|Overall Study|Protocol Violation|0|||
17089550|NCT00283842|38229689|FG004|Overall Study|Protocol Violation|0|||
17089551|NCT00283842|38229685|FG000|Overall Study|Protocol deviation|0|||
17089552|NCT00283842|38229686|FG001|Overall Study|Protocol deviation|0|||
17089553|NCT00283842|38229687|FG002|Overall Study|Protocol deviation|0|||
17089554|NCT00283842|38229688|FG003|Overall Study|Protocol deviation|0|||
17089555|NCT00283842|38229689|FG004|Overall Study|Protocol deviation|2|||
17089556|NCT00283842|38229685|FG000|Overall Study|Withdrawal by Subject|2|||
17089557|NCT00283842|38229686|FG001|Overall Study|Withdrawal by Subject|1|||
17089558|NCT00283842|38229687|FG002|Overall Study|Withdrawal by Subject|1|||
17089559|NCT00283842|38229688|FG003|Overall Study|Withdrawal by Subject|5|||
17089560|NCT00283842|38229689|FG004|Overall Study|Withdrawal by Subject|4|||
17089561|NCT00283842|38229685|FG000|Overall Study|Lack of Efficacy|1|||
17089562|NCT00283842|38229686|FG001|Overall Study|Lack of Efficacy|3|||
17089563|NCT00283842|38229687|FG002|Overall Study|Lack of Efficacy|1|||
17089564|NCT00283842|38229688|FG003|Overall Study|Lack of Efficacy|0|||
17089565|NCT00283842|38229689|FG004|Overall Study|Lack of Efficacy|3|||
17089566|NCT00283842|38229685|FG000|Overall Study|Lost to Follow-up|0|||
17089567|NCT00283842|38229686|FG001|Overall Study|Lost to Follow-up|2|||
17089568|NCT00283842|38229687|FG002|Overall Study|Lost to Follow-up|4|||
17089569|NCT00283842|38229688|FG003|Overall Study|Lost to Follow-up|1|||
17089570|NCT00283842|38229689|FG004|Overall Study|Lost to Follow-up|1|||
17089571|NCT00298038|38229703|FG000|Overall Study|Lost to Follow-up|0|||
17089572|NCT00298038|38229704|FG001|Overall Study|Lost to Follow-up|1|||
17089573|NCT00298038|38229703|FG000|Overall Study|Liver Transplant|0|||
17089574|NCT00298038|38229704|FG001|Overall Study|Liver Transplant|1|||
17089575|NCT00298038|38229703|FG000|Overall Study|Protocol Violation|1|||
17089576|NCT00298038|38229704|FG001|Overall Study|Protocol Violation|3|||
17089577|NCT00298038|38229703|FG000|Overall Study|Death|6|||
17089578|NCT00298038|38229704|FG001|Overall Study|Death|3|||
17089579|NCT00298038|38229703|FG000|Overall Study|Withdrawal by Subject|6|||
17089580|NCT00298038|38229704|FG001|Overall Study|Withdrawal by Subject|9|||
17089581|NCT00298038|38229703|FG000|Overall Study|Adverse Event|8|||
17089582|NCT00298038|38229704|FG001|Overall Study|Adverse Event|7|||
17089583|NCT00298038|38229703|FG000|Overall Study|Breakthrough overt HE episode|28|||
17089584|NCT00298038|38229704|FG001|Overall Study|Breakthrough overt HE episode|69|||
17089585|NCT00298038|38229703|FG000|Overall Study|Noncompliance|1|||
17089586|NCT00298038|38229704|FG001|Overall Study|Noncompliance|0|||
17089587|NCT00298038|38229703|FG000|Overall Study|Cocaine Abuse|1|||
17089588|NCT00298038|38229704|FG001|Overall Study|Cocaine Abuse|0|||
17089589|NCT00298038|38229703|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
17089590|NCT00298038|38229704|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
17089591|NCT00283686|38229714|FG000|Overall Study|Death|1|||
17089592|NCT00283686|38229715|FG001|Overall Study|Death|1|||
17089593|NCT00283686|38229716|FG002|Overall Study|Death|1|||
17089594|NCT00283686|38229717|FG003|Overall Study|Death|0|||
17089595|NCT00283686|38229714|FG000|Overall Study|Lost to Follow-up|21|||
17089596|NCT00283686|38229715|FG001|Overall Study|Lost to Follow-up|31|||
17089597|NCT00283686|38229716|FG002|Overall Study|Lost to Follow-up|26|||
17089598|NCT00283686|38229717|FG003|Overall Study|Lost to Follow-up|20|||
17089599|NCT00283686|38229714|FG000|Overall Study|Less than full participation|7|||
17089600|NCT00283686|38229715|FG001|Overall Study|Less than full participation|9|||
17089601|NCT00283686|38229716|FG002|Overall Study|Less than full participation|6|||
17089602|NCT00283686|38229717|FG003|Overall Study|Less than full participation|12|||
17184888|NCT03044249|38337131|FG000|Overall Study|Lost to Follow-up|1|||
17089603|NCT00297882|38229729|FG000|Day 14|Lack of Efficacy|12|||
17089604|NCT00297882|38229730|FG001|Day 14|Lack of Efficacy|49|||
17089605|NCT00297882|38229729|FG000|Day 28|Lost to Follow-up|13|||
17089606|NCT00297882|38229730|FG001|Day 28|Lost to Follow-up|23|||
17089607|NCT00297882|38229729|FG000|Day 28|Lack of Efficacy|3|||
17089608|NCT00297882|38229730|FG001|Day 28|Lack of Efficacy|0|||
17089609|NCT00297648|38229738|FG000|Overall Study|Adverse Event|13|||
17089610|NCT00297648|38229738|FG000|Overall Study|Lack of Efficacy|18|||
17089611|NCT00297648|38229738|FG000|Overall Study|Lost to Follow-up|1|||
17089612|NCT00297648|38229738|FG000|Overall Study|Withdrawal by Subject|3|||
17089613|NCT00297648|38229738|FG000|Overall Study|Other: Incompliance|1|||
17089614|NCT00283296|38229742|FG000|Overall Study|in-home trial not completed|5|||
17184889|NCT03044249|38337132|FG001|Overall Study|Lost to Follow-up|0|||
17184890|NCT03044249|38337131|FG000|Overall Study|Non-compliance with Study Drug|1|||
17184891|NCT03044249|38337132|FG001|Overall Study|Non-compliance with Study Drug|0|||
17184892|NCT03044249|38337131|FG000|Overall Study|Study Terminated by Sponsor|2|||
17184893|NCT03044249|38337132|FG001|Overall Study|Study Terminated by Sponsor|0|||
17184894|NCT03044249|38337131|FG000|Overall Study|Withdrawal by Subject|2|||
17184895|NCT03044249|38337132|FG001|Overall Study|Withdrawal by Subject|5|||
17184896|NCT04365257|38337145|FG000|Overall Study|Physician Decision|1|||
17184897|NCT04365257|38337146|FG001|Overall Study|Physician Decision|0|||
17184898|NCT04365257|38337145|FG000|Overall Study|Patient Noncompliance|1|||
17184899|NCT04365257|38337146|FG001|Overall Study|Patient Noncompliance|0|||
17184900|NCT04365257|38337145|FG000|Overall Study|Withdrawal by Subject|0|||
17184901|NCT04365257|38337146|FG001|Overall Study|Withdrawal by Subject|1|||
17184902|NCT02704130|38337154|FG000|Overall Study|Physician Decision|5|||
17184903|NCT02704130|38337155|FG001|Overall Study|Physician Decision|3|||
17184904|NCT03740009|38337161|FG000|Overall Study|Physician Decision|9|||
17184905|NCT03740009|38337161|FG000|Overall Study|Lost to Follow-up|1|||
17184906|NCT03649217|38337165|FG000|Overall Study|subject had severe ataxia not initially found|1|||
17184907|NCT03649217|38337165|FG000|Overall Study|subject had cognitive issues not initially found|1|||
17184908|NCT03138889|38337194|FG000|Overall Study|Withdrawal by Subject|5|||
17184909|NCT03138889|38337195|FG001|Overall Study|Withdrawal by Subject|5|||
17184910|NCT03138889|38337196|FG002|Overall Study|Withdrawal by Subject|0|||
17184911|NCT03138889|38337197|FG003|Overall Study|Withdrawal by Subject|2|||
17184912|NCT03138889|38337198|FG004|Overall Study|Withdrawal by Subject|1|||
17184913|NCT03138889|38337199|FG005|Overall Study|Withdrawal by Subject|3|||
17184914|NCT03138889|38337200|FG006|Overall Study|Withdrawal by Subject|0|||
17184915|NCT03138889|38337201|FG007|Overall Study|Withdrawal by Subject|1|||
17184916|NCT02706392|38337253|FG000|Overall Study|Death|1|||
17184917|NCT02706392|38337254|FG001|Overall Study|Death|0|||
17184918|NCT02706392|38337255|FG002|Overall Study|Death|2|||
17184919|NCT02706392|38337256|FG003|Overall Study|Death|2|||
17184920|NCT02706392|38337257|FG004|Overall Study|Death|5|||
17184921|NCT02706392|38337258|FG005|Overall Study|Death|2|||
17184922|NCT02933489|38337274|FG000|Overall Study|Ineligible|3|||
17184923|NCT02933489|38337275|FG001|Overall Study|Ineligible|3|||
17184924|NCT02933489|38337274|FG000|Overall Study|Withdrawal by Subject|27|||
17184925|NCT02933489|38337275|FG001|Overall Study|Withdrawal by Subject|18|||
17184926|NCT02933489|38337274|FG000|Overall Study|Unable to complete exams (other)|14|||
17184927|NCT02933489|38337275|FG001|Overall Study|Unable to complete exams (other)|7|||
17184928|NCT02820623|38337289|FG000|Overall Study|Withdrawal by Subject|1|||
17184929|NCT02820623|38337290|FG001|Overall Study|Withdrawal by Subject|3|||
17184930|NCT02820623|38337291|FG002|Overall Study|Withdrawal by Subject|3|||
17184931|NCT02820623|38337289|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
17184932|NCT02820623|38337290|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
17184933|NCT02820623|38337291|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
17184934|NCT02820623|38337289|FG000|Overall Study|Therapist unable to enroll clients|1|||
17184935|NCT02820623|38337290|FG001|Overall Study|Therapist unable to enroll clients|1|||
17184936|NCT02820623|38337291|FG002|Overall Study|Therapist unable to enroll clients|3|||
17184937|NCT02820623|38337289|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
17184938|NCT02820623|38337290|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
17184939|NCT02820623|38337291|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
17184940|NCT03042767|38337301|FG000|Overall Study|Lost to Follow-up|1|||
17184941|NCT03042767|38337302|FG001|Overall Study|Lost to Follow-up|2|||
17184942|NCT00703820|38337310|FG000|Overall Study|Adverse Event|12|||
17184943|NCT00703820|38337311|FG001|Overall Study|Adverse Event|17|||
17184944|NCT00703820|38337310|FG000|Overall Study|Death|5|||
17184945|NCT00703820|38337311|FG001|Overall Study|Death|0|||
17184946|NCT00703820|38337310|FG000|Overall Study|Lack of Efficacy|11|||
17184947|NCT00703820|38337311|FG001|Overall Study|Lack of Efficacy|11|||
17184948|NCT00703820|38337310|FG000|Overall Study|Received non-protocol therapy|1|||
17184949|NCT00703820|38337311|FG001|Overall Study|Received non-protocol therapy|0|||
17184950|NCT00703820|38337310|FG000|Overall Study|Physician Decision|4|||
17184951|NCT00703820|38337311|FG001|Overall Study|Physician Decision|5|||
17184952|NCT00703820|38337310|FG000|Overall Study|Withdrawal by Subject|2|||
17184953|NCT00703820|38337311|FG001|Overall Study|Withdrawal by Subject|1|||
17184954|NCT03045887|38337329|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
17184955|NCT03045887|38337330|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184956|NCT03045887|38337331|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184957|NCT03045887|38337332|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184958|NCT03045887|38337333|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184959|NCT03045887|38337334|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184960|NCT03045887|38337335|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184961|NCT03045887|38337336|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184962|NCT03045887|38337337|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184963|NCT03045887|38337338|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
17184964|NCT03045887|38337329|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184965|NCT03045887|38337330|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184966|NCT03045887|38337331|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184967|NCT03045887|38337332|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
17184968|NCT03045887|38337333|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184969|NCT03045887|38337334|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184970|NCT03045887|38337335|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184971|NCT03045887|38337336|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184972|NCT03045887|38337337|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184973|NCT03045887|38337338|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
17184974|NCT03045887|38337329|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
17184975|NCT03045887|38337330|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184976|NCT03045887|38337331|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184977|NCT03045887|38337332|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184978|NCT03045887|38337333|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184979|NCT03045887|38337334|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184980|NCT03045887|38337335|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184981|NCT03045887|38337336|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184982|NCT03045887|38337337|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184983|NCT03045887|38337338|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
17184984|NCT03045887|38337329|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
17184985|NCT03045887|38337330|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
17184986|NCT03045887|38337331|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
17184987|NCT03045887|38337332|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
17184988|NCT03045887|38337333|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
17184989|NCT03045887|38337334|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
17184990|NCT03045887|38337335|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
17184991|NCT03045887|38337336|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
17184992|NCT03045887|38337337|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
17184993|NCT03045887|38337338|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
17184994|NCT03045887|38337329|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17184995|NCT03045887|38337330|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17184996|NCT03045887|38337331|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17184997|NCT03045887|38337332|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
17184998|NCT03045887|38337333|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17184999|NCT03045887|38337334|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17185000|NCT03045887|38337335|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17185001|NCT03045887|38337336|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17185002|NCT03045887|38337337|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17185003|NCT03045887|38337338|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
17185004|NCT02583269|38337370|FG000|Overall Study|Patient hospitalized prior to start|1|||
17185005|NCT02583269|38337371|FG001|Overall Study|Patient hospitalized prior to start|0|||
17185006|NCT02583269|38337372|FG002|Overall Study|Patient hospitalized prior to start|0|||
17185007|NCT02583269|38337373|FG003|Overall Study|Patient hospitalized prior to start|0|||
17185008|NCT02583269|38337374|FG004|Overall Study|Patient hospitalized prior to start|0|||
17185009|NCT01564537|38337389|FG000|Overall Study|Site Terminated by Sponsor|1|||
17185010|NCT01564537|38337390|FG001|Overall Study|Site Terminated by Sponsor|0|||
17185011|NCT01564537|38337389|FG000|Overall Study|Withdrawal by Subject|12|||
17185012|NCT01564537|38337390|FG001|Overall Study|Withdrawal by Subject|14|||
17185013|NCT01564537|38337389|FG000|Overall Study|Lost to Follow-up|7|||
17185014|NCT01564537|38337390|FG001|Overall Study|Lost to Follow-up|3|||
17185015|NCT01564537|38337389|FG000|Overall Study|Reason not specified|81|||
17185016|NCT01564537|38337390|FG001|Overall Study|Reason not specified|82|||
17185017|NCT03042611|38337401|FG000|Core Phase|Withdrawal by Subject|13|||
17185018|NCT03042611|38337402|FG001|Core Phase|Withdrawal by Subject|4|||
17185019|NCT03042611|38337403|FG002|Core Phase|Withdrawal by Subject|0|||
17185020|NCT03042611|38337404|FG003|Core Phase|Withdrawal by Subject|0|||
17185021|NCT03042611|38337401|FG000|Core Phase|Death|232|||
17185022|NCT03042611|38337402|FG001|Core Phase|Death|110|||
17185023|NCT03042611|38337403|FG002|Core Phase|Death|0|||
17185024|NCT03042611|38337404|FG003|Core Phase|Death|0|||
17185025|NCT03042611|38337401|FG000|Core Phase|Lost to Follow-up|4|||
17185026|NCT03042611|38337402|FG001|Core Phase|Lost to Follow-up|7|||
17185027|NCT03042611|38337403|FG002|Core Phase|Lost to Follow-up|0|||
17185028|NCT03042611|38337404|FG003|Core Phase|Lost to Follow-up|0|||
17185029|NCT03042611|38337401|FG000|Core Phase|Physician Decision|7|||
17185030|NCT03042611|38337402|FG001|Core Phase|Physician Decision|2|||
17185031|NCT03042611|38337403|FG002|Core Phase|Physician Decision|0|||
17185032|NCT03042611|38337404|FG003|Core Phase|Physician Decision|0|||
17185033|NCT03042611|38337401|FG000|Core Phase|Study Closed|0|||
17185034|NCT03042611|38337402|FG001|Core Phase|Study Closed|1|||
17185035|NCT03042611|38337403|FG002|Core Phase|Study Closed|0|||
17185036|NCT03042611|38337404|FG003|Core Phase|Study Closed|0|||
17185037|NCT03042611|38337401|FG000|Extension Phase|Death|0|||
17185038|NCT03042611|38337402|FG001|Extension Phase|Death|0|||
17185039|NCT03042611|38337403|FG002|Extension Phase|Death|34|||
17185040|NCT03042611|38337404|FG003|Extension Phase|Death|16|||
17185041|NCT03042611|38337401|FG000|Extension Phase|Lost to Follow-up|0|||
17185042|NCT03042611|38337402|FG001|Extension Phase|Lost to Follow-up|0|||
17185043|NCT03042611|38337403|FG002|Extension Phase|Lost to Follow-up|1|||
17185044|NCT03042611|38337404|FG003|Extension Phase|Lost to Follow-up|1|||
17185045|NCT03042611|38337401|FG000|Extension Phase|Study Closed|0|||
17185046|NCT03042611|38337402|FG001|Extension Phase|Study Closed|0|||
17185047|NCT03042611|38337403|FG002|Extension Phase|Study Closed|17|||
17185048|NCT03042611|38337404|FG003|Extension Phase|Study Closed|11|||
17185049|NCT02701634|38337412|FG000|Overall Study|Adverse Event|2|||
17185050|NCT02701634|38337413|FG001|Overall Study|Adverse Event|3|||
17185051|NCT02701634|38337412|FG000|Overall Study|Death|1|||
17185052|NCT02701634|38337413|FG001|Overall Study|Death|0|||
17185053|NCT02701634|38337412|FG000|Overall Study|Investigator's Discretion|7|||
17185054|NCT02701634|38337413|FG001|Overall Study|Investigator's Discretion|4|||
17185055|NCT02701634|38337412|FG000|Overall Study|Study terminated by Sponsor|15|||
17185056|NCT02701634|38337413|FG001|Overall Study|Study terminated by Sponsor|17|||
17185057|NCT02701634|38337412|FG000|Overall Study|Withdrew Consent|6|||
17185058|NCT02701634|38337413|FG001|Overall Study|Withdrew Consent|7|||
17185059|NCT02701634|38337412|FG000|Overall Study|Randomized but not treated|1|||
17185060|NCT02701634|38337413|FG001|Overall Study|Randomized but not treated|0|||
17185061|NCT02442765|38337423|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
17185062|NCT02442765|38337424|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
17185063|NCT02442765|38337425|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
17185064|NCT02442765|38337426|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
17185065|NCT02442765|38337427|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
17185066|NCT02442765|38337428|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
17185067|NCT02442765|38337429|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
17185068|NCT02442765|38337430|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
17185069|NCT02442765|38337423|FG000|Stage 2- (Days 43 to 85)|Death|0|||
17185070|NCT02442765|38337424|FG001|Stage 2- (Days 43 to 85)|Death|0|||
17185071|NCT02442765|38337425|FG002|Stage 2- (Days 43 to 85)|Death|0|||
17185072|NCT02442765|38337426|FG003|Stage 2- (Days 43 to 85)|Death|1|||
17185073|NCT02442765|38337427|FG004|Stage 2- (Days 43 to 85)|Death|1|||
17185074|NCT02442765|38337428|FG005|Stage 2- (Days 43 to 85)|Death|0|||
17185075|NCT02442765|38337429|FG006|Stage 2- (Days 43 to 85)|Death|2|||
17185076|NCT02442765|38337430|FG007|Stage 2- (Days 43 to 85)|Death|0|||
17185077|NCT02442765|38337423|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
17185078|NCT02442765|38337424|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
17185079|NCT02442765|38337425|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
17185080|NCT02442765|38337426|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
17185081|NCT02442765|38337427|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
17185082|NCT02442765|38337428|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
17185083|NCT02442765|38337429|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
17185084|NCT02442765|38337430|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
17185085|NCT02442765|38337423|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
17185086|NCT02442765|38337424|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
17185087|NCT02442765|38337425|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
17185088|NCT02442765|38337426|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
17185089|NCT02442765|38337427|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
17185090|NCT02442765|38337428|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
17185091|NCT02442765|38337429|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
17185092|NCT02442765|38337430|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
17185093|NCT02442765|38337423|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
17185094|NCT02442765|38337424|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
17185095|NCT02442765|38337425|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
17185096|NCT02442765|38337426|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
17185097|NCT02442765|38337427|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
17185098|NCT02442765|38337428|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
17185099|NCT02442765|38337429|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
17185100|NCT02442765|38337430|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
17185101|NCT02442765|38337423|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
17185102|NCT02442765|38337424|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
17185103|NCT02442765|38337425|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
17185104|NCT02442765|38337426|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
17185105|NCT02442765|38337427|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
17185106|NCT02442765|38337428|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
17185107|NCT02442765|38337429|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
17185108|NCT02442765|38337430|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
17185109|NCT02442765|38337423|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
17185110|NCT02442765|38337424|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
17185111|NCT02442765|38337425|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
17185112|NCT02442765|38337426|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
17185113|NCT02442765|38337427|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
17185114|NCT02442765|38337428|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
17185115|NCT02442765|38337429|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
17185116|NCT02442765|38337430|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
17185117|NCT02442765|38337423|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
17185118|NCT02442765|38337424|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
17185119|NCT02442765|38337425|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
17185120|NCT02442765|38337426|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
17185121|NCT02442765|38337427|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
17185122|NCT02442765|38337428|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
17185123|NCT02442765|38337429|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
17185124|NCT02442765|38337430|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
17185125|NCT02180867|38337468|FG000|Overall Study|Adverse Event|3|||
17185126|NCT02180867|38337469|FG001|Overall Study|Adverse Event|4|||
17185127|NCT02180867|38337470|FG002|Overall Study|Adverse Event|1|||
17185128|NCT02180867|38337471|FG003|Overall Study|Adverse Event|5|||
17185129|NCT02180867|38337472|FG004|Overall Study|Adverse Event|0|||
17185130|NCT02180867|38337473|FG005|Overall Study|Adverse Event|0|||
17185131|NCT02180867|38337474|FG006|Overall Study|Adverse Event|0|||
17185132|NCT02180867|38337468|FG000|Overall Study|Death|0|||
17185133|NCT02180867|38337469|FG001|Overall Study|Death|0|||
17185134|NCT02180867|38337470|FG002|Overall Study|Death|0|||
17185135|NCT02180867|38337471|FG003|Overall Study|Death|0|||
17185136|NCT02180867|38337472|FG004|Overall Study|Death|1|||
17185137|NCT02180867|38337473|FG005|Overall Study|Death|0|||
17185138|NCT02180867|38337474|FG006|Overall Study|Death|0|||
17185139|NCT02180867|38337468|FG000|Overall Study|Lack of Efficacy|0|||
17185140|NCT02180867|38337469|FG001|Overall Study|Lack of Efficacy|2|||
17185141|NCT02180867|38337470|FG002|Overall Study|Lack of Efficacy|0|||
17185142|NCT02180867|38337471|FG003|Overall Study|Lack of Efficacy|1|||
17185143|NCT02180867|38337472|FG004|Overall Study|Lack of Efficacy|6|||
17185144|NCT02180867|38337473|FG005|Overall Study|Lack of Efficacy|0|||
17185145|NCT02180867|38337474|FG006|Overall Study|Lack of Efficacy|1|||
17185146|NCT02180867|38337468|FG000|Overall Study|Physician Decision|1|||
17185147|NCT02180867|38337469|FG001|Overall Study|Physician Decision|3|||
17185148|NCT02180867|38337470|FG002|Overall Study|Physician Decision|1|||
17185149|NCT02180867|38337471|FG003|Overall Study|Physician Decision|10|||
17185150|NCT02180867|38337472|FG004|Overall Study|Physician Decision|9|||
17185151|NCT02180867|38337473|FG005|Overall Study|Physician Decision|3|||
17185152|NCT02180867|38337474|FG006|Overall Study|Physician Decision|4|||
17185153|NCT02180867|38337468|FG000|Overall Study|Withdrawal by Subject|0|||
17185154|NCT02180867|38337469|FG001|Overall Study|Withdrawal by Subject|0|||
17185155|NCT02180867|38337470|FG002|Overall Study|Withdrawal by Subject|0|||
17185156|NCT02180867|38337471|FG003|Overall Study|Withdrawal by Subject|1|||
17185157|NCT02180867|38337472|FG004|Overall Study|Withdrawal by Subject|1|||
17185158|NCT02180867|38337473|FG005|Overall Study|Withdrawal by Subject|0|||
17185159|NCT02180867|38337474|FG006|Overall Study|Withdrawal by Subject|0|||
17185160|NCT02180867|38337468|FG000|Overall Study|Ineligible|1|||
17185161|NCT02180867|38337469|FG001|Overall Study|Ineligible|2|||
17185162|NCT02180867|38337470|FG002|Overall Study|Ineligible|0|||
17185163|NCT02180867|38337471|FG003|Overall Study|Ineligible|3|||
17185164|NCT02180867|38337472|FG004|Overall Study|Ineligible|5|||
17185165|NCT02180867|38337473|FG005|Overall Study|Ineligible|0|||
17185166|NCT02180867|38337474|FG006|Overall Study|Ineligible|0|||
17185167|NCT02180867|38337468|FG000|Overall Study|Repeat Eligibility Studies|0|||
17185168|NCT02180867|38337469|FG001|Overall Study|Repeat Eligibility Studies|0|||
17185169|NCT02180867|38337470|FG002|Overall Study|Repeat Eligibility Studies|0|||
17185170|NCT02180867|38337471|FG003|Overall Study|Repeat Eligibility Studies|0|||
17185171|NCT02180867|38337472|FG004|Overall Study|Repeat Eligibility Studies|1|||
17185172|NCT02180867|38337473|FG005|Overall Study|Repeat Eligibility Studies|0|||
17185173|NCT02180867|38337474|FG006|Overall Study|Repeat Eligibility Studies|0|||
17185174|NCT02180867|38337468|FG000|Overall Study|Refusal of further protocol therapy|1|||
17185175|NCT02180867|38337469|FG001|Overall Study|Refusal of further protocol therapy|0|||
17185176|NCT02180867|38337470|FG002|Overall Study|Refusal of further protocol therapy|2|||
17185177|NCT02180867|38337471|FG003|Overall Study|Refusal of further protocol therapy|6|||
17185178|NCT02180867|38337472|FG004|Overall Study|Refusal of further protocol therapy|4|||
17185179|NCT02180867|38337473|FG005|Overall Study|Refusal of further protocol therapy|0|||
17185180|NCT02180867|38337474|FG006|Overall Study|Refusal of further protocol therapy|0|||
17185181|NCT03520413|38337504|FG000|Overall Study|Lost to Follow-up|1|||
17185182|NCT03520413|38337505|FG001|Overall Study|Lost to Follow-up|1|||
17185183|NCT03520413|38337504|FG000|Overall Study|Withdrawal by Subject|1|||
17185184|NCT03520413|38337505|FG001|Overall Study|Withdrawal by Subject|2|||
17185185|NCT03520413|38337504|FG000|Overall Study|Death|0|||
17185186|NCT03520413|38337505|FG001|Overall Study|Death|1|||
17185187|NCT03520413|38337504|FG000|Overall Study|Physician Decision|3|||
17185188|NCT03520413|38337505|FG001|Overall Study|Physician Decision|3|||
17185189|NCT03520413|38337504|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
17185190|NCT03520413|38337505|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
17185191|NCT02699684|38337512|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
17185192|NCT02699684|38337513|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
17185193|NCT02700698|38337522|FG000|Overall Study|Withdrawal by Subject|1|||
17185194|NCT02700698|38337523|FG001|Overall Study|Withdrawal by Subject|0|||
17185195|NCT01774721|38337531|FG000|Overall Study|Death|76|||
17185196|NCT01774721|38337532|FG001|Overall Study|Death|91|||
17185197|NCT01774721|38337531|FG000|Overall Study|Withdrawal by Subject|14|||
17185198|NCT01774721|38337532|FG001|Overall Study|Withdrawal by Subject|10|||
17185199|NCT01774721|38337531|FG000|Overall Study|Lost to Follow-up|1|||
17185200|NCT01774721|38337532|FG001|Overall Study|Lost to Follow-up|1|||
17185201|NCT01774721|38337531|FG000|Overall Study|Did not meet eligibility criteria|0|||
17185202|NCT01774721|38337532|FG001|Overall Study|Did not meet eligibility criteria|3|||
17185203|NCT01774721|38337531|FG000|Overall Study|Ongoing in study|136|||
17185204|NCT01774721|38337532|FG001|Overall Study|Ongoing in study|120|||
17185205|NCT01275677|38337542|FG000|Overall Study|Not at risk for recurrence.|1|||
17185206|NCT01275677|38337543|FG001|Overall Study|Not at risk for recurrence.|1|||
17185207|NCT01275677|38337542|FG000|Overall Study|No follow-up|26|||
17185208|NCT01275677|38337543|FG001|Overall Study|No follow-up|37|||
17185209|NCT01275677|38337542|FG000|Overall Study|No clinical follow up.|1|||
17185210|NCT01275677|38337543|FG001|Overall Study|No clinical follow up.|4|||
17185211|NCT00937937|38337549|FG000|Overall Study|Adverse Event|6|||
17185212|NCT00937937|38337549|FG000|Overall Study|Withdrawal by Subject|2|||
17185213|NCT00937937|38337549|FG000|Overall Study|Progression/relapse|61|||
17185214|NCT00937937|38337549|FG000|Overall Study|Death|1|||
17185215|NCT00937937|38337549|FG000|Overall Study|Other|2|||
17185216|NCT02699450|38337557|FG000|Overall Study|Death|2|||
17185217|NCT02699450|38337558|FG001|Overall Study|Death|1|||
17185218|NCT02699450|38337559|FG002|Overall Study|Death|2|||
17185219|NCT02699450|38337557|FG000|Overall Study|Met Criteria for Study Exit|0|||
17185220|NCT02699450|38337558|FG001|Overall Study|Met Criteria for Study Exit|0|||
17185221|NCT02699450|38337559|FG002|Overall Study|Met Criteria for Study Exit|1|||
17185222|NCT02699450|38337557|FG000|Overall Study|Protocol Violation|4|||
17185223|NCT02699450|38337558|FG001|Overall Study|Protocol Violation|3|||
17185224|NCT02699450|38337559|FG002|Overall Study|Protocol Violation|5|||
17185225|NCT02699450|38337557|FG000|Overall Study|Lost to Follow-up|3|||
17185226|NCT02699450|38337558|FG001|Overall Study|Lost to Follow-up|0|||
17185227|NCT02699450|38337559|FG002|Overall Study|Lost to Follow-up|5|||
17185228|NCT02699450|38337557|FG000|Overall Study|Physician Decision|2|||
17185229|NCT02699450|38337558|FG001|Overall Study|Physician Decision|0|||
17185230|NCT02699450|38337559|FG002|Overall Study|Physician Decision|0|||
17185231|NCT02699450|38337557|FG000|Overall Study|Withdrawal by Subject|3|||
17185232|NCT02699450|38337558|FG001|Overall Study|Withdrawal by Subject|1|||
17185233|NCT02699450|38337559|FG002|Overall Study|Withdrawal by Subject|2|||
17185234|NCT02699450|38337557|FG000|Overall Study|Adverse Event|1|||
17185235|NCT02699450|38337558|FG001|Overall Study|Adverse Event|0|||
17185236|NCT02699450|38337559|FG002|Overall Study|Adverse Event|0|||
17185237|NCT02699996|38337570|FG000|Overall Study|Withdrawal by Subject|5|||
17185238|NCT02699996|38337571|FG001|Overall Study|Withdrawal by Subject|2|||
17185239|NCT02739321|38337580|FG000|Overall Study|Lack of Efficacy|1|||
17185240|NCT02739321|38337581|FG001|Overall Study|Lack of Efficacy|1|||
17185241|NCT02739321|38337580|FG000|Overall Study|Lost to Follow-up|1|||
17185242|NCT02739321|38337581|FG001|Overall Study|Lost to Follow-up|1|||
17185243|NCT02739321|38337580|FG000|Overall Study|Withdrawal by Subject|1|||
17185244|NCT02739321|38337581|FG001|Overall Study|Withdrawal by Subject|2|||
17185245|NCT02696798|38337599|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
17185246|NCT02696798|38337600|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
17185247|NCT02696798|38337601|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
17185248|NCT02696798|38337599|FG000|Blinded Treatment Dosing Period|Death|0|||
17185249|NCT02696798|38337600|FG001|Blinded Treatment Dosing Period|Death|0|||
17185250|NCT02696798|38337601|FG002|Blinded Treatment Dosing Period|Death|1|||
17185251|NCT02696798|38337599|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
17185252|NCT02696798|38337600|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
17185253|NCT02696798|38337601|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
17185254|NCT02696798|38337599|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
17185255|NCT02696798|38337600|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
17185256|NCT02696798|38337601|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
17185257|NCT02696798|38337599|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
17185258|NCT02696798|38337600|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
17185259|NCT02696798|38337601|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
17185260|NCT02696798|38337599|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
17185261|NCT02696798|38337600|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
17185262|NCT02696798|38337601|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
17185263|NCT02696798|38337599|FG000|Extended Treatment Period|Adverse Event|1|||
17185264|NCT02696798|38337600|FG001|Extended Treatment Period|Adverse Event|4|||
17185265|NCT02696798|38337601|FG002|Extended Treatment Period|Adverse Event|5|||
17185266|NCT02696798|38337599|FG000|Extended Treatment Period|Lack of Efficacy|7|||
17185267|NCT02696798|38337600|FG001|Extended Treatment Period|Lack of Efficacy|2|||
17185268|NCT02696798|38337601|FG002|Extended Treatment Period|Lack of Efficacy|2|||
17185269|NCT02696798|38337599|FG000|Extended Treatment Period|Lost to Follow-up|1|||
17185270|NCT02696798|38337600|FG001|Extended Treatment Period|Lost to Follow-up|0|||
17185271|NCT02696798|38337601|FG002|Extended Treatment Period|Lost to Follow-up|0|||
17185272|NCT02696798|38337599|FG000|Extended Treatment Period|Physician Decision|0|||
17185273|NCT02696798|38337600|FG001|Extended Treatment Period|Physician Decision|1|||
17185274|NCT02696798|38337601|FG002|Extended Treatment Period|Physician Decision|0|||
17185275|NCT02696798|38337599|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
17185276|NCT02696798|38337600|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
17185277|NCT02696798|38337601|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
17185278|NCT02696798|38337599|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
17185279|NCT02696798|38337600|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
17185280|NCT02696798|38337601|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
17185281|NCT02696798|38337599|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
17185282|NCT02696798|38337600|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
17185283|NCT02696798|38337601|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
17185284|NCT02696798|38337599|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
17185285|NCT02696798|38337600|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
17185286|NCT02696798|38337601|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
17185287|NCT02696798|38337599|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
17185288|NCT02696798|38337600|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
17185289|NCT02696798|38337601|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
17185290|NCT02696798|38337599|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
17185291|NCT02696798|38337600|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
17185292|NCT02696798|38337601|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
17185293|NCT02696798|38337599|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
17185294|NCT02696798|38337600|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
17185295|NCT02696798|38337601|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
17185296|NCT02698826|38337623|FG000|Overall Study|Death|13|||
17185297|NCT02698826|38337623|FG000|Overall Study|Adverse Event|1|||
17185298|NCT02541604|38337641|FG000|Overall Study|Death|6|||
17185299|NCT02541604|38337642|FG001|Overall Study|Death|5|||
17185300|NCT02541604|38337643|FG002|Overall Study|Death|7|||
17185301|NCT02541604|38337644|FG003|Overall Study|Death|2|||
17185302|NCT02541604|38337645|FG004|Overall Study|Death|9|||
17185303|NCT02541604|38337646|FG005|Overall Study|Death|8|||
17185304|NCT02541604|38337647|FG006|Overall Study|Death|9|||
17185305|NCT02541604|38337648|FG007|Overall Study|Death|9|||
17185306|NCT02541604|38337649|FG008|Overall Study|Death|3|||
17185307|NCT02541604|38337650|FG009|Overall Study|Death|4|||
17185308|NCT02541604|38337651|FG010|Overall Study|Death|2|||
17185309|NCT02541604|38337652|FG011|Overall Study|Death|3|||
17185310|NCT02541604|38337641|FG000|Overall Study|Lost to Follow-up|2|||
17185311|NCT02541604|38337642|FG001|Overall Study|Lost to Follow-up|0|||
17185312|NCT02541604|38337643|FG002|Overall Study|Lost to Follow-up|1|||
17185313|NCT02541604|38337644|FG003|Overall Study|Lost to Follow-up|0|||
17185314|NCT02541604|38337645|FG004|Overall Study|Lost to Follow-up|0|||
17185315|NCT02541604|38337646|FG005|Overall Study|Lost to Follow-up|1|||
17185316|NCT02541604|38337647|FG006|Overall Study|Lost to Follow-up|1|||
17185317|NCT02541604|38337648|FG007|Overall Study|Lost to Follow-up|0|||
17185318|NCT02541604|38337649|FG008|Overall Study|Lost to Follow-up|0|||
17185319|NCT02541604|38337650|FG009|Overall Study|Lost to Follow-up|0|||
17185320|NCT02541604|38337651|FG010|Overall Study|Lost to Follow-up|0|||
17185321|NCT02541604|38337652|FG011|Overall Study|Lost to Follow-up|0|||
17185322|NCT02541604|38337641|FG000|Overall Study|Withdrawal by Subject|2|||
17185323|NCT02541604|38337642|FG001|Overall Study|Withdrawal by Subject|0|||
17185324|NCT02541604|38337643|FG002|Overall Study|Withdrawal by Subject|1|||
17185325|NCT02541604|38337644|FG003|Overall Study|Withdrawal by Subject|0|||
17185326|NCT02541604|38337645|FG004|Overall Study|Withdrawal by Subject|1|||
17185327|NCT02541604|38337646|FG005|Overall Study|Withdrawal by Subject|1|||
17185328|NCT02541604|38337647|FG006|Overall Study|Withdrawal by Subject|0|||
17185329|NCT02541604|38337648|FG007|Overall Study|Withdrawal by Subject|0|||
17185330|NCT02541604|38337649|FG008|Overall Study|Withdrawal by Subject|1|||
17185331|NCT02541604|38337650|FG009|Overall Study|Withdrawal by Subject|0|||
17185332|NCT02541604|38337651|FG010|Overall Study|Withdrawal by Subject|0|||
17185333|NCT02541604|38337652|FG011|Overall Study|Withdrawal by Subject|0|||
17185334|NCT02541604|38337641|FG000|Overall Study|Study Terminated by Sponsor|1|||
17185335|NCT02541604|38337642|FG001|Overall Study|Study Terminated by Sponsor|4|||
17185336|NCT02541604|38337643|FG002|Overall Study|Study Terminated by Sponsor|2|||
17185337|NCT02541604|38337644|FG003|Overall Study|Study Terminated by Sponsor|1|||
17185338|NCT02541604|38337645|FG004|Overall Study|Study Terminated by Sponsor|0|||
17185339|NCT02541604|38337646|FG005|Overall Study|Study Terminated by Sponsor|0|||
17185340|NCT02541604|38337647|FG006|Overall Study|Study Terminated by Sponsor|0|||
17185341|NCT02541604|38337648|FG007|Overall Study|Study Terminated by Sponsor|0|||
17185342|NCT02541604|38337649|FG008|Overall Study|Study Terminated by Sponsor|0|||
17185343|NCT02541604|38337650|FG009|Overall Study|Study Terminated by Sponsor|0|||
17185344|NCT02541604|38337651|FG010|Overall Study|Study Terminated by Sponsor|0|||
17185345|NCT02541604|38337652|FG011|Overall Study|Study Terminated by Sponsor|0|||
17185346|NCT02541604|38337641|FG000|Overall Study|Medical condition may jeopardize safety|0|||
17185347|NCT02541604|38337642|FG001|Overall Study|Medical condition may jeopardize safety|0|||
17185348|NCT02541604|38337643|FG002|Overall Study|Medical condition may jeopardize safety|0|||
17185349|NCT02541604|38337644|FG003|Overall Study|Medical condition may jeopardize safety|0|||
17185350|NCT02541604|38337645|FG004|Overall Study|Medical condition may jeopardize safety|0|||
17185351|NCT02541604|38337646|FG005|Overall Study|Medical condition may jeopardize safety|0|||
17185352|NCT02541604|38337647|FG006|Overall Study|Medical condition may jeopardize safety|0|||
17185353|NCT02541604|38337648|FG007|Overall Study|Medical condition may jeopardize safety|1|||
17185354|NCT02541604|38337649|FG008|Overall Study|Medical condition may jeopardize safety|0|||
17185355|NCT02541604|38337650|FG009|Overall Study|Medical condition may jeopardize safety|0|||
17185356|NCT02541604|38337651|FG010|Overall Study|Medical condition may jeopardize safety|0|||
17185357|NCT02541604|38337652|FG011|Overall Study|Medical condition may jeopardize safety|0|||
17185358|NCT02546674|38337701|FG000|Overall Study|Adverse Event|19|||
17185359|NCT02546674|38337701|FG000|Overall Study|Death|1|||
17185360|NCT02546674|38337701|FG000|Overall Study|Lost to Follow-up|1|||
17185361|NCT02546674|38337701|FG000|Overall Study|Physician Decision|13|||
17185362|NCT02546674|38337701|FG000|Overall Study|Pregnancy|1|||
17185363|NCT02546674|38337701|FG000|Overall Study|Progressive Disease|2|||
17185364|NCT02546674|38337701|FG000|Overall Study|Protocol Deviation|2|||
17185365|NCT02546674|38337701|FG000|Overall Study|Subject/Guardian Decision|6|||
17185366|NCT02546674|38337701|FG000|Overall Study|Withdrawal of Informed Consent|3|||
17185367|NCT02546362|38337706|FG000|4-week Treatment Period|Lost to Follow-up|1|||
17185368|NCT02546362|38337706|FG000|4-week Treatment Period|Change in medication|2|||
17185369|NCT02546362|38337706|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
17185370|NCT02546362|38337706|FG000|12-week Treatment Period|Lost to Follow-up|2|||
17185371|NCT02546362|38337706|FG000|12-week Treatment Period|Change in medication|1|||
17185372|NCT02698436|38337712|FG000|Overall Study|Adverse Event|1|||
17185373|NCT02698436|38337713|FG001|Overall Study|Adverse Event|0|||
17185374|NCT02698436|38337712|FG000|Overall Study|Withdrawal by Subject|3|||
17185375|NCT02698436|38337713|FG001|Overall Study|Withdrawal by Subject|3|||
17185376|NCT02698436|38337712|FG000|Overall Study|Lost to Follow-up|2|||
17185377|NCT02698436|38337713|FG001|Overall Study|Lost to Follow-up|4|||
17185378|NCT02698436|38337712|FG000|Overall Study|Non-compliance with study regimen|1|||
17185379|NCT02698436|38337713|FG001|Overall Study|Non-compliance with study regimen|0|||
17185380|NCT02694536|38337719|FG000|Overall Study|Progressive Disease|40|||
17185381|NCT02694536|38337719|FG000|Overall Study|Lost to Follow-up|1|||
17185382|NCT02694536|38337719|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
17185383|NCT02694536|38337719|FG000|Overall Study|Withdrawal by Subject|8|||
17185384|NCT02694536|38337719|FG000|Overall Study|Death|8|||
17185385|NCT02694536|38337719|FG000|Overall Study|Other|22|||
17185386|NCT01661686|38337725|FG000|Overall Study|Lost to Follow-up|2|||
17185387|NCT01661686|38337726|FG001|Overall Study|Lost to Follow-up|1|||
17185388|NCT01661686|38337725|FG000|Overall Study|did not receive allocated intervention|0|||
17185389|NCT01661686|38337726|FG001|Overall Study|did not receive allocated intervention|1|||
17185390|NCT02696096|38337732|FG000|Overall Study|ruled out at screening|1|||
17185391|NCT02696096|38337732|FG000|Overall Study|did not attend second fMRI|1|||
17185392|NCT02695628|38337740|FG000|Overall Study|Withdrawal by Subject|1|||
17185393|NCT02693834|38337744|FG000|Baseline Measurement|Withdrawal by Subject|1|||
17185394|NCT02693834|38337745|FG001|Baseline Measurement|Withdrawal by Subject|0|||
17185395|NCT02693834|38337744|FG000|Baseline Measurement|Adverse Event|1|||
17185396|NCT02693834|38337745|FG001|Baseline Measurement|Adverse Event|0|||
17185397|NCT02693834|38337744|FG000|Week 2 Practice|Adverse Event|0|||
17185398|NCT02693834|38337745|FG001|Week 2 Practice|Adverse Event|1|||
17185399|NCT02545504|38337753|FG000|Overall Study|Death|174|||
17185400|NCT02545504|38337754|FG001|Overall Study|Death|168|||
17185401|NCT02545504|38337753|FG000|Overall Study|Unknown reason|30|||
17185402|NCT02545504|38337754|FG001|Overall Study|Unknown reason|32|||
17185403|NCT02545504|38337753|FG000|Overall Study|Withdrew consent|9|||
17185404|NCT02545504|38337754|FG001|Overall Study|Withdrew consent|11|||
17185405|NCT02545504|38337753|FG000|Overall Study|Investigator's discretion|3|||
17185406|NCT02545504|38337754|FG001|Overall Study|Investigator's discretion|1|||
17185407|NCT02545504|38337753|FG000|Overall Study|Lost to Follow-up|2|||
17185408|NCT02545504|38337754|FG001|Overall Study|Lost to Follow-up|2|||
17185409|NCT02545270|38337767|FG000|Overall Study|technical difficulties|0|||
17185410|NCT02545270|38337768|FG001|Overall Study|technical difficulties|1|||
17185411|NCT02545270|38337769|FG002|Overall Study|technical difficulties|0|||
17185412|NCT02545270|38337767|FG000|Overall Study|Videos being too similar to other|0|||
17185413|NCT02545270|38337768|FG001|Overall Study|Videos being too similar to other|0|||
17185414|NCT02545270|38337769|FG002|Overall Study|Videos being too similar to other|2|||
17185415|NCT02540668|38337778|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
17185416|NCT02540668|38337779|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
17185417|NCT02339740|38337788|FG000|Overall Study|Death|1|||
17185418|NCT02339740|38337789|FG001|Overall Study|Death|0|||
17185419|NCT02339740|38337788|FG000|Overall Study|Physician Decision|0|||
17185420|NCT02339740|38337789|FG001|Overall Study|Physician Decision|2|||
17185421|NCT02339740|38337788|FG000|Overall Study|Withdrawal by Subject|5|||
17185422|NCT02339740|38337789|FG001|Overall Study|Withdrawal by Subject|1|||
17185423|NCT02339740|38337788|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
17185424|NCT02339740|38337789|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
17185425|NCT00433511|38337815|FG000|Step 1|Adverse Event|50|||
17185426|NCT00433511|38337816|FG001|Step 1|Adverse Event|157|||
17185427|NCT00433511|38337817|FG002|Step 1|Adverse Event|153|||
17185428|NCT00433511|38337815|FG000|Step 1|Withdrawal by Subject|45|||
17185429|NCT00433511|38337816|FG001|Step 1|Withdrawal by Subject|143|||
17185430|NCT00433511|38337817|FG002|Step 1|Withdrawal by Subject|154|||
17185431|NCT00433511|38337815|FG000|Step 1|Death|3|||
17185432|NCT00433511|38337816|FG001|Step 1|Death|1|||
17185433|NCT00433511|38337817|FG002|Step 1|Death|1|||
17185434|NCT00433511|38337815|FG000|Step 1|Physician Decision|1|||
17185435|NCT00433511|38337816|FG001|Step 1|Physician Decision|4|||
17185436|NCT00433511|38337817|FG002|Step 1|Physician Decision|3|||
17185437|NCT00433511|38337815|FG000|Step 1|Never started protocol therapy|28|||
17185438|NCT00433511|38337816|FG001|Step 1|Never started protocol therapy|64|||
17185439|NCT00433511|38337817|FG002|Step 1|Never started protocol therapy|66|||
17185440|NCT00433511|38337815|FG000|Step 1|Alternative therapy|2|||
17185441|NCT00433511|38337816|FG001|Step 1|Alternative therapy|1|||
17185442|NCT00433511|38337817|FG002|Step 1|Alternative therapy|3|||
17185443|NCT00433511|38337815|FG000|Step 1|Disease progression, relapse|5|||
17185444|NCT00433511|38337816|FG001|Step 1|Disease progression, relapse|3|||
17185445|NCT00433511|38337817|FG002|Step 1|Disease progression, relapse|3|||
17185446|NCT00433511|38337815|FG000|Step 1|Other complicating disease|2|||
17185447|NCT00433511|38337816|FG001|Step 1|Other complicating disease|6|||
17185448|NCT00433511|38337817|FG002|Step 1|Other complicating disease|3|||
17185449|NCT00433511|38337815|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
17185450|NCT00433511|38337816|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
17185451|NCT00433511|38337817|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
17185452|NCT00433511|38337815|FG000|Step 1|Suspected recurrence|0|||
17185453|NCT00433511|38337816|FG001|Step 1|Suspected recurrence|1|||
17185454|NCT00433511|38337817|FG002|Step 1|Suspected recurrence|0|||
17185455|NCT00433511|38337815|FG000|Step 1|Insurance/drug distribution issues|0|||
17185456|NCT00433511|38337816|FG001|Step 1|Insurance/drug distribution issues|1|||
17185457|NCT00433511|38337817|FG002|Step 1|Insurance/drug distribution issues|2|||
17185458|NCT00433511|38337815|FG000|Step 1|Patient moved|0|||
17185459|NCT00433511|38337816|FG001|Step 1|Patient moved|0|||
17185460|NCT00433511|38337817|FG002|Step 1|Patient moved|1|||
17185461|NCT00433511|38337815|FG000|Step 2 (Arm D)|Adverse Event|0|||
17185462|NCT00433511|38337816|FG001|Step 2 (Arm D)|Adverse Event|0|||
17185463|NCT00433511|38337817|FG002|Step 2 (Arm D)|Adverse Event|135|||
17185464|NCT00433511|38337815|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
17185465|NCT00433511|38337816|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
17185466|NCT00433511|38337817|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
17185467|NCT00433511|38337815|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
17185468|NCT00433511|38337816|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
17185469|NCT00433511|38337817|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
17185470|NCT00433511|38337815|FG000|Step 2 (Arm D)|Physician Decision|0|||
17185471|NCT00433511|38337816|FG001|Step 2 (Arm D)|Physician Decision|0|||
17185472|NCT00433511|38337817|FG002|Step 2 (Arm D)|Physician Decision|9|||
17185473|NCT00433511|38337815|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
17185474|NCT00433511|38337816|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
17185475|NCT00433511|38337817|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
17185476|NCT00433511|38337815|FG000|Step 2 (Arm D)|Other complicating disease|0|||
17185477|NCT00433511|38337816|FG001|Step 2 (Arm D)|Other complicating disease|0|||
17185478|NCT00433511|38337817|FG002|Step 2 (Arm D)|Other complicating disease|3|||
17185479|NCT00433511|38337815|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
17185480|NCT00433511|38337816|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
17185481|NCT00433511|38337817|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
17185482|NCT00433511|38337815|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
17185483|NCT00433511|38337816|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
17185484|NCT00433511|38337817|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
17185485|NCT00433511|38337815|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
17185486|NCT00433511|38337816|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
17185487|NCT00433511|38337817|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
17185488|NCT00433511|38337815|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
17185489|NCT00433511|38337816|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
17185490|NCT00433511|38337817|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
17185491|NCT02535364|38337828|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
17185492|NCT02535364|38337828|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
17185493|NCT02535364|38337828|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
17185494|NCT02535364|38337828|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
17185495|NCT02535364|38337828|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
17185496|NCT02535364|38337828|FG000|Part B Screening|Death|2|||
17185497|NCT02535364|38337828|FG000|Part B Screening|Physician Decision|1|||
17185498|NCT02535364|38337828|FG000|Part B Screening|Withdrawal by Subject|1|||
17185499|NCT02535364|38337828|FG000|Part B Screening|Adverse Event|1|||
17185500|NCT02535364|38337828|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
17185501|NCT02535364|38337828|FG000|Study Treatment|Death|1|||
17185502|NCT02535364|38337828|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
17185503|NCT02535364|38337828|FG000|12-Month Follow-up Period|Disease progression|22|||
17185504|NCT02535364|38337828|FG000|12-Month Follow-up Period|Death|5|||
17185505|NCT02535364|38337828|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
17185506|NCT02535364|38337828|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
17185507|NCT02535364|38337828|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
17185508|NCT02540356|38337834|FG000|Overall Study|Terminated due to disease progression|1|||
17185509|NCT02540356|38337835|FG001|Overall Study|Terminated due to disease progression|0|||
17185510|NCT02534896|38337843|FG000|Overall Study|Adverse Event|2|||
17185511|NCT02534896|38337844|FG001|Overall Study|Adverse Event|1|||
17185512|NCT02534896|38337845|FG002|Overall Study|Adverse Event|1|||
17185513|NCT02534896|38337843|FG000|Overall Study|Insufficient therapeutic response|2|||
17185514|NCT02534896|38337844|FG001|Overall Study|Insufficient therapeutic response|0|||
17185515|NCT02534896|38337845|FG002|Overall Study|Insufficient therapeutic response|0|||
17185516|NCT02697734|38337855|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
17185517|NCT02697734|38337856|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
17185518|NCT02697734|38337855|FG000|Core Phase - up to Week 48|Adverse Event|1|||
17185519|NCT02697734|38337856|FG001|Core Phase - up to Week 48|Adverse Event|2|||
17185520|NCT02697734|38337855|FG000|Core Phase - up to Week 48|Physician Decision|1|||
17185521|NCT02697734|38337856|FG001|Core Phase - up to Week 48|Physician Decision|0|||
17185522|NCT02697734|38337855|FG000|Optional Extension Phase|Adverse Event|5|||
17185523|NCT02697734|38337856|FG001|Optional Extension Phase|Adverse Event|1|||
17185524|NCT02697734|38337855|FG000|Optional Extension Phase|Physician Decision|0|||
17185525|NCT02697734|38337856|FG001|Optional Extension Phase|Physician Decision|1|||
17185526|NCT02692586|38337870|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
17185527|NCT02692586|38337870|FG000|Overall Study|Received adjunctive thrombolytics|2|||
17185528|NCT02534350|38337876|FG000|Overall Study|Randomized But Not Treated|1|||
17185529|NCT02534350|38337877|FG001|Overall Study|Randomized But Not Treated|0|||
17185530|NCT02534350|38337876|FG000|Overall Study|Protocol Violation|1|||
17185531|NCT02534350|38337877|FG001|Overall Study|Protocol Violation|0|||
17185532|NCT02534350|38337876|FG000|Overall Study|Withdrew Consent|2|||
17185533|NCT02534350|38337877|FG001|Overall Study|Withdrew Consent|0|||
17185534|NCT02689076|38337886|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
17185535|NCT02689076|38337887|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
17185536|NCT02689076|38337888|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
17185537|NCT02689076|38337886|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
17185538|NCT02689076|38337887|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
17185539|NCT02689076|38337888|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
17185540|NCT02689076|38337886|FG000|Overall Study|Did not have an HIE match|2|||
17185541|NCT02689076|38337887|FG001|Overall Study|Did not have an HIE match|0|||
17185542|NCT02689076|38337888|FG002|Overall Study|Did not have an HIE match|0|||
17185543|NCT02689076|38337886|FG000|Overall Study|Death during non-VA encounter|2|||
17185544|NCT02689076|38337887|FG001|Overall Study|Death during non-VA encounter|5|||
17185545|NCT02689076|38337888|FG002|Overall Study|Death during non-VA encounter|0|||
17185546|NCT02689076|38337886|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
17185547|NCT02689076|38337887|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
17185548|NCT02689076|38337888|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
17185549|NCT02689076|38337886|FG000|Overall Study|Participant no longer active in VA system|1|||
17185550|NCT02689076|38337887|FG001|Overall Study|Participant no longer active in VA system|0|||
17185551|NCT02689076|38337888|FG002|Overall Study|Participant no longer active in VA system|0|||
17185552|NCT02689076|38337886|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
17185553|NCT02689076|38337887|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
17185554|NCT02689076|38337888|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
17185555|NCT00070499|38337900|FG000|Overall Study|Adverse Event|6|||
17185556|NCT00070499|38337901|FG001|Overall Study|Adverse Event|6|||
17185557|NCT00070499|38337902|FG002|Overall Study|Adverse Event|19|||
17185558|NCT00070499|38337903|FG003|Overall Study|Adverse Event|15|||
17185559|NCT00070499|38337900|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
17185560|NCT00070499|38337901|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
17185561|NCT00070499|38337902|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
17185562|NCT00070499|38337903|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
17185563|NCT00070499|38337900|FG000|Overall Study|Progression/relapse|4|||
17185564|NCT00070499|38337901|FG001|Overall Study|Progression/relapse|2|||
17185565|NCT00070499|38337902|FG002|Overall Study|Progression/relapse|1|||
17185566|NCT00070499|38337903|FG003|Overall Study|Progression/relapse|4|||
17185567|NCT00070499|38337900|FG000|Overall Study|Death|1|||
17185568|NCT00070499|38337901|FG001|Overall Study|Death|1|||
17185569|NCT00070499|38337902|FG002|Overall Study|Death|1|||
17185570|NCT00070499|38337903|FG003|Overall Study|Death|2|||
17185571|NCT00070499|38337900|FG000|Overall Study|Other - not protocol specified|7|||
17185572|NCT00070499|38337901|FG001|Overall Study|Other - not protocol specified|3|||
17185573|NCT00070499|38337902|FG002|Overall Study|Other - not protocol specified|12|||
17185574|NCT00070499|38337903|FG003|Overall Study|Other - not protocol specified|20|||
17185575|NCT00070499|38337900|FG000|Overall Study|Still on protocol treatment|10|||
17185576|NCT00070499|38337901|FG001|Overall Study|Still on protocol treatment|4|||
17185577|NCT00070499|38337902|FG002|Overall Study|Still on protocol treatment|79|||
17185578|NCT00070499|38337903|FG003|Overall Study|Still on protocol treatment|57|||
17185579|NCT00070499|38337900|FG000|Overall Study|Did not start treatment|1|||
17185580|NCT00070499|38337901|FG001|Overall Study|Did not start treatment|0|||
17185581|NCT00070499|38337902|FG002|Overall Study|Did not start treatment|0|||
17185582|NCT00070499|38337903|FG003|Overall Study|Did not start treatment|2|||
17185583|NCT00070499|38337900|FG000|Overall Study|Not eligible|2|||
17185584|NCT00070499|38337901|FG001|Overall Study|Not eligible|5|||
17185585|NCT00070499|38337902|FG002|Overall Study|Not eligible|3|||
17185586|NCT00070499|38337903|FG003|Overall Study|Not eligible|2|||
17185587|NCT02688764|38337923|FG000|Overall Study|Adverse Event|3|||
17185588|NCT02688764|38337924|FG001|Overall Study|Adverse Event|3|||
17185589|NCT02688764|38337923|FG000|Overall Study|AE/Kidney transplant|1|||
17185590|NCT02688764|38337924|FG001|Overall Study|AE/Kidney transplant|0|||
17185591|NCT02688764|38337923|FG000|Overall Study|AE/Lack of efficacy|1|||
17185592|NCT02688764|38337924|FG001|Overall Study|AE/Lack of efficacy|0|||
17185593|NCT02688764|38337923|FG000|Overall Study|AE/Non-compl.|1|||
17185594|NCT02688764|38337924|FG001|Overall Study|AE/Non-compl.|0|||
17185595|NCT02688764|38337923|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
17185596|NCT02688764|38337924|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
17185597|NCT02688764|38337923|FG000|Overall Study|AE/Other|0|||
17185598|NCT02688764|38337924|FG001|Overall Study|AE/Other|1|||
17185599|NCT02688764|38337923|FG000|Overall Study|AE/Physician decision|1|||
17185600|NCT02688764|38337924|FG001|Overall Study|AE/Physician decision|0|||
17185601|NCT02688764|38337923|FG000|Overall Study|AE/Withd. parent|3|||
17185602|NCT02688764|38337924|FG001|Overall Study|AE/Withd. parent|0|||
17185603|NCT02688764|38337923|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
17185604|NCT02688764|38337924|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
17185605|NCT02688764|38337923|FG000|Overall Study|AE/Withd. subject|1|||
17185606|NCT02688764|38337924|FG001|Overall Study|AE/Withd. subject|0|||
17185607|NCT02688764|38337923|FG000|Overall Study|Kidney transplant|10|||
17185608|NCT02688764|38337924|FG001|Overall Study|Kidney transplant|4|||
17185609|NCT02688764|38337923|FG000|Overall Study|Lack of Efficacy|3|||
17185610|NCT02688764|38337924|FG001|Overall Study|Lack of Efficacy|2|||
17185611|NCT02688764|38337923|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
17185612|NCT02688764|38337924|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
17185613|NCT02688764|38337923|FG000|Overall Study|Non-compliance with study drug|4|||
17185614|NCT02688764|38337924|FG001|Overall Study|Non-compliance with study drug|0|||
17185615|NCT02688764|38337923|FG000|Overall Study|Non-compl./Physician decision|2|||
17185616|NCT02688764|38337924|FG001|Overall Study|Non-compl./Physician decision|0|||
17185617|NCT02688764|38337923|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
17185618|NCT02688764|38337924|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
17185619|NCT02688764|38337923|FG000|Overall Study|Non-compl./Withd. subject|0|||
17185620|NCT02688764|38337924|FG001|Overall Study|Non-compl./Withd. subject|2|||
17185621|NCT02688764|38337923|FG000|Overall Study|Phosphorus level outside safe range|0|||
17185622|NCT02688764|38337924|FG001|Overall Study|Phosphorus level outside safe range|1|||
17185623|NCT02688764|38337923|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
17185624|NCT02688764|38337924|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
17185625|NCT02688764|38337923|FG000|Overall Study|Study drug taste/Withd. parent|1|||
17185626|NCT02688764|38337924|FG001|Overall Study|Study drug taste/Withd. parent|0|||
17185627|NCT02688764|38337923|FG000|Overall Study|Subject moving out|2|||
17185628|NCT02688764|38337924|FG001|Overall Study|Subject moving out|0|||
17185629|NCT02688764|38337923|FG000|Overall Study|Subject taken off dialysis|1|||
17185630|NCT02688764|38337924|FG001|Overall Study|Subject taken off dialysis|0|||
17185631|NCT02688764|38337923|FG000|Overall Study|Withdrawal by parent|3|||
17185632|NCT02688764|38337924|FG001|Overall Study|Withdrawal by parent|0|||
17185633|NCT02688608|38337933|FG000|Overall Study|Lost to Follow-up|1|||
17185634|NCT02688530|38337941|FG000|Overall Study|Withdrawal by Subject|0|||
17185635|NCT02688530|38337942|FG001|Overall Study|Withdrawal by Subject|1|||
17185636|NCT02688530|38337943|FG002|Overall Study|Withdrawal by Subject|0|||
17185637|NCT02688530|38337944|FG003|Overall Study|Withdrawal by Subject|0|||
17185638|NCT02688530|38337941|FG000|Overall Study|Lost to Follow-up|0|||
17185639|NCT02688530|38337942|FG001|Overall Study|Lost to Follow-up|0|||
17185640|NCT02688530|38337943|FG002|Overall Study|Lost to Follow-up|2|||
17185641|NCT02688530|38337944|FG003|Overall Study|Lost to Follow-up|0|||
17185642|NCT02467270|38337961|FG000|Overall Study|Participants Never Treated|0|||
17185643|NCT02467270|38337962|FG001|Overall Study|Participants Never Treated|1|||
17185644|NCT02467270|38337963|FG002|Overall Study|Participants Never Treated|0|||
17185645|NCT02467270|38337961|FG000|Overall Study|Ongoing|50|||
17185646|NCT02467270|38337962|FG001|Overall Study|Ongoing|41|||
17185647|NCT02467270|38337963|FG002|Overall Study|Ongoing|43|||
17185648|NCT02467270|38337961|FG000|Overall Study|Adverse Event|16|||
17185649|NCT02467270|38337962|FG001|Overall Study|Adverse Event|15|||
17185650|NCT02467270|38337963|FG002|Overall Study|Adverse Event|14|||
17185651|NCT02467270|38337961|FG000|Overall Study|Progressive Disease|7|||
17185652|NCT02467270|38337962|FG001|Overall Study|Progressive Disease|7|||
17185653|NCT02467270|38337963|FG002|Overall Study|Progressive Disease|4|||
17185654|NCT02467270|38337961|FG000|Overall Study|Death|2|||
17185655|NCT02467270|38337962|FG001|Overall Study|Death|0|||
17185656|NCT02467270|38337963|FG002|Overall Study|Death|2|||
17185657|NCT02467270|38337961|FG000|Overall Study|Lack of Efficacy|12|||
17185658|NCT02467270|38337962|FG001|Overall Study|Lack of Efficacy|18|||
17185659|NCT02467270|38337963|FG002|Overall Study|Lack of Efficacy|23|||
17185660|NCT02467270|38337961|FG000|Overall Study|Non-compliance With Study Drug|0|||
17185661|NCT02467270|38337962|FG001|Overall Study|Non-compliance With Study Drug|2|||
17185662|NCT02467270|38337963|FG002|Overall Study|Non-compliance With Study Drug|1|||
17185663|NCT02467270|38337961|FG000|Overall Study|Lost to Follow-up|2|||
17185664|NCT02467270|38337962|FG001|Overall Study|Lost to Follow-up|1|||
17185665|NCT02467270|38337963|FG002|Overall Study|Lost to Follow-up|0|||
17185666|NCT02467270|38337961|FG000|Overall Study|Pregnancy|0|||
17185667|NCT02467270|38337962|FG001|Overall Study|Pregnancy|1|||
17185668|NCT02467270|38337963|FG002|Overall Study|Pregnancy|0|||
17185669|NCT02467270|38337961|FG000|Overall Study|Physician Decision|0|||
17185670|NCT02467270|38337962|FG001|Overall Study|Physician Decision|4|||
17185671|NCT02467270|38337963|FG002|Overall Study|Physician Decision|1|||
17185672|NCT02467270|38337961|FG000|Overall Study|Withdrawal by Subject|4|||
17185673|NCT02467270|38337962|FG001|Overall Study|Withdrawal by Subject|3|||
17185674|NCT02467270|38337963|FG002|Overall Study|Withdrawal by Subject|5|||
17185675|NCT02467270|38337961|FG000|Overall Study|Reason not Specified|1|||
17185676|NCT02467270|38337962|FG001|Overall Study|Reason not Specified|2|||
17185677|NCT02467270|38337963|FG002|Overall Study|Reason not Specified|1|||
17185678|NCT05083559|38337973|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
17185679|NCT05083559|38337974|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
17185680|NCT05083559|38337973|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
17185681|NCT05083559|38337974|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
17185682|NCT05083559|38337973|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
17185683|NCT05083559|38337974|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
17185684|NCT03037307|38337980|FG000|Period 1|Did Not Meet Study Criteria|0|||
17185685|NCT03037307|38337981|FG001|Period 1|Did Not Meet Study Criteria|0|||
17185686|NCT03037307|38337982|FG002|Period 1|Did Not Meet Study Criteria|0|||
17185687|NCT03037307|38337983|FG003|Period 1|Did Not Meet Study Criteria|1|||
17185688|NCT03037307|38337984|FG004|Period 1|Did Not Meet Study Criteria|0|||
17185689|NCT03037307|38337985|FG005|Period 1|Did Not Meet Study Criteria|0|||
17185690|NCT02538094|38337994|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
17185691|NCT02538094|38337995|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
17185692|NCT02538094|38337994|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
17185693|NCT02538094|38337995|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
17185694|NCT02686034|38338003|FG000|Run-In Period 1|Eligibility|12|||
17185695|NCT02686034|38338004|FG001|Run-In Period 1|Eligibility|10|||
17185696|NCT02686034|38338003|FG000|Run-In Period 1|Withdrawal by Subject|4|||
17185697|NCT02686034|38338004|FG001|Run-In Period 1|Withdrawal by Subject|3|||
17185698|NCT02686034|38338003|FG000|Run-In Period 1|Lost to Follow-up|4|||
17185699|NCT02686034|38338004|FG001|Run-In Period 1|Lost to Follow-up|4|||
17185700|NCT02686034|38338003|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
17185701|NCT02686034|38338004|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
17185702|NCT02686034|38338003|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
17185703|NCT02686034|38338004|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
17185704|NCT02686034|38338003|FG000|Randomized Controlled Period 2|Adverse Event|0|||
17185705|NCT02686034|38338004|FG001|Randomized Controlled Period 2|Adverse Event|2|||
17185706|NCT02686034|38338003|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
17185707|NCT02686034|38338004|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
17185708|NCT02686034|38338003|FG000|Open Label Period 3|Lost to Follow-up|0|||
17185709|NCT02686034|38338004|FG001|Open Label Period 3|Lost to Follow-up|1|||
17185710|NCT02685488|38338012|FG000|Overall Study|Withdrawal by Subject|0|||
17185711|NCT02685488|38338013|FG001|Overall Study|Withdrawal by Subject|1|||
17185712|NCT02533570|38338022|FG000|Overall Study|Adverse Event|0|||
17185713|NCT02533570|38338023|FG001|Overall Study|Adverse Event|1|||
17185714|NCT02533570|38338024|FG002|Overall Study|Adverse Event|1|||
17185715|NCT03036839|38338035|FG000|Overall Study|Adverse Event|0|||
17185716|NCT03036839|38338036|FG001|Overall Study|Adverse Event|0|||
17185717|NCT03036839|38338037|FG002|Overall Study|Adverse Event|1|||
17185718|NCT03036839|38338035|FG000|Overall Study|Death|3|||
17185719|NCT03036839|38338036|FG001|Overall Study|Death|0|||
17185720|NCT03036839|38338037|FG002|Overall Study|Death|3|||
17185721|NCT03036839|38338035|FG000|Overall Study|Withdrew Consent|0|||
17185722|NCT03036839|38338036|FG001|Overall Study|Withdrew Consent|0|||
17185723|NCT03036839|38338037|FG002|Overall Study|Withdrew Consent|1|||
17185724|NCT01286207|38338048|FG000|Overall Study|Adverse Event|27|||
17185725|NCT01286207|38338049|FG001|Overall Study|Adverse Event|41|||
17185726|NCT01286207|38338050|FG002|Overall Study|Adverse Event|8|||
17185727|NCT01286207|38338048|FG000|Overall Study|Lost to Follow-up|49|||
17185728|NCT01286207|38338049|FG001|Overall Study|Lost to Follow-up|43|||
17185729|NCT01286207|38338050|FG002|Overall Study|Lost to Follow-up|20|||
17185730|NCT01286207|38338048|FG000|Overall Study|Withdrawal by Subject|93|||
17185731|NCT01286207|38338049|FG001|Overall Study|Withdrawal by Subject|79|||
17185732|NCT01286207|38338050|FG002|Overall Study|Withdrawal by Subject|41|||
17185733|NCT01286207|38338048|FG000|Overall Study|Lack of Response|92|||
17185734|NCT01286207|38338049|FG001|Overall Study|Lack of Response|38|||
17185735|NCT01286207|38338050|FG002|Overall Study|Lack of Response|8|||
17185736|NCT01286207|38338048|FG000|Overall Study|Other|37|||
17185737|NCT01286207|38338049|FG001|Overall Study|Other|47|||
17185738|NCT01286207|38338050|FG002|Overall Study|Other|13|||
17185739|NCT00968201|38338087|FG000|Base Study - (Period II)|Adverse Event|8|||
17185740|NCT00968201|38338088|FG001|Base Study - (Period II)|Adverse Event|0|||
17185741|NCT00968201|38338089|FG002|Base Study - (Period II)|Adverse Event|16|||
17185742|NCT00968201|38338087|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
17185743|NCT00968201|38338088|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
17185744|NCT00968201|38338089|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
17185745|NCT00968201|38338087|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
17185746|NCT00968201|38338088|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
17185747|NCT00968201|38338089|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
17185748|NCT00968201|38338087|FG000|Base Study - (Period II)|Protocol Violation|12|||
17185749|NCT00968201|38338088|FG001|Base Study - (Period II)|Protocol Violation|0|||
17185750|NCT00968201|38338089|FG002|Base Study - (Period II)|Protocol Violation|12|||
17185751|NCT00968201|38338087|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
17185752|NCT00968201|38338088|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
17185753|NCT00968201|38338089|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
17185754|NCT00968201|38338087|FG000|Base Study - (Period II)|Site Error|0|||
17185755|NCT00968201|38338088|FG001|Base Study - (Period II)|Site Error|0|||
17185756|NCT00968201|38338089|FG002|Base Study - (Period II)|Site Error|1|||
17185757|NCT00968201|38338087|FG000|Extension Study - (Period III)|Adverse Event|0|||
17185758|NCT00968201|38338088|FG001|Extension Study - (Period III)|Adverse Event|5|||
17185759|NCT00968201|38338089|FG002|Extension Study - (Period III)|Adverse Event|22|||
17185760|NCT00968201|38338087|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
17185761|NCT00968201|38338088|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
17185762|NCT00968201|38338089|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
17185763|NCT00968201|38338087|FG000|Extension Study - (Period III)|Protocol Violation|0|||
17185764|NCT00968201|38338088|FG001|Extension Study - (Period III)|Protocol Violation|17|||
17185765|NCT00968201|38338089|FG002|Extension Study - (Period III)|Protocol Violation|14|||
17185766|NCT00968201|38338087|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
17185767|NCT00968201|38338088|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
17185768|NCT00968201|38338089|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
17185769|NCT00968201|38338087|FG000|Extension Study - (Period III)|Patient Relocated|0|||
17185770|NCT00968201|38338088|FG001|Extension Study - (Period III)|Patient Relocated|1|||
17185771|NCT00968201|38338089|FG002|Extension Study - (Period III)|Patient Relocated|1|||
17185772|NCT00968201|38338087|FG000|Extension Study - (Period III)|Noncompliance|0|||
17185773|NCT00968201|38338088|FG001|Extension Study - (Period III)|Noncompliance|0|||
17185774|NCT00968201|38338089|FG002|Extension Study - (Period III)|Noncompliance|3|||
17185775|NCT00968201|38338087|FG000|Extension Study - (Period III)|Other|0|||
17185776|NCT00968201|38338088|FG001|Extension Study - (Period III)|Other|0|||
17185777|NCT00968201|38338089|FG002|Extension Study - (Period III)|Other|2|||
17185778|NCT00968201|38338087|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
17185779|NCT00968201|38338088|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
17185780|NCT00968201|38338089|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
17185781|NCT00943397|38338100|FG000|Overall Study|Adverse Event|0|||
17185782|NCT00943397|38338101|FG001|Overall Study|Adverse Event|6|||
17185783|NCT00943397|38338100|FG000|Overall Study|Lost to Follow-up|0|||
17185784|NCT00943397|38338101|FG001|Overall Study|Lost to Follow-up|4|||
17185785|NCT00943397|38338100|FG000|Overall Study|Protocol Violation|2|||
17185786|NCT00943397|38338101|FG001|Overall Study|Protocol Violation|5|||
17185787|NCT00943397|38338100|FG000|Overall Study|Withdrawal by Subject|1|||
17185788|NCT00943397|38338101|FG001|Overall Study|Withdrawal by Subject|1|||
17185789|NCT00943397|38338100|FG000|Overall Study|Site terminated and other|12|||
17185790|NCT00943397|38338101|FG001|Overall Study|Site terminated and other|56|||
17185791|NCT00702845|38338109|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
17185792|NCT00702845|38338110|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
17185793|NCT00702845|38338109|FG000|Overall Study|Too high ovarian response|5|||
17185794|NCT00702845|38338110|FG001|Overall Study|Too high ovarian response|1|||
17185795|NCT00702845|38338109|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
17185796|NCT00702845|38338110|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
17185797|NCT00702845|38338109|FG000|Overall Study|Insufficient ovarian response|1|||
17185798|NCT00702845|38338110|FG001|Overall Study|Insufficient ovarian response|0|||
17185799|NCT00702845|38338109|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
17185800|NCT00702845|38338110|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
17185801|NCT00702845|38338109|FG000|Overall Study|No or abnormal fertilization|4|||
17185802|NCT00702845|38338110|FG001|Overall Study|No or abnormal fertilization|2|||
17185803|NCT00702845|38338109|FG000|Overall Study|Patient's decision|2|||
17185804|NCT00702845|38338110|FG001|Overall Study|Patient's decision|1|||
17185805|NCT00702845|38338109|FG000|Overall Study|Not randomized|0|||
17185806|NCT00702845|38338110|FG001|Overall Study|Not randomized|1|||
17185807|NCT01302847|38338124|FG000|Overall Study|Ongoing|0|||
17185808|NCT01302847|38338125|FG001|Overall Study|Ongoing|0|||
17185809|NCT01302847|38338126|FG002|Overall Study|Ongoing|0|||
17185810|NCT01302847|38338127|FG003|Overall Study|Ongoing|0|||
17185811|NCT01302847|38338128|FG004|Overall Study|Ongoing|0|||
17185812|NCT01302847|38338129|FG005|Overall Study|Ongoing|27|||
17185813|NCT01302847|38338130|FG006|Overall Study|Ongoing|22|||
17185814|NCT01302847|38338131|FG007|Overall Study|Ongoing|17|||
17185815|NCT01302847|38338124|FG000|Overall Study|Death|0|||
17185816|NCT01302847|38338125|FG001|Overall Study|Death|1|||
17185817|NCT01302847|38338126|FG002|Overall Study|Death|0|||
17185818|NCT01302847|38338127|FG003|Overall Study|Death|0|||
17185819|NCT01302847|38338128|FG004|Overall Study|Death|0|||
17185820|NCT01302847|38338129|FG005|Overall Study|Death|1|||
17089615|NCT00297492|38229750|FG000|Set Quit Date|Lost to Follow-up|7|||
17089616|NCT00297492|38229751|FG001|Set Quit Date|Lost to Follow-up|13|||
17089617|NCT00297492|38229752|FG002|Set Quit Date|Lost to Follow-up|5|||
17089618|NCT00297492|38229750|FG000|6 Month Follow-up|Lost to Follow-up|63|||
17089619|NCT00297492|38229751|FG001|6 Month Follow-up|Lost to Follow-up|49|||
17089620|NCT00297492|38229752|FG002|6 Month Follow-up|Lost to Follow-up|27|||
17089621|NCT00297258|38229760|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
17089622|NCT00297258|38229760|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
17089623|NCT00297258|38229760|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
17089624|NCT00297258|38229760|FG000|Overall Study|Intercurrent Illness|3|||
17089625|NCT00297258|38229760|FG000|Overall Study|Intercurrent Death|2|||
17089626|NCT00297258|38229760|FG000|Overall Study|Deteriorization of General Condition|1|||
17089627|NCT00297258|38229760|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
17089628|NCT00297258|38229760|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
17089629|NCT00297258|38229760|FG000|Overall Study|Switch to Commercial Treatment|1|||
17089630|NCT00297258|38229760|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
17089631|NCT00496769|38229769|FG000|Double Blind|>=1 reason assigned per patient|558|||
17089632|NCT00496769|38229770|FG001|Double Blind|>=1 reason assigned per patient|649|||
17089633|NCT00496769|38229771|FG002|Double Blind|>=1 reason assigned per patient|0|||
17089634|NCT00496769|38229769|FG000|Open Label|>=1 reason assigned per patient|0|||
17089635|NCT00496769|38229770|FG001|Open Label|>=1 reason assigned per patient|0|||
17089636|NCT00496769|38229771|FG002|Open Label|>=1 reason assigned per patient|1011|||
17089637|NCT00478673|38229780|FG000|30-Days Post-Procedure|Death|2|||
17185821|NCT01302847|38338130|FG006|Overall Study|Death|1|||
17185822|NCT01302847|38338131|FG007|Overall Study|Death|0|||
17185823|NCT01302847|38338124|FG000|Overall Study|Pregnancy|2|||
17185824|NCT01302847|38338125|FG001|Overall Study|Pregnancy|0|||
17185825|NCT01302847|38338126|FG002|Overall Study|Pregnancy|0|||
17185826|NCT01302847|38338127|FG003|Overall Study|Pregnancy|0|||
17185827|NCT01302847|38338128|FG004|Overall Study|Pregnancy|0|||
17185828|NCT01302847|38338129|FG005|Overall Study|Pregnancy|0|||
17089638|NCT00478673|38229780|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
17089639|NCT00478673|38229780|FG000|30-Days Post-Procedure|Missed Visit|7|||
17089640|NCT00478673|38229780|FG000|12-Months Post-Procedure|Death|23|||
17089641|NCT00478673|38229780|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
17185829|NCT01302847|38338130|FG006|Overall Study|Pregnancy|0|||
17185830|NCT01302847|38338131|FG007|Overall Study|Pregnancy|0|||
17185831|NCT01302847|38338124|FG000|Overall Study|Virologic failure|0|||
17185832|NCT01302847|38338125|FG001|Overall Study|Virologic failure|2|||
17185833|NCT01302847|38338126|FG002|Overall Study|Virologic failure|2|||
17185834|NCT01302847|38338127|FG003|Overall Study|Virologic failure|0|||
17185835|NCT01302847|38338128|FG004|Overall Study|Virologic failure|1|||
17185836|NCT01302847|38338129|FG005|Overall Study|Virologic failure|1|||
17185837|NCT01302847|38338130|FG006|Overall Study|Virologic failure|0|||
17185838|NCT01302847|38338131|FG007|Overall Study|Virologic failure|2|||
17185839|NCT01302847|38338124|FG000|Overall Study|Severe debilitation, unable to continue|0|||
17185840|NCT01302847|38338125|FG001|Overall Study|Severe debilitation, unable to continue|0|||
17185841|NCT01302847|38338126|FG002|Overall Study|Severe debilitation, unable to continue|0|||
17185842|NCT01302847|38338127|FG003|Overall Study|Severe debilitation, unable to continue|0|||
17185843|NCT01302847|38338128|FG004|Overall Study|Severe debilitation, unable to continue|0|||
17185844|NCT01302847|38338129|FG005|Overall Study|Severe debilitation, unable to continue|1|||
17185845|NCT01302847|38338130|FG006|Overall Study|Severe debilitation, unable to continue|1|||
17185846|NCT01302847|38338131|FG007|Overall Study|Severe debilitation, unable to continue|0|||
17185847|NCT01302847|38338124|FG000|Overall Study|Not able to get to clinic|1|||
17185848|NCT01302847|38338125|FG001|Overall Study|Not able to get to clinic|1|||
17185849|NCT01302847|38338126|FG002|Overall Study|Not able to get to clinic|0|||
17185850|NCT01302847|38338127|FG003|Overall Study|Not able to get to clinic|0|||
17185851|NCT01302847|38338128|FG004|Overall Study|Not able to get to clinic|0|||
17185852|NCT01302847|38338129|FG005|Overall Study|Not able to get to clinic|0|||
17185853|NCT01302847|38338130|FG006|Overall Study|Not able to get to clinic|0|||
17185854|NCT01302847|38338131|FG007|Overall Study|Not able to get to clinic|0|||
17185855|NCT01302847|38338124|FG000|Overall Study|Site closing|2|||
17185856|NCT01302847|38338125|FG001|Overall Study|Site closing|2|||
17185857|NCT01302847|38338126|FG002|Overall Study|Site closing|0|||
17185858|NCT01302847|38338127|FG003|Overall Study|Site closing|0|||
17185859|NCT01302847|38338128|FG004|Overall Study|Site closing|0|||
17185860|NCT01302847|38338129|FG005|Overall Study|Site closing|0|||
17185861|NCT01302847|38338130|FG006|Overall Study|Site closing|0|||
17185862|NCT01302847|38338131|FG007|Overall Study|Site closing|0|||
17185863|NCT01302847|38338124|FG000|Overall Study|Withdrawal by Subject|1|||
17185864|NCT01302847|38338125|FG001|Overall Study|Withdrawal by Subject|0|||
17185865|NCT01302847|38338126|FG002|Overall Study|Withdrawal by Subject|0|||
17185866|NCT01302847|38338127|FG003|Overall Study|Withdrawal by Subject|0|||
17185867|NCT01302847|38338128|FG004|Overall Study|Withdrawal by Subject|1|||
17185868|NCT01302847|38338129|FG005|Overall Study|Withdrawal by Subject|0|||
17185869|NCT01302847|38338130|FG006|Overall Study|Withdrawal by Subject|0|||
17185870|NCT01302847|38338131|FG007|Overall Study|Withdrawal by Subject|1|||
17185871|NCT01302847|38338124|FG000|Overall Study|Not willing to adhere to requirements|5|||
17185872|NCT01302847|38338125|FG001|Overall Study|Not willing to adhere to requirements|0|||
17185873|NCT01302847|38338126|FG002|Overall Study|Not willing to adhere to requirements|0|||
17185874|NCT01302847|38338127|FG003|Overall Study|Not willing to adhere to requirements|1|||
17185875|NCT01302847|38338128|FG004|Overall Study|Not willing to adhere to requirements|0|||
17185876|NCT01302847|38338129|FG005|Overall Study|Not willing to adhere to requirements|0|||
17185877|NCT01302847|38338130|FG006|Overall Study|Not willing to adhere to requirements|0|||
17185878|NCT01302847|38338131|FG007|Overall Study|Not willing to adhere to requirements|2|||
17185879|NCT01302847|38338124|FG000|Overall Study|Site unable to contact participant|2|||
17185880|NCT01302847|38338125|FG001|Overall Study|Site unable to contact participant|1|||
17185881|NCT01302847|38338126|FG002|Overall Study|Site unable to contact participant|0|||
17185882|NCT01302847|38338127|FG003|Overall Study|Site unable to contact participant|0|||
17185883|NCT01302847|38338128|FG004|Overall Study|Site unable to contact participant|0|||
17185884|NCT01302847|38338129|FG005|Overall Study|Site unable to contact participant|0|||
17185885|NCT01302847|38338130|FG006|Overall Study|Site unable to contact participant|2|||
17185886|NCT01302847|38338131|FG007|Overall Study|Site unable to contact participant|0|||
17185887|NCT03039569|38338160|FG000|Overall Study|Lost to Follow-up|5|||
17185888|NCT03039569|38338161|FG001|Overall Study|Lost to Follow-up|4|||
17185889|NCT02738775|38338174|FG000|Overall Study|Withdrawal by Subject|0|||
17185890|NCT02738775|38338175|FG001|Overall Study|Withdrawal by Subject|1|||
17185891|NCT02738775|38338176|FG002|Overall Study|Withdrawal by Subject|0|||
17185892|NCT02738775|38338177|FG003|Overall Study|Withdrawal by Subject|0|||
17185893|NCT02738775|38338178|FG004|Overall Study|Withdrawal by Subject|0|||
17185894|NCT02738775|38338179|FG005|Overall Study|Withdrawal by Subject|0|||
17185895|NCT02738775|38338174|FG000|Overall Study|Adverse Event|0|||
17185896|NCT02738775|38338175|FG001|Overall Study|Adverse Event|0|||
17185897|NCT02738775|38338176|FG002|Overall Study|Adverse Event|0|||
17185898|NCT02738775|38338177|FG003|Overall Study|Adverse Event|1|||
17185899|NCT02738775|38338178|FG004|Overall Study|Adverse Event|0|||
17185900|NCT02738775|38338179|FG005|Overall Study|Adverse Event|0|||
17185901|NCT02738775|38338174|FG000|Overall Study|Pregnancy|0|||
17185902|NCT02738775|38338175|FG001|Overall Study|Pregnancy|1|||
17185903|NCT02738775|38338176|FG002|Overall Study|Pregnancy|0|||
17185904|NCT02738775|38338177|FG003|Overall Study|Pregnancy|0|||
17185905|NCT02738775|38338178|FG004|Overall Study|Pregnancy|0|||
17185906|NCT02738775|38338179|FG005|Overall Study|Pregnancy|0|||
17185907|NCT02738775|38338174|FG000|Overall Study|Missing|0|||
17185908|NCT02738775|38338175|FG001|Overall Study|Missing|0|||
17185909|NCT02738775|38338176|FG002|Overall Study|Missing|0|||
17185910|NCT02738775|38338177|FG003|Overall Study|Missing|0|||
17185911|NCT02738775|38338178|FG004|Overall Study|Missing|0|||
17185912|NCT02738775|38338179|FG005|Overall Study|Missing|1|||
17185913|NCT02314923|38338216|FG000|Overall Study|Death|0|||
17185914|NCT02314923|38338217|FG001|Overall Study|Death|0|||
17185915|NCT02314923|38338218|FG002|Overall Study|Death|0|||
17185916|NCT02314923|38338219|FG003|Overall Study|Death|1|||
17185917|NCT02314923|38338220|FG004|Overall Study|Death|0|||
17185918|NCT02314923|38338221|FG005|Overall Study|Death|0|||
17185919|NCT02314923|38338222|FG006|Overall Study|Death|0|||
17185920|NCT02314923|38338223|FG007|Overall Study|Death|0|||
17185921|NCT02314923|38338224|FG008|Overall Study|Death|0|||
17185922|NCT02314923|38338225|FG009|Overall Study|Death|0|||
17185923|NCT02314923|38338216|FG000|Overall Study|Lost to Follow-up|2|||
17185924|NCT02314923|38338217|FG001|Overall Study|Lost to Follow-up|3|||
17185925|NCT02314923|38338218|FG002|Overall Study|Lost to Follow-up|1|||
17185926|NCT02314923|38338219|FG003|Overall Study|Lost to Follow-up|0|||
17185927|NCT02314923|38338220|FG004|Overall Study|Lost to Follow-up|0|||
17185928|NCT02314923|38338221|FG005|Overall Study|Lost to Follow-up|0|||
17185929|NCT02314923|38338222|FG006|Overall Study|Lost to Follow-up|3|||
17185930|NCT02314923|38338223|FG007|Overall Study|Lost to Follow-up|4|||
17185931|NCT02314923|38338224|FG008|Overall Study|Lost to Follow-up|2|||
17185932|NCT02314923|38338225|FG009|Overall Study|Lost to Follow-up|0|||
17185933|NCT02314923|38338216|FG000|Overall Study|Withdrawal by Subject|0|||
17185934|NCT02314923|38338217|FG001|Overall Study|Withdrawal by Subject|0|||
17185935|NCT02314923|38338218|FG002|Overall Study|Withdrawal by Subject|1|||
17185936|NCT02314923|38338219|FG003|Overall Study|Withdrawal by Subject|0|||
17185937|NCT02314923|38338220|FG004|Overall Study|Withdrawal by Subject|1|||
17185938|NCT02314923|38338221|FG005|Overall Study|Withdrawal by Subject|0|||
17185939|NCT02314923|38338222|FG006|Overall Study|Withdrawal by Subject|1|||
17185940|NCT02314923|38338223|FG007|Overall Study|Withdrawal by Subject|0|||
17185941|NCT02314923|38338224|FG008|Overall Study|Withdrawal by Subject|0|||
17185942|NCT02314923|38338225|FG009|Overall Study|Withdrawal by Subject|0|||
17185943|NCT02314923|38338216|FG000|Overall Study|Physician Decision|0|||
17185944|NCT02314923|38338217|FG001|Overall Study|Physician Decision|1|||
17185945|NCT02314923|38338218|FG002|Overall Study|Physician Decision|0|||
17185946|NCT02314923|38338219|FG003|Overall Study|Physician Decision|0|||
17185947|NCT02314923|38338220|FG004|Overall Study|Physician Decision|0|||
17185948|NCT02314923|38338221|FG005|Overall Study|Physician Decision|0|||
17185949|NCT02314923|38338222|FG006|Overall Study|Physician Decision|0|||
17185950|NCT02314923|38338223|FG007|Overall Study|Physician Decision|0|||
17185951|NCT02314923|38338224|FG008|Overall Study|Physician Decision|0|||
17185952|NCT02314923|38338225|FG009|Overall Study|Physician Decision|0|||
17185953|NCT02314923|38338216|FG000|Overall Study|Participant unavailable|0|||
17185954|NCT02314923|38338217|FG001|Overall Study|Participant unavailable|0|||
17185955|NCT02314923|38338218|FG002|Overall Study|Participant unavailable|0|||
17185956|NCT02314923|38338219|FG003|Overall Study|Participant unavailable|0|||
17185957|NCT02314923|38338220|FG004|Overall Study|Participant unavailable|0|||
17185958|NCT02314923|38338221|FG005|Overall Study|Participant unavailable|1|||
17185959|NCT02314923|38338222|FG006|Overall Study|Participant unavailable|0|||
17185960|NCT02314923|38338223|FG007|Overall Study|Participant unavailable|0|||
17185961|NCT02314923|38338224|FG008|Overall Study|Participant unavailable|0|||
17185962|NCT02314923|38338225|FG009|Overall Study|Participant unavailable|0|||
17185963|NCT02314923|38338216|FG000|Overall Study|Screen failure|0|||
17185964|NCT02314923|38338217|FG001|Overall Study|Screen failure|0|||
17185965|NCT02314923|38338218|FG002|Overall Study|Screen failure|0|||
17185966|NCT02314923|38338219|FG003|Overall Study|Screen failure|0|||
17185967|NCT02314923|38338220|FG004|Overall Study|Screen failure|0|||
17185968|NCT02314923|38338221|FG005|Overall Study|Screen failure|0|||
17185969|NCT02314923|38338222|FG006|Overall Study|Screen failure|1|||
17185970|NCT02314923|38338223|FG007|Overall Study|Screen failure|0|||
17185971|NCT02314923|38338224|FG008|Overall Study|Screen failure|0|||
17185972|NCT02314923|38338225|FG009|Overall Study|Screen failure|0|||
17185973|NCT02314923|38338216|FG000|Overall Study|Participant relocation|1|||
17185974|NCT02314923|38338217|FG001|Overall Study|Participant relocation|0|||
17185975|NCT02314923|38338218|FG002|Overall Study|Participant relocation|0|||
17185976|NCT02314923|38338219|FG003|Overall Study|Participant relocation|0|||
17185977|NCT02314923|38338220|FG004|Overall Study|Participant relocation|0|||
17185978|NCT02314923|38338221|FG005|Overall Study|Participant relocation|0|||
17185979|NCT02314923|38338222|FG006|Overall Study|Participant relocation|0|||
17185980|NCT02314923|38338223|FG007|Overall Study|Participant relocation|1|||
17185981|NCT02314923|38338224|FG008|Overall Study|Participant relocation|0|||
17185982|NCT02314923|38338225|FG009|Overall Study|Participant relocation|0|||
17185983|NCT03023137|38338250|FG000|Overall Study|Multiple pregnancy|2|||
17185984|NCT03023137|38338251|FG001|Overall Study|Multiple pregnancy|4|||
17185985|NCT03023137|38338250|FG000|Overall Study|Lost to Follow-up|1|||
17185986|NCT03023137|38338251|FG001|Overall Study|Lost to Follow-up|1|||
17185987|NCT03023137|38338250|FG000|Overall Study|Protocol Violation|0|||
17185988|NCT03023137|38338251|FG001|Overall Study|Protocol Violation|4|||
17185989|NCT03023137|38338250|FG000|Overall Study|Lost the baby in a car accident|1|||
17185990|NCT03023137|38338251|FG001|Overall Study|Lost the baby in a car accident|0|||
17185991|NCT03049813|38338262|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
17185992|NCT03049813|38338263|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
17185993|NCT03049813|38338264|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
17185994|NCT03049813|38338265|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
17185995|NCT03049813|38338262|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
17185996|NCT03049813|38338263|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
17185997|NCT03049813|38338264|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
17185998|NCT03049813|38338265|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
17185999|NCT03049813|38338262|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
17186000|NCT03049813|38338263|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
17186001|NCT03049813|38338264|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
17186002|NCT03049813|38338265|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
17186003|NCT03049813|38338262|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
17186004|NCT03049813|38338263|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
17186005|NCT03049813|38338264|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
17186006|NCT03049813|38338265|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
17186007|NCT03022981|38338276|FG000|Overall Study|Adverse Event|0|||
17186008|NCT03022981|38338277|FG001|Overall Study|Adverse Event|1|||
17186009|NCT03022981|38338278|FG002|Overall Study|Adverse Event|0|||
17186010|NCT03022981|38338276|FG000|Overall Study|Investigator's Discretion|0|||
17186011|NCT03022981|38338277|FG001|Overall Study|Investigator's Discretion|1|||
17186012|NCT03022981|38338278|FG002|Overall Study|Investigator's Discretion|2|||
17186013|NCT03022981|38338276|FG000|Overall Study|Lost to Follow-up|6|||
17186014|NCT03022981|38338277|FG001|Overall Study|Lost to Follow-up|2|||
17186015|NCT03022981|38338278|FG002|Overall Study|Lost to Follow-up|1|||
17186016|NCT03022981|38338276|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17186017|NCT03022981|38338277|FG001|Overall Study|Non-Compliance With Study Drug|0|||
17186018|NCT03022981|38338278|FG002|Overall Study|Non-Compliance With Study Drug|2|||
17186019|NCT03022981|38338276|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
17186020|NCT03022981|38338277|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
17186021|NCT03022981|38338278|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
17186022|NCT03377699|38338298|FG000|Overall Study|Withdrawal by Subject|2|||
17186023|NCT03377699|38338299|FG001|Overall Study|Withdrawal by Subject|9|||
17186024|NCT03377699|38338298|FG000|Overall Study|Lost to Follow-up|1|||
17186025|NCT03377699|38338299|FG001|Overall Study|Lost to Follow-up|1|||
17186026|NCT03377699|38338298|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
17186027|NCT03377699|38338299|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
17186028|NCT03377699|38338298|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
17186029|NCT03377699|38338299|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
17186030|NCT03377699|38338298|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
17186031|NCT03377699|38338299|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
17186032|NCT03377699|38338298|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
17186033|NCT03377699|38338299|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
17186034|NCT01314443|38338311|FG000|Overall Study|Withdrawal by Subject|2|||
17186035|NCT01314443|38338312|FG001|Overall Study|Withdrawal by Subject|1|||
17186036|NCT01314443|38338313|FG002|Overall Study|Withdrawal by Subject|1|||
17186037|NCT01314443|38338314|FG003|Overall Study|Withdrawal by Subject|1|||
17186038|NCT01314443|38338311|FG000|Overall Study|Protocol Violation|2|||
17186039|NCT01314443|38338312|FG001|Overall Study|Protocol Violation|2|||
17186040|NCT01314443|38338313|FG002|Overall Study|Protocol Violation|1|||
17186041|NCT01314443|38338314|FG003|Overall Study|Protocol Violation|1|||
17186042|NCT02923921|38338326|FG000|Overall Study|Sponsor Decision|39|||
17186043|NCT02923921|38338327|FG001|Overall Study|Sponsor Decision|38|||
17186044|NCT02923921|38338326|FG000|Overall Study|Lost to Follow-up|1|||
17186045|NCT02923921|38338327|FG001|Overall Study|Lost to Follow-up|0|||
17186046|NCT02923921|38338326|FG000|Overall Study|Withdrawal by Subject|6|||
17186047|NCT02923921|38338327|FG001|Overall Study|Withdrawal by Subject|13|||
17186048|NCT02923921|38338326|FG000|Overall Study|Unknown, Not Collected|7|||
17186049|NCT02923921|38338327|FG001|Overall Study|Unknown, Not Collected|6|||
17186050|NCT03039023|38338338|FG000|Overall Study|Withdrawal by Subject|1|||
17186051|NCT03039023|38338339|FG001|Overall Study|Withdrawal by Subject|0|||
17186052|NCT03039023|38338340|FG002|Overall Study|Withdrawal by Subject|1|||
17186053|NCT03039023|38338341|FG003|Overall Study|Withdrawal by Subject|1|||
17186054|NCT03039023|38338342|FG004|Overall Study|Withdrawal by Subject|0|||
17186055|NCT03039023|38338338|FG000|Overall Study|Physician Decision|0|||
17186056|NCT03039023|38338339|FG001|Overall Study|Physician Decision|0|||
17186057|NCT03039023|38338340|FG002|Overall Study|Physician Decision|0|||
17186058|NCT03039023|38338341|FG003|Overall Study|Physician Decision|1|||
17186059|NCT03039023|38338342|FG004|Overall Study|Physician Decision|0|||
17186060|NCT03022045|38338356|FG000|Overall Study|Adverse Event|0|||
17186061|NCT03022045|38338357|FG001|Overall Study|Adverse Event|1|||
17186062|NCT03022045|38338356|FG000|Overall Study|Withdrawal by Subject|1|||
17186063|NCT03022045|38338357|FG001|Overall Study|Withdrawal by Subject|1|||
17186064|NCT03037619|38338369|FG000|Overall Study|Lost to Follow-up|0|||
17186065|NCT03037619|38338370|FG001|Overall Study|Lost to Follow-up|1|||
17186066|NCT04771013|38338378|FG000|Overall Study|Withdrawal by Subject|2|||
17186067|NCT04771013|38338379|FG001|Overall Study|Withdrawal by Subject|0|||
17186068|NCT04771013|38338378|FG000|Overall Study|Death|0|||
17186069|NCT04771013|38338379|FG001|Overall Study|Death|5|||
17186070|NCT04771013|38338378|FG000|Overall Study|Referred to another hospital before day 20|0|||
17186071|NCT04771013|38338379|FG001|Overall Study|Referred to another hospital before day 20|1|||
17186072|NCT03021265|38338385|FG000|Overall Study|Adverse Event|29|||
17186073|NCT03021265|38338385|FG000|Overall Study|Lack of Efficacy|3|||
17186074|NCT03021265|38338385|FG000|Overall Study|Improved|17|||
17186075|NCT03021265|38338385|FG000|Overall Study|Lost to Follow-up|67|||
17186076|NCT03021265|38338385|FG000|Overall Study|No reason given|2|||
17186077|NCT03021265|38338385|FG000|Overall Study|No visit since the first visit|4|||
17186078|NCT04611789|38338392|FG000|Overall Study|Lost to Follow-up|1|||
17186079|NCT04611789|38338393|FG001|Overall Study|Lost to Follow-up|0|||
17186080|NCT04611789|38338394|FG002|Overall Study|Lost to Follow-up|0|||
17186081|NCT03561597|38338410|FG000|Overall Study|Lost to Follow-up|20|||
17186082|NCT03034967|38338433|FG000|Overall Study|Withdrawal by Subject|9|||
17186083|NCT03034967|38338434|FG001|Overall Study|Withdrawal by Subject|2|||
17186084|NCT03034967|38338435|FG002|Overall Study|Withdrawal by Subject|6|||
17186085|NCT03034967|38338436|FG003|Overall Study|Withdrawal by Subject|6|||
17186086|NCT03034967|38338437|FG004|Overall Study|Withdrawal by Subject|9|||
17186087|NCT03034967|38338438|FG005|Overall Study|Withdrawal by Subject|2|||
17186088|NCT03034967|38338433|FG000|Overall Study|Physician Decision|1|||
17186089|NCT03034967|38338434|FG001|Overall Study|Physician Decision|0|||
17186090|NCT03034967|38338435|FG002|Overall Study|Physician Decision|1|||
17186091|NCT03034967|38338436|FG003|Overall Study|Physician Decision|1|||
17186092|NCT03034967|38338437|FG004|Overall Study|Physician Decision|1|||
17186093|NCT03034967|38338438|FG005|Overall Study|Physician Decision|0|||
17186094|NCT03034967|38338433|FG000|Overall Study|Lost to Follow-up|0|||
17186095|NCT03034967|38338434|FG001|Overall Study|Lost to Follow-up|0|||
17186096|NCT03034967|38338435|FG002|Overall Study|Lost to Follow-up|0|||
17186097|NCT03034967|38338436|FG003|Overall Study|Lost to Follow-up|1|||
17186098|NCT03034967|38338437|FG004|Overall Study|Lost to Follow-up|0|||
17186099|NCT03034967|38338438|FG005|Overall Study|Lost to Follow-up|2|||
17186100|NCT03034967|38338433|FG000|Overall Study|Liver function test abnormality|0|||
17186101|NCT03034967|38338434|FG001|Overall Study|Liver function test abnormality|0|||
17089642|NCT00478673|38229780|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
17089643|NCT00478673|38229780|FG000|12-Months Post-Procedure|Missed Visit|25|||
17089644|NCT00478673|38229780|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
17089645|NCT00488345|38229787|FG000|Overall Study|Adverse Event|0|||
17089646|NCT00488345|38229788|FG001|Overall Study|Adverse Event|1|||
17089647|NCT00488345|38229789|FG002|Overall Study|Adverse Event|1|||
17089648|NCT00488345|38229787|FG000|Overall Study|Unable to administer antibiotics at home|0|||
17089649|NCT00488345|38229788|FG001|Overall Study|Unable to administer antibiotics at home|1|||
17089650|NCT00488345|38229789|FG002|Overall Study|Unable to administer antibiotics at home|0|||
17089651|NCT00488345|38229787|FG000|Overall Study|Institutional Review Board review|0|||
17089652|NCT00488345|38229788|FG001|Overall Study|Institutional Review Board review|0|||
17089653|NCT00488345|38229789|FG002|Overall Study|Institutional Review Board review|1|||
17089654|NCT00488345|38229787|FG000|Overall Study|Surgical team recommendation|0|||
17186102|NCT03034967|38338435|FG002|Overall Study|Liver function test abnormality|1|||
17186103|NCT03034967|38338436|FG003|Overall Study|Liver function test abnormality|0|||
17186104|NCT03034967|38338437|FG004|Overall Study|Liver function test abnormality|0|||
17186105|NCT03034967|38338438|FG005|Overall Study|Liver function test abnormality|0|||
17186106|NCT03034967|38338433|FG000|Overall Study|Protocol Violation|1|||
17186107|NCT03034967|38338434|FG001|Overall Study|Protocol Violation|0|||
17186108|NCT03034967|38338435|FG002|Overall Study|Protocol Violation|0|||
17186109|NCT03034967|38338436|FG003|Overall Study|Protocol Violation|0|||
17186110|NCT03034967|38338437|FG004|Overall Study|Protocol Violation|0|||
17186111|NCT03034967|38338438|FG005|Overall Study|Protocol Violation|2|||
17186112|NCT03034967|38338433|FG000|Overall Study|Lack of Efficacy|0|||
17186113|NCT03034967|38338434|FG001|Overall Study|Lack of Efficacy|1|||
17186114|NCT03034967|38338435|FG002|Overall Study|Lack of Efficacy|2|||
17186115|NCT03034967|38338436|FG003|Overall Study|Lack of Efficacy|1|||
17186116|NCT03034967|38338437|FG004|Overall Study|Lack of Efficacy|1|||
17186117|NCT03034967|38338438|FG005|Overall Study|Lack of Efficacy|0|||
17186118|NCT03034967|38338433|FG000|Overall Study|Adverse Event, non-fatal|3|||
17186119|NCT03034967|38338434|FG001|Overall Study|Adverse Event, non-fatal|1|||
17186120|NCT03034967|38338435|FG002|Overall Study|Adverse Event, non-fatal|2|||
17186121|NCT03034967|38338436|FG003|Overall Study|Adverse Event, non-fatal|0|||
17186122|NCT03034967|38338437|FG004|Overall Study|Adverse Event, non-fatal|2|||
17186123|NCT03034967|38338438|FG005|Overall Study|Adverse Event, non-fatal|8|||
17186124|NCT03034967|38338433|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
17186125|NCT03034967|38338434|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
17186126|NCT03034967|38338435|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
17186127|NCT03034967|38338436|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
17186128|NCT03034967|38338437|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
17186129|NCT03034967|38338438|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
17186130|NCT03021187|38338461|FG000|Overall Study|Death|0|||
17186131|NCT03021187|38338462|FG001|Overall Study|Death|0|||
17186132|NCT03021187|38338463|FG002|Overall Study|Death|3|||
17186133|NCT03021187|38338464|FG003|Overall Study|Death|0|||
17186134|NCT03021187|38338461|FG000|Overall Study|Withdrawal by Subject|0|||
17186135|NCT03021187|38338462|FG001|Overall Study|Withdrawal by Subject|6|||
17186136|NCT03021187|38338463|FG002|Overall Study|Withdrawal by Subject|2|||
17186137|NCT03021187|38338464|FG003|Overall Study|Withdrawal by Subject|5|||
17186138|NCT03021187|38338461|FG000|Overall Study|Lost to Follow-up|10|||
17186139|NCT03021187|38338462|FG001|Overall Study|Lost to Follow-up|3|||
17186140|NCT03021187|38338463|FG002|Overall Study|Lost to Follow-up|1|||
17186141|NCT03021187|38338464|FG003|Overall Study|Lost to Follow-up|4|||
17186142|NCT02143414|38338476|FG000|Induction|Adverse Event|1|||
17186143|NCT02143414|38338477|FG001|Induction|Adverse Event|2|||
17186144|NCT02143414|38338476|FG000|Induction|Death|1|||
17186145|NCT02143414|38338477|FG001|Induction|Death|2|||
17186146|NCT02143414|38338476|FG000|Induction|Patient refusal|1|||
17186147|NCT02143414|38338477|FG001|Induction|Patient refusal|1|||
17186148|NCT02143414|38338476|FG000|Induction|Refractory|1|||
17186149|NCT02143414|38338477|FG001|Induction|Refractory|0|||
17186150|NCT02143414|38338476|FG000|Induction|Began alternative treatment|1|||
17186151|NCT02143414|38338477|FG001|Induction|Began alternative treatment|0|||
17186152|NCT02143414|38338476|FG000|Induction|Ineligible for postremission|5|||
17186153|NCT02143414|38338477|FG001|Induction|Ineligible for postremission|1|||
17186154|NCT02143414|38338476|FG000|Post-remission|Adverse Event|0|||
17186155|NCT02143414|38338477|FG001|Post-remission|Adverse Event|2|||
17186156|NCT02143414|38338476|FG000|Post-remission|Disease progression/relapse|5|||
17186157|NCT02143414|38338477|FG001|Post-remission|Disease progression/relapse|0|||
17186158|NCT02143414|38338476|FG000|Maintenance|Adverse Event|4|||
17186159|NCT02143414|38338477|FG001|Maintenance|Adverse Event|6|||
17186160|NCT02143414|38338476|FG000|Maintenance|Disease progression/relapse|3|||
17186161|NCT02143414|38338477|FG001|Maintenance|Disease progression/relapse|2|||
17186162|NCT02143414|38338476|FG000|Maintenance|Patient refusal|2|||
17186163|NCT02143414|38338477|FG001|Maintenance|Patient refusal|1|||
17186164|NCT02143414|38338476|FG000|Maintenance|Physician Decision|1|||
17186165|NCT02143414|38338477|FG001|Maintenance|Physician Decision|0|||
17186166|NCT02143414|38338476|FG000|Maintenance|Death|0|||
17186167|NCT02143414|38338477|FG001|Maintenance|Death|1|||
17186168|NCT02143414|38338476|FG000|Maintenance|On protocol treatment|0|||
17186169|NCT02143414|38338477|FG001|Maintenance|On protocol treatment|6|||
17186170|NCT03014479|38338496|FG000|Overall Study|Adverse Event|0|||
17186171|NCT03014479|38338497|FG001|Overall Study|Adverse Event|1|||
17186172|NCT03014479|38338496|FG000|Overall Study|Voluntary Withdrawal|0|||
17186173|NCT03014479|38338497|FG001|Overall Study|Voluntary Withdrawal|2|||
17186174|NCT03014479|38338496|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
17186175|NCT03014479|38338497|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
17186176|NCT04766333|38338505|FG000|Overall Study|Lost to Follow-up|40|||
17186177|NCT04766333|38338506|FG001|Overall Study|Lost to Follow-up|826|||
17186178|NCT03020641|38338514|FG000|Overall Study|Lost to Follow-up|0|||
17186179|NCT03020641|38338515|FG001|Overall Study|Lost to Follow-up|1|||
17186180|NCT03020641|38338514|FG000|Overall Study|Converted to open surgery|2|||
17186181|NCT03020641|38338515|FG001|Overall Study|Converted to open surgery|1|||
17186182|NCT03020641|38338514|FG000|Overall Study|for surgery not performed|0|||
17186183|NCT03020641|38338515|FG001|Overall Study|for surgery not performed|1|||
17186184|NCT03020407|38338526|FG000|Overall Study|Withdrawal by Subject|2|||
17186185|NCT03020407|38338527|FG001|Overall Study|Withdrawal by Subject|1|||
17186186|NCT03020407|38338526|FG000|Overall Study|Lost to Follow-up|2|||
17186187|NCT03020407|38338527|FG001|Overall Study|Lost to Follow-up|3|||
17186188|NCT03020407|38338526|FG000|Overall Study|Protocol Violation|0|||
17186189|NCT03020407|38338527|FG001|Overall Study|Protocol Violation|1|||
17186190|NCT02536846|38338533|FG000|Overall Study|Withdrawal by Subject|1|||
17186191|NCT03014011|38338538|FG000|First Intervention|Withdrawal by Subject|1|||
17186192|NCT03014011|38338539|FG001|First Intervention|Withdrawal by Subject|0|||
17186193|NCT03014011|38338538|FG000|Washout|Withdrawal by Subject|1|||
17186194|NCT03014011|38338539|FG001|Washout|Withdrawal by Subject|0|||
17186195|NCT03012841|38338554|FG000|Overall Study|Protocol Violation|0|||
17186196|NCT03012841|38338555|FG001|Overall Study|Protocol Violation|10|||
17186197|NCT03012841|38338554|FG000|Overall Study|Lost to Follow-up|6|||
17186198|NCT03012841|38338555|FG001|Overall Study|Lost to Follow-up|1|||
17186199|NCT03012841|38338554|FG000|Overall Study|Withdrawal by Subject|6|||
17186200|NCT03012841|38338555|FG001|Overall Study|Withdrawal by Subject|0|||
17186201|NCT03012841|38338554|FG000|Overall Study|Unable to complete 12 month visit|6|||
17186202|NCT03012841|38338555|FG001|Overall Study|Unable to complete 12 month visit|0|||
17186203|NCT03012841|38338554|FG000|Overall Study|Subject relocation|1|||
17186204|NCT03012841|38338555|FG001|Overall Study|Subject relocation|0|||
17186205|NCT03012841|38338554|FG000|Overall Study|Seasonal winter travel|1|||
17186206|NCT03012841|38338555|FG001|Overall Study|Seasonal winter travel|0|||
17186207|NCT03012841|38338554|FG000|Overall Study|Physician Decision|0|||
17186208|NCT03012841|38338555|FG001|Overall Study|Physician Decision|2|||
17186209|NCT03012841|38338554|FG000|Overall Study|No ablation performed|0|||
17186210|NCT03012841|38338555|FG001|Overall Study|No ablation performed|2|||
17186211|NCT03012841|38338554|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
17186212|NCT03012841|38338555|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
17186213|NCT03012841|38338554|FG000|Overall Study|Insurance change|0|||
17186214|NCT03012841|38338555|FG001|Overall Study|Insurance change|1|||
17186215|NCT02359864|38338562|FG000|Overall Study|Withdrawal by Subject|1|||
17186216|NCT02359864|38338563|FG001|Overall Study|Withdrawal by Subject|0|||
17186217|NCT02533258|38338569|FG000|Overall Study|Adverse Event|1|||
17186218|NCT02533258|38338569|FG000|Overall Study|Death|2|||
17186219|NCT02533258|38338569|FG000|Overall Study|Other|1|||
17186220|NCT02533258|38338569|FG000|Overall Study|Economic factor|1|||
17186221|NCT02533258|38338569|FG000|Overall Study|Progression of pleural effusion|1|||
17186222|NCT02533258|38338569|FG000|Overall Study|Lack of Efficacy|2|||
17186223|NCT03019627|38338588|FG000|Overall Study|Adverse Event|8|||
17186224|NCT03019627|38338589|FG001|Overall Study|Adverse Event|0|||
17186225|NCT03019627|38338588|FG000|Overall Study|Unrelated to adverse event|1|||
17186226|NCT03019627|38338589|FG001|Overall Study|Unrelated to adverse event|3|||
17186227|NCT03019627|38338588|FG000|Overall Study|Lost to Follow-up|2|||
17186228|NCT03019627|38338589|FG001|Overall Study|Lost to Follow-up|1|||
17186229|NCT03019627|38338588|FG000|Overall Study|not compliance|2|||
17186230|NCT03019627|38338589|FG001|Overall Study|not compliance|2|||
17186231|NCT03019627|38338588|FG000|Overall Study|Other|2|||
17186232|NCT03019627|38338589|FG001|Overall Study|Other|2|||
17186233|NCT01661140|38338595|FG000|Open-Label Period|Adverse Event|44|||
17186234|NCT01661140|38338596|FG001|Open-Label Period|Adverse Event|0|||
17186235|NCT01661140|38338597|FG002|Open-Label Period|Adverse Event|0|||
17186236|NCT01661140|38338595|FG000|Open-Label Period|Protocol Violation|3|||
17186237|NCT01661140|38338596|FG001|Open-Label Period|Protocol Violation|0|||
17089655|NCT00488345|38229788|FG001|Overall Study|Surgical team recommendation|1|||
17089656|NCT00488345|38229789|FG002|Overall Study|Surgical team recommendation|0|||
17089657|NCT00488345|38229787|FG000|Overall Study|Parent/legal guardian request|0|||
17089658|NCT00488345|38229788|FG001|Overall Study|Parent/legal guardian request|1|||
17089659|NCT00488345|38229789|FG002|Overall Study|Parent/legal guardian request|1|||
17089660|NCT00283062|38229802|FG000|Overall Study|Did not receive any study medication|5|||
17089661|NCT00283062|38229803|FG001|Overall Study|Did not receive any study medication|4|||
17089662|NCT00283062|38229804|FG002|Overall Study|Did not receive any study medication|36|||
17089663|NCT00283062|38229805|FG003|Overall Study|Did not receive any study medication|45|||
17089664|NCT00283062|38229802|FG000|Overall Study|Adverse Event|2|||
17089665|NCT00283062|38229803|FG001|Overall Study|Adverse Event|0|||
17089666|NCT00283062|38229804|FG002|Overall Study|Adverse Event|1|||
17089667|NCT00283062|38229805|FG003|Overall Study|Adverse Event|0|||
17089668|NCT00283062|38229802|FG000|Overall Study|Lost to Follow-up|1|||
17089669|NCT00283062|38229803|FG001|Overall Study|Lost to Follow-up|0|||
17089670|NCT00283062|38229804|FG002|Overall Study|Lost to Follow-up|1|||
17089671|NCT00283062|38229805|FG003|Overall Study|Lost to Follow-up|0|||
17089672|NCT00283062|38229802|FG000|Overall Study|Progressive disease|0|||
17089673|NCT00283062|38229803|FG001|Overall Study|Progressive disease|0|||
17089674|NCT00283062|38229804|FG002|Overall Study|Progressive disease|1|||
17089675|NCT00283062|38229805|FG003|Overall Study|Progressive disease|0|||
17089676|NCT00283062|38229802|FG000|Overall Study|Participant did not wish to continue|3|||
17089677|NCT00283062|38229803|FG001|Overall Study|Participant did not wish to continue|2|||
17089678|NCT00283062|38229804|FG002|Overall Study|Participant did not wish to continue|1|||
17089679|NCT00283062|38229805|FG003|Overall Study|Participant did not wish to continue|0|||
17089680|NCT00283062|38229802|FG000|Overall Study|Undefined|0|||
17089681|NCT00283062|38229803|FG001|Overall Study|Undefined|1|||
17089682|NCT00283062|38229804|FG002|Overall Study|Undefined|1|||
17089683|NCT00283062|38229805|FG003|Overall Study|Undefined|4|||
17186238|NCT01661140|38338597|FG002|Open-Label Period|Protocol Violation|0|||
17186239|NCT01661140|38338595|FG000|Open-Label Period|Withdrawal by Subject|5|||
17186240|NCT01661140|38338596|FG001|Open-Label Period|Withdrawal by Subject|0|||
17186241|NCT01661140|38338597|FG002|Open-Label Period|Withdrawal by Subject|0|||
17186242|NCT01661140|38338595|FG000|Open-Label Period|Investigator Decision|3|||
17186243|NCT01661140|38338596|FG001|Open-Label Period|Investigator Decision|0|||
17186244|NCT01661140|38338597|FG002|Open-Label Period|Investigator Decision|0|||
17186245|NCT01661140|38338595|FG000|Open-Label Period|Death|1|||
17186246|NCT01661140|38338596|FG001|Open-Label Period|Death|0|||
17186247|NCT01661140|38338597|FG002|Open-Label Period|Death|0|||
17186248|NCT01661140|38338595|FG000|Open-Label Period|Administrative/Other|1|||
17186249|NCT01661140|38338596|FG001|Open-Label Period|Administrative/Other|0|||
17186250|NCT01661140|38338597|FG002|Open-Label Period|Administrative/Other|0|||
17186251|NCT01661140|38338595|FG000|Open-Label Period|Sponsor termination|16|||
17186252|NCT01661140|38338596|FG001|Open-Label Period|Sponsor termination|0|||
17186253|NCT01661140|38338597|FG002|Open-Label Period|Sponsor termination|0|||
17186254|NCT01661140|38338595|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
17186255|NCT01661140|38338596|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
17186256|NCT01661140|38338597|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
17186257|NCT01661140|38338595|FG000|Open-Label Period|Lost to Follow-up|2|||
17186258|NCT01661140|38338596|FG001|Open-Label Period|Lost to Follow-up|0|||
17186259|NCT01661140|38338597|FG002|Open-Label Period|Lost to Follow-up|0|||
17186260|NCT01661140|38338595|FG000|Double-Blind Period|Refused Treatment|0|||
17186261|NCT01661140|38338596|FG001|Double-Blind Period|Refused Treatment|0|||
17186262|NCT01661140|38338597|FG002|Double-Blind Period|Refused Treatment|1|||
17186263|NCT01661140|38338595|FG000|Double-Blind Period|Adverse Event|0|||
17186264|NCT01661140|38338596|FG001|Double-Blind Period|Adverse Event|16|||
17186265|NCT01661140|38338597|FG002|Double-Blind Period|Adverse Event|18|||
17186266|NCT01661140|38338595|FG000|Double-Blind Period|Protocol Violation|0|||
17186267|NCT01661140|38338596|FG001|Double-Blind Period|Protocol Violation|2|||
17186268|NCT01661140|38338597|FG002|Double-Blind Period|Protocol Violation|3|||
17186269|NCT01661140|38338595|FG000|Double-Blind Period|Withdrawal by Subject|0|||
17186270|NCT01661140|38338596|FG001|Double-Blind Period|Withdrawal by Subject|1|||
17186271|NCT01661140|38338597|FG002|Double-Blind Period|Withdrawal by Subject|3|||
17186272|NCT01661140|38338595|FG000|Double-Blind Period|Investigator's Decision|0|||
17186273|NCT01661140|38338596|FG001|Double-Blind Period|Investigator's Decision|1|||
17186274|NCT01661140|38338597|FG002|Double-Blind Period|Investigator's Decision|2|||
17186275|NCT01661140|38338595|FG000|Double-Blind Period|Sponsor Termination|0|||
17186276|NCT01661140|38338596|FG001|Double-Blind Period|Sponsor Termination|14|||
17186277|NCT01661140|38338597|FG002|Double-Blind Period|Sponsor Termination|17|||
17186278|NCT01661140|38338595|FG000|Double-Blind Period|Administrative/Other|0|||
17186279|NCT01661140|38338596|FG001|Double-Blind Period|Administrative/Other|7|||
17186280|NCT01661140|38338597|FG002|Double-Blind Period|Administrative/Other|6|||
17186281|NCT03019549|38338605|FG000|Washout|DId not meet genotype criteria|11|||
17186282|NCT03019549|38338605|FG000|Period 2|Adverse Event|2|||
17186283|NCT03019549|38338605|FG000|Period 2|Physician Decision|2|||
17186284|NCT03019549|38338605|FG000|Period 2|Withdrawal by Subject|1|||
17186285|NCT01661062|38338614|FG000|Overall Study|Completed Treatment Off Study|3|||
17186286|NCT01661062|38338614|FG000|Overall Study|Withdrawal by Subject|2|||
17186287|NCT02536378|38338620|FG000|Overall Study|Physician Decision|0|||
17186288|NCT02536378|38338621|FG001|Overall Study|Physician Decision|2|||
17186289|NCT02536378|38338620|FG000|Overall Study|Withdrawal by Subject|0|||
17186290|NCT02536378|38338621|FG001|Overall Study|Withdrawal by Subject|1|||
17186291|NCT02536378|38338620|FG000|Overall Study|Death|1|||
17186292|NCT02536378|38338621|FG001|Overall Study|Death|2|||
17186293|NCT02536378|38338620|FG000|Overall Study|Patient refused further follow up|6|||
17186294|NCT02536378|38338621|FG001|Overall Study|Patient refused further follow up|2|||
17186295|NCT01373151|38338636|FG000|Period 1|Lack of Efficacy|3|||
17186296|NCT01373151|38338637|FG001|Period 1|Lack of Efficacy|0|||
17186297|NCT01373151|38338638|FG002|Period 1|Lack of Efficacy|0|||
17186298|NCT01373151|38338639|FG003|Period 1|Lack of Efficacy|0|||
17186299|NCT01373151|38338640|FG004|Period 1|Lack of Efficacy|1|||
17186300|NCT01373151|38338641|FG005|Period 1|Lack of Efficacy|0|||
17186301|NCT01373151|38338642|FG006|Period 1|Lack of Efficacy|0|||
17186302|NCT01373151|38338636|FG000|Period 1|Adverse Event|0|||
17186303|NCT01373151|38338637|FG001|Period 1|Adverse Event|0|||
17186304|NCT01373151|38338638|FG002|Period 1|Adverse Event|1|||
17186305|NCT01373151|38338639|FG003|Period 1|Adverse Event|0|||
17186306|NCT01373151|38338640|FG004|Period 1|Adverse Event|4|||
17186307|NCT01373151|38338641|FG005|Period 1|Adverse Event|3|||
17186308|NCT01373151|38338642|FG006|Period 1|Adverse Event|0|||
17186309|NCT01373151|38338636|FG000|Period 1|Withdrawal by Subject|2|||
17186310|NCT01373151|38338637|FG001|Period 1|Withdrawal by Subject|0|||
17186311|NCT01373151|38338638|FG002|Period 1|Withdrawal by Subject|3|||
17186312|NCT01373151|38338639|FG003|Period 1|Withdrawal by Subject|1|||
17186313|NCT01373151|38338640|FG004|Period 1|Withdrawal by Subject|0|||
17186314|NCT01373151|38338641|FG005|Period 1|Withdrawal by Subject|1|||
17186315|NCT01373151|38338642|FG006|Period 1|Withdrawal by Subject|0|||
17186316|NCT01373151|38338636|FG000|Period 2|Lack of Efficacy|9|||
17186317|NCT01373151|38338637|FG001|Period 2|Lack of Efficacy|0|||
17186318|NCT01373151|38338638|FG002|Period 2|Lack of Efficacy|0|||
17186319|NCT01373151|38338639|FG003|Period 2|Lack of Efficacy|1|||
17186320|NCT01373151|38338640|FG004|Period 2|Lack of Efficacy|2|||
17186321|NCT01373151|38338641|FG005|Period 2|Lack of Efficacy|0|||
17186322|NCT01373151|38338642|FG006|Period 2|Lack of Efficacy|3|||
17186323|NCT01373151|38338636|FG000|Period 2|Adverse Event|0|||
17186324|NCT01373151|38338637|FG001|Period 2|Adverse Event|0|||
17186325|NCT01373151|38338638|FG002|Period 2|Adverse Event|3|||
17186326|NCT01373151|38338639|FG003|Period 2|Adverse Event|3|||
17186327|NCT01373151|38338640|FG004|Period 2|Adverse Event|0|||
17186328|NCT01373151|38338641|FG005|Period 2|Adverse Event|0|||
17186329|NCT01373151|38338642|FG006|Period 2|Adverse Event|1|||
17186330|NCT01373151|38338636|FG000|Period 2|subject request to discontinue|0|||
17186331|NCT01373151|38338637|FG001|Period 2|subject request to discontinue|1|||
17186332|NCT01373151|38338638|FG002|Period 2|subject request to discontinue|0|||
17186333|NCT01373151|38338639|FG003|Period 2|subject request to discontinue|0|||
17186334|NCT01373151|38338640|FG004|Period 2|subject request to discontinue|0|||
17186335|NCT01373151|38338641|FG005|Period 2|subject request to discontinue|0|||
17186336|NCT01373151|38338642|FG006|Period 2|subject request to discontinue|0|||
17186337|NCT01373151|38338636|FG000|Period 2|Withdrawal by Subject|0|||
17186338|NCT01373151|38338637|FG001|Period 2|Withdrawal by Subject|0|||
17186339|NCT01373151|38338638|FG002|Period 2|Withdrawal by Subject|0|||
17186340|NCT01373151|38338639|FG003|Period 2|Withdrawal by Subject|1|||
17186341|NCT01373151|38338640|FG004|Period 2|Withdrawal by Subject|0|||
17186342|NCT01373151|38338641|FG005|Period 2|Withdrawal by Subject|0|||
17186343|NCT01373151|38338642|FG006|Period 2|Withdrawal by Subject|0|||
17186344|NCT01373151|38338636|FG000|Period 2|Other|0|||
17186345|NCT01373151|38338637|FG001|Period 2|Other|0|||
17186346|NCT01373151|38338638|FG002|Period 2|Other|1|||
17186347|NCT01373151|38338639|FG003|Period 2|Other|0|||
17186348|NCT01373151|38338640|FG004|Period 2|Other|0|||
17186349|NCT01373151|38338641|FG005|Period 2|Other|0|||
17186350|NCT01373151|38338642|FG006|Period 2|Other|1|||
17186351|NCT01660906|38338658|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
17186352|NCT03015181|38338678|FG000|Overall Study|Enrolled, but product never administered|1|||
17186353|NCT03015181|38338679|FG001|Overall Study|Enrolled, but product never administered|0|||
17186354|NCT03015181|38338680|FG002|Overall Study|Enrolled, but product never administered|0|||
16997146|NCT00758524|38141142|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
17089684|NCT00283062|38229802|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
17089685|NCT00283062|38229803|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
17089686|NCT00283062|38229804|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
17089687|NCT00283062|38229805|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
17089688|NCT00282984|38229817|FG000|Overall Study|Death|2|||
17089689|NCT00282984|38229818|FG001|Overall Study|Death|5|||
17089690|NCT00282984|38229817|FG000|Overall Study|Adverse Event|8|||
17089691|NCT00282984|38229818|FG001|Overall Study|Adverse Event|5|||
17089692|NCT00282984|38229817|FG000|Overall Study|Lack of Efficacy|0|||
17089693|NCT00282984|38229818|FG001|Overall Study|Lack of Efficacy|2|||
17089694|NCT00282984|38229817|FG000|Overall Study|Lost to Follow-up|14|||
17089695|NCT00282984|38229818|FG001|Overall Study|Lost to Follow-up|10|||
16997147|NCT00758524|38141143|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997148|NCT00758524|38141144|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997149|NCT00758524|38141145|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997150|NCT00758524|38141146|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997151|NCT00758524|38141147|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997152|NCT00758524|38141148|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
16997153|NCT00758524|38141149|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997154|NCT00758524|38141150|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997155|NCT00758524|38141151|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997156|NCT00758524|38141152|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997157|NCT00758524|38141153|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997158|NCT00758524|38141154|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997159|NCT00758524|38141155|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997160|NCT00758524|38141156|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16997161|NCT00758524|38141140|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997162|NCT00758524|38141141|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997163|NCT00758524|38141142|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997164|NCT00758524|38141143|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997165|NCT00758524|38141144|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997166|NCT00758524|38141145|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
17186355|NCT03015181|38338681|FG003|Overall Study|Enrolled, but product never administered|0|||
17186356|NCT03015181|38338682|FG004|Overall Study|Enrolled, but product never administered|0|||
17186357|NCT03015181|38338683|FG005|Overall Study|Enrolled, but product never administered|0|||
17186358|NCT03015181|38338684|FG006|Overall Study|Enrolled, but product never administered|0|||
17186359|NCT03015181|38338678|FG000|Overall Study|Withdrawal by Subject|0|||
17186360|NCT03015181|38338679|FG001|Overall Study|Withdrawal by Subject|0|||
17186361|NCT03015181|38338680|FG002|Overall Study|Withdrawal by Subject|0|||
17186362|NCT03015181|38338681|FG003|Overall Study|Withdrawal by Subject|0|||
17186363|NCT03015181|38338682|FG004|Overall Study|Withdrawal by Subject|0|||
17186364|NCT03015181|38338683|FG005|Overall Study|Withdrawal by Subject|1|||
17186365|NCT03015181|38338684|FG006|Overall Study|Withdrawal by Subject|0|||
17186366|NCT03015181|38338678|FG000|Overall Study|Physician Decision|0|||
17186367|NCT03015181|38338679|FG001|Overall Study|Physician Decision|0|||
17186368|NCT03015181|38338680|FG002|Overall Study|Physician Decision|0|||
17186369|NCT03015181|38338681|FG003|Overall Study|Physician Decision|0|||
17186370|NCT03015181|38338682|FG004|Overall Study|Physician Decision|0|||
17186371|NCT03015181|38338683|FG005|Overall Study|Physician Decision|0|||
17186372|NCT03015181|38338684|FG006|Overall Study|Physician Decision|1|||
17186373|NCT00960297|38338733|FG000|Overall Study|Physician Decision|1|||
17186374|NCT00960297|38338733|FG000|Overall Study|Venous port infection|1|||
17186375|NCT00960297|38338733|FG000|Overall Study|Disease progression|1|||
17186376|NCT03018691|38338740|FG000|Overall Study|Adverse Event|1|||
17186377|NCT03018691|38338741|FG001|Overall Study|Adverse Event|1|||
17186378|NCT03018691|38338742|FG002|Overall Study|Adverse Event|4|||
17186379|NCT03018691|38338740|FG000|Overall Study|Lack of Efficacy|0|||
17186380|NCT03018691|38338741|FG001|Overall Study|Lack of Efficacy|0|||
17186381|NCT03018691|38338742|FG002|Overall Study|Lack of Efficacy|1|||
17186382|NCT03018691|38338740|FG000|Overall Study|Withdrawal by Subject|0|||
17186383|NCT03018691|38338741|FG001|Overall Study|Withdrawal by Subject|0|||
17186384|NCT03018691|38338742|FG002|Overall Study|Withdrawal by Subject|1|||
17186385|NCT03018691|38338740|FG000|Overall Study|Withdrawal by parent/guardian|1|||
17186386|NCT03018691|38338741|FG001|Overall Study|Withdrawal by parent/guardian|0|||
17186387|NCT03018691|38338742|FG002|Overall Study|Withdrawal by parent/guardian|1|||
17186388|NCT03012061|38338755|FG000|Overall Study|Withdrawal by Subject|1|||
17186389|NCT03012061|38338756|FG001|Overall Study|Withdrawal by Subject|5|||
17186390|NCT03012061|38338757|FG002|Overall Study|Withdrawal by Subject|4|||
17089696|NCT00282984|38229817|FG000|Overall Study|Withdrawal by Participant|22|||
17089697|NCT00282984|38229818|FG001|Overall Study|Withdrawal by Participant|34|||
17089698|NCT00282984|38229817|FG000|Overall Study|Participant stopped study medication|2|||
17089699|NCT00282984|38229818|FG001|Overall Study|Participant stopped study medication|2|||
17089700|NCT00282984|38229817|FG000|Overall Study|Participant only allowed phone follow-up|0|||
17089701|NCT00282984|38229818|FG001|Overall Study|Participant only allowed phone follow-up|1|||
17186391|NCT03012061|38338755|FG000|Overall Study|Investigator Site Closed|1|||
17186392|NCT03012061|38338756|FG001|Overall Study|Investigator Site Closed|2|||
17186393|NCT03012061|38338757|FG002|Overall Study|Investigator Site Closed|0|||
17186394|NCT03012061|38338755|FG000|Overall Study|Lost to Follow-up|2|||
17186395|NCT03012061|38338756|FG001|Overall Study|Lost to Follow-up|1|||
17186396|NCT03012061|38338757|FG002|Overall Study|Lost to Follow-up|0|||
17186397|NCT03012061|38338755|FG000|Overall Study|Study closed/ Terminated|0|||
17186398|NCT03012061|38338756|FG001|Overall Study|Study closed/ Terminated|0|||
17186399|NCT03012061|38338757|FG002|Overall Study|Study closed/ Terminated|1|||
17186400|NCT03012061|38338755|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
17186401|NCT03012061|38338756|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
17186402|NCT03012061|38338757|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
17186403|NCT03012061|38338755|FG000|Overall Study|Protocol Violation|0|||
17186404|NCT03012061|38338756|FG001|Overall Study|Protocol Violation|0|||
17186405|NCT03012061|38338757|FG002|Overall Study|Protocol Violation|2|||
17186406|NCT03012061|38338755|FG000|Overall Study|Lack of Efficacy|0|||
17186407|NCT03012061|38338756|FG001|Overall Study|Lack of Efficacy|1|||
17186408|NCT03012061|38338757|FG002|Overall Study|Lack of Efficacy|0|||
17186409|NCT03012061|38338755|FG000|Overall Study|Adverse Event|2|||
17186410|NCT03012061|38338756|FG001|Overall Study|Adverse Event|0|||
17186411|NCT03012061|38338757|FG002|Overall Study|Adverse Event|0|||
17186412|NCT03010501|38338765|FG000|Study Week 1|Withdrawal by Subject|2|||
17186413|NCT03010501|38338766|FG001|Study Week 1|Withdrawal by Subject|1|||
17186414|NCT03010501|38338767|FG002|Study Week 1|Withdrawal by Subject|0|||
17186415|NCT03010501|38338768|FG003|Study Week 1|Withdrawal by Subject|2|||
17186416|NCT03010501|38338769|FG004|Study Week 1|Withdrawal by Subject|0|||
17186417|NCT03010501|38338770|FG005|Study Week 1|Withdrawal by Subject|0|||
17186418|NCT03010501|38338765|FG000|Study Week 3|Withdrawal by Subject|0|||
17186419|NCT03010501|38338766|FG001|Study Week 3|Withdrawal by Subject|0|||
17186420|NCT03010501|38338767|FG002|Study Week 3|Withdrawal by Subject|0|||
17186421|NCT03010501|38338768|FG003|Study Week 3|Withdrawal by Subject|1|||
17186422|NCT03010501|38338769|FG004|Study Week 3|Withdrawal by Subject|0|||
17186423|NCT03010501|38338770|FG005|Study Week 3|Withdrawal by Subject|0|||
17186424|NCT03002623|38338780|FG000|Overall Study|Lost to Follow-up|1|||
17186425|NCT03002623|38338781|FG001|Overall Study|Lost to Follow-up|0|||
17186426|NCT03002623|38338780|FG000|Overall Study|Physician Decision|1|||
17186427|NCT03002623|38338781|FG001|Overall Study|Physician Decision|1|||
17186428|NCT03010423|38338789|FG000|Overall Study|Study termination|8|||
17186429|NCT03002311|38338795|FG000|Overall Study|Lost to Follow-up|13|||
17186430|NCT03002311|38338796|FG001|Overall Study|Lost to Follow-up|26|||
17186431|NCT03002311|38338795|FG000|Overall Study|Referral provider called to schedule app|3|||
17186432|NCT03002311|38338796|FG001|Overall Study|Referral provider called to schedule app|3|||
17186433|NCT03002311|38338795|FG000|Overall Study|Physician Decision|3|||
17186434|NCT03002311|38338796|FG001|Overall Study|Physician Decision|1|||
17186435|NCT03002077|38338802|FG000|Overall Study|Non-compliance with Study Drug|4|||
17186436|NCT03002077|38338802|FG000|Overall Study|Non-compliance w/Background ADT|1|||
17186437|NCT03002077|38338802|FG000|Overall Study|Study Terminated by Sponsor|257|||
17186438|NCT03002077|38338802|FG000|Overall Study|Site Terminated by Sponsor|5|||
17186439|NCT03002077|38338802|FG000|Overall Study|Miscellaneous Reasons|10|||
17186440|NCT03002077|38338802|FG000|Overall Study|Adverse Event|23|||
17186441|NCT03002077|38338802|FG000|Overall Study|Lack of Efficacy|20|||
17186442|NCT03002077|38338802|FG000|Overall Study|Withdrawal by Subject|72|||
17186443|NCT03002077|38338802|FG000|Overall Study|Lost to Follow-up|21|||
17186444|NCT03002077|38338802|FG000|Overall Study|Pregnancy|4|||
17186445|NCT03002077|38338802|FG000|Overall Study|Protocol Violation|21|||
17186446|NCT03008005|38338809|FG000|Overall Study|Physician Decision|1|||
17186447|NCT03008005|38338810|FG001|Overall Study|Physician Decision|0|||
17186448|NCT03008005|38338811|FG002|Overall Study|Physician Decision|0|||
17186449|NCT03008005|38338809|FG000|Overall Study|Withdrawal by Subject|1|||
17186450|NCT03008005|38338810|FG001|Overall Study|Withdrawal by Subject|0|||
17186451|NCT03008005|38338811|FG002|Overall Study|Withdrawal by Subject|0|||
17186452|NCT03008005|38338809|FG000|Overall Study|Ineligible|0|||
17186453|NCT03008005|38338810|FG001|Overall Study|Ineligible|1|||
17186454|NCT03008005|38338811|FG002|Overall Study|Ineligible|0|||
17186455|NCT02440425|38338828|FG000|Overall Study|Death likely due to disease progression|1|||
17186456|NCT02440425|38338828|FG000|Overall Study|Withdrawal by Subject|2|||
17186457|NCT02440425|38338828|FG000|Overall Study|Adverse Event|1|||
17186458|NCT02440425|38338828|FG000|Overall Study|Adverse Event/Ineligible|1|||
17186459|NCT03001219|38338843|FG000|Proof of Concept|Study Termination by Sponsor|0|||
17186460|NCT03001219|38338844|FG001|Proof of Concept|Study Termination by Sponsor|1|||
17186461|NCT03001219|38338843|FG000|Proof of Concept|Withdrawal by Subject|0|||
17186462|NCT03001219|38338844|FG001|Proof of Concept|Withdrawal by Subject|4|||
17186463|NCT03001219|38338843|FG000|Proof of Concept|Protocol Deviation|0|||
17186464|NCT03001219|38338844|FG001|Proof of Concept|Protocol Deviation|1|||
17186465|NCT03001219|38338843|FG000|Proof of Concept|Adverse Event|1|||
17186466|NCT03001219|38338844|FG001|Proof of Concept|Adverse Event|1|||
17186467|NCT03001219|38338843|FG000|Proof of Concept|Physician Decision|1|||
17186468|NCT03001219|38338844|FG001|Proof of Concept|Physician Decision|0|||
17186469|NCT03001219|38338843|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
17186470|NCT03001219|38338844|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
17186471|NCT03001219|38338843|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
17186472|NCT03001219|38338844|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
17186473|NCT03001219|38338843|FG000|Extension Period Analysis|Physician Decision|0|||
17186474|NCT03001219|38338844|FG001|Extension Period Analysis|Physician Decision|1|||
17186475|NCT03001219|38338843|FG000|Extension Period Analysis|Adverse Event|1|||
17186476|NCT03001219|38338844|FG001|Extension Period Analysis|Adverse Event|1|||
17186477|NCT03001219|38338843|FG000|Extension Period Analysis|Protocol Deviation|0|||
17186478|NCT03001219|38338844|FG001|Extension Period Analysis|Protocol Deviation|1|||
17186479|NCT03001219|38338843|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
17186480|NCT03001219|38338844|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
17186481|NCT03000673|38338859|FG000|Overall Study|Withdrawal by Subject|1|||
17186482|NCT03000673|38338860|FG001|Overall Study|Withdrawal by Subject|0|||
17186483|NCT03000673|38338861|FG002|Overall Study|Withdrawal by Subject|0|||
17186484|NCT03000673|38338862|FG003|Overall Study|Withdrawal by Subject|0|||
17186485|NCT02912455|38338875|FG000|Overall Study|Withdrawal by Subject|0|||
17186486|NCT02912455|38338876|FG001|Overall Study|Withdrawal by Subject|1|||
17186487|NCT02912455|38338875|FG000|Overall Study|Lack of Efficacy|0|||
17089702|NCT00282984|38229817|FG000|Overall Study|Participant used antipsychosis meds|0|||
17089703|NCT00282984|38229818|FG001|Overall Study|Participant used antipsychosis meds|1|||
17186488|NCT02912455|38338876|FG001|Overall Study|Lack of Efficacy|1|||
17186489|NCT02912455|38338875|FG000|Overall Study|Lost to Follow-up|2|||
17186490|NCT02912455|38338876|FG001|Overall Study|Lost to Follow-up|1|||
17186491|NCT04524507|38338884|FG000|Overall Study|Lost to Follow-up|2|||
17186492|NCT04524507|38338885|FG001|Overall Study|Lost to Follow-up|4|||
17186493|NCT04524507|38338884|FG000|Overall Study|Withdrawal by Subject|2|||
17186494|NCT04524507|38338885|FG001|Overall Study|Withdrawal by Subject|9|||
17186495|NCT04524507|38338884|FG000|Overall Study|Death|2|||
17186496|NCT04524507|38338885|FG001|Overall Study|Death|10|||
17186497|NCT02999191|38338894|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
17186498|NCT02999191|38338895|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
17186499|NCT02999191|38338896|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
17186500|NCT02531698|38338906|FG000|Overall Study|Adverse Event|2|||
17186501|NCT02531698|38338907|FG001|Overall Study|Adverse Event|1|||
17186502|NCT02531698|38338906|FG000|Overall Study|Withdrawal by Subject|6|||
17186503|NCT02531698|38338907|FG001|Overall Study|Withdrawal by Subject|1|||
17186504|NCT02531698|38338906|FG000|Overall Study|Protocol Violation|2|||
17186505|NCT02531698|38338907|FG001|Overall Study|Protocol Violation|0|||
17186506|NCT02531698|38338906|FG000|Overall Study|Lost to Follow-up|1|||
17186507|NCT02531698|38338907|FG001|Overall Study|Lost to Follow-up|0|||
17186508|NCT02998021|38338924|FG000|Overall Study|Withdrawal by Subject|3|||
17186509|NCT02998021|38338925|FG001|Overall Study|Withdrawal by Subject|1|||
17186510|NCT02998021|38338924|FG000|Overall Study|unsafe home|0|||
17186511|NCT02998021|38338925|FG001|Overall Study|unsafe home|1|||
17186512|NCT01207492|38338937|FG000|Overall Study|Still on study|1|||
17186513|NCT01207492|38338937|FG000|Overall Study|Withdrawal by Subject|9|||
17186514|NCT01207492|38338937|FG000|Overall Study|Physician Decision|1|||
17186515|NCT01207492|38338937|FG000|Overall Study|Progressive disease|3|||
17186516|NCT01207492|38338937|FG000|Overall Study|Toxicity|1|||
17186517|NCT03034577|38338943|FG000|Overall Study|Withdrawal by Subject|6|||
17186518|NCT03034577|38338944|FG001|Overall Study|Withdrawal by Subject|9|||
17186519|NCT03034577|38338943|FG000|Overall Study|Lost to Follow-up|25|||
17186520|NCT03034577|38338944|FG001|Overall Study|Lost to Follow-up|26|||
17186521|NCT01659736|38338954|FG000|Treatment Period|Adverse Event|1|||
17186522|NCT01659736|38338955|FG001|Treatment Period|Adverse Event|1|||
17186523|NCT01659736|38338954|FG000|Treatment Period|Protocol Violation|3|||
17186524|NCT01659736|38338955|FG001|Treatment Period|Protocol Violation|1|||
17186525|NCT01659736|38338954|FG000|Treatment Period|Withdrawal by Subject|1|||
17186526|NCT01659736|38338955|FG001|Treatment Period|Withdrawal by Subject|0|||
17186527|NCT01659736|38338954|FG000|3-month Follow-up|Lost to Follow-up|0|||
17186528|NCT01659736|38338955|FG001|3-month Follow-up|Lost to Follow-up|1|||
17186529|NCT02997163|38338967|FG000|Overall Study|Adverse Event|1|||
17186530|NCT02997163|38338968|FG001|Overall Study|Adverse Event|0|||
17186531|NCT02997163|38338969|FG002|Overall Study|Adverse Event|0|||
17186532|NCT02997163|38338970|FG003|Overall Study|Adverse Event|1|||
17186533|NCT00458536|38338980|FG000|Overall Study|Disease progression prior to treatment|7|||
17186534|NCT00458536|38338980|FG000|Overall Study|Unable to make vaccine|3|||
17186535|NCT00458536|38338980|FG000|Overall Study|No measurable disease after surgery|2|||
17186536|NCT00458536|38338980|FG000|Overall Study|Did not have renal cell carcinoma|2|||
17186537|NCT00458536|38338980|FG000|Overall Study|Patient did not have surgery|1|||
17186538|NCT00458536|38338980|FG000|Overall Study|Ineligible due to toxicity|1|||
17186539|NCT00458536|38338980|FG000|Overall Study|Withdrawal by Subject|1|||
17186540|NCT00458536|38338980|FG000|Overall Study|Progressive disease during treatment|2|||
17186541|NCT02526550|38338984|FG000|Overall Study|Lost to Follow-up|1|||
17186542|NCT03030989|38338999|FG000|Overall Study|Fever|2|||
17186543|NCT03030989|38339000|FG001|Overall Study|Fever|2|||
17186544|NCT03030989|38338999|FG000|Overall Study|Rash|2|||
17186545|NCT03030989|38339000|FG001|Overall Study|Rash|1|||
17186546|NCT03030989|38338999|FG000|Overall Study|Fatigue/Overwhelmed|1|||
17186547|NCT03030989|38339000|FG001|Overall Study|Fatigue/Overwhelmed|5|||
17186548|NCT03030989|38338999|FG000|Overall Study|Positive Blood Cultures|2|||
17186549|NCT03030989|38339000|FG001|Overall Study|Positive Blood Cultures|1|||
17186550|NCT03030989|38338999|FG000|Overall Study|Line Removed|0|||
17186551|NCT03030989|38339000|FG001|Overall Study|Line Removed|2|||
17186552|NCT03030989|38338999|FG000|Overall Study|No longer interested|5|||
17186553|NCT03030989|38339000|FG001|Overall Study|No longer interested|3|||
17186554|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
17186555|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
17186556|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
17186557|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Other|1|||
17186558|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Other|0|||
17186559|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Other|0|||
17186560|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Physician Decision|3|||
17186561|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Physician Decision|0|||
17186562|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Physician Decision|0|||
17186563|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
17186564|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
17186565|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
17186566|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
17186567|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
17186568|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
17186569|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Adverse Event|18|||
17186570|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Adverse Event|0|||
17186571|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Adverse Event|0|||
17186572|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
17186573|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
17186574|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
17186575|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
17186576|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
17186577|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
17186578|NCT03030599|38339006|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
17186579|NCT03030599|38339007|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
17186580|NCT03030599|38339008|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
17186581|NCT03030599|38339006|FG000|Stable Dose|Protocol deviation|3|||
17186582|NCT03030599|38339007|FG001|Stable Dose|Protocol deviation|0|||
17186583|NCT03030599|38339008|FG002|Stable Dose|Protocol deviation|0|||
17186584|NCT03030599|38339006|FG000|Stable Dose|Adverse Event|1|||
17186585|NCT03030599|38339007|FG001|Stable Dose|Adverse Event|0|||
17186586|NCT03030599|38339008|FG002|Stable Dose|Adverse Event|0|||
17186587|NCT03030599|38339006|FG000|Stable Dose|Lost to Follow-up|1|||
17186588|NCT03030599|38339007|FG001|Stable Dose|Lost to Follow-up|0|||
17186589|NCT03030599|38339008|FG002|Stable Dose|Lost to Follow-up|0|||
17186590|NCT03030599|38339006|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
17186591|NCT03030599|38339007|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
17186592|NCT03030599|38339008|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
17186593|NCT03030599|38339006|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
17186594|NCT03030599|38339007|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
17186595|NCT03030599|38339008|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
17186596|NCT03030599|38339006|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
17186597|NCT03030599|38339007|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
17186598|NCT03030599|38339008|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
17186599|NCT03030599|38339006|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
17186600|NCT03030599|38339007|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
17186601|NCT03030599|38339008|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
17186602|NCT03030599|38339006|FG000|Open-label Extension|Adverse Event|3|||
17186603|NCT03030599|38339007|FG001|Open-label Extension|Adverse Event|0|||
17186604|NCT03030599|38339008|FG002|Open-label Extension|Adverse Event|0|||
17186605|NCT03030599|38339006|FG000|Open-label Extension|Lost to Follow-up|2|||
17186606|NCT03030599|38339007|FG001|Open-label Extension|Lost to Follow-up|0|||
17186607|NCT03030599|38339008|FG002|Open-label Extension|Lost to Follow-up|0|||
17186608|NCT03030599|38339006|FG000|Open-label Extension|Lack of Efficacy|1|||
17186609|NCT03030599|38339007|FG001|Open-label Extension|Lack of Efficacy|0|||
17186610|NCT03030599|38339008|FG002|Open-label Extension|Lack of Efficacy|0|||
17186611|NCT03030599|38339006|FG000|Open-label Extension|Other Reason|1|||
17186612|NCT03030599|38339007|FG001|Open-label Extension|Other Reason|0|||
17186613|NCT03030599|38339008|FG002|Open-label Extension|Other Reason|0|||
17186614|NCT03031847|38339018|FG000|Overall Study|Death|1|||
17186615|NCT03031847|38339019|FG001|Overall Study|Death|1|||
17186616|NCT03031847|38339020|FG002|Overall Study|Death|2|||
17186617|NCT03031847|38339021|FG003|Overall Study|Death|3|||
17186618|NCT03031847|38339018|FG000|Overall Study|Lost to Follow-up|1|||
17186619|NCT03031847|38339019|FG001|Overall Study|Lost to Follow-up|1|||
17186620|NCT03031847|38339020|FG002|Overall Study|Lost to Follow-up|2|||
17186621|NCT03031847|38339021|FG003|Overall Study|Lost to Follow-up|3|||
17186622|NCT03028415|38339033|FG000|Overall Study|Lost to Follow-up|6|||
17186623|NCT03028415|38339034|FG001|Overall Study|Lost to Follow-up|3|||
17186624|NCT03028415|38339033|FG000|Overall Study|Withdrawal by Subject|1|||
17186625|NCT03028415|38339034|FG001|Overall Study|Withdrawal by Subject|0|||
17186626|NCT03028415|38339033|FG000|Overall Study|Discontinued due to COVID-19|1|||
17186627|NCT03028415|38339034|FG001|Overall Study|Discontinued due to COVID-19|0|||
17186628|NCT02526160|38339043|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
17186629|NCT02526160|38339044|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
17186630|NCT02526160|38339043|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
17186631|NCT02526160|38339044|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
17186632|NCT02526160|38339043|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
17186633|NCT02526160|38339044|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
17186634|NCT02526160|38339043|FG000|Open-Label Treatment Extension Period I|Death|0|||
17186635|NCT02526160|38339044|FG001|Open-Label Treatment Extension Period I|Death|1|||
17186636|NCT02526160|38339043|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
17186637|NCT02526160|38339044|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
17186638|NCT02526160|38339043|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
17186639|NCT02526160|38339044|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
17186640|NCT02526160|38339043|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
17186641|NCT02526160|38339044|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
17186642|NCT02526160|38339043|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
17186643|NCT02526160|38339044|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
17186644|NCT02692040|38339072|FG000|Overall Study|Protocol Violation|0|||
17186645|NCT02692040|38339073|FG001|Overall Study|Protocol Violation|0|||
17186646|NCT02692040|38339074|FG002|Overall Study|Protocol Violation|0|||
17186647|NCT02692040|38339075|FG003|Overall Study|Protocol Violation|0|||
17186648|NCT02692040|38339076|FG004|Overall Study|Protocol Violation|0|||
17186649|NCT02692040|38339077|FG005|Overall Study|Protocol Violation|0|||
17186650|NCT02692040|38339078|FG006|Overall Study|Protocol Violation|0|||
17186651|NCT02692040|38339079|FG007|Overall Study|Protocol Violation|0|||
17186652|NCT02692040|38339080|FG008|Overall Study|Protocol Violation|0|||
17186653|NCT02692040|38339081|FG009|Overall Study|Protocol Violation|0|||
17186654|NCT02692040|38339082|FG010|Overall Study|Protocol Violation|0|||
17186655|NCT02692040|38339083|FG011|Overall Study|Protocol Violation|0|||
17186656|NCT02692040|38339084|FG012|Overall Study|Protocol Violation|1|||
17186657|NCT02692040|38339085|FG013|Overall Study|Protocol Violation|0|||
17186658|NCT02692040|38339086|FG014|Overall Study|Protocol Violation|0|||
17186659|NCT02692040|38339087|FG015|Overall Study|Protocol Violation|0|||
17186660|NCT02692040|38339088|FG016|Overall Study|Protocol Violation|0|||
17186661|NCT02692040|38339072|FG000|Overall Study|Adverse Event|0|||
17186662|NCT02692040|38339073|FG001|Overall Study|Adverse Event|0|||
17186663|NCT02692040|38339074|FG002|Overall Study|Adverse Event|0|||
17186664|NCT02692040|38339075|FG003|Overall Study|Adverse Event|0|||
17186665|NCT02692040|38339076|FG004|Overall Study|Adverse Event|0|||
17186666|NCT02692040|38339077|FG005|Overall Study|Adverse Event|0|||
17186667|NCT02692040|38339078|FG006|Overall Study|Adverse Event|0|||
17186668|NCT02692040|38339079|FG007|Overall Study|Adverse Event|0|||
17186669|NCT02692040|38339080|FG008|Overall Study|Adverse Event|0|||
17186670|NCT02692040|38339081|FG009|Overall Study|Adverse Event|0|||
17186671|NCT02692040|38339082|FG010|Overall Study|Adverse Event|0|||
17186672|NCT02692040|38339083|FG011|Overall Study|Adverse Event|0|||
17186673|NCT02692040|38339084|FG012|Overall Study|Adverse Event|0|||
17186674|NCT02692040|38339085|FG013|Overall Study|Adverse Event|3|||
17186675|NCT02692040|38339086|FG014|Overall Study|Adverse Event|1|||
17186676|NCT02692040|38339087|FG015|Overall Study|Adverse Event|1|||
17186677|NCT02692040|38339088|FG016|Overall Study|Adverse Event|0|||
17186678|NCT03029819|38339167|FG000|Overall Study|Lost to Follow-up|3|||
17186679|NCT03029819|38339168|FG001|Overall Study|Lost to Follow-up|5|||
17186680|NCT03029819|38339167|FG000|Overall Study|Removed due to disruptive behavior|0|||
17186681|NCT03029819|38339168|FG001|Overall Study|Removed due to disruptive behavior|1|||
17186682|NCT02678390|38339179|FG000|AE (1 Day)|Withdrawal by Subject|0|||
17186683|NCT02678390|38339180|FG001|AE (1 Day)|Withdrawal by Subject|1|||
17186684|NCT03027557|38339189|FG000|Overall Study|Adverse Event|1|||
17186685|NCT03027557|38339190|FG001|Overall Study|Adverse Event|0|||
17186686|NCT03027557|38339191|FG002|Overall Study|Adverse Event|0|||
17186687|NCT03029585|38339201|FG000|Overall Study|Death|1|||
17186688|NCT03029585|38339202|FG001|Overall Study|Death|1|||
17186689|NCT03029585|38339201|FG000|Overall Study|Withdrawal by Subject|1|||
17186690|NCT03029585|38339202|FG001|Overall Study|Withdrawal by Subject|0|||
17186691|NCT02678000|38339213|FG000|PART 2|Adverse Event|0|||
17186692|NCT02678000|38339214|FG001|PART 2|Adverse Event|0|||
17186693|NCT02678000|38339215|FG002|PART 2|Adverse Event|2|||
17186694|NCT02678000|38339216|FG003|PART 2|Adverse Event|1|||
17186695|NCT02678000|38339217|FG004|PART 2|Adverse Event|0|||
17186696|NCT02678000|38339213|FG000|PART 2|Withdrawal by Subject|0|||
17186697|NCT02678000|38339214|FG001|PART 2|Withdrawal by Subject|0|||
17186698|NCT02678000|38339215|FG002|PART 2|Withdrawal by Subject|1|||
17186699|NCT02678000|38339216|FG003|PART 2|Withdrawal by Subject|0|||
17186700|NCT02678000|38339217|FG004|PART 2|Withdrawal by Subject|0|||
17186701|NCT02691572|38339244|FG000|Overall Study|Withdrawal by Subject|1|||
17186702|NCT02691572|38339245|FG001|Overall Study|Withdrawal by Subject|0|||
17186703|NCT02691572|38339244|FG000|Overall Study|Protocol Violation|0|||
17186704|NCT02691572|38339245|FG001|Overall Study|Protocol Violation|1|||
17186705|NCT02677844|38339253|FG000|Period 3|Withdrawal by Subject|0|||
17186706|NCT02677844|38339254|FG001|Period 3|Withdrawal by Subject|0|||
17186707|NCT02677844|38339255|FG002|Period 3|Withdrawal by Subject|0|||
17186708|NCT02677844|38339256|FG003|Period 3|Withdrawal by Subject|1|||
17186709|NCT02677844|38339257|FG004|Period 3|Withdrawal by Subject|0|||
17186710|NCT02677844|38339258|FG005|Period 3|Withdrawal by Subject|0|||
17186711|NCT02677844|38339259|FG006|Period 3|Withdrawal by Subject|0|||
17186712|NCT02691494|38339281|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
17186713|NCT02691494|38339282|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
17186714|NCT02691494|38339283|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
17186715|NCT02691494|38339281|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
17186716|NCT02691494|38339282|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
17186717|NCT02691494|38339283|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
17186718|NCT02691494|38339281|FG000|Post-Treatment Follow-Up Period|Other|2|||
17186719|NCT02691494|38339282|FG001|Post-Treatment Follow-Up Period|Other|1|||
17186720|NCT02691494|38339283|FG002|Post-Treatment Follow-Up Period|Other|1|||
17186721|NCT02691494|38339281|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
17186722|NCT02691494|38339282|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
17186723|NCT02691494|38339283|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
17186724|NCT02691494|38339281|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
17186725|NCT02691494|38339282|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
17186726|NCT02691494|38339283|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
17186727|NCT02677220|38339291|FG000|Overall Study|Adverse Event|1|||
17186728|NCT02682602|38339298|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
17186729|NCT02682602|38339299|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
17186730|NCT02682602|38339298|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
17186731|NCT02682602|38339299|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
17186732|NCT02681510|38339309|FG000|Overall Study|Withdrawal by Subject|1|||
17186733|NCT02681510|38339309|FG000|Overall Study|Lost to Follow-up|9|||
17186734|NCT02690714|38339313|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
17186735|NCT02690714|38339313|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
17186736|NCT03925727|38339324|FG000|Overall Study|Adverse Event|4|||
17186737|NCT03925727|38339325|FG001|Overall Study|Adverse Event|0|||
17186738|NCT03925727|38339326|FG002|Overall Study|Adverse Event|3|||
17186739|NCT03925727|38339324|FG000|Overall Study|Protocol Violation|1|||
17186740|NCT03925727|38339325|FG001|Overall Study|Protocol Violation|2|||
17186741|NCT03925727|38339326|FG002|Overall Study|Protocol Violation|2|||
17186742|NCT03925727|38339324|FG000|Overall Study|Withdrawal by Subject|3|||
17186743|NCT03925727|38339325|FG001|Overall Study|Withdrawal by Subject|2|||
17186744|NCT03925727|38339326|FG002|Overall Study|Withdrawal by Subject|4|||
17186745|NCT03925727|38339324|FG000|Overall Study|Administrative Reasons|3|||
17186746|NCT03925727|38339325|FG001|Overall Study|Administrative Reasons|1|||
17186747|NCT03925727|38339326|FG002|Overall Study|Administrative Reasons|2|||
17186748|NCT03925727|38339324|FG000|Overall Study|Randomized in error or Disqualified|8|||
17186749|NCT03925727|38339325|FG001|Overall Study|Randomized in error or Disqualified|1|||
17186750|NCT03925727|38339326|FG002|Overall Study|Randomized in error or Disqualified|7|||
17186751|NCT01898793|38339343|FG000|Overall Study|Death|2|||
17186752|NCT01898793|38339344|FG001|Overall Study|Death|1|||
17186753|NCT01898793|38339345|FG002|Overall Study|Death|4|||
17186754|NCT01898793|38339346|FG003|Overall Study|Death|0|||
17186755|NCT01898793|38339347|FG004|Overall Study|Death|0|||
17186756|NCT01898793|38339348|FG005|Overall Study|Death|0|||
17186757|NCT01898793|38339349|FG006|Overall Study|Death|0|||
17186758|NCT01791543|38339368|FG000|Overall Study|Lost to Follow-up|1|||
17186759|NCT01791543|38339368|FG000|Overall Study|Adverse Event|1|||
17186760|NCT02925455|38339375|FG000|Overall Study|Withdrawal by Subject|2|||
17186761|NCT02925455|38339376|FG001|Overall Study|Withdrawal by Subject|0|||
17186762|NCT03033069|38339386|FG000|Overall Study|Adverse Event|6|||
17186763|NCT03033069|38339387|FG001|Overall Study|Adverse Event|7|||
17186764|NCT03033069|38339388|FG002|Overall Study|Adverse Event|4|||
17186765|NCT03033069|38339389|FG003|Overall Study|Adverse Event|6|||
17186766|NCT03033069|38339386|FG000|Overall Study|Lack of Efficacy|0|||
17186767|NCT03033069|38339387|FG001|Overall Study|Lack of Efficacy|0|||
17186768|NCT03033069|38339388|FG002|Overall Study|Lack of Efficacy|1|||
17186769|NCT03033069|38339389|FG003|Overall Study|Lack of Efficacy|0|||
17186770|NCT03033069|38339386|FG000|Overall Study|Lost to Follow-up|6|||
17186771|NCT03033069|38339387|FG001|Overall Study|Lost to Follow-up|5|||
17186772|NCT03033069|38339388|FG002|Overall Study|Lost to Follow-up|5|||
17186773|NCT03033069|38339389|FG003|Overall Study|Lost to Follow-up|6|||
17186774|NCT03033069|38339386|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17186775|NCT03033069|38339387|FG001|Overall Study|Non-Compliance With Study Drug|1|||
17186776|NCT03033069|38339388|FG002|Overall Study|Non-Compliance With Study Drug|1|||
17186777|NCT03033069|38339389|FG003|Overall Study|Non-Compliance With Study Drug|0|||
17186778|NCT03033069|38339386|FG000|Overall Study|Protocol Deviation|0|||
17186779|NCT03033069|38339387|FG001|Overall Study|Protocol Deviation|1|||
17186780|NCT03033069|38339388|FG002|Overall Study|Protocol Deviation|0|||
17186781|NCT03033069|38339389|FG003|Overall Study|Protocol Deviation|0|||
17186782|NCT03033069|38339386|FG000|Overall Study|Withdrawal by Subject|10|||
17186783|NCT03033069|38339387|FG001|Overall Study|Withdrawal by Subject|10|||
17186784|NCT03033069|38339388|FG002|Overall Study|Withdrawal by Subject|11|||
17186785|NCT03033069|38339389|FG003|Overall Study|Withdrawal by Subject|6|||
17186786|NCT03033069|38339386|FG000|Overall Study|Withdrawal By Caregiver|1|||
17186787|NCT03033069|38339387|FG001|Overall Study|Withdrawal By Caregiver|0|||
17186788|NCT03033069|38339388|FG002|Overall Study|Withdrawal By Caregiver|0|||
17186789|NCT03033069|38339389|FG003|Overall Study|Withdrawal By Caregiver|0|||
17186790|NCT03033069|38339386|FG000|Overall Study|Reason not Specified|0|||
17186791|NCT03033069|38339387|FG001|Overall Study|Reason not Specified|1|||
17186792|NCT03033069|38339388|FG002|Overall Study|Reason not Specified|0|||
17186793|NCT03033069|38339389|FG003|Overall Study|Reason not Specified|1|||
17186794|NCT02917265|38339401|FG000|Overall Study|Physician Decision|1|||
17186795|NCT02917265|38339402|FG001|Overall Study|Physician Decision|0|||
17186796|NCT02917265|38339401|FG000|Overall Study|Withdrawal by Subject|1|||
17186797|NCT02917265|38339402|FG001|Overall Study|Withdrawal by Subject|0|||
17186798|NCT02136069|38339412|FG000|Overall Study|UC flare-up|1|||
17186799|NCT02136069|38339413|FG001|Overall Study|UC flare-up|0|||
17186800|NCT02136069|38339412|FG000|Overall Study|Adverse Event|6|||
17186801|NCT02136069|38339413|FG001|Overall Study|Adverse Event|8|||
17186802|NCT02136069|38339412|FG000|Overall Study|Death|0|||
17186803|NCT02136069|38339413|FG001|Overall Study|Death|1|||
17186804|NCT02136069|38339412|FG000|Overall Study|Lack of Efficacy|10|||
17186805|NCT02136069|38339413|FG001|Overall Study|Lack of Efficacy|4|||
17186806|NCT02136069|38339412|FG000|Overall Study|Lost to Follow-up|1|||
17186807|NCT02136069|38339413|FG001|Overall Study|Lost to Follow-up|0|||
17186808|NCT02136069|38339412|FG000|Overall Study|Non-Compliance|1|||
17186809|NCT02136069|38339413|FG001|Overall Study|Non-Compliance|0|||
17186810|NCT02136069|38339412|FG000|Overall Study|Physician Decision|5|||
17186811|NCT02136069|38339413|FG001|Overall Study|Physician Decision|4|||
17186812|NCT02136069|38339412|FG000|Overall Study|Withdrawal by Subject|10|||
17186813|NCT02136069|38339413|FG001|Overall Study|Withdrawal by Subject|11|||
17186814|NCT02917031|38339422|FG000|Overall Study|Reason not specified|7|||
17186815|NCT02917031|38339423|FG001|Overall Study|Reason not specified|5|||
17186816|NCT02917031|38339424|FG002|Overall Study|Reason not specified|6|||
17186817|NCT02917031|38339422|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
17186818|NCT02917031|38339423|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
17186819|NCT02917031|38339424|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
17186820|NCT02917031|38339422|FG000|Overall Study|Withdrawal by Subject|3|||
17186821|NCT02917031|38339423|FG001|Overall Study|Withdrawal by Subject|3|||
17186822|NCT02917031|38339424|FG002|Overall Study|Withdrawal by Subject|0|||
17186823|NCT02917031|38339422|FG000|Overall Study|Physician Decision|1|||
17186824|NCT02917031|38339423|FG001|Overall Study|Physician Decision|0|||
17186825|NCT02917031|38339424|FG002|Overall Study|Physician Decision|0|||
17186826|NCT02917031|38339422|FG000|Overall Study|Adverse Event|4|||
17186827|NCT02917031|38339423|FG001|Overall Study|Adverse Event|1|||
17186828|NCT02917031|38339424|FG002|Overall Study|Adverse Event|5|||
17186829|NCT02917031|38339422|FG000|Overall Study|Death|2|||
17186830|NCT02917031|38339423|FG001|Overall Study|Death|3|||
17186831|NCT02917031|38339424|FG002|Overall Study|Death|4|||
17186832|NCT01018563|38339433|FG000|Overall Study|Termination of the study by Sponsor|2|||
17186833|NCT01018563|38339434|FG001|Overall Study|Termination of the study by Sponsor|1|||
17186834|NCT02528188|38339447|FG000|Overall Study|Adverse Event|23|||
17186835|NCT02528188|38339448|FG001|Overall Study|Adverse Event|22|||
17186836|NCT02528188|38339449|FG002|Overall Study|Adverse Event|8|||
17186837|NCT02528188|38339447|FG000|Overall Study|Protocol Violation|4|||
17186838|NCT02528188|38339448|FG001|Overall Study|Protocol Violation|6|||
17186839|NCT02528188|38339449|FG002|Overall Study|Protocol Violation|4|||
17186840|NCT02528188|38339447|FG000|Overall Study|Lack of Efficacy|19|||
17186841|NCT02528188|38339448|FG001|Overall Study|Lack of Efficacy|21|||
17186842|NCT02528188|38339449|FG002|Overall Study|Lack of Efficacy|22|||
17186843|NCT02528188|38339447|FG000|Overall Study|Withdrawal by Subject|97|||
17186844|NCT02528188|38339448|FG001|Overall Study|Withdrawal by Subject|104|||
17186845|NCT02528188|38339449|FG002|Overall Study|Withdrawal by Subject|100|||
17186846|NCT02528188|38339447|FG000|Overall Study|Lost to Follow-up|25|||
17186847|NCT02528188|38339448|FG001|Overall Study|Lost to Follow-up|21|||
17186848|NCT02528188|38339449|FG002|Overall Study|Lost to Follow-up|31|||
17186849|NCT02528188|38339447|FG000|Overall Study|Death|4|||
17186850|NCT02528188|38339448|FG001|Overall Study|Death|4|||
17186851|NCT02528188|38339449|FG002|Overall Study|Death|0|||
17186852|NCT02528188|38339447|FG000|Overall Study|Other|89|||
17186853|NCT02528188|38339448|FG001|Overall Study|Other|91|||
17186854|NCT02528188|38339449|FG002|Overall Study|Other|74|||
17186855|NCT02528188|38339447|FG000|Overall Study|Randomized but not treated|6|||
17186856|NCT02528188|38339448|FG001|Overall Study|Randomized but not treated|7|||
17186857|NCT02528188|38339449|FG002|Overall Study|Randomized but not treated|12|||
17186858|NCT03896165|38339457|FG000|Overall Study|Withdrawal by Subject|2|||
17186859|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
17186860|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
17186861|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
17186862|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
17186863|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
17186864|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
17186865|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
17186866|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
17186867|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
17186868|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
17186869|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
17186870|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
17186871|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
17186872|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
17186873|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
17186874|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
17186875|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
17186876|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
17186877|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
17186878|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
17186879|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
17186880|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
17186881|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
17186882|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
17186883|NCT02269917|38339483|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
17186884|NCT02269917|38339484|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
17186885|NCT02269917|38339485|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
17186886|NCT02269917|38339483|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
17186887|NCT02269917|38339484|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
17186888|NCT02269917|38339485|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
17186889|NCT02269917|38339483|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
17186890|NCT02269917|38339484|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
17186891|NCT02269917|38339485|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
17186892|NCT02269917|38339483|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
17186893|NCT02269917|38339484|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
17186894|NCT02269917|38339485|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
17186895|NCT02269917|38339483|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
17186896|NCT02269917|38339484|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
17186897|NCT02269917|38339485|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
17186898|NCT02269917|38339483|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
17186899|NCT02269917|38339484|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
17186900|NCT02269917|38339485|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
17186901|NCT02269917|38339483|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
17186902|NCT02269917|38339484|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
17186903|NCT02269917|38339485|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
17186904|NCT02269917|38339483|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
17186905|NCT02269917|38339484|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
17186906|NCT02269917|38339485|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
17186907|NCT02522494|38339496|FG000|Overall Study|Lost to Follow-up|6|||
17186908|NCT02522494|38339497|FG001|Overall Study|Lost to Follow-up|2|||
17186909|NCT02522494|38339496|FG000|Overall Study|Withdrawal by Subject|1|||
17186910|NCT02522494|38339497|FG001|Overall Study|Withdrawal by Subject|0|||
17186911|NCT02522494|38339496|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
17186912|NCT02522494|38339497|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
17186913|NCT02522494|38339496|FG000|Overall Study|Participant did not watch the video|1|||
17186914|NCT02522494|38339497|FG001|Overall Study|Participant did not watch the video|0|||
17186915|NCT02522494|38339496|FG000|Overall Study|Death|0|||
17186916|NCT02522494|38339497|FG001|Overall Study|Death|1|||
17186917|NCT01658020|38339505|FG000|Overall Study|Adverse Event|3|||
17186918|NCT01658020|38339506|FG001|Overall Study|Adverse Event|3|||
17186919|NCT01658020|38339505|FG000|Overall Study|Lost to Follow-up|1|||
17186920|NCT01658020|38339506|FG001|Overall Study|Lost to Follow-up|0|||
17186921|NCT01658020|38339505|FG000|Overall Study|Withdrawal by Subject|4|||
17186922|NCT01658020|38339506|FG001|Overall Study|Withdrawal by Subject|5|||
17186923|NCT01658020|38339505|FG000|Overall Study|Protocol Violation|0|||
17186924|NCT01658020|38339506|FG001|Overall Study|Protocol Violation|1|||
17186925|NCT03389477|38339524|FG000|Step 1|Withdrawal by Subject|1|||
17186926|NCT03389477|38339525|FG001|Step 1|Withdrawal by Subject|0|||
17186927|NCT03389477|38339524|FG000|Step 2|Withdrawal by Subject|1|||
17186928|NCT03389477|38339525|FG001|Step 2|Withdrawal by Subject|2|||
17186929|NCT03389477|38339524|FG000|Step 2|Disease progression|1|||
17186930|NCT03389477|38339525|FG001|Step 2|Disease progression|0|||
17186931|NCT03389477|38339524|FG000|Step 2|Death|0|||
17186932|NCT03389477|38339525|FG001|Step 2|Death|1|||
17186933|NCT03389477|38339524|FG000|Step 2|Poor performance status and nutrition|0|||
17186934|NCT03389477|38339525|FG001|Step 2|Poor performance status and nutrition|1|||
17186935|NCT03389477|38339524|FG000|Step 3|Withdrawal after 3 cycles|0|||
17186936|NCT03389477|38339525|FG001|Step 3|Withdrawal after 3 cycles|1|||
17186937|NCT03389477|38339524|FG000|Step 3|Still receiving active treatment|4|||
17186938|NCT03389477|38339525|FG001|Step 3|Still receiving active treatment|0|||
17186939|NCT03389477|38339524|FG000|Step 3|Progressive disease after 2 cycles|1|||
17186940|NCT03389477|38339525|FG001|Step 3|Progressive disease after 2 cycles|0|||
17186941|NCT02680574|38339535|FG000|Overall Study|Death|137|||
17186942|NCT02680574|38339536|FG001|Overall Study|Death|137|||
17186943|NCT02680574|38339535|FG000|Overall Study|Withdrawal by Subject|17|||
17186944|NCT02680574|38339536|FG001|Overall Study|Withdrawal by Subject|9|||
17186945|NCT02680574|38339535|FG000|Overall Study|Lost to Follow-up|4|||
17186946|NCT02680574|38339536|FG001|Overall Study|Lost to Follow-up|6|||
17186947|NCT02522884|38339542|FG000|Overall Study|Withdrawal by Subject|6|||
17186948|NCT02522884|38339542|FG000|Overall Study|Death|3|||
17186949|NCT02522884|38339542|FG000|Overall Study|Missed 12-month Follow-up|9|||
17186950|NCT02674568|38339559|FG000|Overall Study|Withdrawal by Subject|5|||
17186951|NCT02674568|38339559|FG000|Overall Study|Death|303|||
17186952|NCT02674568|38339559|FG000|Overall Study|Physician Decision|2|||
17186953|NCT02674568|38339559|FG000|Overall Study|Lost to Follow-up|9|||
17186954|NCT02674568|38339559|FG000|Overall Study|Other, Not Specified|20|||
17186955|NCT03022799|38339581|FG000|Overall Study|Adverse Event|0|||
17186956|NCT03022799|38339582|FG001|Overall Study|Adverse Event|0|||
17186957|NCT03022799|38339583|FG002|Overall Study|Adverse Event|0|||
17186958|NCT03022799|38339584|FG003|Overall Study|Adverse Event|0|||
17186959|NCT03022799|38339585|FG004|Overall Study|Adverse Event|0|||
17186960|NCT03022799|38339586|FG005|Overall Study|Adverse Event|0|||
17186961|NCT03022799|38339587|FG006|Overall Study|Adverse Event|0|||
17186962|NCT03022799|38339588|FG007|Overall Study|Adverse Event|0|||
17186963|NCT03022799|38339589|FG008|Overall Study|Adverse Event|0|||
17186964|NCT03022799|38339590|FG009|Overall Study|Adverse Event|1|||
17186965|NCT03022799|38339591|FG010|Overall Study|Adverse Event|1|||
17186966|NCT03022799|38339592|FG011|Overall Study|Adverse Event|0|||
17186967|NCT03022799|38339593|FG012|Overall Study|Adverse Event|0|||
17186968|NCT02674334|38339640|FG000|Overall Study|Lost to Follow-up|5|||
17186969|NCT02674334|38339641|FG001|Overall Study|Lost to Follow-up|3|||
17186970|NCT02674334|38339640|FG000|Overall Study|participant difficulty breathing|1|||
17186971|NCT02674334|38339641|FG001|Overall Study|participant difficulty breathing|0|||
17186972|NCT02674334|38339640|FG000|Overall Study|NIRS not recording|1|||
17186973|NCT02674334|38339641|FG001|Overall Study|NIRS not recording|0|||
17186974|NCT03026075|38339647|FG000|Overall Study|Physician Decision|1|||
17186975|NCT01373918|38339653|FG000|Overall Study|Physician Decision|0|||
17186976|NCT01373918|38339654|FG001|Overall Study|Physician Decision|1|||
17186977|NCT02667626|38339662|FG000|Overall Study|Withdrawal by Subject|0|||
17186978|NCT02667626|38339663|FG001|Overall Study|Withdrawal by Subject|1|||
17186979|NCT02522728|38339674|FG000|Overall Study|Withdrawal by Subject|6|||
17186980|NCT02522728|38339675|FG001|Overall Study|Withdrawal by Subject|6|||
17186981|NCT02522728|38339674|FG000|Overall Study|Death|4|||
17186982|NCT02522728|38339675|FG001|Overall Study|Death|3|||
17186983|NCT02522728|38339674|FG000|Overall Study|Adverse Event|2|||
17186984|NCT02522728|38339675|FG001|Overall Study|Adverse Event|1|||
17186985|NCT02522728|38339674|FG000|Overall Study|Did not receive randomized study device|0|||
17186986|NCT02522728|38339675|FG001|Overall Study|Did not receive randomized study device|1|||
17186987|NCT02827877|38339681|FG000|Overall Study|Withdrawal by Subject|1|||
17186988|NCT02675426|38339688|FG000|Overall Study|Adverse Event|6|||
17186989|NCT02675426|38339689|FG001|Overall Study|Adverse Event|2|||
17186990|NCT02675426|38339690|FG002|Overall Study|Adverse Event|9|||
17186991|NCT02675426|38339688|FG000|Overall Study|Withdrawal by Subject|3|||
17186992|NCT02675426|38339689|FG001|Overall Study|Withdrawal by Subject|5|||
17186993|NCT02675426|38339690|FG002|Overall Study|Withdrawal by Subject|5|||
17186994|NCT02675426|38339688|FG000|Overall Study|Lost to Follow-up|1|||
17186995|NCT02675426|38339689|FG001|Overall Study|Lost to Follow-up|0|||
17186996|NCT02675426|38339690|FG002|Overall Study|Lost to Follow-up|2|||
17186997|NCT02675426|38339688|FG000|Overall Study|Other|3|||
17186998|NCT02675426|38339689|FG001|Overall Study|Other|1|||
17186999|NCT02675426|38339690|FG002|Overall Study|Other|2|||
17187000|NCT03025217|38339707|FG000|Overall Study|Pregnancy|1|||
17187001|NCT03025217|38339707|FG000|Overall Study|Lost to Follow-up|1|||
17187002|NCT03025217|38339707|FG000|Overall Study|Not eligible, poor English|2|||
17187003|NCT03023813|38339714|FG000|Overall Study|Lost to Follow-up|1|||
17187004|NCT03023813|38339715|FG001|Overall Study|Lost to Follow-up|2|||
17187005|NCT03023813|38339716|FG002|Overall Study|Lost to Follow-up|0|||
17187006|NCT01365130|38339725|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
17187007|NCT01657162|38339731|FG000|Overall Study|Adverse Event|26|||
17187008|NCT01657162|38339732|FG001|Overall Study|Adverse Event|36|||
17187009|NCT01657162|38339731|FG000|Overall Study|Withdrawal by Subject|13|||
17187010|NCT01657162|38339732|FG001|Overall Study|Withdrawal by Subject|13|||
17187011|NCT01657162|38339731|FG000|Overall Study|Continuing Significant Deterioration|9|||
17187012|NCT01657162|38339732|FG001|Overall Study|Continuing Significant Deterioration|3|||
17187013|NCT01657162|38339731|FG000|Overall Study|Refusal of Treatment|4|||
17187014|NCT01657162|38339732|FG001|Overall Study|Refusal of Treatment|6|||
17187015|NCT01657162|38339731|FG000|Overall Study|Lost to Follow-up|3|||
17187016|NCT01657162|38339732|FG001|Overall Study|Lost to Follow-up|4|||
17187017|NCT01657162|38339731|FG000|Overall Study|Death|2|||
17187018|NCT01657162|38339732|FG001|Overall Study|Death|3|||
17187019|NCT01657162|38339731|FG000|Overall Study|Inability to Complete Study Procedures|1|||
17187020|NCT01657162|38339732|FG001|Overall Study|Inability to Complete Study Procedures|7|||
17187021|NCT01657162|38339731|FG000|Overall Study|Protocol Violation|1|||
17187022|NCT01657162|38339732|FG001|Overall Study|Protocol Violation|0|||
17187023|NCT01657162|38339731|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
17187024|NCT01657162|38339732|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
17187025|NCT01657162|38339731|FG000|Overall Study|Other than Specified|0|||
17187026|NCT01657162|38339732|FG001|Overall Study|Other than Specified|2|||
17187027|NCT01373294|38339766|FG000|Overall Study|Adverse Event|1|||
17187028|NCT01373294|38339767|FG001|Overall Study|Adverse Event|0|||
17187029|NCT01656304|38339773|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
17187030|NCT03023423|38339780|FG000|Overall Study|Death|5|||
17187031|NCT03023423|38339781|FG001|Overall Study|Death|12|||
17187032|NCT03023423|38339782|FG002|Overall Study|Death|20|||
17187033|NCT03023423|38339780|FG000|Overall Study|Other|0|||
17187034|NCT03023423|38339781|FG001|Overall Study|Other|2|||
17187035|NCT03023423|38339782|FG002|Overall Study|Other|2|||
17187036|NCT03023423|38339780|FG000|Overall Study|Ongoing|2|||
17187037|NCT03023423|38339781|FG001|Overall Study|Ongoing|32|||
17187038|NCT03023423|38339782|FG002|Overall Study|Ongoing|24|||
17187039|NCT03185741|38339797|FG000|Baseline|Withdrawal by Subject|1|||
17187040|NCT03185741|38339798|FG001|Baseline|Withdrawal by Subject|3|||
17187041|NCT03185741|38339799|FG002|Baseline|Withdrawal by Subject|2|||
17187042|NCT03185741|38339797|FG000|Baseline|Lost to Follow-up|1|||
17187043|NCT03185741|38339798|FG001|Baseline|Lost to Follow-up|2|||
17187044|NCT03185741|38339799|FG002|Baseline|Lost to Follow-up|3|||
17187045|NCT03185741|38339797|FG000|3Month|Death|1|||
17187046|NCT03185741|38339798|FG001|3Month|Death|1|||
17187047|NCT03185741|38339799|FG002|3Month|Death|2|||
17187048|NCT03185741|38339797|FG000|3Month|Withdrawal by Subject|1|||
17187049|NCT03185741|38339798|FG001|3Month|Withdrawal by Subject|5|||
17187050|NCT03185741|38339799|FG002|3Month|Withdrawal by Subject|1|||
17187051|NCT03185741|38339797|FG000|3Month|Lost to Follow-up|7|||
17187052|NCT03185741|38339798|FG001|3Month|Lost to Follow-up|9|||
17187053|NCT03185741|38339799|FG002|3Month|Lost to Follow-up|8|||
17187054|NCT03185741|38339797|FG000|3Month|Unavailable for 3Month|11|||
17187055|NCT03185741|38339798|FG001|3Month|Unavailable for 3Month|10|||
17187056|NCT03185741|38339799|FG002|3Month|Unavailable for 3Month|11|||
17187057|NCT03185741|38339797|FG000|3Month|Protocol Violation|0|||
17187058|NCT03185741|38339798|FG001|3Month|Protocol Violation|0|||
17187059|NCT03185741|38339799|FG002|3Month|Protocol Violation|3|||
17187060|NCT03185741|38339797|FG000|6Month|Death|1|||
17187061|NCT03185741|38339798|FG001|6Month|Death|1|||
17187062|NCT03185741|38339799|FG002|6Month|Death|2|||
17187063|NCT03185741|38339797|FG000|6Month|Withdrawal by Subject|2|||
17187064|NCT03185741|38339798|FG001|6Month|Withdrawal by Subject|3|||
17187065|NCT03185741|38339799|FG002|6Month|Withdrawal by Subject|1|||
17187066|NCT03185741|38339797|FG000|6Month|Lost to Follow-up|16|||
17187067|NCT03185741|38339798|FG001|6Month|Lost to Follow-up|15|||
17187068|NCT03185741|38339799|FG002|6Month|Lost to Follow-up|16|||
17187069|NCT02672852|38339809|FG000|Part A1|Disease Worsening|1|||
17187070|NCT02672852|38339810|FG001|Part A1|Disease Worsening|0|||
17187071|NCT02672852|38339811|FG002|Part A1|Disease Worsening|0|||
17187072|NCT02672852|38339812|FG003|Part A1|Disease Worsening|0|||
17187073|NCT02672852|38339813|FG004|Part A1|Disease Worsening|0|||
17187074|NCT02672852|38339814|FG005|Part A1|Disease Worsening|0|||
17187075|NCT02672852|38339815|FG006|Part A1|Disease Worsening|0|||
17187076|NCT02672852|38339809|FG000|Part A1|Adverse Event|0|||
17187077|NCT02672852|38339810|FG001|Part A1|Adverse Event|1|||
17187078|NCT02672852|38339811|FG002|Part A1|Adverse Event|0|||
17187079|NCT02672852|38339812|FG003|Part A1|Adverse Event|0|||
17187080|NCT02672852|38339813|FG004|Part A1|Adverse Event|0|||
17187081|NCT02672852|38339814|FG005|Part A1|Adverse Event|0|||
17187082|NCT02672852|38339815|FG006|Part A1|Adverse Event|0|||
17187083|NCT02672852|38339809|FG000|Part A1|Lost to Follow-up|1|||
17187084|NCT02672852|38339810|FG001|Part A1|Lost to Follow-up|2|||
17187085|NCT02672852|38339811|FG002|Part A1|Lost to Follow-up|0|||
17187086|NCT02672852|38339812|FG003|Part A1|Lost to Follow-up|0|||
17187087|NCT02672852|38339813|FG004|Part A1|Lost to Follow-up|0|||
17187088|NCT02672852|38339814|FG005|Part A1|Lost to Follow-up|0|||
17187089|NCT02672852|38339815|FG006|Part A1|Lost to Follow-up|0|||
17187090|NCT02672852|38339809|FG000|Part A1|Withdrawal by Subject|1|||
17187091|NCT02672852|38339810|FG001|Part A1|Withdrawal by Subject|1|||
17187092|NCT02672852|38339811|FG002|Part A1|Withdrawal by Subject|0|||
17187093|NCT02672852|38339812|FG003|Part A1|Withdrawal by Subject|0|||
17187094|NCT02672852|38339813|FG004|Part A1|Withdrawal by Subject|0|||
17187095|NCT02672852|38339814|FG005|Part A1|Withdrawal by Subject|0|||
17187096|NCT02672852|38339815|FG006|Part A1|Withdrawal by Subject|0|||
17187097|NCT02672852|38339809|FG000|Part A2|Disease worsening|0|||
17187098|NCT02672852|38339810|FG001|Part A2|Disease worsening|0|||
17187099|NCT02672852|38339811|FG002|Part A2|Disease worsening|1|||
17187100|NCT02672852|38339812|FG003|Part A2|Disease worsening|0|||
17187101|NCT02672852|38339813|FG004|Part A2|Disease worsening|0|||
17187102|NCT02672852|38339814|FG005|Part A2|Disease worsening|0|||
17187103|NCT02672852|38339815|FG006|Part A2|Disease worsening|0|||
17187104|NCT02672852|38339809|FG000|Part A2|Adverse Event|0|||
17187105|NCT02672852|38339810|FG001|Part A2|Adverse Event|0|||
17187106|NCT02672852|38339811|FG002|Part A2|Adverse Event|3|||
17187107|NCT02672852|38339812|FG003|Part A2|Adverse Event|0|||
17187108|NCT02672852|38339813|FG004|Part A2|Adverse Event|0|||
17187109|NCT02672852|38339814|FG005|Part A2|Adverse Event|0|||
17187110|NCT02672852|38339815|FG006|Part A2|Adverse Event|0|||
17187111|NCT02672852|38339809|FG000|Part A2|Lost to Follow-up|0|||
17187112|NCT02672852|38339810|FG001|Part A2|Lost to Follow-up|0|||
17187113|NCT02672852|38339811|FG002|Part A2|Lost to Follow-up|2|||
17187114|NCT02672852|38339812|FG003|Part A2|Lost to Follow-up|0|||
17187115|NCT02672852|38339813|FG004|Part A2|Lost to Follow-up|0|||
17187116|NCT02672852|38339814|FG005|Part A2|Lost to Follow-up|0|||
17187117|NCT02672852|38339815|FG006|Part A2|Lost to Follow-up|0|||
17187118|NCT02672852|38339809|FG000|Part A2|Withdrawal by Subject|0|||
17187119|NCT02672852|38339810|FG001|Part A2|Withdrawal by Subject|0|||
17187120|NCT02672852|38339811|FG002|Part A2|Withdrawal by Subject|1|||
17187121|NCT02672852|38339812|FG003|Part A2|Withdrawal by Subject|0|||
17187122|NCT02672852|38339813|FG004|Part A2|Withdrawal by Subject|0|||
17187123|NCT02672852|38339814|FG005|Part A2|Withdrawal by Subject|0|||
17187124|NCT02672852|38339815|FG006|Part A2|Withdrawal by Subject|0|||
17187125|NCT02672852|38339809|FG000|Part A2|Other|0|||
17187126|NCT02672852|38339810|FG001|Part A2|Other|0|||
17187127|NCT02672852|38339811|FG002|Part A2|Other|3|||
17187128|NCT02672852|38339812|FG003|Part A2|Other|0|||
17187129|NCT02672852|38339813|FG004|Part A2|Other|0|||
17187130|NCT02672852|38339814|FG005|Part A2|Other|0|||
17187131|NCT02672852|38339815|FG006|Part A2|Other|0|||
17187132|NCT02672852|38339809|FG000|Part A2|Not entered in Part B|0|||
17187133|NCT02672852|38339810|FG001|Part A2|Not entered in Part B|0|||
17187134|NCT02672852|38339811|FG002|Part A2|Not entered in Part B|0|||
17187135|NCT02672852|38339812|FG003|Part A2|Not entered in Part B|4|||
17187136|NCT02672852|38339813|FG004|Part A2|Not entered in Part B|0|||
17187137|NCT02672852|38339814|FG005|Part A2|Not entered in Part B|0|||
17187138|NCT02672852|38339815|FG006|Part A2|Not entered in Part B|0|||
17187139|NCT02672852|38339809|FG000|Part B|Disease worsening|0|||
17187140|NCT02672852|38339810|FG001|Part B|Disease worsening|0|||
17187141|NCT02672852|38339811|FG002|Part B|Disease worsening|0|||
17187142|NCT02672852|38339812|FG003|Part B|Disease worsening|0|||
17187143|NCT02672852|38339813|FG004|Part B|Disease worsening|1|||
17187144|NCT02672852|38339814|FG005|Part B|Disease worsening|0|||
17187145|NCT02672852|38339815|FG006|Part B|Disease worsening|1|||
17187146|NCT02672852|38339809|FG000|Part B|Worsening pre-existing condition|0|||
17187147|NCT02672852|38339810|FG001|Part B|Worsening pre-existing condition|0|||
17187148|NCT02672852|38339811|FG002|Part B|Worsening pre-existing condition|0|||
17187149|NCT02672852|38339812|FG003|Part B|Worsening pre-existing condition|0|||
17187150|NCT02672852|38339813|FG004|Part B|Worsening pre-existing condition|0|||
17187151|NCT02672852|38339814|FG005|Part B|Worsening pre-existing condition|1|||
17187152|NCT02672852|38339815|FG006|Part B|Worsening pre-existing condition|0|||
17187153|NCT02672852|38339809|FG000|Part B|Other adverse event|0|||
17187154|NCT02672852|38339810|FG001|Part B|Other adverse event|0|||
17187155|NCT02672852|38339811|FG002|Part B|Other adverse event|0|||
17187156|NCT02672852|38339812|FG003|Part B|Other adverse event|0|||
17187157|NCT02672852|38339813|FG004|Part B|Other adverse event|3|||
17187158|NCT02672852|38339814|FG005|Part B|Other adverse event|5|||
17187159|NCT02672852|38339815|FG006|Part B|Other adverse event|1|||
17187160|NCT02672852|38339809|FG000|Part B|Lost to Follow-up|0|||
17187161|NCT02672852|38339810|FG001|Part B|Lost to Follow-up|0|||
17187162|NCT02672852|38339811|FG002|Part B|Lost to Follow-up|0|||
17187163|NCT02672852|38339812|FG003|Part B|Lost to Follow-up|0|||
17187164|NCT02672852|38339813|FG004|Part B|Lost to Follow-up|3|||
17187165|NCT02672852|38339814|FG005|Part B|Lost to Follow-up|4|||
17187166|NCT02672852|38339815|FG006|Part B|Lost to Follow-up|1|||
17187167|NCT02672852|38339809|FG000|Part B|Withdrawal by Subject|0|||
17187168|NCT02672852|38339810|FG001|Part B|Withdrawal by Subject|0|||
17187169|NCT02672852|38339811|FG002|Part B|Withdrawal by Subject|0|||
17187170|NCT02672852|38339812|FG003|Part B|Withdrawal by Subject|0|||
17187171|NCT02672852|38339813|FG004|Part B|Withdrawal by Subject|5|||
17187172|NCT02672852|38339814|FG005|Part B|Withdrawal by Subject|0|||
17187173|NCT02672852|38339815|FG006|Part B|Withdrawal by Subject|7|||
17187174|NCT02672852|38339809|FG000|Part B|Other|0|||
17187175|NCT02672852|38339810|FG001|Part B|Other|0|||
17187176|NCT02672852|38339811|FG002|Part B|Other|0|||
17187177|NCT02672852|38339812|FG003|Part B|Other|0|||
17187178|NCT02672852|38339813|FG004|Part B|Other|4|||
17187179|NCT02672852|38339814|FG005|Part B|Other|1|||
17187180|NCT02672852|38339815|FG006|Part B|Other|2|||
17187181|NCT02671760|38339826|FG000|Overall Study|Lost to Follow-up|0|||
17187182|NCT02671760|38339827|FG001|Overall Study|Lost to Follow-up|1|||
17187183|NCT02671760|38339828|FG002|Overall Study|Lost to Follow-up|0|||
17187184|NCT02667236|38339838|FG000|Overall Study|Adverse Event|1|||
17187185|NCT02667236|38339839|FG001|Overall Study|Adverse Event|1|||
17187186|NCT02667236|38339838|FG000|Overall Study|Withdrawal by Subject|2|||
17187187|NCT02667236|38339839|FG001|Overall Study|Withdrawal by Subject|0|||
17187188|NCT01126749|38339849|FG000|Phase 1b|Other|0|||
17187189|NCT01126749|38339850|FG001|Phase 1b|Other|1|||
17187190|NCT01126749|38339851|FG002|Phase 1b|Other|0|||
17187191|NCT01126749|38339852|FG003|Phase 1b|Other|0|||
17187192|NCT01126749|38339849|FG000|Phase 1b|Withdrawal by Subject|0|||
17187193|NCT01126749|38339850|FG001|Phase 1b|Withdrawal by Subject|1|||
17187194|NCT01126749|38339851|FG002|Phase 1b|Withdrawal by Subject|0|||
17187195|NCT01126749|38339852|FG003|Phase 1b|Withdrawal by Subject|0|||
17187196|NCT01126749|38339849|FG000|Phase 1b|Death|3|||
17187197|NCT01126749|38339850|FG001|Phase 1b|Death|4|||
17187198|NCT01126749|38339851|FG002|Phase 1b|Death|0|||
17187199|NCT01126749|38339852|FG003|Phase 1b|Death|0|||
17187200|NCT01126749|38339849|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
17187201|NCT01126749|38339850|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
17187202|NCT01126749|38339851|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
17187203|NCT01126749|38339852|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
17187204|NCT01126749|38339849|FG000|Phase 2|Study Termination by Sponsor|0|||
17187205|NCT01126749|38339850|FG001|Phase 2|Study Termination by Sponsor|0|||
17187206|NCT01126749|38339851|FG002|Phase 2|Study Termination by Sponsor|12|||
17187207|NCT01126749|38339852|FG003|Phase 2|Study Termination by Sponsor|6|||
17187208|NCT01126749|38339849|FG000|Phase 2|Other|0|||
17187209|NCT01126749|38339850|FG001|Phase 2|Other|0|||
17187210|NCT01126749|38339851|FG002|Phase 2|Other|4|||
17187211|NCT01126749|38339852|FG003|Phase 2|Other|2|||
17187212|NCT01126749|38339849|FG000|Phase 2|Withdrawal by Subject|0|||
17187213|NCT01126749|38339850|FG001|Phase 2|Withdrawal by Subject|0|||
17187214|NCT01126749|38339851|FG002|Phase 2|Withdrawal by Subject|0|||
17187215|NCT01126749|38339852|FG003|Phase 2|Withdrawal by Subject|2|||
17187216|NCT01126749|38339849|FG000|Phase 2|Lost to Follow-up|0|||
17187217|NCT01126749|38339850|FG001|Phase 2|Lost to Follow-up|0|||
17187218|NCT01126749|38339851|FG002|Phase 2|Lost to Follow-up|0|||
17187219|NCT01126749|38339852|FG003|Phase 2|Lost to Follow-up|1|||
16997167|NCT00758524|38141146|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
16997168|NCT00758524|38141147|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997169|NCT00758524|38141148|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997170|NCT00758524|38141149|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997171|NCT00758524|38141150|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997172|NCT00758524|38141151|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997173|NCT00758524|38141152|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997174|NCT00758524|38141153|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997175|NCT00758524|38141154|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997176|NCT00758524|38141155|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997177|NCT00758524|38141156|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16997178|NCT00757588|38141196|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
16997179|NCT00757588|38141197|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
16997180|NCT00757588|38141196|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
16997181|NCT00757588|38141197|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
16997182|NCT00757588|38141196|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
16997183|NCT00757588|38141197|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
16997184|NCT00757588|38141196|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
16997185|NCT00757588|38141197|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
16997186|NCT00757588|38141196|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
16997187|NCT00757588|38141197|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
16997188|NCT00757588|38141196|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
16997189|NCT00757588|38141197|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
16997190|NCT00757588|38141196|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
16997191|NCT00757588|38141197|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
16997192|NCT00757588|38141196|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
16997193|NCT00757588|38141197|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
16997194|NCT00757588|38141196|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
16997195|NCT00757588|38141197|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
16997196|NCT00757588|38141196|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
16997197|NCT00757588|38141197|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
16997198|NCT00757588|38141196|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
16997199|NCT00757588|38141197|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
16997200|NCT00757588|38141196|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
16997201|NCT00757588|38141197|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
16997202|NCT00757588|38141196|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
16997203|NCT00757588|38141197|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
16997204|NCT00757588|38141196|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
16997205|NCT00757588|38141197|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
16997206|NCT00757588|38141196|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
16997207|NCT00757588|38141197|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
16997208|NCT00757588|38141196|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
16997209|NCT00757588|38141197|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
16997210|NCT00744796|38141203|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
16997211|NCT00705679|38141212|FG000|Overall Study|Adverse Event|1|||
16997212|NCT00705679|38141213|FG001|Overall Study|Adverse Event|1|||
16997213|NCT00705679|38141214|FG002|Overall Study|Adverse Event|0|||
16997214|NCT00705679|38141215|FG003|Overall Study|Adverse Event|0|||
16997215|NCT00705679|38141216|FG004|Overall Study|Adverse Event|0|||
16997216|NCT00705679|38141212|FG000|Overall Study|Death|0|||
16997217|NCT00705679|38141213|FG001|Overall Study|Death|0|||
16997218|NCT00705679|38141214|FG002|Overall Study|Death|3|||
17187220|NCT01126749|38339849|FG000|Phase 2|Death|0|||
17187221|NCT01126749|38339850|FG001|Phase 2|Death|0|||
17187222|NCT01126749|38339851|FG002|Phase 2|Death|22|||
17187223|NCT01126749|38339852|FG003|Phase 2|Death|22|||
17187224|NCT01126749|38339849|FG000|Phase 2|Adverse Event|0|||
17187225|NCT01126749|38339850|FG001|Phase 2|Adverse Event|0|||
17187226|NCT01126749|38339851|FG002|Phase 2|Adverse Event|0|||
17187227|NCT01126749|38339852|FG003|Phase 2|Adverse Event|1|||
17187228|NCT02521948|38339862|FG000|Overall Study|Adverse Event|2|||
17187229|NCT02521948|38339862|FG000|Overall Study|Death|4|||
17187230|NCT02521948|38339862|FG000|Overall Study|Lost to Follow-up|1|||
17187231|NCT02521948|38339862|FG000|Overall Study|Did not attend one or both follow-ups|6|||
17187232|NCT04446429|38339871|FG000|Overall Study|Lost to Follow-up|6|||
17187233|NCT04446429|38339872|FG001|Overall Study|Lost to Follow-up|0|||
17187234|NCT02832687|38339880|FG000|Overall Study|Adverse Event|0|||
17187235|NCT02832687|38339881|FG001|Overall Study|Adverse Event|2|||
17187236|NCT01656850|38339906|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
17187237|NCT01656850|38339907|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
17187238|NCT03116685|38339919|FG000|Overall Study|Physician Decision|0|||
17187239|NCT03116685|38339920|FG001|Overall Study|Physician Decision|1|||
17187240|NCT02666222|38339940|FG000|Overall Study|Death|2|||
17187241|NCT00739401|38339944|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
17187242|NCT00739401|38339944|FG000|Overall Study|Death|3|||
17187243|NCT00739401|38339944|FG000|Overall Study|Withdrawal by Subject|4|||
17187244|NCT01365052|38339950|FG000|Overall Study|Adverse Event|4|||
17187245|NCT01365052|38339951|FG001|Overall Study|Adverse Event|4|||
17187246|NCT01372748|38339959|FG000|Overall Study|Lost to Follow-up|16|||
17187247|NCT01372748|38339960|FG001|Overall Study|Lost to Follow-up|34|||
17187248|NCT01372748|38339959|FG000|Overall Study|Withdrawal by Subject|7|||
17187249|NCT01372748|38339960|FG001|Overall Study|Withdrawal by Subject|5|||
17187250|NCT02268851|38339972|FG000|Overall Study|Death|0|||
17187251|NCT02268851|38339973|FG001|Overall Study|Death|0|||
17187252|NCT02268851|38339974|FG002|Overall Study|Death|0|||
17187253|NCT02268851|38339975|FG003|Overall Study|Death|1|||
17187254|NCT02268851|38339976|FG004|Overall Study|Death|2|||
17187255|NCT02268851|38339977|FG005|Overall Study|Death|1|||
17187256|NCT02268851|38339972|FG000|Overall Study|Adverse Event|0|||
17187257|NCT02268851|38339973|FG001|Overall Study|Adverse Event|0|||
17187258|NCT02268851|38339974|FG002|Overall Study|Adverse Event|0|||
17187259|NCT02268851|38339975|FG003|Overall Study|Adverse Event|0|||
17187260|NCT02268851|38339976|FG004|Overall Study|Adverse Event|2|||
17187261|NCT02268851|38339977|FG005|Overall Study|Adverse Event|2|||
17187262|NCT02268851|38339972|FG000|Overall Study|Withdrawal by Subject|0|||
17187263|NCT02268851|38339973|FG001|Overall Study|Withdrawal by Subject|0|||
17187264|NCT02268851|38339974|FG002|Overall Study|Withdrawal by Subject|0|||
17187265|NCT02268851|38339975|FG003|Overall Study|Withdrawal by Subject|2|||
17187266|NCT02268851|38339976|FG004|Overall Study|Withdrawal by Subject|0|||
17187267|NCT02268851|38339977|FG005|Overall Study|Withdrawal by Subject|1|||
17187268|NCT02268851|38339972|FG000|Overall Study|Progressive Disease|1|||
17187269|NCT02268851|38339973|FG001|Overall Study|Progressive Disease|3|||
17187270|NCT02268851|38339974|FG002|Overall Study|Progressive Disease|0|||
17187271|NCT02268851|38339975|FG003|Overall Study|Progressive Disease|0|||
17187272|NCT02268851|38339976|FG004|Overall Study|Progressive Disease|1|||
17187273|NCT02268851|38339977|FG005|Overall Study|Progressive Disease|4|||
17187274|NCT02268851|38339972|FG000|Overall Study|Physician Decision|0|||
17187275|NCT02268851|38339973|FG001|Overall Study|Physician Decision|0|||
17187276|NCT02268851|38339974|FG002|Overall Study|Physician Decision|1|||
17187277|NCT02268851|38339975|FG003|Overall Study|Physician Decision|0|||
17187278|NCT02268851|38339976|FG004|Overall Study|Physician Decision|0|||
17187279|NCT02268851|38339977|FG005|Overall Study|Physician Decision|1|||
17187280|NCT02268851|38339972|FG000|Overall Study|Patient Compliance|0|||
17187281|NCT02268851|38339973|FG001|Overall Study|Patient Compliance|0|||
17187282|NCT02268851|38339974|FG002|Overall Study|Patient Compliance|0|||
17187283|NCT02268851|38339975|FG003|Overall Study|Patient Compliance|0|||
17187284|NCT02268851|38339976|FG004|Overall Study|Patient Compliance|1|||
17187285|NCT02268851|38339977|FG005|Overall Study|Patient Compliance|1|||
17187286|NCT02268851|38339972|FG000|Overall Study|Co-Morbid Condition|0|||
17187287|NCT02268851|38339973|FG001|Overall Study|Co-Morbid Condition|0|||
17187288|NCT02268851|38339974|FG002|Overall Study|Co-Morbid Condition|0|||
17187289|NCT02268851|38339975|FG003|Overall Study|Co-Morbid Condition|0|||
17187290|NCT02268851|38339976|FG004|Overall Study|Co-Morbid Condition|1|||
17187291|NCT02268851|38339977|FG005|Overall Study|Co-Morbid Condition|1|||
17187292|NCT02736825|38339993|FG000|Overall Study|Lost to Follow-up|10|||
17187293|NCT02736825|38339994|FG001|Overall Study|Lost to Follow-up|11|||
17187294|NCT02736825|38339993|FG000|Overall Study|Early Termination|0|||
17187295|NCT02736825|38339994|FG001|Overall Study|Early Termination|1|||
17187296|NCT02670122|38340001|FG000|Overall Study|Lost to Follow-up|4|||
17187297|NCT03283371|38340014|FG000|Placebo-controlled|Adverse Event|1|||
17187298|NCT03283371|38340015|FG001|Placebo-controlled|Adverse Event|1|||
17187299|NCT03283371|38340016|FG002|Placebo-controlled|Adverse Event|0|||
17187300|NCT03283371|38340017|FG003|Placebo-controlled|Adverse Event|0|||
17187301|NCT03283371|38340014|FG000|Placebo-controlled|Lack of Efficacy|1|||
17187302|NCT03283371|38340015|FG001|Placebo-controlled|Lack of Efficacy|0|||
17187303|NCT03283371|38340016|FG002|Placebo-controlled|Lack of Efficacy|0|||
17187304|NCT03283371|38340017|FG003|Placebo-controlled|Lack of Efficacy|0|||
17187305|NCT03283371|38340014|FG000|Placebo-controlled|Withdrawal by Subject|1|||
17187306|NCT03283371|38340015|FG001|Placebo-controlled|Withdrawal by Subject|1|||
17187307|NCT03283371|38340016|FG002|Placebo-controlled|Withdrawal by Subject|0|||
17187308|NCT03283371|38340017|FG003|Placebo-controlled|Withdrawal by Subject|0|||
17187309|NCT03283371|38340014|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
17187310|NCT03283371|38340015|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
17187311|NCT03283371|38340016|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
17187312|NCT03283371|38340017|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
17187313|NCT03283371|38340014|FG000|Open-label Phase|Adverse Event|0|||
17187314|NCT03283371|38340015|FG001|Open-label Phase|Adverse Event|0|||
17187315|NCT03283371|38340016|FG002|Open-label Phase|Adverse Event|2|||
17187316|NCT03283371|38340017|FG003|Open-label Phase|Adverse Event|0|||
17187317|NCT03283371|38340014|FG000|Open-label Phase|Withdrawal by Subject|0|||
17187318|NCT03283371|38340015|FG001|Open-label Phase|Withdrawal by Subject|0|||
17187319|NCT03283371|38340016|FG002|Open-label Phase|Withdrawal by Subject|1|||
17187320|NCT03283371|38340017|FG003|Open-label Phase|Withdrawal by Subject|0|||
17187321|NCT03283371|38340014|FG000|Open-label Phase|Other|0|||
17187322|NCT03283371|38340015|FG001|Open-label Phase|Other|0|||
17187323|NCT03283371|38340016|FG002|Open-label Phase|Other|1|||
17187324|NCT03283371|38340017|FG003|Open-label Phase|Other|1|||
17187325|NCT03069417|38340029|FG000|Overall Study|Lost to Follow-up|2|||
17187326|NCT03069417|38340030|FG001|Overall Study|Lost to Follow-up|0|||
17187327|NCT03069417|38340029|FG000|Overall Study|Reason Unknown|4|||
17187328|NCT03069417|38340030|FG001|Overall Study|Reason Unknown|7|||
17187329|NCT04930263|38340048|FG000|Overall Study|Withdrawal by Subject|3|||
17187330|NCT04930263|38340049|FG001|Overall Study|Withdrawal by Subject|5|||
17187331|NCT02665286|38340058|FG000|Overall Study|Lost to Follow-up|3|||
17187332|NCT02665286|38340059|FG001|Overall Study|Lost to Follow-up|2|||
17187333|NCT02665286|38340060|FG002|Overall Study|Lost to Follow-up|1|||
17187334|NCT02158091|38340071|FG000|Overall Study|DLT|2|||
17187335|NCT02158091|38340072|FG001|Overall Study|DLT|1|||
17187336|NCT02158091|38340073|FG002|Overall Study|DLT|0|||
17187337|NCT02134925|38340083|FG000|Overall Study|Withdrawal by Subject|1|||
17187338|NCT02134925|38340084|FG001|Overall Study|Withdrawal by Subject|0|||
17187339|NCT02134925|38340083|FG000|Overall Study|Cancel|1|||
17187340|NCT02134925|38340084|FG001|Overall Study|Cancel|6|||
17187341|NCT02910583|38340092|FG000|Overall Study|Withdrawal by Subject|6|||
17187342|NCT02910583|38340093|FG001|Overall Study|Withdrawal by Subject|7|||
17187343|NCT02910583|38340092|FG000|Overall Study|Other, Not Specified|1|||
17187344|NCT02910583|38340093|FG001|Overall Study|Other, Not Specified|0|||
17187345|NCT02911519|38340129|FG000|Overall Study|Lost to Follow-up|2|||
17187346|NCT02911519|38340130|FG001|Overall Study|Lost to Follow-up|2|||
17187347|NCT02911519|38340129|FG000|Overall Study|Death|0|||
17187348|NCT02911519|38340130|FG001|Overall Study|Death|2|||
17187349|NCT02911285|38340138|FG000|Overall Study|Lost to Follow-up|8|||
17187350|NCT02911285|38340139|FG001|Overall Study|Lost to Follow-up|5|||
17187351|NCT02911285|38340138|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
17187352|NCT02911285|38340139|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
17187353|NCT02910739|38340151|FG000|Overall Study|Adverse Event|1|||
17187354|NCT02910739|38340152|FG001|Overall Study|Adverse Event|0|||
17187355|NCT02910739|38340153|FG002|Overall Study|Adverse Event|0|||
17187356|NCT02910739|38340154|FG003|Overall Study|Adverse Event|0|||
17187357|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
17187358|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
17187359|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
17187360|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
17187361|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
17187362|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
17187363|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
17187364|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
17187365|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
17187366|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
17187367|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
17187368|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
17187369|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
17187370|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
17187371|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
17187372|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
16997219|NCT00705679|38141215|FG003|Overall Study|Death|2|||
17187373|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
17187374|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
17187375|NCT01069939|38340162|FG000|Randomised and Included in the Analyses|Removal|1|||
17187376|NCT01069939|38340163|FG001|Randomised and Included in the Analyses|Removal|0|||
17187377|NCT01069705|38340169|FG000|Overall Study|Adverse Event|1|||
17187378|NCT01069705|38340169|FG000|Overall Study|Withdrawal by Subject|2|||
17187379|NCT01069627|38340173|FG000|Overall Study|Disease progression|7|||
17187380|NCT01069627|38340173|FG000|Overall Study|Adverse Event|12|||
17187381|NCT01069627|38340173|FG000|Overall Study|Protocol Violation|1|||
17187382|NCT02422797|38340179|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
17187383|NCT02422797|38340180|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
17187384|NCT02422797|38340179|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
17187385|NCT02422797|38340180|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
17187386|NCT02422797|38340179|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
17187387|NCT02422797|38340180|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
17187388|NCT02422797|38340179|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
17187389|NCT02422797|38340180|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
17187390|NCT02422797|38340179|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
17187391|NCT02422797|38340180|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
17187392|NCT02422797|38340179|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
17187393|NCT02422797|38340180|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
17187394|NCT02422797|38340179|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
17187395|NCT02422797|38340180|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
17187396|NCT02422797|38340179|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
17187397|NCT02422797|38340180|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
17187398|NCT02422797|38340179|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
17187399|NCT02422797|38340180|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
17187400|NCT02422797|38340179|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
17187401|NCT02422797|38340180|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
17187402|NCT02422797|38340179|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
17187403|NCT02422797|38340180|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
17187404|NCT02422797|38340179|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
17187405|NCT02422797|38340180|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
17187406|NCT02422797|38340179|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
17187407|NCT02422797|38340180|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
17187408|NCT02422797|38340179|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
16997220|NCT00705679|38141216|FG004|Overall Study|Death|1|||
16997221|NCT00705679|38141212|FG000|Overall Study|Lost to Follow-up|32|||
16997222|NCT00705679|38141213|FG001|Overall Study|Lost to Follow-up|60|||
16997223|NCT00705679|38141214|FG002|Overall Study|Lost to Follow-up|44|||
16997224|NCT00705679|38141215|FG003|Overall Study|Lost to Follow-up|30|||
16997225|NCT00705679|38141216|FG004|Overall Study|Lost to Follow-up|35|||
16997226|NCT00705679|38141212|FG000|Overall Study|Physician Decision|0|||
16997227|NCT00705679|38141213|FG001|Overall Study|Physician Decision|1|||
16997228|NCT00705679|38141214|FG002|Overall Study|Physician Decision|0|||
16997229|NCT00705679|38141215|FG003|Overall Study|Physician Decision|1|||
16997230|NCT00705679|38141216|FG004|Overall Study|Physician Decision|0|||
16997231|NCT00705679|38141212|FG000|Overall Study|Withdrawal by Subject|32|||
16997232|NCT00705679|38141213|FG001|Overall Study|Withdrawal by Subject|77|||
16997233|NCT00705679|38141214|FG002|Overall Study|Withdrawal by Subject|68|||
16997234|NCT00705679|38141215|FG003|Overall Study|Withdrawal by Subject|47|||
16997235|NCT00705679|38141216|FG004|Overall Study|Withdrawal by Subject|33|||
16997236|NCT00751348|38141239|FG000|Overall Study|Withdrawal by Subject|5|||
16997237|NCT00751348|38141240|FG001|Overall Study|Withdrawal by Subject|2|||
16997238|NCT00751348|38141239|FG000|Overall Study|Migration from study area|1|||
16997239|NCT00751348|38141240|FG001|Overall Study|Migration from study area|0|||
16997240|NCT00751114|38141248|FG000|Overall Study|Adverse Event|2|||
16997241|NCT00751114|38141249|FG001|Overall Study|Adverse Event|4|||
16997242|NCT00751114|38141248|FG000|Overall Study|Protocol Violation|8|||
16997243|NCT00751114|38141249|FG001|Overall Study|Protocol Violation|9|||
16997244|NCT00751114|38141248|FG000|Overall Study|Withdrawal by Subject|9|||
16997245|NCT00751114|38141249|FG001|Overall Study|Withdrawal by Subject|4|||
16997246|NCT00751114|38141248|FG000|Overall Study|Lost to Follow-up|4|||
16997247|NCT00751114|38141249|FG001|Overall Study|Lost to Follow-up|7|||
16997248|NCT00751114|38141248|FG000|Overall Study|Lack of Efficacy|0|||
16997249|NCT00751114|38141249|FG001|Overall Study|Lack of Efficacy|7|||
16997250|NCT00751114|38141248|FG000|Overall Study|Not Treated|13|||
16997251|NCT00751114|38141249|FG001|Overall Study|Not Treated|1|||
16997252|NCT00751114|38141248|FG000|Overall Study|Out of country for 2 months|1|||
16997253|NCT00751114|38141249|FG001|Overall Study|Out of country for 2 months|0|||
16997254|NCT00751114|38141248|FG000|Overall Study|Move to another city|1|||
16997255|NCT00751114|38141249|FG001|Overall Study|Move to another city|0|||
16997256|NCT00960440|38141259|FG000|Overall Study|Death|0|||
17187409|NCT02422797|38340180|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
17187410|NCT03021551|38340196|FG000|Overall Study|Equipment Issues|2|||
17187411|NCT03021551|38340196|FG000|Overall Study|Protocol Violation|1|||
17187412|NCT01585025|38340203|FG000|Overall Study|Withdrawal by Subject|0|||
17187413|NCT01585025|38340204|FG001|Overall Study|Withdrawal by Subject|3|||
17187414|NCT01585025|38340205|FG002|Overall Study|Withdrawal by Subject|4|||
17187415|NCT01068769|38340213|FG000|Overall Study|Ineligible|1|||
17187416|NCT02738151|38340238|FG000|Overall Study|Randomized but not treated|4|||
17187417|NCT02738151|38340239|FG001|Overall Study|Randomized but not treated|1|||
17187418|NCT02738151|38340238|FG000|Overall Study|Adverse Event|4|||
17187419|NCT02738151|38340239|FG001|Overall Study|Adverse Event|5|||
17187420|NCT02738151|38340238|FG000|Overall Study|Hypoglycemia|0|||
17187421|NCT02738151|38340239|FG001|Overall Study|Hypoglycemia|1|||
17187422|NCT02738151|38340238|FG000|Overall Study|Poor Compliance to Protocol|4|||
17187423|NCT02738151|38340239|FG001|Overall Study|Poor Compliance to Protocol|3|||
17187424|NCT02738151|38340238|FG000|Overall Study|Other than specified above|11|||
17187425|NCT02738151|38340239|FG001|Overall Study|Other than specified above|21|||
17187426|NCT02993731|38340247|FG000|Overall Study|Study Termination|101|||
17187427|NCT02993731|38340248|FG001|Overall Study|Study Termination|105|||
17187428|NCT02915159|38340266|FG000|Overall Study|Participant no longer meets criteria|2|||
17187429|NCT02915159|38340267|FG001|Overall Study|Participant no longer meets criteria|0|||
17187430|NCT02915159|38340266|FG000|Overall Study|poor/non-compliance|1|||
17187431|NCT02915159|38340267|FG001|Overall Study|poor/non-compliance|0|||
17187432|NCT02915159|38340266|FG000|Overall Study|Participant withdrew consent|5|||
17187433|NCT02915159|38340267|FG001|Overall Study|Participant withdrew consent|1|||
17187434|NCT02915159|38340266|FG000|Overall Study|Request to discontinue treatment|1|||
17187435|NCT02915159|38340267|FG001|Overall Study|Request to discontinue treatment|2|||
17187436|NCT02915159|38340266|FG000|Overall Study|Adverse Event|2|||
17187437|NCT02915159|38340267|FG001|Overall Study|Adverse Event|2|||
17187438|NCT02915159|38340266|FG000|Overall Study|Lack of Efficacy|0|||
17187439|NCT02915159|38340267|FG001|Overall Study|Lack of Efficacy|3|||
17187440|NCT02924051|38340279|FG000|Overall Study|Withdrawal by Subject|1|||
17187441|NCT02924051|38340280|FG001|Overall Study|Withdrawal by Subject|9|||
17187442|NCT02923427|38340290|FG000|Overall Study|convert to laparatomy|2|||
17187443|NCT02923427|38340291|FG001|Overall Study|convert to laparatomy|2|||
16997257|NCT00960440|38141260|FG001|Overall Study|Death|0|||
16997258|NCT00960440|38141261|FG002|Overall Study|Death|0|||
16997259|NCT00960440|38141262|FG003|Overall Study|Death|1|||
16997260|NCT00960440|38141259|FG000|Overall Study|Adverse Event|12|||
16997261|NCT00960440|38141260|FG001|Overall Study|Adverse Event|12|||
16997262|NCT00960440|38141261|FG002|Overall Study|Adverse Event|4|||
16997263|NCT00960440|38141262|FG003|Overall Study|Adverse Event|4|||
16997264|NCT00960440|38141259|FG000|Overall Study|Lack of Efficacy|2|||
16997265|NCT00960440|38141260|FG001|Overall Study|Lack of Efficacy|5|||
16997266|NCT00960440|38141261|FG002|Overall Study|Lack of Efficacy|3|||
16997267|NCT00960440|38141262|FG003|Overall Study|Lack of Efficacy|8|||
16997268|NCT00960440|38141259|FG000|Overall Study|Protocol Violation|2|||
16997269|NCT00960440|38141260|FG001|Overall Study|Protocol Violation|8|||
16997270|NCT00960440|38141261|FG002|Overall Study|Protocol Violation|3|||
16997271|NCT00960440|38141262|FG003|Overall Study|Protocol Violation|4|||
16997272|NCT00960440|38141259|FG000|Overall Study|Withdrawal by Subject|9|||
16997273|NCT00960440|38141260|FG001|Overall Study|Withdrawal by Subject|5|||
16997274|NCT00960440|38141261|FG002|Overall Study|Withdrawal by Subject|2|||
16997275|NCT00960440|38141262|FG003|Overall Study|Withdrawal by Subject|1|||
16997276|NCT00960440|38141259|FG000|Overall Study|Other|1|||
16997277|NCT00960440|38141260|FG001|Overall Study|Other|1|||
16997278|NCT00960440|38141261|FG002|Overall Study|Other|1|||
16997279|NCT00960440|38141262|FG003|Overall Study|Other|0|||
16997280|NCT00964028|38141276|FG000|Overall Study|Withdrawal by Subject|0|||
17187444|NCT02923427|38340290|FG000|Overall Study|destaturation|1|||
17187445|NCT02923427|38340291|FG001|Overall Study|destaturation|0|||
17187446|NCT02923427|38340290|FG000|Overall Study|can not replace LMA|1|||
17187447|NCT02923427|38340291|FG001|Overall Study|can not replace LMA|0|||
17187448|NCT02669264|38340304|FG000|Overall Study|Death|5|||
17187449|NCT02669264|38340305|FG001|Overall Study|Death|5|||
17187450|NCT02669264|38340306|FG002|Overall Study|Death|3|||
17187451|NCT02669264|38340307|FG003|Overall Study|Death|3|||
17187452|NCT02669264|38340308|FG004|Overall Study|Death|3|||
17187453|NCT02669264|38340309|FG005|Overall Study|Death|6|||
17187454|NCT02669264|38340310|FG006|Overall Study|Death|3|||
17187455|NCT02669264|38340304|FG000|Overall Study|Withdrawal by Subject|0|||
17187456|NCT02669264|38340305|FG001|Overall Study|Withdrawal by Subject|1|||
17187457|NCT02669264|38340306|FG002|Overall Study|Withdrawal by Subject|0|||
17187458|NCT02669264|38340307|FG003|Overall Study|Withdrawal by Subject|0|||
17187459|NCT02669264|38340308|FG004|Overall Study|Withdrawal by Subject|1|||
17187460|NCT02669264|38340309|FG005|Overall Study|Withdrawal by Subject|0|||
17187461|NCT02669264|38340310|FG006|Overall Study|Withdrawal by Subject|0|||
17187462|NCT02669264|38340304|FG000|Overall Study|Lost to Follow-up|0|||
17187463|NCT02669264|38340305|FG001|Overall Study|Lost to Follow-up|0|||
17187464|NCT02669264|38340306|FG002|Overall Study|Lost to Follow-up|0|||
17187465|NCT02669264|38340307|FG003|Overall Study|Lost to Follow-up|0|||
17187466|NCT02669264|38340308|FG004|Overall Study|Lost to Follow-up|1|||
17187467|NCT02669264|38340309|FG005|Overall Study|Lost to Follow-up|0|||
17187468|NCT02669264|38340310|FG006|Overall Study|Lost to Follow-up|0|||
17187469|NCT02669264|38340304|FG000|Overall Study|Miscellaneous|0|||
17187470|NCT02669264|38340305|FG001|Overall Study|Miscellaneous|0|||
17187471|NCT02669264|38340306|FG002|Overall Study|Miscellaneous|0|||
17187472|NCT02669264|38340307|FG003|Overall Study|Miscellaneous|0|||
17187473|NCT02669264|38340308|FG004|Overall Study|Miscellaneous|0|||
17187474|NCT02669264|38340309|FG005|Overall Study|Miscellaneous|0|||
17187475|NCT02669264|38340310|FG006|Overall Study|Miscellaneous|2|||
17187476|NCT02521870|38340336|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187477|NCT02521870|38340337|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
17187478|NCT02521870|38340338|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187479|NCT02521870|38340339|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187480|NCT02521870|38340340|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187481|NCT02521870|38340341|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187482|NCT02521870|38340342|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187483|NCT02521870|38340343|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187484|NCT02521870|38340344|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187485|NCT02521870|38340345|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187486|NCT02521870|38340346|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187487|NCT02521870|38340347|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
17187488|NCT02521870|38340336|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
17187489|NCT02521870|38340337|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
17187490|NCT02521870|38340338|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
17187491|NCT02521870|38340339|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
17187492|NCT02521870|38340340|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
17187493|NCT02521870|38340341|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
17187494|NCT02521870|38340342|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
17187495|NCT02521870|38340343|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
17187496|NCT02521870|38340344|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
17187497|NCT02521870|38340345|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
17187498|NCT02521870|38340346|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
17187499|NCT02521870|38340347|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
17187500|NCT02521870|38340336|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
17187501|NCT02521870|38340337|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
17187502|NCT02521870|38340338|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
17187503|NCT02521870|38340339|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
17187504|NCT02521870|38340340|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
17187505|NCT02521870|38340341|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
17187506|NCT02521870|38340342|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
17187507|NCT02521870|38340343|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
17187508|NCT02521870|38340344|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
17187509|NCT02521870|38340345|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
17187510|NCT02521870|38340346|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
17187511|NCT02521870|38340347|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
16997281|NCT00964028|38141277|FG001|Overall Study|Withdrawal by Subject|1|||
16997282|NCT00960206|38141286|FG000|Overall Study|Death|7|||
17187512|NCT02521870|38340336|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
17187513|NCT02521870|38340337|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
17187514|NCT02521870|38340338|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
17187515|NCT02521870|38340339|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
17187516|NCT02521870|38340340|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
17187517|NCT02521870|38340341|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
17187518|NCT02521870|38340342|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
17187519|NCT02521870|38340343|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
17187520|NCT02521870|38340344|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
17187521|NCT02521870|38340345|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
17187522|NCT02521870|38340346|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
17187523|NCT02521870|38340347|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
17187524|NCT02521870|38340336|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
17187525|NCT02521870|38340337|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
17187526|NCT02521870|38340338|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
17187527|NCT02521870|38340339|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
17187528|NCT02521870|38340340|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
17187529|NCT02521870|38340341|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
17187530|NCT02521870|38340342|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
17187531|NCT02521870|38340343|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
17187532|NCT02521870|38340344|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
17187533|NCT02521870|38340345|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
17187534|NCT02521870|38340346|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
17187535|NCT02521870|38340347|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
17187536|NCT02521870|38340336|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
17187537|NCT02521870|38340337|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
17187538|NCT02521870|38340338|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
17187539|NCT02521870|38340339|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
17187540|NCT02521870|38340340|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
17187541|NCT02521870|38340341|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
17187542|NCT02521870|38340342|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
17187543|NCT02521870|38340343|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
17187544|NCT02521870|38340344|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
17187545|NCT02521870|38340345|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
17187546|NCT02521870|38340346|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
17187547|NCT02521870|38340347|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
17187548|NCT02521870|38340336|FG000|Phase 2: Dose Expansion|Death|0|||
17187549|NCT02521870|38340337|FG001|Phase 2: Dose Expansion|Death|0|||
17187550|NCT02521870|38340338|FG002|Phase 2: Dose Expansion|Death|0|||
17187551|NCT02521870|38340339|FG003|Phase 2: Dose Expansion|Death|0|||
17187552|NCT02521870|38340340|FG004|Phase 2: Dose Expansion|Death|1|||
17187553|NCT02521870|38340341|FG005|Phase 2: Dose Expansion|Death|1|||
17187554|NCT02521870|38340342|FG006|Phase 2: Dose Expansion|Death|3|||
17187555|NCT02521870|38340343|FG007|Phase 2: Dose Expansion|Death|1|||
17187556|NCT02521870|38340344|FG008|Phase 2: Dose Expansion|Death|1|||
17187557|NCT02521870|38340345|FG009|Phase 2: Dose Expansion|Death|5|||
17187558|NCT02521870|38340346|FG010|Phase 2: Dose Expansion|Death|2|||
17187559|NCT02521870|38340347|FG011|Phase 2: Dose Expansion|Death|2|||
17187560|NCT02521870|38340336|FG000|Phase 2: Dose Expansion|Other|0|||
17187561|NCT02521870|38340337|FG001|Phase 2: Dose Expansion|Other|0|||
17187562|NCT02521870|38340338|FG002|Phase 2: Dose Expansion|Other|0|||
17187563|NCT02521870|38340339|FG003|Phase 2: Dose Expansion|Other|0|||
17187564|NCT02521870|38340340|FG004|Phase 2: Dose Expansion|Other|10|||
17187565|NCT02521870|38340341|FG005|Phase 2: Dose Expansion|Other|3|||
17187566|NCT02521870|38340342|FG006|Phase 2: Dose Expansion|Other|2|||
17187567|NCT02521870|38340343|FG007|Phase 2: Dose Expansion|Other|0|||
17187568|NCT02521870|38340344|FG008|Phase 2: Dose Expansion|Other|10|||
17187569|NCT02521870|38340345|FG009|Phase 2: Dose Expansion|Other|5|||
17187570|NCT02521870|38340346|FG010|Phase 2: Dose Expansion|Other|1|||
17187571|NCT02521870|38340347|FG011|Phase 2: Dose Expansion|Other|7|||
17187572|NCT02521870|38340336|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187573|NCT02521870|38340337|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187574|NCT02521870|38340338|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187575|NCT02521870|38340339|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187576|NCT02521870|38340340|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
17187577|NCT02521870|38340341|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187578|NCT02521870|38340342|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187579|NCT02521870|38340343|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187580|NCT02521870|38340344|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187581|NCT02521870|38340345|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187582|NCT02521870|38340346|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187583|NCT02521870|38340347|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
17187584|NCT02521870|38340336|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187585|NCT02521870|38340337|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187586|NCT02521870|38340338|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187587|NCT02521870|38340339|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187588|NCT02521870|38340340|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
17187589|NCT02521870|38340341|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187590|NCT02521870|38340342|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187591|NCT02521870|38340343|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187592|NCT02521870|38340344|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187593|NCT02521870|38340345|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187594|NCT02521870|38340346|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187595|NCT02521870|38340347|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
17187596|NCT02923349|38340384|FG000|Overall Study|Other|1|||
17187597|NCT02923349|38340385|FG001|Overall Study|Other|2|||
17187598|NCT02923349|38340386|FG002|Overall Study|Other|4|||
17187599|NCT02923349|38340387|FG003|Overall Study|Other|1|||
17187600|NCT02923349|38340388|FG004|Overall Study|Other|3|||
17187601|NCT02923349|38340389|FG005|Overall Study|Other|0|||
17187602|NCT02923349|38340390|FG006|Overall Study|Other|1|||
17187603|NCT02923349|38340384|FG000|Overall Study|Withdrawal by Subject|2|||
17187604|NCT02923349|38340385|FG001|Overall Study|Withdrawal by Subject|2|||
17187605|NCT02923349|38340386|FG002|Overall Study|Withdrawal by Subject|8|||
17187606|NCT02923349|38340387|FG003|Overall Study|Withdrawal by Subject|10|||
17187607|NCT02923349|38340388|FG004|Overall Study|Withdrawal by Subject|12|||
17187608|NCT02923349|38340389|FG005|Overall Study|Withdrawal by Subject|3|||
17187609|NCT02923349|38340390|FG006|Overall Study|Withdrawal by Subject|0|||
17187610|NCT02923349|38340384|FG000|Overall Study|Physician Decision|0|||
17187611|NCT02923349|38340385|FG001|Overall Study|Physician Decision|0|||
17187612|NCT02923349|38340386|FG002|Overall Study|Physician Decision|0|||
17187613|NCT02923349|38340387|FG003|Overall Study|Physician Decision|1|||
17187614|NCT02923349|38340388|FG004|Overall Study|Physician Decision|1|||
17187615|NCT02923349|38340389|FG005|Overall Study|Physician Decision|0|||
17187616|NCT02923349|38340390|FG006|Overall Study|Physician Decision|2|||
17187617|NCT02923349|38340384|FG000|Overall Study|Lost to Follow-up|0|||
17187618|NCT02923349|38340385|FG001|Overall Study|Lost to Follow-up|0|||
17187619|NCT02923349|38340386|FG002|Overall Study|Lost to Follow-up|3|||
17187620|NCT02923349|38340387|FG003|Overall Study|Lost to Follow-up|0|||
17187621|NCT02923349|38340388|FG004|Overall Study|Lost to Follow-up|1|||
17187622|NCT02923349|38340389|FG005|Overall Study|Lost to Follow-up|1|||
17187623|NCT02923349|38340390|FG006|Overall Study|Lost to Follow-up|0|||
17187624|NCT02923349|38340384|FG000|Overall Study|Death|1|||
17187625|NCT02923349|38340385|FG001|Overall Study|Death|0|||
17187626|NCT02923349|38340386|FG002|Overall Study|Death|2|||
17187627|NCT02923349|38340387|FG003|Overall Study|Death|4|||
17187628|NCT02923349|38340388|FG004|Overall Study|Death|2|||
17187629|NCT02923349|38340389|FG005|Overall Study|Death|3|||
17187630|NCT02923349|38340390|FG006|Overall Study|Death|0|||
17187631|NCT02521792|38340406|FG000|Overall Study|Study Terminated|6|||
17187632|NCT03020615|38340413|FG000|Overall Study|Physician Decision|3|||
17187633|NCT03020615|38340414|FG001|Overall Study|Physician Decision|1|||
17187634|NCT03020615|38340415|FG002|Overall Study|Physician Decision|2|||
17187635|NCT03020615|38340413|FG000|Overall Study|Parent/guardian/patient choice|3|||
17187636|NCT03020615|38340414|FG001|Overall Study|Parent/guardian/patient choice|0|||
17187637|NCT03020615|38340415|FG002|Overall Study|Parent/guardian/patient choice|4|||
17187638|NCT03020615|38340413|FG000|Overall Study|Screen failure|0|||
17187639|NCT03020615|38340414|FG001|Overall Study|Screen failure|0|||
17187640|NCT03020615|38340415|FG002|Overall Study|Screen failure|1|||
17187641|NCT03020615|38340413|FG000|Overall Study|Death|1|||
17187642|NCT03020615|38340414|FG001|Overall Study|Death|0|||
17187643|NCT03020615|38340415|FG002|Overall Study|Death|0|||
17187644|NCT03020615|38340413|FG000|Overall Study|Lost to Follow-up|0|||
17187645|NCT03020615|38340414|FG001|Overall Study|Lost to Follow-up|1|||
17187646|NCT03020615|38340415|FG002|Overall Study|Lost to Follow-up|0|||
17187647|NCT03020069|38340428|FG000|Overall Study|Lost to Follow-up|0|||
17187648|NCT03020069|38340429|FG001|Overall Study|Lost to Follow-up|1|||
17187649|NCT03693170|38340435|FG000|Overall Study|Disease Progression|48|||
17187650|NCT03693170|38340435|FG000|Overall Study|Adverse Event|16|||
17187651|NCT03693170|38340435|FG000|Overall Study|Physician Decision|6|||
17187652|NCT03693170|38340435|FG000|Overall Study|Protocol Violation|2|||
17187653|NCT03693170|38340435|FG000|Overall Study|Death|1|||
17187654|NCT03693170|38340435|FG000|Overall Study|Non compliance with study drug|1|||
17187655|NCT03693170|38340435|FG000|Overall Study|Withdrawal by Subject|1|||
17187656|NCT03021005|38340442|FG000|Overall Study|Lost to Follow-up|39|||
17187657|NCT03021005|38340443|FG001|Overall Study|Lost to Follow-up|26|||
17187658|NCT02914457|38340449|FG000|Overall Study|Withdrawal by Subject|1|||
17187659|NCT02914457|38340449|FG000|Overall Study|Physician Decision|1|||
17187660|NCT02914457|38340449|FG000|Overall Study|No veins available for lead placement|1|||
17187661|NCT02914457|38340449|FG000|Overall Study|Electrical instability of patient|1|||
17187662|NCT02914457|38340449|FG000|Overall Study|ECG acquisition error due to sweating|1|||
17187663|NCT02914457|38340449|FG000|Overall Study|Protocol Violation|1|||
17187664|NCT02665052|38340457|FG000|Overall Study|Lost to Follow-up|1|||
17187665|NCT02665052|38340458|FG001|Overall Study|Lost to Follow-up|0|||
17187666|NCT02665052|38340459|FG002|Overall Study|Lost to Follow-up|0|||
17187667|NCT02665052|38340460|FG003|Overall Study|Lost to Follow-up|0|||
17187668|NCT02665052|38340457|FG000|Overall Study|Withdrawal by Subject|1|||
17187669|NCT02665052|38340458|FG001|Overall Study|Withdrawal by Subject|1|||
17187670|NCT02665052|38340459|FG002|Overall Study|Withdrawal by Subject|0|||
17187671|NCT02665052|38340460|FG003|Overall Study|Withdrawal by Subject|5|||
17187672|NCT02665052|38340457|FG000|Overall Study|Adverse Event|1|||
17187673|NCT02665052|38340458|FG001|Overall Study|Adverse Event|1|||
17187674|NCT02665052|38340459|FG002|Overall Study|Adverse Event|0|||
17187675|NCT02665052|38340460|FG003|Overall Study|Adverse Event|0|||
17187676|NCT03019289|38340480|FG000|Overall Study|Adverse Event|1|||
17187677|NCT03019289|38340481|FG001|Overall Study|Adverse Event|0|||
17187678|NCT03019289|38340482|FG002|Overall Study|Adverse Event|0|||
17187679|NCT03019289|38340483|FG003|Overall Study|Adverse Event|0|||
17187680|NCT03019289|38340484|FG004|Overall Study|Adverse Event|0|||
17187681|NCT03019289|38340485|FG005|Overall Study|Adverse Event|0|||
17187682|NCT03019289|38340486|FG006|Overall Study|Adverse Event|0|||
17187683|NCT03019289|38340487|FG007|Overall Study|Adverse Event|0|||
17187684|NCT03019289|38340488|FG008|Overall Study|Adverse Event|1|||
17187685|NCT03019289|38340480|FG000|Overall Study|Other|1|||
17187686|NCT03019289|38340481|FG001|Overall Study|Other|0|||
17187687|NCT03019289|38340482|FG002|Overall Study|Other|0|||
17187688|NCT03019289|38340483|FG003|Overall Study|Other|0|||
17187689|NCT03019289|38340484|FG004|Overall Study|Other|0|||
17187690|NCT03019289|38340485|FG005|Overall Study|Other|0|||
17187691|NCT03019289|38340486|FG006|Overall Study|Other|0|||
17187692|NCT03019289|38340487|FG007|Overall Study|Other|0|||
17187693|NCT03019289|38340488|FG008|Overall Study|Other|0|||
17187694|NCT02520388|38340511|FG000|Overall Study|Physician Decision|1|||
17187695|NCT02520388|38340512|FG001|Overall Study|Physician Decision|0|||
17187696|NCT02520388|38340511|FG000|Overall Study|Subject or parent/guardian request|0|||
17187697|NCT02520388|38340512|FG001|Overall Study|Subject or parent/guardian request|6|||
17187698|NCT02520388|38340511|FG000|Overall Study|Adverse Event|1|||
17187699|NCT02520388|38340512|FG001|Overall Study|Adverse Event|4|||
17187700|NCT02520388|38340511|FG000|Overall Study|Lost to Follow-up|3|||
17187701|NCT02520388|38340512|FG001|Overall Study|Lost to Follow-up|2|||
17089704|NCT00282984|38229817|FG000|Overall Study|lack of motivation|1|||
17089705|NCT00282984|38229818|FG001|Overall Study|lack of motivation|0|||
17089706|NCT00282984|38229817|FG000|Overall Study|in prison|0|||
17089707|NCT00282984|38229818|FG001|Overall Study|in prison|1|||
17089708|NCT00282984|38229817|FG000|Overall Study|Protocol Violation|2|||
17089709|NCT00282984|38229818|FG001|Overall Study|Protocol Violation|0|||
17089710|NCT00282438|38229826|FG000|Overall Study|Lack of Efficacy|1|||
17089711|NCT00282438|38229827|FG001|Overall Study|Lack of Efficacy|0|||
17089712|NCT00282438|38229826|FG000|Overall Study|Death|0|||
17089713|NCT00282438|38229827|FG001|Overall Study|Death|1|||
17089714|NCT00296400|38229836|FG000|Overall Study|Adverse Event|7|||
17089715|NCT00296400|38229837|FG001|Overall Study|Adverse Event|7|||
17089716|NCT00296400|38229838|FG002|Overall Study|Adverse Event|7|||
17187702|NCT02520388|38340511|FG000|Overall Study|Other (reason not defined)|4|||
17187703|NCT02520388|38340512|FG001|Overall Study|Other (reason not defined)|4|||
17187704|NCT02924129|38340520|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
17187705|NCT02924129|38340521|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
17187706|NCT02924129|38340520|FG000|Overall Study|Withdrawal by Subject|2|||
17187707|NCT02924129|38340521|FG001|Overall Study|Withdrawal by Subject|2|||
17089717|NCT00296400|38229836|FG000|Overall Study|Withdrawal by Subject|5|||
17089718|NCT00296400|38229837|FG001|Overall Study|Withdrawal by Subject|6|||
17089719|NCT00296400|38229838|FG002|Overall Study|Withdrawal by Subject|2|||
17187708|NCT02924129|38340520|FG000|Overall Study|Physician Decision|1|||
17187709|NCT02924129|38340521|FG001|Overall Study|Physician Decision|0|||
17187710|NCT02924129|38340520|FG000|Overall Study|Missed Visit|0|||
17187711|NCT02924129|38340521|FG001|Overall Study|Missed Visit|1|||
17187712|NCT02668640|38340527|FG000|Overall Study|Lost to Follow-up|13|||
17187713|NCT02668640|38340527|FG000|Overall Study|Other, not specified|1|||
17187714|NCT03014453|38340531|FG000|Overall Study|Lost to Follow-up|12|||
17187715|NCT03014453|38340531|FG000|Overall Study|Discontinued GER|3|||
17187716|NCT03014453|38340531|FG000|Overall Study|Excluded|19|||
17187717|NCT03014453|38340531|FG000|Overall Study|Refused to take part in|37|||
17187718|NCT02664272|38340535|FG000|Overall Study|Fluoroscopic images not made available|2|||
17187719|NCT02663882|38340541|FG000|Overall Study|Lost to Follow-up|4|||
17187720|NCT02663882|38340542|FG001|Overall Study|Lost to Follow-up|2|||
17187721|NCT03011333|38340555|FG000|Overall Study|Lost to Follow-up|0|||
16997283|NCT00960206|38141287|FG001|Overall Study|Death|4|||
17089720|NCT00296400|38229836|FG000|Overall Study|Incorrect enrollment|2|||
17089721|NCT00296400|38229837|FG001|Overall Study|Incorrect enrollment|0|||
17187722|NCT03011333|38340556|FG001|Overall Study|Lost to Follow-up|1|||
17187723|NCT03011333|38340557|FG002|Overall Study|Lost to Follow-up|0|||
17187724|NCT03011333|38340558|FG003|Overall Study|Lost to Follow-up|1|||
17187725|NCT03011333|38340559|FG004|Overall Study|Lost to Follow-up|4|||
17187726|NCT03011333|38340560|FG005|Overall Study|Lost to Follow-up|4|||
17089722|NCT00296400|38229838|FG002|Overall Study|Incorrect enrollment|0|||
17089723|NCT00296400|38229836|FG000|Overall Study|Protocol Violation|1|||
17187727|NCT03011333|38340561|FG006|Overall Study|Lost to Follow-up|5|||
17187728|NCT03011099|38340579|FG000|Overall Study|Withdrawal by Subject|0|||
17187729|NCT03011099|38340580|FG001|Overall Study|Withdrawal by Subject|2|||
17187730|NCT03013985|38340590|FG000|Overall Study|Protocol Violation|2|||
17187731|NCT03013985|38340591|FG001|Overall Study|Protocol Violation|2|||
17187732|NCT03013985|38340590|FG000|Overall Study|Withdrawal by Subject|14|||
17187733|NCT03013985|38340591|FG001|Overall Study|Withdrawal by Subject|17|||
17187734|NCT03016403|38340601|FG000|Baseline|Death|5|||
17187735|NCT03016403|38340602|FG001|Baseline|Death|8|||
17187736|NCT03016403|38340603|FG002|Baseline|Death|1|||
17187737|NCT03016403|38340604|FG003|Baseline|Death|0|||
17187738|NCT03016403|38340601|FG000|Baseline|Withdrawal by Subject|2|||
17187739|NCT03016403|38340602|FG001|Baseline|Withdrawal by Subject|8|||
17187740|NCT03016403|38340603|FG002|Baseline|Withdrawal by Subject|4|||
17187741|NCT03016403|38340604|FG003|Baseline|Withdrawal by Subject|10|||
17187742|NCT03016403|38340601|FG000|Baseline|Lost to Follow-up|9|||
17187743|NCT03016403|38340602|FG001|Baseline|Lost to Follow-up|11|||
17187744|NCT03016403|38340603|FG002|Baseline|Lost to Follow-up|6|||
17187745|NCT03016403|38340604|FG003|Baseline|Lost to Follow-up|24|||
17187746|NCT03016403|38340601|FG000|6-week Follow-up|Death|1|||
17187747|NCT03016403|38340602|FG001|6-week Follow-up|Death|4|||
17187748|NCT03016403|38340603|FG002|6-week Follow-up|Death|0|||
17187749|NCT03016403|38340604|FG003|6-week Follow-up|Death|0|||
17187750|NCT03016403|38340601|FG000|6-week Follow-up|Lost to Follow-up|2|||
17187751|NCT03016403|38340602|FG001|6-week Follow-up|Lost to Follow-up|7|||
17187752|NCT03016403|38340603|FG002|6-week Follow-up|Lost to Follow-up|4|||
17187753|NCT03016403|38340604|FG003|6-week Follow-up|Lost to Follow-up|8|||
17187754|NCT03016403|38340601|FG000|6-week Follow-up|Withdrawal by Subject|0|||
17187755|NCT03016403|38340602|FG001|6-week Follow-up|Withdrawal by Subject|2|||
17187756|NCT03016403|38340603|FG002|6-week Follow-up|Withdrawal by Subject|0|||
17187757|NCT03016403|38340604|FG003|6-week Follow-up|Withdrawal by Subject|1|||
17187758|NCT03016403|38340601|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
17187759|NCT03016403|38340602|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
17187760|NCT03016403|38340603|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
17187761|NCT03016403|38340604|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
17187762|NCT03016403|38340601|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
17187763|NCT03016403|38340602|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
17187764|NCT03016403|38340603|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
17187765|NCT03016403|38340604|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
17187766|NCT03016403|38340601|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
17187767|NCT03016403|38340602|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
17187768|NCT03016403|38340603|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
17187769|NCT03016403|38340604|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
17187770|NCT02520310|38340616|FG000|At 6 Months Clinical Follow-up|Death|1|||
17187771|NCT02520310|38340616|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
17187772|NCT02520310|38340616|FG000|AT 3 Year Clinical Follow-up|Death|2|||
17187773|NCT02520310|38340616|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
17187774|NCT02520310|38340616|FG000|AT 4 Year Clinical Follow-up|Death|1|||
17187775|NCT02520310|38340616|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
17187776|NCT02662556|38340622|FG000|Overall Study|Adverse Event|4|||
17187777|NCT02662556|38340622|FG000|Overall Study|Lack of Efficacy|4|||
17187778|NCT02516098|38340629|FG000|Period 1|Protocol Violation|1|||
17187779|NCT02516098|38340630|FG001|Period 1|Protocol Violation|0|||
17187780|NCT02516098|38340629|FG000|Washout After Period 1|Adverse Event|0|||
17187781|NCT02516098|38340630|FG001|Washout After Period 1|Adverse Event|1|||
17187782|NCT02516098|38340629|FG000|Period 2|Withdrawal by Subject|0|||
17187783|NCT02516098|38340630|FG001|Period 2|Withdrawal by Subject|1|||
17187784|NCT01364428|38340638|FG000|Overall Study|Adverse Event|1|||
17187785|NCT01364428|38340639|FG001|Overall Study|Adverse Event|2|||
17187786|NCT01364428|38340638|FG000|Overall Study|Protocol Violation|2|||
17187787|NCT01364428|38340639|FG001|Overall Study|Protocol Violation|0|||
17187788|NCT01364428|38340638|FG000|Overall Study|Withdrawal Criteria|14|||
17187789|NCT01364428|38340639|FG001|Overall Study|Withdrawal Criteria|10|||
17187790|NCT01364428|38340638|FG000|Overall Study|Other|3|||
17187791|NCT01364428|38340639|FG001|Overall Study|Other|3|||
17187792|NCT02515942|38340648|FG000|Overall Study|Adverse Event|5|||
17187793|NCT02515942|38340649|FG001|Overall Study|Adverse Event|0|||
17187794|NCT02515942|38340650|FG002|Overall Study|Adverse Event|0|||
17187795|NCT02515942|38340648|FG000|Overall Study|Death|0|||
17187796|NCT02515942|38340649|FG001|Overall Study|Death|0|||
17187797|NCT02515942|38340650|FG002|Overall Study|Death|1|||
17187798|NCT02515942|38340648|FG000|Overall Study|Lack of Efficacy|0|||
17187799|NCT02515942|38340649|FG001|Overall Study|Lack of Efficacy|0|||
17187800|NCT02515942|38340650|FG002|Overall Study|Lack of Efficacy|1|||
17187801|NCT02515942|38340648|FG000|Overall Study|Lost to Follow-up|2|||
17187802|NCT02515942|38340649|FG001|Overall Study|Lost to Follow-up|0|||
17187803|NCT02515942|38340650|FG002|Overall Study|Lost to Follow-up|0|||
17187804|NCT02515942|38340648|FG000|Overall Study|Withdrawal by Subject|0|||
17187805|NCT02515942|38340649|FG001|Overall Study|Withdrawal by Subject|3|||
17187806|NCT02515942|38340650|FG002|Overall Study|Withdrawal by Subject|2|||
17187807|NCT02991859|38340677|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187808|NCT02991859|38340678|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
17187809|NCT02991859|38340679|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187810|NCT02991859|38340680|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187811|NCT02991859|38340681|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
17187812|NCT02991859|38340682|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187813|NCT02991859|38340683|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187814|NCT02991859|38340684|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187815|NCT02991859|38340685|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187816|NCT02991859|38340686|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187817|NCT02991859|38340687|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187818|NCT02991859|38340688|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187819|NCT02991859|38340689|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187820|NCT02991859|38340690|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187821|NCT02991859|38340691|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187822|NCT02991859|38340692|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187823|NCT02991859|38340693|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
17187824|NCT02991859|38340677|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187825|NCT02991859|38340678|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187826|NCT02991859|38340679|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187827|NCT02991859|38340680|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187828|NCT02991859|38340681|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187829|NCT02991859|38340682|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187830|NCT02991859|38340683|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187831|NCT02991859|38340684|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187832|NCT02991859|38340685|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187833|NCT02991859|38340686|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187834|NCT02991859|38340687|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187835|NCT02991859|38340688|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187836|NCT02991859|38340689|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
17187837|NCT02991859|38340690|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
17187838|NCT02991859|38340691|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187839|NCT02991859|38340692|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187840|NCT02991859|38340693|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
17187841|NCT02991859|38340677|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187842|NCT02991859|38340678|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187843|NCT02991859|38340679|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187844|NCT02991859|38340680|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187845|NCT02991859|38340681|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187846|NCT02991859|38340682|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
17187847|NCT02991859|38340683|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187848|NCT02991859|38340684|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187849|NCT02991859|38340685|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187850|NCT02991859|38340686|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187851|NCT02991859|38340687|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187852|NCT02991859|38340688|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187853|NCT02991859|38340689|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187854|NCT02991859|38340690|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187855|NCT02991859|38340691|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187856|NCT02991859|38340692|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187857|NCT02991859|38340693|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
17187858|NCT02991859|38340677|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187859|NCT02991859|38340678|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187860|NCT02991859|38340679|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187861|NCT02991859|38340680|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187862|NCT02991859|38340681|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187863|NCT02991859|38340682|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17089724|NCT00296400|38229837|FG001|Overall Study|Protocol Violation|1|||
17089725|NCT00296400|38229838|FG002|Overall Study|Protocol Violation|1|||
17089726|NCT00296400|38229836|FG000|Overall Study|Lost to Follow-up|1|||
17089727|NCT00296400|38229837|FG001|Overall Study|Lost to Follow-up|1|||
17089728|NCT00296400|38229838|FG002|Overall Study|Lost to Follow-up|2|||
17089729|NCT00296400|38229836|FG000|Overall Study|Study specific discontinuation criteria|0|||
17089730|NCT00296400|38229837|FG001|Overall Study|Study specific discontinuation criteria|0|||
17089731|NCT00296400|38229838|FG002|Overall Study|Study specific discontinuation criteria|1|||
17089732|NCT00296400|38229836|FG000|Overall Study|Visit 10 was performed earlier|0|||
17187864|NCT02991859|38340683|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187865|NCT02991859|38340684|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187866|NCT02991859|38340685|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187867|NCT02991859|38340686|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
17187868|NCT02991859|38340687|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187869|NCT02991859|38340688|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187870|NCT02991859|38340689|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187871|NCT02991859|38340690|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187872|NCT02991859|38340691|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187873|NCT02991859|38340692|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187874|NCT02991859|38340693|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
17187875|NCT02991859|38340677|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187876|NCT02991859|38340678|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187877|NCT02991859|38340679|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187878|NCT02991859|38340680|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187879|NCT02991859|38340681|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187880|NCT02991859|38340682|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187881|NCT02991859|38340683|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187882|NCT02991859|38340684|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187883|NCT02991859|38340685|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
17187884|NCT02991859|38340686|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187885|NCT02991859|38340687|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187886|NCT02991859|38340688|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187887|NCT02991859|38340689|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187888|NCT02991859|38340690|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187889|NCT02991859|38340691|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187890|NCT02991859|38340692|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187891|NCT02991859|38340693|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
17187892|NCT03016325|38340776|FG000|Treatment Period|Participant withdrew consent|0|||
17187893|NCT03016325|38340777|FG001|Treatment Period|Participant withdrew consent|1|||
17187894|NCT03016325|38340778|FG002|Treatment Period|Participant withdrew consent|0|||
17187895|NCT03016325|38340779|FG003|Treatment Period|Participant withdrew consent|0|||
17187896|NCT03016325|38340780|FG004|Treatment Period|Participant withdrew consent|0|||
17187897|NCT03016325|38340781|FG005|Treatment Period|Participant withdrew consent|0|||
17187898|NCT03016325|38340782|FG006|Treatment Period|Participant withdrew consent|0|||
17187899|NCT03016325|38340783|FG007|Treatment Period|Participant withdrew consent|0|||
17187900|NCT03016325|38340776|FG000|Treatment Period|Death|0|||
17187901|NCT03016325|38340777|FG001|Treatment Period|Death|0|||
17187902|NCT03016325|38340778|FG002|Treatment Period|Death|0|||
17187903|NCT03016325|38340779|FG003|Treatment Period|Death|0|||
17187904|NCT03016325|38340780|FG004|Treatment Period|Death|2|||
17187905|NCT03016325|38340781|FG005|Treatment Period|Death|0|||
17187906|NCT03016325|38340782|FG006|Treatment Period|Death|0|||
17187907|NCT03016325|38340783|FG007|Treatment Period|Death|0|||
17187908|NCT03016325|38340776|FG000|Treatment Period|Participant refuses assessments|0|||
17187909|NCT03016325|38340777|FG001|Treatment Period|Participant refuses assessments|0|||
17187910|NCT03016325|38340778|FG002|Treatment Period|Participant refuses assessments|1|||
17187911|NCT03016325|38340779|FG003|Treatment Period|Participant refuses assessments|0|||
17187912|NCT03016325|38340780|FG004|Treatment Period|Participant refuses assessments|0|||
17187913|NCT03016325|38340781|FG005|Treatment Period|Participant refuses assessments|0|||
17187914|NCT03016325|38340782|FG006|Treatment Period|Participant refuses assessments|0|||
17187915|NCT03016325|38340783|FG007|Treatment Period|Participant refuses assessments|0|||
17187916|NCT03016325|38340776|FG000|32-Day Follow-Up Period|Death|2|||
17187917|NCT03016325|38340777|FG001|32-Day Follow-Up Period|Death|0|||
17187918|NCT03016325|38340778|FG002|32-Day Follow-Up Period|Death|5|||
17187919|NCT03016325|38340779|FG003|32-Day Follow-Up Period|Death|6|||
17187920|NCT03016325|38340780|FG004|32-Day Follow-Up Period|Death|3|||
17187921|NCT03016325|38340781|FG005|32-Day Follow-Up Period|Death|0|||
17187922|NCT03016325|38340782|FG006|32-Day Follow-Up Period|Death|0|||
17187923|NCT03016325|38340783|FG007|32-Day Follow-Up Period|Death|0|||
17187924|NCT03016325|38340776|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
17187925|NCT03016325|38340777|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
17187926|NCT03016325|38340778|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
17187927|NCT03016325|38340779|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
17187928|NCT03016325|38340780|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
17187929|NCT03016325|38340781|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
17187930|NCT03016325|38340782|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
17187931|NCT03016325|38340783|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
17187932|NCT03016325|38340776|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
17187933|NCT03016325|38340777|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
17187934|NCT03016325|38340778|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
17187935|NCT03016325|38340779|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
17187936|NCT03016325|38340780|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
17187937|NCT03016325|38340781|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
17187938|NCT03016325|38340782|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
17187939|NCT03016325|38340783|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
17187940|NCT03016325|38340776|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
17187941|NCT03016325|38340777|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
17187942|NCT03016325|38340778|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
17187943|NCT03016325|38340779|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
17187944|NCT03016325|38340780|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
17187945|NCT03016325|38340781|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
17187946|NCT03016325|38340782|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
17187947|NCT03016325|38340783|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
17187948|NCT03016325|38340776|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
17187949|NCT03016325|38340777|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
17187950|NCT03016325|38340778|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
17187951|NCT03016325|38340779|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
17187952|NCT03016325|38340780|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
17187953|NCT03016325|38340781|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
17187954|NCT03016325|38340782|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
17187955|NCT03016325|38340783|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
17187956|NCT03016325|38340776|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
17187957|NCT03016325|38340777|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
17187958|NCT03016325|38340778|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
17187959|NCT03016325|38340779|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
17187960|NCT03016325|38340780|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
17187961|NCT03016325|38340781|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
17187962|NCT03016325|38340782|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
17187963|NCT03016325|38340783|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
17187964|NCT03016325|38340776|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
17187965|NCT03016325|38340777|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
17187966|NCT03016325|38340778|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
17187967|NCT03016325|38340779|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
17187968|NCT03016325|38340780|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
17187969|NCT03016325|38340781|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
17187970|NCT03016325|38340782|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
17187971|NCT03016325|38340783|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
17187972|NCT03016325|38340776|FG000|182-Day Follow-Up Period|Death|3|||
17187973|NCT03016325|38340777|FG001|182-Day Follow-Up Period|Death|3|||
17187974|NCT03016325|38340778|FG002|182-Day Follow-Up Period|Death|11|||
17187975|NCT03016325|38340779|FG003|182-Day Follow-Up Period|Death|12|||
17187976|NCT03016325|38340780|FG004|182-Day Follow-Up Period|Death|9|||
17187977|NCT03016325|38340781|FG005|182-Day Follow-Up Period|Death|0|||
17187978|NCT03016325|38340782|FG006|182-Day Follow-Up Period|Death|0|||
17187979|NCT03016325|38340783|FG007|182-Day Follow-Up Period|Death|1|||
17187980|NCT03016325|38340776|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
17187981|NCT03016325|38340777|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
17187982|NCT03016325|38340778|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
17187983|NCT03016325|38340779|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
17187984|NCT03016325|38340780|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
17187985|NCT03016325|38340781|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
17187986|NCT03016325|38340782|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
17187987|NCT03016325|38340783|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
17187988|NCT03016325|38340776|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
17187989|NCT03016325|38340777|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
17187990|NCT03016325|38340778|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
17187991|NCT03016325|38340779|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
17187992|NCT03016325|38340780|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
17187993|NCT03016325|38340781|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
17187994|NCT03016325|38340782|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
17187995|NCT03016325|38340783|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
17187996|NCT03016325|38340776|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
17187997|NCT03016325|38340777|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
17187998|NCT03016325|38340778|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
17187999|NCT03016325|38340779|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
17188000|NCT03016325|38340780|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
17188001|NCT03016325|38340781|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
17188002|NCT03016325|38340782|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
17188003|NCT03016325|38340783|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
17188004|NCT03016325|38340776|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
17188005|NCT03016325|38340777|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
17188006|NCT03016325|38340778|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
17188007|NCT03016325|38340779|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
17188008|NCT03016325|38340780|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
17188009|NCT03016325|38340781|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
17188010|NCT03016325|38340782|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
17188011|NCT03016325|38340783|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
17188012|NCT03016325|38340776|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
17188013|NCT03016325|38340777|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
17188014|NCT03016325|38340778|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
17188015|NCT03016325|38340779|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
17188016|NCT03016325|38340780|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
17188017|NCT03016325|38340781|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
17188018|NCT03016325|38340782|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
17188019|NCT03016325|38340783|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
17188020|NCT03016325|38340776|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
17188021|NCT03016325|38340777|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
17188022|NCT03016325|38340778|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
17188023|NCT03016325|38340779|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
17188024|NCT03016325|38340780|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
17188025|NCT03016325|38340781|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
17188026|NCT03016325|38340782|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
17188027|NCT03016325|38340783|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
17188028|NCT03016325|38340776|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
17188029|NCT03016325|38340777|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
17188030|NCT03016325|38340778|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
17188031|NCT03016325|38340779|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
17188032|NCT03016325|38340780|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
17188033|NCT03016325|38340781|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
17188034|NCT03016325|38340782|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
17188035|NCT03016325|38340783|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
17188036|NCT02988115|38340806|FG000|Overall Study|Adverse Event|6|||
17188037|NCT02988115|38340807|FG001|Overall Study|Adverse Event|1|||
17188038|NCT02988115|38340806|FG000|Overall Study|Sponsor Decision|5|||
17188039|NCT02988115|38340807|FG001|Overall Study|Sponsor Decision|2|||
17188040|NCT02988115|38340806|FG000|Overall Study|Withdrawal by Subject|1|||
17188041|NCT02988115|38340807|FG001|Overall Study|Withdrawal by Subject|1|||
17188042|NCT02988115|38340806|FG000|Overall Study|Withdrawn by Mistake|1|||
17188043|NCT02988115|38340807|FG001|Overall Study|Withdrawn by Mistake|0|||
17188044|NCT02988115|38340806|FG000|Overall Study|Lost to Follow-up|1|||
17188045|NCT02988115|38340807|FG001|Overall Study|Lost to Follow-up|0|||
17188046|NCT02921425|38340813|FG000|Overall Study|Protocol Violation|9|||
17188047|NCT03008915|38340817|FG000|Treatment 1|Withdrawal by Subject|0|||
17188048|NCT03008915|38340818|FG001|Treatment 1|Withdrawal by Subject|1|||
17188049|NCT02515630|38340831|FG000|Overall Study|Withdrawal by Subject|5|||
17188050|NCT02515630|38340831|FG000|Overall Study|Adverse Event|4|||
17188051|NCT02515630|38340831|FG000|Overall Study|Physician Decision|4|||
17188052|NCT02515630|38340831|FG000|Overall Study|Death|2|||
17188053|NCT02515630|38340831|FG000|Overall Study|Disease Progression|1|||
17188054|NCT02920957|38340838|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
17188055|NCT02920957|38340839|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
17188056|NCT02920957|38340838|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
17188057|NCT02920957|38340839|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
17188058|NCT02920957|38340838|FG000|First Intervention : 1 Month|Adverse Event|1|||
17188059|NCT02920957|38340839|FG001|First Intervention : 1 Month|Adverse Event|0|||
17188060|NCT02920957|38340838|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
17188061|NCT02920957|38340839|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
17188062|NCT03006887|38340856|FG000|Overall Study|Adverse Event|1|||
17188063|NCT02514772|38340862|FG000|Overall Study|Adverse Event|1|||
17188064|NCT02514772|38340863|FG001|Overall Study|Adverse Event|0|||
17188065|NCT02514772|38340862|FG000|Overall Study|Death|0|||
17188066|NCT02514772|38340863|FG001|Overall Study|Death|1|||
17188067|NCT02514772|38340862|FG000|Overall Study|Withdrawal by Subject|2|||
17188068|NCT02514772|38340863|FG001|Overall Study|Withdrawal by Subject|1|||
17188069|NCT03000179|38340871|FG000|Overall Study|Lost to Follow-up|2|||
17188070|NCT02920177|38340877|FG000|Overall Study|Withdrawal by Subject|1|||
17188071|NCT02920177|38340878|FG001|Overall Study|Withdrawal by Subject|1|||
17188072|NCT02920177|38340877|FG000|Overall Study|Physician Decision|1|||
17188073|NCT02920177|38340878|FG001|Overall Study|Physician Decision|0|||
17188074|NCT02920177|38340877|FG000|Overall Study|Lost to Follow-up|0|||
17188075|NCT02920177|38340878|FG001|Overall Study|Lost to Follow-up|1|||
17188076|NCT03006341|38340888|FG000|Overall Study|Not linked in the EMR|25069|||
17188077|NCT03006341|38340889|FG001|Overall Study|Not linked in the EMR|67505|||
17188078|NCT03006341|38340890|FG002|Overall Study|Not linked in the EMR|30993|||
17188079|NCT03006341|38340891|FG003|Overall Study|Not linked in the EMR|10685|||
17188080|NCT03935594|38340899|FG000|Overall Study|Physician Decision|3|||
17188081|NCT02512042|38340907|FG000|Overall Study|Adverse Event|0|||
17188082|NCT02512042|38340908|FG001|Overall Study|Adverse Event|4|||
17188083|NCT02512042|38340907|FG000|Overall Study|Withdrawal by Subject|6|||
17188084|NCT02512042|38340908|FG001|Overall Study|Withdrawal by Subject|6|||
17188085|NCT02512042|38340907|FG000|Overall Study|Non-compliance with study drug|1|||
17188086|NCT02512042|38340908|FG001|Overall Study|Non-compliance with study drug|2|||
17188087|NCT02512042|38340907|FG000|Overall Study|Lost to Follow-up|5|||
17188088|NCT02512042|38340908|FG001|Overall Study|Lost to Follow-up|2|||
17188089|NCT02512042|38340907|FG000|Overall Study|Other|11|||
17188090|NCT02512042|38340908|FG001|Overall Study|Other|11|||
17188091|NCT02911025|38340914|FG000|Overall Study|Lost to Follow-up|3|||
17188092|NCT02919475|38340923|FG000|Overall Study|Adverse Event|3|||
17188093|NCT02919475|38340924|FG001|Overall Study|Adverse Event|3|||
17188094|NCT02919475|38340925|FG002|Overall Study|Adverse Event|3|||
17188095|NCT02919475|38340926|FG003|Overall Study|Adverse Event|9|||
17188096|NCT02919475|38340927|FG004|Overall Study|Adverse Event|2|||
17188097|NCT02919475|38340923|FG000|Overall Study|Death|0|||
17188098|NCT02919475|38340924|FG001|Overall Study|Death|1|||
17188099|NCT02919475|38340925|FG002|Overall Study|Death|0|||
17188100|NCT02919475|38340926|FG003|Overall Study|Death|0|||
17188101|NCT02919475|38340927|FG004|Overall Study|Death|0|||
17188102|NCT02919475|38340923|FG000|Overall Study|Lost to Follow-up|0|||
17188103|NCT02919475|38340924|FG001|Overall Study|Lost to Follow-up|0|||
17188104|NCT02919475|38340925|FG002|Overall Study|Lost to Follow-up|0|||
17188105|NCT02919475|38340926|FG003|Overall Study|Lost to Follow-up|1|||
17188106|NCT02919475|38340927|FG004|Overall Study|Lost to Follow-up|0|||
17188107|NCT02919475|38340923|FG000|Overall Study|Withdrawal by Subject|2|||
17188108|NCT02919475|38340924|FG001|Overall Study|Withdrawal by Subject|3|||
17188109|NCT02919475|38340925|FG002|Overall Study|Withdrawal by Subject|1|||
17188110|NCT02919475|38340926|FG003|Overall Study|Withdrawal by Subject|2|||
17188111|NCT02919475|38340927|FG004|Overall Study|Withdrawal by Subject|2|||
17188112|NCT02919475|38340923|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
17188113|NCT02919475|38340924|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
17188114|NCT02919475|38340925|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
17188115|NCT02919475|38340926|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
17188116|NCT02919475|38340927|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17188117|NCT01066897|38340941|FG000|Overall Study|Withdrawal by Subject|1|||
17188118|NCT01066897|38340942|FG001|Overall Study|Withdrawal by Subject|0|||
17188119|NCT01066897|38340941|FG000|Overall Study|stopped study after developing the flu.|1|||
17188120|NCT01066897|38340942|FG001|Overall Study|stopped study after developing the flu.|0|||
17188121|NCT02985541|38340949|FG000|Overall Study|Withdrawal by Subject|33|||
17188122|NCT02985541|38340949|FG000|Overall Study|Lost to Follow-up|26|||
17188123|NCT02985541|38340949|FG000|Overall Study|Adverse Event|27|||
17188124|NCT02985541|38340949|FG000|Overall Study|Physician Decision|2|||
17188125|NCT02985541|38340949|FG000|Overall Study|Pregnancy|2|||
17188126|NCT02985541|38340949|FG000|Overall Study|Wish for pregnancy|44|||
17188127|NCT02985541|38340949|FG000|Overall Study|Other reason|5|||
17188128|NCT02985541|38340949|FG000|Overall Study|Not valid for analysis|2|||
17188129|NCT02910037|38340962|FG000|Overall Study|Withdrawal by Subject|4|||
17188130|NCT02910037|38340962|FG000|Overall Study|Lost to Follow-up|6|||
17188131|NCT02511184|38340997|FG000|Overall Study|Death|1|||
17188132|NCT02511184|38340998|FG001|Overall Study|Death|0|||
17188133|NCT02511184|38340997|FG000|Overall Study|Lost to Follow-up|0|||
17188134|NCT02511184|38340998|FG001|Overall Study|Lost to Follow-up|1|||
17188135|NCT02511184|38340997|FG000|Overall Study|Study terminated by sponsor|1|||
17188136|NCT02511184|38340998|FG001|Overall Study|Study terminated by sponsor|5|||
16781320|NCT02142712|37720489|FG003|Overall Study|Lost to Follow-up|0|||
17188137|NCT02511184|38340997|FG000|Overall Study|Withdrawal by Subject|0|||
17188138|NCT02511184|38340998|FG001|Overall Study|Withdrawal by Subject|1|||
17188139|NCT02984995|38341011|FG000|Overall Study|Required stem cell transplant|13|||
17188140|NCT02984995|38341012|FG001|Overall Study|Required stem cell transplant|2|||
17188141|NCT02984995|38341011|FG000|Overall Study|Progressive disease|11|||
17188142|NCT02984995|38341012|FG001|Overall Study|Progressive disease|1|||
17188143|NCT02984995|38341011|FG000|Overall Study|Adverse Event|1|||
17188144|NCT02984995|38341012|FG001|Overall Study|Adverse Event|0|||
17188145|NCT02984683|38341036|FG000|Overall Study|Adverse Event|3|||
17188146|NCT02984683|38341037|FG001|Overall Study|Adverse Event|3|||
17188147|NCT02984683|38341036|FG000|Overall Study|Withdrawal by Subject|1|||
17188148|NCT02984683|38341037|FG001|Overall Study|Withdrawal by Subject|0|||
17188149|NCT02984683|38341036|FG000|Overall Study|Disease progression|7|||
17188150|NCT02984683|38341037|FG001|Overall Study|Disease progression|9|||
17188151|NCT02909101|38341045|FG000|Overall Study|Lost to Follow-up|1|||
17188152|NCT02909101|38341046|FG001|Overall Study|Lost to Follow-up|1|||
17188153|NCT03004469|38341055|FG000|Overall Study|Adverse Event|6|||
17188154|NCT03004469|38341056|FG001|Overall Study|Adverse Event|4|||
17188155|NCT03004469|38341057|FG002|Overall Study|Adverse Event|6|||
17188156|NCT03004469|38341055|FG000|Overall Study|Lack of Efficacy|1|||
17188157|NCT03004469|38341056|FG001|Overall Study|Lack of Efficacy|0|||
17188158|NCT03004469|38341057|FG002|Overall Study|Lack of Efficacy|1|||
17188159|NCT03004469|38341055|FG000|Overall Study|Lost to Follow-up|23|||
17188160|NCT03004469|38341056|FG001|Overall Study|Lost to Follow-up|14|||
17188161|NCT03004469|38341057|FG002|Overall Study|Lost to Follow-up|6|||
17188162|NCT03004469|38341055|FG000|Overall Study|Non-Compliance with Study Drug|2|||
17188163|NCT03004469|38341056|FG001|Overall Study|Non-Compliance with Study Drug|0|||
17188164|NCT03004469|38341057|FG002|Overall Study|Non-Compliance with Study Drug|0|||
17188165|NCT03004469|38341055|FG000|Overall Study|Protocol Violation|0|||
17188166|NCT03004469|38341056|FG001|Overall Study|Protocol Violation|0|||
17188167|NCT03004469|38341057|FG002|Overall Study|Protocol Violation|1|||
17188168|NCT03004469|38341055|FG000|Overall Study|Withdrawal by Subject|29|||
17188169|NCT03004469|38341056|FG001|Overall Study|Withdrawal by Subject|27|||
17188170|NCT03004469|38341057|FG002|Overall Study|Withdrawal by Subject|10|||
17188171|NCT03004469|38341055|FG000|Overall Study|Other unspecified reason|0|||
17188172|NCT03004469|38341056|FG001|Overall Study|Other unspecified reason|4|||
17188173|NCT03004469|38341057|FG002|Overall Study|Other unspecified reason|1|||
17188174|NCT02910713|38341066|FG000|Overall Study|Protocol Violation|2|||
17188175|NCT02910713|38341066|FG000|Overall Study|Subject Choice|4|||
17188176|NCT02910713|38341066|FG000|Overall Study|Received One Application|10|||
17188177|NCT02910713|38341066|FG000|Overall Study|Received Neither Application|18|||
17188178|NCT02910713|38341066|FG000|Overall Study|Enrollment cap|7|||
17188179|NCT02910713|38341066|FG000|Overall Study|Investigator Discretion|1|||
17188180|NCT02998541|38341074|FG000|Overall Study|Adverse Event|4|||
17188181|NCT02998541|38341075|FG001|Overall Study|Adverse Event|5|||
17188182|NCT02998541|38341076|FG002|Overall Study|Adverse Event|1|||
17188183|NCT02998541|38341074|FG000|Overall Study|Protocol Violation|1|||
17188184|NCT02998541|38341075|FG001|Overall Study|Protocol Violation|0|||
17188185|NCT02998541|38341076|FG002|Overall Study|Protocol Violation|0|||
17188186|NCT02998541|38341074|FG000|Overall Study|Withdrawal by Subject|3|||
17188187|NCT02998541|38341075|FG001|Overall Study|Withdrawal by Subject|1|||
17188188|NCT02998541|38341076|FG002|Overall Study|Withdrawal by Subject|0|||
17188189|NCT02998541|38341074|FG000|Overall Study|Lost to Follow-up|0|||
17188190|NCT02998541|38341075|FG001|Overall Study|Lost to Follow-up|3|||
17188191|NCT02998541|38341076|FG002|Overall Study|Lost to Follow-up|1|||
17188192|NCT02998541|38341074|FG000|Overall Study|Physician Decision|0|||
17188193|NCT02998541|38341075|FG001|Overall Study|Physician Decision|0|||
17188194|NCT02998541|38341076|FG002|Overall Study|Physician Decision|3|||
17188195|NCT02998541|38341074|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
17188196|NCT02998541|38341075|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
17188197|NCT02998541|38341076|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
17188198|NCT02998151|38341084|FG000|Overall Study|Withdrawal by Subject|3|||
17188199|NCT02998151|38341084|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
17188200|NCT02998151|38341084|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
17188201|NCT01066819|38341115|FG000|Overall Study|Adverse Event|18|||
17188202|NCT01066819|38341116|FG001|Overall Study|Adverse Event|1|||
17188203|NCT01066819|38341117|FG002|Overall Study|Adverse Event|6|||
17188204|NCT01066819|38341118|FG003|Overall Study|Adverse Event|0|||
17188205|NCT01066819|38341119|FG004|Overall Study|Adverse Event|0|||
17188206|NCT01066819|38341120|FG005|Overall Study|Adverse Event|0|||
17188207|NCT01066819|38341115|FG000|Overall Study|Death|5|||
17188208|NCT01066819|38341116|FG001|Overall Study|Death|0|||
17188209|NCT01066819|38341117|FG002|Overall Study|Death|1|||
17188210|NCT01066819|38341118|FG003|Overall Study|Death|0|||
17188211|NCT01066819|38341119|FG004|Overall Study|Death|0|||
17188212|NCT01066819|38341120|FG005|Overall Study|Death|0|||
17188213|NCT01066819|38341115|FG000|Overall Study|Lack of Efficacy|22|||
17188214|NCT01066819|38341116|FG001|Overall Study|Lack of Efficacy|1|||
17188215|NCT01066819|38341117|FG002|Overall Study|Lack of Efficacy|2|||
17188216|NCT01066819|38341118|FG003|Overall Study|Lack of Efficacy|1|||
17188217|NCT01066819|38341119|FG004|Overall Study|Lack of Efficacy|0|||
17188218|NCT01066819|38341120|FG005|Overall Study|Lack of Efficacy|0|||
17188219|NCT01066819|38341115|FG000|Overall Study|Physician Decision|6|||
17188220|NCT01066819|38341116|FG001|Overall Study|Physician Decision|2|||
17188221|NCT01066819|38341117|FG002|Overall Study|Physician Decision|3|||
17188222|NCT01066819|38341118|FG003|Overall Study|Physician Decision|0|||
17188223|NCT01066819|38341119|FG004|Overall Study|Physician Decision|0|||
17188224|NCT01066819|38341120|FG005|Overall Study|Physician Decision|0|||
17188225|NCT01066819|38341115|FG000|Overall Study|Protocol Violation|12|||
17188226|NCT01066819|38341116|FG001|Overall Study|Protocol Violation|6|||
17188227|NCT01066819|38341117|FG002|Overall Study|Protocol Violation|0|||
17188228|NCT01066819|38341118|FG003|Overall Study|Protocol Violation|0|||
17188229|NCT01066819|38341119|FG004|Overall Study|Protocol Violation|0|||
17188230|NCT01066819|38341120|FG005|Overall Study|Protocol Violation|0|||
17188231|NCT01066819|38341115|FG000|Overall Study|Withdrawal by Subject|29|||
17188232|NCT01066819|38341116|FG001|Overall Study|Withdrawal by Subject|11|||
17188233|NCT01066819|38341117|FG002|Overall Study|Withdrawal by Subject|6|||
17188234|NCT01066819|38341118|FG003|Overall Study|Withdrawal by Subject|0|||
17188235|NCT01066819|38341119|FG004|Overall Study|Withdrawal by Subject|0|||
17188236|NCT01066819|38341120|FG005|Overall Study|Withdrawal by Subject|0|||
17188237|NCT01066819|38341115|FG000|Overall Study|Administrative|6|||
17188238|NCT01066819|38341116|FG001|Overall Study|Administrative|4|||
17188239|NCT01066819|38341117|FG002|Overall Study|Administrative|2|||
17188240|NCT01066819|38341118|FG003|Overall Study|Administrative|0|||
17188241|NCT01066819|38341119|FG004|Overall Study|Administrative|0|||
17188242|NCT01066819|38341120|FG005|Overall Study|Administrative|0|||
17188243|NCT01066819|38341115|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
17188244|NCT01066819|38341116|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
17188245|NCT01066819|38341117|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
17188246|NCT01066819|38341118|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
17188247|NCT01066819|38341119|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
17188248|NCT01066819|38341120|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
17188249|NCT01066819|38341115|FG000|Overall Study|Early termination|2|||
17188250|NCT01066819|38341116|FG001|Overall Study|Early termination|0|||
17188251|NCT01066819|38341117|FG002|Overall Study|Early termination|0|||
17188252|NCT01066819|38341118|FG003|Overall Study|Early termination|0|||
17188253|NCT01066819|38341119|FG004|Overall Study|Early termination|0|||
17188254|NCT01066819|38341120|FG005|Overall Study|Early termination|0|||
17188255|NCT01066819|38341115|FG000|Overall Study|Failed to return|298|||
17188256|NCT01066819|38341116|FG001|Overall Study|Failed to return|107|||
17188257|NCT01066819|38341117|FG002|Overall Study|Failed to return|68|||
17188258|NCT01066819|38341118|FG003|Overall Study|Failed to return|7|||
17188259|NCT01066819|38341119|FG004|Overall Study|Failed to return|2|||
17188260|NCT01066819|38341120|FG005|Overall Study|Failed to return|3|||
17188261|NCT01066819|38341115|FG000|Overall Study|Lab test not done|9|||
17188262|NCT01066819|38341116|FG001|Overall Study|Lab test not done|0|||
17188263|NCT01066819|38341117|FG002|Overall Study|Lab test not done|2|||
17188264|NCT01066819|38341118|FG003|Overall Study|Lab test not done|1|||
17188265|NCT01066819|38341119|FG004|Overall Study|Lab test not done|0|||
17188266|NCT01066819|38341120|FG005|Overall Study|Lab test not done|0|||
17188267|NCT01066819|38341115|FG000|Overall Study|Miscellaneous|28|||
17188268|NCT01066819|38341116|FG001|Overall Study|Miscellaneous|10|||
17188269|NCT01066819|38341117|FG002|Overall Study|Miscellaneous|18|||
17188270|NCT01066819|38341118|FG003|Overall Study|Miscellaneous|1|||
17188271|NCT01066819|38341119|FG004|Overall Study|Miscellaneous|0|||
17188272|NCT01066819|38341120|FG005|Overall Study|Miscellaneous|0|||
17188273|NCT01066819|38341115|FG000|Overall Study|Non responders|123|||
17188274|NCT01066819|38341116|FG001|Overall Study|Non responders|2|||
17188275|NCT01066819|38341117|FG002|Overall Study|Non responders|7|||
17188276|NCT01066819|38341118|FG003|Overall Study|Non responders|2|||
17188277|NCT01066819|38341119|FG004|Overall Study|Non responders|0|||
17188278|NCT01066819|38341120|FG005|Overall Study|Non responders|1|||
17188279|NCT01066819|38341115|FG000|Overall Study|Not categorised|9|||
17188280|NCT01066819|38341116|FG001|Overall Study|Not categorised|2|||
17188281|NCT01066819|38341117|FG002|Overall Study|Not categorised|6|||
17188282|NCT01066819|38341118|FG003|Overall Study|Not categorised|1|||
17188283|NCT01066819|38341119|FG004|Overall Study|Not categorised|0|||
17188284|NCT01066819|38341120|FG005|Overall Study|Not categorised|0|||
17188285|NCT01066819|38341115|FG000|Overall Study|Relapse|16|||
17188286|NCT01066819|38341116|FG001|Overall Study|Relapse|4|||
17188287|NCT01066819|38341117|FG002|Overall Study|Relapse|3|||
17188288|NCT01066819|38341118|FG003|Overall Study|Relapse|0|||
17188289|NCT01066819|38341119|FG004|Overall Study|Relapse|0|||
17188290|NCT01066819|38341120|FG005|Overall Study|Relapse|0|||
17188291|NCT01066819|38341115|FG000|Overall Study|Results not available|1|||
17188292|NCT01066819|38341116|FG001|Overall Study|Results not available|0|||
17188293|NCT01066819|38341117|FG002|Overall Study|Results not available|0|||
17188294|NCT01066819|38341118|FG003|Overall Study|Results not available|0|||
16781321|NCT02105272|37720500|FG000|Overall Study|Adverse Event|1|||
17188295|NCT01066819|38341119|FG004|Overall Study|Results not available|0|||
17188296|NCT01066819|38341120|FG005|Overall Study|Results not available|0|||
17188297|NCT01066819|38341115|FG000|Overall Study|Screen failure|1|||
17188298|NCT01066819|38341116|FG001|Overall Study|Screen failure|0|||
17188299|NCT01066819|38341117|FG002|Overall Study|Screen failure|0|||
17188300|NCT01066819|38341118|FG003|Overall Study|Screen failure|0|||
17188301|NCT01066819|38341119|FG004|Overall Study|Screen failure|0|||
17188302|NCT01066819|38341120|FG005|Overall Study|Screen failure|0|||
17188303|NCT01066819|38341115|FG000|Overall Study|Spontaneous cure|1|||
17188304|NCT01066819|38341116|FG001|Overall Study|Spontaneous cure|0|||
17188305|NCT01066819|38341117|FG002|Overall Study|Spontaneous cure|0|||
17188306|NCT01066819|38341118|FG003|Overall Study|Spontaneous cure|0|||
17188307|NCT01066819|38341119|FG004|Overall Study|Spontaneous cure|0|||
17188308|NCT01066819|38341120|FG005|Overall Study|Spontaneous cure|0|||
17188309|NCT01066819|38341115|FG000|Overall Study|Treatment never started|85|||
17188310|NCT01066819|38341116|FG001|Overall Study|Treatment never started|19|||
17188311|NCT01066819|38341117|FG002|Overall Study|Treatment never started|19|||
17188312|NCT01066819|38341118|FG003|Overall Study|Treatment never started|3|||
17188313|NCT01066819|38341119|FG004|Overall Study|Treatment never started|2|||
17188314|NCT01066819|38341120|FG005|Overall Study|Treatment never started|2|||
17188315|NCT01066819|38341115|FG000|Overall Study|Treatment stopped|12|||
17188316|NCT01066819|38341116|FG001|Overall Study|Treatment stopped|1|||
17188317|NCT01066819|38341117|FG002|Overall Study|Treatment stopped|2|||
17188318|NCT01066819|38341118|FG003|Overall Study|Treatment stopped|1|||
17188319|NCT01066819|38341119|FG004|Overall Study|Treatment stopped|0|||
17188320|NCT01066819|38341120|FG005|Overall Study|Treatment stopped|0|||
17188321|NCT01066819|38341115|FG000|Overall Study|Other|5|||
17188322|NCT01066819|38341116|FG001|Overall Study|Other|1|||
17188323|NCT01066819|38341117|FG002|Overall Study|Other|1|||
17188324|NCT01066819|38341118|FG003|Overall Study|Other|0|||
17188325|NCT01066819|38341119|FG004|Overall Study|Other|0|||
17188326|NCT01066819|38341120|FG005|Overall Study|Other|0|||
17188327|NCT04056299|38341134|FG000|Overall Study|Sponsor discontinued study|3|||
17188328|NCT04056299|38341135|FG001|Overall Study|Sponsor discontinued study|3|||
17188329|NCT04057937|38341143|FG000|Placebo-controlled Phase|Adverse Event|3|||
17188330|NCT04057937|38341144|FG001|Placebo-controlled Phase|Adverse Event|0|||
17188331|NCT04057937|38341143|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
17188332|NCT04057937|38341144|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
17188333|NCT04057937|38341143|FG000|Active-treatment Phase|Pregnancy|0|||
17188334|NCT04057937|38341144|FG001|Active-treatment Phase|Pregnancy|1|||
17188335|NCT04057937|38341143|FG000|Active-treatment Phase|Physician Decision|0|||
17188336|NCT04057937|38341144|FG001|Active-treatment Phase|Physician Decision|1|||
17188337|NCT01069523|38341153|FG000|Overall Study|Withdrawal by Subject|4|||
17188338|NCT01069523|38341154|FG001|Overall Study|Withdrawal by Subject|7|||
17188339|NCT01069289|38341164|FG000|Overall Study|Withdrawal by Subject|15|||
17188340|NCT01069289|38341165|FG001|Overall Study|Withdrawal by Subject|26|||
17188341|NCT01069289|38341164|FG000|Overall Study|Adverse Event|21|||
17188342|NCT01069289|38341165|FG001|Overall Study|Adverse Event|28|||
17188343|NCT01069289|38341164|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
17188344|NCT01069289|38341165|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
17188345|NCT01069289|38341164|FG000|Overall Study|Severe non-compliance to protocol|3|||
17188346|NCT01069289|38341165|FG001|Overall Study|Severe non-compliance to protocol|2|||
17188347|NCT01069289|38341164|FG000|Overall Study|Due to deteriorating health condition|1|||
17188348|NCT01069289|38341165|FG001|Overall Study|Due to deteriorating health condition|0|||
17188349|NCT02510794|38341184|FG000|Overall Study|Adverse Event|0|||
17188350|NCT02510794|38341185|FG001|Overall Study|Adverse Event|1|||
17188351|NCT02510794|38341186|FG002|Overall Study|Adverse Event|0|||
17188352|NCT02510794|38341187|FG003|Overall Study|Adverse Event|0|||
17188353|NCT02510794|38341184|FG000|Overall Study|Death|1|||
17188354|NCT02510794|38341185|FG001|Overall Study|Death|2|||
17188355|NCT02510794|38341186|FG002|Overall Study|Death|1|||
17188356|NCT02510794|38341187|FG003|Overall Study|Death|1|||
17188357|NCT02510794|38341184|FG000|Overall Study|Lack of Efficacy|3|||
17188358|NCT02510794|38341185|FG001|Overall Study|Lack of Efficacy|1|||
17188359|NCT02510794|38341186|FG002|Overall Study|Lack of Efficacy|1|||
17188360|NCT02510794|38341187|FG003|Overall Study|Lack of Efficacy|0|||
17188361|NCT02510794|38341184|FG000|Overall Study|Participant moved out of the area|0|||
17188362|NCT02510794|38341185|FG001|Overall Study|Participant moved out of the area|0|||
17188363|NCT02510794|38341186|FG002|Overall Study|Participant moved out of the area|0|||
17188364|NCT02510794|38341187|FG003|Overall Study|Participant moved out of the area|1|||
17188365|NCT02510794|38341184|FG000|Overall Study|Physician Decision|3|||
17188366|NCT02510794|38341185|FG001|Overall Study|Physician Decision|0|||
17188367|NCT02510794|38341186|FG002|Overall Study|Physician Decision|0|||
17188368|NCT02510794|38341187|FG003|Overall Study|Physician Decision|0|||
17188369|NCT02510794|38341184|FG000|Overall Study|Protocol Violation|0|||
17188370|NCT02510794|38341185|FG001|Overall Study|Protocol Violation|0|||
17188371|NCT02510794|38341186|FG002|Overall Study|Protocol Violation|1|||
17188372|NCT02510794|38341187|FG003|Overall Study|Protocol Violation|0|||
17188373|NCT02510794|38341184|FG000|Overall Study|Withdrawal by Subject|1|||
17188374|NCT02510794|38341185|FG001|Overall Study|Withdrawal by Subject|2|||
17188375|NCT02510794|38341186|FG002|Overall Study|Withdrawal by Subject|4|||
17188376|NCT02510794|38341187|FG003|Overall Study|Withdrawal by Subject|3|||
17188377|NCT02937818|38341203|FG000|Overall Study|Participants decision|1|||
17188378|NCT02937818|38341204|FG001|Overall Study|Participants decision|0|||
17188379|NCT02937818|38341205|FG002|Overall Study|Participants decision|1|||
17188380|NCT02937818|38341206|FG003|Overall Study|Participants decision|1|||
17188381|NCT02937818|38341203|FG000|Overall Study|Adverse Event|2|||
17188382|NCT02937818|38341204|FG001|Overall Study|Adverse Event|4|||
17188383|NCT02937818|38341205|FG002|Overall Study|Adverse Event|1|||
17188384|NCT02937818|38341206|FG003|Overall Study|Adverse Event|1|||
17188385|NCT02937818|38341203|FG000|Overall Study|Disease progression|17|||
17188386|NCT02937818|38341204|FG001|Overall Study|Disease progression|14|||
17188387|NCT02937818|38341205|FG002|Overall Study|Disease progression|7|||
17188388|NCT02937818|38341206|FG003|Overall Study|Disease progression|18|||
17188389|NCT02937818|38341203|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
17188390|NCT02937818|38341204|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
17188391|NCT02937818|38341205|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
17188392|NCT02937818|38341206|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
17188393|NCT02937818|38341203|FG000|Overall Study|Condition under investigation worsened|0|||
17188394|NCT02937818|38341204|FG001|Overall Study|Condition under investigation worsened|0|||
17188395|NCT02937818|38341205|FG002|Overall Study|Condition under investigation worsened|1|||
17188396|NCT02937818|38341206|FG003|Overall Study|Condition under investigation worsened|0|||
16997284|NCT00960206|38141288|FG002|Overall Study|Death|1|||
16997285|NCT00960206|38141286|FG000|Overall Study|Unwilling/Unable to return|1|||
16997286|NCT00960206|38141287|FG001|Overall Study|Unwilling/Unable to return|2|||
16997287|NCT00960206|38141288|FG002|Overall Study|Unwilling/Unable to return|0|||
16997288|NCT00960206|38141286|FG000|Overall Study|Lost to Follow-up|8|||
16997289|NCT00960206|38141287|FG001|Overall Study|Lost to Follow-up|14|||
16997290|NCT00960206|38141288|FG002|Overall Study|Lost to Follow-up|8|||
16997291|NCT00960206|38141286|FG000|Overall Study|Withdrawal by Subject|2|||
16997292|NCT00960206|38141287|FG001|Overall Study|Withdrawal by Subject|4|||
16997293|NCT00960206|38141288|FG002|Overall Study|Withdrawal by Subject|0|||
16997294|NCT00960206|38141286|FG000|Overall Study|Revision of study component|2|||
16997295|NCT00960206|38141287|FG001|Overall Study|Revision of study component|2|||
16997296|NCT00960206|38141288|FG002|Overall Study|Revision of study component|2|||
16997297|NCT00960206|38141286|FG000|Overall Study|Missing 10 year data|20|||
16997298|NCT00960206|38141287|FG001|Overall Study|Missing 10 year data|1|||
16997299|NCT00960206|38141288|FG002|Overall Study|Missing 10 year data|1|||
16997300|NCT00751036|38141299|FG000|Overall Study|Disease Progression|28|||
16997301|NCT00751036|38141300|FG001|Overall Study|Disease Progression|29|||
17188397|NCT02937818|38341203|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
17188398|NCT02937818|38341204|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
17188399|NCT02937818|38341205|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
17188400|NCT02937818|38341206|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
17188401|NCT02510014|38341232|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
17188402|NCT02510014|38341233|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
17188403|NCT02510014|38341232|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
17188404|NCT02510014|38341233|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
17188405|NCT02510014|38341232|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
17188406|NCT02510014|38341233|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
17188407|NCT02510014|38341232|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
17188408|NCT02510014|38341233|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
17188409|NCT02510014|38341232|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
17188410|NCT02510014|38341233|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
17188411|NCT02510014|38341232|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
17188412|NCT02510014|38341233|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
17188413|NCT02510014|38341232|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
17188414|NCT02510014|38341233|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
17188415|NCT02510014|38341232|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
17188416|NCT02510014|38341233|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
17188417|NCT02510014|38341232|FG000|Treatment Period|Adverse Event|11|||
16997302|NCT00751036|38141299|FG000|Overall Study|Adverse Event|6|||
16997303|NCT00751036|38141300|FG001|Overall Study|Adverse Event|4|||
16997304|NCT00751036|38141299|FG000|Overall Study|Administrative Problems|3|||
16997305|NCT00751036|38141300|FG001|Overall Study|Administrative Problems|4|||
16997306|NCT00751036|38141299|FG000|Overall Study|Withdrawal by Subject|5|||
17089733|NCT00296400|38229837|FG001|Overall Study|Visit 10 was performed earlier|1|||
17089734|NCT00296400|38229838|FG002|Overall Study|Visit 10 was performed earlier|0|||
17089735|NCT00296400|38229836|FG000|Overall Study|Pregnancy|1|||
17089736|NCT00296400|38229837|FG001|Overall Study|Pregnancy|2|||
17089737|NCT00296400|38229838|FG002|Overall Study|Pregnancy|0|||
17089738|NCT00296244|38229851|FG000|Overall Study|Underwent retransplant|0|||
17089739|NCT00296244|38229852|FG001|Overall Study|Underwent retransplant|1|||
17089740|NCT00274716|38229869|FG000|Phase A|Other non-reported reason|4|||
17089741|NCT00274716|38229870|FG001|Phase A|Other non-reported reason|2|||
16997307|NCT00751036|38141300|FG001|Overall Study|Withdrawal by Subject|2|||
17089742|NCT00274716|38229871|FG002|Phase A|Other non-reported reason|1|||
17089743|NCT00274716|38229872|FG003|Phase A|Other non-reported reason|2|||
17188418|NCT02510014|38341233|FG001|Treatment Period|Adverse Event|4|||
17188419|NCT02510014|38341232|FG000|Treatment Period|Withdrawal symptoms|3|||
17188420|NCT02510014|38341233|FG001|Treatment Period|Withdrawal symptoms|0|||
17188421|NCT02510014|38341232|FG000|Treatment Period|Lost to Follow-up|80|||
17188422|NCT02510014|38341233|FG001|Treatment Period|Lost to Follow-up|19|||
17188423|NCT02510014|38341232|FG000|Treatment Period|Physician Decision|5|||
17188424|NCT02510014|38341233|FG001|Treatment Period|Physician Decision|0|||
17188425|NCT02510014|38341232|FG000|Treatment Period|Withdrawal by Subject|67|||
17188426|NCT02510014|38341233|FG001|Treatment Period|Withdrawal by Subject|24|||
17188427|NCT02510014|38341232|FG000|Treatment Period|Withdrawn by the investigator|7|||
17188428|NCT02510014|38341233|FG001|Treatment Period|Withdrawn by the investigator|1|||
17188429|NCT02510014|38341232|FG000|Treatment Period|Protocol Violation|4|||
17188430|NCT02510014|38341233|FG001|Treatment Period|Protocol Violation|4|||
17188431|NCT02510014|38341232|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
17188432|NCT02510014|38341233|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
17188433|NCT02509312|38341241|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
17188434|NCT02509312|38341242|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
17188435|NCT02509312|38341241|FG000|Overall Study|Obstetrician refusal|0|||
17188436|NCT02509312|38341242|FG001|Overall Study|Obstetrician refusal|1|||
17188437|NCT02509312|38341241|FG000|Overall Study|Patient elected for TOLAC|1|||
17188438|NCT02509312|38341242|FG001|Overall Study|Patient elected for TOLAC|0|||
17188439|NCT02509312|38341241|FG000|Overall Study|Cesarean deemed stat|1|||
17188440|NCT02509312|38341242|FG001|Overall Study|Cesarean deemed stat|0|||
17188441|NCT02509312|38341241|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
17188442|NCT02509312|38341242|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
17188443|NCT02509156|38341252|FG000|Randomized Phase|Death|1|||
17188444|NCT02509156|38341253|FG001|Randomized Phase|Death|0|||
17188445|NCT02509156|38341252|FG000|Randomized Phase|Withdrawal by Subject|1|||
17188446|NCT02509156|38341253|FG001|Randomized Phase|Withdrawal by Subject|1|||
17188447|NCT01654666|38341262|FG000|Overall Study|Protocol Violation|7|||
17188448|NCT01654666|38341263|FG001|Overall Study|Protocol Violation|4|||
17188449|NCT01654666|38341264|FG002|Overall Study|Protocol Violation|8|||
17188450|NCT01654666|38341262|FG000|Overall Study|Lost to Follow-up|4|||
17188451|NCT01654666|38341263|FG001|Overall Study|Lost to Follow-up|5|||
17188452|NCT01654666|38341264|FG002|Overall Study|Lost to Follow-up|5|||
17188453|NCT01654666|38341262|FG000|Overall Study|Withdrawal by Subject|4|||
17188454|NCT01654666|38341263|FG001|Overall Study|Withdrawal by Subject|4|||
17188455|NCT01654666|38341264|FG002|Overall Study|Withdrawal by Subject|1|||
17188456|NCT02519842|38341274|FG000|Base Study: Cycle 1|Screening Failure|1|||
17188457|NCT02519842|38341275|FG001|Base Study: Cycle 1|Screening Failure|1|||
17188458|NCT02519842|38341276|FG002|Base Study: Cycle 1|Screening Failure|0|||
17188459|NCT02519842|38341274|FG000|Base Study: Cycle 1|Adverse Event|1|||
17188460|NCT02519842|38341275|FG001|Base Study: Cycle 1|Adverse Event|0|||
17188461|NCT02519842|38341276|FG002|Base Study: Cycle 1|Adverse Event|0|||
17188462|NCT02519842|38341274|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
17188463|NCT02519842|38341275|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
17188464|NCT02519842|38341276|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
17188465|NCT02519842|38341274|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
17188466|NCT02519842|38341275|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
17188467|NCT02519842|38341276|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
17188468|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
17188469|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
17188470|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
17188471|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
17188472|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
17188473|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
17188474|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
17188475|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
17188476|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
17188477|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
17188478|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
17188479|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
17188480|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Death|0|||
17089744|NCT00274716|38229873|FG004|Phase A|Other non-reported reason|0|||
17089745|NCT00274716|38229874|FG005|Phase A|Other non-reported reason|1|||
17089746|NCT00274716|38229869|FG000|Phase A|Participant moved|0|||
17089747|NCT00274716|38229870|FG001|Phase A|Participant moved|0|||
17089748|NCT00274716|38229871|FG002|Phase A|Participant moved|1|||
17089749|NCT00274716|38229872|FG003|Phase A|Participant moved|0|||
17089750|NCT00274716|38229873|FG004|Phase A|Participant moved|0|||
17089751|NCT00274716|38229874|FG005|Phase A|Participant moved|1|||
17089752|NCT00274716|38229869|FG000|Phase A|Site Terminated|0|||
17188481|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Death|0|||
17188482|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Death|1|||
17188483|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
17188484|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
17188485|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
17188486|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
17188487|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
17188488|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
17188489|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
17188490|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
17188491|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
17188492|NCT02519842|38341274|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
17188493|NCT02519842|38341275|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
17188494|NCT02519842|38341276|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
17188495|NCT02509078|38341286|FG000|Overall Study|Protocol Violation|1|||
17188496|NCT02509078|38341287|FG001|Overall Study|Protocol Violation|1|||
17188497|NCT02993783|38341297|FG000|Overall Study|Reason not Specified|6|||
17188498|NCT02993783|38341298|FG001|Overall Study|Reason not Specified|9|||
17188499|NCT02993471|38341304|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
17188500|NCT02993471|38341304|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
17188501|NCT02988713|38341326|FG000|Overall Study|Withdrawal by Subject|1|||
17188502|NCT02988713|38341326|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
17188503|NCT01068743|38341330|FG000|Period 3|Adverse Event|0|||
17188504|NCT01068743|38341331|FG001|Period 3|Adverse Event|1|||
17188505|NCT01068743|38341332|FG002|Period 3|Adverse Event|0|||
17188506|NCT01068743|38341333|FG003|Period 3|Adverse Event|0|||
17188507|NCT02992691|38341346|FG000|Overall Study|Adverse Event|2|||
17188508|NCT02992691|38341346|FG000|Overall Study|Withdrawal by Subject|1|||
17188509|NCT02921087|38341363|FG000|Overall Study|Withdrawal by Subject|0|||
17188510|NCT02921087|38341364|FG001|Overall Study|Withdrawal by Subject|1|||
17188511|NCT02907619|38341383|FG000|Overall Study|Study terminated by sponsor|18|||
17188512|NCT02907619|38341384|FG001|Overall Study|Study terminated by sponsor|18|||
17188513|NCT02907619|38341385|FG002|Overall Study|Study terminated by sponsor|19|||
17188514|NCT02907619|38341383|FG000|Overall Study|Death|0|||
17188515|NCT02907619|38341384|FG001|Overall Study|Death|0|||
17188516|NCT02907619|38341385|FG002|Overall Study|Death|1|||
17188517|NCT02907619|38341383|FG000|Overall Study|Withdrawal by Subject|1|||
17188518|NCT02907619|38341384|FG001|Overall Study|Withdrawal by Subject|1|||
17188519|NCT02907619|38341385|FG002|Overall Study|Withdrawal by Subject|0|||
17188520|NCT02907619|38341383|FG000|Overall Study|Other|0|||
17188521|NCT02907619|38341384|FG001|Overall Study|Other|1|||
17188522|NCT02907619|38341385|FG002|Overall Study|Other|0|||
17188523|NCT02986373|38341395|FG000|Overall Study|Adverse Event|4|||
17188524|NCT02986373|38341395|FG000|Overall Study|Lost to Follow-up|1|||
17188525|NCT02986373|38341395|FG000|Overall Study|Withdrawal by Subject|10|||
17188526|NCT02986373|38341395|FG000|Overall Study|Other|24|||
17188527|NCT02986139|38341401|FG000|Overall Study|Sponsor Decision|1|||
17188528|NCT02986139|38341402|FG001|Overall Study|Sponsor Decision|2|||
17188529|NCT02986139|38341401|FG000|Overall Study|Withdrawal by Subject|0|||
17188530|NCT02986139|38341402|FG001|Overall Study|Withdrawal by Subject|1|||
17188531|NCT02986139|38341401|FG000|Overall Study|Lost to Follow-up|0|||
17188532|NCT02986139|38341402|FG001|Overall Study|Lost to Follow-up|1|||
17188533|NCT02989805|38341414|FG000|Overall Study|invalid consent|6|||
17188534|NCT02989805|38341415|FG001|Overall Study|invalid consent|4|||
17188535|NCT02907463|38341421|FG000|Overall Study|Lost to Follow-up|17|||
17188536|NCT02907463|38341421|FG000|Overall Study|Death|10|||
17188537|NCT02907463|38341421|FG000|Overall Study|Withdrawal by Subject|4|||
17188538|NCT02907463|38341421|FG000|Overall Study|MIS Approach was not used|2|||
17188539|NCT02907463|38341421|FG000|Overall Study|Not Implanted with Study Device|2|||
17188540|NCT02907463|38341421|FG000|Overall Study|Device Explanted|1|||
17188541|NCT02907463|38341421|FG000|Overall Study|Missing Exit Form|1|||
17188542|NCT02906917|38341435|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
17188543|NCT02906917|38341436|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
17188544|NCT02906917|38341435|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
17188545|NCT02906917|38341436|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
17188546|NCT02906917|38341435|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
17188547|NCT02906917|38341436|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
17188548|NCT02906917|38341435|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
17188549|NCT02906917|38341436|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
17188550|NCT02906917|38341435|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
17188551|NCT02906917|38341436|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
17188552|NCT02906917|38341435|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
17188553|NCT02906917|38341436|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
17188554|NCT02906917|38341435|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
17188555|NCT02906917|38341436|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
17188556|NCT02906917|38341435|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
17188557|NCT02906917|38341436|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
17188558|NCT02982187|38341444|FG000|Overall Study|Withdrawal by Subject|0|||
17188559|NCT02982187|38341445|FG001|Overall Study|Withdrawal by Subject|0|||
17188560|NCT02982187|38341446|FG002|Overall Study|Withdrawal by Subject|0|||
17188561|NCT02982187|38341447|FG003|Overall Study|Withdrawal by Subject|0|||
17188562|NCT02982187|38341448|FG004|Overall Study|Withdrawal by Subject|0|||
17188563|NCT02982187|38341449|FG005|Overall Study|Withdrawal by Subject|0|||
17188564|NCT02982187|38341450|FG006|Overall Study|Withdrawal by Subject|1|||
17188565|NCT02982187|38341451|FG007|Overall Study|Withdrawal by Subject|0|||
17188566|NCT02981953|38341461|FG000|Overall Study|Death|9|||
17188567|NCT02981953|38341461|FG000|Overall Study|Withdrawal by Subject|1|||
17188568|NCT02981953|38341461|FG000|Overall Study|Withdrawal to non-compliance|1|||
17188569|NCT01066585|38341477|FG000|Overall Study|Protocol Violation|1|||
17188570|NCT01066585|38341478|FG001|Overall Study|Protocol Violation|0|||
17188571|NCT01066585|38341477|FG000|Overall Study|Withdrawal by Subject|0|||
17188572|NCT01066585|38341478|FG001|Overall Study|Withdrawal by Subject|3|||
17188573|NCT02980783|38341484|FG000|Overall Study|Lost to Follow-up|1|||
17188574|NCT02980705|38341490|FG000|Overall Study|Adverse Event|0|||
17188575|NCT02980705|38341491|FG001|Overall Study|Adverse Event|1|||
17188576|NCT02980705|38341490|FG000|Overall Study|Withdrawal by Subject|6|||
17188577|NCT02980705|38341491|FG001|Overall Study|Withdrawal by Subject|9|||
17188578|NCT02980705|38341490|FG000|Overall Study|withdrew participation|0|||
17188579|NCT02980705|38341491|FG001|Overall Study|withdrew participation|1|||
17188580|NCT02980705|38341490|FG000|Overall Study|Lost to Follow-up|2|||
17188581|NCT02980705|38341491|FG001|Overall Study|Lost to Follow-up|0|||
17188582|NCT02923115|38341504|FG000|Overall Study|Lost to Follow-up|0|||
17188583|NCT02923115|38341505|FG001|Overall Study|Lost to Follow-up|0|||
17188584|NCT02923115|38341506|FG002|Overall Study|Lost to Follow-up|0|||
17188585|NCT02923115|38341507|FG003|Overall Study|Lost to Follow-up|1|||
17188586|NCT02923115|38341508|FG004|Overall Study|Lost to Follow-up|0|||
17188587|NCT02923115|38341509|FG005|Overall Study|Lost to Follow-up|0|||
17188588|NCT02923115|38341504|FG000|Overall Study|Withdrawal by Subject|0|||
17188589|NCT02923115|38341505|FG001|Overall Study|Withdrawal by Subject|1|||
17188590|NCT02923115|38341506|FG002|Overall Study|Withdrawal by Subject|0|||
17188591|NCT02923115|38341507|FG003|Overall Study|Withdrawal by Subject|0|||
17188592|NCT02923115|38341508|FG004|Overall Study|Withdrawal by Subject|0|||
17188593|NCT02923115|38341509|FG005|Overall Study|Withdrawal by Subject|0|||
17188594|NCT02923115|38341504|FG000|Overall Study|Randomized, but not dosed|0|||
17188595|NCT02923115|38341505|FG001|Overall Study|Randomized, but not dosed|0|||
17188596|NCT02923115|38341506|FG002|Overall Study|Randomized, but not dosed|3|||
17188597|NCT02923115|38341507|FG003|Overall Study|Randomized, but not dosed|1|||
17188598|NCT02923115|38341508|FG004|Overall Study|Randomized, but not dosed|5|||
17188599|NCT02923115|38341509|FG005|Overall Study|Randomized, but not dosed|0|||
17188600|NCT02989649|38341523|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
17188601|NCT02989649|38341523|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
17188602|NCT02989649|38341523|FG000|Overall Study|Lost For Observation During Study|3|||
17188603|NCT02989649|38341523|FG000|Overall Study|Reason Not Specified|13|||
17188604|NCT02905435|38341527|FG000|Overall Study|Death|2|||
17188605|NCT02905435|38341527|FG000|Overall Study|Physician Decision|1|||
17188606|NCT02905435|38341527|FG000|Overall Study|Lost to Follow-up|4|||
17188607|NCT02978833|38341534|FG000|Overall Study|Study terminated|1|||
17188608|NCT02978833|38341535|FG001|Overall Study|Study terminated|1|||
17089753|NCT00274716|38229870|FG001|Phase A|Site Terminated|0|||
17089754|NCT00274716|38229871|FG002|Phase A|Site Terminated|0|||
17089755|NCT00274716|38229872|FG003|Phase A|Site Terminated|1|||
17089756|NCT00274716|38229873|FG004|Phase A|Site Terminated|0|||
17089757|NCT00274716|38229874|FG005|Phase A|Site Terminated|0|||
17089758|NCT00274716|38229869|FG000|Phase A|Protocol Violation|1|||
17089759|NCT00274716|38229870|FG001|Phase A|Protocol Violation|0|||
17089760|NCT00274716|38229871|FG002|Phase A|Protocol Violation|0|||
17089761|NCT00274716|38229872|FG003|Phase A|Protocol Violation|1|||
17089762|NCT00274716|38229873|FG004|Phase A|Protocol Violation|0|||
17089763|NCT00274716|38229874|FG005|Phase A|Protocol Violation|0|||
17089764|NCT00274716|38229869|FG000|Phase A|Met criteria for discontinuation|1|||
17089765|NCT00274716|38229870|FG001|Phase A|Met criteria for discontinuation|1|||
17089766|NCT00274716|38229871|FG002|Phase A|Met criteria for discontinuation|0|||
17089767|NCT00274716|38229872|FG003|Phase A|Met criteria for discontinuation|0|||
17089768|NCT00274716|38229873|FG004|Phase A|Met criteria for discontinuation|0|||
17089769|NCT00274716|38229874|FG005|Phase A|Met criteria for discontinuation|0|||
17089770|NCT00274716|38229869|FG000|Phase A|Withdrawal by Subject|2|||
17089771|NCT00274716|38229870|FG001|Phase A|Withdrawal by Subject|2|||
17188609|NCT01067339|38341544|FG000|Overall Study|Withdrawal by Subject|6|||
17188610|NCT01067339|38341545|FG001|Overall Study|Withdrawal by Subject|5|||
17188611|NCT02573259|38341558|FG000|Overall Study|Death|1|||
17188612|NCT02573259|38341559|FG001|Overall Study|Death|6|||
17188613|NCT02573259|38341560|FG002|Overall Study|Death|5|||
17188614|NCT02573259|38341561|FG003|Overall Study|Death|6|||
17188615|NCT02573259|38341562|FG004|Overall Study|Death|9|||
17188616|NCT02573259|38341563|FG005|Overall Study|Death|32|||
17188617|NCT02573259|38341564|FG006|Overall Study|Death|21|||
17188618|NCT02573259|38341558|FG000|Overall Study|Lost to Follow-up|0|||
17188619|NCT02573259|38341559|FG001|Overall Study|Lost to Follow-up|0|||
17188620|NCT02573259|38341560|FG002|Overall Study|Lost to Follow-up|0|||
17188621|NCT02573259|38341561|FG003|Overall Study|Lost to Follow-up|0|||
17188622|NCT02573259|38341562|FG004|Overall Study|Lost to Follow-up|0|||
17188623|NCT02573259|38341563|FG005|Overall Study|Lost to Follow-up|2|||
17188624|NCT02573259|38341564|FG006|Overall Study|Lost to Follow-up|1|||
17188625|NCT02573259|38341558|FG000|Overall Study|Participant refused further follow-up|0|||
17188626|NCT02573259|38341559|FG001|Overall Study|Participant refused further follow-up|2|||
17188627|NCT02573259|38341560|FG002|Overall Study|Participant refused further follow-up|1|||
17188628|NCT02573259|38341561|FG003|Overall Study|Participant refused further follow-up|0|||
17188629|NCT02573259|38341562|FG004|Overall Study|Participant refused further follow-up|3|||
17188630|NCT02573259|38341563|FG005|Overall Study|Participant refused further follow-up|20|||
17188631|NCT02573259|38341564|FG006|Overall Study|Participant refused further follow-up|7|||
17188632|NCT02573259|38341558|FG000|Overall Study|Other|0|||
17188633|NCT02573259|38341559|FG001|Overall Study|Other|0|||
17188634|NCT02573259|38341560|FG002|Overall Study|Other|0|||
17188635|NCT02573259|38341561|FG003|Overall Study|Other|0|||
17188636|NCT02573259|38341562|FG004|Overall Study|Other|1|||
17188637|NCT02573259|38341563|FG005|Overall Study|Other|4|||
17188638|NCT02573259|38341564|FG006|Overall Study|Other|5|||
17188639|NCT02977507|38341601|FG000|Overall Study|Protocol Deviation|1|||
17188640|NCT02977507|38341602|FG001|Overall Study|Protocol Deviation|0|||
17188641|NCT02977507|38341601|FG000|Overall Study|Lost to Follow-up|1|||
17188642|NCT02977507|38341602|FG001|Overall Study|Lost to Follow-up|0|||
17188643|NCT02976103|38341611|FG000|Overall Study|Withdrawal by Subject|1|||
17188644|NCT02976103|38341612|FG001|Overall Study|Withdrawal by Subject|0|||
17188645|NCT02976103|38341611|FG000|Overall Study|Lost to Follow-up|12|||
17188646|NCT02976103|38341612|FG001|Overall Study|Lost to Follow-up|8|||
17188647|NCT01066039|38341619|FG000|Overall Study|Adverse Event|6|||
17188648|NCT01066039|38341619|FG000|Overall Study|Withdrawal by Subject|17|||
17188649|NCT01066039|38341619|FG000|Overall Study|Protocol Violation|2|||
17188650|NCT01066039|38341619|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
17188651|NCT01066039|38341619|FG000|Overall Study|Investigator's Request|1|||
17188652|NCT01066039|38341619|FG000|Overall Study|Dropout due to Insulin Administration|1|||
17188653|NCT01066039|38341619|FG000|Overall Study|Additional Antihypertensive Required|4|||
17188654|NCT01066039|38341619|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
17188655|NCT01066039|38341619|FG000|Overall Study|Failure to Control Blood Pressure|1|||
17188656|NCT01066039|38341619|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
17188657|NCT02919995|38341629|FG000|Overall Study|Adverse Event|0|||
17188658|NCT02919995|38341630|FG001|Overall Study|Adverse Event|0|||
17188659|NCT02919995|38341631|FG002|Overall Study|Adverse Event|0|||
17188660|NCT02919995|38341632|FG003|Overall Study|Adverse Event|0|||
17188661|NCT02919995|38341633|FG004|Overall Study|Adverse Event|0|||
17188662|NCT02919995|38341634|FG005|Overall Study|Adverse Event|1|||
17188663|NCT02919761|38341642|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
17188664|NCT02919761|38341643|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
17188665|NCT02919761|38341644|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
17188666|NCT02919761|38341642|FG000|Part 1: Open Label|Adverse Event|1|||
17188667|NCT02919761|38341643|FG001|Part 1: Open Label|Adverse Event|0|||
17188668|NCT02919761|38341644|FG002|Part 1: Open Label|Adverse Event|0|||
17188669|NCT02919761|38341642|FG000|Part 1: Open Label|Lost to Follow-up|1|||
17188670|NCT02919761|38341643|FG001|Part 1: Open Label|Lost to Follow-up|0|||
17188671|NCT02919761|38341644|FG002|Part 1: Open Label|Lost to Follow-up|0|||
17188672|NCT02919761|38341642|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
17188673|NCT02919761|38341643|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
17188674|NCT02919761|38341644|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
17188675|NCT02919761|38341642|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
17188676|NCT02919761|38341643|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
17188677|NCT02919761|38341644|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
17188678|NCT02919761|38341642|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
17188679|NCT02919761|38341643|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
17188680|NCT02919761|38341644|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
17188681|NCT02919761|38341642|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
17188682|NCT02919761|38341643|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
17188683|NCT02919761|38341644|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
17188684|NCT02919761|38341642|FG000|Part 1: Open Label|Termination by Sponsor|1|||
17188685|NCT02919761|38341643|FG001|Part 1: Open Label|Termination by Sponsor|0|||
17188686|NCT02919761|38341644|FG002|Part 1: Open Label|Termination by Sponsor|0|||
17188687|NCT02919761|38341642|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
17188688|NCT02919761|38341643|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
17188689|NCT02919761|38341644|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
17188690|NCT02919761|38341642|FG000|Part 2: Double-blind|Adverse Event|0|||
17188691|NCT02919761|38341643|FG001|Part 2: Double-blind|Adverse Event|1|||
17188692|NCT02919761|38341644|FG002|Part 2: Double-blind|Adverse Event|0|||
17188693|NCT02919761|38341642|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
17188694|NCT02919761|38341643|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
17188695|NCT02919761|38341644|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
17188696|NCT02919761|38341642|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
17188697|NCT02919761|38341643|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
16997308|NCT00751036|38141299|FG000|Overall Study|Death|3|||
16997309|NCT00751036|38141300|FG001|Overall Study|Death|3|||
16997310|NCT00751036|38141299|FG000|Overall Study|Lost to Follow-up|0|||
16997311|NCT00751036|38141300|FG001|Overall Study|Lost to Follow-up|1|||
17089772|NCT00274716|38229871|FG002|Phase A|Withdrawal by Subject|1|||
17089773|NCT00274716|38229872|FG003|Phase A|Withdrawal by Subject|3|||
17089774|NCT00274716|38229873|FG004|Phase A|Withdrawal by Subject|0|||
17089775|NCT00274716|38229874|FG005|Phase A|Withdrawal by Subject|1|||
16997312|NCT00751036|38141299|FG000|Overall Study|Protocol Violation|1|||
16997313|NCT00751036|38141300|FG001|Overall Study|Protocol Violation|0|||
16997314|NCT00751036|38141299|FG000|Overall Study|Missing end of Treatment Page|2|||
16997315|NCT00751036|38141300|FG001|Overall Study|Missing end of Treatment Page|3|||
16997316|NCT00961298|38141306|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
16997317|NCT00961298|38141306|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
16997318|NCT00961298|38141306|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
16997319|NCT00744328|38141313|FG000|Overall Study|Lost to Follow-up|2|||
16997320|NCT00744328|38141314|FG001|Overall Study|Lost to Follow-up|5|||
16997321|NCT00744328|38141315|FG002|Overall Study|Lost to Follow-up|3|||
16997322|NCT00744328|38141313|FG000|Overall Study|Withdrawal by Subject|5|||
16997323|NCT00744328|38141314|FG001|Overall Study|Withdrawal by Subject|3|||
16997324|NCT00744328|38141315|FG002|Overall Study|Withdrawal by Subject|4|||
16997325|NCT00744328|38141313|FG000|Overall Study|Found ineligible after randomization|0|||
16997326|NCT00744328|38141314|FG001|Overall Study|Found ineligible after randomization|0|||
16997327|NCT00744328|38141315|FG002|Overall Study|Found ineligible after randomization|1|||
16997328|NCT03245840|38141325|FG000|Overall Study|Adverse Event|6|||
16997329|NCT03245840|38141326|FG001|Overall Study|Adverse Event|0|||
16997330|NCT03245840|38141325|FG000|Overall Study|Death|2|||
16997331|NCT03245840|38141326|FG001|Overall Study|Death|0|||
16997332|NCT03245840|38141325|FG000|Overall Study|Withdrawal by Subject|31|||
16997333|NCT03245840|38141326|FG001|Overall Study|Withdrawal by Subject|1|||
17089776|NCT00274716|38229869|FG000|Phase A|Adverse Event|2|||
17089777|NCT00274716|38229870|FG001|Phase A|Adverse Event|3|||
17089778|NCT00274716|38229871|FG002|Phase A|Adverse Event|3|||
17089779|NCT00274716|38229872|FG003|Phase A|Adverse Event|0|||
17089780|NCT00274716|38229873|FG004|Phase A|Adverse Event|2|||
17089781|NCT00274716|38229874|FG005|Phase A|Adverse Event|0|||
17089782|NCT00274716|38229869|FG000|Phase A|Completed but did not enter Phase B|1|||
17089783|NCT00274716|38229870|FG001|Phase A|Completed but did not enter Phase B|2|||
17089784|NCT00274716|38229871|FG002|Phase A|Completed but did not enter Phase B|2|||
17188698|NCT02919761|38341644|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
16997334|NCT03245840|38141325|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16997335|NCT03245840|38141326|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16997336|NCT03245840|38141325|FG000|Overall Study|Physician Decision|4|||
16997337|NCT03245840|38141326|FG001|Overall Study|Physician Decision|1|||
16997338|NCT03245840|38141325|FG000|Overall Study|Study Terminated by Sponsor|56|||
17089785|NCT00274716|38229872|FG003|Phase A|Completed but did not enter Phase B|2|||
17188699|NCT02919761|38341642|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
16997339|NCT03245840|38141326|FG001|Overall Study|Study Terminated by Sponsor|6|||
16997340|NCT03245840|38141325|FG000|Overall Study|Site Terminated by Sponsor|4|||
16997341|NCT03245840|38141326|FG001|Overall Study|Site Terminated by Sponsor|0|||
16997342|NCT03245840|38141325|FG000|Overall Study|Lost to Follow-up|12|||
16997343|NCT03245840|38141326|FG001|Overall Study|Lost to Follow-up|2|||
16997344|NCT03245840|38141325|FG000|Overall Study|Pregnancy|2|||
16997345|NCT03245840|38141326|FG001|Overall Study|Pregnancy|0|||
16997346|NCT03245840|38141325|FG000|Overall Study|Non-Compliance with Study Drug|2|||
16997347|NCT03245840|38141326|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16997348|NCT03245840|38141325|FG000|Overall Study|Not treated|1|||
16997349|NCT03245840|38141326|FG001|Overall Study|Not treated|1|||
16997350|NCT00959894|38141332|FG000|Overall Study|Lost to Follow-up|10|||
16997351|NCT00959894|38141332|FG000|Overall Study|Adverse Event|3|||
16997352|NCT00959894|38141332|FG000|Overall Study|Withdrawal by Subject|1|||
17089786|NCT00274716|38229873|FG004|Phase A|Completed but did not enter Phase B|1|||
17089787|NCT00274716|38229874|FG005|Phase A|Completed but did not enter Phase B|1|||
17188700|NCT02919761|38341643|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
17188701|NCT02919761|38341644|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
17188702|NCT02919761|38341642|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
17188703|NCT02919761|38341643|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
17188704|NCT02919761|38341644|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
17188705|NCT02919761|38341642|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
17188706|NCT02919761|38341643|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
17188707|NCT02919761|38341644|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
17188708|NCT02919761|38341642|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
17188709|NCT02919761|38341643|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
17188710|NCT02919761|38341644|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
17188711|NCT02910167|38341655|FG000|Overall Study|Adverse Event|1|||
17188712|NCT02910167|38341655|FG000|Overall Study|Lost to Follow-up|18|||
17188713|NCT01067105|38341659|FG000|Overall Study|Adverse Event|14|||
17188714|NCT01067105|38341659|FG000|Overall Study|Protocol Violation|48|||
17188715|NCT01067105|38341659|FG000|Overall Study|Withdrawal by Subject|36|||
17188716|NCT01067105|38341659|FG000|Overall Study|Lost to Follow-up|6|||
17188717|NCT01067105|38341659|FG000|Overall Study|Physician Decision|6|||
17188718|NCT01067105|38341659|FG000|Overall Study|Other|31|||
17188719|NCT02910089|38341669|FG000|Overall Study|Lost insurance eligibility|22|||
17188720|NCT02910089|38341670|FG001|Overall Study|Lost insurance eligibility|16|||
17188721|NCT02985515|38341678|FG000|Olfaction Testing|Lost to Follow-up|0|||
17188722|NCT02985515|38341679|FG001|Olfaction Testing|Lost to Follow-up|5|||
17188723|NCT02985515|38341678|FG000|Olfaction Testing|Protocol Violation|0|||
17188724|NCT02985515|38341679|FG001|Olfaction Testing|Protocol Violation|3|||
17188725|NCT02910011|38341692|FG000|Overall Study|Physician Decision|2|||
17188726|NCT02908841|38341700|FG000|Overall Study|Physician Decision|4|||
17188727|NCT02908841|38341701|FG001|Overall Study|Physician Decision|0|||
17188728|NCT02909153|38341712|FG000|Overall Study|Withdrawal by Subject|0|||
17188729|NCT02909153|38341713|FG001|Overall Study|Withdrawal by Subject|1|||
17188730|NCT02909153|38341714|FG002|Overall Study|Withdrawal by Subject|0|||
17188731|NCT02909153|38341715|FG003|Overall Study|Withdrawal by Subject|0|||
17188732|NCT02909153|38341716|FG004|Overall Study|Withdrawal by Subject|0|||
17188733|NCT02908529|38341728|FG000|Overall Study|Lost to Follow-up|0|||
17188734|NCT02908529|38341729|FG001|Overall Study|Lost to Follow-up|2|||
17188735|NCT02984267|38341739|FG000|Overall Study|Protocol Violation|1|||
17188736|NCT02984267|38341740|FG001|Overall Study|Protocol Violation|0|||
17188737|NCT02984267|38341739|FG000|Overall Study|Withdrawal by Subject|0|||
17188738|NCT02984267|38341740|FG001|Overall Study|Withdrawal by Subject|1|||
17188739|NCT02675751|38341746|FG000|Overall Study|Lost to Follow-up|16|||
17188740|NCT02974855|38341763|FG000|Overall Study|Adverse Event|0|||
17188741|NCT02974855|38341764|FG001|Overall Study|Adverse Event|1|||
17188742|NCT02974855|38341765|FG002|Overall Study|Adverse Event|0|||
17188743|NCT02974855|38341766|FG003|Overall Study|Adverse Event|1|||
17188744|NCT00455403|38341791|FG000|Overall Study|Lost to Follow-up|2|||
17188745|NCT00455403|38341792|FG001|Overall Study|Lost to Follow-up|1|||
17188746|NCT00455403|38341791|FG000|Overall Study|Withdrawal by Subject|1|||
17188747|NCT00455403|38341792|FG001|Overall Study|Withdrawal by Subject|3|||
17188748|NCT00455403|38341791|FG000|Overall Study|Protocol Violation|0|||
17188749|NCT00455403|38341792|FG001|Overall Study|Protocol Violation|2|||
17188750|NCT02979613|38341800|FG000|Double-Blind Phase|Withdrew Consent|2|||
17188751|NCT02979613|38341801|FG001|Double-Blind Phase|Withdrew Consent|4|||
17188752|NCT02979613|38341800|FG000|Double-Blind Phase|Pregnancy|2|||
17188753|NCT02979613|38341801|FG001|Double-Blind Phase|Pregnancy|2|||
17188754|NCT02979613|38341800|FG000|Double-Blind Phase|Adverse Event|2|||
17188755|NCT02979613|38341801|FG001|Double-Blind Phase|Adverse Event|0|||
17188756|NCT02979613|38341800|FG000|Double-Blind Phase|Lost to Follow-up|1|||
17188757|NCT02979613|38341801|FG001|Double-Blind Phase|Lost to Follow-up|1|||
17188758|NCT02979613|38341800|FG000|Double-Blind Phase|Protocol Violation|1|||
17089788|NCT00274716|38229869|FG000|Phase B|Adverse Event|0|||
17089789|NCT00274716|38229870|FG001|Phase B|Adverse Event|0|||
17089790|NCT00274716|38229871|FG002|Phase B|Adverse Event|2|||
17089791|NCT00274716|38229872|FG003|Phase B|Adverse Event|0|||
17089792|NCT00274716|38229873|FG004|Phase B|Adverse Event|0|||
17089793|NCT00274716|38229874|FG005|Phase B|Adverse Event|1|||
17089794|NCT00274716|38229869|FG000|Phase B|Protocol Violation|0|||
17089795|NCT00274716|38229870|FG001|Phase B|Protocol Violation|2|||
17089796|NCT00274716|38229871|FG002|Phase B|Protocol Violation|0|||
17089797|NCT00274716|38229872|FG003|Phase B|Protocol Violation|0|||
17089798|NCT00274716|38229873|FG004|Phase B|Protocol Violation|0|||
17089799|NCT00274716|38229874|FG005|Phase B|Protocol Violation|0|||
17089800|NCT00274716|38229869|FG000|Phase B|Withdrawal by Subject|0|||
17089801|NCT00274716|38229870|FG001|Phase B|Withdrawal by Subject|1|||
17089802|NCT00274716|38229871|FG002|Phase B|Withdrawal by Subject|0|||
17089803|NCT00274716|38229872|FG003|Phase B|Withdrawal by Subject|0|||
17089804|NCT00274716|38229873|FG004|Phase B|Withdrawal by Subject|0|||
17089805|NCT00274716|38229874|FG005|Phase B|Withdrawal by Subject|0|||
17089806|NCT00274716|38229869|FG000|Phase B|Participant moved|1|||
17089807|NCT00274716|38229870|FG001|Phase B|Participant moved|0|||
17089808|NCT00274716|38229871|FG002|Phase B|Participant moved|0|||
16997353|NCT00959894|38141332|FG000|Overall Study|Need for contraindicated medication|1|||
17089809|NCT00274716|38229872|FG003|Phase B|Participant moved|0|||
17089810|NCT00274716|38229873|FG004|Phase B|Participant moved|0|||
17089811|NCT00274716|38229874|FG005|Phase B|Participant moved|0|||
17089812|NCT00274716|38229869|FG000|Phase B|Other non-reported reason|0|||
17089813|NCT00274716|38229870|FG001|Phase B|Other non-reported reason|0|||
17089814|NCT00274716|38229871|FG002|Phase B|Other non-reported reason|1|||
17089815|NCT00274716|38229872|FG003|Phase B|Other non-reported reason|1|||
17089816|NCT00274716|38229873|FG004|Phase B|Other non-reported reason|0|||
17089817|NCT00274716|38229874|FG005|Phase B|Other non-reported reason|0|||
17089818|NCT00274716|38229869|FG000|Phase B|Lost to Follow-up|0|||
17089819|NCT00274716|38229870|FG001|Phase B|Lost to Follow-up|1|||
17089820|NCT00274716|38229871|FG002|Phase B|Lost to Follow-up|0|||
17089821|NCT00274716|38229872|FG003|Phase B|Lost to Follow-up|0|||
17089822|NCT00274716|38229873|FG004|Phase B|Lost to Follow-up|0|||
17089823|NCT00274716|38229874|FG005|Phase B|Lost to Follow-up|0|||
17089824|NCT00282048|38229892|FG000|Overall Study|Lack of Efficacy|30|||
17089825|NCT00282048|38229892|FG000|Overall Study|Adverse Event|22|||
17089826|NCT00282048|38229892|FG000|Overall Study|Withdrawal by Subject|1|||
17089827|NCT00282048|38229892|FG000|Overall Study|Other|8|||
17089828|NCT00282048|38229892|FG000|Overall Study|Ongoing|1|||
17089829|NCT00474539|38229898|FG000|Infant Series|Withdrawal by Subject|3|||
17089830|NCT00474539|38229899|FG001|Infant Series|Withdrawal by Subject|4|||
17089831|NCT00474539|38229898|FG000|Infant Series|Randomization error|5|||
17089832|NCT00474539|38229899|FG001|Infant Series|Randomization error|0|||
17089833|NCT00474539|38229898|FG000|Infant Series|Lost to Follow-up|2|||
17089834|NCT00474539|38229899|FG001|Infant Series|Lost to Follow-up|1|||
17089835|NCT00474539|38229898|FG000|Infant Series|Protocol Violation|0|||
17089836|NCT00474539|38229899|FG001|Infant Series|Protocol Violation|1|||
17089837|NCT00474539|38229898|FG000|After Infant Series|Lost to Follow-up|3|||
17089838|NCT00474539|38229899|FG001|After Infant Series|Lost to Follow-up|0|||
17089839|NCT00474539|38229898|FG000|After Infant Series|Withdrawal by Subject|1|||
17089840|NCT00474539|38229899|FG001|After Infant Series|Withdrawal by Subject|0|||
17089841|NCT00474539|38229898|FG000|Toddler Dose|Protocol Violation|1|||
17089842|NCT00474539|38229899|FG001|Toddler Dose|Protocol Violation|0|||
17089843|NCT00281580|38229946|FG000|Overall Study|Adverse Event|2|||
17089844|NCT00281580|38229947|FG001|Overall Study|Adverse Event|0|||
16997354|NCT00959894|38141332|FG000|Overall Study|Subject moved out of town|1|||
16997355|NCT00750880|38141337|FG000|Overall Study|Adverse Event|76|||
17188759|NCT02979613|38341801|FG001|Double-Blind Phase|Protocol Violation|1|||
17188760|NCT02979613|38341800|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
17188761|NCT02979613|38341801|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
17188762|NCT02979613|38341800|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
17188763|NCT02979613|38341801|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
17188764|NCT02979613|38341800|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
17188765|NCT02979613|38341801|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
17188766|NCT02979613|38341800|FG000|Open-Label Extension (OLE) Phase|Death|0|||
17188767|NCT02979613|38341801|FG001|Open-Label Extension (OLE) Phase|Death|1|||
17188768|NCT02979613|38341800|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
17188769|NCT02979613|38341801|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
17188770|NCT01064167|38341811|FG000|Overall Study|Protocol Violation|14|||
17188771|NCT01064167|38341812|FG001|Overall Study|Protocol Violation|15|||
17188772|NCT02974543|38341820|FG000|Overall Study|Withdrawal by Subject|1|||
17188773|NCT02974543|38341821|FG001|Overall Study|Withdrawal by Subject|0|||
17188774|NCT01064947|38341835|FG000|Overall Study|negative culture|41|||
17188775|NCT02974153|38341846|FG000|Overall Study|Adverse Event|6|||
17188776|NCT02974153|38341847|FG001|Overall Study|Adverse Event|0|||
17188777|NCT02974153|38341848|FG002|Overall Study|Adverse Event|1|||
17188778|NCT02974153|38341846|FG000|Overall Study|Lack of Efficacy|6|||
17188779|NCT02974153|38341847|FG001|Overall Study|Lack of Efficacy|5|||
17188780|NCT02974153|38341848|FG002|Overall Study|Lack of Efficacy|10|||
17188781|NCT02974153|38341846|FG000|Overall Study|Lost to Follow-up|9|||
17188782|NCT02974153|38341847|FG001|Overall Study|Lost to Follow-up|10|||
17089845|NCT00281580|38229948|FG002|Overall Study|Adverse Event|2|||
17089846|NCT00281580|38229949|FG003|Overall Study|Adverse Event|4|||
17089847|NCT00281580|38229950|FG004|Overall Study|Adverse Event|1|||
17089848|NCT00281580|38229951|FG005|Overall Study|Adverse Event|0|||
17089849|NCT00281580|38229952|FG006|Overall Study|Adverse Event|1|||
17089850|NCT00281580|38229953|FG007|Overall Study|Adverse Event|0|||
16997356|NCT00750880|38141337|FG000|Overall Study|Death|4|||
16997357|NCT00750880|38141337|FG000|Overall Study|Lack of Efficacy|46|||
16997358|NCT00750880|38141337|FG000|Overall Study|Lost to Follow-up|10|||
16997359|NCT00750880|38141337|FG000|Overall Study|Protocol Violation|15|||
16997360|NCT00750880|38141337|FG000|Overall Study|Withdrawal by Subject|33|||
17089851|NCT00281580|38229954|FG008|Overall Study|Adverse Event|1|||
17188783|NCT02974153|38341848|FG002|Overall Study|Lost to Follow-up|17|||
17188784|NCT02974153|38341846|FG000|Overall Study|Physician Decision|0|||
17188785|NCT02974153|38341847|FG001|Overall Study|Physician Decision|2|||
17089852|NCT00281580|38229955|FG009|Overall Study|Adverse Event|6|||
17188786|NCT02974153|38341848|FG002|Overall Study|Physician Decision|1|||
17188787|NCT02974153|38341846|FG000|Overall Study|Withdrawal by Subject|9|||
17188788|NCT02974153|38341847|FG001|Overall Study|Withdrawal by Subject|16|||
16997361|NCT00750880|38141337|FG000|Overall Study|Physician Decision|20|||
16997362|NCT00750880|38141337|FG000|Overall Study|Administrative|11|||
16997363|NCT00746590|38141342|FG000|Overall Study|Death|1|||
16997364|NCT01032629|38141349|FG000|Overall Study|Closed Site|21|||
16997365|NCT01032629|38141350|FG001|Overall Study|Closed Site|18|||
16997366|NCT01032629|38141351|FG002|Overall Study|Closed Site|16|||
17188789|NCT02974153|38341848|FG002|Overall Study|Withdrawal by Subject|11|||
17188790|NCT02974153|38341846|FG000|Overall Study|Study Burden|8|||
17188791|NCT02974153|38341847|FG001|Overall Study|Study Burden|7|||
17188792|NCT02974153|38341848|FG002|Overall Study|Study Burden|3|||
17188793|NCT02974153|38341846|FG000|Overall Study|Other|14|||
17188794|NCT02974153|38341847|FG001|Overall Study|Other|8|||
17188795|NCT02974153|38341848|FG002|Overall Study|Other|7|||
17188796|NCT02508532|38341863|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
17188797|NCT02508532|38341864|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
17188798|NCT02508532|38341865|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
17188799|NCT02508532|38341866|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
17188800|NCT02508532|38341867|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16997367|NCT01032629|38141349|FG000|Overall Study|Withdrawal by Subject|50|||
16997368|NCT01032629|38141350|FG001|Overall Study|Withdrawal by Subject|36|||
16997369|NCT01032629|38141351|FG002|Overall Study|Withdrawal by Subject|35|||
16997370|NCT01032629|38141349|FG000|Overall Study|Lost to Follow-up|74|||
16997371|NCT01032629|38141350|FG001|Overall Study|Lost to Follow-up|47|||
16997372|NCT01032629|38141351|FG002|Overall Study|Lost to Follow-up|37|||
16997373|NCT00749944|38141362|FG000|Overall Study|Lost to Follow-up|2|||
16997374|NCT00749944|38141363|FG001|Overall Study|Lost to Follow-up|1|||
16997375|NCT00749944|38141362|FG000|Overall Study|Other|1|||
16997376|NCT00749944|38141363|FG001|Overall Study|Other|0|||
16997377|NCT00749944|38141362|FG000|Overall Study|Withdrawal by Subject|2|||
16997378|NCT00749944|38141363|FG001|Overall Study|Withdrawal by Subject|0|||
16997379|NCT00746356|38141369|FG000|Overall Study|Withdrawal by Subject|2|||
16997380|NCT00746356|38141370|FG001|Overall Study|Withdrawal by Subject|3|||
16997381|NCT00746356|38141369|FG000|Overall Study|Death|7|||
16997382|NCT00746356|38141370|FG001|Overall Study|Death|3|||
16997383|NCT00746356|38141369|FG000|Overall Study|Lost to Follow-up|1|||
16997384|NCT00746356|38141370|FG001|Overall Study|Lost to Follow-up|0|||
16997385|NCT00746356|38141369|FG000|Overall Study|Removal of Device|0|||
16997386|NCT00746356|38141370|FG001|Overall Study|Removal of Device|1|||
16997387|NCT00746356|38141369|FG000|Overall Study|Patient relocated|1|||
16997388|NCT00746356|38141370|FG001|Overall Study|Patient relocated|0|||
16997389|NCT00749398|38141378|FG000|Overall Study|Lack of Efficacy|7|||
16997390|NCT00749398|38141378|FG000|Overall Study|Adverse Event|4|||
16997391|NCT00749398|38141378|FG000|Overall Study|Serious adverse event|11|||
16997392|NCT00749398|38141378|FG000|Overall Study|Withdrawal by Subject|17|||
16997393|NCT00749398|38141378|FG000|Overall Study|Lost to Follow-up|11|||
16997394|NCT00749398|38141378|FG000|Overall Study|Reason not specified|2|||
16997395|NCT00749398|38141378|FG000|Overall Study|Unknown reason|1|||
16997396|NCT01012973|38141384|FG000|Overall Study|Adverse Event|5|||
16997397|NCT01012973|38141385|FG001|Overall Study|Adverse Event|5|||
16997398|NCT01012973|38141384|FG000|Overall Study|Lack of Efficacy|0|||
16997399|NCT01012973|38141385|FG001|Overall Study|Lack of Efficacy|5|||
16997400|NCT01012973|38141384|FG000|Overall Study|Lost to Follow-up|1|||
16997401|NCT01012973|38141385|FG001|Overall Study|Lost to Follow-up|0|||
16997402|NCT01012973|38141384|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
16997403|NCT01012973|38141385|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
16997404|NCT01012973|38141384|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
16997405|NCT01012973|38141385|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
16997406|NCT01012973|38141384|FG000|Overall Study|Protocol Violation|5|||
16997407|NCT01012973|38141385|FG001|Overall Study|Protocol Violation|2|||
16997408|NCT01012973|38141384|FG000|Overall Study|Withdrawal by Subject|4|||
16997409|NCT01012973|38141385|FG001|Overall Study|Withdrawal by Subject|6|||
16997410|NCT00748540|38141395|FG000|Overall Study|Physician Decision|1|||
16997411|NCT01012739|38141399|FG000|Treatment Period 1|Adverse Event|0|||
16997412|NCT01012739|38141400|FG001|Treatment Period 1|Adverse Event|0|||
16997413|NCT01012739|38141401|FG002|Treatment Period 1|Adverse Event|0|||
16997414|NCT01012739|38141402|FG003|Treatment Period 1|Adverse Event|1|||
16997415|NCT01012739|38141399|FG000|Treatment Period 2|Abnormal test procedure results|0|||
16997416|NCT01012739|38141400|FG001|Treatment Period 2|Abnormal test procedure results|0|||
16997417|NCT01012739|38141401|FG002|Treatment Period 2|Abnormal test procedure results|0|||
16997418|NCT01012739|38141402|FG003|Treatment Period 2|Abnormal test procedure results|1|||
16997419|NCT00742924|38141417|FG000|Overall Study|Adverse Event|0|||
16997420|NCT00742924|38141418|FG001|Overall Study|Adverse Event|0|||
17188801|NCT02508532|38341868|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
17089853|NCT00281580|38229956|FG010|Overall Study|Adverse Event|0|||
17089854|NCT00281580|38229957|FG011|Overall Study|Adverse Event|5|||
17089855|NCT00281580|38229958|FG012|Overall Study|Adverse Event|8|||
17089856|NCT00281580|38229959|FG013|Overall Study|Adverse Event|2|||
17089857|NCT00281580|38229960|FG014|Overall Study|Adverse Event|3|||
17089858|NCT00281580|38229961|FG015|Overall Study|Adverse Event|3|||
17089859|NCT00281580|38229946|FG000|Overall Study|Protocol Violation|0|||
17089860|NCT00281580|38229947|FG001|Overall Study|Protocol Violation|0|||
17089861|NCT00281580|38229948|FG002|Overall Study|Protocol Violation|1|||
17089862|NCT00281580|38229949|FG003|Overall Study|Protocol Violation|1|||
17089863|NCT00281580|38229950|FG004|Overall Study|Protocol Violation|0|||
17089864|NCT00281580|38229951|FG005|Overall Study|Protocol Violation|0|||
17089865|NCT00281580|38229952|FG006|Overall Study|Protocol Violation|1|||
17089866|NCT00281580|38229953|FG007|Overall Study|Protocol Violation|0|||
17089867|NCT00281580|38229954|FG008|Overall Study|Protocol Violation|2|||
17089868|NCT00281580|38229955|FG009|Overall Study|Protocol Violation|0|||
17089869|NCT00281580|38229956|FG010|Overall Study|Protocol Violation|1|||
17089870|NCT00281580|38229957|FG011|Overall Study|Protocol Violation|2|||
17089871|NCT00281580|38229958|FG012|Overall Study|Protocol Violation|0|||
17089872|NCT00281580|38229959|FG013|Overall Study|Protocol Violation|1|||
17089873|NCT00281580|38229960|FG014|Overall Study|Protocol Violation|1|||
17089874|NCT00281580|38229961|FG015|Overall Study|Protocol Violation|3|||
16997421|NCT00742924|38141419|FG002|Overall Study|Adverse Event|1|||
16997422|NCT00742924|38141420|FG003|Overall Study|Adverse Event|1|||
16997423|NCT00742924|38141417|FG000|Overall Study|Lack of Efficacy|5|||
16997424|NCT00742924|38141418|FG001|Overall Study|Lack of Efficacy|1|||
16997425|NCT00742924|38141419|FG002|Overall Study|Lack of Efficacy|2|||
16997426|NCT00742924|38141420|FG003|Overall Study|Lack of Efficacy|4|||
16997427|NCT00742924|38141417|FG000|Overall Study|Physician Decision|0|||
17089875|NCT00281580|38229946|FG000|Overall Study|Withdrawal by Subject|3|||
16997428|NCT00742924|38141418|FG001|Overall Study|Physician Decision|0|||
16997429|NCT00742924|38141419|FG002|Overall Study|Physician Decision|0|||
16997430|NCT00742924|38141420|FG003|Overall Study|Physician Decision|1|||
16997431|NCT00742924|38141417|FG000|Overall Study|Withdrawal by Subject|0|||
16997432|NCT00742924|38141418|FG001|Overall Study|Withdrawal by Subject|1|||
16997433|NCT00742924|38141419|FG002|Overall Study|Withdrawal by Subject|1|||
16997434|NCT00742924|38141420|FG003|Overall Study|Withdrawal by Subject|0|||
16997435|NCT00698815|38141433|FG000|Overall Study|Death|1|||
16997436|NCT00698815|38141434|FG001|Overall Study|Death|2|||
16997437|NCT00698815|38141435|FG002|Overall Study|Death|4|||
16997438|NCT00698815|38141433|FG000|Overall Study|Withdrawal by Subject|6|||
16997439|NCT00698815|38141434|FG001|Overall Study|Withdrawal by Subject|3|||
16997440|NCT00698815|38141435|FG002|Overall Study|Withdrawal by Subject|2|||
16997441|NCT00698815|38141433|FG000|Overall Study|MD discretion|2|||
17089876|NCT00281580|38229947|FG001|Overall Study|Withdrawal by Subject|0|||
17089877|NCT00281580|38229948|FG002|Overall Study|Withdrawal by Subject|1|||
17089878|NCT00281580|38229949|FG003|Overall Study|Withdrawal by Subject|1|||
17089879|NCT00281580|38229950|FG004|Overall Study|Withdrawal by Subject|1|||
17089880|NCT00281580|38229951|FG005|Overall Study|Withdrawal by Subject|2|||
16997442|NCT00698815|38141434|FG001|Overall Study|MD discretion|7|||
16997443|NCT00698815|38141435|FG002|Overall Study|MD discretion|2|||
16997444|NCT00698815|38141433|FG000|Overall Study|Did not receive protocol treatment|1|||
16997445|NCT00698815|38141434|FG001|Overall Study|Did not receive protocol treatment|2|||
17089881|NCT00281580|38229952|FG006|Overall Study|Withdrawal by Subject|2|||
17089882|NCT00281580|38229953|FG007|Overall Study|Withdrawal by Subject|0|||
16997446|NCT00698815|38141435|FG002|Overall Study|Did not receive protocol treatment|2|||
16997447|NCT00745498|38141446|FG000|Overall Study|Lost to Follow-up|1|||
16997448|NCT00745498|38141447|FG001|Overall Study|Lost to Follow-up|1|||
16997449|NCT00745498|38141448|FG002|Overall Study|Lost to Follow-up|3|||
17089883|NCT00281580|38229954|FG008|Overall Study|Withdrawal by Subject|1|||
17089884|NCT00281580|38229955|FG009|Overall Study|Withdrawal by Subject|4|||
17089885|NCT00281580|38229956|FG010|Overall Study|Withdrawal by Subject|1|||
17089886|NCT00281580|38229957|FG011|Overall Study|Withdrawal by Subject|1|||
17089887|NCT00281580|38229958|FG012|Overall Study|Withdrawal by Subject|2|||
17089888|NCT00281580|38229959|FG013|Overall Study|Withdrawal by Subject|2|||
17089889|NCT00281580|38229960|FG014|Overall Study|Withdrawal by Subject|1|||
17089890|NCT00281580|38229961|FG015|Overall Study|Withdrawal by Subject|5|||
16997450|NCT00745498|38141446|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
16997451|NCT00745498|38141447|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
16997452|NCT00745498|38141448|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
16997453|NCT00745498|38141446|FG000|Overall Study|Non-PDR related VH|0|||
16997454|NCT00745498|38141447|FG001|Overall Study|Non-PDR related VH|1|||
17089891|NCT00281580|38229946|FG000|Overall Study|Lack of Efficacy|2|||
17089892|NCT00281580|38229947|FG001|Overall Study|Lack of Efficacy|1|||
17089893|NCT00281580|38229948|FG002|Overall Study|Lack of Efficacy|1|||
17089894|NCT00281580|38229949|FG003|Overall Study|Lack of Efficacy|6|||
17089895|NCT00281580|38229950|FG004|Overall Study|Lack of Efficacy|2|||
17089896|NCT00281580|38229951|FG005|Overall Study|Lack of Efficacy|0|||
17089897|NCT00281580|38229952|FG006|Overall Study|Lack of Efficacy|0|||
17089898|NCT00281580|38229953|FG007|Overall Study|Lack of Efficacy|0|||
17188802|NCT02508532|38341869|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
17188803|NCT02508532|38341870|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
17188804|NCT02508532|38341871|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
17188805|NCT02508532|38341863|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
17188806|NCT02508532|38341864|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
17188807|NCT02508532|38341865|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
17188808|NCT02508532|38341866|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
17188809|NCT02508532|38341867|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
17188810|NCT02508532|38341868|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
17188811|NCT02508532|38341869|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
17188812|NCT02508532|38341870|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
17188813|NCT02508532|38341871|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
17188814|NCT02508532|38341863|FG000|Part 2 - Treatment|Disease Progression|0|||
17188815|NCT02508532|38341864|FG001|Part 2 - Treatment|Disease Progression|0|||
17188816|NCT02508532|38341865|FG002|Part 2 - Treatment|Disease Progression|0|||
17188817|NCT02508532|38341866|FG003|Part 2 - Treatment|Disease Progression|0|||
17188818|NCT02508532|38341867|FG004|Part 2 - Treatment|Disease Progression|0|||
17188819|NCT02508532|38341868|FG005|Part 2 - Treatment|Disease Progression|0|||
17188820|NCT02508532|38341869|FG006|Part 2 - Treatment|Disease Progression|0|||
17188821|NCT02508532|38341870|FG007|Part 2 - Treatment|Disease Progression|0|||
17188822|NCT02508532|38341871|FG008|Part 2 - Treatment|Disease Progression|118|||
17188823|NCT02508532|38341863|FG000|Part 2 - Treatment|Adverse Event|0|||
17188824|NCT02508532|38341864|FG001|Part 2 - Treatment|Adverse Event|0|||
17188825|NCT02508532|38341865|FG002|Part 2 - Treatment|Adverse Event|0|||
17188826|NCT02508532|38341866|FG003|Part 2 - Treatment|Adverse Event|0|||
17188827|NCT02508532|38341867|FG004|Part 2 - Treatment|Adverse Event|0|||
17188828|NCT02508532|38341868|FG005|Part 2 - Treatment|Adverse Event|0|||
17188829|NCT02508532|38341869|FG006|Part 2 - Treatment|Adverse Event|0|||
17188830|NCT02508532|38341870|FG007|Part 2 - Treatment|Adverse Event|0|||
17188831|NCT02508532|38341871|FG008|Part 2 - Treatment|Adverse Event|49|||
17188832|NCT02508532|38341863|FG000|Part 2 - Treatment|Physician Decision|0|||
17188833|NCT02508532|38341864|FG001|Part 2 - Treatment|Physician Decision|0|||
17188834|NCT02508532|38341865|FG002|Part 2 - Treatment|Physician Decision|0|||
17188835|NCT02508532|38341866|FG003|Part 2 - Treatment|Physician Decision|0|||
16997455|NCT00745498|38141448|FG002|Overall Study|Non-PDR related VH|1|||
16997456|NCT00745498|38141446|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
16997457|NCT00745498|38141447|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
16997458|NCT00745498|38141448|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
16997459|NCT00744874|38141456|FG000|Overall Study|Lost to Follow-up|1|||
16997460|NCT00744874|38141456|FG000|Overall Study|Withdrawal by Subject|1|||
16997461|NCT00744874|38141456|FG000|Overall Study|Study Device not available at procedure|1|||
16997462|NCT00744874|38141456|FG000|Overall Study|Unable to accomodate schedule|1|||
16997463|NCT00576901|38141467|FG000|Overall Study|Withdrawal by Subject|1|||
16997464|NCT00576901|38141467|FG000|Overall Study|Disease course|1|||
16997465|NCT00576901|38141467|FG000|Overall Study|Protocol Violation|1|||
16997466|NCT00699283|38141473|FG000|Overall Study|Lack of Efficacy|15|||
16997467|NCT00699283|38141474|FG001|Overall Study|Lack of Efficacy|5|||
16997468|NCT00699283|38141473|FG000|Overall Study|Lost to Follow-up|2|||
16997469|NCT00699283|38141474|FG001|Overall Study|Lost to Follow-up|0|||
16997470|NCT00699283|38141473|FG000|Overall Study|Withdrawal by Subject|1|||
16997471|NCT00699283|38141474|FG001|Overall Study|Withdrawal by Subject|0|||
17089899|NCT00281580|38229954|FG008|Overall Study|Lack of Efficacy|0|||
17089900|NCT00281580|38229955|FG009|Overall Study|Lack of Efficacy|0|||
17089901|NCT00281580|38229956|FG010|Overall Study|Lack of Efficacy|0|||
16997472|NCT00699283|38141473|FG000|Overall Study|Other Reason|5|||
16781322|NCT02105272|37720501|FG001|Overall Study|Adverse Event|2|||
17089902|NCT00281580|38229957|FG011|Overall Study|Lack of Efficacy|1|||
16781323|NCT02105272|37720500|FG000|Overall Study|Physician Decision|0|||
16781324|NCT02105272|37720501|FG001|Overall Study|Physician Decision|1|||
16781325|NCT02105272|37720500|FG000|Overall Study|Protocol Violation|2|||
16781326|NCT02105272|37720501|FG001|Overall Study|Protocol Violation|0|||
16781327|NCT02105272|37720500|FG000|Overall Study|Withdrawal by Subject|2|||
16781328|NCT02105272|37720501|FG001|Overall Study|Withdrawal by Subject|0|||
16781329|NCT02141854|37720512|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
16781330|NCT02141854|37720513|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16781331|NCT02141854|37720514|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16781332|NCT02141854|37720515|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16781333|NCT02141854|37720516|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16781334|NCT02141854|37720517|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16781335|NCT02141854|37720512|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
16781336|NCT02141854|37720513|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16781337|NCT02141854|37720514|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16781338|NCT02141854|37720515|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16781339|NCT02141854|37720516|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16781340|NCT02141854|37720517|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16781341|NCT02141854|37720512|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
16781342|NCT02141854|37720513|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16781343|NCT02141854|37720514|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16781344|NCT02141854|37720515|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16781345|NCT02141854|37720516|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16781346|NCT02141854|37720517|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16781347|NCT02141854|37720512|FG000|Run-In Period (Pre-assignment)|Other|14|||
16781348|NCT02141854|37720513|FG001|Run-In Period (Pre-assignment)|Other|0|||
16781349|NCT02141854|37720514|FG002|Run-In Period (Pre-assignment)|Other|0|||
16781350|NCT02141854|37720515|FG003|Run-In Period (Pre-assignment)|Other|0|||
16781351|NCT02141854|37720516|FG004|Run-In Period (Pre-assignment)|Other|0|||
16781352|NCT02141854|37720517|FG005|Run-In Period (Pre-assignment)|Other|0|||
16781353|NCT02141854|37720512|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
16781354|NCT02141854|37720513|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
16781355|NCT02141854|37720514|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
16781356|NCT02141854|37720515|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
16781357|NCT02141854|37720516|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
16781358|NCT02141854|37720517|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
16781359|NCT02141854|37720512|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
16781360|NCT02141854|37720513|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16781361|NCT02141854|37720514|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16781362|NCT02141854|37720515|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16781363|NCT02141854|37720516|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16781364|NCT02141854|37720517|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16781365|NCT02141854|37720512|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
16781366|NCT02141854|37720513|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16781367|NCT02141854|37720514|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16781368|NCT02141854|37720515|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16781369|NCT02141854|37720516|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16781370|NCT02141854|37720517|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16781371|NCT02141854|37720512|FG000|Treatment Period|Protocol Violation|0|||
16781372|NCT02141854|37720513|FG001|Treatment Period|Protocol Violation|1|||
16781373|NCT02141854|37720514|FG002|Treatment Period|Protocol Violation|0|||
16781374|NCT02141854|37720515|FG003|Treatment Period|Protocol Violation|2|||
16781375|NCT02141854|37720516|FG004|Treatment Period|Protocol Violation|2|||
16781376|NCT02141854|37720517|FG005|Treatment Period|Protocol Violation|1|||
16781377|NCT02141854|37720512|FG000|Treatment Period|Noncompliance|0|||
16781378|NCT02141854|37720513|FG001|Treatment Period|Noncompliance|0|||
16781379|NCT02141854|37720514|FG002|Treatment Period|Noncompliance|0|||
16781380|NCT02141854|37720515|FG003|Treatment Period|Noncompliance|1|||
16781381|NCT02141854|37720516|FG004|Treatment Period|Noncompliance|0|||
16781382|NCT02141854|37720517|FG005|Treatment Period|Noncompliance|0|||
16781383|NCT02141854|37720512|FG000|Treatment Period|Lack of Efficacy|0|||
16781384|NCT02141854|37720513|FG001|Treatment Period|Lack of Efficacy|0|||
16781385|NCT02141854|37720514|FG002|Treatment Period|Lack of Efficacy|0|||
16781386|NCT02141854|37720515|FG003|Treatment Period|Lack of Efficacy|1|||
16781387|NCT02141854|37720516|FG004|Treatment Period|Lack of Efficacy|1|||
16781388|NCT02141854|37720517|FG005|Treatment Period|Lack of Efficacy|7|||
16781389|NCT02141854|37720512|FG000|Treatment Period|Pregnancy|0|||
16781390|NCT02141854|37720513|FG001|Treatment Period|Pregnancy|1|||
16781391|NCT02141854|37720514|FG002|Treatment Period|Pregnancy|0|||
16781392|NCT02141854|37720515|FG003|Treatment Period|Pregnancy|0|||
16781393|NCT02141854|37720516|FG004|Treatment Period|Pregnancy|0|||
16781394|NCT02141854|37720517|FG005|Treatment Period|Pregnancy|0|||
16781395|NCT02141854|37720512|FG000|Treatment Period|Other|0|||
16781396|NCT02141854|37720513|FG001|Treatment Period|Other|1|||
16781397|NCT02141854|37720514|FG002|Treatment Period|Other|2|||
16781398|NCT02141854|37720515|FG003|Treatment Period|Other|0|||
16781399|NCT02141854|37720516|FG004|Treatment Period|Other|1|||
16781400|NCT02141854|37720517|FG005|Treatment Period|Other|2|||
16781401|NCT02141854|37720512|FG000|Treatment Period|Adverse Event|0|||
16781402|NCT02141854|37720513|FG001|Treatment Period|Adverse Event|2|||
16781403|NCT02141854|37720514|FG002|Treatment Period|Adverse Event|2|||
16781404|NCT02141854|37720515|FG003|Treatment Period|Adverse Event|0|||
16781405|NCT02141854|37720516|FG004|Treatment Period|Adverse Event|2|||
16781406|NCT02141854|37720517|FG005|Treatment Period|Adverse Event|2|||
16781407|NCT02141854|37720512|FG000|Treatment Period|Withdrawal by Subject|0|||
16781408|NCT02141854|37720513|FG001|Treatment Period|Withdrawal by Subject|2|||
16781409|NCT02141854|37720514|FG002|Treatment Period|Withdrawal by Subject|3|||
16781410|NCT02141854|37720515|FG003|Treatment Period|Withdrawal by Subject|3|||
16781411|NCT02141854|37720516|FG004|Treatment Period|Withdrawal by Subject|4|||
16781412|NCT02141854|37720517|FG005|Treatment Period|Withdrawal by Subject|7|||
16781413|NCT02141854|37720512|FG000|Treatment Period|Disease progression|0|||
16781414|NCT02141854|37720513|FG001|Treatment Period|Disease progression|2|||
16781415|NCT02141854|37720514|FG002|Treatment Period|Disease progression|1|||
16781416|NCT02141854|37720515|FG003|Treatment Period|Disease progression|3|||
16781417|NCT02141854|37720516|FG004|Treatment Period|Disease progression|0|||
16781418|NCT02141854|37720517|FG005|Treatment Period|Disease progression|18|||
16781419|NCT02141854|37720512|FG000|Treatment Period|Lost to Follow-up|0|||
16781420|NCT02141854|37720513|FG001|Treatment Period|Lost to Follow-up|1|||
16781421|NCT02141854|37720514|FG002|Treatment Period|Lost to Follow-up|1|||
16781422|NCT02141854|37720515|FG003|Treatment Period|Lost to Follow-up|1|||
16781423|NCT02141854|37720516|FG004|Treatment Period|Lost to Follow-up|0|||
16781424|NCT02141854|37720517|FG005|Treatment Period|Lost to Follow-up|1|||
16781425|NCT02587221|37720531|FG000|Overall Study|Adverse Event|3|||
16781426|NCT02587221|37720532|FG001|Overall Study|Adverse Event|3|||
16781427|NCT02587221|37720531|FG000|Overall Study|Death|33|||
16781428|NCT02587221|37720532|FG001|Overall Study|Death|34|||
16781429|NCT02587221|37720531|FG000|Overall Study|Withdrawal by Subject|66|||
16781430|NCT02587221|37720532|FG001|Overall Study|Withdrawal by Subject|61|||
16781431|NCT02587221|37720531|FG000|Overall Study|Lost to Follow-up|21|||
16781432|NCT02587221|37720532|FG001|Overall Study|Lost to Follow-up|19|||
16781433|NCT02587221|37720531|FG000|Overall Study|Protocol Violation|6|||
16781434|NCT02587221|37720532|FG001|Overall Study|Protocol Violation|5|||
16781435|NCT02587221|37720531|FG000|Overall Study|Other Reason or Unspecified|2|||
16781436|NCT02587221|37720532|FG001|Overall Study|Other Reason or Unspecified|1|||
16781437|NCT02141620|37720538|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
16781438|NCT02141620|37720539|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
16781439|NCT02106910|37720547|FG000|Overall Study|Lost to Follow-up|1|||
16781440|NCT02106910|37720548|FG001|Overall Study|Lost to Follow-up|1|||
16781441|NCT01664949|37720557|FG000|Overall Study|Adverse Event|11|||
16997473|NCT00699283|38141474|FG001|Overall Study|Other Reason|1|||
16781442|NCT01664949|37720558|FG001|Overall Study|Adverse Event|12|||
16781443|NCT01664949|37720557|FG000|Overall Study|Lack of Efficacy|1|||
16781444|NCT01664949|37720558|FG001|Overall Study|Lack of Efficacy|1|||
16781445|NCT01664949|37720557|FG000|Overall Study|Lost to Follow-up|1|||
16781446|NCT01664949|37720558|FG001|Overall Study|Lost to Follow-up|2|||
16781447|NCT01664949|37720557|FG000|Overall Study|Personal Reasons|3|||
16781448|NCT01664949|37720558|FG001|Overall Study|Personal Reasons|4|||
16781449|NCT01664949|37720557|FG000|Overall Study|Protocol Violation|5|||
16781450|NCT01664949|37720558|FG001|Overall Study|Protocol Violation|5|||
16781451|NCT01664949|37720557|FG000|Overall Study|Other Miscellaneous Reasons|3|||
16781452|NCT01664949|37720558|FG001|Overall Study|Other Miscellaneous Reasons|1|||
16781453|NCT02587143|37720566|FG000|Overall Study|Adverse Event|1|||
16781454|NCT02587143|37720567|FG001|Overall Study|Adverse Event|0|||
16781455|NCT02587065|37720573|FG000|Overall Study|Adverse Event|14|||
16781456|NCT02587065|37720573|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
16781457|NCT02587065|37720573|FG000|Overall Study|Non-adherence to the Protocol|3|||
16781458|NCT02587065|37720573|FG000|Overall Study|Discontinuation of Study Medication|2|||
16781459|NCT02587065|37720573|FG000|Overall Study|Reason not Specified|3|||
16781460|NCT02106832|37720581|FG000|Overall Study|Adverse Event|1|||
16781461|NCT02106832|37720582|FG001|Overall Study|Adverse Event|2|||
16781462|NCT02106832|37720583|FG002|Overall Study|Adverse Event|3|||
16781463|NCT02106832|37720584|FG003|Overall Study|Adverse Event|0|||
16781464|NCT02106832|37720581|FG000|Overall Study|Death|4|||
16781465|NCT02106832|37720582|FG001|Overall Study|Death|4|||
16781466|NCT02106832|37720583|FG002|Overall Study|Death|1|||
16781467|NCT02106832|37720584|FG003|Overall Study|Death|4|||
16781468|NCT02106832|37720581|FG000|Overall Study|Deterioration of general conditions|0|||
16781469|NCT02106832|37720582|FG001|Overall Study|Deterioration of general conditions|0|||
16781470|NCT02106832|37720583|FG002|Overall Study|Deterioration of general conditions|1|||
16781471|NCT02106832|37720584|FG003|Overall Study|Deterioration of general conditions|0|||
16781472|NCT02106832|37720581|FG000|Overall Study|Lost to Follow-up|0|||
16781473|NCT02106832|37720582|FG001|Overall Study|Lost to Follow-up|1|||
16781474|NCT02106832|37720583|FG002|Overall Study|Lost to Follow-up|1|||
16781475|NCT02106832|37720584|FG003|Overall Study|Lost to Follow-up|3|||
16781476|NCT02106832|37720581|FG000|Overall Study|Physician Decision|1|||
16781477|NCT02106832|37720582|FG001|Overall Study|Physician Decision|0|||
16781478|NCT02106832|37720583|FG002|Overall Study|Physician Decision|0|||
16781479|NCT02106832|37720584|FG003|Overall Study|Physician Decision|0|||
16781480|NCT02106832|37720581|FG000|Overall Study|Protocol Violation|0|||
16781481|NCT02106832|37720582|FG001|Overall Study|Protocol Violation|0|||
16781482|NCT02106832|37720583|FG002|Overall Study|Protocol Violation|0|||
16781483|NCT02106832|37720584|FG003|Overall Study|Protocol Violation|1|||
16781484|NCT02106832|37720581|FG000|Overall Study|Withdrawal by Subject|17|||
16781485|NCT02106832|37720582|FG001|Overall Study|Withdrawal by Subject|17|||
16781486|NCT02106832|37720583|FG002|Overall Study|Withdrawal by Subject|10|||
16781487|NCT02106832|37720584|FG003|Overall Study|Withdrawal by Subject|7|||
16781488|NCT02106832|37720581|FG000|Overall Study|Technical problems|0|||
16781489|NCT02106832|37720582|FG001|Overall Study|Technical problems|1|||
16781490|NCT02106832|37720583|FG002|Overall Study|Technical problems|0|||
16781491|NCT02106832|37720584|FG003|Overall Study|Technical problems|0|||
16781492|NCT02106442|37720596|FG000|Overall Study|Case Report Forms Uncollected|7|||
16781493|NCT02106442|37720596|FG000|Overall Study|Protocol Deviation|30|||
16781494|NCT02105116|37720600|FG000|Overall Study|not eligible for step 2 of trial|5|||
16781495|NCT02105116|37720600|FG000|Overall Study|Death|1|||
16781496|NCT02104804|37720606|FG000|Overall Study|Did not take study medication|0|||
16781497|NCT02104804|37720607|FG001|Overall Study|Did not take study medication|1|||
16781498|NCT02104804|37720606|FG000|Overall Study|Study specific discontinuation criteria|6|||
16781499|NCT02104804|37720607|FG001|Overall Study|Study specific discontinuation criteria|1|||
16781500|NCT02104804|37720606|FG000|Overall Study|Other listed|2|||
16781501|NCT02104804|37720607|FG001|Overall Study|Other listed|1|||
16781502|NCT02104804|37720606|FG000|Overall Study|Protocol Violation|0|||
16781503|NCT02104804|37720607|FG001|Overall Study|Protocol Violation|1|||
16781504|NCT02104804|37720606|FG000|Overall Study|Adverse Event|4|||
16781505|NCT02104804|37720607|FG001|Overall Study|Adverse Event|3|||
16781506|NCT02104804|37720606|FG000|Overall Study|Withdrawal by Subject|4|||
16781507|NCT02104804|37720607|FG001|Overall Study|Withdrawal by Subject|12|||
16781508|NCT02075008|37720613|FG000|Overall Study|Technical problems|1|||
16781509|NCT02075008|37720613|FG000|Overall Study|Pregnancy|1|||
16781510|NCT02075008|37720613|FG000|Overall Study|Physician Decision|1|||
16781511|NCT02075008|37720613|FG000|Overall Study|Lost to Follow-up|1|||
16781512|NCT02075008|37720613|FG000|Overall Study|Lack of Efficacy|1|||
16781513|NCT02075008|37720613|FG000|Overall Study|Death|1|||
16781514|NCT02075008|37720613|FG000|Overall Study|Adverse Event|5|||
16781515|NCT02075008|37720613|FG000|Overall Study|Withdrawal by Subject|6|||
16781516|NCT02075008|37720613|FG000|Overall Study|Study terminated by Sponsor|159|||
16781517|NCT01666119|37720617|FG000|Overall Study|Adverse Event|6|||
16781518|NCT01666119|37720617|FG000|Overall Study|Withdrawal by Subject|16|||
16781519|NCT01666119|37720617|FG000|Overall Study|Lost to Follow-up|7|||
16781520|NCT01666119|37720617|FG000|Overall Study|non compliance with study medication, pa|18|||
16781521|NCT01666119|37720617|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
16781522|NCT02586207|37720621|FG000|Overall Study|Physician Decision|1|||
16781523|NCT02586207|37720621|FG000|Overall Study|Withdrawal by Subject|1|||
16781524|NCT01665807|37720628|FG000|Overall Study|Withdrawal by Subject|2|||
16781525|NCT01665807|37720629|FG001|Overall Study|Withdrawal by Subject|0|||
16781526|NCT01665807|37720630|FG002|Overall Study|Withdrawal by Subject|1|||
16781527|NCT02584959|37720641|FG000|Period 1|Withdrawn from study|3|||
16781528|NCT02584959|37720642|FG001|Period 1|Withdrawn from study|4|||
16781529|NCT02584959|37720643|FG002|Period 1|Withdrawn from study|0|||
16781530|NCT02584959|37720641|FG000|Period 2|Withdrawn from study|6|||
16781531|NCT02584959|37720642|FG001|Period 2|Withdrawn from study|1|||
16781532|NCT02584959|37720643|FG002|Period 2|Withdrawn from study|2|||
16781533|NCT02584257|37720660|FG000|Period 1|Withdrawal by Subject|0|||
16781534|NCT02584257|37720661|FG001|Period 1|Withdrawal by Subject|0|||
16781535|NCT02584257|37720662|FG002|Period 1|Withdrawal by Subject|0|||
16781536|NCT02584257|37720663|FG003|Period 1|Withdrawal by Subject|0|||
16868029|NCT01536145|37841038|FG005|Overall Study|Other|0|||
16868030|NCT01536145|37841039|FG006|Overall Study|Other|0|||
16868031|NCT01536145|37841040|FG007|Overall Study|Other|0|||
16868032|NCT01536145|37841041|FG008|Overall Study|Other|0|||
16868033|NCT01536145|37841042|FG009|Overall Study|Other|3|||
16868034|NCT01536145|37841043|FG010|Overall Study|Other|2|||
16868035|NCT01536145|37841033|FG000|Overall Study|Death|0|||
16868036|NCT01536145|37841034|FG001|Overall Study|Death|0|||
16868037|NCT01536145|37841035|FG002|Overall Study|Death|0|||
16868038|NCT01536145|37841036|FG003|Overall Study|Death|0|||
16868039|NCT01536145|37841037|FG004|Overall Study|Death|0|||
16781537|NCT02584257|37720664|FG004|Period 1|Withdrawal by Subject|0|||
16781538|NCT02584257|37720665|FG005|Period 1|Withdrawal by Subject|0|||
16781539|NCT02584257|37720666|FG006|Period 1|Withdrawal by Subject|1|||
16781540|NCT02584257|37720667|FG007|Period 1|Withdrawal by Subject|0|||
16781541|NCT02584257|37720668|FG008|Period 1|Withdrawal by Subject|0|||
16781542|NCT02584257|37720660|FG000|Period 2|Physician Decision|1|||
16868040|NCT01536145|37841038|FG005|Overall Study|Death|0|||
16868041|NCT01536145|37841039|FG006|Overall Study|Death|1|||
16997474|NCT00699283|38141473|FG000|Overall Study|SAE, non-fatal|1|||
16997475|NCT00699283|38141474|FG001|Overall Study|SAE, non-fatal|1|||
16997476|NCT00699283|38141473|FG000|Overall Study|AE, non-serious non-fatal|8|||
16997477|NCT00699283|38141474|FG001|Overall Study|AE, non-serious non-fatal|1|||
16997478|NCT00699283|38141473|FG000|Overall Study|AE of unknown type|1|||
16997479|NCT00699283|38141474|FG001|Overall Study|AE of unknown type|0|||
16997480|NCT00740584|38141479|FG000|Overall Study|Withdrawal by Subject|1|||
16997481|NCT01023815|38141488|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
16997482|NCT01023815|38141489|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
16781543|NCT02584257|37720661|FG001|Period 2|Physician Decision|0|||
17089903|NCT00281580|38229958|FG012|Overall Study|Lack of Efficacy|0|||
17089904|NCT00281580|38229959|FG013|Overall Study|Lack of Efficacy|2|||
17089905|NCT00281580|38229960|FG014|Overall Study|Lack of Efficacy|1|||
17089906|NCT00281580|38229961|FG015|Overall Study|Lack of Efficacy|0|||
17089907|NCT00281580|38229946|FG000|Overall Study|Lost to Follow-up|0|||
17089908|NCT00281580|38229947|FG001|Overall Study|Lost to Follow-up|0|||
16997483|NCT01023815|38141490|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
16997484|NCT01023815|38141491|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
16997485|NCT01023815|38141488|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
16997486|NCT01023815|38141489|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
16997487|NCT01023815|38141490|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
16997488|NCT01023815|38141491|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
16997489|NCT01023815|38141488|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
16997490|NCT01023815|38141489|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
16997491|NCT01023815|38141490|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
16997492|NCT01023815|38141491|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
16997493|NCT01023815|38141488|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
16997494|NCT01023815|38141489|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
16997495|NCT01023815|38141490|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
16997496|NCT01023815|38141491|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
16997497|NCT01023815|38141488|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
16997498|NCT01023815|38141489|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
16997499|NCT01023815|38141490|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
16997500|NCT01023815|38141491|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
16997501|NCT01023659|38141505|FG000|Overall Study|Lost to Follow-up|73|||
17089909|NCT00281580|38229948|FG002|Overall Study|Lost to Follow-up|0|||
17089910|NCT00281580|38229949|FG003|Overall Study|Lost to Follow-up|3|||
17089911|NCT00281580|38229950|FG004|Overall Study|Lost to Follow-up|0|||
17089912|NCT00281580|38229951|FG005|Overall Study|Lost to Follow-up|1|||
17089913|NCT00281580|38229952|FG006|Overall Study|Lost to Follow-up|0|||
17089914|NCT00281580|38229953|FG007|Overall Study|Lost to Follow-up|1|||
17089915|NCT00281580|38229954|FG008|Overall Study|Lost to Follow-up|2|||
17089916|NCT00281580|38229955|FG009|Overall Study|Lost to Follow-up|1|||
17089917|NCT00281580|38229956|FG010|Overall Study|Lost to Follow-up|1|||
17089918|NCT00281580|38229957|FG011|Overall Study|Lost to Follow-up|0|||
17089919|NCT00281580|38229958|FG012|Overall Study|Lost to Follow-up|1|||
17089920|NCT00281580|38229959|FG013|Overall Study|Lost to Follow-up|0|||
17188836|NCT02508532|38341867|FG004|Part 2 - Treatment|Physician Decision|0|||
17188837|NCT02508532|38341868|FG005|Part 2 - Treatment|Physician Decision|0|||
17188838|NCT02508532|38341869|FG006|Part 2 - Treatment|Physician Decision|0|||
17188839|NCT02508532|38341870|FG007|Part 2 - Treatment|Physician Decision|0|||
17188840|NCT02508532|38341871|FG008|Part 2 - Treatment|Physician Decision|12|||
17188841|NCT02508532|38341863|FG000|Part 2 - Treatment|Administrative|0|||
17188842|NCT02508532|38341864|FG001|Part 2 - Treatment|Administrative|0|||
17188843|NCT02508532|38341865|FG002|Part 2 - Treatment|Administrative|0|||
16997502|NCT01023659|38141506|FG001|Overall Study|Lost to Follow-up|228|||
16997503|NCT01023659|38141507|FG002|Overall Study|Lost to Follow-up|99|||
16997504|NCT00740116|38141518|FG000|Overall Study|Withdrawal by Subject|1|||
17089921|NCT00281580|38229960|FG014|Overall Study|Lost to Follow-up|0|||
17089922|NCT00281580|38229961|FG015|Overall Study|Lost to Follow-up|0|||
17188844|NCT02508532|38341866|FG003|Part 2 - Treatment|Administrative|0|||
16781544|NCT02584257|37720662|FG002|Period 2|Physician Decision|0|||
16781545|NCT02584257|37720663|FG003|Period 2|Physician Decision|0|||
16781546|NCT02584257|37720664|FG004|Period 2|Physician Decision|0|||
17188845|NCT02508532|38341867|FG004|Part 2 - Treatment|Administrative|0|||
16781547|NCT02584257|37720665|FG005|Period 2|Physician Decision|0|||
16781548|NCT02584257|37720666|FG006|Period 2|Physician Decision|0|||
16781549|NCT02584257|37720667|FG007|Period 2|Physician Decision|0|||
16781550|NCT02584257|37720668|FG008|Period 2|Physician Decision|0|||
16997505|NCT00740116|38141519|FG001|Overall Study|Withdrawal by Subject|1|||
17188846|NCT02508532|38341868|FG005|Part 2 - Treatment|Administrative|0|||
17188847|NCT02508532|38341869|FG006|Part 2 - Treatment|Administrative|0|||
17188848|NCT02508532|38341870|FG007|Part 2 - Treatment|Administrative|0|||
17188849|NCT02508532|38341871|FG008|Part 2 - Treatment|Administrative|3|||
17188850|NCT02508532|38341863|FG000|Part 2 - Treatment|Sponsor Decision|0|||
17188851|NCT02508532|38341864|FG001|Part 2 - Treatment|Sponsor Decision|0|||
16997506|NCT00740116|38141518|FG000|Overall Study|Protocol Violation|1|||
17188852|NCT02508532|38341865|FG002|Part 2 - Treatment|Sponsor Decision|0|||
17188853|NCT02508532|38341866|FG003|Part 2 - Treatment|Sponsor Decision|0|||
17188854|NCT02508532|38341867|FG004|Part 2 - Treatment|Sponsor Decision|0|||
17188855|NCT02508532|38341868|FG005|Part 2 - Treatment|Sponsor Decision|0|||
17188856|NCT02508532|38341869|FG006|Part 2 - Treatment|Sponsor Decision|0|||
17188857|NCT02508532|38341870|FG007|Part 2 - Treatment|Sponsor Decision|0|||
17188858|NCT02508532|38341871|FG008|Part 2 - Treatment|Sponsor Decision|28|||
17188859|NCT02508532|38341863|FG000|Part 2 - Treatment|Death|0|||
17188860|NCT02508532|38341864|FG001|Part 2 - Treatment|Death|0|||
17188861|NCT02508532|38341865|FG002|Part 2 - Treatment|Death|0|||
17188862|NCT02508532|38341866|FG003|Part 2 - Treatment|Death|0|||
16997507|NCT00740116|38141519|FG001|Overall Study|Protocol Violation|4|||
17089923|NCT00281580|38229946|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
17089924|NCT00281580|38229947|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
17089925|NCT00281580|38229948|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
17089926|NCT00281580|38229949|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
17089927|NCT00281580|38229950|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
17089928|NCT00281580|38229951|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
17089929|NCT00281580|38229952|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
17089930|NCT00281580|38229953|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
17089931|NCT00281580|38229954|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
17089932|NCT00281580|38229955|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
17089933|NCT00281580|38229956|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
17089934|NCT00281580|38229957|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
17089935|NCT00281580|38229958|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
17089936|NCT00281580|38229959|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
17089937|NCT00281580|38229960|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
17089938|NCT00281580|38229961|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
17089939|NCT00495755|38230030|FG000|Overall Study|Adverse Event|3|||
17089940|NCT00495677|38230042|FG000|Stage 1 (25 Days)|Adverse Event|0|||
17089941|NCT00495677|38230043|FG001|Stage 1 (25 Days)|Adverse Event|0|||
17089942|NCT00495677|38230044|FG002|Stage 1 (25 Days)|Adverse Event|1|||
17089943|NCT00495677|38230045|FG003|Stage 1 (25 Days)|Adverse Event|0|||
17089944|NCT00495677|38230046|FG004|Stage 1 (25 Days)|Adverse Event|0|||
17089945|NCT00495677|38230047|FG005|Stage 1 (25 Days)|Adverse Event|0|||
17089946|NCT00495677|38230048|FG006|Stage 1 (25 Days)|Adverse Event|0|||
17089947|NCT00495521|38230066|FG000|Overall Study|Physician Decision|0|||
17089948|NCT00495521|38230067|FG001|Overall Study|Physician Decision|1|||
17089949|NCT00273858|38230073|FG000|Overall Study|Not completed 24 month observation time|334|||
17089950|NCT00273858|38230073|FG000|Overall Study|Lost to Follow-up|101|||
17089951|NCT00273858|38230073|FG000|Overall Study|Withdrawal by Subject|21|||
17089952|NCT00273858|38230073|FG000|Overall Study|Adverse Event|81|||
17089953|NCT00494507|38230081|FG000|Double-Blind Phase|Adverse Event|2|||
17089954|NCT00494507|38230082|FG001|Double-Blind Phase|Adverse Event|0|||
17188863|NCT02508532|38341867|FG004|Part 2 - Treatment|Death|0|||
16997508|NCT00698581|38141529|FG000|Overall Study|Lack of Efficacy|23|||
16997509|NCT00698581|38141530|FG001|Overall Study|Lack of Efficacy|11|||
16997510|NCT00698581|38141529|FG000|Overall Study|Withdrawal by Subject|6|||
16997511|NCT00698581|38141530|FG001|Overall Study|Withdrawal by Subject|0|||
16997512|NCT00698581|38141529|FG000|Overall Study|Other reason|9|||
16997513|NCT00698581|38141530|FG001|Overall Study|Other reason|1|||
16997514|NCT00698581|38141529|FG000|Overall Study|SAE, non-fatal|1|||
16997515|NCT00698581|38141530|FG001|Overall Study|SAE, non-fatal|0|||
16997516|NCT00698581|38141529|FG000|Overall Study|AE, non-serious non-fatal|4|||
16997517|NCT00698581|38141530|FG001|Overall Study|AE, non-serious non-fatal|0|||
16997518|NCT00698581|38141529|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16997519|NCT00698581|38141530|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16997520|NCT00698581|38141529|FG000|Overall Study|AE of unknown type|1|||
16997521|NCT00698581|38141530|FG001|Overall Study|AE of unknown type|0|||
16997522|NCT01023581|38141544|FG000|Overall Study|Adverse Event|4|||
16997523|NCT01023581|38141545|FG001|Overall Study|Adverse Event|4|||
16997524|NCT01023581|38141546|FG002|Overall Study|Adverse Event|7|||
16997525|NCT01023581|38141547|FG003|Overall Study|Adverse Event|3|||
16997526|NCT01023581|38141548|FG004|Overall Study|Adverse Event|2|||
16997527|NCT01023581|38141549|FG005|Overall Study|Adverse Event|5|||
16997528|NCT01023581|38141550|FG006|Overall Study|Adverse Event|11|||
17188864|NCT02508532|38341868|FG005|Part 2 - Treatment|Death|0|||
16997529|NCT01023581|38141544|FG000|Overall Study|Major protocol deviation|2|||
16781551|NCT02584257|37720660|FG000|Period 2|Adverse Event|0|||
16781552|NCT02584257|37720661|FG001|Period 2|Adverse Event|1|||
16781553|NCT02584257|37720662|FG002|Period 2|Adverse Event|0|||
16781554|NCT02584257|37720663|FG003|Period 2|Adverse Event|0|||
16868042|NCT01536145|37841040|FG007|Overall Study|Death|0|||
16781555|NCT02584257|37720664|FG004|Period 2|Adverse Event|0|||
16781556|NCT02584257|37720665|FG005|Period 2|Adverse Event|0|||
16781557|NCT02584257|37720666|FG006|Period 2|Adverse Event|0|||
16868043|NCT01536145|37841041|FG008|Overall Study|Death|0|||
16868044|NCT01536145|37841042|FG009|Overall Study|Death|0|||
16868045|NCT01536145|37841043|FG010|Overall Study|Death|0|||
16868046|NCT01536145|37841033|FG000|Overall Study|Adverse Event|0|||
16868047|NCT01536145|37841034|FG001|Overall Study|Adverse Event|0|||
16868048|NCT01536145|37841035|FG002|Overall Study|Adverse Event|0|||
16868049|NCT01536145|37841036|FG003|Overall Study|Adverse Event|0|||
16868050|NCT01536145|37841037|FG004|Overall Study|Adverse Event|0|||
16868051|NCT01536145|37841038|FG005|Overall Study|Adverse Event|0|||
16868052|NCT01536145|37841039|FG006|Overall Study|Adverse Event|0|||
16868053|NCT01536145|37841040|FG007|Overall Study|Adverse Event|2|||
16868054|NCT01536145|37841041|FG008|Overall Study|Adverse Event|0|||
16868055|NCT01536145|37841042|FG009|Overall Study|Adverse Event|0|||
16868056|NCT01536145|37841043|FG010|Overall Study|Adverse Event|3|||
16868057|NCT01536067|37841074|FG000|Overall Study|Disease Progression|1|||
16868058|NCT01582009|37841078|FG000|Overall Study|Withdrawal by Subject|1|||
16868059|NCT01582009|37841078|FG000|Overall Study|Physician Decision|1|||
16868060|NCT01553591|37841085|FG000|Overall Study|Voluntarily withdrew|94|||
16868061|NCT01553591|37841086|FG001|Overall Study|Voluntarily withdrew|79|||
16868062|NCT01553591|37841087|FG002|Overall Study|Voluntarily withdrew|96|||
16868063|NCT01553591|37841085|FG000|Overall Study|Adverse Event|36|||
16868064|NCT01553591|37841086|FG001|Overall Study|Adverse Event|45|||
16868065|NCT01553591|37841087|FG002|Overall Study|Adverse Event|16|||
16781558|NCT02584257|37720667|FG007|Period 2|Adverse Event|0|||
17089955|NCT00494507|38230083|FG002|Double-Blind Phase|Adverse Event|1|||
17089956|NCT00494507|38230084|FG003|Double-Blind Phase|Adverse Event|0|||
17089957|NCT00494507|38230081|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
17089958|NCT00494507|38230082|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
17188865|NCT02508532|38341869|FG006|Part 2 - Treatment|Death|0|||
17188866|NCT02508532|38341870|FG007|Part 2 - Treatment|Death|0|||
17188867|NCT02508532|38341871|FG008|Part 2 - Treatment|Death|1|||
17188868|NCT02508532|38341863|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
17188869|NCT02508532|38341864|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
17089959|NCT00494507|38230083|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
17089960|NCT00494507|38230084|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
17089961|NCT00494507|38230081|FG000|Double-Blind Phase|Subject Non-compliance|0|||
17089962|NCT00494507|38230082|FG001|Double-Blind Phase|Subject Non-compliance|0|||
17089963|NCT00494507|38230083|FG002|Double-Blind Phase|Subject Non-compliance|1|||
17089964|NCT00494507|38230084|FG003|Double-Blind Phase|Subject Non-compliance|0|||
17089965|NCT00494507|38230081|FG000|Double-Blind Phase|Negative DNA test|0|||
17089966|NCT00494507|38230082|FG001|Double-Blind Phase|Negative DNA test|0|||
17089967|NCT00494507|38230083|FG002|Double-Blind Phase|Negative DNA test|0|||
17089968|NCT00494507|38230084|FG003|Double-Blind Phase|Negative DNA test|1|||
17089969|NCT00494507|38230081|FG000|Open-Label Phase|Adverse Event|0|||
17089970|NCT00494507|38230082|FG001|Open-Label Phase|Adverse Event|1|||
17089971|NCT00494507|38230083|FG002|Open-Label Phase|Adverse Event|5|||
17089972|NCT00494507|38230084|FG003|Open-Label Phase|Adverse Event|3|||
17089973|NCT00494507|38230081|FG000|Open-Label Phase|Worsening Disease|0|||
17089974|NCT00494507|38230082|FG001|Open-Label Phase|Worsening Disease|0|||
17089975|NCT00494507|38230083|FG002|Open-Label Phase|Worsening Disease|0|||
16868066|NCT01553591|37841085|FG000|Overall Study|Lost to Follow-up|25|||
16781559|NCT02584257|37720668|FG008|Period 2|Adverse Event|0|||
16781560|NCT02583711|37720683|FG000|Overall Study|Withdrawal by Subject|0|||
16781561|NCT02583711|37720684|FG001|Overall Study|Withdrawal by Subject|10|||
16781562|NCT02583711|37720685|FG002|Overall Study|Withdrawal by Subject|0|||
16781563|NCT02583477|37720697|FG000|Overall Study|Adverse Event|0|||
16781564|NCT02583477|37720698|FG001|Overall Study|Adverse Event|2|||
16781565|NCT02583477|37720697|FG000|Overall Study|Death|1|||
16781566|NCT02583477|37720698|FG001|Overall Study|Death|16|||
16781567|NCT02583477|37720697|FG000|Overall Study|Study terminated|2|||
16781568|NCT02583477|37720698|FG001|Overall Study|Study terminated|2|||
16781569|NCT02583399|37720705|FG000|Overall Study|Able to be discharged|3|||
16781570|NCT02583399|37720705|FG000|Overall Study|Wanted to use a restricted medication|3|||
16781571|NCT02580591|37720713|FG000|Overall Study|Adverse Event|0|||
16781572|NCT02580591|37720714|FG001|Overall Study|Adverse Event|1|||
16781573|NCT02580591|37720715|FG002|Overall Study|Adverse Event|2|||
16781574|NCT02580591|37720716|FG003|Overall Study|Adverse Event|5|||
16781575|NCT02580591|37720713|FG000|Overall Study|Protocol Violation|3|||
16781576|NCT02580591|37720714|FG001|Overall Study|Protocol Violation|2|||
16781577|NCT02580591|37720715|FG002|Overall Study|Protocol Violation|1|||
16781578|NCT02580591|37720716|FG003|Overall Study|Protocol Violation|1|||
16781579|NCT02580591|37720713|FG000|Overall Study|Lost to Follow-up|5|||
16781580|NCT02580591|37720714|FG001|Overall Study|Lost to Follow-up|3|||
16781581|NCT02580591|37720715|FG002|Overall Study|Lost to Follow-up|3|||
16781582|NCT02580591|37720716|FG003|Overall Study|Lost to Follow-up|1|||
16781583|NCT02580591|37720713|FG000|Overall Study|Withdrawal by Subject|6|||
16781584|NCT02580591|37720714|FG001|Overall Study|Withdrawal by Subject|1|||
16781585|NCT02580591|37720715|FG002|Overall Study|Withdrawal by Subject|2|||
16781586|NCT02580591|37720716|FG003|Overall Study|Withdrawal by Subject|3|||
16781587|NCT02580591|37720713|FG000|Overall Study|Not treated|1|||
16781588|NCT02580591|37720714|FG001|Overall Study|Not treated|1|||
16781589|NCT02580591|37720715|FG002|Overall Study|Not treated|0|||
16781590|NCT02580591|37720716|FG003|Overall Study|Not treated|0|||
16781591|NCT02580591|37720713|FG000|Overall Study|Other than specified|3|||
16781592|NCT02580591|37720714|FG001|Overall Study|Other than specified|2|||
16781593|NCT02580591|37720715|FG002|Overall Study|Other than specified|5|||
16868067|NCT01553591|37841086|FG001|Overall Study|Lost to Follow-up|23|||
17188870|NCT02508532|38341865|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
17188871|NCT02508532|38341866|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
17188872|NCT02508532|38341867|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
17188873|NCT02508532|38341868|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
17188874|NCT02508532|38341869|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
17188875|NCT02508532|38341870|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
17188876|NCT02508532|38341871|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
17188877|NCT02508532|38341863|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
16781594|NCT02580591|37720716|FG003|Overall Study|Other than specified|2|||
16997530|NCT01023581|38141545|FG001|Overall Study|Major protocol deviation|0|||
16997531|NCT01023581|38141546|FG002|Overall Study|Major protocol deviation|3|||
16997532|NCT01023581|38141547|FG003|Overall Study|Major protocol deviation|0|||
16997533|NCT01023581|38141548|FG004|Overall Study|Major protocol deviation|0|||
16997534|NCT01023581|38141549|FG005|Overall Study|Major protocol deviation|0|||
16997535|NCT01023581|38141550|FG006|Overall Study|Major protocol deviation|0|||
16997536|NCT01023581|38141544|FG000|Overall Study|Lost to Follow-up|4|||
16997537|NCT01023581|38141545|FG001|Overall Study|Lost to Follow-up|8|||
16997538|NCT01023581|38141546|FG002|Overall Study|Lost to Follow-up|7|||
16997539|NCT01023581|38141547|FG003|Overall Study|Lost to Follow-up|2|||
16997540|NCT01023581|38141548|FG004|Overall Study|Lost to Follow-up|5|||
16997541|NCT01023581|38141549|FG005|Overall Study|Lost to Follow-up|2|||
16997542|NCT01023581|38141550|FG006|Overall Study|Lost to Follow-up|2|||
16997543|NCT01023581|38141544|FG000|Overall Study|Withdrawal by Subject|13|||
16997544|NCT01023581|38141545|FG001|Overall Study|Withdrawal by Subject|8|||
16997545|NCT01023581|38141546|FG002|Overall Study|Withdrawal by Subject|16|||
16997546|NCT01023581|38141547|FG003|Overall Study|Withdrawal by Subject|10|||
16997547|NCT01023581|38141548|FG004|Overall Study|Withdrawal by Subject|6|||
16997548|NCT01023581|38141549|FG005|Overall Study|Withdrawal by Subject|8|||
16997549|NCT01023581|38141550|FG006|Overall Study|Withdrawal by Subject|5|||
16997550|NCT01023581|38141544|FG000|Overall Study|Pregnancy|0|||
16997551|NCT01023581|38141545|FG001|Overall Study|Pregnancy|0|||
16997552|NCT01023581|38141546|FG002|Overall Study|Pregnancy|0|||
16997553|NCT01023581|38141547|FG003|Overall Study|Pregnancy|2|||
16997554|NCT01023581|38141548|FG004|Overall Study|Pregnancy|0|||
16997555|NCT01023581|38141549|FG005|Overall Study|Pregnancy|1|||
16997556|NCT01023581|38141550|FG006|Overall Study|Pregnancy|0|||
16997557|NCT01023581|38141544|FG000|Overall Study|Lack of Efficacy|9|||
16997558|NCT01023581|38141545|FG001|Overall Study|Lack of Efficacy|3|||
16997559|NCT01023581|38141546|FG002|Overall Study|Lack of Efficacy|6|||
16997560|NCT01023581|38141547|FG003|Overall Study|Lack of Efficacy|2|||
16997561|NCT01023581|38141548|FG004|Overall Study|Lack of Efficacy|1|||
16997562|NCT01023581|38141549|FG005|Overall Study|Lack of Efficacy|2|||
16997563|NCT01023581|38141550|FG006|Overall Study|Lack of Efficacy|1|||
16997564|NCT01023581|38141544|FG000|Overall Study|Physician Decision|2|||
16997565|NCT01023581|38141545|FG001|Overall Study|Physician Decision|0|||
16997566|NCT01023581|38141546|FG002|Overall Study|Physician Decision|2|||
16997567|NCT01023581|38141547|FG003|Overall Study|Physician Decision|1|||
16997568|NCT01023581|38141548|FG004|Overall Study|Physician Decision|1|||
16997569|NCT01023581|38141549|FG005|Overall Study|Physician Decision|1|||
16997570|NCT01023581|38141550|FG006|Overall Study|Physician Decision|1|||
16997571|NCT01023581|38141544|FG000|Overall Study|Other|1|||
16997572|NCT01023581|38141545|FG001|Overall Study|Other|0|||
16997573|NCT01023581|38141546|FG002|Overall Study|Other|1|||
16997574|NCT01023581|38141547|FG003|Overall Study|Other|0|||
16997575|NCT01023581|38141548|FG004|Overall Study|Other|1|||
16997576|NCT01023581|38141549|FG005|Overall Study|Other|0|||
16997577|NCT01023581|38141550|FG006|Overall Study|Other|0|||
16997578|NCT00962780|38141568|FG000|Overall Study|Death|0|||
16997579|NCT00962780|38141569|FG001|Overall Study|Death|1|||
16997580|NCT00962780|38141568|FG000|Overall Study|Protocol Violation|9|||
16997581|NCT00962780|38141569|FG001|Overall Study|Protocol Violation|4|||
16997582|NCT00962780|38141568|FG000|Overall Study|Withdrawal by Subject|1|||
16997583|NCT00962780|38141569|FG001|Overall Study|Withdrawal by Subject|8|||
16997584|NCT00962780|38141568|FG000|Overall Study|Other|0|||
16997585|NCT00962780|38141569|FG001|Overall Study|Other|1|||
16997586|NCT00739882|38141583|FG000|Double-blind Period|Adverse Event|1|||
16997587|NCT00739882|38141584|FG001|Double-blind Period|Adverse Event|2|||
16997588|NCT00739882|38141583|FG000|Double-blind Period|Protocol Violation|1|||
16997589|NCT00739882|38141584|FG001|Double-blind Period|Protocol Violation|0|||
16997590|NCT00739882|38141583|FG000|Double-blind Period|Lack of Efficacy|1|||
16781595|NCT02580357|37720729|FG000|Overall Study|Lost to Follow-up|2|||
16997591|NCT00739882|38141584|FG001|Double-blind Period|Lack of Efficacy|1|||
16997592|NCT00739882|38141583|FG000|Double-blind Period|Other|16|||
16997593|NCT00739882|38141584|FG001|Double-blind Period|Other|8|||
16997594|NCT00739882|38141583|FG000|Open-label Period|Adverse Event|1|||
16781596|NCT02580357|37720730|FG001|Overall Study|Lost to Follow-up|0|||
16781597|NCT02580357|37720731|FG002|Overall Study|Lost to Follow-up|0|||
16781598|NCT02580357|37720729|FG000|Overall Study|Protocol Violation|1|||
16781599|NCT02580357|37720730|FG001|Overall Study|Protocol Violation|0|||
16781600|NCT02580357|37720731|FG002|Overall Study|Protocol Violation|0|||
16781601|NCT01664091|37720739|FG000|Overall Study|Death|1|||
16781602|NCT01664091|37720739|FG000|Overall Study|Disease Progression|2|||
16781603|NCT01664091|37720739|FG000|Overall Study|Lost to Follow-up|2|||
16781604|NCT01664091|37720739|FG000|Overall Study|Withdrawal by Subject|1|||
16781605|NCT02577315|37720746|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16781606|NCT02577315|37720747|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
16781607|NCT02711345|37720763|FG000|Overall Study|Adverse Event|0|||
16868068|NCT01553591|37841087|FG002|Overall Study|Lost to Follow-up|16|||
17188878|NCT02508532|38341864|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
17188879|NCT02508532|38341865|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
17188880|NCT02508532|38341866|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
17188881|NCT02508532|38341867|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
17188882|NCT02508532|38341868|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
17188883|NCT02508532|38341869|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
17188884|NCT02508532|38341870|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
17188885|NCT02508532|38341871|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
17188886|NCT02508532|38341863|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
17188887|NCT02508532|38341864|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
17188888|NCT02508532|38341865|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
17188889|NCT02508532|38341866|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
17188890|NCT02508532|38341867|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
17089976|NCT00494507|38230084|FG003|Open-Label Phase|Worsening Disease|2|||
17089977|NCT00292188|38230106|FG000|Single-Blind|Adverse Event|14|||
17089978|NCT00292188|38230107|FG001|Single-Blind|Adverse Event|0|||
17089979|NCT00292188|38230108|FG002|Single-Blind|Adverse Event|0|||
17089980|NCT00292188|38230106|FG000|Single-Blind|Lack of Efficacy|2|||
17089981|NCT00292188|38230107|FG001|Single-Blind|Lack of Efficacy|0|||
17089982|NCT00292188|38230108|FG002|Single-Blind|Lack of Efficacy|0|||
17089983|NCT00292188|38230106|FG000|Single-Blind|Laboratory Abnormality|5|||
17089984|NCT00292188|38230107|FG001|Single-Blind|Laboratory Abnormality|0|||
17089985|NCT00292188|38230108|FG002|Single-Blind|Laboratory Abnormality|0|||
17089986|NCT00292188|38230106|FG000|Single-Blind|Lost to Follow-up|3|||
17089987|NCT00292188|38230107|FG001|Single-Blind|Lost to Follow-up|0|||
17089988|NCT00292188|38230108|FG002|Single-Blind|Lost to Follow-up|0|||
17089989|NCT00292188|38230106|FG000|Single-Blind|Other|77|||
17089990|NCT00292188|38230107|FG001|Single-Blind|Other|0|||
17089991|NCT00292188|38230108|FG002|Single-Blind|Other|0|||
17089992|NCT00292188|38230106|FG000|Single-Blind|Withdrawal by Subject|12|||
17089993|NCT00292188|38230107|FG001|Single-Blind|Withdrawal by Subject|0|||
17089994|NCT00292188|38230108|FG002|Single-Blind|Withdrawal by Subject|0|||
16781608|NCT02711345|37720764|FG001|Overall Study|Adverse Event|0|||
16781609|NCT02711345|37720765|FG002|Overall Study|Adverse Event|0|||
16781610|NCT02711345|37720766|FG003|Overall Study|Adverse Event|1|||
16781611|NCT02711345|37720767|FG004|Overall Study|Adverse Event|1|||
16781612|NCT02711345|37720768|FG005|Overall Study|Adverse Event|2|||
16781613|NCT02711345|37720769|FG006|Overall Study|Adverse Event|1|||
16781614|NCT02711345|37720770|FG007|Overall Study|Adverse Event|0|||
16781615|NCT02711345|37720771|FG008|Overall Study|Adverse Event|0|||
16781616|NCT02711345|37720772|FG009|Overall Study|Adverse Event|2|||
16781617|NCT02711345|37720763|FG000|Overall Study|Physician Decision|0|||
16781618|NCT02711345|37720764|FG001|Overall Study|Physician Decision|0|||
16781619|NCT02711345|37720765|FG002|Overall Study|Physician Decision|1|||
16781620|NCT02711345|37720766|FG003|Overall Study|Physician Decision|0|||
16781621|NCT02711345|37720767|FG004|Overall Study|Physician Decision|0|||
16781622|NCT02711345|37720768|FG005|Overall Study|Physician Decision|0|||
16781623|NCT02711345|37720769|FG006|Overall Study|Physician Decision|0|||
16781624|NCT02711345|37720770|FG007|Overall Study|Physician Decision|0|||
16781625|NCT02711345|37720771|FG008|Overall Study|Physician Decision|1|||
16781626|NCT02711345|37720772|FG009|Overall Study|Physician Decision|0|||
16781627|NCT02711345|37720763|FG000|Overall Study|Progressive disease|1|||
16781628|NCT02711345|37720764|FG001|Overall Study|Progressive disease|3|||
16781629|NCT02711345|37720765|FG002|Overall Study|Progressive disease|5|||
16781630|NCT02711345|37720766|FG003|Overall Study|Progressive disease|3|||
16781631|NCT02711345|37720767|FG004|Overall Study|Progressive disease|7|||
16781632|NCT02711345|37720768|FG005|Overall Study|Progressive disease|2|||
16781633|NCT02711345|37720769|FG006|Overall Study|Progressive disease|8|||
16781634|NCT02711345|37720770|FG007|Overall Study|Progressive disease|4|||
16781635|NCT02711345|37720771|FG008|Overall Study|Progressive disease|5|||
16781636|NCT02711345|37720772|FG009|Overall Study|Progressive disease|6|||
16781637|NCT02711345|37720763|FG000|Overall Study|Subject/guardian decision|0|||
16781638|NCT02711345|37720764|FG001|Overall Study|Subject/guardian decision|0|||
16781639|NCT02711345|37720765|FG002|Overall Study|Subject/guardian decision|0|||
16781640|NCT02711345|37720766|FG003|Overall Study|Subject/guardian decision|0|||
16781641|NCT02711345|37720767|FG004|Overall Study|Subject/guardian decision|0|||
16781642|NCT02711345|37720768|FG005|Overall Study|Subject/guardian decision|2|||
16781643|NCT02711345|37720769|FG006|Overall Study|Subject/guardian decision|3|||
16781644|NCT02711345|37720770|FG007|Overall Study|Subject/guardian decision|1|||
16781645|NCT02711345|37720771|FG008|Overall Study|Subject/guardian decision|0|||
16781646|NCT02711345|37720772|FG009|Overall Study|Subject/guardian decision|4|||
16781647|NCT02711345|37720763|FG000|Overall Study|Death|1|||
16781648|NCT02711345|37720764|FG001|Overall Study|Death|0|||
16781649|NCT02711345|37720765|FG002|Overall Study|Death|0|||
16781650|NCT02711345|37720766|FG003|Overall Study|Death|0|||
16781651|NCT02711345|37720767|FG004|Overall Study|Death|0|||
16781652|NCT02711345|37720768|FG005|Overall Study|Death|0|||
16781653|NCT02711345|37720769|FG006|Overall Study|Death|0|||
16781654|NCT02711345|37720770|FG007|Overall Study|Death|1|||
16781655|NCT02711345|37720771|FG008|Overall Study|Death|0|||
16781656|NCT02711345|37720772|FG009|Overall Study|Death|0|||
16781657|NCT02581995|37720809|FG000|Overall Study|Unspecified other|3|||
16781658|NCT02581995|37720809|FG000|Overall Study|Adverse Event|6|||
16781659|NCT02581995|37720809|FG000|Overall Study|Lost to Follow-up|5|||
16781660|NCT02581995|37720809|FG000|Overall Study|Withdrawal by participant|12|||
16781661|NCT02581995|37720809|FG000|Overall Study|Physician Decision|1|||
16781662|NCT02581995|37720809|FG000|Overall Study|Death|4|||
16781663|NCT02577003|37720815|FG000|Overall Study|Adverse Event|2|||
16781664|NCT02577003|37720816|FG001|Overall Study|Adverse Event|4|||
16781665|NCT02577003|37720815|FG000|Overall Study|Withdrawal by Subject|0|||
16781666|NCT02577003|37720816|FG001|Overall Study|Withdrawal by Subject|1|||
16781667|NCT02746809|37720822|FG000|Enrollment|Inclusion Exclusion not met|9|||
16781668|NCT02746809|37720822|FG000|Enrollment|Withdrawal by Subject|1|||
16781669|NCT02746809|37720822|FG000|Enrollment|Study Closed to Enrollment|2|||
16781670|NCT02746809|37720822|FG000|Procedure|Death|1|||
16781671|NCT02746809|37720822|FG000|1-Month|Death|5|||
16781672|NCT02746809|37720822|FG000|6-Month|Death|2|||
16781673|NCT02746809|37720822|FG000|6-Month|Withdrawal by Subject|1|||
16781674|NCT02746809|37720822|FG000|12-Month|Death|3|||
16781675|NCT02746809|37720822|FG000|12-Month|Withdrawal by Subject|2|||
16781676|NCT02746809|37720822|FG000|24-Month|Death|1|||
16781677|NCT02746809|37720822|FG000|24-Month|Withdrawal by Subject|1|||
16781678|NCT02746809|37720822|FG000|36-Month|Death|8|||
16781679|NCT02746809|37720822|FG000|36-Month|Withdrawal by Subject|1|||
16781680|NCT02746809|37720822|FG000|48-Month|Death|7|||
16781681|NCT02746809|37720822|FG000|48-Month|Withdrawal by Subject|1|||
16781682|NCT02746809|37720822|FG000|60-Month|Death|1|||
16781683|NCT02746809|37720822|FG000|60-Month|Lost to Follow-up|2|||
16781684|NCT02446899|37720830|FG000|Overall Study|Adverse Event|4|||
16781685|NCT02446899|37720831|FG001|Overall Study|Adverse Event|7|||
16781686|NCT02446899|37720830|FG000|Overall Study|Condition Under Investigation Worsened|1|||
16781687|NCT02446899|37720831|FG001|Overall Study|Condition Under Investigation Worsened|4|||
16781688|NCT02446899|37720830|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
16781689|NCT02446899|37720831|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
16781690|NCT02446899|37720830|FG000|Overall Study|Lack of Efficacy|2|||
16781691|NCT02446899|37720831|FG001|Overall Study|Lack of Efficacy|8|||
16781692|NCT02446899|37720830|FG000|Overall Study|Lost to Follow-up|1|||
16781693|NCT02446899|37720831|FG001|Overall Study|Lost to Follow-up|3|||
16781694|NCT02446899|37720830|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
16781695|NCT02446899|37720831|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
16781696|NCT02446899|37720830|FG000|Overall Study|Withdrawal by Subject|11|||
16781697|NCT02446899|37720831|FG001|Overall Study|Withdrawal by Subject|19|||
16781698|NCT02446899|37720830|FG000|Overall Study|Miscellaneous|5|||
16781699|NCT02446899|37720831|FG001|Overall Study|Miscellaneous|4|||
16781700|NCT02446899|37720830|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
16781701|NCT02446899|37720831|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
16781702|NCT02709785|37720840|FG000|Overall Study|Withdrawal by Subject|1|||
16781703|NCT02709785|37720841|FG001|Overall Study|Withdrawal by Subject|2|||
16781704|NCT02709785|37720842|FG002|Overall Study|Withdrawal by Subject|1|||
16781705|NCT02356887|37720850|FG000|Overall Study|poor compliance|2|||
16781706|NCT01604265|37720862|FG000|Overall Study|Adverse Event|1|||
16781707|NCT01604265|37720863|FG001|Overall Study|Adverse Event|0|||
16781708|NCT01604265|37720862|FG000|Overall Study|Withdrawal by Subject|1|||
16781709|NCT01604265|37720863|FG001|Overall Study|Withdrawal by Subject|0|||
16781710|NCT01664247|37720871|FG000|Overall Study|Adverse Event|5|||
16781711|NCT01664247|37720872|FG001|Overall Study|Adverse Event|3|||
16781712|NCT01664247|37720871|FG000|Overall Study|Protocol Violation|3|||
16781713|NCT01664247|37720872|FG001|Overall Study|Protocol Violation|5|||
16781714|NCT01664247|37720871|FG000|Overall Study|Withdrawal Criteria|1|||
16781715|NCT01664247|37720872|FG001|Overall Study|Withdrawal Criteria|4|||
16781716|NCT01664247|37720871|FG000|Overall Study|Unclassified|5|||
16781717|NCT01664247|37720872|FG001|Overall Study|Unclassified|29|||
16781718|NCT03191903|37720901|FG000|Overall Study|Withdrawal by Subject|6|||
16781719|NCT03191903|37720902|FG001|Overall Study|Withdrawal by Subject|5|||
16781720|NCT03191903|37720903|FG002|Overall Study|Withdrawal by Subject|4|||
16781721|NCT03191903|37720901|FG000|Overall Study|Adverse Event|1|||
16781722|NCT03191903|37720902|FG001|Overall Study|Adverse Event|0|||
16781723|NCT03191903|37720903|FG002|Overall Study|Adverse Event|0|||
16781724|NCT02576535|37720916|FG000|Overall Study|Withdrawal by Subject|2|||
16781725|NCT02576145|37720922|FG000|Overall Study|Adverse Event|1|||
16781726|NCT02576145|37720923|FG001|Overall Study|Adverse Event|0|||
16781727|NCT02576145|37720922|FG000|Overall Study|Withdrawal by Subject|1|||
16781728|NCT02576145|37720923|FG001|Overall Study|Withdrawal by Subject|0|||
16781729|NCT02576145|37720922|FG000|Overall Study|Acute rejection|1|||
16781730|NCT02576145|37720923|FG001|Overall Study|Acute rejection|0|||
16781731|NCT02576145|37720922|FG000|Overall Study|Tetanus Titers Decreased|0|||
16781732|NCT02576145|37720923|FG001|Overall Study|Tetanus Titers Decreased|1|||
16781733|NCT02576067|37720931|FG000|Overall Study|Death|0|||
16781734|NCT02576067|37720932|FG001|Overall Study|Death|1|||
16781735|NCT02576067|37720931|FG000|Overall Study|Lack of Efficacy|1|||
16781736|NCT02576067|37720932|FG001|Overall Study|Lack of Efficacy|0|||
16781737|NCT02576067|37720931|FG000|Overall Study|Lost to Follow-up|11|||
16781738|NCT02576067|37720932|FG001|Overall Study|Lost to Follow-up|0|||
16781739|NCT02576067|37720931|FG000|Overall Study|Withdrawal by Subject|11|||
16781740|NCT02576067|37720932|FG001|Overall Study|Withdrawal by Subject|2|||
16781741|NCT02576067|37720931|FG000|Overall Study|study closure of main CIRT trial)|0|||
16781742|NCT02576067|37720932|FG001|Overall Study|study closure of main CIRT trial)|8|||
16781743|NCT02576067|37720931|FG000|Overall Study|not randomized, failed run-in|7|||
16781744|NCT02576067|37720932|FG001|Overall Study|not randomized, failed run-in|0|||
16781745|NCT02576067|37720931|FG000|Overall Study|screen failure/ re-enrolled|0|||
16781746|NCT02576067|37720932|FG001|Overall Study|screen failure/ re-enrolled|25|||
16781747|NCT02576067|37720931|FG000|Overall Study|Physician Decision|4|||
16781748|NCT02576067|37720932|FG001|Overall Study|Physician Decision|0|||
16781749|NCT02575911|37720938|FG000|Overall Study|Lost to Follow-up|1|||
16781750|NCT02575833|37720952|FG000|Overall Study|Withdrawal by Subject|0|||
16781751|NCT02575833|37720953|FG001|Overall Study|Withdrawal by Subject|1|||
16781752|NCT02575833|37720952|FG000|Overall Study|Lost to Follow-up|1|||
16781753|NCT02575833|37720953|FG001|Overall Study|Lost to Follow-up|0|||
16781754|NCT02709083|37720959|FG000|Overall Study|Original PI left institution|7|||
16781755|NCT02709005|37720965|FG000|Overall Study|Lost to Follow-up|1|||
16781756|NCT02709005|37720966|FG001|Overall Study|Lost to Follow-up|1|||
16781757|NCT02709005|37720965|FG000|Overall Study|Withdrawal by Subject|3|||
16781758|NCT02709005|37720966|FG001|Overall Study|Withdrawal by Subject|0|||
16781759|NCT02573883|37720974|FG000|Six Month Follow Up|Lost to Follow-up|1|||
16781760|NCT02573883|37720975|FG001|Six Month Follow Up|Lost to Follow-up|0|||
16781761|NCT02573883|37720976|FG002|Six Month Follow Up|Lost to Follow-up|0|||
16781762|NCT02573883|37720977|FG003|Six Month Follow Up|Lost to Follow-up|0|||
16781763|NCT02573883|37720974|FG000|One Year Follow Up|Lost to Follow-up|2|||
16781764|NCT02573883|37720975|FG001|One Year Follow Up|Lost to Follow-up|1|||
16781765|NCT02573883|37720976|FG002|One Year Follow Up|Lost to Follow-up|0|||
16781766|NCT02573883|37720977|FG003|One Year Follow Up|Lost to Follow-up|0|||
16781767|NCT02575365|37720992|FG000|Overall Study|Lost to Follow-up|4|||
16781768|NCT02707991|37720998|FG000|Overall Study|Protocol Violation|1|||
16781769|NCT02707991|37720999|FG001|Overall Study|Protocol Violation|0|||
16781770|NCT02707991|37720998|FG000|Overall Study|Became ineligible|0|||
16781771|NCT02707991|37720999|FG001|Overall Study|Became ineligible|1|||
16781772|NCT02707757|37721007|FG000|Overall Study|Protocol Violation|3|||
16781773|NCT02707757|37721008|FG001|Overall Study|Protocol Violation|2|||
16781774|NCT02707757|37721007|FG000|Overall Study|Withdrawal by Subject|2|||
16781775|NCT02707757|37721008|FG001|Overall Study|Withdrawal by Subject|0|||
16781776|NCT02707757|37721007|FG000|Overall Study|Death|0|||
16781777|NCT02707757|37721008|FG001|Overall Study|Death|1|||
16781778|NCT02707757|37721007|FG000|Overall Study|Adverse Event|6|||
16781779|NCT02707757|37721008|FG001|Overall Study|Adverse Event|4|||
16781780|NCT02707757|37721007|FG000|Overall Study|Renal transplant/elective operation|1|||
16781781|NCT02707757|37721008|FG001|Overall Study|Renal transplant/elective operation|5|||
16781782|NCT02572401|37721018|FG000|Overall Study|Lost to Follow-up|5|||
16781783|NCT02572401|37721019|FG001|Overall Study|Lost to Follow-up|8|||
16781784|NCT02572401|37721020|FG002|Overall Study|Lost to Follow-up|9|||
16781785|NCT02572401|37721021|FG003|Overall Study|Lost to Follow-up|9|||
16781786|NCT02572401|37721018|FG000|Overall Study|Death|0|||
16781787|NCT02572401|37721019|FG001|Overall Study|Death|0|||
16781788|NCT02572401|37721020|FG002|Overall Study|Death|0|||
16781789|NCT02572401|37721021|FG003|Overall Study|Death|1|||
16781790|NCT02103478|37721038|FG000|Overall Study|Adverse Event|0|||
16781791|NCT02103478|37721039|FG001|Overall Study|Adverse Event|0|||
16781792|NCT02103478|37721040|FG002|Overall Study|Adverse Event|1|||
16781793|NCT02103478|37721041|FG003|Overall Study|Adverse Event|1|||
16781794|NCT02103478|37721042|FG004|Overall Study|Adverse Event|2|||
16781795|NCT02103478|37721043|FG005|Overall Study|Adverse Event|1|||
16781796|NCT02103478|37721044|FG006|Overall Study|Adverse Event|0|||
16781797|NCT02103478|37721045|FG007|Overall Study|Adverse Event|0|||
16781798|NCT02103478|37721046|FG008|Overall Study|Adverse Event|0|||
16781799|NCT02103478|37721038|FG000|Overall Study|Death|2|||
16781800|NCT02103478|37721039|FG001|Overall Study|Death|2|||
16781801|NCT02103478|37721040|FG002|Overall Study|Death|1|||
16781802|NCT02103478|37721041|FG003|Overall Study|Death|1|||
16781803|NCT02103478|37721042|FG004|Overall Study|Death|5|||
16781804|NCT02103478|37721043|FG005|Overall Study|Death|15|||
16781805|NCT02103478|37721044|FG006|Overall Study|Death|14|||
16781806|NCT02103478|37721045|FG007|Overall Study|Death|10|||
16781807|NCT02103478|37721046|FG008|Overall Study|Death|11|||
16781808|NCT02103478|37721038|FG000|Overall Study|Progressive Disease|2|||
16781809|NCT02103478|37721039|FG001|Overall Study|Progressive Disease|1|||
16781810|NCT02103478|37721040|FG002|Overall Study|Progressive Disease|2|||
16781811|NCT02103478|37721041|FG003|Overall Study|Progressive Disease|0|||
16781812|NCT02103478|37721042|FG004|Overall Study|Progressive Disease|9|||
16781813|NCT02103478|37721043|FG005|Overall Study|Progressive Disease|1|||
16781814|NCT02103478|37721044|FG006|Overall Study|Progressive Disease|2|||
16781815|NCT02103478|37721045|FG007|Overall Study|Progressive Disease|0|||
16781816|NCT02103478|37721046|FG008|Overall Study|Progressive Disease|1|||
16781817|NCT02103478|37721038|FG000|Overall Study|Withdrawal by Subject|2|||
16781818|NCT02103478|37721039|FG001|Overall Study|Withdrawal by Subject|0|||
16781819|NCT02103478|37721040|FG002|Overall Study|Withdrawal by Subject|0|||
16781820|NCT02103478|37721041|FG003|Overall Study|Withdrawal by Subject|4|||
16781821|NCT02103478|37721042|FG004|Overall Study|Withdrawal by Subject|0|||
16781822|NCT02103478|37721043|FG005|Overall Study|Withdrawal by Subject|0|||
16781823|NCT02103478|37721044|FG006|Overall Study|Withdrawal by Subject|1|||
16781824|NCT02103478|37721045|FG007|Overall Study|Withdrawal by Subject|1|||
16781825|NCT02103478|37721046|FG008|Overall Study|Withdrawal by Subject|0|||
16781826|NCT02103478|37721038|FG000|Overall Study|Lost to Follow-up|0|||
16781827|NCT02103478|37721039|FG001|Overall Study|Lost to Follow-up|0|||
16781828|NCT02103478|37721040|FG002|Overall Study|Lost to Follow-up|0|||
16781829|NCT02103478|37721041|FG003|Overall Study|Lost to Follow-up|0|||
16781830|NCT02103478|37721042|FG004|Overall Study|Lost to Follow-up|0|||
16781831|NCT02103478|37721043|FG005|Overall Study|Lost to Follow-up|0|||
16781832|NCT02103478|37721044|FG006|Overall Study|Lost to Follow-up|0|||
16781833|NCT02103478|37721045|FG007|Overall Study|Lost to Follow-up|1|||
16781834|NCT02103478|37721046|FG008|Overall Study|Lost to Follow-up|0|||
16781835|NCT02103478|37721038|FG000|Overall Study|Other|1|||
16781836|NCT02103478|37721039|FG001|Overall Study|Other|3|||
16781837|NCT02103478|37721040|FG002|Overall Study|Other|2|||
16781838|NCT02103478|37721041|FG003|Overall Study|Other|0|||
16781839|NCT02103478|37721042|FG004|Overall Study|Other|3|||
16781840|NCT02103478|37721043|FG005|Overall Study|Other|8|||
16781841|NCT02103478|37721044|FG006|Overall Study|Other|8|||
16781842|NCT02103478|37721045|FG007|Overall Study|Other|4|||
16781843|NCT02103478|37721046|FG008|Overall Study|Other|2|||
16781844|NCT02102464|37721078|FG000|Randomized Study|Withdrawal by Subject|0|||
16781845|NCT02102464|37721079|FG001|Randomized Study|Withdrawal by Subject|1|||
16781846|NCT02102464|37721080|FG002|Randomized Study|Withdrawal by Subject|0|||
16781847|NCT02707601|37721091|FG000|Overall Study|Death|0|||
16781848|NCT02707601|37721092|FG001|Overall Study|Death|1|||
16781849|NCT02707601|37721091|FG000|Overall Study|Lack of Efficacy|0|||
16781850|NCT02707601|37721092|FG001|Overall Study|Lack of Efficacy|1|||
16781851|NCT02707601|37721091|FG000|Overall Study|Investigator's Discretion|1|||
16781852|NCT02707601|37721092|FG001|Overall Study|Investigator's Discretion|0|||
16781853|NCT02707601|37721091|FG000|Overall Study|Withdrew Consent|0|||
16781854|NCT02707601|37721092|FG001|Overall Study|Withdrew Consent|1|||
16781855|NCT02707601|37721091|FG000|Overall Study|Lost to Follow-up|1|||
16781856|NCT02707601|37721092|FG001|Overall Study|Lost to Follow-up|1|||
16781857|NCT02707601|37721091|FG000|Overall Study|Participants Randomized but Not Treated|2|||
16781858|NCT02707601|37721092|FG001|Overall Study|Participants Randomized but Not Treated|0|||
16781859|NCT02707055|37721104|FG000|Phase 1|Withdrawal by Subject|1|||
16781860|NCT02707055|37721105|FG001|Phase 1|Withdrawal by Subject|2|||
16781861|NCT02707055|37721104|FG000|Phase 1|Physician Decision|0|||
16781862|NCT02707055|37721105|FG001|Phase 1|Physician Decision|1|||
16781863|NCT02707055|37721104|FG000|Phase 2|Adverse Event|1|||
16781864|NCT02707055|37721105|FG001|Phase 2|Adverse Event|2|||
16781865|NCT02073682|37721113|FG000|Overall Study|Low Creatinine Clearance|1|||
16781866|NCT02073682|37721114|FG001|Overall Study|Low Creatinine Clearance|2|||
16781867|NCT02073682|37721113|FG000|Overall Study|Death|86|||
16781868|NCT02073682|37721114|FG001|Overall Study|Death|100|||
16781869|NCT02073682|37721113|FG000|Overall Study|Cancer Cured|10|||
16781870|NCT02073682|37721114|FG001|Overall Study|Cancer Cured|15|||
16781871|NCT02073682|37721113|FG000|Overall Study|ID: Patient Noncompliance|1|||
16781872|NCT02073682|37721114|FG001|Overall Study|ID: Patient Noncompliance|2|||
16781873|NCT02073682|37721113|FG000|Overall Study|ID: Palliative Treatment Only|10|||
16781874|NCT02073682|37721114|FG001|Overall Study|ID: Palliative Treatment Only|7|||
16781875|NCT02073682|37721113|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
16781876|NCT02073682|37721114|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
16781877|NCT02073682|37721113|FG000|Overall Study|Platelet Count <50,000/mL|1|||
16781878|NCT02073682|37721114|FG001|Overall Study|Platelet Count <50,000/mL|2|||
16781879|NCT02073682|37721113|FG000|Overall Study|Surgery/Medical Procedure|3|||
16781880|NCT02073682|37721114|FG001|Overall Study|Surgery/Medical Procedure|1|||
16781881|NCT02073682|37721113|FG000|Overall Study|Withdrawal by Subject|6|||
16781882|NCT02073682|37721114|FG001|Overall Study|Withdrawal by Subject|8|||
16781883|NCT02073682|37721113|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
16781884|NCT02073682|37721114|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
16781885|NCT02073682|37721113|FG000|Overall Study|Cancer Progression|53|||
16781886|NCT02073682|37721114|FG001|Overall Study|Cancer Progression|33|||
16781887|NCT02073682|37721113|FG000|Overall Study|Protocol Violation|1|||
16781888|NCT02073682|37721114|FG001|Overall Study|Protocol Violation|0|||
16781889|NCT02073682|37721113|FG000|Overall Study|Adverse Event|79|||
16781890|NCT02073682|37721114|FG001|Overall Study|Adverse Event|62|||
16781891|NCT02073682|37721113|FG000|Overall Study|No reason provided|11|||
16781892|NCT02073682|37721114|FG001|Overall Study|No reason provided|9|||
16781893|NCT02073682|37721113|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
16781894|NCT02073682|37721114|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
16781895|NCT02073682|37721113|FG000|Overall Study|Lost to Follow-up|1|||
16781896|NCT02073682|37721114|FG001|Overall Study|Lost to Follow-up|1|||
16781897|NCT02073682|37721113|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
16781898|NCT02073682|37721114|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
16781899|NCT02072980|37721120|FG000|Period 2, Second Wear|Adverse Event|0|||
16781900|NCT02072980|37721121|FG001|Period 2, Second Wear|Adverse Event|1|||
16781901|NCT02706899|37721129|FG000|Overall Study|Withdrawal by Subject|1|||
16781902|NCT02706899|37721130|FG001|Overall Study|Withdrawal by Subject|0|||
16781903|NCT02706899|37721129|FG000|Overall Study|Death|8|||
16781904|NCT02706899|37721130|FG001|Overall Study|Death|0|||
16781905|NCT02706899|37721129|FG000|Overall Study|Study Termination by Sponsor|4|||
16781906|NCT02706899|37721130|FG001|Overall Study|Study Termination by Sponsor|6|||
16781907|NCT02072824|37721139|FG000|Overall Study|Insufficient clinical response|1|||
16997595|NCT00739882|38141584|FG001|Open-label Period|Adverse Event|0|||
16781908|NCT02072824|37721140|FG001|Overall Study|Insufficient clinical response|0|||
16781909|NCT02072824|37721141|FG002|Overall Study|Insufficient clinical response|1|||
16781910|NCT02072824|37721139|FG000|Overall Study|No longer willing to participate|1|||
16781911|NCT02072824|37721140|FG001|Overall Study|No longer willing to participate|0|||
16781912|NCT02072824|37721141|FG002|Overall Study|No longer willing to participate|1|||
16781913|NCT02072824|37721139|FG000|Overall Study|Medication error|0|||
16781914|NCT02072824|37721140|FG001|Overall Study|Medication error|1|||
16781915|NCT02072824|37721141|FG002|Overall Study|Medication error|0|||
16781916|NCT02072824|37721139|FG000|Overall Study|Adverse Event|0|||
16781917|NCT02072824|37721140|FG001|Overall Study|Adverse Event|0|||
16781918|NCT02072824|37721141|FG002|Overall Study|Adverse Event|1|||
16781919|NCT02072668|37721149|FG000|Second Intervention|Lost to Follow-up|1|||
16781920|NCT02072668|37721150|FG001|Second Intervention|Lost to Follow-up|0|||
16781921|NCT02140762|37721160|FG000|Overall Study|Adverse Event|1|||
16781922|NCT02140762|37721161|FG001|Overall Study|Adverse Event|1|||
16781923|NCT02140762|37721160|FG000|Overall Study|Lost to Follow-up|9|||
16781924|NCT02140762|37721161|FG001|Overall Study|Lost to Follow-up|5|||
16781925|NCT02140762|37721160|FG000|Overall Study|Protocol Violation|1|||
16781926|NCT02140762|37721161|FG001|Overall Study|Protocol Violation|1|||
16781927|NCT02140762|37721160|FG000|Overall Study|Withdrawal by Subject|6|||
16781928|NCT02140762|37721161|FG001|Overall Study|Withdrawal by Subject|4|||
16781929|NCT02140762|37721160|FG000|Overall Study|Other|0|||
16781930|NCT02140762|37721161|FG001|Overall Study|Other|1|||
16781931|NCT02101294|37721172|FG000|Overall Study|Withdrawal by Subject|5|||
16781932|NCT02101294|37721172|FG000|Overall Study|Lost to Follow-up|6|||
16781933|NCT01598506|37721179|FG000|Overall Study|Withdrawal by Subject|2|||
16781934|NCT02140060|37721190|FG000|Overall Study|Adverse Event|0|||
16781935|NCT02140060|37721191|FG001|Overall Study|Adverse Event|0|||
16781936|NCT02140060|37721192|FG002|Overall Study|Adverse Event|0|||
16781937|NCT02140060|37721193|FG003|Overall Study|Adverse Event|1|||
16781938|NCT02140060|37721194|FG004|Overall Study|Adverse Event|1|||
16781939|NCT02140060|37721195|FG005|Overall Study|Adverse Event|1|||
16781940|NCT02140060|37721190|FG000|Overall Study|Lack of Efficacy|0|||
16781941|NCT02140060|37721191|FG001|Overall Study|Lack of Efficacy|0|||
16781942|NCT02140060|37721192|FG002|Overall Study|Lack of Efficacy|0|||
16781943|NCT02140060|37721193|FG003|Overall Study|Lack of Efficacy|1|||
16781944|NCT02140060|37721194|FG004|Overall Study|Lack of Efficacy|0|||
16781945|NCT02140060|37721195|FG005|Overall Study|Lack of Efficacy|0|||
16781946|NCT02139982|37721220|FG000|Overall Study|Lack of Efficacy|0|||
16781947|NCT02139982|37721221|FG001|Overall Study|Lack of Efficacy|1|||
16781948|NCT02139982|37721222|FG002|Overall Study|Lack of Efficacy|0|||
16781949|NCT02139982|37721223|FG003|Overall Study|Lack of Efficacy|1|||
16781950|NCT02139982|37721224|FG004|Overall Study|Lack of Efficacy|0|||
16781951|NCT02139982|37721225|FG005|Overall Study|Lack of Efficacy|0|||
16781952|NCT02139982|37721226|FG006|Overall Study|Lack of Efficacy|0|||
16781953|NCT02139982|37721227|FG007|Overall Study|Lack of Efficacy|0|||
16781954|NCT02139982|37721228|FG008|Overall Study|Lack of Efficacy|0|||
16997596|NCT00739882|38141583|FG000|Open-label Period|Other|9|||
16997597|NCT00739882|38141584|FG001|Open-label Period|Other|5|||
16997598|NCT00961220|38141592|FG000|Overall Study|Adverse Event|3|||
16997599|NCT00961220|38141592|FG000|Overall Study|Lack of Efficacy|1|||
16997600|NCT00961220|38141592|FG000|Overall Study|No IV access for O6BG|1|||
16997601|NCT00961220|38141592|FG000|Overall Study|O6BG no longer supplied|1|||
16997602|NCT00961220|38141592|FG000|Overall Study|Complete Response prior to 12 courses|1|||
16997603|NCT00734656|38141598|FG000|Lab Session 1|Withdrawal by Subject|2|||
16997604|NCT00734656|38141599|FG001|Lab Session 1|Withdrawal by Subject|0|||
16997605|NCT00734656|38141600|FG002|Lab Session 1|Withdrawal by Subject|0|||
16997606|NCT00734656|38141601|FG003|Lab Session 1|Withdrawal by Subject|0|||
16997607|NCT00734656|38141598|FG000|Washout 1|Withdrawal by Subject|1|||
16997608|NCT00734656|38141599|FG001|Washout 1|Withdrawal by Subject|5|||
16997609|NCT00734656|38141600|FG002|Washout 1|Withdrawal by Subject|2|||
16997610|NCT00734656|38141601|FG003|Washout 1|Withdrawal by Subject|3|||
16997611|NCT00734656|38141598|FG000|Lab Session 2|Withdrawal by Subject|1|||
16997612|NCT00734656|38141599|FG001|Lab Session 2|Withdrawal by Subject|0|||
16997613|NCT00734656|38141600|FG002|Lab Session 2|Withdrawal by Subject|0|||
16997614|NCT00734656|38141601|FG003|Lab Session 2|Withdrawal by Subject|1|||
16997615|NCT00734656|38141598|FG000|Washout 2|Withdrawal by Subject|1|||
16997616|NCT00734656|38141599|FG001|Washout 2|Withdrawal by Subject|1|||
16997617|NCT00734656|38141600|FG002|Washout 2|Withdrawal by Subject|1|||
16997618|NCT00734656|38141601|FG003|Washout 2|Withdrawal by Subject|0|||
16997619|NCT00734656|38141598|FG000|Washout 3|Withdrawal by Subject|1|||
16997620|NCT00734656|38141599|FG001|Washout 3|Withdrawal by Subject|0|||
16997621|NCT00734656|38141600|FG002|Washout 3|Withdrawal by Subject|0|||
16997622|NCT00734656|38141601|FG003|Washout 3|Withdrawal by Subject|1|||
16997623|NCT00734656|38141598|FG000|Lab Session 4|Withdrawal by Subject|0|||
16997624|NCT00734656|38141599|FG001|Lab Session 4|Withdrawal by Subject|0|||
16997625|NCT00734656|38141600|FG002|Lab Session 4|Withdrawal by Subject|0|||
16997626|NCT00734656|38141601|FG003|Lab Session 4|Withdrawal by Subject|1|||
16997627|NCT00961064|38141611|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
16997628|NCT00961064|38141611|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
16997629|NCT00961064|38141611|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
16997630|NCT00961064|38141611|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
16997631|NCT00961064|38141611|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
16997632|NCT00961064|38141611|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
16997633|NCT00961064|38141611|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
16997634|NCT00961064|38141611|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
16997635|NCT00739648|38141618|FG000|Overall Study|Adverse Event|3|||
16997636|NCT00739648|38141619|FG001|Overall Study|Adverse Event|15|||
16997637|NCT00739648|38141618|FG000|Overall Study|Withdrawal by Subject|13|||
16997638|NCT00739648|38141619|FG001|Overall Study|Withdrawal by Subject|25|||
16997639|NCT00739648|38141618|FG000|Overall Study|Lost to Follow-up|4|||
16997640|NCT00739648|38141619|FG001|Overall Study|Lost to Follow-up|7|||
17089995|NCT00292188|38230106|FG000|Single-Blind|Did not receive treatment|1|||
17089996|NCT00292188|38230107|FG001|Single-Blind|Did not receive treatment|0|||
17089997|NCT00292188|38230108|FG002|Single-Blind|Did not receive treatment|0|||
16997641|NCT00739648|38141618|FG000|Overall Study|Death|2|||
16997642|NCT00739648|38141619|FG001|Overall Study|Death|0|||
16997643|NCT00739648|38141618|FG000|Overall Study|Do not know|4|||
16997644|NCT00739648|38141619|FG001|Overall Study|Do not know|6|||
16997645|NCT01032239|38141631|FG000|Overall Study|Lost to Follow-up|3|||
16997646|NCT01032239|38141632|FG001|Overall Study|Lost to Follow-up|2|||
16997647|NCT01032239|38141631|FG000|Overall Study|Withdrawal by Subject|2|||
16997648|NCT01032239|38141632|FG001|Overall Study|Withdrawal by Subject|3|||
16997649|NCT01032239|38141631|FG000|Overall Study|Death|1|||
16997650|NCT01032239|38141632|FG001|Overall Study|Death|0|||
16997651|NCT01032239|38141631|FG000|Overall Study|Protocol Violation|1|||
16997652|NCT01032239|38141632|FG001|Overall Study|Protocol Violation|0|||
16997653|NCT00734578|38141641|FG000|Overall Study|Adverse Event|4|||
16997654|NCT00734578|38141642|FG001|Overall Study|Adverse Event|6|||
16997655|NCT00734578|38141643|FG002|Overall Study|Adverse Event|1|||
16997656|NCT00734578|38141641|FG000|Overall Study|Protocol Violation|8|||
16997657|NCT00734578|38141642|FG001|Overall Study|Protocol Violation|6|||
16997658|NCT00734578|38141643|FG002|Overall Study|Protocol Violation|3|||
16997659|NCT00734578|38141641|FG000|Overall Study|Withdrawal by Subject|7|||
16997660|NCT00734578|38141642|FG001|Overall Study|Withdrawal by Subject|8|||
16997661|NCT00734578|38141643|FG002|Overall Study|Withdrawal by Subject|11|||
16781955|NCT02139982|37721229|FG009|Overall Study|Lack of Efficacy|0|||
16781956|NCT02139826|37721251|FG000|Overall Study|Adverse Event|1|||
16781957|NCT02139592|37721261|FG000|Overall Study|Case Report Forms Uncollected|8|||
16781958|NCT02139280|37721267|FG000|Overall Study|No longer eligible|2|||
16781959|NCT02139280|37721268|FG001|Overall Study|No longer eligible|0|||
16781960|NCT02072434|37721276|FG000|Overall Study|Protocol Violation|10|||
16781961|NCT02072434|37721277|FG001|Overall Study|Protocol Violation|9|||
16781962|NCT02072434|37721276|FG000|Overall Study|Physician Decision|5|||
16781963|NCT02072434|37721277|FG001|Overall Study|Physician Decision|10|||
16781964|NCT02072434|37721276|FG000|Overall Study|Adverse event, serious fatal|1|||
16781965|NCT02072434|37721277|FG001|Overall Study|Adverse event, serious fatal|6|||
16781966|NCT02072434|37721276|FG000|Overall Study|Adverse Event|7|||
16781967|NCT02072434|37721277|FG001|Overall Study|Adverse Event|6|||
16781968|NCT02072434|37721276|FG000|Overall Study|Withdrawal by Subject|17|||
16781969|NCT02072434|37721277|FG001|Overall Study|Withdrawal by Subject|29|||
16781970|NCT02072434|37721276|FG000|Overall Study|Other|14|||
16781971|NCT02072434|37721277|FG001|Overall Study|Other|29|||
16781972|NCT02072434|37721276|FG000|Overall Study|Lost to Follow-up|0|||
16781973|NCT02072434|37721277|FG001|Overall Study|Lost to Follow-up|1|||
16781974|NCT02101060|37721285|FG000|Overall Study|Adverse Event|1|||
16781975|NCT02101060|37721286|FG001|Overall Study|Adverse Event|0|||
16781976|NCT02101060|37721285|FG000|Overall Study|Withdrawal by Subject|1|||
16781977|NCT02101060|37721286|FG001|Overall Study|Withdrawal by Subject|1|||
16781978|NCT02101060|37721285|FG000|Overall Study|Lost to Follow-up|3|||
16781979|NCT02101060|37721286|FG001|Overall Study|Lost to Follow-up|3|||
16781980|NCT02139124|37721297|FG000|Overall Study|Adverse Event|2|||
16781981|NCT02139124|37721298|FG001|Overall Study|Adverse Event|0|||
16781982|NCT02139124|37721299|FG002|Overall Study|Adverse Event|1|||
16781983|NCT02139124|37721300|FG003|Overall Study|Adverse Event|2|||
16781984|NCT02139124|37721301|FG004|Overall Study|Adverse Event|5|||
16781985|NCT02139124|37721297|FG000|Overall Study|Withdrawal by Subject|2|||
16781986|NCT02139124|37721298|FG001|Overall Study|Withdrawal by Subject|2|||
16781987|NCT02139124|37721299|FG002|Overall Study|Withdrawal by Subject|2|||
16781988|NCT02139124|37721300|FG003|Overall Study|Withdrawal by Subject|2|||
16781989|NCT02139124|37721301|FG004|Overall Study|Withdrawal by Subject|3|||
16781990|NCT02139124|37721297|FG000|Overall Study|Protocol Violation|0|||
16781991|NCT02139124|37721298|FG001|Overall Study|Protocol Violation|0|||
16781992|NCT02139124|37721299|FG002|Overall Study|Protocol Violation|0|||
16781993|NCT02139124|37721300|FG003|Overall Study|Protocol Violation|1|||
16781994|NCT02139124|37721301|FG004|Overall Study|Protocol Violation|1|||
16781995|NCT02139124|37721297|FG000|Overall Study|non-compliant|1|||
16781996|NCT02139124|37721298|FG001|Overall Study|non-compliant|0|||
16781997|NCT02139124|37721299|FG002|Overall Study|non-compliant|0|||
16781998|NCT02139124|37721300|FG003|Overall Study|non-compliant|2|||
16781999|NCT02139124|37721301|FG004|Overall Study|non-compliant|0|||
16782000|NCT02139124|37721297|FG000|Overall Study|incarceration|0|||
16782001|NCT02139124|37721298|FG001|Overall Study|incarceration|0|||
16782002|NCT02139124|37721299|FG002|Overall Study|incarceration|1|||
16782003|NCT02139124|37721300|FG003|Overall Study|incarceration|0|||
16782004|NCT02139124|37721301|FG004|Overall Study|incarceration|0|||
16782005|NCT02139124|37721297|FG000|Overall Study|subject moved|1|||
16782006|NCT02139124|37721298|FG001|Overall Study|subject moved|0|||
16782007|NCT02139124|37721299|FG002|Overall Study|subject moved|0|||
16782008|NCT02139124|37721300|FG003|Overall Study|subject moved|0|||
16782009|NCT02139124|37721301|FG004|Overall Study|subject moved|0|||
16782010|NCT02139124|37721297|FG000|Overall Study|Lost to Follow-up|3|||
16782011|NCT02139124|37721298|FG001|Overall Study|Lost to Follow-up|2|||
16782012|NCT02139124|37721299|FG002|Overall Study|Lost to Follow-up|0|||
16782013|NCT02139124|37721300|FG003|Overall Study|Lost to Follow-up|5|||
16782014|NCT02139124|37721301|FG004|Overall Study|Lost to Follow-up|4|||
16782015|NCT02139046|37721318|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16782016|NCT02139046|37721319|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
16782017|NCT02139046|37721320|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
16782018|NCT02139046|37721321|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
16782019|NCT02139046|37721322|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
16782020|NCT02139046|37721318|FG000|Overall Study|Major Protocol Deviation|9|||
16782021|NCT02139046|37721319|FG001|Overall Study|Major Protocol Deviation|10|||
16782022|NCT02139046|37721320|FG002|Overall Study|Major Protocol Deviation|16|||
16782023|NCT02139046|37721321|FG003|Overall Study|Major Protocol Deviation|12|||
16782024|NCT02139046|37721322|FG004|Overall Study|Major Protocol Deviation|6|||
16782025|NCT02139046|37721318|FG000|Overall Study|Lost to Follow-up|13|||
16782026|NCT02139046|37721319|FG001|Overall Study|Lost to Follow-up|16|||
16782027|NCT02139046|37721320|FG002|Overall Study|Lost to Follow-up|16|||
16782028|NCT02139046|37721321|FG003|Overall Study|Lost to Follow-up|18|||
16782029|NCT02139046|37721322|FG004|Overall Study|Lost to Follow-up|13|||
16782030|NCT02139046|37721318|FG000|Overall Study|Voluntary Withdrawal|20|||
16782031|NCT02139046|37721319|FG001|Overall Study|Voluntary Withdrawal|8|||
16782032|NCT02139046|37721320|FG002|Overall Study|Voluntary Withdrawal|10|||
16782033|NCT02139046|37721321|FG003|Overall Study|Voluntary Withdrawal|15|||
16782034|NCT02139046|37721322|FG004|Overall Study|Voluntary Withdrawal|16|||
16782035|NCT02139046|37721318|FG000|Overall Study|Lack of Efficacy|0|||
16782036|NCT02139046|37721319|FG001|Overall Study|Lack of Efficacy|1|||
16782037|NCT02139046|37721320|FG002|Overall Study|Lack of Efficacy|2|||
16782038|NCT02139046|37721321|FG003|Overall Study|Lack of Efficacy|1|||
16782039|NCT02139046|37721322|FG004|Overall Study|Lack of Efficacy|2|||
16782040|NCT02139046|37721318|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
16782041|NCT02139046|37721319|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
16782042|NCT02139046|37721320|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
16782043|NCT02139046|37721321|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
16782044|NCT02139046|37721322|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
16782045|NCT02139046|37721318|FG000|Overall Study|Other Miscellaneous Reasons|10|||
16782046|NCT02139046|37721319|FG001|Overall Study|Other Miscellaneous Reasons|9|||
16782047|NCT02139046|37721320|FG002|Overall Study|Other Miscellaneous Reasons|4|||
16782048|NCT02139046|37721321|FG003|Overall Study|Other Miscellaneous Reasons|9|||
16782049|NCT02139046|37721322|FG004|Overall Study|Other Miscellaneous Reasons|12|||
16782050|NCT02138890|37721336|FG000|Overall Study|Adverse Event|1|||
16782051|NCT02138890|37721337|FG001|Overall Study|Adverse Event|0|||
16782052|NCT02100670|37721348|FG000|Overall Study|Adverse Event|10|||
16782053|NCT02100670|37721349|FG001|Overall Study|Adverse Event|3|||
16782054|NCT02100670|37721350|FG002|Overall Study|Adverse Event|3|||
16782055|NCT02100670|37721351|FG003|Overall Study|Adverse Event|0|||
16782056|NCT02100670|37721348|FG000|Overall Study|Lost to Follow-up|1|||
16782057|NCT02100670|37721349|FG001|Overall Study|Lost to Follow-up|0|||
16782058|NCT02100670|37721350|FG002|Overall Study|Lost to Follow-up|0|||
17188891|NCT02508532|38341868|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
17188892|NCT02508532|38341869|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
17188893|NCT02508532|38341870|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
17188894|NCT02508532|38341871|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
17188895|NCT02508532|38341863|FG000|Part 1 and Part 2 End of Study|Death|0|||
16782059|NCT02100670|37721351|FG003|Overall Study|Lost to Follow-up|0|||
16782060|NCT02100670|37721348|FG000|Overall Study|Protocol Violation|0|||
16782061|NCT02100670|37721349|FG001|Overall Study|Protocol Violation|1|||
16782062|NCT02100670|37721350|FG002|Overall Study|Protocol Violation|0|||
16782063|NCT02100670|37721351|FG003|Overall Study|Protocol Violation|1|||
16782064|NCT02100670|37721348|FG000|Overall Study|Withdrawal of Consent|0|||
16782065|NCT02100670|37721349|FG001|Overall Study|Withdrawal of Consent|1|||
16782066|NCT02100670|37721350|FG002|Overall Study|Withdrawal of Consent|1|||
16782067|NCT02100670|37721351|FG003|Overall Study|Withdrawal of Consent|0|||
16782068|NCT02100670|37721348|FG000|Overall Study|No swelling no pain|1|||
16782069|NCT02100670|37721349|FG001|Overall Study|No swelling no pain|0|||
16782070|NCT02100670|37721350|FG002|Overall Study|No swelling no pain|0|||
16782071|NCT02100670|37721351|FG003|Overall Study|No swelling no pain|0|||
16782072|NCT02100670|37721348|FG000|Overall Study|Poor Efficacy|0|||
16782073|NCT02100670|37721349|FG001|Overall Study|Poor Efficacy|1|||
16782074|NCT02100670|37721350|FG002|Overall Study|Poor Efficacy|0|||
16782075|NCT02100670|37721351|FG003|Overall Study|Poor Efficacy|0|||
16782076|NCT02100670|37721348|FG000|Overall Study|Physician Decision|0|||
16782077|NCT02100670|37721349|FG001|Overall Study|Physician Decision|1|||
16782078|NCT02100670|37721350|FG002|Overall Study|Physician Decision|0|||
16782079|NCT02100670|37721351|FG003|Overall Study|Physician Decision|0|||
16782080|NCT02100670|37721348|FG000|Overall Study|Withdrawal by Subject|1|||
16782081|NCT02100670|37721349|FG001|Overall Study|Withdrawal by Subject|0|||
16782082|NCT02100670|37721350|FG002|Overall Study|Withdrawal by Subject|0|||
16782083|NCT02100670|37721351|FG003|Overall Study|Withdrawal by Subject|0|||
16782084|NCT02070484|37721370|FG000|Overall Study|Withdrawal by Subject|1|||
16782085|NCT02070484|37721371|FG001|Overall Study|Withdrawal by Subject|0|||
16782086|NCT02100514|37721379|FG000|Treatment Period|Adverse Event|0|||
16782087|NCT02100514|37721380|FG001|Treatment Period|Adverse Event|5|||
17188896|NCT02508532|38341864|FG001|Part 1 and Part 2 End of Study|Death|4|||
17188897|NCT02508532|38341865|FG002|Part 1 and Part 2 End of Study|Death|2|||
17188898|NCT02508532|38341866|FG003|Part 1 and Part 2 End of Study|Death|4|||
17188899|NCT02508532|38341867|FG004|Part 1 and Part 2 End of Study|Death|3|||
17188900|NCT02508532|38341868|FG005|Part 1 and Part 2 End of Study|Death|0|||
17188901|NCT02508532|38341869|FG006|Part 1 and Part 2 End of Study|Death|0|||
17188902|NCT02508532|38341870|FG007|Part 1 and Part 2 End of Study|Death|1|||
17188903|NCT02508532|38341871|FG008|Part 1 and Part 2 End of Study|Death|111|||
16782088|NCT02100514|37721381|FG002|Treatment Period|Adverse Event|0|||
16782089|NCT02100514|37721382|FG003|Treatment Period|Adverse Event|0|||
16782090|NCT02100514|37721383|FG004|Treatment Period|Adverse Event|0|||
16782091|NCT02100514|37721379|FG000|Treatment Period|Death|2|||
16782092|NCT02100514|37721380|FG001|Treatment Period|Death|2|||
16782093|NCT02100514|37721381|FG002|Treatment Period|Death|0|||
16997662|NCT00734578|38141641|FG000|Overall Study|Lost to Follow-up|9|||
16782094|NCT02100514|37721382|FG003|Treatment Period|Death|0|||
16782095|NCT02100514|37721383|FG004|Treatment Period|Death|0|||
16782096|NCT02100514|37721379|FG000|Treatment Period|Lost to Follow-up|5|||
16782097|NCT02100514|37721380|FG001|Treatment Period|Lost to Follow-up|17|||
17188904|NCT02508532|38341863|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
16782098|NCT02100514|37721381|FG002|Treatment Period|Lost to Follow-up|0|||
16782099|NCT02100514|37721382|FG003|Treatment Period|Lost to Follow-up|0|||
16782100|NCT02100514|37721383|FG004|Treatment Period|Lost to Follow-up|0|||
16782101|NCT02100514|37721379|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
16782102|NCT02100514|37721380|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
16782103|NCT02100514|37721381|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
16782104|NCT02100514|37721382|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
16782105|NCT02100514|37721383|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
16782106|NCT02100514|37721379|FG000|Treatment Period|Protocol Violation|1|||
16782107|NCT02100514|37721380|FG001|Treatment Period|Protocol Violation|1|||
16782108|NCT02100514|37721381|FG002|Treatment Period|Protocol Violation|0|||
16782109|NCT02100514|37721382|FG003|Treatment Period|Protocol Violation|0|||
16782110|NCT02100514|37721383|FG004|Treatment Period|Protocol Violation|0|||
16782111|NCT02100514|37721379|FG000|Treatment Period|Withdrawal by Subject|12|||
16782112|NCT02100514|37721380|FG001|Treatment Period|Withdrawal by Subject|37|||
16782113|NCT02100514|37721381|FG002|Treatment Period|Withdrawal by Subject|0|||
16782114|NCT02100514|37721382|FG003|Treatment Period|Withdrawal by Subject|0|||
16782115|NCT02100514|37721383|FG004|Treatment Period|Withdrawal by Subject|0|||
16782116|NCT02100514|37721379|FG000|Treatment Period|Other|9|||
16782117|NCT02100514|37721380|FG001|Treatment Period|Other|11|||
16782118|NCT02100514|37721381|FG002|Treatment Period|Other|0|||
16782119|NCT02100514|37721382|FG003|Treatment Period|Other|0|||
16782120|NCT02100514|37721383|FG004|Treatment Period|Other|0|||
16782121|NCT02100514|37721379|FG000|Extension Period|Withdrew consent|0|||
16782122|NCT02100514|37721380|FG001|Extension Period|Withdrew consent|0|||
16782123|NCT02100514|37721381|FG002|Extension Period|Withdrew consent|2|||
16782124|NCT02100514|37721382|FG003|Extension Period|Withdrew consent|0|||
16782125|NCT02100514|37721383|FG004|Extension Period|Withdrew consent|0|||
16782126|NCT02069392|37721399|FG000|Overall Study|Withdrawal by Subject|4|||
16782127|NCT02069392|37721400|FG001|Overall Study|Withdrawal by Subject|2|||
16782128|NCT02573493|37721412|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
16782129|NCT02573493|37721413|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
16782130|NCT02573493|37721414|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
16782131|NCT02573493|37721415|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
16782132|NCT02047318|37721439|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
16782133|NCT02047318|37721439|FG000|Core Study Period|Adverse Event|1|||
16782134|NCT02047318|37721439|FG000|Core Study Period|Withdrawal by caregiver|3|||
16782135|NCT02047318|37721439|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
16782136|NCT02100124|37721457|FG000|Overall Study|Lost to Follow-up|5|||
16782137|NCT02100124|37721458|FG001|Overall Study|Lost to Follow-up|11|||
16782138|NCT02100124|37721459|FG002|Overall Study|Lost to Follow-up|3|||
16782139|NCT02100124|37721457|FG000|Overall Study|Withdrawal by Subject|1|||
16782140|NCT02100124|37721458|FG001|Overall Study|Withdrawal by Subject|0|||
16782141|NCT02100124|37721459|FG002|Overall Study|Withdrawal by Subject|0|||
16782142|NCT02068768|37721467|FG000|Overall Study|Lost to Follow-up|5|||
16782143|NCT02068768|37721467|FG000|Overall Study|Early Termination by Sponsor|2|||
16782144|NCT02046616|37721471|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
16782145|NCT02046616|37721471|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
16782146|NCT02046616|37721471|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
16782147|NCT02046616|37721471|FG000|24-Week Treatment Period|Physician Decision|3|||
16782148|NCT02046616|37721471|FG000|24-Week Treatment Period|Other|1|||
16782149|NCT02046616|37721471|FG000|8-Week FU Period|Lost to Follow-up|1|||
16782150|NCT02099344|37721477|FG000|Overall Study|Physician Decision|1|||
16782151|NCT02099344|37721478|FG001|Overall Study|Physician Decision|0|||
16782152|NCT02068222|37721486|FG000|Overall Study|Lost to Follow-up|1|||
16782153|NCT02099110|37721495|FG000|Overall Study|Protocol Violation|2|||
16782154|NCT02099110|37721496|FG001|Overall Study|Protocol Violation|1|||
16782155|NCT02099110|37721497|FG002|Overall Study|Protocol Violation|0|||
16782156|NCT02099110|37721498|FG003|Overall Study|Protocol Violation|3|||
16782157|NCT02099110|37721499|FG004|Overall Study|Protocol Violation|1|||
16782158|NCT02099110|37721495|FG000|Overall Study|Participant moved|1|||
16782159|NCT02099110|37721496|FG001|Overall Study|Participant moved|1|||
16782160|NCT02099110|37721497|FG002|Overall Study|Participant moved|1|||
16782161|NCT02099110|37721498|FG003|Overall Study|Participant moved|0|||
16782162|NCT02099110|37721499|FG004|Overall Study|Participant moved|2|||
16782163|NCT02099110|37721495|FG000|Overall Study|Withdrawal by Subject|7|||
16782164|NCT02099110|37721496|FG001|Overall Study|Withdrawal by Subject|11|||
16782165|NCT02099110|37721497|FG002|Overall Study|Withdrawal by Subject|13|||
16782166|NCT02099110|37721498|FG003|Overall Study|Withdrawal by Subject|9|||
16782167|NCT02099110|37721499|FG004|Overall Study|Withdrawal by Subject|13|||
16782168|NCT02099110|37721495|FG000|Overall Study|Adverse Event|3|||
16782169|NCT02099110|37721496|FG001|Overall Study|Adverse Event|5|||
16782170|NCT02099110|37721497|FG002|Overall Study|Adverse Event|2|||
16782171|NCT02099110|37721498|FG003|Overall Study|Adverse Event|3|||
16782172|NCT02099110|37721499|FG004|Overall Study|Adverse Event|2|||
16782173|NCT02099110|37721495|FG000|Overall Study|Lost to Follow-up|6|||
17188905|NCT02508532|38341864|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
16782174|NCT02099110|37721496|FG001|Overall Study|Lost to Follow-up|12|||
16782175|NCT02099110|37721497|FG002|Overall Study|Lost to Follow-up|11|||
16782176|NCT02099110|37721498|FG003|Overall Study|Lost to Follow-up|5|||
16782177|NCT02099110|37721499|FG004|Overall Study|Lost to Follow-up|6|||
16782178|NCT02099110|37721495|FG000|Overall Study|Death|0|||
16782179|NCT02099110|37721496|FG001|Overall Study|Death|1|||
16782180|NCT02099110|37721497|FG002|Overall Study|Death|0|||
16782181|NCT02099110|37721498|FG003|Overall Study|Death|0|||
16782182|NCT02099110|37721499|FG004|Overall Study|Death|0|||
16782183|NCT02099110|37721495|FG000|Overall Study|Screen failure|0|||
16782184|NCT02099110|37721496|FG001|Overall Study|Screen failure|0|||
16782185|NCT02099110|37721497|FG002|Overall Study|Screen failure|0|||
16782186|NCT02099110|37721498|FG003|Overall Study|Screen failure|0|||
16782187|NCT02099110|37721499|FG004|Overall Study|Screen failure|1|||
16782188|NCT02099110|37721495|FG000|Overall Study|Non-compliance with study drug|2|||
16782189|NCT02099110|37721496|FG001|Overall Study|Non-compliance with study drug|0|||
16782190|NCT02099110|37721497|FG002|Overall Study|Non-compliance with study drug|0|||
16782191|NCT02099110|37721498|FG003|Overall Study|Non-compliance with study drug|0|||
16782192|NCT02099110|37721499|FG004|Overall Study|Non-compliance with study drug|1|||
16782193|NCT02099110|37721495|FG000|Overall Study|Physician Decision|3|||
16782194|NCT02099110|37721496|FG001|Overall Study|Physician Decision|0|||
16782195|NCT02099110|37721497|FG002|Overall Study|Physician Decision|1|||
16782196|NCT02099110|37721498|FG003|Overall Study|Physician Decision|2|||
16782197|NCT02099110|37721499|FG004|Overall Study|Physician Decision|1|||
16782198|NCT02098876|37721513|FG000|Overall Study|Withdrawal by Subject|5|||
16782199|NCT02098876|37721514|FG001|Overall Study|Withdrawal by Subject|5|||
16782200|NCT01624090|37721524|FG000|Overall Study|DLT, taken off therapy|0|||
16782201|NCT01624090|37721525|FG001|Overall Study|DLT, taken off therapy|1|||
16782202|NCT01624090|37721526|FG002|Overall Study|DLT, taken off therapy|0|||
16782203|NCT01624090|37721527|FG003|Overall Study|DLT, taken off therapy|0|||
17188906|NCT02508532|38341865|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
17188907|NCT02508532|38341866|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
16782204|NCT01624090|37721524|FG000|Overall Study|Withdrew prior to treatment|0|||
16782205|NCT01624090|37721525|FG001|Overall Study|Withdrew prior to treatment|1|||
16782206|NCT01624090|37721526|FG002|Overall Study|Withdrew prior to treatment|0|||
16782207|NCT01624090|37721527|FG003|Overall Study|Withdrew prior to treatment|0|||
16782208|NCT01624090|37721524|FG000|Overall Study|Died on study|0|||
16782209|NCT01624090|37721525|FG001|Overall Study|Died on study|0|||
16782210|NCT01624090|37721526|FG002|Overall Study|Died on study|2|||
16782211|NCT01624090|37721527|FG003|Overall Study|Died on study|0|||
16782212|NCT01624090|37721524|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
16782213|NCT01624090|37721525|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
16782214|NCT01624090|37721526|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
16782215|NCT01624090|37721527|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
16782216|NCT01624090|37721524|FG000|Overall Study|Dose escalated|0|||
16782217|NCT01624090|37721525|FG001|Overall Study|Dose escalated|0|||
16782218|NCT01624090|37721526|FG002|Overall Study|Dose escalated|3|||
17188908|NCT02508532|38341867|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
17188909|NCT02508532|38341868|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
17188910|NCT02508532|38341869|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
17188911|NCT02508532|38341870|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
16782219|NCT01624090|37721527|FG003|Overall Study|Dose escalated|0|||
16782220|NCT02571777|37721542|FG000|Overall Study|Subject/guardian decision|34|||
16782221|NCT02571777|37721543|FG001|Overall Study|Subject/guardian decision|26|||
16782222|NCT02571777|37721544|FG002|Overall Study|Subject/guardian decision|26|||
16782223|NCT02571777|37721545|FG003|Overall Study|Subject/guardian decision|25|||
16782224|NCT02571777|37721546|FG004|Overall Study|Subject/guardian decision|27|||
16782225|NCT02571777|37721542|FG000|Overall Study|Protocol Deviation|2|||
16782226|NCT02571777|37721543|FG001|Overall Study|Protocol Deviation|3|||
16782227|NCT02571777|37721544|FG002|Overall Study|Protocol Deviation|4|||
16782228|NCT02571777|37721545|FG003|Overall Study|Protocol Deviation|8|||
16782229|NCT02571777|37721546|FG004|Overall Study|Protocol Deviation|4|||
16782230|NCT02571777|37721542|FG000|Overall Study|Death|1|||
16782231|NCT02571777|37721543|FG001|Overall Study|Death|1|||
16782232|NCT02571777|37721544|FG002|Overall Study|Death|4|||
16782233|NCT02571777|37721545|FG003|Overall Study|Death|0|||
16782234|NCT02571777|37721546|FG004|Overall Study|Death|0|||
16782235|NCT02571777|37721542|FG000|Overall Study|Lost to Follow-up|1|||
16782236|NCT02571777|37721543|FG001|Overall Study|Lost to Follow-up|1|||
16782237|NCT02571777|37721544|FG002|Overall Study|Lost to Follow-up|2|||
16782238|NCT02571777|37721545|FG003|Overall Study|Lost to Follow-up|0|||
16782239|NCT02571777|37721546|FG004|Overall Study|Lost to Follow-up|1|||
16782240|NCT02571777|37721542|FG000|Overall Study|Physician Decision|1|||
16782241|NCT02571777|37721543|FG001|Overall Study|Physician Decision|7|||
16782242|NCT02571777|37721544|FG002|Overall Study|Physician Decision|5|||
16782243|NCT02571777|37721545|FG003|Overall Study|Physician Decision|2|||
16782244|NCT02571777|37721546|FG004|Overall Study|Physician Decision|4|||
16782245|NCT02571777|37721542|FG000|Overall Study|Pregnancy|0|||
16782246|NCT02571777|37721543|FG001|Overall Study|Pregnancy|0|||
16782247|NCT02571777|37721544|FG002|Overall Study|Pregnancy|0|||
16782248|NCT02571777|37721545|FG003|Overall Study|Pregnancy|2|||
16868069|NCT01553591|37841085|FG000|Overall Study|Physician decision: other|11|||
16868070|NCT01553591|37841086|FG001|Overall Study|Physician decision: other|14|||
16868071|NCT01553591|37841087|FG002|Overall Study|Physician decision: other|16|||
16868072|NCT01553591|37841085|FG000|Overall Study|Physician decision: lack of efficacy|2|||
16868073|NCT01553591|37841086|FG001|Overall Study|Physician decision: lack of efficacy|3|||
16868074|NCT01553591|37841087|FG002|Overall Study|Physician decision: lack of efficacy|7|||
16868075|NCT01553591|37841085|FG000|Overall Study|Protocol Violation|3|||
16868076|NCT01553591|37841086|FG001|Overall Study|Protocol Violation|4|||
16868077|NCT01553591|37841087|FG002|Overall Study|Protocol Violation|4|||
16868078|NCT01553591|37841085|FG000|Overall Study|Sponsor decision|1|||
16868079|NCT01553591|37841086|FG001|Overall Study|Sponsor decision|0|||
16868080|NCT01553591|37841087|FG002|Overall Study|Sponsor decision|3|||
16868081|NCT01553591|37841085|FG000|Overall Study|Randomized and never dispensed drug|0|||
16868082|NCT01553591|37841086|FG001|Overall Study|Randomized and never dispensed drug|1|||
16868083|NCT01553591|37841087|FG002|Overall Study|Randomized and never dispensed drug|0|||
16868084|NCT01581931|37841095|FG000|Washout|Adverse Event|0|||
16868085|NCT01581931|37841096|FG001|Washout|Adverse Event|1|||
16997663|NCT00734578|38141642|FG001|Overall Study|Lost to Follow-up|3|||
16782249|NCT02571777|37721546|FG004|Overall Study|Pregnancy|0|||
16782250|NCT02571075|37721560|FG000|Overall Study|Lost to Follow-up|20|||
16782251|NCT02571075|37721561|FG001|Overall Study|Lost to Follow-up|24|||
16782252|NCT02705105|37721575|FG000|Treatment|Objective Disease Progression|1|||
16782253|NCT02705105|37721576|FG001|Treatment|Objective Disease Progression|50|||
17188912|NCT02508532|38341871|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
17188913|NCT02508532|38341863|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
17188914|NCT02508532|38341864|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16782254|NCT02705105|37721575|FG000|Treatment|Withdrawal by Subject|3|||
16782255|NCT02705105|37721576|FG001|Treatment|Withdrawal by Subject|5|||
16782256|NCT02705105|37721575|FG000|Treatment|Adverse Event|0|||
16782257|NCT02705105|37721576|FG001|Treatment|Adverse Event|17|||
16782258|NCT02705105|37721575|FG000|Treatment|Clinical Disease Progression|0|||
16782259|NCT02705105|37721576|FG001|Treatment|Clinical Disease Progression|32|||
16782260|NCT02705105|37721575|FG000|Treatment|Physician Decision|0|||
16782261|NCT02705105|37721576|FG001|Treatment|Physician Decision|3|||
16782262|NCT02705105|37721575|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
16782263|NCT02705105|37721576|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
16782264|NCT02705105|37721575|FG000|Follow-Up|Death|3|||
16782265|NCT02705105|37721576|FG001|Follow-Up|Death|68|||
16782266|NCT02705105|37721575|FG000|Follow-Up|Withdrawal by Subject|1|||
16782267|NCT02705105|37721576|FG001|Follow-Up|Withdrawal by Subject|14|||
16782268|NCT02705105|37721575|FG000|Follow-Up|Study Terminated|0|||
16782269|NCT02705105|37721576|FG001|Follow-Up|Study Terminated|26|||
16782270|NCT02705105|37721575|FG000|Follow-Up|Discontinued per Amendment 3|0|||
16997664|NCT00734578|38141643|FG002|Overall Study|Lost to Follow-up|5|||
17188915|NCT02508532|38341865|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
17188916|NCT02508532|38341866|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
17188917|NCT02508532|38341867|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16868086|NCT01581619|37841102|FG000|Overall Study|Withdrawal by Subject|1|||
16868087|NCT01581619|37841102|FG000|Overall Study|Lost to Follow-up|1|||
17188918|NCT02508532|38341868|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
17188919|NCT02508532|38341869|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
17188920|NCT02508532|38341870|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
17188921|NCT02508532|38341871|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
16868088|NCT01581307|37841108|FG000|Overall Study|Withdrawal by Subject|1|||
16782271|NCT02705105|37721576|FG001|Follow-Up|Discontinued per Amendment 3|2|||
16782272|NCT02097472|37721602|FG000|Received Vaccination 2|Adverse Event|0|||
16782273|NCT02097472|37721603|FG001|Received Vaccination 2|Adverse Event|0|||
16782274|NCT02097472|37721604|FG002|Received Vaccination 2|Adverse Event|0|||
16782275|NCT02097472|37721605|FG003|Received Vaccination 2|Adverse Event|0|||
16782276|NCT02097472|37721606|FG004|Received Vaccination 2|Adverse Event|0|||
16782277|NCT02097472|37721607|FG005|Received Vaccination 2|Adverse Event|0|||
16782278|NCT02097472|37721608|FG006|Received Vaccination 2|Adverse Event|1|||
16782279|NCT02097472|37721609|FG007|Received Vaccination 2|Adverse Event|0|||
16782280|NCT01623310|37721693|FG000|Overall Study|Adverse Event|21|||
16782281|NCT01623310|37721693|FG000|Overall Study|Lost to Follow-up|18|||
16782282|NCT01623310|37721693|FG000|Overall Study|Lack of Efficacy|6|||
16782283|NCT01623310|37721693|FG000|Overall Study|Protocol Violation|6|||
16782284|NCT01623310|37721693|FG000|Overall Study|Withdrawal by Subject|25|||
16782285|NCT01623310|37721693|FG000|Overall Study|Became potentially child-bearing|1|||
16782286|NCT01623310|37721693|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
16782287|NCT01623310|37721693|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
16782288|NCT02046226|37721697|FG000|Overall Study|Lost to Follow-up|7|||
16782289|NCT02046148|37721704|FG000|Overall Study|Lost to Follow-up|1|||
16782290|NCT02046148|37721705|FG001|Overall Study|Lost to Follow-up|1|||
16782291|NCT02046148|37721704|FG000|Overall Study|Withdrawal by Subject|0|||
16782292|NCT02046148|37721705|FG001|Overall Study|Withdrawal by Subject|2|||
16782293|NCT02097238|37721711|FG000|Overall Study|Death|1|||
16782294|NCT02097238|37721711|FG000|Overall Study|Physician Decision|1|||
16782295|NCT02097238|37721711|FG000|Overall Study|Progressive Disease|17|||
16782296|NCT02704091|37721718|FG000|Overall Study|Adverse Event|4|||
16782297|NCT02704091|37721719|FG001|Overall Study|Adverse Event|3|||
16782298|NCT02704091|37721718|FG000|Overall Study|Protocol Violation|5|||
16782299|NCT02704091|37721719|FG001|Overall Study|Protocol Violation|3|||
16782300|NCT02704091|37721718|FG000|Overall Study|Consent withdrawn|4|||
16782301|NCT02704091|37721719|FG001|Overall Study|Consent withdrawn|4|||
16782302|NCT02704091|37721718|FG000|Overall Study|Lost to Follow-up|13|||
16782303|NCT02704091|37721719|FG001|Overall Study|Lost to Follow-up|5|||
16782304|NCT02704091|37721718|FG000|Overall Study|Other|2|||
16782305|NCT02704091|37721719|FG001|Overall Study|Other|8|||
16782306|NCT02702609|37721727|FG000|Overall Study|Lost to Follow-up|8|||
16782307|NCT02702609|37721728|FG001|Overall Study|Lost to Follow-up|4|||
16782308|NCT02702609|37721727|FG000|Overall Study|Physician Decision|1|||
16782309|NCT02702609|37721728|FG001|Overall Study|Physician Decision|0|||
16782310|NCT02046070|37721737|FG000|Overall Study|Progressive Disease|18|||
16782311|NCT02046070|37721738|FG001|Overall Study|Progressive Disease|11|||
16782312|NCT02046070|37721739|FG002|Overall Study|Progressive Disease|40|||
16782313|NCT02046070|37721737|FG000|Overall Study|Adverse Event|8|||
16782314|NCT02046070|37721738|FG001|Overall Study|Adverse Event|10|||
16782315|NCT02046070|37721739|FG002|Overall Study|Adverse Event|17|||
16782316|NCT02046070|37721737|FG000|Overall Study|Withdrawal by Subject|1|||
16782317|NCT02046070|37721738|FG001|Overall Study|Withdrawal by Subject|2|||
16782318|NCT02046070|37721739|FG002|Overall Study|Withdrawal by Subject|6|||
16782319|NCT02046070|37721737|FG000|Overall Study|Study Terminated by Sponsor|1|||
16782320|NCT02046070|37721738|FG001|Overall Study|Study Terminated by Sponsor|1|||
16782321|NCT02046070|37721739|FG002|Overall Study|Study Terminated by Sponsor|1|||
16782322|NCT02046070|37721737|FG000|Overall Study|Reason not Specified|4|||
16782323|NCT02046070|37721738|FG001|Overall Study|Reason not Specified|4|||
16782324|NCT02046070|37721739|FG002|Overall Study|Reason not Specified|6|||
16782325|NCT01663857|37721751|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
16782326|NCT01663857|37721752|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
16782327|NCT01663857|37721753|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
16782328|NCT01663857|37721754|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
16782329|NCT01663857|37721751|FG000|Overall Study|Lost to Follow-up|0|||
16782330|NCT01663857|37721752|FG001|Overall Study|Lost to Follow-up|0|||
16782331|NCT01663857|37721753|FG002|Overall Study|Lost to Follow-up|3|||
16782332|NCT01663857|37721754|FG003|Overall Study|Lost to Follow-up|1|||
16782333|NCT02094898|37721770|FG000|Overall Study|Clinical Worsening|2|||
16782334|NCT02094898|37721770|FG000|Overall Study|Adverse Event|2|||
16782335|NCT02094898|37721770|FG000|Overall Study|Lack of Efficacy|1|||
16782336|NCT02045836|37721778|FG000|Overall Study|Adverse Event|4|||
16782337|NCT02045836|37721779|FG001|Overall Study|Adverse Event|4|||
16782338|NCT02045836|37721778|FG000|Overall Study|Withdrawal by Subject|1|||
16782339|NCT02045836|37721779|FG001|Overall Study|Withdrawal by Subject|1|||
16782340|NCT02045836|37721778|FG000|Overall Study|Lost to Follow-up|4|||
16782341|NCT02045836|37721779|FG001|Overall Study|Lost to Follow-up|7|||
16782342|NCT02045836|37721778|FG000|Overall Study|Migrated from study area|0|||
16782343|NCT02045836|37721779|FG001|Overall Study|Migrated from study area|2|||
16782344|NCT02569437|37721788|FG000|Overall Study|Lost to Follow-up|12|||
16782345|NCT02569437|37721789|FG001|Overall Study|Lost to Follow-up|14|||
16782346|NCT02045212|37721797|FG000|Overall Study|Adverse Event|0|||
16782347|NCT02045212|37721798|FG001|Overall Study|Adverse Event|1|||
16782348|NCT02045212|37721797|FG000|Overall Study|Withdrawal by Subject|1|||
16782349|NCT02045212|37721798|FG001|Overall Study|Withdrawal by Subject|0|||
16782350|NCT02045212|37721797|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
16782351|NCT02045212|37721798|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
16782352|NCT02044822|37721808|FG000|Overall Study|Study Terminated by Sponsor|77|||
16782353|NCT02044822|37721808|FG000|Overall Study|Investigator's Discretion|10|||
16782354|NCT02044822|37721808|FG000|Overall Study|Withdrew Consent|3|||
16782355|NCT02044822|37721808|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
16782356|NCT02044822|37721808|FG000|Overall Study|Lost to Follow-up|1|||
16782357|NCT02044510|37721814|FG000|Overall Study|Adverse Event|1|||
16782358|NCT02044510|37721815|FG001|Overall Study|Adverse Event|2|||
16782359|NCT02067676|37721827|FG000|Overall Study|Withdrawal by Subject|1|||
16782360|NCT02067676|37721828|FG001|Overall Study|Withdrawal by Subject|0|||
16782361|NCT02067676|37721829|FG002|Overall Study|Withdrawal by Subject|0|||
16782362|NCT02067676|37721830|FG003|Overall Study|Withdrawal by Subject|0|||
16782363|NCT02067676|37721831|FG004|Overall Study|Withdrawal by Subject|0|||
16782364|NCT02067676|37721832|FG005|Overall Study|Withdrawal by Subject|0|||
16782365|NCT01623154|37721851|FG000|Overall Study|Did not drink Pranactin Citric|4|||
16782366|NCT00702689|37721857|FG000|Overall Study|Withdrawal by Subject|4|||
16782367|NCT00702689|37721857|FG000|Overall Study|Recurrent malignancy|1|||
16782368|NCT00702689|37721857|FG000|Overall Study|Adverse Event|1|||
16997665|NCT00734578|38141641|FG000|Overall Study|Lack of Efficacy|3|||
16782369|NCT02065570|37721863|FG000|Induction Study|Adverse Event|5|||
16782370|NCT02065570|37721864|FG001|Induction Study|Adverse Event|12|||
16782371|NCT02065570|37721865|FG002|Induction Study|Adverse Event|0|||
16782372|NCT02065570|37721866|FG003|Induction Study|Adverse Event|0|||
16782373|NCT02065570|37721863|FG000|Induction Study|Withdrawal by Subject|2|||
16782374|NCT02065570|37721864|FG001|Induction Study|Withdrawal by Subject|3|||
16782375|NCT02065570|37721865|FG002|Induction Study|Withdrawal by Subject|0|||
16782376|NCT02065570|37721866|FG003|Induction Study|Withdrawal by Subject|0|||
16782377|NCT02065570|37721863|FG000|Induction Study|Lost to Follow-up|1|||
16782378|NCT02065570|37721864|FG001|Induction Study|Lost to Follow-up|1|||
16782379|NCT02065570|37721865|FG002|Induction Study|Lost to Follow-up|0|||
16782380|NCT02065570|37721866|FG003|Induction Study|Lost to Follow-up|0|||
16782381|NCT02065570|37721863|FG000|Induction Study|Other, Not Specified|6|||
16782382|NCT02065570|37721864|FG001|Induction Study|Other, Not Specified|5|||
16782383|NCT02065570|37721865|FG002|Induction Study|Other, Not Specified|0|||
16782384|NCT02065570|37721866|FG003|Induction Study|Other, Not Specified|0|||
16782385|NCT02065570|37721863|FG000|Maintenance Study|Adverse Event|0|||
16782386|NCT02065570|37721864|FG001|Maintenance Study|Adverse Event|0|||
16782387|NCT02065570|37721865|FG002|Maintenance Study|Adverse Event|8|||
16782388|NCT02065570|37721866|FG003|Maintenance Study|Adverse Event|8|||
16782389|NCT02065570|37721863|FG000|Maintenance Study|Withdrawal by Subject|0|||
16782390|NCT02065570|37721864|FG001|Maintenance Study|Withdrawal by Subject|0|||
16782391|NCT02065570|37721865|FG002|Maintenance Study|Withdrawal by Subject|1|||
16782392|NCT02065570|37721866|FG003|Maintenance Study|Withdrawal by Subject|4|||
16782393|NCT02065570|37721863|FG000|Maintenance Study|Lost to Follow-up|0|||
16782394|NCT02065570|37721864|FG001|Maintenance Study|Lost to Follow-up|0|||
16782395|NCT02065570|37721865|FG002|Maintenance Study|Lost to Follow-up|2|||
16782396|NCT02065570|37721866|FG003|Maintenance Study|Lost to Follow-up|2|||
16782397|NCT02065570|37721863|FG000|Maintenance Study|Other, Not Specified|0|||
16782398|NCT02065570|37721864|FG001|Maintenance Study|Other, Not Specified|0|||
16782399|NCT02065570|37721865|FG002|Maintenance Study|Other, Not Specified|11|||
16782400|NCT02065570|37721866|FG003|Maintenance Study|Other, Not Specified|5|||
16782401|NCT02566005|37721879|FG000|Overall Study|vaginal bleeding|0|||
16782402|NCT02566005|37721880|FG001|Overall Study|vaginal bleeding|1|||
16782403|NCT02566005|37721879|FG000|Overall Study|received foley|8|||
16782404|NCT02566005|37721880|FG001|Overall Study|received foley|0|||
16997666|NCT00734578|38141642|FG001|Overall Study|Lack of Efficacy|2|||
16997667|NCT00734578|38141643|FG002|Overall Study|Lack of Efficacy|5|||
16997668|NCT00734578|38141641|FG000|Overall Study|Randomized in error|1|||
16997669|NCT00734578|38141642|FG001|Overall Study|Randomized in error|0|||
16997670|NCT00734578|38141643|FG002|Overall Study|Randomized in error|0|||
16997671|NCT00734578|38141641|FG000|Overall Study|Exclusion criteria|1|||
16997672|NCT00734578|38141642|FG001|Overall Study|Exclusion criteria|0|||
16997673|NCT00734578|38141643|FG002|Overall Study|Exclusion criteria|0|||
16997674|NCT00739102|38141651|FG000|Overall Study|Death|5|||
17089998|NCT00292188|38230106|FG000|Double-Blind|Adverse Event|0|||
17089999|NCT00292188|38230107|FG001|Double-Blind|Adverse Event|25|||
17090000|NCT00292188|38230108|FG002|Double-Blind|Adverse Event|9|||
17090001|NCT00292188|38230106|FG000|Double-Blind|Lack of Efficacy|0|||
17090002|NCT00292188|38230107|FG001|Double-Blind|Lack of Efficacy|2|||
17090003|NCT00292188|38230108|FG002|Double-Blind|Lack of Efficacy|12|||
17090004|NCT00292188|38230106|FG000|Double-Blind|Lost to Follow-up|0|||
17090005|NCT00292188|38230107|FG001|Double-Blind|Lost to Follow-up|1|||
17090006|NCT00292188|38230108|FG002|Double-Blind|Lost to Follow-up|0|||
17090007|NCT00292188|38230106|FG000|Double-Blind|Other|0|||
17090008|NCT00292188|38230107|FG001|Double-Blind|Other|3|||
17090009|NCT00292188|38230108|FG002|Double-Blind|Other|4|||
17090010|NCT00292188|38230106|FG000|Double-Blind|Withdrawal by Subject|0|||
17090011|NCT00292188|38230107|FG001|Double-Blind|Withdrawal by Subject|0|||
17090012|NCT00292188|38230108|FG002|Double-Blind|Withdrawal by Subject|3|||
17090013|NCT00292188|38230106|FG000|Double-Blind|Laboratory Abnormality|0|||
17090014|NCT00292188|38230107|FG001|Double-Blind|Laboratory Abnormality|0|||
17090015|NCT00292188|38230108|FG002|Double-Blind|Laboratory Abnormality|1|||
17090016|NCT00272844|38230115|FG000|Overall Study|Withdrawal by Subject|5|||
16782405|NCT02566005|37721879|FG000|Overall Study|did not receive foley|0|||
16997675|NCT00739102|38141651|FG000|Overall Study|Withdrawal by Subject|10|||
16997676|NCT00959192|38141659|FG000|Overall Study|Adverse Event|1|||
16997677|NCT00959192|38141660|FG001|Overall Study|Adverse Event|1|||
16997678|NCT00959192|38141661|FG002|Overall Study|Adverse Event|1|||
16997679|NCT00959192|38141662|FG003|Overall Study|Adverse Event|0|||
16997680|NCT00959192|38141659|FG000|Overall Study|Investigator Request|1|||
16997681|NCT00959192|38141660|FG001|Overall Study|Investigator Request|0|||
16997682|NCT00959192|38141661|FG002|Overall Study|Investigator Request|0|||
16782406|NCT02566005|37721880|FG001|Overall Study|did not receive foley|1|||
16782407|NCT02566005|37721879|FG000|Overall Study|labor after randomization|0|||
16997683|NCT00959192|38141662|FG003|Overall Study|Investigator Request|0|||
16997684|NCT00959192|38141659|FG000|Overall Study|Caregiver Request|0|||
16997685|NCT00959192|38141660|FG001|Overall Study|Caregiver Request|0|||
17090017|NCT00271596|38230121|FG000|Overall Study|Protocol Violation|1|||
16782408|NCT02566005|37721880|FG001|Overall Study|labor after randomization|4|||
16782409|NCT02065336|37721898|FG000|Extension Phase|Study Terminated by Sponsor|0|||
16782410|NCT02065336|37721899|FG001|Extension Phase|Study Terminated by Sponsor|0|||
16782411|NCT02065336|37721900|FG002|Extension Phase|Study Terminated by Sponsor|0|||
16782412|NCT02065336|37721901|FG003|Extension Phase|Study Terminated by Sponsor|0|||
16782413|NCT02065336|37721902|FG004|Extension Phase|Study Terminated by Sponsor|0|||
16782414|NCT02065336|37721903|FG005|Extension Phase|Study Terminated by Sponsor|0|||
16782415|NCT02065336|37721904|FG006|Extension Phase|Study Terminated by Sponsor|0|||
16782416|NCT02065336|37721905|FG007|Extension Phase|Study Terminated by Sponsor|0|||
16782417|NCT02065336|37721906|FG008|Extension Phase|Study Terminated by Sponsor|2|||
16782418|NCT02065336|37721907|FG009|Extension Phase|Study Terminated by Sponsor|8|||
16782419|NCT02701985|37721940|FG000|Overall Study|Withdrawal by Subject|1|||
16782420|NCT02701985|37721941|FG001|Overall Study|Withdrawal by Subject|1|||
16782421|NCT02701985|37721940|FG000|Overall Study|Lost to Follow-up|1|||
16782422|NCT02701985|37721941|FG001|Overall Study|Lost to Follow-up|0|||
16782423|NCT02701985|37721940|FG000|Overall Study|Death|1|||
16782424|NCT02701985|37721941|FG001|Overall Study|Death|0|||
16782425|NCT02701985|37721940|FG000|Overall Study|Adverse Event|0|||
16782426|NCT02701985|37721941|FG001|Overall Study|Adverse Event|5|||
16782427|NCT02064868|37721950|FG000|Overall Study|Lost to Follow-up|14|||
16782428|NCT02064868|37721951|FG001|Overall Study|Lost to Follow-up|8|||
16782429|NCT02064868|37721950|FG000|Overall Study|Physician Decision|1|||
16782430|NCT02064868|37721951|FG001|Overall Study|Physician Decision|0|||
16782431|NCT02064868|37721950|FG000|Overall Study|Withdrawal by Subject|14|||
16782432|NCT02064868|37721951|FG001|Overall Study|Withdrawal by Subject|3|||
16782433|NCT02064868|37721950|FG000|Overall Study|Technical Problems or Missing|5|||
16782434|NCT02064868|37721951|FG001|Overall Study|Technical Problems or Missing|2|||
16782435|NCT02064166|37721959|FG000|Overall Study|Adverse Event|1|||
16782436|NCT02064166|37721960|FG001|Overall Study|Adverse Event|0|||
16782437|NCT02565615|37721993|FG000|Overall Study|Death|0|||
16782438|NCT02565615|37721994|FG001|Overall Study|Death|1|||
16782439|NCT02565615|37721995|FG002|Overall Study|Death|0|||
16782440|NCT02565615|37721996|FG003|Overall Study|Death|0|||
16782441|NCT02565615|37721997|FG004|Overall Study|Death|4|||
16782442|NCT02565615|37721993|FG000|Overall Study|Not willing to participate in study|2|||
16782443|NCT02565615|37721994|FG001|Overall Study|Not willing to participate in study|21|||
16782444|NCT02565615|37721995|FG002|Overall Study|Not willing to participate in study|0|||
16782445|NCT02565615|37721996|FG003|Overall Study|Not willing to participate in study|1|||
16782446|NCT02565615|37721997|FG004|Overall Study|Not willing to participate in study|169|||
16782447|NCT02565615|37721993|FG000|Overall Study|Lost to Follow-up|0|||
17188922|NCT02508532|38341863|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
17188923|NCT02508532|38341864|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
17188924|NCT02508532|38341865|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
17188925|NCT02508532|38341866|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
17188926|NCT02508532|38341867|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
17188927|NCT02508532|38341868|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
17188928|NCT02508532|38341869|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
16782448|NCT02565615|37721994|FG001|Overall Study|Lost to Follow-up|4|||
16782449|NCT02565615|37721995|FG002|Overall Study|Lost to Follow-up|0|||
16782450|NCT02565615|37721996|FG003|Overall Study|Lost to Follow-up|1|||
16782451|NCT02565615|37721997|FG004|Overall Study|Lost to Follow-up|765|||
16782452|NCT02565615|37721993|FG000|Overall Study|Not meeting eligibility criteria|0|||
16782453|NCT02565615|37721994|FG001|Overall Study|Not meeting eligibility criteria|7|||
16782454|NCT02565615|37721995|FG002|Overall Study|Not meeting eligibility criteria|0|||
16782455|NCT02565615|37721996|FG003|Overall Study|Not meeting eligibility criteria|0|||
16782456|NCT02565615|37721997|FG004|Overall Study|Not meeting eligibility criteria|25|||
16782457|NCT02565615|37721993|FG000|Overall Study|Reason not defined|0|||
16782458|NCT02565615|37721994|FG001|Overall Study|Reason not defined|2|||
16782459|NCT02565615|37721995|FG002|Overall Study|Reason not defined|0|||
16782460|NCT02565615|37721996|FG003|Overall Study|Reason not defined|1|||
16782461|NCT02565615|37721997|FG004|Overall Study|Reason not defined|62|||
16782462|NCT02565615|37721993|FG000|Overall Study|Adverse Event|1|||
17188929|NCT02508532|38341870|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
17188930|NCT02508532|38341871|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
16782463|NCT02565615|37721994|FG001|Overall Study|Adverse Event|1|||
16782464|NCT02565615|37721995|FG002|Overall Study|Adverse Event|0|||
16782465|NCT02565615|37721996|FG003|Overall Study|Adverse Event|0|||
16782466|NCT02565615|37721997|FG004|Overall Study|Adverse Event|9|||
16782467|NCT02565615|37721993|FG000|Overall Study|Untreated|0|||
16782468|NCT02565615|37721994|FG001|Overall Study|Untreated|0|||
16782469|NCT02565615|37721995|FG002|Overall Study|Untreated|0|||
16782470|NCT02565615|37721996|FG003|Overall Study|Untreated|0|||
16782471|NCT02565615|37721997|FG004|Overall Study|Untreated|567|||
16997686|NCT00959192|38141661|FG002|Overall Study|Caregiver Request|2|||
16997687|NCT00959192|38141662|FG003|Overall Study|Caregiver Request|1|||
17188931|NCT02508532|38341863|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
17188932|NCT02508532|38341864|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
17188933|NCT02508532|38341865|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
17188934|NCT02508532|38341866|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
17188935|NCT02508532|38341867|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
17188936|NCT02508532|38341868|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
17188937|NCT02508532|38341869|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
17188938|NCT02508532|38341870|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
17188939|NCT02508532|38341871|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
17188940|NCT02508532|38341863|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
17188941|NCT02508532|38341864|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
17188942|NCT02508532|38341865|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
17188943|NCT02508532|38341866|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
17188944|NCT02508532|38341867|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
17188945|NCT02508532|38341868|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
17188946|NCT02508532|38341869|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
17188947|NCT02508532|38341870|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
16782472|NCT02701361|37722012|FG000|Overall Study|Lost to Follow-up|5|||
17189083|NCT01060111|38342042|FG002|Overall Study|Adverse event and insufficient effect|0|||
17189084|NCT01060111|38342040|FG000|Overall Study|Participants' non-cooperation|1|||
17189085|NCT01060111|38342041|FG001|Overall Study|Participants' non-cooperation|0|||
17189086|NCT01060111|38342042|FG002|Overall Study|Participants' non-cooperation|0|||
17189087|NCT01060111|38342040|FG000|Overall Study|Other|2|||
17189088|NCT01060111|38342041|FG001|Overall Study|Other|3|||
17189089|NCT01060111|38342042|FG002|Overall Study|Other|4|||
17189090|NCT02969863|38342053|FG000|Overall Study|Physician Decision|1|||
17090102|NCT00295022|38230183|FG000|Overall Study|Withdrawal by Subject|0|||
17090103|NCT00295022|38230184|FG001|Overall Study|Withdrawal by Subject|0|||
17090104|NCT00295022|38230185|FG002|Overall Study|Withdrawal by Subject|2|||
17090105|NCT00303446|38230197|FG000|Overall Study|Withdrawal by Subject|2|||
17090106|NCT00303446|38230198|FG001|Overall Study|Withdrawal by Subject|2|||
16997800|NCT00960986|38141808|FG002|Period 3 (7-week Therapy Period)|Death|1|||
16997801|NCT00960986|38141809|FG003|Period 3 (7-week Therapy Period)|Death|0|||
16997802|NCT00960986|38141806|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
16997803|NCT00960986|38141807|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
16997804|NCT00960986|38141808|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
16997805|NCT00960986|38141809|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
16997806|NCT00960986|38141806|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
16997807|NCT00960986|38141807|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
16997808|NCT00960986|38141808|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
16997809|NCT00960986|38141809|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
16997810|NCT00960986|38141806|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
16997811|NCT00960986|38141807|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
17189091|NCT02969863|38342054|FG001|Overall Study|Physician Decision|0|||
17189092|NCT02969863|38342055|FG002|Overall Study|Physician Decision|0|||
17189093|NCT02969863|38342056|FG003|Overall Study|Physician Decision|0|||
17189094|NCT02969863|38342057|FG004|Overall Study|Physician Decision|0|||
17090107|NCT00303446|38230197|FG000|Overall Study|Death|0|||
17090108|NCT00303446|38230198|FG001|Overall Study|Death|1|||
17090109|NCT00303446|38230197|FG000|Overall Study|Physician Decision|0|||
17090110|NCT00303446|38230198|FG001|Overall Study|Physician Decision|1|||
17090111|NCT00316706|38230206|FG000|Overall Study|Lost to Follow-up|38|||
17090112|NCT00316706|38230207|FG001|Overall Study|Lost to Follow-up|48|||
17090113|NCT00291486|38230218|FG000|Overall Study|Adverse Event|0|||
17090114|NCT00291486|38230219|FG001|Overall Study|Adverse Event|3|||
17090115|NCT00291486|38230220|FG002|Overall Study|Adverse Event|0|||
17090116|NCT00291486|38230221|FG003|Overall Study|Adverse Event|1|||
17090117|NCT00291486|38230222|FG004|Overall Study|Adverse Event|0|||
17090118|NCT00291486|38230218|FG000|Overall Study|Withdrawal by Subject|0|||
17090119|NCT00291486|38230219|FG001|Overall Study|Withdrawal by Subject|0|||
17090120|NCT00291486|38230220|FG002|Overall Study|Withdrawal by Subject|0|||
17090121|NCT00291486|38230221|FG003|Overall Study|Withdrawal by Subject|0|||
17090122|NCT00291486|38230222|FG004|Overall Study|Withdrawal by Subject|1|||
17090123|NCT00291486|38230218|FG000|Overall Study|Disease progression|1|||
17090124|NCT00291486|38230219|FG001|Overall Study|Disease progression|0|||
17090125|NCT00291486|38230220|FG002|Overall Study|Disease progression|1|||
17090126|NCT00291486|38230221|FG003|Overall Study|Disease progression|0|||
17090127|NCT00291486|38230222|FG004|Overall Study|Disease progression|0|||
17090128|NCT00301964|38230243|FG000|Overall Study|Second primary|2|||
17090129|NCT00301964|38230243|FG000|Overall Study|Wrong primary|1|||
17090130|NCT00301964|38230243|FG000|Overall Study|Inadequate pathology|1|||
17090131|NCT00301808|38230253|FG000|Overall Study|Adverse Event|5|||
17090132|NCT00301808|38230253|FG000|Overall Study|Death|3|||
17090133|NCT00301808|38230253|FG000|Overall Study|Lack of Efficacy|4|||
17090134|NCT00268242|38230257|FG000|Overall Study|Death|1|||
17090135|NCT00294554|38230263|FG000|Overall Study|Lack of Efficacy|0|||
17090136|NCT00294554|38230264|FG001|Overall Study|Lack of Efficacy|1|||
17189095|NCT02969863|38342058|FG005|Overall Study|Physician Decision|0|||
17189096|NCT02969707|38342074|FG000|Overall Study|Adverse Event|1|||
17189097|NCT02969707|38342075|FG001|Overall Study|Adverse Event|2|||
17189098|NCT02969707|38342074|FG000|Overall Study|Lost to Follow-up|3|||
17090137|NCT00294554|38230263|FG000|Overall Study|Physician Decision|0|||
17090138|NCT00294554|38230264|FG001|Overall Study|Physician Decision|1|||
16997812|NCT00960986|38141808|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
16997813|NCT00960986|38141809|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
16997814|NCT00960986|38141806|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
16997815|NCT00960986|38141807|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
17090139|NCT00294398|38230272|FG000|Overall Study|Lost to Follow-up|21|||
17090140|NCT00294398|38230273|FG001|Overall Study|Lost to Follow-up|26|||
17090141|NCT00279708|38230281|FG000|Overall Study|Withdrawal by Subject|2|||
17090142|NCT00279708|38230282|FG001|Overall Study|Withdrawal by Subject|3|||
17090143|NCT00279708|38230281|FG000|Overall Study|Adverse Event|1|||
17090144|NCT00279708|38230282|FG001|Overall Study|Adverse Event|1|||
17090145|NCT00299702|38230290|FG000|Overall Study|Death|1|||
17189099|NCT02969707|38342075|FG001|Overall Study|Lost to Follow-up|0|||
17090146|NCT00299702|38230291|FG001|Overall Study|Death|0|||
17090147|NCT00299702|38230290|FG000|Overall Study|Adverse Event|0|||
16997816|NCT00960986|38141808|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
16997817|NCT00960986|38141809|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
17090148|NCT00299702|38230291|FG001|Overall Study|Adverse Event|4|||
17090149|NCT00299702|38230290|FG000|Overall Study|Lost to Follow-up|18|||
17090150|NCT00299702|38230291|FG001|Overall Study|Lost to Follow-up|10|||
17090151|NCT00299702|38230290|FG000|Overall Study|Withdrawal by Subject|25|||
16997818|NCT00732238|38141821|FG000|Overall Study|Bacteremia|4|||
16997819|NCT00732238|38141822|FG001|Overall Study|Bacteremia|1|||
16997820|NCT00732238|38141821|FG000|Overall Study|Asymptomatic bacteriuria|1|||
16997821|NCT00732238|38141822|FG001|Overall Study|Asymptomatic bacteriuria|0|||
16997822|NCT00958880|38141832|FG000|Overall Study|Lost to Follow-up|2|||
16997823|NCT00958880|38141833|FG001|Overall Study|Lost to Follow-up|2|||
16997824|NCT00732160|38141843|FG000|Overall Study|Adverse Event|1|||
16997825|NCT00732160|38141844|FG001|Overall Study|Adverse Event|0|||
17090152|NCT00299702|38230291|FG001|Overall Study|Withdrawal by Subject|23|||
17090153|NCT00299702|38230290|FG000|Overall Study|Pregnancy|0|||
17090154|NCT00299702|38230291|FG001|Overall Study|Pregnancy|1|||
17090155|NCT00299702|38230290|FG000|Overall Study|Insufficient Response|4|||
17090156|NCT00299702|38230291|FG001|Overall Study|Insufficient Response|3|||
17090157|NCT00299702|38230290|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
17090158|NCT00299702|38230291|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
17090159|NCT00291330|38230299|FG000|Overall Study|Adverse Event|47|||
17090160|NCT00291330|38230300|FG001|Overall Study|Adverse Event|40|||
16997826|NCT00732160|38141845|FG002|Overall Study|Adverse Event|1|||
16997827|NCT00732160|38141846|FG003|Overall Study|Adverse Event|1|||
16997828|NCT00732160|38141843|FG000|Overall Study|scheduling|4|||
16997829|NCT00732160|38141844|FG001|Overall Study|scheduling|4|||
16997830|NCT00732160|38141845|FG002|Overall Study|scheduling|2|||
16997831|NCT00732160|38141846|FG003|Overall Study|scheduling|1|||
16997832|NCT00958724|38141856|FG000|Overall Study|Disease Progression|6|||
16997833|NCT00738400|38141862|FG000|Overall Study|Adverse Event|3|||
16997834|NCT00738400|38141863|FG001|Overall Study|Adverse Event|1|||
16997835|NCT00738400|38141862|FG000|Overall Study|Withdrawal by Subject|0|||
16997836|NCT00738400|38141863|FG001|Overall Study|Withdrawal by Subject|1|||
16997837|NCT00738400|38141862|FG000|Overall Study|Lack of Efficacy|0|||
16997838|NCT00738400|38141863|FG001|Overall Study|Lack of Efficacy|1|||
16997839|NCT00738400|38141862|FG000|Overall Study|Lost to Follow-up|0|||
16997840|NCT00738400|38141863|FG001|Overall Study|Lost to Follow-up|3|||
17189100|NCT02969707|38342074|FG000|Overall Study|Physician Decision|0|||
16997841|NCT00738400|38141862|FG000|Overall Study|Protocol Violation|1|||
16997842|NCT00738400|38141863|FG001|Overall Study|Protocol Violation|0|||
16997843|NCT00738400|38141862|FG000|Overall Study|Non-compliant with study medication|0|||
16997844|NCT00738400|38141863|FG001|Overall Study|Non-compliant with study medication|1|||
17090161|NCT00291330|38230299|FG000|Overall Study|Protocol Violation|13|||
17090162|NCT00291330|38230300|FG001|Overall Study|Protocol Violation|20|||
17090163|NCT00291330|38230299|FG000|Overall Study|Lost to Follow-up|16|||
17090164|NCT00291330|38230300|FG001|Overall Study|Lost to Follow-up|11|||
17090165|NCT00291330|38230299|FG000|Overall Study|Withdrawal by Subject|22|||
17090166|NCT00291330|38230300|FG001|Overall Study|Withdrawal by Subject|25|||
17090167|NCT00291330|38230299|FG000|Overall Study|Other|3|||
17090168|NCT00291330|38230300|FG001|Overall Study|Other|1|||
17090169|NCT00267150|38230306|FG000|Overall Study|Adverse Event|1|||
17090170|NCT00278148|38230310|FG000|Phase II - Expansion Phase|Disease progression|0|||
17189101|NCT02969707|38342075|FG001|Overall Study|Physician Decision|1|||
17189102|NCT02969707|38342074|FG000|Overall Study|Protocol Violation|1|||
16782566|NCT02042404|37722174|FG000|Overall Study|Unrelated Adverse Event|3|||
16997845|NCT01009463|38141873|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
16997846|NCT01009463|38141874|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16997847|NCT01009463|38141875|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16997848|NCT01009463|38141876|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16997849|NCT01009463|38141877|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16997850|NCT01009463|38141873|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
16997851|NCT01009463|38141874|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
16782567|NCT02042404|37722175|FG001|Overall Study|Unrelated Adverse Event|0|||
16782568|NCT02042404|37722174|FG000|Overall Study|Inability to meet time requirements|1|||
16782569|NCT02042404|37722175|FG001|Overall Study|Inability to meet time requirements|0|||
16782570|NCT02042014|37722182|FG000|Overall Study|Adverse Event|1|||
16782571|NCT02042014|37722182|FG000|Overall Study|Physician Decision|7|||
16782572|NCT02041702|37722188|FG000|Overall Study|Lost to Follow-up|1|||
16782573|NCT02041702|37722189|FG001|Overall Study|Lost to Follow-up|6|||
17090171|NCT00278148|38230311|FG001|Phase II - Expansion Phase|Disease progression|0|||
17090172|NCT00278148|38230312|FG002|Phase II - Expansion Phase|Disease progression|4|||
17090173|NCT00278148|38230310|FG000|Phase II - Expansion Phase|Adverse Event|0|||
17090174|NCT00278148|38230311|FG001|Phase II - Expansion Phase|Adverse Event|0|||
17189103|NCT02969707|38342075|FG001|Overall Study|Protocol Violation|1|||
17090175|NCT00278148|38230312|FG002|Phase II - Expansion Phase|Adverse Event|2|||
17090176|NCT00299546|38230322|FG000|Overall Study|Death|3|||
17090177|NCT00299546|38230323|FG001|Overall Study|Death|2|||
17090178|NCT00299546|38230324|FG002|Overall Study|Death|0|||
17090179|NCT00299546|38230322|FG000|Overall Study|Lost to Follow-up|2|||
17090180|NCT00299546|38230323|FG001|Overall Study|Lost to Follow-up|2|||
17090181|NCT00299546|38230324|FG002|Overall Study|Lost to Follow-up|5|||
17090182|NCT00299546|38230322|FG000|Overall Study|Adverse Event|37|||
17090183|NCT00299546|38230323|FG001|Overall Study|Adverse Event|22|||
17090184|NCT00299546|38230324|FG002|Overall Study|Adverse Event|27|||
17090185|NCT00299546|38230322|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
17090186|NCT00299546|38230323|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
17090187|NCT00299546|38230324|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
17090188|NCT00299546|38230322|FG000|Overall Study|Other|24|||
17090189|NCT00299546|38230323|FG001|Overall Study|Other|26|||
17090190|NCT00299546|38230324|FG002|Overall Study|Other|19|||
17090191|NCT00299546|38230322|FG000|Overall Study|Not treated|0|||
17090192|NCT00299546|38230323|FG001|Overall Study|Not treated|1|||
17090193|NCT00299546|38230324|FG002|Overall Study|Not treated|1|||
17090194|NCT00299156|38230336|FG000|Period 2 (Randomized)|Screen Failure|0|||
17090195|NCT00299156|38230337|FG001|Period 2 (Randomized)|Screen Failure|1|||
17090196|NCT00299156|38230338|FG002|Period 2 (Randomized)|Screen Failure|0|||
17090197|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
17090198|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
17090199|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
17090200|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
17090201|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
17090202|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
17090203|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
17090204|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
17090205|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
17090206|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
17090207|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
17090208|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
17090209|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
17090210|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
17090211|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
17090212|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
17090213|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
17090214|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
17090215|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
17090216|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
16997852|NCT01009463|38141875|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
16997853|NCT01009463|38141876|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
16997854|NCT01009463|38141877|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
17090217|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
17090218|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
17090219|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
16997855|NCT01009463|38141873|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
16997856|NCT01009463|38141874|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16997857|NCT01009463|38141875|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
17090220|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
17090221|NCT00277212|38230346|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
17090222|NCT00277212|38230347|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
17090223|NCT00277212|38230348|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
17090224|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
17090225|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
17090226|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
17090227|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
17090228|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
17090229|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
16782574|NCT02041702|37722188|FG000|Overall Study|Death|4|||
17090230|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
17090231|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
17090232|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
17090233|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
17090234|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
16782575|NCT02041702|37722189|FG001|Overall Study|Death|0|||
16997858|NCT01009463|38141876|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16997859|NCT01009463|38141877|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16997860|NCT01009463|38141873|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
17090235|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
17090236|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
17090237|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
17090238|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
17090239|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
17090240|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
17090241|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
17090242|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
17090243|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
17090244|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
17090245|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
17090246|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
17090247|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
17090248|NCT00277212|38230346|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
17090249|NCT00277212|38230347|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
17090250|NCT00277212|38230348|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
17090251|NCT00276744|38230356|FG000|PART A|Reason unknown|98|||
17090252|NCT00251316|38230362|FG000|Overall Study|Physician Decision|2|||
17090253|NCT00251316|38230363|FG001|Overall Study|Physician Decision|3|||
17090254|NCT00293462|38230372|FG000|Overall Study|Withdrawal by Subject|4|||
17090255|NCT00293462|38230373|FG001|Overall Study|Withdrawal by Subject|3|||
16997861|NCT01009463|38141874|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
16997862|NCT01009463|38141875|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
16997863|NCT01009463|38141876|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
17090256|NCT00293462|38230374|FG002|Overall Study|Withdrawal by Subject|8|||
17090257|NCT00293462|38230372|FG000|Overall Study|Death|1|||
17090258|NCT00293462|38230373|FG001|Overall Study|Death|0|||
17090259|NCT00293462|38230374|FG002|Overall Study|Death|0|||
17090260|NCT00293462|38230372|FG000|Overall Study|Lost to Follow-up|0|||
17090261|NCT00293462|38230373|FG001|Overall Study|Lost to Follow-up|1|||
17090262|NCT00293462|38230374|FG002|Overall Study|Lost to Follow-up|0|||
17090263|NCT00293462|38230372|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
17090264|NCT00293462|38230373|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
17090265|NCT00293462|38230374|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
17090266|NCT00293462|38230372|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
17090267|NCT00293462|38230373|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
17090268|NCT00293462|38230374|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
17090269|NCT00293462|38230372|FG000|Overall Study|Refuse Radiation Treatment|1|||
17090270|NCT00293462|38230373|FG001|Overall Study|Refuse Radiation Treatment|0|||
17090271|NCT00293462|38230374|FG002|Overall Study|Refuse Radiation Treatment|0|||
17090272|NCT00293462|38230372|FG000|Overall Study|No Show|0|||
17090273|NCT00293462|38230373|FG001|Overall Study|No Show|0|||
17090274|NCT00293462|38230374|FG002|Overall Study|No Show|1|||
17090275|NCT00293462|38230372|FG000|Overall Study|Went back to his home country|0|||
17090276|NCT00293462|38230373|FG001|Overall Study|Went back to his home country|0|||
17090277|NCT00293462|38230374|FG002|Overall Study|Went back to his home country|1|||
17090278|NCT00293462|38230372|FG000|Overall Study|Blood clot after chemotherapy|0|||
17090279|NCT00293462|38230373|FG001|Overall Study|Blood clot after chemotherapy|0|||
17090280|NCT00293462|38230374|FG002|Overall Study|Blood clot after chemotherapy|1|||
17090281|NCT00293462|38230372|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
17090282|NCT00293462|38230373|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
17090283|NCT00293462|38230374|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
17090284|NCT00293462|38230372|FG000|Overall Study|Possible Tracheostomy leakage|0|||
17090285|NCT00293462|38230373|FG001|Overall Study|Possible Tracheostomy leakage|1|||
17090286|NCT00293462|38230374|FG002|Overall Study|Possible Tracheostomy leakage|0|||
17090287|NCT00293462|38230372|FG000|Overall Study|Low radiation dose in oral cavity|0|||
17090288|NCT00293462|38230373|FG001|Overall Study|Low radiation dose in oral cavity|1|||
17090289|NCT00293462|38230374|FG002|Overall Study|Low radiation dose in oral cavity|0|||
17090290|NCT00293462|38230372|FG000|Overall Study|Physician Decision|0|||
17090291|NCT00293462|38230373|FG001|Overall Study|Physician Decision|1|||
17090292|NCT00293462|38230374|FG002|Overall Study|Physician Decision|0|||
16782576|NCT02041702|37722188|FG000|Overall Study|Withdrawal by Subject|4|||
16997864|NCT01009463|38141877|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
16997865|NCT01009463|38141873|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
16997866|NCT01009463|38141874|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16997867|NCT01009463|38141875|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16997868|NCT01009463|38141876|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16997869|NCT01009463|38141877|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
17090293|NCT00316082|38230387|FG000|Overall Study|Lack of Efficacy|2|||
17090294|NCT00316082|38230388|FG001|Overall Study|Lack of Efficacy|3|||
17090295|NCT00316082|38230389|FG002|Overall Study|Lack of Efficacy|3|||
17090296|NCT00316082|38230390|FG003|Overall Study|Lack of Efficacy|4|||
17090297|NCT00316082|38230391|FG004|Overall Study|Lack of Efficacy|6|||
17090298|NCT00316082|38230387|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
17090299|NCT00316082|38230388|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
17090300|NCT00316082|38230389|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
17090301|NCT00316082|38230390|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
17090302|NCT00316082|38230391|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
17090303|NCT00316082|38230387|FG000|Overall Study|Lost to Follow-up|7|||
17090304|NCT00316082|38230388|FG001|Overall Study|Lost to Follow-up|6|||
17090305|NCT00316082|38230389|FG002|Overall Study|Lost to Follow-up|7|||
17090306|NCT00316082|38230390|FG003|Overall Study|Lost to Follow-up|8|||
17090307|NCT00316082|38230391|FG004|Overall Study|Lost to Follow-up|6|||
17090308|NCT00316082|38230387|FG000|Overall Study|Poor/noncompliance|6|||
17090309|NCT00316082|38230388|FG001|Overall Study|Poor/noncompliance|1|||
17090310|NCT00316082|38230389|FG002|Overall Study|Poor/noncompliance|4|||
17090311|NCT00316082|38230390|FG003|Overall Study|Poor/noncompliance|1|||
17090312|NCT00316082|38230391|FG004|Overall Study|Poor/noncompliance|4|||
17090313|NCT00316082|38230387|FG000|Overall Study|Adverse Event|4|||
17090314|NCT00316082|38230388|FG001|Overall Study|Adverse Event|2|||
17090315|NCT00316082|38230389|FG002|Overall Study|Adverse Event|5|||
17090316|NCT00316082|38230390|FG003|Overall Study|Adverse Event|1|||
17090317|NCT00316082|38230391|FG004|Overall Study|Adverse Event|3|||
17090318|NCT00316082|38230387|FG000|Overall Study|Subject no longer meets study criteria|3|||
17090319|NCT00316082|38230388|FG001|Overall Study|Subject no longer meets study criteria|1|||
17090320|NCT00316082|38230389|FG002|Overall Study|Subject no longer meets study criteria|2|||
17090321|NCT00316082|38230390|FG003|Overall Study|Subject no longer meets study criteria|2|||
17090322|NCT00316082|38230391|FG004|Overall Study|Subject no longer meets study criteria|1|||
17090323|NCT00316082|38230387|FG000|Overall Study|Physician Decision|1|||
17090324|NCT00316082|38230388|FG001|Overall Study|Physician Decision|1|||
17090325|NCT00316082|38230389|FG002|Overall Study|Physician Decision|2|||
17090326|NCT00316082|38230390|FG003|Overall Study|Physician Decision|1|||
17090327|NCT00316082|38230391|FG004|Overall Study|Physician Decision|1|||
16997870|NCT01009463|38141873|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
16997871|NCT01009463|38141874|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
16997872|NCT01009463|38141875|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
16997873|NCT01009463|38141876|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
16997874|NCT01009463|38141877|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
16997875|NCT01009463|38141873|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16997876|NCT01009463|38141874|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
16997877|NCT01009463|38141875|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
16997878|NCT01009463|38141876|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
16997879|NCT01009463|38141877|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
16997880|NCT01009463|38141873|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
16997881|NCT01009463|38141874|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
17090328|NCT00316082|38230387|FG000|Overall Study|Death|0|||
17090329|NCT00316082|38230388|FG001|Overall Study|Death|0|||
17090330|NCT00316082|38230389|FG002|Overall Study|Death|1|||
17090331|NCT00316082|38230390|FG003|Overall Study|Death|0|||
17189104|NCT02969707|38342074|FG000|Overall Study|Withdrawal by Subject|3|||
17189105|NCT02969707|38342075|FG001|Overall Study|Withdrawal by Subject|4|||
17189106|NCT02967055|38342086|FG000|Overall Study|Excluded|40|||
17189107|NCT02967055|38342086|FG000|Overall Study|Screen fail|3|||
17189108|NCT02967055|38342086|FG000|Overall Study|Lost to Follow-up|2|||
17189109|NCT02967055|38342086|FG000|Overall Study|Stopped due to side effects|3|||
17090332|NCT00316082|38230391|FG004|Overall Study|Death|0|||
17090333|NCT00316082|38230387|FG000|Overall Study|Administrative reason by sponsor|0|||
17090334|NCT00316082|38230388|FG001|Overall Study|Administrative reason by sponsor|0|||
17090335|NCT00316082|38230389|FG002|Overall Study|Administrative reason by sponsor|1|||
17090336|NCT00316082|38230390|FG003|Overall Study|Administrative reason by sponsor|0|||
17090337|NCT00316082|38230391|FG004|Overall Study|Administrative reason by sponsor|0|||
17090338|NCT00316004|38230410|FG000|Overall Study|Subject was not given study fluid.|14|||
17090339|NCT00316004|38230411|FG001|Overall Study|Subject was not given study fluid.|14|||
17090340|NCT00316004|38230412|FG002|Overall Study|Subject was not given study fluid.|21|||
17090341|NCT00298766|38230420|FG000|Overall Study|Adverse Event|18|||
17090342|NCT00298766|38230420|FG000|Overall Study|Death|2|||
17090343|NCT00298766|38230420|FG000|Overall Study|Withdrawal by Subject|9|||
17090344|NCT00298766|38230420|FG000|Overall Study|Treatment ongoing|4|||
17090345|NCT00298766|38230420|FG000|Overall Study|Progression of amyloid markers|4|||
17090346|NCT00298766|38230420|FG000|Overall Study|Deterioration in KPS and organ function|1|||
17090347|NCT00298766|38230420|FG000|Overall Study|Subjects overall condition deterioration|4|||
17090348|NCT00298766|38230420|FG000|Overall Study|Other|4|||
17090349|NCT00315458|38230426|FG000|Overall Study|Administrative|0|||
17090350|NCT00315458|38230427|FG001|Overall Study|Administrative|3|||
17090351|NCT00315458|38230428|FG002|Overall Study|Administrative|8|||
17090352|NCT00315458|38230429|FG003|Overall Study|Administrative|21|||
17090353|NCT00315458|38230426|FG000|Overall Study|Adverse Event|2|||
17090354|NCT00315458|38230427|FG001|Overall Study|Adverse Event|4|||
17090355|NCT00315458|38230428|FG002|Overall Study|Adverse Event|23|||
17090356|NCT00315458|38230429|FG003|Overall Study|Adverse Event|3|||
17090357|NCT00315458|38230426|FG000|Overall Study|Lost to Follow-up|1|||
17090358|NCT00315458|38230427|FG001|Overall Study|Lost to Follow-up|2|||
17090359|NCT00315458|38230428|FG002|Overall Study|Lost to Follow-up|0|||
17090360|NCT00315458|38230429|FG003|Overall Study|Lost to Follow-up|2|||
17090361|NCT00315458|38230426|FG000|Overall Study|Withdrawal by Subject|0|||
17090362|NCT00315458|38230427|FG001|Overall Study|Withdrawal by Subject|3|||
17090363|NCT00315458|38230428|FG002|Overall Study|Withdrawal by Subject|0|||
17090364|NCT00315458|38230429|FG003|Overall Study|Withdrawal by Subject|2|||
17090365|NCT00315458|38230426|FG000|Overall Study|Lack of Efficacy|0|||
17090366|NCT00315458|38230427|FG001|Overall Study|Lack of Efficacy|0|||
17090367|NCT00315458|38230428|FG002|Overall Study|Lack of Efficacy|20|||
17090368|NCT00315458|38230429|FG003|Overall Study|Lack of Efficacy|1|||
17090369|NCT00315458|38230426|FG000|Overall Study|Did not qualify|0|||
17090370|NCT00315458|38230427|FG001|Overall Study|Did not qualify|0|||
17090371|NCT00315458|38230428|FG002|Overall Study|Did not qualify|1|||
17090372|NCT00315458|38230429|FG003|Overall Study|Did not qualify|0|||
17090373|NCT00293384|38230439|FG000|Overall Study|Non-compliance|2|||
17090374|NCT00293384|38230439|FG000|Overall Study|Missed dosage/study drug|1|||
17090375|NCT00293384|38230439|FG000|Overall Study|Ineligible|2|||
17090376|NCT00297830|38230446|FG000|6 Month Visit|Death|1|||
17090377|NCT00297830|38230447|FG001|6 Month Visit|Death|0|||
17090378|NCT00297830|38230448|FG002|6 Month Visit|Death|2|||
17090379|NCT00297830|38230446|FG000|6 Month Visit|Withdrawal by Subject|2|||
17090380|NCT00297830|38230447|FG001|6 Month Visit|Withdrawal by Subject|1|||
17090381|NCT00297830|38230448|FG002|6 Month Visit|Withdrawal by Subject|1|||
17090382|NCT00297830|38230446|FG000|6 Month Visit|Adverse Event|0|||
17090383|NCT00297830|38230447|FG001|6 Month Visit|Adverse Event|1|||
17090384|NCT00297830|38230448|FG002|6 Month Visit|Adverse Event|0|||
17090385|NCT00297830|38230446|FG000|12 Month Visit|Lost to Follow-up|1|||
17090386|NCT00297830|38230447|FG001|12 Month Visit|Lost to Follow-up|0|||
17090387|NCT00297830|38230448|FG002|12 Month Visit|Lost to Follow-up|0|||
17090388|NCT00297830|38230446|FG000|12 Month Visit|Adverse Event|0|||
17090389|NCT00297830|38230447|FG001|12 Month Visit|Adverse Event|3|||
17090390|NCT00297830|38230448|FG002|12 Month Visit|Adverse Event|0|||
17090391|NCT00297830|38230446|FG000|12 Month Visit|Withdrawal by Subject|0|||
17090392|NCT00297830|38230447|FG001|12 Month Visit|Withdrawal by Subject|3|||
17090393|NCT00297830|38230448|FG002|12 Month Visit|Withdrawal by Subject|0|||
17090394|NCT00314366|38230458|FG000|Overall Study|not treated due to patient medical condi|1|||
17090395|NCT00314366|38230459|FG001|Overall Study|not treated due to patient medical condi|0|||
17090396|NCT00296816|38230470|FG000|Overall Study|Disease Progression|37|||
17090397|NCT00296816|38230470|FG000|Overall Study|Adverse Event|18|||
17090398|NCT00296816|38230470|FG000|Overall Study|Investigator/Participant request|5|||
17090399|NCT00296816|38230470|FG000|Overall Study|Non-compliance|1|||
17090400|NCT00296816|38230470|FG000|Overall Study|Missing for end of treatment|4|||
17090401|NCT00296816|38230470|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
17090402|NCT00296816|38230470|FG000|Overall Study|Poor performance status|1|||
17090403|NCT00296816|38230470|FG000|Overall Study|Relocation to Florida|1|||
17090404|NCT00296816|38230470|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
17090405|NCT00296816|38230470|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
17090406|NCT00296816|38230470|FG000|Overall Study|Neuropathy/patient preference|1|||
17090407|NCT00296816|38230470|FG000|Overall Study|Proteinuria|1|||
17090408|NCT00296816|38230470|FG000|Overall Study|ineligibility due to radiation treatment|1|||
17090409|NCT00314132|38230476|FG000|Overall Study|Lost to Follow-up|3|||
17090410|NCT00314132|38230477|FG001|Overall Study|Lost to Follow-up|13|||
17090411|NCT00314132|38230476|FG000|Overall Study|Withdrawal by Subject|3|||
16868157|NCT01548287|37841194|FG001|Screening|Did not meet eligibility criteria|0|||
17090412|NCT00314132|38230477|FG001|Overall Study|Withdrawal by Subject|5|||
17090413|NCT00314132|38230476|FG000|Overall Study|Adverse Event|1|||
17090414|NCT00314132|38230477|FG001|Overall Study|Adverse Event|0|||
17090415|NCT00314132|38230476|FG000|Overall Study|Physician Decision|1|||
17090416|NCT00314132|38230477|FG001|Overall Study|Physician Decision|0|||
17090417|NCT00097786|38230489|FG000|Overall Study|lost to follow-up for all-cause death|296|||
16868158|NCT01548287|37841195|FG002|Screening|Did not meet eligibility criteria|0|||
16868159|NCT01548287|37841196|FG003|Screening|Did not meet eligibility criteria|0|||
17090418|NCT00097786|38230490|FG001|Overall Study|lost to follow-up for all-cause death|292|||
17090419|NCT00097786|38230491|FG002|Overall Study|lost to follow-up for all-cause death|313|||
17090420|NCT00097786|38230492|FG003|Overall Study|lost to follow-up for all-cause death|310|||
17090421|NCT00117988|38230502|FG000|Overall Study|Death|3|||
17090422|NCT00117988|38230502|FG000|Overall Study|Adverse Event|1|||
17090423|NCT00117676|38230508|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
17090424|NCT00117676|38230509|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
16997882|NCT01009463|38141875|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
16997883|NCT01009463|38141876|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
16997884|NCT01009463|38141877|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
16997885|NCT01009463|38141873|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
16997886|NCT01009463|38141874|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
16997887|NCT01009463|38141875|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
17189110|NCT02967055|38342086|FG000|Overall Study|Stopped due to drug cost|1|||
17189111|NCT02904265|38342092|FG000|Overall Study|Physician Decision|1|||
17090425|NCT00117676|38230508|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
17090426|NCT00117676|38230509|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
17090427|NCT00117676|38230508|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
17090428|NCT00117676|38230509|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
17090429|NCT00117676|38230508|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
17090430|NCT00117676|38230509|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
17090431|NCT00117676|38230508|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
17090432|NCT00117676|38230509|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
16997888|NCT01009463|38141876|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
16997889|NCT01009463|38141877|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
16997890|NCT01009463|38141873|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16997891|NCT01009463|38141874|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
16997892|NCT01009463|38141875|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
16997893|NCT01009463|38141876|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
16997894|NCT01009463|38141877|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
16997895|NCT01009463|38141873|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16997896|NCT01009463|38141874|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
16997897|NCT01009463|38141875|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16997898|NCT01009463|38141876|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
16997899|NCT01009463|38141877|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16997900|NCT01009463|38141873|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16997901|NCT01009463|38141874|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
17090433|NCT00117676|38230508|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
17090434|NCT00117676|38230509|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
17090435|NCT00117676|38230508|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
17090436|NCT00117676|38230509|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
17090437|NCT00117676|38230508|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
17090438|NCT00117676|38230509|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
17090439|NCT00117676|38230508|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
17090440|NCT00117676|38230509|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
17090441|NCT00117676|38230508|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
17090442|NCT00117676|38230509|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
17090443|NCT00117676|38230508|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
17090444|NCT00117676|38230509|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
17090445|NCT00117676|38230508|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
17090446|NCT00117676|38230509|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
17090447|NCT00117676|38230508|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
17090448|NCT00117676|38230509|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
17090449|NCT00117676|38230508|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
17090450|NCT00117676|38230509|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
17090451|NCT00117676|38230508|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
17090452|NCT00117676|38230509|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
17090453|NCT00117676|38230508|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
17090454|NCT00117676|38230509|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
17090455|NCT00117676|38230508|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
17090456|NCT00117676|38230509|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
17090457|NCT00117676|38230508|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
17090458|NCT00117676|38230509|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
17090459|NCT00117676|38230508|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
17090460|NCT00117676|38230509|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
17090461|NCT00117676|38230508|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
17090462|NCT00117676|38230509|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
17090463|NCT00117676|38230508|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
17090464|NCT00117676|38230509|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
17189112|NCT02904265|38342093|FG001|Overall Study|Physician Decision|2|||
17090465|NCT00117676|38230508|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
17090466|NCT00117676|38230509|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
17090467|NCT00117676|38230508|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
17090468|NCT00117676|38230509|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
17090469|NCT00117676|38230508|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
17090470|NCT00117676|38230509|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
17090471|NCT00117676|38230508|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
17090472|NCT00117676|38230509|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
17090473|NCT00117676|38230508|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
17090474|NCT00117676|38230509|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
17090475|NCT00117676|38230508|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
17090476|NCT00117676|38230509|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
17090477|NCT00117676|38230508|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
17090478|NCT00117676|38230509|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
17090479|NCT00117676|38230508|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
17090480|NCT00117676|38230509|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
17090481|NCT00117676|38230508|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
17090482|NCT00117676|38230509|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
17090483|NCT00117676|38230508|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
17090484|NCT00117676|38230509|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
17090485|NCT00117676|38230508|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
17090486|NCT00117676|38230509|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
17090487|NCT00117676|38230508|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
17090488|NCT00117676|38230509|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
17090489|NCT00117676|38230508|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
17090490|NCT00117676|38230509|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
17090491|NCT00117676|38230508|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
17090492|NCT00117676|38230509|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
17090493|NCT00251004|38230523|FG000|Overall Study|Withdrawal by Subject|23|||
17090494|NCT00251004|38230524|FG001|Overall Study|Withdrawal by Subject|16|||
17090495|NCT00251004|38230525|FG002|Overall Study|Withdrawal by Subject|14|||
17090496|NCT00251004|38230523|FG000|Overall Study|Death|9|||
17090497|NCT00251004|38230524|FG001|Overall Study|Death|10|||
17090498|NCT00251004|38230525|FG002|Overall Study|Death|8|||
17090499|NCT00251004|38230523|FG000|Overall Study|Lost to Follow-up|1|||
17090500|NCT00251004|38230524|FG001|Overall Study|Lost to Follow-up|2|||
17090501|NCT00251004|38230525|FG002|Overall Study|Lost to Follow-up|1|||
17090502|NCT00251004|38230523|FG000|Overall Study|Graft Loss|12|||
17090503|NCT00251004|38230524|FG001|Overall Study|Graft Loss|13|||
17090504|NCT00251004|38230525|FG002|Overall Study|Graft Loss|8|||
17090505|NCT00275340|38230535|FG000|Overall Study|Lost to Follow-up|2|||
17090506|NCT00275340|38230536|FG001|Overall Study|Lost to Follow-up|4|||
17090507|NCT00275262|38230542|FG000|Overall Study|Adverse Event|2|||
17090508|NCT00275262|38230543|FG001|Overall Study|Adverse Event|0|||
17090509|NCT00275262|38230542|FG000|Overall Study|Disease progression|2|||
17090510|NCT00275262|38230543|FG001|Overall Study|Disease progression|5|||
17090511|NCT00275262|38230542|FG000|Overall Study|Lost to Follow-up|0|||
17090512|NCT00275262|38230543|FG001|Overall Study|Lost to Follow-up|2|||
17090513|NCT00275262|38230542|FG000|Overall Study|Protocol Violation|0|||
17090514|NCT00275262|38230543|FG001|Overall Study|Protocol Violation|2|||
17090515|NCT00275262|38230542|FG000|Overall Study|Death|1|||
17090516|NCT00275262|38230543|FG001|Overall Study|Death|0|||
17090517|NCT00275262|38230542|FG000|Overall Study|Started Chemotherapy|1|||
17090518|NCT00275262|38230543|FG001|Overall Study|Started Chemotherapy|0|||
17090519|NCT00275028|38230549|FG000|Overall Study|Withdrew consent before treatment began|1|||
16782577|NCT02041702|37722189|FG001|Overall Study|Withdrawal by Subject|3|||
16782578|NCT02041702|37722188|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
16782579|NCT02041702|37722189|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
16782580|NCT02041702|37722188|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
16782581|NCT02041702|37722189|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
16782582|NCT02565147|37722197|FG000|Overall Study|Withdrawal by Subject|5|||
16782583|NCT02565147|37722198|FG001|Overall Study|Withdrawal by Subject|1|||
16782584|NCT02565147|37722197|FG000|Overall Study|Lost to Follow-up|0|||
16782585|NCT02565147|37722198|FG001|Overall Study|Lost to Follow-up|1|||
17090520|NCT00275028|38230549|FG000|Overall Study|Withdrawal by Subject|5|||
16782586|NCT02565147|37722197|FG000|Overall Study|Death|1|||
17090521|NCT00275028|38230549|FG000|Overall Study|Adverse Event|9|||
17090522|NCT00275028|38230549|FG000|Overall Study|Progressive Disease|30|||
17090523|NCT00275028|38230549|FG000|Overall Study|Physician Decision|2|||
17090524|NCT00471497|38230556|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
17090525|NCT00471497|38230557|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
17090526|NCT00471497|38230558|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
17090527|NCT00471497|38230556|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
17090528|NCT00471497|38230557|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
17090529|NCT00471497|38230558|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
17090530|NCT00471497|38230556|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
17090531|NCT00471497|38230557|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
17090532|NCT00471497|38230558|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
17090533|NCT00471497|38230556|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
17090534|NCT00471497|38230557|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
17090535|NCT00471497|38230558|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
17090536|NCT00471497|38230556|FG000|Core Treatment Phase|Lost to Follow-up|6|||
17090537|NCT00471497|38230557|FG001|Core Treatment Phase|Lost to Follow-up|6|||
17090538|NCT00471497|38230558|FG002|Core Treatment Phase|Lost to Follow-up|3|||
17090539|NCT00471497|38230556|FG000|Core Treatment Phase|Death|3|||
17090540|NCT00471497|38230557|FG001|Core Treatment Phase|Death|9|||
17090541|NCT00471497|38230558|FG002|Core Treatment Phase|Death|3|||
17090542|NCT00471497|38230556|FG000|Core Treatment Phase|Disease Progression|10|||
17090543|NCT00471497|38230557|FG001|Core Treatment Phase|Disease Progression|2|||
17090544|NCT00471497|38230558|FG002|Core Treatment Phase|Disease Progression|4|||
17090545|NCT00471497|38230556|FG000|Core Treatment Phase|Protocol Violation|6|||
17090546|NCT00471497|38230557|FG001|Core Treatment Phase|Protocol Violation|15|||
17090547|NCT00471497|38230558|FG002|Core Treatment Phase|Protocol Violation|11|||
17090548|NCT00471497|38230556|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
17090549|NCT00471497|38230557|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
17090550|NCT00471497|38230558|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
17090551|NCT00471497|38230556|FG000|Core Treatment Phase|Administrative problems|14|||
17090552|NCT00471497|38230557|FG001|Core Treatment Phase|Administrative problems|14|||
17090553|NCT00471497|38230558|FG002|Core Treatment Phase|Administrative problems|12|||
17090554|NCT00471497|38230556|FG000|Core Treatment Phase|Adverse Event|43|||
17090555|NCT00471497|38230557|FG001|Core Treatment Phase|Adverse Event|53|||
17090556|NCT00471497|38230558|FG002|Core Treatment Phase|Adverse Event|89|||
17090557|NCT00471497|38230556|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
17090558|NCT00471497|38230557|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
17090559|NCT00471497|38230558|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
17090560|NCT00471497|38230556|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
17090561|NCT00471497|38230557|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
17090562|NCT00471497|38230558|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
17090563|NCT00471497|38230556|FG000|Extension Phase|Adverse Event|9|||
17090564|NCT00471497|38230557|FG001|Extension Phase|Adverse Event|5|||
17090565|NCT00471497|38230558|FG002|Extension Phase|Adverse Event|1|||
17090566|NCT00471497|38230556|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
17090567|NCT00471497|38230557|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
17090568|NCT00471497|38230558|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
17090569|NCT00471497|38230556|FG000|Extension Phase|Withdrawal by Subject|3|||
17090570|NCT00471497|38230557|FG001|Extension Phase|Withdrawal by Subject|1|||
17090571|NCT00471497|38230558|FG002|Extension Phase|Withdrawal by Subject|0|||
17090572|NCT00471497|38230556|FG000|Extension Phase|Lost to Follow-up|2|||
17090573|NCT00471497|38230557|FG001|Extension Phase|Lost to Follow-up|0|||
17090574|NCT00471497|38230558|FG002|Extension Phase|Lost to Follow-up|0|||
17090575|NCT00471497|38230556|FG000|Extension Phase|Death|1|||
17090576|NCT00471497|38230557|FG001|Extension Phase|Death|0|||
17090577|NCT00471497|38230558|FG002|Extension Phase|Death|0|||
17090578|NCT00471497|38230556|FG000|Extension Phase|Disease progression|2|||
17090579|NCT00471497|38230557|FG001|Extension Phase|Disease progression|0|||
17090580|NCT00471497|38230558|FG002|Extension Phase|Disease progression|0|||
17090581|NCT00471497|38230556|FG000|Extension Phase|Protocol Violation|2|||
17090582|NCT00471497|38230557|FG001|Extension Phase|Protocol Violation|2|||
17090583|NCT00471497|38230558|FG002|Extension Phase|Protocol Violation|0|||
17090584|NCT00493649|38230569|FG000|Overall Study|Adverse Event|44|||
17090585|NCT00493649|38230569|FG000|Overall Study|Patient Request|21|||
17090586|NCT00493649|38230569|FG000|Overall Study|Investigator Request|2|||
17090587|NCT00493649|38230569|FG000|Overall Study|Disease Progression|1|||
17090588|NCT00493649|38230569|FG000|Overall Study|Lost to Follow-up|1|||
17090589|NCT00493649|38230569|FG000|Overall Study|Other|13|||
17090590|NCT00471107|38230579|FG000|Overall Study|Technical problems/data loss|3|||
17090591|NCT00471107|38230580|FG001|Overall Study|Technical problems/data loss|1|||
17090592|NCT00471107|38230581|FG002|Overall Study|Technical problems/data loss|3|||
17090593|NCT00488033|38230591|FG000|Overall Study|Withdrawal by Subject|1|||
17090594|NCT00488033|38230592|FG001|Overall Study|Withdrawal by Subject|0|||
17090595|NCT00117598|38230601|FG000|Prior to Treatment Cross Over|Death|40|||
17090596|NCT00117598|38230602|FG001|Prior to Treatment Cross Over|Death|41|||
17090597|NCT00117598|38230603|FG002|Prior to Treatment Cross Over|Death|37|||
17090598|NCT00117598|38230604|FG003|Prior to Treatment Cross Over|Death|0|||
17090599|NCT00117598|38230605|FG004|Prior to Treatment Cross Over|Death|0|||
17090600|NCT00117598|38230601|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
17090601|NCT00117598|38230602|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
17090602|NCT00117598|38230603|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
17090603|NCT00117598|38230604|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
17090604|NCT00117598|38230605|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
17090605|NCT00117598|38230601|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
17090606|NCT00117598|38230602|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
17090607|NCT00117598|38230603|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
17090608|NCT00117598|38230604|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
17090609|NCT00117598|38230605|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
17090610|NCT00117598|38230601|FG000|Prior to Treatment Cross Over|Other|15|||
17090611|NCT00117598|38230602|FG001|Prior to Treatment Cross Over|Other|9|||
17090612|NCT00117598|38230603|FG002|Prior to Treatment Cross Over|Other|9|||
17090613|NCT00117598|38230604|FG003|Prior to Treatment Cross Over|Other|0|||
17090614|NCT00117598|38230605|FG004|Prior to Treatment Cross Over|Other|0|||
17090615|NCT00117598|38230601|FG000|After Treament Cross Over|Death|0|||
17090616|NCT00117598|38230602|FG001|After Treament Cross Over|Death|0|||
17090617|NCT00117598|38230603|FG002|After Treament Cross Over|Death|0|||
17090618|NCT00117598|38230604|FG003|After Treament Cross Over|Death|1|||
17090619|NCT00117598|38230605|FG004|After Treament Cross Over|Death|2|||
17090620|NCT00117598|38230601|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
17090621|NCT00117598|38230602|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
17090622|NCT00117598|38230603|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
17090623|NCT00117598|38230604|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
17090624|NCT00117598|38230605|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
17090625|NCT00117598|38230601|FG000|After Treament Cross Over|Other|0|||
17090626|NCT00117598|38230602|FG001|After Treament Cross Over|Other|0|||
17090627|NCT00117598|38230603|FG002|After Treament Cross Over|Other|0|||
17090628|NCT00117598|38230604|FG003|After Treament Cross Over|Other|1|||
17090629|NCT00117598|38230605|FG004|After Treament Cross Over|Other|2|||
17090630|NCT00469859|38230617|FG000|Overall Study|Inevaluable|0|||
17090631|NCT00469859|38230618|FG001|Overall Study|Inevaluable|2|||
17090632|NCT00093808|38230624|FG000|Overall Study|Cancel participation before receiving tx|1|||
17090633|NCT00093808|38230624|FG000|Overall Study|Protocol Violation|1|||
17090634|NCT00469079|38230631|FG000|Overall Study|Lack of Efficacy|3|||
17090635|NCT00469079|38230632|FG001|Overall Study|Lack of Efficacy|8|||
17090636|NCT00469079|38230633|FG002|Overall Study|Lack of Efficacy|5|||
17090637|NCT00469079|38230631|FG000|Overall Study|Adverse Event|1|||
17090638|NCT00469079|38230632|FG001|Overall Study|Adverse Event|3|||
17090639|NCT00469079|38230633|FG002|Overall Study|Adverse Event|2|||
17090640|NCT00469079|38230631|FG000|Overall Study|Lost to Follow-up|4|||
17090641|NCT00469079|38230632|FG001|Overall Study|Lost to Follow-up|8|||
17090642|NCT00469079|38230633|FG002|Overall Study|Lost to Follow-up|10|||
16997902|NCT01009463|38141875|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
16997903|NCT01009463|38141876|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
16997904|NCT01009463|38141877|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
16997905|NCT01009463|38141873|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
16997906|NCT01009463|38141874|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
16997907|NCT01009463|38141875|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
16997908|NCT01009463|38141876|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
16997909|NCT01009463|38141877|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
16997910|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
16997911|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
16997912|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
16997913|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
16997914|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
16997915|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
16997916|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
16997917|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
16997918|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
16997919|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
16997920|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
16997921|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
17090643|NCT00469079|38230631|FG000|Overall Study|Withdrawal by Subject|1|||
17090644|NCT00469079|38230632|FG001|Overall Study|Withdrawal by Subject|2|||
17090645|NCT00469079|38230633|FG002|Overall Study|Withdrawal by Subject|2|||
17090646|NCT00469079|38230631|FG000|Overall Study|Ineligible|0|||
17090647|NCT00469079|38230632|FG001|Overall Study|Ineligible|1|||
17090648|NCT00469079|38230633|FG002|Overall Study|Ineligible|0|||
17090649|NCT00093496|38230649|FG000|Overall Study|Protocol Violation|1|||
17090650|NCT00093496|38230650|FG001|Overall Study|Protocol Violation|3|||
17090651|NCT00117286|38230657|FG000|Overall Study|Adverse Event|12|||
17090652|NCT00117286|38230658|FG001|Overall Study|Adverse Event|6|||
17090653|NCT00117286|38230657|FG000|Overall Study|Lost to Follow-up|2|||
17090654|NCT00117286|38230658|FG001|Overall Study|Lost to Follow-up|0|||
17090655|NCT00117286|38230657|FG000|Overall Study|Protocol Violation|3|||
17090656|NCT00117286|38230658|FG001|Overall Study|Protocol Violation|3|||
17090657|NCT00117286|38230657|FG000|Overall Study|Withdrawal by Subject|6|||
17090658|NCT00117286|38230658|FG001|Overall Study|Withdrawal by Subject|2|||
16997922|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
16997923|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
16997924|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
16997925|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
16997926|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
16997927|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
16997928|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
16997929|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
17189113|NCT03461211|38342101|FG000|Overall Study|Adverse Event|1|||
17189114|NCT03461211|38342102|FG001|Overall Study|Adverse Event|1|||
17189115|NCT03461211|38342101|FG000|Overall Study|Lack of Efficacy|0|||
17189116|NCT03461211|38342102|FG001|Overall Study|Lack of Efficacy|1|||
17189117|NCT02967679|38342110|FG000|Overall Study|Adverse Event|1|||
17189118|NCT02966509|38342120|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
17189119|NCT02966509|38342121|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
17189120|NCT02966509|38342120|FG000|Baseline Satisfaction Survey|Death|0|||
17189121|NCT02966509|38342121|FG001|Baseline Satisfaction Survey|Death|1|||
17189122|NCT02966509|38342120|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
17189123|NCT02966509|38342121|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
17189124|NCT02966509|38342120|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
17189125|NCT02966509|38342121|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
17189126|NCT02966509|38342120|FG000|6 Month Satisfaction Decision Survey|Death|22|||
16997930|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
16997931|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
16997932|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
16997933|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
16997934|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
16997935|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
16997936|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
16997937|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
16997938|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
16997939|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
16997940|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
16997941|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
16997942|NCT00958568|38141888|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
16997943|NCT00958568|38141889|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
16997944|NCT00958568|38141890|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
16997945|NCT00958568|38141891|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
16997946|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
16997947|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
16997948|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
16997949|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
17090659|NCT00117286|38230657|FG000|Overall Study|Physician Decision|3|||
17090660|NCT00117286|38230658|FG001|Overall Study|Physician Decision|7|||
17090661|NCT00117286|38230657|FG000|Overall Study|Lack of Efficacy|2|||
17090662|NCT00117286|38230658|FG001|Overall Study|Lack of Efficacy|1|||
17090663|NCT00117286|38230657|FG000|Overall Study|Research site closing|0|||
17090664|NCT00117286|38230658|FG001|Overall Study|Research site closing|2|||
17090665|NCT00265122|38230670|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
17090666|NCT00265122|38230671|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
17090667|NCT00265122|38230672|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
17090668|NCT00265122|38230673|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
17090669|NCT00265122|38230674|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
17090670|NCT00265122|38230675|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
17090671|NCT00265122|38230670|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
17090672|NCT00265122|38230671|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
17090673|NCT00265122|38230672|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
17090674|NCT00265122|38230673|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
17090675|NCT00265122|38230674|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
17090676|NCT00265122|38230675|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
17189127|NCT02966509|38342121|FG001|6 Month Satisfaction Decision Survey|Death|25|||
17189128|NCT02966509|38342120|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
17090677|NCT00265122|38230670|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
17090678|NCT00265122|38230671|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
17090679|NCT00265122|38230672|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
17090680|NCT00265122|38230673|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
17090681|NCT00265122|38230674|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
17090682|NCT00265122|38230675|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
17090683|NCT00265122|38230670|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
17090684|NCT00265122|38230671|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
17090685|NCT00265122|38230672|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
17090686|NCT00265122|38230673|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
17090687|NCT00265122|38230674|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
17090688|NCT00265122|38230675|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
17090689|NCT00265122|38230670|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
17090690|NCT00265122|38230671|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
17090691|NCT00265122|38230672|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
17090692|NCT00265122|38230673|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
17090693|NCT00265122|38230674|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
17090694|NCT00265122|38230675|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
17090695|NCT00265122|38230670|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
17090696|NCT00265122|38230671|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
17090697|NCT00265122|38230672|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
17090698|NCT00265122|38230673|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
17090699|NCT00265122|38230674|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
17090700|NCT00265122|38230675|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
17090701|NCT00116584|38230696|FG000|Overall Study|Withdrawal by Subject|1|||
17090702|NCT00116584|38230697|FG001|Overall Study|Withdrawal by Subject|0|||
17090703|NCT00116584|38230696|FG000|Overall Study|Protocol Violation|1|||
17090704|NCT00116584|38230697|FG001|Overall Study|Protocol Violation|1|||
17090705|NCT00096538|38230703|FG000|Overall Study|Withdrawal by Subject|1|||
17090706|NCT00239928|38230707|FG000|Overall Study|Lack of Efficacy|1|||
17090707|NCT00239928|38230707|FG000|Overall Study|Adverse Event|4|||
17090708|NCT00239928|38230707|FG000|Overall Study|Not need to continue study|3|||
17090709|NCT00239928|38230707|FG000|Overall Study|Withdrawal by Subject|2|||
17090710|NCT00116428|38230713|FG000|Overall Study|Withdrawal by Subject|2|||
17090711|NCT00116428|38230714|FG001|Overall Study|Withdrawal by Subject|5|||
17090712|NCT00116428|38230713|FG000|Overall Study|Did not meet inclusion criteria|1|||
17090713|NCT00116428|38230714|FG001|Overall Study|Did not meet inclusion criteria|0|||
17090714|NCT00468845|38230726|FG000|Overall Study|Adverse Event|9|||
17090715|NCT00468845|38230727|FG001|Overall Study|Adverse Event|14|||
17090716|NCT00468845|38230728|FG002|Overall Study|Adverse Event|11|||
17090717|NCT00468845|38230726|FG000|Overall Study|Lost to Follow-up|2|||
17090718|NCT00468845|38230727|FG001|Overall Study|Lost to Follow-up|1|||
17090719|NCT00468845|38230728|FG002|Overall Study|Lost to Follow-up|2|||
17090720|NCT00468845|38230726|FG000|Overall Study|Other|4|||
17090721|NCT00468845|38230727|FG001|Overall Study|Other|9|||
17090722|NCT00468845|38230728|FG002|Overall Study|Other|5|||
17090723|NCT00468845|38230726|FG000|Overall Study|No longer willing to participate|5|||
17090724|NCT00468845|38230727|FG001|Overall Study|No longer willing to participate|6|||
17090725|NCT00468845|38230728|FG002|Overall Study|No longer willing to participate|10|||
17090726|NCT00468845|38230726|FG000|Overall Study|Randomized, not treated|1|||
17090727|NCT00468845|38230727|FG001|Overall Study|Randomized, not treated|4|||
17090728|NCT00468845|38230728|FG002|Overall Study|Randomized, not treated|2|||
17090729|NCT00468299|38230738|FG000|Overall Study|Withdrawal by Subject|0|||
17090730|NCT00468299|38230739|FG001|Overall Study|Withdrawal by Subject|1|||
17090731|NCT00468143|38230747|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
17090732|NCT00468143|38230748|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
17090733|NCT00468143|38230747|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
17090734|NCT00468143|38230748|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
17090735|NCT00467831|38230754|FG000|Overall Study|Death|2|||
17090736|NCT00467831|38230754|FG000|Overall Study|Withdrawal by Subject|1|||
17090737|NCT00467753|38230760|FG000|Overall Study|Lost to Follow-up|1|||
17090738|NCT00467753|38230761|FG001|Overall Study|Lost to Follow-up|2|||
17090739|NCT00467753|38230760|FG000|Overall Study|Adverse Event|2|||
16782587|NCT02565147|37722198|FG001|Overall Study|Death|1|||
16868160|NCT01548287|37841197|FG004|Screening|Did not meet eligibility criteria|74|||
17090740|NCT00467753|38230761|FG001|Overall Study|Adverse Event|0|||
17090741|NCT00116272|38230773|FG000|Overall Study|Lost to Follow-up|11|||
17090742|NCT00116272|38230774|FG001|Overall Study|Lost to Follow-up|6|||
17090743|NCT00467597|38230786|FG000|Overall Study|Withdrawal by Subject|2|||
17090744|NCT00467597|38230787|FG001|Overall Study|Withdrawal by Subject|0|||
17090745|NCT00115804|38230797|FG000|Overall Study|Adverse Event|2|||
17090746|NCT00467519|38230805|FG000|Overall Study|Protocol Violation|8|||
17090747|NCT00467519|38230806|FG001|Overall Study|Protocol Violation|4|||
17090748|NCT00467519|38230805|FG000|Overall Study|Lost to Follow-up|2|||
17090749|NCT00467519|38230806|FG001|Overall Study|Lost to Follow-up|9|||
17090750|NCT00467519|38230805|FG000|Overall Study|Withdrawal by Subject|4|||
17090751|NCT00467519|38230806|FG001|Overall Study|Withdrawal by Subject|10|||
17090752|NCT00264810|38230814|FG000|Baseline|Withdrawal by Subject|10|||
17090753|NCT00264810|38230815|FG001|Baseline|Withdrawal by Subject|10|||
17090754|NCT00264810|38230814|FG000|Baseline|Physician Decision|7|||
17090755|NCT00264810|38230815|FG001|Baseline|Physician Decision|8|||
17090756|NCT00264810|38230814|FG000|Baseline|Subject Compliance Failure|3|||
17090757|NCT00264810|38230815|FG001|Baseline|Subject Compliance Failure|3|||
17090758|NCT00264810|38230814|FG000|Baseline|Insufficient Seizure Frequency|2|||
17090759|NCT00264810|38230815|FG001|Baseline|Insufficient Seizure Frequency|2|||
17090760|NCT00264810|38230814|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
17090761|NCT00264810|38230815|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
17090762|NCT00264810|38230814|FG000|Baseline|Other|0|||
17090763|NCT00264810|38230815|FG001|Baseline|Other|1|||
17090764|NCT00264810|38230814|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
17090765|NCT00264810|38230815|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
17090766|NCT00264810|38230814|FG000|Stimulation Optimization Period|Death|0|||
17090767|NCT00264810|38230815|FG001|Stimulation Optimization Period|Death|1|||
17090768|NCT00264810|38230814|FG000|Blinded Evaluation Period|Explant due to infection|1|||
17090769|NCT00264810|38230815|FG001|Blinded Evaluation Period|Explant due to infection|1|||
17090770|NCT00264810|38230814|FG000|Open Label Evaluation Period|Explant due to infection|1|||
17090771|NCT00264810|38230815|FG001|Open Label Evaluation Period|Explant due to infection|1|||
17090772|NCT00264810|38230814|FG000|Open Label Evaluation Period|Death|3|||
17090773|NCT00264810|38230815|FG001|Open Label Evaluation Period|Death|2|||
17090774|NCT00264810|38230814|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
17090775|NCT00264810|38230815|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
17090776|NCT00467363|38230825|FG000|Overall Study|Lost to Follow-up|80|||
17090777|NCT00467363|38230826|FG001|Overall Study|Lost to Follow-up|70|||
17090778|NCT00091390|38230832|FG000|Overall Study|Protocol Violation|1|||
17090779|NCT00091390|38230832|FG000|Overall Study|No protocol treatment|3|||
16782588|NCT02061280|37722206|FG000|Overall Study|Protocol Violation|12|||
16782589|NCT02061280|37722207|FG001|Overall Study|Protocol Violation|8|||
16782590|NCT02061280|37722206|FG000|Overall Study|moved out of state|0|||
16782591|NCT02061280|37722207|FG001|Overall Study|moved out of state|1|||
16782592|NCT02061280|37722206|FG000|Overall Study|Withdrawal by Subject|1|||
16782593|NCT02061280|37722207|FG001|Overall Study|Withdrawal by Subject|2|||
16782594|NCT02061280|37722206|FG000|Overall Study|Lost to Follow-up|5|||
16782595|NCT02061280|37722207|FG001|Overall Study|Lost to Follow-up|1|||
16782596|NCT02061202|37722218|FG000|Overall Study|Lost to Follow-up|1|||
16782597|NCT02061202|37722219|FG001|Overall Study|Lost to Follow-up|1|||
16782598|NCT02059408|37722228|FG000|Overall Study|Did not get tested|0|||
16782599|NCT02059408|37722229|FG001|Overall Study|Did not get tested|330|||
16782600|NCT02059408|37722230|FG002|Overall Study|Did not get tested|358|||
16782601|NCT01625338|37722243|FG000|Overall Study|Enrolled but not Treated|0|||
16782602|NCT01625338|37722244|FG001|Overall Study|Enrolled but not Treated|0|||
16782603|NCT01625338|37722245|FG002|Overall Study|Enrolled but not Treated|1|||
16782604|NCT01625338|37722243|FG000|Overall Study|Efficacy Failure|27|||
16782605|NCT01625338|37722244|FG001|Overall Study|Efficacy Failure|39|||
16782606|NCT01625338|37722245|FG002|Overall Study|Efficacy Failure|31|||
16782607|NCT01625338|37722243|FG000|Overall Study|Lost to Follow-up|3|||
16782608|NCT01625338|37722244|FG001|Overall Study|Lost to Follow-up|3|||
16782609|NCT01625338|37722245|FG002|Overall Study|Lost to Follow-up|2|||
16782610|NCT01625338|37722243|FG000|Overall Study|Investigator Decision|0|||
16782611|NCT01625338|37722244|FG001|Overall Study|Investigator Decision|2|||
16782612|NCT01625338|37722245|FG002|Overall Study|Investigator Decision|1|||
16782613|NCT01625338|37722243|FG000|Overall Study|Subject Withdrew Consent|1|||
16782614|NCT01625338|37722244|FG001|Overall Study|Subject Withdrew Consent|0|||
16782615|NCT01625338|37722245|FG002|Overall Study|Subject Withdrew Consent|2|||
16782616|NCT01625338|37722243|FG000|Overall Study|Adverse Event|1|||
16782617|NCT01625338|37722244|FG001|Overall Study|Adverse Event|0|||
16782618|NCT01625338|37722245|FG002|Overall Study|Adverse Event|1|||
16782619|NCT01625338|37722243|FG000|Overall Study|Study Discontinued by Sponsor|0|||
16782620|NCT01625338|37722244|FG001|Overall Study|Study Discontinued by Sponsor|0|||
16782621|NCT01625338|37722245|FG002|Overall Study|Study Discontinued by Sponsor|1|||
16782622|NCT02560623|37722257|FG000|Overall Study|Unable to swallow sponge|0|||
16782623|NCT02560623|37722258|FG001|Overall Study|Unable to swallow sponge|1|||
17090780|NCT00239226|38230840|FG000|Overall Study|permAF during stabilization period|0|||
16782624|NCT02560623|37722259|FG002|Overall Study|Unable to swallow sponge|0|||
16782625|NCT02560623|37722260|FG003|Overall Study|Unable to swallow sponge|0|||
16782626|NCT02560623|37722257|FG000|Overall Study|Intervention prior to sponge administration|0|||
16782627|NCT02560623|37722258|FG001|Overall Study|Intervention prior to sponge administration|1|||
17090781|NCT00239226|38230841|FG001|Overall Study|permAF during stabilization period|0|||
17090782|NCT00239226|38230842|FG002|Overall Study|permAF during stabilization period|0|||
17090783|NCT00239226|38230843|FG003|Overall Study|permAF during stabilization period|3|||
17090784|NCT00239226|38230840|FG000|Overall Study|Lost to Follow-up|1|||
17090785|NCT00239226|38230841|FG001|Overall Study|Lost to Follow-up|0|||
17090786|NCT00239226|38230842|FG002|Overall Study|Lost to Follow-up|1|||
17090787|NCT00239226|38230843|FG003|Overall Study|Lost to Follow-up|0|||
17090788|NCT00467285|38230855|FG000|Overall Study|Lost to Follow-up|4|||
17090789|NCT00467285|38230856|FG001|Overall Study|Lost to Follow-up|4|||
17090790|NCT00264576|38230866|FG000|Overall Study|Lost to Follow-up|1|||
17090791|NCT00264576|38230867|FG001|Overall Study|Lost to Follow-up|1|||
17090792|NCT00466505|38230874|FG000|Overall Study|disease progression|13|||
17090793|NCT00466505|38230874|FG000|Overall Study|Adverse Event|4|||
17090794|NCT00467051|38230878|FG000|Overall Study|Adverse Event|2|||
17090795|NCT00264498|38230885|FG000|Randomized Treatment|Death|0|||
17090796|NCT00264498|38230886|FG001|Randomized Treatment|Death|3|||
17090797|NCT00264498|38230885|FG000|Randomized Treatment|Withdrawal by Subject|0|||
17090798|NCT00264498|38230886|FG001|Randomized Treatment|Withdrawal by Subject|1|||
17090799|NCT00264498|38230885|FG000|Randomized Treatment|Objective disease Progression|13|||
17090800|NCT00264498|38230886|FG001|Randomized Treatment|Objective disease Progression|14|||
17090801|NCT00264498|38230885|FG000|Randomized Treatment|Physician Decision|1|||
17090802|NCT00264498|38230886|FG001|Randomized Treatment|Physician Decision|0|||
17090803|NCT00264498|38230885|FG000|Randomized Treatment|Incorrectly randomized|1|||
17090804|NCT00264498|38230886|FG001|Randomized Treatment|Incorrectly randomized|0|||
17090805|NCT00264498|38230885|FG000|Randomized Treatment|Study Closure|1|||
17090806|NCT00264498|38230886|FG001|Randomized Treatment|Study Closure|0|||
17090807|NCT00264498|38230885|FG000|Randomized Treatment|Protocol Violation|1|||
17090808|NCT00264498|38230886|FG001|Randomized Treatment|Protocol Violation|0|||
17090809|NCT00264498|38230885|FG000|Crossover Treatment|Death|1|||
17090810|NCT00264498|38230886|FG001|Crossover Treatment|Death|3|||
17090811|NCT00264498|38230885|FG000|Crossover Treatment|Objective disease progression|4|||
17090812|NCT00264498|38230886|FG001|Crossover Treatment|Objective disease progression|5|||
17090813|NCT00264498|38230885|FG000|Crossover Treatment|Study closure|0|||
17090814|NCT00264498|38230886|FG001|Crossover Treatment|Study closure|1|||
17090815|NCT00264498|38230885|FG000|Crossover Treatment|Withdrawal by Subject|1|||
17090816|NCT00264498|38230886|FG001|Crossover Treatment|Withdrawal by Subject|0|||
17090817|NCT00466193|38230894|FG000|Overall Study|Adverse Event|0|||
17090818|NCT00466193|38230895|FG001|Overall Study|Adverse Event|1|||
17090819|NCT00466193|38230894|FG000|Overall Study|Lost to Follow-up|2|||
17090820|NCT00466193|38230895|FG001|Overall Study|Lost to Follow-up|4|||
17090821|NCT00466193|38230894|FG000|Overall Study|Physician Decision|1|||
17090822|NCT00466193|38230895|FG001|Overall Study|Physician Decision|0|||
17090823|NCT00466193|38230894|FG000|Overall Study|Protocol Violation|1|||
17090824|NCT00466193|38230895|FG001|Overall Study|Protocol Violation|1|||
17090825|NCT00466193|38230894|FG000|Overall Study|Withdrawal by Subject|7|||
17090826|NCT00466193|38230895|FG001|Overall Study|Withdrawal by Subject|2|||
17090827|NCT00466193|38230894|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
17090828|NCT00466193|38230895|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
17090829|NCT00263562|38230903|FG000|Overall Study|Protocol Violation|3|||
17090830|NCT00263562|38230904|FG001|Overall Study|Protocol Violation|0|||
17090831|NCT00454181|38230914|FG000|Overall Study|Adverse Event|1|||
17090832|NCT00454181|38230915|FG001|Overall Study|Adverse Event|1|||
17090833|NCT00454181|38230914|FG000|Overall Study|Lost to Follow-up|11|||
17090834|NCT00454181|38230915|FG001|Overall Study|Lost to Follow-up|1|||
17090835|NCT00454181|38230914|FG000|Overall Study|Protocol Violation|1|||
17090836|NCT00454181|38230915|FG001|Overall Study|Protocol Violation|1|||
17090837|NCT00454181|38230914|FG000|Overall Study|Withdrawal by Subject|2|||
16782628|NCT02560623|37722259|FG002|Overall Study|Intervention prior to sponge administration|0|||
16782629|NCT02560623|37722260|FG003|Overall Study|Intervention prior to sponge administration|0|||
16782630|NCT02560389|37722273|FG000|Overall Study|Lost to Follow-up|1|||
16782631|NCT02560389|37722274|FG001|Overall Study|Lost to Follow-up|2|||
16782632|NCT02560389|37722275|FG002|Overall Study|Lost to Follow-up|2|||
16782633|NCT02560389|37722273|FG000|Overall Study|Tested positive for illicit substance|0|||
16782634|NCT02560389|37722274|FG001|Overall Study|Tested positive for illicit substance|1|||
16782635|NCT02560389|37722275|FG002|Overall Study|Tested positive for illicit substance|0|||
16782636|NCT02564211|37722283|FG000|Overall Study|Adverse Event|4|||
16782637|NCT02093026|37722287|FG000|Overall Study|Adverse Event|26|||
17090838|NCT00454181|38230915|FG001|Overall Study|Withdrawal by Subject|0|||
17090839|NCT00237744|38230924|FG000|Overall Study|Withdrawal by Subject|3|||
17090840|NCT00237744|38230925|FG001|Overall Study|Withdrawal by Subject|1|||
17090841|NCT00237744|38230926|FG002|Overall Study|Withdrawal by Subject|0|||
17090842|NCT00237042|38230940|FG000|Treatment|Became ineligible post-randomization|0|||
17090843|NCT00237042|38230941|FG001|Treatment|Became ineligible post-randomization|1|||
17090844|NCT00237042|38230942|FG002|Treatment|Became ineligible post-randomization|16|||
17090845|NCT00237042|38230940|FG000|Treatment|Moved out of state|1|||
17090846|NCT00237042|38230941|FG001|Treatment|Moved out of state|1|||
17090847|NCT00237042|38230942|FG002|Treatment|Moved out of state|1|||
17090848|NCT00237042|38230940|FG000|Treatment|Completed no treatment|5|||
17090849|NCT00237042|38230941|FG001|Treatment|Completed no treatment|5|||
16997950|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
16997951|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
16997952|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
16997953|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
16997954|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
16997955|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
16997956|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
16997957|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
16782638|NCT02093026|37722287|FG000|Overall Study|Death|10|||
16782639|NCT02093026|37722287|FG000|Overall Study|Other|157|||
16782640|NCT02040844|37722295|FG000|Overall Study|Adverse Event|0|||
16782641|NCT02040844|37722296|FG001|Overall Study|Adverse Event|0|||
16782642|NCT02040844|37722297|FG002|Overall Study|Adverse Event|1|||
16782643|NCT02040844|37722295|FG000|Overall Study|Withdrawal by Subject|16|||
16782644|NCT02040844|37722296|FG001|Overall Study|Withdrawal by Subject|22|||
16782645|NCT02040844|37722297|FG002|Overall Study|Withdrawal by Subject|25|||
16782646|NCT02040844|37722295|FG000|Overall Study|Lost to Follow-up|12|||
16782647|NCT02040844|37722296|FG001|Overall Study|Lost to Follow-up|9|||
16782648|NCT02040844|37722297|FG002|Overall Study|Lost to Follow-up|13|||
16782649|NCT02040844|37722295|FG000|Overall Study|Missing|13|||
16782650|NCT02040844|37722296|FG001|Overall Study|Missing|3|||
16782651|NCT02040844|37722297|FG002|Overall Study|Missing|2|||
16782652|NCT02040844|37722295|FG000|Overall Study|Non-specified|8|||
16782653|NCT02040844|37722296|FG001|Overall Study|Non-specified|2|||
16782654|NCT02040844|37722297|FG002|Overall Study|Non-specified|5|||
16782655|NCT02040844|37722295|FG000|Overall Study|Concomitant medication|1|||
16782656|NCT02040844|37722296|FG001|Overall Study|Concomitant medication|3|||
16782657|NCT02040844|37722297|FG002|Overall Study|Concomitant medication|1|||
16782658|NCT02059174|37722305|FG000|Period 1|Withdrawal by Subject|0|||
16782659|NCT02059174|37722306|FG001|Period 1|Withdrawal by Subject|2|||
16782660|NCT02059174|37722305|FG000|Period 2|Withdrawal by Subject|0|||
16782661|NCT02059174|37722306|FG001|Period 2|Withdrawal by Subject|2|||
16782662|NCT02059174|37722305|FG000|Period 2|Protocol Violation|1|||
16782663|NCT02059174|37722306|FG001|Period 2|Protocol Violation|0|||
16782664|NCT02059174|37722305|FG000|Period 3|Physician Decision|1|||
16782665|NCT02059174|37722306|FG001|Period 3|Physician Decision|0|||
16782666|NCT02092324|37722314|FG000|Overall Study|Adverse Event|1|||
16782667|NCT02092324|37722314|FG000|Overall Study|Lack of Efficacy|6|||
16782668|NCT02092324|37722314|FG000|Overall Study|Proceed to Transplant|3|||
16782669|NCT02092324|37722314|FG000|Overall Study|Physician Decision|7|||
16782670|NCT02092324|37722314|FG000|Overall Study|Misdiagnosis|2|||
16782671|NCT02040766|37722326|FG000|Overall Study|Adverse Event|1|||
16782672|NCT02040766|37722327|FG001|Overall Study|Adverse Event|1|||
16782673|NCT02040766|37722328|FG002|Overall Study|Adverse Event|1|||
16782674|NCT02040766|37722329|FG003|Overall Study|Adverse Event|0|||
16782675|NCT02040766|37722330|FG004|Overall Study|Adverse Event|2|||
16782676|NCT02040766|37722326|FG000|Overall Study|Withdrawal by Subject|4|||
16782677|NCT02040766|37722327|FG001|Overall Study|Withdrawal by Subject|3|||
16782678|NCT02040766|37722328|FG002|Overall Study|Withdrawal by Subject|2|||
16782679|NCT02040766|37722329|FG003|Overall Study|Withdrawal by Subject|3|||
16782680|NCT02040766|37722330|FG004|Overall Study|Withdrawal by Subject|2|||
16782681|NCT02040766|37722326|FG000|Overall Study|Non-compliance|0|||
16782682|NCT02040766|37722327|FG001|Overall Study|Non-compliance|1|||
16782683|NCT02040766|37722328|FG002|Overall Study|Non-compliance|0|||
16782684|NCT02040766|37722329|FG003|Overall Study|Non-compliance|0|||
16782685|NCT02040766|37722330|FG004|Overall Study|Non-compliance|0|||
16782686|NCT02040766|37722326|FG000|Overall Study|Protocol Violation|2|||
16782687|NCT02040766|37722327|FG001|Overall Study|Protocol Violation|1|||
16782688|NCT02040766|37722328|FG002|Overall Study|Protocol Violation|2|||
16782689|NCT02040766|37722329|FG003|Overall Study|Protocol Violation|3|||
16782690|NCT02040766|37722330|FG004|Overall Study|Protocol Violation|0|||
16782691|NCT02040766|37722326|FG000|Overall Study|Lost to Follow-up|4|||
16782692|NCT02040766|37722327|FG001|Overall Study|Lost to Follow-up|1|||
16782693|NCT02040766|37722328|FG002|Overall Study|Lost to Follow-up|3|||
16782694|NCT02040766|37722329|FG003|Overall Study|Lost to Follow-up|1|||
16782695|NCT02040766|37722330|FG004|Overall Study|Lost to Follow-up|4|||
16782696|NCT02040766|37722326|FG000|Overall Study|Not reported|1|||
16782697|NCT02040766|37722327|FG001|Overall Study|Not reported|0|||
16782698|NCT02040766|37722328|FG002|Overall Study|Not reported|0|||
16782699|NCT02040766|37722329|FG003|Overall Study|Not reported|0|||
16782700|NCT02040766|37722330|FG004|Overall Study|Not reported|0|||
16868161|NCT01548287|37841193|FG000|Randomized Period|Did not meet inclusion criteria|0|||
16782701|NCT02040766|37722326|FG000|Overall Study|Lack of Efficacy|6|||
16782702|NCT02040766|37722327|FG001|Overall Study|Lack of Efficacy|3|||
16782703|NCT02040766|37722328|FG002|Overall Study|Lack of Efficacy|4|||
16782704|NCT02040766|37722329|FG003|Overall Study|Lack of Efficacy|6|||
16782705|NCT02040766|37722330|FG004|Overall Study|Lack of Efficacy|5|||
16997958|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
16997959|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
16997960|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
16997961|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
16997962|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
16997963|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
16997964|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
16997965|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
16997966|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
16997967|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
16997968|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
16997969|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
16997970|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
16997971|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
16997972|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
16997973|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
16997974|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
16997975|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
16997976|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
16997977|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
16997978|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
16997979|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
16997980|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
16997981|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
16997982|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
16997983|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
16997984|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
16997985|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
16997986|NCT00958568|38141888|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
16997987|NCT00958568|38141889|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
16997988|NCT00958568|38141890|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
16997989|NCT00958568|38141891|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
16997990|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
16997991|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
16997992|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
16997993|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
16997994|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
16997995|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
16997996|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
16997997|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
16997998|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
16997999|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
16998000|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
16998001|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
16998002|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
16998003|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
16998004|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
16998005|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
16998006|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
16998007|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
16998008|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
16998009|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
16998010|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
16998011|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
16998012|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
16998013|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
16998014|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
16998015|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
16998016|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
17090850|NCT00237042|38230942|FG002|Treatment|Completed no treatment|21|||
17090851|NCT00237042|38230940|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
16868162|NCT01548287|37841194|FG001|Randomized Period|Did not meet inclusion criteria|0|||
16868163|NCT01548287|37841195|FG002|Randomized Period|Did not meet inclusion criteria|2|||
16998017|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
16998018|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
16998019|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
16998020|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
16998021|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
16998022|NCT00958568|38141888|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
16998023|NCT00958568|38141889|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
16998024|NCT00958568|38141890|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
16998025|NCT00958568|38141891|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
16998026|NCT00958412|38141902|FG000|Overall Study|Study prematurely terminated|18|||
16998027|NCT00958256|38141906|FG000|Overall Study|Adverse Event|3|||
16998028|NCT00696709|38141915|FG000|Overall Study|Withdrawal by Subject|1|||
16998029|NCT00696709|38141916|FG001|Overall Study|Withdrawal by Subject|2|||
16998030|NCT00696709|38141917|FG002|Overall Study|Withdrawal by Subject|1|||
16998031|NCT00696709|38141918|FG003|Overall Study|Withdrawal by Subject|4|||
16998032|NCT00696709|38141919|FG004|Overall Study|Withdrawal by Subject|3|||
17090852|NCT00237042|38230941|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
17090853|NCT00237042|38230942|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
17090854|NCT00237042|38230940|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
16782706|NCT02040532|37722343|FG000|Overall Study|Lost to Follow-up|1|||
16782707|NCT02040532|37722343|FG000|Overall Study|Physician Decision|4|||
16782708|NCT02040532|37722343|FG000|Overall Study|Adverse Event|4|||
16782709|NCT02040532|37722343|FG000|Overall Study|Withdrawal by Subject|3|||
16782710|NCT02039908|37722347|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
16782711|NCT02039908|37722348|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
16782712|NCT02039908|37722349|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
16782713|NCT02039908|37722350|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
16782714|NCT02039908|37722347|FG000|Phase 1-Summer|Protocol Violation|6|||
16782715|NCT02039908|37722348|FG001|Phase 1-Summer|Protocol Violation|0|||
16782716|NCT02039908|37722349|FG002|Phase 1-Summer|Protocol Violation|0|||
16782717|NCT02039908|37722350|FG003|Phase 1-Summer|Protocol Violation|0|||
16782718|NCT02039908|37722347|FG000|Phase 2-School Year|Lost to Follow-up|0|||
16782719|NCT02039908|37722348|FG001|Phase 2-School Year|Lost to Follow-up|0|||
16868164|NCT01548287|37841196|FG003|Randomized Period|Did not meet inclusion criteria|0|||
16868165|NCT01548287|37841197|FG004|Randomized Period|Did not meet inclusion criteria|0|||
16868166|NCT01548287|37841193|FG000|Randomized Period|Adverse Event|0|||
16868167|NCT01548287|37841194|FG001|Randomized Period|Adverse Event|2|||
16868168|NCT01548287|37841195|FG002|Randomized Period|Adverse Event|5|||
16868169|NCT01548287|37841196|FG003|Randomized Period|Adverse Event|0|||
16868170|NCT01548287|37841197|FG004|Randomized Period|Adverse Event|0|||
16868171|NCT01546883|37841207|FG000|Overall Study|Withdrawal by Subject|3|||
16868172|NCT01546883|37841207|FG000|Overall Study|Adverse Event|4|||
16868173|NCT01546883|37841207|FG000|Overall Study|Lost to Follow-up|2|||
16868174|NCT01546883|37841207|FG000|Overall Study|early closure of study|2|||
16868175|NCT01546883|37841207|FG000|Overall Study|other unrelated illness|1|||
16868176|NCT01580293|37841218|FG000|Part A_Main Trial|Adverse Event|0|||
16868177|NCT01580293|37841219|FG001|Part A_Main Trial|Adverse Event|2|||
16868178|NCT01580293|37841220|FG002|Part A_Main Trial|Adverse Event|0|||
16868179|NCT01580293|37841218|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
16868180|NCT01580293|37841219|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
16868181|NCT01580293|37841220|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
16868182|NCT01580293|37841218|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
16868183|NCT01580293|37841219|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
16868184|NCT01580293|37841220|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
16868185|NCT01580293|37841218|FG000|Part A_Extension|Adverse Event|0|||
16868186|NCT01580293|37841219|FG001|Part A_Extension|Adverse Event|2|||
16868187|NCT01580293|37841220|FG002|Part A_Extension|Adverse Event|0|||
16868188|NCT01580293|37841218|FG000|Part A_Extension|Withdrawal by Subject|0|||
16868189|NCT01580293|37841219|FG001|Part A_Extension|Withdrawal by Subject|3|||
16868190|NCT01580293|37841220|FG002|Part A_Extension|Withdrawal by Subject|0|||
16868191|NCT01580293|37841218|FG000|Part A_Extension|Lost to Follow-up|0|||
16868192|NCT01580293|37841219|FG001|Part A_Extension|Lost to Follow-up|1|||
16868193|NCT01580293|37841220|FG002|Part A_Extension|Lost to Follow-up|0|||
16868194|NCT01580293|37841218|FG000|Part A_Extension|Other Reason|0|||
16868195|NCT01580293|37841219|FG001|Part A_Extension|Other Reason|1|||
16868196|NCT01580293|37841220|FG002|Part A_Extension|Other Reason|0|||
16868197|NCT01580293|37841218|FG000|Part A_Extension|Completed Japan only|0|||
16868198|NCT01580293|37841219|FG001|Part A_Extension|Completed Japan only|5|||
16868199|NCT01580293|37841220|FG002|Part A_Extension|Completed Japan only|0|||
16868200|NCT01580293|37841218|FG000|Part B|Withdrawal by Subject|0|||
16868201|NCT01580293|37841219|FG001|Part B|Withdrawal by Subject|0|||
16868202|NCT01580293|37841220|FG002|Part B|Withdrawal by Subject|1|||
16998033|NCT00696709|38141915|FG000|Overall Study|Protocol Violation|1|||
16998034|NCT00696709|38141916|FG001|Overall Study|Protocol Violation|0|||
16998035|NCT00696709|38141917|FG002|Overall Study|Protocol Violation|0|||
16782720|NCT02039908|37722349|FG002|Phase 2-School Year|Lost to Follow-up|1|||
16998036|NCT00696709|38141918|FG003|Overall Study|Protocol Violation|0|||
16998037|NCT00696709|38141919|FG004|Overall Study|Protocol Violation|0|||
16998038|NCT00696709|38141915|FG000|Overall Study|Lost to Follow-up|1|||
16998039|NCT00696709|38141916|FG001|Overall Study|Lost to Follow-up|1|||
16998040|NCT00696709|38141917|FG002|Overall Study|Lost to Follow-up|0|||
16998041|NCT00696709|38141918|FG003|Overall Study|Lost to Follow-up|0|||
16998042|NCT00696709|38141919|FG004|Overall Study|Lost to Follow-up|0|||
16998043|NCT00696709|38141915|FG000|Overall Study|Adverse Event|0|||
16998044|NCT00696709|38141916|FG001|Overall Study|Adverse Event|0|||
16998045|NCT00696709|38141917|FG002|Overall Study|Adverse Event|0|||
16998046|NCT00696709|38141918|FG003|Overall Study|Adverse Event|1|||
16998047|NCT00696709|38141919|FG004|Overall Study|Adverse Event|0|||
16998048|NCT01006265|38141939|FG000|Overall Study|Lost to Follow-up|1|||
16998049|NCT01006265|38141940|FG001|Overall Study|Lost to Follow-up|0|||
16998050|NCT01006265|38141941|FG002|Overall Study|Lost to Follow-up|1|||
16998051|NCT01006265|38141942|FG003|Overall Study|Lost to Follow-up|0|||
16998052|NCT01006265|38141939|FG000|Overall Study|Withdrawal by Subject|4|||
16998053|NCT01006265|38141940|FG001|Overall Study|Withdrawal by Subject|7|||
16998054|NCT01006265|38141941|FG002|Overall Study|Withdrawal by Subject|5|||
16998055|NCT01006265|38141942|FG003|Overall Study|Withdrawal by Subject|5|||
16998056|NCT01006265|38141939|FG000|Overall Study|Administrative reason|1|||
16998057|NCT01006265|38141940|FG001|Overall Study|Administrative reason|2|||
16998058|NCT01006265|38141941|FG002|Overall Study|Administrative reason|3|||
16998059|NCT01006265|38141942|FG003|Overall Study|Administrative reason|0|||
16998060|NCT01008995|38141954|FG000|Controlled Period|Adverse Event|1|||
16998061|NCT01008995|38141955|FG001|Controlled Period|Adverse Event|2|||
16998062|NCT01008995|38141956|FG002|Controlled Period|Adverse Event|0|||
16998063|NCT01008995|38141957|FG003|Controlled Period|Adverse Event|0|||
16998064|NCT01008995|38141954|FG000|Controlled Period|Other|2|||
16998065|NCT01008995|38141955|FG001|Controlled Period|Other|1|||
16998066|NCT01008995|38141956|FG002|Controlled Period|Other|0|||
16998067|NCT01008995|38141957|FG003|Controlled Period|Other|0|||
16998068|NCT01008995|38141954|FG000|After Controlled Period|Adverse Event|0|||
16998069|NCT01008995|38141955|FG001|After Controlled Period|Adverse Event|0|||
16998070|NCT01008995|38141956|FG002|After Controlled Period|Adverse Event|1|||
16998071|NCT01008995|38141957|FG003|After Controlled Period|Adverse Event|1|||
16998072|NCT01008995|38141954|FG000|After Controlled Period|Other|0|||
16998073|NCT01008995|38141955|FG001|After Controlled Period|Other|0|||
16998074|NCT01008995|38141956|FG002|After Controlled Period|Other|1|||
16998075|NCT01008995|38141957|FG003|After Controlled Period|Other|0|||
16998076|NCT00957944|38141967|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
16998077|NCT00957944|38141968|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
16998078|NCT01005875|38141974|FG000|Overall Study|Death|3|||
16998079|NCT01005719|38141978|FG000|Period 1|Adverse Event|0|||
16998080|NCT01005719|38141979|FG001|Period 1|Adverse Event|0|||
16998081|NCT01005719|38141980|FG002|Period 1|Adverse Event|0|||
16998082|NCT01005719|38141981|FG003|Period 1|Adverse Event|1|||
16998083|NCT01005719|38141982|FG004|Period 1|Adverse Event|0|||
16998084|NCT01005719|38141983|FG005|Period 1|Adverse Event|0|||
16998085|NCT01005719|38141978|FG000|Period 1|Delay in completing study procedures|0|||
16998086|NCT01005719|38141979|FG001|Period 1|Delay in completing study procedures|0|||
16998087|NCT01005719|38141980|FG002|Period 1|Delay in completing study procedures|0|||
16998088|NCT01005719|38141981|FG003|Period 1|Delay in completing study procedures|0|||
16998089|NCT01005719|38141982|FG004|Period 1|Delay in completing study procedures|0|||
16998090|NCT01005719|38141983|FG005|Period 1|Delay in completing study procedures|1|||
16998091|NCT01005719|38141978|FG000|Period 2|Adverse Event|0|||
17189129|NCT02966509|38342121|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
17189130|NCT02966509|38342120|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
17189131|NCT02966509|38342121|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
17189132|NCT02966509|38342120|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
17189133|NCT02966509|38342121|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
17189134|NCT02966509|38342120|FG000|6 Month Satisfaction Survey|Death|36|||
17189135|NCT02966509|38342121|FG001|6 Month Satisfaction Survey|Death|33|||
17189136|NCT02966509|38342120|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
17189137|NCT02966509|38342121|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
17189138|NCT02966509|38342120|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
17189139|NCT02966509|38342121|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
16998092|NCT01005719|38141979|FG001|Period 2|Adverse Event|0|||
16998093|NCT01005719|38141980|FG002|Period 2|Adverse Event|0|||
16998094|NCT01005719|38141981|FG003|Period 2|Adverse Event|0|||
16998095|NCT01005719|38141982|FG004|Period 2|Adverse Event|1|||
16998096|NCT01005719|38141983|FG005|Period 2|Adverse Event|1|||
16998097|NCT00953576|38141994|FG000|Overall Study|Adverse Event|0|||
16998098|NCT00953576|38141995|FG001|Overall Study|Adverse Event|1|||
16998099|NCT00953576|38141994|FG000|Overall Study|Ineligible after Consent|2|||
16998100|NCT00953576|38141995|FG001|Overall Study|Ineligible after Consent|0|||
16998101|NCT01005329|38142010|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
17189140|NCT02966509|38342120|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
16998102|NCT01005251|38142020|FG000|Overall Study|Withdrawal by Subject|2|||
16998103|NCT01005251|38142021|FG001|Overall Study|Withdrawal by Subject|5|||
16998104|NCT01005251|38142022|FG002|Overall Study|Withdrawal by Subject|3|||
16998105|NCT01005251|38142023|FG003|Overall Study|Withdrawal by Subject|4|||
16998106|NCT01005251|38142024|FG004|Overall Study|Withdrawal by Subject|9|||
16998107|NCT01005251|38142020|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
16998108|NCT01005251|38142021|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16998109|NCT01005251|38142022|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
16998110|NCT01005251|38142023|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
17090855|NCT00237042|38230941|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
17090856|NCT00237042|38230942|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
16868203|NCT01580293|37841218|FG000|Part B|Other reason|0|||
16868204|NCT01580293|37841219|FG001|Part B|Other reason|0|||
16868205|NCT01580293|37841220|FG002|Part B|Other reason|1|||
16868206|NCT01546649|37841249|FG000|Overall Study|Adverse Event|4|||
16868207|NCT01546649|37841250|FG001|Overall Study|Adverse Event|5|||
16868208|NCT01546649|37841249|FG000|Overall Study|Protocol Violation|1|||
16868209|NCT01546649|37841250|FG001|Overall Study|Protocol Violation|0|||
16868210|NCT01546649|37841249|FG000|Overall Study|Lack of Efficacy|1|||
16868211|NCT01546649|37841250|FG001|Overall Study|Lack of Efficacy|0|||
16868212|NCT01546649|37841249|FG000|Overall Study|Recurrence|1|||
16868213|NCT01546649|37841250|FG001|Overall Study|Recurrence|1|||
16868214|NCT01546649|37841249|FG000|Overall Study|Discovery of secondary cancer|0|||
16868215|NCT01546649|37841250|FG001|Overall Study|Discovery of secondary cancer|1|||
16868216|NCT01546649|37841249|FG000|Overall Study|Withdrawal by Subject|1|||
16868217|NCT01546649|37841250|FG001|Overall Study|Withdrawal by Subject|2|||
16868218|NCT01544309|37841258|FG000|Overall Study|Withdrawal by Subject|12|||
16868219|NCT01544309|37841259|FG001|Overall Study|Withdrawal by Subject|7|||
16868220|NCT01544309|37841258|FG000|Overall Study|Protocol Violation|2|||
16868221|NCT01544309|37841259|FG001|Overall Study|Protocol Violation|1|||
16868222|NCT01544309|37841258|FG000|Overall Study|Physician Decision|4|||
16868223|NCT01544309|37841259|FG001|Overall Study|Physician Decision|1|||
16868224|NCT01544309|37841258|FG000|Overall Study|Not performed pre-dose examination|1|||
16868225|NCT01544309|37841259|FG001|Overall Study|Not performed pre-dose examination|2|||
16868226|NCT01544309|37841258|FG000|Overall Study|Administered prohibit prior medication|1|||
16868227|NCT01544309|37841259|FG001|Overall Study|Administered prohibit prior medication|0|||
16868228|NCT01544153|37841271|FG000|Overall Study|Under 18|0|||
16868229|NCT01544153|37841272|FG001|Overall Study|Under 18|1|||
16868230|NCT01544153|37841273|FG002|Overall Study|Under 18|0|||
16868231|NCT01544153|37841274|FG003|Overall Study|Under 18|0|||
16868232|NCT01544153|37841271|FG000|Overall Study|Non-smoker|0|||
16868233|NCT01544153|37841272|FG001|Overall Study|Non-smoker|0|||
16868234|NCT01544153|37841273|FG002|Overall Study|Non-smoker|1|||
16868235|NCT01544153|37841274|FG003|Overall Study|Non-smoker|0|||
16868236|NCT01543685|37841289|FG000|Overall Study|Lack of Efficacy|1|||
16868237|NCT01543685|37841290|FG001|Overall Study|Lack of Efficacy|2|||
16868238|NCT01543685|37841291|FG002|Overall Study|Lack of Efficacy|2|||
16868239|NCT01543685|37841292|FG003|Overall Study|Lack of Efficacy|0|||
16868240|NCT01543685|37841293|FG004|Overall Study|Lack of Efficacy|2|||
16868241|NCT01543685|37841289|FG000|Overall Study|Adverse Event|2|||
16868242|NCT01543685|37841290|FG001|Overall Study|Adverse Event|1|||
16868243|NCT01543685|37841291|FG002|Overall Study|Adverse Event|0|||
16868244|NCT01543685|37841292|FG003|Overall Study|Adverse Event|0|||
16868245|NCT01543685|37841293|FG004|Overall Study|Adverse Event|2|||
16868246|NCT01541969|37841307|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
16868247|NCT01541969|37841308|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
16868248|NCT01541969|37841307|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
16868249|NCT01541969|37841308|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
16868250|NCT01541969|37841307|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
16868251|NCT01541969|37841308|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
16868252|NCT01541969|37841307|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
16868253|NCT01541969|37841308|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
16868254|NCT01541969|37841307|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
16868255|NCT01541969|37841308|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
17090857|NCT00465647|38230954|FG000|Overall Study|Administrative|2|||
17090858|NCT00465647|38230955|FG001|Overall Study|Administrative|2|||
17090859|NCT00465647|38230956|FG002|Overall Study|Administrative|3|||
17090860|NCT00465647|38230957|FG003|Overall Study|Administrative|2|||
17090861|NCT00465647|38230954|FG000|Overall Study|Adverse Event|2|||
16868256|NCT01541969|37841307|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
16868257|NCT01541969|37841308|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
16868258|NCT01541969|37841307|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
16868259|NCT01541969|37841308|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
16868260|NCT01541969|37841307|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
16868261|NCT01541969|37841308|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
16868262|NCT01541969|37841307|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
16868263|NCT01541969|37841308|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
16868264|NCT01541969|37841307|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
16868265|NCT01541969|37841308|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
16868266|NCT01540565|37841317|FG000|Overall Study|Ineligible|2|||
16868267|NCT01540487|37841323|FG000|Overall Study|Protocol Violation|1|||
16868268|NCT01540487|37841324|FG001|Overall Study|Protocol Violation|0|||
16868269|NCT01539863|37841336|FG000|Overall Study|Lost to Follow-up|5|||
16868270|NCT01539863|37841337|FG001|Overall Study|Lost to Follow-up|4|||
16868271|NCT01539317|37841345|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
16868272|NCT01539317|37841346|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
16868273|NCT01539239|37841357|FG000|Overall Study|Death|5|||
16868274|NCT01539239|37841358|FG001|Overall Study|Death|5|||
16868275|NCT01539239|37841357|FG000|Overall Study|Lost to Follow-up|7|||
16868276|NCT01539239|37841358|FG001|Overall Study|Lost to Follow-up|12|||
16868277|NCT01539083|37841364|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
16868278|NCT01539083|37841365|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
16868279|NCT01539083|37841366|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
16868280|NCT01539083|37841364|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
16868281|NCT01539083|37841365|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
16868282|NCT01539083|37841366|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
16868283|NCT01539083|37841364|FG000|Before Randomization (VCD Induction)|Death|6|||
16868284|NCT01539083|37841365|FG001|Before Randomization (VCD Induction)|Death|0|||
16868285|NCT01539083|37841366|FG002|Before Randomization (VCD Induction)|Death|0|||
16868286|NCT01539083|37841364|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
16868287|NCT01539083|37841365|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
16868288|NCT01539083|37841366|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
16868289|NCT01539083|37841364|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
16868290|NCT01539083|37841365|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
16868291|NCT01539083|37841366|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
16868292|NCT01539083|37841364|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
16868293|NCT01539083|37841365|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
16868294|NCT01539083|37841366|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
16868295|NCT01539083|37841364|FG000|Before Randomization (VCD Induction)|Other|5|||
16868296|NCT01539083|37841365|FG001|Before Randomization (VCD Induction)|Other|0|||
16868297|NCT01539083|37841366|FG002|Before Randomization (VCD Induction)|Other|0|||
16868298|NCT01539083|37841364|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
16868299|NCT01539083|37841365|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
16868300|NCT01539083|37841366|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
16868301|NCT01539083|37841364|FG000|After Randomization (TP and VTP)|Other|0|||
16868302|NCT01539083|37841365|FG001|After Randomization (TP and VTP)|Other|1|||
16868303|NCT01539083|37841366|FG002|After Randomization (TP and VTP)|Other|1|||
16868304|NCT01539083|37841364|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
16868305|NCT01539083|37841365|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
16868306|NCT01539083|37841366|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
16868307|NCT01539083|37841364|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
16868308|NCT01539083|37841365|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
16868309|NCT01539083|37841366|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
16868310|NCT01539083|37841364|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
16868311|NCT01539083|37841365|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
16868312|NCT01539083|37841366|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
16868313|NCT01539083|37841364|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
16868314|NCT01539083|37841365|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
16868315|NCT01539083|37841366|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
16868316|NCT01539083|37841364|FG000|After Randomization (TP and VTP)|Death|0|||
16868317|NCT01539083|37841365|FG001|After Randomization (TP and VTP)|Death|6|||
16868318|NCT01539083|37841366|FG002|After Randomization (TP and VTP)|Death|11|||
16868319|NCT01537211|37841375|FG000|Overall Study|Lost to Follow-up|0|||
16868320|NCT01537211|37841376|FG001|Overall Study|Lost to Follow-up|1|||
16868321|NCT01537133|37841390|FG000|Overall Study|Withdrawal by Subject|2|||
16868322|NCT01537133|37841391|FG001|Overall Study|Withdrawal by Subject|0|||
16868323|NCT01537133|37841392|FG002|Overall Study|Withdrawal by Subject|0|||
16868324|NCT01537133|37841393|FG003|Overall Study|Withdrawal by Subject|0|||
16868325|NCT01537133|37841390|FG000|Overall Study|Lost to Follow-up|1|||
16868326|NCT01537133|37841391|FG001|Overall Study|Lost to Follow-up|0|||
16868327|NCT01537133|37841392|FG002|Overall Study|Lost to Follow-up|0|||
16868328|NCT01537133|37841393|FG003|Overall Study|Lost to Follow-up|0|||
16868329|NCT01536587|37841401|FG000|Overall Study|Adverse Event|2|||
16868330|NCT01536119|37841407|FG000|Overall Study|Lost to Follow-up|17|||
16868331|NCT01536119|37841408|FG001|Overall Study|Lost to Follow-up|14|||
16868332|NCT01535729|37841414|FG000|Overall Study|Withdrawal by Subject|2|||
16868333|NCT01535729|37841414|FG000|Overall Study|Disease progression|230|||
16868334|NCT01535729|37841414|FG000|Overall Study|Discontinued treatment|25|||
16868335|NCT01535729|37841414|FG000|Overall Study|Lost to Follow-up|8|||
16868336|NCT01535729|37841414|FG000|Overall Study|Death|52|||
16868337|NCT01535729|37841414|FG000|Overall Study|Other|19|||
16868338|NCT01535729|37841414|FG000|Overall Study|Did not sign informed consent|1|||
16868339|NCT01535729|37841414|FG000|Overall Study|No previous chemotherapy|33|||
16868340|NCT01535729|37841414|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
16868341|NCT01535729|37841414|FG000|Overall Study|Protocol Violation|11|||
16868342|NCT01535729|37841414|FG000|Overall Study|Screening failure|1|||
16868343|NCT01535729|37841414|FG000|Overall Study|Not treated|9|||
16868344|NCT01535729|37841414|FG000|Overall Study|No participant record available|5|||
16868345|NCT01535261|37841418|FG000|Overall Study|Physician Decision|8|||
17090862|NCT00465647|38230955|FG001|Overall Study|Adverse Event|0|||
17090863|NCT00465647|38230956|FG002|Overall Study|Adverse Event|3|||
17090864|NCT00465647|38230957|FG003|Overall Study|Adverse Event|2|||
17090865|NCT00465647|38230954|FG000|Overall Study|Withdrawal by Subject|1|||
17090866|NCT00465647|38230955|FG001|Overall Study|Withdrawal by Subject|2|||
17090867|NCT00465647|38230956|FG002|Overall Study|Withdrawal by Subject|2|||
17090868|NCT00465647|38230957|FG003|Overall Study|Withdrawal by Subject|7|||
17090869|NCT00465647|38230954|FG000|Overall Study|"The other reasons included loss of IV"|8|||
17090870|NCT00465647|38230955|FG001|Overall Study|"The other reasons included loss of IV"|4|||
17090871|NCT00465647|38230956|FG002|Overall Study|"The other reasons included loss of IV"|3|||
17090872|NCT00465647|38230957|FG003|Overall Study|"The other reasons included loss of IV"|2|||
17090873|NCT00465569|38230979|FG000|Overall Study|persistent eczema during dose escalation|1|||
17090874|NCT00465569|38230980|FG001|Overall Study|persistent eczema during dose escalation|0|||
17090875|NCT00090766|38230989|FG000|Overall Study|Nephrectomy Planned|0|||
17090876|NCT00090766|38230990|FG001|Overall Study|Nephrectomy Planned|0|||
17090877|NCT00090766|38230991|FG002|Overall Study|Nephrectomy Planned|1|||
17090878|NCT00090766|38230989|FG000|Overall Study|Death|1|||
17090879|NCT00090766|38230990|FG001|Overall Study|Death|0|||
17090880|NCT00090766|38230991|FG002|Overall Study|Death|0|||
17090881|NCT00090766|38230989|FG000|Overall Study|Admin|0|||
17090882|NCT00090766|38230990|FG001|Overall Study|Admin|2|||
17090883|NCT00090766|38230991|FG002|Overall Study|Admin|0|||
17090884|NCT00090766|38230989|FG000|Overall Study|Lost to Follow-up|2|||
17090885|NCT00090766|38230990|FG001|Overall Study|Lost to Follow-up|0|||
17090886|NCT00090766|38230991|FG002|Overall Study|Lost to Follow-up|2|||
17090887|NCT00465179|38231001|FG000|Overall Study|Adverse Event|4|||
17090888|NCT00465179|38231001|FG000|Overall Study|Withdrawal by Subject|2|||
17090889|NCT00465179|38231001|FG000|Overall Study|Progression of Disease|47|||
17090890|NCT00465101|38231005|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
17090891|NCT00465101|38231005|FG000|Overall Study|Change in health precluded follow up|4|||
17090892|NCT00465101|38231005|FG000|Overall Study|Did not meet study criteria|4|||
17090893|NCT00465101|38231005|FG000|Overall Study|Lost to Follow-up|5|||
17090894|NCT00465101|38231005|FG000|Overall Study|Other|6|||
17090895|NCT00465101|38231005|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
17090896|NCT00465101|38231005|FG000|Overall Study|Patient postponed procedure|1|||
17090897|NCT00465101|38231005|FG000|Overall Study|Site closed due to IRB expiration|1|||
17090898|NCT00465101|38231005|FG000|Overall Study|Unable to obtain IRB approval|1|||
17090899|NCT00465101|38231005|FG000|Overall Study|Death|3|||
17090900|NCT00465101|38231005|FG000|Overall Study|Withdrawal by Subject|25|||
17090901|NCT00465101|38231005|FG000|Overall Study|Physician Decision|1|||
17090902|NCT00465101|38231005|FG000|Overall Study|Withdrew consent prior to procedure|3|||
17090903|NCT00084136|38231034|FG000|PI Comparison|Death|10|||
17090904|NCT00084136|38231035|FG001|PI Comparison|Death|9|||
17090905|NCT00084136|38231036|FG002|PI Comparison|Death|0|||
17090906|NCT00084136|38231034|FG000|PI Comparison|Lost to Follow-up|11|||
17090907|NCT00084136|38231035|FG001|PI Comparison|Lost to Follow-up|8|||
17090908|NCT00084136|38231036|FG002|PI Comparison|Lost to Follow-up|0|||
17090909|NCT00084136|38231034|FG000|PI Comparison|Withdrawal by Subject|33|||
17090910|NCT00084136|38231035|FG001|PI Comparison|Withdrawal by Subject|30|||
17090911|NCT00084136|38231036|FG002|PI Comparison|Withdrawal by Subject|0|||
17090912|NCT00084136|38231034|FG000|PI Comparison|Clinic site closed|1|||
17090913|NCT00084136|38231035|FG001|PI Comparison|Clinic site closed|0|||
17090914|NCT00084136|38231036|FG002|PI Comparison|Clinic site closed|0|||
17090915|NCT00084136|38231034|FG000|NRTI Comparison|Death|20|||
16868346|NCT01535261|37841418|FG000|Overall Study|Protocol Violation|3|||
17090916|NCT00084136|38231035|FG001|NRTI Comparison|Death|0|||
17090917|NCT00084136|38231036|FG002|NRTI Comparison|Death|18|||
17090918|NCT00084136|38231034|FG000|NRTI Comparison|Lost to Follow-up|14|||
17090919|NCT00084136|38231035|FG001|NRTI Comparison|Lost to Follow-up|0|||
17090920|NCT00084136|38231036|FG002|NRTI Comparison|Lost to Follow-up|12|||
17090921|NCT00084136|38231034|FG000|NRTI Comparison|Withdrawal by Subject|54|||
17090922|NCT00084136|38231035|FG001|NRTI Comparison|Withdrawal by Subject|0|||
17090923|NCT00084136|38231036|FG002|NRTI Comparison|Withdrawal by Subject|38|||
17090924|NCT00084136|38231034|FG000|NRTI Comparison|Clinic site closed|12|||
17090925|NCT00084136|38231035|FG001|NRTI Comparison|Clinic site closed|0|||
16782721|NCT02039908|37722350|FG003|Phase 2-School Year|Lost to Follow-up|3|||
16782722|NCT02039908|37722347|FG000|Phase 2-School Year|Protocol Violation|0|||
16782723|NCT02039908|37722348|FG001|Phase 2-School Year|Protocol Violation|0|||
16782724|NCT02039908|37722349|FG002|Phase 2-School Year|Protocol Violation|3|||
16782725|NCT02039908|37722350|FG003|Phase 2-School Year|Protocol Violation|0|||
16782726|NCT02039908|37722347|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
16782727|NCT02039908|37722348|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
16782728|NCT02039908|37722349|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
16782729|NCT02039908|37722350|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
16782730|NCT02058940|37722358|FG000|Overall Study|Discharged from Critical Care Unit|1|||
16782731|NCT02058628|37722364|FG000|Overall Study|Adverse Event|1|||
16782732|NCT02058628|37722365|FG001|Overall Study|Adverse Event|0|||
16782733|NCT02058628|37722364|FG000|Overall Study|Withdrawal by Subject|2|||
16782734|NCT02058628|37722365|FG001|Overall Study|Withdrawal by Subject|2|||
16998111|NCT01005251|38142024|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
16998112|NCT01005251|38142020|FG000|Overall Study|Adverse Event|2|||
16998113|NCT01005251|38142021|FG001|Overall Study|Adverse Event|6|||
16998114|NCT01005251|38142022|FG002|Overall Study|Adverse Event|8|||
16998115|NCT01005251|38142023|FG003|Overall Study|Adverse Event|5|||
16998116|NCT01005251|38142024|FG004|Overall Study|Adverse Event|4|||
16998117|NCT01005251|38142020|FG000|Overall Study|Protocol Violation|1|||
16998118|NCT01005251|38142021|FG001|Overall Study|Protocol Violation|0|||
16998119|NCT01005251|38142022|FG002|Overall Study|Protocol Violation|0|||
16998120|NCT01005251|38142023|FG003|Overall Study|Protocol Violation|0|||
16998121|NCT01005251|38142024|FG004|Overall Study|Protocol Violation|2|||
16998122|NCT01005251|38142020|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
16998123|NCT01005251|38142021|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
17090926|NCT00084136|38231036|FG002|NRTI Comparison|Clinic site closed|14|||
17090927|NCT00084136|38231034|FG000|NRTI Comparison|Not reason above|1|||
17090928|NCT00084136|38231035|FG001|NRTI Comparison|Not reason above|0|||
17090929|NCT00084136|38231036|FG002|NRTI Comparison|Not reason above|0|||
17090930|NCT03812380|38231047|FG000|Overall Study|Protocol Violation|3|||
17090931|NCT03812380|38231048|FG001|Overall Study|Protocol Violation|3|||
17090932|NCT03812380|38231047|FG000|Overall Study|Withdrawal by Subject|5|||
17090933|NCT03812380|38231048|FG001|Overall Study|Withdrawal by Subject|4|||
17090934|NCT03812380|38231047|FG000|Overall Study|Early termination of study|14|||
17090935|NCT03812380|38231048|FG001|Overall Study|Early termination of study|14|||
17090936|NCT00464945|38231056|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
17090937|NCT00464945|38231057|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
17090938|NCT00464945|38231056|FG000|Infant Series|Protocol Violation|1|||
17090939|NCT00464945|38231057|FG001|Infant Series|Protocol Violation|0|||
17090940|NCT00464945|38231056|FG000|Infant Series|Lost to Follow-up|1|||
17090941|NCT00464945|38231057|FG001|Infant Series|Lost to Follow-up|0|||
17090942|NCT00464945|38231056|FG000|After Infant Series|Withdrawal by Subject|0|||
17090943|NCT00464945|38231057|FG001|After Infant Series|Withdrawal by Subject|2|||
17090944|NCT00464945|38231056|FG000|Toddler Dose|Lost to Follow-up|0|||
17090945|NCT00464945|38231057|FG001|Toddler Dose|Lost to Follow-up|1|||
17090946|NCT00464087|38231082|FG000|Overall Study|No PCI per inclusion criteria|0|||
17090947|NCT00464087|38231083|FG001|Overall Study|No PCI per inclusion criteria|0|||
17090948|NCT00464087|38231084|FG002|Overall Study|No PCI per inclusion criteria|29|||
17090949|NCT00452699|38231094|FG000|Overall Study|Adverse Event|10|||
17090950|NCT00452699|38231095|FG001|Overall Study|Adverse Event|3|||
17090951|NCT00452699|38231094|FG000|Overall Study|Lack of Efficacy|6|||
17090952|NCT00452699|38231095|FG001|Overall Study|Lack of Efficacy|4|||
17090953|NCT00452699|38231094|FG000|Overall Study|Lost to Follow-up|6|||
17090954|NCT00452699|38231095|FG001|Overall Study|Lost to Follow-up|9|||
17090955|NCT00452699|38231094|FG000|Overall Study|Protocol Violation|21|||
17090956|NCT00452699|38231095|FG001|Overall Study|Protocol Violation|25|||
17090957|NCT00452699|38231094|FG000|Overall Study|Withdrawal by Subject|26|||
17090958|NCT00452699|38231095|FG001|Overall Study|Withdrawal by Subject|25|||
17090959|NCT00452699|38231094|FG000|Overall Study|Other|12|||
17090960|NCT00452699|38231095|FG001|Overall Study|Other|7|||
17090961|NCT00069784|38231103|FG000|Overall Study|Adverse Event|105|||
17090962|NCT00069784|38231104|FG001|Overall Study|Adverse Event|0|||
17090963|NCT00069784|38231103|FG000|Overall Study|Withdrawal by Subject|1090|||
17090964|NCT00069784|38231104|FG001|Overall Study|Withdrawal by Subject|0|||
17090965|NCT00069784|38231103|FG000|Overall Study|Other|17|||
17090966|NCT00069784|38231104|FG001|Overall Study|Other|0|||
17090967|NCT03811834|38231110|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
16782735|NCT02058628|37722364|FG000|Overall Study|Lost to Follow-up|2|||
17090968|NCT00090610|38231125|FG000|Overall Study|Withdrawal by Subject|1|||
17090969|NCT00090610|38231126|FG001|Overall Study|Withdrawal by Subject|1|||
17090970|NCT00463385|38231136|FG000|Overall Study|Other|4|||
17090971|NCT00463385|38231137|FG001|Overall Study|Other|3|||
17090972|NCT00463385|38231138|FG002|Overall Study|Other|6|||
17090973|NCT00463385|38231139|FG003|Overall Study|Other|4|||
17090974|NCT00463385|38231136|FG000|Overall Study|Adverse Event|5|||
17090975|NCT00463385|38231137|FG001|Overall Study|Adverse Event|8|||
17189141|NCT02966509|38342121|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
17189142|NCT02966509|38342120|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
17189143|NCT02966509|38342121|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
17189144|NCT02966509|38342120|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
17189145|NCT02966509|38342121|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
17189146|NCT02966353|38342127|FG000|Overall Study|Withdrawal by Subject|7|||
17189147|NCT02966353|38342127|FG000|Overall Study|Adverse Event|4|||
17189148|NCT02966353|38342127|FG000|Overall Study|Death|4|||
17189149|NCT02966353|38342127|FG000|Overall Study|Physician Decision|3|||
17189150|NCT02966353|38342127|FG000|Overall Study|Progressive disease|2|||
17189151|NCT02966353|38342127|FG000|Overall Study|Protocol deviation|2|||
17189152|NCT02965573|38342160|FG000|Overall Study|Lack of Efficacy|1|||
17189153|NCT02965573|38342161|FG001|Overall Study|Lack of Efficacy|0|||
17189154|NCT02964325|38342169|FG000|Overall Study|Lost to Follow-up|3|||
17189155|NCT02964325|38342170|FG001|Overall Study|Lost to Follow-up|3|||
17189156|NCT02964325|38342169|FG000|Overall Study|Physician Decision|5|||
17189157|NCT02964325|38342170|FG001|Overall Study|Physician Decision|4|||
17189158|NCT02964325|38342169|FG000|Overall Study|Death|1|||
17189159|NCT02964325|38342170|FG001|Overall Study|Death|3|||
17189160|NCT02964325|38342169|FG000|Overall Study|Withdrawal by Subject|2|||
17189161|NCT02964325|38342170|FG001|Overall Study|Withdrawal by Subject|1|||
17189162|NCT02964325|38342169|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
17189163|NCT02964325|38342170|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
17189164|NCT02964247|38342178|FG000|Overall Study|Lost to Follow-up|2|||
17189165|NCT02964247|38342179|FG001|Overall Study|Lost to Follow-up|0|||
17189166|NCT02964247|38342178|FG000|Overall Study|Withdrawal by Subject|1|||
17189167|NCT02964247|38342179|FG001|Overall Study|Withdrawal by Subject|2|||
17189168|NCT03654729|38342188|FG000|Overall Study|Death|9|||
17189169|NCT03654729|38342189|FG001|Overall Study|Death|9|||
17189170|NCT03654729|38342190|FG002|Overall Study|Death|16|||
17189171|NCT03654729|38342188|FG000|Overall Study|Withdrawal by Subject|8|||
17189172|NCT03654729|38342189|FG001|Overall Study|Withdrawal by Subject|6|||
17189173|NCT03654729|38342190|FG002|Overall Study|Withdrawal by Subject|4|||
17189174|NCT03654729|38342188|FG000|Overall Study|Study terminated by Sponsor|3|||
17189175|NCT03654729|38342189|FG001|Overall Study|Study terminated by Sponsor|5|||
17189176|NCT03654729|38342190|FG002|Overall Study|Study terminated by Sponsor|4|||
17189177|NCT03654729|38342188|FG000|Overall Study|Not reported|2|||
17189178|NCT03654729|38342189|FG001|Overall Study|Not reported|4|||
17189179|NCT03654729|38342190|FG002|Overall Study|Not reported|5|||
17189180|NCT03654729|38342188|FG000|Overall Study|Progressive disease|3|||
17189181|NCT03654729|38342189|FG001|Overall Study|Progressive disease|0|||
17189182|NCT03654729|38342190|FG002|Overall Study|Progressive disease|0|||
17189183|NCT03654729|38342188|FG000|Overall Study|Lost to Follow-up|2|||
17189184|NCT03654729|38342189|FG001|Overall Study|Lost to Follow-up|0|||
17189185|NCT03654729|38342190|FG002|Overall Study|Lost to Follow-up|0|||
17189186|NCT03654729|38342188|FG000|Overall Study|Physician Decision|2|||
17189187|NCT03654729|38342189|FG001|Overall Study|Physician Decision|0|||
17189188|NCT03654729|38342190|FG002|Overall Study|Physician Decision|0|||
17189189|NCT03654729|38342188|FG000|Overall Study|Protocol Violation|1|||
17189190|NCT03654729|38342189|FG001|Overall Study|Protocol Violation|1|||
17189191|NCT03654729|38342190|FG002|Overall Study|Protocol Violation|0|||
17189192|NCT03654729|38342188|FG000|Overall Study|Non-compliance with study drug|0|||
17189193|NCT03654729|38342189|FG001|Overall Study|Non-compliance with study drug|1|||
17189194|NCT03654729|38342190|FG002|Overall Study|Non-compliance with study drug|0|||
17189195|NCT03654729|38342188|FG000|Overall Study|Site terminated by Sponsor|1|||
17189196|NCT03654729|38342189|FG001|Overall Study|Site terminated by Sponsor|0|||
17189197|NCT03654729|38342190|FG002|Overall Study|Site terminated by Sponsor|0|||
17189198|NCT01377987|38342198|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
17189199|NCT01377987|38342199|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
17189200|NCT02898259|38342210|FG000|Overall Study|Adverse Event|0|||
17189201|NCT02898259|38342211|FG001|Overall Study|Adverse Event|0|||
17189202|NCT02898259|38342212|FG002|Overall Study|Adverse Event|1|||
17189203|NCT02898259|38342213|FG003|Overall Study|Adverse Event|0|||
17189204|NCT02898259|38342214|FG004|Overall Study|Adverse Event|0|||
17189205|NCT02898259|38342210|FG000|Overall Study|Lack of Efficacy|1|||
17189206|NCT02898259|38342211|FG001|Overall Study|Lack of Efficacy|1|||
17189207|NCT02898259|38342212|FG002|Overall Study|Lack of Efficacy|3|||
17189208|NCT02898259|38342213|FG003|Overall Study|Lack of Efficacy|0|||
17189209|NCT02898259|38342214|FG004|Overall Study|Lack of Efficacy|0|||
17189210|NCT02898259|38342210|FG000|Overall Study|Lost to Follow-up|0|||
17189211|NCT02898259|38342211|FG001|Overall Study|Lost to Follow-up|0|||
17189212|NCT02898259|38342212|FG002|Overall Study|Lost to Follow-up|1|||
17189213|NCT02898259|38342213|FG003|Overall Study|Lost to Follow-up|0|||
17189214|NCT02898259|38342214|FG004|Overall Study|Lost to Follow-up|0|||
17189215|NCT02898259|38342210|FG000|Overall Study|Transformation before study began|0|||
17189216|NCT02898259|38342211|FG001|Overall Study|Transformation before study began|0|||
17189217|NCT02898259|38342212|FG002|Overall Study|Transformation before study began|0|||
17189218|NCT02898259|38342213|FG003|Overall Study|Transformation before study began|1|||
17189219|NCT02898259|38342214|FG004|Overall Study|Transformation before study began|0|||
17189220|NCT02963935|38342229|FG000|Overall Study|Adverse Event|12|||
17189221|NCT02963935|38342230|FG001|Overall Study|Adverse Event|6|||
17189222|NCT02963935|38342229|FG000|Overall Study|Protocol Violation|2|||
17189223|NCT02963935|38342230|FG001|Overall Study|Protocol Violation|1|||
17189224|NCT02963935|38342229|FG000|Overall Study|Lack of Efficacy|0|||
17189225|NCT02963935|38342230|FG001|Overall Study|Lack of Efficacy|2|||
17189226|NCT02963935|38342229|FG000|Overall Study|Lost to Follow-up|1|||
17189227|NCT02963935|38342230|FG001|Overall Study|Lost to Follow-up|6|||
17189228|NCT02963935|38342229|FG000|Overall Study|Unclassified|13|||
17189229|NCT02963935|38342230|FG001|Overall Study|Unclassified|22|||
17189230|NCT02899195|38342236|FG000|Concurrent Durvalumab|Adverse Event|4|||
17189231|NCT02899195|38342236|FG000|Concurrent Durvalumab|Physician Decision|1|||
17189232|NCT02899195|38342236|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
17189233|NCT02899195|38342236|FG000|Concurrent Durvalumab|Progressive Disease|5|||
17189234|NCT02899195|38342236|FG000|Maintenance Durvalumab|Adverse Event|1|||
17189235|NCT02899195|38342236|FG000|Maintenance Durvalumab|Physician Decision|1|||
17189236|NCT02899195|38342236|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
17189237|NCT02899195|38342236|FG000|Maintenance Durvalumab|Progressive Disease|31|||
17189238|NCT02963701|38342242|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
17189239|NCT02963701|38342243|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
17189240|NCT01345591|38342249|FG000|Overall Study|Lost to Follow-up|1|||
17189241|NCT02961751|38342258|FG000|Overall Study|Lost to Follow-up|11|||
17189242|NCT02961751|38342258|FG000|Overall Study|Physician Decision|2|||
17189243|NCT02961751|38342258|FG000|Overall Study|Not Eligible at Enrollment|1|||
17189244|NCT02961751|38342258|FG000|Overall Study|Protocol Violation|1|||
17189245|NCT02963311|38342262|FG000|Overall Study|Withdrawal by Subject|1|||
17189246|NCT02963311|38342262|FG000|Overall Study|Screen Failure|4|||
17189247|NCT02962765|38342266|FG000|Overall Study|Protocol Violation|9|||
17189248|NCT02962765|38342266|FG000|Overall Study|Withdrawal by Subject|3|||
17189249|NCT02962765|38342266|FG000|Overall Study|Lost to Follow-up|1|||
17189250|NCT02962765|38342266|FG000|Overall Study|Death|1|||
17189251|NCT02962765|38342266|FG000|Overall Study|Limited access to study medication|3|||
17189252|NCT02362035|38342277|FG000|Overall Study|Death|67|||
17189253|NCT02362035|38342277|FG000|Overall Study|Lost to Follow-up|3|||
17189254|NCT02362035|38342277|FG000|Overall Study|Adverse Event|1|||
17189255|NCT02362035|38342277|FG000|Overall Study|Physician Decision|1|||
17189256|NCT02362035|38342277|FG000|Overall Study|Subject started another cancer therapy|10|||
17189257|NCT02362035|38342277|FG000|Overall Study|Study terminated by sponsor|45|||
17189258|NCT02362035|38342277|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
17189259|NCT02362035|38342277|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
17189260|NCT02362035|38342277|FG000|Overall Study|Disease progression|11|||
17189261|NCT02362035|38342277|FG000|Overall Study|Withdrawal by Subject|20|||
17189262|NCT02960893|38342283|FG000|Randomization Phase (8-week)|Adverse Event|5|||
17189263|NCT02960893|38342284|FG001|Randomization Phase (8-week)|Adverse Event|0|||
17189264|NCT02960893|38342283|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
17189265|NCT02960893|38342284|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
17189266|NCT02960893|38342283|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
17189267|NCT02960893|38342284|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
17189268|NCT02960893|38342283|FG000|Extension Phase (48-week)|Adverse Event|2|||
17189269|NCT02960893|38342284|FG001|Extension Phase (48-week)|Adverse Event|3|||
17189270|NCT02960893|38342283|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
17189271|NCT02960893|38342284|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
17189272|NCT02960893|38342283|FG000|Extension Phase (48-week)|Other Reason|2|||
17189273|NCT02960893|38342284|FG001|Extension Phase (48-week)|Other Reason|1|||
17189274|NCT02960893|38342283|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
17189275|NCT02960893|38342284|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
17189276|NCT02960893|38342283|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
17189277|NCT02960893|38342284|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
17189278|NCT00965757|38342299|FG000|Double-blind Phase|Progression of concomitant disease|1|||
17189279|NCT00965757|38342300|FG001|Double-blind Phase|Progression of concomitant disease|2|||
17189280|NCT00965757|38342301|FG002|Double-blind Phase|Progression of concomitant disease|0|||
17189281|NCT00965757|38342302|FG003|Double-blind Phase|Progression of concomitant disease|0|||
17189282|NCT00965757|38342299|FG000|Double-blind Phase|Adverse drug reaction|2|||
17189283|NCT00965757|38342300|FG001|Double-blind Phase|Adverse drug reaction|1|||
17189284|NCT00965757|38342301|FG002|Double-blind Phase|Adverse drug reaction|0|||
17189285|NCT00965757|38342302|FG003|Double-blind Phase|Adverse drug reaction|0|||
17189286|NCT00965757|38342299|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
17189287|NCT00965757|38342300|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
17189288|NCT00965757|38342301|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
17189289|NCT00965757|38342302|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
17189290|NCT00965757|38342299|FG000|Double-blind Phase|Lack of Efficacy|7|||
16782736|NCT02058628|37722365|FG001|Overall Study|Lost to Follow-up|4|||
17189291|NCT00965757|38342300|FG001|Double-blind Phase|Lack of Efficacy|11|||
17189292|NCT00965757|38342301|FG002|Double-blind Phase|Lack of Efficacy|0|||
17189293|NCT00965757|38342302|FG003|Double-blind Phase|Lack of Efficacy|0|||
17189294|NCT00965757|38342299|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
17189295|NCT00965757|38342300|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
17090976|NCT00463385|38231138|FG002|Overall Study|Adverse Event|4|||
17090977|NCT00463385|38231139|FG003|Overall Study|Adverse Event|2|||
17090978|NCT00463385|38231136|FG000|Overall Study|Lack of Efficacy|6|||
17090979|NCT00463385|38231137|FG001|Overall Study|Lack of Efficacy|6|||
17090980|NCT00463385|38231138|FG002|Overall Study|Lack of Efficacy|7|||
17090981|NCT00463385|38231139|FG003|Overall Study|Lack of Efficacy|9|||
17090982|NCT00463385|38231136|FG000|Overall Study|Withdrawal by Subject|3|||
17090983|NCT00463385|38231137|FG001|Overall Study|Withdrawal by Subject|3|||
17090984|NCT00463385|38231138|FG002|Overall Study|Withdrawal by Subject|3|||
17090985|NCT00463385|38231139|FG003|Overall Study|Withdrawal by Subject|4|||
17090986|NCT00463385|38231136|FG000|Overall Study|Lost to Follow-up|0|||
17090987|NCT00463385|38231137|FG001|Overall Study|Lost to Follow-up|0|||
17090988|NCT00463385|38231138|FG002|Overall Study|Lost to Follow-up|0|||
17090989|NCT00463385|38231139|FG003|Overall Study|Lost to Follow-up|1|||
17090990|NCT00463385|38231136|FG000|Overall Study|Death|2|||
17090991|NCT00463385|38231137|FG001|Overall Study|Death|1|||
17090992|NCT00463385|38231138|FG002|Overall Study|Death|2|||
17090993|NCT00463385|38231139|FG003|Overall Study|Death|0|||
17090994|NCT00463385|38231136|FG000|Overall Study|Missing|2|||
17090995|NCT00463385|38231137|FG001|Overall Study|Missing|0|||
17090996|NCT00463385|38231138|FG002|Overall Study|Missing|0|||
17090997|NCT00463385|38231139|FG003|Overall Study|Missing|2|||
17090998|NCT00463385|38231136|FG000|Overall Study|1 participant received commercial drug|0|||
17090999|NCT00463385|38231137|FG001|Overall Study|1 participant received commercial drug|1|||
17091000|NCT00463385|38231138|FG002|Overall Study|1 participant received commercial drug|0|||
17091001|NCT00463385|38231139|FG003|Overall Study|1 participant received commercial drug|0|||
17091002|NCT00463229|38231159|FG000|Overall Study|Lost to Follow-up|5|||
17091003|NCT00463229|38231160|FG001|Overall Study|Lost to Follow-up|7|||
17091004|NCT00463229|38231159|FG000|Overall Study|Death|4|||
17091005|NCT00463229|38231160|FG001|Overall Study|Death|3|||
17091006|NCT03839693|38231170|FG000|Overall Study|Lost to Follow-up|0|||
17091007|NCT03839693|38231171|FG001|Overall Study|Lost to Follow-up|2|||
17091008|NCT03839693|38231172|FG002|Overall Study|Lost to Follow-up|2|||
17091009|NCT03839693|38231170|FG000|Overall Study|Withdrawal by Subject|1|||
17091010|NCT03839693|38231171|FG001|Overall Study|Withdrawal by Subject|0|||
17091011|NCT03839693|38231172|FG002|Overall Study|Withdrawal by Subject|2|||
17091012|NCT03839693|38231170|FG000|Overall Study|subject moved out of the area|1|||
17091013|NCT03839693|38231171|FG001|Overall Study|subject moved out of the area|0|||
17091014|NCT03839693|38231172|FG002|Overall Study|subject moved out of the area|0|||
17091015|NCT00068692|38231185|FG000|Step 1: Registration|Disese progression/relapse|5|||
17091016|NCT00068692|38231186|FG001|Step 1: Registration|Disese progression/relapse|0|||
17091017|NCT00068692|38231187|FG002|Step 1: Registration|Disese progression/relapse|0|||
17091018|NCT00068692|38231188|FG003|Step 1: Registration|Disese progression/relapse|0|||
17091019|NCT00068692|38231189|FG004|Step 1: Registration|Disese progression/relapse|0|||
17091020|NCT00068692|38231190|FG005|Step 1: Registration|Disese progression/relapse|0|||
17091021|NCT00068692|38231191|FG006|Step 1: Registration|Disese progression/relapse|0|||
17091022|NCT00068692|38231192|FG007|Step 1: Registration|Disese progression/relapse|0|||
17091023|NCT00068692|38231185|FG000|Step 1: Registration|Adverse Event|7|||
17091024|NCT00068692|38231186|FG001|Step 1: Registration|Adverse Event|0|||
17091025|NCT00068692|38231187|FG002|Step 1: Registration|Adverse Event|0|||
17091026|NCT00068692|38231188|FG003|Step 1: Registration|Adverse Event|0|||
17091027|NCT00068692|38231189|FG004|Step 1: Registration|Adverse Event|0|||
17091028|NCT00068692|38231190|FG005|Step 1: Registration|Adverse Event|0|||
17091029|NCT00068692|38231191|FG006|Step 1: Registration|Adverse Event|0|||
17091030|NCT00068692|38231192|FG007|Step 1: Registration|Adverse Event|0|||
17091031|NCT00068692|38231185|FG000|Step 1: Registration|Death|1|||
17091032|NCT00068692|38231186|FG001|Step 1: Registration|Death|0|||
17091033|NCT00068692|38231187|FG002|Step 1: Registration|Death|0|||
17091034|NCT00068692|38231188|FG003|Step 1: Registration|Death|0|||
17091035|NCT00068692|38231189|FG004|Step 1: Registration|Death|0|||
17091036|NCT00068692|38231190|FG005|Step 1: Registration|Death|0|||
17091037|NCT00068692|38231191|FG006|Step 1: Registration|Death|0|||
17091038|NCT00068692|38231192|FG007|Step 1: Registration|Death|0|||
17091039|NCT00068692|38231185|FG000|Step 1: Registration|Withdrawal by Subject|11|||
17091040|NCT00068692|38231186|FG001|Step 1: Registration|Withdrawal by Subject|0|||
17091041|NCT00068692|38231187|FG002|Step 1: Registration|Withdrawal by Subject|0|||
17091042|NCT00068692|38231188|FG003|Step 1: Registration|Withdrawal by Subject|0|||
17091043|NCT00068692|38231189|FG004|Step 1: Registration|Withdrawal by Subject|0|||
17091044|NCT00068692|38231190|FG005|Step 1: Registration|Withdrawal by Subject|0|||
17091045|NCT00068692|38231191|FG006|Step 1: Registration|Withdrawal by Subject|0|||
17091046|NCT00068692|38231192|FG007|Step 1: Registration|Withdrawal by Subject|0|||
17189296|NCT00965757|38342301|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
17189297|NCT00965757|38342302|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
17189298|NCT00965757|38342299|FG000|Double-blind Phase|Lost to Follow-up|0|||
17189299|NCT00965757|38342300|FG001|Double-blind Phase|Lost to Follow-up|1|||
17189300|NCT00965757|38342301|FG002|Double-blind Phase|Lost to Follow-up|0|||
17189301|NCT00965757|38342302|FG003|Double-blind Phase|Lost to Follow-up|0|||
17189302|NCT00965757|38342299|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
17189303|NCT00965757|38342300|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
17189304|NCT00965757|38342301|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
17189305|NCT00965757|38342302|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
17189306|NCT00965757|38342299|FG000|Double-blind Phase|Other|1|||
17189307|NCT00965757|38342300|FG001|Double-blind Phase|Other|0|||
17091047|NCT00068692|38231185|FG000|Step 1: Registration|Alternative therapy|2|||
17091048|NCT00068692|38231186|FG001|Step 1: Registration|Alternative therapy|0|||
17091049|NCT00068692|38231187|FG002|Step 1: Registration|Alternative therapy|0|||
17091050|NCT00068692|38231188|FG003|Step 1: Registration|Alternative therapy|0|||
17091051|NCT00068692|38231189|FG004|Step 1: Registration|Alternative therapy|0|||
17091052|NCT00068692|38231190|FG005|Step 1: Registration|Alternative therapy|0|||
17091053|NCT00068692|38231191|FG006|Step 1: Registration|Alternative therapy|0|||
17091054|NCT00068692|38231192|FG007|Step 1: Registration|Alternative therapy|0|||
17189308|NCT00965757|38342301|FG002|Double-blind Phase|Other|0|||
17189309|NCT00965757|38342302|FG003|Double-blind Phase|Other|0|||
16868347|NCT01535261|37841418|FG000|Overall Study|Death|5|||
16998124|NCT01005251|38142022|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
16998125|NCT01005251|38142023|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
16998126|NCT01005251|38142024|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
16998127|NCT01005251|38142020|FG000|Overall Study|Lost to Follow-up|1|||
16998128|NCT01005251|38142021|FG001|Overall Study|Lost to Follow-up|4|||
16998129|NCT01005251|38142022|FG002|Overall Study|Lost to Follow-up|2|||
16998130|NCT01005251|38142023|FG003|Overall Study|Lost to Follow-up|0|||
16998131|NCT01005251|38142024|FG004|Overall Study|Lost to Follow-up|0|||
16998132|NCT01005251|38142020|FG000|Overall Study|Physician Decision|0|||
16998133|NCT01005251|38142021|FG001|Overall Study|Physician Decision|0|||
16998134|NCT01005251|38142022|FG002|Overall Study|Physician Decision|0|||
16998135|NCT01005251|38142023|FG003|Overall Study|Physician Decision|0|||
16998136|NCT01005251|38142024|FG004|Overall Study|Physician Decision|2|||
16998137|NCT01005251|38142020|FG000|Overall Study|Patient moved|1|||
16998138|NCT01005251|38142021|FG001|Overall Study|Patient moved|0|||
16998139|NCT01005251|38142022|FG002|Overall Study|Patient moved|0|||
16998140|NCT01005251|38142023|FG003|Overall Study|Patient moved|0|||
16998141|NCT01005251|38142024|FG004|Overall Study|Patient moved|0|||
16998142|NCT01005251|38142020|FG000|Overall Study|Wrong drug dispensed|0|||
16998143|NCT01005251|38142021|FG001|Overall Study|Wrong drug dispensed|1|||
16998144|NCT01005251|38142022|FG002|Overall Study|Wrong drug dispensed|0|||
16998145|NCT01005251|38142023|FG003|Overall Study|Wrong drug dispensed|0|||
16998146|NCT01005251|38142024|FG004|Overall Study|Wrong drug dispensed|0|||
16998147|NCT01005251|38142020|FG000|Overall Study|Randomized in error|0|||
16998148|NCT01005251|38142021|FG001|Overall Study|Randomized in error|0|||
16998149|NCT01005251|38142022|FG002|Overall Study|Randomized in error|1|||
16998150|NCT01005251|38142023|FG003|Overall Study|Randomized in error|1|||
16998151|NCT01005251|38142024|FG004|Overall Study|Randomized in error|0|||
16998152|NCT01005251|38142020|FG000|Overall Study|Lack of Efficacy|0|||
16998153|NCT01005251|38142021|FG001|Overall Study|Lack of Efficacy|0|||
16998154|NCT01005251|38142022|FG002|Overall Study|Lack of Efficacy|1|||
16998155|NCT01005251|38142023|FG003|Overall Study|Lack of Efficacy|1|||
16998156|NCT01005251|38142024|FG004|Overall Study|Lack of Efficacy|0|||
16998157|NCT03048578|38142038|FG000|Overall Study|Withdrawal by Subject|5|||
16998158|NCT03048578|38142039|FG001|Overall Study|Withdrawal by Subject|6|||
16998159|NCT03048578|38142038|FG000|Overall Study|Lost to Follow-up|22|||
16998160|NCT03048578|38142039|FG001|Overall Study|Lost to Follow-up|10|||
16998161|NCT03048578|38142038|FG000|Overall Study|Adverse Event|1|||
16998162|NCT03048578|38142039|FG001|Overall Study|Adverse Event|2|||
16998163|NCT03048578|38142038|FG000|Overall Study|Terminated|3|||
16998164|NCT03048578|38142039|FG001|Overall Study|Terminated|2|||
16998165|NCT01008449|38142047|FG000|Overall Study|Lost to Follow-up|29|||
16998166|NCT01008449|38142048|FG001|Overall Study|Lost to Follow-up|19|||
16998167|NCT00696241|38142059|FG000|Overall Study|Adverse Event|11|||
16868348|NCT01535261|37841418|FG000|Overall Study|Lost to Follow-up|8|||
16998168|NCT00696241|38142060|FG001|Overall Study|Adverse Event|3|||
16998169|NCT00696241|38142061|FG002|Overall Study|Adverse Event|6|||
16998170|NCT00696241|38142062|FG003|Overall Study|Adverse Event|4|||
16998171|NCT00696241|38142063|FG004|Overall Study|Adverse Event|5|||
16998172|NCT00696241|38142059|FG000|Overall Study|Protocol Violation|1|||
16998173|NCT00696241|38142060|FG001|Overall Study|Protocol Violation|1|||
16998174|NCT00696241|38142061|FG002|Overall Study|Protocol Violation|2|||
17091055|NCT00068692|38231185|FG000|Step 1: Registration|Complicating disease|2|||
17091056|NCT00068692|38231186|FG001|Step 1: Registration|Complicating disease|0|||
17091057|NCT00068692|38231187|FG002|Step 1: Registration|Complicating disease|0|||
17189310|NCT00965757|38342299|FG000|Extension Phase|Progression of concomitant disease|0|||
17189311|NCT00965757|38342300|FG001|Extension Phase|Progression of concomitant disease|0|||
17189312|NCT00965757|38342301|FG002|Extension Phase|Progression of concomitant disease|4|||
17189313|NCT00965757|38342302|FG003|Extension Phase|Progression of concomitant disease|2|||
17189314|NCT00965757|38342299|FG000|Extension Phase|Adverse drug reaction|0|||
17189315|NCT00965757|38342300|FG001|Extension Phase|Adverse drug reaction|0|||
17189316|NCT00965757|38342301|FG002|Extension Phase|Adverse drug reaction|6|||
17189317|NCT00965757|38342302|FG003|Extension Phase|Adverse drug reaction|3|||
17189318|NCT00965757|38342299|FG000|Extension Phase|Abnormal Laboratory Value|0|||
17189319|NCT00965757|38342300|FG001|Extension Phase|Abnormal Laboratory Value|0|||
17189320|NCT00965757|38342301|FG002|Extension Phase|Abnormal Laboratory Value|6|||
17189321|NCT00965757|38342302|FG003|Extension Phase|Abnormal Laboratory Value|1|||
17189322|NCT00965757|38342299|FG000|Extension Phase|Lack of Efficacy|0|||
17189323|NCT00965757|38342300|FG001|Extension Phase|Lack of Efficacy|0|||
17189324|NCT00965757|38342301|FG002|Extension Phase|Lack of Efficacy|8|||
17189325|NCT00965757|38342302|FG003|Extension Phase|Lack of Efficacy|12|||
17189326|NCT00965757|38342299|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
17189327|NCT00965757|38342300|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
17189328|NCT00965757|38342301|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
17189329|NCT00965757|38342302|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
17189330|NCT00965757|38342299|FG000|Extension Phase|Lost to Follow-up|0|||
17189331|NCT00965757|38342300|FG001|Extension Phase|Lost to Follow-up|0|||
17189332|NCT00965757|38342301|FG002|Extension Phase|Lost to Follow-up|0|||
17189333|NCT00965757|38342302|FG003|Extension Phase|Lost to Follow-up|1|||
17189334|NCT00965757|38342299|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
17189335|NCT00965757|38342300|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
17189336|NCT00965757|38342301|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
17189337|NCT00965757|38342302|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
17189338|NCT00965757|38342299|FG000|Extension Phase|Protocol Violation|0|||
17189339|NCT00965757|38342300|FG001|Extension Phase|Protocol Violation|0|||
17189340|NCT00965757|38342301|FG002|Extension Phase|Protocol Violation|0|||
17189341|NCT00965757|38342302|FG003|Extension Phase|Protocol Violation|1|||
17189342|NCT00965757|38342299|FG000|Extension Phase|Other|0|||
17189343|NCT00965757|38342300|FG001|Extension Phase|Other|0|||
17189344|NCT00965757|38342301|FG002|Extension Phase|Other|2|||
17189345|NCT00965757|38342302|FG003|Extension Phase|Other|1|||
17189346|NCT03072459|38342310|FG000|Overall Study|Device revised/removed|1|||
17189347|NCT03072459|38342310|FG000|Overall Study|Subject not able to return|1|||
17189348|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
17189349|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
17189350|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
17189351|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
17189352|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
17189353|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
17189354|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
17189355|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
17189356|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
17189357|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
17189358|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
17189359|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
17189360|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
17189361|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
17189362|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
17189363|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
17189364|NCT01067521|38342316|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
17189365|NCT01067521|38342317|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
16868349|NCT01535261|37841418|FG000|Overall Study|Withdrawal by Subject|14|||
16998175|NCT00696241|38142062|FG003|Overall Study|Protocol Violation|0|||
16998176|NCT00696241|38142063|FG004|Overall Study|Protocol Violation|3|||
17091058|NCT00068692|38231188|FG003|Step 1: Registration|Complicating disease|0|||
17091059|NCT00068692|38231189|FG004|Step 1: Registration|Complicating disease|0|||
17091060|NCT00068692|38231190|FG005|Step 1: Registration|Complicating disease|0|||
17091061|NCT00068692|38231191|FG006|Step 1: Registration|Complicating disease|0|||
17091062|NCT00068692|38231192|FG007|Step 1: Registration|Complicating disease|0|||
17091063|NCT00068692|38231185|FG000|Step 1: Registration|Protocol Violation|1|||
17091064|NCT00068692|38231186|FG001|Step 1: Registration|Protocol Violation|0|||
17091065|NCT00068692|38231187|FG002|Step 1: Registration|Protocol Violation|0|||
17091066|NCT00068692|38231188|FG003|Step 1: Registration|Protocol Violation|0|||
17091067|NCT00068692|38231189|FG004|Step 1: Registration|Protocol Violation|0|||
17091068|NCT00068692|38231190|FG005|Step 1: Registration|Protocol Violation|0|||
17091069|NCT00068692|38231191|FG006|Step 1: Registration|Protocol Violation|0|||
17091070|NCT00068692|38231192|FG007|Step 1: Registration|Protocol Violation|0|||
17091071|NCT00068692|38231185|FG000|Step 1: Registration|Not eligible|6|||
17091072|NCT00068692|38231186|FG001|Step 1: Registration|Not eligible|0|||
17091073|NCT00068692|38231187|FG002|Step 1: Registration|Not eligible|0|||
17091074|NCT00068692|38231188|FG003|Step 1: Registration|Not eligible|0|||
17091075|NCT00068692|38231189|FG004|Step 1: Registration|Not eligible|0|||
17091076|NCT00068692|38231190|FG005|Step 1: Registration|Not eligible|0|||
17091077|NCT00068692|38231191|FG006|Step 1: Registration|Not eligible|0|||
17091078|NCT00068692|38231192|FG007|Step 1: Registration|Not eligible|0|||
17091079|NCT00068692|38231185|FG000|Step 1: Registration|Other|2|||
17091080|NCT00068692|38231186|FG001|Step 1: Registration|Other|0|||
17091081|NCT00068692|38231187|FG002|Step 1: Registration|Other|0|||
17091082|NCT00068692|38231188|FG003|Step 1: Registration|Other|0|||
17091083|NCT00068692|38231189|FG004|Step 1: Registration|Other|0|||
17091084|NCT00068692|38231190|FG005|Step 1: Registration|Other|0|||
17091085|NCT00068692|38231191|FG006|Step 1: Registration|Other|0|||
17091086|NCT00068692|38231192|FG007|Step 1: Registration|Other|0|||
17091087|NCT00068692|38231185|FG000|Step 1: Registration|Not start protocol therapy|3|||
17091088|NCT00068692|38231186|FG001|Step 1: Registration|Not start protocol therapy|0|||
17091089|NCT00068692|38231187|FG002|Step 1: Registration|Not start protocol therapy|0|||
17091090|NCT00068692|38231188|FG003|Step 1: Registration|Not start protocol therapy|0|||
17091091|NCT00068692|38231189|FG004|Step 1: Registration|Not start protocol therapy|0|||
17091092|NCT00068692|38231190|FG005|Step 1: Registration|Not start protocol therapy|0|||
17091093|NCT00068692|38231191|FG006|Step 1: Registration|Not start protocol therapy|0|||
17091094|NCT00068692|38231192|FG007|Step 1: Registration|Not start protocol therapy|0|||
17091095|NCT00068692|38231185|FG000|Step 1: Registration|Registered but not randomized|0|||
17091096|NCT00068692|38231186|FG001|Step 1: Registration|Registered but not randomized|1|||
17091097|NCT00068692|38231187|FG002|Step 1: Registration|Registered but not randomized|0|||
17091098|NCT00068692|38231188|FG003|Step 1: Registration|Registered but not randomized|0|||
17189366|NCT01067521|38342316|FG000|Open-Label Period|Death|3|||
17189367|NCT01067521|38342317|FG001|Open-Label Period|Death|1|||
17189368|NCT01067521|38342316|FG000|Open-Label Period|Adverse Event|30|||
17189369|NCT01067521|38342317|FG001|Open-Label Period|Adverse Event|28|||
17091099|NCT00068692|38231189|FG004|Step 1: Registration|Registered but not randomized|0|||
17091100|NCT00068692|38231190|FG005|Step 1: Registration|Registered but not randomized|0|||
17091101|NCT00068692|38231191|FG006|Step 1: Registration|Registered but not randomized|0|||
17091102|NCT00068692|38231192|FG007|Step 1: Registration|Registered but not randomized|0|||
17091103|NCT00068692|38231185|FG000|Step 2: Randomization|Disesae progression/replase|0|||
17091104|NCT00068692|38231186|FG001|Step 2: Randomization|Disesae progression/replase|0|||
17091105|NCT00068692|38231187|FG002|Step 2: Randomization|Disesae progression/replase|1|||
17091106|NCT00068692|38231188|FG003|Step 2: Randomization|Disesae progression/replase|1|||
17091107|NCT00068692|38231189|FG004|Step 2: Randomization|Disesae progression/replase|0|||
17091108|NCT00068692|38231190|FG005|Step 2: Randomization|Disesae progression/replase|0|||
17091109|NCT00068692|38231191|FG006|Step 2: Randomization|Disesae progression/replase|0|||
17091110|NCT00068692|38231192|FG007|Step 2: Randomization|Disesae progression/replase|0|||
17091111|NCT00068692|38231185|FG000|Step 2: Randomization|Adverse Event|0|||
17091112|NCT00068692|38231186|FG001|Step 2: Randomization|Adverse Event|0|||
17091113|NCT00068692|38231187|FG002|Step 2: Randomization|Adverse Event|4|||
17091114|NCT00068692|38231188|FG003|Step 2: Randomization|Adverse Event|2|||
17091115|NCT00068692|38231189|FG004|Step 2: Randomization|Adverse Event|2|||
17091116|NCT00068692|38231190|FG005|Step 2: Randomization|Adverse Event|3|||
17091117|NCT00068692|38231191|FG006|Step 2: Randomization|Adverse Event|4|||
17189370|NCT01067521|38342316|FG000|Open-Label Period|Withdrawal by Subject|160|||
17189371|NCT01067521|38342317|FG001|Open-Label Period|Withdrawal by Subject|88|||
17189372|NCT01067521|38342316|FG000|Open-Label Period|Physician Decision|13|||
17189373|NCT01067521|38342317|FG001|Open-Label Period|Physician Decision|11|||
17091118|NCT00068692|38231192|FG007|Step 2: Randomization|Adverse Event|4|||
17091119|NCT00068692|38231185|FG000|Step 2: Randomization|Death|0|||
17091120|NCT00068692|38231186|FG001|Step 2: Randomization|Death|0|||
17091121|NCT00068692|38231187|FG002|Step 2: Randomization|Death|0|||
17091122|NCT00068692|38231188|FG003|Step 2: Randomization|Death|0|||
17091123|NCT00068692|38231189|FG004|Step 2: Randomization|Death|1|||
17091124|NCT00068692|38231190|FG005|Step 2: Randomization|Death|0|||
17091125|NCT00068692|38231191|FG006|Step 2: Randomization|Death|0|||
17091126|NCT00068692|38231192|FG007|Step 2: Randomization|Death|1|||
17091127|NCT00068692|38231185|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
17091128|NCT00068692|38231186|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
17091129|NCT00068692|38231187|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
17091130|NCT00068692|38231188|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
17091131|NCT00068692|38231189|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
17091132|NCT00068692|38231190|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
17091133|NCT00068692|38231191|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
17091134|NCT00068692|38231192|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
17091135|NCT00068692|38231185|FG000|Step 2: Randomization|alternative therapy|0|||
17091136|NCT00068692|38231186|FG001|Step 2: Randomization|alternative therapy|0|||
17189374|NCT01067521|38342316|FG000|Open-Label Period|Non-compliance with study drug|5|||
17189375|NCT01067521|38342317|FG001|Open-Label Period|Non-compliance with study drug|0|||
17189376|NCT01067521|38342316|FG000|Open-Label Period|Protocol Violation|3|||
17189377|NCT01067521|38342317|FG001|Open-Label Period|Protocol Violation|0|||
17189378|NCT01067521|38342316|FG000|Open-Label Period|Pregnancy|14|||
17189379|NCT01067521|38342317|FG001|Open-Label Period|Pregnancy|8|||
17189380|NCT01067521|38342316|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
17189381|NCT01067521|38342317|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
17189382|NCT01067521|38342316|FG000|Open-Label Period|Lost to Follow-up|21|||
17189383|NCT01067521|38342317|FG001|Open-Label Period|Lost to Follow-up|20|||
17189384|NCT02735577|38342328|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
17189385|NCT02735577|38342328|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
17189386|NCT01345123|38342335|FG000|Overall Study|participants no longer with health plan|79|||
17189387|NCT01345123|38342336|FG001|Overall Study|participants no longer with health plan|85|||
17189388|NCT01345123|38342337|FG002|Overall Study|participants no longer with health plan|88|||
17189389|NCT02735421|38342346|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
17189390|NCT02735421|38342346|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
17189391|NCT02735421|38342346|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
17189392|NCT02735421|38342346|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
17189393|NCT02735421|38342346|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
17189394|NCT02735421|38342346|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
17189395|NCT02735421|38342346|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
17189396|NCT02983799|38342363|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
17189397|NCT02983799|38342364|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
17189398|NCT02983799|38342365|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
17189399|NCT02983799|38342366|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
17189400|NCT02983799|38342367|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
17189401|NCT02983799|38342363|FG000|Overall Study|Death|20|||
17189402|NCT02983799|38342364|FG001|Overall Study|Death|5|||
17189403|NCT02983799|38342365|FG002|Overall Study|Death|23|||
17189404|NCT02983799|38342366|FG003|Overall Study|Death|47|||
17189405|NCT02983799|38342367|FG004|Overall Study|Death|7|||
17189406|NCT02983799|38342363|FG000|Overall Study|Withdrawal by Subject|1|||
17189407|NCT02983799|38342364|FG001|Overall Study|Withdrawal by Subject|0|||
16782737|NCT02058628|37722364|FG000|Overall Study|Not in time schedule|0|||
16782738|NCT02058628|37722365|FG001|Overall Study|Not in time schedule|1|||
16782739|NCT02058628|37722364|FG000|Overall Study|The visit date was not in timeline|0|||
17091137|NCT00068692|38231187|FG002|Step 2: Randomization|alternative therapy|0|||
17091138|NCT00068692|38231188|FG003|Step 2: Randomization|alternative therapy|1|||
17091139|NCT00068692|38231189|FG004|Step 2: Randomization|alternative therapy|1|||
17091140|NCT00068692|38231190|FG005|Step 2: Randomization|alternative therapy|0|||
17091141|NCT00068692|38231191|FG006|Step 2: Randomization|alternative therapy|0|||
17091142|NCT00068692|38231192|FG007|Step 2: Randomization|alternative therapy|0|||
17091143|NCT00068692|38231185|FG000|Step 2: Randomization|Physician Decision|0|||
17091144|NCT00068692|38231186|FG001|Step 2: Randomization|Physician Decision|0|||
17091145|NCT00068692|38231187|FG002|Step 2: Randomization|Physician Decision|0|||
17091146|NCT00068692|38231188|FG003|Step 2: Randomization|Physician Decision|1|||
17091147|NCT00068692|38231189|FG004|Step 2: Randomization|Physician Decision|1|||
17091148|NCT00068692|38231190|FG005|Step 2: Randomization|Physician Decision|0|||
17091149|NCT00068692|38231191|FG006|Step 2: Randomization|Physician Decision|0|||
17091150|NCT00068692|38231192|FG007|Step 2: Randomization|Physician Decision|0|||
17091151|NCT00068692|38231185|FG000|Step 2: Randomization|Other|0|||
17091152|NCT00068692|38231186|FG001|Step 2: Randomization|Other|0|||
17091153|NCT00068692|38231187|FG002|Step 2: Randomization|Other|0|||
17091154|NCT00068692|38231188|FG003|Step 2: Randomization|Other|1|||
17091155|NCT00068692|38231189|FG004|Step 2: Randomization|Other|0|||
17091156|NCT00068692|38231190|FG005|Step 2: Randomization|Other|1|||
17091157|NCT00068692|38231191|FG006|Step 2: Randomization|Other|0|||
17091158|NCT00068692|38231192|FG007|Step 2: Randomization|Other|0|||
17091159|NCT00068692|38231185|FG000|Step 2: Randomization|never start protocol therapy|0|||
17091160|NCT00068692|38231186|FG001|Step 2: Randomization|never start protocol therapy|0|||
17091161|NCT00068692|38231187|FG002|Step 2: Randomization|never start protocol therapy|1|||
17091162|NCT00068692|38231188|FG003|Step 2: Randomization|never start protocol therapy|0|||
17091163|NCT00068692|38231189|FG004|Step 2: Randomization|never start protocol therapy|1|||
17091164|NCT00068692|38231190|FG005|Step 2: Randomization|never start protocol therapy|0|||
17091165|NCT00068692|38231191|FG006|Step 2: Randomization|never start protocol therapy|0|||
17091166|NCT00068692|38231192|FG007|Step 2: Randomization|never start protocol therapy|0|||
17091167|NCT00463151|38231209|FG000|Overall Study|Adverse Event|0|||
17091168|NCT00463151|38231210|FG001|Overall Study|Adverse Event|0|||
17189408|NCT02983799|38342365|FG002|Overall Study|Withdrawal by Subject|3|||
17189409|NCT02983799|38342366|FG003|Overall Study|Withdrawal by Subject|4|||
17091169|NCT00463151|38231211|FG002|Overall Study|Adverse Event|1|||
17091170|NCT00463151|38231212|FG003|Overall Study|Adverse Event|0|||
17091171|NCT00463151|38231209|FG000|Overall Study|Lack of Efficacy|2|||
17091172|NCT00463151|38231210|FG001|Overall Study|Lack of Efficacy|5|||
17091173|NCT00463151|38231211|FG002|Overall Study|Lack of Efficacy|2|||
17091174|NCT00463151|38231212|FG003|Overall Study|Lack of Efficacy|5|||
17091175|NCT00463151|38231209|FG000|Overall Study|Protocol Violation|0|||
17091176|NCT00463151|38231210|FG001|Overall Study|Protocol Violation|0|||
17091177|NCT00463151|38231211|FG002|Overall Study|Protocol Violation|0|||
17091178|NCT00463151|38231212|FG003|Overall Study|Protocol Violation|1|||
17091179|NCT00463151|38231209|FG000|Overall Study|Withdrawal by Subject|0|||
17091180|NCT00463151|38231210|FG001|Overall Study|Withdrawal by Subject|0|||
17091181|NCT00463151|38231211|FG002|Overall Study|Withdrawal by Subject|0|||
17091182|NCT00463151|38231212|FG003|Overall Study|Withdrawal by Subject|1|||
17091183|NCT00068380|38231222|FG000|Overall Study|Withdrawal by Subject|3|||
17091184|NCT00068380|38231222|FG000|Overall Study|Adverse Event|2|||
17091185|NCT00067990|38231228|FG000|Overall Study|Death|5|||
17091186|NCT00067990|38231229|FG001|Overall Study|Death|7|||
17091187|NCT00067990|38231228|FG000|Overall Study|ESRD, Non IF/TA|1|||
17091188|NCT00067990|38231229|FG001|Overall Study|ESRD, Non IF/TA|3|||
17091189|NCT00067990|38231228|FG000|Overall Study|Withdrawal by Subject|4|||
17091190|NCT00067990|38231229|FG001|Overall Study|Withdrawal by Subject|12|||
17091191|NCT00090220|38231237|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
17091192|NCT00090220|38231238|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
17091193|NCT00090220|38231239|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
17091194|NCT00090220|38231240|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
17091195|NCT00090220|38231241|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
17091196|NCT00090220|38231242|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
17091197|NCT00090220|38231237|FG000|Base Study Vaccination Period|Adverse Event|6|||
17091198|NCT00090220|38231238|FG001|Base Study Vaccination Period|Adverse Event|1|||
17091199|NCT00090220|38231239|FG002|Base Study Vaccination Period|Adverse Event|0|||
17091200|NCT00090220|38231240|FG003|Base Study Vaccination Period|Adverse Event|0|||
17091201|NCT00090220|38231241|FG004|Base Study Vaccination Period|Adverse Event|0|||
17189410|NCT02983799|38342367|FG004|Overall Study|Withdrawal by Subject|1|||
17189411|NCT02983799|38342363|FG000|Overall Study|Protocol Violation|0|||
17189412|NCT02983799|38342364|FG001|Overall Study|Protocol Violation|1|||
17189413|NCT02983799|38342365|FG002|Overall Study|Protocol Violation|0|||
17189414|NCT02983799|38342366|FG003|Overall Study|Protocol Violation|0|||
17189415|NCT02983799|38342367|FG004|Overall Study|Protocol Violation|1|||
17189416|NCT02983799|38342363|FG000|Overall Study|Lost to Follow-up|1|||
17189417|NCT02983799|38342364|FG001|Overall Study|Lost to Follow-up|0|||
17189418|NCT02983799|38342365|FG002|Overall Study|Lost to Follow-up|1|||
17091202|NCT00090220|38231242|FG005|Base Study Vaccination Period|Adverse Event|0|||
17091203|NCT00090220|38231237|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
17091204|NCT00090220|38231238|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
17091205|NCT00090220|38231239|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
17091206|NCT00090220|38231240|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
17091207|NCT00090220|38231241|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
17091208|NCT00090220|38231242|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
17091209|NCT00090220|38231237|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
17091210|NCT00090220|38231238|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
17189419|NCT02983799|38342366|FG003|Overall Study|Lost to Follow-up|0|||
17189420|NCT02983799|38342367|FG004|Overall Study|Lost to Follow-up|0|||
17189421|NCT02186847|38342385|FG000|Overall Study|Protocol Violation|3|||
17189422|NCT02186847|38342386|FG001|Overall Study|Protocol Violation|0|||
17189423|NCT01066871|38342396|FG000|Overall Study|Lost to Follow-up|0|||
17189424|NCT01066871|38342397|FG001|Overall Study|Lost to Follow-up|2|||
16998177|NCT00696241|38142059|FG000|Overall Study|Lost to Follow-up|1|||
16998178|NCT00696241|38142060|FG001|Overall Study|Lost to Follow-up|4|||
16998179|NCT00696241|38142061|FG002|Overall Study|Lost to Follow-up|1|||
16998180|NCT00696241|38142062|FG003|Overall Study|Lost to Follow-up|2|||
16998181|NCT00696241|38142063|FG004|Overall Study|Lost to Follow-up|0|||
16998182|NCT00696241|38142059|FG000|Overall Study|Withdrawal by Subject|4|||
16998183|NCT00696241|38142060|FG001|Overall Study|Withdrawal by Subject|8|||
16998184|NCT00696241|38142061|FG002|Overall Study|Withdrawal by Subject|6|||
16998185|NCT00696241|38142062|FG003|Overall Study|Withdrawal by Subject|1|||
16998186|NCT00696241|38142063|FG004|Overall Study|Withdrawal by Subject|0|||
16998187|NCT00696241|38142059|FG000|Overall Study|Lack of Efficacy|1|||
16998188|NCT00696241|38142060|FG001|Overall Study|Lack of Efficacy|5|||
16998189|NCT00696241|38142061|FG002|Overall Study|Lack of Efficacy|4|||
16998190|NCT00696241|38142062|FG003|Overall Study|Lack of Efficacy|5|||
17091211|NCT00090220|38231239|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
17091212|NCT00090220|38231240|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
17091213|NCT00090220|38231241|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
17091214|NCT00090220|38231242|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
17091215|NCT00090220|38231237|FG000|Base Study Vaccination Period|Patient Moved|6|||
17189425|NCT01066871|38342398|FG002|Overall Study|Lost to Follow-up|2|||
17091216|NCT00090220|38231238|FG001|Base Study Vaccination Period|Patient Moved|2|||
17091217|NCT00090220|38231239|FG002|Base Study Vaccination Period|Patient Moved|0|||
17091218|NCT00090220|38231240|FG003|Base Study Vaccination Period|Patient Moved|0|||
17091219|NCT00090220|38231241|FG004|Base Study Vaccination Period|Patient Moved|0|||
17091220|NCT00090220|38231242|FG005|Base Study Vaccination Period|Patient Moved|0|||
17091221|NCT00090220|38231237|FG000|Base Study Vaccination Period|Other|4|||
17091222|NCT00090220|38231238|FG001|Base Study Vaccination Period|Other|4|||
17091223|NCT00090220|38231239|FG002|Base Study Vaccination Period|Other|0|||
17091224|NCT00090220|38231240|FG003|Base Study Vaccination Period|Other|0|||
17091225|NCT00090220|38231241|FG004|Base Study Vaccination Period|Other|0|||
17091226|NCT00090220|38231242|FG005|Base Study Vaccination Period|Other|0|||
17091227|NCT00090220|38231237|FG000|Base Study Follow-up Period|Adverse Event|6|||
17091228|NCT00090220|38231238|FG001|Base Study Follow-up Period|Adverse Event|1|||
17091229|NCT00090220|38231239|FG002|Base Study Follow-up Period|Adverse Event|0|||
17091230|NCT00090220|38231240|FG003|Base Study Follow-up Period|Adverse Event|0|||
17091231|NCT00090220|38231241|FG004|Base Study Follow-up Period|Adverse Event|0|||
17091232|NCT00090220|38231242|FG005|Base Study Follow-up Period|Adverse Event|0|||
17091233|NCT00090220|38231237|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
17091234|NCT00090220|38231238|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
17091235|NCT00090220|38231239|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
17091236|NCT00090220|38231240|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
17091237|NCT00090220|38231241|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
17091238|NCT00090220|38231242|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
17091239|NCT00090220|38231237|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
17091240|NCT00090220|38231238|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
17091241|NCT00090220|38231239|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
16998191|NCT00696241|38142063|FG004|Overall Study|Lack of Efficacy|3|||
16998192|NCT00696241|38142059|FG000|Overall Study|Other|6|||
16998193|NCT00696241|38142060|FG001|Overall Study|Other|1|||
16998194|NCT00696241|38142061|FG002|Overall Study|Other|5|||
16998195|NCT00696241|38142062|FG003|Overall Study|Other|2|||
16998196|NCT00696241|38142063|FG004|Overall Study|Other|1|||
16998197|NCT00957008|38142079|FG000|Overall Study|Withdrawal by Subject|13|||
16998198|NCT00957008|38142080|FG001|Overall Study|Withdrawal by Subject|10|||
16998199|NCT00957008|38142081|FG002|Overall Study|Withdrawal by Subject|12|||
16998200|NCT00957008|38142082|FG003|Overall Study|Withdrawal by Subject|16|||
16998201|NCT00957008|38142079|FG000|Overall Study|Lost to Follow-up|3|||
16998202|NCT00957008|38142080|FG001|Overall Study|Lost to Follow-up|1|||
16998203|NCT00957008|38142081|FG002|Overall Study|Lost to Follow-up|3|||
16998204|NCT00957008|38142082|FG003|Overall Study|Lost to Follow-up|4|||
16998205|NCT00957008|38142079|FG000|Overall Study|Physician Decision|1|||
16998206|NCT00957008|38142080|FG001|Overall Study|Physician Decision|0|||
16998207|NCT00957008|38142081|FG002|Overall Study|Physician Decision|1|||
16998208|NCT00957008|38142082|FG003|Overall Study|Physician Decision|1|||
16998209|NCT00957008|38142079|FG000|Overall Study|Relocated; Family conflict|4|||
16998210|NCT00957008|38142080|FG001|Overall Study|Relocated; Family conflict|1|||
16998211|NCT00957008|38142081|FG002|Overall Study|Relocated; Family conflict|1|||
16998212|NCT00957008|38142082|FG003|Overall Study|Relocated; Family conflict|3|||
16998213|NCT00952484|38142099|FG000|Overall Study|Withdrawal by Subject|0|||
16998214|NCT00952484|38142100|FG001|Overall Study|Withdrawal by Subject|1|||
16998215|NCT00952484|38142101|FG002|Overall Study|Withdrawal by Subject|0|||
16998216|NCT00689611|38142112|FG000|Overall Study|Death|6|||
16998217|NCT00689611|38142113|FG001|Overall Study|Death|9|||
16998218|NCT00689611|38142112|FG000|Overall Study|Withdrawal by Subject|8|||
16998219|NCT00689611|38142113|FG001|Overall Study|Withdrawal by Subject|9|||
16998220|NCT00689611|38142112|FG000|Overall Study|Lost to Follow-up|27|||
16998221|NCT00689611|38142113|FG001|Overall Study|Lost to Follow-up|28|||
16998222|NCT00689299|38142122|FG000|Overall Study|Adverse Event|2|||
16998223|NCT00689299|38142123|FG001|Overall Study|Adverse Event|1|||
16998224|NCT00689299|38142124|FG002|Overall Study|Adverse Event|1|||
16998225|NCT00689299|38142122|FG000|Overall Study|Lost to Follow-up|0|||
16998226|NCT00689299|38142123|FG001|Overall Study|Lost to Follow-up|1|||
16998227|NCT00689299|38142124|FG002|Overall Study|Lost to Follow-up|1|||
16998228|NCT00689299|38142122|FG000|Overall Study|Withdrawal by Subject|4|||
16998229|NCT00689299|38142123|FG001|Overall Study|Withdrawal by Subject|1|||
16998230|NCT00689299|38142124|FG002|Overall Study|Withdrawal by Subject|3|||
16998231|NCT00689299|38142122|FG000|Overall Study|Protocol Violation|1|||
16998232|NCT00689299|38142123|FG001|Overall Study|Protocol Violation|0|||
16998233|NCT00689299|38142124|FG002|Overall Study|Protocol Violation|0|||
16998234|NCT02506244|38142135|FG000|Overall Study|Did not undergo active monitoring|458|||
16998235|NCT02506244|38142136|FG001|Overall Study|Did not undergo active monitoring|459|||
16998236|NCT02506244|38142137|FG002|Overall Study|Did not undergo active monitoring|0|||
16998237|NCT00948974|38142147|FG000|Overall Study|Lost to Follow-up|23|||
16998238|NCT00948974|38142148|FG001|Overall Study|Lost to Follow-up|20|||
17091242|NCT00090220|38231240|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
17189426|NCT01066871|38342399|FG003|Overall Study|Lost to Follow-up|0|||
16998239|NCT01007435|38142158|FG000|Overall Study|Adverse Event|16|||
17189427|NCT01066871|38342396|FG000|Overall Study|Protocol Violation|1|||
17189428|NCT01066871|38342397|FG001|Overall Study|Protocol Violation|0|||
17189429|NCT01066871|38342398|FG002|Overall Study|Protocol Violation|3|||
17189430|NCT01066871|38342399|FG003|Overall Study|Protocol Violation|2|||
17189431|NCT01066871|38342396|FG000|Overall Study|Lack of Efficacy|0|||
17189432|NCT01066871|38342397|FG001|Overall Study|Lack of Efficacy|0|||
17189433|NCT01066871|38342398|FG002|Overall Study|Lack of Efficacy|0|||
17189434|NCT01066871|38342399|FG003|Overall Study|Lack of Efficacy|1|||
17189435|NCT01066871|38342396|FG000|Overall Study|Withdrawal by Subject|3|||
17189436|NCT01066871|38342397|FG001|Overall Study|Withdrawal by Subject|1|||
17189437|NCT01066871|38342398|FG002|Overall Study|Withdrawal by Subject|0|||
17189438|NCT01066871|38342399|FG003|Overall Study|Withdrawal by Subject|0|||
17189439|NCT01066871|38342396|FG000|Overall Study|Other|0|||
17189440|NCT01066871|38342397|FG001|Overall Study|Other|2|||
17189441|NCT01066871|38342398|FG002|Overall Study|Other|1|||
17189442|NCT01066871|38342399|FG003|Overall Study|Other|2|||
17189443|NCT02982863|38342419|FG000|Overall Study|Not eligible patients|809|||
17189444|NCT02982863|38342420|FG001|Overall Study|Not eligible patients|4261|||
17189445|NCT02982863|38342421|FG002|Overall Study|Not eligible patients|1852|||
17189446|NCT02982863|38342422|FG003|Overall Study|Not eligible patients|1400|||
17189447|NCT02982863|38342423|FG004|Overall Study|Not eligible patients|492|||
17189448|NCT04343651|38342466|FG000|Overall Study|Physician Decision|2|||
17189449|NCT04343651|38342467|FG001|Overall Study|Physician Decision|1|||
17189450|NCT04343651|38342466|FG000|Overall Study|Lost to Follow-up|2|||
17189451|NCT04343651|38342467|FG001|Overall Study|Lost to Follow-up|1|||
17189452|NCT04343651|38342466|FG000|Overall Study|Protocol Violation|4|||
17189453|NCT04343651|38342467|FG001|Overall Study|Protocol Violation|6|||
17189454|NCT04343651|38342466|FG000|Overall Study|Missing|3|||
17189455|NCT04343651|38342467|FG001|Overall Study|Missing|9|||
17189456|NCT04343651|38342466|FG000|Overall Study|Withdrawal by Subject|0|||
17189457|NCT04343651|38342467|FG001|Overall Study|Withdrawal by Subject|4|||
17189458|NCT04343651|38342466|FG000|Overall Study|Death|0|||
17189459|NCT04343651|38342467|FG001|Overall Study|Death|1|||
17189460|NCT04343651|38342466|FG000|Overall Study|Did not start treatment|1|||
17189461|NCT04343651|38342467|FG001|Overall Study|Did not start treatment|1|||
17189462|NCT04343651|38342466|FG000|Overall Study|Patient did not complete visits 3-6|0|||
17189463|NCT04343651|38342467|FG001|Overall Study|Patient did not complete visits 3-6|1|||
17189464|NCT02906579|38342475|FG000|Overall Study|Adverse Event|1|||
17189465|NCT02906579|38342475|FG000|Overall Study|Physician Decision|1|||
17189466|NCT01328535|38342495|FG000|Overall Study|Ineligible|1|||
17189467|NCT02905331|38342503|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
17189468|NCT02905331|38342504|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
17189469|NCT02905331|38342505|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
17189470|NCT02905331|38342503|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
17189471|NCT02905331|38342504|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
17189472|NCT02905331|38342505|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
17189473|NCT02905331|38342503|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
17189474|NCT02905331|38342504|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
17189475|NCT02905331|38342505|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
17189476|NCT02905331|38342503|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
17189477|NCT02905331|38342504|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
17189478|NCT02905331|38342505|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
17189479|NCT02905331|38342503|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
17189480|NCT02905331|38342504|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
16868350|NCT01535261|37841418|FG000|Overall Study|Adverse Event|12|||
17091243|NCT00090220|38231241|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
17091244|NCT00090220|38231242|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
17091245|NCT00090220|38231237|FG000|Base Study Follow-up Period|Patient Moved|20|||
17091246|NCT00090220|38231238|FG001|Base Study Follow-up Period|Patient Moved|28|||
17091247|NCT00090220|38231239|FG002|Base Study Follow-up Period|Patient Moved|0|||
17091248|NCT00090220|38231240|FG003|Base Study Follow-up Period|Patient Moved|0|||
17091249|NCT00090220|38231241|FG004|Base Study Follow-up Period|Patient Moved|0|||
17091250|NCT00090220|38231242|FG005|Base Study Follow-up Period|Patient Moved|0|||
17091251|NCT00090220|38231237|FG000|Base Study Follow-up Period|Other|19|||
17189481|NCT02905331|38342505|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
17189482|NCT02979197|38342516|FG000|Overall Study|Adverse Event|4|||
17189483|NCT02979197|38342517|FG001|Overall Study|Adverse Event|2|||
17189484|NCT02979197|38342518|FG002|Overall Study|Adverse Event|0|||
17189485|NCT02979197|38342516|FG000|Overall Study|Protocol Violation|0|||
17189486|NCT02979197|38342517|FG001|Overall Study|Protocol Violation|1|||
17189487|NCT02979197|38342518|FG002|Overall Study|Protocol Violation|0|||
17189488|NCT02979197|38342516|FG000|Overall Study|Subject unable to commit to study dates|0|||
17189489|NCT02979197|38342517|FG001|Overall Study|Subject unable to commit to study dates|1|||
17189490|NCT02979197|38342518|FG002|Overall Study|Subject unable to commit to study dates|0|||
17189491|NCT02982239|38342528|FG000|Overall Study|Lost to Follow-up|3|||
17189492|NCT02982239|38342529|FG001|Overall Study|Lost to Follow-up|2|||
17189493|NCT01066793|38342542|FG000|Overall Study|Death|4|||
17091252|NCT00090220|38231238|FG001|Base Study Follow-up Period|Other|21|||
17091253|NCT00090220|38231239|FG002|Base Study Follow-up Period|Other|0|||
17091254|NCT00090220|38231240|FG003|Base Study Follow-up Period|Other|0|||
17091255|NCT00090220|38231241|FG004|Base Study Follow-up Period|Other|0|||
17091256|NCT00090220|38231242|FG005|Base Study Follow-up Period|Other|0|||
17091257|NCT00090220|38231237|FG000|Extension 1 (EXT1)|Adverse Event|0|||
17091258|NCT00090220|38231238|FG001|Extension 1 (EXT1)|Adverse Event|0|||
17091259|NCT00090220|38231239|FG002|Extension 1 (EXT1)|Adverse Event|4|||
17091260|NCT00090220|38231240|FG003|Extension 1 (EXT1)|Adverse Event|0|||
17091261|NCT00090220|38231241|FG004|Extension 1 (EXT1)|Adverse Event|0|||
17091262|NCT00090220|38231242|FG005|Extension 1 (EXT1)|Adverse Event|0|||
17091263|NCT00090220|38231237|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
17091264|NCT00090220|38231238|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
17091265|NCT00090220|38231239|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
17091266|NCT00090220|38231240|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
17091267|NCT00090220|38231241|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
17091268|NCT00090220|38231242|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
17091269|NCT00090220|38231237|FG000|Extension 1 (EXT1)|Moved|0|||
17091270|NCT00090220|38231238|FG001|Extension 1 (EXT1)|Moved|0|||
17091271|NCT00090220|38231239|FG002|Extension 1 (EXT1)|Moved|2|||
17091272|NCT00090220|38231240|FG003|Extension 1 (EXT1)|Moved|1|||
17091273|NCT00090220|38231241|FG004|Extension 1 (EXT1)|Moved|0|||
17091274|NCT00090220|38231242|FG005|Extension 1 (EXT1)|Moved|0|||
16998240|NCT01007435|38142159|FG001|Overall Study|Adverse Event|25|||
16998241|NCT01007435|38142160|FG002|Overall Study|Adverse Event|47|||
16998242|NCT01007435|38142161|FG003|Overall Study|Adverse Event|31|||
16998243|NCT01007435|38142158|FG000|Overall Study|Death|2|||
16998244|NCT01007435|38142159|FG001|Overall Study|Death|4|||
16998245|NCT01007435|38142160|FG002|Overall Study|Death|2|||
16998246|NCT01007435|38142161|FG003|Overall Study|Death|1|||
16998247|NCT01007435|38142158|FG000|Overall Study|Insufficient Therapeutic Response|21|||
16998248|NCT01007435|38142159|FG001|Overall Study|Insufficient Therapeutic Response|7|||
16998249|NCT01007435|38142160|FG002|Overall Study|Insufficient Therapeutic Response|2|||
16998250|NCT01007435|38142161|FG003|Overall Study|Insufficient Therapeutic Response|9|||
16998251|NCT01007435|38142158|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
16998252|NCT01007435|38142159|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
16998253|NCT01007435|38142160|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
16998254|NCT01007435|38142161|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
16998255|NCT01007435|38142158|FG000|Overall Study|Other Protocol Violation|2|||
16998256|NCT01007435|38142159|FG001|Overall Study|Other Protocol Violation|0|||
16998257|NCT01007435|38142160|FG002|Overall Study|Other Protocol Violation|1|||
16998258|NCT01007435|38142161|FG003|Overall Study|Other Protocol Violation|0|||
16998259|NCT01007435|38142158|FG000|Overall Study|Refused Treatment|13|||
16998260|NCT01007435|38142159|FG001|Overall Study|Refused Treatment|13|||
16998261|NCT01007435|38142160|FG002|Overall Study|Refused Treatment|5|||
16998262|NCT01007435|38142161|FG003|Overall Study|Refused Treatment|8|||
16998263|NCT01007435|38142158|FG000|Overall Study|Failure to Return|5|||
16998264|NCT01007435|38142159|FG001|Overall Study|Failure to Return|4|||
16998265|NCT01007435|38142160|FG002|Overall Study|Failure to Return|3|||
16998266|NCT01007435|38142161|FG003|Overall Study|Failure to Return|6|||
16998267|NCT01007435|38142158|FG000|Overall Study|Reason not Specified|1|||
16998268|NCT01007435|38142159|FG001|Overall Study|Reason not Specified|1|||
16998269|NCT01007435|38142160|FG002|Overall Study|Reason not Specified|2|||
16998270|NCT01007435|38142161|FG003|Overall Study|Reason not Specified|1|||
16998271|NCT00948896|38142179|FG000|Randomization to 24 Months of Age|Death|1|||
16998272|NCT00948896|38142180|FG001|Randomization to 24 Months of Age|Death|0|||
16998273|NCT00948896|38142181|FG002|Randomization to 24 Months of Age|Death|0|||
17091275|NCT00090220|38231237|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
17091276|NCT00090220|38231238|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
17091277|NCT00090220|38231239|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
17091278|NCT00090220|38231240|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
17091279|NCT00090220|38231241|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
17091280|NCT00090220|38231242|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
17091281|NCT00090220|38231237|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
17091282|NCT00090220|38231238|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
17091283|NCT00090220|38231239|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
17091284|NCT00090220|38231240|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
16868351|NCT01534637|37841422|FG000|Overall Study|Physician Decision|3|||
16868352|NCT01534637|37841422|FG000|Overall Study|Lack of Efficacy|3|||
16998274|NCT00948896|38142182|FG003|Randomization to 24 Months of Age|Death|0|||
16998275|NCT00948896|38142183|FG004|Randomization to 24 Months of Age|Death|2|||
16998276|NCT00948896|38142184|FG005|Randomization to 24 Months of Age|Death|1|||
16998277|NCT00948896|38142185|FG006|Randomization to 24 Months of Age|Death|2|||
17091285|NCT00090220|38231241|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
17091286|NCT00090220|38231242|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
17189494|NCT01066793|38342543|FG001|Overall Study|Death|1|||
16998278|NCT00948896|38142186|FG007|Randomization to 24 Months of Age|Death|1|||
16998279|NCT00948896|38142179|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
16998280|NCT00948896|38142180|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
16998281|NCT00948896|38142181|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
16998282|NCT00948896|38142182|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
16998283|NCT00948896|38142183|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
16998284|NCT00948896|38142184|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
16998285|NCT00948896|38142185|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
17091287|NCT00090220|38231237|FG000|Extension 1 (EXT1)|Other reason|0|||
17091288|NCT00090220|38231238|FG001|Extension 1 (EXT1)|Other reason|0|||
17091289|NCT00090220|38231239|FG002|Extension 1 (EXT1)|Other reason|2|||
17091290|NCT00090220|38231240|FG003|Extension 1 (EXT1)|Other reason|0|||
16998286|NCT00948896|38142186|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
17091291|NCT00090220|38231241|FG004|Extension 1 (EXT1)|Other reason|0|||
17091292|NCT00090220|38231242|FG005|Extension 1 (EXT1)|Other reason|0|||
17091293|NCT00090220|38231237|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
17091294|NCT00090220|38231238|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
17091295|NCT00090220|38231239|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
17091296|NCT00090220|38231240|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
17091297|NCT00090220|38231241|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
17091298|NCT00090220|38231242|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
17091299|NCT00090220|38231237|FG000|Long-term Follow-up (EXT2)|Death|0|||
17091300|NCT00090220|38231238|FG001|Long-term Follow-up (EXT2)|Death|0|||
17091301|NCT00090220|38231239|FG002|Long-term Follow-up (EXT2)|Death|0|||
17091302|NCT00090220|38231240|FG003|Long-term Follow-up (EXT2)|Death|0|||
17091303|NCT00090220|38231241|FG004|Long-term Follow-up (EXT2)|Death|1|||
17091304|NCT00090220|38231242|FG005|Long-term Follow-up (EXT2)|Death|1|||
17091305|NCT00090220|38231237|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
17091306|NCT00090220|38231238|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
17091307|NCT00090220|38231239|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
17091308|NCT00090220|38231240|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
17091309|NCT00090220|38231241|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
17091310|NCT00090220|38231242|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
17091311|NCT00090220|38231237|FG000|Long-term Follow-up (EXT2)|Other|0|||
17091312|NCT00090220|38231238|FG001|Long-term Follow-up (EXT2)|Other|0|||
17091313|NCT00090220|38231239|FG002|Long-term Follow-up (EXT2)|Other|0|||
17091314|NCT00090220|38231240|FG003|Long-term Follow-up (EXT2)|Other|0|||
17091315|NCT00090220|38231241|FG004|Long-term Follow-up (EXT2)|Other|1|||
17091316|NCT00090220|38231242|FG005|Long-term Follow-up (EXT2)|Other|0|||
17091317|NCT00263328|38231262|FG000|Overall Study|Death|0|||
17091318|NCT00263328|38231263|FG001|Overall Study|Death|0|||
17091319|NCT00263328|38231264|FG002|Overall Study|Death|1|||
17091320|NCT00263328|38231262|FG000|Overall Study|Lost to Follow-up|1|||
17091321|NCT00263328|38231263|FG001|Overall Study|Lost to Follow-up|1|||
17091322|NCT00263328|38231264|FG002|Overall Study|Lost to Follow-up|0|||
17091323|NCT00263328|38231262|FG000|Overall Study|Withdrawal by Subject|3|||
17091324|NCT00263328|38231263|FG001|Overall Study|Withdrawal by Subject|0|||
17091325|NCT00263328|38231264|FG002|Overall Study|Withdrawal by Subject|1|||
17091326|NCT00263328|38231262|FG000|Overall Study|Other|3|||
17091327|NCT00263328|38231263|FG001|Overall Study|Other|0|||
17091328|NCT00263328|38231264|FG002|Overall Study|Other|1|||
17091329|NCT00263328|38231262|FG000|Overall Study|Adverse Event|1|||
17091330|NCT00263328|38231263|FG001|Overall Study|Adverse Event|1|||
17091331|NCT00263328|38231264|FG002|Overall Study|Adverse Event|4|||
17091332|NCT00262860|38231274|FG000|Overall Study|Adverse Event|2|||
17091333|NCT00236184|38231280|FG000|Overall Study|Adverse Event|5|||
17091334|NCT00236184|38231281|FG001|Overall Study|Adverse Event|2|||
17091335|NCT00236184|38231280|FG000|Overall Study|Lack of Efficacy|0|||
17091336|NCT00236184|38231281|FG001|Overall Study|Lack of Efficacy|1|||
17091337|NCT00236184|38231280|FG000|Overall Study|Lost to Follow-up|3|||
17091338|NCT00236184|38231281|FG001|Overall Study|Lost to Follow-up|4|||
17091339|NCT00236184|38231280|FG000|Overall Study|Physician Decision|1|||
17091340|NCT00236184|38231281|FG001|Overall Study|Physician Decision|1|||
17091341|NCT00236184|38231280|FG000|Overall Study|Withdrawal by Subject|3|||
17091342|NCT00236184|38231281|FG001|Overall Study|Withdrawal by Subject|0|||
17091343|NCT00236184|38231280|FG000|Overall Study|Protocol Violation|3|||
17091344|NCT00236184|38231281|FG001|Overall Study|Protocol Violation|0|||
17091345|NCT00236184|38231280|FG000|Overall Study|non-compliance with study drug|2|||
17091346|NCT00236184|38231281|FG001|Overall Study|non-compliance with study drug|1|||
17091347|NCT00236184|38231280|FG000|Overall Study|other|1|||
17091348|NCT00236184|38231281|FG001|Overall Study|other|2|||
17091349|NCT00296504|38231295|FG000|Interim Analysis|Withdrawal by Subject|8|||
17091350|NCT00296504|38231296|FG001|Interim Analysis|Withdrawal by Subject|0|||
17091351|NCT00296504|38231297|FG002|Interim Analysis|Withdrawal by Subject|12|||
17091352|NCT00296504|38231298|FG003|Interim Analysis|Withdrawal by Subject|0|||
17091353|NCT00296504|38231299|FG004|Interim Analysis|Withdrawal by Subject|5|||
17091354|NCT00296504|38231300|FG005|Interim Analysis|Withdrawal by Subject|5|||
17189495|NCT01066793|38342544|FG002|Overall Study|Death|1|||
17189496|NCT01066793|38342545|FG003|Overall Study|Death|0|||
17189497|NCT01066793|38342546|FG004|Overall Study|Death|0|||
17189498|NCT01066793|38342547|FG005|Overall Study|Death|0|||
17189499|NCT01066793|38342542|FG000|Overall Study|Lack of Efficacy|2|||
17189500|NCT01066793|38342543|FG001|Overall Study|Lack of Efficacy|1|||
17189501|NCT01066793|38342544|FG002|Overall Study|Lack of Efficacy|0|||
17189502|NCT01066793|38342545|FG003|Overall Study|Lack of Efficacy|0|||
17189503|NCT01066793|38342546|FG004|Overall Study|Lack of Efficacy|0|||
17189504|NCT01066793|38342547|FG005|Overall Study|Lack of Efficacy|0|||
17189505|NCT01066793|38342542|FG000|Overall Study|Lost to Follow-up|180|||
17189506|NCT01066793|38342543|FG001|Overall Study|Lost to Follow-up|39|||
17189507|NCT01066793|38342544|FG002|Overall Study|Lost to Follow-up|82|||
17189508|NCT01066793|38342545|FG003|Overall Study|Lost to Follow-up|16|||
17189509|NCT01066793|38342546|FG004|Overall Study|Lost to Follow-up|0|||
17189510|NCT01066793|38342547|FG005|Overall Study|Lost to Follow-up|1|||
17189511|NCT01066793|38342542|FG000|Overall Study|Physician Decision|3|||
17189512|NCT01066793|38342543|FG001|Overall Study|Physician Decision|0|||
17189513|NCT01066793|38342544|FG002|Overall Study|Physician Decision|0|||
17189514|NCT01066793|38342545|FG003|Overall Study|Physician Decision|0|||
17189515|NCT01066793|38342546|FG004|Overall Study|Physician Decision|0|||
17189516|NCT01066793|38342547|FG005|Overall Study|Physician Decision|0|||
17189517|NCT01066793|38342542|FG000|Overall Study|Protocol Violation|3|||
17189518|NCT01066793|38342543|FG001|Overall Study|Protocol Violation|2|||
17189519|NCT01066793|38342544|FG002|Overall Study|Protocol Violation|2|||
17189520|NCT01066793|38342545|FG003|Overall Study|Protocol Violation|0|||
17189521|NCT01066793|38342546|FG004|Overall Study|Protocol Violation|0|||
17189522|NCT01066793|38342547|FG005|Overall Study|Protocol Violation|0|||
17189523|NCT01066793|38342542|FG000|Overall Study|Withdrawal by Subject|7|||
17189524|NCT01066793|38342543|FG001|Overall Study|Withdrawal by Subject|4|||
17189525|NCT01066793|38342544|FG002|Overall Study|Withdrawal by Subject|1|||
17189526|NCT01066793|38342545|FG003|Overall Study|Withdrawal by Subject|0|||
17189527|NCT01066793|38342546|FG004|Overall Study|Withdrawal by Subject|0|||
17189528|NCT01066793|38342547|FG005|Overall Study|Withdrawal by Subject|0|||
17189529|NCT01066793|38342542|FG000|Overall Study|Early Termination|3|||
17189530|NCT01066793|38342543|FG001|Overall Study|Early Termination|0|||
17189531|NCT01066793|38342544|FG002|Overall Study|Early Termination|0|||
17189532|NCT01066793|38342545|FG003|Overall Study|Early Termination|0|||
17189533|NCT01066793|38342546|FG004|Overall Study|Early Termination|0|||
17189534|NCT01066793|38342547|FG005|Overall Study|Early Termination|0|||
17091355|NCT00296504|38231301|FG006|Interim Analysis|Withdrawal by Subject|9|||
17091356|NCT00296504|38231302|FG007|Interim Analysis|Withdrawal by Subject|3|||
17091357|NCT00296504|38231303|FG008|Interim Analysis|Withdrawal by Subject|0|||
17091358|NCT00296504|38231295|FG000|Interim Analysis|Lost to Follow-up|13|||
17091359|NCT00296504|38231296|FG001|Interim Analysis|Lost to Follow-up|3|||
17091360|NCT00296504|38231297|FG002|Interim Analysis|Lost to Follow-up|26|||
17091361|NCT00296504|38231298|FG003|Interim Analysis|Lost to Follow-up|8|||
17091362|NCT00296504|38231299|FG004|Interim Analysis|Lost to Follow-up|14|||
17091363|NCT00296504|38231300|FG005|Interim Analysis|Lost to Follow-up|4|||
17091364|NCT00296504|38231301|FG006|Interim Analysis|Lost to Follow-up|11|||
17091365|NCT00296504|38231302|FG007|Interim Analysis|Lost to Follow-up|4|||
17091366|NCT00296504|38231303|FG008|Interim Analysis|Lost to Follow-up|0|||
17091367|NCT00296504|38231295|FG000|Interim Analysis|Clinical Progression|1|||
17091368|NCT00296504|38231296|FG001|Interim Analysis|Clinical Progression|0|||
17091369|NCT00296504|38231297|FG002|Interim Analysis|Clinical Progression|1|||
17091370|NCT00296504|38231298|FG003|Interim Analysis|Clinical Progression|1|||
17091371|NCT00296504|38231299|FG004|Interim Analysis|Clinical Progression|0|||
17091372|NCT00296504|38231300|FG005|Interim Analysis|Clinical Progression|2|||
17091373|NCT00296504|38231301|FG006|Interim Analysis|Clinical Progression|1|||
17091374|NCT00296504|38231302|FG007|Interim Analysis|Clinical Progression|2|||
17091375|NCT00296504|38231303|FG008|Interim Analysis|Clinical Progression|0|||
17091376|NCT00296504|38231295|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
17091377|NCT00296504|38231296|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
17189535|NCT01066793|38342542|FG000|Overall Study|Lab test not done|7|||
17189536|NCT01066793|38342543|FG001|Overall Study|Lab test not done|0|||
17091378|NCT00296504|38231297|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
17091379|NCT00296504|38231298|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
17189537|NCT01066793|38342544|FG002|Overall Study|Lab test not done|0|||
17189538|NCT01066793|38342545|FG003|Overall Study|Lab test not done|1|||
17189539|NCT01066793|38342546|FG004|Overall Study|Lab test not done|0|||
17189540|NCT01066793|38342547|FG005|Overall Study|Lab test not done|0|||
17189541|NCT01066793|38342542|FG000|Overall Study|Miscellaneous|4|||
17189542|NCT01066793|38342543|FG001|Overall Study|Miscellaneous|5|||
17189543|NCT01066793|38342544|FG002|Overall Study|Miscellaneous|6|||
17189544|NCT01066793|38342545|FG003|Overall Study|Miscellaneous|0|||
17189545|NCT01066793|38342546|FG004|Overall Study|Miscellaneous|0|||
17189546|NCT01066793|38342547|FG005|Overall Study|Miscellaneous|0|||
17189547|NCT01066793|38342542|FG000|Overall Study|Non-responders|104|||
17189548|NCT01066793|38342543|FG001|Overall Study|Non-responders|5|||
17189549|NCT01066793|38342544|FG002|Overall Study|Non-responders|11|||
17189550|NCT01066793|38342545|FG003|Overall Study|Non-responders|25|||
17189551|NCT01066793|38342546|FG004|Overall Study|Non-responders|0|||
17189552|NCT01066793|38342547|FG005|Overall Study|Non-responders|0|||
17189553|NCT01066793|38342542|FG000|Overall Study|Other|15|||
17189554|NCT01066793|38342543|FG001|Overall Study|Other|5|||
17189555|NCT01066793|38342544|FG002|Overall Study|Other|6|||
17189556|NCT01066793|38342545|FG003|Overall Study|Other|2|||
17189557|NCT01066793|38342546|FG004|Overall Study|Other|0|||
17189558|NCT01066793|38342547|FG005|Overall Study|Other|0|||
17189559|NCT01066793|38342542|FG000|Overall Study|Relapse|20|||
17189560|NCT01066793|38342543|FG001|Overall Study|Relapse|8|||
17189561|NCT01066793|38342544|FG002|Overall Study|Relapse|2|||
17189562|NCT01066793|38342545|FG003|Overall Study|Relapse|3|||
17189563|NCT01066793|38342546|FG004|Overall Study|Relapse|0|||
17189564|NCT01066793|38342547|FG005|Overall Study|Relapse|0|||
16782740|NCT02058628|37722365|FG001|Overall Study|The visit date was not in timeline|1|||
16782741|NCT02058628|37722364|FG000|Overall Study|A lot of time for study for participant|1|||
16782742|NCT02058628|37722365|FG001|Overall Study|A lot of time for study for participant|0|||
16782743|NCT02058628|37722364|FG000|Overall Study|Non compliance|1|||
16782744|NCT02058628|37722365|FG001|Overall Study|Non compliance|0|||
16782745|NCT02058160|37722376|FG000|Overall Study|Randomized but not treated|2|||
16782746|NCT02058160|37722377|FG001|Overall Study|Randomized but not treated|4|||
16868353|NCT01534637|37841422|FG000|Overall Study|Withdrawal by Subject|1|||
16868354|NCT01534637|37841422|FG000|Overall Study|Adverse Event|1|||
17189565|NCT01066793|38342542|FG000|Overall Study|Result Not Available|1|||
17189566|NCT01066793|38342543|FG001|Overall Study|Result Not Available|0|||
17189567|NCT01066793|38342544|FG002|Overall Study|Result Not Available|0|||
17189568|NCT01066793|38342545|FG003|Overall Study|Result Not Available|0|||
17189569|NCT01066793|38342546|FG004|Overall Study|Result Not Available|0|||
17189570|NCT01066793|38342547|FG005|Overall Study|Result Not Available|0|||
17189571|NCT01066793|38342542|FG000|Overall Study|Treatment Interrupted|1|||
17189572|NCT01066793|38342543|FG001|Overall Study|Treatment Interrupted|1|||
17189573|NCT01066793|38342544|FG002|Overall Study|Treatment Interrupted|0|||
17189574|NCT01066793|38342545|FG003|Overall Study|Treatment Interrupted|0|||
17189575|NCT01066793|38342546|FG004|Overall Study|Treatment Interrupted|0|||
17189576|NCT01066793|38342547|FG005|Overall Study|Treatment Interrupted|0|||
17189577|NCT01066793|38342542|FG000|Overall Study|Treatment Never Started|18|||
17091380|NCT00296504|38231299|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
17091381|NCT00296504|38231300|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
17091382|NCT00296504|38231301|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
17091383|NCT00296504|38231302|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
17091384|NCT00296504|38231303|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
17091385|NCT00296504|38231295|FG000|Interim Analysis|Adverse Event|0|||
17091386|NCT00296504|38231296|FG001|Interim Analysis|Adverse Event|0|||
17091387|NCT00296504|38231297|FG002|Interim Analysis|Adverse Event|13|||
17091388|NCT00296504|38231298|FG003|Interim Analysis|Adverse Event|4|||
17091389|NCT00296504|38231299|FG004|Interim Analysis|Adverse Event|6|||
17091390|NCT00296504|38231300|FG005|Interim Analysis|Adverse Event|3|||
17091391|NCT00296504|38231301|FG006|Interim Analysis|Adverse Event|4|||
17091392|NCT00296504|38231302|FG007|Interim Analysis|Adverse Event|5|||
17189578|NCT01066793|38342543|FG001|Overall Study|Treatment Never Started|5|||
17189579|NCT01066793|38342544|FG002|Overall Study|Treatment Never Started|4|||
17189580|NCT01066793|38342545|FG003|Overall Study|Treatment Never Started|1|||
17189581|NCT01066793|38342546|FG004|Overall Study|Treatment Never Started|0|||
17189582|NCT01066793|38342547|FG005|Overall Study|Treatment Never Started|0|||
17189583|NCT01066793|38342542|FG000|Overall Study|Treatment Stopped|2|||
17189584|NCT01066793|38342543|FG001|Overall Study|Treatment Stopped|1|||
17189585|NCT01066793|38342544|FG002|Overall Study|Treatment Stopped|0|||
17189586|NCT01066793|38342545|FG003|Overall Study|Treatment Stopped|1|||
17189587|NCT01066793|38342546|FG004|Overall Study|Treatment Stopped|0|||
17189588|NCT01066793|38342547|FG005|Overall Study|Treatment Stopped|0|||
17189589|NCT03985293|38342568|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
16782747|NCT02058160|37722376|FG000|Overall Study|Poor compliance to protocol|4|||
16782748|NCT02058160|37722377|FG001|Overall Study|Poor compliance to protocol|1|||
16868355|NCT01534637|37841422|FG000|Overall Study|Liver Mets before treatment|1|||
17091393|NCT00296504|38231303|FG008|Interim Analysis|Adverse Event|0|||
17189590|NCT03985293|38342569|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
17189591|NCT03985293|38342570|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
17189592|NCT03985293|38342571|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
17189593|NCT03985293|38342572|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
17189594|NCT03985293|38342573|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
17189595|NCT03985293|38342568|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
17189596|NCT03985293|38342569|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
17189597|NCT03985293|38342570|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
17189598|NCT03985293|38342571|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
17189599|NCT03985293|38342572|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
17189600|NCT03985293|38342573|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
17189601|NCT03985293|38342568|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
17189602|NCT03985293|38342569|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
17189603|NCT03985293|38342570|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
16998287|NCT00948896|38142179|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
16998288|NCT00948896|38142180|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
16998289|NCT00948896|38142181|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
16998290|NCT00948896|38142182|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
16998291|NCT00948896|38142183|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
16998292|NCT00948896|38142184|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
16998293|NCT00948896|38142185|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
16998294|NCT00948896|38142186|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
16998295|NCT00948896|38142179|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
16998296|NCT00948896|38142180|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
16998297|NCT00948896|38142181|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
16998298|NCT00948896|38142182|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
16998299|NCT00948896|38142183|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
16998300|NCT00948896|38142184|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
16998301|NCT00948896|38142185|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
16998302|NCT00948896|38142186|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
16998303|NCT00948896|38142179|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
16998304|NCT00948896|38142180|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
17091394|NCT00296504|38231295|FG000|Interim Analysis|Protocol Violation|0|||
17091395|NCT00296504|38231296|FG001|Interim Analysis|Protocol Violation|0|||
17091396|NCT00296504|38231297|FG002|Interim Analysis|Protocol Violation|2|||
17091397|NCT00296504|38231298|FG003|Interim Analysis|Protocol Violation|0|||
17091398|NCT00296504|38231299|FG004|Interim Analysis|Protocol Violation|1|||
17091399|NCT00296504|38231300|FG005|Interim Analysis|Protocol Violation|0|||
17091400|NCT00296504|38231301|FG006|Interim Analysis|Protocol Violation|0|||
17091401|NCT00296504|38231302|FG007|Interim Analysis|Protocol Violation|1|||
17091402|NCT00296504|38231303|FG008|Interim Analysis|Protocol Violation|0|||
17091403|NCT00296504|38231295|FG000|Interim Analysis|Insufficient CD4 Response|0|||
17091404|NCT00296504|38231296|FG001|Interim Analysis|Insufficient CD4 Response|0|||
17091405|NCT00296504|38231297|FG002|Interim Analysis|Insufficient CD4 Response|0|||
17091406|NCT00296504|38231298|FG003|Interim Analysis|Insufficient CD4 Response|0|||
17091407|NCT00296504|38231299|FG004|Interim Analysis|Insufficient CD4 Response|1|||
17091408|NCT00296504|38231300|FG005|Interim Analysis|Insufficient CD4 Response|1|||
17091409|NCT00296504|38231301|FG006|Interim Analysis|Insufficient CD4 Response|0|||
17091410|NCT00296504|38231302|FG007|Interim Analysis|Insufficient CD4 Response|0|||
17091411|NCT00296504|38231303|FG008|Interim Analysis|Insufficient CD4 Response|0|||
17091412|NCT00296504|38231295|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
17091413|NCT00296504|38231296|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
17091414|NCT00296504|38231297|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
17091415|NCT00296504|38231298|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
17091416|NCT00296504|38231299|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
17091417|NCT00296504|38231300|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
17091418|NCT00296504|38231301|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
17091419|NCT00296504|38231302|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
17091420|NCT00296504|38231303|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
17189604|NCT03985293|38342571|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
17189605|NCT03985293|38342572|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
17189606|NCT03985293|38342573|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
17189607|NCT03985293|38342568|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
17189608|NCT03985293|38342569|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
17189609|NCT03985293|38342570|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
17189610|NCT03985293|38342571|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
17189611|NCT03985293|38342572|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
17189612|NCT03985293|38342573|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
17189613|NCT03985293|38342568|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
17189614|NCT03985293|38342569|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
17189615|NCT03985293|38342570|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
17189616|NCT03985293|38342571|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
17189617|NCT03985293|38342572|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
17189618|NCT03985293|38342573|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
17189619|NCT03985293|38342568|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
17189620|NCT03985293|38342569|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
17189621|NCT03985293|38342570|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
17189622|NCT03985293|38342571|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
17189623|NCT03985293|38342572|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
17189624|NCT03985293|38342573|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
17189625|NCT03985293|38342568|FG000|FOLLOW-UP|Lost to Follow-up|0|||
17189626|NCT03985293|38342569|FG001|FOLLOW-UP|Lost to Follow-up|0|||
17189627|NCT03985293|38342570|FG002|FOLLOW-UP|Lost to Follow-up|1|||
17189628|NCT03985293|38342571|FG003|FOLLOW-UP|Lost to Follow-up|0|||
17189629|NCT03985293|38342572|FG004|FOLLOW-UP|Lost to Follow-up|0|||
17189630|NCT03985293|38342573|FG005|FOLLOW-UP|Lost to Follow-up|0|||
17189631|NCT02980601|38342589|FG000|Overall Study|Lost to Follow-up|2|||
17189632|NCT02980601|38342590|FG001|Overall Study|Lost to Follow-up|2|||
17189633|NCT02980601|38342589|FG000|Overall Study|Death|0|||
17189634|NCT02980601|38342590|FG001|Overall Study|Death|1|||
17189635|NCT02980601|38342589|FG000|Overall Study|Graft loss|1|||
17189636|NCT02980601|38342590|FG001|Overall Study|Graft loss|0|||
17189637|NCT02980601|38342589|FG000|Overall Study|Failed to sign consent|2|||
17189638|NCT02980601|38342590|FG001|Overall Study|Failed to sign consent|0|||
17189639|NCT02980523|38342601|FG000|Overall Study|Lost to Follow-up|1|||
17189640|NCT02980523|38342602|FG001|Overall Study|Lost to Follow-up|4|||
17189641|NCT02980523|38342603|FG002|Overall Study|Lost to Follow-up|1|||
17189642|NCT02980523|38342604|FG003|Overall Study|Lost to Follow-up|2|||
17189643|NCT02980523|38342605|FG004|Overall Study|Lost to Follow-up|1|||
17189644|NCT02980523|38342601|FG000|Overall Study|Excluded from analysis|1|||
17189645|NCT02980523|38342602|FG001|Overall Study|Excluded from analysis|3|||
17189646|NCT02980523|38342603|FG002|Overall Study|Excluded from analysis|1|||
17189647|NCT02980523|38342604|FG003|Overall Study|Excluded from analysis|1|||
17189648|NCT02980523|38342605|FG004|Overall Study|Excluded from analysis|1|||
17189649|NCT02980523|38342601|FG000|Overall Study|Lack of Efficacy|1|||
17189650|NCT02980523|38342602|FG001|Overall Study|Lack of Efficacy|4|||
17189651|NCT02980523|38342603|FG002|Overall Study|Lack of Efficacy|4|||
17189652|NCT02980523|38342604|FG003|Overall Study|Lack of Efficacy|5|||
17189653|NCT02980523|38342605|FG004|Overall Study|Lack of Efficacy|8|||
17189654|NCT02980523|38342601|FG000|Overall Study|Did not receive intervention|0|||
17189655|NCT02980523|38342602|FG001|Overall Study|Did not receive intervention|0|||
17189656|NCT02980523|38342603|FG002|Overall Study|Did not receive intervention|0|||
17189657|NCT02980523|38342604|FG003|Overall Study|Did not receive intervention|1|||
17189658|NCT02980523|38342605|FG004|Overall Study|Did not receive intervention|0|||
17189659|NCT02980133|38342624|FG000|Overall Study|Other than specified|1|||
17189660|NCT02980133|38342625|FG001|Overall Study|Other than specified|1|||
17189661|NCT02980133|38342626|FG002|Overall Study|Other than specified|2|||
17189662|NCT02980133|38342627|FG003|Overall Study|Other than specified|2|||
17189663|NCT02980133|38342624|FG000|Overall Study|Lost to Follow-up|0|||
17189664|NCT02980133|38342625|FG001|Overall Study|Lost to Follow-up|0|||
17189665|NCT02980133|38342626|FG002|Overall Study|Lost to Follow-up|1|||
17189666|NCT02980133|38342627|FG003|Overall Study|Lost to Follow-up|3|||
17189667|NCT02980133|38342624|FG000|Overall Study|Protocol Violation|0|||
17189668|NCT02980133|38342625|FG001|Overall Study|Protocol Violation|1|||
17189669|NCT02980133|38342626|FG002|Overall Study|Protocol Violation|0|||
16782749|NCT02058160|37722376|FG000|Overall Study|Adverse Event|12|||
16782750|NCT02058160|37722377|FG001|Overall Study|Adverse Event|3|||
17091421|NCT00296504|38231295|FG000|Interim Analysis|Pregnancy|4|||
17091422|NCT00296504|38231296|FG001|Interim Analysis|Pregnancy|1|||
17091423|NCT00296504|38231297|FG002|Interim Analysis|Pregnancy|4|||
17091424|NCT00296504|38231298|FG003|Interim Analysis|Pregnancy|2|||
17091425|NCT00296504|38231299|FG004|Interim Analysis|Pregnancy|0|||
17091426|NCT00296504|38231300|FG005|Interim Analysis|Pregnancy|1|||
17091427|NCT00296504|38231301|FG006|Interim Analysis|Pregnancy|1|||
17091428|NCT00296504|38231302|FG007|Interim Analysis|Pregnancy|1|||
17091429|NCT00296504|38231303|FG008|Interim Analysis|Pregnancy|0|||
17091430|NCT00296504|38231295|FG000|Interim Analysis|Death|1|||
17091431|NCT00296504|38231296|FG001|Interim Analysis|Death|0|||
17091432|NCT00296504|38231297|FG002|Interim Analysis|Death|3|||
17091433|NCT00296504|38231298|FG003|Interim Analysis|Death|0|||
17091434|NCT00296504|38231299|FG004|Interim Analysis|Death|0|||
17091435|NCT00296504|38231300|FG005|Interim Analysis|Death|0|||
17091436|NCT00296504|38231301|FG006|Interim Analysis|Death|0|||
17091437|NCT00296504|38231302|FG007|Interim Analysis|Death|0|||
17091438|NCT00296504|38231303|FG008|Interim Analysis|Death|0|||
17091439|NCT00296504|38231295|FG000|Interim Analysis|Participant Non-compliant|0|||
17091440|NCT00296504|38231296|FG001|Interim Analysis|Participant Non-compliant|1|||
17091441|NCT00296504|38231297|FG002|Interim Analysis|Participant Non-compliant|2|||
17091442|NCT00296504|38231298|FG003|Interim Analysis|Participant Non-compliant|1|||
17091443|NCT00296504|38231299|FG004|Interim Analysis|Participant Non-compliant|1|||
17091444|NCT00296504|38231300|FG005|Interim Analysis|Participant Non-compliant|3|||
17091445|NCT00296504|38231301|FG006|Interim Analysis|Participant Non-compliant|6|||
17091446|NCT00296504|38231302|FG007|Interim Analysis|Participant Non-compliant|2|||
17091447|NCT00296504|38231303|FG008|Interim Analysis|Participant Non-compliant|0|||
17091448|NCT00296504|38231295|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
17091449|NCT00296504|38231296|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
17091450|NCT00296504|38231297|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
17189670|NCT02980133|38342627|FG003|Overall Study|Protocol Violation|0|||
17091451|NCT00296504|38231298|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
17091452|NCT00296504|38231299|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
17091453|NCT00296504|38231300|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
17091454|NCT00296504|38231301|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
17091455|NCT00296504|38231302|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
17091456|NCT00296504|38231303|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
17091457|NCT00296504|38231295|FG000|Interim Analysis|To Simplify Treatment|0|||
17091458|NCT00296504|38231296|FG001|Interim Analysis|To Simplify Treatment|0|||
17091459|NCT00296504|38231297|FG002|Interim Analysis|To Simplify Treatment|1|||
17091460|NCT00296504|38231298|FG003|Interim Analysis|To Simplify Treatment|0|||
17091461|NCT00296504|38231299|FG004|Interim Analysis|To Simplify Treatment|0|||
17091462|NCT00296504|38231300|FG005|Interim Analysis|To Simplify Treatment|0|||
17091463|NCT00296504|38231301|FG006|Interim Analysis|To Simplify Treatment|2|||
17091464|NCT00296504|38231302|FG007|Interim Analysis|To Simplify Treatment|0|||
17091465|NCT00296504|38231303|FG008|Interim Analysis|To Simplify Treatment|0|||
17091466|NCT00296504|38231295|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
17091467|NCT00296504|38231296|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
17091468|NCT00296504|38231297|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
17091469|NCT00296504|38231298|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
17091470|NCT00296504|38231299|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
17091471|NCT00296504|38231300|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
17091472|NCT00296504|38231301|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
17091473|NCT00296504|38231302|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
17091474|NCT00296504|38231303|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
17091475|NCT00296504|38231295|FG000|Interim Analysis|Participant Moved|1|||
17091476|NCT00296504|38231296|FG001|Interim Analysis|Participant Moved|0|||
17091477|NCT00296504|38231297|FG002|Interim Analysis|Participant Moved|1|||
17091478|NCT00296504|38231298|FG003|Interim Analysis|Participant Moved|0|||
17091479|NCT00296504|38231299|FG004|Interim Analysis|Participant Moved|0|||
17091480|NCT00296504|38231300|FG005|Interim Analysis|Participant Moved|1|||
17091481|NCT00296504|38231301|FG006|Interim Analysis|Participant Moved|1|||
17091482|NCT00296504|38231302|FG007|Interim Analysis|Participant Moved|0|||
17091483|NCT00296504|38231303|FG008|Interim Analysis|Participant Moved|0|||
17091484|NCT00296504|38231295|FG000|Interim Analysis|Participant Was Incarcerated|2|||
17091485|NCT00296504|38231296|FG001|Interim Analysis|Participant Was Incarcerated|0|||
17091486|NCT00296504|38231297|FG002|Interim Analysis|Participant Was Incarcerated|1|||
17091487|NCT00296504|38231298|FG003|Interim Analysis|Participant Was Incarcerated|0|||
17091488|NCT00296504|38231299|FG004|Interim Analysis|Participant Was Incarcerated|0|||
17091489|NCT00296504|38231300|FG005|Interim Analysis|Participant Was Incarcerated|0|||
17091490|NCT00296504|38231301|FG006|Interim Analysis|Participant Was Incarcerated|0|||
17091491|NCT00296504|38231302|FG007|Interim Analysis|Participant Was Incarcerated|0|||
17091492|NCT00296504|38231303|FG008|Interim Analysis|Participant Was Incarcerated|0|||
17091493|NCT00296504|38231295|FG000|Interim Analysis|Resistance to FPV|0|||
17091494|NCT00296504|38231296|FG001|Interim Analysis|Resistance to FPV|0|||
17091495|NCT00296504|38231297|FG002|Interim Analysis|Resistance to FPV|1|||
17091496|NCT00296504|38231298|FG003|Interim Analysis|Resistance to FPV|0|||
17091497|NCT00296504|38231299|FG004|Interim Analysis|Resistance to FPV|0|||
17091498|NCT00296504|38231300|FG005|Interim Analysis|Resistance to FPV|0|||
17091499|NCT00296504|38231301|FG006|Interim Analysis|Resistance to FPV|0|||
17091500|NCT00296504|38231302|FG007|Interim Analysis|Resistance to FPV|0|||
17091501|NCT00296504|38231303|FG008|Interim Analysis|Resistance to FPV|0|||
17091502|NCT00296504|38231295|FG000|Interim Analysis|Physician Decision|0|||
17091503|NCT00296504|38231296|FG001|Interim Analysis|Physician Decision|0|||
17091504|NCT00296504|38231297|FG002|Interim Analysis|Physician Decision|1|||
17091505|NCT00296504|38231298|FG003|Interim Analysis|Physician Decision|0|||
17091506|NCT00296504|38231299|FG004|Interim Analysis|Physician Decision|0|||
17091507|NCT00296504|38231300|FG005|Interim Analysis|Physician Decision|0|||
17091508|NCT00296504|38231301|FG006|Interim Analysis|Physician Decision|0|||
17091509|NCT00296504|38231302|FG007|Interim Analysis|Physician Decision|0|||
17091510|NCT00296504|38231303|FG008|Interim Analysis|Physician Decision|0|||
17091511|NCT00296504|38231295|FG000|Interim Analysis|Principle Investigator Discretion|2|||
17091512|NCT00296504|38231296|FG001|Interim Analysis|Principle Investigator Discretion|0|||
17091513|NCT00296504|38231297|FG002|Interim Analysis|Principle Investigator Discretion|1|||
17091514|NCT00296504|38231298|FG003|Interim Analysis|Principle Investigator Discretion|1|||
17091515|NCT00296504|38231299|FG004|Interim Analysis|Principle Investigator Discretion|0|||
17091516|NCT00296504|38231300|FG005|Interim Analysis|Principle Investigator Discretion|0|||
17091517|NCT00296504|38231301|FG006|Interim Analysis|Principle Investigator Discretion|0|||
17091518|NCT00296504|38231302|FG007|Interim Analysis|Principle Investigator Discretion|0|||
17091519|NCT00296504|38231303|FG008|Interim Analysis|Principle Investigator Discretion|0|||
17091520|NCT00296504|38231295|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
17091521|NCT00296504|38231296|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
17189671|NCT02980133|38342624|FG000|Overall Study|Withdrawal by parent/guardian|6|||
17189672|NCT02980133|38342625|FG001|Overall Study|Withdrawal by parent/guardian|3|||
17189673|NCT02980133|38342626|FG002|Overall Study|Withdrawal by parent/guardian|3|||
17189674|NCT02980133|38342627|FG003|Overall Study|Withdrawal by parent/guardian|1|||
17189675|NCT02980133|38342624|FG000|Overall Study|Withdrawal by Subject|0|||
17189676|NCT02980133|38342625|FG001|Overall Study|Withdrawal by Subject|0|||
17189677|NCT02980133|38342626|FG002|Overall Study|Withdrawal by Subject|1|||
17189678|NCT02980133|38342627|FG003|Overall Study|Withdrawal by Subject|0|||
17189679|NCT02979431|38342644|FG000|Overall Study|Parent/guardian withdrew consent|2|||
17189680|NCT02979431|38342645|FG001|Overall Study|Parent/guardian withdrew consent|1|||
17189681|NCT02979431|38342646|FG002|Overall Study|Parent/guardian withdrew consent|1|||
17189682|NCT02979431|38342647|FG003|Overall Study|Parent/guardian withdrew consent|1|||
17189683|NCT02979431|38342644|FG000|Overall Study|Randomized but received no study drug|1|||
17189684|NCT02979431|38342645|FG001|Overall Study|Randomized but received no study drug|1|||
17189685|NCT02979431|38342646|FG002|Overall Study|Randomized but received no study drug|0|||
17189686|NCT02979431|38342647|FG003|Overall Study|Randomized but received no study drug|0|||
17189687|NCT02979431|38342644|FG000|Overall Study|Adverse Event|0|||
17189688|NCT02979431|38342645|FG001|Overall Study|Adverse Event|0|||
17189689|NCT02979431|38342646|FG002|Overall Study|Adverse Event|1|||
17189690|NCT02979431|38342647|FG003|Overall Study|Adverse Event|0|||
17189691|NCT02979431|38342644|FG000|Overall Study|Subject left country after Day14|1|||
17189692|NCT02979431|38342645|FG001|Overall Study|Subject left country after Day14|0|||
17189693|NCT02979431|38342646|FG002|Overall Study|Subject left country after Day14|0|||
17189694|NCT02979431|38342647|FG003|Overall Study|Subject left country after Day14|0|||
17189695|NCT02978417|38342659|FG000|Overall Study|Lost to Follow-up|2|||
17189696|NCT02978417|38342660|FG001|Overall Study|Lost to Follow-up|2|||
17189697|NCT04368429|38342668|FG000|Overall Study|Adverse Event|1|||
17189698|NCT04368429|38342669|FG001|Overall Study|Adverse Event|0|||
17189699|NCT02733627|38342679|FG000|Overall Study|Adverse Event|0|||
17189700|NCT02733627|38342680|FG001|Overall Study|Adverse Event|1|||
17189701|NCT02733627|38342681|FG002|Overall Study|Adverse Event|1|||
17189702|NCT02733627|38342682|FG003|Overall Study|Adverse Event|0|||
17189703|NCT02733627|38342679|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
17189704|NCT02733627|38342680|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
17189705|NCT02733627|38342681|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
17189706|NCT02733627|38342682|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
17189707|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189708|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
17189709|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189710|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
17091522|NCT00296504|38231297|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
17091523|NCT00296504|38231298|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
17091524|NCT00296504|38231299|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
17091525|NCT00296504|38231300|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
17091526|NCT00296504|38231301|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
17091527|NCT00296504|38231302|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
17091528|NCT00296504|38231303|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
17091529|NCT00296504|38231295|FG000|Interim Analysis|Non-adherence|2|||
17091530|NCT00296504|38231296|FG001|Interim Analysis|Non-adherence|0|||
17091531|NCT00296504|38231297|FG002|Interim Analysis|Non-adherence|0|||
17091532|NCT00296504|38231298|FG003|Interim Analysis|Non-adherence|0|||
17091533|NCT00296504|38231299|FG004|Interim Analysis|Non-adherence|1|||
17091534|NCT00296504|38231300|FG005|Interim Analysis|Non-adherence|0|||
17091535|NCT00296504|38231301|FG006|Interim Analysis|Non-adherence|0|||
17091536|NCT00296504|38231302|FG007|Interim Analysis|Non-adherence|1|||
17091537|NCT00296504|38231303|FG008|Interim Analysis|Non-adherence|0|||
17091538|NCT00296504|38231295|FG000|Interim Analysis|Site Closing|1|||
17091539|NCT00296504|38231296|FG001|Interim Analysis|Site Closing|0|||
17091540|NCT00296504|38231297|FG002|Interim Analysis|Site Closing|0|||
17091541|NCT00296504|38231298|FG003|Interim Analysis|Site Closing|0|||
17091542|NCT00296504|38231299|FG004|Interim Analysis|Site Closing|0|||
17091543|NCT00296504|38231300|FG005|Interim Analysis|Site Closing|1|||
17091544|NCT00296504|38231301|FG006|Interim Analysis|Site Closing|2|||
17091545|NCT00296504|38231302|FG007|Interim Analysis|Site Closing|0|||
17091546|NCT00296504|38231303|FG008|Interim Analysis|Site Closing|0|||
17091547|NCT00296504|38231295|FG000|Interim Analysis|Lack of Personnel at Site|1|||
17091548|NCT00296504|38231296|FG001|Interim Analysis|Lack of Personnel at Site|0|||
17091549|NCT00296504|38231297|FG002|Interim Analysis|Lack of Personnel at Site|0|||
17091550|NCT00296504|38231298|FG003|Interim Analysis|Lack of Personnel at Site|0|||
17091551|NCT00296504|38231299|FG004|Interim Analysis|Lack of Personnel at Site|0|||
17091552|NCT00296504|38231300|FG005|Interim Analysis|Lack of Personnel at Site|0|||
17091553|NCT00296504|38231301|FG006|Interim Analysis|Lack of Personnel at Site|0|||
17091554|NCT00296504|38231302|FG007|Interim Analysis|Lack of Personnel at Site|0|||
17091555|NCT00296504|38231303|FG008|Interim Analysis|Lack of Personnel at Site|0|||
17091556|NCT00296504|38231295|FG000|Interim Analysis|Missed Schedule Date|1|||
17091557|NCT00296504|38231296|FG001|Interim Analysis|Missed Schedule Date|0|||
17091558|NCT00296504|38231297|FG002|Interim Analysis|Missed Schedule Date|0|||
17091559|NCT00296504|38231298|FG003|Interim Analysis|Missed Schedule Date|0|||
17091560|NCT00296504|38231299|FG004|Interim Analysis|Missed Schedule Date|0|||
17091561|NCT00296504|38231300|FG005|Interim Analysis|Missed Schedule Date|0|||
17091562|NCT00296504|38231301|FG006|Interim Analysis|Missed Schedule Date|0|||
17091563|NCT00296504|38231302|FG007|Interim Analysis|Missed Schedule Date|0|||
17091564|NCT00296504|38231303|FG008|Interim Analysis|Missed Schedule Date|0|||
17091565|NCT00296504|38231295|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
17091566|NCT00296504|38231296|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
17091567|NCT00296504|38231297|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
17091568|NCT00296504|38231298|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
17091569|NCT00296504|38231299|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
17091570|NCT00296504|38231300|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
17091571|NCT00296504|38231301|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
17091572|NCT00296504|38231302|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
17091573|NCT00296504|38231303|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
17091574|NCT00296504|38231295|FG000|Interim Analysis|Participant Stopped|0|||
17091575|NCT00296504|38231296|FG001|Interim Analysis|Participant Stopped|0|||
17091576|NCT00296504|38231297|FG002|Interim Analysis|Participant Stopped|0|||
17091577|NCT00296504|38231298|FG003|Interim Analysis|Participant Stopped|0|||
17091578|NCT00296504|38231299|FG004|Interim Analysis|Participant Stopped|1|||
17091579|NCT00296504|38231300|FG005|Interim Analysis|Participant Stopped|0|||
17091580|NCT00296504|38231301|FG006|Interim Analysis|Participant Stopped|0|||
17189711|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
17189712|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
17189713|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
17189714|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189715|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189716|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17091581|NCT00296504|38231302|FG007|Interim Analysis|Participant Stopped|0|||
17091582|NCT00296504|38231303|FG008|Interim Analysis|Participant Stopped|0|||
17091583|NCT00296504|38231295|FG000|Interim Analysis|Physician and Participant Decision|0|||
17091584|NCT00296504|38231296|FG001|Interim Analysis|Physician and Participant Decision|0|||
17189717|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189718|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189719|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189720|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189721|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189722|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
17189723|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
17189724|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
17189725|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
17189726|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
17189727|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
17189728|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
16782751|NCT02058160|37722376|FG000|Overall Study|Lost to Follow-up|1|||
16782752|NCT02058160|37722377|FG001|Overall Study|Lost to Follow-up|0|||
17091585|NCT00296504|38231297|FG002|Interim Analysis|Physician and Participant Decision|0|||
17091586|NCT00296504|38231298|FG003|Interim Analysis|Physician and Participant Decision|0|||
17091587|NCT00296504|38231299|FG004|Interim Analysis|Physician and Participant Decision|0|||
17091588|NCT00296504|38231300|FG005|Interim Analysis|Physician and Participant Decision|1|||
17091589|NCT00296504|38231301|FG006|Interim Analysis|Physician and Participant Decision|0|||
17091590|NCT00296504|38231302|FG007|Interim Analysis|Physician and Participant Decision|0|||
17091591|NCT00296504|38231303|FG008|Interim Analysis|Physician and Participant Decision|0|||
17091592|NCT00296504|38231295|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
17091593|NCT00296504|38231296|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
17091594|NCT00296504|38231297|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
17091595|NCT00296504|38231298|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
17091596|NCT00296504|38231299|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
17091597|NCT00296504|38231300|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
17091598|NCT00296504|38231301|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
17091599|NCT00296504|38231302|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
17091600|NCT00296504|38231303|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
17091601|NCT00296504|38231295|FG000|Interim Analysis|Study Ended|0|||
17091602|NCT00296504|38231296|FG001|Interim Analysis|Study Ended|0|||
17091603|NCT00296504|38231297|FG002|Interim Analysis|Study Ended|0|||
17189729|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
17091604|NCT00296504|38231298|FG003|Interim Analysis|Study Ended|0|||
17091605|NCT00296504|38231299|FG004|Interim Analysis|Study Ended|0|||
17091606|NCT00296504|38231300|FG005|Interim Analysis|Study Ended|0|||
17091607|NCT00296504|38231301|FG006|Interim Analysis|Study Ended|1|||
17091608|NCT00296504|38231302|FG007|Interim Analysis|Study Ended|0|||
17091609|NCT00296504|38231303|FG008|Interim Analysis|Study Ended|0|||
17091610|NCT00296504|38231295|FG000|Interim Analysis|Participant Needed Interferon|0|||
17091611|NCT00296504|38231296|FG001|Interim Analysis|Participant Needed Interferon|0|||
17091612|NCT00296504|38231297|FG002|Interim Analysis|Participant Needed Interferon|0|||
17091613|NCT00296504|38231298|FG003|Interim Analysis|Participant Needed Interferon|0|||
17091614|NCT00296504|38231299|FG004|Interim Analysis|Participant Needed Interferon|0|||
17189730|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
17189731|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
17091615|NCT00296504|38231300|FG005|Interim Analysis|Participant Needed Interferon|0|||
17091616|NCT00296504|38231301|FG006|Interim Analysis|Participant Needed Interferon|0|||
17091617|NCT00296504|38231302|FG007|Interim Analysis|Participant Needed Interferon|1|||
17091618|NCT00296504|38231303|FG008|Interim Analysis|Participant Needed Interferon|0|||
17091619|NCT00296504|38231295|FG000|Interim Analysis|Ongoing|32|||
17091620|NCT00296504|38231296|FG001|Interim Analysis|Ongoing|12|||
17091621|NCT00296504|38231297|FG002|Interim Analysis|Ongoing|16|||
17091622|NCT00296504|38231298|FG003|Interim Analysis|Ongoing|22|||
17091623|NCT00296504|38231299|FG004|Interim Analysis|Ongoing|0|||
17091624|NCT00296504|38231300|FG005|Interim Analysis|Ongoing|0|||
17091625|NCT00296504|38231301|FG006|Interim Analysis|Ongoing|30|||
17091626|NCT00296504|38231302|FG007|Interim Analysis|Ongoing|1|||
17091627|NCT00296504|38231303|FG008|Interim Analysis|Ongoing|0|||
17091628|NCT00296504|38231295|FG000|Final Analysis|Withdrawal by Subject|0|||
17091629|NCT00296504|38231296|FG001|Final Analysis|Withdrawal by Subject|0|||
17091630|NCT00296504|38231297|FG002|Final Analysis|Withdrawal by Subject|0|||
17091631|NCT00296504|38231298|FG003|Final Analysis|Withdrawal by Subject|0|||
17091632|NCT00296504|38231299|FG004|Final Analysis|Withdrawal by Subject|0|||
17091633|NCT00296504|38231300|FG005|Final Analysis|Withdrawal by Subject|0|||
17091634|NCT00296504|38231301|FG006|Final Analysis|Withdrawal by Subject|0|||
17091635|NCT00296504|38231302|FG007|Final Analysis|Withdrawal by Subject|0|||
17091636|NCT00296504|38231303|FG008|Final Analysis|Withdrawal by Subject|1|||
17091637|NCT00296504|38231295|FG000|Final Analysis|Lost to Follow-up|0|||
17091638|NCT00296504|38231296|FG001|Final Analysis|Lost to Follow-up|0|||
17091639|NCT00296504|38231297|FG002|Final Analysis|Lost to Follow-up|0|||
17091640|NCT00296504|38231298|FG003|Final Analysis|Lost to Follow-up|0|||
17091641|NCT00296504|38231299|FG004|Final Analysis|Lost to Follow-up|0|||
17091642|NCT00296504|38231300|FG005|Final Analysis|Lost to Follow-up|0|||
17091643|NCT00296504|38231301|FG006|Final Analysis|Lost to Follow-up|0|||
17091644|NCT00296504|38231302|FG007|Final Analysis|Lost to Follow-up|0|||
17091645|NCT00296504|38231303|FG008|Final Analysis|Lost to Follow-up|5|||
17091646|NCT00296504|38231295|FG000|Final Analysis|Insufficient Viral Load Response|0|||
17091647|NCT00296504|38231296|FG001|Final Analysis|Insufficient Viral Load Response|0|||
17091648|NCT00296504|38231297|FG002|Final Analysis|Insufficient Viral Load Response|0|||
17091649|NCT00296504|38231298|FG003|Final Analysis|Insufficient Viral Load Response|0|||
17091650|NCT00296504|38231299|FG004|Final Analysis|Insufficient Viral Load Response|0|||
17091651|NCT00296504|38231300|FG005|Final Analysis|Insufficient Viral Load Response|0|||
17091652|NCT00296504|38231301|FG006|Final Analysis|Insufficient Viral Load Response|0|||
17091653|NCT00296504|38231302|FG007|Final Analysis|Insufficient Viral Load Response|0|||
17091654|NCT00296504|38231303|FG008|Final Analysis|Insufficient Viral Load Response|6|||
17091655|NCT00296504|38231295|FG000|Final Analysis|Adverse Event|0|||
17189732|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
17189733|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
17189734|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
17189735|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
17189736|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
17189737|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
17189738|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
17189739|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
17189740|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
17189741|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189742|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189743|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189744|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189745|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189746|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17091656|NCT00296504|38231296|FG001|Final Analysis|Adverse Event|0|||
17091657|NCT00296504|38231297|FG002|Final Analysis|Adverse Event|0|||
17091658|NCT00296504|38231298|FG003|Final Analysis|Adverse Event|0|||
17091659|NCT00296504|38231299|FG004|Final Analysis|Adverse Event|0|||
17091660|NCT00296504|38231300|FG005|Final Analysis|Adverse Event|0|||
17189747|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189748|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189749|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189750|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189751|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189752|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189753|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189754|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
17189755|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
17189756|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189757|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
17189758|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
17189759|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
17189760|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
17189761|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
17189762|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189763|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189764|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189765|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189766|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189767|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189768|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189769|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189770|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
17189771|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189772|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189773|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189774|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
17189775|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189776|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189777|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
17189778|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189779|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17091661|NCT00296504|38231301|FG006|Final Analysis|Adverse Event|0|||
17091662|NCT00296504|38231302|FG007|Final Analysis|Adverse Event|0|||
17091663|NCT00296504|38231303|FG008|Final Analysis|Adverse Event|2|||
17091664|NCT00296504|38231295|FG000|Final Analysis|Pregnancy|0|||
17091665|NCT00296504|38231296|FG001|Final Analysis|Pregnancy|0|||
17091666|NCT00296504|38231297|FG002|Final Analysis|Pregnancy|0|||
17091667|NCT00296504|38231298|FG003|Final Analysis|Pregnancy|0|||
17091668|NCT00296504|38231299|FG004|Final Analysis|Pregnancy|0|||
17091669|NCT00296504|38231300|FG005|Final Analysis|Pregnancy|0|||
17091670|NCT00296504|38231301|FG006|Final Analysis|Pregnancy|0|||
17091671|NCT00296504|38231302|FG007|Final Analysis|Pregnancy|0|||
17091672|NCT00296504|38231303|FG008|Final Analysis|Pregnancy|4|||
17091673|NCT00296504|38231295|FG000|Final Analysis|Tuberculosis|0|||
17091674|NCT00296504|38231296|FG001|Final Analysis|Tuberculosis|0|||
17091675|NCT00296504|38231297|FG002|Final Analysis|Tuberculosis|0|||
17091676|NCT00296504|38231298|FG003|Final Analysis|Tuberculosis|0|||
17091677|NCT00296504|38231299|FG004|Final Analysis|Tuberculosis|0|||
17091678|NCT00296504|38231300|FG005|Final Analysis|Tuberculosis|0|||
17091679|NCT00296504|38231301|FG006|Final Analysis|Tuberculosis|0|||
17091680|NCT00296504|38231302|FG007|Final Analysis|Tuberculosis|0|||
17091681|NCT00296504|38231303|FG008|Final Analysis|Tuberculosis|1|||
17091682|NCT00296504|38231295|FG000|Final Analysis|Participant Moved to Another Country|0|||
17091683|NCT00296504|38231296|FG001|Final Analysis|Participant Moved to Another Country|0|||
17091684|NCT00296504|38231297|FG002|Final Analysis|Participant Moved to Another Country|0|||
17189780|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189781|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189782|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189783|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189784|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189785|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189786|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
17189787|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16868356|NCT02655016|37841428|FG000|Overall Study|Disease progression|6|||
17091685|NCT00296504|38231298|FG003|Final Analysis|Participant Moved to Another Country|0|||
17091686|NCT00296504|38231299|FG004|Final Analysis|Participant Moved to Another Country|0|||
17091687|NCT00296504|38231300|FG005|Final Analysis|Participant Moved to Another Country|0|||
17091688|NCT00296504|38231301|FG006|Final Analysis|Participant Moved to Another Country|0|||
17091689|NCT00296504|38231302|FG007|Final Analysis|Participant Moved to Another Country|0|||
17091690|NCT00296504|38231303|FG008|Final Analysis|Participant Moved to Another Country|1|||
17091691|NCT00296504|38231295|FG000|Final Analysis|Poor Adherence|0|||
17091692|NCT00296504|38231296|FG001|Final Analysis|Poor Adherence|0|||
17091693|NCT00296504|38231297|FG002|Final Analysis|Poor Adherence|0|||
17091694|NCT00296504|38231298|FG003|Final Analysis|Poor Adherence|0|||
17091695|NCT00296504|38231299|FG004|Final Analysis|Poor Adherence|0|||
17091696|NCT00296504|38231300|FG005|Final Analysis|Poor Adherence|0|||
17091697|NCT00296504|38231301|FG006|Final Analysis|Poor Adherence|0|||
17189788|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189789|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
17189790|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189791|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189792|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189793|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189794|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189795|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189796|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189797|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189798|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189799|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189800|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189801|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189802|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
17189803|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
17189804|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
17189805|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
17189806|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189807|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189808|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189809|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189810|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189811|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189812|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189813|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189814|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189815|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189816|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189817|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189818|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
17189819|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
17189820|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
17189821|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
17189822|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
17189823|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
17189824|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
17189825|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
17091698|NCT00296504|38231302|FG007|Final Analysis|Poor Adherence|0|||
17091699|NCT00296504|38231303|FG008|Final Analysis|Poor Adherence|1|||
17091700|NCT00313820|38231330|FG000|Assigned to Treatment|Other|1|||
17091701|NCT00313820|38231331|FG001|Assigned to Treatment|Other|0|||
17091702|NCT00313820|38231330|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
17091703|NCT00313820|38231331|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
17091704|NCT00313820|38231330|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
17091705|NCT00313820|38231331|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
17091706|NCT00313820|38231330|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
17091707|NCT00313820|38231331|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
17091708|NCT00313820|38231330|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
17091709|NCT00313820|38231331|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
17091710|NCT00313820|38231330|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
17091711|NCT00313820|38231331|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
17091712|NCT00462761|38231337|FG000|Overall Study|Adverse Event|6|||
17091713|NCT00462761|38231337|FG000|Overall Study|Withdrawal by Subject|9|||
17091714|NCT00462761|38231337|FG000|Overall Study|Physician Decision|5|||
17091715|NCT00462761|38231337|FG000|Overall Study|Disease progression|43|||
17091716|NCT00462761|38231337|FG000|Overall Study|Death|12|||
17091717|NCT00462761|38231337|FG000|Overall Study|Other|1|||
17091718|NCT00235872|38231369|FG000|Overall Study|Adverse Event|34|||
17091719|NCT00235872|38231369|FG000|Overall Study|Death|1|||
17091720|NCT00235872|38231369|FG000|Overall Study|Lost to Follow-up|1|||
17091721|NCT00235872|38231369|FG000|Overall Study|Withdrawal by Subject|50|||
17091722|NCT00235872|38231369|FG000|Overall Study|Administrative reason|61|||
17091723|NCT00461981|38231375|FG000|Overall Study|Lost to Follow-up|9|||
17091724|NCT00461981|38231376|FG001|Overall Study|Lost to Follow-up|6|||
17091725|NCT00461981|38231375|FG000|Overall Study|Withdrawal by Subject|2|||
17091726|NCT00461981|38231376|FG001|Overall Study|Withdrawal by Subject|3|||
17091727|NCT00296036|38231384|FG000|Overall Study|Withdrawal by Subject|1|||
17091728|NCT00296036|38231385|FG001|Overall Study|Withdrawal by Subject|0|||
17091729|NCT00296036|38231386|FG002|Overall Study|Withdrawal by Subject|2|||
17091730|NCT00296036|38231387|FG003|Overall Study|Withdrawal by Subject|1|||
17091731|NCT00296036|38231388|FG004|Overall Study|Withdrawal by Subject|2|||
17091732|NCT00296036|38231389|FG005|Overall Study|Withdrawal by Subject|1|||
17091733|NCT00296036|38231384|FG000|Overall Study|Protocol Violation|0|||
17091734|NCT00296036|38231385|FG001|Overall Study|Protocol Violation|0|||
17091735|NCT00296036|38231386|FG002|Overall Study|Protocol Violation|0|||
17091736|NCT00296036|38231387|FG003|Overall Study|Protocol Violation|0|||
17091737|NCT00296036|38231388|FG004|Overall Study|Protocol Violation|0|||
17091738|NCT00296036|38231389|FG005|Overall Study|Protocol Violation|3|||
17091739|NCT00089674|38231408|FG000|Overall Study|Physician Decision|4|||
17091740|NCT00089674|38231409|FG001|Overall Study|Physician Decision|2|||
17091741|NCT00089674|38231408|FG000|Overall Study|Adverse Event|23|||
17091742|NCT00089674|38231409|FG001|Overall Study|Adverse Event|29|||
17091743|NCT00089674|38231408|FG000|Overall Study|Withdrawal by Subject|143|||
17091744|NCT00089674|38231409|FG001|Overall Study|Withdrawal by Subject|127|||
17091745|NCT00089674|38231408|FG000|Overall Study|Death|43|||
17091746|NCT00089674|38231409|FG001|Overall Study|Death|43|||
17091747|NCT00089674|38231408|FG000|Overall Study|Disease progression|21|||
17091748|NCT00089674|38231409|FG001|Overall Study|Disease progression|23|||
17091749|NCT00089674|38231408|FG000|Overall Study|Ineligibility determined|8|||
17091750|NCT00089674|38231409|FG001|Overall Study|Ineligibility determined|10|||
17091751|NCT00089674|38231408|FG000|Overall Study|Lost to Follow-up|21|||
17091752|NCT00089674|38231409|FG001|Overall Study|Lost to Follow-up|17|||
17091753|NCT00089674|38231408|FG000|Overall Study|Noncompliance|7|||
17091754|NCT00089674|38231409|FG001|Overall Study|Noncompliance|3|||
17091755|NCT00089674|38231408|FG000|Overall Study|Other|5|||
17091756|NCT00089674|38231409|FG001|Overall Study|Other|9|||
17091757|NCT00089674|38231408|FG000|Overall Study|Requirement for alternative therapy|14|||
17091758|NCT00089674|38231409|FG001|Overall Study|Requirement for alternative therapy|4|||
17091759|NCT00313586|38231419|FG000|Overall Study|Disease progression|14|||
17091760|NCT00313586|38231420|FG001|Overall Study|Disease progression|19|||
17091761|NCT00313586|38231421|FG002|Overall Study|Disease progression|10|||
17091762|NCT00313586|38231422|FG003|Overall Study|Disease progression|3|||
17091763|NCT00313586|38231419|FG000|Overall Study|Adverse Event|12|||
17091764|NCT00313586|38231420|FG001|Overall Study|Adverse Event|18|||
17091765|NCT00313586|38231421|FG002|Overall Study|Adverse Event|3|||
17091766|NCT00313586|38231422|FG003|Overall Study|Adverse Event|10|||
17091767|NCT00313586|38231419|FG000|Overall Study|Death|11|||
17091768|NCT00313586|38231420|FG001|Overall Study|Death|8|||
17091769|NCT00313586|38231421|FG002|Overall Study|Death|1|||
17091770|NCT00313586|38231422|FG003|Overall Study|Death|7|||
17091771|NCT00313586|38231419|FG000|Overall Study|Withdrawal by Subject|13|||
17091772|NCT00313586|38231420|FG001|Overall Study|Withdrawal by Subject|6|||
17091773|NCT00313586|38231421|FG002|Overall Study|Withdrawal by Subject|6|||
17091774|NCT00313586|38231422|FG003|Overall Study|Withdrawal by Subject|2|||
17091775|NCT00313586|38231419|FG000|Overall Study|Alternative therapy|3|||
17091776|NCT00313586|38231420|FG001|Overall Study|Alternative therapy|6|||
17091777|NCT00313586|38231421|FG002|Overall Study|Alternative therapy|2|||
17091778|NCT00313586|38231422|FG003|Overall Study|Alternative therapy|0|||
17091779|NCT00313586|38231419|FG000|Overall Study|Other complicating disease|2|||
17091780|NCT00313586|38231420|FG001|Overall Study|Other complicating disease|2|||
17091781|NCT00313586|38231421|FG002|Overall Study|Other complicating disease|0|||
17091782|NCT00313586|38231422|FG003|Overall Study|Other complicating disease|0|||
17091783|NCT00313586|38231419|FG000|Overall Study|Did not achieve HI-major/better response|10|||
17091784|NCT00313586|38231420|FG001|Overall Study|Did not achieve HI-major/better response|7|||
17091785|NCT00313586|38231421|FG002|Overall Study|Did not achieve HI-major/better response|2|||
17091786|NCT00313586|38231422|FG003|Overall Study|Did not achieve HI-major/better response|1|||
17091787|NCT00313586|38231419|FG000|Overall Study|Physician Decision|2|||
17091788|NCT00313586|38231420|FG001|Overall Study|Physician Decision|1|||
17091789|NCT00313586|38231421|FG002|Overall Study|Physician Decision|0|||
17091790|NCT00313586|38231422|FG003|Overall Study|Physician Decision|0|||
17091791|NCT00313586|38231419|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
17091792|NCT00313586|38231420|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
17091793|NCT00313586|38231421|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
17091794|NCT00313586|38231422|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
17091795|NCT00313586|38231419|FG000|Overall Study|Lost insurance|0|||
17091796|NCT00313586|38231420|FG001|Overall Study|Lost insurance|1|||
17091797|NCT00313586|38231421|FG002|Overall Study|Lost insurance|0|||
17091798|NCT00313586|38231422|FG003|Overall Study|Lost insurance|0|||
17091799|NCT00313586|38231419|FG000|Overall Study|Moved|0|||
17091800|NCT00313586|38231420|FG001|Overall Study|Moved|1|||
17091801|NCT00313586|38231421|FG002|Overall Study|Moved|0|||
17091802|NCT00313586|38231422|FG003|Overall Study|Moved|0|||
17091803|NCT00313586|38231419|FG000|Overall Study|Death before starting treatment|1|||
17091804|NCT00313586|38231420|FG001|Overall Study|Death before starting treatment|0|||
17091805|NCT00313586|38231421|FG002|Overall Study|Death before starting treatment|0|||
17091806|NCT00313586|38231422|FG003|Overall Study|Death before starting treatment|0|||
17091807|NCT00312572|38231432|FG000|Overall Study|Adverse Event|10|||
17091808|NCT00312572|38231433|FG001|Overall Study|Adverse Event|16|||
17091809|NCT00312572|38231432|FG000|Overall Study|Lost to Follow-up|1|||
17091810|NCT00312572|38231433|FG001|Overall Study|Lost to Follow-up|1|||
17091811|NCT00312572|38231432|FG000|Overall Study|Administrative|4|||
17091812|NCT00312572|38231433|FG001|Overall Study|Administrative|2|||
17091813|NCT00312572|38231432|FG000|Overall Study|Lack of Efficacy|1|||
17091814|NCT00312572|38231433|FG001|Overall Study|Lack of Efficacy|2|||
17091815|NCT00290888|38231443|FG000|Overall Study|Physician Decision|3|||
17091816|NCT00290888|38231444|FG001|Overall Study|Physician Decision|1|||
17091817|NCT00290732|38231453|FG000|Overall Study|Inability to instill drug intraductally.|0|||
17091818|NCT00290732|38231454|FG001|Overall Study|Inability to instill drug intraductally.|1|||
17091819|NCT00290732|38231455|FG002|Overall Study|Inability to instill drug intraductally.|1|||
17091820|NCT00290732|38231456|FG003|Overall Study|Inability to instill drug intraductally.|0|||
17091821|NCT00290732|38231457|FG004|Overall Study|Inability to instill drug intraductally.|0|||
17091822|NCT00312494|38231473|FG000|Overall Study|Randomized; not treated with study drug|9|||
17091823|NCT00312494|38231474|FG001|Overall Study|Randomized; not treated with study drug|10|||
17091824|NCT00312494|38231475|FG002|Overall Study|Randomized; not treated with study drug|5|||
17091825|NCT00312494|38231473|FG000|Overall Study|Adverse Event|33|||
17091826|NCT00312494|38231474|FG001|Overall Study|Adverse Event|15|||
17091827|NCT00312494|38231475|FG002|Overall Study|Adverse Event|11|||
17091828|NCT00312494|38231473|FG000|Overall Study|Lack of Efficacy|4|||
17091829|NCT00312494|38231474|FG001|Overall Study|Lack of Efficacy|6|||
17091830|NCT00312494|38231475|FG002|Overall Study|Lack of Efficacy|8|||
17091831|NCT00312494|38231473|FG000|Overall Study|Laboratory abnormality|1|||
17091832|NCT00312494|38231474|FG001|Overall Study|Laboratory abnormality|0|||
17091833|NCT00312494|38231475|FG002|Overall Study|Laboratory abnormality|0|||
17091834|NCT00312494|38231473|FG000|Overall Study|Lost to Follow-up|8|||
17091835|NCT00312494|38231474|FG001|Overall Study|Lost to Follow-up|8|||
17091836|NCT00312494|38231475|FG002|Overall Study|Lost to Follow-up|8|||
17091837|NCT00312494|38231473|FG000|Overall Study|Withdrawal by Subject|6|||
17091838|NCT00312494|38231474|FG001|Overall Study|Withdrawal by Subject|9|||
17091839|NCT00312494|38231475|FG002|Overall Study|Withdrawal by Subject|10|||
17091840|NCT00312494|38231473|FG000|Overall Study|Other|10|||
17091841|NCT00312494|38231474|FG001|Overall Study|Other|10|||
17091842|NCT00312494|38231475|FG002|Overall Study|Other|1|||
17091843|NCT00312338|38231485|FG000|Overall Study|Adverse Event|7|||
17091844|NCT00312338|38231486|FG001|Overall Study|Adverse Event|2|||
17091845|NCT00312338|38231485|FG000|Overall Study|Lost to Follow-up|9|||
17091846|NCT00312338|38231486|FG001|Overall Study|Lost to Follow-up|1|||
17091847|NCT00312338|38231485|FG000|Overall Study|Withdrawal by Subject|4|||
17091848|NCT00312338|38231486|FG001|Overall Study|Withdrawal by Subject|0|||
17091849|NCT00312338|38231485|FG000|Overall Study|Subsequent infection|2|||
17091850|NCT00312338|38231486|FG001|Overall Study|Subsequent infection|0|||
17091851|NCT00290498|38231494|FG000|Overall Study|Death|2|||
17091852|NCT00290498|38231495|FG001|Overall Study|Death|0|||
17091853|NCT00290498|38231494|FG000|Overall Study|Physician Decision|1|||
17091854|NCT00290498|38231495|FG001|Overall Study|Physician Decision|0|||
17091855|NCT00290498|38231494|FG000|Overall Study|Withdrawal by Subject|1|||
17091856|NCT00290498|38231495|FG001|Overall Study|Withdrawal by Subject|0|||
17091857|NCT00290498|38231494|FG000|Overall Study|Ineligible|3|||
17091858|NCT00290498|38231495|FG001|Overall Study|Ineligible|0|||
17091859|NCT00290498|38231494|FG000|Overall Study|Non-Compliance|1|||
17091860|NCT00290498|38231495|FG001|Overall Study|Non-Compliance|0|||
17091861|NCT00451451|38231506|FG000|Overall Study|Adverse Event|11|||
17091862|NCT00451451|38231507|FG001|Overall Study|Adverse Event|21|||
17091863|NCT00451451|38231508|FG002|Overall Study|Adverse Event|26|||
17091864|NCT00451451|38231509|FG003|Overall Study|Adverse Event|10|||
17091865|NCT00451451|38231506|FG000|Overall Study|Lost to Follow-up|11|||
17091866|NCT00451451|38231507|FG001|Overall Study|Lost to Follow-up|9|||
17091867|NCT00451451|38231508|FG002|Overall Study|Lost to Follow-up|8|||
17091868|NCT00451451|38231509|FG003|Overall Study|Lost to Follow-up|11|||
17091869|NCT00451451|38231506|FG000|Overall Study|Consent Withdrawn|14|||
17091870|NCT00451451|38231507|FG001|Overall Study|Consent Withdrawn|9|||
17091871|NCT00451451|38231508|FG002|Overall Study|Consent Withdrawn|17|||
17091872|NCT00451451|38231509|FG003|Overall Study|Consent Withdrawn|17|||
17091873|NCT00451451|38231506|FG000|Overall Study|Investigator Decision|6|||
17091874|NCT00451451|38231507|FG001|Overall Study|Investigator Decision|2|||
17091875|NCT00451451|38231508|FG002|Overall Study|Investigator Decision|1|||
17091876|NCT00451451|38231509|FG003|Overall Study|Investigator Decision|2|||
17091877|NCT00451451|38231506|FG000|Overall Study|Subject Non-Compliance|8|||
17091878|NCT00451451|38231507|FG001|Overall Study|Subject Non-Compliance|4|||
17091879|NCT00451451|38231508|FG002|Overall Study|Subject Non-Compliance|3|||
17091880|NCT00451451|38231509|FG003|Overall Study|Subject Non-Compliance|3|||
17091881|NCT00451451|38231506|FG000|Overall Study|Death|1|||
17091882|NCT00451451|38231507|FG001|Overall Study|Death|0|||
17091883|NCT00451451|38231508|FG002|Overall Study|Death|0|||
17091884|NCT00451451|38231509|FG003|Overall Study|Death|1|||
17091885|NCT00451451|38231506|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
17091886|NCT00451451|38231507|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
17091887|NCT00451451|38231508|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
17091888|NCT00451451|38231509|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
17091889|NCT03824912|38231524|FG000|Overall Study|Lost to Follow-up|18|||
17091890|NCT03824912|38231525|FG001|Overall Study|Lost to Follow-up|15|||
17091891|NCT03824912|38231526|FG002|Overall Study|Lost to Follow-up|8|||
17091892|NCT03824912|38231524|FG000|Overall Study|Negative Baseline Culture Result|118|||
17091893|NCT03824912|38231525|FG001|Overall Study|Negative Baseline Culture Result|112|||
17091894|NCT03824912|38231526|FG002|Overall Study|Negative Baseline Culture Result|57|||
17091895|NCT03824912|38231524|FG000|Overall Study|Non-Compliance with Study Drug|0|||
17091896|NCT03824912|38231525|FG001|Overall Study|Non-Compliance with Study Drug|0|||
17091897|NCT03824912|38231526|FG002|Overall Study|Non-Compliance with Study Drug|1|||
17091898|NCT03824912|38231524|FG000|Overall Study|Protocol Violation|1|||
17091899|NCT03824912|38231525|FG001|Overall Study|Protocol Violation|4|||
17091900|NCT03824912|38231526|FG002|Overall Study|Protocol Violation|1|||
17091901|NCT03824912|38231524|FG000|Overall Study|Withdrawal by Subject|3|||
17091902|NCT03824912|38231525|FG001|Overall Study|Withdrawal by Subject|2|||
17091903|NCT03824912|38231526|FG002|Overall Study|Withdrawal by Subject|1|||
17091904|NCT03824912|38231524|FG000|Overall Study|Participation in another study|0|||
17091905|NCT03824912|38231525|FG001|Overall Study|Participation in another study|1|||
17091906|NCT03824912|38231526|FG002|Overall Study|Participation in another study|0|||
17091907|NCT00461123|38231536|FG000|Overall Study|Adverse Event|1|||
17091908|NCT00461123|38231537|FG001|Overall Study|Adverse Event|0|||
17091909|NCT00461123|38231536|FG000|Overall Study|Lost to Follow-up|1|||
17091910|NCT00461123|38231537|FG001|Overall Study|Lost to Follow-up|1|||
17091911|NCT00461123|38231536|FG000|Overall Study|Protocol Violation|3|||
17091912|NCT00461123|38231537|FG001|Overall Study|Protocol Violation|2|||
17091913|NCT00461123|38231536|FG000|Overall Study|Withdrawal by Subject|1|||
17091914|NCT00461123|38231537|FG001|Overall Study|Withdrawal by Subject|3|||
17091915|NCT00290342|38231545|FG000|Overall Study|Other|0|||
17091916|NCT00290342|38231546|FG001|Overall Study|Other|1|||
17091917|NCT00290342|38231545|FG000|Overall Study|Withdrawal by Subject|6|||
17091918|NCT00290342|38231546|FG001|Overall Study|Withdrawal by Subject|4|||
17091919|NCT00290342|38231545|FG000|Overall Study|Lost to Follow-up|1|||
17091920|NCT00290342|38231546|FG001|Overall Study|Lost to Follow-up|0|||
17091921|NCT00460811|38231557|FG000|Overall Study|Adverse Event|4|||
17091922|NCT00460811|38231558|FG001|Overall Study|Adverse Event|6|||
17091923|NCT00460811|38231559|FG002|Overall Study|Adverse Event|3|||
17091924|NCT00460811|38231560|FG003|Overall Study|Adverse Event|10|||
17091925|NCT00460811|38231561|FG004|Overall Study|Adverse Event|2|||
17091926|NCT00460811|38231557|FG000|Overall Study|Noncompliance|1|||
17091927|NCT00460811|38231558|FG001|Overall Study|Noncompliance|0|||
17091928|NCT00460811|38231559|FG002|Overall Study|Noncompliance|0|||
17091929|NCT00460811|38231560|FG003|Overall Study|Noncompliance|2|||
17091930|NCT00460811|38231561|FG004|Overall Study|Noncompliance|1|||
17091931|NCT00460811|38231557|FG000|Overall Study|Withdrawal by Subject|7|||
17091932|NCT00460811|38231558|FG001|Overall Study|Withdrawal by Subject|7|||
17091933|NCT00460811|38231559|FG002|Overall Study|Withdrawal by Subject|6|||
17091934|NCT00460811|38231560|FG003|Overall Study|Withdrawal by Subject|3|||
17091935|NCT00460811|38231561|FG004|Overall Study|Withdrawal by Subject|11|||
17091936|NCT00460811|38231557|FG000|Overall Study|Physician Decision|1|||
17091937|NCT00460811|38231558|FG001|Overall Study|Physician Decision|0|||
17091938|NCT00460811|38231559|FG002|Overall Study|Physician Decision|0|||
17091939|NCT00460811|38231560|FG003|Overall Study|Physician Decision|0|||
17091940|NCT00460811|38231561|FG004|Overall Study|Physician Decision|0|||
17091941|NCT00460811|38231557|FG000|Overall Study|Lost to Follow-up|3|||
17091942|NCT00460811|38231558|FG001|Overall Study|Lost to Follow-up|2|||
17091943|NCT00460811|38231559|FG002|Overall Study|Lost to Follow-up|5|||
17091944|NCT00460811|38231560|FG003|Overall Study|Lost to Follow-up|3|||
17091945|NCT00460811|38231561|FG004|Overall Study|Lost to Follow-up|6|||
17091946|NCT00290186|38231580|FG000|Overall Study|Adverse Event|1|||
17091947|NCT00290186|38231581|FG001|Overall Study|Adverse Event|1|||
17091948|NCT00290186|38231580|FG000|Overall Study|Lost to Follow-up|3|||
17091949|NCT00290186|38231581|FG001|Overall Study|Lost to Follow-up|2|||
17091950|NCT00290186|38231580|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
17091951|NCT00290186|38231581|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
17091952|NCT00290186|38231580|FG000|Overall Study|Withdrawal by Subject|0|||
17091953|NCT00290186|38231581|FG001|Overall Study|Withdrawal by Subject|1|||
17091954|NCT00460655|38231591|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
17091955|NCT00460655|38231592|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17091956|NCT00460655|38231593|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17091957|NCT00460655|38231594|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
17091958|NCT00460655|38231591|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
17091959|NCT00460655|38231592|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17091960|NCT00460655|38231593|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17091961|NCT00460655|38231594|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
17091962|NCT00460655|38231591|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
17091963|NCT00460655|38231592|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
17091964|NCT00460655|38231593|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
17091965|NCT00460655|38231594|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
17091966|NCT00460655|38231591|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
17091967|NCT00460655|38231592|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
17091968|NCT00460655|38231593|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
17091969|NCT00460655|38231594|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
17091970|NCT00460655|38231591|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
17091971|NCT00460655|38231592|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
17091972|NCT00460655|38231593|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
17091973|NCT00460655|38231594|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
17091974|NCT00460655|38231591|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
17091975|NCT00460655|38231592|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
17091976|NCT00460655|38231593|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
17091977|NCT00460655|38231594|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
17091978|NCT00460577|38231606|FG000|Overall Study|Protocol Violation|2|||
17091979|NCT00460577|38231607|FG001|Overall Study|Protocol Violation|6|||
17091980|NCT00289016|38231613|FG000|Overall Study|Disease Progression|29|||
17091981|NCT00289016|38231613|FG000|Overall Study|Death|2|||
17091982|NCT00289016|38231613|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
17091983|NCT00289016|38231613|FG000|Overall Study|Withdrawal by Subject|2|||
17091984|NCT00289016|38231613|FG000|Overall Study|Adverse Event|1|||
17091985|NCT00289016|38231613|FG000|Overall Study|Other|1|||
17091986|NCT00288860|38231619|FG000|Overall Study|Did not complete intake|4|||
17091987|NCT00288860|38231620|FG001|Overall Study|Did not complete intake|8|||
17091988|NCT00288860|38231619|FG000|Overall Study|Death|4|||
17091989|NCT00288860|38231620|FG001|Overall Study|Death|3|||
17091990|NCT00288860|38231619|FG000|Overall Study|Withdrawal by Subject|20|||
17091991|NCT00288860|38231620|FG001|Overall Study|Withdrawal by Subject|15|||
17091992|NCT00288860|38231619|FG000|Overall Study|Lost to Follow-up|74|||
17091993|NCT00288860|38231620|FG001|Overall Study|Lost to Follow-up|71|||
16998305|NCT00948896|38142181|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
16998306|NCT00948896|38142182|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
17091994|NCT00288704|38231632|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
17091995|NCT00288704|38231633|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
17091996|NCT00288704|38231634|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
17091997|NCT00288704|38231632|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
16998307|NCT00948896|38142183|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
16998308|NCT00948896|38142184|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
16998309|NCT00948896|38142185|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
16998310|NCT00948896|38142186|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
16998311|NCT00948896|38142179|FG000|24 Months of Age to 36 Months of Age|Death|0|||
16998312|NCT00948896|38142180|FG001|24 Months of Age to 36 Months of Age|Death|2|||
16998313|NCT00948896|38142181|FG002|24 Months of Age to 36 Months of Age|Death|2|||
16998314|NCT00948896|38142182|FG003|24 Months of Age to 36 Months of Age|Death|0|||
16998315|NCT00948896|38142183|FG004|24 Months of Age to 36 Months of Age|Death|0|||
16998316|NCT00948896|38142184|FG005|24 Months of Age to 36 Months of Age|Death|1|||
17091998|NCT00288704|38231633|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
17091999|NCT00288704|38231634|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
17092000|NCT00288704|38231632|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
17092001|NCT00288704|38231633|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
17092002|NCT00288704|38231634|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
17092003|NCT00288704|38231632|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
17092004|NCT00288704|38231633|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
17092005|NCT00288704|38231634|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
17092006|NCT00288704|38231632|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
17092007|NCT00288704|38231633|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
16998317|NCT00948896|38142185|FG006|24 Months of Age to 36 Months of Age|Death|0|||
17092008|NCT00288704|38231634|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
17092009|NCT00288704|38231632|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
17092010|NCT00288704|38231633|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
17092011|NCT00288704|38231634|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
17092012|NCT00288704|38231632|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
17092013|NCT00288704|38231633|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
17092014|NCT00288704|38231634|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
17092015|NCT00288626|38231641|FG000|Overall Study|Death|3|||
17092016|NCT00288626|38231641|FG000|Overall Study|Withdrawal by Subject|4|||
17092017|NCT00087490|38231649|FG000|Overall Study|Death|6|||
17092018|NCT00087490|38231650|FG001|Overall Study|Death|4|||
17092019|NCT00087490|38231649|FG000|Overall Study|Adverse Event|3|||
17092020|NCT00087490|38231650|FG001|Overall Study|Adverse Event|8|||
17092021|NCT00087490|38231649|FG000|Overall Study|Lack of Efficacy|0|||
17092022|NCT00087490|38231650|FG001|Overall Study|Lack of Efficacy|2|||
17092023|NCT00087490|38231649|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
17092024|NCT00087490|38231650|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
17092025|NCT00087490|38231649|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
17092026|NCT00087490|38231650|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
17092027|NCT00087490|38231649|FG000|Overall Study|Randomized but not treated|7|||
17092028|NCT00087490|38231650|FG001|Overall Study|Randomized but not treated|18|||
17092029|NCT00087178|38231658|FG000|Overall Study|No follow up data|5|||
17092030|NCT00087178|38231659|FG001|Overall Study|No follow up data|15|||
17092031|NCT00087178|38231658|FG000|Overall Study|No clinical assessment|1|||
16998318|NCT00948896|38142186|FG007|24 Months of Age to 36 Months of Age|Death|0|||
16998319|NCT00948896|38142179|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
16998320|NCT00948896|38142180|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16998321|NCT00948896|38142181|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
16998322|NCT00948896|38142182|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
16998323|NCT00948896|38142183|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16998324|NCT00948896|38142184|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16998325|NCT00948896|38142185|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16998326|NCT00948896|38142186|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
17092032|NCT00087178|38231659|FG001|Overall Study|No clinical assessment|2|||
16998327|NCT00948896|38142179|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
16998328|NCT00948896|38142180|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16998329|NCT00948896|38142181|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
16998330|NCT00948896|38142182|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16998331|NCT00948896|38142183|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
16998332|NCT00948896|38142184|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
17092033|NCT00087178|38231658|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
17092034|NCT00087178|38231659|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
17092035|NCT00288080|38231667|FG000|Overall Study|Withdrawal by Subject|1|||
17092036|NCT00288080|38231668|FG001|Overall Study|Withdrawal by Subject|3|||
17092037|NCT00288080|38231667|FG000|Overall Study|Protocol Violation|25|||
17092038|NCT00288080|38231668|FG001|Overall Study|Protocol Violation|20|||
17092039|NCT00287690|38231676|FG000|Overall Study|Protocol Violation|20|||
17092040|NCT00287690|38231677|FG001|Overall Study|Protocol Violation|26|||
17092041|NCT00286754|38231686|FG000|Overall Study|Adverse Event|2|||
17092042|NCT00286754|38231687|FG001|Overall Study|Adverse Event|2|||
17092043|NCT00286754|38231688|FG002|Overall Study|Adverse Event|3|||
17092044|NCT00286754|38231686|FG000|Overall Study|Withdrawal by Subject|6|||
17092045|NCT00286754|38231687|FG001|Overall Study|Withdrawal by Subject|2|||
17092046|NCT00286754|38231688|FG002|Overall Study|Withdrawal by Subject|0|||
17092047|NCT00286754|38231686|FG000|Overall Study|Lost to Follow-up|12|||
17092048|NCT00286754|38231687|FG001|Overall Study|Lost to Follow-up|14|||
17092049|NCT00286754|38231688|FG002|Overall Study|Lost to Follow-up|6|||
17092050|NCT00286754|38231686|FG000|Overall Study|Moved out of state|0|||
17092051|NCT00286754|38231687|FG001|Overall Study|Moved out of state|0|||
17092052|NCT00286754|38231688|FG002|Overall Study|Moved out of state|1|||
17092053|NCT00066742|38231702|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
17092054|NCT00066742|38231702|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
17092055|NCT00066742|38231702|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
17092056|NCT00066742|38231702|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
17092057|NCT00066742|38231702|FG000|Induction Chemoradiotherapy|Ineligible|3|||
17092058|NCT00066742|38231702|FG000|Consolidation Chemotherapy|not protocol specified|1|||
17092059|NCT00066742|38231702|FG000|Consolidation Chemotherapy|Ineligible|2|||
17092060|NCT00460265|38231710|FG000|Overall Study|Lost to Follow-up|14|||
17092061|NCT00460265|38231711|FG001|Overall Study|Lost to Follow-up|15|||
17092062|NCT00460265|38231710|FG000|Overall Study|Physician Decision|1|||
17092063|NCT00460265|38231711|FG001|Overall Study|Physician Decision|2|||
17092064|NCT00460265|38231710|FG000|Overall Study|Withdrawal by Subject|10|||
17092065|NCT00460265|38231711|FG001|Overall Study|Withdrawal by Subject|25|||
17092066|NCT00460265|38231710|FG000|Overall Study|Ongoing|60|||
17092067|NCT00460265|38231711|FG001|Overall Study|Ongoing|47|||
17092068|NCT00460109|38231717|FG000|Overall Study|Death|1|||
17092069|NCT00065260|38231723|FG000|Overall Study|Death|0|||
17092070|NCT00065260|38231724|FG001|Overall Study|Death|1|||
17092071|NCT00460031|38231730|FG000|Overall Study|Adverse Event|5|||
17092072|NCT00460031|38231730|FG000|Overall Study|Withdrawal by Subject|5|||
17092073|NCT00460031|38231730|FG000|Overall Study|Death|1|||
17092074|NCT00451217|38231738|FG000|Overall Study|Lost to Follow-up|0|||
17092075|NCT00451217|38231739|FG001|Overall Study|Lost to Follow-up|1|||
17092076|NCT00451217|38231740|FG002|Overall Study|Lost to Follow-up|1|||
16998333|NCT00948896|38142185|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16998334|NCT00948896|38142186|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16998335|NCT00948896|38142179|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16998336|NCT00948896|38142180|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
17092077|NCT00451217|38231741|FG003|Overall Study|Lost to Follow-up|1|||
17092078|NCT00451217|38231738|FG000|Overall Study|Withdrawal by Subject|1|||
17092079|NCT00451217|38231739|FG001|Overall Study|Withdrawal by Subject|0|||
17092080|NCT00451217|38231740|FG002|Overall Study|Withdrawal by Subject|0|||
17092081|NCT00451217|38231741|FG003|Overall Study|Withdrawal by Subject|0|||
17092082|NCT00451217|38231738|FG000|Overall Study|Not Treated|1|||
17092083|NCT00451217|38231739|FG001|Overall Study|Not Treated|1|||
17092084|NCT00451217|38231740|FG002|Overall Study|Not Treated|3|||
17092085|NCT00451217|38231741|FG003|Overall Study|Not Treated|4|||
17092086|NCT00459953|38231753|FG000|Overall Study|not analyzed-household member in study|1|||
17092087|NCT00459953|38231754|FG001|Overall Study|not analyzed-household member in study|1|||
17092088|NCT00459875|38231760|FG000|Overall Study|Ineligible participant|1|||
16998337|NCT00948896|38142181|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
16998338|NCT00948896|38142182|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16998339|NCT00948896|38142183|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16998340|NCT00948896|38142184|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
16998341|NCT00948896|38142185|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16998342|NCT00948896|38142186|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16998343|NCT00948896|38142179|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16998344|NCT00948896|38142180|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16998345|NCT00948896|38142181|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16998346|NCT00948896|38142182|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
16998347|NCT00948896|38142183|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16998348|NCT00948896|38142184|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16998349|NCT00948896|38142185|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16998350|NCT00948896|38142186|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16998351|NCT01004159|38142208|FG000|Overall Study|Adverse Event|2|||
16998352|NCT01004159|38142208|FG000|Overall Study|Disease Progression|18|||
16998353|NCT00948818|38142214|FG000|Overall Study|Adverse Event|10|||
16998354|NCT00948818|38142215|FG001|Overall Study|Adverse Event|32|||
16998355|NCT00948818|38142214|FG000|Overall Study|Protocol Violation|9|||
16998356|NCT00948818|38142215|FG001|Overall Study|Protocol Violation|10|||
16998357|NCT00948818|38142214|FG000|Overall Study|Withdrawal by Subject|25|||
16998358|NCT00948818|38142215|FG001|Overall Study|Withdrawal by Subject|25|||
16998359|NCT00948818|38142214|FG000|Overall Study|Lost to Follow-up|10|||
16998360|NCT00948818|38142215|FG001|Overall Study|Lost to Follow-up|17|||
16998361|NCT00948818|38142214|FG000|Overall Study|Lack of Efficacy|4|||
16998362|NCT00948818|38142215|FG001|Overall Study|Lack of Efficacy|5|||
16998363|NCT00948818|38142214|FG000|Overall Study|Other Reason|4|||
16998364|NCT00948818|38142215|FG001|Overall Study|Other Reason|5|||
16998365|NCT00948506|38142226|FG000|Overall Study|Withdrawal by Subject|3|||
16998366|NCT00948506|38142227|FG001|Overall Study|Withdrawal by Subject|1|||
16998367|NCT00955682|38142238|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
16998368|NCT00955682|38142239|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
16998369|NCT00689221|38142255|FG000|Overall Study|Ongoing at cut-off date|39|||
16998370|NCT00689221|38142256|FG001|Overall Study|Ongoing at cut-off date|36|||
16998371|NCT01875445|38142264|FG000|Overall Study|Lost to Follow-up|5|||
16998372|NCT01875445|38142265|FG001|Overall Study|Lost to Follow-up|0|||
16998373|NCT01875445|38142264|FG000|Overall Study|Withdrawal by Subject|2|||
16998374|NCT01875445|38142265|FG001|Overall Study|Withdrawal by Subject|0|||
16998375|NCT00688909|38142271|FG000|Overall Study|Adverse Event|28|||
16998376|NCT00688909|38142271|FG000|Overall Study|Patient withdrew consent|2|||
16998377|NCT00688909|38142271|FG000|Overall Study|Administrative problems|1|||
16998378|NCT00688909|38142271|FG000|Overall Study|Protocol Violation|2|||
17092089|NCT00459875|38231760|FG000|Overall Study|Adverse Event|2|||
17092090|NCT00311402|38231766|FG000|Overall Study|Adverse Event|118|||
16998379|NCT00948428|38142279|FG000|Overall Study|Withdrawal by Subject|6|||
16998380|NCT00948428|38142280|FG001|Overall Study|Withdrawal by Subject|12|||
16998381|NCT00948428|38142281|FG002|Overall Study|Withdrawal by Subject|7|||
16998382|NCT00948428|38142279|FG000|Overall Study|Adverse Event|6|||
17092091|NCT00311402|38231767|FG001|Overall Study|Adverse Event|105|||
17092092|NCT00311402|38231766|FG000|Overall Study|Lost to Follow-up|0|||
16998383|NCT00948428|38142280|FG001|Overall Study|Adverse Event|3|||
16998384|NCT00948428|38142281|FG002|Overall Study|Adverse Event|0|||
16998385|NCT00948428|38142279|FG000|Overall Study|Lost to Follow-up|2|||
16998386|NCT00948428|38142280|FG001|Overall Study|Lost to Follow-up|1|||
16998387|NCT00948428|38142281|FG002|Overall Study|Lost to Follow-up|1|||
16998388|NCT00948428|38142279|FG000|Overall Study|Death|2|||
16998389|NCT00948428|38142280|FG001|Overall Study|Death|0|||
16998390|NCT00948428|38142281|FG002|Overall Study|Death|0|||
16998391|NCT00948428|38142279|FG000|Overall Study|Intercurrent Illness|1|||
16998392|NCT00948428|38142280|FG001|Overall Study|Intercurrent Illness|0|||
16998393|NCT00948428|38142281|FG002|Overall Study|Intercurrent Illness|0|||
16998394|NCT00948428|38142279|FG000|Overall Study|Non-compliance|1|||
16998395|NCT00948428|38142280|FG001|Overall Study|Non-compliance|2|||
16998396|NCT00948428|38142281|FG002|Overall Study|Non-compliance|0|||
16998397|NCT00948194|38142291|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
16998398|NCT00948194|38142292|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
16998399|NCT00691483|38142300|FG000|Overall Study|Adverse Event|14|||
16998400|NCT00691483|38142301|FG001|Overall Study|Adverse Event|6|||
16998401|NCT00691483|38142300|FG000|Overall Study|Lost to Follow-up|17|||
16998402|NCT00691483|38142301|FG001|Overall Study|Lost to Follow-up|10|||
16998403|NCT00691483|38142300|FG000|Overall Study|Withdrawal by Subject|24|||
16998404|NCT00691483|38142301|FG001|Overall Study|Withdrawal by Subject|7|||
17092093|NCT00311402|38231767|FG001|Overall Study|Lost to Follow-up|3|||
17092094|NCT00311402|38231766|FG000|Overall Study|Withdrawal by Subject|17|||
17092095|NCT00311402|38231767|FG001|Overall Study|Withdrawal by Subject|18|||
17092096|NCT00311402|38231766|FG000|Overall Study|Lack of Efficacy|58|||
17092097|NCT00311402|38231767|FG001|Overall Study|Lack of Efficacy|42|||
17092098|NCT00311402|38231766|FG000|Overall Study|Protocol Violation|7|||
17092099|NCT00311402|38231767|FG001|Overall Study|Protocol Violation|6|||
17092100|NCT00311402|38231766|FG000|Overall Study|IRB's rejection etc.|10|||
17092101|NCT00311402|38231767|FG001|Overall Study|IRB's rejection etc.|3|||
17092102|NCT00450749|38231776|FG000|Overall Study|Withdrawal by Subject|0|||
17092103|NCT00450749|38231777|FG001|Overall Study|Withdrawal by Subject|0|||
17092104|NCT00450749|38231778|FG002|Overall Study|Withdrawal by Subject|2|||
17092105|NCT00450749|38231776|FG000|Overall Study|Noncompliant|0|||
17092106|NCT00450749|38231777|FG001|Overall Study|Noncompliant|1|||
16998405|NCT00691483|38142300|FG000|Overall Study|Other known cause|6|||
16998406|NCT00691483|38142301|FG001|Overall Study|Other known cause|1|||
16998407|NCT00691483|38142300|FG000|Overall Study|Randomized by not treated|7|||
16998408|NCT00691483|38142301|FG001|Overall Study|Randomized by not treated|1|||
16998409|NCT00691093|38142307|FG000|Overall Study|Adverse Event|1|||
16998410|NCT00691093|38142307|FG000|Overall Study|Lost to Follow-up|1|||
16998411|NCT00691093|38142307|FG000|Overall Study|Lack of Efficacy|1|||
17092107|NCT00450749|38231778|FG002|Overall Study|Noncompliant|0|||
17092108|NCT00292370|38231789|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
17092109|NCT00292370|38231790|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
17092110|NCT00292370|38231791|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
17092111|NCT00292370|38231789|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
17092112|NCT00292370|38231790|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
17092113|NCT00292370|38231791|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
17092114|NCT00292370|38231789|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
17092115|NCT00292370|38231790|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
17092116|NCT00292370|38231791|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
17092117|NCT00292370|38231789|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
17092118|NCT00292370|38231790|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
17092119|NCT00292370|38231791|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
17092120|NCT00292370|38231789|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
17092121|NCT00292370|38231790|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
17092122|NCT00292370|38231791|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
17092123|NCT00292370|38231789|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
17092124|NCT00292370|38231790|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
17092125|NCT00292370|38231791|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
17092126|NCT00065182|38231800|FG000|Overall Study|Adverse Event|24|||
17092127|NCT00065182|38231801|FG001|Overall Study|Adverse Event|17|||
17092128|NCT00065182|38231800|FG000|Overall Study|Lost to Follow-up|0|||
17092129|NCT00065182|38231801|FG001|Overall Study|Lost to Follow-up|4|||
16998412|NCT00691093|38142307|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
16998413|NCT00947882|38142320|FG000|Overall Study|Adverse Event|0|||
16868357|NCT02655016|37841429|FG001|Overall Study|Disease progression|4|||
16998414|NCT00947882|38142321|FG001|Overall Study|Adverse Event|1|||
16998415|NCT00947882|38142322|FG002|Overall Study|Adverse Event|4|||
16998416|NCT00947882|38142323|FG003|Overall Study|Adverse Event|4|||
16998417|NCT00947882|38142320|FG000|Overall Study|Withdrawal by Subject|2|||
16998418|NCT00947882|38142321|FG001|Overall Study|Withdrawal by Subject|0|||
16998419|NCT00947882|38142322|FG002|Overall Study|Withdrawal by Subject|8|||
16998420|NCT00947882|38142323|FG003|Overall Study|Withdrawal by Subject|2|||
16998421|NCT00947882|38142320|FG000|Overall Study|Protocol Violation|0|||
16998422|NCT00947882|38142321|FG001|Overall Study|Protocol Violation|0|||
16998423|NCT00947882|38142322|FG002|Overall Study|Protocol Violation|1|||
16998424|NCT00947882|38142323|FG003|Overall Study|Protocol Violation|0|||
16998425|NCT00947882|38142320|FG000|Overall Study|Lost to Follow-up|0|||
16998426|NCT00947882|38142321|FG001|Overall Study|Lost to Follow-up|2|||
16998427|NCT00947882|38142322|FG002|Overall Study|Lost to Follow-up|1|||
16998428|NCT00947882|38142323|FG003|Overall Study|Lost to Follow-up|0|||
16998429|NCT00947882|38142320|FG000|Overall Study|Other/Unknown|10|||
16998430|NCT00947882|38142321|FG001|Overall Study|Other/Unknown|13|||
16998431|NCT00947882|38142322|FG002|Overall Study|Other/Unknown|3|||
16998432|NCT00947882|38142323|FG003|Overall Study|Other/Unknown|6|||
17092130|NCT00065182|38231800|FG000|Overall Study|Protocol Violation|3|||
17092131|NCT00065182|38231801|FG001|Overall Study|Protocol Violation|4|||
17092132|NCT00065182|38231800|FG000|Overall Study|Serious adverse events (SAE)|1|||
17092133|NCT00065182|38231801|FG001|Overall Study|Serious adverse events (SAE)|0|||
17092134|NCT00065182|38231800|FG000|Overall Study|Sponsor Decision|11|||
17092135|NCT00065182|38231801|FG001|Overall Study|Sponsor Decision|7|||
17092136|NCT00065182|38231800|FG000|Overall Study|Withdrawal by Subject|8|||
17092137|NCT00065182|38231801|FG001|Overall Study|Withdrawal by Subject|3|||
17092138|NCT00065182|38231800|FG000|Overall Study|No clinical benefit|1|||
17092139|NCT00065182|38231801|FG001|Overall Study|No clinical benefit|0|||
17092140|NCT00065182|38231800|FG000|Overall Study|Death|0|||
16782753|NCT02058160|37722376|FG000|Overall Study|Other than specified above|12|||
16998433|NCT00947882|38142320|FG000|Overall Study|Trial Terminated by Sponsor|62|||
16998434|NCT00947882|38142321|FG001|Overall Study|Trial Terminated by Sponsor|61|||
16782754|NCT02058160|37722377|FG001|Overall Study|Other than specified above|6|||
16782755|NCT02090764|37722385|FG000|Overall Study|Adverse Event|1|||
16782756|NCT02090764|37722386|FG001|Overall Study|Adverse Event|3|||
16782757|NCT02090764|37722385|FG000|Overall Study|Lack of Efficacy|0|||
16782758|NCT02090764|37722386|FG001|Overall Study|Lack of Efficacy|13|||
16782759|NCT02090764|37722385|FG000|Overall Study|Withdrawal by Subject|2|||
16782760|NCT02090764|37722386|FG001|Overall Study|Withdrawal by Subject|1|||
16782761|NCT02090764|37722385|FG000|Overall Study|Intercurrent illness and other|1|||
16782762|NCT02090764|37722386|FG001|Overall Study|Intercurrent illness and other|1|||
16782763|NCT02090764|37722385|FG000|Overall Study|Lost to Follow-up|2|||
16782764|NCT02090764|37722386|FG001|Overall Study|Lost to Follow-up|2|||
16782765|NCT02057692|37722396|FG000|Overall Study|Adverse Event|1|||
16782766|NCT02057692|37722397|FG001|Overall Study|Adverse Event|0|||
16782767|NCT02057692|37722398|FG002|Overall Study|Adverse Event|0|||
16782768|NCT02057692|37722399|FG003|Overall Study|Adverse Event|0|||
16782769|NCT02057692|37722396|FG000|Overall Study|Lost to Follow-up|0|||
16782770|NCT02057692|37722397|FG001|Overall Study|Lost to Follow-up|0|||
16782771|NCT02057692|37722398|FG002|Overall Study|Lost to Follow-up|0|||
16782772|NCT02057692|37722399|FG003|Overall Study|Lost to Follow-up|1|||
16782773|NCT02038036|37722417|FG000|Core Study|Adverse Event|7|||
16782774|NCT02038036|37722418|FG001|Core Study|Adverse Event|7|||
16782775|NCT02038036|37722417|FG000|Core Study|Death|1|||
16782776|NCT02038036|37722418|FG001|Core Study|Death|1|||
16782777|NCT02038036|37722417|FG000|Core Study|Disease progression|2|||
16782778|NCT02038036|37722418|FG001|Core Study|Disease progression|2|||
16782779|NCT02038036|37722417|FG000|Core Study|Lost to Follow-up|0|||
16782780|NCT02038036|37722418|FG001|Core Study|Lost to Follow-up|1|||
16782781|NCT02038036|37722417|FG000|Core Study|Physician Decision|2|||
16782782|NCT02038036|37722418|FG001|Core Study|Physician Decision|1|||
16782783|NCT02038036|37722417|FG000|Core Study|Subject/guardian decision|0|||
16782784|NCT02038036|37722418|FG001|Core Study|Subject/guardian decision|1|||
16782785|NCT02038036|37722417|FG000|Core Study|Withdrawal by Subject|3|||
16782786|NCT02038036|37722418|FG001|Core Study|Withdrawal by Subject|1|||
16782787|NCT02038036|37722417|FG000|Crossover Period|Withdrawal by Subject|0|||
16782788|NCT02038036|37722418|FG001|Crossover Period|Withdrawal by Subject|3|||
16782789|NCT02038036|37722417|FG000|Crossover Period|Adverse Event|0|||
16782790|NCT02038036|37722418|FG001|Crossover Period|Adverse Event|9|||
16782791|NCT02038036|37722417|FG000|Crossover Period|Death|0|||
16782792|NCT02038036|37722418|FG001|Crossover Period|Death|2|||
16782793|NCT02038036|37722417|FG000|Crossover Period|Disease progression|0|||
16782794|NCT02038036|37722418|FG001|Crossover Period|Disease progression|3|||
16782795|NCT02038036|37722417|FG000|Crossover Period|Lost to Follow-up|0|||
16998435|NCT00947882|38142322|FG002|Overall Study|Trial Terminated by Sponsor|62|||
16782796|NCT02038036|37722418|FG001|Crossover Period|Lost to Follow-up|1|||
16782797|NCT02038036|37722417|FG000|Crossover Period|Physician Decision|0|||
16782798|NCT02038036|37722418|FG001|Crossover Period|Physician Decision|2|||
16782799|NCT02037568|37722429|FG000|Overall Study|Withdrawal by Subject|17|||
16782800|NCT02037568|37722430|FG001|Overall Study|Withdrawal by Subject|24|||
16782801|NCT02037568|37722429|FG000|Overall Study|Lost to Follow-up|16|||
16782802|NCT02037568|37722430|FG001|Overall Study|Lost to Follow-up|13|||
16998436|NCT00947882|38142323|FG003|Overall Study|Trial Terminated by Sponsor|70|||
16998437|NCT00688753|38142334|FG000|Overall Study|Disease progression|55|||
16998438|NCT00688753|38142334|FG000|Overall Study|Missing|1|||
16998439|NCT00688753|38142334|FG000|Overall Study|Death|9|||
16998440|NCT00688753|38142334|FG000|Overall Study|Withdrawal by Subject|3|||
16998441|NCT00688753|38142334|FG000|Overall Study|Adverse Event|20|||
16998442|NCT00688753|38142334|FG000|Overall Study|Protocol Violation|1|||
16998443|NCT00688753|38142334|FG000|Overall Study|Lost to Follow-up|3|||
16998444|NCT00951080|38142340|FG000|Overall Study|Adverse Event|3|||
16998445|NCT00951080|38142341|FG001|Overall Study|Adverse Event|3|||
16998446|NCT00951080|38142340|FG000|Overall Study|Lost to Follow-up|0|||
16998447|NCT00951080|38142341|FG001|Overall Study|Lost to Follow-up|1|||
16998448|NCT00951080|38142340|FG000|Overall Study|Physician Decision|4|||
16998449|NCT00951080|38142341|FG001|Overall Study|Physician Decision|1|||
16998450|NCT00951080|38142340|FG000|Overall Study|Other|19|||
16998451|NCT00951080|38142341|FG001|Overall Study|Other|22|||
16998452|NCT00946322|38142347|FG000|Pre-treatment|participant failure to follow up|1|||
16998453|NCT00946322|38142347|FG000|Post-treatment|participant failure to follow up|2|||
16998454|NCT00950690|38142351|FG000|Overall Study|Death|4|||
16998455|NCT00950690|38142351|FG000|Overall Study|Adverse Event|15|||
16998456|NCT00950690|38142351|FG000|Overall Study|Lack of Efficacy|22|||
16998457|NCT00950690|38142351|FG000|Overall Study|Lost to Follow-up|40|||
16998458|NCT00950690|38142351|FG000|Overall Study|Other|163|||
16998459|NCT00694369|38142360|FG000|Overall Study|Adverse Event|0|||
16998460|NCT00694369|38142361|FG001|Overall Study|Adverse Event|1|||
16998461|NCT00694369|38142362|FG002|Overall Study|Adverse Event|0|||
16998462|NCT00694369|38142363|FG003|Overall Study|Adverse Event|1|||
16998463|NCT00694369|38142364|FG004|Overall Study|Adverse Event|3|||
16998464|NCT00694369|38142360|FG000|Overall Study|Lost to Follow-up|0|||
16998465|NCT00694369|38142361|FG001|Overall Study|Lost to Follow-up|0|||
17092141|NCT00065182|38231801|FG001|Overall Study|Death|1|||
17092142|NCT00065182|38231800|FG000|Overall Study|Decline in Status|0|||
16998466|NCT00694369|38142362|FG002|Overall Study|Lost to Follow-up|1|||
16998467|NCT00694369|38142363|FG003|Overall Study|Lost to Follow-up|1|||
17092143|NCT00065182|38231801|FG001|Overall Study|Decline in Status|1|||
17092144|NCT00064792|38231809|FG000|Overall Study|Withdrawal by Subject|2|||
17092145|NCT00064792|38231810|FG001|Overall Study|Withdrawal by Subject|0|||
17092146|NCT00064792|38231809|FG000|Overall Study|Adverse Event|3|||
16998468|NCT00694369|38142364|FG004|Overall Study|Lost to Follow-up|0|||
16998469|NCT00694369|38142360|FG000|Overall Study|Physician Decision|0|||
16998470|NCT00694369|38142361|FG001|Overall Study|Physician Decision|0|||
17092147|NCT00064792|38231810|FG001|Overall Study|Adverse Event|0|||
17092148|NCT00450437|38231818|FG000|Overall Study|Withdrawal by Subject|10|||
17092149|NCT00450437|38231819|FG001|Overall Study|Withdrawal by Subject|2|||
17092150|NCT00450437|38231820|FG002|Overall Study|Withdrawal by Subject|0|||
17092151|NCT00450437|38231821|FG003|Overall Study|Withdrawal by Subject|1|||
17092152|NCT00450437|38231818|FG000|Overall Study|Lost to Follow-up|31|||
17092153|NCT00450437|38231819|FG001|Overall Study|Lost to Follow-up|12|||
17092154|NCT00450437|38231820|FG002|Overall Study|Lost to Follow-up|19|||
17092155|NCT00450437|38231821|FG003|Overall Study|Lost to Follow-up|9|||
17092156|NCT00450437|38231818|FG000|Overall Study|Protocol Violation|0|||
17092157|NCT00450437|38231819|FG001|Overall Study|Protocol Violation|1|||
17092158|NCT00450437|38231820|FG002|Overall Study|Protocol Violation|0|||
17092159|NCT00450437|38231821|FG003|Overall Study|Protocol Violation|1|||
17092160|NCT00450437|38231818|FG000|Overall Study|Inappropriate enrollment|4|||
17092161|NCT00450437|38231819|FG001|Overall Study|Inappropriate enrollment|1|||
17092162|NCT00450437|38231820|FG002|Overall Study|Inappropriate enrollment|3|||
17092163|NCT00450437|38231821|FG003|Overall Study|Inappropriate enrollment|0|||
17092164|NCT00450437|38231818|FG000|Overall Study|Administrative reason|0|||
17092165|NCT00450437|38231819|FG001|Overall Study|Administrative reason|0|||
17092166|NCT00450437|38231820|FG002|Overall Study|Administrative reason|1|||
17092167|NCT00450437|38231821|FG003|Overall Study|Administrative reason|0|||
17092168|NCT00450437|38231818|FG000|Overall Study|Unable to Classify|1|||
17092169|NCT00450437|38231819|FG001|Overall Study|Unable to Classify|0|||
17092170|NCT00450437|38231820|FG002|Overall Study|Unable to Classify|1|||
17092171|NCT00450437|38231821|FG003|Overall Study|Unable to Classify|0|||
17092172|NCT00286442|38231838|FG000|Overall Study|Hyperglycemic Rescue|19|||
17092173|NCT00286442|38231839|FG001|Overall Study|Hyperglycemic Rescue|17|||
17092174|NCT00286442|38231840|FG002|Overall Study|Hyperglycemic Rescue|25|||
17092175|NCT00286442|38231838|FG000|Overall Study|Adverse Event|7|||
17092176|NCT00286442|38231839|FG001|Overall Study|Adverse Event|6|||
16998471|NCT00694369|38142362|FG002|Overall Study|Physician Decision|0|||
17092177|NCT00286442|38231840|FG002|Overall Study|Adverse Event|1|||
17092178|NCT00286442|38231838|FG000|Overall Study|Protocol Violation|2|||
16998472|NCT00694369|38142363|FG003|Overall Study|Physician Decision|0|||
16998473|NCT00694369|38142364|FG004|Overall Study|Physician Decision|1|||
17092179|NCT00286442|38231839|FG001|Overall Study|Protocol Violation|4|||
17092180|NCT00286442|38231840|FG002|Overall Study|Protocol Violation|2|||
17092181|NCT00286442|38231838|FG000|Overall Study|Lost to Follow-up|5|||
17092182|NCT00286442|38231839|FG001|Overall Study|Lost to Follow-up|2|||
17092183|NCT00286442|38231840|FG002|Overall Study|Lost to Follow-up|1|||
17092184|NCT00286442|38231838|FG000|Overall Study|Physician Decision|1|||
16998474|NCT00694369|38142360|FG000|Overall Study|Protocol Violation|0|||
16998475|NCT00694369|38142361|FG001|Overall Study|Protocol Violation|1|||
16998476|NCT00694369|38142362|FG002|Overall Study|Protocol Violation|0|||
16998477|NCT00694369|38142363|FG003|Overall Study|Protocol Violation|0|||
17092185|NCT00286442|38231839|FG001|Overall Study|Physician Decision|1|||
17092186|NCT00286442|38231840|FG002|Overall Study|Physician Decision|1|||
17092187|NCT00286442|38231838|FG000|Overall Study|Administrative Error|1|||
17092188|NCT00286442|38231839|FG001|Overall Study|Administrative Error|1|||
17092189|NCT00286442|38231840|FG002|Overall Study|Administrative Error|0|||
17092190|NCT00286442|38231838|FG000|Overall Study|Withdrawal by Subject|2|||
17092191|NCT00286442|38231839|FG001|Overall Study|Withdrawal by Subject|14|||
17092192|NCT00286442|38231840|FG002|Overall Study|Withdrawal by Subject|2|||
17092193|NCT00063934|38231848|FG000|Overall Study|Ineligible|1|||
17092194|NCT00458783|38231854|FG000|Overall Study|Protocol Violation|1228|||
17092195|NCT00458783|38231855|FG001|Overall Study|Protocol Violation|1220|||
17092196|NCT00063154|38231861|FG000|Overall Study|Disease progression|27|||
16998478|NCT00694369|38142364|FG004|Overall Study|Protocol Violation|0|||
16998479|NCT00694369|38142360|FG000|Overall Study|Withdrawal by Subject|1|||
16998480|NCT00694369|38142361|FG001|Overall Study|Withdrawal by Subject|1|||
16998481|NCT00694369|38142362|FG002|Overall Study|Withdrawal by Subject|1|||
16998482|NCT00694369|38142363|FG003|Overall Study|Withdrawal by Subject|1|||
16998483|NCT00694369|38142364|FG004|Overall Study|Withdrawal by Subject|2|||
16998484|NCT03412747|38142379|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
16998485|NCT03412747|38142380|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
16998486|NCT03412747|38142381|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
16998487|NCT03412747|38142379|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
16998488|NCT03412747|38142380|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
16998489|NCT03412747|38142381|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
17092197|NCT00063154|38231861|FG000|Overall Study|Adverse Event|2|||
17092198|NCT00063154|38231861|FG000|Overall Study|Physician Decision|10|||
17092199|NCT00063154|38231861|FG000|Overall Study|Death|3|||
17092200|NCT00063154|38231861|FG000|Overall Study|Reason unspecified|1|||
17092201|NCT00063154|38231861|FG000|Overall Study|Did not receive treatment|8|||
17092202|NCT00311168|38231867|FG000|First Intervention|Withdrawal by Subject|2|||
16998490|NCT03412747|38142379|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
16998491|NCT03412747|38142380|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
16998492|NCT03412747|38142381|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
16998493|NCT03412747|38142379|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
16782803|NCT02037568|37722429|FG000|Overall Study|Screen Failure|3|||
16782804|NCT02037568|37722430|FG001|Overall Study|Screen Failure|1|||
16782805|NCT02037568|37722429|FG000|Overall Study|Patient did not receive transplant|0|||
16782806|NCT02037568|37722430|FG001|Overall Study|Patient did not receive transplant|1|||
16782807|NCT02088034|37722439|FG000|Overall Study|Lost to Follow-up|1|||
16782808|NCT02088034|37722440|FG001|Overall Study|Lost to Follow-up|1|||
16782809|NCT02088034|37722441|FG002|Overall Study|Lost to Follow-up|0|||
16782810|NCT02088034|37722439|FG000|Overall Study|Pregnancy|2|||
16782811|NCT02088034|37722440|FG001|Overall Study|Pregnancy|1|||
16782812|NCT02088034|37722441|FG002|Overall Study|Pregnancy|2|||
16782813|NCT02037256|37722451|FG000|Overall Study|Protocol Violation|0|||
16782814|NCT02037256|37722452|FG001|Overall Study|Protocol Violation|1|||
16782815|NCT02037256|37722451|FG000|Overall Study|Withdrawn prior to Velcade|0|||
16782816|NCT02037256|37722452|FG001|Overall Study|Withdrawn prior to Velcade|2|||
16782817|NCT02035696|37722464|FG000|Overall Study|Lost to Follow-up|0|||
16782818|NCT02035696|37722465|FG001|Overall Study|Lost to Follow-up|3|||
16782819|NCT02035696|37722466|FG002|Overall Study|Lost to Follow-up|1|||
16782820|NCT02035696|37722467|FG003|Overall Study|Lost to Follow-up|2|||
16782821|NCT02035696|37722464|FG000|Overall Study|Withdrawal by Subject|3|||
16782822|NCT02035696|37722465|FG001|Overall Study|Withdrawal by Subject|0|||
16782823|NCT02035696|37722466|FG002|Overall Study|Withdrawal by Subject|2|||
16782824|NCT02035696|37722467|FG003|Overall Study|Withdrawal by Subject|1|||
16782825|NCT02057458|37722481|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
16782826|NCT02057458|37722482|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
16782827|NCT02057458|37722483|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
16782828|NCT02057458|37722481|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
16782829|NCT02057458|37722482|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
16782830|NCT02057458|37722483|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
16782831|NCT02057458|37722481|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
16782832|NCT02057458|37722482|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
16782833|NCT02057458|37722483|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
16782834|NCT02057068|37722515|FG000|Overall Study|Withdrawal by Subject|2|||
16782835|NCT02057068|37722516|FG001|Overall Study|Withdrawal by Subject|2|||
16998494|NCT03412747|38142380|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
16998495|NCT03412747|38142381|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
16998496|NCT03412747|38142379|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
16998497|NCT03412747|38142380|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
16998498|NCT03412747|38142381|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
16998499|NCT03412747|38142379|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
16998500|NCT03412747|38142380|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
16998501|NCT03412747|38142381|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
16998502|NCT03412747|38142379|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
16998503|NCT03412747|38142380|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
16998504|NCT03412747|38142381|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
16998505|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
16998506|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
16998507|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
16998508|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
16998509|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
16998510|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
16998511|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
16998512|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
16998513|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
16998514|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
16998515|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
16998516|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
16998517|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
16998518|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
16998519|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
17092203|NCT00311168|38231868|FG001|First Intervention|Withdrawal by Subject|2|||
17092204|NCT00311168|38231867|FG000|First Intervention|Lost to Follow-up|1|||
17092205|NCT00311168|38231868|FG001|First Intervention|Lost to Follow-up|1|||
17092206|NCT00311168|38231867|FG000|First Intervention|Protocol Violation|1|||
17092207|NCT00311168|38231868|FG001|First Intervention|Protocol Violation|1|||
17092208|NCT00311168|38231867|FG000|First Intervention|Adverse Event|1|||
17092209|NCT00311168|38231868|FG001|First Intervention|Adverse Event|0|||
17092210|NCT00311168|38231867|FG000|First Intervention|Other|2|||
17092211|NCT00311168|38231868|FG001|First Intervention|Other|2|||
17092212|NCT00311168|38231867|FG000|Second Intervention|Lost to Follow-up|9|||
17092213|NCT00311168|38231868|FG001|Second Intervention|Lost to Follow-up|2|||
17092214|NCT00311168|38231867|FG000|Second Intervention|Withdrawal by Subject|0|||
17092215|NCT00311168|38231868|FG001|Second Intervention|Withdrawal by Subject|1|||
17092216|NCT00311168|38231867|FG000|Second Intervention|Other|1|||
17092217|NCT00311168|38231868|FG001|Second Intervention|Other|1|||
17092218|NCT00458705|38231876|FG000|Overall Study|Adverse Event|4|||
17092219|NCT00458705|38231876|FG000|Overall Study|Not Treated|1|||
17092220|NCT00062374|38231880|FG000|Overall Study|Not treated|12|||
17092221|NCT00285818|38231886|FG000|Overall Study|Withdrawal by Subject|3|||
17092222|NCT00285818|38231887|FG001|Overall Study|Withdrawal by Subject|2|||
17092223|NCT00285818|38231886|FG000|Overall Study|Lost to Follow-up|1|||
17092224|NCT00285818|38231887|FG001|Overall Study|Lost to Follow-up|0|||
17092225|NCT00285584|38231895|FG000|Month 3|Lost to Follow-up|3|||
17092226|NCT00285584|38231896|FG001|Month 3|Lost to Follow-up|3|||
16998520|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
16998521|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
16998522|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
16998523|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
16998524|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
16998525|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
16998526|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
16998527|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
16998528|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
16998529|NCT03412747|38142379|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
16998530|NCT03412747|38142380|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
16998531|NCT03412747|38142381|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
16998532|NCT00513019|38142401|FG000|Overall Study|Adverse Event|1|||
16998533|NCT00513019|38142402|FG001|Overall Study|Adverse Event|0|||
16998534|NCT00513019|38142401|FG000|Overall Study|Withdrawal by Subject|4|||
16998535|NCT00513019|38142402|FG001|Overall Study|Withdrawal by Subject|5|||
17092227|NCT00285584|38231895|FG000|Month 3|Withdrawal by Subject|1|||
17092228|NCT00285584|38231896|FG001|Month 3|Withdrawal by Subject|0|||
17092229|NCT00285584|38231895|FG000|Month 6|Lost to Follow-up|0|||
17092230|NCT00285584|38231896|FG001|Month 6|Lost to Follow-up|1|||
16782836|NCT02057068|37722515|FG000|Overall Study|Caregiver (CG) Health|0|||
16782837|NCT02057068|37722516|FG001|Overall Study|Caregiver (CG) Health|2|||
16782838|NCT02057068|37722515|FG000|Overall Study|Carepartner (CP) Health|4|||
16782839|NCT02057068|37722516|FG001|Overall Study|Carepartner (CP) Health|2|||
16998536|NCT00954512|38142423|FG000|Overall Study|Withdrawal by Subject|0|||
16998537|NCT00954512|38142424|FG001|Overall Study|Withdrawal by Subject|0|||
16998538|NCT00954512|38142425|FG002|Overall Study|Withdrawal by Subject|0|||
17092231|NCT03807700|38231908|FG000|Overall Study|Withdrawal by Subject|2|||
17092232|NCT03807700|38231909|FG001|Overall Study|Withdrawal by Subject|1|||
17092233|NCT00291668|38231919|FG000|Overall Study|Lack of Efficacy|1|||
17092234|NCT00291668|38231920|FG001|Overall Study|Lack of Efficacy|0|||
17092235|NCT00291668|38231921|FG002|Overall Study|Lack of Efficacy|0|||
17092236|NCT00291668|38231919|FG000|Overall Study|SAE, non-fatal|1|||
17092237|NCT00291668|38231920|FG001|Overall Study|SAE, non-fatal|1|||
17092238|NCT00291668|38231921|FG002|Overall Study|SAE, non-fatal|1|||
17092239|NCT00291668|38231919|FG000|Overall Study|AE, non-serious non-fatal|1|||
17092240|NCT00291668|38231920|FG001|Overall Study|AE, non-serious non-fatal|0|||
17092241|NCT00291668|38231921|FG002|Overall Study|AE, non-serious non-fatal|0|||
17092242|NCT00291668|38231919|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
17092243|NCT00291668|38231920|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
17092244|NCT00291668|38231921|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
17092245|NCT00458393|38231931|FG000|Overall Study|Withdrawal by Subject|67|||
17092246|NCT00458393|38231932|FG001|Overall Study|Withdrawal by Subject|80|||
17092247|NCT00458393|38231931|FG000|Overall Study|Physician Decision|31|||
17092248|NCT00458393|38231932|FG001|Overall Study|Physician Decision|22|||
17092249|NCT00458393|38231931|FG000|Overall Study|Relocated|77|||
17092250|NCT00458393|38231932|FG001|Overall Study|Relocated|81|||
17092251|NCT00458393|38231931|FG000|Overall Study|Lost to Follow-up|115|||
17092252|NCT00458393|38231932|FG001|Overall Study|Lost to Follow-up|92|||
17092253|NCT00458393|38231931|FG000|Overall Study|Sites marked other on the form.|19|||
17092254|NCT00458393|38231932|FG001|Overall Study|Sites marked other on the form.|20|||
17092255|NCT00310856|38231943|FG000|Overall Study|Withdrawal by Subject|2|||
17092256|NCT00310856|38231944|FG001|Overall Study|Withdrawal by Subject|2|||
17092257|NCT00310856|38231945|FG002|Overall Study|Withdrawal by Subject|2|||
17092258|NCT00310856|38231943|FG000|Overall Study|Lost to Follow-up|1|||
17092259|NCT00310856|38231944|FG001|Overall Study|Lost to Follow-up|2|||
17092260|NCT00310856|38231945|FG002|Overall Study|Lost to Follow-up|6|||
17092261|NCT00310856|38231943|FG000|Overall Study|Inappropriate enrollment|1|||
17092262|NCT00310856|38231944|FG001|Overall Study|Inappropriate enrollment|1|||
17092263|NCT00310856|38231945|FG002|Overall Study|Inappropriate enrollment|0|||
17092264|NCT00310856|38231943|FG000|Overall Study|Unable to classify|1|||
17092265|NCT00310856|38231944|FG001|Overall Study|Unable to classify|0|||
17092266|NCT00310856|38231945|FG002|Overall Study|Unable to classify|0|||
17092267|NCT00283712|38231956|FG000|Overall Study|Death|0|||
17092268|NCT00283712|38231957|FG001|Overall Study|Death|1|||
17092269|NCT00048724|38231965|FG000|Overall Study|Adverse Event|53|||
17092270|NCT00048724|38231966|FG001|Overall Study|Adverse Event|12|||
17092271|NCT00048724|38231965|FG000|Overall Study|Withdrawal by Subject|34|||
17092272|NCT00048724|38231966|FG001|Overall Study|Withdrawal by Subject|54|||
16998539|NCT00954512|38142426|FG003|Overall Study|Withdrawal by Subject|0|||
16998540|NCT00954512|38142427|FG004|Overall Study|Withdrawal by Subject|0|||
16998541|NCT00954512|38142428|FG005|Overall Study|Withdrawal by Subject|1|||
16998542|NCT00954512|38142423|FG000|Overall Study|Adverse Event|0|||
16998543|NCT00954512|38142424|FG001|Overall Study|Adverse Event|0|||
16998544|NCT00954512|38142425|FG002|Overall Study|Adverse Event|0|||
16998545|NCT00954512|38142426|FG003|Overall Study|Adverse Event|0|||
16998546|NCT00954512|38142427|FG004|Overall Study|Adverse Event|1|||
16998547|NCT00954512|38142428|FG005|Overall Study|Adverse Event|2|||
17092273|NCT00048724|38231965|FG000|Overall Study|Lost to Follow-up|5|||
16782840|NCT02057068|37722515|FG000|Overall Study|Lost to Follow-up|2|||
16782841|NCT02057068|37722516|FG001|Overall Study|Lost to Follow-up|2|||
16782842|NCT02056834|37722524|FG000|Overall Study|Lost to Follow-up|7|||
16782843|NCT02087176|37722529|FG000|Overall Study|Withdrawal by Subject|1|||
16782844|NCT02087176|37722529|FG000|Overall Study|Death|10|||
16782845|NCT02087176|37722529|FG000|Overall Study|Censored|19|||
16782846|NCT02087176|37722529|FG000|Overall Study|Study Terminated by Sponsor|2|||
16782847|NCT02056288|37722535|FG000|In-Hospital Data|Surgery cancelled|1|||
16782848|NCT02056288|37722536|FG001|In-Hospital Data|Surgery cancelled|0|||
16782849|NCT02056288|37722535|FG000|In-Hospital Data|Protocol Violation|3|||
16868358|NCT02655016|37841428|FG000|Overall Study|Site closed|0|||
16782850|NCT02056288|37722536|FG001|In-Hospital Data|Protocol Violation|0|||
16782851|NCT02056288|37722535|FG000|In-Hospital Data|Physician Decision|1|||
16782852|NCT02056288|37722536|FG001|In-Hospital Data|Physician Decision|0|||
16782853|NCT02056288|37722535|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
16782854|NCT02056288|37722536|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
16782855|NCT02086162|37722544|FG000|Overall Study|Withdrawal by Subject|4|||
16782856|NCT02086162|37722545|FG001|Overall Study|Withdrawal by Subject|4|||
16998548|NCT00954512|38142423|FG000|Overall Study|Physician Decision|0|||
17092274|NCT00048724|38231966|FG001|Overall Study|Lost to Follow-up|5|||
17092275|NCT00048724|38231965|FG000|Overall Study|Protocol-defined Clinical Event|17|||
17092276|NCT00048724|38231966|FG001|Overall Study|Protocol-defined Clinical Event|32|||
17092277|NCT00048724|38231965|FG000|Overall Study|Noncompliance With Protocol|4|||
16998549|NCT00954512|38142424|FG001|Overall Study|Physician Decision|1|||
16998550|NCT00954512|38142425|FG002|Overall Study|Physician Decision|0|||
16998551|NCT00954512|38142426|FG003|Overall Study|Physician Decision|1|||
16998552|NCT00954512|38142427|FG004|Overall Study|Physician Decision|0|||
16998553|NCT00954512|38142428|FG005|Overall Study|Physician Decision|0|||
16998554|NCT00954512|38142423|FG000|Overall Study|Symptomatic Deterioration|0|||
16998555|NCT00954512|38142424|FG001|Overall Study|Symptomatic Deterioration|1|||
16998556|NCT00954512|38142425|FG002|Overall Study|Symptomatic Deterioration|0|||
16998557|NCT00954512|38142426|FG003|Overall Study|Symptomatic Deterioration|0|||
16998558|NCT00954512|38142427|FG004|Overall Study|Symptomatic Deterioration|2|||
16998559|NCT00954512|38142428|FG005|Overall Study|Symptomatic Deterioration|0|||
16998560|NCT00954512|38142423|FG000|Overall Study|Progression of Disease|2|||
16998561|NCT00954512|38142424|FG001|Overall Study|Progression of Disease|1|||
16998562|NCT00954512|38142425|FG002|Overall Study|Progression of Disease|0|||
16998563|NCT00954512|38142426|FG003|Overall Study|Progression of Disease|1|||
16998564|NCT00954512|38142427|FG004|Overall Study|Progression of Disease|1|||
16998565|NCT00954512|38142428|FG005|Overall Study|Progression of Disease|1|||
16998566|NCT00691015|38142441|FG000|Overall Study|Refused further treatment|1|||
16998567|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
16998568|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
16998569|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
16998570|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
16998571|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
16998572|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
16998573|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
16998574|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
16998575|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
16998576|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
16998577|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
16998578|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
16998579|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
16998580|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
16998581|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
16998582|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
16998583|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
16998584|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
16998585|NCT00950300|38142447|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
16998586|NCT00950300|38142448|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
16998587|NCT00950300|38142447|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
16998588|NCT00950300|38142448|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
16998589|NCT00950300|38142447|FG000|TFFU Period|Death|4|||
16998590|NCT00950300|38142448|FG001|TFFU Period|Death|1|||
16998591|NCT00950300|38142447|FG000|TFFU Period|Refused Treatment|10|||
16998592|NCT00950300|38142448|FG001|TFFU Period|Refused Treatment|11|||
16998593|NCT00950300|38142447|FG000|TFFU Period|Failure to Return|16|||
16998594|NCT00950300|38142448|FG001|TFFU Period|Failure to Return|16|||
16998595|NCT00950300|38142447|FG000|TFFU Period|Recurrence of Disease|63|||
16998596|NCT00950300|38142448|FG001|TFFU Period|Recurrence of Disease|72|||
16998597|NCT00950300|38142447|FG000|TFFU Period|Other|4|||
16998598|NCT00950300|38142448|FG001|TFFU Period|Other|3|||
16998599|NCT00950300|38142447|FG000|SFU Period|Death|44|||
16998600|NCT00950300|38142448|FG001|SFU Period|Death|42|||
16998601|NCT00950300|38142447|FG000|SFU Period|Lost to Follow-up|30|||
16998602|NCT00950300|38142448|FG001|SFU Period|Lost to Follow-up|28|||
16998603|NCT00950300|38142447|FG000|SFU Period|Withdrawal by Subject|4|||
16998604|NCT00950300|38142448|FG001|SFU Period|Withdrawal by Subject|8|||
16998605|NCT00949988|38142455|FG000|Overall Study|Withdrawal by Subject|3|||
16998606|NCT00731692|38142462|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
16998607|NCT00731692|38142463|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
16998608|NCT00731692|38142464|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
16998609|NCT00731692|38142462|FG000|Core Study (36 Months)|Physician Decision|1|||
16998610|NCT00731692|38142463|FG001|Core Study (36 Months)|Physician Decision|0|||
16998611|NCT00731692|38142464|FG002|Core Study (36 Months)|Physician Decision|2|||
16782857|NCT02086162|37722544|FG000|Overall Study|moved|1|||
16782858|NCT02086162|37722545|FG001|Overall Study|moved|1|||
16782859|NCT02086162|37722544|FG000|Overall Study|Lost to Follow-up|4|||
16782860|NCT02086162|37722545|FG001|Overall Study|Lost to Follow-up|2|||
16998612|NCT00731692|38142462|FG000|Core Study (36 Months)|Death|2|||
16998613|NCT00731692|38142463|FG001|Core Study (36 Months)|Death|1|||
16998614|NCT00731692|38142464|FG002|Core Study (36 Months)|Death|2|||
16998615|NCT00731692|38142462|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
16998616|NCT00731692|38142463|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
16998617|NCT00731692|38142464|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
16782861|NCT02086162|37722544|FG000|Overall Study|Death|1|||
16998618|NCT00731692|38142462|FG000|Core Study (36 Months)|Administrative|2|||
16998619|NCT00731692|38142463|FG001|Core Study (36 Months)|Administrative|2|||
16998620|NCT00731692|38142464|FG002|Core Study (36 Months)|Administrative|6|||
16998621|NCT00731692|38142462|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
16998622|NCT00731692|38142463|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
16998623|NCT00731692|38142464|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
16998624|NCT00731692|38142462|FG000|Core Study (36 Months)|Protocol Violation|4|||
16998625|NCT00731692|38142463|FG001|Core Study (36 Months)|Protocol Violation|5|||
16998626|NCT00731692|38142464|FG002|Core Study (36 Months)|Protocol Violation|8|||
16998627|NCT00731692|38142462|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
16998628|NCT00731692|38142463|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
16998629|NCT00731692|38142464|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
16998630|NCT00731692|38142462|FG000|Core Study (36 Months)|Adverse Event|25|||
16998631|NCT00731692|38142463|FG001|Core Study (36 Months)|Adverse Event|28|||
16998632|NCT00731692|38142464|FG002|Core Study (36 Months)|Adverse Event|29|||
16998633|NCT00731692|38142462|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
16998634|NCT00731692|38142463|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
16998635|NCT00731692|38142464|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
16998636|NCT00731692|38142462|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
16998637|NCT00731692|38142463|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
16998638|NCT00731692|38142464|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
16998639|NCT00731692|38142462|FG000|Extension Phase|Abnormal test procedure|0|||
16998640|NCT00731692|38142463|FG001|Extension Phase|Abnormal test procedure|0|||
16998641|NCT00731692|38142464|FG002|Extension Phase|Abnormal test procedure|1|||
16998642|NCT00731692|38142462|FG000|Extension Phase|Abnormal lab values|0|||
16998643|NCT00731692|38142463|FG001|Extension Phase|Abnormal lab values|0|||
16998644|NCT00731692|38142464|FG002|Extension Phase|Abnormal lab values|1|||
16998645|NCT00731692|38142462|FG000|Extension Phase|Lost to Follow-up|0|||
16998646|NCT00731692|38142463|FG001|Extension Phase|Lost to Follow-up|1|||
16998647|NCT00731692|38142464|FG002|Extension Phase|Lost to Follow-up|4|||
16998648|NCT00731692|38142462|FG000|Extension Phase|Withdrawal by Subject|4|||
16998649|NCT00731692|38142463|FG001|Extension Phase|Withdrawal by Subject|5|||
16998650|NCT00731692|38142464|FG002|Extension Phase|Withdrawal by Subject|3|||
16998651|NCT00731692|38142462|FG000|Extension Phase|Adverse Event|1|||
16998652|NCT00731692|38142463|FG001|Extension Phase|Adverse Event|1|||
16998653|NCT00731692|38142464|FG002|Extension Phase|Adverse Event|15|||
16998654|NCT00687193|38142486|FG000|Overall Study|Adverse Event|0|||
16998655|NCT00687193|38142487|FG001|Overall Study|Adverse Event|1|||
16998656|NCT00687193|38142488|FG002|Overall Study|Adverse Event|2|||
16998657|NCT00687193|38142489|FG003|Overall Study|Adverse Event|3|||
16998658|NCT00687193|38142490|FG004|Overall Study|Adverse Event|0|||
16998659|NCT00687193|38142491|FG005|Overall Study|Adverse Event|2|||
16998660|NCT00687193|38142486|FG000|Overall Study|Lack of Efficacy|1|||
16998661|NCT00687193|38142487|FG001|Overall Study|Lack of Efficacy|1|||
16998662|NCT00687193|38142488|FG002|Overall Study|Lack of Efficacy|0|||
16998663|NCT00687193|38142489|FG003|Overall Study|Lack of Efficacy|0|||
16998664|NCT00687193|38142490|FG004|Overall Study|Lack of Efficacy|0|||
16998665|NCT00687193|38142491|FG005|Overall Study|Lack of Efficacy|2|||
16998666|NCT00687193|38142486|FG000|Overall Study|Protocol Violation|1|||
16998667|NCT00687193|38142487|FG001|Overall Study|Protocol Violation|2|||
16998668|NCT00687193|38142488|FG002|Overall Study|Protocol Violation|0|||
16998669|NCT00687193|38142489|FG003|Overall Study|Protocol Violation|1|||
16998670|NCT00687193|38142490|FG004|Overall Study|Protocol Violation|2|||
16998671|NCT00687193|38142491|FG005|Overall Study|Protocol Violation|0|||
16998672|NCT00730912|38142511|FG000|Overall Study|Discontinued|0|||
16998673|NCT00730912|38142512|FG001|Overall Study|Discontinued|0|||
16998674|NCT00730912|38142513|FG002|Overall Study|Discontinued|1|||
16998675|NCT00737698|38142524|FG000|Overall Study|Withdrawal by Subject|6|||
16998676|NCT00737698|38142525|FG001|Overall Study|Withdrawal by Subject|5|||
16998677|NCT00737698|38142526|FG002|Overall Study|Withdrawal by Subject|3|||
16998678|NCT00737698|38142524|FG000|Overall Study|Death|0|||
16998679|NCT00737698|38142525|FG001|Overall Study|Death|0|||
16998680|NCT00737698|38142526|FG002|Overall Study|Death|1|||
16998681|NCT00730756|38142536|FG000|Overall Study|Adverse Event|2|||
16998682|NCT00730756|38142537|FG001|Overall Study|Adverse Event|0|||
16998683|NCT00730756|38142536|FG000|Overall Study|Lack of Efficacy|1|||
16998684|NCT00730756|38142537|FG001|Overall Study|Lack of Efficacy|1|||
16998685|NCT00730756|38142536|FG000|Overall Study|Protocol Deviation|1|||
16998686|NCT00730756|38142537|FG001|Overall Study|Protocol Deviation|2|||
16998687|NCT00730756|38142536|FG000|Overall Study|Lost to Follow-up|0|||
16998688|NCT00730756|38142537|FG001|Overall Study|Lost to Follow-up|1|||
16998689|NCT00730756|38142536|FG000|Overall Study|Withdrew Consent|0|||
16998690|NCT00730756|38142537|FG001|Overall Study|Withdrew Consent|1|||
16998691|NCT00730132|38142543|FG000|Overall Study|Protocol Violation|154|||
16998692|NCT00730132|38142543|FG000|Overall Study|Death|1|||
16998693|NCT00737464|38142550|FG000|Overall Study|Adverse Event|1|||
16998694|NCT00737464|38142550|FG000|Overall Study|Death|6|||
16998695|NCT00737464|38142550|FG000|Overall Study|Other - Failure to Return|1|||
16998696|NCT00737464|38142550|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
16998697|NCT00737464|38142550|FG000|Overall Study|Other reasons|4|||
16998698|NCT00729586|38142556|FG000|Overall Study|Ineligible|0|||
16998699|NCT00729586|38142557|FG001|Overall Study|Ineligible|1|||
16998700|NCT00729586|38142556|FG000|Overall Study|never treated|1|||
16998701|NCT00729586|38142557|FG001|Overall Study|never treated|0|||
16998702|NCT00949910|38142564|FG000|Overall Study|Progressive Disease|3750|||
16998703|NCT00949910|38142564|FG000|Overall Study|Symptomatic Deterioration|1088|||
16998704|NCT00949910|38142564|FG000|Overall Study|Lost to Follow-up|100|||
16998705|NCT00949910|38142564|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
16998706|NCT00949910|38142564|FG000|Overall Study|Participant Refusal|390|||
16998707|NCT00949910|38142564|FG000|Overall Study|Death Due to Malignant Disease|456|||
16998708|NCT00949910|38142564|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
16998709|NCT00949910|38142564|FG000|Overall Study|Death Due to Adverse Event|115|||
16998710|NCT00949910|38142564|FG000|Overall Study|Death Due to Toxicity|3|||
16998711|NCT00949910|38142564|FG000|Overall Study|Death from Unknown Cause|5|||
16998712|NCT00949910|38142564|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
16998713|NCT00949910|38142564|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
16998714|NCT00949910|38142564|FG000|Overall Study|Switched to Commercial Treatment|4|||
16998715|NCT00949910|38142564|FG000|Overall Study|Violation of Eligibility|23|||
16998716|NCT00949910|38142564|FG000|Overall Study|Logistical Reasons|13|||
16998717|NCT00949910|38142564|FG000|Overall Study|Non-Compliance|10|||
16998718|NCT00949910|38142564|FG000|Overall Study|Prolonged Dosing Interruption|4|||
16998719|NCT00949910|38142564|FG000|Overall Study|Adverse Event|83|||
16998720|NCT00949910|38142564|FG000|Overall Study|Serious Adverse Event|6|||
16998721|NCT00949910|38142564|FG000|Overall Study|Physician/Participant Decision|7|||
16998722|NCT00949910|38142564|FG000|Overall Study|Other|4|||
16998723|NCT00949910|38142564|FG000|Overall Study|No Data|9|||
16998724|NCT00686959|38142570|FG000|Overall Study|Participants censored (no death events)|124|||
16998725|NCT00686959|38142571|FG001|Overall Study|Participants censored (no death events)|117|||
16998726|NCT00946088|38142579|FG000|Overall Study|Withdrawal by Subject|0|||
16998727|NCT00946088|38142580|FG001|Overall Study|Withdrawal by Subject|1|||
16998728|NCT00736996|38142591|FG000|Overall Study|Lost to Follow-up|1|||
16998729|NCT00736996|38142592|FG001|Overall Study|Lost to Follow-up|9|||
16998730|NCT00736996|38142593|FG002|Overall Study|Lost to Follow-up|2|||
16998731|NCT00728962|38142607|FG000|Implant Placement Surgery|Adverse Event|8|||
16998732|NCT00728962|38142607|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
16998733|NCT00728962|38142607|FG000|Implant Placement Surgery|Protocol Violation|1|||
16998734|NCT00728962|38142607|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
16998735|NCT00728962|38142607|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
16998736|NCT00954122|38142611|FG000|Overall Study|Withdrawal by Subject|5|||
16998737|NCT00954122|38142611|FG000|Overall Study|Adverse Event|1|||
16998738|NCT00954122|38142611|FG000|Overall Study|Safety Reason|1|||
16998739|NCT00586066|38142618|FG000|Overall Study|Lost to Follow-up|6|||
16998740|NCT00586066|38142619|FG001|Overall Study|Lost to Follow-up|3|||
16998741|NCT00586066|38142618|FG000|Overall Study|Lack of Efficacy|5|||
16998742|NCT00586066|38142619|FG001|Overall Study|Lack of Efficacy|3|||
16998743|NCT00586066|38142618|FG000|Overall Study|Adverse Event|2|||
16998744|NCT00586066|38142619|FG001|Overall Study|Adverse Event|2|||
16998745|NCT00586066|38142618|FG000|Overall Study|Physician Decision|1|||
16998746|NCT00586066|38142619|FG001|Overall Study|Physician Decision|0|||
16998747|NCT00586066|38142618|FG000|Overall Study|Withdrawal of consent|4|||
16998748|NCT00586066|38142619|FG001|Overall Study|Withdrawal of consent|2|||
16998749|NCT01186016|38142627|FG000|Overall Study|Withdrawal by Subject|46|||
16998750|NCT01186016|38142628|FG001|Overall Study|Withdrawal by Subject|29|||
16998751|NCT00728884|38142634|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
16998752|NCT00728884|38142634|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
16998753|NCT00728494|38142640|FG000|Overall Study|Adverse Event|7|||
16998754|NCT00728494|38142641|FG001|Overall Study|Adverse Event|0|||
16998755|NCT00728494|38142640|FG000|Overall Study|Withdrawal by Subject|0|||
16998756|NCT00728494|38142641|FG001|Overall Study|Withdrawal by Subject|2|||
16998757|NCT00728494|38142640|FG000|Overall Study|Lack of Efficacy|2|||
16998758|NCT00728494|38142641|FG001|Overall Study|Lack of Efficacy|4|||
16998759|NCT00728494|38142640|FG000|Overall Study|No data available|0|||
16998760|NCT00728494|38142641|FG001|Overall Study|No data available|1|||
16998761|NCT00728416|38142649|FG000|Overall Study|Adverse Event|1|||
16998762|NCT00728416|38142650|FG001|Overall Study|Adverse Event|1|||
16998763|NCT00728416|38142649|FG000|Overall Study|Treatment Failure|0|||
16998764|NCT00728416|38142650|FG001|Overall Study|Treatment Failure|1|||
16998765|NCT00728416|38142649|FG000|Overall Study|Withdrawal by Subject|1|||
16998766|NCT00728416|38142650|FG001|Overall Study|Withdrawal by Subject|0|||
16998767|NCT00728182|38142658|FG000|Overall Study|Adverse Event|1|||
16998768|NCT00728182|38142659|FG001|Overall Study|Adverse Event|0|||
16998769|NCT00728182|38142658|FG000|Overall Study|Lost to Follow-up|2|||
16998770|NCT00728182|38142659|FG001|Overall Study|Lost to Follow-up|0|||
16998771|NCT00728182|38142658|FG000|Overall Study|Death|0|||
16998772|NCT00728182|38142659|FG001|Overall Study|Death|2|||
16998773|NCT00728182|38142658|FG000|Overall Study|Protocol Noncompliance|0|||
16998774|NCT00728182|38142659|FG001|Overall Study|Protocol Noncompliance|1|||
16998775|NCT00941330|38142669|FG000|Overall Study|Other|1|||
16998776|NCT00941330|38142670|FG001|Overall Study|Other|0|||
16998777|NCT00941330|38142669|FG000|Overall Study|Physician Decision|0|||
16998778|NCT00941330|38142670|FG001|Overall Study|Physician Decision|2|||
16998779|NCT00736450|38142676|FG000|Overall Study|Not ABC gene eligible|19|||
16998780|NCT00736450|38142676|FG000|Overall Study|Withdrawal by Subject|5|||
16998781|NCT00736450|38142676|FG000|Overall Study|Physician Decision|1|||
16998782|NCT00686881|38142682|FG000|Overall Study|Withdrawal by Subject|11|||
16998783|NCT00686881|38142683|FG001|Overall Study|Withdrawal by Subject|18|||
16998784|NCT00686881|38142682|FG000|Overall Study|Lost to Follow-up|0|||
16998785|NCT00686881|38142683|FG001|Overall Study|Lost to Follow-up|1|||
16998786|NCT00686881|38142682|FG000|Overall Study|Treatment-related adverse event|10|||
16998787|NCT00686881|38142683|FG001|Overall Study|Treatment-related adverse event|9|||
16998788|NCT00686881|38142682|FG000|Overall Study|Met discontinuation criteria|5|||
16998789|NCT00686881|38142683|FG001|Overall Study|Met discontinuation criteria|0|||
16998790|NCT00686881|38142682|FG000|Overall Study|Onset of malignant tumor|11|||
16998791|NCT00686881|38142683|FG001|Overall Study|Onset of malignant tumor|11|||
16998792|NCT00686881|38142682|FG000|Overall Study|Lack of Efficacy|4|||
16998793|NCT00686881|38142683|FG001|Overall Study|Lack of Efficacy|3|||
16998794|NCT00686881|38142682|FG000|Overall Study|Physician Decision|1|||
16998795|NCT00686881|38142683|FG001|Overall Study|Physician Decision|0|||
16998796|NCT00686881|38142682|FG000|Overall Study|Circumstances of site|1|||
16998797|NCT00686881|38142683|FG001|Overall Study|Circumstances of site|1|||
16782862|NCT02086162|37722545|FG001|Overall Study|Death|0|||
16782863|NCT02701283|37722558|FG000|Overall Study|Death|25|||
16782864|NCT02701283|37722559|FG001|Overall Study|Death|29|||
16782865|NCT02701283|37722560|FG002|Overall Study|Death|19|||
16782866|NCT02701283|37722558|FG000|Overall Study|Lost to Follow-up|3|||
16782867|NCT02701283|37722559|FG001|Overall Study|Lost to Follow-up|8|||
16782868|NCT02701283|37722560|FG002|Overall Study|Lost to Follow-up|1|||
16782869|NCT02701283|37722558|FG000|Overall Study|Withdrawal by Subject|12|||
16782870|NCT02701283|37722559|FG001|Overall Study|Withdrawal by Subject|41|||
16782871|NCT02701283|37722560|FG002|Overall Study|Withdrawal by Subject|1|||
16782872|NCT02701283|37722558|FG000|Overall Study|Missed 2-year visit|22|||
16782873|NCT02701283|37722559|FG001|Overall Study|Missed 2-year visit|27|||
16782874|NCT02701283|37722560|FG002|Overall Study|Missed 2-year visit|0|||
16782875|NCT02701283|37722558|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
16782876|NCT02701283|37722559|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
16782877|NCT02701283|37722560|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
16782878|NCT02700815|37722575|FG000|Overall Study|Adverse Event|0|||
16782879|NCT02700815|37722576|FG001|Overall Study|Adverse Event|6|||
16782880|NCT02700815|37722577|FG002|Overall Study|Adverse Event|2|||
16782881|NCT02700815|37722578|FG003|Overall Study|Adverse Event|3|||
16782882|NCT02700815|37722575|FG000|Overall Study|Lack of Efficacy|0|||
16782883|NCT02700815|37722576|FG001|Overall Study|Lack of Efficacy|0|||
16782884|NCT02700815|37722577|FG002|Overall Study|Lack of Efficacy|1|||
16782885|NCT02700815|37722578|FG003|Overall Study|Lack of Efficacy|2|||
16782886|NCT02700815|37722575|FG000|Overall Study|Lost to Follow-up|1|||
16782887|NCT02700815|37722576|FG001|Overall Study|Lost to Follow-up|0|||
16782888|NCT02700815|37722577|FG002|Overall Study|Lost to Follow-up|0|||
16782889|NCT02700815|37722578|FG003|Overall Study|Lost to Follow-up|1|||
16782890|NCT02700815|37722575|FG000|Overall Study|Refusal to continue medication|0|||
16782891|NCT02700815|37722576|FG001|Overall Study|Refusal to continue medication|1|||
16782892|NCT02700815|37722577|FG002|Overall Study|Refusal to continue medication|0|||
16782893|NCT02700815|37722578|FG003|Overall Study|Refusal to continue medication|1|||
16782894|NCT02700815|37722575|FG000|Overall Study|Withdrawal by Subject|0|||
16782895|NCT02700815|37722576|FG001|Overall Study|Withdrawal by Subject|0|||
16782896|NCT02700815|37722577|FG002|Overall Study|Withdrawal by Subject|1|||
16782897|NCT02700815|37722578|FG003|Overall Study|Withdrawal by Subject|0|||
16782898|NCT00708305|37722588|FG000|Period 1|Protocol Violation|1|||
16782899|NCT00708305|37722589|FG001|Period 1|Protocol Violation|0|||
16782900|NCT00708305|37722590|FG002|Period 1|Protocol Violation|1|||
16782901|NCT00708305|37722591|FG003|Period 1|Protocol Violation|0|||
16782902|NCT00708305|37722588|FG000|Period 1|Other Reason|0|||
16782903|NCT00708305|37722589|FG001|Period 1|Other Reason|0|||
16782904|NCT00708305|37722590|FG002|Period 1|Other Reason|0|||
16782905|NCT00708305|37722591|FG003|Period 1|Other Reason|2|||
16782906|NCT00708305|37722588|FG000|Period 2|Lost to Follow-up|0|||
16782907|NCT00708305|37722589|FG001|Period 2|Lost to Follow-up|1|||
16782908|NCT00708305|37722590|FG002|Period 2|Lost to Follow-up|0|||
16782909|NCT00708305|37722591|FG003|Period 2|Lost to Follow-up|0|||
16782910|NCT00708305|37722588|FG000|Period 2|Protocol Violation|0|||
16782911|NCT00708305|37722589|FG001|Period 2|Protocol Violation|1|||
16782912|NCT00708305|37722590|FG002|Period 2|Protocol Violation|0|||
16998798|NCT00686881|38142682|FG000|Overall Study|Did not meet protocol eligibility|1|||
16998799|NCT00686881|38142683|FG001|Overall Study|Did not meet protocol eligibility|0|||
16998800|NCT00686881|38142682|FG000|Overall Study|Irregular visits|1|||
16998801|NCT00686881|38142683|FG001|Overall Study|Irregular visits|0|||
16998802|NCT00686881|38142682|FG000|Overall Study|Study discontinuation|35|||
16998803|NCT00686881|38142683|FG001|Overall Study|Study discontinuation|32|||
16998804|NCT00686881|38142682|FG000|Overall Study|Never received study drug|2|||
16998805|NCT00686881|38142683|FG001|Overall Study|Never received study drug|6|||
16782913|NCT00708305|37722591|FG003|Period 2|Protocol Violation|0|||
16782914|NCT00708305|37722588|FG000|Period 2|Other Reason|1|||
16782915|NCT00708305|37722589|FG001|Period 2|Other Reason|0|||
16782916|NCT00708305|37722590|FG002|Period 2|Other Reason|0|||
16782917|NCT00708305|37722591|FG003|Period 2|Other Reason|1|||
16782918|NCT00708305|37722588|FG000|Period 3|Protocol Violation|0|||
16782919|NCT00708305|37722589|FG001|Period 3|Protocol Violation|2|||
16782920|NCT00708305|37722590|FG002|Period 3|Protocol Violation|0|||
16782921|NCT00708305|37722591|FG003|Period 3|Protocol Violation|0|||
16782922|NCT00708305|37722588|FG000|Period 3|Other Reason|1|||
16782923|NCT00708305|37722589|FG001|Period 3|Other Reason|0|||
16782924|NCT00708305|37722590|FG002|Period 3|Other Reason|0|||
16782925|NCT00708305|37722591|FG003|Period 3|Other Reason|0|||
16782926|NCT02055976|37722613|FG000|Overall Study|Other|0|||
16782927|NCT02055976|37722614|FG001|Overall Study|Other|0|||
16782928|NCT02055976|37722615|FG002|Overall Study|Other|1|||
16782929|NCT02055976|37722616|FG003|Overall Study|Other|0|||
16782930|NCT02055976|37722617|FG004|Overall Study|Other|0|||
16782931|NCT02055976|37722618|FG005|Overall Study|Other|0|||
16782932|NCT02055976|37722619|FG006|Overall Study|Other|0|||
16782933|NCT02055976|37722620|FG007|Overall Study|Other|0|||
16782934|NCT02055976|37722621|FG008|Overall Study|Other|0|||
16782935|NCT02055976|37722613|FG000|Overall Study|Adverse Event|0|||
16782936|NCT02055976|37722614|FG001|Overall Study|Adverse Event|0|||
16782937|NCT02055976|37722615|FG002|Overall Study|Adverse Event|0|||
16782938|NCT02055976|37722616|FG003|Overall Study|Adverse Event|0|||
16782939|NCT02055976|37722617|FG004|Overall Study|Adverse Event|0|||
16782940|NCT02055976|37722618|FG005|Overall Study|Adverse Event|1|||
16782941|NCT02055976|37722619|FG006|Overall Study|Adverse Event|1|||
16782942|NCT02055976|37722620|FG007|Overall Study|Adverse Event|0|||
16782943|NCT02055976|37722621|FG008|Overall Study|Adverse Event|0|||
16782944|NCT02055976|37722613|FG000|Overall Study|Does not meet entrance criteria|0|||
16782945|NCT02055976|37722614|FG001|Overall Study|Does not meet entrance criteria|0|||
16782946|NCT02055976|37722615|FG002|Overall Study|Does not meet entrance criteria|0|||
16782947|NCT02055976|37722616|FG003|Overall Study|Does not meet entrance criteria|0|||
16782948|NCT02055976|37722617|FG004|Overall Study|Does not meet entrance criteria|0|||
16782949|NCT02055976|37722618|FG005|Overall Study|Does not meet entrance criteria|0|||
16782950|NCT02055976|37722619|FG006|Overall Study|Does not meet entrance criteria|1|||
16782951|NCT02055976|37722620|FG007|Overall Study|Does not meet entrance criteria|0|||
16782952|NCT02055976|37722621|FG008|Overall Study|Does not meet entrance criteria|0|||
16782953|NCT02055976|37722613|FG000|Overall Study|Lost to Follow-up|0|||
16782954|NCT02055976|37722614|FG001|Overall Study|Lost to Follow-up|0|||
16782955|NCT02055976|37722615|FG002|Overall Study|Lost to Follow-up|0|||
16782956|NCT02055976|37722616|FG003|Overall Study|Lost to Follow-up|1|||
16782957|NCT02055976|37722617|FG004|Overall Study|Lost to Follow-up|0|||
16782958|NCT02055976|37722618|FG005|Overall Study|Lost to Follow-up|0|||
16782959|NCT02055976|37722619|FG006|Overall Study|Lost to Follow-up|0|||
16782960|NCT02055976|37722620|FG007|Overall Study|Lost to Follow-up|0|||
16782961|NCT02055976|37722621|FG008|Overall Study|Lost to Follow-up|0|||
16782962|NCT02055898|37722650|FG000|First Intervention (5 Days)|Physician Decision|2|||
16782963|NCT02055898|37722651|FG001|First Intervention (5 Days)|Physician Decision|0|||
16782964|NCT02055898|37722650|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
16782965|NCT02055898|37722651|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
16782966|NCT02564055|37722663|FG000|Overall Study|Adverse Event|1|||
16782967|NCT02564055|37722664|FG001|Overall Study|Adverse Event|0|||
16782968|NCT02564055|37722665|FG002|Overall Study|Adverse Event|4|||
16782969|NCT02564055|37722666|FG003|Overall Study|Adverse Event|1|||
16782970|NCT02564055|37722667|FG004|Overall Study|Adverse Event|4|||
16782971|NCT02564055|37722668|FG005|Overall Study|Adverse Event|1|||
16782972|NCT02564055|37722663|FG000|Overall Study|Protocol Violation|1|||
16782973|NCT02564055|37722664|FG001|Overall Study|Protocol Violation|0|||
16782974|NCT02564055|37722665|FG002|Overall Study|Protocol Violation|0|||
16782975|NCT02564055|37722666|FG003|Overall Study|Protocol Violation|0|||
16782976|NCT02564055|37722667|FG004|Overall Study|Protocol Violation|0|||
16782977|NCT02564055|37722668|FG005|Overall Study|Protocol Violation|0|||
16782978|NCT02564055|37722663|FG000|Overall Study|Reached stopping criteria|0|||
16782979|NCT02564055|37722664|FG001|Overall Study|Reached stopping criteria|0|||
16782980|NCT02564055|37722665|FG002|Overall Study|Reached stopping criteria|0|||
16782981|NCT02564055|37722666|FG003|Overall Study|Reached stopping criteria|0|||
16782982|NCT02564055|37722667|FG004|Overall Study|Reached stopping criteria|0|||
16782983|NCT02564055|37722668|FG005|Overall Study|Reached stopping criteria|1|||
16782984|NCT02564055|37722663|FG000|Overall Study|Lost to Follow-up|0|||
16998806|NCT00727714|38142691|FG000|Overall Study|Lost to Follow-up|2|||
16998807|NCT00727558|38142697|FG000|Overall Study|Lens issue|0|||
16998808|NCT00727558|38142698|FG001|Overall Study|Lens issue|1|||
16998809|NCT00727558|38142697|FG000|Overall Study|Adverse Event|0|||
16998810|NCT00727558|38142698|FG001|Overall Study|Adverse Event|1|||
16998811|NCT00727558|38142697|FG000|Overall Study|Subject unable to return for follow-up|1|||
16998812|NCT00727558|38142698|FG001|Overall Study|Subject unable to return for follow-up|1|||
16998813|NCT00727558|38142697|FG000|Overall Study|Lost to Follow-up|1|||
16998814|NCT00727558|38142698|FG001|Overall Study|Lost to Follow-up|0|||
16998815|NCT00688597|38142707|FG000|Overall Study|Adverse Event|2|||
16998816|NCT00688597|38142708|FG001|Overall Study|Adverse Event|0|||
16998817|NCT00688597|38142709|FG002|Overall Study|Adverse Event|0|||
16998818|NCT00688597|38142707|FG000|Overall Study|Physician Decision|1|||
16998819|NCT00688597|38142708|FG001|Overall Study|Physician Decision|0|||
16998820|NCT00688597|38142709|FG002|Overall Study|Physician Decision|0|||
16998821|NCT00735904|38142717|FG000|Overall Study|Adverse Event|3|||
16998822|NCT00735904|38142717|FG000|Overall Study|Death|20|||
16998823|NCT00735904|38142717|FG000|Overall Study|Protocol Violation|1|||
16998824|NCT00735904|38142717|FG000|Overall Study|Withdrawal by Subject|1|||
16998825|NCT00735904|38142717|FG000|Overall Study|Study Terminated by Sponsor|5|||
16998826|NCT00735904|38142717|FG000|Overall Study|Other|8|||
16998827|NCT00688519|38142723|FG000|Overall Study|Adverse Event|2|||
16998828|NCT00688519|38142724|FG001|Overall Study|Adverse Event|3|||
16998829|NCT00688519|38142723|FG000|Overall Study|Lost to Follow-up|3|||
16998830|NCT00688519|38142724|FG001|Overall Study|Lost to Follow-up|3|||
16998831|NCT00688519|38142723|FG000|Overall Study|Lack of Efficacy|3|||
16998832|NCT00688519|38142724|FG001|Overall Study|Lack of Efficacy|1|||
16998833|NCT00688519|38142723|FG000|Overall Study|Withdrawal by Subject|7|||
16998834|NCT00688519|38142724|FG001|Overall Study|Withdrawal by Subject|6|||
16998835|NCT00688519|38142723|FG000|Overall Study|Prohibited medication|1|||
16998836|NCT00688519|38142724|FG001|Overall Study|Prohibited medication|0|||
16998837|NCT00688519|38142723|FG000|Overall Study|Non-compliance|0|||
16998838|NCT00688519|38142724|FG001|Overall Study|Non-compliance|1|||
16998839|NCT00688519|38142723|FG000|Overall Study|Subject moved out of state|1|||
16998840|NCT00688519|38142724|FG001|Overall Study|Subject moved out of state|0|||
16998841|NCT00688519|38142723|FG000|Overall Study|Investigator decision|1|||
16998842|NCT00688519|38142724|FG001|Overall Study|Investigator decision|0|||
16998843|NCT00688519|38142723|FG000|Overall Study|Subject moved out of area|1|||
16998844|NCT00688519|38142724|FG001|Overall Study|Subject moved out of area|0|||
16998845|NCT00688519|38142723|FG000|Overall Study|Pregnancy|0|||
16998846|NCT00688519|38142724|FG001|Overall Study|Pregnancy|1|||
16998847|NCT00721630|38142730|FG000|Overall Study|Participant found to be ineligible|1|||
16998848|NCT00686725|38142736|FG000|Overall Study|Adverse Event|1|||
16998849|NCT00686725|38142737|FG001|Overall Study|Adverse Event|1|||
16998850|NCT00686725|38142736|FG000|Overall Study|Progressive Disease|17|||
16998851|NCT00686725|38142737|FG001|Overall Study|Progressive Disease|23|||
16998852|NCT00686725|38142736|FG000|Overall Study|Lost to Follow-up|7|||
16998853|NCT00686725|38142737|FG001|Overall Study|Lost to Follow-up|5|||
16998854|NCT00686725|38142736|FG000|Overall Study|Death|6|||
16998855|NCT00686725|38142737|FG001|Overall Study|Death|3|||
16998856|NCT00686725|38142736|FG000|Overall Study|Withdrawal by Subject|13|||
16998857|NCT00686725|38142737|FG001|Overall Study|Withdrawal by Subject|4|||
16998858|NCT00686725|38142736|FG000|Overall Study|Protocol Violation|1|||
16998859|NCT00686725|38142737|FG001|Overall Study|Protocol Violation|3|||
16998860|NCT00686725|38142736|FG000|Overall Study|Other|1|||
16998861|NCT00686725|38142737|FG001|Overall Study|Other|3|||
16998862|NCT00727402|38142743|FG000|Overall Study|Physician Decision|116|||
16998863|NCT00727246|38142751|FG000|Overall Study|could not complete MRI|0|||
16998864|NCT00727246|38142752|FG001|Overall Study|could not complete MRI|1|||
16998865|NCT00727246|38142753|FG002|Overall Study|could not complete MRI|0|||
16998866|NCT00727246|38142754|FG003|Overall Study|could not complete MRI|1|||
16998867|NCT00727246|38142751|FG000|Overall Study|incidental finding|0|||
16998868|NCT00727246|38142752|FG001|Overall Study|incidental finding|0|||
16998869|NCT00727246|38142753|FG002|Overall Study|incidental finding|0|||
16998870|NCT00727246|38142754|FG003|Overall Study|incidental finding|1|||
16998871|NCT00727246|38142751|FG000|Overall Study|withdrawn|0|||
16998872|NCT00727246|38142752|FG001|Overall Study|withdrawn|0|||
16998873|NCT00727246|38142753|FG002|Overall Study|withdrawn|1|||
16998874|NCT00727246|38142754|FG003|Overall Study|withdrawn|0|||
16998875|NCT00686647|38142764|FG000|Overall Study|Lost to Follow-up|1|||
16998876|NCT00686647|38142764|FG000|Overall Study|Death|1|||
16998877|NCT00687973|38142771|FG000|Overall Study|Adverse Event|18|||
16998878|NCT00687973|38142772|FG001|Overall Study|Adverse Event|28|||
16998879|NCT00687973|38142771|FG000|Overall Study|Lack of Efficacy|2|||
16782985|NCT02564055|37722664|FG001|Overall Study|Lost to Follow-up|1|||
16998880|NCT00687973|38142772|FG001|Overall Study|Lack of Efficacy|3|||
16998881|NCT00687973|38142771|FG000|Overall Study|Protocol Violation|1|||
16998882|NCT00687973|38142772|FG001|Overall Study|Protocol Violation|2|||
16998883|NCT00687973|38142771|FG000|Overall Study|Administrative Reasons|0|||
16998884|NCT00687973|38142772|FG001|Overall Study|Administrative Reasons|2|||
16998885|NCT00687973|38142771|FG000|Overall Study|Withdrawal by Subject|3|||
16998886|NCT00687973|38142772|FG001|Overall Study|Withdrawal by Subject|3|||
16998887|NCT00721396|38142783|FG000|Overall Study|Adverse Event|4|||
16998888|NCT00721396|38142784|FG001|Overall Study|Adverse Event|7|||
16998889|NCT00721396|38142785|FG002|Overall Study|Adverse Event|2|||
16998890|NCT00721396|38142786|FG003|Overall Study|Adverse Event|0|||
16998891|NCT00721396|38142783|FG000|Overall Study|Withdrawal by Subject|12|||
16998892|NCT00721396|38142784|FG001|Overall Study|Withdrawal by Subject|15|||
16998893|NCT00721396|38142785|FG002|Overall Study|Withdrawal by Subject|3|||
16998894|NCT00721396|38142786|FG003|Overall Study|Withdrawal by Subject|7|||
16998895|NCT00721396|38142783|FG000|Overall Study|Lost to Follow-up|7|||
16998896|NCT00721396|38142784|FG001|Overall Study|Lost to Follow-up|9|||
16998897|NCT00721396|38142785|FG002|Overall Study|Lost to Follow-up|3|||
16998898|NCT00721396|38142786|FG003|Overall Study|Lost to Follow-up|3|||
16998899|NCT00721396|38142783|FG000|Overall Study|Protocol Violation|4|||
16998900|NCT00721396|38142784|FG001|Overall Study|Protocol Violation|3|||
16998901|NCT00721396|38142785|FG002|Overall Study|Protocol Violation|1|||
16998902|NCT00721396|38142786|FG003|Overall Study|Protocol Violation|0|||
16998903|NCT00721396|38142783|FG000|Overall Study|Inappropriate enrollment|0|||
16998904|NCT00721396|38142784|FG001|Overall Study|Inappropriate enrollment|2|||
16998905|NCT00721396|38142785|FG002|Overall Study|Inappropriate enrollment|0|||
16998906|NCT00721396|38142786|FG003|Overall Study|Inappropriate enrollment|0|||
16998907|NCT00721396|38142783|FG000|Overall Study|Administrative reason|3|||
16998908|NCT00721396|38142784|FG001|Overall Study|Administrative reason|0|||
16998909|NCT00721396|38142785|FG002|Overall Study|Administrative reason|1|||
16998910|NCT00721396|38142786|FG003|Overall Study|Administrative reason|0|||
16998911|NCT00943826|38142803|FG000|Concurrent Phase|Adverse Event|50|||
16998912|NCT00943826|38142804|FG001|Concurrent Phase|Adverse Event|27|||
16998913|NCT00943826|38142803|FG000|Concurrent Phase|Withdrew consent|3|||
16998914|NCT00943826|38142804|FG001|Concurrent Phase|Withdrew consent|7|||
16998915|NCT00943826|38142803|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
16998916|NCT00943826|38142804|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
16998917|NCT00943826|38142803|FG000|Concurrent Phase|Administrative reasons|2|||
16998918|NCT00943826|38142804|FG001|Concurrent Phase|Administrative reasons|1|||
16998919|NCT00943826|38142803|FG000|Concurrent Phase|Protocol Violation|1|||
16998920|NCT00943826|38142804|FG001|Concurrent Phase|Protocol Violation|0|||
16998921|NCT00943826|38142803|FG000|Maintenance Phase|Adverse Event|31|||
16998922|NCT00943826|38142804|FG001|Maintenance Phase|Adverse Event|30|||
16998923|NCT00943826|38142803|FG000|Maintenance Phase|Withdrew consent|2|||
16998924|NCT00943826|38142804|FG001|Maintenance Phase|Withdrew consent|4|||
16998925|NCT00943826|38142803|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
16998926|NCT00943826|38142804|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
16998927|NCT00943826|38142803|FG000|Maintenance Phase|Administrative reasons|4|||
16998928|NCT00943826|38142804|FG001|Maintenance Phase|Administrative reasons|1|||
16998929|NCT00943826|38142803|FG000|Maintenance Phase|Failure to return|0|||
16998930|NCT00943826|38142804|FG001|Maintenance Phase|Failure to return|1|||
16998931|NCT00943826|38142803|FG000|Monotherapy Phase|Adverse Event|42|||
16998932|NCT00943826|38142804|FG001|Monotherapy Phase|Adverse Event|5|||
16998933|NCT00943826|38142803|FG000|Monotherapy Phase|Administrative reasons|11|||
16998934|NCT00943826|38142804|FG001|Monotherapy Phase|Administrative reasons|5|||
16998935|NCT00943826|38142803|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
16998936|NCT00943826|38142804|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
16998937|NCT00943826|38142803|FG000|Monotherapy Phase|Withdrew Consent|2|||
16998938|NCT00943826|38142804|FG001|Monotherapy Phase|Withdrew Consent|3|||
16998939|NCT00943826|38142803|FG000|Monotherapy Phase|Failure to return|2|||
16998940|NCT00943826|38142804|FG001|Monotherapy Phase|Failure to return|1|||
16998941|NCT00943826|38142803|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
16998942|NCT00943826|38142804|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
16998943|NCT00943826|38142803|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
16998944|NCT00943826|38142804|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
16998945|NCT00943826|38142803|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
16998946|NCT00943826|38142804|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
16998947|NCT00943826|38142803|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
16998948|NCT00943826|38142804|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
16998949|NCT01004003|38142820|FG000|Overall Study|Progressive disease|2|||
16998950|NCT01004003|38142821|FG001|Overall Study|Progressive disease|1|||
16998951|NCT01004003|38142822|FG002|Overall Study|Progressive disease|1|||
16998952|NCT01004003|38142823|FG003|Overall Study|Progressive disease|0|||
16998953|NCT01004003|38142824|FG004|Overall Study|Progressive disease|2|||
16998954|NCT01004003|38142825|FG005|Overall Study|Progressive disease|1|||
16998955|NCT01004003|38142826|FG006|Overall Study|Progressive disease|1|||
16998956|NCT01004003|38142827|FG007|Overall Study|Progressive disease|39|||
16998957|NCT01004003|38142828|FG008|Overall Study|Progressive disease|22|||
16998958|NCT01004003|38142820|FG000|Overall Study|Adverse Event|4|||
16998959|NCT01004003|38142821|FG001|Overall Study|Adverse Event|2|||
17189826|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
16998960|NCT01004003|38142822|FG002|Overall Study|Adverse Event|3|||
16998961|NCT01004003|38142823|FG003|Overall Study|Adverse Event|3|||
16998962|NCT01004003|38142824|FG004|Overall Study|Adverse Event|2|||
16998963|NCT01004003|38142825|FG005|Overall Study|Adverse Event|2|||
16998964|NCT01004003|38142826|FG006|Overall Study|Adverse Event|7|||
16998965|NCT01004003|38142827|FG007|Overall Study|Adverse Event|21|||
16998966|NCT01004003|38142828|FG008|Overall Study|Adverse Event|6|||
16998967|NCT01004003|38142820|FG000|Overall Study|Refused to continue taking trial med.|0|||
16998968|NCT01004003|38142821|FG001|Overall Study|Refused to continue taking trial med.|0|||
16998969|NCT01004003|38142822|FG002|Overall Study|Refused to continue taking trial med.|0|||
16998970|NCT01004003|38142823|FG003|Overall Study|Refused to continue taking trial med.|0|||
16998971|NCT01004003|38142824|FG004|Overall Study|Refused to continue taking trial med.|0|||
16998972|NCT01004003|38142825|FG005|Overall Study|Refused to continue taking trial med.|0|||
16998973|NCT01004003|38142826|FG006|Overall Study|Refused to continue taking trial med.|0|||
16998974|NCT01004003|38142827|FG007|Overall Study|Refused to continue taking trial med.|0|||
16998975|NCT01004003|38142828|FG008|Overall Study|Refused to continue taking trial med.|2|||
16998976|NCT01004003|38142820|FG000|Overall Study|Other|0|||
16998977|NCT01004003|38142821|FG001|Overall Study|Other|0|||
16998978|NCT01004003|38142822|FG002|Overall Study|Other|0|||
16998979|NCT01004003|38142823|FG003|Overall Study|Other|0|||
16998980|NCT01004003|38142824|FG004|Overall Study|Other|0|||
16998981|NCT01004003|38142825|FG005|Overall Study|Other|1|||
16998982|NCT01004003|38142826|FG006|Overall Study|Other|0|||
16998983|NCT01004003|38142827|FG007|Overall Study|Other|0|||
16998984|NCT01004003|38142828|FG008|Overall Study|Other|0|||
16998985|NCT00943670|38142850|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
16998986|NCT00943670|38142850|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
16998987|NCT00943670|38142850|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
16998988|NCT00943670|38142850|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
16998989|NCT00943670|38142850|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
16998990|NCT00943670|38142850|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
16998991|NCT00943670|38142850|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
16998992|NCT00943670|38142850|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
16998993|NCT00943670|38142850|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
16998994|NCT00943670|38142850|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
16998995|NCT00938366|38142867|FG000|Overall Study|Withdrawal by Subject|1|||
16998996|NCT00938366|38142868|FG001|Overall Study|Withdrawal by Subject|0|||
16998997|NCT00943592|38142874|FG000|Overall Study|Death|3|||
16998998|NCT00943124|38142878|FG000|Period 1|Withdrawal by Subject|1|||
16998999|NCT00943124|38142879|FG001|Period 1|Withdrawal by Subject|1|||
16999000|NCT00943124|38142878|FG000|Period 1|Did Not Follow Study Procedures|1|||
16999001|NCT00943124|38142879|FG001|Period 1|Did Not Follow Study Procedures|0|||
16999002|NCT00943124|38142878|FG000|Period 1|Personal Reasons|0|||
16999003|NCT00943124|38142879|FG001|Period 1|Personal Reasons|1|||
16999004|NCT00492050|38142885|FG000|Overall Study|Adverse Event|1|||
16999005|NCT00492050|38142885|FG000|Overall Study|Lack of Efficacy|1|||
16999006|NCT00492050|38142885|FG000|Overall Study|Withdrawal by Subject|3|||
16782986|NCT02564055|37722665|FG002|Overall Study|Lost to Follow-up|4|||
16782987|NCT02564055|37722666|FG003|Overall Study|Lost to Follow-up|2|||
16782988|NCT02564055|37722667|FG004|Overall Study|Lost to Follow-up|1|||
16782989|NCT02564055|37722668|FG005|Overall Study|Lost to Follow-up|0|||
16782990|NCT02564055|37722663|FG000|Overall Study|Physician Decision|0|||
16782991|NCT02564055|37722664|FG001|Overall Study|Physician Decision|0|||
16782992|NCT02564055|37722665|FG002|Overall Study|Physician Decision|1|||
16782993|NCT02564055|37722666|FG003|Overall Study|Physician Decision|0|||
16782994|NCT02564055|37722667|FG004|Overall Study|Physician Decision|0|||
16782995|NCT02564055|37722668|FG005|Overall Study|Physician Decision|0|||
16782996|NCT02564055|37722663|FG000|Overall Study|Withdrawal by Subject|4|||
16782997|NCT02564055|37722664|FG001|Overall Study|Withdrawal by Subject|4|||
16782998|NCT02564055|37722665|FG002|Overall Study|Withdrawal by Subject|3|||
16782999|NCT02564055|37722666|FG003|Overall Study|Withdrawal by Subject|3|||
16783000|NCT02564055|37722667|FG004|Overall Study|Withdrawal by Subject|10|||
16783001|NCT02564055|37722668|FG005|Overall Study|Withdrawal by Subject|10|||
16783002|NCT02563899|37722686|FG000|Overall Study|Protocol Violation|1|||
16783003|NCT02563899|37722687|FG001|Overall Study|Protocol Violation|0|||
16783004|NCT02563899|37722688|FG002|Overall Study|Protocol Violation|0|||
16783005|NCT02563899|37722689|FG003|Overall Study|Protocol Violation|0|||
16999007|NCT00492050|38142885|FG000|Overall Study|Unable to collect SCT|2|||
16999008|NCT00492050|38142885|FG000|Overall Study|Progressive Disease|2|||
16999009|NCT00726622|38142891|FG000|Overall Study|Withdrawal by Subject|16|||
16999010|NCT00726622|38142892|FG001|Overall Study|Withdrawal by Subject|2|||
16999011|NCT00726622|38142891|FG000|Overall Study|Physician Decision|0|||
16999012|NCT00726622|38142892|FG001|Overall Study|Physician Decision|1|||
16999013|NCT00726622|38142891|FG000|Overall Study|Metastasis|2|||
16999014|NCT00726622|38142892|FG001|Overall Study|Metastasis|0|||
16783006|NCT02563899|37722686|FG000|Overall Study|Withdrawal by Subject|0|||
16999015|NCT00940316|38142901|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
16999016|NCT00940316|38142902|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
16999017|NCT00940316|38142903|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
16999018|NCT00940316|38142901|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
16999019|NCT00940316|38142902|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
16999020|NCT00940316|38142903|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
16999021|NCT00940316|38142901|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
16999022|NCT00940316|38142902|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
16999023|NCT00940316|38142903|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
16999024|NCT00940316|38142901|FG000|Treated After Cycle 5|Adverse Event|0|||
16999025|NCT00940316|38142902|FG001|Treated After Cycle 5|Adverse Event|0|||
16999026|NCT00940316|38142903|FG002|Treated After Cycle 5|Adverse Event|1|||
16999027|NCT00940316|38142901|FG000|Treated After Cycle 5|Progressive disease|0|||
16999028|NCT00940316|38142902|FG001|Treated After Cycle 5|Progressive disease|1|||
16999029|NCT00940316|38142903|FG002|Treated After Cycle 5|Progressive disease|0|||
16999030|NCT00726388|38142919|FG000|Overall Study|Withdrawal by Subject|5|||
16999031|NCT00726388|38142919|FG000|Overall Study|Adverse Event|3|||
16999032|NCT00726388|38142919|FG000|Overall Study|Lost to Follow-up|10|||
16999033|NCT00726388|38142919|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
16999034|NCT00726388|38142919|FG000|Overall Study|Other|5|||
16999035|NCT00726388|38142919|FG000|Overall Study|Enrolled, Not Treated|79|||
16999036|NCT00572455|38142937|FG000|Stage I (14 Days)|Adverse Event|0|||
16999037|NCT00572455|38142938|FG001|Stage I (14 Days)|Adverse Event|0|||
16999038|NCT00572455|38142939|FG002|Stage I (14 Days)|Adverse Event|0|||
16999039|NCT00572455|38142940|FG003|Stage I (14 Days)|Adverse Event|0|||
16999040|NCT00572455|38142941|FG004|Stage I (14 Days)|Adverse Event|0|||
16999041|NCT00572455|38142942|FG005|Stage I (14 Days)|Adverse Event|3|||
16999042|NCT00572455|38142943|FG006|Stage I (14 Days)|Adverse Event|0|||
16999043|NCT00572455|38142944|FG007|Stage I (14 Days)|Adverse Event|0|||
16999044|NCT00572455|38142945|FG008|Stage I (14 Days)|Adverse Event|0|||
16999045|NCT00572455|38142946|FG009|Stage I (14 Days)|Adverse Event|0|||
16999046|NCT00572455|38142947|FG010|Stage I (14 Days)|Adverse Event|0|||
16999047|NCT00572455|38142948|FG011|Stage I (14 Days)|Adverse Event|0|||
16999048|NCT00572455|38142949|FG012|Stage I (14 Days)|Adverse Event|0|||
16999049|NCT00572455|38142950|FG013|Stage I (14 Days)|Adverse Event|0|||
16999050|NCT00572455|38142937|FG000|Stage I (14 Days)|Other|0|||
16999051|NCT00572455|38142938|FG001|Stage I (14 Days)|Other|0|||
16999052|NCT00572455|38142939|FG002|Stage I (14 Days)|Other|0|||
16999053|NCT00572455|38142940|FG003|Stage I (14 Days)|Other|0|||
16999054|NCT00572455|38142941|FG004|Stage I (14 Days)|Other|1|||
16999055|NCT00572455|38142942|FG005|Stage I (14 Days)|Other|0|||
16999056|NCT00572455|38142943|FG006|Stage I (14 Days)|Other|0|||
16999057|NCT00572455|38142944|FG007|Stage I (14 Days)|Other|0|||
16999058|NCT00572455|38142945|FG008|Stage I (14 Days)|Other|0|||
16999059|NCT00572455|38142946|FG009|Stage I (14 Days)|Other|0|||
16999060|NCT00572455|38142947|FG010|Stage I (14 Days)|Other|0|||
16999061|NCT00572455|38142948|FG011|Stage I (14 Days)|Other|0|||
16999062|NCT00572455|38142949|FG012|Stage I (14 Days)|Other|0|||
16999063|NCT00572455|38142950|FG013|Stage I (14 Days)|Other|0|||
16999064|NCT00572455|38142937|FG000|Stage II (28 Days)|Adverse Event|0|||
16999065|NCT00572455|38142938|FG001|Stage II (28 Days)|Adverse Event|0|||
16999066|NCT00572455|38142939|FG002|Stage II (28 Days)|Adverse Event|0|||
16999067|NCT00572455|38142940|FG003|Stage II (28 Days)|Adverse Event|0|||
16999068|NCT00572455|38142941|FG004|Stage II (28 Days)|Adverse Event|0|||
16999069|NCT00572455|38142942|FG005|Stage II (28 Days)|Adverse Event|0|||
16999070|NCT00572455|38142943|FG006|Stage II (28 Days)|Adverse Event|0|||
16999071|NCT00572455|38142944|FG007|Stage II (28 Days)|Adverse Event|0|||
16999072|NCT00572455|38142945|FG008|Stage II (28 Days)|Adverse Event|1|||
16999073|NCT00572455|38142946|FG009|Stage II (28 Days)|Adverse Event|3|||
16999074|NCT00572455|38142947|FG010|Stage II (28 Days)|Adverse Event|3|||
16999075|NCT00572455|38142948|FG011|Stage II (28 Days)|Adverse Event|4|||
16999076|NCT00572455|38142949|FG012|Stage II (28 Days)|Adverse Event|5|||
16999077|NCT00572455|38142950|FG013|Stage II (28 Days)|Adverse Event|1|||
16999078|NCT00572455|38142937|FG000|Stage II (28 Days)|Death|0|||
16999079|NCT00572455|38142938|FG001|Stage II (28 Days)|Death|0|||
16999080|NCT00572455|38142939|FG002|Stage II (28 Days)|Death|0|||
16999081|NCT00572455|38142940|FG003|Stage II (28 Days)|Death|0|||
16999082|NCT00572455|38142941|FG004|Stage II (28 Days)|Death|0|||
16868359|NCT02655016|37841429|FG001|Overall Study|Site closed|1|||
16999083|NCT00572455|38142942|FG005|Stage II (28 Days)|Death|0|||
16999084|NCT00572455|38142943|FG006|Stage II (28 Days)|Death|0|||
16999085|NCT00572455|38142944|FG007|Stage II (28 Days)|Death|0|||
16999086|NCT00572455|38142945|FG008|Stage II (28 Days)|Death|1|||
16999087|NCT00572455|38142946|FG009|Stage II (28 Days)|Death|0|||
16868360|NCT02655016|37841428|FG000|Overall Study|Death|30|||
16999088|NCT00572455|38142947|FG010|Stage II (28 Days)|Death|0|||
16999089|NCT00572455|38142948|FG011|Stage II (28 Days)|Death|0|||
16999090|NCT00572455|38142949|FG012|Stage II (28 Days)|Death|0|||
16999091|NCT00572455|38142950|FG013|Stage II (28 Days)|Death|0|||
16999092|NCT00572455|38142937|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
16999093|NCT00572455|38142938|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
16999094|NCT00572455|38142939|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
16999095|NCT00572455|38142940|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
16999096|NCT00572455|38142941|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
16999097|NCT00572455|38142942|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
16999098|NCT00572455|38142943|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
16999099|NCT00572455|38142944|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
16999100|NCT00572455|38142945|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
16999101|NCT00572455|38142946|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
16999102|NCT00572455|38142947|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
16999103|NCT00572455|38142948|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
16999104|NCT00572455|38142949|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
16999105|NCT00572455|38142950|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
16999106|NCT00572455|38142937|FG000|Stage II (28 Days)|Other|0|||
16999107|NCT00572455|38142938|FG001|Stage II (28 Days)|Other|0|||
16999108|NCT00572455|38142939|FG002|Stage II (28 Days)|Other|0|||
16999109|NCT00572455|38142940|FG003|Stage II (28 Days)|Other|0|||
16999110|NCT00572455|38142941|FG004|Stage II (28 Days)|Other|0|||
16999111|NCT00572455|38142942|FG005|Stage II (28 Days)|Other|0|||
16999112|NCT00572455|38142943|FG006|Stage II (28 Days)|Other|0|||
16999113|NCT00572455|38142944|FG007|Stage II (28 Days)|Other|0|||
16999114|NCT00572455|38142945|FG008|Stage II (28 Days)|Other|1|||
16999115|NCT00572455|38142946|FG009|Stage II (28 Days)|Other|0|||
16999116|NCT00572455|38142947|FG010|Stage II (28 Days)|Other|0|||
16999117|NCT00572455|38142948|FG011|Stage II (28 Days)|Other|0|||
16999118|NCT00572455|38142949|FG012|Stage II (28 Days)|Other|0|||
16999119|NCT00572455|38142950|FG013|Stage II (28 Days)|Other|0|||
16999120|NCT00572455|38142937|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
16999121|NCT00572455|38142938|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
16999122|NCT00572455|38142939|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
16999123|NCT00572455|38142940|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
16999124|NCT00572455|38142941|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
16999125|NCT00572455|38142942|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
16999126|NCT00572455|38142943|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
16999127|NCT00572455|38142944|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
16999128|NCT00572455|38142945|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
16999129|NCT00572455|38142946|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
16999130|NCT00572455|38142947|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
16999131|NCT00572455|38142948|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
16999132|NCT00572455|38142949|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
16999133|NCT00572455|38142950|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
16999134|NCT01003691|38142984|FG000|Overall Study|Adverse Event|0|||
16999135|NCT01003691|38142985|FG001|Overall Study|Adverse Event|0|||
16999136|NCT01003691|38142986|FG002|Overall Study|Adverse Event|0|||
16999137|NCT01003691|38142987|FG003|Overall Study|Adverse Event|1|||
16999138|NCT00686335|38142998|FG000|Run-in Period|Adverse Event|1|||
16999139|NCT00686335|38142998|FG000|Run-in Period|asthma exacerbation|1|||
16999140|NCT00686335|38142998|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
16999141|NCT01002989|38143004|FG000|Overall Study|exclusion criteria, no consent|5|||
16999142|NCT00685945|38143008|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
16999143|NCT01007123|38143022|FG000|Overall Study|Adverse Event|3|||
16999144|NCT01007123|38143023|FG001|Overall Study|Adverse Event|4|||
16999145|NCT01007123|38143024|FG002|Overall Study|Adverse Event|7|||
16999146|NCT01007123|38143025|FG003|Overall Study|Adverse Event|1|||
16999147|NCT01007123|38143022|FG000|Overall Study|Lack of Efficacy|1|||
16999148|NCT01007123|38143023|FG001|Overall Study|Lack of Efficacy|0|||
16999149|NCT01007123|38143024|FG002|Overall Study|Lack of Efficacy|1|||
16999150|NCT01007123|38143025|FG003|Overall Study|Lack of Efficacy|4|||
16999151|NCT01007123|38143022|FG000|Overall Study|Protocol Violation|1|||
16999152|NCT01007123|38143023|FG001|Overall Study|Protocol Violation|1|||
16999153|NCT01007123|38143024|FG002|Overall Study|Protocol Violation|2|||
16999154|NCT01007123|38143025|FG003|Overall Study|Protocol Violation|1|||
16999155|NCT01007123|38143022|FG000|Overall Study|Withdrawal by Subject|1|||
16999156|NCT01007123|38143023|FG001|Overall Study|Withdrawal by Subject|0|||
16999157|NCT01007123|38143024|FG002|Overall Study|Withdrawal by Subject|1|||
16999158|NCT01007123|38143025|FG003|Overall Study|Withdrawal by Subject|0|||
16999159|NCT01007123|38143022|FG000|Overall Study|Lost to Follow-up|0|||
16999160|NCT01007123|38143023|FG001|Overall Study|Lost to Follow-up|1|||
16999161|NCT01007123|38143024|FG002|Overall Study|Lost to Follow-up|0|||
16999162|NCT01007123|38143025|FG003|Overall Study|Lost to Follow-up|0|||
16999163|NCT00687739|38143040|FG000|Overall Study|Lost to Follow-up|2|||
16999164|NCT00687739|38143041|FG001|Overall Study|Lost to Follow-up|2|||
16999165|NCT00687739|38143042|FG002|Overall Study|Lost to Follow-up|1|||
16999166|NCT00687739|38143043|FG003|Overall Study|Lost to Follow-up|2|||
16999167|NCT00687739|38143040|FG000|Overall Study|Adverse Event|0|||
16999168|NCT00687739|38143041|FG001|Overall Study|Adverse Event|1|||
16999169|NCT00687739|38143042|FG002|Overall Study|Adverse Event|1|||
17189827|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
16999170|NCT00687739|38143043|FG003|Overall Study|Adverse Event|0|||
16999171|NCT01006889|38143055|FG000|Overall Study|Withdrawal by Subject|3|||
16999172|NCT01001429|38143062|FG000|Overall Study|surgery cancelled|0|||
16999173|NCT01001429|38143063|FG001|Overall Study|surgery cancelled|1|||
16999174|NCT01000961|38143093|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
16999175|NCT01000961|38143094|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16999176|NCT01000961|38143093|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
16999177|NCT01000961|38143094|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
16999178|NCT01000805|38143104|FG000|Overall Study|Adverse Event|21|||
16999179|NCT01000805|38143105|FG001|Overall Study|Adverse Event|9|||
16999180|NCT01000805|38143104|FG000|Overall Study|Lack of Efficacy|5|||
16999181|NCT01000805|38143105|FG001|Overall Study|Lack of Efficacy|16|||
16999182|NCT01000805|38143104|FG000|Overall Study|Lost to Follow-up|16|||
16999183|NCT01000805|38143105|FG001|Overall Study|Lost to Follow-up|21|||
16999184|NCT01000805|38143104|FG000|Overall Study|Physician Decision|0|||
16999185|NCT01000805|38143105|FG001|Overall Study|Physician Decision|1|||
16999186|NCT01000805|38143104|FG000|Overall Study|Protocol Violation|12|||
16999187|NCT01000805|38143105|FG001|Overall Study|Protocol Violation|8|||
16999188|NCT01000805|38143104|FG000|Overall Study|Withdrawal by Subject|16|||
16999189|NCT01000805|38143105|FG001|Overall Study|Withdrawal by Subject|6|||
16999190|NCT01000805|38143104|FG000|Overall Study|Sponsor Decision|0|||
16999191|NCT01000805|38143105|FG001|Overall Study|Sponsor Decision|1|||
16999192|NCT00684307|38143117|FG000|Overall Study|Adverse Event|11|||
16999193|NCT00684307|38143118|FG001|Overall Study|Adverse Event|6|||
16999194|NCT00684307|38143119|FG002|Overall Study|Adverse Event|15|||
16999195|NCT00684307|38143120|FG003|Overall Study|Adverse Event|16|||
16999196|NCT00684307|38143121|FG004|Overall Study|Adverse Event|8|||
16999197|NCT00684307|38143117|FG000|Overall Study|Development of increasing Liver Function|0|||
16999198|NCT00684307|38143118|FG001|Overall Study|Development of increasing Liver Function|2|||
16999199|NCT00684307|38143119|FG002|Overall Study|Development of increasing Liver Function|0|||
16999200|NCT00684307|38143120|FG003|Overall Study|Development of increasing Liver Function|1|||
16783007|NCT02563899|37722687|FG001|Overall Study|Withdrawal by Subject|0|||
16783008|NCT02563899|37722688|FG002|Overall Study|Withdrawal by Subject|1|||
16783009|NCT02563899|37722689|FG003|Overall Study|Withdrawal by Subject|0|||
16783010|NCT02699099|37722703|FG000|Overall Study|Adverse Event|1|||
16783011|NCT02699099|37722704|FG001|Overall Study|Adverse Event|0|||
16783012|NCT02699099|37722705|FG002|Overall Study|Adverse Event|2|||
16783013|NCT02699099|37722703|FG000|Overall Study|Lost to Follow-up|0|||
16783014|NCT02699099|37722704|FG001|Overall Study|Lost to Follow-up|1|||
16783015|NCT02699099|37722705|FG002|Overall Study|Lost to Follow-up|0|||
16783016|NCT02699099|37722703|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
16783017|NCT02699099|37722704|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
16783018|NCT02699099|37722705|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
16783019|NCT02698865|37722717|FG000|Overall Study|Other|11|||
16783020|NCT02698865|37722718|FG001|Overall Study|Other|11|||
16783021|NCT02698865|37722717|FG000|Overall Study|Withdrawal by Subject|20|||
16783022|NCT02698865|37722718|FG001|Overall Study|Withdrawal by Subject|16|||
16783023|NCT02698865|37722717|FG000|Overall Study|Physician Decision|0|||
16783024|NCT02698865|37722718|FG001|Overall Study|Physician Decision|4|||
16783025|NCT02698865|37722717|FG000|Overall Study|Lost to Follow-up|4|||
16783026|NCT02698865|37722718|FG001|Overall Study|Lost to Follow-up|2|||
16783027|NCT02698787|37722726|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
16783028|NCT02698787|37722727|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
16783029|NCT02698475|37722734|FG000|Main Study Period|Lack of Efficacy|1|||
16783030|NCT02698475|37722734|FG000|Main Study Period|Protocol Violation|2|||
16783031|NCT02698475|37722734|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
16783032|NCT02698475|37722734|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
16783033|NCT02698475|37722734|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
16783034|NCT02698475|37722734|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
16783035|NCT02698475|37722734|FG000|Long-Term Extension Period|Other|1|||
16783036|NCT02559687|37722741|FG000|Overall Study|Death|112|||
16783037|NCT02559687|37722741|FG000|Overall Study|Sponsor Decision|5|||
16783038|NCT02559687|37722741|FG000|Overall Study|Withdrawal by Subject|4|||
16783039|NCT04294719|37722755|FG000|Overall Study|Withdrawal by Subject|1|||
16783040|NCT02703311|37722763|FG000|Overall Study|Death|5|||
16783041|NCT02703311|37722763|FG000|Overall Study|Withdrawal by Subject|3|||
16783042|NCT02697617|37722767|FG000|Overall Study|Withdrawal by Subject|0|||
16868361|NCT02655016|37841429|FG001|Overall Study|Death|48|||
16999201|NCT00684307|38143121|FG004|Overall Study|Development of increasing Liver Function|0|||
16999202|NCT00684307|38143117|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
16999203|NCT00684307|38143118|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
16999204|NCT00684307|38143119|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
16783043|NCT02697617|37722768|FG001|Overall Study|Withdrawal by Subject|2|||
16783044|NCT02697617|37722767|FG000|Overall Study|Pregnancy|1|||
16783045|NCT02697617|37722768|FG001|Overall Study|Pregnancy|0|||
16783046|NCT02698241|37722778|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
16999205|NCT00684307|38143120|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
16999206|NCT00684307|38143121|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
16999207|NCT00684307|38143117|FG000|Overall Study|Incorrect enrolment or randomization|4|||
16999208|NCT00684307|38143118|FG001|Overall Study|Incorrect enrolment or randomization|0|||
16999209|NCT00684307|38143119|FG002|Overall Study|Incorrect enrolment or randomization|0|||
16999210|NCT00684307|38143120|FG003|Overall Study|Incorrect enrolment or randomization|0|||
16999211|NCT00684307|38143121|FG004|Overall Study|Incorrect enrolment or randomization|0|||
16999212|NCT00684307|38143117|FG000|Overall Study|Interupted IP for more than 7 days|0|||
16999213|NCT00684307|38143118|FG001|Overall Study|Interupted IP for more than 7 days|4|||
16999214|NCT00684307|38143119|FG002|Overall Study|Interupted IP for more than 7 days|1|||
16999215|NCT00684307|38143120|FG003|Overall Study|Interupted IP for more than 7 days|3|||
16999216|NCT00684307|38143121|FG004|Overall Study|Interupted IP for more than 7 days|3|||
16999217|NCT00684307|38143117|FG000|Overall Study|Severe non compliance to protocol|1|||
16999218|NCT00684307|38143118|FG001|Overall Study|Severe non compliance to protocol|0|||
16999219|NCT00684307|38143119|FG002|Overall Study|Severe non compliance to protocol|0|||
16999220|NCT00684307|38143120|FG003|Overall Study|Severe non compliance to protocol|1|||
16999221|NCT00684307|38143121|FG004|Overall Study|Severe non compliance to protocol|2|||
16999222|NCT00684307|38143117|FG000|Overall Study|Participant not willing to continue|7|||
16999223|NCT00684307|38143118|FG001|Overall Study|Participant not willing to continue|10|||
16999224|NCT00684307|38143119|FG002|Overall Study|Participant not willing to continue|11|||
16999225|NCT00684307|38143120|FG003|Overall Study|Participant not willing to continue|5|||
16999226|NCT00684307|38143121|FG004|Overall Study|Participant not willing to continue|8|||
16999227|NCT00684307|38143117|FG000|Overall Study|Criteria from the CSR|0|||
16999228|NCT00684307|38143118|FG001|Overall Study|Criteria from the CSR|0|||
16999229|NCT00684307|38143119|FG002|Overall Study|Criteria from the CSR|1|||
16999230|NCT00684307|38143120|FG003|Overall Study|Criteria from the CSR|3|||
16999231|NCT00684307|38143121|FG004|Overall Study|Criteria from the CSR|3|||
16999232|NCT00683917|38143136|FG000|Overall Study|Study prematurely terminated|10|||
16999233|NCT00687271|38143148|FG000|Overall Study|Adverse Event|1|||
16999234|NCT00687271|38143149|FG001|Overall Study|Adverse Event|3|||
16999235|NCT00687271|38143150|FG002|Overall Study|Adverse Event|1|||
16999236|NCT00687271|38143151|FG003|Overall Study|Adverse Event|0|||
16999237|NCT00687271|38143148|FG000|Overall Study|Lost to Follow-up|0|||
16999238|NCT00687271|38143149|FG001|Overall Study|Lost to Follow-up|1|||
16999239|NCT00687271|38143150|FG002|Overall Study|Lost to Follow-up|0|||
16999240|NCT00687271|38143151|FG003|Overall Study|Lost to Follow-up|0|||
16999241|NCT00687271|38143148|FG000|Overall Study|Protocol Violation|2|||
16999242|NCT00687271|38143149|FG001|Overall Study|Protocol Violation|1|||
16999243|NCT00687271|38143150|FG002|Overall Study|Protocol Violation|1|||
16999244|NCT00687271|38143151|FG003|Overall Study|Protocol Violation|0|||
16999245|NCT00687271|38143148|FG000|Overall Study|Withdrawal by Subject|0|||
16999246|NCT00687271|38143149|FG001|Overall Study|Withdrawal by Subject|1|||
16999247|NCT00687271|38143150|FG002|Overall Study|Withdrawal by Subject|3|||
16999248|NCT00687271|38143151|FG003|Overall Study|Withdrawal by Subject|0|||
16999249|NCT04617275|38143169|FG000|Treatment Period|Adverse Event|1|||
16999250|NCT04617275|38143170|FG001|Treatment Period|Adverse Event|6|||
16999251|NCT04617275|38143171|FG002|Treatment Period|Adverse Event|4|||
16999252|NCT04617275|38143172|FG003|Treatment Period|Adverse Event|6|||
16999253|NCT04617275|38143173|FG004|Treatment Period|Adverse Event|7|||
16999254|NCT04617275|38143174|FG005|Treatment Period|Adverse Event|8|||
16999255|NCT04617275|38143175|FG006|Treatment Period|Adverse Event|0|||
16999256|NCT04617275|38143176|FG007|Treatment Period|Adverse Event|12|||
16999257|NCT04617275|38143169|FG000|Treatment Period|Lost to Follow-up|0|||
16999258|NCT04617275|38143170|FG001|Treatment Period|Lost to Follow-up|0|||
16999259|NCT04617275|38143171|FG002|Treatment Period|Lost to Follow-up|2|||
16999260|NCT04617275|38143172|FG003|Treatment Period|Lost to Follow-up|0|||
16999261|NCT04617275|38143173|FG004|Treatment Period|Lost to Follow-up|0|||
16999262|NCT04617275|38143174|FG005|Treatment Period|Lost to Follow-up|3|||
16999263|NCT04617275|38143175|FG006|Treatment Period|Lost to Follow-up|0|||
16999264|NCT04617275|38143176|FG007|Treatment Period|Lost to Follow-up|2|||
16783047|NCT02698241|37722778|FG000|Overall Study|Screening not met|7|||
16783048|NCT02698241|37722778|FG000|Overall Study|Withdrawal by Subject|7|||
16783049|NCT02698241|37722778|FG000|Overall Study|Physician Decision|2|||
16783050|NCT02698241|37722778|FG000|Overall Study|Subject underwent system modification|2|||
16783051|NCT02698241|37722778|FG000|Overall Study|Lost to Follow-up|3|||
16783052|NCT02698241|37722778|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
16783053|NCT02698241|37722778|FG000|Overall Study|geographic and licensing issue|1|||
16783054|NCT02698241|37722778|FG000|Overall Study|Death|2|||
16783055|NCT01663233|37722784|FG000|Overall Study|Withdrawal by Subject|3|||
16783056|NCT01663233|37722785|FG001|Overall Study|Withdrawal by Subject|2|||
16783057|NCT01663233|37722784|FG000|Overall Study|Protocol Deviation|1|||
16783058|NCT01663233|37722785|FG001|Overall Study|Protocol Deviation|4|||
16783059|NCT01663233|37722784|FG000|Overall Study|Lost to Follow-up|0|||
16783060|NCT01663233|37722785|FG001|Overall Study|Lost to Follow-up|1|||
16783061|NCT02556255|37722804|FG000|Overall Study|Lost to Follow-up|4|||
16783062|NCT02556801|37722812|FG000|Overall Study|Lost to Follow-up|1|||
16783063|NCT02556801|37722813|FG001|Overall Study|Lost to Follow-up|0|||
16783064|NCT02556801|37722814|FG002|Overall Study|Lost to Follow-up|2|||
16783065|NCT02556801|37722815|FG003|Overall Study|Lost to Follow-up|0|||
16999265|NCT04617275|38143169|FG000|Treatment Period|No longer meets eligibility criteria|0|||
16999266|NCT04617275|38143170|FG001|Treatment Period|No longer meets eligibility criteria|0|||
16999267|NCT04617275|38143171|FG002|Treatment Period|No longer meets eligibility criteria|0|||
16999268|NCT04617275|38143172|FG003|Treatment Period|No longer meets eligibility criteria|1|||
16999269|NCT04617275|38143173|FG004|Treatment Period|No longer meets eligibility criteria|0|||
16999270|NCT04617275|38143174|FG005|Treatment Period|No longer meets eligibility criteria|0|||
16999271|NCT04617275|38143175|FG006|Treatment Period|No longer meets eligibility criteria|0|||
16999272|NCT04617275|38143176|FG007|Treatment Period|No longer meets eligibility criteria|0|||
16999273|NCT04617275|38143169|FG000|Treatment Period|Other|0|||
16999274|NCT04617275|38143170|FG001|Treatment Period|Other|1|||
16999275|NCT04617275|38143171|FG002|Treatment Period|Other|0|||
16999276|NCT04617275|38143172|FG003|Treatment Period|Other|0|||
16999277|NCT04617275|38143173|FG004|Treatment Period|Other|0|||
16999278|NCT04617275|38143174|FG005|Treatment Period|Other|0|||
16999279|NCT04617275|38143175|FG006|Treatment Period|Other|0|||
16999280|NCT04617275|38143176|FG007|Treatment Period|Other|0|||
16999281|NCT04617275|38143169|FG000|Treatment Period|Withdrawal by Subject|2|||
16999282|NCT04617275|38143170|FG001|Treatment Period|Withdrawal by Subject|0|||
16999283|NCT04617275|38143171|FG002|Treatment Period|Withdrawal by Subject|0|||
16999284|NCT04617275|38143172|FG003|Treatment Period|Withdrawal by Subject|2|||
16999285|NCT04617275|38143173|FG004|Treatment Period|Withdrawal by Subject|2|||
16999286|NCT04617275|38143174|FG005|Treatment Period|Withdrawal by Subject|0|||
16999287|NCT04617275|38143175|FG006|Treatment Period|Withdrawal by Subject|1|||
16999288|NCT04617275|38143176|FG007|Treatment Period|Withdrawal by Subject|2|||
16999289|NCT04617275|38143169|FG000|Follow-up Period|Adverse Event|1|||
16999290|NCT04617275|38143170|FG001|Follow-up Period|Adverse Event|1|||
16999291|NCT04617275|38143171|FG002|Follow-up Period|Adverse Event|2|||
16999292|NCT04617275|38143172|FG003|Follow-up Period|Adverse Event|3|||
16999293|NCT04617275|38143173|FG004|Follow-up Period|Adverse Event|4|||
16999294|NCT04617275|38143174|FG005|Follow-up Period|Adverse Event|3|||
16999295|NCT04617275|38143175|FG006|Follow-up Period|Adverse Event|0|||
16999296|NCT04617275|38143176|FG007|Follow-up Period|Adverse Event|3|||
16999297|NCT04617275|38143169|FG000|Follow-up Period|Lost to Follow-up|0|||
16999298|NCT04617275|38143170|FG001|Follow-up Period|Lost to Follow-up|1|||
17092278|NCT00048724|38231966|FG001|Overall Study|Noncompliance With Protocol|12|||
17092279|NCT00048724|38231965|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
17092280|NCT00048724|38231966|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
17092281|NCT00048724|38231965|FG000|Overall Study|Administrative|1|||
17092282|NCT00048724|38231966|FG001|Overall Study|Administrative|1|||
17092283|NCT00449033|38231974|FG000|Treatment Period|Adverse Event|117|||
17092284|NCT00449033|38231975|FG001|Treatment Period|Adverse Event|83|||
17092285|NCT00449033|38231974|FG000|Treatment Period|Death|21|||
17092286|NCT00449033|38231975|FG001|Treatment Period|Death|12|||
17092287|NCT00449033|38231974|FG000|Treatment Period|Lost to Follow-up|0|||
17092288|NCT00449033|38231975|FG001|Treatment Period|Lost to Follow-up|2|||
17092289|NCT00449033|38231974|FG000|Treatment Period|Physician Decision|4|||
17092290|NCT00449033|38231975|FG001|Treatment Period|Physician Decision|5|||
17092291|NCT00449033|38231974|FG000|Treatment Period|Protocol Violation|8|||
17092292|NCT00449033|38231975|FG001|Treatment Period|Protocol Violation|7|||
17092293|NCT00449033|38231974|FG000|Treatment Period|Disease Progression|231|||
17092294|NCT00449033|38231975|FG001|Treatment Period|Disease Progression|288|||
17092295|NCT00449033|38231974|FG000|Treatment Period|Consent Withdrawn|36|||
17092296|NCT00449033|38231975|FG001|Treatment Period|Consent Withdrawn|20|||
17092297|NCT00449033|38231974|FG000|Treatment Period|Amended Protocol Criteria|22|||
17092298|NCT00449033|38231975|FG001|Treatment Period|Amended Protocol Criteria|18|||
17092299|NCT00449033|38231974|FG000|Treatment Period|Non-compliance|7|||
17092300|NCT00449033|38231975|FG001|Treatment Period|Non-compliance|8|||
17092301|NCT00449033|38231974|FG000|Treatment Period|Second Malignancy|0|||
17092302|NCT00449033|38231975|FG001|Treatment Period|Second Malignancy|1|||
16783066|NCT02556801|37722812|FG000|Overall Study|Withdrawal by Subject|1|||
16999299|NCT04617275|38143171|FG002|Follow-up Period|Lost to Follow-up|2|||
16999300|NCT04617275|38143172|FG003|Follow-up Period|Lost to Follow-up|0|||
17092303|NCT00449033|38231974|FG000|Treatment Period|Reason Missing|0|||
17092304|NCT00449033|38231975|FG001|Treatment Period|Reason Missing|4|||
17092305|NCT00449033|38231974|FG000|Treatment Period|Treatment Ongoing|6|||
17092306|NCT00449033|38231975|FG001|Treatment Period|Treatment Ongoing|4|||
17092307|NCT00449033|38231974|FG000|Follow-up Period|Death|299|||
17092308|NCT00449033|38231975|FG001|Follow-up Period|Death|311|||
17092309|NCT00449033|38231974|FG000|Follow-up Period|Lost to Follow-up|6|||
17092310|NCT00449033|38231975|FG001|Follow-up Period|Lost to Follow-up|10|||
17092311|NCT00449033|38231974|FG000|Follow-up Period|Reason Missing|120|||
17092312|NCT00449033|38231975|FG001|Follow-up Period|Reason Missing|113|||
16783067|NCT02556801|37722813|FG001|Overall Study|Withdrawal by Subject|1|||
17092313|NCT00448019|38231981|FG000|Overall Study|Withdrawal by Subject|3|||
17092314|NCT00448019|38231981|FG000|Overall Study|Disease progression|1|||
17092315|NCT00448019|38231981|FG000|Overall Study|Death|2|||
17092316|NCT00448019|38231981|FG000|Overall Study|Insurance Issues|1|||
17092317|NCT00457691|38231987|FG000|Overall Study|Adverse Event|4|||
17092318|NCT00457691|38231988|FG001|Overall Study|Adverse Event|1|||
17092319|NCT00457691|38231987|FG000|Overall Study|Death|163|||
17092320|NCT00457691|38231988|FG001|Overall Study|Death|148|||
17092321|NCT00457691|38231987|FG000|Overall Study|Protocol Violation|1|||
17092322|NCT00457691|38231988|FG001|Overall Study|Protocol Violation|3|||
17092323|NCT00457691|38231987|FG000|Overall Study|Lost to Follow-up|23|||
17092324|NCT00457691|38231988|FG001|Overall Study|Lost to Follow-up|14|||
17092325|NCT00457691|38231987|FG000|Overall Study|Study terminated by Sponsor|1|||
17092326|NCT00457691|38231988|FG001|Overall Study|Study terminated by Sponsor|1|||
17092327|NCT00457691|38231987|FG000|Overall Study|Subject refused (reason other than AE)|14|||
17092328|NCT00457691|38231988|FG001|Overall Study|Subject refused (reason other than AE)|19|||
17092329|NCT00457691|38231987|FG000|Overall Study|Disease progression, study terminated|180|||
17092330|NCT00457691|38231988|FG001|Overall Study|Disease progression, study terminated|196|||
17092331|NCT00457301|38231996|FG000|Overall Study|Withdrawal by Subject|3|||
17092332|NCT00457301|38231997|FG001|Overall Study|Withdrawal by Subject|3|||
17092333|NCT00457301|38231996|FG000|Overall Study|Censored out of the study|15|||
17092334|NCT00457301|38231997|FG001|Overall Study|Censored out of the study|14|||
17092335|NCT00457301|38231996|FG000|Overall Study|Death|5|||
17092336|NCT00457301|38231997|FG001|Overall Study|Death|7|||
17092337|NCT00456755|38232005|FG000|Overall Study|Lost to Follow-up|2|||
17092338|NCT00456755|38232006|FG001|Overall Study|Lost to Follow-up|1|||
17092339|NCT00447005|38232012|FG000|Overall Study|Adverse Event|1|||
17092340|NCT00447005|38232012|FG000|Overall Study|Lack of Efficacy|11|||
17092341|NCT00446849|38232016|FG000|Acute Phase|Lack of Efficacy|64|||
17092342|NCT00446849|38232016|FG000|Acute Phase|Protocol Violation|10|||
17092343|NCT00446849|38232016|FG000|Acute Phase|Consent withdrawn|4|||
17092344|NCT00446849|38232016|FG000|Acute Phase|Lost to Follow-up|2|||
17092345|NCT00446849|38232016|FG000|Acute Phase|Physician Decision|1|||
17189828|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
17189829|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
17189830|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
17189831|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
17189832|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
17189833|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
17189834|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
17189835|NCT02958865|38342699|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189836|NCT02958865|38342700|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189837|NCT02958865|38342701|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189838|NCT02958865|38342702|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189839|NCT02958865|38342703|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
17092346|NCT00446849|38232016|FG000|Acute Phase|noncompliance|1|||
17092347|NCT00446849|38232016|FG000|Maintenance Phase|Lack of Efficacy|40|||
17092348|NCT00446849|38232016|FG000|Maintenance Phase|Protocol Violation|7|||
17092349|NCT00446849|38232016|FG000|Maintenance Phase|Adverse Event|6|||
17092350|NCT00446849|38232016|FG000|Maintenance Phase|Consent withdrawn|5|||
17092351|NCT00446849|38232016|FG000|Maintenance Phase|Lost to Follow-up|3|||
17092352|NCT00446849|38232016|FG000|Maintenance Phase|Pregnancy|1|||
17092353|NCT00446849|38232016|FG000|Maintenance Phase|noncompliance|2|||
17092354|NCT00446849|38232016|FG000|Maintenance Phase|prohibited medication use|2|||
17092355|NCT00446849|38232016|FG000|Maintenance Phase|antibiotic use|1|||
17092356|NCT00446849|38232016|FG000|Maintenance Phase|study closure|1|||
17092357|NCT00446849|38232016|FG000|Maintenance Phase|hydrocodone use|1|||
17092358|NCT00446849|38232016|FG000|Maintenance Phase|concomitant medication use|1|||
17092359|NCT00446459|38232021|FG000|8 Months|Protocol Violation|12|||
17092360|NCT00446459|38232021|FG000|12 Months|Protocol Violation|4|||
16783068|NCT02556801|37722814|FG002|Overall Study|Withdrawal by Subject|1|||
16783069|NCT02556801|37722815|FG003|Overall Study|Withdrawal by Subject|0|||
16783070|NCT02556801|37722812|FG000|Overall Study|Protocol Violation|0|||
16783071|NCT02556801|37722813|FG001|Overall Study|Protocol Violation|3|||
16783072|NCT02556801|37722814|FG002|Overall Study|Protocol Violation|1|||
16783073|NCT02556801|37722815|FG003|Overall Study|Protocol Violation|1|||
16783074|NCT02556801|37722812|FG000|Overall Study|Adverse Event|0|||
16783075|NCT02556801|37722813|FG001|Overall Study|Adverse Event|2|||
16783076|NCT02556801|37722814|FG002|Overall Study|Adverse Event|0|||
16783077|NCT02556801|37722815|FG003|Overall Study|Adverse Event|3|||
17092361|NCT00446459|38232021|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
17092362|NCT00456599|38232025|FG000|Overall Study|Non-compliance|1|||
17092363|NCT00456599|38232025|FG000|Overall Study|Withdrawal by Subject|2|||
17092364|NCT00456521|38232031|FG000|Overall Study|Adverse Event|150|||
17092365|NCT00456521|38232032|FG001|Overall Study|Adverse Event|25|||
17092366|NCT00456521|38232031|FG000|Overall Study|Withdrawal by Subject|43|||
16783078|NCT02556801|37722812|FG000|Overall Study|Pregnancy|0|||
17189840|NCT02958865|38342704|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189841|NCT02958865|38342705|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189842|NCT02958865|38342706|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189843|NCT02958865|38342707|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189844|NCT02958865|38342708|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189845|NCT02958865|38342709|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189846|NCT02958865|38342710|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17092367|NCT00456521|38232032|FG001|Overall Study|Withdrawal by Subject|24|||
17092368|NCT00456521|38232031|FG000|Overall Study|Lost to Follow-up|22|||
17092369|NCT00456521|38232032|FG001|Overall Study|Lost to Follow-up|17|||
17092370|NCT00456521|38232031|FG000|Overall Study|Lack of Efficacy|3|||
17092371|NCT00456521|38232032|FG001|Overall Study|Lack of Efficacy|6|||
17092372|NCT00456521|38232031|FG000|Overall Study|Protocol Violation|4|||
17189847|NCT02958865|38342711|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189848|NCT02958865|38342712|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17092373|NCT00456521|38232032|FG001|Overall Study|Protocol Violation|0|||
17092374|NCT00456521|38232031|FG000|Overall Study|Pregnancy|1|||
17092375|NCT00456521|38232032|FG001|Overall Study|Pregnancy|1|||
17092376|NCT00456521|38232031|FG000|Overall Study|Drug non-compliance, moved, other|26|||
17092377|NCT00456521|38232032|FG001|Overall Study|Drug non-compliance, moved, other|11|||
17092378|NCT00456365|38232041|FG000|Overall Study|Lost to Follow-up|1|||
17092379|NCT00456365|38232042|FG001|Overall Study|Lost to Follow-up|3|||
17092380|NCT00456365|38232041|FG000|Overall Study|Withdrawal by Subject|4|||
17189849|NCT02958865|38342713|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189850|NCT02958865|38342714|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
17189851|NCT02958865|38342699|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
17189852|NCT02958865|38342700|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
17189853|NCT02958865|38342701|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
17189854|NCT02958865|38342702|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
17092381|NCT00456365|38232042|FG001|Overall Study|Withdrawal by Subject|7|||
17092382|NCT00456365|38232041|FG000|Overall Study|Pregnancy|1|||
17092383|NCT00456365|38232042|FG001|Overall Study|Pregnancy|1|||
17092384|NCT00456365|38232041|FG000|Overall Study|oncologic diagnosis|1|||
17092385|NCT00456365|38232042|FG001|Overall Study|oncologic diagnosis|1|||
17092386|NCT00455741|38232052|FG000|Overall Study|Physician Decision|0|||
17092387|NCT00455741|38232053|FG001|Overall Study|Physician Decision|1|||
17092388|NCT00445679|38232073|FG000|Overall Study|Adverse Event|22|||
17092389|NCT00445679|38232074|FG001|Overall Study|Adverse Event|12|||
17092390|NCT00445679|38232075|FG002|Overall Study|Adverse Event|30|||
17092391|NCT00445679|38232076|FG003|Overall Study|Adverse Event|19|||
17092392|NCT00445679|38232073|FG000|Overall Study|Failed to return|1|||
17092393|NCT00445679|38232074|FG001|Overall Study|Failed to return|3|||
17189855|NCT02958865|38342703|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
17189856|NCT02958865|38342704|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
17189857|NCT02958865|38342705|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
17189858|NCT02958865|38342706|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
17189859|NCT02958865|38342707|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
17189860|NCT02958865|38342708|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
17189861|NCT02958865|38342709|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
17189862|NCT02958865|38342710|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
17189863|NCT02958865|38342711|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
17189864|NCT02958865|38342712|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
17189865|NCT02958865|38342713|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
17189866|NCT02958865|38342714|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
17189867|NCT02958865|38342699|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189868|NCT02958865|38342700|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189869|NCT02958865|38342701|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189870|NCT02958865|38342702|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189871|NCT02958865|38342703|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189872|NCT02958865|38342704|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189873|NCT02958865|38342705|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189874|NCT02958865|38342706|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189875|NCT02958865|38342707|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
17189876|NCT02958865|38342708|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
17189877|NCT02958865|38342709|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189878|NCT02958865|38342710|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
17092394|NCT00445679|38232075|FG002|Overall Study|Failed to return|2|||
17092395|NCT00445679|38232076|FG003|Overall Study|Failed to return|2|||
17092396|NCT00445679|38232073|FG000|Overall Study|Physician Decision|0|||
17092397|NCT00445679|38232074|FG001|Overall Study|Physician Decision|0|||
17092398|NCT00445679|38232075|FG002|Overall Study|Physician Decision|1|||
17092399|NCT00445679|38232076|FG003|Overall Study|Physician Decision|0|||
17189879|NCT02958865|38342711|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189880|NCT02958865|38342712|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
17092400|NCT00445679|38232073|FG000|Overall Study|Lost to Follow-up|10|||
17092401|NCT00445679|38232074|FG001|Overall Study|Lost to Follow-up|6|||
17092402|NCT00445679|38232075|FG002|Overall Study|Lost to Follow-up|6|||
17092403|NCT00445679|38232076|FG003|Overall Study|Lost to Follow-up|5|||
17189881|NCT02958865|38342713|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
17189882|NCT02958865|38342714|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
17092404|NCT00445679|38232073|FG000|Overall Study|Compliance|3|||
17092405|NCT00445679|38232074|FG001|Overall Study|Compliance|2|||
17092406|NCT00445679|38232075|FG002|Overall Study|Compliance|1|||
17092407|NCT00445679|38232076|FG003|Overall Study|Compliance|2|||
17092408|NCT00445679|38232073|FG000|Overall Study|Withdrawal of Informed Consent|0|||
17092409|NCT00445679|38232074|FG001|Overall Study|Withdrawal of Informed Consent|0|||
17092410|NCT00445679|38232075|FG002|Overall Study|Withdrawal of Informed Consent|1|||
17092411|NCT00445679|38232076|FG003|Overall Study|Withdrawal of Informed Consent|0|||
17092412|NCT00445679|38232073|FG000|Overall Study|Protocol Violation|2|||
17092413|NCT00445679|38232074|FG001|Overall Study|Protocol Violation|3|||
17092414|NCT00445679|38232075|FG002|Overall Study|Protocol Violation|3|||
17092415|NCT00445679|38232076|FG003|Overall Study|Protocol Violation|1|||
17092416|NCT00445679|38232073|FG000|Overall Study|Withdrawal by Subject|8|||
17092417|NCT00445679|38232074|FG001|Overall Study|Withdrawal by Subject|14|||
17092418|NCT00445679|38232075|FG002|Overall Study|Withdrawal by Subject|20|||
17092419|NCT00445679|38232076|FG003|Overall Study|Withdrawal by Subject|18|||
17092420|NCT00445679|38232073|FG000|Overall Study|Lack of Efficacy|2|||
17092421|NCT00445679|38232074|FG001|Overall Study|Lack of Efficacy|6|||
17092422|NCT00445679|38232075|FG002|Overall Study|Lack of Efficacy|2|||
17092423|NCT00445679|38232076|FG003|Overall Study|Lack of Efficacy|0|||
17092424|NCT00455429|38232090|FG000|Overall Study|Study Terminated by Sponsor|0|||
17092425|NCT00455429|38232091|FG001|Overall Study|Study Terminated by Sponsor|0|||
17092426|NCT00455429|38232092|FG002|Overall Study|Study Terminated by Sponsor|0|||
17092427|NCT00455429|38232093|FG003|Overall Study|Study Terminated by Sponsor|3|||
17092428|NCT00455429|38232090|FG000|Overall Study|Lost to Follow-up|1|||
17092429|NCT00455429|38232091|FG001|Overall Study|Lost to Follow-up|0|||
17092430|NCT00455429|38232092|FG002|Overall Study|Lost to Follow-up|0|||
17092431|NCT00455429|38232093|FG003|Overall Study|Lost to Follow-up|3|||
17092432|NCT00455429|38232090|FG000|Overall Study|Withdrawal by Subject|0|||
17092433|NCT00455429|38232091|FG001|Overall Study|Withdrawal by Subject|1|||
17092434|NCT00455429|38232092|FG002|Overall Study|Withdrawal by Subject|1|||
17092435|NCT00455429|38232093|FG003|Overall Study|Withdrawal by Subject|0|||
17092436|NCT00455429|38232090|FG000|Overall Study|Lack of Efficacy|0|||
17092437|NCT00455429|38232091|FG001|Overall Study|Lack of Efficacy|1|||
17092438|NCT00455429|38232092|FG002|Overall Study|Lack of Efficacy|0|||
17092439|NCT00455429|38232093|FG003|Overall Study|Lack of Efficacy|1|||
17092440|NCT00455429|38232090|FG000|Overall Study|Adverse Event|0|||
17092441|NCT00455429|38232091|FG001|Overall Study|Adverse Event|1|||
17092442|NCT00455429|38232092|FG002|Overall Study|Adverse Event|0|||
17092443|NCT00455429|38232093|FG003|Overall Study|Adverse Event|3|||
17092444|NCT00455429|38232090|FG000|Overall Study|Randomly assigned but not treated|0|||
17092445|NCT00455429|38232091|FG001|Overall Study|Randomly assigned but not treated|0|||
17092446|NCT00455429|38232092|FG002|Overall Study|Randomly assigned but not treated|0|||
17092447|NCT00455429|38232093|FG003|Overall Study|Randomly assigned but not treated|2|||
17092448|NCT00455429|38232090|FG000|Overall Study|Personal Reason|1|||
16783079|NCT02556801|37722813|FG001|Overall Study|Pregnancy|1|||
17092449|NCT00455429|38232091|FG001|Overall Study|Personal Reason|0|||
17092450|NCT00455429|38232092|FG002|Overall Study|Personal Reason|0|||
17092451|NCT00455429|38232093|FG003|Overall Study|Personal Reason|0|||
17092452|NCT00455429|38232090|FG000|Overall Study|Non-compliance|0|||
17092453|NCT00455429|38232091|FG001|Overall Study|Non-compliance|0|||
17092454|NCT00455429|38232092|FG002|Overall Study|Non-compliance|0|||
17092455|NCT00455429|38232093|FG003|Overall Study|Non-compliance|1|||
16868362|NCT02655016|37841428|FG000|Overall Study|Lost to Follow-up|1|||
17092456|NCT00455429|38232090|FG000|Overall Study|Other|0|||
17092457|NCT00455429|38232091|FG001|Overall Study|Other|2|||
17092458|NCT00455429|38232092|FG002|Overall Study|Other|0|||
17092459|NCT00455429|38232093|FG003|Overall Study|Other|1|||
17092460|NCT00445601|38232108|FG000|Overall Study|Withdrawal by Subject|11|||
17092461|NCT00445601|38232109|FG001|Overall Study|Withdrawal by Subject|11|||
17092462|NCT00445601|38232108|FG000|Overall Study|TURBT Complication|12|||
17092463|NCT00445601|38232109|FG001|Overall Study|TURBT Complication|8|||
17092464|NCT00445601|38232108|FG000|Overall Study|Incorrect Disease Status|6|||
17092465|NCT00445601|38232109|FG001|Overall Study|Incorrect Disease Status|6|||
17092466|NCT00445601|38232108|FG000|Overall Study|Drug Delivery Issue|2|||
17092467|NCT00445601|38232109|FG001|Overall Study|Drug Delivery Issue|2|||
17092468|NCT00445601|38232108|FG000|Overall Study|Adverse Event|2|||
17092469|NCT00445601|38232109|FG001|Overall Study|Adverse Event|0|||
17092470|NCT00445601|38232108|FG000|Overall Study|Death prior to TURBT|0|||
17092471|NCT00445601|38232109|FG001|Overall Study|Death prior to TURBT|1|||
17092472|NCT00444587|38232121|FG000|Overall Study|Death|2|||
16783080|NCT02556801|37722814|FG002|Overall Study|Pregnancy|0|||
16783081|NCT02556801|37722815|FG003|Overall Study|Pregnancy|0|||
16783082|NCT02556801|37722812|FG000|Overall Study|Personal reasons patient|0|||
17092473|NCT00444587|38232122|FG001|Overall Study|Death|1|||
17092474|NCT00444587|38232121|FG000|Overall Study|Progression of the disease|73|||
17092475|NCT00444587|38232122|FG001|Overall Study|Progression of the disease|8|||
17092476|NCT00444587|38232121|FG000|Overall Study|Refused treatment/did not cooperate|4|||
17092477|NCT00444587|38232122|FG001|Overall Study|Refused treatment/did not cooperate|1|||
17092478|NCT00444587|38232121|FG000|Overall Study|Investigator decision|3|||
17092479|NCT00444587|38232122|FG001|Overall Study|Investigator decision|0|||
17092480|NCT00444587|38232121|FG000|Overall Study|Protocol Violation|1|||
17092481|NCT00444587|38232122|FG001|Overall Study|Protocol Violation|0|||
17092482|NCT00444587|38232121|FG000|Overall Study|Missing|0|||
17092483|NCT00444587|38232122|FG001|Overall Study|Missing|5|||
17092484|NCT03841331|38232132|FG000|Overall Study|Withdrawal by Subject|4|||
17092485|NCT03841331|38232133|FG001|Overall Study|Withdrawal by Subject|9|||
17092486|NCT03841331|38232132|FG000|Overall Study|Lost to Follow-up|5|||
17092487|NCT03841331|38232133|FG001|Overall Study|Lost to Follow-up|1|||
17092488|NCT00455195|38232141|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
17092489|NCT00455195|38232142|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
17092490|NCT00455195|38232141|FG000|Double-blind Study AGLU02704|Death|1|||
17092491|NCT00455195|38232142|FG001|Double-blind Study AGLU02704|Death|0|||
17092492|NCT00455195|38232141|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
17092493|NCT00455195|38232142|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
17092494|NCT00455195|38232141|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
17092495|NCT00455195|38232142|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
17092496|NCT00235716|38232152|FG000|Overall Study|Death|26|||
17092497|NCT00235716|38232153|FG001|Overall Study|Death|39|||
17092498|NCT00235716|38232154|FG002|Overall Study|Death|32|||
17092499|NCT00235716|38232155|FG003|Overall Study|Death|31|||
17092500|NCT00235716|38232152|FG000|Overall Study|Withdrawal by Subject|23|||
17092501|NCT00235716|38232153|FG001|Overall Study|Withdrawal by Subject|19|||
17092502|NCT00235716|38232154|FG002|Overall Study|Withdrawal by Subject|17|||
17092503|NCT00235716|38232155|FG003|Overall Study|Withdrawal by Subject|18|||
17092504|NCT00235716|38232152|FG000|Overall Study|Lost to Follow-up|12|||
17092505|NCT00235716|38232153|FG001|Overall Study|Lost to Follow-up|7|||
17092506|NCT00235716|38232154|FG002|Overall Study|Lost to Follow-up|14|||
17092507|NCT00235716|38232155|FG003|Overall Study|Lost to Follow-up|10|||
17092508|NCT00235716|38232152|FG000|Overall Study|Adverse Event|1|||
17092509|NCT00235716|38232153|FG001|Overall Study|Adverse Event|1|||
17092510|NCT00235716|38232154|FG002|Overall Study|Adverse Event|1|||
17092511|NCT00235716|38232155|FG003|Overall Study|Adverse Event|0|||
17092512|NCT00235716|38232152|FG000|Overall Study|Physician Decision|0|||
17092513|NCT00235716|38232153|FG001|Overall Study|Physician Decision|1|||
17092514|NCT00235716|38232154|FG002|Overall Study|Physician Decision|1|||
17092515|NCT00235716|38232155|FG003|Overall Study|Physician Decision|3|||
17092516|NCT00274742|38232171|FG000|Overall Study|Adverse Event|0|||
17092517|NCT00274742|38232172|FG001|Overall Study|Adverse Event|4|||
17092518|NCT00274742|38232173|FG002|Overall Study|Adverse Event|1|||
17092519|NCT00274742|38232174|FG003|Overall Study|Adverse Event|4|||
17092520|NCT00274742|38232175|FG004|Overall Study|Adverse Event|12|||
17092521|NCT00274742|38232176|FG005|Overall Study|Adverse Event|3|||
17092522|NCT00274742|38232171|FG000|Overall Study|Lost to Follow-up|0|||
17092523|NCT00274742|38232172|FG001|Overall Study|Lost to Follow-up|0|||
17092524|NCT00274742|38232173|FG002|Overall Study|Lost to Follow-up|0|||
17092525|NCT00274742|38232174|FG003|Overall Study|Lost to Follow-up|0|||
17092526|NCT00274742|38232175|FG004|Overall Study|Lost to Follow-up|1|||
17092527|NCT00274742|38232176|FG005|Overall Study|Lost to Follow-up|0|||
17092528|NCT00274742|38232171|FG000|Overall Study|End of Study|0|||
17092529|NCT00274742|38232172|FG001|Overall Study|End of Study|0|||
17189883|NCT02958865|38342699|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189884|NCT02958865|38342700|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17092530|NCT00274742|38232173|FG002|Overall Study|End of Study|0|||
17092531|NCT00274742|38232174|FG003|Overall Study|End of Study|1|||
17092532|NCT00274742|38232175|FG004|Overall Study|End of Study|0|||
17092533|NCT00274742|38232176|FG005|Overall Study|End of Study|0|||
17092534|NCT00274742|38232171|FG000|Overall Study|Disease Progression|0|||
17092535|NCT00274742|38232172|FG001|Overall Study|Disease Progression|1|||
17092536|NCT00274742|38232173|FG002|Overall Study|Disease Progression|1|||
17092537|NCT00274742|38232174|FG003|Overall Study|Disease Progression|0|||
17092538|NCT00274742|38232175|FG004|Overall Study|Disease Progression|1|||
17092539|NCT00274742|38232176|FG005|Overall Study|Disease Progression|0|||
17092540|NCT00274742|38232171|FG000|Overall Study|Other|0|||
17092541|NCT00274742|38232172|FG001|Overall Study|Other|3|||
17092542|NCT00274742|38232173|FG002|Overall Study|Other|0|||
17092543|NCT00274742|38232174|FG003|Overall Study|Other|0|||
17092544|NCT00274742|38232175|FG004|Overall Study|Other|2|||
17092545|NCT00274742|38232176|FG005|Overall Study|Other|0|||
17189885|NCT02958865|38342701|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16783083|NCT02556801|37722813|FG001|Overall Study|Personal reasons patient|0|||
16783084|NCT02556801|37722814|FG002|Overall Study|Personal reasons patient|0|||
16783085|NCT02556801|37722815|FG003|Overall Study|Personal reasons patient|1|||
16783086|NCT02556177|37722827|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
16783087|NCT02556177|37722828|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
16783088|NCT02554929|37722836|FG000|Overall Study|Lost to Follow-up|4|||
16783089|NCT02554929|37722837|FG001|Overall Study|Lost to Follow-up|4|||
16783090|NCT02554929|37722836|FG000|Overall Study|Withdrawal by Subject|2|||
16783091|NCT02554929|37722837|FG001|Overall Study|Withdrawal by Subject|8|||
16783092|NCT03745989|37722855|FG000|Overall Study|Death|3|||
16783093|NCT03745989|37722856|FG001|Overall Study|Death|7|||
16783094|NCT03745989|37722857|FG002|Overall Study|Death|4|||
16783095|NCT03745989|37722855|FG000|Overall Study|Lost to Follow-up|0|||
17092546|NCT00262314|38232196|FG000|Overall Study|Changing physicians|38|||
17092547|NCT00262314|38232196|FG000|Overall Study|Death|12|||
16783096|NCT03745989|37722856|FG001|Overall Study|Lost to Follow-up|2|||
16783097|NCT03745989|37722857|FG002|Overall Study|Lost to Follow-up|0|||
16783098|NCT03745989|37722855|FG000|Overall Study|Sponsor Decision|0|||
16783099|NCT03745989|37722856|FG001|Overall Study|Sponsor Decision|2|||
16783100|NCT03745989|37722857|FG002|Overall Study|Sponsor Decision|8|||
16783101|NCT03745989|37722855|FG000|Overall Study|Withdrawal by Subject|0|||
16783102|NCT03745989|37722856|FG001|Overall Study|Withdrawal by Subject|1|||
16783103|NCT03745989|37722857|FG002|Overall Study|Withdrawal by Subject|3|||
16783104|NCT02697773|37722868|FG000|Overall Study|Adverse Event|2|||
16783105|NCT02697773|37722869|FG001|Overall Study|Adverse Event|1|||
16783106|NCT02697773|37722870|FG002|Overall Study|Adverse Event|2|||
16783107|NCT02697773|37722868|FG000|Overall Study|Death|0|||
16783108|NCT02697773|37722869|FG001|Overall Study|Death|0|||
16783109|NCT02697773|37722870|FG002|Overall Study|Death|2|||
16783110|NCT02697773|37722868|FG000|Overall Study|Lack of Efficacy|4|||
16783111|NCT02697773|37722869|FG001|Overall Study|Lack of Efficacy|6|||
16783112|NCT02697773|37722870|FG002|Overall Study|Lack of Efficacy|6|||
16783113|NCT02697773|37722868|FG000|Overall Study|Lost to Follow-up|5|||
16783114|NCT02697773|37722869|FG001|Overall Study|Lost to Follow-up|5|||
16783115|NCT02697773|37722870|FG002|Overall Study|Lost to Follow-up|7|||
16783116|NCT02697773|37722868|FG000|Overall Study|Other|15|||
16783117|NCT02697773|37722869|FG001|Overall Study|Other|11|||
16783118|NCT02697773|37722870|FG002|Overall Study|Other|10|||
16783119|NCT02697773|37722868|FG000|Overall Study|Protocol Violation|1|||
16783120|NCT02697773|37722869|FG001|Overall Study|Protocol Violation|1|||
16783121|NCT02697773|37722870|FG002|Overall Study|Protocol Violation|0|||
16783122|NCT02697773|37722868|FG000|Overall Study|Withdrawal by Subject|10|||
16783123|NCT02697773|37722869|FG001|Overall Study|Withdrawal by Subject|13|||
16783124|NCT02697773|37722870|FG002|Overall Study|Withdrawal by Subject|13|||
16783125|NCT02697773|37722868|FG000|Overall Study|Randomized but not treated|1|||
16783126|NCT02697773|37722869|FG001|Overall Study|Randomized but not treated|1|||
16783127|NCT02697773|37722870|FG002|Overall Study|Randomized but not treated|0|||
16783128|NCT02693171|37722878|FG000|Overall Study|Adverse Event|1|||
16783129|NCT02693171|37722878|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
16783130|NCT02692703|37722882|FG000|Overall Study|Lost to Follow-up|1|||
16783131|NCT02692703|37722882|FG000|Overall Study|Other|1|||
16783132|NCT02692235|37722888|FG000|Overall Study|Withdrawal by Subject|2|||
16783133|NCT02692235|37722889|FG001|Overall Study|Withdrawal by Subject|1|||
16783134|NCT02692235|37722888|FG000|Overall Study|Adverse Event|1|||
16783135|NCT02692235|37722889|FG001|Overall Study|Adverse Event|2|||
16783136|NCT02552121|37722903|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
16783137|NCT02552121|37722904|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16783138|NCT02552121|37722905|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16783139|NCT02552121|37722906|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16783140|NCT02552121|37722907|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16783141|NCT02552121|37722908|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16783142|NCT02552121|37722909|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16783143|NCT02552121|37722910|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16783144|NCT02552121|37722903|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
16783145|NCT02552121|37722904|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16783146|NCT02552121|37722905|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
17092548|NCT00262314|38232196|FG000|Overall Study|Patient's decision|92|||
17092549|NCT00262314|38232196|FG000|Overall Study|Other|95|||
17092550|NCT00262314|38232196|FG000|Overall Study|Lost to Follow-up|70|||
17092551|NCT00262314|38232196|FG000|Overall Study|Administrative withdrawal|30|||
17092552|NCT00283400|38232204|FG000|Overall Study|Withdrawal by Subject|1|||
17092553|NCT00283400|38232205|FG001|Overall Study|Withdrawal by Subject|1|||
17092554|NCT00283400|38232206|FG002|Overall Study|Withdrawal by Subject|0|||
17092555|NCT00283400|38232207|FG003|Overall Study|Withdrawal by Subject|0|||
16783147|NCT02552121|37722906|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16868363|NCT02655016|37841429|FG001|Overall Study|Lost to Follow-up|1|||
16783148|NCT02552121|37722907|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16783149|NCT02552121|37722908|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16783150|NCT02552121|37722909|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16783151|NCT02552121|37722910|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16783152|NCT02552121|37722903|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16783153|NCT02552121|37722904|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
16783154|NCT02552121|37722905|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16783155|NCT02552121|37722906|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16783156|NCT02552121|37722907|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16783157|NCT02552121|37722908|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16783158|NCT02552121|37722909|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16783159|NCT02552121|37722910|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16783160|NCT02552121|37722903|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16783161|NCT02552121|37722904|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
16783162|NCT02552121|37722905|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16783163|NCT02552121|37722906|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16783164|NCT02552121|37722907|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16783165|NCT02552121|37722908|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16783166|NCT02552121|37722909|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16783167|NCT02552121|37722910|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16783168|NCT02552121|37722903|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16783169|NCT02552121|37722904|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
16783170|NCT02552121|37722905|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
17092556|NCT00283400|38232204|FG000|Overall Study|Death|1|||
17092557|NCT00283400|38232205|FG001|Overall Study|Death|0|||
17092558|NCT00283400|38232206|FG002|Overall Study|Death|1|||
17092559|NCT00283400|38232207|FG003|Overall Study|Death|0|||
17092560|NCT00444275|38232220|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
17092561|NCT00444275|38232221|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
17092562|NCT00444275|38232222|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
17092563|NCT00444275|38232223|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
17092564|NCT00444275|38232224|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
17092565|NCT00444275|38232220|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
17092566|NCT00444275|38232221|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
17092567|NCT00444275|38232222|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
17092568|NCT00444275|38232223|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
17092569|NCT00444275|38232224|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
17092570|NCT00444275|38232220|FG000|Maintenance Treatment Phase|Adverse Event|0|||
17092571|NCT00444275|38232221|FG001|Maintenance Treatment Phase|Adverse Event|0|||
17092572|NCT00444275|38232222|FG002|Maintenance Treatment Phase|Adverse Event|3|||
17092573|NCT00444275|38232223|FG003|Maintenance Treatment Phase|Adverse Event|2|||
17092574|NCT00444275|38232224|FG004|Maintenance Treatment Phase|Adverse Event|13|||
17092575|NCT00444275|38232220|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
17092576|NCT00444275|38232221|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
17092577|NCT00444275|38232222|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
17092578|NCT00444275|38232223|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
17092579|NCT00444275|38232224|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
17092580|NCT00444275|38232220|FG000|Maintenance Treatment Phase|Patient's wish|0|||
17092581|NCT00444275|38232221|FG001|Maintenance Treatment Phase|Patient's wish|0|||
17092582|NCT00444275|38232222|FG002|Maintenance Treatment Phase|Patient's wish|19|||
17092583|NCT00444275|38232223|FG003|Maintenance Treatment Phase|Patient's wish|9|||
17092584|NCT00444275|38232224|FG004|Maintenance Treatment Phase|Patient's wish|20|||
17189886|NCT02958865|38342702|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189887|NCT02958865|38342703|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189888|NCT02958865|38342704|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189889|NCT02958865|38342705|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189890|NCT02958865|38342706|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189891|NCT02958865|38342707|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189892|NCT02958865|38342708|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
17189893|NCT02958865|38342709|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189894|NCT02958865|38342710|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189895|NCT02958865|38342711|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
17189896|NCT02958865|38342712|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16783171|NCT02552121|37722906|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
17189897|NCT02958865|38342713|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16783172|NCT02552121|37722907|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
17189898|NCT02958865|38342714|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
17189899|NCT02958865|38342699|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16783173|NCT02552121|37722908|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
17189900|NCT02958865|38342700|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17092585|NCT00444275|38232220|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
17092586|NCT00444275|38232221|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
17092587|NCT00444275|38232222|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
17092588|NCT00444275|38232223|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
17092589|NCT00444275|38232224|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
17092590|NCT00444275|38232220|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
17092591|NCT00444275|38232221|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
17092592|NCT00444275|38232222|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
17092593|NCT00444275|38232223|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
17092594|NCT00444275|38232224|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
17092595|NCT00454805|38232241|FG000|Overall Study|Withdrawal by Subject|9|||
17092596|NCT00454805|38232242|FG001|Overall Study|Withdrawal by Subject|2|||
17092597|NCT00454805|38232241|FG000|Overall Study|Death|0|||
17092598|NCT00454805|38232242|FG001|Overall Study|Death|2|||
17092599|NCT00454805|38232241|FG000|Overall Study|Disease progression|16|||
17092600|NCT00454805|38232242|FG001|Overall Study|Disease progression|19|||
17092601|NCT00454805|38232241|FG000|Overall Study|In order to begin radiotherapy|1|||
17092602|NCT00454805|38232242|FG001|Overall Study|In order to begin radiotherapy|0|||
17092603|NCT00283244|38232251|FG000|Overall Study|Adverse Event|0|||
17092604|NCT00283244|38232252|FG001|Overall Study|Adverse Event|8|||
17092605|NCT00283244|38232253|FG002|Overall Study|Adverse Event|11|||
17092606|NCT00283244|38232251|FG000|Overall Study|Death|4|||
17092607|NCT00283244|38232252|FG001|Overall Study|Death|3|||
17092608|NCT00283244|38232253|FG002|Overall Study|Death|2|||
17189901|NCT02958865|38342701|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189902|NCT02958865|38342702|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189903|NCT02958865|38342703|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189904|NCT02958865|38342704|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189905|NCT02958865|38342705|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189906|NCT02958865|38342706|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189907|NCT02958865|38342707|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189908|NCT02958865|38342708|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189909|NCT02958865|38342709|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
17189910|NCT02958865|38342710|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
17189911|NCT02958865|38342711|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
17189912|NCT02958865|38342712|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
17092609|NCT00283244|38232251|FG000|Overall Study|Lack of Efficacy|8|||
17092610|NCT00283244|38232252|FG001|Overall Study|Lack of Efficacy|32|||
17092611|NCT00283244|38232253|FG002|Overall Study|Lack of Efficacy|26|||
17189913|NCT02958865|38342713|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
17189914|NCT02958865|38342714|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
17189915|NCT02958865|38342699|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
17189916|NCT02958865|38342700|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
17189917|NCT02958865|38342701|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
17092612|NCT00283244|38232251|FG000|Overall Study|Withdrawal by Subject|1|||
17092613|NCT00283244|38232252|FG001|Overall Study|Withdrawal by Subject|2|||
17092614|NCT00283244|38232253|FG002|Overall Study|Withdrawal by Subject|2|||
17092615|NCT00283244|38232251|FG000|Overall Study|Physician Decision|0|||
17092616|NCT00283244|38232252|FG001|Overall Study|Physician Decision|0|||
17092617|NCT00283244|38232253|FG002|Overall Study|Physician Decision|1|||
17092618|NCT00283244|38232251|FG000|Overall Study|Medical illness (other complicating dz)|4|||
17092619|NCT00283244|38232252|FG001|Overall Study|Medical illness (other complicating dz)|3|||
17092620|NCT00283244|38232253|FG002|Overall Study|Medical illness (other complicating dz)|6|||
17092621|NCT00283244|38232251|FG000|Overall Study|Clinical deterioration|1|||
17092622|NCT00283244|38232252|FG001|Overall Study|Clinical deterioration|3|||
17092623|NCT00283244|38232253|FG002|Overall Study|Clinical deterioration|3|||
17092624|NCT00282464|38232264|FG000|Overall Study|Adverse Event|26|||
17092625|NCT00282464|38232265|FG001|Overall Study|Adverse Event|20|||
17092626|NCT00282464|38232264|FG000|Overall Study|Lack of Efficacy|8|||
17092627|NCT00282464|38232265|FG001|Overall Study|Lack of Efficacy|8|||
17092628|NCT00282464|38232264|FG000|Overall Study|Lost to Follow-up|10|||
17092629|NCT00282464|38232265|FG001|Overall Study|Lost to Follow-up|10|||
17092630|NCT00282464|38232264|FG000|Overall Study|Withdrawal by Subject|24|||
17092631|NCT00282464|38232265|FG001|Overall Study|Withdrawal by Subject|10|||
17092632|NCT00282464|38232264|FG000|Overall Study|laboratory abnormality|1|||
17092633|NCT00282464|38232265|FG001|Overall Study|laboratory abnormality|2|||
17092634|NCT00282464|38232264|FG000|Overall Study|Protocol Violation|0|||
17092635|NCT00282464|38232265|FG001|Overall Study|Protocol Violation|7|||
17092636|NCT00282464|38232264|FG000|Overall Study|Patient moved|1|||
17092637|NCT00282464|38232265|FG001|Overall Study|Patient moved|0|||
17092638|NCT00282464|38232264|FG000|Overall Study|patient non-compliant|3|||
17092639|NCT00282464|38232265|FG001|Overall Study|patient non-compliant|0|||
17092640|NCT00282464|38232264|FG000|Overall Study|patient no show|0|||
17092641|NCT00282464|38232265|FG001|Overall Study|patient no show|1|||
17092642|NCT00282464|38232264|FG000|Overall Study|patient incarcerated|0|||
17092643|NCT00282464|38232265|FG001|Overall Study|patient incarcerated|1|||
17092644|NCT00282464|38232264|FG000|Overall Study|family crisis|0|||
17092645|NCT00282464|38232265|FG001|Overall Study|family crisis|1|||
17092646|NCT00282464|38232264|FG000|Overall Study|dispensed wrong kit|0|||
17092647|NCT00282464|38232265|FG001|Overall Study|dispensed wrong kit|1|||
17092648|NCT00282464|38232264|FG000|Overall Study|dropped due to missed visits|0|||
17092649|NCT00282464|38232265|FG001|Overall Study|dropped due to missed visits|1|||
17092650|NCT00273182|38232271|FG000|Overall Study|Death|450|||
17092651|NCT00273182|38232271|FG000|Overall Study|Lost to Follow-up|88|||
17092652|NCT00273182|38232271|FG000|Overall Study|Withdrawal by Subject|257|||
17092653|NCT00273182|38232271|FG000|Overall Study|Device/System Explant|154|||
17092654|NCT00273182|38232271|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
17092655|NCT00209274|38232278|FG000|Overall Study|Missed visit|3|||
17092656|NCT00209274|38232279|FG001|Overall Study|Missed visit|2|||
17092657|NCT00209274|38232278|FG000|Overall Study|Death|32|||
17092658|NCT00209274|38232279|FG001|Overall Study|Death|15|||
17092659|NCT00209274|38232278|FG000|Overall Study|Withdrawal by Subject|30|||
17092660|NCT00209274|38232279|FG001|Overall Study|Withdrawal by Subject|15|||
17092661|NCT00209274|38232278|FG000|Overall Study|Randomized not treated (RNT)|6|||
17092662|NCT00209274|38232279|FG001|Overall Study|Randomized not treated (RNT)|15|||
17092663|NCT00262080|38232288|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
17092664|NCT00262080|38232289|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
17092665|NCT00262080|38232290|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
17092666|NCT00262080|38232288|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
17092667|NCT00262080|38232289|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
17092668|NCT00262080|38232290|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
17092669|NCT00262080|38232288|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
17092670|NCT00262080|38232289|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
17092671|NCT00262080|38232290|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
17092672|NCT00262080|38232288|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
17092673|NCT00262080|38232289|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
17092674|NCT00262080|38232290|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
17092675|NCT00262080|38232288|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
17092676|NCT00262080|38232289|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
17092677|NCT00262080|38232290|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
17092678|NCT00262080|38232288|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
17092679|NCT00262080|38232289|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
17092680|NCT00262080|38232290|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
17092681|NCT00282308|38232300|FG000|Treatment Period|Lost to Follow-up|1|||
17092682|NCT00282308|38232301|FG001|Treatment Period|Lost to Follow-up|0|||
17092683|NCT00282308|38232302|FG002|Treatment Period|Lost to Follow-up|0|||
17092684|NCT00282308|38232300|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
17092685|NCT00282308|38232301|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
17092686|NCT00282308|38232302|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
17092687|NCT00282308|38232300|FG000|Treatment Period|Adverse Event|0|||
17092688|NCT00282308|38232301|FG001|Treatment Period|Adverse Event|2|||
17092689|NCT00282308|38232302|FG002|Treatment Period|Adverse Event|0|||
17092690|NCT00282308|38232300|FG000|Treatment Period|Not Treated with Study Drug|1|||
17092691|NCT00282308|38232301|FG001|Treatment Period|Not Treated with Study Drug|0|||
17092692|NCT00282308|38232302|FG002|Treatment Period|Not Treated with Study Drug|0|||
17092693|NCT00282308|38232300|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
17092694|NCT00282308|38232301|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
17092695|NCT00282308|38232302|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
17092696|NCT00282308|38232300|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
17092697|NCT00282308|38232301|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
17092698|NCT00282308|38232302|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
17092699|NCT00282308|38232300|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
17092700|NCT00282308|38232301|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
17092701|NCT00282308|38232302|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
17092702|NCT00282308|38232300|FG000|Safety Follow-up Period|Adverse Event|0|||
17092703|NCT00282308|38232301|FG001|Safety Follow-up Period|Adverse Event|0|||
17189918|NCT02958865|38342702|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
17189919|NCT02958865|38342703|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
17092704|NCT00282308|38232302|FG002|Safety Follow-up Period|Adverse Event|1|||
17092705|NCT00282308|38232300|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
17092706|NCT00282308|38232301|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
17092707|NCT00282308|38232302|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
17092708|NCT00282308|38232300|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
17092709|NCT00282308|38232301|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
17092710|NCT00282308|38232302|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
17092711|NCT00282308|38232300|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
17092712|NCT00282308|38232301|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
17092713|NCT00282308|38232302|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
17092714|NCT00282152|38232314|FG000|Overall Study|Withdrawal by Subject|1|||
17092715|NCT00282152|38232315|FG001|Overall Study|Withdrawal by Subject|0|||
17092716|NCT00281840|38232322|FG000|Overall Study|Adverse Event|12|||
17092717|NCT00281840|38232322|FG000|Overall Study|Physician Decision|6|||
17092718|NCT00281840|38232322|FG000|Overall Study|Withdrawal by Subject|3|||
17092719|NCT00281840|38232322|FG000|Overall Study|Disease Progression|2|||
17092720|NCT00281840|38232322|FG000|Overall Study|exceed maximum delay in treatment|1|||
17092721|NCT00281840|38232322|FG000|Overall Study|Complicating Disease|1|||
17092722|NCT00281684|38232331|FG000|Overall Study|Lost to Follow-up|0|||
17092723|NCT00281684|38232332|FG001|Overall Study|Lost to Follow-up|0|||
17092724|NCT00281684|38232333|FG002|Overall Study|Lost to Follow-up|1|||
17092725|NCT00281684|38232334|FG003|Overall Study|Lost to Follow-up|0|||
17092726|NCT00281684|38232331|FG000|Overall Study|Withdrawal by Subject|1|||
17092727|NCT00281684|38232332|FG001|Overall Study|Withdrawal by Subject|0|||
17092728|NCT00281684|38232333|FG002|Overall Study|Withdrawal by Subject|0|||
17092729|NCT00281684|38232334|FG003|Overall Study|Withdrawal by Subject|0|||
17092730|NCT00272792|38232348|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
17092731|NCT00272792|38232349|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
17092732|NCT00272792|38232348|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
17092733|NCT00272792|38232349|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
17092734|NCT00272792|38232348|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
17092735|NCT00272792|38232349|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
17092736|NCT00272792|38232348|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
17092737|NCT00272792|38232349|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
17092738|NCT00048568|38232357|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
17092739|NCT00048568|38232358|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
17092740|NCT00048568|38232359|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
17092741|NCT00048568|38232357|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
17092742|NCT00048568|38232358|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
17092743|NCT00048568|38232359|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
17092744|NCT00048568|38232357|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
17092745|NCT00048568|38232358|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
17092746|NCT00048568|38232359|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
17189920|NCT02958865|38342704|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
17189921|NCT02958865|38342705|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
17189922|NCT02958865|38342706|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
17189923|NCT02958865|38342707|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
17189924|NCT02958865|38342708|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
17189925|NCT02958865|38342709|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
17189926|NCT02958865|38342710|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
17189927|NCT02958865|38342711|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
17189928|NCT02958865|38342712|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
17189929|NCT02958865|38342713|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
17189930|NCT02958865|38342714|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
17189931|NCT02958865|38342699|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189932|NCT02958865|38342700|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189933|NCT02958865|38342701|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189934|NCT02958865|38342702|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189935|NCT02958865|38342703|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189936|NCT02958865|38342704|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189937|NCT02958865|38342705|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189938|NCT02958865|38342706|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189939|NCT02958865|38342707|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189940|NCT02958865|38342708|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189941|NCT02958865|38342709|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189942|NCT02958865|38342710|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189943|NCT02958865|38342711|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189944|NCT02958865|38342712|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
17189945|NCT02958865|38342713|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189946|NCT02958865|38342714|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
17189947|NCT02958865|38342699|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189948|NCT02958865|38342700|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189949|NCT02958865|38342701|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189950|NCT02958865|38342702|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189951|NCT02958865|38342703|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189952|NCT02958865|38342704|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189953|NCT02958865|38342705|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189954|NCT02958865|38342706|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189955|NCT02958865|38342707|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189956|NCT02958865|38342708|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189957|NCT02958865|38342709|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189958|NCT02958865|38342710|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189959|NCT02958865|38342711|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189960|NCT02958865|38342712|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
17189961|NCT02958865|38342713|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189962|NCT02958865|38342714|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
17189963|NCT02958865|38342699|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189964|NCT02958865|38342700|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189965|NCT02958865|38342701|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189966|NCT02958865|38342702|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189967|NCT02958865|38342703|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189968|NCT02958865|38342704|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189969|NCT02958865|38342705|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189970|NCT02958865|38342706|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189971|NCT02958865|38342707|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189972|NCT02958865|38342708|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
17189973|NCT02958865|38342709|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189974|NCT02958865|38342710|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189975|NCT02958865|38342711|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189976|NCT02958865|38342712|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189977|NCT02958865|38342713|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189978|NCT02958865|38342714|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
17189979|NCT02958553|38342766|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
17189980|NCT02958553|38342766|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
17092747|NCT00048568|38232357|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
17092748|NCT00048568|38232358|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
17092749|NCT00048568|38232359|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
17092750|NCT00048568|38232357|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
17092751|NCT00048568|38232358|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
17092752|NCT00048568|38232359|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
17092753|NCT00048568|38232357|FG000|Double-Blind Period Days 170 to 365|Death|1|||
17092754|NCT00048568|38232358|FG001|Double-Blind Period Days 170 to 365|Death|1|||
17092755|NCT00048568|38232359|FG002|Double-Blind Period Days 170 to 365|Death|0|||
17092756|NCT00048568|38232357|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
17092757|NCT00048568|38232358|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
17092758|NCT00048568|38232359|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
17092759|NCT00048568|38232357|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
17092760|NCT00048568|38232358|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
17092761|NCT00048568|38232359|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
17092762|NCT00048568|38232357|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
17092763|NCT00048568|38232358|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
17092764|NCT00048568|38232359|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
17092765|NCT00048568|38232357|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
17092766|NCT00048568|38232358|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
17189981|NCT02501902|38342779|FG000|Overall Study|Subject Refused Further Follow-up|0|||
17189982|NCT02501902|38342780|FG001|Overall Study|Subject Refused Further Follow-up|0|||
17189983|NCT02501902|38342781|FG002|Overall Study|Subject Refused Further Follow-up|0|||
17189984|NCT02501902|38342782|FG003|Overall Study|Subject Refused Further Follow-up|0|||
17189985|NCT02501902|38342783|FG004|Overall Study|Subject Refused Further Follow-up|0|||
17189986|NCT02501902|38342784|FG005|Overall Study|Subject Refused Further Follow-up|0|||
17189987|NCT02501902|38342785|FG006|Overall Study|Subject Refused Further Follow-up|0|||
17189988|NCT02501902|38342786|FG007|Overall Study|Subject Refused Further Follow-up|1|||
17189989|NCT02501902|38342779|FG000|Overall Study|Study Terminated by Sponsor|0|||
17189990|NCT02501902|38342780|FG001|Overall Study|Study Terminated by Sponsor|3|||
17189991|NCT02501902|38342781|FG002|Overall Study|Study Terminated by Sponsor|0|||
17189992|NCT02501902|38342782|FG003|Overall Study|Study Terminated by Sponsor|1|||
17189993|NCT02501902|38342783|FG004|Overall Study|Study Terminated by Sponsor|1|||
17189994|NCT02501902|38342784|FG005|Overall Study|Study Terminated by Sponsor|0|||
17092767|NCT00048568|38232359|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
17092768|NCT00048568|38232357|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
17092769|NCT00048568|38232358|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
17092770|NCT00048568|38232359|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
17092771|NCT00048568|38232357|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
17092772|NCT00048568|38232358|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
17092773|NCT00048568|38232359|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
17092774|NCT00048568|38232357|FG000|Open-Label Period|Death|0|||
17189995|NCT02501902|38342785|FG006|Overall Study|Study Terminated by Sponsor|2|||
17189996|NCT02501902|38342786|FG007|Overall Study|Study Terminated by Sponsor|4|||
17189997|NCT02501902|38342779|FG000|Overall Study|Death|3|||
17189998|NCT02501902|38342780|FG001|Overall Study|Death|4|||
17189999|NCT02501902|38342781|FG002|Overall Study|Death|4|||
17092775|NCT00048568|38232358|FG001|Open-Label Period|Death|0|||
17092776|NCT00048568|38232359|FG002|Open-Label Period|Death|13|||
17092777|NCT00048568|38232357|FG000|Open-Label Period|Adverse Event|0|||
17092778|NCT00048568|38232358|FG001|Open-Label Period|Adverse Event|0|||
17092779|NCT00048568|38232359|FG002|Open-Label Period|Adverse Event|49|||
17092780|NCT00048568|38232357|FG000|Open-Label Period|Lack of Efficacy|0|||
17092781|NCT00048568|38232358|FG001|Open-Label Period|Lack of Efficacy|0|||
17092782|NCT00048568|38232359|FG002|Open-Label Period|Lack of Efficacy|32|||
17092783|NCT00048568|38232357|FG000|Open-Label Period|Withdrawal by Subject|0|||
17092784|NCT00048568|38232358|FG001|Open-Label Period|Withdrawal by Subject|0|||
17092785|NCT00048568|38232359|FG002|Open-Label Period|Withdrawal by Subject|26|||
17092786|NCT00048568|38232357|FG000|Open-Label Period|Pregnancy|0|||
17092787|NCT00048568|38232358|FG001|Open-Label Period|Pregnancy|0|||
17092788|NCT00048568|38232359|FG002|Open-Label Period|Pregnancy|5|||
17092789|NCT00048568|38232357|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
17092790|NCT00048568|38232358|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
17092791|NCT00048568|38232359|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
17092792|NCT00048568|38232357|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
17092793|NCT00048568|38232358|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
17092794|NCT00048568|38232359|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
17092795|NCT00048568|38232357|FG000|Open-Label Period|Unknown Reasons|0|||
17092796|NCT00048568|38232358|FG001|Open-Label Period|Unknown Reasons|0|||
17190000|NCT02501902|38342782|FG003|Overall Study|Death|10|||
17190001|NCT02501902|38342783|FG004|Overall Study|Death|10|||
17190002|NCT02501902|38342784|FG005|Overall Study|Death|11|||
17092797|NCT00048568|38232359|FG002|Open-Label Period|Unknown Reasons|25|||
17092798|NCT00048568|38232357|FG000|Open-Label Period|Lost to Follow-up|0|||
17092799|NCT00048568|38232358|FG001|Open-Label Period|Lost to Follow-up|0|||
17092800|NCT00048568|38232359|FG002|Open-Label Period|Lost to Follow-up|7|||
16783174|NCT02552121|37722909|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16783175|NCT02552121|37722910|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16783176|NCT02552121|37722903|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16783177|NCT02552121|37722904|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
16783178|NCT02552121|37722905|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16783179|NCT02552121|37722906|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16783180|NCT02552121|37722907|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16783181|NCT02552121|37722908|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16783182|NCT02552121|37722909|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16783183|NCT02552121|37722910|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16783184|NCT02552121|37722903|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
16783185|NCT02552121|37722904|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
16783186|NCT02552121|37722905|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
16783187|NCT02552121|37722906|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
16783188|NCT02552121|37722907|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
16783189|NCT02552121|37722908|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
16783190|NCT02552121|37722909|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
16783191|NCT02552121|37722910|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
16783192|NCT02552121|37722903|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
16783193|NCT02552121|37722904|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
16783194|NCT02552121|37722905|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
16783195|NCT02552121|37722906|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
16783196|NCT02552121|37722907|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
16783197|NCT02552121|37722908|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
17092801|NCT00262002|38232387|FG000|Overall Study|Adverse Event|2|||
17092802|NCT00262002|38232388|FG001|Overall Study|Adverse Event|1|||
17092803|NCT00262002|38232389|FG002|Overall Study|Adverse Event|0|||
17190003|NCT02501902|38342785|FG006|Overall Study|Death|7|||
17190004|NCT02501902|38342786|FG007|Overall Study|Death|15|||
17190005|NCT01955109|38342811|FG000|Overall Study|Adverse Event|2|||
17190006|NCT01955109|38342812|FG001|Overall Study|Adverse Event|0|||
17092804|NCT00262002|38232390|FG003|Overall Study|Adverse Event|0|||
17092805|NCT00262002|38232391|FG004|Overall Study|Adverse Event|0|||
17190007|NCT01955109|38342811|FG000|Overall Study|Participant unwilling to continue|35|||
17190008|NCT01955109|38342812|FG001|Overall Study|Participant unwilling to continue|7|||
17190009|NCT01955109|38342811|FG000|Overall Study|Physician Decision|2|||
17190010|NCT01955109|38342812|FG001|Overall Study|Physician Decision|0|||
17190011|NCT01955109|38342811|FG000|Overall Study|Lost to Follow-up|3|||
17190012|NCT01955109|38342812|FG001|Overall Study|Lost to Follow-up|1|||
17190013|NCT01955109|38342811|FG000|Overall Study|Non-compliance|3|||
17190014|NCT01955109|38342812|FG001|Overall Study|Non-compliance|1|||
17190015|NCT02500732|38342820|FG000|Overall Study|Physician Decision|0|||
17190016|NCT02500732|38342821|FG001|Overall Study|Physician Decision|1|||
17190017|NCT02518048|38342827|FG000|Overall Study|Withdrawal by Subject|1|||
17190018|NCT02499952|38342832|FG000|Overall Study|Lost to Follow-up|1|||
17190019|NCT02499952|38342832|FG000|Overall Study|Death|9|||
17190020|NCT02499406|38342836|FG000|Overall Study|missed 3 treatment sessions|4|||
17190021|NCT02499172|38342844|FG000|Overall Study|Financial reason|0|||
17190022|NCT02499172|38342845|FG001|Overall Study|Financial reason|0|||
17190023|NCT02499172|38342846|FG002|Overall Study|Financial reason|523|||
17190024|NCT02499172|38342847|FG003|Overall Study|Financial reason|436|||
17190025|NCT02499172|38342844|FG000|Overall Study|Lost to Follow-up|65|||
17190026|NCT02499172|38342845|FG001|Overall Study|Lost to Follow-up|64|||
17190027|NCT02499172|38342846|FG002|Overall Study|Lost to Follow-up|0|||
17190028|NCT02499172|38342847|FG003|Overall Study|Lost to Follow-up|0|||
17190029|NCT02498392|38342859|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
17190030|NCT02498392|38342860|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
17190031|NCT02498392|38342859|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
17190032|NCT02498392|38342860|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
17190033|NCT02498392|38342859|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
17190034|NCT02498392|38342860|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
17190035|NCT02498392|38342859|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
17190036|NCT02498392|38342860|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
17190037|NCT02498392|38342859|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
17190038|NCT02498392|38342860|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
17190039|NCT02498392|38342859|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
17190040|NCT02498392|38342860|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
17190041|NCT03205605|38342868|FG000|Overall Study|Withdrawal by Subject|1|||
17190042|NCT02498236|38342886|FG000|Overall Study|Did not show for testing|1|||
17190043|NCT02498236|38342887|FG001|Overall Study|Did not show for testing|0|||
17190044|NCT02498236|38342888|FG002|Overall Study|Did not show for testing|0|||
17190045|NCT02498236|38342889|FG003|Overall Study|Did not show for testing|0|||
17190046|NCT02498236|38342890|FG004|Overall Study|Did not show for testing|0|||
17190047|NCT02498236|38342891|FG005|Overall Study|Did not show for testing|0|||
17190048|NCT02498236|38342892|FG006|Overall Study|Did not show for testing|0|||
17190049|NCT02498236|38342893|FG007|Overall Study|Did not show for testing|1|||
17190050|NCT02498236|38342886|FG000|Overall Study|Equipment failure|0|||
17190051|NCT02498236|38342887|FG001|Overall Study|Equipment failure|0|||
17190052|NCT02498236|38342888|FG002|Overall Study|Equipment failure|0|||
17190053|NCT02498236|38342889|FG003|Overall Study|Equipment failure|0|||
17190054|NCT02498236|38342890|FG004|Overall Study|Equipment failure|0|||
17190055|NCT02498236|38342891|FG005|Overall Study|Equipment failure|0|||
17190056|NCT02498236|38342892|FG006|Overall Study|Equipment failure|1|||
17092806|NCT00262002|38232392|FG005|Overall Study|Adverse Event|1|||
17092807|NCT00262002|38232393|FG006|Overall Study|Adverse Event|0|||
17190057|NCT02498236|38342893|FG007|Overall Study|Equipment failure|0|||
17190058|NCT02498236|38342886|FG000|Overall Study|Withdrawal by Subject|0|||
17190059|NCT02498236|38342887|FG001|Overall Study|Withdrawal by Subject|0|||
17190060|NCT02498236|38342888|FG002|Overall Study|Withdrawal by Subject|0|||
17190061|NCT02498236|38342889|FG003|Overall Study|Withdrawal by Subject|0|||
17092808|NCT00262002|38232387|FG000|Overall Study|Withdrawal by Subject|4|||
17092809|NCT00262002|38232388|FG001|Overall Study|Withdrawal by Subject|2|||
17092810|NCT00262002|38232389|FG002|Overall Study|Withdrawal by Subject|0|||
17092811|NCT00262002|38232390|FG003|Overall Study|Withdrawal by Subject|1|||
17092812|NCT00262002|38232391|FG004|Overall Study|Withdrawal by Subject|2|||
17092813|NCT00262002|38232392|FG005|Overall Study|Withdrawal by Subject|2|||
17092814|NCT00262002|38232393|FG006|Overall Study|Withdrawal by Subject|2|||
17092815|NCT00262002|38232387|FG000|Overall Study|Lost to Follow-up|2|||
17092816|NCT00262002|38232388|FG001|Overall Study|Lost to Follow-up|0|||
17092817|NCT00262002|38232389|FG002|Overall Study|Lost to Follow-up|0|||
17092818|NCT00262002|38232390|FG003|Overall Study|Lost to Follow-up|2|||
17092819|NCT00262002|38232391|FG004|Overall Study|Lost to Follow-up|0|||
17092820|NCT00262002|38232392|FG005|Overall Study|Lost to Follow-up|1|||
17092821|NCT00262002|38232393|FG006|Overall Study|Lost to Follow-up|0|||
17092822|NCT00262002|38232387|FG000|Overall Study|Inapropriate enrollment|0|||
17190062|NCT02498236|38342890|FG004|Overall Study|Withdrawal by Subject|1|||
17190063|NCT02498236|38342891|FG005|Overall Study|Withdrawal by Subject|0|||
17092823|NCT00262002|38232388|FG001|Overall Study|Inapropriate enrollment|1|||
17092824|NCT00262002|38232389|FG002|Overall Study|Inapropriate enrollment|0|||
17190064|NCT02498236|38342892|FG006|Overall Study|Withdrawal by Subject|0|||
17190065|NCT02498236|38342893|FG007|Overall Study|Withdrawal by Subject|0|||
17190066|NCT02496676|38342916|FG000|Phase 1 - Period 1|Adverse Event|0|||
17190067|NCT02496676|38342917|FG001|Phase 1 - Period 1|Adverse Event|1|||
17190068|NCT02496676|38342916|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
17190069|NCT02496676|38342917|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
17092825|NCT00262002|38232390|FG003|Overall Study|Inapropriate enrollment|0|||
17092826|NCT00262002|38232391|FG004|Overall Study|Inapropriate enrollment|0|||
17092827|NCT00262002|38232392|FG005|Overall Study|Inapropriate enrollment|0|||
17092828|NCT00262002|38232393|FG006|Overall Study|Inapropriate enrollment|0|||
17092829|NCT00262002|38232387|FG000|Overall Study|Protocol Violation|3|||
17092830|NCT00262002|38232388|FG001|Overall Study|Protocol Violation|2|||
17092831|NCT00262002|38232389|FG002|Overall Study|Protocol Violation|0|||
17092832|NCT00262002|38232390|FG003|Overall Study|Protocol Violation|2|||
17092833|NCT00262002|38232391|FG004|Overall Study|Protocol Violation|5|||
17092834|NCT00262002|38232392|FG005|Overall Study|Protocol Violation|3|||
17092835|NCT00262002|38232393|FG006|Overall Study|Protocol Violation|2|||
17092836|NCT00262002|38232387|FG000|Overall Study|Unable to classify|0|||
17092837|NCT00262002|38232388|FG001|Overall Study|Unable to classify|0|||
17092838|NCT00262002|38232389|FG002|Overall Study|Unable to classify|0|||
17092839|NCT00262002|38232390|FG003|Overall Study|Unable to classify|0|||
17092840|NCT00262002|38232391|FG004|Overall Study|Unable to classify|0|||
17092841|NCT00262002|38232392|FG005|Overall Study|Unable to classify|0|||
17092842|NCT00262002|38232393|FG006|Overall Study|Unable to classify|2|||
17092843|NCT00281528|38232461|FG000|Overall Study|Progressive Disease|28|||
17092844|NCT00281528|38232462|FG001|Overall Study|Progressive Disease|18|||
17092845|NCT00281528|38232463|FG002|Overall Study|Progressive Disease|27|||
17092846|NCT00281528|38232461|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
17092847|NCT00281528|38232462|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
17092848|NCT00281528|38232463|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
17092849|NCT00281528|38232461|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
17092850|NCT00281528|38232462|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
17092851|NCT00281528|38232463|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
17092852|NCT00281528|38232461|FG000|Overall Study|Physician Decision|11|||
17092853|NCT00281528|38232462|FG001|Overall Study|Physician Decision|4|||
17092854|NCT00281528|38232463|FG002|Overall Study|Physician Decision|5|||
17092855|NCT00281528|38232461|FG000|Overall Study|Protocol Violation|1|||
17092856|NCT00281528|38232462|FG001|Overall Study|Protocol Violation|0|||
17092857|NCT00281528|38232463|FG002|Overall Study|Protocol Violation|1|||
17092858|NCT00281528|38232461|FG000|Overall Study|Withdrawal by Subject|5|||
17092859|NCT00281528|38232462|FG001|Overall Study|Withdrawal by Subject|5|||
17092860|NCT00281528|38232463|FG002|Overall Study|Withdrawal by Subject|7|||
17092861|NCT00281528|38232461|FG000|Overall Study|Other|6|||
17092862|NCT00281528|38232462|FG001|Overall Study|Other|3|||
17092863|NCT00281528|38232463|FG002|Overall Study|Other|5|||
17190070|NCT02517268|38342933|FG000|Overall Study|Withdrawal by Subject|1|||
17190071|NCT02517268|38342934|FG001|Overall Study|Withdrawal by Subject|0|||
17190072|NCT01160211|38342943|FG000|Overall Study|ongoing|90|||
17190073|NCT01160211|38342944|FG001|Overall Study|ongoing|75|||
17190074|NCT01160211|38342945|FG002|Overall Study|ongoing|79|||
17190075|NCT01160211|38342943|FG000|Overall Study|Withdrawal by Subject|3|||
17190076|NCT01160211|38342944|FG001|Overall Study|Withdrawal by Subject|5|||
17190077|NCT01160211|38342945|FG002|Overall Study|Withdrawal by Subject|3|||
17190078|NCT01160211|38342943|FG000|Overall Study|Physician Decision|2|||
17190079|NCT01160211|38342944|FG001|Overall Study|Physician Decision|0|||
17190080|NCT01160211|38342945|FG002|Overall Study|Physician Decision|0|||
17190081|NCT01160211|38342943|FG000|Overall Study|Lost to Follow-up|4|||
17190082|NCT01160211|38342944|FG001|Overall Study|Lost to Follow-up|7|||
17190083|NCT01160211|38342945|FG002|Overall Study|Lost to Follow-up|5|||
17190084|NCT01064687|38342958|FG000|Overall Study|Adverse Event|9|||
17190085|NCT01064687|38342959|FG001|Overall Study|Adverse Event|4|||
17190086|NCT01064687|38342960|FG002|Overall Study|Adverse Event|10|||
17190087|NCT01064687|38342961|FG003|Overall Study|Adverse Event|3|||
17190088|NCT01064687|38342958|FG000|Overall Study|Death|1|||
17190089|NCT01064687|38342959|FG001|Overall Study|Death|1|||
17190090|NCT01064687|38342960|FG002|Overall Study|Death|0|||
17190091|NCT01064687|38342961|FG003|Overall Study|Death|0|||
17190092|NCT01064687|38342958|FG000|Overall Study|Entry Criteria Not Met|3|||
16783198|NCT02552121|37722909|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
17190093|NCT01064687|38342959|FG001|Overall Study|Entry Criteria Not Met|0|||
17190094|NCT01064687|38342960|FG002|Overall Study|Entry Criteria Not Met|0|||
17092864|NCT00280748|38232471|FG000|Overall Study|Decline in performance|3|||
17092865|NCT00280748|38232471|FG000|Overall Study|Extra-cranial disease progression|1|||
17092866|NCT00271856|38232477|FG000|Overall Study|Withdrawal by Subject|1|||
17092867|NCT00271856|38232478|FG001|Overall Study|Withdrawal by Subject|7|||
17092868|NCT00271856|38232477|FG000|Overall Study|Lost to Follow-up|10|||
17092869|NCT00271856|38232478|FG001|Overall Study|Lost to Follow-up|11|||
17092870|NCT00061048|38232484|FG000|Overall Study|Adverse Event|2|||
17190095|NCT01064687|38342961|FG003|Overall Study|Entry Criteria Not Met|0|||
17190096|NCT01064687|38342958|FG000|Overall Study|Lack of Efficacy|1|||
17190097|NCT01064687|38342959|FG001|Overall Study|Lack of Efficacy|0|||
17190098|NCT01064687|38342960|FG002|Overall Study|Lack of Efficacy|2|||
17190099|NCT01064687|38342961|FG003|Overall Study|Lack of Efficacy|3|||
17190100|NCT01064687|38342958|FG000|Overall Study|Lost to Follow-up|7|||
17190101|NCT01064687|38342959|FG001|Overall Study|Lost to Follow-up|10|||
17190102|NCT01064687|38342960|FG002|Overall Study|Lost to Follow-up|13|||
17190103|NCT01064687|38342961|FG003|Overall Study|Lost to Follow-up|5|||
17190104|NCT01064687|38342958|FG000|Overall Study|Physician Decision|2|||
17190105|NCT01064687|38342959|FG001|Overall Study|Physician Decision|2|||
17190106|NCT01064687|38342960|FG002|Overall Study|Physician Decision|0|||
17190107|NCT01064687|38342961|FG003|Overall Study|Physician Decision|0|||
17190108|NCT01064687|38342958|FG000|Overall Study|Protocol Violation|1|||
17190109|NCT01064687|38342959|FG001|Overall Study|Protocol Violation|1|||
17190110|NCT01064687|38342960|FG002|Overall Study|Protocol Violation|0|||
17190111|NCT01064687|38342961|FG003|Overall Study|Protocol Violation|1|||
17190112|NCT01064687|38342958|FG000|Overall Study|Sponsor Decision|0|||
17190113|NCT01064687|38342959|FG001|Overall Study|Sponsor Decision|0|||
17190114|NCT01064687|38342960|FG002|Overall Study|Sponsor Decision|3|||
17190115|NCT01064687|38342961|FG003|Overall Study|Sponsor Decision|0|||
17190116|NCT01064687|38342958|FG000|Overall Study|Withdrawal by Subject|9|||
17190117|NCT01064687|38342959|FG001|Overall Study|Withdrawal by Subject|7|||
17190118|NCT01064687|38342960|FG002|Overall Study|Withdrawal by Subject|12|||
17190119|NCT01064687|38342961|FG003|Overall Study|Withdrawal by Subject|5|||
17190120|NCT01064687|38342958|FG000|Overall Study|Treatment Noncompliance|1|||
17190121|NCT01064687|38342959|FG001|Overall Study|Treatment Noncompliance|1|||
17190122|NCT01064687|38342960|FG002|Overall Study|Treatment Noncompliance|1|||
17190123|NCT01064687|38342961|FG003|Overall Study|Treatment Noncompliance|0|||
17190124|NCT02493946|38342985|FG000|DB Period|Withdrawal by Subject|8|||
17190125|NCT02493946|38342986|FG001|DB Period|Withdrawal by Subject|5|||
17190126|NCT02493946|38342987|FG002|DB Period|Withdrawal by Subject|0|||
17190127|NCT02493946|38342985|FG000|Open Label Period|Withdrawal by Subject|0|||
17190128|NCT02493946|38342986|FG001|Open Label Period|Withdrawal by Subject|0|||
17190129|NCT02493946|38342987|FG002|Open Label Period|Withdrawal by Subject|74|||
17190130|NCT02493946|38342985|FG000|Open Label Period|Adverse Event|0|||
17190131|NCT02493946|38342986|FG001|Open Label Period|Adverse Event|0|||
17190132|NCT02493946|38342987|FG002|Open Label Period|Adverse Event|4|||
17190133|NCT02493946|38342985|FG000|Open Label Period|Lost to Follow-up|0|||
17190134|NCT02493946|38342986|FG001|Open Label Period|Lost to Follow-up|0|||
16783199|NCT02552121|37722910|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
16783200|NCT02552121|37722903|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
16783201|NCT02552121|37722904|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
16783202|NCT02552121|37722905|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
16783203|NCT02552121|37722906|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
16783204|NCT02552121|37722907|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
16783205|NCT02552121|37722908|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
16783206|NCT02552121|37722909|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
16783207|NCT02552121|37722910|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
16783208|NCT02552121|37722903|FG000|Part 2: Cohort Expansion|Death|0|||
16783209|NCT02552121|37722904|FG001|Part 2: Cohort Expansion|Death|0|||
16783210|NCT02552121|37722905|FG002|Part 2: Cohort Expansion|Death|1|||
16783211|NCT02552121|37722906|FG003|Part 2: Cohort Expansion|Death|0|||
16783212|NCT02552121|37722907|FG004|Part 2: Cohort Expansion|Death|0|||
16783213|NCT02552121|37722908|FG005|Part 2: Cohort Expansion|Death|0|||
16783214|NCT02552121|37722909|FG006|Part 2: Cohort Expansion|Death|0|||
16783215|NCT02552121|37722910|FG007|Part 2: Cohort Expansion|Death|0|||
16783216|NCT02552355|37722955|FG000|Overall Study|Adverse Event|0|||
16783217|NCT02552355|37722956|FG001|Overall Study|Adverse Event|2|||
16783218|NCT02552355|37722957|FG002|Overall Study|Adverse Event|2|||
16783219|NCT02552355|37722958|FG003|Overall Study|Adverse Event|0|||
16783220|NCT02552355|37722955|FG000|Overall Study|Withdrawal by Subject|0|||
16783221|NCT02552355|37722956|FG001|Overall Study|Withdrawal by Subject|0|||
16783222|NCT02552355|37722957|FG002|Overall Study|Withdrawal by Subject|0|||
16783223|NCT02552355|37722958|FG003|Overall Study|Withdrawal by Subject|1|||
17190135|NCT02493946|38342987|FG002|Open Label Period|Lost to Follow-up|1|||
17190136|NCT02493946|38342985|FG000|Open Label Period|Investigator decision, non-compliance|0|||
17190137|NCT02493946|38342986|FG001|Open Label Period|Investigator decision, non-compliance|0|||
17190138|NCT02493946|38342987|FG002|Open Label Period|Investigator decision, non-compliance|2|||
17190139|NCT02493946|38342985|FG000|Open Label Period|Investigator decision, non-availability|0|||
17190140|NCT02493946|38342986|FG001|Open Label Period|Investigator decision, non-availability|0|||
17190141|NCT02493946|38342987|FG002|Open Label Period|Investigator decision, non-availability|1|||
17190142|NCT02493946|38342985|FG000|Open Label Period|Pregnancy|0|||
17190143|NCT02493946|38342986|FG001|Open Label Period|Pregnancy|0|||
16783224|NCT02551731|37722968|FG000|Overall Study|Withdrawal by Subject|2|||
16783225|NCT02542605|37722972|FG000|Part B: Challenge Phase|Sponsor decision|1|||
16783226|NCT02542605|37722973|FG001|Part B: Challenge Phase|Sponsor decision|0|||
16783227|NCT02542605|37722974|FG002|Part B: Challenge Phase|Sponsor decision|0|||
17190144|NCT02493946|38342987|FG002|Open Label Period|Pregnancy|3|||
17190145|NCT02493946|38342985|FG000|Open Label Period|Site error|0|||
17190146|NCT02493946|38342986|FG001|Open Label Period|Site error|0|||
17092871|NCT00061048|38232484|FG000|Overall Study|disease progression|20|||
17092872|NCT00270998|38232491|FG000|3 Month Follow-up|Adverse Event|1|||
17092873|NCT00270998|38232492|FG001|3 Month Follow-up|Adverse Event|0|||
17092874|NCT00270998|38232493|FG002|3 Month Follow-up|Adverse Event|0|||
17092875|NCT00270998|38232491|FG000|3 Month Follow-up|Lack of Efficacy|1|||
17092876|NCT00270998|38232492|FG001|3 Month Follow-up|Lack of Efficacy|2|||
17092877|NCT00270998|38232493|FG002|3 Month Follow-up|Lack of Efficacy|1|||
17092878|NCT00270998|38232491|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
17092879|NCT00270998|38232492|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
17092880|NCT00270998|38232493|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
17092881|NCT00270998|38232491|FG000|3 Month Follow-up|Pessary did not fit|12|||
17092882|NCT00270998|38232492|FG001|3 Month Follow-up|Pessary did not fit|0|||
17092883|NCT00270998|38232493|FG002|3 Month Follow-up|Pessary did not fit|0|||
17092884|NCT00270998|38232491|FG000|3 Month Follow-up|Personal/family health|1|||
17092885|NCT00270998|38232492|FG001|3 Month Follow-up|Personal/family health|1|||
17092886|NCT00270998|38232493|FG002|3 Month Follow-up|Personal/family health|0|||
17092887|NCT00270998|38232491|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
17092888|NCT00270998|38232492|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
17092889|NCT00270998|38232493|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
17092890|NCT00270998|38232491|FG000|12 Month Follow-up|Lack of Efficacy|5|||
17092891|NCT00270998|38232492|FG001|12 Month Follow-up|Lack of Efficacy|4|||
17092892|NCT00270998|38232493|FG002|12 Month Follow-up|Lack of Efficacy|3|||
17092893|NCT00270998|38232491|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
17092894|NCT00270998|38232492|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
17092895|NCT00270998|38232493|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
17092896|NCT00270998|38232491|FG000|12 Month Follow-up|Pessary did not fit|1|||
17092897|NCT00270998|38232492|FG001|12 Month Follow-up|Pessary did not fit|0|||
17092898|NCT00270998|38232493|FG002|12 Month Follow-up|Pessary did not fit|0|||
17190147|NCT02493946|38342987|FG002|Open Label Period|Site error|1|||
17190148|NCT01064531|38342997|FG000|Overall Study|Lost to Follow-up|0|||
17190149|NCT01064531|38342998|FG001|Overall Study|Lost to Follow-up|2|||
17190150|NCT01064531|38342997|FG000|Overall Study|Physician Decision|0|||
17190151|NCT01064531|38342998|FG001|Overall Study|Physician Decision|1|||
17190152|NCT01064531|38342997|FG000|Overall Study|Withdrawal by Subject|2|||
17190153|NCT01064531|38342998|FG001|Overall Study|Withdrawal by Subject|2|||
17190154|NCT01064531|38342997|FG000|Overall Study|Revision due to femoral stem loosening|1|||
17190155|NCT01064531|38342998|FG001|Overall Study|Revision due to femoral stem loosening|0|||
17190156|NCT01064531|38342997|FG000|Overall Study|Revision due to dislocation|0|||
17190157|NCT01064531|38342998|FG001|Overall Study|Revision due to dislocation|1|||
17190158|NCT01064531|38342997|FG000|Overall Study|Death|0|||
17190159|NCT01064531|38342998|FG001|Overall Study|Death|1|||
17190160|NCT02220855|38343004|FG000|Overall Study|Adverse Event|8|||
17190161|NCT02220855|38343004|FG000|Overall Study|Disease Progression|5|||
17190162|NCT02220855|38343004|FG000|Overall Study|Withdrawal by Subject|1|||
17190163|NCT02918279|38343010|FG000|Overall Study|Lost to Follow-up|3|||
17190164|NCT02918279|38343011|FG001|Overall Study|Lost to Follow-up|6|||
17190165|NCT02918279|38343010|FG000|Overall Study|Withdrawal by Subject|5|||
17190166|NCT02918279|38343011|FG001|Overall Study|Withdrawal by Subject|15|||
17190167|NCT02918279|38343010|FG000|Overall Study|Withdrawal by parent/guardian|2|||
16783228|NCT02542605|37722972|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
16783229|NCT02542605|37722973|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
16783230|NCT02542605|37722974|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
16783231|NCT02550873|37722985|FG000|Randomized Double Blind|Adverse Event|3|||
16783232|NCT02550873|37722986|FG001|Randomized Double Blind|Adverse Event|1|||
16783233|NCT02550873|37722987|FG002|Randomized Double Blind|Adverse Event|0|||
16783234|NCT02550873|37722985|FG000|Randomized Double Blind|Disease progression|1|||
16783235|NCT02550873|37722986|FG001|Randomized Double Blind|Disease progression|1|||
16783236|NCT02550873|37722987|FG002|Randomized Double Blind|Disease progression|0|||
16783237|NCT02550873|37722985|FG000|Open Label Extension|Study ongoing|0|||
16783238|NCT02550873|37722986|FG001|Open Label Extension|Study ongoing|0|||
16783239|NCT02550873|37722987|FG002|Open Label Extension|Study ongoing|111|||
16783240|NCT02535741|37723009|FG000|Overall Study|Adverse Event|3|||
16783241|NCT02535741|37723009|FG000|Overall Study|Withdrawal by Subject|9|||
16783242|NCT02535741|37723009|FG000|Overall Study|Lost to Follow-up|10|||
16783243|NCT02535741|37723009|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
16783244|NCT02535741|37723009|FG000|Overall Study|Missing data|6|||
16783245|NCT03299049|37723029|FG000|Overall Study|On-going|486|||
16783246|NCT03299049|37723030|FG001|Overall Study|On-going|481|||
17092899|NCT00270998|38232491|FG000|12 Month Follow-up|Personal/family health|0|||
17092900|NCT00270998|38232492|FG001|12 Month Follow-up|Personal/family health|5|||
17092901|NCT00270998|38232493|FG002|12 Month Follow-up|Personal/family health|1|||
17092902|NCT00270998|38232491|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
17190168|NCT02918279|38343011|FG001|Overall Study|Withdrawal by parent/guardian|1|||
17190169|NCT02918279|38343010|FG000|Overall Study|Other|3|||
17190170|NCT02918279|38343011|FG001|Overall Study|Other|1|||
17190171|NCT02956837|38343021|FG000|Overall Study|Serious Adverse Events|0|||
17190172|NCT02956837|38343022|FG001|Overall Study|Serious Adverse Events|1|||
17190173|NCT02956837|38343023|FG002|Overall Study|Serious Adverse Events|0|||
17190174|NCT02956837|38343024|FG003|Overall Study|Serious Adverse Events|0|||
17190175|NCT02956837|38343021|FG000|Overall Study|Withdrawal by Subject|0|||
17190176|NCT02956837|38343022|FG001|Overall Study|Withdrawal by Subject|1|||
17190177|NCT02956837|38343023|FG002|Overall Study|Withdrawal by Subject|0|||
17190178|NCT02956837|38343024|FG003|Overall Study|Withdrawal by Subject|3|||
17190179|NCT02956837|38343021|FG000|Overall Study|Lost to Follow-up|0|||
17190180|NCT02956837|38343022|FG001|Overall Study|Lost to Follow-up|1|||
17190181|NCT02956837|38343023|FG002|Overall Study|Lost to Follow-up|2|||
17190182|NCT02956837|38343024|FG003|Overall Study|Lost to Follow-up|0|||
17190183|NCT01063595|38343037|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
17190184|NCT01063595|38343038|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
17190185|NCT01063595|38343037|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
17190186|NCT01063595|38343038|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
17190187|NCT01063595|38343037|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
17190188|NCT01063595|38343038|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
17190189|NCT01063595|38343037|FG000|First Intervention|Adverse Event|1|||
17190190|NCT01063595|38343038|FG001|First Intervention|Adverse Event|4|||
17190191|NCT01063595|38343037|FG000|First Intervention|Withdrawal by Subject|1|||
17190192|NCT01063595|38343038|FG001|First Intervention|Withdrawal by Subject|0|||
17190193|NCT01063595|38343037|FG000|First Intervention|Reason not Specified|0|||
17190194|NCT01063595|38343038|FG001|First Intervention|Reason not Specified|1|||
17190195|NCT01063283|38343046|FG000|Cycle 1|Adverse Event|2|||
17190196|NCT01063283|38343047|FG001|Cycle 1|Adverse Event|0|||
17190197|NCT01063283|38343048|FG002|Cycle 1|Adverse Event|0|||
17190198|NCT01063283|38343046|FG000|Cycle 1|Technical failure in data collection|1|||
17190199|NCT01063283|38343047|FG001|Cycle 1|Technical failure in data collection|0|||
17190200|NCT01063283|38343048|FG002|Cycle 1|Technical failure in data collection|0|||
17190201|NCT01062971|38343056|FG000|Overall Study|Protocol Violation|1|||
17190202|NCT01062971|38343057|FG001|Overall Study|Protocol Violation|3|||
17190203|NCT01062971|38343056|FG000|Overall Study|Lost to Follow-up|3|||
17190204|NCT01062971|38343057|FG001|Overall Study|Lost to Follow-up|4|||
17190205|NCT01348165|38343070|FG000|Overall Study|Adverse Event|0|||
17190206|NCT01348165|38343071|FG001|Overall Study|Adverse Event|0|||
17190207|NCT01348165|38343072|FG002|Overall Study|Adverse Event|0|||
17190208|NCT01348165|38343073|FG003|Overall Study|Adverse Event|0|||
17190209|NCT01348165|38343074|FG004|Overall Study|Adverse Event|0|||
17190210|NCT01348165|38343075|FG005|Overall Study|Adverse Event|0|||
17190211|NCT01348165|38343076|FG006|Overall Study|Adverse Event|1|||
17190212|NCT02493868|38343096|FG000|Induction Phase: DE Participants|Adverse Event|22|||
17190213|NCT02493868|38343097|FG001|Induction Phase: DE Participants|Adverse Event|0|||
17190214|NCT02493868|38343096|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
17190215|NCT02493868|38343097|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
17190216|NCT02493868|38343096|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
17190217|NCT02493868|38343097|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
17190218|NCT02493868|38343096|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
17190219|NCT02493868|38343097|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
17190220|NCT02493868|38343096|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
17190221|NCT02493868|38343097|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
17190222|NCT02493868|38343096|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
17190223|NCT02493868|38343097|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
17190224|NCT02493868|38343096|FG000|Induction Phase: DE Participants|Other|8|||
17190225|NCT02493868|38343097|FG001|Induction Phase: DE Participants|Other|0|||
17190226|NCT02493868|38343096|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
17092903|NCT00270998|38232492|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
17092904|NCT00270998|38232493|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
17092905|NCT00279812|38232509|FG000|Overall Study|Protocol Violation|1|||
17092906|NCT00279812|38232510|FG001|Overall Study|Protocol Violation|1|||
17092907|NCT00279812|38232511|FG002|Overall Study|Protocol Violation|0|||
17092908|NCT00279812|38232512|FG003|Overall Study|Protocol Violation|0|||
17092909|NCT00279812|38232513|FG004|Overall Study|Protocol Violation|1|||
17092910|NCT00279812|38232514|FG005|Overall Study|Protocol Violation|0|||
17092911|NCT00279812|38232509|FG000|Overall Study|Withdrawal by Subject|0|||
17190227|NCT02493868|38343097|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
17190228|NCT02493868|38343096|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
17190229|NCT02493868|38343097|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
16783247|NCT03299049|37723029|FG000|Overall Study|Withdrawal by Subject|6|||
16783248|NCT03299049|37723030|FG001|Overall Study|Withdrawal by Subject|21|||
17092912|NCT00279812|38232510|FG001|Overall Study|Withdrawal by Subject|4|||
17190230|NCT02493868|38343096|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
17190231|NCT02493868|38343097|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
17190232|NCT02493868|38343096|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
17092913|NCT00279812|38232511|FG002|Overall Study|Withdrawal by Subject|2|||
17092914|NCT00279812|38232512|FG003|Overall Study|Withdrawal by Subject|0|||
17092915|NCT00279812|38232513|FG004|Overall Study|Withdrawal by Subject|0|||
17092916|NCT00279812|38232514|FG005|Overall Study|Withdrawal by Subject|0|||
17092917|NCT00279812|38232509|FG000|Overall Study|Adverse Event|0|||
17092918|NCT00279812|38232510|FG001|Overall Study|Adverse Event|1|||
17190233|NCT02493868|38343097|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
17190234|NCT02493868|38343096|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
17190235|NCT02493868|38343097|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
17190236|NCT02493868|38343096|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
17190237|NCT02493868|38343097|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
17190238|NCT02493868|38343096|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
17190239|NCT02493868|38343097|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
17190240|NCT02493868|38343096|FG000|Optimization Phase: DE+TE Participants|Other|10|||
17190241|NCT02493868|38343097|FG001|Optimization Phase: DE+TE Participants|Other|2|||
17190242|NCT02493868|38343096|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
17190243|NCT02493868|38343097|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
17190244|NCT02493868|38343096|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
17190245|NCT02493868|38343097|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
17190246|NCT02493868|38343096|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
17190247|NCT02493868|38343097|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
17190248|NCT02493868|38343096|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
17190249|NCT02493868|38343097|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
17190250|NCT02493868|38343096|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
17190251|NCT02493868|38343097|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
17190252|NCT02493868|38343096|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
17190253|NCT02493868|38343097|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
17190254|NCT02493868|38343096|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
17190255|NCT02493868|38343097|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
17190256|NCT02493868|38343096|FG000|Follow-up Phase|Lost to Follow-up|1|||
17190257|NCT02493868|38343097|FG001|Follow-up Phase|Lost to Follow-up|0|||
17190258|NCT02493868|38343096|FG000|Follow-up Phase|Withdrawal by Subject|3|||
17190259|NCT02493868|38343097|FG001|Follow-up Phase|Withdrawal by Subject|0|||
17190260|NCT02493868|38343096|FG000|Follow-up Phase|Investigator Decision|5|||
17190261|NCT02493868|38343097|FG001|Follow-up Phase|Investigator Decision|1|||
17190262|NCT02493868|38343096|FG000|Follow-up Phase|Other|2|||
17190263|NCT02493868|38343097|FG001|Follow-up Phase|Other|1|||
17190264|NCT02516410|38343111|FG000|Overall Study|Adverse Event|0|||
17190265|NCT02516410|38343112|FG001|Overall Study|Adverse Event|1|||
17190266|NCT02516410|38343111|FG000|Overall Study|Withdrawal by Subject|0|||
17190267|NCT02516410|38343112|FG001|Overall Study|Withdrawal by Subject|1|||
17190268|NCT02493712|38343122|FG000|Overall Study|Withdrawal by Subject|1|||
17190269|NCT02493712|38343123|FG001|Overall Study|Withdrawal by Subject|0|||
17190270|NCT02493712|38343124|FG002|Overall Study|Withdrawal by Subject|2|||
17190271|NCT02493712|38343122|FG000|Overall Study|Protocol Violation|0|||
17190272|NCT02493712|38343123|FG001|Overall Study|Protocol Violation|0|||
17190273|NCT02493712|38343124|FG002|Overall Study|Protocol Violation|1|||
17190274|NCT02493712|38343122|FG000|Overall Study|Lost to Follow-up|1|||
17190275|NCT02493712|38343123|FG001|Overall Study|Lost to Follow-up|0|||
16783249|NCT03299049|37723029|FG000|Overall Study|Physician Decision|5|||
16783250|NCT03299049|37723030|FG001|Overall Study|Physician Decision|1|||
16783251|NCT03299049|37723029|FG000|Overall Study|Lost to Follow-up|2|||
16783252|NCT03299049|37723030|FG001|Overall Study|Lost to Follow-up|0|||
16783253|NCT03299049|37723029|FG000|Overall Study|Pregnancy|1|||
16783254|NCT03299049|37723030|FG001|Overall Study|Pregnancy|3|||
16783255|NCT03299049|37723029|FG000|Overall Study|Protocol Violation|1|||
16783256|NCT03299049|37723030|FG001|Overall Study|Protocol Violation|1|||
16783257|NCT03299049|37723029|FG000|Overall Study|Lack of Efficacy|9|||
16783258|NCT03299049|37723030|FG001|Overall Study|Lack of Efficacy|3|||
16783259|NCT03299049|37723029|FG000|Overall Study|Adverse Event|12|||
16783260|NCT03299049|37723030|FG001|Overall Study|Adverse Event|13|||
16783261|NCT02550795|37723046|FG000|Overall Study|Physician Decision|0|||
16783262|NCT02550795|37723047|FG001|Overall Study|Physician Decision|1|||
16783263|NCT02550795|37723048|FG002|Overall Study|Physician Decision|0|||
16783264|NCT02541903|37723056|FG000|Overall Study|Death|1|||
17092919|NCT00279812|38232511|FG002|Overall Study|Adverse Event|1|||
17092920|NCT00279812|38232512|FG003|Overall Study|Adverse Event|0|||
17092921|NCT00279812|38232513|FG004|Overall Study|Adverse Event|2|||
17092922|NCT00279812|38232514|FG005|Overall Study|Adverse Event|1|||
17092923|NCT00207714|38232533|FG000|Overall Study|Adverse Event|6|||
16783265|NCT02541669|37723065|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
16783266|NCT02541669|37723066|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
16783267|NCT02541669|37723067|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
16783268|NCT02541669|37723068|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
16783269|NCT02541669|37723069|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
16783270|NCT02549859|37723080|FG000|Long-term 60 Hz DBS|Study Closed|1|||
16783271|NCT02688647|37723090|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
16783272|NCT02688647|37723091|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
16783273|NCT02688647|37723090|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
16783274|NCT02688647|37723091|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
16783275|NCT02688647|37723090|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
16783276|NCT02688647|37723091|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
16783277|NCT02688647|37723090|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
16783278|NCT02688647|37723091|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
16783279|NCT02688647|37723090|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
16783280|NCT02688647|37723091|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
16783281|NCT02688647|37723090|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
16783282|NCT02688647|37723091|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
16783283|NCT02688647|37723090|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
16783284|NCT02688647|37723091|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
16783285|NCT02687711|37723109|FG000|Overall Study|Adverse Event|89|||
16783286|NCT02687711|37723109|FG000|Overall Study|Lack of Efficacy|70|||
16783287|NCT02687711|37723109|FG000|Overall Study|Lost to Follow-up|20|||
16783288|NCT02687711|37723109|FG000|Overall Study|Consent withdrawn|15|||
16783289|NCT02687711|37723109|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
16783290|NCT02687711|37723109|FG000|Overall Study|Too expensive|4|||
16783291|NCT02687711|37723109|FG000|Overall Study|Participant moved abroad|1|||
16783292|NCT02687711|37723109|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
16783293|NCT02687711|37723109|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
16783294|NCT02687711|37723109|FG000|Overall Study|Disliked taste|1|||
16783295|NCT02687711|37723109|FG000|Overall Study|Low mood|1|||
16783296|NCT02687711|37723109|FG000|Overall Study|Side effects|1|||
16783297|NCT02687711|37723109|FG000|Overall Study|Change of Hospital|1|||
16783298|NCT02687711|37723109|FG000|Overall Study|Liver Encephalopathy|1|||
16783299|NCT02687711|37723109|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
16783300|NCT02687711|37723109|FG000|Overall Study|Withdrawn due to intake interruption|1|||
16783301|NCT02687711|37723109|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
16783302|NCT02687711|37723109|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
16783303|NCT02687711|37723109|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
16783304|NCT01662063|37723115|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
16783305|NCT01662063|37723116|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
16783306|NCT01662063|37723117|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
16783307|NCT01662063|37723115|FG000|Overall Study|Lack of Efficacy|1|||
16783308|NCT01662063|37723116|FG001|Overall Study|Lack of Efficacy|6|||
16783309|NCT01662063|37723117|FG002|Overall Study|Lack of Efficacy|0|||
16783310|NCT01662063|37723115|FG000|Overall Study|Lost to Follow-up|0|||
16783311|NCT01662063|37723116|FG001|Overall Study|Lost to Follow-up|4|||
16783312|NCT01662063|37723117|FG002|Overall Study|Lost to Follow-up|0|||
16783313|NCT01662063|37723115|FG000|Overall Study|Protocol Violation|1|||
16783314|NCT01662063|37723116|FG001|Overall Study|Protocol Violation|0|||
16783315|NCT01662063|37723117|FG002|Overall Study|Protocol Violation|0|||
16783316|NCT01662063|37723115|FG000|Overall Study|Withdrawal by Subject|2|||
16783317|NCT01662063|37723116|FG001|Overall Study|Withdrawal by Subject|4|||
16783318|NCT01662063|37723117|FG002|Overall Study|Withdrawal by Subject|1|||
16783319|NCT01662063|37723115|FG000|Overall Study|Physician Decision|0|||
16783320|NCT01662063|37723116|FG001|Overall Study|Physician Decision|2|||
16783321|NCT01662063|37723117|FG002|Overall Study|Physician Decision|0|||
16783322|NCT01662063|37723115|FG000|Overall Study|Other|0|||
16783323|NCT01662063|37723116|FG001|Overall Study|Other|1|||
16783324|NCT01662063|37723117|FG002|Overall Study|Other|0|||
16783325|NCT02548455|37723125|FG000|Overall Study|Withdrawal by Subject|27|||
16783326|NCT02548455|37723125|FG000|Overall Study|Death|26|||
16783327|NCT02548455|37723125|FG000|Overall Study|Lost to Follow-up|14|||
16783328|NCT02548455|37723125|FG000|Overall Study|Visit not completed|173|||
16783329|NCT02691455|37723131|FG000|Overall Study|Withdrawal by Subject|1|||
16783330|NCT02691455|37723132|FG001|Overall Study|Withdrawal by Subject|2|||
16783331|NCT02691455|37723131|FG000|Overall Study|Lost to Follow-up|15|||
16783332|NCT02691455|37723132|FG001|Overall Study|Lost to Follow-up|15|||
16783333|NCT02534883|37723140|FG000|Overall Study|Early Termination|8|||
16783334|NCT02534883|37723141|FG001|Overall Study|Early Termination|3|||
16783335|NCT02685995|37723149|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
16999301|NCT04617275|38143173|FG004|Follow-up Period|Lost to Follow-up|0|||
16999302|NCT04617275|38143174|FG005|Follow-up Period|Lost to Follow-up|4|||
16999303|NCT04617275|38143175|FG006|Follow-up Period|Lost to Follow-up|0|||
16999304|NCT04617275|38143176|FG007|Follow-up Period|Lost to Follow-up|3|||
16999305|NCT04617275|38143169|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
16999306|NCT04617275|38143170|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
16999307|NCT04617275|38143171|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
16999308|NCT04617275|38143172|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
16999309|NCT04617275|38143173|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
16999310|NCT04617275|38143174|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
16999311|NCT04617275|38143175|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
16999312|NCT04617275|38143176|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
16999313|NCT04617275|38143169|FG000|Follow-up Period|Other|0|||
16999314|NCT04617275|38143170|FG001|Follow-up Period|Other|1|||
16999315|NCT04617275|38143171|FG002|Follow-up Period|Other|0|||
16999316|NCT04617275|38143172|FG003|Follow-up Period|Other|0|||
16999317|NCT04617275|38143173|FG004|Follow-up Period|Other|0|||
16999318|NCT04617275|38143174|FG005|Follow-up Period|Other|0|||
16999319|NCT04617275|38143175|FG006|Follow-up Period|Other|0|||
16999320|NCT04617275|38143176|FG007|Follow-up Period|Other|0|||
16999321|NCT04617275|38143169|FG000|Follow-up Period|Withdrawal by Subject|2|||
16999322|NCT04617275|38143170|FG001|Follow-up Period|Withdrawal by Subject|0|||
16999323|NCT04617275|38143171|FG002|Follow-up Period|Withdrawal by Subject|0|||
16999324|NCT04617275|38143172|FG003|Follow-up Period|Withdrawal by Subject|2|||
16999325|NCT04617275|38143173|FG004|Follow-up Period|Withdrawal by Subject|2|||
16999326|NCT04617275|38143174|FG005|Follow-up Period|Withdrawal by Subject|0|||
16999327|NCT04617275|38143175|FG006|Follow-up Period|Withdrawal by Subject|1|||
16999328|NCT04617275|38143176|FG007|Follow-up Period|Withdrawal by Subject|2|||
16999329|NCT01031537|38143211|FG000|Overall Study|medical reasons not related to study|3|||
16999330|NCT01031537|38143211|FG000|Overall Study|Lack of Efficacy|1|||
16999331|NCT01031537|38143211|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
16999332|NCT01031537|38143211|FG000|Overall Study|moved, met exclusion criteria|10|||
16999333|NCT01031537|38143211|FG000|Overall Study|Withdrawal by Subject|5|||
16999334|NCT01031537|38143211|FG000|Overall Study|PI removal, no longer met eligibility|12|||
16999335|NCT01031381|38143215|FG000|Overall Study|Physician Decision|3|||
16999336|NCT01031381|38143215|FG000|Overall Study|Withdrawal by Subject|6|||
16999337|NCT00685399|38143227|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16999338|NCT00685399|38143228|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16999339|NCT00685399|38143229|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16999340|NCT00685399|38143230|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16999341|NCT00685399|38143231|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16999342|NCT00685399|38143232|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16999343|NCT00685399|38143233|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16999344|NCT00685399|38143234|FG007|Treatment Period 1|Withdrawal by Subject|0|||
17190276|NCT02493712|38343124|FG002|Overall Study|Lost to Follow-up|0|||
17092924|NCT00207714|38232534|FG001|Overall Study|Adverse Event|2|||
17092925|NCT00207714|38232535|FG002|Overall Study|Adverse Event|4|||
17092926|NCT00207714|38232536|FG003|Overall Study|Adverse Event|3|||
17092927|NCT00207714|38232537|FG004|Overall Study|Adverse Event|1|||
17092928|NCT00207714|38232533|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
17092929|NCT00207714|38232534|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
17092930|NCT00207714|38232535|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
17092931|NCT00207714|38232536|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
16999345|NCT00685399|38143227|FG000|Treatment Period 1|Protocol Violation|1|||
16999346|NCT00685399|38143228|FG001|Treatment Period 1|Protocol Violation|0|||
16999347|NCT00685399|38143229|FG002|Treatment Period 1|Protocol Violation|0|||
16999348|NCT00685399|38143230|FG003|Treatment Period 1|Protocol Violation|0|||
16999349|NCT00685399|38143231|FG004|Treatment Period 1|Protocol Violation|0|||
17092932|NCT00207714|38232537|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
17092933|NCT00207714|38232533|FG000|Overall Study|Other|3|||
17092934|NCT00207714|38232534|FG001|Overall Study|Other|2|||
17092935|NCT00207714|38232535|FG002|Overall Study|Other|5|||
17092936|NCT00207714|38232536|FG003|Overall Study|Other|1|||
17092937|NCT00207714|38232537|FG004|Overall Study|Other|0|||
17092938|NCT00207090|38232556|FG000|Overall Study|Study drug toxicity|3|||
17092939|NCT00207090|38232556|FG000|Overall Study|Chest wall mass larger|1|||
17092940|NCT00207090|38232556|FG000|Overall Study|Disease progression/relapse|2|||
17092941|NCT00207090|38232556|FG000|Overall Study|Physician Decision|1|||
17092942|NCT00059332|38232567|FG000|Overall Study|Withdrawal by Subject|2|||
17190277|NCT02493712|38343122|FG000|Overall Study|Physician Decision|0|||
17190278|NCT02493712|38343123|FG001|Overall Study|Physician Decision|1|||
17190279|NCT02493712|38343124|FG002|Overall Study|Physician Decision|0|||
16999350|NCT00685399|38143232|FG005|Treatment Period 1|Protocol Violation|0|||
16999351|NCT00685399|38143233|FG006|Treatment Period 1|Protocol Violation|0|||
17092943|NCT00059332|38232568|FG001|Overall Study|Withdrawal by Subject|1|||
17190280|NCT02493712|38343122|FG000|Overall Study|Lack of Efficacy|0|||
17190281|NCT02493712|38343123|FG001|Overall Study|Lack of Efficacy|5|||
17190282|NCT02493712|38343124|FG002|Overall Study|Lack of Efficacy|3|||
17092944|NCT00059332|38232567|FG000|Overall Study|Lost to Follow-up|1|||
17092945|NCT00059332|38232568|FG001|Overall Study|Lost to Follow-up|1|||
16999352|NCT00685399|38143234|FG007|Treatment Period 1|Protocol Violation|0|||
16999353|NCT00685399|38143227|FG000|Treatment Period 1|Administrative|2|||
16999354|NCT00685399|38143228|FG001|Treatment Period 1|Administrative|0|||
16999355|NCT00685399|38143229|FG002|Treatment Period 1|Administrative|0|||
16999356|NCT00685399|38143230|FG003|Treatment Period 1|Administrative|0|||
16999357|NCT00685399|38143231|FG004|Treatment Period 1|Administrative|0|||
16999358|NCT00685399|38143232|FG005|Treatment Period 1|Administrative|0|||
16999359|NCT00685399|38143233|FG006|Treatment Period 1|Administrative|0|||
16999360|NCT00685399|38143234|FG007|Treatment Period 1|Administrative|0|||
16999361|NCT00685399|38143227|FG000|Treatment Period 1|Lack of Efficacy|1|||
16999362|NCT00685399|38143228|FG001|Treatment Period 1|Lack of Efficacy|0|||
16999363|NCT00685399|38143229|FG002|Treatment Period 1|Lack of Efficacy|0|||
16999364|NCT00685399|38143230|FG003|Treatment Period 1|Lack of Efficacy|0|||
16999365|NCT00685399|38143231|FG004|Treatment Period 1|Lack of Efficacy|0|||
16999366|NCT00685399|38143232|FG005|Treatment Period 1|Lack of Efficacy|0|||
16999367|NCT00685399|38143233|FG006|Treatment Period 1|Lack of Efficacy|0|||
16999368|NCT00685399|38143234|FG007|Treatment Period 1|Lack of Efficacy|0|||
16999369|NCT00685399|38143227|FG000|Treatment Period 2|Administrative Problems|0|||
16999370|NCT00685399|38143228|FG001|Treatment Period 2|Administrative Problems|2|||
16999371|NCT00685399|38143229|FG002|Treatment Period 2|Administrative Problems|1|||
16999372|NCT00685399|38143230|FG003|Treatment Period 2|Administrative Problems|0|||
16999373|NCT00685399|38143231|FG004|Treatment Period 2|Administrative Problems|0|||
16999374|NCT00685399|38143232|FG005|Treatment Period 2|Administrative Problems|0|||
16999375|NCT00685399|38143233|FG006|Treatment Period 2|Administrative Problems|0|||
16999376|NCT00685399|38143234|FG007|Treatment Period 2|Administrative Problems|0|||
16999377|NCT00685399|38143227|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16999378|NCT00685399|38143228|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16999379|NCT00685399|38143229|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16999380|NCT00685399|38143230|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16999381|NCT00685399|38143231|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16999382|NCT00685399|38143232|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16999383|NCT00685399|38143233|FG006|Treatment Period 2|Withdrawal by Subject|0|||
17092946|NCT00233454|38232574|FG000|Overall Study|Death|6|||
17092947|NCT00047320|38232578|FG000|Overall Study|Lack of Efficacy|8|||
17092948|NCT00047320|38232578|FG000|Overall Study|Lost to Follow-up|1|||
17092949|NCT00047320|38232578|FG000|Overall Study|Physician Decision|8|||
17092950|NCT00047320|38232578|FG000|Overall Study|Withdrawal by Subject|9|||
17092951|NCT00047320|38232578|FG000|Overall Study|Ineligible|2|||
17092952|NCT00233064|38232584|FG000|Overall Study|Lost to Follow-up|7|||
17092953|NCT00233064|38232585|FG001|Overall Study|Lost to Follow-up|7|||
17092954|NCT00233064|38232584|FG000|Overall Study|Withdrawal by Subject|5|||
17092955|NCT00233064|38232585|FG001|Overall Study|Withdrawal by Subject|3|||
17092956|NCT00233064|38232584|FG000|Overall Study|Death|0|||
17092957|NCT00233064|38232585|FG001|Overall Study|Death|1|||
17092958|NCT00233064|38232584|FG000|Overall Study|Relocation|0|||
17092959|NCT00233064|38232585|FG001|Overall Study|Relocation|1|||
17092960|NCT00233064|38232584|FG000|Overall Study|Protocol Violation|1|||
17092961|NCT00233064|38232585|FG001|Overall Study|Protocol Violation|0|||
17092962|NCT00233064|38232584|FG000|Overall Study|Moved to Dom. Republic|1|||
17092963|NCT00233064|38232585|FG001|Overall Study|Moved to Dom. Republic|0|||
17092964|NCT00268892|38232595|FG000|Overall Study|Adverse Event|14|||
17092965|NCT00268892|38232596|FG001|Overall Study|Adverse Event|17|||
17092966|NCT00268892|38232597|FG002|Overall Study|Adverse Event|20|||
17092967|NCT00268892|38232595|FG000|Overall Study|Lack of Efficacy|1|||
17092968|NCT00268892|38232596|FG001|Overall Study|Lack of Efficacy|3|||
17092969|NCT00268892|38232597|FG002|Overall Study|Lack of Efficacy|0|||
17092970|NCT00268892|38232595|FG000|Overall Study|Withdrawal by Subject|14|||
17092971|NCT00268892|38232596|FG001|Overall Study|Withdrawal by Subject|15|||
17092972|NCT00268892|38232597|FG002|Overall Study|Withdrawal by Subject|13|||
17092973|NCT00268892|38232595|FG000|Overall Study|Physician Decision|0|||
17092974|NCT00268892|38232596|FG001|Overall Study|Physician Decision|1|||
17092975|NCT00268892|38232597|FG002|Overall Study|Physician Decision|0|||
16999384|NCT00685399|38143234|FG007|Treatment Period 2|Withdrawal by Subject|2|||
16999385|NCT00685399|38143227|FG000|Treatment Period 2|Adverse Event|0|||
16999386|NCT00685399|38143228|FG001|Treatment Period 2|Adverse Event|0|||
16999387|NCT00685399|38143229|FG002|Treatment Period 2|Adverse Event|0|||
16999388|NCT00685399|38143230|FG003|Treatment Period 2|Adverse Event|0|||
16999389|NCT00685399|38143231|FG004|Treatment Period 2|Adverse Event|0|||
16999390|NCT00685399|38143232|FG005|Treatment Period 2|Adverse Event|1|||
16999391|NCT00685399|38143233|FG006|Treatment Period 2|Adverse Event|0|||
16999392|NCT00685399|38143234|FG007|Treatment Period 2|Adverse Event|0|||
17092976|NCT00268892|38232595|FG000|Overall Study|Lost to Follow-up|5|||
17190283|NCT02516332|38343135|FG000|Overall Study|Withdrawal by Subject|2|||
16999393|NCT00685399|38143227|FG000|Treatment Period 2|Lack of Efficacy|0|||
16999394|NCT00685399|38143228|FG001|Treatment Period 2|Lack of Efficacy|10|||
16999395|NCT00685399|38143229|FG002|Treatment Period 2|Lack of Efficacy|2|||
16999396|NCT00685399|38143230|FG003|Treatment Period 2|Lack of Efficacy|0|||
16999397|NCT00685399|38143231|FG004|Treatment Period 2|Lack of Efficacy|0|||
17190284|NCT02516332|38343136|FG001|Overall Study|Withdrawal by Subject|1|||
17190285|NCT02516332|38343137|FG002|Overall Study|Withdrawal by Subject|2|||
17190286|NCT02483572|38343147|FG000|Overall Study|Withdrawal by Subject|1|||
17190287|NCT02483572|38343148|FG001|Overall Study|Withdrawal by Subject|0|||
17190288|NCT02483572|38343147|FG000|Overall Study|Lost to Follow-up|1|||
17190289|NCT02483572|38343148|FG001|Overall Study|Lost to Follow-up|0|||
17190290|NCT02483572|38343147|FG000|Overall Study|Physician Decision|0|||
17190291|NCT02483572|38343148|FG001|Overall Study|Physician Decision|1|||
17190292|NCT01062425|38343156|FG000|Overall Study|Protocol Violation|3|||
17190293|NCT01062425|38343157|FG001|Overall Study|Protocol Violation|6|||
17190294|NCT01060553|38343163|FG000|Overall Study|Lost to Follow-up|3|||
17190295|NCT01060553|38343164|FG001|Overall Study|Lost to Follow-up|5|||
17190296|NCT01060553|38343163|FG000|Overall Study|Withdrawal by Subject|5|||
17190297|NCT01060553|38343164|FG001|Overall Study|Withdrawal by Subject|5|||
17190298|NCT01060553|38343163|FG000|Overall Study|Lack of Efficacy|1|||
17190299|NCT01060553|38343164|FG001|Overall Study|Lack of Efficacy|0|||
17190300|NCT02491684|38343171|FG000|Treatment Phase|Adverse Event|2|||
17190301|NCT02491684|38343172|FG001|Treatment Phase|Adverse Event|2|||
17190302|NCT02491684|38343171|FG000|Treatment Phase|Incorrect randomisation|1|||
17190303|NCT02491684|38343172|FG001|Treatment Phase|Incorrect randomisation|0|||
17190304|NCT02491684|38343171|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
17190305|NCT02491684|38343172|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
17190306|NCT01061723|38343184|FG000|Overall Study|Adverse Event|0|||
17190307|NCT01061723|38343185|FG001|Overall Study|Adverse Event|2|||
17190308|NCT01061723|38343186|FG002|Overall Study|Adverse Event|5|||
17190309|NCT01061723|38343187|FG003|Overall Study|Adverse Event|5|||
17190310|NCT01061723|38343188|FG004|Overall Study|Adverse Event|2|||
17190311|NCT01061723|38343189|FG005|Overall Study|Adverse Event|6|||
17190312|NCT01061723|38343184|FG000|Overall Study|Lack of Efficacy|2|||
17190313|NCT01061723|38343185|FG001|Overall Study|Lack of Efficacy|3|||
17190314|NCT01061723|38343186|FG002|Overall Study|Lack of Efficacy|4|||
16783336|NCT02685995|37723150|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
16783337|NCT02548143|37723158|FG000|Overall Study|Adverse Event|1|||
16783338|NCT02548143|37723159|FG001|Overall Study|Adverse Event|0|||
16783339|NCT02548143|37723158|FG000|Overall Study|Withdrawal by Subject|0|||
16783340|NCT02548143|37723159|FG001|Overall Study|Withdrawal by Subject|1|||
16783341|NCT02547987|37723165|FG000|Overall Study|Withdrawal by Subject|1|||
16783342|NCT02547987|37723165|FG000|Overall Study|Adverse Event|2|||
16783343|NCT02547441|37723171|FG000|Double-Blind Study Period|Adverse Event|4|||
16783344|NCT02547441|37723172|FG001|Double-Blind Study Period|Adverse Event|9|||
16783345|NCT02547441|37723171|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
16783346|NCT02547441|37723172|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
16783347|NCT02547441|37723171|FG000|Double-Blind Study Period|Physician Decision|1|||
16783348|NCT02547441|37723172|FG001|Double-Blind Study Period|Physician Decision|0|||
16783349|NCT02547441|37723171|FG000|Double-Blind Study Period|Protocol Violation|1|||
16783350|NCT02547441|37723172|FG001|Double-Blind Study Period|Protocol Violation|2|||
16783351|NCT02547441|37723171|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
16783352|NCT02547441|37723172|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
16783353|NCT02547441|37723171|FG000|Double-Blind Study Period|Sponsor Decision|1|||
16783354|NCT02547441|37723172|FG001|Double-Blind Study Period|Sponsor Decision|0|||
16783355|NCT02547441|37723171|FG000|Open-Label Study Period|Adverse Event|10|||
16783356|NCT02547441|37723172|FG001|Open-Label Study Period|Adverse Event|11|||
16783357|NCT02547441|37723171|FG000|Open-Label Study Period|Lack of Efficacy|3|||
16783358|NCT02547441|37723172|FG001|Open-Label Study Period|Lack of Efficacy|2|||
16783359|NCT02547441|37723171|FG000|Open-Label Study Period|Lost to Follow-up|7|||
16783360|NCT02547441|37723172|FG001|Open-Label Study Period|Lost to Follow-up|8|||
16783361|NCT02547441|37723171|FG000|Open-Label Study Period|Physician Decision|1|||
16783362|NCT02547441|37723172|FG001|Open-Label Study Period|Physician Decision|0|||
16783363|NCT02547441|37723171|FG000|Open-Label Study Period|Protocol Violation|2|||
16783364|NCT02547441|37723172|FG001|Open-Label Study Period|Protocol Violation|0|||
16783365|NCT02547441|37723171|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
16783366|NCT02547441|37723172|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
16783367|NCT02547441|37723171|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
16783368|NCT02547441|37723172|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
16783369|NCT02540265|37723182|FG000|Overall Study|Lost to Follow-up|0|||
16783370|NCT02540265|37723183|FG001|Overall Study|Lost to Follow-up|0|||
16783371|NCT02540265|37723184|FG002|Overall Study|Lost to Follow-up|1|||
16783372|NCT02547363|37723194|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
17190315|NCT01061723|38343187|FG003|Overall Study|Lack of Efficacy|2|||
17190316|NCT01061723|38343188|FG004|Overall Study|Lack of Efficacy|1|||
17190317|NCT01061723|38343189|FG005|Overall Study|Lack of Efficacy|1|||
17190318|NCT01061723|38343184|FG000|Overall Study|Randomized but not treated|0|||
17190319|NCT01061723|38343185|FG001|Overall Study|Randomized but not treated|0|||
17190320|NCT01061723|38343186|FG002|Overall Study|Randomized but not treated|0|||
17190321|NCT01061723|38343187|FG003|Overall Study|Randomized but not treated|0|||
17190322|NCT01061723|38343188|FG004|Overall Study|Randomized but not treated|0|||
17190323|NCT01061723|38343189|FG005|Overall Study|Randomized but not treated|1|||
17190324|NCT01061723|38343184|FG000|Overall Study|Other than specified above|2|||
17190325|NCT01061723|38343185|FG001|Overall Study|Other than specified above|1|||
17190326|NCT01061723|38343186|FG002|Overall Study|Other than specified above|1|||
17190327|NCT01061723|38343187|FG003|Overall Study|Other than specified above|1|||
17190328|NCT01061723|38343188|FG004|Overall Study|Other than specified above|0|||
17190329|NCT01061723|38343189|FG005|Overall Study|Other than specified above|1|||
17190330|NCT01061567|38343208|FG000|Overall Study|Adverse Event|32|||
17190331|NCT01061567|38343208|FG000|Overall Study|Death|2|||
17190332|NCT01061567|38343208|FG000|Overall Study|Lack of Efficacy|3|||
17190333|NCT01061567|38343208|FG000|Overall Study|Lost to Follow-up|24|||
17190334|NCT01061567|38343208|FG000|Overall Study|Protocol Violation|1|||
17190335|NCT01061567|38343208|FG000|Overall Study|Withdrawal by Subject|11|||
17190336|NCT01061567|38343208|FG000|Overall Study|Other reason than stated above|3|||
17190337|NCT01061333|38343212|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
16999398|NCT00685399|38143232|FG005|Treatment Period 2|Lack of Efficacy|1|||
16999399|NCT00685399|38143233|FG006|Treatment Period 2|Lack of Efficacy|0|||
16999400|NCT00685399|38143234|FG007|Treatment Period 2|Lack of Efficacy|0|||
16999401|NCT00685399|38143227|FG000|Extension|Administrative Issues|0|||
16999402|NCT00685399|38143228|FG001|Extension|Administrative Issues|0|||
16999403|NCT00685399|38143229|FG002|Extension|Administrative Issues|0|||
16999404|NCT00685399|38143230|FG003|Extension|Administrative Issues|1|||
17190338|NCT01061333|38343213|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
17190339|NCT02489968|38343226|FG000|Open-label Treatment Period|Adverse Event|14|||
17190340|NCT02489968|38343227|FG001|Open-label Treatment Period|Adverse Event|7|||
17190341|NCT02489968|38343228|FG002|Open-label Treatment Period|Adverse Event|0|||
17190342|NCT02489968|38343229|FG003|Open-label Treatment Period|Adverse Event|0|||
17092977|NCT00268892|38232596|FG001|Overall Study|Lost to Follow-up|2|||
17092978|NCT00268892|38232597|FG002|Overall Study|Lost to Follow-up|4|||
17092979|NCT00268892|38232595|FG000|Overall Study|Protocol Violation|0|||
17092980|NCT00268892|38232596|FG001|Overall Study|Protocol Violation|1|||
17092981|NCT00268892|38232597|FG002|Overall Study|Protocol Violation|0|||
17092982|NCT00268892|38232595|FG000|Overall Study|Disease Progression|1|||
17092983|NCT00268892|38232596|FG001|Overall Study|Disease Progression|1|||
17092984|NCT00268892|38232597|FG002|Overall Study|Disease Progression|0|||
17092985|NCT00268892|38232595|FG000|Overall Study|Trial Site Closed|4|||
17092986|NCT00268892|38232596|FG001|Overall Study|Trial Site Closed|2|||
17092987|NCT00268892|38232597|FG002|Overall Study|Trial Site Closed|2|||
17092988|NCT00206076|38232607|FG000|Overall Study|Physician Decision|2|||
17190343|NCT02489968|38343230|FG004|Open-label Treatment Period|Adverse Event|0|||
17190344|NCT02489968|38343231|FG005|Open-label Treatment Period|Adverse Event|0|||
17190345|NCT02489968|38343226|FG000|Open-label Treatment Period|Protocol Violation|2|||
17190346|NCT02489968|38343227|FG001|Open-label Treatment Period|Protocol Violation|2|||
17190347|NCT02489968|38343228|FG002|Open-label Treatment Period|Protocol Violation|0|||
17190348|NCT02489968|38343229|FG003|Open-label Treatment Period|Protocol Violation|0|||
17190349|NCT02489968|38343230|FG004|Open-label Treatment Period|Protocol Violation|0|||
17190350|NCT02489968|38343231|FG005|Open-label Treatment Period|Protocol Violation|0|||
17092989|NCT00206076|38232608|FG001|Overall Study|Physician Decision|0|||
17092990|NCT00206076|38232607|FG000|Overall Study|Withdrawal by Subject|1|||
17092991|NCT00206076|38232608|FG001|Overall Study|Withdrawal by Subject|1|||
17092992|NCT00278954|38232616|FG000|Overall Study|Adverse Event|3|||
17092993|NCT00278954|38232616|FG000|Overall Study|Lost to Follow-up|1|||
17092994|NCT00278954|38232616|FG000|Overall Study|Withdrawal by Subject|1|||
17092995|NCT00278564|38232620|FG000|Overall Study|Lack of Efficacy|4|||
17092996|NCT00268346|38232626|FG000|Overall Study|Adverse Event|0|||
17092997|NCT00268346|38232627|FG001|Overall Study|Adverse Event|1|||
17190351|NCT02489968|38343226|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
16999405|NCT00685399|38143231|FG004|Extension|Administrative Issues|0|||
16999406|NCT00685399|38143232|FG005|Extension|Administrative Issues|0|||
16999407|NCT00685399|38143233|FG006|Extension|Administrative Issues|0|||
16999408|NCT00685399|38143234|FG007|Extension|Administrative Issues|0|||
16999409|NCT00685399|38143227|FG000|Extension|Withdrawal by Subject|0|||
16999410|NCT00685399|38143228|FG001|Extension|Withdrawal by Subject|0|||
16999411|NCT00685399|38143229|FG002|Extension|Withdrawal by Subject|0|||
16999412|NCT00685399|38143230|FG003|Extension|Withdrawal by Subject|1|||
16999413|NCT00685399|38143231|FG004|Extension|Withdrawal by Subject|0|||
16999414|NCT00685399|38143232|FG005|Extension|Withdrawal by Subject|0|||
16999415|NCT00685399|38143233|FG006|Extension|Withdrawal by Subject|0|||
16999416|NCT00685399|38143234|FG007|Extension|Withdrawal by Subject|0|||
16999417|NCT00685399|38143227|FG000|Extension|Protocol Violation|0|||
16999418|NCT00685399|38143228|FG001|Extension|Protocol Violation|0|||
17092998|NCT00268346|38232626|FG000|Overall Study|Death|0|||
17092999|NCT00268346|38232627|FG001|Overall Study|Death|1|||
17093000|NCT00268346|38232626|FG000|Overall Study|Withdrawal by Subject|0|||
17093001|NCT00268346|38232627|FG001|Overall Study|Withdrawal by Subject|1|||
17093002|NCT00203892|38232636|FG000|Overall Study|Physician Decision|1|||
17093003|NCT00203892|38232637|FG001|Overall Study|Physician Decision|2|||
17093004|NCT00203892|38232638|FG002|Overall Study|Physician Decision|0|||
17093005|NCT00203892|38232636|FG000|Overall Study|Death|1|||
17093006|NCT00203892|38232637|FG001|Overall Study|Death|0|||
17093007|NCT00203892|38232638|FG002|Overall Study|Death|0|||
17093008|NCT00250718|38232646|FG000|Overall Study|Death|1|||
17093009|NCT00250718|38232646|FG000|Overall Study|Adverse Event|1|||
17093010|NCT00250718|38232646|FG000|Overall Study|Withdrawal by Subject|1|||
17093011|NCT00276614|38232650|FG000|Overall Study|Progression of disease under study|3|||
17093012|NCT00276458|38232656|FG000|Overall Study|Adverse Event|0|||
17093013|NCT00276458|38232657|FG001|Overall Study|Adverse Event|2|||
17093014|NCT00276458|38232656|FG000|Overall Study|Lost to Follow-up|2|||
17093015|NCT00276458|38232657|FG001|Overall Study|Lost to Follow-up|2|||
17093016|NCT00276458|38232656|FG000|Overall Study|Protocol Violation|4|||
17093017|NCT00276458|38232657|FG001|Overall Study|Protocol Violation|3|||
17093018|NCT00276380|38232665|FG000|Overall Study|Adverse Event|5|||
17093019|NCT00276380|38232666|FG001|Overall Study|Adverse Event|3|||
17093020|NCT00276380|38232665|FG000|Overall Study|Lost to Follow-up|1|||
17093021|NCT00276380|38232666|FG001|Overall Study|Lost to Follow-up|1|||
17093022|NCT00276380|38232665|FG000|Overall Study|Withdrawal by Subject|3|||
17093023|NCT00276380|38232666|FG001|Overall Study|Withdrawal by Subject|6|||
17093024|NCT00276380|38232665|FG000|Overall Study|Death|5|||
17093025|NCT00276380|38232666|FG001|Overall Study|Death|3|||
17093026|NCT00276380|38232665|FG000|Overall Study|Abnormal aPPT Levels|0|||
17093027|NCT00276380|38232666|FG001|Overall Study|Abnormal aPPT Levels|1|||
17093028|NCT00267956|38232675|FG000|Controlled Period|Adverse Event|4|||
17093029|NCT00267956|38232676|FG001|Controlled Period|Adverse Event|1|||
17093030|NCT00267956|38232677|FG002|Controlled Period|Adverse Event|0|||
17093031|NCT00267956|38232678|FG003|Controlled Period|Adverse Event|0|||
17093032|NCT00267956|38232675|FG000|Controlled Period|Lack of Efficacy|4|||
17093033|NCT00267956|38232676|FG001|Controlled Period|Lack of Efficacy|2|||
17093034|NCT00267956|38232677|FG002|Controlled Period|Lack of Efficacy|0|||
17093035|NCT00267956|38232678|FG003|Controlled Period|Lack of Efficacy|0|||
17093036|NCT00267956|38232675|FG000|Controlled Period|Lost to Follow-up|2|||
17093037|NCT00267956|38232676|FG001|Controlled Period|Lost to Follow-up|0|||
17093038|NCT00267956|38232677|FG002|Controlled Period|Lost to Follow-up|0|||
17093039|NCT00267956|38232678|FG003|Controlled Period|Lost to Follow-up|0|||
17093040|NCT00267956|38232675|FG000|Controlled Period|Withdrew consent|3|||
17093041|NCT00267956|38232676|FG001|Controlled Period|Withdrew consent|1|||
17093042|NCT00267956|38232677|FG002|Controlled Period|Withdrew consent|0|||
17093043|NCT00267956|38232678|FG003|Controlled Period|Withdrew consent|0|||
17093044|NCT00267956|38232675|FG000|After Controlled Period|Adverse Event|0|||
17093045|NCT00267956|38232676|FG001|After Controlled Period|Adverse Event|0|||
17093046|NCT00267956|38232677|FG002|After Controlled Period|Adverse Event|2|||
17093047|NCT00267956|38232678|FG003|After Controlled Period|Adverse Event|1|||
17093048|NCT00267956|38232675|FG000|After Controlled Period|Lack of Efficacy|0|||
17093049|NCT00267956|38232676|FG001|After Controlled Period|Lack of Efficacy|0|||
17093050|NCT00267956|38232677|FG002|After Controlled Period|Lack of Efficacy|1|||
17093051|NCT00267956|38232678|FG003|After Controlled Period|Lack of Efficacy|1|||
17093052|NCT00267956|38232675|FG000|After Controlled Period|Lost to Follow-up|0|||
17093053|NCT00267956|38232676|FG001|After Controlled Period|Lost to Follow-up|0|||
17093054|NCT00267956|38232677|FG002|After Controlled Period|Lost to Follow-up|1|||
17093055|NCT00267956|38232678|FG003|After Controlled Period|Lost to Follow-up|0|||
17093056|NCT00267956|38232675|FG000|After Controlled Period|Withdrew consent|0|||
17093057|NCT00267956|38232676|FG001|After Controlled Period|Withdrew consent|0|||
17093058|NCT00267956|38232677|FG002|After Controlled Period|Withdrew consent|1|||
17093059|NCT00267956|38232678|FG003|After Controlled Period|Withdrew consent|0|||
17093060|NCT00267488|38232686|FG000|Overall Study|Sponsor Terminated Study|9|||
17093061|NCT00267488|38232686|FG000|Overall Study|Protocol Violation|1|||
17093062|NCT00267488|38232686|FG000|Overall Study|Other (Disease Progression)|1|||
17093063|NCT00046930|38232692|FG000|Overall Study|Ineligible|12|||
17093064|NCT00046930|38232693|FG001|Overall Study|Ineligible|4|||
17190352|NCT02489968|38343227|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
17093065|NCT00058552|38232704|FG000|Overall Study|Died prior to receiving treatment|4|||
17093066|NCT00058552|38232705|FG001|Overall Study|Died prior to receiving treatment|2|||
17093067|NCT00058552|38232704|FG000|Overall Study|Disease progression|52|||
17093068|NCT00058552|38232705|FG001|Overall Study|Disease progression|44|||
17093069|NCT00058552|38232704|FG000|Overall Study|Adverse Event|4|||
17093070|NCT00058552|38232705|FG001|Overall Study|Adverse Event|2|||
17093071|NCT00058552|38232704|FG000|Overall Study|Withdrawal by Subject|3|||
17093072|NCT00058552|38232705|FG001|Overall Study|Withdrawal by Subject|5|||
17093073|NCT00058552|38232704|FG000|Overall Study|Physician Decision|2|||
17093074|NCT00058552|38232705|FG001|Overall Study|Physician Decision|5|||
17093075|NCT00058552|38232704|FG000|Overall Study|Clinical disease progression|0|||
17190353|NCT02489968|38343228|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
17093076|NCT00058552|38232705|FG001|Overall Study|Clinical disease progression|4|||
17093077|NCT00044512|38232713|FG000|Follow Up|Lost to Follow-up|2|||
17093078|NCT03805438|38232717|FG000|Overall Study|Lack of Efficacy|1|||
17093079|NCT03805438|38232717|FG000|Overall Study|Protocol Violation|1|||
17093080|NCT00147537|38232725|FG000|Phase 1b|Death|0|||
17093081|NCT00147537|38232726|FG001|Phase 1b|Death|1|||
17093082|NCT00147537|38232727|FG002|Phase 1b|Death|2|||
17093083|NCT00147537|38232728|FG003|Phase 1b|Death|1|||
17093084|NCT00147537|38232729|FG004|Phase 1b|Death|2|||
17093085|NCT00147537|38232730|FG005|Phase 1b|Death|2|||
17093086|NCT00147537|38232731|FG006|Phase 1b|Death|1|||
17190354|NCT02489968|38343229|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
17190355|NCT02489968|38343230|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
17190356|NCT02489968|38343231|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
17190357|NCT02489968|38343226|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
17190358|NCT02489968|38343227|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
17190359|NCT02489968|38343228|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
17190360|NCT02489968|38343229|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
17190361|NCT02489968|38343230|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
17190362|NCT02489968|38343231|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
17190363|NCT02489968|38343226|FG000|Open-label Treatment Period|Other than specified above|204|||
17190364|NCT02489968|38343227|FG001|Open-label Treatment Period|Other than specified above|189|||
16783373|NCT02547363|37723195|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
16783374|NCT02547363|37723194|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
16999419|NCT00685399|38143229|FG002|Extension|Protocol Violation|0|||
16999420|NCT00685399|38143230|FG003|Extension|Protocol Violation|1|||
16999421|NCT00685399|38143231|FG004|Extension|Protocol Violation|0|||
16999422|NCT00685399|38143232|FG005|Extension|Protocol Violation|0|||
16783375|NCT02547363|37723195|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
16783376|NCT02547363|37723194|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
16783377|NCT02547363|37723195|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
16783378|NCT02547363|37723194|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
16783379|NCT02547363|37723195|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
16783380|NCT02547363|37723194|FG000|12-month Follow-up|Withdrawal by Subject|4|||
16783381|NCT02547363|37723195|FG001|12-month Follow-up|Withdrawal by Subject|3|||
16783382|NCT02547363|37723194|FG000|12-month Follow-up|Lost to Follow-up|4|||
16783383|NCT02547363|37723195|FG001|12-month Follow-up|Lost to Follow-up|1|||
16783384|NCT02547363|37723194|FG000|12-month Follow-up|Lack of Efficacy|1|||
16783385|NCT02547363|37723195|FG001|12-month Follow-up|Lack of Efficacy|1|||
16783386|NCT02547363|37723194|FG000|12-month Follow-up|Other|1|||
16783387|NCT02547363|37723195|FG001|12-month Follow-up|Other|0|||
16783388|NCT02539797|37723203|FG000|Overall Study|Lost to Follow-up|0|||
16783389|NCT02539797|37723204|FG001|Overall Study|Lost to Follow-up|1|||
16783390|NCT02539797|37723205|FG002|Overall Study|Lost to Follow-up|0|||
16999423|NCT00685399|38143233|FG006|Extension|Protocol Violation|0|||
16999424|NCT00685399|38143234|FG007|Extension|Protocol Violation|0|||
16783391|NCT02684981|37723216|FG000|Overall Study|Permanently discontinued the treatment|157|||
16783392|NCT02684981|37723217|FG001|Overall Study|Permanently discontinued the treatment|161|||
16783393|NCT02684981|37723218|FG002|Overall Study|Permanently discontinued the treatment|110|||
16783394|NCT02684981|37723216|FG000|Overall Study|Other|83|||
16868364|NCT02655016|37841428|FG000|Overall Study|Withdrawal by Subject|18|||
16999425|NCT00685399|38143227|FG000|Extension|Lack of Efficacy|0|||
16999426|NCT00685399|38143228|FG001|Extension|Lack of Efficacy|0|||
16999427|NCT00685399|38143229|FG002|Extension|Lack of Efficacy|0|||
16999428|NCT00685399|38143230|FG003|Extension|Lack of Efficacy|2|||
16999429|NCT00685399|38143231|FG004|Extension|Lack of Efficacy|0|||
16999430|NCT00685399|38143232|FG005|Extension|Lack of Efficacy|0|||
16999431|NCT00685399|38143233|FG006|Extension|Lack of Efficacy|0|||
16999432|NCT00685399|38143234|FG007|Extension|Lack of Efficacy|0|||
16999433|NCT00685399|38143227|FG000|Extension|Adverse Event|0|||
16999434|NCT00685399|38143228|FG001|Extension|Adverse Event|0|||
16999435|NCT00685399|38143229|FG002|Extension|Adverse Event|0|||
16999436|NCT00685399|38143230|FG003|Extension|Adverse Event|2|||
16999437|NCT00685399|38143231|FG004|Extension|Adverse Event|0|||
16999438|NCT00685399|38143232|FG005|Extension|Adverse Event|0|||
16999439|NCT00685399|38143233|FG006|Extension|Adverse Event|0|||
16999440|NCT00685399|38143234|FG007|Extension|Adverse Event|0|||
16999441|NCT00685165|38143261|FG000|Washout Period of 14 Days|Adverse Event|1|||
16999442|NCT00685165|38143262|FG001|Washout Period of 14 Days|Adverse Event|0|||
17093087|NCT00147537|38232732|FG007|Phase 1b|Death|3|||
17093088|NCT00147537|38232733|FG008|Phase 1b|Death|9|||
16783395|NCT02684981|37723217|FG001|Overall Study|Other|49|||
16783396|NCT02684981|37723218|FG002|Overall Study|Other|17|||
16783397|NCT02684357|37723235|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
16999443|NCT00683449|38143273|FG000|Overall Study|Lost to Follow-up|0|||
17093089|NCT00147537|38232734|FG009|Phase 1b|Death|0|||
17093090|NCT00147537|38232735|FG010|Phase 1b|Death|0|||
17093091|NCT00147537|38232725|FG000|Phase 1b|Lost to Follow-up|2|||
17093092|NCT00147537|38232726|FG001|Phase 1b|Lost to Follow-up|1|||
17093093|NCT00147537|38232727|FG002|Phase 1b|Lost to Follow-up|0|||
17093094|NCT00147537|38232728|FG003|Phase 1b|Lost to Follow-up|0|||
17093095|NCT00147537|38232729|FG004|Phase 1b|Lost to Follow-up|0|||
17093096|NCT00147537|38232730|FG005|Phase 1b|Lost to Follow-up|0|||
17093097|NCT00147537|38232731|FG006|Phase 1b|Lost to Follow-up|2|||
17093098|NCT00147537|38232732|FG007|Phase 1b|Lost to Follow-up|0|||
17093099|NCT00147537|38232733|FG008|Phase 1b|Lost to Follow-up|1|||
17093100|NCT00147537|38232734|FG009|Phase 1b|Lost to Follow-up|0|||
17093101|NCT00147537|38232735|FG010|Phase 1b|Lost to Follow-up|0|||
17093102|NCT00147537|38232725|FG000|Phase 1b|Other|0|||
17093103|NCT00147537|38232726|FG001|Phase 1b|Other|0|||
17093104|NCT00147537|38232727|FG002|Phase 1b|Other|2|||
17093105|NCT00147537|38232728|FG003|Phase 1b|Other|1|||
17093106|NCT00147537|38232729|FG004|Phase 1b|Other|1|||
17093107|NCT00147537|38232730|FG005|Phase 1b|Other|1|||
17093108|NCT00147537|38232731|FG006|Phase 1b|Other|14|||
17093109|NCT00147537|38232732|FG007|Phase 1b|Other|4|||
17093110|NCT00147537|38232733|FG008|Phase 1b|Other|4|||
17093111|NCT00147537|38232734|FG009|Phase 1b|Other|0|||
17093112|NCT00147537|38232735|FG010|Phase 1b|Other|0|||
17093113|NCT00147537|38232725|FG000|Phase 1b|Withdrawal by Subject|0|||
17093114|NCT00147537|38232726|FG001|Phase 1b|Withdrawal by Subject|0|||
17093115|NCT00147537|38232727|FG002|Phase 1b|Withdrawal by Subject|0|||
17093116|NCT00147537|38232728|FG003|Phase 1b|Withdrawal by Subject|0|||
17093117|NCT00147537|38232729|FG004|Phase 1b|Withdrawal by Subject|0|||
17093118|NCT00147537|38232730|FG005|Phase 1b|Withdrawal by Subject|0|||
17093119|NCT00147537|38232731|FG006|Phase 1b|Withdrawal by Subject|0|||
17093120|NCT00147537|38232732|FG007|Phase 1b|Withdrawal by Subject|0|||
16999444|NCT00683449|38143274|FG001|Overall Study|Lost to Follow-up|1|||
16999445|NCT00683449|38143275|FG002|Overall Study|Lost to Follow-up|0|||
16999446|NCT00683449|38143276|FG003|Overall Study|Lost to Follow-up|0|||
16999447|NCT00683449|38143277|FG004|Overall Study|Lost to Follow-up|0|||
17093121|NCT00147537|38232733|FG008|Phase 1b|Withdrawal by Subject|2|||
17093122|NCT00147537|38232734|FG009|Phase 1b|Withdrawal by Subject|0|||
17093123|NCT00147537|38232735|FG010|Phase 1b|Withdrawal by Subject|0|||
17093124|NCT00147537|38232725|FG000|Phase 1b|Randomized but not treated|0|||
16783398|NCT02684357|37723236|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
16783399|NCT02684357|37723237|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
16783400|NCT02684357|37723238|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
16783401|NCT02684357|37723239|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
16783402|NCT02684357|37723240|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
16783403|NCT02684357|37723235|FG000|Part A|Lost to Follow-up|0|||
16783404|NCT02684357|37723236|FG001|Part A|Lost to Follow-up|2|||
16999448|NCT00683293|38143296|FG000|Overall Study|Withdrawal by Subject|2|||
16999449|NCT00683293|38143297|FG001|Overall Study|Withdrawal by Subject|3|||
16783405|NCT02684357|37723237|FG002|Part A|Lost to Follow-up|2|||
16783406|NCT02684357|37723238|FG003|Part A|Lost to Follow-up|0|||
16783407|NCT02684357|37723239|FG004|Part A|Lost to Follow-up|0|||
16783408|NCT02684357|37723240|FG005|Part A|Lost to Follow-up|0|||
16783409|NCT02684357|37723235|FG000|Part A|Withdrawal by Subject|3|||
16783410|NCT02684357|37723236|FG001|Part A|Withdrawal by Subject|0|||
16783411|NCT02684357|37723237|FG002|Part A|Withdrawal by Subject|0|||
16783412|NCT02684357|37723238|FG003|Part A|Withdrawal by Subject|0|||
16783413|NCT02684357|37723239|FG004|Part A|Withdrawal by Subject|0|||
16783414|NCT02684357|37723240|FG005|Part A|Withdrawal by Subject|0|||
16783415|NCT02684357|37723235|FG000|Part A|Other|0|||
16783416|NCT02684357|37723236|FG001|Part A|Other|1|||
16783417|NCT02684357|37723237|FG002|Part A|Other|0|||
16783418|NCT02684357|37723238|FG003|Part A|Other|0|||
16783419|NCT02684357|37723239|FG004|Part A|Other|0|||
16783420|NCT02684357|37723240|FG005|Part A|Other|0|||
16783421|NCT02684357|37723235|FG000|Part B|Adverse Event (Other)|0|||
16783422|NCT02684357|37723236|FG001|Part B|Adverse Event (Other)|0|||
16783423|NCT02684357|37723237|FG002|Part B|Adverse Event (Other)|0|||
16783424|NCT02684357|37723238|FG003|Part B|Adverse Event (Other)|1|||
16783425|NCT02684357|37723239|FG004|Part B|Adverse Event (Other)|1|||
16999450|NCT00726232|38143309|FG000|Initial Phase (Dose-finding)|Death|0|||
16999451|NCT00726232|38143310|FG001|Initial Phase (Dose-finding)|Death|0|||
16999452|NCT00726232|38143311|FG002|Initial Phase (Dose-finding)|Death|0|||
16999453|NCT00726232|38143312|FG003|Initial Phase (Dose-finding)|Death|0|||
16999454|NCT00726232|38143313|FG004|Initial Phase (Dose-finding)|Death|1|||
16999455|NCT00726232|38143314|FG005|Initial Phase (Dose-finding)|Death|0|||
17093125|NCT00147537|38232726|FG001|Phase 1b|Randomized but not treated|0|||
17093126|NCT00147537|38232727|FG002|Phase 1b|Randomized but not treated|0|||
17093127|NCT00147537|38232728|FG003|Phase 1b|Randomized but not treated|0|||
17093128|NCT00147537|38232729|FG004|Phase 1b|Randomized but not treated|0|||
16783426|NCT02684357|37723240|FG005|Part B|Adverse Event (Other)|1|||
16783427|NCT02684357|37723235|FG000|Part B|Lost to Follow-up|0|||
16783428|NCT02684357|37723236|FG001|Part B|Lost to Follow-up|0|||
17093129|NCT00147537|38232730|FG005|Phase 1b|Randomized but not treated|0|||
16999456|NCT00726232|38143315|FG006|Initial Phase (Dose-finding)|Death|0|||
16999457|NCT00726232|38143316|FG007|Initial Phase (Dose-finding)|Death|0|||
17093130|NCT00147537|38232731|FG006|Phase 1b|Randomized but not treated|1|||
17093131|NCT00147537|38232732|FG007|Phase 1b|Randomized but not treated|0|||
16999458|NCT00726232|38143309|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
16999459|NCT00726232|38143310|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
16999460|NCT00726232|38143311|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
16999461|NCT00726232|38143312|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
16999462|NCT00726232|38143313|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
16999463|NCT00726232|38143314|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
16999464|NCT00726232|38143315|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
16999465|NCT00726232|38143316|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
16999466|NCT00726232|38143309|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
16999467|NCT00726232|38143310|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
17093132|NCT00147537|38232733|FG008|Phase 1b|Randomized but not treated|1|||
17093133|NCT00147537|38232734|FG009|Phase 1b|Randomized but not treated|0|||
17093134|NCT00147537|38232735|FG010|Phase 1b|Randomized but not treated|0|||
17093135|NCT00147537|38232725|FG000|Phase 2|Death|0|||
17093136|NCT00147537|38232726|FG001|Phase 2|Death|0|||
17093137|NCT00147537|38232727|FG002|Phase 2|Death|0|||
16999468|NCT00726232|38143311|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
16999469|NCT00726232|38143312|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
16999470|NCT00726232|38143313|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
16999471|NCT00726232|38143314|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
16999472|NCT00726232|38143315|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
17093138|NCT00147537|38232728|FG003|Phase 2|Death|0|||
17093139|NCT00147537|38232729|FG004|Phase 2|Death|0|||
17093140|NCT00147537|38232730|FG005|Phase 2|Death|0|||
17093141|NCT00147537|38232731|FG006|Phase 2|Death|0|||
17093142|NCT00147537|38232732|FG007|Phase 2|Death|0|||
17093143|NCT00147537|38232733|FG008|Phase 2|Death|0|||
17093144|NCT00147537|38232734|FG009|Phase 2|Death|85|||
17093145|NCT00147537|38232735|FG010|Phase 2|Death|31|||
17093146|NCT00147537|38232725|FG000|Phase 2|Lost to Follow-up|0|||
17093147|NCT00147537|38232726|FG001|Phase 2|Lost to Follow-up|0|||
17093148|NCT00147537|38232727|FG002|Phase 2|Lost to Follow-up|0|||
17093149|NCT00147537|38232728|FG003|Phase 2|Lost to Follow-up|0|||
17093150|NCT00147537|38232729|FG004|Phase 2|Lost to Follow-up|0|||
17093151|NCT00147537|38232730|FG005|Phase 2|Lost to Follow-up|0|||
17093152|NCT00147537|38232731|FG006|Phase 2|Lost to Follow-up|0|||
17093153|NCT00147537|38232732|FG007|Phase 2|Lost to Follow-up|0|||
17093154|NCT00147537|38232733|FG008|Phase 2|Lost to Follow-up|0|||
17093155|NCT00147537|38232734|FG009|Phase 2|Lost to Follow-up|12|||
17093156|NCT00147537|38232735|FG010|Phase 2|Lost to Follow-up|4|||
17093157|NCT00147537|38232725|FG000|Phase 2|Other|0|||
17093158|NCT00147537|38232726|FG001|Phase 2|Other|0|||
17093159|NCT00147537|38232727|FG002|Phase 2|Other|0|||
17093160|NCT00147537|38232728|FG003|Phase 2|Other|0|||
17093161|NCT00147537|38232729|FG004|Phase 2|Other|0|||
17093162|NCT00147537|38232730|FG005|Phase 2|Other|0|||
17093163|NCT00147537|38232731|FG006|Phase 2|Other|0|||
17093164|NCT00147537|38232732|FG007|Phase 2|Other|0|||
17093165|NCT00147537|38232733|FG008|Phase 2|Other|0|||
17093166|NCT00147537|38232734|FG009|Phase 2|Other|47|||
17093167|NCT00147537|38232735|FG010|Phase 2|Other|12|||
17093168|NCT00147537|38232725|FG000|Phase 2|Withdrawal by Subject|0|||
17093169|NCT00147537|38232726|FG001|Phase 2|Withdrawal by Subject|0|||
17093170|NCT00147537|38232727|FG002|Phase 2|Withdrawal by Subject|0|||
17093171|NCT00147537|38232728|FG003|Phase 2|Withdrawal by Subject|0|||
17093172|NCT00147537|38232729|FG004|Phase 2|Withdrawal by Subject|0|||
17093173|NCT00147537|38232730|FG005|Phase 2|Withdrawal by Subject|0|||
17093174|NCT00147537|38232731|FG006|Phase 2|Withdrawal by Subject|0|||
17093175|NCT00147537|38232732|FG007|Phase 2|Withdrawal by Subject|0|||
17093176|NCT00147537|38232733|FG008|Phase 2|Withdrawal by Subject|0|||
17093177|NCT00147537|38232734|FG009|Phase 2|Withdrawal by Subject|16|||
17093178|NCT00147537|38232735|FG010|Phase 2|Withdrawal by Subject|4|||
17093179|NCT00147537|38232725|FG000|Phase 2|Randomized but not treated|0|||
17093180|NCT00147537|38232726|FG001|Phase 2|Randomized but not treated|0|||
17093181|NCT00147537|38232727|FG002|Phase 2|Randomized but not treated|0|||
17093182|NCT00147537|38232728|FG003|Phase 2|Randomized but not treated|0|||
17093183|NCT00147537|38232729|FG004|Phase 2|Randomized but not treated|0|||
17093184|NCT00147537|38232730|FG005|Phase 2|Randomized but not treated|0|||
17093185|NCT00147537|38232731|FG006|Phase 2|Randomized but not treated|0|||
17093186|NCT00147537|38232732|FG007|Phase 2|Randomized but not treated|0|||
17093187|NCT00147537|38232733|FG008|Phase 2|Randomized but not treated|0|||
17093188|NCT00147537|38232734|FG009|Phase 2|Randomized but not treated|1|||
17093189|NCT00147537|38232735|FG010|Phase 2|Randomized but not treated|1|||
17093190|NCT00222729|38232780|FG000|Overall Study|Adverse Event|3|||
17093191|NCT00147225|38232790|FG000|Overall Study|Withdrawal by Subject|1|||
17093192|NCT00147225|38232791|FG001|Overall Study|Withdrawal by Subject|0|||
17093193|NCT00147225|38232792|FG002|Overall Study|Withdrawal by Subject|1|||
17190365|NCT02489968|38343228|FG002|Open-label Treatment Period|Other than specified above|0|||
17190366|NCT02489968|38343229|FG003|Open-label Treatment Period|Other than specified above|0|||
17190367|NCT02489968|38343230|FG004|Open-label Treatment Period|Other than specified above|0|||
17190368|NCT02489968|38343231|FG005|Open-label Treatment Period|Other than specified above|0|||
17190369|NCT02489968|38343226|FG000|Double-blind Treatment Period|Adverse Event|0|||
17190370|NCT02489968|38343227|FG001|Double-blind Treatment Period|Adverse Event|0|||
17190371|NCT02489968|38343228|FG002|Double-blind Treatment Period|Adverse Event|2|||
17190372|NCT02489968|38343229|FG003|Double-blind Treatment Period|Adverse Event|6|||
17190373|NCT02489968|38343230|FG004|Double-blind Treatment Period|Adverse Event|4|||
17190374|NCT02489968|38343231|FG005|Double-blind Treatment Period|Adverse Event|5|||
17190375|NCT02489968|38343226|FG000|Double-blind Treatment Period|Protocol Violation|0|||
17190376|NCT02489968|38343227|FG001|Double-blind Treatment Period|Protocol Violation|0|||
17190377|NCT02489968|38343228|FG002|Double-blind Treatment Period|Protocol Violation|0|||
17190378|NCT02489968|38343229|FG003|Double-blind Treatment Period|Protocol Violation|0|||
17190379|NCT02489968|38343230|FG004|Double-blind Treatment Period|Protocol Violation|1|||
17190380|NCT02489968|38343231|FG005|Double-blind Treatment Period|Protocol Violation|1|||
17190381|NCT02489968|38343226|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
17190382|NCT02489968|38343227|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
17190383|NCT02489968|38343228|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
17190384|NCT02489968|38343229|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
17190385|NCT02489968|38343230|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
17190386|NCT02489968|38343231|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
17190387|NCT02489968|38343226|FG000|Double-blind Treatment Period|Other than specified above|0|||
17190388|NCT02489968|38343227|FG001|Double-blind Treatment Period|Other than specified above|0|||
17190389|NCT02489968|38343228|FG002|Double-blind Treatment Period|Other than specified above|0|||
17190390|NCT02489968|38343229|FG003|Double-blind Treatment Period|Other than specified above|0|||
17190391|NCT02489968|38343230|FG004|Double-blind Treatment Period|Other than specified above|1|||
17190392|NCT02489968|38343231|FG005|Double-blind Treatment Period|Other than specified above|0|||
17190393|NCT02483416|38343245|FG000|Overall Study|Other reason|0|||
17190394|NCT02483416|38343246|FG001|Overall Study|Other reason|1|||
17190395|NCT02483416|38343245|FG000|Overall Study|Treatment stop|3|||
17190396|NCT02483416|38343246|FG001|Overall Study|Treatment stop|0|||
17190397|NCT01061177|38343253|FG000|Overall Study|Adverse Event|117|||
17190398|NCT01061177|38343253|FG000|Overall Study|Withdrawal by Subject|27|||
17190399|NCT01061177|38343253|FG000|Overall Study|Disease progression|17|||
17190400|NCT01061177|38343253|FG000|Overall Study|Protocol Violation|11|||
17190401|NCT01061177|38343253|FG000|Overall Study|Lost to Follow-up|9|||
17190402|NCT01061177|38343253|FG000|Overall Study|New cancer therapy|9|||
17190403|NCT01061177|38343253|FG000|Overall Study|Abnormal laboratory values|6|||
17190404|NCT01061177|38343253|FG000|Overall Study|Abnormal test procedure results|4|||
17190405|NCT01061177|38343253|FG000|Overall Study|Administratie problems|4|||
17190406|NCT01061177|38343253|FG000|Overall Study|Death|4|||
17190407|NCT02481934|38343257|FG000|Overall Study|Death|2|||
17190408|NCT02973425|38343263|FG000|Overall Study|Lost to Follow-up|49|||
17190409|NCT02973425|38343264|FG001|Overall Study|Lost to Follow-up|53|||
17190410|NCT02489500|38343273|FG000|Overall Study|Death|1|||
17190411|NCT02489500|38343274|FG001|Overall Study|Death|1|||
17190412|NCT02732847|38343282|FG000|Overall Study|some filled early|42|||
16999473|NCT00726232|38143316|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
16999474|NCT00726232|38143309|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
16999475|NCT00726232|38143310|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
16999476|NCT00726232|38143311|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
16999477|NCT00726232|38143312|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
16999478|NCT00726232|38143313|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
16999479|NCT00726232|38143314|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
16999480|NCT00726232|38143315|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
16999481|NCT00726232|38143316|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
16999482|NCT00726232|38143309|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
16999483|NCT00726232|38143310|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
16999484|NCT00726232|38143311|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
16999485|NCT00726232|38143312|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
16999486|NCT00726232|38143313|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
16868365|NCT02655016|37841429|FG001|Overall Study|Withdrawal by Subject|36|||
16999487|NCT00726232|38143314|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
16999488|NCT00726232|38143315|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
16999489|NCT00726232|38143316|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
16999490|NCT00726232|38143309|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
17190413|NCT02732847|38343283|FG001|Overall Study|some filled early|42|||
17190414|NCT02489344|38343289|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
17190415|NCT02489344|38343289|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
17093194|NCT00147225|38232793|FG003|Overall Study|Withdrawal by Subject|0|||
17093195|NCT00147225|38232794|FG004|Overall Study|Withdrawal by Subject|0|||
17093196|NCT00147225|38232795|FG005|Overall Study|Withdrawal by Subject|1|||
17093197|NCT00147225|38232790|FG000|Overall Study|Adverse Event|0|||
17093198|NCT00147225|38232791|FG001|Overall Study|Adverse Event|0|||
17093199|NCT00147225|38232792|FG002|Overall Study|Adverse Event|1|||
17093200|NCT00147225|38232793|FG003|Overall Study|Adverse Event|1|||
17093201|NCT00147225|38232794|FG004|Overall Study|Adverse Event|0|||
17093202|NCT00147225|38232795|FG005|Overall Study|Adverse Event|0|||
17093203|NCT00147225|38232790|FG000|Overall Study|Screen Failure|0|||
17093204|NCT00147225|38232791|FG001|Overall Study|Screen Failure|0|||
17093205|NCT00147225|38232792|FG002|Overall Study|Screen Failure|0|||
17093206|NCT00147225|38232793|FG003|Overall Study|Screen Failure|0|||
17093207|NCT00147225|38232794|FG004|Overall Study|Screen Failure|1|||
17093208|NCT00147225|38232795|FG005|Overall Study|Screen Failure|0|||
17093209|NCT00147225|38232790|FG000|Overall Study|Chemotherapy Changed|0|||
17093210|NCT00147225|38232791|FG001|Overall Study|Chemotherapy Changed|0|||
17093211|NCT00147225|38232792|FG002|Overall Study|Chemotherapy Changed|0|||
16783429|NCT02684357|37723237|FG002|Part B|Lost to Follow-up|0|||
16783430|NCT02684357|37723238|FG003|Part B|Lost to Follow-up|1|||
16783431|NCT02684357|37723239|FG004|Part B|Lost to Follow-up|1|||
16783432|NCT02684357|37723240|FG005|Part B|Lost to Follow-up|7|||
16783433|NCT02684357|37723235|FG000|Part B|Withdrawal by Subject|0|||
16783434|NCT02684357|37723236|FG001|Part B|Withdrawal by Subject|0|||
16783435|NCT02684357|37723237|FG002|Part B|Withdrawal by Subject|0|||
16783436|NCT02684357|37723238|FG003|Part B|Withdrawal by Subject|0|||
16783437|NCT02684357|37723239|FG004|Part B|Withdrawal by Subject|2|||
16783438|NCT02684357|37723240|FG005|Part B|Withdrawal by Subject|4|||
16783439|NCT02684357|37723235|FG000|Part B|Other|0|||
16783440|NCT02684357|37723236|FG001|Part B|Other|0|||
16783441|NCT02684357|37723237|FG002|Part B|Other|0|||
16783442|NCT02684357|37723238|FG003|Part B|Other|1|||
16783443|NCT02684357|37723239|FG004|Part B|Other|0|||
16783444|NCT02684357|37723240|FG005|Part B|Other|1|||
16783445|NCT02684279|37723253|FG000|Overall Study|Adverse Event|87|||
16783446|NCT02684279|37723253|FG000|Overall Study|Lack of Efficacy|4|||
16783447|NCT02684279|37723253|FG000|Overall Study|Lost to Follow-up|61|||
16783448|NCT02684279|37723253|FG000|Overall Study|Protocol Violation|6|||
16783449|NCT02684279|37723253|FG000|Overall Study|Pregnancy|8|||
16783450|NCT02684279|37723253|FG000|Overall Study|Withdrawal by Subject|92|||
16783451|NCT02684279|37723253|FG000|Overall Study|non-compliance with study drug|9|||
16783452|NCT02684279|37723253|FG000|Overall Study|non compliance with study visits|2|||
16783453|NCT02684279|37723253|FG000|Overall Study|subject to have surgery|1|||
16783454|NCT02684279|37723253|FG000|Overall Study|family emergency|1|||
16783455|NCT02684279|37723253|FG000|Overall Study|Site closures|7|||
16783456|NCT02684279|37723253|FG000|Overall Study|Physician Decision|1|||
16783457|NCT03206073|37723261|FG000|Overall Study|Participant Noncompliance|0|||
16783458|NCT03206073|37723262|FG001|Overall Study|Participant Noncompliance|1|||
16783459|NCT03206073|37723263|FG002|Overall Study|Participant Noncompliance|0|||
16783460|NCT03206073|37723264|FG003|Overall Study|Participant Noncompliance|0|||
16783461|NCT03206073|37723261|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
16783462|NCT03206073|37723262|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
16783463|NCT03206073|37723263|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
16783464|NCT03206073|37723264|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
16783465|NCT03206073|37723261|FG000|Overall Study|Death|0|||
16783466|NCT03206073|37723262|FG001|Overall Study|Death|0|||
16783467|NCT03206073|37723263|FG002|Overall Study|Death|1|||
16783468|NCT03206073|37723264|FG003|Overall Study|Death|0|||
16783469|NCT03206073|37723261|FG000|Overall Study|Taken off active treatment|0|||
16783470|NCT03206073|37723262|FG001|Overall Study|Taken off active treatment|0|||
16783471|NCT03206073|37723263|FG002|Overall Study|Taken off active treatment|3|||
16783472|NCT03206073|37723264|FG003|Overall Study|Taken off active treatment|0|||
16783473|NCT02534493|37723274|FG000|Overall Study|Lost to Follow-up|1|||
16783474|NCT02534493|37723274|FG000|Overall Study|Withdrawal by Subject|1|||
16783475|NCT03106779|37723282|FG000|Overall Study|Lack of Efficacy|33|||
16868366|NCT01533935|37841436|FG000|Overall Study|Adverse Event|5|||
16783476|NCT03106779|37723283|FG001|Overall Study|Lack of Efficacy|24|||
16783477|NCT03106779|37723282|FG000|Overall Study|Adverse Event|8|||
16783478|NCT03106779|37723283|FG001|Overall Study|Adverse Event|16|||
16783479|NCT03106779|37723282|FG000|Overall Study|Physician Decision|10|||
16783480|NCT03106779|37723283|FG001|Overall Study|Physician Decision|6|||
16783481|NCT03106779|37723282|FG000|Overall Study|Patient/guardian decision|4|||
16783482|NCT03106779|37723283|FG001|Overall Study|Patient/guardian decision|3|||
16783483|NCT03106779|37723282|FG000|Overall Study|Progressive disease|1|||
16783484|NCT03106779|37723283|FG001|Overall Study|Progressive disease|3|||
16783485|NCT03106779|37723282|FG000|Overall Study|Lost to Follow-up|1|||
16783486|NCT03106779|37723283|FG001|Overall Study|Lost to Follow-up|2|||
16868367|NCT01533935|37841437|FG001|Overall Study|Adverse Event|7|||
17093212|NCT00147225|38232793|FG003|Overall Study|Chemotherapy Changed|0|||
16783487|NCT03106779|37723282|FG000|Overall Study|Death|1|||
16783488|NCT03106779|37723283|FG001|Overall Study|Death|0|||
16783489|NCT03106779|37723282|FG000|Overall Study|Protocol Violation|1|||
16783490|NCT03106779|37723283|FG001|Overall Study|Protocol Violation|0|||
16783491|NCT03106779|37723282|FG000|Overall Study|Not treated|1|||
16783492|NCT03106779|37723283|FG001|Overall Study|Not treated|0|||
16783493|NCT02547129|37723291|FG000|Overall Study|Difficulty with ongoing infection|1|||
16783494|NCT02547129|37723292|FG001|Overall Study|Difficulty with ongoing infection|0|||
16783495|NCT02546193|37723300|FG000|Overall Study|Withdrawal by Subject|2|||
16783496|NCT02546193|37723301|FG001|Overall Study|Withdrawal by Subject|0|||
16783497|NCT02546193|37723302|FG002|Overall Study|Withdrawal by Subject|1|||
16783498|NCT02546193|37723303|FG003|Overall Study|Withdrawal by Subject|0|||
16783499|NCT02546193|37723300|FG000|Overall Study|Not eligible at time of induction|4|||
16783500|NCT02546193|37723301|FG001|Overall Study|Not eligible at time of induction|6|||
16783501|NCT02546193|37723302|FG002|Overall Study|Not eligible at time of induction|1|||
16783502|NCT02546193|37723303|FG003|Overall Study|Not eligible at time of induction|0|||
16783503|NCT02538471|37723309|FG000|Overall Study|Progression of disease|2|||
16783504|NCT01661595|37723317|FG000|Phase 1: Week 0-4|Adverse Event|1|||
16783505|NCT01661595|37723318|FG001|Phase 1: Week 0-4|Adverse Event|0|||
16783506|NCT01661595|37723319|FG002|Phase 1: Week 0-4|Adverse Event|0|||
16783507|NCT01661595|37723320|FG003|Phase 1: Week 0-4|Adverse Event|0|||
16783508|NCT01661595|37723317|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
16783509|NCT01661595|37723318|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
16783510|NCT01661595|37723319|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
16783511|NCT01661595|37723320|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
16783512|NCT02213133|37723340|FG000|Overall Study|Participant discontinued study therapy|2|||
16783513|NCT02213133|37723341|FG001|Overall Study|Participant discontinued study therapy|0|||
16783514|NCT02213133|37723342|FG002|Overall Study|Participant discontinued study therapy|0|||
16783515|NCT02213133|37723340|FG000|Overall Study|Participant withdrew informed consent|2|||
16783516|NCT02213133|37723341|FG001|Overall Study|Participant withdrew informed consent|1|||
16783517|NCT02213133|37723342|FG002|Overall Study|Participant withdrew informed consent|2|||
16783518|NCT02213133|37723340|FG000|Overall Study|Disease progression|11|||
16783519|NCT02213133|37723341|FG001|Overall Study|Disease progression|2|||
16783520|NCT02213133|37723342|FG002|Overall Study|Disease progression|0|||
16783521|NCT02213133|37723340|FG000|Overall Study|Adverse Event (AE)|1|||
16783522|NCT02213133|37723341|FG001|Overall Study|Adverse Event (AE)|0|||
16783523|NCT02213133|37723342|FG002|Overall Study|Adverse Event (AE)|0|||
16783524|NCT02213133|37723340|FG000|Overall Study|Death|16|||
16783525|NCT02213133|37723341|FG001|Overall Study|Death|2|||
16783526|NCT02213133|37723342|FG002|Overall Study|Death|1|||
16783527|NCT02213133|37723340|FG000|Overall Study|Other|5|||
16783528|NCT02213133|37723341|FG001|Overall Study|Other|0|||
16783529|NCT02213133|37723342|FG002|Overall Study|Other|0|||
16783530|NCT02146833|37723351|FG000|Overall Study|Death|10|||
16783531|NCT02146833|37723351|FG000|Overall Study|No longer consented to study treatment|1|||
16783532|NCT02690207|37723355|FG000|Overall Study|Lost to Follow-up|48|||
16783533|NCT02690207|37723355|FG000|Overall Study|Withdrawal by Subject|46|||
16783534|NCT02690207|37723355|FG000|Overall Study|Protocol Violation|2|||
16783535|NCT02690207|37723355|FG000|Overall Study|Serious adverse event|110|||
16783536|NCT02690207|37723355|FG000|Overall Study|Non-serious Adverse Event|18|||
16783537|NCT02690207|37723355|FG000|Overall Study|Migrated/moved from study area|5|||
16783538|NCT02690207|37723355|FG000|Overall Study|Suspected HZ Episode|1|||
16783539|NCT02690207|37723355|FG000|Overall Study|Other reasons for withdrawal|23|||
16783540|NCT02689349|37723361|FG000|Overall Study|Not implanted|4|||
16783541|NCT02689349|37723362|FG001|Overall Study|Not implanted|0|||
16783542|NCT02689349|37723361|FG000|Overall Study|Withdrawal by Subject|9|||
16783543|NCT02689349|37723362|FG001|Overall Study|Withdrawal by Subject|0|||
16783544|NCT02679287|37723373|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
16783545|NCT02679287|37723374|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
16783546|NCT02679287|37723373|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
16783547|NCT02679287|37723374|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
16783548|NCT02679287|37723373|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
16783549|NCT02679287|37723374|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
16783550|NCT02679287|37723373|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
16783551|NCT02679287|37723374|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
16783552|NCT02679287|37723373|FG000|Period 2|Work/Scheduling Conflict|1|||
16783553|NCT02679287|37723374|FG001|Period 2|Work/Scheduling Conflict|0|||
16783554|NCT02679287|37723373|FG000|Period 2|Disliked Mobile System|2|||
16783555|NCT02679287|37723374|FG001|Period 2|Disliked Mobile System|0|||
16783556|NCT02679287|37723373|FG000|Period 3|Work/Scheduling Conflict|0|||
16868368|NCT01533935|37841438|FG002|Overall Study|Adverse Event|1|||
16868369|NCT01533935|37841439|FG003|Overall Study|Adverse Event|5|||
16868370|NCT01533935|37841440|FG004|Overall Study|Adverse Event|3|||
16783557|NCT02679287|37723374|FG001|Period 3|Work/Scheduling Conflict|1|||
16868371|NCT01533935|37841436|FG000|Overall Study|Protocol Violation|0|||
16783558|NCT02544633|37723390|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
16783559|NCT02544633|37723391|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
16783560|NCT02544633|37723392|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
16783561|NCT02544633|37723393|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
16783562|NCT02544633|37723390|FG000|Treatment Period|Adverse Event|7|||
16783563|NCT02544633|37723391|FG001|Treatment Period|Adverse Event|4|||
16783564|NCT02544633|37723392|FG002|Treatment Period|Adverse Event|0|||
16783565|NCT02544633|37723393|FG003|Treatment Period|Adverse Event|5|||
16783566|NCT02544633|37723390|FG000|Treatment Period|Lack of Efficacy|17|||
16783567|NCT02544633|37723391|FG001|Treatment Period|Lack of Efficacy|11|||
16783568|NCT02544633|37723392|FG002|Treatment Period|Lack of Efficacy|5|||
16783569|NCT02544633|37723393|FG003|Treatment Period|Lack of Efficacy|5|||
16783570|NCT02544633|37723390|FG000|Treatment Period|Global Deterioration of Health|3|||
16783571|NCT02544633|37723391|FG001|Treatment Period|Global Deterioration of Health|3|||
16783572|NCT02544633|37723392|FG002|Treatment Period|Global Deterioration of Health|0|||
16783573|NCT02544633|37723393|FG003|Treatment Period|Global Deterioration of Health|1|||
16783574|NCT02544633|37723390|FG000|Treatment Period|Withdrawal by Subject|1|||
16783575|NCT02544633|37723391|FG001|Treatment Period|Withdrawal by Subject|0|||
16783576|NCT02544633|37723392|FG002|Treatment Period|Withdrawal by Subject|0|||
16783577|NCT02544633|37723393|FG003|Treatment Period|Withdrawal by Subject|0|||
16783578|NCT02544633|37723390|FG000|Treatment Period|Lost to Follow-up|0|||
16783579|NCT02544633|37723391|FG001|Treatment Period|Lost to Follow-up|1|||
16783580|NCT02544633|37723392|FG002|Treatment Period|Lost to Follow-up|0|||
16783581|NCT02544633|37723393|FG003|Treatment Period|Lost to Follow-up|0|||
16783582|NCT02544633|37723390|FG000|Treatment Period|Death|0|||
16783583|NCT02544633|37723391|FG001|Treatment Period|Death|0|||
16783584|NCT02544633|37723392|FG002|Treatment Period|Death|1|||
16783585|NCT02544633|37723393|FG003|Treatment Period|Death|0|||
16783586|NCT02544633|37723390|FG000|Treatment Period|Non-compliance|0|||
16783587|NCT02544633|37723391|FG001|Treatment Period|Non-compliance|0|||
16783588|NCT02544633|37723392|FG002|Treatment Period|Non-compliance|1|||
16783589|NCT02544633|37723393|FG003|Treatment Period|Non-compliance|0|||
16999491|NCT00726232|38143310|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
16999492|NCT00726232|38143311|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
16999493|NCT00726232|38143312|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
16999494|NCT00726232|38143313|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
16999495|NCT00726232|38143314|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
16999496|NCT00726232|38143315|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
16999497|NCT00726232|38143316|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
16999498|NCT00726232|38143309|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
16999499|NCT00726232|38143310|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
17093213|NCT00147225|38232794|FG004|Overall Study|Chemotherapy Changed|0|||
17093214|NCT00147225|38232795|FG005|Overall Study|Chemotherapy Changed|1|||
17093215|NCT00222105|38232809|FG000|Overall Study|Removed due to wrong diagnosis|1|||
17093216|NCT00222105|38232809|FG000|Overall Study|Withdrawal by Subject|1|||
17093217|NCT00222105|38232809|FG000|Overall Study|Adverse Event|8|||
16999500|NCT00726232|38143311|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
16999501|NCT00726232|38143312|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
16999502|NCT00726232|38143313|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
16999503|NCT00726232|38143314|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
16999504|NCT00726232|38143315|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
16999505|NCT00726232|38143316|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
17093218|NCT00222105|38232809|FG000|Overall Study|Treatment delays|2|||
17093219|NCT00222105|38232809|FG000|Overall Study|Death|2|||
17093220|NCT00146757|38232813|FG000|Overall Study|Death|1|||
17093221|NCT00146757|38232814|FG001|Overall Study|Death|0|||
16999506|NCT00726232|38143309|FG000|Expansion Phase|Death|0|||
16999507|NCT00726232|38143310|FG001|Expansion Phase|Death|0|||
16999508|NCT00726232|38143311|FG002|Expansion Phase|Death|0|||
16999509|NCT00726232|38143312|FG003|Expansion Phase|Death|0|||
16999510|NCT00726232|38143313|FG004|Expansion Phase|Death|0|||
16999511|NCT00726232|38143314|FG005|Expansion Phase|Death|0|||
17093222|NCT00146757|38232813|FG000|Overall Study|Adverse Event|1|||
17093223|NCT00146757|38232814|FG001|Overall Study|Adverse Event|0|||
17093224|NCT00267098|38232828|FG000|Overall Study|Death|0|||
17093225|NCT00267098|38232829|FG001|Overall Study|Death|0|||
17093226|NCT00267098|38232830|FG002|Overall Study|Death|57|||
17093227|NCT00267098|38232831|FG003|Overall Study|Death|66|||
17093228|NCT00267098|38232832|FG004|Overall Study|Death|14|||
17093229|NCT00267098|38232833|FG005|Overall Study|Death|23|||
17093230|NCT00267098|38232834|FG006|Overall Study|Death|28|||
17093231|NCT00267098|38232835|FG007|Overall Study|Death|9|||
17093232|NCT00267098|38232828|FG000|Overall Study|Lost to Follow-up|0|||
16783590|NCT02544633|37723390|FG000|Treatment Period|Clinical Disease Progression|0|||
16783591|NCT02544633|37723391|FG001|Treatment Period|Clinical Disease Progression|0|||
17093233|NCT00267098|38232829|FG001|Overall Study|Lost to Follow-up|0|||
17093234|NCT00267098|38232830|FG002|Overall Study|Lost to Follow-up|6|||
16999512|NCT00726232|38143315|FG006|Expansion Phase|Death|0|||
16999513|NCT00726232|38143316|FG007|Expansion Phase|Death|1|||
16999514|NCT00726232|38143309|FG000|Expansion Phase|Adverse Event|0|||
16999515|NCT00726232|38143310|FG001|Expansion Phase|Adverse Event|0|||
16999516|NCT00726232|38143311|FG002|Expansion Phase|Adverse Event|0|||
16999517|NCT00726232|38143312|FG003|Expansion Phase|Adverse Event|0|||
16999518|NCT00726232|38143313|FG004|Expansion Phase|Adverse Event|0|||
16999519|NCT00726232|38143314|FG005|Expansion Phase|Adverse Event|0|||
16999520|NCT00726232|38143315|FG006|Expansion Phase|Adverse Event|6|||
16999521|NCT00726232|38143316|FG007|Expansion Phase|Adverse Event|11|||
16999522|NCT00726232|38143309|FG000|Expansion Phase|Withdrawal by Subject|0|||
16999523|NCT00726232|38143310|FG001|Expansion Phase|Withdrawal by Subject|0|||
16999524|NCT00726232|38143311|FG002|Expansion Phase|Withdrawal by Subject|0|||
16999525|NCT00726232|38143312|FG003|Expansion Phase|Withdrawal by Subject|0|||
16999526|NCT00726232|38143313|FG004|Expansion Phase|Withdrawal by Subject|0|||
16999527|NCT00726232|38143314|FG005|Expansion Phase|Withdrawal by Subject|0|||
16999528|NCT00726232|38143315|FG006|Expansion Phase|Withdrawal by Subject|2|||
16999529|NCT00726232|38143316|FG007|Expansion Phase|Withdrawal by Subject|3|||
16999530|NCT00726232|38143309|FG000|Expansion Phase|Disease progression|0|||
16999531|NCT00726232|38143310|FG001|Expansion Phase|Disease progression|0|||
16999532|NCT00726232|38143311|FG002|Expansion Phase|Disease progression|0|||
16999533|NCT00726232|38143312|FG003|Expansion Phase|Disease progression|0|||
16999534|NCT00726232|38143313|FG004|Expansion Phase|Disease progression|0|||
16999535|NCT00726232|38143314|FG005|Expansion Phase|Disease progression|0|||
16999536|NCT00726232|38143315|FG006|Expansion Phase|Disease progression|4|||
16999537|NCT00726232|38143316|FG007|Expansion Phase|Disease progression|0|||
16999538|NCT00726232|38143309|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
16999539|NCT00726232|38143310|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
16999540|NCT00726232|38143311|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
16999541|NCT00726232|38143312|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
16999542|NCT00726232|38143313|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
16999543|NCT00726232|38143314|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
16999544|NCT00726232|38143315|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
16999545|NCT00726232|38143316|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
16999546|NCT00726232|38143309|FG000|Expansion Phase|Per Investigator: lack of response|0|||
16999547|NCT00726232|38143310|FG001|Expansion Phase|Per Investigator: lack of response|0|||
16999548|NCT00726232|38143311|FG002|Expansion Phase|Per Investigator: lack of response|0|||
16999549|NCT00726232|38143312|FG003|Expansion Phase|Per Investigator: lack of response|0|||
16999550|NCT00726232|38143313|FG004|Expansion Phase|Per Investigator: lack of response|0|||
16999551|NCT00726232|38143314|FG005|Expansion Phase|Per Investigator: lack of response|0|||
16999552|NCT00726232|38143315|FG006|Expansion Phase|Per Investigator: lack of response|1|||
16999553|NCT00726232|38143316|FG007|Expansion Phase|Per Investigator: lack of response|7|||
16999554|NCT00726232|38143309|FG000|Expansion Phase|Unspecified reason|0|||
16999555|NCT00726232|38143310|FG001|Expansion Phase|Unspecified reason|0|||
16999556|NCT00726232|38143311|FG002|Expansion Phase|Unspecified reason|0|||
16999557|NCT00726232|38143312|FG003|Expansion Phase|Unspecified reason|0|||
16999558|NCT00726232|38143313|FG004|Expansion Phase|Unspecified reason|0|||
16999559|NCT00726232|38143314|FG005|Expansion Phase|Unspecified reason|0|||
16783592|NCT02544633|37723392|FG002|Treatment Period|Clinical Disease Progression|0|||
16783593|NCT02544633|37723393|FG003|Treatment Period|Clinical Disease Progression|1|||
16783594|NCT02544633|37723390|FG000|Survival Follow-up Period|Death|12|||
16783595|NCT02544633|37723391|FG001|Survival Follow-up Period|Death|14|||
16783596|NCT02544633|37723392|FG002|Survival Follow-up Period|Death|3|||
16783597|NCT02544633|37723393|FG003|Survival Follow-up Period|Death|9|||
16783598|NCT02544633|37723390|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
16783599|NCT02544633|37723391|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
16783600|NCT02544633|37723392|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
16783601|NCT02544633|37723393|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
16783602|NCT02544633|37723390|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
16783603|NCT02544633|37723391|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
16783604|NCT02544633|37723392|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
16783605|NCT02544633|37723393|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
16783606|NCT02544633|37723390|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
16783607|NCT02544633|37723391|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
16783608|NCT02544633|37723392|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
16783609|NCT02544633|37723393|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
16783610|NCT02678351|37723415|FG000|Overall Study|Withdrawal by Subject|1|||
16783611|NCT02683187|37723419|FG000|Overall Study|Failed IV access|3|||
16999560|NCT00726232|38143315|FG006|Expansion Phase|Unspecified reason|1|||
16999561|NCT00726232|38143316|FG007|Expansion Phase|Unspecified reason|0|||
16999562|NCT00720382|38143337|FG000|Overall Study|Adverse Event|54|||
16999563|NCT00720382|38143338|FG001|Overall Study|Adverse Event|17|||
16999564|NCT00720382|38143337|FG000|Overall Study|Lack of Efficacy|18|||
16999565|NCT00720382|38143338|FG001|Overall Study|Lack of Efficacy|7|||
16999566|NCT00720382|38143337|FG000|Overall Study|Non-Compliance|15|||
16999567|NCT00720382|38143338|FG001|Overall Study|Non-Compliance|5|||
16999568|NCT00720382|38143337|FG000|Overall Study|Withdrawal by Subject|47|||
16999569|NCT00720382|38143338|FG001|Overall Study|Withdrawal by Subject|11|||
16999570|NCT00720382|38143337|FG000|Overall Study|Lost to Follow-up|28|||
16999571|NCT00720382|38143338|FG001|Overall Study|Lost to Follow-up|14|||
16999572|NCT00720382|38143337|FG000|Overall Study|administrative|14|||
16999573|NCT00720382|38143338|FG001|Overall Study|administrative|5|||
16999574|NCT00720226|38143346|FG000|Overall Study|Withdrawal by Subject|7|||
16999575|NCT00720226|38143347|FG001|Overall Study|Withdrawal by Subject|4|||
16999576|NCT00725920|38143355|FG000|Overall Study|Lack of Efficacy|3|||
16999577|NCT00725920|38143356|FG001|Overall Study|Lack of Efficacy|6|||
16999578|NCT00725842|38143362|FG000|Overall Study|Lost to Follow-up|19|||
16999579|NCT00725842|38143362|FG000|Overall Study|Death|1|||
16999580|NCT00725842|38143362|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
16999581|NCT00725842|38143362|FG000|Overall Study|Consent date prior to study start date|5|||
16999582|NCT00725842|38143362|FG000|Overall Study|Inclusion criterion not met|1|||
16999583|NCT00725842|38143362|FG000|Overall Study|No Visit 1 data|1|||
16999584|NCT00725764|38143366|FG000|Overall Study|Withdrawal by Subject|2|||
16999585|NCT00725764|38143366|FG000|Overall Study|Physician Decision|1|||
16999586|NCT00725764|38143366|FG000|Overall Study|Progressive Disease|7|||
16999587|NCT00725764|38143366|FG000|Overall Study|Lost to Follow-up|1|||
16999588|NCT00725764|38143366|FG000|Overall Study|Death|1|||
16999589|NCT00725764|38143366|FG000|Overall Study|Participant non compliant with protocol|1|||
16999590|NCT00725764|38143366|FG000|Overall Study|Decline in performance status|1|||
16999591|NCT00725608|38143371|FG000|Overall Study|Lost to Follow-up|60|||
16999592|NCT00725608|38143371|FG000|Overall Study|Adverse Event|14|||
16999593|NCT00725608|38143371|FG000|Overall Study|Individual reasons|86|||
16999594|NCT00725608|38143371|FG000|Overall Study|Other|7|||
16999595|NCT00725452|38143375|FG000|Overall Study|Adverse Event|3|||
17093235|NCT00267098|38232831|FG003|Overall Study|Lost to Follow-up|5|||
17093236|NCT00267098|38232832|FG004|Overall Study|Lost to Follow-up|2|||
17093237|NCT00267098|38232833|FG005|Overall Study|Lost to Follow-up|3|||
17093238|NCT00267098|38232834|FG006|Overall Study|Lost to Follow-up|1|||
17093239|NCT00267098|38232835|FG007|Overall Study|Lost to Follow-up|1|||
17093240|NCT00267098|38232828|FG000|Overall Study|Withdrawal by Subject|8|||
17093241|NCT00267098|38232829|FG001|Overall Study|Withdrawal by Subject|0|||
17093242|NCT00267098|38232830|FG002|Overall Study|Withdrawal by Subject|24|||
17093243|NCT00267098|38232831|FG003|Overall Study|Withdrawal by Subject|21|||
17093244|NCT00267098|38232832|FG004|Overall Study|Withdrawal by Subject|12|||
17093245|NCT00267098|38232833|FG005|Overall Study|Withdrawal by Subject|9|||
17093246|NCT00267098|38232834|FG006|Overall Study|Withdrawal by Subject|12|||
17093247|NCT00267098|38232835|FG007|Overall Study|Withdrawal by Subject|5|||
17093248|NCT00267098|38232828|FG000|Overall Study|Physician Decision|5|||
17093249|NCT00267098|38232829|FG001|Overall Study|Physician Decision|0|||
17093250|NCT00267098|38232830|FG002|Overall Study|Physician Decision|7|||
17093251|NCT00267098|38232831|FG003|Overall Study|Physician Decision|11|||
17093252|NCT00267098|38232832|FG004|Overall Study|Physician Decision|5|||
17093253|NCT00267098|38232833|FG005|Overall Study|Physician Decision|4|||
17093254|NCT00267098|38232834|FG006|Overall Study|Physician Decision|3|||
17093255|NCT00267098|38232835|FG007|Overall Study|Physician Decision|0|||
17093256|NCT00267098|38232828|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
16999596|NCT00725452|38143375|FG000|Overall Study|Lack of Efficacy|2|||
16999597|NCT00725452|38143375|FG000|Overall Study|Reason not specified|1|||
16999598|NCT00725452|38143375|FG000|Overall Study|Physician Decision|1|||
16999599|NCT00725452|38143375|FG000|Overall Study|Withdrawal by Subject|3|||
16999600|NCT00725452|38143375|FG000|Overall Study|Lost to Follow-up|1|||
16999601|NCT00725296|38143379|FG000|Overall Study|Adverse Event|11|||
16999602|NCT00725296|38143379|FG000|Overall Study|Lack of Efficacy|7|||
16999603|NCT00725296|38143379|FG000|Overall Study|Withdrawal by Subject|3|||
16999604|NCT00725296|38143379|FG000|Overall Study|Non-Compliance|2|||
16999605|NCT00725296|38143379|FG000|Overall Study|Lost to Follow-up|1|||
16999606|NCT00725296|38143379|FG000|Overall Study|Other|38|||
16999607|NCT00719680|38143384|FG000|Overall Study|Adverse Event|1|||
16999608|NCT00719680|38143384|FG000|Overall Study|Lost to Follow-up|1|||
16999609|NCT00719680|38143384|FG000|Overall Study|Withdrawal by Subject|3|||
16999610|NCT00719212|38143388|FG000|Overall Study|Death|41|||
16999611|NCT00719212|38143388|FG000|Overall Study|Lost to Follow-up|2|||
16999612|NCT00719212|38143388|FG000|Overall Study|Withdrawal by Subject|1|||
16999613|NCT00585052|38143392|FG000|Overall Study|Withdrawal by Subject|1|||
16999614|NCT00724282|38143396|FG000|Overall Study|Withdrawal by Subject|3|||
16999615|NCT00724282|38143396|FG000|Overall Study|Physician Decision|1|||
16999616|NCT00724126|38143402|FG000|Overall Study|Adverse Event|2|||
16999617|NCT00724126|38143403|FG001|Overall Study|Adverse Event|0|||
16999618|NCT00724126|38143402|FG000|Overall Study|Withdrawal by Subject|8|||
16999619|NCT00724126|38143403|FG001|Overall Study|Withdrawal by Subject|6|||
17093257|NCT00267098|38232829|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16999620|NCT00724126|38143402|FG000|Overall Study|Lost to Follow-up|6|||
16999621|NCT00724126|38143403|FG001|Overall Study|Lost to Follow-up|6|||
16999622|NCT00724126|38143402|FG000|Overall Study|Noncompliance|2|||
16999623|NCT00724126|38143403|FG001|Overall Study|Noncompliance|1|||
16999624|NCT00724126|38143402|FG000|Overall Study|Subject randomized although ineligible|1|||
16999625|NCT00724126|38143403|FG001|Overall Study|Subject randomized although ineligible|1|||
16999626|NCT00724126|38143402|FG000|Overall Study|Subject had to leave vicinity of site|0|||
16999627|NCT00724126|38143403|FG001|Overall Study|Subject had to leave vicinity of site|1|||
16999628|NCT00723892|38143411|FG000|Overall Study|Participant not tracked|33|||
16999629|NCT00723892|38143412|FG001|Overall Study|Participant not tracked|35|||
16999630|NCT00723892|38143411|FG000|Overall Study|Virological criterion|24|||
17093258|NCT00267098|38232830|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17093259|NCT00267098|38232831|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17093260|NCT00267098|38232832|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
17093261|NCT00267098|38232833|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17093262|NCT00267098|38232834|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17093263|NCT00267098|38232835|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17093264|NCT00267098|38232828|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
17093265|NCT00267098|38232829|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
17093266|NCT00267098|38232830|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
17093267|NCT00267098|38232831|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
16999631|NCT00723892|38143412|FG001|Overall Study|Virological criterion|9|||
16999632|NCT00723892|38143411|FG000|Overall Study|Withdrawal by Subject|6|||
16999633|NCT00723892|38143412|FG001|Overall Study|Withdrawal by Subject|9|||
16999634|NCT00723892|38143411|FG000|Overall Study|End planned|11|||
16999635|NCT00723892|38143412|FG001|Overall Study|End planned|7|||
16999636|NCT00723892|38143411|FG000|Overall Study|Bad tolerance|5|||
16999637|NCT00723892|38143412|FG001|Overall Study|Bad tolerance|5|||
16999638|NCT00723892|38143411|FG000|Overall Study|Multiple reasons|17|||
16999639|NCT00723892|38143412|FG001|Overall Study|Multiple reasons|12|||
16999640|NCT00723892|38143411|FG000|Overall Study|Other|6|||
16999641|NCT00723892|38143412|FG001|Overall Study|Other|3|||
16999642|NCT00723892|38143411|FG000|Overall Study|Study end|1|||
16999643|NCT00723892|38143412|FG001|Overall Study|Study end|3|||
16999644|NCT00723892|38143411|FG000|Overall Study|Weight loss|1|||
16999645|NCT00723892|38143412|FG001|Overall Study|Weight loss|3|||
16999646|NCT00723892|38143411|FG000|Overall Study|Alcohol abuse|0|||
16999647|NCT00723892|38143412|FG001|Overall Study|Alcohol abuse|1|||
16999648|NCT00723892|38143411|FG000|Overall Study|Intercurrent infection|2|||
16999649|NCT00723892|38143412|FG001|Overall Study|Intercurrent infection|0|||
16999650|NCT00723892|38143411|FG000|Overall Study|Drug addiction|1|||
16999651|NCT00723892|38143412|FG001|Overall Study|Drug addiction|0|||
16999652|NCT00718666|38143421|FG000|Booster Phase Year 5|No active participation request|0|||
16999653|NCT00718666|38143422|FG001|Booster Phase Year 5|No active participation request|0|||
16999654|NCT00718666|38143423|FG002|Booster Phase Year 5|No active participation request|1|||
16999655|NCT00718666|38143421|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
16999656|NCT00718666|38143422|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
16999657|NCT00718666|38143423|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
16999658|NCT00718666|38143421|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
16999659|NCT00718666|38143422|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
17093268|NCT00267098|38232832|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
17093269|NCT00267098|38232833|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
17093270|NCT00267098|38232834|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
17093271|NCT00267098|38232835|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
17093272|NCT00267098|38232828|FG000|Overall Study|Site closure|0|||
17093273|NCT00267098|38232829|FG001|Overall Study|Site closure|0|||
17093274|NCT00267098|38232830|FG002|Overall Study|Site closure|0|||
17093275|NCT00267098|38232831|FG003|Overall Study|Site closure|1|||
17093276|NCT00267098|38232832|FG004|Overall Study|Site closure|0|||
17093277|NCT00267098|38232833|FG005|Overall Study|Site closure|1|||
17093278|NCT00267098|38232834|FG006|Overall Study|Site closure|1|||
17093279|NCT00267098|38232835|FG007|Overall Study|Site closure|0|||
17093280|NCT00267098|38232828|FG000|Overall Study|Explanted Medtronic device|0|||
17093281|NCT00267098|38232829|FG001|Overall Study|Explanted Medtronic device|0|||
17093282|NCT00267098|38232830|FG002|Overall Study|Explanted Medtronic device|0|||
17093283|NCT00267098|38232831|FG003|Overall Study|Explanted Medtronic device|1|||
17093284|NCT00267098|38232832|FG004|Overall Study|Explanted Medtronic device|0|||
17093285|NCT00267098|38232833|FG005|Overall Study|Explanted Medtronic device|0|||
17093286|NCT00267098|38232834|FG006|Overall Study|Explanted Medtronic device|0|||
16999660|NCT00718666|38143423|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
16999661|NCT00718666|38143421|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
16999662|NCT00718666|38143422|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
16999663|NCT00718666|38143423|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
16999664|NCT03950440|38143444|FG000|Overall Study|Death|8|||
17093287|NCT00267098|38232835|FG007|Overall Study|Explanted Medtronic device|0|||
17093288|NCT00267098|38232828|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
17093289|NCT00267098|38232829|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
17093290|NCT00267098|38232830|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
17093291|NCT00267098|38232831|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
17093292|NCT00267098|38232832|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
17093293|NCT00267098|38232833|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
17093294|NCT00267098|38232834|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
17093295|NCT00267098|38232835|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
17093296|NCT00267098|38232828|FG000|Overall Study|Subject listed for heart transplant|0|||
17093297|NCT00267098|38232829|FG001|Overall Study|Subject listed for heart transplant|0|||
17093298|NCT00267098|38232830|FG002|Overall Study|Subject listed for heart transplant|0|||
17093299|NCT00267098|38232831|FG003|Overall Study|Subject listed for heart transplant|0|||
17093300|NCT00267098|38232832|FG004|Overall Study|Subject listed for heart transplant|0|||
17093301|NCT00267098|38232833|FG005|Overall Study|Subject listed for heart transplant|0|||
17093302|NCT00267098|38232834|FG006|Overall Study|Subject listed for heart transplant|1|||
17093303|NCT00267098|38232835|FG007|Overall Study|Subject listed for heart transplant|0|||
17093304|NCT00267098|38232828|FG000|Overall Study|Sponsor withdrew subject|0|||
16783612|NCT02683187|37723419|FG000|Overall Study|Withdrawal by Subject|5|||
16783613|NCT02683109|37723429|FG000|Overall Study|Adverse Event|1|||
16783614|NCT02683109|37723430|FG001|Overall Study|Adverse Event|0|||
16783615|NCT02544321|37723439|FG000|Overall Study|Withdrawal by Subject|1|||
16783616|NCT02544321|37723440|FG001|Overall Study|Withdrawal by Subject|2|||
16783617|NCT02544321|37723439|FG000|Overall Study|Adverse Event|1|||
16783618|NCT02544321|37723440|FG001|Overall Study|Adverse Event|1|||
16783619|NCT02544321|37723439|FG000|Overall Study|Protocol Violation|0|||
16783620|NCT02544321|37723440|FG001|Overall Study|Protocol Violation|1|||
16783621|NCT02533401|37723455|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
16783622|NCT02533401|37723455|FG000|Overall Study|Death|5|||
16783623|NCT02533401|37723455|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
16783624|NCT02533401|37723455|FG000|Overall Study|Lost to Follow-up|1|||
16783625|NCT02533401|37723455|FG000|Overall Study|Violation of Selection Criteria|1|||
16783626|NCT02536833|37723463|FG000|Overall Study|Discontinued Before Treatment|0|||
16783627|NCT02536833|37723464|FG001|Overall Study|Discontinued Before Treatment|0|||
16783628|NCT02536833|37723465|FG002|Overall Study|Discontinued Before Treatment|1|||
16783629|NCT02536833|37723466|FG003|Overall Study|Discontinued Before Treatment|2|||
16783630|NCT02536833|37723463|FG000|Overall Study|Adverse Event|1|||
16783631|NCT02536833|37723464|FG001|Overall Study|Adverse Event|3|||
16783632|NCT02536833|37723465|FG002|Overall Study|Adverse Event|4|||
16783633|NCT02536833|37723466|FG003|Overall Study|Adverse Event|1|||
16783634|NCT02536833|37723463|FG000|Overall Study|Lost to Follow-up|2|||
16783635|NCT02536833|37723464|FG001|Overall Study|Lost to Follow-up|1|||
16783636|NCT02536833|37723465|FG002|Overall Study|Lost to Follow-up|2|||
16783637|NCT02536833|37723466|FG003|Overall Study|Lost to Follow-up|2|||
16783638|NCT02536833|37723463|FG000|Overall Study|Physician Decision|0|||
16783639|NCT02536833|37723464|FG001|Overall Study|Physician Decision|0|||
16783640|NCT02536833|37723465|FG002|Overall Study|Physician Decision|0|||
16783641|NCT02536833|37723466|FG003|Overall Study|Physician Decision|1|||
16783642|NCT02536833|37723463|FG000|Overall Study|Site Terminated by Sponsor|2|||
16783643|NCT02536833|37723464|FG001|Overall Study|Site Terminated by Sponsor|2|||
16783644|NCT02536833|37723465|FG002|Overall Study|Site Terminated by Sponsor|2|||
16783645|NCT02536833|37723466|FG003|Overall Study|Site Terminated by Sponsor|2|||
16783646|NCT02536833|37723463|FG000|Overall Study|Subject Non-Compliance|0|||
16783647|NCT02536833|37723464|FG001|Overall Study|Subject Non-Compliance|1|||
16783648|NCT02536833|37723465|FG002|Overall Study|Subject Non-Compliance|1|||
16783649|NCT02536833|37723466|FG003|Overall Study|Subject Non-Compliance|0|||
16783650|NCT02536833|37723463|FG000|Overall Study|Withdrawal by Subject|4|||
16783651|NCT02536833|37723464|FG001|Overall Study|Withdrawal by Subject|3|||
16783652|NCT02536833|37723465|FG002|Overall Study|Withdrawal by Subject|5|||
16783653|NCT02536833|37723466|FG003|Overall Study|Withdrawal by Subject|11|||
16783654|NCT02680847|37723480|FG000|Overall Study|Other|2|||
16783655|NCT02680847|37723481|FG001|Overall Study|Other|0|||
16783656|NCT02680847|37723482|FG002|Overall Study|Other|0|||
16783657|NCT02680847|37723480|FG000|Overall Study|No longer met eligibility criteria|2|||
16783658|NCT02680847|37723481|FG001|Overall Study|No longer met eligibility criteria|2|||
16783659|NCT02680847|37723482|FG002|Overall Study|No longer met eligibility criteria|0|||
16783660|NCT02680847|37723480|FG000|Overall Study|Unwilling to participate in study|1|||
16783661|NCT02680847|37723481|FG001|Overall Study|Unwilling to participate in study|1|||
16783662|NCT02680847|37723482|FG002|Overall Study|Unwilling to participate in study|0|||
16783663|NCT02680847|37723480|FG000|Overall Study|Lack of Efficacy|0|||
16783664|NCT02680847|37723481|FG001|Overall Study|Lack of Efficacy|0|||
16783665|NCT02680847|37723482|FG002|Overall Study|Lack of Efficacy|2|||
16783666|NCT02680847|37723480|FG000|Overall Study|Adverse Event|0|||
16783667|NCT02680847|37723481|FG001|Overall Study|Adverse Event|0|||
16783668|NCT02680847|37723482|FG002|Overall Study|Adverse Event|1|||
16999665|NCT03950440|38143445|FG001|Overall Study|Death|2|||
16999666|NCT03950440|38143446|FG002|Overall Study|Death|1|||
16783669|NCT02532855|37723492|FG000|Overall Study|Lost to Follow-up|4|||
16783670|NCT02532855|37723493|FG001|Overall Study|Lost to Follow-up|3|||
16783671|NCT02532855|37723492|FG000|Overall Study|Withdrawal by Subject|4|||
16783672|NCT02532855|37723493|FG001|Overall Study|Withdrawal by Subject|8|||
16783673|NCT02530125|37723499|FG000|Completed Treatment|Early termination of study|1|||
16783674|NCT02530125|37723499|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
16783675|NCT01661205|37723503|FG000|Overall Study|Physician Decision|2|||
16783676|NCT02055820|37723517|FG000|Phase I: Dose-Finding|Death|1|||
16783677|NCT02055820|37723518|FG001|Phase I: Dose-Finding|Death|0|||
16783678|NCT02055820|37723519|FG002|Phase I: Dose-Finding|Death|1|||
16783679|NCT02055820|37723520|FG003|Phase I: Dose-Finding|Death|2|||
16783680|NCT02055820|37723521|FG004|Phase I: Dose-Finding|Death|0|||
16783681|NCT02055820|37723522|FG005|Phase I: Dose-Finding|Death|1|||
16783682|NCT02055820|37723523|FG006|Phase I: Dose-Finding|Death|1|||
16783683|NCT02055820|37723524|FG007|Phase I: Dose-Finding|Death|0|||
16783684|NCT02055820|37723525|FG008|Phase I: Dose-Finding|Death|0|||
16783685|NCT02055820|37723526|FG009|Phase I: Dose-Finding|Death|0|||
16783686|NCT02055820|37723517|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783687|NCT02055820|37723518|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783688|NCT02055820|37723519|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783689|NCT02055820|37723520|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783690|NCT02055820|37723521|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783691|NCT02055820|37723522|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
16783692|NCT02055820|37723523|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783693|NCT02055820|37723524|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783694|NCT02055820|37723525|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783695|NCT02055820|37723526|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16783696|NCT02055820|37723517|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
16783697|NCT02055820|37723518|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
16783698|NCT02055820|37723519|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
16783699|NCT02055820|37723520|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
16783700|NCT02055820|37723521|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
16783701|NCT02055820|37723522|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
16783702|NCT02055820|37723523|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
16999667|NCT00718510|38143456|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
16999668|NCT00718510|38143457|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16999669|NCT00718510|38143456|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
16999670|NCT00718510|38143457|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
16999671|NCT00585286|38143463|FG000|Overall Study|Lost to Follow-up|1|||
16999672|NCT00723190|38143467|FG000|Overall Study|Withdrawal by Subject|45|||
17093305|NCT00267098|38232829|FG001|Overall Study|Sponsor withdrew subject|0|||
17093306|NCT00267098|38232830|FG002|Overall Study|Sponsor withdrew subject|0|||
17093307|NCT00267098|38232831|FG003|Overall Study|Sponsor withdrew subject|1|||
17093308|NCT00267098|38232832|FG004|Overall Study|Sponsor withdrew subject|0|||
17093309|NCT00267098|38232833|FG005|Overall Study|Sponsor withdrew subject|0|||
17093310|NCT00267098|38232834|FG006|Overall Study|Sponsor withdrew subject|0|||
17093311|NCT00267098|38232835|FG007|Overall Study|Sponsor withdrew subject|0|||
17093312|NCT00247676|38232858|FG000|Overall Study|Death|5|||
17093313|NCT00247676|38232858|FG000|Overall Study|Adverse Event|11|||
17093314|NCT00247676|38232858|FG000|Overall Study|Lack of Efficacy|15|||
17093315|NCT00247676|38232858|FG000|Overall Study|Other|3|||
17093316|NCT00247676|38232858|FG000|Overall Study|Withdrawal by Subject|2|||
17093317|NCT00267020|38232864|FG000|Overall Study|Adverse Event|22|||
17093318|NCT00267020|38232865|FG001|Overall Study|Adverse Event|5|||
17093319|NCT00267020|38232864|FG000|Overall Study|Death|2|||
17093320|NCT00267020|38232865|FG001|Overall Study|Death|1|||
17093321|NCT00267020|38232864|FG000|Overall Study|Withdrawal by Subject|17|||
17093322|NCT00267020|38232865|FG001|Overall Study|Withdrawal by Subject|7|||
17093323|NCT00267020|38232864|FG000|Overall Study|Physician Decision|3|||
17093324|NCT00267020|38232865|FG001|Overall Study|Physician Decision|2|||
17093325|NCT00267020|38232864|FG000|Overall Study|Disease Progression|39|||
17093326|NCT00267020|38232865|FG001|Overall Study|Disease Progression|25|||
17093327|NCT00267020|38232864|FG000|Overall Study|Unrelated Complication|1|||
17093328|NCT00267020|38232865|FG001|Overall Study|Unrelated Complication|1|||
17093329|NCT00267020|38232864|FG000|Overall Study|Sponsor Request|1|||
17093330|NCT00267020|38232865|FG001|Overall Study|Sponsor Request|0|||
16783703|NCT02055820|37723524|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
16783704|NCT02055820|37723525|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
16783705|NCT02055820|37723526|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
16783706|NCT02055820|37723517|FG000|Phase II: Expansion|Death|0|||
16783707|NCT02055820|37723518|FG001|Phase II: Expansion|Death|0|||
16783708|NCT02055820|37723519|FG002|Phase II: Expansion|Death|0|||
16783709|NCT02055820|37723520|FG003|Phase II: Expansion|Death|0|||
17093331|NCT00267020|38232864|FG000|Overall Study|Other|1|||
17093332|NCT00267020|38232865|FG001|Overall Study|Other|2|||
17093333|NCT00242216|38232873|FG000|Overall Study|Lost to Follow-up|12|||
16999673|NCT00723190|38143467|FG000|Overall Study|Lost to Follow-up|37|||
16999674|NCT00723190|38143467|FG000|Overall Study|Adverse Event|18|||
16999675|NCT00723190|38143467|FG000|Overall Study|Lack of Efficacy|16|||
16999676|NCT00723190|38143467|FG000|Overall Study|Protocol Violation|15|||
16999677|NCT00723190|38143467|FG000|Overall Study|Other-Premature Discontinuation|9|||
16999678|NCT00723190|38143467|FG000|Overall Study|Other-Not included in safety population|2|||
16999679|NCT00722800|38143473|FG000|Overall Study|Withdrawal by Subject|1|||
16999680|NCT00722800|38143474|FG001|Overall Study|Withdrawal by Subject|0|||
16999681|NCT00722800|38143473|FG000|Overall Study|Physician Decision|1|||
16999682|NCT00722800|38143474|FG001|Overall Study|Physician Decision|0|||
16999683|NCT00718042|38143486|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16999684|NCT00718042|38143487|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16999685|NCT00718042|38143488|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16999686|NCT00718042|38143489|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16999687|NCT00718042|38143490|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
16999688|NCT00718042|38143491|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16999689|NCT00718042|38143486|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
16999690|NCT00718042|38143487|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
16999691|NCT00718042|38143488|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
16999692|NCT00718042|38143489|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
16999693|NCT00718042|38143490|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
16783710|NCT02055820|37723521|FG004|Phase II: Expansion|Death|33|||
16783711|NCT02055820|37723522|FG005|Phase II: Expansion|Death|0|||
16783712|NCT02055820|37723523|FG006|Phase II: Expansion|Death|0|||
16783713|NCT02055820|37723524|FG007|Phase II: Expansion|Death|0|||
16783714|NCT02055820|37723525|FG008|Phase II: Expansion|Death|0|||
16999694|NCT00718042|38143491|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
16999695|NCT00718042|38143486|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
16999696|NCT00718042|38143487|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
16999697|NCT00718042|38143488|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
16999698|NCT00718042|38143489|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
16999699|NCT00718042|38143490|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
16999700|NCT00718042|38143491|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
16999701|NCT00718042|38143486|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16999702|NCT00718042|38143487|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
16999703|NCT00718042|38143488|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16999704|NCT00718042|38143489|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16999705|NCT00718042|38143490|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16999706|NCT00718042|38143491|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16999707|NCT00718042|38143486|FG000|Donor Follow-up|Lost to Follow-up|13|||
16999708|NCT00718042|38143487|FG001|Donor Follow-up|Lost to Follow-up|0|||
16999709|NCT00718042|38143488|FG002|Donor Follow-up|Lost to Follow-up|0|||
16999710|NCT00718042|38143489|FG003|Donor Follow-up|Lost to Follow-up|0|||
16999711|NCT00718042|38143490|FG004|Donor Follow-up|Lost to Follow-up|19|||
16999712|NCT00718042|38143491|FG005|Donor Follow-up|Lost to Follow-up|0|||
17093334|NCT00242216|38232874|FG001|Overall Study|Lost to Follow-up|17|||
16783715|NCT02055820|37723526|FG009|Phase II: Expansion|Death|0|||
16783716|NCT02055820|37723517|FG000|Phase II: Expansion|Lost to Follow-up|0|||
16783717|NCT02055820|37723518|FG001|Phase II: Expansion|Lost to Follow-up|0|||
16783718|NCT02055820|37723519|FG002|Phase II: Expansion|Lost to Follow-up|0|||
16783719|NCT02055820|37723520|FG003|Phase II: Expansion|Lost to Follow-up|0|||
16783720|NCT02055820|37723521|FG004|Phase II: Expansion|Lost to Follow-up|4|||
16783721|NCT02055820|37723522|FG005|Phase II: Expansion|Lost to Follow-up|0|||
16783722|NCT02055820|37723523|FG006|Phase II: Expansion|Lost to Follow-up|0|||
16783723|NCT02055820|37723524|FG007|Phase II: Expansion|Lost to Follow-up|0|||
16783724|NCT02055820|37723525|FG008|Phase II: Expansion|Lost to Follow-up|0|||
16783725|NCT02055820|37723526|FG009|Phase II: Expansion|Lost to Follow-up|0|||
16783726|NCT02055820|37723517|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
16783727|NCT02055820|37723518|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
16783728|NCT02055820|37723519|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
16783729|NCT02055820|37723520|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
16783730|NCT02055820|37723521|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
16783731|NCT02055820|37723522|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
16783732|NCT02055820|37723523|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
16783733|NCT02055820|37723524|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
16783734|NCT02055820|37723525|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
16783735|NCT02055820|37723526|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
16868372|NCT01533935|37841437|FG001|Overall Study|Protocol Violation|2|||
16783736|NCT02055352|37723570|FG000|Overall Study|Adverse Event|0|||
16783737|NCT02055352|37723571|FG001|Overall Study|Adverse Event|1|||
16783738|NCT02055352|37723570|FG000|Overall Study|Non-eligible|0|||
16999713|NCT00741598|38143505|FG000|Overall Study|Lost to Follow-up|3|||
16999714|NCT00741598|38143506|FG001|Overall Study|Lost to Follow-up|4|||
16999715|NCT00741598|38143505|FG000|Overall Study|Lack of Efficacy|1|||
16999716|NCT00741598|38143506|FG001|Overall Study|Lack of Efficacy|2|||
16999717|NCT00741598|38143505|FG000|Overall Study|Physician Decision|1|||
16999718|NCT00741598|38143506|FG001|Overall Study|Physician Decision|1|||
16999719|NCT00741598|38143505|FG000|Overall Study|Pregnancy|1|||
16999720|NCT00741598|38143506|FG001|Overall Study|Pregnancy|0|||
16999721|NCT00741598|38143505|FG000|Overall Study|Withdrawal by Subject|3|||
16999722|NCT00741598|38143506|FG001|Overall Study|Withdrawal by Subject|2|||
16999723|NCT00717886|38143513|FG000|Overall Study|Withdrawal by Subject|3|||
16999724|NCT00717886|38143513|FG000|Overall Study|Treatment Failure|1|||
16999725|NCT00741286|38143519|FG000|Overall Study|Lost to Follow-up|15|||
16999726|NCT00741286|38143520|FG001|Overall Study|Lost to Follow-up|10|||
16999727|NCT00741286|38143519|FG000|Overall Study|Adverse Event|1|||
16999728|NCT00741286|38143520|FG001|Overall Study|Adverse Event|6|||
16999729|NCT00741286|38143519|FG000|Overall Study|Protocol Violation|3|||
16999730|NCT00741286|38143520|FG001|Overall Study|Protocol Violation|2|||
16999731|NCT00741286|38143519|FG000|Overall Study|Primary Outcome|1|||
16999732|NCT00741286|38143520|FG001|Overall Study|Primary Outcome|1|||
16999733|NCT00716482|38143526|FG000|Overall Study|Lost to Follow-up|6|||
16999734|NCT00716482|38143526|FG000|Overall Study|Inadequate acquisition or analysis|50|||
16999735|NCT00716482|38143526|FG000|Overall Study|no pathology obtained|10|||
16999736|NCT00716482|38143526|FG000|Overall Study|technical/machine error|28|||
16999737|NCT00716482|38143526|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
16999738|NCT00716092|38143539|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
16999739|NCT00716092|38143540|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
16999740|NCT00716092|38143541|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
16999741|NCT00715624|38143551|FG000|Overall Study|Adverse Event|12|||
17093335|NCT00242216|38232873|FG000|Overall Study|Death|4|||
17093336|NCT00242216|38232874|FG001|Overall Study|Death|2|||
17093337|NCT00242216|38232873|FG000|Overall Study|Lack of Efficacy|1|||
17093338|NCT00242216|38232874|FG001|Overall Study|Lack of Efficacy|2|||
17093339|NCT00242216|38232873|FG000|Overall Study|no medicaiton dispensed|1|||
17093340|NCT00242216|38232874|FG001|Overall Study|no medicaiton dispensed|1|||
17093341|NCT00240110|38232882|FG000|Overall Study|Lost to Follow-up|6|||
17093342|NCT00240110|38232883|FG001|Overall Study|Lost to Follow-up|7|||
17093343|NCT00239720|38232893|FG000|Overall Study|Adverse Event|1|||
17093344|NCT00239720|38232894|FG001|Overall Study|Adverse Event|0|||
17093345|NCT00239720|38232893|FG000|Overall Study|Lost to Follow-up|0|||
17093346|NCT00239720|38232894|FG001|Overall Study|Lost to Follow-up|1|||
17093347|NCT00266864|38232902|FG000|Overall Study|Lost to Follow-up|4|||
17093348|NCT00266864|38232903|FG001|Overall Study|Lost to Follow-up|1|||
17093349|NCT00266864|38232902|FG000|Overall Study|Withdrawal by Subject|1|||
17093350|NCT00266864|38232903|FG001|Overall Study|Withdrawal by Subject|1|||
17093351|NCT00266708|38232911|FG000|Overall Study|No renal function|1|||
17093352|NCT00266708|38232912|FG001|Overall Study|No renal function|1|||
17093353|NCT00266708|38232911|FG000|Overall Study|Refused biopsy|3|||
17093354|NCT00266708|38232912|FG001|Overall Study|Refused biopsy|6|||
17093355|NCT00266708|38232911|FG000|Overall Study|Asthma|0|||
17093356|NCT00266708|38232912|FG001|Overall Study|Asthma|2|||
17093357|NCT00266630|38232920|FG000|Overall Study|Adverse Event|8|||
17093358|NCT00266630|38232921|FG001|Overall Study|Adverse Event|6|||
17093359|NCT00266630|38232920|FG000|Overall Study|Lack of Efficacy|1|||
17093360|NCT00266630|38232921|FG001|Overall Study|Lack of Efficacy|4|||
17093361|NCT00266630|38232920|FG000|Overall Study|Entry Criteria not met|1|||
17093362|NCT00266630|38232921|FG001|Overall Study|Entry Criteria not met|0|||
17093363|NCT00266630|38232920|FG000|Overall Study|Protocol Violation|1|||
17093364|NCT00266630|38232921|FG001|Overall Study|Protocol Violation|3|||
17093365|NCT00266630|38232920|FG000|Overall Study|Physician Decision|1|||
17093366|NCT00266630|38232921|FG001|Overall Study|Physician Decision|2|||
17093367|NCT00266630|38232920|FG000|Overall Study|Withdrawal by Subject|10|||
17093368|NCT00266630|38232921|FG001|Overall Study|Withdrawal by Subject|2|||
17093369|NCT00266630|38232920|FG000|Overall Study|Lost to Follow-up|1|||
17093370|NCT00266630|38232921|FG001|Overall Study|Lost to Follow-up|0|||
17093371|NCT00266630|38232920|FG000|Overall Study|Other|19|||
17093372|NCT00266630|38232921|FG001|Overall Study|Other|11|||
17093373|NCT00129129|38232932|FG000|Primary Phase|Adverse Event|2|||
17093374|NCT00129129|38232933|FG001|Primary Phase|Adverse Event|1|||
17093375|NCT00129129|38232934|FG002|Primary Phase|Adverse Event|0|||
17093376|NCT00129129|38232935|FG003|Primary Phase|Adverse Event|0|||
17093377|NCT00129129|38232936|FG004|Primary Phase|Adverse Event|0|||
17093378|NCT00129129|38232932|FG000|Primary Phase|Withdrawal by Subject|12|||
16999742|NCT00715624|38143552|FG001|Overall Study|Adverse Event|37|||
16999743|NCT00715624|38143551|FG000|Overall Study|Lack of Efficacy|11|||
17093379|NCT00129129|38232933|FG001|Primary Phase|Withdrawal by Subject|10|||
17093380|NCT00129129|38232934|FG002|Primary Phase|Withdrawal by Subject|0|||
17093381|NCT00129129|38232935|FG003|Primary Phase|Withdrawal by Subject|0|||
17190416|NCT02489344|38343289|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
16999744|NCT00715624|38143552|FG001|Overall Study|Lack of Efficacy|11|||
17093382|NCT00129129|38232936|FG004|Primary Phase|Withdrawal by Subject|0|||
17093383|NCT00129129|38232932|FG000|Primary Phase|Migration from study area|1|||
17093384|NCT00129129|38232933|FG001|Primary Phase|Migration from study area|3|||
17093385|NCT00129129|38232934|FG002|Primary Phase|Migration from study area|0|||
17093386|NCT00129129|38232935|FG003|Primary Phase|Migration from study area|0|||
17093387|NCT00129129|38232936|FG004|Primary Phase|Migration from study area|0|||
17093388|NCT00129129|38232932|FG000|Primary Phase|Lost to Follow-up|8|||
17093389|NCT00129129|38232933|FG001|Primary Phase|Lost to Follow-up|6|||
17093390|NCT00129129|38232934|FG002|Primary Phase|Lost to Follow-up|0|||
17093391|NCT00129129|38232935|FG003|Primary Phase|Lost to Follow-up|0|||
17093392|NCT00129129|38232936|FG004|Primary Phase|Lost to Follow-up|0|||
17093393|NCT00129129|38232932|FG000|Primary Phase|Other|2|||
17093394|NCT00129129|38232933|FG001|Primary Phase|Other|5|||
17093395|NCT00129129|38232934|FG002|Primary Phase|Other|0|||
17093396|NCT00129129|38232935|FG003|Primary Phase|Other|0|||
17093397|NCT00129129|38232936|FG004|Primary Phase|Other|0|||
17093398|NCT00129129|38232932|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
17093399|NCT00129129|38232933|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
17093400|NCT00129129|38232934|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
17093401|NCT00129129|38232935|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
17093402|NCT00129129|38232936|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
17093403|NCT00129129|38232932|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
17093404|NCT00129129|38232933|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
17093405|NCT00129129|38232934|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
17093406|NCT00129129|38232935|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
17093407|NCT00129129|38232936|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
17093408|NCT00129129|38232932|FG000|Fourth Dose Phase|Migration from study area|0|||
17093409|NCT00129129|38232933|FG001|Fourth Dose Phase|Migration from study area|0|||
17093410|NCT00129129|38232934|FG002|Fourth Dose Phase|Migration from study area|0|||
17093411|NCT00129129|38232935|FG003|Fourth Dose Phase|Migration from study area|0|||
17093412|NCT00129129|38232936|FG004|Fourth Dose Phase|Migration from study area|2|||
17093413|NCT00129129|38232932|FG000|Fourth Dose Phase|Other|0|||
17093414|NCT00129129|38232933|FG001|Fourth Dose Phase|Other|0|||
17093415|NCT00129129|38232934|FG002|Fourth Dose Phase|Other|0|||
17093416|NCT00129129|38232935|FG003|Fourth Dose Phase|Other|1|||
17093417|NCT00129129|38232936|FG004|Fourth Dose Phase|Other|1|||
17093418|NCT00129129|38232932|FG000|Fourth Dose Phase|Protocol Violation|0|||
17093419|NCT00129129|38232933|FG001|Fourth Dose Phase|Protocol Violation|0|||
17093420|NCT00129129|38232934|FG002|Fourth Dose Phase|Protocol Violation|0|||
17093421|NCT00129129|38232935|FG003|Fourth Dose Phase|Protocol Violation|1|||
17093422|NCT00129129|38232936|FG004|Fourth Dose Phase|Protocol Violation|0|||
17093423|NCT00221403|38232959|FG000|Overall Study|Protocol Violation|1|||
17093424|NCT00221403|38232960|FG001|Overall Study|Protocol Violation|0|||
17093425|NCT00221403|38232961|FG002|Overall Study|Protocol Violation|0|||
17093426|NCT00221403|38232959|FG000|Overall Study|Physician Decision|1|||
17093427|NCT00221403|38232960|FG001|Overall Study|Physician Decision|0|||
17093428|NCT00221403|38232961|FG002|Overall Study|Physician Decision|0|||
17093429|NCT00221403|38232959|FG000|Overall Study|Withdrawal by Subject|0|||
17093430|NCT00221403|38232960|FG001|Overall Study|Withdrawal by Subject|3|||
17093431|NCT00221403|38232961|FG002|Overall Study|Withdrawal by Subject|0|||
17093432|NCT00221403|38232959|FG000|Overall Study|Lack of Efficacy|0|||
17093433|NCT00221403|38232960|FG001|Overall Study|Lack of Efficacy|1|||
17093434|NCT00221403|38232961|FG002|Overall Study|Lack of Efficacy|0|||
17093435|NCT00221403|38232959|FG000|Overall Study|Adverse Event|0|||
17093436|NCT00221403|38232960|FG001|Overall Study|Adverse Event|1|||
17093437|NCT00221403|38232961|FG002|Overall Study|Adverse Event|0|||
17093438|NCT00145977|38232971|FG000|Overall Study|Lack of Efficacy|0|||
17093439|NCT00145977|38232972|FG001|Overall Study|Lack of Efficacy|4|||
17093440|NCT00145977|38232971|FG000|Overall Study|Lost to Follow-up|1|||
17093441|NCT00145977|38232972|FG001|Overall Study|Lost to Follow-up|0|||
17093442|NCT00145977|38232971|FG000|Overall Study|Withdrawal by Subject|1|||
17093443|NCT00145977|38232972|FG001|Overall Study|Withdrawal by Subject|0|||
17093444|NCT00238238|38232981|FG000|Overall Study|Withdrawal by Subject|0|||
17093445|NCT00238238|38232982|FG001|Overall Study|Withdrawal by Subject|3|||
17093446|NCT00238238|38232983|FG002|Overall Study|Withdrawal by Subject|0|||
17093447|NCT00128661|38232993|FG000|Overall Study|Adverse Event|14|||
17093448|NCT00128661|38232994|FG001|Overall Study|Adverse Event|11|||
17093449|NCT00128661|38232993|FG000|Overall Study|Lost to Follow-up|10|||
17093450|NCT00128661|38232994|FG001|Overall Study|Lost to Follow-up|7|||
17093451|NCT00128661|38232993|FG000|Overall Study|Withdrawal by Subject|243|||
17093452|NCT00128661|38232994|FG001|Overall Study|Withdrawal by Subject|232|||
17093453|NCT00128661|38232993|FG000|Overall Study|Other|7|||
17093454|NCT00128661|38232994|FG001|Overall Study|Other|8|||
17093455|NCT00145509|38233002|FG000|Overall Study|Adverse Event|10|||
17093456|NCT00145509|38233003|FG001|Overall Study|Adverse Event|3|||
17093457|NCT00145509|38233002|FG000|Overall Study|Lack of Efficacy|3|||
17093458|NCT00145509|38233003|FG001|Overall Study|Lack of Efficacy|1|||
17093459|NCT00145509|38233002|FG000|Overall Study|Lost to Follow-up|5|||
17093460|NCT00145509|38233003|FG001|Overall Study|Lost to Follow-up|9|||
17093461|NCT00145509|38233002|FG000|Overall Study|Withdrew Consent|2|||
17093462|NCT00145509|38233003|FG001|Overall Study|Withdrew Consent|7|||
17093463|NCT00145509|38233002|FG000|Overall Study|Reason not provided|2|||
17093464|NCT00145509|38233003|FG001|Overall Study|Reason not provided|1|||
17093465|NCT00145119|38233009|FG000|Overall Study|Death|45|||
17093466|NCT00220779|38233016|FG000|Overall Study|Adverse Event|1|||
17093467|NCT00220779|38233017|FG001|Overall Study|Adverse Event|0|||
17093468|NCT00220779|38233018|FG002|Overall Study|Adverse Event|0|||
17093469|NCT00220779|38233016|FG000|Overall Study|Withdrawal by Subject|1|||
17093470|NCT00220779|38233017|FG001|Overall Study|Withdrawal by Subject|4|||
17093471|NCT00220779|38233018|FG002|Overall Study|Withdrawal by Subject|1|||
17093472|NCT00220779|38233016|FG000|Overall Study|Non-compliance|1|||
17093473|NCT00220779|38233017|FG001|Overall Study|Non-compliance|0|||
17093474|NCT00220779|38233018|FG002|Overall Study|Non-compliance|0|||
17093475|NCT00220779|38233016|FG000|Overall Study|Too time consuming|1|||
17093476|NCT00220779|38233017|FG001|Overall Study|Too time consuming|0|||
17093477|NCT00220779|38233018|FG002|Overall Study|Too time consuming|0|||
17093478|NCT00220779|38233016|FG000|Overall Study|Pregnancy|0|||
17093479|NCT00220779|38233017|FG001|Overall Study|Pregnancy|0|||
17093480|NCT00220779|38233018|FG002|Overall Study|Pregnancy|2|||
17093481|NCT00220779|38233016|FG000|Overall Study|Lack of Efficacy|3|||
17093482|NCT00220779|38233017|FG001|Overall Study|Lack of Efficacy|0|||
17093483|NCT00220779|38233018|FG002|Overall Study|Lack of Efficacy|1|||
17093484|NCT00207740|38233030|FG000|Overall Study|Adverse Event|4|||
17093485|NCT00207740|38233031|FG001|Overall Study|Adverse Event|14|||
17093486|NCT00207740|38233032|FG002|Overall Study|Adverse Event|14|||
17093487|NCT00207740|38233033|FG003|Overall Study|Adverse Event|11|||
17093488|NCT00207740|38233030|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17093489|NCT00207740|38233031|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17093490|NCT00207740|38233032|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
17093491|NCT00207740|38233033|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
17093492|NCT00207740|38233030|FG000|Overall Study|Lost to Follow-up|0|||
16999745|NCT00715624|38143551|FG000|Overall Study|Lost to Follow-up|1|||
16999746|NCT00715624|38143552|FG001|Overall Study|Lost to Follow-up|2|||
16999747|NCT00715624|38143551|FG000|Overall Study|Protocol Violation|1|||
16999748|NCT00715624|38143552|FG001|Overall Study|Protocol Violation|0|||
16999749|NCT00715624|38143551|FG000|Overall Study|Withdrawal by Subject|11|||
16999750|NCT00715624|38143552|FG001|Overall Study|Withdrawal by Subject|25|||
16999751|NCT00715624|38143551|FG000|Overall Study|Familial and personal reasons|10|||
16999752|NCT00715624|38143552|FG001|Overall Study|Familial and personal reasons|22|||
16999753|NCT00715624|38143551|FG000|Overall Study|Poor compliance|6|||
16999754|NCT00715624|38143552|FG001|Overall Study|Poor compliance|13|||
16999755|NCT00715624|38143551|FG000|Overall Study|Sponsor decision|0|||
16999756|NCT00715624|38143552|FG001|Overall Study|Sponsor decision|4|||
16999757|NCT00715624|38143551|FG000|Overall Study|Incorrect randomization (not treated)|0|||
16999758|NCT00715624|38143552|FG001|Overall Study|Incorrect randomization (not treated)|1|||
16999759|NCT00715624|38143551|FG000|Overall Study|Other|0|||
16999760|NCT00715624|38143552|FG001|Overall Study|Other|1|||
17093493|NCT00207740|38233031|FG001|Overall Study|Lost to Follow-up|2|||
17093494|NCT00207740|38233032|FG002|Overall Study|Lost to Follow-up|1|||
17093495|NCT00207740|38233033|FG003|Overall Study|Lost to Follow-up|1|||
17093496|NCT00207740|38233030|FG000|Overall Study|Death|0|||
17093497|NCT00207740|38233031|FG001|Overall Study|Death|0|||
17093498|NCT00207740|38233032|FG002|Overall Study|Death|0|||
17093499|NCT00207740|38233033|FG003|Overall Study|Death|1|||
17093500|NCT00207740|38233030|FG000|Overall Study|Sponsor Directive|22|||
17093501|NCT00207740|38233031|FG001|Overall Study|Sponsor Directive|15|||
17093502|NCT00207740|38233032|FG002|Overall Study|Sponsor Directive|16|||
17093503|NCT00207740|38233033|FG003|Overall Study|Sponsor Directive|21|||
17093504|NCT00207740|38233030|FG000|Overall Study|Other|2|||
17093505|NCT00207740|38233031|FG001|Overall Study|Other|10|||
17093506|NCT00207740|38233032|FG002|Overall Study|Other|7|||
17093507|NCT00207740|38233033|FG003|Overall Study|Other|5|||
17093508|NCT00265382|38233047|FG000|Overall Study|Adverse Event|21|||
17093509|NCT00265382|38233047|FG000|Overall Study|Laboratory Abnormality|1|||
17093510|NCT00265382|38233047|FG000|Overall Study|Lost to Follow-up|3|||
17093511|NCT00265382|38233047|FG000|Overall Study|Lack of Efficacy|6|||
17093512|NCT00265382|38233047|FG000|Overall Study|Miscellaneous|6|||
17093513|NCT00265382|38233047|FG000|Overall Study|Withdrawal by Subject|13|||
17093514|NCT00265382|38233047|FG000|Overall Study|Study terminated by sponsor|94|||
17093515|NCT00265382|38233047|FG000|Overall Study|Death|1|||
17093516|NCT00206726|38233051|FG000|Overall Study|Delayed recovery of blood counts|1|||
17093517|NCT00206726|38233051|FG000|Overall Study|Progressive disease or relapsed disease|18|||
17093518|NCT00206726|38233051|FG000|Overall Study|Placed on new protocol|1|||
17093519|NCT00206726|38233051|FG000|Overall Study|Bone marrow transplant|1|||
17093520|NCT00206726|38233051|FG000|Overall Study|Adverse Event|17|||
17093521|NCT00206726|38233051|FG000|Overall Study|Death|4|||
16999761|NCT00679783|38143565|FG000|Overall Study|Adverse Event|0|||
16999762|NCT00679783|38143566|FG001|Overall Study|Adverse Event|0|||
17093522|NCT00206726|38233051|FG000|Overall Study|Protocol Violation|1|||
17093523|NCT00206726|38233051|FG000|Overall Study|Withdrawal by Subject|8|||
17093524|NCT00237692|38233059|FG000|Overall Study|Lost to Follow-up|9|||
17093525|NCT00237692|38233060|FG001|Overall Study|Lost to Follow-up|3|||
17093526|NCT00237692|38233061|FG002|Overall Study|Lost to Follow-up|5|||
17093527|NCT00237692|38233062|FG003|Overall Study|Lost to Follow-up|3|||
17093528|NCT00237692|38233059|FG000|Overall Study|Death|1|||
17093529|NCT00237692|38233060|FG001|Overall Study|Death|2|||
16999763|NCT00679783|38143567|FG002|Overall Study|Adverse Event|0|||
17093530|NCT00237692|38233061|FG002|Overall Study|Death|2|||
17093531|NCT00237692|38233062|FG003|Overall Study|Death|3|||
16999764|NCT00679783|38143568|FG003|Overall Study|Adverse Event|3|||
16999765|NCT00679783|38143569|FG004|Overall Study|Adverse Event|0|||
16999766|NCT00679783|38143570|FG005|Overall Study|Adverse Event|0|||
16999767|NCT00679783|38143571|FG006|Overall Study|Adverse Event|1|||
16999768|NCT00679783|38143565|FG000|Overall Study|Lack of Efficacy|0|||
16999769|NCT00679783|38143566|FG001|Overall Study|Lack of Efficacy|1|||
16999770|NCT00679783|38143567|FG002|Overall Study|Lack of Efficacy|0|||
16999771|NCT00679783|38143568|FG003|Overall Study|Lack of Efficacy|2|||
16999772|NCT00679783|38143569|FG004|Overall Study|Lack of Efficacy|0|||
16999773|NCT00679783|38143570|FG005|Overall Study|Lack of Efficacy|0|||
16999774|NCT00679783|38143571|FG006|Overall Study|Lack of Efficacy|0|||
16999775|NCT00679783|38143565|FG000|Overall Study|Withdrawal by Subject|0|||
16999776|NCT00679783|38143566|FG001|Overall Study|Withdrawal by Subject|0|||
16999777|NCT00679783|38143567|FG002|Overall Study|Withdrawal by Subject|1|||
16999778|NCT00679783|38143568|FG003|Overall Study|Withdrawal by Subject|1|||
16999779|NCT00679783|38143569|FG004|Overall Study|Withdrawal by Subject|0|||
16999780|NCT00679783|38143570|FG005|Overall Study|Withdrawal by Subject|0|||
16999781|NCT00679783|38143571|FG006|Overall Study|Withdrawal by Subject|0|||
16999782|NCT00679783|38143565|FG000|Overall Study|Not Captured|0|||
16999783|NCT00679783|38143566|FG001|Overall Study|Not Captured|0|||
16999784|NCT00679783|38143567|FG002|Overall Study|Not Captured|0|||
16999785|NCT00679783|38143568|FG003|Overall Study|Not Captured|5|||
16999786|NCT00679783|38143569|FG004|Overall Study|Not Captured|0|||
16999787|NCT00679783|38143570|FG005|Overall Study|Not Captured|0|||
16999788|NCT00679783|38143571|FG006|Overall Study|Not Captured|0|||
16999789|NCT00679783|38143565|FG000|Overall Study|Ongoing at data cut-off|2|||
16999790|NCT00679783|38143566|FG001|Overall Study|Ongoing at data cut-off|2|||
16999791|NCT00679783|38143567|FG002|Overall Study|Ongoing at data cut-off|0|||
16999792|NCT00679783|38143568|FG003|Overall Study|Ongoing at data cut-off|9|||
16999793|NCT00679783|38143569|FG004|Overall Study|Ongoing at data cut-off|1|||
16999794|NCT00679783|38143570|FG005|Overall Study|Ongoing at data cut-off|0|||
16999795|NCT00679783|38143571|FG006|Overall Study|Ongoing at data cut-off|0|||
16999796|NCT00576199|38143587|FG000|Overall Study|Adverse Event|12|||
16999797|NCT00576199|38143587|FG000|Overall Study|Insufficient Therapeutic Response|14|||
16999798|NCT00576199|38143587|FG000|Overall Study|Refused Treatment|2|||
16999799|NCT00576199|38143587|FG000|Overall Study|Reason Unspecified|2|||
16999800|NCT00715078|38143594|FG000|Overall Study|Death|29|||
16999801|NCT00715078|38143595|FG001|Overall Study|Death|36|||
16999802|NCT00715078|38143596|FG002|Overall Study|Death|36|||
16999803|NCT00715078|38143594|FG000|Overall Study|Withdrawal by Subject|1|||
16999804|NCT00715078|38143595|FG001|Overall Study|Withdrawal by Subject|0|||
16999805|NCT00715078|38143596|FG002|Overall Study|Withdrawal by Subject|1|||
16999806|NCT00715078|38143594|FG000|Overall Study|Unable to start due to disease prog.|0|||
16999807|NCT00715078|38143595|FG001|Overall Study|Unable to start due to disease prog.|0|||
16999808|NCT00715078|38143596|FG002|Overall Study|Unable to start due to disease prog.|1|||
16999809|NCT00679627|38143606|FG000|Overall Study|Death|41|||
17093532|NCT00237692|38233059|FG000|Overall Study|Excluded - did not meet criteria|4|||
16999810|NCT00679627|38143607|FG001|Overall Study|Death|29|||
16999811|NCT00679627|38143606|FG000|Overall Study|Adverse Event|43|||
16999812|NCT00679627|38143607|FG001|Overall Study|Adverse Event|53|||
16999813|NCT00679627|38143606|FG000|Overall Study|Withdrawal by Subject|168|||
16999814|NCT00679627|38143607|FG001|Overall Study|Withdrawal by Subject|172|||
16999815|NCT00679627|38143606|FG000|Overall Study|Lost to Follow-up|22|||
16999816|NCT00679627|38143607|FG001|Overall Study|Lost to Follow-up|26|||
16999817|NCT00679627|38143606|FG000|Overall Study|Early Study Closure|425|||
16999818|NCT00679627|38143607|FG001|Overall Study|Early Study Closure|405|||
16999819|NCT00714688|38143616|FG000|Overall Study|Lack of Efficacy|14|||
16999820|NCT00714688|38143617|FG001|Overall Study|Lack of Efficacy|1|||
16999821|NCT00714688|38143618|FG002|Overall Study|Lack of Efficacy|4|||
17093533|NCT00237692|38233060|FG001|Overall Study|Excluded - did not meet criteria|3|||
17093534|NCT00237692|38233061|FG002|Overall Study|Excluded - did not meet criteria|5|||
16999822|NCT00714688|38143616|FG000|Overall Study|Withdrawal by Subject|4|||
16999823|NCT00714688|38143617|FG001|Overall Study|Withdrawal by Subject|3|||
16999824|NCT00714688|38143618|FG002|Overall Study|Withdrawal by Subject|3|||
17093535|NCT00237692|38233062|FG003|Overall Study|Excluded - did not meet criteria|9|||
16999825|NCT00714688|38143616|FG000|Overall Study|Lost to Follow-up|5|||
16999826|NCT00714688|38143617|FG001|Overall Study|Lost to Follow-up|2|||
16999827|NCT00714688|38143618|FG002|Overall Study|Lost to Follow-up|0|||
16999828|NCT00714688|38143616|FG000|Overall Study|Adverse Event|2|||
16999829|NCT00714688|38143617|FG001|Overall Study|Adverse Event|15|||
17093536|NCT00237692|38233059|FG000|Overall Study|Withdrawal by Subject|4|||
16999830|NCT00714688|38143618|FG002|Overall Study|Adverse Event|19|||
16999831|NCT00714688|38143616|FG000|Overall Study|Subject Non-compliant|3|||
16999832|NCT00714688|38143617|FG001|Overall Study|Subject Non-compliant|5|||
16999833|NCT00714688|38143618|FG002|Overall Study|Subject Non-compliant|5|||
16999834|NCT00714688|38143616|FG000|Overall Study|Ineligible to Continue the Study|0|||
16999835|NCT00714688|38143617|FG001|Overall Study|Ineligible to Continue the Study|1|||
16999836|NCT00714688|38143618|FG002|Overall Study|Ineligible to Continue the Study|1|||
16999837|NCT00714688|38143616|FG000|Overall Study|Sponsor's Decision|0|||
16999838|NCT00714688|38143617|FG001|Overall Study|Sponsor's Decision|2|||
16999839|NCT00714688|38143618|FG002|Overall Study|Sponsor's Decision|0|||
16999840|NCT00714688|38143616|FG000|Overall Study|Other|1|||
16999841|NCT00714688|38143617|FG001|Overall Study|Other|6|||
16999842|NCT00714688|38143618|FG002|Overall Study|Other|5|||
16999843|NCT00679549|38143628|FG000|Overall Study|dropout|2|||
16999844|NCT00679549|38143629|FG001|Overall Study|dropout|4|||
16999845|NCT00679549|38143628|FG000|Overall Study|missing outcome echocardiograms|4|||
16999846|NCT00679549|38143629|FG001|Overall Study|missing outcome echocardiograms|5|||
16999847|NCT01031069|38143639|FG000|Overall Study|Serious Adverse Event|0|||
16999848|NCT01031069|38143640|FG001|Overall Study|Serious Adverse Event|1|||
16999849|NCT01031069|38143641|FG002|Overall Study|Serious Adverse Event|0|||
16999850|NCT01031069|38143642|FG003|Overall Study|Serious Adverse Event|0|||
16999851|NCT01031069|38143639|FG000|Overall Study|Withdrawal by Subject|2|||
16999852|NCT01031069|38143640|FG001|Overall Study|Withdrawal by Subject|3|||
16999853|NCT01031069|38143641|FG002|Overall Study|Withdrawal by Subject|18|||
16999854|NCT01031069|38143642|FG003|Overall Study|Withdrawal by Subject|18|||
16999855|NCT01031069|38143639|FG000|Overall Study|Migrated/moved from study area|1|||
16999856|NCT01031069|38143640|FG001|Overall Study|Migrated/moved from study area|2|||
16999857|NCT01031069|38143641|FG002|Overall Study|Migrated/moved from study area|1|||
16999858|NCT01031069|38143642|FG003|Overall Study|Migrated/moved from study area|1|||
16999859|NCT01031069|38143639|FG000|Overall Study|Lost to Follow-up|9|||
16999860|NCT01031069|38143640|FG001|Overall Study|Lost to Follow-up|5|||
16999861|NCT01031069|38143641|FG002|Overall Study|Lost to Follow-up|21|||
16999862|NCT01031069|38143642|FG003|Overall Study|Lost to Follow-up|15|||
16999863|NCT01031069|38143639|FG000|Overall Study|Other|0|||
16999864|NCT01031069|38143640|FG001|Overall Study|Other|0|||
16999865|NCT01031069|38143641|FG002|Overall Study|Other|1|||
16999866|NCT01031069|38143642|FG003|Overall Study|Other|0|||
16999867|NCT00679081|38143654|FG000|Overall Study|Lost to Follow-up|1|||
16999868|NCT00682435|38143662|FG000|Overall Study|Insufficient data|5|||
16999869|NCT00682435|38143662|FG000|Overall Study|Erroneously enrolled twice|2|||
16999870|NCT00713830|38143668|FG000|Overall Study|Adverse Event|23|||
16999871|NCT00713830|38143669|FG001|Overall Study|Adverse Event|71|||
16999872|NCT00713830|38143668|FG000|Overall Study|Lack of Efficacy|24|||
16999873|NCT00713830|38143669|FG001|Overall Study|Lack of Efficacy|16|||
16999874|NCT00713830|38143668|FG000|Overall Study|Lost to Follow-up|2|||
16999875|NCT00713830|38143669|FG001|Overall Study|Lost to Follow-up|9|||
16999876|NCT00713830|38143668|FG000|Overall Study|Withdrawal by Subject|13|||
16999877|NCT00713830|38143669|FG001|Overall Study|Withdrawal by Subject|23|||
16999878|NCT00713830|38143668|FG000|Overall Study|Poor Compliance to Protocol|7|||
16999879|NCT00713830|38143669|FG001|Overall Study|Poor Compliance to Protocol|14|||
16999880|NCT00713830|38143668|FG000|Overall Study|Familial and Personal Reasons|9|||
16999881|NCT00713830|38143669|FG001|Overall Study|Familial and Personal Reasons|34|||
16999882|NCT00713830|38143668|FG000|Overall Study|Sponsor Decision|4|||
16999883|NCT00713830|38143669|FG001|Overall Study|Sponsor Decision|10|||
16999884|NCT00681811|38143677|FG000|Overall Study|Adverse Event|1|||
16999885|NCT00681811|38143678|FG001|Overall Study|Adverse Event|1|||
16999886|NCT00681811|38143677|FG000|Overall Study|Withdrawal by Subject|2|||
16999887|NCT00681811|38143678|FG001|Overall Study|Withdrawal by Subject|2|||
16999888|NCT00681811|38143677|FG000|Overall Study|Non-compliance|0|||
16999889|NCT00681811|38143678|FG001|Overall Study|Non-compliance|1|||
16999890|NCT00681187|38143697|FG000|Overall Study|Withdrawal by Subject|1|||
16999891|NCT00681187|38143698|FG001|Overall Study|Withdrawal by Subject|0|||
16999892|NCT00681187|38143697|FG000|Overall Study|Death|0|||
16999893|NCT00681187|38143698|FG001|Overall Study|Death|1|||
16999894|NCT00681187|38143697|FG000|Overall Study|Adverse Event|0|||
16999895|NCT00681187|38143698|FG001|Overall Study|Adverse Event|1|||
16999896|NCT00681109|38143720|FG000|Overall Study|Lost to Follow-up|2|||
17093537|NCT00237692|38233060|FG001|Overall Study|Withdrawal by Subject|6|||
17093538|NCT00237692|38233061|FG002|Overall Study|Withdrawal by Subject|10|||
16999897|NCT00681109|38143721|FG001|Overall Study|Lost to Follow-up|6|||
16999898|NCT00681109|38143722|FG002|Overall Study|Lost to Follow-up|0|||
16999899|NCT00680407|38143736|FG000|Overall Study|Lost to Follow-up|3|||
16999900|NCT00680407|38143737|FG001|Overall Study|Lost to Follow-up|3|||
16999901|NCT00680407|38143738|FG002|Overall Study|Lost to Follow-up|1|||
16999902|NCT00680407|38143736|FG000|Overall Study|Withdrawal by Subject|5|||
16999903|NCT00680407|38143737|FG001|Overall Study|Withdrawal by Subject|2|||
16999904|NCT00680407|38143738|FG002|Overall Study|Withdrawal by Subject|2|||
16999905|NCT00677365|38143750|FG000|Overall Study|Adverse Event|2|||
16999906|NCT00677365|38143751|FG001|Overall Study|Adverse Event|1|||
16999907|NCT00677365|38143752|FG002|Overall Study|Adverse Event|1|||
16999908|NCT00677365|38143753|FG003|Overall Study|Adverse Event|2|||
16999909|NCT00677365|38143750|FG000|Overall Study|Withdrawal by Subject|0|||
16999910|NCT00677365|38143751|FG001|Overall Study|Withdrawal by Subject|0|||
16999911|NCT00677365|38143752|FG002|Overall Study|Withdrawal by Subject|1|||
16999912|NCT00677365|38143753|FG003|Overall Study|Withdrawal by Subject|0|||
17093539|NCT00237692|38233062|FG003|Overall Study|Withdrawal by Subject|4|||
17093540|NCT00237458|38233072|FG000|Overall Study|Lack of Efficacy|1|||
17093541|NCT00237458|38233072|FG000|Overall Study|Adverse Event|1|||
17093542|NCT00237458|38233072|FG000|Overall Study|Withdrawal by Subject|1|||
17093543|NCT00265148|38233078|FG000|Overall Study|Adverse Event|2|||
17093544|NCT00265148|38233079|FG001|Overall Study|Adverse Event|2|||
16999913|NCT00677365|38143750|FG000|Overall Study|Other reason|0|||
16999914|NCT00677365|38143751|FG001|Overall Study|Other reason|0|||
16999915|NCT00677365|38143752|FG002|Overall Study|Other reason|0|||
16999916|NCT00677365|38143753|FG003|Overall Study|Other reason|1|||
16999917|NCT00680017|38143765|FG000|Overall Study|Adverse Event|13|||
16999918|NCT00680017|38143766|FG001|Overall Study|Adverse Event|7|||
16999919|NCT00680017|38143765|FG000|Overall Study|Withdrawal by Subject|2|||
16999920|NCT00680017|38143766|FG001|Overall Study|Withdrawal by Subject|5|||
16999921|NCT00680017|38143765|FG000|Overall Study|Lost to Follow-up|2|||
16999922|NCT00680017|38143766|FG001|Overall Study|Lost to Follow-up|0|||
16999923|NCT00676663|38143774|FG000|Overall Study|Death|43|||
16999924|NCT00676663|38143775|FG001|Overall Study|Death|27|||
16999925|NCT00676663|38143774|FG000|Overall Study|Withdrew Consent|1|||
16999926|NCT00676663|38143775|FG001|Overall Study|Withdrew Consent|8|||
16999927|NCT00676663|38143774|FG000|Overall Study|Lost to Follow-up|1|||
16999928|NCT00676663|38143775|FG001|Overall Study|Lost to Follow-up|3|||
16999929|NCT00678691|38143785|FG000|Overall Study|Adverse Event|6|||
16999930|NCT00678691|38143786|FG001|Overall Study|Adverse Event|4|||
16999931|NCT00679939|38143794|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
16999932|NCT00679939|38143795|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
16999933|NCT00679939|38143794|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
16999934|NCT00679939|38143795|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
16999935|NCT00679939|38143794|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
16999936|NCT00679939|38143795|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
16999937|NCT00679939|38143794|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
16999938|NCT00679939|38143795|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
16999939|NCT00679939|38143794|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
17190417|NCT02489344|38343289|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
17190418|NCT02488330|38343293|FG000|Overall Study|Adverse Event|1|||
17190419|NCT02488330|38343293|FG000|Overall Study|Physician Decision|2|||
16999940|NCT00679939|38143795|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
16999941|NCT00679939|38143794|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
16999942|NCT00679939|38143795|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
16999943|NCT00679939|38143794|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
16999944|NCT00679939|38143795|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
16999945|NCT00679939|38143794|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
16999946|NCT00679939|38143795|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
16999947|NCT00679939|38143794|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
16999948|NCT00679939|38143795|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
16999949|NCT00679939|38143794|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
16999950|NCT00679939|38143795|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
16999951|NCT00673933|38143805|FG000|Overall Study|Withdrawal by Subject|2|||
16999952|NCT00673933|38143805|FG000|Overall Study|Lost to Follow-up|1|||
16999953|NCT00571519|38143818|FG000|Overall Study|Subject withdrew consent|0|||
16999954|NCT00571519|38143819|FG001|Overall Study|Subject withdrew consent|1|||
16999955|NCT00571519|38143820|FG002|Overall Study|Subject withdrew consent|0|||
16999956|NCT00571519|38143821|FG003|Overall Study|Subject withdrew consent|2|||
16999957|NCT00571519|38143822|FG004|Overall Study|Subject withdrew consent|1|||
16999958|NCT00571519|38143823|FG005|Overall Study|Subject withdrew consent|1|||
16999959|NCT00571519|38143824|FG006|Overall Study|Subject withdrew consent|2|||
16999960|NCT00571519|38143818|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
16999961|NCT00571519|38143819|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
17093545|NCT00265148|38233078|FG000|Overall Study|Lack of Efficacy|0|||
17093546|NCT00265148|38233079|FG001|Overall Study|Lack of Efficacy|2|||
17093547|NCT00265148|38233078|FG000|Overall Study|Protocol Violation|3|||
17093548|NCT00265148|38233079|FG001|Overall Study|Protocol Violation|2|||
16999962|NCT00571519|38143820|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
17190420|NCT02488330|38343293|FG000|Overall Study|Death|2|||
17190421|NCT02488330|38343293|FG000|Overall Study|Disease Progression|3|||
16999963|NCT00571519|38143821|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
16999964|NCT00571519|38143822|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
16999965|NCT00571519|38143823|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
16999966|NCT00571519|38143824|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
16999967|NCT00571519|38143818|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
16999968|NCT00571519|38143819|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
16999969|NCT00571519|38143820|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
16999970|NCT00571519|38143821|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
16999971|NCT00571519|38143822|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
16999972|NCT00571519|38143823|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
16999973|NCT00571519|38143824|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
16999974|NCT00571519|38143818|FG000|Overall Study|Termination of study by Sponsor|2|||
16999975|NCT00571519|38143819|FG001|Overall Study|Termination of study by Sponsor|7|||
16999976|NCT00571519|38143820|FG002|Overall Study|Termination of study by Sponsor|10|||
16999977|NCT00571519|38143821|FG003|Overall Study|Termination of study by Sponsor|24|||
16999978|NCT00571519|38143822|FG004|Overall Study|Termination of study by Sponsor|8|||
16999979|NCT00571519|38143823|FG005|Overall Study|Termination of study by Sponsor|9|||
16999980|NCT00571519|38143824|FG006|Overall Study|Termination of study by Sponsor|22|||
16999981|NCT00571519|38143818|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16999982|NCT00571519|38143819|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16999983|NCT00571519|38143820|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
16999984|NCT00571519|38143821|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16999985|NCT00571519|38143822|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16999986|NCT00571519|38143823|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16999987|NCT00571519|38143824|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16999988|NCT00676195|38143840|FG000|Overall Study|Lost to Follow-up|1|||
16999989|NCT00676195|38143840|FG000|Overall Study|Adverse Event|1|||
16999990|NCT00676195|38143840|FG000|Overall Study|Physician Decision|1|||
16999991|NCT00675103|38143845|FG000|Overall Study|Lack of Efficacy|2|||
16999992|NCT00675103|38143845|FG000|Overall Study|Adverse Event|1|||
17093549|NCT00265148|38233078|FG000|Overall Study|Lost to Follow-up|0|||
17093550|NCT00265148|38233079|FG001|Overall Study|Lost to Follow-up|1|||
17093551|NCT00265148|38233078|FG000|Overall Study|Withdrawal by Subject|2|||
17093552|NCT00265148|38233079|FG001|Overall Study|Withdrawal by Subject|1|||
17093553|NCT00265148|38233078|FG000|Overall Study|Physician Decision|1|||
17093554|NCT00265148|38233079|FG001|Overall Study|Physician Decision|0|||
16999993|NCT00675025|38143851|FG000|Overall Study|Study Terminated by Sponsor|38|||
16999994|NCT00675025|38143852|FG001|Overall Study|Study Terminated by Sponsor|42|||
16999995|NCT00675025|38143851|FG000|Overall Study|Adverse Event|6|||
16999996|NCT00675025|38143852|FG001|Overall Study|Adverse Event|11|||
16999997|NCT00675025|38143851|FG000|Overall Study|Lost to Follow-up|6|||
16999998|NCT00675025|38143852|FG001|Overall Study|Lost to Follow-up|4|||
16999999|NCT00675025|38143851|FG000|Overall Study|Withdrawal by Subject|4|||
17000000|NCT00675025|38143852|FG001|Overall Study|Withdrawal by Subject|6|||
17000001|NCT00678379|38143870|FG000|Overall Study|Injection performed after tonsillectomy|2|||
17000002|NCT00678379|38143871|FG001|Overall Study|Injection performed after tonsillectomy|0|||
17000003|NCT00678379|38143872|FG002|Overall Study|Injection performed after tonsillectomy|1|||
17000004|NCT00678379|38143870|FG000|Overall Study|Incomplete Data|4|||
17000005|NCT00678379|38143871|FG001|Overall Study|Incomplete Data|3|||
17000006|NCT00678379|38143872|FG002|Overall Study|Incomplete Data|3|||
17000007|NCT00674323|38143883|FG000|Overall Study|Adverse Event|0|||
17000008|NCT00674323|38143884|FG001|Overall Study|Adverse Event|1|||
17000009|NCT00674323|38143885|FG002|Overall Study|Adverse Event|0|||
17000010|NCT00674323|38143883|FG000|Overall Study|Protocol Violation|1|||
17000011|NCT00674323|38143884|FG001|Overall Study|Protocol Violation|0|||
17000012|NCT00674323|38143885|FG002|Overall Study|Protocol Violation|0|||
17000013|NCT00678301|38143895|FG000|Overall Study|Non-compliance with study procedures|0|||
17000014|NCT00678301|38143896|FG001|Overall Study|Non-compliance with study procedures|1|||
17000015|NCT00678301|38143895|FG000|Overall Study|Adverse Event|1|||
17000016|NCT00678301|38143896|FG001|Overall Study|Adverse Event|0|||
17000017|NCT00678301|38143895|FG000|Overall Study|Withdrawal by Subject|4|||
17000018|NCT00678301|38143896|FG001|Overall Study|Withdrawal by Subject|0|||
17000019|NCT00678301|38143895|FG000|Overall Study|Lost to Follow-up|3|||
17000020|NCT00678301|38143896|FG001|Overall Study|Lost to Follow-up|1|||
17000021|NCT00939770|38143910|FG000|Overall Study|Adverse Event|1|||
17000022|NCT00939770|38143911|FG001|Overall Study|Adverse Event|1|||
17000023|NCT00939770|38143912|FG002|Overall Study|Adverse Event|0|||
17000024|NCT00939770|38143913|FG003|Overall Study|Adverse Event|0|||
17000025|NCT00939770|38143914|FG004|Overall Study|Adverse Event|6|||
17000026|NCT00939770|38143915|FG005|Overall Study|Adverse Event|2|||
17000027|NCT00939770|38143916|FG006|Overall Study|Adverse Event|1|||
17093555|NCT00265148|38233078|FG000|Overall Study|Increasing frailty|0|||
17093556|NCT00265148|38233079|FG001|Overall Study|Increasing frailty|1|||
17093557|NCT00265148|38233078|FG000|Overall Study|Subject chose to change of the dose|1|||
17000028|NCT00939770|38143917|FG007|Overall Study|Adverse Event|1|||
17000029|NCT00939770|38143910|FG000|Overall Study|Lack of Efficacy|4|||
17000030|NCT00939770|38143911|FG001|Overall Study|Lack of Efficacy|6|||
17000031|NCT00939770|38143912|FG002|Overall Study|Lack of Efficacy|13|||
17000032|NCT00939770|38143913|FG003|Overall Study|Lack of Efficacy|9|||
17000033|NCT00939770|38143914|FG004|Overall Study|Lack of Efficacy|16|||
17000034|NCT00939770|38143915|FG005|Overall Study|Lack of Efficacy|8|||
17000035|NCT00939770|38143916|FG006|Overall Study|Lack of Efficacy|11|||
17000036|NCT00939770|38143917|FG007|Overall Study|Lack of Efficacy|1|||
17000037|NCT00939770|38143910|FG000|Overall Study|Lost to Follow-up|0|||
17000038|NCT00939770|38143911|FG001|Overall Study|Lost to Follow-up|0|||
17000039|NCT00939770|38143912|FG002|Overall Study|Lost to Follow-up|0|||
17093558|NCT00265148|38233079|FG001|Overall Study|Subject chose to change of the dose|0|||
16783739|NCT02055352|37723571|FG001|Overall Study|Non-eligible|1|||
16783740|NCT02055352|37723570|FG000|Overall Study|Poor compliance|1|||
16783741|NCT02055352|37723571|FG001|Overall Study|Poor compliance|1|||
16783742|NCT02055352|37723570|FG000|Overall Study|Death|1|||
16783743|NCT02055352|37723571|FG001|Overall Study|Death|2|||
16783744|NCT02055352|37723570|FG000|Overall Study|Patient decision|1|||
16783745|NCT02055352|37723571|FG001|Overall Study|Patient decision|1|||
16783746|NCT02055352|37723570|FG000|Overall Study|Use of prohibited treatment|0|||
16783747|NCT02055352|37723571|FG001|Overall Study|Use of prohibited treatment|3|||
16783748|NCT02055352|37723570|FG000|Overall Study|AE, study drug would be detrimental|1|||
16783749|NCT02055352|37723571|FG001|Overall Study|AE, study drug would be detrimental|3|||
16783750|NCT02055352|37723570|FG000|Overall Study|Withdrawal of informed consent|1|||
16783751|NCT02055352|37723571|FG001|Overall Study|Withdrawal of informed consent|0|||
16783752|NCT02055352|37723570|FG000|Overall Study|Reason unknown|1|||
16783753|NCT02055352|37723571|FG001|Overall Study|Reason unknown|5|||
16783754|NCT02034916|37723579|FG000|Overall Study|Death|39|||
16783755|NCT02034916|37723580|FG001|Overall Study|Death|28|||
16783756|NCT02034916|37723579|FG000|Overall Study|Withdrawal by Subject|2|||
16783757|NCT02034916|37723580|FG001|Overall Study|Withdrawal by Subject|1|||
16783758|NCT02034916|37723579|FG000|Overall Study|Lost to Follow-up|4|||
16783759|NCT02034916|37723580|FG001|Overall Study|Lost to Follow-up|1|||
16783760|NCT02034916|37723579|FG000|Overall Study|Study terminated by sponsor|4|||
16783761|NCT02034916|37723580|FG001|Overall Study|Study terminated by sponsor|5|||
16783762|NCT01374425|37723589|FG000|Overall Study|Radiographic Disease Progression|86|||
16783763|NCT01374425|37723590|FG001|Overall Study|Radiographic Disease Progression|81|||
16783764|NCT01374425|37723589|FG000|Overall Study|Clinical Disease Progression|9|||
16783765|NCT01374425|37723590|FG001|Overall Study|Clinical Disease Progression|6|||
16783766|NCT01374425|37723589|FG000|Overall Study|Adverse Event|29|||
16783767|NCT01374425|37723590|FG001|Overall Study|Adverse Event|18|||
16783768|NCT01374425|37723589|FG000|Overall Study|Death (Progression of Disease)|1|||
16783769|NCT01374425|37723590|FG001|Overall Study|Death (Progression of Disease)|0|||
16783770|NCT01374425|37723589|FG000|Overall Study|Death (Adverse Event)|2|||
16783771|NCT01374425|37723590|FG001|Overall Study|Death (Adverse Event)|4|||
16783772|NCT01374425|37723589|FG000|Overall Study|Withdrawal by Subject|6|||
16783773|NCT01374425|37723590|FG001|Overall Study|Withdrawal by Subject|7|||
16783774|NCT01374425|37723589|FG000|Overall Study|Refused Treatment|10|||
16783775|NCT01374425|37723590|FG001|Overall Study|Refused Treatment|24|||
16783776|NCT01374425|37723589|FG000|Overall Study|Protocol Violation|2|||
16783777|NCT01374425|37723590|FG001|Overall Study|Protocol Violation|3|||
16783778|NCT01374425|37723589|FG000|Overall Study|Sponsor Decision|0|||
16783779|NCT01374425|37723590|FG001|Overall Study|Sponsor Decision|1|||
16783780|NCT01374425|37723589|FG000|Overall Study|Lost to Follow-up|2|||
16783781|NCT01374425|37723590|FG001|Overall Study|Lost to Follow-up|1|||
16783782|NCT01374425|37723589|FG000|Overall Study|Other|41|||
16783783|NCT01374425|37723590|FG001|Overall Study|Other|43|||
16783784|NCT02085460|37723620|FG000|Overall Study|Adverse Event|2|||
16783785|NCT02085460|37723621|FG001|Overall Study|Adverse Event|2|||
16783786|NCT02085460|37723622|FG002|Overall Study|Adverse Event|1|||
16783787|NCT02085460|37723620|FG000|Overall Study|Physician Decision|1|||
16783788|NCT02085460|37723621|FG001|Overall Study|Physician Decision|1|||
16783789|NCT02085460|37723622|FG002|Overall Study|Physician Decision|2|||
16783790|NCT02085460|37723620|FG000|Overall Study|Withdrawal by Subject|11|||
16783791|NCT02085460|37723621|FG001|Overall Study|Withdrawal by Subject|5|||
16783792|NCT02085460|37723622|FG002|Overall Study|Withdrawal by Subject|7|||
16783793|NCT02084134|37723632|FG000|Overall Study|Protocol Violation|4|||
16783794|NCT02084134|37723633|FG001|Overall Study|Protocol Violation|2|||
16783795|NCT02084134|37723632|FG000|Overall Study|Death|0|||
16783796|NCT02084134|37723633|FG001|Overall Study|Death|1|||
16783797|NCT02034058|37723639|FG000|Overall Study|Death|3|||
16783798|NCT01374269|37723645|FG000|Overall Study|Withdrawal by Subject|4|||
16783799|NCT01374269|37723646|FG001|Overall Study|Withdrawal by Subject|0|||
16783800|NCT01374269|37723645|FG000|Overall Study|Lost to Follow-up|1|||
16783801|NCT01374269|37723646|FG001|Overall Study|Lost to Follow-up|3|||
16783802|NCT01374269|37723645|FG000|Overall Study|closed research|1|||
17000040|NCT00939770|38143913|FG003|Overall Study|Lost to Follow-up|0|||
17000041|NCT00939770|38143914|FG004|Overall Study|Lost to Follow-up|1|||
16783803|NCT01374269|37723646|FG001|Overall Study|closed research|2|||
16783804|NCT02679755|37723654|FG000|Overall Study|Death|0|||
16783805|NCT02679755|37723655|FG001|Overall Study|Death|3|||
16783806|NCT02679755|37723654|FG000|Overall Study|Global deterioration of health status|1|||
16783807|NCT02679755|37723655|FG001|Overall Study|Global deterioration of health status|8|||
16783808|NCT02679755|37723654|FG000|Overall Study|Lost to Follow-up|1|||
16783809|NCT02679755|37723655|FG001|Overall Study|Lost to Follow-up|0|||
16783810|NCT02679755|37723654|FG000|Overall Study|Objective progression or relapse|24|||
16783811|NCT02679755|37723655|FG001|Overall Study|Objective progression or relapse|83|||
16783812|NCT02679755|37723654|FG000|Overall Study|Not defined|0|||
16783813|NCT02679755|37723655|FG001|Overall Study|Not defined|2|||
16783814|NCT02679755|37723654|FG000|Overall Study|Withdrawal by participant|6|||
16783815|NCT02679755|37723655|FG001|Overall Study|Withdrawal by participant|3|||
16783816|NCT02679755|37723654|FG000|Overall Study|Adverse Event|1|||
16783817|NCT02679755|37723655|FG001|Overall Study|Adverse Event|4|||
16783818|NCT02679755|37723654|FG000|Overall Study|Adverse events not related to study drug|1|||
16783819|NCT02679755|37723655|FG001|Overall Study|Adverse events not related to study drug|2|||
16783820|NCT02675231|37723667|FG000|Overall Study|Withdrawal by Subject|1|||
16783821|NCT02675231|37723668|FG001|Overall Study|Withdrawal by Subject|3|||
16783822|NCT02675231|37723669|FG002|Overall Study|Withdrawal by Subject|1|||
16783823|NCT02675231|37723667|FG000|Overall Study|Lost to Follow-up|2|||
16783824|NCT02675231|37723668|FG001|Overall Study|Lost to Follow-up|2|||
16783825|NCT02675231|37723669|FG002|Overall Study|Lost to Follow-up|2|||
16783826|NCT02675231|37723667|FG000|Overall Study|On study treatment/follow up|23|||
16783827|NCT02675231|37723668|FG001|Overall Study|On study treatment/follow up|31|||
16783828|NCT02675231|37723669|FG002|Overall Study|On study treatment/follow up|23|||
16783829|NCT02675075|37723680|FG000|Overall Study|Lost to Follow-up|3|||
16783830|NCT02675075|37723681|FG001|Overall Study|Lost to Follow-up|0|||
16783831|NCT02674685|37723689|FG000|Overall Study|Protocol Violation|4|||
16783832|NCT02673515|37723695|FG000|Overall Study|Lack of motivation|2|||
16783833|NCT02673515|37723696|FG001|Overall Study|Lack of motivation|1|||
16783834|NCT02667275|37723704|FG000|Overall Study|Protocol Violation|11|||
16783835|NCT02667275|37723705|FG001|Overall Study|Protocol Violation|7|||
16783836|NCT02667275|37723704|FG000|Overall Study|Lost to Follow-up|0|||
16783837|NCT02667275|37723705|FG001|Overall Study|Lost to Follow-up|2|||
16783838|NCT02667275|37723704|FG000|Overall Study|Withdrawal by Subject|0|||
16783839|NCT02667275|37723705|FG001|Overall Study|Withdrawal by Subject|5|||
16783840|NCT02667275|37723704|FG000|Overall Study|Discontinued early without completing|0|||
16783841|NCT02667275|37723705|FG001|Overall Study|Discontinued early without completing|1|||
16783842|NCT02672423|37723714|FG000|Period 1|Adverse Event|0|||
16783843|NCT02672423|37723715|FG001|Period 1|Adverse Event|0|||
16783844|NCT02672423|37723716|FG002|Period 1|Adverse Event|0|||
16783845|NCT02672423|37723717|FG003|Period 1|Adverse Event|0|||
16783846|NCT02672423|37723718|FG004|Period 1|Adverse Event|1|||
16783847|NCT02672423|37723719|FG005|Period 1|Adverse Event|0|||
16783848|NCT02672423|37723720|FG006|Period 1|Adverse Event|0|||
16783849|NCT02672423|37723721|FG007|Period 1|Adverse Event|0|||
16783850|NCT02672423|37723722|FG008|Period 1|Adverse Event|0|||
16783851|NCT02672423|37723723|FG009|Period 1|Adverse Event|0|||
16783852|NCT02672423|37723714|FG000|Period 2|Withdrawal by Subject|0|||
16783853|NCT02672423|37723715|FG001|Period 2|Withdrawal by Subject|0|||
16783854|NCT02672423|37723716|FG002|Period 2|Withdrawal by Subject|1|||
16783855|NCT02672423|37723717|FG003|Period 2|Withdrawal by Subject|0|||
16783856|NCT02672423|37723718|FG004|Period 2|Withdrawal by Subject|0|||
16783857|NCT02672423|37723719|FG005|Period 2|Withdrawal by Subject|0|||
16783858|NCT02672423|37723720|FG006|Period 2|Withdrawal by Subject|0|||
16783859|NCT02672423|37723721|FG007|Period 2|Withdrawal by Subject|0|||
16783860|NCT02672423|37723722|FG008|Period 2|Withdrawal by Subject|0|||
16783861|NCT02672423|37723723|FG009|Period 2|Withdrawal by Subject|0|||
16783862|NCT02672423|37723714|FG000|Period 3|Withdrawal by Subject|0|||
16783863|NCT02672423|37723715|FG001|Period 3|Withdrawal by Subject|0|||
16783864|NCT02672423|37723716|FG002|Period 3|Withdrawal by Subject|0|||
16783865|NCT02672423|37723717|FG003|Period 3|Withdrawal by Subject|0|||
16783866|NCT02672423|37723718|FG004|Period 3|Withdrawal by Subject|0|||
16783867|NCT02672423|37723719|FG005|Period 3|Withdrawal by Subject|0|||
16783868|NCT02672423|37723720|FG006|Period 3|Withdrawal by Subject|0|||
16783869|NCT02672423|37723721|FG007|Period 3|Withdrawal by Subject|1|||
16783870|NCT02672423|37723722|FG008|Period 3|Withdrawal by Subject|0|||
16783871|NCT02672423|37723723|FG009|Period 3|Withdrawal by Subject|0|||
16783872|NCT02672423|37723714|FG000|Period 3|Physician Decision|0|||
16783873|NCT02672423|37723715|FG001|Period 3|Physician Decision|0|||
16783874|NCT02672423|37723716|FG002|Period 3|Physician Decision|0|||
16783875|NCT02672423|37723717|FG003|Period 3|Physician Decision|0|||
16783876|NCT02672423|37723718|FG004|Period 3|Physician Decision|0|||
16783877|NCT02672423|37723719|FG005|Period 3|Physician Decision|1|||
16783878|NCT02672423|37723720|FG006|Period 3|Physician Decision|0|||
16783879|NCT02672423|37723721|FG007|Period 3|Physician Decision|0|||
16783880|NCT02672423|37723722|FG008|Period 3|Physician Decision|0|||
16783881|NCT02672423|37723723|FG009|Period 3|Physician Decision|0|||
16783882|NCT02670551|37723747|FG000|Overall Study|Adverse Event|4|||
17093559|NCT00043186|38233095|FG000|Overall Study|Physician Decision|0|||
17093560|NCT00043186|38233096|FG001|Overall Study|Physician Decision|0|||
17093561|NCT00043186|38233097|FG002|Overall Study|Physician Decision|3|||
17093562|NCT00043186|38233098|FG003|Overall Study|Physician Decision|0|||
17093563|NCT00043186|38233099|FG004|Overall Study|Physician Decision|1|||
17093564|NCT00043186|38233100|FG005|Overall Study|Physician Decision|0|||
17093565|NCT00043186|38233101|FG006|Overall Study|Physician Decision|0|||
17093566|NCT00043186|38233102|FG007|Overall Study|Physician Decision|1|||
17093567|NCT00043186|38233103|FG008|Overall Study|Physician Decision|1|||
17093568|NCT00043186|38233095|FG000|Overall Study|Adverse Event|2|||
17093569|NCT00043186|38233096|FG001|Overall Study|Adverse Event|2|||
17093570|NCT00043186|38233097|FG002|Overall Study|Adverse Event|2|||
17093571|NCT00043186|38233098|FG003|Overall Study|Adverse Event|3|||
17093572|NCT00043186|38233099|FG004|Overall Study|Adverse Event|2|||
17093573|NCT00043186|38233100|FG005|Overall Study|Adverse Event|1|||
17093574|NCT00043186|38233101|FG006|Overall Study|Adverse Event|2|||
17093575|NCT00043186|38233102|FG007|Overall Study|Adverse Event|1|||
17093576|NCT00043186|38233103|FG008|Overall Study|Adverse Event|3|||
17093577|NCT00043186|38233095|FG000|Overall Study|Withdrawal by Subject|11|||
17093578|NCT00043186|38233096|FG001|Overall Study|Withdrawal by Subject|8|||
17093579|NCT00043186|38233097|FG002|Overall Study|Withdrawal by Subject|11|||
17093580|NCT00043186|38233098|FG003|Overall Study|Withdrawal by Subject|13|||
17093581|NCT00043186|38233099|FG004|Overall Study|Withdrawal by Subject|14|||
17093582|NCT00043186|38233100|FG005|Overall Study|Withdrawal by Subject|6|||
17093583|NCT00043186|38233101|FG006|Overall Study|Withdrawal by Subject|12|||
17093584|NCT00043186|38233102|FG007|Overall Study|Withdrawal by Subject|9|||
17093585|NCT00043186|38233103|FG008|Overall Study|Withdrawal by Subject|10|||
17093586|NCT00043186|38233095|FG000|Overall Study|Death|0|||
17093587|NCT00043186|38233096|FG001|Overall Study|Death|0|||
17093588|NCT00043186|38233097|FG002|Overall Study|Death|1|||
17093589|NCT00043186|38233098|FG003|Overall Study|Death|0|||
17093590|NCT00043186|38233099|FG004|Overall Study|Death|0|||
17093591|NCT00043186|38233100|FG005|Overall Study|Death|0|||
17093592|NCT00043186|38233101|FG006|Overall Study|Death|2|||
17093593|NCT00043186|38233102|FG007|Overall Study|Death|0|||
17093594|NCT00043186|38233103|FG008|Overall Study|Death|0|||
17093595|NCT00043186|38233095|FG000|Overall Study|Disease progression|1|||
17093596|NCT00043186|38233096|FG001|Overall Study|Disease progression|0|||
17093597|NCT00043186|38233097|FG002|Overall Study|Disease progression|0|||
17093598|NCT00043186|38233098|FG003|Overall Study|Disease progression|3|||
17093599|NCT00043186|38233099|FG004|Overall Study|Disease progression|0|||
16783883|NCT02670551|37723748|FG001|Overall Study|Adverse Event|7|||
16783884|NCT02670551|37723749|FG002|Overall Study|Adverse Event|9|||
16783885|NCT02670551|37723747|FG000|Overall Study|Lack of Efficacy|2|||
16783886|NCT02670551|37723748|FG001|Overall Study|Lack of Efficacy|0|||
16783887|NCT02670551|37723749|FG002|Overall Study|Lack of Efficacy|3|||
16783888|NCT02670551|37723747|FG000|Overall Study|Withdrawal of Consent|6|||
16783889|NCT02670551|37723748|FG001|Overall Study|Withdrawal of Consent|3|||
16783890|NCT02670551|37723749|FG002|Overall Study|Withdrawal of Consent|8|||
16783891|NCT02670551|37723747|FG000|Overall Study|Lost to Follow-up|5|||
16783892|NCT02670551|37723748|FG001|Overall Study|Lost to Follow-up|7|||
16783893|NCT02670551|37723749|FG002|Overall Study|Lost to Follow-up|6|||
16783894|NCT02670551|37723747|FG000|Overall Study|Protocol Violation|1|||
16783895|NCT02670551|37723748|FG001|Overall Study|Protocol Violation|0|||
16783896|NCT02670551|37723749|FG002|Overall Study|Protocol Violation|0|||
16783897|NCT02670551|37723747|FG000|Overall Study|Noncompliance with study drug|3|||
16783898|NCT02670551|37723748|FG001|Overall Study|Noncompliance with study drug|3|||
16783899|NCT02670551|37723749|FG002|Overall Study|Noncompliance with study drug|2|||
16783900|NCT02670551|37723747|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16783901|NCT02670551|37723748|FG001|Overall Study|Other Miscellaneous Reasons|3|||
16783902|NCT02670551|37723749|FG002|Overall Study|Other Miscellaneous Reasons|3|||
16783903|NCT02670551|37723747|FG000|Overall Study|Did Not Receive Treatment|5|||
16783904|NCT02670551|37723748|FG001|Overall Study|Did Not Receive Treatment|3|||
16783905|NCT02670551|37723749|FG002|Overall Study|Did Not Receive Treatment|0|||
16783906|NCT02670473|37723757|FG000|Overall Study|Withdrawal by Subject|1|||
16783907|NCT02667119|37723772|FG000|Overall Study|Lost to Follow-up|3|||
16783908|NCT02667119|37723773|FG001|Overall Study|Lost to Follow-up|0|||
16783909|NCT02670083|37723781|FG000|Overall Study|Adverse Event|16|||
16783910|NCT02670083|37723782|FG001|Overall Study|Adverse Event|13|||
16783911|NCT02670083|37723781|FG000|Overall Study|Death|4|||
16783912|NCT02670083|37723782|FG001|Overall Study|Death|6|||
16783913|NCT02670083|37723781|FG000|Overall Study|Lost to Follow-up|2|||
16783914|NCT02670083|37723782|FG001|Overall Study|Lost to Follow-up|2|||
16783915|NCT02670083|37723781|FG000|Overall Study|Multiple Reasons|9|||
16783916|NCT02670083|37723782|FG001|Overall Study|Multiple Reasons|9|||
16783917|NCT02670083|37723781|FG000|Overall Study|Physician Decision|0|||
16783918|NCT02670083|37723782|FG001|Overall Study|Physician Decision|2|||
17093600|NCT00043186|38233100|FG005|Overall Study|Disease progression|0|||
17093601|NCT00043186|38233101|FG006|Overall Study|Disease progression|0|||
17093602|NCT00043186|38233102|FG007|Overall Study|Disease progression|4|||
17093603|NCT00043186|38233103|FG008|Overall Study|Disease progression|0|||
16783919|NCT02670083|37723781|FG000|Overall Study|Study Terminated By Sponsor|257|||
16783920|NCT02670083|37723782|FG001|Overall Study|Study Terminated By Sponsor|254|||
16783921|NCT02670083|37723781|FG000|Overall Study|Symptomatic Deterioration|0|||
16783922|NCT02670083|37723782|FG001|Overall Study|Symptomatic Deterioration|2|||
16783923|NCT02670083|37723781|FG000|Overall Study|Withdrawal by Subject|32|||
16783924|NCT02670083|37723782|FG001|Overall Study|Withdrawal by Subject|31|||
16783925|NCT02670083|37723781|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16783926|NCT02670083|37723782|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16783927|NCT02669849|37723792|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
16783928|NCT02669849|37723793|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
16783929|NCT02669849|37723794|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
16783930|NCT02669849|37723792|FG000|Overall Study|Lost to Follow-up|1|||
17000042|NCT00939770|38143915|FG005|Overall Study|Lost to Follow-up|0|||
17093604|NCT00043186|38233095|FG000|Overall Study|Ineligibility determined|0|||
17093605|NCT00043186|38233096|FG001|Overall Study|Ineligibility determined|0|||
17093606|NCT00043186|38233097|FG002|Overall Study|Ineligibility determined|0|||
17093607|NCT00043186|38233098|FG003|Overall Study|Ineligibility determined|0|||
17093608|NCT00043186|38233099|FG004|Overall Study|Ineligibility determined|0|||
17093609|NCT00043186|38233100|FG005|Overall Study|Ineligibility determined|0|||
17093610|NCT00043186|38233101|FG006|Overall Study|Ineligibility determined|0|||
17093611|NCT00043186|38233102|FG007|Overall Study|Ineligibility determined|0|||
17093612|NCT00043186|38233103|FG008|Overall Study|Ineligibility determined|1|||
17093613|NCT00043186|38233095|FG000|Overall Study|Lost to Follow-up|3|||
17093614|NCT00043186|38233096|FG001|Overall Study|Lost to Follow-up|5|||
17093615|NCT00043186|38233097|FG002|Overall Study|Lost to Follow-up|1|||
17093616|NCT00043186|38233098|FG003|Overall Study|Lost to Follow-up|1|||
17093617|NCT00043186|38233099|FG004|Overall Study|Lost to Follow-up|1|||
17093618|NCT00043186|38233100|FG005|Overall Study|Lost to Follow-up|1|||
17093619|NCT00043186|38233101|FG006|Overall Study|Lost to Follow-up|1|||
17093620|NCT00043186|38233102|FG007|Overall Study|Lost to Follow-up|1|||
17093621|NCT00043186|38233103|FG008|Overall Study|Lost to Follow-up|2|||
17093622|NCT00043186|38233095|FG000|Overall Study|Noncompliance|0|||
17093623|NCT00043186|38233096|FG001|Overall Study|Noncompliance|0|||
17093624|NCT00043186|38233097|FG002|Overall Study|Noncompliance|1|||
17093625|NCT00043186|38233098|FG003|Overall Study|Noncompliance|1|||
17093626|NCT00043186|38233099|FG004|Overall Study|Noncompliance|0|||
17093627|NCT00043186|38233100|FG005|Overall Study|Noncompliance|0|||
17093628|NCT00043186|38233101|FG006|Overall Study|Noncompliance|0|||
17093629|NCT00043186|38233102|FG007|Overall Study|Noncompliance|0|||
17093630|NCT00043186|38233103|FG008|Overall Study|Noncompliance|0|||
17093631|NCT00043186|38233095|FG000|Overall Study|Other|0|||
17093632|NCT00043186|38233096|FG001|Overall Study|Other|0|||
17093633|NCT00043186|38233097|FG002|Overall Study|Other|1|||
17093634|NCT00043186|38233098|FG003|Overall Study|Other|1|||
17093635|NCT00043186|38233099|FG004|Overall Study|Other|0|||
17000043|NCT00939770|38143916|FG006|Overall Study|Lost to Follow-up|0|||
17093636|NCT00043186|38233100|FG005|Overall Study|Other|0|||
17093637|NCT00043186|38233101|FG006|Overall Study|Other|0|||
17093638|NCT00043186|38233102|FG007|Overall Study|Other|0|||
17093639|NCT00043186|38233103|FG008|Overall Study|Other|0|||
17093640|NCT00041470|38233124|FG000|Overall Study|Loss of Funding|38|||
17093641|NCT00206102|38233130|FG000|Overall Study|Adverse Event|119|||
17093642|NCT00206102|38233131|FG001|Overall Study|Adverse Event|82|||
17093643|NCT00206102|38233130|FG000|Overall Study|Protocol Violation|0|||
17093644|NCT00206102|38233131|FG001|Overall Study|Protocol Violation|2|||
17093645|NCT00206102|38233130|FG000|Overall Study|Lack of therapeutic response|16|||
17093646|NCT00206102|38233131|FG001|Overall Study|Lack of therapeutic response|11|||
17093647|NCT00206102|38233130|FG000|Overall Study|Lost to Follow-up|95|||
17093648|NCT00206102|38233131|FG001|Overall Study|Lost to Follow-up|66|||
17093649|NCT00206102|38233130|FG000|Overall Study|Withdrawal by Subject|118|||
17093650|NCT00206102|38233131|FG001|Overall Study|Withdrawal by Subject|101|||
17093651|NCT00206102|38233130|FG000|Overall Study|Study-specific discontinuation criteria|18|||
17093652|NCT00206102|38233131|FG001|Overall Study|Study-specific discontinuation criteria|17|||
17093653|NCT00206102|38233130|FG000|Overall Study|None of those categories|42|||
17093654|NCT00206102|38233131|FG001|Overall Study|None of those categories|36|||
17093655|NCT00041080|38233139|FG000|Overall Study|Adverse Event|21|||
16783931|NCT02669849|37723793|FG001|Overall Study|Lost to Follow-up|0|||
17000044|NCT00939770|38143917|FG007|Overall Study|Lost to Follow-up|0|||
17000045|NCT00939770|38143910|FG000|Overall Study|Physician Decision|0|||
17000046|NCT00939770|38143911|FG001|Overall Study|Physician Decision|0|||
17000047|NCT00939770|38143912|FG002|Overall Study|Physician Decision|2|||
17000048|NCT00939770|38143913|FG003|Overall Study|Physician Decision|0|||
17000049|NCT00939770|38143914|FG004|Overall Study|Physician Decision|7|||
17000050|NCT00939770|38143915|FG005|Overall Study|Physician Decision|1|||
17000051|NCT00939770|38143916|FG006|Overall Study|Physician Decision|0|||
17093656|NCT00041080|38233140|FG001|Overall Study|Adverse Event|1|||
17093657|NCT00041080|38233139|FG000|Overall Study|Withdrawal by Subject|6|||
17093658|NCT00041080|38233140|FG001|Overall Study|Withdrawal by Subject|6|||
17093659|NCT00041080|38233139|FG000|Overall Study|Concommitant Illness/Other|1|||
17093660|NCT00041080|38233140|FG001|Overall Study|Concommitant Illness/Other|2|||
17190422|NCT02488330|38343293|FG000|Overall Study|Study Termination by Sponsor|4|||
17190423|NCT02481310|38343300|FG000|Follow up|Still in follow up|0|||
17190424|NCT02481310|38343301|FG001|Follow up|Still in follow up|3|||
17190425|NCT02481310|38343302|FG002|Follow up|Still in follow up|0|||
17190426|NCT02480764|38343309|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
17190427|NCT02480764|38343310|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
17190428|NCT02480764|38343311|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
17190429|NCT02480764|38343309|FG000|Overall Study|Major Protocol Deviation|1|||
17190430|NCT02480764|38343310|FG001|Overall Study|Major Protocol Deviation|4|||
17190431|NCT02480764|38343311|FG002|Overall Study|Major Protocol Deviation|3|||
17190432|NCT02480764|38343309|FG000|Overall Study|Lost to Follow-up|0|||
17190433|NCT02480764|38343310|FG001|Overall Study|Lost to Follow-up|1|||
17190434|NCT02480764|38343311|FG002|Overall Study|Lost to Follow-up|2|||
17190435|NCT02480764|38343309|FG000|Overall Study|Voluntary Withdrawal|6|||
17190436|NCT02480764|38343310|FG001|Overall Study|Voluntary Withdrawal|5|||
17190437|NCT02480764|38343311|FG002|Overall Study|Voluntary Withdrawal|10|||
17190438|NCT02480764|38343309|FG000|Overall Study|Lack of Efficacy|0|||
17190439|NCT02480764|38343310|FG001|Overall Study|Lack of Efficacy|3|||
17190440|NCT02480764|38343311|FG002|Overall Study|Lack of Efficacy|3|||
17190441|NCT02480764|38343309|FG000|Overall Study|Reason not Specified|0|||
17190442|NCT02480764|38343310|FG001|Overall Study|Reason not Specified|1|||
17190443|NCT02480764|38343311|FG002|Overall Study|Reason not Specified|0|||
17190444|NCT02487472|38343319|FG000|Overall Study|Did not complete telephonic interviews|9|||
17190445|NCT02487472|38343319|FG000|Overall Study|Other|2|||
17190446|NCT02451670|38343327|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
17190447|NCT02451670|38343328|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
17190448|NCT02486692|38343336|FG000|Overall Study|did not login for randomization|4|||
17190449|NCT02486692|38343337|FG001|Overall Study|did not login for randomization|7|||
17190450|NCT01060007|38343354|FG000|Overall Study|Withdrawal by Subject|1|||
17190451|NCT01060007|38343354|FG000|Overall Study|Inevaluable for response at surgery|3|||
17093661|NCT00041080|38233139|FG000|Overall Study|Did not start therapy|1|||
17093662|NCT00041080|38233140|FG001|Overall Study|Did not start therapy|1|||
17093663|NCT00041080|38233139|FG000|Overall Study|Ineligible|1|||
17093664|NCT00041080|38233140|FG001|Overall Study|Ineligible|0|||
17093665|NCT00205712|38233148|FG000|Overall Study|Lost to Follow-up|0|||
17093666|NCT00205712|38233149|FG001|Overall Study|Lost to Follow-up|1|||
17093667|NCT00203294|38233159|FG000|Overall Study|Withdrawal by Subject|8|||
17093668|NCT00203294|38233160|FG001|Overall Study|Withdrawal by Subject|13|||
17093669|NCT00264290|38233168|FG000|Intervention (8 Weeks)|Adverse Event|1|||
17093670|NCT00264290|38233169|FG001|Intervention (8 Weeks)|Adverse Event|0|||
17093671|NCT00234494|38233179|FG000|Overall Study|Protocol Violation|2|||
17093672|NCT00234104|38233187|FG000|Overall Study|Adverse Event|4|||
17093673|NCT00234104|38233188|FG001|Overall Study|Adverse Event|0|||
17093674|NCT00234104|38233189|FG002|Overall Study|Adverse Event|3|||
17093675|NCT00234104|38233190|FG003|Overall Study|Adverse Event|5|||
17093676|NCT00234104|38233187|FG000|Overall Study|Protocol Violation|0|||
17093677|NCT00234104|38233188|FG001|Overall Study|Protocol Violation|0|||
17093678|NCT00234104|38233189|FG002|Overall Study|Protocol Violation|0|||
17093679|NCT00234104|38233190|FG003|Overall Study|Protocol Violation|1|||
17093680|NCT00234104|38233187|FG000|Overall Study|Physician Decision|0|||
17093681|NCT00234104|38233188|FG001|Overall Study|Physician Decision|1|||
17093682|NCT00234104|38233189|FG002|Overall Study|Physician Decision|2|||
17093683|NCT00234104|38233190|FG003|Overall Study|Physician Decision|2|||
17093684|NCT00263666|38233202|FG000|Overall Study|Adverse Event|6|||
17093685|NCT00263666|38233203|FG001|Overall Study|Adverse Event|8|||
17093686|NCT00263666|38233202|FG000|Overall Study|Lost to Follow-up|1|||
17093687|NCT00263666|38233203|FG001|Overall Study|Lost to Follow-up|2|||
17093688|NCT00263666|38233202|FG000|Overall Study|Withdrawal by Subject|0|||
17190452|NCT02971163|38343363|FG000|Overall Study|Lost to Follow-up|4|||
17190453|NCT02971163|38343364|FG001|Overall Study|Lost to Follow-up|2|||
16783932|NCT02669849|37723794|FG002|Overall Study|Lost to Follow-up|3|||
16783933|NCT02669849|37723792|FG000|Overall Study|Death|1|||
16783934|NCT02669849|37723793|FG001|Overall Study|Death|1|||
16783935|NCT02669849|37723794|FG002|Overall Study|Death|2|||
16783936|NCT02669849|37723792|FG000|Overall Study|Study terminated by sponsor|16|||
16783937|NCT02669849|37723793|FG001|Overall Study|Study terminated by sponsor|1|||
16783938|NCT02669849|37723794|FG002|Overall Study|Study terminated by sponsor|14|||
16783939|NCT02669849|37723792|FG000|Overall Study|Other|0|||
16783940|NCT02669849|37723793|FG001|Overall Study|Other|0|||
16783941|NCT02669849|37723794|FG002|Overall Study|Other|2|||
16783942|NCT03625895|37723802|FG000|Overall Study|Protocol Violation|585|||
16783943|NCT02663687|37723811|FG000|Overall Study|Adverse Event|1|||
16783944|NCT02663687|37723812|FG001|Overall Study|Adverse Event|0|||
17093689|NCT00263666|38233203|FG001|Overall Study|Withdrawal by Subject|1|||
17093690|NCT00195338|38233209|FG000|Overall Study|Lost to Follow-up|2|||
17093691|NCT00195338|38233209|FG000|Overall Study|Adverse Event|5|||
17093692|NCT00195338|38233209|FG000|Overall Study|Lack of Efficacy|1|||
17093693|NCT00195338|38233209|FG000|Overall Study|Early closure of the site|4|||
17093694|NCT00039130|38233213|FG000|Overall Study|Adverse Event|11|||
17093695|NCT00039130|38233213|FG000|Overall Study|Death|9|||
17093696|NCT00039130|38233213|FG000|Overall Study|Withdrawal by Subject|3|||
17093697|NCT00039130|38233213|FG000|Overall Study|Progression|2|||
17093698|NCT00039130|38233213|FG000|Overall Study|Subsequent treatment|2|||
17093699|NCT00039130|38233213|FG000|Overall Study|Physician Decision|3|||
17093700|NCT00035932|38233220|FG000|Overall Study|Adverse Event|10|||
17093701|NCT00035932|38233221|FG001|Overall Study|Adverse Event|9|||
17093702|NCT00035932|38233222|FG002|Overall Study|Adverse Event|9|||
17093703|NCT00035932|38233220|FG000|Overall Study|Death|0|||
17093704|NCT00035932|38233221|FG001|Overall Study|Death|0|||
17093705|NCT00035932|38233222|FG002|Overall Study|Death|1|||
17093706|NCT00035932|38233220|FG000|Overall Study|Disease Progression / Relapse|1|||
17093707|NCT00035932|38233221|FG001|Overall Study|Disease Progression / Relapse|1|||
17093708|NCT00035932|38233222|FG002|Overall Study|Disease Progression / Relapse|0|||
17093709|NCT00035932|38233220|FG000|Overall Study|Lost to Follow-up|4|||
17093710|NCT00035932|38233221|FG001|Overall Study|Lost to Follow-up|4|||
17093711|NCT00035932|38233222|FG002|Overall Study|Lost to Follow-up|3|||
17093712|NCT00035932|38233220|FG000|Overall Study|Noncompliance|6|||
17093713|NCT00035932|38233221|FG001|Overall Study|Noncompliance|7|||
17093714|NCT00035932|38233222|FG002|Overall Study|Noncompliance|6|||
17093715|NCT00035932|38233220|FG000|Overall Study|Protocol Violation While on Study|0|||
17093716|NCT00035932|38233221|FG001|Overall Study|Protocol Violation While on Study|1|||
17093717|NCT00035932|38233222|FG002|Overall Study|Protocol Violation While on Study|2|||
17093718|NCT00035932|38233220|FG000|Overall Study|Withdrawal by Subject|1|||
17093719|NCT00035932|38233221|FG001|Overall Study|Withdrawal by Subject|5|||
17093720|NCT00035932|38233222|FG002|Overall Study|Withdrawal by Subject|0|||
17093721|NCT00035932|38233220|FG000|Overall Study|Study Termination by Sponsor|1|||
17093722|NCT00035932|38233221|FG001|Overall Study|Study Termination by Sponsor|0|||
17093723|NCT00035932|38233222|FG002|Overall Study|Study Termination by Sponsor|0|||
17093724|NCT00035932|38233220|FG000|Overall Study|Lack of Efficacy|33|||
17093725|NCT00035932|38233221|FG001|Overall Study|Lack of Efficacy|33|||
16783945|NCT02663687|37723813|FG002|Overall Study|Adverse Event|0|||
16783946|NCT02663687|37723814|FG003|Overall Study|Adverse Event|0|||
16783947|NCT02663687|37723815|FG004|Overall Study|Adverse Event|0|||
16783948|NCT02663687|37723811|FG000|Overall Study|Other|1|||
16783949|NCT02663687|37723812|FG001|Overall Study|Other|0|||
16783950|NCT02663687|37723813|FG002|Overall Study|Other|1|||
16783951|NCT02663687|37723814|FG003|Overall Study|Other|0|||
16783952|NCT02663687|37723815|FG004|Overall Study|Other|0|||
16783953|NCT02663453|37723846|FG000|Overall Study|Death|4|||
16783954|NCT02663453|37723847|FG001|Overall Study|Death|4|||
16783955|NCT02663453|37723846|FG000|Overall Study|Withdrawal by Subject|1|||
16783956|NCT02663453|37723847|FG001|Overall Study|Withdrawal by Subject|0|||
16783957|NCT02055118|37723856|FG000|Overall Study|Withdrawal by Subject|0|||
16783958|NCT02055118|37723857|FG001|Overall Study|Withdrawal by Subject|2|||
16783959|NCT02055118|37723858|FG002|Overall Study|Withdrawal by Subject|0|||
16783960|NCT02084056|37723869|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
16783961|NCT02084056|37723870|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16783962|NCT02084056|37723871|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16783963|NCT02084056|37723872|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16783964|NCT02084056|37723869|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
16783965|NCT02084056|37723870|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16783966|NCT02084056|37723871|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16783967|NCT02084056|37723872|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16783968|NCT01625182|37723884|FG000|Overall Study|Administrative problems|1|||
16783969|NCT01625182|37723885|FG001|Overall Study|Administrative problems|0|||
16783970|NCT01625182|37723884|FG000|Overall Study|Protocol deviation|0|||
16783971|NCT01625182|37723885|FG001|Overall Study|Protocol deviation|2|||
16783972|NCT01625182|37723884|FG000|Overall Study|Adverse Event|2|||
16783973|NCT01625182|37723885|FG001|Overall Study|Adverse Event|0|||
16783974|NCT01625182|37723884|FG000|Overall Study|Withdrawal by Subject|5|||
16783975|NCT01625182|37723885|FG001|Overall Study|Withdrawal by Subject|1|||
16783976|NCT01625182|37723884|FG000|Overall Study|Lack of Efficacy|12|||
17093726|NCT00035932|38233222|FG002|Overall Study|Lack of Efficacy|28|||
17093727|NCT00022516|38233237|FG000|Overall Study|Adverse Event|0|||
17093728|NCT00022516|38233238|FG001|Overall Study|Adverse Event|59|||
17093729|NCT00022516|38233237|FG000|Overall Study|Lack of Efficacy|0|||
16783977|NCT01625182|37723885|FG001|Overall Study|Lack of Efficacy|8|||
16783978|NCT02661815|37723896|FG000|Overall Study|Withdrawal by Subject|1|||
16783979|NCT02661815|37723897|FG001|Overall Study|Withdrawal by Subject|0|||
16783980|NCT02661815|37723898|FG002|Overall Study|Withdrawal by Subject|0|||
16783981|NCT02661815|37723899|FG003|Overall Study|Withdrawal by Subject|0|||
17093730|NCT00022516|38233238|FG001|Overall Study|Lack of Efficacy|27|||
17093731|NCT00022516|38233237|FG000|Overall Study|Physician Decision|0|||
17093732|NCT00022516|38233238|FG001|Overall Study|Physician Decision|1|||
17093733|NCT00022516|38233237|FG000|Overall Study|Protocol Violation|1|||
17093734|NCT00022516|38233238|FG001|Overall Study|Protocol Violation|3|||
17093735|NCT00022516|38233237|FG000|Overall Study|Withdrawal by Subject|2|||
17093736|NCT00022516|38233238|FG001|Overall Study|Withdrawal by Subject|113|||
17093737|NCT00022516|38233237|FG000|Overall Study|Incomplete documentation|0|||
17093738|NCT00022516|38233238|FG001|Overall Study|Incomplete documentation|27|||
17093739|NCT00033514|38233246|FG000|Overall Study|Lost to Follow-up|1|||
17093740|NCT00033514|38233247|FG001|Overall Study|Lost to Follow-up|1|||
17093741|NCT00033514|38233246|FG000|Overall Study|Withdrawal by Subject|0|||
17093742|NCT00033514|38233247|FG001|Overall Study|Withdrawal by Subject|3|||
17093743|NCT00006916|38233254|FG000|Overall Study|Device not inserted|4|||
17093744|NCT00006916|38233254|FG000|Overall Study|Complication of device insertion|1|||
17093745|NCT00454649|38233268|FG000|Overall Study|Lack of Efficacy|2|||
17093746|NCT00454649|38233269|FG001|Overall Study|Lack of Efficacy|2|||
17093747|NCT00454649|38233270|FG002|Overall Study|Lack of Efficacy|10|||
17093748|NCT00454649|38233271|FG003|Overall Study|Lack of Efficacy|3|||
17093749|NCT00454649|38233272|FG004|Overall Study|Lack of Efficacy|0|||
17093750|NCT00454649|38233273|FG005|Overall Study|Lack of Efficacy|4|||
17093751|NCT00454649|38233274|FG006|Overall Study|Lack of Efficacy|5|||
17093752|NCT00454649|38233275|FG007|Overall Study|Lack of Efficacy|13|||
17190454|NCT02971007|38343373|FG000|Overall Study|Adverse Event|1|||
17190455|NCT02971007|38343374|FG001|Overall Study|Adverse Event|0|||
17190456|NCT02971007|38343375|FG002|Overall Study|Adverse Event|0|||
17190457|NCT02971007|38343373|FG000|Overall Study|Lost to Follow-up|0|||
17190458|NCT02971007|38343374|FG001|Overall Study|Lost to Follow-up|1|||
17190459|NCT02971007|38343375|FG002|Overall Study|Lost to Follow-up|1|||
17190460|NCT02971007|38343373|FG000|Overall Study|Withdrawal by Subject|0|||
17190461|NCT02971007|38343374|FG001|Overall Study|Withdrawal by Subject|1|||
17190462|NCT02971007|38343375|FG002|Overall Study|Withdrawal by Subject|0|||
17190463|NCT02971007|38343373|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
17190464|NCT02971007|38343374|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
17190465|NCT02971007|38343375|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
17190466|NCT02971007|38343373|FG000|Overall Study|Patient discontinued study drug|0|||
17190467|NCT02971007|38343374|FG001|Overall Study|Patient discontinued study drug|1|||
17190468|NCT02971007|38343375|FG002|Overall Study|Patient discontinued study drug|0|||
17190469|NCT03881553|38343386|FG000|Overall Study|Discharged prior to participation|1|||
17190470|NCT03881553|38343387|FG001|Overall Study|Discharged prior to participation|1|||
17190471|NCT03881553|38343388|FG002|Overall Study|Discharged prior to participation|0|||
17190472|NCT03881553|38343386|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
17190473|NCT03881553|38343387|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
17190474|NCT03881553|38343388|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
17190475|NCT02970929|38343396|FG000|Overall Study|Adverse Event|18|||
17190476|NCT02970929|38343396|FG000|Overall Study|Lack of Efficacy|8|||
17190477|NCT02970929|38343396|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
17190478|NCT02970929|38343396|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
17190479|NCT02970929|38343396|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
17190480|NCT02970929|38343396|FG000|Overall Study|LOST TO FOLLOWUP|6|||
17190481|NCT02970929|38343396|FG000|Overall Study|MOVED OUT OF STATE|1|||
17190482|NCT02970929|38343396|FG000|Overall Study|Withdrawal by Subject|16|||
16783982|NCT02053792|37723915|FG000|Overall Study|Physician Decision|0|||
16783983|NCT02053792|37723916|FG001|Overall Study|Physician Decision|1|||
17000052|NCT00939770|38143917|FG007|Overall Study|Physician Decision|6|||
17000053|NCT00939770|38143910|FG000|Overall Study|Protocol Violation|0|||
17000054|NCT00939770|38143911|FG001|Overall Study|Protocol Violation|0|||
17000055|NCT00939770|38143912|FG002|Overall Study|Protocol Violation|0|||
16783984|NCT02053792|37723915|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
16783985|NCT02053792|37723916|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
16783986|NCT02053792|37723915|FG000|Overall Study|Lack of Efficacy|1|||
16783987|NCT02053792|37723916|FG001|Overall Study|Lack of Efficacy|0|||
16783988|NCT02053792|37723915|FG000|Overall Study|Adverse Event|1|||
16783989|NCT02053792|37723916|FG001|Overall Study|Adverse Event|0|||
16783990|NCT02053792|37723915|FG000|Overall Study|Withdrawal by Subject|2|||
16783991|NCT02053792|37723916|FG001|Overall Study|Withdrawal by Subject|2|||
16783992|NCT02053792|37723915|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
16783993|NCT02053792|37723916|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
16783994|NCT02053792|37723915|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
16783995|NCT02053792|37723916|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
16783996|NCT02082340|37723924|FG000|Overall Study|Lost to Follow-up|1|||
16783997|NCT02082340|37723925|FG001|Overall Study|Lost to Follow-up|1|||
16783998|NCT02053246|37723931|FG000|Overall Study|Withdrawal by Subject|3|||
17000056|NCT00939770|38143913|FG003|Overall Study|Protocol Violation|0|||
17000057|NCT00939770|38143914|FG004|Overall Study|Protocol Violation|1|||
17000058|NCT00939770|38143915|FG005|Overall Study|Protocol Violation|0|||
17000059|NCT00939770|38143916|FG006|Overall Study|Protocol Violation|0|||
17000060|NCT00939770|38143917|FG007|Overall Study|Protocol Violation|0|||
17000061|NCT00939770|38143910|FG000|Overall Study|Withdrawal by Subject|0|||
17093753|NCT00454649|38233276|FG008|Overall Study|Lack of Efficacy|10|||
17093754|NCT00454649|38233277|FG009|Overall Study|Lack of Efficacy|2|||
17093755|NCT00454649|38233268|FG000|Overall Study|Adverse Event|0|||
17093756|NCT00454649|38233269|FG001|Overall Study|Adverse Event|1|||
17093757|NCT00454649|38233270|FG002|Overall Study|Adverse Event|3|||
17093758|NCT00454649|38233271|FG003|Overall Study|Adverse Event|0|||
17093759|NCT00454649|38233272|FG004|Overall Study|Adverse Event|1|||
17093760|NCT00454649|38233273|FG005|Overall Study|Adverse Event|2|||
17093761|NCT00454649|38233274|FG006|Overall Study|Adverse Event|3|||
17093762|NCT00454649|38233275|FG007|Overall Study|Adverse Event|4|||
17093763|NCT00454649|38233276|FG008|Overall Study|Adverse Event|6|||
17093764|NCT00454649|38233277|FG009|Overall Study|Adverse Event|2|||
17190483|NCT02970305|38343413|FG000|Overall Study|Adverse Event|10|||
17190484|NCT02970305|38343414|FG001|Overall Study|Adverse Event|6|||
17190485|NCT02970305|38343413|FG000|Overall Study|Lack of Efficacy|1|||
17190486|NCT02970305|38343414|FG001|Overall Study|Lack of Efficacy|1|||
17190487|NCT02970305|38343413|FG000|Overall Study|Noncompliance with study drug|2|||
17190488|NCT02970305|38343414|FG001|Overall Study|Noncompliance with study drug|4|||
17190489|NCT02970305|38343413|FG000|Overall Study|Protocol Violation|2|||
17190490|NCT02970305|38343414|FG001|Overall Study|Protocol Violation|2|||
17190491|NCT02970305|38343413|FG000|Overall Study|Withdrawal by Subject|12|||
17190492|NCT02970305|38343414|FG001|Overall Study|Withdrawal by Subject|11|||
17190493|NCT02970305|38343413|FG000|Overall Study|Not further specified|1|||
17190494|NCT02970305|38343414|FG001|Overall Study|Not further specified|2|||
17093765|NCT00454649|38233268|FG000|Overall Study|Lost to Follow-up|0|||
17190495|NCT02970305|38343413|FG000|Overall Study|Lost to Follow-up|1|||
17190496|NCT02970305|38343414|FG001|Overall Study|Lost to Follow-up|2|||
17190497|NCT03654651|38343431|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
17190498|NCT03654651|38343432|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
17190499|NCT02022033|38343443|FG000|Overall Study|Physician Decision|1|||
17190500|NCT03505671|38343449|FG000|Overall Study|Withdrawal by Subject|2|||
17190501|NCT03505671|38343450|FG001|Overall Study|Withdrawal by Subject|1|||
17190502|NCT03505671|38343449|FG000|Overall Study|Lost to Follow-up|1|||
17190503|NCT03505671|38343450|FG001|Overall Study|Lost to Follow-up|0|||
17093766|NCT00454649|38233269|FG001|Overall Study|Lost to Follow-up|0|||
17093767|NCT00454649|38233270|FG002|Overall Study|Lost to Follow-up|1|||
17093768|NCT00454649|38233271|FG003|Overall Study|Lost to Follow-up|0|||
17093769|NCT00454649|38233272|FG004|Overall Study|Lost to Follow-up|0|||
17093770|NCT00454649|38233273|FG005|Overall Study|Lost to Follow-up|0|||
17093771|NCT00454649|38233274|FG006|Overall Study|Lost to Follow-up|1|||
17093772|NCT00454649|38233275|FG007|Overall Study|Lost to Follow-up|0|||
17190504|NCT01103349|38343471|FG000|Overall Study|Adverse Event|8|||
17190505|NCT01103349|38343472|FG001|Overall Study|Adverse Event|5|||
17190506|NCT01103349|38343473|FG002|Overall Study|Adverse Event|3|||
17190507|NCT01103349|38343471|FG000|Overall Study|Consent withdrawn|1|||
17190508|NCT01103349|38343472|FG001|Overall Study|Consent withdrawn|0|||
17190509|NCT01103349|38343473|FG002|Overall Study|Consent withdrawn|0|||
17190510|NCT01103349|38343471|FG000|Overall Study|Incorrectly included in the trial|1|||
17190511|NCT01103349|38343472|FG001|Overall Study|Incorrectly included in the trial|0|||
17190512|NCT01103349|38343473|FG002|Overall Study|Incorrectly included in the trial|0|||
17190513|NCT01103349|38343471|FG000|Overall Study|Withdrawal by Subject|1|||
17190514|NCT01103349|38343472|FG001|Overall Study|Withdrawal by Subject|1|||
17190515|NCT01103349|38343473|FG002|Overall Study|Withdrawal by Subject|0|||
17190516|NCT01103349|38343471|FG000|Overall Study|did not want to take trial medication|0|||
17190517|NCT01103349|38343472|FG001|Overall Study|did not want to take trial medication|1|||
17190518|NCT01103349|38343473|FG002|Overall Study|did not want to take trial medication|0|||
17190519|NCT01103349|38343471|FG000|Overall Study|forgot to take medication|0|||
17190520|NCT01103349|38343472|FG001|Overall Study|forgot to take medication|0|||
17190521|NCT01103349|38343473|FG002|Overall Study|forgot to take medication|1|||
17190522|NCT02959177|38343484|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
17000062|NCT00939770|38143911|FG001|Overall Study|Withdrawal by Subject|1|||
17000063|NCT00939770|38143912|FG002|Overall Study|Withdrawal by Subject|5|||
17000064|NCT00939770|38143913|FG003|Overall Study|Withdrawal by Subject|2|||
17000065|NCT00939770|38143914|FG004|Overall Study|Withdrawal by Subject|6|||
17000066|NCT00939770|38143915|FG005|Overall Study|Withdrawal by Subject|0|||
17000067|NCT00939770|38143916|FG006|Overall Study|Withdrawal by Subject|2|||
17000068|NCT00939770|38143917|FG007|Overall Study|Withdrawal by Subject|2|||
17000069|NCT00939692|38143950|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
17000070|NCT00939692|38143951|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
17000071|NCT00939692|38143950|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
17093773|NCT00454649|38233276|FG008|Overall Study|Lost to Follow-up|0|||
17093774|NCT00454649|38233277|FG009|Overall Study|Lost to Follow-up|0|||
17190523|NCT02959177|38343485|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
17190524|NCT02959177|38343486|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
17190525|NCT02959177|38343484|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
17190526|NCT02959177|38343485|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
17190527|NCT02959177|38343486|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
17190528|NCT02959177|38343484|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
17190529|NCT02959177|38343485|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
17190530|NCT02959177|38343486|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
17190531|NCT02959177|38343484|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
17190532|NCT02959177|38343485|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
17190533|NCT02959177|38343486|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
17190534|NCT02959177|38343484|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
17190535|NCT02959177|38343485|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
17190536|NCT02959177|38343486|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
17190537|NCT02959177|38343484|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
17190538|NCT02959177|38343485|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
17190539|NCT02959177|38343486|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
17190540|NCT02959177|38343484|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
17190541|NCT02959177|38343485|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
17093775|NCT00454649|38233268|FG000|Overall Study|Other|1|||
17093776|NCT00454649|38233269|FG001|Overall Study|Other|1|||
17093777|NCT00454649|38233270|FG002|Overall Study|Other|5|||
17093778|NCT00454649|38233271|FG003|Overall Study|Other|3|||
17093779|NCT00454649|38233272|FG004|Overall Study|Other|0|||
17093780|NCT00454649|38233273|FG005|Overall Study|Other|0|||
17093781|NCT00454649|38233274|FG006|Overall Study|Other|0|||
17093782|NCT00454649|38233275|FG007|Overall Study|Other|0|||
17093783|NCT00454649|38233276|FG008|Overall Study|Other|3|||
17093784|NCT00454649|38233277|FG009|Overall Study|Other|1|||
17093785|NCT00454649|38233268|FG000|Overall Study|Withdrawal by Subject|0|||
17093786|NCT00454649|38233269|FG001|Overall Study|Withdrawal by Subject|0|||
17093787|NCT00454649|38233270|FG002|Overall Study|Withdrawal by Subject|0|||
17093788|NCT00454649|38233271|FG003|Overall Study|Withdrawal by Subject|0|||
17093789|NCT00454649|38233272|FG004|Overall Study|Withdrawal by Subject|0|||
17093790|NCT00454649|38233273|FG005|Overall Study|Withdrawal by Subject|1|||
17093791|NCT00454649|38233274|FG006|Overall Study|Withdrawal by Subject|0|||
17093792|NCT00454649|38233275|FG007|Overall Study|Withdrawal by Subject|2|||
17093793|NCT00454649|38233276|FG008|Overall Study|Withdrawal by Subject|1|||
17093794|NCT00454649|38233277|FG009|Overall Study|Withdrawal by Subject|0|||
17093795|NCT00454571|38233320|FG000|Overall Study|Adverse Event|2|||
17093796|NCT00454571|38233321|FG001|Overall Study|Adverse Event|0|||
17093797|NCT00454571|38233320|FG000|Overall Study|Physician Decision|0|||
17093798|NCT00454571|38233321|FG001|Overall Study|Physician Decision|1|||
17093799|NCT00454571|38233320|FG000|Overall Study|Protocol Violation|1|||
17093800|NCT00454571|38233321|FG001|Overall Study|Protocol Violation|0|||
17093801|NCT00454571|38233320|FG000|Overall Study|Withdrawal by Subject|10|||
17093802|NCT00454571|38233321|FG001|Overall Study|Withdrawal by Subject|5|||
17093803|NCT03837743|38233327|FG000|Overall Study|Adverse Event|1|||
17093804|NCT03837743|38233327|FG000|Overall Study|Withdrawal by Subject|2|||
17093805|NCT03836729|38233335|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
17093806|NCT00443729|38233345|FG000|Overall Study|Never Treated|0|||
17093807|NCT00443729|38233346|FG001|Overall Study|Never Treated|1|||
17093808|NCT00443729|38233345|FG000|Overall Study|Lack of Efficacy|4|||
17093809|NCT00443729|38233346|FG001|Overall Study|Lack of Efficacy|2|||
17093810|NCT00443729|38233345|FG000|Overall Study|Lost to Follow-up|0|||
17093811|NCT00443729|38233346|FG001|Overall Study|Lost to Follow-up|1|||
17093812|NCT00443729|38233345|FG000|Overall Study|Physician Decision|2|||
17093813|NCT00443729|38233346|FG001|Overall Study|Physician Decision|1|||
17093814|NCT00443729|38233345|FG000|Overall Study|Protocol Violation|1|||
17093815|NCT00443729|38233346|FG001|Overall Study|Protocol Violation|1|||
17093816|NCT00443729|38233345|FG000|Overall Study|Withdrawal by Subject|3|||
17093817|NCT00443729|38233346|FG001|Overall Study|Withdrawal by Subject|1|||
17093818|NCT00443651|38233354|FG000|Overall Study|Death|1|||
17093819|NCT00443651|38233355|FG001|Overall Study|Death|5|||
17093820|NCT00443651|38233354|FG000|Overall Study|Adverse Event|5|||
17093821|NCT00443651|38233355|FG001|Overall Study|Adverse Event|6|||
17093822|NCT00443651|38233354|FG000|Overall Study|Lost to Follow-up|18|||
17093823|NCT00443651|38233355|FG001|Overall Study|Lost to Follow-up|12|||
17093824|NCT00443651|38233354|FG000|Overall Study|Patient's/Guardian's Decision|58|||
17093825|NCT00443651|38233355|FG001|Overall Study|Patient's/Guardian's Decision|30|||
17093826|NCT00443651|38233354|FG000|Overall Study|Physician Decision|13|||
17093827|NCT00443651|38233355|FG001|Overall Study|Physician Decision|4|||
17093828|NCT00443651|38233354|FG000|Overall Study|Pregnancy|0|||
17093829|NCT00443651|38233355|FG001|Overall Study|Pregnancy|1|||
17093830|NCT00443261|38233361|FG000|Overall Study|Death|1|||
17093831|NCT00439517|38233367|FG000|Overall Study|Subject on treatment|1|||
17190542|NCT02959177|38343486|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
17093832|NCT00439517|38233368|FG001|Overall Study|Subject on treatment|0|||
17093833|NCT00439517|38233367|FG000|Overall Study|Subject in survival follow-up|1|||
17093834|NCT00439517|38233368|FG001|Overall Study|Subject in survival follow-up|0|||
17093835|NCT00438815|38233374|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
17093836|NCT00438815|38233374|FG000|Overall Study|3-month follow-up no longer required|12|||
17093837|NCT00438815|38233374|FG000|Overall Study|Noncompliance with protocol requirements|9|||
17093838|NCT00438815|38233374|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
17093839|NCT00438815|38233374|FG000|Overall Study|Lost to Follow-up|6|||
17093840|NCT00438815|38233374|FG000|Overall Study|Withdrawal by Subject|6|||
17093841|NCT00438815|38233374|FG000|Overall Study|Death|1|||
17190543|NCT01337089|38343498|FG000|Overall Study|Adverse Event|237|||
17190544|NCT01337089|38343498|FG000|Overall Study|Withdrawal by Subject|129|||
17190545|NCT01337089|38343498|FG000|Overall Study|Withdrawal by Investigator|33|||
17190546|NCT01337089|38343498|FG000|Overall Study|Met Withdrawal Criteria|3|||
17190547|NCT01337089|38343498|FG000|Overall Study|Lost to Follow-up|2|||
17190548|NCT04706403|38343507|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
17190549|NCT04706403|38343508|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
17190550|NCT04706403|38343509|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
17190551|NCT04706403|38343510|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
17190552|NCT04706403|38343511|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
17190553|NCT02983617|38343525|FG000|Overall Study|Adverse Event|0|||
17190554|NCT02983617|38343526|FG001|Overall Study|Adverse Event|7|||
17190555|NCT02983617|38343525|FG000|Overall Study|Death|0|||
17190556|NCT02983617|38343526|FG001|Overall Study|Death|1|||
17190557|NCT02983617|38343525|FG000|Overall Study|Investigator's Discretion|0|||
17190558|NCT02983617|38343526|FG001|Overall Study|Investigator's Discretion|1|||
17190559|NCT02873689|38343534|FG000|Overall Study|Lack of Efficacy|1|||
17190560|NCT02873689|38343535|FG001|Overall Study|Lack of Efficacy|0|||
17190561|NCT02873689|38343534|FG000|Overall Study|Withdrawal by Subject|2|||
17190562|NCT02873689|38343535|FG001|Overall Study|Withdrawal by Subject|2|||
17190563|NCT02873689|38343534|FG000|Overall Study|Protocol Violation|1|||
17190564|NCT02873689|38343535|FG001|Overall Study|Protocol Violation|0|||
17190565|NCT02873689|38343534|FG000|Overall Study|Adverse Event|2|||
17190566|NCT02873689|38343535|FG001|Overall Study|Adverse Event|2|||
17190567|NCT02873689|38343534|FG000|Overall Study|Randomized but not Treated|1|||
17190568|NCT02873689|38343535|FG001|Overall Study|Randomized but not Treated|1|||
17190569|NCT02901431|38343549|FG000|PK Part|Adverse Event|0|||
17190570|NCT02901431|38343550|FG001|PK Part|Adverse Event|1|||
17190571|NCT02901431|38343551|FG002|PK Part|Adverse Event|0|||
17190572|NCT02901431|38343552|FG003|PK Part|Adverse Event|0|||
17190573|NCT02901431|38343553|FG004|PK Part|Adverse Event|0|||
17190574|NCT02901431|38343554|FG005|PK Part|Adverse Event|0|||
17190575|NCT02901431|38343555|FG006|PK Part|Adverse Event|0|||
17190576|NCT02901431|38343556|FG007|PK Part|Adverse Event|0|||
17190577|NCT02901431|38343557|FG008|PK Part|Adverse Event|0|||
17190578|NCT02901431|38343558|FG009|PK Part|Adverse Event|0|||
17190579|NCT02901431|38343559|FG010|PK Part|Adverse Event|0|||
17190580|NCT02901431|38343560|FG011|PK Part|Adverse Event|0|||
17190581|NCT02901431|38343561|FG012|PK Part|Adverse Event|0|||
17190582|NCT02901431|38343549|FG000|PK Part|Lost to Follow-up|0|||
17190583|NCT02901431|38343550|FG001|PK Part|Lost to Follow-up|0|||
17190584|NCT02901431|38343551|FG002|PK Part|Lost to Follow-up|1|||
17190585|NCT02901431|38343552|FG003|PK Part|Lost to Follow-up|0|||
17190586|NCT02901431|38343553|FG004|PK Part|Lost to Follow-up|0|||
17190587|NCT02901431|38343554|FG005|PK Part|Lost to Follow-up|0|||
17190588|NCT02901431|38343555|FG006|PK Part|Lost to Follow-up|0|||
17190589|NCT02901431|38343556|FG007|PK Part|Lost to Follow-up|0|||
17190590|NCT02901431|38343557|FG008|PK Part|Lost to Follow-up|0|||
17190591|NCT02901431|38343558|FG009|PK Part|Lost to Follow-up|0|||
17190592|NCT02901431|38343559|FG010|PK Part|Lost to Follow-up|0|||
17190593|NCT02901431|38343560|FG011|PK Part|Lost to Follow-up|0|||
17190594|NCT02901431|38343561|FG012|PK Part|Lost to Follow-up|0|||
17190595|NCT02901431|38343549|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
17190596|NCT02901431|38343550|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16868373|NCT01533935|37841438|FG002|Overall Study|Protocol Violation|0|||
16868374|NCT01533935|37841439|FG003|Overall Study|Protocol Violation|0|||
17190597|NCT02901431|38343551|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190598|NCT02901431|38343552|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190599|NCT02901431|38343553|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190600|NCT02901431|38343554|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190601|NCT02901431|38343555|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190602|NCT02901431|38343556|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190603|NCT02901431|38343557|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190604|NCT02901431|38343558|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190605|NCT02901431|38343559|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190606|NCT02901431|38343560|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17190607|NCT02901431|38343561|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
17093842|NCT00438659|38233380|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
17093843|NCT00438659|38233381|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
17093844|NCT00438659|38233380|FG000|Overall Study|Cancel|5|||
17093845|NCT00438659|38233381|FG001|Overall Study|Cancel|2|||
17093846|NCT00437645|38233390|FG000|Overall Study|Adverse Event|15|||
17093847|NCT00437645|38233391|FG001|Overall Study|Adverse Event|84|||
17093848|NCT00437645|38233390|FG000|Overall Study|Withdrawal by Subject|10|||
17093849|NCT00437645|38233391|FG001|Overall Study|Withdrawal by Subject|22|||
17093850|NCT00437645|38233390|FG000|Overall Study|Protocol Violation|3|||
17093851|NCT00437645|38233391|FG001|Overall Study|Protocol Violation|3|||
17093852|NCT00437645|38233390|FG000|Overall Study|Lost to Follow-up|2|||
17093853|NCT00437645|38233391|FG001|Overall Study|Lost to Follow-up|3|||
17093854|NCT00437645|38233390|FG000|Overall Study|Administrative problems|2|||
17093855|NCT00437645|38233391|FG001|Overall Study|Administrative problems|1|||
17093856|NCT00437645|38233390|FG000|Overall Study|Lack of Efficacy|2|||
17093857|NCT00437645|38233391|FG001|Overall Study|Lack of Efficacy|1|||
17093858|NCT00437645|38233390|FG000|Overall Study|Condition no longer requires study drug|1|||
17093859|NCT00437645|38233391|FG001|Overall Study|Condition no longer requires study drug|1|||
17093860|NCT00437489|38233399|FG000|Overall Study|Study terminated by sponsor|23|||
17093861|NCT00437489|38233400|FG001|Overall Study|Study terminated by sponsor|21|||
17093862|NCT00437489|38233399|FG000|Overall Study|Lost to Follow-up|0|||
17093863|NCT00437489|38233400|FG001|Overall Study|Lost to Follow-up|1|||
17093864|NCT00442559|38233408|FG000|Overall Study|Lost to Follow-up|32|||
17093865|NCT00442559|38233409|FG001|Overall Study|Lost to Follow-up|34|||
17093866|NCT00442559|38233408|FG000|Overall Study|Protocol Violation|1|||
17093867|NCT00442559|38233409|FG001|Overall Study|Protocol Violation|1|||
17093868|NCT00442559|38233408|FG000|Overall Study|Withdrawal by Subject|1|||
17093869|NCT00442559|38233409|FG001|Overall Study|Withdrawal by Subject|0|||
17093870|NCT00441701|38233431|FG000|Overall Study|Adverse Event|3|||
17093871|NCT00441701|38233432|FG001|Overall Study|Adverse Event|2|||
17093872|NCT00441701|38233433|FG002|Overall Study|Adverse Event|1|||
17093873|NCT00441701|38233434|FG003|Overall Study|Adverse Event|0|||
17190608|NCT02901431|38343549|FG000|PK Part|Pending dose confirmation|0|||
17190609|NCT02901431|38343550|FG001|PK Part|Pending dose confirmation|1|||
17000072|NCT00939692|38143951|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
17000073|NCT04672252|38143959|FG000|Overall Study|Protocol Violation|1|||
17000074|NCT04672252|38143960|FG001|Overall Study|Protocol Violation|0|||
17000075|NCT00584740|38143968|FG000|Overall Study|Adverse Event|1|||
17093874|NCT00441701|38233435|FG004|Overall Study|Adverse Event|2|||
17093875|NCT00441701|38233436|FG005|Overall Study|Adverse Event|2|||
17093876|NCT00441701|38233437|FG006|Overall Study|Adverse Event|0|||
17093877|NCT00441701|38233438|FG007|Overall Study|Adverse Event|0|||
17093878|NCT00441701|38233439|FG008|Overall Study|Adverse Event|0|||
17093879|NCT00441701|38233440|FG009|Overall Study|Adverse Event|0|||
17093880|NCT00441701|38233431|FG000|Overall Study|Lack of Efficacy|2|||
17093881|NCT00441701|38233432|FG001|Overall Study|Lack of Efficacy|0|||
17093882|NCT00441701|38233433|FG002|Overall Study|Lack of Efficacy|2|||
17093883|NCT00441701|38233434|FG003|Overall Study|Lack of Efficacy|2|||
17093884|NCT00441701|38233435|FG004|Overall Study|Lack of Efficacy|0|||
17093885|NCT00441701|38233436|FG005|Overall Study|Lack of Efficacy|1|||
17000076|NCT00584740|38143969|FG001|Overall Study|Adverse Event|1|||
17000077|NCT00584740|38143968|FG000|Overall Study|Lack of Efficacy|8|||
17000078|NCT00584740|38143969|FG001|Overall Study|Lack of Efficacy|2|||
17000079|NCT00584740|38143968|FG000|Overall Study|Withdrawal by Subject|3|||
17000080|NCT00584740|38143969|FG001|Overall Study|Withdrawal by Subject|2|||
17000081|NCT00584740|38143968|FG000|Overall Study|Lost to Follow-up|0|||
17000082|NCT00584740|38143969|FG001|Overall Study|Lost to Follow-up|1|||
17000083|NCT00942968|38143975|FG000|Overall Study|Adverse Event|60|||
17000084|NCT00942968|38143975|FG000|Overall Study|Death|76|||
17000085|NCT00942968|38143975|FG000|Overall Study|Protocol Violation|9|||
17000086|NCT00942968|38143975|FG000|Overall Study|Lost to Follow-up|4|||
17000087|NCT00942968|38143975|FG000|Overall Study|Withdrawal by Subject|44|||
17000088|NCT00942968|38143975|FG000|Overall Study|Sponsor request|5|||
17000089|NCT00942968|38143975|FG000|Overall Study|Physician Decision|11|||
17000090|NCT00942968|38143975|FG000|Overall Study|Progression of disease|12|||
17000091|NCT00942968|38143975|FG000|Overall Study|Inferior vena cava filter placement|4|||
17000092|NCT00942968|38143975|FG000|Overall Study|Pulmonary embolism (PE)|1|||
17000093|NCT00942968|38143975|FG000|Overall Study|Participant required pancreatic biopsy|1|||
17000094|NCT00942968|38143975|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
17000095|NCT00942734|38143979|FG000|Overall Study|Adverse Event|2|||
17000096|NCT00942734|38143979|FG000|Overall Study|Protocol Violation|3|||
17000097|NCT00942734|38143979|FG000|Overall Study|Disease Progression|2|||
17000098|NCT00942734|38143979|FG000|Overall Study|Physician Decision|1|||
17000099|NCT00584194|38143983|FG000|Overall Study|Other|135|||
17000100|NCT00942422|38143987|FG000|Overall Study|Withdrawal by Subject|1|||
17000101|NCT00942422|38143987|FG000|Overall Study|Death|1|||
17093886|NCT00441701|38233437|FG006|Overall Study|Lack of Efficacy|0|||
17093887|NCT00441701|38233438|FG007|Overall Study|Lack of Efficacy|0|||
17093888|NCT00441701|38233439|FG008|Overall Study|Lack of Efficacy|0|||
17093889|NCT00441701|38233440|FG009|Overall Study|Lack of Efficacy|0|||
17093890|NCT00441701|38233431|FG000|Overall Study|Withdrawal by Subject|0|||
16783999|NCT02053246|37723931|FG000|Overall Study|Physician Decision|1|||
16784000|NCT02053168|37723935|FG000|Overall Study|Withdrawal by Subject|1|||
16784001|NCT02053168|37723935|FG000|Overall Study|Physician Decision|1|||
16784002|NCT02053168|37723935|FG000|Overall Study|Lost to Follow-up|1|||
16784003|NCT02052466|37723939|FG000|Overall Study|Withdrawal by Subject|1|||
16784004|NCT02052466|37723939|FG000|Overall Study|Acromial fracture|1|||
16784005|NCT02032888|37723946|FG000|Treatment Period|Poor compliance/noncompliance|1|||
16784006|NCT02032888|37723947|FG001|Treatment Period|Poor compliance/noncompliance|1|||
16784007|NCT02032888|37723948|FG002|Treatment Period|Poor compliance/noncompliance|0|||
16784008|NCT02032888|37723946|FG000|Treatment Period|Other|1|||
16784009|NCT02032888|37723947|FG001|Treatment Period|Other|1|||
16784010|NCT02032888|37723948|FG002|Treatment Period|Other|0|||
16784011|NCT02032888|37723946|FG000|Follow-up Period|Lost to Follow-up|1|||
16784012|NCT02032888|37723947|FG001|Follow-up Period|Lost to Follow-up|1|||
16784013|NCT02032888|37723948|FG002|Follow-up Period|Lost to Follow-up|0|||
16784014|NCT02032888|37723946|FG000|Follow-up Period|Death|1|||
16784015|NCT02032888|37723947|FG001|Follow-up Period|Death|1|||
16784016|NCT02032888|37723948|FG002|Follow-up Period|Death|0|||
16784017|NCT02032888|37723946|FG000|Follow-up Period|Other|1|||
16784018|NCT02032888|37723947|FG001|Follow-up Period|Other|0|||
16784019|NCT02032888|37723948|FG002|Follow-up Period|Other|0|||
16784020|NCT02082262|37723965|FG000|Overall Study|Withdrawal by Subject|3|||
16784021|NCT02082262|37723965|FG000|Overall Study|Adverse Event|48|||
16784022|NCT04697069|37723971|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
16784023|NCT04697069|37723972|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
16784024|NCT04697069|37723971|FG000|Overall Study|Study termination|2|||
16784025|NCT04697069|37723972|FG001|Overall Study|Study termination|1|||
16784026|NCT02082184|37723980|FG000|Overall Study|Adverse Event|1|||
16784027|NCT02082184|37723981|FG001|Overall Study|Adverse Event|0|||
16784028|NCT02082184|37723980|FG000|Overall Study|Medical diagnosis|1|||
16784029|NCT02082184|37723981|FG001|Overall Study|Medical diagnosis|2|||
16784030|NCT02082184|37723980|FG000|Overall Study|Device associated symptoms|5|||
16784031|NCT02082184|37723981|FG001|Overall Study|Device associated symptoms|0|||
16784032|NCT02082184|37723980|FG000|Overall Study|Withdrawal by Subject|3|||
16784033|NCT02082184|37723981|FG001|Overall Study|Withdrawal by Subject|2|||
16784034|NCT02082184|37723980|FG000|Overall Study|Protocol Violation|0|||
16784035|NCT02082184|37723981|FG001|Overall Study|Protocol Violation|6|||
16784036|NCT02082184|37723980|FG000|Overall Study|Lost to Follow-up|0|||
16784037|NCT02082184|37723981|FG001|Overall Study|Lost to Follow-up|2|||
16784038|NCT02082184|37723980|FG000|Overall Study|Subject non-compliance|0|||
16784039|NCT02082184|37723981|FG001|Overall Study|Subject non-compliance|1|||
16784040|NCT01624870|37723987|FG000|Overall Study|Death|19|||
16784041|NCT01624870|37723987|FG000|Overall Study|Withdrawal by Subject|1|||
16784042|NCT01624870|37723987|FG000|Overall Study|CoreValve not implanted|6|||
16784043|NCT01624870|37723987|FG000|Overall Study|Lost to follow up|1|||
16784044|NCT02031640|37723998|FG000|Screening Period|Adverse Event|1|||
16784045|NCT02031640|37723999|FG001|Screening Period|Adverse Event|0|||
16784046|NCT02031640|37724000|FG002|Screening Period|Adverse Event|0|||
16784047|NCT02031640|37724001|FG003|Screening Period|Adverse Event|0|||
16784048|NCT02031640|37724002|FG004|Screening Period|Adverse Event|0|||
16784049|NCT02031640|37724003|FG005|Screening Period|Adverse Event|0|||
16784050|NCT02031640|37723998|FG000|Screening Period|Withdrawal by Subject|29|||
16784051|NCT02031640|37723999|FG001|Screening Period|Withdrawal by Subject|0|||
16784052|NCT02031640|37724000|FG002|Screening Period|Withdrawal by Subject|0|||
16784053|NCT02031640|37724001|FG003|Screening Period|Withdrawal by Subject|0|||
16784054|NCT02031640|37724002|FG004|Screening Period|Withdrawal by Subject|0|||
16784055|NCT02031640|37724003|FG005|Screening Period|Withdrawal by Subject|0|||
16784056|NCT02031640|37723998|FG000|Screening Period|Inclusion criteria not met|312|||
16784057|NCT02031640|37723999|FG001|Screening Period|Inclusion criteria not met|0|||
16784058|NCT02031640|37724000|FG002|Screening Period|Inclusion criteria not met|0|||
16784059|NCT02031640|37724001|FG003|Screening Period|Inclusion criteria not met|0|||
17000102|NCT00942422|38143987|FG000|Overall Study|Progressive diease|1|||
17000103|NCT00677833|38143995|FG000|Overall Study|Withdrawal by Subject|4|||
17093891|NCT00441701|38233432|FG001|Overall Study|Withdrawal by Subject|2|||
16784060|NCT02031640|37724002|FG004|Screening Period|Inclusion criteria not met|0|||
16784061|NCT02031640|37724003|FG005|Screening Period|Inclusion criteria not met|0|||
16784062|NCT02031640|37723998|FG000|Screening Period|Exclusion criteria met|30|||
16784063|NCT02031640|37723999|FG001|Screening Period|Exclusion criteria met|0|||
17093892|NCT00441701|38233433|FG002|Overall Study|Withdrawal by Subject|1|||
17093893|NCT00441701|38233434|FG003|Overall Study|Withdrawal by Subject|1|||
17093894|NCT00441701|38233435|FG004|Overall Study|Withdrawal by Subject|0|||
17093895|NCT00441701|38233436|FG005|Overall Study|Withdrawal by Subject|0|||
17093896|NCT00441701|38233437|FG006|Overall Study|Withdrawal by Subject|0|||
17093897|NCT00441701|38233438|FG007|Overall Study|Withdrawal by Subject|0|||
17093898|NCT00441701|38233439|FG008|Overall Study|Withdrawal by Subject|0|||
17000104|NCT00677833|38143996|FG001|Overall Study|Withdrawal by Subject|0|||
17000105|NCT00677833|38143997|FG002|Overall Study|Withdrawal by Subject|1|||
17000106|NCT00677833|38143998|FG003|Overall Study|Withdrawal by Subject|3|||
17000107|NCT00677833|38143995|FG000|Overall Study|Lost to Follow-up|0|||
17000108|NCT00677833|38143996|FG001|Overall Study|Lost to Follow-up|0|||
17000109|NCT00677833|38143997|FG002|Overall Study|Lost to Follow-up|1|||
17000110|NCT00677833|38143998|FG003|Overall Study|Lost to Follow-up|0|||
17000111|NCT00942266|38144008|FG000|Overall Study|Withdrawal by Subject|1|||
17093899|NCT00441701|38233440|FG009|Overall Study|Withdrawal by Subject|0|||
17093900|NCT00441545|38233458|FG000|First Intervention|Adverse Event|6|||
17093901|NCT00441545|38233459|FG001|First Intervention|Adverse Event|5|||
17093902|NCT00441545|38233458|FG000|First Intervention|Protocol Violation|2|||
17093903|NCT00441545|38233459|FG001|First Intervention|Protocol Violation|2|||
17093904|NCT00441545|38233458|FG000|First Intervention|Withdrawal by Subject|3|||
17093905|NCT00441545|38233459|FG001|First Intervention|Withdrawal by Subject|3|||
17093906|NCT00441545|38233458|FG000|First Intervention|Kidney transplant|1|||
17093907|NCT00441545|38233459|FG001|First Intervention|Kidney transplant|1|||
17093908|NCT00441545|38233458|FG000|First Intervention|Lack of Efficacy|2|||
17093909|NCT00441545|38233459|FG001|First Intervention|Lack of Efficacy|0|||
17093910|NCT00441545|38233458|FG000|First Intervention|Subject exceeded safety criteria|0|||
17093911|NCT00441545|38233459|FG001|First Intervention|Subject exceeded safety criteria|1|||
17093912|NCT00441545|38233458|FG000|First Intervention|Subject met an exclusionary criteria|1|||
17093913|NCT00441545|38233459|FG001|First Intervention|Subject met an exclusionary criteria|0|||
17093914|NCT00441545|38233458|FG000|First Intervention|Extended hospitalization|1|||
17093915|NCT00441545|38233459|FG001|First Intervention|Extended hospitalization|0|||
17093916|NCT00441545|38233458|FG000|First Intervention|Site error|1|||
17093917|NCT00441545|38233459|FG001|First Intervention|Site error|0|||
17093918|NCT00441545|38233458|FG000|First Intervention|Sponsor's request|1|||
17093919|NCT00441545|38233459|FG001|First Intervention|Sponsor's request|0|||
17093920|NCT00441545|38233458|FG000|Second Intervention|Adverse Event|5|||
17093921|NCT00441545|38233459|FG001|Second Intervention|Adverse Event|2|||
17093922|NCT00441545|38233458|FG000|Second Intervention|Protocol Violation|4|||
17093923|NCT00441545|38233459|FG001|Second Intervention|Protocol Violation|1|||
17093924|NCT00441545|38233458|FG000|Second Intervention|Withdrawal by Subject|1|||
17093925|NCT00441545|38233459|FG001|Second Intervention|Withdrawal by Subject|1|||
17093926|NCT00441545|38233458|FG000|Second Intervention|Kidney Transplant|1|||
17093927|NCT00441545|38233459|FG001|Second Intervention|Kidney Transplant|1|||
17093928|NCT00441545|38233458|FG000|Second Intervention|Lack of Efficacy|0|||
17093929|NCT00441545|38233459|FG001|Second Intervention|Lack of Efficacy|1|||
17093930|NCT00441545|38233458|FG000|Second Intervention|Subject exceeded safety criteria|1|||
17093931|NCT00441545|38233459|FG001|Second Intervention|Subject exceeded safety criteria|0|||
17093932|NCT00441545|38233458|FG000|Second Intervention|Subject moved|0|||
17093933|NCT00441545|38233459|FG001|Second Intervention|Subject moved|1|||
17093934|NCT00436553|38233468|FG000|Overall Study|Adverse Event|4|||
17093935|NCT00436553|38233469|FG001|Overall Study|Adverse Event|3|||
17093936|NCT00436553|38233470|FG002|Overall Study|Adverse Event|4|||
17093937|NCT00436553|38233468|FG000|Overall Study|Death|3|||
17093938|NCT00436553|38233469|FG001|Overall Study|Death|1|||
17093939|NCT00436553|38233470|FG002|Overall Study|Death|3|||
17093940|NCT00436553|38233468|FG000|Overall Study|Lost to Follow-up|0|||
17093941|NCT00436553|38233469|FG001|Overall Study|Lost to Follow-up|2|||
17093942|NCT00436553|38233470|FG002|Overall Study|Lost to Follow-up|0|||
17093943|NCT00436553|38233468|FG000|Overall Study|Protocol Violation|1|||
17093944|NCT00436553|38233469|FG001|Overall Study|Protocol Violation|0|||
17093945|NCT00436553|38233470|FG002|Overall Study|Protocol Violation|0|||
17093946|NCT00436553|38233468|FG000|Overall Study|Withdrawal by Subject|5|||
17093947|NCT00436553|38233469|FG001|Overall Study|Withdrawal by Subject|6|||
17093948|NCT00436553|38233470|FG002|Overall Study|Withdrawal by Subject|3|||
17093949|NCT00441467|38233478|FG000|Overall Study|Adverse Event|6|||
17093950|NCT00441467|38233478|FG000|Overall Study|Withdrawal by Subject|3|||
17190610|NCT02901431|38343551|FG002|PK Part|Pending dose confirmation|0|||
17190611|NCT02901431|38343552|FG003|PK Part|Pending dose confirmation|0|||
17190612|NCT02901431|38343553|FG004|PK Part|Pending dose confirmation|0|||
17190613|NCT02901431|38343554|FG005|PK Part|Pending dose confirmation|0|||
17190614|NCT02901431|38343555|FG006|PK Part|Pending dose confirmation|0|||
17190615|NCT02901431|38343556|FG007|PK Part|Pending dose confirmation|0|||
17190616|NCT02901431|38343557|FG008|PK Part|Pending dose confirmation|0|||
17190617|NCT02901431|38343558|FG009|PK Part|Pending dose confirmation|0|||
17190618|NCT02901431|38343559|FG010|PK Part|Pending dose confirmation|0|||
17190619|NCT02901431|38343560|FG011|PK Part|Pending dose confirmation|0|||
17190620|NCT02901431|38343561|FG012|PK Part|Pending dose confirmation|0|||
17190621|NCT02901431|38343549|FG000|PK Part|8 weeks of treatment ran out|2|||
17190622|NCT02901431|38343550|FG001|PK Part|8 weeks of treatment ran out|0|||
17190623|NCT02901431|38343551|FG002|PK Part|8 weeks of treatment ran out|0|||
17190624|NCT02901431|38343552|FG003|PK Part|8 weeks of treatment ran out|0|||
17000112|NCT00942266|38144009|FG001|Overall Study|Withdrawal by Subject|0|||
17000113|NCT00942266|38144008|FG000|Overall Study|Adverse Event|2|||
17190625|NCT02901431|38343553|FG004|PK Part|8 weeks of treatment ran out|0|||
17190626|NCT02901431|38343554|FG005|PK Part|8 weeks of treatment ran out|0|||
17190627|NCT02901431|38343555|FG006|PK Part|8 weeks of treatment ran out|0|||
17000114|NCT00942266|38144009|FG001|Overall Study|Adverse Event|1|||
17000115|NCT00942266|38144008|FG000|Overall Study|Disease Progression|38|||
17000116|NCT00942266|38144009|FG001|Overall Study|Disease Progression|11|||
17000117|NCT00942266|38144008|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
17000118|NCT00942266|38144009|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
17000119|NCT00942266|38144008|FG000|Overall Study|Intercurrent illness|0|||
17000120|NCT00942266|38144009|FG001|Overall Study|Intercurrent illness|1|||
17000121|NCT00942266|38144008|FG000|Overall Study|Physician Decision|2|||
17000122|NCT00942266|38144009|FG001|Overall Study|Physician Decision|0|||
17000123|NCT00942266|38144008|FG000|Overall Study|medical deterioration (pneumonia)|0|||
17000124|NCT00942266|38144009|FG001|Overall Study|medical deterioration (pneumonia)|1|||
17000125|NCT00942188|38144019|FG000|Overall Study|Adverse Event|0|||
17000126|NCT00942188|38144020|FG001|Overall Study|Adverse Event|3|||
17000127|NCT00942188|38144021|FG002|Overall Study|Adverse Event|2|||
17000128|NCT00942188|38144022|FG003|Overall Study|Adverse Event|0|||
17000129|NCT00942188|38144019|FG000|Overall Study|Lack of Efficacy|0|||
17000130|NCT00942188|38144020|FG001|Overall Study|Lack of Efficacy|0|||
17000131|NCT00942188|38144021|FG002|Overall Study|Lack of Efficacy|0|||
17000132|NCT00942188|38144022|FG003|Overall Study|Lack of Efficacy|1|||
17000133|NCT00942188|38144019|FG000|Overall Study|Protocol Violation|1|||
17190628|NCT02901431|38343556|FG007|PK Part|8 weeks of treatment ran out|0|||
17190629|NCT02901431|38343557|FG008|PK Part|8 weeks of treatment ran out|0|||
17093951|NCT00441467|38233478|FG000|Overall Study|Progressive disease|9|||
17093952|NCT00436163|38233482|FG000|Overall Study|Lost to Follow-up|2|||
17093953|NCT00436163|38233482|FG000|Overall Study|Adverse Event|1|||
17000134|NCT00942188|38144020|FG001|Overall Study|Protocol Violation|1|||
17000135|NCT00942188|38144021|FG002|Overall Study|Protocol Violation|0|||
17000136|NCT00942188|38144022|FG003|Overall Study|Protocol Violation|0|||
17000137|NCT00942188|38144019|FG000|Overall Study|Lost to Follow-up|2|||
17000138|NCT00942188|38144020|FG001|Overall Study|Lost to Follow-up|1|||
17000139|NCT00942188|38144021|FG002|Overall Study|Lost to Follow-up|2|||
17190630|NCT02901431|38343558|FG009|PK Part|8 weeks of treatment ran out|0|||
17190631|NCT02901431|38343559|FG010|PK Part|8 weeks of treatment ran out|0|||
17190632|NCT02901431|38343560|FG011|PK Part|8 weeks of treatment ran out|0|||
17190633|NCT02901431|38343561|FG012|PK Part|8 weeks of treatment ran out|0|||
17190634|NCT02901431|38343549|FG000|PK Part|Stopped treatment after 8 weeks|1|||
17190635|NCT02901431|38343550|FG001|PK Part|Stopped treatment after 8 weeks|0|||
17190636|NCT02901431|38343551|FG002|PK Part|Stopped treatment after 8 weeks|1|||
17190637|NCT02901431|38343552|FG003|PK Part|Stopped treatment after 8 weeks|0|||
17190638|NCT02901431|38343553|FG004|PK Part|Stopped treatment after 8 weeks|0|||
17190639|NCT02901431|38343554|FG005|PK Part|Stopped treatment after 8 weeks|0|||
17190640|NCT02901431|38343555|FG006|PK Part|Stopped treatment after 8 weeks|0|||
17190641|NCT02901431|38343556|FG007|PK Part|Stopped treatment after 8 weeks|0|||
17190642|NCT02901431|38343557|FG008|PK Part|Stopped treatment after 8 weeks|0|||
17190643|NCT02901431|38343558|FG009|PK Part|Stopped treatment after 8 weeks|0|||
17190644|NCT02901431|38343559|FG010|PK Part|Stopped treatment after 8 weeks|0|||
17190645|NCT02901431|38343560|FG011|PK Part|Stopped treatment after 8 weeks|0|||
17190646|NCT02901431|38343561|FG012|PK Part|Stopped treatment after 8 weeks|0|||
17190647|NCT02901431|38343549|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
17190648|NCT02901431|38343550|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190649|NCT02901431|38343551|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
17190650|NCT02901431|38343552|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190651|NCT02901431|38343553|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190652|NCT02901431|38343554|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16868375|NCT01533935|37841440|FG004|Overall Study|Protocol Violation|0|||
17000140|NCT00942188|38144022|FG003|Overall Study|Lost to Follow-up|0|||
17000141|NCT00942188|38144019|FG000|Overall Study|Withdrawal by Subject|1|||
17000142|NCT00942188|38144020|FG001|Overall Study|Withdrawal by Subject|3|||
17000143|NCT00942188|38144021|FG002|Overall Study|Withdrawal by Subject|4|||
17000144|NCT00942188|38144022|FG003|Overall Study|Withdrawal by Subject|2|||
17000145|NCT00942188|38144019|FG000|Overall Study|Physician Decision|0|||
17000146|NCT00942188|38144020|FG001|Overall Study|Physician Decision|0|||
17000147|NCT00942188|38144021|FG002|Overall Study|Physician Decision|1|||
17000148|NCT00942188|38144022|FG003|Overall Study|Physician Decision|0|||
17000149|NCT00942188|38144019|FG000|Overall Study|Sponsor Decision|0|||
17000150|NCT00942188|38144020|FG001|Overall Study|Sponsor Decision|2|||
17000151|NCT00942188|38144021|FG002|Overall Study|Sponsor Decision|0|||
17000152|NCT00942188|38144022|FG003|Overall Study|Sponsor Decision|1|||
17093954|NCT00006604|38233494|FG000|Overall Study|Met study objective - no further FU|1|||
17093955|NCT00006604|38233495|FG001|Overall Study|Met study objective - no further FU|0|||
17093956|NCT00006604|38233496|FG002|Overall Study|Met study objective - no further FU|0|||
17093957|NCT00006604|38233497|FG003|Overall Study|Met study objective - no further FU|0|||
17093958|NCT00006604|38233498|FG004|Overall Study|Met study objective - no further FU|0|||
17093959|NCT00006604|38233499|FG005|Overall Study|Met study objective - no further FU|0|||
17093960|NCT00006604|38233500|FG006|Overall Study|Met study objective - no further FU|0|||
17093961|NCT00006604|38233501|FG007|Overall Study|Met study objective - no further FU|0|||
17093962|NCT00006604|38233502|FG008|Overall Study|Met study objective - no further FU|0|||
17093963|NCT00006604|38233503|FG009|Overall Study|Met study objective - no further FU|0|||
17093964|NCT00006604|38233504|FG010|Overall Study|Met study objective - no further FU|0|||
17093965|NCT00006604|38233505|FG011|Overall Study|Met study objective - no further FU|0|||
17093966|NCT00006604|38233506|FG012|Overall Study|Met study objective - no further FU|0|||
17093967|NCT00006604|38233507|FG013|Overall Study|Met study objective - no further FU|0|||
17093968|NCT00006604|38233508|FG014|Overall Study|Met study objective - no further FU|1|||
17093969|NCT00006604|38233509|FG015|Overall Study|Met study objective - no further FU|1|||
17093970|NCT00006604|38233510|FG016|Overall Study|Met study objective - no further FU|0|||
17093971|NCT00006604|38233494|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
17093972|NCT00006604|38233495|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
17093973|NCT00006604|38233496|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
17093974|NCT00006604|38233497|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
17093975|NCT00006604|38233498|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
17093976|NCT00006604|38233499|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
17093977|NCT00006604|38233500|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
17093978|NCT00006604|38233501|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
17093979|NCT00006604|38233502|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
17093980|NCT00006604|38233503|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
17093981|NCT00006604|38233504|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
17093982|NCT00006604|38233505|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
17093983|NCT00006604|38233506|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
17093984|NCT00006604|38233507|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
17093985|NCT00006604|38233508|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
17093986|NCT00006604|38233509|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
17093987|NCT00006604|38233510|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
17093988|NCT00006604|38233494|FG000|Overall Study|Death|0|||
17093989|NCT00006604|38233495|FG001|Overall Study|Death|0|||
17093990|NCT00006604|38233496|FG002|Overall Study|Death|0|||
17093991|NCT00006604|38233497|FG003|Overall Study|Death|0|||
17093992|NCT00006604|38233498|FG004|Overall Study|Death|0|||
17093993|NCT00006604|38233499|FG005|Overall Study|Death|0|||
17093994|NCT00006604|38233500|FG006|Overall Study|Death|0|||
17093995|NCT00006604|38233501|FG007|Overall Study|Death|0|||
17093996|NCT00006604|38233502|FG008|Overall Study|Death|0|||
17093997|NCT00006604|38233503|FG009|Overall Study|Death|1|||
17093998|NCT00006604|38233504|FG010|Overall Study|Death|1|||
17093999|NCT00006604|38233505|FG011|Overall Study|Death|1|||
17094000|NCT00006604|38233506|FG012|Overall Study|Death|0|||
17094001|NCT00006604|38233507|FG013|Overall Study|Death|0|||
17094002|NCT00006604|38233508|FG014|Overall Study|Death|0|||
17094003|NCT00006604|38233509|FG015|Overall Study|Death|0|||
17094004|NCT00006604|38233510|FG016|Overall Study|Death|0|||
17094005|NCT00006604|38233494|FG000|Overall Study|Severe debilitation, unable to continue|0|||
17094006|NCT00006604|38233495|FG001|Overall Study|Severe debilitation, unable to continue|0|||
17094007|NCT00006604|38233496|FG002|Overall Study|Severe debilitation, unable to continue|0|||
17094008|NCT00006604|38233497|FG003|Overall Study|Severe debilitation, unable to continue|0|||
17094009|NCT00006604|38233498|FG004|Overall Study|Severe debilitation, unable to continue|0|||
17094010|NCT00006604|38233499|FG005|Overall Study|Severe debilitation, unable to continue|0|||
17094011|NCT00006604|38233500|FG006|Overall Study|Severe debilitation, unable to continue|3|||
17094012|NCT00006604|38233501|FG007|Overall Study|Severe debilitation, unable to continue|0|||
17094013|NCT00006604|38233502|FG008|Overall Study|Severe debilitation, unable to continue|0|||
17094014|NCT00006604|38233503|FG009|Overall Study|Severe debilitation, unable to continue|5|||
17094015|NCT00006604|38233504|FG010|Overall Study|Severe debilitation, unable to continue|0|||
17094016|NCT00006604|38233505|FG011|Overall Study|Severe debilitation, unable to continue|2|||
17094017|NCT00006604|38233506|FG012|Overall Study|Severe debilitation, unable to continue|1|||
17094018|NCT00006604|38233507|FG013|Overall Study|Severe debilitation, unable to continue|0|||
17094019|NCT00006604|38233508|FG014|Overall Study|Severe debilitation, unable to continue|2|||
17094020|NCT00006604|38233509|FG015|Overall Study|Severe debilitation, unable to continue|0|||
17094021|NCT00006604|38233510|FG016|Overall Study|Severe debilitation, unable to continue|0|||
17094022|NCT00006604|38233494|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
17190653|NCT02901431|38343555|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190654|NCT02901431|38343556|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190655|NCT02901431|38343557|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190656|NCT02901431|38343558|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190657|NCT02901431|38343559|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16868376|NCT01533935|37841436|FG000|Overall Study|Lost to Follow-up|0|||
17190658|NCT02901431|38343560|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190659|NCT02901431|38343561|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
17190660|NCT02901431|38343549|FG000|PK Part|Discontinued per Sponsor|0|||
17190661|NCT02901431|38343550|FG001|PK Part|Discontinued per Sponsor|3|||
17190662|NCT02901431|38343551|FG002|PK Part|Discontinued per Sponsor|0|||
17190663|NCT02901431|38343552|FG003|PK Part|Discontinued per Sponsor|0|||
17190664|NCT02901431|38343553|FG004|PK Part|Discontinued per Sponsor|0|||
17190665|NCT02901431|38343554|FG005|PK Part|Discontinued per Sponsor|0|||
17190666|NCT02901431|38343555|FG006|PK Part|Discontinued per Sponsor|0|||
17190667|NCT02901431|38343556|FG007|PK Part|Discontinued per Sponsor|0|||
17190668|NCT02901431|38343557|FG008|PK Part|Discontinued per Sponsor|0|||
17190669|NCT02901431|38343558|FG009|PK Part|Discontinued per Sponsor|0|||
17190670|NCT02901431|38343559|FG010|PK Part|Discontinued per Sponsor|0|||
17190671|NCT02901431|38343560|FG011|PK Part|Discontinued per Sponsor|0|||
17190672|NCT02901431|38343561|FG012|PK Part|Discontinued per Sponsor|0|||
17190673|NCT02901431|38343549|FG000|PK Part|Withdrawal by Subject|1|||
17190674|NCT02901431|38343550|FG001|PK Part|Withdrawal by Subject|1|||
17190675|NCT02901431|38343551|FG002|PK Part|Withdrawal by Subject|3|||
17190676|NCT02901431|38343552|FG003|PK Part|Withdrawal by Subject|0|||
17190677|NCT02901431|38343553|FG004|PK Part|Withdrawal by Subject|0|||
17190678|NCT02901431|38343554|FG005|PK Part|Withdrawal by Subject|0|||
17190679|NCT02901431|38343555|FG006|PK Part|Withdrawal by Subject|0|||
17190680|NCT02901431|38343556|FG007|PK Part|Withdrawal by Subject|0|||
17190681|NCT02901431|38343557|FG008|PK Part|Withdrawal by Subject|0|||
17190682|NCT02901431|38343558|FG009|PK Part|Withdrawal by Subject|0|||
17190683|NCT02901431|38343559|FG010|PK Part|Withdrawal by Subject|0|||
17190684|NCT02901431|38343560|FG011|PK Part|Withdrawal by Subject|0|||
17190685|NCT02901431|38343561|FG012|PK Part|Withdrawal by Subject|0|||
17190686|NCT02901431|38343549|FG000|Main Treatment Part|Adverse Event|0|||
17190687|NCT02901431|38343550|FG001|Main Treatment Part|Adverse Event|0|||
17190688|NCT02901431|38343551|FG002|Main Treatment Part|Adverse Event|0|||
17190689|NCT02901431|38343552|FG003|Main Treatment Part|Adverse Event|3|||
17190690|NCT02901431|38343553|FG004|Main Treatment Part|Adverse Event|3|||
17190691|NCT02901431|38343554|FG005|Main Treatment Part|Adverse Event|4|||
17190692|NCT02901431|38343555|FG006|Main Treatment Part|Adverse Event|1|||
17190693|NCT02901431|38343556|FG007|Main Treatment Part|Adverse Event|0|||
17190694|NCT02901431|38343557|FG008|Main Treatment Part|Adverse Event|0|||
17190695|NCT02901431|38343558|FG009|Main Treatment Part|Adverse Event|0|||
17190696|NCT02901431|38343559|FG010|Main Treatment Part|Adverse Event|0|||
17190697|NCT02901431|38343560|FG011|Main Treatment Part|Adverse Event|0|||
17190698|NCT02901431|38343561|FG012|Main Treatment Part|Adverse Event|0|||
17190699|NCT02901431|38343549|FG000|Main Treatment Part|Lack of Efficacy|0|||
17190700|NCT02901431|38343550|FG001|Main Treatment Part|Lack of Efficacy|0|||
17190701|NCT02901431|38343551|FG002|Main Treatment Part|Lack of Efficacy|0|||
16784064|NCT02031640|37724000|FG002|Screening Period|Exclusion criteria met|0|||
16784065|NCT02031640|37724001|FG003|Screening Period|Exclusion criteria met|0|||
16784066|NCT02031640|37724002|FG004|Screening Period|Exclusion criteria met|0|||
16784067|NCT02031640|37724003|FG005|Screening Period|Exclusion criteria met|0|||
16784068|NCT02031640|37723998|FG000|Screening Period|Lost to Follow-up|14|||
16784069|NCT02031640|37723999|FG001|Screening Period|Lost to Follow-up|0|||
16784070|NCT02031640|37724000|FG002|Screening Period|Lost to Follow-up|0|||
16784071|NCT02031640|37724001|FG003|Screening Period|Lost to Follow-up|0|||
16784072|NCT02031640|37724002|FG004|Screening Period|Lost to Follow-up|0|||
16784073|NCT02031640|37724003|FG005|Screening Period|Lost to Follow-up|0|||
16784074|NCT02031640|37723998|FG000|Screening Period|Enrollment closed|26|||
16784075|NCT02031640|37723999|FG001|Screening Period|Enrollment closed|0|||
16784076|NCT02031640|37724000|FG002|Screening Period|Enrollment closed|0|||
16784077|NCT02031640|37724001|FG003|Screening Period|Enrollment closed|0|||
16784078|NCT02031640|37724002|FG004|Screening Period|Enrollment closed|0|||
16784079|NCT02031640|37724003|FG005|Screening Period|Enrollment closed|0|||
16784080|NCT02031640|37723998|FG000|Run-In Period|Adverse Event|4|||
16784081|NCT02031640|37723999|FG001|Run-In Period|Adverse Event|0|||
16784082|NCT02031640|37724000|FG002|Run-In Period|Adverse Event|0|||
16784083|NCT02031640|37724001|FG003|Run-In Period|Adverse Event|0|||
16784084|NCT02031640|37724002|FG004|Run-In Period|Adverse Event|0|||
16784085|NCT02031640|37724003|FG005|Run-In Period|Adverse Event|0|||
16784086|NCT02031640|37723998|FG000|Run-In Period|Withdrawal by Subject|17|||
16784087|NCT02031640|37723999|FG001|Run-In Period|Withdrawal by Subject|0|||
16784088|NCT02031640|37724000|FG002|Run-In Period|Withdrawal by Subject|0|||
16784089|NCT02031640|37724001|FG003|Run-In Period|Withdrawal by Subject|0|||
16784090|NCT02031640|37724002|FG004|Run-In Period|Withdrawal by Subject|0|||
17190702|NCT02901431|38343552|FG003|Main Treatment Part|Lack of Efficacy|1|||
17190703|NCT02901431|38343553|FG004|Main Treatment Part|Lack of Efficacy|0|||
16784091|NCT02031640|37724003|FG005|Run-In Period|Withdrawal by Subject|0|||
16784092|NCT02031640|37723998|FG000|Run-In Period|Inclusion criteria not met|38|||
16784093|NCT02031640|37723999|FG001|Run-In Period|Inclusion criteria not met|0|||
17190704|NCT02901431|38343554|FG005|Main Treatment Part|Lack of Efficacy|0|||
17190705|NCT02901431|38343555|FG006|Main Treatment Part|Lack of Efficacy|0|||
17190706|NCT02901431|38343556|FG007|Main Treatment Part|Lack of Efficacy|0|||
17190707|NCT02901431|38343557|FG008|Main Treatment Part|Lack of Efficacy|0|||
17190708|NCT02901431|38343558|FG009|Main Treatment Part|Lack of Efficacy|0|||
17190709|NCT02901431|38343559|FG010|Main Treatment Part|Lack of Efficacy|0|||
17190710|NCT02901431|38343560|FG011|Main Treatment Part|Lack of Efficacy|0|||
17190711|NCT02901431|38343561|FG012|Main Treatment Part|Lack of Efficacy|0|||
17190712|NCT02901431|38343549|FG000|Main Treatment Part|Lost to Follow-up|0|||
17190713|NCT02901431|38343550|FG001|Main Treatment Part|Lost to Follow-up|0|||
17190714|NCT02901431|38343551|FG002|Main Treatment Part|Lost to Follow-up|0|||
17190715|NCT02901431|38343552|FG003|Main Treatment Part|Lost to Follow-up|3|||
17190716|NCT02901431|38343553|FG004|Main Treatment Part|Lost to Follow-up|1|||
17190717|NCT02901431|38343554|FG005|Main Treatment Part|Lost to Follow-up|2|||
17190718|NCT02901431|38343555|FG006|Main Treatment Part|Lost to Follow-up|3|||
17190719|NCT02901431|38343556|FG007|Main Treatment Part|Lost to Follow-up|0|||
17190720|NCT02901431|38343557|FG008|Main Treatment Part|Lost to Follow-up|0|||
17190721|NCT02901431|38343558|FG009|Main Treatment Part|Lost to Follow-up|0|||
17190722|NCT02901431|38343559|FG010|Main Treatment Part|Lost to Follow-up|0|||
17190723|NCT02901431|38343560|FG011|Main Treatment Part|Lost to Follow-up|0|||
17190724|NCT02901431|38343561|FG012|Main Treatment Part|Lost to Follow-up|0|||
17190725|NCT02901431|38343549|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
17190726|NCT02901431|38343550|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
17190727|NCT02901431|38343551|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
17190728|NCT02901431|38343552|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
17190729|NCT02901431|38343553|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
17190730|NCT02901431|38343554|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
17190731|NCT02901431|38343555|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
17190732|NCT02901431|38343556|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
17190733|NCT02901431|38343557|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
17190734|NCT02901431|38343558|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
17190735|NCT02901431|38343559|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
17190736|NCT02901431|38343560|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
17190737|NCT02901431|38343561|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
17190738|NCT02901431|38343549|FG000|Main Treatment Part|Physician Decision|0|||
17190739|NCT02901431|38343550|FG001|Main Treatment Part|Physician Decision|0|||
17190740|NCT02901431|38343551|FG002|Main Treatment Part|Physician Decision|0|||
17190741|NCT02901431|38343552|FG003|Main Treatment Part|Physician Decision|1|||
17190742|NCT02901431|38343553|FG004|Main Treatment Part|Physician Decision|0|||
17190743|NCT02901431|38343554|FG005|Main Treatment Part|Physician Decision|0|||
17190744|NCT02901431|38343555|FG006|Main Treatment Part|Physician Decision|1|||
17190745|NCT02901431|38343556|FG007|Main Treatment Part|Physician Decision|0|||
17190746|NCT02901431|38343557|FG008|Main Treatment Part|Physician Decision|0|||
17190747|NCT02901431|38343558|FG009|Main Treatment Part|Physician Decision|0|||
17190748|NCT02901431|38343559|FG010|Main Treatment Part|Physician Decision|0|||
17190749|NCT02901431|38343560|FG011|Main Treatment Part|Physician Decision|0|||
17190750|NCT02901431|38343561|FG012|Main Treatment Part|Physician Decision|0|||
17190751|NCT02901431|38343549|FG000|Main Treatment Part|Withdrawal by Subject|0|||
17190752|NCT02901431|38343550|FG001|Main Treatment Part|Withdrawal by Subject|0|||
17190753|NCT02901431|38343551|FG002|Main Treatment Part|Withdrawal by Subject|0|||
17190754|NCT02901431|38343552|FG003|Main Treatment Part|Withdrawal by Subject|18|||
17190755|NCT02901431|38343553|FG004|Main Treatment Part|Withdrawal by Subject|3|||
17190756|NCT02901431|38343554|FG005|Main Treatment Part|Withdrawal by Subject|5|||
17094023|NCT00006604|38233495|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
17094024|NCT00006604|38233496|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
17094025|NCT00006604|38233497|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
17094026|NCT00006604|38233498|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
17094027|NCT00006604|38233499|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
17094028|NCT00006604|38233500|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
17094029|NCT00006604|38233501|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
17094030|NCT00006604|38233502|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
17094031|NCT00006604|38233503|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
17094032|NCT00006604|38233504|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
17094033|NCT00006604|38233505|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
17094034|NCT00006604|38233506|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
17094035|NCT00006604|38233507|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
17094036|NCT00006604|38233508|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
17094037|NCT00006604|38233509|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
17094038|NCT00006604|38233510|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
17094039|NCT00006604|38233494|FG000|Overall Study|Site closing|0|||
17094040|NCT00006604|38233495|FG001|Overall Study|Site closing|0|||
17094041|NCT00006604|38233496|FG002|Overall Study|Site closing|1|||
17094042|NCT00006604|38233497|FG003|Overall Study|Site closing|1|||
17190757|NCT02901431|38343555|FG006|Main Treatment Part|Withdrawal by Subject|6|||
17094043|NCT00006604|38233498|FG004|Overall Study|Site closing|0|||
17094044|NCT00006604|38233499|FG005|Overall Study|Site closing|0|||
17094045|NCT00006604|38233500|FG006|Overall Study|Site closing|0|||
17094046|NCT00006604|38233501|FG007|Overall Study|Site closing|1|||
17094047|NCT00006604|38233502|FG008|Overall Study|Site closing|0|||
17094048|NCT00006604|38233503|FG009|Overall Study|Site closing|0|||
17094049|NCT00006604|38233504|FG010|Overall Study|Site closing|0|||
17094050|NCT00006604|38233505|FG011|Overall Study|Site closing|1|||
17094051|NCT00006604|38233506|FG012|Overall Study|Site closing|1|||
17094052|NCT00006604|38233507|FG013|Overall Study|Site closing|1|||
17094053|NCT00006604|38233508|FG014|Overall Study|Site closing|0|||
17094054|NCT00006604|38233509|FG015|Overall Study|Site closing|0|||
17094055|NCT00006604|38233510|FG016|Overall Study|Site closing|1|||
17094056|NCT00006604|38233494|FG000|Overall Study|Withdrawal by Subject|1|||
17094057|NCT00006604|38233495|FG001|Overall Study|Withdrawal by Subject|0|||
17094058|NCT00006604|38233496|FG002|Overall Study|Withdrawal by Subject|2|||
17094059|NCT00006604|38233497|FG003|Overall Study|Withdrawal by Subject|0|||
17094060|NCT00006604|38233498|FG004|Overall Study|Withdrawal by Subject|1|||
17094061|NCT00006604|38233499|FG005|Overall Study|Withdrawal by Subject|2|||
17094062|NCT00006604|38233500|FG006|Overall Study|Withdrawal by Subject|2|||
17094063|NCT00006604|38233501|FG007|Overall Study|Withdrawal by Subject|0|||
17094064|NCT00006604|38233502|FG008|Overall Study|Withdrawal by Subject|1|||
17094065|NCT00006604|38233503|FG009|Overall Study|Withdrawal by Subject|3|||
17000153|NCT00673231|38144036|FG000|Overall Study|Withdrawal by Subject|14|||
17000154|NCT00673231|38144037|FG001|Overall Study|Withdrawal by Subject|10|||
17000155|NCT00673231|38144038|FG002|Overall Study|Withdrawal by Subject|8|||
17000156|NCT00673231|38144039|FG003|Overall Study|Withdrawal by Subject|6|||
17000157|NCT00673231|38144036|FG000|Overall Study|Adverse Event|6|||
17000158|NCT00673231|38144037|FG001|Overall Study|Adverse Event|5|||
17000159|NCT00673231|38144038|FG002|Overall Study|Adverse Event|9|||
17000160|NCT00673231|38144039|FG003|Overall Study|Adverse Event|6|||
17000161|NCT00673231|38144036|FG000|Overall Study|Lost to Follow-up|1|||
17000162|NCT00673231|38144037|FG001|Overall Study|Lost to Follow-up|2|||
17000163|NCT00673231|38144038|FG002|Overall Study|Lost to Follow-up|1|||
17000164|NCT00673231|38144039|FG003|Overall Study|Lost to Follow-up|2|||
17000165|NCT00673231|38144036|FG000|Overall Study|Death|0|||
17000166|NCT00673231|38144037|FG001|Overall Study|Death|0|||
17000167|NCT00673231|38144038|FG002|Overall Study|Death|1|||
17000168|NCT00673231|38144039|FG003|Overall Study|Death|0|||
17000169|NCT00673231|38144036|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
17000170|NCT00673231|38144037|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
17000171|NCT00673231|38144038|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
17000172|NCT00673231|38144039|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
17000173|NCT00672841|38144051|FG000|Overall Study|Comfort care|1|||
17000174|NCT00672841|38144052|FG001|Overall Study|Comfort care|4|||
17000175|NCT00672841|38144051|FG000|Overall Study|icteric specimens|0|||
17000176|NCT00672841|38144052|FG001|Overall Study|icteric specimens|3|||
17000177|NCT00672841|38144051|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
17000178|NCT00672841|38144052|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
17000179|NCT00672841|38144051|FG000|Overall Study|Adverse Event|0|||
17000180|NCT00672841|38144052|FG001|Overall Study|Adverse Event|3|||
17000181|NCT00672841|38144051|FG000|Overall Study|Pregnancy|0|||
17000182|NCT00672841|38144052|FG001|Overall Study|Pregnancy|1|||
17000183|NCT00673465|38144061|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000184|NCT00673465|38144062|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000185|NCT00673465|38144063|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000186|NCT00673465|38144064|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000187|NCT00673465|38144065|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
17000188|NCT00673465|38144066|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
17000189|NCT00673465|38144067|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000190|NCT00673465|38144068|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000191|NCT00673465|38144069|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000192|NCT00673465|38144070|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000193|NCT00673465|38144071|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000194|NCT00673465|38144072|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
17000195|NCT00673465|38144061|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000196|NCT00673465|38144062|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000197|NCT00673465|38144063|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
17094066|NCT00006604|38233504|FG010|Overall Study|Withdrawal by Subject|2|||
17094067|NCT00006604|38233505|FG011|Overall Study|Withdrawal by Subject|0|||
17094068|NCT00006604|38233506|FG012|Overall Study|Withdrawal by Subject|1|||
17094069|NCT00006604|38233507|FG013|Overall Study|Withdrawal by Subject|2|||
17094070|NCT00006604|38233508|FG014|Overall Study|Withdrawal by Subject|1|||
17094071|NCT00006604|38233509|FG015|Overall Study|Withdrawal by Subject|0|||
17000198|NCT00673465|38144064|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000199|NCT00673465|38144065|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
17000200|NCT00673465|38144066|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000201|NCT00673465|38144067|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000202|NCT00673465|38144068|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000203|NCT00673465|38144069|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000204|NCT00673465|38144070|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000205|NCT00673465|38144071|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000206|NCT00673465|38144072|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
17000207|NCT00941798|38144082|FG000|Overall Study|Withdrawal by Subject|72|||
17000208|NCT00941798|38144083|FG001|Overall Study|Withdrawal by Subject|74|||
17000209|NCT00941798|38144082|FG000|Overall Study|Adverse Event|43|||
17000210|NCT00941798|38144083|FG001|Overall Study|Adverse Event|23|||
17000211|NCT00941798|38144082|FG000|Overall Study|Lost to Follow-up|29|||
17000212|NCT00941798|38144083|FG001|Overall Study|Lost to Follow-up|23|||
17000213|NCT00941798|38144082|FG000|Overall Study|Protocol Violation|17|||
17000214|NCT00941798|38144083|FG001|Overall Study|Protocol Violation|20|||
17000215|NCT00941798|38144082|FG000|Overall Study|Administrative problems|13|||
17000216|NCT00941798|38144083|FG001|Overall Study|Administrative problems|23|||
17000217|NCT00941798|38144082|FG000|Overall Study|Lack of Efficacy|10|||
17000218|NCT00941798|38144083|FG001|Overall Study|Lack of Efficacy|17|||
17000219|NCT00941798|38144082|FG000|Overall Study|Patient's inability to use device|6|||
17000220|NCT00941798|38144083|FG001|Overall Study|Patient's inability to use device|1|||
17000221|NCT00941798|38144082|FG000|Overall Study|Abnormal test procedure results|3|||
17000222|NCT00941798|38144083|FG001|Overall Study|Abnormal test procedure results|1|||
17000223|NCT00941798|38144082|FG000|Overall Study|Abnormal laboratory values|1|||
17000224|NCT00941798|38144083|FG001|Overall Study|Abnormal laboratory values|2|||
17000225|NCT00941798|38144082|FG000|Overall Study|Death|0|||
17000226|NCT00941798|38144083|FG001|Overall Study|Death|1|||
17000227|NCT00583102|38144089|FG000|Overall Study|Adverse Event|3|||
17000228|NCT00941720|38144093|FG000|Overall Study|Withdrawal by Subject|1|||
17000229|NCT00941720|38144093|FG000|Overall Study|Insurance denied participation|11|||
17000230|NCT00941720|38144093|FG000|Overall Study|ineligible|2|||
17000231|NCT00933686|38144099|FG000|Overall Study|Protocol Violation|0|||
17000232|NCT00933686|38144100|FG001|Overall Study|Protocol Violation|1|||
17000233|NCT00933686|38144099|FG000|Overall Study|Lost to Follow-up|2|||
17000234|NCT00933686|38144100|FG001|Overall Study|Lost to Follow-up|2|||
17000235|NCT00933686|38144099|FG000|Overall Study|Withdrawal by Subject|6|||
17000236|NCT00933686|38144100|FG001|Overall Study|Withdrawal by Subject|5|||
17000237|NCT00933686|38144099|FG000|Overall Study|Adverse Event|1|||
17000238|NCT00933686|38144100|FG001|Overall Study|Adverse Event|1|||
17000239|NCT00933686|38144099|FG000|Overall Study|Physician Decision|1|||
17000240|NCT00933686|38144100|FG001|Overall Study|Physician Decision|0|||
17000241|NCT00933686|38144099|FG000|Overall Study|Failure to show up at endpoint visits|0|||
17000242|NCT00933686|38144100|FG001|Overall Study|Failure to show up at endpoint visits|2|||
17000243|NCT00937040|38144108|FG000|Overall Study|Adverse Event|5|||
17000244|NCT00937040|38144109|FG001|Overall Study|Adverse Event|8|||
17094072|NCT00006604|38233510|FG016|Overall Study|Withdrawal by Subject|1|||
17190758|NCT02901431|38343556|FG007|Main Treatment Part|Withdrawal by Subject|0|||
17190759|NCT02901431|38343557|FG008|Main Treatment Part|Withdrawal by Subject|0|||
17190760|NCT02901431|38343558|FG009|Main Treatment Part|Withdrawal by Subject|0|||
17190761|NCT02901431|38343559|FG010|Main Treatment Part|Withdrawal by Subject|0|||
17094073|NCT00006604|38233494|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
17094074|NCT00006604|38233495|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
17094075|NCT00006604|38233496|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
17094076|NCT00006604|38233497|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
17190762|NCT02901431|38343560|FG011|Main Treatment Part|Withdrawal by Subject|0|||
17190763|NCT02901431|38343561|FG012|Main Treatment Part|Withdrawal by Subject|0|||
17190764|NCT02901431|38343549|FG000|Open Label Part|Adverse Event|0|||
17190765|NCT02901431|38343550|FG001|Open Label Part|Adverse Event|0|||
17190766|NCT02901431|38343551|FG002|Open Label Part|Adverse Event|0|||
17190767|NCT02901431|38343552|FG003|Open Label Part|Adverse Event|0|||
16784094|NCT02031640|37724000|FG002|Run-In Period|Inclusion criteria not met|0|||
17094077|NCT00006604|38233498|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
17094078|NCT00006604|38233499|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
17094079|NCT00006604|38233500|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
17094080|NCT00006604|38233501|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
17094081|NCT00006604|38233502|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
17094082|NCT00006604|38233503|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
17094083|NCT00006604|38233504|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
17000245|NCT00937040|38144108|FG000|Overall Study|Lost to Follow-up|12|||
17000246|NCT00937040|38144109|FG001|Overall Study|Lost to Follow-up|12|||
17094084|NCT00006604|38233505|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
17094085|NCT00006604|38233506|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
17190768|NCT02901431|38343553|FG004|Open Label Part|Adverse Event|0|||
17094086|NCT00006604|38233507|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
17094087|NCT00006604|38233508|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
17094088|NCT00006604|38233509|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
17094089|NCT00006604|38233510|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
17094090|NCT00006604|38233494|FG000|Overall Study|Lost to Follow-up|0|||
17094091|NCT00006604|38233495|FG001|Overall Study|Lost to Follow-up|0|||
17094092|NCT00006604|38233496|FG002|Overall Study|Lost to Follow-up|0|||
17094093|NCT00006604|38233497|FG003|Overall Study|Lost to Follow-up|0|||
17094094|NCT00006604|38233498|FG004|Overall Study|Lost to Follow-up|0|||
17094095|NCT00006604|38233499|FG005|Overall Study|Lost to Follow-up|0|||
17094096|NCT00006604|38233500|FG006|Overall Study|Lost to Follow-up|0|||
17094097|NCT00006604|38233501|FG007|Overall Study|Lost to Follow-up|1|||
17094098|NCT00006604|38233502|FG008|Overall Study|Lost to Follow-up|0|||
17094099|NCT00006604|38233503|FG009|Overall Study|Lost to Follow-up|2|||
17094100|NCT00006604|38233504|FG010|Overall Study|Lost to Follow-up|0|||
17094101|NCT00006604|38233505|FG011|Overall Study|Lost to Follow-up|0|||
17094102|NCT00006604|38233506|FG012|Overall Study|Lost to Follow-up|0|||
17094103|NCT00006604|38233507|FG013|Overall Study|Lost to Follow-up|0|||
17094104|NCT00006604|38233508|FG014|Overall Study|Lost to Follow-up|0|||
17094105|NCT00006604|38233509|FG015|Overall Study|Lost to Follow-up|1|||
17094106|NCT00006604|38233510|FG016|Overall Study|Lost to Follow-up|3|||
17094107|NCT00006604|38233494|FG000|Overall Study|Other Reason|0|||
17094108|NCT00006604|38233495|FG001|Overall Study|Other Reason|0|||
17094109|NCT00006604|38233496|FG002|Overall Study|Other Reason|0|||
17094110|NCT00006604|38233497|FG003|Overall Study|Other Reason|0|||
17094111|NCT00006604|38233498|FG004|Overall Study|Other Reason|0|||
17094112|NCT00006604|38233499|FG005|Overall Study|Other Reason|1|||
17094113|NCT00006604|38233500|FG006|Overall Study|Other Reason|0|||
17094114|NCT00006604|38233501|FG007|Overall Study|Other Reason|0|||
17094115|NCT00006604|38233502|FG008|Overall Study|Other Reason|0|||
17094116|NCT00006604|38233503|FG009|Overall Study|Other Reason|1|||
17094117|NCT00006604|38233504|FG010|Overall Study|Other Reason|0|||
17094118|NCT00006604|38233505|FG011|Overall Study|Other Reason|0|||
17094119|NCT00006604|38233506|FG012|Overall Study|Other Reason|0|||
17094120|NCT00006604|38233507|FG013|Overall Study|Other Reason|0|||
17094121|NCT00006604|38233508|FG014|Overall Study|Other Reason|0|||
17094122|NCT00006604|38233509|FG015|Overall Study|Other Reason|0|||
17094123|NCT00006604|38233510|FG016|Overall Study|Other Reason|0|||
17094124|NCT00006478|38233533|FG000|Overall Study|Vaccine could not be produced|1|||
17094125|NCT00006478|38233533|FG000|Overall Study|Physician Decision|6|||
17094126|NCT00436007|38233540|FG000|Overall Study|Withdrawal by Subject|5|||
17094127|NCT00436007|38233541|FG001|Overall Study|Withdrawal by Subject|3|||
17094128|NCT00436007|38233542|FG002|Overall Study|Withdrawal by Subject|4|||
17094129|NCT00436007|38233540|FG000|Overall Study|Lost to Follow-up|14|||
17094130|NCT00436007|38233541|FG001|Overall Study|Lost to Follow-up|10|||
17094131|NCT00436007|38233542|FG002|Overall Study|Lost to Follow-up|13|||
17094132|NCT00436007|38233540|FG000|Overall Study|Physician Decision|0|||
17094133|NCT00436007|38233541|FG001|Overall Study|Physician Decision|0|||
17094134|NCT00436007|38233542|FG002|Overall Study|Physician Decision|2|||
17094135|NCT00436007|38233540|FG000|Overall Study|Death|0|||
17190769|NCT02901431|38343554|FG005|Open Label Part|Adverse Event|0|||
17190770|NCT02901431|38343555|FG006|Open Label Part|Adverse Event|0|||
17190771|NCT02901431|38343556|FG007|Open Label Part|Adverse Event|0|||
17190772|NCT02901431|38343557|FG008|Open Label Part|Adverse Event|4|||
17190773|NCT02901431|38343558|FG009|Open Label Part|Adverse Event|4|||
17190774|NCT02901431|38343559|FG010|Open Label Part|Adverse Event|0|||
17190775|NCT02901431|38343560|FG011|Open Label Part|Adverse Event|4|||
17190776|NCT02901431|38343561|FG012|Open Label Part|Adverse Event|1|||
17190777|NCT02901431|38343549|FG000|Open Label Part|Lost to Follow-up|0|||
17190778|NCT02901431|38343550|FG001|Open Label Part|Lost to Follow-up|0|||
17190779|NCT02901431|38343551|FG002|Open Label Part|Lost to Follow-up|0|||
17190780|NCT02901431|38343552|FG003|Open Label Part|Lost to Follow-up|0|||
17190781|NCT02901431|38343553|FG004|Open Label Part|Lost to Follow-up|0|||
17190782|NCT02901431|38343554|FG005|Open Label Part|Lost to Follow-up|0|||
17190783|NCT02901431|38343555|FG006|Open Label Part|Lost to Follow-up|0|||
17190784|NCT02901431|38343556|FG007|Open Label Part|Lost to Follow-up|0|||
17190785|NCT02901431|38343557|FG008|Open Label Part|Lost to Follow-up|2|||
17190786|NCT02901431|38343558|FG009|Open Label Part|Lost to Follow-up|2|||
17190787|NCT02901431|38343559|FG010|Open Label Part|Lost to Follow-up|1|||
17190788|NCT02901431|38343560|FG011|Open Label Part|Lost to Follow-up|1|||
17190789|NCT02901431|38343561|FG012|Open Label Part|Lost to Follow-up|1|||
17094136|NCT00436007|38233541|FG001|Overall Study|Death|1|||
17094137|NCT00436007|38233542|FG002|Overall Study|Death|3|||
17094138|NCT00436007|38233540|FG000|Overall Study|Other|0|||
17094139|NCT00436007|38233541|FG001|Overall Study|Other|0|||
17094140|NCT00436007|38233542|FG002|Overall Study|Other|1|||
17094141|NCT00435461|38233558|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
17094142|NCT00435461|38233559|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
17190790|NCT02901431|38343549|FG000|Open Label Part|Physician Decision|0|||
17190791|NCT02901431|38343550|FG001|Open Label Part|Physician Decision|0|||
17190792|NCT02901431|38343551|FG002|Open Label Part|Physician Decision|0|||
17190793|NCT02901431|38343552|FG003|Open Label Part|Physician Decision|0|||
17190794|NCT02901431|38343553|FG004|Open Label Part|Physician Decision|0|||
17190795|NCT02901431|38343554|FG005|Open Label Part|Physician Decision|0|||
17094143|NCT00435461|38233560|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
17094144|NCT00435461|38233558|FG000|Overall Study|Protocol Violation|6|||
17094145|NCT00435461|38233559|FG001|Overall Study|Protocol Violation|9|||
17094146|NCT00435461|38233560|FG002|Overall Study|Protocol Violation|10|||
17094147|NCT00435461|38233558|FG000|Overall Study|Participant randomized(inadequate score)|1|||
17094148|NCT00435461|38233559|FG001|Overall Study|Participant randomized(inadequate score)|0|||
17094149|NCT00435461|38233560|FG002|Overall Study|Participant randomized(inadequate score)|0|||
17094150|NCT00435461|38233558|FG000|Overall Study|Compliance less than 80 percent|1|||
17094151|NCT00435461|38233559|FG001|Overall Study|Compliance less than 80 percent|0|||
17094152|NCT00435461|38233560|FG002|Overall Study|Compliance less than 80 percent|0|||
17094153|NCT00435461|38233558|FG000|Overall Study|In error, two study medications switched|1|||
17094154|NCT00435461|38233559|FG001|Overall Study|In error, two study medications switched|0|||
17094155|NCT00435461|38233560|FG002|Overall Study|In error, two study medications switched|0|||
17094156|NCT00435461|38233558|FG000|Overall Study|Lack of Efficacy|2|||
17094157|NCT00435461|38233559|FG001|Overall Study|Lack of Efficacy|1|||
17094158|NCT00435461|38233560|FG002|Overall Study|Lack of Efficacy|0|||
17094159|NCT00435461|38233558|FG000|Overall Study|Withdrawal by Subject|1|||
17094160|NCT00435461|38233559|FG001|Overall Study|Withdrawal by Subject|0|||
17094161|NCT00435461|38233560|FG002|Overall Study|Withdrawal by Subject|2|||
17094162|NCT00435461|38233558|FG000|Overall Study|Randomized in error|1|||
17094163|NCT00435461|38233559|FG001|Overall Study|Randomized in error|0|||
17094164|NCT00435461|38233560|FG002|Overall Study|Randomized in error|0|||
17094165|NCT00435461|38233558|FG000|Overall Study|Participant could not tolerate symptoms|0|||
17094166|NCT00435461|38233559|FG001|Overall Study|Participant could not tolerate symptoms|0|||
17094167|NCT00435461|38233560|FG002|Overall Study|Participant could not tolerate symptoms|1|||
17094168|NCT00435461|38233558|FG000|Overall Study|Participant could not swallow capsule|0|||
17094169|NCT00435461|38233559|FG001|Overall Study|Participant could not swallow capsule|0|||
17094170|NCT00435461|38233560|FG002|Overall Study|Participant could not swallow capsule|1|||
17094171|NCT00435461|38233558|FG000|Overall Study|Pregnancy|2|||
17094172|NCT00435461|38233559|FG001|Overall Study|Pregnancy|0|||
17094173|NCT00435461|38233560|FG002|Overall Study|Pregnancy|0|||
17094174|NCT00435461|38233558|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
17094175|NCT00435461|38233559|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
17094176|NCT00435461|38233560|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
17094177|NCT00435461|38233558|FG000|Overall Study|Participant ended study one day early|1|||
17094178|NCT00435461|38233559|FG001|Overall Study|Participant ended study one day early|0|||
17094179|NCT00435461|38233560|FG002|Overall Study|Participant ended study one day early|0|||
17094180|NCT00435461|38233558|FG000|Overall Study|Noncompliance with study requirements|1|||
17094181|NCT00435461|38233559|FG001|Overall Study|Noncompliance with study requirements|1|||
17094182|NCT00435461|38233560|FG002|Overall Study|Noncompliance with study requirements|1|||
17094183|NCT00435461|38233558|FG000|Overall Study|Adverse Event|1|||
17094184|NCT00435461|38233559|FG001|Overall Study|Adverse Event|2|||
17094185|NCT00435461|38233560|FG002|Overall Study|Adverse Event|6|||
17094186|NCT00435461|38233558|FG000|Overall Study|Non-Compliance of diary|2|||
17094187|NCT00435461|38233559|FG001|Overall Study|Non-Compliance of diary|0|||
17094188|NCT00435461|38233560|FG002|Overall Study|Non-Compliance of diary|1|||
17094189|NCT00435461|38233558|FG000|Overall Study|Lost to Follow-up|1|||
17094190|NCT00435461|38233559|FG001|Overall Study|Lost to Follow-up|1|||
17094191|NCT00435461|38233560|FG002|Overall Study|Lost to Follow-up|2|||
17094192|NCT00006436|38233568|FG000|Overall Study|Refused further treatment|2|||
17094193|NCT00006436|38233568|FG000|Overall Study|Declined to participate (before treatment started)|1|||
17094194|NCT00434759|38233577|FG000|Overall Study|Lack of Efficacy|5|||
17094195|NCT00434759|38233578|FG001|Overall Study|Lack of Efficacy|4|||
17094196|NCT00434759|38233577|FG000|Overall Study|Withdrawal by Subject|17|||
17094197|NCT00434759|38233578|FG001|Overall Study|Withdrawal by Subject|1|||
17094198|NCT00434759|38233577|FG000|Overall Study|family affairs|2|||
17094199|NCT00434759|38233578|FG001|Overall Study|family affairs|0|||
17094200|NCT00440999|38233588|FG000|Overall Study|Adverse Event|0|||
17094201|NCT00440999|38233589|FG001|Overall Study|Adverse Event|2|||
17094202|NCT00440999|38233588|FG000|Overall Study|Lack of Efficacy|6|||
17094203|NCT00440999|38233589|FG001|Overall Study|Lack of Efficacy|7|||
17094204|NCT00440999|38233588|FG000|Overall Study|Lost to Follow-up|19|||
17094205|NCT00440999|38233589|FG001|Overall Study|Lost to Follow-up|12|||
17190796|NCT02901431|38343555|FG006|Open Label Part|Physician Decision|0|||
17190797|NCT02901431|38343556|FG007|Open Label Part|Physician Decision|0|||
17190798|NCT02901431|38343557|FG008|Open Label Part|Physician Decision|1|||
17190799|NCT02901431|38343558|FG009|Open Label Part|Physician Decision|1|||
17190800|NCT02901431|38343559|FG010|Open Label Part|Physician Decision|0|||
17190801|NCT02901431|38343560|FG011|Open Label Part|Physician Decision|0|||
17094206|NCT00440999|38233588|FG000|Overall Study|Protocol Violation|1|||
17094207|NCT00440999|38233589|FG001|Overall Study|Protocol Violation|0|||
17094208|NCT00440999|38233588|FG000|Overall Study|Withdrawal by Subject|2|||
17094209|NCT00440999|38233589|FG001|Overall Study|Withdrawal by Subject|5|||
17094210|NCT00440999|38233588|FG000|Overall Study|Subjets missed the visit|1|||
17094211|NCT00440999|38233589|FG001|Overall Study|Subjets missed the visit|0|||
17094212|NCT00440999|38233588|FG000|Overall Study|Mixed infection at entry|1|||
17094213|NCT00440999|38233589|FG001|Overall Study|Mixed infection at entry|0|||
17094214|NCT00440999|38233588|FG000|Overall Study|P. falciparum malaria|5|||
17094215|NCT00440999|38233589|FG001|Overall Study|P. falciparum malaria|14|||
17094216|NCT00440999|38233588|FG000|Overall Study|Subj left hosp without inform staff|0|||
17094217|NCT00440999|38233589|FG001|Overall Study|Subj left hosp without inform staff|1|||
17094218|NCT00434213|38233597|FG000|Overall Study|Adverse Event|12|||
17094219|NCT00434213|38233597|FG000|Overall Study|Lack of Efficacy|9|||
17094220|NCT00434213|38233597|FG000|Overall Study|Lost to Follow-up|14|||
17094221|NCT00434213|38233597|FG000|Overall Study|Withdrawal by Subject|7|||
17094222|NCT00434213|38233597|FG000|Overall Study|Protocol Violation|3|||
17094223|NCT00434213|38233597|FG000|Overall Study|Unable to comply with study visit window|2|||
17094224|NCT00434213|38233597|FG000|Overall Study|Application site reaction|1|||
17094225|NCT00434213|38233597|FG000|Overall Study|Non-compliant to study schedule|1|||
17094226|NCT00006184|38233603|FG000|Overall Study|Death|1|||
17094227|NCT00006184|38233604|FG001|Overall Study|Death|0|||
17094228|NCT00434057|38233610|FG000|Overall Study|Withdrawal by Subject|1|||
17094229|NCT00433199|38233616|FG000|Double-Blind Period|Adverse Event|0|||
17094230|NCT00433199|38233617|FG001|Double-Blind Period|Adverse Event|25|||
17094231|NCT00433199|38233616|FG000|Double-Blind Period|Lack of Efficacy|0|||
17094232|NCT00433199|38233617|FG001|Double-Blind Period|Lack of Efficacy|2|||
17094233|NCT00433199|38233616|FG000|Double-Blind Period|Lost to Follow-up|2|||
17094234|NCT00433199|38233617|FG001|Double-Blind Period|Lost to Follow-up|5|||
17094235|NCT00433199|38233616|FG000|Double-Blind Period|Withdrawal by Subject|8|||
17094236|NCT00433199|38233617|FG001|Double-Blind Period|Withdrawal by Subject|19|||
17094237|NCT00433199|38233616|FG000|Double-Blind Period|Protocol Violation|1|||
17094238|NCT00433199|38233617|FG001|Double-Blind Period|Protocol Violation|10|||
17094239|NCT00433199|38233616|FG000|Double-Blind Period|Administrative|1|||
17094240|NCT00433199|38233617|FG001|Double-Blind Period|Administrative|5|||
17094241|NCT00433199|38233616|FG000|Open-Label Period|Adverse Event|0|||
17094242|NCT00433199|38233617|FG001|Open-Label Period|Adverse Event|19|||
17094243|NCT00433199|38233616|FG000|Open-Label Period|Lack of Efficacy|0|||
17094244|NCT00433199|38233617|FG001|Open-Label Period|Lack of Efficacy|2|||
17094245|NCT00433199|38233616|FG000|Open-Label Period|Lost to Follow-up|0|||
17094246|NCT00433199|38233617|FG001|Open-Label Period|Lost to Follow-up|3|||
17094247|NCT00433199|38233616|FG000|Open-Label Period|Withdrawal by Subject|0|||
17094248|NCT00433199|38233617|FG001|Open-Label Period|Withdrawal by Subject|7|||
17094249|NCT00433199|38233616|FG000|Open-Label Period|Protocol Violation|0|||
17094250|NCT00433199|38233617|FG001|Open-Label Period|Protocol Violation|2|||
17094251|NCT00433199|38233616|FG000|Open-Label Period|Administrative|0|||
17094252|NCT00433199|38233617|FG001|Open-Label Period|Administrative|1|||
17094253|NCT00006046|38233633|FG000|Overall Study|Adverse Event|3|||
17094254|NCT00006046|38233634|FG001|Overall Study|Adverse Event|0|||
17094255|NCT00006046|38233635|FG002|Overall Study|Adverse Event|0|||
17094256|NCT00006046|38233636|FG003|Overall Study|Adverse Event|0|||
17094257|NCT00006046|38233637|FG004|Overall Study|Adverse Event|0|||
17094258|NCT00006046|38233633|FG000|Overall Study|Disease Progression|2|||
17094259|NCT00006046|38233634|FG001|Overall Study|Disease Progression|0|||
17094260|NCT00006046|38233635|FG002|Overall Study|Disease Progression|0|||
17094261|NCT00006046|38233636|FG003|Overall Study|Disease Progression|0|||
17094262|NCT00006046|38233637|FG004|Overall Study|Disease Progression|0|||
17094263|NCT00005908|38233649|FG000|Overall Study|Withdrawal by Subject|1|||
17094264|NCT00005908|38233650|FG001|Overall Study|Withdrawal by Subject|0|||
17094265|NCT00432965|38233661|FG000|Overall Study|Lost to Follow-up|22|||
17094266|NCT00432965|38233662|FG001|Overall Study|Lost to Follow-up|19|||
17094267|NCT00432965|38233661|FG000|Overall Study|Withdrawal by Subject|13|||
17094268|NCT00432965|38233662|FG001|Overall Study|Withdrawal by Subject|13|||
17094269|NCT00432965|38233661|FG000|Overall Study|Physician Decision|14|||
17094270|NCT00432965|38233662|FG001|Overall Study|Physician Decision|13|||
17094271|NCT00432965|38233661|FG000|Overall Study|Lack of Efficacy|8|||
17094272|NCT00432965|38233662|FG001|Overall Study|Lack of Efficacy|13|||
17094273|NCT00432965|38233661|FG000|Overall Study|Non-compliance|7|||
17094274|NCT00432965|38233662|FG001|Overall Study|Non-compliance|0|||
17094275|NCT00432965|38233661|FG000|Overall Study|Adverse Event|22|||
17094276|NCT00432965|38233662|FG001|Overall Study|Adverse Event|19|||
17094277|NCT00432965|38233661|FG000|Overall Study|Death|3|||
17094278|NCT00432965|38233662|FG001|Overall Study|Death|4|||
17094279|NCT00432965|38233661|FG000|Overall Study|Exclusionary Methods|1|||
17094280|NCT00432965|38233662|FG001|Overall Study|Exclusionary Methods|2|||
17094281|NCT00432965|38233661|FG000|Overall Study|Incomplete Data|4|||
17094282|NCT00432965|38233662|FG001|Overall Study|Incomplete Data|3|||
17094283|NCT00440297|38233670|FG000|Overall Study|Adverse Event|8|||
17094284|NCT00440297|38233671|FG001|Overall Study|Adverse Event|5|||
17094285|NCT00440297|38233670|FG000|Overall Study|Lost to Follow-up|1|||
17094286|NCT00440297|38233671|FG001|Overall Study|Lost to Follow-up|0|||
17094287|NCT00440297|38233670|FG000|Overall Study|Physician Decision|1|||
17094288|NCT00440297|38233671|FG001|Overall Study|Physician Decision|0|||
17094289|NCT00440297|38233670|FG000|Overall Study|Protocol Violation|11|||
17094290|NCT00440297|38233671|FG001|Overall Study|Protocol Violation|7|||
17094291|NCT00440297|38233670|FG000|Overall Study|Withdrawal by Subject|1|||
17094292|NCT00440297|38233671|FG001|Overall Study|Withdrawal by Subject|6|||
17094293|NCT00440297|38233670|FG000|Overall Study|Randomized by mistake|1|||
17094294|NCT00440297|38233671|FG001|Overall Study|Randomized by mistake|0|||
17094295|NCT00432809|38233680|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
17094296|NCT00432809|38233681|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
17094297|NCT00432809|38233682|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
17094298|NCT00432809|38233680|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
17094299|NCT00432809|38233681|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
17094300|NCT00432809|38233682|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
17094301|NCT00431951|38233694|FG000|Overall Study|Inability to follow study procedures|1|||
17094302|NCT00431951|38233695|FG001|Overall Study|Inability to follow study procedures|0|||
17094303|NCT00431951|38233696|FG002|Overall Study|Inability to follow study procedures|1|||
17094304|NCT00431951|38233697|FG003|Overall Study|Inability to follow study procedures|2|||
17094305|NCT00431951|38233694|FG000|Overall Study|Lost to Follow-up|0|||
17094306|NCT00431951|38233695|FG001|Overall Study|Lost to Follow-up|1|||
17094307|NCT00431951|38233696|FG002|Overall Study|Lost to Follow-up|0|||
17094308|NCT00431951|38233697|FG003|Overall Study|Lost to Follow-up|0|||
17094309|NCT00431951|38233694|FG000|Overall Study|Withdrawal by Subject|0|||
17094310|NCT00431951|38233695|FG001|Overall Study|Withdrawal by Subject|1|||
17094311|NCT00431951|38233696|FG002|Overall Study|Withdrawal by Subject|0|||
17094312|NCT00431951|38233697|FG003|Overall Study|Withdrawal by Subject|0|||
17094313|NCT00431951|38233694|FG000|Overall Study|Adverse Event|0|||
17094314|NCT00431951|38233695|FG001|Overall Study|Adverse Event|0|||
17094315|NCT00431951|38233696|FG002|Overall Study|Adverse Event|1|||
17094316|NCT00431951|38233697|FG003|Overall Study|Adverse Event|0|||
17094317|NCT00004978|38233713|FG000|Overall Study|Death|107|||
17094318|NCT00004978|38233714|FG001|Overall Study|Death|116|||
17094319|NCT00004978|38233713|FG000|Overall Study|Lost to Follow-up|101|||
17094320|NCT00004978|38233714|FG001|Overall Study|Lost to Follow-up|108|||
17094321|NCT00004978|38233713|FG000|Overall Study|Withdrawal by Subject|17|||
17094322|NCT00004978|38233714|FG001|Overall Study|Withdrawal by Subject|26|||
17094323|NCT00004978|38233713|FG000|Overall Study|site closure - not in analysis cohort|19|||
17094324|NCT00004978|38233714|FG001|Overall Study|site closure - not in analysis cohort|20|||
17094325|NCT00430937|38233722|FG000|Overall Study|Adverse Event|3|||
17094326|NCT00430937|38233723|FG001|Overall Study|Adverse Event|8|||
17094327|NCT00430937|38233722|FG000|Overall Study|Death|0|||
17094328|NCT00430937|38233723|FG001|Overall Study|Death|1|||
17094329|NCT00430937|38233722|FG000|Overall Study|Lost to Follow-up|6|||
17094330|NCT00430937|38233723|FG001|Overall Study|Lost to Follow-up|6|||
17094331|NCT00430937|38233722|FG000|Overall Study|Withdrawal by Subject|5|||
17094332|NCT00430937|38233723|FG001|Overall Study|Withdrawal by Subject|2|||
17094333|NCT00430937|38233722|FG000|Overall Study|Protocol Violation|3|||
17094334|NCT00430937|38233723|FG001|Overall Study|Protocol Violation|2|||
17094335|NCT00430937|38233722|FG000|Overall Study|Lack of Efficacy|6|||
17094336|NCT00430937|38233723|FG001|Overall Study|Lack of Efficacy|5|||
17094337|NCT00430937|38233722|FG000|Overall Study|Inappropriate enrollment|2|||
17094338|NCT00430937|38233723|FG001|Overall Study|Inappropriate enrollment|1|||
17094339|NCT00430937|38233722|FG000|Overall Study|Administrative reasons|1|||
17094340|NCT00430937|38233723|FG001|Overall Study|Administrative reasons|0|||
17094341|NCT00430937|38233722|FG000|Overall Study|Protocol discontinuation criteria met|1|||
17094342|NCT00430937|38233723|FG001|Overall Study|Protocol discontinuation criteria met|2|||
17094343|NCT00430937|38233722|FG000|Overall Study|Unable to classify|0|||
17094344|NCT00430937|38233723|FG001|Overall Study|Unable to classify|1|||
17094345|NCT00004888|38233731|FG000|Overall Study|Adverse Event|5|||
17094346|NCT00004888|38233732|FG001|Overall Study|Adverse Event|10|||
17094347|NCT00004888|38233731|FG000|Overall Study|Withdrawal by Subject|0|||
17094348|NCT00004888|38233732|FG001|Overall Study|Withdrawal by Subject|3|||
17094349|NCT00004888|38233731|FG000|Overall Study|Physician Decision|1|||
17094350|NCT00004888|38233732|FG001|Overall Study|Physician Decision|1|||
17094351|NCT00004888|38233731|FG000|Overall Study|Progressive Disease|4|||
17094352|NCT00004888|38233732|FG001|Overall Study|Progressive Disease|9|||
17094353|NCT00004888|38233731|FG000|Overall Study|Death without progressive disease|0|||
17094354|NCT00004888|38233732|FG001|Overall Study|Death without progressive disease|1|||
17094355|NCT00004888|38233731|FG000|Overall Study|Toxic death|1|||
17094356|NCT00004888|38233732|FG001|Overall Study|Toxic death|0|||
17094357|NCT00004732|38233740|FG000|Overall Study|Withdrawal by Subject|36|||
17094358|NCT00004732|38233741|FG001|Overall Study|Withdrawal by Subject|64|||
17094359|NCT00004732|38233740|FG000|Overall Study|Lost to Follow-up|33|||
17094360|NCT00004732|38233741|FG001|Overall Study|Lost to Follow-up|47|||
17094361|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
17094362|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
17094363|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
17094364|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
17094365|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
17094366|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
17094367|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
17094368|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
17094369|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
17094370|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
17094371|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
17094372|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
17094373|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
17094374|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
17094375|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
17094376|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
17094377|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
17094378|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
17094379|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Death|0|||
17094380|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Death|1|||
17094381|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Death|0|||
17094382|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
17094383|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
17094384|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
17094385|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
17094386|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
17094387|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
17094388|NCT00430781|38233752|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
17094389|NCT00430781|38233753|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
17094390|NCT00430781|38233754|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
17094391|NCT00430781|38233752|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
17094392|NCT00430781|38233753|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
17094393|NCT00430781|38233754|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
17094394|NCT00430781|38233752|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
17094395|NCT00430781|38233753|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
17094396|NCT00430781|38233754|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
17190802|NCT02901431|38343561|FG012|Open Label Part|Physician Decision|0|||
17190803|NCT02901431|38343549|FG000|Open Label Part|Study Terminated By Sponsor|0|||
17190804|NCT02901431|38343550|FG001|Open Label Part|Study Terminated By Sponsor|0|||
17190805|NCT02901431|38343551|FG002|Open Label Part|Study Terminated By Sponsor|0|||
17190806|NCT02901431|38343552|FG003|Open Label Part|Study Terminated By Sponsor|0|||
17190807|NCT02901431|38343553|FG004|Open Label Part|Study Terminated By Sponsor|0|||
17094397|NCT00430781|38233752|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
17094398|NCT00430781|38233753|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
17094399|NCT00430781|38233754|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
17094400|NCT00430781|38233752|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
17094401|NCT00430781|38233753|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
17094402|NCT00430781|38233754|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
17094403|NCT00430781|38233752|FG000|Final Analysis; 31 July 2008|Other|0|||
17094404|NCT00430781|38233753|FG001|Final Analysis; 31 July 2008|Other|1|||
17094405|NCT00430781|38233754|FG002|Final Analysis; 31 July 2008|Other|0|||
17094406|NCT00430781|38233752|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
17094407|NCT00430781|38233753|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
17094408|NCT00430781|38233754|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
17094409|NCT00430781|38233752|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
17094410|NCT00430781|38233753|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
17094411|NCT00430781|38233754|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
17094412|NCT00430781|38233752|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
17094413|NCT00430781|38233753|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
17094414|NCT00430781|38233754|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
17094415|NCT00430781|38233752|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
17094416|NCT00430781|38233753|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
17094417|NCT00430781|38233754|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
17094418|NCT00430781|38233752|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
17094419|NCT00430781|38233753|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
17094420|NCT00430781|38233754|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
17094421|NCT00430781|38233752|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
17094422|NCT00430781|38233753|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
17094423|NCT00430781|38233754|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
17094424|NCT00430781|38233752|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
17094425|NCT00430781|38233753|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
17094426|NCT00430781|38233754|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
17094427|NCT00429299|38233768|FG000|Overall Study|Disease Progression|1|||
17094428|NCT00429299|38233769|FG001|Overall Study|Disease Progression|1|||
17094429|NCT00429299|38233770|FG002|Overall Study|Disease Progression|0|||
17094430|NCT00429299|38233768|FG000|Overall Study|Adverse Event|2|||
17094431|NCT00429299|38233769|FG001|Overall Study|Adverse Event|5|||
17094432|NCT00429299|38233770|FG002|Overall Study|Adverse Event|1|||
17094433|NCT00429299|38233768|FG000|Overall Study|Protocol Violation|1|||
17094434|NCT00429299|38233769|FG001|Overall Study|Protocol Violation|0|||
17190808|NCT02901431|38343554|FG005|Open Label Part|Study Terminated By Sponsor|0|||
17190809|NCT02901431|38343555|FG006|Open Label Part|Study Terminated By Sponsor|0|||
17094435|NCT00429299|38233770|FG002|Overall Study|Protocol Violation|0|||
17094436|NCT00429299|38233768|FG000|Overall Study|Withdrawal by Subject|0|||
17094437|NCT00429299|38233769|FG001|Overall Study|Withdrawal by Subject|1|||
17094438|NCT00429299|38233770|FG002|Overall Study|Withdrawal by Subject|3|||
17094439|NCT00428597|38233780|FG000|Overall Study|Randomized but not treated|3|||
17094440|NCT00428597|38233781|FG001|Overall Study|Randomized but not treated|3|||
17094441|NCT00428597|38233780|FG000|Overall Study|Objective Progression or Relapse|19|||
17094442|NCT00428597|38233781|FG001|Overall Study|Objective Progression or Relapse|47|||
17094443|NCT00428597|38233780|FG000|Overall Study|Study Terminated by Sponsor|41|||
17094444|NCT00428597|38233781|FG001|Overall Study|Study Terminated by Sponsor|16|||
17094445|NCT00428597|38233780|FG000|Overall Study|Adverse Event|15|||
17094446|NCT00428597|38233781|FG001|Overall Study|Adverse Event|7|||
17094447|NCT00428597|38233780|FG000|Overall Study|Global Deterioration of Health Status|1|||
17094448|NCT00428597|38233781|FG001|Overall Study|Global Deterioration of Health Status|5|||
17094449|NCT00428597|38233780|FG000|Overall Study|Protocol Violation|2|||
17094450|NCT00428597|38233781|FG001|Overall Study|Protocol Violation|1|||
17094451|NCT00428597|38233780|FG000|Overall Study|Withdrawal by Subject|2|||
17094452|NCT00428597|38233781|FG001|Overall Study|Withdrawal by Subject|1|||
17094453|NCT00428597|38233780|FG000|Overall Study|Other|1|||
17094454|NCT00428597|38233781|FG001|Overall Study|Other|1|||
17094455|NCT00428597|38233780|FG000|Overall Study|Lost to Follow-up|0|||
17094456|NCT00428597|38233781|FG001|Overall Study|Lost to Follow-up|1|||
17094457|NCT00428597|38233780|FG000|Overall Study|Pregnancy|1|||
17094458|NCT00428597|38233781|FG001|Overall Study|Pregnancy|0|||
17094459|NCT00428597|38233780|FG000|Overall Study|Death|1|||
17094460|NCT00428597|38233781|FG001|Overall Study|Death|3|||
17094461|NCT00428441|38233787|FG000|Overall Study|Lost to Follow-up|1|||
17094462|NCT00144339|38233793|FG000|Overall Study|Adverse Event|746|||
17094463|NCT00144339|38233794|FG001|Overall Study|Adverse Event|627|||
17190810|NCT02901431|38343556|FG007|Open Label Part|Study Terminated By Sponsor|0|||
17190811|NCT02901431|38343557|FG008|Open Label Part|Study Terminated By Sponsor|35|||
17190812|NCT02901431|38343558|FG009|Open Label Part|Study Terminated By Sponsor|12|||
17190813|NCT02901431|38343559|FG010|Open Label Part|Study Terminated By Sponsor|21|||
17190814|NCT02901431|38343560|FG011|Open Label Part|Study Terminated By Sponsor|31|||
17190815|NCT02901431|38343561|FG012|Open Label Part|Study Terminated By Sponsor|0|||
17094464|NCT00144339|38233793|FG000|Overall Study|Protocol Violation|75|||
17094465|NCT00144339|38233794|FG001|Overall Study|Protocol Violation|48|||
17190816|NCT02901431|38343549|FG000|Open Label Part|Withdrawal by Subject|0|||
17190817|NCT02901431|38343550|FG001|Open Label Part|Withdrawal by Subject|0|||
17190818|NCT02901431|38343551|FG002|Open Label Part|Withdrawal by Subject|0|||
17094466|NCT00144339|38233793|FG000|Overall Study|Withdrawal by Subject|403|||
17094467|NCT00144339|38233794|FG001|Overall Study|Withdrawal by Subject|300|||
17094468|NCT00144339|38233793|FG000|Overall Study|Lost to Follow-up|76|||
17094469|NCT00144339|38233794|FG001|Overall Study|Lost to Follow-up|64|||
17094470|NCT00144339|38233793|FG000|Overall Study|Other|58|||
17094471|NCT00144339|38233794|FG001|Overall Study|Other|60|||
17094472|NCT00144027|38233802|FG000|Overall Study|Lost to Follow-up|1|||
17094473|NCT00144027|38233803|FG001|Overall Study|Lost to Follow-up|3|||
17094474|NCT00144027|38233802|FG000|Overall Study|Withdrawal by Subject|2|||
17094475|NCT00144027|38233803|FG001|Overall Study|Withdrawal by Subject|2|||
17094476|NCT00144027|38233802|FG000|Overall Study|did not complete baseline assessment|0|||
17094477|NCT00144027|38233803|FG001|Overall Study|did not complete baseline assessment|6|||
17094478|NCT00127803|38233813|FG000|Overall Study|Adverse Event|2|||
17094479|NCT00127803|38233814|FG001|Overall Study|Adverse Event|0|||
17094480|NCT00127803|38233815|FG002|Overall Study|Adverse Event|0|||
17094481|NCT00127803|38233816|FG003|Overall Study|Adverse Event|0|||
17094482|NCT00127803|38233813|FG000|Overall Study|Withdrawal by Subject|1|||
17094483|NCT00127803|38233814|FG001|Overall Study|Withdrawal by Subject|0|||
17094484|NCT00127803|38233815|FG002|Overall Study|Withdrawal by Subject|0|||
17094485|NCT00127803|38233816|FG003|Overall Study|Withdrawal by Subject|0|||
17094486|NCT00127803|38233813|FG000|Overall Study|Lost to Follow-up|0|||
17094487|NCT00127803|38233814|FG001|Overall Study|Lost to Follow-up|0|||
17094488|NCT00127803|38233815|FG002|Overall Study|Lost to Follow-up|0|||
17094489|NCT00127803|38233816|FG003|Overall Study|Lost to Follow-up|1|||
17094490|NCT00127413|38233830|FG000|Overall Study|Lost to Follow-up|6|||
17094491|NCT00127413|38233831|FG001|Overall Study|Lost to Follow-up|4|||
17094492|NCT00127413|38233832|FG002|Overall Study|Lost to Follow-up|8|||
17094493|NCT00127413|38233833|FG003|Overall Study|Lost to Follow-up|2|||
17094494|NCT00143403|38233845|FG000|Overall Study|Adverse Event|3|||
17094495|NCT00143403|38233846|FG001|Overall Study|Adverse Event|8|||
17094496|NCT00143403|38233845|FG000|Overall Study|Death|1|||
17094497|NCT00143403|38233846|FG001|Overall Study|Death|0|||
17094498|NCT00143403|38233845|FG000|Overall Study|Withdrawal by Subject|3|||
17094499|NCT00143403|38233846|FG001|Overall Study|Withdrawal by Subject|12|||
17094500|NCT00143403|38233845|FG000|Overall Study|Relapse|15|||
17094501|NCT00143403|38233846|FG001|Overall Study|Relapse|7|||
17094502|NCT00143403|38233845|FG000|Overall Study|Protocol Violation|2|||
17094503|NCT00143403|38233846|FG001|Overall Study|Protocol Violation|2|||
17094504|NCT00143403|38233845|FG000|Overall Study|specified by site|4|||
17094505|NCT00143403|38233846|FG001|Overall Study|specified by site|9|||
17094506|NCT00143403|38233845|FG000|Overall Study|Randomized Not Treated|7|||
17094507|NCT00143403|38233846|FG001|Overall Study|Randomized Not Treated|8|||
17094508|NCT00220701|38233854|FG000|Overall Study|Lost to Follow-up|5|||
17094509|NCT00220701|38233855|FG001|Overall Study|Lost to Follow-up|4|||
17094510|NCT00127101|38233867|FG000|Base Protocol|Adverse Event|0|||
17094511|NCT00127101|38233868|FG001|Base Protocol|Adverse Event|2|||
17094512|NCT00127101|38233869|FG002|Base Protocol|Adverse Event|1|||
17094513|NCT00127101|38233870|FG003|Base Protocol|Adverse Event|0|||
17094514|NCT00127101|38233871|FG004|Base Protocol|Adverse Event|0|||
17094515|NCT00127101|38233872|FG005|Base Protocol|Adverse Event|0|||
17094516|NCT00127101|38233867|FG000|Base Protocol|Lack of Efficacy|1|||
17094517|NCT00127101|38233868|FG001|Base Protocol|Lack of Efficacy|0|||
17094518|NCT00127101|38233869|FG002|Base Protocol|Lack of Efficacy|0|||
17094519|NCT00127101|38233870|FG003|Base Protocol|Lack of Efficacy|0|||
17094520|NCT00127101|38233871|FG004|Base Protocol|Lack of Efficacy|2|||
17094521|NCT00127101|38233872|FG005|Base Protocol|Lack of Efficacy|0|||
17094522|NCT00127101|38233867|FG000|Base Protocol|Withdrawal by Subject|1|||
17094523|NCT00127101|38233868|FG001|Base Protocol|Withdrawal by Subject|2|||
17094524|NCT00127101|38233869|FG002|Base Protocol|Withdrawal by Subject|1|||
17094525|NCT00127101|38233870|FG003|Base Protocol|Withdrawal by Subject|0|||
17094526|NCT00127101|38233871|FG004|Base Protocol|Withdrawal by Subject|0|||
17094527|NCT00127101|38233872|FG005|Base Protocol|Withdrawal by Subject|1|||
17094528|NCT00127101|38233867|FG000|Continuation Phase|Adverse Event|0|||
17094529|NCT00127101|38233868|FG001|Continuation Phase|Adverse Event|0|||
17094530|NCT00127101|38233869|FG002|Continuation Phase|Adverse Event|0|||
17094531|NCT00127101|38233870|FG003|Continuation Phase|Adverse Event|0|||
17094532|NCT00127101|38233871|FG004|Continuation Phase|Adverse Event|1|||
17094533|NCT00127101|38233872|FG005|Continuation Phase|Adverse Event|1|||
17094534|NCT00127101|38233867|FG000|Continuation Phase|Lack of Efficacy|0|||
17094535|NCT00127101|38233868|FG001|Continuation Phase|Lack of Efficacy|0|||
17094536|NCT00127101|38233869|FG002|Continuation Phase|Lack of Efficacy|0|||
17094537|NCT00127101|38233870|FG003|Continuation Phase|Lack of Efficacy|0|||
17094538|NCT00127101|38233871|FG004|Continuation Phase|Lack of Efficacy|0|||
17094539|NCT00127101|38233872|FG005|Continuation Phase|Lack of Efficacy|1|||
17094540|NCT00127101|38233867|FG000|Continuation Phase|Withdrawal by Subject|0|||
17094541|NCT00127101|38233868|FG001|Continuation Phase|Withdrawal by Subject|0|||
17094542|NCT00127101|38233869|FG002|Continuation Phase|Withdrawal by Subject|1|||
17094543|NCT00127101|38233870|FG003|Continuation Phase|Withdrawal by Subject|0|||
17094544|NCT00127101|38233871|FG004|Continuation Phase|Withdrawal by Subject|2|||
17094545|NCT00127101|38233872|FG005|Continuation Phase|Withdrawal by Subject|1|||
17094546|NCT00126555|38233886|FG000|Overall Study|Withdrawal by Subject|1|||
17094547|NCT00126555|38233886|FG000|Overall Study|Adverse Event|2|||
17094548|NCT00126555|38233886|FG000|Overall Study|Progressive Disease|3|||
17094549|NCT00004228|38233909|FG000|Overall Study|Adverse Event|0|||
17094550|NCT00004228|38233910|FG001|Overall Study|Adverse Event|1|||
17094551|NCT00004228|38233911|FG002|Overall Study|Adverse Event|0|||
17094552|NCT00004228|38233912|FG003|Overall Study|Adverse Event|0|||
17094553|NCT00004228|38233913|FG004|Overall Study|Adverse Event|1|||
17094554|NCT00004228|38233914|FG005|Overall Study|Adverse Event|0|||
17094555|NCT00004228|38233915|FG006|Overall Study|Adverse Event|0|||
17094556|NCT00004228|38233909|FG000|Overall Study|Death|0|||
17094557|NCT00004228|38233910|FG001|Overall Study|Death|1|||
17094558|NCT00004228|38233911|FG002|Overall Study|Death|2|||
17094559|NCT00004228|38233912|FG003|Overall Study|Death|0|||
17094560|NCT00004228|38233913|FG004|Overall Study|Death|1|||
17094561|NCT00004228|38233914|FG005|Overall Study|Death|0|||
17094562|NCT00004228|38233915|FG006|Overall Study|Death|0|||
17094563|NCT00004228|38233909|FG000|Overall Study|Lack of Efficacy|1|||
17094564|NCT00004228|38233910|FG001|Overall Study|Lack of Efficacy|6|||
17094565|NCT00004228|38233911|FG002|Overall Study|Lack of Efficacy|5|||
17094566|NCT00004228|38233912|FG003|Overall Study|Lack of Efficacy|3|||
17094567|NCT00004228|38233913|FG004|Overall Study|Lack of Efficacy|9|||
17094568|NCT00004228|38233914|FG005|Overall Study|Lack of Efficacy|8|||
17190819|NCT02901431|38343552|FG003|Open Label Part|Withdrawal by Subject|0|||
17190820|NCT02901431|38343553|FG004|Open Label Part|Withdrawal by Subject|0|||
17190821|NCT02901431|38343554|FG005|Open Label Part|Withdrawal by Subject|0|||
17190822|NCT02901431|38343555|FG006|Open Label Part|Withdrawal by Subject|0|||
17190823|NCT02901431|38343556|FG007|Open Label Part|Withdrawal by Subject|0|||
17190824|NCT02901431|38343557|FG008|Open Label Part|Withdrawal by Subject|6|||
17190825|NCT02901431|38343558|FG009|Open Label Part|Withdrawal by Subject|5|||
17190826|NCT02901431|38343559|FG010|Open Label Part|Withdrawal by Subject|7|||
17190827|NCT02901431|38343560|FG011|Open Label Part|Withdrawal by Subject|3|||
17190828|NCT02901431|38343561|FG012|Open Label Part|Withdrawal by Subject|1|||
17190829|NCT02873377|38343588|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
17190830|NCT02873377|38343589|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
17190831|NCT02873377|38343588|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
17190832|NCT02873377|38343589|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
17190833|NCT02966795|38343598|FG000|Overall Study|Patient Left the Country|0|||
17190834|NCT02966795|38343599|FG001|Overall Study|Patient Left the Country|1|||
17190835|NCT02873221|38343607|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
17190836|NCT02873221|38343608|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
17190837|NCT02873221|38343609|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
17190838|NCT02873221|38343607|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
17190839|NCT02873221|38343608|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
17190840|NCT02873221|38343609|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
17190841|NCT02873221|38343607|FG000|Treatment Period|Protocol Violation|2|||
16784095|NCT02031640|37724001|FG003|Run-In Period|Inclusion criteria not met|0|||
16784096|NCT02031640|37724002|FG004|Run-In Period|Inclusion criteria not met|0|||
17094569|NCT00004228|38233915|FG006|Overall Study|Lack of Efficacy|4|||
17094570|NCT00004228|38233909|FG000|Overall Study|Lost to Follow-up|0|||
17094571|NCT00004228|38233910|FG001|Overall Study|Lost to Follow-up|0|||
17094572|NCT00004228|38233911|FG002|Overall Study|Lost to Follow-up|1|||
17094573|NCT00004228|38233912|FG003|Overall Study|Lost to Follow-up|0|||
17094574|NCT00004228|38233913|FG004|Overall Study|Lost to Follow-up|0|||
17094575|NCT00004228|38233914|FG005|Overall Study|Lost to Follow-up|0|||
17094576|NCT00004228|38233915|FG006|Overall Study|Lost to Follow-up|0|||
17094577|NCT00004228|38233909|FG000|Overall Study|Physician Decision|1|||
17094578|NCT00004228|38233910|FG001|Overall Study|Physician Decision|0|||
17000247|NCT00937040|38144108|FG000|Overall Study|Protocol Violation|3|||
17000248|NCT00937040|38144109|FG001|Overall Study|Protocol Violation|0|||
17094579|NCT00004228|38233911|FG002|Overall Study|Physician Decision|3|||
16784097|NCT02031640|37724003|FG005|Run-In Period|Inclusion criteria not met|0|||
16784098|NCT02031640|37723998|FG000|Run-In Period|Exclusion criteria met|8|||
16784099|NCT02031640|37723999|FG001|Run-In Period|Exclusion criteria met|0|||
16784100|NCT02031640|37724000|FG002|Run-In Period|Exclusion criteria met|0|||
16784101|NCT02031640|37724001|FG003|Run-In Period|Exclusion criteria met|0|||
16784102|NCT02031640|37724002|FG004|Run-In Period|Exclusion criteria met|0|||
16784103|NCT02031640|37724003|FG005|Run-In Period|Exclusion criteria met|0|||
16784104|NCT02031640|37723998|FG000|Run-In Period|Randomization criteria not met|85|||
17000249|NCT00937040|38144108|FG000|Overall Study|Withdrawal by Subject|13|||
17000250|NCT00937040|38144109|FG001|Overall Study|Withdrawal by Subject|7|||
17000251|NCT00937040|38144108|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
17000252|NCT00937040|38144109|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
17000253|NCT00937040|38144108|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
17000254|NCT00937040|38144109|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
17000255|NCT00673387|38144123|FG000|Overall Study|Withdrawal by Subject|15|||
17000256|NCT00673387|38144124|FG001|Overall Study|Withdrawal by Subject|16|||
17000257|NCT00673387|38144125|FG002|Overall Study|Withdrawal by Subject|20|||
17000258|NCT00673387|38144126|FG003|Overall Study|Withdrawal by Subject|16|||
17000259|NCT00673387|38144127|FG004|Overall Study|Withdrawal by Subject|18|||
17000260|NCT00673387|38144128|FG005|Overall Study|Withdrawal by Subject|21|||
17000261|NCT00673387|38144129|FG006|Overall Study|Withdrawal by Subject|15|||
17000262|NCT00673387|38144130|FG007|Overall Study|Withdrawal by Subject|21|||
17000263|NCT00673387|38144123|FG000|Overall Study|Adverse Event|3|||
17000264|NCT00673387|38144124|FG001|Overall Study|Adverse Event|1|||
17000265|NCT00673387|38144125|FG002|Overall Study|Adverse Event|5|||
17000266|NCT00673387|38144126|FG003|Overall Study|Adverse Event|2|||
17000267|NCT00673387|38144127|FG004|Overall Study|Adverse Event|6|||
17000268|NCT00673387|38144128|FG005|Overall Study|Adverse Event|2|||
17000269|NCT00673387|38144129|FG006|Overall Study|Adverse Event|5|||
17000270|NCT00673387|38144130|FG007|Overall Study|Adverse Event|5|||
17000271|NCT00673387|38144123|FG000|Overall Study|Physician Decision|0|||
17000272|NCT00673387|38144124|FG001|Overall Study|Physician Decision|0|||
17000273|NCT00673387|38144125|FG002|Overall Study|Physician Decision|0|||
17000274|NCT00673387|38144126|FG003|Overall Study|Physician Decision|0|||
17000275|NCT00673387|38144127|FG004|Overall Study|Physician Decision|0|||
17094580|NCT00004228|38233912|FG003|Overall Study|Physician Decision|2|||
17190842|NCT02873221|38343608|FG001|Treatment Period|Protocol Violation|5|||
17190843|NCT02873221|38343609|FG002|Treatment Period|Protocol Violation|8|||
17190844|NCT02873221|38343607|FG000|Treatment Period|Pregnancy|4|||
17190845|NCT02873221|38343608|FG001|Treatment Period|Pregnancy|6|||
17190846|NCT02873221|38343609|FG002|Treatment Period|Pregnancy|3|||
17190847|NCT02873221|38343607|FG000|Treatment Period|Lack of Qualifying Event|0|||
17190848|NCT02873221|38343608|FG001|Treatment Period|Lack of Qualifying Event|3|||
17190849|NCT02873221|38343609|FG002|Treatment Period|Lack of Qualifying Event|1|||
17190850|NCT02873221|38343607|FG000|Treatment Period|Withdrawal of Consent|52|||
17190851|NCT02873221|38343608|FG001|Treatment Period|Withdrawal of Consent|51|||
17190852|NCT02873221|38343609|FG002|Treatment Period|Withdrawal of Consent|41|||
17190853|NCT02873221|38343607|FG000|Treatment Period|Lack of Efficacy|0|||
17190854|NCT02873221|38343608|FG001|Treatment Period|Lack of Efficacy|17|||
17094581|NCT00004228|38233913|FG004|Overall Study|Physician Decision|1|||
17094582|NCT00004228|38233914|FG005|Overall Study|Physician Decision|1|||
17094583|NCT00004228|38233915|FG006|Overall Study|Physician Decision|1|||
17094584|NCT00004228|38233909|FG000|Overall Study|Protocol Violation|0|||
17094585|NCT00004228|38233910|FG001|Overall Study|Protocol Violation|5|||
17094586|NCT00004228|38233911|FG002|Overall Study|Protocol Violation|2|||
17094587|NCT00004228|38233912|FG003|Overall Study|Protocol Violation|1|||
17094588|NCT00004228|38233913|FG004|Overall Study|Protocol Violation|1|||
17094589|NCT00004228|38233914|FG005|Overall Study|Protocol Violation|2|||
17094590|NCT00004228|38233915|FG006|Overall Study|Protocol Violation|0|||
17094591|NCT00004228|38233909|FG000|Overall Study|Withdrawal by Subject|3|||
17094592|NCT00004228|38233910|FG001|Overall Study|Withdrawal by Subject|0|||
17094593|NCT00004228|38233911|FG002|Overall Study|Withdrawal by Subject|1|||
17094594|NCT00004228|38233912|FG003|Overall Study|Withdrawal by Subject|0|||
17094595|NCT00004228|38233913|FG004|Overall Study|Withdrawal by Subject|2|||
17094596|NCT00004228|38233914|FG005|Overall Study|Withdrawal by Subject|1|||
17094597|NCT00004228|38233915|FG006|Overall Study|Withdrawal by Subject|2|||
17094598|NCT00004228|38233909|FG000|Overall Study|Other|0|||
17094599|NCT00004228|38233910|FG001|Overall Study|Other|0|||
17190855|NCT02873221|38343609|FG002|Treatment Period|Lack of Efficacy|12|||
17190856|NCT02873221|38343607|FG000|Treatment Period|Adverse Event|4|||
17190857|NCT02873221|38343608|FG001|Treatment Period|Adverse Event|9|||
17190858|NCT02873221|38343609|FG002|Treatment Period|Adverse Event|11|||
17190859|NCT02873221|38343607|FG000|Treatment Period|Lost to Follow-up|26|||
17190860|NCT02873221|38343608|FG001|Treatment Period|Lost to Follow-up|30|||
17190861|NCT02873221|38343609|FG002|Treatment Period|Lost to Follow-up|26|||
17190862|NCT02873221|38343607|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
17190863|NCT02873221|38343608|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
17190864|NCT02873221|38343609|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
17190865|NCT02873221|38343607|FG000|Safety Follow-up Period|Protocol Violation|0|||
17190866|NCT02873221|38343608|FG001|Safety Follow-up Period|Protocol Violation|0|||
17190867|NCT02873221|38343609|FG002|Safety Follow-up Period|Protocol Violation|1|||
17190868|NCT02873221|38343607|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
17190869|NCT02873221|38343608|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
17190870|NCT02873221|38343609|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
17190871|NCT02873221|38343607|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
17190872|NCT02873221|38343608|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
17190873|NCT02873221|38343609|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
17190874|NCT02968979|38343617|FG000|Overall Study|Protocol Violation|7|||
17190875|NCT02968979|38343617|FG000|Overall Study|Withdrawal by Subject|1|||
17190876|NCT02966015|38343669|FG000|Inclusion Visit|did not answer questionnaire|8|||
17190877|NCT02966015|38343670|FG001|Inclusion Visit|did not answer questionnaire|3|||
17190878|NCT02968433|38343676|FG000|Overall Study|Withdrawal by Subject|1|||
17190879|NCT02872285|38343688|FG000|Overall Study|Withdrawal by Subject|2|||
17190880|NCT02872285|38343689|FG001|Overall Study|Withdrawal by Subject|0|||
17190881|NCT02872285|38343688|FG000|Overall Study|Lost to Follow-up|2|||
17190882|NCT02872285|38343689|FG001|Overall Study|Lost to Follow-up|2|||
17190883|NCT02872285|38343688|FG000|Overall Study|Discontinued due to back surgery|1|||
17190884|NCT02872285|38343689|FG001|Overall Study|Discontinued due to back surgery|0|||
17190885|NCT02871739|38343699|FG000|Overall Study|Lost to Follow-up|3|||
17190886|NCT02871739|38343700|FG001|Overall Study|Lost to Follow-up|2|||
17190887|NCT02871739|38343701|FG002|Overall Study|Lost to Follow-up|0|||
17190888|NCT02871739|38343702|FG003|Overall Study|Lost to Follow-up|2|||
17190889|NCT02896361|38343712|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
17190890|NCT02896361|38343713|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
17190891|NCT02896361|38343714|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
17190892|NCT02896361|38343712|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
17190893|NCT02896361|38343713|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
17190894|NCT02896361|38343714|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
17190895|NCT02962739|38343737|FG000|Overall Study|Withdrawal by Subject|0|||
17190896|NCT02962739|38343738|FG001|Overall Study|Withdrawal by Subject|1|||
17094600|NCT00004228|38233911|FG002|Overall Study|Other|1|||
17094601|NCT00004228|38233912|FG003|Overall Study|Other|0|||
17094602|NCT00004228|38233913|FG004|Overall Study|Other|0|||
17190897|NCT02962739|38343739|FG002|Overall Study|Withdrawal by Subject|0|||
17094603|NCT00004228|38233914|FG005|Overall Study|Other|0|||
17094604|NCT00004228|38233915|FG006|Overall Study|Other|0|||
17094605|NCT00004228|38233909|FG000|Overall Study|ineligible|4|||
17094606|NCT00004228|38233910|FG001|Overall Study|ineligible|2|||
17094607|NCT00004228|38233911|FG002|Overall Study|ineligible|4|||
17094608|NCT00004228|38233912|FG003|Overall Study|ineligible|1|||
17094609|NCT00004228|38233913|FG004|Overall Study|ineligible|1|||
17094610|NCT00004228|38233914|FG005|Overall Study|ineligible|2|||
17094611|NCT00004228|38233915|FG006|Overall Study|ineligible|5|||
17094612|NCT00003526|38233932|FG000|Overall Study|Not evaluable|6|||
17094613|NCT00195260|38233938|FG000|Part 1: Dose Escalation|Adverse Event|0|||
17094614|NCT00195260|38233939|FG001|Part 1: Dose Escalation|Adverse Event|1|||
17094615|NCT00195260|38233940|FG002|Part 1: Dose Escalation|Adverse Event|0|||
17094616|NCT00195260|38233941|FG003|Part 1: Dose Escalation|Adverse Event|1|||
17190898|NCT02962739|38343740|FG003|Overall Study|Withdrawal by Subject|0|||
17190899|NCT02962739|38343741|FG004|Overall Study|Withdrawal by Subject|0|||
17190900|NCT02962739|38343742|FG005|Overall Study|Withdrawal by Subject|0|||
17190901|NCT02962739|38343737|FG000|Overall Study|Protocol Violation|0|||
17190902|NCT02962739|38343738|FG001|Overall Study|Protocol Violation|0|||
17190903|NCT02962739|38343739|FG002|Overall Study|Protocol Violation|1|||
17190904|NCT02962739|38343740|FG003|Overall Study|Protocol Violation|0|||
17190905|NCT02962739|38343741|FG004|Overall Study|Protocol Violation|1|||
17190906|NCT02962739|38343742|FG005|Overall Study|Protocol Violation|0|||
17190907|NCT01344629|38343750|FG000|Crossover Period 2|Withdrawal by Subject|0|||
17190908|NCT01344629|38343751|FG001|Crossover Period 2|Withdrawal by Subject|1|||
17190909|NCT01092117|38343757|FG000|Index Procedure to 1 Month|Death|1|||
17190910|NCT01092117|38343757|FG000|1 Month|Death|1|||
17190911|NCT01092117|38343757|FG000|1 Month|Withdrawal by Subject|1|||
17190912|NCT01092117|38343757|FG000|1 Month|Lost to Follow-up|1|||
17190913|NCT01092117|38343757|FG000|6 Months|Death|2|||
17190914|NCT01092117|38343757|FG000|6 Months|Withdrawal by Subject|3|||
17190915|NCT01092117|38343757|FG000|12 Month|Death|11|||
17190916|NCT01092117|38343757|FG000|12 Month|Withdrawal by Subject|2|||
17190917|NCT01092117|38343757|FG000|12 Month|Lost to Follow-up|1|||
17190918|NCT01092117|38343757|FG000|Year 2|Death|5|||
17190919|NCT01092117|38343757|FG000|Year 2|Withdrawal by Subject|4|||
17094617|NCT00195260|38233942|FG004|Part 1: Dose Escalation|Adverse Event|1|||
17094618|NCT00195260|38233943|FG005|Part 1: Dose Escalation|Adverse Event|0|||
17094619|NCT00195260|38233944|FG006|Part 1: Dose Escalation|Adverse Event|3|||
17094620|NCT00195260|38233945|FG007|Part 1: Dose Escalation|Adverse Event|0|||
17094621|NCT00195260|38233946|FG008|Part 1: Dose Escalation|Adverse Event|0|||
17094622|NCT00195260|38233947|FG009|Part 1: Dose Escalation|Adverse Event|0|||
17094623|NCT00195260|38233948|FG010|Part 1: Dose Escalation|Adverse Event|0|||
17094624|NCT00195260|38233938|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094625|NCT00195260|38233939|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094626|NCT00195260|38233940|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094627|NCT00195260|38233941|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094628|NCT00195260|38233942|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
17094629|NCT00195260|38233943|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094630|NCT00195260|38233944|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094631|NCT00195260|38233945|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
17094632|NCT00195260|38233946|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094633|NCT00195260|38233947|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094634|NCT00195260|38233948|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
17094635|NCT00195260|38233938|FG000|Part 1: Dose Escalation|Death|0|||
17094636|NCT00195260|38233939|FG001|Part 1: Dose Escalation|Death|0|||
17094637|NCT00195260|38233940|FG002|Part 1: Dose Escalation|Death|0|||
17094638|NCT00195260|38233941|FG003|Part 1: Dose Escalation|Death|0|||
17094639|NCT00195260|38233942|FG004|Part 1: Dose Escalation|Death|0|||
17094640|NCT00195260|38233943|FG005|Part 1: Dose Escalation|Death|0|||
17094641|NCT00195260|38233944|FG006|Part 1: Dose Escalation|Death|0|||
17094642|NCT00195260|38233945|FG007|Part 1: Dose Escalation|Death|1|||
17094643|NCT00195260|38233946|FG008|Part 1: Dose Escalation|Death|0|||
17094644|NCT00195260|38233947|FG009|Part 1: Dose Escalation|Death|0|||
17094645|NCT00195260|38233948|FG010|Part 1: Dose Escalation|Death|0|||
17094646|NCT00195260|38233938|FG000|Part 1: Dose Escalation|Disease Progression|3|||
17094647|NCT00195260|38233939|FG001|Part 1: Dose Escalation|Disease Progression|2|||
17094648|NCT00195260|38233940|FG002|Part 1: Dose Escalation|Disease Progression|5|||
17094649|NCT00195260|38233941|FG003|Part 1: Dose Escalation|Disease Progression|6|||
17094650|NCT00195260|38233942|FG004|Part 1: Dose Escalation|Disease Progression|4|||
17094651|NCT00195260|38233943|FG005|Part 1: Dose Escalation|Disease Progression|6|||
17190920|NCT01092117|38343757|FG000|Year 2|Lost to Follow-up|1|||
17190921|NCT01092117|38343757|FG000|Year 3|Death|7|||
17094652|NCT00195260|38233944|FG006|Part 1: Dose Escalation|Disease Progression|7|||
17094653|NCT00195260|38233945|FG007|Part 1: Dose Escalation|Disease Progression|4|||
17094654|NCT00195260|38233946|FG008|Part 1: Dose Escalation|Disease Progression|0|||
17190922|NCT01092117|38343757|FG000|Year 3|Withdrawal by Subject|9|||
17190923|NCT01092117|38343757|FG000|Year 3|Lost to Follow-up|3|||
17190924|NCT01092117|38343757|FG000|Year 4|Death|8|||
17094655|NCT00195260|38233947|FG009|Part 1: Dose Escalation|Disease Progression|0|||
17094656|NCT00195260|38233948|FG010|Part 1: Dose Escalation|Disease Progression|0|||
17094657|NCT00195260|38233938|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
17094658|NCT00195260|38233939|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
17094659|NCT00195260|38233940|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
17094660|NCT00195260|38233941|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
17094661|NCT00195260|38233942|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
17094662|NCT00195260|38233943|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
17094663|NCT00195260|38233944|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
17094664|NCT00195260|38233945|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
17094665|NCT00195260|38233946|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
17094666|NCT00195260|38233947|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
17094667|NCT00195260|38233948|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
17094668|NCT00195260|38233938|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
17094669|NCT00195260|38233939|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
17094670|NCT00195260|38233940|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
17094671|NCT00195260|38233941|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
17094672|NCT00195260|38233942|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
17094673|NCT00195260|38233943|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
17094674|NCT00195260|38233944|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
17094675|NCT00195260|38233945|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
17094676|NCT00195260|38233946|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
17190925|NCT01092117|38343757|FG000|Year 4|Withdrawal by Subject|4|||
17000276|NCT00673387|38144128|FG005|Overall Study|Physician Decision|5|||
17000277|NCT00673387|38144129|FG006|Overall Study|Physician Decision|1|||
17000278|NCT00673387|38144130|FG007|Overall Study|Physician Decision|1|||
17000279|NCT00673387|38144123|FG000|Overall Study|Protocol Violation|3|||
17000280|NCT00673387|38144124|FG001|Overall Study|Protocol Violation|0|||
17000281|NCT00673387|38144125|FG002|Overall Study|Protocol Violation|1|||
17000282|NCT00673387|38144126|FG003|Overall Study|Protocol Violation|2|||
17000283|NCT00673387|38144127|FG004|Overall Study|Protocol Violation|0|||
17000284|NCT00673387|38144128|FG005|Overall Study|Protocol Violation|1|||
17000285|NCT00673387|38144129|FG006|Overall Study|Protocol Violation|1|||
17000286|NCT00673387|38144130|FG007|Overall Study|Protocol Violation|3|||
17000287|NCT00673387|38144123|FG000|Overall Study|Lost to Follow-up|8|||
17094677|NCT00195260|38233947|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
17094678|NCT00195260|38233948|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
17094679|NCT00195260|38233938|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
17000288|NCT00673387|38144124|FG001|Overall Study|Lost to Follow-up|6|||
17000289|NCT00673387|38144125|FG002|Overall Study|Lost to Follow-up|5|||
17000290|NCT00673387|38144126|FG003|Overall Study|Lost to Follow-up|6|||
17000291|NCT00673387|38144127|FG004|Overall Study|Lost to Follow-up|6|||
17000292|NCT00673387|38144128|FG005|Overall Study|Lost to Follow-up|5|||
17000293|NCT00673387|38144129|FG006|Overall Study|Lost to Follow-up|8|||
17000294|NCT00673387|38144130|FG007|Overall Study|Lost to Follow-up|5|||
17000295|NCT00933608|38144160|FG000|Overall Study|Adverse Event|4|||
17000296|NCT00933608|38144161|FG001|Overall Study|Adverse Event|2|||
17000297|NCT00933608|38144160|FG000|Overall Study|Physician Decision|1|||
17000298|NCT00933608|38144161|FG001|Overall Study|Physician Decision|0|||
17000299|NCT00574951|38144167|FG000|Overall Study|Ineligible - improper prior treatment|1|||
17000300|NCT00936884|38144173|FG000|Double-blind|Withdrawal by Subject|6|||
17094680|NCT00195260|38233939|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
17094681|NCT00195260|38233940|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
17094682|NCT00195260|38233941|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
17190926|NCT01092117|38343757|FG000|Year 4|Lost to Follow-up|4|||
17190927|NCT01065779|38343770|FG000|Overall Study|Duplicate Investigation|1|||
17190928|NCT01065779|38343770|FG000|Overall Study|Investigation Before Contract Date|37|||
17190929|NCT01065779|38343770|FG000|Overall Study|Non-enrollment Period Administration|10|||
17190930|NCT01065779|38343770|FG000|Overall Study|Not Administered With Study Drug|17|||
17190931|NCT01065779|38343770|FG000|Overall Study|Failed to Follow-up|10|||
17190932|NCT01065779|38343770|FG000|Overall Study|Inclusion Criteria Violation|7|||
17190933|NCT02963441|38343774|FG000|Overall Study|Protocol violation or withdrawn|8|||
17190934|NCT02963441|38343774|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
17190935|NCT02963441|38343774|FG000|Overall Study|IDx-DR insufficient quality|33|||
17190936|NCT01345253|38343781|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
17190937|NCT01345253|38343782|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
17190938|NCT01345253|38343781|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
17190939|NCT01345253|38343782|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
17190940|NCT01345253|38343781|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
17190941|NCT01345253|38343782|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
17190942|NCT01345253|38343781|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
17000301|NCT00936884|38144174|FG001|Double-blind|Withdrawal by Subject|4|||
17000302|NCT00936884|38144175|FG002|Double-blind|Withdrawal by Subject|0|||
17000303|NCT00936884|38144173|FG000|Double-blind|Death|2|||
17000304|NCT00936884|38144174|FG001|Double-blind|Death|1|||
17000305|NCT00936884|38144175|FG002|Double-blind|Death|0|||
17000306|NCT00936884|38144173|FG000|Double-blind|Lack of Efficacy|1|||
17000307|NCT00936884|38144174|FG001|Double-blind|Lack of Efficacy|1|||
17000308|NCT00936884|38144175|FG002|Double-blind|Lack of Efficacy|0|||
17000309|NCT00936884|38144173|FG000|Double-blind|Adverse Event|1|||
17000310|NCT00936884|38144174|FG001|Double-blind|Adverse Event|0|||
17000311|NCT00936884|38144175|FG002|Double-blind|Adverse Event|0|||
17000312|NCT00936884|38144173|FG000|Double-blind|Physician Decision|1|||
17000313|NCT00936884|38144174|FG001|Double-blind|Physician Decision|0|||
17000314|NCT00936884|38144175|FG002|Double-blind|Physician Decision|0|||
17000315|NCT00936884|38144173|FG000|Double-blind|No post baseline diary entry|1|||
17000316|NCT00936884|38144174|FG001|Double-blind|No post baseline diary entry|0|||
17000317|NCT00936884|38144175|FG002|Double-blind|No post baseline diary entry|0|||
17000318|NCT00936884|38144173|FG000|Double-blind|Did not receive study drug|0|||
17000319|NCT00936884|38144174|FG001|Double-blind|Did not receive study drug|1|||
17000320|NCT00936884|38144175|FG002|Double-blind|Did not receive study drug|0|||
17000321|NCT00668863|38144191|FG000|Overall Study|Objective Progression or Relapse|42|||
17000322|NCT00668863|38144191|FG000|Overall Study|Adverse Event|13|||
17000323|NCT00668863|38144191|FG000|Overall Study|Study Terminated by Sponsor|8|||
17000324|NCT00668863|38144191|FG000|Overall Study|Global Deterioration of Health Status|4|||
17000325|NCT00668863|38144191|FG000|Overall Study|Withdrawal by Subject|1|||
17000326|NCT00668863|38144191|FG000|Overall Study|Surgery|1|||
17000327|NCT00668863|38144191|FG000|Overall Study|Subject's work scheduling problem|1|||
17000328|NCT00668863|38144191|FG000|Overall Study|Physician Decision|1|||
17000329|NCT04067518|38144197|FG000|Overall Study|Adverse Events|1|||
17000330|NCT04067518|38144198|FG001|Overall Study|Adverse Events|3|||
17000331|NCT00935012|38144205|FG000|Overall Study|Death|19|||
17000332|NCT00935012|38144205|FG000|Overall Study|Withdrawal by Subject|3|||
17000333|NCT00935012|38144205|FG000|Overall Study|Other|5|||
17000334|NCT00935012|38144205|FG000|Overall Study|Adverse Event|2|||
17000335|NCT00932360|38144209|FG000|Washout (One Week)|Withdrawal by Subject|0|||
17000336|NCT00932360|38144210|FG001|Washout (One Week)|Withdrawal by Subject|0|||
17000337|NCT00932360|38144211|FG002|Washout (One Week)|Withdrawal by Subject|0|||
17000338|NCT00932360|38144212|FG003|Washout (One Week)|Withdrawal by Subject|0|||
17000339|NCT00932360|38144213|FG004|Washout (One Week)|Withdrawal by Subject|2|||
17000340|NCT00932360|38144214|FG005|Washout (One Week)|Withdrawal by Subject|0|||
17000341|NCT03830866|38144230|FG000|Overall Study|Ongoing study at DCO|312|||
17000342|NCT03830866|38144231|FG001|Overall Study|Ongoing study at DCO|295|||
17000343|NCT03830866|38144230|FG000|Overall Study|Death|58|||
17000344|NCT03830866|38144231|FG001|Overall Study|Death|74|||
17000345|NCT03830866|38144230|FG000|Overall Study|Lost to Follow-up|0|||
17000346|NCT03830866|38144231|FG001|Overall Study|Lost to Follow-up|1|||
17000347|NCT03830866|38144230|FG000|Overall Study|Withdrawal by Subject|15|||
17000348|NCT03830866|38144231|FG001|Overall Study|Withdrawal by Subject|13|||
17000349|NCT03830866|38144230|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
17000350|NCT03830866|38144231|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
17000351|NCT03830866|38144230|FG000|Overall Study|Other|0|||
17000352|NCT03830866|38144231|FG001|Overall Study|Other|1|||
17000353|NCT00668707|38144239|FG000|Overall Study|Cancer Recurrence|58|||
17000354|NCT00668707|38144240|FG001|Overall Study|Cancer Recurrence|58|||
17000355|NCT00668707|38144239|FG000|Overall Study|Withdrawal by Subject|117|||
17000356|NCT00668707|38144240|FG001|Overall Study|Withdrawal by Subject|100|||
17000357|NCT00668707|38144239|FG000|Overall Study|Lost to Follow-up|3|||
17000358|NCT00668707|38144240|FG001|Overall Study|Lost to Follow-up|6|||
17094683|NCT00195260|38233942|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
17094684|NCT00195260|38233943|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
17094685|NCT00195260|38233944|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
17094686|NCT00195260|38233945|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
17094687|NCT00195260|38233946|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
17094688|NCT00195260|38233947|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
17094689|NCT00195260|38233948|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
17094690|NCT00195260|38233938|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
17094691|NCT00195260|38233939|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
17094692|NCT00195260|38233940|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
17094693|NCT00195260|38233941|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
17094694|NCT00195260|38233942|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16868377|NCT01533935|37841437|FG001|Overall Study|Lost to Follow-up|0|||
17000359|NCT00668707|38144239|FG000|Overall Study|Protocol Violation|10|||
17000360|NCT00668707|38144240|FG001|Overall Study|Protocol Violation|12|||
17000361|NCT00668707|38144239|FG000|Overall Study|Death|11|||
17000362|NCT00668707|38144240|FG001|Overall Study|Death|4|||
17000363|NCT00668395|38144254|FG000|Overall Study|Withdrawal by Subject|4|||
17000364|NCT00668395|38144255|FG001|Overall Study|Withdrawal by Subject|4|||
17000365|NCT00668395|38144256|FG002|Overall Study|Withdrawal by Subject|1|||
17000366|NCT00668395|38144254|FG000|Overall Study|Adverse Event|1|||
17000367|NCT00668395|38144255|FG001|Overall Study|Adverse Event|1|||
17000368|NCT00668395|38144256|FG002|Overall Study|Adverse Event|0|||
17000369|NCT00668395|38144254|FG000|Overall Study|Physician Decision|1|||
17000370|NCT00668395|38144255|FG001|Overall Study|Physician Decision|1|||
17000371|NCT00668395|38144256|FG002|Overall Study|Physician Decision|0|||
17000372|NCT00668317|38144264|FG000|Overall Study|Adverse Event|2|||
17000373|NCT00670111|38144285|FG000|Enrollment to One Month|Testing Failure|0|||
17000374|NCT00670111|38144286|FG001|Enrollment to One Month|Testing Failure|0|||
17000375|NCT00670111|38144287|FG002|Enrollment to One Month|Testing Failure|13|||
17000376|NCT00670111|38144285|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
17000377|NCT00670111|38144286|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
17000378|NCT00670111|38144287|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
17000379|NCT00670111|38144285|FG000|Enrollment to One Month|Physician Decision|1|||
17000380|NCT00670111|38144286|FG001|Enrollment to One Month|Physician Decision|0|||
17000381|NCT00670111|38144287|FG002|Enrollment to One Month|Physician Decision|0|||
17000382|NCT00672139|38144297|FG000|Overall Study|Death|14|||
17000383|NCT00672139|38144298|FG001|Overall Study|Death|23|||
17000384|NCT00672139|38144297|FG000|Overall Study|Withdrawal by Subject|2|||
17000385|NCT00672139|38144298|FG001|Overall Study|Withdrawal by Subject|11|||
17000386|NCT00672139|38144297|FG000|Overall Study|Adverse Event|4|||
17000387|NCT00672139|38144298|FG001|Overall Study|Adverse Event|7|||
17000388|NCT00672139|38144297|FG000|Overall Study|Physician Decision|2|||
17000389|NCT00672139|38144298|FG001|Overall Study|Physician Decision|0|||
17000390|NCT00672139|38144297|FG000|Overall Study|Lack of Efficacy|4|||
17000391|NCT00672139|38144298|FG001|Overall Study|Lack of Efficacy|1|||
17000392|NCT00672139|38144297|FG000|Overall Study|Protocol Violation|1|||
17000393|NCT00672139|38144298|FG001|Overall Study|Protocol Violation|1|||
17000394|NCT00672139|38144297|FG000|Overall Study|hospice discharge, caregiver requests|3|||
17000395|NCT00672139|38144298|FG001|Overall Study|hospice discharge, caregiver requests|2|||
17000396|NCT00570739|38144308|FG000|Overall Study|Adverse Event|8|||
17000397|NCT00570739|38144309|FG001|Overall Study|Adverse Event|6|||
17000398|NCT00570739|38144310|FG002|Overall Study|Adverse Event|2|||
17000399|NCT00570739|38144311|FG003|Overall Study|Adverse Event|2|||
17000400|NCT00570739|38144308|FG000|Overall Study|Lost to Follow-up|4|||
17000401|NCT00570739|38144309|FG001|Overall Study|Lost to Follow-up|5|||
17000402|NCT00570739|38144310|FG002|Overall Study|Lost to Follow-up|4|||
17000403|NCT00570739|38144311|FG003|Overall Study|Lost to Follow-up|1|||
17000404|NCT00570739|38144308|FG000|Overall Study|Physician Decision|1|||
17000405|NCT00570739|38144309|FG001|Overall Study|Physician Decision|1|||
17000406|NCT00570739|38144310|FG002|Overall Study|Physician Decision|0|||
17000407|NCT00570739|38144311|FG003|Overall Study|Physician Decision|0|||
17000408|NCT00570739|38144308|FG000|Overall Study|Withdrawal by Subject|7|||
17000409|NCT00570739|38144309|FG001|Overall Study|Withdrawal by Subject|7|||
17000410|NCT00570739|38144310|FG002|Overall Study|Withdrawal by Subject|3|||
17000411|NCT00570739|38144311|FG003|Overall Study|Withdrawal by Subject|5|||
17000412|NCT00570739|38144308|FG000|Overall Study|Required restricted medication|0|||
17000413|NCT00570739|38144309|FG001|Overall Study|Required restricted medication|0|||
17000414|NCT00570739|38144310|FG002|Overall Study|Required restricted medication|1|||
17000415|NCT00570739|38144311|FG003|Overall Study|Required restricted medication|0|||
17000416|NCT00570739|38144308|FG000|Overall Study|Met discontinuation criteria|1|||
17000417|NCT00570739|38144309|FG001|Overall Study|Met discontinuation criteria|0|||
17000418|NCT00570739|38144310|FG002|Overall Study|Met discontinuation criteria|1|||
17000419|NCT00570739|38144311|FG003|Overall Study|Met discontinuation criteria|1|||
17000420|NCT00570739|38144308|FG000|Overall Study|Other|0|||
17000421|NCT00570739|38144309|FG001|Overall Study|Other|2|||
17000422|NCT00570739|38144310|FG002|Overall Study|Other|5|||
17000423|NCT00570739|38144311|FG003|Overall Study|Other|3|||
17000424|NCT03689530|38144343|FG000|Overall Study|Withdrawal by Subject|53|||
17000425|NCT03689530|38144344|FG001|Overall Study|Withdrawal by Subject|16|||
17000426|NCT04188106|38144350|FG000|Overall Study|Lost to Follow-up|5|||
17000427|NCT04188106|38144350|FG000|Overall Study|Non-Compliance|1|||
17000428|NCT00669955|38144358|FG000|Overall Study|Adverse Event|3|||
17000429|NCT00669955|38144359|FG001|Overall Study|Adverse Event|5|||
17000430|NCT00669955|38144358|FG000|Overall Study|Death|0|||
17000431|NCT00669955|38144359|FG001|Overall Study|Death|1|||
17000432|NCT00669955|38144358|FG000|Overall Study|Withdrawal by Subject|2|||
17000433|NCT00669955|38144359|FG001|Overall Study|Withdrawal by Subject|3|||
17000434|NCT00669955|38144358|FG000|Overall Study|Lost to Follow-up|5|||
17000435|NCT00669955|38144359|FG001|Overall Study|Lost to Follow-up|7|||
17000436|NCT00669955|38144358|FG000|Overall Study|Protocol Violation|2|||
17000437|NCT00669955|38144359|FG001|Overall Study|Protocol Violation|7|||
17000438|NCT00669955|38144358|FG000|Overall Study|Investigator Sponsor Judgement|0|||
17000439|NCT00669955|38144359|FG001|Overall Study|Investigator Sponsor Judgement|1|||
17000440|NCT00669955|38144358|FG000|Overall Study|not compliant with study drug/visit|2|||
17000441|NCT00669955|38144359|FG001|Overall Study|not compliant with study drug/visit|3|||
17000442|NCT00671749|38144365|FG000|Overall Study|Adverse Event|2|||
17000443|NCT00671749|38144365|FG000|Overall Study|Withdrawal by Subject|4|||
17000444|NCT00671749|38144365|FG000|Overall Study|Protocol Violation|1|||
17000445|NCT00671749|38144365|FG000|Overall Study|Lost to Follow-up|1|||
17000446|NCT00669877|38144369|FG000|Overall Study|Disease Progression/Death|4|||
17000447|NCT00882999|38144380|FG000|Overall Study|Adverse Event|0|||
17000448|NCT00882999|38144381|FG001|Overall Study|Adverse Event|0|||
17000449|NCT00882999|38144382|FG002|Overall Study|Adverse Event|0|||
17000450|NCT00882999|38144383|FG003|Overall Study|Adverse Event|0|||
17000451|NCT00882999|38144384|FG004|Overall Study|Adverse Event|1|||
17000452|NCT00882999|38144385|FG005|Overall Study|Adverse Event|0|||
17000453|NCT00882999|38144386|FG006|Overall Study|Adverse Event|0|||
17000454|NCT00882999|38144380|FG000|Overall Study|Death|0|||
17000455|NCT00882999|38144381|FG001|Overall Study|Death|1|||
17000456|NCT00882999|38144382|FG002|Overall Study|Death|0|||
17000457|NCT00882999|38144383|FG003|Overall Study|Death|0|||
17000458|NCT00882999|38144384|FG004|Overall Study|Death|0|||
17000459|NCT00882999|38144385|FG005|Overall Study|Death|0|||
17000460|NCT00882999|38144386|FG006|Overall Study|Death|0|||
17000461|NCT00882999|38144380|FG000|Overall Study|Withdrawal by Subject|7|||
17000462|NCT00882999|38144381|FG001|Overall Study|Withdrawal by Subject|6|||
17000463|NCT00882999|38144382|FG002|Overall Study|Withdrawal by Subject|3|||
17000464|NCT00882999|38144383|FG003|Overall Study|Withdrawal by Subject|3|||
17000465|NCT00882999|38144384|FG004|Overall Study|Withdrawal by Subject|6|||
17000466|NCT00882999|38144385|FG005|Overall Study|Withdrawal by Subject|5|||
17000467|NCT00882999|38144386|FG006|Overall Study|Withdrawal by Subject|5|||
17000468|NCT00882999|38144380|FG000|Overall Study|Lost to Follow-up|0|||
17000469|NCT00882999|38144381|FG001|Overall Study|Lost to Follow-up|1|||
17000470|NCT00882999|38144382|FG002|Overall Study|Lost to Follow-up|1|||
17000471|NCT00882999|38144383|FG003|Overall Study|Lost to Follow-up|2|||
17000472|NCT00882999|38144384|FG004|Overall Study|Lost to Follow-up|1|||
17000473|NCT00882999|38144385|FG005|Overall Study|Lost to Follow-up|1|||
17000474|NCT00882999|38144386|FG006|Overall Study|Lost to Follow-up|2|||
17000475|NCT00882999|38144380|FG000|Overall Study|Physician Decision|1|||
17000476|NCT00882999|38144381|FG001|Overall Study|Physician Decision|0|||
17000477|NCT00882999|38144382|FG002|Overall Study|Physician Decision|0|||
17000478|NCT00882999|38144383|FG003|Overall Study|Physician Decision|0|||
17000479|NCT00882999|38144384|FG004|Overall Study|Physician Decision|0|||
17000480|NCT00882999|38144385|FG005|Overall Study|Physician Decision|1|||
17000481|NCT00882999|38144386|FG006|Overall Study|Physician Decision|1|||
17000482|NCT00671437|38144409|FG000|Overall Study|Progressive disease before C1 week 8|8|||
17000483|NCT00671437|38144409|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
17000484|NCT00671437|38144409|FG000|Overall Study|Adverse Event|3|||
17000485|NCT00671437|38144409|FG000|Overall Study|Ineligible post-hoc|1|||
17000486|NCT00882921|38144421|FG000|Overall Study|Death|2|||
17000487|NCT00882921|38144421|FG000|Overall Study|Other|3|||
17000488|NCT00882921|38144421|FG000|Overall Study|Lost to Follow-up|2|||
17000489|NCT00882921|38144421|FG000|Overall Study|Termination By Investigator|3|||
17000490|NCT00882921|38144421|FG000|Overall Study|Withdrawal Of Consent|1|||
17000491|NCT00582712|38144426|FG000|Overall Study|Adverse Event|1|||
17000492|NCT00582712|38144426|FG000|Overall Study|Lack of Efficacy|1|||
17000493|NCT00582712|38144426|FG000|Overall Study|Withdrawal by Subject|1|||
17000494|NCT00582712|38144426|FG000|Overall Study|Complicating disease requiring treatment|1|||
17000495|NCT00667459|38144432|FG000|Overall Study|Death|0|||
17000496|NCT00667459|38144433|FG001|Overall Study|Death|2|||
17000497|NCT00667459|38144432|FG000|Overall Study|Lost to Follow-up|8|||
17000498|NCT00667459|38144433|FG001|Overall Study|Lost to Follow-up|43|||
17000499|NCT00582790|38144439|FG000|Overall Study|Rapid progression of disease|1|||
17000500|NCT00881751|38144446|FG000|Overall Study|Physician Decision|0|||
17000501|NCT00881751|38144447|FG001|Overall Study|Physician Decision|1|||
17000502|NCT00881751|38144446|FG000|Overall Study|Adverse Event|0|||
17000503|NCT00881751|38144447|FG001|Overall Study|Adverse Event|2|||
17000504|NCT00881751|38144446|FG000|Overall Study|Withdrawal by Subject|0|||
17000505|NCT00881751|38144447|FG001|Overall Study|Withdrawal by Subject|2|||
17000506|NCT00934856|38144459|FG000|Feasibility Part|Progressive disease|4|||
17000507|NCT00934856|38144460|FG001|Feasibility Part|Progressive disease|4|||
17000508|NCT00934856|38144461|FG002|Feasibility Part|Progressive disease|2|||
17000509|NCT00934856|38144462|FG003|Feasibility Part|Progressive disease|3|||
17000510|NCT00934856|38144463|FG004|Feasibility Part|Progressive disease|0|||
17000511|NCT00934856|38144464|FG005|Feasibility Part|Progressive disease|0|||
17000512|NCT00934856|38144459|FG000|Feasibility Part|Physician Decision|0|||
17000513|NCT00934856|38144460|FG001|Feasibility Part|Physician Decision|0|||
17000514|NCT00934856|38144461|FG002|Feasibility Part|Physician Decision|1|||
17000515|NCT00934856|38144462|FG003|Feasibility Part|Physician Decision|0|||
17000516|NCT00934856|38144463|FG004|Feasibility Part|Physician Decision|0|||
17000517|NCT00934856|38144464|FG005|Feasibility Part|Physician Decision|0|||
17000518|NCT00934856|38144459|FG000|Feasibility Part|Adverse Event|1|||
17000519|NCT00934856|38144460|FG001|Feasibility Part|Adverse Event|1|||
17000520|NCT00934856|38144461|FG002|Feasibility Part|Adverse Event|0|||
17000521|NCT00934856|38144462|FG003|Feasibility Part|Adverse Event|1|||
17000522|NCT00934856|38144463|FG004|Feasibility Part|Adverse Event|0|||
17000523|NCT00934856|38144464|FG005|Feasibility Part|Adverse Event|2|||
17000524|NCT00934856|38144459|FG000|Feasibility Part|Withdrawal by Subject|0|||
17000525|NCT00934856|38144460|FG001|Feasibility Part|Withdrawal by Subject|0|||
17000526|NCT00934856|38144461|FG002|Feasibility Part|Withdrawal by Subject|0|||
17000527|NCT00934856|38144462|FG003|Feasibility Part|Withdrawal by Subject|1|||
17000528|NCT00934856|38144463|FG004|Feasibility Part|Withdrawal by Subject|0|||
17000529|NCT00934856|38144464|FG005|Feasibility Part|Withdrawal by Subject|1|||
17000530|NCT00934856|38144459|FG000|Extension Part|Adverse Event|0|||
17000531|NCT00934856|38144460|FG001|Extension Part|Adverse Event|0|||
17000532|NCT00934856|38144461|FG002|Extension Part|Adverse Event|0|||
17000533|NCT00934856|38144462|FG003|Extension Part|Adverse Event|1|||
17000534|NCT00934856|38144463|FG004|Extension Part|Adverse Event|4|||
17000535|NCT00934856|38144464|FG005|Extension Part|Adverse Event|4|||
17000536|NCT00934856|38144459|FG000|Extension Part|Progressive disease|0|||
17000537|NCT00934856|38144460|FG001|Extension Part|Progressive disease|0|||
17000538|NCT00934856|38144461|FG002|Extension Part|Progressive disease|0|||
17000539|NCT00934856|38144462|FG003|Extension Part|Progressive disease|1|||
17000540|NCT00934856|38144463|FG004|Extension Part|Progressive disease|0|||
17000541|NCT00934856|38144464|FG005|Extension Part|Progressive disease|0|||
17000542|NCT00934856|38144459|FG000|Extension Part|Non-compliance with drug|0|||
17000543|NCT00934856|38144460|FG001|Extension Part|Non-compliance with drug|0|||
17000544|NCT00934856|38144461|FG002|Extension Part|Non-compliance with drug|0|||
17000545|NCT00934856|38144462|FG003|Extension Part|Non-compliance with drug|0|||
17000546|NCT00934856|38144463|FG004|Extension Part|Non-compliance with drug|0|||
17000547|NCT00934856|38144464|FG005|Extension Part|Non-compliance with drug|1|||
17000548|NCT00934700|38144498|FG000|Overall Study|missing scan|5|||
17000549|NCT00934700|38144499|FG001|Overall Study|missing scan|9|||
17000550|NCT00934700|38144498|FG000|Overall Study|Death|8|||
17000551|NCT00934700|38144499|FG001|Overall Study|Death|3|||
17000552|NCT00930176|38144506|FG000|Overall Study|Death|1|||
17000553|NCT00669409|38144516|FG000|Part 2|Withdrawal by Subject|0|||
17000554|NCT00669409|38144517|FG001|Part 2|Withdrawal by Subject|0|||
17000555|NCT00669409|38144518|FG002|Part 2|Withdrawal by Subject|0|||
17000556|NCT00669409|38144519|FG003|Part 2|Withdrawal by Subject|0|||
17000557|NCT00669409|38144520|FG004|Part 2|Withdrawal by Subject|0|||
17000558|NCT00669409|38144521|FG005|Part 2|Withdrawal by Subject|0|||
17000559|NCT00669409|38144522|FG006|Part 2|Withdrawal by Subject|0|||
17000560|NCT00669409|38144523|FG007|Part 2|Withdrawal by Subject|0|||
17000561|NCT00669409|38144524|FG008|Part 2|Withdrawal by Subject|0|||
17000562|NCT00669409|38144525|FG009|Part 2|Withdrawal by Subject|1|||
17000563|NCT00669409|38144526|FG010|Part 2|Withdrawal by Subject|0|||
17000564|NCT00669331|38144555|FG000|Randomisation to First Dose|Adverse Event|1|||
17000565|NCT00669331|38144556|FG001|Randomisation to First Dose|Adverse Event|0|||
17000566|NCT00669331|38144555|FG000|Randomisation to First Dose|Protocol Violation|1|||
17000567|NCT00669331|38144556|FG001|Randomisation to First Dose|Protocol Violation|0|||
17000568|NCT00669331|38144555|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
17000569|NCT00669331|38144556|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
17000570|NCT00669331|38144555|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
17000571|NCT00669331|38144556|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
17000572|NCT00669331|38144555|FG000|Randomisation to First Dose|Death|1|||
17000573|NCT00669331|38144556|FG001|Randomisation to First Dose|Death|0|||
17000574|NCT00669331|38144555|FG000|Randomisation to First Dose|Sponsor decision|0|||
17000575|NCT00669331|38144556|FG001|Randomisation to First Dose|Sponsor decision|1|||
17000576|NCT00669331|38144555|FG000|Randomisation to First Dose|Randomised in error|3|||
17000577|NCT00669331|38144556|FG001|Randomisation to First Dose|Randomised in error|10|||
17094695|NCT00195260|38233943|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
17094696|NCT00195260|38233944|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
17094697|NCT00195260|38233945|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
17094698|NCT00195260|38233946|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
17094699|NCT00195260|38233947|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
17094700|NCT00195260|38233948|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
17000578|NCT00669331|38144555|FG000|Blinded Treatment Period|Adverse Event|16|||
17000579|NCT00669331|38144556|FG001|Blinded Treatment Period|Adverse Event|10|||
17000580|NCT00669331|38144555|FG000|Blinded Treatment Period|Protocol Violation|1|||
17000581|NCT00669331|38144556|FG001|Blinded Treatment Period|Protocol Violation|1|||
17000582|NCT00669331|38144555|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
17000583|NCT00669331|38144556|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
17000584|NCT00669331|38144555|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
17000585|NCT00669331|38144556|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
17000586|NCT00669331|38144555|FG000|Blinded Treatment Period|Death|0|||
17000587|NCT00669331|38144556|FG001|Blinded Treatment Period|Death|2|||
17000588|NCT00669331|38144555|FG000|Blinded Treatment Period|Physician Decision|3|||
17000589|NCT00669331|38144556|FG001|Blinded Treatment Period|Physician Decision|3|||
17000590|NCT00669331|38144555|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
17000591|NCT00669331|38144556|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
17000592|NCT00932126|38144564|FG000|Overall Study|Adverse Event|0|||
17000593|NCT00932126|38144565|FG001|Overall Study|Adverse Event|0|||
17000594|NCT00932126|38144566|FG002|Overall Study|Adverse Event|0|||
17000595|NCT00932126|38144567|FG003|Overall Study|Adverse Event|0|||
17000596|NCT00932126|38144568|FG004|Overall Study|Adverse Event|0|||
17000597|NCT00932126|38144569|FG005|Overall Study|Adverse Event|0|||
17000598|NCT00932126|38144570|FG006|Overall Study|Adverse Event|1|||
17000599|NCT00932126|38144571|FG007|Overall Study|Adverse Event|2|||
17000600|NCT00932126|38144564|FG000|Overall Study|Protocol Violation|0|||
17000601|NCT00932126|38144565|FG001|Overall Study|Protocol Violation|0|||
17000602|NCT00932126|38144566|FG002|Overall Study|Protocol Violation|0|||
17000603|NCT00932126|38144567|FG003|Overall Study|Protocol Violation|0|||
17000604|NCT00932126|38144568|FG004|Overall Study|Protocol Violation|1|||
17000605|NCT00932126|38144569|FG005|Overall Study|Protocol Violation|0|||
17000606|NCT00932126|38144570|FG006|Overall Study|Protocol Violation|0|||
17000607|NCT00932126|38144571|FG007|Overall Study|Protocol Violation|0|||
17000608|NCT00932126|38144564|FG000|Overall Study|Withdrawal by Subject|0|||
17000609|NCT00932126|38144565|FG001|Overall Study|Withdrawal by Subject|0|||
17000610|NCT00932126|38144566|FG002|Overall Study|Withdrawal by Subject|1|||
17000611|NCT00932126|38144567|FG003|Overall Study|Withdrawal by Subject|0|||
17000612|NCT00932126|38144568|FG004|Overall Study|Withdrawal by Subject|0|||
17000613|NCT00932126|38144569|FG005|Overall Study|Withdrawal by Subject|0|||
17000614|NCT00932126|38144570|FG006|Overall Study|Withdrawal by Subject|0|||
17000615|NCT00932126|38144571|FG007|Overall Study|Withdrawal by Subject|1|||
17000616|NCT00932126|38144564|FG000|Overall Study|Objective progression or relapse|3|||
17000617|NCT00932126|38144565|FG001|Overall Study|Objective progression or relapse|3|||
17000618|NCT00932126|38144566|FG002|Overall Study|Objective progression or relapse|2|||
17000619|NCT00932126|38144567|FG003|Overall Study|Objective progression or relapse|3|||
17000620|NCT00932126|38144568|FG004|Overall Study|Objective progression or relapse|3|||
17000621|NCT00932126|38144569|FG005|Overall Study|Objective progression or relapse|3|||
17000622|NCT00932126|38144570|FG006|Overall Study|Objective progression or relapse|3|||
17000623|NCT00932126|38144571|FG007|Overall Study|Objective progression or relapse|5|||
17000624|NCT00932126|38144564|FG000|Overall Study|Other|0|||
17000625|NCT00932126|38144565|FG001|Overall Study|Other|0|||
17000626|NCT00932126|38144566|FG002|Overall Study|Other|0|||
17000627|NCT00932126|38144567|FG003|Overall Study|Other|0|||
17000628|NCT00932126|38144568|FG004|Overall Study|Other|1|||
17000629|NCT00932126|38144569|FG005|Overall Study|Other|0|||
17000630|NCT00932126|38144570|FG006|Overall Study|Other|1|||
17000631|NCT00932126|38144571|FG007|Overall Study|Other|2|||
17000632|NCT00667225|38144593|FG000|Overall Study|Subject had no more lesions to treat.|1|||
17000633|NCT00667225|38144594|FG001|Overall Study|Subject had no more lesions to treat.|0|||
17000634|NCT00667225|38144593|FG000|Overall Study|Lost to Follow-up|0|||
17000635|NCT00667225|38144594|FG001|Overall Study|Lost to Follow-up|1|||
17000636|NCT00929864|38144602|FG000|Overall Study|Death|1|||
17000637|NCT00929864|38144603|FG001|Overall Study|Death|1|||
17000638|NCT00929864|38144602|FG000|Overall Study|Adverse Event|11|||
17000639|NCT00929864|38144603|FG001|Overall Study|Adverse Event|30|||
17000640|NCT00929864|38144602|FG000|Overall Study|Lack of Efficacy|19|||
17000641|NCT00929864|38144603|FG001|Overall Study|Lack of Efficacy|16|||
17000642|NCT00929864|38144602|FG000|Overall Study|Lost to Follow-up|7|||
17000643|NCT00929864|38144603|FG001|Overall Study|Lost to Follow-up|12|||
17000644|NCT00929864|38144602|FG000|Overall Study|Withdrawal by Subject|20|||
17000645|NCT00929864|38144603|FG001|Overall Study|Withdrawal by Subject|9|||
17000646|NCT00929864|38144602|FG000|Overall Study|No longer met criteria|2|||
17000647|NCT00929864|38144603|FG001|Overall Study|No longer met criteria|1|||
17000648|NCT00929864|38144602|FG000|Overall Study|Poor or non-compliance|3|||
17000649|NCT00929864|38144603|FG001|Overall Study|Poor or non-compliance|3|||
17094701|NCT00195260|38233938|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
17094702|NCT00195260|38233939|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
17000650|NCT00929864|38144602|FG000|Overall Study|Pregnancy|0|||
17000651|NCT00929864|38144603|FG001|Overall Study|Pregnancy|3|||
17000652|NCT00929864|38144602|FG000|Overall Study|Administrative reason by Sponsor|1|||
17000653|NCT00929864|38144603|FG001|Overall Study|Administrative reason by Sponsor|1|||
17000654|NCT00929864|38144602|FG000|Overall Study|Non-specified|2|||
17000655|NCT00929864|38144603|FG001|Overall Study|Non-specified|7|||
17000656|NCT00597753|38144611|FG000|Overall Study|Adverse Event|6|||
17000657|NCT00597753|38144612|FG001|Overall Study|Adverse Event|2|||
17094703|NCT00195260|38233940|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
17094704|NCT00195260|38233941|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
17094705|NCT00195260|38233942|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
17000658|NCT00597753|38144611|FG000|Overall Study|Death|55|||
17000659|NCT00597753|38144612|FG001|Overall Study|Death|29|||
17000660|NCT00597753|38144611|FG000|Overall Study|Lack of Efficacy|2|||
17000661|NCT00597753|38144612|FG001|Overall Study|Lack of Efficacy|0|||
17000662|NCT00597753|38144611|FG000|Overall Study|Lost to Follow-up|10|||
17094706|NCT00195260|38233943|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
17094707|NCT00195260|38233944|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
17094708|NCT00195260|38233945|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
17000663|NCT00597753|38144612|FG001|Overall Study|Lost to Follow-up|3|||
17000664|NCT00597753|38144611|FG000|Overall Study|Physician Decision|5|||
17000665|NCT00597753|38144612|FG001|Overall Study|Physician Decision|1|||
17000666|NCT00597753|38144611|FG000|Overall Study|Pregnancy|1|||
17000667|NCT00597753|38144612|FG001|Overall Study|Pregnancy|0|||
17000668|NCT00597753|38144611|FG000|Overall Study|Withdrawal by Subject|35|||
17000669|NCT00597753|38144612|FG001|Overall Study|Withdrawal by Subject|12|||
17000670|NCT00597753|38144611|FG000|Overall Study|Discontinued Dialysis|0|||
17000671|NCT00597753|38144612|FG001|Overall Study|Discontinued Dialysis|1|||
17000672|NCT00597753|38144611|FG000|Overall Study|Never dosed|2|||
17000673|NCT00597753|38144612|FG001|Overall Study|Never dosed|0|||
17000674|NCT00597753|38144611|FG000|Overall Study|Noncompliance|2|||
17000675|NCT00597753|38144612|FG001|Overall Study|Noncompliance|1|||
17000676|NCT00597753|38144611|FG000|Overall Study|Relocation|17|||
17000677|NCT00597753|38144612|FG001|Overall Study|Relocation|6|||
17000678|NCT00597753|38144611|FG000|Overall Study|Renal transplant|10|||
17000679|NCT00597753|38144612|FG001|Overall Study|Renal transplant|3|||
17000680|NCT00597753|38144611|FG000|Overall Study|Site closed by sponsor|19|||
17000681|NCT00597753|38144612|FG001|Overall Study|Site closed by sponsor|7|||
17000682|NCT00597753|38144611|FG000|Overall Study|Site elected to close|2|||
17000683|NCT00597753|38144612|FG001|Overall Study|Site elected to close|4|||
17000684|NCT00665431|38144621|FG000|Overall Study|Adverse Event|16|||
17000685|NCT00665431|38144622|FG001|Overall Study|Adverse Event|22|||
17000686|NCT00665431|38144623|FG002|Overall Study|Adverse Event|6|||
17000687|NCT00665431|38144621|FG000|Overall Study|Withdrawal by Subject|17|||
17000688|NCT00665431|38144622|FG001|Overall Study|Withdrawal by Subject|25|||
17000689|NCT00665431|38144623|FG002|Overall Study|Withdrawal by Subject|15|||
17000690|NCT00665431|38144621|FG000|Overall Study|Lost to Follow-up|3|||
17000691|NCT00665431|38144622|FG001|Overall Study|Lost to Follow-up|3|||
17000692|NCT00665431|38144623|FG002|Overall Study|Lost to Follow-up|1|||
17000693|NCT00665431|38144621|FG000|Overall Study|Other|4|||
17000694|NCT00665431|38144622|FG001|Overall Study|Other|7|||
17000695|NCT00665431|38144623|FG002|Overall Study|Other|2|||
17000696|NCT00934622|38144631|FG000|Overall Study|Lost to Follow-up|7|||
17000697|NCT00934622|38144631|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
17000698|NCT00881361|38144637|FG000|Overall Study|Terminated prior to surgery|27|||
17000699|NCT00881361|38144638|FG001|Overall Study|Terminated prior to surgery|7|||
17000700|NCT00881361|38144639|FG002|Overall Study|Terminated prior to surgery|0|||
17000701|NCT00881361|38144637|FG000|Overall Study|Ineligible|17|||
17000702|NCT00881361|38144638|FG001|Overall Study|Ineligible|2|||
17000703|NCT00881361|38144639|FG002|Overall Study|Ineligible|2|||
17000704|NCT01000727|38144650|FG000|Overall Study|Lost to Follow-up|41|||
17000705|NCT01000727|38144651|FG001|Overall Study|Lost to Follow-up|43|||
17000706|NCT01000727|38144650|FG000|Overall Study|Withdrawal by Subject|111|||
17000707|NCT01000727|38144651|FG001|Overall Study|Withdrawal by Subject|109|||
17000708|NCT01000727|38144650|FG000|Overall Study|Study closed/terminated|23|||
17000709|NCT01000727|38144651|FG001|Overall Study|Study closed/terminated|24|||
17000710|NCT00881205|38144661|FG000|Overall Study|Adverse Event|8|||
17000711|NCT00881205|38144662|FG001|Overall Study|Adverse Event|3|||
17000712|NCT00881205|38144661|FG000|Overall Study|Withdrawal by Subject|1|||
17000713|NCT00881205|38144662|FG001|Overall Study|Withdrawal by Subject|2|||
17000714|NCT00881205|38144661|FG000|Overall Study|Lost to Follow-up|0|||
17000715|NCT00881205|38144662|FG001|Overall Study|Lost to Follow-up|1|||
17000716|NCT00881205|38144661|FG000|Overall Study|Administrative problems|1|||
17094709|NCT00195260|38233946|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
17094710|NCT00195260|38233947|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
17094711|NCT00195260|38233948|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
17094712|NCT00031486|38233978|FG000|Overall Study|Adverse Event|1|||
17094713|NCT00031486|38233979|FG001|Overall Study|Adverse Event|0|||
17094714|NCT00031486|38233978|FG000|Overall Study|Lost to Follow-up|0|||
17000717|NCT00881205|38144662|FG001|Overall Study|Administrative problems|1|||
17000718|NCT00881205|38144661|FG000|Overall Study|Condition no longer requires drug|1|||
17000719|NCT00881205|38144662|FG001|Overall Study|Condition no longer requires drug|0|||
17000720|NCT00879879|38144669|FG000|Overall Study|Death|1|||
17094715|NCT00031486|38233979|FG001|Overall Study|Lost to Follow-up|1|||
17094716|NCT00031486|38233978|FG000|Overall Study|Withdrawal by Subject|3|||
17094717|NCT00031486|38233979|FG001|Overall Study|Withdrawal by Subject|2|||
17094718|NCT00031486|38233978|FG000|Overall Study|Death|0|||
17094719|NCT00031486|38233979|FG001|Overall Study|Death|3|||
17094720|NCT00031486|38233978|FG000|Overall Study|Non-compliant|0|||
17094721|NCT00031486|38233979|FG001|Overall Study|Non-compliant|4|||
17094722|NCT00031486|38233978|FG000|Overall Study|Did not meet eligibility requirement|2|||
17094723|NCT00031486|38233979|FG001|Overall Study|Did not meet eligibility requirement|1|||
17000721|NCT00879879|38144669|FG000|Overall Study|Withdrawal by Subject|1|||
17000722|NCT00879879|38144669|FG000|Overall Study|Physician Decision|1|||
17000723|NCT00661999|38144678|FG000|Overall Study|Adverse Event|11|||
17000724|NCT00661999|38144679|FG001|Overall Study|Adverse Event|5|||
17000725|NCT00661999|38144680|FG002|Overall Study|Adverse Event|8|||
17000726|NCT00661999|38144678|FG000|Overall Study|Death|8|||
17000727|NCT00661999|38144679|FG001|Overall Study|Death|6|||
17094724|NCT00031486|38233978|FG000|Overall Study|Other|1|||
17094725|NCT00031486|38233979|FG001|Overall Study|Other|1|||
17094726|NCT00003508|38233987|FG000|Overall Study|Not evaluable|5|||
17000728|NCT00661999|38144680|FG002|Overall Study|Death|3|||
17000729|NCT00661999|38144678|FG000|Overall Study|Other Reasons|5|||
17000730|NCT00661999|38144679|FG001|Overall Study|Other Reasons|12|||
17000731|NCT00661999|38144680|FG002|Overall Study|Other Reasons|23|||
17000732|NCT00661999|38144678|FG000|Overall Study|Withdrawal by Subject|30|||
17000733|NCT00661999|38144679|FG001|Overall Study|Withdrawal by Subject|23|||
17000734|NCT00661999|38144680|FG002|Overall Study|Withdrawal by Subject|14|||
17000735|NCT00661999|38144678|FG000|Overall Study|Alternative Treatment|1|||
17000736|NCT00661999|38144679|FG001|Overall Study|Alternative Treatment|0|||
17000737|NCT00661999|38144680|FG002|Overall Study|Alternative Treatment|0|||
17000738|NCT00661999|38144678|FG000|Overall Study|Other Medical Problems|4|||
17000739|NCT00661999|38144679|FG001|Overall Study|Other Medical Problems|4|||
17000740|NCT00661999|38144680|FG002|Overall Study|Other Medical Problems|9|||
17000741|NCT00665353|38144688|FG000|Study Step 1|Adverse Event|1|||
17000742|NCT00665353|38144688|FG000|Study Step 1|Withdrawal by Subject|2|||
17000743|NCT00665353|38144688|FG000|Study Step 2|Lost to Follow-up|2|||
17000744|NCT00665353|38144688|FG000|Study Step 2|Lack of Efficacy|12|||
17000745|NCT00597207|38144694|FG000|Overall Study|Lost to Follow-up|5|||
17000746|NCT00597207|38144695|FG001|Overall Study|Lost to Follow-up|7|||
17000747|NCT00879645|38144705|FG000|Overall Study|Adverse Event|1|||
17000748|NCT00879645|38144706|FG001|Overall Study|Adverse Event|0|||
17000749|NCT00879645|38144707|FG002|Overall Study|Adverse Event|0|||
17000750|NCT00879645|38144708|FG003|Overall Study|Adverse Event|0|||
17000751|NCT00664105|38144718|FG000|Overall Study|Death|3|||
17000752|NCT00664105|38144718|FG000|Overall Study|Withdrawal by Subject|5|||
17000753|NCT00664105|38144718|FG000|Overall Study|Adverse Event|9|||
17000754|NCT00664105|38144718|FG000|Overall Study|Disease progression|7|||
17000755|NCT00661687|38144723|FG000|Overall Study|Study related symptoms and complaints|5|||
17000756|NCT00661687|38144723|FG000|Overall Study|Positive slit lamp findings|4|||
17000757|NCT00661687|38144723|FG000|Overall Study|Inability to maintain wearing schedule|3|||
17000758|NCT00661687|38144723|FG000|Overall Study|Physician Decision|1|||
17000759|NCT00661687|38144723|FG000|Overall Study|Adverse Event|2|||
17000760|NCT00596817|38144732|FG000|Open-label Period|Adverse Event|0|||
17000761|NCT00596817|38144733|FG001|Open-label Period|Adverse Event|49|||
17000762|NCT00596817|38144732|FG000|Open-label Period|Lack of Efficacy|0|||
17000763|NCT00596817|38144733|FG001|Open-label Period|Lack of Efficacy|33|||
17000764|NCT00596817|38144732|FG000|Open-label Period|Other Reasons|0|||
17000765|NCT00596817|38144733|FG001|Open-label Period|Other Reasons|65|||
17000766|NCT00596817|38144732|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
17000767|NCT00596817|38144733|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
17000768|NCT00596817|38144732|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
17000769|NCT00596817|38144733|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
17000770|NCT00596817|38144732|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
17000771|NCT00596817|38144733|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
17000772|NCT00596817|38144732|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
17000773|NCT00596817|38144733|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
17000774|NCT00596817|38144732|FG000|Double-blind Period|Adverse Event|5|||
17000775|NCT00596817|38144733|FG001|Double-blind Period|Adverse Event|16|||
17000776|NCT00596817|38144732|FG000|Double-blind Period|Lack of Efficacy|52|||
17000777|NCT00596817|38144733|FG001|Double-blind Period|Lack of Efficacy|28|||
17000778|NCT00596817|38144732|FG000|Double-blind Period|Non-compliance With Study Product|3|||
17000779|NCT00596817|38144733|FG001|Double-blind Period|Non-compliance With Study Product|4|||
17000780|NCT00596817|38144732|FG000|Double-blind Period|Protocol Violation|11|||
17000781|NCT00596817|38144733|FG001|Double-blind Period|Protocol Violation|8|||
17000782|NCT00596817|38144732|FG000|Double-blind Period|Withdrawal of Consent|7|||
17000783|NCT00596817|38144733|FG001|Double-blind Period|Withdrawal of Consent|3|||
17000784|NCT00596817|38144732|FG000|Double-blind Period|Lost to Follow-up|0|||
17000785|NCT00596817|38144733|FG001|Double-blind Period|Lost to Follow-up|2|||
17000786|NCT00596817|38144732|FG000|Double-blind Period|Other Reasons|10|||
17094727|NCT00003472|38233991|FG000|Overall Study|Not evaluable|3|||
17000787|NCT00596817|38144733|FG001|Double-blind Period|Other Reasons|18|||
17000788|NCT01000649|38144744|FG000|Overall Study|Adverse Event|5|||
17000789|NCT01000649|38144745|FG001|Overall Study|Adverse Event|1|||
17000790|NCT01000649|38144746|FG002|Overall Study|Adverse Event|2|||
17000791|NCT01000649|38144747|FG003|Overall Study|Adverse Event|4|||
17000792|NCT01000649|38144744|FG000|Overall Study|Lost to Follow-up|0|||
17000793|NCT01000649|38144745|FG001|Overall Study|Lost to Follow-up|2|||
17094728|NCT00003298|38233995|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
17094729|NCT00003298|38233995|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
17000794|NCT01000649|38144746|FG002|Overall Study|Lost to Follow-up|0|||
17000795|NCT01000649|38144747|FG003|Overall Study|Lost to Follow-up|2|||
17000796|NCT00666835|38144758|FG000|Overall Study|Withdrawal by Subject|5|||
17000797|NCT00666835|38144759|FG001|Overall Study|Withdrawal by Subject|2|||
17000798|NCT00666835|38144758|FG000|Overall Study|Lack of Efficacy|0|||
17000799|NCT00666835|38144759|FG001|Overall Study|Lack of Efficacy|1|||
17000800|NCT00666835|38144758|FG000|Overall Study|Incl./excl. not fulfilled|7|||
17000801|NCT00666835|38144759|FG001|Overall Study|Incl./excl. not fulfilled|2|||
17000802|NCT00666835|38144758|FG000|Overall Study|Adverse Event|7|||
17000803|NCT00666835|38144759|FG001|Overall Study|Adverse Event|6|||
17000804|NCT00666835|38144758|FG000|Overall Study|Protocol Violation|2|||
17000805|NCT00666835|38144759|FG001|Overall Study|Protocol Violation|0|||
17000806|NCT00666835|38144758|FG000|Overall Study|Death|15|||
17000807|NCT00666835|38144759|FG001|Overall Study|Death|4|||
17000808|NCT00666835|38144758|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
17000809|NCT00666835|38144759|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
17000810|NCT00666835|38144758|FG000|Overall Study|Hemoglobulin concentration|4|||
17000811|NCT00666835|38144759|FG001|Overall Study|Hemoglobulin concentration|3|||
17000812|NCT00666835|38144758|FG000|Overall Study|Planned operation|2|||
17000813|NCT00666835|38144759|FG001|Overall Study|Planned operation|0|||
17094730|NCT00003298|38233995|FG000|Surgery|Unresectable at surgery|3|||
17094731|NCT00003298|38233995|FG000|Surgery|Progression before surgery|2|||
17094732|NCT00003298|38233995|FG000|Surgery|Unevaluable and off study|2|||
17094733|NCT00003298|38233995|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
17000814|NCT00666835|38144758|FG000|Overall Study|Physician Decision|1|||
17000815|NCT00666835|38144759|FG001|Overall Study|Physician Decision|2|||
17000816|NCT00879411|38144766|FG000|Overall Study|lost to follow-up (non-AE)|162|||
17000817|NCT01000493|38144772|FG000|Overall Study|Adverse Event|3|||
17000818|NCT01000493|38144773|FG001|Overall Study|Adverse Event|6|||
17000819|NCT01000493|38144772|FG000|Overall Study|Lack of Efficacy|1|||
17000820|NCT01000493|38144773|FG001|Overall Study|Lack of Efficacy|1|||
17000821|NCT01000493|38144772|FG000|Overall Study|Protocol Violation|1|||
17000822|NCT01000493|38144773|FG001|Overall Study|Protocol Violation|8|||
17000823|NCT01000493|38144772|FG000|Overall Study|Study closed/terminated|25|||
17000824|NCT01000493|38144773|FG001|Overall Study|Study closed/terminated|23|||
17000825|NCT01000493|38144772|FG000|Overall Study|Lost to Follow-up|5|||
17000826|NCT01000493|38144773|FG001|Overall Study|Lost to Follow-up|9|||
17000827|NCT01000493|38144772|FG000|Overall Study|Physician Decision|1|||
17000828|NCT01000493|38144773|FG001|Overall Study|Physician Decision|1|||
17000829|NCT01000493|38144772|FG000|Overall Study|Withdrawal by Subject|3|||
17000830|NCT01000493|38144773|FG001|Overall Study|Withdrawal by Subject|7|||
17000831|NCT00666757|38144781|FG000|Overall Study|Lost to Follow-up|39|||
17000832|NCT00666757|38144782|FG001|Overall Study|Lost to Follow-up|35|||
17000833|NCT00666757|38144781|FG000|Overall Study|Protocol Violation|23|||
17000834|NCT00666757|38144782|FG001|Overall Study|Protocol Violation|24|||
17000835|NCT00666757|38144781|FG000|Overall Study|Adverse Event|22|||
17000836|NCT00666757|38144782|FG001|Overall Study|Adverse Event|12|||
17000837|NCT00666757|38144781|FG000|Overall Study|Withdrawal by Subject|13|||
17000838|NCT00666757|38144782|FG001|Overall Study|Withdrawal by Subject|17|||
17094734|NCT00003298|38233995|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
17094735|NCT00003298|38233995|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
17190943|NCT01345253|38343782|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
17190944|NCT01345253|38343781|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
17190945|NCT01345253|38343782|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
17190946|NCT01345253|38343781|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
17190947|NCT01345253|38343782|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
17190948|NCT01345253|38343781|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
17000839|NCT00666757|38144781|FG000|Overall Study|Lack of Efficacy|3|||
17000840|NCT00666757|38144782|FG001|Overall Study|Lack of Efficacy|6|||
17000841|NCT00666757|38144781|FG000|Overall Study|Physician Decision|0|||
17000842|NCT00666757|38144782|FG001|Overall Study|Physician Decision|2|||
17000843|NCT00666757|38144781|FG000|Overall Study|Sponsor decision|0|||
17000844|NCT00666757|38144782|FG001|Overall Study|Sponsor decision|1|||
17000845|NCT01000337|38144793|FG000|Overall Study|Lost to Follow-up|4|||
17000846|NCT01000337|38144794|FG001|Overall Study|Lost to Follow-up|3|||
17094736|NCT00003298|38233995|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
17094737|NCT00003298|38233995|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
17000847|NCT00666679|38144802|FG000|First Intervention|Lost to Follow-up|1|||
17000848|NCT00666679|38144803|FG001|First Intervention|Lost to Follow-up|0|||
17094738|NCT00003298|38233995|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
17094739|NCT00003298|38233995|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
17094740|NCT00003298|38233995|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
17000849|NCT00666679|38144802|FG000|First Intervention|Protocol Violation|1|||
17094741|NCT00003298|38233995|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
17094742|NCT00003298|38233995|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
17000850|NCT00666679|38144803|FG001|First Intervention|Protocol Violation|0|||
17000851|NCT00666679|38144802|FG000|First Intervention|Withdrawal by Subject|1|||
16868378|NCT01533935|37841438|FG002|Overall Study|Lost to Follow-up|1|||
16868379|NCT01533935|37841439|FG003|Overall Study|Lost to Follow-up|0|||
16868380|NCT01533935|37841440|FG004|Overall Study|Lost to Follow-up|0|||
16868381|NCT01533935|37841436|FG000|Overall Study|Withdrawal by Subject|0|||
16868382|NCT01533935|37841437|FG001|Overall Study|Withdrawal by Subject|4|||
16868383|NCT01533935|37841438|FG002|Overall Study|Withdrawal by Subject|5|||
16868384|NCT01533935|37841439|FG003|Overall Study|Withdrawal by Subject|2|||
16868385|NCT01533935|37841440|FG004|Overall Study|Withdrawal by Subject|4|||
16868386|NCT01533935|37841436|FG000|Overall Study|Other reason not defined above|1|||
16868387|NCT01533935|37841437|FG001|Overall Study|Other reason not defined above|0|||
16868388|NCT01533935|37841438|FG002|Overall Study|Other reason not defined above|1|||
16868389|NCT01533935|37841439|FG003|Overall Study|Other reason not defined above|0|||
16868390|NCT01533935|37841440|FG004|Overall Study|Other reason not defined above|1|||
16868391|NCT01532999|37841454|FG000|Overall Study|Lost to Follow-up|14|||
16868392|NCT01532999|37841455|FG001|Overall Study|Lost to Follow-up|8|||
16868393|NCT01532999|37841454|FG000|Overall Study|Physician Decision|1|||
16868394|NCT01532999|37841455|FG001|Overall Study|Physician Decision|2|||
16868395|NCT01532999|37841454|FG000|Overall Study|Withdrawal by Subject|5|||
16868396|NCT01532999|37841455|FG001|Overall Study|Withdrawal by Subject|0|||
16868397|NCT01532999|37841454|FG000|Overall Study|Relocated|2|||
16868398|NCT01532999|37841455|FG001|Overall Study|Relocated|0|||
16868399|NCT01532999|37841454|FG000|Overall Study|should not have been randomized|1|||
16868400|NCT01532999|37841455|FG001|Overall Study|should not have been randomized|0|||
16868401|NCT01532999|37841454|FG000|Overall Study|substantial noncompliance|2|||
16868402|NCT01532999|37841455|FG001|Overall Study|substantial noncompliance|0|||
16868403|NCT01532999|37841454|FG000|Overall Study|no show for week 9 assessments|6|||
16868404|NCT01532999|37841455|FG001|Overall Study|no show for week 9 assessments|4|||
16868405|NCT01532999|37841454|FG000|Overall Study|Adverse Event|0|||
16868406|NCT01532999|37841455|FG001|Overall Study|Adverse Event|1|||
16868407|NCT01532999|37841454|FG000|Overall Study|incarcerated|0|||
16868408|NCT01532999|37841455|FG001|Overall Study|incarcerated|1|||
16868409|NCT01532999|37841454|FG000|Overall Study|New job|0|||
16868410|NCT01532999|37841455|FG001|Overall Study|New job|2|||
16868411|NCT01532921|37841461|FG000|Overall Study|Death|3|||
16868412|NCT01532921|37841461|FG000|Overall Study|Withdrawal by Subject|2|||
16868413|NCT01532921|37841461|FG000|Overall Study|Lost to Follow-up|3|||
16868414|NCT01532921|37841461|FG000|Overall Study|Physician Decision|7|||
16868415|NCT01532921|37841461|FG000|Overall Study|Device was explanted during procedure|1|||
16868416|NCT01532687|37841471|FG000|Overall Study|Death|2|||
16868417|NCT01532687|37841472|FG001|Overall Study|Death|0|||
16868418|NCT01532687|37841471|FG000|Overall Study|Adverse Event|6|||
16868419|NCT01532687|37841472|FG001|Overall Study|Adverse Event|1|||
16868420|NCT01532687|37841471|FG000|Overall Study|Withdrawal by Subject|1|||
16868421|NCT01532687|37841472|FG001|Overall Study|Withdrawal by Subject|0|||
16868422|NCT01532687|37841471|FG000|Overall Study|Physician Decision|2|||
16868423|NCT01532687|37841472|FG001|Overall Study|Physician Decision|1|||
16868424|NCT01532687|37841471|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
16868425|NCT01532687|37841472|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
16868426|NCT02677116|37841489|FG000|Overall Study|Adverse Event|0|||
16868427|NCT02677116|37841490|FG001|Overall Study|Adverse Event|1|||
16868428|NCT02677116|37841491|FG002|Overall Study|Adverse Event|0|||
16868429|NCT02677116|37841492|FG003|Overall Study|Adverse Event|0|||
16868430|NCT02677116|37841493|FG004|Overall Study|Adverse Event|0|||
16868431|NCT02677116|37841494|FG005|Overall Study|Adverse Event|1|||
16868432|NCT02677116|37841495|FG006|Overall Study|Adverse Event|1|||
16868433|NCT02677116|37841496|FG007|Overall Study|Adverse Event|0|||
16868434|NCT02677116|37841497|FG008|Overall Study|Adverse Event|0|||
16868435|NCT02677116|37841489|FG000|Overall Study|Physician Decision|0|||
16868436|NCT02677116|37841490|FG001|Overall Study|Physician Decision|2|||
16868437|NCT02677116|37841491|FG002|Overall Study|Physician Decision|3|||
16868438|NCT02677116|37841492|FG003|Overall Study|Physician Decision|2|||
16868439|NCT02677116|37841493|FG004|Overall Study|Physician Decision|1|||
16868440|NCT02677116|37841494|FG005|Overall Study|Physician Decision|3|||
16868441|NCT02677116|37841495|FG006|Overall Study|Physician Decision|1|||
17000852|NCT00666679|38144803|FG001|First Intervention|Withdrawal by Subject|0|||
16868442|NCT02677116|37841496|FG007|Overall Study|Physician Decision|1|||
16868443|NCT02677116|37841497|FG008|Overall Study|Physician Decision|2|||
16868444|NCT02677116|37841489|FG000|Overall Study|Withdrawal by parent or guardian|2|||
16868445|NCT02677116|37841490|FG001|Overall Study|Withdrawal by parent or guardian|1|||
16868446|NCT02677116|37841491|FG002|Overall Study|Withdrawal by parent or guardian|0|||
16868447|NCT02677116|37841492|FG003|Overall Study|Withdrawal by parent or guardian|1|||
16868448|NCT02677116|37841493|FG004|Overall Study|Withdrawal by parent or guardian|0|||
16868449|NCT02677116|37841494|FG005|Overall Study|Withdrawal by parent or guardian|0|||
16868450|NCT02677116|37841495|FG006|Overall Study|Withdrawal by parent or guardian|2|||
16868451|NCT02677116|37841496|FG007|Overall Study|Withdrawal by parent or guardian|1|||
16868452|NCT02677116|37841497|FG008|Overall Study|Withdrawal by parent or guardian|0|||
16868453|NCT02677116|37841489|FG000|Overall Study|Withdrawal by Subject|1|||
16868454|NCT02677116|37841490|FG001|Overall Study|Withdrawal by Subject|0|||
16868455|NCT02677116|37841491|FG002|Overall Study|Withdrawal by Subject|0|||
16868456|NCT02677116|37841492|FG003|Overall Study|Withdrawal by Subject|0|||
16868457|NCT02677116|37841493|FG004|Overall Study|Withdrawal by Subject|0|||
16868458|NCT02677116|37841494|FG005|Overall Study|Withdrawal by Subject|0|||
16868459|NCT02677116|37841495|FG006|Overall Study|Withdrawal by Subject|0|||
16868460|NCT02677116|37841496|FG007|Overall Study|Withdrawal by Subject|0|||
16868461|NCT02677116|37841497|FG008|Overall Study|Withdrawal by Subject|0|||
16868462|NCT02689518|37841540|FG000|Overall Study|Withdrawal by Subject|3|||
16868463|NCT02681094|37841547|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
16868464|NCT02681094|37841548|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
16868465|NCT02681094|37841549|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
16868466|NCT02681094|37841547|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
16868467|NCT02681094|37841548|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
16868468|NCT02681094|37841549|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
16868469|NCT02681094|37841547|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
16868470|NCT02681094|37841548|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
16868471|NCT02681094|37841549|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
16868472|NCT02681094|37841547|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
16868473|NCT02681094|37841548|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
16868474|NCT02681094|37841549|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
16868475|NCT02681094|37841547|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
16868476|NCT02681094|37841548|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
16868477|NCT02681094|37841549|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
16868478|NCT02681094|37841547|FG000|1 -Modified Enrolled Participants Set|Other|6|||
16868479|NCT02681094|37841548|FG001|1 -Modified Enrolled Participants Set|Other|6|||
16868480|NCT02681094|37841549|FG002|1 -Modified Enrolled Participants Set|Other|7|||
16868481|NCT02681094|37841547|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
16868482|NCT02681094|37841548|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
16868483|NCT02681094|37841549|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
16868484|NCT02681094|37841547|FG000|2 - Enrolled Participants Set|Participant decision|7|||
16868485|NCT02681094|37841548|FG001|2 - Enrolled Participants Set|Participant decision|10|||
16868486|NCT02681094|37841549|FG002|2 - Enrolled Participants Set|Participant decision|9|||
16868487|NCT02681094|37841547|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
16868488|NCT02681094|37841548|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
16868489|NCT02681094|37841549|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
16868490|NCT02681094|37841547|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
16868491|NCT02681094|37841548|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
16868492|NCT02681094|37841549|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
16868493|NCT02681094|37841547|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
16868494|NCT02681094|37841548|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
16868495|NCT02681094|37841549|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
16868496|NCT02681094|37841547|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
16868497|NCT02681094|37841548|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
16868498|NCT02681094|37841549|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
16868499|NCT02681094|37841547|FG000|2 - Enrolled Participants Set|Other|6|||
16868500|NCT02681094|37841548|FG001|2 - Enrolled Participants Set|Other|6|||
16868501|NCT02681094|37841549|FG002|2 - Enrolled Participants Set|Other|7|||
16868502|NCT02681094|37841547|FG000|2 - Enrolled Participants Set|No treatment given|0|||
16868503|NCT02681094|37841548|FG001|2 - Enrolled Participants Set|No treatment given|1|||
16868504|NCT02681094|37841549|FG002|2 - Enrolled Participants Set|No treatment given|1|||
16868505|NCT02689284|37841560|FG000|Overall Study|Adverse Event|1|||
16868506|NCT02689284|37841561|FG001|Overall Study|Adverse Event|8|||
16868507|NCT02689284|37841560|FG000|Overall Study|Death|0|||
16868508|NCT02689284|37841561|FG001|Overall Study|Death|1|||
16868509|NCT02689284|37841560|FG000|Overall Study|Physician Decision|1|||
16868510|NCT02689284|37841561|FG001|Overall Study|Physician Decision|2|||
16868511|NCT02689284|37841560|FG000|Overall Study|Withdrawal by Subject|0|||
16868512|NCT02689284|37841561|FG001|Overall Study|Withdrawal by Subject|1|||
16868513|NCT02689284|37841560|FG000|Overall Study|progression of cancer|1|||
16868514|NCT02689284|37841561|FG001|Overall Study|progression of cancer|72|||
16868515|NCT02689284|37841560|FG000|Overall Study|decreased heart function|0|||
16868516|NCT02689284|37841561|FG001|Overall Study|decreased heart function|1|||
16868517|NCT02689284|37841560|FG000|Overall Study|concern for anemia|0|||
16868518|NCT02689284|37841561|FG001|Overall Study|concern for anemia|1|||
16868519|NCT02689284|37841560|FG000|Overall Study|no measurable cancer for evaluation|0|||
16868520|NCT02689284|37841561|FG001|Overall Study|no measurable cancer for evaluation|1|||
16868521|NCT02676882|37841570|FG000|Overall Study|Adverse Event|1|||
16868522|NCT02676882|37841571|FG001|Overall Study|Adverse Event|0|||
16868523|NCT02676882|37841570|FG000|Overall Study|Lost to Follow-up|1|||
16784105|NCT02031640|37723999|FG001|Run-In Period|Randomization criteria not met|0|||
16784106|NCT02031640|37724000|FG002|Run-In Period|Randomization criteria not met|0|||
16784107|NCT02031640|37724001|FG003|Run-In Period|Randomization criteria not met|0|||
16784108|NCT02031640|37724002|FG004|Run-In Period|Randomization criteria not met|0|||
16784109|NCT02031640|37724003|FG005|Run-In Period|Randomization criteria not met|0|||
16784110|NCT02031640|37723998|FG000|Run-In Period|Various administrative reasons|17|||
16868524|NCT02676882|37841571|FG001|Overall Study|Lost to Follow-up|0|||
16868525|NCT02676882|37841570|FG000|Overall Study|Withdrawal by Subject|1|||
16868526|NCT02676882|37841571|FG001|Overall Study|Withdrawal by Subject|2|||
16868527|NCT02674386|37841580|FG000|Overall Study|Lost to Follow-up|0|||
16868528|NCT02674386|37841581|FG001|Overall Study|Lost to Follow-up|1|||
16868529|NCT02674386|37841582|FG002|Overall Study|Lost to Follow-up|1|||
16868530|NCT02674386|37841580|FG000|Overall Study|Withdrawal by Subject|0|||
16868531|NCT02674386|37841581|FG001|Overall Study|Withdrawal by Subject|4|||
16868532|NCT02674386|37841582|FG002|Overall Study|Withdrawal by Subject|0|||
16868533|NCT02674386|37841580|FG000|Overall Study|Other|0|||
16868534|NCT02674386|37841581|FG001|Overall Study|Other|1|||
16868535|NCT02674386|37841582|FG002|Overall Study|Other|0|||
16868536|NCT02674386|37841580|FG000|Overall Study|Enrolled but not evaluated|0|||
16868537|NCT02674386|37841581|FG001|Overall Study|Enrolled but not evaluated|4|||
16868538|NCT02674386|37841582|FG002|Overall Study|Enrolled but not evaluated|0|||
16868539|NCT02680002|37841601|FG000|Overall Study|Lost to Follow-up|5|||
16868540|NCT02680002|37841602|FG001|Overall Study|Lost to Follow-up|1|||
16868541|NCT02680002|37841603|FG002|Overall Study|Lost to Follow-up|4|||
16868542|NCT02680002|37841604|FG003|Overall Study|Lost to Follow-up|2|||
16868543|NCT02680002|37841605|FG004|Overall Study|Lost to Follow-up|0|||
16868544|NCT02680002|37841606|FG005|Overall Study|Lost to Follow-up|2|||
16868545|NCT02680002|37841601|FG000|Overall Study|Physician Decision|5|||
16868546|NCT02680002|37841602|FG001|Overall Study|Physician Decision|1|||
16868547|NCT02680002|37841603|FG002|Overall Study|Physician Decision|1|||
16868548|NCT02680002|37841604|FG003|Overall Study|Physician Decision|1|||
16868549|NCT02680002|37841605|FG004|Overall Study|Physician Decision|1|||
16868550|NCT02680002|37841606|FG005|Overall Study|Physician Decision|1|||
16868551|NCT02680002|37841601|FG000|Overall Study|Protocol Violation|1|||
16868552|NCT02680002|37841602|FG001|Overall Study|Protocol Violation|0|||
16868553|NCT02680002|37841603|FG002|Overall Study|Protocol Violation|1|||
16868554|NCT02680002|37841604|FG003|Overall Study|Protocol Violation|0|||
16868555|NCT02680002|37841605|FG004|Overall Study|Protocol Violation|1|||
16868556|NCT02680002|37841606|FG005|Overall Study|Protocol Violation|2|||
16868557|NCT02680002|37841601|FG000|Overall Study|Withdrawal by Subject|0|||
16868558|NCT02680002|37841602|FG001|Overall Study|Withdrawal by Subject|0|||
16868559|NCT02680002|37841603|FG002|Overall Study|Withdrawal by Subject|1|||
16868560|NCT02680002|37841604|FG003|Overall Study|Withdrawal by Subject|0|||
16868561|NCT02680002|37841605|FG004|Overall Study|Withdrawal by Subject|2|||
16868562|NCT02680002|37841606|FG005|Overall Study|Withdrawal by Subject|2|||
16868563|NCT02680002|37841601|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
16868564|NCT02680002|37841602|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
16868565|NCT02680002|37841603|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
16868566|NCT02680002|37841604|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
16868567|NCT02680002|37841605|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
16868568|NCT02680002|37841606|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
16868569|NCT02680002|37841601|FG000|Overall Study|Other|0|||
16868570|NCT02680002|37841602|FG001|Overall Study|Other|1|||
16868571|NCT02680002|37841603|FG002|Overall Study|Other|0|||
16868572|NCT02680002|37841604|FG003|Overall Study|Other|0|||
16868573|NCT02680002|37841605|FG004|Overall Study|Other|1|||
16784111|NCT02031640|37723999|FG001|Run-In Period|Various administrative reasons|0|||
16784112|NCT02031640|37724000|FG002|Run-In Period|Various administrative reasons|0|||
16784113|NCT02031640|37724001|FG003|Run-In Period|Various administrative reasons|0|||
16784114|NCT02031640|37724002|FG004|Run-In Period|Various administrative reasons|0|||
16784115|NCT02031640|37724003|FG005|Run-In Period|Various administrative reasons|0|||
16784116|NCT02031640|37723998|FG000|Double-blind Treatment Period|Protocol deviation|0|||
16784117|NCT02031640|37723999|FG001|Double-blind Treatment Period|Protocol deviation|2|||
16784118|NCT02031640|37724000|FG002|Double-blind Treatment Period|Protocol deviation|0|||
16784119|NCT02031640|37724001|FG003|Double-blind Treatment Period|Protocol deviation|1|||
16784120|NCT02031640|37724002|FG004|Double-blind Treatment Period|Protocol deviation|3|||
16784121|NCT02031640|37724003|FG005|Double-blind Treatment Period|Protocol deviation|1|||
16784122|NCT02031640|37723998|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16784123|NCT02031640|37723999|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
16868574|NCT02680002|37841606|FG005|Overall Study|Other|0|||
16868575|NCT02680002|37841601|FG000|Overall Study|Adverse Event|0|||
16868576|NCT02680002|37841602|FG001|Overall Study|Adverse Event|0|||
16868577|NCT02680002|37841603|FG002|Overall Study|Adverse Event|0|||
16868578|NCT02680002|37841604|FG003|Overall Study|Adverse Event|0|||
16868579|NCT02680002|37841605|FG004|Overall Study|Adverse Event|1|||
16868580|NCT02680002|37841606|FG005|Overall Study|Adverse Event|2|||
16868581|NCT04557384|37841623|FG000|Overall Study|Study Terminated by Sponsor|1|||
16868582|NCT04557384|37841623|FG000|Overall Study|Death|1|||
16868583|NCT02673684|37841629|FG000|Overall Study|Study not completed d/t loss of funding|9|||
16868584|NCT02673684|37841630|FG001|Overall Study|Study not completed d/t loss of funding|8|||
16868585|NCT02675634|37841638|FG000|Test Period 1|Adverse Event|0|||
16868586|NCT02675634|37841639|FG001|Test Period 1|Adverse Event|1|||
16868587|NCT02675634|37841640|FG002|Test Period 1|Adverse Event|0|||
16868588|NCT02675634|37841641|FG003|Test Period 1|Adverse Event|1|||
16868589|NCT02675634|37841642|FG004|Test Period 1|Adverse Event|0|||
16868590|NCT02675634|37841643|FG005|Test Period 1|Adverse Event|0|||
16868591|NCT02675634|37841638|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
16868592|NCT02675634|37841639|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
16868593|NCT02675634|37841640|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
16868594|NCT02675634|37841641|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
16868595|NCT02675634|37841642|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
16868596|NCT02675634|37841643|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
16868597|NCT02675634|37841638|FG000|Test Period 2|Lack of Efficacy|1|||
16868598|NCT02675634|37841639|FG001|Test Period 2|Lack of Efficacy|0|||
16868599|NCT02675634|37841640|FG002|Test Period 2|Lack of Efficacy|0|||
16868600|NCT02675634|37841641|FG003|Test Period 2|Lack of Efficacy|0|||
16868601|NCT02675634|37841642|FG004|Test Period 2|Lack of Efficacy|0|||
16868602|NCT02675634|37841643|FG005|Test Period 2|Lack of Efficacy|0|||
16868603|NCT02675634|37841638|FG000|Test Period 2|Adverse Event|0|||
16868604|NCT02675634|37841639|FG001|Test Period 2|Adverse Event|0|||
16868605|NCT02675634|37841640|FG002|Test Period 2|Adverse Event|0|||
16868606|NCT02675634|37841641|FG003|Test Period 2|Adverse Event|0|||
16868607|NCT02675634|37841642|FG004|Test Period 2|Adverse Event|0|||
16868608|NCT02675634|37841643|FG005|Test Period 2|Adverse Event|1|||
16868609|NCT02671500|37841651|FG000|Overall Study|Lack of Efficacy|12|||
16868610|NCT02671500|37841651|FG000|Overall Study|Lost to Follow-up|2|||
16868611|NCT02671422|37841659|FG000|Overall Study|Lost to Follow-up|1|||
16868612|NCT02671422|37841659|FG000|Overall Study|Adverse Event|68|||
16868613|NCT02671422|37841659|FG000|Overall Study|Lack of Efficacy|1|||
16784124|NCT02031640|37724000|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
16784125|NCT02031640|37724001|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
16784126|NCT02031640|37724002|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
16784127|NCT02031640|37724003|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
16784128|NCT02031640|37723998|FG000|Double-blind Treatment Period|Non-compliance|0|||
16784129|NCT02031640|37723999|FG001|Double-blind Treatment Period|Non-compliance|1|||
16784130|NCT02031640|37724000|FG002|Double-blind Treatment Period|Non-compliance|0|||
16784131|NCT02031640|37724001|FG003|Double-blind Treatment Period|Non-compliance|1|||
16784132|NCT02031640|37724002|FG004|Double-blind Treatment Period|Non-compliance|1|||
16784133|NCT02031640|37724003|FG005|Double-blind Treatment Period|Non-compliance|0|||
16784134|NCT02031640|37723998|FG000|Double-blind Treatment Period|Adverse Event|0|||
16784135|NCT02031640|37723999|FG001|Double-blind Treatment Period|Adverse Event|0|||
16784136|NCT02031640|37724000|FG002|Double-blind Treatment Period|Adverse Event|0|||
16784137|NCT02031640|37724001|FG003|Double-blind Treatment Period|Adverse Event|2|||
16784138|NCT02031640|37724002|FG004|Double-blind Treatment Period|Adverse Event|0|||
16784139|NCT02031640|37724003|FG005|Double-blind Treatment Period|Adverse Event|0|||
16784140|NCT02031640|37723998|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
16784141|NCT02031640|37723999|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
16784142|NCT02031640|37724000|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
16784143|NCT02031640|37724001|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
16868614|NCT02671422|37841659|FG000|Overall Study|Lost to Follow-up|4|||
16868615|NCT02671422|37841659|FG000|Overall Study|Withdrawal by Subject|7|||
16868616|NCT02671422|37841659|FG000|Overall Study|Progressive Disease|156|||
16868617|NCT02671422|37841659|FG000|Overall Study|Worsening of Disease|4|||
16868618|NCT02671422|37841659|FG000|Overall Study|Sponsor decision|5|||
16868619|NCT02671422|37841659|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
16868620|NCT02671422|37841659|FG000|Overall Study|Not treated with Vargatef®|3|||
16868621|NCT02671422|37841659|FG000|Overall Study|Other not defined above|3|||
16868622|NCT02671266|37841665|FG000|Overall Study|Withdrawal by Subject|1|||
16784144|NCT02031640|37724002|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
16784145|NCT02031640|37724003|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
16784146|NCT02031640|37723998|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16784147|NCT02031640|37723999|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
16784148|NCT02031640|37724000|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
16784149|NCT02031640|37724001|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
16868623|NCT02671266|37841666|FG001|Overall Study|Withdrawal by Subject|1|||
16868624|NCT03320070|37841674|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
16868625|NCT03320070|37841675|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
16784150|NCT02031640|37724002|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
16784151|NCT02031640|37724003|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
16784152|NCT02660489|37724029|FG000|Overall Study|Lost to Follow-up|1|||
16784153|NCT02660489|37724030|FG001|Overall Study|Lost to Follow-up|1|||
16784154|NCT02660489|37724029|FG000|Overall Study|Adverse Event|1|||
16784155|NCT02660489|37724030|FG001|Overall Study|Adverse Event|3|||
16784156|NCT02660489|37724029|FG000|Overall Study|no rhinovirus infection|4|||
16868626|NCT03320070|37841674|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
16868627|NCT03320070|37841675|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
16868628|NCT03320070|37841674|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
16868629|NCT03320070|37841675|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
16868630|NCT03320070|37841674|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
16868631|NCT03320070|37841675|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
16868632|NCT03320070|37841674|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
16868633|NCT03320070|37841675|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
16868634|NCT03320070|37841674|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
16868635|NCT03320070|37841675|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
16868636|NCT02667912|37841686|FG000|Overall Study|Death|3|||
16868637|NCT02667912|37841687|FG001|Overall Study|Death|1|||
16868638|NCT02667912|37841686|FG000|Overall Study|Withdrawal by Subject|1|||
16868639|NCT02667912|37841687|FG001|Overall Study|Withdrawal by Subject|2|||
16868640|NCT02667912|37841686|FG000|Overall Study|Withdrawal by Subject|1|||
16868641|NCT02667912|37841687|FG001|Overall Study|Withdrawal by Subject|0|||
16784157|NCT02660489|37724030|FG001|Overall Study|no rhinovirus infection|4|||
16784158|NCT02052310|37724038|FG000|Overall Study|Death|64|||
16868642|NCT01373346|37841693|FG000|Overall Study|Death|1|||
16868643|NCT03284424|37841704|FG000|Overall Study|Death|56|||
16868644|NCT03284424|37841705|FG001|Overall Study|Death|13|||
16868645|NCT03284424|37841704|FG000|Overall Study|Lost to Follow-up|1|||
16868646|NCT03284424|37841705|FG001|Overall Study|Lost to Follow-up|0|||
16868647|NCT03284424|37841704|FG000|Overall Study|Physician Decision|1|||
16868648|NCT03284424|37841705|FG001|Overall Study|Physician Decision|0|||
16868649|NCT03284424|37841704|FG000|Overall Study|Withdrawal by Subject|3|||
16868650|NCT03284424|37841705|FG001|Overall Study|Withdrawal by Subject|2|||
16868651|NCT03284424|37841704|FG000|Overall Study|Ongoing in study|44|||
16868652|NCT03284424|37841705|FG001|Overall Study|Ongoing in study|39|||
16868653|NCT02674854|37841713|FG000|Overall Study|Adverse Event|17|||
16868654|NCT02674854|37841714|FG001|Overall Study|Adverse Event|15|||
16868655|NCT02674854|37841715|FG002|Overall Study|Adverse Event|5|||
16868656|NCT02674854|37841713|FG000|Overall Study|Withdrawal by Subject|1|||
16868657|NCT02674854|37841714|FG001|Overall Study|Withdrawal by Subject|5|||
16868658|NCT02674854|37841715|FG002|Overall Study|Withdrawal by Subject|4|||
16868659|NCT02674854|37841713|FG000|Overall Study|No-compliant subject|1|||
16784159|NCT02052310|37724039|FG001|Overall Study|Death|54|||
16784160|NCT02052310|37724038|FG000|Overall Study|Withdrawal by Subject|37|||
16784161|NCT02052310|37724039|FG001|Overall Study|Withdrawal by Subject|49|||
16868660|NCT02674854|37841714|FG001|Overall Study|No-compliant subject|0|||
16868661|NCT02674854|37841715|FG002|Overall Study|No-compliant subject|1|||
16868662|NCT02674854|37841713|FG000|Overall Study|Lost to Follow-up|1|||
16868663|NCT02674854|37841714|FG001|Overall Study|Lost to Follow-up|0|||
16868664|NCT02674854|37841715|FG002|Overall Study|Lost to Follow-up|2|||
16868665|NCT02674854|37841713|FG000|Overall Study|Lack of Efficacy|0|||
16868666|NCT02674854|37841714|FG001|Overall Study|Lack of Efficacy|3|||
16868667|NCT02674854|37841715|FG002|Overall Study|Lack of Efficacy|0|||
16868668|NCT02674854|37841713|FG000|Overall Study|Disallowed Concurrent Medication|2|||
16868669|NCT02674854|37841714|FG001|Overall Study|Disallowed Concurrent Medication|2|||
16868670|NCT02674854|37841715|FG002|Overall Study|Disallowed Concurrent Medication|0|||
16868671|NCT02674854|37841713|FG000|Overall Study|Protocol Violation|1|||
16868672|NCT02674854|37841714|FG001|Overall Study|Protocol Violation|1|||
16868673|NCT02674854|37841715|FG002|Overall Study|Protocol Violation|2|||
16868674|NCT02674854|37841713|FG000|Overall Study|Death|0|||
16868675|NCT02674854|37841714|FG001|Overall Study|Death|1|||
16868676|NCT02674854|37841715|FG002|Overall Study|Death|0|||
16868677|NCT02674854|37841713|FG000|Overall Study|Subject missed V6.2|1|||
16868678|NCT02674854|37841714|FG001|Overall Study|Subject missed V6.2|0|||
16868679|NCT02674854|37841715|FG002|Overall Study|Subject missed V6.2|0|||
16868680|NCT02667288|37841723|FG000|Overall Study|Protocol Violation|5|||
16868681|NCT02667288|37841723|FG000|Overall Study|Lost to Follow-up|3|||
16868682|NCT02667288|37841723|FG000|Overall Study|Withdrawal by Subject|5|||
16868683|NCT02670330|37841729|FG000|Overall Study|Protocol Deviation|1|||
16868684|NCT02670330|37841730|FG001|Overall Study|Protocol Deviation|0|||
16784162|NCT02052310|37724038|FG000|Overall Study|Other than specified|32|||
16868685|NCT02670330|37841729|FG000|Overall Study|Study Terminated By Sponsor|36|||
16868686|NCT02670330|37841730|FG001|Overall Study|Study Terminated By Sponsor|43|||
16868687|NCT02670330|37841729|FG000|Overall Study|Adverse Event|1|||
16868688|NCT02670330|37841730|FG001|Overall Study|Adverse Event|3|||
16868689|NCT02670330|37841729|FG000|Overall Study|Withdrawal by Subject|34|||
16868690|NCT02670330|37841730|FG001|Overall Study|Withdrawal by Subject|29|||
16868691|NCT02670330|37841729|FG000|Overall Study|Lost to Follow-up|3|||
16868692|NCT02670330|37841730|FG001|Overall Study|Lost to Follow-up|2|||
16868693|NCT02669940|37841738|FG000|Overall Study|Failure to return|0|||
16868694|NCT02669940|37841739|FG001|Overall Study|Failure to return|3|||
16868695|NCT02669940|37841738|FG000|Overall Study|Insufficient follow-up data|1|||
16868696|NCT02669940|37841739|FG001|Overall Study|Insufficient follow-up data|0|||
16868697|NCT02669862|37841755|FG000|Overall Study|Lost to Follow-up|0|||
16868698|NCT02669862|37841756|FG001|Overall Study|Lost to Follow-up|2|||
16868699|NCT02669862|37841757|FG002|Overall Study|Lost to Follow-up|1|||
16868700|NCT02669862|37841755|FG000|Overall Study|Withdrawal by Subject|2|||
16868701|NCT02669862|37841756|FG001|Overall Study|Withdrawal by Subject|2|||
17000853|NCT00666679|38144802|FG000|First Intervention|Randomized did not start treatment|1|||
17190949|NCT01345253|38343782|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
17190950|NCT01345253|38343781|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
17190951|NCT01345253|38343782|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
17190952|NCT01345253|38343781|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
17190953|NCT01345253|38343782|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
17190954|NCT01345253|38343781|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
17190955|NCT01345253|38343782|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
17190956|NCT01345253|38343781|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
17190957|NCT01345253|38343782|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
17190958|NCT01345253|38343781|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
17190959|NCT01345253|38343782|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
17190960|NCT01345253|38343781|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
17190961|NCT01345253|38343782|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
17190962|NCT01345253|38343781|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
17190963|NCT01345253|38343782|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
17190964|NCT01345253|38343781|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
17190965|NCT01345253|38343782|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
17190966|NCT02958527|38343790|FG000|Overall Study|Not collected CRFs|12|||
17190967|NCT02477800|38343806|FG000|Placebo-Controlled Period|Adverse Event|16|||
17190968|NCT02477800|38343807|FG001|Placebo-Controlled Period|Adverse Event|25|||
17190969|NCT02477800|38343808|FG002|Placebo-Controlled Period|Adverse Event|28|||
17190970|NCT02477800|38343809|FG003|Placebo-Controlled Period|Adverse Event|0|||
17190971|NCT02477800|38343810|FG004|Placebo-Controlled Period|Adverse Event|0|||
17190972|NCT02477800|38343811|FG005|Placebo-Controlled Period|Adverse Event|0|||
17190973|NCT02477800|38343812|FG006|Placebo-Controlled Period|Adverse Event|0|||
17190974|NCT02477800|38343806|FG000|Placebo-Controlled Period|Change of Treatment|1|||
17190975|NCT02477800|38343807|FG001|Placebo-Controlled Period|Change of Treatment|2|||
17190976|NCT02477800|38343808|FG002|Placebo-Controlled Period|Change of Treatment|1|||
17190977|NCT02477800|38343809|FG003|Placebo-Controlled Period|Change of Treatment|0|||
17190978|NCT02477800|38343810|FG004|Placebo-Controlled Period|Change of Treatment|0|||
17190979|NCT02477800|38343811|FG005|Placebo-Controlled Period|Change of Treatment|0|||
17190980|NCT02477800|38343812|FG006|Placebo-Controlled Period|Change of Treatment|0|||
17190981|NCT02477800|38343806|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
17190982|NCT02477800|38343807|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
17190983|NCT02477800|38343808|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
17190984|NCT02477800|38343809|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
17190985|NCT02477800|38343810|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
17190986|NCT02477800|38343811|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
17190987|NCT02477800|38343812|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
17190988|NCT02477800|38343806|FG000|Placebo-Controlled Period|Death|0|||
17190989|NCT02477800|38343807|FG001|Placebo-Controlled Period|Death|3|||
17190990|NCT02477800|38343808|FG002|Placebo-Controlled Period|Death|2|||
17190991|NCT02477800|38343809|FG003|Placebo-Controlled Period|Death|0|||
17190992|NCT02477800|38343810|FG004|Placebo-Controlled Period|Death|0|||
17190993|NCT02477800|38343811|FG005|Placebo-Controlled Period|Death|0|||
17190994|NCT02477800|38343812|FG006|Placebo-Controlled Period|Death|0|||
17190995|NCT02477800|38343806|FG000|Placebo-Controlled Period|Disease Progression|1|||
17190996|NCT02477800|38343807|FG001|Placebo-Controlled Period|Disease Progression|0|||
17190997|NCT02477800|38343808|FG002|Placebo-Controlled Period|Disease Progression|1|||
17190998|NCT02477800|38343809|FG003|Placebo-Controlled Period|Disease Progression|0|||
17190999|NCT02477800|38343810|FG004|Placebo-Controlled Period|Disease Progression|0|||
17191000|NCT02477800|38343811|FG005|Placebo-Controlled Period|Disease Progression|0|||
17191001|NCT02477800|38343812|FG006|Placebo-Controlled Period|Disease Progression|0|||
17191002|NCT02477800|38343806|FG000|Placebo-Controlled Period|Investigator Decision|3|||
17191003|NCT02477800|38343807|FG001|Placebo-Controlled Period|Investigator Decision|2|||
16868702|NCT02669862|37841757|FG002|Overall Study|Withdrawal by Subject|3|||
16868703|NCT02669862|37841755|FG000|Overall Study|moved|0|||
16868704|NCT02669862|37841756|FG001|Overall Study|moved|1|||
16868705|NCT02669862|37841757|FG002|Overall Study|moved|0|||
16868706|NCT02669862|37841755|FG000|Overall Study|Protocol Violation|0|||
16868707|NCT02669862|37841756|FG001|Overall Study|Protocol Violation|0|||
16868708|NCT02669862|37841757|FG002|Overall Study|Protocol Violation|1|||
16868709|NCT01531673|37841781|FG000|Overall Study|Non-Compliance|0|||
16868710|NCT01531673|37841782|FG001|Overall Study|Non-Compliance|0|||
16868711|NCT01531673|37841783|FG002|Overall Study|Non-Compliance|0|||
16868712|NCT01531673|37841784|FG003|Overall Study|Non-Compliance|0|||
16868713|NCT01531673|37841785|FG004|Overall Study|Non-Compliance|0|||
16868714|NCT01531673|37841786|FG005|Overall Study|Non-Compliance|1|||
16868715|NCT01531673|37841787|FG006|Overall Study|Non-Compliance|0|||
16868716|NCT01531673|37841788|FG007|Overall Study|Non-Compliance|0|||
16868717|NCT01531673|37841789|FG008|Overall Study|Non-Compliance|0|||
16868718|NCT01531673|37841790|FG009|Overall Study|Non-Compliance|0|||
16868719|NCT01531673|37841791|FG010|Overall Study|Non-Compliance|0|||
16868720|NCT01531673|37841792|FG011|Overall Study|Non-Compliance|0|||
16868721|NCT01531673|37841793|FG012|Overall Study|Non-Compliance|0|||
16868722|NCT01531673|37841781|FG000|Overall Study|Adverse Event|0|||
16868723|NCT01531673|37841782|FG001|Overall Study|Adverse Event|1|||
16868724|NCT01531673|37841783|FG002|Overall Study|Adverse Event|0|||
16868725|NCT01531673|37841784|FG003|Overall Study|Adverse Event|0|||
16868726|NCT01531673|37841785|FG004|Overall Study|Adverse Event|0|||
16868727|NCT01531673|37841786|FG005|Overall Study|Adverse Event|0|||
16868728|NCT01531673|37841787|FG006|Overall Study|Adverse Event|0|||
16868729|NCT01531673|37841788|FG007|Overall Study|Adverse Event|0|||
16868730|NCT01531673|37841789|FG008|Overall Study|Adverse Event|0|||
16868731|NCT01531673|37841790|FG009|Overall Study|Adverse Event|0|||
16868732|NCT01531673|37841791|FG010|Overall Study|Adverse Event|0|||
16868733|NCT01531673|37841792|FG011|Overall Study|Adverse Event|0|||
16868734|NCT01531673|37841793|FG012|Overall Study|Adverse Event|0|||
16868735|NCT01531673|37841781|FG000|Overall Study|Lost to Follow-up|0|||
16868736|NCT01531673|37841782|FG001|Overall Study|Lost to Follow-up|0|||
16868737|NCT01531673|37841783|FG002|Overall Study|Lost to Follow-up|0|||
16868738|NCT01531673|37841784|FG003|Overall Study|Lost to Follow-up|0|||
16868739|NCT01531673|37841785|FG004|Overall Study|Lost to Follow-up|1|||
16868740|NCT01531673|37841786|FG005|Overall Study|Lost to Follow-up|0|||
16868741|NCT01531673|37841787|FG006|Overall Study|Lost to Follow-up|0|||
16868742|NCT01531673|37841788|FG007|Overall Study|Lost to Follow-up|0|||
16868743|NCT01531673|37841789|FG008|Overall Study|Lost to Follow-up|0|||
16868744|NCT01531673|37841790|FG009|Overall Study|Lost to Follow-up|0|||
16868745|NCT01531673|37841791|FG010|Overall Study|Lost to Follow-up|0|||
16868746|NCT01531673|37841792|FG011|Overall Study|Lost to Follow-up|0|||
16868747|NCT01531673|37841793|FG012|Overall Study|Lost to Follow-up|0|||
16868748|NCT01531673|37841781|FG000|Overall Study|Other|0|||
16868749|NCT01531673|37841782|FG001|Overall Study|Other|0|||
16868750|NCT01531673|37841783|FG002|Overall Study|Other|0|||
16868751|NCT01531673|37841784|FG003|Overall Study|Other|1|||
16868752|NCT01531673|37841785|FG004|Overall Study|Other|0|||
16868753|NCT01531673|37841786|FG005|Overall Study|Other|0|||
16868754|NCT01531673|37841787|FG006|Overall Study|Other|0|||
16868755|NCT01531673|37841788|FG007|Overall Study|Other|0|||
16868756|NCT01531673|37841789|FG008|Overall Study|Other|0|||
16868757|NCT01531673|37841790|FG009|Overall Study|Other|1|||
16868758|NCT01531673|37841791|FG010|Overall Study|Other|0|||
16868759|NCT01531673|37841792|FG011|Overall Study|Other|0|||
16868760|NCT01531673|37841793|FG012|Overall Study|Other|0|||
16868761|NCT01531205|37841845|FG000|Overall Study|Did not proceed to surgery|1|||
16868762|NCT01529645|37841861|FG000|Overall Study|Lost to Follow-up|0|||
16868763|NCT01529645|37841862|FG001|Overall Study|Lost to Follow-up|1|||
16868764|NCT01529645|37841863|FG002|Overall Study|Lost to Follow-up|1|||
17094743|NCT00002842|38234000|FG000|Overall Study|ineligible for surgical resection|27|||
17094744|NCT00143247|38234004|FG000|Overall Study|Death|8|||
17094745|NCT00143247|38234004|FG000|Overall Study|Adverse Event|19|||
17094746|NCT00143247|38234004|FG000|Overall Study|Lack of Efficacy|3|||
17094747|NCT00143247|38234004|FG000|Overall Study|Withdrawal by Subject|55|||
17094748|NCT00143247|38234004|FG000|Overall Study|Study terminated by sponsor|31|||
17094749|NCT00143247|38234004|FG000|Overall Study|Protocol Violation|15|||
17094750|NCT00143247|38234004|FG000|Overall Study|Lost to Follow-up|12|||
17094751|NCT00143247|38234004|FG000|Overall Study|following inaccurate lab adverse event|1|||
16868765|NCT01529645|37841864|FG003|Overall Study|Lost to Follow-up|1|||
16868766|NCT01529645|37841865|FG004|Overall Study|Lost to Follow-up|1|||
16868767|NCT01529645|37841866|FG005|Overall Study|Lost to Follow-up|0|||
16868768|NCT01529645|37841867|FG006|Overall Study|Lost to Follow-up|2|||
16868769|NCT01529645|37841868|FG007|Overall Study|Lost to Follow-up|0|||
16868770|NCT01529645|37841869|FG008|Overall Study|Lost to Follow-up|1|||
16868771|NCT01529645|37841870|FG009|Overall Study|Lost to Follow-up|0|||
16868772|NCT01529645|37841861|FG000|Overall Study|SAE - Premature contractions|0|||
16868773|NCT01529645|37841862|FG001|Overall Study|SAE - Premature contractions|0|||
16868774|NCT01529645|37841863|FG002|Overall Study|SAE - Premature contractions|1|||
16868775|NCT01529645|37841864|FG003|Overall Study|SAE - Premature contractions|0|||
16868776|NCT01529645|37841865|FG004|Overall Study|SAE - Premature contractions|0|||
16868777|NCT01529645|37841866|FG005|Overall Study|SAE - Premature contractions|0|||
16868778|NCT01529645|37841867|FG006|Overall Study|SAE - Premature contractions|0|||
16868779|NCT01529645|37841868|FG007|Overall Study|SAE - Premature contractions|0|||
16868780|NCT01529645|37841869|FG008|Overall Study|SAE - Premature contractions|0|||
16868781|NCT01529645|37841870|FG009|Overall Study|SAE - Premature contractions|0|||
16868782|NCT01529645|37841861|FG000|Overall Study|Withdrawal by Subject|2|||
16868783|NCT01529645|37841862|FG001|Overall Study|Withdrawal by Subject|0|||
16868784|NCT01529645|37841863|FG002|Overall Study|Withdrawal by Subject|0|||
16868785|NCT01529645|37841864|FG003|Overall Study|Withdrawal by Subject|1|||
16868786|NCT01529645|37841865|FG004|Overall Study|Withdrawal by Subject|1|||
16868787|NCT01529645|37841866|FG005|Overall Study|Withdrawal by Subject|1|||
16868788|NCT01529645|37841867|FG006|Overall Study|Withdrawal by Subject|0|||
16868789|NCT01529645|37841868|FG007|Overall Study|Withdrawal by Subject|0|||
16868790|NCT01529645|37841869|FG008|Overall Study|Withdrawal by Subject|0|||
17191004|NCT02477800|38343808|FG002|Placebo-Controlled Period|Investigator Decision|1|||
16868791|NCT01529645|37841870|FG009|Overall Study|Withdrawal by Subject|0|||
16868792|NCT01528787|37841904|FG000|Overall Study|Withdrawal by Subject|0|||
16868793|NCT01528787|37841905|FG001|Overall Study|Withdrawal by Subject|0|||
16868794|NCT01528787|37841906|FG002|Overall Study|Withdrawal by Subject|0|||
16868795|NCT01528787|37841907|FG003|Overall Study|Withdrawal by Subject|1|||
16868796|NCT01528787|37841904|FG000|Overall Study|Family Emergency|0|||
16868797|NCT01528787|37841905|FG001|Overall Study|Family Emergency|0|||
16868798|NCT01528787|37841906|FG002|Overall Study|Family Emergency|1|||
16868799|NCT01528787|37841907|FG003|Overall Study|Family Emergency|0|||
16868800|NCT01528709|37841919|FG000|Overall Study|Death|2|||
16868801|NCT01528709|37841920|FG001|Overall Study|Death|0|||
16784163|NCT02052310|37724039|FG001|Overall Study|Other than specified|29|||
16784164|NCT02052310|37724038|FG000|Overall Study|Adverse Event|29|||
16784165|NCT02052310|37724039|FG001|Overall Study|Adverse Event|22|||
16784166|NCT02052310|37724038|FG000|Overall Study|Kidney Transplant|23|||
16784167|NCT02052310|37724039|FG001|Overall Study|Kidney Transplant|29|||
16784168|NCT02052310|37724038|FG000|Overall Study|Physician Decision|14|||
16784169|NCT02052310|37724039|FG001|Overall Study|Physician Decision|7|||
16868802|NCT01528709|37841919|FG000|Overall Study|Withdrawal by Subject|10|||
16868803|NCT01528709|37841920|FG001|Overall Study|Withdrawal by Subject|15|||
16868804|NCT01528709|37841919|FG000|Overall Study|allergy|1|||
16868805|NCT01528709|37841920|FG001|Overall Study|allergy|0|||
16868806|NCT01527383|37841928|FG000|Overall Study|Adverse Event|5|||
16868807|NCT01527383|37841929|FG001|Overall Study|Adverse Event|0|||
16868808|NCT01527383|37841928|FG000|Overall Study|Lost to Follow-up|3|||
17094752|NCT00143247|38234004|FG000|Overall Study|Other|12|||
17094753|NCT00125853|38234008|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
16868809|NCT01527383|37841929|FG001|Overall Study|Lost to Follow-up|0|||
16868810|NCT01527383|37841928|FG000|Overall Study|Physician Decision|2|||
16868811|NCT01527383|37841929|FG001|Overall Study|Physician Decision|0|||
16868812|NCT01527383|37841928|FG000|Overall Study|Pregnancy|1|||
16868813|NCT01527383|37841929|FG001|Overall Study|Pregnancy|0|||
16868814|NCT01527383|37841928|FG000|Overall Study|Protocol Violation|1|||
16868815|NCT01527383|37841929|FG001|Overall Study|Protocol Violation|0|||
16868816|NCT01527383|37841928|FG000|Overall Study|Screen failure|1|||
17094754|NCT00125853|38234009|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
17094755|NCT00219141|38234018|FG000|Overall Study|Adverse Event|4|||
17094756|NCT00219141|38234019|FG001|Overall Study|Adverse Event|10|||
17094757|NCT00219141|38234020|FG002|Overall Study|Adverse Event|5|||
17094758|NCT00219141|38234018|FG000|Overall Study|Lack of Efficacy|3|||
17191005|NCT02477800|38343809|FG003|Placebo-Controlled Period|Investigator Decision|0|||
17191006|NCT02477800|38343810|FG004|Placebo-Controlled Period|Investigator Decision|0|||
17191007|NCT02477800|38343811|FG005|Placebo-Controlled Period|Investigator Decision|0|||
17191008|NCT02477800|38343812|FG006|Placebo-Controlled Period|Investigator Decision|0|||
17191009|NCT02477800|38343806|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
17191010|NCT02477800|38343807|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
17191011|NCT02477800|38343808|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
16868817|NCT01527383|37841929|FG001|Overall Study|Screen failure|0|||
16868818|NCT01527383|37841928|FG000|Overall Study|Participant moved|0|||
16868819|NCT01527383|37841929|FG001|Overall Study|Participant moved|1|||
17000854|NCT00666679|38144803|FG001|First Intervention|Randomized did not start treatment|1|||
17000855|NCT00666679|38144802|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
17191012|NCT02477800|38343809|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
16868820|NCT01527383|37841928|FG000|Overall Study|Withdrawal by Subject|2|||
16868821|NCT01527383|37841929|FG001|Overall Study|Withdrawal by Subject|3|||
16868822|NCT01527149|37841935|FG000|Overall Study|Death|2|||
16868823|NCT01526057|37841942|FG000|Overall Study|Withdrawal by Subject|3|||
17000856|NCT00666679|38144803|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
16868824|NCT01526057|37841943|FG001|Overall Study|Withdrawal by Subject|2|||
16868825|NCT01526057|37841944|FG002|Overall Study|Withdrawal by Subject|2|||
17000857|NCT00666679|38144802|FG000|Washout Period of 1 Week|Protocol Violation|0|||
16784170|NCT02052310|37724038|FG000|Overall Study|Lack of Efficacy|6|||
16868826|NCT01526057|37841942|FG000|Overall Study|Adverse Event|3|||
16868827|NCT01526057|37841943|FG001|Overall Study|Adverse Event|1|||
16868828|NCT01526057|37841944|FG002|Overall Study|Adverse Event|1|||
16868829|NCT01526057|37841942|FG000|Overall Study|Death|1|||
16868830|NCT01526057|37841943|FG001|Overall Study|Death|0|||
16868831|NCT01526057|37841944|FG002|Overall Study|Death|0|||
16868832|NCT01526057|37841942|FG000|Overall Study|Lost to Follow-up|1|||
16868833|NCT01526057|37841943|FG001|Overall Study|Lost to Follow-up|0|||
16868834|NCT01526057|37841944|FG002|Overall Study|Lost to Follow-up|1|||
16868835|NCT01526057|37841942|FG000|Overall Study|Other|1|||
16868836|NCT01526057|37841943|FG001|Overall Study|Other|0|||
16868837|NCT01526057|37841944|FG002|Overall Study|Other|1|||
16868838|NCT01526057|37841942|FG000|Overall Study|Protocol Violation|0|||
16868839|NCT01526057|37841943|FG001|Overall Study|Protocol Violation|0|||
16868840|NCT01526057|37841944|FG002|Overall Study|Protocol Violation|1|||
16868841|NCT01525901|37842023|FG000|Period 2: 12 Weeks|Adverse Event|0|||
16868842|NCT01525901|37842024|FG001|Period 2: 12 Weeks|Adverse Event|1|||
16868843|NCT01525901|37842025|FG002|Period 2: 12 Weeks|Adverse Event|0|||
16868844|NCT01525901|37842026|FG003|Period 2: 12 Weeks|Adverse Event|0|||
16868845|NCT01525589|37842148|FG000|Overall Study|Non-treatment-related AE|1|||
16868846|NCT01525589|37842149|FG001|Overall Study|Non-treatment-related AE|0|||
16868847|NCT01525589|37842150|FG002|Overall Study|Non-treatment-related AE|0|||
16868848|NCT01525589|37842148|FG000|Overall Study|Progressive disease|48|||
16868849|NCT01525589|37842149|FG001|Overall Study|Progressive disease|15|||
16868850|NCT01525589|37842150|FG002|Overall Study|Progressive disease|29|||
16868851|NCT01525589|37842148|FG000|Overall Study|Never treated|2|||
16868852|NCT01525589|37842149|FG001|Overall Study|Never treated|0|||
16868853|NCT01525589|37842150|FG002|Overall Study|Never treated|0|||
16868854|NCT01525589|37842148|FG000|Overall Study|Physician Decision|4|||
16868855|NCT01525589|37842149|FG001|Overall Study|Physician Decision|2|||
16868856|NCT01525589|37842150|FG002|Overall Study|Physician Decision|2|||
16868857|NCT01525589|37842148|FG000|Overall Study|Death|0|||
16868858|NCT01525589|37842149|FG001|Overall Study|Death|0|||
16868859|NCT01525589|37842150|FG002|Overall Study|Death|2|||
16868860|NCT01525589|37842148|FG000|Overall Study|Treatment-related AE|1|||
16868861|NCT01525589|37842149|FG001|Overall Study|Treatment-related AE|1|||
16868862|NCT01525589|37842150|FG002|Overall Study|Treatment-related AE|2|||
16868863|NCT01525589|37842148|FG000|Overall Study|Other reasons|0|||
16868864|NCT01525589|37842149|FG001|Overall Study|Other reasons|1|||
16868865|NCT01525589|37842150|FG002|Overall Study|Other reasons|0|||
16784171|NCT02052310|37724039|FG001|Overall Study|Lack of Efficacy|1|||
16784172|NCT02052310|37724038|FG000|Overall Study|Site Terminated by Sponsor|5|||
16868866|NCT01525589|37842148|FG000|Overall Study|Withdrawal by Subject|0|||
16868867|NCT01525589|37842149|FG001|Overall Study|Withdrawal by Subject|1|||
16868868|NCT01525589|37842150|FG002|Overall Study|Withdrawal by Subject|0|||
16868869|NCT01524887|37842161|FG000|Overall Study|Withdrawal by Subject|6|||
16868870|NCT01524887|37842162|FG001|Overall Study|Withdrawal by Subject|2|||
16868871|NCT01524887|37842163|FG002|Overall Study|Withdrawal by Subject|3|||
16868872|NCT01524887|37842161|FG000|Overall Study|Adverse Event|5|||
16868873|NCT01524887|37842162|FG001|Overall Study|Adverse Event|1|||
16868874|NCT01524887|37842163|FG002|Overall Study|Adverse Event|1|||
16868875|NCT01524887|37842161|FG000|Overall Study|Protocol Violation|0|||
16784173|NCT02052310|37724039|FG001|Overall Study|Site Terminated by Sponsor|13|||
16784174|NCT02052310|37724038|FG000|Overall Study|Lost to Follow-up|4|||
16784175|NCT02052310|37724039|FG001|Overall Study|Lost to Follow-up|2|||
16784176|NCT02052310|37724038|FG000|Overall Study|Protocol Violation|1|||
16784177|NCT02052310|37724039|FG001|Overall Study|Protocol Violation|6|||
16784178|NCT02051764|37724047|FG000|Overall Study|Study terminated by sponsor|0|||
16784179|NCT02051764|37724048|FG001|Overall Study|Study terminated by sponsor|7|||
16784180|NCT02051296|37724056|FG000|Overall Study|Lost to Follow-up|1|||
16784181|NCT02051296|37724057|FG001|Overall Study|Lost to Follow-up|2|||
16784182|NCT02051296|37724056|FG000|Overall Study|withdraw prior to treatment|7|||
16784183|NCT02051296|37724057|FG001|Overall Study|withdraw prior to treatment|7|||
16784184|NCT02050048|37724065|FG000|Overall Study|Lost to Follow-up|0|||
16784185|NCT02050048|37724066|FG001|Overall Study|Lost to Follow-up|1|||
16868876|NCT01524887|37842162|FG001|Overall Study|Protocol Violation|0|||
16868877|NCT01524887|37842163|FG002|Overall Study|Protocol Violation|1|||
16868878|NCT01524887|37842161|FG000|Overall Study|Study termination|73|||
16868879|NCT01524887|37842162|FG001|Overall Study|Study termination|87|||
16868880|NCT01524887|37842163|FG002|Overall Study|Study termination|79|||
16868881|NCT01524887|37842161|FG000|Overall Study|Withdrawal by Caregiver|0|||
16868882|NCT01524887|37842162|FG001|Overall Study|Withdrawal by Caregiver|0|||
16868883|NCT01524887|37842163|FG002|Overall Study|Withdrawal by Caregiver|2|||
16868884|NCT01524887|37842161|FG000|Overall Study|Use of prohibited medication|1|||
16868885|NCT01524887|37842162|FG001|Overall Study|Use of prohibited medication|0|||
16868886|NCT01524887|37842163|FG002|Overall Study|Use of prohibited medication|0|||
16784186|NCT02050048|37724065|FG000|Overall Study|Death|1|||
16784187|NCT02050048|37724066|FG001|Overall Study|Death|0|||
16784188|NCT02050048|37724065|FG000|Overall Study|Ineligible after ERCP|4|||
16868887|NCT01523873|37842189|FG000|Overall Study|Protocol Violation|422|||
16868888|NCT01522235|37842214|FG000|Overall Study|Physician Decision|1|||
16868889|NCT01522235|37842215|FG001|Overall Study|Physician Decision|1|||
16868890|NCT01521923|37842252|FG000|Overall Study|AE, serious fatal|1|||
16868891|NCT01521923|37842253|FG001|Overall Study|AE, serious fatal|0|||
16868892|NCT01521923|37842254|FG002|Overall Study|AE, serious fatal|0|||
16868893|NCT01521923|37842255|FG003|Overall Study|AE, serious fatal|0|||
16868894|NCT01521923|37842252|FG000|Overall Study|SAE, non-fatal|0|||
16868895|NCT01521923|37842253|FG001|Overall Study|SAE, non-fatal|2|||
16868896|NCT01521923|37842254|FG002|Overall Study|SAE, non-fatal|2|||
16868897|NCT01521923|37842255|FG003|Overall Study|SAE, non-fatal|0|||
17094759|NCT00219141|38234019|FG001|Overall Study|Lack of Efficacy|2|||
17094760|NCT00219141|38234020|FG002|Overall Study|Lack of Efficacy|0|||
17094761|NCT00219141|38234018|FG000|Overall Study|Administrative problems|0|||
17094762|NCT00219141|38234019|FG001|Overall Study|Administrative problems|1|||
17094763|NCT00219141|38234020|FG002|Overall Study|Administrative problems|0|||
17094764|NCT00219141|38234018|FG000|Overall Study|Lost to Follow-up|2|||
17094765|NCT00219141|38234019|FG001|Overall Study|Lost to Follow-up|4|||
17094766|NCT00219141|38234020|FG002|Overall Study|Lost to Follow-up|1|||
17191013|NCT02477800|38343810|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
17191014|NCT02477800|38343811|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
17191015|NCT02477800|38343812|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
17191016|NCT02477800|38343806|FG000|Placebo-Controlled Period|Relocation|2|||
17191017|NCT02477800|38343807|FG001|Placebo-Controlled Period|Relocation|0|||
17191018|NCT02477800|38343808|FG002|Placebo-Controlled Period|Relocation|0|||
17191019|NCT02477800|38343809|FG003|Placebo-Controlled Period|Relocation|0|||
17191020|NCT02477800|38343810|FG004|Placebo-Controlled Period|Relocation|0|||
17191021|NCT02477800|38343811|FG005|Placebo-Controlled Period|Relocation|0|||
17191022|NCT02477800|38343812|FG006|Placebo-Controlled Period|Relocation|0|||
17191023|NCT02477800|38343806|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
17191024|NCT02477800|38343807|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
17191025|NCT02477800|38343808|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
17191026|NCT02477800|38343809|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
17191027|NCT02477800|38343810|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
16784189|NCT02050048|37724066|FG001|Overall Study|Ineligible after ERCP|1|||
16784190|NCT02049814|37724074|FG000|Overall Study|Reason not Specified|4|||
16784191|NCT02049814|37724075|FG001|Overall Study|Reason not Specified|3|||
16784192|NCT02049814|37724074|FG000|Overall Study|Pregnancy|1|||
16784193|NCT02049814|37724075|FG001|Overall Study|Pregnancy|0|||
16784194|NCT02049814|37724074|FG000|Overall Study|Lost to Follow-up|2|||
16784195|NCT02049814|37724075|FG001|Overall Study|Lost to Follow-up|3|||
16784196|NCT02049814|37724074|FG000|Overall Study|Serious Protocol Violation|5|||
16784197|NCT02049814|37724075|FG001|Overall Study|Serious Protocol Violation|7|||
16784198|NCT02049814|37724074|FG000|Overall Study|Study Termination|0|||
16784199|NCT02049814|37724075|FG001|Overall Study|Study Termination|1|||
16784200|NCT02049814|37724074|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
16784201|NCT02049814|37724075|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
16784202|NCT02049814|37724074|FG000|Overall Study|Voluntary withdrawal|9|||
16784203|NCT02049814|37724075|FG001|Overall Study|Voluntary withdrawal|8|||
16784204|NCT02079844|37724084|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
16784205|NCT02079844|37724085|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
16784206|NCT02079844|37724086|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
16784207|NCT02079844|37724084|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
16784208|NCT02079844|37724085|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
16784209|NCT02079844|37724086|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
16784210|NCT02048722|37724106|FG000|2 Cycles of Treatment|Adverse Event|2|||
16784211|NCT02048722|37724106|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
16784212|NCT02048722|37724106|FG000|2 Cycles of Treatment|Progressive Disease|2|||
16784213|NCT02048722|37724106|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
16784214|NCT02048722|37724106|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
16784215|NCT02048722|37724106|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
16784216|NCT02030002|37724110|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
16784217|NCT02030002|37724110|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
16784218|NCT02030002|37724110|FG000|Follow-up|Lost to Follow-up|2|||
16784219|NCT02079610|37724118|FG000|Overall Study|Withdrawal by Subject|1|||
16784220|NCT02079610|37724119|FG001|Overall Study|Withdrawal by Subject|1|||
16784221|NCT02029846|37724127|FG000|Overall Study|n=1 each arm|1|||
16784222|NCT02029846|37724128|FG001|Overall Study|n=1 each arm|1|||
16784223|NCT02079532|37724134|FG000|Overall Study|Adverse Event|7|||
16784224|NCT02079532|37724134|FG000|Overall Study|Additional or changed therapy|2|||
16784225|NCT02079532|37724134|FG000|Overall Study|Lack of Efficacy|9|||
16784226|NCT02079532|37724134|FG000|Overall Study|Protocol Violation|3|||
16784227|NCT02079532|37724134|FG000|Overall Study|Withdrawal by Subject|1|||
16784228|NCT02079532|37724134|FG000|Overall Study|Administrative problems|1|||
16868898|NCT01521923|37842252|FG000|Overall Study|AE, non-serious, non-fatal|1|||
16784229|NCT02079532|37724134|FG000|Overall Study|Inclusion into ReFIRST|3|||
16784230|NCT02079532|37724134|FG000|Overall Study|Other|3|||
16784231|NCT02709889|37724187|FG000|Overall Study|Withdrawal by Subject|11|||
16784232|NCT02709889|37724188|FG001|Overall Study|Withdrawal by Subject|10|||
16784233|NCT02709889|37724189|FG002|Overall Study|Withdrawal by Subject|2|||
16784234|NCT02709889|37724190|FG003|Overall Study|Withdrawal by Subject|12|||
16784235|NCT02709889|37724187|FG000|Overall Study|Death|25|||
16784236|NCT02709889|37724188|FG001|Overall Study|Death|38|||
16784237|NCT02709889|37724189|FG002|Overall Study|Death|4|||
16784238|NCT02709889|37724190|FG003|Overall Study|Death|44|||
16784239|NCT02709889|37724187|FG000|Overall Study|Physician Decision|1|||
16784240|NCT02709889|37724188|FG001|Overall Study|Physician Decision|2|||
16868899|NCT01521923|37842253|FG001|Overall Study|AE, non-serious, non-fatal|3|||
16868900|NCT01521923|37842254|FG002|Overall Study|AE, non-serious, non-fatal|6|||
16868901|NCT01521923|37842255|FG003|Overall Study|AE, non-serious, non-fatal|2|||
16868902|NCT01521923|37842252|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
16868903|NCT01521923|37842253|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
16868904|NCT01521923|37842254|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
16868905|NCT01521923|37842255|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
16868906|NCT01521923|37842252|FG000|Overall Study|Lack of Efficacy|1|||
16868907|NCT01521923|37842253|FG001|Overall Study|Lack of Efficacy|1|||
16868908|NCT01521923|37842254|FG002|Overall Study|Lack of Efficacy|0|||
16868909|NCT01521923|37842255|FG003|Overall Study|Lack of Efficacy|0|||
16868910|NCT01521923|37842252|FG000|Overall Study|Protocol Violation|0|||
16868911|NCT01521923|37842253|FG001|Overall Study|Protocol Violation|0|||
16868912|NCT01521923|37842254|FG002|Overall Study|Protocol Violation|1|||
16868913|NCT01521923|37842255|FG003|Overall Study|Protocol Violation|0|||
16868914|NCT01521923|37842252|FG000|Overall Study|Lost to Follow-up|1|||
16868915|NCT01521923|37842253|FG001|Overall Study|Lost to Follow-up|0|||
16868916|NCT01521923|37842254|FG002|Overall Study|Lost to Follow-up|2|||
16868917|NCT01521923|37842255|FG003|Overall Study|Lost to Follow-up|1|||
16868918|NCT01521923|37842252|FG000|Overall Study|Withdrawal by Subject|1|||
16868919|NCT01521923|37842253|FG001|Overall Study|Withdrawal by Subject|1|||
16868920|NCT01521923|37842254|FG002|Overall Study|Withdrawal by Subject|1|||
16868921|NCT01521923|37842255|FG003|Overall Study|Withdrawal by Subject|2|||
16868922|NCT01521923|37842252|FG000|Overall Study|Other|2|||
16784241|NCT02709889|37724189|FG002|Overall Study|Physician Decision|3|||
16784242|NCT02709889|37724190|FG003|Overall Study|Physician Decision|5|||
16784243|NCT02709889|37724187|FG000|Overall Study|Lost to Follow-up|2|||
16784244|NCT02709889|37724188|FG001|Overall Study|Lost to Follow-up|0|||
16784245|NCT02709889|37724189|FG002|Overall Study|Lost to Follow-up|0|||
16784246|NCT02709889|37724190|FG003|Overall Study|Lost to Follow-up|4|||
16784247|NCT02709889|37724187|FG000|Overall Study|Study Terminated by Sponsor|4|||
16868923|NCT01521923|37842253|FG001|Overall Study|Other|1|||
16868924|NCT01521923|37842254|FG002|Overall Study|Other|3|||
16868925|NCT01521923|37842255|FG003|Overall Study|Other|6|||
16868926|NCT01521923|37842252|FG000|Overall Study|AE, captured in Period 1|0|||
16868927|NCT01521923|37842253|FG001|Overall Study|AE, captured in Period 1|1|||
16868928|NCT01521923|37842254|FG002|Overall Study|AE, captured in Period 1|0|||
16868929|NCT01521923|37842255|FG003|Overall Study|AE, captured in Period 1|1|||
16868930|NCT01520987|37842379|FG000|Overall Study|Withdrawal by Subject|1|||
16868931|NCT01520987|37842380|FG001|Overall Study|Withdrawal by Subject|0|||
16868932|NCT01520987|37842381|FG002|Overall Study|Withdrawal by Subject|0|||
16868933|NCT01520987|37842382|FG003|Overall Study|Withdrawal by Subject|0|||
16868934|NCT01520987|37842383|FG004|Overall Study|Withdrawal by Subject|0|||
16868935|NCT01520987|37842384|FG005|Overall Study|Withdrawal by Subject|1|||
16868936|NCT01520987|37842385|FG006|Overall Study|Withdrawal by Subject|0|||
16868937|NCT01520987|37842386|FG007|Overall Study|Withdrawal by Subject|0|||
16868938|NCT01562275|37842460|FG000|Stage 1|Adverse Event|0|||
16868939|NCT01562275|37842461|FG001|Stage 1|Adverse Event|0|||
16868940|NCT01562275|37842462|FG002|Stage 1|Adverse Event|0|||
16868941|NCT01562275|37842463|FG003|Stage 1|Adverse Event|1|||
16868942|NCT01562275|37842464|FG004|Stage 1|Adverse Event|1|||
16868943|NCT01562275|37842465|FG005|Stage 1|Adverse Event|0|||
16868944|NCT01562275|37842466|FG006|Stage 1|Adverse Event|0|||
16868945|NCT01562275|37842467|FG007|Stage 1|Adverse Event|0|||
16868946|NCT01562275|37842468|FG008|Stage 1|Adverse Event|0|||
16868947|NCT01562275|37842469|FG009|Stage 1|Adverse Event|1|||
16868948|NCT01562275|37842470|FG010|Stage 1|Adverse Event|0|||
16868949|NCT01562275|37842471|FG011|Stage 1|Adverse Event|0|||
16868950|NCT01562275|37842472|FG012|Stage 1|Adverse Event|0|||
16868951|NCT01562275|37842460|FG000|Stage 1|Death|1|||
16868952|NCT01562275|37842461|FG001|Stage 1|Death|0|||
16868953|NCT01562275|37842462|FG002|Stage 1|Death|0|||
16868954|NCT01562275|37842463|FG003|Stage 1|Death|0|||
16868955|NCT01562275|37842464|FG004|Stage 1|Death|0|||
16868956|NCT01562275|37842465|FG005|Stage 1|Death|0|||
16868957|NCT01562275|37842466|FG006|Stage 1|Death|0|||
16784248|NCT02709889|37724188|FG001|Overall Study|Study Terminated by Sponsor|6|||
16784249|NCT02709889|37724189|FG002|Overall Study|Study Terminated by Sponsor|2|||
16868958|NCT01562275|37842467|FG007|Stage 1|Death|0|||
16868959|NCT01562275|37842468|FG008|Stage 1|Death|0|||
16868960|NCT01562275|37842469|FG009|Stage 1|Death|0|||
16868961|NCT01562275|37842470|FG010|Stage 1|Death|0|||
16868962|NCT01562275|37842471|FG011|Stage 1|Death|0|||
16868963|NCT01562275|37842472|FG012|Stage 1|Death|0|||
16868964|NCT01562275|37842460|FG000|Stage 1|Non Compliance|0|||
16868965|NCT01562275|37842461|FG001|Stage 1|Non Compliance|0|||
16868966|NCT01562275|37842462|FG002|Stage 1|Non Compliance|1|||
16868967|NCT01562275|37842463|FG003|Stage 1|Non Compliance|0|||
16868968|NCT01562275|37842464|FG004|Stage 1|Non Compliance|0|||
16868969|NCT01562275|37842465|FG005|Stage 1|Non Compliance|0|||
16868970|NCT01562275|37842466|FG006|Stage 1|Non Compliance|0|||
16868971|NCT01562275|37842467|FG007|Stage 1|Non Compliance|0|||
16868972|NCT01562275|37842468|FG008|Stage 1|Non Compliance|0|||
16868973|NCT01562275|37842469|FG009|Stage 1|Non Compliance|0|||
16868974|NCT01562275|37842470|FG010|Stage 1|Non Compliance|0|||
16868975|NCT01562275|37842471|FG011|Stage 1|Non Compliance|0|||
16868976|NCT01562275|37842472|FG012|Stage 1|Non Compliance|0|||
16868977|NCT01562275|37842460|FG000|Stage 1|Physician Decision|0|||
16868978|NCT01562275|37842461|FG001|Stage 1|Physician Decision|0|||
16868979|NCT01562275|37842462|FG002|Stage 1|Physician Decision|0|||
16868980|NCT01562275|37842463|FG003|Stage 1|Physician Decision|0|||
16868981|NCT01562275|37842464|FG004|Stage 1|Physician Decision|1|||
16868982|NCT01562275|37842465|FG005|Stage 1|Physician Decision|0|||
16868983|NCT01562275|37842466|FG006|Stage 1|Physician Decision|1|||
16868984|NCT01562275|37842467|FG007|Stage 1|Physician Decision|0|||
16868985|NCT01562275|37842468|FG008|Stage 1|Physician Decision|1|||
16868986|NCT01562275|37842469|FG009|Stage 1|Physician Decision|0|||
16868987|NCT01562275|37842470|FG010|Stage 1|Physician Decision|0|||
16868988|NCT01562275|37842471|FG011|Stage 1|Physician Decision|0|||
16868989|NCT01562275|37842472|FG012|Stage 1|Physician Decision|0|||
16868990|NCT01562275|37842460|FG000|Stage 1|Progression of Disease|2|||
16868991|NCT01562275|37842461|FG001|Stage 1|Progression of Disease|6|||
16868992|NCT01562275|37842462|FG002|Stage 1|Progression of Disease|2|||
16868993|NCT01562275|37842463|FG003|Stage 1|Progression of Disease|1|||
16868994|NCT01562275|37842464|FG004|Stage 1|Progression of Disease|2|||
16868995|NCT01562275|37842465|FG005|Stage 1|Progression of Disease|4|||
16868996|NCT01562275|37842466|FG006|Stage 1|Progression of Disease|1|||
16868997|NCT01562275|37842467|FG007|Stage 1|Progression of Disease|7|||
16868998|NCT01562275|37842468|FG008|Stage 1|Progression of Disease|2|||
16868999|NCT01562275|37842469|FG009|Stage 1|Progression of Disease|5|||
16869000|NCT01562275|37842470|FG010|Stage 1|Progression of Disease|3|||
16869001|NCT01562275|37842471|FG011|Stage 1|Progression of Disease|0|||
16869002|NCT01562275|37842472|FG012|Stage 1|Progression of Disease|0|||
16869003|NCT01562275|37842460|FG000|Stage 1|Withdrawal by Subject|0|||
16869004|NCT01562275|37842461|FG001|Stage 1|Withdrawal by Subject|1|||
16869005|NCT01562275|37842462|FG002|Stage 1|Withdrawal by Subject|0|||
16869006|NCT01562275|37842463|FG003|Stage 1|Withdrawal by Subject|2|||
16869007|NCT01562275|37842464|FG004|Stage 1|Withdrawal by Subject|0|||
16869008|NCT01562275|37842465|FG005|Stage 1|Withdrawal by Subject|0|||
16869009|NCT01562275|37842466|FG006|Stage 1|Withdrawal by Subject|1|||
16869010|NCT01562275|37842467|FG007|Stage 1|Withdrawal by Subject|0|||
16869011|NCT01562275|37842468|FG008|Stage 1|Withdrawal by Subject|0|||
16869012|NCT01562275|37842469|FG009|Stage 1|Withdrawal by Subject|1|||
16869013|NCT01562275|37842470|FG010|Stage 1|Withdrawal by Subject|0|||
16869014|NCT01562275|37842471|FG011|Stage 1|Withdrawal by Subject|0|||
16869015|NCT01562275|37842472|FG012|Stage 1|Withdrawal by Subject|0|||
16869016|NCT01562275|37842460|FG000|Stage 2|Death|0|||
16869017|NCT01562275|37842461|FG001|Stage 2|Death|0|||
16869018|NCT01562275|37842462|FG002|Stage 2|Death|0|||
16869019|NCT01562275|37842463|FG003|Stage 2|Death|0|||
16869020|NCT01562275|37842464|FG004|Stage 2|Death|0|||
16869021|NCT01562275|37842465|FG005|Stage 2|Death|0|||
16869022|NCT01562275|37842466|FG006|Stage 2|Death|0|||
16869023|NCT01562275|37842467|FG007|Stage 2|Death|0|||
16869024|NCT01562275|37842468|FG008|Stage 2|Death|0|||
16869025|NCT01562275|37842469|FG009|Stage 2|Death|0|||
16869026|NCT01562275|37842470|FG010|Stage 2|Death|0|||
16869027|NCT01562275|37842471|FG011|Stage 2|Death|2|||
16869028|NCT01562275|37842472|FG012|Stage 2|Death|1|||
16869029|NCT01562275|37842460|FG000|Stage 2|Progression of Disease|0|||
16869030|NCT01562275|37842461|FG001|Stage 2|Progression of Disease|0|||
16869031|NCT01562275|37842462|FG002|Stage 2|Progression of Disease|0|||
16869032|NCT01562275|37842463|FG003|Stage 2|Progression of Disease|0|||
16869033|NCT01562275|37842464|FG004|Stage 2|Progression of Disease|0|||
16869034|NCT01562275|37842465|FG005|Stage 2|Progression of Disease|0|||
16869035|NCT01562275|37842466|FG006|Stage 2|Progression of Disease|0|||
16869036|NCT01562275|37842467|FG007|Stage 2|Progression of Disease|0|||
16869037|NCT01562275|37842468|FG008|Stage 2|Progression of Disease|0|||
16869038|NCT01562275|37842469|FG009|Stage 2|Progression of Disease|0|||
16869039|NCT01562275|37842470|FG010|Stage 2|Progression of Disease|0|||
16869040|NCT01562275|37842471|FG011|Stage 2|Progression of Disease|12|||
16869041|NCT01562275|37842472|FG012|Stage 2|Progression of Disease|4|||
16869042|NCT01535053|37842504|FG000|Overall Study|Ineligible|1|||
16869043|NCT01535053|37842505|FG001|Overall Study|Ineligible|2|||
17191028|NCT02477800|38343811|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
17191029|NCT02477800|38343812|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
17191030|NCT02477800|38343806|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
17191031|NCT02477800|38343807|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
16869044|NCT01534663|37842513|FG000|Overall Study|Lost to Follow-up|0|||
16869045|NCT01534663|37842514|FG001|Overall Study|Lost to Follow-up|2|||
16869046|NCT01534663|37842513|FG000|Overall Study|Adverse Event|2|||
16869047|NCT01534663|37842514|FG001|Overall Study|Adverse Event|1|||
16869048|NCT01520909|37842522|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
16869049|NCT01520909|37842523|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
16869050|NCT01520909|37842524|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
16869051|NCT01520909|37842522|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
16869052|NCT01520909|37842523|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
16869053|NCT01520909|37842524|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
16869054|NCT01520909|37842522|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
16869055|NCT01520909|37842523|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
16869056|NCT01520909|37842524|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
16869057|NCT01520909|37842522|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
16869058|NCT01520909|37842523|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
16869059|NCT01520909|37842524|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
16869060|NCT01520363|37842546|FG000|Overall Study|Withdrawal by Subject|2|||
16869061|NCT01520363|37842547|FG001|Overall Study|Withdrawal by Subject|0|||
16869062|NCT01578499|37842579|FG000|Overall Study|Reason not Specified|0|||
16869063|NCT01578499|37842580|FG001|Overall Study|Reason not Specified|1|||
16869064|NCT01578499|37842579|FG000|Overall Study|Lost to Follow-up|2|||
16869065|NCT01578499|37842580|FG001|Overall Study|Lost to Follow-up|1|||
16869066|NCT01578499|37842579|FG000|Overall Study|Withdrawal by Subject|10|||
16869067|NCT01578499|37842580|FG001|Overall Study|Withdrawal by Subject|16|||
16869068|NCT01578499|37842579|FG000|Overall Study|Death|20|||
16869069|NCT01578499|37842580|FG001|Overall Study|Death|25|||
16869070|NCT01578499|37842579|FG000|Overall Study|Died and End of Study Page not Completed|2|||
16869071|NCT01578499|37842580|FG001|Overall Study|Died and End of Study Page not Completed|0|||
16869072|NCT01578187|37842590|FG000|Usability Phase|Withdrawal by Subject|1|||
16869073|NCT01561963|37842596|FG000|Overall Study|Adverse Event|1|||
16869074|NCT01576783|37842607|FG000|Overall Study|Change in Medical Care|1|||
16869075|NCT01576783|37842608|FG001|Overall Study|Change in Medical Care|0|||
16869076|NCT01576783|37842607|FG000|Overall Study|Lost to Follow-up|14|||
16869077|NCT01576783|37842608|FG001|Overall Study|Lost to Follow-up|16|||
16869078|NCT01576783|37842607|FG000|Overall Study|Withdrawal by Subject|5|||
16869079|NCT01576783|37842608|FG001|Overall Study|Withdrawal by Subject|1|||
16869080|NCT01534351|37842617|FG000|Overall Study|Study Terminated Early|1|||
16869081|NCT01534351|37842618|FG001|Overall Study|Study Terminated Early|0|||
16869082|NCT01534351|37842619|FG002|Overall Study|Study Terminated Early|0|||
16869083|NCT02120352|37842627|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
16869084|NCT02120352|37842628|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
16869085|NCT02120352|37842629|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
16869086|NCT02120352|37842630|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
16869087|NCT02120352|37842627|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
16869088|NCT02120352|37842628|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16869089|NCT02120352|37842629|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16869090|NCT02120352|37842630|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16869091|NCT02120352|37842627|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
16869092|NCT02120352|37842628|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
16869093|NCT02120352|37842629|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
16869094|NCT02120352|37842630|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
16869095|NCT02120352|37842627|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
16869096|NCT02120352|37842628|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16869097|NCT02120352|37842629|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16869098|NCT02120352|37842630|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16869099|NCT02120352|37842627|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
16869100|NCT02120352|37842628|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16869101|NCT02120352|37842629|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16869102|NCT02120352|37842630|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16869103|NCT02120352|37842627|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
16869104|NCT02120352|37842628|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16869105|NCT02120352|37842629|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16869106|NCT02120352|37842630|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16869107|NCT02120352|37842627|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
16869108|NCT02120352|37842628|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
16869109|NCT02120352|37842629|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
17191032|NCT02477800|38343808|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
16869110|NCT02120352|37842630|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
16869111|NCT02120352|37842627|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
16869112|NCT02120352|37842628|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
16869113|NCT02120352|37842629|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
16869114|NCT02120352|37842630|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
16869115|NCT02120352|37842627|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
16869116|NCT02120352|37842628|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
16869117|NCT02120352|37842629|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
16869118|NCT02120352|37842630|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
16869119|NCT02120352|37842627|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
16869120|NCT02120352|37842628|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
16869121|NCT02120352|37842629|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
16869122|NCT02120352|37842630|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
16869123|NCT02120352|37842627|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
16869124|NCT02120352|37842628|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
16869125|NCT02120352|37842629|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
16869126|NCT02120352|37842630|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
16869127|NCT02120352|37842627|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
16869128|NCT02120352|37842628|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
16869129|NCT02120352|37842629|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
16869130|NCT02120352|37842630|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
16869131|NCT02120352|37842627|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
16869132|NCT02120352|37842628|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
16869133|NCT02120352|37842629|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
16869134|NCT02120352|37842630|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
16869135|NCT02120352|37842627|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
16869136|NCT02120352|37842628|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
17000858|NCT00666679|38144803|FG001|Washout Period of 1 Week|Protocol Violation|1|||
17000859|NCT00666679|38144802|FG000|Second Intervention|Adverse Event|1|||
16784250|NCT02709889|37724190|FG003|Overall Study|Study Terminated by Sponsor|17|||
16784251|NCT02709889|37724187|FG000|Overall Study|Other, Not Specified|0|||
16784252|NCT02709889|37724188|FG001|Overall Study|Other, Not Specified|1|||
16784253|NCT02709889|37724189|FG002|Overall Study|Other, Not Specified|1|||
16784254|NCT02709889|37724190|FG003|Overall Study|Other, Not Specified|6|||
16784255|NCT02711995|37724235|FG000|Washout (90 Days)|Conflicting medication|1|||
16784256|NCT02514239|37724273|FG000|Overall Study|Refused to continue trial medication|0|||
16784257|NCT02514239|37724274|FG001|Overall Study|Refused to continue trial medication|0|||
16784258|NCT02514239|37724275|FG002|Overall Study|Refused to continue trial medication|0|||
16784259|NCT02514239|37724276|FG003|Overall Study|Refused to continue trial medication|0|||
16784260|NCT02514239|37724277|FG004|Overall Study|Refused to continue trial medication|0|||
16784261|NCT02514239|37724278|FG005|Overall Study|Refused to continue trial medication|0|||
16784262|NCT02514239|37724279|FG006|Overall Study|Refused to continue trial medication|0|||
16784263|NCT02514239|37724280|FG007|Overall Study|Refused to continue trial medication|0|||
16784264|NCT02514239|37724281|FG008|Overall Study|Refused to continue trial medication|0|||
16784265|NCT02514239|37724282|FG009|Overall Study|Refused to continue trial medication|1|||
16784266|NCT02514239|37724273|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
16784267|NCT02514239|37724274|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
16784268|NCT02514239|37724275|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
16784269|NCT02514239|37724276|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
16784270|NCT02514239|37724277|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
16784271|NCT02514239|37724278|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
16784272|NCT02514239|37724279|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
16784273|NCT02514239|37724280|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
16784274|NCT02514239|37724281|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
16784275|NCT02514239|37724282|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
16784276|NCT02514239|37724273|FG000|Overall Study|Not treated|0|||
16784277|NCT02514239|37724274|FG001|Overall Study|Not treated|1|||
16784278|NCT02514239|37724275|FG002|Overall Study|Not treated|0|||
16784279|NCT02514239|37724276|FG003|Overall Study|Not treated|0|||
16784280|NCT02514239|37724277|FG004|Overall Study|Not treated|0|||
16784281|NCT02514239|37724278|FG005|Overall Study|Not treated|0|||
16784282|NCT02514239|37724279|FG006|Overall Study|Not treated|0|||
16784283|NCT02514239|37724280|FG007|Overall Study|Not treated|0|||
16784284|NCT02514239|37724281|FG008|Overall Study|Not treated|0|||
16784285|NCT02514239|37724282|FG009|Overall Study|Not treated|0|||
16784286|NCT02514239|37724273|FG000|Overall Study|Other Adverse Events|2|||
16784287|NCT02514239|37724274|FG001|Overall Study|Other Adverse Events|0|||
16784288|NCT02514239|37724275|FG002|Overall Study|Other Adverse Events|0|||
16784289|NCT02514239|37724276|FG003|Overall Study|Other Adverse Events|1|||
16784290|NCT02514239|37724277|FG004|Overall Study|Other Adverse Events|0|||
16784291|NCT02514239|37724278|FG005|Overall Study|Other Adverse Events|1|||
16784292|NCT02514239|37724279|FG006|Overall Study|Other Adverse Events|0|||
16784293|NCT02514239|37724280|FG007|Overall Study|Other Adverse Events|1|||
16784294|NCT02514239|37724281|FG008|Overall Study|Other Adverse Events|2|||
16784295|NCT02514239|37724282|FG009|Overall Study|Other Adverse Events|0|||
16784296|NCT02514239|37724273|FG000|Overall Study|Progressive disease|3|||
16784297|NCT02514239|37724274|FG001|Overall Study|Progressive disease|3|||
16784298|NCT02514239|37724275|FG002|Overall Study|Progressive disease|2|||
16784299|NCT02514239|37724276|FG003|Overall Study|Progressive disease|2|||
16784300|NCT02514239|37724277|FG004|Overall Study|Progressive disease|3|||
16869137|NCT02120352|37842629|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
16869138|NCT02120352|37842630|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
16869139|NCT01534273|37842648|FG000|Period 1|Physician Decision|0|||
16869140|NCT01534273|37842649|FG001|Period 1|Physician Decision|0|||
16869141|NCT01534273|37842650|FG002|Period 1|Physician Decision|0|||
16869142|NCT01534273|37842651|FG003|Period 1|Physician Decision|1|||
16869143|NCT01534273|37842652|FG004|Period 1|Physician Decision|0|||
16869144|NCT01534273|37842653|FG005|Period 1|Physician Decision|0|||
16869145|NCT01534273|37842654|FG006|Period 1|Physician Decision|0|||
16869146|NCT01534195|37842677|FG000|Overall Study|Withdrawal by Subject|1|||
16869147|NCT01534195|37842678|FG001|Overall Study|Withdrawal by Subject|1|||
16869148|NCT01560949|37842684|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
16869149|NCT01560949|37842684|FG000|Surgery Phase|Physician Decision|3|||
16869150|NCT01372878|37842692|FG000|Overall Study|Withdrawal by Subject|63|||
16869151|NCT01372878|37842692|FG000|Overall Study|Protocol Violation|17|||
16869152|NCT01372878|37842692|FG000|Overall Study|incomplete study procedure|104|||
16869153|NCT01533493|37842698|FG000|Overall Study|Adverse Event|2|||
16869154|NCT01533493|37842699|FG001|Overall Study|Adverse Event|1|||
16869155|NCT01533493|37842698|FG000|Overall Study|Withdrawal by Subject|1|||
16869156|NCT01533493|37842699|FG001|Overall Study|Withdrawal by Subject|2|||
16869157|NCT01533493|37842698|FG000|Overall Study|Lost to Follow-up|2|||
16869158|NCT01533493|37842699|FG001|Overall Study|Lost to Follow-up|0|||
17191033|NCT02477800|38343809|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
17191034|NCT02477800|38343810|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
16869159|NCT01533181|37842775|FG000|Overall Study|Disease progression pre-active treatment|0|||
16869160|NCT01533181|37842776|FG001|Overall Study|Disease progression pre-active treatment|1|||
16869161|NCT01533181|37842775|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
16869162|NCT01533181|37842776|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
16869163|NCT02669082|37842782|FG000|Overall Study|Adverse Event|1|||
16869164|NCT02668692|37842846|FG000|Overall Study|Adverse Event|1|||
16869165|NCT02668692|37842847|FG001|Overall Study|Adverse Event|0|||
16869166|NCT02662764|37842861|FG000|Overall Study|Adverse Event|6|||
16869167|NCT02662764|37842861|FG000|Overall Study|Lack of Efficacy|8|||
16869168|NCT02662764|37842861|FG000|Overall Study|Protocol Violation|1|||
16869169|NCT02662764|37842861|FG000|Overall Study|Withdrawal by Subject|5|||
16869170|NCT02662764|37842861|FG000|Overall Study|Device failure|4|||
16869171|NCT02662764|37842861|FG000|Overall Study|Patient changed treatment|1|||
16869172|NCT02662764|37842861|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
16869173|NCT01519817|37842870|FG000|Overall Study|Withdrawal by Subject|1|||
16869174|NCT01519817|37842871|FG001|Overall Study|Withdrawal by Subject|0|||
16869175|NCT01519817|37842872|FG002|Overall Study|Withdrawal by Subject|0|||
16869176|NCT01519817|37842873|FG003|Overall Study|Withdrawal by Subject|0|||
16869177|NCT01519817|37842870|FG000|Overall Study|Off study due to infection|0|||
16869178|NCT01519817|37842871|FG001|Overall Study|Off study due to infection|0|||
16869179|NCT01519817|37842872|FG002|Overall Study|Off study due to infection|0|||
16869180|NCT01519817|37842873|FG003|Overall Study|Off study due to infection|1|||
16869181|NCT03478956|37842885|FG000|Overall Study|Adverse Event|1|||
16869182|NCT03478956|37842886|FG001|Overall Study|Adverse Event|0|||
16869183|NCT03478956|37842885|FG000|Overall Study|Withdrawal by Subject|0|||
16869184|NCT03478956|37842886|FG001|Overall Study|Withdrawal by Subject|1|||
16869185|NCT03478956|37842885|FG000|Overall Study|Ongoing in the Study|11|||
16869186|NCT03478956|37842886|FG001|Overall Study|Ongoing in the Study|11|||
16869187|NCT01519661|37842892|FG000|Overall Study|Protocol deviation|6|||
16869188|NCT01519661|37842892|FG000|Overall Study|Lost to Follow-up|3|||
16869189|NCT01519661|37842892|FG000|Overall Study|Withdrawal by Subject|17|||
16869190|NCT01519661|37842892|FG000|Overall Study|Lack of Efficacy|6|||
16869191|NCT01519661|37842892|FG000|Overall Study|Adverse Event|29|||
16869192|NCT01519427|37842897|FG000|Overall Study|disease progression|2|||
16869193|NCT01518257|37842903|FG000|Overall Study|Lost to Follow-up|1|||
16869194|NCT01518257|37842904|FG001|Overall Study|Lost to Follow-up|0|||
16869195|NCT01518257|37842903|FG000|Overall Study|Other Miscellaneous Reason|1|||
16869196|NCT01518257|37842904|FG001|Overall Study|Other Miscellaneous Reason|0|||
16869197|NCT02668302|37842912|FG000|Overall Study|Withdrawal by Subject|1|||
16869198|NCT02668302|37842913|FG001|Overall Study|Withdrawal by Subject|0|||
16869199|NCT01517867|37842921|FG000|Overall Study|never started treatment|29|||
16869200|NCT01517867|37842922|FG001|Overall Study|never started treatment|32|||
16869201|NCT01517867|37842921|FG000|Overall Study|Withdrawal by Subject|34|||
16869202|NCT01517867|37842922|FG001|Overall Study|Withdrawal by Subject|30|||
16869203|NCT01517867|37842921|FG000|Overall Study|Still in treatment at study end|0|||
16869204|NCT01517867|37842922|FG001|Overall Study|Still in treatment at study end|3|||
16869205|NCT01514357|37842930|FG000|Overall Study|Screen failure|2|||
16869206|NCT01514357|37842931|FG001|Overall Study|Screen failure|0|||
16869207|NCT01514357|37842930|FG000|Overall Study|Withdrawal by Subject|2|||
16869208|NCT01514357|37842931|FG001|Overall Study|Withdrawal by Subject|0|||
16869209|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
16869210|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
16869211|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
16869212|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
16869213|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
16869214|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
16869215|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
16869216|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
16869217|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
16869218|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
16869219|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
16869220|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
16869221|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
16869222|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
16869223|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
16869224|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
16869225|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
16869226|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
16869227|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
16869228|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
16869229|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
16869230|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
16869231|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
16869232|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
16869233|NCT01532869|37842939|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
16869234|NCT01532869|37842940|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
16869235|NCT01532869|37842939|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
16869236|NCT01532869|37842940|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
16869237|NCT01532869|37842939|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
16869238|NCT01532869|37842940|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
16869239|NCT01532869|37842939|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
16869240|NCT01532869|37842940|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
16869241|NCT01532869|37842939|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
16869242|NCT01532869|37842940|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
16869243|NCT01531387|37842953|FG000|Overall Study|Early termination of study|11|||
16869244|NCT01531387|37842954|FG001|Overall Study|Early termination of study|11|||
16869245|NCT01531153|37842963|FG000|Overall Study|Withdrawal by Subject|10|||
16869246|NCT01531153|37842964|FG001|Overall Study|Withdrawal by Subject|9|||
16869247|NCT01531153|37842965|FG002|Overall Study|Withdrawal by Subject|15|||
16869248|NCT01529749|37842980|FG000|Overall Study|Lost to Follow-up|0|||
16869249|NCT01529749|37842981|FG001|Overall Study|Lost to Follow-up|1|||
16869250|NCT01529749|37842982|FG002|Overall Study|Lost to Follow-up|1|||
16869251|NCT01529749|37842983|FG003|Overall Study|Lost to Follow-up|0|||
16869252|NCT01529749|37842980|FG000|Overall Study|Physician Decision|0|||
16869253|NCT01529749|37842981|FG001|Overall Study|Physician Decision|0|||
16869254|NCT01529749|37842982|FG002|Overall Study|Physician Decision|0|||
16869255|NCT01529749|37842983|FG003|Overall Study|Physician Decision|1|||
16869256|NCT01529749|37842980|FG000|Overall Study|Withdrawal by Subject|0|||
16869257|NCT01529749|37842981|FG001|Overall Study|Withdrawal by Subject|1|||
16869258|NCT01529749|37842982|FG002|Overall Study|Withdrawal by Subject|1|||
16869259|NCT01529749|37842983|FG003|Overall Study|Withdrawal by Subject|0|||
16869260|NCT01529749|37842980|FG000|Overall Study|Protocol Violation|0|||
16869261|NCT01529749|37842981|FG001|Overall Study|Protocol Violation|0|||
16869262|NCT01529749|37842982|FG002|Overall Study|Protocol Violation|0|||
16869263|NCT01529749|37842983|FG003|Overall Study|Protocol Violation|1|||
16869264|NCT01529515|37842995|FG000|TRANSITION PHASE|Adverse Event|16|||
16869265|NCT01529515|37842996|FG001|TRANSITION PHASE|Adverse Event|0|||
16869266|NCT01529515|37842997|FG002|TRANSITION PHASE|Adverse Event|0|||
16869267|NCT01529515|37842998|FG003|TRANSITION PHASE|Adverse Event|0|||
16869268|NCT01529515|37842995|FG000|TRANSITION PHASE|Death|1|||
16869269|NCT01529515|37842996|FG001|TRANSITION PHASE|Death|0|||
16869270|NCT01529515|37842997|FG002|TRANSITION PHASE|Death|0|||
16869271|NCT01529515|37842998|FG003|TRANSITION PHASE|Death|0|||
16869272|NCT01529515|37842995|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
16869273|NCT01529515|37842996|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
16869274|NCT01529515|37842997|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
16869275|NCT01529515|37842998|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
16869276|NCT01529515|37842995|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
16869277|NCT01529515|37842996|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
16869278|NCT01529515|37842997|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
16869279|NCT01529515|37842998|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
16869280|NCT01529515|37842995|FG000|TRANSITION PHASE|Protocol Violation|4|||
16869281|NCT01529515|37842996|FG001|TRANSITION PHASE|Protocol Violation|0|||
16869282|NCT01529515|37842997|FG002|TRANSITION PHASE|Protocol Violation|0|||
16869283|NCT01529515|37842998|FG003|TRANSITION PHASE|Protocol Violation|0|||
16869284|NCT01529515|37842995|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
16869285|NCT01529515|37842996|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
16869286|NCT01529515|37842997|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
16869287|NCT01529515|37842998|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
16869288|NCT01529515|37842995|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
16869289|NCT01529515|37842996|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
16869290|NCT01529515|37842997|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
16869291|NCT01529515|37842998|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
16869292|NCT01529515|37842995|FG000|TRANSITION PHASE|Other|9|||
16869293|NCT01529515|37842996|FG001|TRANSITION PHASE|Other|0|||
16869294|NCT01529515|37842997|FG002|TRANSITION PHASE|Other|0|||
16869295|NCT01529515|37842998|FG003|TRANSITION PHASE|Other|0|||
16869296|NCT01529515|37842995|FG000|MAINTENANCE PHASE|Adverse Event|0|||
16869297|NCT01529515|37842996|FG001|MAINTENANCE PHASE|Adverse Event|10|||
16869298|NCT01529515|37842997|FG002|MAINTENANCE PHASE|Adverse Event|0|||
16869299|NCT01529515|37842998|FG003|MAINTENANCE PHASE|Adverse Event|0|||
16869300|NCT01529515|37842995|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
16869301|NCT01529515|37842996|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
16869302|NCT01529515|37842997|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
16869303|NCT01529515|37842998|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
16869304|NCT01529515|37842995|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
16869305|NCT01529515|37842996|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
16869306|NCT01529515|37842997|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
16869307|NCT01529515|37842998|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
16869308|NCT01529515|37842995|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
16869309|NCT01529515|37842996|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
16869310|NCT01529515|37842997|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
16869311|NCT01529515|37842998|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
16869312|NCT01529515|37842995|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
16784301|NCT02514239|37724278|FG005|Overall Study|Progressive disease|3|||
17094767|NCT00219141|38234018|FG000|Overall Study|Protocol Violation|3|||
17094768|NCT00219141|38234019|FG001|Overall Study|Protocol Violation|1|||
17094769|NCT00219141|38234020|FG002|Overall Study|Protocol Violation|1|||
17094770|NCT00219141|38234018|FG000|Overall Study|Withdrawal by Subject|1|||
17094771|NCT00219141|38234019|FG001|Overall Study|Withdrawal by Subject|3|||
17094772|NCT00219141|38234020|FG002|Overall Study|Withdrawal by Subject|5|||
16784302|NCT02514239|37724279|FG006|Overall Study|Progressive disease|4|||
16784303|NCT02514239|37724280|FG007|Overall Study|Progressive disease|2|||
16784304|NCT02514239|37724281|FG008|Overall Study|Progressive disease|5|||
16784305|NCT02514239|37724282|FG009|Overall Study|Progressive disease|0|||
16784306|NCT02709109|37724326|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
16784307|NCT02709109|37724327|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
16784308|NCT02709109|37724328|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
16784309|NCT02709109|37724329|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
16784310|NCT02709109|37724326|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
16784311|NCT02709109|37724327|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
16784312|NCT02709109|37724328|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
16784313|NCT02709109|37724329|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
16784314|NCT02709109|37724326|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
16784315|NCT02709109|37724327|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
16784316|NCT02709109|37724328|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
16784317|NCT02709109|37724329|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
16784318|NCT02709109|37724326|FG000|Washout Period (28 Days)|Other|2|||
16784319|NCT02709109|37724327|FG001|Washout Period (28 Days)|Other|2|||
16869313|NCT01529515|37842996|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
16869314|NCT01529515|37842997|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
16869315|NCT01529515|37842998|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
16869316|NCT01529515|37842995|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
16869317|NCT01529515|37842996|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
16869318|NCT01529515|37842997|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
16869319|NCT01529515|37842998|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
16869320|NCT01529515|37842995|FG000|MAINTENANCE PHASE|Other|0|||
16784320|NCT02709109|37724328|FG002|Washout Period (28 Days)|Other|3|||
16869321|NCT01529515|37842996|FG001|MAINTENANCE PHASE|Other|10|||
16869322|NCT01529515|37842997|FG002|MAINTENANCE PHASE|Other|0|||
16869323|NCT01529515|37842998|FG003|MAINTENANCE PHASE|Other|0|||
16869324|NCT01529515|37842995|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
16869325|NCT01529515|37842996|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
16869326|NCT01529515|37842997|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
16869327|NCT01529515|37842998|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
16869328|NCT01529515|37842995|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
16869329|NCT01529515|37842996|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
16869330|NCT01529515|37842997|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
16869331|NCT01529515|37842998|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
16869332|NCT01529515|37842995|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
16869333|NCT01529515|37842996|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
16869334|NCT01529515|37842997|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
16869335|NCT01529515|37842998|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
16869336|NCT01529515|37842995|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
16869337|NCT01529515|37842996|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
16869338|NCT01529515|37842997|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
16869339|NCT01529515|37842998|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
16869340|NCT01529515|37842995|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
16869341|NCT01529515|37842996|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
16869342|NCT01529515|37842997|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
16869343|NCT01529515|37842998|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
16869344|NCT01529515|37842995|FG000|DOUBLE BLIND PHASE|Other|0|||
16869345|NCT01529515|37842996|FG001|DOUBLE BLIND PHASE|Other|0|||
16869346|NCT01529515|37842997|FG002|DOUBLE BLIND PHASE|Other|9|||
16869347|NCT01529515|37842998|FG003|DOUBLE BLIND PHASE|Other|2|||
16869348|NCT01528969|37843007|FG000|Overall Study|absent from the school at baseline|2|||
16869349|NCT01528969|37843008|FG001|Overall Study|absent from the school at baseline|0|||
16869350|NCT01514201|37843018|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
16869351|NCT01514201|37843019|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16869352|NCT01514201|37843020|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16869353|NCT01514201|37843021|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16869354|NCT01514201|37843018|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16869355|NCT01514201|37843019|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
16869356|NCT01514201|37843020|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
16869357|NCT01514201|37843021|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16869358|NCT01514201|37843018|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
16869359|NCT01514201|37843019|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
16869360|NCT01514201|37843020|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
16869361|NCT01514201|37843021|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
16869362|NCT01514201|37843018|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
16869363|NCT01514201|37843019|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
16869364|NCT01514201|37843020|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16869365|NCT01514201|37843021|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16869366|NCT01514201|37843018|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
16869367|NCT01514201|37843019|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
16869368|NCT01514201|37843020|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
16869369|NCT01514201|37843021|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
16869370|NCT01514201|37843018|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
16869371|NCT01514201|37843019|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
16869372|NCT01514201|37843020|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
16869373|NCT01514201|37843021|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
16869374|NCT01514201|37843018|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
16869375|NCT01514201|37843019|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
16869376|NCT01514201|37843020|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
16869377|NCT01514201|37843021|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
16869378|NCT01514201|37843018|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16869379|NCT01514201|37843019|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16869380|NCT01514201|37843020|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16869381|NCT01514201|37843021|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
16869382|NCT01514201|37843018|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
16869383|NCT01514201|37843019|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
16869384|NCT01514201|37843020|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
16869385|NCT01514201|37843021|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
16869386|NCT01514201|37843018|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16869387|NCT01514201|37843019|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16869388|NCT01514201|37843020|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16869389|NCT01514201|37843021|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
16869390|NCT01514201|37843018|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16869391|NCT01514201|37843019|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16869392|NCT01514201|37843020|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16869393|NCT01514201|37843021|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
16869394|NCT01514201|37843018|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
16869395|NCT01514201|37843019|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
16869396|NCT01514201|37843020|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
16869397|NCT01514201|37843021|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
16869398|NCT02666664|37843043|FG000|Overall Study|Physician Decision|0|||
16869399|NCT02666664|37843044|FG001|Overall Study|Physician Decision|1|||
16869400|NCT02666664|37843043|FG000|Overall Study|Protocol Violation|0|||
16869401|NCT02666664|37843044|FG001|Overall Study|Protocol Violation|2|||
16869402|NCT02666664|37843043|FG000|Overall Study|Other|0|||
16869403|NCT02666664|37843044|FG001|Overall Study|Other|1|||
16869404|NCT02666664|37843043|FG000|Overall Study|Adverse Event|12|||
16869405|NCT02666664|37843044|FG001|Overall Study|Adverse Event|37|||
16869406|NCT02666664|37843043|FG000|Overall Study|Withdrawal by participant|23|||
16869407|NCT02666664|37843044|FG001|Overall Study|Withdrawal by participant|40|||
16869408|NCT02666664|37843043|FG000|Overall Study|Sponsor decision|0|||
16869409|NCT02666664|37843044|FG001|Overall Study|Sponsor decision|1|||
16869410|NCT02666664|37843043|FG000|Overall Study|Lost to Follow-up|1|||
16869411|NCT02666664|37843044|FG001|Overall Study|Lost to Follow-up|2|||
16869412|NCT01528735|37843052|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
16869413|NCT01528735|37843053|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
16869414|NCT01528735|37843052|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
16869415|NCT01528735|37843053|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
16869416|NCT02661594|37843065|FG000|Overall Study|Protocol Violation|1|||
16869417|NCT02661594|37843066|FG001|Overall Study|Protocol Violation|0|||
16869418|NCT02661594|37843067|FG002|Overall Study|Protocol Violation|1|||
16869419|NCT02661594|37843068|FG003|Overall Study|Protocol Violation|0|||
16869420|NCT01528345|37843080|FG000|Overall Study|Adverse Event|10|||
16869421|NCT01528345|37843081|FG001|Overall Study|Adverse Event|1|||
16869422|NCT01528345|37843080|FG000|Overall Study|Death|1|||
16869423|NCT01528345|37843081|FG001|Overall Study|Death|1|||
16869424|NCT01528345|37843080|FG000|Overall Study|Non-compliance with study treatment|1|||
16869425|NCT01528345|37843081|FG001|Overall Study|Non-compliance with study treatment|0|||
16784321|NCT02709109|37724329|FG003|Washout Period (28 Days)|Other|0|||
16869426|NCT01528345|37843080|FG000|Overall Study|Progressive Disease|26|||
16869427|NCT01528345|37843081|FG001|Overall Study|Progressive Disease|40|||
16869428|NCT01528345|37843080|FG000|Overall Study|Study Terminated by Sponsor|4|||
16869429|NCT01528345|37843081|FG001|Overall Study|Study Terminated by Sponsor|8|||
16869430|NCT01528345|37843080|FG000|Overall Study|Subject/Guardian Decision|5|||
16869431|NCT01528345|37843081|FG001|Overall Study|Subject/Guardian Decision|0|||
16869432|NCT01513967|37843095|FG000|Overall Study|Pregnancy|0|||
16869433|NCT01513967|37843096|FG001|Overall Study|Pregnancy|0|||
16869434|NCT01513967|37843097|FG002|Overall Study|Pregnancy|0|||
16869435|NCT01513967|37843098|FG003|Overall Study|Pregnancy|0|||
16869436|NCT01513967|37843099|FG004|Overall Study|Pregnancy|0|||
16869437|NCT01513967|37843100|FG005|Overall Study|Pregnancy|0|||
16869438|NCT01513967|37843101|FG006|Overall Study|Pregnancy|1|||
16869439|NCT01513967|37843102|FG007|Overall Study|Pregnancy|0|||
16869440|NCT01513967|37843095|FG000|Overall Study|missed a study visit|0|||
16869441|NCT01513967|37843096|FG001|Overall Study|missed a study visit|0|||
16869442|NCT01513967|37843097|FG002|Overall Study|missed a study visit|0|||
16869443|NCT01513967|37843098|FG003|Overall Study|missed a study visit|0|||
16869444|NCT01513967|37843099|FG004|Overall Study|missed a study visit|0|||
16869445|NCT01513967|37843100|FG005|Overall Study|missed a study visit|0|||
16869446|NCT01513967|37843101|FG006|Overall Study|missed a study visit|1|||
16869447|NCT01513967|37843102|FG007|Overall Study|missed a study visit|0|||
16869448|NCT01513967|37843095|FG000|Overall Study|excluded due to positive drug screen|0|||
16869449|NCT01513967|37843096|FG001|Overall Study|excluded due to positive drug screen|0|||
16869450|NCT01513967|37843097|FG002|Overall Study|excluded due to positive drug screen|0|||
16869451|NCT01513967|37843098|FG003|Overall Study|excluded due to positive drug screen|0|||
16869452|NCT01513967|37843099|FG004|Overall Study|excluded due to positive drug screen|0|||
16869453|NCT01513967|37843100|FG005|Overall Study|excluded due to positive drug screen|0|||
16869454|NCT01513967|37843101|FG006|Overall Study|excluded due to positive drug screen|0|||
16869455|NCT01513967|37843102|FG007|Overall Study|excluded due to positive drug screen|2|||
16869456|NCT01513967|37843095|FG000|Overall Study|Physician Decision|0|||
16869457|NCT01513967|37843096|FG001|Overall Study|Physician Decision|0|||
16784322|NCT02709109|37724326|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
16784323|NCT02709109|37724327|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
16784324|NCT02709109|37724328|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
16784325|NCT02709109|37724329|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
16784326|NCT02709109|37724326|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
16784327|NCT02709109|37724327|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
16784328|NCT02709109|37724328|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
16869458|NCT01513967|37843097|FG002|Overall Study|Physician Decision|0|||
16869459|NCT01513967|37843098|FG003|Overall Study|Physician Decision|0|||
16869460|NCT01513967|37843099|FG004|Overall Study|Physician Decision|0|||
16869461|NCT01513967|37843100|FG005|Overall Study|Physician Decision|1|||
16869462|NCT01513967|37843101|FG006|Overall Study|Physician Decision|0|||
16869463|NCT01513967|37843102|FG007|Overall Study|Physician Decision|0|||
16869464|NCT01511939|37843146|FG000|Overall Study|Withdrawal by Subject|2|||
17094773|NCT00219141|38234018|FG000|Overall Study|Condition no longer requires study drug|1|||
17094774|NCT00219141|38234019|FG001|Overall Study|Condition no longer requires study drug|0|||
16784329|NCT02709109|37724329|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
16869465|NCT01511939|37843147|FG001|Overall Study|Withdrawal by Subject|1|||
16869466|NCT01511939|37843148|FG002|Overall Study|Withdrawal by Subject|0|||
16869467|NCT01576705|37843160|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
16869468|NCT01576705|37843161|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
16869469|NCT01576705|37843162|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
16784330|NCT02709109|37724326|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
16784331|NCT02709109|37724327|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
16784332|NCT02709109|37724328|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
16784333|NCT02709109|37724329|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
16784334|NCT02709109|37724326|FG000|Treatment Period 2 (28 Days)|Other|0|||
16784335|NCT02709109|37724327|FG001|Treatment Period 2 (28 Days)|Other|0|||
16784336|NCT02709109|37724328|FG002|Treatment Period 2 (28 Days)|Other|1|||
16784337|NCT02709109|37724329|FG003|Treatment Period 2 (28 Days)|Other|0|||
16869470|NCT01576705|37843163|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
16869471|NCT01576705|37843160|FG000|Overall Study|invalid ICF|0|||
16869472|NCT01576705|37843161|FG001|Overall Study|invalid ICF|1|||
16869473|NCT01576705|37843162|FG002|Overall Study|invalid ICF|0|||
16869474|NCT01576705|37843163|FG003|Overall Study|invalid ICF|0|||
16869475|NCT02666430|37843175|FG000|Period 1|Lost to Follow-up|1|||
16869476|NCT02666430|37843176|FG001|Period 1|Lost to Follow-up|0|||
16869477|NCT02666430|37843175|FG000|Period 1|Adverse Event|0|||
16869478|NCT02666430|37843176|FG001|Period 1|Adverse Event|1|||
16869479|NCT02666430|37843175|FG000|Period 2|Withdrawal by Subject|1|||
16869480|NCT02666430|37843176|FG001|Period 2|Withdrawal by Subject|4|||
16869481|NCT02666430|37843175|FG000|Period 3|Lost to Follow-up|1|||
16869482|NCT02666430|37843176|FG001|Period 3|Lost to Follow-up|0|||
16869483|NCT01576549|37843182|FG000|Overall Study|Sponsor Decision|2|||
16869484|NCT01576159|37843195|FG000|Overall Study|Withdrawal by Subject|0|||
16869485|NCT01576159|37843196|FG001|Overall Study|Withdrawal by Subject|1|||
16869486|NCT01576159|37843197|FG002|Overall Study|Withdrawal by Subject|0|||
16869487|NCT01576159|37843198|FG003|Overall Study|Withdrawal by Subject|0|||
16869488|NCT01576159|37843195|FG000|Overall Study|Physician Decision|0|||
16869489|NCT01576159|37843196|FG001|Overall Study|Physician Decision|0|||
16869490|NCT01576159|37843197|FG002|Overall Study|Physician Decision|1|||
16869491|NCT01576159|37843198|FG003|Overall Study|Physician Decision|0|||
16869492|NCT01576159|37843195|FG000|Overall Study|Lost to Follow-up|0|||
16869493|NCT01576159|37843196|FG001|Overall Study|Lost to Follow-up|0|||
16869494|NCT01576159|37843197|FG002|Overall Study|Lost to Follow-up|0|||
16869495|NCT01576159|37843198|FG003|Overall Study|Lost to Follow-up|1|||
16869496|NCT01576159|37843195|FG000|Overall Study|Protocol Violation|1|||
16869497|NCT01576159|37843196|FG001|Overall Study|Protocol Violation|0|||
16869498|NCT01576159|37843197|FG002|Overall Study|Protocol Violation|0|||
16869499|NCT01576159|37843198|FG003|Overall Study|Protocol Violation|0|||
16869500|NCT01510769|37843229|FG000|Overall Study|Adverse Event|7|||
16869501|NCT01510769|37843230|FG001|Overall Study|Adverse Event|6|||
16869502|NCT01510769|37843231|FG002|Overall Study|Adverse Event|4|||
16869503|NCT01510769|37843229|FG000|Overall Study|Gout Flare|0|||
16869504|NCT01510769|37843230|FG001|Overall Study|Gout Flare|3|||
16869505|NCT01510769|37843231|FG002|Overall Study|Gout Flare|1|||
16869506|NCT01510769|37843229|FG000|Overall Study|Protocol Violation|11|||
16869507|NCT01510769|37843230|FG001|Overall Study|Protocol Violation|10|||
16869508|NCT01510769|37843231|FG002|Overall Study|Protocol Violation|9|||
16869509|NCT01510769|37843229|FG000|Overall Study|Lost to Follow-up|5|||
16869510|NCT01510769|37843230|FG001|Overall Study|Lost to Follow-up|1|||
16869511|NCT01510769|37843231|FG002|Overall Study|Lost to Follow-up|5|||
16869512|NCT01510769|37843229|FG000|Overall Study|Withdrawal by Subject|3|||
16869513|NCT01510769|37843230|FG001|Overall Study|Withdrawal by Subject|4|||
16869514|NCT01510769|37843231|FG002|Overall Study|Withdrawal by Subject|3|||
16869515|NCT01510769|37843229|FG000|Overall Study|Death|1|||
16869516|NCT01510769|37843230|FG001|Overall Study|Death|1|||
16869517|NCT01510769|37843231|FG002|Overall Study|Death|0|||
16869518|NCT01575769|37843239|FG000|Overall Study|Adverse Event|1|||
16869519|NCT01575769|37843239|FG000|Overall Study|Study terminated by sponsor|40|||
16869520|NCT01510145|37843245|FG000|Overall Study|Adverse Event|6|||
16869521|NCT01510145|37843245|FG000|Overall Study|Lost to Follow-up|5|||
16869522|NCT01510145|37843245|FG000|Overall Study|Withdrawal by Subject|6|||
16869523|NCT01510145|37843245|FG000|Overall Study|Relative reported subject withdrew|1|||
16869524|NCT01528033|37843251|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
16869525|NCT01528033|37843252|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
16869526|NCT01528033|37843251|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
16869527|NCT01528033|37843252|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
16869528|NCT01528033|37843251|FG000|Primary Endpoint Assessment ITT|Death|2|||
16869529|NCT01528033|37843252|FG001|Primary Endpoint Assessment ITT|Death|2|||
16869530|NCT01528033|37843251|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
16869531|NCT01528033|37843252|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
16869532|NCT01528033|37843251|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
16869533|NCT01528033|37843252|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
16869534|NCT01528033|37843251|FG000|Follow Up|No data available|46|||
16869535|NCT01528033|37843252|FG001|Follow Up|No data available|44|||
16869536|NCT01560871|37843269|FG000|Overall Study|transportation issues|2|||
16869537|NCT01560871|37843270|FG001|Overall Study|transportation issues|1|||
16869538|NCT01560871|37843269|FG000|Overall Study|relocation|1|||
16869539|NCT01560871|37843270|FG001|Overall Study|relocation|0|||
16869540|NCT01560871|37843269|FG000|Overall Study|readmission to a hospital|2|||
16869541|NCT01560871|37843270|FG001|Overall Study|readmission to a hospital|1|||
16869542|NCT01560871|37843269|FG000|Overall Study|Lost to Follow-up|1|||
16869543|NCT01560871|37843270|FG001|Overall Study|Lost to Follow-up|0|||
16869544|NCT01509053|37843277|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
16869545|NCT01509053|37843277|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
16869546|NCT01509053|37843277|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
16869547|NCT01509053|37843277|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
16869548|NCT01509053|37843277|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
16869549|NCT01509053|37843277|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
16869550|NCT01560403|37843291|FG000|Overall Study|Lost to Follow-up|0|||
16869551|NCT01560403|37843292|FG001|Overall Study|Lost to Follow-up|1|||
16869552|NCT01527487|37843339|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
16869553|NCT01527487|37843340|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
16869554|NCT01527487|37843339|FG000|Overall Study|Disease Progression|4|||
16869555|NCT01527487|37843340|FG001|Overall Study|Disease Progression|1|||
16784338|NCT04289051|37724344|FG000|Overall Study|Lost to Follow-up|0|||
16784339|NCT04289051|37724345|FG001|Overall Study|Lost to Follow-up|0|||
16784340|NCT04289051|37724346|FG002|Overall Study|Lost to Follow-up|2|||
16784341|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
16784342|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
16784343|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
16784344|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
16784345|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
16784346|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
16869556|NCT01527487|37843339|FG000|Overall Study|Adverse Event|1|||
16869557|NCT01527487|37843340|FG001|Overall Study|Adverse Event|1|||
16869558|NCT01527487|37843339|FG000|Overall Study|Death|0|||
16869559|NCT01527487|37843340|FG001|Overall Study|Death|1|||
16869560|NCT01506947|37843351|FG000|Overall Study|Lost to Follow-up|7|||
16869561|NCT01506947|37843351|FG000|Overall Study|Adverse Event|5|||
16869562|NCT01506947|37843351|FG000|Overall Study|Death|1|||
16869563|NCT01506947|37843351|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
16869564|NCT02665338|37843368|FG000|Overall Study|Withdrawal by Subject|0|||
16869565|NCT02665338|37843369|FG001|Overall Study|Withdrawal by Subject|1|||
16869566|NCT01506479|37843378|FG000|Overall Study|Lost to Follow-up|1|||
16869567|NCT01506479|37843379|FG001|Overall Study|Lost to Follow-up|2|||
16869568|NCT01506479|37843380|FG002|Overall Study|Lost to Follow-up|2|||
16869569|NCT01506479|37843378|FG000|Overall Study|Withdrawal by Subject|1|||
16869570|NCT01506479|37843379|FG001|Overall Study|Withdrawal by Subject|2|||
16869571|NCT01506479|37843380|FG002|Overall Study|Withdrawal by Subject|1|||
16869572|NCT01506479|37843378|FG000|Overall Study|Missing assessment|1|||
16869573|NCT01506479|37843379|FG001|Overall Study|Missing assessment|0|||
16869574|NCT01506479|37843380|FG002|Overall Study|Missing assessment|0|||
16869575|NCT01506479|37843378|FG000|Overall Study|Adverse Event|0|||
16869576|NCT01506479|37843379|FG001|Overall Study|Adverse Event|1|||
17000860|NCT00666679|38144803|FG001|Second Intervention|Adverse Event|0|||
16869577|NCT01506479|37843380|FG002|Overall Study|Adverse Event|0|||
16869578|NCT01506323|37843404|FG000|Overall Study|Lost to Follow-up|5|||
16869579|NCT01506323|37843405|FG001|Overall Study|Lost to Follow-up|4|||
16869580|NCT01506323|37843404|FG000|Overall Study|Withdrawal by Subject|4|||
17000861|NCT00666679|38144802|FG000|Second Intervention|Death|0|||
16869581|NCT01506323|37843405|FG001|Overall Study|Withdrawal by Subject|4|||
16869582|NCT01506323|37843404|FG000|Overall Study|Lack of Efficacy|1|||
16869583|NCT01506323|37843405|FG001|Overall Study|Lack of Efficacy|3|||
16869584|NCT01506323|37843404|FG000|Overall Study|Moved out of area|5|||
16869585|NCT01506323|37843405|FG001|Overall Study|Moved out of area|2|||
16869586|NCT01506323|37843404|FG000|Overall Study|Schedule or Transportation conflict|8|||
16869587|NCT01506323|37843405|FG001|Overall Study|Schedule or Transportation conflict|0|||
17000862|NCT00666679|38144803|FG001|Second Intervention|Death|1|||
17191035|NCT02477800|38343811|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
17191036|NCT02477800|38343812|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
16869588|NCT01506323|37843404|FG000|Overall Study|Started another treatment|1|||
16869589|NCT01506323|37843405|FG001|Overall Study|Started another treatment|0|||
16869590|NCT01505387|37843418|FG000|Overall Study|Protocol Violation|1|||
16869591|NCT01505387|37843419|FG001|Overall Study|Protocol Violation|0|||
16869592|NCT01505387|37843418|FG000|Overall Study|Withdrawal by Subject|1|||
16869593|NCT01505387|37843419|FG001|Overall Study|Withdrawal by Subject|1|||
16869594|NCT01559935|37843425|FG000|Car Phase|Toxicity|4|||
16869595|NCT01559935|37843425|FG000|Car Phase|Death|1|||
16869596|NCT01559935|37843425|FG000|Car Phase|Lack of Efficacy|2|||
16869597|NCT01559935|37843425|FG000|Car Phase|Lost to Follow-up|1|||
16869598|NCT01559935|37843425|FG000|Car Phase|Physician Decision|1|||
16869599|NCT01559935|37843425|FG000|Car Phase|Withdrawal by Subject|2|||
16869600|NCT01559935|37843425|FG000|Car Phase|Per protocol|1|||
16869601|NCT01559935|37843425|FG000|Car Phase|Insurance|1|||
16869602|NCT01559935|37843425|FG000|Car Phase|non-compliance|1|||
16869603|NCT01559935|37843425|FG000|BiRD Phase|Toxicity|1|||
17094775|NCT00219141|38234020|FG002|Overall Study|Condition no longer requires study drug|0|||
17094776|NCT00142935|38234031|FG000|Overall Study|Other reason|1|||
17094777|NCT00142935|38234032|FG001|Overall Study|Other reason|1|||
17094778|NCT00142935|38234033|FG002|Overall Study|Other reason|1|||
17094779|NCT00142935|38234031|FG000|Overall Study|Lost to Follow-up|2|||
17094780|NCT00142935|38234032|FG001|Overall Study|Lost to Follow-up|5|||
17094781|NCT00142935|38234033|FG002|Overall Study|Lost to Follow-up|5|||
17094782|NCT00142935|38234031|FG000|Overall Study|Death|0|||
17094783|NCT00142935|38234032|FG001|Overall Study|Death|2|||
17094784|NCT00142935|38234033|FG002|Overall Study|Death|1|||
17094785|NCT00233948|38234047|FG000|Overall Study|Adverse Event|1|||
17094786|NCT00233948|38234048|FG001|Overall Study|Adverse Event|0|||
17094787|NCT00233948|38234049|FG002|Overall Study|Adverse Event|0|||
16869604|NCT01559935|37843425|FG000|BiRD Phase|Lack of Efficacy|1|||
16869605|NCT01559935|37843425|FG000|BiRD Phase|Withdrawal by Subject|2|||
16869606|NCT01559935|37843425|FG000|Maintenance Phase|Remains on study|28|||
16869607|NCT01559935|37843425|FG000|Maintenance Phase|Toxicity|1|||
16869608|NCT01559935|37843425|FG000|Maintenance Phase|Lack of Efficacy|18|||
16869609|NCT01559935|37843425|FG000|Maintenance Phase|Withdrawal by Subject|5|||
16869610|NCT01559935|37843425|FG000|Maintenance Phase|Non-compliance|2|||
16869611|NCT01504841|37843520|FG000|Overall Study|Withdrawal by Subject|1|||
16869612|NCT01504841|37843521|FG001|Overall Study|Withdrawal by Subject|1|||
16869613|NCT01504841|37843522|FG002|Overall Study|Withdrawal by Subject|0|||
16869614|NCT01502423|37843535|FG000|Overall Study|Withdrawal by Subject|0|||
16869615|NCT01502423|37843536|FG001|Overall Study|Withdrawal by Subject|1|||
16869616|NCT01502033|37843542|FG000|Overall Study|1 participant had scalp discomfort|1|||
16869617|NCT01502033|37843542|FG000|Overall Study|1 participant had worsening depression|1|||
16869618|NCT01502033|37843542|FG000|Overall Study|1 participant went back to school|1|||
16869619|NCT01500629|37843550|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
16869620|NCT01500629|37843551|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
16869621|NCT01500317|37843567|FG000|Overall Study|Withdrawal by Subject|3|||
16869622|NCT01500317|37843568|FG001|Overall Study|Withdrawal by Subject|2|||
16869623|NCT01500317|37843569|FG002|Overall Study|Withdrawal by Subject|0|||
16869624|NCT01500083|37843624|FG000|Overall Study|Adverse Event|4|||
16869625|NCT01500083|37843625|FG001|Overall Study|Adverse Event|17|||
16869626|NCT01500083|37843624|FG000|Overall Study|Death|0|||
16869627|NCT01500083|37843625|FG001|Overall Study|Death|2|||
16869628|NCT01500083|37843624|FG000|Overall Study|Lost to Follow-up|1|||
16869629|NCT01500083|37843625|FG001|Overall Study|Lost to Follow-up|0|||
16869630|NCT01500083|37843624|FG000|Overall Study|Withdrawal of Consent|0|||
16869631|NCT01500083|37843625|FG001|Overall Study|Withdrawal of Consent|1|||
16869632|NCT01500083|37843624|FG000|Overall Study|Disease Progression|2|||
16869633|NCT01500083|37843625|FG001|Overall Study|Disease Progression|10|||
16869634|NCT01500083|37843624|FG000|Overall Study|Investigator Discretion|3|||
16869635|NCT01500083|37843625|FG001|Overall Study|Investigator Discretion|8|||
16869636|NCT01500083|37843624|FG000|Overall Study|Other Reasons|2|||
16869637|NCT01500083|37843625|FG001|Overall Study|Other Reasons|5|||
17000863|NCT00595413|38144813|FG000|Overall Study|Adverse Event|0|||
17094788|NCT00233948|38234050|FG003|Overall Study|Adverse Event|0|||
17094789|NCT00233948|38234051|FG004|Overall Study|Adverse Event|0|||
17094790|NCT00233948|38234052|FG005|Overall Study|Adverse Event|0|||
17094791|NCT00233480|38234069|FG000|Overall Study|Underwent status II heart transplant|0|||
16869638|NCT01499849|37843655|FG000|Overall Study|Adverse Event|28|||
16869639|NCT01499849|37843656|FG001|Overall Study|Adverse Event|32|||
16869640|NCT01499849|37843655|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
17094792|NCT00233480|38234070|FG001|Overall Study|Underwent status II heart transplant|1|||
17094793|NCT03801928|38234084|FG000|Overall Study|Adverse Event|1|||
16869641|NCT01499849|37843656|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
16869642|NCT01499849|37843655|FG000|Overall Study|Withdrawal by Subject|43|||
16869643|NCT01499849|37843656|FG001|Overall Study|Withdrawal by Subject|43|||
16869644|NCT01499849|37843655|FG000|Overall Study|Death|5|||
16869645|NCT01499849|37843656|FG001|Overall Study|Death|7|||
16869646|NCT01499849|37843655|FG000|Overall Study|Disease Progression|11|||
16869647|NCT01499849|37843656|FG001|Overall Study|Disease Progression|10|||
16869648|NCT01499849|37843655|FG000|Overall Study|Protocol Violation|11|||
16869649|NCT01499849|37843656|FG001|Overall Study|Protocol Violation|11|||
16869650|NCT01499849|37843655|FG000|Overall Study|Physician Decision|20|||
16869651|NCT01499849|37843656|FG001|Overall Study|Physician Decision|19|||
16869652|NCT01499849|37843655|FG000|Overall Study|Lack of Efficacy|3|||
16869653|NCT01499849|37843656|FG001|Overall Study|Lack of Efficacy|4|||
16869654|NCT01499849|37843655|FG000|Overall Study|Lost to Follow-up|6|||
16869655|NCT01499849|37843656|FG001|Overall Study|Lost to Follow-up|3|||
16869656|NCT01499849|37843655|FG000|Overall Study|Other Reasons|27|||
16869657|NCT01499849|37843656|FG001|Overall Study|Other Reasons|30|||
16869658|NCT01499303|37843684|FG000|Overall Study|Ongoing|2|||
16869659|NCT01499303|37843685|FG001|Overall Study|Ongoing|1|||
16869660|NCT01499303|37843684|FG000|Overall Study|Withdrawal by Subject|0|||
16869661|NCT01499303|37843685|FG001|Overall Study|Withdrawal by Subject|1|||
16869662|NCT01499303|37843684|FG000|Overall Study|Adverse Event|1|||
16869663|NCT01499303|37843685|FG001|Overall Study|Adverse Event|4|||
16869664|NCT01499303|37843684|FG000|Overall Study|Other|0|||
16869665|NCT01499303|37843685|FG001|Overall Study|Other|1|||
16869666|NCT01498679|37843706|FG000|Overall Study|Adverse Event|1|||
16869667|NCT01498679|37843707|FG001|Overall Study|Adverse Event|4|||
16869668|NCT01498679|37843706|FG000|Overall Study|Lack of Efficacy|72|||
16869669|NCT01498679|37843707|FG001|Overall Study|Lack of Efficacy|12|||
16869670|NCT01498679|37843706|FG000|Overall Study|Protocol Violation|4|||
16869671|NCT01498679|37843707|FG001|Overall Study|Protocol Violation|0|||
16869672|NCT01498679|37843706|FG000|Overall Study|Physician Decision|0|||
16869673|NCT01498679|37843707|FG001|Overall Study|Physician Decision|2|||
16869674|NCT01498679|37843706|FG000|Overall Study|Withdrawal by Subject|12|||
16869675|NCT01498679|37843707|FG001|Overall Study|Withdrawal by Subject|4|||
16869676|NCT01526785|37843730|FG000|Overall Study|Study Terminated by Sponsor|8|||
16869677|NCT01526785|37843730|FG000|Overall Study|Death|2|||
16869678|NCT01526785|37843730|FG000|Overall Study|Physician Decision|1|||
16869679|NCT01526785|37843730|FG000|Overall Study|Withdrawal by Subject|2|||
16869680|NCT01559389|37843736|FG000|Overall Study|Withdrawal by Subject|20|||
16869681|NCT01559389|37843737|FG001|Overall Study|Withdrawal by Subject|20|||
16869682|NCT01526551|37843747|FG000|Overall Study|Lack of returned parental consent form|424|||
16869683|NCT01559311|37843825|FG000|Overall Study|Protocol Violation|0|||
16869684|NCT01559311|37843826|FG001|Overall Study|Protocol Violation|0|||
16869685|NCT01559311|37843827|FG002|Overall Study|Protocol Violation|2|||
16869686|NCT01559311|37843825|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
16869687|NCT01559311|37843826|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
16869688|NCT01559311|37843827|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
16869689|NCT01559311|37843825|FG000|Overall Study|Withdrawal by Subject|2|||
16869690|NCT01559311|37843826|FG001|Overall Study|Withdrawal by Subject|1|||
16869691|NCT01559311|37843827|FG002|Overall Study|Withdrawal by Subject|0|||
16869692|NCT01559311|37843825|FG000|Overall Study|Death|0|||
16869693|NCT01559311|37843826|FG001|Overall Study|Death|2|||
16869694|NCT01559311|37843827|FG002|Overall Study|Death|3|||
16869695|NCT01559311|37843825|FG000|Overall Study|Lost to Follow-up|0|||
16869696|NCT01559311|37843826|FG001|Overall Study|Lost to Follow-up|3|||
16869697|NCT01559311|37843827|FG002|Overall Study|Lost to Follow-up|2|||
16869698|NCT01559311|37843825|FG000|Overall Study|Adverse Event|0|||
16869699|NCT01559311|37843826|FG001|Overall Study|Adverse Event|0|||
16869700|NCT01559311|37843827|FG002|Overall Study|Adverse Event|1|||
16869701|NCT01498445|37843850|FG000|Overall Study|Lack of Efficacy|0|||
16869702|NCT01498445|37843851|FG001|Overall Study|Lack of Efficacy|0|||
16869703|NCT01498445|37843852|FG002|Overall Study|Lack of Efficacy|1|||
16869704|NCT01498445|37843853|FG003|Overall Study|Lack of Efficacy|2|||
16869705|NCT01498445|37843854|FG004|Overall Study|Lack of Efficacy|0|||
16869706|NCT01498445|37843855|FG005|Overall Study|Lack of Efficacy|0|||
16869707|NCT01498445|37843850|FG000|Overall Study|Screen Failure|0|||
16869708|NCT01498445|37843851|FG001|Overall Study|Screen Failure|0|||
16869709|NCT01498445|37843852|FG002|Overall Study|Screen Failure|0|||
16869710|NCT01498445|37843853|FG003|Overall Study|Screen Failure|0|||
16869711|NCT01498445|37843854|FG004|Overall Study|Screen Failure|1|||
16869712|NCT01498445|37843855|FG005|Overall Study|Screen Failure|1|||
16869713|NCT01558297|37843872|FG000|Overall Study|Withdrawal by Subject|2|||
16869714|NCT01558297|37843873|FG001|Overall Study|Withdrawal by Subject|2|||
16869715|NCT01558297|37843874|FG002|Overall Study|Withdrawal by Subject|1|||
16869716|NCT01525849|37843884|FG000|Overall Study|Lost to Follow-up|3|||
16869717|NCT01525849|37843885|FG001|Overall Study|Lost to Follow-up|2|||
16869718|NCT01525849|37843884|FG000|Overall Study|Withdrawal by Subject|1|||
16869719|NCT01525849|37843885|FG001|Overall Study|Withdrawal by Subject|9|||
16869720|NCT01525849|37843884|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
16869721|NCT01525849|37843885|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
16869722|NCT01525849|37843884|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
16869723|NCT01525849|37843885|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
16869724|NCT01525615|37843904|FG000|Overall Study|Adverse Event|11|||
16869725|NCT01525615|37843905|FG001|Overall Study|Adverse Event|7|||
16869726|NCT01525615|37843906|FG002|Overall Study|Adverse Event|5|||
16869727|NCT01525615|37843904|FG000|Overall Study|Lost to Follow-up|1|||
16869728|NCT01525615|37843905|FG001|Overall Study|Lost to Follow-up|0|||
16869729|NCT01525615|37843906|FG002|Overall Study|Lost to Follow-up|0|||
16869730|NCT01525615|37843904|FG000|Overall Study|Withdrawal by Subject|1|||
16869731|NCT01525615|37843905|FG001|Overall Study|Withdrawal by Subject|0|||
16869732|NCT01525615|37843906|FG002|Overall Study|Withdrawal by Subject|0|||
16869733|NCT01525615|37843904|FG000|Overall Study|Other reason not described above|1|||
16869734|NCT01525615|37843905|FG001|Overall Study|Other reason not described above|0|||
16869735|NCT01525615|37843906|FG002|Overall Study|Other reason not described above|1|||
16869736|NCT01525225|37843948|FG000|Enrollment|No longer met study criteria|1|||
16869737|NCT01525225|37843948|FG000|Enrollment|Other|1|||
16869738|NCT02660580|37843967|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
16869739|NCT02660580|37843968|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
16869740|NCT02660580|37843969|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
16869741|NCT02660580|37843970|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
16869742|NCT02660580|37843971|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
16869743|NCT02660580|37843967|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
16869744|NCT02660580|37843968|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
16869745|NCT02660580|37843969|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
16869746|NCT02660580|37843970|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
16869747|NCT02660580|37843971|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
16869748|NCT02660580|37843967|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
16869749|NCT02660580|37843968|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
16869750|NCT02660580|37843969|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
16869751|NCT02660580|37843970|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
16869752|NCT02660580|37843971|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
16869753|NCT02660580|37843967|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
16869754|NCT02660580|37843968|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
16869755|NCT02660580|37843969|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
16869756|NCT02660580|37843970|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
16869757|NCT02660580|37843971|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
16869758|NCT02660580|37843967|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
16869759|NCT02660580|37843968|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
16869760|NCT02660580|37843969|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
16869761|NCT02660580|37843970|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
16869762|NCT02660580|37843971|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
16869763|NCT02660580|37843967|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
16869764|NCT02660580|37843968|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
16869765|NCT02660580|37843969|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
16869766|NCT02660580|37843970|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
16869767|NCT02660580|37843971|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
16869768|NCT02660580|37843967|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
16869769|NCT02660580|37843968|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
16869770|NCT02660580|37843969|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
16869771|NCT02660580|37843970|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
16869772|NCT02660580|37843971|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
16869773|NCT02660580|37843967|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
16869774|NCT02660580|37843968|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
16869775|NCT02660580|37843969|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
16869776|NCT02660580|37843970|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
16869777|NCT02660580|37843971|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
16869778|NCT02660580|37843967|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
16869779|NCT02660580|37843968|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
16869780|NCT02660580|37843969|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
16869781|NCT02660580|37843970|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
16869782|NCT02660580|37843971|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
17000864|NCT00595413|38144814|FG001|Overall Study|Adverse Event|2|||
17000865|NCT00595413|38144815|FG002|Overall Study|Adverse Event|1|||
17000866|NCT00595413|38144816|FG003|Overall Study|Adverse Event|1|||
17000867|NCT00595413|38144813|FG000|Overall Study|Lost to Follow-up|2|||
17000868|NCT00595413|38144814|FG001|Overall Study|Lost to Follow-up|2|||
17000869|NCT00595413|38144815|FG002|Overall Study|Lost to Follow-up|1|||
17000870|NCT00595413|38144816|FG003|Overall Study|Lost to Follow-up|3|||
17000871|NCT00595413|38144813|FG000|Overall Study|Death|0|||
16869783|NCT02660580|37843967|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
16869784|NCT02660580|37843968|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
16869785|NCT02660580|37843969|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
16869786|NCT02660580|37843970|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
16869787|NCT02660580|37843971|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
16869788|NCT02660580|37843967|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
16869789|NCT02660580|37843968|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
16869790|NCT02660580|37843969|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
16869791|NCT02660580|37843970|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
16869792|NCT02660580|37843971|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
16869793|NCT02660580|37843967|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
16869794|NCT02660580|37843968|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
16869795|NCT02660580|37843969|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
16869796|NCT02660580|37843970|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
16869797|NCT02660580|37843971|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
16869798|NCT02660580|37843967|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
16869799|NCT02660580|37843968|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
16869800|NCT02660580|37843969|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
16869801|NCT02660580|37843970|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
16869802|NCT02660580|37843971|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
16869803|NCT01524991|37843990|FG000|Overall Study|Adverse Event|12|||
16869804|NCT01524991|37843990|FG000|Overall Study|Death|1|||
16869805|NCT01524991|37843990|FG000|Overall Study|Disease ProgressionDu|17|||
16784347|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
16784348|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
16784349|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
16784350|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
16869806|NCT01524991|37843990|FG000|Overall Study|Other complicating disease|1|||
16869807|NCT01524991|37843990|FG000|Overall Study|Withdrawal by Subject|2|||
16784351|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
16869808|NCT01524991|37843990|FG000|Overall Study|Symptomatic Deterioration|1|||
16869809|NCT01524913|37843997|FG000|Overall Study|Lost to Follow-up|4|||
16869810|NCT01524913|37843998|FG001|Overall Study|Lost to Follow-up|0|||
16869811|NCT01524913|37843999|FG002|Overall Study|Lost to Follow-up|0|||
16869812|NCT01524679|37844009|FG000|Overall Study|Lost to Follow-up|1|||
16869813|NCT01524679|37844010|FG001|Overall Study|Lost to Follow-up|4|||
16869814|NCT01524679|37844009|FG000|Overall Study|Withdrawal by Subject|4|||
16869815|NCT01524679|37844010|FG001|Overall Study|Withdrawal by Subject|4|||
16869816|NCT01524679|37844009|FG000|Overall Study|Adverse Event|9|||
16869817|NCT01524679|37844010|FG001|Overall Study|Adverse Event|0|||
16784352|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
16784353|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
16869818|NCT01524679|37844009|FG000|Overall Study|Protocol Violation|1|||
16869819|NCT01524679|37844010|FG001|Overall Study|Protocol Violation|0|||
16869820|NCT01524679|37844009|FG000|Overall Study|Lack of Efficacy|2|||
16869821|NCT01524679|37844010|FG001|Overall Study|Lack of Efficacy|0|||
16869822|NCT01524679|37844009|FG000|Overall Study|e.g.wish for children, relocation|6|||
16869823|NCT01524679|37844010|FG001|Overall Study|e.g.wish for children, relocation|1|||
16869824|NCT01524289|37844018|FG000|Overall Study|Lost to Follow-up|0|||
16869825|NCT01524289|37844019|FG001|Overall Study|Lost to Follow-up|1|||
16869826|NCT01524289|37844018|FG000|Overall Study|Physician Decision|1|||
16869827|NCT01524289|37844019|FG001|Overall Study|Physician Decision|0|||
16869828|NCT01524289|37844018|FG000|Overall Study|Protocol Violation|5|||
16869829|NCT01524289|37844019|FG001|Overall Study|Protocol Violation|1|||
16869830|NCT01524289|37844018|FG000|Overall Study|Withdrawal by Subject|11|||
16869831|NCT01524289|37844019|FG001|Overall Study|Withdrawal by Subject|7|||
16869832|NCT01524289|37844018|FG000|Overall Study|Adverse Event|12|||
16869833|NCT01524289|37844019|FG001|Overall Study|Adverse Event|5|||
16869834|NCT01524289|37844018|FG000|Overall Study|Did not take study medication|1|||
16869835|NCT01524289|37844019|FG001|Overall Study|Did not take study medication|0|||
16869836|NCT01498289|37844029|FG000|Overall Study|Adverse Event|16|||
16784354|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
16784355|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
16784356|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
16784357|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
16784358|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
16784359|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
16784360|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
16784361|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
16869837|NCT01498289|37844030|FG001|Overall Study|Adverse Event|18|||
16869838|NCT01498289|37844029|FG000|Overall Study|Death|6|||
16869839|NCT01498289|37844030|FG001|Overall Study|Death|8|||
16869840|NCT01498289|37844029|FG000|Overall Study|Withdrawal unrelated to AE|16|||
16869841|NCT01498289|37844030|FG001|Overall Study|Withdrawal unrelated to AE|16|||
16869842|NCT01498289|37844029|FG000|Overall Study|Progression/relapse|53|||
16869843|NCT01498289|37844030|FG001|Overall Study|Progression/relapse|59|||
16869844|NCT01498289|37844029|FG000|Overall Study|Not protocol specified|7|||
16869845|NCT01498289|37844030|FG001|Overall Study|Not protocol specified|2|||
16869846|NCT01498289|37844029|FG000|Overall Study|Reason under review|0|||
16869847|NCT01498289|37844030|FG001|Overall Study|Reason under review|1|||
16869848|NCT01524133|37844043|FG000|Treatment Phase|Withdrawal by Subject|13|||
16869849|NCT01524133|37844044|FG001|Treatment Phase|Withdrawal by Subject|28|||
16869850|NCT01524133|37844045|FG002|Treatment Phase|Withdrawal by Subject|31|||
16869851|NCT01524133|37844043|FG000|Treatment Phase|Physician Decision|6|||
16869852|NCT01524133|37844044|FG001|Treatment Phase|Physician Decision|3|||
16869853|NCT01524133|37844045|FG002|Treatment Phase|Physician Decision|3|||
16869854|NCT01524133|37844043|FG000|Treatment Phase|Lost to Follow-up|0|||
16869855|NCT01524133|37844044|FG001|Treatment Phase|Lost to Follow-up|1|||
16869856|NCT01524133|37844045|FG002|Treatment Phase|Lost to Follow-up|2|||
16869857|NCT01524133|37844043|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
16869858|NCT01524133|37844044|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
17000872|NCT00595413|38144814|FG001|Overall Study|Death|0|||
17000873|NCT00595413|38144815|FG002|Overall Study|Death|1|||
17000874|NCT00595413|38144816|FG003|Overall Study|Death|0|||
17000875|NCT00595413|38144813|FG000|Overall Study|Other|5|||
17000876|NCT00595413|38144814|FG001|Overall Study|Other|1|||
17000877|NCT00595413|38144815|FG002|Overall Study|Other|5|||
16784362|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
16784363|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
17191037|NCT02477800|38343806|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
17191038|NCT02477800|38343807|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
17191039|NCT02477800|38343808|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
17191040|NCT02477800|38343809|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
17191041|NCT02477800|38343810|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
17191042|NCT02477800|38343811|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
17191043|NCT02477800|38343812|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
17191044|NCT02477800|38343806|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
17191045|NCT02477800|38343807|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
17191046|NCT02477800|38343808|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
17191047|NCT02477800|38343809|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
17191048|NCT02477800|38343810|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
17191049|NCT02477800|38343811|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
17191050|NCT02477800|38343812|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
17191051|NCT02477800|38343806|FG000|Placebo-Controlled Period|Reason not Specified|161|||
17191052|NCT02477800|38343807|FG001|Placebo-Controlled Period|Reason not Specified|161|||
17191053|NCT02477800|38343808|FG002|Placebo-Controlled Period|Reason not Specified|189|||
17191054|NCT02477800|38343809|FG003|Placebo-Controlled Period|Reason not Specified|0|||
17094794|NCT03801928|38234085|FG001|Overall Study|Adverse Event|0|||
17094795|NCT03801928|38234086|FG002|Overall Study|Adverse Event|1|||
17094796|NCT03801928|38234087|FG003|Overall Study|Adverse Event|2|||
17191055|NCT02477800|38343810|FG004|Placebo-Controlled Period|Reason not Specified|0|||
17191056|NCT02477800|38343811|FG005|Placebo-Controlled Period|Reason not Specified|0|||
17191057|NCT02477800|38343812|FG006|Placebo-Controlled Period|Reason not Specified|0|||
17191058|NCT02477800|38343806|FG000|Long Term Extension Period|Adverse Event|0|||
17191059|NCT02477800|38343807|FG001|Long Term Extension Period|Adverse Event|0|||
17000878|NCT00595413|38144816|FG003|Overall Study|Other|0|||
17094797|NCT03801928|38234088|FG004|Overall Study|Adverse Event|0|||
17094798|NCT03801928|38234089|FG005|Overall Study|Adverse Event|2|||
17094799|NCT03801928|38234084|FG000|Overall Study|Lack of Efficacy|0|||
17094800|NCT03801928|38234085|FG001|Overall Study|Lack of Efficacy|0|||
17094801|NCT03801928|38234086|FG002|Overall Study|Lack of Efficacy|1|||
17094802|NCT03801928|38234087|FG003|Overall Study|Lack of Efficacy|0|||
17191060|NCT02477800|38343808|FG002|Long Term Extension Period|Adverse Event|0|||
17191061|NCT02477800|38343809|FG003|Long Term Extension Period|Adverse Event|6|||
17191062|NCT02477800|38343810|FG004|Long Term Extension Period|Adverse Event|2|||
17191063|NCT02477800|38343811|FG005|Long Term Extension Period|Adverse Event|4|||
17191064|NCT02477800|38343812|FG006|Long Term Extension Period|Adverse Event|3|||
17191065|NCT02477800|38343806|FG000|Long Term Extension Period|Death|0|||
17191066|NCT02477800|38343807|FG001|Long Term Extension Period|Death|0|||
17191067|NCT02477800|38343808|FG002|Long Term Extension Period|Death|0|||
17191068|NCT02477800|38343809|FG003|Long Term Extension Period|Death|1|||
17191069|NCT02477800|38343810|FG004|Long Term Extension Period|Death|1|||
16784364|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
16784365|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
16784366|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
16784367|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
16869859|NCT01524133|37844045|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
16869860|NCT01524133|37844043|FG000|Overall Study 52 Weeks|Physician Decision|1|||
16869861|NCT01524133|37844044|FG001|Overall Study 52 Weeks|Physician Decision|0|||
16869862|NCT01524133|37844045|FG002|Overall Study 52 Weeks|Physician Decision|2|||
16869863|NCT01524133|37844043|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
16869864|NCT01524133|37844044|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
16869865|NCT01524133|37844045|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
16869866|NCT01497899|37844057|FG000|Double-Blind Phase|Randomized but not Treated|1|||
16869867|NCT01497899|37844058|FG001|Double-Blind Phase|Randomized but not Treated|0|||
16869868|NCT01497899|37844059|FG002|Double-Blind Phase|Randomized but not Treated|0|||
16869869|NCT01497899|37844060|FG003|Double-Blind Phase|Randomized but not Treated|0|||
16869870|NCT01497899|37844057|FG000|Double-Blind Phase|Adverse Event|1|||
16869871|NCT01497899|37844058|FG001|Double-Blind Phase|Adverse Event|0|||
16869872|NCT01497899|37844059|FG002|Double-Blind Phase|Adverse Event|0|||
16869873|NCT01497899|37844060|FG003|Double-Blind Phase|Adverse Event|0|||
16869874|NCT01497899|37844057|FG000|Double-Blind Phase|Lack of Efficacy|0|||
16869875|NCT01497899|37844058|FG001|Double-Blind Phase|Lack of Efficacy|1|||
16869876|NCT01497899|37844059|FG002|Double-Blind Phase|Lack of Efficacy|0|||
16869877|NCT01497899|37844060|FG003|Double-Blind Phase|Lack of Efficacy|0|||
16869878|NCT01497899|37844057|FG000|Double-Blind Phase|Investigator's Discretion|1|||
16869879|NCT01497899|37844058|FG001|Double-Blind Phase|Investigator's Discretion|0|||
16869880|NCT01497899|37844059|FG002|Double-Blind Phase|Investigator's Discretion|0|||
16869881|NCT01497899|37844060|FG003|Double-Blind Phase|Investigator's Discretion|0|||
16869882|NCT01497899|37844057|FG000|Double-Blind Phase|Withdrew Consent|0|||
16869883|NCT01497899|37844058|FG001|Double-Blind Phase|Withdrew Consent|1|||
16869884|NCT01497899|37844059|FG002|Double-Blind Phase|Withdrew Consent|0|||
16869885|NCT01497899|37844060|FG003|Double-Blind Phase|Withdrew Consent|0|||
16869886|NCT01497899|37844057|FG000|Double-Blind Phase|Lost to Follow-up|3|||
16869887|NCT01497899|37844058|FG001|Double-Blind Phase|Lost to Follow-up|2|||
16869888|NCT01497899|37844059|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16869889|NCT01497899|37844060|FG003|Double-Blind Phase|Lost to Follow-up|0|||
16869890|NCT01497899|37844057|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
16869891|NCT01497899|37844058|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
16869892|NCT01497899|37844059|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
16869893|NCT01497899|37844060|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
16869894|NCT01497899|37844057|FG000|Open-Label Extension Phase|Adverse Event|1|||
16869895|NCT01497899|37844058|FG001|Open-Label Extension Phase|Adverse Event|0|||
16869896|NCT01497899|37844059|FG002|Open-Label Extension Phase|Adverse Event|0|||
16869897|NCT01497899|37844060|FG003|Open-Label Extension Phase|Adverse Event|0|||
16869898|NCT01497899|37844057|FG000|Open-Label Extension Phase|Death|1|||
16869899|NCT01497899|37844058|FG001|Open-Label Extension Phase|Death|0|||
16869900|NCT01497899|37844059|FG002|Open-Label Extension Phase|Death|0|||
16869901|NCT01497899|37844060|FG003|Open-Label Extension Phase|Death|0|||
16869902|NCT01497899|37844057|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
16869903|NCT01497899|37844058|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
16869904|NCT01497899|37844059|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
16869905|NCT01497899|37844060|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
16869906|NCT01497899|37844057|FG000|Open-Label Extension Phase|Pregnancy|0|||
16869907|NCT01497899|37844058|FG001|Open-Label Extension Phase|Pregnancy|1|||
16869908|NCT01497899|37844059|FG002|Open-Label Extension Phase|Pregnancy|1|||
16869909|NCT01497899|37844060|FG003|Open-Label Extension Phase|Pregnancy|0|||
16869910|NCT01497899|37844057|FG000|Open-Label Extension Phase|Protocol Violation|0|||
16869911|NCT01497899|37844058|FG001|Open-Label Extension Phase|Protocol Violation|0|||
16869912|NCT01497899|37844059|FG002|Open-Label Extension Phase|Protocol Violation|1|||
16869913|NCT01497899|37844060|FG003|Open-Label Extension Phase|Protocol Violation|0|||
16869914|NCT01497899|37844057|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
16869915|NCT01497899|37844058|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
16869916|NCT01497899|37844059|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
16869917|NCT01497899|37844060|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
16869918|NCT01497275|37844067|FG000|Overall Study|Death|1|||
16869919|NCT01497275|37844067|FG000|Overall Study|Adverse Event|1|||
16869920|NCT01557517|37844073|FG000|Overall Study|Death|1|||
16869921|NCT01557517|37844074|FG001|Overall Study|Death|0|||
16869922|NCT01557517|37844073|FG000|Overall Study|Refused further treatment|0|||
16869923|NCT01557517|37844074|FG001|Overall Study|Refused further treatment|2|||
16869924|NCT01557517|37844073|FG000|Overall Study|Adverse Event|0|||
17094803|NCT03801928|38234088|FG004|Overall Study|Lack of Efficacy|0|||
16869925|NCT01557517|37844074|FG001|Overall Study|Adverse Event|2|||
16869926|NCT01557517|37844073|FG000|Overall Study|Pt declined before treatment started|1|||
16869927|NCT01557517|37844074|FG001|Overall Study|Pt declined before treatment started|0|||
16869928|NCT01497197|37844089|FG000|Overall Study|Lost to Follow-up|1|||
16869929|NCT01497197|37844090|FG001|Overall Study|Lost to Follow-up|0|||
16869930|NCT01497197|37844089|FG000|Overall Study|Protocol Violation|0|||
16869931|NCT01497197|37844090|FG001|Overall Study|Protocol Violation|2|||
16869932|NCT01497197|37844089|FG000|Overall Study|Withdrawal by Subject|2|||
16869933|NCT01497197|37844090|FG001|Overall Study|Withdrawal by Subject|1|||
16869934|NCT01497197|37844089|FG000|Overall Study|Excessive/lack of response to treatment|1|||
16869935|NCT01497197|37844090|FG001|Overall Study|Excessive/lack of response to treatment|0|||
16869936|NCT01497197|37844089|FG000|Overall Study|Risk of OHSS|1|||
16869937|NCT01497197|37844090|FG001|Overall Study|Risk of OHSS|0|||
16869938|NCT01497197|37844089|FG000|Overall Study|No oocytes retrieved|3|||
16869939|NCT01497197|37844090|FG001|Overall Study|No oocytes retrieved|2|||
16869940|NCT01497197|37844089|FG000|Overall Study|No fertilisation|6|||
16869941|NCT01497197|37844090|FG001|Overall Study|No fertilisation|5|||
16869942|NCT01497197|37844089|FG000|Overall Study|Intention to freeze all embryos|0|||
16869943|NCT01497197|37844090|FG001|Overall Study|Intention to freeze all embryos|1|||
16869944|NCT01497197|37844089|FG000|Overall Study|All embryos discarded|0|||
16869945|NCT01497197|37844090|FG001|Overall Study|All embryos discarded|3|||
16869946|NCT01497197|37844089|FG000|Overall Study|Other|3|||
16869947|NCT01497197|37844090|FG001|Overall Study|Other|1|||
16869948|NCT01496885|37844096|FG000|Overall Study|Lost to Follow-up|13|||
16869949|NCT01496885|37844096|FG000|Overall Study|Withdrawal by Subject|7|||
16869950|NCT01496885|37844096|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
16869951|NCT01496885|37844096|FG000|Overall Study|Death|1|||
16869952|NCT01557283|37844100|FG000|Overall Study|Lost to Follow-up|7|||
16869953|NCT01557283|37844100|FG000|Overall Study|Non-responder|19|||
16869954|NCT01557283|37844100|FG000|Overall Study|Adverse Event|7|||
16869955|NCT01557283|37844100|FG000|Overall Study|Lack of Efficacy|1|||
16869956|NCT01557283|37844100|FG000|Overall Study|Non-compliance|1|||
16784368|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
16784369|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
16784370|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
16784371|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
16784372|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
16784373|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
16784374|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
16869957|NCT01557283|37844100|FG000|Overall Study|Withdrawal by Subject|1|||
16869958|NCT01557283|37844100|FG000|Overall Study|Participant's weight too high for dose|1|||
16869959|NCT01557283|37844100|FG000|Overall Study|Worsening of psoriasis|1|||
16869960|NCT01557283|37844100|FG000|Overall Study|Other|6|||
16869961|NCT01523743|37844117|FG000|Period 1|Adverse Event|1|||
16869962|NCT01523743|37844118|FG001|Period 1|Adverse Event|0|||
16869963|NCT01523743|37844117|FG000|Period 1|Withdrawal by Subject|6|||
16869964|NCT01523743|37844118|FG001|Period 1|Withdrawal by Subject|2|||
16869965|NCT01523743|37844117|FG000|Period 1|Lost to Follow-up|1|||
16869966|NCT01523743|37844118|FG001|Period 1|Lost to Follow-up|0|||
16869967|NCT01523743|37844117|FG000|Period 1|Lack of Efficacy|1|||
16869968|NCT01523743|37844118|FG001|Period 1|Lack of Efficacy|0|||
16869969|NCT01523743|37844117|FG000|Period 1|Felt unable to empty bladder|1|||
16869970|NCT01523743|37844118|FG001|Period 1|Felt unable to empty bladder|0|||
16869971|NCT01523743|37844117|FG000|Period 2|Withdrawal by Subject|0|||
16869972|NCT01523743|37844118|FG001|Period 2|Withdrawal by Subject|2|||
16869973|NCT01523743|37844117|FG000|Period 2|Adverse Event|1|||
17094804|NCT03801928|38234089|FG005|Overall Study|Lack of Efficacy|0|||
17094805|NCT03801928|38234084|FG000|Overall Study|Lost to Follow-up|5|||
17094806|NCT03801928|38234085|FG001|Overall Study|Lost to Follow-up|1|||
17094807|NCT03801928|38234086|FG002|Overall Study|Lost to Follow-up|1|||
17094808|NCT03801928|38234087|FG003|Overall Study|Lost to Follow-up|4|||
17094809|NCT03801928|38234088|FG004|Overall Study|Lost to Follow-up|4|||
17094810|NCT03801928|38234089|FG005|Overall Study|Lost to Follow-up|2|||
17094811|NCT03801928|38234084|FG000|Overall Study|Withdrawal by Subject|0|||
16869974|NCT01523743|37844118|FG001|Period 2|Adverse Event|0|||
16869975|NCT01496807|37844133|FG000|Overall Study|Progressive Disease|21|||
16869976|NCT01496807|37844133|FG000|Overall Study|Participant preference/toxicity|8|||
16869977|NCT01496807|37844133|FG000|Overall Study|Change in diagnosis|1|||
16869978|NCT01496183|37844139|FG000|Overall Study|Physician Decision|3|||
16869979|NCT01496183|37844140|FG001|Overall Study|Physician Decision|1|||
16869980|NCT01496183|37844139|FG000|Overall Study|Withdrawal by Subject|0|||
16869981|NCT01496183|37844140|FG001|Overall Study|Withdrawal by Subject|1|||
16869982|NCT03278106|37844147|FG000|Overall Study|No protocol treatment|1|||
16869983|NCT01495793|37844151|FG000|Overall Study|Lost to Follow-up|1|||
16869984|NCT01495793|37844151|FG000|Overall Study|Violation of inclusion criteria|1|||
16869985|NCT01494467|37844157|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
16869986|NCT01494467|37844158|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
16869987|NCT01494467|37844157|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
16869988|NCT01494467|37844158|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
16869989|NCT01494467|37844157|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
16869990|NCT01494467|37844158|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
16869991|NCT01494467|37844157|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
16869992|NCT01494467|37844158|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
16869993|NCT01494467|37844157|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
16869994|NCT01494467|37844158|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
16869995|NCT01494467|37844157|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
16869996|NCT01494467|37844158|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
16869997|NCT01494467|37844157|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
16869998|NCT01494467|37844158|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
16869999|NCT01494467|37844157|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
16870000|NCT01494467|37844158|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
16870001|NCT01494467|37844157|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
16870002|NCT01494467|37844158|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
16870003|NCT01494467|37844157|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
16870004|NCT01494467|37844158|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
16870005|NCT01494467|37844157|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
16870006|NCT01494467|37844158|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
16870007|NCT01494467|37844157|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
16784375|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
16784376|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
16784377|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
16870008|NCT01494467|37844158|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
16870009|NCT01494467|37844157|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
16870010|NCT01494467|37844158|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
16870011|NCT01494467|37844157|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
16870012|NCT01494467|37844158|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
16870013|NCT01493687|37844172|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
16870014|NCT01493687|37844173|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
16870015|NCT01493687|37844172|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
16870016|NCT01493687|37844173|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
16870017|NCT01493687|37844172|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
16870018|NCT01493687|37844173|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
16870019|NCT01493687|37844172|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
16784378|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
16784379|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
16784380|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
16784381|NCT02709655|37724354|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
16784382|NCT02709655|37724355|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
16784383|NCT02709655|37724356|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
16784384|NCT02709655|37724357|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
16784385|NCT02709655|37724358|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
16784386|NCT02709655|37724354|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
16784387|NCT02709655|37724355|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
16784388|NCT02709655|37724356|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
16870020|NCT01493687|37844173|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
16870021|NCT01493687|37844172|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
16870022|NCT01493687|37844173|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
16870023|NCT01493687|37844172|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
16870024|NCT01493687|37844173|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
16870025|NCT01493687|37844172|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
16870026|NCT01493687|37844173|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
16870027|NCT01493687|37844172|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
16870028|NCT01493687|37844173|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
16870029|NCT01493687|37844172|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
16870030|NCT01493687|37844173|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
16870031|NCT01493687|37844172|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
16870032|NCT01493687|37844173|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
16870033|NCT01493687|37844172|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
16870034|NCT01493687|37844173|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
16870035|NCT01493687|37844172|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
16870036|NCT01493687|37844173|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
16870037|NCT01493687|37844172|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
16870038|NCT01493687|37844173|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
16870039|NCT01493687|37844172|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
16870040|NCT01493687|37844173|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
16870041|NCT01493687|37844172|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
16870042|NCT01493687|37844173|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
16870043|NCT01523587|37844205|FG000|Overall Study|Other than listed|5|||
17094812|NCT03801928|38234085|FG001|Overall Study|Withdrawal by Subject|0|||
17000879|NCT01000025|38144828|FG000|Overall Study|Adverse Event|43|||
17000880|NCT01000025|38144829|FG001|Overall Study|Adverse Event|2|||
17000881|NCT01000025|38144828|FG000|Overall Study|Withdrawal by Subject|13|||
17000882|NCT01000025|38144829|FG001|Overall Study|Withdrawal by Subject|8|||
17000883|NCT01000025|38144828|FG000|Overall Study|Death|23|||
17000884|NCT01000025|38144829|FG001|Overall Study|Death|13|||
17000885|NCT01000025|38144828|FG000|Overall Study|Lack of Efficacy|363|||
17094813|NCT03801928|38234086|FG002|Overall Study|Withdrawal by Subject|2|||
16870044|NCT01523587|37844206|FG001|Overall Study|Other than listed|5|||
16870045|NCT01523587|37844205|FG000|Overall Study|Worsening of underlying cancer disease|19|||
16870046|NCT01523587|37844206|FG001|Overall Study|Worsening of underlying cancer disease|34|||
16870047|NCT01523587|37844205|FG000|Overall Study|Adverse Event|68|||
16870048|NCT01523587|37844206|FG001|Overall Study|Adverse Event|52|||
16870049|NCT01523587|37844205|FG000|Overall Study|Protocol Violation|5|||
16870050|NCT01523587|37844206|FG001|Overall Study|Protocol Violation|3|||
16870051|NCT01523587|37844205|FG000|Overall Study|Lost to Follow-up|2|||
16870052|NCT01523587|37844206|FG001|Overall Study|Lost to Follow-up|2|||
16870053|NCT01523587|37844205|FG000|Overall Study|Withdrawal by Subject|28|||
16870054|NCT01523587|37844206|FG001|Overall Study|Withdrawal by Subject|20|||
16870055|NCT01523587|37844205|FG000|Overall Study|Withdrew due to Progressive disease|265|||
16870056|NCT01523587|37844206|FG001|Overall Study|Withdrew due to Progressive disease|279|||
16870057|NCT01523587|37844205|FG000|Overall Study|Randomised but bot treated|6|||
16870058|NCT01523587|37844206|FG001|Overall Study|Randomised but bot treated|2|||
16870059|NCT01493531|37844235|FG000|Overall Study|Adverse Event|4|||
16870060|NCT01493531|37844236|FG001|Overall Study|Adverse Event|12|||
16870061|NCT01493531|37844237|FG002|Overall Study|Adverse Event|9|||
16870062|NCT01493531|37844235|FG000|Overall Study|Gout flare|3|||
16870063|NCT01493531|37844236|FG001|Overall Study|Gout flare|0|||
16870064|NCT01493531|37844237|FG002|Overall Study|Gout flare|2|||
16870065|NCT01493531|37844235|FG000|Overall Study|Protocol Violation|8|||
16870066|NCT01493531|37844236|FG001|Overall Study|Protocol Violation|15|||
16870067|NCT01493531|37844237|FG002|Overall Study|Protocol Violation|12|||
16870068|NCT01493531|37844235|FG000|Overall Study|Sponsor terminated study|5|||
16870069|NCT01493531|37844236|FG001|Overall Study|Sponsor terminated study|2|||
16870070|NCT01493531|37844237|FG002|Overall Study|Sponsor terminated study|3|||
16870071|NCT01493531|37844235|FG000|Overall Study|Lost to Follow-up|5|||
16870072|NCT01493531|37844236|FG001|Overall Study|Lost to Follow-up|7|||
16870073|NCT01493531|37844237|FG002|Overall Study|Lost to Follow-up|11|||
16870074|NCT01493531|37844235|FG000|Overall Study|Withdrawal by Subject|16|||
16870075|NCT01493531|37844236|FG001|Overall Study|Withdrawal by Subject|13|||
16870076|NCT01493531|37844237|FG002|Overall Study|Withdrawal by Subject|11|||
16870077|NCT01493531|37844235|FG000|Overall Study|Death|0|||
16870078|NCT01493531|37844236|FG001|Overall Study|Death|1|||
16870079|NCT01493531|37844237|FG002|Overall Study|Death|0|||
16870080|NCT01523275|37844261|FG000|Overall Study|Lost to Follow-up|1|||
16870081|NCT01523275|37844262|FG001|Overall Study|Lost to Follow-up|2|||
16870082|NCT01523275|37844261|FG000|Overall Study|Withdrawal by Subject|1|||
16870083|NCT01523275|37844262|FG001|Overall Study|Withdrawal by Subject|0|||
16870084|NCT01492439|37844279|FG000|Overall Study|Withdrew from RTE|4|||
16870085|NCT01492439|37844280|FG001|Overall Study|Withdrew from RTE|9|||
16870086|NCT01572727|37844315|FG000|Overall Study|Adverse Event|43|||
16870087|NCT01572727|37844316|FG001|Overall Study|Adverse Event|15|||
16870088|NCT01572727|37844315|FG000|Overall Study|Lost to Follow-up|1|||
16870089|NCT01572727|37844316|FG001|Overall Study|Lost to Follow-up|1|||
16870090|NCT01572727|37844315|FG000|Overall Study|Physician Decision|23|||
16870091|NCT01572727|37844316|FG001|Overall Study|Physician Decision|9|||
16870092|NCT01572727|37844315|FG000|Overall Study|Progressive disease|59|||
16870093|NCT01572727|37844316|FG001|Overall Study|Progressive disease|82|||
16870094|NCT01572727|37844315|FG000|Overall Study|Protocol Violation|0|||
16870095|NCT01572727|37844316|FG001|Overall Study|Protocol Violation|1|||
16870096|NCT01572727|37844315|FG000|Overall Study|Study terminated by sponsor|61|||
16870097|NCT01572727|37844316|FG001|Overall Study|Study terminated by sponsor|83|||
16870098|NCT01572727|37844315|FG000|Overall Study|Parent/guardian decision|14|||
16870099|NCT01572727|37844316|FG001|Overall Study|Parent/guardian decision|9|||
16870100|NCT01572727|37844315|FG000|Overall Study|Death|2|||
16870101|NCT01572727|37844316|FG001|Overall Study|Death|2|||
16870102|NCT01572727|37844315|FG000|Overall Study|Untreated|4|||
16870103|NCT01572727|37844316|FG001|Overall Study|Untreated|7|||
16870104|NCT01522651|37844363|FG000|Overall Study|Adverse Event|3|||
16870105|NCT01522651|37844364|FG001|Overall Study|Adverse Event|4|||
16870106|NCT01522651|37844365|FG002|Overall Study|Adverse Event|4|||
16870107|NCT01522651|37844366|FG003|Overall Study|Adverse Event|5|||
16870108|NCT01522651|37844367|FG004|Overall Study|Adverse Event|4|||
16870109|NCT01522651|37844363|FG000|Overall Study|Cardioversion|1|||
16870110|NCT01522651|37844364|FG001|Overall Study|Cardioversion|0|||
16870111|NCT01522651|37844365|FG002|Overall Study|Cardioversion|0|||
16870112|NCT01522651|37844366|FG003|Overall Study|Cardioversion|0|||
16870113|NCT01522651|37844367|FG004|Overall Study|Cardioversion|0|||
16870114|NCT01522651|37844363|FG000|Overall Study|Device Malfunction|0|||
17000886|NCT01000025|38144829|FG001|Overall Study|Lack of Efficacy|208|||
16870115|NCT01522651|37844364|FG001|Overall Study|Device Malfunction|1|||
16870116|NCT01522651|37844365|FG002|Overall Study|Device Malfunction|0|||
16870117|NCT01522651|37844366|FG003|Overall Study|Device Malfunction|0|||
16870118|NCT01522651|37844367|FG004|Overall Study|Device Malfunction|0|||
16870119|NCT01522651|37844363|FG000|Overall Study|Investigator's Discretion|0|||
16870120|NCT01522651|37844364|FG001|Overall Study|Investigator's Discretion|1|||
16870121|NCT01522651|37844365|FG002|Overall Study|Investigator's Discretion|0|||
16870122|NCT01522651|37844366|FG003|Overall Study|Investigator's Discretion|0|||
16870123|NCT01522651|37844367|FG004|Overall Study|Investigator's Discretion|0|||
16870124|NCT01522651|37844363|FG000|Overall Study|Protocol Violation|3|||
16870125|NCT01522651|37844364|FG001|Overall Study|Protocol Violation|0|||
16870126|NCT01522651|37844365|FG002|Overall Study|Protocol Violation|0|||
16870127|NCT01522651|37844366|FG003|Overall Study|Protocol Violation|0|||
16870128|NCT01522651|37844367|FG004|Overall Study|Protocol Violation|0|||
16870129|NCT01522651|37844363|FG000|Overall Study|Reason Not Specified|0|||
16870130|NCT01522651|37844364|FG001|Overall Study|Reason Not Specified|0|||
16870131|NCT01522651|37844365|FG002|Overall Study|Reason Not Specified|0|||
16870132|NCT01522651|37844366|FG003|Overall Study|Reason Not Specified|1|||
16870133|NCT01522651|37844367|FG004|Overall Study|Reason Not Specified|0|||
16870134|NCT01522651|37844363|FG000|Overall Study|Participant Non-Compliance|1|||
16870135|NCT01522651|37844364|FG001|Overall Study|Participant Non-Compliance|0|||
16870136|NCT01522651|37844365|FG002|Overall Study|Participant Non-Compliance|0|||
16870137|NCT01522651|37844366|FG003|Overall Study|Participant Non-Compliance|0|||
16870138|NCT01522651|37844367|FG004|Overall Study|Participant Non-Compliance|0|||
16870139|NCT01522651|37844363|FG000|Overall Study|Withdrew Consent|1|||
16870140|NCT01522651|37844364|FG001|Overall Study|Withdrew Consent|1|||
16870141|NCT01522651|37844365|FG002|Overall Study|Withdrew Consent|0|||
16870142|NCT01522651|37844366|FG003|Overall Study|Withdrew Consent|1|||
16870143|NCT01522651|37844367|FG004|Overall Study|Withdrew Consent|1|||
16870144|NCT01522651|37844363|FG000|Overall Study|Randomized but Never Treated|0|||
16870145|NCT01522651|37844364|FG001|Overall Study|Randomized but Never Treated|1|||
16870146|NCT01522651|37844365|FG002|Overall Study|Randomized but Never Treated|0|||
16870147|NCT01522651|37844366|FG003|Overall Study|Randomized but Never Treated|1|||
16870148|NCT01522651|37844367|FG004|Overall Study|Randomized but Never Treated|1|||
16870149|NCT01554241|37844394|FG000|Overall Study|Death|3|||
16870150|NCT01554241|37844395|FG001|Overall Study|Death|1|||
16870151|NCT01554241|37844396|FG002|Overall Study|Death|1|||
16870152|NCT01554241|37844397|FG003|Overall Study|Death|0|||
16870153|NCT01554241|37844394|FG000|Overall Study|protocol specified renal stone|0|||
16870154|NCT01554241|37844395|FG001|Overall Study|protocol specified renal stone|0|||
16870155|NCT01554241|37844396|FG002|Overall Study|protocol specified renal stone|0|||
16870156|NCT01554241|37844397|FG003|Overall Study|protocol specified renal stone|1|||
16870157|NCT01554241|37844394|FG000|Overall Study|protocol specified change in eGFR|0|||
16870158|NCT01554241|37844395|FG001|Overall Study|protocol specified change in eGFR|0|||
16870159|NCT01554241|37844396|FG002|Overall Study|protocol specified change in eGFR|1|||
16870160|NCT01554241|37844397|FG003|Overall Study|protocol specified change in eGFR|0|||
16870161|NCT01554241|37844394|FG000|Overall Study|Withdrawal by Subject|0|||
16870162|NCT01554241|37844395|FG001|Overall Study|Withdrawal by Subject|0|||
16870163|NCT01554241|37844396|FG002|Overall Study|Withdrawal by Subject|2|||
16870164|NCT01554241|37844397|FG003|Overall Study|Withdrawal by Subject|0|||
16870165|NCT01521559|37844409|FG000|Overall Study|Adverse Event|0|||
16870166|NCT01521559|37844410|FG001|Overall Study|Adverse Event|4|||
16870167|NCT01521559|37844409|FG000|Overall Study|Death|1|||
16870168|NCT01521559|37844410|FG001|Overall Study|Death|0|||
16870169|NCT01521559|37844409|FG000|Overall Study|Withdrawal by Subject|9|||
16870170|NCT01521559|37844410|FG001|Overall Study|Withdrawal by Subject|11|||
16870171|NCT01521559|37844409|FG000|Overall Study|Lost to Follow-up|3|||
16870172|NCT01521559|37844410|FG001|Overall Study|Lost to Follow-up|1|||
16870173|NCT01521559|37844409|FG000|Overall Study|Protocol Violation|1|||
16870174|NCT01521559|37844410|FG001|Overall Study|Protocol Violation|0|||
16870175|NCT01521559|37844409|FG000|Overall Study|Other|1|||
16870176|NCT01521559|37844410|FG001|Overall Study|Other|2|||
16870177|NCT01554163|37844419|FG000|Overall Study|Adverse Event|3|||
16870178|NCT01554163|37844420|FG001|Overall Study|Adverse Event|0|||
16870179|NCT01554163|37844419|FG000|Overall Study|Lack of Efficacy|1|||
16870180|NCT01554163|37844420|FG001|Overall Study|Lack of Efficacy|0|||
16870181|NCT01554163|37844419|FG000|Overall Study|Lost to Follow-up|1|||
16870182|NCT01554163|37844420|FG001|Overall Study|Lost to Follow-up|0|||
16870183|NCT01554163|37844419|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16870184|NCT01554163|37844420|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16870185|NCT01554163|37844419|FG000|Overall Study|Protocol Violation|0|||
16870186|NCT01554163|37844420|FG001|Overall Study|Protocol Violation|4|||
16870187|NCT01554163|37844419|FG000|Overall Study|Withdrawal by Subject|1|||
16870188|NCT01554163|37844420|FG001|Overall Study|Withdrawal by Subject|5|||
16870189|NCT01554163|37844419|FG000|Overall Study|Not Treated|1|||
16870190|NCT01554163|37844420|FG001|Overall Study|Not Treated|0|||
16870191|NCT01553851|37844426|FG000|Overall Study|Adverse Event|2|||
16870192|NCT01553851|37844426|FG000|Overall Study|constipation|1|||
16870193|NCT01552915|37844446|FG000|Overall Study|Adverse Event|3|||
16870194|NCT01552915|37844447|FG001|Overall Study|Adverse Event|14|||
16870195|NCT01552915|37844448|FG002|Overall Study|Adverse Event|3|||
16870196|NCT01552915|37844446|FG000|Overall Study|Lost to Follow-up|4|||
16870197|NCT01552915|37844447|FG001|Overall Study|Lost to Follow-up|6|||
16870198|NCT01552915|37844448|FG002|Overall Study|Lost to Follow-up|5|||
16784389|NCT02709655|37724357|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
16870199|NCT01552915|37844446|FG000|Overall Study|Withdrawal by Subject|6|||
16870200|NCT01552915|37844447|FG001|Overall Study|Withdrawal by Subject|4|||
16870201|NCT01552915|37844448|FG002|Overall Study|Withdrawal by Subject|5|||
16870202|NCT01552915|37844446|FG000|Overall Study|Protocol Violation|0|||
16870203|NCT01552915|37844447|FG001|Overall Study|Protocol Violation|4|||
16870204|NCT01552915|37844448|FG002|Overall Study|Protocol Violation|4|||
16870205|NCT01552915|37844446|FG000|Overall Study|Lack of Efficacy|8|||
16870206|NCT01552915|37844447|FG001|Overall Study|Lack of Efficacy|1|||
16870207|NCT01552915|37844448|FG002|Overall Study|Lack of Efficacy|4|||
16870208|NCT01552915|37844446|FG000|Overall Study|Other|2|||
16870209|NCT01552915|37844447|FG001|Overall Study|Other|0|||
16870210|NCT01552915|37844448|FG002|Overall Study|Other|6|||
16870211|NCT01552681|37844477|FG000|Overall Study|Withdrawal by Subject|4|||
16870212|NCT01552681|37844478|FG001|Overall Study|Withdrawal by Subject|0|||
16870213|NCT01552681|37844477|FG000|Overall Study|Physician Decision|1|||
16870214|NCT01552681|37844478|FG001|Overall Study|Physician Decision|0|||
16870215|NCT01552681|37844477|FG000|Overall Study|Subject moved away|0|||
16870216|NCT01552681|37844478|FG001|Overall Study|Subject moved away|1|||
16870217|NCT01570387|37844510|FG000|Overall Study|Adverse Event|1|||
16870218|NCT01570387|37844511|FG001|Overall Study|Adverse Event|0|||
16870219|NCT01570387|37844512|FG002|Overall Study|Adverse Event|0|||
16870220|NCT01570387|37844513|FG003|Overall Study|Adverse Event|0|||
16870221|NCT01570387|37844510|FG000|Overall Study|Death|0|||
16870222|NCT01570387|37844511|FG001|Overall Study|Death|0|||
16870223|NCT01570387|37844512|FG002|Overall Study|Death|0|||
16870224|NCT01570387|37844513|FG003|Overall Study|Death|1|||
16870225|NCT01570387|37844510|FG000|Overall Study|Withdrawal by Subject|0|||
16870226|NCT01570387|37844511|FG001|Overall Study|Withdrawal by Subject|0|||
16870227|NCT01570387|37844512|FG002|Overall Study|Withdrawal by Subject|0|||
16870228|NCT01570387|37844513|FG003|Overall Study|Withdrawal by Subject|1|||
16870229|NCT01570309|37844522|FG000|Overall Study|Withdrawal by Subject|3|||
16870230|NCT01570309|37844523|FG001|Overall Study|Withdrawal by Subject|3|||
16870231|NCT01519921|37844535|FG000|Overall Study|Adverse Event|10|||
16870232|NCT01519921|37844536|FG001|Overall Study|Adverse Event|9|||
16870233|NCT01519921|37844535|FG000|Overall Study|Lack of Efficacy|4|||
16870234|NCT01519921|37844536|FG001|Overall Study|Lack of Efficacy|3|||
16870235|NCT01519921|37844535|FG000|Overall Study|Withdrawal by Subject|3|||
16870236|NCT01519921|37844536|FG001|Overall Study|Withdrawal by Subject|0|||
16870237|NCT01519921|37844535|FG000|Overall Study|Lost to Follow-up|2|||
16870238|NCT01519921|37844536|FG001|Overall Study|Lost to Follow-up|1|||
16870239|NCT01519921|37844535|FG000|Overall Study|Treatment refusal|2|||
16870240|NCT01519921|37844536|FG001|Overall Study|Treatment refusal|1|||
16870241|NCT01519921|37844535|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
16870242|NCT01519921|37844536|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
16870243|NCT01519765|37844544|FG000|Overall Study|Adverse Event|0|||
16870244|NCT01519765|37844545|FG001|Overall Study|Adverse Event|1|||
16870245|NCT01519765|37844544|FG000|Overall Study|Lack of Efficacy|2|||
16870246|NCT01519765|37844545|FG001|Overall Study|Lack of Efficacy|0|||
16870247|NCT01519765|37844544|FG000|Overall Study|Protocol Violation|1|||
16870248|NCT01519765|37844545|FG001|Overall Study|Protocol Violation|0|||
16870249|NCT01519765|37844544|FG000|Overall Study|Withdrawal by Subject|0|||
16870250|NCT01519765|37844545|FG001|Overall Study|Withdrawal by Subject|1|||
16784390|NCT02709655|37724358|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
16784391|NCT02709655|37724354|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
16784392|NCT02709655|37724355|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
16784393|NCT02709655|37724356|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
16784394|NCT02709655|37724357|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
16784395|NCT02709655|37724358|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
16784396|NCT02709655|37724354|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
16784397|NCT02709655|37724355|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
16784398|NCT02709655|37724356|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
16784399|NCT02709655|37724357|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
16784400|NCT02709655|37724358|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
16784401|NCT02709655|37724354|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
16784402|NCT02709655|37724355|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
16784403|NCT02709655|37724356|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
16784404|NCT02709655|37724357|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
16784405|NCT02709655|37724358|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
16784406|NCT02709655|37724354|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
16870251|NCT01552603|37844552|FG000|Overall Study|Physician Decision|1|||
16870252|NCT01552369|37844558|FG000|Overall Study|Did not consent to extended follow up|8|||
16870253|NCT01552369|37844559|FG001|Overall Study|Did not consent to extended follow up|9|||
16870254|NCT01552057|37844569|FG000|Overall Study|Adverse Event|14|||
16870255|NCT01552057|37844570|FG001|Overall Study|Adverse Event|15|||
16870256|NCT01552057|37844569|FG000|Overall Study|Lack of Efficacy|8|||
16870257|NCT01552057|37844570|FG001|Overall Study|Lack of Efficacy|23|||
16870258|NCT01552057|37844569|FG000|Overall Study|Withdrawal by Subject|5|||
16870259|NCT01552057|37844570|FG001|Overall Study|Withdrawal by Subject|8|||
16870260|NCT01552057|37844569|FG000|Overall Study|Entry Criteria Not Met|2|||
16870261|NCT01552057|37844570|FG001|Overall Study|Entry Criteria Not Met|2|||
16870262|NCT01552057|37844569|FG000|Overall Study|Physician Decision|1|||
16870263|NCT01552057|37844570|FG001|Overall Study|Physician Decision|0|||
16870264|NCT01551745|37844576|FG000|Overall Study|Withdrawal by Subject|1|||
16870265|NCT01551745|37844576|FG000|Overall Study|Disease Progression|2|||
17094814|NCT03801928|38234087|FG003|Overall Study|Withdrawal by Subject|1|||
16870266|NCT01551355|37844586|FG000|Overall Study|Lost to Follow-up|51|||
16870267|NCT01551355|37844587|FG001|Overall Study|Lost to Follow-up|49|||
16870268|NCT01551355|37844588|FG002|Overall Study|Lost to Follow-up|34|||
16870269|NCT01551355|37844589|FG003|Overall Study|Lost to Follow-up|24|||
16870270|NCT01551355|37844590|FG004|Overall Study|Lost to Follow-up|9|||
16870271|NCT01551355|37844591|FG005|Overall Study|Lost to Follow-up|6|||
16870272|NCT01569841|37844599|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
16870273|NCT01569841|37844600|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
16870274|NCT01569763|37844610|FG000|Overall Study|Lack of Efficacy|2|||
16870275|NCT01569763|37844611|FG001|Overall Study|Lack of Efficacy|7|||
16870276|NCT01569763|37844610|FG000|Overall Study|Adverse Event|1|||
16870277|NCT01569763|37844611|FG001|Overall Study|Adverse Event|0|||
16870278|NCT01550965|37844617|FG000|Overall Study|Adverse Event|26|||
16870279|NCT01550965|37844617|FG000|Overall Study|Withdrawal by Subject|10|||
16870280|NCT01550965|37844617|FG000|Overall Study|Lost to Follow-up|2|||
16870281|NCT01550965|37844617|FG000|Overall Study|Lack of Efficacy|59|||
16870282|NCT01550965|37844617|FG000|Overall Study|Other|13|||
16870283|NCT01569295|37844738|FG000|Overall Study|Progressive Disease|75|||
16870284|NCT01569295|37844739|FG001|Overall Study|Progressive Disease|139|||
16870285|NCT01569295|37844738|FG000|Overall Study|Adverse Event|39|||
16870286|NCT01569295|37844739|FG001|Overall Study|Adverse Event|14|||
16870287|NCT01569295|37844738|FG000|Overall Study|Withdrawal by Subject|25|||
16870288|NCT01569295|37844739|FG001|Overall Study|Withdrawal by Subject|12|||
16870289|NCT01569295|37844738|FG000|Overall Study|Death|19|||
16870290|NCT01569295|37844739|FG001|Overall Study|Death|15|||
16870291|NCT01569295|37844738|FG000|Overall Study|Physician Decision|13|||
16870292|NCT01569295|37844739|FG001|Overall Study|Physician Decision|18|||
16870293|NCT01569295|37844738|FG000|Overall Study|Study Terminated by Sponsor|24|||
16870294|NCT01569295|37844739|FG001|Overall Study|Study Terminated by Sponsor|2|||
16870295|NCT01569295|37844738|FG000|Overall Study|Other Reason not Specified|3|||
16870296|NCT01569295|37844739|FG001|Overall Study|Other Reason not Specified|5|||
16870297|NCT01569295|37844738|FG000|Overall Study|Non-Compliance with Study Drug|6|||
16870298|NCT01569295|37844739|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16870299|NCT01569295|37844738|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
16870300|NCT01569295|37844739|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
16870301|NCT01569295|37844738|FG000|Overall Study|Lost to Follow-up|1|||
17094815|NCT03801928|38234088|FG004|Overall Study|Withdrawal by Subject|0|||
17094816|NCT03801928|38234089|FG005|Overall Study|Withdrawal by Subject|0|||
16870302|NCT01569295|37844739|FG001|Overall Study|Lost to Follow-up|1|||
16870303|NCT01549951|37844796|FG000|Overall Study|Adverse Event|15|||
16870304|NCT01549951|37844796|FG000|Overall Study|Withdrawal by Subject|2|||
16870305|NCT01549951|37844796|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
16870306|NCT01549951|37844796|FG000|Overall Study|Progressive disease|29|||
16870307|NCT01549951|37844796|FG000|Overall Study|Symptomatic deterioration|1|||
16870308|NCT01549951|37844796|FG000|Overall Study|Other|2|||
16870309|NCT01517893|37844802|FG000|Overall Study|Withdrawal by Subject|3|||
16870310|NCT01517893|37844803|FG001|Overall Study|Withdrawal by Subject|0|||
16870311|NCT01489891|37844811|FG000|Overall Study|Endoscopy failure|1|||
16870312|NCT01489891|37844812|FG001|Overall Study|Endoscopy failure|0|||
16870313|NCT04062240|37844894|FG000|Overall Study|equipment malfunction|1|||
16870314|NCT02790138|37844900|FG000|Overall Study|Adverse Event|5|||
16870315|NCT02790138|37844901|FG001|Overall Study|Adverse Event|2|||
16870316|NCT02790138|37844900|FG000|Overall Study|Significant Protocol Deviation|0|||
16870317|NCT02790138|37844901|FG001|Overall Study|Significant Protocol Deviation|1|||
16870318|NCT02790138|37844900|FG000|Overall Study|Lost to Follow-up|1|||
16870319|NCT02790138|37844901|FG001|Overall Study|Lost to Follow-up|0|||
16870320|NCT02790138|37844900|FG000|Overall Study|Voluntary Withdrawal|8|||
16870321|NCT02790138|37844901|FG001|Overall Study|Voluntary Withdrawal|9|||
16870322|NCT02790138|37844900|FG000|Overall Study|Lack of Efficacy|6|||
16870323|NCT02790138|37844901|FG001|Overall Study|Lack of Efficacy|7|||
16870324|NCT02790138|37844900|FG000|Overall Study|Reason not Specified|1|||
17094817|NCT03801928|38234084|FG000|Overall Study|Other|0|||
16870325|NCT02790138|37844901|FG001|Overall Study|Reason not Specified|0|||
16870326|NCT01489189|37845056|FG000|Overall Study|Withdrawal by Subject|20|||
16870327|NCT01489189|37845057|FG001|Overall Study|Withdrawal by Subject|23|||
16870328|NCT01489189|37845056|FG000|Overall Study|Death|10|||
16870329|NCT01489189|37845057|FG001|Overall Study|Death|8|||
16870330|NCT01489189|37845056|FG000|Overall Study|Missed Visit|1|||
16870331|NCT01489189|37845057|FG001|Overall Study|Missed Visit|4|||
16870332|NCT01549873|37845066|FG000|Overall Study|Physician Decision|0|||
16870333|NCT01549873|37845067|FG001|Overall Study|Physician Decision|1|||
16870334|NCT01489111|37845073|FG000|Overall Study|Withdrawal criterion|1|||
16870335|NCT01488487|37845077|FG000|Overall Study|Adverse Event|6|||
16870336|NCT01488487|37845077|FG000|Overall Study|Death|1|||
16870337|NCT01488487|37845077|FG000|Overall Study|Withdrawal by Subject|2|||
16870338|NCT01488097|37845081|FG000|Overall Study|Lost to Follow-up|1|||
16870339|NCT01516879|37845087|FG000|Overall Study|Withdrawal by Subject|9|||
16870340|NCT01516879|37845088|FG001|Overall Study|Withdrawal by Subject|11|||
16870341|NCT01516879|37845087|FG000|Overall Study|Death|0|||
16870342|NCT01516879|37845088|FG001|Overall Study|Death|2|||
16870343|NCT01516879|37845087|FG000|Overall Study|Lost to Follow-up|2|||
16870344|NCT01516879|37845088|FG001|Overall Study|Lost to Follow-up|11|||
16870345|NCT01516879|37845087|FG000|Overall Study|Other|5|||
16870346|NCT01516879|37845088|FG001|Overall Study|Other|10|||
16870347|NCT01515865|37845094|FG000|Part A (Open-label)|Other|3|||
16870348|NCT01515865|37845095|FG001|Part A (Open-label)|Other|0|||
16870349|NCT01515865|37845096|FG002|Part A (Open-label)|Other|0|||
16870350|NCT01515865|37845094|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
16870351|NCT01515865|37845095|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
16870352|NCT01515865|37845096|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
16870353|NCT01515865|37845094|FG000|Part B (Open-label)|Other|1|||
16870354|NCT01515865|37845095|FG001|Part B (Open-label)|Other|0|||
16870355|NCT01515865|37845096|FG002|Part B (Open-label)|Other|0|||
16870356|NCT01547299|37845106|FG000|Overall Study|Withdrawal by Subject|2|||
16870357|NCT01547299|37845107|FG001|Overall Study|Withdrawal by Subject|2|||
16870358|NCT01515475|37845117|FG000|Overall Study|Lost to Follow-up|20|||
16870359|NCT01515475|37845118|FG001|Overall Study|Lost to Follow-up|15|||
16870360|NCT01515475|37845119|FG002|Overall Study|Lost to Follow-up|12|||
16870361|NCT01515475|37845120|FG003|Overall Study|Lost to Follow-up|12|||
16870362|NCT01515319|37845206|FG000|Overall Study|Withdrawal by Subject|0|||
16870363|NCT01515319|37845207|FG001|Overall Study|Withdrawal by Subject|0|||
16870364|NCT01515319|37845208|FG002|Overall Study|Withdrawal by Subject|0|||
16870365|NCT01515319|37845209|FG003|Overall Study|Withdrawal by Subject|0|||
16870366|NCT01515319|37845210|FG004|Overall Study|Withdrawal by Subject|0|||
16870367|NCT01515319|37845211|FG005|Overall Study|Withdrawal by Subject|0|||
16870368|NCT01515319|37845212|FG006|Overall Study|Withdrawal by Subject|1|||
16870369|NCT01515319|37845213|FG007|Overall Study|Withdrawal by Subject|0|||
16870370|NCT01515319|37845214|FG008|Overall Study|Withdrawal by Subject|0|||
16870371|NCT01515319|37845215|FG009|Overall Study|Withdrawal by Subject|0|||
16870372|NCT01515319|37845206|FG000|Overall Study|Adverse Event|0|||
16870373|NCT01515319|37845207|FG001|Overall Study|Adverse Event|0|||
16870374|NCT01515319|37845208|FG002|Overall Study|Adverse Event|0|||
16870375|NCT01515319|37845209|FG003|Overall Study|Adverse Event|0|||
16870376|NCT01515319|37845210|FG004|Overall Study|Adverse Event|0|||
16870377|NCT01515319|37845211|FG005|Overall Study|Adverse Event|0|||
16870378|NCT01515319|37845212|FG006|Overall Study|Adverse Event|0|||
16870379|NCT01515319|37845213|FG007|Overall Study|Adverse Event|0|||
16870380|NCT01515319|37845214|FG008|Overall Study|Adverse Event|3|||
16870381|NCT01515319|37845215|FG009|Overall Study|Adverse Event|0|||
16870382|NCT01515319|37845206|FG000|Overall Study|Protocol Violation|0|||
17094818|NCT03801928|38234085|FG001|Overall Study|Other|2|||
16870383|NCT01515319|37845207|FG001|Overall Study|Protocol Violation|0|||
16870384|NCT01515319|37845208|FG002|Overall Study|Protocol Violation|0|||
16870385|NCT01515319|37845209|FG003|Overall Study|Protocol Violation|0|||
16870386|NCT01515319|37845210|FG004|Overall Study|Protocol Violation|0|||
16870387|NCT01515319|37845211|FG005|Overall Study|Protocol Violation|0|||
16870388|NCT01515319|37845212|FG006|Overall Study|Protocol Violation|0|||
16870389|NCT01515319|37845213|FG007|Overall Study|Protocol Violation|0|||
16870390|NCT01515319|37845214|FG008|Overall Study|Protocol Violation|2|||
16870391|NCT01515319|37845215|FG009|Overall Study|Protocol Violation|0|||
17094819|NCT03801928|38234086|FG002|Overall Study|Other|0|||
16870392|NCT01492361|37845252|FG000|Overall Study|Withdrawal by Subject|281|||
16870393|NCT01492361|37845253|FG001|Overall Study|Withdrawal by Subject|297|||
16870394|NCT01492361|37845252|FG000|Overall Study|Physician Decision|12|||
16870395|NCT01492361|37845253|FG001|Overall Study|Physician Decision|12|||
16870396|NCT01492361|37845252|FG000|Overall Study|Lost to Follow-up|6|||
16870397|NCT01492361|37845253|FG001|Overall Study|Lost to Follow-up|13|||
16870398|NCT01492361|37845252|FG000|Overall Study|Other than specified above|106|||
16870399|NCT01492361|37845253|FG001|Overall Study|Other than specified above|138|||
16870400|NCT01514461|37845332|FG000|Overall Study|Adverse Event|2|||
16870401|NCT01514461|37845333|FG001|Overall Study|Adverse Event|1|||
16870402|NCT01514461|37845334|FG002|Overall Study|Adverse Event|3|||
16870403|NCT01514461|37845332|FG000|Overall Study|Physician Decision|1|||
16870404|NCT01514461|37845333|FG001|Overall Study|Physician Decision|1|||
16870405|NCT01514461|37845334|FG002|Overall Study|Physician Decision|0|||
16870406|NCT01514461|37845332|FG000|Overall Study|Patient/guardian decision|1|||
16870407|NCT01514461|37845333|FG001|Overall Study|Patient/guardian decision|1|||
16870408|NCT01514461|37845334|FG002|Overall Study|Patient/guardian decision|1|||
16870409|NCT01514461|37845332|FG000|Overall Study|Death|1|||
16870410|NCT01514461|37845333|FG001|Overall Study|Death|0|||
16870411|NCT01514461|37845334|FG002|Overall Study|Death|0|||
16870412|NCT01491737|37845380|FG000|Overall Study|Withdrawal by Subject|20|||
16870413|NCT01491737|37845381|FG001|Overall Study|Withdrawal by Subject|17|||
16870414|NCT01491737|37845380|FG000|Overall Study|Lost to Follow-up|2|||
16870415|NCT01491737|37845381|FG001|Overall Study|Lost to Follow-up|10|||
16870416|NCT01491737|37845380|FG000|Overall Study|Death|63|||
16870417|NCT01491737|37845381|FG001|Overall Study|Death|57|||
16870418|NCT01491737|37845380|FG000|Overall Study|Study Termination by Sponsor|36|||
16870419|NCT01491737|37845381|FG001|Overall Study|Study Termination by Sponsor|36|||
16870420|NCT01491737|37845380|FG000|Overall Study|Reason Not Specified|8|||
16870421|NCT01491737|37845381|FG001|Overall Study|Reason Not Specified|9|||
16870422|NCT01487863|37845393|FG000|Overall Study|Death|19|||
16870423|NCT01487863|37845394|FG001|Overall Study|Death|19|||
16870424|NCT01487161|37845413|FG000|Overall Study|Adverse Event|1|||
16870425|NCT01487161|37845414|FG001|Overall Study|Adverse Event|0|||
16870426|NCT01487161|37845415|FG002|Overall Study|Adverse Event|0|||
16870427|NCT01487161|37845416|FG003|Overall Study|Adverse Event|0|||
16870428|NCT01487161|37845413|FG000|Overall Study|Withdrawal by Subject|1|||
16870429|NCT01487161|37845414|FG001|Overall Study|Withdrawal by Subject|1|||
16870430|NCT01487161|37845415|FG002|Overall Study|Withdrawal by Subject|1|||
16870431|NCT01487161|37845416|FG003|Overall Study|Withdrawal by Subject|2|||
16870432|NCT01487161|37845413|FG000|Overall Study|missing data|0|||
16870433|NCT01487161|37845414|FG001|Overall Study|missing data|1|||
16870434|NCT01487161|37845415|FG002|Overall Study|missing data|0|||
16870435|NCT01487161|37845416|FG003|Overall Study|missing data|0|||
16870436|NCT01491035|37845471|FG000|Overall Study|Lost to Follow-up|0|||
16870437|NCT01491035|37845472|FG001|Overall Study|Lost to Follow-up|0|||
16870438|NCT01491035|37845473|FG002|Overall Study|Lost to Follow-up|0|||
16870439|NCT01491035|37845474|FG003|Overall Study|Lost to Follow-up|0|||
16870440|NCT01491035|37845475|FG004|Overall Study|Lost to Follow-up|1|||
16870441|NCT01491035|37845476|FG005|Overall Study|Lost to Follow-up|0|||
16870442|NCT01491035|37845477|FG006|Overall Study|Lost to Follow-up|0|||
16870443|NCT01491035|37845478|FG007|Overall Study|Lost to Follow-up|0|||
16870444|NCT01488071|37845502|FG000|Overall Study|Adverse Event|15|||
16870445|NCT01488071|37845503|FG001|Overall Study|Adverse Event|23|||
16870446|NCT01488071|37845502|FG000|Overall Study|Lack of Efficacy|11|||
16870447|NCT01488071|37845503|FG001|Overall Study|Lack of Efficacy|17|||
16870448|NCT01488071|37845502|FG000|Overall Study|Non-compliance with study drug|2|||
16870449|NCT01488071|37845503|FG001|Overall Study|Non-compliance with study drug|0|||
16870450|NCT01488071|37845502|FG000|Overall Study|Protocol Violation|5|||
16870451|NCT01488071|37845503|FG001|Overall Study|Protocol Violation|7|||
16870452|NCT01488071|37845502|FG000|Overall Study|Withdrawal of Consent|14|||
16870453|NCT01488071|37845503|FG001|Overall Study|Withdrawal of Consent|12|||
16870454|NCT01488071|37845502|FG000|Overall Study|Lost to Follow-up|1|||
16870455|NCT01488071|37845503|FG001|Overall Study|Lost to Follow-up|0|||
16870456|NCT01488071|37845502|FG000|Overall Study|Administrative or Other Reason(s)|5|||
16870457|NCT01488071|37845503|FG001|Overall Study|Administrative or Other Reason(s)|4|||
16870458|NCT01487525|37845511|FG000|Overall Study|Withdrawal by Subject|0|||
16870459|NCT01487525|37845512|FG001|Overall Study|Withdrawal by Subject|1|||
16870460|NCT01486199|37845520|FG000|Two Year Period Between Study Days|Physician Decision|1|||
16870461|NCT01486199|37845521|FG001|Two Year Period Between Study Days|Physician Decision|0|||
16870462|NCT01485887|37845527|FG000|Overall Study|Withdrawal by Subject|2|||
16870463|NCT01485887|37845527|FG000|Overall Study|Adverse Event|8|||
16870464|NCT01485887|37845527|FG000|Overall Study|Deterioration of primary disease|1|||
16870465|NCT01485887|37845527|FG000|Overall Study|Primary disease markedly improved|1|||
16870466|NCT01546519|37845535|FG000|Overall Study|Adverse Event|0|||
16870467|NCT01546519|37845536|FG001|Overall Study|Adverse Event|0|||
17191070|NCT02477800|38343811|FG005|Long Term Extension Period|Death|1|||
16870468|NCT01546519|37845537|FG002|Overall Study|Adverse Event|1|||
16870469|NCT01546519|37845538|FG003|Overall Study|Adverse Event|1|||
16870470|NCT01546519|37845535|FG000|Overall Study|Death|0|||
16870471|NCT01546519|37845536|FG001|Overall Study|Death|1|||
16870472|NCT01546519|37845537|FG002|Overall Study|Death|3|||
16870473|NCT01546519|37845538|FG003|Overall Study|Death|1|||
16870474|NCT01546519|37845535|FG000|Overall Study|related to disease progression|2|||
16870475|NCT01546519|37845536|FG001|Overall Study|related to disease progression|2|||
16870476|NCT01546519|37845537|FG002|Overall Study|related to disease progression|2|||
16870477|NCT01546519|37845538|FG003|Overall Study|related to disease progression|1|||
16870478|NCT01546519|37845535|FG000|Overall Study|Physician Decision|6|||
16870479|NCT01546519|37845536|FG001|Overall Study|Physician Decision|5|||
16870480|NCT01546519|37845537|FG002|Overall Study|Physician Decision|2|||
16870481|NCT01546519|37845538|FG003|Overall Study|Physician Decision|3|||
16870482|NCT01546519|37845535|FG000|Overall Study|Withdrawal by Subject|1|||
16870483|NCT01546519|37845536|FG001|Overall Study|Withdrawal by Subject|0|||
16870484|NCT01546519|37845537|FG002|Overall Study|Withdrawal by Subject|0|||
16870485|NCT01546519|37845538|FG003|Overall Study|Withdrawal by Subject|0|||
16870486|NCT01484951|37845552|FG000|Overall Study|Adverse Event|3|||
16870487|NCT01484951|37845552|FG000|Overall Study|Personal Reasons|1|||
16870488|NCT01484951|37845552|FG000|Overall Study|Non-Compliance|1|||
16870489|NCT01484873|37845556|FG000|Overall Study|Withdrawal by Subject|2|||
16870490|NCT01486927|37845561|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
16870491|NCT01486927|37845561|FG000|Overall Study|Physician Decision|1|||
16870492|NCT01486927|37845561|FG000|Overall Study|50 Exposure days not reached|2|||
16870493|NCT01486927|37845561|FG000|Overall Study|Withdrawal by Subject|8|||
16870494|NCT01486927|37845561|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
16870495|NCT01513759|37845594|FG000|Overall Study|Protocol Violation|4|||
16870496|NCT01513759|37845594|FG000|Overall Study|Death during catheter placement|1|||
17094820|NCT03801928|38234087|FG003|Overall Study|Other|1|||
17094821|NCT03801928|38234088|FG004|Overall Study|Other|0|||
17094822|NCT03801928|38234089|FG005|Overall Study|Other|1|||
17094823|NCT00263588|38234108|FG000|Overall Study|Death|54|||
17094824|NCT00263588|38234109|FG001|Overall Study|Death|90|||
17094825|NCT00263588|38234108|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
17094826|NCT00263588|38234109|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
17094827|NCT00263588|38234108|FG000|Overall Study|Lost to Follow-up|7|||
17094828|NCT00263588|38234109|FG001|Overall Study|Lost to Follow-up|10|||
17094829|NCT00263588|38234108|FG000|Overall Study|Withdrawal by Subject|3|||
17094830|NCT00263588|38234109|FG001|Overall Study|Withdrawal by Subject|4|||
17094831|NCT00263588|38234108|FG000|Overall Study|Protocol Violation|0|||
17094832|NCT00263588|38234109|FG001|Overall Study|Protocol Violation|1|||
17094833|NCT00263588|38234108|FG000|Overall Study|Investigator decision|7|||
17094834|NCT00263588|38234109|FG001|Overall Study|Investigator decision|15|||
16870497|NCT01484561|37845600|FG000|Overall Study|Lack of Efficacy|3|||
17094835|NCT00263588|38234108|FG000|Overall Study|Sponsor terminated study|0|||
17094836|NCT00263588|38234109|FG001|Overall Study|Sponsor terminated study|1|||
17094837|NCT00213135|38234119|FG000|Overall Study|Adverse Event|9|||
17094838|NCT00213135|38234120|FG001|Overall Study|Adverse Event|5|||
17094839|NCT00213135|38234121|FG002|Overall Study|Adverse Event|5|||
17094840|NCT00213135|38234119|FG000|Overall Study|Lost to Follow-up|11|||
17094841|NCT00213135|38234120|FG001|Overall Study|Lost to Follow-up|8|||
17094842|NCT00213135|38234121|FG002|Overall Study|Lost to Follow-up|4|||
17094843|NCT00213135|38234119|FG000|Overall Study|Protocol Violation|4|||
17094844|NCT00213135|38234120|FG001|Overall Study|Protocol Violation|4|||
17094845|NCT00213135|38234121|FG002|Overall Study|Protocol Violation|10|||
17191071|NCT02477800|38343812|FG006|Long Term Extension Period|Death|2|||
17191072|NCT02477800|38343806|FG000|Long Term Extension Period|Consent Withdrawn|0|||
17191073|NCT02477800|38343807|FG001|Long Term Extension Period|Consent Withdrawn|0|||
17191074|NCT02477800|38343808|FG002|Long Term Extension Period|Consent Withdrawn|0|||
17191075|NCT02477800|38343809|FG003|Long Term Extension Period|Consent Withdrawn|10|||
16870498|NCT01484561|37845601|FG001|Overall Study|Lack of Efficacy|1|||
16870499|NCT01484561|37845600|FG000|Overall Study|Lost to Follow-up|1|||
16870500|NCT01484561|37845601|FG001|Overall Study|Lost to Follow-up|0|||
16870501|NCT01484561|37845600|FG000|Overall Study|Withdrawal by Subject|3|||
16870502|NCT01484561|37845601|FG001|Overall Study|Withdrawal by Subject|0|||
16870503|NCT01484561|37845600|FG000|Overall Study|Other|1|||
16870504|NCT01484561|37845601|FG001|Overall Study|Other|1|||
16870505|NCT01484561|37845600|FG000|Overall Study|Adverse Event|1|||
16870506|NCT01484561|37845601|FG001|Overall Study|Adverse Event|4|||
16870507|NCT01546207|37845607|FG000|Overall Study|Death|1|||
17191076|NCT02477800|38343810|FG004|Long Term Extension Period|Consent Withdrawn|4|||
17191077|NCT02477800|38343811|FG005|Long Term Extension Period|Consent Withdrawn|13|||
17191078|NCT02477800|38343812|FG006|Long Term Extension Period|Consent Withdrawn|16|||
16870508|NCT01513291|37845613|FG000|Treatment Period|Adverse Event|8|||
16870509|NCT01513291|37845614|FG001|Treatment Period|Adverse Event|4|||
16870510|NCT01513291|37845615|FG002|Treatment Period|Adverse Event|0|||
16870511|NCT01513291|37845616|FG003|Treatment Period|Adverse Event|0|||
17094846|NCT00213135|38234119|FG000|Overall Study|Death|1|||
17094847|NCT00213135|38234120|FG001|Overall Study|Death|1|||
17191079|NCT02477800|38343806|FG000|Long Term Extension Period|Disease Progression|0|||
16784407|NCT02709655|37724355|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
16784408|NCT02709655|37724356|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
16870512|NCT01513291|37845617|FG004|Treatment Period|Adverse Event|0|||
16870513|NCT01513291|37845613|FG000|Treatment Period|Lack of Efficacy|3|||
16870514|NCT01513291|37845614|FG001|Treatment Period|Lack of Efficacy|0|||
16870515|NCT01513291|37845615|FG002|Treatment Period|Lack of Efficacy|0|||
17094848|NCT00213135|38234121|FG002|Overall Study|Death|2|||
17094849|NCT00213135|38234119|FG000|Overall Study|Disease progression|4|||
17094850|NCT00213135|38234120|FG001|Overall Study|Disease progression|5|||
16784409|NCT02709655|37724357|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
16784410|NCT02709655|37724358|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
16784411|NCT02709655|37724354|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
16784412|NCT02709655|37724355|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
16784413|NCT02709655|37724356|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
16784414|NCT02709655|37724357|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
16870516|NCT01513291|37845616|FG003|Treatment Period|Lack of Efficacy|0|||
16870517|NCT01513291|37845617|FG004|Treatment Period|Lack of Efficacy|0|||
16870518|NCT01513291|37845613|FG000|Treatment Period|Lost to Follow-up|2|||
16870519|NCT01513291|37845614|FG001|Treatment Period|Lost to Follow-up|3|||
16870520|NCT01513291|37845615|FG002|Treatment Period|Lost to Follow-up|0|||
16870521|NCT01513291|37845616|FG003|Treatment Period|Lost to Follow-up|0|||
16870522|NCT01513291|37845617|FG004|Treatment Period|Lost to Follow-up|0|||
16870523|NCT01513291|37845613|FG000|Treatment Period|Physician Decision|1|||
16870524|NCT01513291|37845614|FG001|Treatment Period|Physician Decision|0|||
16870525|NCT01513291|37845615|FG002|Treatment Period|Physician Decision|0|||
16870526|NCT01513291|37845616|FG003|Treatment Period|Physician Decision|0|||
16870527|NCT01513291|37845617|FG004|Treatment Period|Physician Decision|0|||
16870528|NCT01513291|37845613|FG000|Treatment Period|Protocol Violation|1|||
16870529|NCT01513291|37845614|FG001|Treatment Period|Protocol Violation|2|||
16870530|NCT01513291|37845615|FG002|Treatment Period|Protocol Violation|0|||
16870531|NCT01513291|37845616|FG003|Treatment Period|Protocol Violation|0|||
16870532|NCT01513291|37845617|FG004|Treatment Period|Protocol Violation|0|||
16870533|NCT01513291|37845613|FG000|Treatment Period|Withdrawal by Subject|8|||
16870534|NCT01513291|37845614|FG001|Treatment Period|Withdrawal by Subject|5|||
16870535|NCT01513291|37845615|FG002|Treatment Period|Withdrawal by Subject|0|||
16870536|NCT01513291|37845616|FG003|Treatment Period|Withdrawal by Subject|0|||
16870537|NCT01513291|37845617|FG004|Treatment Period|Withdrawal by Subject|0|||
16870538|NCT01513291|37845613|FG000|Treatment Period|Randomized not treated|0|||
16870539|NCT01513291|37845614|FG001|Treatment Period|Randomized not treated|2|||
16870540|NCT01513291|37845615|FG002|Treatment Period|Randomized not treated|0|||
16870541|NCT01513291|37845616|FG003|Treatment Period|Randomized not treated|0|||
16870542|NCT01513291|37845617|FG004|Treatment Period|Randomized not treated|0|||
16870543|NCT01513291|37845613|FG000|Run-out Period|Lost to Follow-up|0|||
16870544|NCT01513291|37845614|FG001|Run-out Period|Lost to Follow-up|0|||
16870545|NCT01513291|37845615|FG002|Run-out Period|Lost to Follow-up|0|||
16870546|NCT01513291|37845616|FG003|Run-out Period|Lost to Follow-up|1|||
16870547|NCT01513291|37845617|FG004|Run-out Period|Lost to Follow-up|0|||
16870548|NCT01513291|37845613|FG000|Run-out Period|Withdrawal by Subject|0|||
16870549|NCT01513291|37845614|FG001|Run-out Period|Withdrawal by Subject|0|||
16870550|NCT01513291|37845615|FG002|Run-out Period|Withdrawal by Subject|0|||
16870551|NCT01513291|37845616|FG003|Run-out Period|Withdrawal by Subject|1|||
16870552|NCT01513291|37845617|FG004|Run-out Period|Withdrawal by Subject|0|||
16870553|NCT01483937|37845631|FG000|Overall Study|Withdrawal by Subject|4|||
16870554|NCT01483937|37845632|FG001|Overall Study|Withdrawal by Subject|3|||
16870555|NCT01483625|37845643|FG000|Overall Study|Adverse Event|1|||
16870556|NCT01483625|37845644|FG001|Overall Study|Adverse Event|1|||
16870557|NCT01483625|37845643|FG000|Overall Study|Refused to continue medication|2|||
16870558|NCT01483625|37845644|FG001|Overall Study|Refused to continue medication|1|||
16870559|NCT01483625|37845643|FG000|Overall Study|Due to other reason|1|||
16870560|NCT01483625|37845644|FG001|Overall Study|Due to other reason|0|||
16870561|NCT01485991|37845652|FG000|Overall Study|Adverse Event|0|||
16870562|NCT01485991|37845653|FG001|Overall Study|Adverse Event|4|||
16870563|NCT01485991|37845652|FG000|Overall Study|Lost to Follow-up|13|||
16870564|NCT01485991|37845653|FG001|Overall Study|Lost to Follow-up|10|||
16870565|NCT01485991|37845652|FG000|Overall Study|Withdrawal by Subject|13|||
16870566|NCT01485991|37845653|FG001|Overall Study|Withdrawal by Subject|20|||
17191080|NCT02477800|38343807|FG001|Long Term Extension Period|Disease Progression|0|||
17191081|NCT02477800|38343808|FG002|Long Term Extension Period|Disease Progression|0|||
16784415|NCT02709655|37724358|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
16784416|NCT02709655|37724354|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
16784417|NCT02709655|37724355|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
16784418|NCT02709655|37724356|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
16784419|NCT02709655|37724357|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
16784420|NCT02709655|37724358|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
16784421|NCT02708485|37724372|FG000|Overall Study|Withdrawal by Subject|3|||
16784422|NCT02708485|37724373|FG001|Overall Study|Withdrawal by Subject|2|||
16784423|NCT02709577|37724385|FG000|Overall Study|non-accommodating anatomy|0|||
16784424|NCT02709577|37724386|FG001|Overall Study|non-accommodating anatomy|1|||
16784425|NCT02709577|37724387|FG002|Overall Study|non-accommodating anatomy|0|||
16784426|NCT02709577|37724388|FG003|Overall Study|non-accommodating anatomy|0|||
16784427|NCT02709577|37724385|FG000|Overall Study|procedural complication|0|||
16784428|NCT02709577|37724386|FG001|Overall Study|procedural complication|1|||
16784429|NCT02709577|37724387|FG002|Overall Study|procedural complication|0|||
16870567|NCT01485991|37845652|FG000|Overall Study|randomized but not treated|6|||
16870568|NCT01485991|37845653|FG001|Overall Study|randomized but not treated|2|||
16870569|NCT01482767|37845685|FG000|Overall Study|Death|1|||
16870570|NCT01482767|37845686|FG001|Overall Study|Death|1|||
16784430|NCT02709577|37724388|FG003|Overall Study|procedural complication|0|||
16784431|NCT02709577|37724385|FG000|Overall Study|Withdrawal by Subject|2|||
16784432|NCT02709577|37724386|FG001|Overall Study|Withdrawal by Subject|3|||
16784433|NCT02709577|37724387|FG002|Overall Study|Withdrawal by Subject|2|||
16784434|NCT02709577|37724388|FG003|Overall Study|Withdrawal by Subject|0|||
16784435|NCT02078752|37724409|FG000|Overall Study|Death|0|||
16784436|NCT02078752|37724410|FG001|Overall Study|Death|3|||
16784437|NCT02078752|37724411|FG002|Overall Study|Death|0|||
16870571|NCT01482767|37845685|FG000|Overall Study|Withdrawal by Subject|7|||
16870572|NCT01482767|37845686|FG001|Overall Study|Withdrawal by Subject|5|||
16870573|NCT01482767|37845685|FG000|Overall Study|Lost to Follow-up|12|||
16870574|NCT01482767|37845686|FG001|Overall Study|Lost to Follow-up|6|||
16870575|NCT01482767|37845685|FG000|Overall Study|Adverse Event|0|||
16870576|NCT01482767|37845686|FG001|Overall Study|Adverse Event|3|||
16870577|NCT01482767|37845685|FG000|Overall Study|Site closure|22|||
16870578|NCT01482767|37845686|FG001|Overall Study|Site closure|14|||
16870579|NCT01482767|37845685|FG000|Overall Study|Non-adherence to study requirements|4|||
16870580|NCT01482767|37845686|FG001|Overall Study|Non-adherence to study requirements|7|||
16870581|NCT01482767|37845685|FG000|Overall Study|Alternate HCV treatment|7|||
16870582|NCT01482767|37845686|FG001|Overall Study|Alternate HCV treatment|8|||
16870583|NCT01482767|37845685|FG000|Overall Study|Ineligible|0|||
16870584|NCT01482767|37845686|FG001|Overall Study|Ineligible|5|||
16870585|NCT01482767|37845685|FG000|Overall Study|Nurse error|1|||
16870586|NCT01482767|37845686|FG001|Overall Study|Nurse error|0|||
16870587|NCT01482221|37845715|FG000|Overall Study|Lack of Efficacy|1|||
16870588|NCT01482221|37845716|FG001|Overall Study|Lack of Efficacy|0|||
16870589|NCT01482221|37845717|FG002|Overall Study|Lack of Efficacy|1|||
16870590|NCT01482221|37845715|FG000|Overall Study|Lost to Follow-up|3|||
16870591|NCT01482221|37845716|FG001|Overall Study|Lost to Follow-up|2|||
16870592|NCT01482221|37845717|FG002|Overall Study|Lost to Follow-up|1|||
17094851|NCT00213135|38234121|FG002|Overall Study|Disease progression|21|||
17094852|NCT00213135|38234119|FG000|Overall Study|Other|21|||
17094853|NCT00213135|38234120|FG001|Overall Study|Other|12|||
17094854|NCT00213135|38234121|FG002|Overall Study|Other|15|||
16870593|NCT01482221|37845715|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
16870594|NCT01482221|37845716|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
16870595|NCT01482221|37845717|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
16870596|NCT01482221|37845715|FG000|Overall Study|Condition under Investigation Worsened|3|||
16870597|NCT01482221|37845716|FG001|Overall Study|Condition under Investigation Worsened|2|||
16870598|NCT01482221|37845717|FG002|Overall Study|Condition under Investigation Worsened|4|||
16870599|NCT01482221|37845715|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
16870600|NCT01482221|37845716|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
16870601|NCT01482221|37845717|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
16870602|NCT01482221|37845715|FG000|Overall Study|Adverse Event|1|||
16870603|NCT01482221|37845716|FG001|Overall Study|Adverse Event|7|||
16870604|NCT01482221|37845717|FG002|Overall Study|Adverse Event|3|||
16870605|NCT01482221|37845715|FG000|Overall Study|Withdrawal by Subject|10|||
16870606|NCT01482221|37845716|FG001|Overall Study|Withdrawal by Subject|7|||
16870607|NCT01482221|37845717|FG002|Overall Study|Withdrawal by Subject|12|||
16870608|NCT01482221|37845715|FG000|Overall Study|Incorrect randomization|0|||
16870609|NCT01482221|37845716|FG001|Overall Study|Incorrect randomization|1|||
16870610|NCT01482221|37845717|FG002|Overall Study|Incorrect randomization|0|||
16870611|NCT01482221|37845715|FG000|Overall Study|Physician Decision|0|||
16870612|NCT01482221|37845716|FG001|Overall Study|Physician Decision|1|||
16870613|NCT01482221|37845717|FG002|Overall Study|Physician Decision|0|||
16870614|NCT01482065|37845727|FG000|Overall Study|Withdrawal by Subject|0|||
16870615|NCT01482065|37845728|FG001|Overall Study|Withdrawal by Subject|1|||
16784438|NCT02078752|37724412|FG003|Overall Study|Death|0|||
16870616|NCT01545817|37845743|FG000|Pazopanib|Disease progression|51|||
16870617|NCT01545817|37845744|FG001|Pazopanib|Disease progression|0|||
16870618|NCT01545817|37845743|FG000|Pazopanib|Adverse Event|19|||
16870619|NCT01545817|37845744|FG001|Pazopanib|Adverse Event|0|||
16870620|NCT01545817|37845743|FG000|Pazopanib|Other reason|4|||
17094855|NCT00077974|38234129|FG000|Overall Study|Adverse Event|22|||
16870621|NCT01545817|37845744|FG001|Pazopanib|Other reason|0|||
17094856|NCT00077974|38234129|FG000|Overall Study|Protocol Violation|1|||
17094857|NCT00077974|38234129|FG000|Overall Study|Withdrawal by Subject|3|||
17094858|NCT00077974|38234129|FG000|Overall Study|Lack of Efficacy|76|||
17094859|NCT00077974|38234129|FG000|Overall Study|Decision of Sponsor|2|||
17094860|NCT00124917|38234133|FG000|Overall Study|Physician Decision|3|||
17094861|NCT00141921|38234138|FG000|Overall Study|Remain on Study|28|||
16870622|NCT01545817|37845743|FG000|Everolimus|Other reason|0|||
16870623|NCT01545817|37845744|FG001|Everolimus|Other reason|7|||
16870624|NCT01545817|37845743|FG000|Everolimus|Disease progression|0|||
16870625|NCT01545817|37845744|FG001|Everolimus|Disease progression|25|||
16870626|NCT01545817|37845743|FG000|Everolimus|Adverse Event|0|||
16870627|NCT01545817|37845744|FG001|Everolimus|Adverse Event|6|||
16870628|NCT01512979|37845763|FG000|Overall Study|Adverse Event|2|||
16870629|NCT01512979|37845764|FG001|Overall Study|Adverse Event|2|||
16870630|NCT01512979|37845763|FG000|Overall Study|Protocol Violation|1|||
16870631|NCT01512979|37845764|FG001|Overall Study|Protocol Violation|4|||
16870632|NCT01512979|37845763|FG000|Overall Study|Lost to Follow-up|2|||
16870633|NCT01512979|37845764|FG001|Overall Study|Lost to Follow-up|5|||
16870634|NCT01512979|37845763|FG000|Overall Study|Withdrawal by Subject|1|||
16870635|NCT01512979|37845764|FG001|Overall Study|Withdrawal by Subject|2|||
16870636|NCT01512979|37845763|FG000|Overall Study|Reason other than stated above|13|||
16870637|NCT01512979|37845764|FG001|Overall Study|Reason other than stated above|9|||
16870638|NCT01512745|37845776|FG000|Overall Study|Adverse Event|22|||
16870639|NCT01512745|37845777|FG001|Overall Study|Adverse Event|3|||
16870640|NCT01512745|37845776|FG000|Overall Study|Death|9|||
16870641|NCT01512745|37845777|FG001|Overall Study|Death|13|||
16870642|NCT01512745|37845776|FG000|Overall Study|Withdrawal by Subject|2|||
16870643|NCT01512745|37845777|FG001|Overall Study|Withdrawal by Subject|2|||
16870644|NCT01512745|37845776|FG000|Overall Study|Lost to Follow-up|4|||
16870645|NCT01512745|37845777|FG001|Overall Study|Lost to Follow-up|0|||
16870646|NCT01512745|37845776|FG000|Overall Study|Lack of Efficacy|2|||
16870647|NCT01512745|37845777|FG001|Overall Study|Lack of Efficacy|2|||
16870648|NCT01512745|37845776|FG000|Overall Study|Protocol Violation|1|||
16870649|NCT01512745|37845777|FG001|Overall Study|Protocol Violation|0|||
16870650|NCT01478321|37845783|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
16870651|NCT01478321|37845783|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
16870652|NCT01478321|37845783|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
16870653|NCT01478321|37845783|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
16870654|NCT01478321|37845783|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
16870655|NCT01478321|37845783|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
16870656|NCT01478321|37845783|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
16870657|NCT01478321|37845783|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
16870658|NCT01544491|37845789|FG000|Overall Study|Withdrawal by Subject|3|||
16870659|NCT01544491|37845790|FG001|Overall Study|Withdrawal by Subject|2|||
16870660|NCT01544491|37845789|FG000|Overall Study|Lost to Follow-up|0|||
16870661|NCT01544491|37845790|FG001|Overall Study|Lost to Follow-up|1|||
16870662|NCT01544491|37845789|FG000|Overall Study|administrative problems|2|||
16870663|NCT01544491|37845790|FG001|Overall Study|administrative problems|0|||
16870664|NCT01478087|37845809|FG000|Overall Study|due to sponsor closing study|1|||
17191082|NCT02477800|38343809|FG003|Long Term Extension Period|Disease Progression|3|||
17191083|NCT02477800|38343810|FG004|Long Term Extension Period|Disease Progression|1|||
16870665|NCT01477853|37845827|FG000|Phase A|Adverse Event|1|||
16870666|NCT01477853|37845828|FG001|Phase A|Adverse Event|2|||
16870667|NCT01477853|37845829|FG002|Phase A|Adverse Event|2|||
16870668|NCT01477853|37845827|FG000|Phase A|Lost to Follow-up|4|||
16870669|NCT01477853|37845828|FG001|Phase A|Lost to Follow-up|3|||
16870670|NCT01477853|37845829|FG002|Phase A|Lost to Follow-up|2|||
16870671|NCT01477853|37845827|FG000|Phase A|Physician Decision|1|||
16870672|NCT01477853|37845828|FG001|Phase A|Physician Decision|0|||
17000887|NCT01000025|38144828|FG000|Overall Study|Intercurrent Illness|26|||
17191084|NCT02477800|38343811|FG005|Long Term Extension Period|Disease Progression|1|||
16870673|NCT01477853|37845829|FG002|Phase A|Physician Decision|1|||
16870674|NCT01477853|37845827|FG000|Phase A|Study terminated by sponsor|37|||
16870675|NCT01477853|37845828|FG001|Phase A|Study terminated by sponsor|40|||
16870676|NCT01477853|37845829|FG002|Phase A|Study terminated by sponsor|39|||
16870677|NCT01477853|37845827|FG000|Phase B|Lost to Follow-up|0|||
16870678|NCT01477853|37845828|FG001|Phase B|Lost to Follow-up|1|||
16870679|NCT01477853|37845829|FG002|Phase B|Lost to Follow-up|0|||
17094862|NCT00141921|38234138|FG000|Overall Study|Withdrawal by Subject|42|||
17000888|NCT01000025|38144829|FG001|Overall Study|Intercurrent Illness|7|||
17000889|NCT00595335|38144837|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
17094863|NCT00141921|38234138|FG000|Overall Study|Lost to Follow-up|19|||
17094864|NCT00141921|38234138|FG000|Overall Study|Noncompliance|17|||
17094865|NCT00141921|38234138|FG000|Overall Study|Disease Progression|7|||
17094866|NCT00141921|38234138|FG000|Overall Study|Protocol Deviation|7|||
17094867|NCT00141921|38234138|FG000|Overall Study|Adverse Event|5|||
17094868|NCT00141921|38234138|FG000|Overall Study|Administrative Decision|2|||
17094869|NCT00141921|38234138|FG000|Overall Study|Pregnancy|4|||
17094870|NCT00141921|38234138|FG000|Overall Study|Ineligibility Determined|2|||
17094871|NCT00141921|38234138|FG000|Overall Study|Other|8|||
17094872|NCT00029146|38234144|FG000|Overall Study|Lost to Follow-up|2|||
17094873|NCT00029146|38234145|FG001|Overall Study|Lost to Follow-up|1|||
17094874|NCT00026494|38234155|FG000|Overall Study|Withdrawal by Subject|1|||
17094875|NCT00026494|38234156|FG001|Overall Study|Withdrawal by Subject|0|||
17094876|NCT00026494|38234157|FG002|Overall Study|Withdrawal by Subject|1|||
17094877|NCT00026494|38234158|FG003|Overall Study|Withdrawal by Subject|0|||
16870680|NCT01477853|37845827|FG000|Phase B|Study terminated by sponsor|12|||
16870681|NCT01477853|37845828|FG001|Phase B|Study terminated by sponsor|10|||
16870682|NCT01477853|37845829|FG002|Phase B|Study terminated by sponsor|11|||
17191085|NCT02477800|38343812|FG006|Long Term Extension Period|Disease Progression|0|||
17191086|NCT02477800|38343806|FG000|Long Term Extension Period|Investigator Decision|0|||
17191087|NCT02477800|38343807|FG001|Long Term Extension Period|Investigator Decision|0|||
17191088|NCT02477800|38343808|FG002|Long Term Extension Period|Investigator Decision|0|||
17191089|NCT02477800|38343809|FG003|Long Term Extension Period|Investigator Decision|0|||
17191090|NCT02477800|38343810|FG004|Long Term Extension Period|Investigator Decision|0|||
17191091|NCT02477800|38343811|FG005|Long Term Extension Period|Investigator Decision|0|||
17191092|NCT02477800|38343812|FG006|Long Term Extension Period|Investigator Decision|2|||
17191093|NCT02477800|38343806|FG000|Long Term Extension Period|Lost to Follow-up|0|||
17191094|NCT02477800|38343807|FG001|Long Term Extension Period|Lost to Follow-up|0|||
17191095|NCT02477800|38343808|FG002|Long Term Extension Period|Lost to Follow-up|0|||
17191096|NCT02477800|38343809|FG003|Long Term Extension Period|Lost to Follow-up|0|||
17191097|NCT02477800|38343810|FG004|Long Term Extension Period|Lost to Follow-up|1|||
17191098|NCT02477800|38343811|FG005|Long Term Extension Period|Lost to Follow-up|3|||
17191099|NCT02477800|38343812|FG006|Long Term Extension Period|Lost to Follow-up|0|||
17191100|NCT02477800|38343806|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
17191101|NCT02477800|38343807|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
17094878|NCT00026494|38234155|FG000|Overall Study|Patient non-compliance|1|||
17094879|NCT00026494|38234156|FG001|Overall Study|Patient non-compliance|0|||
17191102|NCT02477800|38343808|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
17191103|NCT02477800|38343809|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
17191104|NCT02477800|38343810|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
17191105|NCT02477800|38343811|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
17191106|NCT02477800|38343812|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
17191107|NCT02477800|38343806|FG000|Long Term Extension Period|Study Visit Burden|0|||
17191108|NCT02477800|38343807|FG001|Long Term Extension Period|Study Visit Burden|0|||
16784439|NCT02078752|37724413|FG004|Overall Study|Death|0|||
16784440|NCT02078752|37724414|FG005|Overall Study|Death|1|||
16784441|NCT02078752|37724415|FG006|Overall Study|Death|0|||
16870683|NCT01511419|37845861|FG000|Dose 2|Physician Decision|1|||
17000890|NCT00595335|38144838|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
17000891|NCT00595335|38144837|FG000|Baseline to Six Months|Disease Progression|1|||
17000892|NCT00595335|38144838|FG001|Baseline to Six Months|Disease Progression|1|||
17000893|NCT00595335|38144837|FG000|Baseline to Six Months|Adverse Event|1|||
17000894|NCT00595335|38144838|FG001|Baseline to Six Months|Adverse Event|0|||
17000895|NCT00595335|38144837|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
17000896|NCT00595335|38144838|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
17000897|NCT00595335|38144837|FG000|Six Months to Twelve Months|Disease Progression|1|||
17000898|NCT00595335|38144838|FG001|Six Months to Twelve Months|Disease Progression|0|||
17000899|NCT00661609|38144848|FG000|Overall Study|Adverse Event|4|||
17000900|NCT00661609|38144848|FG000|Overall Study|Death|20|||
17000901|NCT00661609|38144848|FG000|Overall Study|Withdrawal by Subject|2|||
17000902|NCT00661609|38144848|FG000|Overall Study|PI Decision|1|||
17000903|NCT00661609|38144848|FG000|Overall Study|Survival follow up stage discontinued|11|||
17000904|NCT00661609|38144848|FG000|Overall Study|Disease progression|3|||
17000905|NCT00661531|38144852|FG000|Overall Study|Withdrawal by Subject|3|||
17000906|NCT00998309|38144856|FG000|Overall Study|Protocol Violation|4|||
17000907|NCT00999713|38144910|FG000|Overall Study|Physician Decision|2|||
17000908|NCT00999713|38144911|FG001|Overall Study|Physician Decision|0|||
17000909|NCT00997373|38144919|FG000|Overall Study|Withdrawal by Subject|5|||
17000910|NCT00997373|38144920|FG001|Overall Study|Withdrawal by Subject|0|||
17000911|NCT00997373|38144919|FG000|Overall Study|wrong tumor type|4|||
17000912|NCT00997373|38144920|FG001|Overall Study|wrong tumor type|0|||
17000913|NCT00997373|38144919|FG000|Overall Study|could not have hysterectomy|6|||
17000914|NCT00997373|38144920|FG001|Overall Study|could not have hysterectomy|0|||
17000915|NCT00663871|38144928|FG000|Overall Study|Lost to Follow-up|5|||
17094880|NCT00026494|38234157|FG002|Overall Study|Patient non-compliance|0|||
17094881|NCT00026494|38234158|FG003|Overall Study|Patient non-compliance|0|||
17094882|NCT00026494|38234155|FG000|Overall Study|Patient not treated|0|||
17094883|NCT00026494|38234156|FG001|Overall Study|Patient not treated|0|||
17094884|NCT00026494|38234157|FG002|Overall Study|Patient not treated|2|||
17094885|NCT00026494|38234158|FG003|Overall Study|Patient not treated|0|||
17094886|NCT00026494|38234155|FG000|Overall Study|Clinical progression|0|||
17094887|NCT00026494|38234156|FG001|Overall Study|Clinical progression|0|||
17094888|NCT00026494|38234157|FG002|Overall Study|Clinical progression|3|||
17094889|NCT00026494|38234158|FG003|Overall Study|Clinical progression|0|||
17094890|NCT00023764|38234168|FG000|Overall Study|Other|1|||
17094891|NCT00023764|38234168|FG000|Overall Study|Adverse Event|4|||
17094892|NCT00023764|38234168|FG000|Overall Study|Withdrawal by Subject|1|||
17094893|NCT00023764|38234168|FG000|Overall Study|Progression of disease|6|||
17094894|NCT00023764|38234168|FG000|Overall Study|patient received other treatment|1|||
17094895|NCT00023764|38234168|FG000|Overall Study|delay in obtaining staging images|1|||
17094896|NCT00189488|38234175|FG000|Overall Study|Ineligibility determined|1|||
17094897|NCT00189488|38234176|FG001|Overall Study|Ineligibility determined|0|||
16784442|NCT02078752|37724416|FG007|Overall Study|Death|1|||
16784443|NCT02078752|37724417|FG008|Overall Study|Death|0|||
16784444|NCT02078752|37724418|FG009|Overall Study|Death|4|||
16784445|NCT02078752|37724409|FG000|Overall Study|Lost to Follow-up|1|||
16784446|NCT02078752|37724410|FG001|Overall Study|Lost to Follow-up|0|||
16784447|NCT02078752|37724411|FG002|Overall Study|Lost to Follow-up|0|||
16784448|NCT02078752|37724412|FG003|Overall Study|Lost to Follow-up|1|||
16784449|NCT02078752|37724413|FG004|Overall Study|Lost to Follow-up|0|||
16784450|NCT02078752|37724414|FG005|Overall Study|Lost to Follow-up|0|||
16784451|NCT02078752|37724415|FG006|Overall Study|Lost to Follow-up|0|||
17000916|NCT00663871|38144929|FG001|Overall Study|Lost to Follow-up|5|||
17000917|NCT00663871|38144928|FG000|Overall Study|Withdrawal by Subject|5|||
17000918|NCT00663871|38144929|FG001|Overall Study|Withdrawal by Subject|2|||
16784452|NCT02078752|37724416|FG007|Overall Study|Lost to Follow-up|0|||
16784453|NCT02078752|37724417|FG008|Overall Study|Lost to Follow-up|0|||
16784454|NCT02078752|37724418|FG009|Overall Study|Lost to Follow-up|0|||
16784455|NCT02078752|37724409|FG000|Overall Study|Withdrawal by Subject|1|||
16784456|NCT02078752|37724410|FG001|Overall Study|Withdrawal by Subject|1|||
16784457|NCT02078752|37724411|FG002|Overall Study|Withdrawal by Subject|1|||
16870684|NCT01511419|37845862|FG001|Dose 2|Physician Decision|0|||
16870685|NCT01511107|37845924|FG000|Overall Study|Ineligible|3|||
16870686|NCT01511107|37845925|FG001|Overall Study|Ineligible|2|||
16870687|NCT01511107|37845924|FG000|Overall Study|Lost to Follow-up|10|||
16870688|NCT01511107|37845925|FG001|Overall Study|Lost to Follow-up|19|||
16870689|NCT01511107|37845924|FG000|Overall Study|Withdrawal by Subject|9|||
16870690|NCT01511107|37845925|FG001|Overall Study|Withdrawal by Subject|20|||
16870691|NCT01484977|37845960|FG000|Overall Study|Adverse Event|8|||
16870692|NCT01484977|37845960|FG000|Overall Study|Lack of Efficacy|4|||
16870693|NCT01484977|37845960|FG000|Overall Study|Protocol Violation|6|||
16870694|NCT01484977|37845960|FG000|Overall Study|Lost to Follow-up|1|||
16870695|NCT01484977|37845960|FG000|Overall Study|Withdrawal by Subject|4|||
16870696|NCT01484977|37845960|FG000|Overall Study|Subject Protocol Non-compliant|1|||
16870697|NCT01484977|37845960|FG000|Overall Study|Moving Overseas|1|||
16870698|NCT01484977|37845960|FG000|Overall Study|Low White Blood Cell Count|1|||
16870699|NCT01484977|37845960|FG000|Overall Study|Lack of Compliance|1|||
16870700|NCT01475825|37846040|FG000|Overall Study|Adverse Event|41|||
16870701|NCT01475825|37846041|FG001|Overall Study|Adverse Event|15|||
16870702|NCT01475825|37846042|FG002|Overall Study|Adverse Event|27|||
16784458|NCT02078752|37724412|FG003|Overall Study|Withdrawal by Subject|1|||
16784459|NCT02078752|37724413|FG004|Overall Study|Withdrawal by Subject|0|||
16870703|NCT01475825|37846043|FG003|Overall Study|Adverse Event|11|||
16870704|NCT01475825|37846040|FG000|Overall Study|Death|1|||
17191109|NCT02477800|38343808|FG002|Long Term Extension Period|Study Visit Burden|0|||
17191110|NCT02477800|38343809|FG003|Long Term Extension Period|Study Visit Burden|3|||
17191111|NCT02477800|38343810|FG004|Long Term Extension Period|Study Visit Burden|0|||
17191112|NCT02477800|38343811|FG005|Long Term Extension Period|Study Visit Burden|2|||
17191113|NCT02477800|38343812|FG006|Long Term Extension Period|Study Visit Burden|2|||
17191114|NCT02477800|38343806|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
17191115|NCT02477800|38343807|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
17191116|NCT02477800|38343808|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
17191117|NCT02477800|38343809|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
17191118|NCT02477800|38343810|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
17000919|NCT04152447|38144939|FG000|Overall Study|Lost to Follow-up|1|||
16784460|NCT02078752|37724414|FG005|Overall Study|Withdrawal by Subject|3|||
16784461|NCT02078752|37724415|FG006|Overall Study|Withdrawal by Subject|2|||
16784462|NCT02078752|37724416|FG007|Overall Study|Withdrawal by Subject|1|||
16784463|NCT02078752|37724417|FG008|Overall Study|Withdrawal by Subject|0|||
16784464|NCT02078752|37724418|FG009|Overall Study|Withdrawal by Subject|1|||
16784465|NCT02078752|37724409|FG000|Overall Study|Other|0|||
16784466|NCT02078752|37724410|FG001|Overall Study|Other|3|||
16870705|NCT01475825|37846041|FG001|Overall Study|Death|0|||
16870706|NCT01475825|37846042|FG002|Overall Study|Death|1|||
16870707|NCT01475825|37846043|FG003|Overall Study|Death|0|||
16870708|NCT01475825|37846040|FG000|Overall Study|Lack of Efficacy|0|||
16870709|NCT01475825|37846041|FG001|Overall Study|Lack of Efficacy|0|||
16870710|NCT01475825|37846042|FG002|Overall Study|Lack of Efficacy|1|||
17000920|NCT04152447|38144940|FG001|Overall Study|Lost to Follow-up|0|||
17000921|NCT04152447|38144939|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
16870711|NCT01475825|37846043|FG003|Overall Study|Lack of Efficacy|0|||
17000922|NCT04152447|38144940|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
17000923|NCT04152447|38144939|FG000|Overall Study|Withdrawal by Subject|0|||
17000924|NCT04152447|38144940|FG001|Overall Study|Withdrawal by Subject|1|||
17000925|NCT04152447|38144939|FG000|Overall Study|Found ineligible after enrolling|1|||
16870712|NCT01475825|37846040|FG000|Overall Study|Lost to Follow-up|0|||
17000926|NCT04152447|38144940|FG001|Overall Study|Found ineligible after enrolling|1|||
16870713|NCT01475825|37846041|FG001|Overall Study|Lost to Follow-up|0|||
16870714|NCT01475825|37846042|FG002|Overall Study|Lost to Follow-up|3|||
16870715|NCT01475825|37846043|FG003|Overall Study|Lost to Follow-up|1|||
16870716|NCT01475825|37846040|FG000|Overall Study|Non-compliance with Study Drug|1|||
16870717|NCT01475825|37846041|FG001|Overall Study|Non-compliance with Study Drug|2|||
16870718|NCT01475825|37846042|FG002|Overall Study|Non-compliance with Study Drug|4|||
16870719|NCT01475825|37846043|FG003|Overall Study|Non-compliance with Study Drug|0|||
16870720|NCT01475825|37846040|FG000|Overall Study|Other: Not available|0|||
16870721|NCT01475825|37846041|FG001|Overall Study|Other: Not available|0|||
16870722|NCT01475825|37846042|FG002|Overall Study|Other: Not available|2|||
16870723|NCT01475825|37846043|FG003|Overall Study|Other: Not available|0|||
16870724|NCT01475825|37846040|FG000|Overall Study|Protocol Violation|1|||
16870725|NCT01475825|37846041|FG001|Overall Study|Protocol Violation|0|||
16870726|NCT01475825|37846042|FG002|Overall Study|Protocol Violation|0|||
16870727|NCT01475825|37846043|FG003|Overall Study|Protocol Violation|0|||
16870728|NCT01475825|37846040|FG000|Overall Study|Physician Decision|0|||
16870729|NCT01475825|37846041|FG001|Overall Study|Physician Decision|1|||
16870730|NCT01475825|37846042|FG002|Overall Study|Physician Decision|0|||
16870731|NCT01475825|37846043|FG003|Overall Study|Physician Decision|0|||
16870732|NCT01475825|37846040|FG000|Overall Study|Withdrawal by Subject|8|||
16870733|NCT01475825|37846041|FG001|Overall Study|Withdrawal by Subject|3|||
16870734|NCT01475825|37846042|FG002|Overall Study|Withdrawal by Subject|11|||
16870735|NCT01475825|37846043|FG003|Overall Study|Withdrawal by Subject|7|||
16870736|NCT01475825|37846040|FG000|Overall Study|Did not enter OLC|15|||
16870737|NCT01475825|37846041|FG001|Overall Study|Did not enter OLC|11|||
16870738|NCT01475825|37846042|FG002|Overall Study|Did not enter OLC|15|||
16870739|NCT01475825|37846043|FG003|Overall Study|Did not enter OLC|11|||
16870740|NCT01484431|37846065|FG000|Period 1: High Dose|Physician Decision|0|||
16870741|NCT01484431|37846066|FG001|Period 1: High Dose|Physician Decision|1|||
16870742|NCT01484431|37846067|FG002|Period 1: High Dose|Physician Decision|0|||
16870743|NCT01484431|37846065|FG000|Period 2|Death|0|||
16870744|NCT01484431|37846066|FG001|Period 2|Death|1|||
16870745|NCT01484431|37846067|FG002|Period 2|Death|1|||
16870746|NCT01484431|37846065|FG000|Period 2|Physician Decision|0|||
16870747|NCT01484431|37846066|FG001|Period 2|Physician Decision|0|||
16870748|NCT01484431|37846067|FG002|Period 2|Physician Decision|1|||
16870749|NCT01484431|37846065|FG000|Period 2|Non-Compliance with Study Drug|1|||
16870750|NCT01484431|37846066|FG001|Period 2|Non-Compliance with Study Drug|0|||
16870751|NCT01484431|37846067|FG002|Period 2|Non-Compliance with Study Drug|0|||
16870752|NCT01473953|37846115|FG000|Overall Study|Other|1|||
16870753|NCT01473953|37846116|FG001|Overall Study|Other|0|||
16870754|NCT01473953|37846117|FG002|Overall Study|Other|0|||
16870755|NCT01473953|37846118|FG003|Overall Study|Other|0|||
16870756|NCT01473953|37846119|FG004|Overall Study|Other|0|||
16870757|NCT01510717|37846133|FG000|Overall Study|Adverse Event|1|||
16870758|NCT01510717|37846134|FG001|Overall Study|Adverse Event|2|||
16870759|NCT01510717|37846133|FG000|Overall Study|Death|1|||
16870760|NCT01510717|37846134|FG001|Overall Study|Death|0|||
16870761|NCT01510717|37846133|FG000|Overall Study|Lost to Follow-up|0|||
16870762|NCT01510717|37846134|FG001|Overall Study|Lost to Follow-up|1|||
16870763|NCT01510717|37846133|FG000|Overall Study|Withdrawal by Subject|0|||
16870764|NCT01510717|37846134|FG001|Overall Study|Withdrawal by Subject|2|||
16870765|NCT01473563|37846150|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
16870766|NCT01484275|37846168|FG000|Overall Study|Study terminated by sponsor|28|||
16870767|NCT01484275|37846169|FG001|Overall Study|Study terminated by sponsor|32|||
16870768|NCT01484275|37846168|FG000|Overall Study|Other|10|||
16870769|NCT01484275|37846169|FG001|Overall Study|Other|0|||
16870770|NCT01484275|37846168|FG000|Overall Study|Death|3|||
16870771|NCT01484275|37846169|FG001|Overall Study|Death|4|||
16870772|NCT01484275|37846168|FG000|Overall Study|Withdrawal by Subject|1|||
16870773|NCT01484275|37846169|FG001|Overall Study|Withdrawal by Subject|5|||
17000927|NCT04152447|38144939|FG000|Overall Study|Did not receive VR headset in time.|0|||
17000928|NCT04152447|38144940|FG001|Overall Study|Did not receive VR headset in time.|2|||
17000929|NCT00996593|38144946|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
17000930|NCT00996593|38144946|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
17000931|NCT00996593|38144946|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
17094898|NCT00189488|38234175|FG000|Overall Study|Protocol deviation|2|||
16870774|NCT01484275|37846168|FG000|Overall Study|Lost to Follow-up|1|||
16870775|NCT01484275|37846169|FG001|Overall Study|Lost to Follow-up|1|||
16870776|NCT01544335|37846175|FG000|Overall Study|Lost to Follow-up|27|||
16870777|NCT01544335|37846175|FG000|Overall Study|Death|4|||
16870778|NCT01544335|37846175|FG000|Overall Study|Disease progression|3|||
16870779|NCT01544335|37846175|FG000|Overall Study|Baseline Measurements not Available|19|||
16870780|NCT01484197|37846179|FG000|Treatment Period 1|Adverse Event|1|||
16870781|NCT01484197|37846180|FG001|Treatment Period 1|Adverse Event|0|||
16870782|NCT01484197|37846181|FG002|Treatment Period 1|Adverse Event|0|||
16870783|NCT01484197|37846182|FG003|Treatment Period 1|Adverse Event|0|||
16870784|NCT01484197|37846179|FG000|Treatment Period 2|Subject withdrew consent|0|||
16870785|NCT01484197|37846180|FG001|Treatment Period 2|Subject withdrew consent|0|||
16870786|NCT01484197|37846181|FG002|Treatment Period 2|Subject withdrew consent|0|||
16870787|NCT01484197|37846182|FG003|Treatment Period 2|Subject withdrew consent|1|||
16870788|NCT01473407|37846194|FG000|Overall Study|Physician Decision|1|||
16784467|NCT02078752|37724411|FG002|Overall Study|Other|0|||
16784468|NCT02078752|37724412|FG003|Overall Study|Other|0|||
16784469|NCT02078752|37724413|FG004|Overall Study|Other|1|||
16784470|NCT02078752|37724414|FG005|Overall Study|Other|0|||
16784471|NCT02078752|37724415|FG006|Overall Study|Other|0|||
16784472|NCT02078752|37724416|FG007|Overall Study|Other|1|||
16870789|NCT01473407|37846195|FG001|Overall Study|Physician Decision|4|||
16870790|NCT01473407|37846194|FG000|Overall Study|Lost to Follow-up|10|||
16870791|NCT01473407|37846195|FG001|Overall Study|Lost to Follow-up|4|||
16870792|NCT01473407|37846194|FG000|Overall Study|Adverse Event|8|||
16870793|NCT01473407|37846195|FG001|Overall Study|Adverse Event|8|||
16870794|NCT01473407|37846194|FG000|Overall Study|Randomization Error|3|||
16870795|NCT01473407|37846195|FG001|Overall Study|Randomization Error|1|||
16870796|NCT01473407|37846194|FG000|Overall Study|Withdrawal by Subject|4|||
16870797|NCT01473407|37846195|FG001|Overall Study|Withdrawal by Subject|7|||
16870798|NCT01473407|37846194|FG000|Overall Study|Kidney Transplant|7|||
16870799|NCT01473407|37846195|FG001|Overall Study|Kidney Transplant|6|||
16870800|NCT01473407|37846194|FG000|Overall Study|Vacation/Travel|1|||
16870801|NCT01473407|37846195|FG001|Overall Study|Vacation/Travel|1|||
16870802|NCT01473407|37846194|FG000|Overall Study|Elevated Hemoglobin|1|||
16870803|NCT01473407|37846195|FG001|Overall Study|Elevated Hemoglobin|0|||
16870804|NCT01473407|37846194|FG000|Overall Study|Patient Received Aranesp|1|||
16870805|NCT01473407|37846195|FG001|Overall Study|Patient Received Aranesp|0|||
16870806|NCT01473407|37846194|FG000|Overall Study|Patient Lost Green Card Status|1|||
16870807|NCT01473407|37846195|FG001|Overall Study|Patient Lost Green Card Status|0|||
16870808|NCT01473407|37846194|FG000|Overall Study|Temperature Excursion|2|||
16870809|NCT01473407|37846195|FG001|Overall Study|Temperature Excursion|3|||
16870810|NCT01473407|37846194|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
16870811|NCT01473407|37846195|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
16870812|NCT01473407|37846194|FG000|Overall Study|Sponsor's Decision|10|||
16870813|NCT01473407|37846195|FG001|Overall Study|Sponsor's Decision|10|||
16870814|NCT01473407|37846194|FG000|Overall Study|Site Closure|1|||
16870815|NCT01473407|37846195|FG001|Overall Study|Site Closure|0|||
16870816|NCT01472939|37846205|FG000|Overall Study|Adverse Event|3|||
16870817|NCT01472939|37846206|FG001|Overall Study|Adverse Event|7|||
16870818|NCT01472939|37846207|FG002|Overall Study|Adverse Event|7|||
16870819|NCT01472939|37846208|FG003|Overall Study|Adverse Event|14|||
16870820|NCT01472939|37846205|FG000|Overall Study|Lack of Efficacy|1|||
16870821|NCT01472939|37846206|FG001|Overall Study|Lack of Efficacy|0|||
16870822|NCT01472939|37846207|FG002|Overall Study|Lack of Efficacy|0|||
16870823|NCT01472939|37846208|FG003|Overall Study|Lack of Efficacy|1|||
16870824|NCT01472939|37846205|FG000|Overall Study|Lost to Follow-up|3|||
16870825|NCT01472939|37846206|FG001|Overall Study|Lost to Follow-up|0|||
16870826|NCT01472939|37846207|FG002|Overall Study|Lost to Follow-up|2|||
16870827|NCT01472939|37846208|FG003|Overall Study|Lost to Follow-up|0|||
16870828|NCT01472939|37846205|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
16870829|NCT01472939|37846206|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
16870830|NCT01472939|37846207|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
16870831|NCT01472939|37846208|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
16870832|NCT01472939|37846205|FG000|Overall Study|Prohibited Medication|0|||
16870833|NCT01472939|37846206|FG001|Overall Study|Prohibited Medication|1|||
16870834|NCT01472939|37846207|FG002|Overall Study|Prohibited Medication|0|||
16870835|NCT01472939|37846208|FG003|Overall Study|Prohibited Medication|0|||
16870836|NCT01472939|37846205|FG000|Overall Study|Withdrawal By PI|1|||
16870837|NCT01472939|37846206|FG001|Overall Study|Withdrawal By PI|0|||
16870838|NCT01472939|37846207|FG002|Overall Study|Withdrawal By PI|0|||
16870839|NCT01472939|37846208|FG003|Overall Study|Withdrawal By PI|0|||
16870840|NCT01472939|37846205|FG000|Overall Study|Protocol Violation|3|||
16870841|NCT01472939|37846206|FG001|Overall Study|Protocol Violation|3|||
16870842|NCT01472939|37846207|FG002|Overall Study|Protocol Violation|0|||
16870843|NCT01472939|37846208|FG003|Overall Study|Protocol Violation|1|||
16870844|NCT01472939|37846205|FG000|Overall Study|Withdrawal by Subject|9|||
16870845|NCT01472939|37846206|FG001|Overall Study|Withdrawal by Subject|3|||
17094899|NCT00189488|38234176|FG001|Overall Study|Protocol deviation|1|||
16870846|NCT01472939|37846207|FG002|Overall Study|Withdrawal by Subject|1|||
16784473|NCT02078752|37724417|FG008|Overall Study|Other|0|||
16784474|NCT02078752|37724418|FG009|Overall Study|Other|0|||
16784475|NCT02078752|37724409|FG000|Overall Study|Study terminated by sponsor|0|||
16784476|NCT02078752|37724410|FG001|Overall Study|Study terminated by sponsor|0|||
16784477|NCT02078752|37724411|FG002|Overall Study|Study terminated by sponsor|0|||
16784478|NCT02078752|37724412|FG003|Overall Study|Study terminated by sponsor|0|||
16784479|NCT02078752|37724413|FG004|Overall Study|Study terminated by sponsor|0|||
16784480|NCT02078752|37724414|FG005|Overall Study|Study terminated by sponsor|0|||
16784481|NCT02078752|37724415|FG006|Overall Study|Study terminated by sponsor|0|||
16784482|NCT02078752|37724416|FG007|Overall Study|Study terminated by sponsor|0|||
16870847|NCT01472939|37846208|FG003|Overall Study|Withdrawal by Subject|4|||
16870848|NCT01544179|37846223|FG000|Overall Study|Death|50|||
16870849|NCT01544179|37846224|FG001|Overall Study|Death|37|||
16870850|NCT01544179|37846223|FG000|Overall Study|Lost to Follow-up|0|||
16784483|NCT02078752|37724417|FG008|Overall Study|Study terminated by sponsor|0|||
16784484|NCT02078752|37724418|FG009|Overall Study|Study terminated by sponsor|5|||
16870851|NCT01544179|37846224|FG001|Overall Study|Lost to Follow-up|1|||
16784485|NCT02022748|37724451|FG000|Overall Study|Adverse Event|1|||
16784486|NCT02022748|37724452|FG001|Overall Study|Adverse Event|1|||
16784487|NCT02022748|37724453|FG002|Overall Study|Adverse Event|0|||
16784488|NCT02022748|37724451|FG000|Overall Study|Withdrawal by Subject|0|||
16784489|NCT02022748|37724452|FG001|Overall Study|Withdrawal by Subject|1|||
16784490|NCT02022748|37724453|FG002|Overall Study|Withdrawal by Subject|0|||
16784491|NCT02022670|37724464|FG000|Overall Study|Adverse Event|1|||
16784492|NCT02022670|37724465|FG001|Overall Study|Adverse Event|0|||
16784493|NCT02022670|37724466|FG002|Overall Study|Adverse Event|1|||
16784494|NCT02076334|37724479|FG000|Overall Study|Protocol Violation|1|||
16870852|NCT01544179|37846223|FG000|Overall Study|Adverse Event|0|||
16870853|NCT01544179|37846224|FG001|Overall Study|Adverse Event|1|||
16870854|NCT01544179|37846223|FG000|Overall Study|Withdrawal by Subject|12|||
16870855|NCT01544179|37846224|FG001|Overall Study|Withdrawal by Subject|7|||
16870856|NCT01544179|37846223|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
16870857|NCT01544179|37846224|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16870858|NCT01483651|37846230|FG000|Overall Study|Withdrawal by Subject|0|||
16870859|NCT01483651|37846231|FG001|Overall Study|Withdrawal by Subject|1|||
16870860|NCT01483651|37846232|FG002|Overall Study|Withdrawal by Subject|1|||
16870861|NCT01483651|37846233|FG003|Overall Study|Withdrawal by Subject|0|||
16870862|NCT01483651|37846234|FG004|Overall Study|Withdrawal by Subject|0|||
16870863|NCT01483651|37846235|FG005|Overall Study|Withdrawal by Subject|1|||
16870864|NCT01464307|37846245|FG000|Main Period|Death|0|||
16870865|NCT01464307|37846246|FG001|Main Period|Death|1|||
16870866|NCT01464307|37846245|FG000|Main Period|Adverse Event|6|||
16870867|NCT01464307|37846246|FG001|Main Period|Adverse Event|1|||
16870868|NCT01464307|37846245|FG000|Main Period|Lack of Efficacy|2|||
16870869|NCT01464307|37846246|FG001|Main Period|Lack of Efficacy|0|||
16870870|NCT01464307|37846245|FG000|Main Period|Withdrawal by Subject|5|||
16870871|NCT01464307|37846246|FG001|Main Period|Withdrawal by Subject|2|||
16870872|NCT01464307|37846245|FG000|Main Period|Predefined discontinuation criteria|2|||
16870873|NCT01464307|37846246|FG001|Main Period|Predefined discontinuation criteria|1|||
16870874|NCT01464307|37846245|FG000|Open-Label Extension Period|Adverse Event|15|||
16870875|NCT01464307|37846246|FG001|Open-Label Extension Period|Adverse Event|0|||
16870876|NCT01464307|37846245|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
16870877|NCT01464307|37846246|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
16870878|NCT01464307|37846245|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
16870879|NCT01464307|37846246|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
16870880|NCT01464307|37846245|FG000|Open-Label Extension Period|Death|1|||
16870881|NCT01464307|37846246|FG001|Open-Label Extension Period|Death|0|||
16870882|NCT01464307|37846245|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
16870883|NCT01464307|37846246|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
16870884|NCT01464307|37846245|FG000|Open-Label Extension Period|Non-compliance|9|||
17191119|NCT02477800|38343811|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
17191120|NCT02477800|38343812|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
17191121|NCT02477800|38343806|FG000|Long Term Extension Period|Reason not Specified|0|||
17191122|NCT02477800|38343807|FG001|Long Term Extension Period|Reason not Specified|0|||
17191123|NCT02477800|38343808|FG002|Long Term Extension Period|Reason not Specified|0|||
17191124|NCT02477800|38343809|FG003|Long Term Extension Period|Reason not Specified|126|||
17191125|NCT02477800|38343810|FG004|Long Term Extension Period|Reason not Specified|140|||
17191126|NCT02477800|38343811|FG005|Long Term Extension Period|Reason not Specified|270|||
17191127|NCT02477800|38343812|FG006|Long Term Extension Period|Reason not Specified|224|||
17191128|NCT02957747|38343826|FG000|Overall Study|Withdrawal by Subject|0|||
17191129|NCT02957747|38343827|FG001|Overall Study|Withdrawal by Subject|3|||
17191130|NCT02957747|38343826|FG000|Overall Study|Lost to Follow-up|10|||
17191131|NCT02957747|38343827|FG001|Overall Study|Lost to Follow-up|5|||
17191132|NCT01344161|38343836|FG000|Overall Study|Lost to Follow-up|4|||
17191133|NCT01344161|38343837|FG001|Overall Study|Lost to Follow-up|1|||
17191134|NCT01344161|38343836|FG000|Overall Study|Pregnancy|0|||
17191135|NCT01344161|38343837|FG001|Overall Study|Pregnancy|1|||
17191136|NCT01344161|38343836|FG000|Overall Study|Protocol Violation|1|||
17191137|NCT01344161|38343837|FG001|Overall Study|Protocol Violation|1|||
17191138|NCT02451358|38343847|FG000|Overall Study|Withdrawal by Subject|1|||
17191139|NCT02451358|38343848|FG001|Overall Study|Withdrawal by Subject|1|||
17191140|NCT02451358|38343849|FG002|Overall Study|Withdrawal by Subject|0|||
17191141|NCT02451358|38343850|FG003|Overall Study|Withdrawal by Subject|0|||
17191142|NCT02451358|38343847|FG000|Overall Study|Protocol Violation|0|||
17191143|NCT02451358|38343848|FG001|Overall Study|Protocol Violation|1|||
17191144|NCT02451358|38343849|FG002|Overall Study|Protocol Violation|1|||
16870885|NCT01464307|37846246|FG001|Open-Label Extension Period|Non-compliance|0|||
17094900|NCT00189488|38234175|FG000|Overall Study|Adverse Event|2|||
17191145|NCT02451358|38343850|FG003|Overall Study|Protocol Violation|0|||
16784495|NCT02076334|37724480|FG001|Overall Study|Protocol Violation|0|||
16784496|NCT02076334|37724481|FG002|Overall Study|Protocol Violation|0|||
16870886|NCT01464307|37846245|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
16870887|NCT01464307|37846246|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
16870888|NCT01483183|37846263|FG000|Overall Study|Physician Decision|0|||
16870889|NCT01483183|37846264|FG001|Overall Study|Physician Decision|0|||
16870890|NCT01483183|37846265|FG002|Overall Study|Physician Decision|0|||
16870891|NCT01483183|37846266|FG003|Overall Study|Physician Decision|0|||
16870892|NCT01483183|37846267|FG004|Overall Study|Physician Decision|0|||
16870893|NCT01483183|37846268|FG005|Overall Study|Physician Decision|0|||
16870894|NCT01483183|37846269|FG006|Overall Study|Physician Decision|2|||
16870895|NCT01483183|37846270|FG007|Overall Study|Physician Decision|0|||
16870896|NCT01483183|37846271|FG008|Overall Study|Physician Decision|0|||
16870897|NCT01483183|37846272|FG009|Overall Study|Physician Decision|0|||
16870898|NCT01483183|37846263|FG000|Overall Study|Withdrawal by Subject|0|||
16870899|NCT01483183|37846264|FG001|Overall Study|Withdrawal by Subject|0|||
16870900|NCT01483183|37846265|FG002|Overall Study|Withdrawal by Subject|0|||
16870901|NCT01483183|37846266|FG003|Overall Study|Withdrawal by Subject|0|||
16870902|NCT01483183|37846267|FG004|Overall Study|Withdrawal by Subject|0|||
16870903|NCT01483183|37846268|FG005|Overall Study|Withdrawal by Subject|0|||
16870904|NCT01483183|37846269|FG006|Overall Study|Withdrawal by Subject|0|||
16870905|NCT01483183|37846270|FG007|Overall Study|Withdrawal by Subject|0|||
16870906|NCT01483183|37846271|FG008|Overall Study|Withdrawal by Subject|0|||
16870907|NCT01483183|37846272|FG009|Overall Study|Withdrawal by Subject|1|||
16870908|NCT01483027|37846302|FG000|Overall Study|Administrative Reasons|2|||
16870909|NCT01483027|37846303|FG001|Overall Study|Administrative Reasons|1|||
16870910|NCT01483027|37846302|FG000|Overall Study|Withdrawal by Subject|21|||
17191146|NCT02749721|38343860|FG000|Screening|Withdrawal by Subject|1|||
17191147|NCT02749721|38343860|FG000|Screening|Lost to Follow-up|2|||
16784497|NCT02076334|37724482|FG003|Overall Study|Protocol Violation|0|||
16784498|NCT02076334|37724479|FG000|Overall Study|Lost to Follow-up|0|||
16784499|NCT02076334|37724480|FG001|Overall Study|Lost to Follow-up|1|||
16784500|NCT02076334|37724481|FG002|Overall Study|Lost to Follow-up|1|||
16784501|NCT02076334|37724482|FG003|Overall Study|Lost to Follow-up|0|||
16784502|NCT02076334|37724479|FG000|Overall Study|muscle soreness|0|||
16784503|NCT02076334|37724480|FG001|Overall Study|muscle soreness|0|||
16784504|NCT02076334|37724481|FG002|Overall Study|muscle soreness|0|||
16784505|NCT02076334|37724482|FG003|Overall Study|muscle soreness|1|||
16784506|NCT02021812|37724492|FG000|Overall Study|Death|8|||
16784507|NCT02021812|37724492|FG000|Overall Study|Withdrawal by Subject|3|||
16784508|NCT02021812|37724492|FG000|Overall Study|Lost to Follow-up|2|||
16784509|NCT02021812|37724492|FG000|Overall Study|Refuse to return, COVD 19|2|||
16784510|NCT02021656|37724496|FG000|Overall Study|Adverse Event|1|||
16784511|NCT02021656|37724496|FG000|Overall Study|Lack of Efficacy|2|||
16784512|NCT02021656|37724496|FG000|Overall Study|Lost to Follow-up|1|||
16784513|NCT02021656|37724496|FG000|Overall Study|Withdrew Consent|2|||
16784514|NCT02076022|37724506|FG000|Overall Study|Withdrawal by Subject|2|||
16784515|NCT02076022|37724507|FG001|Overall Study|Withdrawal by Subject|0|||
16784516|NCT02075632|37724515|FG000|Overall Study|Adverse Event|1|||
16784517|NCT02075632|37724516|FG001|Overall Study|Adverse Event|1|||
16784518|NCT02075632|37724515|FG000|Overall Study|Lost to Follow-up|0|||
16784519|NCT02075632|37724516|FG001|Overall Study|Lost to Follow-up|3|||
16784520|NCT02075632|37724515|FG000|Overall Study|Withdrawal by Subject|0|||
16784521|NCT02075632|37724516|FG001|Overall Study|Withdrawal by Subject|1|||
16784522|NCT02075554|37724522|FG000|Overall Study|Lost to Follow-up|7|||
17191148|NCT02749721|38343860|FG000|Screening|Protocol Violation|3|||
17191149|NCT02749721|38343860|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
17191150|NCT02749721|38343860|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
17191151|NCT01348139|38343866|FG000|Period 1|Adverse Event|1|||
17191152|NCT01348139|38343867|FG001|Period 1|Adverse Event|0|||
17191153|NCT01348139|38343868|FG002|Period 1|Adverse Event|0|||
17191154|NCT01348139|38343869|FG003|Period 1|Adverse Event|0|||
17191155|NCT01348139|38343870|FG004|Period 1|Adverse Event|0|||
17191156|NCT01348139|38343871|FG005|Period 1|Adverse Event|0|||
17191157|NCT02868229|38343889|FG000|Overall Study|Adverse Event|1|||
16784523|NCT02075554|37724522|FG000|Overall Study|Withdrawal by Subject|5|||
16784524|NCT02075554|37724522|FG000|Overall Study|Physician Decision|3|||
16784525|NCT02075476|37724528|FG000|Overall Study|Death|2|||
16784526|NCT02075476|37724529|FG001|Overall Study|Death|2|||
16784527|NCT02075476|37724528|FG000|Overall Study|Lost to Follow-up|1|||
16784528|NCT02075476|37724529|FG001|Overall Study|Lost to Follow-up|3|||
16784529|NCT02075320|37724535|FG000|Overall Study|Withdrawal by Subject|2|||
16784530|NCT02708095|37724542|FG000|Overall Study|Adverse Event|4|||
16784531|NCT02708095|37724543|FG001|Overall Study|Adverse Event|10|||
16784532|NCT02708095|37724544|FG002|Overall Study|Adverse Event|11|||
16784533|NCT02708095|37724542|FG000|Overall Study|Lack of Efficacy|9|||
16784534|NCT02708095|37724543|FG001|Overall Study|Lack of Efficacy|3|||
16870911|NCT01483027|37846303|FG001|Overall Study|Withdrawal by Subject|32|||
17191158|NCT02868229|38343890|FG001|Overall Study|Adverse Event|0|||
16784535|NCT02708095|37724544|FG002|Overall Study|Lack of Efficacy|0|||
16784536|NCT02708095|37724542|FG000|Overall Study|Lost to Follow-up|2|||
16784537|NCT02708095|37724543|FG001|Overall Study|Lost to Follow-up|0|||
16784538|NCT02708095|37724544|FG002|Overall Study|Lost to Follow-up|0|||
16784539|NCT02708095|37724542|FG000|Overall Study|Physician Decision|2|||
16784540|NCT02708095|37724543|FG001|Overall Study|Physician Decision|3|||
16784541|NCT02708095|37724544|FG002|Overall Study|Physician Decision|2|||
16784542|NCT02708095|37724542|FG000|Overall Study|Protocol Violation|0|||
16784543|NCT02708095|37724543|FG001|Overall Study|Protocol Violation|0|||
16784544|NCT02708095|37724544|FG002|Overall Study|Protocol Violation|1|||
16784545|NCT02708095|37724542|FG000|Overall Study|Withdrawal by Subject|5|||
16784546|NCT02708095|37724543|FG001|Overall Study|Withdrawal by Subject|3|||
16784547|NCT02708095|37724544|FG002|Overall Study|Withdrawal by Subject|4|||
16784548|NCT02707861|37724556|FG000|Overall Study|Went onto commercial drug|30|||
16784549|NCT02707861|37724557|FG001|Overall Study|Went onto commercial drug|23|||
16784550|NCT02707861|37724556|FG000|Overall Study|Adverse Event|2|||
16784551|NCT02707861|37724557|FG001|Overall Study|Adverse Event|3|||
16784552|NCT02707861|37724556|FG000|Overall Study|Death|5|||
16784553|NCT02707861|37724557|FG001|Overall Study|Death|2|||
16784554|NCT02707861|37724556|FG000|Overall Study|Lack of Efficacy|0|||
16784555|NCT02707861|37724557|FG001|Overall Study|Lack of Efficacy|2|||
16784556|NCT02707861|37724556|FG000|Overall Study|Physician Decision|1|||
16784557|NCT02707861|37724557|FG001|Overall Study|Physician Decision|4|||
16784558|NCT02707861|37724556|FG000|Overall Study|Withdrawal by Subject|2|||
16784559|NCT02707861|37724557|FG001|Overall Study|Withdrawal by Subject|1|||
16784560|NCT02707861|37724556|FG000|Overall Study|Lost to Follow-up|1|||
16784561|NCT02707861|37724557|FG001|Overall Study|Lost to Follow-up|3|||
16784562|NCT02027428|37724565|FG000|Induction|Never treated|7|||
16784563|NCT02027428|37724566|FG001|Induction|Never treated|0|||
16870912|NCT01483027|37846302|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
16870913|NCT01483027|37846303|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
16870914|NCT01483027|37846302|FG000|Overall Study|Lost to Follow-up|1|||
16870915|NCT01483027|37846303|FG001|Overall Study|Lost to Follow-up|1|||
16870916|NCT01483027|37846302|FG000|Overall Study|Adverse Event|0|||
16870917|NCT01483027|37846303|FG001|Overall Study|Adverse Event|1|||
16870918|NCT01483027|37846302|FG000|Overall Study|Withdrawal by Subject|0|||
16870919|NCT01483027|37846303|FG001|Overall Study|Withdrawal by Subject|1|||
16870920|NCT01463683|37846312|FG000|Overall Study|Adverse Event|2|||
16870921|NCT01463683|37846313|FG001|Overall Study|Adverse Event|0|||
16870922|NCT01463683|37846314|FG002|Overall Study|Adverse Event|0|||
16870923|NCT01463683|37846312|FG000|Overall Study|Lost to Follow-up|10|||
16870924|NCT01463683|37846313|FG001|Overall Study|Lost to Follow-up|9|||
16870925|NCT01463683|37846314|FG002|Overall Study|Lost to Follow-up|7|||
16870926|NCT01463683|37846312|FG000|Overall Study|Physician Decision|0|||
16870927|NCT01463683|37846313|FG001|Overall Study|Physician Decision|3|||
16870928|NCT01463683|37846314|FG002|Overall Study|Physician Decision|1|||
16870929|NCT01463683|37846312|FG000|Overall Study|Pregnancy|2|||
16870930|NCT01463683|37846313|FG001|Overall Study|Pregnancy|2|||
16870931|NCT01463683|37846314|FG002|Overall Study|Pregnancy|1|||
16870932|NCT01463683|37846312|FG000|Overall Study|Withdrawal by Subject|5|||
16870933|NCT01463683|37846313|FG001|Overall Study|Withdrawal by Subject|17|||
16870934|NCT01463683|37846314|FG002|Overall Study|Withdrawal by Subject|2|||
16870935|NCT01482169|37846322|FG000|Overall Study|Physician Decision|2|||
16870936|NCT01481779|37846331|FG000|Overall Study|Adverse Event|23|||
16870937|NCT01481779|37846332|FG001|Overall Study|Adverse Event|5|||
16870938|NCT01481779|37846331|FG000|Overall Study|Lost to Follow-up|3|||
16870939|NCT01481779|37846332|FG001|Overall Study|Lost to Follow-up|2|||
16870940|NCT01481779|37846331|FG000|Overall Study|Protocol Violation|2|||
16870941|NCT01481779|37846332|FG001|Overall Study|Protocol Violation|3|||
16870942|NCT01481779|37846331|FG000|Overall Study|Withdrawal by Subject|26|||
16870943|NCT01481779|37846332|FG001|Overall Study|Withdrawal by Subject|13|||
16870944|NCT01481779|37846331|FG000|Overall Study|Physician Decision|13|||
16870945|NCT01481779|37846332|FG001|Overall Study|Physician Decision|4|||
16870946|NCT01481779|37846331|FG000|Overall Study|Sponsor Decision|3|||
16870947|NCT01481779|37846332|FG001|Overall Study|Sponsor Decision|1|||
16870948|NCT01463527|37846340|FG000|Overall Study|Protocol Violation|1|||
16870949|NCT01463527|37846341|FG001|Overall Study|Protocol Violation|1|||
16870950|NCT01463527|37846340|FG000|Overall Study|Crying >20% of sedation|5|||
16870951|NCT01463527|37846341|FG001|Overall Study|Crying >20% of sedation|6|||
16870952|NCT01509547|37846349|FG000|Overall Study|Lost to Follow-up|24|||
16870953|NCT01509547|37846350|FG001|Overall Study|Lost to Follow-up|14|||
16870954|NCT01509547|37846349|FG000|Overall Study|Withdrawal by Subject|11|||
16870955|NCT01509547|37846350|FG001|Overall Study|Withdrawal by Subject|24|||
16870956|NCT01509547|37846349|FG000|Overall Study|Physician Decision|0|||
16870957|NCT01509547|37846350|FG001|Overall Study|Physician Decision|1|||
16870958|NCT01509079|37846358|FG000|Overall Study|Lack of Efficacy|0|||
16870959|NCT01509079|37846359|FG001|Overall Study|Lack of Efficacy|2|||
16870960|NCT01509079|37846358|FG000|Overall Study|started an excluded medication|0|||
16870961|NCT01509079|37846359|FG001|Overall Study|started an excluded medication|1|||
17191159|NCT02868229|38343891|FG002|Overall Study|Adverse Event|0|||
17191160|NCT02868229|38343892|FG003|Overall Study|Adverse Event|1|||
17191161|NCT02868229|38343889|FG000|Overall Study|Death|0|||
17191162|NCT02868229|38343890|FG001|Overall Study|Death|0|||
16784564|NCT02027428|37724567|FG002|Induction|Never treated|0|||
16784565|NCT02027428|37724565|FG000|Induction|Progressive disease|77|||
17094901|NCT00189488|38234176|FG001|Overall Study|Adverse Event|1|||
17094902|NCT00189488|38234175|FG000|Overall Study|Withdrawal by Subject|2|||
17094903|NCT00189488|38234176|FG001|Overall Study|Withdrawal by Subject|6|||
17094904|NCT00189488|38234175|FG000|Overall Study|Disease progression|2|||
16870962|NCT01463293|37846368|FG000|Overall Study|Lost to Follow-up|1|||
16870963|NCT01463293|37846369|FG001|Overall Study|Lost to Follow-up|4|||
16870964|NCT01463293|37846370|FG002|Overall Study|Lost to Follow-up|5|||
16870965|NCT01463293|37846368|FG000|Overall Study|Adverse Event|1|||
16870966|NCT01463293|37846369|FG001|Overall Study|Adverse Event|2|||
16870967|NCT01463293|37846370|FG002|Overall Study|Adverse Event|0|||
16870968|NCT01463293|37846368|FG000|Overall Study|Withdrawal by Subject|4|||
16870969|NCT01463293|37846369|FG001|Overall Study|Withdrawal by Subject|10|||
16870970|NCT01463293|37846370|FG002|Overall Study|Withdrawal by Subject|5|||
16870971|NCT01463293|37846368|FG000|Overall Study|Other|0|||
16870972|NCT01463293|37846369|FG001|Overall Study|Other|0|||
16870973|NCT01463293|37846370|FG002|Overall Study|Other|2|||
16870974|NCT01479985|37846401|FG000|Overall Study|Tablet malfunction, no data saved|1|||
16870975|NCT01479985|37846402|FG001|Overall Study|Tablet malfunction, no data saved|1|||
16870976|NCT01479985|37846401|FG000|Overall Study|No decisional conflict scale responses|0|||
16870977|NCT01479985|37846402|FG001|Overall Study|No decisional conflict scale responses|2|||
16870978|NCT01479985|37846401|FG000|Overall Study|No post-visit survey|5|||
16870979|NCT01479985|37846402|FG001|Overall Study|No post-visit survey|3|||
16870980|NCT01462435|37846416|FG000|Overall Study|Lack of Efficacy|1|||
16870981|NCT01462435|37846417|FG001|Overall Study|Lack of Efficacy|0|||
16870982|NCT01462435|37846418|FG002|Overall Study|Lack of Efficacy|0|||
16870983|NCT01462435|37846419|FG003|Overall Study|Lack of Efficacy|3|||
16870984|NCT01462435|37846416|FG000|Overall Study|Physician Decision|0|||
16784566|NCT02027428|37724566|FG001|Induction|Progressive disease|0|||
16784567|NCT02027428|37724567|FG002|Induction|Progressive disease|0|||
16784568|NCT02027428|37724565|FG000|Induction|Adverse Event|51|||
16784569|NCT02027428|37724566|FG001|Induction|Adverse Event|0|||
16784570|NCT02027428|37724567|FG002|Induction|Adverse Event|0|||
16870985|NCT01462435|37846417|FG001|Overall Study|Physician Decision|0|||
16870986|NCT01462435|37846418|FG002|Overall Study|Physician Decision|1|||
16870987|NCT01462435|37846419|FG003|Overall Study|Physician Decision|0|||
16870988|NCT01462435|37846416|FG000|Overall Study|Withdrawal by Subject|0|||
16870989|NCT01462435|37846417|FG001|Overall Study|Withdrawal by Subject|0|||
16870990|NCT01462435|37846418|FG002|Overall Study|Withdrawal by Subject|0|||
16870991|NCT01462435|37846419|FG003|Overall Study|Withdrawal by Subject|1|||
16870992|NCT01462435|37846416|FG000|Overall Study|Lost to Follow-up|0|||
16870993|NCT01462435|37846417|FG001|Overall Study|Lost to Follow-up|0|||
16870994|NCT01462435|37846418|FG002|Overall Study|Lost to Follow-up|0|||
16870995|NCT01462435|37846419|FG003|Overall Study|Lost to Follow-up|1|||
16870996|NCT01472081|37846435|FG000|Overall Study|Continuing treatment at time of analysis|1|||
16870997|NCT01472081|37846436|FG001|Overall Study|Continuing treatment at time of analysis|4|||
16870998|NCT01472081|37846437|FG002|Overall Study|Continuing treatment at time of analysis|1|||
16870999|NCT01472081|37846438|FG003|Overall Study|Continuing treatment at time of analysis|8|||
17094905|NCT00189488|38234176|FG001|Overall Study|Disease progression|4|||
17094906|NCT00189488|38234175|FG000|Overall Study|Administrative Decision|0|||
17094907|NCT00189488|38234176|FG001|Overall Study|Administrative Decision|2|||
17094908|NCT00189488|38234175|FG000|Overall Study|Death|5|||
17094909|NCT00189488|38234176|FG001|Overall Study|Death|8|||
16784571|NCT02027428|37724565|FG000|Induction|Withdrawal by Subject|22|||
16784572|NCT02027428|37724566|FG001|Induction|Withdrawal by Subject|0|||
16784573|NCT02027428|37724567|FG002|Induction|Withdrawal by Subject|0|||
16784574|NCT02027428|37724565|FG000|Induction|Death|21|||
16784575|NCT02027428|37724566|FG001|Induction|Death|0|||
16784576|NCT02027428|37724567|FG002|Induction|Death|0|||
16784577|NCT02027428|37724565|FG000|Induction|Symptomatic deterioration|16|||
16784578|NCT02027428|37724566|FG001|Induction|Symptomatic deterioration|0|||
16784579|NCT02027428|37724567|FG002|Induction|Symptomatic deterioration|0|||
16784580|NCT02027428|37724565|FG000|Induction|Study terminated by sponsor|12|||
16784581|NCT02027428|37724566|FG001|Induction|Study terminated by sponsor|0|||
16784582|NCT02027428|37724567|FG002|Induction|Study terminated by sponsor|0|||
16784583|NCT02027428|37724565|FG000|Induction|Protocol Violation|1|||
16784584|NCT02027428|37724566|FG001|Induction|Protocol Violation|0|||
16784585|NCT02027428|37724567|FG002|Induction|Protocol Violation|0|||
16784586|NCT02027428|37724565|FG000|Induction|Miscellaneous|14|||
16784587|NCT02027428|37724566|FG001|Induction|Miscellaneous|0|||
16784588|NCT02027428|37724567|FG002|Induction|Miscellaneous|0|||
16784589|NCT02027428|37724565|FG000|Induction|Induction Treatment Ongoing|4|||
16784590|NCT02027428|37724566|FG001|Induction|Induction Treatment Ongoing|0|||
16784591|NCT02027428|37724567|FG002|Induction|Induction Treatment Ongoing|0|||
16871000|NCT01472081|37846439|FG004|Overall Study|Continuing treatment at time of analysis|9|||
16871001|NCT01472081|37846440|FG005|Overall Study|Continuing treatment at time of analysis|0|||
16871002|NCT01472081|37846435|FG000|Overall Study|Disease Progression|4|||
16871003|NCT01472081|37846436|FG001|Overall Study|Disease Progression|10|||
16871004|NCT01472081|37846437|FG002|Overall Study|Disease Progression|12|||
16871005|NCT01472081|37846438|FG003|Overall Study|Disease Progression|31|||
16871006|NCT01472081|37846439|FG004|Overall Study|Disease Progression|22|||
16871007|NCT01472081|37846440|FG005|Overall Study|Disease Progression|3|||
16871008|NCT01472081|37846435|FG000|Overall Study|Study drug toxicity|2|||
16871009|NCT01472081|37846436|FG001|Overall Study|Study drug toxicity|9|||
16871010|NCT01472081|37846437|FG002|Overall Study|Study drug toxicity|4|||
16784592|NCT02027428|37724565|FG000|Maintenance|Death|0|||
16784593|NCT02027428|37724566|FG001|Maintenance|Death|3|||
16784594|NCT02027428|37724567|FG002|Maintenance|Death|2|||
16784595|NCT02027428|37724565|FG000|Maintenance|Adverse Event|0|||
16784596|NCT02027428|37724566|FG001|Maintenance|Adverse Event|21|||
16784597|NCT02027428|37724567|FG002|Maintenance|Adverse Event|1|||
16871011|NCT01472081|37846438|FG003|Overall Study|Study drug toxicity|6|||
16871012|NCT01472081|37846439|FG004|Overall Study|Study drug toxicity|13|||
16784598|NCT02027428|37724565|FG000|Maintenance|Progressive disease|0|||
16784599|NCT02027428|37724566|FG001|Maintenance|Progressive disease|84|||
17000932|NCT00996593|38144946|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
17000933|NCT00996593|38144946|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
17000934|NCT00996593|38144946|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
17000935|NCT00996593|38144946|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
17000936|NCT00996593|38144946|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
17000937|NCT00996593|38144946|FG000|Long-Term Follow-Up|Site Closed|1|||
17000938|NCT00570661|38144950|FG000|Overall Study|Disease worsening|5|||
17000939|NCT00570661|38144950|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
17000940|NCT00570661|38144950|FG000|Overall Study|Adverse Event|1|||
17000941|NCT00934544|38144957|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
17000942|NCT00934544|38144958|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
17000943|NCT00934544|38144959|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
17000944|NCT00934544|38144957|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
17000945|NCT00934544|38144958|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
17000946|NCT00934544|38144959|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
17000947|NCT00934544|38144957|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
16784600|NCT02027428|37724567|FG002|Maintenance|Progressive disease|47|||
16784601|NCT02027428|37724565|FG000|Maintenance|Symptomatic deterioration|0|||
16784602|NCT02027428|37724566|FG001|Maintenance|Symptomatic deterioration|4|||
16784603|NCT02027428|37724567|FG002|Maintenance|Symptomatic deterioration|1|||
16784604|NCT02027428|37724565|FG000|Maintenance|Withdrawal by Subject|0|||
16784605|NCT02027428|37724566|FG001|Maintenance|Withdrawal by Subject|6|||
16784606|NCT02027428|37724567|FG002|Maintenance|Withdrawal by Subject|5|||
16784607|NCT02027428|37724565|FG000|Maintenance|Protocol Violation|0|||
16784608|NCT02027428|37724566|FG001|Maintenance|Protocol Violation|0|||
16784609|NCT02027428|37724567|FG002|Maintenance|Protocol Violation|1|||
16784610|NCT02027428|37724565|FG000|Maintenance|Other|0|||
16784611|NCT02027428|37724566|FG001|Maintenance|Other|6|||
16784612|NCT02027428|37724567|FG002|Maintenance|Other|3|||
16784613|NCT02027428|37724565|FG000|Survival Follow-up|Death|0|||
16871013|NCT01472081|37846440|FG005|Overall Study|Study drug toxicity|2|||
16871014|NCT01472081|37846435|FG000|Overall Study|Death|0|||
16871015|NCT01472081|37846436|FG001|Overall Study|Death|0|||
16871016|NCT01472081|37846437|FG002|Overall Study|Death|0|||
16871017|NCT01472081|37846438|FG003|Overall Study|Death|0|||
16871018|NCT01472081|37846439|FG004|Overall Study|Death|1|||
16871019|NCT01472081|37846440|FG005|Overall Study|Death|0|||
16871020|NCT01472081|37846435|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
16871021|NCT01472081|37846436|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
16871022|NCT01472081|37846437|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
16871023|NCT01472081|37846438|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
16871024|NCT01472081|37846439|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
16871025|NCT01472081|37846440|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
16871026|NCT01472081|37846435|FG000|Overall Study|Withdrawal by Subject|0|||
17000948|NCT00934544|38144958|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
16784614|NCT02027428|37724566|FG001|Survival Follow-up|Death|78|||
16784615|NCT02027428|37724567|FG002|Survival Follow-up|Death|45|||
16784616|NCT02027428|37724565|FG000|Survival Follow-up|Lost to Follow-up|0|||
16784617|NCT02027428|37724566|FG001|Survival Follow-up|Lost to Follow-up|1|||
16784618|NCT02027428|37724567|FG002|Survival Follow-up|Lost to Follow-up|1|||
16784619|NCT01995136|37724590|FG000|Overall Study|Change in residence|1|||
16784620|NCT01994902|37724594|FG000|Test Period 1|Withdrawal by Subject|3|||
16784621|NCT01994902|37724595|FG001|Test Period 1|Withdrawal by Subject|0|||
16784622|NCT01994902|37724594|FG000|Test Period 1|device deficiency with adverse event|0|||
16784623|NCT01994902|37724595|FG001|Test Period 1|device deficiency with adverse event|1|||
16784624|NCT01994902|37724594|FG000|Test Period 1|Adverse Event|2|||
16871027|NCT01472081|37846436|FG001|Overall Study|Withdrawal by Subject|0|||
16871028|NCT01472081|37846437|FG002|Overall Study|Withdrawal by Subject|0|||
16871029|NCT01472081|37846438|FG003|Overall Study|Withdrawal by Subject|0|||
16871030|NCT01472081|37846439|FG004|Overall Study|Withdrawal by Subject|0|||
16871031|NCT01472081|37846440|FG005|Overall Study|Withdrawal by Subject|1|||
16871032|NCT01472081|37846435|FG000|Overall Study|Poor/non-compliance|0|||
16871033|NCT01472081|37846436|FG001|Overall Study|Poor/non-compliance|0|||
16871034|NCT01472081|37846437|FG002|Overall Study|Poor/non-compliance|1|||
16871035|NCT01472081|37846438|FG003|Overall Study|Poor/non-compliance|0|||
16871036|NCT01472081|37846439|FG004|Overall Study|Poor/non-compliance|1|||
16871037|NCT01472081|37846440|FG005|Overall Study|Poor/non-compliance|0|||
16871038|NCT01472081|37846435|FG000|Overall Study|No longer meets study criteria|0|||
16871039|NCT01472081|37846436|FG001|Overall Study|No longer meets study criteria|0|||
16784625|NCT01994902|37724595|FG001|Test Period 1|Adverse Event|1|||
16871040|NCT01472081|37846437|FG002|Overall Study|No longer meets study criteria|1|||
16871041|NCT01472081|37846438|FG003|Overall Study|No longer meets study criteria|0|||
16871042|NCT01472081|37846439|FG004|Overall Study|No longer meets study criteria|0|||
16871043|NCT01472081|37846440|FG005|Overall Study|No longer meets study criteria|0|||
16871044|NCT01472081|37846435|FG000|Overall Study|Subject request to discontinue treatment|0|||
16871045|NCT01472081|37846436|FG001|Overall Study|Subject request to discontinue treatment|3|||
17000949|NCT00934544|38144959|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
17000950|NCT00934544|38144957|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
17000951|NCT00934544|38144958|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
16871046|NCT01472081|37846437|FG002|Overall Study|Subject request to discontinue treatment|1|||
16871047|NCT01472081|37846438|FG003|Overall Study|Subject request to discontinue treatment|1|||
16871048|NCT01472081|37846439|FG004|Overall Study|Subject request to discontinue treatment|0|||
16871049|NCT01472081|37846440|FG005|Overall Study|Subject request to discontinue treatment|0|||
16871050|NCT01471691|37846455|FG000|Overall Study|Lack of Efficacy|0|||
16871051|NCT01471691|37846456|FG001|Overall Study|Lack of Efficacy|1|||
16871052|NCT01471379|37846465|FG000|Overall Study|Adverse Event|1|||
16871053|NCT01471379|37846466|FG001|Overall Study|Adverse Event|0|||
16871054|NCT01471379|37846467|FG002|Overall Study|Adverse Event|0|||
16871055|NCT01471379|37846465|FG000|Overall Study|Study terminated|0|||
16871056|NCT01471379|37846466|FG001|Overall Study|Study terminated|1|||
16784626|NCT01994902|37724594|FG000|Test Period 1|Lack of Efficacy|0|||
16784627|NCT01994902|37724595|FG001|Test Period 1|Lack of Efficacy|1|||
16784628|NCT01994902|37724594|FG000|Test Period 1|bag too small|1|||
16784629|NCT01994902|37724595|FG001|Test Period 1|bag too small|0|||
16784630|NCT01994902|37724594|FG000|Test Period 2|Withdrawal by Subject|0|||
16784631|NCT01994902|37724595|FG001|Test Period 2|Withdrawal by Subject|2|||
16784632|NCT01994902|37724594|FG000|Test Period 2|Lack of Efficacy|0|||
16784633|NCT01994902|37724595|FG001|Test Period 2|Lack of Efficacy|1|||
16784634|NCT01994902|37724594|FG000|Test Period 2|Other|0|||
16784635|NCT01994902|37724595|FG001|Test Period 2|Other|3|||
16784636|NCT02026258|37724603|FG000|Randomized|Did not start treatment|2|||
16784637|NCT02026258|37724604|FG001|Randomized|Did not start treatment|1|||
16871057|NCT01471379|37846467|FG002|Overall Study|Study terminated|0|||
16871058|NCT01470989|37846478|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
16871059|NCT01470989|37846479|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
16871060|NCT01470989|37846478|FG000|Overall Study|Adverse Event|2|||
16871061|NCT01470989|37846479|FG001|Overall Study|Adverse Event|5|||
16871062|NCT01470989|37846478|FG000|Overall Study|Abnormal laboratory value|1|||
16871063|NCT01470989|37846479|FG001|Overall Study|Abnormal laboratory value|1|||
16871064|NCT01470989|37846478|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16871065|NCT01470989|37846479|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
16871066|NCT01470989|37846478|FG000|Overall Study|Withdrawal by Subject|19|||
16871067|NCT01470989|37846479|FG001|Overall Study|Withdrawal by Subject|17|||
16871068|NCT01470989|37846478|FG000|Overall Study|Lost to Follow-up|18|||
16871069|NCT01470989|37846479|FG001|Overall Study|Lost to Follow-up|13|||
16871070|NCT01470989|37846478|FG000|Overall Study|Administrative problems|2|||
16871071|NCT01470989|37846479|FG001|Overall Study|Administrative problems|4|||
16871072|NCT01470989|37846478|FG000|Overall Study|Death|2|||
16871073|NCT01470989|37846479|FG001|Overall Study|Death|2|||
16871074|NCT01470989|37846478|FG000|Overall Study|Protocol deviation|1|||
16871075|NCT01470989|37846479|FG001|Overall Study|Protocol deviation|2|||
16871076|NCT01470599|37846489|FG000|Overall Study|Did not meet entrance criteria|1|||
16871077|NCT01470599|37846490|FG001|Overall Study|Did not meet entrance criteria|0|||
16871078|NCT01470599|37846489|FG000|Overall Study|Lost to Follow-up|2|||
16871079|NCT01470599|37846490|FG001|Overall Study|Lost to Follow-up|1|||
16871080|NCT01470599|37846489|FG000|Overall Study|Withdrawal by Subject|3|||
17000952|NCT00934544|38144959|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
17000953|NCT00934544|38144957|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
16784638|NCT02026258|37724603|FG000|Randomized|Change in treatment plan|1|||
16784639|NCT02026258|37724604|FG001|Randomized|Change in treatment plan|0|||
16784640|NCT02026258|37724603|FG000|Randomized|Presence of periodontal disease|1|||
16871081|NCT01470599|37846490|FG001|Overall Study|Withdrawal by Subject|4|||
16871082|NCT01470599|37846489|FG000|Overall Study|Other|1|||
16871083|NCT01470599|37846490|FG001|Overall Study|Other|0|||
16871084|NCT01470599|37846489|FG000|Overall Study|Protocol Violation|3|||
16871085|NCT01470599|37846490|FG001|Overall Study|Protocol Violation|1|||
16871086|NCT01470599|37846489|FG000|Overall Study|Adverse event related to study drug|2|||
16871087|NCT01470599|37846490|FG001|Overall Study|Adverse event related to study drug|5|||
16871088|NCT01470599|37846489|FG000|Overall Study|Insufficient clinical response|6|||
16871089|NCT01470599|37846490|FG001|Overall Study|Insufficient clinical response|27|||
16871090|NCT01470599|37846489|FG000|Overall Study|Adverse event not related to study drug|1|||
16871091|NCT01470599|37846490|FG001|Overall Study|Adverse event not related to study drug|5|||
16871092|NCT01469819|37846496|FG000|Overall Study|Withdrawal by Subject|1|||
16871093|NCT01469819|37846496|FG000|Overall Study|Did not meet inclusionary criteria|2|||
16871094|NCT01469819|37846496|FG000|Overall Study|Could not swallow SmartPill|2|||
16871095|NCT01469819|37846496|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
16871096|NCT01507831|37846508|FG000|Overall Study|Randomized but not treated|0|||
16871097|NCT01507831|37846509|FG001|Overall Study|Randomized but not treated|3|||
16871098|NCT01507831|37846508|FG000|Overall Study|Adverse Event|48|||
16871099|NCT01507831|37846509|FG001|Overall Study|Adverse Event|113|||
16871100|NCT01507831|37846508|FG000|Overall Study|Death|6|||
16871101|NCT01507831|37846509|FG001|Overall Study|Death|2|||
16871102|NCT01507831|37846508|FG000|Overall Study|Poor compliance to protocol|38|||
16871103|NCT01507831|37846509|FG001|Overall Study|Poor compliance to protocol|60|||
16871104|NCT01507831|37846508|FG000|Overall Study|Physician Decision|0|||
16871105|NCT01507831|37846509|FG001|Overall Study|Physician Decision|4|||
16871106|NCT01507831|37846508|FG000|Overall Study|Participant moved|5|||
16871107|NCT01507831|37846509|FG001|Overall Study|Participant moved|19|||
16871108|NCT01507831|37846508|FG000|Overall Study|Consent withdrawn by participant|34|||
16871109|NCT01507831|37846509|FG001|Overall Study|Consent withdrawn by participant|72|||
16871110|NCT01507831|37846508|FG000|Overall Study|Related to study drug administration|5|||
16871111|NCT01507831|37846509|FG001|Overall Study|Related to study drug administration|14|||
16871112|NCT01507831|37846508|FG000|Overall Study|Last visit outside protocol visit window|51|||
16871113|NCT01507831|37846509|FG001|Overall Study|Last visit outside protocol visit window|143|||
16871114|NCT01507831|37846508|FG000|Overall Study|Selection criteria finally not met|0|||
16871115|NCT01507831|37846509|FG001|Overall Study|Selection criteria finally not met|1|||
16871116|NCT01507831|37846508|FG000|Overall Study|Site closure|0|||
16871117|NCT01507831|37846509|FG001|Overall Study|Site closure|3|||
16871118|NCT01507831|37846508|FG000|Overall Study|Potential lost to follow-up|3|||
16871119|NCT01507831|37846509|FG001|Overall Study|Potential lost to follow-up|0|||
16871120|NCT01507831|37846508|FG000|Overall Study|Other|3|||
16871121|NCT01507831|37846509|FG001|Overall Study|Other|6|||
16871122|NCT01479595|37846517|FG000|Overall Study|Protocol deviation|0|||
16871123|NCT01479595|37846518|FG001|Overall Study|Protocol deviation|1|||
16871124|NCT01479595|37846517|FG000|Overall Study|Adverse Event|2|||
16871125|NCT01479595|37846518|FG001|Overall Study|Adverse Event|1|||
16871126|NCT01462357|37846527|FG000|Overall Study|Death|0|||
16871127|NCT01462357|37846528|FG001|Overall Study|Death|0|||
16871128|NCT01462357|37846529|FG002|Overall Study|Death|1|||
16871129|NCT01462357|37846527|FG000|Overall Study|Withdrawal by Subject|3|||
16871130|NCT01462357|37846528|FG001|Overall Study|Withdrawal by Subject|11|||
16784641|NCT02026258|37724604|FG001|Randomized|Presence of periodontal disease|1|||
16784642|NCT02026258|37724603|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
16871131|NCT01462357|37846529|FG002|Overall Study|Withdrawal by Subject|3|||
16871132|NCT01462357|37846527|FG000|Overall Study|Migrated/moved from study area|2|||
16871133|NCT01462357|37846528|FG001|Overall Study|Migrated/moved from study area|3|||
16871134|NCT01462357|37846529|FG002|Overall Study|Migrated/moved from study area|1|||
16871135|NCT01462357|37846527|FG000|Overall Study|Lost to Follow-up|3|||
16871136|NCT01462357|37846528|FG001|Overall Study|Lost to Follow-up|5|||
16871137|NCT01462357|37846529|FG002|Overall Study|Lost to Follow-up|7|||
16871138|NCT01479439|37846540|FG000|Overall Study|Adverse Event|1|||
16871139|NCT01479439|37846541|FG001|Overall Study|Adverse Event|0|||
16871140|NCT01479439|37846542|FG002|Overall Study|Adverse Event|0|||
16784643|NCT02026258|37724604|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
16871141|NCT01479439|37846540|FG000|Overall Study|Lost to Follow-up|0|||
16784644|NCT02026258|37724603|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
16784645|NCT02026258|37724604|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
16784646|NCT01994590|37724611|FG000|Overall Study|Adverse Event|1|||
16784647|NCT01994590|37724611|FG000|Overall Study|Trial Terminated|1|||
16784648|NCT02019550|37724617|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16784649|NCT02019550|37724618|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
16784650|NCT02019472|37724629|FG000|Overall Study|Adverse Event|14|||
16784651|NCT02019472|37724630|FG001|Overall Study|Adverse Event|23|||
16784652|NCT02019472|37724631|FG002|Overall Study|Adverse Event|17|||
16784653|NCT02019472|37724629|FG000|Overall Study|Death|0|||
16784654|NCT02019472|37724630|FG001|Overall Study|Death|1|||
16784655|NCT02019472|37724631|FG002|Overall Study|Death|1|||
16871142|NCT01479439|37846541|FG001|Overall Study|Lost to Follow-up|1|||
16871143|NCT01479439|37846542|FG002|Overall Study|Lost to Follow-up|0|||
16871144|NCT01479439|37846540|FG000|Overall Study|Protocol Violation|0|||
16871145|NCT01479439|37846541|FG001|Overall Study|Protocol Violation|0|||
16871146|NCT01479439|37846542|FG002|Overall Study|Protocol Violation|2|||
16871147|NCT01478971|37846553|FG000|Standard of Care Period|Adverse Event|1|||
16871148|NCT01478971|37846553|FG000|Standard of Care Period|Withdrawal by Subject|3|||
16871149|NCT01478971|37846553|FG000|Standard of Care Period|Death|8|||
16871150|NCT01478971|37846553|FG000|Standard of Care Period|Lost to Follow-up|9|||
16871151|NCT01478971|37846553|FG000|Standard of Care Period|Other|4|||
16871152|NCT01478971|37846553|FG000|Peginesatide Treatment Period|Adverse Event|1|||
16871153|NCT01478971|37846553|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
16871154|NCT01478971|37846553|FG000|Peginesatide Treatment Period|Death|4|||
16784656|NCT02019472|37724629|FG000|Overall Study|Lack of Efficacy|7|||
16871155|NCT01478971|37846553|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
16871156|NCT01478971|37846553|FG000|Peginesatide Treatment Period|Other|4|||
16871157|NCT01507051|37846565|FG000|Overall Study|Withdrawal by Subject|1|||
16871158|NCT01507051|37846566|FG001|Overall Study|Withdrawal by Subject|3|||
16871159|NCT01507051|37846567|FG002|Overall Study|Withdrawal by Subject|1|||
16871160|NCT01507051|37846568|FG003|Overall Study|Withdrawal by Subject|6|||
16871161|NCT01507051|37846565|FG000|Overall Study|Physician Decision|0|||
16871162|NCT01507051|37846566|FG001|Overall Study|Physician Decision|0|||
16871163|NCT01507051|37846567|FG002|Overall Study|Physician Decision|0|||
16871164|NCT01507051|37846568|FG003|Overall Study|Physician Decision|1|||
16871165|NCT01507051|37846565|FG000|Overall Study|Adverse Event|1|||
16871166|NCT01507051|37846566|FG001|Overall Study|Adverse Event|0|||
16871167|NCT01507051|37846567|FG002|Overall Study|Adverse Event|0|||
16871168|NCT01507051|37846568|FG003|Overall Study|Adverse Event|0|||
16871169|NCT01478347|37846578|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
16871170|NCT01478347|37846578|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
16871171|NCT01478347|37846578|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
16871172|NCT01478113|37846584|FG000|Overall Study|Withdrawal by Subject|0|||
16871173|NCT01478113|37846585|FG001|Overall Study|Withdrawal by Subject|1|||
16871174|NCT01478113|37846584|FG000|Overall Study|Physician Decision|1|||
16871175|NCT01478113|37846585|FG001|Overall Study|Physician Decision|0|||
16871176|NCT01506271|37846596|FG000|Overall Study|Progressive disease|0|||
16871177|NCT01506271|37846597|FG001|Overall Study|Progressive disease|1|||
16871178|NCT01506271|37846598|FG002|Overall Study|Progressive disease|0|||
17191163|NCT02868229|38343891|FG002|Overall Study|Death|1|||
16871179|NCT01506271|37846596|FG000|Overall Study|Protocol Violation|3|||
16871180|NCT01506271|37846597|FG001|Overall Study|Protocol Violation|1|||
16871181|NCT01506271|37846598|FG002|Overall Study|Protocol Violation|0|||
16871182|NCT01506271|37846596|FG000|Overall Study|Death|0|||
16871183|NCT01506271|37846597|FG001|Overall Study|Death|1|||
16871184|NCT01506271|37846598|FG002|Overall Study|Death|0|||
16871185|NCT01506271|37846596|FG000|Overall Study|Adverse Event|0|||
16871186|NCT01506271|37846597|FG001|Overall Study|Adverse Event|2|||
16871187|NCT01506271|37846598|FG002|Overall Study|Adverse Event|0|||
16871188|NCT01506271|37846596|FG000|Overall Study|Insufficient supply of study drug|1|||
17191164|NCT02868229|38343892|FG003|Overall Study|Death|1|||
16784657|NCT02019472|37724630|FG001|Overall Study|Lack of Efficacy|4|||
16784658|NCT02019472|37724631|FG002|Overall Study|Lack of Efficacy|4|||
16784659|NCT02019472|37724629|FG000|Overall Study|Lost to Follow-up|0|||
16784660|NCT02019472|37724630|FG001|Overall Study|Lost to Follow-up|2|||
16784661|NCT02019472|37724631|FG002|Overall Study|Lost to Follow-up|1|||
16784662|NCT02019472|37724629|FG000|Overall Study|Physician Decision|1|||
16784663|NCT02019472|37724630|FG001|Overall Study|Physician Decision|2|||
16784664|NCT02019472|37724631|FG002|Overall Study|Physician Decision|0|||
16784665|NCT02019472|37724629|FG000|Overall Study|Pregnancy|1|||
16784666|NCT02019472|37724630|FG001|Overall Study|Pregnancy|2|||
16784667|NCT02019472|37724631|FG002|Overall Study|Pregnancy|2|||
16784668|NCT02019472|37724629|FG000|Overall Study|Withdrawal by Subject|11|||
16784669|NCT02019472|37724630|FG001|Overall Study|Withdrawal by Subject|10|||
16784670|NCT02019472|37724631|FG002|Overall Study|Withdrawal by Subject|11|||
16784671|NCT02019472|37724629|FG000|Overall Study|Other|3|||
16784672|NCT02019472|37724630|FG001|Overall Study|Other|8|||
16784673|NCT02019472|37724631|FG002|Overall Study|Other|6|||
16784674|NCT02705755|37724643|FG000|Part A (6 Days)|Adverse Event|1|||
16784675|NCT02705755|37724644|FG001|Part A (6 Days)|Adverse Event|0|||
16784676|NCT02705755|37724645|FG002|Part A (6 Days)|Adverse Event|0|||
16871189|NCT01506271|37846597|FG001|Overall Study|Insufficient supply of study drug|0|||
16871190|NCT01506271|37846598|FG002|Overall Study|Insufficient supply of study drug|0|||
16871191|NCT01506271|37846596|FG000|Overall Study|Withdrawal by Subject|0|||
16784677|NCT02705755|37724646|FG003|Part A (6 Days)|Adverse Event|0|||
16871192|NCT01506271|37846597|FG001|Overall Study|Withdrawal by Subject|1|||
16871193|NCT01506271|37846598|FG002|Overall Study|Withdrawal by Subject|1|||
17191165|NCT02868229|38343889|FG000|Overall Study|Missed dose|0|||
16784678|NCT02705755|37724643|FG000|Part A (6 Days)|Physician Decision|3|||
16784679|NCT02705755|37724644|FG001|Part A (6 Days)|Physician Decision|0|||
16871194|NCT01506271|37846596|FG000|Overall Study|Lost to Follow-up|0|||
16871195|NCT01506271|37846597|FG001|Overall Study|Lost to Follow-up|1|||
16871196|NCT01506271|37846598|FG002|Overall Study|Lost to Follow-up|2|||
16871197|NCT01506193|37846609|FG000|Overall Study|Protocol Violation|1|||
16871198|NCT01506193|37846610|FG001|Overall Study|Protocol Violation|0|||
16871199|NCT01506193|37846611|FG002|Overall Study|Protocol Violation|1|||
16871200|NCT01506193|37846609|FG000|Overall Study|Migrated/moved from study area|0|||
16871201|NCT01506193|37846610|FG001|Overall Study|Migrated/moved from study area|0|||
16871202|NCT01506193|37846611|FG002|Overall Study|Migrated/moved from study area|1|||
16871203|NCT01506193|37846609|FG000|Overall Study|Adverse event, non-fatal|0|||
16871204|NCT01506193|37846610|FG001|Overall Study|Adverse event, non-fatal|0|||
16871205|NCT01506193|37846611|FG002|Overall Study|Adverse event, non-fatal|1|||
16871206|NCT01506193|37846609|FG000|Overall Study|Withdrawal by Subject|5|||
16871207|NCT01506193|37846610|FG001|Overall Study|Withdrawal by Subject|1|||
16871208|NCT01506193|37846611|FG002|Overall Study|Withdrawal by Subject|8|||
16871209|NCT01506193|37846609|FG000|Overall Study|Lost to Follow-up|8|||
16871210|NCT01506193|37846610|FG001|Overall Study|Lost to Follow-up|3|||
16871211|NCT01506193|37846611|FG002|Overall Study|Lost to Follow-up|3|||
16871212|NCT01505881|37846622|FG000|Overall Study|Adverse Event|0|||
16871213|NCT01505881|37846623|FG001|Overall Study|Adverse Event|1|||
16871214|NCT01505881|37846622|FG000|Overall Study|Lost to Follow-up|2|||
16871215|NCT01505881|37846623|FG001|Overall Study|Lost to Follow-up|0|||
16871216|NCT01505881|37846622|FG000|Overall Study|Withdrawal by Subject|2|||
16871217|NCT01505881|37846623|FG001|Overall Study|Withdrawal by Subject|0|||
16871218|NCT01462045|37846633|FG000|Overall Study|Family matter|0|||
16871219|NCT01462045|37846634|FG001|Overall Study|Family matter|1|||
16871220|NCT01462045|37846635|FG002|Overall Study|Family matter|0|||
16871221|NCT01505647|37846645|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
16871222|NCT01505647|37846646|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
16871223|NCT01505647|37846645|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
16871224|NCT01505647|37846646|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
16871225|NCT01505647|37846645|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
16871226|NCT01505647|37846646|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
16871227|NCT01505647|37846645|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
16871228|NCT01505647|37846646|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
16871229|NCT01505647|37846645|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
16871230|NCT01505647|37846646|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
16871231|NCT01477333|37846652|FG000|Overall Study|Adverse Event|1|||
16871232|NCT01477333|37846652|FG000|Overall Study|Withdrawal by Subject|1|||
16871233|NCT01477333|37846652|FG000|Overall Study|Clinical Deterioration|1|||
16871234|NCT01461811|37846662|FG000|Overall Study|Adverse Event|2|||
16871235|NCT01461811|37846663|FG001|Overall Study|Adverse Event|1|||
16871236|NCT01461811|37846662|FG000|Overall Study|Subject decision unrelated to an AE|1|||
16871237|NCT01461811|37846663|FG001|Overall Study|Subject decision unrelated to an AE|1|||
16871238|NCT01461811|37846662|FG000|Overall Study|Noncompliance|1|||
16871239|NCT01461811|37846663|FG001|Overall Study|Noncompliance|1|||
16871240|NCT01505491|37846672|FG000|Overall Study|Other reason not listed|1|||
16871241|NCT01505491|37846673|FG001|Overall Study|Other reason not listed|0|||
16871242|NCT01505491|37846674|FG002|Overall Study|Other reason not listed|0|||
16871243|NCT01505491|37846672|FG000|Overall Study|Withdrawal by Subject|1|||
16871244|NCT01505491|37846673|FG001|Overall Study|Withdrawal by Subject|1|||
16871245|NCT01505491|37846674|FG002|Overall Study|Withdrawal by Subject|4|||
16871246|NCT01505491|37846672|FG000|Overall Study|Lost to Follow-up|0|||
16871247|NCT01505491|37846673|FG001|Overall Study|Lost to Follow-up|0|||
16871248|NCT01505491|37846674|FG002|Overall Study|Lost to Follow-up|1|||
16871249|NCT01504867|37846684|FG000|Overall Study|Inclusion criteria not met|2|||
16871250|NCT01504867|37846685|FG001|Overall Study|Inclusion criteria not met|2|||
16871251|NCT01504867|37846684|FG000|Overall Study|Consent revoked|5|||
16871252|NCT01504867|37846685|FG001|Overall Study|Consent revoked|1|||
16871253|NCT01476475|37846693|FG000|Overall Study|Adverse Event|6|||
17191166|NCT02868229|38343890|FG001|Overall Study|Missed dose|0|||
17191167|NCT02868229|38343891|FG002|Overall Study|Missed dose|0|||
16871254|NCT01476475|37846694|FG001|Overall Study|Adverse Event|0|||
16871255|NCT01476475|37846693|FG000|Overall Study|Poor compliance to protocol|1|||
16871256|NCT01476475|37846694|FG001|Overall Study|Poor compliance to protocol|1|||
16871257|NCT01476475|37846693|FG000|Overall Study|Other reasons|4|||
16871258|NCT01476475|37846694|FG001|Overall Study|Other reasons|2|||
16871259|NCT01475851|37846703|FG000|Overall Study|Protocol defined stopping criteria|1|||
16871260|NCT01475851|37846704|FG001|Overall Study|Protocol defined stopping criteria|0|||
16871261|NCT01460719|37846710|FG000|Overall Study|Adverse Event|1|||
16871262|NCT01460719|37846710|FG000|Overall Study|Withdrawal by Subject|1|||
16871263|NCT01468181|37846780|FG000|Overall Study|Adverse Event|8|||
16871264|NCT01468181|37846781|FG001|Overall Study|Adverse Event|1|||
16871265|NCT01468181|37846782|FG002|Overall Study|Adverse Event|6|||
16871266|NCT01468181|37846783|FG003|Overall Study|Adverse Event|2|||
16871267|NCT01468181|37846784|FG004|Overall Study|Adverse Event|2|||
17191168|NCT02868229|38343892|FG003|Overall Study|Missed dose|3|||
16871268|NCT01468181|37846780|FG000|Overall Study|Protocol Violation|2|||
16871269|NCT01468181|37846781|FG001|Overall Study|Protocol Violation|0|||
16871270|NCT01468181|37846782|FG002|Overall Study|Protocol Violation|1|||
16871271|NCT01468181|37846783|FG003|Overall Study|Protocol Violation|0|||
16871272|NCT01468181|37846784|FG004|Overall Study|Protocol Violation|1|||
16871273|NCT01468181|37846780|FG000|Overall Study|Physician Decision|0|||
16871274|NCT01468181|37846781|FG001|Overall Study|Physician Decision|0|||
16871275|NCT01468181|37846782|FG002|Overall Study|Physician Decision|0|||
16871276|NCT01468181|37846783|FG003|Overall Study|Physician Decision|1|||
16871277|NCT01468181|37846784|FG004|Overall Study|Physician Decision|1|||
16871278|NCT01468181|37846780|FG000|Overall Study|Lost to Follow-up|0|||
16871279|NCT01468181|37846781|FG001|Overall Study|Lost to Follow-up|0|||
16871280|NCT01468181|37846782|FG002|Overall Study|Lost to Follow-up|1|||
16871281|NCT01468181|37846783|FG003|Overall Study|Lost to Follow-up|0|||
16871282|NCT01468181|37846784|FG004|Overall Study|Lost to Follow-up|1|||
16871283|NCT01468181|37846780|FG000|Overall Study|Withdrawal by Subject|0|||
16871284|NCT01468181|37846781|FG001|Overall Study|Withdrawal by Subject|1|||
16871285|NCT01468181|37846782|FG002|Overall Study|Withdrawal by Subject|0|||
16871286|NCT01468181|37846783|FG003|Overall Study|Withdrawal by Subject|0|||
16871287|NCT01468181|37846784|FG004|Overall Study|Withdrawal by Subject|0|||
16871288|NCT01693562|37846819|FG000|Escalation Phase|Withdrawal by Subject|0|||
16871289|NCT01693562|37846820|FG001|Escalation Phase|Withdrawal by Subject|1|||
16871290|NCT01693562|37846821|FG002|Escalation Phase|Withdrawal by Subject|0|||
16871291|NCT01693562|37846822|FG003|Escalation Phase|Withdrawal by Subject|0|||
16871292|NCT01693562|37846823|FG004|Escalation Phase|Withdrawal by Subject|0|||
16871293|NCT01693562|37846824|FG005|Escalation Phase|Withdrawal by Subject|2|||
16871294|NCT01693562|37846825|FG006|Escalation Phase|Withdrawal by Subject|0|||
17191169|NCT02956967|38343907|FG000|Overall Study|Adverse Event|3|||
17191170|NCT02956967|38343907|FG000|Overall Study|Reason non-related to neutropenia|10|||
16871295|NCT01693562|37846826|FG007|Escalation Phase|Withdrawal by Subject|0|||
16871296|NCT01693562|37846827|FG008|Escalation Phase|Withdrawal by Subject|0|||
16871297|NCT01693562|37846828|FG009|Escalation Phase|Withdrawal by Subject|0|||
16871298|NCT01693562|37846829|FG010|Escalation Phase|Withdrawal by Subject|0|||
16871299|NCT01693562|37846830|FG011|Escalation Phase|Withdrawal by Subject|0|||
16871300|NCT01693562|37846831|FG012|Escalation Phase|Withdrawal by Subject|0|||
16871301|NCT01693562|37846832|FG013|Escalation Phase|Withdrawal by Subject|0|||
16871302|NCT01693562|37846833|FG014|Escalation Phase|Withdrawal by Subject|0|||
16871303|NCT01693562|37846834|FG015|Escalation Phase|Withdrawal by Subject|0|||
16871304|NCT01693562|37846835|FG016|Escalation Phase|Withdrawal by Subject|0|||
16871305|NCT01693562|37846836|FG017|Escalation Phase|Withdrawal by Subject|0|||
16871306|NCT01693562|37846837|FG018|Escalation Phase|Withdrawal by Subject|0|||
16871307|NCT01693562|37846838|FG019|Escalation Phase|Withdrawal by Subject|0|||
16871308|NCT01693562|37846839|FG020|Escalation Phase|Withdrawal by Subject|0|||
16871309|NCT01693562|37846840|FG021|Escalation Phase|Withdrawal by Subject|0|||
16871310|NCT01693562|37846841|FG022|Escalation Phase|Withdrawal by Subject|0|||
16871311|NCT01693562|37846819|FG000|Escalation Phase|Death|4|||
16871312|NCT01693562|37846820|FG001|Escalation Phase|Death|2|||
16871313|NCT01693562|37846821|FG002|Escalation Phase|Death|0|||
16871314|NCT01693562|37846822|FG003|Escalation Phase|Death|3|||
16871315|NCT01693562|37846823|FG004|Escalation Phase|Death|6|||
16871316|NCT01693562|37846824|FG005|Escalation Phase|Death|4|||
16871317|NCT01693562|37846825|FG006|Escalation Phase|Death|0|||
16871318|NCT01693562|37846826|FG007|Escalation Phase|Death|0|||
16871319|NCT01693562|37846827|FG008|Escalation Phase|Death|0|||
16871320|NCT01693562|37846828|FG009|Escalation Phase|Death|0|||
16871321|NCT01693562|37846829|FG010|Escalation Phase|Death|0|||
16871322|NCT01693562|37846830|FG011|Escalation Phase|Death|0|||
16871323|NCT01693562|37846831|FG012|Escalation Phase|Death|0|||
16871324|NCT01693562|37846832|FG013|Escalation Phase|Death|0|||
16871325|NCT01693562|37846833|FG014|Escalation Phase|Death|0|||
16871326|NCT01693562|37846834|FG015|Escalation Phase|Death|0|||
16871327|NCT01693562|37846835|FG016|Escalation Phase|Death|0|||
16871328|NCT01693562|37846836|FG017|Escalation Phase|Death|0|||
16871329|NCT01693562|37846837|FG018|Escalation Phase|Death|0|||
16871330|NCT01693562|37846838|FG019|Escalation Phase|Death|0|||
16871331|NCT01693562|37846839|FG020|Escalation Phase|Death|0|||
16871332|NCT01693562|37846840|FG021|Escalation Phase|Death|0|||
16871333|NCT01693562|37846841|FG022|Escalation Phase|Death|0|||
16871334|NCT01693562|37846819|FG000|Escalation Phase|Lost to Follow-up|0|||
16871335|NCT01693562|37846820|FG001|Escalation Phase|Lost to Follow-up|1|||
16871336|NCT01693562|37846821|FG002|Escalation Phase|Lost to Follow-up|1|||
16871337|NCT01693562|37846822|FG003|Escalation Phase|Lost to Follow-up|0|||
16871338|NCT01693562|37846823|FG004|Escalation Phase|Lost to Follow-up|0|||
16871339|NCT01693562|37846824|FG005|Escalation Phase|Lost to Follow-up|0|||
16871340|NCT01693562|37846825|FG006|Escalation Phase|Lost to Follow-up|0|||
17191171|NCT02956967|38343907|FG000|Overall Study|Lost to Follow-up|5|||
17191172|NCT02956967|38343907|FG000|Overall Study|Missing|1|||
16871341|NCT01693562|37846826|FG007|Escalation Phase|Lost to Follow-up|0|||
16871342|NCT01693562|37846827|FG008|Escalation Phase|Lost to Follow-up|0|||
16871343|NCT01693562|37846828|FG009|Escalation Phase|Lost to Follow-up|0|||
16871344|NCT01693562|37846829|FG010|Escalation Phase|Lost to Follow-up|0|||
16871345|NCT01693562|37846830|FG011|Escalation Phase|Lost to Follow-up|0|||
16871346|NCT01693562|37846831|FG012|Escalation Phase|Lost to Follow-up|0|||
16871347|NCT01693562|37846832|FG013|Escalation Phase|Lost to Follow-up|0|||
16871348|NCT01693562|37846833|FG014|Escalation Phase|Lost to Follow-up|0|||
16871349|NCT01693562|37846834|FG015|Escalation Phase|Lost to Follow-up|0|||
16871350|NCT01693562|37846835|FG016|Escalation Phase|Lost to Follow-up|0|||
16871351|NCT01693562|37846836|FG017|Escalation Phase|Lost to Follow-up|0|||
16871352|NCT01693562|37846837|FG018|Escalation Phase|Lost to Follow-up|0|||
16871353|NCT01693562|37846838|FG019|Escalation Phase|Lost to Follow-up|0|||
16871354|NCT01693562|37846839|FG020|Escalation Phase|Lost to Follow-up|0|||
16871355|NCT01693562|37846840|FG021|Escalation Phase|Lost to Follow-up|0|||
16871356|NCT01693562|37846841|FG022|Escalation Phase|Lost to Follow-up|0|||
16871357|NCT01693562|37846819|FG000|Escalation Phase|Other|0|||
16871358|NCT01693562|37846820|FG001|Escalation Phase|Other|0|||
16871359|NCT01693562|37846821|FG002|Escalation Phase|Other|2|||
16871360|NCT01693562|37846822|FG003|Escalation Phase|Other|0|||
16871361|NCT01693562|37846823|FG004|Escalation Phase|Other|0|||
16871362|NCT01693562|37846824|FG005|Escalation Phase|Other|1|||
16871363|NCT01693562|37846825|FG006|Escalation Phase|Other|0|||
16871364|NCT01693562|37846826|FG007|Escalation Phase|Other|0|||
16871365|NCT01693562|37846827|FG008|Escalation Phase|Other|0|||
16871366|NCT01693562|37846828|FG009|Escalation Phase|Other|0|||
16871367|NCT01693562|37846829|FG010|Escalation Phase|Other|0|||
16871368|NCT01693562|37846830|FG011|Escalation Phase|Other|0|||
16871369|NCT01693562|37846831|FG012|Escalation Phase|Other|0|||
16871370|NCT01693562|37846832|FG013|Escalation Phase|Other|0|||
16871371|NCT01693562|37846833|FG014|Escalation Phase|Other|0|||
16871372|NCT01693562|37846834|FG015|Escalation Phase|Other|0|||
16871373|NCT01693562|37846835|FG016|Escalation Phase|Other|0|||
16871374|NCT01693562|37846836|FG017|Escalation Phase|Other|0|||
16871375|NCT01693562|37846837|FG018|Escalation Phase|Other|0|||
16871376|NCT01693562|37846838|FG019|Escalation Phase|Other|0|||
16871377|NCT01693562|37846839|FG020|Escalation Phase|Other|0|||
16871378|NCT01693562|37846840|FG021|Escalation Phase|Other|0|||
16871379|NCT01693562|37846841|FG022|Escalation Phase|Other|0|||
16871380|NCT01693562|37846819|FG000|Exploration Phase|Withdrawal by Subject|0|||
16871381|NCT01693562|37846820|FG001|Exploration Phase|Withdrawal by Subject|0|||
16871382|NCT01693562|37846821|FG002|Exploration Phase|Withdrawal by Subject|0|||
16871383|NCT01693562|37846822|FG003|Exploration Phase|Withdrawal by Subject|0|||
16871384|NCT01693562|37846823|FG004|Exploration Phase|Withdrawal by Subject|0|||
16871385|NCT01693562|37846824|FG005|Exploration Phase|Withdrawal by Subject|0|||
16871386|NCT01693562|37846825|FG006|Exploration Phase|Withdrawal by Subject|2|||
16871387|NCT01693562|37846826|FG007|Exploration Phase|Withdrawal by Subject|0|||
16871388|NCT01693562|37846827|FG008|Exploration Phase|Withdrawal by Subject|0|||
16871389|NCT01693562|37846828|FG009|Exploration Phase|Withdrawal by Subject|0|||
16871390|NCT01693562|37846829|FG010|Exploration Phase|Withdrawal by Subject|0|||
16871391|NCT01693562|37846830|FG011|Exploration Phase|Withdrawal by Subject|0|||
16871392|NCT01693562|37846831|FG012|Exploration Phase|Withdrawal by Subject|0|||
16871393|NCT01693562|37846832|FG013|Exploration Phase|Withdrawal by Subject|0|||
16871394|NCT01693562|37846833|FG014|Exploration Phase|Withdrawal by Subject|0|||
16871395|NCT01693562|37846834|FG015|Exploration Phase|Withdrawal by Subject|0|||
16871396|NCT01693562|37846835|FG016|Exploration Phase|Withdrawal by Subject|0|||
16871397|NCT01693562|37846836|FG017|Exploration Phase|Withdrawal by Subject|0|||
16871398|NCT01693562|37846837|FG018|Exploration Phase|Withdrawal by Subject|0|||
16871399|NCT01693562|37846838|FG019|Exploration Phase|Withdrawal by Subject|0|||
16871400|NCT01693562|37846839|FG020|Exploration Phase|Withdrawal by Subject|0|||
16871401|NCT01693562|37846840|FG021|Exploration Phase|Withdrawal by Subject|0|||
16871402|NCT01693562|37846841|FG022|Exploration Phase|Withdrawal by Subject|0|||
16871403|NCT01693562|37846819|FG000|Exploration Phase|Death|0|||
16871404|NCT01693562|37846820|FG001|Exploration Phase|Death|0|||
16871405|NCT01693562|37846821|FG002|Exploration Phase|Death|0|||
16871406|NCT01693562|37846822|FG003|Exploration Phase|Death|0|||
16871407|NCT01693562|37846823|FG004|Exploration Phase|Death|0|||
16871408|NCT01693562|37846824|FG005|Exploration Phase|Death|0|||
16871409|NCT01693562|37846825|FG006|Exploration Phase|Death|17|||
16871410|NCT01693562|37846826|FG007|Exploration Phase|Death|0|||
16871411|NCT01693562|37846827|FG008|Exploration Phase|Death|0|||
16871412|NCT01693562|37846828|FG009|Exploration Phase|Death|0|||
16871413|NCT01693562|37846829|FG010|Exploration Phase|Death|0|||
16871414|NCT01693562|37846830|FG011|Exploration Phase|Death|0|||
16871415|NCT01693562|37846831|FG012|Exploration Phase|Death|0|||
16871416|NCT01693562|37846832|FG013|Exploration Phase|Death|0|||
16871417|NCT01693562|37846833|FG014|Exploration Phase|Death|0|||
16871418|NCT01693562|37846834|FG015|Exploration Phase|Death|0|||
16871419|NCT01693562|37846835|FG016|Exploration Phase|Death|0|||
16871420|NCT01693562|37846836|FG017|Exploration Phase|Death|0|||
16871421|NCT01693562|37846837|FG018|Exploration Phase|Death|0|||
16871422|NCT01693562|37846838|FG019|Exploration Phase|Death|0|||
16871423|NCT01693562|37846839|FG020|Exploration Phase|Death|0|||
16871424|NCT01693562|37846840|FG021|Exploration Phase|Death|0|||
16871425|NCT01693562|37846841|FG022|Exploration Phase|Death|0|||
16871426|NCT01693562|37846819|FG000|Exploration Phase|Other|0|||
16871427|NCT01693562|37846820|FG001|Exploration Phase|Other|0|||
16871428|NCT01693562|37846821|FG002|Exploration Phase|Other|0|||
16871429|NCT01693562|37846822|FG003|Exploration Phase|Other|0|||
16871430|NCT01693562|37846823|FG004|Exploration Phase|Other|0|||
16871431|NCT01693562|37846824|FG005|Exploration Phase|Other|0|||
16871432|NCT01693562|37846825|FG006|Exploration Phase|Other|2|||
16871433|NCT01693562|37846826|FG007|Exploration Phase|Other|0|||
16871434|NCT01693562|37846827|FG008|Exploration Phase|Other|0|||
16871435|NCT01693562|37846828|FG009|Exploration Phase|Other|0|||
16871436|NCT01693562|37846829|FG010|Exploration Phase|Other|0|||
16871437|NCT01693562|37846830|FG011|Exploration Phase|Other|0|||
16871438|NCT01693562|37846831|FG012|Exploration Phase|Other|0|||
16871439|NCT01693562|37846832|FG013|Exploration Phase|Other|0|||
16871440|NCT01693562|37846833|FG014|Exploration Phase|Other|0|||
16871441|NCT01693562|37846834|FG015|Exploration Phase|Other|0|||
16871442|NCT01693562|37846835|FG016|Exploration Phase|Other|0|||
16871443|NCT01693562|37846836|FG017|Exploration Phase|Other|0|||
16871444|NCT01693562|37846837|FG018|Exploration Phase|Other|0|||
16784680|NCT02705755|37724645|FG002|Part A (6 Days)|Physician Decision|0|||
16784681|NCT02705755|37724646|FG003|Part A (6 Days)|Physician Decision|0|||
16784682|NCT02705755|37724643|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
16784683|NCT02705755|37724644|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
16784684|NCT02705755|37724645|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
16784685|NCT02705755|37724646|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
16784686|NCT02705755|37724643|FG000|Part C (20 Weeks)|Physician Decision|0|||
16784687|NCT02705755|37724644|FG001|Part C (20 Weeks)|Physician Decision|0|||
16784688|NCT02705755|37724645|FG002|Part C (20 Weeks)|Physician Decision|0|||
16784689|NCT02705755|37724646|FG003|Part C (20 Weeks)|Physician Decision|2|||
16784690|NCT02705755|37724643|FG000|Part C (20 Weeks)|Adverse Event|0|||
16784691|NCT02705755|37724644|FG001|Part C (20 Weeks)|Adverse Event|0|||
16784692|NCT02705755|37724645|FG002|Part C (20 Weeks)|Adverse Event|0|||
16784693|NCT02705755|37724646|FG003|Part C (20 Weeks)|Adverse Event|6|||
16784694|NCT02705755|37724643|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
16784695|NCT02705755|37724644|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
16784696|NCT02705755|37724645|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
16784697|NCT02705755|37724646|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
16784698|NCT02024932|37724679|FG000|Overall Study|Adverse Event|2|||
16871445|NCT01693562|37846838|FG019|Exploration Phase|Other|0|||
16871446|NCT01693562|37846839|FG020|Exploration Phase|Other|0|||
16871447|NCT01693562|37846840|FG021|Exploration Phase|Other|0|||
16871448|NCT01693562|37846841|FG022|Exploration Phase|Other|0|||
16871449|NCT01693562|37846819|FG000|Expansion Phase|Withdrawal by Subject|0|||
16871450|NCT01693562|37846820|FG001|Expansion Phase|Withdrawal by Subject|0|||
16871451|NCT01693562|37846821|FG002|Expansion Phase|Withdrawal by Subject|0|||
16871452|NCT01693562|37846822|FG003|Expansion Phase|Withdrawal by Subject|0|||
16871453|NCT01693562|37846823|FG004|Expansion Phase|Withdrawal by Subject|0|||
16871454|NCT01693562|37846824|FG005|Expansion Phase|Withdrawal by Subject|0|||
16871455|NCT01693562|37846825|FG006|Expansion Phase|Withdrawal by Subject|0|||
16871456|NCT01693562|37846826|FG007|Expansion Phase|Withdrawal by Subject|16|||
16871457|NCT01693562|37846827|FG008|Expansion Phase|Withdrawal by Subject|2|||
16871458|NCT01693562|37846828|FG009|Expansion Phase|Withdrawal by Subject|54|||
16871459|NCT01693562|37846829|FG010|Expansion Phase|Withdrawal by Subject|2|||
16871460|NCT01693562|37846830|FG011|Expansion Phase|Withdrawal by Subject|2|||
16871461|NCT01693562|37846831|FG012|Expansion Phase|Withdrawal by Subject|3|||
16871462|NCT01693562|37846832|FG013|Expansion Phase|Withdrawal by Subject|5|||
16871463|NCT01693562|37846833|FG014|Expansion Phase|Withdrawal by Subject|16|||
16871464|NCT01693562|37846834|FG015|Expansion Phase|Withdrawal by Subject|7|||
16871465|NCT01693562|37846835|FG016|Expansion Phase|Withdrawal by Subject|40|||
16871466|NCT01693562|37846836|FG017|Expansion Phase|Withdrawal by Subject|4|||
16871467|NCT01693562|37846837|FG018|Expansion Phase|Withdrawal by Subject|8|||
16871468|NCT01693562|37846838|FG019|Expansion Phase|Withdrawal by Subject|3|||
16871469|NCT01693562|37846839|FG020|Expansion Phase|Withdrawal by Subject|1|||
16871470|NCT01693562|37846840|FG021|Expansion Phase|Withdrawal by Subject|8|||
16871471|NCT01693562|37846841|FG022|Expansion Phase|Withdrawal by Subject|1|||
16871472|NCT01693562|37846819|FG000|Expansion Phase|Death|0|||
16871473|NCT01693562|37846820|FG001|Expansion Phase|Death|0|||
16871474|NCT01693562|37846821|FG002|Expansion Phase|Death|0|||
16871475|NCT01693562|37846822|FG003|Expansion Phase|Death|0|||
16871476|NCT01693562|37846823|FG004|Expansion Phase|Death|0|||
16871477|NCT01693562|37846824|FG005|Expansion Phase|Death|0|||
16871478|NCT01693562|37846825|FG006|Expansion Phase|Death|0|||
16784699|NCT02024932|37724680|FG001|Overall Study|Adverse Event|3|||
16871479|NCT01693562|37846826|FG007|Expansion Phase|Death|42|||
16871480|NCT01693562|37846827|FG008|Expansion Phase|Death|17|||
16871481|NCT01693562|37846828|FG009|Expansion Phase|Death|208|||
16871482|NCT01693562|37846829|FG010|Expansion Phase|Death|30|||
16871483|NCT01693562|37846830|FG011|Expansion Phase|Death|8|||
16871484|NCT01693562|37846831|FG012|Expansion Phase|Death|19|||
16871485|NCT01693562|37846832|FG013|Expansion Phase|Death|42|||
16871486|NCT01693562|37846833|FG014|Expansion Phase|Death|23|||
16871487|NCT01693562|37846834|FG015|Expansion Phase|Death|23|||
16871488|NCT01693562|37846835|FG016|Expansion Phase|Death|128|||
16871489|NCT01693562|37846836|FG017|Expansion Phase|Death|16|||
16871490|NCT01693562|37846837|FG018|Expansion Phase|Death|36|||
16871491|NCT01693562|37846838|FG019|Expansion Phase|Death|16|||
16871492|NCT01693562|37846839|FG020|Expansion Phase|Death|17|||
16871493|NCT01693562|37846840|FG021|Expansion Phase|Death|35|||
16871494|NCT01693562|37846841|FG022|Expansion Phase|Death|7|||
16871495|NCT01693562|37846819|FG000|Expansion Phase|Lost to Follow-up|0|||
16871496|NCT01693562|37846820|FG001|Expansion Phase|Lost to Follow-up|0|||
16871497|NCT01693562|37846821|FG002|Expansion Phase|Lost to Follow-up|0|||
16871498|NCT01693562|37846822|FG003|Expansion Phase|Lost to Follow-up|0|||
16871499|NCT01693562|37846823|FG004|Expansion Phase|Lost to Follow-up|0|||
16871500|NCT01693562|37846824|FG005|Expansion Phase|Lost to Follow-up|0|||
16871501|NCT01693562|37846825|FG006|Expansion Phase|Lost to Follow-up|0|||
16871502|NCT01693562|37846826|FG007|Expansion Phase|Lost to Follow-up|1|||
16871503|NCT01693562|37846827|FG008|Expansion Phase|Lost to Follow-up|2|||
16871504|NCT01693562|37846828|FG009|Expansion Phase|Lost to Follow-up|10|||
16871505|NCT01693562|37846829|FG010|Expansion Phase|Lost to Follow-up|4|||
16871506|NCT01693562|37846830|FG011|Expansion Phase|Lost to Follow-up|4|||
16871507|NCT01693562|37846831|FG012|Expansion Phase|Lost to Follow-up|1|||
16871508|NCT01693562|37846832|FG013|Expansion Phase|Lost to Follow-up|3|||
16871509|NCT01693562|37846833|FG014|Expansion Phase|Lost to Follow-up|0|||
16871510|NCT01693562|37846834|FG015|Expansion Phase|Lost to Follow-up|1|||
16871511|NCT01693562|37846835|FG016|Expansion Phase|Lost to Follow-up|1|||
16871512|NCT01693562|37846836|FG017|Expansion Phase|Lost to Follow-up|0|||
16871513|NCT01693562|37846837|FG018|Expansion Phase|Lost to Follow-up|2|||
16871514|NCT01693562|37846838|FG019|Expansion Phase|Lost to Follow-up|1|||
16871515|NCT01693562|37846839|FG020|Expansion Phase|Lost to Follow-up|2|||
16871516|NCT01693562|37846840|FG021|Expansion Phase|Lost to Follow-up|2|||
16871517|NCT01693562|37846841|FG022|Expansion Phase|Lost to Follow-up|1|||
16871518|NCT01693562|37846819|FG000|Expansion Phase|Other|0|||
16871519|NCT01693562|37846820|FG001|Expansion Phase|Other|0|||
16871520|NCT01693562|37846821|FG002|Expansion Phase|Other|0|||
16871521|NCT01693562|37846822|FG003|Expansion Phase|Other|0|||
16871522|NCT01693562|37846823|FG004|Expansion Phase|Other|0|||
16871523|NCT01693562|37846824|FG005|Expansion Phase|Other|0|||
16871524|NCT01693562|37846825|FG006|Expansion Phase|Other|0|||
16871525|NCT01693562|37846826|FG007|Expansion Phase|Other|3|||
16871526|NCT01693562|37846827|FG008|Expansion Phase|Other|1|||
16871527|NCT01693562|37846828|FG009|Expansion Phase|Other|28|||
16871528|NCT01693562|37846829|FG010|Expansion Phase|Other|4|||
16871529|NCT01693562|37846830|FG011|Expansion Phase|Other|7|||
16871530|NCT01693562|37846831|FG012|Expansion Phase|Other|0|||
16871531|NCT01693562|37846832|FG013|Expansion Phase|Other|1|||
16871532|NCT01693562|37846833|FG014|Expansion Phase|Other|1|||
16871533|NCT01693562|37846834|FG015|Expansion Phase|Other|0|||
16871534|NCT01693562|37846835|FG016|Expansion Phase|Other|28|||
16871535|NCT01693562|37846836|FG017|Expansion Phase|Other|0|||
16871536|NCT01693562|37846837|FG018|Expansion Phase|Other|1|||
16871537|NCT01693562|37846838|FG019|Expansion Phase|Other|0|||
16871538|NCT01693562|37846839|FG020|Expansion Phase|Other|1|||
16871539|NCT01693562|37846840|FG021|Expansion Phase|Other|17|||
16871540|NCT01693562|37846841|FG022|Expansion Phase|Other|1|||
16871541|NCT01467713|37846938|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
16871542|NCT01467713|37846939|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
16871543|NCT01467713|37846940|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
16871544|NCT01467713|37846941|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
16871545|NCT01467713|37846938|FG000|Overall Study|Major Protocol Deviation|2|||
16871546|NCT01467713|37846939|FG001|Overall Study|Major Protocol Deviation|4|||
16871547|NCT01467713|37846940|FG002|Overall Study|Major Protocol Deviation|4|||
16871548|NCT01467713|37846941|FG003|Overall Study|Major Protocol Deviation|1|||
16871549|NCT01467713|37846938|FG000|Overall Study|Lost to Follow-up|9|||
16871550|NCT01467713|37846939|FG001|Overall Study|Lost to Follow-up|12|||
16871551|NCT01467713|37846940|FG002|Overall Study|Lost to Follow-up|6|||
16871552|NCT01467713|37846941|FG003|Overall Study|Lost to Follow-up|9|||
16871553|NCT01467713|37846938|FG000|Overall Study|Voluntary Withdrawal|18|||
16871554|NCT01467713|37846939|FG001|Overall Study|Voluntary Withdrawal|14|||
16871555|NCT01467713|37846940|FG002|Overall Study|Voluntary Withdrawal|21|||
16871556|NCT01467713|37846941|FG003|Overall Study|Voluntary Withdrawal|20|||
17094910|NCT00189488|38234175|FG000|Overall Study|Other|1|||
16871557|NCT01467713|37846938|FG000|Overall Study|Study Termination|23|||
16871558|NCT01467713|37846939|FG001|Overall Study|Study Termination|33|||
16871559|NCT01467713|37846940|FG002|Overall Study|Study Termination|28|||
16871560|NCT01467713|37846941|FG003|Overall Study|Study Termination|29|||
16871561|NCT01467713|37846938|FG000|Overall Study|Pregnancy|0|||
16871562|NCT01467713|37846939|FG001|Overall Study|Pregnancy|1|||
16871563|NCT01467713|37846940|FG002|Overall Study|Pregnancy|1|||
16871564|NCT01467713|37846941|FG003|Overall Study|Pregnancy|3|||
16871565|NCT01467713|37846938|FG000|Overall Study|Relapse|35|||
16871566|NCT01467713|37846939|FG001|Overall Study|Relapse|25|||
16871567|NCT01467713|37846940|FG002|Overall Study|Relapse|28|||
16871568|NCT01467713|37846941|FG003|Overall Study|Relapse|35|||
16871569|NCT01467713|37846938|FG000|Overall Study|Reason not Specified|6|||
16871570|NCT01467713|37846939|FG001|Overall Study|Reason not Specified|11|||
16871571|NCT01467713|37846940|FG002|Overall Study|Reason not Specified|8|||
16871572|NCT01467713|37846941|FG003|Overall Study|Reason not Specified|7|||
16871573|NCT01693250|37846979|FG000|Overall Study|Lost to Follow-up|2|||
16871574|NCT01693250|37846980|FG001|Overall Study|Lost to Follow-up|2|||
16871575|NCT01590758|37847003|FG000|Overall Study|Withdrawal by Subject|0|||
16871576|NCT01590758|37847004|FG001|Overall Study|Withdrawal by Subject|3|||
16871577|NCT01590758|37847003|FG000|Overall Study|Physician Decision|1|||
16871578|NCT01590758|37847004|FG001|Overall Study|Physician Decision|2|||
16871579|NCT01590758|37847003|FG000|Overall Study|Lost to Follow-up|4|||
16871580|NCT01590758|37847004|FG001|Overall Study|Lost to Follow-up|2|||
16871581|NCT01590212|37847013|FG000|Overall Study|Withdrawal by Subject|2|||
16871582|NCT01590212|37847014|FG001|Overall Study|Withdrawal by Subject|2|||
16871583|NCT01590212|37847015|FG002|Overall Study|Withdrawal by Subject|2|||
16871584|NCT01590212|37847013|FG000|Overall Study|Lost to Follow-up|1|||
16871585|NCT01590212|37847014|FG001|Overall Study|Lost to Follow-up|2|||
16871586|NCT01590212|37847015|FG002|Overall Study|Lost to Follow-up|3|||
16871587|NCT01692938|37847026|FG000|Overall Study|Protocol Deviation|1|||
16871588|NCT01692938|37847027|FG001|Overall Study|Protocol Deviation|1|||
16871589|NCT01692938|37847026|FG000|Overall Study|Study completed prior to site completion|3|||
16871590|NCT01692938|37847027|FG001|Overall Study|Study completed prior to site completion|3|||
16871591|NCT01692782|37847040|FG000|Overall Study|Adverse Event|12|||
16871592|NCT01692782|37847041|FG001|Overall Study|Adverse Event|32|||
16871593|NCT01692782|37847042|FG002|Overall Study|Adverse Event|2|||
17000954|NCT00934544|38144958|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
17000955|NCT00934544|38144959|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
16871594|NCT01692782|37847040|FG000|Overall Study|Lack of Efficacy|1|||
16871595|NCT01692782|37847041|FG001|Overall Study|Lack of Efficacy|2|||
16871596|NCT01692782|37847042|FG002|Overall Study|Lack of Efficacy|0|||
16871597|NCT01692782|37847040|FG000|Overall Study|Lost to Follow-up|2|||
16871598|NCT01692782|37847041|FG001|Overall Study|Lost to Follow-up|7|||
17000956|NCT00934544|38144957|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
17000957|NCT00934544|38144958|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
17000958|NCT00934544|38144959|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
17000959|NCT00934544|38144957|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
17000960|NCT00934544|38144958|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
17000961|NCT00934544|38144959|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
17000962|NCT00934544|38144957|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
17000963|NCT00934544|38144958|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
17000964|NCT00934544|38144959|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
17000965|NCT00934544|38144957|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
17000966|NCT00934544|38144958|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
17000967|NCT00934544|38144959|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
17000968|NCT00934544|38144957|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
17000969|NCT00934544|38144958|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
17000970|NCT00934544|38144959|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
17000971|NCT00934544|38144957|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
17000972|NCT00934544|38144958|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
17094911|NCT00189488|38234176|FG001|Overall Study|Other|0|||
17094912|NCT00233402|38234185|FG000|Overall Study|No pathology data|12|||
17094913|NCT00233402|38234186|FG001|Overall Study|No pathology data|9|||
17094914|NCT00233402|38234185|FG000|Overall Study|No Ta/T1|89|||
17094915|NCT00233402|38234186|FG001|Overall Study|No Ta/T1|94|||
16871599|NCT01692782|37847042|FG002|Overall Study|Lost to Follow-up|1|||
16871600|NCT01692782|37847040|FG000|Overall Study|Pregnancy|1|||
16871601|NCT01692782|37847041|FG001|Overall Study|Pregnancy|0|||
16871602|NCT01692782|37847042|FG002|Overall Study|Pregnancy|0|||
16871603|NCT01692782|37847040|FG000|Overall Study|Protocol Violation|1|||
16871604|NCT01692782|37847041|FG001|Overall Study|Protocol Violation|0|||
16871605|NCT01692782|37847042|FG002|Overall Study|Protocol Violation|2|||
16871606|NCT01692782|37847040|FG000|Overall Study|Non-complance with study drug|0|||
16871607|NCT01692782|37847041|FG001|Overall Study|Non-complance with study drug|4|||
17094916|NCT00233402|38234185|FG000|Overall Study|Lost to follow up etc|3|||
17094917|NCT00233402|38234186|FG001|Overall Study|Lost to follow up etc|21|||
17094918|NCT00233324|38234198|FG000|Main Study|Death|68|||
17094919|NCT00233324|38234199|FG001|Main Study|Death|60|||
17094920|NCT00233324|38234200|FG002|Main Study|Death|62|||
17094921|NCT00233324|38234201|FG003|Main Study|Death|47|||
16871608|NCT01692782|37847042|FG002|Overall Study|Non-complance with study drug|1|||
16871609|NCT01692782|37847040|FG000|Overall Study|Non-compliant with study visits|0|||
17094922|NCT00233324|38234198|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
16871610|NCT01692782|37847041|FG001|Overall Study|Non-compliant with study visits|0|||
17000973|NCT00934544|38144959|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
17000974|NCT00934544|38144957|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
17000975|NCT00934544|38144958|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
17000976|NCT00934544|38144959|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
17000977|NCT00934544|38144957|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
17000978|NCT00934544|38144958|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
17000979|NCT00934544|38144959|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
17000980|NCT00934544|38144957|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
16871611|NCT01692782|37847042|FG002|Overall Study|Non-compliant with study visits|1|||
16871612|NCT01692782|37847040|FG000|Overall Study|SAE not related to study drug|0|||
16871613|NCT01692782|37847041|FG001|Overall Study|SAE not related to study drug|1|||
16871614|NCT01692782|37847042|FG002|Overall Study|SAE not related to study drug|0|||
16871615|NCT01692782|37847040|FG000|Overall Study|Withdrawal by Subject|3|||
16871616|NCT01692782|37847041|FG001|Overall Study|Withdrawal by Subject|10|||
16871617|NCT01692782|37847042|FG002|Overall Study|Withdrawal by Subject|3|||
16871618|NCT01692626|37847050|FG000|Overall Study|Death|0|||
16871619|NCT01692626|37847051|FG001|Overall Study|Death|1|||
16871620|NCT01692626|37847050|FG000|Overall Study|Adverse Event|2|||
16871621|NCT01692626|37847051|FG001|Overall Study|Adverse Event|3|||
16871622|NCT01692626|37847050|FG000|Overall Study|Protocol Violation|1|||
16871623|NCT01692626|37847051|FG001|Overall Study|Protocol Violation|2|||
16871624|NCT01692626|37847050|FG000|Overall Study|Withdrawal by Subject|1|||
16871625|NCT01692626|37847051|FG001|Overall Study|Withdrawal by Subject|0|||
16871626|NCT01475461|37847077|FG000|Run-in Period|Not meet eligibility criteria|16|||
16871627|NCT01475461|37847078|FG001|Run-in Period|Not meet eligibility criteria|0|||
16871628|NCT01475461|37847079|FG002|Run-in Period|Not meet eligibility criteria|0|||
16871629|NCT01475461|37847080|FG003|Run-in Period|Not meet eligibility criteria|0|||
16871630|NCT01475461|37847081|FG004|Run-in Period|Not meet eligibility criteria|0|||
16871631|NCT01475461|37847082|FG005|Run-in Period|Not meet eligibility criteria|0|||
16871632|NCT01475461|37847083|FG006|Run-in Period|Not meet eligibility criteria|0|||
16871633|NCT01475461|37847077|FG000|Run-in Period|Lost to Follow-up|7|||
16784700|NCT02024932|37724681|FG002|Overall Study|Adverse Event|0|||
16784701|NCT02024932|37724682|FG003|Overall Study|Adverse Event|0|||
16784702|NCT02024932|37724683|FG004|Overall Study|Adverse Event|2|||
16784703|NCT02024932|37724684|FG005|Overall Study|Adverse Event|0|||
16784704|NCT02024932|37724679|FG000|Overall Study|Abnormal laboratory value|0|||
16784705|NCT02024932|37724680|FG001|Overall Study|Abnormal laboratory value|0|||
16784706|NCT02024932|37724681|FG002|Overall Study|Abnormal laboratory value|0|||
16784707|NCT02024932|37724682|FG003|Overall Study|Abnormal laboratory value|2|||
16784708|NCT02024932|37724683|FG004|Overall Study|Abnormal laboratory value|0|||
16784709|NCT02024932|37724684|FG005|Overall Study|Abnormal laboratory value|0|||
16784710|NCT01993888|37724715|FG000|Overall Study|Death|1|||
16784711|NCT01993888|37724716|FG001|Overall Study|Death|1|||
16784712|NCT01993888|37724715|FG000|Overall Study|Lost to Follow-up|1|||
16784713|NCT01993888|37724716|FG001|Overall Study|Lost to Follow-up|1|||
16784714|NCT01993888|37724715|FG000|Overall Study|Withdrawal by Subject|0|||
16784715|NCT01993888|37724716|FG001|Overall Study|Withdrawal by Subject|1|||
16784716|NCT02024698|37724722|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
16784717|NCT02024698|37724723|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
16784718|NCT02018458|37724729|FG000|Overall Study|Death|4|||
16784719|NCT02017522|37724733|FG000|Overall Study|Withdrawal by Subject|1|||
16784720|NCT02017444|37724740|FG000|Overall Study|Physician Decision|1|||
16784721|NCT02017444|37724741|FG001|Overall Study|Physician Decision|0|||
16784722|NCT02017444|37724740|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
16784723|NCT02017444|37724741|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
16784724|NCT01993186|37724749|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
16871634|NCT01475461|37847078|FG001|Run-in Period|Lost to Follow-up|0|||
16871635|NCT01475461|37847079|FG002|Run-in Period|Lost to Follow-up|0|||
16871636|NCT01475461|37847080|FG003|Run-in Period|Lost to Follow-up|0|||
16871637|NCT01475461|37847081|FG004|Run-in Period|Lost to Follow-up|0|||
16871638|NCT01475461|37847082|FG005|Run-in Period|Lost to Follow-up|0|||
16871639|NCT01475461|37847083|FG006|Run-in Period|Lost to Follow-up|0|||
16871640|NCT01475461|37847077|FG000|Run-in Period|Withdrawal by Subject|11|||
16871641|NCT01475461|37847078|FG001|Run-in Period|Withdrawal by Subject|0|||
16871642|NCT01475461|37847079|FG002|Run-in Period|Withdrawal by Subject|0|||
16871643|NCT01475461|37847080|FG003|Run-in Period|Withdrawal by Subject|0|||
16871644|NCT01475461|37847081|FG004|Run-in Period|Withdrawal by Subject|0|||
16871645|NCT01475461|37847082|FG005|Run-in Period|Withdrawal by Subject|0|||
16871646|NCT01475461|37847083|FG006|Run-in Period|Withdrawal by Subject|0|||
16871647|NCT01475461|37847077|FG000|Run-in Period|Other|3|||
16871648|NCT01475461|37847078|FG001|Run-in Period|Other|0|||
16871649|NCT01475461|37847079|FG002|Run-in Period|Other|0|||
16871650|NCT01475461|37847080|FG003|Run-in Period|Other|0|||
16871651|NCT01475461|37847081|FG004|Run-in Period|Other|0|||
16784725|NCT01993186|37724750|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
16784726|NCT01993186|37724749|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
16784727|NCT01993186|37724750|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
16784728|NCT01993186|37724749|FG000|Open-Label Extension Period|Other, Not Specified|0|||
16871652|NCT01475461|37847082|FG005|Run-in Period|Other|0|||
16871653|NCT01475461|37847083|FG006|Run-in Period|Other|0|||
16871654|NCT01475461|37847077|FG000|Run-in Period|Protocol Violation|4|||
16871655|NCT01475461|37847078|FG001|Run-in Period|Protocol Violation|0|||
16871656|NCT01475461|37847079|FG002|Run-in Period|Protocol Violation|0|||
16871657|NCT01475461|37847080|FG003|Run-in Period|Protocol Violation|0|||
16871658|NCT01475461|37847081|FG004|Run-in Period|Protocol Violation|0|||
16871659|NCT01475461|37847082|FG005|Run-in Period|Protocol Violation|0|||
17000981|NCT00934544|38144958|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
17000982|NCT00934544|38144959|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
17000983|NCT00934544|38144957|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
17000984|NCT00934544|38144958|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
17000985|NCT00934544|38144959|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
17000986|NCT00934544|38144957|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
17000987|NCT00934544|38144958|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
17000988|NCT00934544|38144959|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
17000989|NCT00999167|38144978|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
17000990|NCT00999167|38144979|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
17000991|NCT00999167|38144980|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
17000992|NCT00999167|38144978|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
17000993|NCT00999167|38144979|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
17000994|NCT00999167|38144980|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
17000995|NCT00999167|38144978|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
17000996|NCT00999167|38144979|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
17000997|NCT00999167|38144980|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
17000998|NCT00999167|38144978|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
17000999|NCT00999167|38144979|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
17001000|NCT00999167|38144980|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
17001001|NCT00999167|38144978|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
17001002|NCT00999167|38144979|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
17001003|NCT00999167|38144980|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
17001004|NCT00999167|38144978|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
17001005|NCT00999167|38144979|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
17001006|NCT00999167|38144980|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
17001007|NCT00999167|38144978|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
17001008|NCT00999167|38144979|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
17001009|NCT00999167|38144980|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
17001010|NCT00999167|38144978|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
17001011|NCT00999167|38144979|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
17001012|NCT00999167|38144980|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
17001013|NCT00570505|38144990|FG000|Overall Study|Adverse Event|7|||
17001014|NCT00570505|38144990|FG000|Overall Study|Withdrawal by Subject|7|||
17001015|NCT00570505|38144990|FG000|Overall Study|Lost to Follow-up|23|||
17001016|NCT00570505|38144990|FG000|Overall Study|Other loss to follow-up|4|||
17001017|NCT00931892|38144996|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
17001018|NCT00931892|38144997|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
17001019|NCT00666211|38145045|FG000|Overall Study|Withdrawal by Subject|10|||
17001020|NCT00666211|38145046|FG001|Overall Study|Withdrawal by Subject|13|||
17094923|NCT00233324|38234199|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
17094924|NCT00233324|38234200|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
16784729|NCT01993186|37724750|FG001|Open-Label Extension Period|Other, Not Specified|1|||
16784730|NCT01993186|37724749|FG000|Open-Label Extension Period|Adverse Event|1|||
16784731|NCT01993186|37724750|FG001|Open-Label Extension Period|Adverse Event|0|||
16784732|NCT01993186|37724749|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
16784733|NCT01993186|37724750|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
16784734|NCT01993186|37724749|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
16784735|NCT01993186|37724750|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
16784736|NCT01993186|37724749|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
16784737|NCT01993186|37724750|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
16871660|NCT01475461|37847083|FG006|Run-in Period|Protocol Violation|0|||
16871661|NCT01475461|37847077|FG000|Treatment Period|Death|0|||
16871662|NCT01475461|37847078|FG001|Treatment Period|Death|0|||
17094925|NCT00233324|38234201|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
17094926|NCT00233324|38234198|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
17001021|NCT00666211|38145045|FG000|Overall Study|went off medication, no more pain|1|||
17001022|NCT00666211|38145046|FG001|Overall Study|went off medication, no more pain|0|||
17001023|NCT00666211|38145045|FG000|Overall Study|patient non-compliant|6|||
17001024|NCT00666211|38145046|FG001|Overall Study|patient non-compliant|6|||
17001025|NCT00666211|38145045|FG000|Overall Study|disease progression|1|||
17001026|NCT00666211|38145046|FG001|Overall Study|disease progression|8|||
17001027|NCT00666211|38145045|FG000|Overall Study|Lost to Follow-up|2|||
17001028|NCT00666211|38145046|FG001|Overall Study|Lost to Follow-up|0|||
17001029|NCT00666211|38145045|FG000|Overall Study|toxicity|0|||
17001030|NCT00666211|38145046|FG001|Overall Study|toxicity|2|||
17001031|NCT00666211|38145045|FG000|Overall Study|hospital admission|0|||
17001032|NCT00666211|38145046|FG001|Overall Study|hospital admission|5|||
17001033|NCT00666211|38145045|FG000|Overall Study|Death|0|||
17001034|NCT00666211|38145046|FG001|Overall Study|Death|2|||
17001035|NCT00666211|38145045|FG000|Overall Study|off tx for other complicating disease|0|||
17001036|NCT00666211|38145046|FG001|Overall Study|off tx for other complicating disease|1|||
17001037|NCT00666211|38145045|FG000|Overall Study|Physician Decision|0|||
17094927|NCT00233324|38234199|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
17001038|NCT00666211|38145046|FG001|Overall Study|Physician Decision|1|||
17001039|NCT00878709|38145054|FG000|Overall Study|Withdrawal by Subject|197|||
17001040|NCT00878709|38145055|FG001|Overall Study|Withdrawal by Subject|120|||
17001041|NCT00878709|38145054|FG000|Overall Study|Lost to Follow-up|35|||
17001042|NCT00878709|38145055|FG001|Overall Study|Lost to Follow-up|33|||
17001043|NCT00878709|38145054|FG000|Overall Study|Other Reasons|93|||
17001044|NCT00878709|38145055|FG001|Overall Study|Other Reasons|84|||
17001045|NCT00927758|38145062|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
17001046|NCT00927758|38145063|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
17001047|NCT00927758|38145064|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
17001048|NCT00927758|38145065|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
17001049|NCT00927758|38145066|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
17001050|NCT00927758|38145067|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
17001051|NCT00927758|38145062|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
17001052|NCT00927758|38145063|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
17001053|NCT00927758|38145064|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
17001054|NCT00927758|38145065|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
17001055|NCT00927758|38145066|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
17001056|NCT00927758|38145067|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
17001057|NCT00927368|38145078|FG000|Overall Study|enrollment in another study|1|||
17001058|NCT00927368|38145079|FG001|Overall Study|enrollment in another study|1|||
16871663|NCT01475461|37847079|FG002|Treatment Period|Death|0|||
16871664|NCT01475461|37847080|FG003|Treatment Period|Death|1|||
16871665|NCT01475461|37847081|FG004|Treatment Period|Death|0|||
16871666|NCT01475461|37847082|FG005|Treatment Period|Death|0|||
16871667|NCT01475461|37847083|FG006|Treatment Period|Death|0|||
16871668|NCT01475461|37847077|FG000|Treatment Period|Lost to Follow-up|0|||
16871669|NCT01475461|37847078|FG001|Treatment Period|Lost to Follow-up|3|||
16871670|NCT01475461|37847079|FG002|Treatment Period|Lost to Follow-up|2|||
16871671|NCT01475461|37847080|FG003|Treatment Period|Lost to Follow-up|3|||
16871672|NCT01475461|37847081|FG004|Treatment Period|Lost to Follow-up|1|||
16871673|NCT01475461|37847082|FG005|Treatment Period|Lost to Follow-up|2|||
16871674|NCT01475461|37847083|FG006|Treatment Period|Lost to Follow-up|1|||
16871675|NCT01475461|37847077|FG000|Treatment Period|Withdrawal by Subject|0|||
16871676|NCT01475461|37847078|FG001|Treatment Period|Withdrawal by Subject|2|||
16871677|NCT01475461|37847079|FG002|Treatment Period|Withdrawal by Subject|2|||
16871678|NCT01475461|37847080|FG003|Treatment Period|Withdrawal by Subject|0|||
16871679|NCT01475461|37847081|FG004|Treatment Period|Withdrawal by Subject|2|||
16871680|NCT01475461|37847082|FG005|Treatment Period|Withdrawal by Subject|2|||
16871681|NCT01475461|37847083|FG006|Treatment Period|Withdrawal by Subject|0|||
16871682|NCT01475461|37847077|FG000|Treatment Period|Other|0|||
16871683|NCT01475461|37847078|FG001|Treatment Period|Other|1|||
16871684|NCT01475461|37847079|FG002|Treatment Period|Other|0|||
17001059|NCT00927368|38145080|FG002|Overall Study|enrollment in another study|2|||
17001060|NCT00927368|38145078|FG000|Overall Study|Lost to Follow-up|4|||
17001061|NCT00927368|38145079|FG001|Overall Study|Lost to Follow-up|0|||
17001062|NCT00927368|38145080|FG002|Overall Study|Lost to Follow-up|0|||
17001063|NCT00927368|38145078|FG000|Overall Study|equipment failure|1|||
16871685|NCT01475461|37847080|FG003|Treatment Period|Other|0|||
16871686|NCT01475461|37847081|FG004|Treatment Period|Other|0|||
16871687|NCT01475461|37847082|FG005|Treatment Period|Other|0|||
16871688|NCT01475461|37847083|FG006|Treatment Period|Other|0|||
16871689|NCT01475461|37847077|FG000|Treatment Period|Protocol Violation|0|||
16871690|NCT01475461|37847078|FG001|Treatment Period|Protocol Violation|1|||
16871691|NCT01475461|37847079|FG002|Treatment Period|Protocol Violation|0|||
16871692|NCT01475461|37847080|FG003|Treatment Period|Protocol Violation|0|||
16871693|NCT01475461|37847081|FG004|Treatment Period|Protocol Violation|0|||
16871694|NCT01475461|37847082|FG005|Treatment Period|Protocol Violation|0|||
16871695|NCT01475461|37847083|FG006|Treatment Period|Protocol Violation|1|||
16871696|NCT01475461|37847077|FG000|Treatment Period|Lack of Efficacy|0|||
16871697|NCT01475461|37847078|FG001|Treatment Period|Lack of Efficacy|2|||
16871698|NCT01475461|37847079|FG002|Treatment Period|Lack of Efficacy|0|||
16871699|NCT01475461|37847080|FG003|Treatment Period|Lack of Efficacy|2|||
16871700|NCT01475461|37847081|FG004|Treatment Period|Lack of Efficacy|1|||
16871701|NCT01475461|37847082|FG005|Treatment Period|Lack of Efficacy|1|||
16871702|NCT01475461|37847083|FG006|Treatment Period|Lack of Efficacy|0|||
16871703|NCT01475461|37847077|FG000|Treatment Period|Medication Error|0|||
16871704|NCT01475461|37847078|FG001|Treatment Period|Medication Error|0|||
16871705|NCT01475461|37847079|FG002|Treatment Period|Medication Error|0|||
16871706|NCT01475461|37847080|FG003|Treatment Period|Medication Error|1|||
16871707|NCT01475461|37847081|FG004|Treatment Period|Medication Error|0|||
16871708|NCT01475461|37847082|FG005|Treatment Period|Medication Error|0|||
16871709|NCT01475461|37847083|FG006|Treatment Period|Medication Error|0|||
16871710|NCT01475461|37847077|FG000|Treatment Period|Adverse Event|0|||
16871711|NCT01475461|37847078|FG001|Treatment Period|Adverse Event|0|||
16871712|NCT01475461|37847079|FG002|Treatment Period|Adverse Event|0|||
17001064|NCT00927368|38145079|FG001|Overall Study|equipment failure|0|||
17001065|NCT00927368|38145080|FG002|Overall Study|equipment failure|0|||
17001066|NCT00927368|38145078|FG000|Overall Study|ineligible post randomization|0|||
17001067|NCT00927368|38145079|FG001|Overall Study|ineligible post randomization|3|||
16871713|NCT01475461|37847080|FG003|Treatment Period|Adverse Event|1|||
16871714|NCT01475461|37847081|FG004|Treatment Period|Adverse Event|0|||
16871715|NCT01475461|37847082|FG005|Treatment Period|Adverse Event|0|||
16871716|NCT01475461|37847083|FG006|Treatment Period|Adverse Event|0|||
16871717|NCT01589822|37847119|FG000|Overall Study|Withdrawal by Subject|1|||
16871718|NCT01589822|37847120|FG001|Overall Study|Withdrawal by Subject|2|||
16871719|NCT01589822|37847121|FG002|Overall Study|Withdrawal by Subject|0|||
16871720|NCT01589822|37847119|FG000|Overall Study|Death|1|||
16871721|NCT01589822|37847120|FG001|Overall Study|Death|0|||
16871722|NCT01589822|37847121|FG002|Overall Study|Death|0|||
16871723|NCT01589822|37847119|FG000|Overall Study|Missed 90 day visit|2|||
16871724|NCT01589822|37847120|FG001|Overall Study|Missed 90 day visit|1|||
16871725|NCT01589822|37847121|FG002|Overall Study|Missed 90 day visit|1|||
16871726|NCT01565642|37847133|FG000|Overall Study|Withdrawal by Subject|2|||
16871727|NCT01565642|37847134|FG001|Overall Study|Withdrawal by Subject|1|||
16871728|NCT01475071|37847140|FG000|Overall Study|Physician Decision|1|||
16871729|NCT01475071|37847140|FG000|Overall Study|Withdrawal by Subject|6|||
16871730|NCT01475071|37847140|FG000|Overall Study|Lost to Follow-up|1|||
16784738|NCT02016898|37724759|FG000|Overall Study|Death|1|||
16784739|NCT02016898|37724760|FG001|Overall Study|Death|1|||
16784740|NCT02016898|37724759|FG000|Overall Study|Lost to Follow-up|4|||
16784741|NCT02016898|37724760|FG001|Overall Study|Lost to Follow-up|4|||
16784742|NCT01993030|37724768|FG000|Overall Study|Adverse Event|0|||
16784743|NCT01993030|37724769|FG001|Overall Study|Adverse Event|4|||
16871731|NCT01474993|37847148|FG000|Overall Study|Lost to Follow-up|1|||
16871732|NCT01474993|37847149|FG001|Overall Study|Lost to Follow-up|2|||
16871733|NCT01474993|37847148|FG000|Overall Study|Adverse Event|0|||
16871734|NCT01474993|37847149|FG001|Overall Study|Adverse Event|1|||
16871735|NCT01691768|37847159|FG000|Overall Study|Death|0|||
16871736|NCT01691768|37847160|FG001|Overall Study|Death|2|||
16784744|NCT01992094|37724778|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
16784745|NCT01992094|37724779|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
16784746|NCT01992094|37724780|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
16784747|NCT01992094|37724778|FG000|Overall Study|Adverse Event|1|||
16871737|NCT01691768|37847159|FG000|Overall Study|Lost to Follow-up|4|||
16871738|NCT01691768|37847160|FG001|Overall Study|Lost to Follow-up|3|||
16871739|NCT01691768|37847159|FG000|Overall Study|Withdrawal by Subject|10|||
16871740|NCT01691768|37847160|FG001|Overall Study|Withdrawal by Subject|9|||
16871741|NCT01691768|37847159|FG000|Overall Study|Relocated|0|||
16871742|NCT01691768|37847160|FG001|Overall Study|Relocated|1|||
16871743|NCT01691768|37847159|FG000|Overall Study|Investigator decision|1|||
16871744|NCT01691768|37847160|FG001|Overall Study|Investigator decision|1|||
17001068|NCT00927368|38145080|FG002|Overall Study|ineligible post randomization|1|||
16784748|NCT01992094|37724779|FG001|Overall Study|Adverse Event|0|||
16871745|NCT01503229|37847167|FG000|Overall Study|Withdrew consent|1|||
16871746|NCT01691612|37847171|FG000|Overall Study|deemed ineligible after 1st visit|6|||
16871747|NCT01691612|37847171|FG000|Overall Study|Adverse Event|1|||
16871748|NCT01565564|37847177|FG000|Overall Study|Lost to Follow-up|5|||
16871749|NCT01565564|37847178|FG001|Overall Study|Lost to Follow-up|1|||
16871750|NCT01460407|37847184|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
16871751|NCT01460407|37847185|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
16871752|NCT01502371|37847197|FG000|Overall Study|Withdrawal by Subject|1|||
16871753|NCT01502371|37847198|FG001|Overall Study|Withdrawal by Subject|2|||
16871754|NCT01502371|37847199|FG002|Overall Study|Withdrawal by Subject|1|||
16871755|NCT01502371|37847200|FG003|Overall Study|Withdrawal by Subject|1|||
16784749|NCT01992094|37724780|FG002|Overall Study|Adverse Event|0|||
16784750|NCT01992094|37724778|FG000|Overall Study|Death|5|||
16784751|NCT01992094|37724779|FG001|Overall Study|Death|5|||
16784752|NCT01992094|37724780|FG002|Overall Study|Death|2|||
16871756|NCT01502371|37847201|FG004|Overall Study|Withdrawal by Subject|1|||
16871757|NCT01502371|37847197|FG000|Overall Study|Adverse Event|2|||
16871758|NCT01502371|37847198|FG001|Overall Study|Adverse Event|1|||
16871759|NCT01502371|37847199|FG002|Overall Study|Adverse Event|0|||
16871760|NCT01502371|37847200|FG003|Overall Study|Adverse Event|4|||
16871761|NCT01502371|37847201|FG004|Overall Study|Adverse Event|3|||
16871762|NCT01502371|37847197|FG000|Overall Study|Treatment Failure|22|||
17094928|NCT00233324|38234200|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
17094929|NCT00233324|38234201|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
17094930|NCT00023452|38234220|FG000|Overall Study|Ineligible for Study|163|||
17094931|NCT00023452|38234221|FG001|Overall Study|Ineligible for Study|159|||
17094932|NCT00023452|38234220|FG000|Overall Study|Out of Window|129|||
17094933|NCT00023452|38234221|FG001|Overall Study|Out of Window|69|||
17094934|NCT00023452|38234220|FG000|Overall Study|Death|2|||
17094935|NCT00023452|38234221|FG001|Overall Study|Death|0|||
17094936|NCT00023452|38234220|FG000|Overall Study|Withdrawal by Subject|66|||
17094937|NCT00023452|38234221|FG001|Overall Study|Withdrawal by Subject|54|||
17094938|NCT00023452|38234220|FG000|Overall Study|Adverse Event|139|||
17094939|NCT00023452|38234221|FG001|Overall Study|Adverse Event|196|||
17094940|NCT00023452|38234220|FG000|Overall Study|Lost to Follow-up|293|||
17094941|NCT00023452|38234221|FG001|Overall Study|Lost to Follow-up|60|||
17094942|NCT00023452|38234220|FG000|Overall Study|Physician Decision|49|||
17094943|NCT00023452|38234221|FG001|Overall Study|Physician Decision|21|||
17094944|NCT00023452|38234220|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
17094945|NCT00023452|38234221|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
17094946|NCT00023452|38234220|FG000|Overall Study|Pregnant|53|||
17094947|NCT00023452|38234221|FG001|Overall Study|Pregnant|20|||
17094948|NCT00023452|38234220|FG000|Overall Study|Other|204|||
17094949|NCT00023452|38234221|FG001|Overall Study|Other|69|||
17191173|NCT02956967|38343907|FG000|Overall Study|Termination of Nivestim administration|29|||
17191174|NCT02867995|38343931|FG000|Overall Study|Withdrawal by Subject|0|||
17191175|NCT02867995|38343932|FG001|Overall Study|Withdrawal by Subject|1|||
17191176|NCT02867995|38343931|FG000|Overall Study|Lost to Follow-up|0|||
17191177|NCT02867995|38343932|FG001|Overall Study|Lost to Follow-up|2|||
17191178|NCT02867761|38343944|FG000|Overall Study|Participant withdrawn by investigator|0|||
17191179|NCT02867761|38343945|FG001|Overall Study|Participant withdrawn by investigator|1|||
17191180|NCT02867761|38343944|FG000|Overall Study|Lost to Follow-up|25|||
17191181|NCT02867761|38343945|FG001|Overall Study|Lost to Follow-up|18|||
17191182|NCT02867761|38343944|FG000|Overall Study|Unable to complete protocol|3|||
17191183|NCT02867761|38343945|FG001|Overall Study|Unable to complete protocol|7|||
17191184|NCT03392883|38343954|FG000|Overall Study|Lost to Follow-up|122|||
16871763|NCT01502371|37847198|FG001|Overall Study|Treatment Failure|20|||
16871764|NCT01502371|37847199|FG002|Overall Study|Treatment Failure|12|||
16871765|NCT01502371|37847200|FG003|Overall Study|Treatment Failure|19|||
16871766|NCT01502371|37847201|FG004|Overall Study|Treatment Failure|30|||
16871767|NCT01502371|37847197|FG000|Overall Study|Lack of Efficacy|3|||
16871768|NCT01502371|37847198|FG001|Overall Study|Lack of Efficacy|3|||
16871769|NCT01502371|37847199|FG002|Overall Study|Lack of Efficacy|2|||
16871770|NCT01502371|37847200|FG003|Overall Study|Lack of Efficacy|2|||
16871771|NCT01502371|37847201|FG004|Overall Study|Lack of Efficacy|4|||
16871772|NCT01502371|37847197|FG000|Overall Study|Physician Decision|3|||
16871773|NCT01502371|37847198|FG001|Overall Study|Physician Decision|0|||
16871774|NCT01502371|37847199|FG002|Overall Study|Physician Decision|0|||
17094950|NCT00022672|38234233|FG000|Main Phase: 24 Months|Adverse Event|6|||
17094951|NCT00022672|38234234|FG001|Main Phase: 24 Months|Adverse Event|0|||
17094952|NCT00022672|38234233|FG000|Main Phase: 24 Months|Death|0|||
17191185|NCT03392883|38343955|FG001|Overall Study|Lost to Follow-up|13|||
16784753|NCT01992094|37724778|FG000|Overall Study|Lost to Follow-up|26|||
17094953|NCT00022672|38234234|FG001|Main Phase: 24 Months|Death|3|||
16784754|NCT01992094|37724779|FG001|Overall Study|Lost to Follow-up|9|||
16784755|NCT01992094|37724780|FG002|Overall Study|Lost to Follow-up|13|||
16784756|NCT01992094|37724778|FG000|Overall Study|OTHER|4|||
16784757|NCT01992094|37724779|FG001|Overall Study|OTHER|0|||
16784758|NCT01992094|37724780|FG002|Overall Study|OTHER|0|||
16784759|NCT01992094|37724778|FG000|Overall Study|Protocol Violation|1|||
16784760|NCT01992094|37724779|FG001|Overall Study|Protocol Violation|0|||
16784761|NCT01992094|37724780|FG002|Overall Study|Protocol Violation|1|||
16784762|NCT01992094|37724778|FG000|Overall Study|Withdrawal by Subject|7|||
16784763|NCT01992094|37724779|FG001|Overall Study|Withdrawal by Subject|3|||
16784764|NCT01992094|37724780|FG002|Overall Study|Withdrawal by Subject|4|||
16784765|NCT02706691|37724804|FG000|Overall Study|Adverse Event|1|||
16871775|NCT01502371|37847200|FG003|Overall Study|Physician Decision|0|||
16871776|NCT01502371|37847201|FG004|Overall Study|Physician Decision|1|||
16871777|NCT01502371|37847197|FG000|Overall Study|Noncompliance with Study Drug|0|||
16871778|NCT01502371|37847198|FG001|Overall Study|Noncompliance with Study Drug|0|||
16871779|NCT01502371|37847199|FG002|Overall Study|Noncompliance with Study Drug|1|||
16871780|NCT01502371|37847200|FG003|Overall Study|Noncompliance with Study Drug|2|||
16871781|NCT01502371|37847201|FG004|Overall Study|Noncompliance with Study Drug|1|||
16871782|NCT01502371|37847197|FG000|Overall Study|Technical Problems|1|||
16871783|NCT01502371|37847198|FG001|Overall Study|Technical Problems|0|||
16871784|NCT01502371|37847199|FG002|Overall Study|Technical Problems|2|||
16871785|NCT01502371|37847200|FG003|Overall Study|Technical Problems|4|||
16871786|NCT01502371|37847201|FG004|Overall Study|Technical Problems|1|||
16871787|NCT01502371|37847197|FG000|Overall Study|Protocol Violation|9|||
16871788|NCT01502371|37847198|FG001|Overall Study|Protocol Violation|5|||
16871789|NCT01502371|37847199|FG002|Overall Study|Protocol Violation|6|||
16871790|NCT01502371|37847200|FG003|Overall Study|Protocol Violation|5|||
16871791|NCT01502371|37847201|FG004|Overall Study|Protocol Violation|10|||
16871792|NCT01502371|37847197|FG000|Overall Study|Excluded Medication|0|||
16871793|NCT01502371|37847198|FG001|Overall Study|Excluded Medication|1|||
16871794|NCT01502371|37847199|FG002|Overall Study|Excluded Medication|1|||
16871795|NCT01502371|37847200|FG003|Overall Study|Excluded Medication|0|||
16871796|NCT01502371|37847201|FG004|Overall Study|Excluded Medication|1|||
16871797|NCT01588496|37847217|FG000|Overall Study|Withdrawal by Subject|0|||
16871798|NCT01588496|37847218|FG001|Overall Study|Withdrawal by Subject|1|||
16871799|NCT01588496|37847219|FG002|Overall Study|Withdrawal by Subject|0|||
16871800|NCT01502293|37847230|FG000|Overall Study|Progressive Disease|20|||
16871801|NCT01502293|37847231|FG001|Overall Study|Progressive Disease|12|||
16871802|NCT01502293|37847232|FG002|Overall Study|Progressive Disease|2|||
16871803|NCT01502293|37847230|FG000|Overall Study|Withdrawal by Subject|3|||
16871804|NCT01502293|37847231|FG001|Overall Study|Withdrawal by Subject|3|||
16871805|NCT01502293|37847232|FG002|Overall Study|Withdrawal by Subject|1|||
16871806|NCT01502293|37847230|FG000|Overall Study|Adverse Event|0|||
16871807|NCT01502293|37847231|FG001|Overall Study|Adverse Event|2|||
16871808|NCT01502293|37847232|FG002|Overall Study|Adverse Event|0|||
16871809|NCT01502293|37847230|FG000|Overall Study|Reason Not Specified|2|||
16871810|NCT01502293|37847231|FG001|Overall Study|Reason Not Specified|0|||
16871811|NCT01502293|37847232|FG002|Overall Study|Reason Not Specified|0|||
16871812|NCT01502293|37847230|FG000|Overall Study|Physician Decision|0|||
16871813|NCT01502293|37847231|FG001|Overall Study|Physician Decision|0|||
16871814|NCT01502293|37847232|FG002|Overall Study|Physician Decision|1|||
16871815|NCT01474681|37847245|FG000|Overall Study|Death|0|||
16871816|NCT01474681|37847246|FG001|Overall Study|Death|3|||
16871817|NCT01474681|37847247|FG002|Overall Study|Death|2|||
16871818|NCT01474681|37847248|FG003|Overall Study|Death|6|||
17001069|NCT00927368|38145078|FG000|Overall Study|cancellation of surgery|0|||
17001070|NCT00927368|38145079|FG001|Overall Study|cancellation of surgery|1|||
16871819|NCT01459783|37847264|FG000|Baseline to 6 Months|Death|1|||
16871820|NCT01459783|37847265|FG001|Baseline to 6 Months|Death|0|||
16871821|NCT01459783|37847264|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
16871822|NCT01459783|37847265|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
16871823|NCT01459783|37847264|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
16871824|NCT01459783|37847265|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
16871825|NCT01459783|37847264|FG000|6 Months to 12 Months|Death|0|||
16871826|NCT01459783|37847265|FG001|6 Months to 12 Months|Death|1|||
16871827|NCT01459783|37847264|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
16871828|NCT01459783|37847265|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
16871829|NCT01459783|37847264|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
16871830|NCT01459783|37847265|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
16871831|NCT01459783|37847264|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
16871832|NCT01459783|37847265|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
16871833|NCT01588184|37847277|FG000|Overall Study|Death|1|||
16871834|NCT01588184|37847278|FG001|Overall Study|Death|0|||
16871835|NCT01588184|37847279|FG002|Overall Study|Death|0|||
16871836|NCT01588184|37847280|FG003|Overall Study|Death|1|||
16871837|NCT01588184|37847281|FG004|Overall Study|Death|1|||
16871838|NCT01588184|37847282|FG005|Overall Study|Death|1|||
16871839|NCT01588184|37847277|FG000|Overall Study|Withdrawal by Subject|2|||
16871840|NCT01588184|37847278|FG001|Overall Study|Withdrawal by Subject|4|||
16871841|NCT01588184|37847279|FG002|Overall Study|Withdrawal by Subject|0|||
16871842|NCT01588184|37847280|FG003|Overall Study|Withdrawal by Subject|1|||
16871843|NCT01588184|37847281|FG004|Overall Study|Withdrawal by Subject|0|||
16871844|NCT01588184|37847282|FG005|Overall Study|Withdrawal by Subject|0|||
16871845|NCT01588184|37847277|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
16871846|NCT01588184|37847278|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
16871847|NCT01588184|37847279|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
16871848|NCT01588184|37847280|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
16871849|NCT01588184|37847281|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
16871850|NCT01588184|37847282|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
16871851|NCT01588184|37847277|FG000|Overall Study|multiple reasons|0|||
16871852|NCT01588184|37847278|FG001|Overall Study|multiple reasons|3|||
16871853|NCT01588184|37847279|FG002|Overall Study|multiple reasons|0|||
16871854|NCT01588184|37847280|FG003|Overall Study|multiple reasons|1|||
16871855|NCT01588184|37847281|FG004|Overall Study|multiple reasons|0|||
16871856|NCT01588184|37847282|FG005|Overall Study|multiple reasons|0|||
16871857|NCT01588106|37847298|FG000|Overall Study|Withdrawal by Subject|5|||
16871858|NCT01588106|37847299|FG001|Overall Study|Withdrawal by Subject|4|||
16871859|NCT01564862|37847308|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
16871860|NCT01564862|37847309|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
16871861|NCT01564862|37847310|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
16871862|NCT01564862|37847308|FG000|Overall Study|Major Protocol Deviation|3|||
16871863|NCT01564862|37847309|FG001|Overall Study|Major Protocol Deviation|3|||
16871864|NCT01564862|37847310|FG002|Overall Study|Major Protocol Deviation|4|||
16871865|NCT01564862|37847308|FG000|Overall Study|Lost to Follow-up|10|||
16871866|NCT01564862|37847309|FG001|Overall Study|Lost to Follow-up|8|||
16871867|NCT01564862|37847310|FG002|Overall Study|Lost to Follow-up|6|||
16871868|NCT01564862|37847308|FG000|Overall Study|Voluntary Withdrawal|9|||
16871869|NCT01564862|37847309|FG001|Overall Study|Voluntary Withdrawal|6|||
16871870|NCT01564862|37847310|FG002|Overall Study|Voluntary Withdrawal|8|||
16871871|NCT01564862|37847308|FG000|Overall Study|Lack of Efficacy|1|||
16871872|NCT01564862|37847309|FG001|Overall Study|Lack of Efficacy|5|||
16871873|NCT01564862|37847310|FG002|Overall Study|Lack of Efficacy|6|||
16871874|NCT01564862|37847308|FG000|Overall Study|Other reason(s)|1|||
16871875|NCT01564862|37847309|FG001|Overall Study|Other reason(s)|0|||
16871876|NCT01564862|37847310|FG002|Overall Study|Other reason(s)|0|||
16871877|NCT01691378|37847320|FG000|Overall Study|Withdrawal by Subject|2|||
16871878|NCT01691378|37847321|FG001|Overall Study|Withdrawal by Subject|0|||
16871879|NCT01691378|37847320|FG000|Overall Study|Lost to Follow-up|5|||
16871880|NCT01691378|37847321|FG001|Overall Study|Lost to Follow-up|2|||
16871881|NCT01467479|37847330|FG000|Overall Study|No Study Medication|1|||
16871882|NCT01467479|37847331|FG001|Overall Study|No Study Medication|0|||
16871883|NCT01467479|37847332|FG002|Overall Study|No Study Medication|2|||
16871884|NCT01467479|37847330|FG000|Overall Study|Adverse Event|1|||
16871885|NCT01467479|37847331|FG001|Overall Study|Adverse Event|2|||
16871886|NCT01467479|37847332|FG002|Overall Study|Adverse Event|0|||
16871887|NCT01467479|37847330|FG000|Overall Study|Death|0|||
16871888|NCT01467479|37847331|FG001|Overall Study|Death|0|||
16871889|NCT01467479|37847332|FG002|Overall Study|Death|1|||
16871890|NCT01467479|37847330|FG000|Overall Study|Lost to Follow-up|2|||
16871891|NCT01467479|37847331|FG001|Overall Study|Lost to Follow-up|5|||
16871892|NCT01467479|37847332|FG002|Overall Study|Lost to Follow-up|3|||
16871893|NCT01467479|37847330|FG000|Overall Study|Withdrawal of Consent|3|||
16871894|NCT01467479|37847331|FG001|Overall Study|Withdrawal of Consent|7|||
16871895|NCT01467479|37847332|FG002|Overall Study|Withdrawal of Consent|7|||
16871896|NCT01467479|37847330|FG000|Overall Study|Study Terminated by Sponsor|1|||
16871897|NCT01467479|37847331|FG001|Overall Study|Study Terminated by Sponsor|3|||
16871898|NCT01467479|37847332|FG002|Overall Study|Study Terminated by Sponsor|3|||
16871899|NCT01467479|37847330|FG000|Overall Study|Other|1|||
16871900|NCT01467479|37847331|FG001|Overall Study|Other|0|||
16871901|NCT01467479|37847332|FG002|Overall Study|Other|0|||
16871902|NCT01466387|37847347|FG000|Overall Study|Adverse Event|0|||
16871903|NCT01466387|37847348|FG001|Overall Study|Adverse Event|0|||
16871904|NCT01466387|37847349|FG002|Overall Study|Adverse Event|1|||
16871905|NCT01466387|37847350|FG003|Overall Study|Adverse Event|1|||
16871906|NCT01466387|37847351|FG004|Overall Study|Adverse Event|0|||
16871907|NCT01466387|37847352|FG005|Overall Study|Adverse Event|0|||
16871908|NCT01466387|37847347|FG000|Overall Study|Lost to Follow-up|0|||
16871909|NCT01466387|37847348|FG001|Overall Study|Lost to Follow-up|0|||
16871910|NCT01466387|37847349|FG002|Overall Study|Lost to Follow-up|0|||
16871911|NCT01466387|37847350|FG003|Overall Study|Lost to Follow-up|0|||
16871912|NCT01466387|37847351|FG004|Overall Study|Lost to Follow-up|0|||
16871913|NCT01466387|37847352|FG005|Overall Study|Lost to Follow-up|1|||
16871914|NCT01466387|37847347|FG000|Overall Study|Protocol Violation|1|||
16784766|NCT01991470|37724809|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
16784767|NCT01991470|37724809|FG000|Enlite 1 Period|Adverse Event|1|||
16784768|NCT01991470|37724809|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
16784769|NCT01991470|37724809|FG000|Enlite 3 Period|Lost to Follow-up|1|||
16784770|NCT01991470|37724809|FG000|Enlite 3 Period|Physician Decision|2|||
16784771|NCT01991470|37724809|FG000|Enlite 3 Period|Physician Decision|8|||
16784772|NCT01991470|37724809|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
16784773|NCT01991314|37724823|FG000|Overall Study|Adverse Event|5|||
16784774|NCT01991314|37724824|FG001|Overall Study|Adverse Event|1|||
16784775|NCT01991314|37724823|FG000|Overall Study|Lost to Follow-up|6|||
16784776|NCT01991314|37724824|FG001|Overall Study|Lost to Follow-up|10|||
16871915|NCT01466387|37847348|FG001|Overall Study|Protocol Violation|0|||
16871916|NCT01466387|37847349|FG002|Overall Study|Protocol Violation|0|||
16871917|NCT01466387|37847350|FG003|Overall Study|Protocol Violation|1|||
16871918|NCT01466387|37847351|FG004|Overall Study|Protocol Violation|0|||
16871919|NCT01466387|37847352|FG005|Overall Study|Protocol Violation|0|||
16871920|NCT01564784|37847483|FG000|Overall Study|Other|1|||
16871921|NCT01564784|37847484|FG001|Overall Study|Other|0|||
16784777|NCT01990768|37724833|FG000|Intervention Started|Found to be ineligible|14|||
16784778|NCT01990768|37724834|FG001|Intervention Started|Found to be ineligible|13|||
16784779|NCT01990768|37724835|FG002|Intervention Started|Found to be ineligible|11|||
16784780|NCT01990768|37724833|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
16784781|NCT01990768|37724834|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
16784782|NCT01990768|37724835|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
16784783|NCT01990768|37724833|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
16784784|NCT01990768|37724834|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
16784785|NCT01990768|37724835|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
16784786|NCT01990768|37724833|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
16784787|NCT01990768|37724834|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
16784788|NCT01990768|37724835|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
16784789|NCT01990768|37724833|FG000|Intervention Started|Patient care priority|1|||
16784790|NCT01990768|37724834|FG001|Intervention Started|Patient care priority|2|||
16784791|NCT01990768|37724835|FG002|Intervention Started|Patient care priority|3|||
16784792|NCT01990768|37724833|FG000|Intervention Started|IV lost|2|||
16784793|NCT01990768|37724834|FG001|Intervention Started|IV lost|2|||
16784794|NCT01990768|37724835|FG002|Intervention Started|IV lost|2|||
16784795|NCT01990768|37724833|FG000|Intervention Started|Required CPR|1|||
16871922|NCT01564784|37847483|FG000|Overall Study|Subject refused further follow-up|1|||
16871923|NCT01564784|37847484|FG001|Overall Study|Subject refused further follow-up|6|||
16871924|NCT01564784|37847483|FG000|Overall Study|Lost to Follow-up|1|||
16871925|NCT01564784|37847484|FG001|Overall Study|Lost to Follow-up|1|||
16871926|NCT01564784|37847483|FG000|Overall Study|Death|131|||
16871927|NCT01564784|37847484|FG001|Overall Study|Death|126|||
16871928|NCT01564394|37847527|FG000|Overall Study|Withdrawal by Subject|6|||
16871929|NCT01564394|37847528|FG001|Overall Study|Withdrawal by Subject|10|||
16871930|NCT01690988|37847542|FG000|Overall Study|Withdrawal by Subject|2|||
16871931|NCT01690988|37847543|FG001|Overall Study|Withdrawal by Subject|2|||
16871932|NCT01690988|37847544|FG002|Overall Study|Withdrawal by Subject|3|||
16871933|NCT01690988|37847542|FG000|Overall Study|Physician Decision|0|||
16871934|NCT01690988|37847543|FG001|Overall Study|Physician Decision|0|||
16871935|NCT01690988|37847544|FG002|Overall Study|Physician Decision|1|||
16871936|NCT01690988|37847542|FG000|Overall Study|Operation Cancelled|1|||
17001071|NCT00927368|38145080|FG002|Overall Study|cancellation of surgery|2|||
17001072|NCT00662857|38145088|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
17001073|NCT00662857|38145089|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
17001074|NCT00662857|38145088|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
17001075|NCT00662857|38145089|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
17001076|NCT00662857|38145088|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
17001077|NCT00662857|38145089|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
17001078|NCT00878553|38145102|FG000|Sleep Study|Withdrawal by Subject|2|||
17001079|NCT00878553|38145103|FG001|Sleep Study|Withdrawal by Subject|0|||
17001080|NCT00878553|38145104|FG002|Sleep Study|Withdrawal by Subject|0|||
17001081|NCT00878553|38145105|FG003|Sleep Study|Withdrawal by Subject|0|||
17001082|NCT00878553|38145106|FG004|Sleep Study|Withdrawal by Subject|0|||
17001083|NCT00878553|38145102|FG000|Sleep Study|Lost to Follow-up|1|||
17001084|NCT00878553|38145103|FG001|Sleep Study|Lost to Follow-up|0|||
17001085|NCT00878553|38145104|FG002|Sleep Study|Lost to Follow-up|0|||
17001086|NCT00878553|38145105|FG003|Sleep Study|Lost to Follow-up|0|||
17001087|NCT00878553|38145106|FG004|Sleep Study|Lost to Follow-up|0|||
17001088|NCT00878553|38145102|FG000|Sleep Study|car accident|1|||
17001089|NCT00878553|38145103|FG001|Sleep Study|car accident|0|||
17001090|NCT00878553|38145104|FG002|Sleep Study|car accident|0|||
17001091|NCT00878553|38145105|FG003|Sleep Study|car accident|0|||
17001092|NCT00878553|38145106|FG004|Sleep Study|car accident|0|||
17001093|NCT00878553|38145102|FG000|Sleep Study|family emergency|1|||
17001094|NCT00878553|38145103|FG001|Sleep Study|family emergency|0|||
17001095|NCT00878553|38145104|FG002|Sleep Study|family emergency|0|||
17001096|NCT00878553|38145105|FG003|Sleep Study|family emergency|0|||
17001097|NCT00878553|38145106|FG004|Sleep Study|family emergency|0|||
17001098|NCT00878553|38145102|FG000|PK Study|Withdrawal by Subject|0|||
17001099|NCT00878553|38145103|FG001|PK Study|Withdrawal by Subject|0|||
17001100|NCT00878553|38145104|FG002|PK Study|Withdrawal by Subject|0|||
17001101|NCT00878553|38145105|FG003|PK Study|Withdrawal by Subject|1|||
17001102|NCT00878553|38145106|FG004|PK Study|Withdrawal by Subject|0|||
17001103|NCT00996437|38145125|FG000|Overall Study|Death|1|||
17001104|NCT00996437|38145126|FG001|Overall Study|Death|0|||
17001105|NCT00996437|38145125|FG000|Overall Study|Dropped|2|||
17001106|NCT00996437|38145126|FG001|Overall Study|Dropped|2|||
17001107|NCT00996437|38145125|FG000|Overall Study|Missed|2|||
17001108|NCT00996437|38145126|FG001|Overall Study|Missed|5|||
17001109|NCT00662311|38145135|FG000|Overall Study|Respiratory Infection|1|||
17001110|NCT00662311|38145136|FG001|Overall Study|Respiratory Infection|0|||
17001111|NCT00662311|38145137|FG002|Overall Study|Respiratory Infection|0|||
17001112|NCT00929708|38145150|FG000|Overall Study|Protocol Violation|2|||
17001113|NCT00929708|38145151|FG001|Overall Study|Protocol Violation|1|||
17001114|NCT00929708|38145152|FG002|Overall Study|Protocol Violation|1|||
17001115|NCT00929708|38145153|FG003|Overall Study|Protocol Violation|1|||
17001116|NCT00929708|38145154|FG004|Overall Study|Protocol Violation|1|||
17001117|NCT00929708|38145150|FG000|Overall Study|Withdrawal by Subject|2|||
17001118|NCT00929708|38145151|FG001|Overall Study|Withdrawal by Subject|0|||
17001119|NCT00929708|38145152|FG002|Overall Study|Withdrawal by Subject|0|||
17001120|NCT00929708|38145153|FG003|Overall Study|Withdrawal by Subject|2|||
17001121|NCT00929708|38145154|FG004|Overall Study|Withdrawal by Subject|1|||
17191186|NCT03392883|38343956|FG002|Overall Study|Lost to Follow-up|9|||
16871937|NCT01690988|37847543|FG001|Overall Study|Operation Cancelled|1|||
16871938|NCT01690988|37847544|FG002|Overall Study|Operation Cancelled|0|||
16871939|NCT01690988|37847542|FG000|Overall Study|Determined ineligible|1|||
16871940|NCT01690988|37847543|FG001|Overall Study|Determined ineligible|0|||
16871941|NCT01690988|37847544|FG002|Overall Study|Determined ineligible|0|||
16871942|NCT01690988|37847542|FG000|Overall Study|Death|1|||
16871943|NCT01690988|37847543|FG001|Overall Study|Death|1|||
16871944|NCT01690988|37847544|FG002|Overall Study|Death|1|||
16871945|NCT01690988|37847542|FG000|Overall Study|Sedated|1|||
16871946|NCT01690988|37847543|FG001|Overall Study|Sedated|1|||
16871947|NCT01690988|37847544|FG002|Overall Study|Sedated|2|||
16871948|NCT01466153|37847575|FG000|Overall Study|Disease Progression|2|||
16871949|NCT01466153|37847576|FG001|Overall Study|Disease Progression|2|||
16871950|NCT01466153|37847577|FG002|Overall Study|Disease Progression|0|||
16871951|NCT01466153|37847575|FG000|Overall Study|Adverse Event|14|||
16871952|NCT01466153|37847576|FG001|Overall Study|Adverse Event|13|||
16871953|NCT01466153|37847577|FG002|Overall Study|Adverse Event|17|||
16871954|NCT01466153|37847575|FG000|Overall Study|Withdrawal of Consent|2|||
16871955|NCT01466153|37847576|FG001|Overall Study|Withdrawal of Consent|0|||
16871956|NCT01466153|37847577|FG002|Overall Study|Withdrawal of Consent|0|||
16871957|NCT01466153|37847575|FG000|Overall Study|Investigator Discretion|3|||
16871958|NCT01466153|37847576|FG001|Overall Study|Investigator Discretion|2|||
16871959|NCT01466153|37847577|FG002|Overall Study|Investigator Discretion|2|||
16871960|NCT01466153|37847575|FG000|Overall Study|Randomized-Not Treated|2|||
16871961|NCT01466153|37847576|FG001|Overall Study|Randomized-Not Treated|3|||
16871962|NCT01466153|37847577|FG002|Overall Study|Randomized-Not Treated|4|||
16871963|NCT01466153|37847575|FG000|Overall Study|Other-Unspecified|6|||
16871964|NCT01466153|37847576|FG001|Overall Study|Other-Unspecified|4|||
16871965|NCT01466153|37847577|FG002|Overall Study|Other-Unspecified|2|||
16871966|NCT01474291|37847598|FG000|Overall Study|Not Evaluable for Efficacy|26|||
16871967|NCT01474291|37847598|FG000|Overall Study|Lack of Treatment Efficacy|88|||
16871968|NCT01474291|37847598|FG000|Overall Study|Adverse Event|53|||
16871969|NCT01474291|37847598|FG000|Overall Study|Lost to Follow-up|29|||
16871970|NCT01474291|37847598|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
16871971|NCT01474291|37847598|FG000|Overall Study|No Reason Reported|10|||
16871972|NCT01474291|37847598|FG000|Overall Study|Death|2|||
16871973|NCT01465997|37847607|FG000|Overall Study|Adverse Event|12|||
16871974|NCT01465997|37847608|FG001|Overall Study|Adverse Event|22|||
16871975|NCT01465997|37847607|FG000|Overall Study|Lack of Efficacy|13|||
16871976|NCT01465997|37847608|FG001|Overall Study|Lack of Efficacy|1|||
16871977|NCT01465997|37847607|FG000|Overall Study|Protocol Violation|1|||
16871978|NCT01465997|37847608|FG001|Overall Study|Protocol Violation|4|||
16871979|NCT01465997|37847607|FG000|Overall Study|Lost to Follow-up|6|||
17191187|NCT03392883|38343954|FG000|Overall Study|Death|4|||
17191188|NCT03392883|38343955|FG001|Overall Study|Death|0|||
17191189|NCT03392883|38343956|FG002|Overall Study|Death|0|||
17191190|NCT03392883|38343954|FG000|Overall Study|Lack of Efficacy|29|||
17191191|NCT03392883|38343955|FG001|Overall Study|Lack of Efficacy|0|||
17191192|NCT03392883|38343956|FG002|Overall Study|Lack of Efficacy|0|||
17191193|NCT03392883|38343954|FG000|Overall Study|Withdrawal by Subject|180|||
17191194|NCT03392883|38343955|FG001|Overall Study|Withdrawal by Subject|0|||
17191195|NCT03392883|38343956|FG002|Overall Study|Withdrawal by Subject|0|||
17191196|NCT03392883|38343954|FG000|Overall Study|Adverse Event|1|||
17001122|NCT00929708|38145150|FG000|Overall Study|Adverse Event|0|||
17001123|NCT00929708|38145151|FG001|Overall Study|Adverse Event|0|||
17001124|NCT00929708|38145152|FG002|Overall Study|Adverse Event|0|||
17191197|NCT03392883|38343955|FG001|Overall Study|Adverse Event|0|||
17191198|NCT03392883|38343956|FG002|Overall Study|Adverse Event|0|||
17191199|NCT02748863|38343967|FG000|Treatment Period 1|Adverse Event|0|||
17191200|NCT02748863|38343968|FG001|Treatment Period 1|Adverse Event|1|||
17191201|NCT02748863|38343969|FG002|Treatment Period 1|Adverse Event|0|||
17191202|NCT02748863|38343970|FG003|Treatment Period 1|Adverse Event|0|||
17191203|NCT02748863|38343971|FG004|Treatment Period 1|Adverse Event|0|||
17191204|NCT02748863|38343967|FG000|Treatment Period 1|Lack of Efficacy|0|||
17191205|NCT02748863|38343968|FG001|Treatment Period 1|Lack of Efficacy|0|||
17191206|NCT02748863|38343969|FG002|Treatment Period 1|Lack of Efficacy|1|||
17191207|NCT02748863|38343970|FG003|Treatment Period 1|Lack of Efficacy|0|||
17191208|NCT02748863|38343971|FG004|Treatment Period 1|Lack of Efficacy|0|||
16871980|NCT01465997|37847608|FG001|Overall Study|Lost to Follow-up|9|||
17001125|NCT00929708|38145153|FG003|Overall Study|Adverse Event|0|||
17191209|NCT02748863|38343967|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16871981|NCT01465997|37847607|FG000|Overall Study|Withdrawal by Subject|32|||
16871982|NCT01465997|37847608|FG001|Overall Study|Withdrawal by Subject|35|||
16871983|NCT01465997|37847607|FG000|Overall Study|investigator's decision|1|||
16871984|NCT01465997|37847608|FG001|Overall Study|investigator's decision|1|||
16871985|NCT01465997|37847607|FG000|Overall Study|Death|0|||
16871986|NCT01465997|37847608|FG001|Overall Study|Death|1|||
16871987|NCT01465997|37847607|FG000|Overall Study|sponsor's decision|1|||
16871988|NCT01465997|37847608|FG001|Overall Study|sponsor's decision|1|||
16871989|NCT01465997|37847607|FG000|Overall Study|subject withdrew consent|1|||
16871990|NCT01465997|37847608|FG001|Overall Study|subject withdrew consent|0|||
16871991|NCT01465997|37847607|FG000|Overall Study|local lab unblinded site|1|||
16871992|NCT01465997|37847608|FG001|Overall Study|local lab unblinded site|0|||
16871993|NCT01465997|37847607|FG000|Overall Study|withdrew before follow-up|0|||
16871994|NCT01465997|37847608|FG001|Overall Study|withdrew before follow-up|13|||
16871995|NCT01465997|37847607|FG000|Overall Study|decision by site staff|0|||
16871996|NCT01465997|37847608|FG001|Overall Study|decision by site staff|1|||
16871997|NCT01465997|37847607|FG000|Overall Study|subject left participation SP0993|0|||
16871998|NCT01465997|37847608|FG001|Overall Study|subject left participation SP0993|1|||
16871999|NCT01465763|37847629|FG000|Overall Study|Withdrawal by Subject|4|||
16872000|NCT01465763|37847630|FG001|Overall Study|Withdrawal by Subject|0|||
16872001|NCT01465763|37847631|FG002|Overall Study|Withdrawal by Subject|1|||
16872002|NCT01465763|37847629|FG000|Overall Study|Insufficient Clinical Response|11|||
16872003|NCT01465763|37847630|FG001|Overall Study|Insufficient Clinical Response|0|||
16872004|NCT01465763|37847631|FG002|Overall Study|Insufficient Clinical Response|1|||
16872005|NCT01465763|37847629|FG000|Overall Study|Adverse Event|9|||
16872006|NCT01465763|37847630|FG001|Overall Study|Adverse Event|0|||
16872007|NCT01465763|37847631|FG002|Overall Study|Adverse Event|1|||
16872008|NCT01465763|37847629|FG000|Overall Study|Other|2|||
16872009|NCT01465763|37847630|FG001|Overall Study|Other|0|||
16872010|NCT01465763|37847631|FG002|Overall Study|Other|0|||
16872011|NCT01465763|37847629|FG000|Overall Study|Protocol Violation|4|||
16872012|NCT01465763|37847630|FG001|Overall Study|Protocol Violation|1|||
16872013|NCT01465763|37847631|FG002|Overall Study|Protocol Violation|1|||
16872014|NCT01465763|37847629|FG000|Overall Study|Death|1|||
16872015|NCT01465763|37847630|FG001|Overall Study|Death|0|||
16872016|NCT01465763|37847631|FG002|Overall Study|Death|0|||
16872017|NCT01690520|37847664|FG000|Overall Study|Death|25|||
16872018|NCT01690520|37847665|FG001|Overall Study|Death|21|||
16872019|NCT01690520|37847664|FG000|Overall Study|Lost to Follow-up|2|||
16872020|NCT01690520|37847665|FG001|Overall Study|Lost to Follow-up|3|||
16872021|NCT01690520|37847664|FG000|Overall Study|Withdrawal by Subject|2|||
16872022|NCT01690520|37847665|FG001|Overall Study|Withdrawal by Subject|0|||
16872023|NCT01690520|37847664|FG000|Overall Study|Relapse|0|||
16872024|NCT01690520|37847665|FG001|Overall Study|Relapse|1|||
16872025|NCT01690520|37847664|FG000|Overall Study|Other|0|||
16872026|NCT01690520|37847665|FG001|Overall Study|Other|1|||
16872027|NCT01690520|37847664|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
16872028|NCT01690520|37847665|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
16872029|NCT01563536|37847686|FG000|Overall Study|Withdrawal by Subject|0|||
16872030|NCT01563536|37847687|FG001|Overall Study|Withdrawal by Subject|2|||
16872031|NCT01563536|37847686|FG000|Overall Study|Lost to Follow-up|1|||
16872032|NCT01563536|37847687|FG001|Overall Study|Lost to Follow-up|0|||
16872033|NCT01690130|37847695|FG000|Overall Study|Subject have cancelled visit.|1|||
16872034|NCT01690130|37847696|FG001|Overall Study|Subject have cancelled visit.|0|||
16872035|NCT01690052|37847702|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
16872036|NCT01690052|37847703|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
17001126|NCT00929708|38145154|FG004|Overall Study|Adverse Event|3|||
17001127|NCT00929708|38145150|FG000|Overall Study|Physician Decision|0|||
17001128|NCT00929708|38145151|FG001|Overall Study|Physician Decision|2|||
17001129|NCT00929708|38145152|FG002|Overall Study|Physician Decision|2|||
17001130|NCT00929708|38145153|FG003|Overall Study|Physician Decision|2|||
17001131|NCT00929708|38145154|FG004|Overall Study|Physician Decision|1|||
17001132|NCT00929708|38145150|FG000|Overall Study|Lost to Follow-up|0|||
17001133|NCT00929708|38145151|FG001|Overall Study|Lost to Follow-up|0|||
16872037|NCT01689974|37847730|FG000|Overall Study|Termination of Study|5|||
16872038|NCT01689974|37847731|FG001|Overall Study|Termination of Study|5|||
16872039|NCT01587014|37847737|FG000|Overall Study|Death|2|||
16872040|NCT01458535|37847849|FG000|Overall Study|Other|0|||
16872041|NCT01458535|37847850|FG001|Overall Study|Other|0|||
16872042|NCT01458535|37847851|FG002|Overall Study|Other|0|||
16872043|NCT01458535|37847852|FG003|Overall Study|Other|0|||
16872044|NCT01458535|37847853|FG004|Overall Study|Other|1|||
17001134|NCT00929708|38145152|FG002|Overall Study|Lost to Follow-up|0|||
16872045|NCT01458535|37847854|FG005|Overall Study|Other|1|||
16872046|NCT01458535|37847849|FG000|Overall Study|Withdrawal by Subject|0|||
16872047|NCT01458535|37847850|FG001|Overall Study|Withdrawal by Subject|0|||
16872048|NCT01458535|37847851|FG002|Overall Study|Withdrawal by Subject|2|||
16872049|NCT01458535|37847852|FG003|Overall Study|Withdrawal by Subject|0|||
16872050|NCT01458535|37847853|FG004|Overall Study|Withdrawal by Subject|1|||
17001135|NCT00929708|38145153|FG003|Overall Study|Lost to Follow-up|1|||
17001136|NCT00929708|38145154|FG004|Overall Study|Lost to Follow-up|0|||
17001137|NCT00996281|38145168|FG000|Overall Study|Adverse Event|75|||
17001138|NCT00996281|38145169|FG001|Overall Study|Adverse Event|37|||
17001139|NCT00996281|38145168|FG000|Overall Study|Major Protocol Deviation|6|||
17001140|NCT00996281|38145169|FG001|Overall Study|Major Protocol Deviation|7|||
17001141|NCT00996281|38145168|FG000|Overall Study|Lost to Follow-up|14|||
17001142|NCT00996281|38145169|FG001|Overall Study|Lost to Follow-up|16|||
17001143|NCT00996281|38145168|FG000|Overall Study|Withdrawal by Subject|31|||
16784796|NCT01990768|37724834|FG001|Intervention Started|Required CPR|1|||
16784797|NCT01990768|37724835|FG002|Intervention Started|Required CPR|0|||
16784798|NCT01990768|37724833|FG000|Intervention Started|Seizure or hx of seizure|0|||
16784799|NCT01990768|37724834|FG001|Intervention Started|Seizure or hx of seizure|0|||
16784800|NCT01990768|37724835|FG002|Intervention Started|Seizure or hx of seizure|2|||
16784801|NCT01990768|37724833|FG000|Intervention Started|Discovered to be pregnant|0|||
16784802|NCT01990768|37724834|FG001|Intervention Started|Discovered to be pregnant|1|||
16784803|NCT01990768|37724835|FG002|Intervention Started|Discovered to be pregnant|0|||
16784804|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
16784805|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
16872051|NCT01458535|37847854|FG005|Overall Study|Withdrawal by Subject|1|||
16872052|NCT01458535|37847849|FG000|Overall Study|Lost to Follow-up|0|||
16872053|NCT01458535|37847850|FG001|Overall Study|Lost to Follow-up|2|||
16872054|NCT01458535|37847851|FG002|Overall Study|Lost to Follow-up|0|||
16872055|NCT01458535|37847852|FG003|Overall Study|Lost to Follow-up|3|||
16872056|NCT01458535|37847853|FG004|Overall Study|Lost to Follow-up|2|||
16872057|NCT01458535|37847854|FG005|Overall Study|Lost to Follow-up|2|||
16872058|NCT01458535|37847849|FG000|Overall Study|Adverse Event|0|||
16872059|NCT01458535|37847850|FG001|Overall Study|Adverse Event|0|||
16872060|NCT01458535|37847851|FG002|Overall Study|Adverse Event|0|||
16872061|NCT01458535|37847852|FG003|Overall Study|Adverse Event|1|||
16872062|NCT01458535|37847853|FG004|Overall Study|Adverse Event|0|||
16872063|NCT01458535|37847854|FG005|Overall Study|Adverse Event|0|||
16872064|NCT01464827|37847882|FG000|Overall Study|Adverse Event|0|||
16872065|NCT01464827|37847883|FG001|Overall Study|Adverse Event|0|||
16872066|NCT01464827|37847884|FG002|Overall Study|Adverse Event|0|||
16872067|NCT01464827|37847885|FG003|Overall Study|Adverse Event|0|||
16872068|NCT01464827|37847886|FG004|Overall Study|Adverse Event|0|||
16872069|NCT01464827|37847887|FG005|Overall Study|Adverse Event|0|||
16872070|NCT01464827|37847888|FG006|Overall Study|Adverse Event|0|||
16872071|NCT01464827|37847889|FG007|Overall Study|Adverse Event|0|||
16872072|NCT01464827|37847890|FG008|Overall Study|Adverse Event|0|||
16872073|NCT01464827|37847891|FG009|Overall Study|Adverse Event|0|||
16872074|NCT01464827|37847892|FG010|Overall Study|Adverse Event|0|||
16872075|NCT01464827|37847893|FG011|Overall Study|Adverse Event|0|||
16872076|NCT01464827|37847894|FG012|Overall Study|Adverse Event|1|||
16872077|NCT01464827|37847895|FG013|Overall Study|Adverse Event|0|||
16872078|NCT01464827|37847882|FG000|Overall Study|Withdrawal by Subject|1|||
16872079|NCT01464827|37847883|FG001|Overall Study|Withdrawal by Subject|0|||
16872080|NCT01464827|37847884|FG002|Overall Study|Withdrawal by Subject|0|||
16872081|NCT01464827|37847885|FG003|Overall Study|Withdrawal by Subject|0|||
16872082|NCT01464827|37847886|FG004|Overall Study|Withdrawal by Subject|1|||
16872083|NCT01464827|37847887|FG005|Overall Study|Withdrawal by Subject|0|||
16872084|NCT01464827|37847888|FG006|Overall Study|Withdrawal by Subject|0|||
16872085|NCT01464827|37847889|FG007|Overall Study|Withdrawal by Subject|1|||
16872086|NCT01464827|37847890|FG008|Overall Study|Withdrawal by Subject|0|||
16872087|NCT01464827|37847891|FG009|Overall Study|Withdrawal by Subject|0|||
16872088|NCT01464827|37847892|FG010|Overall Study|Withdrawal by Subject|0|||
16872089|NCT01464827|37847893|FG011|Overall Study|Withdrawal by Subject|0|||
16872090|NCT01464827|37847894|FG012|Overall Study|Withdrawal by Subject|0|||
16872091|NCT01464827|37847895|FG013|Overall Study|Withdrawal by Subject|0|||
16872092|NCT01464827|37847882|FG000|Overall Study|Lost to Follow-up|0|||
16872093|NCT01464827|37847883|FG001|Overall Study|Lost to Follow-up|2|||
16872094|NCT01464827|37847884|FG002|Overall Study|Lost to Follow-up|0|||
16872095|NCT01464827|37847885|FG003|Overall Study|Lost to Follow-up|2|||
16872096|NCT01464827|37847886|FG004|Overall Study|Lost to Follow-up|3|||
16872097|NCT01464827|37847887|FG005|Overall Study|Lost to Follow-up|1|||
17001144|NCT00996281|38145169|FG001|Overall Study|Withdrawal by Subject|20|||
17001145|NCT00996281|38145168|FG000|Overall Study|Lack of Efficacy|0|||
16784806|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
16784807|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
16784808|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
16784809|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
16784810|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
17001146|NCT00996281|38145169|FG001|Overall Study|Lack of Efficacy|2|||
16872098|NCT01464827|37847888|FG006|Overall Study|Lost to Follow-up|2|||
16872099|NCT01464827|37847889|FG007|Overall Study|Lost to Follow-up|2|||
16872100|NCT01464827|37847890|FG008|Overall Study|Lost to Follow-up|0|||
16784811|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
16872101|NCT01464827|37847891|FG009|Overall Study|Lost to Follow-up|0|||
16872102|NCT01464827|37847892|FG010|Overall Study|Lost to Follow-up|0|||
16872103|NCT01464827|37847893|FG011|Overall Study|Lost to Follow-up|1|||
16872104|NCT01464827|37847894|FG012|Overall Study|Lost to Follow-up|0|||
16872105|NCT01464827|37847895|FG013|Overall Study|Lost to Follow-up|1|||
16872106|NCT01464827|37847882|FG000|Overall Study|Other|2|||
16872107|NCT01464827|37847883|FG001|Overall Study|Other|3|||
16872108|NCT01464827|37847884|FG002|Overall Study|Other|0|||
16872109|NCT01464827|37847885|FG003|Overall Study|Other|2|||
16872110|NCT01464827|37847886|FG004|Overall Study|Other|3|||
16872111|NCT01464827|37847887|FG005|Overall Study|Other|0|||
16872112|NCT01464827|37847888|FG006|Overall Study|Other|1|||
16872113|NCT01464827|37847889|FG007|Overall Study|Other|0|||
16872114|NCT01464827|37847890|FG008|Overall Study|Other|3|||
16872115|NCT01464827|37847891|FG009|Overall Study|Other|1|||
16872116|NCT01464827|37847892|FG010|Overall Study|Other|2|||
16872117|NCT01464827|37847893|FG011|Overall Study|Other|0|||
16872118|NCT01464827|37847894|FG012|Overall Study|Other|1|||
16872119|NCT01464827|37847895|FG013|Overall Study|Other|0|||
16872120|NCT01464827|37847882|FG000|Overall Study|Not Treated|0|||
16872121|NCT01464827|37847883|FG001|Overall Study|Not Treated|2|||
16872122|NCT01464827|37847884|FG002|Overall Study|Not Treated|0|||
16872123|NCT01464827|37847885|FG003|Overall Study|Not Treated|0|||
16872124|NCT01464827|37847886|FG004|Overall Study|Not Treated|1|||
16872125|NCT01464827|37847887|FG005|Overall Study|Not Treated|0|||
16872126|NCT01464827|37847888|FG006|Overall Study|Not Treated|1|||
17001147|NCT00996281|38145168|FG000|Overall Study|Other|5|||
17001148|NCT00996281|38145169|FG001|Overall Study|Other|7|||
17001149|NCT00996203|38145175|FG000|Overall Study|Adverse Event|3|||
17001150|NCT00996203|38145175|FG000|Overall Study|Lost to Follow-up|1|||
17001151|NCT00996203|38145175|FG000|Overall Study|Lack of Efficacy|1|||
17001152|NCT00996203|38145175|FG000|Overall Study|Protocol Violation|2|||
17001153|NCT00877929|38145182|FG000|Overall Study|Adverse Event|11|||
17001154|NCT00877929|38145183|FG001|Overall Study|Adverse Event|20|||
17001155|NCT00877929|38145182|FG000|Overall Study|Protocol Violation|3|||
17001156|NCT00877929|38145183|FG001|Overall Study|Protocol Violation|3|||
17001157|NCT00877929|38145182|FG000|Overall Study|Lost to Follow-up|0|||
17001158|NCT00877929|38145183|FG001|Overall Study|Lost to Follow-up|1|||
17001159|NCT00877929|38145182|FG000|Overall Study|Withdrawal by Subject|4|||
17001160|NCT00877929|38145183|FG001|Overall Study|Withdrawal by Subject|4|||
17001161|NCT00877929|38145182|FG000|Overall Study|Lack of Efficacy|0|||
17001162|NCT00877929|38145183|FG001|Overall Study|Lack of Efficacy|1|||
17001163|NCT00877929|38145182|FG000|Overall Study|Other reason (not specified)|2|||
17001164|NCT00877929|38145183|FG001|Overall Study|Other reason (not specified)|6|||
17001165|NCT00931268|38145193|FG000|Overall Study|Lost to Follow-up|6|||
17001166|NCT00996125|38145199|FG000|Overall Study|Adverse Event|0|||
17001167|NCT00996125|38145200|FG001|Overall Study|Adverse Event|2|||
17001168|NCT00996125|38145199|FG000|Overall Study|Lost to Follow-up|1|||
17001169|NCT00996125|38145200|FG001|Overall Study|Lost to Follow-up|6|||
17001170|NCT00996125|38145199|FG000|Overall Study|Withdrawal by Subject|4|||
17001171|NCT00996125|38145200|FG001|Overall Study|Withdrawal by Subject|3|||
17001172|NCT04211363|38145208|FG000|Overall Study|Adverse Event|5|||
17001173|NCT04211363|38145209|FG001|Overall Study|Adverse Event|2|||
16872127|NCT01464827|37847889|FG007|Overall Study|Not Treated|0|||
16872128|NCT01464827|37847890|FG008|Overall Study|Not Treated|0|||
16872129|NCT01464827|37847891|FG009|Overall Study|Not Treated|2|||
16872130|NCT01464827|37847892|FG010|Overall Study|Not Treated|0|||
16872131|NCT01464827|37847893|FG011|Overall Study|Not Treated|1|||
16872132|NCT01464827|37847894|FG012|Overall Study|Not Treated|0|||
17001174|NCT04211363|38145208|FG000|Overall Study|Physician Decision|0|||
17001175|NCT04211363|38145209|FG001|Overall Study|Physician Decision|1|||
17001176|NCT04211363|38145208|FG000|Overall Study|Protocol Violation|1|||
17001177|NCT04211363|38145209|FG001|Overall Study|Protocol Violation|0|||
17001178|NCT04211363|38145208|FG000|Overall Study|Pregnancy|1|||
17001179|NCT04211363|38145209|FG001|Overall Study|Pregnancy|0|||
16784812|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
16784813|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
16784814|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
16784815|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
16784816|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Death|3|||
16784817|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Death|1|||
16784818|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Death|1|||
16784819|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Discharged|2|||
16872133|NCT01464827|37847895|FG013|Overall Study|Not Treated|2|||
16872134|NCT01463111|37847936|FG000|Overall Study|Withdrawal by Subject|2|||
16872135|NCT01463111|37847936|FG000|Overall Study|Lost to Follow-up|5|||
16872136|NCT01463111|37847936|FG000|Overall Study|Physician Decision|2|||
17001180|NCT04211363|38145208|FG000|Overall Study|Lost to Follow-up|12|||
17001181|NCT04211363|38145209|FG001|Overall Study|Lost to Follow-up|4|||
17001182|NCT04211363|38145208|FG000|Overall Study|Withdrawal by Subject|11|||
16872137|NCT01463033|37847942|FG000|Overall Study|Lost to Follow-up|4|||
16872138|NCT01463033|37847943|FG001|Overall Study|Lost to Follow-up|4|||
16872139|NCT01463033|37847942|FG000|Overall Study|Death|3|||
16872140|NCT01463033|37847943|FG001|Overall Study|Death|2|||
16872141|NCT01461707|37847952|FG000|Overall Study|Withdrawal by Subject|1|||
16872142|NCT01461707|37847953|FG001|Overall Study|Withdrawal by Subject|0|||
16872143|NCT01461551|37847962|FG000|Overall Study|Physician Decision|2|||
16872144|NCT01461551|37847963|FG001|Overall Study|Physician Decision|1|||
16872145|NCT01461551|37847964|FG002|Overall Study|Physician Decision|2|||
16872146|NCT01461005|37847972|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
16872147|NCT01460381|37847979|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
16872148|NCT01460381|37847980|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
16872149|NCT01473589|37848064|FG000|Overall Study|Adverse Event|1|||
16872150|NCT01473589|37848065|FG001|Overall Study|Adverse Event|1|||
16872151|NCT01473589|37848064|FG000|Overall Study|Death|2|||
16872152|NCT01473589|37848065|FG001|Overall Study|Death|0|||
16872153|NCT01473589|37848064|FG000|Overall Study|Lost to Follow-up|2|||
16872154|NCT01473589|37848065|FG001|Overall Study|Lost to Follow-up|2|||
16872155|NCT01473589|37848064|FG000|Overall Study|Protocol Violation|1|||
16872156|NCT01473589|37848065|FG001|Overall Study|Protocol Violation|0|||
16872157|NCT01473589|37848064|FG000|Overall Study|Withdrawal by Subject|5|||
16872158|NCT01473589|37848065|FG001|Overall Study|Withdrawal by Subject|11|||
16872159|NCT01473589|37848064|FG000|Overall Study|Physician Decision|0|||
16872160|NCT01473589|37848065|FG001|Overall Study|Physician Decision|1|||
16872161|NCT01473589|37848064|FG000|Overall Study|Entry criteria not met|0|||
16872162|NCT01473589|37848065|FG001|Overall Study|Entry criteria not met|1|||
17001183|NCT04211363|38145209|FG001|Overall Study|Withdrawal by Subject|11|||
17001184|NCT04211363|38145208|FG000|Overall Study|Other|1|||
17001185|NCT04211363|38145209|FG001|Overall Study|Other|2|||
17001186|NCT00995345|38145220|FG000|Overall Study|Withdrawal by Subject|4|||
17001187|NCT00995345|38145221|FG001|Overall Study|Withdrawal by Subject|2|||
17001188|NCT00995345|38145222|FG002|Overall Study|Withdrawal by Subject|1|||
17001189|NCT00995345|38145223|FG003|Overall Study|Withdrawal by Subject|3|||
17001190|NCT00995345|38145224|FG004|Overall Study|Withdrawal by Subject|1|||
17001191|NCT00995345|38145220|FG000|Overall Study|Adverse Event|3|||
17001192|NCT00995345|38145221|FG001|Overall Study|Adverse Event|1|||
17001193|NCT00995345|38145222|FG002|Overall Study|Adverse Event|2|||
17001194|NCT00995345|38145223|FG003|Overall Study|Adverse Event|0|||
17001195|NCT00995345|38145224|FG004|Overall Study|Adverse Event|1|||
17001196|NCT00995345|38145220|FG000|Overall Study|Lost to Follow-up|2|||
17001197|NCT00995345|38145221|FG001|Overall Study|Lost to Follow-up|2|||
17001198|NCT00995345|38145222|FG002|Overall Study|Lost to Follow-up|2|||
17001199|NCT00995345|38145223|FG003|Overall Study|Lost to Follow-up|1|||
17001200|NCT00995345|38145224|FG004|Overall Study|Lost to Follow-up|0|||
17001201|NCT00995345|38145220|FG000|Overall Study|all other reasons combined|2|||
17001202|NCT00995345|38145221|FG001|Overall Study|all other reasons combined|2|||
17001203|NCT00995345|38145222|FG002|Overall Study|all other reasons combined|2|||
17001204|NCT00995345|38145223|FG003|Overall Study|all other reasons combined|1|||
17001205|NCT00995345|38145224|FG004|Overall Study|all other reasons combined|3|||
17001206|NCT00660907|38145238|FG000|Overall Study|Incorrect Enrollment|1|||
17001207|NCT00660907|38145239|FG001|Overall Study|Incorrect Enrollment|1|||
17001208|NCT00660907|38145238|FG000|Overall Study|Adverse Event|33|||
17001209|NCT00660907|38145239|FG001|Overall Study|Adverse Event|19|||
17001210|NCT00660907|38145238|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
17001211|NCT00660907|38145239|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
17001212|NCT00660907|38145238|FG000|Overall Study|Withdrawal by Subject|23|||
17001213|NCT00660907|38145239|FG001|Overall Study|Withdrawal by Subject|32|||
17001214|NCT00660907|38145238|FG000|Overall Study|Lost to Follow-up|3|||
17001215|NCT00660907|38145239|FG001|Overall Study|Lost to Follow-up|3|||
17001216|NCT00660907|38145238|FG000|Overall Study|Poor/Non-Compliance|5|||
17001217|NCT00660907|38145239|FG001|Overall Study|Poor/Non-Compliance|1|||
17001218|NCT00660907|38145238|FG000|Overall Study|Safety|1|||
17001219|NCT00660907|38145239|FG001|Overall Study|Safety|0|||
17001220|NCT00660907|38145238|FG000|Overall Study|Death|1|||
17001221|NCT00660907|38145239|FG001|Overall Study|Death|3|||
16872163|NCT01500187|37848084|FG000|Overall Study|Lost to Follow-up|6|||
16872164|NCT01500187|37848085|FG001|Overall Study|Lost to Follow-up|0|||
17001222|NCT00660907|38145238|FG000|Overall Study|Various|11|||
17001223|NCT00660907|38145239|FG001|Overall Study|Various|8|||
17191210|NCT02748863|38343968|FG001|Treatment Period 1|Withdrawal by Subject|1|||
17001224|NCT00877773|38145245|FG000|Overall Study|Disease Progression|44|||
17001225|NCT00659815|38145251|FG000|Overall Study|Study related symptoms and complaints|2|||
17001226|NCT00659815|38145252|FG001|Overall Study|Study related symptoms and complaints|1|||
16872165|NCT01500031|37848103|FG000|Overall Study|Death|1|||
16872166|NCT01500031|37848103|FG000|Overall Study|Withdrawal by Subject|4|||
17001227|NCT00659815|38145251|FG000|Overall Study|Inability to maintain wearing schedule|1|||
17001228|NCT00659815|38145252|FG001|Overall Study|Inability to maintain wearing schedule|2|||
17001229|NCT00659815|38145251|FG000|Overall Study|Withdrawal by Subject|1|||
17001230|NCT00659815|38145252|FG001|Overall Study|Withdrawal by Subject|1|||
17001231|NCT00994643|38145258|FG000|Overall Study|Withdrawal by Subject|1|||
17001232|NCT00660829|38145264|FG000|Overall Study|Adverse Event|3|||
17001233|NCT00660829|38145265|FG001|Overall Study|Adverse Event|4|||
17001234|NCT00660829|38145264|FG000|Overall Study|Lack of Efficacy|2|||
17001235|NCT00660829|38145265|FG001|Overall Study|Lack of Efficacy|3|||
17001236|NCT00660829|38145264|FG000|Overall Study|Non-Compliance|0|||
17001237|NCT00660829|38145265|FG001|Overall Study|Non-Compliance|4|||
17001238|NCT00660829|38145264|FG000|Overall Study|Withdrawal by Subject|1|||
17001239|NCT00660829|38145265|FG001|Overall Study|Withdrawal by Subject|2|||
17001240|NCT00660829|38145264|FG000|Overall Study|Lost to Follow-up|3|||
17001241|NCT00660829|38145265|FG001|Overall Study|Lost to Follow-up|2|||
17001242|NCT00660829|38145264|FG000|Overall Study|Other|9|||
17001243|NCT00660829|38145265|FG001|Overall Study|Other|4|||
17001244|NCT00877383|38145273|FG000|Overall Study|Adverse Event|13|||
17001245|NCT00877383|38145274|FG001|Overall Study|Adverse Event|14|||
17001246|NCT00877383|38145273|FG000|Overall Study|Lost to Follow-up|5|||
17001247|NCT00877383|38145274|FG001|Overall Study|Lost to Follow-up|3|||
17001248|NCT00877383|38145273|FG000|Overall Study|Subject withdrew consent|3|||
17001249|NCT00877383|38145274|FG001|Overall Study|Subject withdrew consent|12|||
17001250|NCT00877383|38145273|FG000|Overall Study|Subject no longer requires study drug|2|||
17001251|NCT00877383|38145274|FG001|Overall Study|Subject no longer requires study drug|0|||
17001252|NCT00877383|38145273|FG000|Overall Study|Administrative problems|2|||
17001253|NCT00877383|38145274|FG001|Overall Study|Administrative problems|0|||
17001254|NCT00877383|38145273|FG000|Overall Study|Protocol deviation|2|||
17191211|NCT02748863|38343969|FG002|Treatment Period 1|Withdrawal by Subject|1|||
17191212|NCT02748863|38343970|FG003|Treatment Period 1|Withdrawal by Subject|0|||
17191213|NCT02748863|38343971|FG004|Treatment Period 1|Withdrawal by Subject|0|||
17191214|NCT02748863|38343967|FG000|Treatment Period 2|Lost to Follow-up|2|||
17191215|NCT02748863|38343968|FG001|Treatment Period 2|Lost to Follow-up|0|||
17191216|NCT02748863|38343969|FG002|Treatment Period 2|Lost to Follow-up|0|||
17191217|NCT02748863|38343970|FG003|Treatment Period 2|Lost to Follow-up|0|||
17191218|NCT02748863|38343971|FG004|Treatment Period 2|Lost to Follow-up|0|||
17191219|NCT02748863|38343967|FG000|Treatment Period 2|Adverse Event|3|||
17191220|NCT02748863|38343968|FG001|Treatment Period 2|Adverse Event|2|||
17191221|NCT02748863|38343969|FG002|Treatment Period 2|Adverse Event|0|||
17191222|NCT02748863|38343970|FG003|Treatment Period 2|Adverse Event|2|||
17191223|NCT02748863|38343971|FG004|Treatment Period 2|Adverse Event|0|||
17191224|NCT02748863|38343967|FG000|Treatment Period 2|Lack of Efficacy|0|||
17191225|NCT02748863|38343968|FG001|Treatment Period 2|Lack of Efficacy|1|||
17191226|NCT02748863|38343969|FG002|Treatment Period 2|Lack of Efficacy|0|||
17191227|NCT02748863|38343970|FG003|Treatment Period 2|Lack of Efficacy|0|||
17191228|NCT02748863|38343971|FG004|Treatment Period 2|Lack of Efficacy|0|||
17191229|NCT02748863|38343967|FG000|Treatment Period 2|Pregnancy|0|||
17191230|NCT02748863|38343968|FG001|Treatment Period 2|Pregnancy|0|||
17191231|NCT02748863|38343969|FG002|Treatment Period 2|Pregnancy|0|||
17191232|NCT02748863|38343970|FG003|Treatment Period 2|Pregnancy|0|||
17191233|NCT02748863|38343971|FG004|Treatment Period 2|Pregnancy|1|||
17191234|NCT02865499|38343992|FG000|Baseline|Adverse Event|1|||
17191235|NCT02865499|38343992|FG000|Baseline|Withdrawal by Subject|1|||
17191236|NCT02870933|38343998|FG000|Overall Study|Death|2|||
17191237|NCT02870933|38343999|FG001|Overall Study|Death|1|||
17191238|NCT02870933|38343998|FG000|Overall Study|Withdrawal by Subject|0|||
17191239|NCT02870933|38343999|FG001|Overall Study|Withdrawal by Subject|1|||
17191240|NCT02864407|38344006|FG000|Overall Study|Protocol Violation|3|||
17191241|NCT02864407|38344006|FG000|Overall Study|Lost to Follow-up|115|||
17191242|NCT02864407|38344006|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
17191243|NCT02864407|38344006|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
17191244|NCT02864407|38344006|FG000|Overall Study|Consent prior to the contract date|1|||
17191245|NCT02873429|38344012|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
17191246|NCT02873429|38344013|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
16872167|NCT01473355|37848116|FG000|Overall Study|Protocol Violation|2|||
17001255|NCT00877383|38145274|FG001|Overall Study|Protocol deviation|6|||
17001256|NCT00877383|38145273|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17001257|NCT00877383|38145274|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17094954|NCT00022672|38234233|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
17094955|NCT00022672|38234234|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
17094956|NCT00022672|38234233|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
17094957|NCT00022672|38234234|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
17094958|NCT00022672|38234233|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
17094959|NCT00022672|38234234|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
17094960|NCT00022672|38234233|FG000|Main Phase: 24 Months|Refused Treatment|3|||
17094961|NCT00022672|38234234|FG001|Main Phase: 24 Months|Refused Treatment|4|||
17191247|NCT02873429|38344012|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
17191248|NCT02873429|38344013|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
17191249|NCT02873429|38344012|FG000|16 Weeks|Lost to Follow-up|3|||
17001258|NCT00877383|38145273|FG000|Overall Study|Death|1|||
17001259|NCT00877383|38145274|FG001|Overall Study|Death|2|||
17001260|NCT00993473|38145282|FG000|Overall Study|Adverse Event|0|||
17001261|NCT00993473|38145283|FG001|Overall Study|Adverse Event|2|||
17001262|NCT00993473|38145282|FG000|Overall Study|Protocol Violation|1|||
17001263|NCT00993473|38145283|FG001|Overall Study|Protocol Violation|2|||
17001264|NCT00993473|38145282|FG000|Overall Study|Lost to Follow-up|1|||
17001265|NCT00993473|38145283|FG001|Overall Study|Lost to Follow-up|0|||
17001266|NCT00993473|38145282|FG000|Overall Study|Withdrawal by Subject|1|||
17191250|NCT02873429|38344013|FG001|16 Weeks|Lost to Follow-up|0|||
17094962|NCT00022672|38234233|FG000|Main Phase: 24 Months|Failure to Return|1|||
17094963|NCT00022672|38234234|FG001|Main Phase: 24 Months|Failure to Return|1|||
17094964|NCT00022672|38234233|FG000|Main Phase: 24 Months|Other|1|||
17094965|NCT00022672|38234234|FG001|Main Phase: 24 Months|Other|0|||
17094966|NCT00022672|38234233|FG000|Extension Phase|Adverse Event|1|||
17094967|NCT00022672|38234234|FG001|Extension Phase|Adverse Event|3|||
17094968|NCT00022672|38234233|FG000|Extension Phase|Death|0|||
17094969|NCT00022672|38234234|FG001|Extension Phase|Death|1|||
17094970|NCT00022672|38234233|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
17094971|NCT00022672|38234234|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
17094972|NCT00022672|38234233|FG000|Extension Phase|Refused Treatment|0|||
17094973|NCT00022672|38234234|FG001|Extension Phase|Refused Treatment|2|||
17094974|NCT00022672|38234233|FG000|Extension Phase|Other|1|||
17094975|NCT00022672|38234234|FG001|Extension Phase|Other|1|||
17094976|NCT00076804|38234243|FG000|Overall Study|Death|9|||
17094977|NCT00076804|38234244|FG001|Overall Study|Death|20|||
17094978|NCT00076804|38234243|FG000|Overall Study|Lost to Follow-up|9|||
17094979|NCT00076804|38234244|FG001|Overall Study|Lost to Follow-up|9|||
17094980|NCT00076804|38234243|FG000|Overall Study|Withdrawal by Subject|10|||
17094981|NCT00076804|38234244|FG001|Overall Study|Withdrawal by Subject|8|||
17094982|NCT00076804|38234243|FG000|Overall Study|Early study Closure|32|||
17094983|NCT00076804|38234244|FG001|Overall Study|Early study Closure|32|||
17094984|NCT00141453|38234252|FG000|Overall Study|Protocol Violation|6|||
17094985|NCT00141453|38234253|FG001|Overall Study|Protocol Violation|5|||
17094986|NCT00076570|38234261|FG000|Overall Study|Drug intolerance|8|||
17094987|NCT00076570|38234262|FG001|Overall Study|Drug intolerance|8|||
17094988|NCT00124449|38234270|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
17094989|NCT00124449|38234271|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
17094990|NCT00124449|38234270|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
17191251|NCT02486302|38344019|FG000|Overall Study|Discontinued prematurely|410|||
17191252|NCT02486302|38344019|FG000|Overall Study|Documentation not completed|255|||
17191253|NCT02486302|38344019|FG000|Overall Study|Excluded due to legal reasons|8|||
17191254|NCT02486302|38344019|FG000|Overall Study|Not treated|3|||
17001267|NCT00993473|38145283|FG001|Overall Study|Withdrawal by Subject|5|||
17001268|NCT00993473|38145282|FG000|Overall Study|Technical problem with CGM device|0|||
17001269|NCT00993473|38145283|FG001|Overall Study|Technical problem with CGM device|1|||
17001270|NCT00993473|38145282|FG000|Overall Study|Family event|1|||
17001271|NCT00993473|38145283|FG001|Overall Study|Family event|0|||
17001272|NCT00660595|38145291|FG000|Overall Study|Lost to Follow-up|0|||
17001273|NCT00660595|38145292|FG001|Overall Study|Lost to Follow-up|1|||
17001274|NCT00660595|38145291|FG000|Overall Study|Did not consent to participate in study|12|||
17001275|NCT00660595|38145292|FG001|Overall Study|Did not consent to participate in study|8|||
17001276|NCT00660595|38145291|FG000|Overall Study|Participant left hospital|1|||
17001277|NCT00660595|38145292|FG001|Overall Study|Participant left hospital|0|||
17001278|NCT00660595|38145291|FG000|Overall Study|Non Specified reasons|5|||
17001279|NCT00660595|38145292|FG001|Overall Study|Non Specified reasons|0|||
17001280|NCT00929240|38145298|FG000|Initial Treatment Phase|Adverse Event|31|||
17001281|NCT00929240|38145299|FG001|Initial Treatment Phase|Adverse Event|0|||
17001282|NCT00929240|38145300|FG002|Initial Treatment Phase|Adverse Event|0|||
17001283|NCT00929240|38145298|FG000|Initial Treatment Phase|Disease progression|41|||
17001284|NCT00929240|38145299|FG001|Initial Treatment Phase|Disease progression|0|||
17001285|NCT00929240|38145300|FG002|Initial Treatment Phase|Disease progression|0|||
17001286|NCT00929240|38145298|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
17001287|NCT00929240|38145299|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
17001288|NCT00929240|38145300|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
17001289|NCT00929240|38145298|FG000|Initial Treatment Phase|Protocol Violation|5|||
17001290|NCT00929240|38145299|FG001|Initial Treatment Phase|Protocol Violation|0|||
17001291|NCT00929240|38145300|FG002|Initial Treatment Phase|Protocol Violation|0|||
17001292|NCT00929240|38145298|FG000|Initial Treatment Phase|Death|2|||
17001293|NCT00929240|38145299|FG001|Initial Treatment Phase|Death|0|||
17001294|NCT00929240|38145300|FG002|Initial Treatment Phase|Death|0|||
17001295|NCT00929240|38145298|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
17001296|NCT00929240|38145299|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
17001297|NCT00929240|38145300|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
17094991|NCT00124449|38234271|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
17094992|NCT00124449|38234270|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
17001298|NCT00929240|38145298|FG000|Initial Treatment Phase|Physician Decision|4|||
17001299|NCT00929240|38145299|FG001|Initial Treatment Phase|Physician Decision|0|||
17001300|NCT00929240|38145300|FG002|Initial Treatment Phase|Physician Decision|0|||
17001301|NCT00929240|38145298|FG000|Maintenance Phase|Disease progression|0|||
17001302|NCT00929240|38145299|FG001|Maintenance Phase|Disease progression|73|||
17001303|NCT00929240|38145300|FG002|Maintenance Phase|Disease progression|60|||
17001304|NCT00929240|38145298|FG000|Maintenance Phase|Adverse Event|0|||
17001305|NCT00929240|38145299|FG001|Maintenance Phase|Adverse Event|9|||
17001306|NCT00929240|38145300|FG002|Maintenance Phase|Adverse Event|12|||
17001307|NCT00929240|38145298|FG000|Maintenance Phase|Withdrawal by Subject|0|||
17001308|NCT00929240|38145299|FG001|Maintenance Phase|Withdrawal by Subject|2|||
17001309|NCT00929240|38145300|FG002|Maintenance Phase|Withdrawal by Subject|6|||
17001310|NCT00929240|38145298|FG000|Maintenance Phase|Protocol Violation|0|||
17001311|NCT00929240|38145299|FG001|Maintenance Phase|Protocol Violation|1|||
17094993|NCT00124449|38234271|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
17094994|NCT00124449|38234270|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
17094995|NCT00124449|38234271|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
17094996|NCT00124449|38234270|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
17094997|NCT00124449|38234271|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
17094998|NCT00124449|38234270|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
17001312|NCT00929240|38145300|FG002|Maintenance Phase|Protocol Violation|0|||
17001313|NCT00929240|38145298|FG000|Maintenance Phase|Health authority/Study termination|0|||
17001314|NCT00929240|38145299|FG001|Maintenance Phase|Health authority/Study termination|1|||
17001315|NCT00929240|38145300|FG002|Maintenance Phase|Health authority/Study termination|2|||
17001316|NCT00929240|38145298|FG000|Maintenance Phase|Physician Decision|0|||
17001317|NCT00929240|38145299|FG001|Maintenance Phase|Physician Decision|2|||
17001318|NCT00929240|38145300|FG002|Maintenance Phase|Physician Decision|1|||
17001319|NCT00929240|38145298|FG000|Maintenance Phase|Change of treatment|0|||
17001320|NCT00929240|38145299|FG001|Maintenance Phase|Change of treatment|4|||
17001321|NCT00929240|38145300|FG002|Maintenance Phase|Change of treatment|0|||
17001322|NCT00929240|38145298|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
17001323|NCT00929240|38145299|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
17001324|NCT00929240|38145300|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
17001325|NCT00929240|38145298|FG000|Maintenance Phase|Participant not treated|0|||
17001326|NCT00929240|38145299|FG001|Maintenance Phase|Participant not treated|2|||
17001327|NCT00929240|38145300|FG002|Maintenance Phase|Participant not treated|0|||
17001328|NCT00993317|38145311|FG000|Overall Study|Adverse Event|2|||
17001329|NCT00993317|38145312|FG001|Overall Study|Adverse Event|4|||
17001330|NCT00993317|38145311|FG000|Overall Study|Lack of Efficacy|18|||
17001331|NCT00993317|38145312|FG001|Overall Study|Lack of Efficacy|18|||
17001332|NCT00993317|38145311|FG000|Overall Study|Withdrawal by Subject|0|||
17001333|NCT00993317|38145312|FG001|Overall Study|Withdrawal by Subject|2|||
17001334|NCT00993317|38145311|FG000|Overall Study|Investigator's opinion|0|||
17001335|NCT00993317|38145312|FG001|Overall Study|Investigator's opinion|1|||
17001336|NCT00993317|38145311|FG000|Overall Study|Early study termination at the site|1|||
17001337|NCT00993317|38145312|FG001|Overall Study|Early study termination at the site|0|||
17001338|NCT01030133|38145320|FG000|Overall Study|failed to experience pain at level 7/10|2|||
17001339|NCT01030133|38145321|FG001|Overall Study|failed to experience pain at level 7/10|2|||
17001340|NCT00877071|38145331|FG000|Overall Study|disease progression|2|||
17001341|NCT00987389|38145337|FG000|Overall Study|Ineligible|0|||
17001342|NCT00987389|38145338|FG001|Overall Study|Ineligible|3|||
17001343|NCT00987389|38145339|FG002|Overall Study|Ineligible|0|||
17001344|NCT00987389|38145340|FG003|Overall Study|Ineligible|0|||
17001345|NCT00987389|38145337|FG000|Overall Study|Lost to Follow-up|4|||
17001346|NCT00987389|38145338|FG001|Overall Study|Lost to Follow-up|1|||
17001347|NCT00987389|38145339|FG002|Overall Study|Lost to Follow-up|3|||
17001348|NCT00987389|38145340|FG003|Overall Study|Lost to Follow-up|1|||
17001349|NCT00987389|38145337|FG000|Overall Study|Withdrawal by Subject|4|||
17094999|NCT00124449|38234271|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
17191255|NCT02747875|38344034|FG000|Overall Study|Physician Decision|1|||
17001350|NCT00987389|38145338|FG001|Overall Study|Withdrawal by Subject|3|||
17001351|NCT00987389|38145339|FG002|Overall Study|Withdrawal by Subject|2|||
17001352|NCT00987389|38145340|FG003|Overall Study|Withdrawal by Subject|1|||
17001353|NCT00987389|38145337|FG000|Overall Study|Withdrawn from Treatment|0|||
17001354|NCT00987389|38145338|FG001|Overall Study|Withdrawn from Treatment|1|||
17001355|NCT00987389|38145339|FG002|Overall Study|Withdrawn from Treatment|0|||
17001356|NCT00987389|38145340|FG003|Overall Study|Withdrawn from Treatment|0|||
17001357|NCT00987389|38145337|FG000|Overall Study|Multiple different reasons|1|||
17001358|NCT00987389|38145338|FG001|Overall Study|Multiple different reasons|0|||
17001359|NCT00987389|38145339|FG002|Overall Study|Multiple different reasons|3|||
17001360|NCT00987389|38145340|FG003|Overall Study|Multiple different reasons|1|||
17001361|NCT00929162|38145350|FG000|Overall Study|Adverse Event|8|||
17001362|NCT00929162|38145351|FG001|Overall Study|Adverse Event|5|||
17001363|NCT00929162|38145350|FG000|Overall Study|Withdrawal by Subject|3|||
17001364|NCT00929162|38145351|FG001|Overall Study|Withdrawal by Subject|1|||
17001365|NCT00929162|38145350|FG000|Overall Study|Protocol Violation|32|||
17001366|NCT00929162|38145351|FG001|Overall Study|Protocol Violation|30|||
17001367|NCT00929162|38145350|FG000|Overall Study|Other termination reason|5|||
17001368|NCT00929162|38145351|FG001|Overall Study|Other termination reason|6|||
17001369|NCT00992459|38145359|FG000|Overall Study|Withdrawal by Subject|0|||
17001370|NCT00992459|38145360|FG001|Overall Study|Withdrawal by Subject|1|||
17001371|NCT00992459|38145359|FG000|Overall Study|Adverse Event|1|||
17001372|NCT00992459|38145360|FG001|Overall Study|Adverse Event|0|||
17001373|NCT00930722|38145366|FG000|Overall Study|Lost to Follow-up|16|||
17001374|NCT00930722|38145366|FG000|Overall Study|No longer willing to participate|9|||
17001375|NCT00930722|38145366|FG000|Overall Study|Study terminated by sponsor|2|||
17001376|NCT00992225|38145370|FG000|Overall Study|Entry Criteria Not Met|8|||
17001377|NCT00992225|38145370|FG000|Overall Study|Adverse Event|2|||
17001378|NCT00659581|38145374|FG000|Overall Study|Adverse Event|1006|||
17095000|NCT00124449|38234270|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
17191256|NCT02747875|38344035|FG001|Overall Study|Physician Decision|0|||
17191257|NCT02747875|38344034|FG000|Overall Study|Adverse Event|0|||
17191258|NCT02747875|38344035|FG001|Overall Study|Adverse Event|1|||
17191259|NCT02451124|38344041|FG000|Overall Study|Withdrawal by Subject|1|||
17191260|NCT02636725|38344049|FG000|Baseline|Adverse Event|1|||
17191261|NCT02636725|38344049|FG000|Baseline|Lack of Efficacy|2|||
17191262|NCT02450578|38344057|FG000|Overall Study|ECG abnormality so not treated|1|||
17191263|NCT02450578|38344058|FG001|Overall Study|ECG abnormality so not treated|0|||
17191264|NCT02450578|38344059|FG002|Overall Study|ECG abnormality so not treated|0|||
17191265|NCT02450578|38344060|FG003|Overall Study|ECG abnormality so not treated|0|||
17191266|NCT02449018|38344087|FG000|Overall Study|Abnormal laboratory value|0|||
17191267|NCT02449018|38344088|FG001|Overall Study|Abnormal laboratory value|1|||
17191268|NCT02449018|38344087|FG000|Overall Study|Administrative problems|1|||
17191269|NCT02449018|38344088|FG001|Overall Study|Administrative problems|0|||
17191270|NCT02449018|38344087|FG000|Overall Study|Adverse Event|5|||
17191271|NCT02449018|38344088|FG001|Overall Study|Adverse Event|1|||
17191272|NCT02449018|38344087|FG000|Overall Study|Protocol deviation|4|||
17191273|NCT02449018|38344088|FG001|Overall Study|Protocol deviation|0|||
17191274|NCT02449018|38344087|FG000|Overall Study|Patient decision|2|||
17191275|NCT02449018|38344088|FG001|Overall Study|Patient decision|0|||
17191276|NCT02859415|38344096|FG000|Overall Study|Physician Decision|1|||
17191277|NCT02859415|38344097|FG001|Overall Study|Physician Decision|0|||
17191278|NCT02859415|38344096|FG000|Overall Study|Off treatment due to cardiac event|0|||
17191279|NCT02859415|38344097|FG001|Overall Study|Off treatment due to cardiac event|1|||
17191280|NCT02871791|38344107|FG000|Phase 1b|Death|0|||
17191281|NCT02871791|38344108|FG001|Phase 1b|Death|1|||
17191282|NCT02871791|38344107|FG000|Phase 1b|progressive disease|6|||
17191283|NCT02871791|38344108|FG001|Phase 1b|progressive disease|2|||
17191284|NCT02871791|38344107|FG000|Phase 2|Death|1|||
17191285|NCT02871791|38344108|FG001|Phase 2|Death|0|||
17191286|NCT02871791|38344107|FG000|Phase 2|Lost to Follow-up|2|||
17191287|NCT02871791|38344108|FG001|Phase 2|Lost to Follow-up|0|||
17191288|NCT02871635|38344116|FG000|Overall Study|Primary lack of efficacy|4|||
17191289|NCT02871635|38344117|FG001|Overall Study|Primary lack of efficacy|4|||
17191290|NCT02871635|38344116|FG000|Overall Study|Protocol Violation|3|||
17191291|NCT02871635|38344117|FG001|Overall Study|Protocol Violation|1|||
17191292|NCT02871635|38344116|FG000|Overall Study|Lost to Follow-up|1|||
17191293|NCT02871635|38344117|FG001|Overall Study|Lost to Follow-up|2|||
17191294|NCT02871635|38344116|FG000|Overall Study|Pregnancy|0|||
17191295|NCT02871635|38344117|FG001|Overall Study|Pregnancy|2|||
17191296|NCT02871635|38344116|FG000|Overall Study|Physician Decision|1|||
17191297|NCT02871635|38344117|FG001|Overall Study|Physician Decision|1|||
17191298|NCT02871635|38344116|FG000|Overall Study|Withdrawal by Subject|3|||
17191299|NCT02871635|38344117|FG001|Overall Study|Withdrawal by Subject|4|||
17191300|NCT02871635|38344116|FG000|Overall Study|Adverse Event|4|||
17191301|NCT02871635|38344117|FG001|Overall Study|Adverse Event|4|||
17191302|NCT02871635|38344116|FG000|Overall Study|Secondary lack of efficacy|2|||
17191303|NCT02871635|38344117|FG001|Overall Study|Secondary lack of efficacy|1|||
17191304|NCT02477332|38344131|FG000|Overall Study|Adverse Event|0|||
17191305|NCT02477332|38344132|FG001|Overall Study|Adverse Event|1|||
17191306|NCT02477332|38344133|FG002|Overall Study|Adverse Event|1|||
17191307|NCT02477332|38344134|FG003|Overall Study|Adverse Event|2|||
17191308|NCT02477332|38344135|FG004|Overall Study|Adverse Event|1|||
16784820|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Discharged|1|||
17001379|NCT00659581|38145374|FG000|Overall Study|Lack of Efficacy|1183|||
17095001|NCT00124449|38234271|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
17095002|NCT00124449|38234270|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
17095003|NCT00124449|38234271|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
17095004|NCT00124449|38234270|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
17095005|NCT00124449|38234271|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
17191309|NCT02477332|38344136|FG005|Overall Study|Adverse Event|2|||
17191310|NCT02477332|38344131|FG000|Overall Study|Lack of Efficacy|1|||
17001380|NCT00659581|38145374|FG000|Overall Study|Other|6393|||
17001381|NCT00991289|38145378|FG000|Overall Study|Adverse Event|1|||
17001382|NCT00991289|38145378|FG000|Overall Study|Physician Decision|2|||
17001383|NCT00991289|38145378|FG000|Overall Study|Withdrawal by Subject|3|||
17001384|NCT00991289|38145378|FG000|Overall Study|Lost to Follow-up|4|||
17001385|NCT00991289|38145378|FG000|Overall Study|Protocol Violation|2|||
17001386|NCT00930644|38145382|FG000|Overall Study|Withdrawal by Subject|4|||
17001387|NCT00930644|38145382|FG000|Overall Study|Physician Decision|2|||
17001388|NCT00930644|38145382|FG000|Overall Study|Death|1|||
17001389|NCT00930644|38145382|FG000|Overall Study|Adverse Event|16|||
17001390|NCT00990821|38145403|FG000|Overall Study|Withdrawal by Subject|0|||
17001391|NCT00990821|38145404|FG001|Overall Study|Withdrawal by Subject|2|||
17095006|NCT00124449|38234270|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
17095007|NCT00124449|38234271|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
17095008|NCT00124449|38234270|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
17095009|NCT00124449|38234271|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
17095010|NCT00124449|38234270|FG000|18-Month Untreated Observation Period|Relocated|1|||
17095011|NCT00124449|38234271|FG001|18-Month Untreated Observation Period|Relocated|0|||
17095012|NCT00076336|38234280|FG000|Overall Study|Death|13|||
17095013|NCT00076336|38234281|FG001|Overall Study|Death|17|||
17095014|NCT00076336|38234280|FG000|Overall Study|Adverse Event|4|||
17095015|NCT00076336|38234281|FG001|Overall Study|Adverse Event|4|||
17001392|NCT00990821|38145405|FG002|Overall Study|Withdrawal by Subject|0|||
17001393|NCT00990821|38145406|FG003|Overall Study|Withdrawal by Subject|0|||
17001394|NCT00990821|38145407|FG004|Overall Study|Withdrawal by Subject|3|||
17001395|NCT00990821|38145408|FG005|Overall Study|Withdrawal by Subject|3|||
17001396|NCT00990821|38145409|FG006|Overall Study|Withdrawal by Subject|1|||
17001397|NCT00990821|38145410|FG007|Overall Study|Withdrawal by Subject|0|||
17001398|NCT00990821|38145411|FG008|Overall Study|Withdrawal by Subject|0|||
17001399|NCT00990821|38145412|FG009|Overall Study|Withdrawal by Subject|1|||
17001400|NCT00990821|38145413|FG010|Overall Study|Withdrawal by Subject|3|||
17001401|NCT00990821|38145414|FG011|Overall Study|Withdrawal by Subject|5|||
17001402|NCT00990821|38145415|FG012|Overall Study|Withdrawal by Subject|2|||
17001403|NCT00990821|38145416|FG013|Overall Study|Withdrawal by Subject|1|||
17001404|NCT00990665|38145433|FG000|Overall Study|Unsuccessful Implant|8|||
17001405|NCT00990665|38145433|FG000|Overall Study|Death|29|||
17001406|NCT00990665|38145433|FG000|Overall Study|Heart Transplant|1|||
17001407|NCT00990665|38145433|FG000|Overall Study|Withdrawal by Subject|6|||
17001408|NCT00990665|38145433|FG000|Overall Study|Lost to Follow-up|1|||
17001409|NCT00990665|38145433|FG000|Overall Study|System Explant|3|||
17001410|NCT00658567|38145442|FG000|Overall Study|Adverse Event|5|||
17001411|NCT00658567|38145443|FG001|Overall Study|Adverse Event|2|||
17001412|NCT00658567|38145444|FG002|Overall Study|Adverse Event|3|||
17001413|NCT00658567|38145442|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
17001414|NCT00658567|38145443|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
17001415|NCT00658567|38145444|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
17001416|NCT00658567|38145442|FG000|Overall Study|Physician Decision|0|||
17001417|NCT00658567|38145443|FG001|Overall Study|Physician Decision|1|||
17001418|NCT00658567|38145444|FG002|Overall Study|Physician Decision|0|||
17001419|NCT00658567|38145442|FG000|Overall Study|At Discretion of Sponsor|1|||
17001420|NCT00658567|38145443|FG001|Overall Study|At Discretion of Sponsor|1|||
17001421|NCT00658567|38145444|FG002|Overall Study|At Discretion of Sponsor|1|||
17001422|NCT00875433|38145452|FG000|Overall Study|Progressive disease|41|||
17001423|NCT00875433|38145452|FG000|Overall Study|Other Adverse Event|14|||
17001424|NCT00875433|38145452|FG000|Overall Study|Withdrawal by Subject|2|||
17001425|NCT00875433|38145452|FG000|Overall Study|Other|3|||
17001426|NCT00985985|38145460|FG000|Overall Study|Adverse Event|4|||
17001427|NCT00985985|38145461|FG001|Overall Study|Adverse Event|2|||
17001428|NCT00985985|38145462|FG002|Overall Study|Adverse Event|2|||
17001429|NCT00985985|38145463|FG003|Overall Study|Adverse Event|2|||
17001430|NCT00985985|38145460|FG000|Overall Study|Lost to Follow-up|4|||
17001431|NCT00985985|38145461|FG001|Overall Study|Lost to Follow-up|11|||
17001432|NCT00985985|38145462|FG002|Overall Study|Lost to Follow-up|2|||
17001433|NCT00985985|38145463|FG003|Overall Study|Lost to Follow-up|3|||
17001434|NCT00985985|38145460|FG000|Overall Study|Protocol Violation|1|||
17001435|NCT00985985|38145461|FG001|Overall Study|Protocol Violation|2|||
17001436|NCT00985985|38145462|FG002|Overall Study|Protocol Violation|0|||
17095016|NCT00076336|38234280|FG000|Overall Study|Lost to Follow-up|4|||
17095017|NCT00076336|38234281|FG001|Overall Study|Lost to Follow-up|4|||
17095018|NCT00076336|38234280|FG000|Overall Study|Non-Compliance|2|||
17001437|NCT00985985|38145463|FG003|Overall Study|Protocol Violation|1|||
17001438|NCT00985985|38145460|FG000|Overall Study|Lack of Efficacy|5|||
17001439|NCT00985985|38145461|FG001|Overall Study|Lack of Efficacy|6|||
17001440|NCT00985985|38145462|FG002|Overall Study|Lack of Efficacy|1|||
17001441|NCT00985985|38145463|FG003|Overall Study|Lack of Efficacy|3|||
17001442|NCT00985985|38145460|FG000|Overall Study|Withdrawal by Subject|4|||
17001443|NCT00985985|38145461|FG001|Overall Study|Withdrawal by Subject|2|||
17095019|NCT00076336|38234281|FG001|Overall Study|Non-Compliance|0|||
17001444|NCT00985985|38145462|FG002|Overall Study|Withdrawal by Subject|2|||
17001445|NCT00985985|38145463|FG003|Overall Study|Withdrawal by Subject|2|||
17001446|NCT00985985|38145460|FG000|Overall Study|Other Reason|6|||
17001447|NCT00985985|38145461|FG001|Overall Study|Other Reason|1|||
17001448|NCT00985985|38145462|FG002|Overall Study|Other Reason|4|||
17001449|NCT00985985|38145463|FG003|Overall Study|Other Reason|2|||
17001450|NCT00923936|38145480|FG000|Overall Study|progressive disease on study|2|||
17001451|NCT00923936|38145481|FG001|Overall Study|progressive disease on study|1|||
17001452|NCT00923936|38145480|FG000|Overall Study|Adverse Event|2|||
17001453|NCT00923936|38145481|FG001|Overall Study|Adverse Event|1|||
17001454|NCT00923936|38145480|FG000|Overall Study|Lost to follow up|2|||
17001455|NCT00923936|38145481|FG001|Overall Study|Lost to follow up|0|||
17001456|NCT00923936|38145480|FG000|Overall Study|Continuing in follow up period|2|||
17001457|NCT00923936|38145481|FG001|Overall Study|Continuing in follow up period|1|||
17001458|NCT00924950|38145489|FG000|Overall Study|Lost to Follow-up|2|||
17001459|NCT00988637|38145498|FG000|Overall Study|Lost to Follow-up|2|||
17001460|NCT00988637|38145499|FG001|Overall Study|Lost to Follow-up|1|||
17001461|NCT00988637|38145498|FG000|Overall Study|Withdrawal by Subject|1|||
17001462|NCT00988637|38145499|FG001|Overall Study|Withdrawal by Subject|1|||
17001463|NCT00988637|38145498|FG000|Overall Study|non-compliance with study drug|0|||
17001464|NCT00988637|38145499|FG001|Overall Study|non-compliance with study drug|1|||
17095020|NCT00076336|38234280|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
17095021|NCT00076336|38234281|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
17095022|NCT00076336|38234280|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
17095023|NCT00076336|38234281|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
17095024|NCT00076336|38234280|FG000|Overall Study|Liver Transplantation|3|||
17095025|NCT00076336|38234281|FG001|Overall Study|Liver Transplantation|3|||
17095026|NCT00076336|38234280|FG000|Overall Study|Virologic Breakthrough|14|||
17095027|NCT00076336|38234281|FG001|Overall Study|Virologic Breakthrough|16|||
17095028|NCT00076336|38234280|FG000|Overall Study|Treatment failure|4|||
17095029|NCT00076336|38234281|FG001|Overall Study|Treatment failure|5|||
17095030|NCT00185588|38234291|FG000|Overall Study|Adverse Event|3|||
17095031|NCT00185588|38234292|FG001|Overall Study|Adverse Event|1|||
17095032|NCT00185588|38234293|FG002|Overall Study|Adverse Event|4|||
17095033|NCT00185588|38234294|FG003|Overall Study|Adverse Event|2|||
17095034|NCT00185588|38234291|FG000|Overall Study|Lost to Follow-up|0|||
17095035|NCT00185588|38234292|FG001|Overall Study|Lost to Follow-up|0|||
17095036|NCT00185588|38234293|FG002|Overall Study|Lost to Follow-up|1|||
17095037|NCT00185588|38234294|FG003|Overall Study|Lost to Follow-up|2|||
17095038|NCT00185588|38234291|FG000|Overall Study|Withdrawal by Subject|0|||
17095039|NCT00185588|38234292|FG001|Overall Study|Withdrawal by Subject|1|||
17095040|NCT00185588|38234293|FG002|Overall Study|Withdrawal by Subject|0|||
17095041|NCT00185588|38234294|FG003|Overall Study|Withdrawal by Subject|0|||
17095042|NCT00185588|38234291|FG000|Overall Study|Physician Decision|0|||
17095043|NCT00185588|38234292|FG001|Overall Study|Physician Decision|0|||
17095044|NCT00185588|38234293|FG002|Overall Study|Physician Decision|1|||
17095045|NCT00185588|38234294|FG003|Overall Study|Physician Decision|0|||
17095046|NCT00232544|38234306|FG000|Overall Study|Lost to Follow-up|20|||
17095047|NCT00232544|38234307|FG001|Overall Study|Lost to Follow-up|15|||
17095048|NCT00231842|38234313|FG000|Overall Study|Withdrawal by Subject|3|||
17001465|NCT00923702|38145510|FG000|Overall Study|Ongoing enrollment|0|||
17001466|NCT00923702|38145511|FG001|Overall Study|Ongoing enrollment|0|||
17001467|NCT00923702|38145512|FG002|Overall Study|Ongoing enrollment|0|||
17001468|NCT00923702|38145513|FG003|Overall Study|Ongoing enrollment|0|||
17001469|NCT00923702|38145514|FG004|Overall Study|Ongoing enrollment|354|||
17001470|NCT00923156|38145529|FG000|Overall Study|Adverse Event|0|||
17001471|NCT00923156|38145530|FG001|Overall Study|Adverse Event|2|||
17001472|NCT00923156|38145531|FG002|Overall Study|Adverse Event|1|||
17001473|NCT00923156|38145529|FG000|Overall Study|Abnormal laboratory values|0|||
17001474|NCT00923156|38145530|FG001|Overall Study|Abnormal laboratory values|0|||
17001475|NCT00923156|38145531|FG002|Overall Study|Abnormal laboratory values|1|||
17001476|NCT00923156|38145529|FG000|Overall Study|Withdrawal by Subject|0|||
17001477|NCT00923156|38145530|FG001|Overall Study|Withdrawal by Subject|1|||
17001478|NCT00923156|38145531|FG002|Overall Study|Withdrawal by Subject|0|||
17001479|NCT00923156|38145529|FG000|Overall Study|Death|0|||
17001480|NCT00923156|38145530|FG001|Overall Study|Death|1|||
17001481|NCT00923156|38145531|FG002|Overall Study|Death|0|||
17001482|NCT00923156|38145529|FG000|Overall Study|Lack of Efficacy|0|||
17001483|NCT00923156|38145530|FG001|Overall Study|Lack of Efficacy|0|||
17001484|NCT00923156|38145531|FG002|Overall Study|Lack of Efficacy|1|||
17001485|NCT00874731|38145539|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
17001486|NCT00874731|38145540|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
17001487|NCT00874731|38145541|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
17001488|NCT00874731|38145539|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
17001489|NCT00874731|38145540|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
17001490|NCT00874731|38145541|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
17001491|NCT00874731|38145539|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
17095049|NCT00231842|38234313|FG000|Overall Study|Did not complete the last 3 cycle|8|||
17095050|NCT00076102|38234318|FG000|Overall Study|Clinical progression|1|||
17095051|NCT00076102|38234318|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
17095052|NCT00076102|38234318|FG000|Overall Study|plexiform neurofibroma surgery|1|||
17095053|NCT00076102|38234318|FG000|Overall Study|refusal of further therapy|2|||
17001492|NCT00874731|38145540|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
17001493|NCT00874731|38145541|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
17001494|NCT00924638|38145551|FG000|Overall Study|Death|3|||
17001495|NCT00924638|38145552|FG001|Overall Study|Death|2|||
17001496|NCT00924638|38145551|FG000|Overall Study|Lost to Follow-up|1|||
17001497|NCT00924638|38145552|FG001|Overall Study|Lost to Follow-up|1|||
17001498|NCT00924638|38145551|FG000|Overall Study|Withdrawal by Subject|5|||
17001499|NCT00924638|38145552|FG001|Overall Study|Withdrawal by Subject|7|||
17001500|NCT00924638|38145551|FG000|Overall Study|Physician Decision|3|||
17001501|NCT00924638|38145552|FG001|Overall Study|Physician Decision|3|||
17001502|NCT00874497|38145560|FG000|Overall Study|Lost to Follow-up|2|||
17001503|NCT00874497|38145561|FG001|Overall Study|Lost to Follow-up|4|||
17001504|NCT00874497|38145560|FG000|Overall Study|Adverse Event|9|||
17001505|NCT00874497|38145561|FG001|Overall Study|Adverse Event|4|||
17001506|NCT00874497|38145560|FG000|Overall Study|Sponsor Discontinued Trial|7|||
17095054|NCT00231062|38234332|FG000|Overall Study|Physician Decision|6|||
17095055|NCT00184028|38234336|FG000|Overall Study|Death|1|||
17095056|NCT00184028|38234336|FG000|Overall Study|Lack of Efficacy|4|||
17095057|NCT00184028|38234336|FG000|Overall Study|Adverse Event|2|||
17095058|NCT00184028|38234336|FG000|Overall Study|Withdrawal by Subject|1|||
17095059|NCT00184028|38234336|FG000|Overall Study|Non-compliance|2|||
17095060|NCT00183872|38234341|FG000|Overall Study|Death|3|||
17095061|NCT00183872|38234341|FG000|Overall Study|Adverse Event|9|||
17095062|NCT00183872|38234341|FG000|Overall Study|Withdrawal by Subject|2|||
17095063|NCT00183872|38234341|FG000|Overall Study|Drug delayed more than 28 days|2|||
17095064|NCT03815175|38234345|FG000|Overall Study|Subject Lost to Follow-up|6|||
16872168|NCT01473355|37848116|FG000|Overall Study|Adverse Event|2|||
16872169|NCT01473355|37848116|FG000|Overall Study|Lost to Follow-up|2|||
16872170|NCT01472965|37848126|FG000|Overall Study|Withdrawal by Subject|1|||
16872171|NCT01472965|37848127|FG001|Overall Study|Withdrawal by Subject|0|||
16872172|NCT01457053|37848137|FG000|Overall Study|Unable to undergo selected treatment|1|||
16872173|NCT01457053|37848138|FG001|Overall Study|Unable to undergo selected treatment|1|||
16872174|NCT01472341|37848153|FG000|Overall Study|Started insulin therapy|55|||
16872175|NCT01472341|37848153|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
16872176|NCT01472341|37848153|FG000|Overall Study|Withdrawal by Subject|39|||
16872177|NCT01472341|37848153|FG000|Overall Study|Lost to Follow-up|52|||
16872178|NCT01472341|37848153|FG000|Overall Study|Laboratory parameters unavailable|25|||
16872179|NCT01472341|37848153|FG000|Overall Study|Death|9|||
16872180|NCT01472185|37848159|FG000|Overall Study|Randomized but Not Treated|0|||
16872181|NCT01472185|37848160|FG001|Overall Study|Randomized but Not Treated|1|||
16872182|NCT01472185|37848159|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
16872183|NCT01472185|37848160|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
16872184|NCT01472185|37848159|FG000|Overall Study|Hyperglycemia|5|||
16872185|NCT01472185|37848160|FG001|Overall Study|Hyperglycemia|2|||
16872186|NCT01472185|37848159|FG000|Overall Study|Investigator's Discretion|3|||
16872187|NCT01472185|37848160|FG001|Overall Study|Investigator's Discretion|1|||
16872188|NCT01472185|37848159|FG000|Overall Study|Lost to Follow-up|4|||
16872189|NCT01472185|37848160|FG001|Overall Study|Lost to Follow-up|1|||
16872190|NCT01472185|37848159|FG000|Overall Study|Protocol Violation|5|||
16872191|NCT01472185|37848160|FG001|Overall Study|Protocol Violation|1|||
16872192|NCT01472185|37848159|FG000|Overall Study|Subject Noncompliance|8|||
16872193|NCT01472185|37848160|FG001|Overall Study|Subject Noncompliance|15|||
16872194|NCT01472185|37848159|FG000|Overall Study|Subject Withdrew Consent|6|||
16872195|NCT01472185|37848160|FG001|Overall Study|Subject Withdrew Consent|3|||
16872196|NCT01456897|37848181|FG000|Overall Study|Adverse Event|19|||
16872197|NCT01456897|37848182|FG001|Overall Study|Adverse Event|22|||
16872198|NCT01456897|37848181|FG000|Overall Study|Protocol Violation|3|||
16872199|NCT01456897|37848182|FG001|Overall Study|Protocol Violation|4|||
16872200|NCT01456897|37848181|FG000|Overall Study|Physician Decision|5|||
16872201|NCT01456897|37848182|FG001|Overall Study|Physician Decision|3|||
16872202|NCT01456897|37848181|FG000|Overall Study|Withdrawal by Subject|44|||
16872203|NCT01456897|37848182|FG001|Overall Study|Withdrawal by Subject|17|||
16872204|NCT01456897|37848181|FG000|Overall Study|Lack of Efficacy|4|||
16872205|NCT01456897|37848182|FG001|Overall Study|Lack of Efficacy|11|||
17095065|NCT03815175|38234345|FG000|Overall Study|Subject Withdrew Consent|48|||
16872206|NCT01456195|37848195|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16872207|NCT01456195|37848196|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
16872208|NCT01456195|37848197|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
16872209|NCT01456195|37848195|FG000|Overall Study|Lost to Follow-up|3|||
17001507|NCT00874497|38145561|FG001|Overall Study|Sponsor Discontinued Trial|3|||
17001508|NCT00874497|38145560|FG000|Overall Study|Met Withdrawal Criteria|4|||
17001509|NCT00874497|38145561|FG001|Overall Study|Met Withdrawal Criteria|2|||
16872210|NCT01456195|37848196|FG001|Overall Study|Lost to Follow-up|1|||
16872211|NCT01456195|37848197|FG002|Overall Study|Lost to Follow-up|3|||
16872212|NCT01456195|37848195|FG000|Overall Study|Voluntary Withdrawal|5|||
16872213|NCT01456195|37848196|FG001|Overall Study|Voluntary Withdrawal|3|||
16872214|NCT01456195|37848197|FG002|Overall Study|Voluntary Withdrawal|7|||
16872215|NCT01456195|37848195|FG000|Overall Study|Lack of Efficacy|0|||
16872216|NCT01456195|37848196|FG001|Overall Study|Lack of Efficacy|1|||
16872217|NCT01456195|37848197|FG002|Overall Study|Lack of Efficacy|0|||
16872218|NCT01456195|37848195|FG000|Overall Study|Other Reasons|2|||
16872219|NCT01456195|37848196|FG001|Overall Study|Other Reasons|1|||
16872220|NCT01456195|37848197|FG002|Overall Study|Other Reasons|3|||
16872221|NCT01456039|37848265|FG000|Phase 1 (First Step)|Disease Progression|1|||
16872222|NCT01456039|37848266|FG001|Phase 1 (First Step)|Disease Progression|1|||
16872223|NCT01456039|37848267|FG002|Phase 1 (First Step)|Disease Progression|0|||
16872224|NCT01456039|37848265|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
16872225|NCT01456039|37848266|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
16872226|NCT01456039|37848267|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
16872227|NCT01456039|37848265|FG000|Phase 1 (First Step)|Adverse Event|0|||
16784821|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Discharged|0|||
16784822|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
16784823|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
16872228|NCT01456039|37848266|FG001|Phase 1 (First Step)|Adverse Event|3|||
16872229|NCT01456039|37848267|FG002|Phase 1 (First Step)|Adverse Event|0|||
16872230|NCT01456039|37848265|FG000|Phase 1 (First Step)|Other|0|||
16872231|NCT01456039|37848266|FG001|Phase 1 (First Step)|Other|1|||
16872232|NCT01456039|37848267|FG002|Phase 1 (First Step)|Other|0|||
16872233|NCT01456039|37848265|FG000|Phase 2 (Second Step)|Disease Progression|0|||
16872234|NCT01456039|37848266|FG001|Phase 2 (Second Step)|Disease Progression|0|||
16872235|NCT01456039|37848267|FG002|Phase 2 (Second Step)|Disease Progression|17|||
16872236|NCT01456039|37848265|FG000|Phase 2 (Second Step)|Adverse Event|0|||
16872237|NCT01456039|37848266|FG001|Phase 2 (Second Step)|Adverse Event|0|||
16872238|NCT01456039|37848267|FG002|Phase 2 (Second Step)|Adverse Event|10|||
16872239|NCT01456039|37848265|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
16872240|NCT01456039|37848266|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
16872241|NCT01456039|37848267|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
16872242|NCT01456039|37848265|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
16872243|NCT01456039|37848266|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
16872244|NCT01456039|37848267|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
16872245|NCT01456039|37848265|FG000|Phase 2 (Second Step)|Other|0|||
16872246|NCT01456039|37848266|FG001|Phase 2 (Second Step)|Other|0|||
16872247|NCT01456039|37848267|FG002|Phase 2 (Second Step)|Other|1|||
16872248|NCT01455415|37848285|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
16872249|NCT01455415|37848286|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
16872250|NCT01455415|37848285|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
16872251|NCT01455415|37848286|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
16872252|NCT01455415|37848285|FG000|Period 1|Drug Error not Associated to AE|0|||
16872253|NCT01455415|37848286|FG001|Period 1|Drug Error not Associated to AE|1|||
16872254|NCT01455415|37848285|FG000|Period 1|AE Not Related to Study Drug|2|||
16872255|NCT01455415|37848286|FG001|Period 1|AE Not Related to Study Drug|6|||
16872256|NCT01455415|37848285|FG000|Period 1|Withdrawal by Subject|4|||
16872257|NCT01455415|37848286|FG001|Period 1|Withdrawal by Subject|5|||
16872258|NCT01455415|37848285|FG000|Period 1|Unspecified Reason|1|||
16872259|NCT01455415|37848286|FG001|Period 1|Unspecified Reason|1|||
16872260|NCT01455415|37848285|FG000|Period 1|Protocol Violation|0|||
16872261|NCT01455415|37848286|FG001|Period 1|Protocol Violation|2|||
16872262|NCT01455415|37848285|FG000|Washout|AE Related to Study Drug|2|||
16872263|NCT01455415|37848286|FG001|Washout|AE Related to Study Drug|0|||
16784824|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
16784825|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
16784826|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
16784827|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
16784828|NCT01990768|37724833|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
16784829|NCT01990768|37724834|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
16784830|NCT01990768|37724835|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
16784831|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
16872264|NCT01455415|37848285|FG000|Washout|Lost to Follow-up|1|||
16872265|NCT01455415|37848286|FG001|Washout|Lost to Follow-up|0|||
16872266|NCT01455415|37848285|FG000|Washout|Drug Error not Associated to AE|2|||
16872267|NCT01455415|37848286|FG001|Washout|Drug Error not Associated to AE|1|||
16872268|NCT01455415|37848285|FG000|Washout|AE Not Related to Study Drug|2|||
16872269|NCT01455415|37848286|FG001|Washout|AE Not Related to Study Drug|3|||
16872270|NCT01455415|37848285|FG000|Washout|Unspecified Reason|1|||
16872271|NCT01455415|37848286|FG001|Washout|Unspecified Reason|2|||
16872272|NCT01455415|37848285|FG000|Washout|Protocol Violation|0|||
16872273|NCT01455415|37848286|FG001|Washout|Protocol Violation|1|||
16872274|NCT01455415|37848285|FG000|Period 2|AE Related to Study Drug|1|||
16872275|NCT01455415|37848286|FG001|Period 2|AE Related to Study Drug|2|||
16872276|NCT01455415|37848285|FG000|Period 2|Lost to Follow-up|2|||
16872277|NCT01455415|37848286|FG001|Period 2|Lost to Follow-up|1|||
16872278|NCT01455415|37848285|FG000|Period 2|AE Not Related to Study Drug|2|||
16872279|NCT01455415|37848286|FG001|Period 2|AE Not Related to Study Drug|1|||
16872280|NCT01455415|37848285|FG000|Period 2|Lack of Efficacy|2|||
16872281|NCT01455415|37848286|FG001|Period 2|Lack of Efficacy|0|||
16872282|NCT01455415|37848285|FG000|Period 2|Withdrawal by Subject|2|||
16872283|NCT01455415|37848286|FG001|Period 2|Withdrawal by Subject|3|||
16872284|NCT01455415|37848285|FG000|Period 2|Unspecified Reason|2|||
16872285|NCT01455415|37848286|FG001|Period 2|Unspecified Reason|3|||
16872286|NCT01455415|37848285|FG000|Period 2|Protocol Violation|2|||
16872287|NCT01455415|37848286|FG001|Period 2|Protocol Violation|0|||
16872288|NCT01455415|37848285|FG000|Follow-up|AE Related to Study Drug|0|||
16872289|NCT01455415|37848286|FG001|Follow-up|AE Related to Study Drug|1|||
16872290|NCT01455415|37848285|FG000|Follow-up|Lack of Efficacy|0|||
16872291|NCT01455415|37848286|FG001|Follow-up|Lack of Efficacy|1|||
16872292|NCT01455415|37848285|FG000|Follow-up|Withdrawal by Subject|2|||
16872293|NCT01455415|37848286|FG001|Follow-up|Withdrawal by Subject|0|||
16872294|NCT01455415|37848285|FG000|Follow-up|Unspecified Reason|1|||
16872295|NCT01455415|37848286|FG001|Follow-up|Unspecified Reason|0|||
16872296|NCT01471171|37848292|FG000|Treatment Period 1|Adverse Event|4|||
16872297|NCT01471171|37848293|FG001|Treatment Period 1|Adverse Event|1|||
16872298|NCT01471171|37848292|FG000|Treatment Period 2|Adverse Event|1|||
16872299|NCT01471171|37848293|FG001|Treatment Period 2|Adverse Event|0|||
16872300|NCT01471093|37848301|FG000|Overall Study|Adverse Event|1|||
16872301|NCT01471093|37848302|FG001|Overall Study|Adverse Event|0|||
16872302|NCT01471093|37848303|FG002|Overall Study|Adverse Event|0|||
16872303|NCT01471093|37848304|FG003|Overall Study|Adverse Event|0|||
16872304|NCT01471015|37848313|FG000|Overall Study|Death|0|||
16872305|NCT01471015|37848314|FG001|Overall Study|Death|1|||
16872306|NCT01471015|37848315|FG002|Overall Study|Death|1|||
16872307|NCT01497067|37848323|FG000|Overall Study|Lost to Follow-up|56|||
16872308|NCT01497067|37848323|FG000|Overall Study|Adverse Event|3|||
17001510|NCT00874497|38145560|FG000|Overall Study|Physician Decision|1|||
17001511|NCT00874497|38145561|FG001|Overall Study|Physician Decision|1|||
17001512|NCT00874497|38145560|FG000|Overall Study|Withdrawal by Subject|5|||
17001513|NCT00874497|38145561|FG001|Overall Study|Withdrawal by Subject|4|||
17001514|NCT00924560|38145570|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
17001515|NCT00924560|38145571|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
17001516|NCT00924560|38145572|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
16872309|NCT01497067|37848323|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
16872310|NCT01497067|37848323|FG000|Overall Study|Other|13|||
16872311|NCT01470469|37848353|FG000|Overall Study|Withdrawal by Subject|4|||
16872312|NCT01470469|37848354|FG001|Overall Study|Withdrawal by Subject|6|||
16872313|NCT01470469|37848353|FG000|Overall Study|Lack of Efficacy|1|||
16872314|NCT01470469|37848354|FG001|Overall Study|Lack of Efficacy|7|||
16872315|NCT01470469|37848353|FG000|Overall Study|Adverse Event|0|||
16872316|NCT01470469|37848354|FG001|Overall Study|Adverse Event|7|||
16872317|NCT01470469|37848353|FG000|Overall Study|Lost to Follow-up|2|||
16872318|NCT01470469|37848354|FG001|Overall Study|Lost to Follow-up|2|||
16872319|NCT01470469|37848353|FG000|Overall Study|Protocol Violation|1|||
16784832|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
16784833|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
16784834|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
16784835|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
16872320|NCT01470469|37848354|FG001|Overall Study|Protocol Violation|1|||
16872321|NCT01470469|37848353|FG000|Overall Study|Other|2|||
16872322|NCT01470469|37848354|FG001|Overall Study|Other|1|||
16872323|NCT01454401|37848360|FG000|Overall Study|Death|1|||
16872324|NCT01454401|37848360|FG000|Overall Study|hospitalised|1|||
16872325|NCT01454401|37848360|FG000|Overall Study|osteomyelitis|2|||
16872326|NCT01454401|37848360|FG000|Overall Study|non-adherence|1|||
16872327|NCT01470001|37848366|FG000|Overall Study|Lost to Follow-up|1|||
17191311|NCT02477332|38344132|FG001|Overall Study|Lack of Efficacy|2|||
16784836|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
16784837|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
16784838|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
16784839|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
16784840|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
16784841|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
16784842|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
16784843|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
16872328|NCT01470001|37848367|FG001|Overall Study|Lost to Follow-up|1|||
16872329|NCT01470001|37848366|FG000|Overall Study|Physician Decision|2|||
16872330|NCT01470001|37848367|FG001|Overall Study|Physician Decision|0|||
17001517|NCT00924560|38145570|FG000|Overall Study|Non Compliance with the Protocol|20|||
16872331|NCT01470001|37848366|FG000|Overall Study|Withdrawal by Subject|2|||
16872332|NCT01470001|37848367|FG001|Overall Study|Withdrawal by Subject|1|||
16872333|NCT01469377|37848376|FG000|Overall Study|Protocol Deviation|7|||
16872334|NCT01469377|37848377|FG001|Overall Study|Protocol Deviation|10|||
16872335|NCT01469377|37848378|FG002|Overall Study|Protocol Deviation|10|||
16872336|NCT01469377|37848376|FG000|Overall Study|Lost to Follow-up|3|||
16872337|NCT01469377|37848377|FG001|Overall Study|Lost to Follow-up|2|||
16872338|NCT01469377|37848378|FG002|Overall Study|Lost to Follow-up|5|||
16872339|NCT01469377|37848376|FG000|Overall Study|Withdrawal of Consent|12|||
16872340|NCT01469377|37848377|FG001|Overall Study|Withdrawal of Consent|14|||
16872341|NCT01469377|37848378|FG002|Overall Study|Withdrawal of Consent|15|||
16872342|NCT01469377|37848376|FG000|Overall Study|Adverse Event|8|||
16872343|NCT01469377|37848377|FG001|Overall Study|Adverse Event|18|||
17001518|NCT00924560|38145571|FG001|Overall Study|Non Compliance with the Protocol|15|||
17001519|NCT00924560|38145572|FG002|Overall Study|Non Compliance with the Protocol|4|||
17001520|NCT00924560|38145570|FG000|Overall Study|Physician Decision|2|||
17001521|NCT00924560|38145571|FG001|Overall Study|Physician Decision|3|||
17001522|NCT00924560|38145572|FG002|Overall Study|Physician Decision|4|||
17001523|NCT00924560|38145570|FG000|Overall Study|Withdrawal by Subject|50|||
17001524|NCT00924560|38145571|FG001|Overall Study|Withdrawal by Subject|44|||
17001525|NCT00924560|38145572|FG002|Overall Study|Withdrawal by Subject|18|||
17001526|NCT00924560|38145570|FG000|Overall Study|Adverse Event|39|||
17001527|NCT00924560|38145571|FG001|Overall Study|Adverse Event|33|||
17001528|NCT00924560|38145572|FG002|Overall Study|Adverse Event|0|||
16872344|NCT01469377|37848378|FG002|Overall Study|Adverse Event|36|||
16872345|NCT01469377|37848376|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16872346|NCT01469377|37848377|FG001|Overall Study|Insufficient Therapeutic Response|4|||
16872347|NCT01469377|37848378|FG002|Overall Study|Insufficient Therapeutic Response|0|||
16872348|NCT01469377|37848376|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16872349|NCT01469377|37848377|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16872350|NCT01469377|37848378|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16872351|NCT01469221|37848388|FG000|Double Blind Phase|Protocol Violation|1|||
16872352|NCT01469221|37848389|FG001|Double Blind Phase|Protocol Violation|0|||
16872353|NCT01469221|37848390|FG002|Double Blind Phase|Protocol Violation|0|||
16872354|NCT01469221|37848388|FG000|Double Blind Phase|Physician Decision|1|||
16872355|NCT01469221|37848389|FG001|Double Blind Phase|Physician Decision|1|||
16872356|NCT01469221|37848390|FG002|Double Blind Phase|Physician Decision|0|||
16872357|NCT01469221|37848388|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
16872358|NCT01469221|37848389|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
16872359|NCT01469221|37848390|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
16872360|NCT01453855|37848399|FG000|Overall Study|Adverse Event|3|||
16872361|NCT01453855|37848400|FG001|Overall Study|Adverse Event|4|||
16872362|NCT01453855|37848399|FG000|Overall Study|Lost to Follow-up|2|||
16872363|NCT01453855|37848400|FG001|Overall Study|Lost to Follow-up|1|||
16872364|NCT01453855|37848399|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
16872365|NCT01453855|37848400|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
16872366|NCT01453855|37848399|FG000|Overall Study|Noncompliance|1|||
16872367|NCT01453855|37848400|FG001|Overall Study|Noncompliance|0|||
16872368|NCT01453855|37848399|FG000|Overall Study|Inadequate Control of IOP|1|||
16872369|NCT01453855|37848400|FG001|Overall Study|Inadequate Control of IOP|5|||
16872370|NCT01453855|37848399|FG000|Overall Study|Other|0|||
16872371|NCT01453855|37848400|FG001|Overall Study|Other|1|||
16872372|NCT01469065|37848411|FG000|Overall Study|Lack of Efficacy|0|||
16872373|NCT01469065|37848412|FG001|Overall Study|Lack of Efficacy|0|||
16872374|NCT01469065|37848413|FG002|Overall Study|Lack of Efficacy|0|||
16872375|NCT01469065|37848414|FG003|Overall Study|Lack of Efficacy|0|||
16872376|NCT01469065|37848415|FG004|Overall Study|Lack of Efficacy|1|||
16872377|NCT01469065|37848411|FG000|Overall Study|Other|0|||
16872378|NCT01469065|37848412|FG001|Overall Study|Other|1|||
16872379|NCT01469065|37848413|FG002|Overall Study|Other|0|||
16872380|NCT01469065|37848414|FG003|Overall Study|Other|0|||
16872381|NCT01469065|37848415|FG004|Overall Study|Other|0|||
16872382|NCT01586624|37848439|FG000|Overall Study|Adverse Event|3|||
16872383|NCT01586624|37848440|FG001|Overall Study|Adverse Event|0|||
16872384|NCT01586624|37848441|FG002|Overall Study|Adverse Event|2|||
16872385|NCT01586624|37848442|FG003|Overall Study|Adverse Event|1|||
16872386|NCT01586624|37848443|FG004|Overall Study|Adverse Event|3|||
16872387|NCT01586624|37848444|FG005|Overall Study|Adverse Event|3|||
16872388|NCT01586624|37848445|FG006|Overall Study|Adverse Event|2|||
16872389|NCT01586624|37848446|FG007|Overall Study|Adverse Event|3|||
16872390|NCT01586624|37848439|FG000|Overall Study|Physician Decision|0|||
17001529|NCT00924560|38145570|FG000|Overall Study|Pregnancy|5|||
16872391|NCT01586624|37848440|FG001|Overall Study|Physician Decision|1|||
16872392|NCT01586624|37848441|FG002|Overall Study|Physician Decision|1|||
16872393|NCT01586624|37848442|FG003|Overall Study|Physician Decision|0|||
16872394|NCT01586624|37848443|FG004|Overall Study|Physician Decision|2|||
17001530|NCT00924560|38145571|FG001|Overall Study|Pregnancy|7|||
17001531|NCT00924560|38145572|FG002|Overall Study|Pregnancy|1|||
17001532|NCT00924560|38145570|FG000|Overall Study|Lost to Follow-up|78|||
16872395|NCT01586624|37848444|FG005|Overall Study|Physician Decision|0|||
16872396|NCT01586624|37848445|FG006|Overall Study|Physician Decision|1|||
16872397|NCT01586624|37848446|FG007|Overall Study|Physician Decision|1|||
16872398|NCT01586624|37848439|FG000|Overall Study|Withdrawal by Subject|0|||
16872399|NCT01586624|37848440|FG001|Overall Study|Withdrawal by Subject|0|||
16872400|NCT01586624|37848441|FG002|Overall Study|Withdrawal by Subject|0|||
16872401|NCT01586624|37848442|FG003|Overall Study|Withdrawal by Subject|1|||
16872402|NCT01586624|37848443|FG004|Overall Study|Withdrawal by Subject|0|||
16872403|NCT01586624|37848444|FG005|Overall Study|Withdrawal by Subject|0|||
16872404|NCT01586624|37848445|FG006|Overall Study|Withdrawal by Subject|0|||
16872405|NCT01586624|37848446|FG007|Overall Study|Withdrawal by Subject|0|||
16872406|NCT01586624|37848439|FG000|Overall Study|Evidence of disease progression|1|||
16872407|NCT01586624|37848440|FG001|Overall Study|Evidence of disease progression|3|||
16872408|NCT01586624|37848441|FG002|Overall Study|Evidence of disease progression|2|||
16872409|NCT01586624|37848442|FG003|Overall Study|Evidence of disease progression|5|||
16872410|NCT01586624|37848443|FG004|Overall Study|Evidence of disease progression|3|||
16872411|NCT01586624|37848444|FG005|Overall Study|Evidence of disease progression|5|||
16872412|NCT01586624|37848445|FG006|Overall Study|Evidence of disease progression|4|||
16872413|NCT01586624|37848446|FG007|Overall Study|Evidence of disease progression|6|||
16872414|NCT01586624|37848439|FG000|Overall Study|Screen failure (no treatment received)|0|||
16872415|NCT01586624|37848440|FG001|Overall Study|Screen failure (no treatment received)|0|||
16872416|NCT01586624|37848441|FG002|Overall Study|Screen failure (no treatment received)|0|||
17001533|NCT00924560|38145571|FG001|Overall Study|Lost to Follow-up|94|||
17001534|NCT00924560|38145572|FG002|Overall Study|Lost to Follow-up|45|||
17001535|NCT00924560|38145570|FG000|Overall Study|Miscellaneous Reasons|13|||
17001536|NCT00924560|38145571|FG001|Overall Study|Miscellaneous Reasons|10|||
17001537|NCT00924560|38145572|FG002|Overall Study|Miscellaneous Reasons|10|||
17001538|NCT00923078|38145585|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
17001539|NCT00923078|38145586|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
17095066|NCT03815175|38234345|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
17095067|NCT03815175|38234345|FG000|Overall Study|Death|86|||
17095068|NCT03815175|38234345|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
17001540|NCT00923078|38145587|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
17001541|NCT00923078|38145585|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
17001542|NCT00923078|38145586|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
17001543|NCT00923078|38145587|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
17001544|NCT00978731|38145598|FG000|Overall Study|Death|4|||
17001545|NCT00978731|38145599|FG001|Overall Study|Death|1|||
17001546|NCT00978731|38145600|FG002|Overall Study|Death|1|||
17001547|NCT00978731|38145601|FG003|Overall Study|Death|0|||
17001548|NCT00978731|38145598|FG000|Overall Study|Lost to Follow-up|0|||
17001549|NCT00978731|38145599|FG001|Overall Study|Lost to Follow-up|0|||
17001550|NCT00978731|38145600|FG002|Overall Study|Lost to Follow-up|0|||
17001551|NCT00978731|38145601|FG003|Overall Study|Lost to Follow-up|1|||
17001552|NCT00978731|38145598|FG000|Overall Study|Adverse Event|5|||
17001553|NCT00978731|38145599|FG001|Overall Study|Adverse Event|2|||
17001554|NCT00978731|38145600|FG002|Overall Study|Adverse Event|0|||
17001555|NCT00978731|38145601|FG003|Overall Study|Adverse Event|0|||
17001556|NCT00978731|38145598|FG000|Overall Study|Participant's request|1|||
17001557|NCT00978731|38145599|FG001|Overall Study|Participant's request|0|||
17001558|NCT00978731|38145600|FG002|Overall Study|Participant's request|0|||
17001559|NCT00978731|38145601|FG003|Overall Study|Participant's request|0|||
17001560|NCT00978731|38145598|FG000|Overall Study|Administrative reason|3|||
17001561|NCT00978731|38145599|FG001|Overall Study|Administrative reason|3|||
17001562|NCT00978731|38145600|FG002|Overall Study|Administrative reason|1|||
17001563|NCT00978731|38145601|FG003|Overall Study|Administrative reason|0|||
17001564|NCT00978731|38145598|FG000|Overall Study|Deterioration without progression|0|||
17001565|NCT00978731|38145599|FG001|Overall Study|Deterioration without progression|1|||
17001566|NCT00978731|38145600|FG002|Overall Study|Deterioration without progression|0|||
17001567|NCT00978731|38145601|FG003|Overall Study|Deterioration without progression|0|||
17001568|NCT00978731|38145598|FG000|Overall Study|Disease progression/relapse|5|||
17001569|NCT00978731|38145599|FG001|Overall Study|Disease progression/relapse|4|||
17001570|NCT00978731|38145600|FG002|Overall Study|Disease progression/relapse|2|||
17001571|NCT00978731|38145601|FG003|Overall Study|Disease progression/relapse|2|||
17001572|NCT00978731|38145598|FG000|Overall Study|Study closure|3|||
17001573|NCT00978731|38145599|FG001|Overall Study|Study closure|4|||
17001574|NCT00978731|38145600|FG002|Overall Study|Study closure|1|||
17001575|NCT00978731|38145601|FG003|Overall Study|Study closure|1|||
17001576|NCT00978731|38145598|FG000|Overall Study|No response|1|||
17001577|NCT00978731|38145599|FG001|Overall Study|No response|0|||
17095069|NCT03815175|38234345|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
16872417|NCT01586624|37848442|FG003|Overall Study|Screen failure (no treatment received)|0|||
17001578|NCT00978731|38145600|FG002|Overall Study|No response|0|||
17001579|NCT00978731|38145601|FG003|Overall Study|No response|0|||
17001580|NCT00978341|38145615|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
17001581|NCT00978341|38145616|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
16784844|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
16784845|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
16784846|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
16784847|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
16784848|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
16784849|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
16784850|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
16784851|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
16784852|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
16784853|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
16784854|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
16784855|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
16784856|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
16784857|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
16784858|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
16784859|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
16784860|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
16784861|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
16784862|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
16784863|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
16784864|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
16784865|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
16784866|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
16784867|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
16784868|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
16784869|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
16784870|NCT01990768|37724833|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
16784871|NCT01990768|37724834|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
16784872|NCT01990768|37724835|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
16784873|NCT01990768|37724833|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
16784874|NCT01990768|37724834|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
16784875|NCT01990768|37724835|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
16784876|NCT01990768|37724833|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
16784877|NCT01990768|37724834|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
16784878|NCT01990768|37724835|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
16784879|NCT01990768|37724833|FG000|6-Month Follow-up|No contact information|5|||
16784880|NCT01990768|37724834|FG001|6-Month Follow-up|No contact information|6|||
16784881|NCT01990768|37724835|FG002|6-Month Follow-up|No contact information|5|||
16784882|NCT01990768|37724833|FG000|6-Month Follow-up|Homeless|4|||
16784883|NCT01990768|37724834|FG001|6-Month Follow-up|Homeless|3|||
16784884|NCT01990768|37724835|FG002|6-Month Follow-up|Homeless|6|||
16784885|NCT01990768|37724833|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
16784886|NCT01990768|37724834|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
16784887|NCT01990768|37724835|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
16784888|NCT01990768|37724833|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
16784889|NCT01990768|37724834|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
16784890|NCT01990768|37724835|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
16784891|NCT01990768|37724833|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
16784892|NCT01990768|37724834|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
16784893|NCT01990768|37724835|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
17001582|NCT00978029|38145626|FG000|Overall Study|Adverse Event|1|||
17001583|NCT00978029|38145627|FG001|Overall Study|Adverse Event|2|||
17001584|NCT00978029|38145628|FG002|Overall Study|Adverse Event|5|||
17001585|NCT00978029|38145626|FG000|Overall Study|Withdrawal by Subject|0|||
17001586|NCT00978029|38145627|FG001|Overall Study|Withdrawal by Subject|0|||
17001587|NCT00978029|38145628|FG002|Overall Study|Withdrawal by Subject|1|||
17001588|NCT00978029|38145626|FG000|Overall Study|Protocol Violation|0|||
17001589|NCT00978029|38145627|FG001|Overall Study|Protocol Violation|1|||
17001590|NCT00978029|38145628|FG002|Overall Study|Protocol Violation|0|||
17001591|NCT00871377|38145636|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
17001592|NCT00871377|38145637|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
17001593|NCT00871377|38145638|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
17001594|NCT00871377|38145639|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
17001595|NCT00871377|38145640|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
17001596|NCT00871377|38145641|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
17001597|NCT00871377|38145636|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
17001598|NCT00871377|38145637|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
17001599|NCT00871377|38145638|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
17001600|NCT00871377|38145639|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
17001601|NCT00871377|38145640|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
17095070|NCT03815175|38234345|FG000|Overall Study|Other Status Change Reason|1|||
17095071|NCT03815175|38234345|FG000|Overall Study|Missed Visit|12|||
17095072|NCT00262028|38234358|FG000|Overall Study|Withdrawal by Subject|6|||
17095073|NCT00262028|38234359|FG001|Overall Study|Withdrawal by Subject|3|||
17095074|NCT00262028|38234360|FG002|Overall Study|Withdrawal by Subject|6|||
16872418|NCT01586624|37848443|FG004|Overall Study|Screen failure (no treatment received)|0|||
16872419|NCT01586624|37848444|FG005|Overall Study|Screen failure (no treatment received)|0|||
16872420|NCT01586624|37848445|FG006|Overall Study|Screen failure (no treatment received)|1|||
16872421|NCT01586624|37848446|FG007|Overall Study|Screen failure (no treatment received)|0|||
16872422|NCT01586156|37848468|FG000|Overall Study|Pregnancy|0|||
16872423|NCT01586156|37848469|FG001|Overall Study|Pregnancy|1|||
16872424|NCT01586156|37848470|FG002|Overall Study|Pregnancy|0|||
16872425|NCT01459913|37848482|FG000|Overall Study|Adverse Event|0|||
16872426|NCT01459913|37848483|FG001|Overall Study|Adverse Event|0|||
16872427|NCT01459913|37848484|FG002|Overall Study|Adverse Event|0|||
16872428|NCT01459913|37848485|FG003|Overall Study|Adverse Event|3|||
16872429|NCT01459913|37848482|FG000|Overall Study|Withdrawal by Subject|4|||
16872430|NCT01459913|37848483|FG001|Overall Study|Withdrawal by Subject|0|||
16872431|NCT01459913|37848484|FG002|Overall Study|Withdrawal by Subject|0|||
16872432|NCT01459913|37848485|FG003|Overall Study|Withdrawal by Subject|5|||
16872433|NCT01459913|37848482|FG000|Overall Study|Lost to Follow-up|7|||
16872434|NCT01459913|37848483|FG001|Overall Study|Lost to Follow-up|4|||
16872435|NCT01459913|37848484|FG002|Overall Study|Lost to Follow-up|1|||
16872436|NCT01459913|37848485|FG003|Overall Study|Lost to Follow-up|8|||
16872437|NCT01459913|37848482|FG000|Overall Study|Death|0|||
16872438|NCT01459913|37848483|FG001|Overall Study|Death|0|||
16872439|NCT01459913|37848484|FG002|Overall Study|Death|0|||
16872440|NCT01459913|37848485|FG003|Overall Study|Death|1|||
16872441|NCT01459913|37848482|FG000|Overall Study|Non- Compliance|0|||
16872442|NCT01459913|37848483|FG001|Overall Study|Non- Compliance|0|||
16872443|NCT01459913|37848484|FG002|Overall Study|Non- Compliance|0|||
16872444|NCT01459913|37848485|FG003|Overall Study|Non- Compliance|3|||
16872445|NCT01459913|37848482|FG000|Overall Study|Physician Decision|0|||
16872446|NCT01459913|37848483|FG001|Overall Study|Physician Decision|1|||
16872447|NCT01459913|37848484|FG002|Overall Study|Physician Decision|0|||
16872448|NCT01459913|37848485|FG003|Overall Study|Physician Decision|0|||
16872449|NCT01459913|37848482|FG000|Overall Study|Study Terminated by Sponsor|30|||
16872450|NCT01459913|37848483|FG001|Overall Study|Study Terminated by Sponsor|15|||
16872451|NCT01459913|37848484|FG002|Overall Study|Study Terminated by Sponsor|9|||
16872452|NCT01459913|37848485|FG003|Overall Study|Study Terminated by Sponsor|11|||
16872453|NCT01459913|37848482|FG000|Overall Study|Other|0|||
16872454|NCT01459913|37848483|FG001|Overall Study|Other|0|||
16872455|NCT01459913|37848484|FG002|Overall Study|Other|3|||
16872456|NCT01459913|37848485|FG003|Overall Study|Other|1|||
16872457|NCT01459913|37848482|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
16872458|NCT01459913|37848483|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
16872459|NCT01459913|37848484|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
16872460|NCT01459913|37848485|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
16872461|NCT01458587|37848499|FG000|Overall Study|Withdrawal by Subject|1|||
16872462|NCT01458587|37848500|FG001|Overall Study|Withdrawal by Subject|0|||
16872463|NCT01458275|37848511|FG000|Overall Study|Adverse Event|3|||
16872464|NCT01458275|37848512|FG001|Overall Study|Adverse Event|4|||
16872465|NCT01458275|37848513|FG002|Overall Study|Adverse Event|1|||
16872466|NCT01458275|37848511|FG000|Overall Study|Lost to Follow-up|3|||
17001602|NCT00871377|38145641|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
17001603|NCT00871377|38145636|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
17001604|NCT00871377|38145637|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
17001605|NCT00871377|38145638|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
17001606|NCT00871377|38145639|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
17001607|NCT00871377|38145640|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
17001608|NCT00871377|38145641|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
17001609|NCT00871377|38145636|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
17001610|NCT00871377|38145637|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
16872467|NCT01458275|37848512|FG001|Overall Study|Lost to Follow-up|2|||
16872468|NCT01458275|37848513|FG002|Overall Study|Lost to Follow-up|5|||
16872469|NCT01458275|37848511|FG000|Overall Study|Protocol Violation|5|||
16872470|NCT01458275|37848512|FG001|Overall Study|Protocol Violation|5|||
16872471|NCT01458275|37848513|FG002|Overall Study|Protocol Violation|2|||
16872472|NCT01458275|37848511|FG000|Overall Study|Withdrawal by Subject|3|||
16872473|NCT01458275|37848512|FG001|Overall Study|Withdrawal by Subject|2|||
16872474|NCT01458275|37848513|FG002|Overall Study|Withdrawal by Subject|1|||
16872475|NCT01458119|37848523|FG000|Overall Study|Physician Decision|4|||
16872476|NCT01458119|37848523|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
16872477|NCT01458119|37848523|FG000|Overall Study|Pregnancy|1|||
16872478|NCT01458119|37848523|FG000|Overall Study|Death|2|||
16872479|NCT01458119|37848523|FG000|Overall Study|Adverse Event|1|||
16872480|NCT01458119|37848523|FG000|Overall Study|Consent Withdrawn by Participant|8|||
16872481|NCT01458119|37848523|FG000|Overall Study|Non-compliance With Study Drug|3|||
16872482|NCT01688882|37848538|FG000|Overall Study|Adverse Event|1|||
16872483|NCT01688882|37848539|FG001|Overall Study|Adverse Event|0|||
16872484|NCT01688882|37848538|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16872485|NCT01688882|37848539|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16872486|NCT01688882|37848538|FG000|Overall Study|Administrative problems|1|||
16872487|NCT01688882|37848539|FG001|Overall Study|Administrative problems|0|||
16872488|NCT01688726|37848551|FG000|Overall Study|Adverse Event|1|||
16872489|NCT01688726|37848552|FG001|Overall Study|Adverse Event|0|||
16872490|NCT01688726|37848551|FG000|Overall Study|Relocated abroad|0|||
16872491|NCT01688726|37848552|FG001|Overall Study|Relocated abroad|1|||
16872492|NCT01585766|37848568|FG000|Overall Study|Withdrawal by Subject|0|||
16872493|NCT01585766|37848569|FG001|Overall Study|Withdrawal by Subject|1|||
16872494|NCT01585766|37848570|FG002|Overall Study|Withdrawal by Subject|1|||
16872495|NCT01585766|37848571|FG003|Overall Study|Withdrawal by Subject|0|||
16872496|NCT01585766|37848572|FG004|Overall Study|Withdrawal by Subject|0|||
16872497|NCT01585766|37848573|FG005|Overall Study|Withdrawal by Subject|0|||
16872498|NCT01585766|37848568|FG000|Overall Study|Death|0|||
16872499|NCT01585766|37848569|FG001|Overall Study|Death|1|||
16872500|NCT01585766|37848570|FG002|Overall Study|Death|0|||
16872501|NCT01585766|37848571|FG003|Overall Study|Death|0|||
16872502|NCT01585766|37848572|FG004|Overall Study|Death|0|||
16872503|NCT01585766|37848573|FG005|Overall Study|Death|0|||
16872504|NCT01585766|37848568|FG000|Overall Study|Physician Decision|0|||
16872505|NCT01585766|37848569|FG001|Overall Study|Physician Decision|0|||
16872506|NCT01585766|37848570|FG002|Overall Study|Physician Decision|1|||
16872507|NCT01585766|37848571|FG003|Overall Study|Physician Decision|0|||
16872508|NCT01585766|37848572|FG004|Overall Study|Physician Decision|0|||
16872509|NCT01585766|37848573|FG005|Overall Study|Physician Decision|0|||
16872510|NCT01562444|37848597|FG000|Overall Study|Did not meet entry criteria|2|||
16872511|NCT01562444|37848598|FG001|Overall Study|Did not meet entry criteria|0|||
16872512|NCT01562444|37848599|FG002|Overall Study|Did not meet entry criteria|3|||
16872513|NCT01562444|37848597|FG000|Overall Study|Did not comply with blood draw schedule|1|||
16872514|NCT01562444|37848598|FG001|Overall Study|Did not comply with blood draw schedule|0|||
16872515|NCT01562444|37848599|FG002|Overall Study|Did not comply with blood draw schedule|1|||
16872516|NCT01562444|37848597|FG000|Overall Study|Unavailable serological results|0|||
16872517|NCT01562444|37848598|FG001|Overall Study|Unavailable serological results|2|||
16872518|NCT01562444|37848599|FG002|Overall Study|Unavailable serological results|2|||
16872519|NCT01562444|37848597|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
16872520|NCT01562444|37848598|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
16872521|NCT01562444|37848599|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
16872522|NCT01562444|37848597|FG000|Overall Study|Protocol forbidden medication|1|||
16872523|NCT01562444|37848598|FG001|Overall Study|Protocol forbidden medication|0|||
16872524|NCT01562444|37848599|FG002|Overall Study|Protocol forbidden medication|0|||
16872525|NCT01457339|37848609|FG000|Period 3 (100 mg)|Adverse Event|0|||
16872526|NCT01457339|37848610|FG001|Period 3 (100 mg)|Adverse Event|1|||
16872527|NCT01457339|37848609|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
16872528|NCT01457339|37848610|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
16872529|NCT01457339|37848609|FG000|Period 6 (250 mg)|Family Emergency|1|||
16872530|NCT01457339|37848610|FG001|Period 6 (250 mg)|Family Emergency|0|||
16872531|NCT01457339|37848609|FG000|Period 6 (250 mg)|Personal appointment|0|||
16872532|NCT01457339|37848610|FG001|Period 6 (250 mg)|Personal appointment|1|||
16872533|NCT01456949|37848633|FG000|Enrollment|PI death- incomplete data|6|||
16872534|NCT01456949|37848633|FG000|Enrollment|Death|1|||
16872535|NCT01456949|37848633|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
16872536|NCT01456949|37848633|FG000|Enrollment|Physician Decision|10|||
16872537|NCT01456949|37848633|FG000|Enrollment|Withdrawal by Subject|7|||
16872538|NCT01456949|37848633|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
16872539|NCT01456949|37848633|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
16872540|NCT01456949|37848633|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
16872541|NCT01456949|37848633|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
16872542|NCT01456949|37848633|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
16872543|NCT01456949|37848633|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
16872544|NCT01456949|37848633|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
16872545|NCT01456949|37848633|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
16872546|NCT01456169|37848640|FG000|Overall Study|Adverse Event|1|||
16872547|NCT01456169|37848641|FG001|Overall Study|Adverse Event|2|||
16872548|NCT01456169|37848642|FG002|Overall Study|Adverse Event|7|||
16872549|NCT01456169|37848640|FG000|Overall Study|Major Protocol Deviation|3|||
16872550|NCT01456169|37848641|FG001|Overall Study|Major Protocol Deviation|2|||
16872551|NCT01456169|37848642|FG002|Overall Study|Major Protocol Deviation|3|||
16872552|NCT01456169|37848640|FG000|Overall Study|Voluntary Withdrawal|3|||
16872553|NCT01456169|37848641|FG001|Overall Study|Voluntary Withdrawal|0|||
16872554|NCT01456169|37848642|FG002|Overall Study|Voluntary Withdrawal|2|||
16872555|NCT01456169|37848640|FG000|Overall Study|Lack of Efficacy|2|||
16872556|NCT01456169|37848641|FG001|Overall Study|Lack of Efficacy|0|||
16872557|NCT01456169|37848642|FG002|Overall Study|Lack of Efficacy|0|||
16872558|NCT01456169|37848640|FG000|Overall Study|Other|1|||
16872559|NCT01456169|37848641|FG001|Overall Study|Other|1|||
16872560|NCT01456169|37848642|FG002|Overall Study|Other|0|||
16872561|NCT01454531|37848651|FG000|Overall Study|Adverse Event|14|||
16872562|NCT01454531|37848651|FG000|Overall Study|Withdrawal by Subject|5|||
16872563|NCT01454531|37848651|FG000|Overall Study|Lost to Follow-up|1|||
16872564|NCT01454531|37848651|FG000|Overall Study|Physician Decision|1|||
16872565|NCT01454531|37848651|FG000|Overall Study|Delay in IMP administration|1|||
16872566|NCT01454531|37848651|FG000|Overall Study|Other|1|||
16872567|NCT01454063|37848657|FG000|Randomized|Adverse Event|1|||
16872568|NCT01454063|37848658|FG001|Randomized|Adverse Event|1|||
16872569|NCT01454063|37848657|FG000|Randomized|Protocol Violation|0|||
16872570|NCT01454063|37848658|FG001|Randomized|Protocol Violation|1|||
16872571|NCT01453595|37848667|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16872572|NCT01453595|37848668|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16872573|NCT01453595|37848669|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16872574|NCT01453439|37848677|FG000|Treatment Phase|Withdrawal by Subject|13|||
16872575|NCT01453439|37848678|FG001|Treatment Phase|Withdrawal by Subject|10|||
16872576|NCT01453439|37848677|FG000|Treatment Phase|Suicidal Ideation|2|||
16872577|NCT01453439|37848678|FG001|Treatment Phase|Suicidal Ideation|0|||
16872578|NCT01453439|37848677|FG000|Treatment Phase|Need for higher level of care|1|||
16872579|NCT01453439|37848678|FG001|Treatment Phase|Need for higher level of care|1|||
16872580|NCT01453439|37848677|FG000|Treatment Phase|Therapist conflict of interest|1|||
16872581|NCT01453439|37848678|FG001|Treatment Phase|Therapist conflict of interest|0|||
16872582|NCT01453439|37848677|FG000|Follow-up|Withdrawal by Subject|0|||
16872583|NCT01453439|37848678|FG001|Follow-up|Withdrawal by Subject|1|||
16872584|NCT01453439|37848677|FG000|Follow-up|Lost to Follow-up|5|||
16872585|NCT01453439|37848678|FG001|Follow-up|Lost to Follow-up|10|||
16872586|NCT01453361|37848684|FG000|Overall Study|Disease Progression|6|||
16872587|NCT01453361|37848684|FG000|Overall Study|Screen-Failures|10|||
16872588|NCT01585298|37848688|FG000|Overall Study|Study completion was not documented.|1|||
16784894|NCT01990612|37724846|FG000|Overall Study|Lost to Follow-up|2|||
16784895|NCT01990612|37724847|FG001|Overall Study|Lost to Follow-up|1|||
16784896|NCT01990612|37724846|FG000|Overall Study|Withdrawal by Subject|5|||
16784897|NCT01990612|37724847|FG001|Overall Study|Withdrawal by Subject|2|||
16784898|NCT01990534|37724853|FG000|Overall Study|Death|22|||
16784899|NCT01990534|37724853|FG000|Overall Study|Progressive disease|3|||
16784900|NCT01990534|37724853|FG000|Overall Study|Protocol Violation|1|||
16784901|NCT01990534|37724853|FG000|Overall Study|Withdrawal of Informed Consent|2|||
16784902|NCT01990534|37724853|FG000|Overall Study|Symptomatic Deterioration|1|||
16784903|NCT01990534|37724853|FG000|Overall Study|Withdrawal by Subject|3|||
16784904|NCT01990534|37724853|FG000|Overall Study|Reason not Specified|2|||
16784905|NCT01990534|37724853|FG000|Overall Study|Lost to Follow-up|1|||
16784906|NCT01967134|37724860|FG000|Overall Study|Lost to Follow-up|0|||
16784907|NCT01967134|37724861|FG001|Overall Study|Lost to Follow-up|1|||
16784908|NCT01967134|37724862|FG002|Overall Study|Lost to Follow-up|0|||
16784909|NCT01990300|37724870|FG000|Overall Study|Case Report Forms Uncollected|89|||
16784910|NCT01990300|37724870|FG000|Overall Study|Protocol Deviation|53|||
16784911|NCT01966432|37724877|FG000|Overall Study|Lost to Follow-up|3|||
16784912|NCT01966432|37724878|FG001|Overall Study|Lost to Follow-up|2|||
16784913|NCT01966432|37724879|FG002|Overall Study|Lost to Follow-up|5|||
16784914|NCT01966432|37724877|FG000|Overall Study|Withdrawal by Subject|1|||
16784915|NCT01966432|37724878|FG001|Overall Study|Withdrawal by Subject|3|||
16784916|NCT01966432|37724879|FG002|Overall Study|Withdrawal by Subject|0|||
16784917|NCT01966432|37724877|FG000|Overall Study|Subject Incarcerated|0|||
16784918|NCT01966432|37724878|FG001|Overall Study|Subject Incarcerated|0|||
16784919|NCT01966432|37724879|FG002|Overall Study|Subject Incarcerated|1|||
16784920|NCT01966432|37724877|FG000|Overall Study|SBIRT program ended|1|||
16784921|NCT01966432|37724878|FG001|Overall Study|SBIRT program ended|8|||
16784922|NCT01966432|37724879|FG002|Overall Study|SBIRT program ended|20|||
16784923|NCT01966120|37724891|FG000|Overall Study|Withdrawal by Subject|0|||
16784924|NCT01966120|37724892|FG001|Overall Study|Withdrawal by Subject|5|||
16784925|NCT01966120|37724891|FG000|Overall Study|Lost to Follow-up|1|||
16784926|NCT01966120|37724892|FG001|Overall Study|Lost to Follow-up|1|||
16784927|NCT02702401|37724900|FG000|Overall Study|Death|242|||
16784928|NCT02702401|37724901|FG001|Overall Study|Death|125|||
16784929|NCT02702401|37724900|FG000|Overall Study|Withdrawal by Subject|15|||
16784930|NCT02702401|37724901|FG001|Overall Study|Withdrawal by Subject|5|||
16784931|NCT02702401|37724900|FG000|Overall Study|Sponsor Decision|19|||
16784932|NCT02702401|37724901|FG001|Overall Study|Sponsor Decision|3|||
16784933|NCT02702401|37724900|FG000|Overall Study|Physician Decision|1|||
16784934|NCT02702401|37724901|FG001|Overall Study|Physician Decision|2|||
16784935|NCT02702401|37724900|FG000|Overall Study|Lost to Follow-up|1|||
16872589|NCT01585298|37848688|FG000|Overall Study|Protocol deviation|1|||
16784936|NCT02702401|37724901|FG001|Overall Study|Lost to Follow-up|0|||
16784937|NCT02703337|37724908|FG000|Period One (Part A)|Withdrawal by Subject|0|||
16784938|NCT02703337|37724909|FG001|Period One (Part A)|Withdrawal by Subject|0|||
16784939|NCT02703337|37724910|FG002|Period One (Part A)|Withdrawal by Subject|0|||
16784940|NCT02703337|37724911|FG003|Period One (Part A)|Withdrawal by Subject|0|||
16784941|NCT02703337|37724912|FG004|Period One (Part A)|Withdrawal by Subject|1|||
16784942|NCT02703337|37724913|FG005|Period One (Part A)|Withdrawal by Subject|0|||
16784943|NCT02703337|37724914|FG006|Period One (Part A)|Withdrawal by Subject|0|||
16784944|NCT02703337|37724915|FG007|Period One (Part A)|Withdrawal by Subject|0|||
16784945|NCT01680497|37724933|FG000|Overall Study|Lost to Follow-up|2|||
16784946|NCT01680341|37724939|FG000|Overall Study|Adverse Event|3|||
16784947|NCT01680341|37724940|FG001|Overall Study|Adverse Event|2|||
16784948|NCT01680341|37724939|FG000|Overall Study|Unclassified|18|||
16784949|NCT01680341|37724940|FG001|Overall Study|Unclassified|15|||
16784950|NCT01679405|37724948|FG000|Overall Study|Death|2|||
16784951|NCT01679405|37724949|FG001|Overall Study|Death|5|||
16784952|NCT01603355|37724955|FG000|Overall Study|Lack of Efficacy|2|||
16784953|NCT02703259|37724961|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
16784954|NCT02703259|37724962|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
16784955|NCT02703259|37724961|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
16872590|NCT01585298|37848688|FG000|Overall Study|Administrative problems|4|||
16872591|NCT01585298|37848688|FG000|Overall Study|Lost to Follow-up|2|||
16872592|NCT01585298|37848688|FG000|Overall Study|Withdrawal by Subject|4|||
16872593|NCT01585298|37848688|FG000|Overall Study|Abnormal test procedure results|1|||
16872594|NCT01585298|37848688|FG000|Overall Study|Adverse Event|24|||
16872595|NCT01453205|37848695|FG000|Overall Study|Lost to Follow-up|3|||
16872596|NCT01453205|37848696|FG001|Overall Study|Lost to Follow-up|0|||
16872597|NCT01453205|37848697|FG002|Overall Study|Lost to Follow-up|1|||
16872598|NCT01453205|37848695|FG000|Overall Study|Withdrawal by Subject|8|||
16872599|NCT01453205|37848696|FG001|Overall Study|Withdrawal by Subject|3|||
16872600|NCT01453205|37848697|FG002|Overall Study|Withdrawal by Subject|0|||
16872601|NCT01453205|37848695|FG000|Overall Study|Death|24|||
16784956|NCT02703259|37724962|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
16784957|NCT02703259|37724961|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
16784958|NCT02703259|37724962|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
16872602|NCT01453205|37848696|FG001|Overall Study|Death|22|||
16872603|NCT01453205|37848697|FG002|Overall Study|Death|18|||
16872604|NCT01453205|37848695|FG000|Overall Study|Other|45|||
16872605|NCT01453205|37848696|FG001|Overall Study|Other|27|||
16872606|NCT01453205|37848697|FG002|Overall Study|Other|35|||
16872607|NCT01453049|37848710|FG000|Overall Study|Protocol Violation|2|||
16872608|NCT01453049|37848711|FG001|Overall Study|Protocol Violation|5|||
16872609|NCT01453049|37848710|FG000|Overall Study|Lost to Follow-up|2|||
16872610|NCT01453049|37848711|FG001|Overall Study|Lost to Follow-up|1|||
16872611|NCT01453049|37848710|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
16872612|NCT01453049|37848711|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
16872613|NCT01453049|37848710|FG000|Overall Study|Withdrawal by Subject|1|||
16872614|NCT01453049|37848711|FG001|Overall Study|Withdrawal by Subject|0|||
16872615|NCT01453049|37848710|FG000|Overall Study|Randomized in Error|1|||
16872616|NCT01453049|37848711|FG001|Overall Study|Randomized in Error|0|||
16872617|NCT01452347|37848719|FG000|Overall Study|Adverse Event|2|||
16872618|NCT01452347|37848720|FG001|Overall Study|Adverse Event|1|||
16872619|NCT01452347|37848719|FG000|Overall Study|Non compliance protocol|2|||
16872620|NCT01452347|37848720|FG001|Overall Study|Non compliance protocol|0|||
16872621|NCT01452347|37848719|FG000|Overall Study|Lost to Follow-up|2|||
16872622|NCT01452347|37848720|FG001|Overall Study|Lost to Follow-up|0|||
16872623|NCT01452347|37848719|FG000|Overall Study|Withdrawal by Subject|3|||
16872624|NCT01452347|37848720|FG001|Overall Study|Withdrawal by Subject|3|||
16872625|NCT01452347|37848719|FG000|Overall Study|Not treated|6|||
16872626|NCT01452347|37848720|FG001|Overall Study|Not treated|3|||
16872627|NCT01452347|37848719|FG000|Overall Study|Other reason not defined above|2|||
16872628|NCT01452347|37848720|FG001|Overall Study|Other reason not defined above|0|||
16872629|NCT01451723|37848730|FG000|Overall Study|study halted|6|||
16872630|NCT01451723|37848731|FG001|Overall Study|study halted|5|||
16872631|NCT01451645|37848739|FG000|Overall Study|Protocol Violation|1|||
16872632|NCT01451645|37848740|FG001|Overall Study|Protocol Violation|0|||
16872633|NCT01451645|37848739|FG000|Overall Study|Adverse Event|0|||
16872634|NCT01451645|37848740|FG001|Overall Study|Adverse Event|3|||
16872635|NCT01451645|37848739|FG000|Overall Study|Withdrawal by Subject|4|||
16872636|NCT01451645|37848740|FG001|Overall Study|Withdrawal by Subject|2|||
16872637|NCT01451645|37848739|FG000|Overall Study|Lost to Follow-up|4|||
16872638|NCT01451645|37848740|FG001|Overall Study|Lost to Follow-up|3|||
17095075|NCT00262028|38234361|FG003|Overall Study|Withdrawal by Subject|5|||
16872639|NCT01450943|37848749|FG000|Overall Study|Screen failure, loss to follow-up|2|||
16872640|NCT01450943|37848750|FG001|Overall Study|Screen failure, loss to follow-up|7|||
16872641|NCT01450943|37848751|FG002|Overall Study|Screen failure, loss to follow-up|6|||
16872642|NCT01450631|37848765|FG000|Overall Study|Lost to Follow-up|2|||
16872643|NCT01450631|37848766|FG001|Overall Study|Lost to Follow-up|4|||
16872644|NCT01450631|37848765|FG000|Overall Study|Withdrawal by Subject|1|||
16872645|NCT01450631|37848766|FG001|Overall Study|Withdrawal by Subject|0|||
16872646|NCT01450007|37848775|FG000|Overall Study|Late exclusion before treatment|2|||
16872647|NCT01450007|37848776|FG001|Overall Study|Late exclusion before treatment|3|||
16872648|NCT01450007|37848777|FG002|Overall Study|Late exclusion before treatment|2|||
16872649|NCT01450007|37848775|FG000|Overall Study|Protocol Violation|0|||
16872650|NCT01450007|37848776|FG001|Overall Study|Protocol Violation|1|||
16872651|NCT01450007|37848777|FG002|Overall Study|Protocol Violation|1|||
16872652|NCT01450007|37848775|FG000|Overall Study|Adverse Event|0|||
16872653|NCT01450007|37848776|FG001|Overall Study|Adverse Event|1|||
16872654|NCT01450007|37848777|FG002|Overall Study|Adverse Event|0|||
16872655|NCT01496365|37848792|FG000|Overall Study|Adverse Event|2|||
16872656|NCT01496365|37848793|FG001|Overall Study|Adverse Event|3|||
16872657|NCT01496365|37848794|FG002|Overall Study|Adverse Event|3|||
16872658|NCT01496365|37848795|FG003|Overall Study|Adverse Event|2|||
16872659|NCT01496365|37848796|FG004|Overall Study|Adverse Event|5|||
16872660|NCT01496365|37848797|FG005|Overall Study|Adverse Event|6|||
16872661|NCT01496365|37848798|FG006|Overall Study|Adverse Event|4|||
16872662|NCT01496365|37848792|FG000|Overall Study|Withdrawal by Subject|6|||
16872663|NCT01496365|37848793|FG001|Overall Study|Withdrawal by Subject|6|||
16872664|NCT01496365|37848794|FG002|Overall Study|Withdrawal by Subject|0|||
16872665|NCT01496365|37848795|FG003|Overall Study|Withdrawal by Subject|1|||
16872666|NCT01496365|37848796|FG004|Overall Study|Withdrawal by Subject|3|||
16872667|NCT01496365|37848797|FG005|Overall Study|Withdrawal by Subject|2|||
16872668|NCT01496365|37848798|FG006|Overall Study|Withdrawal by Subject|1|||
16872669|NCT01496365|37848792|FG000|Overall Study|Protocol Violation|2|||
16872670|NCT01496365|37848793|FG001|Overall Study|Protocol Violation|1|||
16872671|NCT01496365|37848794|FG002|Overall Study|Protocol Violation|1|||
16872672|NCT01496365|37848795|FG003|Overall Study|Protocol Violation|0|||
16872673|NCT01496365|37848796|FG004|Overall Study|Protocol Violation|0|||
16872674|NCT01496365|37848797|FG005|Overall Study|Protocol Violation|1|||
16872675|NCT01496365|37848798|FG006|Overall Study|Protocol Violation|0|||
16872676|NCT01496365|37848792|FG000|Overall Study|Lack of Efficacy|1|||
16872677|NCT01496365|37848793|FG001|Overall Study|Lack of Efficacy|0|||
16872678|NCT01496365|37848794|FG002|Overall Study|Lack of Efficacy|0|||
16872679|NCT01496365|37848795|FG003|Overall Study|Lack of Efficacy|0|||
16872680|NCT01496365|37848796|FG004|Overall Study|Lack of Efficacy|0|||
16872681|NCT01496365|37848797|FG005|Overall Study|Lack of Efficacy|1|||
16872682|NCT01496365|37848798|FG006|Overall Study|Lack of Efficacy|0|||
16872683|NCT01496365|37848792|FG000|Overall Study|Lost to Follow-up|0|||
16872684|NCT01496365|37848793|FG001|Overall Study|Lost to Follow-up|1|||
16872685|NCT01496365|37848794|FG002|Overall Study|Lost to Follow-up|0|||
16872686|NCT01496365|37848795|FG003|Overall Study|Lost to Follow-up|0|||
16872687|NCT01496365|37848796|FG004|Overall Study|Lost to Follow-up|2|||
16872688|NCT01496365|37848797|FG005|Overall Study|Lost to Follow-up|0|||
16872689|NCT01496365|37848798|FG006|Overall Study|Lost to Follow-up|0|||
16872690|NCT01496365|37848792|FG000|Overall Study|Other|4|||
16872691|NCT01496365|37848793|FG001|Overall Study|Other|4|||
16872692|NCT01496365|37848794|FG002|Overall Study|Other|2|||
16872693|NCT01496365|37848795|FG003|Overall Study|Other|1|||
16872694|NCT01496365|37848796|FG004|Overall Study|Other|3|||
16872695|NCT01496365|37848797|FG005|Overall Study|Other|0|||
16872696|NCT01496365|37848798|FG006|Overall Study|Other|1|||
16872697|NCT01496287|37848814|FG000|Overall Study|Lost to Follow-up|1|||
16872698|NCT01496287|37848814|FG000|Overall Study|Incomplete anesthesia|5|||
16872699|NCT01495975|37848821|FG000|Overall Study|Lost to Follow-up|1|||
16872700|NCT01495975|37848822|FG001|Overall Study|Lost to Follow-up|0|||
16872701|NCT01468987|37848830|FG000|Overall Study|Adverse Event|12|||
16872702|NCT01468987|37848831|FG001|Overall Study|Adverse Event|9|||
16872703|NCT01468987|37848830|FG000|Overall Study|Death|4|||
16872704|NCT01468987|37848831|FG001|Overall Study|Death|1|||
16872705|NCT01468987|37848830|FG000|Overall Study|Lost to Follow-up|10|||
16872706|NCT01468987|37848831|FG001|Overall Study|Lost to Follow-up|5|||
16872707|NCT01468987|37848830|FG000|Overall Study|Protocol Violation|8|||
16872708|NCT01468987|37848831|FG001|Overall Study|Protocol Violation|2|||
16872709|NCT01468987|37848830|FG000|Overall Study|Withdrawal by Subject|28|||
16872710|NCT01468987|37848831|FG001|Overall Study|Withdrawal by Subject|28|||
16872711|NCT01468987|37848830|FG000|Overall Study|Physician Decision|8|||
16872712|NCT01468987|37848831|FG001|Overall Study|Physician Decision|15|||
16872713|NCT01468987|37848830|FG000|Overall Study|Sponsor Decision|1|||
16872714|NCT01468987|37848831|FG001|Overall Study|Sponsor Decision|0|||
16872715|NCT01687712|37848841|FG000|Cycle 1|Not Biochemically Pregnant|386|||
16872716|NCT01687712|37848842|FG001|Cycle 1|Not Biochemically Pregnant|348|||
16872717|NCT01687712|37848841|FG000|Cycle 1|Early Pregnancy Loss|43|||
16872718|NCT01687712|37848842|FG001|Cycle 1|Early Pregnancy Loss|60|||
16872719|NCT01687712|37848841|FG000|Cycle 1|Ectopic Pregnancy|5|||
16872720|NCT01687712|37848842|FG001|Cycle 1|Ectopic Pregnancy|5|||
16872721|NCT01687712|37848841|FG000|Cycle 1|Heterotropic Pregnancy|1|||
16872722|NCT01687712|37848842|FG001|Cycle 1|Heterotropic Pregnancy|0|||
16872723|NCT01687712|37848841|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
16872724|NCT01687712|37848842|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
16872725|NCT01687712|37848841|FG000|Cycle 1|Abortion|3|||
16872726|NCT01687712|37848842|FG001|Cycle 1|Abortion|0|||
16872727|NCT01687712|37848841|FG000|Cycle 1|Intrauterine Fetal Death|0|||
16872728|NCT01687712|37848842|FG001|Cycle 1|Intrauterine Fetal Death|1|||
16872729|NCT01687712|37848841|FG000|Cycle 1|Lost to Follow-up|1|||
16872730|NCT01687712|37848842|FG001|Cycle 1|Lost to Follow-up|1|||
16872731|NCT01687712|37848841|FG000|Cycle 2|Not Biochemically Pregnant|74|||
16872732|NCT01687712|37848842|FG001|Cycle 2|Not Biochemically Pregnant|77|||
16872733|NCT01687712|37848841|FG000|Cycle 2|Early Pregnancy Loss|18|||
16872734|NCT01687712|37848842|FG001|Cycle 2|Early Pregnancy Loss|16|||
16872735|NCT01687712|37848841|FG000|Cycle 2|Ectopic Pregnancy|0|||
16872736|NCT01687712|37848842|FG001|Cycle 2|Ectopic Pregnancy|1|||
16872737|NCT01687712|37848841|FG000|Cycle 2|Still Birth|1|||
16872738|NCT01687712|37848842|FG001|Cycle 2|Still Birth|0|||
16872739|NCT01687712|37848841|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
16872740|NCT01687712|37848842|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
16872741|NCT01687712|37848841|FG000|Cycle 3|Not Biochemically Pregnant|21|||
16872742|NCT01687712|37848842|FG001|Cycle 3|Not Biochemically Pregnant|22|||
16872743|NCT01687712|37848841|FG000|Cycle 3|Early Pregnancy Loss|1|||
16872744|NCT01687712|37848842|FG001|Cycle 3|Early Pregnancy Loss|2|||
16872745|NCT01687712|37848841|FG000|Cycle 3|Ectopic Pregnancy|1|||
16872746|NCT01687712|37848842|FG001|Cycle 3|Ectopic Pregnancy|0|||
16872747|NCT01687712|37848841|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
16872748|NCT01687712|37848842|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
16872749|NCT01603628|37848855|FG000|Overall Study|Personal Reasons|1|||
16872750|NCT01603628|37848856|FG001|Overall Study|Personal Reasons|1|||
16872751|NCT01603628|37848857|FG002|Overall Study|Personal Reasons|2|||
16872752|NCT01603628|37848855|FG000|Overall Study|Protocol Violation|1|||
16872753|NCT01603628|37848856|FG001|Overall Study|Protocol Violation|1|||
16872754|NCT01603628|37848857|FG002|Overall Study|Protocol Violation|0|||
16872755|NCT01603628|37848855|FG000|Overall Study|Lost to Follow-up|0|||
16872756|NCT01603628|37848856|FG001|Overall Study|Lost to Follow-up|1|||
16872757|NCT01603628|37848857|FG002|Overall Study|Lost to Follow-up|0|||
16872758|NCT01603628|37848855|FG000|Overall Study|Other Miscellaneous Reason|1|||
16872759|NCT01603628|37848856|FG001|Overall Study|Other Miscellaneous Reason|0|||
16872760|NCT01603628|37848857|FG002|Overall Study|Other Miscellaneous Reason|0|||
16872761|NCT01453153|37848868|FG000|Overall Study|Physician Decision|0|||
16872762|NCT01453153|37848869|FG001|Overall Study|Physician Decision|0|||
16872763|NCT01453153|37848870|FG002|Overall Study|Physician Decision|1|||
16872764|NCT01453153|37848868|FG000|Overall Study|Progressive Disease|3|||
16872765|NCT01453153|37848869|FG001|Overall Study|Progressive Disease|2|||
16872766|NCT01453153|37848870|FG002|Overall Study|Progressive Disease|16|||
16872767|NCT01453153|37848868|FG000|Overall Study|Withdrawal by Subject|0|||
16872768|NCT01453153|37848869|FG001|Overall Study|Withdrawal by Subject|1|||
16872769|NCT01453153|37848870|FG002|Overall Study|Withdrawal by Subject|2|||
16872770|NCT01453153|37848868|FG000|Overall Study|Adverse Event|1|||
16872771|NCT01453153|37848869|FG001|Overall Study|Adverse Event|1|||
16872772|NCT01453153|37848870|FG002|Overall Study|Adverse Event|1|||
16872773|NCT01584440|37848884|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
16872774|NCT01584440|37848885|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
16872775|NCT01584440|37848886|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
16872776|NCT01584440|37848887|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
16872777|NCT01584440|37848888|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
16872778|NCT01584440|37848884|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
16872779|NCT01584440|37848885|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
16872780|NCT01584440|37848886|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
16872781|NCT01584440|37848887|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
16872782|NCT01584440|37848888|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
16872783|NCT01584440|37848884|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
16872784|NCT01584440|37848885|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
16872785|NCT01584440|37848886|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
16872786|NCT01584440|37848887|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
16784959|NCT00701701|37724970|FG000|Overall Study|Withdrawal by Subject|0|||
16784960|NCT00701701|37724971|FG001|Overall Study|Withdrawal by Subject|1|||
16784961|NCT00701701|37724970|FG000|Overall Study|Adverse Event|0|||
16784962|NCT00701701|37724971|FG001|Overall Study|Adverse Event|1|||
16784963|NCT01989754|37724980|FG000|Overall Study|Withdrawal by Subject|10|||
16784964|NCT01989754|37724981|FG001|Overall Study|Withdrawal by Subject|14|||
16784965|NCT01989754|37724980|FG000|Overall Study|Lost to Follow-up|28|||
16784966|NCT01989754|37724981|FG001|Overall Study|Lost to Follow-up|20|||
16872787|NCT01584440|37848888|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
16872788|NCT01584440|37848884|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
16872789|NCT01584440|37848885|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
16872790|NCT01584440|37848886|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
16872791|NCT01584440|37848887|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
16872792|NCT01584440|37848888|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
16872793|NCT01584440|37848884|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
16872794|NCT01584440|37848885|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
16872795|NCT01584440|37848886|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
16872796|NCT01584440|37848887|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
16872797|NCT01584440|37848888|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
16872798|NCT01584440|37848884|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
16872799|NCT01584440|37848885|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
16872800|NCT01584440|37848886|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
16872801|NCT01584440|37848887|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
17191312|NCT02477332|38344133|FG002|Overall Study|Lack of Efficacy|1|||
17191313|NCT02477332|38344134|FG003|Overall Study|Lack of Efficacy|2|||
17191314|NCT02477332|38344135|FG004|Overall Study|Lack of Efficacy|1|||
17191315|NCT02477332|38344136|FG005|Overall Study|Lack of Efficacy|1|||
17191316|NCT02477332|38344131|FG000|Overall Study|Non-compliance with study treatment|0|||
17191317|NCT02477332|38344132|FG001|Overall Study|Non-compliance with study treatment|1|||
17191318|NCT02477332|38344133|FG002|Overall Study|Non-compliance with study treatment|2|||
17191319|NCT02477332|38344134|FG003|Overall Study|Non-compliance with study treatment|0|||
17191320|NCT02477332|38344135|FG004|Overall Study|Non-compliance with study treatment|0|||
17191321|NCT02477332|38344136|FG005|Overall Study|Non-compliance with study treatment|0|||
17191322|NCT02477332|38344131|FG000|Overall Study|Pregnancy|0|||
17191323|NCT02477332|38344132|FG001|Overall Study|Pregnancy|0|||
17191324|NCT02477332|38344133|FG002|Overall Study|Pregnancy|0|||
17191325|NCT02477332|38344134|FG003|Overall Study|Pregnancy|1|||
17191326|NCT02477332|38344135|FG004|Overall Study|Pregnancy|0|||
17191327|NCT02477332|38344136|FG005|Overall Study|Pregnancy|0|||
17191328|NCT02477332|38344131|FG000|Overall Study|Protocol Violation|2|||
17191329|NCT02477332|38344132|FG001|Overall Study|Protocol Violation|0|||
17191330|NCT02477332|38344133|FG002|Overall Study|Protocol Violation|3|||
17191331|NCT02477332|38344134|FG003|Overall Study|Protocol Violation|3|||
17191332|NCT02477332|38344135|FG004|Overall Study|Protocol Violation|1|||
17191333|NCT02477332|38344136|FG005|Overall Study|Protocol Violation|1|||
17191334|NCT02477332|38344131|FG000|Overall Study|Technical problems|0|||
17191335|NCT02477332|38344132|FG001|Overall Study|Technical problems|0|||
17191336|NCT02477332|38344133|FG002|Overall Study|Technical problems|1|||
17191337|NCT02477332|38344134|FG003|Overall Study|Technical problems|0|||
17191338|NCT02477332|38344135|FG004|Overall Study|Technical problems|0|||
17191339|NCT02477332|38344136|FG005|Overall Study|Technical problems|0|||
17191340|NCT02477332|38344131|FG000|Overall Study|Lost to Follow-up|0|||
17191341|NCT02477332|38344132|FG001|Overall Study|Lost to Follow-up|0|||
17191342|NCT02477332|38344133|FG002|Overall Study|Lost to Follow-up|2|||
17191343|NCT02477332|38344134|FG003|Overall Study|Lost to Follow-up|0|||
17191344|NCT02477332|38344135|FG004|Overall Study|Lost to Follow-up|0|||
17191345|NCT02477332|38344136|FG005|Overall Study|Lost to Follow-up|0|||
17191346|NCT02477332|38344131|FG000|Overall Study|Physician Decision|0|||
17191347|NCT02477332|38344132|FG001|Overall Study|Physician Decision|0|||
17191348|NCT02477332|38344133|FG002|Overall Study|Physician Decision|1|||
17191349|NCT02477332|38344134|FG003|Overall Study|Physician Decision|3|||
17191350|NCT02477332|38344135|FG004|Overall Study|Physician Decision|0|||
17191351|NCT02477332|38344136|FG005|Overall Study|Physician Decision|1|||
17191352|NCT02477332|38344131|FG000|Overall Study|Withdrawal by Subject|0|||
17191353|NCT02477332|38344132|FG001|Overall Study|Withdrawal by Subject|3|||
17191354|NCT02477332|38344133|FG002|Overall Study|Withdrawal by Subject|1|||
17191355|NCT02477332|38344134|FG003|Overall Study|Withdrawal by Subject|2|||
17191356|NCT02477332|38344135|FG004|Overall Study|Withdrawal by Subject|1|||
17191357|NCT02477332|38344136|FG005|Overall Study|Withdrawal by Subject|0|||
17191358|NCT02477020|38344154|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
17191359|NCT02477020|38344155|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
17191360|NCT02477020|38344154|FG000|Overall Study|Voluntary Withdrawal|7|||
17191361|NCT02477020|38344155|FG001|Overall Study|Voluntary Withdrawal|16|||
17191362|NCT02477020|38344154|FG000|Overall Study|Reason not Specified|3|||
17191363|NCT02477020|38344155|FG001|Overall Study|Reason not Specified|1|||
17191364|NCT02477020|38344154|FG000|Overall Study|Lack of Efficacy|14|||
17191365|NCT02477020|38344155|FG001|Overall Study|Lack of Efficacy|5|||
17191366|NCT02862535|38344165|FG000|Overall Study|Death|7|||
17191367|NCT02862535|38344166|FG001|Overall Study|Death|3|||
17191368|NCT02862535|38344167|FG002|Overall Study|Death|2|||
17191369|NCT02862535|38344168|FG003|Overall Study|Death|5|||
17191370|NCT02862535|38344165|FG000|Overall Study|Study Terminated by Sponsor|1|||
17191371|NCT02862535|38344166|FG001|Overall Study|Study Terminated by Sponsor|3|||
17191372|NCT02862535|38344167|FG002|Overall Study|Study Terminated by Sponsor|8|||
17191373|NCT02862535|38344168|FG003|Overall Study|Study Terminated by Sponsor|5|||
17191374|NCT02862535|38344165|FG000|Overall Study|Enrolled, not Treated|1|||
17191375|NCT02862535|38344166|FG001|Overall Study|Enrolled, not Treated|0|||
17191376|NCT02862535|38344167|FG002|Overall Study|Enrolled, not Treated|0|||
17191377|NCT02862535|38344168|FG003|Overall Study|Enrolled, not Treated|1|||
17191378|NCT02448706|38344178|FG000|Overall Study|Withdrawal by Subject|4|||
17191379|NCT02448706|38344179|FG001|Overall Study|Withdrawal by Subject|3|||
17191380|NCT02448706|38344178|FG000|Overall Study|Protocol Violation|1|||
16872802|NCT01584440|37848888|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
16872803|NCT01584440|37848884|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
16872804|NCT01584440|37848885|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
16872805|NCT01584440|37848886|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
16872806|NCT01584440|37848887|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
16872807|NCT01584440|37848888|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
16872808|NCT01584440|37848884|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
16872809|NCT01584440|37848885|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
16872810|NCT01584440|37848886|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
16872811|NCT01584440|37848887|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
16872812|NCT01584440|37848888|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
16872813|NCT01584440|37848884|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
16872814|NCT01584440|37848885|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
16872815|NCT01584440|37848886|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
16872816|NCT01584440|37848887|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
16872817|NCT01584440|37848888|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
16872818|NCT01687478|37848903|FG000|Overall Study|Adverse Event|3|||
16872819|NCT01687478|37848904|FG001|Overall Study|Adverse Event|10|||
16872820|NCT01687478|37848903|FG000|Overall Study|Lost to Follow-up|1|||
16872821|NCT01687478|37848904|FG001|Overall Study|Lost to Follow-up|3|||
16872822|NCT01687478|37848903|FG000|Overall Study|Protocol Violation|0|||
16872823|NCT01687478|37848904|FG001|Overall Study|Protocol Violation|2|||
16872824|NCT01687478|37848903|FG000|Overall Study|Withdrawal by Subject|21|||
16872825|NCT01687478|37848904|FG001|Overall Study|Withdrawal by Subject|19|||
16872826|NCT01687478|37848903|FG000|Overall Study|Physician Decision|1|||
16872827|NCT01687478|37848904|FG001|Overall Study|Physician Decision|3|||
16872828|NCT01687478|37848903|FG000|Overall Study|Entry Criteria Not Met|6|||
16872829|NCT01687478|37848904|FG001|Overall Study|Entry Criteria Not Met|2|||
16872830|NCT01468909|37848912|FG000|Overall Study|Never Treated|2|||
16872831|NCT01468909|37848913|FG001|Overall Study|Never Treated|2|||
16872832|NCT01468597|37848919|FG000|Overall Study|Found ineligible|17|||
16872833|NCT01468597|37848919|FG000|Overall Study|concomitant valves|12|||
16872834|NCT01468597|37848919|FG000|Overall Study|off-pump CABG|1|||
16872835|NCT01468597|37848919|FG000|Overall Study|no platelet function data|5|||
16872836|NCT01687166|37848927|FG000|Overall Study|Attempt subject|2|||
16872837|NCT01687166|37848928|FG001|Overall Study|Attempt subject|3|||
16872838|NCT01687166|37848929|FG002|Overall Study|Attempt subject|2|||
16872839|NCT01687166|37848930|FG003|Overall Study|Attempt subject|0|||
16872840|NCT01687166|37848927|FG000|Overall Study|Did not meet eligibility criteria|4|||
16872841|NCT01687166|37848928|FG001|Overall Study|Did not meet eligibility criteria|6|||
16872842|NCT01687166|37848929|FG002|Overall Study|Did not meet eligibility criteria|1|||
16872843|NCT01687166|37848930|FG003|Overall Study|Did not meet eligibility criteria|1|||
16872844|NCT01687166|37848927|FG000|Overall Study|Adverse Event|2|||
16872845|NCT01687166|37848928|FG001|Overall Study|Adverse Event|1|||
16872846|NCT01687166|37848929|FG002|Overall Study|Adverse Event|0|||
16872847|NCT01687166|37848930|FG003|Overall Study|Adverse Event|0|||
16872848|NCT01687166|37848927|FG000|Overall Study|Physician Decision|3|||
16872849|NCT01687166|37848928|FG001|Overall Study|Physician Decision|2|||
16872850|NCT01687166|37848929|FG002|Overall Study|Physician Decision|1|||
16872851|NCT01687166|37848930|FG003|Overall Study|Physician Decision|0|||
16872852|NCT01687166|37848927|FG000|Overall Study|Withdrawal by Subject|11|||
16872853|NCT01687166|37848928|FG001|Overall Study|Withdrawal by Subject|4|||
16872854|NCT01687166|37848929|FG002|Overall Study|Withdrawal by Subject|3|||
16872855|NCT01687166|37848930|FG003|Overall Study|Withdrawal by Subject|0|||
16872856|NCT01687166|37848927|FG000|Overall Study|Lost to Follow-up|2|||
16872857|NCT01687166|37848928|FG001|Overall Study|Lost to Follow-up|5|||
16872858|NCT01687166|37848929|FG002|Overall Study|Lost to Follow-up|1|||
16872859|NCT01687166|37848930|FG003|Overall Study|Lost to Follow-up|0|||
16872860|NCT01687166|37848927|FG000|Overall Study|Equipment/Device Availability|0|||
16872861|NCT01687166|37848928|FG001|Overall Study|Equipment/Device Availability|1|||
16872862|NCT01687166|37848929|FG002|Overall Study|Equipment/Device Availability|0|||
16872863|NCT01687166|37848930|FG003|Overall Study|Equipment/Device Availability|0|||
16872864|NCT01687166|37848927|FG000|Overall Study|Death|1|||
16872865|NCT01687166|37848928|FG001|Overall Study|Death|1|||
16872866|NCT01687166|37848929|FG002|Overall Study|Death|0|||
16872867|NCT01687166|37848930|FG003|Overall Study|Death|0|||
16872868|NCT01687166|37848927|FG000|Overall Study|Protocol Violation|1|||
16872869|NCT01687166|37848928|FG001|Overall Study|Protocol Violation|1|||
16872870|NCT01687166|37848929|FG002|Overall Study|Protocol Violation|1|||
16872871|NCT01687166|37848930|FG003|Overall Study|Protocol Violation|0|||
16872872|NCT01687166|37848927|FG000|Overall Study|Subject moved out of state|0|||
16872873|NCT01687166|37848928|FG001|Overall Study|Subject moved out of state|1|||
16872874|NCT01687166|37848929|FG002|Overall Study|Subject moved out of state|0|||
16872875|NCT01687166|37848930|FG003|Overall Study|Subject moved out of state|0|||
16872876|NCT01687166|37848927|FG000|Overall Study|Patient unable to be compliant|1|||
16872877|NCT01687166|37848928|FG001|Overall Study|Patient unable to be compliant|0|||
16784967|NCT01989754|37724980|FG000|Overall Study|Closed Site|1|||
16872878|NCT01687166|37848929|FG002|Overall Study|Patient unable to be compliant|0|||
16872879|NCT01687166|37848930|FG003|Overall Study|Patient unable to be compliant|0|||
16872880|NCT01687166|37848927|FG000|Overall Study|Physician choice to use different device|1|||
16872881|NCT01687166|37848928|FG001|Overall Study|Physician choice to use different device|2|||
16872882|NCT01687166|37848929|FG002|Overall Study|Physician choice to use different device|4|||
16872883|NCT01687166|37848930|FG003|Overall Study|Physician choice to use different device|0|||
16872884|NCT01687166|37848927|FG000|Overall Study|Insurance|0|||
16872885|NCT01687166|37848928|FG001|Overall Study|Insurance|0|||
16872886|NCT01687166|37848929|FG002|Overall Study|Insurance|1|||
16872887|NCT01687166|37848930|FG003|Overall Study|Insurance|1|||
16872888|NCT01561976|37848944|FG000|Period 1|Adverse Event|0|||
16872889|NCT01561976|37848945|FG001|Period 1|Adverse Event|0|||
16872890|NCT01561976|37848946|FG002|Period 1|Adverse Event|1|||
16872891|NCT01561976|37848947|FG003|Period 1|Adverse Event|0|||
16872892|NCT01561976|37848948|FG004|Period 1|Adverse Event|0|||
16872893|NCT01561976|37848949|FG005|Period 1|Adverse Event|0|||
16872894|NCT01561976|37848944|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
16872895|NCT01561976|37848945|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
16872896|NCT01561976|37848946|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
16872897|NCT01561976|37848947|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
16872898|NCT01561976|37848948|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
16872899|NCT01561976|37848949|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
16872900|NCT01561976|37848944|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16872901|NCT01561976|37848945|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16872902|NCT01561976|37848946|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16872903|NCT01561976|37848947|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16872904|NCT01561976|37848948|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16872905|NCT01561976|37848949|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16872906|NCT01561976|37848944|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
16872907|NCT01561976|37848945|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
16872908|NCT01561976|37848946|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
16872909|NCT01561976|37848947|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
16872910|NCT01561976|37848948|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
16872911|NCT01561976|37848949|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
16872912|NCT01686932|37848959|FG000|Period 1|Adverse Event|1|||
16872913|NCT01686932|37848960|FG001|Period 1|Adverse Event|1|||
16872914|NCT01468207|37848968|FG000|Treatment Period 1|Adverse Event|1|||
16872915|NCT01468207|37848969|FG001|Treatment Period 1|Adverse Event|0|||
16872916|NCT01468207|37848970|FG002|Treatment Period 1|Adverse Event|0|||
16872917|NCT01468207|37848971|FG003|Treatment Period 1|Adverse Event|0|||
16872918|NCT01468207|37848972|FG004|Treatment Period 1|Adverse Event|0|||
16872919|NCT01468207|37848973|FG005|Treatment Period 1|Adverse Event|0|||
16872920|NCT01468207|37848968|FG000|Treatment Period 1|Protocol Violation|1|||
16872921|NCT01468207|37848969|FG001|Treatment Period 1|Protocol Violation|1|||
16872922|NCT01468207|37848970|FG002|Treatment Period 1|Protocol Violation|0|||
16872923|NCT01468207|37848971|FG003|Treatment Period 1|Protocol Violation|0|||
16872924|NCT01468207|37848972|FG004|Treatment Period 1|Protocol Violation|0|||
16872925|NCT01468207|37848973|FG005|Treatment Period 1|Protocol Violation|0|||
16872926|NCT01468207|37848968|FG000|Treatment Period 1|Withdrawal by Subject|5|||
16872927|NCT01468207|37848969|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16872928|NCT01468207|37848970|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16872929|NCT01468207|37848971|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16872930|NCT01468207|37848972|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16872931|NCT01468207|37848973|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16872932|NCT01468207|37848968|FG000|Treatment Period 1|Lost to Follow-up|2|||
16872933|NCT01468207|37848969|FG001|Treatment Period 1|Lost to Follow-up|1|||
16872934|NCT01468207|37848970|FG002|Treatment Period 1|Lost to Follow-up|0|||
16872935|NCT01468207|37848971|FG003|Treatment Period 1|Lost to Follow-up|0|||
16872936|NCT01468207|37848972|FG004|Treatment Period 1|Lost to Follow-up|0|||
16872937|NCT01468207|37848973|FG005|Treatment Period 1|Lost to Follow-up|0|||
16872938|NCT01468207|37848968|FG000|Treatment Period 1|Other|0|||
16872939|NCT01468207|37848969|FG001|Treatment Period 1|Other|2|||
16784968|NCT01989754|37724981|FG001|Overall Study|Closed Site|1|||
16784969|NCT01619878|37724987|FG000|6 Week Follow-up Phase|Adverse Event|1|||
16784970|NCT01619878|37724987|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
16872940|NCT01468207|37848970|FG002|Treatment Period 1|Other|0|||
16872941|NCT01468207|37848971|FG003|Treatment Period 1|Other|0|||
16872942|NCT01468207|37848972|FG004|Treatment Period 1|Other|0|||
16872943|NCT01468207|37848973|FG005|Treatment Period 1|Other|0|||
16872944|NCT01468207|37848968|FG000|Treatment Period 2|Adverse Event|0|||
16784971|NCT01619878|37724987|FG000|Follow-up at 12 Months of Age|Death|2|||
16784972|NCT02015104|37724993|FG000|Overall Study|Withdrew consent after first dose drug|1|||
16784973|NCT02015104|37724994|FG001|Overall Study|Withdrew consent after first dose drug|0|||
16784974|NCT02015104|37724993|FG000|Overall Study|Withdrew consent prior to treatment|0|||
16872945|NCT01468207|37848969|FG001|Treatment Period 2|Adverse Event|0|||
16872946|NCT01468207|37848970|FG002|Treatment Period 2|Adverse Event|6|||
16872947|NCT01468207|37848971|FG003|Treatment Period 2|Adverse Event|1|||
16784975|NCT02015104|37724994|FG001|Overall Study|Withdrew consent prior to treatment|1|||
16784976|NCT01619800|37725005|FG000|Overall Study|study terminated|2|||
16784977|NCT01619800|37725006|FG001|Overall Study|study terminated|0|||
16784978|NCT01989208|37725014|FG000|200 mg (7 Days)|Protocol Violation|0|||
16784979|NCT01989208|37725015|FG001|200 mg (7 Days)|Protocol Violation|1|||
16784980|NCT01619410|37725035|FG000|Overall Study|Lost to Follow-up|7|||
16784981|NCT01619410|37725036|FG001|Overall Study|Lost to Follow-up|4|||
16784982|NCT01966042|37725042|FG000|Overall Study|Death|2|||
16784983|NCT02014480|37725046|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16784984|NCT02014480|37725047|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16784985|NCT02014480|37725048|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
16784986|NCT02014480|37725049|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16784987|NCT02014480|37725050|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16784988|NCT02014480|37725051|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16784989|NCT02014480|37725046|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16784990|NCT02014480|37725047|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16784991|NCT02014480|37725048|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16784992|NCT02014480|37725049|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
16784993|NCT02014480|37725050|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16784994|NCT02014480|37725051|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16872948|NCT01468207|37848972|FG004|Treatment Period 2|Adverse Event|2|||
16872949|NCT01468207|37848973|FG005|Treatment Period 2|Adverse Event|1|||
16872950|NCT01468207|37848968|FG000|Treatment Period 2|Lack of Efficacy|0|||
16872951|NCT01468207|37848969|FG001|Treatment Period 2|Lack of Efficacy|0|||
16872952|NCT01468207|37848970|FG002|Treatment Period 2|Lack of Efficacy|1|||
16872953|NCT01468207|37848971|FG003|Treatment Period 2|Lack of Efficacy|1|||
16872954|NCT01468207|37848972|FG004|Treatment Period 2|Lack of Efficacy|0|||
16872955|NCT01468207|37848973|FG005|Treatment Period 2|Lack of Efficacy|2|||
16872956|NCT01468207|37848968|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16872957|NCT01468207|37848969|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16872958|NCT01468207|37848970|FG002|Treatment Period 2|Withdrawal by Subject|5|||
16872959|NCT01468207|37848971|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16872960|NCT01468207|37848972|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16872961|NCT01468207|37848973|FG005|Treatment Period 2|Withdrawal by Subject|2|||
16872962|NCT01468207|37848968|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
16872963|NCT01468207|37848969|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
16872964|NCT01468207|37848970|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
16872965|NCT01468207|37848971|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
16872966|NCT01468207|37848972|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
16872967|NCT01468207|37848973|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
16872968|NCT01468207|37848968|FG000|Treatment Period 2|Lost to Follow-up|0|||
16872969|NCT01468207|37848969|FG001|Treatment Period 2|Lost to Follow-up|0|||
16872970|NCT01468207|37848970|FG002|Treatment Period 2|Lost to Follow-up|5|||
16872971|NCT01468207|37848971|FG003|Treatment Period 2|Lost to Follow-up|1|||
16872972|NCT01468207|37848972|FG004|Treatment Period 2|Lost to Follow-up|0|||
16872973|NCT01468207|37848973|FG005|Treatment Period 2|Lost to Follow-up|0|||
16872974|NCT01468207|37848968|FG000|Treatment Period 2|Other|0|||
16872975|NCT01468207|37848969|FG001|Treatment Period 2|Other|0|||
16872976|NCT01468207|37848970|FG002|Treatment Period 2|Other|5|||
16872977|NCT01468207|37848971|FG003|Treatment Period 2|Other|1|||
16872978|NCT01468207|37848972|FG004|Treatment Period 2|Other|1|||
16872979|NCT01468207|37848973|FG005|Treatment Period 2|Other|2|||
16872980|NCT01494649|37848993|FG000|Overall Study|Lost to Follow-up|0|||
16872981|NCT01494649|37848994|FG001|Overall Study|Lost to Follow-up|1|||
16872982|NCT01686152|37849005|FG000|Overall Study|Withdrawal by Subject|11|||
16872983|NCT01686152|37849006|FG001|Overall Study|Withdrawal by Subject|11|||
16872984|NCT01686152|37849007|FG002|Overall Study|Withdrawal by Subject|3|||
16872985|NCT01686152|37849005|FG000|Overall Study|Drug Code Unblinded|0|||
16872986|NCT01686152|37849006|FG001|Overall Study|Drug Code Unblinded|1|||
16872987|NCT01686152|37849007|FG002|Overall Study|Drug Code Unblinded|0|||
16872988|NCT01686152|37849005|FG000|Overall Study|Protocol Violation|6|||
16872989|NCT01686152|37849006|FG001|Overall Study|Protocol Violation|1|||
16872990|NCT01686152|37849007|FG002|Overall Study|Protocol Violation|0|||
16872991|NCT01686152|37849005|FG000|Overall Study|Adverse Event|12|||
16872992|NCT01686152|37849006|FG001|Overall Study|Adverse Event|11|||
16872993|NCT01686152|37849007|FG002|Overall Study|Adverse Event|0|||
16872994|NCT01686152|37849005|FG000|Overall Study|Lack of Efficacy|0|||
16872995|NCT01686152|37849006|FG001|Overall Study|Lack of Efficacy|0|||
16872996|NCT01686152|37849007|FG002|Overall Study|Lack of Efficacy|1|||
16872997|NCT01686152|37849005|FG000|Overall Study|IP Non-compliance|5|||
16872998|NCT01686152|37849006|FG001|Overall Study|IP Non-compliance|5|||
16872999|NCT01686152|37849007|FG002|Overall Study|IP Non-compliance|0|||
16873000|NCT01686152|37849005|FG000|Overall Study|Lost to Follow-up|7|||
16873001|NCT01686152|37849006|FG001|Overall Study|Lost to Follow-up|6|||
16873002|NCT01686152|37849007|FG002|Overall Study|Lost to Follow-up|5|||
16784995|NCT02014480|37725046|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16784996|NCT02014480|37725047|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16784997|NCT02014480|37725048|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
16784998|NCT02014480|37725049|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16784999|NCT02014480|37725050|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16785000|NCT02014480|37725051|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16785001|NCT02014480|37725046|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16785002|NCT02014480|37725047|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16785003|NCT02014480|37725048|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
16785004|NCT02014480|37725049|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16785005|NCT02014480|37725050|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16873003|NCT01452919|37849015|FG000|Open-Label Treatment|Adverse Event|5|||
16873004|NCT01452919|37849016|FG001|Open-Label Treatment|Adverse Event|0|||
16873005|NCT01452919|37849017|FG002|Open-Label Treatment|Adverse Event|0|||
16873006|NCT01452919|37849015|FG000|Open-Label Treatment|Lost to Follow-up|4|||
16873007|NCT01452919|37849016|FG001|Open-Label Treatment|Lost to Follow-up|0|||
16873008|NCT01452919|37849017|FG002|Open-Label Treatment|Lost to Follow-up|0|||
16873009|NCT01452919|37849015|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
16873010|NCT01452919|37849016|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
16873011|NCT01452919|37849017|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
16873012|NCT01452919|37849015|FG000|Open-Label Treatment|Protocol Violation|4|||
16873013|NCT01452919|37849016|FG001|Open-Label Treatment|Protocol Violation|0|||
16873014|NCT01452919|37849017|FG002|Open-Label Treatment|Protocol Violation|0|||
16873015|NCT01452919|37849015|FG000|Open-Label Treatment|Sponsor Decision|1|||
16873016|NCT01452919|37849016|FG001|Open-Label Treatment|Sponsor Decision|0|||
16873017|NCT01452919|37849017|FG002|Open-Label Treatment|Sponsor Decision|0|||
16873018|NCT01452919|37849015|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
16873019|NCT01452919|37849016|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
16873020|NCT01452919|37849017|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
16873021|NCT01452919|37849015|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
16873022|NCT01452919|37849016|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
16873023|NCT01452919|37849017|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
16873024|NCT01452919|37849015|FG000|Randomization Treatment|Adverse Event|0|||
16873025|NCT01452919|37849016|FG001|Randomization Treatment|Adverse Event|0|||
16873026|NCT01452919|37849017|FG002|Randomization Treatment|Adverse Event|2|||
16873027|NCT01452919|37849015|FG000|Randomization Treatment|Sponsor Decision|0|||
16873028|NCT01452919|37849016|FG001|Randomization Treatment|Sponsor Decision|1|||
16873029|NCT01452919|37849017|FG002|Randomization Treatment|Sponsor Decision|0|||
16873030|NCT01452919|37849015|FG000|Randomization Treatment|Withdrawal by Subject|0|||
16785006|NCT02014480|37725051|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16785007|NCT02014480|37725046|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16785008|NCT02014480|37725047|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
16785009|NCT02014480|37725048|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16785010|NCT02014480|37725049|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16785011|NCT02014480|37725050|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16785012|NCT02014480|37725051|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16785013|NCT02014480|37725046|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
16785014|NCT02014480|37725047|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
16785015|NCT02014480|37725048|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
16873031|NCT01452919|37849016|FG001|Randomization Treatment|Withdrawal by Subject|1|||
16873032|NCT01452919|37849017|FG002|Randomization Treatment|Withdrawal by Subject|0|||
16873033|NCT01452919|37849015|FG000|Randomization Treatment|Subject is moving or has moved|0|||
16785016|NCT02014480|37725049|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
16785017|NCT02014480|37725050|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
16873034|NCT01452919|37849016|FG001|Randomization Treatment|Subject is moving or has moved|1|||
16873035|NCT01452919|37849017|FG002|Randomization Treatment|Subject is moving or has moved|0|||
16873036|NCT01582178|37849029|FG000|Overall Study|Physician Decision|6|||
16873037|NCT01582178|37849030|FG001|Overall Study|Physician Decision|5|||
16873038|NCT01561898|37849040|FG000|Overall Study|Withdrawal by Subject|0|||
16873039|NCT01561898|37849041|FG001|Overall Study|Withdrawal by Subject|8|||
16873040|NCT01561898|37849042|FG002|Overall Study|Withdrawal by Subject|12|||
16873041|NCT01561898|37849043|FG003|Overall Study|Withdrawal by Subject|5|||
16873042|NCT01561898|37849040|FG000|Overall Study|Lack of Efficacy|0|||
16873043|NCT01561898|37849041|FG001|Overall Study|Lack of Efficacy|8|||
16873044|NCT01561898|37849042|FG002|Overall Study|Lack of Efficacy|10|||
16873045|NCT01561898|37849043|FG003|Overall Study|Lack of Efficacy|5|||
16873046|NCT01561898|37849040|FG000|Overall Study|Worsening of complications|0|||
16873047|NCT01561898|37849041|FG001|Overall Study|Worsening of complications|1|||
16785018|NCT02014480|37725051|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
16785019|NCT02014480|37725046|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16785020|NCT02014480|37725047|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16785021|NCT02014480|37725048|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16785022|NCT02014480|37725049|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16785023|NCT02014480|37725050|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16785024|NCT02014480|37725051|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
16873048|NCT01561898|37849042|FG002|Overall Study|Worsening of complications|0|||
16873049|NCT01561898|37849043|FG003|Overall Study|Worsening of complications|0|||
16873050|NCT01561898|37849040|FG000|Overall Study|Lost to Follow-up|0|||
16873051|NCT01561898|37849041|FG001|Overall Study|Lost to Follow-up|0|||
16873052|NCT01561898|37849042|FG002|Overall Study|Lost to Follow-up|1|||
16873053|NCT01561898|37849043|FG003|Overall Study|Lost to Follow-up|0|||
16873054|NCT01561898|37849040|FG000|Overall Study|Adverse Event|1|||
16873055|NCT01561898|37849041|FG001|Overall Study|Adverse Event|19|||
16873056|NCT01561898|37849042|FG002|Overall Study|Adverse Event|14|||
16873057|NCT01561898|37849043|FG003|Overall Study|Adverse Event|9|||
16873058|NCT01561898|37849040|FG000|Overall Study|Physician Decision|1|||
16873059|NCT01561898|37849041|FG001|Overall Study|Physician Decision|5|||
16873060|NCT01561898|37849042|FG002|Overall Study|Physician Decision|7|||
16873061|NCT01561898|37849043|FG003|Overall Study|Physician Decision|1|||
16873062|NCT01685840|37849053|FG000|Overall Study|Death|77|||
16873063|NCT01685840|37849054|FG001|Overall Study|Death|66|||
16873064|NCT01685840|37849053|FG000|Overall Study|Lost to Follow-up|27|||
16873065|NCT01685840|37849054|FG001|Overall Study|Lost to Follow-up|25|||
16873066|NCT01685840|37849053|FG000|Overall Study|Physician Decision|3|||
16873067|NCT01685840|37849054|FG001|Overall Study|Physician Decision|7|||
16873068|NCT01685840|37849053|FG000|Overall Study|Withdrawal by Subject|14|||
16873069|NCT01685840|37849054|FG001|Overall Study|Withdrawal by Subject|17|||
16873070|NCT01685840|37849053|FG000|Overall Study|Futility|197|||
16873071|NCT01685840|37849054|FG001|Overall Study|Futility|200|||
16873072|NCT01685840|37849053|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
16873073|NCT01685840|37849054|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
16873074|NCT01452529|37849064|FG000|Run-in Period|Adverse Event|96|||
16873075|NCT01452529|37849065|FG001|Run-in Period|Adverse Event|0|||
16873076|NCT01452529|37849066|FG002|Run-in Period|Adverse Event|0|||
16873077|NCT01452529|37849064|FG000|Run-in Period|Withdrawal by Subject|49|||
16873078|NCT01452529|37849065|FG001|Run-in Period|Withdrawal by Subject|0|||
16873079|NCT01452529|37849066|FG002|Run-in Period|Withdrawal by Subject|0|||
16785025|NCT01668719|37725062|FG000|Phase I|On treatment|1|||
16785026|NCT01668719|37725063|FG001|Phase I|On treatment|0|||
16785027|NCT01668719|37725064|FG002|Phase I|On treatment|0|||
16785028|NCT01668719|37725062|FG000|Phase I|Adverse Event|2|||
16785029|NCT01668719|37725063|FG001|Phase I|Adverse Event|0|||
16785030|NCT01668719|37725064|FG002|Phase I|Adverse Event|0|||
16785031|NCT01668719|37725062|FG000|Phase I|Progression/relapse|1|||
16785032|NCT01668719|37725063|FG001|Phase I|Progression/relapse|0|||
16785033|NCT01668719|37725064|FG002|Phase I|Progression/relapse|0|||
16873080|NCT01452529|37849064|FG000|Run-in Period|Lost to Follow-up|19|||
16873081|NCT01452529|37849065|FG001|Run-in Period|Lost to Follow-up|0|||
16873082|NCT01452529|37849066|FG002|Run-in Period|Lost to Follow-up|0|||
16873083|NCT01452529|37849064|FG000|Run-in Period|Lack of Efficacy|46|||
16873084|NCT01452529|37849065|FG001|Run-in Period|Lack of Efficacy|0|||
16873085|NCT01452529|37849066|FG002|Run-in Period|Lack of Efficacy|0|||
16873086|NCT01452529|37849064|FG000|Run-in Period|Confirmed or suspected diversion|23|||
16873087|NCT01452529|37849065|FG001|Run-in Period|Confirmed or suspected diversion|0|||
16873088|NCT01452529|37849066|FG002|Run-in Period|Confirmed or suspected diversion|0|||
16873089|NCT01452529|37849064|FG000|Run-in Period|Administrative|21|||
16873090|NCT01452529|37849065|FG001|Run-in Period|Administrative|0|||
16873091|NCT01452529|37849066|FG002|Run-in Period|Administrative|0|||
16873092|NCT01452529|37849064|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
16873093|NCT01452529|37849065|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
16873094|NCT01452529|37849066|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
16873095|NCT01452529|37849064|FG000|Double-blind (DB) Period|Adverse Event|0|||
16873096|NCT01452529|37849065|FG001|Double-blind (DB) Period|Adverse Event|18|||
16873097|NCT01452529|37849066|FG002|Double-blind (DB) Period|Adverse Event|11|||
16873098|NCT01452529|37849064|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
16873099|NCT01452529|37849065|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
16873100|NCT01452529|37849066|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
16873101|NCT01452529|37849064|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
16873102|NCT01452529|37849065|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
16873103|NCT01452529|37849066|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
16873104|NCT01452529|37849064|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
16873105|NCT01452529|37849065|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
16873106|NCT01452529|37849066|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
16873107|NCT01452529|37849064|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
16873108|NCT01452529|37849065|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
17191381|NCT02448706|38344179|FG001|Overall Study|Protocol Violation|1|||
16785034|NCT01668719|37725062|FG000|Phase I|not protocol specified|2|||
16785035|NCT01668719|37725063|FG001|Phase I|not protocol specified|0|||
16785036|NCT01668719|37725064|FG002|Phase I|not protocol specified|0|||
16785037|NCT01668719|37725062|FG000|Phase II|On treatment|0|||
16873109|NCT01452529|37849066|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
16873110|NCT01452529|37849064|FG000|Double-blind (DB) Period|Administrative|0|||
16873111|NCT01452529|37849065|FG001|Double-blind (DB) Period|Administrative|11|||
16873112|NCT01452529|37849066|FG002|Double-blind (DB) Period|Administrative|7|||
16873113|NCT01560416|37849075|FG000|Randomized Phase|Crossover Participants|7|||
16873114|NCT01560416|37849076|FG001|Randomized Phase|Crossover Participants|0|||
16873115|NCT01685606|37849084|FG000|Overall Study|Withdrawal by Subject|1|||
16873116|NCT01685372|37849090|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
16873117|NCT01685372|37849091|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
16873118|NCT01685216|37849097|FG000|Overall Study|Did not receive study drug|1|||
16873119|NCT01685138|37849101|FG000|Overall Study|Lost to Follow-up|1|||
16873120|NCT01685138|37849101|FG000|Overall Study|Protocol Violation|1|||
16873121|NCT01685138|37849101|FG000|Overall Study|No longer requires treatment|1|||
16873122|NCT01685138|37849101|FG000|Overall Study|Subject/guardian decision|2|||
16873123|NCT01685138|37849101|FG000|Overall Study|Physician Decision|6|||
16873124|NCT01685138|37849101|FG000|Overall Study|Death|10|||
16873125|NCT01685138|37849101|FG000|Overall Study|Adverse Event|18|||
16873126|NCT01685138|37849101|FG000|Overall Study|Progressive disease|53|||
16873127|NCT01685060|37849105|FG000|Overall Study|Rollover patients|16|||
16873128|NCT01685060|37849105|FG000|Overall Study|Adverse Event|12|||
16873129|NCT01685060|37849105|FG000|Overall Study|Progressive disease|69|||
16873130|NCT01685060|37849105|FG000|Overall Study|Physician Decision|14|||
16873131|NCT01685060|37849105|FG000|Overall Study|Subject/guardian decision|20|||
16873132|NCT01685060|37849105|FG000|Overall Study|Lost to Follow-up|1|||
16873133|NCT01685060|37849105|FG000|Overall Study|Death|8|||
16873134|NCT01582100|37849109|FG000|Overall Study|Adverse Event|1|||
16873135|NCT01582100|37849109|FG000|Overall Study|Withdrawal by Subject|1|||
16873136|NCT01579916|37849115|FG000|Overall Study|Lost to Follow-up|6|||
16873137|NCT01579916|37849116|FG001|Overall Study|Lost to Follow-up|1|||
16873138|NCT01579916|37849115|FG000|Overall Study|Withdrawal by Subject|1|||
16873139|NCT01579916|37849116|FG001|Overall Study|Withdrawal by Subject|1|||
16873140|NCT01579916|37849115|FG000|Overall Study|Death|1|||
16873141|NCT01579916|37849116|FG001|Overall Study|Death|0|||
16873142|NCT01684202|37849126|FG000|Dose-escalation Period|Adverse Event|0|||
16873143|NCT01684202|37849127|FG001|Dose-escalation Period|Adverse Event|1|||
16873144|NCT01684202|37849128|FG002|Dose-escalation Period|Adverse Event|0|||
16873145|NCT01684202|37849129|FG003|Dose-escalation Period|Adverse Event|0|||
16873146|NCT01684202|37849126|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
16785038|NCT01668719|37725063|FG001|Phase II|On treatment|4|||
16785039|NCT01668719|37725064|FG002|Phase II|On treatment|3|||
16785040|NCT01668719|37725062|FG000|Phase II|Adverse Event|0|||
16785041|NCT01668719|37725063|FG001|Phase II|Adverse Event|18|||
16785042|NCT01668719|37725064|FG002|Phase II|Adverse Event|18|||
16785043|NCT01668719|37725062|FG000|Phase II|Refusal unrelated to adverse event|0|||
16785044|NCT01668719|37725063|FG001|Phase II|Refusal unrelated to adverse event|4|||
16785045|NCT01668719|37725064|FG002|Phase II|Refusal unrelated to adverse event|1|||
16873147|NCT01684202|37849127|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
16873148|NCT01684202|37849128|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
16873149|NCT01684202|37849129|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
16873150|NCT01684202|37849126|FG000|Maintenance Period|Adverse Event|1|||
16873151|NCT01684202|37849127|FG001|Maintenance Period|Adverse Event|1|||
16873152|NCT01684202|37849128|FG002|Maintenance Period|Adverse Event|1|||
16873153|NCT01684202|37849129|FG003|Maintenance Period|Adverse Event|1|||
16873154|NCT01684202|37849126|FG000|Maintenance Period|Physician Decision|0|||
16873155|NCT01684202|37849127|FG001|Maintenance Period|Physician Decision|1|||
16873156|NCT01684202|37849128|FG002|Maintenance Period|Physician Decision|0|||
16873157|NCT01684202|37849129|FG003|Maintenance Period|Physician Decision|0|||
16873158|NCT01684202|37849126|FG000|Maintenance Period|Withdrawal by Subject|0|||
16873159|NCT01684202|37849127|FG001|Maintenance Period|Withdrawal by Subject|1|||
16873160|NCT01684202|37849128|FG002|Maintenance Period|Withdrawal by Subject|0|||
16873161|NCT01684202|37849129|FG003|Maintenance Period|Withdrawal by Subject|0|||
16873162|NCT01684046|37849139|FG000|Period 1, First 30 Days|Adverse Event|0|||
16873163|NCT01684046|37849140|FG001|Period 1, First 30 Days|Adverse Event|2|||
16873164|NCT01559090|37849149|FG000|Stage I|Withdrawal by Subject|2|||
16873165|NCT01559090|37849150|FG001|Stage I|Withdrawal by Subject|2|||
16873166|NCT01559090|37849151|FG002|Stage I|Withdrawal by Subject|3|||
16873167|NCT01559090|37849149|FG000|Stage II|Withdrawal by Subject|1|||
16873168|NCT01559090|37849150|FG001|Stage II|Withdrawal by Subject|0|||
16873169|NCT01559090|37849151|FG002|Stage II|Withdrawal by Subject|0|||
16873170|NCT01683266|37849161|FG000|Overall Study|Adverse Event|5|||
16873171|NCT01683266|37849162|FG001|Overall Study|Adverse Event|4|||
16873172|NCT01683266|37849161|FG000|Overall Study|Lack of Efficacy|5|||
16873173|NCT01683266|37849162|FG001|Overall Study|Lack of Efficacy|2|||
16873174|NCT01683266|37849161|FG000|Overall Study|Protocol Violation|13|||
16873175|NCT01683266|37849162|FG001|Overall Study|Protocol Violation|6|||
16785046|NCT01668719|37725062|FG000|Phase II|Progression/relapse|0|||
16785047|NCT01668719|37725063|FG001|Phase II|Progression/relapse|13|||
16873176|NCT01683266|37849161|FG000|Overall Study|Personal Reason|17|||
16873177|NCT01683266|37849162|FG001|Overall Study|Personal Reason|25|||
16873178|NCT01683266|37849161|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
16873179|NCT01683266|37849162|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
16873180|NCT01683266|37849161|FG000|Overall Study|Lost to Follow-up|5|||
16873181|NCT01683266|37849162|FG001|Overall Study|Lost to Follow-up|0|||
16873182|NCT01683266|37849161|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
16873183|NCT01683266|37849162|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
16873184|NCT01683266|37849161|FG000|Overall Study|Nonserious Hypoglycemia|0|||
16873185|NCT01683266|37849162|FG001|Overall Study|Nonserious Hypoglycemia|3|||
16873186|NCT01683266|37849161|FG000|Overall Study|Perceived Lack of Efficacy|1|||
16873187|NCT01683266|37849162|FG001|Overall Study|Perceived Lack of Efficacy|1|||
16873188|NCT01683266|37849161|FG000|Overall Study|Possibly Hypoglycemia|1|||
16873189|NCT01683266|37849162|FG001|Overall Study|Possibly Hypoglycemia|0|||
16873190|NCT01683266|37849161|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
16873191|NCT01683266|37849162|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
16873192|NCT01467661|37849168|FG000|Overall Study|Adverse Event|16|||
16873193|NCT01467661|37849168|FG000|Overall Study|Withdrawal by Subject|1|||
16873194|NCT01467661|37849168|FG000|Overall Study|Lack of Efficacy|3|||
16873195|NCT01467661|37849168|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
16873196|NCT01577186|37849174|FG000|Overall Study|Adverse Event|23|||
16873197|NCT01577186|37849174|FG000|Overall Study|Death|1|||
16873198|NCT01577186|37849174|FG000|Overall Study|Lost to Follow-up|28|||
16873199|NCT01577186|37849174|FG000|Overall Study|Withdrawal by Subject|35|||
16873200|NCT01577186|37849174|FG000|Overall Study|Insufficient Response|18|||
16873201|NCT01577186|37849174|FG000|Overall Study|Ineligible to Continue|15|||
16873202|NCT01577186|37849174|FG000|Overall Study|Non-Compliant|8|||
16873203|NCT01577186|37849174|FG000|Overall Study|Other|2|||
16873204|NCT01559012|37849180|FG000|Overall Study|Withdrawal by Subject|0|||
16873205|NCT01559012|37849181|FG001|Overall Study|Withdrawal by Subject|1|||
16873206|NCT01451827|37849206|FG000|Overall Study|Adverse Event|2|||
16873207|NCT01451827|37849207|FG001|Overall Study|Adverse Event|0|||
16873208|NCT01451827|37849208|FG002|Overall Study|Adverse Event|1|||
16873209|NCT01451827|37849209|FG003|Overall Study|Adverse Event|1|||
16873210|NCT01451827|37849206|FG000|Overall Study|Protocol deviation|1|||
16873211|NCT01451827|37849207|FG001|Overall Study|Protocol deviation|0|||
16873212|NCT01451827|37849208|FG002|Overall Study|Protocol deviation|0|||
16873213|NCT01451827|37849209|FG003|Overall Study|Protocol deviation|0|||
16873214|NCT01451827|37849206|FG000|Overall Study|Lost to Follow-up|0|||
16873215|NCT01451827|37849207|FG001|Overall Study|Lost to Follow-up|3|||
16873216|NCT01451827|37849208|FG002|Overall Study|Lost to Follow-up|0|||
16873217|NCT01451827|37849209|FG003|Overall Study|Lost to Follow-up|2|||
16873218|NCT01451827|37849206|FG000|Overall Study|Participant met withdrawal criteria|0|||
16785048|NCT01668719|37725064|FG002|Phase II|Progression/relapse|17|||
16785049|NCT01668719|37725062|FG000|Phase II|Death|0|||
16785050|NCT01668719|37725063|FG001|Phase II|Death|0|||
16873219|NCT01451827|37849207|FG001|Overall Study|Participant met withdrawal criteria|2|||
16873220|NCT01451827|37849208|FG002|Overall Study|Participant met withdrawal criteria|0|||
16873221|NCT01451827|37849209|FG003|Overall Study|Participant met withdrawal criteria|0|||
16785051|NCT01668719|37725064|FG002|Phase II|Death|2|||
16785052|NCT01668719|37725062|FG000|Phase II|not protocol specified|0|||
16785053|NCT01668719|37725063|FG001|Phase II|not protocol specified|13|||
16785054|NCT01668719|37725064|FG002|Phase II|not protocol specified|7|||
16785055|NCT01261247|37725074|FG000|Overall Study|Ineligible|2|||
16785056|NCT01677767|37725078|FG000|Overall Study|Adverse Event|1|||
16873222|NCT01451827|37849206|FG000|Overall Study|Withdrawal by Subject|0|||
16873223|NCT01451827|37849207|FG001|Overall Study|Withdrawal by Subject|0|||
16873224|NCT01451827|37849208|FG002|Overall Study|Withdrawal by Subject|1|||
16873225|NCT01451827|37849209|FG003|Overall Study|Withdrawal by Subject|1|||
16873226|NCT01557920|37849219|FG000|Overall Study|Withdrawal by Subject|2|||
16873227|NCT01557920|37849220|FG001|Overall Study|Withdrawal by Subject|3|||
16873228|NCT01557920|37849219|FG000|Overall Study|Lack of Efficacy|1|||
16873229|NCT01557920|37849220|FG001|Overall Study|Lack of Efficacy|0|||
16873230|NCT01467583|37849256|FG000|Overall Study|Death|1|||
16873231|NCT01467583|37849257|FG001|Overall Study|Death|1|||
16873232|NCT01467583|37849258|FG002|Overall Study|Death|0|||
16873233|NCT01467583|37849256|FG000|Overall Study|Withdrawal by Subject|1|||
16873234|NCT01467583|37849257|FG001|Overall Study|Withdrawal by Subject|0|||
16873235|NCT01467583|37849258|FG002|Overall Study|Withdrawal by Subject|0|||
16873236|NCT01467583|37849256|FG000|Overall Study|Protocol Violation|0|||
16873237|NCT01467583|37849257|FG001|Overall Study|Protocol Violation|0|||
16873238|NCT01467583|37849258|FG002|Overall Study|Protocol Violation|2|||
16873239|NCT01576718|37849275|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
16785057|NCT01677767|37725078|FG000|Overall Study|Death|4|||
16785058|NCT01677767|37725078|FG000|Overall Study|Protocol Violation|4|||
16785059|NCT01677767|37725078|FG000|Overall Study|Withdrawal by Subject|10|||
16873240|NCT01576718|37849276|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
17191382|NCT02868281|38344189|FG000|Overall Study|Adverse Event|2|||
16873241|NCT01576718|37849277|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16873242|NCT01576718|37849278|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16873243|NCT01576718|37849279|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16873244|NCT01576718|37849280|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16873245|NCT01576718|37849281|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16873246|NCT01576718|37849275|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
16873247|NCT01576718|37849276|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16873248|NCT01576718|37849277|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16873249|NCT01576718|37849278|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16873250|NCT01576718|37849279|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16873251|NCT01576718|37849280|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16873252|NCT01576718|37849281|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16873253|NCT01576718|37849275|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
16873254|NCT01576718|37849276|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16873255|NCT01576718|37849277|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16873256|NCT01576718|37849278|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16873257|NCT01576718|37849279|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16873258|NCT01576718|37849280|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16873259|NCT01576718|37849281|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16873260|NCT01576718|37849275|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
16873261|NCT01576718|37849276|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16873262|NCT01576718|37849277|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16873263|NCT01576718|37849278|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16873264|NCT01576718|37849279|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16873265|NCT01576718|37849280|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16873266|NCT01576718|37849281|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16873267|NCT01576718|37849275|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
16873268|NCT01576718|37849276|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16873269|NCT01576718|37849277|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16873270|NCT01576718|37849278|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16873271|NCT01576718|37849279|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16873272|NCT01576718|37849280|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16873273|NCT01576718|37849281|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16873274|NCT01576718|37849275|FG000|Treatment Period|Adverse Event|0|||
16873275|NCT01576718|37849276|FG001|Treatment Period|Adverse Event|1|||
16873276|NCT01576718|37849277|FG002|Treatment Period|Adverse Event|1|||
16873277|NCT01576718|37849278|FG003|Treatment Period|Adverse Event|1|||
16873278|NCT01576718|37849279|FG004|Treatment Period|Adverse Event|1|||
16873279|NCT01576718|37849280|FG005|Treatment Period|Adverse Event|1|||
16873280|NCT01576718|37849281|FG006|Treatment Period|Adverse Event|0|||
16873281|NCT01576718|37849275|FG000|Treatment Period|Withdrawal by Subject|0|||
16873282|NCT01576718|37849276|FG001|Treatment Period|Withdrawal by Subject|1|||
16873283|NCT01576718|37849277|FG002|Treatment Period|Withdrawal by Subject|1|||
16873284|NCT01576718|37849278|FG003|Treatment Period|Withdrawal by Subject|0|||
16873285|NCT01576718|37849279|FG004|Treatment Period|Withdrawal by Subject|2|||
16873286|NCT01576718|37849280|FG005|Treatment Period|Withdrawal by Subject|4|||
16873287|NCT01576718|37849281|FG006|Treatment Period|Withdrawal by Subject|2|||
16873288|NCT01576718|37849275|FG000|Treatment Period|Physician Decision|0|||
16873289|NCT01576718|37849276|FG001|Treatment Period|Physician Decision|1|||
16873290|NCT01576718|37849277|FG002|Treatment Period|Physician Decision|1|||
16873291|NCT01576718|37849278|FG003|Treatment Period|Physician Decision|1|||
16873292|NCT01576718|37849279|FG004|Treatment Period|Physician Decision|1|||
16873293|NCT01576718|37849280|FG005|Treatment Period|Physician Decision|0|||
16873294|NCT01576718|37849281|FG006|Treatment Period|Physician Decision|0|||
16873295|NCT01576718|37849275|FG000|Treatment Period|Protocol Violation|0|||
16873296|NCT01576718|37849276|FG001|Treatment Period|Protocol Violation|5|||
16873297|NCT01576718|37849277|FG002|Treatment Period|Protocol Violation|4|||
16873298|NCT01576718|37849278|FG003|Treatment Period|Protocol Violation|10|||
16873299|NCT01576718|37849279|FG004|Treatment Period|Protocol Violation|6|||
16873300|NCT01576718|37849280|FG005|Treatment Period|Protocol Violation|8|||
16873301|NCT01576718|37849281|FG006|Treatment Period|Protocol Violation|12|||
16873302|NCT01576718|37849275|FG000|Treatment Period|Sponsor request|0|||
16873303|NCT01576718|37849276|FG001|Treatment Period|Sponsor request|1|||
16873304|NCT01576718|37849277|FG002|Treatment Period|Sponsor request|0|||
16873305|NCT01576718|37849278|FG003|Treatment Period|Sponsor request|0|||
16873306|NCT01576718|37849279|FG004|Treatment Period|Sponsor request|0|||
17001611|NCT00871377|38145638|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
17095076|NCT00262028|38234362|FG004|Overall Study|Withdrawal by Subject|2|||
17191383|NCT02868281|38344190|FG001|Overall Study|Adverse Event|2|||
17191384|NCT02868281|38344189|FG000|Overall Study|Protocol Violation|13|||
16873307|NCT01576718|37849280|FG005|Treatment Period|Sponsor request|1|||
16873308|NCT01576718|37849281|FG006|Treatment Period|Sponsor request|0|||
16873309|NCT01576718|37849275|FG000|Treatment Period|Met stopping criteria|0|||
16873310|NCT01576718|37849276|FG001|Treatment Period|Met stopping criteria|16|||
16873311|NCT01576718|37849277|FG002|Treatment Period|Met stopping criteria|13|||
16873312|NCT01576718|37849278|FG003|Treatment Period|Met stopping criteria|19|||
16873313|NCT01576718|37849279|FG004|Treatment Period|Met stopping criteria|16|||
16873314|NCT01576718|37849280|FG005|Treatment Period|Met stopping criteria|33|||
16873315|NCT01576718|37849281|FG006|Treatment Period|Met stopping criteria|15|||
16873316|NCT01576718|37849275|FG000|Treatment Period|Lost to Follow-up|0|||
16873317|NCT01576718|37849276|FG001|Treatment Period|Lost to Follow-up|0|||
16873318|NCT01576718|37849277|FG002|Treatment Period|Lost to Follow-up|0|||
16873319|NCT01576718|37849278|FG003|Treatment Period|Lost to Follow-up|0|||
16873320|NCT01576718|37849279|FG004|Treatment Period|Lost to Follow-up|1|||
16873321|NCT01576718|37849280|FG005|Treatment Period|Lost to Follow-up|0|||
16873322|NCT01576718|37849281|FG006|Treatment Period|Lost to Follow-up|0|||
16873323|NCT01576718|37849275|FG000|Treatment Period|Noncompliance to study medication|0|||
16873324|NCT01576718|37849276|FG001|Treatment Period|Noncompliance to study medication|0|||
16873325|NCT01576718|37849277|FG002|Treatment Period|Noncompliance to study medication|0|||
16873326|NCT01576718|37849278|FG003|Treatment Period|Noncompliance to study medication|0|||
16873327|NCT01576718|37849279|FG004|Treatment Period|Noncompliance to study medication|0|||
16873328|NCT01576718|37849280|FG005|Treatment Period|Noncompliance to study medication|1|||
16873329|NCT01576718|37849281|FG006|Treatment Period|Noncompliance to study medication|1|||
16873330|NCT01493557|37849298|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
16873331|NCT01493557|37849299|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
16873332|NCT01493557|37849300|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
16873333|NCT01493557|37849298|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
16873334|NCT01493557|37849299|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
16873335|NCT01493557|37849300|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
16873336|NCT01493557|37849298|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
16873337|NCT01493557|37849299|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
16873338|NCT01493557|37849300|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
16873339|NCT01493557|37849298|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
16873340|NCT01493557|37849299|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
16873341|NCT01493557|37849300|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
16873342|NCT01493557|37849298|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
16873343|NCT01493557|37849299|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
16873344|NCT01493557|37849300|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
16873345|NCT01493557|37849298|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
16873346|NCT01493557|37849299|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
16873347|NCT01493557|37849300|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
16873348|NCT01493557|37849298|FG000|Not Randomized to Management Strategies|Early termination|0|||
16873349|NCT01493557|37849299|FG001|Not Randomized to Management Strategies|Early termination|0|||
16873350|NCT01493557|37849300|FG002|Not Randomized to Management Strategies|Early termination|34|||
16873351|NCT01493557|37849298|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
16873352|NCT01493557|37849299|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
16873353|NCT01493557|37849300|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
16873354|NCT01493557|37849298|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
16873355|NCT01493557|37849299|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
16873356|NCT01493557|37849300|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
16873357|NCT01493557|37849298|FG000|Randomized to Management Strategies|Other adverse event|8|||
16873358|NCT01493557|37849299|FG001|Randomized to Management Strategies|Other adverse event|5|||
16873359|NCT01493557|37849300|FG002|Randomized to Management Strategies|Other adverse event|0|||
16873360|NCT01493557|37849298|FG000|Randomized to Management Strategies|Protocol Violation|3|||
16873361|NCT01493557|37849299|FG001|Randomized to Management Strategies|Protocol Violation|0|||
16873362|NCT01493557|37849300|FG002|Randomized to Management Strategies|Protocol Violation|0|||
17001612|NCT00871377|38145639|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
16785060|NCT01677767|37725078|FG000|Overall Study|Non-compliance by the participants|3|||
16785061|NCT01603277|37725099|FG000|Overall Study|Adverse Event|1|||
16785062|NCT01603277|37725100|FG001|Overall Study|Adverse Event|2|||
16785063|NCT01603277|37725099|FG000|Overall Study|Physician Decision|0|||
16785064|NCT01603277|37725100|FG001|Overall Study|Physician Decision|1|||
16785065|NCT01603277|37725099|FG000|Overall Study|Protocol Violation|6|||
16785066|NCT01603277|37725100|FG001|Overall Study|Protocol Violation|10|||
16785067|NCT01603277|37725099|FG000|Overall Study|Withdrawal by Subject|5|||
16785068|NCT01603277|37725100|FG001|Overall Study|Withdrawal by Subject|4|||
16785069|NCT01603277|37725099|FG000|Overall Study|Non-Compliance|2|||
16785070|NCT01603277|37725100|FG001|Overall Study|Non-Compliance|1|||
16785071|NCT01678313|37725108|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
16785072|NCT01678313|37725109|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
16785073|NCT01678313|37725108|FG000|Completed the 3-month Therapy|Physician Decision|3|||
16785074|NCT01678313|37725109|FG001|Completed the 3-month Therapy|Physician Decision|4|||
16873363|NCT01493557|37849298|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
16873364|NCT01493557|37849299|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
16873365|NCT01493557|37849300|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
16873366|NCT01493557|37849298|FG000|Randomized to Management Strategies|Other than stated above|1|||
16873367|NCT01493557|37849299|FG001|Randomized to Management Strategies|Other than stated above|3|||
16873368|NCT01493557|37849300|FG002|Randomized to Management Strategies|Other than stated above|0|||
16873369|NCT01493557|37849298|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
16873370|NCT01493557|37849299|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
16873371|NCT01493557|37849300|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
16873372|NCT01493557|37849298|FG000|Adding the Second Strategy|Other adverse event|1|||
16873373|NCT01493557|37849299|FG001|Adding the Second Strategy|Other adverse event|2|||
16873374|NCT01493557|37849300|FG002|Adding the Second Strategy|Other adverse event|0|||
16873375|NCT01493557|37849298|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
16873376|NCT01493557|37849299|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
16873377|NCT01493557|37849300|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
16873378|NCT01451749|37849309|FG000|Overall Study|Protocol Violation|14|||
16873379|NCT01451749|37849310|FG001|Overall Study|Protocol Violation|7|||
16873380|NCT01451749|37849309|FG000|Overall Study|Lost to Follow-up|15|||
16873381|NCT01451749|37849310|FG001|Overall Study|Lost to Follow-up|5|||
16873382|NCT01451749|37849309|FG000|Overall Study|Meet the exclusion criteria,and|1|||
16873383|NCT01451749|37849310|FG001|Overall Study|Meet the exclusion criteria,and|1|||
16873384|NCT01451749|37849309|FG000|Overall Study|Adverse Event|2|||
16873385|NCT01451749|37849310|FG001|Overall Study|Adverse Event|0|||
16873386|NCT01451749|37849309|FG000|Overall Study|Withdrawal by Subject|0|||
16873387|NCT01451749|37849310|FG001|Overall Study|Withdrawal by Subject|1|||
16873388|NCT01576484|37849320|FG000|Overall Study|Adverse Event|1|||
16873389|NCT01576484|37849321|FG001|Overall Study|Adverse Event|1|||
16873390|NCT01576484|37849320|FG000|Overall Study|Protocol Violation|0|||
16873391|NCT01576484|37849321|FG001|Overall Study|Protocol Violation|2|||
16873392|NCT01576484|37849320|FG000|Overall Study|Sponsor Decision|2|||
16873393|NCT01576484|37849321|FG001|Overall Study|Sponsor Decision|8|||
16873394|NCT01576484|37849320|FG000|Overall Study|Withdrawal by Subject|0|||
16873395|NCT01576484|37849321|FG001|Overall Study|Withdrawal by Subject|3|||
16873396|NCT01576484|37849320|FG000|Overall Study|Other|2|||
16873397|NCT01576484|37849321|FG001|Overall Study|Other|5|||
16873398|NCT01467505|37849331|FG000|Overall Study|Adverse Event|1|||
16785075|NCT01678313|37725108|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
16785076|NCT01678313|37725109|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
16785077|NCT01678313|37725108|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
16785078|NCT01678313|37725109|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
16785079|NCT01603121|37725115|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
16785080|NCT01603121|37725116|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
16873399|NCT01467505|37849332|FG001|Overall Study|Adverse Event|0|||
16873400|NCT01467505|37849331|FG000|Overall Study|Withdrawal by Subject|4|||
16873401|NCT01467505|37849332|FG001|Overall Study|Withdrawal by Subject|0|||
16873402|NCT01467505|37849331|FG000|Overall Study|Study Terminated by Sponsor|28|||
16873403|NCT01467505|37849332|FG001|Overall Study|Study Terminated by Sponsor|3|||
16873404|NCT01467427|37849340|FG000|Overall Study|Withdrawal by Subject|1|||
16873405|NCT01467427|37849341|FG001|Overall Study|Withdrawal by Subject|0|||
16873406|NCT01467427|37849340|FG000|Overall Study|Entered extension phase|11|||
16873407|NCT01467427|37849341|FG001|Overall Study|Entered extension phase|11|||
16873408|NCT01467427|37849340|FG000|Overall Study|Not continuing in extension phase|0|||
16873409|NCT01467427|37849341|FG001|Overall Study|Not continuing in extension phase|2|||
16873410|NCT01467271|37849347|FG000|Overall Study|Death|84|||
16873411|NCT01467271|37849347|FG000|Overall Study|Lost to Follow-up|83|||
16873412|NCT01467271|37849347|FG000|Overall Study|Retraction of patient's consent|21|||
16873413|NCT01467271|37849347|FG000|Overall Study|Other reason|14|||
16873414|NCT01449929|37849353|FG000|Randomization Phase 96 Week|Adverse Event|5|||
16873415|NCT01449929|37849354|FG001|Randomization Phase 96 Week|Adverse Event|13|||
16873416|NCT01449929|37849355|FG002|Randomization Phase 96 Week|Adverse Event|0|||
16873417|NCT01449929|37849353|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
16873418|NCT01449929|37849354|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
16873419|NCT01449929|37849355|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
16873420|NCT01449929|37849353|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
16873421|NCT01449929|37849354|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
16873422|NCT01449929|37849355|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
16785081|NCT01603043|37725124|FG000|Overall Study|Study Futility|7|||
16873423|NCT01449929|37849353|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
16873424|NCT01449929|37849354|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
16873425|NCT01449929|37849355|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
16873426|NCT01449929|37849353|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
16873427|NCT01449929|37849354|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
16873428|NCT01449929|37849355|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
16873429|NCT01449929|37849353|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
16873430|NCT01449929|37849354|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
16873431|NCT01449929|37849355|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
16873432|NCT01449929|37849353|FG000|Randomization Phase 96 Week|Physician Decision|2|||
16873433|NCT01449929|37849354|FG001|Randomization Phase 96 Week|Physician Decision|3|||
16873434|NCT01449929|37849355|FG002|Randomization Phase 96 Week|Physician Decision|0|||
16873435|NCT01449929|37849353|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
16873436|NCT01449929|37849354|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
16873437|NCT01449929|37849355|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
16873438|NCT01449929|37849353|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
16873439|NCT01449929|37849354|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
16873440|NCT01449929|37849355|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
16873441|NCT01449929|37849353|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
16873442|NCT01449929|37849354|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
16873443|NCT01449929|37849355|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
16873444|NCT01449929|37849353|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
16873445|NCT01449929|37849354|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
16873446|NCT01449929|37849355|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
16873447|NCT01449539|37849365|FG000|Overall Study|Withdrawal by Subject|3|||
16873448|NCT01449539|37849365|FG000|Overall Study|Toxicity not study related|1|||
16873449|NCT01451515|37849372|FG000|Overall Study|Death|0|||
16873450|NCT01451515|37849373|FG001|Overall Study|Death|1|||
16873451|NCT01451515|37849374|FG002|Overall Study|Death|0|||
16873452|NCT01451515|37849372|FG000|Overall Study|Withdrawal by Subject|0|||
16873453|NCT01451515|37849373|FG001|Overall Study|Withdrawal by Subject|1|||
16873454|NCT01451515|37849374|FG002|Overall Study|Withdrawal by Subject|0|||
16873455|NCT01451515|37849372|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
16873456|NCT01451515|37849373|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
16873457|NCT01451515|37849374|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
16873458|NCT01451515|37849372|FG000|Overall Study|Relapse (except CNS)|1|||
16873459|NCT01451515|37849373|FG001|Overall Study|Relapse (except CNS)|1|||
16873460|NCT01451515|37849374|FG002|Overall Study|Relapse (except CNS)|0|||
16873461|NCT01466881|37849385|FG000|Overall Study|Ineligible|5|||
16873462|NCT01466881|37849385|FG000|Overall Study|Adverse Event|6|||
16873463|NCT01466881|37849385|FG000|Overall Study|Progression/relapse|20|||
16873464|NCT01466881|37849385|FG000|Overall Study|Death|4|||
16873465|NCT01466881|37849385|FG000|Overall Study|Other reason not protocol specified|5|||
16873466|NCT01576406|37849397|FG000|Overall Study|Lost to Follow-up|1|||
16873467|NCT01576406|37849398|FG001|Overall Study|Lost to Follow-up|2|||
16873468|NCT01576406|37849399|FG002|Overall Study|Lost to Follow-up|0|||
16873469|NCT01576406|37849400|FG003|Overall Study|Lost to Follow-up|0|||
16873470|NCT01576406|37849401|FG004|Overall Study|Lost to Follow-up|0|||
16873471|NCT01576406|37849402|FG005|Overall Study|Lost to Follow-up|0|||
16873472|NCT01576406|37849397|FG000|Overall Study|Death|3|||
16873473|NCT01576406|37849398|FG001|Overall Study|Death|4|||
16873474|NCT01576406|37849399|FG002|Overall Study|Death|8|||
16873475|NCT01576406|37849400|FG003|Overall Study|Death|5|||
16873476|NCT01576406|37849401|FG004|Overall Study|Death|7|||
16873477|NCT01576406|37849402|FG005|Overall Study|Death|9|||
16873478|NCT01576406|37849397|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
16873479|NCT01576406|37849398|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
16873480|NCT01576406|37849399|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
16873481|NCT01576406|37849400|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
16873482|NCT01576406|37849401|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
16873483|NCT01576406|37849402|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
16873484|NCT01576406|37849397|FG000|Overall Study|Withdrawal the consent|2|||
16873485|NCT01576406|37849398|FG001|Overall Study|Withdrawal the consent|2|||
16873486|NCT01576406|37849399|FG002|Overall Study|Withdrawal the consent|5|||
16873487|NCT01576406|37849400|FG003|Overall Study|Withdrawal the consent|1|||
16873488|NCT01576406|37849401|FG004|Overall Study|Withdrawal the consent|1|||
16873489|NCT01576406|37849402|FG005|Overall Study|Withdrawal the consent|3|||
16873490|NCT01576406|37849397|FG000|Overall Study|Other|0|||
16873491|NCT01576406|37849398|FG001|Overall Study|Other|0|||
16873492|NCT01576406|37849399|FG002|Overall Study|Other|2|||
16873493|NCT01576406|37849400|FG003|Overall Study|Other|2|||
16873494|NCT01576406|37849401|FG004|Overall Study|Other|0|||
16873495|NCT01576406|37849402|FG005|Overall Study|Other|0|||
16873496|NCT01576172|37849418|FG000|Overall Study|Ineligible|2|||
16873497|NCT01576172|37849419|FG001|Overall Study|Ineligible|1|||
16873498|NCT01576172|37849418|FG000|Overall Study|Withdrawal by Subject|2|||
16873499|NCT01576172|37849419|FG001|Overall Study|Withdrawal by Subject|0|||
16873500|NCT01576172|37849418|FG000|Overall Study|Insurance issue|1|||
16873501|NCT01576172|37849419|FG001|Overall Study|Insurance issue|0|||
16873502|NCT01542788|37849429|FG000|Overall Study|Randomized but Not Treated|2|||
16873503|NCT01542788|37849430|FG001|Overall Study|Randomized but Not Treated|0|||
16873504|NCT01542788|37849429|FG000|Overall Study|Lack of Efficacy|41|||
16873505|NCT01542788|37849430|FG001|Overall Study|Lack of Efficacy|71|||
16873506|NCT01542788|37849429|FG000|Overall Study|Lost to Follow-up|5|||
16873507|NCT01542788|37849430|FG001|Overall Study|Lost to Follow-up|0|||
16873508|NCT01542788|37849429|FG000|Overall Study|Death|3|||
16873509|NCT01542788|37849430|FG001|Overall Study|Death|0|||
16873510|NCT01542788|37849429|FG000|Overall Study|Protocol Violation|2|||
16873511|NCT01542788|37849430|FG001|Overall Study|Protocol Violation|0|||
16873512|NCT01542788|37849429|FG000|Overall Study|Physician Decision|1|||
16873513|NCT01542788|37849430|FG001|Overall Study|Physician Decision|0|||
16873514|NCT01542788|37849429|FG000|Overall Study|Withdrawal by Subject|1|||
17095077|NCT00262028|38234363|FG005|Overall Study|Withdrawal by Subject|3|||
16785082|NCT01603043|37725125|FG001|Overall Study|Study Futility|3|||
16785083|NCT02014402|37725135|FG000|Overall Study|Adverse Event|1|||
16785084|NCT02014402|37725136|FG001|Overall Study|Adverse Event|0|||
16785085|NCT02014402|37725137|FG002|Overall Study|Adverse Event|0|||
16785086|NCT02014402|37725138|FG003|Overall Study|Adverse Event|0|||
16785087|NCT02014402|37725135|FG000|Overall Study|Withdrawal by Subject|1|||
16785088|NCT02014402|37725136|FG001|Overall Study|Withdrawal by Subject|2|||
16785089|NCT02014402|37725137|FG002|Overall Study|Withdrawal by Subject|2|||
16785090|NCT02014402|37725138|FG003|Overall Study|Withdrawal by Subject|1|||
16785091|NCT02014402|37725135|FG000|Overall Study|Subject did not have transportation|0|||
16785092|NCT02014402|37725136|FG001|Overall Study|Subject did not have transportation|1|||
16785093|NCT02014402|37725137|FG002|Overall Study|Subject did not have transportation|0|||
16785094|NCT02014402|37725138|FG003|Overall Study|Subject did not have transportation|0|||
16785095|NCT02014402|37725135|FG000|Overall Study|Lost to Follow-up|0|||
16785096|NCT02014402|37725136|FG001|Overall Study|Lost to Follow-up|0|||
16785097|NCT02014402|37725137|FG002|Overall Study|Lost to Follow-up|1|||
16785098|NCT02014402|37725138|FG003|Overall Study|Lost to Follow-up|2|||
16785099|NCT01988662|37725157|FG000|Overall Study|Subject/guardian decision|1|||
16785100|NCT01988662|37725158|FG001|Overall Study|Subject/guardian decision|1|||
16785101|NCT01988662|37725157|FG000|Overall Study|Adverse Event|3|||
16785102|NCT01988662|37725158|FG001|Overall Study|Adverse Event|1|||
16785103|NCT02839343|37725167|FG000|Overall Study|Withdrawal by Subject|3|||
16785104|NCT02839343|37725168|FG001|Overall Study|Withdrawal by Subject|1|||
16785105|NCT02839343|37725167|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
16785106|NCT02839343|37725168|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
16785107|NCT02839343|37725167|FG000|Overall Study|Adverse Event|1|||
16785108|NCT02839343|37725168|FG001|Overall Study|Adverse Event|0|||
16785109|NCT01965652|37725197|FG000|Overall Study|Adverse Event|40|||
16785110|NCT01965652|37725198|FG001|Overall Study|Adverse Event|37|||
16785111|NCT01965652|37725197|FG000|Overall Study|Withdrawal by Subject|62|||
16785112|NCT01965652|37725198|FG001|Overall Study|Withdrawal by Subject|69|||
16785113|NCT01965652|37725197|FG000|Overall Study|Lost to Follow-up|53|||
16785114|NCT01965652|37725198|FG001|Overall Study|Lost to Follow-up|40|||
16785115|NCT01965652|37725197|FG000|Overall Study|Protocol Violation|34|||
16785116|NCT01965652|37725198|FG001|Overall Study|Protocol Violation|38|||
16785117|NCT01965652|37725197|FG000|Overall Study|Death|3|||
16785118|NCT01965652|37725198|FG001|Overall Study|Death|4|||
16785119|NCT01965652|37725197|FG000|Overall Study|Other - Miscellaneous|18|||
16785120|NCT01965652|37725198|FG001|Overall Study|Other - Miscellaneous|21|||
16785121|NCT01965652|37725197|FG000|Overall Study|Pregnancy|0|||
16785122|NCT01965652|37725198|FG001|Overall Study|Pregnancy|1|||
16785123|NCT01602965|37725206|FG000|Overall Study|Lost to Follow-up|4|||
16785124|NCT01602965|37725207|FG001|Overall Study|Lost to Follow-up|2|||
16785125|NCT01987960|37725215|FG000|Period 1|Adverse Event|24|||
16785126|NCT01987960|37725216|FG001|Period 1|Adverse Event|0|||
16785127|NCT01987960|37725217|FG002|Period 1|Adverse Event|0|||
16785128|NCT01987960|37725218|FG003|Period 1|Adverse Event|0|||
16785129|NCT01987960|37725215|FG000|Period 1|Lack of Efficacy|4|||
16785130|NCT01987960|37725216|FG001|Period 1|Lack of Efficacy|0|||
16785131|NCT01987960|37725217|FG002|Period 1|Lack of Efficacy|0|||
16785132|NCT01987960|37725218|FG003|Period 1|Lack of Efficacy|0|||
16785133|NCT01987960|37725215|FG000|Period 1|Non-compliance with IMP|6|||
16785134|NCT01987960|37725216|FG001|Period 1|Non-compliance with IMP|0|||
16785135|NCT01987960|37725217|FG002|Period 1|Non-compliance with IMP|0|||
16785136|NCT01987960|37725218|FG003|Period 1|Non-compliance with IMP|0|||
16785137|NCT01987960|37725215|FG000|Period 1|Protocol Violation|12|||
16785138|NCT01987960|37725216|FG001|Period 1|Protocol Violation|0|||
16785139|NCT01987960|37725217|FG002|Period 1|Protocol Violation|0|||
16785140|NCT01987960|37725218|FG003|Period 1|Protocol Violation|0|||
16785141|NCT01987960|37725215|FG000|Period 1|Withdrawal by Subject|21|||
16785142|NCT01987960|37725216|FG001|Period 1|Withdrawal by Subject|0|||
16785143|NCT01987960|37725217|FG002|Period 1|Withdrawal by Subject|0|||
16785144|NCT01987960|37725218|FG003|Period 1|Withdrawal by Subject|0|||
16785145|NCT01987960|37725215|FG000|Period 1|Lost to Follow-up|40|||
16785146|NCT01987960|37725216|FG001|Period 1|Lost to Follow-up|0|||
16785147|NCT01987960|37725217|FG002|Period 1|Lost to Follow-up|0|||
16785148|NCT01987960|37725218|FG003|Period 1|Lost to Follow-up|0|||
16873515|NCT01542788|37849430|FG001|Overall Study|Withdrawal by Subject|0|||
16873516|NCT01542632|37849442|FG000|Overall Study|Withdrawal of Consent|0|||
16873517|NCT01542632|37849443|FG001|Overall Study|Withdrawal of Consent|0|||
16873518|NCT01542632|37849444|FG002|Overall Study|Withdrawal of Consent|0|||
16873519|NCT01542632|37849445|FG003|Overall Study|Withdrawal of Consent|2|||
16873520|NCT01542632|37849446|FG004|Overall Study|Withdrawal of Consent|3|||
16873521|NCT01542632|37849447|FG005|Overall Study|Withdrawal of Consent|0|||
16873522|NCT01542632|37849442|FG000|Overall Study|Adverse Event|0|||
16873523|NCT01542632|37849443|FG001|Overall Study|Adverse Event|0|||
16873524|NCT01542632|37849444|FG002|Overall Study|Adverse Event|1|||
16873525|NCT01542632|37849445|FG003|Overall Study|Adverse Event|0|||
16873526|NCT01542632|37849446|FG004|Overall Study|Adverse Event|0|||
16873527|NCT01542632|37849447|FG005|Overall Study|Adverse Event|0|||
16873528|NCT01542632|37849442|FG000|Overall Study|Lost to Follow-up|0|||
16873529|NCT01542632|37849443|FG001|Overall Study|Lost to Follow-up|1|||
16873530|NCT01542632|37849444|FG002|Overall Study|Lost to Follow-up|0|||
16873531|NCT01542632|37849445|FG003|Overall Study|Lost to Follow-up|0|||
16873532|NCT01542632|37849446|FG004|Overall Study|Lost to Follow-up|0|||
16873533|NCT01542632|37849447|FG005|Overall Study|Lost to Follow-up|0|||
16873534|NCT01542632|37849442|FG000|Overall Study|Sponsor/Investigator Decision|0|||
16873535|NCT01542632|37849443|FG001|Overall Study|Sponsor/Investigator Decision|0|||
16873536|NCT01542632|37849444|FG002|Overall Study|Sponsor/Investigator Decision|0|||
16873537|NCT01542632|37849445|FG003|Overall Study|Sponsor/Investigator Decision|0|||
16873538|NCT01542632|37849446|FG004|Overall Study|Sponsor/Investigator Decision|1|||
16873539|NCT01542632|37849447|FG005|Overall Study|Sponsor/Investigator Decision|0|||
16873540|NCT01557842|37849468|FG000|Overall Study|Lost to Follow-up|0|||
16873541|NCT01557842|37849469|FG001|Overall Study|Lost to Follow-up|1|||
16873542|NCT01557842|37849468|FG000|Overall Study|Death|1|||
16873543|NCT01557842|37849469|FG001|Overall Study|Death|0|||
16873544|NCT01557842|37849468|FG000|Overall Study|Lack of Efficacy|0|||
16873545|NCT01557842|37849469|FG001|Overall Study|Lack of Efficacy|1|||
16873546|NCT01557842|37849468|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
16873547|NCT01557842|37849469|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
16873548|NCT01557842|37849468|FG000|Overall Study|Study Terminated by Sponsor|3|||
16873549|NCT01557842|37849469|FG001|Overall Study|Study Terminated by Sponsor|4|||
16873550|NCT01557842|37849468|FG000|Overall Study|Not Ablated|2|||
16873551|NCT01557842|37849469|FG001|Overall Study|Not Ablated|0|||
16873552|NCT01541930|37849475|FG000|Overall Study|Withdrawal by Subject|1|||
16873553|NCT01576016|37849492|FG000|Lead Safety|Death|132|||
16873554|NCT01576016|37849493|FG001|Lead Safety|Death|0|||
16785149|NCT01987960|37725215|FG000|Period 1|administrative or other reason|75|||
16873555|NCT01576016|37849492|FG000|Lead Safety|Withdrawal by Subject|81|||
16873556|NCT01576016|37849493|FG001|Lead Safety|Withdrawal by Subject|0|||
16873557|NCT01576016|37849492|FG000|Lead Safety|System Explanted without Replacement|24|||
16873558|NCT01576016|37849493|FG001|Lead Safety|System Explanted without Replacement|0|||
16873559|NCT01576016|37849492|FG000|Lead Safety|Physician Decision|14|||
16873560|NCT01576016|37849493|FG001|Lead Safety|Physician Decision|0|||
16873561|NCT01576016|37849492|FG000|Lead Safety|Lost to Follow-up|13|||
16873562|NCT01576016|37849493|FG001|Lead Safety|Lost to Follow-up|0|||
16873563|NCT01576016|37849492|FG000|Lead Safety|Unsuccessful implant|2|||
16873564|NCT01576016|37849493|FG001|Lead Safety|Unsuccessful implant|0|||
16873565|NCT01576016|37849492|FG000|Lead Safety|Sponsor request|1|||
16873566|NCT01576016|37849493|FG001|Lead Safety|Sponsor request|0|||
16873567|NCT01576016|37849492|FG000|Lead Safety|Device replaced with CRT-D|1|||
16873568|NCT01576016|37849493|FG001|Lead Safety|Device replaced with CRT-D|0|||
16873569|NCT01576016|37849492|FG000|Lead Safety|Patient on Palliative Care|1|||
16873570|NCT01576016|37849493|FG001|Lead Safety|Patient on Palliative Care|0|||
16873571|NCT01576016|37849492|FG000|Lead Safety|Patient noncompliance|1|||
16873572|NCT01576016|37849493|FG001|Lead Safety|Patient noncompliance|0|||
16873573|NCT01576016|37849492|FG000|Lead Safety|Too far from study site|1|||
16873574|NCT01576016|37849493|FG001|Lead Safety|Too far from study site|0|||
16873575|NCT01576016|37849492|FG000|Lead Safety|System deactivated|1|||
16873576|NCT01576016|37849493|FG001|Lead Safety|System deactivated|0|||
16873577|NCT01576016|37849492|FG000|Lead Safety|Patient no longer followed by study PI|1|||
16873578|NCT01576016|37849493|FG001|Lead Safety|Patient no longer followed by study PI|0|||
16873579|NCT01576016|37849492|FG000|MRI Safety|Withdrawal by Subject|0|||
16873580|NCT01576016|37849493|FG001|MRI Safety|Withdrawal by Subject|10|||
16873581|NCT01576016|37849492|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
16873582|NCT01576016|37849493|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
16873583|NCT01576016|37849492|FG000|MRI Safety|Has not yet completed MRI scan|0|||
16785150|NCT01987960|37725216|FG001|Period 1|administrative or other reason|0|||
16873584|NCT01576016|37849493|FG001|MRI Safety|Has not yet completed MRI scan|56|||
16873585|NCT01576016|37849492|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
16873586|NCT01576016|37849493|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
17001613|NCT00871377|38145640|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
17001614|NCT00871377|38145641|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
16873589|NCT01540838|37849508|FG000|Overall Study|Open nasogastric tube|9|||
16873590|NCT01540838|37849509|FG001|Overall Study|Open nasogastric tube|7|||
16873591|NCT01540838|37849508|FG000|Overall Study|Treatment doses missing|8|||
16873592|NCT01540838|37849509|FG001|Overall Study|Treatment doses missing|12|||
16873593|NCT01540838|37849508|FG000|Overall Study|Additional antibiotic treatment|1|||
16873594|NCT01540838|37849509|FG001|Overall Study|Additional antibiotic treatment|2|||
16873595|NCT01540838|37849508|FG000|Overall Study|Died before treatment initiation|1|||
16873596|NCT01540838|37849509|FG001|Overall Study|Died before treatment initiation|1|||
16873597|NCT01540838|37849508|FG000|Overall Study|Not BM. Other treatment|3|||
16873598|NCT01540838|37849509|FG001|Overall Study|Not BM. Other treatment|1|||
16785151|NCT01987960|37725217|FG002|Period 1|administrative or other reason|0|||
16785152|NCT01987960|37725218|FG003|Period 1|administrative or other reason|0|||
16785153|NCT01987960|37725215|FG000|Period 1|Withdrawal of consent before treatment|4|||
16785154|NCT01987960|37725216|FG001|Period 1|Withdrawal of consent before treatment|0|||
16785155|NCT01987960|37725217|FG002|Period 1|Withdrawal of consent before treatment|0|||
16785156|NCT01987960|37725218|FG003|Period 1|Withdrawal of consent before treatment|0|||
16785157|NCT01987960|37725215|FG000|Period 2|Adverse Event|0|||
16785158|NCT01987960|37725216|FG001|Period 2|Adverse Event|0|||
16785159|NCT01987960|37725217|FG002|Period 2|Adverse Event|1|||
16785160|NCT01987960|37725218|FG003|Period 2|Adverse Event|0|||
16785161|NCT01987960|37725215|FG000|Period 2|Withdrawal by Subject|0|||
16785162|NCT01987960|37725216|FG001|Period 2|Withdrawal by Subject|0|||
16785163|NCT01987960|37725217|FG002|Period 2|Withdrawal by Subject|1|||
16873599|NCT01451437|37849524|FG000|Overall Study|Adverse Event|0|||
16873600|NCT01451437|37849525|FG001|Overall Study|Adverse Event|0|||
16873601|NCT01451437|37849526|FG002|Overall Study|Adverse Event|0|||
16873602|NCT01451437|37849527|FG003|Overall Study|Adverse Event|0|||
16873603|NCT01451437|37849528|FG004|Overall Study|Adverse Event|0|||
16873604|NCT01451437|37849529|FG005|Overall Study|Adverse Event|1|||
16873605|NCT01451437|37849530|FG006|Overall Study|Adverse Event|1|||
16873606|NCT01451437|37849531|FG007|Overall Study|Adverse Event|2|||
16873607|NCT01451437|37849532|FG008|Overall Study|Adverse Event|1|||
16873608|NCT01451437|37849524|FG000|Overall Study|Physician Decision|1|||
16873609|NCT01451437|37849525|FG001|Overall Study|Physician Decision|1|||
16873610|NCT01451437|37849526|FG002|Overall Study|Physician Decision|2|||
16873611|NCT01451437|37849527|FG003|Overall Study|Physician Decision|0|||
16873612|NCT01451437|37849528|FG004|Overall Study|Physician Decision|0|||
16873613|NCT01451437|37849529|FG005|Overall Study|Physician Decision|0|||
16873614|NCT01451437|37849530|FG006|Overall Study|Physician Decision|0|||
16873615|NCT01451437|37849531|FG007|Overall Study|Physician Decision|0|||
16873616|NCT01451437|37849532|FG008|Overall Study|Physician Decision|0|||
16873617|NCT01451437|37849524|FG000|Overall Study|Disease Progression|0|||
16873618|NCT01451437|37849525|FG001|Overall Study|Disease Progression|0|||
16873619|NCT01451437|37849526|FG002|Overall Study|Disease Progression|1|||
16873620|NCT01451437|37849527|FG003|Overall Study|Disease Progression|1|||
16873621|NCT01451437|37849528|FG004|Overall Study|Disease Progression|3|||
16873622|NCT01451437|37849529|FG005|Overall Study|Disease Progression|2|||
16873623|NCT01451437|37849530|FG006|Overall Study|Disease Progression|3|||
16873624|NCT01451437|37849531|FG007|Overall Study|Disease Progression|1|||
16873625|NCT01451437|37849532|FG008|Overall Study|Disease Progression|3|||
16873626|NCT01451437|37849524|FG000|Overall Study|Protocol Violation|0|||
16873627|NCT01451437|37849525|FG001|Overall Study|Protocol Violation|0|||
16873628|NCT01451437|37849526|FG002|Overall Study|Protocol Violation|0|||
16873629|NCT01451437|37849527|FG003|Overall Study|Protocol Violation|0|||
16873630|NCT01451437|37849528|FG004|Overall Study|Protocol Violation|0|||
16873631|NCT01451437|37849529|FG005|Overall Study|Protocol Violation|0|||
16873632|NCT01451437|37849530|FG006|Overall Study|Protocol Violation|1|||
16873633|NCT01451437|37849531|FG007|Overall Study|Protocol Violation|0|||
16873634|NCT01451437|37849532|FG008|Overall Study|Protocol Violation|0|||
16873635|NCT01451437|37849524|FG000|Overall Study|Withdrawal by Subject|0|||
16873636|NCT01451437|37849525|FG001|Overall Study|Withdrawal by Subject|0|||
16873637|NCT01451437|37849526|FG002|Overall Study|Withdrawal by Subject|0|||
16873638|NCT01451437|37849527|FG003|Overall Study|Withdrawal by Subject|0|||
16873639|NCT01451437|37849528|FG004|Overall Study|Withdrawal by Subject|1|||
16873640|NCT01451437|37849529|FG005|Overall Study|Withdrawal by Subject|0|||
16873641|NCT01451437|37849530|FG006|Overall Study|Withdrawal by Subject|1|||
17001615|NCT00871377|38145636|FG000|Third Intervention (10 Weeks)|Death|0|||
16785164|NCT01987960|37725218|FG003|Period 2|Withdrawal by Subject|0|||
16785165|NCT01987960|37725215|FG000|Period 2|Administrative or other reason|0|||
16873642|NCT01451437|37849531|FG007|Overall Study|Withdrawal by Subject|0|||
16873643|NCT01451437|37849532|FG008|Overall Study|Withdrawal by Subject|0|||
16873644|NCT01451203|37849563|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
16873645|NCT01451203|37849564|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
16873646|NCT01451203|37849563|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
16873647|NCT01451203|37849564|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
16873648|NCT01451203|37849563|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
16873649|NCT01451203|37849564|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
16873650|NCT01451203|37849563|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
16873651|NCT01451203|37849564|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
16873652|NCT01451203|37849563|FG000|Double-blind Treatment Period|Adverse Event|6|||
16873653|NCT01451203|37849564|FG001|Double-blind Treatment Period|Adverse Event|9|||
16873654|NCT01451203|37849563|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
16873655|NCT01451203|37849564|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
16873656|NCT01451203|37849563|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
16873657|NCT01451203|37849564|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
16873658|NCT01451203|37849563|FG000|Double-blind Treatment Period|Investigator decision|2|||
16873659|NCT01451203|37849564|FG001|Double-blind Treatment Period|Investigator decision|0|||
16873660|NCT01451203|37849563|FG000|Post-treatment Period|Consent withdrawn|2|||
16873661|NCT01451203|37849564|FG001|Post-treatment Period|Consent withdrawn|4|||
16873662|NCT01451203|37849563|FG000|Post-treatment Period|Lack of Efficacy|12|||
16873663|NCT01451203|37849564|FG001|Post-treatment Period|Lack of Efficacy|28|||
16873664|NCT01451203|37849563|FG000|Post-treatment Period|Adverse Event|0|||
16873665|NCT01451203|37849564|FG001|Post-treatment Period|Adverse Event|1|||
16873666|NCT01451203|37849563|FG000|Post-treatment Period|Investigator decision|0|||
16873667|NCT01451203|37849564|FG001|Post-treatment Period|Investigator decision|1|||
16873668|NCT01556438|37849572|FG000|Overall Study|Adverse Event|4|||
16873669|NCT01556438|37849573|FG001|Overall Study|Adverse Event|2|||
16873670|NCT01556438|37849572|FG000|Overall Study|Sponsor Decision|0|||
16873671|NCT01556438|37849573|FG001|Overall Study|Sponsor Decision|2|||
16873672|NCT01556438|37849572|FG000|Overall Study|Progressive Disease|0|||
16873673|NCT01556438|37849573|FG001|Overall Study|Progressive Disease|6|||
16873674|NCT01556438|37849572|FG000|Overall Study|Death|0|||
16873675|NCT01556438|37849573|FG001|Overall Study|Death|1|||
16873676|NCT01554176|37849599|FG000|Treatment Phase|Protocol Violation|1|||
16873677|NCT01554176|37849600|FG001|Treatment Phase|Protocol Violation|2|||
16873678|NCT01554176|37849601|FG002|Treatment Phase|Protocol Violation|0|||
16873679|NCT01554176|37849602|FG003|Treatment Phase|Protocol Violation|0|||
16873680|NCT01554176|37849603|FG004|Treatment Phase|Protocol Violation|0|||
16873681|NCT01554176|37849599|FG000|Treatment Phase|Physician Decision|1|||
16873682|NCT01554176|37849600|FG001|Treatment Phase|Physician Decision|1|||
16873683|NCT01554176|37849601|FG002|Treatment Phase|Physician Decision|0|||
16873684|NCT01554176|37849602|FG003|Treatment Phase|Physician Decision|0|||
16873685|NCT01554176|37849603|FG004|Treatment Phase|Physician Decision|0|||
16873686|NCT01554176|37849599|FG000|Treatment Phase|Lack of Efficacy|0|||
16873687|NCT01554176|37849600|FG001|Treatment Phase|Lack of Efficacy|1|||
16873688|NCT01554176|37849601|FG002|Treatment Phase|Lack of Efficacy|0|||
16873689|NCT01554176|37849602|FG003|Treatment Phase|Lack of Efficacy|0|||
16873690|NCT01554176|37849603|FG004|Treatment Phase|Lack of Efficacy|0|||
16873691|NCT01554176|37849599|FG000|Treatment Phase|Adverse event, non-fatal|1|||
16873692|NCT01554176|37849600|FG001|Treatment Phase|Adverse event, non-fatal|1|||
16873693|NCT01554176|37849601|FG002|Treatment Phase|Adverse event, non-fatal|0|||
16873694|NCT01554176|37849602|FG003|Treatment Phase|Adverse event, non-fatal|0|||
16873695|NCT01554176|37849603|FG004|Treatment Phase|Adverse event, non-fatal|0|||
16873696|NCT01554176|37849599|FG000|Treatment Phase|Non-compliance with study drug|1|||
16873697|NCT01554176|37849600|FG001|Treatment Phase|Non-compliance with study drug|0|||
16873698|NCT01554176|37849601|FG002|Treatment Phase|Non-compliance with study drug|0|||
16873699|NCT01554176|37849602|FG003|Treatment Phase|Non-compliance with study drug|0|||
16873700|NCT01554176|37849603|FG004|Treatment Phase|Non-compliance with study drug|0|||
16873701|NCT01554176|37849599|FG000|Treatment Phase|Withdrawal by Subject|1|||
16873702|NCT01554176|37849600|FG001|Treatment Phase|Withdrawal by Subject|0|||
16873703|NCT01554176|37849601|FG002|Treatment Phase|Withdrawal by Subject|0|||
16873704|NCT01554176|37849602|FG003|Treatment Phase|Withdrawal by Subject|0|||
16873705|NCT01554176|37849603|FG004|Treatment Phase|Withdrawal by Subject|0|||
16873706|NCT01554176|37849599|FG000|Treatment Phase|Lost to Follow-up|3|||
16873707|NCT01554176|37849600|FG001|Treatment Phase|Lost to Follow-up|0|||
16873708|NCT01554176|37849601|FG002|Treatment Phase|Lost to Follow-up|0|||
16873709|NCT01554176|37849602|FG003|Treatment Phase|Lost to Follow-up|0|||
16873710|NCT01554176|37849603|FG004|Treatment Phase|Lost to Follow-up|0|||
16873711|NCT01554176|37849599|FG000|Run-out Phase|Protocol Violation|0|||
16873712|NCT01554176|37849600|FG001|Run-out Phase|Protocol Violation|0|||
16873713|NCT01554176|37849601|FG002|Run-out Phase|Protocol Violation|0|||
16873714|NCT01554176|37849602|FG003|Run-out Phase|Protocol Violation|1|||
16873715|NCT01554176|37849603|FG004|Run-out Phase|Protocol Violation|0|||
16873716|NCT01466491|37849619|FG000|Overall Study|Protocol Violation|0|||
16873717|NCT01466491|37849620|FG001|Overall Study|Protocol Violation|3|||
16873718|NCT01466491|37849621|FG002|Overall Study|Protocol Violation|2|||
16873719|NCT01466491|37849622|FG003|Overall Study|Protocol Violation|0|||
16873720|NCT01466491|37849619|FG000|Overall Study|Missing Data|0|||
16873721|NCT01466491|37849620|FG001|Overall Study|Missing Data|0|||
16873722|NCT01466491|37849621|FG002|Overall Study|Missing Data|1|||
16873723|NCT01466491|37849622|FG003|Overall Study|Missing Data|0|||
16873724|NCT01466179|37849632|FG000|Overall Study|Ongoing in core study|2|||
16873725|NCT01466179|37849632|FG000|Overall Study|Physician Decision|46|||
16873726|NCT01466179|37849632|FG000|Overall Study|Progressive disease|43|||
16873727|NCT01466179|37849632|FG000|Overall Study|Adverse Event|32|||
16873728|NCT01466179|37849632|FG000|Overall Study|Disease relapse|23|||
16873729|NCT01466179|37849632|FG000|Overall Study|Lack of Efficacy|14|||
16873730|NCT01466179|37849632|FG000|Overall Study|Death|7|||
16873731|NCT01466179|37849632|FG000|Overall Study|Withdrawal by Subject|7|||
16873732|NCT01466179|37849632|FG000|Overall Study|Protocol Violation|2|||
16873733|NCT01466179|37849632|FG000|Overall Study|Other|3|||
16873734|NCT01493089|37849641|FG000|Overall Study|Protocol Violation|2|||
16873735|NCT01493089|37849642|FG001|Overall Study|Protocol Violation|2|||
16873736|NCT01493089|37849641|FG000|Overall Study|Withdrawal by Subject|1|||
16873737|NCT01493089|37849642|FG001|Overall Study|Withdrawal by Subject|0|||
16785166|NCT01987960|37725216|FG001|Period 2|Administrative or other reason|5|||
16785167|NCT01987960|37725217|FG002|Period 2|Administrative or other reason|7|||
16785168|NCT01987960|37725218|FG003|Period 2|Administrative or other reason|0|||
16785169|NCT01987960|37725215|FG000|Period 3|Adverse Event|0|||
16785170|NCT01987960|37725216|FG001|Period 3|Adverse Event|0|||
16785171|NCT01987960|37725217|FG002|Period 3|Adverse Event|0|||
16785172|NCT01987960|37725218|FG003|Period 3|Adverse Event|7|||
16785173|NCT01987960|37725215|FG000|Period 3|Non-compliance with IMP|0|||
16785174|NCT01987960|37725216|FG001|Period 3|Non-compliance with IMP|0|||
16785175|NCT01987960|37725217|FG002|Period 3|Non-compliance with IMP|0|||
16785176|NCT01987960|37725218|FG003|Period 3|Non-compliance with IMP|1|||
16785177|NCT01987960|37725215|FG000|Period 3|Protocol Violation|0|||
16785178|NCT01987960|37725216|FG001|Period 3|Protocol Violation|0|||
16785179|NCT01987960|37725217|FG002|Period 3|Protocol Violation|0|||
16873738|NCT01493089|37849641|FG000|Overall Study|Physician Decision|0|||
16873739|NCT01493089|37849642|FG001|Overall Study|Physician Decision|1|||
16873740|NCT01450813|37849654|FG000|Overall Study|Physician Decision|1|||
16873741|NCT01450813|37849655|FG001|Overall Study|Physician Decision|1|||
16873742|NCT01450813|37849656|FG002|Overall Study|Physician Decision|0|||
16873743|NCT01450813|37849657|FG003|Overall Study|Physician Decision|3|||
16873744|NCT01539512|37849671|FG000|Overall Study|Adverse Event|9|||
16873745|NCT01539512|37849672|FG001|Overall Study|Adverse Event|7|||
16873746|NCT01539512|37849671|FG000|Overall Study|Physician Decision|1|||
16873747|NCT01539512|37849672|FG001|Overall Study|Physician Decision|1|||
16873748|NCT01539512|37849671|FG000|Overall Study|Withdrawal by Subject|12|||
16873749|NCT01539512|37849672|FG001|Overall Study|Withdrawal by Subject|5|||
16873750|NCT01539512|37849671|FG000|Overall Study|Richter's Transformation|1|||
16873751|NCT01539512|37849672|FG001|Overall Study|Richter's Transformation|0|||
16873752|NCT01449955|37849680|FG000|Overall Study|Withdrawal by Subject|1|||
16873753|NCT01449955|37849681|FG001|Overall Study|Withdrawal by Subject|2|||
16873754|NCT01574612|37849694|FG000|Overall Study|Adverse Event|3|||
16873755|NCT01574612|37849694|FG000|Overall Study|non compliant with drug|2|||
16873756|NCT01574612|37849694|FG000|Overall Study|Withdrawal by Subject|1|||
16785180|NCT01987960|37725218|FG003|Period 3|Protocol Violation|6|||
16785181|NCT01987960|37725215|FG000|Period 3|Withdrawal by Subject|0|||
16873757|NCT01574612|37849694|FG000|Overall Study|Lost to Follow-up|2|||
16873758|NCT01573910|37849700|FG000|Overall Study|Adverse Event|4|||
16873759|NCT01573910|37849701|FG001|Overall Study|Adverse Event|4|||
16873760|NCT01573910|37849700|FG000|Overall Study|Lost to Follow-up|2|||
16873761|NCT01573910|37849701|FG001|Overall Study|Lost to Follow-up|1|||
16873762|NCT01573910|37849700|FG000|Overall Study|Withdrawal by Subject|0|||
16873763|NCT01573910|37849701|FG001|Overall Study|Withdrawal by Subject|1|||
16873764|NCT01573910|37849700|FG000|Overall Study|Protocol Violation|3|||
16873765|NCT01573910|37849701|FG001|Overall Study|Protocol Violation|0|||
16873766|NCT01573910|37849700|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
16873767|NCT01573910|37849701|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
16873768|NCT01491919|37849710|FG000|Overall Study|Insufficient PK sampling|1|||
16873769|NCT01491919|37849711|FG001|Overall Study|Insufficient PK sampling|2|||
16873770|NCT01491919|37849712|FG002|Overall Study|Insufficient PK sampling|1|||
16873771|NCT01573442|37849724|FG000|Overall Study|Cancels|9|||
16873772|NCT01573442|37849725|FG001|Overall Study|Cancels|10|||
16873773|NCT01491841|37849794|FG000|Overall Study|Screen Failure|10|||
16873774|NCT01491841|37849794|FG000|Overall Study|Withdrawal by Subject|1|||
16873775|NCT01553318|37849813|FG000|Overall Study|Protocol Violation|3|||
16873776|NCT01553318|37849814|FG001|Overall Study|Protocol Violation|2|||
16873777|NCT01572740|37849833|FG000|Overall Study|Adverse Event|1|||
16873778|NCT01572740|37849834|FG001|Overall Study|Adverse Event|1|||
16873779|NCT01572740|37849833|FG000|Overall Study|Withdrawal by Subject|1|||
16785182|NCT01987960|37725216|FG001|Period 3|Withdrawal by Subject|0|||
16785183|NCT01987960|37725217|FG002|Period 3|Withdrawal by Subject|0|||
16785184|NCT01987960|37725218|FG003|Period 3|Withdrawal by Subject|9|||
16785185|NCT01987960|37725215|FG000|Period 3|Lost to Follow-up|0|||
16785186|NCT01987960|37725216|FG001|Period 3|Lost to Follow-up|0|||
17095078|NCT00262028|38234364|FG006|Overall Study|Withdrawal by Subject|5|||
16873780|NCT01572740|37849834|FG001|Overall Study|Withdrawal by Subject|1|||
16873781|NCT01572740|37849833|FG000|Overall Study|unclassified|4|||
16873782|NCT01572740|37849834|FG001|Overall Study|unclassified|3|||
16873783|NCT01491607|37849844|FG000|Overall Study|Lost to Follow-up|7|||
16873784|NCT01491607|37849844|FG000|Overall Study|Withdrawal by Subject|3|||
16873785|NCT01449721|37849927|FG000|Overall Study|Physician Decision|0|||
16873786|NCT01449721|37849928|FG001|Overall Study|Physician Decision|1|||
16873787|NCT01449721|37849927|FG000|Overall Study|Physician Decision|0|||
16873788|NCT01449721|37849928|FG001|Overall Study|Physician Decision|1|||
16873789|NCT01553084|37849937|FG000|Overall Study|Withdrawal by Subject|15|||
16785187|NCT01987960|37725217|FG002|Period 3|Lost to Follow-up|0|||
16785188|NCT01987960|37725218|FG003|Period 3|Lost to Follow-up|5|||
16873790|NCT01553084|37849938|FG001|Overall Study|Withdrawal by Subject|13|||
16873791|NCT01553084|37849939|FG002|Overall Study|Withdrawal by Subject|35|||
16873792|NCT01536860|37849949|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
16873793|NCT01536860|37849950|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
16873794|NCT01536860|37849951|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
16873795|NCT01552928|37849963|FG000|Period 3|Adverse Event|0|||
16873796|NCT01552928|37849964|FG001|Period 3|Adverse Event|0|||
16873797|NCT01552928|37849965|FG002|Period 3|Adverse Event|1|||
16873798|NCT01552928|37849966|FG003|Period 3|Adverse Event|0|||
16873799|NCT01448707|37849985|FG000|Overall Study|Adverse Event|3|||
16873800|NCT01448707|37849986|FG001|Overall Study|Adverse Event|1|||
16873801|NCT01448707|37849985|FG000|Overall Study|Lost to Follow-up|2|||
16873802|NCT01448707|37849986|FG001|Overall Study|Lost to Follow-up|6|||
16785189|NCT01987960|37725215|FG000|Period 3|Administrative or other reason|0|||
16785190|NCT01987960|37725216|FG001|Period 3|Administrative or other reason|0|||
16785191|NCT01987960|37725217|FG002|Period 3|Administrative or other reason|0|||
16785192|NCT01987960|37725218|FG003|Period 3|Administrative or other reason|43|||
16785193|NCT02013778|37725228|FG000|Overall Study|Death|4|||
16785194|NCT02013778|37725228|FG000|Overall Study|Withdrawal by Subject|1|||
16785195|NCT02013778|37725228|FG000|Overall Study|Physician Decision|1|||
16785196|NCT02013778|37725228|FG000|Overall Study|Adverse Event|1|||
16785197|NCT02013622|37725232|FG000|Overall Study|Lost to Follow-up|10|||
16785198|NCT02013622|37725232|FG000|Overall Study|Adverse Event|3|||
16785199|NCT02013622|37725232|FG000|Overall Study|Met Withdrawal Criteria|3|||
16785200|NCT02013622|37725232|FG000|Overall Study|Withdrawal by Subject|6|||
16785201|NCT02013622|37725232|FG000|Overall Study|Protocol Deviation|1|||
16785202|NCT02013622|37725232|FG000|Overall Study|Lack of Efficacy|1|||
16785203|NCT01987102|37725238|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
16785204|NCT01987102|37725239|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
16785205|NCT01987102|37725238|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
16785206|NCT01987102|37725239|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
16785207|NCT01987102|37725238|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
16785208|NCT01987102|37725239|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
16785209|NCT01987102|37725238|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
16785210|NCT01987102|37725239|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
16785211|NCT01987102|37725238|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
16785212|NCT01987102|37725239|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
16785213|NCT01987102|37725238|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
16873803|NCT01448707|37849985|FG000|Overall Study|Withdrawal by Subject|6|||
16873804|NCT01448707|37849986|FG001|Overall Study|Withdrawal by Subject|7|||
16873805|NCT01448707|37849985|FG000|Overall Study|Other|7|||
16873806|NCT01448707|37849986|FG001|Overall Study|Other|4|||
16873807|NCT01536704|37849992|FG000|Washout Period 1|Withdrawal by Subject|1|||
16873808|NCT01536704|37849993|FG001|Washout Period 1|Withdrawal by Subject|2|||
16873809|NCT01536704|37849994|FG002|Washout Period 1|Withdrawal by Subject|0|||
17095079|NCT00262028|38234365|FG007|Overall Study|Withdrawal by Subject|7|||
17191385|NCT02868281|38344190|FG001|Overall Study|Protocol Violation|10|||
17191386|NCT02868281|38344189|FG000|Overall Study|Lost to Follow-up|3|||
17191387|NCT02868281|38344190|FG001|Overall Study|Lost to Follow-up|6|||
17191388|NCT02868281|38344189|FG000|Overall Study|Withdrawal by Subject|11|||
17191389|NCT02868281|38344190|FG001|Overall Study|Withdrawal by Subject|15|||
17191390|NCT02868281|38344189|FG000|Overall Study|Physician Decision|2|||
17191391|NCT02868281|38344190|FG001|Overall Study|Physician Decision|0|||
17191392|NCT02868281|38344189|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
17191393|NCT02868281|38344190|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
17191394|NCT02868281|38344189|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
17191395|NCT02868281|38344190|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
17191396|NCT02868281|38344189|FG000|Overall Study|Long journey/moving away|1|||
17191397|NCT02868281|38344190|FG001|Overall Study|Long journey/moving away|1|||
17191398|NCT02476006|38344196|FG000|Overall Study|Death|4|||
17191399|NCT02476006|38344196|FG000|Overall Study|Lack of treatment efficacy|2|||
17191400|NCT02476006|38344196|FG000|Overall Study|Pregnancy|1|||
16785214|NCT01987102|37725239|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
16873810|NCT01536704|37849995|FG003|Washout Period 1|Withdrawal by Subject|0|||
16873811|NCT01536704|37849992|FG000|Washout Period 2|Adverse Event|1|||
16873812|NCT01536704|37849993|FG001|Washout Period 2|Adverse Event|0|||
16873813|NCT01536704|37849994|FG002|Washout Period 2|Adverse Event|0|||
16873814|NCT01536704|37849995|FG003|Washout Period 2|Adverse Event|0|||
16873815|NCT01536704|37849992|FG000|Washout Period 2|Withdrawal by Subject|0|||
16873816|NCT01536704|37849993|FG001|Washout Period 2|Withdrawal by Subject|0|||
16873817|NCT01536704|37849994|FG002|Washout Period 2|Withdrawal by Subject|0|||
16873818|NCT01536704|37849995|FG003|Washout Period 2|Withdrawal by Subject|1|||
16873819|NCT01536704|37849992|FG000|Period 3|Adverse Event|0|||
16873820|NCT01536704|37849993|FG001|Period 3|Adverse Event|0|||
16873821|NCT01536704|37849994|FG002|Period 3|Adverse Event|0|||
16873822|NCT01536704|37849995|FG003|Period 3|Adverse Event|1|||
16873823|NCT01536704|37849992|FG000|Washout Period 3|Adverse Event|0|||
16873824|NCT01536704|37849993|FG001|Washout Period 3|Adverse Event|0|||
16873825|NCT01536704|37849994|FG002|Washout Period 3|Adverse Event|1|||
16873826|NCT01536704|37849995|FG003|Washout Period 3|Adverse Event|0|||
16873827|NCT01552772|37850009|FG000|Overall Study|Lost to Follow-up|2|||
16873828|NCT01552772|37850009|FG000|Overall Study|Adverse Event|1|||
16873829|NCT01552772|37850009|FG000|Overall Study|Protocol Deviation|1|||
16873830|NCT01552694|37850016|FG000|Overall Study|Lost to Follow-up|0|||
16873831|NCT01552694|37850017|FG001|Overall Study|Lost to Follow-up|1|||
16873832|NCT01552694|37850016|FG000|Overall Study|Protocol Violation|0|||
16873833|NCT01552694|37850017|FG001|Overall Study|Protocol Violation|1|||
16873834|NCT01464931|37850025|FG000|Overall Study|Withdrawal by Subject|1|||
16873835|NCT01464931|37850026|FG001|Overall Study|Withdrawal by Subject|0|||
16873836|NCT01536392|37850051|FG000|Overall Study|Adverse Event|2|||
16873837|NCT01536392|37850052|FG001|Overall Study|Adverse Event|2|||
16873838|NCT01536392|37850051|FG000|Overall Study|Physician Decision|2|||
16873839|NCT01536392|37850052|FG001|Overall Study|Physician Decision|3|||
16873840|NCT01536392|37850051|FG000|Overall Study|Withdrawal by Subject|3|||
16873841|NCT01536392|37850052|FG001|Overall Study|Withdrawal by Subject|6|||
16873842|NCT01536392|37850051|FG000|Overall Study|Non Compliance|3|||
16873843|NCT01536392|37850052|FG001|Overall Study|Non Compliance|4|||
16873844|NCT01536392|37850051|FG000|Overall Study|Completed therapy early|3|||
16873845|NCT01536392|37850052|FG001|Overall Study|Completed therapy early|0|||
16873846|NCT01464619|37850060|FG000|Overall Study|Lost to Follow-up|3|||
16873847|NCT01464619|37850061|FG001|Overall Study|Lost to Follow-up|4|||
16873848|NCT01447927|37850102|FG000|Overall Study|Adverse Event|4|||
16873849|NCT01447927|37850103|FG001|Overall Study|Adverse Event|3|||
16873850|NCT01447927|37850102|FG000|Overall Study|Withdrawal by Subject|1|||
16873851|NCT01447927|37850103|FG001|Overall Study|Withdrawal by Subject|0|||
16873852|NCT01490125|37850136|FG000|Period I|Adverse Event|4|||
16873853|NCT01490125|37850137|FG001|Period I|Adverse Event|1|||
16873854|NCT01490125|37850138|FG002|Period I|Adverse Event|1|||
16873855|NCT01490125|37850139|FG003|Period I|Adverse Event|3|||
16873856|NCT01490125|37850140|FG004|Period I|Adverse Event|2|||
16873857|NCT01490125|37850141|FG005|Period I|Adverse Event|4|||
16873858|NCT01490125|37850136|FG000|Period I|Protocol Violation|1|||
16873859|NCT01490125|37850137|FG001|Period I|Protocol Violation|1|||
16873860|NCT01490125|37850138|FG002|Period I|Protocol Violation|1|||
16873861|NCT01490125|37850139|FG003|Period I|Protocol Violation|1|||
16873862|NCT01490125|37850140|FG004|Period I|Protocol Violation|0|||
16873863|NCT01490125|37850141|FG005|Period I|Protocol Violation|0|||
16873864|NCT01490125|37850136|FG000|Period I|Withdrawal by Subject|1|||
16873865|NCT01490125|37850137|FG001|Period I|Withdrawal by Subject|3|||
16873866|NCT01490125|37850138|FG002|Period I|Withdrawal by Subject|2|||
16873867|NCT01490125|37850139|FG003|Period I|Withdrawal by Subject|1|||
16873868|NCT01490125|37850140|FG004|Period I|Withdrawal by Subject|2|||
16873869|NCT01490125|37850141|FG005|Period I|Withdrawal by Subject|1|||
16873870|NCT01490125|37850136|FG000|Period II|Adverse Event|2|||
16873871|NCT01490125|37850137|FG001|Period II|Adverse Event|3|||
16873872|NCT01490125|37850138|FG002|Period II|Adverse Event|2|||
16873873|NCT01490125|37850139|FG003|Period II|Adverse Event|2|||
16873874|NCT01490125|37850140|FG004|Period II|Adverse Event|4|||
16873875|NCT01490125|37850141|FG005|Period II|Adverse Event|2|||
16873876|NCT01490125|37850136|FG000|Period II|Protocol Violation|0|||
16873877|NCT01490125|37850137|FG001|Period II|Protocol Violation|0|||
16873878|NCT01490125|37850138|FG002|Period II|Protocol Violation|1|||
16873879|NCT01490125|37850139|FG003|Period II|Protocol Violation|1|||
16873880|NCT01490125|37850140|FG004|Period II|Protocol Violation|0|||
17095080|NCT00262028|38234366|FG008|Overall Study|Withdrawal by Subject|2|||
16873881|NCT01490125|37850141|FG005|Period II|Protocol Violation|0|||
16873882|NCT01490125|37850136|FG000|Period II|Lost to Follow-up|0|||
16873883|NCT01490125|37850137|FG001|Period II|Lost to Follow-up|1|||
16873884|NCT01490125|37850138|FG002|Period II|Lost to Follow-up|0|||
16873885|NCT01490125|37850139|FG003|Period II|Lost to Follow-up|0|||
16873886|NCT01490125|37850140|FG004|Period II|Lost to Follow-up|0|||
16873887|NCT01490125|37850141|FG005|Period II|Lost to Follow-up|0|||
16873888|NCT01490125|37850136|FG000|Period II|Withdrawal by Subject|1|||
16873889|NCT01490125|37850137|FG001|Period II|Withdrawal by Subject|0|||
16785215|NCT02013544|37725248|FG000|Overall Study|Adverse Event|5|||
16785216|NCT02013544|37725249|FG001|Overall Study|Adverse Event|5|||
16785217|NCT02013544|37725248|FG000|Overall Study|Lost to Follow-up|2|||
16785218|NCT02013544|37725249|FG001|Overall Study|Lost to Follow-up|3|||
16785219|NCT02013544|37725248|FG000|Overall Study|Withdrawal by Subject|2|||
16785220|NCT02013544|37725249|FG001|Overall Study|Withdrawal by Subject|8|||
16785221|NCT02013544|37725248|FG000|Overall Study|Physician Decision|0|||
16785222|NCT02013544|37725249|FG001|Overall Study|Physician Decision|1|||
16785223|NCT02013544|37725248|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
16785224|NCT02013544|37725249|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
16785225|NCT02013388|37725263|FG000|Overall Study|work emergency|1|||
16785226|NCT02013388|37725264|FG001|Overall Study|work emergency|0|||
16873890|NCT01490125|37850138|FG002|Period II|Withdrawal by Subject|0|||
16873891|NCT01490125|37850139|FG003|Period II|Withdrawal by Subject|0|||
16873892|NCT01490125|37850140|FG004|Period II|Withdrawal by Subject|0|||
16873893|NCT01490125|37850141|FG005|Period II|Withdrawal by Subject|0|||
16873894|NCT01490125|37850136|FG000|Period III|Adverse Event|3|||
16873895|NCT01490125|37850137|FG001|Period III|Adverse Event|1|||
16873896|NCT01490125|37850138|FG002|Period III|Adverse Event|0|||
16873897|NCT01490125|37850139|FG003|Period III|Adverse Event|1|||
16873898|NCT01490125|37850140|FG004|Period III|Adverse Event|0|||
16873899|NCT01490125|37850141|FG005|Period III|Adverse Event|0|||
16873900|NCT01490125|37850136|FG000|Period III|Death|0|||
16873901|NCT01490125|37850137|FG001|Period III|Death|0|||
16873902|NCT01490125|37850138|FG002|Period III|Death|0|||
16873903|NCT01490125|37850139|FG003|Period III|Death|1|||
16873904|NCT01490125|37850140|FG004|Period III|Death|0|||
16873905|NCT01490125|37850141|FG005|Period III|Death|0|||
16873906|NCT01490125|37850136|FG000|Period III|Lack of Efficacy|0|||
16873907|NCT01490125|37850137|FG001|Period III|Lack of Efficacy|0|||
16873908|NCT01490125|37850138|FG002|Period III|Lack of Efficacy|0|||
16873909|NCT01490125|37850139|FG003|Period III|Lack of Efficacy|0|||
16873910|NCT01490125|37850140|FG004|Period III|Lack of Efficacy|1|||
16873911|NCT01490125|37850141|FG005|Period III|Lack of Efficacy|0|||
16873912|NCT01446913|37850152|FG000|Overall Study|Significant illness|1|||
16873913|NCT01446913|37850153|FG001|Overall Study|Significant illness|1|||
16873914|NCT01446913|37850154|FG002|Overall Study|Significant illness|1|||
16873915|NCT01446913|37850152|FG000|Overall Study|Withdrawal by Subject|5|||
16873916|NCT01446913|37850153|FG001|Overall Study|Withdrawal by Subject|3|||
16873917|NCT01446913|37850154|FG002|Overall Study|Withdrawal by Subject|5|||
16873918|NCT01446913|37850152|FG000|Overall Study|Physician Decision|0|||
16873919|NCT01446913|37850153|FG001|Overall Study|Physician Decision|0|||
16873920|NCT01446913|37850154|FG002|Overall Study|Physician Decision|2|||
16873921|NCT01446913|37850152|FG000|Overall Study|Lost to Follow-up|3|||
16873922|NCT01446913|37850153|FG001|Overall Study|Lost to Follow-up|5|||
16873923|NCT01446913|37850154|FG002|Overall Study|Lost to Follow-up|3|||
16873924|NCT01420549|37850185|FG000|Overall Study|Adverse Event|1|||
16873925|NCT01420549|37850186|FG001|Overall Study|Adverse Event|1|||
16873926|NCT01420549|37850185|FG000|Overall Study|Lost to Follow-up|2|||
16873927|NCT01420549|37850186|FG001|Overall Study|Lost to Follow-up|2|||
16873928|NCT01420549|37850185|FG000|Overall Study|Protocol Violation|0|||
16873929|NCT01420549|37850186|FG001|Overall Study|Protocol Violation|1|||
16873930|NCT01420549|37850185|FG000|Overall Study|Non-adherence to medication|4|||
16873931|NCT01420549|37850186|FG001|Overall Study|Non-adherence to medication|1|||
16873932|NCT01440595|37850207|FG000|Overall Study|Lost to Follow-up|0|||
16873933|NCT01440595|37850208|FG001|Overall Study|Lost to Follow-up|1|||
16873934|NCT01440595|37850209|FG002|Overall Study|Lost to Follow-up|0|||
16873935|NCT01440595|37850207|FG000|Overall Study|Study terminated by sponsor.|1|||
16873936|NCT01440595|37850208|FG001|Overall Study|Study terminated by sponsor.|2|||
16873937|NCT01440595|37850209|FG002|Overall Study|Study terminated by sponsor.|1|||
16873938|NCT01440517|37850215|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
16873939|NCT01440283|37850219|FG000|Overall Study|Death|3|||
16873940|NCT01440283|37850219|FG000|Overall Study|Withdrawal by Subject|4|||
16873941|NCT01440283|37850219|FG000|Overall Study|Physician Decision|3|||
16873942|NCT01440049|37850229|FG000|Overall Study|Adverse Event|5|||
16873943|NCT01439971|37850290|FG000|Overall Study|Required number in cohort dosed|0|||
16873944|NCT01439971|37850291|FG001|Overall Study|Required number in cohort dosed|1|||
16873945|NCT01439971|37850292|FG002|Overall Study|Required number in cohort dosed|2|||
16785227|NCT02013388|37725265|FG002|Overall Study|work emergency|0|||
16873946|NCT01439971|37850293|FG003|Overall Study|Required number in cohort dosed|0|||
16873947|NCT01439971|37850294|FG004|Overall Study|Required number in cohort dosed|1|||
16873948|NCT01551758|37850375|FG000|Overall Study|Adverse Event|29|||
16873949|NCT01551758|37850376|FG001|Overall Study|Adverse Event|43|||
16873950|NCT01551758|37850375|FG000|Overall Study|Lack of Efficacy|0|||
16785228|NCT02013388|37725266|FG003|Overall Study|work emergency|0|||
16785229|NCT02013388|37725267|FG004|Overall Study|work emergency|1|||
16873951|NCT01551758|37850376|FG001|Overall Study|Lack of Efficacy|1|||
16873952|NCT01551758|37850375|FG000|Overall Study|Protocol Violation|5|||
16873953|NCT01551758|37850376|FG001|Overall Study|Protocol Violation|6|||
16873954|NCT01551758|37850375|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
16873955|NCT01551758|37850376|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
16873956|NCT01551758|37850375|FG000|Overall Study|Lost to Follow-up|29|||
16873957|NCT01551758|37850376|FG001|Overall Study|Lost to Follow-up|25|||
16873958|NCT01551758|37850375|FG000|Overall Study|Physician Decision|9|||
16873959|NCT01551758|37850376|FG001|Overall Study|Physician Decision|3|||
16785230|NCT02013388|37725268|FG005|Overall Study|work emergency|0|||
16785231|NCT02013388|37725269|FG006|Overall Study|work emergency|0|||
16785232|NCT02013388|37725270|FG007|Overall Study|work emergency|0|||
16873960|NCT01551758|37850375|FG000|Overall Study|Withdrawal by Subject|14|||
16873961|NCT01551758|37850376|FG001|Overall Study|Withdrawal by Subject|17|||
16873962|NCT01449461|37850579|FG000|Overall Study|Adverse Event|0|||
16873963|NCT01449461|37850580|FG001|Overall Study|Adverse Event|3|||
16873964|NCT01449461|37850581|FG002|Overall Study|Adverse Event|2|||
16873965|NCT01449461|37850582|FG003|Overall Study|Adverse Event|3|||
16873966|NCT01449461|37850583|FG004|Overall Study|Adverse Event|4|||
16873967|NCT01449461|37850584|FG005|Overall Study|Adverse Event|4|||
16873968|NCT01449461|37850579|FG000|Overall Study|Death|0|||
16873969|NCT01449461|37850580|FG001|Overall Study|Death|2|||
16873970|NCT01449461|37850581|FG002|Overall Study|Death|0|||
16873971|NCT01449461|37850582|FG003|Overall Study|Death|0|||
16873972|NCT01449461|37850583|FG004|Overall Study|Death|7|||
16873973|NCT01449461|37850584|FG005|Overall Study|Death|1|||
16873974|NCT01449461|37850579|FG000|Overall Study|Physician Decision|0|||
16873975|NCT01449461|37850580|FG001|Overall Study|Physician Decision|1|||
16873976|NCT01449461|37850581|FG002|Overall Study|Physician Decision|0|||
16873977|NCT01449461|37850582|FG003|Overall Study|Physician Decision|4|||
16873978|NCT01449461|37850583|FG004|Overall Study|Physician Decision|1|||
16873979|NCT01449461|37850584|FG005|Overall Study|Physician Decision|0|||
16873980|NCT01449461|37850579|FG000|Overall Study|Documented Progressive Disease|4|||
16785233|NCT02012686|37725294|FG000|Overall Study|muscle contraction|0|||
16785234|NCT02012686|37725295|FG001|Overall Study|muscle contraction|1|||
16785235|NCT02012686|37725294|FG000|Overall Study|electrocardiography monitoring noise|0|||
16873981|NCT01449461|37850580|FG001|Overall Study|Documented Progressive Disease|7|||
16873982|NCT01449461|37850581|FG002|Overall Study|Documented Progressive Disease|14|||
16873983|NCT01449461|37850582|FG003|Overall Study|Documented Progressive Disease|15|||
16873984|NCT01449461|37850583|FG004|Overall Study|Documented Progressive Disease|24|||
16873985|NCT01449461|37850584|FG005|Overall Study|Documented Progressive Disease|5|||
16873986|NCT01449461|37850579|FG000|Overall Study|Clinical Progressive Disease|2|||
16873987|NCT01449461|37850580|FG001|Overall Study|Clinical Progressive Disease|2|||
16873988|NCT01449461|37850581|FG002|Overall Study|Clinical Progressive Disease|0|||
16873989|NCT01449461|37850582|FG003|Overall Study|Clinical Progressive Disease|3|||
16873990|NCT01449461|37850583|FG004|Overall Study|Clinical Progressive Disease|4|||
16873991|NCT01449461|37850584|FG005|Overall Study|Clinical Progressive Disease|2|||
16873992|NCT01449461|37850579|FG000|Overall Study|Protocol Violation|0|||
16873993|NCT01449461|37850580|FG001|Overall Study|Protocol Violation|0|||
16873994|NCT01449461|37850581|FG002|Overall Study|Protocol Violation|0|||
16873995|NCT01449461|37850582|FG003|Overall Study|Protocol Violation|1|||
16873996|NCT01449461|37850583|FG004|Overall Study|Protocol Violation|0|||
16873997|NCT01449461|37850584|FG005|Overall Study|Protocol Violation|0|||
16873998|NCT01449461|37850579|FG000|Overall Study|Site Terminated by Sponsor|0|||
16873999|NCT01449461|37850580|FG001|Overall Study|Site Terminated by Sponsor|1|||
16874000|NCT01449461|37850581|FG002|Overall Study|Site Terminated by Sponsor|2|||
16874001|NCT01449461|37850582|FG003|Overall Study|Site Terminated by Sponsor|3|||
16874002|NCT01449461|37850583|FG004|Overall Study|Site Terminated by Sponsor|4|||
16874003|NCT01449461|37850584|FG005|Overall Study|Site Terminated by Sponsor|1|||
16874004|NCT01449461|37850579|FG000|Overall Study|Withdrawal by Subject|0|||
16874005|NCT01449461|37850580|FG001|Overall Study|Withdrawal by Subject|1|||
16785236|NCT02012686|37725295|FG001|Overall Study|electrocardiography monitoring noise|1|||
16785237|NCT02012452|37725303|FG000|Overall Study|Lost to Follow-up|2|||
16785238|NCT02012452|37725304|FG001|Overall Study|Lost to Follow-up|1|||
16874006|NCT01449461|37850581|FG002|Overall Study|Withdrawal by Subject|0|||
16874007|NCT01449461|37850582|FG003|Overall Study|Withdrawal by Subject|0|||
16874008|NCT01449461|37850583|FG004|Overall Study|Withdrawal by Subject|2|||
16874009|NCT01449461|37850584|FG005|Overall Study|Withdrawal by Subject|1|||
16874010|NCT01449461|37850579|FG000|Overall Study|Reason not Specified|0|||
16874011|NCT01449461|37850580|FG001|Overall Study|Reason not Specified|1|||
16874012|NCT01449461|37850581|FG002|Overall Study|Reason not Specified|0|||
16874013|NCT01449461|37850582|FG003|Overall Study|Reason not Specified|3|||
16874014|NCT01449461|37850583|FG004|Overall Study|Reason not Specified|2|||
16874015|NCT01449461|37850584|FG005|Overall Study|Reason not Specified|1|||
16874016|NCT01572038|37850620|FG000|Overall Study|Death|648|||
16874017|NCT01572038|37850620|FG000|Overall Study|Withdrawal by Subject|204|||
16874018|NCT01572038|37850620|FG000|Overall Study|Lost to Follow-up|81|||
16874019|NCT01572038|37850620|FG000|Overall Study|Physician Decision|20|||
17095081|NCT00262028|38234358|FG000|Overall Study|Lost to Follow-up|7|||
16785239|NCT02012452|37725303|FG000|Overall Study|Withdrawal by Subject|4|||
16874020|NCT01572038|37850620|FG000|Overall Study|Patient Decision|14|||
16874021|NCT01572038|37850620|FG000|Overall Study|Progressive Disease|8|||
16874022|NCT01572038|37850620|FG000|Overall Study|Site Closed Before Completing Form|6|||
16874023|NCT01572038|37850620|FG000|Overall Study|Enrolled into Another Trial|3|||
16874024|NCT01572038|37850620|FG000|Overall Study|Participated in Another Trial|3|||
16874025|NCT01572038|37850620|FG000|Overall Study|Termination by Sponsor|2|||
16874026|NCT01572038|37850620|FG000|Overall Study|Patient Deterioration|1|||
16874027|NCT01572038|37850620|FG000|Overall Study|Sponsor Decision|1|||
16874028|NCT01448213|37850648|FG000|Overall Study|Lost to Follow-up|12|||
16874029|NCT01448213|37850649|FG001|Overall Study|Lost to Follow-up|10|||
16874030|NCT01448213|37850648|FG000|Overall Study|Adverse Event|4|||
16874031|NCT01448213|37850649|FG001|Overall Study|Adverse Event|10|||
16874032|NCT01448213|37850648|FG000|Overall Study|Protocol Violation|1|||
16874033|NCT01448213|37850649|FG001|Overall Study|Protocol Violation|2|||
16874034|NCT01448057|37850666|FG000|Overall Study|Protocol Violation|3|||
16874035|NCT01448057|37850667|FG001|Overall Study|Protocol Violation|2|||
16874036|NCT01448057|37850666|FG000|Overall Study|Lost to Follow-up|3|||
16874037|NCT01448057|37850667|FG001|Overall Study|Lost to Follow-up|0|||
16874038|NCT01448057|37850666|FG000|Overall Study|Adverse Event|0|||
16874039|NCT01448057|37850667|FG001|Overall Study|Adverse Event|2|||
16874040|NCT01448057|37850666|FG000|Overall Study|Withdrawal by Subject|2|||
16874041|NCT01448057|37850667|FG001|Overall Study|Withdrawal by Subject|0|||
16874042|NCT01447433|37850675|FG000|Overall Study|Lost to Follow-up|0|||
16874043|NCT01447433|37850676|FG001|Overall Study|Lost to Follow-up|2|||
16874044|NCT01447433|37850675|FG000|Overall Study|Withdrawal by Subject|3|||
16874045|NCT01447433|37850676|FG001|Overall Study|Withdrawal by Subject|3|||
16874046|NCT01447433|37850675|FG000|Overall Study|Protocol Violation|1|||
16874047|NCT01447433|37850676|FG001|Overall Study|Protocol Violation|1|||
16874048|NCT01446965|37850684|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
16874049|NCT01446965|37850685|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
16874050|NCT01446965|37850684|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
16874051|NCT01446965|37850685|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
16874052|NCT01446809|37850693|FG000|Overall Study|Adverse Event|0|||
16874053|NCT01446809|37850694|FG001|Overall Study|Adverse Event|0|||
16874054|NCT01446809|37850695|FG002|Overall Study|Adverse Event|1|||
16874055|NCT01446809|37850693|FG000|Overall Study|Failure to complete study procedures|0|||
16874056|NCT01446809|37850694|FG001|Overall Study|Failure to complete study procedures|0|||
16874057|NCT01446809|37850695|FG002|Overall Study|Failure to complete study procedures|1|||
16874058|NCT01446419|37850706|FG000|Overall Study|Death|1|||
16874059|NCT01446419|37850707|FG001|Overall Study|Death|0|||
16874060|NCT01446419|37850706|FG000|Overall Study|Withdrawal by Subject|1|||
16874061|NCT01446419|37850707|FG001|Overall Study|Withdrawal by Subject|1|||
16874062|NCT01446419|37850706|FG000|Overall Study|Terminated per protocol|3|||
16874063|NCT01446419|37850707|FG001|Overall Study|Terminated per protocol|0|||
16874064|NCT01445951|37850716|FG000|Overall Study|Adverse Event|16|||
16874065|NCT01445951|37850717|FG001|Overall Study|Adverse Event|9|||
16874066|NCT01445951|37850718|FG002|Overall Study|Adverse Event|0|||
16874067|NCT01445951|37850716|FG000|Overall Study|Protocol Violation|2|||
16874068|NCT01445951|37850717|FG001|Overall Study|Protocol Violation|2|||
16874069|NCT01445951|37850718|FG002|Overall Study|Protocol Violation|2|||
16874070|NCT01445951|37850716|FG000|Overall Study|Withdrawal by Subject|21|||
16874071|NCT01445951|37850717|FG001|Overall Study|Withdrawal by Subject|16|||
16874072|NCT01445951|37850718|FG002|Overall Study|Withdrawal by Subject|8|||
16874073|NCT01445951|37850716|FG000|Overall Study|Physician Decision|3|||
16874074|NCT01445951|37850717|FG001|Overall Study|Physician Decision|1|||
16874075|NCT01445951|37850718|FG002|Overall Study|Physician Decision|0|||
16874076|NCT01445951|37850716|FG000|Overall Study|Lost to Follow-up|1|||
16874077|NCT01445951|37850717|FG001|Overall Study|Lost to Follow-up|2|||
16874078|NCT01445951|37850718|FG002|Overall Study|Lost to Follow-up|4|||
16874079|NCT01445951|37850716|FG000|Overall Study|Pregnancy|0|||
16874080|NCT01445951|37850717|FG001|Overall Study|Pregnancy|1|||
16874081|NCT01445951|37850718|FG002|Overall Study|Pregnancy|4|||
16874082|NCT01445951|37850716|FG000|Overall Study|Death|0|||
16874083|NCT01445951|37850717|FG001|Overall Study|Death|0|||
16874084|NCT01445951|37850718|FG002|Overall Study|Death|1|||
16874085|NCT01445951|37850716|FG000|Overall Study|Non-compliance with study drug|1|||
16874086|NCT01445951|37850717|FG001|Overall Study|Non-compliance with study drug|2|||
16874087|NCT01445951|37850718|FG002|Overall Study|Non-compliance with study drug|0|||
16874088|NCT01445951|37850716|FG000|Overall Study|Non-compliance with protocol|0|||
16874089|NCT01445951|37850717|FG001|Overall Study|Non-compliance with protocol|1|||
16874090|NCT01445951|37850718|FG002|Overall Study|Non-compliance with protocol|0|||
16874091|NCT01445951|37850716|FG000|Overall Study|Sponsor decision - subject travel|0|||
16874092|NCT01445951|37850717|FG001|Overall Study|Sponsor decision - subject travel|1|||
16874093|NCT01445951|37850718|FG002|Overall Study|Sponsor decision - subject travel|0|||
16874094|NCT01445951|37850716|FG000|Overall Study|Cough|0|||
17095082|NCT00262028|38234359|FG001|Overall Study|Lost to Follow-up|7|||
16874095|NCT01445951|37850717|FG001|Overall Study|Cough|1|||
16874096|NCT01445951|37850718|FG002|Overall Study|Cough|0|||
16874097|NCT01445171|37850726|FG000|Overall Study|Lost to Follow-up|11|||
16874098|NCT01445171|37850726|FG000|Overall Study|Withdrawal by Subject|16|||
16874099|NCT01445171|37850726|FG000|Overall Study|Death|51|||
16874100|NCT01445171|37850726|FG000|Overall Study|Subjects declined to return for followup|9|||
16874101|NCT01445171|37850726|FG000|Overall Study|Consented but did not receive device|8|||
16874102|NCT01444781|37850735|FG000|Overall Study|Lost to Follow-up|0|||
16874103|NCT01444781|37850736|FG001|Overall Study|Lost to Follow-up|3|||
16874104|NCT01444781|37850737|FG002|Overall Study|Lost to Follow-up|1|||
16874105|NCT01444781|37850735|FG000|Overall Study|Withdrawal by Subject|3|||
16874106|NCT01444781|37850736|FG001|Overall Study|Withdrawal by Subject|1|||
16874107|NCT01444781|37850737|FG002|Overall Study|Withdrawal by Subject|2|||
16874108|NCT01444391|37850752|FG000|Overall Study|Death|1|||
16874109|NCT01443923|37850758|FG000|Overall Study|Adverse Event|1|||
16874110|NCT01443923|37850759|FG001|Overall Study|Adverse Event|0|||
16874111|NCT01551212|37850771|FG000|Overall Study|Graft loss/Retransplantation|0|||
16874112|NCT01551212|37850772|FG001|Overall Study|Graft loss/Retransplantation|1|||
16874113|NCT01551212|37850771|FG000|Overall Study|Administrative problems|1|||
16874114|NCT01551212|37850772|FG001|Overall Study|Administrative problems|2|||
16874115|NCT01551212|37850771|FG000|Overall Study|Lost to Follow-up|0|||
16874116|NCT01551212|37850772|FG001|Overall Study|Lost to Follow-up|1|||
16874117|NCT01551212|37850771|FG000|Overall Study|Protocol Violation|0|||
16874118|NCT01551212|37850772|FG001|Overall Study|Protocol Violation|1|||
16874119|NCT01551212|37850771|FG000|Overall Study|Withdrawal by Subject|0|||
16874120|NCT01551212|37850772|FG001|Overall Study|Withdrawal by Subject|7|||
16874121|NCT01551212|37850771|FG000|Overall Study|Death|2|||
16874122|NCT01551212|37850772|FG001|Overall Study|Death|4|||
16874123|NCT01551212|37850771|FG000|Overall Study|Never Received Study Treatment|2|||
16874124|NCT01551212|37850772|FG001|Overall Study|Never Received Study Treatment|4|||
16874135|NCT01550744|37850845|FG000|Open-Label|Lost to Follow-up|7|||
16874136|NCT01550744|37850846|FG001|Open-Label|Lost to Follow-up|0|||
16874137|NCT01550744|37850847|FG002|Open-Label|Lost to Follow-up|0|||
16874138|NCT01550744|37850845|FG000|Open-Label|Withdrawal by Subject|13|||
16874139|NCT01550744|37850846|FG001|Open-Label|Withdrawal by Subject|0|||
16874140|NCT01550744|37850847|FG002|Open-Label|Withdrawal by Subject|0|||
16874141|NCT01550744|37850845|FG000|Open-Label|Adverse Event|11|||
16874142|NCT01550744|37850846|FG001|Open-Label|Adverse Event|0|||
16874143|NCT01550744|37850847|FG002|Open-Label|Adverse Event|0|||
16874144|NCT01550744|37850845|FG000|Open-Label|Lack of Efficacy|4|||
16874145|NCT01550744|37850846|FG001|Open-Label|Lack of Efficacy|0|||
16874146|NCT01550744|37850847|FG002|Open-Label|Lack of Efficacy|0|||
16874147|NCT01550744|37850845|FG000|Open-Label|Protocol Violation|4|||
16874148|NCT01550744|37850846|FG001|Open-Label|Protocol Violation|0|||
16874149|NCT01550744|37850847|FG002|Open-Label|Protocol Violation|0|||
16874150|NCT01550744|37850845|FG000|Open-Label|Not all 3 study drug injections received|2|||
16874151|NCT01550744|37850846|FG001|Open-Label|Not all 3 study drug injections received|0|||
16874152|NCT01550744|37850847|FG002|Open-Label|Not all 3 study drug injections received|0|||
16874153|NCT01550744|37850845|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
16874154|NCT01550744|37850846|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
16874155|NCT01550744|37850847|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
16874156|NCT01550744|37850845|FG000|Open-Label|Other|1|||
16874157|NCT01550744|37850846|FG001|Open-Label|Other|0|||
16874158|NCT01550744|37850847|FG002|Open-Label|Other|0|||
16874159|NCT01550744|37850845|FG000|Double-Blind|Lost to Follow-up|0|||
16874160|NCT01550744|37850846|FG001|Double-Blind|Lost to Follow-up|6|||
16874161|NCT01550744|37850847|FG002|Double-Blind|Lost to Follow-up|12|||
16874162|NCT01550744|37850845|FG000|Double-Blind|Withdrawal by Subject|0|||
16874163|NCT01550744|37850846|FG001|Double-Blind|Withdrawal by Subject|2|||
16874164|NCT01550744|37850847|FG002|Double-Blind|Withdrawal by Subject|15|||
16874165|NCT01550744|37850845|FG000|Double-Blind|Adverse Event|0|||
16874166|NCT01550744|37850846|FG001|Double-Blind|Adverse Event|4|||
16874167|NCT01550744|37850847|FG002|Double-Blind|Adverse Event|15|||
16874168|NCT01550744|37850845|FG000|Double-Blind|Death|0|||
16874169|NCT01550744|37850846|FG001|Double-Blind|Death|1|||
16874170|NCT01550744|37850847|FG002|Double-Blind|Death|0|||
16874171|NCT01550744|37850845|FG000|Double-Blind|Lack of Efficacy|0|||
16874172|NCT01550744|37850846|FG001|Double-Blind|Lack of Efficacy|2|||
16874173|NCT01550744|37850847|FG002|Double-Blind|Lack of Efficacy|8|||
16874174|NCT01550744|37850845|FG000|Double-Blind|Protocol Violation|0|||
16874175|NCT01550744|37850846|FG001|Double-Blind|Protocol Violation|0|||
16874176|NCT01550744|37850847|FG002|Double-Blind|Protocol Violation|4|||
16874177|NCT01550744|37850845|FG000|Double-Blind|Pregnancy|0|||
16874178|NCT01550744|37850846|FG001|Double-Blind|Pregnancy|0|||
16874179|NCT01550744|37850847|FG002|Double-Blind|Pregnancy|3|||
16874180|NCT01550744|37850845|FG000|Double-Blind|Other|0|||
16874181|NCT01550744|37850846|FG001|Double-Blind|Other|2|||
16874182|NCT01550744|37850847|FG002|Double-Blind|Other|10|||
16874183|NCT01549964|37850908|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
16874184|NCT01549964|37850909|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
16874185|NCT01549964|37850910|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
16874186|NCT01549964|37850911|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
16874187|NCT01549964|37850908|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
16874188|NCT01549964|37850909|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
16874189|NCT01549964|37850910|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
16874190|NCT01549964|37850911|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
16874191|NCT01549964|37850908|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
16874192|NCT01549964|37850909|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
16874193|NCT01549964|37850910|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
16874194|NCT01549964|37850911|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
16874195|NCT01549964|37850908|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
16874196|NCT01549964|37850909|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
16874197|NCT01549964|37850910|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
16874198|NCT01549964|37850911|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
16874199|NCT01549964|37850908|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
16874200|NCT01549964|37850909|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
16874201|NCT01549964|37850910|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
16874202|NCT01549964|37850911|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
16874203|NCT01549964|37850908|FG000|24-Week Treatment Period|Other|1|||
16874204|NCT01549964|37850909|FG001|24-Week Treatment Period|Other|0|||
16874205|NCT01549964|37850910|FG002|24-Week Treatment Period|Other|1|||
16874206|NCT01549964|37850911|FG003|24-Week Treatment Period|Other|0|||
16874207|NCT01549964|37850908|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
16874208|NCT01549964|37850909|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
16874209|NCT01549964|37850910|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
16874210|NCT01549964|37850911|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
16874211|NCT01549964|37850908|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
16874212|NCT01549964|37850909|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
16874213|NCT01549964|37850910|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
16874214|NCT01549964|37850911|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
16874215|NCT01549964|37850908|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
16874216|NCT01549964|37850909|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
16874217|NCT01549964|37850910|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
16874218|NCT01549964|37850911|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
16874219|NCT01549964|37850908|FG000|80-Week Extension Period|Pregnancy|0|||
16874220|NCT01549964|37850909|FG001|80-Week Extension Period|Pregnancy|0|||
16874221|NCT01549964|37850910|FG002|80-Week Extension Period|Pregnancy|1|||
16874222|NCT01549964|37850911|FG003|80-Week Extension Period|Pregnancy|0|||
16874223|NCT01549964|37850908|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
16874224|NCT01549964|37850909|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
16874225|NCT01549964|37850910|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
16874226|NCT01549964|37850911|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
16874227|NCT01549964|37850908|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
16874228|NCT01549964|37850909|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
16874229|NCT01549964|37850910|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
16874230|NCT01549964|37850911|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
16874231|NCT01549964|37850908|FG000|80-Week Extension Period|Lost to Follow-up|1|||
16874232|NCT01549964|37850909|FG001|80-Week Extension Period|Lost to Follow-up|0|||
16874233|NCT01549964|37850910|FG002|80-Week Extension Period|Lost to Follow-up|2|||
16874234|NCT01549964|37850911|FG003|80-Week Extension Period|Lost to Follow-up|1|||
16874235|NCT01549964|37850908|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
16874236|NCT01549964|37850909|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
16874237|NCT01549964|37850910|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
16874238|NCT01549964|37850911|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
16874239|NCT01570244|37850993|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
16874240|NCT01535222|37851028|FG000|Overall Study|Inclusion/exclusion|0|||
16874241|NCT01535222|37851029|FG001|Overall Study|Inclusion/exclusion|0|||
16874242|NCT01535222|37851030|FG002|Overall Study|Inclusion/exclusion|1|||
16874243|NCT01535222|37851031|FG003|Overall Study|Inclusion/exclusion|0|||
16874244|NCT01535222|37851032|FG004|Overall Study|Inclusion/exclusion|0|||
16874245|NCT01535222|37851033|FG005|Overall Study|Inclusion/exclusion|0|||
16874246|NCT01549886|37851049|FG000|Overall Study|Sponsor's decision|2|||
16874247|NCT01549886|37851050|FG001|Overall Study|Sponsor's decision|3|||
16874248|NCT01443845|37851079|FG000|Overall Study|Protocol Violation|43|||
16874249|NCT01443845|37851080|FG001|Overall Study|Protocol Violation|45|||
16874250|NCT01443845|37851079|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
16874251|NCT01443845|37851080|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
16874252|NCT01443845|37851079|FG000|Overall Study|Deterioration in pulmonary function|1|||
16874253|NCT01443845|37851080|FG001|Overall Study|Deterioration in pulmonary function|4|||
16874254|NCT01443845|37851079|FG000|Overall Study|Lack of Efficacy|10|||
16874255|NCT01443845|37851080|FG001|Overall Study|Lack of Efficacy|5|||
16874256|NCT01443845|37851079|FG000|Overall Study|Adverse Event|64|||
16874257|NCT01443845|37851080|FG001|Overall Study|Adverse Event|138|||
16874258|NCT01443845|37851079|FG000|Overall Study|Withdrawal by Subject|63|||
16874259|NCT01443845|37851080|FG001|Overall Study|Withdrawal by Subject|67|||
16874260|NCT01443845|37851079|FG000|Overall Study|Military Conflict - Site Terminated|20|||
16874261|NCT01443845|37851080|FG001|Overall Study|Military Conflict - Site Terminated|21|||
16874262|NCT01443845|37851079|FG000|Overall Study|Lost to Follow-up|9|||
16874263|NCT01443845|37851080|FG001|Overall Study|Lost to Follow-up|13|||
16874264|NCT01549652|37851089|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
16874265|NCT01549652|37851090|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
16874266|NCT01549652|37851091|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
16874267|NCT01549652|37851092|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
16874268|NCT01549652|37851089|FG000|Overall Study|Study Drug Titration Failure|5|||
16874269|NCT01549652|37851090|FG001|Overall Study|Study Drug Titration Failure|6|||
16874270|NCT01549652|37851091|FG002|Overall Study|Study Drug Titration Failure|0|||
16874271|NCT01549652|37851092|FG003|Overall Study|Study Drug Titration Failure|0|||
16874272|NCT01549652|37851089|FG000|Overall Study|Withdrawal Effect|0|||
16874273|NCT01549652|37851090|FG001|Overall Study|Withdrawal Effect|2|||
16874274|NCT01549652|37851091|FG002|Overall Study|Withdrawal Effect|0|||
16874275|NCT01549652|37851092|FG003|Overall Study|Withdrawal Effect|0|||
16874276|NCT01549652|37851089|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
16874277|NCT01549652|37851090|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
16874278|NCT01549652|37851091|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
16874279|NCT01549652|37851092|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
16874280|NCT01549652|37851089|FG000|Overall Study|Problem with Infusion|1|||
16874281|NCT01549652|37851090|FG001|Overall Study|Problem with Infusion|0|||
16874282|NCT01549652|37851091|FG002|Overall Study|Problem with Infusion|0|||
16874283|NCT01549652|37851092|FG003|Overall Study|Problem with Infusion|0|||
16874284|NCT01549652|37851089|FG000|Overall Study|Titration Non-Compliance|1|||
16874285|NCT01549652|37851090|FG001|Overall Study|Titration Non-Compliance|3|||
16874286|NCT01549652|37851091|FG002|Overall Study|Titration Non-Compliance|4|||
16874287|NCT01549652|37851092|FG003|Overall Study|Titration Non-Compliance|5|||
16874288|NCT01549652|37851089|FG000|Overall Study|Titration Side Effects|0|||
16874289|NCT01549652|37851090|FG001|Overall Study|Titration Side Effects|0|||
16874290|NCT01549652|37851091|FG002|Overall Study|Titration Side Effects|6|||
16874291|NCT01549652|37851092|FG003|Overall Study|Titration Side Effects|3|||
16874292|NCT01549652|37851089|FG000|Overall Study|Withdrawal by Subject|0|||
16874293|NCT01549652|37851090|FG001|Overall Study|Withdrawal by Subject|0|||
16874294|NCT01549652|37851091|FG002|Overall Study|Withdrawal by Subject|5|||
16874295|NCT01549652|37851092|FG003|Overall Study|Withdrawal by Subject|3|||
16874296|NCT01569464|37851100|FG000|Overall Study|Adverse Event|4|||
16874297|NCT01569464|37851101|FG001|Overall Study|Adverse Event|0|||
16874298|NCT01569464|37851100|FG000|Overall Study|Lack of Efficacy|1|||
16874299|NCT01569464|37851101|FG001|Overall Study|Lack of Efficacy|0|||
16874300|NCT01569464|37851100|FG000|Overall Study|Protocol Violation|1|||
16874301|NCT01569464|37851101|FG001|Overall Study|Protocol Violation|0|||
16874302|NCT01569464|37851100|FG000|Overall Study|Lost to Follow-up|2|||
16874303|NCT01569464|37851101|FG001|Overall Study|Lost to Follow-up|3|||
16874304|NCT01569464|37851100|FG000|Overall Study|Withdrawal by Subject|1|||
16874305|NCT01569464|37851101|FG001|Overall Study|Withdrawal by Subject|1|||
16874306|NCT01569464|37851100|FG000|Overall Study|Other|1|||
16874307|NCT01569464|37851101|FG001|Overall Study|Other|1|||
16874308|NCT01534676|37851111|FG000|Overall Study|Study closed due to poor enrollment|2|||
16874309|NCT01534676|37851112|FG001|Overall Study|Study closed due to poor enrollment|1|||
16874310|NCT01442675|37851118|FG000|Overall Study|Protocol Violation|6|||
16874311|NCT01442675|37851118|FG000|Overall Study|Lost to Follow-up|2|||
16874312|NCT01442675|37851118|FG000|Overall Study|Withdrawal by Subject|4|||
16874313|NCT01534520|37851125|FG000|Overall Study|Adverse Event|0|||
16874314|NCT01534520|37851126|FG001|Overall Study|Adverse Event|1|||
16874315|NCT01534208|37851156|FG000|Overall Study|Lost to Follow-up|19|||
16874316|NCT01534208|37851157|FG001|Overall Study|Lost to Follow-up|14|||
16874317|NCT01534208|37851156|FG000|Overall Study|Withdrawal by Subject|6|||
16874318|NCT01534208|37851157|FG001|Overall Study|Withdrawal by Subject|20|||
16874319|NCT01534208|37851156|FG000|Overall Study|Adverse Event|15|||
16874320|NCT01534208|37851157|FG001|Overall Study|Adverse Event|8|||
16874321|NCT01534208|37851156|FG000|Overall Study|Physician Decision|2|||
16874322|NCT01534208|37851157|FG001|Overall Study|Physician Decision|0|||
16874323|NCT01534208|37851156|FG000|Overall Study|Lack of Efficacy|0|||
16874324|NCT01534208|37851157|FG001|Overall Study|Lack of Efficacy|3|||
16874325|NCT01534208|37851156|FG000|Overall Study|Protocol Violation|2|||
16874326|NCT01534208|37851157|FG001|Overall Study|Protocol Violation|2|||
16874327|NCT01534208|37851156|FG000|Overall Study|Sponsor decision|4|||
16874328|NCT01534208|37851157|FG001|Overall Study|Sponsor decision|1|||
16874329|NCT01534208|37851156|FG000|Overall Study|Subject relocation|2|||
16874330|NCT01534208|37851157|FG001|Overall Study|Subject relocation|0|||
16874331|NCT01534208|37851156|FG000|Overall Study|Lab assessment|2|||
16874332|NCT01534208|37851157|FG001|Overall Study|Lab assessment|1|||
16874333|NCT01534208|37851156|FG000|Overall Study|Eligibility error|3|||
16874334|NCT01534208|37851157|FG001|Overall Study|Eligibility error|0|||
16874335|NCT01534208|37851156|FG000|Overall Study|PCP decision|1|||
16874336|NCT01534208|37851157|FG001|Overall Study|PCP decision|0|||
16874337|NCT01534208|37851156|FG000|Overall Study|Needed prohibited meds|1|||
16874338|NCT01534208|37851157|FG001|Overall Study|Needed prohibited meds|0|||
16874339|NCT01548638|37851163|FG000|Overall Study|Protocol Violation|3|||
16874340|NCT01548638|37851163|FG000|Overall Study|Withdrawal by Subject|1|||
16874341|NCT01533428|37851187|FG000|Overall Study|Adverse Event|0|||
16874342|NCT01533428|37851188|FG001|Overall Study|Adverse Event|1|||
16874343|NCT01533428|37851187|FG000|Overall Study|Lost to Follow-up|2|||
16874344|NCT01533428|37851188|FG001|Overall Study|Lost to Follow-up|1|||
16874345|NCT01533428|37851187|FG000|Overall Study|Withdrawal by Subject|7|||
16874346|NCT01533428|37851188|FG001|Overall Study|Withdrawal by Subject|6|||
16874347|NCT01517984|37851201|FG000|Overall Study|Lost to Follow-up|0|||
16874348|NCT01517984|37851202|FG001|Overall Study|Lost to Follow-up|1|||
16874349|NCT01517984|37851203|FG002|Overall Study|Lost to Follow-up|0|||
16874350|NCT01517984|37851204|FG003|Overall Study|Lost to Follow-up|0|||
16874351|NCT01517984|37851201|FG000|Overall Study|Withdrawal by Subject|1|||
16874352|NCT01517984|37851202|FG001|Overall Study|Withdrawal by Subject|8|||
16874353|NCT01517984|37851203|FG002|Overall Study|Withdrawal by Subject|4|||
16874354|NCT01517984|37851204|FG003|Overall Study|Withdrawal by Subject|1|||
16874355|NCT01517984|37851201|FG000|Overall Study|Screen Failure|4|||
16874356|NCT01517984|37851202|FG001|Overall Study|Screen Failure|0|||
16874357|NCT01517984|37851203|FG002|Overall Study|Screen Failure|0|||
17095083|NCT00262028|38234360|FG002|Overall Study|Lost to Follow-up|5|||
17095084|NCT00262028|38234361|FG003|Overall Study|Lost to Follow-up|5|||
17095085|NCT00262028|38234362|FG004|Overall Study|Lost to Follow-up|4|||
17095086|NCT00262028|38234363|FG005|Overall Study|Lost to Follow-up|3|||
16874358|NCT01517984|37851204|FG003|Overall Study|Screen Failure|0|||
16874359|NCT01517984|37851201|FG000|Overall Study|Ineligible for randomization|0|||
16874360|NCT01517984|37851202|FG001|Overall Study|Ineligible for randomization|14|||
16874361|NCT01517984|37851203|FG002|Overall Study|Ineligible for randomization|0|||
16874362|NCT01517984|37851204|FG003|Overall Study|Ineligible for randomization|0|||
16874363|NCT01517750|37851232|FG000|Overall Study|Lost to Follow-up|1|||
16874364|NCT01517750|37851233|FG001|Overall Study|Lost to Follow-up|2|||
16874365|NCT01517750|37851234|FG002|Overall Study|Lost to Follow-up|4|||
16874366|NCT01517750|37851235|FG003|Overall Study|Lost to Follow-up|1|||
16874367|NCT01548404|37851260|FG000|Overall Study|Adverse Event|3|||
16874368|NCT01548404|37851261|FG001|Overall Study|Adverse Event|1|||
16874369|NCT01548404|37851260|FG000|Overall Study|Physician Decision|2|||
16874370|NCT01548404|37851261|FG001|Overall Study|Physician Decision|1|||
16874371|NCT01548404|37851260|FG000|Overall Study|Inadequate response to study treatment|23|||
16874372|NCT01548404|37851261|FG001|Overall Study|Inadequate response to study treatment|7|||
16874373|NCT01548404|37851260|FG000|Overall Study|Lost to Follow-up|2|||
16874374|NCT01548404|37851261|FG001|Overall Study|Lost to Follow-up|0|||
16874375|NCT01548404|37851260|FG000|Overall Study|Withdrawal by Subject|0|||
16874376|NCT01548404|37851261|FG001|Overall Study|Withdrawal by Subject|3|||
16874377|NCT01548404|37851260|FG000|Overall Study|Other than specified above|0|||
16874378|NCT01548404|37851261|FG001|Overall Study|Other than specified above|2|||
16874379|NCT01547780|37851275|FG000|Baseline PET Scan|Physician Decision|1|||
16874380|NCT01547780|37851276|FG001|Baseline PET Scan|Physician Decision|0|||
16874381|NCT01547780|37851277|FG002|Baseline PET Scan|Physician Decision|1|||
16874382|NCT01547780|37851278|FG003|Baseline PET Scan|Physician Decision|0|||
16874383|NCT01547780|37851275|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
16874384|NCT01547780|37851276|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
16874385|NCT01547780|37851277|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
16874386|NCT01547780|37851278|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
16874387|NCT01547390|37851300|FG000|Overall Study|Withdrawal by Subject|10|||
16874388|NCT01547390|37851301|FG001|Overall Study|Withdrawal by Subject|7|||
16874389|NCT01547390|37851300|FG000|Overall Study|termination of pregnancy|0|||
17095087|NCT00262028|38234364|FG006|Overall Study|Lost to Follow-up|3|||
16874390|NCT01547390|37851301|FG001|Overall Study|termination of pregnancy|1|||
16874391|NCT01547390|37851300|FG000|Overall Study|Lost to Follow-up|0|||
16874392|NCT01547390|37851301|FG001|Overall Study|Lost to Follow-up|2|||
16874393|NCT01547390|37851300|FG000|Overall Study|Adverse Event|3|||
16874394|NCT01547390|37851301|FG001|Overall Study|Adverse Event|0|||
16874395|NCT01546922|37851307|FG000|First Period of 10 Weeks|Protocol Violation|3|||
16874396|NCT01546922|37851308|FG001|First Period of 10 Weeks|Protocol Violation|1|||
16874397|NCT01546922|37851307|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
16874398|NCT01546922|37851308|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
16785240|NCT02012452|37725304|FG001|Overall Study|Withdrawal by Subject|0|||
16785241|NCT01676909|37725312|FG000|Overall Study|Withdrawal by Subject|3|||
16785242|NCT01676909|37725313|FG001|Overall Study|Withdrawal by Subject|5|||
16785243|NCT01676909|37725312|FG000|Overall Study|Lost to Follow-up|15|||
16785244|NCT01676909|37725313|FG001|Overall Study|Lost to Follow-up|9|||
16785245|NCT02012296|37725324|FG000|Overall Study|Lack of Efficacy|0|||
16785246|NCT02012296|37725325|FG001|Overall Study|Lack of Efficacy|0|||
16785247|NCT02012296|37725326|FG002|Overall Study|Lack of Efficacy|15|||
16785248|NCT02012296|37725324|FG000|Overall Study|Adverse Event|0|||
16785249|NCT02012296|37725325|FG001|Overall Study|Adverse Event|0|||
16785250|NCT02012296|37725326|FG002|Overall Study|Adverse Event|2|||
16785251|NCT02012296|37725324|FG000|Overall Study|Early study closure|0|||
16785252|NCT02012296|37725325|FG001|Overall Study|Early study closure|0|||
16785253|NCT02012296|37725326|FG002|Overall Study|Early study closure|5|||
16785254|NCT02012296|37725324|FG000|Overall Study|Protocol Violation|0|||
16785255|NCT02012296|37725325|FG001|Overall Study|Protocol Violation|1|||
16785256|NCT02012296|37725326|FG002|Overall Study|Protocol Violation|0|||
16785257|NCT02012218|37725343|FG000|Overall Study|Withdrawal by Subject|1|||
16785258|NCT02012218|37725344|FG001|Overall Study|Withdrawal by Subject|0|||
16785259|NCT02012218|37725345|FG002|Overall Study|Withdrawal by Subject|1|||
16785260|NCT02012218|37725346|FG003|Overall Study|Withdrawal by Subject|1|||
16785261|NCT02012218|37725347|FG004|Overall Study|Withdrawal by Subject|1|||
16785262|NCT02012218|37725343|FG000|Overall Study|Adverse Event|1|||
16785263|NCT02012218|37725344|FG001|Overall Study|Adverse Event|0|||
16785264|NCT02012218|37725345|FG002|Overall Study|Adverse Event|0|||
16785265|NCT02012218|37725346|FG003|Overall Study|Adverse Event|1|||
16785266|NCT02012218|37725347|FG004|Overall Study|Adverse Event|0|||
16785267|NCT02012218|37725343|FG000|Overall Study|Lost to Follow-up|0|||
16785268|NCT02012218|37725344|FG001|Overall Study|Lost to Follow-up|1|||
16785269|NCT02012218|37725345|FG002|Overall Study|Lost to Follow-up|1|||
16785270|NCT02012218|37725346|FG003|Overall Study|Lost to Follow-up|0|||
16785271|NCT02012218|37725347|FG004|Overall Study|Lost to Follow-up|0|||
16785272|NCT02012218|37725343|FG000|Overall Study|Protocol Specified|1|||
16785273|NCT02012218|37725344|FG001|Overall Study|Protocol Specified|0|||
16785274|NCT02012218|37725345|FG002|Overall Study|Protocol Specified|0|||
16785275|NCT02012218|37725346|FG003|Overall Study|Protocol Specified|0|||
16785276|NCT02012218|37725347|FG004|Overall Study|Protocol Specified|0|||
16785277|NCT02012218|37725343|FG000|Overall Study|Protocol Deviation|1|||
16785278|NCT02012218|37725344|FG001|Overall Study|Protocol Deviation|0|||
16785279|NCT02012218|37725345|FG002|Overall Study|Protocol Deviation|0|||
16785280|NCT02012218|37725346|FG003|Overall Study|Protocol Deviation|0|||
16785281|NCT02012218|37725347|FG004|Overall Study|Protocol Deviation|0|||
16785282|NCT01965262|37725359|FG000|Second Intervention (7 Days)|Discontinued|0|||
16785283|NCT01965262|37725360|FG001|Second Intervention (7 Days)|Discontinued|1|||
16785284|NCT01965262|37725359|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
16785285|NCT01965262|37725360|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
16785286|NCT01965262|37725359|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
16785287|NCT01965262|37725360|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
16785288|NCT01677377|37725369|FG000|Overall Study|Protocol Violation|1|||
16785289|NCT01677377|37725370|FG001|Overall Study|Protocol Violation|0|||
16785290|NCT01677377|37725371|FG002|Overall Study|Protocol Violation|0|||
16785291|NCT01677377|37725369|FG000|Overall Study|Lost to Follow-up|0|||
16785292|NCT01677377|37725370|FG001|Overall Study|Lost to Follow-up|1|||
16785293|NCT01677377|37725371|FG002|Overall Study|Lost to Follow-up|1|||
16785294|NCT01677377|37725369|FG000|Overall Study|Withdrawal by Subject|0|||
16785295|NCT01677377|37725370|FG001|Overall Study|Withdrawal by Subject|0|||
16785296|NCT01677377|37725371|FG002|Overall Study|Withdrawal by Subject|3|||
16785297|NCT01677377|37725369|FG000|Overall Study|Lack of Efficacy|0|||
16785298|NCT01677377|37725370|FG001|Overall Study|Lack of Efficacy|0|||
16785299|NCT01677377|37725371|FG002|Overall Study|Lack of Efficacy|1|||
16785300|NCT01677377|37725369|FG000|Overall Study|Pregnancy|0|||
16785301|NCT01677377|37725370|FG001|Overall Study|Pregnancy|0|||
16785302|NCT01677377|37725371|FG002|Overall Study|Pregnancy|1|||
16785303|NCT01964950|37725381|FG000|Overall Study|Protocol Violation|25|||
16785304|NCT01964716|37725390|FG000|Overall Study|Withdrawal by Subject|2|||
16785305|NCT01964716|37725391|FG001|Overall Study|Withdrawal by Subject|3|||
16785306|NCT01964716|37725390|FG000|Overall Study|Lost to Follow-up|1|||
16785307|NCT01964716|37725391|FG001|Overall Study|Lost to Follow-up|2|||
16785308|NCT01964716|37725390|FG000|Overall Study|No longer met eligibility criteria|1|||
16785309|NCT01964716|37725391|FG001|Overall Study|No longer met eligibility criteria|1|||
16785310|NCT01964716|37725390|FG000|Overall Study|Death|1|||
16785311|NCT01964716|37725391|FG001|Overall Study|Death|0|||
16785312|NCT01964560|37725405|FG000|Overall Study|Adverse Event|23|||
16785313|NCT01964560|37725405|FG000|Overall Study|Lack of Efficacy|46|||
16785314|NCT01964560|37725405|FG000|Overall Study|Protocol deviation|2|||
16874399|NCT01546922|37851307|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
16874400|NCT01546922|37851308|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
16874401|NCT01546922|37851307|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
16874402|NCT01546922|37851308|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
16874403|NCT01546922|37851307|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
16874404|NCT01546922|37851308|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
16874405|NCT01532648|37851325|FG000|Overall Study|Lost to Follow-up|3|||
16874406|NCT01532648|37851326|FG001|Overall Study|Lost to Follow-up|4|||
16874407|NCT01532648|37851325|FG000|Overall Study|Lack of Efficacy|4|||
16874408|NCT01532648|37851326|FG001|Overall Study|Lack of Efficacy|1|||
16874409|NCT01532648|37851325|FG000|Overall Study|Protocol Violation|1|||
16874410|NCT01532648|37851326|FG001|Overall Study|Protocol Violation|1|||
16874411|NCT01532648|37851325|FG000|Overall Study|Adverse Event|12|||
16874412|NCT01532648|37851326|FG001|Overall Study|Adverse Event|9|||
16874413|NCT01532648|37851325|FG000|Overall Study|Withdrawal by Subject|16|||
16874414|NCT01532648|37851326|FG001|Overall Study|Withdrawal by Subject|2|||
16874415|NCT01532570|37851356|FG000|Overall Study|Lack of Efficacy|1|||
16874416|NCT01532570|37851357|FG001|Overall Study|Lack of Efficacy|0|||
16874417|NCT01532570|37851358|FG002|Overall Study|Lack of Efficacy|0|||
16874418|NCT01532570|37851359|FG003|Overall Study|Lack of Efficacy|0|||
16874419|NCT01532570|37851356|FG000|Overall Study|Withdrawal by Subject|0|||
16874420|NCT01532570|37851357|FG001|Overall Study|Withdrawal by Subject|1|||
16874421|NCT01532570|37851358|FG002|Overall Study|Withdrawal by Subject|0|||
16874422|NCT01532570|37851359|FG003|Overall Study|Withdrawal by Subject|0|||
16874423|NCT01532414|37851405|FG000|Overall Study|Lost to Follow-up|3|||
16874424|NCT01532414|37851406|FG001|Overall Study|Lost to Follow-up|0|||
16874425|NCT01532414|37851407|FG002|Overall Study|Lost to Follow-up|1|||
16874426|NCT01532414|37851405|FG000|Overall Study|Withdrawal by Subject|3|||
16874427|NCT01532414|37851406|FG001|Overall Study|Withdrawal by Subject|0|||
16874428|NCT01532414|37851407|FG002|Overall Study|Withdrawal by Subject|0|||
16874429|NCT01532414|37851405|FG000|Overall Study|No V6 semen sample|0|||
16874430|NCT01532414|37851406|FG001|Overall Study|No V6 semen sample|1|||
16874431|NCT01532414|37851407|FG002|Overall Study|No V6 semen sample|0|||
16874432|NCT01532414|37851405|FG000|Overall Study|Adverse Event|0|||
16874433|NCT01532414|37851406|FG001|Overall Study|Adverse Event|1|||
16874434|NCT01532414|37851407|FG002|Overall Study|Adverse Event|1|||
16874435|NCT01532414|37851405|FG000|Overall Study|Unable to complete 24 hour PK|0|||
16874436|NCT01532414|37851406|FG001|Overall Study|Unable to complete 24 hour PK|0|||
16874437|NCT01532414|37851407|FG002|Overall Study|Unable to complete 24 hour PK|1|||
16874438|NCT01532414|37851405|FG000|Overall Study|Withdrawn by sponsor|1|||
16874439|NCT01532414|37851406|FG001|Overall Study|Withdrawn by sponsor|0|||
16874440|NCT01532414|37851407|FG002|Overall Study|Withdrawn by sponsor|0|||
16874441|NCT01441973|37851417|FG000|Overall Study|Disease progression|8|||
16874442|NCT01441973|37851418|FG001|Overall Study|Disease progression|6|||
16874443|NCT01441973|37851417|FG000|Overall Study|Adverse event unrelated to study drug|3|||
16874444|NCT01441973|37851418|FG001|Overall Study|Adverse event unrelated to study drug|2|||
16874445|NCT01441973|37851417|FG000|Overall Study|Participant request to discontinue|1|||
16874446|NCT01441973|37851418|FG001|Overall Study|Participant request to discontinue|1|||
16874447|NCT01441973|37851417|FG000|Overall Study|Poor compliance/noncompliance|0|||
16874448|NCT01441973|37851418|FG001|Overall Study|Poor compliance/noncompliance|1|||
16874449|NCT01441973|37851417|FG000|Overall Study|Administrative reason by sponsor|3|||
16874450|NCT01441973|37851418|FG001|Overall Study|Administrative reason by sponsor|5|||
16874451|NCT01441973|37851417|FG000|Overall Study|Participant withdrew consent|0|||
16874452|NCT01441973|37851418|FG001|Overall Study|Participant withdrew consent|1|||
16874453|NCT01575899|37851437|FG000|Overall Study|Lost to Follow-up|3|||
16874454|NCT01575899|37851438|FG001|Overall Study|Lost to Follow-up|4|||
16874455|NCT01575899|37851439|FG002|Overall Study|Lost to Follow-up|2|||
16874456|NCT01575899|37851437|FG000|Overall Study|Protocol Violation|2|||
16874457|NCT01575899|37851438|FG001|Overall Study|Protocol Violation|1|||
16874458|NCT01575899|37851439|FG002|Overall Study|Protocol Violation|0|||
16874459|NCT01440881|37851451|FG000|Overall Study|Death|0|||
16874460|NCT01440881|37851452|FG001|Overall Study|Death|1|||
16874461|NCT01575197|37851467|FG000|Overall Study|Migration out of study area|1|||
16874462|NCT01575197|37851468|FG001|Overall Study|Migration out of study area|5|||
16874463|NCT01575197|37851469|FG002|Overall Study|Migration out of study area|4|||
16874464|NCT01575197|37851467|FG000|Overall Study|SAE|0|||
16874465|NCT01575197|37851468|FG001|Overall Study|SAE|1|||
16874466|NCT01575197|37851469|FG002|Overall Study|SAE|0|||
16874467|NCT01575197|37851467|FG000|Overall Study|Lost to Follow-up|0|||
16874468|NCT01575197|37851468|FG001|Overall Study|Lost to Follow-up|1|||
16874469|NCT01575197|37851469|FG002|Overall Study|Lost to Follow-up|0|||
16874470|NCT01575197|37851467|FG000|Overall Study|Withdrawal by Subject|0|||
16874471|NCT01575197|37851468|FG001|Overall Study|Withdrawal by Subject|1|||
16874472|NCT01575197|37851469|FG002|Overall Study|Withdrawal by Subject|1|||
16874473|NCT01575197|37851467|FG000|Overall Study|Protocol Violation|2|||
16874474|NCT01575197|37851468|FG001|Overall Study|Protocol Violation|1|||
16874475|NCT01575197|37851469|FG002|Overall Study|Protocol Violation|1|||
16874476|NCT01574651|37851500|FG000|Overall Study|Lost to Follow-up|2|||
16874477|NCT01574651|37851501|FG001|Overall Study|Lost to Follow-up|4|||
16874478|NCT01574651|37851500|FG000|Overall Study|Administrative problems|0|||
16874479|NCT01574651|37851501|FG001|Overall Study|Administrative problems|1|||
16874480|NCT01574651|37851500|FG000|Overall Study|Death|3|||
16874481|NCT01574651|37851501|FG001|Overall Study|Death|3|||
16874482|NCT01574651|37851500|FG000|Overall Study|Patient's inability to use the device|0|||
16874483|NCT01574651|37851501|FG001|Overall Study|Patient's inability to use the device|1|||
16874484|NCT01574651|37851500|FG000|Overall Study|Adverse Event|36|||
16874485|NCT01574651|37851501|FG001|Overall Study|Adverse Event|27|||
16874486|NCT01574651|37851500|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16874487|NCT01574651|37851501|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16874488|NCT01574651|37851500|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16874489|NCT01574651|37851501|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16874490|NCT01574651|37851500|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
16874491|NCT01574651|37851501|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16874492|NCT01574651|37851500|FG000|Overall Study|Protocol Violation|3|||
16874493|NCT01574651|37851501|FG001|Overall Study|Protocol Violation|5|||
16874494|NCT01574651|37851500|FG000|Overall Study|Withdrawal by Subject|9|||
16874495|NCT01574651|37851501|FG001|Overall Study|Withdrawal by Subject|10|||
16874496|NCT01440803|37851513|FG000|Overall Study|Met study stopping rule|2|||
16874497|NCT01440803|37851514|FG001|Overall Study|Met study stopping rule|1|||
16874498|NCT01440803|37851513|FG000|Overall Study|Lost to Follow-up|0|||
16874499|NCT01440803|37851514|FG001|Overall Study|Lost to Follow-up|2|||
16874500|NCT01440803|37851513|FG000|Overall Study|Withdrawal by Subject|0|||
16874501|NCT01440803|37851514|FG001|Overall Study|Withdrawal by Subject|1|||
16874502|NCT01517282|37851525|FG000|Overall Study|Consent withdrawn|0|||
16874503|NCT01517282|37851526|FG001|Overall Study|Consent withdrawn|1|||
16874504|NCT01517282|37851527|FG002|Overall Study|Consent withdrawn|1|||
16874505|NCT01517282|37851528|FG003|Overall Study|Consent withdrawn|1|||
16874506|NCT01517282|37851525|FG000|Overall Study|Physician Decision|1|||
16874507|NCT01517282|37851526|FG001|Overall Study|Physician Decision|0|||
16874508|NCT01517282|37851527|FG002|Overall Study|Physician Decision|0|||
16874509|NCT01517282|37851528|FG003|Overall Study|Physician Decision|0|||
16874510|NCT01440647|37851549|FG000|Overall Study|Death|2|||
16874511|NCT01440647|37851550|FG001|Overall Study|Death|3|||
16874512|NCT01516970|37851558|FG000|Overall Study|Lost to Follow-up|7|||
16874513|NCT01516970|37851559|FG001|Overall Study|Lost to Follow-up|8|||
16874514|NCT01516970|37851558|FG000|Overall Study|Adverse Event|1|||
16874515|NCT01516970|37851559|FG001|Overall Study|Adverse Event|5|||
16874516|NCT01516970|37851558|FG000|Overall Study|Withdrawal by Subject|1|||
16874517|NCT01516970|37851559|FG001|Overall Study|Withdrawal by Subject|1|||
16874518|NCT01516970|37851558|FG000|Overall Study|Other|9|||
16874519|NCT01516970|37851559|FG001|Overall Study|Other|7|||
16874520|NCT01516892|37851580|FG000|Overall Study|Adverse Event|25|||
16874521|NCT01516892|37851580|FG000|Overall Study|Lack of Efficacy|35|||
16874522|NCT01516892|37851580|FG000|Overall Study|Pregnancy|5|||
16874523|NCT01516892|37851580|FG000|Overall Study|Lost to Follow-up|82|||
16874524|NCT01516892|37851580|FG000|Overall Study|Subject Withdrew Consent|92|||
16874525|NCT01516892|37851580|FG000|Overall Study|Protocol Violation|60|||
16874526|NCT01516892|37851580|FG000|Overall Study|Other Miscellaneous Reasons|43|||
16874527|NCT01516892|37851580|FG000|Overall Study|Missing|1|||
16874528|NCT01516736|37851605|FG000|Overall Study|Withdrawal by Subject|10|||
16874529|NCT01516736|37851606|FG001|Overall Study|Withdrawal by Subject|4|||
16785315|NCT01964560|37725405|FG000|Overall Study|Lost to Follow-up|4|||
16785316|NCT01964560|37725405|FG000|Overall Study|Withdrawal by Subject|64|||
16785317|NCT01964560|37725405|FG000|Overall Study|Surgery-hemispherotomy|1|||
16785318|NCT01964560|37725405|FG000|Overall Study|Surgery|1|||
16874530|NCT01516736|37851605|FG000|Overall Study|Adverse Event|4|||
16874531|NCT01516736|37851606|FG001|Overall Study|Adverse Event|5|||
16874532|NCT01516736|37851605|FG000|Overall Study|Death|3|||
16874533|NCT01516736|37851606|FG001|Overall Study|Death|1|||
16874534|NCT01516736|37851605|FG000|Overall Study|Physician Decision|2|||
16874535|NCT01516736|37851606|FG001|Overall Study|Physician Decision|1|||
16874536|NCT01516736|37851605|FG000|Overall Study|Lack of Efficacy|1|||
16874537|NCT01516736|37851606|FG001|Overall Study|Lack of Efficacy|0|||
16874538|NCT01516736|37851605|FG000|Overall Study|Protocol Violation|0|||
16785319|NCT01964560|37725405|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
16785320|NCT01964560|37725405|FG000|Overall Study|Patient and Investigator choice|1|||
16785321|NCT01964560|37725405|FG000|Overall Study|Patient was prescribed CBD|1|||
16785322|NCT01964560|37725405|FG000|Overall Study|Participant moved to another country|1|||
16785323|NCT02659943|37725416|FG000|Overall Study|Switched to alternative treatment|1|||
16785324|NCT02659943|37725417|FG001|Overall Study|Switched to alternative treatment|1|||
16785325|NCT02659943|37725418|FG002|Overall Study|Switched to alternative treatment|0|||
16785326|NCT02659943|37725419|FG003|Overall Study|Switched to alternative treatment|2|||
16785327|NCT02659943|37725420|FG004|Overall Study|Switched to alternative treatment|1|||
16874539|NCT01516736|37851606|FG001|Overall Study|Protocol Violation|1|||
16874540|NCT01516736|37851605|FG000|Overall Study|Other (not specified)|0|||
16874541|NCT01516736|37851606|FG001|Overall Study|Other (not specified)|1|||
16874542|NCT01546688|37851618|FG000|Overall Study|Adverse Event|0|||
16874543|NCT01546688|37851619|FG001|Overall Study|Adverse Event|4|||
16874544|NCT01546688|37851618|FG000|Overall Study|Withdrawal by Subject|2|||
16874545|NCT01546688|37851619|FG001|Overall Study|Withdrawal by Subject|1|||
16874546|NCT01546688|37851618|FG000|Overall Study|Lack of Efficacy|1|||
16874547|NCT01546688|37851619|FG001|Overall Study|Lack of Efficacy|0|||
16874548|NCT01516034|37851625|FG000|Overall Study|Physician Decision|1|||
16874549|NCT01516034|37851625|FG000|Overall Study|Lack of Efficacy|7|||
16874550|NCT01440569|37851636|FG000|Main Study|Enrolled but not treated|1|||
16874551|NCT01440569|37851637|FG001|Main Study|Enrolled but not treated|0|||
16874552|NCT01440569|37851636|FG000|Main Study|Adverse Event|9|||
16874553|NCT01440569|37851637|FG001|Main Study|Adverse Event|0|||
16874554|NCT01440569|37851636|FG000|Main Study|Pregnancy|1|||
16874555|NCT01440569|37851637|FG001|Main Study|Pregnancy|0|||
16874556|NCT01440569|37851636|FG000|Main Study|Investigator's Discretion|1|||
16874557|NCT01440569|37851637|FG001|Main Study|Investigator's Discretion|1|||
16874558|NCT01440569|37851636|FG000|Main Study|Withdrew Consent|7|||
16874559|NCT01440569|37851637|FG001|Main Study|Withdrew Consent|1|||
16874560|NCT01440569|37851636|FG000|Main Study|Lost to Follow-up|13|||
16874561|NCT01440569|37851637|FG001|Main Study|Lost to Follow-up|2|||
16874562|NCT01440569|37851636|FG000|Main Study|Subject Non-Compliance|3|||
16874563|NCT01440569|37851637|FG001|Main Study|Subject Non-Compliance|0|||
16874564|NCT01440569|37851636|FG000|Main Study|Protocol Violation|1|||
16874565|NCT01440569|37851637|FG001|Main Study|Protocol Violation|0|||
16874566|NCT01440569|37851636|FG000|Open-Label Rollover Phase|Adverse Event|3|||
16874567|NCT01440569|37851637|FG001|Open-Label Rollover Phase|Adverse Event|0|||
16874568|NCT01440569|37851636|FG000|Open-Label Rollover Phase|Pregnancy|1|||
16874569|NCT01440569|37851637|FG001|Open-Label Rollover Phase|Pregnancy|0|||
16874570|NCT01440569|37851636|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
16874571|NCT01440569|37851637|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
16874572|NCT01440569|37851636|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
16874573|NCT01440569|37851637|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
16874574|NCT01440569|37851636|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
16874575|NCT01440569|37851637|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
16874576|NCT01440569|37851636|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
16874577|NCT01440569|37851637|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
16874578|NCT01440569|37851636|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
16874579|NCT01440569|37851637|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
16874580|NCT01546142|37851660|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
16874581|NCT01546142|37851661|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
16874582|NCT01546142|37851660|FG000|Overall Study|Subject Noncompliance|1|||
16874583|NCT01546142|37851661|FG001|Overall Study|Subject Noncompliance|1|||
16874584|NCT01546142|37851660|FG000|Overall Study|Adverse Event|6|||
16874585|NCT01546142|37851661|FG001|Overall Study|Adverse Event|3|||
16874586|NCT01546142|37851660|FG000|Overall Study|Lost to Follow-up|20|||
16874587|NCT01546142|37851661|FG001|Overall Study|Lost to Follow-up|15|||
16874588|NCT01546142|37851660|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
16874589|NCT01546142|37851661|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
16874590|NCT01546142|37851660|FG000|Overall Study|Subject Randomized but Not Treated|1|||
16874591|NCT01546142|37851661|FG001|Overall Study|Subject Randomized but Not Treated|0|||
16874592|NCT01440101|37851695|FG000|Overall Study|Adverse Event|2|||
16874593|NCT01440101|37851696|FG001|Overall Study|Adverse Event|0|||
16874594|NCT01440101|37851697|FG002|Overall Study|Adverse Event|0|||
16785328|NCT02659943|37725421|FG005|Overall Study|Switched to alternative treatment|0|||
16785329|NCT02659943|37725422|FG006|Overall Study|Switched to alternative treatment|1|||
16785330|NCT02659943|37725416|FG000|Overall Study|Disease progression on study|0|||
16785331|NCT02659943|37725417|FG001|Overall Study|Disease progression on study|1|||
16785332|NCT02659943|37725418|FG002|Overall Study|Disease progression on study|1|||
16874595|NCT01440101|37851695|FG000|Overall Study|Withdrawal by Subject|0|||
16874596|NCT01440101|37851696|FG001|Overall Study|Withdrawal by Subject|3|||
16874597|NCT01440101|37851697|FG002|Overall Study|Withdrawal by Subject|1|||
16874598|NCT01440101|37851695|FG000|Overall Study|Other|0|||
16874599|NCT01440101|37851696|FG001|Overall Study|Other|1|||
16874600|NCT01440101|37851697|FG002|Overall Study|Other|0|||
16874601|NCT01530464|37851708|FG000|Washout (24h)|Withdrawal by Subject|1|||
16874602|NCT01530464|37851709|FG001|Washout (24h)|Withdrawal by Subject|0|||
16874603|NCT01530464|37851708|FG000|Washout (24h)|Withdrawal by Subject|0|||
16874604|NCT01530464|37851709|FG001|Washout (24h)|Withdrawal by Subject|1|||
16874605|NCT01439945|37851776|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
16874606|NCT01439945|37851777|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
16785333|NCT02659943|37725419|FG003|Overall Study|Disease progression on study|1|||
16785334|NCT02659943|37725420|FG004|Overall Study|Disease progression on study|1|||
16785335|NCT02659943|37725421|FG005|Overall Study|Disease progression on study|4|||
16785336|NCT02659943|37725422|FG006|Overall Study|Disease progression on study|0|||
16874607|NCT01439945|37851778|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
16874608|NCT01439945|37851779|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
16874609|NCT01439945|37851776|FG000|Double-Blind Treatment Phase|Ineligible|1|||
16874610|NCT01439945|37851777|FG001|Double-Blind Treatment Phase|Ineligible|2|||
16874611|NCT01439945|37851778|FG002|Double-Blind Treatment Phase|Ineligible|0|||
16874612|NCT01439945|37851779|FG003|Double-Blind Treatment Phase|Ineligible|1|||
16874613|NCT01420081|37851884|FG000|Overall Study|Death|1|||
16874614|NCT01420081|37851885|FG001|Overall Study|Death|0|||
16874615|NCT01420081|37851886|FG002|Overall Study|Death|8|||
16874616|NCT01420081|37851887|FG003|Overall Study|Death|0|||
16874617|NCT01420081|37851888|FG004|Overall Study|Death|7|||
16874618|NCT01420081|37851889|FG005|Overall Study|Death|12|||
16874619|NCT01420081|37851890|FG006|Overall Study|Death|0|||
16874620|NCT01420081|37851891|FG007|Overall Study|Death|1|||
16874621|NCT01420081|37851892|FG008|Overall Study|Death|1|||
16874622|NCT01420081|37851884|FG000|Overall Study|Lost to Follow-up|0|||
16874623|NCT01420081|37851885|FG001|Overall Study|Lost to Follow-up|0|||
16874624|NCT01420081|37851886|FG002|Overall Study|Lost to Follow-up|0|||
16874625|NCT01420081|37851887|FG003|Overall Study|Lost to Follow-up|0|||
16874626|NCT01420081|37851888|FG004|Overall Study|Lost to Follow-up|1|||
16874627|NCT01420081|37851889|FG005|Overall Study|Lost to Follow-up|1|||
16874628|NCT01420081|37851890|FG006|Overall Study|Lost to Follow-up|0|||
16874629|NCT01420081|37851891|FG007|Overall Study|Lost to Follow-up|0|||
16874630|NCT01420081|37851892|FG008|Overall Study|Lost to Follow-up|0|||
16874631|NCT01420081|37851884|FG000|Overall Study|Study Terminated by Sponsor|2|||
16874632|NCT01420081|37851885|FG001|Overall Study|Study Terminated by Sponsor|1|||
16874633|NCT01420081|37851886|FG002|Overall Study|Study Terminated by Sponsor|1|||
16874634|NCT01420081|37851887|FG003|Overall Study|Study Terminated by Sponsor|3|||
16874635|NCT01420081|37851888|FG004|Overall Study|Study Terminated by Sponsor|11|||
16874636|NCT01420081|37851889|FG005|Overall Study|Study Terminated by Sponsor|7|||
16874637|NCT01420081|37851890|FG006|Overall Study|Study Terminated by Sponsor|3|||
16874638|NCT01420081|37851891|FG007|Overall Study|Study Terminated by Sponsor|2|||
16874639|NCT01420081|37851892|FG008|Overall Study|Study Terminated by Sponsor|2|||
16874640|NCT01420081|37851884|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
16874641|NCT01420081|37851885|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
16874642|NCT01420081|37851886|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
16874643|NCT01420081|37851887|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
16874644|NCT01420081|37851888|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
16874645|NCT01420081|37851889|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
16874646|NCT01420081|37851890|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
16874647|NCT01420081|37851891|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
16874648|NCT01420081|37851892|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
16874649|NCT01420081|37851884|FG000|Overall Study|Other Reasons|0|||
16874650|NCT01420081|37851885|FG001|Overall Study|Other Reasons|0|||
16874651|NCT01420081|37851886|FG002|Overall Study|Other Reasons|1|||
16874652|NCT01420081|37851887|FG003|Overall Study|Other Reasons|0|||
16874653|NCT01420081|37851888|FG004|Overall Study|Other Reasons|0|||
16874654|NCT01420081|37851889|FG005|Overall Study|Other Reasons|0|||
16874655|NCT01420081|37851890|FG006|Overall Study|Other Reasons|0|||
16874656|NCT01420081|37851891|FG007|Overall Study|Other Reasons|0|||
16874657|NCT01420081|37851892|FG008|Overall Study|Other Reasons|0|||
16874658|NCT01439867|37851910|FG000|Overall Study|Non-compliance|0|||
16874659|NCT01439867|37851911|FG001|Overall Study|Non-compliance|1|||
16874660|NCT01439867|37851910|FG000|Overall Study|Withdrawal by Subject|1|||
16874661|NCT01439867|37851911|FG001|Overall Study|Withdrawal by Subject|2|||
17191401|NCT02476006|38344196|FG000|Overall Study|Participant did not wish to continue|39|||
16785337|NCT02659943|37725416|FG000|Overall Study|Patient's condition per principal investigator|0|||
16785338|NCT02659943|37725417|FG001|Overall Study|Patient's condition per principal investigator|0|||
16785339|NCT02659943|37725418|FG002|Overall Study|Patient's condition per principal investigator|0|||
16785340|NCT02659943|37725419|FG003|Overall Study|Patient's condition per principal investigator|0|||
16785341|NCT02659943|37725420|FG004|Overall Study|Patient's condition per principal investigator|0|||
16785342|NCT02659943|37725421|FG005|Overall Study|Patient's condition per principal investigator|1|||
16785343|NCT02659943|37725422|FG006|Overall Study|Patient's condition per principal investigator|0|||
16785344|NCT02659943|37725416|FG000|Overall Study|Ineligible|0|||
16785345|NCT02659943|37725417|FG001|Overall Study|Ineligible|0|||
16785346|NCT02659943|37725418|FG002|Overall Study|Ineligible|0|||
16785347|NCT02659943|37725419|FG003|Overall Study|Ineligible|0|||
16785348|NCT02659943|37725420|FG004|Overall Study|Ineligible|0|||
16785349|NCT02659943|37725421|FG005|Overall Study|Ineligible|0|||
16785350|NCT02659943|37725422|FG006|Overall Study|Ineligible|1|||
16785351|NCT02659943|37725416|FG000|Overall Study|No longer meets eligibility|0|||
16785352|NCT02659943|37725417|FG001|Overall Study|No longer meets eligibility|0|||
16874662|NCT01439867|37851910|FG000|Overall Study|Administrative Decision|4|||
16874663|NCT01439867|37851911|FG001|Overall Study|Administrative Decision|5|||
16874664|NCT01439867|37851910|FG000|Overall Study|Protocol-specified Criteria|1|||
16874665|NCT01439867|37851911|FG001|Overall Study|Protocol-specified Criteria|0|||
16874666|NCT01439711|37851928|FG000|Overall Study|Ineligible|13|||
16874667|NCT01439711|37851928|FG000|Overall Study|Cancel|3|||
16874668|NCT01439711|37851928|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
17191402|NCT02476006|38344196|FG000|Overall Study|Adverse Event|41|||
17191403|NCT02476006|38344196|FG000|Overall Study|Poor compliance to study protocol|3|||
17191404|NCT02476006|38344196|FG000|Overall Study|Sponsor decision|6|||
17191405|NCT02476006|38344196|FG000|Overall Study|Lost to Follow-up|5|||
17191406|NCT02476006|38344196|FG000|Overall Study|Physician Decision|5|||
17191407|NCT02476006|38344196|FG000|Overall Study|Study ended treatment not available|4|||
17191408|NCT02476006|38344196|FG000|Overall Study|Switched to commercial drug|4|||
17191409|NCT02476006|38344196|FG000|Overall Study|Excluded from study|1|||
17191410|NCT02476006|38344196|FG000|Overall Study|Protocol Violation|1|||
17191411|NCT02476006|38344196|FG000|Overall Study|Enrolled but not treated|4|||
17191412|NCT02475850|38344202|FG000|Overall Study|Death|155|||
17191413|NCT02475850|38344203|FG001|Overall Study|Death|141|||
17191414|NCT02475850|38344202|FG000|Overall Study|Lost to Follow-up|217|||
17191415|NCT02475850|38344203|FG001|Overall Study|Lost to Follow-up|188|||
17191416|NCT02475850|38344202|FG000|Overall Study|Withdrawal by Subject|221|||
17191417|NCT02475850|38344203|FG001|Overall Study|Withdrawal by Subject|155|||
17191418|NCT02419612|38344212|FG000|Short-term Treatment Period|Adverse Event|1|||
17191419|NCT02419612|38344213|FG001|Short-term Treatment Period|Adverse Event|1|||
17191420|NCT02419612|38344212|FG000|Short-term Treatment Period|Death|0|||
17191421|NCT02419612|38344213|FG001|Short-term Treatment Period|Death|2|||
17191422|NCT02419612|38344212|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
17191423|NCT02419612|38344213|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
17191424|NCT02419612|38344212|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
17191425|NCT02419612|38344213|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
17191426|NCT02419612|38344212|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
17191427|NCT02419612|38344213|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
17191428|NCT02419612|38344212|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
17191429|NCT02419612|38344213|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
17191430|NCT02419612|38344212|FG000|Short-term Treatment Period|Worsening of liver function|0|||
17191431|NCT02419612|38344213|FG001|Short-term Treatment Period|Worsening of liver function|1|||
17191432|NCT02419612|38344212|FG000|Short-term Treatment Period|Subject moved out of state|0|||
17191433|NCT02419612|38344213|FG001|Short-term Treatment Period|Subject moved out of state|1|||
17191434|NCT02419612|38344212|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
17191435|NCT02419612|38344213|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
17191436|NCT02419612|38344212|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
17191437|NCT02419612|38344213|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
17191438|NCT02419612|38344212|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
17191439|NCT02419612|38344213|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
17191440|NCT02419612|38344212|FG000|Long-term Treatment Period|Death|0|||
17191441|NCT02419612|38344213|FG001|Long-term Treatment Period|Death|1|||
17191442|NCT02419612|38344212|FG000|Long-term Treatment Period|Adverse Event|0|||
17191443|NCT02419612|38344213|FG001|Long-term Treatment Period|Adverse Event|5|||
17191444|NCT02419612|38344212|FG000|Long-term Treatment Period|Other|4|||
17191445|NCT02419612|38344213|FG001|Long-term Treatment Period|Other|4|||
17191446|NCT02419612|38344212|FG000|Long-term Treatment Period|Subject Decision|2|||
17191447|NCT02419612|38344213|FG001|Long-term Treatment Period|Subject Decision|4|||
17191448|NCT02419612|38344212|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
17191449|NCT02419612|38344213|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
17191450|NCT02447848|38344219|FG000|Overall Study|Patient discharged|3|||
17191451|NCT02447848|38344219|FG000|Overall Study|Lack of Efficacy|4|||
17191452|NCT02447848|38344219|FG000|Overall Study|Withdrawal by Subject|4|||
17191453|NCT02418910|38344223|FG000|Overall Study|Lost to Follow-up|3|||
17191454|NCT02418910|38344223|FG000|Overall Study|Withdrawal by Subject|4|||
17191455|NCT02418754|38344239|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
17191456|NCT02418754|38344240|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
17191457|NCT02418754|38344241|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
17191458|NCT02418754|38344242|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
17191459|NCT02418754|38344243|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
17191460|NCT02418754|38344239|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
17191461|NCT02418754|38344240|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
17191462|NCT02418754|38344241|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
17191463|NCT02418754|38344242|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
17191464|NCT02418754|38344243|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
17191465|NCT02418754|38344239|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
17191466|NCT02418754|38344240|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
17191467|NCT02418754|38344241|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
17191468|NCT02418754|38344242|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
17191469|NCT02418754|38344243|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
17191470|NCT02418754|38344239|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
17191471|NCT02418754|38344240|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
17191472|NCT02418754|38344241|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
16874669|NCT01439711|37851928|FG000|Overall Study|Adverse Event|5|||
16874670|NCT01439711|37851928|FG000|Overall Study|Withdrawal by Subject|3|||
16874671|NCT01439711|37851928|FG000|Overall Study|Progression During Active Tx|3|||
16874672|NCT01439711|37851928|FG000|Overall Study|Noncompliance|3|||
16874673|NCT01439711|37851928|FG000|Overall Study|No MRI|9|||
16874674|NCT01439555|37851932|FG000|Overall Study|Protocol Violation|1|||
16874675|NCT01544582|37851952|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
16874676|NCT01544582|37851953|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
16874677|NCT01544582|37851954|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
16874678|NCT01544582|37851955|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
16874679|NCT01544582|37851952|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
16874680|NCT01544582|37851953|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
16874681|NCT01544582|37851954|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
16874682|NCT01544582|37851955|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
16874683|NCT01544582|37851952|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
16874684|NCT01544582|37851953|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
16874685|NCT01544582|37851954|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
16874686|NCT01544582|37851955|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
16874687|NCT01544582|37851952|FG000|Analysis Population|Physician Decision|0|||
16874688|NCT01544582|37851953|FG001|Analysis Population|Physician Decision|13|||
16874689|NCT01544582|37851954|FG002|Analysis Population|Physician Decision|10|||
16874690|NCT01544582|37851955|FG003|Analysis Population|Physician Decision|9|||
16874691|NCT01544582|37851952|FG000|Analysis Population|Safety Reason|0|||
16874692|NCT01544582|37851953|FG001|Analysis Population|Safety Reason|33|||
16874693|NCT01544582|37851954|FG002|Analysis Population|Safety Reason|31|||
16874694|NCT01544582|37851955|FG003|Analysis Population|Safety Reason|8|||
16874695|NCT01544582|37851952|FG000|Analysis Population|Effectiveness Reason|0|||
16874696|NCT01544582|37851953|FG001|Analysis Population|Effectiveness Reason|48|||
16874697|NCT01544582|37851954|FG002|Analysis Population|Effectiveness Reason|29|||
16874698|NCT01544582|37851955|FG003|Analysis Population|Effectiveness Reason|12|||
16874699|NCT01544582|37851952|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
16874700|NCT01544582|37851953|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
16874701|NCT01544582|37851954|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
16874702|NCT01544582|37851955|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
16874703|NCT01544582|37851952|FG000|Analysis Population|Lost to Follow-up|0|||
16874704|NCT01544582|37851953|FG001|Analysis Population|Lost to Follow-up|6|||
16874705|NCT01544582|37851954|FG002|Analysis Population|Lost to Follow-up|6|||
16874706|NCT01544582|37851955|FG003|Analysis Population|Lost to Follow-up|5|||
16874707|NCT01544582|37851952|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
16874708|NCT01544582|37851953|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
16874709|NCT01544582|37851954|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
16874710|NCT01544582|37851955|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
16874711|NCT01544582|37851952|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
16874712|NCT01544582|37851953|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
16874713|NCT01544582|37851954|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
16874714|NCT01544582|37851955|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
16874715|NCT01544582|37851952|FG000|Analysis Population|Intolerance|0|||
16874716|NCT01544582|37851953|FG001|Analysis Population|Intolerance|1|||
16874717|NCT01544582|37851954|FG002|Analysis Population|Intolerance|0|||
16874718|NCT01544582|37851955|FG003|Analysis Population|Intolerance|0|||
16874719|NCT01544582|37851952|FG000|Analysis Population|Liver Transplantation|0|||
16874720|NCT01544582|37851953|FG001|Analysis Population|Liver Transplantation|0|||
16874721|NCT01544582|37851954|FG002|Analysis Population|Liver Transplantation|1|||
16874722|NCT01544582|37851955|FG003|Analysis Population|Liver Transplantation|0|||
16874723|NCT01544582|37851952|FG000|Analysis Population|No Social Insurance|0|||
16874724|NCT01544582|37851953|FG001|Analysis Population|No Social Insurance|0|||
16874725|NCT01544582|37851954|FG002|Analysis Population|No Social Insurance|1|||
16874726|NCT01544582|37851955|FG003|Analysis Population|No Social Insurance|0|||
16874727|NCT01544582|37851952|FG000|Analysis Population|Poor Adherence|0|||
16874728|NCT01544582|37851953|FG001|Analysis Population|Poor Adherence|0|||
16874729|NCT01544582|37851954|FG002|Analysis Population|Poor Adherence|1|||
16874730|NCT01544582|37851955|FG003|Analysis Population|Poor Adherence|0|||
16874731|NCT01544582|37851952|FG000|Analysis Population|Poor Participant Compliance|0|||
16874732|NCT01544582|37851953|FG001|Analysis Population|Poor Participant Compliance|1|||
16874733|NCT01544582|37851954|FG002|Analysis Population|Poor Participant Compliance|0|||
16874734|NCT01544582|37851955|FG003|Analysis Population|Poor Participant Compliance|0|||
16874735|NCT01544582|37851952|FG000|Analysis Population|Programmed Surgery|0|||
16874736|NCT01544582|37851953|FG001|Analysis Population|Programmed Surgery|1|||
16874737|NCT01544582|37851954|FG002|Analysis Population|Programmed Surgery|0|||
16874738|NCT01544582|37851955|FG003|Analysis Population|Programmed Surgery|0|||
16874739|NCT01544582|37851952|FG000|Analysis Population|Participant in Jail|0|||
16874740|NCT01544582|37851953|FG001|Analysis Population|Participant in Jail|0|||
17095088|NCT00262028|38234365|FG007|Overall Study|Lost to Follow-up|5|||
16874741|NCT01544582|37851954|FG002|Analysis Population|Participant in Jail|1|||
16874742|NCT01544582|37851955|FG003|Analysis Population|Participant in Jail|0|||
16874743|NCT01439165|37851983|FG000|Overall Study|Protocol Violation|3|||
16874744|NCT01439165|37851984|FG001|Overall Study|Protocol Violation|0|||
16874745|NCT01439165|37851983|FG000|Overall Study|Lost to Follow-up|11|||
16874746|NCT01439165|37851984|FG001|Overall Study|Lost to Follow-up|1|||
16874747|NCT01439165|37851983|FG000|Overall Study|Withdrawal by Subject|7|||
16874748|NCT01439165|37851984|FG001|Overall Study|Withdrawal by Subject|1|||
16874749|NCT01529606|37851998|FG000|Overall Study|Lost to Follow-up|21|||
16874750|NCT01529606|37851999|FG001|Overall Study|Lost to Follow-up|18|||
16785353|NCT02659943|37725418|FG002|Overall Study|No longer meets eligibility|0|||
16785354|NCT02659943|37725419|FG003|Overall Study|No longer meets eligibility|0|||
16785355|NCT02659943|37725420|FG004|Overall Study|No longer meets eligibility|0|||
16785356|NCT02659943|37725421|FG005|Overall Study|No longer meets eligibility|0|||
16785357|NCT02659943|37725422|FG006|Overall Study|No longer meets eligibility|1|||
16785358|NCT02659943|37725416|FG000|Overall Study|No treatment, per protocol|0|||
16785359|NCT02659943|37725417|FG001|Overall Study|No treatment, per protocol|0|||
16785360|NCT02659943|37725418|FG002|Overall Study|No treatment, per protocol|0|||
16785361|NCT02659943|37725419|FG003|Overall Study|No treatment, per protocol|0|||
16785362|NCT02659943|37725420|FG004|Overall Study|No treatment, per protocol|0|||
16785363|NCT02659943|37725421|FG005|Overall Study|No treatment, per protocol|0|||
16785364|NCT02659943|37725422|FG006|Overall Study|No treatment, per protocol|3|||
16785365|NCT01677299|37725447|FG000|Overall Study|Adverse Event|0|||
16785366|NCT01677299|37725448|FG001|Overall Study|Adverse Event|2|||
16785367|NCT01677299|37725449|FG002|Overall Study|Adverse Event|1|||
16785368|NCT01677299|37725450|FG003|Overall Study|Adverse Event|0|||
16785369|NCT01677299|37725447|FG000|Overall Study|Withdrawal by Subject|0|||
16785370|NCT01677299|37725448|FG001|Overall Study|Withdrawal by Subject|1|||
16785371|NCT01677299|37725449|FG002|Overall Study|Withdrawal by Subject|0|||
16785372|NCT01677299|37725450|FG003|Overall Study|Withdrawal by Subject|1|||
16785373|NCT01964326|37725464|FG000|Overall Study|Adverse Event|48|||
16874751|NCT01439009|37852016|FG000|Overall Study|Physician Decision|5|||
16874752|NCT01439009|37852017|FG001|Overall Study|Physician Decision|3|||
16874753|NCT01439009|37852016|FG000|Overall Study|Protocol Violation|2|||
16874754|NCT01439009|37852017|FG001|Overall Study|Protocol Violation|0|||
16874755|NCT01439009|37852016|FG000|Overall Study|Deviation of exclusion criteria|1|||
16874756|NCT01439009|37852017|FG001|Overall Study|Deviation of exclusion criteria|0|||
16874757|NCT01572389|37852036|FG000|Overall Study|Death|1|||
16874758|NCT01572389|37852037|FG001|Overall Study|Death|3|||
16874759|NCT01572389|37852036|FG000|Overall Study|Withdrawal by Subject|14|||
16874760|NCT01572389|37852037|FG001|Overall Study|Withdrawal by Subject|2|||
16874761|NCT01572389|37852036|FG000|Overall Study|Lost to Follow-up|25|||
16785374|NCT01964326|37725464|FG000|Overall Study|Death|2|||
16785375|NCT01964326|37725464|FG000|Overall Study|Protocol Violation|4|||
16785376|NCT01964326|37725464|FG000|Overall Study|Lost to Follow-up|88|||
16785377|NCT01964326|37725464|FG000|Overall Study|Withdrawal by Subject|87|||
16785378|NCT01964326|37725464|FG000|Overall Study|Pregnancy|1|||
16785379|NCT01964326|37725464|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
16785380|NCT01964326|37725464|FG000|Overall Study|Physician Decision|55|||
16785381|NCT01964326|37725464|FG000|Overall Study|Investigator Discretion|1|||
16785382|NCT01964326|37725464|FG000|Overall Study|Other|9|||
16785383|NCT01964326|37725464|FG000|Overall Study|Did not meet eligibility criteria|1|||
16785384|NCT02699749|37725482|FG000|Overall Study|Other|0|||
16785385|NCT02699749|37725483|FG001|Overall Study|Other|0|||
16874762|NCT01572389|37852037|FG001|Overall Study|Lost to Follow-up|14|||
16874763|NCT01572389|37852036|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
16874764|NCT01572389|37852037|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
16874765|NCT01571453|37852049|FG000|Overall Study|Adverse Event|14|||
16874766|NCT01571453|37852050|FG001|Overall Study|Adverse Event|32|||
16874767|NCT01571453|37852049|FG000|Overall Study|Lack of Efficacy|8|||
16874768|NCT01571453|37852050|FG001|Overall Study|Lack of Efficacy|3|||
16874769|NCT01571453|37852049|FG000|Overall Study|Non-compliance|2|||
16874770|NCT01571453|37852050|FG001|Overall Study|Non-compliance|4|||
16874771|NCT01571453|37852049|FG000|Overall Study|Protocol Violation|1|||
16874772|NCT01571453|37852050|FG001|Overall Study|Protocol Violation|5|||
16874773|NCT01571453|37852049|FG000|Overall Study|Withdrawal of consent|5|||
16874774|NCT01571453|37852050|FG001|Overall Study|Withdrawal of consent|13|||
16874775|NCT01571453|37852049|FG000|Overall Study|Lost to Follow-up|4|||
16874776|NCT01571453|37852050|FG001|Overall Study|Lost to Follow-up|2|||
16874777|NCT01571453|37852049|FG000|Overall Study|Administrative or other reason(s)|4|||
16874778|NCT01571453|37852050|FG001|Overall Study|Administrative or other reason(s)|3|||
16785386|NCT02699749|37725484|FG002|Overall Study|Other|2|||
16785387|NCT02699749|37725485|FG003|Overall Study|Other|0|||
16785388|NCT02699749|37725486|FG004|Overall Study|Other|0|||
16785389|NCT02699749|37725487|FG005|Overall Study|Other|1|||
16785390|NCT02699749|37725488|FG006|Overall Study|Other|1|||
16785391|NCT02699749|37725489|FG007|Overall Study|Other|0|||
16874779|NCT01446289|37852060|FG000|Overall Study|Withdrawal by Subject|1|||
17095089|NCT00262028|38234366|FG008|Overall Study|Lost to Follow-up|6|||
16874780|NCT01446289|37852061|FG001|Overall Study|Withdrawal by Subject|0|||
16874781|NCT01446289|37852062|FG002|Overall Study|Withdrawal by Subject|1|||
16874782|NCT01446289|37852063|FG003|Overall Study|Withdrawal by Subject|0|||
16874783|NCT01438541|37852075|FG000|Overall Study|Physician Decision|1|||
16874784|NCT01438541|37852075|FG000|Overall Study|Withdrawal by Subject|1|||
16874785|NCT01438541|37852075|FG000|Overall Study|discharge from the hospital|5|||
16874786|NCT01419769|37852079|FG000|Overall Study|Did not receive the AXIOS stent|3|||
16874787|NCT01419769|37852079|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
16874788|NCT01438307|37852085|FG000|Overall Study|Death|1|||
16874789|NCT01438307|37852086|FG001|Overall Study|Death|1|||
16874790|NCT01444651|37852094|FG000|Overall Study|Adverse Event|3|||
16874791|NCT01444651|37852095|FG001|Overall Study|Adverse Event|2|||
16874792|NCT01444651|37852094|FG000|Overall Study|Lost to Follow-up|5|||
16874793|NCT01444651|37852095|FG001|Overall Study|Lost to Follow-up|5|||
16874794|NCT01444651|37852094|FG000|Overall Study|Non-fasting|2|||
16874795|NCT01444651|37852095|FG001|Overall Study|Non-fasting|1|||
16874796|NCT01444651|37852094|FG000|Overall Study|Missing data|1|||
16874797|NCT01444651|37852095|FG001|Overall Study|Missing data|1|||
16874798|NCT01570751|37852103|FG000|Period A (16 Weeks)|Protocol Violation|1|||
16874799|NCT01570751|37852104|FG001|Period A (16 Weeks)|Protocol Violation|1|||
16874800|NCT01570751|37852103|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
16874801|NCT01570751|37852104|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
16874802|NCT01570751|37852103|FG000|Period A (16 Weeks)|Unclassified|2|||
16874803|NCT01570751|37852104|FG001|Period A (16 Weeks)|Unclassified|3|||
16874804|NCT01570751|37852103|FG000|Period B (16 Weeks)|Adverse Event|1|||
16874805|NCT01570751|37852104|FG001|Period B (16 Weeks)|Adverse Event|0|||
16874806|NCT01570751|37852103|FG000|Period B (16 Weeks)|Protocol Violation|0|||
16874807|NCT01570751|37852104|FG001|Period B (16 Weeks)|Protocol Violation|1|||
16874808|NCT01419535|37852114|FG000|Overall Study|could not maintain iv line|1|||
16874809|NCT01419535|37852115|FG001|Overall Study|could not maintain iv line|1|||
16874810|NCT01419535|37852114|FG000|Overall Study|Withdrawal by Subject|0|||
16874811|NCT01419535|37852115|FG001|Overall Study|Withdrawal by Subject|1|||
16874812|NCT01438151|37852121|FG000|Overall Study|study terminated|8|||
16874813|NCT01418365|37852147|FG000|First Intervention|Withdrawal by Subject|0|||
16874814|NCT01418365|37852148|FG001|First Intervention|Withdrawal by Subject|1|||
16874815|NCT01418365|37852147|FG000|First Intervention|Non-compliance|1|||
16874816|NCT01418365|37852148|FG001|First Intervention|Non-compliance|0|||
16874817|NCT01418365|37852147|FG000|Second Intervention|Withdrawal by Subject|0|||
16874818|NCT01418365|37852148|FG001|Second Intervention|Withdrawal by Subject|1|||
16874819|NCT01437995|37852183|FG000|Overall Study|Lost to Follow-up|11|||
16874820|NCT01437995|37852184|FG001|Overall Study|Lost to Follow-up|18|||
16874821|NCT01437995|37852185|FG002|Overall Study|Lost to Follow-up|20|||
16874822|NCT01439347|37852234|FG000|Overall Study|Death|10|||
16874823|NCT01439347|37852235|FG001|Overall Study|Death|9|||
16874824|NCT01439347|37852234|FG000|Overall Study|Withdrawal by Subject|0|||
16874825|NCT01439347|37852235|FG001|Overall Study|Withdrawal by Subject|1|||
16874826|NCT01439347|37852234|FG000|Overall Study|Physician Decision|1|||
16874827|NCT01439347|37852235|FG001|Overall Study|Physician Decision|0|||
16874828|NCT01439347|37852234|FG000|Overall Study|Sponsor Terminated Study|2|||
16874829|NCT01439347|37852235|FG001|Overall Study|Sponsor Terminated Study|3|||
16874830|NCT01438957|37852282|FG000|Overall Study|Physician Decision|1|||
16874831|NCT01438957|37852283|FG001|Overall Study|Physician Decision|1|||
16874832|NCT01438957|37852284|FG002|Overall Study|Physician Decision|0|||
16874833|NCT01438957|37852285|FG003|Overall Study|Physician Decision|1|||
16874834|NCT01438957|37852286|FG004|Overall Study|Physician Decision|0|||
16874835|NCT01444417|37852335|FG000|Overall Study|Ineligibility Determined|0|||
16874836|NCT01444417|37852336|FG001|Overall Study|Ineligibility Determined|1|||
16874837|NCT01444417|37852335|FG000|Overall Study|Withdrawal by Subject|2|||
16874838|NCT01444417|37852336|FG001|Overall Study|Withdrawal by Subject|0|||
16874839|NCT01444027|37852363|FG000|Overall Study|Withdrawal by Subject|4|||
16874840|NCT01444027|37852364|FG001|Overall Study|Withdrawal by Subject|10|||
16874841|NCT01444027|37852365|FG002|Overall Study|Withdrawal by Subject|24|||
16874842|NCT01444027|37852363|FG000|Overall Study|Lost to Follow-up|26|||
16874843|NCT01444027|37852364|FG001|Overall Study|Lost to Follow-up|20|||
16874844|NCT01444027|37852365|FG002|Overall Study|Lost to Follow-up|14|||
16874845|NCT01438489|37852407|FG000|Overall Study|Lost to Follow-up|4|||
16874846|NCT01438489|37852408|FG001|Overall Study|Lost to Follow-up|2|||
16874847|NCT01438489|37852409|FG002|Overall Study|Lost to Follow-up|2|||
16874848|NCT01438489|37852407|FG000|Overall Study|Withdrawal by Subject|11|||
16874849|NCT01438489|37852408|FG001|Overall Study|Withdrawal by Subject|3|||
16874850|NCT01438489|37852409|FG002|Overall Study|Withdrawal by Subject|8|||
16874851|NCT01438489|37852407|FG000|Overall Study|Death|0|||
16874852|NCT01438489|37852408|FG001|Overall Study|Death|0|||
16874853|NCT01438489|37852409|FG002|Overall Study|Death|1|||
16874854|NCT01438489|37852407|FG000|Overall Study|Sponsor decision|4|||
16874855|NCT01438489|37852408|FG001|Overall Study|Sponsor decision|1|||
16874856|NCT01438489|37852409|FG002|Overall Study|Sponsor decision|4|||
16874857|NCT01438489|37852407|FG000|Overall Study|Subject choice/Subject moved|2|||
16874858|NCT01438489|37852408|FG001|Overall Study|Subject choice/Subject moved|1|||
16874859|NCT01438489|37852409|FG002|Overall Study|Subject choice/Subject moved|1|||
16874860|NCT01438489|37852407|FG000|Overall Study|Investigator decision|0|||
16874861|NCT01438489|37852408|FG001|Overall Study|Investigator decision|1|||
16874862|NCT01438489|37852409|FG002|Overall Study|Investigator decision|0|||
16874863|NCT01438489|37852407|FG000|Overall Study|AE/SAEs|2|||
16874864|NCT01438489|37852408|FG001|Overall Study|AE/SAEs|1|||
16874865|NCT01438489|37852409|FG002|Overall Study|AE/SAEs|1|||
16874866|NCT01438489|37852407|FG000|Overall Study|Received prohibited medication|1|||
16874867|NCT01438489|37852408|FG001|Overall Study|Received prohibited medication|0|||
16874868|NCT01438489|37852409|FG002|Overall Study|Received prohibited medication|0|||
16874869|NCT01438489|37852407|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
16874870|NCT01438489|37852408|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
16874871|NCT01438489|37852409|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
16874872|NCT01438489|37852407|FG000|Overall Study|Inadequate venous access|0|||
16874873|NCT01438489|37852408|FG001|Overall Study|Inadequate venous access|2|||
16785392|NCT02699749|37725490|FG008|Overall Study|Other|0|||
16785393|NCT02699749|37725491|FG009|Overall Study|Other|0|||
16785394|NCT02699749|37725492|FG010|Overall Study|Other|1|||
16785395|NCT02699749|37725493|FG011|Overall Study|Other|0|||
16785396|NCT02699749|37725494|FG012|Overall Study|Other|0|||
16785397|NCT02699749|37725495|FG013|Overall Study|Other|0|||
16785398|NCT02699749|37725482|FG000|Overall Study|Progressive Disease|3|||
16785399|NCT02699749|37725483|FG001|Overall Study|Progressive Disease|3|||
16785400|NCT02699749|37725484|FG002|Overall Study|Progressive Disease|14|||
16785401|NCT02699749|37725485|FG003|Overall Study|Progressive Disease|3|||
16785402|NCT02699749|37725486|FG004|Overall Study|Progressive Disease|3|||
16785403|NCT02699749|37725487|FG005|Overall Study|Progressive Disease|7|||
16874874|NCT01438489|37852409|FG002|Overall Study|Inadequate venous access|0|||
16874875|NCT01418209|37852435|FG000|Overall Study|Withdrawal by Subject|1|||
16874876|NCT01418209|37852436|FG001|Overall Study|Withdrawal by Subject|0|||
16874877|NCT01418209|37852437|FG002|Overall Study|Withdrawal by Subject|1|||
16874878|NCT01418209|37852435|FG000|Overall Study|Did not provide hot flash diary data|1|||
16874879|NCT01418209|37852436|FG001|Overall Study|Did not provide hot flash diary data|3|||
16874880|NCT01418209|37852437|FG002|Overall Study|Did not provide hot flash diary data|3|||
16874881|NCT01570361|37852456|FG000|Overall Study|Subject discontinued|1|||
16874882|NCT01570361|37852457|FG001|Overall Study|Subject discontinued|2|||
16874883|NCT01570361|37852456|FG000|Overall Study|Sponsor closing the study|51|||
16874884|NCT01570361|37852457|FG001|Overall Study|Sponsor closing the study|50|||
16874885|NCT01570361|37852456|FG000|Overall Study|Subject excluded|5|||
16874886|NCT01570361|37852457|FG001|Overall Study|Subject excluded|3|||
16874887|NCT01570361|37852456|FG000|Overall Study|Subject withdrew consent|14|||
16874888|NCT01570361|37852457|FG001|Overall Study|Subject withdrew consent|9|||
16874889|NCT01570361|37852456|FG000|Overall Study|Adverse Event|2|||
16874890|NCT01570361|37852457|FG001|Overall Study|Adverse Event|1|||
16874891|NCT01570361|37852456|FG000|Overall Study|Lost to Follow-up|4|||
16874892|NCT01570361|37852457|FG001|Overall Study|Lost to Follow-up|4|||
16874893|NCT01570361|37852456|FG000|Overall Study|Death|5|||
16874894|NCT01570361|37852457|FG001|Overall Study|Death|4|||
16874895|NCT01570361|37852456|FG000|Overall Study|Other|0|||
16874896|NCT01570361|37852457|FG001|Overall Study|Other|2|||
16874897|NCT01417195|37852468|FG000|Overall Study|Stimulation failure|1|||
16874898|NCT01417195|37852469|FG001|Overall Study|Stimulation failure|0|||
16874899|NCT01417195|37852468|FG000|Overall Study|No embryos for transfer|0|||
16874900|NCT01417195|37852469|FG001|Overall Study|No embryos for transfer|1|||
16874901|NCT01417195|37852468|FG000|Overall Study|No transfer due to risk of OHSS|1|||
16874902|NCT01417195|37852469|FG001|Overall Study|No transfer due to risk of OHSS|0|||
16874903|NCT01417195|37852468|FG000|Overall Study|No transfer due to elevated progesterone|1|||
16874904|NCT01417195|37852469|FG001|Overall Study|No transfer due to elevated progesterone|0|||
16874905|NCT01438411|37852494|FG000|Overall Study|Adverse Event|8|||
16874906|NCT01438411|37852494|FG000|Overall Study|Lost to Follow-up|1|||
16874907|NCT01438411|37852494|FG000|Overall Study|Lack of Efficacy|1|||
16874908|NCT01438411|37852494|FG000|Overall Study|Withdrawal by Subject|3|||
16874909|NCT01443403|37852506|FG000|Overall Study|Adverse Event|1|||
16874910|NCT01443403|37852507|FG001|Overall Study|Adverse Event|1|||
16874911|NCT01443403|37852508|FG002|Overall Study|Adverse Event|4|||
16874912|NCT01443403|37852509|FG003|Overall Study|Adverse Event|5|||
16874913|NCT01443403|37852506|FG000|Overall Study|Withdrawal by Subject|0|||
16874914|NCT01443403|37852507|FG001|Overall Study|Withdrawal by Subject|1|||
16874915|NCT01443403|37852508|FG002|Overall Study|Withdrawal by Subject|2|||
16874916|NCT01443403|37852509|FG003|Overall Study|Withdrawal by Subject|1|||
16874917|NCT01443403|37852506|FG000|Overall Study|Lost to Follow-up|0|||
16874918|NCT01443403|37852507|FG001|Overall Study|Lost to Follow-up|0|||
16874919|NCT01443403|37852508|FG002|Overall Study|Lost to Follow-up|0|||
16874920|NCT01443403|37852509|FG003|Overall Study|Lost to Follow-up|1|||
16785404|NCT02699749|37725488|FG006|Overall Study|Progressive Disease|5|||
16874921|NCT01443403|37852506|FG000|Overall Study|Protocol Violation|2|||
16874922|NCT01443403|37852507|FG001|Overall Study|Protocol Violation|1|||
16874923|NCT01443403|37852508|FG002|Overall Study|Protocol Violation|1|||
16874924|NCT01443403|37852509|FG003|Overall Study|Protocol Violation|1|||
16874925|NCT01443403|37852506|FG000|Overall Study|Use of Prohibited Treatment|2|||
16874926|NCT01443403|37852507|FG001|Overall Study|Use of Prohibited Treatment|3|||
16874927|NCT01443403|37852508|FG002|Overall Study|Use of Prohibited Treatment|0|||
16874928|NCT01443403|37852509|FG003|Overall Study|Use of Prohibited Treatment|0|||
16874929|NCT01443403|37852506|FG000|Overall Study|Other - Miscellaneous|1|||
16874930|NCT01443403|37852507|FG001|Overall Study|Other - Miscellaneous|0|||
16874931|NCT01443403|37852508|FG002|Overall Study|Other - Miscellaneous|0|||
16874932|NCT01443403|37852509|FG003|Overall Study|Other - Miscellaneous|1|||
16874933|NCT01438177|37852522|FG000|Overall Study|Withdrawal by Subject|1|||
16874934|NCT01438177|37852522|FG000|Overall Study|Initiation of new therapy|1|||
16874935|NCT01442779|37852526|FG000|Overall Study|Withdrawal by Subject|3|||
16874936|NCT01442779|37852526|FG000|Overall Study|Death|3|||
16874937|NCT01442779|37852526|FG000|Overall Study|Non-compliance|1|||
16874938|NCT01416805|37852532|FG000|Overall Study|Lost to Follow-up|4|||
16874939|NCT01416805|37852533|FG001|Overall Study|Lost to Follow-up|4|||
16874940|NCT01437943|37852541|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
16874941|NCT01437943|37852542|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
16874942|NCT01437943|37852541|FG000|Overall Study|Subject expressed pregnancy plans|1|||
16874943|NCT01437943|37852542|FG001|Overall Study|Subject expressed pregnancy plans|0|||
16874944|NCT01437943|37852541|FG000|Overall Study|Adverse Event|2|||
16874945|NCT01437943|37852542|FG001|Overall Study|Adverse Event|0|||
16874946|NCT01570283|37852551|FG000|Cohort 1: Dose Level 1|Death|0|||
16874947|NCT01570283|37852552|FG001|Cohort 1: Dose Level 1|Death|1|||
16874948|NCT01570283|37852553|FG002|Cohort 1: Dose Level 1|Death|0|||
16874949|NCT01570283|37852554|FG003|Cohort 1: Dose Level 1|Death|0|||
16874950|NCT01570283|37852555|FG004|Cohort 1: Dose Level 1|Death|0|||
16874951|NCT01570283|37852556|FG005|Cohort 1: Dose Level 1|Death|0|||
16874952|NCT01570283|37852551|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16874953|NCT01570283|37852552|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
16874954|NCT01570283|37852553|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16874955|NCT01570283|37852554|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16874956|NCT01570283|37852555|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16874957|NCT01570283|37852556|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16874958|NCT01570283|37852551|FG000|Cohort 2: Dose Level 2|Death|0|||
17001616|NCT00871377|38145637|FG001|Third Intervention (10 Weeks)|Death|0|||
17001617|NCT00871377|38145638|FG002|Third Intervention (10 Weeks)|Death|0|||
17001618|NCT00871377|38145639|FG003|Third Intervention (10 Weeks)|Death|1|||
17001619|NCT00871377|38145640|FG004|Third Intervention (10 Weeks)|Death|0|||
17001620|NCT00871377|38145641|FG005|Third Intervention (10 Weeks)|Death|0|||
17001621|NCT00977561|38145651|FG000|Overall Study|Death|3|||
17001622|NCT00977561|38145652|FG001|Overall Study|Death|2|||
16874959|NCT01570283|37852552|FG001|Cohort 2: Dose Level 2|Death|0|||
16874960|NCT01570283|37852553|FG002|Cohort 2: Dose Level 2|Death|1|||
16874961|NCT01570283|37852554|FG003|Cohort 2: Dose Level 2|Death|0|||
16874962|NCT01570283|37852555|FG004|Cohort 2: Dose Level 2|Death|0|||
16874963|NCT01570283|37852556|FG005|Cohort 2: Dose Level 2|Death|0|||
16874964|NCT01570283|37852551|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16874965|NCT01570283|37852552|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16874966|NCT01570283|37852553|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16874967|NCT01570283|37852554|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
16874968|NCT01570283|37852555|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16874969|NCT01570283|37852556|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16874970|NCT01570283|37852551|FG000|Cohort 3: Dose Level 3|Death|0|||
16874971|NCT01570283|37852552|FG001|Cohort 3: Dose Level 3|Death|0|||
16874972|NCT01570283|37852553|FG002|Cohort 3: Dose Level 3|Death|0|||
16874973|NCT01570283|37852554|FG003|Cohort 3: Dose Level 3|Death|0|||
16874974|NCT01570283|37852555|FG004|Cohort 3: Dose Level 3|Death|0|||
16874975|NCT01570283|37852556|FG005|Cohort 3: Dose Level 3|Death|1|||
16874976|NCT01570283|37852551|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16874977|NCT01570283|37852552|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16874978|NCT01570283|37852553|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16874979|NCT01570283|37852554|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16874980|NCT01570283|37852555|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16874981|NCT01570283|37852556|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
16874982|NCT01436357|37852572|FG000|Overall Study|Death|5|||
16874983|NCT01436357|37852573|FG001|Overall Study|Death|1|||
16874984|NCT01436357|37852572|FG000|Overall Study|Enrolled but not vaccinated|1|||
16874985|NCT01436357|37852573|FG001|Overall Study|Enrolled but not vaccinated|1|||
17001623|NCT00977561|38145651|FG000|Overall Study|Study terminated|0|||
17191473|NCT02418754|38344242|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
16874986|NCT01436357|37852572|FG000|Overall Study|Incarceration|18|||
16874987|NCT01436357|37852573|FG001|Overall Study|Incarceration|20|||
16874988|NCT01436357|37852572|FG000|Overall Study|Lost to Follow-up|67|||
16874989|NCT01436357|37852573|FG001|Overall Study|Lost to Follow-up|61|||
16874990|NCT01436357|37852572|FG000|Overall Study|Protocol Violation|1|||
16874991|NCT01436357|37852573|FG001|Overall Study|Protocol Violation|0|||
16874992|NCT01436357|37852572|FG000|Overall Study|Withdrawal by Subject|26|||
16874993|NCT01436357|37852573|FG001|Overall Study|Withdrawal by Subject|38|||
16874994|NCT01436357|37852572|FG000|Overall Study|Physician Decision|3|||
16874995|NCT01436357|37852573|FG001|Overall Study|Physician Decision|4|||
16874996|NCT01436357|37852572|FG000|Overall Study|Moved out of area|1|||
16874997|NCT01436357|37852573|FG001|Overall Study|Moved out of area|2|||
16874998|NCT01436357|37852572|FG000|Overall Study|Subject in rehab|0|||
16874999|NCT01436357|37852573|FG001|Overall Study|Subject in rehab|1|||
16875000|NCT01436201|37852579|FG000|Overall Study|Adverse Event|2|||
16875001|NCT01436201|37852579|FG000|Overall Study|Withdrawal by Subject|1|||
16875002|NCT01436201|37852579|FG000|Overall Study|Protocol Violation|1|||
16875003|NCT01437397|37852590|FG000|Overall Study|Lost to Follow-up|9|||
16875004|NCT01437397|37852591|FG001|Overall Study|Lost to Follow-up|4|||
16875005|NCT01437397|37852592|FG002|Overall Study|Lost to Follow-up|2|||
16875006|NCT01437397|37852593|FG003|Overall Study|Lost to Follow-up|4|||
16875007|NCT01437397|37852594|FG004|Overall Study|Lost to Follow-up|5|||
16875008|NCT01437397|37852590|FG000|Overall Study|Withdrawal by Subject|11|||
16875009|NCT01437397|37852591|FG001|Overall Study|Withdrawal by Subject|12|||
16875010|NCT01437397|37852592|FG002|Overall Study|Withdrawal by Subject|24|||
16875011|NCT01437397|37852593|FG003|Overall Study|Withdrawal by Subject|11|||
16875012|NCT01437397|37852594|FG004|Overall Study|Withdrawal by Subject|22|||
16875013|NCT01437397|37852590|FG000|Overall Study|Protocol Violation|10|||
16875014|NCT01437397|37852591|FG001|Overall Study|Protocol Violation|12|||
16875015|NCT01437397|37852592|FG002|Overall Study|Protocol Violation|13|||
16875016|NCT01437397|37852593|FG003|Overall Study|Protocol Violation|21|||
16875017|NCT01437397|37852594|FG004|Overall Study|Protocol Violation|19|||
16875018|NCT01437397|37852590|FG000|Overall Study|Lack of Efficacy|5|||
16875019|NCT01437397|37852591|FG001|Overall Study|Lack of Efficacy|4|||
16875020|NCT01437397|37852592|FG002|Overall Study|Lack of Efficacy|8|||
16875021|NCT01437397|37852593|FG003|Overall Study|Lack of Efficacy|10|||
16875022|NCT01437397|37852594|FG004|Overall Study|Lack of Efficacy|20|||
16875023|NCT01437397|37852590|FG000|Overall Study|Adverse Event|21|||
16875024|NCT01437397|37852591|FG001|Overall Study|Adverse Event|22|||
16875025|NCT01437397|37852592|FG002|Overall Study|Adverse Event|16|||
16875026|NCT01437397|37852593|FG003|Overall Study|Adverse Event|14|||
16875027|NCT01437397|37852594|FG004|Overall Study|Adverse Event|21|||
16875028|NCT01437397|37852590|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
16875029|NCT01437397|37852591|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
16875030|NCT01437397|37852592|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
16875031|NCT01437397|37852593|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
16875032|NCT01437397|37852594|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
16875033|NCT01437319|37852606|FG000|Phase I|Lost to Follow-up|2|||
16875034|NCT01437319|37852607|FG001|Phase I|Lost to Follow-up|0|||
16875035|NCT01437319|37852608|FG002|Phase I|Lost to Follow-up|0|||
16875036|NCT01437319|37852606|FG000|Phase I|Protocol Violation|1|||
16875037|NCT01437319|37852607|FG001|Phase I|Protocol Violation|0|||
16875038|NCT01437319|37852608|FG002|Phase I|Protocol Violation|0|||
16875039|NCT01437319|37852606|FG000|Phase I|Study related symptoms/complaints|27|||
16875040|NCT01437319|37852607|FG001|Phase I|Study related symptoms/complaints|0|||
16875041|NCT01437319|37852608|FG002|Phase I|Study related symptoms/complaints|0|||
16875042|NCT01437319|37852606|FG000|Phase I|Withdrawal by Subject|25|||
16875043|NCT01437319|37852607|FG001|Phase I|Withdrawal by Subject|0|||
16875044|NCT01437319|37852608|FG002|Phase I|Withdrawal by Subject|0|||
16785405|NCT02699749|37725489|FG007|Overall Study|Progressive Disease|5|||
16785406|NCT02699749|37725490|FG008|Overall Study|Progressive Disease|6|||
16785407|NCT02699749|37725491|FG009|Overall Study|Progressive Disease|6|||
16785408|NCT02699749|37725492|FG010|Overall Study|Progressive Disease|5|||
16785409|NCT02699749|37725493|FG011|Overall Study|Progressive Disease|4|||
16785410|NCT02699749|37725494|FG012|Overall Study|Progressive Disease|3|||
16785411|NCT02699749|37725495|FG013|Overall Study|Progressive Disease|5|||
16785412|NCT02699749|37725482|FG000|Overall Study|Death|0|||
16875045|NCT01437319|37852606|FG000|Phase II|Withdrawal by Subject|0|||
16875046|NCT01437319|37852607|FG001|Phase II|Withdrawal by Subject|8|||
16875047|NCT01437319|37852608|FG002|Phase II|Withdrawal by Subject|16|||
16875048|NCT01437319|37852606|FG000|Phase II|Lost to Follow-up|0|||
16875049|NCT01437319|37852607|FG001|Phase II|Lost to Follow-up|7|||
16875050|NCT01437319|37852608|FG002|Phase II|Lost to Follow-up|2|||
16875051|NCT01437319|37852606|FG000|Phase II|Study related symptoms/complaints|0|||
16875052|NCT01437319|37852607|FG001|Phase II|Study related symptoms/complaints|28|||
16875053|NCT01437319|37852608|FG002|Phase II|Study related symptoms/complaints|19|||
16785413|NCT02699749|37725483|FG001|Overall Study|Death|0|||
16785414|NCT02699749|37725484|FG002|Overall Study|Death|0|||
16875054|NCT01437319|37852606|FG000|Phase II|Protocol Violation|0|||
16875055|NCT01437319|37852607|FG001|Phase II|Protocol Violation|1|||
16875056|NCT01437319|37852608|FG002|Phase II|Protocol Violation|0|||
16875057|NCT01416571|37852617|FG000|Overall Study|Lost to Follow-up|2|||
16875058|NCT01442155|37852638|FG000|Overall Study|Complete remission|35|||
16875059|NCT01442155|37852638|FG000|Overall Study|Recurrence|26|||
16875060|NCT01442155|37852638|FG000|Overall Study|Adverse Event|2|||
16875061|NCT01442155|37852638|FG000|Overall Study|Lost to Follow-up|2|||
16875062|NCT01416181|37852644|FG000|Part 1|Other|10|||
16875063|NCT01416181|37852645|FG001|Part 1|Other|24|||
16875064|NCT01416181|37852644|FG000|Part 1|Death|0|||
16785415|NCT02699749|37725485|FG003|Overall Study|Death|0|||
16785416|NCT02699749|37725486|FG004|Overall Study|Death|0|||
16785417|NCT02699749|37725487|FG005|Overall Study|Death|0|||
16785418|NCT02699749|37725488|FG006|Overall Study|Death|0|||
16785419|NCT02699749|37725489|FG007|Overall Study|Death|0|||
16785420|NCT02699749|37725490|FG008|Overall Study|Death|0|||
16785421|NCT02699749|37725491|FG009|Overall Study|Death|0|||
16785422|NCT02699749|37725492|FG010|Overall Study|Death|0|||
16785423|NCT02699749|37725493|FG011|Overall Study|Death|0|||
16875065|NCT01416181|37852645|FG001|Part 1|Death|1|||
16875066|NCT01416181|37852644|FG000|Part 1|Investigator Decision|7|||
16875067|NCT01416181|37852645|FG001|Part 1|Investigator Decision|6|||
16875068|NCT01416181|37852644|FG000|Part 1|Withdrawal by Subject|74|||
16875069|NCT01416181|37852645|FG001|Part 1|Withdrawal by Subject|48|||
16875070|NCT01416181|37852644|FG000|Part 1|Lack of Efficacy|16|||
16875071|NCT01416181|37852645|FG001|Part 1|Lack of Efficacy|8|||
16875072|NCT01416181|37852644|FG000|Part 1|Lost to Follow-up|1|||
16875073|NCT01416181|37852645|FG001|Part 1|Lost to Follow-up|1|||
16875074|NCT01416181|37852644|FG000|Part 1|Adverse Event|15|||
16875075|NCT01416181|37852645|FG001|Part 1|Adverse Event|18|||
16875076|NCT01416181|37852644|FG000|Part 1|Ongoing in Follow-Up|14|||
16875077|NCT01416181|37852645|FG001|Part 1|Ongoing in Follow-Up|8|||
16875078|NCT01416181|37852644|FG000|Part 2|Adverse Event|11|||
16875079|NCT01416181|37852645|FG001|Part 2|Adverse Event|4|||
16875080|NCT01416181|37852644|FG000|Part 2|Other|234|||
16875081|NCT01416181|37852645|FG001|Part 2|Other|267|||
16875082|NCT01416181|37852644|FG000|Part 2|Investigator Decision|6|||
16875083|NCT01416181|37852645|FG001|Part 2|Investigator Decision|7|||
16875084|NCT01416181|37852644|FG000|Part 2|Withdrawal by Subject|14|||
16875085|NCT01416181|37852645|FG001|Part 2|Withdrawal by Subject|5|||
16875086|NCT01416181|37852644|FG000|Part 2|Lack of Efficacy|4|||
16875087|NCT01416181|37852645|FG001|Part 2|Lack of Efficacy|1|||
16875088|NCT01416181|37852644|FG000|Part 2|Lost to Follow-up|2|||
16875089|NCT01416181|37852645|FG001|Part 2|Lost to Follow-up|2|||
16875090|NCT01441765|37852653|FG000|Overall Study|Death|1|||
16875091|NCT01441765|37852654|FG001|Overall Study|Death|0|||
16875092|NCT01419665|37852662|FG000|Combination Treatment|Adverse Event|7|||
16875093|NCT01419665|37852663|FG001|Combination Treatment|Adverse Event|10|||
16875094|NCT01419665|37852662|FG000|Combination Treatment|Physician Decision|5|||
16875095|NCT01419665|37852663|FG001|Combination Treatment|Physician Decision|8|||
16785424|NCT02699749|37725494|FG012|Overall Study|Death|0|||
16785425|NCT02699749|37725495|FG013|Overall Study|Death|1|||
16785426|NCT02699749|37725482|FG000|Overall Study|Lost to Follow-up|0|||
16785427|NCT02699749|37725483|FG001|Overall Study|Lost to Follow-up|0|||
16785428|NCT02699749|37725484|FG002|Overall Study|Lost to Follow-up|0|||
16785429|NCT02699749|37725485|FG003|Overall Study|Lost to Follow-up|0|||
16785430|NCT02699749|37725486|FG004|Overall Study|Lost to Follow-up|0|||
16785431|NCT02699749|37725487|FG005|Overall Study|Lost to Follow-up|1|||
16785432|NCT02699749|37725488|FG006|Overall Study|Lost to Follow-up|0|||
16785433|NCT02699749|37725489|FG007|Overall Study|Lost to Follow-up|1|||
16875096|NCT01419665|37852662|FG000|Combination Treatment|Protocol Violation|6|||
16875097|NCT01419665|37852663|FG001|Combination Treatment|Protocol Violation|2|||
16875098|NCT01419665|37852662|FG000|Combination Treatment|disease progression|10|||
16875099|NCT01419665|37852663|FG001|Combination Treatment|disease progression|9|||
16875100|NCT01419665|37852662|FG000|Combination Treatment|Death|5|||
16875101|NCT01419665|37852663|FG001|Combination Treatment|Death|7|||
16875102|NCT01419665|37852662|FG000|Combination Treatment|administrative problems|0|||
16875103|NCT01419665|37852663|FG001|Combination Treatment|administrative problems|1|||
16875104|NCT01419665|37852662|FG000|Combination Treatment|Withdrawal by Subject|5|||
16875105|NCT01419665|37852663|FG001|Combination Treatment|Withdrawal by Subject|4|||
16875106|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
16875107|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
16875108|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
16875109|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
16875110|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
16875111|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
16785434|NCT02699749|37725490|FG008|Overall Study|Lost to Follow-up|0|||
16785435|NCT02699749|37725491|FG009|Overall Study|Lost to Follow-up|0|||
16785436|NCT02699749|37725492|FG010|Overall Study|Lost to Follow-up|0|||
16875112|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
16875113|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
16875114|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
16875115|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
16875116|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
16875117|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
16875118|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|Death|1|||
16875119|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|Death|2|||
16875120|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
16875121|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
16875122|NCT01419665|37852662|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
16875123|NCT01419665|37852663|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
16875124|NCT01419665|37852662|FG000|Open Label Phase|Death|1|||
16875125|NCT01419665|37852663|FG001|Open Label Phase|Death|0|||
16875126|NCT01419665|37852662|FG000|Open Label Phase|disease progression|0|||
16875127|NCT01419665|37852663|FG001|Open Label Phase|disease progression|1|||
16875128|NCT01436305|37852674|FG000|Overall Study|Death|1|||
16875129|NCT01436305|37852675|FG001|Overall Study|Death|0|||
16875130|NCT01436305|37852676|FG002|Overall Study|Death|0|||
16875131|NCT01436305|37852674|FG000|Overall Study|Lost to Follow-up|0|||
16875132|NCT01436305|37852675|FG001|Overall Study|Lost to Follow-up|1|||
16875133|NCT01436305|37852676|FG002|Overall Study|Lost to Follow-up|0|||
16875134|NCT01436305|37852674|FG000|Overall Study|Withdrawal by Subject|1|||
16785437|NCT02699749|37725493|FG011|Overall Study|Lost to Follow-up|0|||
16785438|NCT02699749|37725494|FG012|Overall Study|Lost to Follow-up|0|||
16785439|NCT02699749|37725495|FG013|Overall Study|Lost to Follow-up|0|||
16785440|NCT02699593|37725525|FG000|Period 1|Unsatisfactory Visual Response|0|||
16785441|NCT02699593|37725526|FG001|Period 1|Unsatisfactory Visual Response|1|||
16785442|NCT02699593|37725525|FG000|Period 1|Torn Contact Len|4|||
16785443|NCT02699593|37725526|FG001|Period 1|Torn Contact Len|3|||
16785444|NCT02699593|37725525|FG000|Period 1|Protocol Violation|0|||
16785445|NCT02699593|37725526|FG001|Period 1|Protocol Violation|1|||
16785446|NCT02699593|37725525|FG000|Period 1|Withdrawal by Subject|0|||
16785447|NCT02699593|37725526|FG001|Period 1|Withdrawal by Subject|1|||
16785448|NCT02699593|37725525|FG000|Period 1|Adverse Event|1|||
16785449|NCT02699593|37725526|FG001|Period 1|Adverse Event|1|||
16785450|NCT02699593|37725525|FG000|Period 2|Adverse Event|1|||
16785451|NCT02699593|37725526|FG001|Period 2|Adverse Event|1|||
16785452|NCT02699593|37725525|FG000|Period 2|Lost Contact Lens|0|||
16785453|NCT02699593|37725526|FG001|Period 2|Lost Contact Lens|1|||
16785454|NCT02699593|37725525|FG000|Period 2|Torn Contact Lens|1|||
16785455|NCT02699593|37725526|FG001|Period 2|Torn Contact Lens|0|||
16785456|NCT00708097|37725532|FG000|Period 1|Protocol Violation|0|||
16785457|NCT00708097|37725533|FG001|Period 1|Protocol Violation|1|||
16785458|NCT00708097|37725534|FG002|Period 1|Protocol Violation|0|||
16785459|NCT00708097|37725535|FG003|Period 1|Protocol Violation|2|||
16785460|NCT00708097|37725536|FG004|Period 1|Protocol Violation|0|||
16785461|NCT00708097|37725532|FG000|Period 1|Other Reason|0|||
16785462|NCT00708097|37725533|FG001|Period 1|Other Reason|0|||
16785463|NCT00708097|37725534|FG002|Period 1|Other Reason|0|||
16785464|NCT00708097|37725535|FG003|Period 1|Other Reason|0|||
16785465|NCT00708097|37725536|FG004|Period 1|Other Reason|1|||
16785466|NCT00708097|37725532|FG000|Period 2|Protocol Violation|0|||
16785467|NCT00708097|37725533|FG001|Period 2|Protocol Violation|1|||
16785468|NCT00708097|37725534|FG002|Period 2|Protocol Violation|1|||
16785469|NCT00708097|37725535|FG003|Period 2|Protocol Violation|1|||
16785470|NCT00708097|37725536|FG004|Period 2|Protocol Violation|0|||
16785471|NCT02659631|37725563|FG000|Overall Study|Lost to Follow-up|0|||
16785472|NCT02659631|37725564|FG001|Overall Study|Lost to Follow-up|0|||
16785473|NCT02659631|37725565|FG002|Overall Study|Lost to Follow-up|2|||
16785474|NCT02659631|37725566|FG003|Overall Study|Lost to Follow-up|0|||
16785475|NCT02659631|37725567|FG004|Overall Study|Lost to Follow-up|0|||
16785476|NCT02659631|37725568|FG005|Overall Study|Lost to Follow-up|1|||
16785477|NCT02659631|37725569|FG006|Overall Study|Lost to Follow-up|0|||
16785478|NCT02659631|37725570|FG007|Overall Study|Lost to Follow-up|0|||
16785479|NCT02659631|37725571|FG008|Overall Study|Lost to Follow-up|0|||
16785480|NCT02659631|37725572|FG009|Overall Study|Lost to Follow-up|0|||
16875135|NCT01436305|37852675|FG001|Overall Study|Withdrawal by Subject|3|||
16875136|NCT01436305|37852676|FG002|Overall Study|Withdrawal by Subject|0|||
16875137|NCT01436149|37852686|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
16875138|NCT01436149|37852687|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
16875139|NCT01436149|37852688|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
16875140|NCT01436149|37852686|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
16785481|NCT02659631|37725563|FG000|Overall Study|Withdrawal prior to treatment|0|||
16785482|NCT02659631|37725564|FG001|Overall Study|Withdrawal prior to treatment|0|||
16785483|NCT02659631|37725565|FG002|Overall Study|Withdrawal prior to treatment|0|||
16785484|NCT02659631|37725566|FG003|Overall Study|Withdrawal prior to treatment|0|||
16785485|NCT02659631|37725567|FG004|Overall Study|Withdrawal prior to treatment|1|||
16785486|NCT02659631|37725568|FG005|Overall Study|Withdrawal prior to treatment|0|||
16785487|NCT02659631|37725569|FG006|Overall Study|Withdrawal prior to treatment|0|||
16875141|NCT01436149|37852687|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
16875142|NCT01436149|37852688|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
16875143|NCT01436149|37852686|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
16875144|NCT01436149|37852687|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16875145|NCT01436149|37852688|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16875146|NCT01436149|37852686|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
16875147|NCT01436149|37852687|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16875148|NCT01436149|37852688|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16875149|NCT01436149|37852686|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
16875150|NCT01436149|37852687|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
16875151|NCT01436149|37852688|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
16875152|NCT01436149|37852686|FG000|Antidepressant Lead-in Phase|Other|119|||
16875153|NCT01436149|37852687|FG001|Antidepressant Lead-in Phase|Other|0|||
16875154|NCT01436149|37852688|FG002|Antidepressant Lead-in Phase|Other|0|||
16875155|NCT01436149|37852686|FG000|Randomized Phase|Adverse Event|9|||
16875156|NCT01436149|37852687|FG001|Randomized Phase|Adverse Event|10|||
16875157|NCT01436149|37852688|FG002|Randomized Phase|Adverse Event|11|||
16875158|NCT01436149|37852686|FG000|Randomized Phase|Protocol Violation|4|||
16875159|NCT01436149|37852687|FG001|Randomized Phase|Protocol Violation|5|||
16875160|NCT01436149|37852688|FG002|Randomized Phase|Protocol Violation|0|||
16875161|NCT01436149|37852686|FG000|Randomized Phase|Withdrawal by Subject|16|||
16875162|NCT01436149|37852687|FG001|Randomized Phase|Withdrawal by Subject|10|||
16875163|NCT01436149|37852688|FG002|Randomized Phase|Withdrawal by Subject|10|||
16875164|NCT01436149|37852686|FG000|Randomized Phase|Lost to Follow-up|34|||
16875165|NCT01436149|37852687|FG001|Randomized Phase|Lost to Follow-up|5|||
16875166|NCT01436149|37852688|FG002|Randomized Phase|Lost to Follow-up|6|||
16875167|NCT01436149|37852686|FG000|Randomized Phase|Lack of Efficacy|0|||
16875168|NCT01436149|37852687|FG001|Randomized Phase|Lack of Efficacy|0|||
16875169|NCT01436149|37852688|FG002|Randomized Phase|Lack of Efficacy|1|||
16875170|NCT01436149|37852686|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
16875171|NCT01436149|37852687|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
16875172|NCT01436149|37852688|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
16875173|NCT01436149|37852686|FG000|Randomized Phase|Other|12|||
16875174|NCT01436149|37852687|FG001|Randomized Phase|Other|5|||
16875175|NCT01436149|37852688|FG002|Randomized Phase|Other|11|||
16875176|NCT01415401|37852694|FG000|Overall Study|Adverse Event|5|||
16875177|NCT01415401|37852694|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
16875178|NCT01415401|37852694|FG000|Overall Study|Terminated by Sponsor|1|||
16875179|NCT01414855|37852698|FG000|Overall Study|Death|17|||
16875180|NCT01414855|37852698|FG000|Overall Study|Lost to Follow-up|5|||
16875181|NCT01414855|37852698|FG000|Overall Study|Withdrawal by Subject|7|||
16875182|NCT01527500|37852706|FG000|Part A|Administrative|11|||
16875183|NCT01527500|37852707|FG001|Part A|Administrative|7|||
16875184|NCT01527500|37852706|FG000|Part A|Adverse Event|4|||
16875185|NCT01527500|37852707|FG001|Part A|Adverse Event|2|||
16875186|NCT01527500|37852706|FG000|Part A|Death|4|||
16875187|NCT01527500|37852707|FG001|Part A|Death|1|||
16875188|NCT01527500|37852706|FG000|Part A|Lost to Follow-up|0|||
16875189|NCT01527500|37852707|FG001|Part A|Lost to Follow-up|1|||
16875190|NCT01527500|37852706|FG000|Part A|Protocol Deviation|9|||
16875191|NCT01527500|37852707|FG001|Part A|Protocol Deviation|2|||
17095090|NCT00262028|38234358|FG000|Overall Study|Administrative Reason|11|||
16875192|NCT01527500|37852706|FG000|Part A|Withdrawal by Subject|2|||
16875193|NCT01527500|37852707|FG001|Part A|Withdrawal by Subject|0|||
16875194|NCT01527500|37852706|FG000|Part B|Adverse Event|1|||
16875195|NCT01527500|37852707|FG001|Part B|Adverse Event|0|||
16875196|NCT01527110|37852732|FG000|Overall Study|Adverse Event|1|||
16875197|NCT01441063|37852736|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
16875198|NCT01441063|37852736|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
16875199|NCT01436071|37852745|FG000|Overall Study|Adverse Event|1|||
16875200|NCT01436071|37852746|FG001|Overall Study|Adverse Event|0|||
16875201|NCT01436071|37852745|FG000|Overall Study|Lack of Efficacy|16|||
16875202|NCT01436071|37852746|FG001|Overall Study|Lack of Efficacy|7|||
16875203|NCT01436071|37852745|FG000|Overall Study|Protocol Violation|0|||
16875204|NCT01436071|37852746|FG001|Overall Study|Protocol Violation|1|||
16875205|NCT01436071|37852745|FG000|Overall Study|Lost to Follow-up|3|||
16875206|NCT01436071|37852746|FG001|Overall Study|Lost to Follow-up|1|||
16875207|NCT01436071|37852745|FG000|Overall Study|Physician Decision|1|||
16875208|NCT01436071|37852746|FG001|Overall Study|Physician Decision|0|||
16875209|NCT01436071|37852745|FG000|Overall Study|Withdrawal by Subject|2|||
16875210|NCT01436071|37852746|FG001|Overall Study|Withdrawal by Subject|2|||
16875211|NCT01436071|37852745|FG000|Overall Study|Did Not Receive Trial Medication|3|||
16875212|NCT01436071|37852746|FG001|Overall Study|Did Not Receive Trial Medication|3|||
16875213|NCT01514864|37852754|FG000|Overall Study|Disease progression|7|||
16875214|NCT01514864|37852755|FG001|Overall Study|Disease progression|5|||
16875215|NCT01514864|37852754|FG000|Overall Study|Study drug toxicity|2|||
16875216|NCT01514864|37852755|FG001|Overall Study|Study drug toxicity|0|||
16875217|NCT01514240|37852764|FG000|Overall Study|Adverse Event|4|||
16875218|NCT01514240|37852765|FG001|Overall Study|Adverse Event|4|||
16875219|NCT01514240|37852764|FG000|Overall Study|Subject Decision|2|||
16875220|NCT01514240|37852765|FG001|Overall Study|Subject Decision|7|||
16875221|NCT01435759|37852776|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
16875222|NCT01435759|37852777|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
16875223|NCT01435759|37852778|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
16875224|NCT01435759|37852779|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
16875225|NCT01435759|37852780|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
16875226|NCT01435759|37852781|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
16875227|NCT01435759|37852776|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
16875228|NCT01435759|37852777|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
16875229|NCT01435759|37852778|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
16875230|NCT01435759|37852779|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
16875231|NCT01435759|37852780|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
16875232|NCT01435759|37852781|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
16875233|NCT01435759|37852776|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
16875234|NCT01435759|37852777|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16875235|NCT01435759|37852778|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16875236|NCT01435759|37852779|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16875237|NCT01435759|37852780|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16875238|NCT01435759|37852781|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16875239|NCT01435759|37852776|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
16875240|NCT01435759|37852777|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16875241|NCT01435759|37852778|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16875242|NCT01435759|37852779|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16875243|NCT01435759|37852780|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16875244|NCT01435759|37852781|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16875245|NCT01435759|37852776|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
16875246|NCT01435759|37852777|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875247|NCT01435759|37852778|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875248|NCT01435759|37852779|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875249|NCT01435759|37852780|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875250|NCT01435759|37852781|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875251|NCT01435759|37852776|FG000|Antidepressant Lead-in Phase|Other|119|||
16875252|NCT01435759|37852777|FG001|Antidepressant Lead-in Phase|Other|0|||
16875253|NCT01435759|37852778|FG002|Antidepressant Lead-in Phase|Other|0|||
16875254|NCT01435759|37852779|FG003|Antidepressant Lead-in Phase|Other|0|||
16875255|NCT01435759|37852780|FG004|Antidepressant Lead-in Phase|Other|0|||
16875256|NCT01435759|37852781|FG005|Antidepressant Lead-in Phase|Other|0|||
16875257|NCT01435759|37852776|FG000|Double-blind Phase|Adverse Event|7|||
16875258|NCT01435759|37852777|FG001|Double-blind Phase|Adverse Event|0|||
16875259|NCT01435759|37852778|FG002|Double-blind Phase|Adverse Event|1|||
16875260|NCT01435759|37852779|FG003|Double-blind Phase|Adverse Event|1|||
16875261|NCT01435759|37852780|FG004|Double-blind Phase|Adverse Event|1|||
16875262|NCT01435759|37852781|FG005|Double-blind Phase|Adverse Event|3|||
16875263|NCT01435759|37852776|FG000|Double-blind Phase|Protocol Violation|2|||
16875264|NCT01435759|37852777|FG001|Double-blind Phase|Protocol Violation|0|||
16875265|NCT01435759|37852778|FG002|Double-blind Phase|Protocol Violation|1|||
16875266|NCT01435759|37852779|FG003|Double-blind Phase|Protocol Violation|2|||
16875267|NCT01435759|37852780|FG004|Double-blind Phase|Protocol Violation|0|||
16875268|NCT01435759|37852781|FG005|Double-blind Phase|Protocol Violation|1|||
16875269|NCT01435759|37852776|FG000|Double-blind Phase|Withdrawal by Subject|17|||
16875270|NCT01435759|37852777|FG001|Double-blind Phase|Withdrawal by Subject|4|||
16875271|NCT01435759|37852778|FG002|Double-blind Phase|Withdrawal by Subject|3|||
16875272|NCT01435759|37852779|FG003|Double-blind Phase|Withdrawal by Subject|4|||
16875273|NCT01435759|37852780|FG004|Double-blind Phase|Withdrawal by Subject|2|||
16875274|NCT01435759|37852781|FG005|Double-blind Phase|Withdrawal by Subject|2|||
16875275|NCT01435759|37852776|FG000|Double-blind Phase|Lost to Follow-up|31|||
16875276|NCT01435759|37852777|FG001|Double-blind Phase|Lost to Follow-up|1|||
16875277|NCT01435759|37852778|FG002|Double-blind Phase|Lost to Follow-up|2|||
16875278|NCT01435759|37852779|FG003|Double-blind Phase|Lost to Follow-up|0|||
16875279|NCT01435759|37852780|FG004|Double-blind Phase|Lost to Follow-up|3|||
16875280|NCT01435759|37852781|FG005|Double-blind Phase|Lost to Follow-up|3|||
16875281|NCT01435759|37852776|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
16875282|NCT01435759|37852777|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875283|NCT01435759|37852778|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875284|NCT01435759|37852779|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875285|NCT01435759|37852780|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
16875286|NCT01435759|37852781|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
16875287|NCT01435759|37852776|FG000|Double-blind Phase|Other|8|||
16875288|NCT01435759|37852777|FG001|Double-blind Phase|Other|2|||
16875289|NCT01435759|37852778|FG002|Double-blind Phase|Other|0|||
16875290|NCT01435759|37852779|FG003|Double-blind Phase|Other|2|||
16875291|NCT01435759|37852780|FG004|Double-blind Phase|Other|0|||
16875292|NCT01435759|37852781|FG005|Double-blind Phase|Other|0|||
16875293|NCT01393405|37852793|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
16875294|NCT01393405|37852794|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
16875295|NCT01393405|37852795|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
16875296|NCT01393405|37852793|FG000|Induction Period (week1-16)|Adverse Event|16|||
16875297|NCT01393405|37852794|FG001|Induction Period (week1-16)|Adverse Event|0|||
16875298|NCT01393405|37852795|FG002|Induction Period (week1-16)|Adverse Event|0|||
16875299|NCT01393405|37852793|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
16875300|NCT01393405|37852794|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
16875301|NCT01393405|37852795|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
16875302|NCT01393405|37852793|FG000|Maintenance Period Week|Lack of Efficacy|0|||
16875303|NCT01393405|37852794|FG001|Maintenance Period Week|Lack of Efficacy|22|||
16875304|NCT01393405|37852795|FG002|Maintenance Period Week|Lack of Efficacy|22|||
16875305|NCT01393405|37852793|FG000|Maintenance Period Week|Adverse Event|0|||
16875306|NCT01393405|37852794|FG001|Maintenance Period Week|Adverse Event|5|||
16875307|NCT01393405|37852795|FG002|Maintenance Period Week|Adverse Event|2|||
16875308|NCT01393405|37852793|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
16875309|NCT01393405|37852794|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
16875310|NCT01393405|37852795|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
16875311|NCT01393405|37852793|FG000|Maintenance Period Week|Lost to Follow-up|0|||
16875312|NCT01393405|37852794|FG001|Maintenance Period Week|Lost to Follow-up|1|||
16875313|NCT01393405|37852795|FG002|Maintenance Period Week|Lost to Follow-up|0|||
16875314|NCT01419197|37852807|FG000|Overall Study|Death|247|||
16875315|NCT01419197|37852808|FG001|Overall Study|Death|122|||
16875316|NCT01419197|37852807|FG000|Overall Study|Physician Decision|4|||
16875317|NCT01419197|37852808|FG001|Overall Study|Physician Decision|4|||
16875318|NCT01419197|37852807|FG000|Overall Study|Non-compliance|3|||
16875319|NCT01419197|37852808|FG001|Overall Study|Non-compliance|1|||
16875320|NCT01419197|37852807|FG000|Overall Study|Withdrawal by Subject|33|||
16875321|NCT01419197|37852808|FG001|Overall Study|Withdrawal by Subject|32|||
16875322|NCT01419197|37852807|FG000|Overall Study|Study Completed by Sponsor|103|||
16875323|NCT01419197|37852808|FG001|Overall Study|Study Completed by Sponsor|34|||
16875324|NCT01419197|37852807|FG000|Overall Study|Reason Not Specified|0|||
16875325|NCT01419197|37852808|FG001|Overall Study|Reason Not Specified|1|||
16875326|NCT01419197|37852807|FG000|Overall Study|Lost to Follow-up|14|||
16875327|NCT01419197|37852808|FG001|Overall Study|Lost to Follow-up|4|||
16875328|NCT01414075|37852819|FG000|Overall Study|Adverse Event|1|||
16875329|NCT01414075|37852820|FG001|Overall Study|Adverse Event|0|||
16875330|NCT01414075|37852821|FG002|Overall Study|Adverse Event|1|||
16875331|NCT01414075|37852822|FG003|Overall Study|Adverse Event|0|||
16875332|NCT01414075|37852819|FG000|Overall Study|Death|1|||
16875333|NCT01414075|37852820|FG001|Overall Study|Death|0|||
16875334|NCT01414075|37852821|FG002|Overall Study|Death|0|||
16875335|NCT01414075|37852822|FG003|Overall Study|Death|1|||
16875336|NCT01414075|37852819|FG000|Overall Study|Withdrawal by Subject|0|||
16875337|NCT01414075|37852820|FG001|Overall Study|Withdrawal by Subject|0|||
16875338|NCT01414075|37852821|FG002|Overall Study|Withdrawal by Subject|0|||
16875339|NCT01414075|37852822|FG003|Overall Study|Withdrawal by Subject|1|||
16875340|NCT01414075|37852819|FG000|Overall Study|Other than specified|1|||
16875341|NCT01414075|37852820|FG001|Overall Study|Other than specified|0|||
16875342|NCT01414075|37852821|FG002|Overall Study|Other than specified|1|||
16875343|NCT01414075|37852822|FG003|Overall Study|Other than specified|0|||
16875344|NCT01434823|37852834|FG000|Overall Study|Incomplete data in medical record|4|||
16875345|NCT01434823|37852835|FG001|Overall Study|Incomplete data in medical record|7|||
16875346|NCT01513460|37852845|FG000|Overall Study|Death|0|||
16875347|NCT01513460|37852846|FG001|Overall Study|Death|0|||
16875348|NCT01513460|37852847|FG002|Overall Study|Death|1|||
16875349|NCT01513460|37852845|FG000|Overall Study|Lost to Follow-up|0|||
16875350|NCT01513460|37852846|FG001|Overall Study|Lost to Follow-up|0|||
16875351|NCT01513460|37852847|FG002|Overall Study|Lost to Follow-up|2|||
16875352|NCT01513460|37852845|FG000|Overall Study|Abnormal laboratory value|1|||
16875353|NCT01513460|37852846|FG001|Overall Study|Abnormal laboratory value|0|||
16875354|NCT01513460|37852847|FG002|Overall Study|Abnormal laboratory value|1|||
16875355|NCT01513460|37852845|FG000|Overall Study|Lack of Efficacy|1|||
16875356|NCT01513460|37852846|FG001|Overall Study|Lack of Efficacy|2|||
16875357|NCT01513460|37852847|FG002|Overall Study|Lack of Efficacy|5|||
16875358|NCT01513460|37852845|FG000|Overall Study|Protocol deviations|3|||
16875359|NCT01513460|37852846|FG001|Overall Study|Protocol deviations|4|||
16875360|NCT01513460|37852847|FG002|Overall Study|Protocol deviations|3|||
16875361|NCT01513460|37852845|FG000|Overall Study|Withdrawal by Subject|7|||
16875362|NCT01513460|37852846|FG001|Overall Study|Withdrawal by Subject|8|||
16875363|NCT01513460|37852847|FG002|Overall Study|Withdrawal by Subject|21|||
16875364|NCT01513460|37852845|FG000|Overall Study|Adverse Event|16|||
16875365|NCT01513460|37852846|FG001|Overall Study|Adverse Event|18|||
16875366|NCT01513460|37852847|FG002|Overall Study|Adverse Event|23|||
16875367|NCT01513460|37852845|FG000|Overall Study|Abnormal test procedure|1|||
16875368|NCT01513460|37852846|FG001|Overall Study|Abnormal test procedure|0|||
16875369|NCT01513460|37852847|FG002|Overall Study|Abnormal test procedure|0|||
16875370|NCT01392547|37852857|FG000|Overall Study|Adverse Event|2|||
16875371|NCT01392547|37852857|FG000|Overall Study|Non-compliance|2|||
16875372|NCT01392547|37852857|FG000|Overall Study|Withdrawal criteria|3|||
16875373|NCT01392547|37852857|FG000|Overall Study|Unclassified|1|||
16875374|NCT01435655|37852863|FG000|Overall Study|Death|2|||
16875375|NCT01435655|37852863|FG000|Overall Study|Other|1|||
16875376|NCT01434667|37852869|FG000|Overall Study|Lost to Follow-up|5|||
16875377|NCT01434667|37852870|FG001|Overall Study|Lost to Follow-up|10|||
16875378|NCT01513148|37852878|FG000|Overall Study|Protocol Violation|2|||
16875379|NCT01513148|37852879|FG001|Overall Study|Protocol Violation|2|||
16875380|NCT01418339|37852927|FG000|Overall Study|Adverse Event|5|||
16875381|NCT01418339|37852928|FG001|Overall Study|Adverse Event|2|||
16875382|NCT01418339|37852927|FG000|Overall Study|Subject Withdrew Consent|1|||
16875383|NCT01418339|37852928|FG001|Overall Study|Subject Withdrew Consent|2|||
16875384|NCT01418339|37852927|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
16875385|NCT01418339|37852928|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
16875386|NCT01512368|37852934|FG000|Overall Study|Protocol Violation|3|||
16875387|NCT01412983|37852938|FG000|1st Period|Ineligible|0|||
16875388|NCT01412983|37852939|FG001|1st Period|Ineligible|1|||
16875389|NCT01412983|37852938|FG000|1st Period|Positive slit lamp finding|0|||
16875390|NCT01412983|37852939|FG001|1st Period|Positive slit lamp finding|1|||
16875391|NCT01412983|37852938|FG000|1st Period|Unacceptable lens movement|0|||
16875392|NCT01412983|37852939|FG001|1st Period|Unacceptable lens movement|1|||
16875393|NCT01412983|37852938|FG000|1st Period|Inability to maintain wear|0|||
16875394|NCT01412983|37852939|FG001|1st Period|Inability to maintain wear|1|||
16875395|NCT01417481|37852948|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
16875396|NCT01417481|37852949|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16875397|NCT01392469|37852955|FG000|Overall Study|Adverse Event|2|||
16875398|NCT01392469|37852955|FG000|Overall Study|Withdrawal by Subject|1|||
16875399|NCT01392469|37852955|FG000|Overall Study|Protocol Violation|1|||
16875400|NCT01435577|37852972|FG000|Overall Study|Adverse Event|10|||
16875401|NCT01435577|37852973|FG001|Overall Study|Adverse Event|0|||
16875402|NCT01435577|37852972|FG000|Overall Study|Lack of Efficacy|7|||
16875403|NCT01435577|37852973|FG001|Overall Study|Lack of Efficacy|51|||
16875404|NCT01435577|37852972|FG000|Overall Study|Alternative treatment started|0|||
16875405|NCT01435577|37852973|FG001|Overall Study|Alternative treatment started|1|||
16875406|NCT01411891|37852985|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
16875407|NCT01411891|37852986|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
16875408|NCT01416389|37852994|FG000|Overall Study|Lost to Follow-up|1|||
16875409|NCT01416389|37852995|FG001|Overall Study|Lost to Follow-up|0|||
16875410|NCT01416389|37852994|FG000|Overall Study|Started New Therapy|2|||
16875411|NCT01416389|37852995|FG001|Overall Study|Started New Therapy|0|||
16875412|NCT01544348|37853011|FG000|Overall Study|Lost to Follow-up|1|||
16875413|NCT01544348|37853012|FG001|Overall Study|Lost to Follow-up|0|||
16875414|NCT01544348|37853013|FG002|Overall Study|Lost to Follow-up|0|||
16875415|NCT01544348|37853014|FG003|Overall Study|Lost to Follow-up|0|||
16875416|NCT01544348|37853015|FG004|Overall Study|Lost to Follow-up|0|||
16875417|NCT01544348|37853016|FG005|Overall Study|Lost to Follow-up|0|||
16875418|NCT01544348|37853017|FG006|Overall Study|Lost to Follow-up|1|||
16875419|NCT01544348|37853018|FG007|Overall Study|Lost to Follow-up|0|||
16875420|NCT01544348|37853011|FG000|Overall Study|Withdrawal by Subject|1|||
16875421|NCT01544348|37853012|FG001|Overall Study|Withdrawal by Subject|0|||
16875422|NCT01544348|37853013|FG002|Overall Study|Withdrawal by Subject|0|||
16875423|NCT01544348|37853014|FG003|Overall Study|Withdrawal by Subject|0|||
16875424|NCT01544348|37853015|FG004|Overall Study|Withdrawal by Subject|1|||
16875425|NCT01544348|37853016|FG005|Overall Study|Withdrawal by Subject|2|||
16875426|NCT01544348|37853017|FG006|Overall Study|Withdrawal by Subject|1|||
16875427|NCT01544348|37853018|FG007|Overall Study|Withdrawal by Subject|0|||
16875428|NCT01544348|37853011|FG000|Overall Study|Physician Decision|0|||
16875429|NCT01544348|37853012|FG001|Overall Study|Physician Decision|0|||
16875430|NCT01544348|37853013|FG002|Overall Study|Physician Decision|0|||
16875431|NCT01544348|37853014|FG003|Overall Study|Physician Decision|0|||
16875432|NCT01544348|37853015|FG004|Overall Study|Physician Decision|0|||
16875433|NCT01544348|37853016|FG005|Overall Study|Physician Decision|1|||
16875434|NCT01544348|37853017|FG006|Overall Study|Physician Decision|0|||
16875435|NCT01544348|37853018|FG007|Overall Study|Physician Decision|0|||
16875436|NCT01416155|37853043|FG000|Overall Study|Adverse Event|8|||
16875437|NCT01416155|37853043|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
16875438|NCT01416155|37853043|FG000|Overall Study|Withdrawal by Subject|33|||
16875439|NCT01416155|37853043|FG000|Overall Study|Investigator decision|8|||
16875440|NCT01416155|37853043|FG000|Overall Study|Other|7|||
16875441|NCT01415921|37853049|FG000|Overall Study|Adverse Event|0|||
16875442|NCT01415921|37853050|FG001|Overall Study|Adverse Event|1|||
16875443|NCT01415921|37853049|FG000|Overall Study|Physician Decision|1|||
16875444|NCT01415921|37853050|FG001|Overall Study|Physician Decision|1|||
16875445|NCT01415921|37853049|FG000|Overall Study|Withdrawal by Subject|0|||
16875446|NCT01415921|37853050|FG001|Overall Study|Withdrawal by Subject|1|||
16875447|NCT01415921|37853049|FG000|Overall Study|Other|2|||
16875448|NCT01415921|37853050|FG001|Overall Study|Other|0|||
16875449|NCT01415531|37853058|FG000|Overall Study|Adverse Event|7|||
16875450|NCT01415531|37853059|FG001|Overall Study|Adverse Event|10|||
16875451|NCT01415531|37853058|FG000|Overall Study|Lack of Efficacy|3|||
16875452|NCT01415531|37853059|FG001|Overall Study|Lack of Efficacy|2|||
16875453|NCT01415531|37853058|FG000|Overall Study|Protocol Violation|0|||
16875454|NCT01415531|37853059|FG001|Overall Study|Protocol Violation|1|||
16785488|NCT02659631|37725570|FG007|Overall Study|Withdrawal prior to treatment|0|||
16785489|NCT02659631|37725571|FG008|Overall Study|Withdrawal prior to treatment|0|||
16785490|NCT02659631|37725572|FG009|Overall Study|Withdrawal prior to treatment|0|||
16785491|NCT02659631|37725563|FG000|Overall Study|Participant refused further follow-up|0|||
16875455|NCT01415531|37853058|FG000|Overall Study|Withdrawal by Subject|5|||
16875456|NCT01415531|37853059|FG001|Overall Study|Withdrawal by Subject|4|||
16875457|NCT01415531|37853058|FG000|Overall Study|Lost to Follow-up|6|||
16875458|NCT01415531|37853059|FG001|Overall Study|Lost to Follow-up|14|||
16875459|NCT01415531|37853058|FG000|Overall Study|Lack of Compliance|1|||
16875460|NCT01415531|37853059|FG001|Overall Study|Lack of Compliance|4|||
16875461|NCT01415531|37853058|FG000|Overall Study|Other Reasons|3|||
16875462|NCT01415531|37853059|FG001|Overall Study|Other Reasons|2|||
16875463|NCT01544114|37853068|FG000|Overall Study|Withdrawal by Subject|0|||
16875464|NCT01544114|37853069|FG001|Overall Study|Withdrawal by Subject|0|||
16875465|NCT01544114|37853070|FG002|Overall Study|Withdrawal by Subject|3|||
16875466|NCT01544114|37853068|FG000|Overall Study|Lost to Follow-up|0|||
16875467|NCT01544114|37853069|FG001|Overall Study|Lost to Follow-up|2|||
16875468|NCT01544114|37853070|FG002|Overall Study|Lost to Follow-up|0|||
16875469|NCT01544114|37853068|FG000|Overall Study|Adverse Event|1|||
16875470|NCT01544114|37853069|FG001|Overall Study|Adverse Event|1|||
16875471|NCT01544114|37853070|FG002|Overall Study|Adverse Event|2|||
16875472|NCT01544114|37853068|FG000|Overall Study|Protocol Violation|0|||
16875473|NCT01544114|37853069|FG001|Overall Study|Protocol Violation|1|||
16875474|NCT01544114|37853070|FG002|Overall Study|Protocol Violation|0|||
16875475|NCT01435265|37853082|FG000|Overall Study|Lost to Follow-up|0|||
16875476|NCT01435265|37853083|FG001|Overall Study|Lost to Follow-up|1|||
16875477|NCT01433263|37853091|FG000|Overall Study|Adverse Event|3|||
16875478|NCT01433263|37853092|FG001|Overall Study|Adverse Event|1|||
16875479|NCT01433263|37853091|FG000|Overall Study|Death|5|||
16875480|NCT01433263|37853092|FG001|Overall Study|Death|3|||
16875481|NCT01433263|37853091|FG000|Overall Study|Lost to Follow-up|0|||
16875482|NCT01433263|37853092|FG001|Overall Study|Lost to Follow-up|1|||
16875483|NCT01433263|37853091|FG000|Overall Study|Protocol Deviation|1|||
16875484|NCT01433263|37853092|FG001|Overall Study|Protocol Deviation|0|||
16875485|NCT01433263|37853091|FG000|Overall Study|Withdrawal by Subject|10|||
16875486|NCT01433263|37853092|FG001|Overall Study|Withdrawal by Subject|7|||
16875487|NCT01432951|37853101|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
16875488|NCT01432327|37853110|FG000|Posttest 3 Months|depression|3|||
16875489|NCT01432327|37853111|FG001|Posttest 3 Months|depression|0|||
16875490|NCT01432327|37853112|FG002|Posttest 3 Months|depression|0|||
16875491|NCT01432327|37853113|FG003|Posttest 3 Months|depression|0|||
16875492|NCT01432327|37853110|FG000|Posttest 3 Months|Lost to Follow-up|1|||
16875493|NCT01432327|37853111|FG001|Posttest 3 Months|Lost to Follow-up|0|||
16875494|NCT01432327|37853112|FG002|Posttest 3 Months|Lost to Follow-up|2|||
16875495|NCT01432327|37853113|FG003|Posttest 3 Months|Lost to Follow-up|1|||
16875496|NCT01432327|37853110|FG000|Posttest 3 Months|Allergic reaction|0|||
16875497|NCT01432327|37853111|FG001|Posttest 3 Months|Allergic reaction|2|||
16875498|NCT01432327|37853112|FG002|Posttest 3 Months|Allergic reaction|0|||
16875499|NCT01432327|37853113|FG003|Posttest 3 Months|Allergic reaction|0|||
16875500|NCT01432327|37853110|FG000|Posttest 6 Months|Lost to Follow-up|0|||
16875501|NCT01432327|37853111|FG001|Posttest 6 Months|Lost to Follow-up|0|||
16875502|NCT01432327|37853112|FG002|Posttest 6 Months|Lost to Follow-up|3|||
16875503|NCT01432327|37853113|FG003|Posttest 6 Months|Lost to Follow-up|2|||
16875504|NCT01432327|37853110|FG000|Posttest 6 Months|Allergic reaction|0|||
16875505|NCT01432327|37853111|FG001|Posttest 6 Months|Allergic reaction|0|||
16875506|NCT01432327|37853112|FG002|Posttest 6 Months|Allergic reaction|1|||
16875507|NCT01432327|37853113|FG003|Posttest 6 Months|Allergic reaction|0|||
16875508|NCT01432327|37853110|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
16875509|NCT01432327|37853111|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
16875510|NCT01432327|37853112|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
16785492|NCT02659631|37725564|FG001|Overall Study|Participant refused further follow-up|0|||
16785493|NCT02659631|37725565|FG002|Overall Study|Participant refused further follow-up|0|||
16785494|NCT02659631|37725566|FG003|Overall Study|Participant refused further follow-up|1|||
16785495|NCT02659631|37725567|FG004|Overall Study|Participant refused further follow-up|0|||
16785496|NCT02659631|37725568|FG005|Overall Study|Participant refused further follow-up|0|||
16875511|NCT01432327|37853113|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
16875512|NCT01432327|37853110|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
16875513|NCT01432327|37853111|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
16875514|NCT01432327|37853112|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
16875515|NCT01432327|37853113|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
16875516|NCT01432327|37853110|FG000|Posttest 1 Year|Lost to Follow-up|0|||
16875517|NCT01432327|37853111|FG001|Posttest 1 Year|Lost to Follow-up|0|||
16875518|NCT01432327|37853112|FG002|Posttest 1 Year|Lost to Follow-up|4|||
16875519|NCT01432327|37853113|FG003|Posttest 1 Year|Lost to Follow-up|2|||
16875520|NCT01432327|37853110|FG000|Posttest 1 Year|Allergic reaction|0|||
16875521|NCT01432327|37853111|FG001|Posttest 1 Year|Allergic reaction|0|||
16875522|NCT01432327|37853112|FG002|Posttest 1 Year|Allergic reaction|1|||
16875523|NCT01432327|37853113|FG003|Posttest 1 Year|Allergic reaction|1|||
16875524|NCT01410799|37853123|FG000|Overall Study|PI decision|13|||
16875525|NCT01432171|37853129|FG000|Overall Study|Death|1|||
16875526|NCT01432171|37853130|FG001|Overall Study|Death|2|||
16875527|NCT01432171|37853129|FG000|Overall Study|Lost to Follow-up|6|||
16875528|NCT01432171|37853130|FG001|Overall Study|Lost to Follow-up|5|||
16875529|NCT01432171|37853129|FG000|Overall Study|Withdrawal by Subject|3|||
16875530|NCT01432171|37853130|FG001|Overall Study|Withdrawal by Subject|1|||
16875531|NCT01432171|37853129|FG000|Overall Study|Noncompliance|2|||
16875532|NCT01432171|37853130|FG001|Overall Study|Noncompliance|3|||
16875533|NCT01432171|37853129|FG000|Overall Study|Insurance denial trial coverage|1|||
16875534|NCT01432171|37853130|FG001|Overall Study|Insurance denial trial coverage|0|||
16875535|NCT01432171|37853129|FG000|Overall Study|Patient moved to palliative care|1|||
16875536|NCT01432171|37853130|FG001|Overall Study|Patient moved to palliative care|0|||
16875537|NCT01435031|37853140|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
16875538|NCT01435031|37853140|FG000|ITT at 1 Month|Death|1|||
16875539|NCT01435031|37853140|FG000|ITT at 1 Month|Lost to Follow-up|4|||
16875540|NCT01435031|37853140|FG000|ITT at 6 Months|Death|2|||
16875541|NCT01435031|37853140|FG000|ITT at 6 Months|Lost to Follow-up|3|||
16875542|NCT01435031|37853140|FG000|ITT at 1 Year|Death|1|||
16875543|NCT01435031|37853140|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
16875544|NCT01435031|37853140|FG000|ITT at 1 Year|Lost to Follow-up|6|||
16875545|NCT01435031|37853140|FG000|ITT at 2 Years|Death|7|||
16875546|NCT01435031|37853140|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
16875547|NCT01435031|37853140|FG000|ITT at 2 Years|Lost to Follow-up|4|||
16875548|NCT01435031|37853140|FG000|ITT at 3 Years|Death|5|||
16875549|NCT01435031|37853140|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
16875550|NCT01435031|37853140|FG000|ITT at 3 Years|Lost to Follow-up|4|||
16875551|NCT01435031|37853140|FG000|ITT at 4 Years|Death|4|||
16875552|NCT01435031|37853140|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
16875553|NCT01435031|37853140|FG000|ITT at 4 Years|Lost to Follow-up|1|||
16875554|NCT01433549|37853144|FG000|Phase 2: Second Study Product|Adverse Event|0|||
16875555|NCT01433549|37853145|FG001|Phase 2: Second Study Product|Adverse Event|1|||
16875556|NCT01414205|37853153|FG000|Overall Study|Death|5|||
16875557|NCT01414205|37853154|FG001|Overall Study|Death|1|||
16875558|NCT01414205|37853153|FG000|Overall Study|Lost to Follow-up|1|||
16875559|NCT01414205|37853154|FG001|Overall Study|Lost to Follow-up|4|||
16875560|NCT01414205|37853153|FG000|Overall Study|Physician Decision|0|||
16875561|NCT01414205|37853154|FG001|Overall Study|Physician Decision|1|||
16875562|NCT01414205|37853153|FG000|Overall Study|Randomized but not Treated|1|||
16875563|NCT01414205|37853154|FG001|Overall Study|Randomized but not Treated|1|||
16875564|NCT01433471|37853162|FG000|Overall Study|Withdrawal by Subject|0|||
16875565|NCT01433471|37853163|FG001|Overall Study|Withdrawal by Subject|1|||
16875566|NCT01433159|37853173|FG000|Overall Study|Adverse Event|1|||
16875567|NCT01433159|37853174|FG001|Overall Study|Adverse Event|0|||
16875568|NCT01433159|37853173|FG000|Overall Study|Physician Decision|1|||
16875569|NCT01433159|37853174|FG001|Overall Study|Physician Decision|0|||
16875570|NCT01433159|37853173|FG000|Overall Study|Protocol Violation|0|||
16875571|NCT01433159|37853174|FG001|Overall Study|Protocol Violation|1|||
16875572|NCT01413503|37853189|FG000|Overall Study|Lost to Follow-up|1|||
16875573|NCT01413191|37853193|FG000|Overall Study|Lost to Follow-up|5|||
16875574|NCT01413191|37853193|FG000|Overall Study|Disease Progression|5|||
16875575|NCT01413191|37853193|FG000|Overall Study|Death|1|||
16875576|NCT02036970|37853207|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
16875577|NCT02036970|37853208|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
16875578|NCT02036970|37853209|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
16875579|NCT02036970|37853210|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
16875580|NCT02036970|37853211|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
16875581|NCT02036970|37853212|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
16875582|NCT02036970|37853213|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
16875583|NCT02036970|37853214|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
16875584|NCT02036970|37853215|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
16875585|NCT02036970|37853216|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
16875586|NCT02036970|37853207|FG000|Part 1: Day 1 Through Week 16|Death|0|||
16875587|NCT02036970|37853208|FG001|Part 1: Day 1 Through Week 16|Death|0|||
16875588|NCT02036970|37853209|FG002|Part 1: Day 1 Through Week 16|Death|0|||
16875589|NCT02036970|37853210|FG003|Part 1: Day 1 Through Week 16|Death|0|||
16875590|NCT02036970|37853211|FG004|Part 1: Day 1 Through Week 16|Death|0|||
16875591|NCT02036970|37853212|FG005|Part 1: Day 1 Through Week 16|Death|0|||
16875592|NCT02036970|37853213|FG006|Part 1: Day 1 Through Week 16|Death|0|||
16875593|NCT02036970|37853214|FG007|Part 1: Day 1 Through Week 16|Death|0|||
16875594|NCT02036970|37853215|FG008|Part 1: Day 1 Through Week 16|Death|1|||
16875595|NCT02036970|37853216|FG009|Part 1: Day 1 Through Week 16|Death|0|||
16875596|NCT02036970|37853207|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
16875597|NCT02036970|37853208|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16875598|NCT02036970|37853209|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
16875599|NCT02036970|37853210|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16875600|NCT02036970|37853211|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16875601|NCT02036970|37853212|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16875602|NCT02036970|37853213|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16875603|NCT02036970|37853214|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16875604|NCT02036970|37853215|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
16875605|NCT02036970|37853216|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16875606|NCT02036970|37853207|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16875607|NCT02036970|37853208|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16875608|NCT02036970|37853209|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16875609|NCT02036970|37853210|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16875610|NCT02036970|37853211|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
16875611|NCT02036970|37853212|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16875612|NCT02036970|37853213|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16875613|NCT02036970|37853214|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16875614|NCT02036970|37853215|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
16875615|NCT02036970|37853216|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
16875616|NCT02036970|37853207|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875617|NCT02036970|37853208|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875618|NCT02036970|37853209|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875619|NCT02036970|37853210|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
16875620|NCT02036970|37853211|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875621|NCT02036970|37853212|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875622|NCT02036970|37853213|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875623|NCT02036970|37853214|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875624|NCT02036970|37853215|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875625|NCT02036970|37853216|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16875626|NCT02036970|37853207|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
16875627|NCT02036970|37853208|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
16875628|NCT02036970|37853209|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
16875629|NCT02036970|37853210|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
16875630|NCT02036970|37853211|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
16875631|NCT02036970|37853212|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
16875632|NCT02036970|37853213|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
16875633|NCT02036970|37853214|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
16875634|NCT02036970|37853215|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
16875635|NCT02036970|37853216|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
16875636|NCT02036970|37853207|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875637|NCT02036970|37853208|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875638|NCT02036970|37853209|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875639|NCT02036970|37853210|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875640|NCT02036970|37853211|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875641|NCT02036970|37853212|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875642|NCT02036970|37853213|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875643|NCT02036970|37853214|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
16875644|NCT02036970|37853215|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875645|NCT02036970|37853216|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
16875646|NCT02036970|37853207|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16875647|NCT02036970|37853208|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
16875648|NCT02036970|37853209|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
16875649|NCT02036970|37853210|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16875650|NCT02036970|37853211|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16875651|NCT02036970|37853212|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16875652|NCT02036970|37853213|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16875653|NCT02036970|37853214|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16875654|NCT02036970|37853215|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
16875655|NCT02036970|37853216|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16875656|NCT02036970|37853207|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
16875657|NCT02036970|37853208|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
16875658|NCT02036970|37853209|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
16875659|NCT02036970|37853210|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
16875660|NCT02036970|37853211|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
16875661|NCT02036970|37853212|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
16875662|NCT02036970|37853213|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
16875663|NCT02036970|37853214|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
16875664|NCT02036970|37853215|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
16875665|NCT02036970|37853216|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
16875666|NCT01412957|37853250|FG000|Overall Study|Withdrawal by Subject|6|||
16875667|NCT01412957|37853251|FG001|Overall Study|Withdrawal by Subject|22|||
16875668|NCT01412957|37853250|FG000|Overall Study|Lost to Follow-up|7|||
16875669|NCT01412957|37853251|FG001|Overall Study|Lost to Follow-up|2|||
16875670|NCT01412957|37853250|FG000|Overall Study|Death|136|||
16875671|NCT01412957|37853251|FG001|Overall Study|Death|133|||
16875672|NCT01432457|37853260|FG000|Overall Study|Adverse Event|7|||
16875673|NCT01432457|37853261|FG001|Overall Study|Adverse Event|10|||
16875674|NCT01432457|37853262|FG002|Overall Study|Adverse Event|16|||
16875675|NCT01432457|37853260|FG000|Overall Study|Lack of Efficacy|2|||
16875676|NCT01432457|37853261|FG001|Overall Study|Lack of Efficacy|1|||
16875677|NCT01432457|37853262|FG002|Overall Study|Lack of Efficacy|1|||
16875678|NCT01432457|37853260|FG000|Overall Study|Lost to Follow-up|11|||
16875679|NCT01432457|37853261|FG001|Overall Study|Lost to Follow-up|15|||
16875680|NCT01432457|37853262|FG002|Overall Study|Lost to Follow-up|20|||
16875681|NCT01432457|37853260|FG000|Overall Study|Protocol Violation|3|||
16875682|NCT01432457|37853261|FG001|Overall Study|Protocol Violation|2|||
16875683|NCT01432457|37853262|FG002|Overall Study|Protocol Violation|6|||
16875684|NCT01432457|37853260|FG000|Overall Study|Withdrawal by Subject|6|||
16875685|NCT01432457|37853261|FG001|Overall Study|Withdrawal by Subject|11|||
16875686|NCT01432457|37853262|FG002|Overall Study|Withdrawal by Subject|9|||
16875687|NCT01432457|37853260|FG000|Overall Study|Reasons not defined|2|||
16875688|NCT01432457|37853261|FG001|Overall Study|Reasons not defined|3|||
16875689|NCT01432457|37853262|FG002|Overall Study|Reasons not defined|4|||
16875690|NCT01432457|37853260|FG000|Overall Study|Did not take study drug|6|||
16875691|NCT01432457|37853261|FG001|Overall Study|Did not take study drug|6|||
16875692|NCT01432457|37853262|FG002|Overall Study|Did not take study drug|3|||
16875693|NCT01390441|37853284|FG000|Treatment Period|Protocol Violation|0|||
16875694|NCT01390441|37853285|FG001|Treatment Period|Protocol Violation|1|||
16875695|NCT01390441|37853286|FG002|Treatment Period|Protocol Violation|0|||
16875696|NCT01390441|37853287|FG003|Treatment Period|Protocol Violation|0|||
16875697|NCT01390441|37853288|FG004|Treatment Period|Protocol Violation|0|||
16875698|NCT01390441|37853284|FG000|Treatment Period|Physician Decision|0|||
16875699|NCT01390441|37853285|FG001|Treatment Period|Physician Decision|0|||
16875700|NCT01390441|37853286|FG002|Treatment Period|Physician Decision|0|||
16875701|NCT01390441|37853287|FG003|Treatment Period|Physician Decision|1|||
16875702|NCT01390441|37853288|FG004|Treatment Period|Physician Decision|0|||
16875703|NCT01390441|37853284|FG000|Treatment Period|Lack of Efficacy|0|||
16875704|NCT01390441|37853285|FG001|Treatment Period|Lack of Efficacy|0|||
16875705|NCT01390441|37853286|FG002|Treatment Period|Lack of Efficacy|0|||
16875706|NCT01390441|37853287|FG003|Treatment Period|Lack of Efficacy|0|||
16875707|NCT01390441|37853288|FG004|Treatment Period|Lack of Efficacy|1|||
16875708|NCT01390441|37853284|FG000|Treatment Period|Unknown due to early stopping of study|0|||
16875709|NCT01390441|37853285|FG001|Treatment Period|Unknown due to early stopping of study|0|||
16875710|NCT01390441|37853286|FG002|Treatment Period|Unknown due to early stopping of study|8|||
16875711|NCT01390441|37853287|FG003|Treatment Period|Unknown due to early stopping of study|11|||
16875712|NCT01390441|37853288|FG004|Treatment Period|Unknown due to early stopping of study|7|||
16875713|NCT01390441|37853284|FG000|Treatment Period|Adverse Event|0|||
16875714|NCT01390441|37853285|FG001|Treatment Period|Adverse Event|0|||
16875715|NCT01390441|37853286|FG002|Treatment Period|Adverse Event|1|||
16875716|NCT01390441|37853287|FG003|Treatment Period|Adverse Event|1|||
16875717|NCT01390441|37853288|FG004|Treatment Period|Adverse Event|2|||
16875718|NCT01390441|37853284|FG000|Treatment Period|Withdrawal by Subject|0|||
16875719|NCT01390441|37853285|FG001|Treatment Period|Withdrawal by Subject|0|||
16875720|NCT01390441|37853286|FG002|Treatment Period|Withdrawal by Subject|1|||
16875721|NCT01390441|37853287|FG003|Treatment Period|Withdrawal by Subject|0|||
16875722|NCT01390441|37853288|FG004|Treatment Period|Withdrawal by Subject|1|||
16875723|NCT01390441|37853284|FG000|Treatment Period|Lost to Follow-up|1|||
16875724|NCT01390441|37853285|FG001|Treatment Period|Lost to Follow-up|0|||
16875725|NCT01390441|37853286|FG002|Treatment Period|Lost to Follow-up|0|||
16875726|NCT01390441|37853287|FG003|Treatment Period|Lost to Follow-up|0|||
16875727|NCT01390441|37853288|FG004|Treatment Period|Lost to Follow-up|0|||
16875728|NCT01390441|37853284|FG000|Extension Period|Protocol Violation|3|||
16875729|NCT01390441|37853285|FG001|Extension Period|Protocol Violation|1|||
16875730|NCT01390441|37853286|FG002|Extension Period|Protocol Violation|0|||
16875731|NCT01390441|37853287|FG003|Extension Period|Protocol Violation|1|||
16875732|NCT01390441|37853288|FG004|Extension Period|Protocol Violation|0|||
16875733|NCT01412879|37853337|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
16875734|NCT01412879|37853338|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
16875735|NCT01412879|37853339|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
16875736|NCT01412879|37853337|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
16875737|NCT01412879|37853338|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
16875738|NCT01412879|37853339|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
16875739|NCT01412879|37853337|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
16875740|NCT01412879|37853338|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
16875741|NCT01412879|37853339|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
16875742|NCT01412879|37853337|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
16875743|NCT01412879|37853338|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
16875744|NCT01412879|37853339|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
16875745|NCT01412879|37853337|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
16875746|NCT01412879|37853338|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
16875747|NCT01412879|37853339|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
16875748|NCT01431079|37853351|FG000|Overall Study|Lost to Follow-up|35|||
16875749|NCT01431079|37853352|FG001|Overall Study|Lost to Follow-up|39|||
16875750|NCT01430611|37853384|FG000|Overall Study|Adverse Event|0|||
16875751|NCT01430611|37853385|FG001|Overall Study|Adverse Event|1|||
16875752|NCT01430611|37853384|FG000|Overall Study|Protocol Violation|1|||
16875753|NCT01430611|37853385|FG001|Overall Study|Protocol Violation|0|||
16875754|NCT01430611|37853384|FG000|Overall Study|Lost to Follow-up|1|||
16875755|NCT01430611|37853385|FG001|Overall Study|Lost to Follow-up|0|||
16875756|NCT01430611|37853384|FG000|Overall Study|Withdrawal by Subject|15|||
16875757|NCT01430611|37853385|FG001|Overall Study|Withdrawal by Subject|14|||
16875758|NCT01409707|37853394|FG000|Overall Study|Withdrawal by Subject|5|||
16875759|NCT01409707|37853395|FG001|Overall Study|Withdrawal by Subject|17|||
16875760|NCT01409707|37853396|FG002|Overall Study|Withdrawal by Subject|16|||
16875761|NCT01389973|37853403|FG000|Overall Study|Lost to Follow-up|1|||
16875762|NCT01389973|37853403|FG000|Overall Study|Trial Stopped by Sponsor|9|||
16875763|NCT01389973|37853403|FG000|Overall Study|Other|10|||
16875764|NCT01389817|37853423|FG000|Overall Study|Physician Decision|1|||
16875765|NCT01389817|37853424|FG001|Overall Study|Physician Decision|0|||
16875766|NCT01389817|37853423|FG000|Overall Study|Lost to Follow-up|1|||
16875767|NCT01389817|37853424|FG001|Overall Study|Lost to Follow-up|0|||
16875768|NCT01389817|37853423|FG000|Overall Study|Withdrawal by Subject|2|||
16875769|NCT01389817|37853424|FG001|Overall Study|Withdrawal by Subject|0|||
16875770|NCT01430455|37853439|FG000|Overall Study|Withdrawal by Subject|1|||
16875771|NCT01430455|37853439|FG000|Overall Study|Switched to follow-up phase|1|||
16875772|NCT01429441|37853467|FG000|Overall Study|Adverse Event|5|||
16875773|NCT01429441|37853468|FG001|Overall Study|Adverse Event|1|||
16875774|NCT01429441|37853467|FG000|Overall Study|Death|0|||
16875775|NCT01429441|37853468|FG001|Overall Study|Death|2|||
16875776|NCT01429441|37853467|FG000|Overall Study|Lost to Follow-up|5|||
16875777|NCT01429441|37853468|FG001|Overall Study|Lost to Follow-up|2|||
16875778|NCT01429441|37853467|FG000|Overall Study|Physician Decision|1|||
16875779|NCT01429441|37853468|FG001|Overall Study|Physician Decision|0|||
16875780|NCT01429441|37853467|FG000|Overall Study|Withdrawal by Subject|27|||
16875781|NCT01429441|37853468|FG001|Overall Study|Withdrawal by Subject|18|||
16875782|NCT01429285|37853503|FG000|Overall Study|Protocol Violation|9|||
16875783|NCT01429285|37853504|FG001|Overall Study|Protocol Violation|4|||
16875784|NCT01429285|37853503|FG000|Overall Study|Missing Data|5|||
16875785|NCT01429285|37853504|FG001|Overall Study|Missing Data|3|||
16875786|NCT01429285|37853503|FG000|Overall Study|Erroneously Enrolled Twice|8|||
16875787|NCT01429285|37853504|FG001|Overall Study|Erroneously Enrolled Twice|2|||
16875788|NCT01429051|37853581|FG000|Titration Phase|Death|1|||
16875789|NCT01429051|37853581|FG000|Titration Phase|Withdrawal by Subject|7|||
16875790|NCT01429051|37853581|FG000|Titration Phase|Physician Decision|1|||
16875791|NCT01429051|37853581|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
16875792|NCT01429051|37853581|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
16875793|NCT01429051|37853581|FG000|Efficacy Phase|Adverse Event|1|||
16875794|NCT01429051|37853581|FG000|Efficacy Phase|Death|1|||
16875795|NCT01429051|37853581|FG000|Tolerability Phase|Death|5|||
16875796|NCT01429051|37853581|FG000|Tolerability Phase|Adverse Event|2|||
16875797|NCT01429051|37853581|FG000|Tolerability Phase|Withdrawal by Subject|5|||
16875798|NCT01429051|37853581|FG000|Tolerability Phase|Physician Decision|1|||
16875799|NCT01429051|37853581|FG000|Tolerability Phase|Other|2|||
16875800|NCT01428661|37853614|FG000|Double-Masked Phase|Protocol Violation|9|||
16875801|NCT01428661|37853615|FG001|Double-Masked Phase|Protocol Violation|4|||
16875802|NCT01428661|37853616|FG002|Double-Masked Phase|Protocol Violation|0|||
16875803|NCT01428661|37853614|FG000|Double-Masked Phase|Adverse Event|13|||
16875804|NCT01428661|37853615|FG001|Double-Masked Phase|Adverse Event|4|||
16875805|NCT01428661|37853616|FG002|Double-Masked Phase|Adverse Event|0|||
16875806|NCT01428661|37853614|FG000|Double-Masked Phase|Lost to Follow-up|14|||
16875807|NCT01428661|37853615|FG001|Double-Masked Phase|Lost to Follow-up|14|||
16875808|NCT01428661|37853616|FG002|Double-Masked Phase|Lost to Follow-up|0|||
16875809|NCT01428661|37853614|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
16875810|NCT01428661|37853615|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
16875811|NCT01428661|37853616|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
16875812|NCT01428661|37853614|FG000|Double-Masked Phase|Lack of Efficacy|2|||
16875813|NCT01428661|37853615|FG001|Double-Masked Phase|Lack of Efficacy|1|||
16875814|NCT01428661|37853616|FG002|Double-Masked Phase|Lack of Efficacy|0|||
16875815|NCT01428661|37853614|FG000|Double-Masked Phase|*Various|1|||
16875816|NCT01428661|37853615|FG001|Double-Masked Phase|*Various|6|||
16875817|NCT01428661|37853616|FG002|Double-Masked Phase|*Various|0|||
16875818|NCT01428661|37853614|FG000|Open Label Extension|Protocol Violation|0|||
16875819|NCT01428661|37853615|FG001|Open Label Extension|Protocol Violation|0|||
16875820|NCT01428661|37853616|FG002|Open Label Extension|Protocol Violation|9|||
16875821|NCT01428661|37853614|FG000|Open Label Extension|Adverse Event|0|||
16875822|NCT01428661|37853615|FG001|Open Label Extension|Adverse Event|0|||
16875823|NCT01428661|37853616|FG002|Open Label Extension|Adverse Event|15|||
16875824|NCT01428661|37853614|FG000|Open Label Extension|Lost to Follow-up|0|||
16875825|NCT01428661|37853615|FG001|Open Label Extension|Lost to Follow-up|0|||
16875826|NCT01428661|37853616|FG002|Open Label Extension|Lost to Follow-up|38|||
16875827|NCT01428661|37853614|FG000|Open Label Extension|Withdrawal by Subject|0|||
16875828|NCT01428661|37853615|FG001|Open Label Extension|Withdrawal by Subject|0|||
17191474|NCT02418754|38344243|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
17191475|NCT02418754|38344239|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
17191476|NCT02418754|38344240|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
17191477|NCT02418754|38344241|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
17191478|NCT02418754|38344242|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
17191479|NCT02418754|38344243|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
17191480|NCT02418754|38344239|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
17191481|NCT02418754|38344240|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
17191482|NCT02418754|38344241|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
17191483|NCT02418754|38344242|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
17191484|NCT02418754|38344243|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
17191485|NCT02418754|38344239|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
17191486|NCT02418754|38344240|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
17191487|NCT02418754|38344241|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
17191488|NCT02418754|38344242|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
17191489|NCT02418754|38344243|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
17191490|NCT02418754|38344239|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
17191491|NCT02418754|38344240|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
17191492|NCT02418754|38344241|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
17191493|NCT02418754|38344242|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
17191494|NCT02418754|38344243|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
17191495|NCT02418754|38344239|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
17191496|NCT02418754|38344240|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
17191497|NCT02418754|38344241|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
17191498|NCT02418754|38344242|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
17191499|NCT02418754|38344243|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
17191500|NCT02418754|38344239|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
17191501|NCT02418754|38344240|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
17191502|NCT02418754|38344241|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
17191503|NCT02418754|38344242|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
17191504|NCT02418754|38344243|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
17191505|NCT02418754|38344239|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
17191506|NCT02418754|38344240|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
17191507|NCT02418754|38344241|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
17191508|NCT02418754|38344242|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
17191509|NCT02418754|38344243|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
17191510|NCT02447458|38344259|FG000|Overall Study|Other|0|||
17191511|NCT02447458|38344260|FG001|Overall Study|Other|0|||
17191512|NCT02447458|38344261|FG002|Overall Study|Other|1|||
17191513|NCT02447458|38344262|FG003|Overall Study|Other|0|||
17191514|NCT02447458|38344263|FG004|Overall Study|Other|0|||
17191515|NCT02447458|38344264|FG005|Overall Study|Other|0|||
17191516|NCT02862457|38344290|FG000|Overall Study|Death|1|||
17191517|NCT02862457|38344291|FG001|Overall Study|Death|3|||
17191518|NCT02862457|38344292|FG002|Overall Study|Death|2|||
17191519|NCT02862457|38344293|FG003|Overall Study|Death|3|||
17191520|NCT02862457|38344294|FG004|Overall Study|Death|0|||
17191521|NCT02862457|38344295|FG005|Overall Study|Death|2|||
17191522|NCT02862457|38344296|FG006|Overall Study|Death|1|||
17191523|NCT02862457|38344290|FG000|Overall Study|Lost to Follow-up|1|||
17191524|NCT02862457|38344291|FG001|Overall Study|Lost to Follow-up|0|||
17191525|NCT02862457|38344292|FG002|Overall Study|Lost to Follow-up|0|||
17191526|NCT02862457|38344293|FG003|Overall Study|Lost to Follow-up|1|||
17191527|NCT02862457|38344294|FG004|Overall Study|Lost to Follow-up|0|||
17191528|NCT02862457|38344295|FG005|Overall Study|Lost to Follow-up|0|||
16875829|NCT01428661|37853616|FG002|Open Label Extension|Withdrawal by Subject|49|||
16875830|NCT01428661|37853614|FG000|Open Label Extension|Lack of Efficacy|0|||
16875831|NCT01428661|37853615|FG001|Open Label Extension|Lack of Efficacy|0|||
16875832|NCT01428661|37853616|FG002|Open Label Extension|Lack of Efficacy|24|||
16875833|NCT01428661|37853614|FG000|Open Label Extension|**Various|0|||
16875834|NCT01428661|37853615|FG001|Open Label Extension|**Various|0|||
16875835|NCT01428661|37853616|FG002|Open Label Extension|**Various|185|||
16875836|NCT01428583|37853624|FG000|Overall Study|Adverse Event|75|||
16875837|NCT01428583|37853624|FG000|Overall Study|Withdrawal by Subject|51|||
16875838|NCT01428583|37853624|FG000|Overall Study|Lack of Efficacy|37|||
16875839|NCT01428583|37853624|FG000|Overall Study|Lost to Follow-up|17|||
16875840|NCT01428583|37853624|FG000|Overall Study|Death|1|||
16875841|NCT01428583|37853624|FG000|Overall Study|Pregnancy|1|||
16875842|NCT01428583|37853624|FG000|Overall Study|Protocol Violation|1|||
16875843|NCT01428583|37853624|FG000|Overall Study|Physician Decision|12|||
16875844|NCT01428583|37853624|FG000|Overall Study|Non-compliant|25|||
16875845|NCT01428583|37853624|FG000|Overall Study|Confirmed positive urine drug test|8|||
16875846|NCT01428583|37853624|FG000|Overall Study|Sponsor's request|3|||
16875847|NCT01428583|37853624|FG000|Overall Study|Other|6|||
16875848|NCT01428193|37853641|FG000|Overall Study|Physician Decision|1|||
16875849|NCT01428193|37853641|FG000|Overall Study|Elevated screening liver enzymes|1|||
16875850|NCT01428115|37853645|FG000|Overall Study|Lack of Efficacy|3|||
16875851|NCT01428115|37853645|FG000|Overall Study|Lost to Follow-up|10|||
16875852|NCT01428115|37853645|FG000|Overall Study|Pregnancy|1|||
16875853|NCT01428115|37853645|FG000|Overall Study|Protocol Violation|3|||
16875854|NCT01428115|37853645|FG000|Overall Study|Withdrawal by Subject|4|||
16875855|NCT01427803|37853652|FG000|Overall Study|Lost to Follow-up|32|||
16875856|NCT01427803|37853653|FG001|Overall Study|Lost to Follow-up|26|||
16875857|NCT01427803|37853652|FG000|Overall Study|Withdrawal by Subject|20|||
16875858|NCT01427803|37853653|FG001|Overall Study|Withdrawal by Subject|0|||
16875859|NCT01427803|37853652|FG000|Overall Study|Unable to complete full treatment period|6|||
16875860|NCT01427803|37853653|FG001|Overall Study|Unable to complete full treatment period|0|||
16875861|NCT01427803|37853652|FG000|Overall Study|Protocol Violation|1|||
16875862|NCT01427803|37853653|FG001|Overall Study|Protocol Violation|0|||
16875863|NCT01427803|37853652|FG000|Overall Study|Physician Decision|3|||
16875864|NCT01427803|37853653|FG001|Overall Study|Physician Decision|0|||
16875865|NCT01427803|37853652|FG000|Overall Study|did not take product|1|||
16875866|NCT01427803|37853653|FG001|Overall Study|did not take product|0|||
16875867|NCT01408537|37853657|FG000|Overall Study|Withdrawal by Subject|2|||
16875868|NCT01408537|37853657|FG000|Overall Study|Protocol Violation|3|||
16875869|NCT01408537|37853657|FG000|Overall Study|Lost to Follow-up|3|||
16875870|NCT01408459|37853690|FG000|Overall Study|Withdrawal by Subject|1|||
16875871|NCT01408459|37853691|FG001|Overall Study|Withdrawal by Subject|1|||
16875872|NCT01408303|37853710|FG000|Overall Study|Adverse Event|3|||
16875873|NCT01408303|37853711|FG001|Overall Study|Adverse Event|7|||
16875874|NCT01408303|37853712|FG002|Overall Study|Adverse Event|2|||
16875875|NCT01408303|37853710|FG000|Overall Study|Lost to Follow-up|0|||
16875876|NCT01408303|37853711|FG001|Overall Study|Lost to Follow-up|1|||
16875877|NCT01408303|37853712|FG002|Overall Study|Lost to Follow-up|2|||
16875878|NCT01408303|37853710|FG000|Overall Study|Withdrawal by Subject|2|||
16875879|NCT01408303|37853711|FG001|Overall Study|Withdrawal by Subject|3|||
16875880|NCT01408303|37853712|FG002|Overall Study|Withdrawal by Subject|1|||
16875881|NCT01408303|37853710|FG000|Overall Study|Protocol Violation|0|||
16875882|NCT01408303|37853711|FG001|Overall Study|Protocol Violation|1|||
16875883|NCT01408303|37853712|FG002|Overall Study|Protocol Violation|0|||
16875884|NCT01408303|37853710|FG000|Overall Study|Noncompliance|1|||
16875885|NCT01408303|37853711|FG001|Overall Study|Noncompliance|0|||
16875886|NCT01408303|37853712|FG002|Overall Study|Noncompliance|1|||
16875887|NCT01408147|37853733|FG000|Overall Study|Withdrawal by Subject|0|||
16875888|NCT01408147|37853734|FG001|Overall Study|Withdrawal by Subject|1|||
16875889|NCT01407367|37853742|FG000|Overall Study|Death|24|||
16875890|NCT01407367|37853743|FG001|Overall Study|Death|32|||
16875891|NCT01407367|37853742|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
16875892|NCT01407367|37853743|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
16875893|NCT01407367|37853742|FG000|Overall Study|Withdrawal by Subject|4|||
16875894|NCT01407367|37853743|FG001|Overall Study|Withdrawal by Subject|15|||
16875895|NCT01407367|37853742|FG000|Overall Study|Lost to Follow-up|0|||
16875896|NCT01407367|37853743|FG001|Overall Study|Lost to Follow-up|2|||
16875897|NCT01405027|37853779|FG000|Overall Study|Withdrawn consent|3|||
16875898|NCT01405027|37853780|FG001|Overall Study|Withdrawn consent|0|||
16875899|NCT01405027|37853779|FG000|Overall Study|Lost to Follow-up|16|||
16875900|NCT01405027|37853780|FG001|Overall Study|Lost to Follow-up|24|||
16875901|NCT01405027|37853779|FG000|Overall Study|Investigator judgement|0|||
16875902|NCT01405027|37853780|FG001|Overall Study|Investigator judgement|2|||
16875903|NCT01405027|37853779|FG000|Overall Study|Death|1|||
16875904|NCT01405027|37853780|FG001|Overall Study|Death|0|||
16875905|NCT01405027|37853779|FG000|Overall Study|Other or Unknown|12|||
16875906|NCT01405027|37853780|FG001|Overall Study|Other or Unknown|25|||
16875907|NCT01412801|37853801|FG000|Overall Study|Death|0|||
16875908|NCT01412801|37853802|FG001|Overall Study|Death|1|||
16875909|NCT01412801|37853803|FG002|Overall Study|Death|0|||
16875910|NCT01412801|37853804|FG003|Overall Study|Death|4|||
16875911|NCT01412801|37853805|FG004|Overall Study|Death|2|||
16875912|NCT01412801|37853806|FG005|Overall Study|Death|2|||
16875913|NCT01412801|37853801|FG000|Overall Study|Lost to Follow-up|1|||
16875914|NCT01412801|37853802|FG001|Overall Study|Lost to Follow-up|2|||
16875915|NCT01412801|37853803|FG002|Overall Study|Lost to Follow-up|4|||
16875916|NCT01412801|37853804|FG003|Overall Study|Lost to Follow-up|0|||
16875917|NCT01412801|37853805|FG004|Overall Study|Lost to Follow-up|1|||
16875918|NCT01412801|37853806|FG005|Overall Study|Lost to Follow-up|1|||
16875919|NCT01412801|37853801|FG000|Overall Study|Withdrawal by Subject|3|||
16875920|NCT01412801|37853802|FG001|Overall Study|Withdrawal by Subject|2|||
16875921|NCT01412801|37853803|FG002|Overall Study|Withdrawal by Subject|1|||
16875922|NCT01412801|37853804|FG003|Overall Study|Withdrawal by Subject|0|||
16875923|NCT01412801|37853805|FG004|Overall Study|Withdrawal by Subject|0|||
16875924|NCT01412801|37853806|FG005|Overall Study|Withdrawal by Subject|0|||
16875925|NCT01412801|37853801|FG000|Overall Study|Relocated to another area|0|||
16875926|NCT01412801|37853802|FG001|Overall Study|Relocated to another area|0|||
16875927|NCT01412801|37853803|FG002|Overall Study|Relocated to another area|2|||
16875928|NCT01412801|37853804|FG003|Overall Study|Relocated to another area|0|||
16875929|NCT01412801|37853805|FG004|Overall Study|Relocated to another area|0|||
16875930|NCT01412801|37853806|FG005|Overall Study|Relocated to another area|0|||
16875931|NCT01525628|37853854|FG000|Overall Study|Adverse Event|1|||
16875932|NCT01525628|37853855|FG001|Overall Study|Adverse Event|1|||
16875933|NCT01525628|37853856|FG002|Overall Study|Adverse Event|2|||
16875934|NCT01525628|37853857|FG003|Overall Study|Adverse Event|0|||
16875935|NCT01525628|37853858|FG004|Overall Study|Adverse Event|1|||
16875936|NCT01525628|37853854|FG000|Overall Study|Lack of Efficacy|0|||
16875937|NCT01525628|37853855|FG001|Overall Study|Lack of Efficacy|2|||
16875938|NCT01525628|37853856|FG002|Overall Study|Lack of Efficacy|2|||
16875939|NCT01525628|37853857|FG003|Overall Study|Lack of Efficacy|1|||
16875940|NCT01525628|37853858|FG004|Overall Study|Lack of Efficacy|2|||
16875941|NCT01525628|37853854|FG000|Overall Study|Protocol Violation|0|||
16875942|NCT01525628|37853855|FG001|Overall Study|Protocol Violation|0|||
16875943|NCT01525628|37853856|FG002|Overall Study|Protocol Violation|1|||
16875944|NCT01525628|37853857|FG003|Overall Study|Protocol Violation|0|||
16875945|NCT01525628|37853858|FG004|Overall Study|Protocol Violation|0|||
16875946|NCT01525628|37853854|FG000|Overall Study|Lost to Follow-up|1|||
16875947|NCT01525628|37853855|FG001|Overall Study|Lost to Follow-up|1|||
16875948|NCT01525628|37853856|FG002|Overall Study|Lost to Follow-up|0|||
16875949|NCT01525628|37853857|FG003|Overall Study|Lost to Follow-up|0|||
16875950|NCT01525628|37853858|FG004|Overall Study|Lost to Follow-up|0|||
16875951|NCT01525628|37853854|FG000|Overall Study|Withdrawal by Subject|0|||
16875952|NCT01525628|37853855|FG001|Overall Study|Withdrawal by Subject|1|||
16875953|NCT01525628|37853856|FG002|Overall Study|Withdrawal by Subject|0|||
16875954|NCT01525628|37853857|FG003|Overall Study|Withdrawal by Subject|0|||
16875955|NCT01525628|37853858|FG004|Overall Study|Withdrawal by Subject|0|||
16875956|NCT01525628|37853854|FG000|Overall Study|Other reason not defined above|0|||
16875957|NCT01525628|37853855|FG001|Overall Study|Other reason not defined above|0|||
16875958|NCT01525628|37853856|FG002|Overall Study|Other reason not defined above|0|||
16875959|NCT01525628|37853857|FG003|Overall Study|Other reason not defined above|3|||
16875960|NCT01525628|37853858|FG004|Overall Study|Other reason not defined above|0|||
16875961|NCT01412021|37853876|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
16875962|NCT01412021|37853876|FG000|Overall Study|Treatment Prior to Approval|3|||
16875963|NCT01412021|37853876|FG000|Overall Study|Transferred to Other Hospital|9|||
16875964|NCT01426789|37853882|FG000|Part 1|Protocol deviation|0|||
16875965|NCT01426789|37853883|FG001|Part 1|Protocol deviation|1|||
16875966|NCT01426789|37853884|FG002|Part 1|Protocol deviation|0|||
16875967|NCT01426789|37853885|FG003|Part 1|Protocol deviation|0|||
16875968|NCT01426789|37853886|FG004|Part 1|Protocol deviation|0|||
16875969|NCT01426789|37853887|FG005|Part 1|Protocol deviation|0|||
16875970|NCT01426789|37853882|FG000|Part 1|Lost to Follow-up|1|||
16875971|NCT01426789|37853883|FG001|Part 1|Lost to Follow-up|2|||
16875972|NCT01426789|37853884|FG002|Part 1|Lost to Follow-up|0|||
16875973|NCT01426789|37853885|FG003|Part 1|Lost to Follow-up|0|||
16875974|NCT01426789|37853886|FG004|Part 1|Lost to Follow-up|0|||
16875975|NCT01426789|37853887|FG005|Part 1|Lost to Follow-up|0|||
16875976|NCT01426789|37853882|FG000|Part 1|Lack of Efficacy|2|||
16875977|NCT01426789|37853883|FG001|Part 1|Lack of Efficacy|1|||
16875978|NCT01426789|37853884|FG002|Part 1|Lack of Efficacy|0|||
16875979|NCT01426789|37853885|FG003|Part 1|Lack of Efficacy|0|||
16875980|NCT01426789|37853886|FG004|Part 1|Lack of Efficacy|0|||
16875981|NCT01426789|37853887|FG005|Part 1|Lack of Efficacy|0|||
16875982|NCT01426789|37853882|FG000|Part 1|Adverse Event|3|||
16875983|NCT01426789|37853883|FG001|Part 1|Adverse Event|0|||
16875984|NCT01426789|37853884|FG002|Part 1|Adverse Event|0|||
16875985|NCT01426789|37853885|FG003|Part 1|Adverse Event|0|||
16875986|NCT01426789|37853886|FG004|Part 1|Adverse Event|0|||
16875987|NCT01426789|37853887|FG005|Part 1|Adverse Event|0|||
16875988|NCT01426789|37853882|FG000|Part 2|Protocol deviation|0|||
16875989|NCT01426789|37853883|FG001|Part 2|Protocol deviation|0|||
16875990|NCT01426789|37853884|FG002|Part 2|Protocol deviation|1|||
16875991|NCT01426789|37853885|FG003|Part 2|Protocol deviation|0|||
16875992|NCT01426789|37853886|FG004|Part 2|Protocol deviation|0|||
16875993|NCT01426789|37853887|FG005|Part 2|Protocol deviation|0|||
16875994|NCT01426789|37853882|FG000|Part 2|Death|0|||
16875995|NCT01426789|37853883|FG001|Part 2|Death|0|||
16875996|NCT01426789|37853884|FG002|Part 2|Death|1|||
16875997|NCT01426789|37853885|FG003|Part 2|Death|0|||
16875998|NCT01426789|37853886|FG004|Part 2|Death|1|||
16875999|NCT01426789|37853887|FG005|Part 2|Death|0|||
16876000|NCT01426789|37853882|FG000|Part 2|Administrative problems|0|||
16876001|NCT01426789|37853883|FG001|Part 2|Administrative problems|0|||
16876002|NCT01426789|37853884|FG002|Part 2|Administrative problems|2|||
16876003|NCT01426789|37853885|FG003|Part 2|Administrative problems|0|||
16876004|NCT01426789|37853886|FG004|Part 2|Administrative problems|1|||
16876005|NCT01426789|37853887|FG005|Part 2|Administrative problems|0|||
16876006|NCT01426789|37853882|FG000|Part 2|Lost to Follow-up|0|||
16876007|NCT01426789|37853883|FG001|Part 2|Lost to Follow-up|0|||
16876008|NCT01426789|37853884|FG002|Part 2|Lost to Follow-up|4|||
16876009|NCT01426789|37853885|FG003|Part 2|Lost to Follow-up|0|||
16876010|NCT01426789|37853886|FG004|Part 2|Lost to Follow-up|1|||
16876011|NCT01426789|37853887|FG005|Part 2|Lost to Follow-up|0|||
16876012|NCT01426789|37853882|FG000|Part 2|Withdrawal by Subject|0|||
16876013|NCT01426789|37853883|FG001|Part 2|Withdrawal by Subject|0|||
16876014|NCT01426789|37853884|FG002|Part 2|Withdrawal by Subject|0|||
16876015|NCT01426789|37853885|FG003|Part 2|Withdrawal by Subject|1|||
16876016|NCT01426789|37853886|FG004|Part 2|Withdrawal by Subject|2|||
16876017|NCT01426789|37853887|FG005|Part 2|Withdrawal by Subject|0|||
16876018|NCT01426789|37853882|FG000|Part 2|Lack of Efficacy|0|||
16876019|NCT01426789|37853883|FG001|Part 2|Lack of Efficacy|0|||
16876020|NCT01426789|37853884|FG002|Part 2|Lack of Efficacy|5|||
16876021|NCT01426789|37853885|FG003|Part 2|Lack of Efficacy|0|||
16876022|NCT01426789|37853886|FG004|Part 2|Lack of Efficacy|2|||
16876023|NCT01426789|37853887|FG005|Part 2|Lack of Efficacy|0|||
16876024|NCT01426789|37853882|FG000|Part 2|Adverse Event|0|||
16876025|NCT01426789|37853883|FG001|Part 2|Adverse Event|0|||
16876026|NCT01426789|37853884|FG002|Part 2|Adverse Event|2|||
16876027|NCT01426789|37853885|FG003|Part 2|Adverse Event|0|||
16876028|NCT01426789|37853886|FG004|Part 2|Adverse Event|1|||
16876029|NCT01426789|37853887|FG005|Part 2|Adverse Event|0|||
16876030|NCT01426009|37853908|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
16876031|NCT01426009|37853908|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
16876032|NCT01426009|37853908|FG000|Washout 1|Withdrawal by Subject|1|||
16876033|NCT01426009|37853908|FG000|Washout 1|Personal Reasons|1|||
16876034|NCT01426009|37853908|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
16876035|NCT01426009|37853908|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
16876036|NCT01426009|37853908|FG000|Washout 2|electrive surgery|1|||
16876037|NCT01426009|37853908|FG000|Washout 3|personal reasons|1|||
17095091|NCT00262028|38234359|FG001|Overall Study|Administrative Reason|14|||
17095092|NCT00262028|38234360|FG002|Overall Study|Administrative Reason|9|||
17095093|NCT00262028|38234361|FG003|Overall Study|Administrative Reason|12|||
17095094|NCT00262028|38234362|FG004|Overall Study|Administrative Reason|6|||
17095095|NCT00262028|38234363|FG005|Overall Study|Administrative Reason|7|||
17095096|NCT00262028|38234364|FG006|Overall Study|Administrative Reason|4|||
17095097|NCT00262028|38234365|FG007|Overall Study|Administrative Reason|6|||
17095098|NCT00262028|38234366|FG008|Overall Study|Administrative Reason|10|||
17095099|NCT00262028|38234358|FG000|Overall Study|Protocol Violation|0|||
17095100|NCT00262028|38234359|FG001|Overall Study|Protocol Violation|0|||
17095101|NCT00262028|38234360|FG002|Overall Study|Protocol Violation|0|||
17095102|NCT00262028|38234361|FG003|Overall Study|Protocol Violation|1|||
17095103|NCT00262028|38234362|FG004|Overall Study|Protocol Violation|0|||
17095104|NCT00262028|38234363|FG005|Overall Study|Protocol Violation|0|||
17095105|NCT00262028|38234364|FG006|Overall Study|Protocol Violation|0|||
17095106|NCT00262028|38234365|FG007|Overall Study|Protocol Violation|0|||
17095107|NCT00262028|38234366|FG008|Overall Study|Protocol Violation|0|||
17095108|NCT00262028|38234358|FG000|Overall Study|Unable to classify|0|||
17095109|NCT00262028|38234359|FG001|Overall Study|Unable to classify|3|||
17095110|NCT00262028|38234360|FG002|Overall Study|Unable to classify|0|||
17095111|NCT00262028|38234361|FG003|Overall Study|Unable to classify|0|||
17095112|NCT00262028|38234362|FG004|Overall Study|Unable to classify|0|||
17095113|NCT00262028|38234363|FG005|Overall Study|Unable to classify|0|||
17095114|NCT00262028|38234364|FG006|Overall Study|Unable to classify|0|||
16876038|NCT01426009|37853908|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
16876039|NCT01426009|37853908|FG000|Washout 4|Lost to Follow-up|1|||
16876040|NCT01411319|37853937|FG000|Overall Study|Lost to Follow-up|1|||
16876041|NCT01543958|37853941|FG000|Overall Study|Loss to follow-up|3|||
17095115|NCT00262028|38234365|FG007|Overall Study|Unable to classify|0|||
17095116|NCT00262028|38234366|FG008|Overall Study|Unable to classify|1|||
17095117|NCT00183248|38234410|FG000|Overall Study|Lost to Follow-up|0|||
17095118|NCT00183248|38234411|FG001|Overall Study|Lost to Follow-up|1|||
17095119|NCT00183248|38234410|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
17095120|NCT00183248|38234411|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
17095121|NCT00183170|38234419|FG000|First Intervention|Did not complete study|1|||
17095122|NCT00183170|38234420|FG001|First Intervention|Did not complete study|0|||
17095123|NCT00183170|38234419|FG000|First Intervention|Did not meet targeted BrAC|1|||
17095124|NCT00183170|38234420|FG001|First Intervention|Did not meet targeted BrAC|0|||
17095125|NCT00183170|38234419|FG000|Washout 1 Week|Did not complete study|6|||
17095126|NCT00183170|38234420|FG001|Washout 1 Week|Did not complete study|8|||
17095127|NCT00183170|38234419|FG000|Second Intervention|Did not complete study|1|||
17095128|NCT00183170|38234420|FG001|Second Intervention|Did not complete study|0|||
17095129|NCT00183170|38234419|FG000|Second Intervention|Did not meet targeted BrAC|0|||
17095130|NCT00183170|38234420|FG001|Second Intervention|Did not meet targeted BrAC|2|||
17095131|NCT00230282|38234426|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
17095132|NCT00230282|38234426|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
17095133|NCT00230282|38234426|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
17095134|NCT00230282|38234426|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
17095135|NCT00261950|38234430|FG000|Overall Study|Lost to Follow-up|2|||
17095136|NCT00261950|38234430|FG000|Overall Study|Death|6|||
17095137|NCT00261950|38234430|FG000|Overall Study|Withdrawal by Subject|5|||
17095138|NCT00261950|38234430|FG000|Overall Study|Other|1|||
17095139|NCT00261950|38234430|FG000|Overall Study|Physician Decision|1|||
17095140|NCT00261950|38234430|FG000|Overall Study|Protocol specified Criteria|11|||
17095141|NCT00230048|38234436|FG000|Overall Study|Lost to Follow-up|13|||
17095142|NCT00230048|38234437|FG001|Overall Study|Lost to Follow-up|18|||
17095143|NCT00229658|38234447|FG000|Overall Study|Administrative|2|||
17095144|NCT00229658|38234448|FG001|Overall Study|Administrative|1|||
17095145|NCT00229658|38234447|FG000|Overall Study|Investigator decision|13|||
17095146|NCT00229658|38234448|FG001|Overall Study|Investigator decision|10|||
17095147|NCT00229658|38234447|FG000|Overall Study|Other|80|||
17095148|NCT00229658|38234448|FG001|Overall Study|Other|60|||
17095149|NCT00229658|38234447|FG000|Overall Study|Lost to Follow-up|82|||
17095150|NCT00229658|38234448|FG001|Overall Study|Lost to Follow-up|55|||
17095151|NCT00229658|38234447|FG000|Overall Study|Serious Adverse Event|2|||
17095152|NCT00229658|38234448|FG001|Overall Study|Serious Adverse Event|2|||
17095153|NCT00229658|38234447|FG000|Overall Study|Withdrawal of consent|46|||
17095154|NCT00229658|38234448|FG001|Overall Study|Withdrawal of consent|39|||
17095155|NCT00182078|38234456|FG000|Overall Study|Withdrawal by Subject|1|||
17095156|NCT00182078|38234457|FG001|Overall Study|Withdrawal by Subject|0|||
17095157|NCT00181844|38234463|FG000|Signed Consent|Withdrawal by Subject|5|||
17095158|NCT00181844|38234463|FG000|Signed Consent|Did not meet entrance criteria|7|||
17095159|NCT00181844|38234463|FG000|Exposed to Study Medication|Adverse Event|10|||
17095160|NCT00181844|38234463|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
17095161|NCT00181844|38234463|FG000|Exposed to Study Medication|Non-compliance|2|||
17095162|NCT00181844|38234463|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
17095163|NCT00181844|38234463|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
17095164|NCT00181766|38234467|FG000|Overall Study|Lost to Follow-up|6|||
17095165|NCT00181766|38234467|FG000|Overall Study|Adverse Event|4|||
17095166|NCT00181766|38234467|FG000|Overall Study|non-compliance|2|||
17095167|NCT00180674|38234471|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
17095168|NCT00180674|38234471|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
17095169|NCT00076024|38234482|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
17095170|NCT00076024|38234483|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
17095171|NCT00076024|38234484|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
17095172|NCT00076024|38234485|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
17095173|NCT00076024|38234482|FG000|Phase 1, Lead-in|Adverse Event|1|||
17095174|NCT00076024|38234483|FG001|Phase 1, Lead-in|Adverse Event|0|||
17095175|NCT00076024|38234484|FG002|Phase 1, Lead-in|Adverse Event|0|||
17095176|NCT00076024|38234485|FG003|Phase 1, Lead-in|Adverse Event|0|||
17095177|NCT00076024|38234482|FG000|Phase 1, Lead-in|Clinical progression|1|||
17001624|NCT00977561|38145652|FG001|Overall Study|Study terminated|2|||
17001625|NCT00977561|38145651|FG000|Overall Study|Other|2|||
17001626|NCT00977561|38145652|FG001|Overall Study|Other|0|||
17001627|NCT00594165|38145660|FG000|Overall Study|Major protocol violation|1|||
17095178|NCT00076024|38234483|FG001|Phase 1, Lead-in|Clinical progression|0|||
17001628|NCT00594165|38145660|FG000|Overall Study|Lack of Efficacy|12|||
17001629|NCT00594165|38145660|FG000|Overall Study|Adverse Event|52|||
17001630|NCT00594165|38145660|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
17001631|NCT00594165|38145660|FG000|Overall Study|Subject withdrew consent|27|||
17001632|NCT00594165|38145660|FG000|Overall Study|Study ended per sponsor|102|||
17001633|NCT00594165|38145660|FG000|Overall Study|Lost to Follow-up|4|||
17001634|NCT00594165|38145660|FG000|Overall Study|Other: PI discretion|5|||
17001635|NCT00594165|38145660|FG000|Overall Study|Other: Subject moving|3|||
17001636|NCT00594165|38145660|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
17001637|NCT00594165|38145660|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
17001638|NCT00594165|38145660|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
17095179|NCT00076024|38234484|FG002|Phase 1, Lead-in|Clinical progression|0|||
17095180|NCT00076024|38234485|FG003|Phase 1, Lead-in|Clinical progression|0|||
16876042|NCT01543958|37853941|FG000|Overall Study|ART initiation|1|||
16876043|NCT01411085|37853945|FG000|Overall Study|Physician Decision|1|||
16876044|NCT01411085|37853945|FG000|Overall Study|Protocol Violation|1|||
16876045|NCT01411085|37853945|FG000|Overall Study|Adverse Event|1|||
16876046|NCT01543490|37853951|FG000|Overall Study|Adverse Event|4|||
16876047|NCT01543490|37853952|FG001|Overall Study|Adverse Event|0|||
16876048|NCT01543490|37853951|FG000|Overall Study|Physician Decision|1|||
16876049|NCT01543490|37853952|FG001|Overall Study|Physician Decision|0|||
16876050|NCT01543490|37853951|FG000|Overall Study|Lack of Efficacy|3|||
16876051|NCT01543490|37853952|FG001|Overall Study|Lack of Efficacy|3|||
16876052|NCT01543490|37853951|FG000|Overall Study|Lost to Follow-up|5|||
16876053|NCT01543490|37853952|FG001|Overall Study|Lost to Follow-up|0|||
16876054|NCT01543490|37853951|FG000|Overall Study|Withdrawal by Subject|2|||
16876055|NCT01543490|37853952|FG001|Overall Study|Withdrawal by Subject|0|||
16876056|NCT01543490|37853951|FG000|Overall Study|Other-Various Administrative Reasons|1|||
16876057|NCT01543490|37853952|FG001|Overall Study|Other-Various Administrative Reasons|2|||
16876058|NCT01404949|37853958|FG000|Overall Study|Not Treated|1|||
16876059|NCT01431521|37853966|FG000|Overall Study|Withdrawal by Subject|0|||
16876060|NCT01431521|37853967|FG001|Overall Study|Withdrawal by Subject|0|||
16876061|NCT01431521|37853968|FG002|Overall Study|Withdrawal by Subject|1|||
16876062|NCT01431521|37853969|FG003|Overall Study|Withdrawal by Subject|0|||
16876063|NCT01404325|37854054|FG000|Overall Study|Lost to Follow-up|1|||
16876064|NCT01404325|37854055|FG001|Overall Study|Lost to Follow-up|0|||
16876065|NCT01404325|37854054|FG000|Overall Study|Death|2|||
16876066|NCT01404325|37854055|FG001|Overall Study|Death|0|||
16876067|NCT01404325|37854054|FG000|Overall Study|Graft loss/Retransplantation|1|||
16876068|NCT01404325|37854055|FG001|Overall Study|Graft loss/Retransplantation|0|||
16876069|NCT01404325|37854054|FG000|Overall Study|non-specified reason|0|||
16876070|NCT01404325|37854055|FG001|Overall Study|non-specified reason|2|||
16876071|NCT01425463|37854076|FG000|Overall Study|Adverse Event|5|||
16876072|NCT01425463|37854077|FG001|Overall Study|Adverse Event|7|||
16876073|NCT01425463|37854076|FG000|Overall Study|Lack of Efficacy|1|||
16876074|NCT01425463|37854077|FG001|Overall Study|Lack of Efficacy|1|||
16876075|NCT01425463|37854076|FG000|Overall Study|Protocol Violation|2|||
16876076|NCT01425463|37854077|FG001|Overall Study|Protocol Violation|2|||
16876077|NCT01425463|37854076|FG000|Overall Study|Lost to Follow-up|5|||
16876078|NCT01425463|37854077|FG001|Overall Study|Lost to Follow-up|2|||
16876079|NCT01425463|37854076|FG000|Overall Study|Withdrawal by Subject|7|||
16876080|NCT01425463|37854077|FG001|Overall Study|Withdrawal by Subject|5|||
16876081|NCT01425463|37854076|FG000|Overall Study|Unknown Reason|4|||
16876082|NCT01425463|37854077|FG001|Overall Study|Unknown Reason|7|||
16876083|NCT04655586|37854099|FG000|Overall Study|Physician Decision|1|||
16876084|NCT04655586|37854100|FG001|Overall Study|Physician Decision|3|||
16876085|NCT04655586|37854101|FG002|Overall Study|Physician Decision|4|||
16876086|NCT04655586|37854099|FG000|Overall Study|Withdrawal by Subject|1|||
16876087|NCT04655586|37854100|FG001|Overall Study|Withdrawal by Subject|3|||
16876088|NCT04655586|37854101|FG002|Overall Study|Withdrawal by Subject|1|||
16876089|NCT01388647|37854124|FG000|Overall Study|Adverse Event|1|||
16876090|NCT01388647|37854125|FG001|Overall Study|Adverse Event|2|||
16876091|NCT01402063|37854200|FG000|Overall Study|Withdrawal by Subject|3|||
16876092|NCT01402063|37854201|FG001|Overall Study|Withdrawal by Subject|3|||
16876093|NCT01796301|37854209|FG000|Overall Study|Withdrawal by Subject|15|||
16876094|NCT01796301|37854210|FG001|Overall Study|Withdrawal by Subject|15|||
16876095|NCT01796301|37854209|FG000|Overall Study|Lost to Follow-up|3|||
16876096|NCT01796301|37854210|FG001|Overall Study|Lost to Follow-up|3|||
16876097|NCT01796301|37854209|FG000|Overall Study|Death|0|||
16876098|NCT01796301|37854210|FG001|Overall Study|Death|1|||
16876099|NCT01796301|37854209|FG000|Overall Study|Decision by Sponsor|0|||
16876100|NCT01796301|37854210|FG001|Overall Study|Decision by Sponsor|1|||
16876101|NCT01388335|37854229|FG000|Period 1|Progressive Disease|1|||
16876102|NCT01388335|37854229|FG000|Period 2|Progressive Disease|2|||
16876103|NCT01388335|37854229|FG000|Period 2|Sponsor Decision|1|||
16876104|NCT01388335|37854229|FG000|Safety Extension|Progressive Disease|7|||
16876105|NCT01401361|37854285|FG000|Overall Study|Withdrawal by Subject|16|||
16876106|NCT01401361|37854285|FG000|Overall Study|Lack of Efficacy|6|||
16876107|NCT01401361|37854285|FG000|Overall Study|Physician Decision|1|||
16876108|NCT01401361|37854285|FG000|Overall Study|Lost to Follow-up|3|||
16876109|NCT01401361|37854285|FG000|Overall Study|Subject/family decision post procedure|2|||
16876110|NCT01401283|37854291|FG000|Overall Study|surgery cancelled|5|||
16876111|NCT01401283|37854292|FG001|Overall Study|surgery cancelled|8|||
16876112|NCT01401283|37854291|FG000|Overall Study|preoperative arrhythmia|5|||
16876113|NCT01401283|37854292|FG001|Overall Study|preoperative arrhythmia|0|||
16876114|NCT01401283|37854291|FG000|Overall Study|no central venous access|0|||
16876115|NCT01401283|37854292|FG001|Overall Study|no central venous access|1|||
16876116|NCT01401283|37854291|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
16876117|NCT01401283|37854292|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
16876118|NCT01422889|37854315|FG000|Overall Study|No Data Entered for Study Stent|9|||
16876119|NCT01400971|37854319|FG000|Overall Study|Death|82|||
16876120|NCT01400971|37854319|FG000|Overall Study|Lost to Follow-up|196|||
16876121|NCT01400971|37854319|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
16876122|NCT01400971|37854319|FG000|Overall Study|Physician Decision|57|||
16876123|NCT01400971|37854319|FG000|Overall Study|Withdrawal by Subject|158|||
16876124|NCT01400971|37854319|FG000|Overall Study|Other|422|||
16876125|NCT01387789|37854323|FG000|Overall Study|Adverse Event|5|||
16876126|NCT01387789|37854323|FG000|Overall Study|Lack of Efficacy|2|||
16876127|NCT01387789|37854323|FG000|Overall Study|Lost to Follow-up|1|||
16876128|NCT01400893|37854334|FG000|Overall Study|Death|27|||
16876129|NCT01400893|37854335|FG001|Overall Study|Death|21|||
16876130|NCT01400893|37854334|FG000|Overall Study|Lost to Follow-up|0|||
16876131|NCT01400893|37854335|FG001|Overall Study|Lost to Follow-up|6|||
16876132|NCT01400815|37854375|FG000|Overall Study|Adverse Event|3|||
16876133|NCT01400815|37854376|FG001|Overall Study|Adverse Event|0|||
16876134|NCT01400815|37854375|FG000|Overall Study|Death|0|||
16876135|NCT01400815|37854376|FG001|Overall Study|Death|1|||
16876136|NCT01400815|37854375|FG000|Overall Study|Lost to Follow-up|18|||
16876137|NCT01400815|37854376|FG001|Overall Study|Lost to Follow-up|11|||
16876138|NCT01400815|37854375|FG000|Overall Study|Protocol Violation|0|||
16876139|NCT01400815|37854376|FG001|Overall Study|Protocol Violation|1|||
16876140|NCT01400815|37854375|FG000|Overall Study|Physician Decision|1|||
16876141|NCT01400815|37854376|FG001|Overall Study|Physician Decision|0|||
16876142|NCT01400815|37854375|FG000|Overall Study|Withdrawal by Subject|15|||
16876143|NCT01400815|37854376|FG001|Overall Study|Withdrawal by Subject|8|||
16876144|NCT01400815|37854375|FG000|Overall Study|Subject in jail|1|||
16876145|NCT01400815|37854376|FG001|Overall Study|Subject in jail|0|||
16876146|NCT01400503|37854415|FG000|Overall Study|Withdrawal by Subject|1|||
16876147|NCT01400503|37854415|FG000|Overall Study|Study Terminated by Sponsor|58|||
16876148|NCT01400503|37854415|FG000|Overall Study|Other|1|||
16876149|NCT01400425|37854431|FG000|Overall Study|Withdrawal by Subject|10|||
16876150|NCT01422187|37854440|FG000|Overall Study|Personal reason|1|||
16876151|NCT01422187|37854441|FG001|Overall Study|Personal reason|0|||
16876152|NCT01422187|37854442|FG002|Overall Study|Personal reason|0|||
16876153|NCT01422187|37854440|FG000|Overall Study|Lost to Follow-up|0|||
16876154|NCT01422187|37854441|FG001|Overall Study|Lost to Follow-up|1|||
16876155|NCT01422187|37854442|FG002|Overall Study|Lost to Follow-up|0|||
16876156|NCT01421719|37854450|FG000|Overall Study|Withdrawal by Subject|4|||
16876157|NCT01421641|37854457|FG000|Overall Study|Protocol Violation|2|||
16876158|NCT01421641|37854458|FG001|Overall Study|Protocol Violation|2|||
16876159|NCT01385995|37854466|FG000|Period 1, 2 Months|Physician Decision|1|||
16876160|NCT01385995|37854467|FG001|Period 1, 2 Months|Physician Decision|0|||
16876161|NCT01421017|37854478|FG000|Overall Study|Withdrawal by Subject|2|||
16876162|NCT01421017|37854479|FG001|Overall Study|Withdrawal by Subject|0|||
16876163|NCT01421017|37854480|FG002|Overall Study|Withdrawal by Subject|0|||
16876164|NCT01421017|37854478|FG000|Overall Study|POD|0|||
16876165|NCT01421017|37854479|FG001|Overall Study|POD|6|||
16876166|NCT01421017|37854480|FG002|Overall Study|POD|3|||
16876167|NCT01420627|37854527|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
16876168|NCT01400113|37854537|FG000|Overall Study|Withdrawal by Subject|1|||
16876169|NCT01400113|37854538|FG001|Overall Study|Withdrawal by Subject|1|||
16876170|NCT01399723|37854546|FG000|Overall Study|Lost to Follow-up|0|||
16876171|NCT01399723|37854547|FG001|Overall Study|Lost to Follow-up|1|||
16876172|NCT01385371|37854556|FG000|Overall Study|Adverse Event|54|||
16876173|NCT01385371|37854557|FG001|Overall Study|Adverse Event|19|||
16876174|NCT01385371|37854556|FG000|Overall Study|Lost to Follow-up|16|||
16876175|NCT01385371|37854557|FG001|Overall Study|Lost to Follow-up|16|||
16876176|NCT01385371|37854556|FG000|Overall Study|Withdrawal by Subject|52|||
16876177|NCT01385371|37854557|FG001|Overall Study|Withdrawal by Subject|39|||
16876178|NCT01385371|37854556|FG000|Overall Study|Protocol Violation|25|||
16876179|NCT01385371|37854557|FG001|Overall Study|Protocol Violation|21|||
16876180|NCT01385371|37854556|FG000|Overall Study|Administrative|2|||
16876181|NCT01385371|37854557|FG001|Overall Study|Administrative|2|||
16876182|NCT01399099|37854563|FG000|Overall Study|Lost to Follow-up|11|||
16876183|NCT01399099|37854563|FG000|Overall Study|Physician Decision|1|||
16876184|NCT01399099|37854563|FG000|Overall Study|Protocol Violation|1|||
16876185|NCT01399099|37854563|FG000|Overall Study|Skin Irritation|13|||
16876186|NCT01399099|37854563|FG000|Overall Study|Infection|1|||
16876187|NCT01399099|37854563|FG000|Overall Study|Miscellaneous|4|||
16876188|NCT01398787|37854568|FG000|Overall Study|Adverse Event|1|||
16876189|NCT01383499|37854574|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
16876190|NCT01383499|37854575|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
17095181|NCT00076024|38234482|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
17095182|NCT00076024|38234483|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
16876191|NCT01383499|37854576|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16876192|NCT01383499|37854577|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16876193|NCT01397461|37854593|FG000|Overall Study|Withdrawal by Subject|2|||
16876194|NCT01397461|37854594|FG001|Overall Study|Withdrawal by Subject|1|||
16876195|NCT01397461|37854595|FG002|Overall Study|Withdrawal by Subject|0|||
16876196|NCT01397461|37854593|FG000|Overall Study|Lost to Follow-up|0|||
16876197|NCT01397461|37854594|FG001|Overall Study|Lost to Follow-up|2|||
16876198|NCT01397461|37854595|FG002|Overall Study|Lost to Follow-up|1|||
16876199|NCT01397461|37854593|FG000|Overall Study|Lack of Efficacy|0|||
16876200|NCT01397461|37854594|FG001|Overall Study|Lack of Efficacy|3|||
16876201|NCT01397461|37854595|FG002|Overall Study|Lack of Efficacy|0|||
16876202|NCT01397461|37854593|FG000|Overall Study|Not treated|0|||
16876203|NCT01397461|37854594|FG001|Overall Study|Not treated|0|||
16876204|NCT01397461|37854595|FG002|Overall Study|Not treated|1|||
16876205|NCT01382251|37854605|FG000|Overall Study|Surgeries cancelled or delayed|16|||
16876206|NCT01382251|37854606|FG001|Overall Study|Surgeries cancelled or delayed|16|||
16876207|NCT01382251|37854605|FG000|Overall Study|Lost to Follow-up|4|||
16876208|NCT01382251|37854606|FG001|Overall Study|Lost to Follow-up|4|||
16876209|NCT01382251|37854605|FG000|Overall Study|Contacted after study closed|1|||
16876210|NCT01382251|37854606|FG001|Overall Study|Contacted after study closed|1|||
16876211|NCT02992743|37854613|FG000|Overall Study|Withdrawal by Subject|1|||
16876212|NCT02992743|37854614|FG001|Overall Study|Withdrawal by Subject|1|||
16876213|NCT02992743|37854613|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
16876214|NCT02992743|37854614|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
16876215|NCT02992743|37854613|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
16876216|NCT02992743|37854614|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
16876217|NCT02992743|37854613|FG000|Overall Study|No measurable disease|1|||
16876218|NCT02992743|37854614|FG001|Overall Study|No measurable disease|0|||
16876219|NCT02992743|37854613|FG000|Overall Study|In Follow-up|0|||
16876220|NCT02992743|37854614|FG001|Overall Study|In Follow-up|1|||
16876221|NCT02992743|37854613|FG000|Overall Study|On Study Treatment|0|||
16876222|NCT02992743|37854614|FG001|Overall Study|On Study Treatment|1|||
16876223|NCT01396525|37854620|FG000|Overall Study|Withdrawal by Subject|8|||
16876224|NCT01396525|37854620|FG000|Overall Study|Death|14|||
16876225|NCT01396525|37854620|FG000|Overall Study|Lost to Follow-up|4|||
16876226|NCT02849652|37854632|FG000|Overall Study|Lost to Follow-up|104|||
16876227|NCT02849652|37854633|FG001|Overall Study|Lost to Follow-up|35|||
16876228|NCT02849652|37854634|FG002|Overall Study|Lost to Follow-up|116|||
16876229|NCT02849652|37854635|FG003|Overall Study|Lost to Follow-up|22|||
16876230|NCT02849652|37854632|FG000|Overall Study|Withdrawal by Subject|10|||
16876231|NCT02849652|37854633|FG001|Overall Study|Withdrawal by Subject|2|||
16876232|NCT02849652|37854634|FG002|Overall Study|Withdrawal by Subject|8|||
16876233|NCT02849652|37854635|FG003|Overall Study|Withdrawal by Subject|4|||
16876234|NCT01396447|37854647|FG000|Overall Study|Did Not Receive Treatment|3|||
16876235|NCT01396447|37854648|FG001|Overall Study|Did Not Receive Treatment|2|||
16876236|NCT01396447|37854649|FG002|Overall Study|Did Not Receive Treatment|1|||
16876237|NCT01396447|37854650|FG003|Overall Study|Did Not Receive Treatment|0|||
16876238|NCT01396447|37854647|FG000|Overall Study|Adverse Event|15|||
16876239|NCT01396447|37854648|FG001|Overall Study|Adverse Event|12|||
16876240|NCT01396447|37854649|FG002|Overall Study|Adverse Event|12|||
16876241|NCT01396447|37854650|FG003|Overall Study|Adverse Event|17|||
16876242|NCT01396447|37854647|FG000|Overall Study|Insufficient Therapeutic Response|5|||
16876243|NCT01396447|37854648|FG001|Overall Study|Insufficient Therapeutic Response|5|||
16876244|NCT01396447|37854649|FG002|Overall Study|Insufficient Therapeutic Response|2|||
16876245|NCT01396447|37854650|FG003|Overall Study|Insufficient Therapeutic Response|4|||
16876246|NCT01396447|37854647|FG000|Overall Study|Protocol Violation|5|||
16876247|NCT01396447|37854648|FG001|Overall Study|Protocol Violation|2|||
16876248|NCT01396447|37854649|FG002|Overall Study|Protocol Violation|3|||
16876249|NCT01396447|37854650|FG003|Overall Study|Protocol Violation|7|||
16876250|NCT01396447|37854647|FG000|Overall Study|Withdrawal of Consent|11|||
16876251|NCT01396447|37854648|FG001|Overall Study|Withdrawal of Consent|9|||
16876252|NCT01396447|37854649|FG002|Overall Study|Withdrawal of Consent|4|||
16876253|NCT01396447|37854650|FG003|Overall Study|Withdrawal of Consent|15|||
16876254|NCT01396447|37854647|FG000|Overall Study|Lost to Follow-up|4|||
16876255|NCT01396447|37854648|FG001|Overall Study|Lost to Follow-up|8|||
16876256|NCT01396447|37854649|FG002|Overall Study|Lost to Follow-up|7|||
16876257|NCT01396447|37854650|FG003|Overall Study|Lost to Follow-up|9|||
16876258|NCT01396447|37854647|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16876259|NCT01396447|37854648|FG001|Overall Study|Other Miscellaneous Reasons|2|||
16876260|NCT01396447|37854649|FG002|Overall Study|Other Miscellaneous Reasons|1|||
16876261|NCT01396447|37854650|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16876262|NCT01678560|37854734|FG000|Overall Study|Physician Decision|4|||
16876263|NCT01678560|37854735|FG001|Overall Study|Physician Decision|4|||
16876264|NCT01678560|37854734|FG000|Overall Study|Death|0|||
16876265|NCT01678560|37854735|FG001|Overall Study|Death|1|||
16876266|NCT01678560|37854734|FG000|Overall Study|Withdrawal by Subject|0|||
16876267|NCT01678560|37854735|FG001|Overall Study|Withdrawal by Subject|1|||
16876268|NCT01381549|37854774|FG000|Overall Study|Ineligible: No organisms isolated|0|||
16876269|NCT01381549|37854775|FG001|Overall Study|Ineligible: No organisms isolated|0|||
16876270|NCT01381549|37854776|FG002|Overall Study|Ineligible: No organisms isolated|1|||
16876271|NCT00159432|37854785|FG000|Overall Study|Adverse Event|1|||
16876272|NCT00159432|37854785|FG000|Overall Study|Death|1|||
16876273|NCT00159432|37854785|FG000|Overall Study|Lack of Efficacy|8|||
16876274|NCT01396057|37854791|FG000|Overall Study|Adverse Event|2|||
16876275|NCT01396057|37854792|FG001|Overall Study|Adverse Event|6|||
16876276|NCT01396057|37854791|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16876277|NCT01396057|37854792|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
16876278|NCT01396057|37854791|FG000|Overall Study|Protocol deviation|4|||
16876279|NCT01396057|37854792|FG001|Overall Study|Protocol deviation|4|||
16876280|NCT01396057|37854791|FG000|Overall Study|Consent withdrawn|3|||
16876281|NCT01396057|37854792|FG001|Overall Study|Consent withdrawn|2|||
16876282|NCT01380769|37854809|FG000|Overall Study|Withdrawal by Subject|7|||
16876283|NCT01380769|37854810|FG001|Overall Study|Withdrawal by Subject|11|||
16876284|NCT01380769|37854809|FG000|Overall Study|Physician Decision|1|||
16876285|NCT01380769|37854810|FG001|Overall Study|Physician Decision|1|||
16876286|NCT01380769|37854809|FG000|Overall Study|Adverse Event|1|||
16876287|NCT01380769|37854810|FG001|Overall Study|Adverse Event|1|||
16876288|NCT01380769|37854809|FG000|Overall Study|Protocol Violation|0|||
16876289|NCT01380769|37854810|FG001|Overall Study|Protocol Violation|1|||
16876290|NCT01395901|37854818|FG000|Overall Study|Lost to Follow-up|4|||
16876291|NCT01395901|37854819|FG001|Overall Study|Lost to Follow-up|0|||
16876292|NCT01395901|37854818|FG000|Overall Study|Randomized but not received study drug|5|||
16876293|NCT01395901|37854819|FG001|Overall Study|Randomized but not received study drug|4|||
16876294|NCT01395901|37854818|FG000|Overall Study|Adverse Event|0|||
16876295|NCT01395901|37854819|FG001|Overall Study|Adverse Event|1|||
16876296|NCT01395901|37854818|FG000|Overall Study|Withdrawal of consent|1|||
16876297|NCT01395901|37854819|FG001|Overall Study|Withdrawal of consent|0|||
16876298|NCT01395823|37854827|FG000|Overall Study|Death|4|||
16876299|NCT01395823|37854828|FG001|Overall Study|Death|4|||
16876300|NCT01395823|37854827|FG000|Overall Study|Physician Decision|3|||
16876301|NCT01395823|37854828|FG001|Overall Study|Physician Decision|1|||
16876302|NCT01395823|37854827|FG000|Overall Study|Lost to Follow-up|1|||
16876303|NCT01395823|37854828|FG001|Overall Study|Lost to Follow-up|0|||
16876304|NCT01395823|37854827|FG000|Overall Study|Transplant|1|||
16876305|NCT01395823|37854828|FG001|Overall Study|Transplant|0|||
16876306|NCT01395823|37854827|FG000|Overall Study|GI symptoms|1|||
16876307|NCT01395823|37854828|FG001|Overall Study|GI symptoms|0|||
16876308|NCT01395823|37854827|FG000|Overall Study|Withdrawal by Subject|5|||
16876309|NCT01395823|37854828|FG001|Overall Study|Withdrawal by Subject|4|||
16876310|NCT00158184|37854836|FG000|Overall Study|personal issues|3|||
16876311|NCT00158184|37854837|FG001|Overall Study|personal issues|1|||
16876312|NCT00158184|37854836|FG000|Overall Study|failed for follow unit/study rules|2|||
16876313|NCT00158184|37854837|FG001|Overall Study|failed for follow unit/study rules|0|||
16876314|NCT00158184|37854836|FG000|Overall Study|Adverse Event|1|||
16876315|NCT00158184|37854837|FG001|Overall Study|Adverse Event|1|||
16876316|NCT01380691|37854845|FG000|Washout (7 Days)|Protocol Violation|0|||
16876317|NCT01380691|37854846|FG001|Washout (7 Days)|Protocol Violation|0|||
16876318|NCT01380691|37854847|FG002|Washout (7 Days)|Protocol Violation|0|||
16876319|NCT01380691|37854848|FG003|Washout (7 Days)|Protocol Violation|1|||
16876320|NCT01380691|37854845|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
16876321|NCT01380691|37854846|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
16876322|NCT01380691|37854847|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
16876323|NCT01380691|37854848|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
16876324|NCT01380535|37854874|FG000|Overall Study|Adverse Event|3|||
16876325|NCT01380535|37854875|FG001|Overall Study|Adverse Event|3|||
16876326|NCT01380535|37854874|FG000|Overall Study|Death|3|||
16876327|NCT01380535|37854875|FG001|Overall Study|Death|0|||
16876328|NCT01380535|37854874|FG000|Overall Study|Study site closed|0|||
16876329|NCT01380535|37854875|FG001|Overall Study|Study site closed|5|||
16876330|NCT01380535|37854874|FG000|Overall Study|Withdrawal by Subject|1|||
16876331|NCT01380535|37854875|FG001|Overall Study|Withdrawal by Subject|2|||
16876332|NCT01380535|37854874|FG000|Overall Study|Protocol Violation|0|||
16876333|NCT01380535|37854875|FG001|Overall Study|Protocol Violation|2|||
16876334|NCT01380535|37854874|FG000|Overall Study|Lack of Efficacy|0|||
16876335|NCT01380535|37854875|FG001|Overall Study|Lack of Efficacy|3|||
16876336|NCT01380379|37854885|FG000|Overall Study|Pregnancy|1|||
16876337|NCT01380145|37854889|FG000|Overall Study|Progressive disease|4|||
16876338|NCT03420222|37854915|FG000|Overall Study|Withdrawal by Subject|5|||
16876339|NCT03420222|37854916|FG001|Overall Study|Withdrawal by Subject|0|||
16876340|NCT03420222|37854915|FG000|Overall Study|Physician Decision|0|||
16876341|NCT03420222|37854916|FG001|Overall Study|Physician Decision|1|||
16876342|NCT01394185|37854922|FG000|Overall Study|Withdrawal by Subject|2|||
16876343|NCT01394185|37854923|FG001|Overall Study|Withdrawal by Subject|0|||
16876344|NCT01394185|37854924|FG002|Overall Study|Withdrawal by Subject|0|||
16876345|NCT01394185|37854925|FG003|Overall Study|Withdrawal by Subject|0|||
16876346|NCT01394185|37854926|FG004|Overall Study|Withdrawal by Subject|1|||
16876347|NCT01394185|37854927|FG005|Overall Study|Withdrawal by Subject|0|||
16876348|NCT01394185|37854922|FG000|Overall Study|Change in protocol|3|||
16876349|NCT01394185|37854923|FG001|Overall Study|Change in protocol|0|||
16876350|NCT01394185|37854924|FG002|Overall Study|Change in protocol|0|||
16876351|NCT01394185|37854925|FG003|Overall Study|Change in protocol|0|||
16876352|NCT01394185|37854926|FG004|Overall Study|Change in protocol|3|||
16876353|NCT01394185|37854927|FG005|Overall Study|Change in protocol|0|||
16876354|NCT01394185|37854922|FG000|Overall Study|Protocol Violation|1|||
16876355|NCT01394185|37854923|FG001|Overall Study|Protocol Violation|0|||
16876356|NCT01394185|37854924|FG002|Overall Study|Protocol Violation|0|||
16876357|NCT01394185|37854925|FG003|Overall Study|Protocol Violation|1|||
16876358|NCT01394185|37854926|FG004|Overall Study|Protocol Violation|0|||
16876359|NCT01394185|37854927|FG005|Overall Study|Protocol Violation|1|||
16876360|NCT01677936|37854960|FG000|Overall Study|Lost to Follow-up|4|||
16876361|NCT01677936|37854961|FG001|Overall Study|Lost to Follow-up|1|||
16876362|NCT01677936|37854960|FG000|Overall Study|Protocol Violation|3|||
16876363|NCT01677936|37854961|FG001|Overall Study|Protocol Violation|0|||
16876364|NCT01677936|37854960|FG000|Overall Study|Adverse Event|1|||
16876365|NCT01677936|37854961|FG001|Overall Study|Adverse Event|0|||
16876366|NCT01677936|37854960|FG000|Overall Study|Lost to Follow-up|1|||
16876367|NCT01677936|37854961|FG001|Overall Study|Lost to Follow-up|0|||
16876368|NCT01677936|37854960|FG000|Overall Study|Protocol Violation|0|||
16876369|NCT01677936|37854961|FG001|Overall Study|Protocol Violation|4|||
16876370|NCT01525550|37854992|FG000|Overall Study|Lost to Follow-up|8|||
16876371|NCT01525550|37854993|FG001|Overall Study|Lost to Follow-up|2|||
16876372|NCT01525550|37854992|FG000|Overall Study|Death|19|||
16876373|NCT01525550|37854993|FG001|Overall Study|Death|28|||
16876374|NCT01525550|37854992|FG000|Overall Study|Other|0|||
16876375|NCT01525550|37854993|FG001|Overall Study|Other|4|||
16876376|NCT01525550|37854992|FG000|Overall Study|Sponsor's Decision|30|||
16876377|NCT01525550|37854993|FG001|Overall Study|Sponsor's Decision|11|||
16876378|NCT01525550|37854992|FG000|Overall Study|Withdrawal by Subject|4|||
16876379|NCT01525550|37854993|FG001|Overall Study|Withdrawal by Subject|0|||
16876380|NCT00211237|37855005|FG000|Baseline|Withdrew|1|||
16876381|NCT00211237|37855006|FG001|Baseline|Withdrew|3|||
16876382|NCT00211237|37855007|FG002|Baseline|Withdrew|0|||
16876383|NCT00211237|37855005|FG000|Baseline|Refused random assignment|1|||
16876384|NCT00211237|37855006|FG001|Baseline|Refused random assignment|0|||
16876385|NCT00211237|37855007|FG002|Baseline|Refused random assignment|0|||
16876386|NCT00211237|37855005|FG000|1 Month|Death|2|||
16876387|NCT00211237|37855006|FG001|1 Month|Death|1|||
16876388|NCT00211237|37855007|FG002|1 Month|Death|0|||
16876389|NCT00211237|37855005|FG000|1 Month|Lost to Follow-up|0|||
16876390|NCT00211237|37855006|FG001|1 Month|Lost to Follow-up|2|||
16876391|NCT00211237|37855007|FG002|1 Month|Lost to Follow-up|0|||
16876392|NCT00211237|37855005|FG000|1 Month|Withdrew|0|||
16876393|NCT00211237|37855006|FG001|1 Month|Withdrew|4|||
16876394|NCT00211237|37855007|FG002|1 Month|Withdrew|0|||
16876395|NCT00211237|37855005|FG000|1 Month|Additional surgery needed|1|||
16876396|NCT00211237|37855006|FG001|1 Month|Additional surgery needed|0|||
16876397|NCT00211237|37855007|FG002|1 Month|Additional surgery needed|0|||
16876398|NCT00211237|37855005|FG000|1 Month|Non-medical problem|0|||
16876399|NCT00211237|37855006|FG001|1 Month|Non-medical problem|2|||
16876400|NCT00211237|37855007|FG002|1 Month|Non-medical problem|0|||
16876401|NCT00211237|37855005|FG000|3 Months|Death|7|||
16876402|NCT00211237|37855006|FG001|3 Months|Death|3|||
16876403|NCT00211237|37855007|FG002|3 Months|Death|0|||
16876404|NCT00211237|37855005|FG000|3 Months|Could not comply with protocol|1|||
16876405|NCT00211237|37855006|FG001|3 Months|Could not comply with protocol|0|||
16876406|NCT00211237|37855007|FG002|3 Months|Could not comply with protocol|0|||
16876407|NCT00211237|37855005|FG000|3 Months|Withdrew|0|||
16876408|NCT00211237|37855006|FG001|3 Months|Withdrew|1|||
16876409|NCT00211237|37855007|FG002|3 Months|Withdrew|0|||
16876410|NCT00211237|37855005|FG000|3 Months|Non-medical problem|0|||
16876411|NCT00211237|37855006|FG001|3 Months|Non-medical problem|0|||
16876412|NCT00211237|37855007|FG002|3 Months|Non-medical problem|1|||
16876413|NCT00211237|37855005|FG000|6 Months|Death|6|||
16876414|NCT00211237|37855006|FG001|6 Months|Death|0|||
16876415|NCT00211237|37855007|FG002|6 Months|Death|3|||
16876416|NCT00211237|37855005|FG000|6 Months|Lost to Follow-up|2|||
16876417|NCT00211237|37855006|FG001|6 Months|Lost to Follow-up|0|||
17095183|NCT00076024|38234484|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
16876418|NCT00211237|37855007|FG002|6 Months|Lost to Follow-up|0|||
16876419|NCT00211237|37855005|FG000|6 Months|Could not comply with protocol|0|||
16876420|NCT00211237|37855006|FG001|6 Months|Could not comply with protocol|2|||
16876421|NCT00211237|37855007|FG002|6 Months|Could not comply with protocol|0|||
16876422|NCT00211237|37855005|FG000|12 Months|Death|8|||
16876423|NCT00211237|37855006|FG001|12 Months|Death|2|||
16876424|NCT00211237|37855007|FG002|12 Months|Death|3|||
16876425|NCT00211237|37855005|FG000|12 Months|Lost to Follow-up|1|||
16876426|NCT00211237|37855006|FG001|12 Months|Lost to Follow-up|0|||
16876427|NCT00211237|37855007|FG002|12 Months|Lost to Follow-up|1|||
16876428|NCT00211237|37855005|FG000|12 Months|Withdrew|0|||
16876429|NCT00211237|37855006|FG001|12 Months|Withdrew|0|||
16876430|NCT00211237|37855007|FG002|12 Months|Withdrew|1|||
16876431|NCT00211237|37855005|FG000|12 Months|unrelated medical problem|0|||
16876432|NCT00211237|37855006|FG001|12 Months|unrelated medical problem|0|||
16876433|NCT00211237|37855007|FG002|12 Months|unrelated medical problem|1|||
16876434|NCT01489358|37855027|FG000|Overall Study|Lost to Follow-up|0|||
16876435|NCT01489358|37855028|FG001|Overall Study|Lost to Follow-up|0|||
16876436|NCT01489358|37855029|FG002|Overall Study|Lost to Follow-up|2|||
16876437|NCT01525238|37855040|FG000|Overall Study|Withdrawal by Subject|1|||
16876438|NCT01525238|37855041|FG001|Overall Study|Withdrawal by Subject|0|||
16876439|NCT01525238|37855042|FG002|Overall Study|Withdrawal by Subject|0|||
16876440|NCT01525082|37855063|FG000|Overall Study|Death|1|||
16876441|NCT01488578|37855070|FG000|Overall Study|Protocol Violation|1836|||
16876442|NCT01524770|37855111|FG000|First Intervention|Withdrawal by Subject|1|||
16876443|NCT01524770|37855112|FG001|First Intervention|Withdrawal by Subject|0|||
16876444|NCT01524770|37855111|FG000|First Intervention|Adverse Event|1|||
16876445|NCT01524770|37855112|FG001|First Intervention|Adverse Event|1|||
16876446|NCT01524770|37855111|FG000|First Intervention|Protocol Violation|1|||
16876447|NCT01524770|37855112|FG001|First Intervention|Protocol Violation|0|||
16876448|NCT01524692|37855118|FG000|Overall Study|Withdrawal by Subject|3|||
16876449|NCT01431287|37855137|FG000|Overall Study|not treated|0|||
16876450|NCT01431287|37855138|FG001|Overall Study|not treated|0|||
16876451|NCT01431287|37855139|FG002|Overall Study|not treated|1|||
16876452|NCT01431287|37855140|FG003|Overall Study|not treated|0|||
16876453|NCT01431287|37855141|FG004|Overall Study|not treated|0|||
16876454|NCT01431287|37855137|FG000|Overall Study|Adverse Event|59|||
16876455|NCT01431287|37855138|FG001|Overall Study|Adverse Event|57|||
16876456|NCT01431287|37855139|FG002|Overall Study|Adverse Event|53|||
16876457|NCT01431287|37855140|FG003|Overall Study|Adverse Event|33|||
16876458|NCT01431287|37855141|FG004|Overall Study|Adverse Event|41|||
16876459|NCT01431287|37855137|FG000|Overall Study|Non compliant with protocol|6|||
16876460|NCT01431287|37855138|FG001|Overall Study|Non compliant with protocol|6|||
16876461|NCT01431287|37855139|FG002|Overall Study|Non compliant with protocol|5|||
16876462|NCT01431287|37855140|FG003|Overall Study|Non compliant with protocol|6|||
16876463|NCT01431287|37855141|FG004|Overall Study|Non compliant with protocol|5|||
16876464|NCT01431287|37855137|FG000|Overall Study|Lost to Follow-up|0|||
16876465|NCT01431287|37855138|FG001|Overall Study|Lost to Follow-up|3|||
16876466|NCT01431287|37855139|FG002|Overall Study|Lost to Follow-up|2|||
16876467|NCT01431287|37855140|FG003|Overall Study|Lost to Follow-up|3|||
16876468|NCT01431287|37855141|FG004|Overall Study|Lost to Follow-up|1|||
16876469|NCT01431287|37855137|FG000|Overall Study|Consent withdrawn not due to AE|29|||
16876470|NCT01431287|37855138|FG001|Overall Study|Consent withdrawn not due to AE|30|||
16876471|NCT01431287|37855139|FG002|Overall Study|Consent withdrawn not due to AE|34|||
16876472|NCT01431287|37855140|FG003|Overall Study|Consent withdrawn not due to AE|19|||
16876473|NCT01431287|37855141|FG004|Overall Study|Consent withdrawn not due to AE|29|||
16876474|NCT01431287|37855137|FG000|Overall Study|not stated above|4|||
16876475|NCT01431287|37855138|FG001|Overall Study|not stated above|2|||
16876476|NCT01431287|37855139|FG002|Overall Study|not stated above|2|||
16876477|NCT01431287|37855140|FG003|Overall Study|not stated above|2|||
16876478|NCT01431287|37855141|FG004|Overall Study|not stated above|1|||
16876479|NCT01274715|37855187|FG000|Overall Study|Lost to Follow-up|1|||
16876480|NCT01274715|37855187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
16876481|NCT01274715|37855187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
16876482|NCT01274715|37855187|FG000|Overall Study|After consent, met exclusion criteria.|1|||
16876483|NCT01410227|37855191|FG000|Overall Study|Adverse Event|1|||
16876484|NCT01410227|37855192|FG001|Overall Study|Adverse Event|0|||
16876485|NCT01410227|37855193|FG002|Overall Study|Adverse Event|0|||
16876486|NCT01410227|37855194|FG003|Overall Study|Adverse Event|0|||
16876487|NCT01410227|37855191|FG000|Overall Study|Withdrawal by Subject|3|||
16876488|NCT01410227|37855192|FG001|Overall Study|Withdrawal by Subject|0|||
16876489|NCT01410227|37855193|FG002|Overall Study|Withdrawal by Subject|1|||
16876490|NCT01410227|37855194|FG003|Overall Study|Withdrawal by Subject|0|||
16876491|NCT01410227|37855191|FG000|Overall Study|Pregnancy|0|||
16876492|NCT01410227|37855192|FG001|Overall Study|Pregnancy|0|||
16876493|NCT01410227|37855193|FG002|Overall Study|Pregnancy|0|||
16876494|NCT01410227|37855194|FG003|Overall Study|Pregnancy|1|||
16876495|NCT01410227|37855191|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
16876496|NCT01410227|37855192|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
16876497|NCT01410227|37855193|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
16876498|NCT01410227|37855194|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
17095184|NCT00076024|38234485|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
17095185|NCT00076024|38234482|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
16876499|NCT01274559|37855206|FG000|Overall Study|Adverse Event|57|||
16876500|NCT01274559|37855207|FG001|Overall Study|Adverse Event|13|||
16876501|NCT01274559|37855206|FG000|Overall Study|Death|1|||
16876502|NCT01274559|37855207|FG001|Overall Study|Death|1|||
16876503|NCT01274559|37855206|FG000|Overall Study|Lost to Follow-up|3|||
16876504|NCT01274559|37855207|FG001|Overall Study|Lost to Follow-up|3|||
16876505|NCT01274559|37855206|FG000|Overall Study|Non-compliance with Study Drug|2|||
16876506|NCT01274559|37855207|FG001|Overall Study|Non-compliance with Study Drug|4|||
16876507|NCT01274559|37855206|FG000|Overall Study|Physician Decision|2|||
16876508|NCT01274559|37855207|FG001|Overall Study|Physician Decision|1|||
16876509|NCT01274559|37855206|FG000|Overall Study|Protocol Violation|28|||
16876510|NCT01274559|37855207|FG001|Overall Study|Protocol Violation|23|||
16876511|NCT01274559|37855206|FG000|Overall Study|Study Terminated by Sponsor|79|||
16876512|NCT01274559|37855207|FG001|Overall Study|Study Terminated by Sponsor|87|||
16876513|NCT01274559|37855206|FG000|Overall Study|Withdrawal by Subject|25|||
16876514|NCT01274559|37855207|FG001|Overall Study|Withdrawal by Subject|13|||
16876515|NCT01409993|37855215|FG000|Overall Study|Adverse Event|4|||
16876516|NCT01409993|37855216|FG001|Overall Study|Adverse Event|4|||
16876517|NCT01409993|37855217|FG002|Overall Study|Adverse Event|3|||
16876518|NCT01409993|37855218|FG003|Overall Study|Adverse Event|1|||
16876519|NCT01409993|37855215|FG000|Overall Study|Withdrawal by Subject|0|||
16876520|NCT01409993|37855216|FG001|Overall Study|Withdrawal by Subject|0|||
16876521|NCT01409993|37855217|FG002|Overall Study|Withdrawal by Subject|0|||
16876522|NCT01409993|37855218|FG003|Overall Study|Withdrawal by Subject|4|||
16876523|NCT01409993|37855215|FG000|Overall Study|Lost to Follow-up|0|||
16876524|NCT01409993|37855216|FG001|Overall Study|Lost to Follow-up|1|||
16876525|NCT01409993|37855217|FG002|Overall Study|Lost to Follow-up|0|||
16876526|NCT01409993|37855218|FG003|Overall Study|Lost to Follow-up|0|||
16876527|NCT01273623|37855232|FG000|Overall Study|did not meet IVUS criteria|29|||
16876528|NCT01409915|37855240|FG000|Overall Study|Adverse Event|0|||
16876529|NCT01409915|37855241|FG001|Overall Study|Adverse Event|2|||
16876530|NCT01409915|37855240|FG000|Overall Study|Withdrawal by Subject|0|||
16876531|NCT01409915|37855241|FG001|Overall Study|Withdrawal by Subject|1|||
16876532|NCT01409915|37855240|FG000|Overall Study|Protocol Violation|1|||
16876533|NCT01409915|37855241|FG001|Overall Study|Protocol Violation|0|||
16876534|NCT01272921|37855249|FG000|Overall Study|Protocol Violation|2|||
16876535|NCT01272921|37855250|FG001|Overall Study|Protocol Violation|1|||
16876536|NCT01409837|37855260|FG000|Overall Study|Withdrawal by Subject|2|||
16876537|NCT01409837|37855261|FG001|Overall Study|Withdrawal by Subject|1|||
16876538|NCT01409837|37855260|FG000|Overall Study|Lost to Follow-up|1|||
16876539|NCT01409837|37855261|FG001|Overall Study|Lost to Follow-up|0|||
16876540|NCT01409837|37855260|FG000|Overall Study|Physician Decision|0|||
16876541|NCT01409837|37855261|FG001|Overall Study|Physician Decision|1|||
16876542|NCT01430585|37855280|FG000|Overall Study|Death|1|||
16876543|NCT01430585|37855280|FG000|Overall Study|Objective Progression or Relapse|3|||
16876544|NCT01430585|37855280|FG000|Overall Study|Study Terminated by Sponsor|3|||
16876545|NCT01430585|37855280|FG000|Overall Study|Other|7|||
16876546|NCT01408901|37855303|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
16876547|NCT01408901|37855304|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
16876548|NCT01408901|37855305|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
16876549|NCT01408901|37855306|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
16876550|NCT01408901|37855303|FG000|6-Week Follow-Up|Death|1|||
16876551|NCT01408901|37855304|FG001|6-Week Follow-Up|Death|0|||
16876552|NCT01408901|37855305|FG002|6-Week Follow-Up|Death|0|||
16876553|NCT01408901|37855306|FG003|6-Week Follow-Up|Death|0|||
16876554|NCT01408901|37855303|FG000|6-Week Follow-Up|Cancelled visit|0|||
16876555|NCT01408901|37855304|FG001|6-Week Follow-Up|Cancelled visit|1|||
16876556|NCT01408901|37855305|FG002|6-Week Follow-Up|Cancelled visit|0|||
16876557|NCT01408901|37855306|FG003|6-Week Follow-Up|Cancelled visit|2|||
16876558|NCT01408901|37855303|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
16876559|NCT01408901|37855304|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
16876560|NCT01408901|37855305|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
16876561|NCT01408901|37855306|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
16876562|NCT01408901|37855303|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
16876563|NCT01408901|37855304|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
16876564|NCT01408901|37855305|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
16876565|NCT01408901|37855306|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
16876566|NCT01408901|37855303|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
16876567|NCT01408901|37855304|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
16876568|NCT01408901|37855305|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
16876569|NCT01408901|37855306|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
16876570|NCT01408901|37855303|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
16876571|NCT01408901|37855304|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
16876572|NCT01408901|37855305|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
16876573|NCT01408901|37855306|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
16876574|NCT01408901|37855303|FG000|26-Week Follow-Up|Death|0|||
16876575|NCT01408901|37855304|FG001|26-Week Follow-Up|Death|1|||
16876576|NCT01408901|37855305|FG002|26-Week Follow-Up|Death|0|||
16876577|NCT01408901|37855306|FG003|26-Week Follow-Up|Death|0|||
16876578|NCT01428713|37855322|FG000|Overall Study|Non-compliance|2|||
16876579|NCT01428713|37855323|FG001|Overall Study|Non-compliance|2|||
16876580|NCT01428713|37855322|FG000|Overall Study|Withdrawal by Subject|1|||
16876581|NCT01428713|37855323|FG001|Overall Study|Withdrawal by Subject|1|||
16876582|NCT01428713|37855322|FG000|Overall Study|Adverse Event|0|||
16876583|NCT01428713|37855323|FG001|Overall Study|Adverse Event|2|||
16876584|NCT01408277|37855331|FG000|Overall Study|Adverse Event|3|||
16876585|NCT01408277|37855332|FG001|Overall Study|Adverse Event|4|||
16876586|NCT01408277|37855331|FG000|Overall Study|Lost to Follow-up|1|||
16876587|NCT01408277|37855332|FG001|Overall Study|Lost to Follow-up|0|||
16876588|NCT01408277|37855331|FG000|Overall Study|Withdrawal by Subject|2|||
16876589|NCT01408277|37855332|FG001|Overall Study|Withdrawal by Subject|0|||
16876590|NCT01408277|37855331|FG000|Overall Study|Protocol Violation|2|||
16876591|NCT01408277|37855332|FG001|Overall Study|Protocol Violation|0|||
16876592|NCT01408043|37855338|FG000|Overall Study|unable to collect cells|1|||
16876593|NCT01524224|37855350|FG000|Overall Study|Progressive Disease|1|||
16876594|NCT01524224|37855351|FG001|Overall Study|Progressive Disease|0|||
16876595|NCT01524224|37855352|FG002|Overall Study|Progressive Disease|2|||
16876596|NCT01524224|37855353|FG003|Overall Study|Progressive Disease|1|||
16876597|NCT01524224|37855354|FG004|Overall Study|Progressive Disease|2|||
16876598|NCT01524224|37855355|FG005|Overall Study|Progressive Disease|1|||
16876599|NCT01524224|37855356|FG006|Overall Study|Progressive Disease|1|||
16876600|NCT01524224|37855357|FG007|Overall Study|Progressive Disease|5|||
16876601|NCT01524224|37855350|FG000|Overall Study|Withdrawal by Subject|2|||
16876602|NCT01524224|37855351|FG001|Overall Study|Withdrawal by Subject|0|||
16876603|NCT01524224|37855352|FG002|Overall Study|Withdrawal by Subject|0|||
16876604|NCT01524224|37855353|FG003|Overall Study|Withdrawal by Subject|0|||
16876605|NCT01524224|37855354|FG004|Overall Study|Withdrawal by Subject|0|||
16876606|NCT01524224|37855355|FG005|Overall Study|Withdrawal by Subject|0|||
16876607|NCT01524224|37855356|FG006|Overall Study|Withdrawal by Subject|2|||
16876608|NCT01524224|37855357|FG007|Overall Study|Withdrawal by Subject|0|||
16876609|NCT01524224|37855350|FG000|Overall Study|Adverse Event|0|||
16876610|NCT01524224|37855351|FG001|Overall Study|Adverse Event|1|||
16876611|NCT01524224|37855352|FG002|Overall Study|Adverse Event|0|||
16876612|NCT01524224|37855353|FG003|Overall Study|Adverse Event|0|||
16876613|NCT01524224|37855354|FG004|Overall Study|Adverse Event|0|||
16876614|NCT01524224|37855355|FG005|Overall Study|Adverse Event|1|||
16876615|NCT01524224|37855356|FG006|Overall Study|Adverse Event|0|||
16876616|NCT01524224|37855357|FG007|Overall Study|Adverse Event|0|||
16876617|NCT01524224|37855350|FG000|Overall Study|Physician Decision|0|||
16876618|NCT01524224|37855351|FG001|Overall Study|Physician Decision|0|||
16876619|NCT01524224|37855352|FG002|Overall Study|Physician Decision|0|||
16876620|NCT01524224|37855353|FG003|Overall Study|Physician Decision|1|||
16876621|NCT01524224|37855354|FG004|Overall Study|Physician Decision|1|||
16876622|NCT01524224|37855355|FG005|Overall Study|Physician Decision|0|||
16876623|NCT01524224|37855356|FG006|Overall Study|Physician Decision|0|||
16876624|NCT01524224|37855357|FG007|Overall Study|Physician Decision|1|||
16876625|NCT01524224|37855350|FG000|Overall Study|Sponsor Decision|0|||
16876626|NCT01524224|37855351|FG001|Overall Study|Sponsor Decision|0|||
16876627|NCT01524224|37855352|FG002|Overall Study|Sponsor Decision|0|||
16876628|NCT01524224|37855353|FG003|Overall Study|Sponsor Decision|0|||
16876629|NCT01524224|37855354|FG004|Overall Study|Sponsor Decision|1|||
16876630|NCT01524224|37855355|FG005|Overall Study|Sponsor Decision|0|||
16876631|NCT01524224|37855356|FG006|Overall Study|Sponsor Decision|0|||
16876632|NCT01524224|37855357|FG007|Overall Study|Sponsor Decision|0|||
16876633|NCT00219349|37855375|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
16876634|NCT00219349|37855375|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
16876635|NCT00219349|37855375|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
16876636|NCT00219349|37855375|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
16876637|NCT01523756|37855379|FG000|Baseline Period|Adverse Event|0|||
16876638|NCT01523756|37855380|FG001|Baseline Period|Adverse Event|1|||
16876639|NCT01523756|37855379|FG000|Test Period 1|Adverse Event|1|||
16876640|NCT01523756|37855380|FG001|Test Period 1|Adverse Event|0|||
16876641|NCT01523756|37855379|FG000|Test Period 2|Withdrawal by Subject|0|||
16876642|NCT01523756|37855380|FG001|Test Period 2|Withdrawal by Subject|1|||
16876643|NCT00218257|37855388|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
16876644|NCT00218257|37855389|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
16876645|NCT01523366|37855400|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16876646|NCT01523366|37855401|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16876647|NCT01523366|37855400|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
16876648|NCT01523366|37855401|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
16876649|NCT01427933|37855411|FG000|Overall Study|Withdrawal by Subject|5|||
16876650|NCT01427933|37855412|FG001|Overall Study|Withdrawal by Subject|8|||
16876651|NCT01427933|37855411|FG000|Overall Study|Lost to Follow-up|1|||
16876652|NCT01427933|37855412|FG001|Overall Study|Lost to Follow-up|5|||
16876653|NCT01427933|37855411|FG000|Overall Study|Other|1|||
16876654|NCT01427933|37855412|FG001|Overall Study|Other|0|||
16876655|NCT01427933|37855411|FG000|Overall Study|Investigator's Decision|1|||
16876656|NCT01427933|37855412|FG001|Overall Study|Investigator's Decision|0|||
16876657|NCT00217087|37855421|FG000|Overall Study|decided to have esophagectomy|1|||
16876658|NCT00217087|37855422|FG001|Overall Study|decided to have esophagectomy|2|||
16876659|NCT00217087|37855421|FG000|Overall Study|completed less than 12 months return|10|||
16876660|NCT00217087|37855422|FG001|Overall Study|completed less than 12 months return|18|||
16876661|NCT01406873|37855436|FG000|Overall Study|Withdrawal by Subject|1|||
16876662|NCT01406873|37855437|FG001|Overall Study|Withdrawal by Subject|1|||
16876663|NCT01406795|37855453|FG000|Overall Study|Withdrawal by Subject|1|||
16876664|NCT01406717|37855459|FG000|Overall Study|Subject non-compliance|4|||
16876665|NCT01406717|37855460|FG001|Overall Study|Subject non-compliance|3|||
16876666|NCT01406717|37855459|FG000|Overall Study|Protocol Violation|5|||
16876667|NCT01406717|37855460|FG001|Overall Study|Protocol Violation|1|||
16876668|NCT01406717|37855459|FG000|Overall Study|Lost to Follow-up|14|||
16876669|NCT01406717|37855460|FG001|Overall Study|Lost to Follow-up|8|||
16876670|NCT01406717|37855459|FG000|Overall Study|Withdrawal by Subject|19|||
16876671|NCT01406717|37855460|FG001|Overall Study|Withdrawal by Subject|15|||
16876672|NCT01406717|37855459|FG000|Overall Study|Adverse Event|1|||
16876673|NCT01406717|37855460|FG001|Overall Study|Adverse Event|2|||
16876674|NCT01406717|37855459|FG000|Overall Study|Lack of Efficacy|0|||
16876675|NCT01406717|37855460|FG001|Overall Study|Lack of Efficacy|1|||
16876676|NCT01406717|37855459|FG000|Overall Study|Non-completion of visit activity|0|||
16876677|NCT01406717|37855460|FG001|Overall Study|Non-completion of visit activity|1|||
16876678|NCT01406015|37855478|FG000|Overall Study|Withdrawal by Subject|3|||
16876679|NCT01406015|37855479|FG001|Overall Study|Withdrawal by Subject|3|||
16876680|NCT00215683|37855488|FG000|Overall Study|Adverse Event|15|||
16876681|NCT00215683|37855489|FG001|Overall Study|Adverse Event|16|||
16876682|NCT00215683|37855490|FG002|Overall Study|Adverse Event|15|||
16876683|NCT00215683|37855488|FG000|Overall Study|Lack of Efficacy|5|||
16876684|NCT00215683|37855489|FG001|Overall Study|Lack of Efficacy|1|||
16876685|NCT00215683|37855490|FG002|Overall Study|Lack of Efficacy|2|||
16876686|NCT00215683|37855488|FG000|Overall Study|Lost to Follow-up|0|||
16876687|NCT00215683|37855489|FG001|Overall Study|Lost to Follow-up|2|||
16876688|NCT00215683|37855490|FG002|Overall Study|Lost to Follow-up|1|||
16876689|NCT00215683|37855488|FG000|Overall Study|Withdrawal by Subject|9|||
16876690|NCT00215683|37855489|FG001|Overall Study|Withdrawal by Subject|4|||
16876691|NCT00215683|37855490|FG002|Overall Study|Withdrawal by Subject|13|||
16876692|NCT00215683|37855488|FG000|Overall Study|Physician Decision|0|||
16876693|NCT00215683|37855489|FG001|Overall Study|Physician Decision|0|||
16876694|NCT00215683|37855490|FG002|Overall Study|Physician Decision|1|||
16876695|NCT00215683|37855488|FG000|Overall Study|Difficult to attend visits|0|||
16876696|NCT00215683|37855489|FG001|Overall Study|Difficult to attend visits|1|||
16876697|NCT00215683|37855490|FG002|Overall Study|Difficult to attend visits|0|||
16876698|NCT00215683|37855488|FG000|Overall Study|No study drug available|0|||
16876699|NCT00215683|37855489|FG001|Overall Study|No study drug available|1|||
16876700|NCT00215683|37855490|FG002|Overall Study|No study drug available|0|||
16876701|NCT00215683|37855488|FG000|Overall Study|Intermittent therapy required|0|||
16876702|NCT00215683|37855489|FG001|Overall Study|Intermittent therapy required|1|||
16876703|NCT00215683|37855490|FG002|Overall Study|Intermittent therapy required|0|||
16876704|NCT00215137|37855498|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
16876705|NCT00215137|37855499|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
16876706|NCT00215137|37855500|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
16876707|NCT00215137|37855498|FG000|Randomization Period|Lost to Follow-up|0|||
16876708|NCT00215137|37855499|FG001|Randomization Period|Lost to Follow-up|1|||
16876709|NCT00215137|37855500|FG002|Randomization Period|Lost to Follow-up|0|||
16876710|NCT00215137|37855498|FG000|Randomization Period|Withdrawal by Subject|0|||
16876711|NCT00215137|37855499|FG001|Randomization Period|Withdrawal by Subject|1|||
16876712|NCT00215137|37855500|FG002|Randomization Period|Withdrawal by Subject|0|||
16876713|NCT00214201|37855510|FG000|Overall Study|Withdrawal by Subject|2|||
16876714|NCT00214201|37855511|FG001|Overall Study|Withdrawal by Subject|0|||
16876715|NCT00214201|37855510|FG000|Overall Study|Death|0|||
16876716|NCT00214201|37855511|FG001|Overall Study|Death|2|||
16876717|NCT01486784|37855524|FG000|Overall Study|Withdrawal by Subject|0|||
16876718|NCT01486784|37855525|FG001|Overall Study|Withdrawal by Subject|0|||
16876719|NCT01486784|37855526|FG002|Overall Study|Withdrawal by Subject|1|||
16876720|NCT01486784|37855527|FG003|Overall Study|Withdrawal by Subject|0|||
16876721|NCT01486784|37855528|FG004|Overall Study|Withdrawal by Subject|1|||
16876722|NCT01486784|37855529|FG005|Overall Study|Withdrawal by Subject|2|||
16876723|NCT01486784|37855524|FG000|Overall Study|Subject did not meet entry criteria|0|||
16876724|NCT01486784|37855525|FG001|Overall Study|Subject did not meet entry criteria|0|||
16876725|NCT01486784|37855526|FG002|Overall Study|Subject did not meet entry criteria|0|||
16876726|NCT01486784|37855527|FG003|Overall Study|Subject did not meet entry criteria|0|||
16876727|NCT01486784|37855528|FG004|Overall Study|Subject did not meet entry criteria|1|||
16876728|NCT01486784|37855529|FG005|Overall Study|Subject did not meet entry criteria|0|||
16876729|NCT01486784|37855524|FG000|Overall Study|Death|0|||
16876730|NCT01486784|37855525|FG001|Overall Study|Death|0|||
16876731|NCT01486784|37855526|FG002|Overall Study|Death|0|||
16876732|NCT01486784|37855527|FG003|Overall Study|Death|0|||
16876733|NCT01486784|37855528|FG004|Overall Study|Death|0|||
16876734|NCT01486784|37855529|FG005|Overall Study|Death|1|||
16876735|NCT01521884|37855543|FG000|Overall Study|Non Responders|10|||
16876736|NCT01521884|37855543|FG000|Overall Study|Adverse Event|5|||
16876737|NCT01521884|37855543|FG000|Overall Study|Pregnancy|1|||
16876738|NCT01521884|37855543|FG000|Overall Study|Withdrawal by Subject|1|||
16876739|NCT01521884|37855543|FG000|Overall Study|Physician Decision|2|||
16876740|NCT01521884|37855543|FG000|Overall Study|Protocol Violation|3|||
16876741|NCT01521884|37855543|FG000|Overall Study|Participant non-eligible|1|||
16876742|NCT01521884|37855543|FG000|Overall Study|Lost to Follow-up|4|||
16876743|NCT01677858|37855552|FG000|Overall Study|Adverse Event|0|||
16876744|NCT01677858|37855553|FG001|Overall Study|Adverse Event|0|||
16876745|NCT01677858|37855554|FG002|Overall Study|Adverse Event|2|||
16876746|NCT01677858|37855555|FG003|Overall Study|Adverse Event|3|||
16876747|NCT01677858|37855556|FG004|Overall Study|Adverse Event|13|||
16876748|NCT01677858|37855552|FG000|Overall Study|Death|0|||
16876749|NCT01677858|37855553|FG001|Overall Study|Death|0|||
16876750|NCT01677858|37855554|FG002|Overall Study|Death|0|||
16876751|NCT01677858|37855555|FG003|Overall Study|Death|0|||
16876752|NCT01677858|37855556|FG004|Overall Study|Death|1|||
16876753|NCT01677858|37855552|FG000|Overall Study|Physician Decision|1|||
16876754|NCT01677858|37855553|FG001|Overall Study|Physician Decision|0|||
16876755|NCT01677858|37855554|FG002|Overall Study|Physician Decision|2|||
16876756|NCT01677858|37855555|FG003|Overall Study|Physician Decision|0|||
16876757|NCT01677858|37855556|FG004|Overall Study|Physician Decision|12|||
16876758|NCT01677858|37855552|FG000|Overall Study|Progressive Disease|2|||
16876759|NCT01677858|37855553|FG001|Overall Study|Progressive Disease|1|||
16876760|NCT01677858|37855554|FG002|Overall Study|Progressive Disease|9|||
16876761|NCT01677858|37855555|FG003|Overall Study|Progressive Disease|3|||
16876762|NCT01677858|37855556|FG004|Overall Study|Progressive Disease|43|||
16876763|NCT01677858|37855552|FG000|Overall Study|Withdrawal by Subject|0|||
16876764|NCT01677858|37855553|FG001|Overall Study|Withdrawal by Subject|1|||
16876765|NCT01677858|37855554|FG002|Overall Study|Withdrawal by Subject|1|||
16876766|NCT01677858|37855555|FG003|Overall Study|Withdrawal by Subject|0|||
16876767|NCT01677858|37855556|FG004|Overall Study|Withdrawal by Subject|15|||
16876768|NCT01677858|37855552|FG000|Overall Study|Lost to Follow-up|0|||
16876769|NCT01677858|37855553|FG001|Overall Study|Lost to Follow-up|0|||
16876770|NCT01677858|37855554|FG002|Overall Study|Lost to Follow-up|0|||
16876771|NCT01677858|37855555|FG003|Overall Study|Lost to Follow-up|0|||
16876772|NCT01677858|37855556|FG004|Overall Study|Lost to Follow-up|1|||
16876773|NCT01486316|37855576|FG000|Overall Study|Device explanted with/without re-implant|3|||
16876774|NCT01486316|37855577|FG001|Overall Study|Device explanted with/without re-implant|2|||
16876775|NCT01486316|37855578|FG002|Overall Study|Device explanted with/without re-implant|0|||
16876776|NCT01486316|37855579|FG003|Overall Study|Device explanted with/without re-implant|2|||
16876777|NCT01486316|37855576|FG000|Overall Study|Not meeting eligibility criteria|0|||
16876778|NCT01486316|37855577|FG001|Overall Study|Not meeting eligibility criteria|0|||
16876779|NCT01486316|37855578|FG002|Overall Study|Not meeting eligibility criteria|1|||
16876780|NCT01486316|37855579|FG003|Overall Study|Not meeting eligibility criteria|0|||
16876781|NCT01486316|37855576|FG000|Overall Study|Withdrawal by Subject|1|||
16876782|NCT01486316|37855577|FG001|Overall Study|Withdrawal by Subject|0|||
16876783|NCT01486316|37855578|FG002|Overall Study|Withdrawal by Subject|3|||
16876784|NCT01486316|37855579|FG003|Overall Study|Withdrawal by Subject|0|||
16876785|NCT01486316|37855576|FG000|Overall Study|Physician Decision|0|||
16876786|NCT01486316|37855577|FG001|Overall Study|Physician Decision|0|||
16876787|NCT01486316|37855578|FG002|Overall Study|Physician Decision|1|||
16876788|NCT01486316|37855579|FG003|Overall Study|Physician Decision|0|||
16876789|NCT01486316|37855576|FG000|Overall Study|Death|0|||
16876790|NCT01486316|37855577|FG001|Overall Study|Death|1|||
16876791|NCT01486316|37855578|FG002|Overall Study|Death|0|||
16876792|NCT01486316|37855579|FG003|Overall Study|Death|0|||
16876793|NCT01486238|37855590|FG000|Overall Study|Death|0|||
16876794|NCT01486238|37855591|FG001|Overall Study|Death|2|||
16876795|NCT01486238|37855590|FG000|Overall Study|Withdrawal by Subject|2|||
16876796|NCT01486238|37855591|FG001|Overall Study|Withdrawal by Subject|1|||
16876797|NCT01486238|37855590|FG000|Overall Study|Lost to Follow-up|0|||
16876798|NCT01486238|37855591|FG001|Overall Study|Lost to Follow-up|3|||
17001639|NCT00594165|38145660|FG000|Overall Study|Other: Site terminated participation|2|||
17001640|NCT00975923|38145666|FG000|Overall Study|Withdrawal by Subject|0|||
17001641|NCT00975923|38145667|FG001|Overall Study|Withdrawal by Subject|1|||
17001642|NCT00928070|38145676|FG000|Overall Study|Lost to Follow-up|1|||
17001643|NCT00928070|38145677|FG001|Overall Study|Lost to Follow-up|2|||
17001644|NCT00928070|38145676|FG000|Overall Study|Withdrawal by Subject|10|||
17001645|NCT00928070|38145677|FG001|Overall Study|Withdrawal by Subject|3|||
17001646|NCT00928070|38145676|FG000|Overall Study|Adverse Event|14|||
17001647|NCT00928070|38145677|FG001|Overall Study|Adverse Event|26|||
17001648|NCT00928070|38145676|FG000|Overall Study|Lack of Efficacy|9|||
17001649|NCT00928070|38145677|FG001|Overall Study|Lack of Efficacy|5|||
17001650|NCT00928070|38145676|FG000|Overall Study|Did not meet entrance criteria|16|||
17001651|NCT00928070|38145677|FG001|Overall Study|Did not meet entrance criteria|9|||
17001652|NCT00928070|38145676|FG000|Overall Study|Protocol Violation|6|||
17001653|NCT00928070|38145677|FG001|Overall Study|Protocol Violation|5|||
17001654|NCT00928070|38145676|FG000|Overall Study|Randomized but not treated|2|||
17001655|NCT00928070|38145677|FG001|Overall Study|Randomized but not treated|2|||
17001656|NCT00928070|38145676|FG000|Overall Study|Other|5|||
17001657|NCT00928070|38145677|FG001|Overall Study|Other|5|||
17001658|NCT00924404|38145685|FG000|Overall Study|Lost to Follow-up|6|||
17001659|NCT00924404|38145686|FG001|Overall Study|Lost to Follow-up|4|||
17001660|NCT00976937|38145694|FG000|Overall Study|Adverse Event|4|||
17001661|NCT00976937|38145695|FG001|Overall Study|Adverse Event|5|||
16876799|NCT01602744|37855599|FG000|Overall Study|Death|17|||
16876800|NCT01602744|37855600|FG001|Overall Study|Death|15|||
16876801|NCT01602744|37855599|FG000|Overall Study|Lost to Follow-up|13|||
16876802|NCT01602744|37855600|FG001|Overall Study|Lost to Follow-up|8|||
16876803|NCT03598777|37855611|FG000|Overall Study|Study Terminated by Sponsor|3|||
16876804|NCT03598777|37855612|FG001|Overall Study|Study Terminated by Sponsor|0|||
16876805|NCT03598777|37855613|FG002|Overall Study|Study Terminated by Sponsor|0|||
16876806|NCT03598777|37855614|FG003|Overall Study|Study Terminated by Sponsor|0|||
16876807|NCT03598777|37855615|FG004|Overall Study|Study Terminated by Sponsor|15|||
16876808|NCT03598777|37855611|FG000|Overall Study|Withdrawal by Subject|1|||
16876809|NCT03598777|37855612|FG001|Overall Study|Withdrawal by Subject|1|||
16876810|NCT03598777|37855613|FG002|Overall Study|Withdrawal by Subject|0|||
16876811|NCT03598777|37855614|FG003|Overall Study|Withdrawal by Subject|0|||
16876812|NCT03598777|37855615|FG004|Overall Study|Withdrawal by Subject|0|||
16876813|NCT03598777|37855611|FG000|Overall Study|Adverse Event|1|||
16876814|NCT03598777|37855612|FG001|Overall Study|Adverse Event|0|||
16876815|NCT03598777|37855613|FG002|Overall Study|Adverse Event|0|||
16876816|NCT03598777|37855614|FG003|Overall Study|Adverse Event|0|||
16876817|NCT03598777|37855615|FG004|Overall Study|Adverse Event|0|||
16876818|NCT03598777|37855611|FG000|Overall Study|Lost to Follow-up|1|||
16876819|NCT03598777|37855612|FG001|Overall Study|Lost to Follow-up|0|||
16876820|NCT03598777|37855613|FG002|Overall Study|Lost to Follow-up|0|||
16876821|NCT03598777|37855614|FG003|Overall Study|Lost to Follow-up|0|||
16876822|NCT03598777|37855615|FG004|Overall Study|Lost to Follow-up|0|||
16876823|NCT03594955|37855630|FG000|Overall Study|Adverse Event|1|||
16876824|NCT03594955|37855630|FG000|Overall Study|Progressive disease|5|||
16876825|NCT03594955|37855630|FG000|Overall Study|Sponsor's decision|1|||
16876826|NCT01677624|37855658|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
16876827|NCT01272219|37855704|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
16876828|NCT01272219|37855705|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
16876829|NCT01272219|37855706|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
16876830|NCT01272219|37855707|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
16876831|NCT01272219|37855708|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
16876832|NCT01272219|37855709|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
16876833|NCT01272219|37855704|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
16876834|NCT01272219|37855705|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
16876835|NCT01272219|37855706|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
16876836|NCT01272219|37855707|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
16876837|NCT01272219|37855708|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
16876838|NCT01272219|37855709|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
16876839|NCT01272219|37855704|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
16876840|NCT01272219|37855705|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
16876841|NCT01272219|37855706|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
16876842|NCT01272219|37855707|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
16876843|NCT01272219|37855708|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
16876844|NCT01272219|37855709|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
16876845|NCT01272219|37855704|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
16876846|NCT01272219|37855705|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
16876847|NCT01272219|37855706|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
16876848|NCT01272219|37855707|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
16876849|NCT01272219|37855708|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
16876850|NCT01272219|37855709|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
16876851|NCT01272219|37855704|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
16876852|NCT01272219|37855705|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
16876853|NCT01272219|37855706|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
16876854|NCT01272219|37855707|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
16876855|NCT01272219|37855708|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
16876856|NCT01272219|37855709|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
16876857|NCT01272219|37855704|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
16876858|NCT01272219|37855705|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
16876859|NCT01272219|37855706|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
16876860|NCT01272219|37855707|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
16876861|NCT01272219|37855708|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
16876862|NCT01272219|37855709|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
16876863|NCT01272219|37855704|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16876864|NCT01272219|37855705|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16876865|NCT01272219|37855706|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16876866|NCT01272219|37855707|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
16876867|NCT01272219|37855708|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16876868|NCT01272219|37855709|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16876869|NCT01272219|37855704|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
16876870|NCT01272219|37855705|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
16876871|NCT01272219|37855706|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
16876872|NCT01272219|37855707|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
16876873|NCT01272219|37855708|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
16876874|NCT01272219|37855709|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
16876875|NCT01272219|37855704|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
16876876|NCT01272219|37855705|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
16876877|NCT01272219|37855706|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
16876878|NCT01272219|37855707|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
16876879|NCT01272219|37855708|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
16876880|NCT01272219|37855709|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
16876881|NCT01272219|37855704|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
16876882|NCT01272219|37855705|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
16876883|NCT01272219|37855706|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
16876884|NCT01272219|37855707|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
16876885|NCT01272219|37855708|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
16876886|NCT01272219|37855709|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
16876887|NCT01272219|37855704|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
16876888|NCT01272219|37855705|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
16876889|NCT01272219|37855706|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
16876890|NCT01272219|37855707|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
16876891|NCT01272219|37855708|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
16876892|NCT01272219|37855709|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
16876893|NCT01272219|37855704|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
16876894|NCT01272219|37855705|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
16876895|NCT01272219|37855706|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
16876896|NCT01272219|37855707|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
16876897|NCT01272219|37855708|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
16876898|NCT01272219|37855709|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
16876899|NCT01272219|37855704|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
16876900|NCT01272219|37855705|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
16876901|NCT01272219|37855706|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
16876902|NCT01272219|37855707|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
16876903|NCT01272219|37855708|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
16876904|NCT01272219|37855709|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
16876905|NCT01272219|37855704|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
16876906|NCT01272219|37855705|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
16876907|NCT01272219|37855706|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
16876908|NCT01272219|37855707|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
16876909|NCT01272219|37855708|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
16876910|NCT01272219|37855709|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
16876911|NCT01272219|37855704|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
16876912|NCT01272219|37855705|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
16876913|NCT01272219|37855706|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
16876914|NCT01272219|37855707|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
16876915|NCT01272219|37855708|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
16876916|NCT01272219|37855709|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
16876917|NCT01272219|37855704|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
16876918|NCT01272219|37855705|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
16876919|NCT01272219|37855706|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
16876920|NCT01272219|37855707|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
16876921|NCT01272219|37855708|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
16876922|NCT01272219|37855709|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
16876923|NCT01510028|37855726|FG000|Overall Study|Lack of Efficacy|1|||
16876924|NCT01510028|37855727|FG001|Overall Study|Lack of Efficacy|0|||
16876925|NCT01510028|37855728|FG002|Overall Study|Lack of Efficacy|0|||
16876926|NCT01510028|37855729|FG003|Overall Study|Lack of Efficacy|0|||
16876927|NCT01521494|37855750|FG000|Overall Study|Adverse Event|1|||
16876928|NCT01521494|37855751|FG001|Overall Study|Adverse Event|2|||
16876929|NCT01521494|37855752|FG002|Overall Study|Adverse Event|9|||
16876930|NCT01521494|37855753|FG003|Overall Study|Adverse Event|6|||
16876931|NCT01521494|37855754|FG004|Overall Study|Adverse Event|2|||
16876932|NCT01521494|37855750|FG000|Overall Study|Lack of Efficacy|0|||
16876933|NCT01521494|37855751|FG001|Overall Study|Lack of Efficacy|0|||
16876934|NCT01521494|37855752|FG002|Overall Study|Lack of Efficacy|0|||
16876935|NCT01521494|37855753|FG003|Overall Study|Lack of Efficacy|0|||
16876936|NCT01521494|37855754|FG004|Overall Study|Lack of Efficacy|2|||
16876937|NCT01521494|37855750|FG000|Overall Study|Withdrawal by Subject|1|||
16876938|NCT01521494|37855751|FG001|Overall Study|Withdrawal by Subject|1|||
16876939|NCT01521494|37855752|FG002|Overall Study|Withdrawal by Subject|0|||
16876940|NCT01521494|37855753|FG003|Overall Study|Withdrawal by Subject|2|||
16876941|NCT01521494|37855754|FG004|Overall Study|Withdrawal by Subject|0|||
16876942|NCT01521494|37855750|FG000|Overall Study|Decrease in serum phosphate|0|||
16876943|NCT01521494|37855751|FG001|Overall Study|Decrease in serum phosphate|2|||
16876944|NCT01521494|37855752|FG002|Overall Study|Decrease in serum phosphate|3|||
16876945|NCT01521494|37855753|FG003|Overall Study|Decrease in serum phosphate|12|||
16876946|NCT01521494|37855754|FG004|Overall Study|Decrease in serum phosphate|0|||
17001662|NCT00976937|38145694|FG000|Overall Study|Lost to Follow-up|2|||
17001663|NCT00976937|38145695|FG001|Overall Study|Lost to Follow-up|1|||
17001664|NCT00976937|38145694|FG000|Overall Study|Withdrawal by Subject|5|||
17001665|NCT00976937|38145695|FG001|Overall Study|Withdrawal by Subject|3|||
17001666|NCT00976937|38145694|FG000|Overall Study|Poor compliance to protocol|3|||
17001667|NCT00976937|38145695|FG001|Overall Study|Poor compliance to protocol|0|||
17001668|NCT00976937|38145694|FG000|Overall Study|Personal and Familial Reason|2|||
17001669|NCT00976937|38145695|FG001|Overall Study|Personal and Familial Reason|2|||
17001670|NCT00976703|38145703|FG000|Overall Study|Physician Decision|1|||
17001671|NCT00976703|38145704|FG001|Overall Study|Physician Decision|1|||
17001672|NCT00976703|38145703|FG000|Overall Study|ineligible for study|2|||
17001673|NCT00976703|38145704|FG001|Overall Study|ineligible for study|2|||
17001674|NCT00975689|38145712|FG000|Overall Study|Adverse Event|0|||
17001675|NCT00975689|38145713|FG001|Overall Study|Adverse Event|3|||
17001676|NCT00975689|38145712|FG000|Overall Study|Withdrawal by Subject|1|||
17001677|NCT00975689|38145713|FG001|Overall Study|Withdrawal by Subject|0|||
17001678|NCT00975689|38145712|FG000|Overall Study|Physician Decision|1|||
17001679|NCT00975689|38145713|FG001|Overall Study|Physician Decision|0|||
17001680|NCT00922766|38145719|FG000|Overall Study|Death|3|||
17001681|NCT00922766|38145719|FG000|Overall Study|Withdrawal by Subject|2|||
17001682|NCT00922766|38145719|FG000|Overall Study|Other|1|||
17001683|NCT00922766|38145719|FG000|Overall Study|Adverse Event|1|||
17001684|NCT00917852|38145723|FG000|Overall Study|Death|6|||
17001685|NCT00976391|38145730|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
17001686|NCT00976391|38145731|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
17001687|NCT00976391|38145730|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
17001688|NCT00976391|38145731|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
17001689|NCT00976391|38145730|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
17001690|NCT00976391|38145731|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
17001691|NCT00976391|38145730|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
17001692|NCT00976391|38145731|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
17001693|NCT00976391|38145730|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
17001694|NCT00976391|38145731|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
17001695|NCT00976391|38145730|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
17001696|NCT00976391|38145731|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
17001697|NCT00976391|38145730|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
17001698|NCT00976391|38145731|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
17001699|NCT00976391|38145730|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
17001700|NCT00976391|38145731|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
17001701|NCT00976391|38145730|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
17001702|NCT00976391|38145731|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
17001703|NCT00976391|38145730|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
17001704|NCT00976391|38145731|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
17001705|NCT00976391|38145730|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
17001706|NCT00976391|38145731|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
17001707|NCT00976391|38145730|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
17001708|NCT00976391|38145731|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
17001709|NCT00976391|38145730|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
17001710|NCT00976391|38145731|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
17001711|NCT00976391|38145730|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
17001712|NCT00976391|38145731|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
17001713|NCT00917462|38145737|FG000|Overall Study|Clinical Deterioration|1|||
17001714|NCT00979901|38145745|FG000|Overall Study|Adverse Event|1|||
17001715|NCT00979901|38145746|FG001|Overall Study|Adverse Event|3|||
17001716|NCT00979901|38145747|FG002|Overall Study|Adverse Event|9|||
16785497|NCT02659631|37725569|FG006|Overall Study|Participant refused further follow-up|0|||
16785498|NCT02659631|37725570|FG007|Overall Study|Participant refused further follow-up|0|||
16785499|NCT02659631|37725571|FG008|Overall Study|Participant refused further follow-up|1|||
16785500|NCT02659631|37725572|FG009|Overall Study|Participant refused further follow-up|0|||
16785501|NCT02659631|37725563|FG000|Overall Study|Death (follow-up phase)|1|||
16785502|NCT02659631|37725564|FG001|Overall Study|Death (follow-up phase)|2|||
16785503|NCT02659631|37725565|FG002|Overall Study|Death (follow-up phase)|1|||
16785504|NCT02659631|37725566|FG003|Overall Study|Death (follow-up phase)|1|||
16785505|NCT02659631|37725567|FG004|Overall Study|Death (follow-up phase)|3|||
16785506|NCT02659631|37725568|FG005|Overall Study|Death (follow-up phase)|2|||
16785507|NCT02659631|37725569|FG006|Overall Study|Death (follow-up phase)|0|||
16785508|NCT02659631|37725570|FG007|Overall Study|Death (follow-up phase)|3|||
16785509|NCT02659631|37725571|FG008|Overall Study|Death (follow-up phase)|1|||
16785510|NCT02659631|37725572|FG009|Overall Study|Death (follow-up phase)|0|||
16785511|NCT02659631|37725563|FG000|Overall Study|Death (treatment phase)|0|||
16876947|NCT01521494|37855750|FG000|Overall Study|Decrease in serum calcium|0|||
16876948|NCT01521494|37855751|FG001|Overall Study|Decrease in serum calcium|0|||
16876949|NCT01521494|37855752|FG002|Overall Study|Decrease in serum calcium|0|||
16876950|NCT01521494|37855753|FG003|Overall Study|Decrease in serum calcium|1|||
16876951|NCT01521494|37855754|FG004|Overall Study|Decrease in serum calcium|1|||
16876952|NCT01521494|37855750|FG000|Overall Study|Physician Decision|0|||
16876953|NCT01521494|37855751|FG001|Overall Study|Physician Decision|0|||
16876954|NCT01521494|37855752|FG002|Overall Study|Physician Decision|0|||
16876955|NCT01521494|37855753|FG003|Overall Study|Physician Decision|0|||
16876956|NCT01521494|37855754|FG004|Overall Study|Physician Decision|2|||
16876957|NCT01270971|37855768|FG000|Overall Study|Withdrawal by Subject|24|||
16876958|NCT01270971|37855769|FG001|Overall Study|Withdrawal by Subject|11|||
16876959|NCT01270971|37855768|FG000|Overall Study|Lost to Follow-up|18|||
16876960|NCT01270971|37855769|FG001|Overall Study|Lost to Follow-up|5|||
16876961|NCT01270971|37855768|FG000|Overall Study|Adverse Event|1|||
16876962|NCT01270971|37855769|FG001|Overall Study|Adverse Event|2|||
16876963|NCT01270971|37855768|FG000|Overall Study|Non compliance|2|||
16876964|NCT01270971|37855769|FG001|Overall Study|Non compliance|2|||
16876965|NCT01270971|37855768|FG000|Overall Study|Non-specific|7|||
16876966|NCT01270971|37855769|FG001|Overall Study|Non-specific|3|||
16876967|NCT01270503|37855796|FG000|Overall Study|Lost to Follow-up|1|||
16876968|NCT01277211|37855813|FG000|Overall Study|Adverse Event|60|||
16876969|NCT01277211|37855814|FG001|Overall Study|Adverse Event|22|||
16876970|NCT01277211|37855813|FG000|Overall Study|Pregnancy|9|||
16876971|NCT01277211|37855814|FG001|Overall Study|Pregnancy|4|||
16876972|NCT01277211|37855813|FG000|Overall Study|Lost to Follow-up|14|||
16876973|NCT01277211|37855814|FG001|Overall Study|Lost to Follow-up|9|||
16876974|NCT01277211|37855813|FG000|Overall Study|Did not wish to continue|17|||
16876975|NCT01277211|37855814|FG001|Overall Study|Did not wish to continue|0|||
16876976|NCT01277211|37855813|FG000|Overall Study|Withdrew Consent|9|||
16876977|NCT01277211|37855814|FG001|Overall Study|Withdrew Consent|9|||
16876978|NCT01277211|37855813|FG000|Overall Study|Non-compliance with protocol|13|||
16876979|NCT01277211|37855814|FG001|Overall Study|Non-compliance with protocol|4|||
16876980|NCT01277211|37855813|FG000|Overall Study|Did not meet protocol eligibility|1|||
16876981|NCT01277211|37855814|FG001|Overall Study|Did not meet protocol eligibility|0|||
16876982|NCT01277211|37855813|FG000|Overall Study|Administrative|3|||
16876983|NCT01277211|37855814|FG001|Overall Study|Administrative|0|||
16876984|NCT01277211|37855813|FG000|Overall Study|Pregnancy wish|0|||
16876985|NCT01277211|37855814|FG001|Overall Study|Pregnancy wish|2|||
16876986|NCT01277211|37855813|FG000|Overall Study|Discontinued prior to treatment|24|||
16876987|NCT01277211|37855814|FG001|Overall Study|Discontinued prior to treatment|13|||
16876988|NCT01676220|37855822|FG000|Overall Study|Randomized But Not Treated|4|||
16876989|NCT01676220|37855823|FG001|Overall Study|Randomized But Not Treated|1|||
16876990|NCT01676220|37855822|FG000|Overall Study|Adverse Event|10|||
16876991|NCT01676220|37855823|FG001|Overall Study|Adverse Event|8|||
16876992|NCT01676220|37855822|FG000|Overall Study|Lack of Efficacy|2|||
16876993|NCT01676220|37855823|FG001|Overall Study|Lack of Efficacy|5|||
16876994|NCT01676220|37855822|FG000|Overall Study|Protocol Violation|11|||
16876995|NCT01676220|37855823|FG001|Overall Study|Protocol Violation|12|||
16876996|NCT01676220|37855822|FG000|Overall Study|Received Rescue Therapy|14|||
16876997|NCT01676220|37855823|FG001|Overall Study|Received Rescue Therapy|22|||
16876998|NCT01676220|37855822|FG000|Overall Study|Personal Reason|34|||
16876999|NCT01676220|37855823|FG001|Overall Study|Personal Reason|45|||
16877000|NCT01676220|37855822|FG000|Overall Study|Lost to Follow-up|11|||
16877001|NCT01676220|37855823|FG001|Overall Study|Lost to Follow-up|18|||
16877002|NCT01676220|37855822|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
16877003|NCT01676220|37855823|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
16877004|NCT01676220|37855822|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
16877005|NCT01676220|37855823|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
16877006|NCT01676220|37855822|FG000|Overall Study|Perceived Lack of Efficacy|3|||
16877007|NCT01676220|37855823|FG001|Overall Study|Perceived Lack of Efficacy|1|||
16877008|NCT01676220|37855822|FG000|Overall Study|Non Serious Hypoglycemia|2|||
16877009|NCT01676220|37855823|FG001|Overall Study|Non Serious Hypoglycemia|0|||
16877010|NCT01676220|37855822|FG000|Overall Study|No More Need of Insulin|1|||
16877011|NCT01676220|37855823|FG001|Overall Study|No More Need of Insulin|0|||
16877012|NCT01485614|37855853|FG000|Randomization|Not Treated|1|||
16877013|NCT01485614|37855854|FG001|Randomization|Not Treated|0|||
16877014|NCT01485614|37855855|FG002|Randomization|Not Treated|0|||
16877015|NCT01485614|37855856|FG003|Randomization|Not Treated|0|||
16877016|NCT01485614|37855853|FG000|Weeks 0-20|Lost to Follow-up|2|||
16785512|NCT02659631|37725564|FG001|Overall Study|Death (treatment phase)|0|||
16785513|NCT02659631|37725565|FG002|Overall Study|Death (treatment phase)|0|||
16785514|NCT02659631|37725566|FG003|Overall Study|Death (treatment phase)|0|||
16785515|NCT02659631|37725567|FG004|Overall Study|Death (treatment phase)|1|||
16785516|NCT02659631|37725568|FG005|Overall Study|Death (treatment phase)|0|||
16877017|NCT01485614|37855854|FG001|Weeks 0-20|Lost to Follow-up|0|||
16877018|NCT01485614|37855855|FG002|Weeks 0-20|Lost to Follow-up|0|||
16877019|NCT01485614|37855856|FG003|Weeks 0-20|Lost to Follow-up|0|||
16877020|NCT01485614|37855853|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
16877021|NCT01485614|37855854|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
16877022|NCT01485614|37855855|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
16877023|NCT01485614|37855856|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
16877024|NCT01485614|37855853|FG000|Weeks 0-20|Withdrawal by Subject|3|||
16877025|NCT01485614|37855854|FG001|Weeks 0-20|Withdrawal by Subject|2|||
16877026|NCT01485614|37855855|FG002|Weeks 0-20|Withdrawal by Subject|1|||
16877027|NCT01485614|37855856|FG003|Weeks 0-20|Withdrawal by Subject|0|||
16877028|NCT01485614|37855853|FG000|Weeks 20-54|Lost to Follow-up|4|||
16877029|NCT01485614|37855854|FG001|Weeks 20-54|Lost to Follow-up|3|||
16877030|NCT01485614|37855855|FG002|Weeks 20-54|Lost to Follow-up|1|||
16877031|NCT01485614|37855856|FG003|Weeks 20-54|Lost to Follow-up|0|||
16877032|NCT01485614|37855853|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
16877033|NCT01485614|37855854|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
16877034|NCT01485614|37855855|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
16877035|NCT01485614|37855856|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
16877036|NCT01485614|37855853|FG000|Weeks 20-54|Withdrawal by Subject|5|||
16877037|NCT01485614|37855854|FG001|Weeks 20-54|Withdrawal by Subject|3|||
16877038|NCT01485614|37855855|FG002|Weeks 20-54|Withdrawal by Subject|0|||
16877039|NCT01485614|37855856|FG003|Weeks 20-54|Withdrawal by Subject|0|||
17001717|NCT00979901|38145748|FG003|Overall Study|Adverse Event|2|||
17001718|NCT00979901|38145745|FG000|Overall Study|Lack of Efficacy|8|||
17001719|NCT00979901|38145746|FG001|Overall Study|Lack of Efficacy|4|||
17001720|NCT00979901|38145747|FG002|Overall Study|Lack of Efficacy|9|||
17001721|NCT00979901|38145748|FG003|Overall Study|Lack of Efficacy|0|||
17001722|NCT00979901|38145745|FG000|Overall Study|Lost to Follow-up|1|||
17001723|NCT00979901|38145746|FG001|Overall Study|Lost to Follow-up|1|||
17001724|NCT00979901|38145747|FG002|Overall Study|Lost to Follow-up|2|||
17001725|NCT00979901|38145748|FG003|Overall Study|Lost to Follow-up|0|||
17001726|NCT00979901|38145745|FG000|Overall Study|Protocol Violation|2|||
17001727|NCT00979901|38145746|FG001|Overall Study|Protocol Violation|2|||
17001728|NCT00979901|38145747|FG002|Overall Study|Protocol Violation|7|||
17001729|NCT00979901|38145748|FG003|Overall Study|Protocol Violation|1|||
17001730|NCT00979901|38145745|FG000|Overall Study|Withdrawal by Subject|2|||
17001731|NCT00979901|38145746|FG001|Overall Study|Withdrawal by Subject|1|||
17001732|NCT00979901|38145747|FG002|Overall Study|Withdrawal by Subject|1|||
17001733|NCT00979901|38145748|FG003|Overall Study|Withdrawal by Subject|1|||
17001734|NCT00979901|38145745|FG000|Overall Study|Noncompliance|1|||
17001735|NCT00979901|38145746|FG001|Overall Study|Noncompliance|0|||
17001736|NCT00979901|38145747|FG002|Overall Study|Noncompliance|0|||
17001737|NCT00979901|38145748|FG003|Overall Study|Noncompliance|0|||
17001738|NCT00979901|38145745|FG000|Overall Study|out-of-state|1|||
17001739|NCT00979901|38145746|FG001|Overall Study|out-of-state|0|||
17001740|NCT00979901|38145747|FG002|Overall Study|out-of-state|0|||
17001741|NCT00979901|38145748|FG003|Overall Study|out-of-state|0|||
17001742|NCT00979901|38145745|FG000|Overall Study|vacation|1|||
17001743|NCT00979901|38145746|FG001|Overall Study|vacation|0|||
17001744|NCT00979901|38145747|FG002|Overall Study|vacation|0|||
17001745|NCT00979901|38145748|FG003|Overall Study|vacation|0|||
17001746|NCT00979901|38145745|FG000|Overall Study|elevated lab values pre-randomization|1|||
17001747|NCT00979901|38145746|FG001|Overall Study|elevated lab values pre-randomization|0|||
17001748|NCT00979901|38145747|FG002|Overall Study|elevated lab values pre-randomization|0|||
17001749|NCT00979901|38145748|FG003|Overall Study|elevated lab values pre-randomization|0|||
17001750|NCT00979901|38145745|FG000|Overall Study|Discontinued in Error|0|||
17001751|NCT00979901|38145746|FG001|Overall Study|Discontinued in Error|1|||
17001752|NCT00979901|38145747|FG002|Overall Study|Discontinued in Error|0|||
17001753|NCT00979901|38145748|FG003|Overall Study|Discontinued in Error|0|||
17001754|NCT00979901|38145745|FG000|Overall Study|Left Country|0|||
17001755|NCT00979901|38145746|FG001|Overall Study|Left Country|0|||
17001756|NCT00979901|38145747|FG002|Overall Study|Left Country|1|||
17001757|NCT00979901|38145748|FG003|Overall Study|Left Country|0|||
17001758|NCT00979901|38145745|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
17001759|NCT00979901|38145746|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
16877040|NCT01485536|37855906|FG000|Overall Study|Withdrawal by Subject|3|||
16877041|NCT01485536|37855906|FG000|Overall Study|Adverse Event|1|||
17001760|NCT00979901|38145747|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
17001761|NCT00979901|38145748|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
17001762|NCT00975611|38145757|FG000|Overall Study|Screen Fail|16|||
17001763|NCT00975611|38145757|FG000|Overall Study|Physician Decision|1|||
17001764|NCT00970307|38145764|FG000|Overall Study|Serious Adverse Event|1|||
17001765|NCT00970307|38145765|FG001|Overall Study|Serious Adverse Event|0|||
17001766|NCT00970307|38145766|FG002|Overall Study|Serious Adverse Event|0|||
17001767|NCT00970307|38145764|FG000|Overall Study|Withdrawal by Subject|2|||
17001768|NCT00970307|38145765|FG001|Overall Study|Withdrawal by Subject|3|||
17001769|NCT00970307|38145766|FG002|Overall Study|Withdrawal by Subject|2|||
16877042|NCT02658630|37855910|FG000|Overall Study|Withdrawal by Subject|4|||
16877043|NCT01484912|37855916|FG000|Overall Study|Withdrawal by Subject|1|||
16877044|NCT01484912|37855917|FG001|Overall Study|Withdrawal by Subject|0|||
16877045|NCT01484912|37855916|FG000|Overall Study|Physician Decision|0|||
16877046|NCT01484912|37855917|FG001|Overall Study|Physician Decision|1|||
16877047|NCT01520870|37855923|FG000|Overall Study|Withdrawal by Subject|2|||
16877048|NCT01520714|37855929|FG000|Overall Study|Protocol Violation|0|||
16877049|NCT01520714|37855930|FG001|Overall Study|Protocol Violation|3|||
16877050|NCT01520714|37855929|FG000|Overall Study|Adverse Event|0|||
16877051|NCT01520714|37855930|FG001|Overall Study|Adverse Event|2|||
16877052|NCT01520714|37855929|FG000|Overall Study|Lack of Efficacy|0|||
16877053|NCT01520714|37855930|FG001|Overall Study|Lack of Efficacy|1|||
16877054|NCT02659098|37855949|FG000|Overall Study|Withdrawal by Subject|7|||
16877055|NCT01508936|37855960|FG000|Overall Study|Adverse Event|11|||
16877056|NCT01508936|37855961|FG001|Overall Study|Adverse Event|32|||
16877057|NCT01508936|37855960|FG000|Overall Study|Lack of Efficacy|0|||
16877058|NCT01508936|37855961|FG001|Overall Study|Lack of Efficacy|1|||
16877059|NCT01508936|37855960|FG000|Overall Study|Withdrawal by Subject|4|||
16877060|NCT01508936|37855961|FG001|Overall Study|Withdrawal by Subject|18|||
16877061|NCT01508936|37855960|FG000|Overall Study|Protocol Violation|2|||
16877062|NCT01508936|37855961|FG001|Overall Study|Protocol Violation|3|||
16877063|NCT01508936|37855960|FG000|Overall Study|Lost to Follow-up|2|||
16877064|NCT01508936|37855961|FG001|Overall Study|Lost to Follow-up|9|||
16877065|NCT01508936|37855960|FG000|Overall Study|Other|0|||
16877066|NCT01508936|37855961|FG001|Overall Study|Other|5|||
16877067|NCT01508936|37855960|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
17095186|NCT00076024|38234483|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
17095187|NCT00076024|38234484|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
17095188|NCT00076024|38234485|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
17001770|NCT00917384|38145776|FG000|Overall Study|Lost to Follow-up|4|||
17001771|NCT00917384|38145777|FG001|Overall Study|Lost to Follow-up|2|||
17001772|NCT00917384|38145776|FG000|Overall Study|Withdrawal by Subject|10|||
17001773|NCT00917384|38145777|FG001|Overall Study|Withdrawal by Subject|2|||
17001774|NCT00864513|38145783|FG000|Overall Study|Withdrawal by Subject|3|||
17001775|NCT00917150|38145791|FG000|Overall Study|Adverse Event|12|||
17001776|NCT00917150|38145792|FG001|Overall Study|Adverse Event|7|||
17095189|NCT00076024|38234482|FG000|Phase 2, Double-blind|Adverse Event|0|||
17095190|NCT00076024|38234483|FG001|Phase 2, Double-blind|Adverse Event|25|||
17095191|NCT00076024|38234484|FG002|Phase 2, Double-blind|Adverse Event|6|||
17095192|NCT00076024|38234485|FG003|Phase 2, Double-blind|Adverse Event|0|||
17095193|NCT00076024|38234482|FG000|Phase 2, Double-blind|Un-specified|0|||
17095194|NCT00076024|38234483|FG001|Phase 2, Double-blind|Un-specified|14|||
17095195|NCT00076024|38234484|FG002|Phase 2, Double-blind|Un-specified|6|||
17095196|NCT00076024|38234485|FG003|Phase 2, Double-blind|Un-specified|0|||
17095197|NCT00076024|38234482|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
17095198|NCT00076024|38234483|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
17095199|NCT00076024|38234484|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
17095200|NCT00076024|38234485|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
17095201|NCT00076024|38234482|FG000|Phase 2, Open-label|Adverse Event|0|||
17095202|NCT00076024|38234483|FG001|Phase 2, Open-label|Adverse Event|0|||
17095203|NCT00076024|38234484|FG002|Phase 2, Open-label|Adverse Event|0|||
17095204|NCT00076024|38234485|FG003|Phase 2, Open-label|Adverse Event|2|||
17095205|NCT00076024|38234482|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
17095206|NCT00076024|38234483|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
17095207|NCT00076024|38234484|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
17095208|NCT00076024|38234485|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
17095209|NCT00076024|38234482|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
17095210|NCT00076024|38234483|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
17095211|NCT00076024|38234484|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
17095212|NCT00076024|38234485|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
17095213|NCT00076024|38234482|FG000|Phase 2, Open-label|Other|0|||
17095214|NCT00076024|38234483|FG001|Phase 2, Open-label|Other|0|||
17095215|NCT00076024|38234484|FG002|Phase 2, Open-label|Other|0|||
17095216|NCT00076024|38234485|FG003|Phase 2, Open-label|Other|2|||
17095217|NCT00075478|38234496|FG000|Overall Study|not eligible|1|||
17095218|NCT00075478|38234497|FG001|Overall Study|not eligible|0|||
17095219|NCT00075478|38234496|FG000|Overall Study|Physician Decision|0|||
17095220|NCT00075478|38234497|FG001|Overall Study|Physician Decision|1|||
17095221|NCT00175916|38234503|FG000|Overall Study|Death|19|||
17095222|NCT00175916|38234503|FG000|Overall Study|Adverse Event|81|||
17095223|NCT00175916|38234503|FG000|Overall Study|Lack of Efficacy|354|||
16877068|NCT01508936|37855961|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
16877069|NCT01508702|37855982|FG000|Overall Study|Adverse Event|7|||
16877070|NCT01508702|37855983|FG001|Overall Study|Adverse Event|3|||
17001777|NCT00917150|38145793|FG002|Overall Study|Adverse Event|12|||
17001778|NCT00917150|38145794|FG003|Overall Study|Adverse Event|11|||
17001779|NCT00917150|38145791|FG000|Overall Study|Death|1|||
17095224|NCT00175916|38234503|FG000|Overall Study|Lost to Follow-up|17|||
16877071|NCT01508702|37855982|FG000|Overall Study|Gout flare|2|||
16877072|NCT01508702|37855983|FG001|Overall Study|Gout flare|0|||
17191529|NCT02862457|38344296|FG006|Overall Study|Lost to Follow-up|0|||
17191530|NCT02862457|38344290|FG000|Overall Study|Withdrawal by Subject|0|||
17191531|NCT02862457|38344291|FG001|Overall Study|Withdrawal by Subject|0|||
17191532|NCT02862457|38344292|FG002|Overall Study|Withdrawal by Subject|1|||
17191533|NCT02862457|38344293|FG003|Overall Study|Withdrawal by Subject|0|||
17191534|NCT02862457|38344294|FG004|Overall Study|Withdrawal by Subject|0|||
17191535|NCT02862457|38344295|FG005|Overall Study|Withdrawal by Subject|1|||
17191536|NCT02862457|38344296|FG006|Overall Study|Withdrawal by Subject|0|||
17191537|NCT02447302|38344323|FG000|Overall Study|Physician Decision|1|||
17191538|NCT02447302|38344324|FG001|Overall Study|Physician Decision|0|||
17191539|NCT02447302|38344325|FG002|Overall Study|Physician Decision|0|||
17191540|NCT02447302|38344323|FG000|Overall Study|Adverse Event|4|||
17191541|NCT02447302|38344324|FG001|Overall Study|Adverse Event|3|||
17191542|NCT02447302|38344325|FG002|Overall Study|Adverse Event|0|||
17191543|NCT02447302|38344323|FG000|Overall Study|Withdrawal by Subject|0|||
17191544|NCT02447302|38344324|FG001|Overall Study|Withdrawal by Subject|1|||
17191545|NCT02447302|38344325|FG002|Overall Study|Withdrawal by Subject|5|||
17191546|NCT02447302|38344323|FG000|Overall Study|Sponsor Decision|0|||
17191547|NCT02447302|38344324|FG001|Overall Study|Sponsor Decision|0|||
17191548|NCT02447302|38344325|FG002|Overall Study|Sponsor Decision|1|||
17191549|NCT02454517|38344335|FG000|Overall Study|Withdrawal by Subject|3|||
17191550|NCT02454517|38344336|FG001|Overall Study|Withdrawal by Subject|0|||
17191551|NCT02454517|38344335|FG000|Overall Study|Lost to Follow-up|4|||
17191552|NCT02454517|38344336|FG001|Overall Study|Lost to Follow-up|7|||
17191553|NCT02454517|38344335|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
17191554|NCT02454517|38344336|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
17191555|NCT03861039|38344347|FG000|Overall Study|Adverse Event|2|||
17191556|NCT03861039|38344348|FG001|Overall Study|Adverse Event|5|||
17191557|NCT03861039|38344349|FG002|Overall Study|Adverse Event|11|||
17191558|NCT03861039|38344347|FG000|Overall Study|Withdrawal by Subject|1|||
17191559|NCT03861039|38344348|FG001|Overall Study|Withdrawal by Subject|3|||
17191560|NCT03861039|38344349|FG002|Overall Study|Withdrawal by Subject|4|||
17191561|NCT02731755|38344359|FG000|First Intervention|Withdrawal by Subject|0|||
17191562|NCT02731755|38344360|FG001|First Intervention|Withdrawal by Subject|2|||
17191563|NCT02866175|38344389|FG000|Overall Study|Adverse Event|56|||
17191564|NCT02866175|38344390|FG001|Overall Study|Adverse Event|54|||
17191565|NCT02866175|38344389|FG000|Overall Study|Withdrawal by Subject|31|||
17191566|NCT02866175|38344390|FG001|Overall Study|Withdrawal by Subject|52|||
17191567|NCT02866175|38344389|FG000|Overall Study|Death|30|||
17191568|NCT02866175|38344390|FG001|Overall Study|Death|23|||
17191569|NCT02866175|38344389|FG000|Overall Study|Other|7|||
17191570|NCT02866175|38344390|FG001|Overall Study|Other|14|||
17191571|NCT02866175|38344389|FG000|Overall Study|Progressive disease|1|||
17191572|NCT02866175|38344390|FG001|Overall Study|Progressive disease|1|||
17191573|NCT02866175|38344389|FG000|Overall Study|Lost to Follow-up|2|||
17191574|NCT02866175|38344390|FG001|Overall Study|Lost to Follow-up|0|||
17191575|NCT02866175|38344389|FG000|Overall Study|Lack of Efficacy|0|||
17191576|NCT02866175|38344390|FG001|Overall Study|Lack of Efficacy|1|||
17191577|NCT02866175|38344389|FG000|Overall Study|Physician Decision|3|||
17191578|NCT02866175|38344390|FG001|Overall Study|Physician Decision|15|||
17191579|NCT02866175|38344389|FG000|Overall Study|Did not receive treatment|5|||
17191580|NCT02866175|38344390|FG001|Overall Study|Did not receive treatment|15|||
17191581|NCT03675308|38344403|FG000|Overall Study|Adverse Event|3|||
17191582|NCT03675308|38344404|FG001|Overall Study|Adverse Event|2|||
17191583|NCT03675308|38344403|FG000|Overall Study|Withdrawal by Subject|6|||
17191584|NCT03675308|38344404|FG001|Overall Study|Withdrawal by Subject|4|||
17191585|NCT03675308|38344403|FG000|Overall Study|Lost to Follow-up|3|||
17191586|NCT03675308|38344404|FG001|Overall Study|Lost to Follow-up|0|||
17191587|NCT03675308|38344403|FG000|Overall Study|Lack of Efficacy|1|||
17191588|NCT03675308|38344404|FG001|Overall Study|Lack of Efficacy|1|||
17191589|NCT03675308|38344403|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
16785517|NCT02659631|37725569|FG006|Overall Study|Death (treatment phase)|1|||
16785518|NCT02659631|37725570|FG007|Overall Study|Death (treatment phase)|0|||
17191590|NCT03675308|38344404|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
17191591|NCT03675308|38344403|FG000|Overall Study|Other|0|||
17191592|NCT03675308|38344404|FG001|Overall Study|Other|1|||
17191593|NCT01336205|38344412|FG000|Overall Study|Other|22|||
17191594|NCT01336205|38344413|FG001|Overall Study|Other|9|||
17191595|NCT01336205|38344412|FG000|Overall Study|Lost to Follow-up|40|||
17191596|NCT01336205|38344413|FG001|Overall Study|Lost to Follow-up|20|||
17191597|NCT01336205|38344412|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
17191598|NCT01336205|38344413|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
17191599|NCT01336205|38344412|FG000|Overall Study|Lack of Efficacy|4|||
17191600|NCT01336205|38344413|FG001|Overall Study|Lack of Efficacy|0|||
17191601|NCT01336205|38344412|FG000|Overall Study|Severe noncompliance with protocol|9|||
17191602|NCT01336205|38344413|FG001|Overall Study|Severe noncompliance with protocol|2|||
16877073|NCT01508702|37855982|FG000|Overall Study|Protocol Violation|2|||
16877074|NCT01508702|37855983|FG001|Overall Study|Protocol Violation|1|||
16877075|NCT01508702|37855982|FG000|Overall Study|Lost to Follow-up|1|||
16877076|NCT01508702|37855983|FG001|Overall Study|Lost to Follow-up|2|||
16877077|NCT01508702|37855982|FG000|Overall Study|Withdrawal by Subject|11|||
16877078|NCT01508702|37855983|FG001|Overall Study|Withdrawal by Subject|7|||
16877079|NCT01484834|37855997|FG000|Overall Study|Lost to Follow-up|5|||
16877080|NCT01484834|37855998|FG001|Overall Study|Lost to Follow-up|8|||
16877081|NCT01484834|37855999|FG002|Overall Study|Lost to Follow-up|1|||
16877082|NCT01484834|37856000|FG003|Overall Study|Lost to Follow-up|4|||
16877083|NCT01484132|37856010|FG000|Overall Study|Lost to Follow-up|8|||
16877084|NCT01484132|37856010|FG000|Overall Study|Difficulty with time commitment|2|||
16877085|NCT01484132|37856010|FG000|Overall Study|Ineligible|1|||
16877086|NCT01484132|37856010|FG000|Overall Study|No pre-treatment urine sample collected|1|||
16877087|NCT01484132|37856010|FG000|Overall Study|No post-treatment urine sample collected|10|||
16877088|NCT01276041|37856014|FG000|Overall Study|Adverse Event|2|||
16877089|NCT01276041|37856014|FG000|Overall Study|Protocol Violation|1|||
16877090|NCT01275339|37856022|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
16877091|NCT01275339|37856023|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
16877092|NCT01275339|37856024|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
16877093|NCT01275339|37856025|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
16877094|NCT01275339|37856022|FG000|Overall Study|Withdrawal by Subject|0|||
16877095|NCT01275339|37856023|FG001|Overall Study|Withdrawal by Subject|0|||
16877096|NCT01275339|37856024|FG002|Overall Study|Withdrawal by Subject|1|||
16877097|NCT01275339|37856025|FG003|Overall Study|Withdrawal by Subject|0|||
16877098|NCT01520402|37856035|FG000|Overall Study|Withdrawal by Subject|2|||
16877099|NCT01520402|37856035|FG000|Overall Study|Physician Decision|3|||
16877100|NCT01520324|37856050|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
16877101|NCT01519934|37856054|FG000|Overall Study|Lost to Follow-up|3|||
16877102|NCT01484054|37856058|FG000|Period 1|Withdrawal by Subject|0|||
16877103|NCT01484054|37856059|FG001|Period 1|Withdrawal by Subject|1|||
16877104|NCT01483820|37856066|FG000|Overall Study|Lack of Efficacy|6|||
16877105|NCT01483820|37856066|FG000|Overall Study|Adverse Event|1|||
16877106|NCT01483820|37856066|FG000|Overall Study|Death|1|||
16877107|NCT01507298|37856081|FG000|Overall Study|Protocol Violation|0|||
16877108|NCT01507298|37856082|FG001|Overall Study|Protocol Violation|6|||
16877109|NCT01483118|37856091|FG000|Overall Study|Lost to Follow-up|12|||
16877110|NCT01483118|37856092|FG001|Overall Study|Lost to Follow-up|16|||
16877111|NCT01506908|37856102|FG000|Overall Study|Adverse Event|1|||
16877112|NCT01506908|37856103|FG001|Overall Study|Adverse Event|0|||
16877113|NCT01519778|37856111|FG000|Overall Study|Withdrawal by Subject|3|||
16877114|NCT01519778|37856111|FG000|Overall Study|Lost to Follow-up|10|||
16877115|NCT01519778|37856111|FG000|Overall Study|Physician Decision|1|||
16877116|NCT01519700|37856119|FG000|Overall Study|Death|1|||
16877117|NCT01519700|37856120|FG001|Overall Study|Death|0|||
16877118|NCT01519700|37856121|FG002|Overall Study|Death|0|||
16877119|NCT01519700|37856122|FG003|Overall Study|Death|0|||
16877120|NCT01519700|37856119|FG000|Overall Study|Lost to Follow-up|0|||
16877121|NCT01519700|37856120|FG001|Overall Study|Lost to Follow-up|0|||
16877122|NCT01519700|37856121|FG002|Overall Study|Lost to Follow-up|1|||
16877123|NCT01519700|37856122|FG003|Overall Study|Lost to Follow-up|1|||
16877124|NCT01519700|37856119|FG000|Overall Study|Physician Decision|1|||
16877125|NCT01519700|37856120|FG001|Overall Study|Physician Decision|1|||
16877126|NCT01519700|37856121|FG002|Overall Study|Physician Decision|3|||
16877127|NCT01519700|37856122|FG003|Overall Study|Physician Decision|0|||
16877128|NCT01519700|37856119|FG000|Overall Study|Withdrawal by Subject|5|||
16877129|NCT01519700|37856120|FG001|Overall Study|Withdrawal by Subject|3|||
16877130|NCT01519700|37856121|FG002|Overall Study|Withdrawal by Subject|3|||
16877131|NCT01519700|37856122|FG003|Overall Study|Withdrawal by Subject|2|||
16877132|NCT01519700|37856119|FG000|Overall Study|Other Reason|2|||
16877133|NCT01519700|37856120|FG001|Overall Study|Other Reason|2|||
16877134|NCT01519700|37856121|FG002|Overall Study|Other Reason|0|||
16877135|NCT01519700|37856122|FG003|Overall Study|Other Reason|4|||
16877136|NCT02656680|37856140|FG000|Overall Study|Lost to Follow-up|0|||
16877137|NCT02656680|37856141|FG001|Overall Study|Lost to Follow-up|1|||
16877138|NCT02658084|37856177|FG000|Overall Study|Withdrawal by Subject|1|||
16877139|NCT02658084|37856178|FG001|Overall Study|Withdrawal by Subject|0|||
16877140|NCT02658084|37856177|FG000|Overall Study|Study Termination|1|||
16877141|NCT02658084|37856178|FG001|Overall Study|Study Termination|0|||
16877142|NCT01482962|37856194|FG000|Overall Study|Progressive Disease|65|||
16877143|NCT01482962|37856195|FG001|Overall Study|Progressive Disease|53|||
16877144|NCT01482962|37856194|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
16877145|NCT01482962|37856195|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
16877146|NCT01482962|37856194|FG000|Overall Study|Adverse Event|18|||
16877147|NCT01482962|37856195|FG001|Overall Study|Adverse Event|22|||
16877148|NCT01482962|37856194|FG000|Overall Study|Withdrawal by Participant|8|||
16877149|NCT01482962|37856195|FG001|Overall Study|Withdrawal by Participant|13|||
16877150|NCT01482962|37856194|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
16877151|NCT01482962|37856195|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
16877152|NCT01482962|37856194|FG000|Overall Study|Other Reason|1|||
16877153|NCT01482962|37856195|FG001|Overall Study|Other Reason|5|||
16877154|NCT01482962|37856194|FG000|Overall Study|Study Terminated by Sponsor|5|||
16877155|NCT01482962|37856195|FG001|Overall Study|Study Terminated by Sponsor|2|||
16877156|NCT01482962|37856194|FG000|Overall Study|Did not Receive Study Drug|1|||
16877157|NCT01482962|37856195|FG001|Overall Study|Did not Receive Study Drug|6|||
16877158|NCT02655666|37856203|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
16877159|NCT01506596|37856207|FG000|Overall Study|ineligible pathology|1|||
16877160|NCT01482884|37856226|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
16877161|NCT01482884|37856227|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
16877162|NCT01482884|37856226|FG000|Overall Study|Protocol Violation|1|||
16877163|NCT01482884|37856227|FG001|Overall Study|Protocol Violation|0|||
16877164|NCT01482884|37856226|FG000|Overall Study|Lost to Follow-up|2|||
16877165|NCT01482884|37856227|FG001|Overall Study|Lost to Follow-up|2|||
16877166|NCT01482884|37856226|FG000|Overall Study|Lack of Efficacy|0|||
16877167|NCT01482884|37856227|FG001|Overall Study|Lack of Efficacy|1|||
16877168|NCT01482884|37856226|FG000|Overall Study|Adverse Event|2|||
16877169|NCT01482884|37856227|FG001|Overall Study|Adverse Event|1|||
16877170|NCT01482884|37856226|FG000|Overall Study|Withdrawal by Subject|8|||
16877171|NCT01482884|37856227|FG001|Overall Study|Withdrawal by Subject|13|||
16877172|NCT01518374|37856233|FG000|Overall Study|Withdrawal by Subject|2|||
16877173|NCT01518374|37856233|FG000|Overall Study|Protocol Violation|3|||
16877174|NCT01518374|37856233|FG000|Overall Study|Lost to Follow-up|2|||
16877175|NCT01481324|37856240|FG000|Overall Study|Missing Data|0|||
16877176|NCT01481324|37856241|FG001|Overall Study|Missing Data|2|||
16877177|NCT01481324|37856242|FG002|Overall Study|Missing Data|2|||
16877178|NCT01602510|37856250|FG000|Open Label Phase|Adverse Event|46|||
16877179|NCT01602510|37856251|FG001|Open Label Phase|Adverse Event|0|||
16877180|NCT01602510|37856252|FG002|Open Label Phase|Adverse Event|0|||
16877181|NCT01602510|37856250|FG000|Open Label Phase|Lack of Efficacy|22|||
16877182|NCT01602510|37856251|FG001|Open Label Phase|Lack of Efficacy|0|||
16877183|NCT01602510|37856252|FG002|Open Label Phase|Lack of Efficacy|0|||
16877184|NCT01602510|37856250|FG000|Open Label Phase|Protocol Violation|15|||
16877185|NCT01602510|37856251|FG001|Open Label Phase|Protocol Violation|0|||
16877186|NCT01602510|37856252|FG002|Open Label Phase|Protocol Violation|0|||
16877187|NCT01602510|37856250|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
16877188|NCT01602510|37856251|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
16877189|NCT01602510|37856252|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
16877190|NCT01602510|37856250|FG000|Open Label Phase|Lost to Follow-up|22|||
16877191|NCT01602510|37856251|FG001|Open Label Phase|Lost to Follow-up|0|||
16877192|NCT01602510|37856252|FG002|Open Label Phase|Lost to Follow-up|0|||
16877193|NCT01602510|37856250|FG000|Open Label Phase|Physician Decision|19|||
16877194|NCT01602510|37856251|FG001|Open Label Phase|Physician Decision|0|||
16877195|NCT01602510|37856252|FG002|Open Label Phase|Physician Decision|0|||
16877196|NCT01602510|37856250|FG000|Open Label Phase|Withdrawal by Subject|57|||
16877197|NCT01602510|37856251|FG001|Open Label Phase|Withdrawal by Subject|0|||
16877198|NCT01602510|37856252|FG002|Open Label Phase|Withdrawal by Subject|0|||
16877199|NCT01602510|37856250|FG000|Randomized Phase|Adverse Event|0|||
16877200|NCT01602510|37856251|FG001|Randomized Phase|Adverse Event|2|||
16877201|NCT01602510|37856252|FG002|Randomized Phase|Adverse Event|6|||
16877202|NCT01602510|37856250|FG000|Randomized Phase|Lack of Efficacy|0|||
16877203|NCT01602510|37856251|FG001|Randomized Phase|Lack of Efficacy|4|||
16877204|NCT01602510|37856252|FG002|Randomized Phase|Lack of Efficacy|4|||
16877205|NCT01602510|37856250|FG000|Randomized Phase|Protocol Violation|0|||
16877206|NCT01602510|37856251|FG001|Randomized Phase|Protocol Violation|3|||
16877207|NCT01602510|37856252|FG002|Randomized Phase|Protocol Violation|3|||
16877208|NCT01602510|37856250|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
16877209|NCT01602510|37856251|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
16877210|NCT01602510|37856252|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
16877211|NCT01602510|37856250|FG000|Randomized Phase|Lost to Follow-up|0|||
16877212|NCT01602510|37856251|FG001|Randomized Phase|Lost to Follow-up|1|||
16877213|NCT01602510|37856252|FG002|Randomized Phase|Lost to Follow-up|3|||
16877214|NCT01602510|37856250|FG000|Randomized Phase|Physician Decision|0|||
16877215|NCT01602510|37856251|FG001|Randomized Phase|Physician Decision|0|||
16877216|NCT01602510|37856252|FG002|Randomized Phase|Physician Decision|2|||
16877217|NCT01602510|37856250|FG000|Randomized Phase|Withdrawal by Subject|0|||
16877218|NCT01602510|37856251|FG001|Randomized Phase|Withdrawal by Subject|6|||
16877219|NCT01602510|37856252|FG002|Randomized Phase|Withdrawal by Subject|7|||
16877220|NCT01675596|37856267|FG000|Overall Study|Death|6|||
16877221|NCT01675596|37856267|FG000|Overall Study|Exit with other reason|1|||
16877222|NCT01675596|37856267|FG000|Overall Study|Missed Visit|1|||
16877223|NCT02653326|37856277|FG000|Overall Study|Lost to Follow-up|10|||
16877224|NCT02653326|37856278|FG001|Overall Study|Lost to Follow-up|7|||
16877225|NCT02653170|37856287|FG000|Overall Study|Withdrawal by Subject|3|||
16877226|NCT02653170|37856288|FG001|Overall Study|Withdrawal by Subject|8|||
16877227|NCT02653170|37856289|FG002|Overall Study|Withdrawal by Subject|3|||
16877228|NCT02653170|37856287|FG000|Overall Study|withdrawn by study team|2|||
16877229|NCT02653170|37856288|FG001|Overall Study|withdrawn by study team|4|||
16877230|NCT02653170|37856289|FG002|Overall Study|withdrawn by study team|5|||
16877231|NCT02653170|37856287|FG000|Overall Study|Lost to Follow-up|12|||
16877232|NCT02653170|37856288|FG001|Overall Study|Lost to Follow-up|4|||
16877233|NCT02653170|37856289|FG002|Overall Study|Lost to Follow-up|10|||
16877234|NCT01463696|37856318|FG000|Overall Study|Adverse Event|0|||
16877235|NCT01463696|37856319|FG001|Overall Study|Adverse Event|1|||
16877236|NCT01463696|37856320|FG002|Overall Study|Adverse Event|0|||
16877237|NCT01463696|37856321|FG003|Overall Study|Adverse Event|2|||
16877238|NCT01463696|37856322|FG004|Overall Study|Adverse Event|0|||
16877239|NCT01463696|37856323|FG005|Overall Study|Adverse Event|1|||
16877240|NCT01463696|37856324|FG006|Overall Study|Adverse Event|3|||
16877241|NCT01463696|37856325|FG007|Overall Study|Adverse Event|2|||
16877242|NCT01463696|37856318|FG000|Overall Study|Lost to Follow-up|0|||
16877243|NCT01463696|37856319|FG001|Overall Study|Lost to Follow-up|0|||
16877244|NCT01463696|37856320|FG002|Overall Study|Lost to Follow-up|1|||
16877245|NCT01463696|37856321|FG003|Overall Study|Lost to Follow-up|0|||
16877246|NCT01463696|37856322|FG004|Overall Study|Lost to Follow-up|0|||
16877247|NCT01463696|37856323|FG005|Overall Study|Lost to Follow-up|0|||
16877248|NCT01463696|37856324|FG006|Overall Study|Lost to Follow-up|0|||
16877249|NCT01463696|37856325|FG007|Overall Study|Lost to Follow-up|0|||
16877250|NCT01463696|37856318|FG000|Overall Study|Progressive Disease|0|||
16877251|NCT01463696|37856319|FG001|Overall Study|Progressive Disease|1|||
16877252|NCT01463696|37856320|FG002|Overall Study|Progressive Disease|0|||
16877253|NCT01463696|37856321|FG003|Overall Study|Progressive Disease|1|||
16877254|NCT01463696|37856322|FG004|Overall Study|Progressive Disease|0|||
16877255|NCT01463696|37856323|FG005|Overall Study|Progressive Disease|1|||
16877256|NCT01463696|37856324|FG006|Overall Study|Progressive Disease|4|||
16877257|NCT01463696|37856325|FG007|Overall Study|Progressive Disease|2|||
16877258|NCT01463696|37856318|FG000|Overall Study|Withdrawal by Subject|0|||
16877259|NCT01463696|37856319|FG001|Overall Study|Withdrawal by Subject|0|||
16877260|NCT01463696|37856320|FG002|Overall Study|Withdrawal by Subject|0|||
16877261|NCT01463696|37856321|FG003|Overall Study|Withdrawal by Subject|1|||
16877262|NCT01463696|37856322|FG004|Overall Study|Withdrawal by Subject|1|||
16877263|NCT01463696|37856323|FG005|Overall Study|Withdrawal by Subject|1|||
16877264|NCT01463696|37856324|FG006|Overall Study|Withdrawal by Subject|2|||
16877265|NCT01463696|37856325|FG007|Overall Study|Withdrawal by Subject|0|||
16877266|NCT01463696|37856318|FG000|Overall Study|Not Treated|0|||
16877267|NCT01463696|37856319|FG001|Overall Study|Not Treated|0|||
16877268|NCT01463696|37856320|FG002|Overall Study|Not Treated|0|||
16877269|NCT01463696|37856321|FG003|Overall Study|Not Treated|0|||
16877270|NCT01463696|37856322|FG004|Overall Study|Not Treated|0|||
16877271|NCT01463696|37856323|FG005|Overall Study|Not Treated|0|||
16877272|NCT01463696|37856324|FG006|Overall Study|Not Treated|1|||
16877273|NCT01463696|37856325|FG007|Overall Study|Not Treated|0|||
16877274|NCT02653482|37856345|FG000|Overall Study|Death|1|||
16877275|NCT02653482|37856346|FG001|Overall Study|Death|1|||
16877276|NCT01362348|37856352|FG000|Overall Study|Protocol-defined stopping criteria|9|||
16877277|NCT01362348|37856352|FG000|Overall Study|Study closed/terminated|5|||
16877278|NCT01675128|37856422|FG000|Overall Study|Disease progression on study|1|||
16877279|NCT01675128|37856423|FG001|Overall Study|Disease progression on study|1|||
16877280|NCT01675128|37856424|FG002|Overall Study|Disease progression on study|1|||
16877281|NCT01675128|37856422|FG000|Overall Study|Refused further treatment|1|||
16877282|NCT01675128|37856423|FG001|Overall Study|Refused further treatment|0|||
16877283|NCT01675128|37856424|FG002|Overall Study|Refused further treatment|0|||
16877284|NCT01675128|37856422|FG000|Overall Study|Pulmonary complication; off study|0|||
16877285|NCT01675128|37856423|FG001|Overall Study|Pulmonary complication; off study|1|||
16877286|NCT01675128|37856424|FG002|Overall Study|Pulmonary complication; off study|0|||
16877287|NCT01427309|37856470|FG000|Overall Study|Lost to Follow-up|130|||
16877288|NCT01427309|37856471|FG001|Overall Study|Lost to Follow-up|145|||
16877289|NCT01427309|37856472|FG002|Overall Study|Lost to Follow-up|122|||
16877290|NCT01427309|37856473|FG003|Overall Study|Lost to Follow-up|135|||
16877291|NCT01427309|37856470|FG000|Overall Study|Protocol Violation|42|||
16877292|NCT01427309|37856471|FG001|Overall Study|Protocol Violation|69|||
16877293|NCT01427309|37856472|FG002|Overall Study|Protocol Violation|125|||
16877294|NCT01427309|37856473|FG003|Overall Study|Protocol Violation|124|||
16877295|NCT01427309|37856470|FG000|Overall Study|Adverse Event|0|||
16877296|NCT01427309|37856471|FG001|Overall Study|Adverse Event|0|||
16877297|NCT01427309|37856472|FG002|Overall Study|Adverse Event|3|||
16877298|NCT01427309|37856473|FG003|Overall Study|Adverse Event|1|||
16877299|NCT01427309|37856470|FG000|Overall Study|Serious adverse event|52|||
16877300|NCT01427309|37856471|FG001|Overall Study|Serious adverse event|45|||
16877301|NCT01427309|37856472|FG002|Overall Study|Serious adverse event|50|||
16877302|NCT01427309|37856473|FG003|Overall Study|Serious adverse event|61|||
16877303|NCT01427309|37856470|FG000|Overall Study|Withdrawal by Subject|148|||
16877304|NCT01427309|37856471|FG001|Overall Study|Withdrawal by Subject|148|||
16877305|NCT01427309|37856472|FG002|Overall Study|Withdrawal by Subject|61|||
16877306|NCT01427309|37856473|FG003|Overall Study|Withdrawal by Subject|55|||
16877307|NCT01426373|37856483|FG000|Overall Study|Adverse Event|6|||
16877308|NCT01426373|37856483|FG000|Overall Study|Lost to Follow-up|14|||
16877309|NCT01426373|37856483|FG000|Overall Study|Participant Convenience|10|||
16877310|NCT01426373|37856483|FG000|Overall Study|Miscellaneous Reasons|4|||
16877311|NCT01426217|37856491|FG000|Overall Study|lost sample|8|||
16877312|NCT01426217|37856492|FG001|Overall Study|lost sample|14|||
16877313|NCT01425749|37856500|FG000|Overall Study|progression of melanoma|0|||
16877314|NCT01425749|37856501|FG001|Overall Study|progression of melanoma|1|||
16877315|NCT01403987|37856517|FG000|Overall Study|Residents forgot their secret PIN|18|||
16877316|NCT01403987|37856518|FG001|Overall Study|Residents forgot their secret PIN|17|||
16877317|NCT01403987|37856519|FG002|Overall Study|Residents forgot their secret PIN|18|||
16877318|NCT01425359|37856529|FG000|Overall Study|Randomized but Not Treated|2|||
16877319|NCT01425359|37856530|FG001|Overall Study|Randomized but Not Treated|3|||
16877320|NCT01425359|37856529|FG000|Overall Study|Adverse Event|9|||
16877321|NCT01425359|37856530|FG001|Overall Study|Adverse Event|8|||
16877322|NCT01425359|37856529|FG000|Overall Study|Revascularization|0|||
16877323|NCT01425359|37856530|FG001|Overall Study|Revascularization|1|||
16877324|NCT01425359|37856529|FG000|Overall Study|Death|0|||
16877325|NCT01425359|37856530|FG001|Overall Study|Death|1|||
16877326|NCT01425359|37856529|FG000|Overall Study|Unsatisfactory Response|1|||
16877327|NCT01425359|37856530|FG001|Overall Study|Unsatisfactory Response|0|||
16877328|NCT01425359|37856529|FG000|Overall Study|Protocol Violation|1|||
16877329|NCT01425359|37856530|FG001|Overall Study|Protocol Violation|2|||
16877330|NCT01425359|37856529|FG000|Overall Study|Subject Withdrew Consent|1|||
16877331|NCT01425359|37856530|FG001|Overall Study|Subject Withdrew Consent|2|||
16877332|NCT01425359|37856529|FG000|Overall Study|Investigator's Discretion|2|||
16877333|NCT01425359|37856530|FG001|Overall Study|Investigator's Discretion|0|||
16877334|NCT01425359|37856529|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
16877335|NCT01425359|37856530|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
16877336|NCT01403051|37856550|FG000|Overall Study|Protocol Violation|2|||
16877337|NCT01403051|37856551|FG001|Overall Study|Protocol Violation|0|||
16877338|NCT01403051|37856550|FG000|Overall Study|Death|1|||
16877339|NCT01403051|37856551|FG001|Overall Study|Death|0|||
16877340|NCT01403051|37856550|FG000|Overall Study|Withdrawal by Subject|2|||
16877341|NCT01403051|37856551|FG001|Overall Study|Withdrawal by Subject|1|||
16877342|NCT01403051|37856550|FG000|Overall Study|Lost to Follow-up|5|||
16877343|NCT01403051|37856551|FG001|Overall Study|Lost to Follow-up|5|||
16877344|NCT04115748|37856566|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
16877345|NCT04115748|37856567|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
16877346|NCT04115748|37856568|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
16877347|NCT04115748|37856569|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
16877348|NCT04115748|37856570|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16877349|NCT04115748|37856571|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16877350|NCT04115748|37856572|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16877351|NCT04115748|37856573|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16877352|NCT04115748|37856574|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16877353|NCT04115748|37856575|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16877354|NCT04115748|37856566|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877355|NCT04115748|37856567|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877356|NCT04115748|37856568|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877357|NCT04115748|37856569|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
16877358|NCT04115748|37856570|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877359|NCT04115748|37856571|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877360|NCT04115748|37856572|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877361|NCT04115748|37856573|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877362|NCT04115748|37856574|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877363|NCT04115748|37856575|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16877364|NCT04115748|37856566|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
16877365|NCT04115748|37856567|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
16877366|NCT04115748|37856568|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
16877367|NCT04115748|37856569|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
16877368|NCT04115748|37856570|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
16877369|NCT04115748|37856571|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
16877370|NCT04115748|37856572|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
16877371|NCT04115748|37856573|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
16877372|NCT04115748|37856574|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
16877373|NCT04115748|37856575|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
16877374|NCT04115748|37856566|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877375|NCT04115748|37856567|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877376|NCT04115748|37856568|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877377|NCT04115748|37856569|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877378|NCT04115748|37856570|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877379|NCT04115748|37856571|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877380|NCT04115748|37856572|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877381|NCT04115748|37856573|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877382|NCT04115748|37856574|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
16877383|NCT04115748|37856575|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16877384|NCT02652624|37856632|FG000|Randomized Phase|Pregnancy|3|||
16877385|NCT02652624|37856633|FG001|Randomized Phase|Pregnancy|1|||
16877386|NCT02652624|37856632|FG000|Randomized Phase|Investigator's Discretion|0|||
16877387|NCT02652624|37856633|FG001|Randomized Phase|Investigator's Discretion|2|||
16877388|NCT02652624|37856632|FG000|Randomized Phase|Death|0|||
16877389|NCT02652624|37856633|FG001|Randomized Phase|Death|1|||
16877390|NCT02652624|37856632|FG000|Randomized Phase|Lost to Follow-up|0|||
16877391|NCT02652624|37856633|FG001|Randomized Phase|Lost to Follow-up|1|||
16877392|NCT02652624|37856632|FG000|Extension Phase|Lost to Follow-up|3|||
16877393|NCT02652624|37856633|FG001|Extension Phase|Lost to Follow-up|1|||
16877394|NCT02652624|37856632|FG000|Extension Phase|Pregnancy|1|||
16877395|NCT02652624|37856633|FG001|Extension Phase|Pregnancy|1|||
16877396|NCT02652624|37856632|FG000|Extension Phase|Adverse Event|0|||
16877397|NCT02652624|37856633|FG001|Extension Phase|Adverse Event|1|||
16877398|NCT02652624|37856632|FG000|Extension Phase|Withdrew Consent|0|||
16877399|NCT02652624|37856633|FG001|Extension Phase|Withdrew Consent|1|||
16877400|NCT00249795|37856643|FG000|Overall Study|Not treated|16|||
16877401|NCT00249795|37856644|FG001|Overall Study|Not treated|14|||
16877402|NCT00249795|37856643|FG000|Overall Study|Symptomatic hypotension|127|||
16877403|NCT00249795|37856644|FG001|Overall Study|Symptomatic hypotension|64|||
16877404|NCT00249795|37856643|FG000|Overall Study|Other Serious Adverse Event|84|||
16877405|NCT00249795|37856644|FG001|Overall Study|Other Serious Adverse Event|93|||
16877406|NCT00249795|37856643|FG000|Overall Study|Qualifying condition not present|26|||
16877407|NCT00249795|37856644|FG001|Overall Study|Qualifying condition not present|29|||
16877408|NCT00249795|37856643|FG000|Overall Study|Withdrawal by Subject|678|||
16877409|NCT00249795|37856644|FG001|Overall Study|Withdrawal by Subject|742|||
16877410|NCT00249795|37856643|FG000|Overall Study|Thromboembolic / outcome event|39|||
16877411|NCT00249795|37856644|FG001|Overall Study|Thromboembolic / outcome event|45|||
16877412|NCT00249795|37856643|FG000|Overall Study|Oral anticoagulant required|2|||
16877413|NCT00249795|37856644|FG001|Overall Study|Oral anticoagulant required|0|||
16877414|NCT00249795|37856643|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
16877415|NCT00249795|37856644|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
16877416|NCT00249795|37856643|FG000|Overall Study|Non-compliance|71|||
16877417|NCT00249795|37856644|FG001|Overall Study|Non-compliance|69|||
16877418|NCT00249795|37856643|FG000|Overall Study|Study drug intolerance|3|||
16877419|NCT00249795|37856644|FG001|Overall Study|Study drug intolerance|3|||
16877420|NCT00249795|37856643|FG000|Overall Study|Other adverse events (non-serious)|188|||
16877421|NCT00249795|37856644|FG001|Overall Study|Other adverse events (non-serious)|159|||
16877422|NCT00249795|37856643|FG000|Overall Study|Physician withdrew consent|71|||
16877423|NCT00249795|37856644|FG001|Overall Study|Physician withdrew consent|63|||
16877424|NCT00249795|37856643|FG000|Overall Study|Surgery / procedure|4|||
16877425|NCT00249795|37856644|FG001|Overall Study|Surgery / procedure|5|||
16877426|NCT00249795|37856643|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
16877427|NCT00249795|37856644|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
16877428|NCT00249795|37856643|FG000|Overall Study|Lightheadedness / dizziness|15|||
16877429|NCT00249795|37856644|FG001|Overall Study|Lightheadedness / dizziness|11|||
16877430|NCT00249795|37856643|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
16877431|NCT00249795|37856644|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
16877432|NCT00249795|37856643|FG000|Overall Study|Other contraindicated medication|1|||
16877433|NCT00249795|37856644|FG001|Overall Study|Other contraindicated medication|1|||
16877434|NCT00249795|37856643|FG000|Overall Study|Event related to cardiac condition|17|||
16877435|NCT00249795|37856644|FG001|Overall Study|Event related to cardiac condition|16|||
16877436|NCT00249795|37856643|FG000|Overall Study|Patient not wish to continue after May08|4|||
16877437|NCT00249795|37856644|FG001|Overall Study|Patient not wish to continue after May08|6|||
16877438|NCT00249795|37856643|FG000|Overall Study|Site not agree to continue after May08|1|||
16877439|NCT00249795|37856644|FG001|Overall Study|Site not agree to continue after May08|1|||
16877440|NCT00249795|37856643|FG000|Overall Study|Lost to Follow-up|0|||
16877441|NCT00249795|37856644|FG001|Overall Study|Lost to Follow-up|2|||
16877442|NCT00249795|37856643|FG000|Overall Study|Missing|0|||
16877443|NCT00249795|37856644|FG001|Overall Study|Missing|1|||
16785519|NCT02659631|37725571|FG008|Overall Study|Death (treatment phase)|0|||
16785520|NCT02659631|37725572|FG009|Overall Study|Death (treatment phase)|0|||
16785521|NCT02699125|37725596|FG000|Placebo|Lost to Follow-up|2|||
16785522|NCT02699125|37725597|FG001|Placebo|Lost to Follow-up|0|||
16785523|NCT02699125|37725596|FG000|Placebo|Protocol Violation|1|||
16785524|NCT02699125|37725597|FG001|Placebo|Protocol Violation|0|||
16785525|NCT02699125|37725596|FG000|Placebo|Withdrawal by Subject|0|||
16785526|NCT02699125|37725597|FG001|Placebo|Withdrawal by Subject|4|||
16785527|NCT02699125|37725596|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
16877444|NCT02651220|37856653|FG000|Overall Study|Adverse Event|1|||
16877445|NCT02651220|37856654|FG001|Overall Study|Adverse Event|5|||
16877446|NCT02651220|37856655|FG002|Overall Study|Adverse Event|1|||
16877447|NCT02651220|37856653|FG000|Overall Study|Lost to Follow-up|8|||
16877448|NCT02651220|37856654|FG001|Overall Study|Lost to Follow-up|14|||
16877449|NCT02651220|37856655|FG002|Overall Study|Lost to Follow-up|14|||
16877450|NCT02651220|37856653|FG000|Overall Study|Non-Compliance with Study Drug|4|||
16877451|NCT02651220|37856654|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16877452|NCT02651220|37856655|FG002|Overall Study|Non-Compliance with Study Drug|1|||
16877453|NCT02651220|37856653|FG000|Overall Study|Pregnancy|1|||
16877454|NCT02651220|37856654|FG001|Overall Study|Pregnancy|0|||
16877455|NCT02651220|37856655|FG002|Overall Study|Pregnancy|1|||
16877456|NCT02651220|37856653|FG000|Overall Study|Protocol Violation|0|||
16877457|NCT02651220|37856654|FG001|Overall Study|Protocol Violation|0|||
16877458|NCT02651220|37856655|FG002|Overall Study|Protocol Violation|1|||
16877459|NCT02651220|37856653|FG000|Overall Study|Withdrawal by Subject|5|||
16877460|NCT02651220|37856654|FG001|Overall Study|Withdrawal by Subject|6|||
16877461|NCT02651220|37856655|FG002|Overall Study|Withdrawal by Subject|8|||
16877462|NCT02651220|37856653|FG000|Overall Study|Miscellaneous|4|||
16877463|NCT02651220|37856654|FG001|Overall Study|Miscellaneous|1|||
16877464|NCT02651220|37856655|FG002|Overall Study|Miscellaneous|2|||
16877465|NCT02651220|37856653|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16877466|NCT02651220|37856654|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16877467|NCT02651220|37856655|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
16877468|NCT00247611|37856703|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
16877469|NCT00247611|37856704|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
16877470|NCT00247611|37856703|FG000|Baselined|Completed baseline only|9|||
16877471|NCT00247611|37856704|FG001|Baselined|Completed baseline only|8|||
16877472|NCT00246753|37856720|FG000|Overall Study|Withdrawal by Subject|2|||
16877473|NCT00246753|37856720|FG000|Overall Study|Physician Decision|2|||
16877474|NCT00246753|37856720|FG000|Overall Study|Adverse Event|2|||
16877475|NCT00246753|37856720|FG000|Overall Study|Unacceptable toxicity|2|||
16877476|NCT00246129|37856737|FG000|Overall Study|Lost to Follow-up|1|||
16877477|NCT00246129|37856738|FG001|Overall Study|Lost to Follow-up|0|||
16877478|NCT00246129|37856737|FG000|Overall Study|Death|2|||
16877479|NCT00246129|37856738|FG001|Overall Study|Death|1|||
16877480|NCT00246129|37856737|FG000|Overall Study|suffered primary non-function|1|||
16877481|NCT00246129|37856738|FG001|Overall Study|suffered primary non-function|0|||
16877482|NCT00246129|37856737|FG000|Overall Study|grafts failed|3|||
16877483|NCT00246129|37856738|FG001|Overall Study|grafts failed|1|||
16877484|NCT03182868|37856761|FG000|Overall Study|Protocol Violation|3|||
16877485|NCT03182868|37856762|FG001|Overall Study|Protocol Violation|0|||
16877486|NCT03182868|37856763|FG002|Overall Study|Protocol Violation|4|||
16877487|NCT03182868|37856764|FG003|Overall Study|Protocol Violation|1|||
16877488|NCT03182868|37856765|FG004|Overall Study|Protocol Violation|8|||
16877489|NCT00245583|37856789|FG000|Overall Study|Lost to Follow-up|1|||
16877490|NCT00245583|37856790|FG001|Overall Study|Lost to Follow-up|5|||
16877491|NCT00245583|37856789|FG000|Overall Study|Adverse Event|2|||
16877492|NCT00245583|37856790|FG001|Overall Study|Adverse Event|1|||
16877493|NCT00245583|37856789|FG000|Overall Study|Lack of Efficacy|1|||
16877494|NCT00245583|37856790|FG001|Overall Study|Lack of Efficacy|0|||
16877495|NCT00245583|37856789|FG000|Overall Study|Withdrawal by Subject|2|||
16877496|NCT00245583|37856790|FG001|Overall Study|Withdrawal by Subject|3|||
16877497|NCT02652156|37856810|FG000|Overall Study|Physician Decision|1|||
16877498|NCT02652156|37856811|FG001|Overall Study|Physician Decision|0|||
16877499|NCT02652156|37856812|FG002|Overall Study|Physician Decision|0|||
16877500|NCT01675050|37856859|FG000|Period One Treatment|Withdrawal by Subject|1|||
16877501|NCT01675050|37856860|FG001|Period One Treatment|Withdrawal by Subject|0|||
16877502|NCT00244881|37856879|FG000|Overall Study|Withdrawal by Subject|3|||
16877503|NCT00244725|37856910|FG000|Overall Study|Lost to Follow-up|3|||
16877504|NCT00244725|37856911|FG001|Overall Study|Lost to Follow-up|4|||
16877505|NCT00244725|37856912|FG002|Overall Study|Lost to Follow-up|9|||
16877506|NCT00244725|37856913|FG003|Overall Study|Lost to Follow-up|2|||
16877507|NCT00244725|37856910|FG000|Overall Study|Withdrawal by Subject|9|||
16877508|NCT00244725|37856911|FG001|Overall Study|Withdrawal by Subject|7|||
16877509|NCT00244725|37856912|FG002|Overall Study|Withdrawal by Subject|7|||
16877510|NCT00244725|37856913|FG003|Overall Study|Withdrawal by Subject|8|||
16877511|NCT00244725|37856910|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
16877512|NCT00244725|37856911|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
16877513|NCT00244725|37856912|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
16877514|NCT00244725|37856913|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
16877515|NCT00244725|37856910|FG000|Overall Study|Physician Decision|3|||
16877516|NCT00244725|37856911|FG001|Overall Study|Physician Decision|0|||
16877517|NCT00244725|37856912|FG002|Overall Study|Physician Decision|1|||
16877518|NCT00244725|37856913|FG003|Overall Study|Physician Decision|2|||
16877519|NCT00244725|37856910|FG000|Overall Study|Adverse Events|3|||
16877520|NCT00244725|37856911|FG001|Overall Study|Adverse Events|1|||
16877521|NCT00244725|37856912|FG002|Overall Study|Adverse Events|4|||
16877522|NCT00244725|37856913|FG003|Overall Study|Adverse Events|4|||
16877523|NCT00244725|37856910|FG000|Overall Study|Withdrwal by participant|1|||
16877524|NCT00244725|37856911|FG001|Overall Study|Withdrwal by participant|0|||
16877525|NCT00244725|37856912|FG002|Overall Study|Withdrwal by participant|0|||
16877526|NCT00244725|37856913|FG003|Overall Study|Withdrwal by participant|1|||
16877527|NCT00244725|37856910|FG000|Overall Study|Liver function test abnormality|2|||
16877528|NCT00244725|37856911|FG001|Overall Study|Liver function test abnormality|0|||
16877529|NCT00244725|37856912|FG002|Overall Study|Liver function test abnormality|0|||
16877530|NCT00244725|37856913|FG003|Overall Study|Liver function test abnormality|1|||
16877531|NCT00244725|37856910|FG000|Overall Study|Sponsor withdrew the participant|1|||
16877532|NCT00244725|37856911|FG001|Overall Study|Sponsor withdrew the participant|0|||
16877533|NCT00244725|37856912|FG002|Overall Study|Sponsor withdrew the participant|0|||
16877534|NCT00244725|37856913|FG003|Overall Study|Sponsor withdrew the participant|1|||
16877535|NCT00244725|37856910|FG000|Overall Study|Mediciation Error|0|||
16877536|NCT00244725|37856911|FG001|Overall Study|Mediciation Error|1|||
16877537|NCT00244725|37856912|FG002|Overall Study|Mediciation Error|0|||
16877538|NCT00244725|37856913|FG003|Overall Study|Mediciation Error|0|||
16877539|NCT00244725|37856910|FG000|Overall Study|Rehab Refused to allow participantion|0|||
16877540|NCT00244725|37856911|FG001|Overall Study|Rehab Refused to allow participantion|1|||
16877541|NCT00244725|37856912|FG002|Overall Study|Rehab Refused to allow participantion|0|||
16877542|NCT00244725|37856913|FG003|Overall Study|Rehab Refused to allow participantion|0|||
16877543|NCT00244725|37856910|FG000|Overall Study|Headache|0|||
16877544|NCT00244725|37856911|FG001|Overall Study|Headache|1|||
16877545|NCT00244725|37856912|FG002|Overall Study|Headache|0|||
16877546|NCT00244725|37856913|FG003|Overall Study|Headache|0|||
16877547|NCT00244725|37856910|FG000|Overall Study|Received prohibited medication|0|||
16877548|NCT00244725|37856911|FG001|Overall Study|Received prohibited medication|1|||
16877549|NCT00244725|37856912|FG002|Overall Study|Received prohibited medication|0|||
16877550|NCT00244725|37856913|FG003|Overall Study|Received prohibited medication|1|||
16877551|NCT00244725|37856910|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
16877552|NCT00244725|37856911|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
16877553|NCT00244725|37856912|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
16877554|NCT00244725|37856913|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
16877555|NCT00244725|37856910|FG000|Overall Study|Administrative reason|0|||
16877556|NCT00244725|37856911|FG001|Overall Study|Administrative reason|0|||
16877557|NCT00244725|37856912|FG002|Overall Study|Administrative reason|1|||
16877558|NCT00244725|37856913|FG003|Overall Study|Administrative reason|0|||
16877559|NCT00244725|37856910|FG000|Overall Study|Vomit|0|||
16877560|NCT00244725|37856911|FG001|Overall Study|Vomit|0|||
16877561|NCT00244725|37856912|FG002|Overall Study|Vomit|1|||
16877562|NCT00244725|37856913|FG003|Overall Study|Vomit|0|||
16877563|NCT00244725|37856910|FG000|Overall Study|Failed to follow-up|0|||
16877564|NCT00244725|37856911|FG001|Overall Study|Failed to follow-up|0|||
16877565|NCT00244725|37856912|FG002|Overall Study|Failed to follow-up|1|||
16877566|NCT00244725|37856913|FG003|Overall Study|Failed to follow-up|1|||
16877567|NCT02649894|37856925|FG000|Overall Study|Adverse Event|1|||
16877568|NCT02649894|37856926|FG001|Overall Study|Adverse Event|0|||
16877569|NCT02649894|37856925|FG000|Overall Study|Physician Decision|0|||
16877570|NCT02649894|37856926|FG001|Overall Study|Physician Decision|1|||
16877571|NCT02649894|37856925|FG000|Overall Study|Withdrawal by Subject|5|||
16877572|NCT02649894|37856926|FG001|Overall Study|Withdrawal by Subject|2|||
16877573|NCT02649894|37856925|FG000|Overall Study|Lost to Follow-up|2|||
16877574|NCT02649894|37856926|FG001|Overall Study|Lost to Follow-up|1|||
16877575|NCT02649894|37856925|FG000|Overall Study|Death|30|||
16877576|NCT02649894|37856926|FG001|Overall Study|Death|7|||
16877577|NCT02649894|37856925|FG000|Overall Study|Other, not specified|6|||
16877578|NCT02649894|37856926|FG001|Overall Study|Other, not specified|0|||
16877579|NCT01278615|37856932|FG000|Overall Study|Withdrawal by Subject|2|||
16877580|NCT01505114|37856958|FG000|Overall Study|Withdrawal by Subject|5|||
16877581|NCT01505114|37856959|FG001|Overall Study|Withdrawal by Subject|4|||
16877582|NCT01505114|37856960|FG002|Overall Study|Withdrawal by Subject|4|||
16877583|NCT01505114|37856961|FG003|Overall Study|Withdrawal by Subject|7|||
16877584|NCT01505114|37856958|FG000|Overall Study|Death|1|||
16877585|NCT01505114|37856959|FG001|Overall Study|Death|0|||
16877586|NCT01505114|37856960|FG002|Overall Study|Death|0|||
16877587|NCT01505114|37856961|FG003|Overall Study|Death|1|||
16877588|NCT01505114|37856958|FG000|Overall Study|unable to adhere to visit schedule|3|||
16877589|NCT01505114|37856959|FG001|Overall Study|unable to adhere to visit schedule|2|||
16877590|NCT01505114|37856960|FG002|Overall Study|unable to adhere to visit schedule|3|||
16877591|NCT01505114|37856961|FG003|Overall Study|unable to adhere to visit schedule|3|||
16877592|NCT01505114|37856958|FG000|Overall Study|Lost to Follow-up|11|||
16877593|NCT01505114|37856959|FG001|Overall Study|Lost to Follow-up|5|||
16877594|NCT01505114|37856960|FG002|Overall Study|Lost to Follow-up|8|||
16877595|NCT01505114|37856961|FG003|Overall Study|Lost to Follow-up|7|||
16877596|NCT01505114|37856958|FG000|Overall Study|relocated|4|||
16877597|NCT01505114|37856959|FG001|Overall Study|relocated|2|||
16877598|NCT01505114|37856960|FG002|Overall Study|relocated|2|||
16877599|NCT01505114|37856961|FG003|Overall Study|relocated|3|||
16877600|NCT01505114|37856958|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
16877601|NCT01505114|37856959|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
16877602|NCT01505114|37856960|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
16877603|NCT01505114|37856961|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
16877604|NCT01505114|37856958|FG000|Overall Study|staff safety concerns|0|||
16877605|NCT01505114|37856959|FG001|Overall Study|staff safety concerns|0|||
16877606|NCT01505114|37856960|FG002|Overall Study|staff safety concerns|0|||
16877607|NCT01505114|37856961|FG003|Overall Study|staff safety concerns|1|||
16877608|NCT01505114|37856958|FG000|Overall Study|investigator decision|1|||
16877609|NCT01505114|37856959|FG001|Overall Study|investigator decision|0|||
16877610|NCT01505114|37856960|FG002|Overall Study|investigator decision|1|||
16877611|NCT01505114|37856961|FG003|Overall Study|investigator decision|0|||
16877612|NCT02651922|37856993|FG000|Overall Study|due to exclusion criteria|2|||
16877613|NCT01277757|37856997|FG000|Overall Study|Disease Progression|1|||
16877614|NCT01277757|37856997|FG000|Overall Study|Withdrawal by Subject|1|||
16877615|NCT01276821|37857003|FG000|Overall Study|Protocol Violation|0|||
16877616|NCT01276821|37857004|FG001|Overall Study|Protocol Violation|1|||
16877617|NCT00245037|37857010|FG000|Overall Study|Death|17|||
16877618|NCT00241839|37857016|FG000|Overall Study|Withdrawal by Subject|18|||
16877619|NCT00241839|37857017|FG001|Overall Study|Withdrawal by Subject|17|||
16877620|NCT00241839|37857016|FG000|Overall Study|Adverse Event|1|||
16877621|NCT00241839|37857017|FG001|Overall Study|Adverse Event|1|||
16877622|NCT02651688|37857026|FG000|Overall Study|Non-compliance|0|||
16877623|NCT02651688|37857027|FG001|Overall Study|Non-compliance|0|||
16877624|NCT02651688|37857028|FG002|Overall Study|Non-compliance|1|||
16877625|NCT02651688|37857026|FG000|Overall Study|Principal Investigator (PI) decision|0|||
16877626|NCT02651688|37857027|FG001|Overall Study|Principal Investigator (PI) decision|2|||
16877627|NCT02651688|37857028|FG002|Overall Study|Principal Investigator (PI) decision|0|||
16877628|NCT02651688|37857026|FG000|Overall Study|Lost to Follow-up|1|||
16877629|NCT02651688|37857027|FG001|Overall Study|Lost to Follow-up|3|||
16877630|NCT02651688|37857028|FG002|Overall Study|Lost to Follow-up|0|||
16877631|NCT02651688|37857026|FG000|Overall Study|Withdrawal by Subject|1|||
16877632|NCT02651688|37857027|FG001|Overall Study|Withdrawal by Subject|0|||
16877633|NCT02651688|37857028|FG002|Overall Study|Withdrawal by Subject|2|||
16877634|NCT01276353|37857038|FG000|Double-blind|Adverse Event|2|||
16877635|NCT01276353|37857039|FG001|Double-blind|Adverse Event|0|||
16877636|NCT01276353|37857038|FG000|Double-blind|Withdrawal by Subject|1|||
16877637|NCT01276353|37857039|FG001|Double-blind|Withdrawal by Subject|0|||
16877638|NCT01276353|37857038|FG000|Extension|Adverse Event|2|||
17001780|NCT00917150|38145792|FG001|Overall Study|Death|4|||
17001781|NCT00917150|38145793|FG002|Overall Study|Death|3|||
17001782|NCT00917150|38145794|FG003|Overall Study|Death|2|||
17001783|NCT00917150|38145791|FG000|Overall Study|Lost to Follow-up|1|||
17001784|NCT00917150|38145792|FG001|Overall Study|Lost to Follow-up|0|||
17001785|NCT00917150|38145793|FG002|Overall Study|Lost to Follow-up|4|||
17001786|NCT00917150|38145794|FG003|Overall Study|Lost to Follow-up|2|||
17001787|NCT00917150|38145791|FG000|Overall Study|Physician Decision|0|||
17001788|NCT00917150|38145792|FG001|Overall Study|Physician Decision|2|||
17001789|NCT00917150|38145793|FG002|Overall Study|Physician Decision|0|||
17001790|NCT00917150|38145794|FG003|Overall Study|Physician Decision|1|||
17001791|NCT00917150|38145791|FG000|Overall Study|Protocol Violation|5|||
17001792|NCT00917150|38145792|FG001|Overall Study|Protocol Violation|5|||
17001793|NCT00917150|38145793|FG002|Overall Study|Protocol Violation|3|||
17001794|NCT00917150|38145794|FG003|Overall Study|Protocol Violation|5|||
17001795|NCT00917150|38145791|FG000|Overall Study|Withdrawal by Subject|15|||
17001796|NCT00917150|38145792|FG001|Overall Study|Withdrawal by Subject|16|||
17001797|NCT00917150|38145793|FG002|Overall Study|Withdrawal by Subject|18|||
17001798|NCT00917150|38145794|FG003|Overall Study|Withdrawal by Subject|11|||
17001799|NCT00917150|38145791|FG000|Overall Study|Other than specified|3|||
17001800|NCT00917150|38145792|FG001|Overall Study|Other than specified|3|||
17001801|NCT00917150|38145793|FG002|Overall Study|Other than specified|2|||
17001802|NCT00917150|38145794|FG003|Overall Study|Other than specified|2|||
17001803|NCT00659425|38145814|FG000|Overall Study|Disease progression|1|||
17001804|NCT00659425|38145815|FG001|Overall Study|Disease progression|0|||
17001805|NCT00659425|38145816|FG002|Overall Study|Disease progression|0|||
17001806|NCT00659425|38145817|FG003|Overall Study|Disease progression|1|||
17001807|NCT00659425|38145818|FG004|Overall Study|Disease progression|0|||
17001808|NCT00659425|38145819|FG005|Overall Study|Disease progression|2|||
17001809|NCT00659425|38145820|FG006|Overall Study|Disease progression|4|||
17001810|NCT00659425|38145821|FG007|Overall Study|Disease progression|3|||
17001811|NCT00659425|38145822|FG008|Overall Study|Disease progression|5|||
17001812|NCT00659425|38145823|FG009|Overall Study|Disease progression|3|||
17001813|NCT00659425|38145814|FG000|Overall Study|Death|0|||
17001814|NCT00659425|38145815|FG001|Overall Study|Death|0|||
17001815|NCT00659425|38145816|FG002|Overall Study|Death|0|||
17001816|NCT00659425|38145817|FG003|Overall Study|Death|1|||
17001817|NCT00659425|38145818|FG004|Overall Study|Death|0|||
16877639|NCT01276353|37857039|FG001|Extension|Adverse Event|5|||
16877640|NCT01276353|37857038|FG000|Extension|Withdrawal by Subject|1|||
16877641|NCT01276353|37857039|FG001|Extension|Withdrawal by Subject|2|||
16877642|NCT01276353|37857038|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
16877643|NCT01276353|37857039|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
16877644|NCT01276353|37857038|FG000|Extension|Physician Decision|1|||
16877645|NCT01276353|37857039|FG001|Extension|Physician Decision|0|||
16877646|NCT01276353|37857038|FG000|Extension|Prohibited concomitant medications|0|||
16877647|NCT01276353|37857039|FG001|Extension|Prohibited concomitant medications|1|||
16877648|NCT02536794|37857074|FG000|Reached 1st Response Assessment|Adverse Event|2|||
16877649|NCT02536794|37857074|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
16877650|NCT02536794|37857074|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
16877651|NCT02536794|37857074|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
16877652|NCT02536794|37857074|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
16877653|NCT02536794|37857074|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
16877654|NCT01480076|37857153|FG000|Overall Study|Run-in Failure|52|||
16877655|NCT01480076|37857153|FG000|Overall Study|Adverse Event|39|||
16877656|NCT01480076|37857153|FG000|Overall Study|Death|2|||
16877657|NCT01480076|37857153|FG000|Overall Study|Disease Progression|5|||
16877658|NCT01480076|37857153|FG000|Overall Study|Non-compliance With Study Protocol|15|||
16877659|NCT01480076|37857153|FG000|Overall Study|Withdrawal by Subject|105|||
16877660|NCT01480076|37857153|FG000|Overall Study|Lost to Follow-up|7|||
16877661|NCT01480076|37857153|FG000|Overall Study|Investigator Decision|13|||
16877662|NCT01480076|37857153|FG000|Overall Study|Other|52|||
16877663|NCT02650128|37857241|FG000|Overall Study|Death|2|||
16877664|NCT01362270|37857256|FG000|Overall Study|Withdrawal by Subject|1|||
16877665|NCT01362270|37857257|FG001|Overall Study|Withdrawal by Subject|0|||
16877666|NCT01362270|37857256|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
16877667|NCT01362270|37857257|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
16877668|NCT01362270|37857256|FG000|Overall Study|Met excl. criteria before 1st session|1|||
16877669|NCT01362270|37857257|FG001|Overall Study|Met excl. criteria before 1st session|1|||
16877670|NCT00089479|37857278|FG000|Overall Study|Death|108|||
16877671|NCT00089479|37857279|FG001|Overall Study|Death|75|||
16877672|NCT00089479|37857278|FG000|Overall Study|Withdrawal by Subject|86|||
16877673|NCT00089479|37857279|FG001|Overall Study|Withdrawal by Subject|107|||
16877674|NCT00089479|37857278|FG000|Overall Study|Lost to Follow-up|137|||
16877675|NCT00089479|37857279|FG001|Overall Study|Lost to Follow-up|107|||
16877676|NCT01463306|37857288|FG000|Overall Study|Adverse Event|6|||
16877677|NCT01463306|37857289|FG001|Overall Study|Adverse Event|9|||
16877678|NCT01463306|37857290|FG002|Overall Study|Adverse Event|3|||
16877679|NCT01463306|37857288|FG000|Overall Study|Death|3|||
16877680|NCT01463306|37857289|FG001|Overall Study|Death|3|||
16877681|NCT01463306|37857290|FG002|Overall Study|Death|0|||
16877682|NCT01463306|37857288|FG000|Overall Study|Lack of Efficacy|22|||
16877683|NCT01463306|37857289|FG001|Overall Study|Lack of Efficacy|16|||
16877684|NCT01463306|37857290|FG002|Overall Study|Lack of Efficacy|1|||
16877685|NCT01463306|37857288|FG000|Overall Study|Lost to Follow-up|5|||
16877686|NCT01463306|37857289|FG001|Overall Study|Lost to Follow-up|2|||
16877687|NCT01463306|37857290|FG002|Overall Study|Lost to Follow-up|0|||
16877688|NCT01463306|37857288|FG000|Overall Study|Protocol Violation|4|||
16877689|NCT01463306|37857289|FG001|Overall Study|Protocol Violation|0|||
16877690|NCT01463306|37857290|FG002|Overall Study|Protocol Violation|0|||
16877691|NCT01463306|37857288|FG000|Overall Study|Withdrawal by Subject|19|||
16877692|NCT01463306|37857289|FG001|Overall Study|Withdrawal by Subject|9|||
16877693|NCT01463306|37857290|FG002|Overall Study|Withdrawal by Subject|1|||
16877694|NCT01463306|37857288|FG000|Overall Study|Other|26|||
16877695|NCT01463306|37857289|FG001|Overall Study|Other|13|||
16877696|NCT01463306|37857290|FG002|Overall Study|Other|0|||
16877697|NCT01463306|37857288|FG000|Overall Study|Approval expiry at site|1|||
16877698|NCT01463306|37857289|FG001|Overall Study|Approval expiry at site|0|||
16877699|NCT01463306|37857290|FG002|Overall Study|Approval expiry at site|0|||
16877700|NCT01504412|37857319|FG000|Overall Study|Adverse Event|1|||
16877701|NCT01504412|37857320|FG001|Overall Study|Adverse Event|8|||
16877702|NCT01504412|37857321|FG002|Overall Study|Adverse Event|1|||
16877703|NCT01504412|37857322|FG003|Overall Study|Adverse Event|7|||
16877704|NCT01504412|37857323|FG004|Overall Study|Adverse Event|10|||
16877705|NCT01504412|37857319|FG000|Overall Study|Withdrawal by Subject|2|||
16877706|NCT01504412|37857320|FG001|Overall Study|Withdrawal by Subject|1|||
16877707|NCT01504412|37857321|FG002|Overall Study|Withdrawal by Subject|1|||
16877708|NCT01504412|37857322|FG003|Overall Study|Withdrawal by Subject|5|||
16877709|NCT01504412|37857323|FG004|Overall Study|Withdrawal by Subject|1|||
16877710|NCT01504412|37857319|FG000|Overall Study|Other|2|||
16877711|NCT01504412|37857320|FG001|Overall Study|Other|1|||
16877712|NCT01504412|37857321|FG002|Overall Study|Other|1|||
16877713|NCT01504412|37857322|FG003|Overall Study|Other|6|||
16877714|NCT01504412|37857323|FG004|Overall Study|Other|1|||
16877715|NCT01504412|37857319|FG000|Overall Study|Lost to Follow-up|0|||
16877716|NCT01504412|37857320|FG001|Overall Study|Lost to Follow-up|2|||
16877717|NCT01504412|37857321|FG002|Overall Study|Lost to Follow-up|0|||
16877718|NCT01504412|37857322|FG003|Overall Study|Lost to Follow-up|0|||
16877719|NCT01504412|37857323|FG004|Overall Study|Lost to Follow-up|0|||
16877720|NCT01504412|37857319|FG000|Overall Study|Lack of Efficacy|0|||
16877721|NCT01504412|37857320|FG001|Overall Study|Lack of Efficacy|0|||
16877722|NCT01504412|37857321|FG002|Overall Study|Lack of Efficacy|1|||
16877723|NCT01504412|37857322|FG003|Overall Study|Lack of Efficacy|0|||
16877724|NCT01504412|37857323|FG004|Overall Study|Lack of Efficacy|1|||
16877725|NCT01504412|37857319|FG000|Overall Study|Death|0|||
16877726|NCT01504412|37857320|FG001|Overall Study|Death|0|||
16877727|NCT01504412|37857321|FG002|Overall Study|Death|0|||
16877728|NCT01504412|37857322|FG003|Overall Study|Death|1|||
16877729|NCT01504412|37857323|FG004|Overall Study|Death|0|||
16877730|NCT01503164|37857353|FG000|Overall Study|Withdrawal by Subject|2|||
16877731|NCT01503164|37857354|FG001|Overall Study|Withdrawal by Subject|1|||
16877732|NCT00088465|37857360|FG000|Overall Study|Withdrawal by Subject|290|||
16877733|NCT00088465|37857360|FG000|Overall Study|Adverse Event|77|||
16877734|NCT00088465|37857360|FG000|Overall Study|Lost to Follow-up|57|||
16877735|NCT00088465|37857360|FG000|Overall Study|Physician Decision|45|||
16877736|NCT00088465|37857360|FG000|Overall Study|Sponsor Decision|37|||
16877737|NCT00088465|37857360|FG000|Overall Study|Lack of Efficacy|27|||
16877738|NCT00088465|37857360|FG000|Overall Study|Protocol Violation|17|||
16877739|NCT00088465|37857360|FG000|Overall Study|Death|11|||
16877740|NCT00088153|37857388|FG000|Overall Study|Physician Decision|3|||
16877741|NCT00088153|37857389|FG001|Overall Study|Physician Decision|3|||
16877742|NCT00088153|37857388|FG000|Overall Study|Withdrawal by Subject|10|||
16877743|NCT00088153|37857389|FG001|Overall Study|Withdrawal by Subject|10|||
16877744|NCT00088153|37857388|FG000|Overall Study|Lost to Follow-up|11|||
16877745|NCT00088153|37857389|FG001|Overall Study|Lost to Follow-up|12|||
16877746|NCT00087685|37857408|FG000|Overall Study|Adverse Event|5|||
16877747|NCT00087685|37857408|FG000|Overall Study|Non-Compliance|1|||
16877748|NCT00087685|37857408|FG000|Overall Study|Progressive Disease|5|||
16877749|NCT00087685|37857408|FG000|Overall Study|Withdrawal by Subject|3|||
16877750|NCT01502228|37857412|FG000|Overall Study|Death|1|||
16877751|NCT01502072|37857419|FG000|Overall Study|Withdrawal by Subject|1|||
16877752|NCT01502072|37857420|FG001|Overall Study|Withdrawal by Subject|0|||
16877753|NCT01502072|37857421|FG002|Overall Study|Withdrawal by Subject|0|||
16877754|NCT01502072|37857419|FG000|Overall Study|Death|0|||
16877755|NCT01502072|37857420|FG001|Overall Study|Death|1|||
16877756|NCT01502072|37857421|FG002|Overall Study|Death|0|||
16877757|NCT01462370|37857429|FG000|Overall Study|Lack of Qualifying Event|1|||
16877758|NCT01462370|37857430|FG001|Overall Study|Lack of Qualifying Event|1|||
16877759|NCT01462370|37857429|FG000|Overall Study|Physician Decision|0|||
16877760|NCT01462370|37857430|FG001|Overall Study|Physician Decision|1|||
16877761|NCT01462370|37857429|FG000|Overall Study|Withdrawal by Subject|0|||
16877762|NCT01462370|37857430|FG001|Overall Study|Withdrawal by Subject|3|||
16877763|NCT01479764|37857438|FG000|Randomized|Adverse Event|1|||
16877764|NCT01479764|37857439|FG001|Randomized|Adverse Event|1|||
16877765|NCT01479764|37857438|FG000|Randomized|Withdrawal by Subject|1|||
16877766|NCT01479764|37857439|FG001|Randomized|Withdrawal by Subject|0|||
16877767|NCT01479764|37857438|FG000|Treated|Lost to Follow-up|0|||
16877768|NCT01479764|37857439|FG001|Treated|Lost to Follow-up|2|||
16877769|NCT01479530|37857447|FG000|Overall Study|Adverse Event|5|||
16877770|NCT01479530|37857448|FG001|Overall Study|Adverse Event|6|||
16877771|NCT01479530|37857447|FG000|Overall Study|Lack of Efficacy|0|||
16877772|NCT01479530|37857448|FG001|Overall Study|Lack of Efficacy|1|||
16877773|NCT01479530|37857447|FG000|Overall Study|Protocol Violation|2|||
16877774|NCT01479530|37857448|FG001|Overall Study|Protocol Violation|3|||
16877775|NCT01479530|37857447|FG000|Overall Study|Withdrawal of Consent|3|||
16877776|NCT01479530|37857448|FG001|Overall Study|Withdrawal of Consent|2|||
16877777|NCT01479374|37857457|FG000|Overall Study|Adverse Event|2|||
16877778|NCT01479374|37857458|FG001|Overall Study|Adverse Event|1|||
16877779|NCT01479374|37857459|FG002|Overall Study|Adverse Event|0|||
16877780|NCT01479374|37857457|FG000|Overall Study|Lost to Follow-up|1|||
16877781|NCT01479374|37857458|FG001|Overall Study|Lost to Follow-up|2|||
16877782|NCT01479374|37857459|FG002|Overall Study|Lost to Follow-up|0|||
16877783|NCT01479374|37857457|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
16877784|NCT01479374|37857458|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
16877785|NCT01479374|37857459|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
16877786|NCT01479374|37857457|FG000|Overall Study|Other|0|||
16877787|NCT01479374|37857458|FG001|Overall Study|Other|4|||
16877788|NCT01479374|37857459|FG002|Overall Study|Other|5|||
16877789|NCT00087529|37857469|FG000|Overall Study|Death|1|||
16877790|NCT00087529|37857470|FG001|Overall Study|Death|0|||
16877791|NCT00087529|37857469|FG000|Overall Study|Adverse Event|0|||
16877792|NCT00087529|37857470|FG001|Overall Study|Adverse Event|8|||
16877793|NCT00087529|37857469|FG000|Overall Study|Pregnancy|0|||
16877794|NCT00087529|37857470|FG001|Overall Study|Pregnancy|1|||
16877795|NCT00087529|37857469|FG000|Overall Study|Lost to Follow-up|2|||
16877796|NCT00087529|37857470|FG001|Overall Study|Lost to Follow-up|3|||
16877797|NCT00087529|37857469|FG000|Overall Study|Participant Decision|14|||
16877798|NCT00087529|37857470|FG001|Overall Study|Participant Decision|37|||
16877799|NCT00087529|37857469|FG000|Overall Study|Physician Decision|4|||
16877800|NCT00087529|37857470|FG001|Overall Study|Physician Decision|8|||
16877801|NCT00087529|37857469|FG000|Overall Study|Initiation of Excluded Therapy|0|||
16877802|NCT00087529|37857470|FG001|Overall Study|Initiation of Excluded Therapy|1|||
16877803|NCT00087529|37857469|FG000|Overall Study|Participant Noncompliance|0|||
16877804|NCT00087529|37857470|FG001|Overall Study|Participant Noncompliance|1|||
16877805|NCT00087529|37857469|FG000|Overall Study|Disease Progression|5|||
16877806|NCT00087529|37857470|FG001|Overall Study|Disease Progression|4|||
16877807|NCT00087529|37857469|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
16877808|NCT00087529|37857470|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
16877809|NCT01500434|37857493|FG000|Overall Study|Death|1|||
16877810|NCT01500434|37857493|FG000|Overall Study|Withdrawal by Subject|1|||
16877811|NCT01500434|37857493|FG000|Overall Study|Missed 12-month follow-up|5|||
16877812|NCT00087139|37857500|FG000|Overall Study|Adverse Event|18|||
16877813|NCT00087139|37857501|FG001|Overall Study|Adverse Event|17|||
16877814|NCT00087139|37857502|FG002|Overall Study|Adverse Event|13|||
16877815|NCT00087139|37857500|FG000|Overall Study|Death|2|||
16877816|NCT00087139|37857501|FG001|Overall Study|Death|1|||
16877817|NCT00087139|37857502|FG002|Overall Study|Death|0|||
16877818|NCT00087139|37857500|FG000|Overall Study|Withdrawal by Subject|3|||
16877819|NCT00087139|37857501|FG001|Overall Study|Withdrawal by Subject|2|||
16877820|NCT00087139|37857502|FG002|Overall Study|Withdrawal by Subject|2|||
16877821|NCT00087139|37857500|FG000|Overall Study|Physician Decision|1|||
16877822|NCT00087139|37857501|FG001|Overall Study|Physician Decision|1|||
16877823|NCT00087139|37857502|FG002|Overall Study|Physician Decision|1|||
16877824|NCT00087139|37857500|FG000|Overall Study|Disease progression|9|||
16877825|NCT00087139|37857501|FG001|Overall Study|Disease progression|19|||
16877826|NCT00087139|37857502|FG002|Overall Study|Disease progression|12|||
16877827|NCT00087139|37857500|FG000|Overall Study|Ineligible|4|||
16877828|NCT00087139|37857501|FG001|Overall Study|Ineligible|7|||
16877829|NCT00087139|37857502|FG002|Overall Study|Ineligible|4|||
16877830|NCT00087139|37857500|FG000|Overall Study|Symptomatic deterioration|1|||
16877831|NCT00087139|37857501|FG001|Overall Study|Symptomatic deterioration|1|||
16877832|NCT00087139|37857502|FG002|Overall Study|Symptomatic deterioration|3|||
16877833|NCT00087139|37857500|FG000|Overall Study|Use of coumadin|1|||
16877834|NCT00087139|37857501|FG001|Overall Study|Use of coumadin|0|||
16877835|NCT00087139|37857502|FG002|Overall Study|Use of coumadin|0|||
16877836|NCT00087139|37857500|FG000|Overall Study|Response achieved|0|||
16877837|NCT00087139|37857501|FG001|Overall Study|Response achieved|1|||
16877838|NCT00087139|37857502|FG002|Overall Study|Response achieved|0|||
16877839|NCT00087139|37857500|FG000|Overall Study|Extradural disease|0|||
16877840|NCT00087139|37857501|FG001|Overall Study|Extradural disease|0|||
16877841|NCT00087139|37857502|FG002|Overall Study|Extradural disease|1|||
16877842|NCT01500278|37857554|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
16877843|NCT01500278|37857555|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
16877844|NCT01500278|37857554|FG000|Week 0 - Week 12|Protocol Violation|10|||
16877845|NCT01500278|37857555|FG001|Week 0 - Week 12|Protocol Violation|16|||
16877846|NCT01500278|37857554|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
16877847|NCT01500278|37857555|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
16877848|NCT01500278|37857554|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
16877849|NCT01500278|37857555|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
16877850|NCT01500278|37857554|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
16877851|NCT01500278|37857555|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
16877852|NCT01500278|37857554|FG000|Week 0 - Week 12|Patient decision|1|||
16877853|NCT01500278|37857555|FG001|Week 0 - Week 12|Patient decision|0|||
16877854|NCT01500278|37857554|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
16877855|NCT01500278|37857555|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
16877856|NCT01500278|37857554|FG000|Week 0 - Week 12|Investigator decision|1|||
16877857|NCT01500278|37857555|FG001|Week 0 - Week 12|Investigator decision|0|||
16877858|NCT01500278|37857554|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
16877859|NCT01500278|37857555|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
16877860|NCT01500278|37857554|FG000|Week 0 - Week 12|Sponsor decision|1|||
16877861|NCT01500278|37857555|FG001|Week 0 - Week 12|Sponsor decision|0|||
16877862|NCT01500278|37857554|FG000|Week 0 - Week 12|Personal reason|0|||
16877863|NCT01500278|37857555|FG001|Week 0 - Week 12|Personal reason|1|||
16877864|NCT01500278|37857554|FG000|Week 0 - Week 12|Other serious disease|0|||
16877865|NCT01500278|37857555|FG001|Week 0 - Week 12|Other serious disease|1|||
16877866|NCT01500278|37857554|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
16877867|NCT01500278|37857555|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
16877868|NCT01500278|37857554|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
16877869|NCT01500278|37857555|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
16877870|NCT01500278|37857554|FG000|Week 13 - Week 104|Protocol Violation|6|||
16877871|NCT01500278|37857555|FG001|Week 13 - Week 104|Protocol Violation|6|||
16877872|NCT01500278|37857554|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
16877873|NCT01500278|37857555|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
16877874|NCT01500278|37857554|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
16877875|NCT01500278|37857555|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
16877876|NCT01500278|37857554|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
16877877|NCT01500278|37857555|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
16877878|NCT01500278|37857554|FG000|Week 13 - Week 104|Non/bad compliance|7|||
16877879|NCT01500278|37857555|FG001|Week 13 - Week 104|Non/bad compliance|5|||
16877880|NCT01500278|37857554|FG000|Week 13 - Week 104|Recurrent infections|1|||
16877881|NCT01500278|37857555|FG001|Week 13 - Week 104|Recurrent infections|0|||
16877882|NCT01500278|37857554|FG000|Week 13 - Week 104|False positive test|1|||
16877883|NCT01500278|37857555|FG001|Week 13 - Week 104|False positive test|2|||
16877884|NCT01500278|37857554|FG000|Week 13 - Week 104|Sponsor request|4|||
16877885|NCT01500278|37857555|FG001|Week 13 - Week 104|Sponsor request|0|||
16877886|NCT01500278|37857554|FG000|Week 13 - Week 104|Withdrawn in error|1|||
16877887|NCT01500278|37857555|FG001|Week 13 - Week 104|Withdrawn in error|0|||
16877888|NCT01500278|37857554|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
16877889|NCT01500278|37857555|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
16877890|NCT01500278|37857554|FG000|Week 13 - Week 104|Protocol deviation|1|||
16877891|NCT01500278|37857555|FG001|Week 13 - Week 104|Protocol deviation|0|||
16877892|NCT01500278|37857554|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
16877893|NCT01500278|37857555|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
16877894|NCT01500278|37857554|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
16877895|NCT01500278|37857555|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
16877896|NCT01500278|37857554|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
16877897|NCT01500278|37857555|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
16877898|NCT01500278|37857554|FG000|Week 13 - Week 104|Relocation|0|||
16877899|NCT01500278|37857555|FG001|Week 13 - Week 104|Relocation|1|||
16877900|NCT01500278|37857554|FG000|Week 13 - Week 104|Sponsor decision|0|||
16877901|NCT01500278|37857555|FG001|Week 13 - Week 104|Sponsor decision|2|||
16877902|NCT01500278|37857554|FG000|Week 13 - Week 104|Medical monitor decision|0|||
16877903|NCT01500278|37857555|FG001|Week 13 - Week 104|Medical monitor decision|2|||
16877904|NCT01500278|37857554|FG000|Week 13 - Week 104|Personal reason|0|||
16877905|NCT01500278|37857555|FG001|Week 13 - Week 104|Personal reason|1|||
16877906|NCT01500278|37857554|FG000|Week 13 - Week 104|Not completed|0|||
16877907|NCT01500278|37857555|FG001|Week 13 - Week 104|Not completed|1|||
16877908|NCT01500278|37857554|FG000|Week 13 - Week 104|Death|2|||
16877909|NCT01500278|37857555|FG001|Week 13 - Week 104|Death|4|||
16877910|NCT01500278|37857554|FG000|Week 13 - Week 104|Adverse Event|54|||
16877911|NCT01500278|37857555|FG001|Week 13 - Week 104|Adverse Event|54|||
16877912|NCT00086281|37857578|FG000|Phase 1|Adverse Event|0|||
16877913|NCT00086281|37857579|FG001|Phase 1|Adverse Event|0|||
16877914|NCT00086281|37857580|FG002|Phase 1|Adverse Event|0|||
16877915|NCT00086281|37857581|FG003|Phase 1|Adverse Event|0|||
16877916|NCT00086281|37857582|FG004|Phase 1|Adverse Event|0|||
16877917|NCT00086281|37857583|FG005|Phase 1|Adverse Event|0|||
16877918|NCT00086281|37857584|FG006|Phase 1|Adverse Event|0|||
16877919|NCT00086281|37857585|FG007|Phase 1|Adverse Event|0|||
16877920|NCT00086281|37857586|FG008|Phase 1|Adverse Event|0|||
16877921|NCT00086281|37857587|FG009|Phase 1|Adverse Event|1|||
16877922|NCT00086281|37857588|FG010|Phase 1|Adverse Event|2|||
16877923|NCT00086281|37857589|FG011|Phase 1|Adverse Event|1|||
16877924|NCT00086281|37857590|FG012|Phase 1|Adverse Event|1|||
16877925|NCT00086281|37857591|FG013|Phase 1|Adverse Event|1|||
16877926|NCT00086281|37857592|FG014|Phase 1|Adverse Event|2|||
16877927|NCT00086281|37857578|FG000|Phase 1|Protocol Violation|0|||
16877928|NCT00086281|37857579|FG001|Phase 1|Protocol Violation|0|||
16877929|NCT00086281|37857580|FG002|Phase 1|Protocol Violation|0|||
16877930|NCT00086281|37857581|FG003|Phase 1|Protocol Violation|0|||
16877931|NCT00086281|37857582|FG004|Phase 1|Protocol Violation|0|||
16877932|NCT00086281|37857583|FG005|Phase 1|Protocol Violation|0|||
16877933|NCT00086281|37857584|FG006|Phase 1|Protocol Violation|0|||
16877934|NCT00086281|37857585|FG007|Phase 1|Protocol Violation|0|||
16877935|NCT00086281|37857586|FG008|Phase 1|Protocol Violation|0|||
16877936|NCT00086281|37857587|FG009|Phase 1|Protocol Violation|0|||
16877937|NCT00086281|37857588|FG010|Phase 1|Protocol Violation|1|||
16877938|NCT00086281|37857589|FG011|Phase 1|Protocol Violation|0|||
16877939|NCT00086281|37857590|FG012|Phase 1|Protocol Violation|0|||
16877940|NCT00086281|37857591|FG013|Phase 1|Protocol Violation|0|||
16877941|NCT00086281|37857592|FG014|Phase 1|Protocol Violation|0|||
16877942|NCT00086281|37857578|FG000|Phase 1|Serious Adverse Event|0|||
16877943|NCT00086281|37857579|FG001|Phase 1|Serious Adverse Event|0|||
16877944|NCT00086281|37857580|FG002|Phase 1|Serious Adverse Event|0|||
16877945|NCT00086281|37857581|FG003|Phase 1|Serious Adverse Event|0|||
16877946|NCT00086281|37857582|FG004|Phase 1|Serious Adverse Event|0|||
16877947|NCT00086281|37857583|FG005|Phase 1|Serious Adverse Event|0|||
16877948|NCT00086281|37857584|FG006|Phase 1|Serious Adverse Event|0|||
16877949|NCT00086281|37857585|FG007|Phase 1|Serious Adverse Event|0|||
16877950|NCT00086281|37857586|FG008|Phase 1|Serious Adverse Event|0|||
16877951|NCT00086281|37857587|FG009|Phase 1|Serious Adverse Event|0|||
16877952|NCT00086281|37857588|FG010|Phase 1|Serious Adverse Event|0|||
16877953|NCT00086281|37857589|FG011|Phase 1|Serious Adverse Event|0|||
16877954|NCT00086281|37857590|FG012|Phase 1|Serious Adverse Event|0|||
16877955|NCT00086281|37857591|FG013|Phase 1|Serious Adverse Event|0|||
16877956|NCT00086281|37857592|FG014|Phase 1|Serious Adverse Event|1|||
16877957|NCT00086281|37857578|FG000|Phase 2|Adverse Event|0|||
16877958|NCT00086281|37857579|FG001|Phase 2|Adverse Event|0|||
16877959|NCT00086281|37857580|FG002|Phase 2|Adverse Event|0|||
16877960|NCT00086281|37857581|FG003|Phase 2|Adverse Event|0|||
16877961|NCT00086281|37857582|FG004|Phase 2|Adverse Event|0|||
16877962|NCT00086281|37857583|FG005|Phase 2|Adverse Event|0|||
16877963|NCT00086281|37857584|FG006|Phase 2|Adverse Event|0|||
16877964|NCT00086281|37857585|FG007|Phase 2|Adverse Event|0|||
16877965|NCT00086281|37857586|FG008|Phase 2|Adverse Event|0|||
16877966|NCT00086281|37857587|FG009|Phase 2|Adverse Event|0|||
16877967|NCT00086281|37857588|FG010|Phase 2|Adverse Event|0|||
16877968|NCT00086281|37857589|FG011|Phase 2|Adverse Event|0|||
16877969|NCT00086281|37857590|FG012|Phase 2|Adverse Event|1|||
16877970|NCT00086281|37857591|FG013|Phase 2|Adverse Event|1|||
16877971|NCT00086281|37857592|FG014|Phase 2|Adverse Event|0|||
16877972|NCT00086047|37857604|FG000|Overall Study|Lost to Follow-up|7|||
16877973|NCT00086047|37857605|FG001|Overall Study|Lost to Follow-up|6|||
16877974|NCT00086047|37857604|FG000|Overall Study|Physician Decision|0|||
16877975|NCT00086047|37857605|FG001|Overall Study|Physician Decision|1|||
16877976|NCT01478828|37857617|FG000|Overall Study|Adverse Event|1|||
16877977|NCT00085423|37857622|FG000|Overall Study|Withdrawal by Subject|1|||
16877978|NCT00085423|37857622|FG000|Overall Study|screen failure|1|||
16877979|NCT00084487|37857626|FG000|Overall Study|Death|1|||
16877980|NCT01425281|37857666|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
16877981|NCT01425281|37857667|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
16877982|NCT01425281|37857666|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
16877983|NCT01425281|37857667|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
16877984|NCT01425281|37857666|FG000|At 180-day Clinical Follow-up|Death|0|||
16877985|NCT01425281|37857667|FG001|At 180-day Clinical Follow-up|Death|1|||
16877986|NCT01425281|37857666|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
16877987|NCT01425281|37857667|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
16877988|NCT01425281|37857666|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
16877989|NCT01425281|37857667|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
16877990|NCT01425281|37857666|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
16877991|NCT01425281|37857667|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
16877992|NCT01425281|37857666|FG000|At 2-year Clinical Follow-up|Death|2|||
16877993|NCT01425281|37857667|FG001|At 2-year Clinical Follow-up|Death|0|||
16877994|NCT01425281|37857666|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
16877995|NCT01425281|37857667|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
16877996|NCT01425281|37857666|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
16877997|NCT01425281|37857667|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
16877998|NCT01425281|37857666|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
16877999|NCT01425281|37857667|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
16878000|NCT01425281|37857666|FG000|At 3-year Clinical Follow-up|Death|2|||
16878001|NCT01425281|37857667|FG001|At 3-year Clinical Follow-up|Death|3|||
16878002|NCT01425281|37857666|FG000|At 4-year Clinical Follow-up|Death|7|||
16878003|NCT01425281|37857667|FG001|At 4-year Clinical Follow-up|Death|3|||
16878004|NCT01425281|37857666|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
16878005|NCT01425281|37857667|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
16878006|NCT01425281|37857666|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
16878007|NCT01425281|37857667|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
16878008|NCT01425281|37857666|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
16878009|NCT01425281|37857667|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
16878010|NCT01425281|37857666|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
16878011|NCT01425281|37857667|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
16878012|NCT01425281|37857666|FG000|At 5-year Clinical Follow-up|Death|2|||
16878013|NCT01425281|37857667|FG001|At 5-year Clinical Follow-up|Death|0|||
16878014|NCT01425281|37857666|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
16878015|NCT01425281|37857667|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
16878016|NCT01425281|37857666|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
16878017|NCT01425281|37857667|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
16878018|NCT01425281|37857666|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
16878019|NCT01425281|37857667|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
16878020|NCT02648724|37857695|FG000|Overall Study|Withdrawal by Subject|0|||
16878021|NCT02648724|37857696|FG001|Overall Study|Withdrawal by Subject|1|||
16878022|NCT02648724|37857697|FG002|Overall Study|Withdrawal by Subject|1|||
16878023|NCT02648724|37857698|FG003|Overall Study|Withdrawal by Subject|0|||
16878024|NCT02648724|37857699|FG004|Overall Study|Withdrawal by Subject|1|||
16878025|NCT02648724|37857700|FG005|Overall Study|Withdrawal by Subject|0|||
16878026|NCT02648724|37857701|FG006|Overall Study|Withdrawal by Subject|0|||
16878027|NCT02648724|37857695|FG000|Overall Study|Progressive disease|2|||
16878028|NCT02648724|37857696|FG001|Overall Study|Progressive disease|2|||
16878029|NCT02648724|37857697|FG002|Overall Study|Progressive disease|2|||
16878030|NCT02648724|37857698|FG003|Overall Study|Progressive disease|3|||
16878031|NCT02648724|37857699|FG004|Overall Study|Progressive disease|22|||
16878032|NCT02648724|37857700|FG005|Overall Study|Progressive disease|7|||
16878033|NCT02648724|37857701|FG006|Overall Study|Progressive disease|8|||
16785528|NCT02699125|37725597|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
16785529|NCT02698891|37725607|FG000|Overall Study|Withdrawal by Subject|2|||
16785530|NCT02698891|37725607|FG000|Overall Study|deemed ineligible|1|||
16785531|NCT02698891|37725607|FG000|Overall Study|Adverse Event|9|||
16785532|NCT02698423|37725613|FG000|Overall Study|Lost to Follow-up|19|||
16878034|NCT02648724|37857695|FG000|Overall Study|Other reason (unknown)|1|||
16878035|NCT02648724|37857696|FG001|Overall Study|Other reason (unknown)|0|||
16878036|NCT02648724|37857697|FG002|Overall Study|Other reason (unknown)|0|||
16878037|NCT02648724|37857698|FG003|Overall Study|Other reason (unknown)|0|||
16878038|NCT02648724|37857699|FG004|Overall Study|Other reason (unknown)|0|||
16878039|NCT02648724|37857700|FG005|Overall Study|Other reason (unknown)|0|||
16878040|NCT02648724|37857701|FG006|Overall Study|Other reason (unknown)|0|||
16878041|NCT02648724|37857695|FG000|Overall Study|Protocol Violation|0|||
16878042|NCT02648724|37857696|FG001|Overall Study|Protocol Violation|0|||
16878043|NCT02648724|37857697|FG002|Overall Study|Protocol Violation|0|||
16878044|NCT02648724|37857698|FG003|Overall Study|Protocol Violation|0|||
16878045|NCT02648724|37857699|FG004|Overall Study|Protocol Violation|1|||
16878046|NCT02648724|37857700|FG005|Overall Study|Protocol Violation|0|||
16878047|NCT02648724|37857701|FG006|Overall Study|Protocol Violation|0|||
16878048|NCT02648724|37857695|FG000|Overall Study|Death|0|||
16878049|NCT02648724|37857696|FG001|Overall Study|Death|0|||
16878050|NCT02648724|37857697|FG002|Overall Study|Death|0|||
16878051|NCT02648724|37857698|FG003|Overall Study|Death|0|||
16878052|NCT02648724|37857699|FG004|Overall Study|Death|0|||
16878053|NCT02648724|37857700|FG005|Overall Study|Death|0|||
16878054|NCT02648724|37857701|FG006|Overall Study|Death|3|||
16878055|NCT02648724|37857695|FG000|Overall Study|Physician Decision|0|||
16878056|NCT02648724|37857696|FG001|Overall Study|Physician Decision|0|||
16878057|NCT02648724|37857697|FG002|Overall Study|Physician Decision|0|||
16878058|NCT02648724|37857698|FG003|Overall Study|Physician Decision|0|||
16878059|NCT02648724|37857699|FG004|Overall Study|Physician Decision|1|||
16878060|NCT02648724|37857700|FG005|Overall Study|Physician Decision|0|||
16878061|NCT02648724|37857701|FG006|Overall Study|Physician Decision|1|||
16878062|NCT02648724|37857695|FG000|Overall Study|Transferred to named patient program|0|||
16878063|NCT02648724|37857696|FG001|Overall Study|Transferred to named patient program|0|||
16878064|NCT02648724|37857697|FG002|Overall Study|Transferred to named patient program|0|||
16878065|NCT02648724|37857698|FG003|Overall Study|Transferred to named patient program|0|||
16878066|NCT02648724|37857699|FG004|Overall Study|Transferred to named patient program|0|||
16878067|NCT02648724|37857700|FG005|Overall Study|Transferred to named patient program|1|||
16878068|NCT02648724|37857701|FG006|Overall Study|Transferred to named patient program|0|||
16878069|NCT01402817|37857733|FG000|Overall Study|Withdrawal by Subject|3|||
16878070|NCT01402817|37857733|FG000|Overall Study|Study Suspended by FDA|8|||
16878071|NCT01425203|37857740|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
16878072|NCT01425203|37857741|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
16878073|NCT01425203|37857742|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
16878074|NCT01425203|37857740|FG000|Treatment Phase|Failure at futility timepoint|8|||
16878075|NCT01425203|37857741|FG001|Treatment Phase|Failure at futility timepoint|27|||
16878076|NCT01425203|37857742|FG002|Treatment Phase|Failure at futility timepoint|0|||
16878077|NCT01425203|37857740|FG000|Treatment Phase|Other virologic failure criteria|5|||
16878078|NCT01425203|37857741|FG001|Treatment Phase|Other virologic failure criteria|3|||
16878079|NCT01425203|37857742|FG002|Treatment Phase|Other virologic failure criteria|0|||
16878080|NCT01425203|37857740|FG000|Treatment Phase|Unidentified reasons|11|||
16878081|NCT01425203|37857741|FG001|Treatment Phase|Unidentified reasons|5|||
16785533|NCT02698423|37725614|FG001|Overall Study|Lost to Follow-up|24|||
16785534|NCT02700997|37725622|FG000|Overall Study|Did not undergo CT imaging|1|||
16878082|NCT01425203|37857742|FG002|Treatment Phase|Unidentified reasons|0|||
16878083|NCT01425203|37857740|FG000|Treatment Phase|Did not receive treatment|0|||
16878084|NCT01425203|37857741|FG001|Treatment Phase|Did not receive treatment|1|||
16878085|NCT01425203|37857742|FG002|Treatment Phase|Did not receive treatment|0|||
16878086|NCT01425203|37857740|FG000|Crossover Phase|Failure at futility timepoint|0|||
16878087|NCT01425203|37857741|FG001|Crossover Phase|Failure at futility timepoint|0|||
16878088|NCT01425203|37857742|FG002|Crossover Phase|Failure at futility timepoint|3|||
16878089|NCT01425203|37857740|FG000|Crossover Phase|Other virologic failure criteria|0|||
16878090|NCT01425203|37857741|FG001|Crossover Phase|Other virologic failure criteria|0|||
16878091|NCT01425203|37857742|FG002|Crossover Phase|Other virologic failure criteria|3|||
16878092|NCT00081289|37857752|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
16878093|NCT00081289|37857753|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
16878094|NCT00081289|37857752|FG000|Overall Study|Ineligible / no protocol treatment|3|||
16878095|NCT00081289|37857753|FG001|Overall Study|Ineligible / no protocol treatment|4|||
16878096|NCT01478594|37857762|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
16878097|NCT01478594|37857763|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
16878098|NCT01478594|37857762|FG000|Overall Study|Death|45|||
16878099|NCT01478594|37857763|FG001|Overall Study|Death|18|||
16878100|NCT01478594|37857762|FG000|Overall Study|Lost to Follow-up|3|||
16878101|NCT01478594|37857763|FG001|Overall Study|Lost to Follow-up|1|||
16878102|NCT01478594|37857762|FG000|Overall Study|Withdrawal by Subject|9|||
16878103|NCT01478594|37857763|FG001|Overall Study|Withdrawal by Subject|3|||
16878104|NCT01478594|37857762|FG000|Overall Study|Study Closed by Sponsor|8|||
16878105|NCT01478594|37857763|FG001|Overall Study|Study Closed by Sponsor|5|||
16878106|NCT01424813|37857824|FG000|Overall Study|Withdrawal by Subject|3|||
16878107|NCT01424813|37857825|FG001|Overall Study|Withdrawal by Subject|0|||
16878108|NCT01424813|37857824|FG000|Overall Study|Protocol Violation|1|||
16878109|NCT01424813|37857825|FG001|Overall Study|Protocol Violation|0|||
16878110|NCT01424813|37857824|FG000|Overall Study|Other|1|||
16878111|NCT01424813|37857825|FG001|Overall Study|Other|2|||
16878112|NCT00080899|37857831|FG000|Overall Study|Adverse Event|1|||
16878113|NCT00089635|37857835|FG000|Overall Study|Adverse Event|2|||
16878114|NCT00089635|37857835|FG000|Overall Study|Death|17|||
16878115|NCT00089635|37857835|FG000|Overall Study|Disease Progression|12|||
16878116|NCT00089635|37857835|FG000|Overall Study|Lost to Follow-up|3|||
16878117|NCT00089635|37857835|FG000|Overall Study|Withdrawal by Subject|6|||
16878118|NCT00089635|37857835|FG000|Overall Study|Ineligibility determined|1|||
16878119|NCT00089635|37857835|FG000|Overall Study|Other|2|||
16878120|NCT01500200|37857849|FG000|Stage 1|Adverse Event|1|||
16878121|NCT01500200|37857850|FG001|Stage 1|Adverse Event|4|||
16878122|NCT01500200|37857851|FG002|Stage 1|Adverse Event|5|||
16878123|NCT01500200|37857852|FG003|Stage 1|Adverse Event|0|||
16878124|NCT01500200|37857853|FG004|Stage 1|Adverse Event|0|||
16878125|NCT01500200|37857854|FG005|Stage 1|Adverse Event|0|||
16878126|NCT01500200|37857849|FG000|Stage 1|Lost to Follow-up|2|||
16878127|NCT01500200|37857850|FG001|Stage 1|Lost to Follow-up|2|||
16878128|NCT01500200|37857851|FG002|Stage 1|Lost to Follow-up|1|||
16878129|NCT01500200|37857852|FG003|Stage 1|Lost to Follow-up|0|||
16878130|NCT01500200|37857853|FG004|Stage 1|Lost to Follow-up|0|||
16878131|NCT01500200|37857854|FG005|Stage 1|Lost to Follow-up|0|||
16878132|NCT01500200|37857849|FG000|Stage 1|Withdrawal by Subject|3|||
16878133|NCT01500200|37857850|FG001|Stage 1|Withdrawal by Subject|0|||
16878134|NCT01500200|37857851|FG002|Stage 1|Withdrawal by Subject|0|||
16878135|NCT01500200|37857852|FG003|Stage 1|Withdrawal by Subject|0|||
16878136|NCT01500200|37857853|FG004|Stage 1|Withdrawal by Subject|0|||
16878137|NCT01500200|37857854|FG005|Stage 1|Withdrawal by Subject|0|||
16878138|NCT01500200|37857849|FG000|Stage 1|Noncompliance with Study Drug|1|||
16878139|NCT01500200|37857850|FG001|Stage 1|Noncompliance with Study Drug|0|||
16878140|NCT01500200|37857851|FG002|Stage 1|Noncompliance with Study Drug|0|||
17191603|NCT01336205|38344412|FG000|Overall Study|Adverse Event|56|||
17191604|NCT01336205|38344413|FG001|Overall Study|Adverse Event|6|||
17191605|NCT01336205|38344412|FG000|Overall Study|Death|1|||
17191606|NCT01336205|38344413|FG001|Overall Study|Death|1|||
17191607|NCT01336205|38344412|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
17191608|NCT01336205|38344413|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
17191609|NCT01336205|38344412|FG000|Overall Study|Withdrawal by Subject|72|||
17191610|NCT01336205|38344413|FG001|Overall Study|Withdrawal by Subject|38|||
17191611|NCT01336205|38344412|FG000|Overall Study|Did not receive treatment|4|||
17191612|NCT01336205|38344413|FG001|Overall Study|Did not receive treatment|0|||
17191613|NCT02865395|38344422|FG000|Overall Study|Physician Decision|6|||
17191614|NCT02865395|38344423|FG001|Overall Study|Physician Decision|10|||
17191615|NCT02865395|38344424|FG002|Overall Study|Physician Decision|7|||
17191616|NCT01123707|38344436|FG000|Overall Study|Lost to Follow-up|3|||
17191617|NCT01123707|38344437|FG001|Overall Study|Lost to Follow-up|1|||
17191618|NCT01123707|38344438|FG002|Overall Study|Lost to Follow-up|3|||
17191619|NCT01123707|38344439|FG003|Overall Study|Lost to Follow-up|2|||
17191620|NCT01123707|38344436|FG000|Overall Study|Adverse Event|5|||
17191621|NCT01123707|38344437|FG001|Overall Study|Adverse Event|7|||
17191622|NCT01123707|38344438|FG002|Overall Study|Adverse Event|5|||
17191623|NCT01123707|38344439|FG003|Overall Study|Adverse Event|3|||
17191624|NCT01123707|38344436|FG000|Overall Study|Sponsor Discontinued Study|30|||
17191625|NCT01123707|38344437|FG001|Overall Study|Sponsor Discontinued Study|24|||
17191626|NCT01123707|38344438|FG002|Overall Study|Sponsor Discontinued Study|25|||
17191627|NCT01123707|38344439|FG003|Overall Study|Sponsor Discontinued Study|40|||
17191628|NCT01123707|38344436|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
17191629|NCT01123707|38344437|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
16878141|NCT01500200|37857852|FG003|Stage 1|Noncompliance with Study Drug|0|||
16878142|NCT01500200|37857853|FG004|Stage 1|Noncompliance with Study Drug|0|||
16878143|NCT01500200|37857854|FG005|Stage 1|Noncompliance with Study Drug|0|||
16878144|NCT01500200|37857849|FG000|Stage 1|Physician Decision|1|||
16878145|NCT01500200|37857850|FG001|Stage 1|Physician Decision|0|||
16878146|NCT01500200|37857851|FG002|Stage 1|Physician Decision|0|||
16878147|NCT01500200|37857852|FG003|Stage 1|Physician Decision|0|||
16878148|NCT01500200|37857853|FG004|Stage 1|Physician Decision|0|||
16878149|NCT01500200|37857854|FG005|Stage 1|Physician Decision|0|||
16878150|NCT01500200|37857849|FG000|Stage 2|Adverse Event|0|||
16878151|NCT01500200|37857850|FG001|Stage 2|Adverse Event|0|||
16878152|NCT01500200|37857851|FG002|Stage 2|Adverse Event|0|||
16878153|NCT01500200|37857852|FG003|Stage 2|Adverse Event|0|||
16878154|NCT01500200|37857853|FG004|Stage 2|Adverse Event|5|||
16878155|NCT01500200|37857854|FG005|Stage 2|Adverse Event|4|||
16878156|NCT01478360|37857870|FG000|Overall Study|Lost to Follow-up|1|||
16878157|NCT01478360|37857871|FG001|Overall Study|Lost to Follow-up|0|||
16878158|NCT01478360|37857870|FG000|Overall Study|Adverse Event|0|||
17191630|NCT01123707|38344438|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
17191631|NCT01123707|38344439|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
17191632|NCT01123707|38344436|FG000|Overall Study|Investigator Withdrew Participant|0|||
17191633|NCT01123707|38344437|FG001|Overall Study|Investigator Withdrew Participant|1|||
17191634|NCT01123707|38344438|FG002|Overall Study|Investigator Withdrew Participant|1|||
17191635|NCT01123707|38344439|FG003|Overall Study|Investigator Withdrew Participant|1|||
17191636|NCT01123707|38344436|FG000|Overall Study|Subject Withdrew Consent|4|||
17191637|NCT01123707|38344437|FG001|Overall Study|Subject Withdrew Consent|5|||
17191638|NCT01123707|38344438|FG002|Overall Study|Subject Withdrew Consent|1|||
17191639|NCT01123707|38344439|FG003|Overall Study|Subject Withdrew Consent|2|||
17191640|NCT01123707|38344436|FG000|Overall Study|Lack of Efficacy|1|||
17191641|NCT01123707|38344437|FG001|Overall Study|Lack of Efficacy|2|||
17191642|NCT01123707|38344438|FG002|Overall Study|Lack of Efficacy|1|||
17191643|NCT01123707|38344439|FG003|Overall Study|Lack of Efficacy|0|||
17191644|NCT01123707|38344436|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
17191645|NCT01123707|38344437|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
17191646|NCT01123707|38344438|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
17191647|NCT01123707|38344439|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
17191648|NCT02755103|38344451|FG000|Overall Study|Lost to Follow-up|17|||
17191649|NCT02755103|38344452|FG001|Overall Study|Lost to Follow-up|15|||
17191650|NCT02755103|38344451|FG000|Overall Study|Death|0|||
17191651|NCT02755103|38344452|FG001|Overall Study|Death|1|||
17191652|NCT02755103|38344451|FG000|Overall Study|Physician Decision|0|||
17191653|NCT02755103|38344452|FG001|Overall Study|Physician Decision|1|||
17191654|NCT02755103|38344451|FG000|Overall Study|Pregnancy|0|||
17191655|NCT02755103|38344452|FG001|Overall Study|Pregnancy|1|||
17191656|NCT02755103|38344451|FG000|Overall Study|Withdrawal by Subject|3|||
17191657|NCT02755103|38344452|FG001|Overall Study|Withdrawal by Subject|0|||
17191658|NCT01258803|38344462|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
17191659|NCT01258803|38344463|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
17191660|NCT01258803|38344464|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
17191661|NCT01258803|38344465|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
17191662|NCT01258803|38344466|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
17191663|NCT01258803|38344467|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
17191664|NCT01258803|38344462|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
17191665|NCT01258803|38344463|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
17191666|NCT01258803|38344464|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
17191667|NCT01258803|38344465|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
17191668|NCT01258803|38344466|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
17191669|NCT01258803|38344467|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
17191670|NCT01258803|38344462|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
17191671|NCT01258803|38344463|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
17191672|NCT01258803|38344464|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
17191673|NCT01258803|38344465|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
17191674|NCT01258803|38344466|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
17191675|NCT01258803|38344467|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
17191676|NCT02865083|38344483|FG000|Overall Study|Early Termination|3|||
17191677|NCT02865083|38344484|FG001|Overall Study|Early Termination|1|||
17191678|NCT00862251|38344493|FG000|Overall Study|Adverse Event|8|||
17191679|NCT00862251|38344494|FG001|Overall Study|Adverse Event|3|||
17191680|NCT00862251|38344495|FG002|Overall Study|Adverse Event|1|||
17191681|NCT00862251|38344493|FG000|Overall Study|Lost to Follow-up|0|||
17191682|NCT00862251|38344494|FG001|Overall Study|Lost to Follow-up|0|||
17191683|NCT00862251|38344495|FG002|Overall Study|Lost to Follow-up|1|||
17191684|NCT00862251|38344493|FG000|Overall Study|Protocol Violation|2|||
17191685|NCT00862251|38344494|FG001|Overall Study|Protocol Violation|0|||
16878159|NCT01478360|37857871|FG001|Overall Study|Adverse Event|1|||
16878160|NCT01478360|37857870|FG000|Overall Study|Administrative problems|1|||
16878161|NCT01478360|37857871|FG001|Overall Study|Administrative problems|2|||
16878162|NCT01461980|37857889|FG000|Overall Study|Other|9|||
16878163|NCT01461980|37857890|FG001|Overall Study|Other|8|||
16878164|NCT01461980|37857891|FG002|Overall Study|Other|6|||
16878165|NCT01461980|37857889|FG000|Overall Study|Medication error|7|||
16878166|NCT01461980|37857890|FG001|Overall Study|Medication error|5|||
16878167|NCT01461980|37857891|FG002|Overall Study|Medication error|6|||
16878168|NCT01461980|37857889|FG000|Overall Study|Adverse Event|12|||
16878169|NCT01461980|37857890|FG001|Overall Study|Adverse Event|5|||
16878170|NCT01461980|37857891|FG002|Overall Study|Adverse Event|6|||
16878171|NCT01461980|37857889|FG000|Overall Study|Protocol Violation|12|||
16878172|NCT01461980|37857890|FG001|Overall Study|Protocol Violation|19|||
16878173|NCT01461980|37857891|FG002|Overall Study|Protocol Violation|16|||
16878174|NCT01461980|37857889|FG000|Overall Study|No longer meets eligibility criteria|18|||
16878175|NCT01461980|37857890|FG001|Overall Study|No longer meets eligibility criteria|9|||
16878176|NCT01461980|37857891|FG002|Overall Study|No longer meets eligibility criteria|19|||
16878177|NCT01461980|37857889|FG000|Overall Study|Lost to Follow-up|52|||
17095225|NCT00175916|38234503|FG000|Overall Study|Subject Choice|98|||
17095226|NCT00175916|38234503|FG000|Overall Study|Lack of compliance|8|||
17001818|NCT00659425|38145819|FG005|Overall Study|Death|0|||
17001819|NCT00659425|38145820|FG006|Overall Study|Death|1|||
17095227|NCT00175916|38234503|FG000|Overall Study|Patient cannot record seizures|1|||
17095228|NCT00175916|38234503|FG000|Overall Study|Sponsor decision|17|||
17095229|NCT00175916|38234503|FG000|Overall Study|Vigabatrin intake|1|||
17095230|NCT00175916|38234503|FG000|Overall Study|Suicidal behaviour|1|||
17095231|NCT00175916|38234503|FG000|Overall Study|Withdrawal by Subject|1|||
17095232|NCT00175916|38234503|FG000|Overall Study|Seizure - free|4|||
17095233|NCT00175916|38234503|FG000|Overall Study|Administrative reason|1|||
17095234|NCT00175916|38234503|FG000|Overall Study|Pregnancy|1|||
17095235|NCT00175916|38234503|FG000|Overall Study|Patient's request|2|||
17095236|NCT00175916|38234503|FG000|Overall Study|Treating physiciant's choice|1|||
17095237|NCT00175916|38234503|FG000|Overall Study|Moved overseas|1|||
17095238|NCT00175916|38234503|FG000|Overall Study|Loss of job and economic burden|1|||
17095239|NCT00175916|38234503|FG000|Overall Study|Site was closed|9|||
17001820|NCT00659425|38145821|FG007|Overall Study|Death|0|||
17001821|NCT00659425|38145822|FG008|Overall Study|Death|0|||
17001822|NCT00659425|38145823|FG009|Overall Study|Death|0|||
17001823|NCT00659425|38145814|FG000|Overall Study|Adverse Event|0|||
17001824|NCT00659425|38145815|FG001|Overall Study|Adverse Event|0|||
17001825|NCT00659425|38145816|FG002|Overall Study|Adverse Event|0|||
17001826|NCT00659425|38145817|FG003|Overall Study|Adverse Event|0|||
17001827|NCT00659425|38145818|FG004|Overall Study|Adverse Event|0|||
17001828|NCT00659425|38145819|FG005|Overall Study|Adverse Event|1|||
17001829|NCT00659425|38145820|FG006|Overall Study|Adverse Event|0|||
17001830|NCT00659425|38145821|FG007|Overall Study|Adverse Event|3|||
17001831|NCT00659425|38145822|FG008|Overall Study|Adverse Event|1|||
17001832|NCT00659425|38145823|FG009|Overall Study|Adverse Event|4|||
17001833|NCT00659425|38145814|FG000|Overall Study|Investigator Discretion|0|||
17095240|NCT00175916|38234503|FG000|Overall Study|Patient went to prison|1|||
17095241|NCT00075400|38234508|FG000|Overall Study|Ineligible: wrong primary|1|||
17095242|NCT00075400|38234508|FG000|Overall Study|Never treated|2|||
17095243|NCT00228566|38234517|FG000|Overall Study|Adverse Event|31|||
17001834|NCT00659425|38145815|FG001|Overall Study|Investigator Discretion|0|||
17001835|NCT00659425|38145816|FG002|Overall Study|Investigator Discretion|0|||
17001836|NCT00659425|38145817|FG003|Overall Study|Investigator Discretion|0|||
17001837|NCT00659425|38145818|FG004|Overall Study|Investigator Discretion|0|||
17001838|NCT00659425|38145819|FG005|Overall Study|Investigator Discretion|1|||
17001839|NCT00659425|38145820|FG006|Overall Study|Investigator Discretion|0|||
17001840|NCT00659425|38145821|FG007|Overall Study|Investigator Discretion|3|||
17001841|NCT00659425|38145822|FG008|Overall Study|Investigator Discretion|0|||
17001842|NCT00659425|38145823|FG009|Overall Study|Investigator Discretion|0|||
17001843|NCT00659425|38145814|FG000|Overall Study|Other|0|||
17001844|NCT00659425|38145815|FG001|Overall Study|Other|1|||
17001845|NCT00659425|38145816|FG002|Overall Study|Other|1|||
17001846|NCT00659425|38145817|FG003|Overall Study|Other|2|||
17001847|NCT00659425|38145818|FG004|Overall Study|Other|4|||
17001848|NCT00659425|38145819|FG005|Overall Study|Other|0|||
17001849|NCT00659425|38145820|FG006|Overall Study|Other|3|||
17001850|NCT00659425|38145821|FG007|Overall Study|Other|2|||
17001851|NCT00659425|38145822|FG008|Overall Study|Other|0|||
17001852|NCT00659425|38145823|FG009|Overall Study|Other|6|||
17001853|NCT00656851|38145860|FG000|Overall Study|Withdrawal by Subject|0|||
16878178|NCT01461980|37857890|FG001|Overall Study|Lost to Follow-up|53|||
16878179|NCT01461980|37857891|FG002|Overall Study|Lost to Follow-up|51|||
16878180|NCT01461980|37857889|FG000|Overall Study|No longer willing to participate|52|||
17001854|NCT00656851|38145861|FG001|Overall Study|Withdrawal by Subject|4|||
17001855|NCT00656617|38145867|FG000|Overall Study|Adverse Event|1|||
17001856|NCT00656617|38145867|FG000|Overall Study|Death|2|||
17001857|NCT00656617|38145867|FG000|Overall Study|Insurance Issues|2|||
16878181|NCT01461980|37857890|FG001|Overall Study|No longer willing to participate|38|||
17001858|NCT00656617|38145867|FG000|Overall Study|Move to different clinical trial|2|||
17001859|NCT04797637|38145874|FG000|Overall Study|Lost to Follow-up|23|||
16878182|NCT01461980|37857891|FG002|Overall Study|No longer willing to participate|54|||
16878183|NCT01461980|37857889|FG000|Overall Study|Randomized but not vaccinated|4|||
16878184|NCT01461980|37857890|FG001|Overall Study|Randomized but not vaccinated|8|||
16878185|NCT01461980|37857891|FG002|Overall Study|Randomized but not vaccinated|7|||
16878186|NCT01424501|37857906|FG000|Overall Study|Withdrawal by Subject|1|||
16878187|NCT01424501|37857907|FG001|Overall Study|Withdrawal by Subject|0|||
16878188|NCT01424501|37857908|FG002|Overall Study|Withdrawal by Subject|1|||
16878189|NCT01424501|37857909|FG003|Overall Study|Withdrawal by Subject|0|||
16878190|NCT01424501|37857910|FG004|Overall Study|Withdrawal by Subject|0|||
16878191|NCT01424501|37857911|FG005|Overall Study|Withdrawal by Subject|0|||
16878192|NCT01424501|37857906|FG000|Overall Study|Lost to Follow-up|0|||
16878193|NCT01424501|37857907|FG001|Overall Study|Lost to Follow-up|1|||
16878194|NCT01424501|37857908|FG002|Overall Study|Lost to Follow-up|1|||
16878195|NCT01424501|37857909|FG003|Overall Study|Lost to Follow-up|0|||
16878196|NCT01424501|37857910|FG004|Overall Study|Lost to Follow-up|0|||
16878197|NCT01424501|37857911|FG005|Overall Study|Lost to Follow-up|0|||
16878198|NCT01401959|37857992|FG000|Enrolled|Withdrawal by Subject|1|||
16878199|NCT01401959|37857993|FG001|Enrolled|Withdrawal by Subject|0|||
16878200|NCT01401959|37857994|FG002|Enrolled|Withdrawal by Subject|0|||
16878201|NCT01401959|37857992|FG000|Treated|Disease Progression|2|||
16878202|NCT01401959|37857993|FG001|Treated|Disease Progression|2|||
16878203|NCT01401959|37857994|FG002|Treated|Disease Progression|1|||
16878204|NCT01401959|37857992|FG000|Treated|Adverse Event|4|||
16878205|NCT01401959|37857993|FG001|Treated|Adverse Event|3|||
16878206|NCT01401959|37857994|FG002|Treated|Adverse Event|2|||
16878207|NCT01401959|37857992|FG000|Treated|Withdrawal by Subject|1|||
16878208|NCT01401959|37857993|FG001|Treated|Withdrawal by Subject|2|||
16878209|NCT01401959|37857994|FG002|Treated|Withdrawal by Subject|2|||
16878210|NCT01401959|37857992|FG000|Treated|Protocol Violation|0|||
16878211|NCT01401959|37857993|FG001|Treated|Protocol Violation|1|||
16878212|NCT01401959|37857994|FG002|Treated|Protocol Violation|0|||
16878213|NCT01478048|37858024|FG000|Overall Study|Disease Progression|52|||
16878214|NCT01478048|37858025|FG001|Overall Study|Disease Progression|35|||
16878215|NCT01478048|37858024|FG000|Overall Study|study drug toxicity|11|||
16878216|NCT01478048|37858025|FG001|Overall Study|study drug toxicity|14|||
16878217|NCT01478048|37858024|FG000|Overall Study|Adverse Event|2|||
16878218|NCT01478048|37858025|FG001|Overall Study|Adverse Event|11|||
16878219|NCT01478048|37858024|FG000|Overall Study|subject request to discontinue treatment|3|||
16878220|NCT01478048|37858025|FG001|Overall Study|subject request to discontinue treatment|5|||
16878221|NCT01478048|37858024|FG000|Overall Study|Withdrawal by Subject|2|||
16878222|NCT01478048|37858025|FG001|Overall Study|Withdrawal by Subject|5|||
16878223|NCT01478048|37858024|FG000|Overall Study|non-specified|6|||
16878224|NCT01478048|37858025|FG001|Overall Study|non-specified|4|||
16878225|NCT01478048|37858024|FG000|Overall Study|poor/non-compliance|0|||
16878226|NCT01478048|37858025|FG001|Overall Study|poor/non-compliance|1|||
16878227|NCT01478048|37858024|FG000|Overall Study|no longer meets study criteria|1|||
16878228|NCT01478048|37858025|FG001|Overall Study|no longer meets study criteria|0|||
16878229|NCT01424189|37858033|FG000|Overall Study|Adverse Event|1|||
16878230|NCT01424189|37858034|FG001|Overall Study|Adverse Event|0|||
16878231|NCT01424189|37858033|FG000|Overall Study|Lost to Follow-up|4|||
16878232|NCT01424189|37858034|FG001|Overall Study|Lost to Follow-up|1|||
16878233|NCT01424189|37858033|FG000|Overall Study|Withdrawal by Subject|4|||
16878234|NCT01424189|37858034|FG001|Overall Study|Withdrawal by Subject|4|||
16878235|NCT01424189|37858033|FG000|Overall Study|Subject moved|1|||
16878236|NCT01424189|37858034|FG001|Overall Study|Subject moved|0|||
16878237|NCT01424189|37858033|FG000|Overall Study|Death|3|||
16878238|NCT01424189|37858034|FG001|Overall Study|Death|1|||
16878239|NCT01401647|37858047|FG000|Overall Study|Withdrawal by Subject|1|||
16878240|NCT01401647|37858048|FG001|Overall Study|Withdrawal by Subject|5|||
16878241|NCT01401647|37858049|FG002|Overall Study|Withdrawal by Subject|2|||
16878242|NCT01401647|37858047|FG000|Overall Study|Lost to Follow-up|3|||
16878243|NCT01401647|37858048|FG001|Overall Study|Lost to Follow-up|3|||
16878244|NCT01401647|37858049|FG002|Overall Study|Lost to Follow-up|1|||
16878245|NCT01499810|37858057|FG000|Overall Study|Lost to Follow-up|10|||
16878246|NCT01499810|37858057|FG000|Overall Study|Protocol Violation|1|||
16878247|NCT01499810|37858057|FG000|Overall Study|Withdrawal by Subject|1|||
16878248|NCT01423253|37858062|FG000|Overall Study|Adverse Event|2|||
16878249|NCT01423253|37858062|FG000|Overall Study|Lack of Efficacy|2|||
16878250|NCT01423253|37858062|FG000|Overall Study|Lost to Follow-up|1|||
16878251|NCT01423253|37858062|FG000|Overall Study|Protocol Violation|2|||
16878252|NCT01423253|37858062|FG000|Overall Study|Withdrawal by Subject|2|||
16878253|NCT01477892|37858068|FG000|Overall Study|Withdrawal by Subject|0|||
16878254|NCT01477892|37858069|FG001|Overall Study|Withdrawal by Subject|2|||
16878255|NCT01422239|37858082|FG000|Overall Study|Lost to Follow-up|4|||
16878256|NCT01422239|37858083|FG001|Overall Study|Lost to Follow-up|3|||
16878257|NCT01499576|37858089|FG000|Overall Study|Physician Decision|12|||
16878258|NCT01499576|37858089|FG000|Overall Study|Withdrawal by Subject|9|||
16878259|NCT01476722|37858103|FG000|Overall Study|Adverse Event|1|||
16878260|NCT01476644|37858116|FG000|Overall Study|Death|5|||
16878261|NCT01476644|37858116|FG000|Overall Study|moved to another state|2|||
16878262|NCT01476644|37858116|FG000|Overall Study|Lost to Follow-up|19|||
16878263|NCT01476644|37858116|FG000|Overall Study|Withdrawal by Subject|13|||
16878264|NCT01421459|37858140|FG000|Overall Study|Adverse Event|6|||
16878265|NCT01421459|37858141|FG001|Overall Study|Adverse Event|10|||
16878266|NCT01421459|37858140|FG000|Overall Study|Death|1|||
16878267|NCT01421459|37858141|FG001|Overall Study|Death|1|||
16878268|NCT01421459|37858140|FG000|Overall Study|Lack of Efficacy|1|||
16878269|NCT01421459|37858141|FG001|Overall Study|Lack of Efficacy|2|||
16878270|NCT01421459|37858140|FG000|Overall Study|Lost to Follow-up|8|||
16878271|NCT01421459|37858141|FG001|Overall Study|Lost to Follow-up|9|||
16878272|NCT01421459|37858140|FG000|Overall Study|Physician Decision|9|||
16878273|NCT01421459|37858141|FG001|Overall Study|Physician Decision|9|||
16878274|NCT01421459|37858140|FG000|Overall Study|Protocol Violation|8|||
16878275|NCT01421459|37858141|FG001|Overall Study|Protocol Violation|5|||
16878276|NCT01421459|37858140|FG000|Overall Study|Withdrawal by Subject|12|||
16878277|NCT01421459|37858141|FG001|Overall Study|Withdrawal by Subject|16|||
16878278|NCT01498952|37858149|FG000|Overall Study|Death|2|||
16878279|NCT01498952|37858150|FG001|Overall Study|Death|2|||
16878280|NCT01498952|37858151|FG002|Overall Study|Death|0|||
16878281|NCT01498952|37858152|FG003|Overall Study|Death|0|||
16878282|NCT01498952|37858153|FG004|Overall Study|Death|0|||
16878283|NCT01461044|37858185|FG000|Overall Study|Death|58|||
16878284|NCT01461044|37858186|FG001|Overall Study|Death|35|||
16878285|NCT01461044|37858185|FG000|Overall Study|Lost to Follow-up|12|||
16878286|NCT01461044|37858186|FG001|Overall Study|Lost to Follow-up|5|||
16878287|NCT01421303|37858219|FG000|Overall Study|Lost to Follow-up|13|||
16878288|NCT01421303|37858219|FG000|Overall Study|Non compliance with study procedure|1|||
16878289|NCT01421303|37858219|FG000|Overall Study|Other|7|||
16878290|NCT01421303|37858219|FG000|Overall Study|Withdrawal by Subject|1|||
16878291|NCT01475474|37858223|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
16878292|NCT01475474|37858223|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
16878293|NCT01400243|37858230|FG000|Overall Study|Protocol Violation|8|||
16878294|NCT01400243|37858231|FG001|Overall Study|Protocol Violation|11|||
16878295|NCT01475162|37858248|FG000|Overall Study|Physician Decision|1|||
16878296|NCT01475162|37858248|FG000|Overall Study|Death|10|||
16878297|NCT01475162|37858248|FG000|Overall Study|Study closed for safety|3|||
16878298|NCT01421225|37858255|FG000|Overall Study|Withdrawal by Subject|0|||
16878299|NCT01421225|37858256|FG001|Overall Study|Withdrawal by Subject|1|||
16878300|NCT01498640|37858272|FG000|Overall Study|Lost to Follow-up|1|||
16878301|NCT01498640|37858272|FG000|Overall Study|Death|1|||
16878302|NCT01498640|37858272|FG000|Overall Study|Other|3|||
16878303|NCT01498484|37858284|FG000|Overall Study|Death|6|||
16878304|NCT01498484|37858285|FG001|Overall Study|Death|3|||
16878305|NCT01498484|37858286|FG002|Overall Study|Death|1|||
16878306|NCT01498484|37858287|FG003|Overall Study|Death|1|||
16878307|NCT01498484|37858288|FG004|Overall Study|Death|0|||
16878308|NCT01498484|37858289|FG005|Overall Study|Death|0|||
16878309|NCT01498484|37858290|FG006|Overall Study|Death|10|||
16878310|NCT01498484|37858291|FG007|Overall Study|Death|1|||
16878311|NCT01498484|37858292|FG008|Overall Study|Death|0|||
16878312|NCT01498484|37858284|FG000|Overall Study|Physician Decision|3|||
16878313|NCT01498484|37858285|FG001|Overall Study|Physician Decision|2|||
16878314|NCT01498484|37858286|FG002|Overall Study|Physician Decision|1|||
16878315|NCT01498484|37858287|FG003|Overall Study|Physician Decision|1|||
16878316|NCT01498484|37858288|FG004|Overall Study|Physician Decision|0|||
16878317|NCT01498484|37858289|FG005|Overall Study|Physician Decision|0|||
16878318|NCT01498484|37858290|FG006|Overall Study|Physician Decision|8|||
16878319|NCT01498484|37858291|FG007|Overall Study|Physician Decision|13|||
16878320|NCT01498484|37858292|FG008|Overall Study|Physician Decision|1|||
16878321|NCT01498484|37858284|FG000|Overall Study|Adverse Event|0|||
16878322|NCT01498484|37858285|FG001|Overall Study|Adverse Event|0|||
16878323|NCT01498484|37858286|FG002|Overall Study|Adverse Event|0|||
16878324|NCT01498484|37858287|FG003|Overall Study|Adverse Event|0|||
16878325|NCT01498484|37858288|FG004|Overall Study|Adverse Event|0|||
16878326|NCT01498484|37858289|FG005|Overall Study|Adverse Event|1|||
16878327|NCT01498484|37858290|FG006|Overall Study|Adverse Event|0|||
16878328|NCT01498484|37858291|FG007|Overall Study|Adverse Event|0|||
16878329|NCT01498484|37858292|FG008|Overall Study|Adverse Event|0|||
16878330|NCT01498484|37858284|FG000|Overall Study|Withdrawal by Subject|0|||
16878331|NCT01498484|37858285|FG001|Overall Study|Withdrawal by Subject|0|||
16878332|NCT01498484|37858286|FG002|Overall Study|Withdrawal by Subject|0|||
16878333|NCT01498484|37858287|FG003|Overall Study|Withdrawal by Subject|1|||
16878334|NCT01498484|37858288|FG004|Overall Study|Withdrawal by Subject|0|||
16878335|NCT01498484|37858289|FG005|Overall Study|Withdrawal by Subject|0|||
16878336|NCT01498484|37858290|FG006|Overall Study|Withdrawal by Subject|1|||
16878337|NCT01498484|37858291|FG007|Overall Study|Withdrawal by Subject|0|||
16878338|NCT01498484|37858292|FG008|Overall Study|Withdrawal by Subject|0|||
16878339|NCT01498484|37858284|FG000|Overall Study|Other|5|||
16878340|NCT01498484|37858285|FG001|Overall Study|Other|2|||
16878341|NCT01498484|37858286|FG002|Overall Study|Other|0|||
16878342|NCT01498484|37858287|FG003|Overall Study|Other|0|||
16878343|NCT01498484|37858288|FG004|Overall Study|Other|1|||
16878344|NCT01498484|37858289|FG005|Overall Study|Other|0|||
16878345|NCT01498484|37858290|FG006|Overall Study|Other|3|||
16878346|NCT01498484|37858291|FG007|Overall Study|Other|0|||
16878347|NCT01498484|37858292|FG008|Overall Study|Other|1|||
16878348|NCT01474772|37858301|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
16878349|NCT01474772|37858302|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
16878350|NCT01474772|37858301|FG000|Period 1|AE not Related to Study Drug|1|||
16878351|NCT01474772|37858302|FG001|Period 1|AE not Related to Study Drug|0|||
16878352|NCT01474772|37858301|FG000|Period 1|Withdrawal by Subject|3|||
16878353|NCT01474772|37858302|FG001|Period 1|Withdrawal by Subject|1|||
16878354|NCT01474772|37858301|FG000|Period 1|Lost to Follow-up|1|||
16878355|NCT01474772|37858302|FG001|Period 1|Lost to Follow-up|0|||
16878356|NCT01474772|37858301|FG000|Period 1|Reason not Specified|1|||
16878357|NCT01474772|37858302|FG001|Period 1|Reason not Specified|1|||
16878358|NCT01474772|37858301|FG000|Washout|AE not Related to Study Drug|2|||
16878359|NCT01474772|37858302|FG001|Washout|AE not Related to Study Drug|0|||
16878360|NCT01474772|37858301|FG000|Washout|Withdrawal by Subject|1|||
16878361|NCT01474772|37858302|FG001|Washout|Withdrawal by Subject|0|||
16878362|NCT01474772|37858301|FG000|Washout|Lost to Follow-up|0|||
16878363|NCT01474772|37858302|FG001|Washout|Lost to Follow-up|1|||
16878364|NCT01474772|37858301|FG000|Washout|Reason not Specified|0|||
16878365|NCT01474772|37858302|FG001|Washout|Reason not Specified|1|||
16878366|NCT01474772|37858301|FG000|Period 2|Death|0|||
16878367|NCT01474772|37858302|FG001|Period 2|Death|1|||
16878368|NCT01474772|37858301|FG000|Period 2|AE Related to Study Drug|0|||
16878369|NCT01474772|37858302|FG001|Period 2|AE Related to Study Drug|1|||
16878370|NCT01474772|37858301|FG000|Period 2|AE not Related to Study Drug|4|||
16878371|NCT01474772|37858302|FG001|Period 2|AE not Related to Study Drug|1|||
16878372|NCT01474772|37858301|FG000|Period 2|Lack of Efficacy|1|||
16878373|NCT01474772|37858302|FG001|Period 2|Lack of Efficacy|0|||
16878374|NCT01474772|37858301|FG000|Period 2|Withdrawal by Subject|3|||
16878375|NCT01474772|37858302|FG001|Period 2|Withdrawal by Subject|4|||
16878376|NCT01474772|37858301|FG000|Period 2|Lost to Follow-up|1|||
16878377|NCT01474772|37858302|FG001|Period 2|Lost to Follow-up|1|||
16878378|NCT01474772|37858301|FG000|Period 2|Reason not Specified|0|||
16878379|NCT01474772|37858302|FG001|Period 2|Reason not Specified|2|||
16878380|NCT01474772|37858301|FG000|Follow-up|AE not Related to Study Drug|0|||
16878381|NCT01474772|37858302|FG001|Follow-up|AE not Related to Study Drug|1|||
16878382|NCT01421147|37858310|FG000|Treatment Period|Adverse Event|2|||
16878383|NCT01421147|37858311|FG001|Treatment Period|Adverse Event|3|||
16878384|NCT01421147|37858310|FG000|Treatment Period|Lost to Follow-up|2|||
16878385|NCT01421147|37858311|FG001|Treatment Period|Lost to Follow-up|1|||
16878386|NCT01421147|37858310|FG000|Treatment Period|Physician Decision|2|||
16878387|NCT01421147|37858311|FG001|Treatment Period|Physician Decision|2|||
16878388|NCT01421147|37858310|FG000|Treatment Period|Withdrawal by Subject|10|||
16878389|NCT01421147|37858311|FG001|Treatment Period|Withdrawal by Subject|5|||
16878390|NCT01421147|37858310|FG000|Extension Period|Adverse Event|0|||
16878391|NCT01421147|37858311|FG001|Extension Period|Adverse Event|2|||
16878392|NCT01421147|37858310|FG000|Extension Period|Death|0|||
16878393|NCT01421147|37858311|FG001|Extension Period|Death|1|||
16878394|NCT01421147|37858310|FG000|Extension Period|Lost to Follow-up|2|||
16878395|NCT01421147|37858311|FG001|Extension Period|Lost to Follow-up|5|||
16878396|NCT01421147|37858310|FG000|Extension Period|Physician Decision|1|||
16878397|NCT01421147|37858311|FG001|Extension Period|Physician Decision|0|||
16878398|NCT01421147|37858310|FG000|Extension Period|Withdrawal by Subject|5|||
16878399|NCT01421147|37858311|FG001|Extension Period|Withdrawal by Subject|3|||
16878400|NCT01497938|37858328|FG000|Overall Study|Adverse Event|0|||
16878401|NCT01497938|37858329|FG001|Overall Study|Adverse Event|1|||
16878402|NCT01497938|37858328|FG000|Overall Study|Physician Decision|0|||
16878403|NCT01497938|37858329|FG001|Overall Study|Physician Decision|1|||
16878404|NCT01497938|37858328|FG000|Overall Study|Withdrawal by Subject|4|||
16878405|NCT01497938|37858329|FG001|Overall Study|Withdrawal by Subject|0|||
16785535|NCT02700997|37725622|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
16785536|NCT02658149|37725628|FG000|Overall Study|Physician Decision|1|||
16785537|NCT02658149|37725629|FG001|Overall Study|Physician Decision|0|||
16785538|NCT02698189|37725637|FG000|Overall Study|Physician Decision|3|||
16785539|NCT02698189|37725638|FG001|Overall Study|Physician Decision|0|||
16785540|NCT02698189|37725637|FG000|Overall Study|Progressive disease|0|||
16785541|NCT02698189|37725638|FG001|Overall Study|Progressive disease|5|||
16785542|NCT02698189|37725637|FG000|Overall Study|Study terminated by sponsor|0|||
16785543|NCT02698189|37725638|FG001|Overall Study|Study terminated by sponsor|1|||
16785544|NCT02702011|37725650|FG000|Overall Study|Withdrawal by Subject|0|||
16785545|NCT02702011|37725651|FG001|Overall Study|Withdrawal by Subject|1|||
16785546|NCT02702011|37725652|FG002|Overall Study|Withdrawal by Subject|0|||
16785547|NCT02702011|37725653|FG003|Overall Study|Withdrawal by Subject|0|||
16785548|NCT02657369|37725663|FG000|Overall Study|Death|27|||
16878406|NCT01497938|37858328|FG000|Overall Study|Device Violation|1|||
16878407|NCT01497938|37858329|FG001|Overall Study|Device Violation|0|||
16878408|NCT01460342|37858379|FG000|Overall Study|Adverse Event|5|||
16878409|NCT01460342|37858380|FG001|Overall Study|Adverse Event|4|||
16878410|NCT01460342|37858379|FG000|Overall Study|Lost to Follow-up|1|||
16878411|NCT01460342|37858380|FG001|Overall Study|Lost to Follow-up|2|||
16878412|NCT01460342|37858379|FG000|Overall Study|Protocol Violation|0|||
16878413|NCT01460342|37858380|FG001|Overall Study|Protocol Violation|1|||
16878414|NCT01460342|37858379|FG000|Overall Study|Withdrawal by Subject|3|||
16878415|NCT01460342|37858380|FG001|Overall Study|Withdrawal by Subject|4|||
16878416|NCT01460342|37858379|FG000|Overall Study|Physician Decision|1|||
16878417|NCT01460342|37858380|FG001|Overall Study|Physician Decision|3|||
16878418|NCT01460342|37858379|FG000|Overall Study|Lack of Efficacy|1|||
16878419|NCT01460342|37858380|FG001|Overall Study|Lack of Efficacy|0|||
16878420|NCT01459796|37858412|FG000|Overall Study|Non compliance with protocol|2|||
16878421|NCT01459796|37858413|FG001|Overall Study|Non compliance with protocol|4|||
16878422|NCT01459796|37858412|FG000|Overall Study|Adverse Event|5|||
16878423|NCT01459796|37858413|FG001|Overall Study|Adverse Event|5|||
16878424|NCT01459796|37858412|FG000|Overall Study|Withdrawal by Subject|6|||
16878425|NCT01459796|37858413|FG001|Overall Study|Withdrawal by Subject|3|||
16878426|NCT01459796|37858412|FG000|Overall Study|Lost to Follow-up|5|||
16878427|NCT01459796|37858413|FG001|Overall Study|Lost to Follow-up|4|||
16878428|NCT01459796|37858412|FG000|Overall Study|Reason unspecified|1|||
16878429|NCT01459796|37858413|FG001|Overall Study|Reason unspecified|2|||
16878430|NCT01459796|37858412|FG000|Overall Study|Decision by the sponsor|75|||
16878431|NCT01459796|37858413|FG001|Overall Study|Decision by the sponsor|108|||
16878432|NCT01459718|37858423|FG000|Overall Study|Physician Decision|1|||
16878433|NCT01459718|37858423|FG000|Overall Study|Lost to Follow-up|1|||
16878434|NCT01459718|37858423|FG000|Overall Study|Adverse Event|1|||
16878435|NCT02900976|37858433|FG000|Overall Study|Adverse Event|0|||
16878436|NCT02900976|37858434|FG001|Overall Study|Adverse Event|1|||
16878437|NCT02900976|37858433|FG000|Overall Study|Physician Decision|0|||
16878438|NCT02900976|37858434|FG001|Overall Study|Physician Decision|2|||
16878439|NCT02900976|37858433|FG000|Overall Study|Progressive disease|0|||
16878440|NCT02900976|37858434|FG001|Overall Study|Progressive disease|6|||
16878441|NCT01474538|37858447|FG000|Treatment Period 1|Death|1|||
16878442|NCT01474538|37858448|FG001|Treatment Period 1|Death|0|||
16878443|NCT01474538|37858447|FG000|Treatment Period 1|Physician Decision|1|||
16878444|NCT01474538|37858448|FG001|Treatment Period 1|Physician Decision|0|||
16878445|NCT01474538|37858447|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16878446|NCT01474538|37858448|FG001|Treatment Period 1|Withdrawal by Subject|3|||
16878447|NCT01474538|37858447|FG000|Treatment Period 1|Protocol Violation|0|||
16878448|NCT01474538|37858448|FG001|Treatment Period 1|Protocol Violation|1|||
16878449|NCT01474538|37858447|FG000|Treatment Period 2|Death|1|||
16878450|NCT01474538|37858448|FG001|Treatment Period 2|Death|0|||
16878451|NCT01474538|37858447|FG000|Treatment Period 2|Adverse Event|1|||
16878452|NCT01474538|37858448|FG001|Treatment Period 2|Adverse Event|1|||
16878453|NCT01474538|37858447|FG000|Treatment Period 2|Withdrawal by Subject|2|||
16878454|NCT01474538|37858448|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16878455|NCT01474538|37858447|FG000|Treatment Period 2|Sponsor decision|1|||
16878456|NCT01474538|37858448|FG001|Treatment Period 2|Sponsor decision|0|||
16878457|NCT01474538|37858447|FG000|Treatment Period 2|Physician Decision|0|||
16878458|NCT01474538|37858448|FG001|Treatment Period 2|Physician Decision|1|||
16878459|NCT01474538|37858447|FG000|Treatment Period 2|Protocol Violation|1|||
16878460|NCT01474538|37858448|FG001|Treatment Period 2|Protocol Violation|0|||
16878461|NCT02647788|37858456|FG000|Overall Study|Lost to Follow-up|13|||
16878462|NCT02647788|37858457|FG001|Overall Study|Lost to Follow-up|11|||
16878463|NCT02647788|37858456|FG000|Overall Study|Did not want opiate|0|||
16878464|NCT02647788|37858457|FG001|Overall Study|Did not want opiate|1|||
16878465|NCT02647788|37858456|FG000|Overall Study|Withdrawal by Subject|1|||
16878466|NCT02647788|37858457|FG001|Overall Study|Withdrawal by Subject|0|||
16878467|NCT02647788|37858456|FG000|Overall Study|Felt itchy with assigned medication|1|||
16878468|NCT02647788|37858457|FG001|Overall Study|Felt itchy with assigned medication|0|||
16878469|NCT02647788|37858456|FG000|Overall Study|Felt nauseous with assigned medication|1|||
16878470|NCT02647788|37858457|FG001|Overall Study|Felt nauseous with assigned medication|1|||
16878471|NCT01459016|37858463|FG000|Overall Study|Withdrawal by Subject|11|||
16878472|NCT01459016|37858463|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
16878473|NCT01458392|37858505|FG000|Overall Study|Death|2|||
16878474|NCT01458392|37858506|FG001|Overall Study|Death|11|||
16878475|NCT01458392|37858507|FG002|Overall Study|Death|22|||
16878476|NCT01458392|37858505|FG000|Overall Study|At the discretion of the sponsor|0|||
16878477|NCT01458392|37858506|FG001|Overall Study|At the discretion of the sponsor|2|||
16878478|NCT01458392|37858507|FG002|Overall Study|At the discretion of the sponsor|7|||
16878479|NCT01458392|37858505|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
16878480|NCT01458392|37858506|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
16878481|NCT01458392|37858507|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
16878482|NCT01421069|37858519|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
16878483|NCT01421069|37858519|FG000|Parent Study|Failed to return|3|||
16878484|NCT01421069|37858519|FG000|Parent Study|Withdrawal by Subject|1|||
16878485|NCT01421069|37858519|FG000|Parent Study|Lost to Follow-up|2|||
16878486|NCT01421069|37858519|FG000|Parent Study|Lack of Efficacy|1|||
16878487|NCT01421069|37858519|FG000|Overall Period for Extension Study|Other|2|||
16878488|NCT01421069|37858519|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
16878489|NCT01421069|37858519|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
16878490|NCT01421069|37858519|FG000|Overall Period for Extension Study|Pregnancy|1|||
16878491|NCT01421069|37858519|FG000|Overall Period for Extension Study|Adverse Event|1|||
16878492|NCT01421069|37858519|FG000|Overall Period for Extension Study|Protocol Violation|1|||
16878493|NCT01421069|37858519|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
16878494|NCT01421069|37858519|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
16878495|NCT01421069|37858519|FG000|Active Treatment Period|Other|1|||
16878496|NCT01421069|37858519|FG000|Active Treatment Period|No longer willing to participate in study|8|||
16878497|NCT01421069|37858519|FG000|Active Treatment Period|Insufficient clinical response|1|||
16878498|NCT01421069|37858519|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
16878499|NCT01421069|37858519|FG000|Active Treatment Period|Pregnancy|1|||
16878500|NCT01421069|37858519|FG000|Active Treatment Period|Adverse Event|1|||
16878501|NCT01421069|37858519|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
16878502|NCT01421069|37858519|FG000|Active Treatment Period|Enrolled in observational period|29|||
16878503|NCT01421069|37858519|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
16878504|NCT01421069|37858519|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
16878505|NCT01421069|37858519|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
16878506|NCT01421069|37858519|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
16878507|NCT01421069|37858519|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
16878508|NCT01421069|37858519|FG000|2b. Retreatment Period|Protocol Violation|1|||
16878509|NCT01421069|37858519|FG000|Observational Period|Other|1|||
16878510|NCT01421069|37858519|FG000|Observational Period|No longer willing to participate in study|4|||
16878511|NCT01421069|37858519|FG000|Observational Period|Lost to Follow-up|3|||
16878512|NCT01473836|37858551|FG000|Overall Study|Adverse Event|4|||
16878513|NCT01473836|37858551|FG000|Overall Study|Lack of Efficacy|1|||
16878514|NCT01473836|37858551|FG000|Overall Study|Does not meet entrance criteria|1|||
16878515|NCT01473758|37858591|FG000|Cycle 1|Adverse Event|10|||
16878516|NCT01473758|37858592|FG001|Cycle 1|Adverse Event|2|||
16878517|NCT01473758|37858593|FG002|Cycle 1|Adverse Event|0|||
16878518|NCT01473758|37858594|FG003|Cycle 1|Adverse Event|0|||
16878519|NCT01473758|37858591|FG000|Cycle 1|Withdrawal by Subject|1|||
16878520|NCT01473758|37858592|FG001|Cycle 1|Withdrawal by Subject|1|||
16878521|NCT01473758|37858593|FG002|Cycle 1|Withdrawal by Subject|0|||
16878522|NCT01473758|37858594|FG003|Cycle 1|Withdrawal by Subject|0|||
16878523|NCT01473758|37858591|FG000|Cycle 2|Adverse Event|0|||
16878524|NCT01473758|37858592|FG001|Cycle 2|Adverse Event|0|||
16878525|NCT01473758|37858593|FG002|Cycle 2|Adverse Event|5|||
16878526|NCT01473758|37858594|FG003|Cycle 2|Adverse Event|0|||
16878527|NCT01420679|37858604|FG000|Overall Study|Disease Progression|3|||
16878528|NCT01420679|37858605|FG001|Overall Study|Disease Progression|2|||
16878529|NCT01420679|37858604|FG000|Overall Study|Adverse Event|4|||
16878530|NCT01420679|37858605|FG001|Overall Study|Adverse Event|0|||
16878531|NCT01420679|37858604|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
16878532|NCT01420679|37858605|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
16878533|NCT01420679|37858604|FG000|Overall Study|Patient Decision|1|||
16878534|NCT01420679|37858605|FG001|Overall Study|Patient Decision|0|||
16878535|NCT01420679|37858604|FG000|Overall Study|Investigator Decision|1|||
16878536|NCT01420679|37858605|FG001|Overall Study|Investigator Decision|2|||
16878537|NCT01420679|37858604|FG000|Overall Study|Sponsor Decision|3|||
16878538|NCT01420679|37858605|FG001|Overall Study|Sponsor Decision|3|||
16878539|NCT01420679|37858604|FG000|Overall Study|Other|1|||
16878540|NCT01420679|37858605|FG001|Overall Study|Other|0|||
16878541|NCT01496846|37858622|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
16878542|NCT01496846|37858623|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
16878543|NCT01496846|37858624|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
16878544|NCT01496846|37858625|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
16878545|NCT01496846|37858626|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
16878546|NCT01496846|37858627|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
16878547|NCT00964002|37858638|FG000|Overall Study|Protocol Violation|8|||
16878548|NCT01399697|37858650|FG000|Overall Study|Adverse Event|13|||
16878549|NCT01399697|37858651|FG001|Overall Study|Adverse Event|3|||
16878550|NCT01399697|37858652|FG002|Overall Study|Adverse Event|1|||
16878551|NCT01399697|37858650|FG000|Overall Study|Lost to Follow-up|2|||
16878552|NCT01399697|37858651|FG001|Overall Study|Lost to Follow-up|0|||
16878553|NCT01399697|37858652|FG002|Overall Study|Lost to Follow-up|0|||
16878554|NCT01399697|37858650|FG000|Overall Study|Withdrawal by Subject|8|||
16878555|NCT01399697|37858651|FG001|Overall Study|Withdrawal by Subject|0|||
16878556|NCT01399697|37858652|FG002|Overall Study|Withdrawal by Subject|0|||
16878557|NCT01399697|37858650|FG000|Overall Study|Investigator Decisión|1|||
16878558|NCT01399697|37858651|FG001|Overall Study|Investigator Decisión|0|||
16878559|NCT01399697|37858652|FG002|Overall Study|Investigator Decisión|2|||
16878560|NCT01399697|37858650|FG000|Overall Study|Lack of Efficacy|9|||
16878561|NCT01399697|37858651|FG001|Overall Study|Lack of Efficacy|0|||
16878562|NCT01399697|37858652|FG002|Overall Study|Lack of Efficacy|1|||
16878563|NCT01399697|37858650|FG000|Overall Study|Protocol Violation|2|||
16878564|NCT01399697|37858651|FG001|Overall Study|Protocol Violation|0|||
16878565|NCT01399697|37858652|FG002|Overall Study|Protocol Violation|0|||
16878566|NCT01399697|37858650|FG000|Overall Study|Non-Compliant|1|||
17001860|NCT04797637|38145875|FG001|Overall Study|Lost to Follow-up|32|||
17001861|NCT04797637|38145874|FG000|Overall Study|Withdrawal by Subject|0|||
17001862|NCT04797637|38145875|FG001|Overall Study|Withdrawal by Subject|1|||
17001863|NCT00659269|38145883|FG000|Overall Study|Physician Decision|1|||
17001864|NCT00659269|38145884|FG001|Overall Study|Physician Decision|1|||
17001865|NCT00658333|38145901|FG000|Overall Study|Adverse Event|2|||
16878567|NCT01399697|37858651|FG001|Overall Study|Non-Compliant|0|||
16878568|NCT01399697|37858652|FG002|Overall Study|Non-Compliant|0|||
16878569|NCT01399697|37858650|FG000|Overall Study|Inclusion Error|2|||
16878570|NCT01399697|37858651|FG001|Overall Study|Inclusion Error|0|||
16878571|NCT01399697|37858652|FG002|Overall Study|Inclusion Error|0|||
16878572|NCT01399697|37858650|FG000|Overall Study|Positive result for hepatitis B|1|||
16878573|NCT01399697|37858651|FG001|Overall Study|Positive result for hepatitis B|0|||
16878574|NCT01399697|37858652|FG002|Overall Study|Positive result for hepatitis B|0|||
16878575|NCT01399697|37858650|FG000|Overall Study|Clinical RA remission|1|||
16878576|NCT01399697|37858651|FG001|Overall Study|Clinical RA remission|0|||
16878577|NCT01399697|37858652|FG002|Overall Study|Clinical RA remission|0|||
16878578|NCT01399697|37858650|FG000|Overall Study|Sponsor Decision|1|||
16878579|NCT01399697|37858651|FG001|Overall Study|Sponsor Decision|0|||
16878580|NCT01399697|37858652|FG002|Overall Study|Sponsor Decision|0|||
16878581|NCT01473602|37858686|FG000|Overall Study|Adverse Event|1|||
16878582|NCT01473602|37858687|FG001|Overall Study|Adverse Event|2|||
16878583|NCT01473602|37858686|FG000|Overall Study|Death|0|||
16878584|NCT01473602|37858687|FG001|Overall Study|Death|1|||
16878585|NCT01473602|37858686|FG000|Overall Study|Lost to Follow-up|1|||
16878586|NCT01473602|37858687|FG001|Overall Study|Lost to Follow-up|1|||
16878587|NCT01473602|37858686|FG000|Overall Study|Withdrawal by Subject|5|||
16878588|NCT01473602|37858687|FG001|Overall Study|Withdrawal by Subject|4|||
16878589|NCT01473602|37858686|FG000|Overall Study|Physician Decision|1|||
16878590|NCT01473602|37858687|FG001|Overall Study|Physician Decision|0|||
16878591|NCT01496612|37858695|FG000|1st Intervention|Adverse Event|1|||
16878592|NCT01496612|37858696|FG001|1st Intervention|Adverse Event|0|||
16878593|NCT01496612|37858695|FG000|1st Intervention|Withdrawal by Subject|1|||
16878594|NCT01496612|37858696|FG001|1st Intervention|Withdrawal by Subject|0|||
16878595|NCT00790218|37858713|FG000|Overall Study|Death|1|||
16878596|NCT00790218|37858714|FG001|Overall Study|Death|0|||
16878597|NCT00790218|37858715|FG002|Overall Study|Death|0|||
16878598|NCT01457924|37858741|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
16878599|NCT01457924|37858742|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
16878600|NCT01457924|37858743|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
16878601|NCT01457924|37858744|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
16878602|NCT01457924|37858745|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
16878603|NCT01457924|37858741|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
16878604|NCT01457924|37858742|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
16878605|NCT01457924|37858743|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
16878606|NCT01457924|37858744|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
16878607|NCT01457924|37858745|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
16878608|NCT01457924|37858741|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
16878609|NCT01457924|37858742|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
16878610|NCT01457924|37858743|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
16878611|NCT01457924|37858744|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
16878612|NCT01457924|37858745|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
16878613|NCT01457924|37858741|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
16878614|NCT01457924|37858742|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
16878615|NCT01457924|37858743|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
16878616|NCT01457924|37858744|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
16878617|NCT01457924|37858745|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
16878618|NCT01457924|37858741|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
16878619|NCT01457924|37858742|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
17001866|NCT00658333|38145902|FG001|Overall Study|Adverse Event|1|||
17001867|NCT00658879|38145908|FG000|Overall Study|Protocol Violation|1|||
16878620|NCT01457924|37858743|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
17001868|NCT00570037|38145914|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
16878621|NCT01457924|37858744|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
16878622|NCT01457924|37858745|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
16878623|NCT01457924|37858741|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
16878624|NCT01457924|37858742|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
16878625|NCT01457924|37858743|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
16878626|NCT01457924|37858744|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
16878627|NCT01457924|37858745|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
16878628|NCT01457924|37858741|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
16878629|NCT01457924|37858742|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
16878630|NCT01457924|37858743|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
16878631|NCT01457924|37858744|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
16878632|NCT01457924|37858745|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
16878633|NCT01457924|37858741|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
16878634|NCT01457924|37858742|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
16878635|NCT01457924|37858743|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
16878636|NCT01457924|37858744|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
16878637|NCT01457924|37858745|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
16878638|NCT01457924|37858741|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
16878639|NCT01457924|37858742|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
16878640|NCT01457924|37858743|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
16878641|NCT01457924|37858744|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
16878642|NCT01457924|37858745|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
16878643|NCT01457924|37858741|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
16878644|NCT01457924|37858742|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
16878645|NCT01457924|37858743|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
16878646|NCT01457924|37858744|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
16878647|NCT01457924|37858745|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
16878648|NCT01457924|37858741|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
16878649|NCT01457924|37858742|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
16878650|NCT01457924|37858743|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
16878651|NCT01457924|37858744|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
16878652|NCT01457924|37858745|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
16878653|NCT01457924|37858741|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
16878654|NCT01457924|37858742|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
16878655|NCT01457924|37858743|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
16878656|NCT01457924|37858744|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
16878657|NCT01457924|37858745|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
16878658|NCT01457924|37858741|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
16878659|NCT01457924|37858742|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
16878660|NCT01457924|37858743|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
16878661|NCT01457924|37858744|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
16878662|NCT01457924|37858745|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
16878663|NCT01399619|37858766|FG000|Overall Study|Adverse Event|10|||
16878664|NCT01399619|37858767|FG001|Overall Study|Adverse Event|0|||
16878665|NCT01399619|37858768|FG002|Overall Study|Adverse Event|4|||
16878666|NCT01399619|37858769|FG003|Overall Study|Adverse Event|10|||
16878667|NCT01399619|37858766|FG000|Overall Study|Lack of Efficacy|9|||
16878668|NCT01399619|37858767|FG001|Overall Study|Lack of Efficacy|0|||
16878669|NCT01399619|37858768|FG002|Overall Study|Lack of Efficacy|5|||
16878670|NCT01399619|37858769|FG003|Overall Study|Lack of Efficacy|0|||
16878671|NCT01399619|37858766|FG000|Overall Study|Withdrawal by Subject|6|||
16878672|NCT01399619|37858767|FG001|Overall Study|Withdrawal by Subject|0|||
16878673|NCT01399619|37858768|FG002|Overall Study|Withdrawal by Subject|3|||
16878674|NCT01399619|37858769|FG003|Overall Study|Withdrawal by Subject|4|||
16878675|NCT01399619|37858766|FG000|Overall Study|Protocol Violation|0|||
16878676|NCT01399619|37858767|FG001|Overall Study|Protocol Violation|0|||
16878677|NCT01399619|37858768|FG002|Overall Study|Protocol Violation|0|||
17001869|NCT00570037|38145915|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
17001870|NCT00863655|38145923|FG000|Overall Study|Protocol Violation|4|||
17001871|NCT00863655|38145924|FG001|Overall Study|Protocol Violation|0|||
17001872|NCT00863655|38145923|FG000|Overall Study|Adverse Event|52|||
17001873|NCT00863655|38145924|FG001|Overall Study|Adverse Event|8|||
17001874|NCT00863655|38145923|FG000|Overall Study|Withdrawal by Subject|47|||
17001875|NCT00863655|38145924|FG001|Overall Study|Withdrawal by Subject|7|||
17001876|NCT00863655|38145923|FG000|Overall Study|Administrative problems|1|||
17001877|NCT00863655|38145924|FG001|Overall Study|Administrative problems|0|||
17001878|NCT00863655|38145923|FG000|Overall Study|Death|7|||
17001879|NCT00863655|38145924|FG001|Overall Study|Death|1|||
17001880|NCT00863655|38145923|FG000|Overall Study|New cancer therapy|5|||
17001881|NCT00863655|38145924|FG001|Overall Study|New cancer therapy|1|||
17001882|NCT00863655|38145923|FG000|Overall Study|Disease progression|364|||
17001883|NCT00863655|38145924|FG001|Overall Study|Disease progression|221|||
17001884|NCT00863655|38145923|FG000|Overall Study|Treatment completed as per protocol|5|||
17001885|NCT00863655|38145924|FG001|Overall Study|Treatment completed as per protocol|1|||
17001886|NCT00658723|38145932|FG000|Overall Study|Lost to Follow-up|0|||
17001887|NCT00658723|38145933|FG001|Overall Study|Lost to Follow-up|2|||
16878678|NCT01399619|37858769|FG003|Overall Study|Protocol Violation|1|||
16878679|NCT01399619|37858766|FG000|Overall Study|Not treated|0|||
16878680|NCT01399619|37858767|FG001|Overall Study|Not treated|0|||
16878681|NCT01399619|37858768|FG002|Overall Study|Not treated|0|||
16878682|NCT01399619|37858769|FG003|Overall Study|Not treated|2|||
16878683|NCT01496456|37858784|FG000|Overall Study|Protocol Violation|1|||
16878684|NCT01496456|37858784|FG000|Overall Study|Lost to Follow-up|7|||
16878685|NCT04999111|37858947|FG000|Overall Study|Lost to Follow-up|0|||
16878686|NCT04999111|37858948|FG001|Overall Study|Lost to Follow-up|3|||
16878687|NCT04999111|37858949|FG002|Overall Study|Lost to Follow-up|1|||
16878688|NCT04999111|37858950|FG003|Overall Study|Lost to Follow-up|1|||
16878689|NCT04999111|37858951|FG004|Overall Study|Lost to Follow-up|1|||
16878690|NCT04999111|37858952|FG005|Overall Study|Lost to Follow-up|1|||
16878691|NCT04999111|37858947|FG000|Overall Study|Physician Decision|0|||
16878692|NCT04999111|37858948|FG001|Overall Study|Physician Decision|0|||
16878693|NCT04999111|37858949|FG002|Overall Study|Physician Decision|0|||
16878694|NCT04999111|37858950|FG003|Overall Study|Physician Decision|1|||
16878695|NCT04999111|37858951|FG004|Overall Study|Physician Decision|0|||
16878696|NCT04999111|37858952|FG005|Overall Study|Physician Decision|0|||
16878697|NCT04999111|37858947|FG000|Overall Study|Withdrawal by Subject|3|||
16878698|NCT04999111|37858948|FG001|Overall Study|Withdrawal by Subject|3|||
16878699|NCT04999111|37858949|FG002|Overall Study|Withdrawal by Subject|2|||
16878700|NCT04999111|37858950|FG003|Overall Study|Withdrawal by Subject|1|||
16878701|NCT04999111|37858951|FG004|Overall Study|Withdrawal by Subject|3|||
16878702|NCT04999111|37858952|FG005|Overall Study|Withdrawal by Subject|0|||
16878703|NCT04999111|37858947|FG000|Overall Study|Other|1|||
16878704|NCT04999111|37858948|FG001|Overall Study|Other|1|||
16878705|NCT04999111|37858949|FG002|Overall Study|Other|1|||
16878706|NCT04999111|37858950|FG003|Overall Study|Other|0|||
16878707|NCT04999111|37858951|FG004|Overall Study|Other|0|||
16878708|NCT04999111|37858952|FG005|Overall Study|Other|0|||
16878709|NCT04999111|37858947|FG000|Overall Study|Ongoing|326|||
16878710|NCT04999111|37858948|FG001|Overall Study|Ongoing|321|||
16878711|NCT04999111|37858949|FG002|Overall Study|Ongoing|112|||
16878712|NCT04999111|37858950|FG003|Overall Study|Ongoing|323|||
16878713|NCT04999111|37858951|FG004|Overall Study|Ongoing|322|||
16878714|NCT04999111|37858952|FG005|Overall Study|Ongoing|105|||
16878715|NCT04999111|37858947|FG000|Overall Study|Randomized but not vaccinated|1|||
16878716|NCT04999111|37858948|FG001|Overall Study|Randomized but not vaccinated|2|||
16878717|NCT04999111|37858949|FG002|Overall Study|Randomized but not vaccinated|0|||
16878718|NCT04999111|37858950|FG003|Overall Study|Randomized but not vaccinated|3|||
16878719|NCT04999111|37858951|FG004|Overall Study|Randomized but not vaccinated|3|||
16878720|NCT04999111|37858952|FG005|Overall Study|Randomized but not vaccinated|0|||
16878721|NCT01673646|37859013|FG000|Overall Study|Adverse Event|2|||
16878722|NCT01673646|37859014|FG001|Overall Study|Adverse Event|1|||
16878723|NCT01673646|37859015|FG002|Overall Study|Adverse Event|1|||
16878724|NCT01673646|37859013|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16878725|NCT01673646|37859014|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16878726|NCT01673646|37859015|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16878727|NCT01673646|37859013|FG000|Overall Study|Condition no longer requires study drug|0|||
16878728|NCT01673646|37859014|FG001|Overall Study|Condition no longer requires study drug|1|||
16878729|NCT01673646|37859015|FG002|Overall Study|Condition no longer requires study drug|0|||
16878730|NCT01673646|37859013|FG000|Overall Study|Withdrawal by Subject|0|||
16878731|NCT01673646|37859014|FG001|Overall Study|Withdrawal by Subject|2|||
16878732|NCT01673646|37859015|FG002|Overall Study|Withdrawal by Subject|2|||
16878733|NCT01673646|37859013|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
17001888|NCT00658723|38145934|FG002|Overall Study|Lost to Follow-up|2|||
17001889|NCT00658723|38145932|FG000|Overall Study|Death|2|||
17001890|NCT00658723|38145933|FG001|Overall Study|Death|1|||
17001891|NCT00658723|38145934|FG002|Overall Study|Death|4|||
17001892|NCT00658723|38145932|FG000|Overall Study|Scheduling Issue|1|||
17001893|NCT00658723|38145933|FG001|Overall Study|Scheduling Issue|1|||
17001894|NCT00658723|38145934|FG002|Overall Study|Scheduling Issue|0|||
17001895|NCT00658723|38145932|FG000|Overall Study|Withdrawal by Subject|1|||
17001896|NCT00658723|38145933|FG001|Overall Study|Withdrawal by Subject|0|||
17001897|NCT00658723|38145934|FG002|Overall Study|Withdrawal by Subject|1|||
17001898|NCT00593385|38145945|FG000|Overall Study|Death|14|||
16878734|NCT01673646|37859014|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
16878735|NCT01673646|37859015|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
16878736|NCT02647944|37859029|FG000|Overall Study|Withdrawal by Subject|0|||
16878737|NCT02647944|37859030|FG001|Overall Study|Withdrawal by Subject|3|||
16878738|NCT02647944|37859029|FG000|Overall Study|Adverse Event|2|||
16878739|NCT02647944|37859030|FG001|Overall Study|Adverse Event|0|||
16878740|NCT01397825|37859111|FG000|Overall Study|Progressive Disease|10|||
17001899|NCT00593385|38145945|FG000|Overall Study|Lost to Follow-up|17|||
16878741|NCT01397825|37859112|FG001|Overall Study|Progressive Disease|3|||
16878742|NCT01397825|37859113|FG002|Overall Study|Progressive Disease|11|||
16878743|NCT01397825|37859114|FG003|Overall Study|Progressive Disease|1|||
16878744|NCT01397825|37859115|FG004|Overall Study|Progressive Disease|0|||
16878745|NCT01397825|37859111|FG000|Overall Study|Symptomatic Deterioration|2|||
16878746|NCT01397825|37859112|FG001|Overall Study|Symptomatic Deterioration|0|||
16878747|NCT01397825|37859113|FG002|Overall Study|Symptomatic Deterioration|4|||
16878748|NCT01397825|37859114|FG003|Overall Study|Symptomatic Deterioration|0|||
16878749|NCT01397825|37859115|FG004|Overall Study|Symptomatic Deterioration|0|||
16878750|NCT01397825|37859111|FG000|Overall Study|Adverse Event|0|||
16878751|NCT01397825|37859112|FG001|Overall Study|Adverse Event|1|||
16878752|NCT01397825|37859113|FG002|Overall Study|Adverse Event|5|||
16878753|NCT01397825|37859114|FG003|Overall Study|Adverse Event|1|||
16878754|NCT01397825|37859115|FG004|Overall Study|Adverse Event|0|||
16878755|NCT01397825|37859111|FG000|Overall Study|Withdrawal by Subject|1|||
16878756|NCT01397825|37859112|FG001|Overall Study|Withdrawal by Subject|0|||
16878757|NCT01397825|37859113|FG002|Overall Study|Withdrawal by Subject|5|||
16878758|NCT01397825|37859114|FG003|Overall Study|Withdrawal by Subject|1|||
16878759|NCT01397825|37859115|FG004|Overall Study|Withdrawal by Subject|0|||
16878760|NCT01397747|37859138|FG000|Overall Study|Multitarget DNA test excluded|689|||
16878761|NCT01397747|37859138|FG000|Overall Study|Colonoscopy excluded|304|||
16878762|NCT01397747|37859138|FG000|Overall Study|FIT excluded|34|||
16878763|NCT01397201|37859176|FG000|Overall Study|Not treated|0|||
16878764|NCT01397201|37859177|FG001|Overall Study|Not treated|0|||
16878765|NCT01397201|37859178|FG002|Overall Study|Not treated|1|||
16878766|NCT01397201|37859179|FG003|Overall Study|Not treated|0|||
16878767|NCT01397201|37859180|FG004|Overall Study|Not treated|0|||
16878768|NCT01397201|37859176|FG000|Overall Study|Not yet defined|3|||
16878769|NCT01397201|37859177|FG001|Overall Study|Not yet defined|6|||
16878770|NCT01397201|37859178|FG002|Overall Study|Not yet defined|5|||
16878771|NCT01397201|37859179|FG003|Overall Study|Not yet defined|5|||
16878772|NCT01397201|37859180|FG004|Overall Study|Not yet defined|4|||
16878773|NCT01397201|37859176|FG000|Overall Study|Adverse Event|2|||
16878774|NCT01397201|37859177|FG001|Overall Study|Adverse Event|0|||
16878775|NCT01397201|37859178|FG002|Overall Study|Adverse Event|0|||
16878776|NCT01397201|37859179|FG003|Overall Study|Adverse Event|0|||
16878777|NCT01397201|37859180|FG004|Overall Study|Adverse Event|0|||
16878778|NCT01393613|37859214|FG000|Overall Study|Adverse Event|11|||
16878779|NCT01393613|37859215|FG001|Overall Study|Adverse Event|11|||
16878780|NCT01393613|37859216|FG002|Overall Study|Adverse Event|13|||
16878781|NCT01393613|37859217|FG003|Overall Study|Adverse Event|22|||
16878782|NCT01393613|37859214|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
16878783|NCT01393613|37859215|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
16878784|NCT01393613|37859216|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
16878785|NCT01393613|37859217|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
16878786|NCT01393613|37859214|FG000|Overall Study|Physician Decision|2|||
16878787|NCT01393613|37859215|FG001|Overall Study|Physician Decision|0|||
16878788|NCT01393613|37859216|FG002|Overall Study|Physician Decision|0|||
16878789|NCT01393613|37859217|FG003|Overall Study|Physician Decision|1|||
16878790|NCT01393613|37859214|FG000|Overall Study|Withdrawal by Subject|15|||
16878791|NCT01393613|37859215|FG001|Overall Study|Withdrawal by Subject|25|||
16878792|NCT01393613|37859216|FG002|Overall Study|Withdrawal by Subject|23|||
16878793|NCT01393613|37859217|FG003|Overall Study|Withdrawal by Subject|21|||
16878794|NCT01393613|37859214|FG000|Overall Study|Protocol Deviation|2|||
17001900|NCT00593385|38145945|FG000|Overall Study|Withdrawal by Subject|9|||
17095244|NCT00228566|38234517|FG000|Overall Study|Lack of Efficacy|14|||
16878795|NCT01393613|37859215|FG001|Overall Study|Protocol Deviation|1|||
16878796|NCT01393613|37859216|FG002|Overall Study|Protocol Deviation|0|||
16878797|NCT01393613|37859217|FG003|Overall Study|Protocol Deviation|0|||
16878798|NCT01393613|37859214|FG000|Overall Study|Lack of Efficacy|9|||
16878799|NCT01393613|37859215|FG001|Overall Study|Lack of Efficacy|20|||
16878800|NCT01393613|37859216|FG002|Overall Study|Lack of Efficacy|16|||
16878801|NCT01393613|37859217|FG003|Overall Study|Lack of Efficacy|21|||
16878802|NCT01396421|37859267|FG000|Overall Study|Lost to Follow-up|0|||
16878803|NCT01396421|37859268|FG001|Overall Study|Lost to Follow-up|0|||
16878804|NCT01396421|37859269|FG002|Overall Study|Lost to Follow-up|0|||
16878805|NCT01396421|37859270|FG003|Overall Study|Lost to Follow-up|1|||
16878806|NCT01396421|37859267|FG000|Overall Study|Adverse Event|17|||
16878807|NCT01396421|37859268|FG001|Overall Study|Adverse Event|15|||
16878808|NCT01396421|37859269|FG002|Overall Study|Adverse Event|12|||
16878809|NCT01396421|37859270|FG003|Overall Study|Adverse Event|32|||
16878810|NCT01396421|37859267|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
16878811|NCT01396421|37859268|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
16878812|NCT01396421|37859269|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
16878813|NCT01396421|37859270|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
16878814|NCT01396421|37859267|FG000|Overall Study|Physician Decision|1|||
16878815|NCT01396421|37859268|FG001|Overall Study|Physician Decision|1|||
16878816|NCT01396421|37859269|FG002|Overall Study|Physician Decision|0|||
16878817|NCT01396421|37859270|FG003|Overall Study|Physician Decision|3|||
16878818|NCT01396421|37859267|FG000|Overall Study|Withdrawal by Subject|31|||
16878819|NCT01396421|37859268|FG001|Overall Study|Withdrawal by Subject|24|||
16878820|NCT01396421|37859269|FG002|Overall Study|Withdrawal by Subject|13|||
16878821|NCT01396421|37859270|FG003|Overall Study|Withdrawal by Subject|21|||
16878822|NCT01396421|37859267|FG000|Overall Study|Protocol Deviation|2|||
16878823|NCT01396421|37859268|FG001|Overall Study|Protocol Deviation|1|||
16878824|NCT01396421|37859269|FG002|Overall Study|Protocol Deviation|1|||
16878825|NCT01396421|37859270|FG003|Overall Study|Protocol Deviation|0|||
16878826|NCT01396421|37859267|FG000|Overall Study|Lack of Efficacy|7|||
16878827|NCT01396421|37859268|FG001|Overall Study|Lack of Efficacy|17|||
16878828|NCT01396421|37859269|FG002|Overall Study|Lack of Efficacy|7|||
16878829|NCT01396421|37859270|FG003|Overall Study|Lack of Efficacy|18|||
16878830|NCT01396265|37859328|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
16878831|NCT02647866|37859373|FG000|Overall Study|Adverse Event|0|||
16878832|NCT02647866|37859374|FG001|Overall Study|Adverse Event|0|||
16878833|NCT02647866|37859375|FG002|Overall Study|Adverse Event|2|||
16878834|NCT02647866|37859376|FG003|Overall Study|Adverse Event|2|||
16878835|NCT02647866|37859377|FG004|Overall Study|Adverse Event|1|||
16878836|NCT02647866|37859373|FG000|Overall Study|Disease Worsening|3|||
16878837|NCT02647866|37859374|FG001|Overall Study|Disease Worsening|1|||
16878838|NCT02647866|37859375|FG002|Overall Study|Disease Worsening|0|||
16878839|NCT02647866|37859376|FG003|Overall Study|Disease Worsening|0|||
16878840|NCT02647866|37859377|FG004|Overall Study|Disease Worsening|1|||
16878841|NCT02647866|37859373|FG000|Overall Study|Withdrawal by Subject|1|||
16878842|NCT02647866|37859374|FG001|Overall Study|Withdrawal by Subject|1|||
16878843|NCT02647866|37859375|FG002|Overall Study|Withdrawal by Subject|2|||
16878844|NCT02647866|37859376|FG003|Overall Study|Withdrawal by Subject|4|||
16878845|NCT02647866|37859377|FG004|Overall Study|Withdrawal by Subject|4|||
16878846|NCT02647866|37859373|FG000|Overall Study|Physician Decision|0|||
16878847|NCT02647866|37859374|FG001|Overall Study|Physician Decision|1|||
16878848|NCT02647866|37859375|FG002|Overall Study|Physician Decision|1|||
16878849|NCT02647866|37859376|FG003|Overall Study|Physician Decision|0|||
16878850|NCT02647866|37859377|FG004|Overall Study|Physician Decision|2|||
16878851|NCT02647866|37859373|FG000|Overall Study|Death|0|||
16878852|NCT02647866|37859374|FG001|Overall Study|Death|1|||
16878853|NCT02647866|37859375|FG002|Overall Study|Death|0|||
16878854|NCT02647866|37859376|FG003|Overall Study|Death|0|||
16878855|NCT02647866|37859377|FG004|Overall Study|Death|0|||
16878856|NCT02647866|37859373|FG000|Overall Study|Subject moved to different country|1|||
16878857|NCT02647866|37859374|FG001|Overall Study|Subject moved to different country|0|||
16878858|NCT02647866|37859375|FG002|Overall Study|Subject moved to different country|0|||
16878859|NCT02647866|37859376|FG003|Overall Study|Subject moved to different country|0|||
16878860|NCT02647866|37859377|FG004|Overall Study|Subject moved to different country|0|||
16878861|NCT01396187|37859437|FG000|Overall Study|Adverse Event|0|||
16878862|NCT01396187|37859438|FG001|Overall Study|Adverse Event|1|||
16878863|NCT01396187|37859439|FG002|Overall Study|Adverse Event|0|||
16878864|NCT01396187|37859440|FG003|Overall Study|Adverse Event|0|||
16878865|NCT01396187|37859441|FG004|Overall Study|Adverse Event|0|||
16878866|NCT01396187|37859437|FG000|Overall Study|Withdrawal by Subject|0|||
16878867|NCT01396187|37859438|FG001|Overall Study|Withdrawal by Subject|1|||
16878868|NCT01396187|37859439|FG002|Overall Study|Withdrawal by Subject|1|||
16878869|NCT01396187|37859440|FG003|Overall Study|Withdrawal by Subject|0|||
16878870|NCT01396187|37859441|FG004|Overall Study|Withdrawal by Subject|0|||
16878871|NCT01396187|37859437|FG000|Overall Study|Other|1|||
16878872|NCT01396187|37859438|FG001|Overall Study|Other|1|||
16878873|NCT01396187|37859439|FG002|Overall Study|Other|0|||
16878874|NCT01396187|37859440|FG003|Overall Study|Other|0|||
16878875|NCT01396187|37859441|FG004|Overall Study|Other|1|||
16878876|NCT01393301|37859480|FG000|Overall Study|Lost to Follow-up|5|||
16878877|NCT01393301|37859481|FG001|Overall Study|Lost to Follow-up|3|||
16878878|NCT01393301|37859480|FG000|Overall Study|Withdrawal by Subject|2|||
16878879|NCT01393301|37859481|FG001|Overall Study|Withdrawal by Subject|0|||
16878880|NCT01393301|37859480|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
16878881|NCT01393301|37859481|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
16878882|NCT01392677|37859497|FG000|Overall Study|Adverse Event|3|||
16878883|NCT01392677|37859498|FG001|Overall Study|Adverse Event|1|||
16878884|NCT01392677|37859497|FG000|Overall Study|Withdrawal by Subject|0|||
16878885|NCT01392677|37859498|FG001|Overall Study|Withdrawal by Subject|2|||
16878886|NCT01392677|37859497|FG000|Overall Study|Incorrect enrollment|2|||
16878887|NCT01392677|37859498|FG001|Overall Study|Incorrect enrollment|3|||
16878888|NCT01392677|37859497|FG000|Overall Study|Other reason|3|||
16878889|NCT01392677|37859498|FG001|Overall Study|Other reason|2|||
16878890|NCT01392443|37859547|FG000|Overall Study|Disease progression|30|||
16878891|NCT01392443|37859547|FG000|Overall Study|Adverse Event|24|||
16878892|NCT01392443|37859547|FG000|Overall Study|Death|7|||
16878893|NCT01392443|37859547|FG000|Overall Study|Withdrawal by Subject|5|||
16878894|NCT01392443|37859547|FG000|Overall Study|Lost to Follow-up|1|||
16878895|NCT01392443|37859547|FG000|Overall Study|Protocol Violation|1|||
16878896|NCT01391819|37859551|FG000|Overall Study|Withdrawal by Subject|56|||
16878897|NCT01391819|37859551|FG000|Overall Study|Migrated/moved from study area|82|||
16878898|NCT01391819|37859551|FG000|Overall Study|Lost to Follow-up|252|||
16878899|NCT01391819|37859551|FG000|Overall Study|Death|3|||
16878900|NCT01391819|37859551|FG000|Overall Study|Other|9|||
16878901|NCT03845023|37859562|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
16878902|NCT03845023|37859563|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
16878903|NCT03845023|37859564|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
16878904|NCT03845023|37859565|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
16878905|NCT03845023|37859562|FG000|Follow-Up (14 Days)|Adverse Event|0|||
16878906|NCT03845023|37859563|FG001|Follow-Up (14 Days)|Adverse Event|0|||
16878907|NCT03845023|37859564|FG002|Follow-Up (14 Days)|Adverse Event|1|||
16878908|NCT03845023|37859565|FG003|Follow-Up (14 Days)|Adverse Event|1|||
16878909|NCT01395017|37859627|FG000|Overall Study|Lost to Follow-up|1|||
16878910|NCT01395017|37859628|FG001|Overall Study|Lost to Follow-up|0|||
16878911|NCT01395017|37859627|FG000|Overall Study|Adverse Event|26|||
16878912|NCT01395017|37859628|FG001|Overall Study|Adverse Event|12|||
16878913|NCT01395017|37859627|FG000|Overall Study|Physician Decision|11|||
16878914|NCT01395017|37859628|FG001|Overall Study|Physician Decision|15|||
16878915|NCT01395017|37859627|FG000|Overall Study|Withdrawal by Subject|14|||
16878916|NCT01395017|37859628|FG001|Overall Study|Withdrawal by Subject|8|||
16878917|NCT01395017|37859627|FG000|Overall Study|Protocol deviation|1|||
16878918|NCT01395017|37859628|FG001|Overall Study|Protocol deviation|2|||
16878919|NCT01395017|37859627|FG000|Overall Study|Death|4|||
16878920|NCT01395017|37859628|FG001|Overall Study|Death|3|||
16878921|NCT01395017|37859627|FG000|Overall Study|Disease progression|42|||
16878922|NCT01395017|37859628|FG001|Overall Study|Disease progression|58|||
16878923|NCT01395017|37859627|FG000|Overall Study|Sponsor discontinued study|1|||
16878924|NCT01395017|37859628|FG001|Overall Study|Sponsor discontinued study|4|||
16878925|NCT02647320|37859680|FG000|Overall Study|Adverse Event|0|||
16878926|NCT02647320|37859681|FG001|Overall Study|Adverse Event|1|||
16878927|NCT02647320|37859682|FG002|Overall Study|Adverse Event|3|||
16878928|NCT02647320|37859683|FG003|Overall Study|Adverse Event|2|||
16878929|NCT02647320|37859684|FG004|Overall Study|Adverse Event|1|||
16878930|NCT02647320|37859680|FG000|Overall Study|Protocol Violation|0|||
16878931|NCT02647320|37859681|FG001|Overall Study|Protocol Violation|0|||
16878932|NCT02647320|37859682|FG002|Overall Study|Protocol Violation|3|||
16878933|NCT02647320|37859683|FG003|Overall Study|Protocol Violation|0|||
16878934|NCT02647320|37859684|FG004|Overall Study|Protocol Violation|0|||
16878935|NCT02647320|37859680|FG000|Overall Study|Withdrawal by Subject|7|||
16878936|NCT02647320|37859681|FG001|Overall Study|Withdrawal by Subject|4|||
16878937|NCT02647320|37859682|FG002|Overall Study|Withdrawal by Subject|2|||
16878938|NCT02647320|37859683|FG003|Overall Study|Withdrawal by Subject|2|||
16878939|NCT02647320|37859684|FG004|Overall Study|Withdrawal by Subject|7|||
16878940|NCT02647320|37859680|FG000|Overall Study|Persistent hyperglycemia|0|||
16878941|NCT02647320|37859681|FG001|Overall Study|Persistent hyperglycemia|1|||
16878942|NCT02647320|37859682|FG002|Overall Study|Persistent hyperglycemia|1|||
16878943|NCT02647320|37859683|FG003|Overall Study|Persistent hyperglycemia|1|||
16878944|NCT02647320|37859684|FG004|Overall Study|Persistent hyperglycemia|1|||
16878945|NCT02647320|37859680|FG000|Overall Study|Study terminated by sponsor|1|||
16878946|NCT02647320|37859681|FG001|Overall Study|Study terminated by sponsor|1|||
16878947|NCT02647320|37859682|FG002|Overall Study|Study terminated by sponsor|1|||
16878948|NCT02647320|37859683|FG003|Overall Study|Study terminated by sponsor|1|||
16878949|NCT02647320|37859684|FG004|Overall Study|Study terminated by sponsor|2|||
16878950|NCT02647320|37859680|FG000|Overall Study|Reason not provided|0|||
16878951|NCT02647320|37859681|FG001|Overall Study|Reason not provided|0|||
16878952|NCT02647320|37859682|FG002|Overall Study|Reason not provided|1|||
16878953|NCT02647320|37859683|FG003|Overall Study|Reason not provided|0|||
16878954|NCT02647320|37859684|FG004|Overall Study|Reason not provided|2|||
16878955|NCT02647320|37859680|FG000|Overall Study|Lost to Follow-up|1|||
16878956|NCT02647320|37859681|FG001|Overall Study|Lost to Follow-up|1|||
16878957|NCT02647320|37859682|FG002|Overall Study|Lost to Follow-up|0|||
17001901|NCT00658021|38145954|FG000|28-Week Treatment Period|Adverse Event|3|||
17001902|NCT00658021|38145955|FG001|28-Week Treatment Period|Adverse Event|1|||
17001903|NCT00658021|38145956|FG002|28-Week Treatment Period|Adverse Event|0|||
17001904|NCT00658021|38145954|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
17001905|NCT00658021|38145955|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
17001906|NCT00658021|38145956|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
17001907|NCT00658021|38145954|FG000|28-Week Treatment Period|Protocol Violation|0|||
17001908|NCT00658021|38145955|FG001|28-Week Treatment Period|Protocol Violation|2|||
17001909|NCT00658021|38145956|FG002|28-Week Treatment Period|Protocol Violation|1|||
17001910|NCT00658021|38145954|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
17095245|NCT00228566|38234517|FG000|Overall Study|Lost to Follow-up|16|||
17095246|NCT00228566|38234517|FG000|Overall Study|Physician Decision|5|||
17095247|NCT00228566|38234517|FG000|Overall Study|Withdrawal by Subject|4|||
17095248|NCT00228566|38234517|FG000|Overall Study|Miscellaneous|1|||
17095249|NCT00074152|38234523|FG000|Overall Study|Death|21|||
16878958|NCT02647320|37859683|FG003|Overall Study|Lost to Follow-up|0|||
16878959|NCT02647320|37859684|FG004|Overall Study|Lost to Follow-up|0|||
16878960|NCT02647320|37859680|FG000|Overall Study|Develop anemia|1|||
16878961|NCT02647320|37859681|FG001|Overall Study|Develop anemia|0|||
16878962|NCT02647320|37859682|FG002|Overall Study|Develop anemia|0|||
16878963|NCT02647320|37859683|FG003|Overall Study|Develop anemia|0|||
16878964|NCT02647320|37859684|FG004|Overall Study|Develop anemia|0|||
16878965|NCT02647320|37859680|FG000|Overall Study|Lack of Efficacy|0|||
16878966|NCT02647320|37859681|FG001|Overall Study|Lack of Efficacy|0|||
16878967|NCT02647320|37859682|FG002|Overall Study|Lack of Efficacy|0|||
16878968|NCT02647320|37859683|FG003|Overall Study|Lack of Efficacy|1|||
16878969|NCT02647320|37859684|FG004|Overall Study|Lack of Efficacy|0|||
16878970|NCT02647320|37859680|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
16878971|NCT02647320|37859681|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
16878972|NCT02647320|37859682|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
16878973|NCT02647320|37859683|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
16878974|NCT02647320|37859684|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
16878975|NCT03458325|37859707|FG000|Overall Study|Withdrawal by Subject|1|||
16878976|NCT02646618|37859716|FG000|Overall Study|Lost to Follow-up|10|||
16878977|NCT02646618|37859717|FG001|Overall Study|Lost to Follow-up|14|||
16878978|NCT02644122|37859757|FG000|Overall Study|Withdrawal by Subject|1|||
16878979|NCT02294461|37859764|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
16878980|NCT02294461|37859765|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
16878981|NCT02294461|37859764|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
16878982|NCT02294461|37859765|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
16878983|NCT02294461|37859764|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
16878984|NCT02294461|37859765|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
16878985|NCT02294461|37859764|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
16878986|NCT02294461|37859765|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
16878987|NCT02294461|37859764|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
16878988|NCT02294461|37859765|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
16878989|NCT02294461|37859764|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
16878990|NCT02294461|37859765|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
16878991|NCT02294461|37859764|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
16878992|NCT02294461|37859765|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
16878993|NCT02294461|37859764|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
16878994|NCT02294461|37859765|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
16878995|NCT02294461|37859764|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
16878996|NCT02294461|37859765|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
16878997|NCT02294461|37859764|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
16878998|NCT02294461|37859765|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
16878999|NCT02294461|37859764|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
16879000|NCT02294461|37859765|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
16879001|NCT02294461|37859764|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
16879002|NCT02294461|37859765|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
16879003|NCT02294461|37859764|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
16879004|NCT02294461|37859765|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
16879005|NCT02294461|37859764|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
16879006|NCT02294461|37859765|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
16879007|NCT02294461|37859764|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
16879008|NCT02294461|37859765|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
16879009|NCT01394939|37859804|FG000|Overall Study|Adverse Event|1|||
16879010|NCT01394939|37859805|FG001|Overall Study|Adverse Event|3|||
16879011|NCT01394939|37859806|FG002|Overall Study|Adverse Event|0|||
16879012|NCT01394939|37859807|FG003|Overall Study|Adverse Event|2|||
16879013|NCT01394939|37859804|FG000|Overall Study|Death|0|||
16879014|NCT01394939|37859805|FG001|Overall Study|Death|2|||
16879015|NCT01394939|37859806|FG002|Overall Study|Death|0|||
16879016|NCT01394939|37859807|FG003|Overall Study|Death|0|||
16879017|NCT01394939|37859804|FG000|Overall Study|Physician Decision|0|||
16879018|NCT01394939|37859805|FG001|Overall Study|Physician Decision|1|||
16879019|NCT01394939|37859806|FG002|Overall Study|Physician Decision|0|||
16879020|NCT01394939|37859807|FG003|Overall Study|Physician Decision|0|||
16879021|NCT01394939|37859804|FG000|Overall Study|Withdrawal by Subject|0|||
16879022|NCT01394939|37859805|FG001|Overall Study|Withdrawal by Subject|2|||
16879023|NCT01394939|37859806|FG002|Overall Study|Withdrawal by Subject|0|||
16879024|NCT01394939|37859807|FG003|Overall Study|Withdrawal by Subject|2|||
16879025|NCT01394939|37859804|FG000|Overall Study|Others|0|||
16879026|NCT01394939|37859805|FG001|Overall Study|Others|2|||
16879027|NCT01394939|37859806|FG002|Overall Study|Others|0|||
16879028|NCT01394939|37859807|FG003|Overall Study|Others|3|||
16879029|NCT01394627|37859821|FG000|First Intervention (1 Day)|poor intravenous access|0|||
16879030|NCT01394627|37859822|FG001|First Intervention (1 Day)|poor intravenous access|1|||
16879031|NCT01394627|37859821|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
16879032|NCT01394627|37859822|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
16879033|NCT01391663|37859841|FG000|Overall Study|Withdrawal by Subject|0|||
16879034|NCT01391663|37859842|FG001|Overall Study|Withdrawal by Subject|0|||
17095250|NCT00074152|38234524|FG001|Overall Study|Death|9|||
16879035|NCT01391663|37859843|FG002|Overall Study|Withdrawal by Subject|1|||
16879036|NCT01391663|37859844|FG003|Overall Study|Withdrawal by Subject|0|||
16879037|NCT02641392|37859865|FG000|Overall Study|Lost to Follow-up|0|||
16879038|NCT02641392|37859866|FG001|Overall Study|Lost to Follow-up|0|||
16879039|NCT02641392|37859867|FG002|Overall Study|Lost to Follow-up|2|||
16879040|NCT02641392|37859865|FG000|Overall Study|Withdrawal by Subject|0|||
16879041|NCT02641392|37859866|FG001|Overall Study|Withdrawal by Subject|0|||
16879042|NCT02641392|37859867|FG002|Overall Study|Withdrawal by Subject|17|||
16879043|NCT02641392|37859865|FG000|Overall Study|Adverse Event|0|||
16879044|NCT02641392|37859866|FG001|Overall Study|Adverse Event|1|||
16879045|NCT02641392|37859867|FG002|Overall Study|Adverse Event|25|||
16879046|NCT02641392|37859865|FG000|Overall Study|Study Terminated by Sponsor|4|||
16879047|NCT02641392|37859866|FG001|Overall Study|Study Terminated by Sponsor|12|||
16879048|NCT02641392|37859867|FG002|Overall Study|Study Terminated by Sponsor|144|||
16879049|NCT02641392|37859865|FG000|Overall Study|Lack of Efficacy|0|||
16879050|NCT02641392|37859866|FG001|Overall Study|Lack of Efficacy|0|||
16879051|NCT02641392|37859867|FG002|Overall Study|Lack of Efficacy|101|||
16879052|NCT02641392|37859865|FG000|Overall Study|Miscellaneous|0|||
16879053|NCT02641392|37859866|FG001|Overall Study|Miscellaneous|0|||
16879054|NCT02641392|37859867|FG002|Overall Study|Miscellaneous|3|||
16879055|NCT02641392|37859865|FG000|Overall Study|Death|0|||
16879056|NCT02641392|37859866|FG001|Overall Study|Death|0|||
16879057|NCT02641392|37859867|FG002|Overall Study|Death|1|||
16879058|NCT04440007|37859877|FG000|Overall Study|Adverse Event|0|||
16879059|NCT04440007|37859878|FG001|Overall Study|Adverse Event|1|||
16879060|NCT04440007|37859877|FG000|Overall Study|Lost to Follow-up|1|||
16879061|NCT04440007|37859878|FG001|Overall Study|Lost to Follow-up|3|||
16879062|NCT04440007|37859877|FG000|Overall Study|Death|7|||
16879063|NCT04440007|37859878|FG001|Overall Study|Death|2|||
16879064|NCT04440007|37859877|FG000|Overall Study|Physician Decision|1|||
16879065|NCT04440007|37859878|FG001|Overall Study|Physician Decision|1|||
16879066|NCT04440007|37859877|FG000|Overall Study|Withdrawal by Subject|2|||
16879067|NCT04440007|37859878|FG001|Overall Study|Withdrawal by Subject|1|||
16879068|NCT04440007|37859877|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
16879069|NCT04440007|37859878|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
16879070|NCT04440007|37859877|FG000|Overall Study|Discontinued prior to dosing|0|||
16879071|NCT04440007|37859878|FG001|Overall Study|Discontinued prior to dosing|2|||
16879072|NCT01391507|37859897|FG000|Overall Study|Death|0|||
16879073|NCT01391507|37859898|FG001|Overall Study|Death|0|||
16879074|NCT01391507|37859899|FG002|Overall Study|Death|0|||
16879075|NCT01391507|37859900|FG003|Overall Study|Death|1|||
16879076|NCT01391507|37859897|FG000|Overall Study|Adverse Event|1|||
16879077|NCT01391507|37859898|FG001|Overall Study|Adverse Event|1|||
16879078|NCT01391507|37859899|FG002|Overall Study|Adverse Event|2|||
16879079|NCT01391507|37859900|FG003|Overall Study|Adverse Event|2|||
16879080|NCT01391507|37859897|FG000|Overall Study|Withdrawal by Subject|1|||
16879081|NCT01391507|37859898|FG001|Overall Study|Withdrawal by Subject|2|||
17001911|NCT00658021|38145955|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
17001912|NCT00658021|38145956|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
17001913|NCT00658021|38145954|FG000|28-Week Treatment Period|Physician Decision|1|||
17001914|NCT00658021|38145955|FG001|28-Week Treatment Period|Physician Decision|2|||
17001915|NCT00658021|38145956|FG002|28-Week Treatment Period|Physician Decision|1|||
17001916|NCT00658021|38145954|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
17001917|NCT00658021|38145955|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
17001918|NCT00658021|38145956|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
17001919|NCT00658021|38145954|FG000|28-Week Treatment Period|Loss of glucose control|1|||
17001920|NCT00658021|38145955|FG001|28-Week Treatment Period|Loss of glucose control|1|||
17001921|NCT00658021|38145956|FG002|28-Week Treatment Period|Loss of glucose control|10|||
16879082|NCT01391507|37859899|FG002|Overall Study|Withdrawal by Subject|1|||
16879083|NCT01391507|37859900|FG003|Overall Study|Withdrawal by Subject|1|||
16879084|NCT01391507|37859897|FG000|Overall Study|Lack of Efficacy|0|||
16879085|NCT01391507|37859898|FG001|Overall Study|Lack of Efficacy|0|||
16879086|NCT01391507|37859899|FG002|Overall Study|Lack of Efficacy|0|||
16879087|NCT01391507|37859900|FG003|Overall Study|Lack of Efficacy|1|||
16879088|NCT01391507|37859897|FG000|Overall Study|Protocol Violation|2|||
16879089|NCT01391507|37859898|FG001|Overall Study|Protocol Violation|1|||
16879090|NCT01391507|37859899|FG002|Overall Study|Protocol Violation|1|||
16879091|NCT01391507|37859900|FG003|Overall Study|Protocol Violation|2|||
16879092|NCT01473524|37859922|FG000|DB Phase|Adverse Event|4|||
16879093|NCT01473524|37859923|FG001|DB Phase|Adverse Event|8|||
16879094|NCT01473524|37859924|FG002|DB Phase|Adverse Event|2|||
16879095|NCT01473524|37859925|FG003|DB Phase|Adverse Event|0|||
16879096|NCT01473524|37859926|FG004|DB Phase|Adverse Event|0|||
16879097|NCT01473524|37859927|FG005|DB Phase|Adverse Event|0|||
16879098|NCT01473524|37859922|FG000|DB Phase|Death|1|||
16879099|NCT01473524|37859923|FG001|DB Phase|Death|0|||
16879100|NCT01473524|37859924|FG002|DB Phase|Death|0|||
16879101|NCT01473524|37859925|FG003|DB Phase|Death|0|||
17001922|NCT00658021|38145954|FG000|28-Week Treatment Period|Other|2|||
17001923|NCT00658021|38145955|FG001|28-Week Treatment Period|Other|3|||
17001924|NCT00658021|38145956|FG002|28-Week Treatment Period|Other|1|||
17001925|NCT00658021|38145954|FG000|28-Week Treatment Period|Did not receive treatment|2|||
17001926|NCT00658021|38145955|FG001|28-Week Treatment Period|Did not receive treatment|0|||
17001927|NCT00658021|38145956|FG002|28-Week Treatment Period|Did not receive treatment|0|||
17001928|NCT00658021|38145954|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
17001929|NCT00658021|38145955|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
17001930|NCT00658021|38145956|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
17001931|NCT00658021|38145954|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
17001932|NCT00658021|38145955|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
17001933|NCT00658021|38145956|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
17001934|NCT00920816|38145970|FG000|Overall Study|Death|116|||
17001935|NCT00920816|38145971|FG001|Overall Study|Death|63|||
17001936|NCT00920816|38145972|FG002|Overall Study|Death|8|||
17001937|NCT00920816|38145973|FG003|Overall Study|Death|3|||
17001938|NCT00920816|38145970|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
17001939|NCT00920816|38145971|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
17001940|NCT00920816|38145972|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
17001941|NCT00920816|38145973|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
17001942|NCT00920816|38145970|FG000|Overall Study|Global deterioration of health status|2|||
17001943|NCT00920816|38145971|FG001|Overall Study|Global deterioration of health status|0|||
17001944|NCT00920816|38145972|FG002|Overall Study|Global deterioration of health status|0|||
17001945|NCT00920816|38145973|FG003|Overall Study|Global deterioration of health status|0|||
17001946|NCT00920816|38145970|FG000|Overall Study|Objective progression or relapse|6|||
17001947|NCT00920816|38145971|FG001|Overall Study|Objective progression or relapse|2|||
17001948|NCT00920816|38145972|FG002|Overall Study|Objective progression or relapse|0|||
17001949|NCT00920816|38145973|FG003|Overall Study|Objective progression or relapse|0|||
17001950|NCT00920816|38145970|FG000|Overall Study|Other|26|||
17001951|NCT00920816|38145971|FG001|Overall Study|Other|15|||
17001952|NCT00920816|38145972|FG002|Overall Study|Other|1|||
17001953|NCT00920816|38145973|FG003|Overall Study|Other|2|||
17001954|NCT00920816|38145970|FG000|Overall Study|Lost to Follow-up|11|||
17001955|NCT00920816|38145971|FG001|Overall Study|Lost to Follow-up|2|||
17001956|NCT00920816|38145972|FG002|Overall Study|Lost to Follow-up|0|||
17001957|NCT00920816|38145973|FG003|Overall Study|Lost to Follow-up|0|||
17001958|NCT00920816|38145970|FG000|Overall Study|Adverse Event|1|||
17001959|NCT00920816|38145971|FG001|Overall Study|Adverse Event|1|||
17001960|NCT00920816|38145972|FG002|Overall Study|Adverse Event|1|||
17001961|NCT00920816|38145973|FG003|Overall Study|Adverse Event|0|||
17001962|NCT00920816|38145970|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
17001963|NCT00920816|38145971|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
17001964|NCT00920816|38145972|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
17001965|NCT00920816|38145973|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
17001966|NCT00920816|38145970|FG000|Overall Study|Randomized but not treated|3|||
17001967|NCT00920816|38145971|FG001|Overall Study|Randomized but not treated|0|||
17001968|NCT00920816|38145972|FG002|Overall Study|Randomized but not treated|0|||
17001969|NCT00920816|38145973|FG003|Overall Study|Randomized but not treated|0|||
17001970|NCT00657709|38145988|FG000|Overall Study|AE or Death|7|||
17001971|NCT00657709|38145989|FG001|Overall Study|AE or Death|7|||
17001972|NCT00657709|38145990|FG002|Overall Study|AE or Death|6|||
17001973|NCT00657709|38145991|FG003|Overall Study|AE or Death|7|||
17001974|NCT00657709|38145992|FG004|Overall Study|AE or Death|1|||
17001975|NCT00657709|38145988|FG000|Overall Study|Withdrawal by Subject|7|||
17001976|NCT00657709|38145989|FG001|Overall Study|Withdrawal by Subject|15|||
17001977|NCT00657709|38145990|FG002|Overall Study|Withdrawal by Subject|15|||
17001978|NCT00657709|38145991|FG003|Overall Study|Withdrawal by Subject|5|||
17001979|NCT00657709|38145992|FG004|Overall Study|Withdrawal by Subject|9|||
17001980|NCT00657709|38145988|FG000|Overall Study|Lost to Follow-up|9|||
17001981|NCT00657709|38145989|FG001|Overall Study|Lost to Follow-up|9|||
17001982|NCT00657709|38145990|FG002|Overall Study|Lost to Follow-up|7|||
17001983|NCT00657709|38145991|FG003|Overall Study|Lost to Follow-up|1|||
17001984|NCT00657709|38145992|FG004|Overall Study|Lost to Follow-up|21|||
17001985|NCT00657709|38145988|FG000|Overall Study|Protocol Violation|0|||
17001986|NCT00657709|38145989|FG001|Overall Study|Protocol Violation|2|||
17001987|NCT00657709|38145990|FG002|Overall Study|Protocol Violation|0|||
17001988|NCT00657709|38145991|FG003|Overall Study|Protocol Violation|1|||
17001989|NCT00657709|38145992|FG004|Overall Study|Protocol Violation|2|||
17001990|NCT00915356|38146019|FG000|Overall Study|Withdrawal by Subject|1|||
17001991|NCT00915356|38146020|FG001|Overall Study|Withdrawal by Subject|0|||
17001992|NCT00915356|38146021|FG002|Overall Study|Withdrawal by Subject|0|||
17001993|NCT00915356|38146022|FG003|Overall Study|Withdrawal by Subject|0|||
17001994|NCT00915356|38146023|FG004|Overall Study|Withdrawal by Subject|0|||
17095251|NCT00074152|38234523|FG000|Overall Study|Lack of Efficacy|34|||
17001995|NCT00657553|38146037|FG000|Overall Study|low accrual, no analysis run|5|||
17001996|NCT00657553|38146038|FG001|Overall Study|low accrual, no analysis run|5|||
17001997|NCT00862719|38146048|FG000|Overall Study|Disease Progression|5|||
17001998|NCT00862719|38146049|FG001|Overall Study|Disease Progression|0|||
17001999|NCT00862719|38146050|FG002|Overall Study|Disease Progression|1|||
17002000|NCT00862719|38146051|FG003|Overall Study|Disease Progression|0|||
17002001|NCT00862719|38146048|FG000|Overall Study|Death|5|||
17002002|NCT00862719|38146049|FG001|Overall Study|Death|6|||
17002003|NCT00862719|38146050|FG002|Overall Study|Death|1|||
17002004|NCT00862719|38146051|FG003|Overall Study|Death|1|||
17002005|NCT00862719|38146048|FG000|Overall Study|Engraftment failure|0|||
17002006|NCT00862719|38146049|FG001|Overall Study|Engraftment failure|0|||
17002007|NCT00862719|38146050|FG002|Overall Study|Engraftment failure|1|||
17002008|NCT00862719|38146051|FG003|Overall Study|Engraftment failure|0|||
17002009|NCT00862719|38146048|FG000|Overall Study|Veno-Occlusive Disease|0|||
17002010|NCT00862719|38146049|FG001|Overall Study|Veno-Occlusive Disease|0|||
17002011|NCT00862719|38146050|FG002|Overall Study|Veno-Occlusive Disease|1|||
17002012|NCT00862719|38146051|FG003|Overall Study|Veno-Occlusive Disease|0|||
17002013|NCT00862641|38146065|FG000|Overall Study|Randomized, but drug not received|1|||
17002014|NCT00862641|38146066|FG001|Overall Study|Randomized, but drug not received|4|||
17002015|NCT00862641|38146067|FG002|Overall Study|Randomized, but drug not received|1|||
17002016|NCT00862641|38146068|FG003|Overall Study|Randomized, but drug not received|4|||
17002017|NCT00861471|38146078|FG000|Overall Study|Withdrawal by Subject|1|||
17002018|NCT00861471|38146078|FG000|Overall Study|Adverse Event|2|||
17002019|NCT00861471|38146078|FG000|Overall Study|Lack of Efficacy|3|||
17002020|NCT00861471|38146078|FG000|Overall Study|treatment for lumbar laminectomy|1|||
17002021|NCT00861471|38146078|FG000|Overall Study|Physician Decision|2|||
17002022|NCT00860067|38146085|FG000|Overall Study|Lost to Follow-up|46|||
17002023|NCT00860067|38146086|FG001|Overall Study|Lost to Follow-up|9|||
17002024|NCT00860067|38146087|FG002|Overall Study|Lost to Follow-up|9|||
17002025|NCT00860067|38146085|FG000|Overall Study|Withdrawal by Subject|4|||
17002026|NCT00860067|38146086|FG001|Overall Study|Withdrawal by Subject|0|||
17002027|NCT00860067|38146087|FG002|Overall Study|Withdrawal by Subject|0|||
17002028|NCT00860067|38146085|FG000|Overall Study|Pregnancy|1|||
17002029|NCT00860067|38146086|FG001|Overall Study|Pregnancy|0|||
17002030|NCT00860067|38146087|FG002|Overall Study|Pregnancy|0|||
17002031|NCT00858117|38146098|FG000|Treatment on Study|Adverse Event|2|||
17002032|NCT00858117|38146098|FG000|Follow up for 5 Years|Death|4|||
17002033|NCT00858117|38146098|FG000|Follow up for 5 Years|No further data collected for study|9|||
17002034|NCT00652951|38146105|FG000|Booster Phase|Adverse event, non-fatal|0|||
17002035|NCT00652951|38146106|FG001|Booster Phase|Adverse event, non-fatal|1|||
17002036|NCT00652951|38146107|FG002|Booster Phase|Adverse event, non-fatal|0|||
17002037|NCT00652951|38146105|FG000|Booster Phase|Other|1|||
17002038|NCT00652951|38146106|FG001|Booster Phase|Other|0|||
16879102|NCT01473524|37859926|FG004|DB Phase|Death|0|||
16879103|NCT01473524|37859927|FG005|DB Phase|Death|0|||
16879104|NCT01473524|37859922|FG000|DB Phase|Withdrawal by Subject|2|||
16879105|NCT01473524|37859923|FG001|DB Phase|Withdrawal by Subject|1|||
16879106|NCT01473524|37859924|FG002|DB Phase|Withdrawal by Subject|1|||
16879107|NCT01473524|37859925|FG003|DB Phase|Withdrawal by Subject|0|||
16879108|NCT01473524|37859926|FG004|DB Phase|Withdrawal by Subject|0|||
16879109|NCT01473524|37859927|FG005|DB Phase|Withdrawal by Subject|0|||
16879110|NCT01473524|37859922|FG000|LTSE Phase|Withdrawal by Subject|0|||
17002039|NCT00652951|38146107|FG002|Booster Phase|Other|0|||
17002040|NCT00848211|38146119|FG000|Overall Study|Protocol Violation|0|||
17002041|NCT00848211|38146120|FG001|Overall Study|Protocol Violation|1|||
17002042|NCT00848211|38146121|FG002|Overall Study|Protocol Violation|1|||
17002043|NCT00848211|38146122|FG003|Overall Study|Protocol Violation|0|||
17002044|NCT00848211|38146119|FG000|Overall Study|Adverse Event|0|||
17002045|NCT00848211|38146120|FG001|Overall Study|Adverse Event|0|||
17002046|NCT00848211|38146121|FG002|Overall Study|Adverse Event|0|||
17002047|NCT00848211|38146122|FG003|Overall Study|Adverse Event|0|||
17002048|NCT00592683|38146134|FG000|Overall Study|Found ineligible|0|||
17002049|NCT00592683|38146135|FG001|Overall Study|Found ineligible|1|||
17002050|NCT00592683|38146134|FG000|Overall Study|Withdrawal by Subject|1|||
17002051|NCT00592683|38146135|FG001|Overall Study|Withdrawal by Subject|0|||
17002052|NCT00592683|38146134|FG000|Overall Study|Adverse Event|0|||
17002053|NCT00592683|38146135|FG001|Overall Study|Adverse Event|2|||
17002054|NCT00592683|38146134|FG000|Overall Study|Protocol Violation|1|||
17002055|NCT00592683|38146135|FG001|Overall Study|Protocol Violation|0|||
16879111|NCT01473524|37859923|FG001|LTSE Phase|Withdrawal by Subject|0|||
16879112|NCT01473524|37859924|FG002|LTSE Phase|Withdrawal by Subject|0|||
17002056|NCT00592683|38146134|FG000|Overall Study|Study drug expired|1|||
17002057|NCT00592683|38146135|FG001|Overall Study|Study drug expired|0|||
17002058|NCT00592683|38146134|FG000|Overall Study|Other|1|||
17002059|NCT00592683|38146135|FG001|Overall Study|Other|0|||
17002060|NCT00592683|38146134|FG000|Overall Study|Lost to Follow-up|0|||
17002061|NCT00592683|38146135|FG001|Overall Study|Lost to Follow-up|1|||
17002062|NCT00847665|38146143|FG000|Overall Study|Withdrawal by Subject|1|||
17002063|NCT00847665|38146144|FG001|Overall Study|Withdrawal by Subject|0|||
16879113|NCT01473524|37859925|FG003|LTSE Phase|Withdrawal by Subject|3|||
16879114|NCT01473524|37859926|FG004|LTSE Phase|Withdrawal by Subject|3|||
16879115|NCT01473524|37859927|FG005|LTSE Phase|Withdrawal by Subject|6|||
16879116|NCT01473524|37859922|FG000|LTSE Phase|Death|0|||
16879117|NCT01473524|37859923|FG001|LTSE Phase|Death|0|||
16879118|NCT01473524|37859924|FG002|LTSE Phase|Death|0|||
16879119|NCT01473524|37859925|FG003|LTSE Phase|Death|0|||
16879120|NCT01473524|37859926|FG004|LTSE Phase|Death|1|||
16879121|NCT01473524|37859927|FG005|LTSE Phase|Death|0|||
16879122|NCT01473524|37859922|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
16879123|NCT01473524|37859923|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
16879124|NCT01473524|37859924|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
16879125|NCT01473524|37859925|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
16879126|NCT01473524|37859926|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
16879127|NCT01473524|37859927|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
16879128|NCT01473524|37859922|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
16879129|NCT01473524|37859923|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
16879130|NCT01473524|37859924|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
16879131|NCT01473524|37859925|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
16879132|NCT01473524|37859926|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
16879133|NCT01473524|37859927|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
16879134|NCT01473524|37859922|FG000|LTSE Phase|Lost to Follow-up|0|||
16879135|NCT01473524|37859923|FG001|LTSE Phase|Lost to Follow-up|0|||
16879136|NCT01473524|37859924|FG002|LTSE Phase|Lost to Follow-up|0|||
16879137|NCT01473524|37859925|FG003|LTSE Phase|Lost to Follow-up|1|||
16879138|NCT01473524|37859926|FG004|LTSE Phase|Lost to Follow-up|3|||
16879139|NCT01473524|37859927|FG005|LTSE Phase|Lost to Follow-up|2|||
16879140|NCT01473524|37859922|FG000|LTSE Phase|Principal Investigator Decision|0|||
16879141|NCT01473524|37859923|FG001|LTSE Phase|Principal Investigator Decision|0|||
16879142|NCT01473524|37859924|FG002|LTSE Phase|Principal Investigator Decision|0|||
16879143|NCT01473524|37859925|FG003|LTSE Phase|Principal Investigator Decision|1|||
16879144|NCT01473524|37859926|FG004|LTSE Phase|Principal Investigator Decision|1|||
16879145|NCT01473524|37859927|FG005|LTSE Phase|Principal Investigator Decision|3|||
16879146|NCT01473524|37859922|FG000|LTSE Phase|Liver Transplantation|0|||
16879147|NCT01473524|37859923|FG001|LTSE Phase|Liver Transplantation|0|||
17002064|NCT00916370|38146152|FG000|Overall Study|Death|3|||
17002065|NCT00916370|38146153|FG001|Overall Study|Death|1|||
17002066|NCT00916370|38146152|FG000|Overall Study|Withdrawal by Subject|2|||
17002067|NCT00916370|38146153|FG001|Overall Study|Withdrawal by Subject|0|||
17002068|NCT00916370|38146152|FG000|Overall Study|Physician Decision|0|||
17002069|NCT00916370|38146153|FG001|Overall Study|Physician Decision|1|||
17002070|NCT00847197|38146162|FG000|Overall Study|Adverse Event|21|||
17002071|NCT00847197|38146163|FG001|Overall Study|Adverse Event|3|||
17002072|NCT00847197|38146162|FG000|Overall Study|Protocol Violation|0|||
17002073|NCT00847197|38146163|FG001|Overall Study|Protocol Violation|1|||
17002074|NCT00847197|38146162|FG000|Overall Study|Withdrawal by Subject|3|||
17002075|NCT00847197|38146163|FG001|Overall Study|Withdrawal by Subject|1|||
17002076|NCT00654901|38146173|FG000|Overall Study|Lost to Follow-up|1|||
17002077|NCT00654901|38146174|FG001|Overall Study|Lost to Follow-up|0|||
17002078|NCT00654901|38146175|FG002|Overall Study|Lost to Follow-up|1|||
17002079|NCT00654901|38146176|FG003|Overall Study|Lost to Follow-up|0|||
17002080|NCT00654901|38146173|FG000|Overall Study|Withdrawal by Subject|3|||
17002081|NCT00654901|38146174|FG001|Overall Study|Withdrawal by Subject|0|||
17002082|NCT00654901|38146175|FG002|Overall Study|Withdrawal by Subject|1|||
17002083|NCT00654901|38146176|FG003|Overall Study|Withdrawal by Subject|0|||
17002084|NCT00846807|38146186|FG000|Overall Study|Adverse Event|270|||
17002085|NCT00846807|38146186|FG000|Overall Study|Lost to Follow-up|94|||
17002086|NCT00846807|38146186|FG000|Overall Study|Withdrawal by Subject|56|||
17002087|NCT00846807|38146186|FG000|Overall Study|Non compliant with European label|7|||
17002088|NCT00846807|38146186|FG000|Overall Study|Switch to other anticoagulants|89|||
17002089|NCT00846807|38146186|FG000|Overall Study|No prescription after hospital discharge|56|||
17002090|NCT00846807|38146186|FG000|Overall Study|Other|60|||
17002091|NCT00846495|38146192|FG000|Overall Study|Lost to Follow-up|1|||
17002092|NCT00846495|38146193|FG001|Overall Study|Lost to Follow-up|0|||
17002093|NCT00846495|38146192|FG000|Overall Study|Adverse Event|5|||
17002094|NCT00846495|38146193|FG001|Overall Study|Adverse Event|1|||
17002095|NCT00846495|38146192|FG000|Overall Study|Lack of Efficacy|1|||
17002096|NCT00846495|38146193|FG001|Overall Study|Lack of Efficacy|2|||
17002097|NCT00846495|38146192|FG000|Overall Study|Physician Decision|1|||
17002098|NCT00846495|38146193|FG001|Overall Study|Physician Decision|0|||
17002099|NCT00654745|38146199|FG000|Overall Study|Adverse Event|12|||
17002100|NCT00654745|38146199|FG000|Overall Study|Lost to Follow-up|7|||
16879148|NCT01473524|37859924|FG002|LTSE Phase|Liver Transplantation|0|||
16879149|NCT01473524|37859925|FG003|LTSE Phase|Liver Transplantation|0|||
17002101|NCT00654745|38146199|FG000|Overall Study|Protocol Violation|11|||
17002102|NCT00654745|38146199|FG000|Overall Study|Withdrawal by Subject|10|||
17002103|NCT00654745|38146199|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
17002104|NCT00846027|38146209|FG000|Overall Study|Death|3|||
16879150|NCT01473524|37859926|FG004|LTSE Phase|Liver Transplantation|0|||
16879151|NCT01473524|37859927|FG005|LTSE Phase|Liver Transplantation|1|||
16879152|NCT01473524|37859922|FG000|LTSE Phase|Pregnancy|0|||
16879153|NCT01473524|37859923|FG001|LTSE Phase|Pregnancy|0|||
16879154|NCT01473524|37859924|FG002|LTSE Phase|Pregnancy|0|||
16879155|NCT01473524|37859925|FG003|LTSE Phase|Pregnancy|1|||
16879156|NCT01473524|37859926|FG004|LTSE Phase|Pregnancy|0|||
16879157|NCT01473524|37859927|FG005|LTSE Phase|Pregnancy|0|||
16879158|NCT01473524|37859922|FG000|LTSE Phase|Protocol Violation|0|||
16879159|NCT01473524|37859923|FG001|LTSE Phase|Protocol Violation|0|||
16879160|NCT01473524|37859924|FG002|LTSE Phase|Protocol Violation|0|||
16879161|NCT01473524|37859925|FG003|LTSE Phase|Protocol Violation|0|||
16879162|NCT01473524|37859926|FG004|LTSE Phase|Protocol Violation|0|||
16879163|NCT01473524|37859927|FG005|LTSE Phase|Protocol Violation|1|||
16879164|NCT01390649|37859958|FG000|Overall Study|Physician Decision|1|||
16879165|NCT01390181|37859962|FG000|Overall Study|Lost to Follow-up|1|||
16879166|NCT01390181|37859962|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
16879167|NCT02641080|37859968|FG000|Overall Study|Physician Decision|2|||
16879168|NCT02641080|37859969|FG001|Overall Study|Physician Decision|0|||
16879169|NCT02641080|37859968|FG000|Overall Study|Withdrawal by Subject|0|||
16879170|NCT02641080|37859969|FG001|Overall Study|Withdrawal by Subject|1|||
16879171|NCT02641080|37859968|FG000|Overall Study|Rehab Center denied use of pumps|0|||
16879172|NCT02641080|37859969|FG001|Overall Study|Rehab Center denied use of pumps|3|||
16879173|NCT02641080|37859968|FG000|Overall Study|Lost to Follow-up|0|||
16879174|NCT02641080|37859969|FG001|Overall Study|Lost to Follow-up|3|||
16879175|NCT01457846|37859977|FG000|Overall Study|Death before treatment|1|||
16879176|NCT01457846|37859978|FG001|Overall Study|Death before treatment|2|||
16879177|NCT01457846|37859977|FG000|Overall Study|Did not receive treatment|0|||
16879178|NCT01457846|37859978|FG001|Overall Study|Did not receive treatment|1|||
16879179|NCT01457846|37859977|FG000|Overall Study|Death|27|||
16879180|NCT01457846|37859978|FG001|Overall Study|Death|16|||
16879181|NCT01457846|37859977|FG000|Overall Study|Unclassified reason for not completed|11|||
16879182|NCT01457846|37859978|FG001|Overall Study|Unclassified reason for not completed|10|||
16879183|NCT01457846|37859977|FG000|Overall Study|Withdrawal by Subject|1|||
16879184|NCT01457846|37859978|FG001|Overall Study|Withdrawal by Subject|1|||
16879185|NCT01457846|37859977|FG000|Overall Study|Lost to Follow-up|1|||
16879186|NCT01457846|37859978|FG001|Overall Study|Lost to Follow-up|0|||
16879187|NCT01496066|37859990|FG000|Overall Study|Lost to Follow-up|8|||
16879188|NCT01496066|37859991|FG001|Overall Study|Lost to Follow-up|5|||
16879189|NCT01496066|37859990|FG000|Overall Study|Explant|3|||
16879190|NCT01496066|37859991|FG001|Overall Study|Explant|0|||
16879191|NCT01496066|37859990|FG000|Overall Study|Death|1|||
16879192|NCT01496066|37859991|FG001|Overall Study|Death|4|||
16879193|NCT01389323|37860004|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
16879194|NCT01389323|37860004|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
16879195|NCT01389323|37860004|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
16879196|NCT01389323|37860004|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
16879197|NCT01389323|37860004|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
16879198|NCT01389323|37860004|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
16879199|NCT01389323|37860004|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
16879200|NCT01389323|37860004|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
16879201|NCT01389323|37860004|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
16879202|NCT01389323|37860004|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
16879203|NCT01389323|37860004|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
16879204|NCT01389245|37860015|FG000|Overall Study|Protocol Violation|10|||
16879205|NCT01389245|37860015|FG000|Overall Study|Lost to Follow-up|3|||
16879206|NCT01389245|37860015|FG000|Overall Study|Withdrawal by Subject|2|||
16879207|NCT01494818|37860021|FG000|Overall Study|Relocation|1|||
16879208|NCT01494818|37860022|FG001|Overall Study|Relocation|2|||
16879209|NCT01494818|37860021|FG000|Overall Study|Lost to Follow-up|1|||
16879210|NCT01494818|37860022|FG001|Overall Study|Lost to Follow-up|0|||
16879211|NCT01494584|37860028|FG000|Overall Study|Study Closed/Terminated|1|||
16879212|NCT01388543|37860053|FG000|Day 14|Adverse Event|1|||
16879213|NCT01388543|37860054|FG001|Day 14|Adverse Event|4|||
16879214|NCT00512317|37860118|FG000|Overall Study|Insufficient clinical response|36|||
16879215|NCT00512317|37860118|FG000|Overall Study|Withdrawal by Subject|23|||
16879216|NCT00512317|37860118|FG000|Overall Study|Sponsor closure of study|21|||
16879217|NCT00512317|37860118|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
16879218|NCT00512317|37860118|FG000|Overall Study|Adverse Event|13|||
16879219|NCT00512317|37860118|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
16879220|NCT00512317|37860118|FG000|Overall Study|Lost to Follow-up|2|||
16879221|NCT00512317|37860118|FG000|Overall Study|Other|2|||
17002105|NCT00846027|38146209|FG000|Overall Study|Disease Progression|30|||
17002106|NCT00846027|38146209|FG000|Overall Study|Toxicity|12|||
16879222|NCT01494506|37860134|FG000|Overall Study|Lack of Efficacy|77|||
16879223|NCT01494506|37860135|FG001|Overall Study|Lack of Efficacy|83|||
16879224|NCT01494506|37860136|FG002|Overall Study|Lack of Efficacy|57|||
16879225|NCT01494506|37860134|FG000|Overall Study|Adverse Event|17|||
16879226|NCT01494506|37860135|FG001|Overall Study|Adverse Event|10|||
16879227|NCT01494506|37860136|FG002|Overall Study|Adverse Event|11|||
16879228|NCT01494506|37860134|FG000|Overall Study|Death|9|||
16879229|NCT01494506|37860135|FG001|Overall Study|Death|5|||
16879230|NCT01494506|37860136|FG002|Overall Study|Death|2|||
16879231|NCT01494506|37860134|FG000|Overall Study|Physician Decision|7|||
16879232|NCT01494506|37860135|FG001|Overall Study|Physician Decision|5|||
16879233|NCT01494506|37860136|FG002|Overall Study|Physician Decision|4|||
16879234|NCT01494506|37860134|FG000|Overall Study|Withdrawal by Subject|17|||
16879235|NCT01494506|37860135|FG001|Overall Study|Withdrawal by Subject|20|||
16879236|NCT01494506|37860136|FG002|Overall Study|Withdrawal by Subject|14|||
16879237|NCT01494506|37860134|FG000|Overall Study|Clinical Deterioration|21|||
16879238|NCT01494506|37860135|FG001|Overall Study|Clinical Deterioration|17|||
16879239|NCT01494506|37860136|FG002|Overall Study|Clinical Deterioration|13|||
16879240|NCT01494506|37860134|FG000|Overall Study|Sponsor Decision|0|||
16879241|NCT01494506|37860135|FG001|Overall Study|Sponsor Decision|0|||
16879242|NCT01494506|37860136|FG002|Overall Study|Sponsor Decision|1|||
16879243|NCT01494506|37860134|FG000|Overall Study|Other|0|||
16879244|NCT01494506|37860135|FG001|Overall Study|Other|3|||
16879245|NCT01494506|37860136|FG002|Overall Study|Other|1|||
16879246|NCT02643420|37860148|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
16879247|NCT02643420|37860149|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
16879248|NCT02643420|37860148|FG000|Overall Study|Withdrawal by Subject|25|||
16879249|NCT02643420|37860149|FG001|Overall Study|Withdrawal by Subject|19|||
16879250|NCT02643420|37860148|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
16879251|NCT02643420|37860149|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
16879252|NCT02643420|37860148|FG000|Overall Study|Lost to Follow-up|6|||
16879253|NCT02643420|37860149|FG001|Overall Study|Lost to Follow-up|10|||
16879254|NCT02643420|37860148|FG000|Overall Study|Investigator Decision|2|||
16879255|NCT02643420|37860149|FG001|Overall Study|Investigator Decision|4|||
16879256|NCT02643420|37860148|FG000|Overall Study|Sponsor decision|1|||
16879257|NCT02643420|37860149|FG001|Overall Study|Sponsor decision|1|||
16879258|NCT02643420|37860148|FG000|Overall Study|Death|0|||
16879259|NCT02643420|37860149|FG001|Overall Study|Death|2|||
16879260|NCT02643420|37860148|FG000|Overall Study|Reason not Specified|8|||
16879261|NCT02643420|37860149|FG001|Overall Study|Reason not Specified|7|||
16879262|NCT03485911|37860164|FG000|Overall Study|Withdrawal by Subject|0|||
16879263|NCT03485911|37860165|FG001|Overall Study|Withdrawal by Subject|2|||
16879264|NCT03485911|37860166|FG002|Overall Study|Withdrawal by Subject|2|||
16879265|NCT03485911|37860164|FG000|Overall Study|Adverse Event|1|||
16879266|NCT03485911|37860165|FG001|Overall Study|Adverse Event|0|||
16879267|NCT03485911|37860166|FG002|Overall Study|Adverse Event|1|||
16879268|NCT03485911|37860164|FG000|Overall Study|High frequency of HAE attacks|0|||
16879269|NCT03485911|37860165|FG001|Overall Study|High frequency of HAE attacks|0|||
16879270|NCT03485911|37860166|FG002|Overall Study|High frequency of HAE attacks|1|||
16879271|NCT01456130|37860185|FG000|Overall Study|Adverse Event|4|||
16879272|NCT01456130|37860185|FG000|Overall Study|Voluntary Withdrawal|1|||
16879273|NCT01456130|37860185|FG000|Overall Study|Lack of Efficacy|4|||
16879274|NCT01456130|37860185|FG000|Overall Study|Other|1|||
16879275|NCT01456052|37860192|FG000|Overall Study|Adverse Event|1|||
16879276|NCT01456052|37860193|FG001|Overall Study|Adverse Event|1|||
16879277|NCT01456052|37860194|FG002|Overall Study|Adverse Event|2|||
16879278|NCT01456052|37860192|FG000|Overall Study|Consent withdrawn|0|||
16879279|NCT01456052|37860193|FG001|Overall Study|Consent withdrawn|2|||
16879280|NCT01456052|37860194|FG002|Overall Study|Consent withdrawn|1|||
16879281|NCT01456052|37860192|FG000|Overall Study|Protocol Violation|0|||
16879282|NCT01456052|37860193|FG001|Overall Study|Protocol Violation|1|||
16879283|NCT01456052|37860194|FG002|Overall Study|Protocol Violation|0|||
16879284|NCT01456052|37860192|FG000|Overall Study|Physician Decision|1|||
16879285|NCT01456052|37860193|FG001|Overall Study|Physician Decision|0|||
16879286|NCT01456052|37860194|FG002|Overall Study|Physician Decision|1|||
16879287|NCT01456052|37860192|FG000|Overall Study|Treatment Failure|0|||
16879288|NCT01456052|37860193|FG001|Overall Study|Treatment Failure|1|||
16879289|NCT01456052|37860194|FG002|Overall Study|Treatment Failure|1|||
16879290|NCT01387607|37860205|FG000|Overall Study|Adverse Event|23|||
16879291|NCT01387607|37860206|FG001|Overall Study|Adverse Event|11|||
16879292|NCT01387607|37860205|FG000|Overall Study|Lack of Efficacy|8|||
16879293|NCT01387607|37860206|FG001|Overall Study|Lack of Efficacy|6|||
16879294|NCT01387607|37860205|FG000|Overall Study|Lost to Follow-up|2|||
16879295|NCT01387607|37860206|FG001|Overall Study|Lost to Follow-up|1|||
16879296|NCT01387607|37860205|FG000|Overall Study|No longer meets eligibility criteria|0|||
16879297|NCT01387607|37860206|FG001|Overall Study|No longer meets eligibility criteria|1|||
17002107|NCT00846027|38146209|FG000|Overall Study|Patient Decision|7|||
16879298|NCT01387607|37860205|FG000|Overall Study|Protocol Violation|1|||
16879299|NCT01387607|37860206|FG001|Overall Study|Protocol Violation|5|||
16879300|NCT01387607|37860205|FG000|Overall Study|Withdrawal by Subject|13|||
16879301|NCT01387607|37860206|FG001|Overall Study|Withdrawal by Subject|14|||
16879302|NCT01387607|37860205|FG000|Overall Study|Other|1|||
16879303|NCT01387607|37860206|FG001|Overall Study|Other|1|||
16879304|NCT01387607|37860205|FG000|Overall Study|Randomized, not treated|3|||
16879305|NCT01387607|37860206|FG001|Overall Study|Randomized, not treated|6|||
16879306|NCT03451045|37860215|FG000|Overall Study|Lack of Efficacy|3|||
16879307|NCT03451045|37860216|FG001|Overall Study|Lack of Efficacy|2|||
16879308|NCT03451045|37860217|FG002|Overall Study|Lack of Efficacy|2|||
16879309|NCT03451045|37860215|FG000|Overall Study|Physician Decision|1|||
16879310|NCT03451045|37860216|FG001|Overall Study|Physician Decision|1|||
16879311|NCT03451045|37860217|FG002|Overall Study|Physician Decision|1|||
16879312|NCT03451045|37860215|FG000|Overall Study|Withdrawal by Subject|4|||
16879313|NCT03451045|37860216|FG001|Overall Study|Withdrawal by Subject|0|||
16879314|NCT03451045|37860217|FG002|Overall Study|Withdrawal by Subject|5|||
16879315|NCT03451045|37860215|FG000|Overall Study|Pregnancy|0|||
16785549|NCT02657369|37725663|FG000|Overall Study|Study terminated by sponsor|7|||
16785550|NCT02701777|37725671|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
16879316|NCT03451045|37860216|FG001|Overall Study|Pregnancy|0|||
16879317|NCT03451045|37860217|FG002|Overall Study|Pregnancy|2|||
16879318|NCT03451045|37860215|FG000|Overall Study|Adverse Event|7|||
16879319|NCT03451045|37860216|FG001|Overall Study|Adverse Event|1|||
16879320|NCT03451045|37860217|FG002|Overall Study|Adverse Event|3|||
16879321|NCT03451045|37860215|FG000|Overall Study|Non-compliance with study|2|||
16879322|NCT03451045|37860216|FG001|Overall Study|Non-compliance with study|0|||
16879323|NCT03451045|37860217|FG002|Overall Study|Non-compliance with study|1|||
16879324|NCT03451045|37860215|FG000|Overall Study|any other reason|10|||
16879325|NCT03451045|37860216|FG001|Overall Study|any other reason|2|||
16879326|NCT03451045|37860217|FG002|Overall Study|any other reason|13|||
16879327|NCT03219567|37860228|FG000|Overall Study|Withdrawal by Subject|0|||
16879328|NCT03219567|37860229|FG001|Overall Study|Withdrawal by Subject|1|||
16879329|NCT01386125|37860238|FG000|Overall Study|Lost to Follow-up|3|||
16879330|NCT01386125|37860239|FG001|Overall Study|Lost to Follow-up|9|||
16879331|NCT01386125|37860238|FG000|Overall Study|Physician Decision|0|||
16879332|NCT01386125|37860239|FG001|Overall Study|Physician Decision|1|||
16879333|NCT01386125|37860238|FG000|Overall Study|Protocol Violation|5|||
16879334|NCT01386125|37860239|FG001|Overall Study|Protocol Violation|7|||
16879335|NCT01386125|37860238|FG000|Overall Study|Disease Progress|1|||
16879336|NCT01386125|37860239|FG001|Overall Study|Disease Progress|2|||
16879337|NCT01386125|37860238|FG000|Overall Study|Withdrawal by Subject|13|||
16879338|NCT01386125|37860239|FG001|Overall Study|Withdrawal by Subject|12|||
16879339|NCT01386125|37860238|FG000|Overall Study|Adverse Event|2|||
16879340|NCT01386125|37860239|FG001|Overall Study|Adverse Event|5|||
16879341|NCT01386125|37860238|FG000|Overall Study|Lack of Efficacy|0|||
16879342|NCT01386125|37860239|FG001|Overall Study|Lack of Efficacy|1|||
16879343|NCT01386125|37860238|FG000|Overall Study|Participant Leaving Country|1|||
16879344|NCT01386125|37860239|FG001|Overall Study|Participant Leaving Country|0|||
16879345|NCT01384877|37860247|FG000|Treatment 2|Lost to Follow-up|2|||
16879346|NCT01384877|37860248|FG001|Treatment 2|Lost to Follow-up|2|||
16879347|NCT00114517|37860258|FG000|Overall Study|Adverse Event|6|||
16879348|NCT00114517|37860259|FG001|Overall Study|Adverse Event|1|||
16879349|NCT00114517|37860260|FG002|Overall Study|Adverse Event|6|||
16785551|NCT02701777|37725672|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
16785552|NCT02701777|37725673|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
16785553|NCT02701777|37725674|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
16785554|NCT02701777|37725671|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
16785555|NCT02701777|37725672|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
16785556|NCT02701777|37725673|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
16785557|NCT02701777|37725674|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
16785558|NCT01675661|37725690|FG000|Overall Study|Lost to Follow-up|22|||
16785559|NCT01675661|37725691|FG001|Overall Study|Lost to Follow-up|23|||
16785560|NCT01675661|37725690|FG000|Overall Study|Practical problems|9|||
16785561|NCT01675661|37725691|FG001|Overall Study|Practical problems|5|||
16785562|NCT01675661|37725690|FG000|Overall Study|Moved away|5|||
16785563|NCT01675661|37725691|FG001|Overall Study|Moved away|6|||
16785564|NCT01675661|37725690|FG000|Overall Study|Withdrawal by Subject|3|||
16785565|NCT01675661|37725691|FG001|Overall Study|Withdrawal by Subject|7|||
16785566|NCT01675661|37725690|FG000|Overall Study|Physician Decision|0|||
16879350|NCT00114517|37860261|FG003|Overall Study|Adverse Event|3|||
16879351|NCT00114517|37860258|FG000|Overall Study|Lost to Follow-up|2|||
16879352|NCT00114517|37860259|FG001|Overall Study|Lost to Follow-up|2|||
16879353|NCT00114517|37860260|FG002|Overall Study|Lost to Follow-up|2|||
16879354|NCT00114517|37860261|FG003|Overall Study|Lost to Follow-up|1|||
16879355|NCT00114517|37860258|FG000|Overall Study|Too busy|3|||
16879356|NCT00114517|37860259|FG001|Overall Study|Too busy|1|||
16879357|NCT00114517|37860260|FG002|Overall Study|Too busy|1|||
16879358|NCT00114517|37860261|FG003|Overall Study|Too busy|2|||
16879359|NCT00114517|37860258|FG000|Overall Study|Moved from area|0|||
16879360|NCT00114517|37860259|FG001|Overall Study|Moved from area|3|||
16879361|NCT00114517|37860260|FG002|Overall Study|Moved from area|2|||
16879362|NCT00114517|37860261|FG003|Overall Study|Moved from area|1|||
16879363|NCT00114517|37860258|FG000|Overall Study|Did not want estradiol|1|||
16879364|NCT00114517|37860259|FG001|Overall Study|Did not want estradiol|1|||
16879365|NCT00114517|37860260|FG002|Overall Study|Did not want estradiol|0|||
16879366|NCT00114517|37860261|FG003|Overall Study|Did not want estradiol|0|||
16879367|NCT00114517|37860258|FG000|Overall Study|Armed-services duty|0|||
16879368|NCT00114517|37860259|FG001|Overall Study|Armed-services duty|1|||
16879369|NCT00114517|37860260|FG002|Overall Study|Armed-services duty|0|||
16879370|NCT00114517|37860261|FG003|Overall Study|Armed-services duty|1|||
16879371|NCT00114517|37860258|FG000|Overall Study|Competing family issue|0|||
16879372|NCT00114517|37860259|FG001|Overall Study|Competing family issue|1|||
16879373|NCT00114517|37860260|FG002|Overall Study|Competing family issue|0|||
16879374|NCT00114517|37860261|FG003|Overall Study|Competing family issue|1|||
16879375|NCT00114517|37860258|FG000|Overall Study|Physician Decision|0|||
16879376|NCT00114517|37860259|FG001|Overall Study|Physician Decision|1|||
16879377|NCT00114517|37860260|FG002|Overall Study|Physician Decision|0|||
16879378|NCT00114517|37860261|FG003|Overall Study|Physician Decision|0|||
16879379|NCT00114517|37860258|FG000|Overall Study|Lost interest|0|||
16879380|NCT00114517|37860259|FG001|Overall Study|Lost interest|0|||
16879381|NCT00114517|37860260|FG002|Overall Study|Lost interest|1|||
16879382|NCT00114517|37860261|FG003|Overall Study|Lost interest|0|||
16879383|NCT00114517|37860258|FG000|Overall Study|Weight increase|0|||
16879384|NCT00114517|37860259|FG001|Overall Study|Weight increase|0|||
16879385|NCT00114517|37860260|FG002|Overall Study|Weight increase|1|||
16879386|NCT00114517|37860261|FG003|Overall Study|Weight increase|0|||
16879387|NCT00114517|37860258|FG000|Overall Study|Concern about blood clots|0|||
16879388|NCT00114517|37860259|FG001|Overall Study|Concern about blood clots|0|||
16879389|NCT00114517|37860260|FG002|Overall Study|Concern about blood clots|1|||
16879390|NCT00114517|37860261|FG003|Overall Study|Concern about blood clots|0|||
16879391|NCT00114517|37860258|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
16879392|NCT00114517|37860259|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
16879393|NCT00114517|37860260|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
16879394|NCT00114517|37860261|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
16879395|NCT01384019|37860269|FG000|Overall Study|Withdrawal by Subject|3|||
16879396|NCT01384019|37860270|FG001|Overall Study|Withdrawal by Subject|0|||
16879397|NCT01384019|37860269|FG000|Overall Study|Death|1|||
16879398|NCT01384019|37860270|FG001|Overall Study|Death|0|||
16879399|NCT01384019|37860269|FG000|Overall Study|MRI refusal|6|||
16879400|NCT01384019|37860270|FG001|Overall Study|MRI refusal|6|||
16879401|NCT00033631|37860278|FG000|Overall Study|Protocol Violation|14|||
16879402|NCT00033631|37860279|FG001|Overall Study|Protocol Violation|11|||
16879403|NCT00033631|37860278|FG000|Overall Study|Withdrawal by Subject|4|||
16879404|NCT00033631|37860279|FG001|Overall Study|Withdrawal by Subject|4|||
16879405|NCT01471574|37860290|FG000|Treatment Period|Lack of Efficacy|12|||
16879406|NCT01471574|37860291|FG001|Treatment Period|Lack of Efficacy|4|||
16879407|NCT01471574|37860292|FG002|Treatment Period|Lack of Efficacy|14|||
16879408|NCT01471574|37860293|FG003|Treatment Period|Lack of Efficacy|1|||
16879409|NCT01471574|37860290|FG000|Treatment Period|Adverse Event|7|||
16879410|NCT01471574|37860291|FG001|Treatment Period|Adverse Event|3|||
16879411|NCT01471574|37860292|FG002|Treatment Period|Adverse Event|6|||
16879412|NCT01471574|37860293|FG003|Treatment Period|Adverse Event|1|||
16879413|NCT01471574|37860290|FG000|Treatment Period|Withdrawal by Subject|5|||
17191686|NCT00862251|38344495|FG002|Overall Study|Protocol Violation|1|||
17191687|NCT00862251|38344493|FG000|Overall Study|Withdrawal by Subject|9|||
17191688|NCT00862251|38344494|FG001|Overall Study|Withdrawal by Subject|2|||
17191689|NCT00862251|38344495|FG002|Overall Study|Withdrawal by Subject|6|||
17191690|NCT02864381|38344524|FG000|Overall Study|Death|58|||
17191691|NCT02864381|38344525|FG001|Overall Study|Death|61|||
17191692|NCT02864381|38344524|FG000|Overall Study|Withdrew Consent|5|||
17191693|NCT02864381|38344525|FG001|Overall Study|Withdrew Consent|6|||
17191694|NCT02864381|38344524|FG000|Overall Study|Reason Unknown|7|||
17191695|NCT02864381|38344525|FG001|Overall Study|Reason Unknown|3|||
17191696|NCT02864381|38344524|FG000|Overall Study|Lost to Follow-up|1|||
17191697|NCT02864381|38344525|FG001|Overall Study|Lost to Follow-up|1|||
17191698|NCT02864381|38344524|FG000|Overall Study|Investigator's Discretion|1|||
17191699|NCT02864381|38344525|FG001|Overall Study|Investigator's Discretion|0|||
17191700|NCT02864381|38344524|FG000|Overall Study|Protocol Violation|0|||
17191701|NCT02864381|38344525|FG001|Overall Study|Protocol Violation|1|||
17191702|NCT02860169|38344533|FG000|Part A|Withdrawal by Subject|1|||
17191703|NCT02860169|38344533|FG000|Part A|Other (Screening failure)|6|||
17191704|NCT02860169|38344533|FG000|Part A|Other (Survey not completed)|3|||
17191705|NCT02860169|38344533|FG000|Part A|Other (did not completed consent)|1|||
17191706|NCT02860169|38344533|FG000|Part B|Other (Screening failure)|10|||
16879414|NCT01471574|37860291|FG001|Treatment Period|Withdrawal by Subject|1|||
16879415|NCT01471574|37860292|FG002|Treatment Period|Withdrawal by Subject|1|||
16879416|NCT01471574|37860293|FG003|Treatment Period|Withdrawal by Subject|0|||
17191707|NCT02860169|38344533|FG000|Part B|Withdrawal by Subject|1|||
17191708|NCT02860169|38344533|FG000|Part C|Other (Screening failure)|1|||
16879417|NCT01471574|37860290|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
16879418|NCT01471574|37860291|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
16879419|NCT01471574|37860292|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
16879420|NCT01471574|37860293|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
16879421|NCT01471574|37860290|FG000|Treatment Period|Lost to Follow-up|1|||
16879422|NCT01471574|37860291|FG001|Treatment Period|Lost to Follow-up|2|||
16879423|NCT01471574|37860292|FG002|Treatment Period|Lost to Follow-up|2|||
16879424|NCT01471574|37860293|FG003|Treatment Period|Lost to Follow-up|0|||
16879425|NCT01471574|37860290|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
16879426|NCT01471574|37860291|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
16879427|NCT01471574|37860292|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
16879428|NCT01471574|37860293|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
16879429|NCT01471574|37860290|FG000|Treatment Period|Other|1|||
16879430|NCT01471574|37860291|FG001|Treatment Period|Other|0|||
16879431|NCT01471574|37860292|FG002|Treatment Period|Other|0|||
16879432|NCT01471574|37860293|FG003|Treatment Period|Other|0|||
16879433|NCT01471574|37860290|FG000|Follow-up Period|Withdrawal by Subject|3|||
16879434|NCT01471574|37860291|FG001|Follow-up Period|Withdrawal by Subject|0|||
16879435|NCT01471574|37860292|FG002|Follow-up Period|Withdrawal by Subject|3|||
16879436|NCT01471574|37860293|FG003|Follow-up Period|Withdrawal by Subject|1|||
16879437|NCT01471574|37860290|FG000|Follow-up Period|Lost to Follow-up|4|||
16879438|NCT01471574|37860291|FG001|Follow-up Period|Lost to Follow-up|1|||
16879439|NCT01471574|37860292|FG002|Follow-up Period|Lost to Follow-up|3|||
16879440|NCT01471574|37860293|FG003|Follow-up Period|Lost to Follow-up|2|||
16879441|NCT01471574|37860290|FG000|Follow-up Period|Death|0|||
16879442|NCT01471574|37860291|FG001|Follow-up Period|Death|0|||
16879443|NCT01471574|37860292|FG002|Follow-up Period|Death|1|||
16879444|NCT01471574|37860293|FG003|Follow-up Period|Death|0|||
16879445|NCT01471574|37860290|FG000|Follow-up Period|Follow-up no longer required|0|||
16879446|NCT01471574|37860291|FG001|Follow-up Period|Follow-up no longer required|1|||
16879447|NCT01471574|37860292|FG002|Follow-up Period|Follow-up no longer required|0|||
16879448|NCT01471574|37860293|FG003|Follow-up Period|Follow-up no longer required|0|||
16879449|NCT01383707|37860309|FG000|Overall Study|Consent withdrawal|6|||
16879450|NCT01383707|37860309|FG000|Overall Study|Death|19|||
16879451|NCT01383707|37860309|FG000|Overall Study|Other|8|||
16879452|NCT01383707|37860309|FG000|Overall Study|Sponsor's decision|2|||
16879453|NCT01383707|37860309|FG000|Overall Study|Adverse Event|14|||
16879454|NCT01383707|37860309|FG000|Overall Study|Progressive disease|23|||
16879455|NCT01383317|37860315|FG000|Overall Study|Lost to Follow-up|2|||
16879456|NCT01383317|37860316|FG001|Overall Study|Lost to Follow-up|1|||
16879457|NCT01383317|37860315|FG000|Overall Study|Death|1|||
16879458|NCT01383317|37860316|FG001|Overall Study|Death|0|||
16879459|NCT01383317|37860315|FG000|Overall Study|Adverse Event|0|||
16879460|NCT01383317|37860316|FG001|Overall Study|Adverse Event|1|||
16879461|NCT01455428|37860324|FG000|Overall Study|Protocol Violation|2|||
16879462|NCT01455428|37860325|FG001|Overall Study|Protocol Violation|1|||
16879463|NCT01455428|37860324|FG000|Overall Study|Adverse Event|6|||
16879464|NCT01455428|37860325|FG001|Overall Study|Adverse Event|2|||
16879465|NCT01455428|37860324|FG000|Overall Study|Lost to Follow-up|1|||
16879466|NCT01455428|37860325|FG001|Overall Study|Lost to Follow-up|1|||
16879467|NCT01455428|37860324|FG000|Overall Study|Withdrawal by Subject|2|||
16879468|NCT01455428|37860325|FG001|Overall Study|Withdrawal by Subject|5|||
16879469|NCT01455428|37860324|FG000|Overall Study|Did not meet entrance criteria|0|||
16879470|NCT01455428|37860325|FG001|Overall Study|Did not meet entrance criteria|2|||
16879471|NCT01455428|37860324|FG000|Overall Study|Insufficient clinical response|0|||
16879472|NCT01455428|37860325|FG001|Overall Study|Insufficient clinical response|2|||
16879473|NCT01455428|37860324|FG000|Overall Study|Did not receive treatment|1|||
16879474|NCT01455428|37860325|FG001|Overall Study|Did not receive treatment|1|||
16879475|NCT01455428|37860324|FG000|Overall Study|Other|2|||
16879476|NCT01455428|37860325|FG001|Overall Study|Other|4|||
16879477|NCT01383161|37860333|FG000|Overall Study|Adverse Event|5|||
16879478|NCT01383161|37860334|FG001|Overall Study|Adverse Event|1|||
16879479|NCT01383161|37860333|FG000|Overall Study|Withdrawal by Subject|0|||
16879480|NCT01383161|37860334|FG001|Overall Study|Withdrawal by Subject|2|||
16879481|NCT01383161|37860333|FG000|Overall Study|Lack of Efficacy|0|||
16879482|NCT01383161|37860334|FG001|Overall Study|Lack of Efficacy|1|||
16879483|NCT01382225|37860360|FG000|Overall Study|Adverse Event|3|||
16879484|NCT01382225|37860361|FG001|Overall Study|Adverse Event|2|||
16879485|NCT01382225|37860360|FG000|Overall Study|Protocol Violation|2|||
16879486|NCT01382225|37860361|FG001|Overall Study|Protocol Violation|1|||
16879487|NCT01382225|37860360|FG000|Overall Study|Subject Withdrew Consent|5|||
16879488|NCT01382225|37860361|FG001|Overall Study|Subject Withdrew Consent|2|||
16879489|NCT01382225|37860360|FG000|Overall Study|Other|4|||
16879490|NCT01382225|37860361|FG001|Overall Study|Other|2|||
16879491|NCT01381679|37860367|FG000|Overall Study|Adverse Event|3|||
16879492|NCT01381679|37860367|FG000|Overall Study|Lost to Follow-up|885|||
16879493|NCT01455194|37860374|FG000|Overall Study|Screen Failure|20|||
16879494|NCT01455194|37860375|FG001|Overall Study|Screen Failure|0|||
16879495|NCT01455194|37860376|FG002|Overall Study|Screen Failure|0|||
16879496|NCT01455194|37860377|FG003|Overall Study|Screen Failure|0|||
16879497|NCT01455194|37860374|FG000|Overall Study|Randomisation Failure|90|||
16879498|NCT01455194|37860375|FG001|Overall Study|Randomisation Failure|0|||
16879499|NCT01455194|37860376|FG002|Overall Study|Randomisation Failure|0|||
16879500|NCT01455194|37860377|FG003|Overall Study|Randomisation Failure|0|||
16879501|NCT01455194|37860374|FG000|Overall Study|Deterioration in asthma|12|||
16879502|NCT01455194|37860375|FG001|Overall Study|Deterioration in asthma|6|||
16879503|NCT01455194|37860376|FG002|Overall Study|Deterioration in asthma|14|||
16879504|NCT01455194|37860377|FG003|Overall Study|Deterioration in asthma|9|||
16879505|NCT01455194|37860374|FG000|Overall Study|Adverse Event|1|||
16879506|NCT01455194|37860375|FG001|Overall Study|Adverse Event|1|||
16879507|NCT01455194|37860376|FG002|Overall Study|Adverse Event|1|||
16879508|NCT01455194|37860377|FG003|Overall Study|Adverse Event|3|||
16879509|NCT01455194|37860374|FG000|Overall Study|Withdrawal by Subject|21|||
16879510|NCT01455194|37860375|FG001|Overall Study|Withdrawal by Subject|16|||
16879511|NCT01455194|37860376|FG002|Overall Study|Withdrawal by Subject|12|||
16879512|NCT01455194|37860377|FG003|Overall Study|Withdrawal by Subject|9|||
16879513|NCT01455194|37860374|FG000|Overall Study|Lost to Follow-up|2|||
16879514|NCT01455194|37860375|FG001|Overall Study|Lost to Follow-up|0|||
16879515|NCT01455194|37860376|FG002|Overall Study|Lost to Follow-up|1|||
16879516|NCT01455194|37860377|FG003|Overall Study|Lost to Follow-up|1|||
16879517|NCT01455194|37860374|FG000|Overall Study|Pregnancy|0|||
16879518|NCT01455194|37860375|FG001|Overall Study|Pregnancy|1|||
16879519|NCT01455194|37860376|FG002|Overall Study|Pregnancy|1|||
16879520|NCT01455194|37860377|FG003|Overall Study|Pregnancy|0|||
16879521|NCT01455194|37860374|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
16879522|NCT01455194|37860375|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
16879523|NCT01455194|37860376|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
16879524|NCT01455194|37860377|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
16879525|NCT01455194|37860374|FG000|Overall Study|Miscellaneous|4|||
16879526|NCT01455194|37860375|FG001|Overall Study|Miscellaneous|5|||
16879527|NCT01455194|37860376|FG002|Overall Study|Miscellaneous|1|||
16879528|NCT01455194|37860377|FG003|Overall Study|Miscellaneous|4|||
16879529|NCT01454726|37860401|FG000|Overall Study|Withdrawal by Subject|0|||
16879530|NCT01454726|37860402|FG001|Overall Study|Withdrawal by Subject|1|||
16879531|NCT01361568|37860414|FG000|Overall Study|Adverse Event|0|||
16879532|NCT01361568|37860415|FG001|Overall Study|Adverse Event|0|||
16879533|NCT01361568|37860416|FG002|Overall Study|Adverse Event|0|||
16879534|NCT01361568|37860417|FG003|Overall Study|Adverse Event|0|||
16879535|NCT01361568|37860418|FG004|Overall Study|Adverse Event|1|||
16879536|NCT01361568|37860419|FG005|Overall Study|Adverse Event|0|||
16879537|NCT01361568|37860414|FG000|Overall Study|Physician Decision|0|||
16879538|NCT01361568|37860415|FG001|Overall Study|Physician Decision|0|||
16879539|NCT01361568|37860416|FG002|Overall Study|Physician Decision|0|||
16879540|NCT01361568|37860417|FG003|Overall Study|Physician Decision|0|||
16879541|NCT01361568|37860418|FG004|Overall Study|Physician Decision|0|||
16879542|NCT01361568|37860419|FG005|Overall Study|Physician Decision|1|||
16879543|NCT01361568|37860414|FG000|Overall Study|Withdrawal by Subject|2|||
16879544|NCT01361568|37860415|FG001|Overall Study|Withdrawal by Subject|1|||
16879545|NCT01361568|37860416|FG002|Overall Study|Withdrawal by Subject|0|||
16879546|NCT01361568|37860417|FG003|Overall Study|Withdrawal by Subject|0|||
16879547|NCT01361568|37860418|FG004|Overall Study|Withdrawal by Subject|0|||
16879548|NCT01361568|37860419|FG005|Overall Study|Withdrawal by Subject|1|||
16879549|NCT03084367|37860434|FG000|Overall Study|Lost to Follow-up|32|||
16879550|NCT03084367|37860434|FG000|Overall Study|Withdrawal by Subject|4|||
16879551|NCT03084367|37860434|FG000|Overall Study|Other|1|||
16879552|NCT01454570|37860447|FG000|Overall Study|Withdrawal by Subject|2|||
16879553|NCT01454570|37860447|FG000|Overall Study|Screen Failure|7|||
16879554|NCT01494350|37860460|FG000|Overall Study|Worsening of lesion|1|||
16879555|NCT03281629|37860470|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
16879556|NCT03281629|37860471|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
16879557|NCT03281629|37860470|FG000|Overall Study|Death|0|||
16879558|NCT03281629|37860471|FG001|Overall Study|Death|1|||
16879559|NCT03281629|37860470|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
16785567|NCT01675661|37725691|FG001|Overall Study|Physician Decision|2|||
16879560|NCT03281629|37860471|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
16879561|NCT00218543|37860477|FG000|Overall Study|Lost to Follow-up|8|||
16879562|NCT00218543|37860477|FG000|Overall Study|relocated|1|||
16879563|NCT00218543|37860477|FG000|Overall Study|Withdrawal by Subject|1|||
16785568|NCT01675661|37725690|FG000|Overall Study|Death|0|||
16785569|NCT01675661|37725691|FG001|Overall Study|Death|1|||
16785570|NCT01675661|37725690|FG000|Overall Study|Other reason|1|||
16785571|NCT01675661|37725691|FG001|Overall Study|Other reason|2|||
16785572|NCT01602341|37725699|FG000|Overall Study|Adverse Event|0|||
16785573|NCT01602341|37725700|FG001|Overall Study|Adverse Event|1|||
16785574|NCT02700919|37725713|FG000|Overall Study|Physician Decision|1|||
16785575|NCT02700919|37725714|FG001|Overall Study|Physician Decision|0|||
16879564|NCT00218543|37860477|FG000|Overall Study|Physician Decision|3|||
16879565|NCT00218543|37860477|FG000|Overall Study|Adverse Event|2|||
16879566|NCT00216671|37860492|FG000|Overall Study|Adverse Event|4|||
16879567|NCT00216671|37860493|FG001|Overall Study|Adverse Event|9|||
16879568|NCT00216671|37860492|FG000|Overall Study|Pregnancy|0|||
16879569|NCT00216671|37860493|FG001|Overall Study|Pregnancy|1|||
16879570|NCT00216671|37860492|FG000|Overall Study|Withdrawal by Subject|4|||
16879571|NCT00216671|37860493|FG001|Overall Study|Withdrawal by Subject|2|||
16879572|NCT00216671|37860492|FG000|Overall Study|Refused Injections|3|||
16879573|NCT00216671|37860493|FG001|Overall Study|Refused Injections|13|||
16879574|NCT00216671|37860492|FG000|Overall Study|No Need to Continue Medication|1|||
16879575|NCT00216671|37860493|FG001|Overall Study|No Need to Continue Medication|1|||
16879576|NCT00216671|37860492|FG000|Overall Study|Insufficient Response|9|||
16879577|NCT00216671|37860493|FG001|Overall Study|Insufficient Response|4|||
16879578|NCT00216671|37860492|FG000|Overall Study|Lost to Follow-up|3|||
16879579|NCT00216671|37860493|FG001|Overall Study|Lost to Follow-up|5|||
16879580|NCT00216671|37860492|FG000|Overall Study|Non compliant|2|||
16879581|NCT00216671|37860493|FG001|Overall Study|Non compliant|2|||
16879582|NCT00216671|37860492|FG000|Overall Study|Ineligible|0|||
16879583|NCT00216671|37860493|FG001|Overall Study|Ineligible|2|||
16879584|NCT00216671|37860492|FG000|Overall Study|Physician Decision|1|||
16879585|NCT00216671|37860493|FG001|Overall Study|Physician Decision|1|||
16879586|NCT00216671|37860492|FG000|Overall Study|Protocol Violation|3|||
16879587|NCT00216671|37860493|FG001|Overall Study|Protocol Violation|5|||
16879588|NCT00216671|37860492|FG000|Overall Study|Relapse|1|||
16879589|NCT00216671|37860493|FG001|Overall Study|Relapse|0|||
16879590|NCT00216671|37860492|FG000|Overall Study|Investigator Illness|0|||
16879591|NCT00216671|37860493|FG001|Overall Study|Investigator Illness|1|||
16879592|NCT00216671|37860492|FG000|Overall Study|Patient Moved|0|||
16879593|NCT00216671|37860493|FG001|Overall Study|Patient Moved|1|||
16879594|NCT00216671|37860492|FG000|Overall Study|Ineligible, no efficacy data|2|||
16879595|NCT00216671|37860493|FG001|Overall Study|Ineligible, no efficacy data|2|||
16879596|NCT00216671|37860492|FG000|Overall Study|Insufficient Response Adverse Event|2|||
16879597|NCT00216671|37860493|FG001|Overall Study|Insufficient Response Adverse Event|1|||
16879598|NCT00216203|37860499|FG000|Overall Study|Withdrawal by Subject|2|||
16879599|NCT02644668|37860525|FG000|Overall Study|Adverse Event|2|||
16879600|NCT02644668|37860526|FG001|Overall Study|Adverse Event|0|||
16879601|NCT02644668|37860527|FG002|Overall Study|Adverse Event|1|||
16879602|NCT02644668|37860525|FG000|Overall Study|Protocol Violation|0|||
16879603|NCT02644668|37860526|FG001|Overall Study|Protocol Violation|0|||
16879604|NCT02644668|37860527|FG002|Overall Study|Protocol Violation|1|||
16879605|NCT02644668|37860525|FG000|Overall Study|Withdrawal by Subject|0|||
16879606|NCT02644668|37860526|FG001|Overall Study|Withdrawal by Subject|0|||
16879607|NCT02644668|37860527|FG002|Overall Study|Withdrawal by Subject|1|||
16879608|NCT04115293|37860548|FG000|Overall Study|Adverse Event|0|||
16879609|NCT04115293|37860549|FG001|Overall Study|Adverse Event|2|||
16879610|NCT04115293|37860548|FG000|Overall Study|Withdrawal by Subject|2|||
16879611|NCT04115293|37860549|FG001|Overall Study|Withdrawal by Subject|1|||
16879612|NCT04115293|37860548|FG000|Overall Study|Physician Decision|1|||
16879613|NCT04115293|37860549|FG001|Overall Study|Physician Decision|0|||
16879614|NCT04115293|37860548|FG000|Overall Study|Death|1|||
16879615|NCT04115293|37860549|FG001|Overall Study|Death|1|||
16879616|NCT02644356|37860555|FG000|Overall Study|Withdrawal by Subject|2|||
16879617|NCT01494038|37860596|FG000|Overall Study|Protocol Violation|1|||
16879618|NCT01494038|37860597|FG001|Overall Study|Protocol Violation|1|||
16879619|NCT01494038|37860596|FG000|Overall Study|Lost to Follow-up|18|||
16879620|NCT01494038|37860597|FG001|Overall Study|Lost to Follow-up|20|||
16879621|NCT01494038|37860596|FG000|Overall Study|Withdrawal by Subject|44|||
16879622|NCT01494038|37860597|FG001|Overall Study|Withdrawal by Subject|34|||
16879623|NCT01494038|37860596|FG000|Overall Study|Not able to get to clinic|21|||
16879624|NCT01494038|37860597|FG001|Overall Study|Not able to get to clinic|15|||
16879625|NCT01494038|37860596|FG000|Overall Study|Not willing to adhere to reqs|2|||
16879626|NCT01494038|37860597|FG001|Overall Study|Not willing to adhere to reqs|9|||
16879627|NCT01494038|37860596|FG000|Overall Study|Death|2|||
16879628|NCT01494038|37860597|FG001|Overall Study|Death|4|||
16879629|NCT02640612|37860634|FG000|Overall Study|Adverse Event|6|||
16879630|NCT02640612|37860635|FG001|Overall Study|Adverse Event|7|||
16879631|NCT02640612|37860636|FG002|Overall Study|Adverse Event|2|||
16879632|NCT02640612|37860634|FG000|Overall Study|Death|1|||
16879633|NCT02640612|37860635|FG001|Overall Study|Death|0|||
16879634|NCT02640612|37860636|FG002|Overall Study|Death|0|||
16879635|NCT02640612|37860634|FG000|Overall Study|Withdrawal by Subject|10|||
16879636|NCT02640612|37860635|FG001|Overall Study|Withdrawal by Subject|3|||
16879637|NCT02640612|37860636|FG002|Overall Study|Withdrawal by Subject|3|||
16879638|NCT02640612|37860634|FG000|Overall Study|Lost to Follow-up|4|||
16879639|NCT02640612|37860635|FG001|Overall Study|Lost to Follow-up|1|||
16879640|NCT02640612|37860636|FG002|Overall Study|Lost to Follow-up|1|||
16879641|NCT02640612|37860634|FG000|Overall Study|Protocol Violation|0|||
16879642|NCT02640612|37860635|FG001|Overall Study|Protocol Violation|2|||
16879643|NCT02640612|37860636|FG002|Overall Study|Protocol Violation|0|||
16879644|NCT02640612|37860634|FG000|Overall Study|Lack of Efficacy|1|||
16879645|NCT02640612|37860635|FG001|Overall Study|Lack of Efficacy|1|||
16879646|NCT02640612|37860636|FG002|Overall Study|Lack of Efficacy|0|||
16879647|NCT00639769|37860644|FG000|Overall Study|Death|2|||
16879648|NCT00639769|37860644|FG000|Overall Study|Adverse Event|7|||
16879649|NCT00639769|37860644|FG000|Overall Study|Lack of Efficacy|1|||
16879650|NCT00639769|37860644|FG000|Overall Study|Disease progression|26|||
16879651|NCT00639769|37860644|FG000|Overall Study|Withdrawal by Subject|4|||
16879652|NCT00639457|37860650|FG000|Overall Study|Withdrawal by Subject|2|||
16879653|NCT00639457|37860651|FG001|Overall Study|Withdrawal by Subject|3|||
16879654|NCT00639379|37860657|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
16879655|NCT00639379|37860658|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
16879656|NCT00639379|37860657|FG000|Period 1 - 2 Weeks|lens issue|3|||
16879657|NCT00639379|37860658|FG001|Period 1 - 2 Weeks|lens issue|0|||
16879658|NCT00639223|37860666|FG000|Overall Study|Lost to Follow-up|0|||
16879659|NCT00639223|37860667|FG001|Overall Study|Lost to Follow-up|2|||
16879660|NCT00638989|37860676|FG000|Overall Study|Lost to Follow-up|0|||
16879661|NCT00638989|37860677|FG001|Overall Study|Lost to Follow-up|0|||
16879662|NCT00638989|37860678|FG002|Overall Study|Lost to Follow-up|1|||
16879663|NCT00637273|37860699|FG000|Overall Study|Adverse Event|11|||
16879664|NCT00637273|37860700|FG001|Overall Study|Adverse Event|5|||
16879665|NCT00637273|37860701|FG002|Overall Study|Adverse Event|7|||
16879666|NCT00637273|37860699|FG000|Overall Study|Lost to Follow-up|8|||
16879667|NCT00637273|37860700|FG001|Overall Study|Lost to Follow-up|9|||
16879668|NCT00637273|37860701|FG002|Overall Study|Lost to Follow-up|13|||
16879669|NCT00637273|37860699|FG000|Overall Study|Protocol Violation|2|||
16879670|NCT00637273|37860700|FG001|Overall Study|Protocol Violation|4|||
16879671|NCT00637273|37860701|FG002|Overall Study|Protocol Violation|1|||
16879672|NCT00637273|37860699|FG000|Overall Study|Withdrawal of Consent|18|||
16879673|NCT00637273|37860700|FG001|Overall Study|Withdrawal of Consent|6|||
16879674|NCT00637273|37860701|FG002|Overall Study|Withdrawal of Consent|18|||
16879675|NCT00637273|37860699|FG000|Overall Study|Investigator Decision|1|||
17191709|NCT02484443|38344539|FG000|Overall Study|Lack of Efficacy|28|||
17191710|NCT02484443|38344539|FG000|Overall Study|Physician Decision|2|||
17191711|NCT02484443|38344539|FG000|Overall Study|Ineligible|2|||
17191712|NCT00409773|38344548|FG000|Overall Study|Adverse Event|3|||
17191713|NCT00409773|38344549|FG001|Overall Study|Adverse Event|4|||
17191714|NCT00409773|38344550|FG002|Overall Study|Adverse Event|4|||
16879676|NCT00637273|37860700|FG001|Overall Study|Investigator Decision|3|||
16879677|NCT00637273|37860701|FG002|Overall Study|Investigator Decision|1|||
16879678|NCT00637273|37860699|FG000|Overall Study|Administrative|2|||
16879679|NCT00637273|37860700|FG001|Overall Study|Administrative|0|||
16879680|NCT00637273|37860701|FG002|Overall Study|Administrative|0|||
16879681|NCT00637273|37860699|FG000|Overall Study|Loss of Glucose Control|1|||
16879682|NCT00637273|37860700|FG001|Overall Study|Loss of Glucose Control|1|||
16879683|NCT00637273|37860701|FG002|Overall Study|Loss of Glucose Control|1|||
16879684|NCT00988351|37860711|FG000|Overall Study|Withdrawal by Subject|8|||
16879685|NCT00988351|37860712|FG001|Overall Study|Withdrawal by Subject|0|||
16879686|NCT00988351|37860711|FG000|Overall Study|Lost to Follow-up|6|||
16879687|NCT00988351|37860712|FG001|Overall Study|Lost to Follow-up|9|||
16879688|NCT00988351|37860711|FG000|Overall Study|not using CPAP|5|||
16879689|NCT00988351|37860712|FG001|Overall Study|not using CPAP|3|||
16879690|NCT00988117|37860718|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
16879691|NCT00988117|37860718|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
16879692|NCT00637195|37860725|FG000|Overall Study|Lost to Follow-up|1|||
16879693|NCT00637195|37860726|FG001|Overall Study|Lost to Follow-up|0|||
16879694|NCT00637195|37860725|FG000|Overall Study|Other|2|||
16879695|NCT00637195|37860726|FG001|Overall Study|Other|0|||
16879696|NCT00637195|37860725|FG000|Overall Study|Withdrawal by Subject|0|||
16879697|NCT00637195|37860726|FG001|Overall Study|Withdrawal by Subject|1|||
16879698|NCT00636961|37860744|FG000|Period 1|Administrative problems|1|||
16879699|NCT00636961|37860745|FG001|Period 1|Administrative problems|1|||
16879700|NCT00636961|37860744|FG000|Period 2|Adverse Event|1|||
16879701|NCT00636961|37860745|FG001|Period 2|Adverse Event|0|||
16879702|NCT00635089|37860751|FG000|Overall Study|Adverse Event|7|||
16879703|NCT00635089|37860751|FG000|Overall Study|Lack of Efficacy|28|||
16879704|NCT00635089|37860751|FG000|Overall Study|Protocol Deviation|4|||
16879705|NCT00635089|37860751|FG000|Overall Study|Lost to Follow-up|8|||
16879706|NCT00635089|37860751|FG000|Overall Study|Other|31|||
17191715|NCT00409773|38344551|FG003|Overall Study|Adverse Event|2|||
16879707|NCT01493414|37860768|FG000|Overall Study|Adverse Event|405|||
16879708|NCT01493414|37860768|FG000|Overall Study|Disease progression|204|||
16879709|NCT01493414|37860768|FG000|Overall Study|Death|101|||
16879710|NCT01493414|37860768|FG000|Overall Study|Physician Decision|93|||
16879711|NCT01493414|37860768|FG000|Overall Study|Withdrawal by Subject|79|||
16879712|NCT01493414|37860768|FG000|Overall Study|Protocol deviation|27|||
16879713|NCT01493414|37860768|FG000|Overall Study|Administrative problems|25|||
16879714|NCT01493414|37860768|FG000|Overall Study|Lost to Follow-up|16|||
16879715|NCT00634543|37860778|FG000|Overall Study|Other|1|||
16879716|NCT00634543|37860779|FG001|Overall Study|Other|2|||
16879717|NCT00634543|37860778|FG000|Overall Study|Protocol Violation|3|||
16879718|NCT00634543|37860779|FG001|Overall Study|Protocol Violation|3|||
16879719|NCT00634543|37860778|FG000|Overall Study|Adverse Event|11|||
16879720|NCT00634543|37860779|FG001|Overall Study|Adverse Event|11|||
16879721|NCT00634543|37860778|FG000|Overall Study|Withdrawal by Subject|4|||
16879722|NCT00634543|37860779|FG001|Overall Study|Withdrawal by Subject|4|||
16879723|NCT00634543|37860778|FG000|Overall Study|Lost to Follow-up|0|||
16879724|NCT00634543|37860779|FG001|Overall Study|Lost to Follow-up|1|||
16879725|NCT00985465|37860787|FG000|Overall Study|Withdrawal by Subject|1|||
16879726|NCT00985465|37860788|FG001|Overall Study|Withdrawal by Subject|2|||
16879727|NCT00985465|37860787|FG000|Overall Study|Considered to be part of the other group|0|||
16879728|NCT00985465|37860788|FG001|Overall Study|Considered to be part of the other group|1|||
16879729|NCT01049919|37860797|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
16879730|NCT01049919|37860798|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
16879731|NCT01049919|37860797|FG000|Overall Study|Withdrawal by Subject|5|||
16879732|NCT01049919|37860798|FG001|Overall Study|Withdrawal by Subject|0|||
16879733|NCT01049919|37860797|FG000|Overall Study|Lost to Follow-up|6|||
16879734|NCT01049919|37860798|FG001|Overall Study|Lost to Follow-up|1|||
16879735|NCT01049919|37860797|FG000|Overall Study|Physician Decision|2|||
16879736|NCT01049919|37860798|FG001|Overall Study|Physician Decision|0|||
16879737|NCT01049919|37860797|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
16879738|NCT01049919|37860798|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
16879739|NCT01049919|37860797|FG000|Overall Study|Early study termination by sponsor.|2|||
16879740|NCT01049919|37860798|FG001|Overall Study|Early study termination by sponsor.|0|||
16879741|NCT01049373|37860806|FG000|Overall Study|Protocol Violation|9|||
16879742|NCT01049373|37860807|FG001|Overall Study|Protocol Violation|9|||
16879743|NCT01049373|37860806|FG000|Overall Study|Withdrawal by Subject|8|||
16879744|NCT01049373|37860807|FG001|Overall Study|Withdrawal by Subject|5|||
16879745|NCT01049373|37860806|FG000|Overall Study|Adverse Event|3|||
16879746|NCT01049373|37860807|FG001|Overall Study|Adverse Event|3|||
16879747|NCT01049373|37860806|FG000|Overall Study|Lost to Follow-up|9|||
16879748|NCT01049373|37860807|FG001|Overall Study|Lost to Follow-up|4|||
16879749|NCT01049373|37860806|FG000|Overall Study|no evaluable study values|9|||
16879750|NCT01049373|37860807|FG001|Overall Study|no evaluable study values|21|||
16879751|NCT01049373|37860806|FG000|Overall Study|Other|1|||
16879752|NCT01049373|37860807|FG001|Overall Study|Other|1|||
16879753|NCT01049373|37860806|FG000|Overall Study|Non-cooperation|0|||
16879754|NCT01049373|37860807|FG001|Overall Study|Non-cooperation|1|||
16879755|NCT00985231|37860817|FG000|Overall Study|ineligible|1|||
16879756|NCT00985231|37860818|FG001|Overall Study|ineligible|0|||
16879757|NCT00985231|37860817|FG000|Overall Study|Protocol Violation|1|||
16879758|NCT00985231|37860818|FG001|Overall Study|Protocol Violation|0|||
16879759|NCT00985231|37860817|FG000|Overall Study|Withdrawal by Subject|1|||
16879760|NCT00985231|37860818|FG001|Overall Study|Withdrawal by Subject|0|||
16879761|NCT00985231|37860817|FG000|Overall Study|Lost to Follow-up|0|||
16879762|NCT00985231|37860818|FG001|Overall Study|Lost to Follow-up|1|||
16879763|NCT00985231|37860817|FG000|Overall Study|Study related symptoms & complaints|0|||
16879764|NCT00985231|37860818|FG001|Overall Study|Study related symptoms & complaints|2|||
16879765|NCT01048671|37860838|FG000|Overall Study|Protocol Violation|0|||
16879766|NCT01048671|37860839|FG001|Overall Study|Protocol Violation|1|||
16879767|NCT01048671|37860840|FG002|Overall Study|Protocol Violation|1|||
16879768|NCT01360866|37860852|FG000|Overall Study|Lost to Follow-up|11|||
16879769|NCT01360866|37860853|FG001|Overall Study|Lost to Follow-up|28|||
16879770|NCT01360866|37860854|FG002|Overall Study|Lost to Follow-up|41|||
16879771|NCT01360866|37860855|FG003|Overall Study|Lost to Follow-up|0|||
16879772|NCT01360866|37860852|FG000|Overall Study|Adverse Event|56|||
16879773|NCT01360866|37860853|FG001|Overall Study|Adverse Event|61|||
16879774|NCT01360866|37860854|FG002|Overall Study|Adverse Event|134|||
16879775|NCT01360866|37860855|FG003|Overall Study|Adverse Event|6|||
16879776|NCT01360866|37860852|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
16879777|NCT01360866|37860853|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
16879778|NCT01360866|37860854|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
16879779|NCT01360866|37860855|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
16879780|NCT01360866|37860852|FG000|Overall Study|Withdrawn by Investigator|9|||
16879781|NCT01360866|37860853|FG001|Overall Study|Withdrawn by Investigator|8|||
16879782|NCT01360866|37860854|FG002|Overall Study|Withdrawn by Investigator|31|||
16879783|NCT01360866|37860855|FG003|Overall Study|Withdrawn by Investigator|2|||
16879784|NCT01360866|37860852|FG000|Overall Study|Withdrawal by participant|79|||
16879785|NCT01360866|37860853|FG001|Overall Study|Withdrawal by participant|89|||
16879786|NCT01360866|37860854|FG002|Overall Study|Withdrawal by participant|168|||
16879787|NCT01360866|37860855|FG003|Overall Study|Withdrawal by participant|8|||
16879788|NCT01360866|37860852|FG000|Overall Study|Protocol Deviation|25|||
16879789|NCT01360866|37860853|FG001|Overall Study|Protocol Deviation|33|||
16879790|NCT01360866|37860854|FG002|Overall Study|Protocol Deviation|61|||
16879791|NCT01360866|37860855|FG003|Overall Study|Protocol Deviation|2|||
17002108|NCT00846027|38146209|FG000|Overall Study|Investigator Discretion|29|||
16879792|NCT01360866|37860852|FG000|Overall Study|Lack of Efficacy|30|||
16879793|NCT01360866|37860853|FG001|Overall Study|Lack of Efficacy|40|||
16879794|NCT01360866|37860854|FG002|Overall Study|Lack of Efficacy|30|||
16879795|NCT01360866|37860855|FG003|Overall Study|Lack of Efficacy|4|||
16879796|NCT00985153|37860869|FG000|Overall Study|Lost to Follow-up|16|||
16879797|NCT00985153|37860870|FG001|Overall Study|Lost to Follow-up|19|||
16879798|NCT00985153|37860871|FG002|Overall Study|Lost to Follow-up|17|||
16879799|NCT00985153|37860872|FG003|Overall Study|Lost to Follow-up|20|||
16879800|NCT00985153|37860869|FG000|Overall Study|Protocol Violation|3|||
16879801|NCT00985153|37860870|FG001|Overall Study|Protocol Violation|2|||
16879802|NCT00985153|37860871|FG002|Overall Study|Protocol Violation|4|||
16879803|NCT00985153|37860872|FG003|Overall Study|Protocol Violation|3|||
16879804|NCT00985153|37860869|FG000|Overall Study|Withdrawal by Subject|6|||
16879805|NCT00985153|37860870|FG001|Overall Study|Withdrawal by Subject|11|||
16879806|NCT00985153|37860871|FG002|Overall Study|Withdrawal by Subject|11|||
16879807|NCT00985153|37860872|FG003|Overall Study|Withdrawal by Subject|10|||
16879808|NCT00985153|37860869|FG000|Overall Study|Missed One or More Bleeds|7|||
16879809|NCT00985153|37860870|FG001|Overall Study|Missed One or More Bleeds|7|||
16879810|NCT00985153|37860871|FG002|Overall Study|Missed One or More Bleeds|8|||
16879811|NCT00985153|37860872|FG003|Overall Study|Missed One or More Bleeds|10|||
16879812|NCT00985153|37860869|FG000|Overall Study|Incomplete Safety Follow-up|3|||
16879813|NCT00985153|37860870|FG001|Overall Study|Incomplete Safety Follow-up|5|||
16879814|NCT00985153|37860871|FG002|Overall Study|Incomplete Safety Follow-up|4|||
16879815|NCT00985153|37860872|FG003|Overall Study|Incomplete Safety Follow-up|4|||
16879816|NCT01047345|37860884|FG000|Base Study|Adverse Event|3|||
16879817|NCT01047345|37860885|FG001|Base Study|Adverse Event|0|||
16879818|NCT01047345|37860886|FG002|Base Study|Adverse Event|0|||
16879819|NCT01047345|37860884|FG000|Base Study|Lost to Follow-up|4|||
16879820|NCT01047345|37860885|FG001|Base Study|Lost to Follow-up|1|||
16879821|NCT01047345|37860886|FG002|Base Study|Lost to Follow-up|0|||
16879822|NCT01047345|37860884|FG000|Base Study|Protocol Violation|3|||
16879823|NCT01047345|37860885|FG001|Base Study|Protocol Violation|1|||
16879824|NCT01047345|37860886|FG002|Base Study|Protocol Violation|0|||
16879825|NCT01047345|37860884|FG000|Base Study|Withdrawal by Subject|12|||
16879826|NCT01047345|37860885|FG001|Base Study|Withdrawal by Subject|4|||
16879827|NCT01047345|37860886|FG002|Base Study|Withdrawal by Subject|0|||
16879828|NCT01047345|37860884|FG000|Extension|Withdrawal by Subject|0|||
16879829|NCT01047345|37860885|FG001|Extension|Withdrawal by Subject|0|||
16879830|NCT01047345|37860886|FG002|Extension|Withdrawal by Subject|1|||
16879831|NCT01047345|37860884|FG000|Extension|Lost to Follow-up|0|||
16879832|NCT01047345|37860885|FG001|Extension|Lost to Follow-up|0|||
16879833|NCT01047345|37860886|FG002|Extension|Lost to Follow-up|5|||
16879834|NCT01046877|37860894|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
16879835|NCT01046877|37860894|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
16879836|NCT00984061|37860898|FG000|Clarithromycin Alone|Protocol Violation|1|||
16879837|NCT01046643|37860907|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
16879838|NCT01046643|37860908|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
16879839|NCT01046643|37860909|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
16879840|NCT01046643|37860910|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
16879841|NCT00983905|37860920|FG000|Theophylline Alone|Adverse Event|1|||
16879842|NCT00983905|37860920|FG000|Colchicine Alone|Adverse Event|2|||
16879843|NCT01046565|37860927|FG000|Overall Study|Adverse Event|2|||
16879844|NCT01046565|37860927|FG000|Overall Study|Withdrawal by Subject|7|||
16879845|NCT00983827|37860936|FG000|Overall Study|Withdrawal by Subject|1|||
16879846|NCT00983749|37860942|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
16879847|NCT00983749|37860943|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
16879848|NCT01046253|37860951|FG000|Second Intervention|Adverse Event|0|||
16879849|NCT01046253|37860952|FG001|Second Intervention|Adverse Event|1|||
16879850|NCT01046253|37860951|FG000|Second Intervention|Protocol Violation|0|||
16879851|NCT01046253|37860952|FG001|Second Intervention|Protocol Violation|1|||
16879852|NCT00983515|37860958|FG000|Ritonavir Alone|liver panel out of range|6|||
16879853|NCT00983515|37860958|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
16879854|NCT00982735|37860965|FG000|Overall Study|Lost to Follow-up|6|||
16879855|NCT00982735|37860965|FG000|Overall Study|Patient ineligible for trial|224|||
16879856|NCT01361178|37860971|FG000|Overall Study|Death|13|||
16879857|NCT01361178|37860972|FG001|Overall Study|Death|0|||
16879858|NCT00981799|37860982|FG000|Overall Study|Adverse Event|1|||
16879859|NCT00981799|37860983|FG001|Overall Study|Adverse Event|1|||
16879860|NCT00981799|37860984|FG002|Overall Study|Adverse Event|0|||
16879861|NCT00981799|37860985|FG003|Overall Study|Adverse Event|0|||
16879862|NCT00981175|37860999|FG000|Primary Dose Vaccination|Adverse Event|1|||
16879863|NCT00981175|37861000|FG001|Primary Dose Vaccination|Adverse Event|0|||
16879864|NCT00981175|37860999|FG000|Primary Dose Vaccination|Protocol Violation|0|||
16879865|NCT00981175|37861000|FG001|Primary Dose Vaccination|Protocol Violation|1|||
16879866|NCT00981175|37860999|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
16879867|NCT00981175|37861000|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
16879868|NCT00981175|37860999|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
16879869|NCT00981175|37861000|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
16879870|NCT00981019|37861013|FG000|Overall Study|Did not respond|65|||
16879871|NCT00981019|37861013|FG000|Overall Study|Did not match target population|94|||
16879872|NCT00981019|37861013|FG000|Overall Study|Inadvertent exclusion|239|||
16879873|NCT00981019|37861013|FG000|Overall Study|Hit the survey after closure|79|||
16879874|NCT01045161|37861020|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
16879875|NCT01045161|37861021|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
16879876|NCT01045161|37861022|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
16879877|NCT01045161|37861020|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
16879878|NCT01045161|37861021|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
16879879|NCT01045161|37861022|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
16879880|NCT01045161|37861020|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
16879881|NCT01045161|37861021|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
16879882|NCT01045161|37861022|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
16879883|NCT01045161|37861020|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
16879884|NCT01045161|37861021|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
16879885|NCT01045161|37861022|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
16879886|NCT01045161|37861020|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
16879887|NCT01045161|37861021|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
16879888|NCT01045161|37861022|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
16879889|NCT01045161|37861020|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
16879890|NCT01045161|37861021|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
16879891|NCT01045161|37861022|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
16879892|NCT01045161|37861020|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
16879893|NCT01045161|37861021|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
16879894|NCT01045161|37861022|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
16879895|NCT01045161|37861020|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
16879896|NCT01045161|37861021|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
16879897|NCT01045161|37861022|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
16879898|NCT01045161|37861020|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
16879899|NCT01045161|37861021|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
16879900|NCT01045161|37861022|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
16879901|NCT01045161|37861020|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
16879902|NCT01045161|37861021|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
16879903|NCT01045161|37861022|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
16879904|NCT01045161|37861020|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
16879905|NCT01045161|37861021|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
16879906|NCT01045161|37861022|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
16879907|NCT01045161|37861020|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
16879908|NCT01045161|37861021|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
16879909|NCT01045161|37861022|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
16879910|NCT01045161|37861020|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
16879911|NCT01045161|37861021|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
16879912|NCT01045161|37861022|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
16879913|NCT01045161|37861020|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
16879914|NCT01045161|37861021|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
16879915|NCT01045161|37861022|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
16879916|NCT00633217|37861041|FG000|Overall Study|Adverse Event|5|||
16879917|NCT00633217|37861042|FG001|Overall Study|Adverse Event|9|||
16879918|NCT00633217|37861041|FG000|Overall Study|Lack of Efficacy|0|||
16879919|NCT00633217|37861042|FG001|Overall Study|Lack of Efficacy|2|||
16879920|NCT00633217|37861041|FG000|Overall Study|Protocol Violation|3|||
16879921|NCT00633217|37861042|FG001|Overall Study|Protocol Violation|7|||
16879922|NCT00633217|37861041|FG000|Overall Study|Lost to Follow-up|2|||
16879923|NCT00633217|37861042|FG001|Overall Study|Lost to Follow-up|2|||
16879924|NCT00633217|37861041|FG000|Overall Study|Investigator Discretion|2|||
16879925|NCT00633217|37861042|FG001|Overall Study|Investigator Discretion|0|||
16879926|NCT00633217|37861041|FG000|Overall Study|Withdrew Consent|3|||
16879927|NCT00633217|37861042|FG001|Overall Study|Withdrew Consent|3|||
16879928|NCT01673490|37861048|FG000|Overall Study|Lost to Follow-up|1|||
16879929|NCT01673490|37861048|FG000|Overall Study|Adverse Event|3|||
16879930|NCT01673490|37861048|FG000|Overall Study|Withdrawal by Subject|3|||
16879931|NCT00215657|37861060|FG000|Overall Study|Adverse Event|5|||
16879932|NCT00215657|37861061|FG001|Overall Study|Adverse Event|1|||
16879933|NCT00215657|37861062|FG002|Overall Study|Adverse Event|3|||
16879934|NCT00215657|37861063|FG003|Overall Study|Adverse Event|0|||
16879935|NCT00215657|37861064|FG004|Overall Study|Adverse Event|3|||
16879936|NCT00215657|37861065|FG005|Overall Study|Adverse Event|1|||
16879937|NCT00215657|37861066|FG006|Overall Study|Adverse Event|0|||
16879938|NCT00215657|37861067|FG007|Overall Study|Adverse Event|3|||
16879939|NCT00215657|37861060|FG000|Overall Study|Withdrawal by Subject|6|||
16879940|NCT00215657|37861061|FG001|Overall Study|Withdrawal by Subject|3|||
16879941|NCT00215657|37861062|FG002|Overall Study|Withdrawal by Subject|3|||
16879942|NCT00215657|37861063|FG003|Overall Study|Withdrawal by Subject|1|||
16879943|NCT00215657|37861064|FG004|Overall Study|Withdrawal by Subject|6|||
16879944|NCT00215657|37861065|FG005|Overall Study|Withdrawal by Subject|1|||
16879945|NCT00215657|37861066|FG006|Overall Study|Withdrawal by Subject|10|||
16879946|NCT00215657|37861067|FG007|Overall Study|Withdrawal by Subject|3|||
16879947|NCT00215657|37861060|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
16879948|NCT00215657|37861061|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
16879949|NCT00215657|37861062|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
16879950|NCT00215657|37861063|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
16879951|NCT00215657|37861064|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
16879952|NCT00215657|37861065|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
16879953|NCT00215657|37861066|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
16879954|NCT00215657|37861067|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
16879955|NCT00215657|37861060|FG000|Overall Study|Insufficient testosterone response|5|||
16879956|NCT00215657|37861061|FG001|Overall Study|Insufficient testosterone response|4|||
16879957|NCT00215657|37861062|FG002|Overall Study|Insufficient testosterone response|1|||
16879958|NCT00215657|37861063|FG003|Overall Study|Insufficient testosterone response|12|||
16879959|NCT00215657|37861064|FG004|Overall Study|Insufficient testosterone response|8|||
16879960|NCT00215657|37861065|FG005|Overall Study|Insufficient testosterone response|12|||
16879961|NCT00215657|37861066|FG006|Overall Study|Insufficient testosterone response|4|||
16879962|NCT00215657|37861067|FG007|Overall Study|Insufficient testosterone response|7|||
16879963|NCT00215657|37861060|FG000|Overall Study|Other|3|||
16879964|NCT00215657|37861061|FG001|Overall Study|Other|1|||
16879965|NCT00215657|37861062|FG002|Overall Study|Other|2|||
16879966|NCT00215657|37861063|FG003|Overall Study|Other|3|||
16879967|NCT00215657|37861064|FG004|Overall Study|Other|5|||
16879968|NCT00215657|37861065|FG005|Overall Study|Other|4|||
16879969|NCT00215657|37861066|FG006|Overall Study|Other|6|||
16879970|NCT00215657|37861067|FG007|Overall Study|Other|1|||
16879971|NCT00633061|37861087|FG000|Overall Study|Study closed|86|||
16879972|NCT00633061|37861088|FG001|Overall Study|Study closed|0|||
16879973|NCT00632827|37861096|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
16879974|NCT00632827|37861096|FG000|Overall Study|Death|2|||
16879975|NCT00632827|37861096|FG000|Overall Study|Adverse Event|5|||
16879976|NCT00632827|37861096|FG000|Overall Study|Lost to Follow-up|1|||
16879977|NCT00214019|37861101|FG000|Overall Study|Lost to Follow-up|11|||
16879978|NCT00214019|37861101|FG000|Overall Study|Withdrawal by Subject|2|||
16879979|NCT00214019|37861101|FG000|Overall Study|Screen Failed prior to randomization|17|||
16879980|NCT00210119|37861108|FG000|Overall Study|Protocol Violation|1|||
16879981|NCT00210119|37861108|FG000|Overall Study|Withdrawal by Subject|1|||
16879982|NCT01044459|37861114|FG000|Overall Study|Withdrawal by Subject|21|||
16879983|NCT01044459|37861115|FG001|Overall Study|Withdrawal by Subject|28|||
16879984|NCT01044459|37861114|FG000|Overall Study|Terminated by Sponsor|22|||
16879985|NCT01044459|37861115|FG001|Overall Study|Terminated by Sponsor|21|||
16879986|NCT01044459|37861114|FG000|Overall Study|Adverse Event|22|||
16879987|NCT01044459|37861115|FG001|Overall Study|Adverse Event|20|||
16879988|NCT01044459|37861114|FG000|Overall Study|Lack of Efficacy|23|||
16879989|NCT01044459|37861115|FG001|Overall Study|Lack of Efficacy|12|||
16879990|NCT01044459|37861114|FG000|Overall Study|Protocol Violation|11|||
16879991|NCT01044459|37861115|FG001|Overall Study|Protocol Violation|16|||
16879992|NCT01044459|37861114|FG000|Overall Study|Other Reason|7|||
16879993|NCT01044459|37861115|FG001|Overall Study|Other Reason|14|||
16879994|NCT01044459|37861114|FG000|Overall Study|COPD exacerbation|9|||
16879995|NCT01044459|37861115|FG001|Overall Study|COPD exacerbation|8|||
16879996|NCT01044459|37861114|FG000|Overall Study|Lost to Follow-up|18|||
16879997|NCT01044459|37861115|FG001|Overall Study|Lost to Follow-up|12|||
16879998|NCT00980005|37861123|FG000|Overall Study|Withdrawal by Subject|6|||
16879999|NCT00980005|37861124|FG001|Overall Study|Withdrawal by Subject|17|||
16880000|NCT00980005|37861123|FG000|Overall Study|Lost to Follow-up|37|||
16880001|NCT00980005|37861124|FG001|Overall Study|Lost to Follow-up|43|||
16880002|NCT00980005|37861123|FG000|Overall Study|Other|4|||
16880003|NCT00980005|37861124|FG001|Overall Study|Other|3|||
17002109|NCT00846027|38146209|FG000|Overall Study|Protocol Violation|2|||
17002110|NCT00846027|38146209|FG000|Overall Study|Subject Not Treated|7|||
16880004|NCT01044303|37861134|FG000|Overall Study|Lost to Follow-up|2|||
16880005|NCT00983437|37861141|FG000|Overall Study|Adverse Event|9|||
16880006|NCT00983437|37861141|FG000|Overall Study|Lack of Efficacy|1|||
16880007|NCT00983437|37861141|FG000|Overall Study|Withdrawal by Subject|8|||
16880008|NCT00983437|37861141|FG000|Overall Study|Noncompliance to Study Procedures|1|||
16880009|NCT00983437|37861141|FG000|Overall Study|Lost to Follow-up|2|||
16880010|NCT00983437|37861141|FG000|Overall Study|Other Reason|26|||
16880011|NCT01042977|37861147|FG000|Overall Study|Adverse Event|4|||
16880012|NCT01042977|37861148|FG001|Overall Study|Adverse Event|12|||
16880013|NCT01042977|37861147|FG000|Overall Study|Death|2|||
16880014|NCT01042977|37861148|FG001|Overall Study|Death|1|||
16880015|NCT01042977|37861147|FG000|Overall Study|Withdrawal by Subject|8|||
16880016|NCT01042977|37861148|FG001|Overall Study|Withdrawal by Subject|16|||
16880017|NCT01042977|37861147|FG000|Overall Study|Lost to Follow-up|0|||
16880018|NCT01042977|37861148|FG001|Overall Study|Lost to Follow-up|2|||
16880019|NCT01042977|37861147|FG000|Overall Study|Poor/non-compliance|3|||
16880020|NCT01042977|37861148|FG001|Overall Study|Poor/non-compliance|4|||
16880021|NCT01042977|37861147|FG000|Overall Study|Subject no longer meets study criteria|15|||
16880022|NCT01042977|37861148|FG001|Overall Study|Subject no longer meets study criteria|13|||
16880023|NCT01042977|37861147|FG000|Overall Study|Incorrect enrollment|6|||
16880024|NCT01042977|37861148|FG001|Overall Study|Incorrect enrollment|4|||
16880025|NCT01042977|37861147|FG000|Overall Study|Safety|0|||
16880026|NCT01042977|37861148|FG001|Overall Study|Safety|2|||
16880027|NCT01042977|37861147|FG000|Overall Study|Administrative reason by sponsor|0|||
16880028|NCT01042977|37861148|FG001|Overall Study|Administrative reason by sponsor|1|||
16880029|NCT01042977|37861147|FG000|Overall Study|Various|3|||
16880030|NCT01042977|37861148|FG001|Overall Study|Various|0|||
16880031|NCT01041573|37861158|FG000|Overall Study|Withdrawal by Subject|2|||
16880032|NCT01041573|37861159|FG001|Overall Study|Withdrawal by Subject|5|||
16880033|NCT01041573|37861160|FG002|Overall Study|Withdrawal by Subject|2|||
16880034|NCT01041573|37861161|FG003|Overall Study|Withdrawal by Subject|0|||
16880035|NCT01041573|37861158|FG000|Overall Study|Death|1|||
16880036|NCT01041573|37861159|FG001|Overall Study|Death|0|||
16880037|NCT01041573|37861160|FG002|Overall Study|Death|0|||
16880038|NCT01041573|37861161|FG003|Overall Study|Death|0|||
16880039|NCT01041573|37861158|FG000|Overall Study|Lost to Follow-up|0|||
16880040|NCT01041573|37861159|FG001|Overall Study|Lost to Follow-up|1|||
16880041|NCT01041573|37861160|FG002|Overall Study|Lost to Follow-up|2|||
16880042|NCT01041573|37861161|FG003|Overall Study|Lost to Follow-up|1|||
16880043|NCT01041573|37861158|FG000|Overall Study|Adverse Event|0|||
16880044|NCT01041573|37861159|FG001|Overall Study|Adverse Event|2|||
16880045|NCT01041573|37861160|FG002|Overall Study|Adverse Event|0|||
16880046|NCT01041573|37861161|FG003|Overall Study|Adverse Event|0|||
16880047|NCT01041573|37861158|FG000|Overall Study|relocation|1|||
16880048|NCT01041573|37861159|FG001|Overall Study|relocation|4|||
16880049|NCT01041573|37861160|FG002|Overall Study|relocation|3|||
16880050|NCT01041573|37861161|FG003|Overall Study|relocation|1|||
16880051|NCT01041573|37861158|FG000|Overall Study|further blood extraction|0|||
16880052|NCT01041573|37861159|FG001|Overall Study|further blood extraction|1|||
16880053|NCT01041573|37861160|FG002|Overall Study|further blood extraction|0|||
16880054|NCT01041573|37861161|FG003|Overall Study|further blood extraction|0|||
16880055|NCT01041573|37861158|FG000|Overall Study|positive to anti-HCV|1|||
16880056|NCT01041573|37861159|FG001|Overall Study|positive to anti-HCV|0|||
16880057|NCT01041573|37861160|FG002|Overall Study|positive to anti-HCV|0|||
16880058|NCT01041573|37861161|FG003|Overall Study|positive to anti-HCV|0|||
16880059|NCT01041495|37861188|FG000|Overall Study|Withdrawal by Subject|2|||
16880060|NCT01041495|37861189|FG001|Overall Study|Withdrawal by Subject|5|||
16880061|NCT01041495|37861188|FG000|Overall Study|Adverse Event|2|||
16880062|NCT01041495|37861189|FG001|Overall Study|Adverse Event|1|||
16880063|NCT01041495|37861188|FG000|Overall Study|Lost to Follow-up|0|||
16880064|NCT01041495|37861189|FG001|Overall Study|Lost to Follow-up|1|||
16880065|NCT01041417|37861197|FG000|Overall Study|Adverse Event|5|||
16880066|NCT01041417|37861198|FG001|Overall Study|Adverse Event|2|||
16880067|NCT01041417|37861197|FG000|Overall Study|Lost to Follow-up|1|||
16880068|NCT01041417|37861198|FG001|Overall Study|Lost to Follow-up|1|||
16880069|NCT01041417|37861197|FG000|Overall Study|Death|1|||
16880070|NCT01041417|37861198|FG001|Overall Study|Death|0|||
16880071|NCT01040871|37861208|FG000|Overall Study|Adverse Event|6|||
16880072|NCT01040871|37861209|FG001|Overall Study|Adverse Event|2|||
16880073|NCT01040871|37861208|FG000|Overall Study|Withdrawal by Subject|2|||
16880074|NCT01040871|37861209|FG001|Overall Study|Withdrawal by Subject|0|||
16880075|NCT01040871|37861208|FG000|Overall Study|Death|1|||
16880076|NCT01040871|37861209|FG001|Overall Study|Death|3|||
16880077|NCT01040871|37861208|FG000|Overall Study|Lack of Efficacy|1|||
16880078|NCT01040871|37861209|FG001|Overall Study|Lack of Efficacy|1|||
16880079|NCT01040871|37861208|FG000|Overall Study|drug supply issue|1|||
16880080|NCT01040871|37861209|FG001|Overall Study|drug supply issue|0|||
16880081|NCT01040871|37861208|FG000|Overall Study|Randomized and Not Treated|2|||
16880082|NCT01040871|37861209|FG001|Overall Study|Randomized and Not Treated|1|||
16880083|NCT01040169|37861217|FG000|Overall Study|Lost to Follow-up|3|||
16880084|NCT01040169|37861218|FG001|Overall Study|Lost to Follow-up|8|||
16880085|NCT01673178|37861238|FG000|Overall Study|Lost to Follow-up|0|||
16880086|NCT01673178|37861239|FG001|Overall Study|Lost to Follow-up|1|||
16880087|NCT01673178|37861240|FG002|Overall Study|Lost to Follow-up|0|||
16880088|NCT01673178|37861241|FG003|Overall Study|Lost to Follow-up|0|||
16880089|NCT01673178|37861242|FG004|Overall Study|Lost to Follow-up|0|||
16880090|NCT01673178|37861238|FG000|Overall Study|Withdrawal by Subject|0|||
16880091|NCT01673178|37861239|FG001|Overall Study|Withdrawal by Subject|0|||
16880092|NCT01673178|37861240|FG002|Overall Study|Withdrawal by Subject|1|||
16880093|NCT01673178|37861241|FG003|Overall Study|Withdrawal by Subject|4|||
16880094|NCT01673178|37861242|FG004|Overall Study|Withdrawal by Subject|2|||
16880095|NCT01673178|37861238|FG000|Overall Study|Protocol Violation|1|||
16880096|NCT01673178|37861239|FG001|Overall Study|Protocol Violation|1|||
16880097|NCT01673178|37861240|FG002|Overall Study|Protocol Violation|0|||
16880098|NCT01673178|37861241|FG003|Overall Study|Protocol Violation|1|||
16880099|NCT01673178|37861242|FG004|Overall Study|Protocol Violation|0|||
16880100|NCT01673178|37861238|FG000|Overall Study|Adverse Event|1|||
16880101|NCT01673178|37861239|FG001|Overall Study|Adverse Event|0|||
16880102|NCT01673178|37861240|FG002|Overall Study|Adverse Event|0|||
16880103|NCT01673178|37861241|FG003|Overall Study|Adverse Event|2|||
16880104|NCT01673178|37861242|FG004|Overall Study|Adverse Event|0|||
16880105|NCT01673178|37861238|FG000|Overall Study|Other|1|||
16880106|NCT01673178|37861239|FG001|Overall Study|Other|0|||
16880107|NCT01673178|37861240|FG002|Overall Study|Other|2|||
16880108|NCT01673178|37861241|FG003|Overall Study|Other|1|||
16880109|NCT01673178|37861242|FG004|Overall Study|Other|0|||
16880110|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
16880111|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
16880112|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
16880113|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
16880114|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
16880115|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
16880116|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
16880117|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
16880118|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
16880119|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
16880120|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
16880121|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
16880122|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
16880123|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
16880124|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
16880125|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
16880126|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
16880127|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
16880128|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
16880129|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
16880130|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
16880131|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
16880132|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
16880133|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
16880134|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
16880135|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
16880136|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
16880137|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
16880138|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
16880139|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
16880140|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
16880141|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
16880142|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
16880143|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
16880144|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
16880145|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
16880146|NCT03593213|37861271|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
16880147|NCT03593213|37861272|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
16880148|NCT03593213|37861273|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
16880149|NCT03593213|37861274|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
16880150|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
16880151|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
16880152|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
16880153|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
16880154|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
16880155|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
16880156|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
16880157|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
16880158|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
16880159|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
16880160|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
16880161|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
16880162|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
16880163|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
16880164|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
16880165|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
16880166|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
16880167|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
16880168|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
16880169|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
16880170|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
16880171|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
16880172|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
16880173|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
16880174|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
16880175|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
16880176|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
16880177|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
16880178|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
16880179|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
16880180|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
16880181|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
16880182|NCT03593213|37861271|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
16880183|NCT03593213|37861272|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
16880184|NCT03593213|37861273|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
16880185|NCT03593213|37861274|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
16880186|NCT00013611|37861318|FG000|Overall Study|Lost to Follow-up|91|||
17002111|NCT00646399|38146215|FG000|Overall Study|Death|63|||
17002112|NCT00646399|38146216|FG001|Overall Study|Death|53|||
17002113|NCT00646399|38146215|FG000|Overall Study|Withdrawal by Subject|9|||
17002114|NCT00646399|38146216|FG001|Overall Study|Withdrawal by Subject|10|||
17002115|NCT00646399|38146215|FG000|Overall Study|Other Reason|11|||
17002116|NCT00646399|38146216|FG001|Overall Study|Other Reason|11|||
17002117|NCT00652327|38146224|FG000|Overall Study|Adverse Event|0|||
17095252|NCT00074152|38234524|FG001|Overall Study|Lack of Efficacy|24|||
17095253|NCT00261846|38234540|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
17095254|NCT00261846|38234541|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
17095255|NCT00261846|38234542|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
17002118|NCT00652327|38146225|FG001|Overall Study|Adverse Event|2|||
17002119|NCT00652327|38146224|FG000|Overall Study|Lost to Follow-up|0|||
17002120|NCT00652327|38146225|FG001|Overall Study|Lost to Follow-up|3|||
17002121|NCT00645853|38146233|FG000|Overall Study|Adverse Event|18|||
17002122|NCT00645853|38146234|FG001|Overall Study|Adverse Event|7|||
17002123|NCT00645853|38146233|FG000|Overall Study|AZ study closure in Hungary|60|||
17002124|NCT00645853|38146234|FG001|Overall Study|AZ study closure in Hungary|40|||
17002125|NCT00645853|38146233|FG000|Overall Study|Withdrawal by Subject|5|||
17002126|NCT00645853|38146234|FG001|Overall Study|Withdrawal by Subject|2|||
17002127|NCT00645853|38146233|FG000|Overall Study|Protocol Violation|0|||
17095256|NCT00261846|38234543|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16880187|NCT00013611|37861319|FG001|Overall Study|Lost to Follow-up|100|||
16880188|NCT00010257|37861327|FG000|Overall Study|Withdrawal by Subject|1|||
16880189|NCT00010257|37861328|FG001|Overall Study|Withdrawal by Subject|0|||
16880190|NCT00211757|37861366|FG000|Overall Study|Withdrawal by Subject|1|||
16880191|NCT00211757|37861367|FG001|Overall Study|Withdrawal by Subject|1|||
16880192|NCT00211757|37861366|FG000|Overall Study|Lack of Efficacy|0|||
16880193|NCT00211757|37861367|FG001|Overall Study|Lack of Efficacy|1|||
16880194|NCT02639052|37861384|FG000|Overall Study|Lost to Follow-up|1|||
16880195|NCT02635776|37861491|FG000|Overall Study|Physician Decision|1|||
16880196|NCT02635776|37861492|FG001|Overall Study|Physician Decision|0|||
16880197|NCT02635776|37861491|FG000|Overall Study|Adverse Event|51|||
16880198|NCT02635776|37861492|FG001|Overall Study|Adverse Event|3|||
16880199|NCT02635776|37861491|FG000|Overall Study|Withdrawal by Subject|41|||
16880200|NCT02635776|37861492|FG001|Overall Study|Withdrawal by Subject|7|||
17002128|NCT00645853|38146234|FG001|Overall Study|Protocol Violation|2|||
17002129|NCT00645853|38146233|FG000|Overall Study|Discontinuation criteria|2|||
17002130|NCT00645853|38146234|FG001|Overall Study|Discontinuation criteria|2|||
17095257|NCT00261846|38234544|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
17095258|NCT00261846|38234545|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
17095259|NCT00261846|38234546|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16880201|NCT02635776|37861491|FG000|Overall Study|Lost to Follow-up|4|||
16880202|NCT02635776|37861492|FG001|Overall Study|Lost to Follow-up|0|||
16880203|NCT02635776|37861491|FG000|Overall Study|Other reasons|5|||
16880204|NCT02635776|37861492|FG001|Overall Study|Other reasons|1|||
16880205|NCT02704403|37861506|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
16880206|NCT02704403|37861507|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
16880207|NCT02704403|37861506|FG000|Overall Study|Administrative reasons by sponsor|1251|||
16880208|NCT02704403|37861507|FG001|Overall Study|Administrative reasons by sponsor|616|||
16880209|NCT02704403|37861506|FG000|Overall Study|Death|4|||
16880210|NCT02704403|37861507|FG001|Overall Study|Death|3|||
16880211|NCT02704403|37861506|FG000|Overall Study|Endpoint event|52|||
16880212|NCT02704403|37861507|FG001|Overall Study|Endpoint event|24|||
16880213|NCT02704403|37861506|FG000|Overall Study|Lost to Follow-up|22|||
16880214|NCT02704403|37861507|FG001|Overall Study|Lost to Follow-up|11|||
16880215|NCT02704403|37861506|FG000|Overall Study|Protocol Violation|15|||
16880216|NCT02704403|37861507|FG001|Overall Study|Protocol Violation|15|||
16880217|NCT02704403|37861506|FG000|Overall Study|Adverse Event|2|||
16880218|NCT02704403|37861507|FG001|Overall Study|Adverse Event|0|||
16880219|NCT02704403|37861506|FG000|Overall Study|Withdrawal by Subject|85|||
16880220|NCT02704403|37861507|FG001|Overall Study|Withdrawal by Subject|45|||
16880221|NCT02704403|37861506|FG000|Overall Study|Investigator decision|1|||
16880222|NCT02704403|37861507|FG001|Overall Study|Investigator decision|1|||
16880223|NCT02704403|37861506|FG000|Overall Study|Follow-up not possible|1|||
16880224|NCT02704403|37861507|FG001|Overall Study|Follow-up not possible|2|||
16880225|NCT02636868|37861542|FG000|Overall Study|Death|0|||
16880226|NCT02636868|37861543|FG001|Overall Study|Death|1|||
16880227|NCT02636868|37861544|FG002|Overall Study|Death|2|||
16880228|NCT02635386|37861625|FG000|Overall Study|Pregnancy|2|||
16880229|NCT02635386|37861626|FG001|Overall Study|Pregnancy|0|||
16880230|NCT02635386|37861627|FG002|Overall Study|Pregnancy|0|||
16880231|NCT02635386|37861628|FG003|Overall Study|Pregnancy|0|||
17095260|NCT00261846|38234547|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
17095261|NCT00261846|38234548|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16880232|NCT02635386|37861629|FG004|Overall Study|Pregnancy|2|||
16880233|NCT02635386|37861625|FG000|Overall Study|Withdrawal by Subject|1|||
16880234|NCT02635386|37861626|FG001|Overall Study|Withdrawal by Subject|1|||
16880235|NCT02635386|37861627|FG002|Overall Study|Withdrawal by Subject|0|||
16880236|NCT02635386|37861628|FG003|Overall Study|Withdrawal by Subject|1|||
16880237|NCT02635386|37861629|FG004|Overall Study|Withdrawal by Subject|0|||
16880238|NCT02635386|37861625|FG000|Overall Study|Physician Decision|0|||
16880239|NCT02635386|37861626|FG001|Overall Study|Physician Decision|1|||
16880240|NCT02635386|37861627|FG002|Overall Study|Physician Decision|0|||
16880241|NCT02635386|37861628|FG003|Overall Study|Physician Decision|0|||
16880242|NCT02635386|37861629|FG004|Overall Study|Physician Decision|0|||
16880243|NCT02635386|37861625|FG000|Overall Study|Moved Out of State|0|||
16880244|NCT02635386|37861626|FG001|Overall Study|Moved Out of State|1|||
16880245|NCT02635386|37861627|FG002|Overall Study|Moved Out of State|0|||
16880246|NCT02635386|37861628|FG003|Overall Study|Moved Out of State|0|||
16880247|NCT02635386|37861629|FG004|Overall Study|Moved Out of State|0|||
16880248|NCT02635386|37861625|FG000|Overall Study|Noncompliant|0|||
16880249|NCT02635386|37861626|FG001|Overall Study|Noncompliant|2|||
16880250|NCT02635386|37861627|FG002|Overall Study|Noncompliant|1|||
16880251|NCT02635386|37861628|FG003|Overall Study|Noncompliant|1|||
16880252|NCT02635386|37861629|FG004|Overall Study|Noncompliant|1|||
16880253|NCT02635386|37861625|FG000|Overall Study|side effects|0|||
16880254|NCT02635386|37861626|FG001|Overall Study|side effects|0|||
16880255|NCT02635386|37861627|FG002|Overall Study|side effects|1|||
16880256|NCT02635386|37861628|FG003|Overall Study|side effects|4|||
16880257|NCT02635386|37861629|FG004|Overall Study|side effects|6|||
16880258|NCT02635386|37861625|FG000|Overall Study|needed other major surgery|0|||
16880259|NCT02635386|37861626|FG001|Overall Study|needed other major surgery|1|||
16880260|NCT02635386|37861627|FG002|Overall Study|needed other major surgery|0|||
16880261|NCT02635386|37861628|FG003|Overall Study|needed other major surgery|0|||
16880262|NCT02635386|37861629|FG004|Overall Study|needed other major surgery|0|||
16880263|NCT02635386|37861625|FG000|Overall Study|Other medical problems not drug related|0|||
16880264|NCT02635386|37861626|FG001|Overall Study|Other medical problems not drug related|0|||
16880265|NCT02635386|37861627|FG002|Overall Study|Other medical problems not drug related|0|||
16880266|NCT02635386|37861628|FG003|Overall Study|Other medical problems not drug related|1|||
16880267|NCT02635386|37861629|FG004|Overall Study|Other medical problems not drug related|0|||
16880268|NCT02634606|37861736|FG000|Overall Study|unable to obtain the drug at start|13|||
16880269|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
16880270|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
16880271|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
16880272|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
16880273|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
16880274|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
16880275|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
16880276|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
16880277|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
16880278|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
16880279|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
16880280|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
16880281|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
16880282|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
16880283|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
16880284|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
16880285|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
16880286|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
16880287|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
16880288|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
16880289|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
16880290|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
16880291|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
16880292|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
16880293|NCT01672866|37861782|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
16880294|NCT01672866|37861783|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
16880295|NCT01672866|37861784|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
16880296|NCT01672866|37861782|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
16880297|NCT01672866|37861783|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
16880298|NCT01672866|37861784|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
16880299|NCT01672866|37861782|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
16880300|NCT01672866|37861783|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
16880301|NCT01672866|37861784|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
16880302|NCT01672866|37861782|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
16880303|NCT01672866|37861783|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
16880304|NCT01672866|37861784|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
16880305|NCT01672866|37861782|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
16880306|NCT01672866|37861783|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
16880307|NCT01672866|37861784|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
16880308|NCT04465877|37862010|FG000|Overall Study|Noncompliant with study requirements|0|||
16880309|NCT04465877|37862011|FG001|Overall Study|Noncompliant with study requirements|0|||
16880310|NCT04465877|37862012|FG002|Overall Study|Noncompliant with study requirements|1|||
16880311|NCT04465877|37862013|FG003|Overall Study|Noncompliant with study requirements|0|||
16880312|NCT04267133|37862070|FG000|Overall Study|Withdrawal by Subject|1|||
16880313|NCT04267133|37862070|FG000|Overall Study|Adverse Event|4|||
16880314|NCT01711541|37862161|FG000|Overall Study|Cancel prior to treatment|0|||
16880315|NCT01711541|37862162|FG001|Overall Study|Cancel prior to treatment|0|||
16880316|NCT01711541|37862163|FG002|Overall Study|Cancel prior to treatment|0|||
16880317|NCT01711541|37862164|FG003|Overall Study|Cancel prior to treatment|1|||
16880318|NCT01711541|37862165|FG004|Overall Study|Cancel prior to treatment|0|||
16880319|NCT01711541|37862161|FG000|Overall Study|Ineligible|0|||
16880320|NCT01711541|37862162|FG001|Overall Study|Ineligible|1|||
16880321|NCT01711541|37862163|FG002|Overall Study|Ineligible|0|||
16880322|NCT01711541|37862164|FG003|Overall Study|Ineligible|0|||
16880323|NCT01711541|37862165|FG004|Overall Study|Ineligible|0|||
16880324|NCT02631876|37862227|FG000|Overall Study|Death|96|||
16880325|NCT02631876|37862228|FG001|Overall Study|Death|50|||
16880326|NCT02631876|37862227|FG000|Overall Study|Investigator's discretion|1|||
16880327|NCT02631876|37862228|FG001|Overall Study|Investigator's discretion|0|||
16880328|NCT02631876|37862227|FG000|Overall Study|Lost to Follow-up|2|||
16880329|NCT02631876|37862228|FG001|Overall Study|Lost to Follow-up|0|||
16880330|NCT02631876|37862227|FG000|Overall Study|Withdrawal by Subject|16|||
16880331|NCT02631876|37862228|FG001|Overall Study|Withdrawal by Subject|9|||
16880332|NCT02631876|37862227|FG000|Overall Study|Other than specified|4|||
16880333|NCT02631876|37862228|FG001|Overall Study|Other than specified|4|||
16880334|NCT02633046|37862257|FG000|Overall Study|Adverse Event|8|||
16880335|NCT02633046|37862257|FG000|Overall Study|Physician Decision|7|||
16880336|NCT02633046|37862257|FG000|Overall Study|Withdrawal by Subject|8|||
16880337|NCT02633046|37862257|FG000|Overall Study|Increased proteinuria|2|||
16880338|NCT02633046|37862257|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
16880339|NCT02633046|37862257|FG000|Overall Study|Mutual decision patient and physician|1|||
17095262|NCT00261846|38234549|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16880340|NCT01672788|37862316|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
16880341|NCT01672788|37862317|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
16880342|NCT01672788|37862318|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
16880343|NCT01672788|37862319|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
17095263|NCT00261846|38234550|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16880344|NCT02632110|37862334|FG000|Overall Study|Withdrawal by Subject|1|||
16880345|NCT02632110|37862335|FG001|Overall Study|Withdrawal by Subject|1|||
16880346|NCT02632110|37862336|FG002|Overall Study|Withdrawal by Subject|0|||
16880347|NCT02632110|37862337|FG003|Overall Study|Withdrawal by Subject|0|||
16880348|NCT02632110|37862338|FG004|Overall Study|Withdrawal by Subject|1|||
16880349|NCT02632110|37862339|FG005|Overall Study|Withdrawal by Subject|1|||
16880350|NCT02632110|37862340|FG006|Overall Study|Withdrawal by Subject|3|||
16880351|NCT02632110|37862341|FG007|Overall Study|Withdrawal by Subject|3|||
16880352|NCT02632110|37862342|FG008|Overall Study|Withdrawal by Subject|1|||
16880353|NCT02632110|37862343|FG009|Overall Study|Withdrawal by Subject|1|||
16880354|NCT01672710|37862585|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
16880355|NCT01672710|37862586|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
16880356|NCT01672710|37862585|FG000|3 Month Follow up|Lost to Follow-up|2|||
16880357|NCT01672710|37862586|FG001|3 Month Follow up|Lost to Follow-up|3|||
16880358|NCT01672710|37862585|FG000|3 Month Follow up|follow up due after termination date|4|||
16880359|NCT01672710|37862586|FG001|3 Month Follow up|follow up due after termination date|1|||
16880360|NCT02630472|37862621|FG000|Overall Study|Physician Decision|10|||
16880361|NCT02630472|37862622|FG001|Overall Study|Physician Decision|0|||
16880362|NCT01670526|37862658|FG000|Overall Study|Withdrawal by Subject|3|||
16880363|NCT01670526|37862659|FG001|Overall Study|Withdrawal by Subject|1|||
16880364|NCT01670526|37862658|FG000|Overall Study|Lost to Follow-up|9|||
16880365|NCT01670526|37862659|FG001|Overall Study|Lost to Follow-up|5|||
16880366|NCT02630706|37862703|FG000|Overall Study|Adverse Event|2|||
16880367|NCT02630706|37862704|FG001|Overall Study|Adverse Event|1|||
16880368|NCT02630706|37862705|FG002|Overall Study|Adverse Event|1|||
16880369|NCT02630706|37862703|FG000|Overall Study|Lost to Follow-up|0|||
16880370|NCT02630706|37862704|FG001|Overall Study|Lost to Follow-up|1|||
16880371|NCT02630706|37862705|FG002|Overall Study|Lost to Follow-up|2|||
16880372|NCT02630706|37862703|FG000|Overall Study|Physician Decision|1|||
16880373|NCT02630706|37862704|FG001|Overall Study|Physician Decision|1|||
16880374|NCT02630706|37862705|FG002|Overall Study|Physician Decision|0|||
16880375|NCT02630706|37862703|FG000|Overall Study|Pregnancy|0|||
16880376|NCT02630706|37862704|FG001|Overall Study|Pregnancy|1|||
16880377|NCT02630706|37862705|FG002|Overall Study|Pregnancy|0|||
16880378|NCT02630706|37862703|FG000|Overall Study|Withdrawal by Subject|4|||
16880379|NCT02630706|37862704|FG001|Overall Study|Withdrawal by Subject|5|||
16880380|NCT02630706|37862705|FG002|Overall Study|Withdrawal by Subject|7|||
16880381|NCT02089997|37862882|FG000|Overall Study|Case report forms uncollected|99|||
16880382|NCT02089997|37862882|FG000|Overall Study|Protocol Violation|147|||
16880383|NCT01363661|37862888|FG000|Overall Study|Adverse Event|9|||
16880384|NCT01363661|37862889|FG001|Overall Study|Adverse Event|2|||
16880385|NCT01363661|37862888|FG000|Overall Study|Withdrawal by Subject|1|||
16880386|NCT01363661|37862889|FG001|Overall Study|Withdrawal by Subject|1|||
16880387|NCT01363661|37862888|FG000|Overall Study|Protocol Violation|1|||
16880388|NCT01363661|37862889|FG001|Overall Study|Protocol Violation|0|||
16880389|NCT01363661|37862888|FG000|Overall Study|Lost to Follow-up|3|||
16880390|NCT01363661|37862889|FG001|Overall Study|Lost to Follow-up|1|||
16880391|NCT02628600|37862897|FG000|Overall Study|Death|2|||
16880392|NCT02628600|37862898|FG001|Overall Study|Death|1|||
16880393|NCT02628600|37862897|FG000|Overall Study|Adverse Event|3|||
16880394|NCT02628600|37862898|FG001|Overall Study|Adverse Event|20|||
16880395|NCT02628600|37862897|FG000|Overall Study|Protocol Violation|0|||
16880396|NCT02628600|37862898|FG001|Overall Study|Protocol Violation|1|||
16880397|NCT02628600|37862897|FG000|Overall Study|Lack of Efficacy|2|||
16880398|NCT02628600|37862898|FG001|Overall Study|Lack of Efficacy|0|||
16880399|NCT02628600|37862897|FG000|Overall Study|Withdrawal by Subject|13|||
16880400|NCT02628600|37862898|FG001|Overall Study|Withdrawal by Subject|8|||
16880401|NCT02628600|37862897|FG000|Overall Study|Lost to Follow-up|1|||
16880402|NCT02628600|37862898|FG001|Overall Study|Lost to Follow-up|0|||
16880403|NCT02628600|37862897|FG000|Overall Study|Physician Decision|2|||
16880404|NCT02628600|37862898|FG001|Overall Study|Physician Decision|2|||
16880405|NCT02628600|37862897|FG000|Overall Study|Other not specified|1|||
16880406|NCT02628600|37862898|FG001|Overall Study|Other not specified|0|||
16880407|NCT00591318|37862915|FG000|Overall Study|Lack of Efficacy|2|||
16880408|NCT00591318|37862916|FG001|Overall Study|Lack of Efficacy|0|||
16880409|NCT00591318|37862915|FG000|Overall Study|Adverse Event|2|||
16880410|NCT00591318|37862916|FG001|Overall Study|Adverse Event|0|||
16880411|NCT01360632|37862929|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
16880412|NCT01360632|37862930|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
16880413|NCT01360632|37862931|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
16880414|NCT01360632|37862932|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
16880415|NCT01360632|37862933|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
16880416|NCT01360632|37862929|FG000|Phase A (8 Weeks)|Adverse Event|60|||
16880417|NCT01360632|37862930|FG001|Phase A (8 Weeks)|Adverse Event|0|||
16880418|NCT01360632|37862931|FG002|Phase A (8 Weeks)|Adverse Event|0|||
16880419|NCT01360632|37862932|FG003|Phase A (8 Weeks)|Adverse Event|0|||
16880420|NCT01360632|37862933|FG004|Phase A (8 Weeks)|Adverse Event|0|||
16880421|NCT01360632|37862929|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
16880422|NCT01360632|37862930|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
16880423|NCT01360632|37862931|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
16880424|NCT01360632|37862932|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
16880425|NCT01360632|37862933|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
16880426|NCT01360632|37862929|FG000|Phase A (8 Weeks)|Physician Decision|10|||
16880427|NCT01360632|37862930|FG001|Phase A (8 Weeks)|Physician Decision|0|||
16880428|NCT01360632|37862931|FG002|Phase A (8 Weeks)|Physician Decision|0|||
16880429|NCT01360632|37862932|FG003|Phase A (8 Weeks)|Physician Decision|0|||
16880430|NCT01360632|37862933|FG004|Phase A (8 Weeks)|Physician Decision|0|||
16880431|NCT01360632|37862929|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
16880432|NCT01360632|37862930|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
16880433|NCT01360632|37862931|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
16880434|NCT01360632|37862932|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
16880435|NCT01360632|37862933|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
16880436|NCT01360632|37862929|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
16880437|NCT01360632|37862930|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
16880438|NCT01360632|37862931|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
16880439|NCT01360632|37862932|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
16880440|NCT01360632|37862933|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
16880441|NCT01360632|37862929|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
16880442|NCT01360632|37862930|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
16880443|NCT01360632|37862931|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
16880444|NCT01360632|37862932|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
16880445|NCT01360632|37862933|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
16880446|NCT01360632|37862929|FG000|Phase B (6 Weeks)|Adverse Event|0|||
16880447|NCT01360632|37862930|FG001|Phase B (6 Weeks)|Adverse Event|3|||
16880448|NCT01360632|37862931|FG002|Phase B (6 Weeks)|Adverse Event|9|||
16880449|NCT01360632|37862932|FG003|Phase B (6 Weeks)|Adverse Event|3|||
16880450|NCT01360632|37862933|FG004|Phase B (6 Weeks)|Adverse Event|0|||
16880451|NCT01360632|37862929|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16880452|NCT01360632|37862930|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16880453|NCT01360632|37862931|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
16880454|NCT01360632|37862932|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
16880455|NCT01360632|37862933|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16880456|NCT01360632|37862929|FG000|Phase B (6 Weeks)|Physician Decision|0|||
16880457|NCT01360632|37862930|FG001|Phase B (6 Weeks)|Physician Decision|0|||
16880458|NCT01360632|37862931|FG002|Phase B (6 Weeks)|Physician Decision|0|||
16880459|NCT01360632|37862932|FG003|Phase B (6 Weeks)|Physician Decision|1|||
16880460|NCT01360632|37862933|FG004|Phase B (6 Weeks)|Physician Decision|0|||
16880461|NCT01360632|37862929|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
16880462|NCT01360632|37862930|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
16880463|NCT01360632|37862931|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
16880464|NCT01360632|37862932|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
16880465|NCT01360632|37862933|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
16880466|NCT01360632|37862929|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
16880467|NCT01360632|37862930|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
16880468|NCT01360632|37862931|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
16880469|NCT01360632|37862932|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
16880470|NCT01360632|37862933|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
16880471|NCT01360632|37862929|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
16880472|NCT01360632|37862930|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
16880473|NCT01360632|37862931|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
16880474|NCT01360632|37862932|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
16880475|NCT01360632|37862933|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
16880476|NCT01360632|37862929|FG000|Phase A+|Lost to Follow-up|0|||
16880477|NCT01360632|37862930|FG001|Phase A+|Lost to Follow-up|0|||
16880478|NCT01360632|37862931|FG002|Phase A+|Lost to Follow-up|0|||
16880479|NCT01360632|37862932|FG003|Phase A+|Lost to Follow-up|0|||
16880480|NCT01360632|37862933|FG004|Phase A+|Lost to Follow-up|2|||
16880481|NCT01360632|37862929|FG000|Phase A+|Adverse Event|0|||
16880482|NCT01360632|37862930|FG001|Phase A+|Adverse Event|0|||
16880483|NCT01360632|37862931|FG002|Phase A+|Adverse Event|0|||
16880484|NCT01360632|37862932|FG003|Phase A+|Adverse Event|0|||
16785576|NCT02700919|37725715|FG002|Overall Study|Physician Decision|0|||
16880485|NCT01360632|37862933|FG004|Phase A+|Adverse Event|2|||
16880486|NCT01360632|37862929|FG000|Phase A+|Met Withdrawal Criteria|0|||
16880487|NCT01360632|37862930|FG001|Phase A+|Met Withdrawal Criteria|0|||
16880488|NCT01360632|37862931|FG002|Phase A+|Met Withdrawal Criteria|0|||
16880489|NCT01360632|37862932|FG003|Phase A+|Met Withdrawal Criteria|0|||
16880490|NCT01360632|37862933|FG004|Phase A+|Met Withdrawal Criteria|7|||
16880491|NCT01360632|37862929|FG000|Phase A+|Physician Decision|0|||
16880492|NCT01360632|37862930|FG001|Phase A+|Physician Decision|0|||
16880493|NCT01360632|37862931|FG002|Phase A+|Physician Decision|0|||
16880494|NCT01360632|37862932|FG003|Phase A+|Physician Decision|0|||
16880495|NCT01360632|37862933|FG004|Phase A+|Physician Decision|3|||
16880496|NCT01360632|37862929|FG000|Phase A+|Withdrawal by Subject|0|||
16880497|NCT01360632|37862930|FG001|Phase A+|Withdrawal by Subject|0|||
16880498|NCT01360632|37862931|FG002|Phase A+|Withdrawal by Subject|0|||
16880499|NCT01360632|37862932|FG003|Phase A+|Withdrawal by Subject|0|||
16880500|NCT01360632|37862933|FG004|Phase A+|Withdrawal by Subject|8|||
16880501|NCT01360632|37862929|FG000|Phase A+|Protocol Deviation|0|||
16880502|NCT01360632|37862930|FG001|Phase A+|Protocol Deviation|0|||
16880503|NCT01360632|37862931|FG002|Phase A+|Protocol Deviation|0|||
16880504|NCT01360632|37862932|FG003|Phase A+|Protocol Deviation|0|||
16880505|NCT01360632|37862933|FG004|Phase A+|Protocol Deviation|3|||
16880506|NCT04157400|37862979|FG000|Overall Study|Withdrawal by Subject|1|||
16880507|NCT04157400|37862979|FG000|Overall Study|Lost to Follow-up|3|||
16880508|NCT02626182|37863060|FG000|Overall Study|Adverse Event|2|||
16880509|NCT02626182|37863061|FG001|Overall Study|Adverse Event|0|||
16880510|NCT01669902|37863168|FG000|Overall Study|Adverse Event|11|||
16880511|NCT01669902|37863168|FG000|Overall Study|Lack of Efficacy|10|||
16880512|NCT01669902|37863168|FG000|Overall Study|Other|8|||
16880513|NCT01670292|37863201|FG000|Overall Study|Lost to Follow-up|14|||
16880514|NCT01360554|37863438|FG000|Overall Study|Death|359|||
16880515|NCT01360554|37863439|FG001|Overall Study|Death|371|||
16880516|NCT01360554|37863438|FG000|Overall Study|Lost to Follow-up|4|||
16880517|NCT01360554|37863439|FG001|Overall Study|Lost to Follow-up|4|||
16880518|NCT01360554|37863438|FG000|Overall Study|Withdrawal by Subject|23|||
16880519|NCT01360554|37863439|FG001|Overall Study|Withdrawal by Subject|24|||
16880520|NCT01360554|37863438|FG000|Overall Study|Study terminated by sponsor|49|||
16880521|NCT01360554|37863439|FG001|Overall Study|Study terminated by sponsor|37|||
16880522|NCT01360554|37863438|FG000|Overall Study|Other, not specified|1|||
16880523|NCT01360554|37863439|FG001|Overall Study|Other, not specified|0|||
16880524|NCT01360554|37863438|FG000|Overall Study|Randomized but not treated.|3|||
16880525|NCT01360554|37863439|FG001|Overall Study|Randomized but not treated.|3|||
16880526|NCT01360398|37863461|FG000|Overall Study|Withdrawal by Subject|14|||
16880527|NCT01360398|37863461|FG000|Overall Study|Other|7|||
16880528|NCT01360398|37863461|FG000|Overall Study|Migrated/moved from study area|1|||
16880529|NCT02626026|37863471|FG000|Overall Study|Randomized but Never Treated|0|||
16880530|NCT02626026|37863472|FG001|Overall Study|Randomized but Never Treated|0|||
16880531|NCT02626026|37863473|FG002|Overall Study|Randomized but Never Treated|0|||
16880532|NCT02626026|37863474|FG003|Overall Study|Randomized but Never Treated|0|||
16880533|NCT02626026|37863475|FG004|Overall Study|Randomized but Never Treated|1|||
16880534|NCT02626026|37863476|FG005|Overall Study|Randomized but Never Treated|0|||
16880535|NCT01765296|37863740|FG000|Overall Study|Protocol Violation|0|||
16880536|NCT01765296|37863741|FG001|Overall Study|Protocol Violation|5|||
16880537|NCT01765296|37863742|FG002|Overall Study|Protocol Violation|4|||
16880538|NCT01765296|37863740|FG000|Overall Study|Withdrawal by Subject|4|||
16880539|NCT01765296|37863741|FG001|Overall Study|Withdrawal by Subject|2|||
16880540|NCT01765296|37863742|FG002|Overall Study|Withdrawal by Subject|2|||
16880541|NCT01765296|37863740|FG000|Overall Study|Adverse Event|1|||
16880542|NCT01765296|37863741|FG001|Overall Study|Adverse Event|13|||
16880543|NCT01765296|37863742|FG002|Overall Study|Adverse Event|5|||
16880544|NCT01765296|37863740|FG000|Overall Study|Lack of Efficacy|0|||
17095264|NCT00261846|38234551|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
17095265|NCT00261846|38234540|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17095266|NCT00261846|38234541|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17095267|NCT00261846|38234542|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17095268|NCT00261846|38234543|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
17002131|NCT00645853|38146233|FG000|Overall Study|recall of ICF, planned operation, death|7|||
17002132|NCT00645853|38146234|FG001|Overall Study|recall of ICF, planned operation, death|4|||
16880545|NCT01765296|37863741|FG001|Overall Study|Lack of Efficacy|0|||
16880546|NCT01765296|37863742|FG002|Overall Study|Lack of Efficacy|2|||
16880547|NCT02089685|37863816|FG000|Overall Study|Adverse Event|1|||
16880548|NCT02089685|37863817|FG001|Overall Study|Adverse Event|0|||
16880549|NCT02089685|37863818|FG002|Overall Study|Adverse Event|0|||
16880550|NCT02089685|37863819|FG003|Overall Study|Adverse Event|0|||
16880551|NCT02089685|37863820|FG004|Overall Study|Adverse Event|1|||
16880552|NCT02089685|37863821|FG005|Overall Study|Adverse Event|0|||
16880553|NCT02089685|37863816|FG000|Overall Study|Clinical Progression|4|||
16880554|NCT02089685|37863817|FG001|Overall Study|Clinical Progression|0|||
16880555|NCT02089685|37863818|FG002|Overall Study|Clinical Progression|0|||
16880556|NCT02089685|37863819|FG003|Overall Study|Clinical Progression|5|||
16880557|NCT02089685|37863820|FG004|Overall Study|Clinical Progression|1|||
16880558|NCT02089685|37863821|FG005|Overall Study|Clinical Progression|2|||
16880559|NCT02089685|37863816|FG000|Overall Study|Excluded Medication|1|||
16880560|NCT02089685|37863817|FG001|Overall Study|Excluded Medication|0|||
16880561|NCT02089685|37863818|FG002|Overall Study|Excluded Medication|0|||
16880562|NCT02089685|37863819|FG003|Overall Study|Excluded Medication|11|||
16880563|NCT02089685|37863820|FG004|Overall Study|Excluded Medication|2|||
16880564|NCT02089685|37863821|FG005|Overall Study|Excluded Medication|1|||
16880565|NCT02089685|37863816|FG000|Overall Study|Progressive disease|13|||
16880566|NCT02089685|37863817|FG001|Overall Study|Progressive disease|10|||
16880567|NCT02089685|37863818|FG002|Overall Study|Progressive disease|3|||
17002133|NCT00652093|38146246|FG000|Overall Study|Withdrawal by Subject|0|||
16880568|NCT02089685|37863819|FG003|Overall Study|Progressive disease|51|||
16880569|NCT02089685|37863820|FG004|Overall Study|Progressive disease|17|||
16880570|NCT02089685|37863821|FG005|Overall Study|Progressive disease|12|||
16880571|NCT02089685|37863816|FG000|Overall Study|Follow up ended by sponsor|2|||
16880572|NCT02089685|37863817|FG001|Overall Study|Follow up ended by sponsor|2|||
16880573|NCT02089685|37863818|FG002|Overall Study|Follow up ended by sponsor|0|||
16880574|NCT02089685|37863819|FG003|Overall Study|Follow up ended by sponsor|70|||
16880575|NCT02089685|37863820|FG004|Overall Study|Follow up ended by sponsor|26|||
16880576|NCT02089685|37863821|FG005|Overall Study|Follow up ended by sponsor|26|||
16880577|NCT02089685|37863816|FG000|Overall Study|Withdrawal by Subject|0|||
16880578|NCT02089685|37863817|FG001|Overall Study|Withdrawal by Subject|2|||
16880579|NCT02089685|37863818|FG002|Overall Study|Withdrawal by Subject|0|||
16880580|NCT02089685|37863819|FG003|Overall Study|Withdrawal by Subject|8|||
16880581|NCT02089685|37863820|FG004|Overall Study|Withdrawal by Subject|1|||
16880582|NCT02089685|37863821|FG005|Overall Study|Withdrawal by Subject|1|||
16880583|NCT02089685|37863816|FG000|Overall Study|Status not recorded|1|||
16880584|NCT02089685|37863817|FG001|Overall Study|Status not recorded|0|||
17191716|NCT00409773|38344552|FG004|Overall Study|Adverse Event|6|||
17191717|NCT00409773|38344548|FG000|Overall Study|Lost to Follow-up|6|||
17191718|NCT00409773|38344549|FG001|Overall Study|Lost to Follow-up|1|||
17191719|NCT00409773|38344550|FG002|Overall Study|Lost to Follow-up|2|||
17191720|NCT00409773|38344551|FG003|Overall Study|Lost to Follow-up|3|||
17191721|NCT00409773|38344552|FG004|Overall Study|Lost to Follow-up|1|||
17191722|NCT00409773|38344548|FG000|Overall Study|Physician Decision|0|||
17191723|NCT00409773|38344549|FG001|Overall Study|Physician Decision|0|||
17191724|NCT00409773|38344550|FG002|Overall Study|Physician Decision|0|||
17191725|NCT00409773|38344551|FG003|Overall Study|Physician Decision|2|||
17191726|NCT00409773|38344552|FG004|Overall Study|Physician Decision|0|||
17191727|NCT00409773|38344548|FG000|Overall Study|Protocol Violation|0|||
17191728|NCT00409773|38344549|FG001|Overall Study|Protocol Violation|2|||
17191729|NCT00409773|38344550|FG002|Overall Study|Protocol Violation|3|||
16785577|NCT02700919|37725713|FG000|Overall Study|Protocol Violation|1|||
17191730|NCT00409773|38344551|FG003|Overall Study|Protocol Violation|3|||
17191731|NCT00409773|38344552|FG004|Overall Study|Protocol Violation|1|||
17191732|NCT00409773|38344548|FG000|Overall Study|Withdrawal by Subject|0|||
17191733|NCT00409773|38344549|FG001|Overall Study|Withdrawal by Subject|0|||
17191734|NCT00409773|38344550|FG002|Overall Study|Withdrawal by Subject|0|||
17191735|NCT00409773|38344551|FG003|Overall Study|Withdrawal by Subject|2|||
17191736|NCT00409773|38344552|FG004|Overall Study|Withdrawal by Subject|1|||
17191737|NCT00409773|38344548|FG000|Overall Study|Lack of Eligibility|0|||
17191738|NCT00409773|38344549|FG001|Overall Study|Lack of Eligibility|0|||
17191739|NCT00409773|38344550|FG002|Overall Study|Lack of Eligibility|0|||
17191740|NCT00409773|38344551|FG003|Overall Study|Lack of Eligibility|0|||
17191741|NCT00409773|38344552|FG004|Overall Study|Lack of Eligibility|1|||
17191742|NCT02861807|38344566|FG000|Overall Study|Lost to Follow-up|7|||
17191743|NCT02861807|38344567|FG001|Overall Study|Lost to Follow-up|6|||
17191744|NCT02861807|38344566|FG000|Overall Study|Withdrawal by Subject|5|||
17191745|NCT02861807|38344567|FG001|Overall Study|Withdrawal by Subject|8|||
17191746|NCT02858401|38344580|FG000|Overall Study|Withdrew Consent|0|||
17191747|NCT02858401|38344581|FG001|Overall Study|Withdrew Consent|0|||
17191748|NCT02858401|38344582|FG002|Overall Study|Withdrew Consent|0|||
17191749|NCT02858401|38344583|FG003|Overall Study|Withdrew Consent|0|||
17191750|NCT02858401|38344584|FG004|Overall Study|Withdrew Consent|0|||
17191751|NCT02858401|38344585|FG005|Overall Study|Withdrew Consent|1|||
17191752|NCT02858401|38344586|FG006|Overall Study|Withdrew Consent|0|||
17191753|NCT02858401|38344580|FG000|Overall Study|Lost to Follow-up|0|||
17191754|NCT02858401|38344581|FG001|Overall Study|Lost to Follow-up|1|||
17191755|NCT02858401|38344582|FG002|Overall Study|Lost to Follow-up|0|||
17191756|NCT02858401|38344583|FG003|Overall Study|Lost to Follow-up|0|||
17191757|NCT02858401|38344584|FG004|Overall Study|Lost to Follow-up|0|||
17191758|NCT02858401|38344585|FG005|Overall Study|Lost to Follow-up|0|||
17191759|NCT02858401|38344586|FG006|Overall Study|Lost to Follow-up|0|||
17191760|NCT02857283|38344613|FG000|First Exposure|Withdrawal by Subject|1|||
17191761|NCT02857283|38344614|FG001|First Exposure|Withdrawal by Subject|0|||
17191762|NCT02747927|38344632|FG000|Overall Study|Adverse Event|5|||
17191763|NCT02747927|38344633|FG001|Overall Study|Adverse Event|14|||
17191764|NCT02747927|38344632|FG000|Overall Study|Lost to Follow-up|22|||
17191765|NCT02747927|38344633|FG001|Overall Study|Lost to Follow-up|43|||
17191766|NCT02747927|38344632|FG000|Overall Study|Pregnancy|34|||
17191767|NCT02747927|38344633|FG001|Overall Study|Pregnancy|66|||
17191768|NCT02747927|38344632|FG000|Overall Study|Protocol Violation|2|||
17191769|NCT02747927|38344633|FG001|Overall Study|Protocol Violation|4|||
17191770|NCT02747927|38344632|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
17191771|NCT02747927|38344633|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
17191772|NCT02747927|38344632|FG000|Overall Study|Reason not Specified|11|||
16880585|NCT02089685|37863818|FG002|Overall Study|Status not recorded|0|||
16880586|NCT02089685|37863819|FG003|Overall Study|Status not recorded|0|||
16880587|NCT02089685|37863820|FG004|Overall Study|Status not recorded|1|||
17191773|NCT02747927|38344633|FG001|Overall Study|Reason not Specified|27|||
16880588|NCT02089685|37863821|FG005|Overall Study|Status not recorded|0|||
16880589|NCT02089685|37863816|FG000|Overall Study|Death|0|||
16880590|NCT02089685|37863817|FG001|Overall Study|Death|0|||
16880591|NCT02089685|37863818|FG002|Overall Study|Death|0|||
16880592|NCT02089685|37863819|FG003|Overall Study|Death|7|||
16880593|NCT02089685|37863820|FG004|Overall Study|Death|2|||
16880594|NCT02089685|37863821|FG005|Overall Study|Death|5|||
16880595|NCT02089685|37863816|FG000|Overall Study|Lost to Follow-up|0|||
16880596|NCT02089685|37863817|FG001|Overall Study|Lost to Follow-up|0|||
16880597|NCT02089685|37863818|FG002|Overall Study|Lost to Follow-up|0|||
16880598|NCT02089685|37863819|FG003|Overall Study|Lost to Follow-up|1|||
16880599|NCT02089685|37863820|FG004|Overall Study|Lost to Follow-up|0|||
16880600|NCT02089685|37863821|FG005|Overall Study|Lost to Follow-up|0|||
16880601|NCT02089685|37863816|FG000|Overall Study|Physician Decision|0|||
16880602|NCT02089685|37863817|FG001|Overall Study|Physician Decision|0|||
16880603|NCT02089685|37863818|FG002|Overall Study|Physician Decision|0|||
16880604|NCT02089685|37863819|FG003|Overall Study|Physician Decision|0|||
16880605|NCT02089685|37863820|FG004|Overall Study|Physician Decision|0|||
16880606|NCT02089685|37863821|FG005|Overall Study|Physician Decision|4|||
16880607|NCT02089685|37863816|FG000|Overall Study|Screen failure|1|||
16880608|NCT02089685|37863817|FG001|Overall Study|Screen failure|0|||
16880609|NCT02089685|37863818|FG002|Overall Study|Screen failure|0|||
16880610|NCT02089685|37863819|FG003|Overall Study|Screen failure|0|||
16880611|NCT02089685|37863820|FG004|Overall Study|Screen failure|0|||
16880612|NCT02089685|37863821|FG005|Overall Study|Screen failure|0|||
16880613|NCT02088905|37863890|FG000|Overall Study|Withdrawal by Subject|5|||
16880614|NCT02088905|37863891|FG001|Overall Study|Withdrawal by Subject|1|||
16880615|NCT02088047|37863899|FG000|Overall Study|Withdrawal by Subject|1|||
16880616|NCT02088047|37863900|FG001|Overall Study|Withdrawal by Subject|0|||
16880617|NCT02086565|37863926|FG000|Overall Study|Lost to Follow-up|9|||
16880618|NCT02086565|37863927|FG001|Overall Study|Lost to Follow-up|7|||
16880619|NCT02086565|37863926|FG000|Overall Study|Withdrawal by Subject|2|||
16880620|NCT02086565|37863927|FG001|Overall Study|Withdrawal by Subject|1|||
16880621|NCT02086565|37863926|FG000|Overall Study|Death|3|||
16880622|NCT02086565|37863927|FG001|Overall Study|Death|2|||
16880623|NCT02086565|37863926|FG000|Overall Study|withdrawn by research team|2|||
16880624|NCT02086565|37863927|FG001|Overall Study|withdrawn by research team|2|||
16880625|NCT02085941|37863935|FG000|Overall Study|Lack of Efficacy|1|||
16880626|NCT02085941|37863936|FG001|Overall Study|Lack of Efficacy|0|||
16880627|NCT02085941|37863935|FG000|Overall Study|Death|6|||
16880628|NCT02085941|37863936|FG001|Overall Study|Death|1|||
16880629|NCT02085941|37863935|FG000|Overall Study|Lost to Follow-up|1|||
16880630|NCT02085941|37863936|FG001|Overall Study|Lost to Follow-up|0|||
16880631|NCT02085941|37863935|FG000|Overall Study|Physician Decision|0|||
16880632|NCT02085941|37863936|FG001|Overall Study|Physician Decision|2|||
16880633|NCT02085785|37863944|FG000|Overall Study|Withdrawal by Subject|2|||
16880634|NCT02085785|37863945|FG001|Overall Study|Withdrawal by Subject|1|||
16880635|NCT02085785|37863944|FG000|Overall Study|Lost to Follow-up|0|||
16880636|NCT02085785|37863945|FG001|Overall Study|Lost to Follow-up|1|||
16880637|NCT02085161|37863973|FG000|Overall Study|Not Treated|1|||
16880638|NCT02085161|37863974|FG001|Overall Study|Not Treated|0|||
16880639|NCT02085161|37863975|FG002|Overall Study|Not Treated|0|||
16880640|NCT02085161|37863976|FG003|Overall Study|Not Treated|0|||
16880641|NCT02085161|37863973|FG000|Overall Study|Adverse Event|8|||
16880642|NCT02085161|37863974|FG001|Overall Study|Adverse Event|5|||
16880643|NCT02085161|37863975|FG002|Overall Study|Adverse Event|4|||
16880644|NCT02085161|37863976|FG003|Overall Study|Adverse Event|5|||
16880645|NCT02085161|37863973|FG000|Overall Study|Protocol Violation|0|||
16880646|NCT02085161|37863974|FG001|Overall Study|Protocol Violation|1|||
16880647|NCT02085161|37863975|FG002|Overall Study|Protocol Violation|0|||
16880648|NCT02085161|37863976|FG003|Overall Study|Protocol Violation|1|||
16880649|NCT02085161|37863973|FG000|Overall Study|Withdrawal by Subject|2|||
16880650|NCT02085161|37863974|FG001|Overall Study|Withdrawal by Subject|4|||
16880651|NCT02085161|37863975|FG002|Overall Study|Withdrawal by Subject|0|||
16880652|NCT02085161|37863976|FG003|Overall Study|Withdrawal by Subject|3|||
16880653|NCT02085161|37863973|FG000|Overall Study|Other Reason|1|||
16880654|NCT02085161|37863974|FG001|Overall Study|Other Reason|0|||
16880655|NCT02085161|37863975|FG002|Overall Study|Other Reason|1|||
16785578|NCT02700919|37725714|FG001|Overall Study|Protocol Violation|0|||
16785579|NCT02700919|37725715|FG002|Overall Study|Protocol Violation|0|||
16785580|NCT02700919|37725713|FG000|Overall Study|Adverse Event|1|||
16785581|NCT02700919|37725714|FG001|Overall Study|Adverse Event|3|||
16785582|NCT02700919|37725715|FG002|Overall Study|Adverse Event|1|||
16785583|NCT02700919|37725713|FG000|Overall Study|Withdrawal by Subject|5|||
16785584|NCT02700919|37725714|FG001|Overall Study|Withdrawal by Subject|8|||
16785585|NCT02700919|37725715|FG002|Overall Study|Withdrawal by Subject|2|||
16880656|NCT02085161|37863976|FG003|Overall Study|Other Reason|1|||
16880657|NCT02082977|37864876|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
16880658|NCT02082977|37864877|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
16880659|NCT02082977|37864878|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
16880660|NCT02082977|37864879|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
16880661|NCT02082977|37864880|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
16880662|NCT02082977|37864881|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
16880663|NCT02082977|37864882|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
16880664|NCT02082977|37864883|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
16880665|NCT02082977|37864884|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
16880666|NCT02082977|37864885|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
16880667|NCT02082977|37864876|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880668|NCT02082977|37864877|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880669|NCT02082977|37864878|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880670|NCT02082977|37864879|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880671|NCT02082977|37864880|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880672|NCT02082977|37864881|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880673|NCT02082977|37864882|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880674|NCT02082977|37864883|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
16880675|NCT02082977|37864884|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880676|NCT02082977|37864885|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16880677|NCT02082977|37864876|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880678|NCT02082977|37864877|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880679|NCT02082977|37864878|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880680|NCT02082977|37864879|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880681|NCT02082977|37864880|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880682|NCT02082977|37864881|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
16880683|NCT02082977|37864882|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880684|NCT02082977|37864883|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880685|NCT02082977|37864884|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880686|NCT02082977|37864885|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16880687|NCT02082977|37864876|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16880688|NCT02082977|37864877|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16880689|NCT02082977|37864878|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16880690|NCT02082977|37864879|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16880691|NCT02082977|37864880|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
16880692|NCT02082977|37864881|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
16880693|NCT02082977|37864882|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
16880694|NCT02082977|37864883|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
16880695|NCT02082977|37864884|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
16880696|NCT02082977|37864885|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16880697|NCT02082977|37864876|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880698|NCT02082977|37864877|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880699|NCT02082977|37864878|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880700|NCT02082977|37864879|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880701|NCT02082977|37864880|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880702|NCT02082977|37864881|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880703|NCT02082977|37864882|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880704|NCT02082977|37864883|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
16880705|NCT02082977|37864884|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880706|NCT02082977|37864885|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16880707|NCT01624259|37864919|FG000|Overall Study|Adverse Event|18|||
16880708|NCT01624259|37864920|FG001|Overall Study|Adverse Event|18|||
16880709|NCT01624259|37864919|FG000|Overall Study|Protocol Violation|1|||
16880710|NCT01624259|37864920|FG001|Overall Study|Protocol Violation|2|||
16880711|NCT01624259|37864919|FG000|Overall Study|Withdrawal by Subject|5|||
16880712|NCT01624259|37864920|FG001|Overall Study|Withdrawal by Subject|7|||
16880713|NCT01624259|37864919|FG000|Overall Study|Physician Decision|1|||
16880714|NCT01624259|37864920|FG001|Overall Study|Physician Decision|1|||
16880715|NCT01624259|37864919|FG000|Overall Study|Lost to Follow-up|2|||
16880716|NCT01624259|37864920|FG001|Overall Study|Lost to Follow-up|3|||
16880717|NCT01624259|37864919|FG000|Overall Study|Abnormal laboratory measure|3|||
16880718|NCT01624259|37864920|FG001|Overall Study|Abnormal laboratory measure|0|||
16880719|NCT02081417|37864930|FG000|Overall Study|Lost to Follow-up|26|||
16880720|NCT02081417|37864931|FG001|Overall Study|Lost to Follow-up|23|||
16880721|NCT02081417|37864930|FG000|Overall Study|Moved Away|1|||
16880722|NCT02081417|37864931|FG001|Overall Study|Moved Away|2|||
16880723|NCT02081417|37864930|FG000|Overall Study|Incarcerated|2|||
16880724|NCT02081417|37864931|FG001|Overall Study|Incarcerated|2|||
16880725|NCT02081417|37864930|FG000|Overall Study|Death|4|||
16880726|NCT02081417|37864931|FG001|Overall Study|Death|3|||
16880727|NCT02081417|37864930|FG000|Overall Study|Withdrawal by Subject|4|||
16880728|NCT02081417|37864931|FG001|Overall Study|Withdrawal by Subject|0|||
16880729|NCT02081417|37864930|FG000|Overall Study|Admitted to Residential Treatment|2|||
16880730|NCT02081417|37864931|FG001|Overall Study|Admitted to Residential Treatment|0|||
16880731|NCT02081417|37864930|FG000|Overall Study|Did not start treatment|17|||
16880732|NCT02081417|37864931|FG001|Overall Study|Did not start treatment|21|||
16880733|NCT02081183|37864939|FG000|Overall Study|Lost to Follow-up|0|||
16880734|NCT02081183|37864940|FG001|Overall Study|Lost to Follow-up|1|||
16880735|NCT02081183|37864939|FG000|Overall Study|Protocol Violation|1|||
16880736|NCT02081183|37864940|FG001|Overall Study|Protocol Violation|0|||
16880737|NCT02081183|37864939|FG000|Overall Study|Other|3|||
16880738|NCT02081183|37864940|FG001|Overall Study|Other|3|||
16880739|NCT02080871|37864946|FG000|Overall Study|Death|1|||
16880740|NCT02080871|37864946|FG000|Overall Study|Lost to Follow-up|1|||
16880741|NCT02080481|37864952|FG000|Overall Study|Never received a block.|1|||
16880742|NCT02080481|37864953|FG001|Overall Study|Never received a block.|0|||
16880743|NCT02080403|37864961|FG000|Overall Study|Adverse Event|5|||
16880744|NCT02080403|37864962|FG001|Overall Study|Adverse Event|1|||
16880745|NCT02080403|37864961|FG000|Overall Study|Death|0|||
16880746|NCT02080403|37864962|FG001|Overall Study|Death|2|||
16880747|NCT02080403|37864961|FG000|Overall Study|Lost to Follow-up|2|||
16880748|NCT02080403|37864962|FG001|Overall Study|Lost to Follow-up|0|||
16880749|NCT02080403|37864961|FG000|Overall Study|Pregnancy|0|||
16880750|NCT02080403|37864962|FG001|Overall Study|Pregnancy|1|||
16880751|NCT02080403|37864961|FG000|Overall Study|Protocol Violation|3|||
16880752|NCT02080403|37864962|FG001|Overall Study|Protocol Violation|7|||
16880753|NCT02080403|37864961|FG000|Overall Study|Withdrawal by Subject|5|||
16880754|NCT02080403|37864962|FG001|Overall Study|Withdrawal by Subject|1|||
16880755|NCT02080091|37864968|FG000|Overall Study|Study Terminated|22|||
16880756|NCT02080091|37864968|FG000|Overall Study|Death|1|||
16880757|NCT02080091|37864968|FG000|Overall Study|Withdrawal by Subject|1|||
16880758|NCT02080091|37864968|FG000|Overall Study|Other|1|||
16880759|NCT02079077|37864974|FG000|Overall Study|Lost to Follow-up|5|||
16880760|NCT02079077|37864975|FG001|Overall Study|Lost to Follow-up|7|||
16880761|NCT02079077|37864974|FG000|Overall Study|Became STIs Positive|1|||
16880762|NCT02079077|37864975|FG001|Overall Study|Became STIs Positive|2|||
16880763|NCT02078219|37865003|FG000|Overall Study|Other|2|||
16880764|NCT02078219|37865004|FG001|Overall Study|Other|2|||
16880765|NCT02078219|37865005|FG002|Overall Study|Other|3|||
16880766|NCT02078219|37865006|FG003|Overall Study|Other|0|||
16880767|NCT02078219|37865007|FG004|Overall Study|Other|1|||
16880768|NCT02078219|37865003|FG000|Overall Study|Withdrawal by Subject|0|||
16880769|NCT02078219|37865004|FG001|Overall Study|Withdrawal by Subject|1|||
16880770|NCT02078219|37865005|FG002|Overall Study|Withdrawal by Subject|0|||
16880771|NCT02078219|37865006|FG003|Overall Study|Withdrawal by Subject|1|||
16880772|NCT02078219|37865007|FG004|Overall Study|Withdrawal by Subject|1|||
16880773|NCT02078219|37865003|FG000|Overall Study|Protocol Violation|0|||
16880774|NCT02078219|37865004|FG001|Overall Study|Protocol Violation|0|||
16880775|NCT02078219|37865005|FG002|Overall Study|Protocol Violation|0|||
16880776|NCT02078219|37865006|FG003|Overall Study|Protocol Violation|1|||
16880777|NCT02078219|37865007|FG004|Overall Study|Protocol Violation|0|||
16880778|NCT02078219|37865003|FG000|Overall Study|Death|0|||
16880779|NCT02078219|37865004|FG001|Overall Study|Death|0|||
16880780|NCT02078219|37865005|FG002|Overall Study|Death|0|||
16880781|NCT02078219|37865006|FG003|Overall Study|Death|1|||
17002134|NCT00652093|38146247|FG001|Overall Study|Withdrawal by Subject|0|||
17002135|NCT00652093|38146248|FG002|Overall Study|Withdrawal by Subject|1|||
17002136|NCT00652093|38146249|FG003|Overall Study|Withdrawal by Subject|0|||
17002137|NCT00652093|38146250|FG004|Overall Study|Withdrawal by Subject|1|||
17002138|NCT00652093|38146251|FG005|Overall Study|Withdrawal by Subject|0|||
17002139|NCT00652093|38146246|FG000|Overall Study|Physician Decision|0|||
17002140|NCT00652093|38146247|FG001|Overall Study|Physician Decision|0|||
17002141|NCT00652093|38146248|FG002|Overall Study|Physician Decision|0|||
17002142|NCT00652093|38146249|FG003|Overall Study|Physician Decision|0|||
17002143|NCT00652093|38146250|FG004|Overall Study|Physician Decision|1|||
17002144|NCT00652093|38146251|FG005|Overall Study|Physician Decision|0|||
17002145|NCT00651937|38146267|FG000|Overall Study|Withdrawal by Subject|4|||
17002146|NCT00651937|38146268|FG001|Overall Study|Withdrawal by Subject|1|||
17002147|NCT00654355|38146276|FG000|Overall Study|Lost to Follow-up|2|||
17002148|NCT00654355|38146277|FG001|Overall Study|Lost to Follow-up|2|||
16785586|NCT02700919|37725713|FG000|Overall Study|Lost to Follow-up|2|||
17002149|NCT00651313|38146285|FG000|Overall Study|Adverse Event|0|||
17002150|NCT00651313|38146286|FG001|Overall Study|Adverse Event|1|||
17002151|NCT00651313|38146285|FG000|Overall Study|Withdrawal by Subject|3|||
17002152|NCT00651313|38146286|FG001|Overall Study|Withdrawal by Subject|1|||
16785587|NCT02700919|37725714|FG001|Overall Study|Lost to Follow-up|0|||
16785588|NCT02700919|37725715|FG002|Overall Study|Lost to Follow-up|0|||
16785589|NCT02700919|37725713|FG000|Overall Study|Other|2|||
16785590|NCT02700919|37725714|FG001|Overall Study|Other|1|||
16785591|NCT02700919|37725715|FG002|Overall Study|Other|1|||
16785592|NCT01986010|37725740|FG000|Overall Study|Adverse Event|0|||
16785593|NCT01986010|37725741|FG001|Overall Study|Adverse Event|1|||
16785594|NCT01986010|37725742|FG002|Overall Study|Adverse Event|0|||
16880782|NCT02078219|37865007|FG004|Overall Study|Death|0|||
16880783|NCT02078219|37865003|FG000|Overall Study|Adverse Event|1|||
16880784|NCT02078219|37865004|FG001|Overall Study|Adverse Event|1|||
16880785|NCT02078219|37865005|FG002|Overall Study|Adverse Event|3|||
16880786|NCT02078219|37865006|FG003|Overall Study|Adverse Event|1|||
16880787|NCT02078219|37865007|FG004|Overall Study|Adverse Event|0|||
17002153|NCT00651313|38146285|FG000|Overall Study|Lost to Follow-up|1|||
17002154|NCT00651313|38146286|FG001|Overall Study|Lost to Follow-up|1|||
17002155|NCT00651313|38146285|FG000|Overall Study|Adminstrative Discontinuation|2|||
17002156|NCT00651313|38146286|FG001|Overall Study|Adminstrative Discontinuation|3|||
17002157|NCT00969761|38146304|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
17002158|NCT00969761|38146305|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
17002159|NCT00969761|38146306|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
17002160|NCT00969761|38146307|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
17002161|NCT00969761|38146308|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
17002162|NCT00969761|38146309|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
17002163|NCT00969761|38146310|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
17002164|NCT00969761|38146311|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
17002165|NCT00969761|38146312|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
17002166|NCT00969761|38146313|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
17002167|NCT00969761|38146314|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
17002168|NCT00969761|38146315|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
17002169|NCT00969761|38146304|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002170|NCT00969761|38146305|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002171|NCT00969761|38146306|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
17002172|NCT00969761|38146307|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002173|NCT00969761|38146308|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002174|NCT00969761|38146309|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002175|NCT00969761|38146310|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002176|NCT00969761|38146311|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002177|NCT00969761|38146312|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002178|NCT00969761|38146313|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002179|NCT00969761|38146314|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002180|NCT00969761|38146315|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
17002181|NCT00969761|38146304|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002182|NCT00969761|38146305|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002183|NCT00969761|38146306|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
17002184|NCT00969761|38146307|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002185|NCT00969761|38146308|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002186|NCT00969761|38146309|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002187|NCT00969761|38146310|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002188|NCT00969761|38146311|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002189|NCT00969761|38146312|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002190|NCT00969761|38146313|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002191|NCT00969761|38146314|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002192|NCT00969761|38146315|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
17002193|NCT00969761|38146304|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002194|NCT00969761|38146305|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002195|NCT00969761|38146306|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002196|NCT00969761|38146307|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002197|NCT00969761|38146308|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002198|NCT00969761|38146309|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002199|NCT00969761|38146310|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002200|NCT00969761|38146311|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002201|NCT00969761|38146312|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
17002202|NCT00969761|38146313|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002203|NCT00969761|38146314|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002204|NCT00969761|38146315|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
17002205|NCT00969761|38146304|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
17002206|NCT00969761|38146305|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
17002207|NCT00969761|38146306|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
17002208|NCT00969761|38146307|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
17002209|NCT00969761|38146308|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
17002210|NCT00969761|38146309|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
17002211|NCT00969761|38146310|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
16880788|NCT02076113|37865021|FG000|Overall Study|Lost to Follow-up|4|||
17002212|NCT00969761|38146311|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
17002213|NCT00969761|38146312|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
17002214|NCT00969761|38146313|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
17002215|NCT00969761|38146314|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
17002216|NCT00969761|38146315|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
17002217|NCT00969761|38146304|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
17002218|NCT00969761|38146305|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16880789|NCT02076113|37865022|FG001|Overall Study|Lost to Follow-up|1|||
16880790|NCT02076113|37865021|FG000|Overall Study|Withdrawal by Subject|2|||
16880791|NCT02076113|37865022|FG001|Overall Study|Withdrawal by Subject|3|||
16880792|NCT02076113|37865021|FG000|Overall Study|Death|1|||
16880793|NCT02076113|37865022|FG001|Overall Study|Death|3|||
16880794|NCT02075255|37865034|FG000|Overall Study|Study specific withdrawal criteria|0|||
16880795|NCT02075255|37865035|FG001|Overall Study|Study specific withdrawal criteria|1|||
16880796|NCT02075255|37865036|FG002|Overall Study|Study specific withdrawal criteria|1|||
16880797|NCT02075255|37865034|FG000|Overall Study|Withdrawal by Subject|4|||
16880798|NCT02075255|37865035|FG001|Overall Study|Withdrawal by Subject|1|||
16880799|NCT02075255|37865036|FG002|Overall Study|Withdrawal by Subject|0|||
16880800|NCT02075255|37865034|FG000|Overall Study|Lost to Follow-up|0|||
16880801|NCT02075255|37865035|FG001|Overall Study|Lost to Follow-up|0|||
16880802|NCT02075255|37865036|FG002|Overall Study|Lost to Follow-up|1|||
17002219|NCT00969761|38146306|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
17002220|NCT00969761|38146307|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
17002221|NCT00969761|38146308|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
17002222|NCT00969761|38146309|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
17002223|NCT00969761|38146310|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
17002224|NCT00969761|38146311|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
17002225|NCT00969761|38146312|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
17002226|NCT00969761|38146313|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
17002227|NCT00969761|38146314|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16880803|NCT02075255|37865034|FG000|Overall Study|Adverse Event|0|||
16880804|NCT02075255|37865035|FG001|Overall Study|Adverse Event|0|||
16880805|NCT02075255|37865036|FG002|Overall Study|Adverse Event|1|||
16880806|NCT02075255|37865034|FG000|Overall Study|Death|0|||
16880807|NCT02075255|37865035|FG001|Overall Study|Death|2|||
16880808|NCT02075255|37865036|FG002|Overall Study|Death|0|||
16880809|NCT02400671|37865207|FG000|Overall Study|Death|5|||
16880810|NCT02400671|37865208|FG001|Overall Study|Death|3|||
16880811|NCT02400671|37865209|FG002|Overall Study|Death|4|||
16880812|NCT02400671|37865207|FG000|Overall Study|Lost to Follow-up|20|||
16880813|NCT02400671|37865208|FG001|Overall Study|Lost to Follow-up|27|||
16880814|NCT02400671|37865209|FG002|Overall Study|Lost to Follow-up|24|||
16880815|NCT02400671|37865207|FG000|Overall Study|Withdrawal by Subject|2|||
16880816|NCT02400671|37865208|FG001|Overall Study|Withdrawal by Subject|2|||
16880817|NCT02400671|37865209|FG002|Overall Study|Withdrawal by Subject|0|||
16880818|NCT00089999|37865219|FG000|Overall Study|Adverse Event|4|||
16880819|NCT00089999|37865220|FG001|Overall Study|Adverse Event|7|||
16880820|NCT00089999|37865219|FG000|Overall Study|Withdrawal by Subject|0|||
16880821|NCT00089999|37865220|FG001|Overall Study|Withdrawal by Subject|4|||
16880822|NCT00089999|37865219|FG000|Overall Study|Lost to Follow-up|2|||
16880823|NCT00089999|37865220|FG001|Overall Study|Lost to Follow-up|1|||
16880824|NCT00089999|37865219|FG000|Overall Study|Radiological Progression of Cancer|52|||
16880825|NCT00089999|37865220|FG001|Overall Study|Radiological Progression of Cancer|44|||
16880826|NCT00089999|37865219|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
16880827|NCT00089999|37865220|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
16880828|NCT00089999|37865219|FG000|Overall Study|Death|3|||
16880829|NCT00089999|37865220|FG001|Overall Study|Death|3|||
16880830|NCT00089999|37865219|FG000|Overall Study|Poor General Condition|1|||
16880831|NCT00089999|37865220|FG001|Overall Study|Poor General Condition|0|||
16880832|NCT00089999|37865219|FG000|Overall Study|Clinical Progression|1|||
16880833|NCT00089999|37865220|FG001|Overall Study|Clinical Progression|2|||
16880834|NCT00089999|37865219|FG000|Overall Study|Physician Decision|2|||
16880835|NCT00089999|37865220|FG001|Overall Study|Physician Decision|2|||
16880836|NCT00089999|37865219|FG000|Overall Study|Patient Underwent Surgery|2|||
16880837|NCT00089999|37865220|FG001|Overall Study|Patient Underwent Surgery|0|||
16880838|NCT00089999|37865219|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
16880839|NCT00089999|37865220|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
17191774|NCT02746679|38344641|FG000|Overall Study|Lost to Follow-up|4|||
16880840|NCT00089843|37865231|FG000|Overall Study|Withdrawal by Subject|1|||
16880841|NCT00089843|37865232|FG001|Overall Study|Withdrawal by Subject|4|||
17002228|NCT00969761|38146315|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16880842|NCT00089843|37865233|FG002|Overall Study|Withdrawal by Subject|5|||
16880843|NCT00089843|37865234|FG003|Overall Study|Withdrawal by Subject|6|||
16880844|NCT00089843|37865231|FG000|Overall Study|Physician Decision|1|||
16880845|NCT00089843|37865232|FG001|Overall Study|Physician Decision|0|||
16880846|NCT00089843|37865233|FG002|Overall Study|Physician Decision|0|||
16880847|NCT00089843|37865234|FG003|Overall Study|Physician Decision|1|||
16880848|NCT00089297|37865244|FG000|Overall Study|Adverse Event|9|||
16880849|NCT00089297|37865244|FG000|Overall Study|Death|1|||
16880850|NCT00089297|37865244|FG000|Overall Study|Withdrawal by Subject|12|||
16880851|NCT00089297|37865244|FG000|Overall Study|Disease progression|2|||
16880852|NCT00089297|37865244|FG000|Overall Study|Ineligible|11|||
16880853|NCT00089297|37865244|FG000|Overall Study|Secondary malignancy|1|||
16880854|NCT00089297|37865244|FG000|Overall Study|IRB approval not ready|1|||
16880855|NCT00089297|37865244|FG000|Overall Study|Non-compliance|1|||
16880856|NCT00088907|37865286|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
16880857|NCT00088907|37865287|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
16880858|NCT00088907|37865286|FG000|Randomized Study (Step 1)|Adverse Event|14|||
16880859|NCT00088907|37865287|FG001|Randomized Study (Step 1)|Adverse Event|19|||
16880860|NCT00088907|37865286|FG000|Randomized Study (Step 1)|Death|11|||
16880861|NCT00088907|37865287|FG001|Randomized Study (Step 1)|Death|12|||
16880862|NCT00088907|37865286|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
16880863|NCT00088907|37865287|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
16880864|NCT00088907|37865286|FG000|Randomized Study (Step 1)|complicating disease|3|||
16880865|NCT00088907|37865287|FG001|Randomized Study (Step 1)|complicating disease|1|||
16880866|NCT00088907|37865286|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
16880867|NCT00088907|37865287|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
16880868|NCT00088907|37865286|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
16880869|NCT00088907|37865287|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
16880870|NCT00088907|37865286|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
16880871|NCT00088907|37865287|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
16880872|NCT00088907|37865286|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
16880873|NCT00088907|37865287|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
16880874|NCT00088907|37865286|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
16880875|NCT00088907|37865287|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
16880876|NCT00088907|37865286|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
16880877|NCT00088907|37865287|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
16880878|NCT00088829|37865294|FG000|Overall Study|PI left institution and study was close|22|||
16880879|NCT00088595|37865298|FG000|Overall Study|Adverse Event|11|||
16880880|NCT00088595|37865298|FG000|Overall Study|Withdrawal by Subject|8|||
16880881|NCT00088595|37865298|FG000|Overall Study|Ongoing (After Core)|7|||
16880882|NCT00088595|37865298|FG000|Overall Study|New Cancer Therapy|2|||
16880883|NCT00088205|37865312|FG000|Overall Study|Adverse Event|4|||
16880884|NCT00088205|37865312|FG000|Overall Study|Progressive Disease|51|||
16880885|NCT00088205|37865312|FG000|Overall Study|Physician Decision|1|||
16880886|NCT00088205|37865312|FG000|Overall Study|Death Due to Study Disease|4|||
16880887|NCT00085709|37865406|FG000|Overall Study|Adverse Event|8|||
16880888|NCT00085709|37865407|FG001|Overall Study|Adverse Event|0|||
16880889|NCT00085709|37865406|FG000|Overall Study|Death|8|||
16880890|NCT00085709|37865407|FG001|Overall Study|Death|2|||
16880891|NCT00085709|37865406|FG000|Overall Study|Refusal unrelated to adverse events|1|||
16880892|NCT00085709|37865407|FG001|Overall Study|Refusal unrelated to adverse events|2|||
16880893|NCT00085709|37865406|FG000|Overall Study|Progression|3|||
16880894|NCT00085709|37865407|FG001|Overall Study|Progression|4|||
16880895|NCT00085709|37865406|FG000|Overall Study|Not protocol specified|12|||
16880896|NCT00085709|37865407|FG001|Overall Study|Not protocol specified|22|||
16880897|NCT00085709|37865406|FG000|Overall Study|Not eligible|19|||
16880898|NCT00085709|37865407|FG001|Overall Study|Not eligible|19|||
16880899|NCT00085709|37865406|FG000|Overall Study|Withdrawal by Subject|2|||
17095269|NCT00261846|38234544|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17002229|NCT00845871|38146341|FG000|Assessment Period|Adverse Event|2|||
17002230|NCT00845871|38146341|FG000|Assessment Period|Abnormal laboratory values|1|||
17002231|NCT00845871|38146341|FG000|Assessment Period|Abnormal test procedure results|1|||
17002232|NCT00845871|38146341|FG000|Assessment Period|Patient withdrew consent|3|||
17002233|NCT00915278|38146371|FG000|Overall Study|Death|1|||
17002234|NCT00915278|38146372|FG001|Overall Study|Death|0|||
17002235|NCT00915278|38146373|FG002|Overall Study|Death|0|||
17002236|NCT00915278|38146374|FG003|Overall Study|Death|0|||
17002237|NCT00915278|38146375|FG004|Overall Study|Death|0|||
17002238|NCT00915278|38146376|FG005|Overall Study|Death|0|||
16880900|NCT00085709|37865407|FG001|Overall Study|Withdrawal by Subject|1|||
16880901|NCT00085631|37865442|FG000|Overall Study|Missing Data|4|||
16880902|NCT00085631|37865443|FG001|Overall Study|Missing Data|11|||
16880903|NCT00085631|37865444|FG002|Overall Study|Missing Data|7|||
16880904|NCT00084929|37865460|FG000|Overall Study|ineligible - medical contraindication|1|||
16880905|NCT00084929|37865460|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
17002239|NCT00915278|38146371|FG000|Overall Study|Lost to Follow-up|0|||
17002240|NCT00915278|38146372|FG001|Overall Study|Lost to Follow-up|1|||
16880906|NCT00084929|37865460|FG000|Overall Study|Ineligible - Medical history|6|||
16880907|NCT00084929|37865460|FG000|Overall Study|Withdrawal by Subject|10|||
16880908|NCT00084929|37865460|FG000|Overall Study|Missing/incomplete CTC exam|9|||
16880909|NCT00084929|37865460|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
16880910|NCT00084617|37865518|FG000|Overall Study|Withdrawal by Subject|7|||
16880911|NCT00084617|37865518|FG000|Overall Study|Lack of Efficacy|1|||
16880912|NCT00084617|37865518|FG000|Overall Study|Protocol Violation|1|||
16880913|NCT00083915|37865632|FG000|Overall Study|Death|6|||
16880914|NCT00083915|37865633|FG001|Overall Study|Death|3|||
16880915|NCT00083915|37865632|FG000|Overall Study|Physician Decision|11|||
16880916|NCT00083915|37865633|FG001|Overall Study|Physician Decision|6|||
16880917|NCT00083915|37865632|FG000|Overall Study|Withdrawal by Subject|8|||
16880918|NCT00083915|37865633|FG001|Overall Study|Withdrawal by Subject|3|||
16880919|NCT00083915|37865632|FG000|Overall Study|disease progression|18|||
16880920|NCT00083915|37865633|FG001|Overall Study|disease progression|23|||
16880921|NCT00083915|37865632|FG000|Overall Study|Failure to collect|3|||
16880922|NCT00083915|37865633|FG001|Overall Study|Failure to collect|0|||
16880923|NCT00083915|37865632|FG000|Overall Study|No response|3|||
16880924|NCT00083915|37865633|FG001|Overall Study|No response|1|||
16880925|NCT00083915|37865632|FG000|Overall Study|Insurance issues|1|||
16880926|NCT00083915|37865633|FG001|Overall Study|Insurance issues|1|||
16880927|NCT00632749|37866457|FG000|Overall Study|Progressive disease|3|||
16880928|NCT00632749|37866458|FG001|Overall Study|Progressive disease|2|||
16880929|NCT00632749|37866459|FG002|Overall Study|Progressive disease|2|||
16880930|NCT00632749|37866460|FG003|Overall Study|Progressive disease|2|||
16880931|NCT00632749|37866461|FG004|Overall Study|Progressive disease|4|||
16880932|NCT00632749|37866462|FG005|Overall Study|Progressive disease|4|||
16880933|NCT00632749|37866463|FG006|Overall Study|Progressive disease|3|||
16880934|NCT00632749|37866464|FG007|Overall Study|Progressive disease|2|||
16880935|NCT00632749|37866465|FG008|Overall Study|Progressive disease|3|||
16880936|NCT00632749|37866466|FG009|Overall Study|Progressive disease|2|||
16880937|NCT00632749|37866467|FG010|Overall Study|Progressive disease|4|||
16880938|NCT00632749|37866468|FG011|Overall Study|Progressive disease|3|||
16880939|NCT00632749|37866469|FG012|Overall Study|Progressive disease|2|||
16880940|NCT00632749|37866470|FG013|Overall Study|Progressive disease|4|||
16880941|NCT00632749|37866457|FG000|Overall Study|Other Adverse event|1|||
16880942|NCT00632749|37866458|FG001|Overall Study|Other Adverse event|1|||
16880943|NCT00632749|37866459|FG002|Overall Study|Other Adverse event|1|||
16880944|NCT00632749|37866460|FG003|Overall Study|Other Adverse event|1|||
16880945|NCT00632749|37866461|FG004|Overall Study|Other Adverse event|2|||
16880946|NCT00632749|37866462|FG005|Overall Study|Other Adverse event|4|||
16880947|NCT00632749|37866463|FG006|Overall Study|Other Adverse event|1|||
16880948|NCT00632749|37866464|FG007|Overall Study|Other Adverse event|2|||
16880949|NCT00632749|37866465|FG008|Overall Study|Other Adverse event|2|||
16880950|NCT00632749|37866466|FG009|Overall Study|Other Adverse event|0|||
16880951|NCT00632749|37866467|FG010|Overall Study|Other Adverse event|1|||
16880952|NCT00632749|37866468|FG011|Overall Study|Other Adverse event|0|||
16880953|NCT00632749|37866469|FG012|Overall Study|Other Adverse event|1|||
16880954|NCT00632749|37866470|FG013|Overall Study|Other Adverse event|0|||
16880955|NCT00632749|37866457|FG000|Overall Study|Refuse to continue medication|0|||
16880956|NCT00632749|37866458|FG001|Overall Study|Refuse to continue medication|0|||
16880957|NCT00632749|37866459|FG002|Overall Study|Refuse to continue medication|0|||
16880958|NCT00632749|37866460|FG003|Overall Study|Refuse to continue medication|1|||
16880959|NCT00632749|37866461|FG004|Overall Study|Refuse to continue medication|0|||
16880960|NCT00632749|37866462|FG005|Overall Study|Refuse to continue medication|0|||
16880961|NCT00632749|37866463|FG006|Overall Study|Refuse to continue medication|0|||
16880962|NCT00632749|37866464|FG007|Overall Study|Refuse to continue medication|0|||
16880963|NCT00632749|37866465|FG008|Overall Study|Refuse to continue medication|0|||
16880964|NCT00632749|37866466|FG009|Overall Study|Refuse to continue medication|1|||
16880965|NCT00632749|37866467|FG010|Overall Study|Refuse to continue medication|0|||
16880966|NCT00632749|37866468|FG011|Overall Study|Refuse to continue medication|0|||
16880967|NCT00632749|37866469|FG012|Overall Study|Refuse to continue medication|0|||
16880968|NCT00632749|37866470|FG013|Overall Study|Refuse to continue medication|0|||
16880969|NCT00632749|37866457|FG000|Overall Study|Reason other than those specified above|0|||
16880970|NCT00632749|37866458|FG001|Overall Study|Reason other than those specified above|2|||
16880971|NCT00632749|37866459|FG002|Overall Study|Reason other than those specified above|0|||
16880972|NCT00632749|37866460|FG003|Overall Study|Reason other than those specified above|0|||
17191775|NCT02746679|38344642|FG001|Overall Study|Lost to Follow-up|6|||
16880973|NCT00632749|37866461|FG004|Overall Study|Reason other than those specified above|1|||
16880974|NCT00632749|37866462|FG005|Overall Study|Reason other than those specified above|0|||
16880975|NCT00632749|37866463|FG006|Overall Study|Reason other than those specified above|1|||
16880976|NCT00632749|37866464|FG007|Overall Study|Reason other than those specified above|0|||
16880977|NCT00632749|37866465|FG008|Overall Study|Reason other than those specified above|0|||
16880978|NCT00632749|37866466|FG009|Overall Study|Reason other than those specified above|0|||
16880979|NCT00632749|37866467|FG010|Overall Study|Reason other than those specified above|2|||
16880980|NCT00632749|37866468|FG011|Overall Study|Reason other than those specified above|1|||
16880981|NCT00632749|37866469|FG012|Overall Study|Reason other than those specified above|0|||
16880982|NCT00632749|37866470|FG013|Overall Study|Reason other than those specified above|2|||
16880983|NCT00632359|37866540|FG000|Overall Study|Withdrawal by Subject|2|||
17002241|NCT00915278|38146373|FG002|Overall Study|Lost to Follow-up|0|||
17095270|NCT00261846|38234545|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17095271|NCT00261846|38234546|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17095272|NCT00261846|38234547|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16880984|NCT00632203|37866547|FG000|Overall Study|Did not start study treatment|1|||
16880985|NCT00632203|37866548|FG001|Overall Study|Did not start study treatment|0|||
16880986|NCT03830333|37866569|FG000|Overall Study|Death|0|||
16880987|NCT03830333|37866570|FG001|Overall Study|Death|1|||
16880988|NCT03830333|37866569|FG000|Overall Study|Withdrawal by Subject|5|||
16880989|NCT03830333|37866570|FG001|Overall Study|Withdrawal by Subject|1|||
16880990|NCT03830333|37866569|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
16880991|NCT03830333|37866570|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
16880992|NCT00631969|37866656|FG000|Overall Study|Adverse Event|3|||
16880993|NCT00631969|37866657|FG001|Overall Study|Adverse Event|1|||
16880994|NCT00631969|37866656|FG000|Overall Study|Lack of Efficacy|2|||
16880995|NCT00631969|37866657|FG001|Overall Study|Lack of Efficacy|8|||
16880996|NCT00631969|37866656|FG000|Overall Study|Lost to Follow-up|2|||
16880997|NCT00631969|37866657|FG001|Overall Study|Lost to Follow-up|1|||
16880998|NCT00631969|37866656|FG000|Overall Study|Protocol Violation|1|||
16880999|NCT00631969|37866657|FG001|Overall Study|Protocol Violation|1|||
16881000|NCT00631969|37866656|FG000|Overall Study|Consent Withdrawn|5|||
16881001|NCT00631969|37866657|FG001|Overall Study|Consent Withdrawn|7|||
16881002|NCT00631969|37866656|FG000|Overall Study|Noncompliant With Study Medication|0|||
16785595|NCT01986010|37725743|FG003|Overall Study|Adverse Event|0|||
16785596|NCT01986010|37725744|FG004|Overall Study|Adverse Event|0|||
16785597|NCT01986010|37725745|FG005|Overall Study|Adverse Event|0|||
16785598|NCT01986010|37725746|FG006|Overall Study|Adverse Event|0|||
16785599|NCT01986010|37725747|FG007|Overall Study|Adverse Event|0|||
16785600|NCT01986010|37725748|FG008|Overall Study|Adverse Event|0|||
16785601|NCT01986010|37725749|FG009|Overall Study|Adverse Event|0|||
16785602|NCT01986010|37725750|FG010|Overall Study|Adverse Event|0|||
16785603|NCT01986010|37725751|FG011|Overall Study|Adverse Event|0|||
16785604|NCT01986010|37725752|FG012|Overall Study|Adverse Event|0|||
16881003|NCT00631969|37866657|FG001|Overall Study|Noncompliant With Study Medication|1|||
16881004|NCT00631969|37866656|FG000|Overall Study|No Drug Exposure|2|||
16881005|NCT00631969|37866657|FG001|Overall Study|No Drug Exposure|2|||
16881006|NCT00631657|37866693|FG000|6-Month Treatment Period|Adverse Event|47|||
16881007|NCT00631657|37866694|FG001|6-Month Treatment Period|Adverse Event|0|||
16881008|NCT00631657|37866695|FG002|6-Month Treatment Period|Adverse Event|7|||
17095273|NCT00261846|38234548|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
17002242|NCT00915278|38146374|FG003|Overall Study|Lost to Follow-up|0|||
17002243|NCT00915278|38146375|FG004|Overall Study|Lost to Follow-up|0|||
16785605|NCT01986010|37725753|FG013|Overall Study|Adverse Event|0|||
16785606|NCT01986010|37725754|FG014|Overall Study|Adverse Event|0|||
16785607|NCT01986010|37725755|FG015|Overall Study|Adverse Event|1|||
16785608|NCT01986010|37725756|FG016|Overall Study|Adverse Event|0|||
16785609|NCT01986010|37725740|FG000|Overall Study|Lost to Follow-up|2|||
16881009|NCT00631657|37866693|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
17002244|NCT00915278|38146376|FG005|Overall Study|Lost to Follow-up|0|||
17002245|NCT00915278|38146371|FG000|Overall Study|Withdrawal by Subject|0|||
17002246|NCT00915278|38146372|FG001|Overall Study|Withdrawal by Subject|1|||
17002247|NCT00915278|38146373|FG002|Overall Study|Withdrawal by Subject|0|||
17002248|NCT00915278|38146374|FG003|Overall Study|Withdrawal by Subject|0|||
17002249|NCT00915278|38146375|FG004|Overall Study|Withdrawal by Subject|1|||
17002250|NCT00915278|38146376|FG005|Overall Study|Withdrawal by Subject|4|||
17002251|NCT00915278|38146371|FG000|Overall Study|Adverse Event|4|||
17002252|NCT00915278|38146372|FG001|Overall Study|Adverse Event|1|||
17002253|NCT00915278|38146373|FG002|Overall Study|Adverse Event|0|||
17002254|NCT00915278|38146374|FG003|Overall Study|Adverse Event|0|||
17002255|NCT00915278|38146375|FG004|Overall Study|Adverse Event|0|||
17002256|NCT00915278|38146376|FG005|Overall Study|Adverse Event|0|||
17095274|NCT00261846|38234549|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17095275|NCT00261846|38234550|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17095276|NCT00261846|38234551|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
17095277|NCT00261846|38234540|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
17095278|NCT00261846|38234541|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
17095279|NCT00261846|38234542|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
17095280|NCT00261846|38234543|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
17095281|NCT00261846|38234544|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
17095282|NCT00261846|38234545|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
17095283|NCT00261846|38234546|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
17095284|NCT00261846|38234547|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
17095285|NCT00261846|38234548|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
16785610|NCT01986010|37725741|FG001|Overall Study|Lost to Follow-up|1|||
17002257|NCT00915278|38146371|FG000|Overall Study|Progressive disease/clinical progression|0|||
16881010|NCT00631657|37866694|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
16881011|NCT00631657|37866695|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
16881012|NCT00631657|37866693|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
16881013|NCT00631657|37866694|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
16881014|NCT00631657|37866695|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
16881015|NCT00631657|37866693|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
16881016|NCT00631657|37866694|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
16881017|NCT00631657|37866695|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
16881018|NCT00631657|37866693|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
16881019|NCT00631657|37866694|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
16881020|NCT00631657|37866695|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
16881021|NCT00631657|37866693|FG000|6-Month Treatment Period|Other|16|||
16881022|NCT00631657|37866694|FG001|6-Month Treatment Period|Other|0|||
16881023|NCT00631657|37866695|FG002|6-Month Treatment Period|Other|4|||
16881024|NCT00631657|37866693|FG000|6-Month Treatment Period|Not Treated|2|||
16881025|NCT00631657|37866694|FG001|6-Month Treatment Period|Not Treated|0|||
16881026|NCT00631657|37866695|FG002|6-Month Treatment Period|Not Treated|1|||
16881027|NCT00631657|37866693|FG000|7-Day Discontinuation Period|Not Treated|1|||
16881028|NCT00631657|37866694|FG001|7-Day Discontinuation Period|Not Treated|1|||
16881029|NCT00631657|37866695|FG002|7-Day Discontinuation Period|Not Treated|1|||
16881030|NCT00631657|37866693|FG000|7-Day Discontinuation Period|Other|1|||
16881031|NCT00631657|37866694|FG001|7-Day Discontinuation Period|Other|0|||
16881032|NCT00631657|37866695|FG002|7-Day Discontinuation Period|Other|0|||
16881033|NCT00631189|37866733|FG000|Initial Phase|Protocol Violation|347|||
16881034|NCT00631189|37866734|FG001|Initial Phase|Protocol Violation|0|||
16881035|NCT00631189|37866735|FG002|Initial Phase|Protocol Violation|0|||
16881036|NCT00631189|37866736|FG003|Initial Phase|Protocol Violation|0|||
16881037|NCT00631189|37866733|FG000|Initial Phase|Withdrawal by Subject|4|||
16881038|NCT00631189|37866734|FG001|Initial Phase|Withdrawal by Subject|0|||
16881039|NCT00631189|37866735|FG002|Initial Phase|Withdrawal by Subject|0|||
16881040|NCT00631189|37866736|FG003|Initial Phase|Withdrawal by Subject|0|||
16881041|NCT00631189|37866733|FG000|Treatment Phase|Withdrawal by Subject|0|||
16881042|NCT00631189|37866734|FG001|Treatment Phase|Withdrawal by Subject|2|||
16881043|NCT00631189|37866735|FG002|Treatment Phase|Withdrawal by Subject|1|||
16881044|NCT00631189|37866736|FG003|Treatment Phase|Withdrawal by Subject|1|||
16881045|NCT00631189|37866733|FG000|Treatment Phase|Protocol Violation|0|||
16881046|NCT00631189|37866734|FG001|Treatment Phase|Protocol Violation|1|||
16881047|NCT00631189|37866735|FG002|Treatment Phase|Protocol Violation|6|||
16881048|NCT00631189|37866736|FG003|Treatment Phase|Protocol Violation|2|||
16881049|NCT00631189|37866733|FG000|Treatment Phase|Adverse Event|0|||
16881050|NCT00631189|37866734|FG001|Treatment Phase|Adverse Event|3|||
16881051|NCT00631189|37866735|FG002|Treatment Phase|Adverse Event|2|||
16881052|NCT00631189|37866736|FG003|Treatment Phase|Adverse Event|4|||
16881053|NCT00631189|37866733|FG000|Treatment Phase|Lost to Follow-up|0|||
16881054|NCT00631189|37866734|FG001|Treatment Phase|Lost to Follow-up|1|||
16881055|NCT00631189|37866735|FG002|Treatment Phase|Lost to Follow-up|0|||
16881056|NCT00631189|37866736|FG003|Treatment Phase|Lost to Follow-up|0|||
16881057|NCT00631189|37866733|FG000|Treatment Phase|Pregnancy|0|||
16881058|NCT00631189|37866734|FG001|Treatment Phase|Pregnancy|0|||
16881059|NCT00631189|37866735|FG002|Treatment Phase|Pregnancy|1|||
16881060|NCT00631189|37866736|FG003|Treatment Phase|Pregnancy|0|||
16881061|NCT00631189|37866733|FG000|Treatment Phase|patient did not take pravastatin|0|||
16881062|NCT00631189|37866734|FG001|Treatment Phase|patient did not take pravastatin|0|||
16881063|NCT00631189|37866735|FG002|Treatment Phase|patient did not take pravastatin|1|||
16881064|NCT00631189|37866736|FG003|Treatment Phase|patient did not take pravastatin|0|||
16881065|NCT00630877|37866749|FG000|Overall Study|Adverse Event|11|||
16881066|NCT00630877|37866750|FG001|Overall Study|Adverse Event|8|||
16881067|NCT00630877|37866751|FG002|Overall Study|Adverse Event|7|||
16881068|NCT00630877|37866749|FG000|Overall Study|Withdrawal by Subject|3|||
16881069|NCT00630877|37866750|FG001|Overall Study|Withdrawal by Subject|4|||
16881070|NCT00630877|37866751|FG002|Overall Study|Withdrawal by Subject|0|||
16881071|NCT00630877|37866749|FG000|Overall Study|Lost to Follow-up|2|||
16881072|NCT00630877|37866750|FG001|Overall Study|Lost to Follow-up|0|||
16881073|NCT00630877|37866751|FG002|Overall Study|Lost to Follow-up|0|||
16881074|NCT00630877|37866749|FG000|Overall Study|Noncompliance|2|||
16881075|NCT00630877|37866750|FG001|Overall Study|Noncompliance|3|||
16881076|NCT00630877|37866751|FG002|Overall Study|Noncompliance|1|||
16881077|NCT00630877|37866749|FG000|Overall Study|Protocol violation|1|||
16881078|NCT00630877|37866750|FG001|Overall Study|Protocol violation|0|||
16881079|NCT00630877|37866751|FG002|Overall Study|Protocol violation|1|||
16881080|NCT00630877|37866749|FG000|Overall Study|Personal reasons|0|||
16881081|NCT00630877|37866750|FG001|Overall Study|Personal reasons|0|||
16881082|NCT00630877|37866751|FG002|Overall Study|Personal reasons|1|||
16881083|NCT02915783|37866763|FG000|Overall Study|Death|21|||
16881084|NCT02915783|37866763|FG000|Overall Study|Lost to Follow-up|1|||
16881085|NCT02915783|37866763|FG000|Overall Study|Withdrawal by Subject|2|||
16881086|NCT00630331|37866778|FG000|Overall Study|Death|2|||
16881087|NCT00630331|37866779|FG001|Overall Study|Death|1|||
16881088|NCT00630331|37866780|FG002|Overall Study|Death|1|||
16881089|NCT00630331|37866778|FG000|Overall Study|Adverse Event|1|||
16881090|NCT00630331|37866779|FG001|Overall Study|Adverse Event|0|||
16881091|NCT00630331|37866780|FG002|Overall Study|Adverse Event|0|||
16881092|NCT00630331|37866778|FG000|Overall Study|Withdrawal by Subject|12|||
16881093|NCT00630331|37866779|FG001|Overall Study|Withdrawal by Subject|7|||
16881094|NCT00630331|37866780|FG002|Overall Study|Withdrawal by Subject|5|||
16881095|NCT00630331|37866778|FG000|Overall Study|Lost to Follow-up|175|||
16881096|NCT00630331|37866779|FG001|Overall Study|Lost to Follow-up|143|||
16881097|NCT00630331|37866780|FG002|Overall Study|Lost to Follow-up|170|||
16881098|NCT00630331|37866778|FG000|Overall Study|Inappropriate enrollment|3|||
16881099|NCT00630331|37866779|FG001|Overall Study|Inappropriate enrollment|6|||
16881100|NCT00630331|37866780|FG002|Overall Study|Inappropriate enrollment|3|||
16881101|NCT00630331|37866778|FG000|Overall Study|Unable to classify|9|||
16881102|NCT00630331|37866779|FG001|Overall Study|Unable to classify|4|||
16881103|NCT00630331|37866780|FG002|Overall Study|Unable to classify|3|||
16881104|NCT00630331|37866778|FG000|Overall Study|Protocol Violation|4|||
16881105|NCT00630331|37866779|FG001|Overall Study|Protocol Violation|5|||
16881106|NCT00630331|37866780|FG002|Overall Study|Protocol Violation|6|||
16881107|NCT00676715|37866792|FG000|Overall Study|Withdrawal by Subject|7|||
16881108|NCT00676715|37866793|FG001|Overall Study|Withdrawal by Subject|9|||
16881109|NCT00676715|37866794|FG002|Overall Study|Withdrawal by Subject|10|||
16881110|NCT00676715|37866795|FG003|Overall Study|Withdrawal by Subject|10|||
16881111|NCT00676715|37866792|FG000|Overall Study|Other|2|||
16881112|NCT00676715|37866793|FG001|Overall Study|Other|6|||
16881113|NCT00676715|37866794|FG002|Overall Study|Other|4|||
16881114|NCT00676715|37866795|FG003|Overall Study|Other|3|||
16881115|NCT00676715|37866792|FG000|Overall Study|Lost to Follow-up|1|||
16881116|NCT00676715|37866793|FG001|Overall Study|Lost to Follow-up|1|||
16881117|NCT00676715|37866794|FG002|Overall Study|Lost to Follow-up|7|||
16881118|NCT00676715|37866795|FG003|Overall Study|Lost to Follow-up|3|||
16881119|NCT00676715|37866792|FG000|Overall Study|Death|1|||
16881120|NCT00676715|37866793|FG001|Overall Study|Death|1|||
16881121|NCT00676715|37866794|FG002|Overall Study|Death|1|||
16881122|NCT00676715|37866795|FG003|Overall Study|Death|0|||
16881123|NCT00676715|37866792|FG000|Overall Study|Adverse Event|0|||
16881124|NCT00676715|37866793|FG001|Overall Study|Adverse Event|1|||
16881125|NCT00676715|37866794|FG002|Overall Study|Adverse Event|2|||
16881126|NCT00676715|37866795|FG003|Overall Study|Adverse Event|0|||
16881127|NCT00676715|37866792|FG000|Overall Study|Participants Ongoing|29|||
16881128|NCT00676715|37866793|FG001|Overall Study|Participants Ongoing|29|||
16881129|NCT00676715|37866794|FG002|Overall Study|Participants Ongoing|17|||
16881130|NCT00676715|37866795|FG003|Overall Study|Participants Ongoing|24|||
16881131|NCT00639509|37866849|FG000|Overall Study|Death|1|||
16881132|NCT00638963|37866855|FG000|Overall Study|Withdrawal by Subject|1|||
16881133|NCT00638963|37866856|FG001|Overall Study|Withdrawal by Subject|0|||
16881134|NCT00638183|37866862|FG000|Overall Study|Adverse Event|23|||
16881135|NCT00638183|37866862|FG000|Overall Study|Lack of Efficacy|14|||
16881136|NCT00638183|37866862|FG000|Overall Study|Physician Decision|9|||
16881137|NCT00638183|37866862|FG000|Overall Study|Lost to Follow-up|46|||
16881138|NCT00638183|37866862|FG000|Overall Study|Other reason not defined above|27|||
16881139|NCT00638027|37866868|FG000|Overall Study|Adverse Event|0|||
16881140|NCT00638027|37866869|FG001|Overall Study|Adverse Event|2|||
16881141|NCT00636155|37866875|FG000|Overall Study|Adverse Event|8|||
16881142|NCT00636155|37866875|FG000|Overall Study|Lack of Efficacy|1|||
16881143|NCT00636155|37866875|FG000|Overall Study|Withdrawal by Subject|3|||
16881144|NCT00636155|37866875|FG000|Overall Study|Stem cell transplant|1|||
16881145|NCT00636155|37866875|FG000|Overall Study|Physician Decision|5|||
16881146|NCT00634907|37866881|FG000|Overall Study|Withdrawal by Subject|3|||
16881147|NCT00634907|37866882|FG001|Overall Study|Withdrawal by Subject|0|||
16881148|NCT00634907|37866881|FG000|Overall Study|Physician Decision|3|||
16881149|NCT00634907|37866882|FG001|Overall Study|Physician Decision|9|||
16881150|NCT00634907|37866881|FG000|Overall Study|Withdrawal by Subject|11|||
16881151|NCT00634907|37866882|FG001|Overall Study|Withdrawal by Subject|8|||
16881152|NCT00634751|37866896|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
16881153|NCT00634751|37866897|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
16881154|NCT00634751|37866898|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
16881155|NCT00634751|37866899|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
16881156|NCT00634751|37866896|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
16881157|NCT00634751|37866897|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
16881158|NCT00634751|37866898|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
16881159|NCT00634751|37866899|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
16881160|NCT00634751|37866896|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
16881161|NCT00634751|37866897|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
16881162|NCT00634751|37866898|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
16881163|NCT00634751|37866899|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
16881164|NCT00634049|37866938|FG000|Overall Study|Never received study drug|1|||
16881165|NCT00634049|37866938|FG000|Overall Study|Died prior to receiving study drug|1|||
16881166|NCT00634049|37866938|FG000|Overall Study|Screening failure|1|||
16881167|NCT00632099|37866977|FG000|Overall Study|Lost to Follow-up|3|||
16881168|NCT00632099|37866978|FG001|Overall Study|Lost to Follow-up|3|||
16881169|NCT00632021|37866986|FG000|Overall Study|Withdrawal/death|4|||
16881170|NCT00632021|37866987|FG001|Overall Study|Withdrawal/death|7|||
16881171|NCT00631475|37866994|FG000|Overall Study|Death|18|||
16881172|NCT00631475|37866994|FG000|Overall Study|Adverse Event|14|||
16881173|NCT00631475|37866994|FG000|Overall Study|Withdrew consent|5|||
16881174|NCT00631475|37866994|FG000|Overall Study|Preparation for lung transplant|8|||
16881175|NCT00631163|37867015|FG000|Number of Participants in Year 1|Adverse Event|12|||
16881176|NCT00631163|37867015|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
16881177|NCT00631163|37867015|FG000|Number of Participants in Year 1|Death|6|||
16881178|NCT00631163|37867015|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
16881179|NCT00631163|37867015|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
16881180|NCT00631163|37867015|FG000|Number of Participants in Year 1|Administrative problems|6|||
16881181|NCT00631163|37867015|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
16881182|NCT00631163|37867015|FG000|Number of Participants in Year 2|Adverse Event|1|||
16881183|NCT00631163|37867015|FG000|Number of Participants in Year 2|Protocol Violation|1|||
16881184|NCT00631163|37867015|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
16881185|NCT00631007|37867032|FG000|Overall Study|Adverse Event|0|||
16881186|NCT00631007|37867033|FG001|Overall Study|Adverse Event|2|||
16881187|NCT00631007|37867034|FG002|Overall Study|Adverse Event|0|||
16881188|NCT00631007|37867035|FG003|Overall Study|Adverse Event|2|||
16881189|NCT00631007|37867036|FG004|Overall Study|Adverse Event|3|||
16881190|NCT00631007|37867037|FG005|Overall Study|Adverse Event|2|||
16881191|NCT00631007|37867032|FG000|Overall Study|Lost to Follow-up|2|||
16881192|NCT00631007|37867033|FG001|Overall Study|Lost to Follow-up|1|||
16881193|NCT00631007|37867034|FG002|Overall Study|Lost to Follow-up|2|||
16881194|NCT00631007|37867035|FG003|Overall Study|Lost to Follow-up|4|||
16881195|NCT00631007|37867036|FG004|Overall Study|Lost to Follow-up|5|||
16881196|NCT00631007|37867037|FG005|Overall Study|Lost to Follow-up|3|||
16881197|NCT00631007|37867032|FG000|Overall Study|Physician Decision|1|||
16881198|NCT00631007|37867033|FG001|Overall Study|Physician Decision|0|||
16881199|NCT00631007|37867034|FG002|Overall Study|Physician Decision|1|||
16881200|NCT00631007|37867035|FG003|Overall Study|Physician Decision|0|||
16881201|NCT00631007|37867036|FG004|Overall Study|Physician Decision|0|||
16881202|NCT00631007|37867037|FG005|Overall Study|Physician Decision|2|||
16881203|NCT00631007|37867032|FG000|Overall Study|Persistent Hyperglycemia|2|||
16881204|NCT00631007|37867033|FG001|Overall Study|Persistent Hyperglycemia|2|||
16881205|NCT00631007|37867034|FG002|Overall Study|Persistent Hyperglycemia|5|||
16881206|NCT00631007|37867035|FG003|Overall Study|Persistent Hyperglycemia|1|||
16881207|NCT00631007|37867036|FG004|Overall Study|Persistent Hyperglycemia|2|||
16881208|NCT00631007|37867037|FG005|Overall Study|Persistent Hyperglycemia|5|||
16881209|NCT00631007|37867032|FG000|Overall Study|Withdrawal by Subject|4|||
16881210|NCT00631007|37867033|FG001|Overall Study|Withdrawal by Subject|5|||
16881211|NCT00631007|37867034|FG002|Overall Study|Withdrawal by Subject|2|||
16881212|NCT00631007|37867035|FG003|Overall Study|Withdrawal by Subject|2|||
16881213|NCT00631007|37867036|FG004|Overall Study|Withdrawal by Subject|1|||
16881214|NCT00631007|37867037|FG005|Overall Study|Withdrawal by Subject|3|||
16881215|NCT00631007|37867032|FG000|Overall Study|Other|2|||
16881216|NCT00631007|37867033|FG001|Overall Study|Other|1|||
16881217|NCT00631007|37867034|FG002|Overall Study|Other|0|||
16881218|NCT00631007|37867035|FG003|Overall Study|Other|0|||
16881219|NCT00631007|37867036|FG004|Overall Study|Other|1|||
16881220|NCT00631007|37867037|FG005|Overall Study|Other|0|||
16881221|NCT00630539|37867064|FG000|Overall Study|Adverse Event|1|||
16881222|NCT00630539|37867065|FG001|Overall Study|Adverse Event|3|||
16881223|NCT00630539|37867066|FG002|Overall Study|Adverse Event|1|||
16881224|NCT00630539|37867067|FG003|Overall Study|Adverse Event|2|||
16881225|NCT00630539|37867064|FG000|Overall Study|Withdrawal by Subject|0|||
16881226|NCT00630539|37867065|FG001|Overall Study|Withdrawal by Subject|1|||
16881227|NCT00630539|37867066|FG002|Overall Study|Withdrawal by Subject|0|||
16881228|NCT00630539|37867067|FG003|Overall Study|Withdrawal by Subject|1|||
16881229|NCT00630305|37867145|FG000|Overall Study|Withdrawal by Subject|1|||
16881230|NCT00630305|37867145|FG000|Overall Study|Inability to insert contact lens|1|||
16881231|NCT01926197|37867388|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
16881232|NCT01926197|37867389|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
16881233|NCT01926197|37867388|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
16881234|NCT01926197|37867389|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
16881235|NCT00989963|37867414|FG000|Overall Study|Adverse Event|1|||
16881236|NCT00989963|37867415|FG001|Overall Study|Adverse Event|1|||
16881237|NCT00989963|37867416|FG002|Overall Study|Adverse Event|1|||
16881238|NCT00989573|37867454|FG000|Overall Study|Adverse Event|8|||
16881239|NCT00989573|37867455|FG001|Overall Study|Adverse Event|12|||
16881240|NCT00989573|37867456|FG002|Overall Study|Adverse Event|4|||
16881241|NCT00989573|37867454|FG000|Overall Study|Physician Decision|0|||
16881242|NCT00989573|37867455|FG001|Overall Study|Physician Decision|2|||
16881243|NCT00989573|37867456|FG002|Overall Study|Physician Decision|0|||
16881244|NCT00989573|37867454|FG000|Overall Study|Protocol Violation|1|||
16881245|NCT00989573|37867455|FG001|Overall Study|Protocol Violation|1|||
16881246|NCT00989573|37867456|FG002|Overall Study|Protocol Violation|1|||
16881247|NCT00989573|37867454|FG000|Overall Study|Withdrawal by Subject|4|||
16881248|NCT00989573|37867455|FG001|Overall Study|Withdrawal by Subject|7|||
16881249|NCT00989573|37867456|FG002|Overall Study|Withdrawal by Subject|3|||
16881250|NCT04126213|37867530|FG000|Overall Study|Lost to Follow-up|9|||
16881251|NCT04126213|37867531|FG001|Overall Study|Lost to Follow-up|1|||
16881252|NCT04126213|37867532|FG002|Overall Study|Lost to Follow-up|5|||
16881253|NCT04126213|37867533|FG003|Overall Study|Lost to Follow-up|10|||
16881254|NCT04126213|37867534|FG004|Overall Study|Lost to Follow-up|4|||
16881255|NCT04126213|37867535|FG005|Overall Study|Lost to Follow-up|7|||
16881256|NCT04126213|37867530|FG000|Overall Study|Withdrawal by Subject|3|||
16881257|NCT04126213|37867531|FG001|Overall Study|Withdrawal by Subject|2|||
16881258|NCT04126213|37867532|FG002|Overall Study|Withdrawal by Subject|1|||
16881259|NCT04126213|37867533|FG003|Overall Study|Withdrawal by Subject|1|||
16881260|NCT04126213|37867534|FG004|Overall Study|Withdrawal by Subject|1|||
16881261|NCT04126213|37867535|FG005|Overall Study|Withdrawal by Subject|1|||
16881262|NCT04126213|37867530|FG000|Overall Study|Other|0|||
16881263|NCT04126213|37867531|FG001|Overall Study|Other|0|||
16881264|NCT04126213|37867532|FG002|Overall Study|Other|2|||
16881265|NCT04126213|37867533|FG003|Overall Study|Other|2|||
16881266|NCT04126213|37867534|FG004|Overall Study|Other|0|||
16881267|NCT04126213|37867535|FG005|Overall Study|Other|1|||
16881268|NCT04126213|37867530|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16881269|NCT04126213|37867531|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
16881270|NCT04126213|37867532|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16881271|NCT04126213|37867533|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16881272|NCT04126213|37867534|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16881273|NCT04126213|37867535|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
16881274|NCT04128319|37867552|FG000|Overall Study|Death|3|||
16881275|NCT01647828|37867605|FG000|Overall Study|Death|3|||
16881276|NCT01647828|37867606|FG001|Overall Study|Death|4|||
16881277|NCT01647828|37867607|FG002|Overall Study|Death|4|||
16881278|NCT01647828|37867608|FG003|Overall Study|Death|5|||
16881279|NCT01647828|37867609|FG004|Overall Study|Death|6|||
16881280|NCT01647828|37867610|FG005|Overall Study|Death|3|||
16881281|NCT01647828|37867611|FG006|Overall Study|Death|10|||
16881282|NCT01647828|37867612|FG007|Overall Study|Death|60|||
16785611|NCT01986010|37725742|FG002|Overall Study|Lost to Follow-up|2|||
16785612|NCT01986010|37725743|FG003|Overall Study|Lost to Follow-up|2|||
16785613|NCT01986010|37725744|FG004|Overall Study|Lost to Follow-up|2|||
16785614|NCT01986010|37725745|FG005|Overall Study|Lost to Follow-up|2|||
16785615|NCT01986010|37725746|FG006|Overall Study|Lost to Follow-up|0|||
16785616|NCT01986010|37725747|FG007|Overall Study|Lost to Follow-up|0|||
16785617|NCT01986010|37725748|FG008|Overall Study|Lost to Follow-up|4|||
16785618|NCT01986010|37725749|FG009|Overall Study|Lost to Follow-up|2|||
16785619|NCT01986010|37725750|FG010|Overall Study|Lost to Follow-up|0|||
16785620|NCT01986010|37725751|FG011|Overall Study|Lost to Follow-up|1|||
16785621|NCT01986010|37725752|FG012|Overall Study|Lost to Follow-up|1|||
16785622|NCT01986010|37725753|FG013|Overall Study|Lost to Follow-up|1|||
16785623|NCT01986010|37725754|FG014|Overall Study|Lost to Follow-up|2|||
16785624|NCT01986010|37725755|FG015|Overall Study|Lost to Follow-up|0|||
16785625|NCT01986010|37725756|FG016|Overall Study|Lost to Follow-up|0|||
16785626|NCT01986010|37725740|FG000|Overall Study|Physician Decision|0|||
16785627|NCT01986010|37725741|FG001|Overall Study|Physician Decision|0|||
16785628|NCT01986010|37725742|FG002|Overall Study|Physician Decision|0|||
16785629|NCT01986010|37725743|FG003|Overall Study|Physician Decision|0|||
16785630|NCT01986010|37725744|FG004|Overall Study|Physician Decision|0|||
16785631|NCT01986010|37725745|FG005|Overall Study|Physician Decision|0|||
16881283|NCT01647828|37867613|FG008|Overall Study|Death|71|||
16881284|NCT01647828|37867605|FG000|Overall Study|Withdrawal by Subject|2|||
16881285|NCT01647828|37867606|FG001|Overall Study|Withdrawal by Subject|0|||
16881286|NCT01647828|37867607|FG002|Overall Study|Withdrawal by Subject|0|||
16881287|NCT01647828|37867608|FG003|Overall Study|Withdrawal by Subject|1|||
16881288|NCT01647828|37867609|FG004|Overall Study|Withdrawal by Subject|0|||
16881289|NCT01647828|37867610|FG005|Overall Study|Withdrawal by Subject|0|||
16881290|NCT01647828|37867611|FG006|Overall Study|Withdrawal by Subject|1|||
16881291|NCT01647828|37867612|FG007|Overall Study|Withdrawal by Subject|0|||
16881292|NCT01647828|37867613|FG008|Overall Study|Withdrawal by Subject|2|||
16881293|NCT01647828|37867605|FG000|Overall Study|Study terminated by Sponsor|0|||
16881294|NCT01647828|37867606|FG001|Overall Study|Study terminated by Sponsor|0|||
16881295|NCT01647828|37867607|FG002|Overall Study|Study terminated by Sponsor|0|||
16881296|NCT01647828|37867608|FG003|Overall Study|Study terminated by Sponsor|0|||
16881297|NCT01647828|37867609|FG004|Overall Study|Study terminated by Sponsor|0|||
16881298|NCT01647828|37867610|FG005|Overall Study|Study terminated by Sponsor|0|||
16881299|NCT01647828|37867611|FG006|Overall Study|Study terminated by Sponsor|1|||
16881300|NCT01647828|37867612|FG007|Overall Study|Study terminated by Sponsor|26|||
16881301|NCT01647828|37867613|FG008|Overall Study|Study terminated by Sponsor|16|||
16881302|NCT01647828|37867605|FG000|Overall Study|Lost to Follow-up|0|||
16881303|NCT01647828|37867606|FG001|Overall Study|Lost to Follow-up|0|||
16881304|NCT01647828|37867607|FG002|Overall Study|Lost to Follow-up|0|||
16881305|NCT01647828|37867608|FG003|Overall Study|Lost to Follow-up|0|||
16881306|NCT01647828|37867609|FG004|Overall Study|Lost to Follow-up|0|||
16881307|NCT01647828|37867610|FG005|Overall Study|Lost to Follow-up|0|||
16881308|NCT01647828|37867611|FG006|Overall Study|Lost to Follow-up|0|||
16881309|NCT01647828|37867612|FG007|Overall Study|Lost to Follow-up|2|||
16881310|NCT01647828|37867613|FG008|Overall Study|Lost to Follow-up|0|||
16881311|NCT00989261|37867635|FG000|Overall Study|Still in follow up|12|||
16881312|NCT00989261|37867636|FG001|Overall Study|Still in follow up|21|||
16881313|NCT00989261|37867635|FG000|Overall Study|Withdrawal by Subject|0|||
16881314|NCT00989261|37867636|FG001|Overall Study|Withdrawal by Subject|1|||
16881315|NCT00989261|37867635|FG000|Overall Study|Lost to Follow-up|3|||
16881316|NCT00989261|37867636|FG001|Overall Study|Lost to Follow-up|0|||
16881317|NCT00988559|37867655|FG000|Overall Study|Withdrawal by Subject|1|||
16881318|NCT00988559|37867656|FG001|Overall Study|Withdrawal by Subject|1|||
16881319|NCT00988559|37867657|FG002|Overall Study|Withdrawal by Subject|0|||
16881320|NCT00988559|37867658|FG003|Overall Study|Withdrawal by Subject|1|||
16881321|NCT00988559|37867655|FG000|Overall Study|Pregnancy|0|||
16881322|NCT00988559|37867656|FG001|Overall Study|Pregnancy|1|||
16881323|NCT00988559|37867657|FG002|Overall Study|Pregnancy|1|||
16881324|NCT00988559|37867658|FG003|Overall Study|Pregnancy|0|||
16881325|NCT00988559|37867655|FG000|Overall Study|Lost to Follow-up|0|||
16881326|NCT00988559|37867656|FG001|Overall Study|Lost to Follow-up|0|||
16881327|NCT00988559|37867657|FG002|Overall Study|Lost to Follow-up|1|||
16881328|NCT00988559|37867658|FG003|Overall Study|Lost to Follow-up|0|||
16881329|NCT00988169|37867668|FG000|Overall Study|Withdrawal by Subject|1|||
16881330|NCT00988091|37867695|FG000|Double-blind Period|Withdrawal by Subject|15|||
16881331|NCT00988091|37867696|FG001|Double-blind Period|Withdrawal by Subject|13|||
16881332|NCT00988091|37867695|FG000|Double-blind Period|Lost to Follow-up|12|||
16881333|NCT00988091|37867696|FG001|Double-blind Period|Lost to Follow-up|14|||
16881334|NCT00988091|37867695|FG000|Double-blind Period|Other|8|||
16881335|NCT00988091|37867696|FG001|Double-blind Period|Other|8|||
16881336|NCT00988091|37867695|FG000|Double-blind Period|Adverse Event|6|||
16881337|NCT00988091|37867696|FG001|Double-blind Period|Adverse Event|9|||
16881338|NCT00988091|37867695|FG000|Double-blind Period|Use of exclusionary medication|2|||
16881339|NCT00988091|37867696|FG001|Double-blind Period|Use of exclusionary medication|3|||
16881340|NCT00988091|37867695|FG000|Open-label Period|Adverse Event|4|||
16881341|NCT00988091|37867696|FG001|Open-label Period|Adverse Event|7|||
16881342|NCT00988091|37867695|FG000|Open-label Period|Use of exclusionary medication|1|||
16881343|NCT00988091|37867696|FG001|Open-label Period|Use of exclusionary medication|1|||
16881344|NCT00988091|37867695|FG000|Open-label Period|Protocol Violation|1|||
16881345|NCT00988091|37867696|FG001|Open-label Period|Protocol Violation|1|||
16881346|NCT00988091|37867695|FG000|Open-label Period|Withdrawal by Subject|10|||
16881347|NCT00988091|37867696|FG001|Open-label Period|Withdrawal by Subject|16|||
16881348|NCT00988091|37867695|FG000|Open-label Period|Lost to Follow-up|3|||
16881349|NCT00988091|37867696|FG001|Open-label Period|Lost to Follow-up|5|||
16881350|NCT00988091|37867695|FG000|Open-label Period|Other|2|||
16881351|NCT00988091|37867696|FG001|Open-label Period|Other|3|||
16881352|NCT02623218|37867986|FG000|Overall Study|Lost to Follow-up|0|||
16881353|NCT02623218|37867987|FG001|Overall Study|Lost to Follow-up|1|||
16881354|NCT02623218|37867988|FG002|Overall Study|Lost to Follow-up|0|||
16881355|NCT02623218|37867989|FG003|Overall Study|Lost to Follow-up|0|||
16881356|NCT02623218|37867990|FG004|Overall Study|Lost to Follow-up|0|||
16881357|NCT02622828|37868024|FG000|Overall Study|participant withdrew|3|||
16881358|NCT02621424|37868140|FG000|Overall Study|Withdrawal by Subject|1|||
17191776|NCT02731131|38344650|FG000|Overall Study|Psychiatric Disorder|0|||
16881359|NCT02621424|37868141|FG001|Overall Study|Withdrawal by Subject|2|||
16881360|NCT02621034|37868169|FG000|Overall Study|Lost to Follow-up|3|||
16881361|NCT02621034|37868170|FG001|Overall Study|Lost to Follow-up|2|||
16881362|NCT02621034|37868171|FG002|Overall Study|Lost to Follow-up|5|||
16881363|NCT02620020|37868253|FG000|Overall Study|Adverse Event|8|||
16881364|NCT02620020|37868254|FG001|Overall Study|Adverse Event|4|||
16881365|NCT02620020|37868255|FG002|Overall Study|Adverse Event|3|||
16881366|NCT02620020|37868256|FG003|Overall Study|Adverse Event|5|||
16881367|NCT02620020|37868253|FG000|Overall Study|Lost to Follow-up|4|||
16881368|NCT02620020|37868254|FG001|Overall Study|Lost to Follow-up|8|||
16881369|NCT02620020|37868255|FG002|Overall Study|Lost to Follow-up|1|||
16881370|NCT02620020|37868256|FG003|Overall Study|Lost to Follow-up|4|||
16881371|NCT02620020|37868253|FG000|Overall Study|Physician Decision|7|||
16881372|NCT02620020|37868254|FG001|Overall Study|Physician Decision|4|||
16881373|NCT02620020|37868255|FG002|Overall Study|Physician Decision|3|||
16881374|NCT02620020|37868256|FG003|Overall Study|Physician Decision|4|||
16881375|NCT02620020|37868253|FG000|Overall Study|Protocol Violation|5|||
16881376|NCT02620020|37868254|FG001|Overall Study|Protocol Violation|2|||
16881377|NCT02620020|37868255|FG002|Overall Study|Protocol Violation|1|||
16881378|NCT02620020|37868256|FG003|Overall Study|Protocol Violation|1|||
16881379|NCT02620020|37868253|FG000|Overall Study|Withdrawal by Subject|20|||
16881380|NCT02620020|37868254|FG001|Overall Study|Withdrawal by Subject|16|||
16881381|NCT02620020|37868255|FG002|Overall Study|Withdrawal by Subject|17|||
16881382|NCT02620020|37868256|FG003|Overall Study|Withdrawal by Subject|12|||
16881383|NCT02620020|37868253|FG000|Overall Study|Death|0|||
16881384|NCT02620020|37868254|FG001|Overall Study|Death|1|||
16881385|NCT02620020|37868255|FG002|Overall Study|Death|0|||
16881386|NCT02620020|37868256|FG003|Overall Study|Death|0|||
16881387|NCT02549989|37868266|FG000|Overall Study|Adverse Event|4|||
16881388|NCT02549989|37868266|FG000|Overall Study|Death|1|||
16881389|NCT02549989|37868266|FG000|Overall Study|Lack of Efficacy|19|||
16881390|NCT02549989|37868266|FG000|Overall Study|Withdrawal by Subject|3|||
16881391|NCT00987935|37868425|FG000|Overall Study|Progressive disease|3|||
16881392|NCT00987935|37868426|FG001|Overall Study|Progressive disease|2|||
16881393|NCT00987935|37868427|FG002|Overall Study|Progressive disease|3|||
16881394|NCT00987935|37868428|FG003|Overall Study|Progressive disease|2|||
16881395|NCT00987935|37868429|FG004|Overall Study|Progressive disease|5|||
16881396|NCT00987935|37868430|FG005|Overall Study|Progressive disease|3|||
16881397|NCT00987935|37868431|FG006|Overall Study|Progressive disease|9|||
16881398|NCT00987935|37868432|FG007|Overall Study|Progressive disease|48|||
16881399|NCT00987935|37868433|FG008|Overall Study|Progressive disease|23|||
16881400|NCT00987935|37868425|FG000|Overall Study|Adverse Event|0|||
16881401|NCT00987935|37868426|FG001|Overall Study|Adverse Event|1|||
16881402|NCT00987935|37868427|FG002|Overall Study|Adverse Event|0|||
16881403|NCT00987935|37868428|FG003|Overall Study|Adverse Event|1|||
16881404|NCT00987935|37868429|FG004|Overall Study|Adverse Event|1|||
16881405|NCT00987935|37868430|FG005|Overall Study|Adverse Event|0|||
16881406|NCT00987935|37868431|FG006|Overall Study|Adverse Event|2|||
16881407|NCT00987935|37868432|FG007|Overall Study|Adverse Event|10|||
16881408|NCT00987935|37868433|FG008|Overall Study|Adverse Event|6|||
16881409|NCT00987935|37868425|FG000|Overall Study|Refused to continue taking trial med.|1|||
16881410|NCT00987935|37868426|FG001|Overall Study|Refused to continue taking trial med.|0|||
16881411|NCT00987935|37868427|FG002|Overall Study|Refused to continue taking trial med.|0|||
16881412|NCT00987935|37868428|FG003|Overall Study|Refused to continue taking trial med.|0|||
16881413|NCT00987935|37868429|FG004|Overall Study|Refused to continue taking trial med.|1|||
16881414|NCT00987935|37868430|FG005|Overall Study|Refused to continue taking trial med.|0|||
16881415|NCT00987935|37868431|FG006|Overall Study|Refused to continue taking trial med.|4|||
16881416|NCT00987935|37868432|FG007|Overall Study|Refused to continue taking trial med.|4|||
16881417|NCT00987935|37868433|FG008|Overall Study|Refused to continue taking trial med.|2|||
16881418|NCT00987935|37868425|FG000|Overall Study|Reason other than those specified above|0|||
16881419|NCT00987935|37868426|FG001|Overall Study|Reason other than those specified above|0|||
16881420|NCT00987935|37868427|FG002|Overall Study|Reason other than those specified above|0|||
16881421|NCT00987935|37868428|FG003|Overall Study|Reason other than those specified above|0|||
16881422|NCT00987935|37868429|FG004|Overall Study|Reason other than those specified above|0|||
16881423|NCT00987935|37868430|FG005|Overall Study|Reason other than those specified above|0|||
16881424|NCT00987935|37868431|FG006|Overall Study|Reason other than those specified above|0|||
16881425|NCT00987935|37868432|FG007|Overall Study|Reason other than those specified above|0|||
16881426|NCT00987935|37868433|FG008|Overall Study|Reason other than those specified above|1|||
16881427|NCT01597050|37868461|FG000|Overall Study|Withdrawal by Subject|1|||
16881428|NCT01597050|37868462|FG001|Overall Study|Withdrawal by Subject|0|||
16881429|NCT00987623|37868479|FG000|Overall Study|Lost to Follow-up|2|||
16881430|NCT00987623|37868480|FG001|Overall Study|Lost to Follow-up|1|||
16881431|NCT00987623|37868479|FG000|Overall Study|Time/job conflict|2|||
16881432|NCT00987623|37868480|FG001|Overall Study|Time/job conflict|0|||
16881433|NCT00987623|37868479|FG000|Overall Study|Discomfort|1|||
16881434|NCT00987623|37868480|FG001|Overall Study|Discomfort|0|||
16881435|NCT00987623|37868479|FG000|Overall Study|Biomicroscopy|0|||
16881436|NCT00987623|37868480|FG001|Overall Study|Biomicroscopy|1|||
16881437|NCT00987623|37868479|FG000|Overall Study|Influenza|0|||
16881438|NCT00987623|37868480|FG001|Overall Study|Influenza|1|||
16881439|NCT00987467|37868486|FG000|Overall Study|Lost to Follow-up|2|||
16881440|NCT00986921|37868497|FG000|Overall Study|Physician Decision|1|||
16881441|NCT00986921|37868498|FG001|Overall Study|Physician Decision|0|||
16881442|NCT01596972|37868509|FG000|Overall Study|Physician Decision|1|||
16881443|NCT01596972|37868510|FG001|Overall Study|Physician Decision|9|||
16881444|NCT01596972|37868509|FG000|Overall Study|Lost to Follow-up|0|||
16881445|NCT01596972|37868510|FG001|Overall Study|Lost to Follow-up|4|||
16881446|NCT01596972|37868509|FG000|Overall Study|Withdrawal by Subject|0|||
16881447|NCT01596972|37868510|FG001|Overall Study|Withdrawal by Subject|1|||
16881448|NCT00985751|37868611|FG000|Overall Study|Adverse Event|0|||
16881449|NCT00985751|37868612|FG001|Overall Study|Adverse Event|0|||
16881450|NCT00985751|37868613|FG002|Overall Study|Adverse Event|0|||
16881451|NCT00985751|37868614|FG003|Overall Study|Adverse Event|0|||
16881452|NCT00985751|37868615|FG004|Overall Study|Adverse Event|1|||
16881453|NCT01596582|37868660|FG000|Overall Study|Deemed ineligible after study visit|3|||
16881454|NCT01596582|37868661|FG001|Overall Study|Deemed ineligible after study visit|6|||
16881455|NCT01596582|37868660|FG000|Overall Study|Missing all outcome data|1|||
16881456|NCT01596582|37868661|FG001|Overall Study|Missing all outcome data|1|||
16881457|NCT01596504|37868677|FG000|Overall Study|Participant's Private Reason|0|||
16881458|NCT01596504|37868678|FG001|Overall Study|Participant's Private Reason|1|||
16881459|NCT01596504|37868679|FG002|Overall Study|Participant's Private Reason|0|||
16881460|NCT01596504|37868677|FG000|Overall Study|Adverse Event|1|||
16881461|NCT01596504|37868678|FG001|Overall Study|Adverse Event|2|||
16881462|NCT01596504|37868679|FG002|Overall Study|Adverse Event|1|||
16881463|NCT01596504|37868677|FG000|Overall Study|Withdrawal by Subject|1|||
16881464|NCT01596504|37868678|FG001|Overall Study|Withdrawal by Subject|0|||
16881465|NCT01596504|37868679|FG002|Overall Study|Withdrawal by Subject|0|||
16881466|NCT02616900|37868734|FG000|Overall Study|Lack of Efficacy|7|||
16881467|NCT02616900|37868734|FG000|Overall Study|Lost to Follow-up|2|||
16881468|NCT02616900|37868734|FG000|Overall Study|Protocol Violation|5|||
16881469|NCT02616900|37868734|FG000|Overall Study|Withdrawal by Subject|3|||
16881470|NCT02616900|37868734|FG000|Overall Study|Incomplete data|6|||
16881471|NCT00985673|37868846|FG000|Overall Study|Lost to Follow-up|6|||
16881472|NCT00985673|37868847|FG001|Overall Study|Lost to Follow-up|7|||
16881473|NCT00985673|37868848|FG002|Overall Study|Lost to Follow-up|6|||
16881474|NCT00985673|37868849|FG003|Overall Study|Lost to Follow-up|10|||
16881475|NCT00985673|37868850|FG004|Overall Study|Lost to Follow-up|5|||
16881476|NCT00985673|37868851|FG005|Overall Study|Lost to Follow-up|3|||
16881477|NCT00985673|37868846|FG000|Overall Study|Withdrawal by Subject|0|||
16881478|NCT00985673|37868847|FG001|Overall Study|Withdrawal by Subject|4|||
16881479|NCT00985673|37868848|FG002|Overall Study|Withdrawal by Subject|5|||
16881480|NCT00985673|37868849|FG003|Overall Study|Withdrawal by Subject|2|||
16881481|NCT00985673|37868850|FG004|Overall Study|Withdrawal by Subject|2|||
16881482|NCT00985673|37868851|FG005|Overall Study|Withdrawal by Subject|3|||
16881483|NCT00985673|37868846|FG000|Overall Study|Other|1|||
16881484|NCT00985673|37868847|FG001|Overall Study|Other|0|||
16881485|NCT00985673|37868848|FG002|Overall Study|Other|1|||
16881486|NCT00985673|37868849|FG003|Overall Study|Other|0|||
16881487|NCT00985673|37868850|FG004|Overall Study|Other|1|||
16881488|NCT00985673|37868851|FG005|Overall Study|Other|0|||
16881489|NCT00985439|37868897|FG000|Overall Study|Adverse Event|0|||
16881490|NCT00985439|37868898|FG001|Overall Study|Adverse Event|0|||
16881491|NCT00985439|37868899|FG002|Overall Study|Adverse Event|1|||
16881492|NCT00985439|37868900|FG003|Overall Study|Adverse Event|0|||
16881493|NCT02618928|37868910|FG000|Overall Study|Failure to Return|28|||
16881494|NCT02618928|37868910|FG000|Overall Study|Insufficient Virological Response|1|||
16881495|NCT02618928|37868910|FG000|Overall Study|Withdrawal by Subject|2|||
16881496|NCT02618928|37868910|FG000|Overall Study|Death|3|||
16881497|NCT02618928|37868910|FG000|Overall Study|Other|11|||
16881498|NCT02618928|37868910|FG000|Overall Study|Missing|6|||
16881499|NCT02618928|37868910|FG000|Overall Study|Treatment Never Started|7|||
16881500|NCT00983957|37868921|FG000|Overall Study|Adverse Event|1|||
16881501|NCT00983957|37868921|FG000|Overall Study|Personal Reasons|1|||
16881502|NCT00981461|37868966|FG000|Overall Study|Lost to Follow-up|5|||
16881503|NCT00981461|37868967|FG001|Overall Study|Lost to Follow-up|2|||
16881504|NCT00981149|37868984|FG000|Overall Study|Lost to Follow-up|1|||
16881505|NCT00981149|37868985|FG001|Overall Study|Lost to Follow-up|2|||
16881506|NCT00981149|37868984|FG000|Overall Study|Withdrawal by Subject|1|||
16881507|NCT00981149|37868985|FG001|Overall Study|Withdrawal by Subject|1|||
16881508|NCT01595646|37869043|FG000|Overall Study|Withdrawal by Subject|1|||
16881509|NCT01595646|37869044|FG001|Overall Study|Withdrawal by Subject|0|||
16881510|NCT01595646|37869045|FG002|Overall Study|Withdrawal by Subject|0|||
16881511|NCT02618616|37869082|FG000|Overall Study|Lack of Efficacy|4|||
16881512|NCT02618616|37869083|FG001|Overall Study|Lack of Efficacy|0|||
16881513|NCT02618616|37869082|FG000|Overall Study|Pregnancy|0|||
16881514|NCT02618616|37869083|FG001|Overall Study|Pregnancy|1|||
16881515|NCT02618616|37869082|FG000|Overall Study|Adverse Event|8|||
16881516|NCT02618616|37869083|FG001|Overall Study|Adverse Event|0|||
16881517|NCT02618616|37869082|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
16881518|NCT02618616|37869083|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
17191777|NCT02731131|38344651|FG001|Overall Study|Psychiatric Disorder|1|||
16881519|NCT02618616|37869082|FG000|Overall Study|Consent withdrawn by subject|8|||
16881520|NCT02618616|37869083|FG001|Overall Study|Consent withdrawn by subject|5|||
16881521|NCT02618616|37869082|FG000|Overall Study|Lost to Follow-up|0|||
16881522|NCT02618616|37869083|FG001|Overall Study|Lost to Follow-up|1|||
16881523|NCT02618382|37869162|FG000|Overall Study|Physician Decision|1|||
16881524|NCT02618382|37869162|FG000|Overall Study|Withdrawal by Subject|1|||
16881525|NCT02618382|37869162|FG000|Overall Study|Protocol Violation|1|||
16881526|NCT00980057|37869180|FG000|Overall Study|Death|13|||
16881527|NCT00980057|37869181|FG001|Overall Study|Death|3|||
16881528|NCT00980057|37869180|FG000|Overall Study|Adverse Event|0|||
16881529|NCT00980057|37869181|FG001|Overall Study|Adverse Event|1|||
16881530|NCT00980057|37869180|FG000|Overall Study|Physician Decision|4|||
16881531|NCT00980057|37869181|FG001|Overall Study|Physician Decision|0|||
16881532|NCT00980057|37869180|FG000|Overall Study|Lost to Follow-up|1|||
16881533|NCT00980057|37869181|FG001|Overall Study|Lost to Follow-up|0|||
16881534|NCT00980057|37869180|FG000|Overall Study|Withdrawal by Subject|1|||
16881535|NCT00980057|37869181|FG001|Overall Study|Withdrawal by Subject|1|||
16881536|NCT04126733|37869319|FG000|Treatment Period|Other Reason|1|||
16881537|NCT04126733|37869319|FG000|Treatment Period|Death|1|||
16881538|NCT04126733|37869319|FG000|Treatment Period|Physician Decision|3|||
16881539|NCT04126733|37869319|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
16881540|NCT04126733|37869319|FG000|Treatment Period|Adverse Event|7|||
16881541|NCT04126733|37869319|FG000|Treatment Period|Progressive Disease - Radiological Progression|44|||
16881542|NCT04126733|37869319|FG000|Treatment Period|Ongoing with Study Treatment|7|||
16881543|NCT04126733|37869319|FG000|Active Follow-up Period|Death|13|||
16881544|NCT04126733|37869319|FG000|Active Follow-up Period|Other Reason|1|||
16881545|NCT04126733|37869319|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
16881546|NCT04126733|37869319|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
16881547|NCT04126733|37869319|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
16881548|NCT04126733|37869319|FG000|Long-term Follow-up Period|Death|5|||
16881549|NCT02614794|37869354|FG000|Overall Study|On treatment|118|||
16881550|NCT02614794|37869355|FG001|Overall Study|On treatment|27|||
16881551|NCT02614794|37869354|FG000|Overall Study|In long term follow up|148|||
16881552|NCT02614794|37869355|FG001|Overall Study|In long term follow up|85|||
16881553|NCT02614794|37869354|FG000|Overall Study|Death|126|||
16881554|NCT02614794|37869355|FG001|Overall Study|Death|84|||
16881555|NCT02614794|37869354|FG000|Overall Study|Withdrawal by Subject|16|||
16881556|NCT02614794|37869355|FG001|Overall Study|Withdrawal by Subject|5|||
16881557|NCT02614794|37869354|FG000|Overall Study|Lost to Follow-up|2|||
16881558|NCT02614794|37869355|FG001|Overall Study|Lost to Follow-up|0|||
16881559|NCT02614794|37869354|FG000|Overall Study|Physician Decision|0|||
16881560|NCT02614794|37869355|FG001|Overall Study|Physician Decision|1|||
16881561|NCT00988247|37869363|FG000|Overall Study|Adverse Event|17|||
16881562|NCT00988247|37869364|FG001|Overall Study|Adverse Event|3|||
16881563|NCT00988247|37869363|FG000|Overall Study|Withdrawal by Subject|44|||
16881564|NCT00988247|37869364|FG001|Overall Study|Withdrawal by Subject|13|||
16881565|NCT00988247|37869363|FG000|Overall Study|Pregnancy|1|||
16881566|NCT00988247|37869364|FG001|Overall Study|Pregnancy|2|||
16881567|NCT00988247|37869363|FG000|Overall Study|Lost to Follow-up|11|||
16881568|NCT00988247|37869364|FG001|Overall Study|Lost to Follow-up|2|||
16881569|NCT00988247|37869363|FG000|Overall Study|Protocol Violation|4|||
16881570|NCT00988247|37869364|FG001|Overall Study|Protocol Violation|5|||
16881571|NCT00988247|37869363|FG000|Overall Study|Sponsor requested withdrawal|3|||
16881572|NCT00988247|37869364|FG001|Overall Study|Sponsor requested withdrawal|1|||
16881573|NCT00988247|37869363|FG000|Overall Study|Other|3|||
16881574|NCT00988247|37869364|FG001|Overall Study|Other|0|||
16881575|NCT00984659|37869374|FG000|2-week Run-in Period|Adverse Event|8|||
16881576|NCT00984659|37869375|FG001|2-week Run-in Period|Adverse Event|0|||
16881577|NCT00984659|37869376|FG002|2-week Run-in Period|Adverse Event|0|||
16881578|NCT00984659|37869377|FG003|2-week Run-in Period|Adverse Event|0|||
16881579|NCT00984659|37869374|FG000|2-week Run-in Period|Protocol Violation|5|||
16881580|NCT00984659|37869375|FG001|2-week Run-in Period|Protocol Violation|0|||
16881581|NCT00984659|37869376|FG002|2-week Run-in Period|Protocol Violation|0|||
16881582|NCT00984659|37869377|FG003|2-week Run-in Period|Protocol Violation|0|||
16881583|NCT00984659|37869374|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
16881584|NCT00984659|37869375|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
16881585|NCT00984659|37869376|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
16881586|NCT00984659|37869377|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
16881587|NCT00984659|37869374|FG000|2-week Run-in Period|Lost to Follow-up|3|||
16881588|NCT00984659|37869375|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16881589|NCT00984659|37869376|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16881590|NCT00984659|37869377|FG003|2-week Run-in Period|Lost to Follow-up|0|||
16881591|NCT00984659|37869374|FG000|2-week Run-in Period|Physician Decision|10|||
16881592|NCT00984659|37869375|FG001|2-week Run-in Period|Physician Decision|0|||
16881593|NCT00984659|37869376|FG002|2-week Run-in Period|Physician Decision|0|||
16881594|NCT00984659|37869377|FG003|2-week Run-in Period|Physician Decision|0|||
16881595|NCT00984659|37869374|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
16881596|NCT00984659|37869375|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16881597|NCT00984659|37869376|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16881598|NCT00984659|37869377|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
16881599|NCT00984659|37869374|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
16881600|NCT00984659|37869375|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16881601|NCT00984659|37869376|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
17191778|NCT02731131|38344650|FG000|Overall Study|Refused Therapy|0|||
16881602|NCT00984659|37869377|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16881603|NCT00984659|37869374|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
16881604|NCT00984659|37869375|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
16881605|NCT00984659|37869376|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
16881606|NCT00984659|37869377|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
16881607|NCT00984659|37869374|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
16881608|NCT00984659|37869375|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
16881609|NCT00984659|37869376|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
16881610|NCT00984659|37869377|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
16881611|NCT00984659|37869374|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
16881612|NCT00984659|37869375|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
16881613|NCT00984659|37869376|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
16881614|NCT00984659|37869377|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
16881615|NCT00984659|37869374|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
16881616|NCT00984659|37869375|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
16881617|NCT00984659|37869376|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
16881618|NCT00984659|37869377|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
16881619|NCT00984659|37869374|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16881620|NCT00984659|37869375|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
16881621|NCT00984659|37869376|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
16881622|NCT00984659|37869377|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
16881623|NCT00982319|37869386|FG000|Overall Study|Surgery date change|1|||
16881624|NCT00982319|37869387|FG001|Overall Study|Surgery date change|0|||
16881625|NCT00982319|37869386|FG000|Overall Study|Preop values out of acceptable range|1|||
16881626|NCT00982319|37869387|FG001|Overall Study|Preop values out of acceptable range|1|||
16881627|NCT00982319|37869386|FG000|Overall Study|Pregnancy|0|||
16881628|NCT00982319|37869387|FG001|Overall Study|Pregnancy|1|||
16881629|NCT02612064|37869411|FG000|Overall Study|Withdrawal by Subject|1|||
16881630|NCT02612064|37869412|FG001|Overall Study|Withdrawal by Subject|1|||
16881631|NCT02612064|37869411|FG000|Overall Study|Other|0|||
16881632|NCT02612064|37869412|FG001|Overall Study|Other|2|||
16881633|NCT02614560|37869431|FG000|Overall Study|Death|6|||
16881634|NCT02614560|37869432|FG001|Overall Study|Death|2|||
16881635|NCT01669122|37869460|FG000|Period I|Lost to Follow-up|1|||
16881636|NCT01669122|37869460|FG000|Washout Period II|Protocol Violation|2|||
16881637|NCT02611752|37869493|FG000|Overall Study|Adverse Event|0|||
16881638|NCT02611752|37869494|FG001|Overall Study|Adverse Event|1|||
16881639|NCT02611362|37869515|FG000|Overall Study|Withdrawal by Subject|7|||
16881640|NCT02611362|37869516|FG001|Overall Study|Withdrawal by Subject|2|||
16881641|NCT02611362|37869515|FG000|Overall Study|Lost to Follow-up|2|||
16881642|NCT02611362|37869516|FG001|Overall Study|Lost to Follow-up|4|||
16881643|NCT01594476|37869536|FG000|Overall Study|Protocol Violation|1|||
16881644|NCT01594476|37869537|FG001|Overall Study|Protocol Violation|3|||
16881645|NCT01668966|37869551|FG000|Overall Study|Withdrawal by Subject|1|||
16881646|NCT01668966|37869551|FG000|Overall Study|Death|1|||
16881647|NCT01668966|37869551|FG000|Overall Study|Not treated|2|||
16881648|NCT02609724|37869558|FG000|Overall Study|Death|2|||
16881649|NCT02609724|37869559|FG001|Overall Study|Death|0|||
16881650|NCT02609724|37869560|FG002|Overall Study|Death|1|||
16881651|NCT02609724|37869558|FG000|Overall Study|Withdrawal by Subject|1|||
16881652|NCT02609724|37869559|FG001|Overall Study|Withdrawal by Subject|2|||
16881653|NCT02609724|37869560|FG002|Overall Study|Withdrawal by Subject|3|||
16881654|NCT02609724|37869558|FG000|Overall Study|Illness|2|||
16881655|NCT02609724|37869559|FG001|Overall Study|Illness|1|||
16881656|NCT02609724|37869560|FG002|Overall Study|Illness|0|||
16881657|NCT02610816|37869593|FG000|Phase 1|Withdrawal by Subject|2|||
16881658|NCT02610816|37869594|FG001|Phase 1|Withdrawal by Subject|6|||
16881659|NCT02610816|37869595|FG002|Phase 1|Withdrawal by Subject|0|||
16881660|NCT02610816|37869596|FG003|Phase 1|Withdrawal by Subject|0|||
16881661|NCT02610816|37869593|FG000|Phase 1|Lost to Follow-up|2|||
16881662|NCT02610816|37869594|FG001|Phase 1|Lost to Follow-up|1|||
16881663|NCT02610816|37869595|FG002|Phase 1|Lost to Follow-up|0|||
16881664|NCT02610816|37869596|FG003|Phase 1|Lost to Follow-up|0|||
16881665|NCT02610816|37869593|FG000|Phase 1|Physician Decision|0|||
16881666|NCT02610816|37869594|FG001|Phase 1|Physician Decision|1|||
16881667|NCT02610816|37869595|FG002|Phase 1|Physician Decision|0|||
16881668|NCT02610816|37869596|FG003|Phase 1|Physician Decision|0|||
16881669|NCT02610816|37869593|FG000|Phase 2|Withdrawal by Subject|0|||
16881670|NCT02610816|37869594|FG001|Phase 2|Withdrawal by Subject|0|||
16881671|NCT02610816|37869595|FG002|Phase 2|Withdrawal by Subject|9|||
16881672|NCT02610816|37869596|FG003|Phase 2|Withdrawal by Subject|3|||
16881673|NCT02610816|37869593|FG000|Phase 2|Lost to Follow-up|0|||
16881674|NCT02610816|37869594|FG001|Phase 2|Lost to Follow-up|0|||
16881675|NCT02610816|37869595|FG002|Phase 2|Lost to Follow-up|2|||
16881676|NCT02610816|37869596|FG003|Phase 2|Lost to Follow-up|0|||
16881677|NCT02610816|37869593|FG000|Phase 2|Physician Decision|0|||
16881678|NCT02610816|37869594|FG001|Phase 2|Physician Decision|0|||
16881679|NCT02610816|37869595|FG002|Phase 2|Physician Decision|0|||
16881680|NCT02610816|37869596|FG003|Phase 2|Physician Decision|2|||
16881681|NCT02610816|37869593|FG000|Phase 2|Pregnancy|0|||
16881682|NCT02610816|37869594|FG001|Phase 2|Pregnancy|0|||
16881683|NCT02610816|37869595|FG002|Phase 2|Pregnancy|0|||
16881684|NCT02610816|37869596|FG003|Phase 2|Pregnancy|1|||
16881685|NCT02612610|37869692|FG000|Overall Study|Withdrawal by Subject|1|||
16881686|NCT02612610|37869693|FG001|Overall Study|Withdrawal by Subject|1|||
16881687|NCT02612610|37869694|FG002|Overall Study|Withdrawal by Subject|0|||
16881688|NCT02612610|37869695|FG003|Overall Study|Withdrawal by Subject|2|||
16881689|NCT02612610|37869692|FG000|Overall Study|Adverse Event|2|||
16881690|NCT02612610|37869693|FG001|Overall Study|Adverse Event|2|||
16881691|NCT02612610|37869694|FG002|Overall Study|Adverse Event|3|||
16881692|NCT02612610|37869695|FG003|Overall Study|Adverse Event|10|||
16881693|NCT02612610|37869692|FG000|Overall Study|Lost to Follow-up|0|||
16881694|NCT02612610|37869693|FG001|Overall Study|Lost to Follow-up|1|||
16881695|NCT02612610|37869694|FG002|Overall Study|Lost to Follow-up|0|||
16881696|NCT02612610|37869695|FG003|Overall Study|Lost to Follow-up|0|||
16881697|NCT02612610|37869692|FG000|Overall Study|Protocol Violation|0|||
16881698|NCT02612610|37869693|FG001|Overall Study|Protocol Violation|1|||
16881699|NCT02612610|37869694|FG002|Overall Study|Protocol Violation|1|||
16881700|NCT02612610|37869695|FG003|Overall Study|Protocol Violation|0|||
16881701|NCT02612610|37869692|FG000|Overall Study|Lack of Efficacy|1|||
16881702|NCT02612610|37869693|FG001|Overall Study|Lack of Efficacy|2|||
16881703|NCT02612610|37869694|FG002|Overall Study|Lack of Efficacy|0|||
16881704|NCT02612610|37869695|FG003|Overall Study|Lack of Efficacy|1|||
16881705|NCT02612610|37869692|FG000|Overall Study|Physician Decision|0|||
16881706|NCT02612610|37869693|FG001|Overall Study|Physician Decision|1|||
16881707|NCT02612610|37869694|FG002|Overall Study|Physician Decision|0|||
16881708|NCT02612610|37869695|FG003|Overall Study|Physician Decision|0|||
16881709|NCT02612610|37869692|FG000|Overall Study|Noncompliance|1|||
16881710|NCT02612610|37869693|FG001|Overall Study|Noncompliance|0|||
16881711|NCT02612610|37869694|FG002|Overall Study|Noncompliance|0|||
16881712|NCT02612610|37869695|FG003|Overall Study|Noncompliance|0|||
16881713|NCT02612610|37869692|FG000|Overall Study|Cough Improvement|0|||
16881714|NCT02612610|37869693|FG001|Overall Study|Cough Improvement|0|||
16881715|NCT02612610|37869694|FG002|Overall Study|Cough Improvement|1|||
16881716|NCT02612610|37869695|FG003|Overall Study|Cough Improvement|0|||
16881717|NCT02610192|37869904|FG000|Overall Study|Received other treatment|8|||
16881718|NCT02610192|37869904|FG000|Overall Study|Physician Decision|1|||
16881719|NCT02609178|37870066|FG000|First Crown|Withdrawal by Subject|0|||
16881720|NCT02609178|37870067|FG001|First Crown|Withdrawal by Subject|0|||
16881721|NCT02609178|37870068|FG002|First Crown|Withdrawal by Subject|1|||
16881722|NCT02609178|37870069|FG003|First Crown|Withdrawal by Subject|1|||
16881723|NCT02609178|37870070|FG004|First Crown|Withdrawal by Subject|0|||
16881724|NCT02609178|37870071|FG005|First Crown|Withdrawal by Subject|0|||
16881725|NCT02607228|37870295|FG000|Overall Study|Progressive Disease|4|||
16881726|NCT02607228|37870296|FG001|Overall Study|Progressive Disease|3|||
16881727|NCT02607228|37870297|FG002|Overall Study|Progressive Disease|1|||
16881728|NCT02607228|37870298|FG003|Overall Study|Progressive Disease|5|||
16881729|NCT02607228|37870299|FG004|Overall Study|Progressive Disease|4|||
16881730|NCT02607228|37870300|FG005|Overall Study|Progressive Disease|3|||
16881731|NCT02607228|37870301|FG006|Overall Study|Progressive Disease|1|||
16881732|NCT02607228|37870295|FG000|Overall Study|Adverse Event|1|||
16881733|NCT02607228|37870296|FG001|Overall Study|Adverse Event|0|||
16881734|NCT02607228|37870297|FG002|Overall Study|Adverse Event|1|||
16881735|NCT02607228|37870298|FG003|Overall Study|Adverse Event|0|||
16881736|NCT02607228|37870299|FG004|Overall Study|Adverse Event|1|||
16881737|NCT02607228|37870300|FG005|Overall Study|Adverse Event|1|||
16881738|NCT02607228|37870301|FG006|Overall Study|Adverse Event|1|||
16881739|NCT02607228|37870295|FG000|Overall Study|Investigator's Discretion|0|||
16881740|NCT02607228|37870296|FG001|Overall Study|Investigator's Discretion|0|||
16881741|NCT02607228|37870297|FG002|Overall Study|Investigator's Discretion|1|||
16881742|NCT02607228|37870298|FG003|Overall Study|Investigator's Discretion|0|||
16881743|NCT02607228|37870299|FG004|Overall Study|Investigator's Discretion|0|||
16881744|NCT02607228|37870300|FG005|Overall Study|Investigator's Discretion|1|||
16881745|NCT02607228|37870301|FG006|Overall Study|Investigator's Discretion|0|||
16881746|NCT02607228|37870295|FG000|Overall Study|Withdrew Consent|0|||
16881747|NCT02607228|37870296|FG001|Overall Study|Withdrew Consent|1|||
16881748|NCT02607228|37870297|FG002|Overall Study|Withdrew Consent|0|||
16881749|NCT02607228|37870298|FG003|Overall Study|Withdrew Consent|0|||
16881750|NCT02607228|37870299|FG004|Overall Study|Withdrew Consent|0|||
16881751|NCT02607228|37870300|FG005|Overall Study|Withdrew Consent|1|||
16881752|NCT02607228|37870301|FG006|Overall Study|Withdrew Consent|0|||
16881753|NCT02607228|37870295|FG000|Overall Study|Study Terminated by Sponsor|0|||
16881754|NCT02607228|37870296|FG001|Overall Study|Study Terminated by Sponsor|0|||
16881755|NCT02607228|37870297|FG002|Overall Study|Study Terminated by Sponsor|0|||
16881756|NCT02607228|37870298|FG003|Overall Study|Study Terminated by Sponsor|1|||
16881757|NCT02607228|37870299|FG004|Overall Study|Study Terminated by Sponsor|0|||
16881758|NCT02607228|37870300|FG005|Overall Study|Study Terminated by Sponsor|0|||
16881759|NCT02607228|37870301|FG006|Overall Study|Study Terminated by Sponsor|0|||
16881760|NCT01668654|37870343|FG000|Overall Study|Study Closed/Terminated|3|||
16881761|NCT01668654|37870343|FG000|Overall Study|Withdrawal by Subject|1|||
16881762|NCT02608476|37870437|FG000|Overall Study|Withdrawal by Subject|30|||
16881763|NCT02608476|37870438|FG001|Overall Study|Withdrawal by Subject|37|||
16881764|NCT02608476|37870437|FG000|Overall Study|Lost to Follow-up|24|||
16881765|NCT02608476|37870438|FG001|Overall Study|Lost to Follow-up|24|||
16881766|NCT02608476|37870437|FG000|Overall Study|Adverse Event|2|||
16881767|NCT02608476|37870438|FG001|Overall Study|Adverse Event|8|||
16881768|NCT02608476|37870437|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
16881769|NCT02608476|37870438|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
16881770|NCT02608476|37870437|FG000|Overall Study|Noncompliance with treatment|1|||
16881771|NCT02608476|37870438|FG001|Overall Study|Noncompliance with treatment|5|||
16881772|NCT02608476|37870437|FG000|Overall Study|Lack of Efficacy|3|||
16881773|NCT02608476|37870438|FG001|Overall Study|Lack of Efficacy|1|||
16881774|NCT02608476|37870437|FG000|Overall Study|Other|0|||
16881775|NCT02608476|37870438|FG001|Overall Study|Other|1|||
16881776|NCT02608476|37870437|FG000|Overall Study|Physician Decision|1|||
16881777|NCT02608476|37870438|FG001|Overall Study|Physician Decision|0|||
16881778|NCT02608476|37870437|FG000|Overall Study|Pregnancy|0|||
16881779|NCT02608476|37870438|FG001|Overall Study|Pregnancy|1|||
16881780|NCT02608476|37870437|FG000|Overall Study|Progressive disease|1|||
16881781|NCT02608476|37870438|FG001|Overall Study|Progressive disease|0|||
16881782|NCT02607306|37870576|FG000|Overall Study|Adverse Event|8|||
16881783|NCT02607306|37870577|FG001|Overall Study|Adverse Event|6|||
16881784|NCT02607306|37870578|FG002|Overall Study|Adverse Event|6|||
16881785|NCT02607306|37870576|FG000|Overall Study|Unclassified|1|||
16881786|NCT02607306|37870577|FG001|Overall Study|Unclassified|4|||
16881787|NCT02607306|37870578|FG002|Overall Study|Unclassified|0|||
16881788|NCT02607306|37870576|FG000|Overall Study|Withdrawal by Subject|8|||
16881789|NCT02607306|37870577|FG001|Overall Study|Withdrawal by Subject|10|||
16881790|NCT02607306|37870578|FG002|Overall Study|Withdrawal by Subject|2|||
16881791|NCT02607306|37870576|FG000|Overall Study|Lack of Efficacy|0|||
16881792|NCT02607306|37870577|FG001|Overall Study|Lack of Efficacy|1|||
16881793|NCT02607306|37870578|FG002|Overall Study|Lack of Efficacy|1|||
16881794|NCT02607306|37870576|FG000|Overall Study|Protocol Violation|4|||
16881795|NCT02607306|37870577|FG001|Overall Study|Protocol Violation|2|||
16881796|NCT02607306|37870578|FG002|Overall Study|Protocol Violation|1|||
16881797|NCT02603952|37870901|FG000|Overall Study|Withdrawal by Subject|1|||
16881798|NCT02603952|37870902|FG001|Overall Study|Withdrawal by Subject|0|||
16881799|NCT02603952|37870903|FG002|Overall Study|Withdrawal by Subject|0|||
16881800|NCT02603952|37870904|FG003|Overall Study|Withdrawal by Subject|0|||
16881801|NCT02603952|37870901|FG000|Overall Study|Received oseltamivir by error|0|||
16881802|NCT02603952|37870902|FG001|Overall Study|Received oseltamivir by error|0|||
16881803|NCT02603952|37870903|FG002|Overall Study|Received oseltamivir by error|0|||
16881804|NCT02603952|37870904|FG003|Overall Study|Received oseltamivir by error|1|||
16881805|NCT02603172|37871443|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16881806|NCT02603172|37871444|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16881807|NCT02603172|37871445|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
16881808|NCT02603172|37871446|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16881809|NCT02603172|37871447|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16881810|NCT02603172|37871448|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16881811|NCT02603172|37871449|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16881812|NCT02603172|37871450|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16881813|NCT02605824|37871551|FG000|Overall Study|Physician Decision|1|||
16881814|NCT02605824|37871552|FG001|Overall Study|Physician Decision|0|||
16881815|NCT02605122|37871682|FG000|Overall Study|Withdrawal by Subject|4|||
16881816|NCT02605122|37871683|FG001|Overall Study|Withdrawal by Subject|1|||
16881817|NCT02605122|37871682|FG000|Overall Study|Lost to Follow-up|1|||
16881818|NCT02605122|37871683|FG001|Overall Study|Lost to Follow-up|1|||
16881819|NCT01454102|37871723|FG000|Overall Study|Continuing in the treatment period|0|||
16881820|NCT01454102|37871724|FG001|Overall Study|Continuing in the treatment period|0|||
16881821|NCT01454102|37871725|FG002|Overall Study|Continuing in the treatment period|0|||
16881822|NCT01454102|37871726|FG003|Overall Study|Continuing in the treatment period|0|||
16881823|NCT01454102|37871727|FG004|Overall Study|Continuing in the treatment period|3|||
16881824|NCT01454102|37871728|FG005|Overall Study|Continuing in the treatment period|3|||
16881825|NCT01454102|37871729|FG006|Overall Study|Continuing in the treatment period|2|||
16881826|NCT01454102|37871730|FG007|Overall Study|Continuing in the treatment period|0|||
16881827|NCT01454102|37871731|FG008|Overall Study|Continuing in the treatment period|1|||
16881828|NCT01454102|37871732|FG009|Overall Study|Continuing in the treatment period|0|||
16881829|NCT01454102|37871733|FG010|Overall Study|Continuing in the treatment period|0|||
16881830|NCT01454102|37871734|FG011|Overall Study|Continuing in the treatment period|4|||
16881831|NCT01454102|37871735|FG012|Overall Study|Continuing in the treatment period|7|||
16881832|NCT01454102|37871736|FG013|Overall Study|Continuing in the treatment period|4|||
16881833|NCT01454102|37871737|FG014|Overall Study|Continuing in the treatment period|3|||
16881834|NCT01454102|37871738|FG015|Overall Study|Continuing in the treatment period|1|||
16881835|NCT02602080|37871843|FG000|Overall Study|Protocol Violation|6|||
16881836|NCT02602080|37871844|FG001|Overall Study|Protocol Violation|1|||
16881837|NCT02602080|37871845|FG002|Overall Study|Protocol Violation|3|||
16881838|NCT02604342|37871929|FG000|Overall Study|Death|32|||
16881839|NCT02604342|37871930|FG001|Overall Study|Death|16|||
16881840|NCT02604342|37871929|FG000|Overall Study|Progression of disease|1|||
16881841|NCT02604342|37871930|FG001|Overall Study|Progression of disease|0|||
16881842|NCT02604342|37871929|FG000|Overall Study|Withdrawal by Subject|5|||
16881843|NCT02604342|37871930|FG001|Overall Study|Withdrawal by Subject|6|||
16881844|NCT02604342|37871929|FG000|Overall Study|Other|1|||
16881845|NCT02604342|37871930|FG001|Overall Study|Other|0|||
16881846|NCT02604342|37871929|FG000|Overall Study|Study Termination by Sponsor|1|||
16881847|NCT02604342|37871930|FG001|Overall Study|Study Termination by Sponsor|0|||
16881848|NCT02604342|37871929|FG000|Overall Study|Lost to Follow-up|1|||
16881849|NCT02604342|37871930|FG001|Overall Study|Lost to Follow-up|1|||
16881850|NCT02604342|37871929|FG000|Overall Study|Physician Decision|2|||
16881851|NCT02604342|37871930|FG001|Overall Study|Physician Decision|0|||
16881852|NCT02604264|37871959|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
16881853|NCT02604264|37871960|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
16881854|NCT02601300|37871997|FG000|Induction Phase|Lack of Efficacy|2|||
16881855|NCT02601300|37871997|FG000|Induction Phase|Protocol Violation|1|||
16881856|NCT02601300|37871997|FG000|Extension Phase|Withdrawal by Subject|3|||
16881857|NCT02601300|37871997|FG000|Extension Phase|Adverse Event|4|||
17095286|NCT00261846|38234549|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
17095287|NCT00261846|38234550|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
17095288|NCT00261846|38234551|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
17095289|NCT00261846|38234540|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
17095290|NCT00261846|38234541|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
17095291|NCT00261846|38234542|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
16881858|NCT02601300|37871997|FG000|Extension Phase|Lack of Efficacy|10|||
16881859|NCT01471340|37872036|FG000|Overall Study|Death|5|||
16881860|NCT01471340|37872037|FG001|Overall Study|Death|4|||
16881861|NCT01471340|37872036|FG000|Overall Study|Lost to Follow-up|0|||
16881862|NCT01471340|37872037|FG001|Overall Study|Lost to Follow-up|1|||
16881863|NCT01471340|37872036|FG000|Overall Study|Investigational site closure|0|||
16881864|NCT01471340|37872037|FG001|Overall Study|Investigational site closure|1|||
16881865|NCT01471340|37872036|FG000|Overall Study|Invalid informed consent|1|||
16881866|NCT01471340|37872037|FG001|Overall Study|Invalid informed consent|0|||
16881867|NCT01492400|37872059|FG000|Overall Study|Miscellaneous Reasons|2|||
16881868|NCT01492400|37872060|FG001|Overall Study|Miscellaneous Reasons|3|||
16881869|NCT01492400|37872059|FG000|Overall Study|Personal Reasons|0|||
16881870|NCT01492400|37872060|FG001|Overall Study|Personal Reasons|5|||
16881871|NCT01492400|37872059|FG000|Overall Study|Lost to Follow-up|3|||
16881872|NCT01492400|37872060|FG001|Overall Study|Lost to Follow-up|1|||
16881873|NCT01492400|37872059|FG000|Overall Study|Pregnancy|0|||
16881874|NCT01492400|37872060|FG001|Overall Study|Pregnancy|1|||
16881875|NCT01492400|37872059|FG000|Overall Study|Lack of Efficacy|1|||
16881876|NCT01492400|37872060|FG001|Overall Study|Lack of Efficacy|1|||
16881877|NCT01492400|37872059|FG000|Overall Study|Adverse Event|10|||
16881878|NCT01492400|37872060|FG001|Overall Study|Adverse Event|5|||
16881879|NCT02596854|37872185|FG000|Overall Study|Withdrawn|8|||
16881880|NCT02592876|37872330|FG000|Overall Study|Withdrawal by Subject|3|||
16881881|NCT02592876|37872331|FG001|Overall Study|Withdrawal by Subject|3|||
16881882|NCT02592876|37872330|FG000|Overall Study|Study Termination by Sponsor|32|||
16881883|NCT02592876|37872331|FG001|Overall Study|Study Termination by Sponsor|27|||
16881884|NCT02592876|37872330|FG000|Overall Study|Lost to Follow-up|0|||
16881885|NCT02592876|37872331|FG001|Overall Study|Lost to Follow-up|1|||
16881886|NCT02592876|37872330|FG000|Overall Study|Death|6|||
16881887|NCT02592876|37872331|FG001|Overall Study|Death|9|||
16881888|NCT01492088|37872348|FG000|Overall Study|Withdrawal by Patient|0|||
16881889|NCT01492088|37872349|FG001|Overall Study|Withdrawal by Patient|2|||
16881890|NCT01492088|37872350|FG002|Overall Study|Withdrawal by Patient|0|||
16881891|NCT01492088|37872348|FG000|Overall Study|Death|1|||
16881892|NCT01492088|37872349|FG001|Overall Study|Death|6|||
16881893|NCT01492088|37872350|FG002|Overall Study|Death|2|||
16881894|NCT01492088|37872348|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
16881895|NCT01492088|37872349|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
17095292|NCT00261846|38234543|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
17095293|NCT00261846|38234544|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
16881896|NCT01492088|37872350|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
16881897|NCT01492088|37872348|FG000|Overall Study|Alive at Last Follow-up|0|||
16881898|NCT01492088|37872349|FG001|Overall Study|Alive at Last Follow-up|6|||
16881899|NCT01492088|37872350|FG002|Overall Study|Alive at Last Follow-up|11|||
16881900|NCT02592798|37872592|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
16881901|NCT02592798|37872593|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
16881902|NCT02592798|37872592|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
16881903|NCT02592798|37872593|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
16881904|NCT02592798|37872592|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
16881905|NCT02592798|37872593|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
16881906|NCT02592798|37872592|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
16881907|NCT02592798|37872593|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
16881908|NCT02592798|37872592|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
16881909|NCT02592798|37872593|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
16881910|NCT02592798|37872592|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
16881911|NCT02592798|37872593|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
16881912|NCT02592798|37872592|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
16881913|NCT02592798|37872593|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
16881914|NCT02592798|37872592|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
16881915|NCT02592798|37872593|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
16881916|NCT02592798|37872592|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
16881917|NCT02592798|37872593|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
16881918|NCT02592798|37872592|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
16881919|NCT02592798|37872593|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
16881920|NCT02592798|37872592|FG000|Transition From DB2 to OLE|Other reasons|1|||
16881921|NCT02592798|37872593|FG001|Transition From DB2 to OLE|Other reasons|0|||
16881922|NCT02592798|37872592|FG000|Open Label Period (OLE)|Other reasons|0|||
16881923|NCT02592798|37872593|FG001|Open Label Period (OLE)|Other reasons|2|||
16881924|NCT02592798|37872592|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
16881925|NCT02592798|37872593|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
16881926|NCT02592798|37872592|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
16881927|NCT02592798|37872593|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
16881928|NCT02592798|37872592|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
16881929|NCT02592798|37872593|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
16881930|NCT02592798|37872592|FG000|Open Label Period (OLE)|Adverse Event|0|||
16881931|NCT02592798|37872593|FG001|Open Label Period (OLE)|Adverse Event|1|||
16881932|NCT00081653|37872633|FG000|Overall Study|Adverse Event|23|||
16881933|NCT00081653|37872634|FG001|Overall Study|Adverse Event|17|||
16881934|NCT00081653|37872633|FG000|Overall Study|Lost to Follow-up|2|||
16881935|NCT00081653|37872634|FG001|Overall Study|Lost to Follow-up|4|||
16881936|NCT00081653|37872633|FG000|Overall Study|Refused Treatment|18|||
16881937|NCT00081653|37872634|FG001|Overall Study|Refused Treatment|14|||
16881938|NCT00081653|37872633|FG000|Overall Study|Low bone mineral density|1|||
16881939|NCT00081653|37872634|FG001|Overall Study|Low bone mineral density|0|||
16881940|NCT00081653|37872633|FG000|Overall Study|Bone loss|2|||
16881941|NCT00081653|37872634|FG001|Overall Study|Bone loss|0|||
16881942|NCT00081653|37872633|FG000|Overall Study|Participant leaving country|1|||
16881943|NCT00081653|37872634|FG001|Overall Study|Participant leaving country|0|||
16881944|NCT00081653|37872633|FG000|Overall Study|Loss of bone mass|0|||
16881945|NCT00081653|37872634|FG001|Overall Study|Loss of bone mass|2|||
16881946|NCT02596620|37872704|FG000|Overall Study|Lost to Follow-up|1|||
16881947|NCT02596620|37872705|FG001|Overall Study|Lost to Follow-up|1|||
16881948|NCT02596230|37872861|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
16881949|NCT02596230|37872862|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
16881950|NCT02596230|37872863|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
16881951|NCT02596230|37872864|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
16881952|NCT02596230|37872865|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
16881953|NCT02596230|37872861|FG000|Objective 2, One Year|Lost to Follow-up|0|||
16881954|NCT02596230|37872862|FG001|Objective 2, One Year|Lost to Follow-up|41|||
16881955|NCT02596230|37872863|FG002|Objective 2, One Year|Lost to Follow-up|41|||
16881956|NCT02596230|37872864|FG003|Objective 2, One Year|Lost to Follow-up|32|||
16881957|NCT02596230|37872865|FG004|Objective 2, One Year|Lost to Follow-up|46|||
16881958|NCT02596230|37872861|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
16881959|NCT02596230|37872862|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
16881960|NCT02596230|37872863|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
16881961|NCT02596230|37872864|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
16881962|NCT02596230|37872865|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
16881963|NCT02596230|37872861|FG000|Objective 2, One Year|Adverse drug reaction|0|||
16881964|NCT02596230|37872862|FG001|Objective 2, One Year|Adverse drug reaction|1|||
16881965|NCT02596230|37872863|FG002|Objective 2, One Year|Adverse drug reaction|0|||
16881966|NCT02596230|37872864|FG003|Objective 2, One Year|Adverse drug reaction|0|||
16881967|NCT02596230|37872865|FG004|Objective 2, One Year|Adverse drug reaction|0|||
16881968|NCT02596230|37872861|FG000|Objective 2, One Year|Death|0|||
16881969|NCT02596230|37872862|FG001|Objective 2, One Year|Death|12|||
16881970|NCT02596230|37872863|FG002|Objective 2, One Year|Death|41|||
16881971|NCT02596230|37872864|FG003|Objective 2, One Year|Death|21|||
16881972|NCT02596230|37872865|FG004|Objective 2, One Year|Death|30|||
16881973|NCT02596230|37872861|FG000|Objective 2, One Year|Other|0|||
16881974|NCT02596230|37872862|FG001|Objective 2, One Year|Other|3|||
16881975|NCT02596230|37872863|FG002|Objective 2, One Year|Other|2|||
17095294|NCT00261846|38234545|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
16881976|NCT02596230|37872864|FG003|Objective 2, One Year|Other|0|||
16881977|NCT02596230|37872865|FG004|Objective 2, One Year|Other|0|||
16881978|NCT01667562|37872914|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
16881979|NCT01667562|37872915|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
16881980|NCT01667562|37872914|FG000|Erlotinib Phase|Lost to Follow-up|0|||
16881981|NCT01667562|37872915|FG001|Erlotinib Phase|Lost to Follow-up|1|||
16881982|NCT01667562|37872914|FG000|Erlotinib Phase|Adverse Event|0|||
16881983|NCT01667562|37872915|FG001|Erlotinib Phase|Adverse Event|1|||
16881984|NCT01667562|37872914|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
16881985|NCT01667562|37872915|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
16881986|NCT02595528|37872952|FG000|Overall Study|Withdrawal by Subject|1|||
16881987|NCT02595528|37872953|FG001|Overall Study|Withdrawal by Subject|2|||
16881988|NCT02595528|37872954|FG002|Overall Study|Withdrawal by Subject|1|||
16881989|NCT02595528|37872955|FG003|Overall Study|Withdrawal by Subject|3|||
16881990|NCT02595528|37872952|FG000|Overall Study|Lost to Follow-up|1|||
16881991|NCT02595528|37872953|FG001|Overall Study|Lost to Follow-up|1|||
16881992|NCT02595528|37872954|FG002|Overall Study|Lost to Follow-up|0|||
16881993|NCT02595528|37872955|FG003|Overall Study|Lost to Follow-up|1|||
16881994|NCT02595450|37872983|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
16881995|NCT02595450|37872983|FG000|Overall Study|Enrolled, but not treated|8|||
16881996|NCT02592018|37872987|FG000|Overall Study|Adverse Event|1|||
16881997|NCT02592018|37872987|FG000|Overall Study|Lost to Follow-up|1|||
16881998|NCT02591238|37872995|FG000|Overall Study|Pregnancy|1|||
16881999|NCT02591238|37872996|FG001|Overall Study|Pregnancy|0|||
16882000|NCT02591238|37872997|FG002|Overall Study|Pregnancy|0|||
16882001|NCT02591238|37872998|FG003|Overall Study|Pregnancy|0|||
16882002|NCT02591238|37872995|FG000|Overall Study|Withdrawal by Subject|0|||
16882003|NCT02591238|37872996|FG001|Overall Study|Withdrawal by Subject|0|||
16882004|NCT02591238|37872997|FG002|Overall Study|Withdrawal by Subject|0|||
16882005|NCT02591238|37872998|FG003|Overall Study|Withdrawal by Subject|1|||
16882006|NCT02591238|37872995|FG000|Overall Study|influenza|0|||
16882007|NCT02591238|37872996|FG001|Overall Study|influenza|0|||
16882008|NCT02591238|37872997|FG002|Overall Study|influenza|0|||
16882009|NCT02591238|37872998|FG003|Overall Study|influenza|1|||
16882010|NCT02591238|37872995|FG000|Overall Study|personal circumstances|0|||
16882011|NCT02591238|37872996|FG001|Overall Study|personal circumstances|0|||
16882012|NCT02591238|37872997|FG002|Overall Study|personal circumstances|0|||
16882013|NCT02591238|37872998|FG003|Overall Study|personal circumstances|1|||
16882014|NCT02591238|37872995|FG000|Overall Study|personal circumstances|0|||
16882015|NCT02591238|37872996|FG001|Overall Study|personal circumstances|1|||
16882016|NCT02591238|37872997|FG002|Overall Study|personal circumstances|0|||
16882017|NCT02591238|37872998|FG003|Overall Study|personal circumstances|0|||
16882018|NCT02597946|37873080|FG000|Overall Study|Withdrawal by Subject|1|||
16882019|NCT02597946|37873080|FG000|Overall Study|Progressive disease|16|||
16882020|NCT02597946|37873080|FG000|Overall Study|Other than above|1|||
16882021|NCT02597712|37873086|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
16882022|NCT02597712|37873087|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
16882023|NCT02597712|37873086|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
16882024|NCT02597712|37873087|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
16882025|NCT02597712|37873086|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
16882026|NCT02597712|37873087|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
16882027|NCT02597478|37873095|FG000|Overall Study|Withdrawal by Subject|2|||
16882028|NCT02597478|37873096|FG001|Overall Study|Withdrawal by Subject|0|||
16882029|NCT02597478|37873095|FG000|Overall Study|Change of opioid dose|1|||
16882030|NCT02597478|37873096|FG001|Overall Study|Change of opioid dose|0|||
16882031|NCT02597478|37873095|FG000|Overall Study|Insufficient exertional dyspnea|0|||
16882032|NCT02597478|37873096|FG001|Overall Study|Insufficient exertional dyspnea|1|||
16882033|NCT01471028|37873191|FG000|VTI-208|Adverse Event|39|||
16882034|NCT01471028|37873192|FG001|VTI-208|Adverse Event|41|||
16882035|NCT01471028|37873191|FG000|VTI-208|Withdrawal by Subject|0|||
16882036|NCT01471028|37873192|FG001|VTI-208|Withdrawal by Subject|2|||
16882037|NCT01471028|37873191|FG000|VTI-208|Lost to Follow-up|1|||
16882038|NCT01471028|37873192|FG001|VTI-208|Lost to Follow-up|1|||
17191779|NCT02731131|38344651|FG001|Overall Study|Refused Therapy|1|||
17191780|NCT02746705|38344659|FG000|Overall Study|Physician Decision|1|||
17191781|NCT02746705|38344660|FG001|Overall Study|Physician Decision|1|||
17191782|NCT02746705|38344659|FG000|Overall Study|Lost to Follow-up|1|||
17191783|NCT02746705|38344660|FG001|Overall Study|Lost to Follow-up|0|||
17191784|NCT02746705|38344659|FG000|Overall Study|outlier scores deemed not valid|0|||
17191785|NCT02746705|38344660|FG001|Overall Study|outlier scores deemed not valid|1|||
17191786|NCT02746627|38344669|FG000|Overall Study|Withdrawal by Subject|1|||
17191787|NCT02746627|38344670|FG001|Overall Study|Withdrawal by Subject|1|||
17191788|NCT02746627|38344671|FG002|Overall Study|Withdrawal by Subject|1|||
17191789|NCT02856113|38344681|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
17191790|NCT02856113|38344682|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
17191791|NCT02856113|38344681|FG000|Overall Study|Significant Protocol Deviation|1|||
17191792|NCT02856113|38344682|FG001|Overall Study|Significant Protocol Deviation|0|||
17191793|NCT02856113|38344681|FG000|Overall Study|Lost to Follow-up|3|||
17191794|NCT02856113|38344682|FG001|Overall Study|Lost to Follow-up|5|||
16882039|NCT01471028|37873191|FG000|VTI-208E|Death|7|||
16882040|NCT01471028|37873192|FG001|VTI-208E|Death|10|||
16882041|NCT01471028|37873191|FG000|VTI-208E|Withdrawal by Subject|1|||
16882042|NCT01471028|37873192|FG001|VTI-208E|Withdrawal by Subject|0|||
16882043|NCT01471028|37873191|FG000|VTI-208E|Lost to Follow-up|0|||
16882044|NCT01471028|37873192|FG001|VTI-208E|Lost to Follow-up|2|||
16882045|NCT01491854|37873206|FG000|Overall Study|mainly due to premature termination|93|||
16882046|NCT01491854|37873206|FG000|Overall Study|Death|1|||
16882047|NCT01491854|37873206|FG000|Overall Study|Withdrawal by Subject|3|||
16882048|NCT01491854|37873206|FG000|Overall Study|Lost to Follow-up|33|||
16882049|NCT01470248|37873214|FG000|Overall Study|Withdrawal by Subject|1|||
16882050|NCT01490918|37873234|FG000|Overall Study|Lost to Follow-up|2|||
16882051|NCT01490918|37873235|FG001|Overall Study|Lost to Follow-up|1|||
16882052|NCT01490918|37873236|FG002|Overall Study|Lost to Follow-up|0|||
16882053|NCT01490918|37873234|FG000|Overall Study|Withdrawal by Subject|7|||
16882054|NCT01490918|37873235|FG001|Overall Study|Withdrawal by Subject|8|||
16882055|NCT01490918|37873236|FG002|Overall Study|Withdrawal by Subject|3|||
16882056|NCT01490918|37873234|FG000|Overall Study|Adverse Event|0|||
16882057|NCT01490918|37873235|FG001|Overall Study|Adverse Event|0|||
16882058|NCT01490918|37873236|FG002|Overall Study|Adverse Event|1|||
16882059|NCT01490918|37873234|FG000|Overall Study|other cause|4|||
16882060|NCT01490918|37873235|FG001|Overall Study|other cause|5|||
16882061|NCT01490918|37873236|FG002|Overall Study|other cause|8|||
16882062|NCT01490840|37873268|FG000|Phase 1|Lost to Follow-up|1|||
16882063|NCT01490840|37873269|FG001|Phase 1|Lost to Follow-up|0|||
16882064|NCT01490840|37873268|FG000|Phase 1|Adverse Event|2|||
16882065|NCT01490840|37873269|FG001|Phase 1|Adverse Event|1|||
16882066|NCT01490840|37873268|FG000|Phase 1|Withdrawal by Subject|6|||
16882067|NCT01490840|37873269|FG001|Phase 1|Withdrawal by Subject|5|||
16882068|NCT01490840|37873268|FG000|Phase 1|Visit 6a omitted|1|||
16882069|NCT01490840|37873269|FG001|Phase 1|Visit 6a omitted|0|||
16882070|NCT01490840|37873268|FG000|Phase 2|Withdrawal by Subject|4|||
16882071|NCT01490840|37873269|FG001|Phase 2|Withdrawal by Subject|3|||
16882072|NCT01490840|37873268|FG000|Phase 2|Permanent interruption of fingolimod|0|||
16882073|NCT01490840|37873269|FG001|Phase 2|Permanent interruption of fingolimod|1|||
16882074|NCT01490840|37873268|FG000|Phase 2|Lost to Follow-up|1|||
16882075|NCT01490840|37873269|FG001|Phase 2|Lost to Follow-up|1|||
16882076|NCT01490840|37873268|FG000|Phase 2|Adverse Event|1|||
16882077|NCT01490840|37873269|FG001|Phase 2|Adverse Event|1|||
16882078|NCT01490450|37873301|FG000|Period 1|Lack of Efficacy|2|||
16882079|NCT01490450|37873302|FG001|Period 1|Lack of Efficacy|0|||
16882080|NCT01490450|37873303|FG002|Period 1|Lack of Efficacy|3|||
16882081|NCT01490450|37873304|FG003|Period 1|Lack of Efficacy|0|||
16882082|NCT01490450|37873301|FG000|Period 1|Adverse Event|0|||
16882083|NCT01490450|37873302|FG001|Period 1|Adverse Event|0|||
16882084|NCT01490450|37873303|FG002|Period 1|Adverse Event|0|||
16882085|NCT01490450|37873304|FG003|Period 1|Adverse Event|5|||
16882086|NCT01490450|37873301|FG000|Period 1|Request to discontinue treatment|1|||
16882087|NCT01490450|37873302|FG001|Period 1|Request to discontinue treatment|0|||
16882088|NCT01490450|37873303|FG002|Period 1|Request to discontinue treatment|0|||
16882089|NCT01490450|37873304|FG003|Period 1|Request to discontinue treatment|0|||
16882090|NCT01490450|37873301|FG000|Period 1|Withdrawal by Subject|0|||
16882091|NCT01490450|37873302|FG001|Period 1|Withdrawal by Subject|0|||
16882092|NCT01490450|37873303|FG002|Period 1|Withdrawal by Subject|0|||
16882093|NCT01490450|37873304|FG003|Period 1|Withdrawal by Subject|3|||
16882094|NCT01490450|37873301|FG000|Period 1|No longer met study criteria|0|||
16882095|NCT01490450|37873302|FG001|Period 1|No longer met study criteria|1|||
16882096|NCT01490450|37873303|FG002|Period 1|No longer met study criteria|1|||
16882097|NCT01490450|37873304|FG003|Period 1|No longer met study criteria|0|||
16882098|NCT01490450|37873301|FG000|Period 2|Lack of Efficacy|0|||
16882099|NCT01490450|37873302|FG001|Period 2|Lack of Efficacy|0|||
16882100|NCT01490450|37873303|FG002|Period 2|Lack of Efficacy|0|||
16882101|NCT01490450|37873304|FG003|Period 2|Lack of Efficacy|1|||
16882102|NCT01490450|37873301|FG000|Period 2|Adverse Event|1|||
16882103|NCT01490450|37873302|FG001|Period 2|Adverse Event|1|||
16882104|NCT01490450|37873303|FG002|Period 2|Adverse Event|0|||
16882105|NCT01490450|37873304|FG003|Period 2|Adverse Event|1|||
16882106|NCT01490450|37873301|FG000|Period 2|Withdrawal by Subject|1|||
16882107|NCT01490450|37873302|FG001|Period 2|Withdrawal by Subject|0|||
16882108|NCT01490450|37873303|FG002|Period 2|Withdrawal by Subject|0|||
16882109|NCT01490450|37873304|FG003|Period 2|Withdrawal by Subject|0|||
16882110|NCT01490450|37873301|FG000|Period 2|Lost to Follow-up|0|||
16882111|NCT01490450|37873302|FG001|Period 2|Lost to Follow-up|0|||
16882112|NCT01490450|37873303|FG002|Period 2|Lost to Follow-up|0|||
16882113|NCT01490450|37873304|FG003|Period 2|Lost to Follow-up|2|||
16882114|NCT01469546|37873348|FG000|Received 5 mg Dose|Adverse Event|13|||
16882115|NCT01469546|37873348|FG000|Received 5 mg Dose|Death|2|||
17095295|NCT00261846|38234546|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
16882116|NCT01469546|37873348|FG000|Received 5 mg Dose|Protocol Violation|2|||
16882117|NCT01469546|37873348|FG000|Received 5 mg Dose|Progressive Disease|3|||
16882118|NCT01469546|37873348|FG000|Received 5 mg Dose|Physician Decision|3|||
16882119|NCT00081497|37873354|FG000|Overall Study|Adverse Event|2|||
16882120|NCT00081497|37873355|FG001|Overall Study|Adverse Event|0|||
16882121|NCT00081497|37873354|FG000|Overall Study|Death|0|||
16882122|NCT00081497|37873355|FG001|Overall Study|Death|1|||
16882123|NCT00081497|37873354|FG000|Overall Study|Withdrawal by Subject|1|||
16882124|NCT00081497|37873355|FG001|Overall Study|Withdrawal by Subject|0|||
16882125|NCT00081497|37873354|FG000|Overall Study|Non-compliance|0|||
16882126|NCT00081497|37873355|FG001|Overall Study|Non-compliance|1|||
16882127|NCT00081263|37873369|FG000|Overall Study|clerical error|1|||
16882128|NCT00081263|37873370|FG001|Overall Study|clerical error|0|||
16882129|NCT00081263|37873369|FG000|Overall Study|wrong cell type|7|||
16882130|NCT00081263|37873370|FG001|Overall Study|wrong cell type|5|||
16882131|NCT00081263|37873369|FG000|Overall Study|improper pre-protocol therapy|0|||
16882132|NCT00081263|37873370|FG001|Overall Study|improper pre-protocol therapy|1|||
16882133|NCT00081263|37873369|FG000|Overall Study|Inadequate pathology|0|||
16882134|NCT00081263|37873370|FG001|Overall Study|Inadequate pathology|1|||
16882135|NCT00081263|37873369|FG000|Overall Study|Never treated|4|||
16882136|NCT00081263|37873370|FG001|Overall Study|Never treated|5|||
16882137|NCT00081263|37873369|FG000|Overall Study|Inadequate data|5|||
16882138|NCT00081263|37873370|FG001|Overall Study|Inadequate data|10|||
16882139|NCT01490294|37873380|FG000|Overall Study|Prematurely discontinuation|4|||
16882140|NCT01490294|37873381|FG001|Overall Study|Prematurely discontinuation|0|||
16882141|NCT01490294|37873382|FG002|Overall Study|Prematurely discontinuation|1|||
16882142|NCT01490294|37873383|FG003|Overall Study|Prematurely discontinuation|1|||
16882143|NCT01490294|37873380|FG000|Overall Study|Adverse Event|1|||
16882144|NCT01490294|37873381|FG001|Overall Study|Adverse Event|0|||
16882145|NCT01490294|37873382|FG002|Overall Study|Adverse Event|0|||
16882146|NCT01490294|37873383|FG003|Overall Study|Adverse Event|0|||
16882147|NCT00080483|37873410|FG000|Overall Study|Lost to Follow-up|1|||
16882148|NCT00080483|37873411|FG001|Overall Study|Lost to Follow-up|1|||
16882149|NCT00080483|37873410|FG000|Overall Study|Physician Decision|1|||
16882150|NCT00080483|37873411|FG001|Overall Study|Physician Decision|1|||
16882151|NCT00089141|37873432|FG000|Overall Study|Termination of trial|18|||
16882152|NCT00089141|37873433|FG001|Overall Study|Termination of trial|24|||
16882153|NCT02588664|37873496|FG000|Overall Study|Death|56|||
16882154|NCT02588664|37873497|FG001|Overall Study|Death|55|||
16882155|NCT02588664|37873496|FG000|Overall Study|Lost to Follow-up|1305|||
16882156|NCT02588664|37873497|FG001|Overall Study|Lost to Follow-up|990|||
16882157|NCT00083759|37873560|FG000|Overall Study|Adverse Event|5|||
16882158|NCT00083759|37873561|FG001|Overall Study|Adverse Event|3|||
16882159|NCT00083759|37873560|FG000|Overall Study|Lost to Follow-up|1|||
16882160|NCT00083759|37873561|FG001|Overall Study|Lost to Follow-up|0|||
16882161|NCT00083759|37873560|FG000|Overall Study|Death|1|||
16882162|NCT00083759|37873561|FG001|Overall Study|Death|1|||
16882163|NCT00083759|37873560|FG000|Overall Study|Inadequate Therapeutic Response|32|||
16882164|NCT00083759|37873561|FG001|Overall Study|Inadequate Therapeutic Response|35|||
16882165|NCT00083759|37873560|FG000|Overall Study|Subject Withdrew Consent|2|||
16882166|NCT00083759|37873561|FG001|Overall Study|Subject Withdrew Consent|2|||
16882167|NCT00083759|37873560|FG000|Overall Study|Non-Compliance|1|||
16882168|NCT00083759|37873561|FG001|Overall Study|Non-Compliance|0|||
16882169|NCT00083759|37873560|FG000|Overall Study|Sponsor's Discretion|28|||
16882170|NCT00083759|37873561|FG001|Overall Study|Sponsor's Discretion|29|||
16882171|NCT00083759|37873560|FG000|Overall Study|Other|14|||
16882172|NCT00083759|37873561|FG001|Overall Study|Other|13|||
16882173|NCT00089609|37873683|FG000|Overall Study|Withdrawal by Subject|3|||
16882174|NCT00089609|37873684|FG001|Overall Study|Withdrawal by Subject|1|||
16882175|NCT02440581|37873816|FG000|Overall Study|Death|0|||
16882176|NCT02440581|37873817|FG001|Overall Study|Death|0|||
16882177|NCT02440581|37873818|FG002|Overall Study|Death|7|||
16882178|NCT02440581|37873819|FG003|Overall Study|Death|5|||
16882179|NCT02440581|37873816|FG000|Overall Study|Transplanted|1|||
16882180|NCT02440581|37873817|FG001|Overall Study|Transplanted|0|||
16882181|NCT02440581|37873818|FG002|Overall Study|Transplanted|3|||
16882182|NCT02440581|37873819|FG003|Overall Study|Transplanted|2|||
16882183|NCT02440581|37873816|FG000|Overall Study|Withdrawal by Subject|4|||
16882184|NCT02440581|37873817|FG001|Overall Study|Withdrawal by Subject|11|||
16882185|NCT02440581|37873818|FG002|Overall Study|Withdrawal by Subject|3|||
16882186|NCT02440581|37873819|FG003|Overall Study|Withdrawal by Subject|7|||
16882187|NCT01359150|37873831|FG000|Overall Study|Lack of Efficacy|1|||
16882188|NCT01359150|37873832|FG001|Overall Study|Lack of Efficacy|1|||
16882189|NCT01359150|37873831|FG000|Overall Study|Withdrawal by Subject|1|||
16882190|NCT01359150|37873832|FG001|Overall Study|Withdrawal by Subject|1|||
16882191|NCT01359150|37873831|FG000|Overall Study|Adverse Event|4|||
16882192|NCT01359150|37873832|FG001|Overall Study|Adverse Event|3|||
16882193|NCT01359150|37873831|FG000|Overall Study|Other|1|||
16882194|NCT01359150|37873832|FG001|Overall Study|Other|0|||
16882195|NCT01469000|37873893|FG000|Overall Study|Withdrawal by Subject|16|||
16882196|NCT01469000|37873894|FG001|Overall Study|Withdrawal by Subject|3|||
16882197|NCT01469000|37873893|FG000|Overall Study|Sponsor Decision|4|||
16882198|NCT01469000|37873894|FG001|Overall Study|Sponsor Decision|1|||
16882199|NCT01490060|37873907|FG000|Cycle 1|Change of Treatment|0|||
16882200|NCT01490060|37873908|FG001|Cycle 1|Change of Treatment|1|||
16882201|NCT01490060|37873909|FG002|Cycle 1|Change of Treatment|1|||
16882202|NCT01490060|37873910|FG003|Cycle 1|Change of Treatment|1|||
16882203|NCT01490060|37873907|FG000|Cycle 1|Insurance Denied|0|||
16882204|NCT01490060|37873908|FG001|Cycle 1|Insurance Denied|0|||
16882205|NCT01490060|37873909|FG002|Cycle 1|Insurance Denied|2|||
16882206|NCT01490060|37873910|FG003|Cycle 1|Insurance Denied|0|||
16882207|NCT01490060|37873907|FG000|Cycle 1|Withdrawal by Subject|0|||
16882208|NCT01490060|37873908|FG001|Cycle 1|Withdrawal by Subject|0|||
16882209|NCT01490060|37873909|FG002|Cycle 1|Withdrawal by Subject|0|||
16882210|NCT01490060|37873910|FG003|Cycle 1|Withdrawal by Subject|1|||
16882211|NCT01490060|37873907|FG000|Cycle 1|Treatment at Another Facility|0|||
16882212|NCT01490060|37873908|FG001|Cycle 1|Treatment at Another Facility|0|||
16882213|NCT01490060|37873909|FG002|Cycle 1|Treatment at Another Facility|0|||
16882214|NCT01490060|37873910|FG003|Cycle 1|Treatment at Another Facility|1|||
16882215|NCT01490060|37873907|FG000|Cycle 2|Change of Treatment|1|||
16882216|NCT01490060|37873908|FG001|Cycle 2|Change of Treatment|1|||
16882217|NCT01490060|37873909|FG002|Cycle 2|Change of Treatment|0|||
16882218|NCT01490060|37873910|FG003|Cycle 2|Change of Treatment|0|||
16882219|NCT01490060|37873907|FG000|Cycle 2|Non-Compliance|0|||
16882220|NCT01490060|37873908|FG001|Cycle 2|Non-Compliance|0|||
16882221|NCT01490060|37873909|FG002|Cycle 2|Non-Compliance|1|||
16882222|NCT01490060|37873910|FG003|Cycle 2|Non-Compliance|0|||
16882223|NCT01490060|37873907|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
16882224|NCT01490060|37873908|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
16882225|NCT01490060|37873909|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
16882226|NCT01490060|37873910|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
16882227|NCT01452152|37873962|FG000|Overall Study|Study termination by sponsor|5|||
16882228|NCT01452152|37873963|FG001|Overall Study|Study termination by sponsor|0|||
16882229|NCT01452152|37873964|FG002|Overall Study|Study termination by sponsor|4|||
16882230|NCT01451762|37873975|FG000|Overall Study|Lost to Follow-up|3|||
16882231|NCT01451762|37873976|FG001|Overall Study|Lost to Follow-up|6|||
16882232|NCT01451762|37873977|FG002|Overall Study|Lost to Follow-up|6|||
16882233|NCT01468844|37874012|FG000|Overall Study|Adverse Event|1|||
16882234|NCT01468844|37874013|FG001|Overall Study|Adverse Event|0|||
16882235|NCT01468844|37874012|FG000|Overall Study|Withdrawal by Subject|1|||
16882236|NCT01468844|37874013|FG001|Overall Study|Withdrawal by Subject|0|||
16882237|NCT01451606|37874037|FG000|Overall Study|Withdrawal by Subject|4|||
16882238|NCT01451606|37874038|FG001|Overall Study|Withdrawal by Subject|3|||
16882239|NCT00473343|37874093|FG000|Overall Study|Adverse Event|9|||
16882240|NCT00473343|37874093|FG000|Overall Study|Lost to Follow-up|8|||
16882241|NCT00473343|37874093|FG000|Overall Study|Treatment failure|27|||
16882242|NCT00473343|37874093|FG000|Overall Study|Withdrew consent|3|||
16882243|NCT00473343|37874093|FG000|Overall Study|Other un-specified reason|3|||
16882244|NCT02587962|37874550|FG000|Overall Study|Adverse Event|0|||
16882245|NCT02587962|37874551|FG001|Overall Study|Adverse Event|0|||
16882246|NCT02587962|37874552|FG002|Overall Study|Adverse Event|1|||
16882247|NCT02587962|37874553|FG003|Overall Study|Adverse Event|0|||
16882248|NCT02587962|37874554|FG004|Overall Study|Adverse Event|0|||
16882249|NCT02587962|37874550|FG000|Overall Study|Withdrawal by Subject|0|||
16882250|NCT02587962|37874551|FG001|Overall Study|Withdrawal by Subject|0|||
16882251|NCT02587962|37874552|FG002|Overall Study|Withdrawal by Subject|1|||
16882252|NCT02587962|37874553|FG003|Overall Study|Withdrawal by Subject|1|||
16882253|NCT02587962|37874554|FG004|Overall Study|Withdrawal by Subject|4|||
16882254|NCT02587962|37874550|FG000|Overall Study|Radiological progression|2|||
16882255|NCT02587962|37874551|FG001|Overall Study|Radiological progression|2|||
16882256|NCT02587962|37874552|FG002|Overall Study|Radiological progression|2|||
16882257|NCT02587962|37874553|FG003|Overall Study|Radiological progression|5|||
16882258|NCT02587962|37874554|FG004|Overall Study|Radiological progression|10|||
16882259|NCT02587962|37874550|FG000|Overall Study|Clinical progression|0|||
16882260|NCT02587962|37874551|FG001|Overall Study|Clinical progression|1|||
16882261|NCT02587962|37874552|FG002|Overall Study|Clinical progression|2|||
16882262|NCT02587962|37874553|FG003|Overall Study|Clinical progression|0|||
16882263|NCT02587962|37874554|FG004|Overall Study|Clinical progression|1|||
16882264|NCT01440374|37874708|FG000|Part 1: Open-label Phase|Adverse Event|5|||
16882265|NCT01440374|37874709|FG001|Part 1: Open-label Phase|Adverse Event|0|||
16882266|NCT01440374|37874710|FG002|Part 1: Open-label Phase|Adverse Event|0|||
16882267|NCT01440374|37874711|FG003|Part 1: Open-label Phase|Adverse Event|0|||
16882268|NCT01440374|37874708|FG000|Part 1: Open-label Phase|Physician Decision|1|||
16882269|NCT01440374|37874709|FG001|Part 1: Open-label Phase|Physician Decision|0|||
16882270|NCT01440374|37874710|FG002|Part 1: Open-label Phase|Physician Decision|0|||
16882271|NCT01440374|37874711|FG003|Part 1: Open-label Phase|Physician Decision|0|||
16882272|NCT01440374|37874708|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
16882273|NCT01440374|37874709|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
16882274|NCT01440374|37874710|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
16882275|NCT01440374|37874711|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
16882276|NCT01440374|37874708|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
16882277|NCT01440374|37874709|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
16882278|NCT01440374|37874710|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
16785632|NCT01986010|37725746|FG006|Overall Study|Physician Decision|0|||
16785633|NCT01986010|37725747|FG007|Overall Study|Physician Decision|0|||
16785634|NCT01986010|37725748|FG008|Overall Study|Physician Decision|0|||
16882279|NCT01440374|37874711|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
16882280|NCT01440374|37874708|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
16882281|NCT01440374|37874709|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
16882282|NCT01440374|37874710|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
16882283|NCT01440374|37874711|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
16882284|NCT01440374|37874708|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
16882285|NCT01440374|37874709|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
16882286|NCT01440374|37874710|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
16882287|NCT01440374|37874711|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
16882288|NCT01440374|37874708|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
16882289|NCT01440374|37874709|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
16882290|NCT01440374|37874710|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
16882291|NCT01440374|37874711|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
16882292|NCT01440374|37874708|FG000|Part 2; Double-blind Phase|Not treated|0|||
16882293|NCT01440374|37874709|FG001|Part 2; Double-blind Phase|Not treated|0|||
16882294|NCT01440374|37874710|FG002|Part 2; Double-blind Phase|Not treated|1|||
16882295|NCT01440374|37874711|FG003|Part 2; Double-blind Phase|Not treated|0|||
16882296|NCT01440374|37874708|FG000|Part 3: Extension|Withdrawal by Subject|0|||
16882297|NCT01440374|37874709|FG001|Part 3: Extension|Withdrawal by Subject|0|||
16882298|NCT01440374|37874710|FG002|Part 3: Extension|Withdrawal by Subject|0|||
16882299|NCT01440374|37874711|FG003|Part 3: Extension|Withdrawal by Subject|5|||
16882300|NCT01440374|37874708|FG000|Part 3: Extension|Adverse Event|0|||
16882301|NCT01440374|37874709|FG001|Part 3: Extension|Adverse Event|0|||
16882302|NCT01440374|37874710|FG002|Part 3: Extension|Adverse Event|0|||
16882303|NCT01440374|37874711|FG003|Part 3: Extension|Adverse Event|13|||
16882304|NCT01440374|37874708|FG000|Part 3: Extension|Physician Decision|0|||
16882305|NCT01440374|37874709|FG001|Part 3: Extension|Physician Decision|0|||
16882306|NCT01440374|37874710|FG002|Part 3: Extension|Physician Decision|0|||
16882307|NCT01440374|37874711|FG003|Part 3: Extension|Physician Decision|14|||
16882308|NCT01666782|37874859|FG000|Overall Study|Received 2 doses of vaccine|0|||
16882309|NCT01666782|37874860|FG001|Overall Study|Received 2 doses of vaccine|1|||
16882310|NCT01666782|37874859|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
16882311|NCT01666782|37874860|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
16882312|NCT01439360|37874876|FG000|Overall Study|Adverse Event|4|||
17002258|NCT00915278|38146372|FG001|Overall Study|Progressive disease/clinical progression|0|||
17002259|NCT00915278|38146373|FG002|Overall Study|Progressive disease/clinical progression|0|||
17095296|NCT00261846|38234547|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
17095297|NCT00261846|38234548|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
17095298|NCT00261846|38234549|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
17095299|NCT00261846|38234550|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
17095300|NCT00261846|38234551|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
17095301|NCT00261846|38234540|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
17002260|NCT00915278|38146374|FG003|Overall Study|Progressive disease/clinical progression|3|||
17002261|NCT00915278|38146375|FG004|Overall Study|Progressive disease/clinical progression|1|||
17002262|NCT00915278|38146376|FG005|Overall Study|Progressive disease/clinical progression|2|||
17002263|NCT00915278|38146371|FG000|Overall Study|Infusion related AEs|0|||
17002264|NCT00915278|38146372|FG001|Overall Study|Infusion related AEs|0|||
17002265|NCT00915278|38146373|FG002|Overall Study|Infusion related AEs|0|||
17002266|NCT00915278|38146374|FG003|Overall Study|Infusion related AEs|0|||
17002267|NCT00915278|38146375|FG004|Overall Study|Infusion related AEs|0|||
17002268|NCT00915278|38146376|FG005|Overall Study|Infusion related AEs|2|||
17002269|NCT00915278|38146371|FG000|Overall Study|Admission to hospice|0|||
17002270|NCT00915278|38146372|FG001|Overall Study|Admission to hospice|0|||
17002271|NCT00915278|38146373|FG002|Overall Study|Admission to hospice|1|||
17002272|NCT00915278|38146374|FG003|Overall Study|Admission to hospice|0|||
17002273|NCT00915278|38146375|FG004|Overall Study|Admission to hospice|0|||
17002274|NCT00915278|38146376|FG005|Overall Study|Admission to hospice|0|||
17002275|NCT00844857|38146392|FG000|Overall Study|Adverse Event|24|||
17002276|NCT00844857|38146393|FG001|Overall Study|Adverse Event|5|||
17095302|NCT00261846|38234541|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
17095303|NCT00261846|38234542|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
17095304|NCT00261846|38234543|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
16785635|NCT01986010|37725749|FG009|Overall Study|Physician Decision|0|||
16785636|NCT01986010|37725750|FG010|Overall Study|Physician Decision|0|||
16785637|NCT01986010|37725751|FG011|Overall Study|Physician Decision|0|||
16785638|NCT01986010|37725752|FG012|Overall Study|Physician Decision|0|||
16785639|NCT01986010|37725753|FG013|Overall Study|Physician Decision|0|||
16882313|NCT01439360|37874877|FG001|Overall Study|Adverse Event|16|||
16882314|NCT01439360|37874876|FG000|Overall Study|Lost to Follow-up|43|||
16882315|NCT01439360|37874877|FG001|Overall Study|Lost to Follow-up|58|||
16882316|NCT01439360|37874876|FG000|Overall Study|Others|10|||
16882317|NCT01439360|37874877|FG001|Overall Study|Others|5|||
16882318|NCT01439360|37874876|FG000|Overall Study|Protocol Violation|1|||
16882319|NCT01439360|37874877|FG001|Overall Study|Protocol Violation|0|||
16882320|NCT01439360|37874876|FG000|Overall Study|Withdrawal by Subject|140|||
16882321|NCT01439360|37874877|FG001|Overall Study|Withdrawal by Subject|129|||
16882322|NCT01439282|37875057|FG000|Overall Study|Adverse Event|5|||
16882323|NCT01439282|37875058|FG001|Overall Study|Adverse Event|0|||
16882324|NCT01439282|37875057|FG000|Overall Study|Withdrawal by Subject|2|||
16882325|NCT01439282|37875058|FG001|Overall Study|Withdrawal by Subject|0|||
16882326|NCT01439282|37875057|FG000|Overall Study|Other|1|||
16882327|NCT01439282|37875058|FG001|Overall Study|Other|1|||
16882328|NCT01439204|37875078|FG000|Overall Study|Withdrawal by Subject|0|||
16882329|NCT01439204|37875079|FG001|Overall Study|Withdrawal by Subject|1|||
16882330|NCT01439204|37875078|FG000|Overall Study|Lost to Follow-up|0|||
16882331|NCT01439204|37875079|FG001|Overall Study|Lost to Follow-up|2|||
16882332|NCT01439204|37875078|FG000|Overall Study|No longer meets study criteria|1|||
16882333|NCT01439204|37875079|FG001|Overall Study|No longer meets study criteria|0|||
16882334|NCT01439204|37875078|FG000|Overall Study|poor/non-compliance|3|||
16882335|NCT01439204|37875079|FG001|Overall Study|poor/non-compliance|0|||
16882336|NCT01439126|37875125|FG000|Overall Study|Adverse Event|2|||
16882337|NCT01439126|37875126|FG001|Overall Study|Adverse Event|0|||
16882338|NCT01439126|37875125|FG000|Overall Study|Withdrawal by Subject|5|||
16882339|NCT01439126|37875126|FG001|Overall Study|Withdrawal by Subject|21|||
16882340|NCT01439126|37875125|FG000|Overall Study|Protocol Violation|6|||
16882341|NCT01439126|37875126|FG001|Overall Study|Protocol Violation|4|||
16882342|NCT01439126|37875125|FG000|Overall Study|Lost to Follow-up|6|||
16882343|NCT01439126|37875126|FG001|Overall Study|Lost to Follow-up|3|||
16882344|NCT01439126|37875125|FG000|Overall Study|Other-Use of prohibited treatment|0|||
16882345|NCT01439126|37875126|FG001|Overall Study|Other-Use of prohibited treatment|2|||
16882346|NCT01439126|37875125|FG000|Overall Study|Other-Miscellaneous|12|||
16882347|NCT01439126|37875126|FG001|Overall Study|Other-Miscellaneous|12|||
16882348|NCT01449812|37875152|FG000|Overall Study|Migrated/moved from study area|1|||
16882349|NCT01449812|37875153|FG001|Overall Study|Migrated/moved from study area|0|||
16882350|NCT01449812|37875154|FG002|Overall Study|Migrated/moved from study area|0|||
16882351|NCT01449812|37875152|FG000|Overall Study|Withdrawal by Subject|0|||
16882352|NCT01449812|37875153|FG001|Overall Study|Withdrawal by Subject|0|||
16882353|NCT01449812|37875154|FG002|Overall Study|Withdrawal by Subject|1|||
16882354|NCT01449812|37875152|FG000|Overall Study|Lost to Follow-up|1|||
16882355|NCT01449812|37875153|FG001|Overall Study|Lost to Follow-up|0|||
16882356|NCT01449812|37875154|FG002|Overall Study|Lost to Follow-up|0|||
16882357|NCT01665144|37875207|FG000|Overall Study|New therapy for study indication|2|||
16882358|NCT01665144|37875208|FG001|Overall Study|New therapy for study indication|1|||
16882359|NCT01665144|37875207|FG000|Overall Study|Technical problems|2|||
16882360|NCT01665144|37875208|FG001|Overall Study|Technical problems|0|||
16882361|NCT01665144|37875207|FG000|Overall Study|Death|3|||
16882362|NCT01665144|37875208|FG001|Overall Study|Death|1|||
16882363|NCT01665144|37875207|FG000|Overall Study|Protocol deviation|3|||
16882364|NCT01665144|37875208|FG001|Overall Study|Protocol deviation|1|||
16882365|NCT01665144|37875207|FG000|Overall Study|Non-compliance w/study treatment|5|||
16882366|NCT01665144|37875208|FG001|Overall Study|Non-compliance w/study treatment|0|||
16882367|NCT01665144|37875207|FG000|Overall Study|Progressive disease|8|||
16882368|NCT01665144|37875208|FG001|Overall Study|Progressive disease|4|||
16882369|NCT01665144|37875207|FG000|Overall Study|Lost to Follow-up|9|||
16882370|NCT01665144|37875208|FG001|Overall Study|Lost to Follow-up|8|||
16882371|NCT01665144|37875207|FG000|Overall Study|Physician Decision|13|||
16882372|NCT01665144|37875208|FG001|Overall Study|Physician Decision|1|||
16882373|NCT01665144|37875207|FG000|Overall Study|Lack of Efficacy|16|||
16882374|NCT01665144|37875208|FG001|Overall Study|Lack of Efficacy|11|||
16882375|NCT01665144|37875207|FG000|Overall Study|Adverse Event|45|||
16882376|NCT01665144|37875208|FG001|Overall Study|Adverse Event|18|||
16882377|NCT01665144|37875207|FG000|Overall Study|Withdrawal by Subject|96|||
16882378|NCT01665144|37875208|FG001|Overall Study|Withdrawal by Subject|77|||
16882379|NCT01466660|37875347|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
16882380|NCT01466660|37875348|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
16882381|NCT01466660|37875347|FG000|Overall Study|Worsening of underlying cancer disease|5|||
16882382|NCT01466660|37875348|FG001|Overall Study|Worsening of underlying cancer disease|2|||
16882383|NCT01466660|37875347|FG000|Overall Study|Other adverse event|19|||
16882384|NCT01466660|37875348|FG001|Overall Study|Other adverse event|18|||
16882385|NCT01466660|37875347|FG000|Overall Study|Protocol Violation|2|||
16882386|NCT01466660|37875348|FG001|Overall Study|Protocol Violation|1|||
16882387|NCT01466660|37875347|FG000|Overall Study|Refused continuation of trial medication|4|||
16882388|NCT01466660|37875348|FG001|Overall Study|Refused continuation of trial medication|3|||
16882389|NCT01466660|37875347|FG000|Overall Study|Other reason not defined above|10|||
16882390|NCT01466660|37875348|FG001|Overall Study|Other reason not defined above|8|||
16882391|NCT01466348|37875373|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
16882392|NCT01466348|37875374|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
16882393|NCT01466270|37875397|FG000|Overall Study|Withdrawal by Subject|4|||
16882394|NCT01466270|37875398|FG001|Overall Study|Withdrawal by Subject|1|||
16882395|NCT01466270|37875397|FG000|Overall Study|Physician Decision|1|||
16882396|NCT01466270|37875398|FG001|Overall Study|Physician Decision|0|||
16882397|NCT01466270|37875397|FG000|Overall Study|Lost to Follow-up|1|||
16882398|NCT01466270|37875398|FG001|Overall Study|Lost to Follow-up|3|||
16882399|NCT01466270|37875397|FG000|Overall Study|Progression|1|||
16882400|NCT01466270|37875398|FG001|Overall Study|Progression|0|||
16882401|NCT01466270|37875397|FG000|Overall Study|Toxicity|4|||
16882402|NCT01466270|37875398|FG001|Overall Study|Toxicity|1|||
16882403|NCT01466270|37875397|FG000|Overall Study|Multiple|1|||
16882404|NCT01466270|37875398|FG001|Overall Study|Multiple|1|||
16882405|NCT01466192|37875431|FG000|Overall Study|Physician Decision|1|||
16882406|NCT01466192|37875431|FG000|Overall Study|Withdrawal by Subject|3|||
16882407|NCT01438814|37875451|FG000|Overall Study|Adverse Event|3|||
16882408|NCT01438814|37875452|FG001|Overall Study|Adverse Event|3|||
16882409|NCT01438814|37875451|FG000|Overall Study|Protocol Violation|1|||
16882410|NCT01438814|37875452|FG001|Overall Study|Protocol Violation|2|||
16882411|NCT01438814|37875451|FG000|Overall Study|Lost to Follow-up|4|||
16882412|NCT01438814|37875452|FG001|Overall Study|Lost to Follow-up|3|||
16882413|NCT01438814|37875451|FG000|Overall Study|Withdrawal by Subject|4|||
16882414|NCT01438814|37875452|FG001|Overall Study|Withdrawal by Subject|2|||
16882415|NCT01438814|37875451|FG000|Overall Study|Other|2|||
16882416|NCT01438814|37875452|FG001|Overall Study|Other|4|||
16882417|NCT02926833|37876033|FG000|Overall Study|Full Consent Withdrawal|0|||
16882418|NCT02926833|37876034|FG001|Overall Study|Full Consent Withdrawal|0|||
16882419|NCT02926833|37876035|FG002|Overall Study|Full Consent Withdrawal|0|||
16882420|NCT02926833|37876036|FG003|Overall Study|Full Consent Withdrawal|2|||
16882421|NCT02926833|37876033|FG000|Overall Study|Death|1|||
16882422|NCT02926833|37876034|FG001|Overall Study|Death|1|||
16882423|NCT02926833|37876035|FG002|Overall Study|Death|1|||
16882424|NCT02926833|37876036|FG003|Overall Study|Death|7|||
16882425|NCT02926833|37876033|FG000|Overall Study|Still on study|2|||
16882426|NCT02926833|37876034|FG001|Overall Study|Still on study|3|||
16882427|NCT02926833|37876035|FG002|Overall Study|Still on study|5|||
16882428|NCT02926833|37876036|FG003|Overall Study|Still on study|14|||
16882429|NCT02926833|37876033|FG000|Overall Study|Adverse Event|0|||
16882430|NCT02926833|37876034|FG001|Overall Study|Adverse Event|0|||
16882431|NCT02926833|37876035|FG002|Overall Study|Adverse Event|1|||
16882432|NCT02926833|37876036|FG003|Overall Study|Adverse Event|0|||
16882433|NCT02851797|37876083|FG000|Overall Study|Withdrawal by Subject|4|||
16882434|NCT02851797|37876084|FG001|Overall Study|Withdrawal by Subject|2|||
16882435|NCT02851797|37876083|FG000|Overall Study|Adverse Event|3|||
16882436|NCT02851797|37876084|FG001|Overall Study|Adverse Event|0|||
16882437|NCT01666314|37876308|FG000|Overall Study|Adverse Event|3|||
16882438|NCT01666314|37876309|FG001|Overall Study|Adverse Event|13|||
16882439|NCT01666314|37876310|FG002|Overall Study|Adverse Event|7|||
16882440|NCT01666314|37876311|FG003|Overall Study|Adverse Event|7|||
16882441|NCT01666314|37876308|FG000|Overall Study|Progressive Disease|11|||
16882442|NCT01666314|37876309|FG001|Overall Study|Progressive Disease|9|||
16882443|NCT01666314|37876310|FG002|Overall Study|Progressive Disease|19|||
16882444|NCT01666314|37876311|FG003|Overall Study|Progressive Disease|20|||
16882445|NCT01666314|37876308|FG000|Overall Study|Symptomatic Deterioration|1|||
16882446|NCT01666314|37876309|FG001|Overall Study|Symptomatic Deterioration|0|||
16882447|NCT01666314|37876310|FG002|Overall Study|Symptomatic Deterioration|2|||
16882448|NCT01666314|37876311|FG003|Overall Study|Symptomatic Deterioration|0|||
16882449|NCT01666314|37876308|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
16882450|NCT01666314|37876309|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
16882451|NCT01666314|37876310|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
16882452|NCT01666314|37876311|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
16882453|NCT01666314|37876308|FG000|Overall Study|Withdrawal by Subject|1|||
16882454|NCT01666314|37876309|FG001|Overall Study|Withdrawal by Subject|1|||
16882455|NCT01666314|37876310|FG002|Overall Study|Withdrawal by Subject|2|||
16882456|NCT01666314|37876311|FG003|Overall Study|Withdrawal by Subject|3|||
16882457|NCT01666314|37876308|FG000|Overall Study|Reason not Specified|10|||
16882458|NCT01666314|37876309|FG001|Overall Study|Reason not Specified|7|||
16882459|NCT01666314|37876310|FG002|Overall Study|Reason not Specified|5|||
16882460|NCT01666314|37876311|FG003|Overall Study|Reason not Specified|5|||
16882461|NCT01666002|37876342|FG000|Overall Study|Lost to Follow-up|5|||
16882462|NCT01666002|37876343|FG001|Overall Study|Lost to Follow-up|0|||
16882463|NCT01665768|37876415|FG000|Overall Study|Adverse Event|3|||
16882464|NCT01665768|37876415|FG000|Overall Study|Lack of Efficacy|19|||
16882465|NCT01665768|37876415|FG000|Overall Study|Withdrawal by Subject|1|||
16882466|NCT02584452|37876623|FG000|Overall Study|Physician Decision|1|||
16882467|NCT02584452|37876624|FG001|Overall Study|Physician Decision|1|||
16882468|NCT02584452|37876623|FG000|Overall Study|Lost to Follow-up|1|||
16882469|NCT02584452|37876624|FG001|Overall Study|Lost to Follow-up|1|||
16882470|NCT02586012|37876671|FG000|Overall Study|Withdrawal by Subject|1|||
16882471|NCT02586012|37876672|FG001|Overall Study|Withdrawal by Subject|1|||
16882472|NCT02586012|37876673|FG002|Overall Study|Withdrawal by Subject|0|||
16882473|NCT02586012|37876674|FG003|Overall Study|Withdrawal by Subject|1|||
16882474|NCT02586012|37876675|FG004|Overall Study|Withdrawal by Subject|0|||
16882475|NCT02586012|37876676|FG005|Overall Study|Withdrawal by Subject|2|||
16882476|NCT02586012|37876671|FG000|Overall Study|Protocol Violation|0|||
16882477|NCT02586012|37876672|FG001|Overall Study|Protocol Violation|0|||
16882478|NCT02586012|37876673|FG002|Overall Study|Protocol Violation|0|||
16785640|NCT01986010|37725754|FG014|Overall Study|Physician Decision|1|||
16785641|NCT01986010|37725755|FG015|Overall Study|Physician Decision|0|||
16785642|NCT01986010|37725756|FG016|Overall Study|Physician Decision|0|||
16785643|NCT01986010|37725740|FG000|Overall Study|Withdrawal by Subject|2|||
16785644|NCT01986010|37725741|FG001|Overall Study|Withdrawal by Subject|2|||
16785645|NCT01986010|37725742|FG002|Overall Study|Withdrawal by Subject|3|||
16785646|NCT01986010|37725743|FG003|Overall Study|Withdrawal by Subject|0|||
16785647|NCT01986010|37725744|FG004|Overall Study|Withdrawal by Subject|2|||
16785648|NCT01986010|37725745|FG005|Overall Study|Withdrawal by Subject|4|||
16785649|NCT01986010|37725746|FG006|Overall Study|Withdrawal by Subject|0|||
16785650|NCT01986010|37725747|FG007|Overall Study|Withdrawal by Subject|0|||
16785651|NCT01986010|37725748|FG008|Overall Study|Withdrawal by Subject|0|||
16785652|NCT01986010|37725749|FG009|Overall Study|Withdrawal by Subject|0|||
16785653|NCT01986010|37725750|FG010|Overall Study|Withdrawal by Subject|0|||
16785654|NCT01986010|37725751|FG011|Overall Study|Withdrawal by Subject|2|||
16785655|NCT01986010|37725752|FG012|Overall Study|Withdrawal by Subject|0|||
16785656|NCT01986010|37725753|FG013|Overall Study|Withdrawal by Subject|1|||
16785657|NCT01986010|37725754|FG014|Overall Study|Withdrawal by Subject|2|||
16785658|NCT01986010|37725755|FG015|Overall Study|Withdrawal by Subject|0|||
16785659|NCT01986010|37725756|FG016|Overall Study|Withdrawal by Subject|0|||
16785660|NCT01986010|37725740|FG000|Overall Study|Status Not Recorded|2|||
16785661|NCT01986010|37725741|FG001|Overall Study|Status Not Recorded|4|||
16785662|NCT01986010|37725742|FG002|Overall Study|Status Not Recorded|2|||
16785663|NCT01986010|37725743|FG003|Overall Study|Status Not Recorded|0|||
16785664|NCT01986010|37725744|FG004|Overall Study|Status Not Recorded|1|||
16785665|NCT01986010|37725745|FG005|Overall Study|Status Not Recorded|2|||
16785666|NCT01986010|37725746|FG006|Overall Study|Status Not Recorded|0|||
16785667|NCT01986010|37725747|FG007|Overall Study|Status Not Recorded|0|||
16785668|NCT01986010|37725748|FG008|Overall Study|Status Not Recorded|2|||
16785669|NCT01986010|37725749|FG009|Overall Study|Status Not Recorded|1|||
16785670|NCT01986010|37725750|FG010|Overall Study|Status Not Recorded|7|||
16785671|NCT01986010|37725751|FG011|Overall Study|Status Not Recorded|7|||
16785672|NCT01986010|37725752|FG012|Overall Study|Status Not Recorded|9|||
16785673|NCT01986010|37725753|FG013|Overall Study|Status Not Recorded|9|||
16785674|NCT01986010|37725754|FG014|Overall Study|Status Not Recorded|5|||
16785675|NCT01986010|37725755|FG015|Overall Study|Status Not Recorded|10|||
16785676|NCT01986010|37725756|FG016|Overall Study|Status Not Recorded|4|||
16785677|NCT01963780|37725802|FG000|Overall Study|Death|7|||
16785678|NCT02009878|37725809|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
16785679|NCT02009878|37725810|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
16785680|NCT02009878|37725811|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
16785681|NCT02009722|37725821|FG000|Overall Study|Protocol Violation|1|||
16785682|NCT02009722|37725822|FG001|Overall Study|Protocol Violation|2|||
16785683|NCT02009722|37725821|FG000|Overall Study|Did not receive intervention|0|||
16785684|NCT02009722|37725822|FG001|Overall Study|Did not receive intervention|1|||
16785685|NCT02655419|37725830|FG000|Overall Study|Enrolled but not treated|1|||
16785686|NCT02655419|37725831|FG001|Overall Study|Enrolled but not treated|5|||
16785687|NCT02655419|37725830|FG000|Overall Study|Withdrawal by Subject|4|||
16785688|NCT02655419|37725831|FG001|Overall Study|Withdrawal by Subject|1|||
16785689|NCT02655419|37725830|FG000|Overall Study|Other|0|||
16785690|NCT02655419|37725831|FG001|Overall Study|Other|1|||
16785691|NCT01962922|37725843|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
16785692|NCT01962922|37725844|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
16785693|NCT01962922|37725843|FG000|PK Portion Day 7|non-compliance|1|||
16785694|NCT01962922|37725844|FG001|PK Portion Day 7|non-compliance|0|||
16785695|NCT01962922|37725843|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
16785696|NCT01962922|37725844|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
16785697|NCT01962922|37725843|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
16785698|NCT01962922|37725844|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
16785699|NCT01984684|37725852|FG000|Overall Study|Lost to Follow-up|25|||
16785700|NCT01984684|37725853|FG001|Overall Study|Lost to Follow-up|24|||
16785701|NCT01984684|37725852|FG000|Overall Study|Adverse Event|8|||
16785702|NCT01984684|37725853|FG001|Overall Study|Adverse Event|12|||
16882479|NCT02586012|37876674|FG003|Overall Study|Protocol Violation|0|||
16882480|NCT02586012|37876675|FG004|Overall Study|Protocol Violation|0|||
16785703|NCT01984684|37725852|FG000|Overall Study|Withdrawal by Subject|9|||
16882481|NCT02586012|37876676|FG005|Overall Study|Protocol Violation|1|||
16882482|NCT02586012|37876671|FG000|Overall Study|study terminated|0|||
16882483|NCT02586012|37876672|FG001|Overall Study|study terminated|2|||
16882484|NCT02586012|37876673|FG002|Overall Study|study terminated|1|||
16882485|NCT02586012|37876674|FG003|Overall Study|study terminated|1|||
16882486|NCT02586012|37876675|FG004|Overall Study|study terminated|1|||
16882487|NCT02586012|37876676|FG005|Overall Study|study terminated|0|||
16882488|NCT02582814|37876687|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16882489|NCT02582814|37876688|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16882490|NCT02582814|37876687|FG000|Overall Study|Withdrawal by Subject|4|||
16882491|NCT02582814|37876688|FG001|Overall Study|Withdrawal by Subject|3|||
16882492|NCT02582814|37876687|FG000|Overall Study|Adverse Event|4|||
16882493|NCT02582814|37876688|FG001|Overall Study|Adverse Event|4|||
16882494|NCT02585934|37876836|FG000|Overall Study|Lost to Follow-up|2|||
16882495|NCT02585934|37876837|FG001|Overall Study|Lost to Follow-up|2|||
16882496|NCT02585934|37876836|FG000|Overall Study|Protocol Violation|14|||
16882497|NCT02585934|37876837|FG001|Overall Study|Protocol Violation|11|||
16882498|NCT02585934|37876836|FG000|Overall Study|Adverse Event|21|||
16882499|NCT02585934|37876837|FG001|Overall Study|Adverse Event|22|||
16882500|NCT02585934|37876836|FG000|Overall Study|Physician Decision|3|||
16882501|NCT02585934|37876837|FG001|Overall Study|Physician Decision|2|||
16882502|NCT02585934|37876836|FG000|Overall Study|Withdrawal by Subject|7|||
16882503|NCT02585934|37876837|FG001|Overall Study|Withdrawal by Subject|21|||
16882504|NCT02585934|37876836|FG000|Overall Study|Lack of Efficacy|2|||
16882505|NCT02585934|37876837|FG001|Overall Study|Lack of Efficacy|1|||
16882506|NCT02585934|37876836|FG000|Overall Study|Death|2|||
16882507|NCT02585934|37876837|FG001|Overall Study|Death|0|||
16882508|NCT02585934|37876836|FG000|Overall Study|Caregiver Withdrew Consent|7|||
16882509|NCT02585934|37876837|FG001|Overall Study|Caregiver Withdrew Consent|7|||
16882510|NCT02585934|37876836|FG000|Overall Study|Sponsor Termination|1|||
16882511|NCT02585934|37876837|FG001|Overall Study|Sponsor Termination|2|||
16882512|NCT02585934|37876836|FG000|Overall Study|Another Reason|10|||
16882513|NCT02585934|37876837|FG001|Overall Study|Another Reason|5|||
16882514|NCT02582658|37876866|FG000|Overall Study|Failure to Return|10|||
16882515|NCT02582658|37876866|FG000|Overall Study|Insufficient Virological Response|2|||
17095305|NCT00261846|38234544|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
17095306|NCT00261846|38234545|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
16882516|NCT02582658|37876866|FG000|Overall Study|Withdrawn Consent|1|||
16882517|NCT02582658|37876866|FG000|Overall Study|Death|1|||
16882518|NCT02582658|37876866|FG000|Overall Study|Not further specified|11|||
16882519|NCT02585778|37876968|FG000|Overall Study|Adverse Event|17|||
16882520|NCT02585778|37876969|FG001|Overall Study|Adverse Event|4|||
16882521|NCT02585778|37876968|FG000|Overall Study|Participant did not wish to continue|9|||
16882522|NCT02585778|37876969|FG001|Overall Study|Participant did not wish to continue|4|||
16882523|NCT02585778|37876968|FG000|Overall Study|Poor compliance to study protocol|0|||
16882524|NCT02585778|37876969|FG001|Overall Study|Poor compliance to study protocol|2|||
16882525|NCT02585778|37876968|FG000|Overall Study|Death|0|||
16882526|NCT02585778|37876969|FG001|Overall Study|Death|1|||
16882527|NCT02585778|37876968|FG000|Overall Study|Randomized but not treated|1|||
16882528|NCT02585778|37876969|FG001|Overall Study|Randomized but not treated|2|||
16882529|NCT02585778|37876968|FG000|Overall Study|Other than specified above|6|||
16882530|NCT02585778|37876969|FG001|Overall Study|Other than specified above|2|||
16882531|NCT01438424|37876992|FG000|Overall Study|Continuing treatment|29|||
16882532|NCT01438424|37876992|FG000|Overall Study|Minimal virologic response|95|||
16882533|NCT01438424|37876992|FG000|Overall Study|Not identified|55|||
16882534|NCT01438424|37876992|FG000|Overall Study|Withdrawal by Subject|104|||
16882535|NCT01438424|37876992|FG000|Overall Study|Progression of chronic hepatitis B|22|||
16882536|NCT01438424|37876992|FG000|Overall Study|Death|22|||
16882537|NCT01438424|37876992|FG000|Overall Study|Adverse Event|17|||
16882538|NCT01438424|37876992|FG000|Overall Study|Lost to Follow-up|17|||
16882539|NCT01438424|37876992|FG000|Overall Study|Abnormal laboratory test result|14|||
16882540|NCT01438424|37876992|FG000|Overall Study|Need for drug prohibited by protocol|14|||
16882541|NCT01438424|37876992|FG000|Overall Study|Pregnancy|7|||
16882542|NCT01438424|37876992|FG000|Overall Study|No longer met inclusion criteria|1|||
16882543|NCT01438424|37876992|FG000|Overall Study|Participant noncompliance|20|||
16882544|NCT02580240|37877008|FG000|Overall Study|Physician Decision|2|||
16882545|NCT02580240|37877009|FG001|Overall Study|Physician Decision|0|||
16882546|NCT01465958|37877015|FG000|Run-in Phase|Protocol Violation|1|||
16882547|NCT01465958|37877016|FG001|Run-in Phase|Protocol Violation|0|||
16882548|NCT01465958|37877015|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
16882549|NCT01465958|37877016|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
16882550|NCT02581488|37877229|FG000|Overall Study|Adverse Event|6|||
16882551|NCT02581488|37877230|FG001|Overall Study|Adverse Event|7|||
16882552|NCT02581488|37877229|FG000|Overall Study|Lost to Follow-up|1|||
16882553|NCT02581488|37877230|FG001|Overall Study|Lost to Follow-up|0|||
16882554|NCT02581488|37877229|FG000|Overall Study|Withdrawal by Subject|1|||
16882555|NCT02581488|37877230|FG001|Overall Study|Withdrawal by Subject|0|||
16882556|NCT02581488|37877229|FG000|Overall Study|Non-Compliance|1|||
16882557|NCT02581488|37877230|FG001|Overall Study|Non-Compliance|0|||
16882558|NCT02581488|37877229|FG000|Overall Study|Protocol Violation|0|||
16882559|NCT02581488|37877230|FG001|Overall Study|Protocol Violation|4|||
16882560|NCT02581410|37877273|FG000|Vaccination Phase|Adverse Event|2|||
16882561|NCT02581410|37877274|FG001|Vaccination Phase|Adverse Event|1|||
16882562|NCT02581410|37877273|FG000|Vaccination Phase|Withdrawal by Subject|0|||
16882563|NCT02581410|37877274|FG001|Vaccination Phase|Withdrawal by Subject|1|||
16882564|NCT02581410|37877273|FG000|Vaccination Phase|Migrated/moved from study area|0|||
16882565|NCT02581410|37877274|FG001|Vaccination Phase|Migrated/moved from study area|1|||
16882566|NCT02581410|37877273|FG000|End of Study Phase|Adverse Event|4|||
16882567|NCT02581410|37877274|FG001|End of Study Phase|Adverse Event|3|||
16882568|NCT02581410|37877273|FG000|End of Study Phase|Withdrawal by Subject|1|||
16882569|NCT02581410|37877274|FG001|End of Study Phase|Withdrawal by Subject|2|||
16882570|NCT02581410|37877273|FG000|End of Study Phase|Migrated/moved from study area|0|||
16882571|NCT02581410|37877274|FG001|End of Study Phase|Migrated/moved from study area|3|||
16882572|NCT02581410|37877273|FG000|End of Study Phase|Lost to Follow-up|0|||
16882573|NCT02581410|37877274|FG001|End of Study Phase|Lost to Follow-up|2|||
16882574|NCT02581410|37877273|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
16882575|NCT02581410|37877274|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
16882576|NCT01664130|37877350|FG000|Overall Study|competing secondary disease|2|||
16882577|NCT02579928|37877381|FG000|Overall Study|Withdrawal by Subject|1|||
16882578|NCT02579928|37877382|FG001|Overall Study|Withdrawal by Subject|0|||
16882579|NCT00551460|37877476|FG000|Overall Study|Adverse Event|1|||
16882580|NCT00551460|37877476|FG000|Overall Study|Withdrawal by Subject|1|||
16882581|NCT00551460|37877476|FG000|Overall Study|Physician Decision|1|||
16882582|NCT00551460|37877476|FG000|Overall Study|Death|7|||
16882583|NCT00551460|37877476|FG000|Overall Study|Ineligible|4|||
16882584|NCT00551460|37877476|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
16882585|NCT02579772|37877537|FG000|Overall Study|Withdrawal by Subject|0|||
16882586|NCT02579772|37877538|FG001|Overall Study|Withdrawal by Subject|1|||
16882587|NCT02579772|37877537|FG000|Overall Study|Usage of additional antioxidants|1|||
16882588|NCT02579772|37877538|FG001|Overall Study|Usage of additional antioxidants|0|||
16882589|NCT02579772|37877537|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
16882590|NCT02579772|37877538|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
16882591|NCT02579616|37877611|FG000|Overall Study|Participants did not receive treatment|3|||
16882592|NCT04027608|37877688|FG000|Overall Study|Withdrawal by Subject|13|||
16882593|NCT04027608|37877689|FG001|Overall Study|Withdrawal by Subject|2|||
16882594|NCT04027608|37877688|FG000|Overall Study|Protocol Violation|2|||
16882595|NCT04027608|37877689|FG001|Overall Study|Protocol Violation|1|||
16882596|NCT04027608|37877688|FG000|Overall Study|Physician Decision|1|||
16882597|NCT04027608|37877689|FG001|Overall Study|Physician Decision|0|||
16882598|NCT04027608|37877688|FG000|Overall Study|Lost to Follow-up|20|||
16882599|NCT04027608|37877689|FG001|Overall Study|Lost to Follow-up|4|||
16882600|NCT01664052|37877780|FG000|Phase 1|No device placement|6|||
16882601|NCT01664052|37877781|FG001|Phase 1|No device placement|0|||
16882602|NCT01664052|37877780|FG000|Phase 1|No HSG 1 hr post placement|1|||
16882603|NCT01664052|37877781|FG001|Phase 1|No HSG 1 hr post placement|0|||
16882604|NCT01664052|37877780|FG000|Phase 2|No device placement|0|||
16882605|NCT01664052|37877781|FG001|Phase 2|No device placement|4|||
16882606|NCT01465802|37877828|FG000|Overall Study|Study terminated by sponsor|1|||
16882607|NCT01465802|37877829|FG001|Overall Study|Study terminated by sponsor|0|||
16882608|NCT01465802|37877830|FG002|Overall Study|Study terminated by sponsor|0|||
16882609|NCT01465802|37877831|FG003|Overall Study|Study terminated by sponsor|1|||
16882610|NCT01465802|37877832|FG004|Overall Study|Study terminated by sponsor|7|||
16882611|NCT01465802|37877828|FG000|Overall Study|Withdrawal by Subject|7|||
16882612|NCT01465802|37877829|FG001|Overall Study|Withdrawal by Subject|7|||
16882613|NCT01465802|37877830|FG002|Overall Study|Withdrawal by Subject|0|||
16882614|NCT01465802|37877831|FG003|Overall Study|Withdrawal by Subject|8|||
16882615|NCT01465802|37877832|FG004|Overall Study|Withdrawal by Subject|1|||
16882616|NCT01465802|37877828|FG000|Overall Study|Lost to Follow-up|1|||
16882617|NCT01465802|37877829|FG001|Overall Study|Lost to Follow-up|1|||
16882618|NCT01465802|37877830|FG002|Overall Study|Lost to Follow-up|0|||
16882619|NCT01465802|37877831|FG003|Overall Study|Lost to Follow-up|0|||
16882620|NCT01465802|37877832|FG004|Overall Study|Lost to Follow-up|0|||
16882621|NCT01465802|37877828|FG000|Overall Study|Reason not specified|9|||
16882622|NCT01465802|37877829|FG001|Overall Study|Reason not specified|4|||
16882623|NCT01465802|37877830|FG002|Overall Study|Reason not specified|0|||
16882624|NCT01465802|37877831|FG003|Overall Study|Reason not specified|10|||
16882625|NCT01465802|37877832|FG004|Overall Study|Reason not specified|2|||
16882626|NCT01465802|37877828|FG000|Overall Study|Death|15|||
16882627|NCT01465802|37877829|FG001|Overall Study|Death|12|||
16882628|NCT01465802|37877830|FG002|Overall Study|Death|0|||
16882629|NCT01465802|37877831|FG003|Overall Study|Death|10|||
16882630|NCT01465802|37877832|FG004|Overall Study|Death|2|||
16882631|NCT01437878|37877877|FG000|Overall Study|Withdrawal by Subject|1|||
16882632|NCT01437878|37877878|FG001|Overall Study|Withdrawal by Subject|0|||
16882633|NCT01465178|37877904|FG000|Overall Study|Withdrawal by Subject|1|||
16882634|NCT01465178|37877905|FG001|Overall Study|Withdrawal by Subject|0|||
16882635|NCT01445678|37878011|FG000|Overall Study|Adverse Event|12|||
16882636|NCT01445678|37878012|FG001|Overall Study|Adverse Event|8|||
16882637|NCT01445678|37878011|FG000|Overall Study|Lack of Efficacy|0|||
16882638|NCT01445678|37878012|FG001|Overall Study|Lack of Efficacy|2|||
16882639|NCT01445678|37878011|FG000|Overall Study|Lost to Follow-up|8|||
16882640|NCT01445678|37878012|FG001|Overall Study|Lost to Follow-up|5|||
16882641|NCT01445678|37878011|FG000|Overall Study|Protocol Violation|1|||
16882642|NCT01445678|37878012|FG001|Overall Study|Protocol Violation|1|||
16882643|NCT01445678|37878011|FG000|Overall Study|Withdrawal by Subject|9|||
16882644|NCT01445678|37878012|FG001|Overall Study|Withdrawal by Subject|5|||
16882645|NCT03769194|37878031|FG000|Overall Study|Withdrawal by Subject|0|||
16882646|NCT03769194|37878032|FG001|Overall Study|Withdrawal by Subject|7|||
16882647|NCT03769194|37878033|FG002|Overall Study|Withdrawal by Subject|4|||
16882648|NCT03769194|37878034|FG003|Overall Study|Withdrawal by Subject|1|||
16882649|NCT03769194|37878031|FG000|Overall Study|moved from study area|0|||
16882650|NCT03769194|37878032|FG001|Overall Study|moved from study area|2|||
16882651|NCT03769194|37878033|FG002|Overall Study|moved from study area|1|||
16882652|NCT03769194|37878034|FG003|Overall Study|moved from study area|1|||
16882653|NCT03769194|37878031|FG000|Overall Study|Lost to Follow-up|3|||
16882654|NCT03769194|37878032|FG001|Overall Study|Lost to Follow-up|6|||
16882655|NCT03769194|37878033|FG002|Overall Study|Lost to Follow-up|3|||
16882656|NCT03769194|37878034|FG003|Overall Study|Lost to Follow-up|6|||
16882657|NCT03769194|37878031|FG000|Overall Study|other|1|||
16882658|NCT03769194|37878032|FG001|Overall Study|other|3|||
16882659|NCT03769194|37878033|FG002|Overall Study|other|0|||
16882660|NCT03769194|37878034|FG003|Overall Study|other|1|||
16882661|NCT01465022|37878060|FG000|Overall Study|Lost to Follow-up|15|||
16882662|NCT01465022|37878061|FG001|Overall Study|Lost to Follow-up|14|||
16882663|NCT01465022|37878062|FG002|Overall Study|Lost to Follow-up|0|||
16882664|NCT01465022|37878060|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
16882665|NCT01465022|37878061|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
16882666|NCT01465022|37878062|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
16882667|NCT01465022|37878060|FG000|Overall Study|Not Randomized|0|||
16882668|NCT01465022|37878061|FG001|Overall Study|Not Randomized|0|||
16882669|NCT01465022|37878062|FG002|Overall Study|Not Randomized|70|||
16882670|NCT01464788|37878106|FG000|Overall Study|Lost to Follow-up|0|||
16882671|NCT01464788|37878107|FG001|Overall Study|Lost to Follow-up|1|||
16882672|NCT01464788|37878108|FG002|Overall Study|Lost to Follow-up|0|||
16882673|NCT01464788|37878106|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
16882674|NCT01464788|37878107|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
16882675|NCT01464788|37878108|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
16882676|NCT01444898|37878118|FG000|Overall Study|Withdrawal by Subject|1|||
16882677|NCT01419626|37878140|FG000|Overall Study|Protocol Violation|3|||
16882678|NCT01419626|37878141|FG001|Overall Study|Protocol Violation|2|||
16882679|NCT01419626|37878142|FG002|Overall Study|Protocol Violation|2|||
16882680|NCT01419626|37878140|FG000|Overall Study|Withdrawal by Subject|1|||
16882681|NCT01419626|37878141|FG001|Overall Study|Withdrawal by Subject|0|||
16882682|NCT01419626|37878142|FG002|Overall Study|Withdrawal by Subject|0|||
16882683|NCT01419626|37878140|FG000|Overall Study|Lost to Follow-up|0|||
16882684|NCT01419626|37878141|FG001|Overall Study|Lost to Follow-up|1|||
16882685|NCT01419626|37878142|FG002|Overall Study|Lost to Follow-up|1|||
16882686|NCT01444742|37878190|FG000|Overall Study|Death|1|||
16882687|NCT01444430|37878390|FG000|Overall Study|Withdrawal by Subject|53|||
16882688|NCT01444430|37878391|FG001|Overall Study|Withdrawal by Subject|72|||
16882689|NCT01444430|37878390|FG000|Overall Study|Death|6|||
16882690|NCT01444430|37878391|FG001|Overall Study|Death|8|||
16882691|NCT01444430|37878390|FG000|Overall Study|Lost to Follow-up|2|||
16882692|NCT01444430|37878391|FG001|Overall Study|Lost to Follow-up|0|||
16882693|NCT01444430|37878390|FG000|Overall Study|CRF termination module not completed.|0|||
16882694|NCT01444430|37878391|FG001|Overall Study|CRF termination module not completed.|1|||
16882695|NCT01436162|37878467|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
16882696|NCT01436162|37878468|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
16882697|NCT01436162|37878469|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
16882698|NCT01436162|37878467|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
16882699|NCT01436162|37878468|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
16882700|NCT01436162|37878469|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
16882701|NCT01436162|37878467|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
16882702|NCT01436162|37878468|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
16882703|NCT01436162|37878469|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
16882704|NCT01436162|37878467|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
16882705|NCT01436162|37878468|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
16882706|NCT01436162|37878469|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
16882707|NCT01436162|37878467|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
16882708|NCT01436162|37878468|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16882709|NCT01436162|37878469|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16882710|NCT01436162|37878467|FG000|Single-blind Lead-in Phase|Other|107|||
16882711|NCT01436162|37878468|FG001|Single-blind Lead-in Phase|Other|0|||
16882712|NCT01436162|37878469|FG002|Single-blind Lead-in Phase|Other|0|||
16882713|NCT01436162|37878467|FG000|Randomized Phase|Adverse Event|1|||
16882714|NCT01436162|37878468|FG001|Randomized Phase|Adverse Event|5|||
16882715|NCT01436162|37878469|FG002|Randomized Phase|Adverse Event|6|||
16882716|NCT01436162|37878467|FG000|Randomized Phase|Protocol Violation|4|||
16882717|NCT01436162|37878468|FG001|Randomized Phase|Protocol Violation|4|||
16882718|NCT01436162|37878469|FG002|Randomized Phase|Protocol Violation|2|||
16882719|NCT01436162|37878467|FG000|Randomized Phase|Withdrawal by Subject|16|||
16882720|NCT01436162|37878468|FG001|Randomized Phase|Withdrawal by Subject|9|||
16882721|NCT01436162|37878469|FG002|Randomized Phase|Withdrawal by Subject|8|||
16882722|NCT01436162|37878467|FG000|Randomized Phase|Lost to Follow-up|17|||
16882723|NCT01436162|37878468|FG001|Randomized Phase|Lost to Follow-up|5|||
16882724|NCT01436162|37878469|FG002|Randomized Phase|Lost to Follow-up|4|||
16882725|NCT01436162|37878467|FG000|Randomized Phase|Lack of Efficacy|0|||
16882726|NCT01436162|37878468|FG001|Randomized Phase|Lack of Efficacy|1|||
16882727|NCT01436162|37878469|FG002|Randomized Phase|Lack of Efficacy|1|||
16882728|NCT01436162|37878467|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
16882729|NCT01436162|37878468|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
16882730|NCT01436162|37878469|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
16882731|NCT01436162|37878467|FG000|Randomized Phase|Other|2|||
16882732|NCT01436162|37878468|FG001|Randomized Phase|Other|5|||
16882733|NCT01436162|37878469|FG002|Randomized Phase|Other|4|||
16882734|NCT02579382|37878481|FG000|Main Study Phase|Lost to Follow-up|0|||
16882735|NCT02579382|37878482|FG001|Main Study Phase|Lost to Follow-up|0|||
16882736|NCT02579382|37878483|FG002|Main Study Phase|Lost to Follow-up|2|||
16882737|NCT02579382|37878484|FG003|Main Study Phase|Lost to Follow-up|0|||
16882738|NCT02579382|37878481|FG000|Main Study Phase|Withdrew Consent|0|||
16882739|NCT02579382|37878482|FG001|Main Study Phase|Withdrew Consent|0|||
16882740|NCT02579382|37878483|FG002|Main Study Phase|Withdrew Consent|0|||
16882741|NCT02579382|37878484|FG003|Main Study Phase|Withdrew Consent|2|||
16882742|NCT02579382|37878481|FG000|Main Study Phase|Lack of Efficacy|0|||
16882743|NCT02579382|37878482|FG001|Main Study Phase|Lack of Efficacy|0|||
16882744|NCT02579382|37878483|FG002|Main Study Phase|Lack of Efficacy|0|||
16882745|NCT02579382|37878484|FG003|Main Study Phase|Lack of Efficacy|1|||
16882746|NCT02579382|37878481|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
16882747|NCT02579382|37878482|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
16882748|NCT02579382|37878483|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
16882749|NCT02579382|37878484|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
16882750|NCT02579382|37878481|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
16882751|NCT02579382|37878482|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
16882752|NCT02579382|37878483|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
16882753|NCT02579382|37878484|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
16882754|NCT02579382|37878481|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
16882755|NCT02579382|37878482|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
16882756|NCT02579382|37878483|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
16882757|NCT02579382|37878484|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
16882758|NCT02579382|37878481|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
16882759|NCT02579382|37878482|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
16882760|NCT02579382|37878483|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
16882761|NCT02579382|37878484|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
16882762|NCT02579382|37878481|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
16882763|NCT02579382|37878482|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
16882764|NCT02579382|37878483|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
16882765|NCT02579382|37878484|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
16882766|NCT02579382|37878481|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
16882767|NCT02579382|37878482|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
16882768|NCT02579382|37878483|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
16882769|NCT02579382|37878484|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
16882770|NCT01436084|37878520|FG000|Overall Study|Disease Progression|2|||
16882771|NCT01436084|37878520|FG000|Overall Study|Withdrawal by Subject|1|||
16882772|NCT01436084|37878520|FG000|Overall Study|Early Closure of Study|1|||
16882773|NCT01419314|37878535|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
16882774|NCT01419314|37878536|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
16882775|NCT01419314|37878535|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
16882776|NCT01419314|37878536|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
16882777|NCT01419314|37878535|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
16882778|NCT01419314|37878536|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
16882779|NCT01419236|37878593|FG000|Overall Study|Adverse Event|1|||
16882780|NCT01419236|37878594|FG001|Overall Study|Adverse Event|0|||
17002277|NCT00844857|38146392|FG000|Overall Study|Sponsor Decision|1|||
17002278|NCT00844857|38146393|FG001|Overall Study|Sponsor Decision|1|||
16882781|NCT01419236|37878593|FG000|Overall Study|Lack of Efficacy|0|||
16882782|NCT01419236|37878594|FG001|Overall Study|Lack of Efficacy|1|||
16882783|NCT01419236|37878593|FG000|Overall Study|Lost to Follow-up|1|||
16882784|NCT01419236|37878594|FG001|Overall Study|Lost to Follow-up|0|||
16882785|NCT01419236|37878593|FG000|Overall Study|Physician Decision|1|||
16882786|NCT01419236|37878594|FG001|Overall Study|Physician Decision|0|||
16882787|NCT01419236|37878593|FG000|Overall Study|Withdrawal by Subject|1|||
16882788|NCT01419236|37878594|FG001|Overall Study|Withdrawal by Subject|4|||
16882789|NCT01419236|37878593|FG000|Overall Study|Entry Criteria Not Met|1|||
16882790|NCT01419236|37878594|FG001|Overall Study|Entry Criteria Not Met|0|||
16882791|NCT01419080|37878604|FG000|Overall Study|Withdrawal by Subject|75|||
16882792|NCT01419080|37878604|FG000|Overall Study|Death|30|||
16882793|NCT01419080|37878604|FG000|Overall Study|Lost to Follow-up|23|||
16882794|NCT01419080|37878604|FG000|Overall Study|Too Ill|3|||
16882795|NCT03323658|37878613|FG000|Overall Study|Adverse Event|0|||
16882796|NCT03323658|37878614|FG001|Overall Study|Adverse Event|1|||
16882797|NCT03323658|37878615|FG002|Overall Study|Adverse Event|0|||
16882798|NCT01443026|37878640|FG000|Overall Study|Physician Decision|1|||
16882799|NCT01443026|37878641|FG001|Overall Study|Physician Decision|0|||
16882800|NCT01443026|37878640|FG000|Overall Study|Death|0|||
16882801|NCT01443026|37878641|FG001|Overall Study|Death|1|||
16882802|NCT01443026|37878640|FG000|Overall Study|Withdrawal by Subject|0|||
16882803|NCT01443026|37878641|FG001|Overall Study|Withdrawal by Subject|3|||
16882804|NCT01443026|37878640|FG000|Overall Study|Lost to Follow-up|2|||
16882805|NCT01443026|37878641|FG001|Overall Study|Lost to Follow-up|1|||
16882806|NCT01442714|37878666|FG000|Overall Study|Death|11|||
16882807|NCT01442714|37878666|FG000|Overall Study|Withdrawal by Subject|1|||
16882808|NCT01418378|37878679|FG000|Overall Study|Death|1|||
16882809|NCT01418378|37878680|FG001|Overall Study|Death|2|||
16882810|NCT01418378|37878679|FG000|Overall Study|Physician Decision|0|||
16882811|NCT01418378|37878680|FG001|Overall Study|Physician Decision|1|||
16882812|NCT01418378|37878679|FG000|Overall Study|ligament imbalance|0|||
16882813|NCT01418378|37878680|FG001|Overall Study|ligament imbalance|1|||
16882814|NCT01418378|37878679|FG000|Overall Study|developed chronic myopathy|0|||
16882815|NCT01418378|37878680|FG001|Overall Study|developed chronic myopathy|1|||
16882816|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
16882817|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
16882818|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
16882819|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
16882820|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
16882821|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
16882822|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
16882823|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
16882824|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
16882825|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
16882826|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
16882827|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
16882828|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
16882829|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
16882830|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
16882831|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
16882832|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
16882833|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
16882834|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
16882835|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
16882836|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
16882837|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
16882838|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
16882839|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
16882840|NCT01435928|37878712|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
16882841|NCT01435928|37878713|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
16882842|NCT01435928|37878714|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
16882843|NCT01435928|37878712|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
16882844|NCT01435928|37878713|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
16882845|NCT01435928|37878714|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
16882846|NCT01435928|37878712|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
16882847|NCT01435928|37878713|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
16882848|NCT01435928|37878714|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
16882849|NCT01435928|37878712|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
16882850|NCT01435928|37878713|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
16882851|NCT01435928|37878714|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
16882852|NCT01435928|37878712|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
16882853|NCT01435928|37878713|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
16882854|NCT01435928|37878714|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
16882855|NCT01435928|37878712|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
16882856|NCT01435928|37878713|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
16882857|NCT01435928|37878714|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
16882858|NCT01435928|37878712|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
16882859|NCT01435928|37878713|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
16882860|NCT01435928|37878714|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
16882861|NCT01435928|37878712|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
16882862|NCT01435928|37878713|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
16882863|NCT01435928|37878714|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
16882864|NCT01416272|37878726|FG000|Overall Study|Unacceptable distance visual acuity|2|||
16882865|NCT01416272|37878726|FG000|Overall Study|Lost to Follow-up|1|||
16882866|NCT01416272|37878726|FG000|Overall Study|Study related complaints|1|||
16882867|NCT01435772|37879225|FG000|Overall Study|Adverse Event|1|||
16882868|NCT01435772|37879226|FG001|Overall Study|Adverse Event|0|||
16882869|NCT01435772|37879227|FG002|Overall Study|Adverse Event|2|||
16882870|NCT01435772|37879225|FG000|Overall Study|Withdrawal by Subject|0|||
16882871|NCT01435772|37879226|FG001|Overall Study|Withdrawal by Subject|1|||
17002279|NCT00844857|38146392|FG000|Overall Study|Physician Decision|2|||
17002280|NCT00844857|38146393|FG001|Overall Study|Physician Decision|0|||
17002281|NCT00844857|38146392|FG000|Overall Study|Parent/Caregiver Decision|6|||
17002282|NCT00844857|38146393|FG001|Overall Study|Parent/Caregiver Decision|2|||
17002283|NCT00844857|38146392|FG000|Overall Study|Withdrawal by Subject|8|||
17002284|NCT00844857|38146393|FG001|Overall Study|Withdrawal by Subject|7|||
17002285|NCT00844857|38146392|FG000|Overall Study|Protocol Violation|6|||
17002286|NCT00844857|38146393|FG001|Overall Study|Protocol Violation|0|||
16882872|NCT01435772|37879227|FG002|Overall Study|Withdrawal by Subject|3|||
16882873|NCT01435772|37879225|FG000|Overall Study|Other - study termination|2|||
16882874|NCT01435772|37879226|FG001|Overall Study|Other - study termination|2|||
16882875|NCT01435772|37879227|FG002|Overall Study|Other - study termination|10|||
16882876|NCT01435616|37879446|FG000|Overall Study|Adverse Event|39|||
16882877|NCT01435616|37879447|FG001|Overall Study|Adverse Event|21|||
16882878|NCT01435616|37879446|FG000|Overall Study|Death|7|||
16882879|NCT01435616|37879447|FG001|Overall Study|Death|2|||
16882880|NCT01435616|37879446|FG000|Overall Study|Lost to Follow-up|22|||
16882881|NCT01435616|37879447|FG001|Overall Study|Lost to Follow-up|13|||
16882882|NCT01435616|37879446|FG000|Overall Study|Protocol Violation|16|||
16882883|NCT01435616|37879447|FG001|Overall Study|Protocol Violation|13|||
16882884|NCT01435616|37879446|FG000|Overall Study|Withdrawal by Subject|66|||
16882885|NCT01435616|37879447|FG001|Overall Study|Withdrawal by Subject|24|||
16882886|NCT01435616|37879446|FG000|Overall Study|Physician Decision|20|||
16882887|NCT01435616|37879447|FG001|Overall Study|Physician Decision|7|||
16882888|NCT01435616|37879446|FG000|Overall Study|Sponsor Decision|1|||
16882889|NCT01435616|37879447|FG001|Overall Study|Sponsor Decision|0|||
16882890|NCT01435460|37879497|FG000|Overall Study|Adverse Event|2|||
16882891|NCT01435460|37879498|FG001|Overall Study|Adverse Event|1|||
16882892|NCT01435460|37879497|FG000|Overall Study|Lost to Follow-up|6|||
16882893|NCT01435460|37879498|FG001|Overall Study|Lost to Follow-up|1|||
16882894|NCT01435460|37879497|FG000|Overall Study|Withdrawal by Subject|1|||
16882895|NCT01435460|37879498|FG001|Overall Study|Withdrawal by Subject|3|||
16882896|NCT01435460|37879497|FG000|Overall Study|Protocol Violation|0|||
16882897|NCT01435460|37879498|FG001|Overall Study|Protocol Violation|1|||
16882898|NCT01435460|37879497|FG000|Overall Study|Did not meet eligibility criteria|2|||
16882899|NCT01435460|37879498|FG001|Overall Study|Did not meet eligibility criteria|0|||
16882900|NCT01435382|37879584|FG000|Overall Study|Lost to Follow-up|1|||
16882901|NCT01435382|37879585|FG001|Overall Study|Lost to Follow-up|0|||
16882902|NCT01435382|37879586|FG002|Overall Study|Lost to Follow-up|1|||
16882903|NCT01435382|37879587|FG003|Overall Study|Lost to Follow-up|0|||
16882904|NCT01435382|37879584|FG000|Overall Study|Withdrawal by Subject|0|||
16882905|NCT01435382|37879585|FG001|Overall Study|Withdrawal by Subject|2|||
16882906|NCT01435382|37879586|FG002|Overall Study|Withdrawal by Subject|0|||
16882907|NCT01435382|37879587|FG003|Overall Study|Withdrawal by Subject|1|||
16882908|NCT01414166|37879652|FG000|Overall Study|Adverse Event|10|||
16882909|NCT01414166|37879653|FG001|Overall Study|Adverse Event|2|||
16882910|NCT01414166|37879652|FG000|Overall Study|Lost to Follow-up|4|||
16882911|NCT01414166|37879653|FG001|Overall Study|Lost to Follow-up|1|||
16882912|NCT01414166|37879652|FG000|Overall Study|Non-compliance with study drug|2|||
16882913|NCT01414166|37879653|FG001|Overall Study|Non-compliance with study drug|0|||
17002287|NCT00844857|38146392|FG000|Overall Study|Lack of Efficacy|5|||
16882914|NCT01414166|37879652|FG000|Overall Study|Physician Decision|2|||
16882915|NCT01414166|37879653|FG001|Overall Study|Physician Decision|0|||
16882916|NCT01414166|37879652|FG000|Overall Study|Protocol Violation|2|||
16882917|NCT01414166|37879653|FG001|Overall Study|Protocol Violation|0|||
16882918|NCT01414166|37879652|FG000|Overall Study|Study terminated by Sponsor|68|||
16882919|NCT01414166|37879653|FG001|Overall Study|Study terminated by Sponsor|75|||
16882920|NCT01414166|37879652|FG000|Overall Study|Withdrawal by Subject|3|||
16882921|NCT01414166|37879653|FG001|Overall Study|Withdrawal by Subject|5|||
16882922|NCT01434680|37879663|FG000|Overall Study|Withdrawal by Subject|1|||
16882923|NCT01434680|37879664|FG001|Overall Study|Withdrawal by Subject|0|||
16882924|NCT01434680|37879665|FG002|Overall Study|Withdrawal by Subject|2|||
16882925|NCT01434680|37879666|FG003|Overall Study|Withdrawal by Subject|0|||
16882926|NCT01434680|37879663|FG000|Overall Study|Lost to Follow-up|1|||
16882927|NCT01434680|37879664|FG001|Overall Study|Lost to Follow-up|1|||
16882928|NCT01434680|37879665|FG002|Overall Study|Lost to Follow-up|0|||
16882929|NCT01434680|37879666|FG003|Overall Study|Lost to Follow-up|0|||
16882930|NCT01434680|37879663|FG000|Overall Study|Protocol Violation|1|||
16882931|NCT01434680|37879664|FG001|Overall Study|Protocol Violation|1|||
16882932|NCT01434680|37879665|FG002|Overall Study|Protocol Violation|0|||
16882933|NCT01434680|37879666|FG003|Overall Study|Protocol Violation|0|||
16882934|NCT01433978|37879799|FG000|Core Study|Adverse Event, Non-Fatal|0|||
16882935|NCT01433978|37879800|FG001|Core Study|Adverse Event, Non-Fatal|1|||
16882936|NCT01433978|37879801|FG002|Core Study|Adverse Event, Non-Fatal|0|||
16882937|NCT01433978|37879799|FG000|Core Study|Lack of Efficacy|5|||
16882938|NCT01433978|37879800|FG001|Core Study|Lack of Efficacy|1|||
16882939|NCT01433978|37879801|FG002|Core Study|Lack of Efficacy|0|||
16882940|NCT01433978|37879799|FG000|Core Study|Study Terminated by Sponsor|6|||
16882941|NCT01433978|37879800|FG001|Core Study|Study Terminated by Sponsor|9|||
16882942|NCT01433978|37879801|FG002|Core Study|Study Terminated by Sponsor|0|||
16882943|NCT01433978|37879799|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
16882944|NCT01433978|37879800|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
16882945|NCT01433978|37879801|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
16882946|NCT01433978|37879799|FG000|Extension Phase|Lack of Efficacy|0|||
16882947|NCT01433978|37879800|FG001|Extension Phase|Lack of Efficacy|0|||
16882948|NCT01433978|37879801|FG002|Extension Phase|Lack of Efficacy|1|||
16882949|NCT01433978|37879799|FG000|Extension Phase|Study Terminated by Sponsor|0|||
16882950|NCT01433978|37879800|FG001|Extension Phase|Study Terminated by Sponsor|0|||
16882951|NCT01433978|37879801|FG002|Extension Phase|Study Terminated by Sponsor|4|||
16882952|NCT01433354|37879850|FG000|Overall Study|Adverse Event|6|||
16882953|NCT01433354|37879850|FG000|Overall Study|Lost to Follow-up|1|||
16882954|NCT01433354|37879850|FG000|Overall Study|Administrative problems|90|||
16882955|NCT01433354|37879850|FG000|Overall Study|Protocol Violation|2|||
16882956|NCT01433354|37879850|FG000|Overall Study|Lack of Efficacy|17|||
16882957|NCT01433354|37879850|FG000|Overall Study|Subject Withdrew Consent|3|||
16882958|NCT00559845|37880414|FG000|Overall Study|Withdrew Consent|1|||
16882959|NCT00559845|37880414|FG000|Overall Study|Disease Progression|1|||
16882960|NCT00559845|37880414|FG000|Overall Study|Adverse Event|3|||
16882961|NCT00559845|37880414|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
16882962|NCT00559845|37880414|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
16882963|NCT01393964|37880517|FG000|Overall Study|Disease Progression|4|||
16882964|NCT01393964|37880518|FG001|Overall Study|Disease Progression|3|||
16882965|NCT01393964|37880519|FG002|Overall Study|Disease Progression|5|||
16882966|NCT01393964|37880517|FG000|Overall Study|Study drug toxicity|1|||
16882967|NCT01393964|37880518|FG001|Overall Study|Study drug toxicity|0|||
16882968|NCT01393964|37880519|FG002|Overall Study|Study drug toxicity|0|||
16882969|NCT01393964|37880517|FG000|Overall Study|Withdrawal by Subject|0|||
16882970|NCT01393964|37880518|FG001|Overall Study|Withdrawal by Subject|0|||
16882971|NCT01393964|37880519|FG002|Overall Study|Withdrawal by Subject|1|||
16882972|NCT01393964|37880517|FG000|Overall Study|Adverse event unrelated to study drug|0|||
16882973|NCT01393964|37880518|FG001|Overall Study|Adverse event unrelated to study drug|3|||
16882974|NCT01393964|37880519|FG002|Overall Study|Adverse event unrelated to study drug|0|||
16882975|NCT01393964|37880517|FG000|Overall Study|Subject request stop study treatment|0|||
16882976|NCT01393964|37880518|FG001|Overall Study|Subject request stop study treatment|1|||
16882977|NCT01393964|37880519|FG002|Overall Study|Subject request stop study treatment|0|||
16882978|NCT01393964|37880517|FG000|Overall Study|Subject decided to move to transplant|1|||
16882979|NCT01393964|37880518|FG001|Overall Study|Subject decided to move to transplant|0|||
16882980|NCT01393964|37880519|FG002|Overall Study|Subject decided to move to transplant|0|||
16882981|NCT01393964|37880517|FG000|Overall Study|Subject switched to commercial supply|1|||
16882982|NCT01393964|37880518|FG001|Overall Study|Subject switched to commercial supply|0|||
16882983|NCT01393964|37880519|FG002|Overall Study|Subject switched to commercial supply|2|||
16882984|NCT01393964|37880517|FG000|Overall Study|Subject plateaued in terms of effect|1|||
16882985|NCT01393964|37880518|FG001|Overall Study|Subject plateaued in terms of effect|0|||
16882986|NCT01393964|37880519|FG002|Overall Study|Subject plateaued in terms of effect|0|||
16882987|NCT01393964|37880517|FG000|Overall Study|Investigator removed subject from study|0|||
16882988|NCT01393964|37880518|FG001|Overall Study|Investigator removed subject from study|1|||
16882989|NCT01393964|37880519|FG002|Overall Study|Investigator removed subject from study|0|||
16882990|NCT01393964|37880517|FG000|Overall Study|Subject converted to roll-over study|0|||
16882991|NCT01393964|37880518|FG001|Overall Study|Subject converted to roll-over study|1|||
16882992|NCT01393964|37880519|FG002|Overall Study|Subject converted to roll-over study|0|||
17002288|NCT00844857|38146393|FG001|Overall Study|Lack of Efficacy|5|||
17002289|NCT00844857|38146392|FG000|Overall Study|Clinical Relapse|0|||
16882993|NCT01393964|37880517|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
16882994|NCT01393964|37880518|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
16882995|NCT01393964|37880519|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
16882996|NCT01393730|37880607|FG000|Overall Study|Withdrawal by Subject|3|||
16882997|NCT01393730|37880607|FG000|Overall Study|Other|2|||
16882998|NCT01393730|37880607|FG000|Overall Study|Adverse Event|1|||
16882999|NCT01393106|37880626|FG000|Overall Study|Adverse Event|3|||
16883000|NCT01393106|37880626|FG000|Overall Study|Withdrawal by Subject|1|||
16883001|NCT01393106|37880626|FG000|Overall Study|Lack of Efficacy|1|||
16883002|NCT00553059|37880632|FG000|Overall Study|Deemed ineligible|1|||
16883003|NCT00553059|37880633|FG001|Overall Study|Deemed ineligible|1|||
16883004|NCT00553059|37880632|FG000|Overall Study|Drug supply not available|0|||
16883005|NCT00553059|37880633|FG001|Overall Study|Drug supply not available|1|||
16883006|NCT01413542|37880666|FG000|Overall Study|Physician Decision|1|||
16883007|NCT01413542|37880667|FG001|Overall Study|Physician Decision|0|||
16883008|NCT01413542|37880668|FG002|Overall Study|Physician Decision|3|||
16883009|NCT01413542|37880669|FG003|Overall Study|Physician Decision|0|||
16883010|NCT01413542|37880666|FG000|Overall Study|Adverse Event|0|||
16883011|NCT01413542|37880667|FG001|Overall Study|Adverse Event|0|||
16883012|NCT01413542|37880668|FG002|Overall Study|Adverse Event|0|||
16883013|NCT01413542|37880669|FG003|Overall Study|Adverse Event|1|||
16883014|NCT01432730|37880701|FG000|Period 1|Adverse Event|2|||
16883015|NCT01432730|37880702|FG001|Period 1|Adverse Event|0|||
16883016|NCT01432730|37880701|FG000|Period 2|Adverse Event|0|||
16883017|NCT01432730|37880702|FG001|Period 2|Adverse Event|4|||
16883018|NCT01432574|37880717|FG000|Overall Study|Moved|2|||
16883019|NCT01432574|37880717|FG000|Overall Study|Not interested|1|||
16883020|NCT01392560|37880750|FG000|Overall Study|Adverse Event|2|||
16883021|NCT01392560|37880750|FG000|Overall Study|not entered|8|||
16883022|NCT01392560|37880750|FG000|Overall Study|discontinued during placebo run-in|2|||
16883023|NCT00552279|37880802|FG000|Overall Study|Adverse Event|0|||
16883024|NCT00552279|37880803|FG001|Overall Study|Adverse Event|1|||
16883025|NCT00552279|37880802|FG000|Overall Study|Withdrawal by Subject|12|||
16883026|NCT00552279|37880803|FG001|Overall Study|Withdrawal by Subject|1|||
16883027|NCT00552279|37880802|FG000|Overall Study|Lost to Follow-up|1|||
16883028|NCT00552279|37880803|FG001|Overall Study|Lost to Follow-up|0|||
16883029|NCT00552279|37880802|FG000|Overall Study|Other|1|||
16883030|NCT00552279|37880803|FG001|Overall Study|Other|1|||
16883031|NCT00559377|37880844|FG000|Overall Study|Withdrawal by Subject|9|||
16883032|NCT01412060|37880851|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
16883033|NCT01412060|37880852|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
16883034|NCT01412060|37880853|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
16883035|NCT01412060|37880851|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
16883036|NCT01412060|37880852|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
16883037|NCT01412060|37880853|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
16883038|NCT01412060|37880851|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
16883039|NCT01412060|37880852|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
16883040|NCT01412060|37880853|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
16883041|NCT01412060|37880851|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
16883042|NCT01412060|37880852|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
16883043|NCT01412060|37880853|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
16883044|NCT01412060|37880851|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
16883045|NCT01412060|37880852|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
16883046|NCT01412060|37880853|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
16883047|NCT01412060|37880851|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
16883048|NCT01412060|37880852|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
16883049|NCT01412060|37880853|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
16883050|NCT01412060|37880851|FG000|Period Between RIP and SP|Adverse Event|4|||
16883051|NCT01412060|37880852|FG001|Period Between RIP and SP|Adverse Event|0|||
16883052|NCT01412060|37880853|FG002|Period Between RIP and SP|Adverse Event|0|||
16883053|NCT01412060|37880851|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
16883054|NCT01412060|37880852|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
16883055|NCT01412060|37880853|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
17095307|NCT00261846|38234546|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
16883056|NCT01412060|37880851|FG000|Period Between RIP and SP|Protocol Violation|2|||
16883057|NCT01412060|37880852|FG001|Period Between RIP and SP|Protocol Violation|0|||
16883058|NCT01412060|37880853|FG002|Period Between RIP and SP|Protocol Violation|0|||
16883059|NCT01412060|37880851|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
16883060|NCT01412060|37880852|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
16883061|NCT01412060|37880853|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
16883062|NCT01412060|37880851|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
16883063|NCT01412060|37880852|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
16883064|NCT01412060|37880853|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
17095308|NCT00261846|38234547|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
16883065|NCT01412060|37880851|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
16883066|NCT01412060|37880852|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
16883067|NCT01412060|37880853|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
16883068|NCT01412060|37880851|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
16883069|NCT01412060|37880852|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
16883070|NCT01412060|37880853|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
16883071|NCT01412060|37880851|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
16883072|NCT01412060|37880852|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
16883073|NCT01412060|37880853|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
16883074|NCT01412060|37880851|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
16883075|NCT01412060|37880852|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
16883076|NCT01412060|37880853|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
16883077|NCT01412060|37880851|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
16883078|NCT01412060|37880852|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
16883079|NCT01412060|37880853|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
16883080|NCT01412060|37880851|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
16883081|NCT01412060|37880852|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
16883082|NCT01412060|37880853|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
16883083|NCT01412060|37880851|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
16883084|NCT01412060|37880852|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
16883085|NCT01412060|37880853|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
16883086|NCT01412060|37880851|FG000|Period Between SP and DBP|Protocol Violation|2|||
16883087|NCT01412060|37880852|FG001|Period Between SP and DBP|Protocol Violation|0|||
16883088|NCT01412060|37880853|FG002|Period Between SP and DBP|Protocol Violation|0|||
16883089|NCT01412060|37880851|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
16883090|NCT01412060|37880852|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
16883091|NCT01412060|37880853|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
16883092|NCT01412060|37880851|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
16883093|NCT01412060|37880852|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
16883094|NCT01412060|37880853|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
16883095|NCT01412060|37880851|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
16883096|NCT01412060|37880852|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
16883097|NCT01412060|37880853|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
16883098|NCT01412060|37880851|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
16883099|NCT01412060|37880852|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
16883100|NCT01412060|37880853|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
16883101|NCT01412060|37880851|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
16883102|NCT01412060|37880852|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
16883103|NCT01412060|37880853|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
16883104|NCT01412060|37880851|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
16883105|NCT01412060|37880852|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
16883106|NCT01412060|37880853|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
16883107|NCT01412060|37880851|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
16883108|NCT01412060|37880852|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
16883109|NCT01412060|37880853|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
16883110|NCT01412060|37880851|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
16883111|NCT01412060|37880852|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
16883112|NCT01412060|37880853|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
16883113|NCT01412060|37880851|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
16883114|NCT01412060|37880852|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
16883115|NCT01412060|37880853|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
16883116|NCT01412060|37880851|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
16883117|NCT01412060|37880852|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
16883118|NCT01412060|37880853|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
16883119|NCT00551421|37880884|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
16883120|NCT01891643|37880904|FG000|Overall Study|Adverse event unrelated to study drug|2|||
16883121|NCT01891643|37880905|FG001|Overall Study|Adverse event unrelated to study drug|5|||
16883122|NCT01891643|37880904|FG000|Overall Study|Disease Progression|4|||
16883123|NCT01891643|37880905|FG001|Overall Study|Disease Progression|3|||
16883124|NCT01891643|37880904|FG000|Overall Study|Study Drug Toxicity|3|||
16883125|NCT01891643|37880905|FG001|Overall Study|Study Drug Toxicity|0|||
16883126|NCT01891643|37880904|FG000|Overall Study|Maximum Clinical Benefit|0|||
16883127|NCT01891643|37880905|FG001|Overall Study|Maximum Clinical Benefit|1|||
17002290|NCT00844857|38146393|FG001|Overall Study|Clinical Relapse|1|||
16883128|NCT01891643|37880904|FG000|Overall Study|Poor/Non-compliance|0|||
16883129|NCT01891643|37880905|FG001|Overall Study|Poor/Non-compliance|1|||
16883130|NCT01891643|37880904|FG000|Overall Study|Participant request to discontinue|1|||
16883131|NCT01891643|37880905|FG001|Overall Study|Participant request to discontinue|0|||
16883132|NCT01392326|37881039|FG000|Overall Study|Death|2|||
16883133|NCT01392326|37881040|FG001|Overall Study|Death|0|||
16883134|NCT01392326|37881041|FG002|Overall Study|Death|0|||
16883135|NCT01392326|37881039|FG000|Overall Study|Withdrawal by Subject|12|||
16883136|NCT01392326|37881040|FG001|Overall Study|Withdrawal by Subject|11|||
16883137|NCT01392326|37881041|FG002|Overall Study|Withdrawal by Subject|15|||
16883138|NCT01392326|37881039|FG000|Overall Study|Protocol Violation|2|||
16883139|NCT01392326|37881040|FG001|Overall Study|Protocol Violation|0|||
16883140|NCT01392326|37881041|FG002|Overall Study|Protocol Violation|0|||
16883141|NCT01392326|37881039|FG000|Overall Study|Pregnancy|0|||
16883142|NCT01392326|37881040|FG001|Overall Study|Pregnancy|0|||
16883143|NCT01392326|37881041|FG002|Overall Study|Pregnancy|1|||
16883144|NCT01392326|37881039|FG000|Overall Study|Physician Decision|7|||
16883145|NCT01392326|37881040|FG001|Overall Study|Physician Decision|5|||
16883146|NCT01392326|37881041|FG002|Overall Study|Physician Decision|2|||
16883147|NCT01392326|37881039|FG000|Overall Study|Lost to Follow-up|1|||
16883148|NCT01392326|37881040|FG001|Overall Study|Lost to Follow-up|3|||
16883149|NCT01392326|37881041|FG002|Overall Study|Lost to Follow-up|4|||
16883150|NCT01392326|37881039|FG000|Overall Study|Lack of Efficacy|14|||
16883151|NCT01392326|37881040|FG001|Overall Study|Lack of Efficacy|10|||
16883152|NCT01392326|37881041|FG002|Overall Study|Lack of Efficacy|15|||
16883153|NCT01392326|37881039|FG000|Overall Study|Adverse Event|9|||
16883154|NCT01392326|37881040|FG001|Overall Study|Adverse Event|6|||
16883155|NCT01392326|37881041|FG002|Overall Study|Adverse Event|11|||
16883156|NCT01432262|37881084|FG000|Overall Study|Withdrawal by Subject|2|||
16883157|NCT01432262|37881085|FG001|Overall Study|Withdrawal by Subject|1|||
16883158|NCT01410890|37881105|FG000|Overall Study|Withdrawal by Subject|0|||
16883159|NCT01410890|37881106|FG001|Overall Study|Withdrawal by Subject|1|||
16883160|NCT01431950|37881116|FG000|Overall Study|Study Site Closed/Terminated|7|||
16883161|NCT01431950|37881117|FG001|Overall Study|Study Site Closed/Terminated|3|||
16883162|NCT01431950|37881116|FG000|Overall Study|Withdrawal by Subject|4|||
16883163|NCT01431950|37881117|FG001|Overall Study|Withdrawal by Subject|3|||
16883164|NCT01431950|37881116|FG000|Overall Study|Protocol Violation|2|||
16883165|NCT01431950|37881117|FG001|Overall Study|Protocol Violation|3|||
16883166|NCT01431950|37881116|FG000|Overall Study|Adverse Event|2|||
16883167|NCT01431950|37881117|FG001|Overall Study|Adverse Event|2|||
16883168|NCT01431950|37881116|FG000|Overall Study|Physician Decision|2|||
16883169|NCT01431950|37881117|FG001|Overall Study|Physician Decision|1|||
16883170|NCT01431950|37881116|FG000|Overall Study|Lack of Efficacy|2|||
16883171|NCT01431950|37881117|FG001|Overall Study|Lack of Efficacy|1|||
16883172|NCT01431950|37881116|FG000|Overall Study|Lost to Follow-up|0|||
16883173|NCT01431950|37881117|FG001|Overall Study|Lost to Follow-up|1|||
16883174|NCT01431950|37881116|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16883175|NCT01431950|37881117|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16883176|NCT00551031|37881128|FG000|Overall Study|Adverse Event|0|||
16883177|NCT00551031|37881129|FG001|Overall Study|Adverse Event|1|||
16883178|NCT00551031|37881130|FG002|Overall Study|Adverse Event|0|||
16883179|NCT00551031|37881131|FG003|Overall Study|Adverse Event|0|||
16883180|NCT00551031|37881132|FG004|Overall Study|Adverse Event|0|||
16883181|NCT00551031|37881128|FG000|Overall Study|Protocol Violation|1|||
16883182|NCT00551031|37881129|FG001|Overall Study|Protocol Violation|1|||
16883183|NCT00551031|37881130|FG002|Overall Study|Protocol Violation|0|||
16883184|NCT00551031|37881131|FG003|Overall Study|Protocol Violation|0|||
16883185|NCT00551031|37881132|FG004|Overall Study|Protocol Violation|0|||
16883186|NCT00551031|37881128|FG000|Overall Study|Lost to Follow-up|0|||
16883187|NCT00551031|37881129|FG001|Overall Study|Lost to Follow-up|1|||
16883188|NCT00551031|37881130|FG002|Overall Study|Lost to Follow-up|0|||
16883189|NCT00551031|37881131|FG003|Overall Study|Lost to Follow-up|1|||
16883190|NCT00551031|37881132|FG004|Overall Study|Lost to Follow-up|1|||
16883191|NCT00551031|37881128|FG000|Overall Study|Withdrawal by Subject|0|||
16883192|NCT00551031|37881129|FG001|Overall Study|Withdrawal by Subject|4|||
16883193|NCT00551031|37881130|FG002|Overall Study|Withdrawal by Subject|1|||
16883194|NCT00551031|37881131|FG003|Overall Study|Withdrawal by Subject|2|||
16883195|NCT00551031|37881132|FG004|Overall Study|Withdrawal by Subject|0|||
16883196|NCT00551031|37881128|FG000|Overall Study|Serious Adverse Event|0|||
17095309|NCT00261846|38234548|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
17095310|NCT00261846|38234549|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
16883197|NCT00551031|37881129|FG001|Overall Study|Serious Adverse Event|2|||
16883198|NCT00551031|37881130|FG002|Overall Study|Serious Adverse Event|1|||
16883199|NCT00551031|37881131|FG003|Overall Study|Serious Adverse Event|0|||
16883200|NCT00551031|37881132|FG004|Overall Study|Serious Adverse Event|0|||
16883201|NCT00551031|37881128|FG000|Overall Study|Did not receive vaccine|1|||
16883202|NCT00551031|37881129|FG001|Overall Study|Did not receive vaccine|2|||
16883203|NCT00551031|37881130|FG002|Overall Study|Did not receive vaccine|0|||
16883204|NCT00551031|37881131|FG003|Overall Study|Did not receive vaccine|0|||
16883205|NCT00551031|37881132|FG004|Overall Study|Did not receive vaccine|0|||
16883206|NCT01431716|37881144|FG000|Overall Study|Withdrawal of consent|1|||
16883207|NCT00550953|37881150|FG000|Overall Study|Adverse Event|4|||
16883208|NCT00550953|37881151|FG001|Overall Study|Adverse Event|3|||
16883209|NCT00550953|37881150|FG000|Overall Study|Not able to visit the site|2|||
16883210|NCT00550953|37881151|FG001|Overall Study|Not able to visit the site|3|||
16883211|NCT00558831|37881186|FG000|Overall Study|Lost to Follow-up|1|||
16883212|NCT01431638|37881195|FG000|Overall Study|Adverse Event|1|||
16883213|NCT01431638|37881196|FG001|Overall Study|Adverse Event|3|||
16883214|NCT01431638|37881197|FG002|Overall Study|Adverse Event|1|||
16883215|NCT01431638|37881195|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16883216|NCT01431638|37881196|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16883217|NCT01431638|37881197|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
16883218|NCT01431638|37881195|FG000|Overall Study|Participants condition no longer requires study drug|0|||
16883219|NCT01431638|37881196|FG001|Overall Study|Participants condition no longer requires study drug|1|||
16883220|NCT01431638|37881197|FG002|Overall Study|Participants condition no longer requires study drug|0|||
16883221|NCT01431638|37881195|FG000|Overall Study|Participant withdrew consent|14|||
16883222|NCT01431638|37881196|FG001|Overall Study|Participant withdrew consent|5|||
16883223|NCT01431638|37881197|FG002|Overall Study|Participant withdrew consent|8|||
16883224|NCT01431638|37881195|FG000|Overall Study|Lost to Follow-up|7|||
16883225|NCT01431638|37881196|FG001|Overall Study|Lost to Follow-up|9|||
16883226|NCT01431638|37881197|FG002|Overall Study|Lost to Follow-up|7|||
16883227|NCT01431638|37881195|FG000|Overall Study|Administrative problems|1|||
16883228|NCT01431638|37881196|FG001|Overall Study|Administrative problems|4|||
16883229|NCT01431638|37881197|FG002|Overall Study|Administrative problems|6|||
16883230|NCT01431638|37881195|FG000|Overall Study|Death|1|||
16883231|NCT01431638|37881196|FG001|Overall Study|Death|0|||
16883232|NCT01431638|37881197|FG002|Overall Study|Death|0|||
16883233|NCT01431638|37881195|FG000|Overall Study|Protocol deviation|1|||
16883234|NCT01431638|37881196|FG001|Overall Study|Protocol deviation|1|||
16883235|NCT01431638|37881197|FG002|Overall Study|Protocol deviation|4|||
16883236|NCT01431638|37881195|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
16883237|NCT01431638|37881196|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
16883238|NCT01431638|37881197|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
16883239|NCT01392170|37881205|FG000|Overall Study|Withdrawal by Subject|1|||
16883240|NCT01392170|37881205|FG000|Overall Study|Ineligible|1|||
16883241|NCT00558753|37881211|FG000|Overall Study|Lost to Follow-up|5|||
16883242|NCT00558753|37881212|FG001|Overall Study|Lost to Follow-up|7|||
16883243|NCT01391546|37881220|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
16883244|NCT01391546|37881221|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
16883245|NCT01410110|37881230|FG000|Overall Study|Withdrawal by Subject|4|||
16883246|NCT01410110|37881231|FG001|Overall Study|Withdrawal by Subject|2|||
16883247|NCT01391000|37881239|FG000|Overall Study|Lost to Follow-up|2|||
16883248|NCT01391000|37881240|FG001|Overall Study|Lost to Follow-up|0|||
16883249|NCT01390844|37881315|FG000|Treatment Phase|Adverse Event|12|||
16883250|NCT01390844|37881316|FG001|Treatment Phase|Adverse Event|2|||
16883251|NCT01390844|37881317|FG002|Treatment Phase|Adverse Event|3|||
16883252|NCT01390844|37881318|FG003|Treatment Phase|Adverse Event|2|||
16883253|NCT01390844|37881315|FG000|Treatment Phase|Treatment Failure|23|||
16883254|NCT01390844|37881316|FG001|Treatment Phase|Treatment Failure|25|||
16883255|NCT01390844|37881317|FG002|Treatment Phase|Treatment Failure|10|||
16883256|NCT01390844|37881318|FG003|Treatment Phase|Treatment Failure|13|||
16883257|NCT01390844|37881315|FG000|Treatment Phase|Non-Medical Reasons|5|||
16883258|NCT01390844|37881316|FG001|Treatment Phase|Non-Medical Reasons|1|||
16883259|NCT01390844|37881317|FG002|Treatment Phase|Non-Medical Reasons|8|||
16883260|NCT01390844|37881318|FG003|Treatment Phase|Non-Medical Reasons|1|||
16883261|NCT01390844|37881315|FG000|Treatment Phase|Non-GCP Compliant|0|||
16883262|NCT01390844|37881316|FG001|Treatment Phase|Non-GCP Compliant|0|||
16883263|NCT01390844|37881317|FG002|Treatment Phase|Non-GCP Compliant|10|||
16883264|NCT01390844|37881318|FG003|Treatment Phase|Non-GCP Compliant|3|||
16883265|NCT01390844|37881315|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
16883266|NCT01390844|37881316|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
16883267|NCT01390844|37881317|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
16883268|NCT01390844|37881318|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
16883269|NCT01430624|37881331|FG000|Overall Study|Lost to Follow-up|23|||
16883270|NCT01430624|37881332|FG001|Overall Study|Lost to Follow-up|29|||
16883271|NCT01430624|37881333|FG002|Overall Study|Lost to Follow-up|27|||
16883272|NCT01430624|37881331|FG000|Overall Study|technical or eligibility|5|||
16883273|NCT01430624|37881332|FG001|Overall Study|technical or eligibility|5|||
16883274|NCT01430624|37881333|FG002|Overall Study|technical or eligibility|2|||
16883275|NCT01430468|37881358|FG000|Overall Study|Physician Decision|2|||
16883276|NCT01430468|37881359|FG001|Overall Study|Physician Decision|1|||
16883277|NCT01430468|37881358|FG000|Overall Study|Withdrawal by Subject|5|||
16883278|NCT01430468|37881359|FG001|Overall Study|Withdrawal by Subject|5|||
16883279|NCT01409564|37881380|FG000|Overall Study|low medication compliance|4|||
16883280|NCT01409564|37881381|FG001|Overall Study|low medication compliance|3|||
16883281|NCT01409564|37881380|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
16883282|NCT01409564|37881381|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
16883283|NCT01390298|37881391|FG000|Overall Study|Death|1|||
16883284|NCT01390298|37881391|FG000|Overall Study|long term ICU admission|1|||
16883285|NCT01390298|37881391|FG000|Overall Study|Withdrawal by Subject|14|||
16883286|NCT01390298|37881391|FG000|Overall Study|Lost to Follow-up|7|||
16883287|NCT01390298|37881391|FG000|Overall Study|Surgery cancelled|1|||
16883288|NCT01390220|37881409|FG000|Test Dose Phase|Adverse Event|17|||
16883289|NCT01390220|37881410|FG001|Test Dose Phase|Adverse Event|0|||
16883290|NCT01390220|37881411|FG002|Test Dose Phase|Adverse Event|0|||
16883291|NCT01390220|37881409|FG000|Test Dose Phase|Withdrawal by Subject|8|||
16883292|NCT01390220|37881410|FG001|Test Dose Phase|Withdrawal by Subject|0|||
16883293|NCT01390220|37881411|FG002|Test Dose Phase|Withdrawal by Subject|0|||
16883294|NCT01390220|37881409|FG000|Test Dose Phase|Lost to Follow-up|2|||
16883295|NCT01390220|37881410|FG001|Test Dose Phase|Lost to Follow-up|0|||
16883296|NCT01390220|37881411|FG002|Test Dose Phase|Lost to Follow-up|0|||
16883297|NCT01390220|37881409|FG000|Test Dose Phase|Protocol Violation|8|||
16883298|NCT01390220|37881410|FG001|Test Dose Phase|Protocol Violation|0|||
17191795|NCT02856113|38344681|FG000|Overall Study|Voluntary Withdrawal|3|||
17191796|NCT02856113|38344682|FG001|Overall Study|Voluntary Withdrawal|5|||
17191797|NCT02856113|38344681|FG000|Overall Study|Pregnancy|0|||
17191798|NCT02856113|38344682|FG001|Overall Study|Pregnancy|1|||
17191799|NCT02856113|38344681|FG000|Overall Study|Principal Investigator Discretion|2|||
17191800|NCT02856113|38344682|FG001|Overall Study|Principal Investigator Discretion|1|||
17191801|NCT02856113|38344681|FG000|Overall Study|Randomized but not Treated|1|||
17191802|NCT02856113|38344682|FG001|Overall Study|Randomized but not Treated|0|||
17191803|NCT02856113|38344681|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
17191804|NCT02856113|38344682|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
17191805|NCT02855411|38344689|FG000|Overall Study|Study terminated by sponsor|21|||
17191806|NCT02855411|38344689|FG000|Overall Study|Does not meet entrance criteria|14|||
17191807|NCT02745145|38344696|FG000|Overall Study|Adverse Event|1|||
17191808|NCT02745145|38344697|FG001|Overall Study|Adverse Event|0|||
17191809|NCT02745145|38344698|FG002|Overall Study|Adverse Event|0|||
17191810|NCT02745145|38344696|FG000|Overall Study|Death|0|||
17191811|NCT02745145|38344697|FG001|Overall Study|Death|1|||
17191812|NCT02745145|38344698|FG002|Overall Study|Death|0|||
17191813|NCT02745145|38344696|FG000|Overall Study|Progressive disease|0|||
17191814|NCT02745145|38344697|FG001|Overall Study|Progressive disease|0|||
17191815|NCT02745145|38344698|FG002|Overall Study|Progressive disease|1|||
17191816|NCT02745145|38344696|FG000|Overall Study|Withdrew consent|1|||
17191817|NCT02745145|38344697|FG001|Overall Study|Withdrew consent|1|||
17191818|NCT02745145|38344698|FG002|Overall Study|Withdrew consent|1|||
17191819|NCT02745145|38344696|FG000|Overall Study|Study Termination|8|||
17191820|NCT02745145|38344697|FG001|Overall Study|Study Termination|3|||
17191821|NCT02745145|38344698|FG002|Overall Study|Study Termination|7|||
17191822|NCT02854631|38344717|FG000|Overall Study|Adverse Event|1|||
17191823|NCT02854631|38344718|FG001|Overall Study|Adverse Event|2|||
17191824|NCT02854631|38344717|FG000|Overall Study|Withdrew Consent|3|||
17191825|NCT02854631|38344718|FG001|Overall Study|Withdrew Consent|2|||
17191826|NCT02854631|38344717|FG000|Overall Study|Investigator's Discretion|2|||
17191827|NCT02854631|38344718|FG001|Overall Study|Investigator's Discretion|0|||
17191828|NCT02854631|38344717|FG000|Overall Study|Death|12|||
17191829|NCT02854631|38344718|FG001|Overall Study|Death|8|||
17191830|NCT02854631|38344717|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
17191831|NCT02854631|38344718|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
17191832|NCT02854631|38344717|FG000|Overall Study|Protocol Violation|0|||
17191833|NCT02854631|38344718|FG001|Overall Study|Protocol Violation|1|||
17191834|NCT02854631|38344717|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
17191835|NCT02854631|38344718|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
17191836|NCT02854631|38344717|FG000|Overall Study|Lost to Follow-up|4|||
17191837|NCT02854631|38344718|FG001|Overall Study|Lost to Follow-up|2|||
17191838|NCT02855359|38344726|FG000|Overall Study|Death|2|||
17191839|NCT02855359|38344727|FG001|Overall Study|Death|2|||
17191840|NCT02855359|38344728|FG002|Overall Study|Death|0|||
17191841|NCT02855359|38344729|FG003|Overall Study|Death|0|||
17191842|NCT02855359|38344726|FG000|Overall Study|Study Termination by Sponsor|9|||
17191843|NCT02855359|38344727|FG001|Overall Study|Study Termination by Sponsor|11|||
17191844|NCT02855359|38344728|FG002|Overall Study|Study Termination by Sponsor|0|||
17191845|NCT02855359|38344729|FG003|Overall Study|Study Termination by Sponsor|0|||
17191846|NCT02853929|38344743|FG000|Overall Study|Lost to Follow-up|3|||
17191847|NCT02853929|38344744|FG001|Overall Study|Lost to Follow-up|0|||
17191848|NCT02853929|38344743|FG000|Overall Study|Withdrawal by Subject|1|||
16883299|NCT01390220|37881411|FG002|Test Dose Phase|Protocol Violation|0|||
16883300|NCT01390220|37881409|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
17191849|NCT02853929|38344744|FG001|Overall Study|Withdrawal by Subject|0|||
17191850|NCT02853929|38344743|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
17191851|NCT02853929|38344744|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
17191852|NCT02730819|38344780|FG000|Overall Study|Lost to Follow-up|9|||
17191853|NCT02038946|38344784|FG000|Overall Study|Death|5|||
17191854|NCT02038946|38344784|FG000|Overall Study|Withdrawal by Subject|3|||
16883301|NCT01390220|37881410|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
16883302|NCT01390220|37881411|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
16883303|NCT01390220|37881409|FG000|Test Dose Phase|Study/Site closure|6|||
16883304|NCT01390220|37881410|FG001|Test Dose Phase|Study/Site closure|0|||
16883305|NCT01390220|37881411|FG002|Test Dose Phase|Study/Site closure|0|||
16883306|NCT01390220|37881409|FG000|Test Dose Phase|Caregiver no longer available|5|||
16883307|NCT01390220|37881410|FG001|Test Dose Phase|Caregiver no longer available|0|||
16883308|NCT01390220|37881411|FG002|Test Dose Phase|Caregiver no longer available|0|||
16883309|NCT01390220|37881409|FG000|Test Dose Phase|Noncompliance|2|||
16883310|NCT01390220|37881410|FG001|Test Dose Phase|Noncompliance|0|||
16883311|NCT01390220|37881411|FG002|Test Dose Phase|Noncompliance|0|||
16883312|NCT01390220|37881409|FG000|Test Dose Phase|Logistical|6|||
16883313|NCT01390220|37881410|FG001|Test Dose Phase|Logistical|0|||
16883314|NCT01390220|37881411|FG002|Test Dose Phase|Logistical|0|||
16883315|NCT01390220|37881409|FG000|Comparative Phase|Withdrawal by Subject|0|||
16883316|NCT01390220|37881410|FG001|Comparative Phase|Withdrawal by Subject|1|||
16883317|NCT01390220|37881411|FG002|Comparative Phase|Withdrawal by Subject|0|||
16883318|NCT00550173|37881441|FG000|Overall Study|Death|45|||
16883319|NCT00550173|37881442|FG001|Overall Study|Death|38|||
16883320|NCT00550173|37881443|FG002|Overall Study|Death|50|||
16883321|NCT00550173|37881441|FG000|Overall Study|Physician Decision|1|||
16883322|NCT00550173|37881442|FG001|Overall Study|Physician Decision|2|||
16883323|NCT00550173|37881443|FG002|Overall Study|Physician Decision|2|||
16883324|NCT00550173|37881441|FG000|Overall Study|Withdrawal by Subject|9|||
16883325|NCT00550173|37881442|FG001|Overall Study|Withdrawal by Subject|12|||
16883326|NCT00550173|37881443|FG002|Overall Study|Withdrawal by Subject|17|||
16883327|NCT00550173|37881441|FG000|Overall Study|Sponsor Decision|13|||
16883328|NCT00550173|37881442|FG001|Overall Study|Sponsor Decision|7|||
16883329|NCT00550173|37881443|FG002|Overall Study|Sponsor Decision|1|||
16883330|NCT00550173|37881441|FG000|Overall Study|Lost to Follow-up|4|||
16883331|NCT00550173|37881442|FG001|Overall Study|Lost to Follow-up|4|||
16883332|NCT00550173|37881443|FG002|Overall Study|Lost to Follow-up|3|||
16883333|NCT01429298|37881454|FG000|Overall Study|Protocol Violation|4|||
16883334|NCT01429298|37881455|FG001|Overall Study|Protocol Violation|6|||
16883335|NCT01408706|37881467|FG000|Overall Study|Physician Decision|1|||
16883336|NCT01408706|37881468|FG001|Overall Study|Physician Decision|0|||
16883337|NCT01408628|37881476|FG000|Consented|Withdrawal by Subject|12|||
16883338|NCT01408628|37881476|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
16883339|NCT01408628|37881476|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
16883340|NCT01408628|37881476|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
16883341|NCT01389752|37881481|FG000|Study Period 1|Sponsor decision|0|||
16883342|NCT01389752|37881482|FG001|Study Period 1|Sponsor decision|2|||
16883343|NCT01389752|37881481|FG000|Study Period 2|Sponsor decision|1|||
16883344|NCT01389752|37881482|FG001|Study Period 2|Sponsor decision|0|||
16883345|NCT01428128|37881489|FG000|Overall Study|Withdrawal by Subject|4|||
16883346|NCT01428128|37881489|FG000|Overall Study|Screen failure by p53|10|||
16883347|NCT01428128|37881489|FG000|Overall Study|Received Neulasta in one cycle|2|||
16883348|NCT01428128|37881489|FG000|Overall Study|Adverse Event|1|||
16883349|NCT01407926|37881494|FG000|Overall Study|Lost to Follow-up|55|||
16883350|NCT01427972|37881521|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883351|NCT01427972|37881522|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883352|NCT01427972|37881523|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883353|NCT01427972|37881524|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883354|NCT01427972|37881525|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883355|NCT01427972|37881526|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883356|NCT01427972|37881527|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883357|NCT01427972|37881528|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
16883358|NCT01427972|37881529|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883359|NCT01427972|37881530|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883360|NCT01427972|37881531|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883361|NCT01427972|37881532|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16883362|NCT01427972|37881521|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883363|NCT01427972|37881522|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883364|NCT01427972|37881523|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883365|NCT01427972|37881524|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883366|NCT01427972|37881525|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883367|NCT01427972|37881526|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
16883368|NCT01427972|37881527|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883369|NCT01427972|37881528|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883370|NCT01427972|37881529|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883371|NCT01427972|37881530|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883372|NCT01427972|37881531|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883373|NCT01427972|37881532|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16883374|NCT01427972|37881521|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883375|NCT01427972|37881522|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
16883376|NCT01427972|37881523|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883377|NCT01427972|37881524|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883378|NCT01427972|37881525|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883379|NCT01427972|37881526|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883380|NCT01427972|37881527|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883381|NCT01427972|37881528|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883382|NCT01427972|37881529|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883383|NCT01427972|37881530|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883384|NCT01427972|37881531|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883385|NCT01427972|37881532|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16883386|NCT01427738|37881569|FG000|Overall Study|Death|12|||
16883387|NCT01427738|37881570|FG001|Overall Study|Death|9|||
16883388|NCT01427738|37881569|FG000|Overall Study|Severe debilitation, unable to continue|0|||
16883389|NCT01427738|37881570|FG001|Overall Study|Severe debilitation, unable to continue|1|||
16883390|NCT01427738|37881569|FG000|Overall Study|Subject unable to get to clinic|5|||
16883391|NCT01427738|37881570|FG001|Overall Study|Subject unable to get to clinic|2|||
16883392|NCT01427738|37881569|FG000|Overall Study|Withdrawal by Subject|0|||
16883393|NCT01427738|37881570|FG001|Overall Study|Withdrawal by Subject|2|||
16883394|NCT01427738|37881569|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
16883395|NCT01427738|37881570|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
16883396|NCT01427738|37881569|FG000|Overall Study|Lost to Follow-up|1|||
16883397|NCT01427738|37881570|FG001|Overall Study|Lost to Follow-up|5|||
16883398|NCT01426958|37881576|FG000|Overall Study|Adverse Event|2|||
16883399|NCT03043872|37881693|FG000|Overall Study|Withdrawal by Subject|6|||
16883400|NCT03043872|37881694|FG001|Overall Study|Withdrawal by Subject|6|||
16883401|NCT03043872|37881695|FG002|Overall Study|Withdrawal by Subject|15|||
16883402|NCT03043872|37881693|FG000|Overall Study|Lost to Follow-up|2|||
16883403|NCT03043872|37881694|FG001|Overall Study|Lost to Follow-up|1|||
16883404|NCT03043872|37881695|FG002|Overall Study|Lost to Follow-up|1|||
16883405|NCT03043872|37881693|FG000|Overall Study|Death|270|||
16883406|NCT03043872|37881694|FG001|Overall Study|Death|269|||
16883407|NCT03043872|37881695|FG002|Overall Study|Death|296|||
16883408|NCT02578992|37881777|FG000|Overall Study|equipment not available or malfunction|3|||
16883409|NCT02578992|37881778|FG001|Overall Study|equipment not available or malfunction|3|||
16883410|NCT00558519|37881842|FG000|Overall Study|Ph+|20|||
16883411|NCT00558519|37881842|FG000|Overall Study|Ineligible|1|||
16883412|NCT00558519|37881842|FG000|Overall Study|Insufficient data|1|||
16883413|NCT00558519|37881842|FG000|Overall Study|Never received treatment|1|||
16883414|NCT00558285|37881886|FG000|Overall Study|Adverse Event|1|||
16883415|NCT00558285|37881887|FG001|Overall Study|Adverse Event|1|||
16883416|NCT00558285|37881888|FG002|Overall Study|Adverse Event|4|||
16883417|NCT00558285|37881889|FG003|Overall Study|Adverse Event|1|||
16883418|NCT00558285|37881890|FG004|Overall Study|Adverse Event|2|||
16883419|NCT00558285|37881886|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16883420|NCT00558285|37881887|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16883421|NCT00558285|37881888|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16883422|NCT00558285|37881889|FG003|Overall Study|Abnormal test procedure result(s)|0|||
16883423|NCT00558285|37881890|FG004|Overall Study|Abnormal test procedure result(s)|0|||
16883424|NCT00558285|37881886|FG000|Overall Study|Subject withdrew consent|2|||
16883425|NCT00558285|37881887|FG001|Overall Study|Subject withdrew consent|0|||
16883426|NCT00558285|37881888|FG002|Overall Study|Subject withdrew consent|1|||
16883427|NCT00558285|37881889|FG003|Overall Study|Subject withdrew consent|1|||
16883428|NCT00558285|37881890|FG004|Overall Study|Subject withdrew consent|1|||
16883429|NCT00558285|37881886|FG000|Overall Study|Lost to Follow-up|1|||
16883430|NCT00558285|37881887|FG001|Overall Study|Lost to Follow-up|1|||
16883431|NCT00558285|37881888|FG002|Overall Study|Lost to Follow-up|0|||
16883432|NCT00558285|37881889|FG003|Overall Study|Lost to Follow-up|0|||
16883433|NCT00558285|37881890|FG004|Overall Study|Lost to Follow-up|0|||
16883434|NCT00558285|37881886|FG000|Overall Study|Administrative problems|0|||
16883435|NCT00558285|37881887|FG001|Overall Study|Administrative problems|0|||
16883436|NCT00558285|37881888|FG002|Overall Study|Administrative problems|0|||
16883437|NCT00558285|37881889|FG003|Overall Study|Administrative problems|1|||
16883438|NCT00558285|37881890|FG004|Overall Study|Administrative problems|1|||
16883439|NCT00558285|37881886|FG000|Overall Study|Protocol deviation|1|||
16883440|NCT00558285|37881887|FG001|Overall Study|Protocol deviation|1|||
16883441|NCT00558285|37881888|FG002|Overall Study|Protocol deviation|0|||
16883442|NCT00558285|37881889|FG003|Overall Study|Protocol deviation|1|||
16883443|NCT00558285|37881890|FG004|Overall Study|Protocol deviation|0|||
16883444|NCT01389596|37881905|FG000|Overall Study|Protocol Violation|3|||
16883445|NCT01389596|37881906|FG001|Overall Study|Protocol Violation|4|||
16883446|NCT01389596|37881907|FG002|Overall Study|Protocol Violation|3|||
16883447|NCT01389596|37881905|FG000|Overall Study|Withdrawal by Subject|1|||
16883448|NCT01389596|37881906|FG001|Overall Study|Withdrawal by Subject|2|||
16883449|NCT01389596|37881907|FG002|Overall Study|Withdrawal by Subject|2|||
16883450|NCT01389596|37881905|FG000|Overall Study|Insufficient Clinical Response|3|||
16883451|NCT01389596|37881906|FG001|Overall Study|Insufficient Clinical Response|4|||
16883452|NCT01389596|37881907|FG002|Overall Study|Insufficient Clinical Response|5|||
16883453|NCT01389596|37881905|FG000|Overall Study|Adverse Event|1|||
16883454|NCT01389596|37881906|FG001|Overall Study|Adverse Event|4|||
16883455|NCT01389596|37881907|FG002|Overall Study|Adverse Event|0|||
16883456|NCT01389596|37881905|FG000|Overall Study|Death|0|||
16883457|NCT01389596|37881906|FG001|Overall Study|Death|1|||
16883458|NCT01389596|37881907|FG002|Overall Study|Death|0|||
16883459|NCT01389596|37881905|FG000|Overall Study|Other Unspecified|2|||
16883460|NCT01389596|37881906|FG001|Overall Study|Other Unspecified|1|||
16883461|NCT01389596|37881907|FG002|Overall Study|Other Unspecified|0|||
16883462|NCT01405898|37881943|FG000|Overall Study|Withdrawal by Subject|2|||
16883463|NCT01405898|37881944|FG001|Overall Study|Withdrawal by Subject|2|||
16883464|NCT01389128|37881970|FG000|Overall Study|Fetal distress|1|||
16883465|NCT01389128|37881971|FG001|Overall Study|Fetal distress|0|||
16883466|NCT01389128|37881970|FG000|Overall Study|Cervix dilation stop|1|||
16883467|NCT01389128|37881971|FG001|Overall Study|Cervix dilation stop|2|||
16883468|NCT01389128|37881970|FG000|Overall Study|Rapid labor evolution|3|||
16883469|NCT01389128|37881971|FG001|Overall Study|Rapid labor evolution|2|||
16883470|NCT01389128|37881970|FG000|Overall Study|Intolerance to procedure|0|||
16883471|NCT01389128|37881971|FG001|Overall Study|Intolerance to procedure|2|||
16883472|NCT01388816|37882002|FG000|Overall Study|Adverse Event|0|||
16883473|NCT01388816|37882003|FG001|Overall Study|Adverse Event|2|||
16883474|NCT01388816|37882004|FG002|Overall Study|Adverse Event|0|||
16883475|NCT01388816|37882005|FG003|Overall Study|Adverse Event|0|||
16883476|NCT01388816|37882002|FG000|Overall Study|Lost to Follow-up|0|||
16883477|NCT01388816|37882003|FG001|Overall Study|Lost to Follow-up|1|||
16883478|NCT01388816|37882004|FG002|Overall Study|Lost to Follow-up|0|||
16883479|NCT01388816|37882005|FG003|Overall Study|Lost to Follow-up|0|||
16883480|NCT01388816|37882002|FG000|Overall Study|Withdrawal by Subject|2|||
16883481|NCT01388816|37882003|FG001|Overall Study|Withdrawal by Subject|1|||
16883482|NCT01388816|37882004|FG002|Overall Study|Withdrawal by Subject|1|||
16883483|NCT01388816|37882005|FG003|Overall Study|Withdrawal by Subject|0|||
16883484|NCT01388816|37882002|FG000|Overall Study|Protocol Violation|0|||
16883485|NCT01388816|37882003|FG001|Overall Study|Protocol Violation|0|||
16883486|NCT01388816|37882004|FG002|Overall Study|Protocol Violation|2|||
16883487|NCT01388816|37882005|FG003|Overall Study|Protocol Violation|0|||
16883488|NCT00555477|37882159|FG000|Overall Study|Adverse Event|0|||
16883489|NCT00555477|37882160|FG001|Overall Study|Adverse Event|9|||
16883490|NCT00555477|37882159|FG000|Overall Study|Withdrawal by Subject|1|||
16883491|NCT00555477|37882160|FG001|Overall Study|Withdrawal by Subject|2|||
16883492|NCT00555477|37882159|FG000|Overall Study|Physician Decision|1|||
16883493|NCT00555477|37882160|FG001|Overall Study|Physician Decision|2|||
16883494|NCT00554619|37882177|FG000|Overall Study|Adverse Event|1|||
16883495|NCT00554619|37882177|FG000|Overall Study|Physician Decision|1|||
16883496|NCT00554619|37882177|FG000|Overall Study|Liver Function Test Abnormality|1|||
16883497|NCT01426412|37882237|FG000|Overall Study|Withdrawal by Subject|1|||
16883498|NCT01426412|37882238|FG001|Overall Study|Withdrawal by Subject|0|||
16883499|NCT01426412|37882239|FG002|Overall Study|Withdrawal by Subject|0|||
16883500|NCT01426412|37882240|FG003|Overall Study|Withdrawal by Subject|0|||
16883501|NCT01426412|37882241|FG004|Overall Study|Withdrawal by Subject|1|||
16883502|NCT01426412|37882242|FG005|Overall Study|Withdrawal by Subject|0|||
16883503|NCT01426412|37882243|FG006|Overall Study|Withdrawal by Subject|0|||
16883504|NCT01426412|37882244|FG007|Overall Study|Withdrawal by Subject|3|||
16883505|NCT01426412|37882245|FG008|Overall Study|Withdrawal by Subject|1|||
16883506|NCT00554229|37882440|FG000|Overall Study|Lost to Follow-up|3|||
16883507|NCT00554229|37882441|FG001|Overall Study|Lost to Follow-up|6|||
16883508|NCT00554229|37882440|FG000|Overall Study|Withdrawal by Subject|29|||
16883509|NCT00554229|37882441|FG001|Overall Study|Withdrawal by Subject|37|||
16883510|NCT00554229|37882440|FG000|Overall Study|Adverse Event|71|||
16883511|NCT00554229|37882441|FG001|Overall Study|Adverse Event|39|||
16883512|NCT00554229|37882440|FG000|Overall Study|Protocol Violation|3|||
16883513|NCT00554229|37882441|FG001|Overall Study|Protocol Violation|3|||
16883514|NCT00554229|37882440|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
16883515|NCT00554229|37882441|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
16883516|NCT00554229|37882440|FG000|Overall Study|Randomised but no treatment received|1|||
16883517|NCT00554229|37882441|FG001|Overall Study|Randomised but no treatment received|0|||
16883518|NCT05065983|37882521|FG000|Overall Study|Lost to Follow-up|2|||
16883519|NCT01405820|37882555|FG000|Randomized Treatment Period|Adverse Event|3|||
16883520|NCT01405820|37882556|FG001|Randomized Treatment Period|Adverse Event|3|||
16883521|NCT01405820|37882557|FG002|Randomized Treatment Period|Adverse Event|3|||
16883522|NCT01405820|37882558|FG003|Randomized Treatment Period|Adverse Event|0|||
16883523|NCT01405820|37882559|FG004|Randomized Treatment Period|Adverse Event|2|||
16883524|NCT01405820|37882560|FG005|Randomized Treatment Period|Adverse Event|1|||
16883525|NCT01405820|37882555|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
16883526|NCT01405820|37882556|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
16883527|NCT01405820|37882557|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
16883528|NCT01405820|37882558|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
16883529|NCT01405820|37882559|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
16883530|NCT01405820|37882560|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
16883531|NCT01405820|37882555|FG000|Randomized Treatment Period|Other|2|||
16883532|NCT01405820|37882556|FG001|Randomized Treatment Period|Other|2|||
16883533|NCT01405820|37882557|FG002|Randomized Treatment Period|Other|1|||
16883534|NCT01405820|37882558|FG003|Randomized Treatment Period|Other|1|||
16883535|NCT01405820|37882559|FG004|Randomized Treatment Period|Other|0|||
16883536|NCT01405820|37882560|FG005|Randomized Treatment Period|Other|0|||
16883537|NCT01405820|37882555|FG000|Randomized Treatment Period|Physician Decision|0|||
16883538|NCT01405820|37882556|FG001|Randomized Treatment Period|Physician Decision|2|||
16883539|NCT01405820|37882557|FG002|Randomized Treatment Period|Physician Decision|1|||
16883540|NCT01405820|37882558|FG003|Randomized Treatment Period|Physician Decision|0|||
16883541|NCT01405820|37882559|FG004|Randomized Treatment Period|Physician Decision|0|||
16883542|NCT01405820|37882560|FG005|Randomized Treatment Period|Physician Decision|0|||
16883543|NCT01405820|37882555|FG000|Randomized Treatment Period|Rescue|0|||
16883544|NCT01405820|37882556|FG001|Randomized Treatment Period|Rescue|1|||
16883545|NCT01405820|37882557|FG002|Randomized Treatment Period|Rescue|13|||
16883546|NCT01405820|37882558|FG003|Randomized Treatment Period|Rescue|10|||
16883547|NCT01405820|37882559|FG004|Randomized Treatment Period|Rescue|8|||
16883548|NCT01405820|37882560|FG005|Randomized Treatment Period|Rescue|8|||
16883549|NCT01405820|37882555|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
16883550|NCT01405820|37882556|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
16883551|NCT01405820|37882557|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
16883552|NCT01405820|37882558|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
16883553|NCT01405820|37882559|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
16883554|NCT01405820|37882560|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
16883555|NCT01405820|37882555|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
16883556|NCT01405820|37882556|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
16883557|NCT01405820|37882557|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
16883558|NCT01405820|37882558|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
16883559|NCT01405820|37882559|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
16883560|NCT01405820|37882560|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
16883561|NCT01405820|37882555|FG000|Randomized Treatment Period|Death|0|||
16883562|NCT01405820|37882556|FG001|Randomized Treatment Period|Death|0|||
16883563|NCT01405820|37882557|FG002|Randomized Treatment Period|Death|0|||
16883564|NCT01405820|37882558|FG003|Randomized Treatment Period|Death|1|||
16883565|NCT01405820|37882559|FG004|Randomized Treatment Period|Death|0|||
16883566|NCT01405820|37882560|FG005|Randomized Treatment Period|Death|0|||
16883567|NCT01405820|37882555|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16883568|NCT01405820|37882556|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16883569|NCT01405820|37882557|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16883570|NCT01405820|37882558|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
16883571|NCT01405820|37882559|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16883572|NCT01405820|37882560|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16883573|NCT01405820|37882555|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
16883574|NCT01405820|37882556|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
16883575|NCT01405820|37882557|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
16883576|NCT01405820|37882558|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
16883577|NCT01405820|37882559|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
16883578|NCT01405820|37882560|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
16883579|NCT01405820|37882555|FG000|Open-Label Treatment Period|Other|1|||
16883580|NCT01405820|37882556|FG001|Open-Label Treatment Period|Other|1|||
16883581|NCT01405820|37882557|FG002|Open-Label Treatment Period|Other|1|||
16883582|NCT01405820|37882558|FG003|Open-Label Treatment Period|Other|1|||
16883583|NCT01405820|37882559|FG004|Open-Label Treatment Period|Other|1|||
16883584|NCT01405820|37882560|FG005|Open-Label Treatment Period|Other|1|||
16883585|NCT01405820|37882555|FG000|Open-Label Treatment Period|Physician Decision|0|||
16883586|NCT01405820|37882556|FG001|Open-Label Treatment Period|Physician Decision|0|||
16883587|NCT01405820|37882557|FG002|Open-Label Treatment Period|Physician Decision|1|||
16883588|NCT01405820|37882558|FG003|Open-Label Treatment Period|Physician Decision|2|||
16883589|NCT01405820|37882559|FG004|Open-Label Treatment Period|Physician Decision|1|||
16883590|NCT01405820|37882560|FG005|Open-Label Treatment Period|Physician Decision|0|||
16883591|NCT01405820|37882555|FG000|Open-Label Treatment Period|Adverse Event|0|||
16883592|NCT01405820|37882556|FG001|Open-Label Treatment Period|Adverse Event|0|||
16883593|NCT01405820|37882557|FG002|Open-Label Treatment Period|Adverse Event|0|||
16883594|NCT01405820|37882558|FG003|Open-Label Treatment Period|Adverse Event|1|||
16883595|NCT01405820|37882559|FG004|Open-Label Treatment Period|Adverse Event|0|||
16883596|NCT01405820|37882560|FG005|Open-Label Treatment Period|Adverse Event|0|||
16883597|NCT01405742|37882589|FG000|Overall Study|Lost to Follow-up|1|||
16883598|NCT01405742|37882590|FG001|Overall Study|Lost to Follow-up|0|||
16883599|NCT01425632|37882619|FG000|Overall Study|Adverse Event|0|||
16883600|NCT01425632|37882620|FG001|Overall Study|Adverse Event|1|||
16883601|NCT01425632|37882621|FG002|Overall Study|Adverse Event|1|||
16883602|NCT01425632|37882619|FG000|Overall Study|Physician Decision|1|||
16883603|NCT01425632|37882620|FG001|Overall Study|Physician Decision|0|||
16883604|NCT01425632|37882621|FG002|Overall Study|Physician Decision|0|||
16883605|NCT01425632|37882619|FG000|Overall Study|Protocol Violation|0|||
16883606|NCT01425632|37882620|FG001|Overall Study|Protocol Violation|0|||
16883607|NCT01425632|37882621|FG002|Overall Study|Protocol Violation|2|||
16883608|NCT01425632|37882619|FG000|Overall Study|Withdrawal by Subject|0|||
16883609|NCT01425632|37882620|FG001|Overall Study|Withdrawal by Subject|0|||
16883610|NCT01425632|37882621|FG002|Overall Study|Withdrawal by Subject|1|||
16883611|NCT01405508|37882658|FG000|Overall Study|AE, non-serious non-fatal|1|||
16883612|NCT01405508|37882659|FG001|Overall Study|AE, non-serious non-fatal|1|||
16883613|NCT01405508|37882660|FG002|Overall Study|AE, non-serious non-fatal|0|||
16883614|NCT01405508|37882661|FG003|Overall Study|AE, non-serious non-fatal|0|||
16883615|NCT01405196|37882797|FG000|Overall Study|Study Terminated by Sponsor|0|||
16883616|NCT01405196|37882798|FG001|Overall Study|Study Terminated by Sponsor|0|||
16883617|NCT01405196|37882799|FG002|Overall Study|Study Terminated by Sponsor|9|||
16883618|NCT01405196|37882800|FG003|Overall Study|Study Terminated by Sponsor|0|||
16883619|NCT01405196|37882797|FG000|Overall Study|Other|2|||
16883620|NCT01405196|37882798|FG001|Overall Study|Other|2|||
16883621|NCT01405196|37882799|FG002|Overall Study|Other|5|||
16883622|NCT01405196|37882800|FG003|Overall Study|Other|0|||
16883623|NCT01405196|37882797|FG000|Overall Study|Withdrawal by Subject|4|||
16883624|NCT01405196|37882798|FG001|Overall Study|Withdrawal by Subject|6|||
16883625|NCT01405196|37882799|FG002|Overall Study|Withdrawal by Subject|3|||
16883626|NCT01405196|37882800|FG003|Overall Study|Withdrawal by Subject|6|||
16883627|NCT01405196|37882797|FG000|Overall Study|Adverse Event|2|||
16883628|NCT01405196|37882798|FG001|Overall Study|Adverse Event|2|||
16883629|NCT01405196|37882799|FG002|Overall Study|Adverse Event|0|||
16883630|NCT01405196|37882800|FG003|Overall Study|Adverse Event|2|||
16883631|NCT01405196|37882797|FG000|Overall Study|Death|1|||
16883632|NCT01405196|37882798|FG001|Overall Study|Death|0|||
16883633|NCT01405196|37882799|FG002|Overall Study|Death|3|||
16883634|NCT01405196|37882800|FG003|Overall Study|Death|0|||
16883635|NCT01405196|37882797|FG000|Overall Study|Lost to Follow-up|2|||
16883636|NCT01405196|37882798|FG001|Overall Study|Lost to Follow-up|2|||
16883637|NCT01405196|37882799|FG002|Overall Study|Lost to Follow-up|3|||
16883638|NCT01405196|37882800|FG003|Overall Study|Lost to Follow-up|1|||
16883639|NCT01402700|37882850|FG000|Overall Study|Death|3|||
16883640|NCT01402700|37882850|FG000|Overall Study|Withdrawal by Subject|3|||
16883641|NCT01402700|37882850|FG000|Overall Study|Missed Visit|1|||
16883642|NCT01424930|37882972|FG000|Overall Study|Adverse Event|0|||
16883643|NCT01424930|37882973|FG001|Overall Study|Adverse Event|1|||
16883644|NCT01424930|37882972|FG000|Overall Study|Death|1|||
16883645|NCT01424930|37882973|FG001|Overall Study|Death|0|||
16883646|NCT01424930|37882972|FG000|Overall Study|Progressive Disease|3|||
16883647|NCT01424930|37882973|FG001|Overall Study|Progressive Disease|6|||
16883648|NCT01424930|37882972|FG000|Overall Study|Screen Failure|0|||
16883649|NCT01424930|37882973|FG001|Overall Study|Screen Failure|1|||
16883650|NCT01424930|37882972|FG000|Overall Study|Reason not specified|0|||
16883651|NCT01424930|37882973|FG001|Overall Study|Reason not specified|6|||
16883652|NCT01424306|37882988|FG000|Overall Study|Protocol Violation|0|||
16883653|NCT01424306|37882989|FG001|Overall Study|Protocol Violation|0|||
16883654|NCT01424306|37882990|FG002|Overall Study|Protocol Violation|0|||
16883655|NCT01424306|37882991|FG003|Overall Study|Protocol Violation|0|||
16883656|NCT01424306|37882992|FG004|Overall Study|Protocol Violation|1|||
16883657|NCT01424306|37882993|FG005|Overall Study|Protocol Violation|0|||
16883658|NCT01424228|37883037|FG000|Overall Study|Withdrawal by Subject|27|||
16883659|NCT01424228|37883038|FG001|Overall Study|Withdrawal by Subject|11|||
16883660|NCT01424228|37883037|FG000|Overall Study|Adverse Event|10|||
16883661|NCT01424228|37883038|FG001|Overall Study|Adverse Event|14|||
16785704|NCT01984684|37725853|FG001|Overall Study|Withdrawal by Subject|9|||
16883662|NCT01424228|37883037|FG000|Overall Study|Sponsor's decision|9|||
16785705|NCT01984684|37725852|FG000|Overall Study|Lack of Efficacy|3|||
16785706|NCT01984684|37725853|FG001|Overall Study|Lack of Efficacy|6|||
16785707|NCT01984684|37725852|FG000|Overall Study|Physician Decision|4|||
16785708|NCT01984684|37725853|FG001|Overall Study|Physician Decision|2|||
16785709|NCT01984684|37725852|FG000|Overall Study|Protocol Violation|4|||
16785710|NCT01984684|37725853|FG001|Overall Study|Protocol Violation|2|||
16785711|NCT01984684|37725852|FG000|Overall Study|Death|0|||
16785712|NCT01984684|37725853|FG001|Overall Study|Death|1|||
16785713|NCT01984684|37725852|FG000|Overall Study|Noncompliance with study drug|2|||
16785714|NCT01984684|37725853|FG001|Overall Study|Noncompliance with study drug|1|||
16785715|NCT01984684|37725852|FG000|Overall Study|Subject incarcerated|1|||
16785716|NCT01984684|37725853|FG001|Overall Study|Subject incarcerated|0|||
16785717|NCT01984684|37725852|FG000|Overall Study|Study drug not available at site|1|||
16785718|NCT01984684|37725853|FG001|Overall Study|Study drug not available at site|1|||
16785719|NCT01984684|37725852|FG000|Overall Study|Subject had inadequate IV access|0|||
16785720|NCT01984684|37725853|FG001|Overall Study|Subject had inadequate IV access|1|||
16883663|NCT01424228|37883038|FG001|Overall Study|Sponsor's decision|12|||
16883664|NCT01424228|37883037|FG000|Overall Study|Lack of Efficacy|5|||
16883665|NCT01424228|37883038|FG001|Overall Study|Lack of Efficacy|7|||
16883666|NCT01424228|37883037|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
16883667|NCT01424228|37883038|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
16883668|NCT01424228|37883037|FG000|Overall Study|Non-compliance|2|||
16883669|NCT01424228|37883038|FG001|Overall Study|Non-compliance|0|||
16883670|NCT01424228|37883037|FG000|Overall Study|Worsening of symptoms|1|||
16883671|NCT01424228|37883038|FG001|Overall Study|Worsening of symptoms|0|||
16883672|NCT01424228|37883037|FG000|Overall Study|Unplanned journey|0|||
16883673|NCT01424228|37883038|FG001|Overall Study|Unplanned journey|1|||
16883674|NCT01423916|37883047|FG000|Overall Study|Adverse Event|5|||
16883675|NCT01423916|37883048|FG001|Overall Study|Adverse Event|9|||
16883676|NCT01423916|37883049|FG002|Overall Study|Adverse Event|2|||
16883677|NCT01423916|37883047|FG000|Overall Study|Met Withdrawal Criteria|1|||
16883678|NCT01423916|37883048|FG001|Overall Study|Met Withdrawal Criteria|1|||
16883679|NCT01423916|37883049|FG002|Overall Study|Met Withdrawal Criteria|1|||
16883680|NCT01423916|37883047|FG000|Overall Study|Physician Decision|1|||
16883681|NCT01423916|37883048|FG001|Overall Study|Physician Decision|0|||
16883682|NCT01423916|37883049|FG002|Overall Study|Physician Decision|1|||
16883683|NCT01423916|37883047|FG000|Overall Study|Withdrawal by Subject|3|||
16883684|NCT01423916|37883048|FG001|Overall Study|Withdrawal by Subject|10|||
16883685|NCT01423916|37883049|FG002|Overall Study|Withdrawal by Subject|3|||
16883686|NCT01423916|37883047|FG000|Overall Study|Protocol Deviation|1|||
16883687|NCT01423916|37883048|FG001|Overall Study|Protocol Deviation|0|||
16883688|NCT01423916|37883049|FG002|Overall Study|Protocol Deviation|0|||
16883689|NCT01423604|37883168|FG000|Safety Run-In|Adverse Event|3|||
16883690|NCT01423604|37883169|FG001|Safety Run-In|Adverse Event|0|||
16883691|NCT01423604|37883168|FG000|Safety Run-In|Death|1|||
16883692|NCT01423604|37883169|FG001|Safety Run-In|Death|0|||
16883693|NCT01423604|37883168|FG000|Safety Run-In|Physician Decision|1|||
16883694|NCT01423604|37883169|FG001|Safety Run-In|Physician Decision|0|||
16883695|NCT01423604|37883168|FG000|Safety Run-In|Disease progression|3|||
16883696|NCT01423604|37883169|FG001|Safety Run-In|Disease progression|0|||
16883697|NCT01423604|37883168|FG000|Safety Run-In|Patient decision|1|||
16883698|NCT01423604|37883169|FG001|Safety Run-In|Patient decision|0|||
16883699|NCT01423604|37883168|FG000|Randomized|Adverse Event|4|||
16883700|NCT01423604|37883169|FG001|Randomized|Adverse Event|10|||
16883701|NCT01423604|37883168|FG000|Randomized|Death|1|||
16883702|NCT01423604|37883169|FG001|Randomized|Death|0|||
16883703|NCT01423604|37883168|FG000|Randomized|Physician Decision|16|||
16883704|NCT01423604|37883169|FG001|Randomized|Physician Decision|13|||
16883705|NCT01423604|37883168|FG000|Randomized|Other - unspecified|37|||
16883706|NCT01423604|37883169|FG001|Randomized|Other - unspecified|31|||
16883707|NCT01423604|37883168|FG000|Randomized|Patient decision|5|||
16883708|NCT01423604|37883169|FG001|Randomized|Patient decision|9|||
16883709|NCT01402544|37883185|FG000|Overall Study|Withdrawal by Subject|6|||
16883710|NCT01401842|37883191|FG000|Overall Study|Withdrawal by Subject|3|||
16883711|NCT01401842|37883192|FG001|Overall Study|Withdrawal by Subject|2|||
16883712|NCT01401842|37883191|FG000|Overall Study|academic reason|4|||
16883713|NCT01401842|37883192|FG001|Overall Study|academic reason|1|||
16883714|NCT01401842|37883191|FG000|Overall Study|changed companies|20|||
16883715|NCT01401842|37883192|FG001|Overall Study|changed companies|34|||
16883716|NCT01401842|37883191|FG000|Overall Study|discharged from US Army|3|||
16883717|NCT01401842|37883192|FG001|Overall Study|discharged from US Army|4|||
16883718|NCT01401842|37883191|FG000|Overall Study|invalid follow-up strength data|1|||
16883719|NCT01401842|37883192|FG001|Overall Study|invalid follow-up strength data|4|||
16883720|NCT01401842|37883191|FG000|Overall Study|on profile|9|||
16883721|NCT01401842|37883192|FG001|Overall Study|on profile|5|||
16883722|NCT01401842|37883191|FG000|Overall Study|other/unknown|28|||
16883723|NCT01401842|37883192|FG001|Overall Study|other/unknown|17|||
16883724|NCT01422824|37883198|FG000|Overall Study|Case record form not evaluated|1|||
16883725|NCT01422824|37883198|FG000|Overall Study|Lost to Follow-up|37|||
16883726|NCT01401530|37883261|FG000|Overall Study|Disease Progression|1|||
16883727|NCT01401530|37883262|FG001|Overall Study|Disease Progression|2|||
16883728|NCT01401530|37883263|FG002|Overall Study|Disease Progression|1|||
16883729|NCT01401530|37883261|FG000|Overall Study|Adverse Event|1|||
16883730|NCT01401530|37883262|FG001|Overall Study|Adverse Event|1|||
16883731|NCT01401530|37883263|FG002|Overall Study|Adverse Event|1|||
16883732|NCT01401530|37883261|FG000|Overall Study|Participant Choice|1|||
16883733|NCT01401530|37883262|FG001|Overall Study|Participant Choice|2|||
16883734|NCT01401530|37883263|FG002|Overall Study|Participant Choice|1|||
16883735|NCT01401530|37883261|FG000|Overall Study|Physician Decision|0|||
16883736|NCT01401530|37883262|FG001|Overall Study|Physician Decision|1|||
16883737|NCT01401530|37883263|FG002|Overall Study|Physician Decision|0|||
16883738|NCT01387022|37883275|FG000|Overall Study|Death|1|||
16883739|NCT01387022|37883276|FG001|Overall Study|Death|1|||
16883740|NCT01387022|37883275|FG000|Overall Study|Lost to Follow-up|0|||
16883741|NCT01387022|37883276|FG001|Overall Study|Lost to Follow-up|3|||
16883742|NCT01386944|37883302|FG000|Overall Study|Adverse Event|26|||
16883743|NCT01386944|37883302|FG000|Overall Study|Lack of Efficacy|14|||
16883744|NCT01386944|37883302|FG000|Overall Study|Lost to Follow-up|8|||
16883745|NCT01386944|37883302|FG000|Overall Study|Unspecified reason|8|||
16883746|NCT01386788|37883313|FG000|Overall Study|Lost to Follow-up|2|||
16883747|NCT01386554|37883378|FG000|Overall Study|Lost to Follow-up|0|||
16883748|NCT01386554|37883379|FG001|Overall Study|Lost to Follow-up|0|||
16883749|NCT01386554|37883380|FG002|Overall Study|Lost to Follow-up|1|||
16883750|NCT01386554|37883378|FG000|Overall Study|Adverse Event|2|||
16883751|NCT01386554|37883379|FG001|Overall Study|Adverse Event|5|||
16883752|NCT01386554|37883380|FG002|Overall Study|Adverse Event|2|||
16883753|NCT01386554|37883378|FG000|Overall Study|Progressive disease|1|||
16883754|NCT01386554|37883379|FG001|Overall Study|Progressive disease|2|||
16883755|NCT01386554|37883380|FG002|Overall Study|Progressive disease|2|||
16883756|NCT01386554|37883378|FG000|Overall Study|Administration of live vaccines|0|||
16883757|NCT01386554|37883379|FG001|Overall Study|Administration of live vaccines|1|||
16883758|NCT01386554|37883380|FG002|Overall Study|Administration of live vaccines|0|||
16883759|NCT01386554|37883378|FG000|Overall Study|Investigator discretion|0|||
16883760|NCT01386554|37883379|FG001|Overall Study|Investigator discretion|0|||
16883761|NCT01386554|37883380|FG002|Overall Study|Investigator discretion|1|||
16883762|NCT01386554|37883378|FG000|Overall Study|Reason not collected|0|||
16883763|NCT01386554|37883379|FG001|Overall Study|Reason not collected|1|||
16883764|NCT01386554|37883380|FG002|Overall Study|Reason not collected|0|||
16883765|NCT01386008|37883405|FG000|Overall Study|exited w/o incident /study discontinued|17|||
16883766|NCT01386008|37883405|FG000|Overall Study|Adverse Event|3|||
16883767|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
16883768|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
16883769|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
16883770|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
16883771|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
16883772|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
16883773|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
16883774|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
16883775|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
16883776|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
16883777|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
16883778|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
16883779|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
16883780|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
16883781|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
16883782|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
16883783|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
16883784|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
16883785|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
16883786|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
16883787|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
16883788|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
16883789|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
16883790|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
16883791|NCT01421342|37883562|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
16883792|NCT01421342|37883563|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
16883793|NCT01421342|37883564|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
16883794|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
16883795|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
16883796|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
16883797|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
16883798|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
16883799|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
16883800|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
16883801|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
16883802|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
16883803|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
16883804|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
16883805|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
16883806|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
16883807|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
16883808|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
16883809|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
16883810|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
16883811|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
17002291|NCT00844857|38146392|FG000|Overall Study|Entry Criteria Not Met|0|||
16883812|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
16883813|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
16883814|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
16883815|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
16883816|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
16883817|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
16883818|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
16883819|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
16883820|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
16883821|NCT01421342|37883562|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
16883822|NCT01421342|37883563|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
16883823|NCT01421342|37883564|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
16883824|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
16883825|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
16883826|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
16883827|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
16883828|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
16883829|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
16883830|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
16883831|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
16883832|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
16883833|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
16883834|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
16883835|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
16883836|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
16883837|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
16883838|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
16883839|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
16883840|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
16883841|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
16883842|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
16883843|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
16883844|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
16883845|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
16883846|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
16883847|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
16883848|NCT01421342|37883562|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
16883849|NCT01421342|37883563|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
16883850|NCT01421342|37883564|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
16883851|NCT01384760|37883587|FG000|Overall Study|Lost to Follow-up|0|||
16883852|NCT01384760|37883588|FG001|Overall Study|Lost to Follow-up|6|||
16883853|NCT01384760|37883587|FG000|Overall Study|Protocol Violation|16|||
16883854|NCT01384760|37883588|FG001|Overall Study|Protocol Violation|0|||
16883855|NCT01384292|37883628|FG000|Part B|Severe non-compliance to protocol|1|||
16883856|NCT01384292|37883629|FG001|Part B|Severe non-compliance to protocol|0|||
16883857|NCT01384292|37883630|FG002|Part B|Severe non-compliance to protocol|0|||
16883858|NCT01401452|37883640|FG000|Overall Study|Adverse reaction|9|||
16883859|NCT01401452|37883640|FG000|Overall Study|Lost to Follow-up|12|||
16883860|NCT01401452|37883640|FG000|Overall Study|Lack of Efficacy|30|||
16883861|NCT01401452|37883640|FG000|Overall Study|Participant developed breast cancer|1|||
16883862|NCT01401452|37883640|FG000|Overall Study|Tx stopped due to financial reasons|1|||
16883863|NCT01401452|37883640|FG000|Overall Study|Tx stopped by psychiatrist|1|||
16883864|NCT01401452|37883640|FG000|Overall Study|No more visits within the 36 wk followup|4|||
16883865|NCT01401452|37883640|FG000|Overall Study|Subject did not come to follow up visits|2|||
16883866|NCT01401452|37883640|FG000|Overall Study|Subject didn't return for routine visits|1|||
17002292|NCT00844857|38146393|FG001|Overall Study|Entry Criteria Not Met|1|||
17191855|NCT02038946|38344784|FG000|Overall Study|Lost to Follow-up|2|||
17191856|NCT02038946|38344784|FG000|Overall Study|Other reasons|2|||
17191857|NCT03143829|38344790|FG000|Overall Study|Withdrawal by Subject|2|||
17191858|NCT03143829|38344791|FG001|Overall Study|Withdrawal by Subject|5|||
17191859|NCT03143829|38344790|FG000|Overall Study|Lost to Follow-up|0|||
17191860|NCT03143829|38344791|FG001|Overall Study|Lost to Follow-up|2|||
17191861|NCT03143829|38344790|FG000|Overall Study|Death|1|||
17191862|NCT03143829|38344791|FG001|Overall Study|Death|1|||
17191863|NCT03143829|38344790|FG000|Overall Study|changed treatment, no longer eligible|2|||
17191864|NCT03143829|38344791|FG001|Overall Study|changed treatment, no longer eligible|2|||
17002293|NCT00844857|38146392|FG000|Overall Study|Lost to Follow-up|2|||
16883867|NCT01401452|37883640|FG000|Overall Study|Subject moved to another city|1|||
16883868|NCT01401452|37883640|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
16883869|NCT01401452|37883640|FG000|Overall Study|Psoriatic arthritis|1|||
16883870|NCT01401452|37883640|FG000|Overall Study|Participant stopped Tx|2|||
16883871|NCT01401452|37883640|FG000|Overall Study|Discontinuation for personal reasons|1|||
16883872|NCT01401452|37883640|FG000|Overall Study|Treatment failure|1|||
16883873|NCT01401452|37883640|FG000|Overall Study|Unsatisfactory output|1|||
16883874|NCT01401452|37883640|FG000|Overall Study|Subject withdrew because of Tx success|1|||
16883875|NCT01401452|37883640|FG000|Overall Study|Subject chose to discontinue treatment|1|||
16883876|NCT01401452|37883640|FG000|Overall Study|Participant withdrew consent|1|||
16883877|NCT01401062|37883675|FG000|Overall Study|Death|9|||
16883878|NCT01401062|37883676|FG001|Overall Study|Death|7|||
16883879|NCT01401062|37883675|FG000|Overall Study|Physician Decision|1|||
16883880|NCT01401062|37883676|FG001|Overall Study|Physician Decision|0|||
16883881|NCT01401062|37883675|FG000|Overall Study|Withdrawal by Subject|1|||
16883882|NCT01401062|37883676|FG001|Overall Study|Withdrawal by Subject|1|||
16883883|NCT01400516|37883709|FG000|Primary Trial|Withdrawal by Subject|0|||
16883884|NCT01400516|37883710|FG001|Primary Trial|Withdrawal by Subject|2|||
16883885|NCT01383356|37883716|FG000|Period 1|Adverse Event|5|||
16883886|NCT01383356|37883717|FG001|Period 1|Adverse Event|3|||
16883887|NCT01383356|37883716|FG000|Period 1|Non-compliance|3|||
16883888|NCT01383356|37883717|FG001|Period 1|Non-compliance|0|||
16883889|NCT01383356|37883716|FG000|Period 1|Out of Range Mid-study-Test|0|||
16883890|NCT01383356|37883717|FG001|Period 1|Out of Range Mid-study-Test|1|||
16883891|NCT01383356|37883716|FG000|Period 1|Personal|0|||
16883892|NCT01383356|37883717|FG001|Period 1|Personal|2|||
16883893|NCT01399736|37883768|FG000|Overall Study|Withdrawal by Subject|4|||
16883894|NCT01399736|37883769|FG001|Overall Study|Withdrawal by Subject|2|||
16883895|NCT01399736|37883768|FG000|Overall Study|Lost to Follow-up|0|||
16883896|NCT01399736|37883769|FG001|Overall Study|Lost to Follow-up|2|||
16883897|NCT01381874|37883902|FG000|Overall Study|Lost to Follow-up|1|||
16883898|NCT01381874|37883903|FG001|Overall Study|Lost to Follow-up|1|||
16883899|NCT01381874|37883904|FG002|Overall Study|Lost to Follow-up|0|||
16883900|NCT01381874|37883902|FG000|Overall Study|Withdrawal by Subject|9|||
16883901|NCT01381874|37883903|FG001|Overall Study|Withdrawal by Subject|10|||
16883902|NCT01381874|37883904|FG002|Overall Study|Withdrawal by Subject|9|||
16883903|NCT01381874|37883902|FG000|Overall Study|Other|67|||
16883904|NCT01381874|37883903|FG001|Overall Study|Other|52|||
16883905|NCT01381874|37883904|FG002|Overall Study|Other|67|||
16883906|NCT01399190|37883912|FG000|Overall Study|Not Eligible for Final Analysis|5|||
16883907|NCT01399190|37883912|FG000|Overall Study|Adverse Event|8|||
16883908|NCT01399190|37883912|FG000|Overall Study|Participant's Request|5|||
16883909|NCT01399190|37883912|FG000|Overall Study|Physician Decision|2|||
16883910|NCT01381718|37883930|FG000|Overall Study|Withdrawal by Subject|2|||
16883911|NCT01381718|37883931|FG001|Overall Study|Withdrawal by Subject|5|||
16883912|NCT01381718|37883930|FG000|Overall Study|Lost to Follow-up|3|||
16883913|NCT01381718|37883931|FG001|Overall Study|Lost to Follow-up|5|||
16883914|NCT01381718|37883930|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
16883915|NCT01381718|37883931|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
16883916|NCT01398956|37883950|FG000|Overall Study|Withdrawal by Subject|4|||
16883917|NCT01398956|37883950|FG000|Overall Study|AE, non-serious non-fatal|4|||
16883918|NCT01398956|37883950|FG000|Overall Study|Withdrawal Criteria No.3|1|||
16883919|NCT01398956|37883950|FG000|Overall Study|Subject moved a long distance|1|||
16883920|NCT01381562|37883976|FG000|Overall Study|Adverse Event|0|||
16883921|NCT01381562|37883977|FG001|Overall Study|Adverse Event|1|||
16883922|NCT01381562|37883978|FG002|Overall Study|Adverse Event|0|||
16883923|NCT01381016|37884001|FG000|Overall Study|Lost to Follow-up|1|||
16883924|NCT01381016|37884002|FG001|Overall Study|Lost to Follow-up|1|||
16883925|NCT01381016|37884001|FG000|Overall Study|Screen Failure|2|||
16883926|NCT01381016|37884002|FG001|Overall Study|Screen Failure|2|||
16883927|NCT01381016|37884001|FG000|Overall Study|Withdrawal by Subject|0|||
16883928|NCT01381016|37884002|FG001|Overall Study|Withdrawal by Subject|1|||
16883929|NCT01381016|37884001|FG000|Overall Study|Physician Decision|0|||
16883930|NCT01381016|37884002|FG001|Overall Study|Physician Decision|2|||
16883931|NCT01398410|37884029|FG000|Overall Study|Adverse Event|12|||
16883932|NCT01398410|37884030|FG001|Overall Study|Adverse Event|16|||
16883933|NCT01398410|37884029|FG000|Overall Study|Participants Choice|8|||
16883934|NCT01398410|37884030|FG001|Overall Study|Participants Choice|11|||
16883935|NCT01398410|37884029|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
16883936|NCT01398410|37884030|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
16883937|NCT01398410|37884029|FG000|Overall Study|Other|36|||
16883938|NCT01398410|37884030|FG001|Overall Study|Other|29|||
16883939|NCT01380782|37884096|FG000|Overall Study|Adverse Event|0|||
16883940|NCT01380782|37884097|FG001|Overall Study|Adverse Event|1|||
16883941|NCT01380782|37884098|FG002|Overall Study|Adverse Event|0|||
16883942|NCT01380782|37884099|FG003|Overall Study|Adverse Event|0|||
16883943|NCT01380782|37884096|FG000|Overall Study|Death|1|||
16883944|NCT01380782|37884097|FG001|Overall Study|Death|0|||
16883945|NCT01380782|37884098|FG002|Overall Study|Death|0|||
16883946|NCT01380782|37884099|FG003|Overall Study|Death|0|||
16883947|NCT01380782|37884096|FG000|Overall Study|Lack of Efficacy|10|||
16883948|NCT01380782|37884097|FG001|Overall Study|Lack of Efficacy|9|||
16883949|NCT01380782|37884098|FG002|Overall Study|Lack of Efficacy|10|||
16883950|NCT01380782|37884099|FG003|Overall Study|Lack of Efficacy|3|||
16883951|NCT01380782|37884096|FG000|Overall Study|Physician Decision|1|||
16883952|NCT01380782|37884097|FG001|Overall Study|Physician Decision|0|||
16883953|NCT01380782|37884098|FG002|Overall Study|Physician Decision|0|||
16883954|NCT01380782|37884099|FG003|Overall Study|Physician Decision|0|||
16883955|NCT01380782|37884096|FG000|Overall Study|Withdrawal by Subject|0|||
16883956|NCT01380782|37884097|FG001|Overall Study|Withdrawal by Subject|0|||
16883957|NCT01380782|37884098|FG002|Overall Study|Withdrawal by Subject|1|||
16883958|NCT01380782|37884099|FG003|Overall Study|Withdrawal by Subject|1|||
16883959|NCT01398176|37884113|FG000|Overall Study|Lost to Follow-up|1|||
16883960|NCT01398176|37884114|FG001|Overall Study|Lost to Follow-up|3|||
16883961|NCT01398176|37884113|FG000|Overall Study|Physician Decision|2|||
16883962|NCT01398176|37884114|FG001|Overall Study|Physician Decision|3|||
16883963|NCT01397786|37884167|FG000|Phase A|Lost to Follow-up|0|||
16883964|NCT01397786|37884168|FG001|Phase A|Lost to Follow-up|0|||
16883965|NCT01397786|37884169|FG002|Phase A|Lost to Follow-up|6|||
16883966|NCT01397786|37884167|FG000|Phase A|Adverse Event|0|||
16883967|NCT01397786|37884168|FG001|Phase A|Adverse Event|0|||
16883968|NCT01397786|37884169|FG002|Phase A|Adverse Event|8|||
16883969|NCT01397786|37884167|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
16883970|NCT01397786|37884168|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
16883971|NCT01397786|37884169|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
16883972|NCT01397786|37884167|FG000|Phase A|Physician Decision|0|||
16883973|NCT01397786|37884168|FG001|Phase A|Physician Decision|0|||
16883974|NCT01397786|37884169|FG002|Phase A|Physician Decision|1|||
16883975|NCT01397786|37884167|FG000|Phase A|Withdrawal by Subject|0|||
16883976|NCT01397786|37884168|FG001|Phase A|Withdrawal by Subject|0|||
16883977|NCT01397786|37884169|FG002|Phase A|Withdrawal by Subject|5|||
16883978|NCT01397786|37884167|FG000|Phase A|Lack of Efficacy|0|||
16883979|NCT01397786|37884168|FG001|Phase A|Lack of Efficacy|0|||
16883980|NCT01397786|37884169|FG002|Phase A|Lack of Efficacy|1|||
16883981|NCT01397786|37884167|FG000|Phase B|Lost to Follow-up|22|||
16883982|NCT01397786|37884168|FG001|Phase B|Lost to Follow-up|12|||
16883983|NCT01397786|37884169|FG002|Phase B|Lost to Follow-up|22|||
16883984|NCT01397786|37884167|FG000|Phase B|Adverse Event|109|||
16883985|NCT01397786|37884168|FG001|Phase B|Adverse Event|23|||
16883986|NCT01397786|37884169|FG002|Phase B|Adverse Event|27|||
16883987|NCT01397786|37884167|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
16883988|NCT01397786|37884168|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
16883989|NCT01397786|37884169|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
16883990|NCT01397786|37884167|FG000|Phase B|Physician Decision|9|||
16883991|NCT01397786|37884168|FG001|Phase B|Physician Decision|1|||
16883992|NCT01397786|37884169|FG002|Phase B|Physician Decision|3|||
16883993|NCT01397786|37884167|FG000|Phase B|Withdrawal by Subject|102|||
16883994|NCT01397786|37884168|FG001|Phase B|Withdrawal by Subject|45|||
16883995|NCT01397786|37884169|FG002|Phase B|Withdrawal by Subject|30|||
16883996|NCT01397786|37884167|FG000|Phase B|Protocol Deviation|1|||
16883997|NCT01397786|37884168|FG001|Phase B|Protocol Deviation|2|||
16883998|NCT01397786|37884169|FG002|Phase B|Protocol Deviation|4|||
16883999|NCT01397786|37884167|FG000|Phase B|Lack of Efficacy|22|||
16884000|NCT01397786|37884168|FG001|Phase B|Lack of Efficacy|7|||
16884001|NCT01397786|37884169|FG002|Phase B|Lack of Efficacy|14|||
16884002|NCT01397552|37884228|FG000|Overall Study|Adverse Event|1|||
16884003|NCT01397552|37884229|FG001|Overall Study|Adverse Event|0|||
16884004|NCT01397552|37884228|FG000|Overall Study|Withdrawal by Subject|2|||
16884005|NCT01397552|37884229|FG001|Overall Study|Withdrawal by Subject|1|||
16884006|NCT01397162|37884249|FG000|Overall Study|Adverse Event|4|||
16884007|NCT01397162|37884250|FG001|Overall Study|Adverse Event|0|||
16884008|NCT01397162|37884251|FG002|Overall Study|Adverse Event|0|||
16884009|NCT01397162|37884252|FG003|Overall Study|Adverse Event|0|||
16884010|NCT01397162|37884253|FG004|Overall Study|Adverse Event|0|||
16884011|NCT01397162|37884249|FG000|Overall Study|Not yet defined|3|||
16884012|NCT01397162|37884250|FG001|Overall Study|Not yet defined|4|||
16884013|NCT01397162|37884251|FG002|Overall Study|Not yet defined|3|||
17095311|NCT00261846|38234550|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
17095312|NCT00261846|38234551|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
16884014|NCT01397162|37884252|FG003|Overall Study|Not yet defined|5|||
16884015|NCT01397162|37884253|FG004|Overall Study|Not yet defined|3|||
16884016|NCT01397084|37884286|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
16884017|NCT01397084|37884286|FG000|Overall Study|Protocol Violation|2|||
16884018|NCT01397084|37884286|FG000|Overall Study|Adverse Event|2|||
16884019|NCT01397084|37884286|FG000|Overall Study|Withdrawal by Subject|1|||
16884020|NCT01397084|37884286|FG000|Overall Study|Lost to Follow-up|1|||
16884021|NCT01397084|37884286|FG000|Overall Study|Used other proton pump inhibitor|1|||
16884022|NCT01396148|37884326|FG000|Overall Study|Patient Decision|1|||
16884023|NCT01396070|37884359|FG000|Overall Study|Withdrawal by Subject|2|||
16884024|NCT01396070|37884359|FG000|Overall Study|Death|2|||
16884025|NCT01396070|37884359|FG000|Overall Study|Adverse Event|8|||
16884026|NCT01396070|37884359|FG000|Overall Study|Physician Decision|3|||
16884027|NCT01396070|37884359|FG000|Overall Study|Lack of Efficacy|4|||
16884028|NCT01395914|37884376|FG000|Overall Study|Unrelated to study drug AE|6|||
16884029|NCT01395914|37884377|FG001|Overall Study|Unrelated to study drug AE|1|||
16884030|NCT01395914|37884376|FG000|Overall Study|Death|23|||
16884031|NCT01395914|37884377|FG001|Overall Study|Death|17|||
16884032|NCT01395914|37884376|FG000|Overall Study|Other|9|||
16884033|NCT01395914|37884377|FG001|Overall Study|Other|3|||
16884034|NCT01395914|37884376|FG000|Overall Study|Withdrawal by patient|27|||
16884035|NCT01395914|37884377|FG001|Overall Study|Withdrawal by patient|14|||
16884036|NCT01395914|37884376|FG000|Overall Study|Study drug-related AE|1|||
16884037|NCT01395914|37884377|FG001|Overall Study|Study drug-related AE|0|||
16884038|NCT01395914|37884376|FG000|Overall Study|Lost to Follow-up|6|||
16884039|NCT01395914|37884377|FG001|Overall Study|Lost to Follow-up|2|||
16884040|NCT01395758|37884639|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
16884041|NCT01395758|37884640|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16884042|NCT01395758|37884641|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
16884043|NCT01395524|37884695|FG000|Overall Study|Non-compliance with study schedule|1|||
16884044|NCT01395524|37884696|FG001|Overall Study|Non-compliance with study schedule|0|||
16884045|NCT01395524|37884697|FG002|Overall Study|Non-compliance with study schedule|1|||
16884046|NCT01395524|37884695|FG000|Overall Study|Lost to Follow-up|3|||
16884047|NCT01395524|37884696|FG001|Overall Study|Lost to Follow-up|1|||
16884048|NCT01395524|37884697|FG002|Overall Study|Lost to Follow-up|1|||
16884049|NCT01395524|37884695|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
16884050|NCT01395524|37884696|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
16884051|NCT01395524|37884697|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
16884052|NCT01395524|37884695|FG000|Overall Study|Severe noncompliance with protocol|1|||
16884053|NCT01395524|37884696|FG001|Overall Study|Severe noncompliance with protocol|0|||
16884054|NCT01395524|37884697|FG002|Overall Study|Severe noncompliance with protocol|0|||
16884055|NCT01395524|37884695|FG000|Overall Study|Adverse Event|4|||
16884056|NCT01395524|37884696|FG001|Overall Study|Adverse Event|4|||
16884057|NCT01395524|37884697|FG002|Overall Study|Adverse Event|3|||
16884058|NCT01395524|37884695|FG000|Overall Study|Death|1|||
16884059|NCT01395524|37884696|FG001|Overall Study|Death|0|||
16884060|NCT01395524|37884697|FG002|Overall Study|Death|0|||
16884061|NCT01395524|37884695|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
16884062|NCT01395524|37884696|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16884063|NCT01395524|37884697|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16884064|NCT01395524|37884695|FG000|Overall Study|Withdrawal by Subject|4|||
16884065|NCT01395524|37884696|FG001|Overall Study|Withdrawal by Subject|8|||
16884066|NCT01395524|37884697|FG002|Overall Study|Withdrawal by Subject|8|||
16785721|NCT02694523|37725861|FG000|Part A|Adverse Event|7|||
16785722|NCT02694523|37725862|FG001|Part A|Adverse Event|3|||
16785723|NCT02694523|37725863|FG002|Part A|Adverse Event|0|||
16785724|NCT02694523|37725864|FG003|Part A|Adverse Event|0|||
16785725|NCT02694523|37725865|FG004|Part A|Adverse Event|0|||
16785726|NCT02694523|37725866|FG005|Part A|Adverse Event|0|||
16785727|NCT02694523|37725867|FG006|Part A|Adverse Event|0|||
16785728|NCT02694523|37725861|FG000|Part A|Protocol Violation|1|||
16785729|NCT02694523|37725862|FG001|Part A|Protocol Violation|0|||
16785730|NCT02694523|37725863|FG002|Part A|Protocol Violation|0|||
16785731|NCT02694523|37725864|FG003|Part A|Protocol Violation|0|||
16785732|NCT02694523|37725865|FG004|Part A|Protocol Violation|0|||
16785733|NCT02694523|37725866|FG005|Part A|Protocol Violation|0|||
16785734|NCT02694523|37725867|FG006|Part A|Protocol Violation|0|||
16785735|NCT02694523|37725861|FG000|Part A|Lost to Follow-up|1|||
16785736|NCT02694523|37725862|FG001|Part A|Lost to Follow-up|2|||
16785737|NCT02694523|37725863|FG002|Part A|Lost to Follow-up|0|||
16785738|NCT02694523|37725864|FG003|Part A|Lost to Follow-up|0|||
16785739|NCT02694523|37725865|FG004|Part A|Lost to Follow-up|0|||
16785740|NCT02694523|37725866|FG005|Part A|Lost to Follow-up|0|||
16785741|NCT02694523|37725867|FG006|Part A|Lost to Follow-up|0|||
16785742|NCT02694523|37725861|FG000|Part A|Withdrawal by Subject|3|||
16785743|NCT02694523|37725862|FG001|Part A|Withdrawal by Subject|1|||
16785744|NCT02694523|37725863|FG002|Part A|Withdrawal by Subject|0|||
16785745|NCT02694523|37725864|FG003|Part A|Withdrawal by Subject|0|||
16785746|NCT02694523|37725865|FG004|Part A|Withdrawal by Subject|0|||
16785747|NCT02694523|37725866|FG005|Part A|Withdrawal by Subject|0|||
16785748|NCT02694523|37725867|FG006|Part A|Withdrawal by Subject|0|||
16785749|NCT02694523|37725861|FG000|Part A|Other|1|||
16785750|NCT02694523|37725862|FG001|Part A|Other|1|||
16785751|NCT02694523|37725863|FG002|Part A|Other|0|||
16785752|NCT02694523|37725864|FG003|Part A|Other|0|||
16785753|NCT02694523|37725865|FG004|Part A|Other|0|||
16785754|NCT02694523|37725866|FG005|Part A|Other|0|||
16785755|NCT02694523|37725867|FG006|Part A|Other|0|||
16884067|NCT01395524|37884695|FG000|Overall Study|Did not receive treatment|1|||
16884068|NCT01395524|37884696|FG001|Overall Study|Did not receive treatment|1|||
16884069|NCT01395524|37884697|FG002|Overall Study|Did not receive treatment|3|||
16884070|NCT01395524|37884695|FG000|Overall Study|Subject had spinal surgery|0|||
16884071|NCT01395524|37884696|FG001|Overall Study|Subject had spinal surgery|0|||
16884072|NCT01395524|37884697|FG002|Overall Study|Subject had spinal surgery|1|||
16884073|NCT01395368|37884705|FG000|Overall Study|Physician Decision|14|||
16884074|NCT01395368|37884705|FG000|Overall Study|Withdrawal by Subject|2|||
16884075|NCT01394978|37884712|FG000|Overall Study|Withdrawal by Subject|2|||
16884076|NCT01394978|37884713|FG001|Overall Study|Withdrawal by Subject|4|||
16884077|NCT01394978|37884712|FG000|Overall Study|Lost to Follow-up|13|||
16884078|NCT01394978|37884713|FG001|Overall Study|Lost to Follow-up|20|||
16884079|NCT01394978|37884712|FG000|Overall Study|Death|6|||
16884080|NCT01394978|37884713|FG001|Overall Study|Death|7|||
16884081|NCT01394276|37884720|FG000|Overall Study|Related Adverse event (AEs)|15|||
16884082|NCT01394276|37884720|FG000|Overall Study|Not related AEs|9|||
16884083|NCT01394276|37884720|FG000|Overall Study|Remission of disease|2|||
16884084|NCT01394276|37884720|FG000|Overall Study|Insufficient therapeutic effect|17|||
16884085|NCT01394276|37884720|FG000|Overall Study|Insufficient compliance|9|||
16884086|NCT01394276|37884720|FG000|Overall Study|Lost to Follow-up|5|||
16884087|NCT01394276|37884720|FG000|Overall Study|Participant moved to another site|1|||
16884088|NCT01394276|37884720|FG000|Overall Study|Pregnancy|1|||
16884089|NCT01394276|37884720|FG000|Overall Study|unavailability of drug at the Hospital|2|||
16884090|NCT01394276|37884720|FG000|Overall Study|Symptoms of concurrent diseases|1|||
16884091|NCT00211172|37884820|FG000|Overall Study|Died or lost health plan eligibility|39|||
16884092|NCT00211172|37884821|FG001|Overall Study|Died or lost health plan eligibility|32|||
16884093|NCT00210626|37884872|FG000|Overall Study|Adverse Event|1|||
16884094|NCT00210626|37884873|FG001|Overall Study|Adverse Event|2|||
16884095|NCT00210626|37884872|FG000|Overall Study|Protocol Violation|1|||
16884096|NCT00210626|37884873|FG001|Overall Study|Protocol Violation|5|||
16884097|NCT00210626|37884872|FG000|Overall Study|Lost to Follow-up|11|||
16884098|NCT00210626|37884873|FG001|Overall Study|Lost to Follow-up|11|||
16884099|NCT00210626|37884872|FG000|Overall Study|Death|1|||
16884100|NCT00210626|37884873|FG001|Overall Study|Death|0|||
16884101|NCT00210626|37884872|FG000|Overall Study|Withdrawal by Subject|29|||
16884102|NCT00210626|37884873|FG001|Overall Study|Withdrawal by Subject|20|||
16884103|NCT00210626|37884872|FG000|Overall Study|Physician Decision|0|||
16884104|NCT00210626|37884873|FG001|Overall Study|Physician Decision|2|||
16884105|NCT00210626|37884872|FG000|Overall Study|Sponser Request|1|||
16884106|NCT00210626|37884873|FG001|Overall Study|Sponser Request|0|||
16884107|NCT00210626|37884872|FG000|Overall Study|Other|4|||
16884108|NCT00210626|37884873|FG001|Overall Study|Other|5|||
16884109|NCT00217022|37884895|FG000|Overall Study|Withdrawal by Subject|1|||
16884110|NCT00217022|37884896|FG001|Overall Study|Withdrawal by Subject|1|||
16884111|NCT00219284|37885243|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
16884112|NCT00219284|37885244|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
16884113|NCT00219284|37885243|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
16884114|NCT00219284|37885244|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
16884115|NCT00219284|37885243|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
16884116|NCT00219284|37885244|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
16884117|NCT00219284|37885243|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
16884118|NCT00219284|37885244|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
16884119|NCT00219284|37885243|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
16884120|NCT00219284|37885244|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
16884121|NCT00219284|37885243|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
16884122|NCT00219284|37885244|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
16884123|NCT00219284|37885243|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
16884124|NCT00219284|37885244|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
16884125|NCT00219284|37885243|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
16884126|NCT00219284|37885244|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
16884127|NCT00219284|37885243|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
16884128|NCT00219284|37885244|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
16884129|NCT00216476|37885383|FG000|Overall Study|Withdrawal by Subject|59|||
16884130|NCT00216476|37885384|FG001|Overall Study|Withdrawal by Subject|72|||
17095313|NCT00261846|38234540|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
17095314|NCT00261846|38234541|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
16884131|NCT00216476|37885385|FG002|Overall Study|Withdrawal by Subject|9|||
16884132|NCT00216476|37885383|FG000|Overall Study|Lost to Follow-up|10|||
16884133|NCT00216476|37885384|FG001|Overall Study|Lost to Follow-up|9|||
16884134|NCT00216476|37885385|FG002|Overall Study|Lost to Follow-up|1|||
16884135|NCT00216476|37885383|FG000|Overall Study|Adverse Event|6|||
16884136|NCT00216476|37885384|FG001|Overall Study|Adverse Event|10|||
16884137|NCT00216476|37885385|FG002|Overall Study|Adverse Event|1|||
16884138|NCT00216476|37885383|FG000|Overall Study|Lack of Efficacy|4|||
16884139|NCT00216476|37885384|FG001|Overall Study|Lack of Efficacy|3|||
16884140|NCT00216476|37885385|FG002|Overall Study|Lack of Efficacy|0|||
16884141|NCT00216476|37885383|FG000|Overall Study|Death|2|||
16884142|NCT00216476|37885384|FG001|Overall Study|Death|0|||
16884143|NCT00216476|37885385|FG002|Overall Study|Death|0|||
16884144|NCT00216476|37885383|FG000|Overall Study|Pregnancy|0|||
16884145|NCT00216476|37885384|FG001|Overall Study|Pregnancy|1|||
16884146|NCT00216476|37885385|FG002|Overall Study|Pregnancy|1|||
16884147|NCT00216476|37885383|FG000|Overall Study|Other|0|||
16884148|NCT00216476|37885384|FG001|Overall Study|Other|0|||
16884149|NCT00216476|37885385|FG002|Overall Study|Other|1|||
16884150|NCT00216476|37885383|FG000|Overall Study|Refuses Injection|11|||
16884151|NCT00216476|37885384|FG001|Overall Study|Refuses Injection|0|||
16884152|NCT00216476|37885385|FG002|Overall Study|Refuses Injection|0|||
16884153|NCT00216476|37885383|FG000|Overall Study|No Further Need for Treatment|3|||
16884154|NCT00216476|37885384|FG001|Overall Study|No Further Need for Treatment|4|||
16884155|NCT00216476|37885385|FG002|Overall Study|No Further Need for Treatment|1|||
16884156|NCT00216476|37885383|FG000|Overall Study|Non-compliance|0|||
16884157|NCT00216476|37885384|FG001|Overall Study|Non-compliance|4|||
16884158|NCT00216476|37885385|FG002|Overall Study|Non-compliance|1|||
16884159|NCT00216476|37885383|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
16884160|NCT00216476|37885384|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
16884161|NCT00216476|37885385|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
16884162|NCT00216476|37885383|FG000|Overall Study|Administrative Reasons|1|||
16884163|NCT00216476|37885384|FG001|Overall Study|Administrative Reasons|1|||
16884164|NCT00216476|37885385|FG002|Overall Study|Administrative Reasons|0|||
16884165|NCT00216476|37885383|FG000|Overall Study|Protocol Deviation|5|||
16884166|NCT00216476|37885384|FG001|Overall Study|Protocol Deviation|1|||
16884167|NCT00216476|37885385|FG002|Overall Study|Protocol Deviation|0|||
16884168|NCT00216476|37885383|FG000|Overall Study|Patient Moved|2|||
16884169|NCT00216476|37885384|FG001|Overall Study|Patient Moved|2|||
16884170|NCT00216476|37885385|FG002|Overall Study|Patient Moved|0|||
16884171|NCT00216086|37885436|FG000|Overall Study|Protocol Violation|1|||
16884172|NCT00216086|37885436|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
16884173|NCT00216086|37885436|FG000|Overall Study|Social Reasons|2|||
16884174|NCT00215150|37885467|FG000|Open Label Phase|Lost to Follow-up|7|||
16884175|NCT00215150|37885467|FG000|Open Label Phase|Withdrawal by Subject|1|||
16884176|NCT00215150|37885467|FG000|Open Label Phase|Did not complete a post base visit|13|||
16884177|NCT00215150|37885467|FG000|Open Label Phase|Did not meet randomization criteria|9|||
16884178|NCT00215150|37885467|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
16884179|NCT00215150|37885467|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
16884180|NCT00215150|37885467|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
16884181|NCT00214136|37885475|FG000|Overall Study|Death|5|||
16884182|NCT00213980|37885481|FG000|Overall Study|Withdrawal by Subject|3|||
16884183|NCT00213980|37885482|FG001|Overall Study|Withdrawal by Subject|1|||
16884184|NCT00213980|37885481|FG000|Overall Study|Adverse Event|1|||
16884185|NCT00213980|37885482|FG001|Overall Study|Adverse Event|1|||
16884186|NCT00213980|37885481|FG000|Overall Study|Disease progression|0|||
16884187|NCT00213980|37885482|FG001|Overall Study|Disease progression|2|||
16884188|NCT00213980|37885481|FG000|Overall Study|Developed ovarian cancer|1|||
16884189|NCT00213980|37885482|FG001|Overall Study|Developed ovarian cancer|0|||
16884190|NCT00213980|37885481|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
16884191|NCT00213980|37885482|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
16884192|NCT04388527|37885926|FG000|Overall Study|Death|14|||
16884193|NCT04388527|37885926|FG000|Overall Study|Withdrawal by Subject|2|||
16884194|NCT04388527|37885926|FG000|Overall Study|Lost to Follow-up|1|||
16884195|NCT04149002|37886174|FG000|Overall Study|Lost to Follow-up|1|||
16884196|NCT04149002|37886175|FG001|Overall Study|Lost to Follow-up|0|||
16884197|NCT04149002|37886174|FG000|Overall Study|Withdrawal by Subject|1|||
16884198|NCT04149002|37886175|FG001|Overall Study|Withdrawal by Subject|0|||
16884199|NCT00555321|37886258|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
16884200|NCT00555321|37886259|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
16884201|NCT00555321|37886260|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
16884202|NCT00555321|37886261|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
16884203|NCT00555321|37886262|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
16884204|NCT00555321|37886258|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
16884205|NCT00555321|37886259|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
16884206|NCT00555321|37886260|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
16884207|NCT00555321|37886261|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
16884208|NCT00555321|37886262|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
16884209|NCT00555321|37886258|FG000|Treatment Phase up to 12-months|Death|2|||
16884210|NCT00555321|37886259|FG001|Treatment Phase up to 12-months|Death|1|||
16884211|NCT00555321|37886260|FG002|Treatment Phase up to 12-months|Death|4|||
16884212|NCT00555321|37886261|FG003|Treatment Phase up to 12-months|Death|0|||
16884213|NCT00555321|37886262|FG004|Treatment Phase up to 12-months|Death|0|||
16884214|NCT00555321|37886258|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
16884215|NCT00555321|37886259|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
16884216|NCT00555321|37886260|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
16884217|NCT00555321|37886261|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
16884218|NCT00555321|37886262|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
16884219|NCT00555321|37886258|FG000|Treatment Phase up to 12-months|Other Reason|1|||
16884220|NCT00555321|37886259|FG001|Treatment Phase up to 12-months|Other Reason|3|||
16884221|NCT00555321|37886260|FG002|Treatment Phase up to 12-months|Other Reason|2|||
16884222|NCT00555321|37886261|FG003|Treatment Phase up to 12-months|Other Reason|0|||
16884223|NCT00555321|37886262|FG004|Treatment Phase up to 12-months|Other Reason|0|||
16884224|NCT00555321|37886258|FG000|Treatment Phase up to 12-months|Never treated|2|||
16884225|NCT00555321|37886259|FG001|Treatment Phase up to 12-months|Never treated|3|||
16884226|NCT00555321|37886260|FG002|Treatment Phase up to 12-months|Never treated|1|||
16884227|NCT00555321|37886261|FG003|Treatment Phase up to 12-months|Never treated|0|||
16884228|NCT00555321|37886262|FG004|Treatment Phase up to 12-months|Never treated|4|||
16884229|NCT00555321|37886258|FG000|Long-term Extension Phase|Adverse Event|2|||
16884230|NCT00555321|37886259|FG001|Long-term Extension Phase|Adverse Event|5|||
16884231|NCT00555321|37886260|FG002|Long-term Extension Phase|Adverse Event|2|||
16884232|NCT00555321|37886261|FG003|Long-term Extension Phase|Adverse Event|1|||
16884233|NCT00555321|37886262|FG004|Long-term Extension Phase|Adverse Event|0|||
16884234|NCT00555321|37886258|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
16884235|NCT00555321|37886259|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
16884236|NCT00555321|37886260|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
16884237|NCT00555321|37886261|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
16884238|NCT00555321|37886262|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
16884239|NCT00555321|37886258|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
16884240|NCT00555321|37886259|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
16884241|NCT00555321|37886260|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
16884242|NCT00555321|37886261|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
16884243|NCT00555321|37886262|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
16884244|NCT00555321|37886258|FG000|Long-term Extension Phase|Death|2|||
16884245|NCT00555321|37886259|FG001|Long-term Extension Phase|Death|0|||
16884246|NCT00555321|37886260|FG002|Long-term Extension Phase|Death|0|||
16884247|NCT00555321|37886261|FG003|Long-term Extension Phase|Death|3|||
16884248|NCT00555321|37886262|FG004|Long-term Extension Phase|Death|0|||
16884249|NCT00555321|37886258|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
16884250|NCT00555321|37886259|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
16884251|NCT00555321|37886260|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
16884252|NCT00555321|37886261|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
16884253|NCT00555321|37886262|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
16884254|NCT00555321|37886258|FG000|Long-term Extension Phase|Other Reason|1|||
16884255|NCT00555321|37886259|FG001|Long-term Extension Phase|Other Reason|0|||
16884256|NCT00555321|37886260|FG002|Long-term Extension Phase|Other Reason|2|||
16884257|NCT00555321|37886261|FG003|Long-term Extension Phase|Other Reason|0|||
16884258|NCT00555321|37886262|FG004|Long-term Extension Phase|Other Reason|0|||
16884259|NCT03589976|37886783|FG000|Overall Study|Death|5|||
16884260|NCT03589976|37886784|FG001|Overall Study|Death|1|||
16884261|NCT03589976|37886783|FG000|Overall Study|Adverse Event|5|||
16884262|NCT03589976|37886784|FG001|Overall Study|Adverse Event|1|||
16884263|NCT03589976|37886783|FG000|Overall Study|Withdrawal by Subject|4|||
16884264|NCT03589976|37886784|FG001|Overall Study|Withdrawal by Subject|1|||
16884265|NCT03589976|37886783|FG000|Overall Study|Lost to Follow-up|1|||
16884266|NCT03589976|37886784|FG001|Overall Study|Lost to Follow-up|0|||
16884267|NCT03589976|37886783|FG000|Overall Study|Other|4|||
16884268|NCT03589976|37886784|FG001|Overall Study|Other|3|||
16884269|NCT03029780|37886940|FG000|Overall Study|Disease Progression|20|||
16884270|NCT03029780|37886941|FG001|Overall Study|Disease Progression|22|||
16884271|NCT03029780|37886940|FG000|Overall Study|Study Drug Toxicity|15|||
16884272|NCT03029780|37886941|FG001|Overall Study|Study Drug Toxicity|11|||
16884273|NCT03029780|37886940|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16884274|NCT03029780|37886941|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
16884275|NCT03029780|37886940|FG000|Overall Study|Participant request to discontinue study treatment|4|||
16884276|NCT03029780|37886941|FG001|Overall Study|Participant request to discontinue study treatment|1|||
16884277|NCT03029780|37886940|FG000|Overall Study|Maximum clinical benefit|1|||
16884278|NCT03029780|37886941|FG001|Overall Study|Maximum clinical benefit|0|||
16884279|NCT03029780|37886940|FG000|Overall Study|Participant no longer meets study criteria|0|||
16884280|NCT03029780|37886941|FG001|Overall Study|Participant no longer meets study criteria|1|||
16884281|NCT03029780|37886940|FG000|Overall Study|Other reasons|6|||
16884282|NCT03029780|37886941|FG001|Overall Study|Other reasons|6|||
16884283|NCT03029780|37886940|FG000|Overall Study|Not reported|1|||
16884284|NCT03029780|37886941|FG001|Overall Study|Not reported|1|||
16884285|NCT03029780|37886940|FG000|Overall Study|Death|2|||
16884286|NCT03029780|37886941|FG001|Overall Study|Death|6|||
16884287|NCT03029234|37887001|FG000|Overall Study|Sponsor Decision|1|||
16884288|NCT03029234|37887001|FG000|Overall Study|Withdrawal by Subject|5|||
16884289|NCT03029234|37887001|FG000|Overall Study|Death|91|||
16884290|NCT03029234|37887001|FG000|Overall Study|Lost to Follow-up|2|||
16884291|NCT03018080|37887599|FG000|Overall Study|Death|11|||
16884292|NCT03018080|37887600|FG001|Overall Study|Death|19|||
16884293|NCT03018080|37887599|FG000|Overall Study|Still On Study (in follow up)|10|||
16884294|NCT03018080|37887600|FG001|Overall Study|Still On Study (in follow up)|0|||
16884295|NCT00557193|37887654|FG000|Induction|Adverse Event|2|||
16884296|NCT00557193|37887655|FG001|Induction|Adverse Event|0|||
16884297|NCT00557193|37887656|FG002|Induction|Adverse Event|0|||
16884298|NCT00557193|37887657|FG003|Induction|Adverse Event|0|||
16884299|NCT00557193|37887658|FG004|Induction|Adverse Event|0|||
16884300|NCT00557193|37887659|FG005|Induction|Adverse Event|0|||
16884301|NCT00557193|37887654|FG000|Induction|Death|6|||
16884302|NCT00557193|37887655|FG001|Induction|Death|0|||
16884303|NCT00557193|37887656|FG002|Induction|Death|0|||
16884304|NCT00557193|37887657|FG003|Induction|Death|0|||
16884305|NCT00557193|37887658|FG004|Induction|Death|0|||
16884306|NCT00557193|37887659|FG005|Induction|Death|0|||
16884307|NCT00557193|37887654|FG000|Induction|Physician Decision|3|||
16884308|NCT00557193|37887655|FG001|Induction|Physician Decision|0|||
16884309|NCT00557193|37887656|FG002|Induction|Physician Decision|0|||
16884310|NCT00557193|37887657|FG003|Induction|Physician Decision|0|||
16884311|NCT00557193|37887658|FG004|Induction|Physician Decision|0|||
16884312|NCT00557193|37887659|FG005|Induction|Physician Decision|0|||
16884313|NCT00557193|37887654|FG000|Induction|Withdrawal by Subject|1|||
16884314|NCT00557193|37887655|FG001|Induction|Withdrawal by Subject|0|||
16884315|NCT00557193|37887656|FG002|Induction|Withdrawal by Subject|0|||
16884316|NCT00557193|37887657|FG003|Induction|Withdrawal by Subject|0|||
16884317|NCT00557193|37887658|FG004|Induction|Withdrawal by Subject|0|||
16884318|NCT00557193|37887659|FG005|Induction|Withdrawal by Subject|0|||
16884319|NCT00557193|37887654|FG000|Induction|Refusal of Further Protocol Therapy|2|||
16884320|NCT00557193|37887655|FG001|Induction|Refusal of Further Protocol Therapy|0|||
16884321|NCT00557193|37887656|FG002|Induction|Refusal of Further Protocol Therapy|0|||
16884322|NCT00557193|37887657|FG003|Induction|Refusal of Further Protocol Therapy|0|||
16884323|NCT00557193|37887658|FG004|Induction|Refusal of Further Protocol Therapy|0|||
16884324|NCT00557193|37887659|FG005|Induction|Refusal of Further Protocol Therapy|0|||
16884325|NCT00557193|37887654|FG000|Induction|Ineligible|8|||
16884326|NCT00557193|37887655|FG001|Induction|Ineligible|0|||
16884327|NCT00557193|37887656|FG002|Induction|Ineligible|0|||
16884328|NCT00557193|37887657|FG003|Induction|Ineligible|0|||
16884329|NCT00557193|37887658|FG004|Induction|Ineligible|0|||
16884330|NCT00557193|37887659|FG005|Induction|Ineligible|0|||
16884331|NCT00557193|37887654|FG000|Induction|Inevaluable for post Induction|2|||
16884332|NCT00557193|37887655|FG001|Induction|Inevaluable for post Induction|0|||
16884333|NCT00557193|37887656|FG002|Induction|Inevaluable for post Induction|0|||
16884334|NCT00557193|37887657|FG003|Induction|Inevaluable for post Induction|0|||
16884335|NCT00557193|37887658|FG004|Induction|Inevaluable for post Induction|0|||
16884336|NCT00557193|37887659|FG005|Induction|Inevaluable for post Induction|0|||
16884337|NCT00557193|37887654|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
16884338|NCT00557193|37887655|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16884339|NCT00557193|37887656|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16884340|NCT00557193|37887657|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16884341|NCT00557193|37887658|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16884342|NCT00557193|37887659|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16884343|NCT00557193|37887654|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
16884344|NCT00557193|37887655|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
16884345|NCT00557193|37887656|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
16884346|NCT00557193|37887657|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
16884347|NCT00557193|37887658|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
16884348|NCT00557193|37887659|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
16884349|NCT00557193|37887654|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
16884350|NCT00557193|37887655|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
16884351|NCT00557193|37887656|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
16884352|NCT00557193|37887657|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
16884353|NCT00557193|37887658|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
16884354|NCT00557193|37887659|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
16884355|NCT00557193|37887654|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
16884356|NCT00557193|37887655|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
16884357|NCT00557193|37887656|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
16884358|NCT00557193|37887657|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
16884359|NCT00557193|37887658|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
16884360|NCT00557193|37887659|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
17095315|NCT00261846|38234542|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
16884361|NCT00557193|37887654|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
16884362|NCT00557193|37887655|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
16884363|NCT00557193|37887656|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
16884364|NCT00557193|37887657|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
16884365|NCT00557193|37887658|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
17002294|NCT00844857|38146393|FG001|Overall Study|Lost to Follow-up|3|||
16884366|NCT00557193|37887659|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
16884367|NCT00557193|37887654|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
16884368|NCT00557193|37887655|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
16884369|NCT00557193|37887656|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
16884370|NCT00557193|37887657|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
16884371|NCT00557193|37887658|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
16884372|NCT00557193|37887659|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
16884373|NCT00557193|37887654|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16884374|NCT00557193|37887655|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16884375|NCT00557193|37887656|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
16884376|NCT00557193|37887657|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16884377|NCT00557193|37887658|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16884378|NCT00557193|37887659|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16884379|NCT00557193|37887654|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16884380|NCT00557193|37887655|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16884381|NCT00557193|37887656|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
16884382|NCT00557193|37887657|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16884383|NCT00557193|37887658|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16884384|NCT00557193|37887659|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16884385|NCT00557193|37887654|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
16884386|NCT00557193|37887655|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
16884387|NCT00557193|37887656|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
16884388|NCT00557193|37887657|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
16884389|NCT00557193|37887658|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
16884390|NCT00557193|37887659|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
16884391|NCT03991299|37887715|FG000|Overall Study|Study closed, sponsor decision|3|||
16884392|NCT03991299|37887715|FG000|Overall Study|Withdrawal by Subject|1|||
16884393|NCT03155373|37887733|FG000|Overall Study|No longer required surgery|1|||
16884394|NCT03155373|37887733|FG000|Overall Study|Protocol Violation|1|||
16884395|NCT03155373|37887733|FG000|Overall Study|Death|2|||
16884396|NCT03155373|37887733|FG000|Overall Study|Withdrawal by Subject|3|||
16884397|NCT02775903|37888442|FG000|Overall Study|Death|7|||
16884398|NCT02775903|37888443|FG001|Overall Study|Death|11|||
16884399|NCT02775903|37888444|FG002|Overall Study|Death|12|||
16884400|NCT02775903|37888445|FG003|Overall Study|Death|11|||
16884401|NCT02775903|37888442|FG000|Overall Study|Adverse Event|0|||
16884402|NCT02775903|37888443|FG001|Overall Study|Adverse Event|1|||
16884403|NCT02775903|37888444|FG002|Overall Study|Adverse Event|12|||
16884404|NCT02775903|37888445|FG003|Overall Study|Adverse Event|3|||
16884405|NCT02775903|37888442|FG000|Overall Study|Progressive disease|15|||
16884406|NCT02775903|37888443|FG001|Overall Study|Progressive disease|14|||
16884407|NCT02775903|37888444|FG002|Overall Study|Progressive disease|30|||
16884408|NCT02775903|37888445|FG003|Overall Study|Progressive disease|20|||
16884409|NCT02775903|37888442|FG000|Overall Study|Lack of Efficacy|2|||
16884410|NCT02775903|37888443|FG001|Overall Study|Lack of Efficacy|2|||
16884411|NCT02775903|37888444|FG002|Overall Study|Lack of Efficacy|2|||
16884412|NCT02775903|37888445|FG003|Overall Study|Lack of Efficacy|6|||
16884413|NCT02775903|37888442|FG000|Overall Study|Withdrawal by Subject|7|||
16884414|NCT02775903|37888443|FG001|Overall Study|Withdrawal by Subject|5|||
16884415|NCT02775903|37888444|FG002|Overall Study|Withdrawal by Subject|5|||
16884416|NCT02775903|37888445|FG003|Overall Study|Withdrawal by Subject|8|||
16884417|NCT02775903|37888442|FG000|Overall Study|Other reasons|7|||
16884418|NCT02775903|37888443|FG001|Overall Study|Other reasons|8|||
16884419|NCT02775903|37888444|FG002|Overall Study|Other reasons|2|||
16884420|NCT02775903|37888445|FG003|Overall Study|Other reasons|12|||
16884421|NCT02723019|37888518|FG000|Overall Study|Death|17|||
16884422|NCT02723019|37888519|FG001|Overall Study|Death|13|||
16884423|NCT02723019|37888518|FG000|Overall Study|Withdrawal by Subject|11|||
16884424|NCT02723019|37888519|FG001|Overall Study|Withdrawal by Subject|7|||
16884425|NCT02723019|37888518|FG000|Overall Study|Lost to Follow-up|57|||
16884426|NCT02723019|37888519|FG001|Overall Study|Lost to Follow-up|70|||
16884427|NCT02152995|37888607|FG000|Overall Study|Withdrawal by Subject|1|||
16884428|NCT02152995|37888608|FG001|Overall Study|Withdrawal by Subject|0|||
17095316|NCT00261846|38234543|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
16884429|NCT00088166|37888784|FG000|Overall Study|Adverse Event|11|||
16884430|NCT00088166|37888785|FG001|Overall Study|Adverse Event|9|||
16884431|NCT00088166|37888784|FG000|Overall Study|Death|3|||
16884432|NCT00088166|37888785|FG001|Overall Study|Death|1|||
16884433|NCT00088166|37888784|FG000|Overall Study|Lost to Follow-up|0|||
16884434|NCT00088166|37888785|FG001|Overall Study|Lost to Follow-up|1|||
17002295|NCT00844857|38146392|FG000|Overall Study|Did Not Take Study Drug|3|||
17095317|NCT00261846|38234544|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
16884435|NCT00088166|37888784|FG000|Overall Study|Physician Decision|4|||
16884436|NCT00088166|37888785|FG001|Overall Study|Physician Decision|1|||
16884437|NCT00088166|37888784|FG000|Overall Study|Protocol Violation|1|||
16884438|NCT00088166|37888785|FG001|Overall Study|Protocol Violation|5|||
16884439|NCT00088166|37888784|FG000|Overall Study|Patient deterioration|29|||
16884440|NCT00088166|37888785|FG001|Overall Study|Patient deterioration|39|||
16884441|NCT00088166|37888784|FG000|Overall Study|Withdrawal by Subject|5|||
16884442|NCT00088166|37888785|FG001|Overall Study|Withdrawal by Subject|5|||
16884451|NCT00087698|37888842|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
16884452|NCT00087698|37888842|FG000|Overall Study|Death from Other Causes|3|||
16884453|NCT00087698|37888842|FG000|Overall Study|Adverse Event|4|||
16884454|NCT00087698|37888842|FG000|Overall Study|Withdrawal by Subject|4|||
16884455|NCT00087698|37888842|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
16884456|NCT00087698|37888842|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
16884457|NCT00087698|37888842|FG000|Overall Study|Clinical Relapse|1|||
16884458|NCT00087698|37888842|FG000|Overall Study|Death from Study Disease|2|||
16884459|NCT00087698|37888842|FG000|Overall Study|Death from Study Drug Toxicity|2|||
16884460|NCT00087698|37888842|FG000|Overall Study|Protocol Violation|1|||
16884461|NCT00087152|37888860|FG000|Overall Study|Ineligible|6|||
16884462|NCT00086996|37888912|FG000|Overall Study|Adverse Event|29|||
16884463|NCT00086996|37888912|FG000|Overall Study|Death|4|||
16884464|NCT00086996|37888912|FG000|Overall Study|progression/relapse|7|||
16884465|NCT00086996|37888912|FG000|Overall Study|Withdrawal by Subject|13|||
16884466|NCT00086996|37888912|FG000|Overall Study|Other|6|||
16884467|NCT00086996|37888912|FG000|Overall Study|not eligible|5|||
16884468|NCT00086684|37889214|FG000|Overall Study|Adverse Event|12|||
16884469|NCT00086684|37889215|FG001|Overall Study|Adverse Event|17|||
16884470|NCT00086684|37889216|FG002|Overall Study|Adverse Event|14|||
16884471|NCT00086684|37889214|FG000|Overall Study|Lack of Efficacy|6|||
16884472|NCT00086684|37889215|FG001|Overall Study|Lack of Efficacy|6|||
16884473|NCT00086684|37889216|FG002|Overall Study|Lack of Efficacy|5|||
16884474|NCT00086684|37889214|FG000|Overall Study|Lost to Follow-up|15|||
16884475|NCT00086684|37889215|FG001|Overall Study|Lost to Follow-up|8|||
16884476|NCT00086684|37889216|FG002|Overall Study|Lost to Follow-up|10|||
16884477|NCT00086684|37889214|FG000|Overall Study|Protocol Violation|8|||
16884478|NCT00086684|37889215|FG001|Overall Study|Protocol Violation|3|||
16884479|NCT00086684|37889216|FG002|Overall Study|Protocol Violation|0|||
16884480|NCT00086684|37889214|FG000|Overall Study|Withdrawal by Subject|0|||
16884481|NCT00086684|37889215|FG001|Overall Study|Withdrawal by Subject|4|||
16884482|NCT00086684|37889216|FG002|Overall Study|Withdrawal by Subject|10|||
16884483|NCT00086684|37889214|FG000|Overall Study|NONCOMPLIANCE|5|||
16884484|NCT00086684|37889215|FG001|Overall Study|NONCOMPLIANCE|7|||
16884485|NCT00086684|37889216|FG002|Overall Study|NONCOMPLIANCE|6|||
16884486|NCT00086684|37889214|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16884487|NCT00086684|37889215|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
16884488|NCT00086684|37889216|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16884489|NCT00086684|37889214|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
16884490|NCT00086684|37889215|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
16884491|NCT00086684|37889216|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
16884492|NCT00086684|37889214|FG000|Overall Study|Other|4|||
16884493|NCT00086684|37889215|FG001|Overall Study|Other|2|||
16884494|NCT00086684|37889216|FG002|Overall Study|Other|3|||
16884495|NCT00082628|37889280|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
16884496|NCT00082628|37889281|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
16884497|NCT00082628|37889282|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
16884498|NCT00082628|37889283|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
16884499|NCT00082628|37889284|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
16884500|NCT00082628|37889280|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
16884501|NCT00082628|37889281|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
16884502|NCT00082628|37889282|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
16884503|NCT00082628|37889283|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
16884504|NCT00082628|37889284|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
16884505|NCT00082628|37889280|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
16884506|NCT00082628|37889281|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
16884507|NCT00082628|37889282|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
16884508|NCT00082628|37889283|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
16884509|NCT00082628|37889284|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
16884510|NCT00082628|37889280|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
16884511|NCT00082628|37889281|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
16884512|NCT00082628|37889282|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
16884513|NCT00082628|37889283|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
16884514|NCT00082628|37889284|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
16884515|NCT00082628|37889280|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
16884516|NCT00082628|37889281|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
16884517|NCT00082628|37889282|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
16884518|NCT00082628|37889283|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
16884519|NCT00082628|37889284|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
16884520|NCT00082628|37889280|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
16884521|NCT00082628|37889281|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
16884522|NCT00082628|37889282|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
16884523|NCT00082628|37889283|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
16884524|NCT00082628|37889284|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
16884525|NCT00082628|37889280|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
16884526|NCT00082628|37889281|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
16884527|NCT00082628|37889282|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
16884528|NCT00082628|37889283|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
16884529|NCT00082628|37889284|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
16884530|NCT02993263|37889648|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
16884531|NCT01274533|37889693|FG000|Overall Study|Withdrawal by Subject|1|||
16884532|NCT01274533|37889693|FG000|Overall Study|Non-compliance|1|||
16884533|NCT01274533|37889693|FG000|Overall Study|Disease progression|2|||
16884534|NCT01273597|37889697|FG000|Overall Study|Adverse Event|5|||
16884535|NCT01273597|37889697|FG000|Overall Study|Underwent Kidney Transplantation|2|||
16884536|NCT01273597|37889697|FG000|Overall Study|Reason Not Reported|1|||
16884537|NCT01273519|37889704|FG000|Overall Study|Adverse Event|3|||
16884538|NCT01273519|37889705|FG001|Overall Study|Adverse Event|0|||
16884539|NCT01273519|37889706|FG002|Overall Study|Adverse Event|0|||
16884540|NCT01273519|37889704|FG000|Overall Study|Lost to Follow-up|2|||
16884541|NCT01273519|37889705|FG001|Overall Study|Lost to Follow-up|1|||
16884542|NCT01273519|37889706|FG002|Overall Study|Lost to Follow-up|3|||
16884543|NCT01273519|37889704|FG000|Overall Study|Lack of Efficacy|8|||
16884544|NCT01273519|37889705|FG001|Overall Study|Lack of Efficacy|3|||
16884545|NCT01273519|37889706|FG002|Overall Study|Lack of Efficacy|4|||
16884546|NCT01273519|37889704|FG000|Overall Study|Other|6|||
16884547|NCT01273519|37889705|FG001|Overall Study|Other|1|||
16884548|NCT01273519|37889706|FG002|Overall Study|Other|1|||
16884549|NCT01272661|37889763|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
16884550|NCT01272661|37889764|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
16884551|NCT01272661|37889765|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
16884552|NCT04276051|37889925|FG000|Overall Study|Lost to Follow-up|0|||
16884553|NCT04276051|37889926|FG001|Overall Study|Lost to Follow-up|1|||
16884554|NCT04276051|37889925|FG000|Overall Study|Physician Decision|0|||
16884555|NCT04276051|37889926|FG001|Overall Study|Physician Decision|1|||
16884556|NCT04276051|37889925|FG000|Overall Study|Withdrawal by Subject|1|||
16884557|NCT04276051|37889926|FG001|Overall Study|Withdrawal by Subject|1|||
16884558|NCT00081770|37890186|FG000|Overall Study|Adverse Event|130|||
16884559|NCT00081770|37890187|FG001|Overall Study|Adverse Event|98|||
16884560|NCT00081770|37890188|FG002|Overall Study|Adverse Event|136|||
16884561|NCT00081770|37890186|FG000|Overall Study|Lack of Efficacy|262|||
16884562|NCT00081770|37890187|FG001|Overall Study|Lack of Efficacy|357|||
16884563|NCT00081770|37890188|FG002|Overall Study|Lack of Efficacy|211|||
16884564|NCT00081770|37890186|FG000|Overall Study|Lost to Follow-up|45|||
16884565|NCT00081770|37890187|FG001|Overall Study|Lost to Follow-up|34|||
16884566|NCT00081770|37890188|FG002|Overall Study|Lost to Follow-up|45|||
16884567|NCT00081770|37890186|FG000|Overall Study|Protocol Violation|15|||
16884568|NCT00081770|37890187|FG001|Overall Study|Protocol Violation|10|||
16884569|NCT00081770|37890188|FG002|Overall Study|Protocol Violation|10|||
16884570|NCT00081770|37890186|FG000|Overall Study|Withdrawal by Subject|45|||
16884571|NCT00081770|37890187|FG001|Overall Study|Withdrawal by Subject|40|||
16884572|NCT00081770|37890188|FG002|Overall Study|Withdrawal by Subject|42|||
16884573|NCT00081770|37890186|FG000|Overall Study|Did not meet protocol eligibility|2|||
16884574|NCT00081770|37890187|FG001|Overall Study|Did not meet protocol eligibility|0|||
16884575|NCT00081770|37890188|FG002|Overall Study|Did not meet protocol eligibility|3|||
16884576|NCT00081770|37890186|FG000|Overall Study|Administrative|1|||
16884577|NCT00081770|37890187|FG001|Overall Study|Administrative|0|||
16884578|NCT00081770|37890188|FG002|Overall Study|Administrative|1|||
16884579|NCT00081770|37890186|FG000|Overall Study|Other|2|||
17191865|NCT02853331|38344799|FG000|Overall Study|Death|59|||
17191866|NCT02853331|38344800|FG001|Overall Study|Death|95|||
17191867|NCT02853331|38344799|FG000|Overall Study|Withdrawal by Subject|5|||
17191868|NCT02853331|38344800|FG001|Overall Study|Withdrawal by Subject|9|||
17191869|NCT02853331|38344799|FG000|Overall Study|Ongoing in study|368|||
17191870|NCT02853331|38344800|FG001|Overall Study|Ongoing in study|325|||
17191871|NCT01595061|38344806|FG000|Overall Study|Never Treated|3|||
17191872|NCT01595061|38344806|FG000|Overall Study|Inadequate Pathology|1|||
17191873|NCT02852005|38344827|FG000|Overall Study|Lost to Follow-up|0|||
17191874|NCT02852005|38344828|FG001|Overall Study|Lost to Follow-up|0|||
17191875|NCT02852005|38344829|FG002|Overall Study|Lost to Follow-up|0|||
17191876|NCT02852005|38344830|FG003|Overall Study|Lost to Follow-up|0|||
17191877|NCT02852005|38344831|FG004|Overall Study|Lost to Follow-up|1|||
17191878|NCT02852005|38344827|FG000|Overall Study|Withdrawal by Subject|1|||
17191879|NCT02852005|38344828|FG001|Overall Study|Withdrawal by Subject|0|||
17191880|NCT02852005|38344829|FG002|Overall Study|Withdrawal by Subject|0|||
17191881|NCT02852005|38344830|FG003|Overall Study|Withdrawal by Subject|0|||
17191882|NCT02852005|38344831|FG004|Overall Study|Withdrawal by Subject|0|||
17191883|NCT02851615|38344847|FG000|Overall Study|Cognitive Issue|1|||
17191884|NCT02851615|38344848|FG001|Overall Study|Cognitive Issue|0|||
17191885|NCT02851615|38344847|FG000|Overall Study|Lost to Follow-up|0|||
17191886|NCT02851615|38344848|FG001|Overall Study|Lost to Follow-up|4|||
17191887|NCT02849743|38344866|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
17191888|NCT02849743|38344867|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
17191889|NCT02849743|38344866|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
17191890|NCT02849743|38344867|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
17191891|NCT02851069|38344902|FG000|Overall Study|Failure to Return|3|||
17191892|NCT02851069|38344902|FG000|Overall Study|Other|3|||
17191893|NCT02849509|38344914|FG000|Overall Study|Worsening of disease under study|1|||
17191894|NCT02849509|38344915|FG001|Overall Study|Worsening of disease under study|1|||
17191895|NCT02849509|38344916|FG002|Overall Study|Worsening of disease under study|1|||
17191896|NCT02849509|38344914|FG000|Overall Study|Worsening of other pre-existing disease|0|||
17191897|NCT02849509|38344915|FG001|Overall Study|Worsening of other pre-existing disease|1|||
17191898|NCT02849509|38344916|FG002|Overall Study|Worsening of other pre-existing disease|2|||
17191899|NCT02849509|38344914|FG000|Overall Study|Other adverse event|36|||
17191900|NCT02849509|38344915|FG001|Overall Study|Other adverse event|41|||
17191901|NCT02849509|38344916|FG002|Overall Study|Other adverse event|8|||
17191902|NCT02849509|38344914|FG000|Overall Study|Withdrawal by Subject|6|||
17191903|NCT02849509|38344915|FG001|Overall Study|Withdrawal by Subject|17|||
17191904|NCT02849509|38344916|FG002|Overall Study|Withdrawal by Subject|12|||
17191905|NCT02849509|38344914|FG000|Overall Study|Lost to Follow-up|27|||
17191906|NCT02849509|38344915|FG001|Overall Study|Lost to Follow-up|67|||
17191907|NCT02849509|38344916|FG002|Overall Study|Lost to Follow-up|36|||
17191908|NCT02849509|38344914|FG000|Overall Study|Other, reason not specified|14|||
17191909|NCT02849509|38344915|FG001|Overall Study|Other, reason not specified|29|||
17191910|NCT02849509|38344916|FG002|Overall Study|Other, reason not specified|25|||
17191911|NCT02849509|38344914|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
17191912|NCT02849509|38344915|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
17191913|NCT02849509|38344916|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
17191914|NCT02853305|38344929|FG000|Overall Study|Death|244|||
17191915|NCT02853305|38344930|FG001|Overall Study|Death|207|||
17191916|NCT02853305|38344931|FG002|Overall Study|Death|263|||
17191917|NCT02853305|38344929|FG000|Overall Study|Withdrawal by Subject|2|||
17191918|NCT02853305|38344930|FG001|Overall Study|Withdrawal by Subject|4|||
17191919|NCT02853305|38344931|FG002|Overall Study|Withdrawal by Subject|2|||
17191920|NCT02853305|38344929|FG000|Overall Study|Ongoing in Trial|105|||
17191921|NCT02853305|38344930|FG001|Overall Study|Ongoing in Trial|96|||
17191922|NCT02853305|38344931|FG002|Overall Study|Ongoing in Trial|87|||
17191923|NCT02848729|38344941|FG000|Overall Study|Withdrawal by Subject|1|||
17191924|NCT02848729|38344942|FG001|Overall Study|Withdrawal by Subject|0|||
17191925|NCT02848729|38344941|FG000|Overall Study|Emesis|15|||
17191926|NCT02848729|38344942|FG001|Overall Study|Emesis|11|||
17191927|NCT00158756|38344960|FG000|Overall Study|Withdrawal by Subject|5|||
17191928|NCT00158756|38344961|FG001|Overall Study|Withdrawal by Subject|0|||
17191929|NCT00158756|38344962|FG002|Overall Study|Withdrawal by Subject|6|||
17191930|NCT00158756|38344963|FG003|Overall Study|Withdrawal by Subject|1|||
17191931|NCT00158756|38344964|FG004|Overall Study|Withdrawal by Subject|3|||
17191932|NCT00158756|38344960|FG000|Overall Study|Adverse Event|0|||
17191933|NCT00158756|38344961|FG001|Overall Study|Adverse Event|0|||
17191934|NCT00158756|38344962|FG002|Overall Study|Adverse Event|1|||
17191935|NCT00158756|38344963|FG003|Overall Study|Adverse Event|0|||
17191936|NCT00158756|38344964|FG004|Overall Study|Adverse Event|0|||
17191937|NCT00158756|38344960|FG000|Overall Study|Serious adverse event|0|||
17191938|NCT00158756|38344961|FG001|Overall Study|Serious adverse event|0|||
17191939|NCT00158756|38344962|FG002|Overall Study|Serious adverse event|1|||
16884580|NCT00081770|37890187|FG001|Overall Study|Other|7|||
16884581|NCT00081770|37890188|FG002|Overall Study|Other|8|||
16884582|NCT00081458|37890288|FG000|Overall Study|Adverse Event|1|||
16884583|NCT00081458|37890289|FG001|Overall Study|Adverse Event|5|||
16884584|NCT00081458|37890290|FG002|Overall Study|Adverse Event|2|||
16884585|NCT00081458|37890288|FG000|Overall Study|Withdrawal by Subject|0|||
16884586|NCT00081458|37890289|FG001|Overall Study|Withdrawal by Subject|3|||
16884587|NCT00081458|37890290|FG002|Overall Study|Withdrawal by Subject|1|||
16884588|NCT00081458|37890288|FG000|Overall Study|Randomized but not dosed|0|||
16884589|NCT00081458|37890289|FG001|Overall Study|Randomized but not dosed|0|||
16884590|NCT00081458|37890290|FG002|Overall Study|Randomized but not dosed|1|||
16884591|NCT01271803|37890367|FG000|Overall Study|Progressive disease|0|||
16884592|NCT01271803|37890368|FG001|Overall Study|Progressive disease|0|||
16884593|NCT01271803|37890369|FG002|Overall Study|Progressive disease|2|||
16884594|NCT01271803|37890367|FG000|Overall Study|Death|53|||
16884595|NCT01271803|37890368|FG001|Overall Study|Death|34|||
16884596|NCT01271803|37890369|FG002|Overall Study|Death|0|||
16884597|NCT01271803|37890367|FG000|Overall Study|Withdrawal by Subject|1|||
16884598|NCT01271803|37890368|FG001|Overall Study|Withdrawal by Subject|5|||
16884599|NCT01271803|37890369|FG002|Overall Study|Withdrawal by Subject|0|||
16884600|NCT01271803|37890367|FG000|Overall Study|Lost to Follow-up|1|||
16884601|NCT01271803|37890368|FG001|Overall Study|Lost to Follow-up|0|||
16884602|NCT01271803|37890369|FG002|Overall Study|Lost to Follow-up|0|||
16884603|NCT00080288|37890420|FG000|Overall Study|Adverse Event|7|||
16884604|NCT00080288|37890421|FG001|Overall Study|Adverse Event|4|||
16884605|NCT00080288|37890420|FG000|Overall Study|Lost to Follow-up|3|||
16884606|NCT00080288|37890421|FG001|Overall Study|Lost to Follow-up|5|||
16884607|NCT00080288|37890420|FG000|Overall Study|Physician Decision|6|||
16884608|NCT00080288|37890421|FG001|Overall Study|Physician Decision|2|||
16884609|NCT00080288|37890420|FG000|Overall Study|Withdrawal by Subject|3|||
16884610|NCT00080288|37890421|FG001|Overall Study|Withdrawal by Subject|16|||
16884611|NCT00080288|37890420|FG000|Overall Study|Miscellaneous|11|||
16884612|NCT00080288|37890421|FG001|Overall Study|Miscellaneous|11|||
16884613|NCT01271725|37890492|FG000|Part A|Progressive disease according to RECIST|8|||
16884614|NCT01271725|37890493|FG001|Part A|Progressive disease according to RECIST|0|||
16884615|NCT01271725|37890492|FG000|Part A|Clinical signs/symptoms of progression|2|||
16884616|NCT01271725|37890493|FG001|Part A|Clinical signs/symptoms of progression|0|||
16884617|NCT01271725|37890492|FG000|Part A|Other Adverse Event|8|||
16884618|NCT01271725|37890493|FG001|Part A|Other Adverse Event|0|||
16884619|NCT01271725|37890492|FG000|Part A|Lost to Follow-up|1|||
16884620|NCT01271725|37890493|FG001|Part A|Lost to Follow-up|0|||
16884621|NCT01271725|37890492|FG000|Part A|Withdrawal by Subject|12|||
16884622|NCT01271725|37890493|FG001|Part A|Withdrawal by Subject|0|||
16884623|NCT01271725|37890492|FG000|Part A|Other than specified|3|||
16884624|NCT01271725|37890493|FG001|Part A|Other than specified|0|||
16884625|NCT01271725|37890492|FG000|Part A|Protocol Violation|1|||
16884626|NCT01271725|37890493|FG001|Part A|Protocol Violation|0|||
16884627|NCT01271725|37890492|FG000|Part B|Other than specified|0|||
16884628|NCT01271725|37890493|FG001|Part B|Other than specified|2|||
16884629|NCT01271725|37890492|FG000|Part B|Clinical signs/symptoms of progression|0|||
16884630|NCT01271725|37890493|FG001|Part B|Clinical signs/symptoms of progression|2|||
16884631|NCT01271725|37890492|FG000|Part B|Other Adverse Event|0|||
16884632|NCT01271725|37890493|FG001|Part B|Other Adverse Event|1|||
16884633|NCT01271725|37890492|FG000|Part B|Protocol Violation|0|||
16884634|NCT01271725|37890493|FG001|Part B|Protocol Violation|1|||
16884635|NCT01271725|37890492|FG000|Part B|Withdrawal by Subject|0|||
16884636|NCT01271725|37890493|FG001|Part B|Withdrawal by Subject|6|||
16884637|NCT01270321|37890518|FG000|Overall Study|Death|3|||
16884638|NCT01270321|37890519|FG001|Overall Study|Death|1|||
16884639|NCT01270321|37890520|FG002|Overall Study|Death|4|||
16884640|NCT01270321|37890518|FG000|Overall Study|Adverse Event|7|||
16884641|NCT01270321|37890519|FG001|Overall Study|Adverse Event|9|||
16884642|NCT01270321|37890520|FG002|Overall Study|Adverse Event|5|||
16884643|NCT00249769|37890595|FG000|Overall Study|Withdrawal by Subject|1|||
16884644|NCT00249769|37890596|FG001|Overall Study|Withdrawal by Subject|10|||
17095318|NCT00261846|38234545|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
16884645|NCT00249769|37890597|FG002|Overall Study|Withdrawal by Subject|6|||
16884646|NCT00249769|37890595|FG000|Overall Study|Migration from Study Area|1|||
16884647|NCT00249769|37890596|FG001|Overall Study|Migration from Study Area|3|||
16884648|NCT00249769|37890597|FG002|Overall Study|Migration from Study Area|14|||
16884649|NCT00249769|37890595|FG000|Overall Study|Miscellaneous|0|||
16884650|NCT00249769|37890596|FG001|Overall Study|Miscellaneous|2|||
16884651|NCT00249769|37890597|FG002|Overall Study|Miscellaneous|2|||
16884652|NCT00249769|37890595|FG000|Overall Study|Adverse Event|0|||
16884653|NCT00249769|37890596|FG001|Overall Study|Adverse Event|0|||
16884654|NCT00249769|37890597|FG002|Overall Study|Adverse Event|1|||
16884655|NCT00249769|37890595|FG000|Overall Study|Physician Decision|0|||
16884656|NCT00249769|37890596|FG001|Overall Study|Physician Decision|0|||
16884657|NCT00249769|37890597|FG002|Overall Study|Physician Decision|2|||
16884658|NCT00249769|37890595|FG000|Overall Study|Lost to Follow-up|0|||
16884659|NCT00249769|37890596|FG001|Overall Study|Lost to Follow-up|0|||
16884660|NCT00249769|37890597|FG002|Overall Study|Lost to Follow-up|3|||
16884661|NCT00249613|37890607|FG000|12 Month Follow-up|Death|1|||
16884662|NCT00249613|37890608|FG001|12 Month Follow-up|Death|1|||
16884663|NCT00249613|37890607|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
16884664|NCT00249613|37890608|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
16884665|NCT00249613|37890607|FG000|12 Month Follow-up|Lost to Follow-up|10|||
16884666|NCT00249613|37890608|FG001|12 Month Follow-up|Lost to Follow-up|8|||
16884667|NCT00248833|37890644|FG000|Overall Study|Adverse Event|2|||
16884668|NCT00248833|37890645|FG001|Overall Study|Adverse Event|0|||
16884669|NCT00248833|37890646|FG002|Overall Study|Adverse Event|0|||
16884670|NCT00248833|37890644|FG000|Overall Study|Withdrawal by Subject|0|||
16884671|NCT00248833|37890645|FG001|Overall Study|Withdrawal by Subject|1|||
16884672|NCT00248833|37890646|FG002|Overall Study|Withdrawal by Subject|1|||
16884673|NCT00248833|37890644|FG000|Overall Study|Lost to Follow-up|1|||
16884674|NCT00248833|37890645|FG001|Overall Study|Lost to Follow-up|1|||
16884675|NCT00248833|37890646|FG002|Overall Study|Lost to Follow-up|1|||
16884676|NCT00248833|37890644|FG000|Overall Study|Other|0|||
16884677|NCT00248833|37890645|FG001|Overall Study|Other|1|||
16884678|NCT00248833|37890646|FG002|Overall Study|Other|0|||
16884679|NCT00247273|37890826|FG000|Overall Study|Adverse Event|85|||
16884680|NCT00247273|37890827|FG001|Overall Study|Adverse Event|80|||
16884681|NCT00247273|37890826|FG000|Overall Study|Physician Decision|6|||
16884682|NCT00247273|37890827|FG001|Overall Study|Physician Decision|3|||
16884683|NCT00247273|37890826|FG000|Overall Study|Lost to Follow-up|7|||
16884684|NCT00247273|37890827|FG001|Overall Study|Lost to Follow-up|7|||
16884685|NCT00247273|37890826|FG000|Overall Study|Withdrawal by Subject|46|||
16884686|NCT00247273|37890827|FG001|Overall Study|Withdrawal by Subject|47|||
16884687|NCT00247273|37890826|FG000|Overall Study|Did not take any study drug|2|||
16884688|NCT00247273|37890827|FG001|Overall Study|Did not take any study drug|0|||
16884689|NCT00246259|37890915|FG000|Overall Study|Other|3|||
16884690|NCT00246259|37890916|FG001|Overall Study|Other|3|||
16884691|NCT00246259|37890915|FG000|Overall Study|Not stable by Week 18|2|||
16884692|NCT00246259|37890916|FG001|Overall Study|Not stable by Week 18|1|||
16884693|NCT00246259|37890915|FG000|Overall Study|Participant non-compliant|4|||
16884694|NCT00246259|37890916|FG001|Overall Study|Participant non-compliant|9|||
16884695|NCT00246259|37890915|FG000|Overall Study|Lack of Efficacy|2|||
16884696|NCT00246259|37890916|FG001|Overall Study|Lack of Efficacy|2|||
16884697|NCT00246259|37890915|FG000|Overall Study|Investigator withdrew participant|2|||
16884698|NCT00246259|37890916|FG001|Overall Study|Investigator withdrew participant|0|||
16884699|NCT00246259|37890915|FG000|Overall Study|Adverse Event|5|||
16884700|NCT00246259|37890916|FG001|Overall Study|Adverse Event|0|||
16884701|NCT00246259|37890915|FG000|Overall Study|Lost to Follow-up|3|||
16884702|NCT00246259|37890916|FG001|Overall Study|Lost to Follow-up|4|||
16884703|NCT00246259|37890915|FG000|Overall Study|Withdrawal by Subject|5|||
16884704|NCT00246259|37890916|FG001|Overall Study|Withdrawal by Subject|1|||
16884705|NCT00246259|37890915|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
16884706|NCT00246259|37890916|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
16884707|NCT00246025|37890968|FG000|Overall Study|Adverse Event|7|||
16884708|NCT00246025|37890969|FG001|Overall Study|Adverse Event|9|||
16884709|NCT00246025|37890970|FG002|Overall Study|Adverse Event|9|||
16884710|NCT00246025|37890971|FG003|Overall Study|Adverse Event|10|||
16884711|NCT00246025|37890968|FG000|Overall Study|Withdrawal by Subject|3|||
16884712|NCT00246025|37890969|FG001|Overall Study|Withdrawal by Subject|0|||
16884713|NCT00246025|37890970|FG002|Overall Study|Withdrawal by Subject|1|||
16884714|NCT00246025|37890971|FG003|Overall Study|Withdrawal by Subject|2|||
16884715|NCT00246025|37890968|FG000|Overall Study|unsuitable medical history was found|0|||
16884716|NCT00246025|37890969|FG001|Overall Study|unsuitable medical history was found|0|||
16884717|NCT00246025|37890970|FG002|Overall Study|unsuitable medical history was found|0|||
16884718|NCT00246025|37890971|FG003|Overall Study|unsuitable medical history was found|1|||
16884719|NCT00245011|37891114|FG000|Overall Study|Lack of Efficacy|1|||
16884720|NCT00244933|37891127|FG000|Overall Study|Not response evaluable|2|||
16884721|NCT00244855|37891137|FG000|Overall Study|Withdrawal by Subject|0|||
16884722|NCT00244855|37891138|FG001|Overall Study|Withdrawal by Subject|1|||
16884723|NCT00244621|37891168|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16884724|NCT00244621|37891169|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
16884725|NCT00244621|37891170|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
16884726|NCT00244621|37891168|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
16884727|NCT00244621|37891169|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
16884728|NCT00244621|37891170|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16884729|NCT00244621|37891168|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16884730|NCT00244621|37891169|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
16884731|NCT00244621|37891170|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
16884732|NCT00244621|37891168|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
16884733|NCT00244621|37891169|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
16884734|NCT00244621|37891170|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
16884735|NCT00244621|37891168|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
16884736|NCT00244621|37891169|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
16884737|NCT00244621|37891170|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
16884738|NCT00244621|37891168|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
16884739|NCT00244621|37891169|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16884740|NCT00244621|37891170|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
16884741|NCT00244621|37891168|FG000|Open-label Treatment Period|Adverse Event|0|||
16884742|NCT00244621|37891169|FG001|Open-label Treatment Period|Adverse Event|0|||
16884743|NCT00244621|37891170|FG002|Open-label Treatment Period|Adverse Event|1|||
16884744|NCT00244621|37891168|FG000|Open-label Treatment Period|Moved abroad|0|||
16884745|NCT00244621|37891169|FG001|Open-label Treatment Period|Moved abroad|0|||
16884746|NCT00244621|37891170|FG002|Open-label Treatment Period|Moved abroad|1|||
16884747|NCT00243841|37891253|FG000|Overall Study|Physician Decision|0|||
16884748|NCT00243841|37891254|FG001|Overall Study|Physician Decision|0|||
16884749|NCT00243841|37891255|FG002|Overall Study|Physician Decision|1|||
16884750|NCT00243841|37891256|FG003|Overall Study|Physician Decision|0|||
16884751|NCT00243841|37891257|FG004|Overall Study|Physician Decision|0|||
16884752|NCT00243841|37891258|FG005|Overall Study|Physician Decision|2|||
16884753|NCT03100149|37891384|FG000|Overall Study|Adverse Event|0|||
16884754|NCT03100149|37891385|FG001|Overall Study|Adverse Event|1|||
16884755|NCT03100149|37891386|FG002|Overall Study|Adverse Event|0|||
16884756|NCT03100149|37891384|FG000|Overall Study|Participant Moved out of Country|0|||
16884757|NCT03100149|37891385|FG001|Overall Study|Participant Moved out of Country|0|||
16884758|NCT03100149|37891386|FG002|Overall Study|Participant Moved out of Country|1|||
16884759|NCT03100149|37891384|FG000|Overall Study|Withdrawal by Subject|0|||
16884760|NCT03100149|37891385|FG001|Overall Study|Withdrawal by Subject|3|||
16884761|NCT03100149|37891386|FG002|Overall Study|Withdrawal by Subject|1|||
16884762|NCT02980731|37891477|FG000|Overall Study|Death|63|||
16884763|NCT02980731|37891477|FG000|Overall Study|Withdrawal by Subject|6|||
16884764|NCT02980731|37891477|FG000|Overall Study|Lost to Follow-up|5|||
16884765|NCT02980731|37891477|FG000|Overall Study|Study terminated by Sponsor|4|||
16884766|NCT02980731|37891477|FG000|Overall Study|Completed survival follow-up period|65|||
16884767|NCT02980731|37891477|FG000|Overall Study|COVID-19 infection|1|||
16884768|NCT02980731|37891477|FG000|Overall Study|Other, not specified|66|||
16884769|NCT02641587|37891517|FG000|Confinement Period|Adverse Event|1|||
16884770|NCT02641587|37891518|FG001|Confinement Period|Adverse Event|0|||
16884771|NCT02641587|37891517|FG000|Confinement Period|Withdrawal by Subject|2|||
16884772|NCT02641587|37891518|FG001|Confinement Period|Withdrawal by Subject|1|||
16884773|NCT02641587|37891517|FG000|Ambulatory Period|Withdrawal by Subject|1|||
16884774|NCT02641587|37891518|FG001|Ambulatory Period|Withdrawal by Subject|0|||
16884775|NCT04672083|37891642|FG000|Overall Study|Lost to Follow-up|1|||
16884776|NCT04672083|37891643|FG001|Overall Study|Lost to Follow-up|0|||
16884777|NCT04672083|37891644|FG002|Overall Study|Lost to Follow-up|0|||
16884778|NCT04672083|37891645|FG003|Overall Study|Lost to Follow-up|0|||
16884779|NCT04672083|37891646|FG004|Overall Study|Lost to Follow-up|0|||
16884780|NCT02094261|37891725|FG000|Overall Study|Death|24|||
16884781|NCT02094261|37891725|FG000|Overall Study|Lost to Follow-up|1|||
16884782|NCT02094261|37891725|FG000|Overall Study|Withdrawal by Subject|4|||
16884783|NCT02094261|37891725|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
16884784|NCT01781637|37891753|FG000|Overall Study|Adverse Event|1|||
16884785|NCT01781637|37891754|FG001|Overall Study|Adverse Event|0|||
16884786|NCT01781637|37891753|FG000|Overall Study|Lack of Efficacy|2|||
16884787|NCT01781637|37891754|FG001|Overall Study|Lack of Efficacy|6|||
16884788|NCT01781637|37891753|FG000|Overall Study|Withdrawal by Subject|1|||
16884789|NCT01781637|37891754|FG001|Overall Study|Withdrawal by Subject|0|||
16884790|NCT01459497|37891802|FG000|Overall Study|Inability to meet trial constraints.|1|||
16884791|NCT01459497|37891803|FG001|Overall Study|Inability to meet trial constraints.|0|||
16884792|NCT01459497|37891802|FG000|Overall Study|Physician Decision|1|||
16884793|NCT01459497|37891803|FG001|Overall Study|Physician Decision|1|||
16884794|NCT01459497|37891802|FG000|Overall Study|Hospitalization.|0|||
16884795|NCT01459497|37891803|FG001|Overall Study|Hospitalization.|3|||
16884796|NCT01459497|37891802|FG000|Overall Study|Disease progression.|0|||
16884797|NCT01459497|37891803|FG001|Overall Study|Disease progression.|1|||
16884798|NCT04723394|37892081|FG000|Overall Study|Adverse Event|0|||
16884799|NCT04723394|37892082|FG001|Overall Study|Adverse Event|2|||
16884800|NCT04723394|37892081|FG000|Overall Study|Death|6|||
16884801|NCT04723394|37892082|FG001|Overall Study|Death|5|||
16884802|NCT04723394|37892081|FG000|Overall Study|Lost to Follow-up|2|||
16884803|NCT04723394|37892082|FG001|Overall Study|Lost to Follow-up|2|||
16884804|NCT04723394|37892081|FG000|Overall Study|Physician Decision|2|||
16884805|NCT04723394|37892082|FG001|Overall Study|Physician Decision|0|||
16884806|NCT04723394|37892081|FG000|Overall Study|Withdrawal by Subject|10|||
16884807|NCT04723394|37892082|FG001|Overall Study|Withdrawal by Subject|8|||
16884808|NCT04723394|37892081|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
16884809|NCT04723394|37892082|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|5|||
16884810|NCT04723394|37892081|FG000|Overall Study|Still Ongoing at Data Cut-Off|436|||
16884811|NCT04723394|37892082|FG001|Overall Study|Still Ongoing at Data Cut-Off|432|||
16884812|NCT04575584|37892161|FG000|Overall Study|Death|6|||
16884813|NCT04575584|37892162|FG001|Overall Study|Death|4|||
16884814|NCT04575584|37892163|FG002|Overall Study|Death|6|||
16884815|NCT04575584|37892164|FG003|Overall Study|Death|2|||
16884816|NCT04575584|37892165|FG004|Overall Study|Death|0|||
16884817|NCT04575584|37892166|FG005|Overall Study|Death|0|||
16884818|NCT04575584|37892161|FG000|Overall Study|Lost to Follow-up|1|||
16884819|NCT04575584|37892162|FG001|Overall Study|Lost to Follow-up|1|||
16884820|NCT04575584|37892163|FG002|Overall Study|Lost to Follow-up|1|||
16884821|NCT04575584|37892164|FG003|Overall Study|Lost to Follow-up|1|||
16884822|NCT04575584|37892165|FG004|Overall Study|Lost to Follow-up|0|||
16884823|NCT04575584|37892166|FG005|Overall Study|Lost to Follow-up|0|||
16884824|NCT04575584|37892161|FG000|Overall Study|Physician Decision|0|||
16884825|NCT04575584|37892162|FG001|Overall Study|Physician Decision|1|||
16884826|NCT04575584|37892163|FG002|Overall Study|Physician Decision|1|||
16884827|NCT04575584|37892164|FG003|Overall Study|Physician Decision|1|||
16884828|NCT04575584|37892165|FG004|Overall Study|Physician Decision|0|||
16884829|NCT04575584|37892166|FG005|Overall Study|Physician Decision|0|||
16884830|NCT04575584|37892161|FG000|Overall Study|Withdrawal by Subject|7|||
16884831|NCT04575584|37892162|FG001|Overall Study|Withdrawal by Subject|9|||
16884832|NCT04575584|37892163|FG002|Overall Study|Withdrawal by Subject|5|||
16884833|NCT04575584|37892164|FG003|Overall Study|Withdrawal by Subject|3|||
16884834|NCT04575584|37892165|FG004|Overall Study|Withdrawal by Subject|0|||
16884835|NCT04575584|37892166|FG005|Overall Study|Withdrawal by Subject|0|||
16884836|NCT04575584|37892161|FG000|Overall Study|Not recorded|0|||
16884837|NCT04575584|37892162|FG001|Overall Study|Not recorded|0|||
16884838|NCT04575584|37892163|FG002|Overall Study|Not recorded|0|||
16884839|NCT04575584|37892164|FG003|Overall Study|Not recorded|1|||
16884840|NCT04575584|37892165|FG004|Overall Study|Not recorded|0|||
16884841|NCT04575584|37892166|FG005|Overall Study|Not recorded|0|||
16884842|NCT03726879|37892182|FG000|Overall Study|Death|6|||
16884843|NCT03726879|37892183|FG001|Overall Study|Death|4|||
16884844|NCT03726879|37892182|FG000|Overall Study|Physician Decision|0|||
16884845|NCT03726879|37892183|FG001|Overall Study|Physician Decision|2|||
16884846|NCT03726879|37892182|FG000|Overall Study|Protocol Violation|0|||
16884847|NCT03726879|37892183|FG001|Overall Study|Protocol Violation|1|||
16884848|NCT03726879|37892182|FG000|Overall Study|Withdrawal by Subject|5|||
16884849|NCT03726879|37892183|FG001|Overall Study|Withdrawal by Subject|5|||
16884850|NCT03726879|37892182|FG000|Overall Study|TSH result is unstable|0|||
16884851|NCT03726879|37892183|FG001|Overall Study|TSH result is unstable|1|||
16884852|NCT03726879|37892182|FG000|Overall Study|Continuing on Study|215|||
16884853|NCT03726879|37892183|FG001|Overall Study|Continuing on Study|215|||
16884854|NCT03721965|37892214|FG000|Overall Study|Death|1|||
16884855|NCT03721965|37892214|FG000|Overall Study|Study Terminated by Sponsor|1|||
16884856|NCT03873116|37892270|FG000|Overall Study|Study drug discontinuation due to rash|0|||
16884857|NCT03873116|37892271|FG001|Overall Study|Study drug discontinuation due to rash|0|||
16884858|NCT03873116|37892272|FG002|Overall Study|Study drug discontinuation due to rash|1|||
16884859|NCT02312258|37892558|FG000|Overall Study|Adverse Event|15|||
16884860|NCT02312258|37892559|FG001|Overall Study|Adverse Event|47|||
16884861|NCT02312258|37892558|FG000|Overall Study|Lost to Follow-up|0|||
16884862|NCT02312258|37892559|FG001|Overall Study|Lost to Follow-up|1|||
16884863|NCT02312258|37892558|FG000|Overall Study|Progressive Disease|174|||
16884864|NCT02312258|37892559|FG001|Overall Study|Progressive Disease|188|||
16884865|NCT02312258|37892558|FG000|Overall Study|Withdrawal by Subject|8|||
16884866|NCT02312258|37892559|FG001|Overall Study|Withdrawal by Subject|9|||
16884867|NCT02312258|37892558|FG000|Overall Study|Reason not Specified|11|||
16884868|NCT02312258|37892559|FG001|Overall Study|Reason not Specified|31|||
16884869|NCT02312258|37892558|FG000|Overall Study|Participants Ongoing Treatment|43|||
16884870|NCT02312258|37892559|FG001|Overall Study|Participants Ongoing Treatment|83|||
16884871|NCT03686384|37892729|FG000|Overall Study|Lack of Efficacy|4|||
16884872|NCT03686384|37892730|FG001|Overall Study|Lack of Efficacy|13|||
16884873|NCT03686384|37892729|FG000|Overall Study|Lost to Follow-up|3|||
16884874|NCT03686384|37892730|FG001|Overall Study|Lost to Follow-up|0|||
16884875|NCT03686384|37892729|FG000|Overall Study|Physician Decision|0|||
16884876|NCT03686384|37892730|FG001|Overall Study|Physician Decision|1|||
16884877|NCT03686384|37892729|FG000|Overall Study|Took prohibited medication|0|||
16884878|NCT03686384|37892730|FG001|Overall Study|Took prohibited medication|1|||
16884879|NCT00240331|37892802|FG000|Overall Study|Withdrawal by Subject|125|||
16884880|NCT00240331|37892803|FG001|Overall Study|Withdrawal by Subject|132|||
16884881|NCT00240331|37892802|FG000|Overall Study|Option selected by investigator|1|||
16884882|NCT00240331|37892803|FG001|Overall Study|Option selected by investigator|2|||
16884883|NCT00240097|37892809|FG000|Part I|Adverse Event|1|||
16884884|NCT00240097|37892809|FG000|Part I|Death|1|||
16884885|NCT00240097|37892809|FG000|Part I|histology|1|||
16884886|NCT00240097|37892809|FG000|Part I|unevaluable|1|||
16884887|NCT00240097|37892809|FG000|Part II|did not continue from Part I|23|||
16884888|NCT03620162|37892900|FG000|Overall Study|Physician Decision|4|||
16884889|NCT03620162|37892901|FG001|Overall Study|Physician Decision|0|||
16884890|NCT03620162|37892902|FG002|Overall Study|Physician Decision|1|||
16884891|NCT03620162|37892903|FG003|Overall Study|Physician Decision|0|||
16884892|NCT03620162|37892904|FG004|Overall Study|Physician Decision|2|||
16884893|NCT03620162|37892900|FG000|Overall Study|Lost to Follow-up|2|||
16884894|NCT03620162|37892901|FG001|Overall Study|Lost to Follow-up|6|||
16884895|NCT03620162|37892902|FG002|Overall Study|Lost to Follow-up|7|||
16884896|NCT03620162|37892903|FG003|Overall Study|Lost to Follow-up|3|||
16884897|NCT03620162|37892904|FG004|Overall Study|Lost to Follow-up|2|||
16884898|NCT03620162|37892900|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
16884899|NCT03620162|37892901|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
16884900|NCT03620162|37892902|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
16884901|NCT03620162|37892903|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
16884902|NCT03620162|37892904|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
16884903|NCT00248287|37892920|FG000|Overall Study|Adverse Event|11|||
16884904|NCT00248287|37892921|FG001|Overall Study|Adverse Event|10|||
16884905|NCT00248287|37892920|FG000|Overall Study|Death|1|||
16884906|NCT00248287|37892921|FG001|Overall Study|Death|0|||
16884907|NCT00248287|37892920|FG000|Overall Study|Lost to Follow-up|0|||
16884908|NCT00248287|37892921|FG001|Overall Study|Lost to Follow-up|1|||
16884909|NCT00248287|37892920|FG000|Overall Study|Investigator Request|4|||
16884910|NCT00248287|37892921|FG001|Overall Study|Investigator Request|3|||
16884911|NCT00248287|37892920|FG000|Overall Study|Patient Request|5|||
16884912|NCT00248287|37892921|FG001|Overall Study|Patient Request|3|||
16884913|NCT00248287|37892920|FG000|Overall Study|Other|3|||
16884914|NCT00248287|37892921|FG001|Overall Study|Other|2|||
16884915|NCT00378482|37893054|FG000|Overall Study|Lost to Follow-up|1|||
16884916|NCT00378482|37893054|FG000|Overall Study|Lack of Efficacy|8|||
16884917|NCT00378482|37893054|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
16884918|NCT00378482|37893054|FG000|Overall Study|Withdrawal by Subject|4|||
16884919|NCT00378482|37893054|FG000|Overall Study|Adverse Event|9|||
16884920|NCT03084302|37893058|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
16884921|NCT03084302|37893058|FG000|Overall Study|No valid objective monitor data|6|||
16884922|NCT01279681|37893191|FG000|Overall Study|Disease Progression|9|||
16884923|NCT01279681|37893192|FG001|Overall Study|Disease Progression|6|||
16884924|NCT01279681|37893191|FG000|Overall Study|Withdrawal by Subject|3|||
16884925|NCT01279681|37893192|FG001|Overall Study|Withdrawal by Subject|4|||
16884926|NCT01279681|37893191|FG000|Overall Study|Adverse Event|2|||
16884927|NCT01279681|37893192|FG001|Overall Study|Adverse Event|3|||
16884928|NCT01279681|37893191|FG000|Overall Study|Death|0|||
16884929|NCT01279681|37893192|FG001|Overall Study|Death|1|||
16884930|NCT01279681|37893191|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
16884931|NCT01279681|37893192|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
16884932|NCT01279681|37893191|FG000|Overall Study|Physician Decision|1|||
16884933|NCT01279681|37893192|FG001|Overall Study|Physician Decision|0|||
16884934|NCT01279681|37893191|FG000|Overall Study|Other Reason|0|||
16884935|NCT01279681|37893192|FG001|Overall Study|Other Reason|2|||
16884936|NCT01279057|37893210|FG000|Overall Study|Adverse Event|1|||
16884937|NCT01279057|37893211|FG001|Overall Study|Adverse Event|0|||
16884938|NCT01279057|37893212|FG002|Overall Study|Adverse Event|1|||
16884939|NCT01279057|37893210|FG000|Overall Study|Insufficient therapeutic response|0|||
16884940|NCT01279057|37893211|FG001|Overall Study|Insufficient therapeutic response|0|||
16884941|NCT01279057|37893212|FG002|Overall Study|Insufficient therapeutic response|1|||
16884942|NCT01279057|37893210|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
16884943|NCT01279057|37893211|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
16884944|NCT01279057|37893212|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
16884945|NCT01279057|37893210|FG000|Overall Study|Withdrew consent|2|||
16884946|NCT01279057|37893211|FG001|Overall Study|Withdrew consent|0|||
16884947|NCT01279057|37893212|FG002|Overall Study|Withdrew consent|1|||
16884948|NCT01279057|37893210|FG000|Overall Study|Pregnancy|0|||
16884949|NCT01279057|37893211|FG001|Overall Study|Pregnancy|1|||
16884950|NCT01279057|37893212|FG002|Overall Study|Pregnancy|0|||
16884951|NCT01279057|37893210|FG000|Overall Study|Other|3|||
16884952|NCT01279057|37893211|FG001|Overall Study|Other|3|||
16884953|NCT01279057|37893212|FG002|Overall Study|Other|0|||
16884954|NCT02999633|37893220|FG000|Overall Study|Adverse Event|2|||
16884955|NCT02999633|37893220|FG000|Overall Study|Progressive disease|12|||
16884956|NCT01278745|37893322|FG000|Overall Study|Death|2|||
16884957|NCT01278745|37893323|FG001|Overall Study|Death|5|||
16884958|NCT01278745|37893324|FG002|Overall Study|Death|7|||
16884959|NCT01278745|37893325|FG003|Overall Study|Death|0|||
16884960|NCT01278745|37893322|FG000|Overall Study|Physician Decision|1|||
16884961|NCT01278745|37893323|FG001|Overall Study|Physician Decision|0|||
16884962|NCT01278745|37893324|FG002|Overall Study|Physician Decision|0|||
16884963|NCT01278745|37893325|FG003|Overall Study|Physician Decision|9|||
16884964|NCT01278745|37893322|FG000|Overall Study|Withdrawal by Subject|1|||
16884965|NCT01278745|37893323|FG001|Overall Study|Withdrawal by Subject|1|||
16884966|NCT01278745|37893324|FG002|Overall Study|Withdrawal by Subject|5|||
16884967|NCT01278745|37893325|FG003|Overall Study|Withdrawal by Subject|1|||
16884968|NCT01278745|37893322|FG000|Overall Study|Sponsor Decision|1|||
16884969|NCT01278745|37893323|FG001|Overall Study|Sponsor Decision|0|||
16884970|NCT01278745|37893324|FG002|Overall Study|Sponsor Decision|62|||
16884971|NCT01278745|37893325|FG003|Overall Study|Sponsor Decision|6|||
16884972|NCT01278745|37893322|FG000|Overall Study|Ineligible|0|||
16884973|NCT01278745|37893323|FG001|Overall Study|Ineligible|0|||
16884974|NCT01278745|37893324|FG002|Overall Study|Ineligible|42|||
16884975|NCT01278745|37893325|FG003|Overall Study|Ineligible|61|||
16884976|NCT01278745|37893322|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
16884977|NCT01278745|37893323|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
16884978|NCT01278745|37893324|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
16884979|NCT01278745|37893325|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
16884980|NCT03006926|37893335|FG000|Overall Study|Death|0|||
16884981|NCT03006926|37893336|FG001|Overall Study|Death|33|||
16884982|NCT03006926|37893335|FG000|Overall Study|Ongoing Survival Follow-up|0|||
16884983|NCT03006926|37893336|FG001|Overall Study|Ongoing Survival Follow-up|26|||
16884984|NCT03006926|37893335|FG000|Overall Study|Ongoing-on Treatment|0|||
16884985|NCT03006926|37893336|FG001|Overall Study|Ongoing-on Treatment|36|||
16884986|NCT03006926|37893335|FG000|Overall Study|Lost to Follow-up|0|||
16884987|NCT03006926|37893336|FG001|Overall Study|Lost to Follow-up|1|||
16884988|NCT03006926|37893335|FG000|Overall Study|Withdrawal by Subject|0|||
16884989|NCT03006926|37893336|FG001|Overall Study|Withdrawal by Subject|2|||
16884990|NCT01277887|37893398|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
16884991|NCT01277887|37893399|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
16884992|NCT01277887|37893398|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
16884993|NCT01277887|37893399|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
16884994|NCT01277887|37893398|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
16884995|NCT01277887|37893399|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
16884996|NCT01276327|37893413|FG000|Overall Study|Adverse Event|1|||
16884997|NCT01276327|37893414|FG001|Overall Study|Adverse Event|3|||
16884998|NCT01276327|37893413|FG000|Overall Study|Withdrawal by Subject|1|||
16884999|NCT01276327|37893414|FG001|Overall Study|Withdrawal by Subject|0|||
16885000|NCT00639002|37893536|FG000|Overall Study|Death|1|||
16885001|NCT00639002|37893536|FG000|Overall Study|Adverse Event|1|||
16885002|NCT00639002|37893536|FG000|Overall Study|Protocol Violation|1|||
16885003|NCT00639002|37893536|FG000|Overall Study|Disease progression|3|||
16885004|NCT00639002|37893536|FG000|Overall Study|Physician Decision|6|||
16885005|NCT00639002|37893536|FG000|Overall Study|Lack of Efficacy|1|||
16885006|NCT00638846|37893572|FG000|Overall Study|Adverse Event|0|||
16885007|NCT00638846|37893573|FG001|Overall Study|Adverse Event|1|||
16885008|NCT00638846|37893572|FG000|Overall Study|Lost to Follow-up|3|||
16885009|NCT00638846|37893573|FG001|Overall Study|Lost to Follow-up|2|||
16885010|NCT00638846|37893572|FG000|Overall Study|lens issue|1|||
16885011|NCT00638846|37893573|FG001|Overall Study|lens issue|3|||
16885012|NCT00638456|37893581|FG000|Overall Study|Withdrawal by Subject|6|||
16885013|NCT00638456|37893582|FG001|Overall Study|Withdrawal by Subject|2|||
16885014|NCT00638378|37893611|FG000|Overall Study|Death|2|||
16885015|NCT00638378|37893611|FG000|Overall Study|Adverse Event|1|||
16885016|NCT00638378|37893611|FG000|Overall Study|Disease progression|15|||
16885017|NCT00638378|37893611|FG000|Overall Study|Physician Decision|4|||
16885018|NCT03807349|37893788|FG000|Overall Study|Early Study Termination|9|||
16885019|NCT03802825|37893798|FG000|Overall Study|Lost to follow-up for intervention|12|||
16885020|NCT03802825|37893799|FG001|Overall Study|Lost to follow-up for intervention|3|||
16885021|NCT03802825|37893798|FG000|Overall Study|Received only 1 component of intervention|0|||
16885022|NCT03802825|37893799|FG001|Overall Study|Received only 1 component of intervention|13|||
16885023|NCT03808909|37893818|FG000|Overall Study|Lost to Follow-up|3|||
16885024|NCT03808909|37893819|FG001|Overall Study|Lost to Follow-up|0|||
16885025|NCT03802513|37893840|FG000|Overall Study|Lost to Follow-up|1|||
16885026|NCT01276223|37894031|FG000|Overall Study|Adverse Event|7|||
16885027|NCT01276223|37894032|FG001|Overall Study|Adverse Event|4|||
16885028|NCT01276223|37894033|FG002|Overall Study|Adverse Event|1|||
16885029|NCT01276223|37894031|FG000|Overall Study|Lost to Follow-up|0|||
16885030|NCT01276223|37894032|FG001|Overall Study|Lost to Follow-up|0|||
16885031|NCT01276223|37894033|FG002|Overall Study|Lost to Follow-up|1|||
16885032|NCT01276223|37894031|FG000|Overall Study|Other|0|||
16885033|NCT01276223|37894032|FG001|Overall Study|Other|0|||
16885034|NCT01276223|37894033|FG002|Overall Study|Other|1|||
16885035|NCT01276223|37894031|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
16885036|NCT01276223|37894032|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
16885037|NCT01276223|37894033|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
16885038|NCT01276223|37894031|FG000|Overall Study|Protocol Violation|1|||
16885039|NCT01276223|37894032|FG001|Overall Study|Protocol Violation|0|||
16885040|NCT01276223|37894033|FG002|Overall Study|Protocol Violation|0|||
16885041|NCT01275833|37894042|FG000|Overall Study|Study terminated|1|||
16885042|NCT01275833|37894043|FG001|Overall Study|Study terminated|1|||
16885043|NCT01275755|37894051|FG000|Double-blind Treatment Period|Adverse Event|0|||
16885044|NCT01275755|37894052|FG001|Double-blind Treatment Period|Adverse Event|2|||
16885045|NCT01275755|37894051|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
16885046|NCT01275755|37894052|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
16885047|NCT01275755|37894051|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16885048|NCT01275755|37894052|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
16885049|NCT01275755|37894051|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
16885050|NCT01275755|37894052|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
16885051|NCT01275131|37894083|FG000|Period 1|Withdrawal by Subject|1|||
16885052|NCT01275131|37894084|FG001|Period 1|Withdrawal by Subject|0|||
16885053|NCT01275131|37894085|FG002|Period 1|Withdrawal by Subject|3|||
16885054|NCT01275131|37894086|FG003|Period 1|Withdrawal by Subject|2|||
16885055|NCT01275131|37894083|FG000|Period 1|Physician Decision|1|||
16885056|NCT01275131|37894084|FG001|Period 1|Physician Decision|0|||
16885057|NCT01275131|37894085|FG002|Period 1|Physician Decision|0|||
16885058|NCT01275131|37894086|FG003|Period 1|Physician Decision|0|||
16885059|NCT01275131|37894083|FG000|Period 2 (Crossover)|Adverse Event|0|||
16885060|NCT01275131|37894084|FG001|Period 2 (Crossover)|Adverse Event|1|||
16885061|NCT01275131|37894085|FG002|Period 2 (Crossover)|Adverse Event|0|||
16885062|NCT01275131|37894086|FG003|Period 2 (Crossover)|Adverse Event|0|||
16885063|NCT01275131|37894083|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
16885064|NCT01275131|37894084|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
16885065|NCT01275131|37894085|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
16885066|NCT01275131|37894086|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
16885067|NCT01274429|37894115|FG000|Overall Study|Study closed do to lack of funding|5|||
16885068|NCT01273883|37894119|FG000|First Intervention|Adverse Event|2|||
16885069|NCT01273883|37894120|FG001|First Intervention|Adverse Event|1|||
16885070|NCT01273883|37894119|FG000|Second Intervention|Lost to Follow-up|1|||
16885071|NCT01273883|37894120|FG001|Second Intervention|Lost to Follow-up|1|||
16885072|NCT01273883|37894119|FG000|Second Intervention|Lack of Efficacy|1|||
16885073|NCT01273883|37894120|FG001|Second Intervention|Lack of Efficacy|0|||
16885074|NCT01273805|37894128|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
16885075|NCT01273805|37894129|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
16885076|NCT01273181|37894139|FG000|Phase I, Dose 1|Study termination|1|||
16885077|NCT01273181|37894140|FG001|Phase I, Dose 1|Study termination|0|||
16885078|NCT01273181|37894141|FG002|Phase I, Dose 1|Study termination|0|||
16885079|NCT01273181|37894142|FG003|Phase I, Dose 1|Study termination|0|||
16885080|NCT01273181|37894139|FG000|Phase I, Dose 2|Death during treatment|0|||
16885081|NCT01273181|37894140|FG001|Phase I, Dose 2|Death during treatment|1|||
16885082|NCT01273181|37894141|FG002|Phase I, Dose 2|Death during treatment|0|||
16885083|NCT01273181|37894142|FG003|Phase I, Dose 2|Death during treatment|0|||
16885084|NCT01273181|37894139|FG000|Phase 2, Dose 1|Study termination|0|||
16885085|NCT01273181|37894140|FG001|Phase 2, Dose 1|Study termination|0|||
16885086|NCT01273181|37894141|FG002|Phase 2, Dose 1|Study termination|1|||
16885087|NCT01273181|37894142|FG003|Phase 2, Dose 1|Study termination|0|||
16885088|NCT01273181|37894139|FG000|Phase 2, Dose 2|Death during treatment|0|||
16885089|NCT01273181|37894140|FG001|Phase 2, Dose 2|Death during treatment|0|||
16885090|NCT01273181|37894141|FG002|Phase 2, Dose 2|Death during treatment|0|||
16885091|NCT01273181|37894142|FG003|Phase 2, Dose 2|Death during treatment|1|||
16885092|NCT01272947|37894158|FG000|Overall Study|Abnormal Laboratory Value|2|||
16885093|NCT01272947|37894159|FG001|Overall Study|Abnormal Laboratory Value|2|||
16885094|NCT01279343|37894167|FG000|Overall Study|Did not receive treatment|2|||
16885095|NCT01279343|37894168|FG001|Overall Study|Did not receive treatment|6|||
16885096|NCT01278797|37894174|FG000|Period 1|Adverse Event|0|||
16885097|NCT01278797|37894175|FG001|Period 1|Adverse Event|1|||
16885098|NCT01278797|37894174|FG000|Period 1|Protocol Violation|1|||
16885099|NCT01278797|37894175|FG001|Period 1|Protocol Violation|0|||
16885100|NCT01272869|37894183|FG000|Period 2 (14 Days)|Adverse Event|1|||
16885101|NCT01272869|37894184|FG001|Period 2 (14 Days)|Adverse Event|0|||
16885102|NCT01272635|37894192|FG000|Overall Study|Lost to Follow-up|31|||
16885103|NCT01272635|37894193|FG001|Overall Study|Lost to Follow-up|20|||
16885104|NCT01272635|37894194|FG002|Overall Study|Lost to Follow-up|31|||
16885105|NCT01272635|37894195|FG003|Overall Study|Lost to Follow-up|23|||
16885106|NCT01272011|37894206|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
16885107|NCT01272011|37894207|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
16885108|NCT01272011|37894208|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
16885109|NCT01270841|37894229|FG000|Overall Study|Adverse Event|0|||
16885110|NCT01270841|37894230|FG001|Overall Study|Adverse Event|1|||
16885111|NCT01270841|37894231|FG002|Overall Study|Adverse Event|0|||
16885112|NCT01270841|37894232|FG003|Overall Study|Adverse Event|3|||
16885113|NCT01270841|37894229|FG000|Overall Study|Withdrawal by Subject|3|||
16885114|NCT01270841|37894230|FG001|Overall Study|Withdrawal by Subject|2|||
16885115|NCT01270841|37894231|FG002|Overall Study|Withdrawal by Subject|3|||
16885116|NCT01270841|37894232|FG003|Overall Study|Withdrawal by Subject|3|||
16885117|NCT01270841|37894229|FG000|Overall Study|Lost to Follow-up|3|||
16885118|NCT01270841|37894230|FG001|Overall Study|Lost to Follow-up|1|||
16885119|NCT01270841|37894231|FG002|Overall Study|Lost to Follow-up|4|||
16885120|NCT01270841|37894232|FG003|Overall Study|Lost to Follow-up|2|||
16885121|NCT01270841|37894229|FG000|Overall Study|Physician Decision|0|||
16885122|NCT01270841|37894230|FG001|Overall Study|Physician Decision|1|||
16885123|NCT01270841|37894231|FG002|Overall Study|Physician Decision|0|||
16885124|NCT01270841|37894232|FG003|Overall Study|Physician Decision|0|||
16885125|NCT01270841|37894229|FG000|Overall Study|Did not qualify|6|||
16885126|NCT01270841|37894230|FG001|Overall Study|Did not qualify|3|||
16885127|NCT01270841|37894231|FG002|Overall Study|Did not qualify|4|||
16885128|NCT01270841|37894232|FG003|Overall Study|Did not qualify|5|||
16885129|NCT01270841|37894229|FG000|Overall Study|Protocol Violation|1|||
16885130|NCT01270841|37894230|FG001|Overall Study|Protocol Violation|5|||
16885131|NCT01270841|37894231|FG002|Overall Study|Protocol Violation|0|||
16885132|NCT01270841|37894232|FG003|Overall Study|Protocol Violation|0|||
16885133|NCT01270841|37894229|FG000|Overall Study|Enrolled in error|0|||
16885134|NCT01270841|37894230|FG001|Overall Study|Enrolled in error|1|||
16885135|NCT01270841|37894231|FG002|Overall Study|Enrolled in error|0|||
16885136|NCT01270841|37894232|FG003|Overall Study|Enrolled in error|0|||
16885137|NCT01270139|37894245|FG000|Overall Study|Adverse Event|8|||
16885138|NCT01270139|37894246|FG001|Overall Study|Adverse Event|17|||
16885139|NCT01270139|37894247|FG002|Overall Study|Adverse Event|18|||
16885140|NCT01270139|37894245|FG000|Overall Study|Lost to Follow-up|10|||
16885141|NCT01270139|37894246|FG001|Overall Study|Lost to Follow-up|9|||
16885142|NCT01270139|37894247|FG002|Overall Study|Lost to Follow-up|2|||
16885143|NCT01278407|37894265|FG000|Confirmatory Phase|Adverse Event|5|||
16885144|NCT01278407|37894266|FG001|Confirmatory Phase|Adverse Event|10|||
16885145|NCT01278407|37894267|FG002|Confirmatory Phase|Adverse Event|1|||
16885146|NCT01278407|37894268|FG003|Confirmatory Phase|Adverse Event|0|||
16885147|NCT01278407|37894269|FG004|Confirmatory Phase|Adverse Event|0|||
16885148|NCT01278407|37894265|FG000|Confirmatory Phase|Participant's Choice|3|||
16885149|NCT01278407|37894266|FG001|Confirmatory Phase|Participant's Choice|5|||
16885150|NCT01278407|37894267|FG002|Confirmatory Phase|Participant's Choice|3|||
16885151|NCT01278407|37894268|FG003|Confirmatory Phase|Participant's Choice|0|||
16885152|NCT01278407|37894269|FG004|Confirmatory Phase|Participant's Choice|0|||
16885153|NCT01278407|37894265|FG000|Confirmatory Phase|Other|1|||
16885154|NCT01278407|37894266|FG001|Confirmatory Phase|Other|1|||
16885155|NCT01278407|37894267|FG002|Confirmatory Phase|Other|2|||
16885156|NCT01278407|37894268|FG003|Confirmatory Phase|Other|0|||
16885157|NCT01278407|37894269|FG004|Confirmatory Phase|Other|0|||
16885158|NCT01278407|37894265|FG000|Extension Phase|Adverse Event|0|||
16885159|NCT01278407|37894266|FG001|Extension Phase|Adverse Event|0|||
16885160|NCT01278407|37894267|FG002|Extension Phase|Adverse Event|0|||
16885161|NCT01278407|37894268|FG003|Extension Phase|Adverse Event|7|||
16885162|NCT01278407|37894269|FG004|Extension Phase|Adverse Event|16|||
17002296|NCT00844857|38146393|FG001|Overall Study|Did Not Take Study Drug|1|||
16885163|NCT01278407|37894265|FG000|Extension Phase|Participant's Choice|0|||
16885164|NCT01278407|37894266|FG001|Extension Phase|Participant's Choice|0|||
16885165|NCT01278407|37894267|FG002|Extension Phase|Participant's Choice|0|||
16885166|NCT01278407|37894268|FG003|Extension Phase|Participant's Choice|4|||
16885167|NCT01278407|37894269|FG004|Extension Phase|Participant's Choice|11|||
16885168|NCT01278407|37894265|FG000|Extension Phase|Other|0|||
16885169|NCT01278407|37894266|FG001|Extension Phase|Other|0|||
16885170|NCT01278407|37894267|FG002|Extension Phase|Other|0|||
16885171|NCT01278407|37894268|FG003|Extension Phase|Other|1|||
16885172|NCT01278407|37894269|FG004|Extension Phase|Other|3|||
16885173|NCT01278173|37894279|FG000|Overall Study|Lack of Efficacy|13|||
16885174|NCT01278173|37894279|FG000|Overall Study|Adverse Event|8|||
16885175|NCT01278173|37894279|FG000|Overall Study|Administrative or other reason|4|||
16885176|NCT01278173|37894279|FG000|Overall Study|Protocol Violation|1|||
16885177|NCT01278173|37894279|FG000|Overall Study|Withdrawal by Subject|1|||
16885178|NCT01277861|37894323|FG000|Overall Study|Physician Decision|2|||
16885179|NCT01277861|37894324|FG001|Overall Study|Physician Decision|2|||
16885180|NCT01277549|37894351|FG000|Overall Study|Failed to meet eligibility criteria|13|||
16885181|NCT01277549|37894352|FG001|Overall Study|Failed to meet eligibility criteria|9|||
16885182|NCT01277549|37894351|FG000|Overall Study|Withdrawal by Subject|1|||
16885183|NCT01277549|37894352|FG001|Overall Study|Withdrawal by Subject|3|||
16885184|NCT01277549|37894351|FG000|Overall Study|Protocol Violation|10|||
16885185|NCT01277549|37894352|FG001|Overall Study|Protocol Violation|1|||
16885186|NCT01277549|37894351|FG000|Overall Study|Physician Decision|2|||
16885187|NCT01277549|37894352|FG001|Overall Study|Physician Decision|1|||
16885188|NCT01276847|37894364|FG000|Overall Study|Withdrawal by Subject|1|||
16885189|NCT01276847|37894365|FG001|Overall Study|Withdrawal by Subject|0|||
16885190|NCT01276847|37894366|FG002|Overall Study|Withdrawal by Subject|0|||
16885191|NCT01276457|37894398|FG000|Core Study|Adverse Event|6|||
16885192|NCT01276457|37894399|FG001|Core Study|Adverse Event|3|||
16885193|NCT01276457|37894398|FG000|Core Study|Lost to Follow-up|1|||
16885194|NCT01276457|37894399|FG001|Core Study|Lost to Follow-up|2|||
16885195|NCT01276457|37894398|FG000|Core Study|Administrative problems|1|||
16885196|NCT01276457|37894399|FG001|Core Study|Administrative problems|1|||
16885197|NCT01276457|37894398|FG000|Core Study|Death|2|||
16885198|NCT01276457|37894399|FG001|Core Study|Death|2|||
16885199|NCT01276457|37894398|FG000|Core Study|Lack of Efficacy|3|||
16885200|NCT01276457|37894399|FG001|Core Study|Lack of Efficacy|12|||
16885201|NCT01276457|37894398|FG000|Extension Study|Lost to Follow-up|3|||
16885202|NCT01276457|37894399|FG001|Extension Study|Lost to Follow-up|0|||
16885203|NCT01276457|37894398|FG000|Extension Study|Death|0|||
16885204|NCT01276457|37894399|FG001|Extension Study|Death|1|||
16885205|NCT01276457|37894398|FG000|Extension Study|Lack of Efficacy|3|||
16885206|NCT01276457|37894399|FG001|Extension Study|Lack of Efficacy|1|||
16885207|NCT01276379|37894489|FG000|Overall Study|Screening failure|40|||
16885208|NCT03809663|37894785|FG000|Overall Study|Decision by sponsor|24|||
16885209|NCT03809663|37894786|FG001|Overall Study|Decision by sponsor|18|||
16885210|NCT03809663|37894787|FG002|Overall Study|Decision by sponsor|20|||
16885211|NCT03809663|37894788|FG003|Overall Study|Decision by sponsor|20|||
16885212|NCT03809663|37894789|FG004|Overall Study|Decision by sponsor|0|||
16885213|NCT03809663|37894790|FG005|Overall Study|Decision by sponsor|0|||
16885214|NCT03809663|37894785|FG000|Overall Study|Withdrawal by Subject|26|||
16885215|NCT03809663|37894786|FG001|Overall Study|Withdrawal by Subject|22|||
16885216|NCT03809663|37894787|FG002|Overall Study|Withdrawal by Subject|27|||
16885217|NCT03809663|37894788|FG003|Overall Study|Withdrawal by Subject|26|||
16885218|NCT03809663|37894789|FG004|Overall Study|Withdrawal by Subject|0|||
16885219|NCT03809663|37894790|FG005|Overall Study|Withdrawal by Subject|0|||
16885220|NCT03809663|37894785|FG000|Overall Study|Lost to Follow-up|1|||
16885221|NCT03809663|37894786|FG001|Overall Study|Lost to Follow-up|4|||
16885222|NCT03809663|37894787|FG002|Overall Study|Lost to Follow-up|1|||
16885223|NCT03809663|37894788|FG003|Overall Study|Lost to Follow-up|1|||
16885224|NCT03809663|37894789|FG004|Overall Study|Lost to Follow-up|0|||
16885225|NCT03809663|37894790|FG005|Overall Study|Lost to Follow-up|0|||
16885226|NCT00249821|37894852|FG000|Overall Study|Technical problem|0|||
16885227|NCT00249821|37894853|FG001|Overall Study|Technical problem|1|||
16885228|NCT00248651|37894928|FG000|Overall Study|Withdrawal by Subject|28|||
16885229|NCT00248651|37894929|FG001|Overall Study|Withdrawal by Subject|40|||
16885230|NCT00248651|37894930|FG002|Overall Study|Withdrawal by Subject|32|||
16885231|NCT00248495|37894967|FG000|Overall Study|Withdrawal by Subject|1|||
16885232|NCT03802565|37895064|FG000|Overall Study|Adverse Event|0|||
16885233|NCT03802565|37895065|FG001|Overall Study|Adverse Event|1|||
16885234|NCT03802565|37895066|FG002|Overall Study|Adverse Event|2|||
16885235|NCT03802565|37895067|FG003|Overall Study|Adverse Event|1|||
16885236|NCT03802565|37895068|FG004|Overall Study|Adverse Event|1|||
16885237|NCT03802565|37895064|FG000|Overall Study|Withdrawal by Subject|2|||
16885238|NCT03802565|37895065|FG001|Overall Study|Withdrawal by Subject|2|||
16885239|NCT03802565|37895066|FG002|Overall Study|Withdrawal by Subject|2|||
16885240|NCT03802565|37895067|FG003|Overall Study|Withdrawal by Subject|0|||
16885241|NCT03802565|37895068|FG004|Overall Study|Withdrawal by Subject|1|||
16885242|NCT03802565|37895064|FG000|Overall Study|Protocol Violation|2|||
16885243|NCT03802565|37895065|FG001|Overall Study|Protocol Violation|1|||
16885244|NCT03802565|37895066|FG002|Overall Study|Protocol Violation|4|||
16885245|NCT03802565|37895067|FG003|Overall Study|Protocol Violation|5|||
16885246|NCT03802565|37895068|FG004|Overall Study|Protocol Violation|1|||
16885247|NCT03802565|37895064|FG000|Overall Study|Lost to Follow-up|0|||
16885248|NCT03802565|37895065|FG001|Overall Study|Lost to Follow-up|0|||
16885249|NCT03802565|37895066|FG002|Overall Study|Lost to Follow-up|1|||
16885250|NCT03802565|37895067|FG003|Overall Study|Lost to Follow-up|0|||
16885251|NCT03802565|37895068|FG004|Overall Study|Lost to Follow-up|0|||
16885252|NCT03802565|37895064|FG000|Overall Study|Subjects Related to Each Other|1|||
16885253|NCT03802565|37895065|FG001|Overall Study|Subjects Related to Each Other|0|||
16885254|NCT03802565|37895066|FG002|Overall Study|Subjects Related to Each Other|0|||
16885255|NCT03802565|37895067|FG003|Overall Study|Subjects Related to Each Other|2|||
16885256|NCT03802565|37895068|FG004|Overall Study|Subjects Related to Each Other|1|||
16885257|NCT03802565|37895064|FG000|Overall Study|Elevated Enzymes|0|||
16885258|NCT03802565|37895065|FG001|Overall Study|Elevated Enzymes|0|||
16885259|NCT03802565|37895066|FG002|Overall Study|Elevated Enzymes|0|||
16885260|NCT03802565|37895067|FG003|Overall Study|Elevated Enzymes|0|||
16885261|NCT03802565|37895068|FG004|Overall Study|Elevated Enzymes|2|||
16885262|NCT00245765|37895112|FG000|Overall Study|Adverse Event|1|||
16885263|NCT00245765|37895113|FG001|Overall Study|Adverse Event|1|||
16885264|NCT00245765|37895114|FG002|Overall Study|Adverse Event|0|||
16885265|NCT00245765|37895112|FG000|Overall Study|Lack of Efficacy|14|||
16885266|NCT00245765|37895113|FG001|Overall Study|Lack of Efficacy|7|||
16885267|NCT00245765|37895114|FG002|Overall Study|Lack of Efficacy|0|||
16885268|NCT00245765|37895112|FG000|Overall Study|Lost to Follow-up|1|||
16885269|NCT00245765|37895113|FG001|Overall Study|Lost to Follow-up|2|||
16885270|NCT00245765|37895114|FG002|Overall Study|Lost to Follow-up|0|||
16885271|NCT00245765|37895112|FG000|Overall Study|Withdrawal by Subject|1|||
16885272|NCT00245765|37895113|FG001|Overall Study|Withdrawal by Subject|0|||
16885273|NCT00245765|37895114|FG002|Overall Study|Withdrawal by Subject|3|||
16885274|NCT00245765|37895112|FG000|Overall Study|Other reason|2|||
16885275|NCT00245765|37895113|FG001|Overall Study|Other reason|0|||
16885276|NCT00245765|37895114|FG002|Overall Study|Other reason|1|||
16885277|NCT00245765|37895112|FG000|Overall Study|Other|13|||
16885278|NCT00245765|37895113|FG001|Overall Study|Other|4|||
16885279|NCT00245765|37895114|FG002|Overall Study|Other|4|||
16885280|NCT00245063|37895186|FG000|Overall Study|Adverse Event|6|||
16885281|NCT00245063|37895187|FG001|Overall Study|Adverse Event|5|||
16885282|NCT00245063|37895186|FG000|Overall Study|Death|1|||
16885283|NCT00245063|37895187|FG001|Overall Study|Death|0|||
16885284|NCT04329091|37895252|FG000|Overall Study|Physician Decision|5|||
16885285|NCT00244751|37895259|FG000|Overall Study|Adverse Event|7|||
16885286|NCT00244751|37895260|FG001|Overall Study|Adverse Event|7|||
16885287|NCT00244751|37895261|FG002|Overall Study|Adverse Event|5|||
16885288|NCT00244751|37895259|FG000|Overall Study|Lost to Follow-up|0|||
16885289|NCT00244751|37895260|FG001|Overall Study|Lost to Follow-up|1|||
16885290|NCT00244751|37895261|FG002|Overall Study|Lost to Follow-up|0|||
16885291|NCT00244751|37895259|FG000|Overall Study|Protocol Violation|1|||
16885292|NCT00244751|37895260|FG001|Overall Study|Protocol Violation|0|||
16885293|NCT00244751|37895261|FG002|Overall Study|Protocol Violation|1|||
16885294|NCT00244751|37895259|FG000|Overall Study|Withdrawal by Subject|7|||
16885295|NCT00244751|37895260|FG001|Overall Study|Withdrawal by Subject|5|||
16885296|NCT00244751|37895261|FG002|Overall Study|Withdrawal by Subject|3|||
16885297|NCT00244751|37895259|FG000|Overall Study|Elevated liver enzymes|1|||
16885298|NCT00244751|37895260|FG001|Overall Study|Elevated liver enzymes|0|||
16885299|NCT00244751|37895261|FG002|Overall Study|Elevated liver enzymes|0|||
16885300|NCT00244751|37895259|FG000|Overall Study|Lack of compliance with protocol|0|||
16885301|NCT00244751|37895260|FG001|Overall Study|Lack of compliance with protocol|1|||
16885302|NCT00244751|37895261|FG002|Overall Study|Lack of compliance with protocol|0|||
16885303|NCT00244751|37895259|FG000|Overall Study|Safety reasons|0|||
16885304|NCT00244751|37895260|FG001|Overall Study|Safety reasons|1|||
16885305|NCT00244751|37895261|FG002|Overall Study|Safety reasons|0|||
16885306|NCT00244751|37895259|FG000|Overall Study|Participant randomized by mistake|0|||
16885307|NCT00244751|37895260|FG001|Overall Study|Participant randomized by mistake|0|||
16885308|NCT00244751|37895261|FG002|Overall Study|Participant randomized by mistake|1|||
16885309|NCT00243659|37895303|FG000|Overall Study|Withdrawal by Subject|1|||
16885310|NCT00243659|37895304|FG001|Overall Study|Withdrawal by Subject|1|||
16885311|NCT00243659|37895303|FG000|Overall Study|Protocol Violation|1|||
16885312|NCT00243659|37895304|FG001|Overall Study|Protocol Violation|2|||
16885313|NCT00243347|37895319|FG000|Overall Study|Lack of Efficacy|4|||
16885314|NCT00243347|37895319|FG000|Overall Study|Adverse Event|2|||
16885315|NCT00243347|37895319|FG000|Overall Study|Death|1|||
16885316|NCT00243347|37895319|FG000|Overall Study|Withdrawal by Subject|5|||
16885317|NCT00243347|37895319|FG000|Overall Study|Condition worsened|7|||
16885318|NCT00243269|37895327|FG000|Overall Study|Protocol Violation|2|||
16885319|NCT00243269|37895328|FG001|Overall Study|Protocol Violation|1|||
16885320|NCT00243269|37895329|FG002|Overall Study|Protocol Violation|0|||
16885321|NCT00243269|37895330|FG003|Overall Study|Protocol Violation|1|||
16885322|NCT00243269|37895327|FG000|Overall Study|Lost to Follow-up|1|||
16885323|NCT00243269|37895328|FG001|Overall Study|Lost to Follow-up|0|||
16885324|NCT00243269|37895329|FG002|Overall Study|Lost to Follow-up|1|||
16885325|NCT00243269|37895330|FG003|Overall Study|Lost to Follow-up|3|||
16885326|NCT00242567|37896571|FG000|Overall Study|Adverse Event|70|||
16885327|NCT00242567|37896572|FG001|Overall Study|Adverse Event|43|||
16885328|NCT00242567|37896571|FG000|Overall Study|Disease Progression|17|||
16885329|NCT00242567|37896572|FG001|Overall Study|Disease Progression|22|||
16885330|NCT00242567|37896571|FG000|Overall Study|Symptomatic deterioration|9|||
16885331|NCT00242567|37896572|FG001|Overall Study|Symptomatic deterioration|3|||
16885332|NCT00242567|37896571|FG000|Overall Study|Lack of Efficacy|2|||
16885333|NCT00242567|37896572|FG001|Overall Study|Lack of Efficacy|2|||
16885334|NCT00242567|37896571|FG000|Overall Study|Lost to Follow-up|9|||
16885335|NCT00242567|37896572|FG001|Overall Study|Lost to Follow-up|19|||
16885336|NCT00242567|37896571|FG000|Overall Study|Withdrawal by Subject|33|||
16885337|NCT00242567|37896572|FG001|Overall Study|Withdrawal by Subject|28|||
16885338|NCT00242567|37896571|FG000|Overall Study|Protocol Violation|12|||
16885339|NCT00242567|37896572|FG001|Overall Study|Protocol Violation|12|||
16885340|NCT00242567|37896571|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
16885341|NCT00242567|37896572|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
16885342|NCT00242567|37896571|FG000|Overall Study|Other|14|||
16885343|NCT00242567|37896572|FG001|Overall Study|Other|9|||
16885344|NCT00241631|37896582|FG000|Run in (2 Weeks)|Physician Decision|3|||
16885345|NCT00241631|37896583|FG001|Run in (2 Weeks)|Physician Decision|3|||
16885346|NCT00241631|37896582|FG000|Phase 1 (4 Weeks)|sore throat|1|||
16885347|NCT00241631|37896583|FG001|Phase 1 (4 Weeks)|sore throat|0|||
16885348|NCT00241631|37896582|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
16885349|NCT00241631|37896583|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
16885350|NCT00241631|37896582|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
16885351|NCT00241631|37896583|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
16885352|NCT00241631|37896582|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
16885353|NCT00241631|37896583|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
16885354|NCT00240071|37896598|FG000|Overall Study|Withdrawal by Subject|3|||
16885355|NCT03761277|37897586|FG000|Enrollment to Implant|Screen Failure|17|||
16885356|NCT03761277|37897586|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
16885357|NCT03761277|37897586|FG000|Enrollment to Implant|Physician Decision|2|||
16885358|NCT03761277|37897586|FG000|Enrollment to Implant|Site Closure|3|||
16885359|NCT03761277|37897586|FG000|Enrollment to Implant|Sponsor Request|2|||
16885360|NCT03761277|37897586|FG000|Post-Implant to 6 Months|Adverse Event|2|||
16885361|NCT03761277|37897586|FG000|Post-Implant to 6 Months|Death|1|||
16885362|NCT03761277|37897586|FG000|Post-Implant to 6 Months|Site Closure|2|||
16885363|NCT03761277|37897586|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
16885364|NCT03761277|37897586|FG000|6 Months to 12 Months|Physician Decision|2|||
16885365|NCT03761277|37897586|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
16885366|NCT04099641|37897637|FG000|Overall Study|Death|46|||
16885367|NCT04099641|37897638|FG001|Overall Study|Death|12|||
16885368|NCT04099641|37897637|FG000|Overall Study|Lost to Follow-up|1|||
16885369|NCT04099641|37897638|FG001|Overall Study|Lost to Follow-up|0|||
16885370|NCT04099641|37897637|FG000|Overall Study|Withdrawal by Subject|2|||
16885371|NCT04099641|37897638|FG001|Overall Study|Withdrawal by Subject|0|||
16885372|NCT02499328|37897676|FG000|Overall Study|Withdrawal by Subject|1|||
16885373|NCT02499328|37897677|FG001|Overall Study|Withdrawal by Subject|1|||
16885374|NCT02499328|37897678|FG002|Overall Study|Withdrawal by Subject|5|||
16885375|NCT02499328|37897679|FG003|Overall Study|Withdrawal by Subject|3|||
16885376|NCT02499328|37897680|FG004|Overall Study|Withdrawal by Subject|5|||
16885377|NCT02499328|37897681|FG005|Overall Study|Withdrawal by Subject|0|||
16885378|NCT02499328|37897682|FG006|Overall Study|Withdrawal by Subject|0|||
16885379|NCT02499328|37897683|FG007|Overall Study|Withdrawal by Subject|0|||
16885380|NCT02499328|37897684|FG008|Overall Study|Withdrawal by Subject|2|||
16885381|NCT02499328|37897685|FG009|Overall Study|Withdrawal by Subject|2|||
16885382|NCT02499328|37897686|FG010|Overall Study|Withdrawal by Subject|0|||
16885383|NCT02499328|37897687|FG011|Overall Study|Withdrawal by Subject|3|||
16885384|NCT02499328|37897688|FG012|Overall Study|Withdrawal by Subject|7|||
16885385|NCT02499328|37897689|FG013|Overall Study|Withdrawal by Subject|3|||
16885386|NCT02499328|37897690|FG014|Overall Study|Withdrawal by Subject|1|||
16885387|NCT02499328|37897691|FG015|Overall Study|Withdrawal by Subject|0|||
16885388|NCT02499328|37897692|FG016|Overall Study|Withdrawal by Subject|0|||
16885389|NCT02499328|37897693|FG017|Overall Study|Withdrawal by Subject|3|||
16885390|NCT02499328|37897694|FG018|Overall Study|Withdrawal by Subject|0|||
16885391|NCT02499328|37897676|FG000|Overall Study|Lost to Follow-up|0|||
16885392|NCT02499328|37897677|FG001|Overall Study|Lost to Follow-up|1|||
16885393|NCT02499328|37897678|FG002|Overall Study|Lost to Follow-up|1|||
16885394|NCT02499328|37897679|FG003|Overall Study|Lost to Follow-up|2|||
16885395|NCT02499328|37897680|FG004|Overall Study|Lost to Follow-up|0|||
16885396|NCT02499328|37897681|FG005|Overall Study|Lost to Follow-up|0|||
16885397|NCT02499328|37897682|FG006|Overall Study|Lost to Follow-up|0|||
16885398|NCT02499328|37897683|FG007|Overall Study|Lost to Follow-up|2|||
16885399|NCT02499328|37897684|FG008|Overall Study|Lost to Follow-up|3|||
16885400|NCT02499328|37897685|FG009|Overall Study|Lost to Follow-up|0|||
16885401|NCT02499328|37897686|FG010|Overall Study|Lost to Follow-up|0|||
16885402|NCT02499328|37897687|FG011|Overall Study|Lost to Follow-up|0|||
16885403|NCT02499328|37897688|FG012|Overall Study|Lost to Follow-up|0|||
16885404|NCT02499328|37897689|FG013|Overall Study|Lost to Follow-up|0|||
16885405|NCT02499328|37897690|FG014|Overall Study|Lost to Follow-up|0|||
16885406|NCT02499328|37897691|FG015|Overall Study|Lost to Follow-up|0|||
16885407|NCT02499328|37897692|FG016|Overall Study|Lost to Follow-up|0|||
16885408|NCT02499328|37897693|FG017|Overall Study|Lost to Follow-up|0|||
16885409|NCT02499328|37897694|FG018|Overall Study|Lost to Follow-up|1|||
16885410|NCT02499328|37897676|FG000|Overall Study|Death|0|||
16885411|NCT02499328|37897677|FG001|Overall Study|Death|3|||
16885412|NCT02499328|37897678|FG002|Overall Study|Death|3|||
16885413|NCT02499328|37897679|FG003|Overall Study|Death|2|||
16885414|NCT02499328|37897680|FG004|Overall Study|Death|4|||
16885415|NCT02499328|37897681|FG005|Overall Study|Death|7|||
16885416|NCT02499328|37897682|FG006|Overall Study|Death|3|||
16885417|NCT02499328|37897683|FG007|Overall Study|Death|0|||
16885418|NCT02499328|37897684|FG008|Overall Study|Death|2|||
16885419|NCT02499328|37897685|FG009|Overall Study|Death|6|||
16885420|NCT02499328|37897686|FG010|Overall Study|Death|6|||
16885421|NCT02499328|37897687|FG011|Overall Study|Death|20|||
16885422|NCT02499328|37897688|FG012|Overall Study|Death|9|||
16885423|NCT02499328|37897689|FG013|Overall Study|Death|7|||
16885424|NCT02499328|37897690|FG014|Overall Study|Death|3|||
16885425|NCT02499328|37897691|FG015|Overall Study|Death|1|||
16885426|NCT02499328|37897692|FG016|Overall Study|Death|1|||
16885427|NCT02499328|37897693|FG017|Overall Study|Death|16|||
16885428|NCT02499328|37897694|FG018|Overall Study|Death|5|||
16885429|NCT02499328|37897676|FG000|Overall Study|"Other"|2|||
17095319|NCT00261846|38234546|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
17095320|NCT00261846|38234547|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
16885430|NCT02499328|37897677|FG001|Overall Study|"Other"|2|||
16885431|NCT02499328|37897678|FG002|Overall Study|"Other"|1|||
16885432|NCT02499328|37897679|FG003|Overall Study|"Other"|3|||
16885433|NCT02499328|37897680|FG004|Overall Study|"Other"|6|||
16885434|NCT02499328|37897681|FG005|Overall Study|"Other"|2|||
16885435|NCT02499328|37897682|FG006|Overall Study|"Other"|3|||
16885436|NCT02499328|37897683|FG007|Overall Study|"Other"|4|||
16885437|NCT02499328|37897684|FG008|Overall Study|"Other"|6|||
16885438|NCT02499328|37897685|FG009|Overall Study|"Other"|16|||
16885439|NCT02499328|37897686|FG010|Overall Study|"Other"|13|||
16885440|NCT02499328|37897687|FG011|Overall Study|"Other"|31|||
16885441|NCT02499328|37897688|FG012|Overall Study|"Other"|8|||
16885442|NCT02499328|37897689|FG013|Overall Study|"Other"|7|||
16885443|NCT02499328|37897690|FG014|Overall Study|"Other"|6|||
16885444|NCT02499328|37897691|FG015|Overall Study|"Other"|0|||
16885445|NCT02499328|37897692|FG016|Overall Study|"Other"|0|||
16885446|NCT02499328|37897693|FG017|Overall Study|"Other"|34|||
16885447|NCT02499328|37897694|FG018|Overall Study|"Other"|43|||
16885448|NCT02499328|37897676|FG000|Overall Study|Disease Progression|0|||
16885449|NCT02499328|37897677|FG001|Overall Study|Disease Progression|0|||
16885450|NCT02499328|37897678|FG002|Overall Study|Disease Progression|0|||
16885451|NCT02499328|37897679|FG003|Overall Study|Disease Progression|0|||
16885452|NCT02499328|37897680|FG004|Overall Study|Disease Progression|0|||
16885453|NCT02499328|37897681|FG005|Overall Study|Disease Progression|0|||
16885454|NCT02499328|37897682|FG006|Overall Study|Disease Progression|1|||
16885455|NCT02499328|37897683|FG007|Overall Study|Disease Progression|0|||
16885456|NCT02499328|37897684|FG008|Overall Study|Disease Progression|1|||
16885457|NCT02499328|37897685|FG009|Overall Study|Disease Progression|0|||
16885458|NCT02499328|37897686|FG010|Overall Study|Disease Progression|1|||
16885459|NCT02499328|37897687|FG011|Overall Study|Disease Progression|0|||
16885460|NCT02499328|37897688|FG012|Overall Study|Disease Progression|0|||
16885461|NCT02499328|37897689|FG013|Overall Study|Disease Progression|0|||
16885462|NCT02499328|37897690|FG014|Overall Study|Disease Progression|0|||
16885463|NCT02499328|37897691|FG015|Overall Study|Disease Progression|0|||
16885464|NCT02499328|37897692|FG016|Overall Study|Disease Progression|0|||
16885465|NCT02499328|37897693|FG017|Overall Study|Disease Progression|2|||
16885466|NCT02499328|37897694|FG018|Overall Study|Disease Progression|0|||
16885467|NCT02499328|37897676|FG000|Overall Study|Adverse Event|1|||
16885468|NCT02499328|37897677|FG001|Overall Study|Adverse Event|0|||
16885469|NCT02499328|37897678|FG002|Overall Study|Adverse Event|0|||
16885470|NCT02499328|37897679|FG003|Overall Study|Adverse Event|1|||
16885471|NCT02499328|37897680|FG004|Overall Study|Adverse Event|0|||
16885472|NCT02499328|37897681|FG005|Overall Study|Adverse Event|0|||
16885473|NCT02499328|37897682|FG006|Overall Study|Adverse Event|0|||
16885474|NCT02499328|37897683|FG007|Overall Study|Adverse Event|0|||
16885475|NCT02499328|37897684|FG008|Overall Study|Adverse Event|0|||
16885476|NCT02499328|37897685|FG009|Overall Study|Adverse Event|0|||
16885477|NCT02499328|37897686|FG010|Overall Study|Adverse Event|0|||
16885478|NCT02499328|37897687|FG011|Overall Study|Adverse Event|0|||
16885479|NCT02499328|37897688|FG012|Overall Study|Adverse Event|1|||
16885480|NCT02499328|37897689|FG013|Overall Study|Adverse Event|0|||
16885481|NCT02499328|37897690|FG014|Overall Study|Adverse Event|0|||
16885482|NCT02499328|37897691|FG015|Overall Study|Adverse Event|0|||
16885483|NCT02499328|37897692|FG016|Overall Study|Adverse Event|0|||
16885484|NCT02499328|37897693|FG017|Overall Study|Adverse Event|0|||
16885485|NCT02499328|37897694|FG018|Overall Study|Adverse Event|0|||
16885486|NCT03123393|37897884|FG000|Overall Study|Study Terminated by Sponsor|6|||
16885487|NCT03123393|37897885|FG001|Overall Study|Study Terminated by Sponsor|9|||
16885488|NCT03123393|37897884|FG000|Overall Study|Withdrawal by Subject|2|||
16885489|NCT03123393|37897885|FG001|Overall Study|Withdrawal by Subject|1|||
16885490|NCT03123393|37897884|FG000|Overall Study|Reason not Specified|13|||
16885491|NCT03123393|37897885|FG001|Overall Study|Reason not Specified|13|||
16885492|NCT02834247|37898516|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
16885493|NCT02834247|37898517|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
16885494|NCT02834247|37898518|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
16885495|NCT02834247|37898519|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
16885496|NCT02834247|37898516|FG000|Dose Escalation Phase|Death|5|||
16885497|NCT02834247|37898517|FG001|Dose Escalation Phase|Death|6|||
16885498|NCT02834247|37898518|FG002|Dose Escalation Phase|Death|5|||
16885499|NCT02834247|37898519|FG003|Dose Escalation Phase|Death|0|||
16885500|NCT02834247|37898516|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
16885501|NCT02834247|37898517|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
16885502|NCT02834247|37898518|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
16885503|NCT02834247|37898519|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
16885504|NCT02834247|37898516|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
16885505|NCT02834247|37898517|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
16885506|NCT02834247|37898518|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16885507|NCT02834247|37898519|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16885508|NCT02834247|37898516|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
16885509|NCT02834247|37898517|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
16885510|NCT02834247|37898518|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
16885511|NCT02834247|37898519|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
16885512|NCT02834247|37898516|FG000|Dose Expansion Phase|Death|0|||
16885513|NCT02834247|37898517|FG001|Dose Expansion Phase|Death|0|||
16885514|NCT02834247|37898518|FG002|Dose Expansion Phase|Death|0|||
16885515|NCT02834247|37898519|FG003|Dose Expansion Phase|Death|8|||
16885516|NCT02834247|37898516|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
16885517|NCT02834247|37898517|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
16885518|NCT02834247|37898518|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
16885519|NCT02834247|37898519|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
16885520|NCT02834247|37898516|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
16885521|NCT02834247|37898517|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
16885522|NCT02834247|37898518|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
16885523|NCT02834247|37898519|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
16885524|NCT01839331|37899845|FG000|Overall Study|Early Termination|3|||
16885525|NCT01839331|37899846|FG001|Overall Study|Early Termination|0|||
16885526|NCT01839331|37899847|FG002|Overall Study|Early Termination|1|||
16885527|NCT01839331|37899848|FG003|Overall Study|Early Termination|2|||
16885528|NCT01839331|37899845|FG000|Overall Study|Protocol Violation|1|||
16885529|NCT01839331|37899846|FG001|Overall Study|Protocol Violation|6|||
16885530|NCT01839331|37899847|FG002|Overall Study|Protocol Violation|4|||
16885531|NCT01839331|37899848|FG003|Overall Study|Protocol Violation|3|||
16885532|NCT02733042|37899994|FG000|Treatment Period|Adverse Event|1|||
16885533|NCT02733042|37899995|FG001|Treatment Period|Adverse Event|0|||
16885534|NCT02733042|37899996|FG002|Treatment Period|Adverse Event|1|||
16885535|NCT02733042|37899997|FG003|Treatment Period|Adverse Event|1|||
16885536|NCT02733042|37899998|FG004|Treatment Period|Adverse Event|0|||
16885537|NCT02733042|37899999|FG005|Treatment Period|Adverse Event|0|||
16885538|NCT02733042|37900000|FG006|Treatment Period|Adverse Event|0|||
16885539|NCT02733042|37900001|FG007|Treatment Period|Adverse Event|0|||
16885540|NCT02733042|37900002|FG008|Treatment Period|Adverse Event|0|||
16885541|NCT02733042|37900003|FG009|Treatment Period|Adverse Event|0|||
16885542|NCT02733042|37900004|FG010|Treatment Period|Adverse Event|2|||
16885543|NCT02733042|37900005|FG011|Treatment Period|Adverse Event|2|||
16885544|NCT02733042|37900006|FG012|Treatment Period|Adverse Event|0|||
16885545|NCT02733042|37900007|FG013|Treatment Period|Adverse Event|2|||
16885546|NCT02733042|37900008|FG014|Treatment Period|Adverse Event|0|||
16885547|NCT02733042|37900009|FG015|Treatment Period|Adverse Event|0|||
16885548|NCT02733042|37900010|FG016|Treatment Period|Adverse Event|0|||
16885549|NCT02733042|37900011|FG017|Treatment Period|Adverse Event|1|||
16885550|NCT02733042|37900012|FG018|Treatment Period|Adverse Event|0|||
16885551|NCT02733042|37899994|FG000|Treatment Period|Progressive Disease|2|||
16885552|NCT02733042|37899995|FG001|Treatment Period|Progressive Disease|1|||
16885553|NCT02733042|37899996|FG002|Treatment Period|Progressive Disease|3|||
16885554|NCT02733042|37899997|FG003|Treatment Period|Progressive Disease|1|||
16885555|NCT02733042|37899998|FG004|Treatment Period|Progressive Disease|1|||
16885556|NCT02733042|37899999|FG005|Treatment Period|Progressive Disease|3|||
16885557|NCT02733042|37900000|FG006|Treatment Period|Progressive Disease|0|||
16885558|NCT02733042|37900001|FG007|Treatment Period|Progressive Disease|3|||
16885559|NCT02733042|37900002|FG008|Treatment Period|Progressive Disease|3|||
16885560|NCT02733042|37900003|FG009|Treatment Period|Progressive Disease|0|||
16885561|NCT02733042|37900004|FG010|Treatment Period|Progressive Disease|2|||
16885562|NCT02733042|37900005|FG011|Treatment Period|Progressive Disease|2|||
16885563|NCT02733042|37900006|FG012|Treatment Period|Progressive Disease|8|||
16885564|NCT02733042|37900007|FG013|Treatment Period|Progressive Disease|1|||
16885565|NCT02733042|37900008|FG014|Treatment Period|Progressive Disease|4|||
16885566|NCT02733042|37900009|FG015|Treatment Period|Progressive Disease|7|||
16885567|NCT02733042|37900010|FG016|Treatment Period|Progressive Disease|2|||
16885568|NCT02733042|37900011|FG017|Treatment Period|Progressive Disease|3|||
16885569|NCT02733042|37900012|FG018|Treatment Period|Progressive Disease|4|||
16885570|NCT02733042|37899994|FG000|Treatment Period|Withdrawal by Subject|0|||
16885571|NCT02733042|37899995|FG001|Treatment Period|Withdrawal by Subject|1|||
16885572|NCT02733042|37899996|FG002|Treatment Period|Withdrawal by Subject|2|||
16885573|NCT02733042|37899997|FG003|Treatment Period|Withdrawal by Subject|1|||
16885574|NCT02733042|37899998|FG004|Treatment Period|Withdrawal by Subject|0|||
16885575|NCT02733042|37899999|FG005|Treatment Period|Withdrawal by Subject|0|||
16885576|NCT02733042|37900000|FG006|Treatment Period|Withdrawal by Subject|0|||
16885577|NCT02733042|37900001|FG007|Treatment Period|Withdrawal by Subject|0|||
16885578|NCT02733042|37900002|FG008|Treatment Period|Withdrawal by Subject|1|||
16885579|NCT02733042|37900003|FG009|Treatment Period|Withdrawal by Subject|1|||
16885580|NCT02733042|37900004|FG010|Treatment Period|Withdrawal by Subject|0|||
16885581|NCT02733042|37900005|FG011|Treatment Period|Withdrawal by Subject|2|||
16885582|NCT02733042|37900006|FG012|Treatment Period|Withdrawal by Subject|1|||
16885583|NCT02733042|37900007|FG013|Treatment Period|Withdrawal by Subject|1|||
16885584|NCT02733042|37900008|FG014|Treatment Period|Withdrawal by Subject|0|||
16885585|NCT02733042|37900009|FG015|Treatment Period|Withdrawal by Subject|0|||
16885586|NCT02733042|37900010|FG016|Treatment Period|Withdrawal by Subject|0|||
16885587|NCT02733042|37900011|FG017|Treatment Period|Withdrawal by Subject|0|||
16885588|NCT02733042|37900012|FG018|Treatment Period|Withdrawal by Subject|0|||
17095321|NCT00261846|38234548|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
16885589|NCT02733042|37899994|FG000|Treatment Period|Other|0|||
16885590|NCT02733042|37899995|FG001|Treatment Period|Other|0|||
16885591|NCT02733042|37899996|FG002|Treatment Period|Other|1|||
16885592|NCT02733042|37899997|FG003|Treatment Period|Other|0|||
16885593|NCT02733042|37899998|FG004|Treatment Period|Other|0|||
16885594|NCT02733042|37899999|FG005|Treatment Period|Other|0|||
16885595|NCT02733042|37900000|FG006|Treatment Period|Other|0|||
16885596|NCT02733042|37900001|FG007|Treatment Period|Other|0|||
16885597|NCT02733042|37900002|FG008|Treatment Period|Other|0|||
16885598|NCT02733042|37900003|FG009|Treatment Period|Other|1|||
16885599|NCT02733042|37900004|FG010|Treatment Period|Other|1|||
16885600|NCT02733042|37900005|FG011|Treatment Period|Other|0|||
16885601|NCT02733042|37900006|FG012|Treatment Period|Other|0|||
16885602|NCT02733042|37900007|FG013|Treatment Period|Other|0|||
16885603|NCT02733042|37900008|FG014|Treatment Period|Other|0|||
16885604|NCT02733042|37900009|FG015|Treatment Period|Other|1|||
16885605|NCT02733042|37900010|FG016|Treatment Period|Other|0|||
16885606|NCT02733042|37900011|FG017|Treatment Period|Other|1|||
16885607|NCT02733042|37900012|FG018|Treatment Period|Other|0|||
16885608|NCT02733042|37899994|FG000|Treatment Period|Ongoing on Assigned Treatment|0|||
16885609|NCT02733042|37899995|FG001|Treatment Period|Ongoing on Assigned Treatment|0|||
16885610|NCT02733042|37899996|FG002|Treatment Period|Ongoing on Assigned Treatment|0|||
16885611|NCT02733042|37899997|FG003|Treatment Period|Ongoing on Assigned Treatment|0|||
16885612|NCT02733042|37899998|FG004|Treatment Period|Ongoing on Assigned Treatment|3|||
16885613|NCT02733042|37899999|FG005|Treatment Period|Ongoing on Assigned Treatment|0|||
16885614|NCT02733042|37900000|FG006|Treatment Period|Ongoing on Assigned Treatment|0|||
16885615|NCT02733042|37900001|FG007|Treatment Period|Ongoing on Assigned Treatment|0|||
16885616|NCT02733042|37900002|FG008|Treatment Period|Ongoing on Assigned Treatment|0|||
16885617|NCT02733042|37900003|FG009|Treatment Period|Ongoing on Assigned Treatment|8|||
16885618|NCT02733042|37900004|FG010|Treatment Period|Ongoing on Assigned Treatment|4|||
16885619|NCT02733042|37900005|FG011|Treatment Period|Ongoing on Assigned Treatment|0|||
16885620|NCT02733042|37900006|FG012|Treatment Period|Ongoing on Assigned Treatment|0|||
16885621|NCT02733042|37900007|FG013|Treatment Period|Ongoing on Assigned Treatment|0|||
16885622|NCT02733042|37900008|FG014|Treatment Period|Ongoing on Assigned Treatment|0|||
16885623|NCT02733042|37900009|FG015|Treatment Period|Ongoing on Assigned Treatment|0|||
16885624|NCT02733042|37900010|FG016|Treatment Period|Ongoing on Assigned Treatment|0|||
16885625|NCT02733042|37900011|FG017|Treatment Period|Ongoing on Assigned Treatment|0|||
16885626|NCT02733042|37900012|FG018|Treatment Period|Ongoing on Assigned Treatment|1|||
16885627|NCT02733042|37899994|FG000|Treatment Period|Death|0|||
16885628|NCT02733042|37899995|FG001|Treatment Period|Death|0|||
16885629|NCT02733042|37899996|FG002|Treatment Period|Death|0|||
16885630|NCT02733042|37899997|FG003|Treatment Period|Death|0|||
16885631|NCT02733042|37899998|FG004|Treatment Period|Death|0|||
16885632|NCT02733042|37899999|FG005|Treatment Period|Death|0|||
16885633|NCT02733042|37900000|FG006|Treatment Period|Death|1|||
16885634|NCT02733042|37900001|FG007|Treatment Period|Death|0|||
16885635|NCT02733042|37900002|FG008|Treatment Period|Death|1|||
16885636|NCT02733042|37900003|FG009|Treatment Period|Death|0|||
16885637|NCT02733042|37900004|FG010|Treatment Period|Death|1|||
16885638|NCT02733042|37900005|FG011|Treatment Period|Death|0|||
16885639|NCT02733042|37900006|FG012|Treatment Period|Death|0|||
16885640|NCT02733042|37900007|FG013|Treatment Period|Death|0|||
16885641|NCT02733042|37900008|FG014|Treatment Period|Death|1|||
16885642|NCT02733042|37900009|FG015|Treatment Period|Death|2|||
16885643|NCT02733042|37900010|FG016|Treatment Period|Death|0|||
16885644|NCT02733042|37900011|FG017|Treatment Period|Death|0|||
16885645|NCT02733042|37900012|FG018|Treatment Period|Death|0|||
16885646|NCT02733042|37899994|FG000|Follow-up Period|Ongoing on Follow-up|2|||
16885647|NCT02733042|37899995|FG001|Follow-up Period|Ongoing on Follow-up|2|||
16885648|NCT02733042|37899996|FG002|Follow-up Period|Ongoing on Follow-up|4|||
16885649|NCT02733042|37899997|FG003|Follow-up Period|Ongoing on Follow-up|2|||
16885650|NCT02733042|37899998|FG004|Follow-up Period|Ongoing on Follow-up|0|||
16885651|NCT02733042|37899999|FG005|Follow-up Period|Ongoing on Follow-up|0|||
16885652|NCT02733042|37900000|FG006|Follow-up Period|Ongoing on Follow-up|0|||
16885653|NCT02733042|37900001|FG007|Follow-up Period|Ongoing on Follow-up|1|||
16885654|NCT02733042|37900002|FG008|Follow-up Period|Ongoing on Follow-up|0|||
17095322|NCT00261846|38234549|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
16885655|NCT02733042|37900003|FG009|Follow-up Period|Ongoing on Follow-up|2|||
16885656|NCT02733042|37900004|FG010|Follow-up Period|Ongoing on Follow-up|4|||
16885657|NCT02733042|37900005|FG011|Follow-up Period|Ongoing on Follow-up|9|||
16885658|NCT02733042|37900006|FG012|Follow-up Period|Ongoing on Follow-up|1|||
16885659|NCT02733042|37900007|FG013|Follow-up Period|Ongoing on Follow-up|3|||
16885660|NCT02733042|37900008|FG014|Follow-up Period|Ongoing on Follow-up|0|||
16885661|NCT02733042|37900009|FG015|Follow-up Period|Ongoing on Follow-up|0|||
16885662|NCT02733042|37900010|FG016|Follow-up Period|Ongoing on Follow-up|0|||
16885663|NCT02733042|37900011|FG017|Follow-up Period|Ongoing on Follow-up|1|||
16885664|NCT02733042|37900012|FG018|Follow-up Period|Ongoing on Follow-up|0|||
16885665|NCT02733042|37899994|FG000|Follow-up Period|Death|1|||
16885666|NCT02733042|37899995|FG001|Follow-up Period|Death|1|||
16885667|NCT02733042|37899996|FG002|Follow-up Period|Death|2|||
16885668|NCT02733042|37899997|FG003|Follow-up Period|Death|0|||
16885669|NCT02733042|37899998|FG004|Follow-up Period|Death|1|||
16885670|NCT02733042|37899999|FG005|Follow-up Period|Death|2|||
16885671|NCT02733042|37900000|FG006|Follow-up Period|Death|0|||
16885672|NCT02733042|37900001|FG007|Follow-up Period|Death|3|||
16885673|NCT02733042|37900002|FG008|Follow-up Period|Death|3|||
16885674|NCT02733042|37900003|FG009|Follow-up Period|Death|0|||
16885675|NCT02733042|37900004|FG010|Follow-up Period|Death|0|||
16885676|NCT02733042|37900005|FG011|Follow-up Period|Death|0|||
16885677|NCT02733042|37900006|FG012|Follow-up Period|Death|8|||
16885678|NCT02733042|37900007|FG013|Follow-up Period|Death|1|||
16885679|NCT02733042|37900008|FG014|Follow-up Period|Death|1|||
16885680|NCT02733042|37900009|FG015|Follow-up Period|Death|4|||
16885681|NCT02733042|37900010|FG016|Follow-up Period|Death|0|||
16885682|NCT02733042|37900011|FG017|Follow-up Period|Death|1|||
16885683|NCT02733042|37900012|FG018|Follow-up Period|Death|2|||
16885684|NCT02733042|37899994|FG000|Follow-up Period|Other|0|||
16885685|NCT02733042|37899995|FG001|Follow-up Period|Other|0|||
16885686|NCT02733042|37899996|FG002|Follow-up Period|Other|0|||
16885687|NCT02733042|37899997|FG003|Follow-up Period|Other|1|||
16885688|NCT02733042|37899998|FG004|Follow-up Period|Other|0|||
16885689|NCT02733042|37899999|FG005|Follow-up Period|Other|0|||
16885690|NCT02733042|37900000|FG006|Follow-up Period|Other|0|||
16885691|NCT02733042|37900001|FG007|Follow-up Period|Other|0|||
16885692|NCT02733042|37900002|FG008|Follow-up Period|Other|0|||
16885693|NCT02733042|37900003|FG009|Follow-up Period|Other|0|||
16885694|NCT02733042|37900004|FG010|Follow-up Period|Other|0|||
16885695|NCT02733042|37900005|FG011|Follow-up Period|Other|0|||
16885696|NCT02733042|37900006|FG012|Follow-up Period|Other|0|||
16885697|NCT02733042|37900007|FG013|Follow-up Period|Other|0|||
16885698|NCT02733042|37900008|FG014|Follow-up Period|Other|0|||
16885699|NCT02733042|37900009|FG015|Follow-up Period|Other|0|||
16885700|NCT02733042|37900010|FG016|Follow-up Period|Other|0|||
16885701|NCT02733042|37900011|FG017|Follow-up Period|Other|0|||
16885702|NCT02733042|37900012|FG018|Follow-up Period|Other|0|||
16885703|NCT02733042|37899994|FG000|Follow-up Period|Withdrawal by Subject|0|||
16885704|NCT02733042|37899995|FG001|Follow-up Period|Withdrawal by Subject|0|||
16885705|NCT02733042|37899996|FG002|Follow-up Period|Withdrawal by Subject|0|||
16885706|NCT02733042|37899997|FG003|Follow-up Period|Withdrawal by Subject|0|||
16885707|NCT02733042|37899998|FG004|Follow-up Period|Withdrawal by Subject|0|||
16885708|NCT02733042|37899999|FG005|Follow-up Period|Withdrawal by Subject|0|||
16885709|NCT02733042|37900000|FG006|Follow-up Period|Withdrawal by Subject|0|||
16885710|NCT02733042|37900001|FG007|Follow-up Period|Withdrawal by Subject|0|||
16885711|NCT02733042|37900002|FG008|Follow-up Period|Withdrawal by Subject|1|||
16885712|NCT02733042|37900003|FG009|Follow-up Period|Withdrawal by Subject|0|||
16885713|NCT02733042|37900004|FG010|Follow-up Period|Withdrawal by Subject|1|||
16885714|NCT02733042|37900005|FG011|Follow-up Period|Withdrawal by Subject|0|||
16885715|NCT02733042|37900006|FG012|Follow-up Period|Withdrawal by Subject|0|||
16885716|NCT02733042|37900007|FG013|Follow-up Period|Withdrawal by Subject|0|||
16885717|NCT02733042|37900008|FG014|Follow-up Period|Withdrawal by Subject|0|||
16885718|NCT02733042|37900009|FG015|Follow-up Period|Withdrawal by Subject|1|||
16885719|NCT02733042|37900010|FG016|Follow-up Period|Withdrawal by Subject|0|||
16885720|NCT02733042|37900011|FG017|Follow-up Period|Withdrawal by Subject|0|||
16885721|NCT02733042|37900012|FG018|Follow-up Period|Withdrawal by Subject|0|||
16885722|NCT02426658|37900200|FG000|Overall Study|Withdrawal by Subject|1|||
16885723|NCT02426658|37900200|FG000|Overall Study|Patient expired before treatment|2|||
16885724|NCT01606176|37900284|FG000|Overall Study|Adverse Event|2|||
16885725|NCT01606176|37900285|FG001|Overall Study|Adverse Event|3|||
16885726|NCT01606176|37900284|FG000|Overall Study|Disease progression|1|||
16885727|NCT01606176|37900285|FG001|Overall Study|Disease progression|0|||
16885728|NCT01606176|37900284|FG000|Overall Study|Withdrawal by Subject|1|||
16885729|NCT01606176|37900285|FG001|Overall Study|Withdrawal by Subject|0|||
16885730|NCT01663896|37900351|FG000|Overall Study|Various reasons|43|||
16885731|NCT02576652|37900404|FG000|Overall Study|Withdrawal by Subject|2|||
16885732|NCT02575950|37900488|FG000|Overall Study|Withdrawal by Subject|0|||
16885733|NCT02575950|37900489|FG001|Overall Study|Withdrawal by Subject|0|||
16885734|NCT02575950|37900490|FG002|Overall Study|Withdrawal by Subject|0|||
16885735|NCT02575950|37900491|FG003|Overall Study|Withdrawal by Subject|2|||
16885736|NCT02575950|37900488|FG000|Overall Study|Lost to Follow-up|0|||
16885737|NCT02575950|37900489|FG001|Overall Study|Lost to Follow-up|1|||
16885738|NCT02575950|37900490|FG002|Overall Study|Lost to Follow-up|0|||
16885739|NCT02575950|37900491|FG003|Overall Study|Lost to Follow-up|3|||
16885740|NCT01049581|37900599|FG000|Overall Study|Lost to Follow-up|2|||
16885741|NCT01049581|37900600|FG001|Overall Study|Lost to Follow-up|1|||
16885742|NCT03462719|37900620|FG000|Overall Study|Withdrawal by Subject|2|||
16885743|NCT03462719|37900621|FG001|Overall Study|Withdrawal by Subject|3|||
16885744|NCT03462719|37900620|FG000|Overall Study|Ongoing|93|||
16885745|NCT03462719|37900621|FG001|Overall Study|Ongoing|91|||
16885746|NCT02571972|37900627|FG000|Overall Study|Protocol Violation|2|||
16885747|NCT02571972|37900627|FG000|Overall Study|Withdrawal by Subject|2|||
16885748|NCT02166905|37900716|FG000|Overall Study|Withdrawal by Subject|1|||
16885749|NCT02166905|37900717|FG001|Overall Study|Withdrawal by Subject|0|||
16885750|NCT02166905|37900718|FG002|Overall Study|Withdrawal by Subject|0|||
16885751|NCT02166905|37900719|FG003|Overall Study|Withdrawal by Subject|0|||
16885752|NCT01501955|37900766|FG000|Overall Study|Withdrawal by Subject|1|||
16885753|NCT01501955|37900767|FG001|Overall Study|Withdrawal by Subject|0|||
16885754|NCT01501955|37900766|FG000|Overall Study|Adverse Event|1|||
16885755|NCT01501955|37900767|FG001|Overall Study|Adverse Event|3|||
16885756|NCT02574312|37900895|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
16885757|NCT02574312|37900896|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
16885758|NCT01049035|37900918|FG000|Overall Study|Serious adverse event|0|||
16885759|NCT01049035|37900919|FG001|Overall Study|Serious adverse event|1|||
16885760|NCT01049035|37900920|FG002|Overall Study|Serious adverse event|1|||
16885761|NCT01049035|37900921|FG003|Overall Study|Serious adverse event|2|||
16885762|NCT01049035|37900922|FG004|Overall Study|Serious adverse event|0|||
16885763|NCT01049035|37900923|FG005|Overall Study|Serious adverse event|0|||
16885764|NCT01049035|37900924|FG006|Overall Study|Serious adverse event|0|||
16885765|NCT01049035|37900918|FG000|Overall Study|Other adverse event (AE)|0|||
16885766|NCT01049035|37900919|FG001|Overall Study|Other adverse event (AE)|0|||
16885767|NCT01049035|37900920|FG002|Overall Study|Other adverse event (AE)|0|||
16885768|NCT01049035|37900921|FG003|Overall Study|Other adverse event (AE)|1|||
16885769|NCT01049035|37900922|FG004|Overall Study|Other adverse event (AE)|0|||
16885770|NCT01049035|37900923|FG005|Overall Study|Other adverse event (AE)|0|||
16885771|NCT01049035|37900924|FG006|Overall Study|Other adverse event (AE)|0|||
16885772|NCT01049035|37900918|FG000|Overall Study|Non-compliance with the protocol|12|||
16885773|NCT01049035|37900919|FG001|Overall Study|Non-compliance with the protocol|6|||
16885774|NCT01049035|37900920|FG002|Overall Study|Non-compliance with the protocol|14|||
16885775|NCT01049035|37900921|FG003|Overall Study|Non-compliance with the protocol|5|||
16885776|NCT01049035|37900922|FG004|Overall Study|Non-compliance with the protocol|3|||
16885777|NCT01049035|37900923|FG005|Overall Study|Non-compliance with the protocol|4|||
16885778|NCT01049035|37900924|FG006|Overall Study|Non-compliance with the protocol|10|||
16885779|NCT01049035|37900918|FG000|Overall Study|Lost to Follow-up|5|||
16885780|NCT01049035|37900919|FG001|Overall Study|Lost to Follow-up|4|||
16885781|NCT01049035|37900920|FG002|Overall Study|Lost to Follow-up|4|||
16885782|NCT01049035|37900921|FG003|Overall Study|Lost to Follow-up|1|||
16885783|NCT01049035|37900922|FG004|Overall Study|Lost to Follow-up|0|||
16885784|NCT01049035|37900923|FG005|Overall Study|Lost to Follow-up|3|||
16885785|NCT01049035|37900924|FG006|Overall Study|Lost to Follow-up|3|||
16885786|NCT01049035|37900918|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
16885787|NCT01049035|37900919|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
16885788|NCT01049035|37900920|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
16885789|NCT01049035|37900921|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
16885790|NCT01049035|37900922|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
16885791|NCT01049035|37900923|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
16885792|NCT01049035|37900924|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
16885793|NCT01048333|37900950|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16885794|NCT01048333|37900951|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
16885795|NCT01048333|37900952|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16885796|NCT01048333|37900953|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16885797|NCT01048333|37900954|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16885798|NCT01048333|37900955|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16885799|NCT02323113|37900970|FG000|Overall Study|Adverse Event|3|||
16885800|NCT02323113|37900971|FG001|Overall Study|Adverse Event|3|||
16885801|NCT02323113|37900972|FG002|Overall Study|Adverse Event|2|||
16885802|NCT02323113|37900973|FG003|Overall Study|Adverse Event|5|||
16885803|NCT02323113|37900974|FG004|Overall Study|Adverse Event|8|||
16885804|NCT02323113|37900975|FG005|Overall Study|Adverse Event|3|||
16885805|NCT02323113|37900976|FG006|Overall Study|Adverse Event|6|||
16885806|NCT02323113|37900977|FG007|Overall Study|Adverse Event|0|||
16885807|NCT02323113|37900970|FG000|Overall Study|Progressive Disease|0|||
16885808|NCT02323113|37900971|FG001|Overall Study|Progressive Disease|1|||
16885809|NCT02323113|37900972|FG002|Overall Study|Progressive Disease|1|||
16885810|NCT02323113|37900973|FG003|Overall Study|Progressive Disease|0|||
16885811|NCT02323113|37900974|FG004|Overall Study|Progressive Disease|0|||
16885812|NCT02323113|37900975|FG005|Overall Study|Progressive Disease|3|||
16885813|NCT02323113|37900976|FG006|Overall Study|Progressive Disease|0|||
16885814|NCT02323113|37900977|FG007|Overall Study|Progressive Disease|0|||
16885815|NCT02323113|37900970|FG000|Overall Study|Symptomatic Deterioration|0|||
16885816|NCT02323113|37900971|FG001|Overall Study|Symptomatic Deterioration|0|||
16885817|NCT02323113|37900972|FG002|Overall Study|Symptomatic Deterioration|1|||
16885818|NCT02323113|37900973|FG003|Overall Study|Symptomatic Deterioration|0|||
16885819|NCT02323113|37900974|FG004|Overall Study|Symptomatic Deterioration|1|||
16885820|NCT02323113|37900975|FG005|Overall Study|Symptomatic Deterioration|0|||
16885821|NCT02323113|37900976|FG006|Overall Study|Symptomatic Deterioration|0|||
16885822|NCT02323113|37900977|FG007|Overall Study|Symptomatic Deterioration|0|||
17002297|NCT00844857|38146392|FG000|Overall Study|Good Clinical Practice Violations|21|||
16885823|NCT02323113|37900970|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
16885824|NCT02323113|37900971|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
16885825|NCT02323113|37900972|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
16885826|NCT02323113|37900973|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
16885827|NCT02323113|37900974|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
16885828|NCT02323113|37900975|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
16885829|NCT02323113|37900976|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
16885830|NCT02323113|37900977|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
16885831|NCT02323113|37900970|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16885832|NCT02323113|37900971|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
16885833|NCT02323113|37900972|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16885834|NCT02323113|37900973|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16885835|NCT02323113|37900974|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16885836|NCT02323113|37900975|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16885837|NCT02323113|37900976|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16885838|NCT02323113|37900977|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16885839|NCT02281383|37901028|FG000|Overall Study|Progressive Disease|1|||
16885840|NCT02281383|37901028|FG000|Overall Study|Withdrawal by Subject|6|||
16885841|NCT02281383|37901028|FG000|Overall Study|Protocol Violation|2|||
16885842|NCT02281383|37901028|FG000|Overall Study|Death|1|||
16885843|NCT02281383|37901028|FG000|Overall Study|Adverse Event|2|||
16885844|NCT01047553|37901034|FG000|Overall Study|Adverse Event|10|||
16885845|NCT01047553|37901035|FG001|Overall Study|Adverse Event|5|||
16885846|NCT01047553|37901034|FG000|Overall Study|Withdrawal by Subject|4|||
16885847|NCT01047553|37901035|FG001|Overall Study|Withdrawal by Subject|2|||
16885848|NCT01047553|37901034|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
16885849|NCT01047553|37901035|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
16885850|NCT01047553|37901034|FG000|Overall Study|Lost to Follow-up|1|||
16785756|NCT02694523|37725861|FG000|Part B|Adverse Event|0|||
16785757|NCT02694523|37725862|FG001|Part B|Adverse Event|0|||
16785758|NCT02694523|37725863|FG002|Part B|Adverse Event|7|||
16785759|NCT02694523|37725864|FG003|Part B|Adverse Event|1|||
16785760|NCT02694523|37725865|FG004|Part B|Adverse Event|1|||
16785761|NCT02694523|37725866|FG005|Part B|Adverse Event|2|||
16785762|NCT02694523|37725867|FG006|Part B|Adverse Event|0|||
16785763|NCT02694523|37725861|FG000|Part B|Protocol Violation|0|||
16785764|NCT02694523|37725862|FG001|Part B|Protocol Violation|0|||
16785765|NCT02694523|37725863|FG002|Part B|Protocol Violation|1|||
16785766|NCT02694523|37725864|FG003|Part B|Protocol Violation|0|||
16785767|NCT02694523|37725865|FG004|Part B|Protocol Violation|0|||
16785768|NCT02694523|37725866|FG005|Part B|Protocol Violation|0|||
16785769|NCT02694523|37725867|FG006|Part B|Protocol Violation|0|||
16785770|NCT02694523|37725861|FG000|Part B|Lost to Follow-up|0|||
16785771|NCT02694523|37725862|FG001|Part B|Lost to Follow-up|0|||
16785772|NCT02694523|37725863|FG002|Part B|Lost to Follow-up|2|||
16785773|NCT02694523|37725864|FG003|Part B|Lost to Follow-up|3|||
16885851|NCT01047553|37901035|FG001|Overall Study|Lost to Follow-up|0|||
16885852|NCT01047553|37901034|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
16885853|NCT01047553|37901035|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
16885854|NCT01047553|37901034|FG000|Overall Study|PI's decision|0|||
16885855|NCT01047553|37901035|FG001|Overall Study|PI's decision|1|||
16885856|NCT01047007|37901069|FG000|Overall Study|Adverse Event|0|||
16885857|NCT01047007|37901070|FG001|Overall Study|Adverse Event|2|||
16885858|NCT01047007|37901071|FG002|Overall Study|Adverse Event|1|||
16885859|NCT01047007|37901072|FG003|Overall Study|Adverse Event|0|||
16885860|NCT01047007|37901069|FG000|Overall Study|Progressive Disease|2|||
16885861|NCT01047007|37901070|FG001|Overall Study|Progressive Disease|4|||
16885862|NCT01047007|37901071|FG002|Overall Study|Progressive Disease|1|||
16885863|NCT01047007|37901072|FG003|Overall Study|Progressive Disease|0|||
16885864|NCT01046695|37901084|FG000|Overall Study|Subject had a pacemaker|0|||
16885865|NCT01046695|37901085|FG001|Overall Study|Subject had a pacemaker|1|||
16885866|NCT01046695|37901084|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
16885867|NCT01046695|37901085|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
16885868|NCT03304379|37901100|FG000|Overall Study|Protocol Violation|8|||
16785774|NCT02694523|37725865|FG004|Part B|Lost to Follow-up|2|||
16785775|NCT02694523|37725866|FG005|Part B|Lost to Follow-up|0|||
16785776|NCT02694523|37725867|FG006|Part B|Lost to Follow-up|1|||
16785777|NCT02694523|37725861|FG000|Part B|Withdrawal by Subject|0|||
16785778|NCT02694523|37725862|FG001|Part B|Withdrawal by Subject|0|||
16885869|NCT03304379|37901101|FG001|Overall Study|Protocol Violation|10|||
16885870|NCT03304379|37901102|FG002|Overall Study|Protocol Violation|5|||
16885871|NCT03304379|37901103|FG003|Overall Study|Protocol Violation|0|||
16885872|NCT03304379|37901104|FG004|Overall Study|Protocol Violation|2|||
16885873|NCT03304379|37901100|FG000|Overall Study|Adverse Event|4|||
16885874|NCT03304379|37901101|FG001|Overall Study|Adverse Event|20|||
16885875|NCT03304379|37901102|FG002|Overall Study|Adverse Event|17|||
16885876|NCT03304379|37901103|FG003|Overall Study|Adverse Event|1|||
16885877|NCT03304379|37901104|FG004|Overall Study|Adverse Event|0|||
16885878|NCT03304379|37901100|FG000|Overall Study|Lack of Efficacy|17|||
16885879|NCT03304379|37901101|FG001|Overall Study|Lack of Efficacy|16|||
16885880|NCT03304379|37901102|FG002|Overall Study|Lack of Efficacy|20|||
16885881|NCT03304379|37901103|FG003|Overall Study|Lack of Efficacy|0|||
16885882|NCT03304379|37901104|FG004|Overall Study|Lack of Efficacy|0|||
16885883|NCT03304379|37901100|FG000|Overall Study|Physician Decision|6|||
16885884|NCT03304379|37901101|FG001|Overall Study|Physician Decision|10|||
16885885|NCT03304379|37901102|FG002|Overall Study|Physician Decision|6|||
16885886|NCT03304379|37901103|FG003|Overall Study|Physician Decision|9|||
16885887|NCT03304379|37901104|FG004|Overall Study|Physician Decision|10|||
16885888|NCT03304379|37901100|FG000|Overall Study|Withdrawal by Subject|26|||
16885889|NCT03304379|37901101|FG001|Overall Study|Withdrawal by Subject|58|||
16885890|NCT03304379|37901102|FG002|Overall Study|Withdrawal by Subject|66|||
16885891|NCT03304379|37901103|FG003|Overall Study|Withdrawal by Subject|3|||
16885892|NCT03304379|37901104|FG004|Overall Study|Withdrawal by Subject|5|||
16885893|NCT03304379|37901100|FG000|Overall Study|Lost to Follow-up|8|||
16885894|NCT03304379|37901101|FG001|Overall Study|Lost to Follow-up|24|||
16885895|NCT03304379|37901102|FG002|Overall Study|Lost to Follow-up|35|||
16885896|NCT03304379|37901103|FG003|Overall Study|Lost to Follow-up|4|||
16885897|NCT03304379|37901104|FG004|Overall Study|Lost to Follow-up|0|||
16885898|NCT03304379|37901100|FG000|Overall Study|Death|1|||
16885899|NCT03304379|37901101|FG001|Overall Study|Death|2|||
16885900|NCT03304379|37901102|FG002|Overall Study|Death|0|||
16885901|NCT03304379|37901103|FG003|Overall Study|Death|0|||
16885902|NCT03304379|37901104|FG004|Overall Study|Death|0|||
16885903|NCT03304379|37901100|FG000|Overall Study|Other|0|||
16885904|NCT03304379|37901101|FG001|Overall Study|Other|1|||
16885905|NCT03304379|37901102|FG002|Overall Study|Other|0|||
16885906|NCT03304379|37901103|FG003|Overall Study|Other|0|||
16885907|NCT03304379|37901104|FG004|Overall Study|Other|0|||
16885908|NCT01044745|37901159|FG000|Overall Study|Ineiligible|2|||
16885909|NCT01044433|37901182|FG000|Overall Study|Lost to Follow-up|3|||
16885910|NCT01044433|37901182|FG000|Overall Study|Withdrawal by Subject|3|||
16885911|NCT01043185|37901187|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
16885912|NCT01043185|37901188|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
16885913|NCT01043185|37901189|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
16885914|NCT01043185|37901190|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
16885915|NCT01043185|37901191|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
16885916|NCT01043185|37901192|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
16885917|NCT01043185|37901193|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
16885918|NCT01043185|37901194|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
16885919|NCT01043185|37901195|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
16885920|NCT01043185|37901196|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
16885921|NCT01042093|37901221|FG000|Overall Study|Protocol Violation|2|||
16885922|NCT01042093|37901222|FG001|Overall Study|Protocol Violation|2|||
16885923|NCT01042093|37901223|FG002|Overall Study|Protocol Violation|2|||
16885924|NCT01042093|37901224|FG003|Overall Study|Protocol Violation|3|||
16885925|NCT01042093|37901221|FG000|Overall Study|Withdrawal by Subject|0|||
16885926|NCT01042093|37901222|FG001|Overall Study|Withdrawal by Subject|0|||
16885927|NCT01042093|37901223|FG002|Overall Study|Withdrawal by Subject|0|||
16885928|NCT01042093|37901224|FG003|Overall Study|Withdrawal by Subject|1|||
16885929|NCT01041859|37901254|FG000|Open-Label Titration|Adverse Event|69|||
16885930|NCT01041859|37901255|FG001|Open-Label Titration|Adverse Event|0|||
16885931|NCT01041859|37901256|FG002|Open-Label Titration|Adverse Event|0|||
16885932|NCT01041859|37901254|FG000|Open-Label Titration|Lack of Efficacy|3|||
16885933|NCT01041859|37901255|FG001|Open-Label Titration|Lack of Efficacy|0|||
16885934|NCT01041859|37901256|FG002|Open-Label Titration|Lack of Efficacy|0|||
16885935|NCT01041859|37901254|FG000|Open-Label Titration|Lost to Follow-up|1|||
16885936|NCT01041859|37901255|FG001|Open-Label Titration|Lost to Follow-up|0|||
16885937|NCT01041859|37901256|FG002|Open-Label Titration|Lost to Follow-up|0|||
16885938|NCT01041859|37901254|FG000|Open-Label Titration|Physician Decision|1|||
16885939|NCT01041859|37901255|FG001|Open-Label Titration|Physician Decision|0|||
16885940|NCT01041859|37901256|FG002|Open-Label Titration|Physician Decision|0|||
16885941|NCT01041859|37901254|FG000|Open-Label Titration|Protocol Violation|1|||
16885942|NCT01041859|37901255|FG001|Open-Label Titration|Protocol Violation|0|||
16885943|NCT01041859|37901256|FG002|Open-Label Titration|Protocol Violation|0|||
16885944|NCT01041859|37901254|FG000|Open-Label Titration|Other|7|||
16885945|NCT01041859|37901255|FG001|Open-Label Titration|Other|0|||
16885946|NCT01041859|37901256|FG002|Open-Label Titration|Other|0|||
16885947|NCT01041859|37901254|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
16885948|NCT01041859|37901255|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
16885949|NCT01041859|37901256|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
16885950|NCT01041859|37901254|FG000|Open-Label Titration|Withdrawal by Subject|11|||
16885951|NCT01041859|37901255|FG001|Open-Label Titration|Withdrawal by Subject|0|||
16885952|NCT01041859|37901256|FG002|Open-Label Titration|Withdrawal by Subject|0|||
16885953|NCT01041859|37901254|FG000|Double-Blind Maintenance|Adverse Event|0|||
16885954|NCT01041859|37901255|FG001|Double-Blind Maintenance|Adverse Event|23|||
16885955|NCT01041859|37901256|FG002|Double-Blind Maintenance|Adverse Event|13|||
16885956|NCT01041859|37901254|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
16885957|NCT01041859|37901255|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
16885958|NCT01041859|37901256|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
16885959|NCT01041859|37901254|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
16885960|NCT01041859|37901255|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
16885961|NCT01041859|37901256|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
16885962|NCT01041859|37901254|FG000|Double-Blind Maintenance|Physician Decision|0|||
16885963|NCT01041859|37901255|FG001|Double-Blind Maintenance|Physician Decision|2|||
16885964|NCT01041859|37901256|FG002|Double-Blind Maintenance|Physician Decision|1|||
16885965|NCT01041859|37901254|FG000|Double-Blind Maintenance|Protocol Violation|0|||
16885966|NCT01041859|37901255|FG001|Double-Blind Maintenance|Protocol Violation|1|||
16885967|NCT01041859|37901256|FG002|Double-Blind Maintenance|Protocol Violation|3|||
16885968|NCT01041859|37901254|FG000|Double-Blind Maintenance|Other|0|||
16885969|NCT01041859|37901255|FG001|Double-Blind Maintenance|Other|6|||
16885970|NCT01041859|37901256|FG002|Double-Blind Maintenance|Other|2|||
16885971|NCT01041859|37901254|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
17002298|NCT00844857|38146393|FG001|Overall Study|Good Clinical Practice Violations|11|||
17002299|NCT00569803|38146410|FG000|Overall Study|Lost to Follow-up|1|||
17191940|NCT00158756|38344963|FG003|Overall Study|Serious adverse event|0|||
17191941|NCT00158756|38344964|FG004|Overall Study|Serious adverse event|0|||
17191942|NCT02730195|38344976|FG000|Overall Study|Withdrawal by Subject|1|||
17191943|NCT02730351|38344980|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
17191944|NCT02730351|38344981|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
17191945|NCT02730351|38344980|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
17191946|NCT02730351|38344981|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
17191947|NCT02730351|38344980|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
17191948|NCT02730351|38344981|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
17191949|NCT02730351|38344980|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
17191950|NCT02730351|38344981|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
17191951|NCT02730351|38344980|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
17191952|NCT02730351|38344981|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
17191953|NCT01376349|38344990|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
17191954|NCT01376349|38344991|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
17191955|NCT01376349|38344992|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
17191956|NCT01376349|38344990|FG000|Raondomized Treatment|Adverse Event|13|||
17191957|NCT01376349|38344991|FG001|Raondomized Treatment|Adverse Event|17|||
17191958|NCT01376349|38344992|FG002|Raondomized Treatment|Adverse Event|14|||
17191959|NCT01376349|38344990|FG000|Raondomized Treatment|Unkown|1|||
17191960|NCT01376349|38344991|FG001|Raondomized Treatment|Unkown|2|||
17191961|NCT01376349|38344992|FG002|Raondomized Treatment|Unkown|1|||
17191962|NCT01376349|38344990|FG000|Raondomized Treatment|Alternative Treatment|0|||
17191963|NCT01376349|38344991|FG001|Raondomized Treatment|Alternative Treatment|0|||
17191964|NCT01376349|38344992|FG002|Raondomized Treatment|Alternative Treatment|1|||
17191965|NCT00158600|38345030|FG000|Overall Study|unable to commit time to study|0|||
17191966|NCT00158600|38345031|FG001|Overall Study|unable to commit time to study|1|||
17191967|NCT00158600|38345030|FG000|Overall Study|Adverse Event|2|||
17191968|NCT00158600|38345031|FG001|Overall Study|Adverse Event|1|||
17191969|NCT00158600|38345030|FG000|Overall Study|Death|1|||
17191970|NCT00158600|38345031|FG001|Overall Study|Death|0|||
17191971|NCT00158600|38345030|FG000|Overall Study|Withdrawal by Subject|2|||
17191972|NCT00158600|38345031|FG001|Overall Study|Withdrawal by Subject|2|||
17191973|NCT01680458|38345042|FG000|Overall Study|Protocol Violation|3|||
17191974|NCT00709761|38345046|FG000|Overall Study|Withdrawal by Subject|8|||
17191975|NCT00709761|38345046|FG000|Overall Study|study closed/terminated|17|||
17191976|NCT00709761|38345046|FG000|Overall Study|Lost to Follow-up|2|||
17191977|NCT02358031|38345059|FG000|Overall Study|Death|226|||
17191978|NCT02358031|38345060|FG001|Overall Study|Death|204|||
17191979|NCT02358031|38345061|FG002|Overall Study|Death|249|||
17191980|NCT02358031|38345059|FG000|Overall Study|Lost to Follow-up|0|||
17191981|NCT02358031|38345060|FG001|Overall Study|Lost to Follow-up|1|||
17191982|NCT02358031|38345061|FG002|Overall Study|Lost to Follow-up|1|||
17191983|NCT02358031|38345059|FG000|Overall Study|Withdrawal by Subject|14|||
17191984|NCT02358031|38345060|FG001|Overall Study|Withdrawal by Subject|12|||
17191985|NCT02358031|38345061|FG002|Overall Study|Withdrawal by Subject|17|||
17191986|NCT02358031|38345059|FG000|Overall Study|Ongoing in Study|61|||
17191987|NCT02358031|38345060|FG001|Overall Study|Ongoing in Study|64|||
16885972|NCT01041859|37901255|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
16885973|NCT01041859|37901256|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
16885974|NCT01041859|37901254|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
16885975|NCT01041859|37901255|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
16885976|NCT01041859|37901256|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
16885977|NCT01040845|37901265|FG000|Overall Study|Withdrawal by Subject|1|||
16885978|NCT01040845|37901266|FG001|Overall Study|Withdrawal by Subject|1|||
16885979|NCT01040845|37901265|FG000|Overall Study|Physician Decision|1|||
16885980|NCT01040845|37901266|FG001|Overall Study|Physician Decision|0|||
16885981|NCT01040689|37901274|FG000|Overall Study|Adverse Event|0|||
16885982|NCT01040689|37901275|FG001|Overall Study|Adverse Event|0|||
16885983|NCT01040689|37901276|FG002|Overall Study|Adverse Event|2|||
16885984|NCT01040689|37901277|FG003|Overall Study|Adverse Event|4|||
16885985|NCT01040689|37901274|FG000|Overall Study|Lack of Efficacy|0|||
16885986|NCT01040689|37901275|FG001|Overall Study|Lack of Efficacy|0|||
16885987|NCT01040689|37901276|FG002|Overall Study|Lack of Efficacy|1|||
16885988|NCT01040689|37901277|FG003|Overall Study|Lack of Efficacy|0|||
16885989|NCT01040689|37901274|FG000|Overall Study|Lost to Follow-up|1|||
16885990|NCT01040689|37901275|FG001|Overall Study|Lost to Follow-up|0|||
16885991|NCT01040689|37901276|FG002|Overall Study|Lost to Follow-up|0|||
16885992|NCT01040689|37901277|FG003|Overall Study|Lost to Follow-up|0|||
16885993|NCT01040689|37901274|FG000|Overall Study|Withdrawal by Subject|2|||
16885994|NCT01040689|37901275|FG001|Overall Study|Withdrawal by Subject|1|||
16885995|NCT01040689|37901276|FG002|Overall Study|Withdrawal by Subject|1|||
16885996|NCT01040689|37901277|FG003|Overall Study|Withdrawal by Subject|0|||
16885997|NCT01040689|37901274|FG000|Overall Study|Other reasons not listed above|0|||
16885998|NCT01040689|37901275|FG001|Overall Study|Other reasons not listed above|1|||
16885999|NCT01040689|37901276|FG002|Overall Study|Other reasons not listed above|0|||
16886000|NCT01040689|37901277|FG003|Overall Study|Other reasons not listed above|0|||
17002300|NCT00569803|38146411|FG001|Overall Study|Lost to Follow-up|0|||
17002301|NCT00569803|38146412|FG002|Overall Study|Lost to Follow-up|0|||
17002302|NCT00569803|38146413|FG003|Overall Study|Lost to Follow-up|0|||
17002303|NCT00569803|38146414|FG004|Overall Study|Lost to Follow-up|0|||
17002304|NCT00569803|38146415|FG005|Overall Study|Lost to Follow-up|0|||
17002305|NCT00569803|38146416|FG006|Overall Study|Lost to Follow-up|0|||
17002306|NCT00569803|38146417|FG007|Overall Study|Lost to Follow-up|0|||
17002307|NCT00569803|38146410|FG000|Overall Study|injection syringe leaked during dosing|0|||
17002308|NCT00569803|38146411|FG001|Overall Study|injection syringe leaked during dosing|0|||
17002309|NCT00569803|38146412|FG002|Overall Study|injection syringe leaked during dosing|0|||
17002310|NCT00569803|38146413|FG003|Overall Study|injection syringe leaked during dosing|1|||
16886013|NCT01047319|37901338|FG000|Overall Study|Teva requested participant withdrawal|3|||
16886014|NCT01047319|37901339|FG001|Overall Study|Teva requested participant withdrawal|0|||
16886015|NCT01047319|37901340|FG002|Overall Study|Teva requested participant withdrawal|1|||
16886016|NCT01047319|37901338|FG000|Overall Study|Protocol Violation|3|||
16886017|NCT01047319|37901339|FG001|Overall Study|Protocol Violation|2|||
16886018|NCT01047319|37901340|FG002|Overall Study|Protocol Violation|4|||
16886019|NCT01047319|37901338|FG000|Overall Study|Lack of Efficacy|4|||
16886020|NCT01047319|37901339|FG001|Overall Study|Lack of Efficacy|3|||
16886021|NCT01047319|37901340|FG002|Overall Study|Lack of Efficacy|3|||
16886022|NCT01047319|37901338|FG000|Overall Study|Death|5|||
16886023|NCT01047319|37901339|FG001|Overall Study|Death|1|||
16886024|NCT01047319|37901340|FG002|Overall Study|Death|5|||
16886025|NCT01047319|37901338|FG000|Overall Study|Pregnancy|13|||
16886026|NCT01047319|37901339|FG001|Overall Study|Pregnancy|8|||
16886027|NCT01047319|37901340|FG002|Overall Study|Pregnancy|8|||
16886028|NCT01047319|37901338|FG000|Overall Study|Physician Decision|12|||
16886029|NCT01047319|37901339|FG001|Overall Study|Physician Decision|9|||
16886030|NCT01047319|37901340|FG002|Overall Study|Physician Decision|10|||
16886031|NCT01047319|37901338|FG000|Overall Study|Lost to Follow-up|14|||
16886032|NCT01047319|37901339|FG001|Overall Study|Lost to Follow-up|10|||
16886033|NCT01047319|37901340|FG002|Overall Study|Lost to Follow-up|10|||
16886034|NCT01047319|37901338|FG000|Overall Study|Adverse Event|16|||
16886035|NCT01047319|37901339|FG001|Overall Study|Adverse Event|27|||
16886036|NCT01047319|37901340|FG002|Overall Study|Adverse Event|21|||
16886037|NCT01047319|37901338|FG000|Overall Study|Withdrawal by Subject|77|||
16886038|NCT01047319|37901339|FG001|Overall Study|Withdrawal by Subject|75|||
16886039|NCT01047319|37901340|FG002|Overall Study|Withdrawal by Subject|87|||
16886040|NCT01047319|37901338|FG000|Overall Study|Study terminated by Sponsor|198|||
16886041|NCT01047319|37901339|FG001|Overall Study|Study terminated by Sponsor|215|||
16886042|NCT01047319|37901340|FG002|Overall Study|Study terminated by Sponsor|203|||
16886043|NCT00014911|37901657|FG000|Overall Study|Adverse Event|1|||
16886044|NCT00014911|37901657|FG000|Overall Study|Lost to Follow-up|1|||
16886045|NCT00014911|37901657|FG000|Overall Study|Withdrawal by Subject|6|||
16886046|NCT00014911|37901657|FG000|Overall Study|Unknown Reasons|2|||
16886047|NCT00014911|37901657|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
16886048|NCT01049009|37902230|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
16886049|NCT01049009|37902231|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
16886050|NCT01049009|37902230|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16886051|NCT01049009|37902231|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16886052|NCT01049009|37902230|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
16886053|NCT01049009|37902231|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
16886054|NCT01049009|37902230|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
16886055|NCT01049009|37902231|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
16886056|NCT01047683|37902253|FG000|Overall Study|Adverse Event|3|||
16886057|NCT01047683|37902254|FG001|Overall Study|Adverse Event|1|||
16886058|NCT01047683|37902255|FG002|Overall Study|Adverse Event|0|||
16886059|NCT01047683|37902253|FG000|Overall Study|Withdrew Consent|1|||
16886060|NCT01047683|37902254|FG001|Overall Study|Withdrew Consent|4|||
16886061|NCT01047683|37902255|FG002|Overall Study|Withdrew Consent|2|||
16886062|NCT01047683|37902253|FG000|Overall Study|Lost to Follow-up|0|||
16886063|NCT01047683|37902254|FG001|Overall Study|Lost to Follow-up|1|||
16886064|NCT01047683|37902255|FG002|Overall Study|Lost to Follow-up|0|||
16886065|NCT01047683|37902253|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
16886066|NCT01047683|37902254|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
16886067|NCT01047683|37902255|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
16886068|NCT01047293|37902343|FG000|Overall Study|DLT criteria not fulfilled|1|||
16886069|NCT01047293|37902344|FG001|Overall Study|DLT criteria not fulfilled|1|||
16886070|NCT01047293|37902345|FG002|Overall Study|DLT criteria not fulfilled|0|||
16886071|NCT01047293|37902346|FG003|Overall Study|DLT criteria not fulfilled|0|||
16886072|NCT01045967|37902355|FG000|Second Intervention|Protocol Violation|0|||
16886073|NCT01045967|37902356|FG001|Second Intervention|Protocol Violation|1|||
16886074|NCT01045421|37902942|FG000|Phase 1|Progressive Disease|0|||
16886075|NCT01045421|37902943|FG001|Phase 1|Progressive Disease|0|||
16886076|NCT01045421|37902944|FG002|Phase 1|Progressive Disease|0|||
16886077|NCT01045421|37902945|FG003|Phase 1|Progressive Disease|0|||
16886078|NCT01045421|37902946|FG004|Phase 1|Progressive Disease|1|||
16886079|NCT01045421|37902947|FG005|Phase 1|Progressive Disease|0|||
16886080|NCT01045421|37902948|FG006|Phase 1|Progressive Disease|0|||
16886081|NCT01045421|37902949|FG007|Phase 1|Progressive Disease|0|||
16886082|NCT01045421|37902950|FG008|Phase 1|Progressive Disease|0|||
16886083|NCT01045421|37902951|FG009|Phase 1|Progressive Disease|0|||
16886084|NCT01045421|37902952|FG010|Phase 1|Progressive Disease|0|||
16886085|NCT01045421|37902942|FG000|Phase 1|Withdrawal by Subject|0|||
16886086|NCT01045421|37902943|FG001|Phase 1|Withdrawal by Subject|0|||
16886087|NCT01045421|37902944|FG002|Phase 1|Withdrawal by Subject|0|||
16886088|NCT01045421|37902945|FG003|Phase 1|Withdrawal by Subject|1|||
16886089|NCT01045421|37902946|FG004|Phase 1|Withdrawal by Subject|0|||
16886090|NCT01045421|37902947|FG005|Phase 1|Withdrawal by Subject|0|||
16886091|NCT01045421|37902948|FG006|Phase 1|Withdrawal by Subject|0|||
16886092|NCT01045421|37902949|FG007|Phase 1|Withdrawal by Subject|0|||
16886093|NCT01045421|37902950|FG008|Phase 1|Withdrawal by Subject|0|||
16886094|NCT01045421|37902951|FG009|Phase 1|Withdrawal by Subject|0|||
16886095|NCT01045421|37902952|FG010|Phase 1|Withdrawal by Subject|0|||
16886096|NCT01045421|37902942|FG000|Phase 2|Progressive Disease|0|||
16886097|NCT01045421|37902943|FG001|Phase 2|Progressive Disease|0|||
16886098|NCT01045421|37902944|FG002|Phase 2|Progressive Disease|0|||
16886099|NCT01045421|37902945|FG003|Phase 2|Progressive Disease|0|||
16886100|NCT01045421|37902946|FG004|Phase 2|Progressive Disease|0|||
16886101|NCT01045421|37902947|FG005|Phase 2|Progressive Disease|0|||
16886102|NCT01045421|37902948|FG006|Phase 2|Progressive Disease|0|||
16886103|NCT01045421|37902949|FG007|Phase 2|Progressive Disease|1|||
16886104|NCT01045421|37902950|FG008|Phase 2|Progressive Disease|1|||
16886105|NCT01045421|37902951|FG009|Phase 2|Progressive Disease|1|||
16886106|NCT01045421|37902952|FG010|Phase 2|Progressive Disease|1|||
16886107|NCT01045421|37902942|FG000|Phase 2|Death|0|||
16886108|NCT01045421|37902943|FG001|Phase 2|Death|0|||
16886109|NCT01045421|37902944|FG002|Phase 2|Death|0|||
16886110|NCT01045421|37902945|FG003|Phase 2|Death|0|||
16886111|NCT01045421|37902946|FG004|Phase 2|Death|0|||
16886112|NCT01045421|37902947|FG005|Phase 2|Death|0|||
16886113|NCT01045421|37902948|FG006|Phase 2|Death|0|||
16886114|NCT01045421|37902949|FG007|Phase 2|Death|1|||
16886115|NCT01045421|37902950|FG008|Phase 2|Death|1|||
16886116|NCT01045421|37902951|FG009|Phase 2|Death|2|||
16886117|NCT01045421|37902952|FG010|Phase 2|Death|0|||
16886118|NCT01045421|37902942|FG000|Phase 2|Other|0|||
16886119|NCT01045421|37902943|FG001|Phase 2|Other|0|||
16886120|NCT01045421|37902944|FG002|Phase 2|Other|0|||
16886121|NCT01045421|37902945|FG003|Phase 2|Other|0|||
16886122|NCT01045421|37902946|FG004|Phase 2|Other|0|||
16886123|NCT01045421|37902947|FG005|Phase 2|Other|0|||
17002311|NCT00569803|38146414|FG004|Overall Study|injection syringe leaked during dosing|0|||
16886124|NCT01045421|37902948|FG006|Phase 2|Other|0|||
16886125|NCT01045421|37902949|FG007|Phase 2|Other|3|||
16886126|NCT01045421|37902950|FG008|Phase 2|Other|0|||
16886127|NCT01045421|37902951|FG009|Phase 2|Other|0|||
16886128|NCT01045421|37902952|FG010|Phase 2|Other|1|||
17095323|NCT00261846|38234550|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
16886129|NCT01042535|37903000|FG000|Overall Study|disease progression prior to treatment|3|||
16886130|NCT01042535|37903000|FG000|Overall Study|disease progression during treatment|3|||
16886131|NCT01042535|37903000|FG000|Overall Study|complications from other disease|2|||
16886132|NCT01041287|37903006|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
16886133|NCT01041287|37903007|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
16886134|NCT01041287|37903006|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
16886135|NCT01041287|37903007|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
16886136|NCT01040351|37903028|FG000|Overall Study|poor ovarian response|1|||
16886137|NCT01040351|37903029|FG001|Overall Study|poor ovarian response|2|||
16886138|NCT02049957|37903049|FG000|Overall Study|Progressive Disease|5|||
16886139|NCT02049957|37903050|FG001|Overall Study|Progressive Disease|4|||
16886140|NCT02049957|37903051|FG002|Overall Study|Progressive Disease|2|||
16886141|NCT02049957|37903052|FG003|Overall Study|Progressive Disease|2|||
16886142|NCT02049957|37903053|FG004|Overall Study|Progressive Disease|6|||
16886143|NCT02049957|37903054|FG005|Overall Study|Progressive Disease|35|||
16886144|NCT02049957|37903055|FG006|Overall Study|Progressive Disease|7|||
16886145|NCT02049957|37903056|FG007|Overall Study|Progressive Disease|26|||
16886146|NCT02049957|37903057|FG008|Overall Study|Progressive Disease|6|||
16886147|NCT02049957|37903049|FG000|Overall Study|Adverse Event|1|||
16886148|NCT02049957|37903050|FG001|Overall Study|Adverse Event|1|||
16886149|NCT02049957|37903051|FG002|Overall Study|Adverse Event|1|||
16886150|NCT02049957|37903052|FG003|Overall Study|Adverse Event|0|||
16886151|NCT02049957|37903053|FG004|Overall Study|Adverse Event|0|||
16886152|NCT02049957|37903054|FG005|Overall Study|Adverse Event|5|||
16886153|NCT02049957|37903055|FG006|Overall Study|Adverse Event|0|||
16886154|NCT02049957|37903056|FG007|Overall Study|Adverse Event|6|||
16886155|NCT02049957|37903057|FG008|Overall Study|Adverse Event|1|||
16886156|NCT02049957|37903049|FG000|Overall Study|Study Terminated by Sponsor|0|||
16886157|NCT02049957|37903050|FG001|Overall Study|Study Terminated by Sponsor|1|||
16886158|NCT02049957|37903051|FG002|Overall Study|Study Terminated by Sponsor|0|||
16886159|NCT02049957|37903052|FG003|Overall Study|Study Terminated by Sponsor|0|||
16886160|NCT02049957|37903053|FG004|Overall Study|Study Terminated by Sponsor|0|||
16886161|NCT02049957|37903054|FG005|Overall Study|Study Terminated by Sponsor|0|||
16886162|NCT02049957|37903055|FG006|Overall Study|Study Terminated by Sponsor|1|||
16886163|NCT02049957|37903056|FG007|Overall Study|Study Terminated by Sponsor|0|||
16886164|NCT02049957|37903057|FG008|Overall Study|Study Terminated by Sponsor|0|||
16886165|NCT02049957|37903049|FG000|Overall Study|Withdrawal by Subject|0|||
16886166|NCT02049957|37903050|FG001|Overall Study|Withdrawal by Subject|0|||
16886167|NCT02049957|37903051|FG002|Overall Study|Withdrawal by Subject|0|||
16886168|NCT02049957|37903052|FG003|Overall Study|Withdrawal by Subject|1|||
16886169|NCT02049957|37903053|FG004|Overall Study|Withdrawal by Subject|0|||
16886170|NCT02049957|37903054|FG005|Overall Study|Withdrawal by Subject|2|||
16886171|NCT02049957|37903055|FG006|Overall Study|Withdrawal by Subject|0|||
16886172|NCT02049957|37903056|FG007|Overall Study|Withdrawal by Subject|3|||
16886173|NCT02049957|37903057|FG008|Overall Study|Withdrawal by Subject|1|||
16886174|NCT02049957|37903049|FG000|Overall Study|Physician Decision|0|||
16886175|NCT02049957|37903050|FG001|Overall Study|Physician Decision|0|||
16886176|NCT02049957|37903051|FG002|Overall Study|Physician Decision|0|||
16886177|NCT02049957|37903052|FG003|Overall Study|Physician Decision|0|||
16886178|NCT02049957|37903053|FG004|Overall Study|Physician Decision|0|||
16886179|NCT02049957|37903054|FG005|Overall Study|Physician Decision|1|||
16886180|NCT02049957|37903055|FG006|Overall Study|Physician Decision|0|||
16886181|NCT02049957|37903056|FG007|Overall Study|Physician Decision|0|||
16886182|NCT02049957|37903057|FG008|Overall Study|Physician Decision|0|||
16886183|NCT03400943|37903229|FG000|Treatment Period 1|Adverse Event|0|||
16886184|NCT03400943|37903230|FG001|Treatment Period 1|Adverse Event|0|||
16886185|NCT03400943|37903231|FG002|Treatment Period 1|Adverse Event|0|||
16886186|NCT03400943|37903232|FG003|Treatment Period 1|Adverse Event|1|||
16886187|NCT03400943|37903229|FG000|Treatment Period 1|Lost to Follow-up|1|||
16886188|NCT03400943|37903230|FG001|Treatment Period 1|Lost to Follow-up|0|||
16886189|NCT03400943|37903231|FG002|Treatment Period 1|Lost to Follow-up|0|||
16886190|NCT03400943|37903232|FG003|Treatment Period 1|Lost to Follow-up|0|||
16886191|NCT03400943|37903229|FG000|Treatment Period 1|Protocol Violation|0|||
16886192|NCT03400943|37903230|FG001|Treatment Period 1|Protocol Violation|1|||
16886193|NCT03400943|37903231|FG002|Treatment Period 1|Protocol Violation|1|||
16886194|NCT03400943|37903232|FG003|Treatment Period 1|Protocol Violation|0|||
16886195|NCT03400943|37903229|FG000|Treatment Period 1|Study terminated by sponsor|2|||
16886196|NCT03400943|37903230|FG001|Treatment Period 1|Study terminated by sponsor|0|||
16886197|NCT03400943|37903231|FG002|Treatment Period 1|Study terminated by sponsor|0|||
16886198|NCT03400943|37903232|FG003|Treatment Period 1|Study terminated by sponsor|1|||
16886199|NCT03400943|37903229|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16886200|NCT03400943|37903230|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16886201|NCT03400943|37903231|FG002|Treatment Period 1|Withdrawal by Subject|3|||
16886202|NCT03400943|37903232|FG003|Treatment Period 1|Withdrawal by Subject|1|||
16886203|NCT03400943|37903229|FG000|Treatment Period 1|Other|2|||
16886204|NCT03400943|37903230|FG001|Treatment Period 1|Other|1|||
16886205|NCT03400943|37903231|FG002|Treatment Period 1|Other|2|||
16886206|NCT03400943|37903232|FG003|Treatment Period 1|Other|2|||
16886207|NCT03400943|37903229|FG000|Post-treatment Period 1|Adverse Event|2|||
16886208|NCT03400943|37903230|FG001|Post-treatment Period 1|Adverse Event|0|||
16886209|NCT03400943|37903231|FG002|Post-treatment Period 1|Adverse Event|0|||
16886210|NCT03400943|37903232|FG003|Post-treatment Period 1|Adverse Event|0|||
16886211|NCT03400943|37903229|FG000|Post-treatment Period 1|Protocol Violation|1|||
16886212|NCT03400943|37903230|FG001|Post-treatment Period 1|Protocol Violation|0|||
16886213|NCT03400943|37903231|FG002|Post-treatment Period 1|Protocol Violation|0|||
16886214|NCT03400943|37903232|FG003|Post-treatment Period 1|Protocol Violation|0|||
16886215|NCT03400943|37903229|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
16886216|NCT03400943|37903230|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
16886217|NCT03400943|37903231|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
16886218|NCT03400943|37903232|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
16886219|NCT03400943|37903229|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
16886220|NCT03400943|37903230|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
16886221|NCT03400943|37903231|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
16886222|NCT03400943|37903232|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
16886223|NCT03400943|37903229|FG000|Post-treatment Period 1|Other|2|||
16886224|NCT03400943|37903230|FG001|Post-treatment Period 1|Other|0|||
16886225|NCT03400943|37903231|FG002|Post-treatment Period 1|Other|4|||
16886226|NCT03400943|37903232|FG003|Post-treatment Period 1|Other|5|||
16886227|NCT03400943|37903229|FG000|Treatment Period 2|Study terminated by sponsor|0|||
16886228|NCT03400943|37903230|FG001|Treatment Period 2|Study terminated by sponsor|1|||
16886229|NCT03400943|37903231|FG002|Treatment Period 2|Study terminated by sponsor|0|||
16886230|NCT03400943|37903232|FG003|Treatment Period 2|Study terminated by sponsor|0|||
16886231|NCT03400943|37903229|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16886232|NCT03400943|37903230|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16886233|NCT03400943|37903231|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16886234|NCT03400943|37903232|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16886235|NCT03400943|37903229|FG000|Treatment Period 2|Other|1|||
16886236|NCT03400943|37903230|FG001|Treatment Period 2|Other|6|||
16886237|NCT03400943|37903231|FG002|Treatment Period 2|Other|0|||
16886238|NCT03400943|37903232|FG003|Treatment Period 2|Other|0|||
16886239|NCT03400943|37903229|FG000|Follow-up Period|Withdrawal by Subject|1|||
16886240|NCT03400943|37903230|FG001|Follow-up Period|Withdrawal by Subject|0|||
16886241|NCT03400943|37903231|FG002|Follow-up Period|Withdrawal by Subject|0|||
16886242|NCT03400943|37903232|FG003|Follow-up Period|Withdrawal by Subject|0|||
16886243|NCT00014495|37903339|FG000|Overall Study|Death|0|||
16886244|NCT00014495|37903340|FG001|Overall Study|Death|0|||
16886245|NCT00014495|37903341|FG002|Overall Study|Death|1|||
16886246|NCT00014495|37903342|FG003|Overall Study|Death|0|||
16886247|NCT00014495|37903339|FG000|Overall Study|Clinical deterioration|0|||
16886248|NCT00014495|37903340|FG001|Overall Study|Clinical deterioration|0|||
16886249|NCT00014495|37903341|FG002|Overall Study|Clinical deterioration|0|||
16886250|NCT00014495|37903342|FG003|Overall Study|Clinical deterioration|1|||
16886251|NCT03439293|37905252|FG000|Overall Study|Ongoing on Treatment|15|||
16886252|NCT03439293|37905252|FG000|Overall Study|Ongoing off Treatment|19|||
16886253|NCT03439293|37905252|FG000|Overall Study|Death|18|||
16886254|NCT03439293|37905252|FG000|Overall Study|Withdrawal by Subject|7|||
16886255|NCT03439293|37905252|FG000|Overall Study|Lost to Follow-up|2|||
16886256|NCT01351623|37905409|FG000|Overall Study|Protocol Violation|2|||
16886257|NCT01351623|37905409|FG000|Overall Study|Adverse Event|4|||
16886258|NCT01351623|37905409|FG000|Overall Study|Withdrawal by Subject|1|||
16886259|NCT01351623|37905409|FG000|Overall Study|Death|2|||
16886260|NCT03670953|37905546|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
16886261|NCT03670953|37905547|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
16886262|NCT03670953|37905548|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
16886263|NCT03670953|37905549|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
16886264|NCT03670953|37905546|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
16886265|NCT03670953|37905547|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
16886266|NCT03670953|37905548|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
16886267|NCT03670953|37905549|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
16886268|NCT03670953|37905546|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
16886269|NCT03670953|37905547|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
16886270|NCT03670953|37905548|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
16886271|NCT03670953|37905549|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
16886272|NCT03670953|37905546|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
16886273|NCT03670953|37905547|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
16886274|NCT03670953|37905548|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
16886275|NCT03670953|37905549|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
16886276|NCT03670953|37905546|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
17095324|NCT00261846|38234551|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
16886277|NCT03670953|37905547|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
16886278|NCT03670953|37905548|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
16886279|NCT03670953|37905549|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
16886280|NCT03670953|37905546|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
16886281|NCT03670953|37905547|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
16886282|NCT03670953|37905548|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
16886283|NCT03670953|37905549|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
16886284|NCT03670953|37905546|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
16886285|NCT03670953|37905547|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
16886286|NCT03670953|37905548|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
16886287|NCT03670953|37905549|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
16886288|NCT03670953|37905546|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
16886289|NCT03670953|37905547|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
16886290|NCT03670953|37905548|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
16886291|NCT03670953|37905549|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
16886292|NCT03670953|37905546|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
16886293|NCT03670953|37905547|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
16886294|NCT03670953|37905548|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
16886295|NCT03670953|37905549|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
16886296|NCT03670953|37905546|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
16886297|NCT03670953|37905547|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
16886298|NCT03670953|37905548|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
16886299|NCT03670953|37905549|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
16886300|NCT03670953|37905546|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
16886301|NCT03670953|37905547|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
16886302|NCT03670953|37905548|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
16886303|NCT03670953|37905549|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
16886304|NCT03670953|37905546|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
16886305|NCT03670953|37905547|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
16886306|NCT03670953|37905548|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
16886307|NCT03670953|37905549|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
16886308|NCT03670953|37905546|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
16886309|NCT03670953|37905547|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
16886310|NCT03670953|37905548|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
16886311|NCT03670953|37905549|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
16886312|NCT03670953|37905546|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
16886313|NCT03670953|37905547|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
16886314|NCT03670953|37905548|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
16886315|NCT03670953|37905549|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
16886316|NCT03670953|37905546|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
16886317|NCT03670953|37905547|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
16886318|NCT03670953|37905548|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
16886319|NCT03670953|37905549|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
16886320|NCT03670953|37905546|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
16886321|NCT03670953|37905547|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
16886322|NCT03670953|37905548|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
16886323|NCT03670953|37905549|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
16886324|NCT03670953|37905546|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
16886325|NCT03670953|37905547|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
16886326|NCT03670953|37905548|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
16886327|NCT03670953|37905549|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
16886328|NCT03670953|37905546|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
16886329|NCT03670953|37905547|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
16886330|NCT03670953|37905548|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
16886331|NCT03670953|37905549|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
16886332|NCT02519348|37905600|FG000|Overall Study|Death|31|||
16886333|NCT02519348|37905601|FG001|Overall Study|Death|74|||
16886334|NCT02519348|37905602|FG002|Overall Study|Death|47|||
16886335|NCT02519348|37905603|FG003|Overall Study|Death|54|||
16886336|NCT02519348|37905604|FG004|Overall Study|Death|63|||
16886337|NCT02519348|37905605|FG005|Overall Study|Death|18|||
16886338|NCT02519348|37905606|FG006|Overall Study|Death|2|||
16886339|NCT02519348|37905607|FG007|Overall Study|Death|5|||
16886340|NCT02519348|37905608|FG008|Overall Study|Death|5|||
16886341|NCT02519348|37905600|FG000|Overall Study|Withdrawal by Subject|4|||
16886342|NCT02519348|37905601|FG001|Overall Study|Withdrawal by Subject|7|||
16886343|NCT02519348|37905602|FG002|Overall Study|Withdrawal by Subject|4|||
16886344|NCT02519348|37905603|FG003|Overall Study|Withdrawal by Subject|3|||
16886345|NCT02519348|37905604|FG004|Overall Study|Withdrawal by Subject|3|||
16886346|NCT02519348|37905605|FG005|Overall Study|Withdrawal by Subject|2|||
16886347|NCT02519348|37905606|FG006|Overall Study|Withdrawal by Subject|0|||
16886348|NCT02519348|37905607|FG007|Overall Study|Withdrawal by Subject|0|||
17095325|NCT00261846|38234540|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
17095326|NCT00261846|38234541|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
17095327|NCT00261846|38234542|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
16886349|NCT02519348|37905608|FG008|Overall Study|Withdrawal by Subject|1|||
16886350|NCT02519348|37905600|FG000|Overall Study|Lost to Follow-up|0|||
16886351|NCT02519348|37905601|FG001|Overall Study|Lost to Follow-up|0|||
16886352|NCT02519348|37905602|FG002|Overall Study|Lost to Follow-up|1|||
16886353|NCT02519348|37905603|FG003|Overall Study|Lost to Follow-up|0|||
16886354|NCT02519348|37905604|FG004|Overall Study|Lost to Follow-up|2|||
16886355|NCT02519348|37905605|FG005|Overall Study|Lost to Follow-up|1|||
16886356|NCT02519348|37905606|FG006|Overall Study|Lost to Follow-up|1|||
16886357|NCT02519348|37905607|FG007|Overall Study|Lost to Follow-up|0|||
16886358|NCT02519348|37905608|FG008|Overall Study|Lost to Follow-up|0|||
16886359|NCT02519348|37905600|FG000|Overall Study|Other|0|||
16886360|NCT02519348|37905601|FG001|Overall Study|Other|3|||
16886361|NCT02519348|37905602|FG002|Overall Study|Other|0|||
16886362|NCT02519348|37905603|FG003|Overall Study|Other|0|||
16886363|NCT02519348|37905604|FG004|Overall Study|Other|1|||
16886364|NCT02519348|37905605|FG005|Overall Study|Other|0|||
16886365|NCT02519348|37905606|FG006|Overall Study|Other|0|||
16886366|NCT02519348|37905607|FG007|Overall Study|Other|0|||
16886367|NCT02519348|37905608|FG008|Overall Study|Other|0|||
16886368|NCT02519348|37905600|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
16886369|NCT02519348|37905601|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
16886370|NCT02519348|37905602|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
16886371|NCT02519348|37905603|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
16886372|NCT02519348|37905604|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
16886373|NCT02519348|37905605|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
16886374|NCT02519348|37905606|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
16886375|NCT02519348|37905607|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
16886376|NCT02519348|37905608|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
16886377|NCT00636818|37905629|FG000|Overall Study|Adverse Event|1|||
16886378|NCT00636818|37905629|FG000|Overall Study|Lost to Follow-up|2|||
16886379|NCT00636818|37905629|FG000|Overall Study|Entry Criteria Exclusion|3|||
16886380|NCT00636818|37905629|FG000|Overall Study|Protocol Violation|1|||
16886381|NCT00636818|37905629|FG000|Overall Study|Withdrawal by Subject|4|||
16886382|NCT03127137|37905635|FG000|Overall Study|Requested sedation after consent|1|||
16886383|NCT03127137|37905636|FG001|Overall Study|Requested sedation after consent|0|||
16886384|NCT03127137|37905635|FG000|Overall Study|Malfunction in electronic data collection|1|||
16886385|NCT03127137|37905636|FG001|Overall Study|Malfunction in electronic data collection|0|||
16886386|NCT03127137|37905635|FG000|Overall Study|Post procedure testing could not be obtained|0|||
16886387|NCT03127137|37905636|FG001|Overall Study|Post procedure testing could not be obtained|1|||
16886388|NCT00636506|37905644|FG000|Overall Study|Lost to Follow-up|8|||
16886389|NCT00636506|37905644|FG000|Overall Study|Explanted|1|||
16886390|NCT00636506|37905644|FG000|Overall Study|Withdrawal by Subject|6|||
16886391|NCT00636506|37905644|FG000|Overall Study|Procedure aborted|1|||
16886392|NCT00636194|37905668|FG000|Overall Study|Study related symptoms and complaints|1|||
16886393|NCT00636194|37905669|FG001|Overall Study|Study related symptoms and complaints|0|||
16886394|NCT00636194|37905668|FG000|Overall Study|Protocol Violation|2|||
16886395|NCT00636194|37905669|FG001|Overall Study|Protocol Violation|0|||
16886396|NCT00635804|37905735|FG000|Overall Study|Adverse Event|0|||
16886397|NCT00635804|37905736|FG001|Overall Study|Adverse Event|0|||
16886398|NCT00635804|37905737|FG002|Overall Study|Adverse Event|0|||
16886399|NCT00635804|37905738|FG003|Overall Study|Adverse Event|0|||
16886400|NCT00635804|37905739|FG004|Overall Study|Adverse Event|0|||
16886401|NCT00635804|37905740|FG005|Overall Study|Adverse Event|1|||
16886402|NCT00635804|37905741|FG006|Overall Study|Adverse Event|0|||
16886403|NCT00635804|37905742|FG007|Overall Study|Adverse Event|0|||
16886404|NCT00635804|37905735|FG000|Overall Study|Withdrawal by Subject|1|||
16886405|NCT00635804|37905736|FG001|Overall Study|Withdrawal by Subject|0|||
16886406|NCT00635804|37905737|FG002|Overall Study|Withdrawal by Subject|0|||
16886407|NCT00635804|37905738|FG003|Overall Study|Withdrawal by Subject|0|||
16886408|NCT00635804|37905739|FG004|Overall Study|Withdrawal by Subject|0|||
16886409|NCT00635804|37905740|FG005|Overall Study|Withdrawal by Subject|0|||
16886410|NCT00635804|37905741|FG006|Overall Study|Withdrawal by Subject|0|||
16886411|NCT00635804|37905742|FG007|Overall Study|Withdrawal by Subject|0|||
16886412|NCT00635648|37905772|FG000|Overall Study|Adverse Event|12|||
16886413|NCT00635648|37905772|FG000|Overall Study|Withdrawal by Subject|9|||
16886414|NCT00635648|37905772|FG000|Overall Study|Physician Decision|4|||
16886415|NCT00635648|37905772|FG000|Overall Study|Rapid progression of baseline disease|4|||
16886416|NCT00635648|37905772|FG000|Overall Study|Use of other antifungal agent needed|1|||
16886417|NCT00635648|37905772|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
16886418|NCT00635648|37905772|FG000|Overall Study|Noncompliance with protocol|1|||
16886419|NCT00635648|37905772|FG000|Overall Study|Other reason|2|||
16886420|NCT03056001|37905776|FG000|Overall Study|Death|24|||
16886421|NCT03056001|37905776|FG000|Overall Study|Still On Study (in follow up)|1|||
16886422|NCT00635102|37905801|FG000|Overall Study|Withdrawal by Subject|7|||
16886423|NCT00635102|37905802|FG001|Overall Study|Withdrawal by Subject|8|||
16886424|NCT00635024|37905817|FG000|Overall Study|Adverse Event|1|||
16886425|NCT00634244|37905879|FG000|Overall Study|Never started treatment|0|||
16886426|NCT00634244|37905880|FG001|Overall Study|Never started treatment|1|||
16886427|NCT00634244|37905881|FG002|Overall Study|Never started treatment|0|||
16886428|NCT00634244|37905879|FG000|Overall Study|Death|1|||
16886429|NCT00634244|37905880|FG001|Overall Study|Death|6|||
16886430|NCT00634244|37905881|FG002|Overall Study|Death|0|||
16886431|NCT00634244|37905879|FG000|Overall Study|Adverse Event|0|||
16886432|NCT00634244|37905880|FG001|Overall Study|Adverse Event|2|||
16886433|NCT00634244|37905881|FG002|Overall Study|Adverse Event|0|||
16886434|NCT00634244|37905879|FG000|Overall Study|Withdrawal by Subject|0|||
16886435|NCT00634244|37905880|FG001|Overall Study|Withdrawal by Subject|1|||
16886436|NCT00634244|37905881|FG002|Overall Study|Withdrawal by Subject|0|||
16886437|NCT00634244|37905879|FG000|Overall Study|Physician Decision|0|||
16886438|NCT00634244|37905880|FG001|Overall Study|Physician Decision|1|||
16886439|NCT00634244|37905881|FG002|Overall Study|Physician Decision|0|||
16886440|NCT00634244|37905879|FG000|Overall Study|Disease progression/relapse|0|||
16886441|NCT00634244|37905880|FG001|Overall Study|Disease progression/relapse|1|||
16886442|NCT00634244|37905881|FG002|Overall Study|Disease progression/relapse|0|||
16886443|NCT00634244|37905879|FG000|Overall Study|Other complicating disease|0|||
16886444|NCT00634244|37905880|FG001|Overall Study|Other complicating disease|1|||
16886445|NCT00634244|37905881|FG002|Overall Study|Other complicating disease|0|||
16886446|NCT00634088|37906065|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
16886447|NCT00634088|37906066|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
16886448|NCT00634088|37906067|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
16886449|NCT00634088|37906068|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
16886450|NCT00634088|37906065|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
16886451|NCT00634088|37906066|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
16886452|NCT00634088|37906067|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
16886453|NCT00634088|37906068|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
16886454|NCT00634088|37906065|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
16886455|NCT00634088|37906066|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
16886456|NCT00634088|37906067|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
16886457|NCT00634088|37906068|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
16886458|NCT00634088|37906065|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
16886459|NCT00634088|37906066|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
16886460|NCT00634088|37906067|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
16886461|NCT00634088|37906068|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
16886462|NCT00634088|37906065|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
16886463|NCT00634088|37906066|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
16886464|NCT00634088|37906067|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
16886465|NCT00634088|37906068|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
16886466|NCT00634088|37906065|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
16886467|NCT00634088|37906066|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
16886468|NCT00634088|37906067|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
16886469|NCT00634088|37906068|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
16886470|NCT00634010|37906179|FG000|Overall Study|Adverse Event|2|||
16886471|NCT00634010|37906180|FG001|Overall Study|Adverse Event|5|||
16886472|NCT00634010|37906179|FG000|Overall Study|Withdrawal by Subject|5|||
16886473|NCT00634010|37906180|FG001|Overall Study|Withdrawal by Subject|6|||
16886474|NCT00634010|37906179|FG000|Overall Study|Physician Decision|1|||
16886475|NCT00634010|37906180|FG001|Overall Study|Physician Decision|1|||
16886476|NCT00634010|37906179|FG000|Overall Study|Disease Progression|1|||
16886477|NCT00634010|37906180|FG001|Overall Study|Disease Progression|1|||
16886478|NCT00634010|37906179|FG000|Overall Study|Non-Compliant|1|||
16886479|NCT00634010|37906180|FG001|Overall Study|Non-Compliant|1|||
16886480|NCT00633932|37906193|FG000|Overall Study|Adverse Event|1|||
16886481|NCT00633932|37906194|FG001|Overall Study|Adverse Event|3|||
16886482|NCT00633932|37906195|FG002|Overall Study|Adverse Event|4|||
16886483|NCT00633932|37906193|FG000|Overall Study|Withdrawal by Subject|3|||
16886484|NCT00633932|37906194|FG001|Overall Study|Withdrawal by Subject|9|||
16886485|NCT00633932|37906195|FG002|Overall Study|Withdrawal by Subject|1|||
16886486|NCT00633932|37906193|FG000|Overall Study|Lost to Follow-up|1|||
16886487|NCT00633932|37906194|FG001|Overall Study|Lost to Follow-up|0|||
16886488|NCT00633932|37906195|FG002|Overall Study|Lost to Follow-up|2|||
16886489|NCT00633932|37906193|FG000|Overall Study|Protocol Violation|5|||
16886490|NCT00633932|37906194|FG001|Overall Study|Protocol Violation|2|||
16886491|NCT00633932|37906195|FG002|Overall Study|Protocol Violation|3|||
16886492|NCT00633932|37906193|FG000|Overall Study|Physician Decision|0|||
16886493|NCT00633932|37906194|FG001|Overall Study|Physician Decision|0|||
16886494|NCT00633932|37906195|FG002|Overall Study|Physician Decision|1|||
16886495|NCT00633932|37906193|FG000|Overall Study|Doctor's judgement|1|||
16886496|NCT00633932|37906194|FG001|Overall Study|Doctor's judgement|0|||
16886497|NCT00633932|37906195|FG002|Overall Study|Doctor's judgement|0|||
16886498|NCT00633932|37906193|FG000|Overall Study|Moved Away|1|||
16886499|NCT00633932|37906194|FG001|Overall Study|Moved Away|0|||
16886500|NCT00633932|37906195|FG002|Overall Study|Moved Away|0|||
16886501|NCT00633464|37906325|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
16886502|NCT00633464|37906326|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
16886503|NCT00633464|37906325|FG000|Overall Study|Never Treated (Randomized in error)|0|||
16886504|NCT00633464|37906326|FG001|Overall Study|Never Treated (Randomized in error)|1|||
16886505|NCT00633152|37906372|FG000|Overall Study|Adverse Event|1|||
16886506|NCT00633152|37906373|FG001|Overall Study|Adverse Event|0|||
16886507|NCT00633152|37906372|FG000|Overall Study|Randomized, did not receive study drug|5|||
16886508|NCT00633152|37906373|FG001|Overall Study|Randomized, did not receive study drug|2|||
16886509|NCT00633152|37906372|FG000|Overall Study|Withdrawal by Subject|1|||
16886510|NCT00633152|37906373|FG001|Overall Study|Withdrawal by Subject|1|||
16886511|NCT00633152|37906372|FG000|Overall Study|Lost to Follow-up|4|||
16886512|NCT00633152|37906373|FG001|Overall Study|Lost to Follow-up|1|||
16886513|NCT00633152|37906372|FG000|Overall Study|Miscellaneous Other|3|||
16886514|NCT00633152|37906373|FG001|Overall Study|Miscellaneous Other|2|||
16886515|NCT00633074|37906392|FG000|Overall Study|Adverse Event|1|||
16886516|NCT00633074|37906393|FG001|Overall Study|Adverse Event|0|||
16886517|NCT00630344|37906580|FG000|Overall Study|Adverse Event|5|||
16886518|NCT00630344|37906580|FG000|Overall Study|Progressive Disease|19|||
16886519|NCT00630344|37906580|FG000|Overall Study|Physician Decision|9|||
16886520|NCT00630344|37906580|FG000|Overall Study|Withdrawal by Subject|1|||
16886521|NCT00630344|37906580|FG000|Overall Study|Intercurrent Illness|1|||
16886522|NCT00630344|37906580|FG000|Overall Study|Other|1|||
16886523|NCT02913261|37906606|FG000|Overall Study|Technical problems|0|||
16886524|NCT02913261|37906607|FG001|Overall Study|Technical problems|1|||
16886525|NCT02913261|37906606|FG000|Overall Study|Lack of Efficacy|32|||
16886526|NCT02913261|37906607|FG001|Overall Study|Lack of Efficacy|69|||
16886527|NCT02913261|37906606|FG000|Overall Study|Adverse Event|27|||
16886528|NCT02913261|37906607|FG001|Overall Study|Adverse Event|5|||
16886529|NCT02913261|37906606|FG000|Overall Study|Death|25|||
16886530|NCT02913261|37906607|FG001|Overall Study|Death|22|||
16886531|NCT02913261|37906606|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
16886532|NCT02913261|37906607|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
16886533|NCT02913261|37906606|FG000|Overall Study|Disease relapse|8|||
16886534|NCT02913261|37906607|FG001|Overall Study|Disease relapse|13|||
16886535|NCT02913261|37906606|FG000|Overall Study|Physician Decision|8|||
16886536|NCT02913261|37906607|FG001|Overall Study|Physician Decision|9|||
16886537|NCT02913261|37906606|FG000|Overall Study|Subject/guardian decision|4|||
16886538|NCT02913261|37906607|FG001|Overall Study|Subject/guardian decision|6|||
16886539|NCT02913261|37906606|FG000|Overall Study|Graft loss|2|||
16886540|NCT02913261|37906607|FG001|Overall Study|Graft loss|0|||
16886541|NCT00635882|37906671|FG000|Overall Study|Protocol Violation|1|||
16886542|NCT00635882|37906672|FG001|Overall Study|Protocol Violation|0|||
16886543|NCT00635882|37906673|FG002|Overall Study|Protocol Violation|0|||
16886544|NCT00635882|37906674|FG003|Overall Study|Protocol Violation|0|||
16886545|NCT00635882|37906675|FG004|Overall Study|Protocol Violation|0|||
16886546|NCT00635882|37906676|FG005|Overall Study|Protocol Violation|0|||
16886547|NCT02393859|37906744|FG000|Overall Study|Decision by Sponsor|1|||
16886548|NCT02393859|37906745|FG001|Overall Study|Decision by Sponsor|1|||
16886549|NCT02393859|37906744|FG000|Overall Study|Withdrawal by Subject|5|||
16886550|NCT02393859|37906745|FG001|Overall Study|Withdrawal by Subject|2|||
16886551|NCT02393859|37906744|FG000|Overall Study|Death|16|||
16886552|NCT02393859|37906745|FG001|Overall Study|Death|8|||
16886553|NCT02393859|37906744|FG000|Overall Study|Continuing Study|32|||
16886554|NCT02393859|37906745|FG001|Overall Study|Continuing Study|43|||
16886555|NCT00986570|37906937|FG000|Overall Study|Lost to Follow-up|6|||
16886556|NCT00986570|37906937|FG000|Overall Study|Potential bias for objective assessment|1|||
16886557|NCT00986258|37906941|FG000|Observation Period|Not eligible to be dosed|11|||
16886558|NCT00986258|37906941|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
16886559|NCT00986258|37906941|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
16886560|NCT00986258|37906941|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
16886561|NCT00986258|37906941|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
16886562|NCT00986258|37906941|FG000|Titration and Optimal Dose Period|Other|1|||
16886563|NCT00986258|37906941|FG000|Maintenance Period|Adverse Event|5|||
16886564|NCT00986258|37906941|FG000|Maintenance Period|Lack of Efficacy|2|||
16886565|NCT00986258|37906941|FG000|Maintenance Period|Withdrawal by Subject|2|||
16886566|NCT00986180|37906957|FG000|Overall Study|Adverse Event|21|||
16886567|NCT00986180|37906958|FG001|Overall Study|Adverse Event|23|||
16886568|NCT00986180|37906957|FG000|Overall Study|Lack of Efficacy|4|||
16886569|NCT00986180|37906958|FG001|Overall Study|Lack of Efficacy|3|||
16886570|NCT00986180|37906957|FG000|Overall Study|Lost to Follow-up|5|||
16886571|NCT00986180|37906958|FG001|Overall Study|Lost to Follow-up|7|||
16886572|NCT00986180|37906957|FG000|Overall Study|Physician Decision|1|||
16886573|NCT00986180|37906958|FG001|Overall Study|Physician Decision|3|||
16886574|NCT00986180|37906957|FG000|Overall Study|Protocol Violation|2|||
16886575|NCT00986180|37906958|FG001|Overall Study|Protocol Violation|0|||
16886576|NCT00986180|37906957|FG000|Overall Study|Withdrawal by Subject|1|||
16886577|NCT00986180|37906958|FG001|Overall Study|Withdrawal by Subject|9|||
16886578|NCT00986180|37906957|FG000|Overall Study|Miscellanies|10|||
16886579|NCT00986180|37906958|FG001|Overall Study|Miscellanies|11|||
16886580|NCT00986102|37907140|FG000|Overall Study|Lost to Follow-up|0|||
16886581|NCT00986102|37907141|FG001|Overall Study|Lost to Follow-up|1|||
16886582|NCT00986102|37907142|FG002|Overall Study|Lost to Follow-up|0|||
16886583|NCT00986102|37907143|FG003|Overall Study|Lost to Follow-up|1|||
16886584|NCT00986102|37907140|FG000|Overall Study|Withdrawal by Subject|1|||
16886585|NCT00986102|37907141|FG001|Overall Study|Withdrawal by Subject|1|||
16886586|NCT00986102|37907142|FG002|Overall Study|Withdrawal by Subject|0|||
16886587|NCT00986102|37907143|FG003|Overall Study|Withdrawal by Subject|0|||
16886588|NCT00985946|37907166|FG000|Overall Study|Lost to Follow-up|6|||
16886589|NCT00985946|37907166|FG000|Overall Study|Withdrawal by Subject|1|||
16886590|NCT00985790|37907181|FG000|Overall Study|Withdrawal by Subject|1|||
16886591|NCT00985790|37907182|FG001|Overall Study|Withdrawal by Subject|1|||
16886592|NCT00985790|37907181|FG000|Overall Study|Lost to Follow-up|6|||
16886593|NCT00985790|37907182|FG001|Overall Study|Lost to Follow-up|7|||
16886594|NCT00985712|37907209|FG000|Overall Study|Adverse Event|0|||
16886595|NCT00985712|37907210|FG001|Overall Study|Adverse Event|1|||
16886596|NCT00985712|37907209|FG000|Overall Study|Lost to Follow-up|2|||
16886597|NCT00985712|37907210|FG001|Overall Study|Lost to Follow-up|2|||
16886598|NCT00985712|37907209|FG000|Overall Study|Protocol Violation|0|||
16886599|NCT00985712|37907210|FG001|Overall Study|Protocol Violation|1|||
16886600|NCT00985712|37907209|FG000|Overall Study|Withdrawal by Subject|4|||
16886601|NCT00985712|37907210|FG001|Overall Study|Withdrawal by Subject|1|||
16886602|NCT00985712|37907209|FG000|Overall Study|Sponsor decision|0|||
16886603|NCT00985712|37907210|FG001|Overall Study|Sponsor decision|2|||
16886604|NCT00985166|37907317|FG000|Overall Study|Lost to Follow-up|3|||
16886605|NCT00985166|37907318|FG001|Overall Study|Lost to Follow-up|2|||
16886606|NCT00985166|37907319|FG002|Overall Study|Lost to Follow-up|2|||
16886607|NCT00985166|37907317|FG000|Overall Study|Withdrawal by Subject|3|||
16886608|NCT00985166|37907318|FG001|Overall Study|Withdrawal by Subject|2|||
16886609|NCT00985166|37907319|FG002|Overall Study|Withdrawal by Subject|0|||
16886610|NCT00985166|37907317|FG000|Overall Study|Test not done|2|||
16886611|NCT00985166|37907318|FG001|Overall Study|Test not done|0|||
16886612|NCT00985166|37907319|FG002|Overall Study|Test not done|4|||
16886613|NCT00985166|37907317|FG000|Overall Study|Other|1|||
16886614|NCT00985166|37907318|FG001|Overall Study|Other|0|||
16886615|NCT00985166|37907319|FG002|Overall Study|Other|1|||
16886616|NCT02184195|37907481|FG000|Overall Study|Patients ongoing Study Treatment|19|||
16886617|NCT02184195|37907482|FG001|Overall Study|Patients ongoing Study Treatment|7|||
16886618|NCT01341405|37907583|FG000|Overall Study|Adverse Event|0|||
16886619|NCT01341405|37907584|FG001|Overall Study|Adverse Event|1|||
16886620|NCT01341405|37907585|FG002|Overall Study|Adverse Event|1|||
16886621|NCT01341405|37907583|FG000|Overall Study|Withdrawal by Subject|3|||
16886622|NCT01341405|37907584|FG001|Overall Study|Withdrawal by Subject|2|||
16886623|NCT01341405|37907585|FG002|Overall Study|Withdrawal by Subject|1|||
16886624|NCT02516241|37908792|FG000|Overall Study|Death|255|||
16886625|NCT02516241|37908793|FG001|Overall Study|Death|262|||
16886626|NCT02516241|37908794|FG002|Overall Study|Death|270|||
16886627|NCT02516241|37908792|FG000|Overall Study|Lost to Follow-up|1|||
16886628|NCT02516241|37908793|FG001|Overall Study|Lost to Follow-up|1|||
16886629|NCT02516241|37908794|FG002|Overall Study|Lost to Follow-up|3|||
16886630|NCT02516241|37908792|FG000|Overall Study|Withdrawal by Subject|2|||
16886631|NCT02516241|37908793|FG001|Overall Study|Withdrawal by Subject|7|||
16886632|NCT02516241|37908794|FG002|Overall Study|Withdrawal by Subject|12|||
16886633|NCT02516241|37908792|FG000|Overall Study|participants ongoing at data cut-off|84|||
16886634|NCT02516241|37908793|FG001|Overall Study|participants ongoing at data cut-off|76|||
16886635|NCT02516241|37908794|FG002|Overall Study|participants ongoing at data cut-off|59|||
16886636|NCT00633945|37908867|FG000|Overall Study|Physician Decision|2|||
16886637|NCT02574078|37909140|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886638|NCT02574078|37909141|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886639|NCT02574078|37909142|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886640|NCT02574078|37909143|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886641|NCT02574078|37909144|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886642|NCT02574078|37909145|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16886643|NCT02574078|37909146|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
16886644|NCT02574078|37909147|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886645|NCT02574078|37909148|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16886646|NCT02574078|37909149|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886647|NCT02574078|37909150|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886648|NCT02574078|37909151|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886649|NCT02574078|37909152|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16886650|NCT02574078|37909140|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
16886651|NCT02574078|37909141|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
16886652|NCT02574078|37909142|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
16886653|NCT02574078|37909143|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
16886654|NCT02574078|37909144|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
16886655|NCT02574078|37909145|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
16886656|NCT02574078|37909146|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
16886657|NCT02574078|37909147|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
16886658|NCT02574078|37909148|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
16886659|NCT02574078|37909149|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
16886660|NCT02574078|37909150|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
16886661|NCT02574078|37909151|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
16886662|NCT02574078|37909152|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
16886663|NCT02574078|37909140|FG000|Pre-Treatment Period|Other reasons|0|||
16886664|NCT02574078|37909141|FG001|Pre-Treatment Period|Other reasons|0|||
16886665|NCT02574078|37909142|FG002|Pre-Treatment Period|Other reasons|0|||
16886666|NCT02574078|37909143|FG003|Pre-Treatment Period|Other reasons|0|||
16886667|NCT02574078|37909144|FG004|Pre-Treatment Period|Other reasons|0|||
16886668|NCT02574078|37909145|FG005|Pre-Treatment Period|Other reasons|0|||
16886669|NCT02574078|37909146|FG006|Pre-Treatment Period|Other reasons|2|||
16886670|NCT02574078|37909147|FG007|Pre-Treatment Period|Other reasons|0|||
16886671|NCT02574078|37909148|FG008|Pre-Treatment Period|Other reasons|0|||
16886672|NCT02574078|37909149|FG009|Pre-Treatment Period|Other reasons|0|||
16886673|NCT02574078|37909150|FG010|Pre-Treatment Period|Other reasons|2|||
16886674|NCT02574078|37909151|FG011|Pre-Treatment Period|Other reasons|0|||
16886675|NCT02574078|37909152|FG012|Pre-Treatment Period|Other reasons|0|||
16886676|NCT02574078|37909140|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
16886677|NCT02574078|37909141|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
16886678|NCT02574078|37909142|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
16886679|NCT02574078|37909143|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
16886680|NCT02574078|37909144|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
16886681|NCT02574078|37909145|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
16886682|NCT02574078|37909146|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
16886683|NCT02574078|37909147|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
17002312|NCT00569803|38146415|FG005|Overall Study|injection syringe leaked during dosing|0|||
17002313|NCT00569803|38146416|FG006|Overall Study|injection syringe leaked during dosing|0|||
17002314|NCT00569803|38146417|FG007|Overall Study|injection syringe leaked during dosing|0|||
17002315|NCT00569803|38146410|FG000|Overall Study|Withdrawal by Subject|0|||
17002316|NCT00569803|38146411|FG001|Overall Study|Withdrawal by Subject|0|||
17002317|NCT00569803|38146412|FG002|Overall Study|Withdrawal by Subject|0|||
17002318|NCT00569803|38146413|FG003|Overall Study|Withdrawal by Subject|0|||
17002319|NCT00569803|38146414|FG004|Overall Study|Withdrawal by Subject|0|||
17002320|NCT00569803|38146415|FG005|Overall Study|Withdrawal by Subject|0|||
17002321|NCT00569803|38146416|FG006|Overall Study|Withdrawal by Subject|0|||
17002322|NCT00569803|38146417|FG007|Overall Study|Withdrawal by Subject|1|||
17002323|NCT00920426|38146442|FG000|ITZ111451|Adverse Event|1|||
17002324|NCT00920426|38146443|FG001|ITZ111451|Adverse Event|0|||
17002325|NCT00920426|38146444|FG002|ITZ111451|Adverse Event|0|||
17002326|NCT00920426|38146445|FG003|ITZ111451|Adverse Event|0|||
17002327|NCT00644995|38146459|FG000|Overall Study|Lost to Follow-up|1|||
17002328|NCT00644995|38146460|FG001|Overall Study|Lost to Follow-up|4|||
17002329|NCT00644995|38146459|FG000|Overall Study|Refused|1|||
17002330|NCT00644995|38146460|FG001|Overall Study|Refused|0|||
17002331|NCT00914966|38146468|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
17002332|NCT00914966|38146468|FG000|Step 1: 1500 Units|Physician Decision|1|||
17002333|NCT00914966|38146468|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
17002334|NCT00914810|38146479|FG000|Overall Study|Withdrawal by Subject|1|||
17002335|NCT00914810|38146480|FG001|Overall Study|Withdrawal by Subject|0|||
17002336|NCT00914810|38146479|FG000|Overall Study|Relocated out of state|1|||
17002337|NCT00914810|38146480|FG001|Overall Study|Relocated out of state|0|||
17002338|NCT00914810|38146479|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
17002339|NCT00914810|38146480|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
17002340|NCT00644917|38146486|FG000|Overall Study|Withdrawal by Subject|2|||
17002341|NCT00914732|38146497|FG000|Overall Study|Lost to Follow-up|6|||
17002342|NCT00914732|38146498|FG001|Overall Study|Lost to Follow-up|7|||
17002343|NCT00914732|38146499|FG002|Overall Study|Lost to Follow-up|9|||
17002344|NCT00914732|38146497|FG000|Overall Study|Withdrawal by Subject|3|||
17002345|NCT00914732|38146498|FG001|Overall Study|Withdrawal by Subject|0|||
17002346|NCT00914732|38146499|FG002|Overall Study|Withdrawal by Subject|2|||
17002347|NCT00914732|38146497|FG000|Overall Study|Adverse Event|1|||
17002348|NCT00914732|38146498|FG001|Overall Study|Adverse Event|0|||
17002349|NCT00914732|38146499|FG002|Overall Study|Adverse Event|0|||
17002350|NCT00844545|38146508|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
17002351|NCT00844545|38146508|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
17002352|NCT00844545|38146508|FG000|Extension Treatment Period|Adverse Event|2|||
17002353|NCT00844545|38146508|FG000|Post Treatment Period|Withdrawal by Subject|1|||
17002354|NCT00651157|38146513|FG000|Overall Study|Death|1|||
17002355|NCT00651157|38146513|FG000|Overall Study|Protocol Violation|1|||
17002356|NCT00843843|38146519|FG000|Overall Study|Physician Decision|1|||
16785779|NCT02694523|37725863|FG002|Part B|Withdrawal by Subject|9|||
17002357|NCT00843843|38146520|FG001|Overall Study|Physician Decision|1|||
17002358|NCT00843843|38146519|FG000|Overall Study|Protocol Violation|1|||
17002359|NCT00843843|38146520|FG001|Overall Study|Protocol Violation|1|||
17002360|NCT00650845|38146528|FG000|Overall Study|Withdrawal by Subject|5|||
17002361|NCT00650845|38146529|FG001|Overall Study|Withdrawal by Subject|0|||
17002362|NCT00650845|38146528|FG000|Overall Study|Protocol Violation|0|||
17002363|NCT00650845|38146529|FG001|Overall Study|Protocol Violation|13|||
17002364|NCT00842985|38146536|FG000|Screening|Did not meet entrance requirements|27|||
17002365|NCT00842985|38146536|FG000|First Intervention|Withdrawal by Subject|3|||
17002366|NCT00842985|38146536|FG000|First Intervention|Protocol Violation|3|||
17002367|NCT00842985|38146536|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
17002368|NCT00842985|38146536|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
17095328|NCT00261846|38234543|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
17002369|NCT00842829|38146545|FG000|Dose Titration Period|Adverse Event|11|||
17002370|NCT00842829|38146546|FG001|Dose Titration Period|Adverse Event|10|||
16886684|NCT02574078|37909148|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
16886685|NCT02574078|37909149|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
16886686|NCT02574078|37909150|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
16886687|NCT02574078|37909151|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
16886688|NCT02574078|37909152|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
16886689|NCT02574078|37909140|FG000|Treatment Period|Disease progression|6|||
16886690|NCT02574078|37909141|FG001|Treatment Period|Disease progression|4|||
16886691|NCT02574078|37909142|FG002|Treatment Period|Disease progression|7|||
16886692|NCT02574078|37909143|FG003|Treatment Period|Disease progression|18|||
16886693|NCT02574078|37909144|FG004|Treatment Period|Disease progression|16|||
16886694|NCT02574078|37909145|FG005|Treatment Period|Disease progression|26|||
16886695|NCT02574078|37909146|FG006|Treatment Period|Disease progression|5|||
16886696|NCT02574078|37909147|FG007|Treatment Period|Disease progression|9|||
16886697|NCT02574078|37909148|FG008|Treatment Period|Disease progression|8|||
16886698|NCT02574078|37909149|FG009|Treatment Period|Disease progression|5|||
16886699|NCT02574078|37909150|FG010|Treatment Period|Disease progression|20|||
16886700|NCT02574078|37909151|FG011|Treatment Period|Disease progression|29|||
16886701|NCT02574078|37909152|FG012|Treatment Period|Disease progression|2|||
16886702|NCT02574078|37909140|FG000|Treatment Period|Study drug toxicity|1|||
16886703|NCT02574078|37909141|FG001|Treatment Period|Study drug toxicity|1|||
16886704|NCT02574078|37909142|FG002|Treatment Period|Study drug toxicity|0|||
16886705|NCT02574078|37909143|FG003|Treatment Period|Study drug toxicity|5|||
16886706|NCT02574078|37909144|FG004|Treatment Period|Study drug toxicity|3|||
16886707|NCT02574078|37909145|FG005|Treatment Period|Study drug toxicity|1|||
16886708|NCT02574078|37909146|FG006|Treatment Period|Study drug toxicity|2|||
16886709|NCT02574078|37909147|FG007|Treatment Period|Study drug toxicity|0|||
16886710|NCT02574078|37909148|FG008|Treatment Period|Study drug toxicity|2|||
16886711|NCT02574078|37909149|FG009|Treatment Period|Study drug toxicity|1|||
16886712|NCT02574078|37909150|FG010|Treatment Period|Study drug toxicity|16|||
16886713|NCT02574078|37909151|FG011|Treatment Period|Study drug toxicity|2|||
16886714|NCT02574078|37909152|FG012|Treatment Period|Study drug toxicity|4|||
16886715|NCT02574078|37909140|FG000|Treatment Period|Death|2|||
16886716|NCT02574078|37909141|FG001|Treatment Period|Death|0|||
16886717|NCT02574078|37909142|FG002|Treatment Period|Death|0|||
16886718|NCT02574078|37909143|FG003|Treatment Period|Death|0|||
16886719|NCT02574078|37909144|FG004|Treatment Period|Death|1|||
16886720|NCT02574078|37909145|FG005|Treatment Period|Death|1|||
16886721|NCT02574078|37909146|FG006|Treatment Period|Death|1|||
16886722|NCT02574078|37909147|FG007|Treatment Period|Death|1|||
16886723|NCT02574078|37909148|FG008|Treatment Period|Death|7|||
16886724|NCT02574078|37909149|FG009|Treatment Period|Death|1|||
16886725|NCT02574078|37909150|FG010|Treatment Period|Death|0|||
16886726|NCT02574078|37909151|FG011|Treatment Period|Death|2|||
16886727|NCT02574078|37909152|FG012|Treatment Period|Death|1|||
16886728|NCT02574078|37909140|FG000|Treatment Period|Adverse event unrelated to drug|0|||
16886729|NCT02574078|37909141|FG001|Treatment Period|Adverse event unrelated to drug|0|||
16886730|NCT02574078|37909142|FG002|Treatment Period|Adverse event unrelated to drug|1|||
16886731|NCT02574078|37909143|FG003|Treatment Period|Adverse event unrelated to drug|0|||
16886732|NCT02574078|37909144|FG004|Treatment Period|Adverse event unrelated to drug|2|||
16886733|NCT02574078|37909145|FG005|Treatment Period|Adverse event unrelated to drug|3|||
16886734|NCT02574078|37909146|FG006|Treatment Period|Adverse event unrelated to drug|0|||
16886735|NCT02574078|37909147|FG007|Treatment Period|Adverse event unrelated to drug|0|||
16886736|NCT02574078|37909148|FG008|Treatment Period|Adverse event unrelated to drug|1|||
16886737|NCT02574078|37909149|FG009|Treatment Period|Adverse event unrelated to drug|2|||
16886738|NCT02574078|37909150|FG010|Treatment Period|Adverse event unrelated to drug|4|||
16886739|NCT02574078|37909151|FG011|Treatment Period|Adverse event unrelated to drug|1|||
16886740|NCT02574078|37909152|FG012|Treatment Period|Adverse event unrelated to drug|0|||
16886741|NCT02574078|37909140|FG000|Treatment Period|Administrative reason by Sponsor|0|||
16886742|NCT02574078|37909141|FG001|Treatment Period|Administrative reason by Sponsor|1|||
16886743|NCT02574078|37909142|FG002|Treatment Period|Administrative reason by Sponsor|0|||
17002371|NCT00842829|38146547|FG002|Dose Titration Period|Adverse Event|0|||
17002372|NCT00842829|38146545|FG000|Dose Titration Period|Lack of Efficacy|4|||
17002373|NCT00842829|38146546|FG001|Dose Titration Period|Lack of Efficacy|1|||
16785780|NCT02694523|37725864|FG003|Part B|Withdrawal by Subject|0|||
16886744|NCT02574078|37909143|FG003|Treatment Period|Administrative reason by Sponsor|0|||
16886745|NCT02574078|37909144|FG004|Treatment Period|Administrative reason by Sponsor|0|||
16886746|NCT02574078|37909145|FG005|Treatment Period|Administrative reason by Sponsor|0|||
16886747|NCT02574078|37909146|FG006|Treatment Period|Administrative reason by Sponsor|1|||
16886748|NCT02574078|37909147|FG007|Treatment Period|Administrative reason by Sponsor|0|||
16886749|NCT02574078|37909148|FG008|Treatment Period|Administrative reason by Sponsor|0|||
16886750|NCT02574078|37909149|FG009|Treatment Period|Administrative reason by Sponsor|0|||
16886751|NCT02574078|37909150|FG010|Treatment Period|Administrative reason by Sponsor|0|||
16886752|NCT02574078|37909151|FG011|Treatment Period|Administrative reason by Sponsor|0|||
16886753|NCT02574078|37909152|FG012|Treatment Period|Administrative reason by Sponsor|3|||
16886754|NCT02574078|37909140|FG000|Treatment Period|Other reasons|1|||
16886755|NCT02574078|37909141|FG001|Treatment Period|Other reasons|0|||
16886756|NCT02574078|37909142|FG002|Treatment Period|Other reasons|1|||
16886757|NCT02574078|37909143|FG003|Treatment Period|Other reasons|3|||
16886758|NCT02574078|37909144|FG004|Treatment Period|Other reasons|3|||
16886759|NCT02574078|37909145|FG005|Treatment Period|Other reasons|1|||
16886760|NCT02574078|37909146|FG006|Treatment Period|Other reasons|2|||
16886761|NCT02574078|37909147|FG007|Treatment Period|Other reasons|1|||
16886762|NCT02574078|37909148|FG008|Treatment Period|Other reasons|3|||
16886763|NCT02574078|37909149|FG009|Treatment Period|Other reasons|1|||
16886764|NCT02574078|37909150|FG010|Treatment Period|Other reasons|1|||
16886765|NCT02574078|37909151|FG011|Treatment Period|Other reasons|3|||
16886766|NCT02574078|37909152|FG012|Treatment Period|Other reasons|1|||
16886767|NCT02574078|37909140|FG000|Treatment Period|Participant request to stop drug|0|||
16886768|NCT02574078|37909141|FG001|Treatment Period|Participant request to stop drug|0|||
16886769|NCT02574078|37909142|FG002|Treatment Period|Participant request to stop drug|0|||
16886770|NCT02574078|37909143|FG003|Treatment Period|Participant request to stop drug|2|||
16886771|NCT02574078|37909144|FG004|Treatment Period|Participant request to stop drug|4|||
16886772|NCT02574078|37909145|FG005|Treatment Period|Participant request to stop drug|0|||
16886773|NCT02574078|37909146|FG006|Treatment Period|Participant request to stop drug|1|||
16886774|NCT02574078|37909147|FG007|Treatment Period|Participant request to stop drug|0|||
16886775|NCT02574078|37909148|FG008|Treatment Period|Participant request to stop drug|3|||
16886776|NCT02574078|37909149|FG009|Treatment Period|Participant request to stop drug|2|||
16886777|NCT02574078|37909150|FG010|Treatment Period|Participant request to stop drug|2|||
16886778|NCT02574078|37909151|FG011|Treatment Period|Participant request to stop drug|4|||
16886779|NCT02574078|37909152|FG012|Treatment Period|Participant request to stop drug|1|||
16886780|NCT02574078|37909140|FG000|Treatment Period|Participant withdrew consent|0|||
16886781|NCT02574078|37909141|FG001|Treatment Period|Participant withdrew consent|0|||
16886782|NCT02574078|37909142|FG002|Treatment Period|Participant withdrew consent|0|||
16886783|NCT02574078|37909143|FG003|Treatment Period|Participant withdrew consent|0|||
16886784|NCT02574078|37909144|FG004|Treatment Period|Participant withdrew consent|1|||
16886785|NCT02574078|37909145|FG005|Treatment Period|Participant withdrew consent|1|||
16886786|NCT02574078|37909146|FG006|Treatment Period|Participant withdrew consent|0|||
16886787|NCT02574078|37909147|FG007|Treatment Period|Participant withdrew consent|1|||
16886788|NCT02574078|37909148|FG008|Treatment Period|Participant withdrew consent|0|||
16886789|NCT02574078|37909149|FG009|Treatment Period|Participant withdrew consent|2|||
16886790|NCT02574078|37909150|FG010|Treatment Period|Participant withdrew consent|1|||
16886791|NCT02574078|37909151|FG011|Treatment Period|Participant withdrew consent|4|||
16886792|NCT02574078|37909152|FG012|Treatment Period|Participant withdrew consent|1|||
16886793|NCT02574078|37909140|FG000|Treatment Period|Participant no longer meets criteria|0|||
16886794|NCT02574078|37909141|FG001|Treatment Period|Participant no longer meets criteria|0|||
16886795|NCT02574078|37909142|FG002|Treatment Period|Participant no longer meets criteria|0|||
16886796|NCT02574078|37909143|FG003|Treatment Period|Participant no longer meets criteria|0|||
16886797|NCT02574078|37909144|FG004|Treatment Period|Participant no longer meets criteria|1|||
16886798|NCT02574078|37909145|FG005|Treatment Period|Participant no longer meets criteria|0|||
16886799|NCT02574078|37909146|FG006|Treatment Period|Participant no longer meets criteria|0|||
16886800|NCT02574078|37909147|FG007|Treatment Period|Participant no longer meets criteria|0|||
16886801|NCT02574078|37909148|FG008|Treatment Period|Participant no longer meets criteria|0|||
16886802|NCT02574078|37909149|FG009|Treatment Period|Participant no longer meets criteria|1|||
16886803|NCT02574078|37909150|FG010|Treatment Period|Participant no longer meets criteria|1|||
16886804|NCT02574078|37909151|FG011|Treatment Period|Participant no longer meets criteria|1|||
16886805|NCT02574078|37909152|FG012|Treatment Period|Participant no longer meets criteria|0|||
16886806|NCT02574078|37909140|FG000|Treatment Period|Lost to Follow-up|0|||
16886807|NCT02574078|37909141|FG001|Treatment Period|Lost to Follow-up|0|||
16886808|NCT02574078|37909142|FG002|Treatment Period|Lost to Follow-up|0|||
16886809|NCT02574078|37909143|FG003|Treatment Period|Lost to Follow-up|0|||
16886810|NCT02574078|37909144|FG004|Treatment Period|Lost to Follow-up|0|||
17191988|NCT02358031|38345061|FG002|Overall Study|Ongoing in Study|33|||
16886811|NCT02574078|37909145|FG005|Treatment Period|Lost to Follow-up|0|||
16886812|NCT02574078|37909146|FG006|Treatment Period|Lost to Follow-up|0|||
16886813|NCT02574078|37909147|FG007|Treatment Period|Lost to Follow-up|0|||
16886814|NCT02574078|37909148|FG008|Treatment Period|Lost to Follow-up|0|||
16886815|NCT02574078|37909149|FG009|Treatment Period|Lost to Follow-up|1|||
16886816|NCT02574078|37909150|FG010|Treatment Period|Lost to Follow-up|0|||
16886817|NCT02574078|37909151|FG011|Treatment Period|Lost to Follow-up|1|||
16886818|NCT02574078|37909152|FG012|Treatment Period|Lost to Follow-up|0|||
16886819|NCT02574078|37909140|FG000|Treatment Period|Maximum clinical benefit|0|||
16886820|NCT02574078|37909141|FG001|Treatment Period|Maximum clinical benefit|0|||
16886821|NCT02574078|37909142|FG002|Treatment Period|Maximum clinical benefit|0|||
16886822|NCT02574078|37909143|FG003|Treatment Period|Maximum clinical benefit|0|||
16886823|NCT02574078|37909144|FG004|Treatment Period|Maximum clinical benefit|0|||
16886824|NCT02574078|37909145|FG005|Treatment Period|Maximum clinical benefit|0|||
16886825|NCT02574078|37909146|FG006|Treatment Period|Maximum clinical benefit|0|||
16886826|NCT02574078|37909147|FG007|Treatment Period|Maximum clinical benefit|0|||
16886827|NCT02574078|37909148|FG008|Treatment Period|Maximum clinical benefit|0|||
16886828|NCT02574078|37909149|FG009|Treatment Period|Maximum clinical benefit|1|||
16886829|NCT02574078|37909150|FG010|Treatment Period|Maximum clinical benefit|0|||
16886830|NCT02574078|37909151|FG011|Treatment Period|Maximum clinical benefit|0|||
16886831|NCT02574078|37909152|FG012|Treatment Period|Maximum clinical benefit|0|||
16886832|NCT02565810|37909270|FG000|Overall Study|Withdrawal by Subject|1|||
16886833|NCT02561832|37909435|FG000|Overall Study|Withdrawal by Subject|1|||
16886834|NCT02561832|37909436|FG001|Overall Study|Withdrawal by Subject|1|||
16886835|NCT02561832|37909435|FG000|Overall Study|Adverse Event|3|||
16886836|NCT02561832|37909436|FG001|Overall Study|Adverse Event|0|||
16886837|NCT02561832|37909435|FG000|Overall Study|Disease progression|3|||
16886838|NCT02561832|37909436|FG001|Overall Study|Disease progression|3|||
16886839|NCT00985088|37911101|FG000|Overall Study|Serious Adverse Event|1|||
16886840|NCT00985088|37911102|FG001|Overall Study|Serious Adverse Event|1|||
16886841|NCT00985088|37911103|FG002|Overall Study|Serious Adverse Event|0|||
16886842|NCT00985088|37911104|FG003|Overall Study|Serious Adverse Event|0|||
16886843|NCT00985088|37911105|FG004|Overall Study|Serious Adverse Event|0|||
16886844|NCT00985088|37911106|FG005|Overall Study|Serious Adverse Event|0|||
16886845|NCT00985088|37911107|FG006|Overall Study|Serious Adverse Event|0|||
16886846|NCT00985088|37911108|FG007|Overall Study|Serious Adverse Event|1|||
16886847|NCT00985088|37911101|FG000|Overall Study|Adverse Event|0|||
16886848|NCT00985088|37911102|FG001|Overall Study|Adverse Event|0|||
16886849|NCT00985088|37911103|FG002|Overall Study|Adverse Event|1|||
16886850|NCT00985088|37911104|FG003|Overall Study|Adverse Event|0|||
16886851|NCT00985088|37911105|FG004|Overall Study|Adverse Event|0|||
16886852|NCT00985088|37911106|FG005|Overall Study|Adverse Event|0|||
16886853|NCT00985088|37911107|FG006|Overall Study|Adverse Event|0|||
16886854|NCT00985088|37911108|FG007|Overall Study|Adverse Event|0|||
16886855|NCT00985088|37911101|FG000|Overall Study|Withdrawal by Subject|4|||
16886856|NCT00985088|37911102|FG001|Overall Study|Withdrawal by Subject|0|||
16886857|NCT00985088|37911103|FG002|Overall Study|Withdrawal by Subject|0|||
16886858|NCT00985088|37911104|FG003|Overall Study|Withdrawal by Subject|1|||
16886859|NCT00985088|37911105|FG004|Overall Study|Withdrawal by Subject|3|||
16886860|NCT00985088|37911106|FG005|Overall Study|Withdrawal by Subject|2|||
16886861|NCT00985088|37911107|FG006|Overall Study|Withdrawal by Subject|1|||
16886862|NCT00985088|37911108|FG007|Overall Study|Withdrawal by Subject|2|||
16886863|NCT00985088|37911101|FG000|Overall Study|Migrated/moved from study area|0|||
16886864|NCT00985088|37911102|FG001|Overall Study|Migrated/moved from study area|0|||
16886865|NCT00985088|37911103|FG002|Overall Study|Migrated/moved from study area|1|||
16886866|NCT00985088|37911104|FG003|Overall Study|Migrated/moved from study area|0|||
16886867|NCT00985088|37911105|FG004|Overall Study|Migrated/moved from study area|0|||
16886868|NCT00985088|37911106|FG005|Overall Study|Migrated/moved from study area|0|||
16886869|NCT00985088|37911107|FG006|Overall Study|Migrated/moved from study area|0|||
16886870|NCT00985088|37911108|FG007|Overall Study|Migrated/moved from study area|1|||
16886871|NCT00985088|37911101|FG000|Overall Study|Lost to Follow-up|6|||
16886872|NCT00985088|37911102|FG001|Overall Study|Lost to Follow-up|1|||
16886873|NCT00985088|37911103|FG002|Overall Study|Lost to Follow-up|2|||
16886874|NCT00985088|37911104|FG003|Overall Study|Lost to Follow-up|6|||
16886875|NCT00985088|37911105|FG004|Overall Study|Lost to Follow-up|6|||
16886876|NCT00985088|37911106|FG005|Overall Study|Lost to Follow-up|5|||
16886877|NCT00985088|37911107|FG006|Overall Study|Lost to Follow-up|3|||
16886878|NCT00985088|37911108|FG007|Overall Study|Lost to Follow-up|2|||
16886879|NCT00984542|37911154|FG000|Overall Study|disease progression|19|||
16886880|NCT00984542|37911154|FG000|Overall Study|toxicity|7|||
16886881|NCT00984542|37911154|FG000|Overall Study|Death|7|||
16886882|NCT00984542|37911154|FG000|Overall Study|complicating disease|3|||
16886883|NCT00984542|37911154|FG000|Overall Study|Withdrawal by Subject|3|||
16886884|NCT00984542|37911154|FG000|Overall Study|clinical deterioration|2|||
16886885|NCT00983918|37911163|FG000|Overall Study|conversion to open cholecystectomy|0|||
16886886|NCT00983918|37911164|FG001|Overall Study|conversion to open cholecystectomy|2|||
16886887|NCT00983918|37911165|FG002|Overall Study|conversion to open cholecystectomy|2|||
16886888|NCT00983918|37911166|FG003|Overall Study|conversion to open cholecystectomy|2|||
16886889|NCT00983528|37911176|FG000|Overall Study|Death|4|||
16886890|NCT00983528|37911176|FG000|Overall Study|Lost to Follow-up|1|||
16886891|NCT00983528|37911176|FG000|Overall Study|Study Terminated|1|||
16886892|NCT00983372|37911180|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
16886893|NCT00983372|37911180|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
16886894|NCT00983372|37911180|FG000|Diltiazem ER Alone|Adverse Event|1|||
16886895|NCT00983294|37911212|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
16886896|NCT00983294|37911212|FG000|Colchicine With Azithromycin|Adverse Event|1|||
16886897|NCT00982280|37911228|FG000|Observation Period|Not eligible to be dosed|19|||
16886898|NCT00982280|37911228|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
16886899|NCT00982280|37911228|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
16886900|NCT00982280|37911228|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
16886901|NCT00982280|37911228|FG000|Maintenance Period|Adverse Event|1|||
16886902|NCT00981578|37911246|FG000|Overall Study|Death|1|||
16886903|NCT00981578|37911246|FG000|Overall Study|Withdrawal by Subject|2|||
16886904|NCT00980798|37911269|FG000|Overall Study|Adverse Event|7|||
16886905|NCT00980798|37911270|FG001|Overall Study|Adverse Event|36|||
16886906|NCT00980798|37911269|FG000|Overall Study|Lack of Efficacy|16|||
16886907|NCT00980798|37911270|FG001|Overall Study|Lack of Efficacy|5|||
16886908|NCT00980798|37911269|FG000|Overall Study|Lost to Follow-up|0|||
16886909|NCT00980798|37911270|FG001|Overall Study|Lost to Follow-up|1|||
16886910|NCT00980798|37911269|FG000|Overall Study|Physician Decision|2|||
16886911|NCT00980798|37911270|FG001|Overall Study|Physician Decision|1|||
16886912|NCT00980798|37911269|FG000|Overall Study|Withdrawal by Subject|8|||
16886913|NCT00980798|37911270|FG001|Overall Study|Withdrawal by Subject|11|||
16886914|NCT00980798|37911269|FG000|Overall Study|Other|0|||
16886915|NCT00980798|37911270|FG001|Overall Study|Other|1|||
16886916|NCT00980330|37911415|FG000|Overall Study|Adverse Event|0|||
16886917|NCT00980330|37911416|FG001|Overall Study|Adverse Event|0|||
16886918|NCT00980330|37911417|FG002|Overall Study|Adverse Event|0|||
16886919|NCT00980330|37911418|FG003|Overall Study|Adverse Event|1|||
16886920|NCT00980330|37911419|FG004|Overall Study|Adverse Event|0|||
16886921|NCT00980330|37911420|FG005|Overall Study|Adverse Event|0|||
16886922|NCT00980330|37911421|FG006|Overall Study|Adverse Event|0|||
16886923|NCT00980330|37911415|FG000|Overall Study|Lost to Follow-up|1|||
16886924|NCT00980330|37911416|FG001|Overall Study|Lost to Follow-up|1|||
16886925|NCT00980330|37911417|FG002|Overall Study|Lost to Follow-up|4|||
16886926|NCT00980330|37911418|FG003|Overall Study|Lost to Follow-up|2|||
16886927|NCT00980330|37911419|FG004|Overall Study|Lost to Follow-up|1|||
16886928|NCT00980330|37911420|FG005|Overall Study|Lost to Follow-up|1|||
16886929|NCT00980330|37911421|FG006|Overall Study|Lost to Follow-up|2|||
16886930|NCT00980330|37911415|FG000|Overall Study|Withdrawal by Subject|2|||
16886931|NCT00980330|37911416|FG001|Overall Study|Withdrawal by Subject|4|||
16886932|NCT00980330|37911417|FG002|Overall Study|Withdrawal by Subject|4|||
16886933|NCT00980330|37911418|FG003|Overall Study|Withdrawal by Subject|1|||
16886934|NCT00980330|37911419|FG004|Overall Study|Withdrawal by Subject|3|||
16886935|NCT00980330|37911420|FG005|Overall Study|Withdrawal by Subject|2|||
16886936|NCT00980330|37911421|FG006|Overall Study|Withdrawal by Subject|5|||
16886937|NCT00980330|37911415|FG000|Overall Study|(not specified)|2|||
16886938|NCT00980330|37911416|FG001|Overall Study|(not specified)|0|||
16886939|NCT00980330|37911417|FG002|Overall Study|(not specified)|0|||
16886940|NCT00980330|37911418|FG003|Overall Study|(not specified)|1|||
16886941|NCT00980330|37911419|FG004|Overall Study|(not specified)|1|||
16886942|NCT00980330|37911420|FG005|Overall Study|(not specified)|1|||
16886943|NCT00980330|37911421|FG006|Overall Study|(not specified)|0|||
16886944|NCT00980174|37911465|FG000|Overall Study|Withdrawal by Subject|1|||
16886945|NCT00980174|37911466|FG001|Overall Study|Withdrawal by Subject|4|||
16886946|NCT00980174|37911465|FG000|Overall Study|Adverse Event|0|||
16886947|NCT00980174|37911466|FG001|Overall Study|Adverse Event|3|||
16886948|NCT00980174|37911465|FG000|Overall Study|Ineligibility determined|2|||
16886949|NCT00980174|37911466|FG001|Overall Study|Ineligibility determined|1|||
16886950|NCT00980174|37911465|FG000|Overall Study|Death|1|||
16886951|NCT00980174|37911466|FG001|Overall Study|Death|1|||
16886952|NCT00980174|37911465|FG000|Overall Study|Other|0|||
16886953|NCT00980174|37911466|FG001|Overall Study|Other|1|||
16886954|NCT00980018|37911494|FG000|Overall Study|Adverse Event|8|||
16886955|NCT00980018|37911494|FG000|Overall Study|Patient withdrew consent|3|||
16886956|NCT00980018|37911494|FG000|Overall Study|Lost to Follow-up|1|||
16886957|NCT00981656|37911515|FG000|Overall Study|Protocol Violation|1|||
16886958|NCT00981656|37911515|FG000|Overall Study|Did not start protocol treatment|2|||
16886959|NCT00988052|37911521|FG000|Overall Study|Missing|1|||
16886960|NCT00988052|37911522|FG001|Overall Study|Missing|0|||
16886961|NCT00988052|37911521|FG000|Overall Study|Teva requested subject withdrawal|3|||
16886962|NCT00988052|37911522|FG001|Overall Study|Teva requested subject withdrawal|1|||
16886963|NCT00988052|37911521|FG000|Overall Study|Death|1|||
16886964|NCT00988052|37911522|FG001|Overall Study|Death|3|||
16886965|NCT00988052|37911521|FG000|Overall Study|Protocol Violation|6|||
16886966|NCT00988052|37911522|FG001|Overall Study|Protocol Violation|5|||
16886967|NCT00988052|37911521|FG000|Overall Study|Pregnancy|6|||
16886968|NCT00988052|37911522|FG001|Overall Study|Pregnancy|6|||
17095329|NCT00261846|38234544|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
16886969|NCT00988052|37911521|FG000|Overall Study|Lack of Efficacy|8|||
16886970|NCT00988052|37911522|FG001|Overall Study|Lack of Efficacy|7|||
16886971|NCT00988052|37911521|FG000|Overall Study|Lost to Follow-up|6|||
16886972|NCT00988052|37911522|FG001|Overall Study|Lost to Follow-up|11|||
16886973|NCT00988052|37911521|FG000|Overall Study|Physician Decision|27|||
16886974|NCT00988052|37911522|FG001|Overall Study|Physician Decision|28|||
16886975|NCT00988052|37911521|FG000|Overall Study|Adverse Event|35|||
16886976|NCT00988052|37911522|FG001|Overall Study|Adverse Event|28|||
16886977|NCT00988052|37911521|FG000|Overall Study|Withdrawal by Subject|90|||
16886978|NCT00988052|37911522|FG001|Overall Study|Withdrawal by Subject|91|||
16886979|NCT00988052|37911521|FG000|Overall Study|Study terminated by sponsor|240|||
16886980|NCT00988052|37911522|FG001|Overall Study|Study terminated by sponsor|236|||
16886981|NCT02569710|37911623|FG000|Overall Study|Adverse Event|1|||
16886982|NCT02569710|37911624|FG001|Overall Study|Adverse Event|0|||
16886983|NCT02569710|37911625|FG002|Overall Study|Adverse Event|0|||
16886984|NCT02569710|37911626|FG003|Overall Study|Adverse Event|0|||
16886985|NCT02569710|37911627|FG004|Overall Study|Adverse Event|0|||
16886986|NCT02569710|37911628|FG005|Overall Study|Adverse Event|0|||
16886987|NCT02569710|37911629|FG006|Overall Study|Adverse Event|0|||
16886988|NCT02569710|37911630|FG007|Overall Study|Adverse Event|0|||
16886989|NCT02569710|37911631|FG008|Overall Study|Adverse Event|0|||
16886990|NCT02569710|37911632|FG009|Overall Study|Adverse Event|0|||
16886991|NCT02569710|37911623|FG000|Overall Study|Lost to Follow-up|0|||
16886992|NCT02569710|37911624|FG001|Overall Study|Lost to Follow-up|0|||
16886993|NCT02569710|37911625|FG002|Overall Study|Lost to Follow-up|0|||
16886994|NCT02569710|37911626|FG003|Overall Study|Lost to Follow-up|0|||
16886995|NCT02569710|37911627|FG004|Overall Study|Lost to Follow-up|0|||
16886996|NCT02569710|37911628|FG005|Overall Study|Lost to Follow-up|0|||
16886997|NCT02569710|37911629|FG006|Overall Study|Lost to Follow-up|1|||
16886998|NCT02569710|37911630|FG007|Overall Study|Lost to Follow-up|0|||
16886999|NCT02569710|37911631|FG008|Overall Study|Lost to Follow-up|1|||
16887000|NCT02569710|37911632|FG009|Overall Study|Lost to Follow-up|0|||
16887001|NCT02569710|37911623|FG000|Overall Study|Virologic failure|0|||
16887002|NCT02569710|37911624|FG001|Overall Study|Virologic failure|0|||
16887003|NCT02569710|37911625|FG002|Overall Study|Virologic failure|0|||
16887004|NCT02569710|37911626|FG003|Overall Study|Virologic failure|0|||
16887005|NCT02569710|37911627|FG004|Overall Study|Virologic failure|1|||
16887006|NCT02569710|37911628|FG005|Overall Study|Virologic failure|0|||
16887007|NCT02569710|37911629|FG006|Overall Study|Virologic failure|1|||
16887008|NCT02569710|37911630|FG007|Overall Study|Virologic failure|0|||
16887009|NCT02569710|37911631|FG008|Overall Study|Virologic failure|0|||
16887010|NCT02569710|37911632|FG009|Overall Study|Virologic failure|0|||
16887011|NCT02569710|37911623|FG000|Overall Study|Withdrawal by Subject|0|||
16887012|NCT02569710|37911624|FG001|Overall Study|Withdrawal by Subject|0|||
16887013|NCT02569710|37911625|FG002|Overall Study|Withdrawal by Subject|0|||
16887014|NCT02569710|37911626|FG003|Overall Study|Withdrawal by Subject|0|||
16887015|NCT02569710|37911627|FG004|Overall Study|Withdrawal by Subject|0|||
16887016|NCT02569710|37911628|FG005|Overall Study|Withdrawal by Subject|1|||
16887017|NCT02569710|37911629|FG006|Overall Study|Withdrawal by Subject|0|||
16887018|NCT02569710|37911630|FG007|Overall Study|Withdrawal by Subject|0|||
16887019|NCT02569710|37911631|FG008|Overall Study|Withdrawal by Subject|0|||
16887020|NCT02569710|37911632|FG009|Overall Study|Withdrawal by Subject|0|||
16887021|NCT02569476|37911734|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
16887022|NCT02569476|37911734|FG000|Overall Study|Death|33|||
16887023|NCT02569476|37911734|FG000|Overall Study|Withdrawal by Subject|9|||
16887024|NCT02569476|37911734|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
16887025|NCT02569476|37911734|FG000|Overall Study|Palliative care|1|||
16887026|NCT02569476|37911734|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
16887027|NCT02569476|37911734|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
16887028|NCT02565576|37911806|FG000|Overall Study|abnormal lab value|2|||
16887029|NCT02565576|37911807|FG001|Overall Study|abnormal lab value|0|||
16887030|NCT02565576|37911806|FG000|Overall Study|subject / guardian decision|1|||
16887031|NCT02565576|37911807|FG001|Overall Study|subject / guardian decision|3|||
16887032|NCT02565576|37911806|FG000|Overall Study|Lost to Follow-up|1|||
16887033|NCT02565576|37911807|FG001|Overall Study|Lost to Follow-up|0|||
16887034|NCT02565576|37911806|FG000|Overall Study|Death|0|||
16887035|NCT02565576|37911807|FG001|Overall Study|Death|2|||
16887036|NCT02565576|37911806|FG000|Overall Study|Adverse Event|1|||
16887037|NCT02565576|37911807|FG001|Overall Study|Adverse Event|0|||
16887038|NCT02569398|37911838|FG000|Overall Study|Adverse Event|0|||
16887039|NCT02569398|37911839|FG001|Overall Study|Adverse Event|1|||
16887040|NCT02569398|37911840|FG002|Overall Study|Adverse Event|6|||
16887041|NCT02569398|37911838|FG000|Overall Study|Withdrawal by Subject|43|||
16887042|NCT02569398|37911839|FG001|Overall Study|Withdrawal by Subject|43|||
16887043|NCT02569398|37911840|FG002|Overall Study|Withdrawal by Subject|30|||
16887044|NCT02569398|37911838|FG000|Overall Study|Study terminated by sponsor|130|||
16887045|NCT02569398|37911839|FG001|Overall Study|Study terminated by sponsor|131|||
16887046|NCT02569398|37911840|FG002|Overall Study|Study terminated by sponsor|134|||
16887047|NCT02569398|37911838|FG000|Overall Study|Other|12|||
16887048|NCT02569398|37911839|FG001|Overall Study|Other|14|||
16887049|NCT02569398|37911840|FG002|Overall Study|Other|13|||
16887050|NCT02569242|37911884|FG000|Overall Study|Death|1|||
16887051|NCT02569242|37911885|FG001|Overall Study|Death|0|||
16887052|NCT02569242|37911884|FG000|Overall Study|Withdrawal by Subject|0|||
16887053|NCT02569242|37911885|FG001|Overall Study|Withdrawal by Subject|1|||
16887054|NCT01663740|37911953|FG000|Overall Study|Lost to Follow-up|1|||
16887055|NCT01663740|37911954|FG001|Overall Study|Lost to Follow-up|4|||
16887056|NCT01663740|37911953|FG000|Overall Study|Other|9|||
16887057|NCT01663740|37911954|FG001|Overall Study|Other|2|||
16887058|NCT01663740|37911953|FG000|Overall Study|Inclusion/Exclusion not met|1|||
16887059|NCT01663740|37911954|FG001|Overall Study|Inclusion/Exclusion not met|0|||
16887060|NCT01663740|37911953|FG000|Overall Study|Death|0|||
16887061|NCT01663740|37911954|FG001|Overall Study|Death|1|||
16887062|NCT01663740|37911953|FG000|Overall Study|Withdrawal by Subject|2|||
16887063|NCT01663740|37911954|FG001|Overall Study|Withdrawal by Subject|1|||
16887064|NCT01663740|37911953|FG000|Overall Study|No end of study status|3|||
16887065|NCT01663740|37911954|FG001|Overall Study|No end of study status|0|||
16887066|NCT01663506|37912070|FG000|Overall Study|Lack of Efficacy|3|||
16887067|NCT01663506|37912070|FG000|Overall Study|Consent Withdrawal by Subject|1|||
16887068|NCT01663506|37912070|FG000|Overall Study|Lost to Follow-up|1|||
16887069|NCT01663506|37912070|FG000|Overall Study|Adverse Event|1|||
16887070|NCT01663506|37912070|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
16887071|NCT02568384|37912074|FG000|Overall Study|Mobile devices incompatible with App|2|||
16887072|NCT02965976|37912170|FG000|Overall Study|Withdrawal by Subject|2|||
16887073|NCT02965976|37912171|FG001|Overall Study|Withdrawal by Subject|0|||
16887074|NCT04125680|37912189|FG000|Overall Study|Lost to Follow-up|15|||
16887075|NCT02565186|37912213|FG000|Overall Study|Adverse Event|113|||
16887076|NCT02565186|37912214|FG001|Overall Study|Adverse Event|148|||
16887077|NCT02565186|37912213|FG000|Overall Study|Lost to Follow-up|102|||
16887078|NCT02565186|37912214|FG001|Overall Study|Lost to Follow-up|93|||
16887079|NCT02565186|37912213|FG000|Overall Study|Non-Compliance|57|||
16887080|NCT02565186|37912214|FG001|Overall Study|Non-Compliance|55|||
16887081|NCT02565186|37912213|FG000|Overall Study|Withdrawal by Subject|229|||
16887082|NCT02565186|37912214|FG001|Overall Study|Withdrawal by Subject|214|||
16887083|NCT02565186|37912213|FG000|Overall Study|Physician Decision|18|||
16887084|NCT02565186|37912214|FG001|Overall Study|Physician Decision|16|||
16887085|NCT02565186|37912213|FG000|Overall Study|Sponsor Request|5|||
16887086|NCT02565186|37912214|FG001|Overall Study|Sponsor Request|9|||
16887087|NCT02565186|37912213|FG000|Overall Study|Missing|1|||
16887088|NCT02565186|37912214|FG001|Overall Study|Missing|0|||
16887089|NCT02565186|37912213|FG000|Overall Study|Did Not Receive Study Drug|55|||
16887090|NCT02565186|37912214|FG001|Overall Study|Did Not Receive Study Drug|86|||
16887091|NCT02568072|37912220|FG000|Overall Study|Unavailable for appointment|23|||
16887092|NCT02568072|37912220|FG000|Overall Study|Unable to contact|3|||
16887093|NCT02568072|37912220|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
16887094|NCT02568072|37912220|FG000|Overall Study|Withdrawal by Subject|1|||
16887095|NCT02568072|37912220|FG000|Overall Study|Sustained injury, marathon not run|24|||
16887096|NCT02565108|37912227|FG000|Overall Study|Adverse Event|1|||
16887097|NCT02565108|37912228|FG001|Overall Study|Adverse Event|0|||
16887098|NCT02565108|37912227|FG000|Overall Study|Withdrew Consent|1|||
16887099|NCT02565108|37912228|FG001|Overall Study|Withdrew Consent|0|||
16887100|NCT02564952|37912234|FG000|Overall Study|Adverse Event|6|||
16887101|NCT02564952|37912234|FG000|Overall Study|Lost to Follow-up|1|||
16887102|NCT02564952|37912234|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
16887103|NCT02564952|37912234|FG000|Overall Study|Withdrawal by Subject|1|||
16887104|NCT02564952|37912234|FG000|Overall Study|Low Efficacy|1|||
16887105|NCT02564952|37912234|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
16887106|NCT02566902|37912240|FG000|Overall Study|Protocol Violation|2|||
16887107|NCT02566902|37912241|FG001|Overall Study|Protocol Violation|1|||
16887108|NCT02564796|37912249|FG000|Overall Study|Physician Decision|2|||
16887109|NCT02564796|37912250|FG001|Overall Study|Physician Decision|2|||
16887110|NCT02564718|37912258|FG000|Overall Study|Withdrew from treatment|0|||
16887111|NCT02564718|37912259|FG001|Overall Study|Withdrew from treatment|1|||
16887112|NCT01453946|37912265|FG000|Overall Study|Did not receive drug for the taper phase|1|||
16887113|NCT01453946|37912265|FG000|Overall Study|Protocol Violation|2|||
16887114|NCT01453946|37912265|FG000|Overall Study|Lack of Efficacy|3|||
16887115|NCT01453946|37912265|FG000|Overall Study|Adverse Event|3|||
16887116|NCT02563548|37912387|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
16887117|NCT02563548|37912388|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
16887118|NCT02563548|37912389|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
16887119|NCT02563548|37912390|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
16887120|NCT02563548|37912391|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
16887121|NCT02563548|37912392|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
16887122|NCT02563548|37912387|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
16887123|NCT02563548|37912388|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
17191989|NCT02848651|38345069|FG000|Overall Study|Death|85|||
16887124|NCT02563548|37912389|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
16887125|NCT02563548|37912390|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
16887126|NCT02563548|37912391|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
16887127|NCT02563548|37912392|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
16887128|NCT02563548|37912387|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16887129|NCT02563548|37912388|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16887130|NCT02563548|37912389|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
16887131|NCT02563548|37912390|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16887132|NCT02563548|37912391|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16887133|NCT02563548|37912392|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16887134|NCT02563548|37912387|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
16887135|NCT02563548|37912388|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
16887136|NCT02563548|37912389|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
16887137|NCT02563548|37912390|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
16887138|NCT02563548|37912391|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
16887139|NCT02563548|37912392|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
17095330|NCT00261846|38234545|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
17095331|NCT00261846|38234546|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
17095332|NCT00261846|38234547|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
17095333|NCT00261846|38234548|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
17095334|NCT00261846|38234549|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
17191990|NCT02848651|38345069|FG000|Overall Study|Lost to Follow-up|1|||
17002374|NCT00842829|38146547|FG002|Dose Titration Period|Lack of Efficacy|0|||
17002375|NCT00842829|38146545|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
17002376|NCT00842829|38146546|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
17002377|NCT00842829|38146547|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
17002378|NCT00842829|38146545|FG000|Dose Titration Period|Withdrawal by Subject|2|||
16887140|NCT02563548|37912387|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
16887141|NCT02563548|37912388|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
16887142|NCT02563548|37912389|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
16887143|NCT02563548|37912390|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
16887144|NCT02563548|37912391|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
16887145|NCT02563548|37912392|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
16887146|NCT02563548|37912387|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
16887147|NCT02563548|37912388|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
16887148|NCT02563548|37912389|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
16887149|NCT02563548|37912390|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
16887150|NCT02563548|37912391|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
16887151|NCT02563548|37912392|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
16887152|NCT02563548|37912387|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16887153|NCT02563548|37912388|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16887154|NCT02563548|37912389|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16887155|NCT02563548|37912390|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16887156|NCT02563548|37912391|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
16887157|NCT02563548|37912392|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16887158|NCT02563548|37912387|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
16887159|NCT02563548|37912388|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
16887160|NCT02563548|37912389|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
16887161|NCT02563548|37912390|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
16887162|NCT02563548|37912391|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
16887163|NCT02563548|37912392|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
16887164|NCT02563548|37912387|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16887165|NCT02563548|37912388|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16887166|NCT02563548|37912389|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16887167|NCT02563548|37912390|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16887168|NCT02563548|37912391|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16887169|NCT02563548|37912392|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
16887170|NCT02563548|37912387|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16887171|NCT02563548|37912388|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16887172|NCT02563548|37912389|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16887173|NCT02563548|37912390|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16887174|NCT02563548|37912391|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16887175|NCT02563548|37912392|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
17002379|NCT00842829|38146546|FG001|Dose Titration Period|Withdrawal by Subject|6|||
17002380|NCT00842829|38146547|FG002|Dose Titration Period|Withdrawal by Subject|0|||
17002381|NCT00842829|38146545|FG000|Dose Titration Period|Other|5|||
17002382|NCT00842829|38146546|FG001|Dose Titration Period|Other|4|||
16887176|NCT02563548|37912387|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16887177|NCT02563548|37912388|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16887178|NCT02563548|37912389|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16887179|NCT02563548|37912390|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16887180|NCT02563548|37912391|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16887181|NCT02563548|37912392|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
16887182|NCT02563548|37912387|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16887183|NCT02563548|37912388|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16887184|NCT02563548|37912389|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16887185|NCT02563548|37912390|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16887186|NCT02563548|37912391|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
16887187|NCT02563548|37912392|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16887188|NCT02559570|37912473|FG000|Overall Study|Adverse Event|0|||
16887189|NCT02559570|37912474|FG001|Overall Study|Adverse Event|2|||
16887190|NCT02559570|37912475|FG002|Overall Study|Adverse Event|0|||
16887191|NCT02559570|37912476|FG003|Overall Study|Adverse Event|1|||
16887192|NCT02559570|37912477|FG004|Overall Study|Adverse Event|0|||
16887193|NCT02559570|37912473|FG000|Overall Study|Withdrawal of Consent|0|||
16887194|NCT02559570|37912474|FG001|Overall Study|Withdrawal of Consent|0|||
16887195|NCT02559570|37912475|FG002|Overall Study|Withdrawal of Consent|1|||
16887196|NCT02559570|37912476|FG003|Overall Study|Withdrawal of Consent|2|||
16887197|NCT02559570|37912477|FG004|Overall Study|Withdrawal of Consent|1|||
16887198|NCT02559570|37912473|FG000|Overall Study|Lost to Follow-up|1|||
16887199|NCT02559570|37912474|FG001|Overall Study|Lost to Follow-up|0|||
16887200|NCT02559570|37912475|FG002|Overall Study|Lost to Follow-up|0|||
16887201|NCT02559570|37912476|FG003|Overall Study|Lost to Follow-up|0|||
16887202|NCT02559570|37912477|FG004|Overall Study|Lost to Follow-up|0|||
16887203|NCT02559570|37912473|FG000|Overall Study|Protocol Violation|1|||
16887204|NCT02559570|37912474|FG001|Overall Study|Protocol Violation|0|||
16887205|NCT02559570|37912475|FG002|Overall Study|Protocol Violation|0|||
16887206|NCT02559570|37912476|FG003|Overall Study|Protocol Violation|0|||
16887207|NCT02559570|37912477|FG004|Overall Study|Protocol Violation|1|||
16887208|NCT02559570|37912473|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16887209|NCT02559570|37912474|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16887210|NCT02559570|37912475|FG002|Overall Study|Other Miscellaneous Reasons|1|||
16887211|NCT02559570|37912476|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16887212|NCT02559570|37912477|FG004|Overall Study|Other Miscellaneous Reasons|0|||
16887213|NCT02559414|37912832|FG000|Overall Study|Lost to Follow-up|0|||
16887214|NCT02559414|37912833|FG001|Overall Study|Lost to Follow-up|1|||
16887215|NCT02559414|37912834|FG002|Overall Study|Lost to Follow-up|0|||
16887216|NCT02559414|37912832|FG000|Overall Study|Withdrawal by Subject|1|||
16887217|NCT02559414|37912833|FG001|Overall Study|Withdrawal by Subject|0|||
16887218|NCT02559414|37912834|FG002|Overall Study|Withdrawal by Subject|1|||
16887219|NCT02559414|37912832|FG000|Overall Study|Other|0|||
16887220|NCT02559414|37912833|FG001|Overall Study|Other|1|||
16887221|NCT02559414|37912834|FG002|Overall Study|Other|1|||
16887222|NCT02558790|37912913|FG000|Overall Study|Lost to Follow-up|2|||
16887223|NCT02558790|37912913|FG000|Overall Study|Physician Decision|1|||
16887224|NCT02558790|37912913|FG000|Overall Study|Withdrawal by Subject|1|||
16887225|NCT02558790|37912913|FG000|Overall Study|Screen Fail|3|||
16887226|NCT02556138|37912935|FG000|Overall Study|Withdrawal by Subject|1|||
16887227|NCT02558400|37913018|FG000|Overall Study|Adverse Event|47|||
16887228|NCT02558400|37913019|FG001|Overall Study|Adverse Event|53|||
16887229|NCT02558400|37913020|FG002|Overall Study|Adverse Event|4|||
17002383|NCT00842829|38146547|FG002|Dose Titration Period|Other|0|||
17002384|NCT00842829|38146545|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
17002385|NCT00842829|38146546|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
17002386|NCT00842829|38146547|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
17002387|NCT00842829|38146545|FG000|Dose Titration Period|Non-compliance to study drug|2|||
17002388|NCT00842829|38146546|FG001|Dose Titration Period|Non-compliance to study drug|1|||
17002389|NCT00842829|38146547|FG002|Dose Titration Period|Non-compliance to study drug|0|||
17002390|NCT00842829|38146545|FG000|Treatment Period|Adverse Event|0|||
17002391|NCT00842829|38146546|FG001|Treatment Period|Adverse Event|0|||
17002392|NCT00842829|38146547|FG002|Treatment Period|Adverse Event|15|||
17002393|NCT00842829|38146545|FG000|Treatment Period|Lack of Efficacy|0|||
16887230|NCT02558400|37913018|FG000|Overall Study|Withdrawal by Subject|13|||
16887231|NCT02558400|37913019|FG001|Overall Study|Withdrawal by Subject|9|||
16887232|NCT02558400|37913020|FG002|Overall Study|Withdrawal by Subject|8|||
16887233|NCT02558400|37913018|FG000|Overall Study|Non-Compliant|0|||
16887234|NCT02558400|37913019|FG001|Overall Study|Non-Compliant|1|||
16887235|NCT02558400|37913020|FG002|Overall Study|Non-Compliant|3|||
16887236|NCT02558400|37913018|FG000|Overall Study|Lost to Follow-up|5|||
16887237|NCT02558400|37913019|FG001|Overall Study|Lost to Follow-up|5|||
16887238|NCT02558400|37913020|FG002|Overall Study|Lost to Follow-up|4|||
16887239|NCT02558400|37913018|FG000|Overall Study|Lack of Efficacy|0|||
16887240|NCT02558400|37913019|FG001|Overall Study|Lack of Efficacy|13|||
17002394|NCT00842829|38146546|FG001|Treatment Period|Lack of Efficacy|0|||
17002395|NCT00842829|38146547|FG002|Treatment Period|Lack of Efficacy|6|||
17002396|NCT00842829|38146545|FG000|Treatment Period|Unstable persistent cancer pain|0|||
17002397|NCT00842829|38146546|FG001|Treatment Period|Unstable persistent cancer pain|0|||
17002398|NCT00842829|38146547|FG002|Treatment Period|Unstable persistent cancer pain|5|||
16887241|NCT02558400|37913020|FG002|Overall Study|Lack of Efficacy|1|||
16887242|NCT02558400|37913018|FG000|Overall Study|Disallowed Concurrent Medication|6|||
16887243|NCT02558400|37913019|FG001|Overall Study|Disallowed Concurrent Medication|7|||
16887244|NCT02558400|37913020|FG002|Overall Study|Disallowed Concurrent Medication|5|||
16887245|NCT02558400|37913018|FG000|Overall Study|Physician Decision|2|||
16887246|NCT02558400|37913019|FG001|Overall Study|Physician Decision|2|||
16887247|NCT02558400|37913020|FG002|Overall Study|Physician Decision|0|||
16887248|NCT02558400|37913018|FG000|Overall Study|Protocol Violation|6|||
16887249|NCT02558400|37913019|FG001|Overall Study|Protocol Violation|3|||
16887250|NCT02558400|37913020|FG002|Overall Study|Protocol Violation|8|||
16887251|NCT02558400|37913018|FG000|Overall Study|Death|0|||
16887252|NCT02558400|37913019|FG001|Overall Study|Death|1|||
16887253|NCT02558400|37913020|FG002|Overall Study|Death|0|||
16887254|NCT02558400|37913018|FG000|Overall Study|Ineligible for the study|0|||
16887255|NCT02558400|37913019|FG001|Overall Study|Ineligible for the study|2|||
16887256|NCT02558400|37913020|FG002|Overall Study|Ineligible for the study|0|||
16887257|NCT01662648|37913156|FG000|Overall Study|Death|1|||
16887258|NCT01662648|37913157|FG001|Overall Study|Death|3|||
16887259|NCT01662648|37913156|FG000|Overall Study|Adverse Event|40|||
16887260|NCT01662648|37913157|FG001|Overall Study|Adverse Event|37|||
16887261|NCT01662648|37913156|FG000|Overall Study|Lack of Efficacy|17|||
16887262|NCT01662648|37913157|FG001|Overall Study|Lack of Efficacy|16|||
16887263|NCT01662648|37913156|FG000|Overall Study|Participant ineligible to continue trial|1|||
16887264|NCT01662648|37913157|FG001|Overall Study|Participant ineligible to continue trial|1|||
16887265|NCT01662648|37913156|FG000|Overall Study|Lost to Follow-up|24|||
16887266|NCT01662648|37913157|FG001|Overall Study|Lost to Follow-up|36|||
16887267|NCT01662648|37913156|FG000|Overall Study|Withdrawal by Subject|36|||
16887268|NCT01662648|37913157|FG001|Overall Study|Withdrawal by Subject|53|||
16887269|NCT01662648|37913156|FG000|Overall Study|Participant non-compliant|16|||
16887270|NCT01662648|37913157|FG001|Overall Study|Participant non-compliant|20|||
16887271|NCT01662648|37913156|FG000|Overall Study|Other|8|||
16887272|NCT01662648|37913157|FG001|Overall Study|Other|11|||
16887273|NCT01662648|37913156|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
16887274|NCT01662648|37913157|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
16887275|NCT01662648|37913156|FG000|Overall Study|LOE and other reason unspecified|1|||
16887276|NCT01662648|37913157|FG001|Overall Study|LOE and other reason unspecified|0|||
16887277|NCT01662648|37913156|FG000|Overall Study|LOE and Participant non-compliant|0|||
16887278|NCT01662648|37913157|FG001|Overall Study|LOE and Participant non-compliant|1|||
16887279|NCT02556918|37913222|FG000|Overall Study|Protocol Violation|5|||
16887280|NCT02556918|37913223|FG001|Overall Study|Protocol Violation|6|||
16887281|NCT02556918|37913222|FG000|Overall Study|Withdrawal by Subject|4|||
16887282|NCT02556918|37913223|FG001|Overall Study|Withdrawal by Subject|4|||
16887283|NCT01662492|37913339|FG000|Overall Study|Other miscellaneous reasons.|1|||
16887284|NCT01662492|37913340|FG001|Overall Study|Other miscellaneous reasons.|0|||
16887285|NCT01662492|37913341|FG002|Overall Study|Other miscellaneous reasons.|1|||
16887286|NCT01662492|37913339|FG000|Overall Study|Withdrawal by Subject|0|||
16887287|NCT01662492|37913340|FG001|Overall Study|Withdrawal by Subject|0|||
16887288|NCT01662492|37913341|FG002|Overall Study|Withdrawal by Subject|1|||
16887289|NCT01662492|37913339|FG000|Overall Study|Protocol Violation|1|||
17002399|NCT00842829|38146545|FG000|Treatment Period|Withdrawal by Subject|0|||
17002400|NCT00842829|38146546|FG001|Treatment Period|Withdrawal by Subject|0|||
17002401|NCT00842829|38146547|FG002|Treatment Period|Withdrawal by Subject|11|||
17002402|NCT00842829|38146545|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
17002403|NCT00842829|38146546|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
17002404|NCT00842829|38146547|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
17002405|NCT00842829|38146545|FG000|Treatment Period|Protocol Violation|0|||
17002406|NCT00842829|38146546|FG001|Treatment Period|Protocol Violation|0|||
17002407|NCT00842829|38146547|FG002|Treatment Period|Protocol Violation|2|||
17002408|NCT00842829|38146545|FG000|Treatment Period|Other|0|||
16785781|NCT02694523|37725865|FG004|Part B|Withdrawal by Subject|1|||
16785782|NCT02694523|37725866|FG005|Part B|Withdrawal by Subject|3|||
16887290|NCT01662492|37913340|FG001|Overall Study|Protocol Violation|0|||
16887291|NCT01662492|37913341|FG002|Overall Study|Protocol Violation|0|||
16887292|NCT01662492|37913339|FG000|Overall Study|Lost to Follow-up|0|||
16887293|NCT01662492|37913340|FG001|Overall Study|Lost to Follow-up|0|||
16887294|NCT01662492|37913341|FG002|Overall Study|Lost to Follow-up|2|||
16887295|NCT01662492|37913339|FG000|Overall Study|Lack of Efficacy|1|||
16887296|NCT01662492|37913340|FG001|Overall Study|Lack of Efficacy|1|||
16887297|NCT01662492|37913341|FG002|Overall Study|Lack of Efficacy|2|||
16887298|NCT02552238|37913511|FG000|Overall Study|Withdrawal by Subject|2|||
16887299|NCT02552238|37913511|FG000|Overall Study|Adverse Event|2|||
17002409|NCT00842829|38146546|FG001|Treatment Period|Other|0|||
16887300|NCT01662102|37913729|FG000|Overall Study|Sponsor's decision|1|||
16887301|NCT01662102|37913730|FG001|Overall Study|Sponsor's decision|0|||
16887302|NCT02554656|37913770|FG000|Overall Study|Protocol Violation|3|||
16887303|NCT03414684|37913930|FG000|First-course Treatment|Complete response|0|||
16887304|NCT03414684|37913931|FG001|First-course Treatment|Complete response|1|||
16887305|NCT03414684|37913930|FG000|First-course Treatment|Intercurrent illness|1|||
16887306|NCT03414684|37913931|FG001|First-course Treatment|Intercurrent illness|0|||
16887307|NCT03414684|37913930|FG000|First-course Treatment|Progressive Disease|31|||
16887308|NCT03414684|37913931|FG001|First-course Treatment|Progressive Disease|32|||
16887309|NCT03414684|37913930|FG000|First-course Treatment|Adverse Event|1|||
16887310|NCT03414684|37913931|FG001|First-course Treatment|Adverse Event|2|||
16887311|NCT03414684|37913930|FG000|First-course Treatment|Physician Decision|0|||
16887312|NCT03414684|37913931|FG001|First-course Treatment|Physician Decision|1|||
16887313|NCT03414684|37913930|FG000|First-course Treatment|Withdrawal by Subject|0|||
16887314|NCT03414684|37913931|FG001|First-course Treatment|Withdrawal by Subject|1|||
16887315|NCT03414684|37913930|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
16887316|NCT03414684|37913931|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
16887317|NCT03414684|37913930|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
16887318|NCT03414684|37913931|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
16887319|NCT03414684|37913930|FG000|First-course Treatment|Still on treatment|3|||
16887320|NCT03414684|37913931|FG001|First-course Treatment|Still on treatment|0|||
16887321|NCT03414684|37913930|FG000|First-course Treatment|Never started protocol therapy|2|||
16887322|NCT03414684|37913931|FG001|First-course Treatment|Never started protocol therapy|1|||
16887323|NCT03414684|37913930|FG000|Crossover Treatment|Progressive disease|0|||
16887324|NCT03414684|37913931|FG001|Crossover Treatment|Progressive disease|12|||
16887325|NCT03414684|37913930|FG000|Crossover Treatment|Adverse Event|0|||
16887326|NCT03414684|37913931|FG001|Crossover Treatment|Adverse Event|3|||
16887327|NCT03414684|37913930|FG000|Crossover Treatment|Physician Decision|0|||
16887328|NCT03414684|37913931|FG001|Crossover Treatment|Physician Decision|1|||
16887329|NCT03414684|37913930|FG000|Crossover Treatment|Still on treatment|0|||
16887330|NCT03414684|37913931|FG001|Crossover Treatment|Still on treatment|2|||
16887331|NCT02551692|37914010|FG000|Overall Study|Lost to Follow-up|0|||
16887332|NCT02551692|37914011|FG001|Overall Study|Lost to Follow-up|1|||
16887333|NCT02551692|37914012|FG002|Overall Study|Lost to Follow-up|4|||
16887334|NCT02551692|37914010|FG000|Overall Study|Withdrawal by Subject|1|||
16887335|NCT02551692|37914011|FG001|Overall Study|Withdrawal by Subject|0|||
16887336|NCT02551692|37914012|FG002|Overall Study|Withdrawal by Subject|1|||
16887337|NCT02553330|37914099|FG000|Overall Study|Study Terminated by Sponsor|2|||
16887338|NCT02553330|37914100|FG001|Overall Study|Study Terminated by Sponsor|13|||
16887339|NCT02553330|37914101|FG002|Overall Study|Study Terminated by Sponsor|12|||
16887340|NCT02553330|37914099|FG000|Overall Study|Withdrawal by Subject|3|||
16887341|NCT02553330|37914100|FG001|Overall Study|Withdrawal by Subject|19|||
16887342|NCT02553330|37914101|FG002|Overall Study|Withdrawal by Subject|21|||
16887343|NCT02553330|37914099|FG000|Overall Study|Other|0|||
16887344|NCT02553330|37914100|FG001|Overall Study|Other|1|||
16887345|NCT02553330|37914101|FG002|Overall Study|Other|0|||
16887346|NCT02553330|37914099|FG000|Overall Study|Non compliance to study treatment|0|||
16887347|NCT02553330|37914100|FG001|Overall Study|Non compliance to study treatment|1|||
16887348|NCT02553330|37914101|FG002|Overall Study|Non compliance to study treatment|0|||
16887349|NCT02553330|37914099|FG000|Overall Study|Adverse Event|0|||
16887350|NCT02553330|37914100|FG001|Overall Study|Adverse Event|1|||
16887351|NCT02553330|37914101|FG002|Overall Study|Adverse Event|0|||
16887352|NCT02553330|37914099|FG000|Overall Study|Lost to Follow-up|0|||
16887353|NCT02553330|37914100|FG001|Overall Study|Lost to Follow-up|4|||
16887354|NCT02553330|37914101|FG002|Overall Study|Lost to Follow-up|4|||
16887355|NCT02550288|37914143|FG000|Overall Study|Adverse Event|0|||
16887356|NCT02550288|37914144|FG001|Overall Study|Adverse Event|1|||
16887357|NCT02550288|37914145|FG002|Overall Study|Adverse Event|0|||
16887358|NCT02550288|37914146|FG003|Overall Study|Adverse Event|0|||
16887359|NCT02550288|37914147|FG004|Overall Study|Adverse Event|0|||
16887360|NCT02550288|37914143|FG000|Overall Study|Physician Decision|0|||
16887361|NCT02550288|37914144|FG001|Overall Study|Physician Decision|0|||
16887362|NCT02550288|37914145|FG002|Overall Study|Physician Decision|0|||
16887363|NCT02550288|37914146|FG003|Overall Study|Physician Decision|1|||
16887364|NCT02550288|37914147|FG004|Overall Study|Physician Decision|0|||
16887365|NCT02550288|37914143|FG000|Overall Study|Protocol Violation|2|||
16887366|NCT02550288|37914144|FG001|Overall Study|Protocol Violation|2|||
16887367|NCT02550288|37914145|FG002|Overall Study|Protocol Violation|1|||
16887368|NCT02550288|37914146|FG003|Overall Study|Protocol Violation|0|||
16887369|NCT02550288|37914147|FG004|Overall Study|Protocol Violation|3|||
16887370|NCT02550288|37914143|FG000|Overall Study|Participant moved|0|||
16887371|NCT02550288|37914144|FG001|Overall Study|Participant moved|0|||
16887372|NCT02550288|37914145|FG002|Overall Study|Participant moved|0|||
16887373|NCT02550288|37914146|FG003|Overall Study|Participant moved|1|||
16887374|NCT02550288|37914147|FG004|Overall Study|Participant moved|0|||
16887375|NCT02550288|37914143|FG000|Overall Study|Withdrawal by Subject|0|||
16887376|NCT02550288|37914144|FG001|Overall Study|Withdrawal by Subject|0|||
16887377|NCT02550288|37914145|FG002|Overall Study|Withdrawal by Subject|0|||
16887378|NCT02550288|37914146|FG003|Overall Study|Withdrawal by Subject|1|||
16887379|NCT02550288|37914147|FG004|Overall Study|Withdrawal by Subject|0|||
16887380|NCT01662336|37914212|FG000|Overall Study|Adverse Event|1|||
16887381|NCT01662336|37914212|FG000|Overall Study|No longer on LPV/r|30|||
16887382|NCT01662336|37914212|FG000|Overall Study|Other|29|||
16887383|NCT01662336|37914212|FG000|Overall Study|Withdrawal by Subject|6|||
16887384|NCT02549352|37914231|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
16887385|NCT02549352|37914232|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
16887386|NCT02549352|37914231|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
16887387|NCT02549352|37914232|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
16887388|NCT02549352|37914231|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
16887389|NCT02549352|37914232|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
16887390|NCT02549352|37914231|FG000|12-month Follow-up|Withdrawal by Subject|4|||
16887391|NCT02549352|37914232|FG001|12-month Follow-up|Withdrawal by Subject|5|||
16887392|NCT02549352|37914231|FG000|12-month Follow-up|Lost to Follow-up|3|||
16887393|NCT02549352|37914232|FG001|12-month Follow-up|Lost to Follow-up|2|||
16887394|NCT02549352|37914231|FG000|12-month Follow-up|Death|0|||
16887395|NCT02549352|37914232|FG001|12-month Follow-up|Death|1|||
16887396|NCT02549352|37914231|FG000|12-month Follow-up|Protocol Violation|0|||
16887397|NCT02549352|37914232|FG001|12-month Follow-up|Protocol Violation|1|||
16887398|NCT02549352|37914231|FG000|12-month Follow-up|Other|1|||
16887399|NCT02549352|37914232|FG001|12-month Follow-up|Other|3|||
16887400|NCT02554890|37914422|FG000|Double-blind|Adverse Event|45|||
16887401|NCT02554890|37914423|FG001|Double-blind|Adverse Event|51|||
16887402|NCT02554890|37914422|FG000|Double-blind|Death|6|||
16887403|NCT02554890|37914423|FG001|Double-blind|Death|4|||
16887404|NCT02554890|37914422|FG000|Double-blind|Protocol Violation|1|||
16887405|NCT02554890|37914423|FG001|Double-blind|Protocol Violation|1|||
17002410|NCT00842829|38146547|FG002|Treatment Period|Other|18|||
17002411|NCT00842829|38146545|FG000|Treatment Period|Non-compliance to study procedures|0|||
17002412|NCT00842829|38146546|FG001|Treatment Period|Non-compliance to study procedures|0|||
17002413|NCT00842829|38146547|FG002|Treatment Period|Non-compliance to study procedures|4|||
17002414|NCT00842829|38146545|FG000|Treatment Period|Unclear completion status|0|||
17002415|NCT00842829|38146546|FG001|Treatment Period|Unclear completion status|0|||
17002416|NCT00842829|38146547|FG002|Treatment Period|Unclear completion status|1|||
17191991|NCT02848651|38345069|FG000|Overall Study|Non-Compliance|1|||
17191992|NCT02848651|38345069|FG000|Overall Study|Symptomatic Deterioration|1|||
17191993|NCT02848651|38345069|FG000|Overall Study|Physician Decision|4|||
17191994|NCT02848651|38345069|FG000|Overall Study|Withdrawal by Subject|14|||
17191995|NCT00709059|38345089|FG000|Overall Study|Lost to Follow-up|34|||
17191996|NCT00709059|38345089|FG000|Overall Study|Withdrawal by Subject|19|||
17191997|NCT00709059|38345089|FG000|Overall Study|Physician Decision|7|||
17191998|NCT00709059|38345089|FG000|Overall Study|Disease complication|3|||
17191999|NCT00709059|38345089|FG000|Overall Study|Side effects|20|||
17192000|NCT00709059|38345089|FG000|Overall Study|Serious side effects|11|||
17192001|NCT01678898|38345096|FG000|PB-102-F01|Adverse Event|0|||
17192002|NCT01678898|38345097|FG001|PB-102-F01|Adverse Event|1|||
17192003|NCT01678898|38345098|FG002|PB-102-F01|Adverse Event|0|||
17192004|NCT01678898|38345096|FG000|PB-102-F01|Physician Decision|0|||
17192005|NCT01678898|38345097|FG001|PB-102-F01|Physician Decision|1|||
17192006|NCT01678898|38345098|FG002|PB-102-F01|Physician Decision|0|||
17192007|NCT01678820|38345118|FG000|Overall Study|Study Terminated by Sponsor|45|||
17192008|NCT01678820|38345119|FG001|Overall Study|Study Terminated by Sponsor|43|||
17192009|NCT01678820|38345120|FG002|Overall Study|Study Terminated by Sponsor|43|||
17192010|NCT01678820|38345118|FG000|Overall Study|Withdrawal by Subject|2|||
17192011|NCT01678820|38345119|FG001|Overall Study|Withdrawal by Subject|5|||
17192012|NCT01678820|38345120|FG002|Overall Study|Withdrawal by Subject|2|||
17192013|NCT01678820|38345118|FG000|Overall Study|Protocol Specified Criteria|2|||
17192014|NCT01678820|38345119|FG001|Overall Study|Protocol Specified Criteria|3|||
17192015|NCT01678820|38345120|FG002|Overall Study|Protocol Specified Criteria|1|||
17192016|NCT01678820|38345118|FG000|Overall Study|Adverse Event|2|||
17192017|NCT01678820|38345119|FG001|Overall Study|Adverse Event|2|||
17192018|NCT01678820|38345120|FG002|Overall Study|Adverse Event|2|||
17192019|NCT01678820|38345118|FG000|Overall Study|Lost to Follow-up|7|||
17192020|NCT01678820|38345119|FG001|Overall Study|Lost to Follow-up|2|||
17192021|NCT01678820|38345120|FG002|Overall Study|Lost to Follow-up|2|||
17192022|NCT01678820|38345118|FG000|Overall Study|Non-compliance with study drug|0|||
17192023|NCT01678820|38345119|FG001|Overall Study|Non-compliance with study drug|1|||
17192024|NCT01678820|38345120|FG002|Overall Study|Non-compliance with study drug|0|||
16785783|NCT02694523|37725867|FG006|Part B|Withdrawal by Subject|0|||
16785784|NCT02694523|37725861|FG000|Part B|Other|0|||
16887406|NCT02554890|37914422|FG000|Double-blind|Physician Decision|4|||
16887407|NCT02554890|37914423|FG001|Double-blind|Physician Decision|3|||
17192025|NCT01678820|38345118|FG000|Overall Study|Physician Decision|0|||
17192026|NCT01678820|38345119|FG001|Overall Study|Physician Decision|0|||
16887408|NCT02554890|37914422|FG000|Double-blind|Subject/Guardian decision|21|||
16887409|NCT02554890|37914423|FG001|Double-blind|Subject/Guardian decision|16|||
16887410|NCT02554890|37914422|FG000|Double-blind|Lost to Follow-up|7|||
16887411|NCT02554890|37914423|FG001|Double-blind|Lost to Follow-up|5|||
16887412|NCT02554890|37914422|FG000|Double-blind|Technical problems|1|||
16887413|NCT02554890|37914423|FG001|Double-blind|Technical problems|0|||
16887414|NCT02554890|37914422|FG000|Double-blind|Withdrawal by Subject|5|||
16887415|NCT02554890|37914423|FG001|Double-blind|Withdrawal by Subject|6|||
16887416|NCT02554890|37914422|FG000|Double-blind|Noncompliance with study treatment|6|||
16887417|NCT02554890|37914423|FG001|Double-blind|Noncompliance with study treatment|5|||
16887418|NCT02554890|37914422|FG000|Open-label|Adverse Event|0|||
16887419|NCT02554890|37914423|FG001|Open-label|Adverse Event|30|||
16887420|NCT02554890|37914422|FG000|Open-label|Death|0|||
16887421|NCT02554890|37914423|FG001|Open-label|Death|1|||
16887422|NCT02554890|37914422|FG000|Open-label|Physician Decision|0|||
16887423|NCT02554890|37914423|FG001|Open-label|Physician Decision|1|||
16887424|NCT02554890|37914422|FG000|Open-label|Subject/Guardian decision|0|||
16887425|NCT02554890|37914423|FG001|Open-label|Subject/Guardian decision|11|||
16887426|NCT02554890|37914422|FG000|Open-label|Lost to Follow-up|0|||
16887427|NCT02554890|37914423|FG001|Open-label|Lost to Follow-up|7|||
16887428|NCT02554890|37914422|FG000|Open-label|Technical problems|0|||
16887429|NCT02554890|37914423|FG001|Open-label|Technical problems|1|||
16887430|NCT02554890|37914422|FG000|Open-label|Withdrawal by Subject|0|||
16887431|NCT02554890|37914423|FG001|Open-label|Withdrawal by Subject|1|||
16887432|NCT02552316|37914440|FG000|Overall Study|Withdrawal by Subject|1|||
16887433|NCT02552316|37914440|FG000|Overall Study|Withdrawal due to non-compliance|1|||
17002417|NCT00842829|38146545|FG000|Continuation Period|Adverse Event|0|||
17002418|NCT00842829|38146546|FG001|Continuation Period|Adverse Event|0|||
17002419|NCT00842829|38146547|FG002|Continuation Period|Adverse Event|32|||
17002420|NCT00842829|38146545|FG000|Continuation Period|Lack of Efficacy|0|||
17002421|NCT00842829|38146546|FG001|Continuation Period|Lack of Efficacy|0|||
17002422|NCT00842829|38146547|FG002|Continuation Period|Lack of Efficacy|6|||
17002423|NCT00842829|38146545|FG000|Continuation Period|Unstable persistent cancer pain|0|||
17002424|NCT00842829|38146546|FG001|Continuation Period|Unstable persistent cancer pain|0|||
17095335|NCT00261846|38234550|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
17095336|NCT00261846|38234551|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
16887434|NCT02543346|37914488|FG000|Second Priming Visit|Withdrawal by Subject|0|||
16887435|NCT02543346|37914489|FG001|Second Priming Visit|Withdrawal by Subject|2|||
16887436|NCT02543346|37914490|FG002|Second Priming Visit|Withdrawal by Subject|2|||
16887437|NCT02543346|37914491|FG003|Second Priming Visit|Withdrawal by Subject|2|||
16887438|NCT02543346|37914488|FG000|Second Priming Visit|Adverse Event|1|||
16887439|NCT02543346|37914489|FG001|Second Priming Visit|Adverse Event|0|||
16887440|NCT02543346|37914490|FG002|Second Priming Visit|Adverse Event|0|||
17095337|NCT00169442|38234596|FG000|Overall Study|Withdrawal by Subject|0|||
17095338|NCT00169442|38234597|FG001|Overall Study|Withdrawal by Subject|0|||
17192027|NCT01678820|38345120|FG002|Overall Study|Physician Decision|1|||
17192028|NCT01678820|38345118|FG000|Overall Study|Protocol Violation|4|||
17192029|NCT01678820|38345119|FG001|Overall Study|Protocol Violation|5|||
17192030|NCT01678820|38345120|FG002|Overall Study|Protocol Violation|4|||
17192031|NCT01678820|38345118|FG000|Overall Study|Not treated with double-blind study drug|0|||
17192032|NCT01678820|38345119|FG001|Overall Study|Not treated with double-blind study drug|2|||
17192033|NCT01678820|38345120|FG002|Overall Study|Not treated with double-blind study drug|2|||
17192034|NCT00770809|38345132|FG000|Overall Study|Adverse Event|9|||
17192035|NCT00770809|38345133|FG001|Overall Study|Adverse Event|1|||
17192036|NCT00770809|38345134|FG002|Overall Study|Adverse Event|12|||
17192037|NCT00770809|38345132|FG000|Overall Study|Death|1|||
17192038|NCT00770809|38345133|FG001|Overall Study|Death|0|||
17192039|NCT00770809|38345134|FG002|Overall Study|Death|0|||
17192040|NCT00770809|38345132|FG000|Overall Study|Withdrawal by Subject|3|||
17192041|NCT00770809|38345133|FG001|Overall Study|Withdrawal by Subject|3|||
17192042|NCT00770809|38345134|FG002|Overall Study|Withdrawal by Subject|7|||
17192043|NCT00770809|38345132|FG000|Overall Study|Progression|2|||
17192044|NCT00770809|38345133|FG001|Overall Study|Progression|2|||
17192045|NCT00770809|38345134|FG002|Overall Study|Progression|0|||
17192046|NCT00770809|38345132|FG000|Overall Study|Complicating illness|0|||
17095339|NCT00169442|38234598|FG002|Overall Study|Withdrawal by Subject|1|||
17095340|NCT00169442|38234599|FG003|Overall Study|Withdrawal by Subject|0|||
17095341|NCT00169442|38234600|FG004|Overall Study|Withdrawal by Subject|0|||
17095342|NCT00169442|38234601|FG005|Overall Study|Withdrawal by Subject|0|||
17095343|NCT00169442|38234596|FG000|Overall Study|Migrated/moved from study area|0|||
17192047|NCT00770809|38345133|FG001|Overall Study|Complicating illness|0|||
16887441|NCT02543346|37914491|FG003|Second Priming Visit|Adverse Event|0|||
16887442|NCT02549196|37914505|FG000|Overall Study|Protocol Violation|0|||
16887443|NCT02549196|37914506|FG001|Overall Study|Protocol Violation|0|||
17002425|NCT00842829|38146547|FG002|Continuation Period|Unstable persistent cancer pain|3|||
17192048|NCT00770809|38345134|FG002|Overall Study|Complicating illness|1|||
17192049|NCT00770809|38345132|FG000|Overall Study|Other Medical Reasons|2|||
17095344|NCT00169442|38234597|FG001|Overall Study|Migrated/moved from study area|0|||
17192050|NCT00770809|38345133|FG001|Overall Study|Other Medical Reasons|4|||
17192051|NCT00770809|38345134|FG002|Overall Study|Other Medical Reasons|3|||
17192052|NCT02660138|38345145|FG000|Overall Study|Adverse Event|0|||
17192053|NCT02660138|38345146|FG001|Overall Study|Adverse Event|3|||
17192054|NCT02660138|38345147|FG002|Overall Study|Adverse Event|2|||
17192055|NCT02660138|38345145|FG000|Overall Study|Lack of Efficacy|1|||
17095345|NCT00169442|38234598|FG002|Overall Study|Migrated/moved from study area|0|||
17095346|NCT00169442|38234599|FG003|Overall Study|Migrated/moved from study area|0|||
17095347|NCT00169442|38234600|FG004|Overall Study|Migrated/moved from study area|0|||
17095348|NCT00169442|38234601|FG005|Overall Study|Migrated/moved from study area|2|||
17095349|NCT00169442|38234596|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
17095350|NCT00169442|38234597|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
17095351|NCT00169442|38234598|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
17095352|NCT00169442|38234599|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
17095353|NCT00169442|38234600|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
17095354|NCT00169442|38234601|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
16785785|NCT02694523|37725862|FG001|Part B|Other|0|||
16887444|NCT02549196|37914507|FG002|Overall Study|Protocol Violation|0|||
16887445|NCT02549196|37914508|FG003|Overall Study|Protocol Violation|1|||
16887446|NCT02549196|37914505|FG000|Overall Study|Withdrawal by Subject|1|||
16887447|NCT02549196|37914506|FG001|Overall Study|Withdrawal by Subject|0|||
16887448|NCT02549196|37914507|FG002|Overall Study|Withdrawal by Subject|1|||
16887449|NCT02549196|37914508|FG003|Overall Study|Withdrawal by Subject|0|||
16887450|NCT02904954|37914520|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
16887451|NCT02904954|37914521|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
16887452|NCT02904954|37914520|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
16887453|NCT02904954|37914521|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
16887454|NCT02904954|37914520|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
16887455|NCT02904954|37914521|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
16887456|NCT02904954|37914520|FG000|Adjuvant Durvalumab|Recurrence|2|||
16887457|NCT02904954|37914521|FG001|Adjuvant Durvalumab|Recurrence|0|||
16887458|NCT02904954|37914520|FG000|Adjuvant Durvalumab|Adverse Event|2|||
16887459|NCT02904954|37914521|FG001|Adjuvant Durvalumab|Adverse Event|6|||
16887460|NCT02904954|37914520|FG000|Adjuvant Durvalumab|Participant wishes|12|||
16887461|NCT02904954|37914521|FG001|Adjuvant Durvalumab|Participant wishes|7|||
16887462|NCT02904954|37914520|FG000|Adjuvant Durvalumab|Physician Decision|2|||
16887463|NCT02904954|37914521|FG001|Adjuvant Durvalumab|Physician Decision|1|||
16887464|NCT02904954|37914520|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
16887465|NCT02904954|37914521|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
16887466|NCT02904954|37914520|FG000|Adjuvant Durvalumab|Death|0|||
16887467|NCT02904954|37914521|FG001|Adjuvant Durvalumab|Death|1|||
16887468|NCT02904954|37914520|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
16887469|NCT02904954|37914521|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
16887470|NCT02548962|37914637|FG000|Overall Study|Withdrawal by Subject|1|||
16887471|NCT02548962|37914638|FG001|Overall Study|Withdrawal by Subject|0|||
16887472|NCT02548650|37914665|FG000|Triple Therapy|Adverse Event|1|||
16887473|NCT02548650|37914666|FG001|Triple Therapy|Adverse Event|0|||
16887474|NCT02548650|37914665|FG000|Triple Therapy|Withdrawal by Subject|0|||
16887475|NCT02548650|37914666|FG001|Triple Therapy|Withdrawal by Subject|4|||
16887476|NCT02548650|37914665|FG000|Double Therapy|Adverse Event|1|||
16887477|NCT02548650|37914666|FG001|Double Therapy|Adverse Event|1|||
16887478|NCT02548650|37914665|FG000|Double Therapy|Withdrawal by Subject|0|||
16887479|NCT02548650|37914666|FG001|Double Therapy|Withdrawal by Subject|1|||
16887480|NCT02535000|37914761|FG000|Overall Study|Cancellation of surgery.|1|||
16887481|NCT02535000|37914762|FG001|Overall Study|Cancellation of surgery.|2|||
16887482|NCT03110562|37914891|FG000|Overall Study|Withdrawal by Subject|37|||
16887483|NCT03110562|37914892|FG001|Overall Study|Withdrawal by Subject|35|||
16887484|NCT03110562|37914891|FG000|Overall Study|Death|47|||
16887485|NCT03110562|37914892|FG001|Overall Study|Death|61|||
16887486|NCT03110562|37914891|FG000|Overall Study|Lost to Follow-up|7|||
16887487|NCT03110562|37914892|FG001|Overall Study|Lost to Follow-up|6|||
16887488|NCT03110562|37914891|FG000|Overall Study|Other|2|||
16887489|NCT03110562|37914892|FG001|Overall Study|Other|1|||
16887490|NCT03110562|37914891|FG000|Overall Study|Randomized but never treated|0|||
16887491|NCT03110562|37914892|FG001|Overall Study|Randomized but never treated|3|||
16887492|NCT03110562|37914891|FG000|Overall Study|Ongoing|102|||
16887493|NCT03110562|37914892|FG001|Overall Study|Ongoing|101|||
16887494|NCT02546856|37914935|FG000|4 Months Evaluation|Death|2|||
16887495|NCT02546856|37914936|FG001|4 Months Evaluation|Death|3|||
16785786|NCT02694523|37725863|FG002|Part B|Other|1|||
16887496|NCT02546856|37914935|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
16887497|NCT02546856|37914936|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
16887498|NCT02546856|37914935|FG000|4 Months Evaluation|Lost to Follow-up|3|||
17192056|NCT02660138|38345146|FG001|Overall Study|Lack of Efficacy|2|||
16785787|NCT02694523|37725864|FG003|Part B|Other|0|||
16887499|NCT02546856|37914936|FG001|4 Months Evaluation|Lost to Follow-up|3|||
16887500|NCT02546856|37914935|FG000|4 Months Evaluation|Physician Decision|3|||
16887501|NCT02546856|37914936|FG001|4 Months Evaluation|Physician Decision|0|||
16887502|NCT02546856|37914935|FG000|4 Months Evaluation|Working or living abroad|5|||
16887503|NCT02546856|37914936|FG001|4 Months Evaluation|Working or living abroad|1|||
16887504|NCT02546856|37914935|FG000|4 Months Evaluation|reasons not due to titration|4|||
16887505|NCT02546856|37914936|FG001|4 Months Evaluation|reasons not due to titration|1|||
16887506|NCT02546856|37914935|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
16887507|NCT02546856|37914936|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
16887508|NCT02546856|37914935|FG000|6 Months Evaluation|Death|1|||
16887509|NCT02546856|37914936|FG001|6 Months Evaluation|Death|1|||
16887510|NCT02546856|37914935|FG000|6 Months Evaluation|Lost to Follow-up|1|||
16887511|NCT02546856|37914936|FG001|6 Months Evaluation|Lost to Follow-up|1|||
16887512|NCT02546856|37914935|FG000|6 Months Evaluation|Working or living abroad|6|||
16887513|NCT02546856|37914936|FG001|6 Months Evaluation|Working or living abroad|4|||
16887514|NCT02546856|37914935|FG000|6 Months Evaluation|reasons not due to titration|0|||
16887515|NCT02546856|37914936|FG001|6 Months Evaluation|reasons not due to titration|1|||
16887516|NCT02696616|37915061|FG000|Overall Study|Adverse Event|0|||
16887517|NCT02696616|37915062|FG001|Overall Study|Adverse Event|1|||
16887518|NCT02696616|37915063|FG002|Overall Study|Adverse Event|0|||
16887519|NCT02696616|37915064|FG003|Overall Study|Adverse Event|0|||
16887520|NCT02696616|37915065|FG004|Overall Study|Adverse Event|0|||
16887521|NCT02696616|37915066|FG005|Overall Study|Adverse Event|0|||
16887522|NCT02696616|37915067|FG006|Overall Study|Adverse Event|0|||
16887523|NCT01661790|37915118|FG000|Overall Study|Lost to Follow-up|0|||
16887524|NCT01661790|37915119|FG001|Overall Study|Lost to Follow-up|2|||
16887525|NCT02546544|37915139|FG000|Overall Study|Disease Progression|14|||
16887526|NCT02546544|37915139|FG000|Overall Study|Adverse Event|1|||
16887527|NCT02546544|37915139|FG000|Overall Study|Withdrawal by Subject|1|||
16887528|NCT02533674|37915775|FG000|Dose Level I|Progressive disease|1|||
16887529|NCT02533674|37915776|FG001|Dose Level I|Progressive disease|0|||
16887530|NCT02533674|37915777|FG002|Dose Level I|Progressive disease|0|||
16887531|NCT02533674|37915778|FG003|Dose Level I|Progressive disease|0|||
16887532|NCT02533674|37915779|FG004|Dose Level I|Progressive disease|0|||
16887533|NCT02533674|37915780|FG005|Dose Level I|Progressive disease|0|||
16887534|NCT02533674|37915781|FG006|Dose Level I|Progressive disease|0|||
16887535|NCT02533674|37915782|FG007|Dose Level I|Progressive disease|0|||
16887536|NCT02533674|37915775|FG000|Dose Level I|Withdrawal by Subject|1|||
16887537|NCT02533674|37915776|FG001|Dose Level I|Withdrawal by Subject|0|||
16887538|NCT02533674|37915777|FG002|Dose Level I|Withdrawal by Subject|0|||
16887539|NCT02533674|37915778|FG003|Dose Level I|Withdrawal by Subject|0|||
16887540|NCT02533674|37915779|FG004|Dose Level I|Withdrawal by Subject|0|||
16887541|NCT02533674|37915780|FG005|Dose Level I|Withdrawal by Subject|0|||
16887542|NCT02533674|37915781|FG006|Dose Level I|Withdrawal by Subject|0|||
16887543|NCT02533674|37915782|FG007|Dose Level I|Withdrawal by Subject|0|||
16887544|NCT02533674|37915775|FG000|Dose Level I|Physician Decision|1|||
16887545|NCT02533674|37915776|FG001|Dose Level I|Physician Decision|0|||
16887546|NCT02533674|37915777|FG002|Dose Level I|Physician Decision|0|||
16887547|NCT02533674|37915778|FG003|Dose Level I|Physician Decision|0|||
16887548|NCT02533674|37915779|FG004|Dose Level I|Physician Decision|0|||
16887549|NCT02533674|37915780|FG005|Dose Level I|Physician Decision|0|||
16887550|NCT02533674|37915781|FG006|Dose Level I|Physician Decision|0|||
16887551|NCT02533674|37915782|FG007|Dose Level I|Physician Decision|0|||
16887552|NCT02533674|37915775|FG000|Dose Level I|Death|1|||
16887553|NCT02533674|37915776|FG001|Dose Level I|Death|0|||
16887554|NCT02533674|37915777|FG002|Dose Level I|Death|0|||
16887555|NCT02533674|37915778|FG003|Dose Level I|Death|0|||
16887556|NCT02533674|37915779|FG004|Dose Level I|Death|0|||
16887557|NCT02533674|37915780|FG005|Dose Level I|Death|0|||
16887558|NCT02533674|37915781|FG006|Dose Level I|Death|0|||
16887559|NCT02533674|37915782|FG007|Dose Level I|Death|0|||
16887560|NCT02533674|37915775|FG000|Dose Level I|Never Treated|1|||
16887561|NCT02533674|37915776|FG001|Dose Level I|Never Treated|0|||
16887562|NCT02533674|37915777|FG002|Dose Level I|Never Treated|0|||
16887563|NCT02533674|37915778|FG003|Dose Level I|Never Treated|0|||
16887564|NCT02533674|37915779|FG004|Dose Level I|Never Treated|0|||
16887565|NCT02533674|37915780|FG005|Dose Level I|Never Treated|0|||
16887566|NCT02533674|37915781|FG006|Dose Level I|Never Treated|0|||
16887567|NCT02533674|37915782|FG007|Dose Level I|Never Treated|0|||
16887568|NCT02533674|37915775|FG000|Dose Level II|Progressive disease|0|||
16887569|NCT02533674|37915776|FG001|Dose Level II|Progressive disease|3|||
16887570|NCT02533674|37915777|FG002|Dose Level II|Progressive disease|0|||
16887571|NCT02533674|37915778|FG003|Dose Level II|Progressive disease|0|||
16887572|NCT02533674|37915779|FG004|Dose Level II|Progressive disease|0|||
16887573|NCT02533674|37915780|FG005|Dose Level II|Progressive disease|0|||
16887574|NCT02533674|37915781|FG006|Dose Level II|Progressive disease|0|||
16887575|NCT02533674|37915782|FG007|Dose Level II|Progressive disease|0|||
16887576|NCT02533674|37915775|FG000|Dose Level II|Withdrawal by Subject|0|||
16887577|NCT02533674|37915776|FG001|Dose Level II|Withdrawal by Subject|1|||
16887578|NCT02533674|37915777|FG002|Dose Level II|Withdrawal by Subject|0|||
16887579|NCT02533674|37915778|FG003|Dose Level II|Withdrawal by Subject|0|||
16887580|NCT02533674|37915779|FG004|Dose Level II|Withdrawal by Subject|0|||
16887581|NCT02533674|37915780|FG005|Dose Level II|Withdrawal by Subject|0|||
16887582|NCT02533674|37915781|FG006|Dose Level II|Withdrawal by Subject|0|||
16887583|NCT02533674|37915782|FG007|Dose Level II|Withdrawal by Subject|0|||
16887584|NCT02533674|37915775|FG000|Dose Level II|Treatment-related AE|0|||
16887585|NCT02533674|37915776|FG001|Dose Level II|Treatment-related AE|1|||
16887586|NCT02533674|37915777|FG002|Dose Level II|Treatment-related AE|0|||
16887587|NCT02533674|37915778|FG003|Dose Level II|Treatment-related AE|0|||
16887588|NCT02533674|37915779|FG004|Dose Level II|Treatment-related AE|0|||
16887589|NCT02533674|37915780|FG005|Dose Level II|Treatment-related AE|0|||
16887590|NCT02533674|37915781|FG006|Dose Level II|Treatment-related AE|0|||
16887591|NCT02533674|37915782|FG007|Dose Level II|Treatment-related AE|0|||
16887592|NCT02533674|37915775|FG000|Dose Level II|Physician Decision|0|||
16887593|NCT02533674|37915776|FG001|Dose Level II|Physician Decision|1|||
16887594|NCT02533674|37915777|FG002|Dose Level II|Physician Decision|0|||
16887595|NCT02533674|37915778|FG003|Dose Level II|Physician Decision|0|||
16887596|NCT02533674|37915779|FG004|Dose Level II|Physician Decision|0|||
16887597|NCT02533674|37915780|FG005|Dose Level II|Physician Decision|0|||
16887598|NCT02533674|37915781|FG006|Dose Level II|Physician Decision|0|||
16887599|NCT02533674|37915782|FG007|Dose Level II|Physician Decision|0|||
16887600|NCT02533674|37915775|FG000|Dose Level II|Non-treatment-related AE|0|||
16887601|NCT02533674|37915776|FG001|Dose Level II|Non-treatment-related AE|1|||
16887602|NCT02533674|37915777|FG002|Dose Level II|Non-treatment-related AE|0|||
16887603|NCT02533674|37915778|FG003|Dose Level II|Non-treatment-related AE|0|||
16887604|NCT02533674|37915779|FG004|Dose Level II|Non-treatment-related AE|0|||
16887605|NCT02533674|37915780|FG005|Dose Level II|Non-treatment-related AE|0|||
16887606|NCT02533674|37915781|FG006|Dose Level II|Non-treatment-related AE|0|||
16887607|NCT02533674|37915782|FG007|Dose Level II|Non-treatment-related AE|0|||
16887608|NCT02533674|37915775|FG000|Dose Level III|Progressive disease|0|||
16887609|NCT02533674|37915776|FG001|Dose Level III|Progressive disease|0|||
16887610|NCT02533674|37915777|FG002|Dose Level III|Progressive disease|2|||
16887611|NCT02533674|37915778|FG003|Dose Level III|Progressive disease|0|||
16887612|NCT02533674|37915779|FG004|Dose Level III|Progressive disease|0|||
16887613|NCT02533674|37915780|FG005|Dose Level III|Progressive disease|0|||
16887614|NCT02533674|37915781|FG006|Dose Level III|Progressive disease|0|||
16887615|NCT02533674|37915782|FG007|Dose Level III|Progressive disease|0|||
16887616|NCT02533674|37915775|FG000|Dose Level III|Withdrawal by Subject|0|||
16887617|NCT02533674|37915776|FG001|Dose Level III|Withdrawal by Subject|0|||
16887618|NCT02533674|37915777|FG002|Dose Level III|Withdrawal by Subject|1|||
16887619|NCT02533674|37915778|FG003|Dose Level III|Withdrawal by Subject|0|||
16887620|NCT02533674|37915779|FG004|Dose Level III|Withdrawal by Subject|0|||
16887621|NCT02533674|37915780|FG005|Dose Level III|Withdrawal by Subject|0|||
16887622|NCT02533674|37915781|FG006|Dose Level III|Withdrawal by Subject|0|||
16887623|NCT02533674|37915782|FG007|Dose Level III|Withdrawal by Subject|0|||
16887624|NCT02533674|37915775|FG000|Dose Level III|Treatment-related AE|0|||
16887625|NCT02533674|37915776|FG001|Dose Level III|Treatment-related AE|0|||
16887626|NCT02533674|37915777|FG002|Dose Level III|Treatment-related AE|1|||
16887627|NCT02533674|37915778|FG003|Dose Level III|Treatment-related AE|0|||
16887628|NCT02533674|37915779|FG004|Dose Level III|Treatment-related AE|0|||
16887629|NCT02533674|37915780|FG005|Dose Level III|Treatment-related AE|0|||
16887630|NCT02533674|37915781|FG006|Dose Level III|Treatment-related AE|0|||
16887631|NCT02533674|37915782|FG007|Dose Level III|Treatment-related AE|0|||
16887632|NCT02533674|37915775|FG000|Dose Level IV|Progressive disease|0|||
16887633|NCT02533674|37915776|FG001|Dose Level IV|Progressive disease|0|||
16887634|NCT02533674|37915777|FG002|Dose Level IV|Progressive disease|0|||
16887635|NCT02533674|37915778|FG003|Dose Level IV|Progressive disease|3|||
16887636|NCT02533674|37915779|FG004|Dose Level IV|Progressive disease|0|||
16887637|NCT02533674|37915780|FG005|Dose Level IV|Progressive disease|0|||
16887638|NCT02533674|37915781|FG006|Dose Level IV|Progressive disease|0|||
16887639|NCT02533674|37915782|FG007|Dose Level IV|Progressive disease|0|||
16887640|NCT02533674|37915775|FG000|Dose Level IV|Withdrawal by Subject|0|||
16887641|NCT02533674|37915776|FG001|Dose Level IV|Withdrawal by Subject|0|||
16887642|NCT02533674|37915777|FG002|Dose Level IV|Withdrawal by Subject|0|||
16887643|NCT02533674|37915778|FG003|Dose Level IV|Withdrawal by Subject|1|||
16887644|NCT02533674|37915779|FG004|Dose Level IV|Withdrawal by Subject|0|||
16887645|NCT02533674|37915780|FG005|Dose Level IV|Withdrawal by Subject|0|||
16887646|NCT02533674|37915781|FG006|Dose Level IV|Withdrawal by Subject|0|||
16887647|NCT02533674|37915782|FG007|Dose Level IV|Withdrawal by Subject|0|||
16887648|NCT02533674|37915775|FG000|Dose Level IV|Physician Decision|0|||
16887649|NCT02533674|37915776|FG001|Dose Level IV|Physician Decision|0|||
16887650|NCT02533674|37915777|FG002|Dose Level IV|Physician Decision|0|||
16887651|NCT02533674|37915778|FG003|Dose Level IV|Physician Decision|1|||
16887652|NCT02533674|37915779|FG004|Dose Level IV|Physician Decision|0|||
16887653|NCT02533674|37915780|FG005|Dose Level IV|Physician Decision|0|||
16887654|NCT02533674|37915781|FG006|Dose Level IV|Physician Decision|0|||
16887655|NCT02533674|37915782|FG007|Dose Level IV|Physician Decision|0|||
16887656|NCT02533674|37915775|FG000|Dose Level V|Progressive disease|0|||
16887657|NCT02533674|37915776|FG001|Dose Level V|Progressive disease|0|||
16887658|NCT02533674|37915777|FG002|Dose Level V|Progressive disease|0|||
16887659|NCT02533674|37915778|FG003|Dose Level V|Progressive disease|0|||
16887660|NCT02533674|37915779|FG004|Dose Level V|Progressive disease|3|||
16887661|NCT02533674|37915780|FG005|Dose Level V|Progressive disease|0|||
16887662|NCT02533674|37915781|FG006|Dose Level V|Progressive disease|0|||
16887663|NCT02533674|37915782|FG007|Dose Level V|Progressive disease|0|||
16887664|NCT02533674|37915775|FG000|Dose Level V|Withdrawal by Subject|0|||
16887665|NCT02533674|37915776|FG001|Dose Level V|Withdrawal by Subject|0|||
16887666|NCT02533674|37915777|FG002|Dose Level V|Withdrawal by Subject|0|||
16887667|NCT02533674|37915778|FG003|Dose Level V|Withdrawal by Subject|0|||
16887668|NCT02533674|37915779|FG004|Dose Level V|Withdrawal by Subject|1|||
16887669|NCT02533674|37915780|FG005|Dose Level V|Withdrawal by Subject|0|||
16887670|NCT02533674|37915781|FG006|Dose Level V|Withdrawal by Subject|0|||
16887671|NCT02533674|37915782|FG007|Dose Level V|Withdrawal by Subject|0|||
16887672|NCT02533674|37915775|FG000|Dose Level V|Physician Decision|0|||
16887673|NCT02533674|37915776|FG001|Dose Level V|Physician Decision|0|||
16887674|NCT02533674|37915777|FG002|Dose Level V|Physician Decision|0|||
16887675|NCT02533674|37915778|FG003|Dose Level V|Physician Decision|0|||
16887676|NCT02533674|37915779|FG004|Dose Level V|Physician Decision|1|||
16887677|NCT02533674|37915780|FG005|Dose Level V|Physician Decision|0|||
16887678|NCT02533674|37915781|FG006|Dose Level V|Physician Decision|0|||
16887679|NCT02533674|37915782|FG007|Dose Level V|Physician Decision|0|||
16887680|NCT02533674|37915775|FG000|Dose Level VI|Progressive disease|0|||
16887681|NCT02533674|37915776|FG001|Dose Level VI|Progressive disease|0|||
16887682|NCT02533674|37915777|FG002|Dose Level VI|Progressive disease|0|||
16887683|NCT02533674|37915778|FG003|Dose Level VI|Progressive disease|0|||
16887684|NCT02533674|37915779|FG004|Dose Level VI|Progressive disease|0|||
16887685|NCT02533674|37915780|FG005|Dose Level VI|Progressive disease|7|||
16887686|NCT02533674|37915781|FG006|Dose Level VI|Progressive disease|0|||
16887687|NCT02533674|37915782|FG007|Dose Level VI|Progressive disease|0|||
16887688|NCT02533674|37915775|FG000|Dose Level VI|Withdrawal by Subject|0|||
16887689|NCT02533674|37915776|FG001|Dose Level VI|Withdrawal by Subject|0|||
16887690|NCT02533674|37915777|FG002|Dose Level VI|Withdrawal by Subject|0|||
16887691|NCT02533674|37915778|FG003|Dose Level VI|Withdrawal by Subject|0|||
16887692|NCT02533674|37915779|FG004|Dose Level VI|Withdrawal by Subject|0|||
16887693|NCT02533674|37915780|FG005|Dose Level VI|Withdrawal by Subject|1|||
16887694|NCT02533674|37915781|FG006|Dose Level VI|Withdrawal by Subject|0|||
16887695|NCT02533674|37915782|FG007|Dose Level VI|Withdrawal by Subject|0|||
16887696|NCT02533674|37915775|FG000|Dose Level VI|Treatment-related AE|0|||
16887697|NCT02533674|37915776|FG001|Dose Level VI|Treatment-related AE|0|||
16887698|NCT02533674|37915777|FG002|Dose Level VI|Treatment-related AE|0|||
16887699|NCT02533674|37915778|FG003|Dose Level VI|Treatment-related AE|0|||
16887700|NCT02533674|37915779|FG004|Dose Level VI|Treatment-related AE|0|||
16887701|NCT02533674|37915780|FG005|Dose Level VI|Treatment-related AE|1|||
16887702|NCT02533674|37915781|FG006|Dose Level VI|Treatment-related AE|0|||
16887703|NCT02533674|37915782|FG007|Dose Level VI|Treatment-related AE|0|||
16887704|NCT02533674|37915775|FG000|Dose Level VII|Progressive disease|0|||
16887705|NCT02533674|37915776|FG001|Dose Level VII|Progressive disease|0|||
16887706|NCT02533674|37915777|FG002|Dose Level VII|Progressive disease|0|||
16887707|NCT02533674|37915778|FG003|Dose Level VII|Progressive disease|0|||
16887708|NCT02533674|37915779|FG004|Dose Level VII|Progressive disease|0|||
16887709|NCT02533674|37915780|FG005|Dose Level VII|Progressive disease|0|||
16887710|NCT02533674|37915781|FG006|Dose Level VII|Progressive disease|10|||
16887711|NCT02533674|37915782|FG007|Dose Level VII|Progressive disease|0|||
16887712|NCT02533674|37915775|FG000|Dose Level VII|Withdrawal by Subject|0|||
16887713|NCT02533674|37915776|FG001|Dose Level VII|Withdrawal by Subject|0|||
16887714|NCT02533674|37915777|FG002|Dose Level VII|Withdrawal by Subject|0|||
16887715|NCT02533674|37915778|FG003|Dose Level VII|Withdrawal by Subject|0|||
16887716|NCT02533674|37915779|FG004|Dose Level VII|Withdrawal by Subject|0|||
16887717|NCT02533674|37915780|FG005|Dose Level VII|Withdrawal by Subject|0|||
16887718|NCT02533674|37915781|FG006|Dose Level VII|Withdrawal by Subject|3|||
16887719|NCT02533674|37915782|FG007|Dose Level VII|Withdrawal by Subject|0|||
16887720|NCT02533674|37915775|FG000|Dose Level VII|Treatment-related AE|0|||
16887721|NCT02533674|37915776|FG001|Dose Level VII|Treatment-related AE|0|||
17192057|NCT02660138|38345147|FG002|Overall Study|Lack of Efficacy|1|||
16887722|NCT02533674|37915777|FG002|Dose Level VII|Treatment-related AE|0|||
16887723|NCT02533674|37915778|FG003|Dose Level VII|Treatment-related AE|0|||
16887724|NCT02533674|37915779|FG004|Dose Level VII|Treatment-related AE|0|||
16887725|NCT02533674|37915780|FG005|Dose Level VII|Treatment-related AE|0|||
16887726|NCT02533674|37915781|FG006|Dose Level VII|Treatment-related AE|1|||
16887727|NCT02533674|37915782|FG007|Dose Level VII|Treatment-related AE|0|||
16887728|NCT02533674|37915775|FG000|Dose Level VII|Death|0|||
16887729|NCT02533674|37915776|FG001|Dose Level VII|Death|0|||
16887730|NCT02533674|37915777|FG002|Dose Level VII|Death|0|||
16887731|NCT02533674|37915778|FG003|Dose Level VII|Death|0|||
16887732|NCT02533674|37915779|FG004|Dose Level VII|Death|0|||
16887733|NCT02533674|37915780|FG005|Dose Level VII|Death|0|||
16887734|NCT02533674|37915781|FG006|Dose Level VII|Death|2|||
16887735|NCT02533674|37915782|FG007|Dose Level VII|Death|0|||
16887736|NCT02533674|37915775|FG000|Dose Level VIII|Progressive disease|0|||
16887737|NCT02533674|37915776|FG001|Dose Level VIII|Progressive disease|0|||
16887738|NCT02533674|37915777|FG002|Dose Level VIII|Progressive disease|0|||
16887739|NCT02533674|37915778|FG003|Dose Level VIII|Progressive disease|0|||
16887740|NCT02533674|37915779|FG004|Dose Level VIII|Progressive disease|0|||
16887741|NCT02533674|37915780|FG005|Dose Level VIII|Progressive disease|0|||
16887742|NCT02533674|37915781|FG006|Dose Level VIII|Progressive disease|0|||
16887743|NCT02533674|37915782|FG007|Dose Level VIII|Progressive disease|3|||
16887744|NCT02533674|37915775|FG000|Dose Level VIII|Withdrawal by Subject|0|||
16887745|NCT02533674|37915776|FG001|Dose Level VIII|Withdrawal by Subject|0|||
16887746|NCT02533674|37915777|FG002|Dose Level VIII|Withdrawal by Subject|0|||
16887747|NCT02533674|37915778|FG003|Dose Level VIII|Withdrawal by Subject|0|||
16887748|NCT02533674|37915779|FG004|Dose Level VIII|Withdrawal by Subject|0|||
16887749|NCT02533674|37915780|FG005|Dose Level VIII|Withdrawal by Subject|0|||
16887750|NCT02533674|37915781|FG006|Dose Level VIII|Withdrawal by Subject|0|||
16887751|NCT02533674|37915782|FG007|Dose Level VIII|Withdrawal by Subject|1|||
16887752|NCT02533674|37915775|FG000|Dose Level VIII|Treatment-related AE|0|||
16887753|NCT02533674|37915776|FG001|Dose Level VIII|Treatment-related AE|0|||
16887754|NCT02533674|37915777|FG002|Dose Level VIII|Treatment-related AE|0|||
16887755|NCT02533674|37915778|FG003|Dose Level VIII|Treatment-related AE|0|||
16887756|NCT02533674|37915779|FG004|Dose Level VIII|Treatment-related AE|0|||
16887757|NCT02533674|37915780|FG005|Dose Level VIII|Treatment-related AE|0|||
16887758|NCT02533674|37915781|FG006|Dose Level VIII|Treatment-related AE|0|||
16887759|NCT02533674|37915782|FG007|Dose Level VIII|Treatment-related AE|1|||
16887760|NCT02533674|37915775|FG000|Dose Level VIII|Never treated|0|||
16887761|NCT02533674|37915776|FG001|Dose Level VIII|Never treated|0|||
16887762|NCT02533674|37915777|FG002|Dose Level VIII|Never treated|0|||
16887763|NCT02533674|37915778|FG003|Dose Level VIII|Never treated|0|||
16887764|NCT02533674|37915779|FG004|Dose Level VIII|Never treated|0|||
16887765|NCT02533674|37915780|FG005|Dose Level VIII|Never treated|0|||
16887766|NCT02533674|37915781|FG006|Dose Level VIII|Never treated|0|||
16887767|NCT02533674|37915782|FG007|Dose Level VIII|Never treated|1|||
16887768|NCT02540850|37915803|FG000|Overall Study|Lost to Follow-up|69|||
16887769|NCT02540850|37915804|FG001|Overall Study|Lost to Follow-up|66|||
16887770|NCT02540850|37915805|FG002|Overall Study|Lost to Follow-up|34|||
16887771|NCT01662024|37915813|FG000|Overall Study|Pregnancy|2|||
16887772|NCT01662024|37915813|FG000|Overall Study|Withdrawal by Subject|3|||
16887773|NCT02544750|37915895|FG000|Overall Study|Physician Decision|3|||
16887774|NCT02544750|37915896|FG001|Overall Study|Physician Decision|1|||
16887775|NCT02544750|37915895|FG000|Overall Study|Other reasons|69|||
16887776|NCT02544750|37915896|FG001|Overall Study|Other reasons|39|||
16887777|NCT02544750|37915895|FG000|Overall Study|Met withdrawal criteria|2|||
16887778|NCT02544750|37915896|FG001|Overall Study|Met withdrawal criteria|2|||
16887779|NCT02544750|37915895|FG000|Overall Study|Transition To Commercial Product|1|||
16887780|NCT02544750|37915896|FG001|Overall Study|Transition To Commercial Product|0|||
16887781|NCT02544750|37915895|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
16785788|NCT02694523|37725865|FG004|Part B|Other|0|||
16785789|NCT02694523|37725866|FG005|Part B|Other|0|||
16785790|NCT02694523|37725867|FG006|Part B|Other|1|||
16785791|NCT01353703|37725881|FG000|Overall Study|Migrated/moved from study area|1|||
16785792|NCT01353703|37725882|FG001|Overall Study|Migrated/moved from study area|0|||
16785793|NCT02009332|37725896|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16785794|NCT02009332|37725897|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
16785795|NCT02009332|37725898|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16785796|NCT02009332|37725899|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16785797|NCT02009332|37725900|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16785798|NCT02009332|37725901|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16785799|NCT02009332|37725896|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16785800|NCT02009332|37725897|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16785801|NCT02009332|37725898|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16785802|NCT02009332|37725899|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16785803|NCT02009332|37725900|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
16785804|NCT02009332|37725901|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16785805|NCT02009332|37725896|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16785806|NCT02009332|37725897|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16887782|NCT02544750|37915896|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
16887783|NCT02544750|37915895|FG000|Overall Study|Adverse Event|8|||
16887784|NCT02544750|37915896|FG001|Overall Study|Adverse Event|10|||
16887785|NCT02544750|37915895|FG000|Overall Study|Withdrawal by Subject|10|||
16887786|NCT02544750|37915896|FG001|Overall Study|Withdrawal by Subject|4|||
16887787|NCT02544750|37915895|FG000|Overall Study|Lost to Follow-up|1|||
16887788|NCT02544750|37915896|FG001|Overall Study|Lost to Follow-up|0|||
17002426|NCT00842829|38146545|FG000|Continuation Period|Withdrawal by Subject|0|||
17002427|NCT00842829|38146546|FG001|Continuation Period|Withdrawal by Subject|0|||
17002428|NCT00842829|38146547|FG002|Continuation Period|Withdrawal by Subject|10|||
17002429|NCT00842829|38146545|FG000|Continuation Period|Other|0|||
17002430|NCT00842829|38146546|FG001|Continuation Period|Other|0|||
17002431|NCT00842829|38146547|FG002|Continuation Period|Other|7|||
17002432|NCT00842829|38146545|FG000|Continuation Period|Non-compliance to study procedures|0|||
17002433|NCT00842829|38146546|FG001|Continuation Period|Non-compliance to study procedures|0|||
17002434|NCT00842829|38146547|FG002|Continuation Period|Non-compliance to study procedures|2|||
17002435|NCT00842829|38146545|FG000|Continuation Period|Non-compliance to study drug|0|||
17002436|NCT00842829|38146546|FG001|Continuation Period|Non-compliance to study drug|0|||
17002437|NCT00842829|38146547|FG002|Continuation Period|Non-compliance to study drug|1|||
17002438|NCT00653263|38146559|FG000|Overall Study|Withdrawal by Subject|1|||
17002439|NCT00653263|38146559|FG000|Overall Study|Physician Decision|1|||
17002440|NCT00842361|38146565|FG000|Overall Study|Protocol Violation|1|||
17002441|NCT00842361|38146566|FG001|Overall Study|Protocol Violation|0|||
17002442|NCT00842361|38146565|FG000|Overall Study|Unclassified|0|||
17002443|NCT00842361|38146566|FG001|Overall Study|Unclassified|2|||
17002444|NCT00841035|38146572|FG000|Phase 1 Overall Study|Physician Decision|13|||
17002445|NCT00642811|38146583|FG000|Overall Study|Adverse Event|2|||
17002446|NCT00642811|38146584|FG001|Overall Study|Adverse Event|3|||
17002447|NCT00642811|38146585|FG002|Overall Study|Adverse Event|0|||
17002448|NCT00642811|38146586|FG003|Overall Study|Adverse Event|0|||
17002449|NCT00642811|38146587|FG004|Overall Study|Adverse Event|0|||
16887789|NCT02540538|37915942|FG000|Overall Study|Pregnancy|0|||
16887790|NCT02540538|37915943|FG001|Overall Study|Pregnancy|1|||
16887791|NCT02540538|37915944|FG002|Overall Study|Pregnancy|0|||
16887792|NCT04697056|37915977|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
16887793|NCT04697056|37915978|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
16887794|NCT02181738|37916102|FG000|Overall Study|Death|1|||
16887795|NCT02181738|37916103|FG001|Overall Study|Death|1|||
16887796|NCT02181738|37916104|FG002|Overall Study|Death|6|||
16887797|NCT02181738|37916105|FG003|Overall Study|Death|1|||
16887798|NCT02181738|37916102|FG000|Overall Study|Subject Withdrew Consent|1|||
16887799|NCT02181738|37916103|FG001|Overall Study|Subject Withdrew Consent|3|||
16887800|NCT02181738|37916104|FG002|Overall Study|Subject Withdrew Consent|2|||
16887801|NCT02181738|37916105|FG003|Overall Study|Subject Withdrew Consent|1|||
16887802|NCT02181738|37916102|FG000|Overall Study|Lost to Follow-up|0|||
16887803|NCT02181738|37916103|FG001|Overall Study|Lost to Follow-up|4|||
16887804|NCT02181738|37916104|FG002|Overall Study|Lost to Follow-up|2|||
16887805|NCT02181738|37916105|FG003|Overall Study|Lost to Follow-up|0|||
16887806|NCT02181738|37916102|FG000|Overall Study|Patient Return to Home Country|0|||
16887807|NCT02181738|37916103|FG001|Overall Study|Patient Return to Home Country|1|||
16887808|NCT02181738|37916104|FG002|Overall Study|Patient Return to Home Country|0|||
16887809|NCT02181738|37916105|FG003|Overall Study|Patient Return to Home Country|0|||
16887810|NCT03493282|37916136|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
16887811|NCT03493282|37916137|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
16887812|NCT03493282|37916138|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
16887813|NCT03493282|37916136|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
16887814|NCT03493282|37916137|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
16887815|NCT03493282|37916138|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
16887816|NCT02091960|37916152|FG000|Overall Study|Death|7|||
16887817|NCT02091960|37916152|FG000|Overall Study|Withdrawal by Subject|1|||
16887818|NCT02091960|37916152|FG000|Overall Study|Miscellaneous Reasons|31|||
16887819|NCT02091960|37916152|FG000|Overall Study|On Study at Data Cut-off|12|||
16887820|NCT02532972|37916156|FG000|Overall Study|Withdrawal by Subject|1|||
16887821|NCT03187834|37916209|FG000|Overall Study|Lost to Follow-up|0|||
16887822|NCT03187834|37916210|FG001|Overall Study|Lost to Follow-up|1|||
16887823|NCT03187834|37916211|FG002|Overall Study|Lost to Follow-up|2|||
16887824|NCT03187834|37916212|FG003|Overall Study|Lost to Follow-up|2|||
16887825|NCT03187834|37916209|FG000|Overall Study|Had invalid anthropometric measurements|5|||
16887826|NCT03187834|37916210|FG001|Overall Study|Had invalid anthropometric measurements|3|||
16887827|NCT03187834|37916211|FG002|Overall Study|Had invalid anthropometric measurements|4|||
16887828|NCT03187834|37916212|FG003|Overall Study|Had invalid anthropometric measurements|2|||
16887829|NCT03713944|37916365|FG000|Study Treatment|Patient non-compliance|1|||
16887830|NCT03713944|37916365|FG000|Study Treatment|Alternative Cancer Therapy|3|||
16887831|NCT03713944|37916365|FG000|Study Treatment|Disease Progression|18|||
16887832|NCT03713944|37916365|FG000|Study Treatment|AE/Side Effects/Complications|2|||
16887833|NCT03713944|37916365|FG000|Study Treatment|Death|2|||
16887834|NCT03713944|37916365|FG000|Study Treatment|Withdrawal by Subject|1|||
17002450|NCT00642811|38146588|FG005|Overall Study|Adverse Event|1|||
17002451|NCT00642811|38146583|FG000|Overall Study|Developement of discontinuation criteria|0|||
17002452|NCT00642811|38146584|FG001|Overall Study|Developement of discontinuation criteria|0|||
17002453|NCT00642811|38146585|FG002|Overall Study|Developement of discontinuation criteria|0|||
16887835|NCT03713944|37916365|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
16887836|NCT03713944|37916365|FG000|Study Treatment|Symptomatic Deterioration|2|||
16887837|NCT03713944|37916365|FG000|Follow up|Withdrawal by Subject|2|||
16887838|NCT03713944|37916365|FG000|Follow up|Death|11|||
16887839|NCT03713944|37916365|FG000|Follow up|Study Terminated|3|||
16887840|NCT02325154|37916465|FG000|Overall Study|Physician Decision|1|||
16887841|NCT00493870|37916592|FG000|Overall Study|Lost to Follow-up|12|||
16887842|NCT00493870|37916593|FG001|Overall Study|Lost to Follow-up|15|||
16887843|NCT04439344|37916878|FG000|Overall Study|Never started threapy|3|||
16887844|NCT04439344|37916878|FG000|Overall Study|Ineligible|3|||
16887845|NCT04439344|37916878|FG000|Overall Study|Adverse Event|13|||
16887846|NCT04439344|37916878|FG000|Overall Study|Death|2|||
16887847|NCT04439344|37916878|FG000|Overall Study|Disease progression|29|||
16887848|NCT04439344|37916878|FG000|Overall Study|Withdrawal by Subject|2|||
16887849|NCT04439344|37916878|FG000|Overall Study|Alternative therapy|1|||
16887850|NCT04439279|37916882|FG000|Overall Study|Adverse Event|7|||
16887851|NCT04439279|37916882|FG000|Overall Study|Death|4|||
16887852|NCT04439279|37916882|FG000|Overall Study|Disease progression|17|||
16887853|NCT04439279|37916882|FG000|Overall Study|Complicating disease|3|||
16887854|NCT04439279|37916882|FG000|Overall Study|Withdrawal by Subject|2|||
16887855|NCT04439279|37916882|FG000|Overall Study|Ineligible|1|||
16887856|NCT04439279|37916882|FG000|Overall Study|Treatment still ongoing|1|||
16887857|NCT04439175|37916886|FG000|Overall Study|Never started treatment|4|||
16887858|NCT04439175|37916886|FG000|Overall Study|Ineligible|5|||
16887859|NCT04439175|37916886|FG000|Overall Study|Adverse Event|6|||
16887860|NCT04439175|37916886|FG000|Overall Study|Death|4|||
16887861|NCT04439175|37916886|FG000|Overall Study|Disease progression|44|||
16887862|NCT04439175|37916886|FG000|Overall Study|Withdrawal by Subject|4|||
16887863|NCT04439175|37916886|FG000|Overall Study|Alternative Therapy|1|||
16887864|NCT04439175|37916886|FG000|Overall Study|Other|2|||
16887865|NCT04232215|37916901|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
16887866|NCT04232215|37916902|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16887867|NCT03951753|37916915|FG000|Overall Study|Adverse Event|1|||
16887868|NCT03951753|37916916|FG001|Overall Study|Adverse Event|0|||
16887869|NCT03951753|37916917|FG002|Overall Study|Adverse Event|3|||
16887870|NCT03951753|37916915|FG000|Overall Study|Withdrawal by Subject|3|||
16887871|NCT03951753|37916916|FG001|Overall Study|Withdrawal by Subject|1|||
16887872|NCT03951753|37916917|FG002|Overall Study|Withdrawal by Subject|0|||
16887873|NCT03951753|37916915|FG000|Overall Study|Lost to Follow-up|0|||
16887874|NCT03951753|37916916|FG001|Overall Study|Lost to Follow-up|0|||
16887875|NCT03951753|37916917|FG002|Overall Study|Lost to Follow-up|1|||
16887876|NCT03941964|37916927|FG000|Overall Study|Adverse Event|1|||
16887877|NCT03941964|37916928|FG001|Overall Study|Adverse Event|8|||
16887878|NCT03941964|37916927|FG000|Overall Study|Progressive disease|7|||
16887879|NCT03941964|37916928|FG001|Overall Study|Progressive disease|3|||
16887880|NCT03941964|37916927|FG000|Overall Study|Lack of Efficacy|0|||
16887881|NCT03941964|37916928|FG001|Overall Study|Lack of Efficacy|1|||
16887882|NCT03941964|37916927|FG000|Overall Study|Death|3|||
16887883|NCT03941964|37916928|FG001|Overall Study|Death|1|||
16887884|NCT03941964|37916927|FG000|Overall Study|Withdrew consent|1|||
16887885|NCT03941964|37916928|FG001|Overall Study|Withdrew consent|3|||
16887886|NCT03941964|37916927|FG000|Overall Study|Physician Decision|9|||
16887887|NCT03941964|37916928|FG001|Overall Study|Physician Decision|2|||
16887888|NCT03941964|37916927|FG000|Overall Study|Other, not specified|2|||
16887889|NCT03941964|37916928|FG001|Overall Study|Other, not specified|1|||
16887890|NCT03837509|37916958|FG000|Phase 1|Death|5|||
16887891|NCT03837509|37916959|FG001|Phase 1|Death|2|||
16887892|NCT03837509|37916960|FG002|Phase 1|Death|0|||
16887893|NCT03837509|37916961|FG003|Phase 1|Death|0|||
16887894|NCT03837509|37916962|FG004|Phase 1|Death|0|||
16887895|NCT03837509|37916958|FG000|Phase 2|Death|0|||
16887896|NCT03837509|37916959|FG001|Phase 2|Death|0|||
16887897|NCT03837509|37916960|FG002|Phase 2|Death|0|||
16887898|NCT03837509|37916961|FG003|Phase 2|Death|1|||
16887899|NCT03837509|37916962|FG004|Phase 2|Death|1|||
16887900|NCT03822117|37916982|FG000|Overall Study|Death|18|||
16887901|NCT03822117|37916983|FG001|Overall Study|Death|17|||
16887902|NCT03822117|37916984|FG002|Overall Study|Death|12|||
16887903|NCT03822117|37916985|FG003|Overall Study|Death|4|||
16887904|NCT03822117|37916982|FG000|Overall Study|Lost to Follow-up|1|||
16887905|NCT03822117|37916983|FG001|Overall Study|Lost to Follow-up|2|||
16887906|NCT03822117|37916984|FG002|Overall Study|Lost to Follow-up|3|||
16887907|NCT03822117|37916985|FG003|Overall Study|Lost to Follow-up|0|||
16887908|NCT03822117|37916982|FG000|Overall Study|Study Terminated by Sponsor|25|||
16887909|NCT03822117|37916983|FG001|Overall Study|Study Terminated by Sponsor|11|||
17002454|NCT00642811|38146586|FG003|Overall Study|Developement of discontinuation criteria|0|||
16887910|NCT03822117|37916984|FG002|Overall Study|Study Terminated by Sponsor|6|||
16887911|NCT03822117|37916985|FG003|Overall Study|Study Terminated by Sponsor|0|||
16887912|NCT03822117|37916982|FG000|Overall Study|Withdrawal by Subject|4|||
16887913|NCT03822117|37916983|FG001|Overall Study|Withdrawal by Subject|0|||
16887914|NCT03822117|37916984|FG002|Overall Study|Withdrawal by Subject|3|||
16887915|NCT03822117|37916985|FG003|Overall Study|Withdrawal by Subject|0|||
16887916|NCT03822117|37916982|FG000|Overall Study|Disease Progression|1|||
16887917|NCT03822117|37916983|FG001|Overall Study|Disease Progression|2|||
16887918|NCT03822117|37916984|FG002|Overall Study|Disease Progression|1|||
16887919|NCT03822117|37916985|FG003|Overall Study|Disease Progression|0|||
16887920|NCT03822117|37916982|FG000|Overall Study|Never Returned to Hospital|0|||
16887921|NCT03822117|37916983|FG001|Overall Study|Never Returned to Hospital|0|||
16887922|NCT03822117|37916984|FG002|Overall Study|Never Returned to Hospital|1|||
16887923|NCT03822117|37916985|FG003|Overall Study|Never Returned to Hospital|0|||
16887924|NCT03602586|37916996|FG000|Overall Study|Withdrawal by Subject|3|||
16887925|NCT03497897|37917003|FG000|Overall Study|Adverse Event|1|||
16887926|NCT03497897|37917004|FG001|Overall Study|Adverse Event|1|||
16887927|NCT03497897|37917005|FG002|Overall Study|Adverse Event|1|||
16887928|NCT03497897|37917003|FG000|Overall Study|Lost to Follow-up|2|||
16887929|NCT03497897|37917004|FG001|Overall Study|Lost to Follow-up|0|||
16887930|NCT03497897|37917005|FG002|Overall Study|Lost to Follow-up|2|||
16887931|NCT03497897|37917003|FG000|Overall Study|Physician Decision|1|||
16887932|NCT03497897|37917004|FG001|Overall Study|Physician Decision|0|||
16887933|NCT03497897|37917005|FG002|Overall Study|Physician Decision|0|||
16887934|NCT03497897|37917003|FG000|Overall Study|Subject/Guardian Decision|2|||
16887935|NCT03497897|37917004|FG001|Overall Study|Subject/Guardian Decision|1|||
16887936|NCT03497897|37917005|FG002|Overall Study|Subject/Guardian Decision|3|||
16887937|NCT03428217|37917016|FG000|Overall Study|Death|89|||
16887938|NCT03428217|37917017|FG001|Overall Study|Death|93|||
16887939|NCT03428217|37917016|FG000|Overall Study|Withdrawal by Subject|8|||
16887940|NCT03428217|37917017|FG001|Overall Study|Withdrawal by Subject|7|||
16887941|NCT03428217|37917016|FG000|Overall Study|Lost to Follow-up|1|||
16887942|NCT03428217|37917017|FG001|Overall Study|Lost to Follow-up|3|||
16887943|NCT03428217|37917016|FG000|Overall Study|Study terminated by sponsor|124|||
16887944|NCT03428217|37917017|FG001|Overall Study|Study terminated by sponsor|118|||
16887945|NCT03428217|37917016|FG000|Overall Study|Other, Not Specified|1|||
16887946|NCT03428217|37917017|FG001|Overall Study|Other, Not Specified|0|||
16887947|NCT03189719|37917027|FG000|Overall Study|Death|260|||
16887948|NCT03189719|37917028|FG001|Overall Study|Death|308|||
16887949|NCT03189719|37917027|FG000|Overall Study|Withdrawal by Subject|5|||
16887950|NCT03189719|37917028|FG001|Overall Study|Withdrawal by Subject|3|||
16887951|NCT03189719|37917027|FG000|Overall Study|Ongoing in Study|108|||
16887952|NCT03189719|37917028|FG001|Overall Study|Ongoing in Study|65|||
16887953|NCT02969525|37917039|FG000|Double-Blind Period|Adverse Event|0|||
16887954|NCT02969525|37917040|FG001|Double-Blind Period|Adverse Event|0|||
16887955|NCT02969525|37917041|FG002|Double-Blind Period|Adverse Event|1|||
16887956|NCT02969525|37917042|FG003|Double-Blind Period|Adverse Event|1|||
16887957|NCT02969525|37917043|FG004|Double-Blind Period|Adverse Event|0|||
16887958|NCT02969525|37917044|FG005|Double-Blind Period|Adverse Event|0|||
16887959|NCT02969525|37917045|FG006|Double-Blind Period|Adverse Event|0|||
16887960|NCT02969525|37917046|FG007|Double-Blind Period|Adverse Event|0|||
16887961|NCT02969525|37917047|FG008|Double-Blind Period|Adverse Event|0|||
16887962|NCT02969525|37917048|FG009|Double-Blind Period|Adverse Event|0|||
16887963|NCT02969525|37917049|FG010|Double-Blind Period|Adverse Event|0|||
16887964|NCT02969525|37917050|FG011|Double-Blind Period|Adverse Event|0|||
16887965|NCT02969525|37917039|FG000|Double-Blind Period|LOW EGFR|0|||
16887966|NCT02969525|37917040|FG001|Double-Blind Period|LOW EGFR|0|||
16887967|NCT02969525|37917041|FG002|Double-Blind Period|LOW EGFR|0|||
16887968|NCT02969525|37917042|FG003|Double-Blind Period|LOW EGFR|1|||
16887969|NCT02969525|37917043|FG004|Double-Blind Period|LOW EGFR|0|||
16887970|NCT02969525|37917044|FG005|Double-Blind Period|LOW EGFR|0|||
16887971|NCT02969525|37917045|FG006|Double-Blind Period|LOW EGFR|0|||
16887972|NCT02969525|37917046|FG007|Double-Blind Period|LOW EGFR|0|||
16887973|NCT02969525|37917047|FG008|Double-Blind Period|LOW EGFR|0|||
16887974|NCT02969525|37917048|FG009|Double-Blind Period|LOW EGFR|0|||
17002455|NCT00642811|38146587|FG004|Overall Study|Developement of discontinuation criteria|1|||
17002456|NCT00642811|38146588|FG005|Overall Study|Developement of discontinuation criteria|0|||
17002457|NCT00642811|38146583|FG000|Overall Study|Severe Non-compliance to protocol|1|||
17002458|NCT00642811|38146584|FG001|Overall Study|Severe Non-compliance to protocol|0|||
17002459|NCT00642811|38146585|FG002|Overall Study|Severe Non-compliance to protocol|0|||
17002460|NCT00642811|38146586|FG003|Overall Study|Severe Non-compliance to protocol|0|||
17002461|NCT00642811|38146587|FG004|Overall Study|Severe Non-compliance to protocol|0|||
17192058|NCT02660138|38345145|FG000|Overall Study|Withdrawal by Subject|7|||
16887975|NCT02969525|37917049|FG010|Double-Blind Period|LOW EGFR|0|||
16887976|NCT02969525|37917050|FG011|Double-Blind Period|LOW EGFR|0|||
16887977|NCT02969525|37917039|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
16887978|NCT02969525|37917040|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887979|NCT02969525|37917041|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
17192059|NCT02660138|38345146|FG001|Overall Study|Withdrawal by Subject|6|||
17192060|NCT02660138|38345147|FG002|Overall Study|Withdrawal by Subject|6|||
17192061|NCT02660138|38345145|FG000|Overall Study|Lost to Follow-up|4|||
17192062|NCT02660138|38345146|FG001|Overall Study|Lost to Follow-up|4|||
17192063|NCT02660138|38345147|FG002|Overall Study|Lost to Follow-up|1|||
16887980|NCT02969525|37917042|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
16887981|NCT02969525|37917043|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887982|NCT02969525|37917044|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887983|NCT02969525|37917045|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887984|NCT02969525|37917046|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887985|NCT02969525|37917047|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887986|NCT02969525|37917048|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887987|NCT02969525|37917049|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887988|NCT02969525|37917050|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16887989|NCT02969525|37917039|FG000|Dose-Blind Period|Adverse Event|0|||
16887990|NCT02969525|37917040|FG001|Dose-Blind Period|Adverse Event|0|||
16887991|NCT02969525|37917041|FG002|Dose-Blind Period|Adverse Event|0|||
16887992|NCT02969525|37917042|FG003|Dose-Blind Period|Adverse Event|0|||
16887993|NCT02969525|37917043|FG004|Dose-Blind Period|Adverse Event|0|||
16887994|NCT02969525|37917044|FG005|Dose-Blind Period|Adverse Event|0|||
16887995|NCT02969525|37917045|FG006|Dose-Blind Period|Adverse Event|0|||
16887996|NCT02969525|37917046|FG007|Dose-Blind Period|Adverse Event|0|||
16887997|NCT02969525|37917047|FG008|Dose-Blind Period|Adverse Event|0|||
16887998|NCT02969525|37917048|FG009|Dose-Blind Period|Adverse Event|1|||
16887999|NCT02969525|37917049|FG010|Dose-Blind Period|Adverse Event|1|||
16888000|NCT02969525|37917050|FG011|Dose-Blind Period|Adverse Event|1|||
16888001|NCT02969525|37917039|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
16888002|NCT02969525|37917040|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
16888003|NCT02969525|37917041|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
16888004|NCT02969525|37917042|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
16888005|NCT02969525|37917043|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
16888006|NCT02969525|37917044|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
16888007|NCT02969525|37917045|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
16888008|NCT02969525|37917046|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
16888009|NCT02969525|37917047|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
16888010|NCT02969525|37917048|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
16888011|NCT02969525|37917049|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
16888012|NCT02969525|37917050|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
16888013|NCT02969525|37917039|FG000|Dose-Blind Period|Non-cooperating patient|0|||
16888014|NCT02969525|37917040|FG001|Dose-Blind Period|Non-cooperating patient|0|||
16888015|NCT02969525|37917041|FG002|Dose-Blind Period|Non-cooperating patient|0|||
16888016|NCT02969525|37917042|FG003|Dose-Blind Period|Non-cooperating patient|0|||
16888017|NCT02969525|37917043|FG004|Dose-Blind Period|Non-cooperating patient|0|||
16888018|NCT02969525|37917044|FG005|Dose-Blind Period|Non-cooperating patient|0|||
16888019|NCT02969525|37917045|FG006|Dose-Blind Period|Non-cooperating patient|0|||
16888020|NCT02969525|37917046|FG007|Dose-Blind Period|Non-cooperating patient|0|||
16888021|NCT02969525|37917047|FG008|Dose-Blind Period|Non-cooperating patient|0|||
16888022|NCT02969525|37917048|FG009|Dose-Blind Period|Non-cooperating patient|0|||
16888023|NCT02969525|37917049|FG010|Dose-Blind Period|Non-cooperating patient|0|||
16888024|NCT02969525|37917050|FG011|Dose-Blind Period|Non-cooperating patient|1|||
16888025|NCT02969525|37917039|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888026|NCT02969525|37917040|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888027|NCT02969525|37917041|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888028|NCT02969525|37917042|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888029|NCT02969525|37917043|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888030|NCT02969525|37917044|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888031|NCT02969525|37917045|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888032|NCT02969525|37917046|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888033|NCT02969525|37917047|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888034|NCT02969525|37917048|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888035|NCT02969525|37917049|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
16888036|NCT02969525|37917050|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16888037|NCT02667587|37917090|FG000|Pre-Treatment|Not reported|1|||
16888038|NCT02667587|37917091|FG001|Pre-Treatment|Not reported|0|||
16888039|NCT02667587|37917090|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
16888040|NCT02667587|37917091|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
16888041|NCT02667587|37917090|FG000|Pre-Treatment|Participant withdrew consent|0|||
16888042|NCT02667587|37917091|FG001|Pre-Treatment|Participant withdrew consent|1|||
16888043|NCT02667587|37917090|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
16888044|NCT02667587|37917091|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
16888045|NCT02667587|37917090|FG000|End of Treatment|Other reasons|11|||
16888046|NCT02667587|37917091|FG001|End of Treatment|Other reasons|8|||
16888047|NCT02667587|37917090|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
16888048|NCT02667587|37917091|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
16888049|NCT02667587|37917090|FG000|End of Treatment|Poor/Non-Compliance|0|||
16888050|NCT02667587|37917091|FG001|End of Treatment|Poor/Non-Compliance|1|||
16888051|NCT02667587|37917090|FG000|End of Treatment|Maximum Clinical Benefit|3|||
16888052|NCT02667587|37917091|FG001|End of Treatment|Maximum Clinical Benefit|3|||
16888053|NCT02667587|37917090|FG000|End of Treatment|Participant Withdrew Consent|5|||
16888054|NCT02667587|37917091|FG001|End of Treatment|Participant Withdrew Consent|6|||
16888055|NCT02667587|37917090|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
16888056|NCT02667587|37917091|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
17002462|NCT00642811|38146588|FG005|Overall Study|Severe Non-compliance to protocol|0|||
17002463|NCT00642811|38146583|FG000|Overall Study|Other|0|||
17002464|NCT00642811|38146584|FG001|Overall Study|Other|1|||
17002465|NCT00642811|38146585|FG002|Overall Study|Other|0|||
17002466|NCT00642811|38146586|FG003|Overall Study|Other|1|||
17002467|NCT00642811|38146587|FG004|Overall Study|Other|0|||
17002468|NCT00642811|38146588|FG005|Overall Study|Other|0|||
17002469|NCT00838929|38146605|FG000|Overall Study|Protocol Violation|0|||
17002470|NCT00838929|38146606|FG001|Overall Study|Protocol Violation|1|||
17002471|NCT00838929|38146607|FG002|Overall Study|Protocol Violation|0|||
17002472|NCT00838929|38146605|FG000|Overall Study|Disease progression|0|||
17002473|NCT00838929|38146606|FG001|Overall Study|Disease progression|2|||
17002474|NCT00838929|38146607|FG002|Overall Study|Disease progression|1|||
17002475|NCT00916058|38146620|FG000|Phase 1|Screen Failure|0|||
17002476|NCT00916058|38146621|FG001|Phase 1|Screen Failure|0|||
17002477|NCT00916058|38146622|FG002|Phase 1|Screen Failure|0|||
16888057|NCT02667587|37917090|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
16888058|NCT02667587|37917091|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
16888059|NCT02667587|37917090|FG000|End of Treatment|Death|2|||
16888060|NCT02667587|37917091|FG001|End of Treatment|Death|1|||
16888061|NCT02667587|37917090|FG000|End of Treatment|Study Drug Toxicity|74|||
16888062|NCT02667587|37917091|FG001|End of Treatment|Study Drug Toxicity|18|||
16888063|NCT02667587|37917090|FG000|End of Treatment|Disease progression|177|||
16888064|NCT02667587|37917091|FG001|End of Treatment|Disease progression|222|||
16888065|NCT02667587|37917090|FG000|End of Treatment|Lost to Follow-up|1|||
16888066|NCT02667587|37917091|FG001|End of Treatment|Lost to Follow-up|3|||
16888067|NCT02399813|37917097|FG000|Overall Study|Progressive Disease-Radiographic|2|||
16888068|NCT02399813|37917097|FG000|Overall Study|Death|20|||
16888069|NCT02399813|37917097|FG000|Overall Study|Withdrawal by Subject|3|||
16888070|NCT02399813|37917097|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
17002478|NCT00916058|38146623|FG003|Phase 1|Screen Failure|0|||
17002479|NCT00916058|38146624|FG004|Phase 1|Screen Failure|0|||
17002480|NCT00916058|38146625|FG005|Phase 1|Screen Failure|1|||
17002481|NCT00916058|38146626|FG006|Phase 1|Screen Failure|0|||
17002482|NCT00916058|38146620|FG000|Phase 2|Screen Failure|0|||
17002483|NCT00916058|38146621|FG001|Phase 2|Screen Failure|0|||
17002484|NCT00916058|38146622|FG002|Phase 2|Screen Failure|0|||
17192064|NCT02660138|38345145|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
16888071|NCT02399813|37917097|FG000|Overall Study|Lost to Follow-up|2|||
16888072|NCT02399813|37917097|FG000|Overall Study|Other than specified|5|||
16888073|NCT02291055|37917106|FG000|Overall Study|Death|2|||
16888074|NCT02291055|37917107|FG001|Overall Study|Death|2|||
16888075|NCT02291055|37917108|FG002|Overall Study|Death|5|||
16888076|NCT02291055|37917109|FG003|Overall Study|Death|8|||
16888077|NCT02291055|37917110|FG004|Overall Study|Death|12|||
16888078|NCT02291055|37917106|FG000|Overall Study|Lost to Follow-up|0|||
16888079|NCT02291055|37917107|FG001|Overall Study|Lost to Follow-up|0|||
16888080|NCT02291055|37917108|FG002|Overall Study|Lost to Follow-up|0|||
16888081|NCT02291055|37917109|FG003|Overall Study|Lost to Follow-up|1|||
16888082|NCT02291055|37917110|FG004|Overall Study|Lost to Follow-up|2|||
16888083|NCT02291055|37917106|FG000|Overall Study|Withdrawal by Subject|3|||
16888084|NCT02291055|37917107|FG001|Overall Study|Withdrawal by Subject|1|||
16888085|NCT02291055|37917108|FG002|Overall Study|Withdrawal by Subject|1|||
16888086|NCT02291055|37917109|FG003|Overall Study|Withdrawal by Subject|5|||
16888087|NCT02291055|37917110|FG004|Overall Study|Withdrawal by Subject|10|||
16888088|NCT02291055|37917106|FG000|Overall Study|Progressive Disease|0|||
16888089|NCT02291055|37917107|FG001|Overall Study|Progressive Disease|0|||
16888090|NCT02291055|37917108|FG002|Overall Study|Progressive Disease|1|||
16888091|NCT02291055|37917109|FG003|Overall Study|Progressive Disease|4|||
16888092|NCT02291055|37917110|FG004|Overall Study|Progressive Disease|2|||
16888093|NCT02291055|37917106|FG000|Overall Study|Study Terminated by Sponsor|0|||
16888094|NCT02291055|37917107|FG001|Overall Study|Study Terminated by Sponsor|0|||
16888095|NCT02291055|37917108|FG002|Overall Study|Study Terminated by Sponsor|0|||
16888096|NCT02291055|37917109|FG003|Overall Study|Study Terminated by Sponsor|5|||
16888097|NCT02291055|37917110|FG004|Overall Study|Study Terminated by Sponsor|1|||
16888098|NCT02291055|37917106|FG000|Overall Study|Other|0|||
16888099|NCT02291055|37917107|FG001|Overall Study|Other|2|||
16888100|NCT02291055|37917108|FG002|Overall Study|Other|1|||
16888101|NCT02291055|37917109|FG003|Overall Study|Other|4|||
16888102|NCT02291055|37917110|FG004|Overall Study|Other|0|||
17002485|NCT00916058|38146623|FG003|Phase 2|Screen Failure|0|||
16888103|NCT01970865|37917143|FG000|Overall Study|Death|3|||
16888104|NCT01970865|37917144|FG001|Overall Study|Death|1|||
17002486|NCT00916058|38146624|FG004|Phase 2|Screen Failure|0|||
16888105|NCT01970865|37917145|FG002|Overall Study|Death|3|||
16888106|NCT01970865|37917146|FG003|Overall Study|Death|4|||
16888107|NCT01970865|37917147|FG004|Overall Study|Death|6|||
16888108|NCT01970865|37917148|FG005|Overall Study|Death|3|||
16888109|NCT01970865|37917149|FG006|Overall Study|Death|1|||
16888110|NCT01970865|37917150|FG007|Overall Study|Death|3|||
16888111|NCT01970865|37917151|FG008|Overall Study|Death|2|||
16888112|NCT01970865|37917152|FG009|Overall Study|Death|1|||
16888113|NCT01970865|37917153|FG010|Overall Study|Death|1|||
16888114|NCT01970865|37917154|FG011|Overall Study|Death|4|||
16888115|NCT01970865|37917155|FG012|Overall Study|Death|14|||
16888116|NCT01970865|37917156|FG013|Overall Study|Death|19|||
16888117|NCT01970865|37917157|FG014|Overall Study|Death|15|||
16888118|NCT01970865|37917158|FG015|Overall Study|Death|10|||
16888119|NCT01970865|37917159|FG016|Overall Study|Death|1|||
16888120|NCT01970865|37917143|FG000|Overall Study|Lost to Follow-up|0|||
16888121|NCT01970865|37917144|FG001|Overall Study|Lost to Follow-up|0|||
16888122|NCT01970865|37917145|FG002|Overall Study|Lost to Follow-up|0|||
16888123|NCT01970865|37917146|FG003|Overall Study|Lost to Follow-up|1|||
16888124|NCT01970865|37917147|FG004|Overall Study|Lost to Follow-up|1|||
16888125|NCT01970865|37917148|FG005|Overall Study|Lost to Follow-up|0|||
16888126|NCT01970865|37917149|FG006|Overall Study|Lost to Follow-up|0|||
16888127|NCT01970865|37917150|FG007|Overall Study|Lost to Follow-up|0|||
16888128|NCT01970865|37917151|FG008|Overall Study|Lost to Follow-up|0|||
16888129|NCT01970865|37917152|FG009|Overall Study|Lost to Follow-up|0|||
16888130|NCT01970865|37917153|FG010|Overall Study|Lost to Follow-up|0|||
16888131|NCT01970865|37917154|FG011|Overall Study|Lost to Follow-up|0|||
16888132|NCT01970865|37917155|FG012|Overall Study|Lost to Follow-up|1|||
16888133|NCT01970865|37917156|FG013|Overall Study|Lost to Follow-up|0|||
16888134|NCT01970865|37917157|FG014|Overall Study|Lost to Follow-up|0|||
16888135|NCT01970865|37917158|FG015|Overall Study|Lost to Follow-up|0|||
16888136|NCT01970865|37917159|FG016|Overall Study|Lost to Follow-up|0|||
16888137|NCT01970865|37917143|FG000|Overall Study|Withdrawal by Subject|0|||
16888138|NCT01970865|37917144|FG001|Overall Study|Withdrawal by Subject|0|||
16888139|NCT01970865|37917145|FG002|Overall Study|Withdrawal by Subject|0|||
16888140|NCT01970865|37917146|FG003|Overall Study|Withdrawal by Subject|1|||
16888141|NCT01970865|37917147|FG004|Overall Study|Withdrawal by Subject|2|||
16888142|NCT01970865|37917148|FG005|Overall Study|Withdrawal by Subject|0|||
16888143|NCT01970865|37917149|FG006|Overall Study|Withdrawal by Subject|0|||
16888144|NCT01970865|37917150|FG007|Overall Study|Withdrawal by Subject|0|||
16888145|NCT01970865|37917151|FG008|Overall Study|Withdrawal by Subject|0|||
16888146|NCT01970865|37917152|FG009|Overall Study|Withdrawal by Subject|0|||
16888147|NCT01970865|37917153|FG010|Overall Study|Withdrawal by Subject|0|||
16888148|NCT01970865|37917154|FG011|Overall Study|Withdrawal by Subject|1|||
16888149|NCT01970865|37917155|FG012|Overall Study|Withdrawal by Subject|2|||
16888150|NCT01970865|37917156|FG013|Overall Study|Withdrawal by Subject|5|||
16888151|NCT01970865|37917157|FG014|Overall Study|Withdrawal by Subject|2|||
16888152|NCT01970865|37917158|FG015|Overall Study|Withdrawal by Subject|7|||
16888153|NCT01970865|37917159|FG016|Overall Study|Withdrawal by Subject|0|||
16888154|NCT01970865|37917143|FG000|Overall Study|Other|0|||
16888155|NCT01970865|37917144|FG001|Overall Study|Other|0|||
16888156|NCT01970865|37917145|FG002|Overall Study|Other|0|||
16888157|NCT01970865|37917146|FG003|Overall Study|Other|1|||
16888158|NCT01970865|37917147|FG004|Overall Study|Other|0|||
16888159|NCT01970865|37917148|FG005|Overall Study|Other|0|||
16888160|NCT01970865|37917149|FG006|Overall Study|Other|0|||
16888161|NCT01970865|37917150|FG007|Overall Study|Other|0|||
16888162|NCT01970865|37917151|FG008|Overall Study|Other|0|||
16888163|NCT01970865|37917152|FG009|Overall Study|Other|0|||
16888164|NCT01970865|37917153|FG010|Overall Study|Other|0|||
16888165|NCT01970865|37917154|FG011|Overall Study|Other|0|||
16888166|NCT01970865|37917155|FG012|Overall Study|Other|0|||
16888167|NCT01970865|37917156|FG013|Overall Study|Other|1|||
16888168|NCT01970865|37917157|FG014|Overall Study|Other|0|||
16888169|NCT01970865|37917158|FG015|Overall Study|Other|1|||
16888170|NCT01970865|37917159|FG016|Overall Study|Other|0|||
16888171|NCT01970865|37917143|FG000|Overall Study|Study ongoing|0|||
16888172|NCT01970865|37917144|FG001|Overall Study|Study ongoing|2|||
16888173|NCT01970865|37917145|FG002|Overall Study|Study ongoing|0|||
16888174|NCT01970865|37917146|FG003|Overall Study|Study ongoing|6|||
16888175|NCT01970865|37917147|FG004|Overall Study|Study ongoing|8|||
16888176|NCT01970865|37917148|FG005|Overall Study|Study ongoing|0|||
16888177|NCT01970865|37917149|FG006|Overall Study|Study ongoing|2|||
16888178|NCT01970865|37917150|FG007|Overall Study|Study ongoing|0|||
16888179|NCT01970865|37917151|FG008|Overall Study|Study ongoing|1|||
16888180|NCT01970865|37917152|FG009|Overall Study|Study ongoing|3|||
16888181|NCT01970865|37917153|FG010|Overall Study|Study ongoing|29|||
16888182|NCT01970865|37917154|FG011|Overall Study|Study ongoing|22|||
16888183|NCT01970865|37917155|FG012|Overall Study|Study ongoing|43|||
16888184|NCT01970865|37917156|FG013|Overall Study|Study ongoing|41|||
16888185|NCT01970865|37917157|FG014|Overall Study|Study ongoing|29|||
16888186|NCT01970865|37917158|FG015|Overall Study|Study ongoing|29|||
16888187|NCT01970865|37917159|FG016|Overall Study|Study ongoing|2|||
16888188|NCT00723697|37917220|FG000|Overall Study|Physician questionnaires not received|2|||
16888189|NCT00723697|37917220|FG000|Overall Study|Missing Informed Consent Form|10|||
16888190|NCT00723697|37917220|FG000|Overall Study|Other exclusion criteria applied|6|||
16888191|NCT00684073|37917227|FG000|Selection|Selection/non-selection criteria|3|||
16888192|NCT00684073|37917227|FG000|Selection|Death|1|||
16888193|NCT00684073|37917227|FG000|Selection|noncompliance|1|||
16888194|NCT00684073|37917227|FG000|Selection|Lost to Follow-up|1|||
16888195|NCT00684073|37917227|FG000|Selection|request of the sponsor|1|||
16888196|NCT00684073|37917227|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
16888197|NCT02539368|37919207|FG000|Overall Study|Death|4|||
16888198|NCT02539368|37919208|FG001|Overall Study|Death|2|||
16888199|NCT02539368|37919209|FG002|Overall Study|Death|1|||
16888200|NCT02539368|37919210|FG003|Overall Study|Death|0|||
16888201|NCT02539368|37919211|FG004|Overall Study|Death|0|||
16888202|NCT02539368|37919207|FG000|Overall Study|Withdrawal by Subject|44|||
16888203|NCT02539368|37919208|FG001|Overall Study|Withdrawal by Subject|35|||
16888204|NCT02539368|37919209|FG002|Overall Study|Withdrawal by Subject|9|||
16888205|NCT02539368|37919210|FG003|Overall Study|Withdrawal by Subject|1|||
16888206|NCT02539368|37919211|FG004|Overall Study|Withdrawal by Subject|3|||
16888207|NCT02539368|37919207|FG000|Overall Study|Physician Decision|49|||
16888208|NCT02539368|37919208|FG001|Overall Study|Physician Decision|15|||
16888209|NCT02539368|37919209|FG002|Overall Study|Physician Decision|7|||
16888210|NCT02539368|37919210|FG003|Overall Study|Physician Decision|0|||
16888211|NCT02539368|37919211|FG004|Overall Study|Physician Decision|2|||
16888212|NCT02539368|37919207|FG000|Overall Study|Lost to Follow-up|96|||
16888213|NCT02539368|37919208|FG001|Overall Study|Lost to Follow-up|21|||
16888214|NCT02539368|37919209|FG002|Overall Study|Lost to Follow-up|16|||
16888215|NCT02539368|37919210|FG003|Overall Study|Lost to Follow-up|4|||
16888216|NCT02539368|37919211|FG004|Overall Study|Lost to Follow-up|3|||
16888217|NCT02539368|37919207|FG000|Overall Study|Adverse Event|44|||
16888218|NCT02539368|37919208|FG001|Overall Study|Adverse Event|5|||
16888219|NCT02539368|37919209|FG002|Overall Study|Adverse Event|9|||
16888220|NCT02539368|37919210|FG003|Overall Study|Adverse Event|0|||
16888221|NCT02539368|37919211|FG004|Overall Study|Adverse Event|3|||
16888222|NCT02539368|37919207|FG000|Overall Study|Participant Non-compliant|13|||
16888223|NCT02539368|37919208|FG001|Overall Study|Participant Non-compliant|2|||
16888224|NCT02539368|37919209|FG002|Overall Study|Participant Non-compliant|1|||
16888225|NCT02539368|37919210|FG003|Overall Study|Participant Non-compliant|1|||
16888226|NCT02539368|37919211|FG004|Overall Study|Participant Non-compliant|0|||
16888227|NCT02539368|37919207|FG000|Overall Study|Other|145|||
16888228|NCT02539368|37919208|FG001|Overall Study|Other|18|||
16888229|NCT02539368|37919209|FG002|Overall Study|Other|24|||
16888230|NCT02539368|37919210|FG003|Overall Study|Other|1|||
16888231|NCT02539368|37919211|FG004|Overall Study|Other|3|||
16888232|NCT02539368|37919207|FG000|Overall Study|Missing|10|||
16888233|NCT02539368|37919208|FG001|Overall Study|Missing|3|||
16888234|NCT02539368|37919209|FG002|Overall Study|Missing|0|||
16888235|NCT02539368|37919210|FG003|Overall Study|Missing|0|||
16888236|NCT02539368|37919211|FG004|Overall Study|Missing|0|||
16888237|NCT02539134|37919364|FG000|Overall Study|Lost to Follow-up|1|||
16888238|NCT02539134|37919365|FG001|Overall Study|Lost to Follow-up|0|||
16888239|NCT02539134|37919366|FG002|Overall Study|Lost to Follow-up|0|||
16888240|NCT02539134|37919367|FG003|Overall Study|Lost to Follow-up|0|||
16888241|NCT02539134|37919368|FG004|Overall Study|Lost to Follow-up|0|||
16888242|NCT02539134|37919369|FG005|Overall Study|Lost to Follow-up|0|||
16888243|NCT02538900|37919473|FG000|Overall Study|Death|2|||
16888244|NCT02538900|37919474|FG001|Overall Study|Death|2|||
16888245|NCT02538900|37919475|FG002|Overall Study|Death|2|||
16888246|NCT02538900|37919473|FG000|Overall Study|Withdrawal by Subject|18|||
16888247|NCT02538900|37919474|FG001|Overall Study|Withdrawal by Subject|16|||
16888248|NCT02538900|37919475|FG002|Overall Study|Withdrawal by Subject|15|||
16888249|NCT02941926|37919785|FG000|Overall Study|Progressive disease|1109|||
16888250|NCT02941926|37919785|FG000|Overall Study|Adverse Event|504|||
16888251|NCT02941926|37919785|FG000|Overall Study|Subject/guardian decision|127|||
16888252|NCT02941926|37919785|FG000|Overall Study|Physician Decision|112|||
16888253|NCT02941926|37919785|FG000|Overall Study|Death|46|||
16888254|NCT02941926|37919785|FG000|Overall Study|Protocol deviation|34|||
16888255|NCT02941926|37919785|FG000|Overall Study|Lost to Follow-up|8|||
16888256|NCT02941926|37919785|FG000|Overall Study|Technical problems|5|||
16888257|NCT01986348|37919970|FG000|Overall Study|Death|8|||
16888258|NCT01986348|37919971|FG001|Overall Study|Death|22|||
16888259|NCT01986348|37919972|FG002|Overall Study|Death|10|||
16888260|NCT01986348|37919973|FG003|Overall Study|Death|21|||
16888261|NCT01986348|37919970|FG000|Overall Study|Lost to Follow-up|0|||
16888262|NCT01986348|37919971|FG001|Overall Study|Lost to Follow-up|0|||
16888263|NCT01986348|37919972|FG002|Overall Study|Lost to Follow-up|0|||
16888264|NCT01986348|37919973|FG003|Overall Study|Lost to Follow-up|2|||
16888265|NCT01986348|37919970|FG000|Overall Study|Physician Decision|0|||
16888266|NCT01986348|37919971|FG001|Overall Study|Physician Decision|0|||
16888267|NCT01986348|37919972|FG002|Overall Study|Physician Decision|0|||
16888268|NCT01986348|37919973|FG003|Overall Study|Physician Decision|1|||
16888269|NCT01986348|37919970|FG000|Overall Study|Progressive Disease|0|||
16888270|NCT01986348|37919971|FG001|Overall Study|Progressive Disease|0|||
16888271|NCT01986348|37919972|FG002|Overall Study|Progressive Disease|2|||
16888272|NCT01986348|37919973|FG003|Overall Study|Progressive Disease|0|||
16888273|NCT01986348|37919970|FG000|Overall Study|Withdrawal by Participant|0|||
16888274|NCT01986348|37919971|FG001|Overall Study|Withdrawal by Participant|1|||
16888275|NCT01986348|37919972|FG002|Overall Study|Withdrawal by Participant|2|||
16888276|NCT01986348|37919973|FG003|Overall Study|Withdrawal by Participant|1|||
16888277|NCT01986348|37919970|FG000|Overall Study|Study Terminated by Sponsor|0|||
16888278|NCT01986348|37919971|FG001|Overall Study|Study Terminated by Sponsor|0|||
16888279|NCT01986348|37919972|FG002|Overall Study|Study Terminated by Sponsor|0|||
16888280|NCT01986348|37919973|FG003|Overall Study|Study Terminated by Sponsor|3|||
16888281|NCT01986348|37919970|FG000|Overall Study|Other-unspecified|0|||
16888282|NCT01986348|37919971|FG001|Overall Study|Other-unspecified|1|||
16888283|NCT01986348|37919972|FG002|Overall Study|Other-unspecified|0|||
16888284|NCT01986348|37919973|FG003|Overall Study|Other-unspecified|2|||
16888285|NCT02543892|37920551|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
16888286|NCT02543892|37920552|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
16888287|NCT02543892|37920553|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
16888288|NCT02543892|37920554|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
16888289|NCT02543892|37920555|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
16888290|NCT02543892|37920556|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
16888291|NCT02543892|37920557|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
16888292|NCT02543892|37920558|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
16888293|NCT02543892|37920551|FG000|Received Vaccination 2|Physician Decision|0|||
16888294|NCT02543892|37920552|FG001|Received Vaccination 2|Physician Decision|0|||
16888295|NCT02543892|37920553|FG002|Received Vaccination 2|Physician Decision|0|||
16888296|NCT02543892|37920554|FG003|Received Vaccination 2|Physician Decision|0|||
16888297|NCT02543892|37920555|FG004|Received Vaccination 2|Physician Decision|0|||
16888298|NCT02543892|37920556|FG005|Received Vaccination 2|Physician Decision|1|||
16888299|NCT02543892|37920557|FG006|Received Vaccination 2|Physician Decision|0|||
16888300|NCT02543892|37920558|FG007|Received Vaccination 2|Physician Decision|0|||
16888301|NCT02543892|37920551|FG000|Received Vaccination 2|Adverse Event|0|||
16888302|NCT02543892|37920552|FG001|Received Vaccination 2|Adverse Event|1|||
16888303|NCT02543892|37920553|FG002|Received Vaccination 2|Adverse Event|0|||
16888304|NCT02543892|37920554|FG003|Received Vaccination 2|Adverse Event|0|||
16888305|NCT02543892|37920555|FG004|Received Vaccination 2|Adverse Event|0|||
16888306|NCT02543892|37920556|FG005|Received Vaccination 2|Adverse Event|0|||
16888307|NCT02543892|37920557|FG006|Received Vaccination 2|Adverse Event|0|||
16888308|NCT02543892|37920558|FG007|Received Vaccination 2|Adverse Event|0|||
16888309|NCT02543892|37920551|FG000|Had Immunology Data|Withdrawal by Subject|0|||
16888310|NCT02543892|37920552|FG001|Had Immunology Data|Withdrawal by Subject|0|||
16888311|NCT02543892|37920553|FG002|Had Immunology Data|Withdrawal by Subject|0|||
16888312|NCT02543892|37920554|FG003|Had Immunology Data|Withdrawal by Subject|0|||
16888313|NCT02543892|37920555|FG004|Had Immunology Data|Withdrawal by Subject|0|||
16888314|NCT02543892|37920556|FG005|Had Immunology Data|Withdrawal by Subject|0|||
16888315|NCT02543892|37920557|FG006|Had Immunology Data|Withdrawal by Subject|1|||
16888316|NCT02543892|37920558|FG007|Had Immunology Data|Withdrawal by Subject|0|||
16888317|NCT02543658|37920639|FG000|Overall Study|Lack of Efficacy|0|||
16888318|NCT02543658|37920640|FG001|Overall Study|Lack of Efficacy|4|||
16888319|NCT01607892|37921399|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
16888320|NCT01607892|37921400|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
16888321|NCT01607892|37921401|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
16888322|NCT01607892|37921402|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
16888323|NCT01607892|37921403|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
16888324|NCT01607892|37921399|FG000|Overall Study|Death|4|||
16888325|NCT01607892|37921400|FG001|Overall Study|Death|2|||
16888326|NCT01607892|37921401|FG002|Overall Study|Death|8|||
16888327|NCT01607892|37921402|FG003|Overall Study|Death|10|||
16888328|NCT01607892|37921403|FG004|Overall Study|Death|3|||
17002487|NCT00916058|38146625|FG005|Phase 2|Screen Failure|0|||
17002488|NCT00916058|38146626|FG006|Phase 2|Screen Failure|3|||
17002489|NCT00912782|38146646|FG000|Overall Study|Death|2|||
17002490|NCT00912782|38146647|FG001|Overall Study|Death|1|||
17002491|NCT00912782|38146646|FG000|Overall Study|Lost to Follow-up|0|||
16888329|NCT01607892|37921399|FG000|Overall Study|Investigator discretion|2|||
16888330|NCT01607892|37921400|FG001|Overall Study|Investigator discretion|4|||
16888331|NCT01607892|37921401|FG002|Overall Study|Investigator discretion|4|||
16888332|NCT01607892|37921402|FG003|Overall Study|Investigator discretion|8|||
16888333|NCT01607892|37921403|FG004|Overall Study|Investigator discretion|0|||
16888334|NCT01607892|37921399|FG000|Overall Study|Other treatments became available|1|||
16888335|NCT01607892|37921400|FG001|Overall Study|Other treatments became available|1|||
16888336|NCT01607892|37921401|FG002|Overall Study|Other treatments became available|0|||
16888337|NCT01607892|37921402|FG003|Overall Study|Other treatments became available|0|||
17002492|NCT00912782|38146647|FG001|Overall Study|Lost to Follow-up|1|||
16888338|NCT01607892|37921403|FG004|Overall Study|Other treatments became available|2|||
16888339|NCT01607892|37921399|FG000|Overall Study|Intercurrent illness|1|||
16888340|NCT01607892|37921400|FG001|Overall Study|Intercurrent illness|0|||
16888341|NCT01607892|37921401|FG002|Overall Study|Intercurrent illness|0|||
16888342|NCT01607892|37921402|FG003|Overall Study|Intercurrent illness|3|||
16888343|NCT01607892|37921403|FG004|Overall Study|Intercurrent illness|0|||
16888344|NCT01607892|37921399|FG000|Overall Study|Non-Compliance with study procedures|0|||
16888345|NCT01607892|37921400|FG001|Overall Study|Non-Compliance with study procedures|0|||
16888346|NCT01607892|37921401|FG002|Overall Study|Non-Compliance with study procedures|1|||
16888347|NCT01607892|37921402|FG003|Overall Study|Non-Compliance with study procedures|0|||
16888348|NCT01607892|37921403|FG004|Overall Study|Non-Compliance with study procedures|0|||
16888349|NCT01607892|37921399|FG000|Overall Study|Consent withdrawn by participant|9|||
16888350|NCT01607892|37921400|FG001|Overall Study|Consent withdrawn by participant|4|||
16888351|NCT01607892|37921401|FG002|Overall Study|Consent withdrawn by participant|24|||
16888352|NCT01607892|37921402|FG003|Overall Study|Consent withdrawn by participant|14|||
16888353|NCT01607892|37921403|FG004|Overall Study|Consent withdrawn by participant|4|||
16888354|NCT01607892|37921399|FG000|Overall Study|Disease progression|38|||
16888355|NCT01607892|37921400|FG001|Overall Study|Disease progression|13|||
16888356|NCT01607892|37921401|FG002|Overall Study|Disease progression|37|||
16888357|NCT01607892|37921402|FG003|Overall Study|Disease progression|57|||
16888358|NCT01607892|37921403|FG004|Overall Study|Disease progression|9|||
16888359|NCT01607892|37921399|FG000|Overall Study|Incidence or severity of Adverse events|3|||
16888360|NCT01607892|37921400|FG001|Overall Study|Incidence or severity of Adverse events|3|||
16888361|NCT01607892|37921401|FG002|Overall Study|Incidence or severity of Adverse events|7|||
16888362|NCT01607892|37921402|FG003|Overall Study|Incidence or severity of Adverse events|2|||
16888363|NCT01607892|37921403|FG004|Overall Study|Incidence or severity of Adverse events|6|||
16888364|NCT02530242|37921449|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
16888365|NCT02530242|37921450|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
16888366|NCT02537574|37921474|FG000|Overall Study|Adverse Event|1|||
16888367|NCT02537574|37921475|FG001|Overall Study|Adverse Event|3|||
16888368|NCT02537574|37921476|FG002|Overall Study|Adverse Event|2|||
16888369|NCT02537574|37921474|FG000|Overall Study|Lost to Follow-up|40|||
16888370|NCT02537574|37921475|FG001|Overall Study|Lost to Follow-up|51|||
16888371|NCT02537574|37921476|FG002|Overall Study|Lost to Follow-up|55|||
17002493|NCT00912782|38146646|FG000|Overall Study|Did not receive vascular access type|1|||
17002494|NCT00912782|38146647|FG001|Overall Study|Did not receive vascular access type|2|||
17002495|NCT00912782|38146646|FG000|Overall Study|Relocated before study completion|0|||
17002496|NCT00912782|38146647|FG001|Overall Study|Relocated before study completion|1|||
17002497|NCT03444038|38146653|FG000|Overall Study|Adverse Event|12|||
17002498|NCT03444038|38146653|FG000|Overall Study|Withdrawal by Subject|7|||
17002499|NCT03444038|38146653|FG000|Overall Study|Lost to Follow-up|1|||
17002500|NCT03444038|38146653|FG000|Overall Study|Physician Decision|2|||
17002501|NCT03444038|38146653|FG000|Overall Study|Lack of Efficacy|7|||
17002502|NCT00911534|38146659|FG000|Overall Study|Adverse Event|4|||
17002503|NCT00911534|38146660|FG001|Overall Study|Adverse Event|4|||
17002504|NCT00911534|38146659|FG000|Overall Study|Lost to Follow-up|2|||
17002505|NCT00911534|38146660|FG001|Overall Study|Lost to Follow-up|4|||
17002506|NCT00911534|38146659|FG000|Overall Study|Withdrawal by Subject|2|||
16888372|NCT02537574|37921474|FG000|Overall Study|Noncompliance with study drug|0|||
16888373|NCT02537574|37921475|FG001|Overall Study|Noncompliance with study drug|1|||
16888374|NCT02537574|37921476|FG002|Overall Study|Noncompliance with study drug|1|||
16888375|NCT02537574|37921474|FG000|Overall Study|Physician Decision|2|||
16888376|NCT02537574|37921475|FG001|Overall Study|Physician Decision|0|||
16888377|NCT02537574|37921476|FG002|Overall Study|Physician Decision|0|||
16888378|NCT02537574|37921474|FG000|Overall Study|Protocol Violation|4|||
16888379|NCT02537574|37921475|FG001|Overall Study|Protocol Violation|2|||
16888380|NCT02537574|37921476|FG002|Overall Study|Protocol Violation|3|||
16888381|NCT02537574|37921474|FG000|Overall Study|Withdrawal by Subject|37|||
16888382|NCT02537574|37921475|FG001|Overall Study|Withdrawal by Subject|27|||
16888383|NCT02537574|37921476|FG002|Overall Study|Withdrawal by Subject|29|||
16888384|NCT02537574|37921474|FG000|Overall Study|Lack of Efficacy|14|||
16888385|NCT02537574|37921475|FG001|Overall Study|Lack of Efficacy|16|||
17002507|NCT00911534|38146660|FG001|Overall Study|Withdrawal by Subject|1|||
16888386|NCT02537574|37921476|FG002|Overall Study|Lack of Efficacy|15|||
16888387|NCT02537574|37921474|FG000|Overall Study|Duplicate Patient|1|||
16888388|NCT02537574|37921475|FG001|Overall Study|Duplicate Patient|0|||
16888389|NCT02537574|37921476|FG002|Overall Study|Duplicate Patient|0|||
16888390|NCT02537574|37921474|FG000|Overall Study|Patient not Stable|0|||
16888391|NCT02537574|37921475|FG001|Overall Study|Patient not Stable|1|||
16888392|NCT02537574|37921476|FG002|Overall Study|Patient not Stable|0|||
16888393|NCT02537574|37921474|FG000|Overall Study|Incarceration|0|||
16888394|NCT02537574|37921475|FG001|Overall Study|Incarceration|1|||
16888395|NCT02537574|37921476|FG002|Overall Study|Incarceration|0|||
16888396|NCT02537574|37921474|FG000|Overall Study|Failed Naloxone Challenge|0|||
17002508|NCT00911534|38146659|FG000|Overall Study|Lack of Efficacy|4|||
16888397|NCT02537574|37921475|FG001|Overall Study|Failed Naloxone Challenge|1|||
16888398|NCT02537574|37921476|FG002|Overall Study|Failed Naloxone Challenge|0|||
16888399|NCT02537574|37921474|FG000|Overall Study|Transportation Issues|0|||
16888400|NCT02537574|37921475|FG001|Overall Study|Transportation Issues|0|||
16888401|NCT02537574|37921476|FG002|Overall Study|Transportation Issues|1|||
16888402|NCT02537574|37921474|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
16888403|NCT02537574|37921475|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
16888404|NCT02537574|37921476|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
16888405|NCT02537574|37921474|FG000|Overall Study|Noncompliance with Protocol|0|||
16888406|NCT02537574|37921475|FG001|Overall Study|Noncompliance with Protocol|0|||
16888407|NCT02537574|37921476|FG002|Overall Study|Noncompliance with Protocol|1|||
16888408|NCT02531802|37922141|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
16888409|NCT02531802|37922142|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
16888410|NCT02531802|37922143|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
16888411|NCT02531802|37922144|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
16888412|NCT02531802|37922145|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
16888413|NCT02531802|37922146|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
16888414|NCT02531802|37922147|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
16888415|NCT02531802|37922148|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
16888416|NCT02531802|37922149|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
16888417|NCT02531802|37922150|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
16888418|NCT02531802|37922151|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
16888419|NCT02531802|37922152|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
16888420|NCT02531802|37922153|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
16888421|NCT02531802|37922154|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
16888422|NCT02531802|37922155|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
16888423|NCT02531802|37922156|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
16888424|NCT02531802|37922157|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
16888425|NCT02531802|37922158|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
17002509|NCT00911534|38146660|FG001|Overall Study|Lack of Efficacy|1|||
17002510|NCT00911534|38146659|FG000|Overall Study|Withdrawal of consent|1|||
16888426|NCT02531802|37922159|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
16888427|NCT02531802|37922160|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
16888428|NCT02531802|37922161|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
16888429|NCT02531802|37922141|FG000|Received Vaccination 2|Physician Decision|0|||
16888430|NCT02531802|37922142|FG001|Received Vaccination 2|Physician Decision|0|||
16888431|NCT02531802|37922143|FG002|Received Vaccination 2|Physician Decision|0|||
16888432|NCT02531802|37922144|FG003|Received Vaccination 2|Physician Decision|0|||
16888433|NCT02531802|37922145|FG004|Received Vaccination 2|Physician Decision|0|||
16888434|NCT02531802|37922146|FG005|Received Vaccination 2|Physician Decision|1|||
16888435|NCT02531802|37922147|FG006|Received Vaccination 2|Physician Decision|0|||
16888436|NCT02531802|37922148|FG007|Received Vaccination 2|Physician Decision|0|||
16888437|NCT02531802|37922149|FG008|Received Vaccination 2|Physician Decision|0|||
16888438|NCT02531802|37922150|FG009|Received Vaccination 2|Physician Decision|2|||
16888439|NCT02531802|37922151|FG010|Received Vaccination 2|Physician Decision|0|||
16888440|NCT02531802|37922152|FG011|Received Vaccination 2|Physician Decision|0|||
16888441|NCT02531802|37922153|FG012|Received Vaccination 2|Physician Decision|0|||
16888442|NCT02531802|37922154|FG013|Received Vaccination 2|Physician Decision|1|||
16888443|NCT02531802|37922155|FG014|Received Vaccination 2|Physician Decision|0|||
16888444|NCT02531802|37922156|FG015|Received Vaccination 2|Physician Decision|0|||
16888445|NCT02531802|37922157|FG016|Received Vaccination 2|Physician Decision|0|||
16888446|NCT02531802|37922158|FG017|Received Vaccination 2|Physician Decision|1|||
16888447|NCT02531802|37922159|FG018|Received Vaccination 2|Physician Decision|0|||
16888448|NCT02531802|37922160|FG019|Received Vaccination 2|Physician Decision|0|||
16888449|NCT02531802|37922161|FG020|Received Vaccination 2|Physician Decision|0|||
16888450|NCT02531802|37922141|FG000|Received Vaccination 2|Adverse Event|0|||
16888451|NCT02531802|37922142|FG001|Received Vaccination 2|Adverse Event|0|||
16888452|NCT02531802|37922143|FG002|Received Vaccination 2|Adverse Event|0|||
16888453|NCT02531802|37922144|FG003|Received Vaccination 2|Adverse Event|0|||
16888454|NCT02531802|37922145|FG004|Received Vaccination 2|Adverse Event|0|||
16888455|NCT02531802|37922146|FG005|Received Vaccination 2|Adverse Event|2|||
16888456|NCT02531802|37922147|FG006|Received Vaccination 2|Adverse Event|0|||
16888457|NCT02531802|37922148|FG007|Received Vaccination 2|Adverse Event|0|||
16888458|NCT02531802|37922149|FG008|Received Vaccination 2|Adverse Event|0|||
16888459|NCT02531802|37922150|FG009|Received Vaccination 2|Adverse Event|0|||
16888460|NCT02531802|37922151|FG010|Received Vaccination 2|Adverse Event|0|||
16888461|NCT02531802|37922152|FG011|Received Vaccination 2|Adverse Event|0|||
16888462|NCT02531802|37922153|FG012|Received Vaccination 2|Adverse Event|0|||
16888463|NCT02531802|37922154|FG013|Received Vaccination 2|Adverse Event|0|||
16888464|NCT02531802|37922155|FG014|Received Vaccination 2|Adverse Event|0|||
16888465|NCT02531802|37922156|FG015|Received Vaccination 2|Adverse Event|0|||
16888466|NCT02531802|37922157|FG016|Received Vaccination 2|Adverse Event|0|||
16888467|NCT02531802|37922158|FG017|Received Vaccination 2|Adverse Event|2|||
16888468|NCT02531802|37922159|FG018|Received Vaccination 2|Adverse Event|1|||
16888469|NCT02531802|37922160|FG019|Received Vaccination 2|Adverse Event|0|||
16888470|NCT02531802|37922161|FG020|Received Vaccination 2|Adverse Event|1|||
16888471|NCT02531802|37922141|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
16888472|NCT02531802|37922142|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
16888473|NCT02531802|37922143|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
16888474|NCT02531802|37922144|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
16888475|NCT02531802|37922145|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
16888476|NCT02531802|37922146|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
16888477|NCT02531802|37922147|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
16888478|NCT02531802|37922148|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
16888479|NCT02531802|37922149|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
16888480|NCT02531802|37922150|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
16888481|NCT02531802|37922151|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
16888482|NCT02531802|37922152|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
16888483|NCT02531802|37922153|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
16888484|NCT02531802|37922154|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
16888485|NCT02531802|37922155|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
16888486|NCT02531802|37922156|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
16888487|NCT02531802|37922157|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
16888488|NCT02531802|37922158|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
16888489|NCT02531802|37922159|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
16888490|NCT02531802|37922160|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
16888491|NCT02531802|37922161|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
16888492|NCT01602666|37922264|FG000|Induction Chemotherapy|Death|2|||
16888493|NCT01602666|37922265|FG001|Induction Chemotherapy|Death|1|||
16888494|NCT01602666|37922264|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
16888495|NCT01602666|37922265|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
16888496|NCT01602666|37922264|FG000|Induction Chemotherapy|Physician Decision|12|||
16888497|NCT01602666|37922265|FG001|Induction Chemotherapy|Physician Decision|5|||
16888498|NCT01602666|37922264|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
16888499|NCT01602666|37922265|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
16888500|NCT01602666|37922264|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
16888501|NCT01602666|37922265|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
16888502|NCT01602666|37922264|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
16888503|NCT01602666|37922265|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
16888504|NCT01602666|37922264|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
16888505|NCT01602666|37922265|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
16888506|NCT01602666|37922264|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
16888507|NCT01602666|37922265|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
16888508|NCT01602666|37922264|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
16888509|NCT01602666|37922265|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
16888510|NCT01602666|37922264|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
16888511|NCT01602666|37922265|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
16888512|NCT01602666|37922264|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
16888513|NCT01602666|37922265|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
16888514|NCT02531646|37922276|FG000|Overall Study|equip. image processing issue|5|||
16888515|NCT02531646|37922277|FG001|Overall Study|equip. image processing issue|1|||
16888516|NCT02531646|37922278|FG002|Overall Study|equip. image processing issue|0|||
16888517|NCT02536404|37922343|FG000|Overall Study|Adverse Event|5|||
16888518|NCT02536404|37922344|FG001|Overall Study|Adverse Event|0|||
16888519|NCT02536404|37922343|FG000|Overall Study|Withdrawal by Subject|4|||
16888520|NCT02536404|37922344|FG001|Overall Study|Withdrawal by Subject|1|||
16888521|NCT02536404|37922343|FG000|Overall Study|Physician Decision|10|||
16888522|NCT02536404|37922344|FG001|Overall Study|Physician Decision|0|||
16888523|NCT02536404|37922343|FG000|Overall Study|Sponsor decision|1|||
16888524|NCT02536404|37922344|FG001|Overall Study|Sponsor decision|0|||
16888525|NCT02352948|37922894|FG000|Overall Study|Death|47|||
16888526|NCT02352948|37922895|FG001|Overall Study|Death|48|||
16888527|NCT02352948|37922896|FG002|Overall Study|Death|114|||
16888528|NCT02352948|37922897|FG003|Overall Study|Death|74|||
16888529|NCT02352948|37922898|FG004|Overall Study|Death|77|||
16888530|NCT02352948|37922899|FG005|Overall Study|Death|44|||
16888531|NCT02352948|37922894|FG000|Overall Study|Lost to Follow-up|1|||
16888532|NCT02352948|37922895|FG001|Overall Study|Lost to Follow-up|0|||
16888533|NCT02352948|37922896|FG002|Overall Study|Lost to Follow-up|2|||
16888534|NCT02352948|37922897|FG003|Overall Study|Lost to Follow-up|1|||
16888535|NCT02352948|37922898|FG004|Overall Study|Lost to Follow-up|2|||
16888536|NCT02352948|37922899|FG005|Overall Study|Lost to Follow-up|1|||
16888537|NCT02352948|37922894|FG000|Overall Study|Withdrawal by Subject|1|||
16888538|NCT02352948|37922895|FG001|Overall Study|Withdrawal by Subject|10|||
16888539|NCT02352948|37922896|FG002|Overall Study|Withdrawal by Subject|11|||
16888540|NCT02352948|37922897|FG003|Overall Study|Withdrawal by Subject|23|||
16888541|NCT02352948|37922898|FG004|Overall Study|Withdrawal by Subject|9|||
16888542|NCT02352948|37922899|FG005|Overall Study|Withdrawal by Subject|4|||
16888543|NCT02352948|37922894|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16888544|NCT02352948|37922895|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16888545|NCT02352948|37922896|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
16888546|NCT02352948|37922897|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
16888547|NCT02352948|37922898|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
16888548|NCT02352948|37922899|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
16888549|NCT02352948|37922894|FG000|Overall Study|Other|0|||
16888550|NCT02352948|37922895|FG001|Overall Study|Other|0|||
16888551|NCT02352948|37922896|FG002|Overall Study|Other|2|||
16888552|NCT02352948|37922897|FG003|Overall Study|Other|0|||
16888553|NCT02352948|37922898|FG004|Overall Study|Other|0|||
16888554|NCT02352948|37922899|FG005|Overall Study|Other|0|||
16888555|NCT02527200|37923306|FG000|Overall Study|Withdrawal by Subject|3|||
16888556|NCT02527200|37923307|FG001|Overall Study|Withdrawal by Subject|2|||
16888557|NCT02527200|37923308|FG002|Overall Study|Withdrawal by Subject|1|||
16888558|NCT02527200|37923309|FG003|Overall Study|Withdrawal by Subject|0|||
16888559|NCT02527200|37923306|FG000|Overall Study|Unclassified|0|||
16888560|NCT02527200|37923307|FG001|Overall Study|Unclassified|1|||
16888561|NCT02527200|37923308|FG002|Overall Study|Unclassified|0|||
16888562|NCT02527200|37923309|FG003|Overall Study|Unclassified|0|||
16888563|NCT02527200|37923306|FG000|Overall Study|Lost to Follow-up|0|||
16888564|NCT02527200|37923307|FG001|Overall Study|Lost to Follow-up|0|||
16888565|NCT02527200|37923308|FG002|Overall Study|Lost to Follow-up|1|||
16888566|NCT02527200|37923309|FG003|Overall Study|Lost to Follow-up|0|||
16888567|NCT01659996|37923356|FG000|Overall Study|Protocol Violation|3|||
16888568|NCT01659996|37923357|FG001|Overall Study|Protocol Violation|3|||
16888569|NCT01659996|37923358|FG002|Overall Study|Protocol Violation|3|||
16888570|NCT01659996|37923356|FG000|Overall Study|Lost to Follow-up|1|||
16888571|NCT01659996|37923357|FG001|Overall Study|Lost to Follow-up|3|||
16888572|NCT01659996|37923358|FG002|Overall Study|Lost to Follow-up|2|||
16888573|NCT01659996|37923356|FG000|Overall Study|Adverse Event|0|||
16888574|NCT01659996|37923357|FG001|Overall Study|Adverse Event|0|||
16888575|NCT01659996|37923358|FG002|Overall Study|Adverse Event|1|||
16888576|NCT01659996|37923356|FG000|Overall Study|Withdrawal by Subject|4|||
16888577|NCT01659996|37923357|FG001|Overall Study|Withdrawal by Subject|1|||
16888578|NCT01659996|37923358|FG002|Overall Study|Withdrawal by Subject|5|||
16888579|NCT00980460|37923609|FG000|Overall Study|Death|0|||
16888580|NCT00980460|37923610|FG001|Overall Study|Death|0|||
16888581|NCT00980460|37923611|FG002|Overall Study|Death|1|||
16888582|NCT00980460|37923612|FG003|Overall Study|Death|2|||
16888583|NCT00980460|37923613|FG004|Overall Study|Death|1|||
17002511|NCT00911534|38146660|FG001|Overall Study|Withdrawal of consent|4|||
17002512|NCT00911534|38146659|FG000|Overall Study|Other|2|||
17002513|NCT00911534|38146660|FG001|Overall Study|Other|2|||
17002514|NCT00911300|38146668|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
17002515|NCT00911300|38146669|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
17002516|NCT00911300|38146668|FG000|Overall Study|Death|1|||
17002517|NCT00911300|38146669|FG001|Overall Study|Death|0|||
17002518|NCT00911300|38146668|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
17002519|NCT00911300|38146669|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
17002520|NCT00911300|38146668|FG000|Overall Study|Adverse Event|14|||
17002521|NCT00911300|38146669|FG001|Overall Study|Adverse Event|6|||
17002522|NCT00911300|38146668|FG000|Overall Study|Protocol Violation|3|||
17002523|NCT00911300|38146669|FG001|Overall Study|Protocol Violation|2|||
17002524|NCT00911300|38146668|FG000|Overall Study|Consent Withdrawn|4|||
17002525|NCT00911300|38146669|FG001|Overall Study|Consent Withdrawn|12|||
17002526|NCT00911300|38146668|FG000|Overall Study|Coronary Angiography Performed|1|||
17002527|NCT00911300|38146669|FG001|Overall Study|Coronary Angiography Performed|0|||
17002528|NCT00911300|38146668|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
17002529|NCT00911300|38146669|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
16888584|NCT00980460|37923609|FG000|Overall Study|Lack of Efficacy|0|||
16888585|NCT00980460|37923610|FG001|Overall Study|Lack of Efficacy|0|||
16888586|NCT00980460|37923611|FG002|Overall Study|Lack of Efficacy|10|||
16888587|NCT00980460|37923612|FG003|Overall Study|Lack of Efficacy|6|||
16888588|NCT00980460|37923613|FG004|Overall Study|Lack of Efficacy|8|||
16888589|NCT00980460|37923609|FG000|Overall Study|Lost to Follow-up|0|||
16888590|NCT00980460|37923610|FG001|Overall Study|Lost to Follow-up|0|||
16888591|NCT00980460|37923611|FG002|Overall Study|Lost to Follow-up|0|||
16888592|NCT00980460|37923612|FG003|Overall Study|Lost to Follow-up|1|||
16888593|NCT00980460|37923613|FG004|Overall Study|Lost to Follow-up|0|||
16888594|NCT00980460|37923609|FG000|Overall Study|Physician Decision|0|||
17002530|NCT00911300|38146668|FG000|Overall Study|Received Commercial Treatment|1|||
17002531|NCT00911300|38146669|FG001|Overall Study|Received Commercial Treatment|0|||
16888595|NCT00980460|37923610|FG001|Overall Study|Physician Decision|0|||
16888596|NCT00980460|37923611|FG002|Overall Study|Physician Decision|11|||
16888597|NCT00980460|37923612|FG003|Overall Study|Physician Decision|5|||
16888598|NCT00980460|37923613|FG004|Overall Study|Physician Decision|3|||
16888599|NCT00980460|37923609|FG000|Overall Study|Withdrawal by Subject|0|||
16888600|NCT00980460|37923610|FG001|Overall Study|Withdrawal by Subject|0|||
16888601|NCT00980460|37923611|FG002|Overall Study|Withdrawal by Subject|1|||
16888602|NCT00980460|37923612|FG003|Overall Study|Withdrawal by Subject|0|||
16888603|NCT00980460|37923613|FG004|Overall Study|Withdrawal by Subject|0|||
16888604|NCT00980460|37923609|FG000|Overall Study|Ineligible|0|||
16888605|NCT00980460|37923610|FG001|Overall Study|Ineligible|2|||
16888606|NCT00980460|37923611|FG002|Overall Study|Ineligible|3|||
16888607|NCT00980460|37923612|FG003|Overall Study|Ineligible|1|||
16888608|NCT00980460|37923613|FG004|Overall Study|Ineligible|4|||
16888609|NCT00980460|37923609|FG000|Overall Study|Refusal of further therapy|0|||
16888610|NCT00980460|37923610|FG001|Overall Study|Refusal of further therapy|2|||
16888611|NCT00980460|37923611|FG002|Overall Study|Refusal of further therapy|3|||
16888612|NCT00980460|37923612|FG003|Overall Study|Refusal of further therapy|2|||
16888613|NCT00980460|37923613|FG004|Overall Study|Refusal of further therapy|0|||
16888614|NCT00980460|37923609|FG000|Overall Study|No therapy within 42 days of resection|0|||
16888615|NCT00980460|37923610|FG001|Overall Study|No therapy within 42 days of resection|0|||
16888616|NCT00980460|37923611|FG002|Overall Study|No therapy within 42 days of resection|3|||
16888617|NCT00980460|37923612|FG003|Overall Study|No therapy within 42 days of resection|1|||
16888618|NCT00980460|37923613|FG004|Overall Study|No therapy within 42 days of resection|0|||
16888619|NCT00980460|37923609|FG000|Overall Study|No transplant by protocol timepoints|0|||
16888620|NCT00980460|37923610|FG001|Overall Study|No transplant by protocol timepoints|0|||
16888621|NCT00980460|37923611|FG002|Overall Study|No transplant by protocol timepoints|3|||
16888622|NCT00980460|37923612|FG003|Overall Study|No transplant by protocol timepoints|0|||
16888623|NCT00980460|37923613|FG004|Overall Study|No transplant by protocol timepoints|0|||
16888624|NCT00389610|37923699|FG000|Overall Study|Disease Progression|0|||
16888625|NCT00389610|37923700|FG001|Overall Study|Disease Progression|19|||
16888626|NCT00389610|37923699|FG000|Overall Study|Death|0|||
16888627|NCT00389610|37923700|FG001|Overall Study|Death|1|||
16888628|NCT00389610|37923699|FG000|Overall Study|Physician Decision|0|||
16888629|NCT00389610|37923700|FG001|Overall Study|Physician Decision|1|||
16888630|NCT00389610|37923699|FG000|Overall Study|Withdrawal by Subject|0|||
16888631|NCT00389610|37923700|FG001|Overall Study|Withdrawal by Subject|1|||
16888632|NCT02525874|37923775|FG000|Overall Study|Other|1|||
16888633|NCT02525874|37923775|FG000|Overall Study|Investigator Decision|1|||
16888634|NCT02525874|37923775|FG000|Overall Study|Consent withdrawn|22|||
16888635|NCT02525874|37923775|FG000|Overall Study|Non-compliance with study drug|3|||
16888636|NCT02525874|37923775|FG000|Overall Study|Adverse Event|17|||
16888637|NCT02525874|37923775|FG000|Overall Study|Lost to Follow-up|7|||
16888638|NCT02525874|37923775|FG000|Overall Study|Disease progression, defined by protocol|2|||
16888639|NCT02525874|37923775|FG000|Overall Study|Disease relapse|4|||
16888640|NCT02525874|37923775|FG000|Overall Study|Alternative Treatment for MS|2|||
16888641|NCT02525874|37923775|FG000|Overall Study|New lesions in Brain|1|||
16888642|NCT02528214|37923785|FG000|Overall Study|Protocol Violation|0|||
16888643|NCT02528214|37923786|FG001|Overall Study|Protocol Violation|1|||
16888644|NCT02528214|37923785|FG000|Overall Study|Adverse Event|0|||
16888645|NCT02528214|37923786|FG001|Overall Study|Adverse Event|1|||
16888646|NCT02528214|37923785|FG000|Overall Study|Other than specified above|0|||
16888647|NCT02528214|37923786|FG001|Overall Study|Other than specified above|1|||
16888648|NCT02524158|37923843|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
16888649|NCT02524158|37923844|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
16888650|NCT02524158|37923843|FG000|12-weeks Assessment|Lost to Follow-up|18|||
16888651|NCT02524158|37923844|FG001|12-weeks Assessment|Lost to Follow-up|12|||
16888652|NCT02524158|37923843|FG000|6-month Assessment|Withdrawal by Subject|1|||
16888653|NCT02524158|37923844|FG001|6-month Assessment|Withdrawal by Subject|1|||
16888654|NCT02524158|37923843|FG000|6-month Assessment|Lost to Follow-up|21|||
16888655|NCT02524158|37923844|FG001|6-month Assessment|Lost to Follow-up|20|||
16888656|NCT02525094|37923864|FG000|Overall Study|Lost to Follow-up|2|||
16888657|NCT02525094|37923865|FG001|Overall Study|Lost to Follow-up|1|||
16888658|NCT02525094|37923864|FG000|Overall Study|Withdrawal by Subject|5|||
16888659|NCT02525094|37923865|FG001|Overall Study|Withdrawal by Subject|6|||
16888660|NCT02525094|37923864|FG000|Overall Study|Not Treated|1|||
16888661|NCT02525094|37923865|FG001|Overall Study|Not Treated|1|||
16888662|NCT01657266|37924022|FG000|Overall Study|Lost to Follow-up|2|||
16888663|NCT01657266|37924023|FG001|Overall Study|Lost to Follow-up|2|||
16888664|NCT01657266|37924022|FG000|Overall Study|Adverse Event|2|||
16888665|NCT01657266|37924023|FG001|Overall Study|Adverse Event|3|||
16888666|NCT01657032|37924108|FG000|Overall Study|Lost to Follow-up|0|||
16888667|NCT01657032|37924109|FG001|Overall Study|Lost to Follow-up|7|||
16888668|NCT01657500|37924237|FG000|Overall Study|set impropperly matched|3|||
16888669|NCT01657500|37924238|FG001|Overall Study|set impropperly matched|3|||
16888670|NCT01657500|37924237|FG000|Overall Study|Lost to Follow-up|2|||
16888671|NCT01657500|37924238|FG001|Overall Study|Lost to Follow-up|2|||
16888672|NCT01658904|37924251|FG000|Overall Study|Principal Investigator discretion|2|||
16888673|NCT01658904|37924252|FG001|Overall Study|Principal Investigator discretion|0|||
16888674|NCT01658904|37924253|FG002|Overall Study|Principal Investigator discretion|0|||
16888675|NCT01658514|37924437|FG000|Overall Study|Protocol Violation|1|||
16888676|NCT01658514|37924438|FG001|Overall Study|Protocol Violation|0|||
16888677|NCT01658514|37924439|FG002|Overall Study|Protocol Violation|2|||
16888678|NCT01658436|37924460|FG000|Overall Study|Adverse Event|6|||
16888679|NCT01658436|37924461|FG001|Overall Study|Adverse Event|5|||
16888680|NCT01658436|37924460|FG000|Overall Study|Physician Decision|1|||
16888681|NCT01658436|37924461|FG001|Overall Study|Physician Decision|0|||
16888682|NCT01658436|37924460|FG000|Overall Study|Progressive disease|12|||
16888683|NCT01658436|37924461|FG001|Overall Study|Progressive disease|4|||
16888684|NCT01658436|37924460|FG000|Overall Study|Study terminated by sponsor|0|||
16888685|NCT01658436|37924461|FG001|Overall Study|Study terminated by sponsor|1|||
16888686|NCT01658436|37924460|FG000|Overall Study|Subject/guardian decision|0|||
16888687|NCT01658436|37924461|FG001|Overall Study|Subject/guardian decision|1|||
16888688|NCT01658436|37924460|FG000|Overall Study|Death|1|||
16888689|NCT01658436|37924461|FG001|Overall Study|Death|0|||
16888690|NCT01656408|37925029|FG000|Overall Study|Adverse Event|0|||
16888691|NCT01656408|37925030|FG001|Overall Study|Adverse Event|0|||
16888692|NCT01656408|37925031|FG002|Overall Study|Adverse Event|1|||
16888693|NCT01656408|37925032|FG003|Overall Study|Adverse Event|0|||
16888694|NCT01656408|37925033|FG004|Overall Study|Adverse Event|0|||
16888695|NCT01656408|37925034|FG005|Overall Study|Adverse Event|1|||
16888696|NCT01656408|37925035|FG006|Overall Study|Adverse Event|1|||
16888697|NCT01656408|37925036|FG007|Overall Study|Adverse Event|0|||
16888698|NCT01656408|37925037|FG008|Overall Study|Adverse Event|1|||
16888699|NCT01656408|37925038|FG009|Overall Study|Adverse Event|0|||
16888700|NCT01656408|37925029|FG000|Overall Study|Physician Decision|1|||
16888701|NCT01656408|37925030|FG001|Overall Study|Physician Decision|0|||
16888702|NCT01656408|37925031|FG002|Overall Study|Physician Decision|1|||
17002532|NCT00911300|38146668|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
17002533|NCT00911300|38146669|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
17002534|NCT00911300|38146668|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
17002535|NCT00911300|38146669|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
17002536|NCT00911300|38146668|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
17002537|NCT00911300|38146669|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
17002538|NCT00911300|38146668|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
17002539|NCT00911300|38146669|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
17002540|NCT00911300|38146668|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
17002541|NCT00911300|38146669|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
17002542|NCT00911300|38146668|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
17002543|NCT00911300|38146669|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
17002544|NCT00911300|38146668|FG000|Overall Study|International Normalized Ratio Too High|0|||
17002545|NCT00911300|38146669|FG001|Overall Study|International Normalized Ratio Too High|1|||
17002546|NCT00911300|38146668|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
17002547|NCT00911300|38146669|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
17002548|NCT00911300|38146668|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
17002549|NCT00911300|38146669|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
17002550|NCT00911300|38146668|FG000|Overall Study|Physician Decision|0|||
17002551|NCT00911300|38146669|FG001|Overall Study|Physician Decision|1|||
17002552|NCT00911300|38146668|FG000|Overall Study|Treatment Stopped by Mistake|0|||
17002553|NCT00911300|38146669|FG001|Overall Study|Treatment Stopped by Mistake|1|||
17002554|NCT00911300|38146668|FG000|Overall Study|Randomized; No Study Medication Received|0|||
17002555|NCT00911300|38146669|FG001|Overall Study|Randomized; No Study Medication Received|2|||
17002556|NCT00911144|38146678|FG000|Overall Study|Withdrawal by Subject|16|||
17002557|NCT00911144|38146679|FG001|Overall Study|Withdrawal by Subject|5|||
17002558|NCT00910988|38146689|FG000|Overall Study|Lost to Follow-up|2|||
17002559|NCT00910988|38146690|FG001|Overall Study|Lost to Follow-up|4|||
17002560|NCT00910988|38146691|FG002|Overall Study|Lost to Follow-up|3|||
17002561|NCT00910988|38146692|FG003|Overall Study|Lost to Follow-up|0|||
17002562|NCT00644059|38146721|FG000|Overall Study|Lost to Follow-up|37|||
17002563|NCT00644059|38146722|FG001|Overall Study|Lost to Follow-up|34|||
17002564|NCT00644059|38146723|FG002|Overall Study|Lost to Follow-up|16|||
17002565|NCT00644059|38146721|FG000|Overall Study|Withdrawal by Subject|52|||
17002566|NCT00644059|38146722|FG001|Overall Study|Withdrawal by Subject|60|||
17002567|NCT00644059|38146723|FG002|Overall Study|Withdrawal by Subject|30|||
16888703|NCT01656408|37925032|FG003|Overall Study|Physician Decision|0|||
16888704|NCT01656408|37925033|FG004|Overall Study|Physician Decision|1|||
16888705|NCT01656408|37925034|FG005|Overall Study|Physician Decision|1|||
16888706|NCT01656408|37925035|FG006|Overall Study|Physician Decision|0|||
16888707|NCT01656408|37925036|FG007|Overall Study|Physician Decision|1|||
16888708|NCT01656408|37925037|FG008|Overall Study|Physician Decision|1|||
16888709|NCT01656408|37925038|FG009|Overall Study|Physician Decision|3|||
16888710|NCT01364298|37925547|FG000|Overall Study|Adverse Event|3|||
16888711|NCT01364298|37925548|FG001|Overall Study|Adverse Event|4|||
16888712|NCT01364298|37925547|FG000|Overall Study|Lack of adherence to treatment|1|||
16888713|NCT01364298|37925548|FG001|Overall Study|Lack of adherence to treatment|3|||
16888714|NCT01364298|37925547|FG000|Overall Study|Lack of Efficacy|1|||
16888715|NCT01364298|37925548|FG001|Overall Study|Lack of Efficacy|0|||
16888716|NCT01364298|37925547|FG000|Overall Study|Lost to Follow-up|5|||
16888717|NCT01364298|37925548|FG001|Overall Study|Lost to Follow-up|10|||
16888718|NCT01364298|37925547|FG000|Overall Study|Withdrawal by Subject|3|||
16888719|NCT01364298|37925548|FG001|Overall Study|Withdrawal by Subject|3|||
16888720|NCT01364298|37925547|FG000|Overall Study|Other|1|||
16888721|NCT01364298|37925548|FG001|Overall Study|Other|3|||
16888722|NCT01364922|37925607|FG000|Open-label (OL) Period|Adverse Event|7|||
16888723|NCT01364922|37925608|FG001|Open-label (OL) Period|Adverse Event|0|||
16888724|NCT01364922|37925609|FG002|Open-label (OL) Period|Adverse Event|0|||
16888725|NCT01364922|37925607|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
16888726|NCT01364922|37925608|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
16888727|NCT01364922|37925609|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
16888728|NCT01364922|37925607|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
16888729|NCT01364922|37925608|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
16888730|NCT01364922|37925609|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
16888731|NCT01364922|37925607|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
16888732|NCT01364922|37925608|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
16888733|NCT01364922|37925609|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
16888734|NCT01364922|37925607|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
16888735|NCT01364922|37925608|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
16888736|NCT01364922|37925609|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
16888737|NCT01364922|37925607|FG000|Open-label (OL) Period|Other, Unspecified|1|||
16888738|NCT01364922|37925608|FG001|Open-label (OL) Period|Other, Unspecified|0|||
16888739|NCT01364922|37925609|FG002|Open-label (OL) Period|Other, Unspecified|0|||
16888740|NCT01364922|37925607|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
16888741|NCT01364922|37925608|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
16888742|NCT01364922|37925609|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
16888743|NCT01364922|37925607|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
16888744|NCT01364922|37925608|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
16888745|NCT01364922|37925609|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
16888746|NCT01364922|37925607|FG000|Double-Blind (DB) Period|Adverse Event|0|||
16888747|NCT01364922|37925608|FG001|Double-Blind (DB) Period|Adverse Event|0|||
16888748|NCT01364922|37925609|FG002|Double-Blind (DB) Period|Adverse Event|1|||
16888749|NCT01364922|37925607|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
16888750|NCT01364922|37925608|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
16888751|NCT01364922|37925609|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
16888752|NCT02522286|37925783|FG000|Overall Study|Withdrawal by Subject|3|||
16888753|NCT02522286|37925784|FG001|Overall Study|Withdrawal by Subject|0|||
16888754|NCT02522286|37925785|FG002|Overall Study|Withdrawal by Subject|0|||
16888755|NCT02522286|37925786|FG003|Overall Study|Withdrawal by Subject|3|||
16888756|NCT02520726|37925807|FG000|Overall Study|Lost to Follow-up|3|||
16888757|NCT02520726|37925808|FG001|Overall Study|Lost to Follow-up|2|||
16888758|NCT02519712|37925831|FG000|Overall Study|Disease Relapse|1|||
16888759|NCT02519712|37925831|FG000|Overall Study|Disease Progression|1|||
16888760|NCT02519712|37925831|FG000|Overall Study|Accruals are donors|2|||
16888761|NCT02516202|37926095|FG000|Overall Study|Withdrawal by Subject|1|||
16888762|NCT02516202|37926096|FG001|Overall Study|Withdrawal by Subject|0|||
16888763|NCT02516202|37926097|FG002|Overall Study|Withdrawal by Subject|1|||
16888764|NCT02516202|37926095|FG000|Overall Study|Lost to Follow-up|1|||
16888765|NCT02516202|37926096|FG001|Overall Study|Lost to Follow-up|1|||
16888766|NCT02516202|37926097|FG002|Overall Study|Lost to Follow-up|1|||
16888767|NCT02516202|37926095|FG000|Overall Study|Stopped Follow-up|0|||
16888768|NCT02516202|37926096|FG001|Overall Study|Stopped Follow-up|0|||
16888769|NCT02516202|37926097|FG002|Overall Study|Stopped Follow-up|1|||
16888770|NCT02518620|37926303|FG000|Overall Study|Adverse Event|23|||
16888771|NCT02518620|37926304|FG001|Overall Study|Adverse Event|11|||
16888772|NCT02518620|37926303|FG000|Overall Study|Lack of Efficacy|2|||
16888773|NCT02518620|37926304|FG001|Overall Study|Lack of Efficacy|0|||
16888774|NCT02518620|37926303|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16888775|NCT02518620|37926304|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16888776|NCT02518620|37926303|FG000|Overall Study|Physician Decision|1|||
16888777|NCT02518620|37926304|FG001|Overall Study|Physician Decision|1|||
16888778|NCT02518620|37926303|FG000|Overall Study|Sponsor's Decision|0|||
17002568|NCT00644059|38146721|FG000|Overall Study|Adverse Event|8|||
17002569|NCT00644059|38146722|FG001|Overall Study|Adverse Event|5|||
17002570|NCT00644059|38146723|FG002|Overall Study|Adverse Event|1|||
17002571|NCT00644059|38146721|FG000|Overall Study|Inappropriate Enrollment|1|||
17002572|NCT00644059|38146722|FG001|Overall Study|Inappropriate Enrollment|3|||
17002573|NCT00644059|38146723|FG002|Overall Study|Inappropriate Enrollment|0|||
17002574|NCT00644059|38146721|FG000|Overall Study|Protocol Deviation/violation|20|||
17002575|NCT00644059|38146722|FG001|Overall Study|Protocol Deviation/violation|19|||
17002576|NCT00644059|38146723|FG002|Overall Study|Protocol Deviation/violation|15|||
17002577|NCT00644059|38146721|FG000|Overall Study|Unable to classify|6|||
17002578|NCT00644059|38146722|FG001|Overall Study|Unable to classify|2|||
17002579|NCT00644059|38146723|FG002|Overall Study|Unable to classify|3|||
17002580|NCT00643279|38146774|FG000|Overall Study|Death|13|||
17002581|NCT00643279|38146775|FG001|Overall Study|Death|11|||
17002582|NCT00643279|38146774|FG000|Overall Study|Withdrawal by Subject|3|||
17002583|NCT00643279|38146775|FG001|Overall Study|Withdrawal by Subject|0|||
17002584|NCT00643279|38146774|FG000|Overall Study|Lost to Follow-up|0|||
17002585|NCT00643279|38146775|FG001|Overall Study|Lost to Follow-up|1|||
17002586|NCT00643279|38146774|FG000|Overall Study|Physician Decision|0|||
17002587|NCT00643279|38146775|FG001|Overall Study|Physician Decision|1|||
17002588|NCT00910910|38146785|FG000|Overall Study|Adverse Event|63|||
17002589|NCT00910910|38146786|FG001|Overall Study|Adverse Event|35|||
17002590|NCT00910910|38146785|FG000|Overall Study|PD without histologic change|27|||
17002591|NCT00910910|38146786|FG001|Overall Study|PD without histologic change|23|||
17002592|NCT00910910|38146785|FG000|Overall Study|PD with histologic change|0|||
17002593|NCT00910910|38146786|FG001|Overall Study|PD with histologic change|2|||
17002594|NCT00910910|38146785|FG000|Overall Study|Withdrawal by Subject|7|||
16888779|NCT02518620|37926304|FG001|Overall Study|Sponsor's Decision|3|||
16888780|NCT02518620|37926303|FG000|Overall Study|Lost to Follow-up|1|||
16888781|NCT02518620|37926304|FG001|Overall Study|Lost to Follow-up|1|||
16888782|NCT02518620|37926303|FG000|Overall Study|Withdrawal by Subject|17|||
16888783|NCT02518620|37926304|FG001|Overall Study|Withdrawal by Subject|9|||
16888784|NCT02518620|37926303|FG000|Overall Study|Death|1|||
16888785|NCT02518620|37926304|FG001|Overall Study|Death|0|||
16888786|NCT02518620|37926303|FG000|Overall Study|Pregnancy Wish|3|||
16888787|NCT02518620|37926304|FG001|Overall Study|Pregnancy Wish|0|||
16888788|NCT02518620|37926303|FG000|Overall Study|Pregnancy|1|||
16888789|NCT02518620|37926304|FG001|Overall Study|Pregnancy|0|||
16888790|NCT02518620|37926303|FG000|Overall Study|Relocation|2|||
16888791|NCT02518620|37926304|FG001|Overall Study|Relocation|1|||
16888792|NCT01653912|37926488|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16888793|NCT01653912|37926489|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
16888794|NCT01653912|37926490|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16888795|NCT01653912|37926491|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16888796|NCT01653912|37926492|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16888797|NCT01653912|37926493|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16888798|NCT01653912|37926488|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16888799|NCT01653912|37926489|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16888800|NCT01653912|37926490|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
16888801|NCT01653912|37926491|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16888802|NCT01653912|37926492|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16888803|NCT01653912|37926493|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16888804|NCT01653912|37926488|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16888805|NCT01653912|37926489|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16888806|NCT01653912|37926490|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16888807|NCT01653912|37926491|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
16888808|NCT01653912|37926492|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16888809|NCT01653912|37926493|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16888810|NCT01653912|37926488|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888811|NCT01653912|37926489|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888812|NCT01653912|37926490|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888813|NCT01653912|37926491|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
16888814|NCT01653912|37926492|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888815|NCT01653912|37926493|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888816|NCT01653912|37926488|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16888817|NCT01653912|37926489|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16888818|NCT01653912|37926490|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16888819|NCT01653912|37926491|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16888820|NCT01653912|37926492|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16888821|NCT01653912|37926493|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
16888822|NCT01653912|37926488|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16888823|NCT01653912|37926489|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16888824|NCT01653912|37926490|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16888825|NCT01653912|37926491|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16888826|NCT01653912|37926492|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16888827|NCT01653912|37926493|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
16888828|NCT01653912|37926488|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888829|NCT01653912|37926489|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888830|NCT01653912|37926490|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888831|NCT01653912|37926491|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888832|NCT01653912|37926492|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16888833|NCT01653912|37926493|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
16888834|NCT02483520|37926519|FG000|Overall Study|Lost to Follow-up|3|||
16888835|NCT02483520|37926520|FG001|Overall Study|Lost to Follow-up|4|||
16888836|NCT02483520|37926519|FG000|Overall Study|Withdrawal by Subject|4|||
16888837|NCT02483520|37926520|FG001|Overall Study|Withdrawal by Subject|14|||
16888838|NCT02483520|37926519|FG000|Overall Study|Hospitalized|2|||
16888839|NCT02483520|37926520|FG001|Overall Study|Hospitalized|3|||
16888840|NCT02483520|37926519|FG000|Overall Study|Moved to LTC|2|||
16888841|NCT02483520|37926520|FG001|Overall Study|Moved to LTC|3|||
16888842|NCT02514174|37926526|FG000|Overall Study|Patient refused to continue medication|1|||
16888843|NCT02514174|37926526|FG000|Overall Study|Adverse Event|2|||
16888844|NCT02514174|37926526|FG000|Overall Study|Study closed by sponsor|9|||
16888845|NCT02514174|37926526|FG000|Overall Study|Progressive disease|11|||
16888846|NCT02514174|37926526|FG000|Overall Study|Treatment change|1|||
16888847|NCT02514174|37926526|FG000|Overall Study|Treated off study with Afatinib.|1|||
16888848|NCT02482428|37926586|FG000|Overall Study|Lost to Follow-up|4|||
16888849|NCT02482428|37926587|FG001|Overall Study|Lost to Follow-up|9|||
16888850|NCT02482428|37926588|FG002|Overall Study|Lost to Follow-up|1|||
16888851|NCT02482428|37926589|FG003|Overall Study|Lost to Follow-up|2|||
16888852|NCT02482428|37926590|FG004|Overall Study|Lost to Follow-up|4|||
16888853|NCT02482428|37926586|FG000|Overall Study|Physician Decision|0|||
16888854|NCT02482428|37926587|FG001|Overall Study|Physician Decision|0|||
16888855|NCT02482428|37926588|FG002|Overall Study|Physician Decision|0|||
16888856|NCT02482428|37926589|FG003|Overall Study|Physician Decision|0|||
16888857|NCT02482428|37926590|FG004|Overall Study|Physician Decision|1|||
16888858|NCT02482428|37926586|FG000|Overall Study|protocol deviation|1|||
16888859|NCT02482428|37926587|FG001|Overall Study|protocol deviation|1|||
16888860|NCT02482428|37926588|FG002|Overall Study|protocol deviation|0|||
16888861|NCT02482428|37926589|FG003|Overall Study|protocol deviation|0|||
16888862|NCT02482428|37926590|FG004|Overall Study|protocol deviation|0|||
16888863|NCT02482428|37926586|FG000|Overall Study|subject/guardian decision|4|||
16888864|NCT02482428|37926587|FG001|Overall Study|subject/guardian decision|2|||
16888865|NCT02482428|37926588|FG002|Overall Study|subject/guardian decision|0|||
16888866|NCT02482428|37926589|FG003|Overall Study|subject/guardian decision|0|||
16888867|NCT02482428|37926590|FG004|Overall Study|subject/guardian decision|2|||
16888868|NCT02480712|37926644|FG000|Overall Study|Enrolled but Never Treated|1|||
16888869|NCT02480712|37926644|FG000|Overall Study|Lost to Follow-up|5|||
16888870|NCT02480712|37926644|FG000|Overall Study|Withdrew Consent|3|||
16888871|NCT02480712|37926644|FG000|Overall Study|Death|1|||
16888872|NCT02480712|37926644|FG000|Overall Study|Lack of Efficacy|1|||
16888873|NCT02513550|37927975|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
16888874|NCT02513550|37927976|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
16888875|NCT02513550|37927977|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
16888876|NCT02513550|37927978|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
16888877|NCT02513550|37927979|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
16888878|NCT02513550|37927980|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
16888879|NCT02513550|37927975|FG000|Double Blind Treatment Period|Adverse Event|5|||
16888880|NCT02513550|37927976|FG001|Double Blind Treatment Period|Adverse Event|13|||
16888881|NCT02513550|37927977|FG002|Double Blind Treatment Period|Adverse Event|17|||
16888882|NCT02513550|37927978|FG003|Double Blind Treatment Period|Adverse Event|0|||
16888883|NCT02513550|37927979|FG004|Double Blind Treatment Period|Adverse Event|1|||
16888884|NCT02513550|37927980|FG005|Double Blind Treatment Period|Adverse Event|0|||
16888885|NCT02513550|37927975|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
16888886|NCT02513550|37927976|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
16888887|NCT02513550|37927977|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
16888888|NCT02513550|37927978|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
16888889|NCT02513550|37927979|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
16888890|NCT02513550|37927980|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
16888891|NCT02513550|37927975|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
16888892|NCT02513550|37927976|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
16888893|NCT02513550|37927977|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
16888894|NCT02513550|37927978|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
16888895|NCT02513550|37927979|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
16888896|NCT02513550|37927980|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
16888897|NCT02513550|37927975|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16888898|NCT02513550|37927976|FG001|Double Blind Treatment Period|Protocol Violation|1|||
16888899|NCT02513550|37927977|FG002|Double Blind Treatment Period|Protocol Violation|4|||
16888900|NCT02513550|37927978|FG003|Double Blind Treatment Period|Protocol Violation|0|||
17095355|NCT00169442|38234596|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
16888901|NCT02513550|37927979|FG004|Double Blind Treatment Period|Protocol Violation|0|||
16888902|NCT02513550|37927980|FG005|Double Blind Treatment Period|Protocol Violation|0|||
17095356|NCT00169442|38234597|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
16888903|NCT02513550|37927975|FG000|Double Blind Treatment Period|Physician Decision|2|||
16888904|NCT02513550|37927976|FG001|Double Blind Treatment Period|Physician Decision|0|||
16888905|NCT02513550|37927977|FG002|Double Blind Treatment Period|Physician Decision|4|||
16888906|NCT02513550|37927978|FG003|Double Blind Treatment Period|Physician Decision|0|||
16888907|NCT02513550|37927979|FG004|Double Blind Treatment Period|Physician Decision|0|||
16888908|NCT02513550|37927980|FG005|Double Blind Treatment Period|Physician Decision|0|||
16888909|NCT02513550|37927975|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
16888910|NCT02513550|37927976|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
16888911|NCT02513550|37927977|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
16888912|NCT02513550|37927978|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
16888913|NCT02513550|37927979|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
16888914|NCT02513550|37927980|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
16888915|NCT02513550|37927975|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16888916|NCT02513550|37927976|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16888917|NCT02513550|37927977|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
16888918|NCT02513550|37927978|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16888919|NCT02513550|37927979|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16888920|NCT02513550|37927980|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16888921|NCT02513550|37927975|FG000|Double Blind Treatment Period|Due to personal business|2|||
17002595|NCT00910910|38146786|FG001|Overall Study|Withdrawal by Subject|5|||
17002596|NCT00910910|38146785|FG000|Overall Study|Lost to Follow-up|2|||
17002597|NCT00910910|38146786|FG001|Overall Study|Lost to Follow-up|2|||
17002598|NCT00910910|38146785|FG000|Overall Study|Death|9|||
16888922|NCT02513550|37927976|FG001|Double Blind Treatment Period|Due to personal business|0|||
16888923|NCT02513550|37927977|FG002|Double Blind Treatment Period|Due to personal business|1|||
16888924|NCT02513550|37927978|FG003|Double Blind Treatment Period|Due to personal business|0|||
16888925|NCT02513550|37927979|FG004|Double Blind Treatment Period|Due to personal business|0|||
16888926|NCT02513550|37927980|FG005|Double Blind Treatment Period|Due to personal business|0|||
16888927|NCT02513550|37927975|FG000|Double Blind Treatment Period|Death|1|||
16888928|NCT02513550|37927976|FG001|Double Blind Treatment Period|Death|0|||
16888929|NCT02513550|37927977|FG002|Double Blind Treatment Period|Death|2|||
16888930|NCT02513550|37927978|FG003|Double Blind Treatment Period|Death|0|||
16888931|NCT02513550|37927979|FG004|Double Blind Treatment Period|Death|0|||
16888932|NCT02513550|37927980|FG005|Double Blind Treatment Period|Death|0|||
16888933|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
16888934|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
16888935|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
16888936|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16888937|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16888938|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16888939|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
16888940|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
16888941|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
16888942|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
16888943|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
16888944|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
17002599|NCT00910910|38146786|FG001|Overall Study|Death|3|||
17002600|NCT00910910|38146785|FG000|Overall Study|Protocol Violation|2|||
17002601|NCT00910910|38146786|FG001|Overall Study|Protocol Violation|2|||
17002602|NCT00910910|38146785|FG000|Overall Study|Completed 13 cycles of treatment|0|||
17002603|NCT00910910|38146786|FG001|Overall Study|Completed 13 cycles of treatment|118|||
17002604|NCT00910910|38146785|FG000|Overall Study|Other|114|||
17095357|NCT00169442|38234598|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
17002605|NCT00910910|38146786|FG001|Overall Study|Other|32|||
17002606|NCT00910910|38146785|FG000|Overall Study|Untreated before cycle 1|1|||
17002607|NCT00910910|38146786|FG001|Overall Study|Untreated before cycle 1|2|||
17002608|NCT00911768|38146794|FG000|Overall Study|Protocol Violation|5|||
17002609|NCT00911768|38146795|FG001|Overall Study|Protocol Violation|4|||
17002610|NCT00911768|38146794|FG000|Overall Study|Withdrawal by Subject|1|||
17095358|NCT00169442|38234599|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
17095359|NCT00169442|38234600|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
17095360|NCT00169442|38234601|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
17095361|NCT00261716|38234619|FG000|Overall Study|Withdrawal by Subject|6|||
17095362|NCT00261716|38234620|FG001|Overall Study|Withdrawal by Subject|8|||
17095363|NCT00261716|38234619|FG000|Overall Study|Lost to Follow-up|0|||
17002611|NCT00911768|38146795|FG001|Overall Study|Withdrawal by Subject|0|||
17002612|NCT00909038|38146801|FG000|Overall Study|Protocol Violation|187|||
17002613|NCT00909038|38146801|FG000|Overall Study|Non-evaluable Subjects|230|||
17002614|NCT00909428|38146808|FG000|Overall Study|Lost to Follow-up|13|||
17002615|NCT00909428|38146809|FG001|Overall Study|Lost to Follow-up|10|||
17002616|NCT00909428|38146810|FG002|Overall Study|Lost to Follow-up|9|||
16888945|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
17002617|NCT00908960|38146820|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
17002618|NCT00908960|38146821|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
17002619|NCT00908960|38146822|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
17002620|NCT00650767|38146840|FG000|Overall Study|Adverse Event|0|||
17002621|NCT00650767|38146841|FG001|Overall Study|Adverse Event|3|||
17002622|NCT00650767|38146842|FG002|Overall Study|Adverse Event|10|||
17002623|NCT00650767|38146843|FG003|Overall Study|Adverse Event|8|||
17002624|NCT00650767|38146840|FG000|Overall Study|Death|1|||
17002625|NCT00650767|38146841|FG001|Overall Study|Death|0|||
17002626|NCT00650767|38146842|FG002|Overall Study|Death|0|||
17002627|NCT00650767|38146843|FG003|Overall Study|Death|0|||
17002628|NCT00650767|38146840|FG000|Overall Study|Withdrawal by Subject|2|||
17002629|NCT00650767|38146841|FG001|Overall Study|Withdrawal by Subject|4|||
17002630|NCT00650767|38146842|FG002|Overall Study|Withdrawal by Subject|3|||
17002631|NCT00650767|38146843|FG003|Overall Study|Withdrawal by Subject|3|||
17002632|NCT00650767|38146840|FG000|Overall Study|Lost to Follow-up|1|||
16888946|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
16888947|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
16888948|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16888949|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16888950|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16888951|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
16888952|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
16888953|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
16888954|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
16888955|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
16888956|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
16888957|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
16888958|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
16888959|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
16888960|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
17002633|NCT00650767|38146841|FG001|Overall Study|Lost to Follow-up|1|||
17002634|NCT00650767|38146842|FG002|Overall Study|Lost to Follow-up|1|||
16888961|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
16888962|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
16888963|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Death|0|||
16888964|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Death|0|||
16888965|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Death|1|||
16888966|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Death|0|||
16888967|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Death|0|||
16888968|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Death|0|||
16888969|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
16888970|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
16888971|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
16888972|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
16888973|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
16888974|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
16888975|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16888976|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16888977|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
16888978|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16888979|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16888980|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16888981|NCT02513550|37927975|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
16888982|NCT02513550|37927976|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
16888983|NCT02513550|37927977|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
16888984|NCT02513550|37927978|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
16888985|NCT02513550|37927979|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
16888986|NCT02513550|37927980|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
16888987|NCT02513472|37928306|FG000|Overall Study|Radiological Disease Progression|45|||
16888988|NCT02513472|37928307|FG001|Overall Study|Radiological Disease Progression|57|||
16888989|NCT02513472|37928306|FG000|Overall Study|Clinical Disease Progression|5|||
16888990|NCT02513472|37928307|FG001|Overall Study|Clinical Disease Progression|13|||
17002635|NCT00650767|38146843|FG003|Overall Study|Lost to Follow-up|0|||
17002636|NCT00650767|38146840|FG000|Overall Study|Other|1|||
17002637|NCT00650767|38146841|FG001|Overall Study|Other|1|||
16888991|NCT02513472|37928306|FG000|Overall Study|Adverse Event|8|||
16888992|NCT02513472|37928307|FG001|Overall Study|Adverse Event|11|||
16888993|NCT02513472|37928306|FG000|Overall Study|Withdrawal by Subject|0|||
16888994|NCT02513472|37928307|FG001|Overall Study|Withdrawal by Subject|4|||
17002638|NCT00650767|38146842|FG002|Overall Study|Other|0|||
16888995|NCT02513472|37928306|FG000|Overall Study|Subject Choice|2|||
16888996|NCT02513472|37928307|FG001|Overall Study|Subject Choice|7|||
16888997|NCT02513472|37928306|FG000|Overall Study|Treatment Completed as per Protocol|3|||
16888998|NCT02513472|37928307|FG001|Overall Study|Treatment Completed as per Protocol|3|||
16888999|NCT02513472|37928306|FG000|Overall Study|Other|3|||
16889000|NCT02513472|37928307|FG001|Overall Study|Other|6|||
17002639|NCT00650767|38146843|FG003|Overall Study|Other|0|||
17002640|NCT00973349|38146869|FG000|Overall Study|Adverse Event|0|||
16889001|NCT04490395|37928536|FG000|Overall Study|Lost to Follow-up|0|||
16889002|NCT04490395|37928537|FG001|Overall Study|Lost to Follow-up|1|||
16889003|NCT01798004|37928964|FG000|Overall Study|Death|2|||
16889004|NCT01798004|37928964|FG000|Overall Study|Lack of Efficacy|8|||
16889005|NCT01798004|37928964|FG000|Overall Study|Physician Decision|25|||
16889006|NCT01798004|37928964|FG000|Overall Study|Withdrawal by Subject|4|||
16889007|NCT01798004|37928964|FG000|Overall Study|Ineligible|4|||
16889008|NCT01798004|37928964|FG000|Overall Study|Patient/parent refusal|7|||
16889009|NCT01798004|37928964|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
16889010|NCT01798004|37928964|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
16889011|NCT03843541|37928984|FG000|Overall Study|Adverse Event|4|||
16889012|NCT03843541|37928985|FG001|Overall Study|Adverse Event|2|||
16889013|NCT03843541|37928986|FG002|Overall Study|Adverse Event|3|||
16889014|NCT03843541|37928984|FG000|Overall Study|Death|1|||
16889015|NCT03843541|37928985|FG001|Overall Study|Death|0|||
16889016|NCT03843541|37928986|FG002|Overall Study|Death|0|||
16889017|NCT03843541|37928984|FG000|Overall Study|Lack of adherence to study medication|0|||
16889018|NCT03843541|37928985|FG001|Overall Study|Lack of adherence to study medication|0|||
16889019|NCT03843541|37928986|FG002|Overall Study|Lack of adherence to study medication|1|||
16889020|NCT03843541|37928984|FG000|Overall Study|Physician Decision|1|||
16889021|NCT03843541|37928985|FG001|Overall Study|Physician Decision|2|||
16889022|NCT03843541|37928986|FG002|Overall Study|Physician Decision|2|||
16889023|NCT03843541|37928984|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
16889024|NCT03843541|37928985|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
16889025|NCT03843541|37928986|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
17192065|NCT02660138|38345146|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
17192066|NCT02660138|38345147|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
17192067|NCT02660138|38345145|FG000|Overall Study|Other|1|||
17192068|NCT02660138|38345146|FG001|Overall Study|Other|1|||
17192069|NCT02660138|38345147|FG002|Overall Study|Other|0|||
17192070|NCT02660138|38345145|FG000|Overall Study|Not treated|0|||
17192071|NCT02660138|38345146|FG001|Overall Study|Not treated|1|||
17192072|NCT02660138|38345147|FG002|Overall Study|Not treated|0|||
17192073|NCT01603394|38345158|FG000|Overall Study|Adverse Event|1|||
17192074|NCT02729025|38345164|FG000|Overall Study|Sponsor Decision|0|||
17192075|NCT02729025|38345165|FG001|Overall Study|Sponsor Decision|1|||
17192076|NCT03093350|38345171|FG000|Overall Study|Death|1|||
17192077|NCT03093350|38345171|FG000|Overall Study|Signed consent, never began treartment|1|||
17192078|NCT01603082|38345177|FG000|Overall Study|Adverse Event|0|||
17192079|NCT01603082|38345178|FG001|Overall Study|Adverse Event|1|||
17192080|NCT01603082|38345177|FG000|Overall Study|Withdrawal by Subject|1|||
17192081|NCT01603082|38345178|FG001|Overall Study|Withdrawal by Subject|0|||
17192082|NCT01603082|38345177|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
17192083|NCT01603082|38345178|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
17192084|NCT02499835|38345188|FG000|Overall Study|Withdrawal by Subject|1|||
17192085|NCT02499835|38345189|FG001|Overall Study|Withdrawal by Subject|0|||
17192086|NCT02499835|38345190|FG002|Overall Study|Withdrawal by Subject|0|||
17192087|NCT02499835|38345191|FG003|Overall Study|Withdrawal by Subject|1|||
17192088|NCT02499835|38345188|FG000|Overall Study|Physician Decision|0|||
17192089|NCT02499835|38345189|FG001|Overall Study|Physician Decision|3|||
17192090|NCT02499835|38345190|FG002|Overall Study|Physician Decision|18|||
17192091|NCT02499835|38345191|FG003|Overall Study|Physician Decision|7|||
17192092|NCT02499835|38345188|FG000|Overall Study|Adverse Event|0|||
17192093|NCT02499835|38345189|FG001|Overall Study|Adverse Event|0|||
17192094|NCT02499835|38345190|FG002|Overall Study|Adverse Event|0|||
17192095|NCT02499835|38345191|FG003|Overall Study|Adverse Event|1|||
17192096|NCT02499835|38345188|FG000|Overall Study|Disease progression|2|||
17192097|NCT02499835|38345189|FG001|Overall Study|Disease progression|1|||
17192098|NCT02499835|38345190|FG002|Overall Study|Disease progression|0|||
17192099|NCT02499835|38345191|FG003|Overall Study|Disease progression|7|||
17192100|NCT02846779|38345210|FG000|Overall Study|Lost Enrollment|83|||
17192101|NCT02846779|38345211|FG001|Overall Study|Lost Enrollment|82|||
17192102|NCT02846779|38345212|FG002|Overall Study|Lost Enrollment|86|||
16889026|NCT03843541|37928984|FG000|Overall Study|Withdrawal by Subject|6|||
16889027|NCT03843541|37928985|FG001|Overall Study|Withdrawal by Subject|9|||
17002641|NCT00973349|38146870|FG001|Overall Study|Adverse Event|0|||
17192103|NCT02846779|38345210|FG000|Overall Study|Less than 31 days of follow-up|56|||
17192104|NCT02846779|38345211|FG001|Overall Study|Less than 31 days of follow-up|45|||
17192105|NCT02846779|38345212|FG002|Overall Study|Less than 31 days of follow-up|52|||
16889028|NCT03843541|37928986|FG002|Overall Study|Withdrawal by Subject|7|||
16889029|NCT03843541|37928984|FG000|Overall Study|Administration of rescue mucolytic|0|||
16889030|NCT03843541|37928985|FG001|Overall Study|Administration of rescue mucolytic|0|||
16889031|NCT03843541|37928986|FG002|Overall Study|Administration of rescue mucolytic|1|||
16889032|NCT03843541|37928984|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
16889033|NCT03843541|37928985|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
16889034|NCT03843541|37928986|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
16889035|NCT02992418|37930253|FG000|Overall Study|Withdrawal by Subject|11|||
16889036|NCT02992418|37930254|FG001|Overall Study|Withdrawal by Subject|12|||
16889037|NCT02992418|37930253|FG000|Overall Study|Non-compliance with the protocol|308|||
16889038|NCT02992418|37930254|FG001|Overall Study|Non-compliance with the protocol|308|||
16889039|NCT02992418|37930253|FG000|Overall Study|Lost to Follow-up|27|||
16889040|NCT02992418|37930254|FG001|Overall Study|Lost to Follow-up|22|||
16889041|NCT01276106|37930496|FG000|Overall Study|Adverse Event|3|||
16889042|NCT01276106|37930497|FG001|Overall Study|Adverse Event|3|||
16889043|NCT01276106|37930498|FG002|Overall Study|Adverse Event|11|||
16889044|NCT01276106|37930499|FG003|Overall Study|Adverse Event|3|||
16889045|NCT01276106|37930496|FG000|Overall Study|Withdrawal by Subject|6|||
16889046|NCT01276106|37930497|FG001|Overall Study|Withdrawal by Subject|3|||
17002642|NCT00973349|38146871|FG002|Overall Study|Adverse Event|0|||
17002643|NCT00973349|38146872|FG003|Overall Study|Adverse Event|0|||
17002644|NCT00973349|38146873|FG004|Overall Study|Adverse Event|1|||
17002645|NCT00973349|38146874|FG005|Overall Study|Adverse Event|0|||
17002646|NCT00973349|38146875|FG006|Overall Study|Adverse Event|0|||
17002647|NCT00973349|38146876|FG007|Overall Study|Adverse Event|0|||
17002648|NCT00973349|38146877|FG008|Overall Study|Adverse Event|1|||
17002649|NCT00973349|38146878|FG009|Overall Study|Adverse Event|0|||
17002650|NCT00973349|38146879|FG010|Overall Study|Adverse Event|0|||
17002651|NCT00973349|38146880|FG011|Overall Study|Adverse Event|0|||
17002652|NCT00973349|38146881|FG012|Overall Study|Adverse Event|0|||
17002653|NCT00973349|38146882|FG013|Overall Study|Adverse Event|0|||
17002654|NCT00973349|38146883|FG014|Overall Study|Adverse Event|1|||
17002655|NCT00973349|38146884|FG015|Overall Study|Adverse Event|0|||
17002656|NCT00973349|38146869|FG000|Overall Study|Withdrawal by Subject|1|||
16889047|NCT01276106|37930498|FG002|Overall Study|Withdrawal by Subject|1|||
16889048|NCT01276106|37930499|FG003|Overall Study|Withdrawal by Subject|6|||
16889049|NCT01276106|37930496|FG000|Overall Study|Lack of Efficacy|0|||
16889050|NCT01276106|37930497|FG001|Overall Study|Lack of Efficacy|1|||
16889051|NCT01276106|37930498|FG002|Overall Study|Lack of Efficacy|0|||
16889052|NCT01276106|37930499|FG003|Overall Study|Lack of Efficacy|1|||
16889053|NCT01276106|37930496|FG000|Overall Study|Lost to Follow-up|2|||
16889054|NCT01276106|37930497|FG001|Overall Study|Lost to Follow-up|1|||
16889055|NCT01276106|37930498|FG002|Overall Study|Lost to Follow-up|1|||
16889056|NCT01276106|37930499|FG003|Overall Study|Lost to Follow-up|0|||
16889057|NCT01276106|37930496|FG000|Overall Study|Physician Decision|0|||
16889058|NCT01276106|37930497|FG001|Overall Study|Physician Decision|0|||
16889059|NCT01276106|37930498|FG002|Overall Study|Physician Decision|1|||
16889060|NCT01276106|37930499|FG003|Overall Study|Physician Decision|1|||
16889061|NCT01276106|37930496|FG000|Overall Study|Protocol Violation|1|||
16889062|NCT01276106|37930497|FG001|Overall Study|Protocol Violation|1|||
16889063|NCT01276106|37930498|FG002|Overall Study|Protocol Violation|0|||
17002657|NCT00973349|38146870|FG001|Overall Study|Withdrawal by Subject|2|||
17002658|NCT00973349|38146871|FG002|Overall Study|Withdrawal by Subject|2|||
17002659|NCT00973349|38146872|FG003|Overall Study|Withdrawal by Subject|3|||
17002660|NCT00973349|38146873|FG004|Overall Study|Withdrawal by Subject|2|||
17002661|NCT00973349|38146874|FG005|Overall Study|Withdrawal by Subject|0|||
17002662|NCT00973349|38146875|FG006|Overall Study|Withdrawal by Subject|2|||
17002663|NCT00973349|38146876|FG007|Overall Study|Withdrawal by Subject|2|||
17002664|NCT00973349|38146877|FG008|Overall Study|Withdrawal by Subject|0|||
17002665|NCT00973349|38146878|FG009|Overall Study|Withdrawal by Subject|2|||
17002666|NCT00973349|38146879|FG010|Overall Study|Withdrawal by Subject|0|||
17002667|NCT00973349|38146880|FG011|Overall Study|Withdrawal by Subject|1|||
17002668|NCT00973349|38146881|FG012|Overall Study|Withdrawal by Subject|0|||
17002669|NCT00973349|38146882|FG013|Overall Study|Withdrawal by Subject|0|||
17002670|NCT00973349|38146883|FG014|Overall Study|Withdrawal by Subject|0|||
16889064|NCT01276106|37930499|FG003|Overall Study|Protocol Violation|2|||
16889065|NCT01276106|37930496|FG000|Overall Study|Insufficient therapeutic effects|0|||
16889066|NCT01276106|37930497|FG001|Overall Study|Insufficient therapeutic effects|0|||
16889067|NCT01276106|37930498|FG002|Overall Study|Insufficient therapeutic effects|2|||
16889068|NCT01276106|37930499|FG003|Overall Study|Insufficient therapeutic effects|0|||
16889069|NCT01275170|37930517|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
16889070|NCT01275170|37930518|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
16889071|NCT01275170|37930519|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
16889072|NCT01275170|37930520|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
16889073|NCT01275170|37930521|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
16889074|NCT01275170|37930522|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
16889075|NCT01275170|37930523|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
16889076|NCT01275170|37930524|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
16889077|NCT01273064|37930571|FG000|Overall Study|Adverse Event|5|||
16889078|NCT01273064|37930572|FG001|Overall Study|Adverse Event|1|||
16889079|NCT01273064|37930573|FG002|Overall Study|Adverse Event|3|||
16889080|NCT01273064|37930574|FG003|Overall Study|Adverse Event|2|||
16889081|NCT01273064|37930575|FG004|Overall Study|Adverse Event|1|||
16889082|NCT01273064|37930571|FG000|Overall Study|Withdrawal by Subject|4|||
16889083|NCT01273064|37930572|FG001|Overall Study|Withdrawal by Subject|2|||
16889084|NCT01273064|37930573|FG002|Overall Study|Withdrawal by Subject|2|||
16889085|NCT01273064|37930574|FG003|Overall Study|Withdrawal by Subject|2|||
16889086|NCT01273064|37930575|FG004|Overall Study|Withdrawal by Subject|0|||
16889087|NCT01273064|37930571|FG000|Overall Study|Study Termination|13|||
16889088|NCT01273064|37930572|FG001|Overall Study|Study Termination|27|||
16889089|NCT01273064|37930573|FG002|Overall Study|Study Termination|26|||
16889090|NCT01273064|37930574|FG003|Overall Study|Study Termination|16|||
16889091|NCT01273064|37930575|FG004|Overall Study|Study Termination|8|||
16889092|NCT01273064|37930571|FG000|Overall Study|Lost to Follow-up|1|||
16889093|NCT01273064|37930572|FG001|Overall Study|Lost to Follow-up|0|||
17002671|NCT00973349|38146884|FG015|Overall Study|Withdrawal by Subject|0|||
17002672|NCT00973349|38146869|FG000|Overall Study|Lost to Follow-up|3|||
17002673|NCT00973349|38146870|FG001|Overall Study|Lost to Follow-up|1|||
17002674|NCT00973349|38146871|FG002|Overall Study|Lost to Follow-up|2|||
17002675|NCT00973349|38146872|FG003|Overall Study|Lost to Follow-up|2|||
16889094|NCT01273064|37930573|FG002|Overall Study|Lost to Follow-up|0|||
16889095|NCT01273064|37930574|FG003|Overall Study|Lost to Follow-up|0|||
16889096|NCT01273064|37930575|FG004|Overall Study|Lost to Follow-up|0|||
16889097|NCT01273064|37930571|FG000|Overall Study|Physician Decision|0|||
16889098|NCT01273064|37930572|FG001|Overall Study|Physician Decision|0|||
16889099|NCT01273064|37930573|FG002|Overall Study|Physician Decision|0|||
16889100|NCT01273064|37930574|FG003|Overall Study|Physician Decision|0|||
16889101|NCT01273064|37930575|FG004|Overall Study|Physician Decision|1|||
16889102|NCT01272908|37930587|FG000|Initial Treatment Period|Adverse Event|1|||
16889103|NCT01272908|37930587|FG000|Initial Treatment Period|Lack of Efficacy|5|||
16889104|NCT01272908|37930587|FG000|Initial Treatment Period|Protocol Violation|1|||
16889105|NCT01272908|37930587|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
16889106|NCT01272908|37930587|FG000|Re-Treatment Period|Adverse Event|2|||
16889107|NCT01272908|37930587|FG000|Re-Treatment Period|Lack of Efficacy|3|||
16889108|NCT01272908|37930587|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
16889109|NCT01271504|37930597|FG000|Overall Study|Death|7|||
17002676|NCT00973349|38146873|FG004|Overall Study|Lost to Follow-up|1|||
17002677|NCT00973349|38146874|FG005|Overall Study|Lost to Follow-up|3|||
17002678|NCT00973349|38146875|FG006|Overall Study|Lost to Follow-up|0|||
17002679|NCT00973349|38146876|FG007|Overall Study|Lost to Follow-up|1|||
17002680|NCT00973349|38146877|FG008|Overall Study|Lost to Follow-up|2|||
17002681|NCT00973349|38146878|FG009|Overall Study|Lost to Follow-up|1|||
17002682|NCT00973349|38146879|FG010|Overall Study|Lost to Follow-up|0|||
17002683|NCT00973349|38146880|FG011|Overall Study|Lost to Follow-up|1|||
17002684|NCT00973349|38146881|FG012|Overall Study|Lost to Follow-up|0|||
17002685|NCT00973349|38146882|FG013|Overall Study|Lost to Follow-up|0|||
17002686|NCT00973349|38146883|FG014|Overall Study|Lost to Follow-up|0|||
17002687|NCT00973349|38146884|FG015|Overall Study|Lost to Follow-up|1|||
17002688|NCT00973349|38146869|FG000|Overall Study|Inappropriate enrolment|0|||
17095364|NCT00261716|38234620|FG001|Overall Study|Lost to Follow-up|2|||
16889110|NCT01271504|37930598|FG001|Overall Study|Death|6|||
16889111|NCT01271504|37930599|FG002|Overall Study|Death|32|||
16889112|NCT01271504|37930600|FG003|Overall Study|Death|32|||
16889113|NCT01271504|37930597|FG000|Overall Study|Lost to Follow-up|0|||
16889114|NCT01271504|37930598|FG001|Overall Study|Lost to Follow-up|1|||
16889115|NCT01271504|37930599|FG002|Overall Study|Lost to Follow-up|3|||
16889116|NCT01271504|37930600|FG003|Overall Study|Lost to Follow-up|1|||
16889117|NCT01271504|37930597|FG000|Overall Study|Protocol Violation|0|||
16889118|NCT01271504|37930598|FG001|Overall Study|Protocol Violation|0|||
16889119|NCT01271504|37930599|FG002|Overall Study|Protocol Violation|0|||
16889120|NCT01271504|37930600|FG003|Overall Study|Protocol Violation|2|||
16889121|NCT01271504|37930597|FG000|Overall Study|Administrative Reasons|0|||
16889122|NCT01271504|37930598|FG001|Overall Study|Administrative Reasons|0|||
16889123|NCT01271504|37930599|FG002|Overall Study|Administrative Reasons|6|||
16889124|NCT01271504|37930600|FG003|Overall Study|Administrative Reasons|5|||
16889125|NCT01271504|37930597|FG000|Overall Study|Withdrawal by Subject|0|||
16889126|NCT01271504|37930598|FG001|Overall Study|Withdrawal by Subject|0|||
16889127|NCT01271504|37930599|FG002|Overall Study|Withdrawal by Subject|1|||
16889128|NCT01271504|37930600|FG003|Overall Study|Withdrawal by Subject|3|||
16889129|NCT01271504|37930597|FG000|Overall Study|Other|0|||
16889130|NCT01271504|37930598|FG001|Overall Study|Other|1|||
16889131|NCT01271504|37930599|FG002|Overall Study|Other|2|||
16889132|NCT01271504|37930600|FG003|Overall Study|Other|0|||
16889133|NCT01270958|37930643|FG000|Overall Study|Lost to Follow-up|2|||
16889134|NCT01270958|37930643|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
16889135|NCT01270880|37930647|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
16889136|NCT01270802|37930653|FG000|Overall Study|Withdrawal by Subject|1|||
16889137|NCT01270802|37930654|FG001|Overall Study|Withdrawal by Subject|0|||
16889138|NCT01270802|37930653|FG000|Overall Study|Adverse Event|1|||
16889139|NCT01270802|37930654|FG001|Overall Study|Adverse Event|0|||
16889140|NCT01270802|37930653|FG000|Overall Study|Lost to Follow-up|0|||
16889141|NCT01270802|37930654|FG001|Overall Study|Lost to Follow-up|1|||
16889142|NCT01270256|37930663|FG000|Overall Study|Withdrawal by Subject|1|||
16889143|NCT01270256|37930664|FG001|Overall Study|Withdrawal by Subject|0|||
16889144|NCT01279616|37930734|FG000|Overall Study|donor could not be located|5|||
16889145|NCT01279616|37930734|FG000|Overall Study|no signs of sickle cell disease|2|||
16889146|NCT01279070|37930745|FG000|Overall Study|Withdrawal by Subject|2|||
16889147|NCT01279070|37930746|FG001|Overall Study|Withdrawal by Subject|3|||
16889148|NCT01279070|37930745|FG000|Overall Study|Acute exacerbation|3|||
16889149|NCT01279070|37930746|FG001|Overall Study|Acute exacerbation|1|||
16889150|NCT01277744|37930756|FG000|Overall Study|Physician Decision|2|||
16889151|NCT01277822|37930762|FG000|Overall Study|Adverse Event|2|||
16889152|NCT01277822|37930763|FG001|Overall Study|Adverse Event|1|||
16889153|NCT01277822|37930762|FG000|Overall Study|Withdrawal by Subject|6|||
16889154|NCT01277822|37930763|FG001|Overall Study|Withdrawal by Subject|7|||
16889155|NCT01277822|37930762|FG000|Overall Study|Physician Decision|1|||
16889156|NCT01277822|37930763|FG001|Overall Study|Physician Decision|1|||
16889157|NCT01277822|37930762|FG000|Overall Study|Protocol Violation|1|||
16889158|NCT01277822|37930763|FG001|Overall Study|Protocol Violation|0|||
16889159|NCT01277822|37930762|FG000|Overall Study|Lost to Follow-up|2|||
16889160|NCT01277822|37930763|FG001|Overall Study|Lost to Follow-up|1|||
16889161|NCT01277822|37930762|FG000|Overall Study|Contraindicated medication used|2|||
16889162|NCT01277822|37930763|FG001|Overall Study|Contraindicated medication used|1|||
16889163|NCT01277822|37930762|FG000|Overall Study|Participant moved|1|||
16889164|NCT01277822|37930763|FG001|Overall Study|Participant moved|0|||
16889165|NCT01277666|37930772|FG000|Overall Study|Adverse Event|26|||
16889166|NCT01277666|37930773|FG001|Overall Study|Adverse Event|25|||
16889167|NCT01277666|37930774|FG002|Overall Study|Adverse Event|20|||
16889168|NCT01277666|37930772|FG000|Overall Study|Lack of Efficacy|8|||
16889169|NCT01277666|37930773|FG001|Overall Study|Lack of Efficacy|20|||
16889170|NCT01277666|37930774|FG002|Overall Study|Lack of Efficacy|12|||
16889171|NCT01277666|37930772|FG000|Overall Study|Protocol Violation|2|||
16889172|NCT01277666|37930773|FG001|Overall Study|Protocol Violation|3|||
16889173|NCT01277666|37930774|FG002|Overall Study|Protocol Violation|2|||
16889174|NCT01277666|37930772|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
16889175|NCT01277666|37930773|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
17002689|NCT00973349|38146870|FG001|Overall Study|Inappropriate enrolment|0|||
16889176|NCT01277666|37930774|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
16889177|NCT01277666|37930772|FG000|Overall Study|Lost to Follow-up|1|||
16889178|NCT01277666|37930773|FG001|Overall Study|Lost to Follow-up|1|||
16889179|NCT01277666|37930774|FG002|Overall Study|Lost to Follow-up|2|||
16889180|NCT01277666|37930772|FG000|Overall Study|Withdrawal by Subject|7|||
16889181|NCT01277666|37930773|FG001|Overall Study|Withdrawal by Subject|8|||
16889182|NCT01277666|37930774|FG002|Overall Study|Withdrawal by Subject|6|||
16889183|NCT01277666|37930772|FG000|Overall Study|Death|0|||
16889184|NCT01277666|37930773|FG001|Overall Study|Death|0|||
16889185|NCT01277666|37930774|FG002|Overall Study|Death|1|||
16889186|NCT00249002|37930782|FG000|Overall Study|Adverse Event|2|||
16889187|NCT00249002|37930782|FG000|Overall Study|Study cancellation|3|||
16889188|NCT00249002|37930782|FG000|Overall Study|Other|2|||
16889189|NCT01277042|37930788|FG000|Overall Study|Adverse Event|4|||
16889190|NCT01277042|37930789|FG001|Overall Study|Adverse Event|3|||
16889191|NCT01277042|37930788|FG000|Overall Study|Lost to Follow-up|2|||
16889192|NCT01277042|37930789|FG001|Overall Study|Lost to Follow-up|2|||
16889193|NCT01277042|37930788|FG000|Overall Study|Withdrawal by Subject|2|||
16889194|NCT01277042|37930789|FG001|Overall Study|Withdrawal by Subject|0|||
16889195|NCT00246740|37930829|FG000|Initial Enrollment|Death|1|||
16889196|NCT00246740|37930830|FG001|Initial Enrollment|Death|0|||
16889197|NCT00246740|37930829|FG000|Initial Enrollment|Additional surgery scheduled|0|||
16889198|NCT00246740|37930830|FG001|Initial Enrollment|Additional surgery scheduled|2|||
16889199|NCT00246740|37930829|FG000|Initial Enrollment|Surgery schedule change|4|||
16889200|NCT00246740|37930830|FG001|Initial Enrollment|Surgery schedule change|4|||
16889201|NCT00246740|37930829|FG000|Initial Enrollment|Other|1|||
16889202|NCT00246740|37930830|FG001|Initial Enrollment|Other|2|||
16889203|NCT00245102|37930875|FG000|Overall Study|Not Treated|1|||
16889204|NCT00245102|37930876|FG001|Overall Study|Not Treated|0|||
16889205|NCT00245102|37930877|FG002|Overall Study|Not Treated|1|||
16889206|NCT00245102|37930878|FG003|Overall Study|Not Treated|0|||
16889207|NCT00245102|37930879|FG004|Overall Study|Not Treated|0|||
16889208|NCT00245102|37930880|FG005|Overall Study|Not Treated|0|||
16889209|NCT00245102|37930875|FG000|Overall Study|Protocol Violation|1|||
16889210|NCT00245102|37930876|FG001|Overall Study|Protocol Violation|0|||
16889211|NCT00245102|37930877|FG002|Overall Study|Protocol Violation|0|||
16889212|NCT00245102|37930878|FG003|Overall Study|Protocol Violation|0|||
16889213|NCT00245102|37930879|FG004|Overall Study|Protocol Violation|0|||
16889214|NCT00245102|37930880|FG005|Overall Study|Protocol Violation|0|||
16889215|NCT00245102|37930875|FG000|Overall Study|Death|0|||
17002690|NCT00973349|38146871|FG002|Overall Study|Inappropriate enrolment|1|||
17002691|NCT00973349|38146872|FG003|Overall Study|Inappropriate enrolment|0|||
16889216|NCT00245102|37930876|FG001|Overall Study|Death|0|||
16889217|NCT00245102|37930877|FG002|Overall Study|Death|0|||
16889218|NCT00245102|37930878|FG003|Overall Study|Death|1|||
16889219|NCT00245102|37930879|FG004|Overall Study|Death|0|||
16889220|NCT00245102|37930880|FG005|Overall Study|Death|0|||
16889221|NCT00245102|37930875|FG000|Overall Study|Adverse Event|4|||
16889222|NCT00245102|37930876|FG001|Overall Study|Adverse Event|2|||
16889223|NCT00245102|37930877|FG002|Overall Study|Adverse Event|5|||
16889224|NCT00245102|37930878|FG003|Overall Study|Adverse Event|1|||
16889225|NCT00245102|37930879|FG004|Overall Study|Adverse Event|0|||
16889226|NCT00245102|37930880|FG005|Overall Study|Adverse Event|2|||
16889227|NCT00245102|37930875|FG000|Overall Study|Decline in performance|0|||
16889228|NCT00245102|37930876|FG001|Overall Study|Decline in performance|2|||
16889229|NCT00245102|37930877|FG002|Overall Study|Decline in performance|0|||
16889230|NCT00245102|37930878|FG003|Overall Study|Decline in performance|1|||
16889231|NCT00245102|37930879|FG004|Overall Study|Decline in performance|0|||
16889232|NCT00245102|37930880|FG005|Overall Study|Decline in performance|2|||
16889233|NCT00245102|37930875|FG000|Overall Study|Participant needed surgery|0|||
16889234|NCT00245102|37930876|FG001|Overall Study|Participant needed surgery|0|||
16889235|NCT00245102|37930877|FG002|Overall Study|Participant needed surgery|1|||
16889236|NCT00245102|37930878|FG003|Overall Study|Participant needed surgery|0|||
16889237|NCT00245102|37930879|FG004|Overall Study|Participant needed surgery|0|||
16889238|NCT00245102|37930880|FG005|Overall Study|Participant needed surgery|0|||
16889239|NCT00245102|37930875|FG000|Overall Study|Clinical progression|1|||
16889240|NCT00245102|37930876|FG001|Overall Study|Clinical progression|0|||
16889241|NCT00245102|37930877|FG002|Overall Study|Clinical progression|0|||
16889242|NCT00245102|37930878|FG003|Overall Study|Clinical progression|0|||
16889243|NCT00245102|37930879|FG004|Overall Study|Clinical progression|0|||
16889244|NCT00245102|37930880|FG005|Overall Study|Clinical progression|0|||
16889245|NCT00244712|37930925|FG000|Overall Study|Adverse Event|20|||
16889246|NCT00244712|37930926|FG001|Overall Study|Adverse Event|21|||
16889247|NCT00244712|37930925|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
16889248|NCT00244712|37930926|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
16889249|NCT00244712|37930925|FG000|Overall Study|Lack of Compliance|10|||
16889250|NCT00244712|37930926|FG001|Overall Study|Lack of Compliance|11|||
16889251|NCT00244712|37930925|FG000|Overall Study|Lost to Follow-up|45|||
16889252|NCT00244712|37930926|FG001|Overall Study|Lost to Follow-up|52|||
17002692|NCT00973349|38146873|FG004|Overall Study|Inappropriate enrolment|0|||
16889253|NCT00244712|37930925|FG000|Overall Study|Withdrawal by Subject|13|||
16889254|NCT00244712|37930926|FG001|Overall Study|Withdrawal by Subject|23|||
16889255|NCT00244712|37930925|FG000|Overall Study|Protocol Violation, disease progression|13|||
16889256|NCT00244712|37930926|FG001|Overall Study|Protocol Violation, disease progression|11|||
16889257|NCT00243932|37930944|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
16889258|NCT00243932|37930945|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
16889259|NCT00243932|37930946|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
16889260|NCT00243386|37930954|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
16889261|NCT00243386|37930955|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
16889262|NCT00243386|37930956|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
16889263|NCT00243386|37930954|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
16889264|NCT00243386|37930955|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
16889265|NCT00243386|37930956|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
16889266|NCT00243386|37930954|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
16889267|NCT00243386|37930955|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
16889268|NCT00243386|37930956|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
16889269|NCT00243386|37930954|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
16889270|NCT00243386|37930955|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
16889271|NCT00243386|37930956|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
16889272|NCT00243386|37930954|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
16889273|NCT00243386|37930955|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
16889274|NCT00243386|37930956|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
16889275|NCT00243386|37930954|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
16889276|NCT00243386|37930955|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
16889277|NCT00243386|37930956|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
16889278|NCT00243386|37930954|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
16889279|NCT00243386|37930955|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
16889280|NCT00243386|37930956|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
16889281|NCT00243386|37930954|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
16889282|NCT00243386|37930955|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
16889283|NCT00243386|37930956|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
16889284|NCT00243230|37931015|FG000|Double-Blind Period|Adverse Event|0|||
16889285|NCT00243230|37931016|FG001|Double-Blind Period|Adverse Event|2|||
16889286|NCT00243230|37931017|FG002|Double-Blind Period|Adverse Event|2|||
16889287|NCT00243230|37931018|FG003|Double-Blind Period|Adverse Event|0|||
16889288|NCT00243230|37931015|FG000|Double-Blind Period|Withdrawal by Subject|1|||
16889289|NCT00243230|37931016|FG001|Double-Blind Period|Withdrawal by Subject|0|||
16889290|NCT00243230|37931017|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16889291|NCT00243230|37931018|FG003|Double-Blind Period|Withdrawal by Subject|0|||
16889292|NCT00243230|37931015|FG000|Double-Blind Period|Protocol Violation|0|||
16889293|NCT00243230|37931016|FG001|Double-Blind Period|Protocol Violation|0|||
16889294|NCT00243230|37931017|FG002|Double-Blind Period|Protocol Violation|1|||
16889295|NCT00243230|37931018|FG003|Double-Blind Period|Protocol Violation|0|||
16889296|NCT00243230|37931015|FG000|Double-Blind Period|Randomized but Not Treated|0|||
16889297|NCT00243230|37931016|FG001|Double-Blind Period|Randomized but Not Treated|0|||
16889298|NCT00243230|37931017|FG002|Double-Blind Period|Randomized but Not Treated|2|||
16889299|NCT00243230|37931018|FG003|Double-Blind Period|Randomized but Not Treated|0|||
16889300|NCT00243230|37931015|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
16889301|NCT00243230|37931016|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
16889302|NCT00243230|37931017|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
16889303|NCT00243230|37931018|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
16889304|NCT00243230|37931015|FG000|Open Label Period|Adverse Event|0|||
16889305|NCT00243230|37931016|FG001|Open Label Period|Adverse Event|0|||
16889306|NCT00243230|37931017|FG002|Open Label Period|Adverse Event|0|||
16889307|NCT00243230|37931018|FG003|Open Label Period|Adverse Event|2|||
16889308|NCT00243230|37931015|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
16889309|NCT00243230|37931016|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
16889310|NCT00243230|37931017|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
16889311|NCT00243230|37931018|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
16889312|NCT00243230|37931015|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
16889313|NCT00243230|37931016|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
16889314|NCT00243230|37931017|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
16889315|NCT00243230|37931018|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
16889316|NCT00243230|37931015|FG000|Open Label Period|Lost to Follow-up|0|||
16889317|NCT00243230|37931016|FG001|Open Label Period|Lost to Follow-up|0|||
16889318|NCT00243230|37931017|FG002|Open Label Period|Lost to Follow-up|0|||
17002693|NCT00973349|38146874|FG005|Overall Study|Inappropriate enrolment|0|||
17095365|NCT03809104|38234630|FG000|Overall Study|Withdrawal by Subject|3|||
16889319|NCT00243230|37931018|FG003|Open Label Period|Lost to Follow-up|2|||
16889320|NCT00243230|37931015|FG000|Open Label Period|Withdrawal by Subject|0|||
16889321|NCT00243230|37931016|FG001|Open Label Period|Withdrawal by Subject|0|||
16889322|NCT00243230|37931017|FG002|Open Label Period|Withdrawal by Subject|0|||
16889323|NCT00243230|37931018|FG003|Open Label Period|Withdrawal by Subject|2|||
16889324|NCT00243230|37931015|FG000|Open Label Period|Protocol Violation|0|||
16889325|NCT00243230|37931016|FG001|Open Label Period|Protocol Violation|0|||
16889326|NCT00243230|37931017|FG002|Open Label Period|Protocol Violation|0|||
16889327|NCT00243230|37931018|FG003|Open Label Period|Protocol Violation|2|||
16889328|NCT00243230|37931015|FG000|Open Label Period|Administrative Reason|0|||
16889329|NCT00243230|37931016|FG001|Open Label Period|Administrative Reason|0|||
16889330|NCT00243230|37931017|FG002|Open Label Period|Administrative Reason|0|||
16889331|NCT00243230|37931018|FG003|Open Label Period|Administrative Reason|63|||
16889332|NCT00243074|37931028|FG000|Overall Study|Ineligible|6|||
16889333|NCT00243074|37931028|FG000|Overall Study|Adverse Event|6|||
16889334|NCT00243074|37931028|FG000|Overall Study|Withdrawal by Subject|2|||
16889335|NCT00243074|37931028|FG000|Overall Study|Lack of Efficacy|36|||
16889336|NCT00243074|37931028|FG000|Overall Study|Death|2|||
16889337|NCT00243074|37931028|FG000|Overall Study|not protocol specified|1|||
16889338|NCT00243074|37931028|FG000|Overall Study|Did not receive any treatment|1|||
16889339|NCT00241358|37931036|FG000|Overall Study|Determined to be not ineligible|0|||
16889340|NCT00241358|37931037|FG001|Overall Study|Determined to be not ineligible|1|||
16889341|NCT00241358|37931038|FG002|Overall Study|Determined to be not ineligible|1|||
16889342|NCT00241280|37931047|FG000|Overall Study|Adverse Event|2|||
16889343|NCT00241280|37931048|FG001|Overall Study|Adverse Event|6|||
16889344|NCT00241280|37931047|FG000|Overall Study|Discomfort|11|||
16889345|NCT00241280|37931048|FG001|Overall Study|Discomfort|16|||
16889346|NCT00241280|37931047|FG000|Overall Study|Pregnancy|1|||
16889347|NCT00241280|37931048|FG001|Overall Study|Pregnancy|5|||
16889348|NCT00241280|37931047|FG000|Overall Study|Lost to Follow-up|5|||
16889349|NCT00241280|37931048|FG001|Overall Study|Lost to Follow-up|8|||
16889350|NCT00241280|37931047|FG000|Overall Study|Withdrawal by Subject|7|||
16889351|NCT00241280|37931048|FG001|Overall Study|Withdrawal by Subject|4|||
16889352|NCT00241280|37931047|FG000|Overall Study|Protocol Violation|4|||
16889353|NCT00241280|37931048|FG001|Overall Study|Protocol Violation|10|||
16889354|NCT00241280|37931047|FG000|Overall Study|Relocation|4|||
16889355|NCT00241280|37931048|FG001|Overall Study|Relocation|4|||
16889356|NCT00241280|37931047|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
16889357|NCT00241280|37931048|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
16889358|NCT00241280|37931047|FG000|Overall Study|Unsatisfactory Visual Response|1|||
16889359|NCT00241280|37931048|FG001|Overall Study|Unsatisfactory Visual Response|1|||
16889360|NCT00241280|37931047|FG000|Overall Study|Diabetic|1|||
16889361|NCT00241280|37931048|FG001|Overall Study|Diabetic|0|||
16889362|NCT00241280|37931047|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
16889363|NCT00241280|37931048|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
16889364|NCT00241280|37931047|FG000|Overall Study|Dispensed incorrect test article|1|||
16889365|NCT00241280|37931048|FG001|Overall Study|Dispensed incorrect test article|2|||
16889366|NCT00241280|37931047|FG000|Overall Study|Unacceptable Fit|0|||
16889367|NCT00241280|37931048|FG001|Overall Study|Unacceptable Fit|1|||
16889368|NCT00241280|37931047|FG000|Overall Study|Scheduling Conflict|0|||
16889369|NCT00241280|37931048|FG001|Overall Study|Scheduling Conflict|2|||
16889370|NCT00241280|37931047|FG000|Overall Study|History of Ocular Surgery|0|||
16889371|NCT00241280|37931048|FG001|Overall Study|History of Ocular Surgery|1|||
16889372|NCT00241280|37931047|FG000|Overall Study|Coating on Lens|1|||
16889373|NCT00241280|37931048|FG001|Overall Study|Coating on Lens|0|||
16889374|NCT00241280|37931047|FG000|Overall Study|Excessive Dryness|0|||
16889375|NCT00241280|37931048|FG001|Overall Study|Excessive Dryness|1|||
16889376|NCT04278872|37931644|FG000|Overall Study|Adverse Event|1|||
16889377|NCT04278872|37931645|FG001|Overall Study|Adverse Event|0|||
16889378|NCT04278872|37931644|FG000|Overall Study|Protocol Violation|0|||
16889379|NCT04278872|37931645|FG001|Overall Study|Protocol Violation|1|||
16889380|NCT04278872|37931644|FG000|Overall Study|Study Termination|2|||
16889381|NCT04278872|37931645|FG001|Overall Study|Study Termination|0|||
16889382|NCT02513394|37934073|FG000|Overall Study|Withdrawal by Subject|11|||
16889383|NCT02513394|37934074|FG001|Overall Study|Withdrawal by Subject|23|||
16889384|NCT02513394|37934073|FG000|Overall Study|Ineligible|1|||
16889385|NCT02513394|37934074|FG001|Overall Study|Ineligible|0|||
16889386|NCT02513160|37934124|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
16889387|NCT02513160|37934125|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
16889388|NCT02513160|37934126|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
16889389|NCT02513160|37934127|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
16889390|NCT02513160|37934124|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
16889391|NCT02513160|37934125|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
16889392|NCT02513160|37934126|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
16889393|NCT02513160|37934127|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
17095366|NCT00203502|38234634|FG000|Overall Study|Death|1|||
16889394|NCT02513160|37934124|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
16889395|NCT02513160|37934125|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
16889396|NCT02513160|37934126|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
16889397|NCT02513160|37934127|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
16889398|NCT02513160|37934124|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
16889399|NCT02513160|37934125|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
16889400|NCT02513160|37934126|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
16889401|NCT02513160|37934127|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
16889402|NCT02513160|37934124|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
16889403|NCT02513160|37934125|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
16889404|NCT02513160|37934126|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
16889405|NCT02513160|37934127|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
16889406|NCT02513160|37934124|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
16889407|NCT02513160|37934125|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
16889408|NCT02513160|37934126|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
16889409|NCT02513160|37934127|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
16889410|NCT02513160|37934124|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
16889411|NCT02513160|37934125|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
16889412|NCT02513160|37934126|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
16889413|NCT02513160|37934127|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
16889414|NCT02513160|37934124|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
16889415|NCT02513160|37934125|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
16889416|NCT02513160|37934126|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
16889417|NCT02513160|37934127|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
16889418|NCT02513160|37934124|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
16889419|NCT02513160|37934125|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
16889420|NCT02513160|37934126|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
16889421|NCT02513160|37934127|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
16889422|NCT02513160|37934124|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
16889423|NCT02513160|37934125|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
16889424|NCT02513160|37934126|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
17002694|NCT00973349|38146875|FG006|Overall Study|Inappropriate enrolment|0|||
17002695|NCT00973349|38146876|FG007|Overall Study|Inappropriate enrolment|0|||
17002696|NCT00973349|38146877|FG008|Overall Study|Inappropriate enrolment|0|||
17002697|NCT00973349|38146878|FG009|Overall Study|Inappropriate enrolment|2|||
17002698|NCT00973349|38146879|FG010|Overall Study|Inappropriate enrolment|0|||
17002699|NCT00973349|38146880|FG011|Overall Study|Inappropriate enrolment|0|||
17002700|NCT00973349|38146881|FG012|Overall Study|Inappropriate enrolment|1|||
17002701|NCT00973349|38146882|FG013|Overall Study|Inappropriate enrolment|0|||
16889425|NCT02513160|37934127|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
16889426|NCT02513160|37934124|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
16889427|NCT02513160|37934125|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
16889428|NCT02513160|37934126|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
16889429|NCT02513160|37934127|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
16889430|NCT02513160|37934124|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
16889431|NCT02513160|37934125|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
16889432|NCT02513160|37934126|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
16889433|NCT02513160|37934127|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
16889434|NCT02480010|37934162|FG000|Overall Study|Adverse Event|3|||
16889435|NCT02480010|37934163|FG001|Overall Study|Adverse Event|1|||
16889436|NCT02480010|37934162|FG000|Overall Study|Death|1|||
16889437|NCT02480010|37934163|FG001|Overall Study|Death|0|||
16889438|NCT02480010|37934162|FG000|Overall Study|Insufficient therapeutic response|31|||
16889439|NCT02480010|37934163|FG001|Overall Study|Insufficient therapeutic response|29|||
16889440|NCT02480010|37934162|FG000|Overall Study|Refused Treatment|0|||
16889441|NCT02480010|37934163|FG001|Overall Study|Refused Treatment|3|||
16889442|NCT02512302|37934191|FG000|Period 1|Adverse Event|0|||
16889443|NCT02512302|37934192|FG001|Period 1|Adverse Event|1|||
16889444|NCT02512302|37934193|FG002|Period 1|Adverse Event|0|||
17002702|NCT00973349|38146883|FG014|Overall Study|Inappropriate enrolment|1|||
17002703|NCT00973349|38146884|FG015|Overall Study|Inappropriate enrolment|1|||
16889445|NCT02512302|37934194|FG003|Period 1|Adverse Event|0|||
16889446|NCT02512302|37934195|FG004|Period 1|Adverse Event|0|||
16889447|NCT02512302|37934196|FG005|Period 1|Adverse Event|0|||
16889448|NCT02512302|37934197|FG006|Period 1|Adverse Event|0|||
16889449|NCT02512302|37934198|FG007|Period 1|Adverse Event|0|||
17002704|NCT00973349|38146869|FG000|Overall Study|Protocol Violation|0|||
16889450|NCT02512302|37934199|FG008|Period 1|Adverse Event|0|||
16889451|NCT02512302|37934200|FG009|Period 1|Adverse Event|0|||
16889452|NCT02512302|37934191|FG000|Period 2|Adverse Event|0|||
17002705|NCT00973349|38146870|FG001|Overall Study|Protocol Violation|0|||
16889453|NCT02512302|37934192|FG001|Period 2|Adverse Event|0|||
16889454|NCT02512302|37934193|FG002|Period 2|Adverse Event|0|||
16889455|NCT02512302|37934194|FG003|Period 2|Adverse Event|0|||
16889456|NCT02512302|37934195|FG004|Period 2|Adverse Event|0|||
16889457|NCT02512302|37934196|FG005|Period 2|Adverse Event|0|||
16889458|NCT02512302|37934197|FG006|Period 2|Adverse Event|0|||
16889459|NCT02512302|37934198|FG007|Period 2|Adverse Event|0|||
16889460|NCT02512302|37934199|FG008|Period 2|Adverse Event|0|||
16889461|NCT02512302|37934200|FG009|Period 2|Adverse Event|1|||
16889462|NCT02512302|37934191|FG000|Period 3|Lost to Follow-up|0|||
16889463|NCT02512302|37934192|FG001|Period 3|Lost to Follow-up|0|||
16889464|NCT02512302|37934193|FG002|Period 3|Lost to Follow-up|1|||
16889465|NCT02512302|37934194|FG003|Period 3|Lost to Follow-up|0|||
16889466|NCT02512302|37934195|FG004|Period 3|Lost to Follow-up|0|||
16889467|NCT02512302|37934196|FG005|Period 3|Lost to Follow-up|0|||
16889468|NCT02512302|37934197|FG006|Period 3|Lost to Follow-up|0|||
16889469|NCT02512302|37934198|FG007|Period 3|Lost to Follow-up|0|||
16889470|NCT02512302|37934199|FG008|Period 3|Lost to Follow-up|0|||
16889471|NCT02512302|37934200|FG009|Period 3|Lost to Follow-up|0|||
16889472|NCT02512302|37934191|FG000|Period 4|Adverse Event|0|||
16889473|NCT02512302|37934192|FG001|Period 4|Adverse Event|0|||
16889474|NCT02512302|37934193|FG002|Period 4|Adverse Event|0|||
16889475|NCT02512302|37934194|FG003|Period 4|Adverse Event|0|||
16889476|NCT02512302|37934195|FG004|Period 4|Adverse Event|0|||
16889477|NCT02512302|37934196|FG005|Period 4|Adverse Event|0|||
16889478|NCT02512302|37934197|FG006|Period 4|Adverse Event|1|||
16889479|NCT02512302|37934198|FG007|Period 4|Adverse Event|0|||
16889480|NCT02512302|37934199|FG008|Period 4|Adverse Event|0|||
16889481|NCT02512302|37934200|FG009|Period 4|Adverse Event|0|||
16889482|NCT02512068|37934308|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
16889483|NCT02512068|37934309|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
16889484|NCT02512068|37934308|FG000|Overall Study|Major Protocol Deviation|1|||
16889485|NCT02512068|37934309|FG001|Overall Study|Major Protocol Deviation|0|||
16889486|NCT02512068|37934308|FG000|Overall Study|Voluntary Withdrawal|0|||
16889487|NCT02512068|37934309|FG001|Overall Study|Voluntary Withdrawal|1|||
16889488|NCT02512068|37934308|FG000|Overall Study|Lack of Efficacy|0|||
16889489|NCT02512068|37934309|FG001|Overall Study|Lack of Efficacy|1|||
16889490|NCT02512068|37934308|FG000|Overall Study|Reason Not Specified|3|||
16889491|NCT02512068|37934309|FG001|Overall Study|Reason Not Specified|5|||
16889492|NCT02511678|37934324|FG000|Overall Study|Withdrawal by Subject|2|||
16889493|NCT02511678|37934324|FG000|Overall Study|Lost to Follow-up|4|||
16889494|NCT02511678|37934324|FG000|Overall Study|Death|19|||
16889495|NCT02511678|37934324|FG000|Overall Study|Adverse Event|1|||
16889496|NCT02511678|37934324|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
16889497|NCT02511678|37934324|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
16889498|NCT02511678|37934324|FG000|Overall Study|Required Radiofrequency Ablation|1|||
16889499|NCT02511678|37934324|FG000|Overall Study|Biopsy was Negative|1|||
16889500|NCT02511678|37934324|FG000|Overall Study|Protocol Violation|1|||
16889501|NCT02511678|37934324|FG000|Overall Study|Received Radiation Treatment|1|||
16889502|NCT02518464|37934351|FG000|Overall Study|Adverse Event|2|||
16889503|NCT02510820|37934355|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
16889504|NCT02510820|37934356|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16889505|NCT02510820|37934355|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16889506|NCT02510820|37934356|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16889507|NCT02510664|37934366|FG000|Overall Study|Transferred Care|9|||
16889508|NCT02510664|37934367|FG001|Overall Study|Transferred Care|9|||
16889509|NCT02510664|37934368|FG002|Overall Study|Transferred Care|0|||
16889510|NCT02510664|37934366|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
16889511|NCT02510664|37934367|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
16889512|NCT02510664|37934368|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
16889513|NCT02510664|37934366|FG000|Overall Study|Time Constraints|1|||
16889514|NCT02510664|37934367|FG001|Overall Study|Time Constraints|1|||
16889515|NCT02510664|37934368|FG002|Overall Study|Time Constraints|0|||
17002706|NCT00973349|38146871|FG002|Overall Study|Protocol Violation|0|||
16889516|NCT02510040|37934393|FG000|Overall Study|Deemed no longer eligible|18|||
16889517|NCT02510040|37934394|FG001|Overall Study|Deemed no longer eligible|3|||
16889518|NCT02510040|37934395|FG002|Overall Study|Deemed no longer eligible|1|||
16889519|NCT01363986|37934413|FG000|Overall Study|Disease progression|1|||
16889520|NCT02478372|37934447|FG000|Overall Study|Protocol Violation|12|||
16889521|NCT02478372|37934448|FG001|Overall Study|Protocol Violation|8|||
16889522|NCT02478372|37934447|FG000|Overall Study|Lost to Follow-up|1|||
16889523|NCT02478372|37934448|FG001|Overall Study|Lost to Follow-up|4|||
16889524|NCT02478372|37934447|FG000|Overall Study|Death|0|||
16889525|NCT02478372|37934448|FG001|Overall Study|Death|2|||
16889526|NCT01654536|37934460|FG000|Overall Study|Lost to Follow-up|5|||
16889527|NCT01654536|37934461|FG001|Overall Study|Lost to Follow-up|5|||
16889528|NCT01654536|37934460|FG000|Overall Study|Physician Decision|12|||
16889529|NCT01654536|37934461|FG001|Overall Study|Physician Decision|8|||
16889530|NCT01654536|37934460|FG000|Overall Study|Withdrawal by Subject|27|||
16889531|NCT01654536|37934461|FG001|Overall Study|Withdrawal by Subject|25|||
16889532|NCT01654380|37934470|FG000|Part B, Period 1|Physician Decision|0|||
16889533|NCT01654380|37934471|FG001|Part B, Period 1|Physician Decision|0|||
16889534|NCT01654380|37934472|FG002|Part B, Period 1|Physician Decision|1|||
16889535|NCT01654380|37934473|FG003|Part B, Period 1|Physician Decision|0|||
16889536|NCT02477670|37934492|FG000|Stage 1|Adverse Event|2|||
16889537|NCT02477670|37934493|FG001|Stage 1|Adverse Event|7|||
16889538|NCT02477670|37934494|FG002|Stage 1|Adverse Event|0|||
16889539|NCT02477670|37934495|FG003|Stage 1|Adverse Event|0|||
16889540|NCT02477670|37934496|FG004|Stage 1|Adverse Event|0|||
16889541|NCT02477670|37934497|FG005|Stage 1|Adverse Event|0|||
16889542|NCT02477670|37934498|FG006|Stage 1|Adverse Event|0|||
16889543|NCT02477670|37934492|FG000|Stage 1|Lost to Follow-up|0|||
16889544|NCT02477670|37934493|FG001|Stage 1|Lost to Follow-up|2|||
16889545|NCT02477670|37934494|FG002|Stage 1|Lost to Follow-up|0|||
16889546|NCT02477670|37934495|FG003|Stage 1|Lost to Follow-up|0|||
16889547|NCT02477670|37934496|FG004|Stage 1|Lost to Follow-up|0|||
16889548|NCT02477670|37934497|FG005|Stage 1|Lost to Follow-up|0|||
16889549|NCT02477670|37934498|FG006|Stage 1|Lost to Follow-up|0|||
16889550|NCT02477670|37934492|FG000|Stage 1|Withdrawal by Subject|1|||
16889551|NCT02477670|37934493|FG001|Stage 1|Withdrawal by Subject|2|||
16889552|NCT02477670|37934494|FG002|Stage 1|Withdrawal by Subject|0|||
16889553|NCT02477670|37934495|FG003|Stage 1|Withdrawal by Subject|0|||
16889554|NCT02477670|37934496|FG004|Stage 1|Withdrawal by Subject|0|||
16889555|NCT02477670|37934497|FG005|Stage 1|Withdrawal by Subject|0|||
16889556|NCT02477670|37934498|FG006|Stage 1|Withdrawal by Subject|0|||
16889557|NCT02477670|37934492|FG000|Stage 1|Non-compliance with Study Drug|1|||
16889558|NCT02477670|37934493|FG001|Stage 1|Non-compliance with Study Drug|2|||
17002707|NCT00973349|38146872|FG003|Overall Study|Protocol Violation|0|||
17002708|NCT00973349|38146873|FG004|Overall Study|Protocol Violation|0|||
17002709|NCT00973349|38146874|FG005|Overall Study|Protocol Violation|0|||
17002710|NCT00973349|38146875|FG006|Overall Study|Protocol Violation|0|||
17002711|NCT00973349|38146876|FG007|Overall Study|Protocol Violation|0|||
17002712|NCT00973349|38146877|FG008|Overall Study|Protocol Violation|1|||
17002713|NCT00973349|38146878|FG009|Overall Study|Protocol Violation|0|||
17002714|NCT00973349|38146879|FG010|Overall Study|Protocol Violation|0|||
17002715|NCT00973349|38146880|FG011|Overall Study|Protocol Violation|0|||
17002716|NCT00973349|38146881|FG012|Overall Study|Protocol Violation|0|||
17002717|NCT00973349|38146882|FG013|Overall Study|Protocol Violation|0|||
17002718|NCT00973349|38146883|FG014|Overall Study|Protocol Violation|0|||
17002719|NCT00973349|38146884|FG015|Overall Study|Protocol Violation|0|||
17002720|NCT00973349|38146869|FG000|Overall Study|Unable to classify|0|||
17002721|NCT00973349|38146870|FG001|Overall Study|Unable to classify|0|||
17002722|NCT00973349|38146871|FG002|Overall Study|Unable to classify|0|||
17002723|NCT00973349|38146872|FG003|Overall Study|Unable to classify|0|||
17002724|NCT00973349|38146873|FG004|Overall Study|Unable to classify|1|||
17002725|NCT00973349|38146874|FG005|Overall Study|Unable to classify|1|||
17002726|NCT00973349|38146875|FG006|Overall Study|Unable to classify|0|||
17002727|NCT00973349|38146876|FG007|Overall Study|Unable to classify|0|||
17002728|NCT00973349|38146877|FG008|Overall Study|Unable to classify|0|||
17002729|NCT00973349|38146878|FG009|Overall Study|Unable to classify|1|||
17002730|NCT00973349|38146879|FG010|Overall Study|Unable to classify|0|||
17002731|NCT00973349|38146880|FG011|Overall Study|Unable to classify|0|||
17002732|NCT00973349|38146881|FG012|Overall Study|Unable to classify|0|||
17002733|NCT00973349|38146882|FG013|Overall Study|Unable to classify|0|||
17002734|NCT00973349|38146883|FG014|Overall Study|Unable to classify|0|||
17002735|NCT00973349|38146884|FG015|Overall Study|Unable to classify|0|||
17002736|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Death|20|||
17002737|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Death|26|||
17002738|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
17002739|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
17002740|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
17002741|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
17002742|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
17002743|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
17002744|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
17002745|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
17002746|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
17002747|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
17002748|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
17002749|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
17095367|NCT03799198|38234640|FG000|Overall Study|Lost to Follow-up|4|||
16889559|NCT02477670|37934494|FG002|Stage 1|Non-compliance with Study Drug|0|||
16889560|NCT02477670|37934495|FG003|Stage 1|Non-compliance with Study Drug|0|||
17095368|NCT03799198|38234641|FG001|Overall Study|Lost to Follow-up|8|||
16889561|NCT02477670|37934496|FG004|Stage 1|Non-compliance with Study Drug|0|||
16889562|NCT02477670|37934497|FG005|Stage 1|Non-compliance with Study Drug|0|||
16889563|NCT02477670|37934498|FG006|Stage 1|Non-compliance with Study Drug|0|||
16889564|NCT02477670|37934492|FG000|Stage 2|Adverse Event|0|||
16889565|NCT02477670|37934493|FG001|Stage 2|Adverse Event|0|||
16889566|NCT02477670|37934494|FG002|Stage 2|Adverse Event|1|||
16889567|NCT02477670|37934495|FG003|Stage 2|Adverse Event|0|||
16889568|NCT02477670|37934496|FG004|Stage 2|Adverse Event|0|||
16889569|NCT02477670|37934497|FG005|Stage 2|Adverse Event|0|||
16889570|NCT02477670|37934498|FG006|Stage 2|Adverse Event|0|||
16889571|NCT02477670|37934492|FG000|Stage 2|Antipsychotic Medication Changed|0|||
16889572|NCT02477670|37934493|FG001|Stage 2|Antipsychotic Medication Changed|0|||
16889573|NCT02477670|37934494|FG002|Stage 2|Antipsychotic Medication Changed|1|||
16889574|NCT02477670|37934495|FG003|Stage 2|Antipsychotic Medication Changed|0|||
16889575|NCT02477670|37934496|FG004|Stage 2|Antipsychotic Medication Changed|0|||
16889576|NCT02477670|37934497|FG005|Stage 2|Antipsychotic Medication Changed|0|||
16889577|NCT02477670|37934498|FG006|Stage 2|Antipsychotic Medication Changed|0|||
16889578|NCT02477670|37934492|FG000|Stage 2|Withdrawal by Subject|0|||
16889579|NCT02477670|37934493|FG001|Stage 2|Withdrawal by Subject|0|||
16889580|NCT02477670|37934494|FG002|Stage 2|Withdrawal by Subject|0|||
16889581|NCT02477670|37934495|FG003|Stage 2|Withdrawal by Subject|1|||
16889582|NCT02477670|37934496|FG004|Stage 2|Withdrawal by Subject|0|||
16889583|NCT02477670|37934497|FG005|Stage 2|Withdrawal by Subject|0|||
16889584|NCT02477670|37934498|FG006|Stage 2|Withdrawal by Subject|0|||
16889585|NCT02509026|37934509|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
16889586|NCT02509026|37934509|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
16889587|NCT02509026|37934509|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
16889588|NCT02509026|37934509|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
16889589|NCT02509026|37934509|FG000|Induction Period (24 Weeks)|Other|2|||
16889590|NCT02509026|37934509|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
16889591|NCT02509026|37934509|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
16889592|NCT02509026|37934509|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
16889593|NCT02509026|37934509|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
16889594|NCT02509026|37934509|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
16889595|NCT02509026|37934509|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
16889596|NCT02509026|37934509|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
16889597|NCT02509026|37934509|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
16889598|NCT02476968|37934892|FG000|Overall Study|Other|0|||
16889599|NCT02476968|37934893|FG001|Overall Study|Other|2|||
16889600|NCT02476968|37934894|FG002|Overall Study|Other|0|||
16889601|NCT02476968|37934892|FG000|Overall Study|Lost to Follow-up|10|||
16889602|NCT02476968|37934893|FG001|Overall Study|Lost to Follow-up|0|||
16889603|NCT02476968|37934894|FG002|Overall Study|Lost to Follow-up|1|||
16889604|NCT02476968|37934892|FG000|Overall Study|Death|48|||
16889605|NCT02476968|37934893|FG001|Overall Study|Death|8|||
16889606|NCT02476968|37934894|FG002|Overall Study|Death|1|||
16889607|NCT02476968|37934892|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16889608|NCT02476968|37934893|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16889609|NCT02476968|37934894|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
16889610|NCT02476968|37934892|FG000|Overall Study|Patient decision|37|||
16889611|NCT02476968|37934893|FG001|Overall Study|Patient decision|8|||
16889612|NCT02476968|37934894|FG002|Overall Study|Patient decision|0|||
16889613|NCT02476578|37934915|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
16889614|NCT02476578|37934916|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
16889615|NCT02476578|37934915|FG000|Overall Study|Lost to Follow-up|6|||
16889616|NCT02476578|37934916|FG001|Overall Study|Lost to Follow-up|13|||
16889617|NCT02504892|37934934|FG000|Overall Study|Adverse event-pneumonitis|2|||
16889618|NCT02504502|37934940|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
16889619|NCT02504502|37934941|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
16889620|NCT02504502|37934940|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
16889621|NCT02504502|37934941|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
16889622|NCT02504424|37934969|FG000|Overall Study|Withdrawal by Subject|2|||
16889623|NCT02548832|37935309|FG000|Overall Study|Lost to Follow-up|2|||
16889624|NCT02548832|37935310|FG001|Overall Study|Lost to Follow-up|2|||
16889625|NCT02548832|37935311|FG002|Overall Study|Lost to Follow-up|2|||
16889626|NCT02504268|37935561|FG000|Overall Study|Adverse Event|18|||
16889627|NCT02504268|37935562|FG001|Overall Study|Adverse Event|8|||
16889628|NCT02504268|37935563|FG002|Overall Study|Adverse Event|14|||
16889629|NCT02504268|37935564|FG003|Overall Study|Adverse Event|0|||
16889630|NCT02504268|37935565|FG004|Overall Study|Adverse Event|0|||
16889631|NCT02504268|37935566|FG005|Overall Study|Adverse Event|0|||
16889632|NCT02504268|37935567|FG006|Overall Study|Adverse Event|0|||
16889633|NCT02504268|37935568|FG007|Overall Study|Adverse Event|0|||
16889634|NCT02504268|37935569|FG008|Overall Study|Adverse Event|0|||
16889635|NCT02504268|37935561|FG000|Overall Study|Withdrawal of Consent|11|||
17002750|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
16889636|NCT02504268|37935562|FG001|Overall Study|Withdrawal of Consent|10|||
16889637|NCT02504268|37935563|FG002|Overall Study|Withdrawal of Consent|3|||
16889638|NCT02504268|37935564|FG003|Overall Study|Withdrawal of Consent|0|||
16889639|NCT02504268|37935565|FG004|Overall Study|Withdrawal of Consent|0|||
16889640|NCT02504268|37935566|FG005|Overall Study|Withdrawal of Consent|0|||
16889641|NCT02504268|37935567|FG006|Overall Study|Withdrawal of Consent|0|||
16889642|NCT02504268|37935568|FG007|Overall Study|Withdrawal of Consent|0|||
16889643|NCT02504268|37935569|FG008|Overall Study|Withdrawal of Consent|0|||
17002751|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
17002752|NCT00643201|38146912|FG000|Randomized, Completed 6 Months of Study|Other|107|||
17002753|NCT00643201|38146913|FG001|Randomized, Completed 6 Months of Study|Other|107|||
17002754|NCT00643201|38146912|FG000|Completed Study Follow Up|Death|28|||
17002755|NCT00643201|38146913|FG001|Completed Study Follow Up|Death|34|||
17002756|NCT00643201|38146912|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
17002757|NCT00643201|38146913|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
17002758|NCT00643201|38146912|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
17002759|NCT00643201|38146913|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
16889644|NCT02504268|37935561|FG000|Overall Study|Pregnancy|2|||
16889645|NCT02504268|37935562|FG001|Overall Study|Pregnancy|0|||
16889646|NCT02504268|37935563|FG002|Overall Study|Pregnancy|0|||
16889647|NCT02504268|37935564|FG003|Overall Study|Pregnancy|0|||
16889648|NCT02504268|37935565|FG004|Overall Study|Pregnancy|0|||
16889649|NCT02504268|37935566|FG005|Overall Study|Pregnancy|0|||
16889650|NCT02504268|37935567|FG006|Overall Study|Pregnancy|0|||
16889651|NCT02504268|37935568|FG007|Overall Study|Pregnancy|0|||
16889652|NCT02504268|37935569|FG008|Overall Study|Pregnancy|0|||
16889653|NCT02504268|37935561|FG000|Overall Study|Lost to Follow-up|3|||
16889654|NCT02504268|37935562|FG001|Overall Study|Lost to Follow-up|6|||
16889655|NCT02504268|37935563|FG002|Overall Study|Lost to Follow-up|4|||
16889656|NCT02504268|37935564|FG003|Overall Study|Lost to Follow-up|0|||
16889657|NCT02504268|37935565|FG004|Overall Study|Lost to Follow-up|0|||
16889658|NCT02504268|37935566|FG005|Overall Study|Lost to Follow-up|0|||
16889659|NCT02504268|37935567|FG006|Overall Study|Lost to Follow-up|0|||
16889660|NCT02504268|37935568|FG007|Overall Study|Lost to Follow-up|0|||
16889661|NCT02504268|37935569|FG008|Overall Study|Lost to Follow-up|0|||
17002760|NCT00643201|38146912|FG000|Completed Study Follow Up|non-specified|1|||
17002761|NCT00643201|38146913|FG001|Completed Study Follow Up|non-specified|0|||
16889662|NCT02504268|37935561|FG000|Overall Study|Death|1|||
16889663|NCT02504268|37935562|FG001|Overall Study|Death|1|||
16889664|NCT02504268|37935563|FG002|Overall Study|Death|0|||
16889665|NCT02504268|37935564|FG003|Overall Study|Death|0|||
16889666|NCT02504268|37935565|FG004|Overall Study|Death|0|||
16889667|NCT02504268|37935566|FG005|Overall Study|Death|0|||
16889668|NCT02504268|37935567|FG006|Overall Study|Death|0|||
16889669|NCT02504268|37935568|FG007|Overall Study|Death|0|||
16889670|NCT02504268|37935569|FG008|Overall Study|Death|0|||
16889671|NCT02504268|37935561|FG000|Overall Study|Subject Request to Discontinue|11|||
16889672|NCT02504268|37935562|FG001|Overall Study|Subject Request to Discontinue|3|||
16889673|NCT02504268|37935563|FG002|Overall Study|Subject Request to Discontinue|6|||
16889674|NCT02504268|37935564|FG003|Overall Study|Subject Request to Discontinue|0|||
16889675|NCT02504268|37935565|FG004|Overall Study|Subject Request to Discontinue|0|||
16889676|NCT02504268|37935566|FG005|Overall Study|Subject Request to Discontinue|0|||
16889677|NCT02504268|37935567|FG006|Overall Study|Subject Request to Discontinue|0|||
16889678|NCT02504268|37935568|FG007|Overall Study|Subject Request to Discontinue|0|||
16889679|NCT02504268|37935569|FG008|Overall Study|Subject Request to Discontinue|0|||
16889680|NCT02504268|37935561|FG000|Overall Study|No Longer Meets Study Criteria|2|||
16889681|NCT02504268|37935562|FG001|Overall Study|No Longer Meets Study Criteria|3|||
16889682|NCT02504268|37935563|FG002|Overall Study|No Longer Meets Study Criteria|0|||
16889683|NCT02504268|37935564|FG003|Overall Study|No Longer Meets Study Criteria|0|||
16889684|NCT02504268|37935565|FG004|Overall Study|No Longer Meets Study Criteria|0|||
16889685|NCT02504268|37935566|FG005|Overall Study|No Longer Meets Study Criteria|0|||
16889686|NCT02504268|37935567|FG006|Overall Study|No Longer Meets Study Criteria|0|||
16889687|NCT02504268|37935568|FG007|Overall Study|No Longer Meets Study Criteria|0|||
16889688|NCT02504268|37935569|FG008|Overall Study|No Longer Meets Study Criteria|0|||
16889689|NCT02504268|37935561|FG000|Overall Study|Lack of Efficacy|11|||
16889690|NCT02504268|37935562|FG001|Overall Study|Lack of Efficacy|35|||
16889691|NCT02504268|37935563|FG002|Overall Study|Lack of Efficacy|9|||
16889692|NCT02504268|37935564|FG003|Overall Study|Lack of Efficacy|0|||
16889693|NCT02504268|37935565|FG004|Overall Study|Lack of Efficacy|0|||
16889694|NCT02504268|37935566|FG005|Overall Study|Lack of Efficacy|0|||
16889695|NCT02504268|37935567|FG006|Overall Study|Lack of Efficacy|0|||
16889696|NCT02504268|37935568|FG007|Overall Study|Lack of Efficacy|0|||
16889697|NCT02504268|37935569|FG008|Overall Study|Lack of Efficacy|0|||
16889698|NCT02504268|37935561|FG000|Overall Study|Poor/Non-Compliance|3|||
16889699|NCT02504268|37935562|FG001|Overall Study|Poor/Non-Compliance|2|||
16889700|NCT02504268|37935563|FG002|Overall Study|Poor/Non-Compliance|3|||
16889701|NCT02504268|37935564|FG003|Overall Study|Poor/Non-Compliance|0|||
16889702|NCT02504268|37935565|FG004|Overall Study|Poor/Non-Compliance|0|||
16889703|NCT02504268|37935566|FG005|Overall Study|Poor/Non-Compliance|0|||
17002762|NCT00643123|38146923|FG000|Overall Study|Lost to Follow-up|4|||
17002763|NCT00643123|38146924|FG001|Overall Study|Lost to Follow-up|0|||
17002764|NCT00643123|38146923|FG000|Overall Study|Withdrawal by Subject|1|||
16889704|NCT02504268|37935567|FG006|Overall Study|Poor/Non-Compliance|0|||
16889705|NCT02504268|37935568|FG007|Overall Study|Poor/Non-Compliance|0|||
16889706|NCT02504268|37935569|FG008|Overall Study|Poor/Non-Compliance|0|||
16889707|NCT02504268|37935561|FG000|Overall Study|Not Disclosed|1|||
16889708|NCT02504268|37935562|FG001|Overall Study|Not Disclosed|0|||
16889709|NCT02504268|37935563|FG002|Overall Study|Not Disclosed|2|||
16889710|NCT02504268|37935564|FG003|Overall Study|Not Disclosed|0|||
16889711|NCT02504268|37935565|FG004|Overall Study|Not Disclosed|0|||
16889712|NCT02504268|37935566|FG005|Overall Study|Not Disclosed|0|||
16889713|NCT02504268|37935567|FG006|Overall Study|Not Disclosed|0|||
16889714|NCT02504268|37935568|FG007|Overall Study|Not Disclosed|0|||
16889715|NCT02504268|37935569|FG008|Overall Study|Not Disclosed|0|||
16889716|NCT01654302|37935627|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
16889717|NCT01654302|37935628|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
16889718|NCT02476422|37935644|FG000|Overall Study|Subject/guardian decision|0|||
16889719|NCT02476422|37935645|FG001|Overall Study|Subject/guardian decision|1|||
16889720|NCT02475954|37935657|FG000|Overall Study|Withdrawal by Subject|2|||
16889721|NCT02475954|37935658|FG001|Overall Study|Withdrawal by Subject|2|||
16889722|NCT02475954|37935657|FG000|Overall Study|Lost to Follow-up|11|||
16889723|NCT02475954|37935658|FG001|Overall Study|Lost to Follow-up|9|||
16889724|NCT02475954|37935657|FG000|Overall Study|Death|1|||
16889725|NCT02475954|37935658|FG001|Overall Study|Death|1|||
16889726|NCT02475564|37935685|FG000|Overall Study|Withdrawal by Subject|1|||
16889727|NCT02475564|37935686|FG001|Overall Study|Withdrawal by Subject|0|||
16889728|NCT02475564|37935685|FG000|Overall Study|Lost to Follow-up|2|||
16889729|NCT02475564|37935686|FG001|Overall Study|Lost to Follow-up|1|||
16889730|NCT02475564|37935685|FG000|Overall Study|Intense Menstrual bleeding|1|||
16889731|NCT02475564|37935686|FG001|Overall Study|Intense Menstrual bleeding|0|||
16889732|NCT02503332|37935969|FG000|Overall Study|Adverse Event|17|||
16889733|NCT02503332|37935970|FG001|Overall Study|Adverse Event|5|||
16889734|NCT02503332|37935971|FG002|Overall Study|Adverse Event|3|||
16889735|NCT02503332|37935972|FG003|Overall Study|Adverse Event|1|||
16889736|NCT02503332|37935969|FG000|Overall Study|Investigator's Decision|5|||
16889737|NCT02503332|37935970|FG001|Overall Study|Investigator's Decision|1|||
16889738|NCT02503332|37935971|FG002|Overall Study|Investigator's Decision|0|||
16889739|NCT02503332|37935972|FG003|Overall Study|Investigator's Decision|0|||
16889740|NCT02503332|37935969|FG000|Overall Study|Sponsor's Decision|1|||
16889741|NCT02503332|37935970|FG001|Overall Study|Sponsor's Decision|0|||
16889742|NCT02503332|37935971|FG002|Overall Study|Sponsor's Decision|0|||
16889743|NCT02503332|37935972|FG003|Overall Study|Sponsor's Decision|1|||
16889744|NCT02503332|37935969|FG000|Overall Study|Subject Request|6|||
16889745|NCT02503332|37935970|FG001|Overall Study|Subject Request|5|||
16889746|NCT02503332|37935971|FG002|Overall Study|Subject Request|2|||
16889747|NCT02503332|37935972|FG003|Overall Study|Subject Request|1|||
16889748|NCT02503332|37935969|FG000|Overall Study|Death|0|||
16889749|NCT02503332|37935970|FG001|Overall Study|Death|2|||
16889750|NCT02503332|37935971|FG002|Overall Study|Death|2|||
16889751|NCT02503332|37935972|FG003|Overall Study|Death|0|||
16889752|NCT02503332|37935969|FG000|Overall Study|Other|5|||
16889753|NCT02503332|37935970|FG001|Overall Study|Other|6|||
16889754|NCT02503332|37935971|FG002|Overall Study|Other|1|||
16889755|NCT02503332|37935972|FG003|Overall Study|Other|1|||
16889756|NCT02502864|37935990|FG000|Overall Study|Withdrawal by Subject|1|||
16889757|NCT02474082|37936024|FG000|Overall Study|Adverse Event|2|||
16889758|NCT02474082|37936025|FG001|Overall Study|Adverse Event|32|||
16889759|NCT02474082|37936024|FG000|Overall Study|Withdrawal of informed consent|1|||
16889760|NCT02474082|37936025|FG001|Overall Study|Withdrawal of informed consent|11|||
16889761|NCT02474082|37936024|FG000|Overall Study|Lost to Follow-up|2|||
16889762|NCT02474082|37936025|FG001|Overall Study|Lost to Follow-up|2|||
16889763|NCT02474082|37936024|FG000|Overall Study|Dose tapering not achieved|0|||
16889764|NCT02474082|37936025|FG001|Overall Study|Dose tapering not achieved|4|||
16889765|NCT02474082|37936024|FG000|Overall Study|Participant/guardian decision|1|||
16889766|NCT02474082|37936025|FG001|Overall Study|Participant/guardian decision|2|||
16889767|NCT02474082|37936024|FG000|Overall Study|Non-compliance with study treatment|0|||
16889768|NCT02474082|37936025|FG001|Overall Study|Non-compliance with study treatment|2|||
16889769|NCT02474082|37936024|FG000|Overall Study|Protocol deviation|0|||
16889770|NCT02474082|37936025|FG001|Overall Study|Protocol deviation|1|||
16889771|NCT02501928|37936135|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
16889772|NCT02501928|37936136|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
16889773|NCT02501928|37936137|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
16889774|NCT02501928|37936138|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
16889775|NCT02501928|37936139|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
16889776|NCT02501928|37936140|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
16889777|NCT02473614|37936204|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
16889778|NCT02473614|37936205|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
16889779|NCT02500758|37936227|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
16889780|NCT02500758|37936228|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
16889781|NCT02500758|37936227|FG000|Washout (1 Week)|Lost to Follow-up|2|||
16889782|NCT02500758|37936228|FG001|Washout (1 Week)|Lost to Follow-up|2|||
16889783|NCT02500758|37936227|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
16889784|NCT02500758|37936228|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
16889785|NCT02500758|37936227|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
16889786|NCT02500758|37936228|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
16889787|NCT02500758|37936227|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
16889788|NCT02500758|37936228|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
16889789|NCT02500056|37936242|FG000|Overall Study|Lost to Follow-up|3|||
16889790|NCT02500056|37936243|FG001|Overall Study|Lost to Follow-up|7|||
16889791|NCT02500056|37936242|FG000|Overall Study|Recurrence|1|||
16889792|NCT02500056|37936243|FG001|Overall Study|Recurrence|0|||
16889793|NCT02500056|37936242|FG000|Overall Study|Death|3|||
16889794|NCT02500056|37936243|FG001|Overall Study|Death|1|||
16889795|NCT02472756|37936292|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
16889796|NCT02472756|37936292|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
16889797|NCT02472756|37936292|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
16889798|NCT02472756|37936292|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
16889799|NCT02472756|37936292|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
16889800|NCT02498652|37936302|FG000|Overall Study|Protocol Violation|0|||
16889801|NCT02498652|37936303|FG001|Overall Study|Protocol Violation|1|||
16889802|NCT03213158|37936327|FG000|Overall Study|Withdrawal by Subject|1|||
16889803|NCT03213158|37936327|FG000|Overall Study|Physician Decision|2|||
16889804|NCT02498418|37936334|FG000|Overall Study|Lack of Efficacy|0|||
16889805|NCT02498418|37936335|FG001|Overall Study|Lack of Efficacy|0|||
16889806|NCT02498418|37936336|FG002|Overall Study|Lack of Efficacy|1|||
16889807|NCT02498418|37936334|FG000|Overall Study|Withdrawal by Subject|2|||
16889808|NCT02498418|37936335|FG001|Overall Study|Withdrawal by Subject|0|||
16889809|NCT02498418|37936336|FG002|Overall Study|Withdrawal by Subject|3|||
16889810|NCT02498418|37936334|FG000|Overall Study|Lost to Follow-up|0|||
16889811|NCT02498418|37936335|FG001|Overall Study|Lost to Follow-up|1|||
16889812|NCT02498418|37936336|FG002|Overall Study|Lost to Follow-up|1|||
16889813|NCT02498418|37936334|FG000|Overall Study|Participant taken prohibited medication|0|||
16889814|NCT02498418|37936335|FG001|Overall Study|Participant taken prohibited medication|1|||
16889815|NCT02498418|37936336|FG002|Overall Study|Participant taken prohibited medication|1|||
16889816|NCT02472366|37936354|FG000|Overall Study|Lost to Follow-up|1|||
16889817|NCT02472366|37936355|FG001|Overall Study|Lost to Follow-up|0|||
16889818|NCT03217136|37936363|FG000|Overall Study|Lost to Follow-up|2|||
16889819|NCT03217136|37936364|FG001|Overall Study|Lost to Follow-up|1|||
16889820|NCT03217136|37936363|FG000|Overall Study|Site Randomized Participant in Error|0|||
16889821|NCT03217136|37936364|FG001|Overall Study|Site Randomized Participant in Error|1|||
16889822|NCT03217136|37936363|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
16889823|NCT03217136|37936364|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
16889824|NCT03217136|37936363|FG000|Overall Study|Dispensing Error|1|||
16889825|NCT03217136|37936364|FG001|Overall Study|Dispensing Error|0|||
16889826|NCT03217136|37936363|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16889827|NCT03217136|37936364|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16889828|NCT03219164|37936372|FG000|Overall Study|Study Terminated by Sponsor|16|||
16889829|NCT03219164|37936373|FG001|Overall Study|Study Terminated by Sponsor|12|||
16889830|NCT03219164|37936372|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
16889831|NCT03219164|37936373|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
16889832|NCT03219164|37936372|FG000|Overall Study|Lost to Follow-up|1|||
16889833|NCT03219164|37936373|FG001|Overall Study|Lost to Follow-up|1|||
16889834|NCT03219164|37936372|FG000|Overall Study|Adverse Event|1|||
16889835|NCT03219164|37936373|FG001|Overall Study|Adverse Event|0|||
16889836|NCT03219164|37936372|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16889837|NCT03219164|37936373|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16889838|NCT03219164|37936372|FG000|Overall Study|Protocol Violation|0|||
16889839|NCT03219164|37936373|FG001|Overall Study|Protocol Violation|1|||
16889840|NCT03219164|37936372|FG000|Overall Study|Withdrew Assent|1|||
16889841|NCT03219164|37936373|FG001|Overall Study|Withdrew Assent|0|||
16889842|NCT02471586|37936391|FG000|Overall Study|Lost to Follow-up|3|||
16889843|NCT02471586|37936392|FG001|Overall Study|Lost to Follow-up|8|||
16889844|NCT02471586|37936393|FG002|Overall Study|Lost to Follow-up|4|||
16889845|NCT02471586|37936391|FG000|Overall Study|Death|2|||
16889846|NCT02471586|37936392|FG001|Overall Study|Death|2|||
16889847|NCT02471586|37936393|FG002|Overall Study|Death|0|||
16889848|NCT02470806|37936544|FG000|Overall Study|Lost to Follow-up|1|||
16889849|NCT02470806|37936545|FG001|Overall Study|Lost to Follow-up|1|||
16889850|NCT02470806|37936544|FG000|Overall Study|Adverse Event|5|||
16889851|NCT02470806|37936545|FG001|Overall Study|Adverse Event|2|||
16889852|NCT02470806|37936544|FG000|Overall Study|Protocol Violation|4|||
16889853|NCT02470806|37936545|FG001|Overall Study|Protocol Violation|11|||
16889854|NCT02470806|37936544|FG000|Overall Study|Physician Decision|0|||
16889855|NCT02470806|37936545|FG001|Overall Study|Physician Decision|3|||
16889856|NCT02470806|37936544|FG000|Overall Study|Withdrawal by Subject|3|||
17095369|NCT03799198|38234640|FG000|Overall Study|Death|0|||
16889857|NCT02470806|37936545|FG001|Overall Study|Withdrawal by Subject|10|||
16889858|NCT02470806|37936544|FG000|Overall Study|Lack of Efficacy|5|||
16889859|NCT02470806|37936545|FG001|Overall Study|Lack of Efficacy|15|||
16889860|NCT01363908|37936587|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
16889861|NCT01363908|37936588|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
16889862|NCT01363908|37936587|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
16889863|NCT01363908|37936588|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
16889864|NCT01363908|37936587|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
16889865|NCT01363908|37936588|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
16889866|NCT01363908|37936587|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
16889867|NCT01363908|37936588|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
16889868|NCT02497404|37936626|FG000|Overall Study|Adverse Event|1|||
16889869|NCT02496702|37936659|FG000|Overall Study|Lost to Follow-up|8|||
16889870|NCT02496702|37936660|FG001|Overall Study|Lost to Follow-up|6|||
16889871|NCT02496702|37936659|FG000|Overall Study|Only partially tested|0|||
16889872|NCT02496702|37936660|FG001|Overall Study|Only partially tested|2|||
16889873|NCT02469246|37936736|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
16889874|NCT02469246|37936737|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
16889875|NCT02469246|37936736|FG000|Double-Blind Phase|Adverse Event|12|||
16889876|NCT02469246|37936737|FG001|Double-Blind Phase|Adverse Event|9|||
16889877|NCT02469246|37936736|FG000|Double-Blind Phase|Death|2|||
16889878|NCT02469246|37936737|FG001|Double-Blind Phase|Death|0|||
16889879|NCT02469246|37936736|FG000|Double-Blind Phase|Lack of Efficacy|2|||
16889880|NCT02469246|37936737|FG001|Double-Blind Phase|Lack of Efficacy|1|||
16889881|NCT02469246|37936736|FG000|Double-Blind Phase|Investigator's Discretion|8|||
16889882|NCT02469246|37936737|FG001|Double-Blind Phase|Investigator's Discretion|8|||
16889883|NCT02469246|37936736|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
16889884|NCT02469246|37936737|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16889885|NCT02469246|37936736|FG000|Double-Blind Phase|Protocol Violation|1|||
16889886|NCT02469246|37936737|FG001|Double-Blind Phase|Protocol Violation|1|||
16889887|NCT02469246|37936736|FG000|Double-Blind Phase|Withdrew Consent|25|||
16889888|NCT02469246|37936737|FG001|Double-Blind Phase|Withdrew Consent|25|||
16889889|NCT02469246|37936736|FG000|Double-Blind Phase|Lost to Follow-up|9|||
16889890|NCT02469246|37936737|FG001|Double-Blind Phase|Lost to Follow-up|5|||
16889891|NCT02469168|37936756|FG000|Overall Study|Trial closed|1|||
16889892|NCT02469168|37936757|FG001|Overall Study|Trial closed|0|||
16889893|NCT02469090|37936765|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
16889894|NCT02469090|37936766|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
16889895|NCT02469090|37936767|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
16889896|NCT02469090|37936765|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
16889897|NCT02469090|37936766|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
16889898|NCT02469090|37936767|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
16889899|NCT02469090|37936765|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
16889900|NCT02469090|37936766|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
16889901|NCT02469090|37936767|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
16889902|NCT02469090|37936765|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
16889903|NCT02469090|37936766|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
16889904|NCT02469090|37936767|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
16889905|NCT02469090|37936765|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
16889906|NCT02469090|37936766|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
16889907|NCT02469090|37936767|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
16889908|NCT02469090|37936765|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
16889909|NCT02469090|37936766|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
16889910|NCT02469090|37936767|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
16889911|NCT02469090|37936765|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
16889912|NCT02469090|37936766|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
16889913|NCT02469090|37936767|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
16889914|NCT02469090|37936765|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
16889915|NCT02469090|37936766|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
16889916|NCT02469090|37936767|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
16889917|NCT02496000|37936777|FG000|Overall Study|Withdrawal by Subject|1|||
16889918|NCT02496000|37936778|FG001|Overall Study|Withdrawal by Subject|2|||
16889919|NCT02496000|37936779|FG002|Overall Study|Withdrawal by Subject|0|||
16889920|NCT02496000|37936777|FG000|Overall Study|Lost to Follow-up|1|||
16889921|NCT02496000|37936778|FG001|Overall Study|Lost to Follow-up|0|||
16889922|NCT02496000|37936779|FG002|Overall Study|Lost to Follow-up|1|||
16889923|NCT02496000|37936777|FG000|Overall Study|Protocol Violation|0|||
16889924|NCT02496000|37936778|FG001|Overall Study|Protocol Violation|0|||
16889925|NCT02496000|37936779|FG002|Overall Study|Protocol Violation|1|||
16889926|NCT02496000|37936777|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
16889927|NCT02496000|37936778|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
16889928|NCT02496000|37936779|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
16889929|NCT02496000|37936777|FG000|Overall Study|undetermined|0|||
16889930|NCT02496000|37936778|FG001|Overall Study|undetermined|1|||
16889931|NCT02496000|37936779|FG002|Overall Study|undetermined|0|||
16889932|NCT02468934|37936788|FG000|Overall Study|Withdrawal by Subject|4|||
16889933|NCT02468934|37936788|FG000|Overall Study|Screen Failure|3|||
16889934|NCT02517528|37936794|FG000|Overall Study|Withdrawal by Subject|1|||
16889935|NCT02495844|37936800|FG000|Overall Study|Lack of Efficacy|1|||
16889936|NCT02495844|37936801|FG001|Overall Study|Lack of Efficacy|2|||
16889937|NCT02495844|37936800|FG000|Overall Study|AE, non-fatal|0|||
16889938|NCT02495844|37936801|FG001|Overall Study|AE, non-fatal|1|||
16889939|NCT02495844|37936800|FG000|Overall Study|Hepatitis Positivity|0|||
16889940|NCT02495844|37936801|FG001|Overall Study|Hepatitis Positivity|1|||
16889941|NCT02468778|37936812|FG000|Overall Study|Death|2|||
16889942|NCT02468778|37936813|FG001|Overall Study|Death|1|||
16889943|NCT02468778|37936814|FG002|Overall Study|Death|0|||
16889944|NCT02468778|37936812|FG000|Overall Study|Lost to Follow-up|1|||
16889945|NCT02468778|37936813|FG001|Overall Study|Lost to Follow-up|2|||
16889946|NCT02468778|37936814|FG002|Overall Study|Lost to Follow-up|2|||
16889947|NCT02468778|37936812|FG000|Overall Study|Withdrawal by Subject|0|||
16889948|NCT02468778|37936813|FG001|Overall Study|Withdrawal by Subject|1|||
16889949|NCT02468778|37936814|FG002|Overall Study|Withdrawal by Subject|1|||
17192106|NCT00406393|38345222|FG000|Overall Study|Did not undergo transplantation|2|||
17192107|NCT00406393|38345223|FG001|Overall Study|Did not undergo transplantation|1|||
17192108|NCT02845375|38345232|FG000|Overall Study|upper airway obstruction|1|||
17192109|NCT02845375|38345233|FG001|Overall Study|upper airway obstruction|2|||
17192110|NCT02845375|38345234|FG002|Overall Study|upper airway obstruction|1|||
17192111|NCT02658734|38345242|FG000|Overall Study|Adverse Event|2|||
17192112|NCT02658734|38345242|FG000|Overall Study|Death|4|||
17192113|NCT02658734|38345242|FG000|Overall Study|Lost to Follow-up|7|||
17192114|NCT02658734|38345242|FG000|Overall Study|Withdrawal of Consent|16|||
17192115|NCT02658734|38345242|FG000|Overall Study|Disease Progression|28|||
17192116|NCT02844439|38345246|FG000|Overall Study|Withdrawal by Subject|1|||
17192117|NCT02844439|38345246|FG000|Overall Study|Lost to Follow-up|2|||
17192118|NCT02844439|38345246|FG000|Overall Study|Termination by Sponsor|4|||
17192119|NCT02844439|38345246|FG000|Overall Study|Death|28|||
17192120|NCT02844439|38345246|FG000|Overall Study|Other|5|||
17192121|NCT01677182|38345260|FG000|Overall Study|Adverse Event|2|||
17192122|NCT01677182|38345261|FG001|Overall Study|Adverse Event|1|||
17192123|NCT01677182|38345262|FG002|Overall Study|Adverse Event|8|||
17192124|NCT01677182|38345260|FG000|Overall Study|Protocol Violation|5|||
17192125|NCT01677182|38345261|FG001|Overall Study|Protocol Violation|1|||
17192126|NCT01677182|38345262|FG002|Overall Study|Protocol Violation|4|||
17192127|NCT01677182|38345260|FG000|Overall Study|Lost to Follow-up|4|||
17192128|NCT01677182|38345261|FG001|Overall Study|Lost to Follow-up|0|||
17192129|NCT01677182|38345262|FG002|Overall Study|Lost to Follow-up|3|||
17192130|NCT01677182|38345260|FG000|Overall Study|Withdrawal by Subject|7|||
17192131|NCT01677182|38345261|FG001|Overall Study|Withdrawal by Subject|12|||
17192132|NCT01677182|38345262|FG002|Overall Study|Withdrawal by Subject|10|||
17192133|NCT01677182|38345260|FG000|Overall Study|Study termination|12|||
17192134|NCT01677182|38345261|FG001|Overall Study|Study termination|9|||
17192135|NCT01677182|38345262|FG002|Overall Study|Study termination|11|||
17192136|NCT01677182|38345260|FG000|Overall Study|Lack of Efficacy|3|||
17192137|NCT01677182|38345261|FG001|Overall Study|Lack of Efficacy|0|||
17192138|NCT01677182|38345262|FG002|Overall Study|Lack of Efficacy|1|||
17192139|NCT01677182|38345260|FG000|Overall Study|Other reasons|1|||
17192140|NCT01677182|38345261|FG001|Overall Study|Other reasons|5|||
17192141|NCT01677182|38345262|FG002|Overall Study|Other reasons|2|||
17192142|NCT02843659|38345273|FG000|Overall Study|Subject Withdrew Consent|0|||
17192143|NCT02843659|38345274|FG001|Overall Study|Subject Withdrew Consent|0|||
17192144|NCT02843659|38345275|FG002|Overall Study|Subject Withdrew Consent|1|||
17192145|NCT02843659|38345273|FG000|Overall Study|Administrative Reason by Sponsor|4|||
17192146|NCT02843659|38345274|FG001|Overall Study|Administrative Reason by Sponsor|5|||
17192147|NCT02843659|38345275|FG002|Overall Study|Administrative Reason by Sponsor|4|||
17192148|NCT02843659|38345273|FG000|Overall Study|Adverse Event|0|||
17192149|NCT02843659|38345274|FG001|Overall Study|Adverse Event|1|||
17192150|NCT02843659|38345275|FG002|Overall Study|Adverse Event|0|||
17192151|NCT00708435|38345285|FG000|Overall Study|Death / Serious Adverse Event|10|||
17192152|NCT00708435|38345286|FG001|Overall Study|Death / Serious Adverse Event|5|||
17192153|NCT00708435|38345285|FG000|Overall Study|Lost to Follow-up|9|||
17192154|NCT00708435|38345286|FG001|Overall Study|Lost to Follow-up|4|||
17192155|NCT00708435|38345285|FG000|Overall Study|Withdrawal by Subject|3|||
17192156|NCT00708435|38345286|FG001|Overall Study|Withdrawal by Subject|7|||
17192157|NCT00708435|38345285|FG000|Overall Study|Adverse Event|1|||
17192158|NCT00708435|38345286|FG001|Overall Study|Adverse Event|0|||
17192159|NCT00708435|38345285|FG000|Overall Study|Protocol Violation|0|||
17192160|NCT00708435|38345286|FG001|Overall Study|Protocol Violation|1|||
17192161|NCT00708435|38345285|FG000|Overall Study|Intervention by primary care physician|1|||
16889950|NCT01727336|37936828|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
16889951|NCT01727336|37936829|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
16889952|NCT01727336|37936830|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
16889953|NCT01727336|37936831|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
16889954|NCT01727336|37936832|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
16889955|NCT01727336|37936833|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
16889956|NCT01727336|37936828|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
16889957|NCT01727336|37936829|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
16889958|NCT01727336|37936830|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
16889959|NCT01727336|37936831|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
16889960|NCT01727336|37936832|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
16889961|NCT01727336|37936833|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
17002765|NCT00643123|38146924|FG001|Overall Study|Withdrawal by Subject|1|||
17002766|NCT00968981|38146933|FG000|Overall Study|Adverse Event|2|||
17002767|NCT00968981|38146934|FG001|Overall Study|Adverse Event|0|||
17002768|NCT00968981|38146935|FG002|Overall Study|Adverse Event|0|||
17002769|NCT00968981|38146933|FG000|Overall Study|Disease Progression|14|||
17002770|NCT00968981|38146934|FG001|Overall Study|Disease Progression|16|||
17002771|NCT00968981|38146935|FG002|Overall Study|Disease Progression|13|||
17002772|NCT00968981|38146933|FG000|Overall Study|Lost to Follow-up|0|||
17002773|NCT00968981|38146934|FG001|Overall Study|Lost to Follow-up|0|||
17002774|NCT00968981|38146935|FG002|Overall Study|Lost to Follow-up|1|||
17002775|NCT00968981|38146933|FG000|Overall Study|Physician Decision|5|||
17002776|NCT00968981|38146934|FG001|Overall Study|Physician Decision|3|||
17002777|NCT00968981|38146935|FG002|Overall Study|Physician Decision|5|||
17002778|NCT00968981|38146933|FG000|Overall Study|Withdrawal by Subject|1|||
17002779|NCT00968981|38146934|FG001|Overall Study|Withdrawal by Subject|3|||
17002780|NCT00968981|38146935|FG002|Overall Study|Withdrawal by Subject|3|||
17002781|NCT00641719|38146946|FG000|Overall Study|Lack of Efficacy|1|||
17002782|NCT00641719|38146947|FG001|Overall Study|Lack of Efficacy|2|||
17002783|NCT00641719|38146946|FG000|Overall Study|Adverse Event|24|||
17002784|NCT00641719|38146947|FG001|Overall Study|Adverse Event|29|||
17002785|NCT00641719|38146946|FG000|Overall Study|Withdrawal by Subject|4|||
17002786|NCT00641719|38146947|FG001|Overall Study|Withdrawal by Subject|4|||
17002787|NCT00641719|38146946|FG000|Overall Study|Reason Not Specified|1|||
17002788|NCT00641719|38146947|FG001|Overall Study|Reason Not Specified|2|||
17095370|NCT03799198|38234641|FG001|Overall Study|Death|1|||
16889962|NCT01727336|37936828|FG000|Part 2 Blinded|Death|0|||
16889963|NCT01727336|37936829|FG001|Part 2 Blinded|Death|0|||
16889964|NCT01727336|37936830|FG002|Part 2 Blinded|Death|0|||
16889965|NCT01727336|37936831|FG003|Part 2 Blinded|Death|0|||
16889966|NCT01727336|37936832|FG004|Part 2 Blinded|Death|20|||
16889967|NCT01727336|37936833|FG005|Part 2 Blinded|Death|16|||
16889968|NCT01727336|37936828|FG000|Part 2 Blinded|Lack of Efficacy|0|||
16889969|NCT01727336|37936829|FG001|Part 2 Blinded|Lack of Efficacy|0|||
16889970|NCT01727336|37936830|FG002|Part 2 Blinded|Lack of Efficacy|0|||
16889971|NCT01727336|37936831|FG003|Part 2 Blinded|Lack of Efficacy|0|||
16889972|NCT01727336|37936832|FG004|Part 2 Blinded|Lack of Efficacy|42|||
16889973|NCT01727336|37936833|FG005|Part 2 Blinded|Lack of Efficacy|44|||
16889974|NCT01727336|37936828|FG000|Part 2 Blinded|Lost to Follow-up|0|||
16889975|NCT01727336|37936829|FG001|Part 2 Blinded|Lost to Follow-up|0|||
16889976|NCT01727336|37936830|FG002|Part 2 Blinded|Lost to Follow-up|0|||
16889977|NCT01727336|37936831|FG003|Part 2 Blinded|Lost to Follow-up|0|||
16889978|NCT01727336|37936832|FG004|Part 2 Blinded|Lost to Follow-up|0|||
16889979|NCT01727336|37936833|FG005|Part 2 Blinded|Lost to Follow-up|1|||
16889980|NCT01727336|37936828|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
16889981|NCT01727336|37936829|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
16889982|NCT01727336|37936830|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
16889983|NCT01727336|37936831|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
16889984|NCT01727336|37936832|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
16889985|NCT01727336|37936833|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
16889986|NCT01727336|37936828|FG000|Part 2 Blinded|use of prohibited medications|0|||
16889987|NCT01727336|37936829|FG001|Part 2 Blinded|use of prohibited medications|0|||
16889988|NCT01727336|37936830|FG002|Part 2 Blinded|use of prohibited medications|0|||
16889989|NCT01727336|37936831|FG003|Part 2 Blinded|use of prohibited medications|0|||
16889990|NCT01727336|37936832|FG004|Part 2 Blinded|use of prohibited medications|1|||
16889991|NCT01727336|37936833|FG005|Part 2 Blinded|use of prohibited medications|3|||
16889992|NCT02466516|37936867|FG000|Overall Study|Adverse Event|1|||
16889993|NCT02466516|37936868|FG001|Overall Study|Adverse Event|1|||
16889994|NCT02466516|37936869|FG002|Overall Study|Adverse Event|0|||
16889995|NCT02466516|37936870|FG003|Overall Study|Adverse Event|0|||
16889996|NCT02466516|37936871|FG004|Overall Study|Adverse Event|0|||
16889997|NCT02466516|37936867|FG000|Overall Study|Withdrew Consent|1|||
16889998|NCT02466516|37936868|FG001|Overall Study|Withdrew Consent|0|||
16889999|NCT02466516|37936869|FG002|Overall Study|Withdrew Consent|0|||
16890000|NCT02466516|37936870|FG003|Overall Study|Withdrew Consent|0|||
17002789|NCT00648895|38146955|FG000|Overall Study|Lack of Efficacy|0|||
16890001|NCT02466516|37936871|FG004|Overall Study|Withdrew Consent|0|||
16890002|NCT02466516|37936867|FG000|Overall Study|Lost to Follow-up|2|||
16890003|NCT02466516|37936868|FG001|Overall Study|Lost to Follow-up|0|||
16890004|NCT02466516|37936869|FG002|Overall Study|Lost to Follow-up|1|||
16890005|NCT02466516|37936870|FG003|Overall Study|Lost to Follow-up|0|||
16890006|NCT02466516|37936871|FG004|Overall Study|Lost to Follow-up|0|||
16890007|NCT01049984|37936893|FG000|Overall Study|Withdrawal by Subject|1|||
16890008|NCT01049984|37936894|FG001|Overall Study|Withdrawal by Subject|5|||
16890009|NCT01049984|37936893|FG000|Overall Study|Protocol Violation|3|||
16890010|NCT01049984|37936894|FG001|Overall Study|Protocol Violation|4|||
16890011|NCT01049984|37936893|FG000|Overall Study|Lost to Follow-up|2|||
16890012|NCT01049984|37936894|FG001|Overall Study|Lost to Follow-up|1|||
16890013|NCT01049984|37936893|FG000|Overall Study|Adverse Event|13|||
16890014|NCT01049984|37936894|FG001|Overall Study|Adverse Event|7|||
16890015|NCT01049984|37936893|FG000|Overall Study|Treatment failure|0|||
16890016|NCT01049984|37936894|FG001|Overall Study|Treatment failure|2|||
16890017|NCT01049360|37936900|FG000|Period 1|Adverse Event|0|||
16890018|NCT01049360|37936901|FG001|Period 1|Adverse Event|1|||
16890019|NCT01049360|37936902|FG002|Period 1|Adverse Event|0|||
16890020|NCT01049360|37936903|FG003|Period 1|Adverse Event|1|||
16890021|NCT01049360|37936904|FG004|Period 1|Adverse Event|0|||
16890022|NCT01049360|37936905|FG005|Period 1|Adverse Event|0|||
16890023|NCT01049360|37936906|FG006|Period 1|Adverse Event|0|||
16890024|NCT01049360|37936907|FG007|Period 1|Adverse Event|1|||
16890025|NCT01049360|37936908|FG008|Period 1|Adverse Event|0|||
16890026|NCT01049360|37936909|FG009|Period 1|Adverse Event|0|||
17002790|NCT00648895|38146956|FG001|Overall Study|Lack of Efficacy|1|||
17002791|NCT00975221|38146964|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
16890027|NCT01049360|37936910|FG010|Period 1|Adverse Event|0|||
16890028|NCT01049360|37936911|FG011|Period 1|Adverse Event|0|||
16890029|NCT01049360|37936912|FG012|Period 1|Adverse Event|1|||
16890030|NCT01049360|37936913|FG013|Period 1|Adverse Event|1|||
16890031|NCT01049360|37936914|FG014|Period 1|Adverse Event|0|||
16890032|NCT01049360|37936915|FG015|Period 1|Adverse Event|0|||
16890033|NCT01049360|37936916|FG016|Period 1|Adverse Event|1|||
17002792|NCT00975221|38146965|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
17002793|NCT00975221|38146964|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
17002794|NCT00975221|38146965|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
17002795|NCT00975221|38146964|FG000|Titration Phase (Weeks 1-12)|Other|0|||
17002796|NCT00975221|38146965|FG001|Titration Phase (Weeks 1-12)|Other|1|||
17002797|NCT00975221|38146964|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
17002798|NCT00975221|38146965|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
17002799|NCT00975221|38146964|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
17002800|NCT00975221|38146965|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
17002801|NCT00975221|38146964|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
17002802|NCT00975221|38146965|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
17002803|NCT00972179|38146980|FG000|Overall Study|Noncompliance|1|||
17002804|NCT00972179|38146981|FG001|Overall Study|Noncompliance|0|||
17002805|NCT00972179|38146982|FG002|Overall Study|Noncompliance|0|||
16890034|NCT01049360|37936917|FG017|Period 1|Adverse Event|0|||
16890035|NCT01049360|37936918|FG018|Period 1|Adverse Event|1|||
16890036|NCT01049360|37936919|FG019|Period 1|Adverse Event|0|||
16890037|NCT01049360|37936900|FG000|Period 1|Did not meet inc/exc criteria|0|||
16890038|NCT01049360|37936901|FG001|Period 1|Did not meet inc/exc criteria|0|||
16890039|NCT01049360|37936902|FG002|Period 1|Did not meet inc/exc criteria|0|||
16890040|NCT01049360|37936903|FG003|Period 1|Did not meet inc/exc criteria|0|||
16890041|NCT01049360|37936904|FG004|Period 1|Did not meet inc/exc criteria|0|||
16890042|NCT01049360|37936905|FG005|Period 1|Did not meet inc/exc criteria|0|||
16890043|NCT01049360|37936906|FG006|Period 1|Did not meet inc/exc criteria|0|||
16890044|NCT01049360|37936907|FG007|Period 1|Did not meet inc/exc criteria|1|||
16890045|NCT01049360|37936908|FG008|Period 1|Did not meet inc/exc criteria|1|||
16890046|NCT01049360|37936909|FG009|Period 1|Did not meet inc/exc criteria|0|||
16890047|NCT01049360|37936910|FG010|Period 1|Did not meet inc/exc criteria|0|||
16890048|NCT01049360|37936911|FG011|Period 1|Did not meet inc/exc criteria|0|||
16890049|NCT01049360|37936912|FG012|Period 1|Did not meet inc/exc criteria|0|||
16890050|NCT01049360|37936913|FG013|Period 1|Did not meet inc/exc criteria|0|||
16890051|NCT01049360|37936914|FG014|Period 1|Did not meet inc/exc criteria|0|||
16890052|NCT01049360|37936915|FG015|Period 1|Did not meet inc/exc criteria|0|||
16890053|NCT01049360|37936916|FG016|Period 1|Did not meet inc/exc criteria|0|||
16890054|NCT01049360|37936917|FG017|Period 1|Did not meet inc/exc criteria|0|||
16890055|NCT01049360|37936918|FG018|Period 1|Did not meet inc/exc criteria|0|||
16890056|NCT01049360|37936919|FG019|Period 1|Did not meet inc/exc criteria|0|||
16890057|NCT01049360|37936900|FG000|Period 1|Withdrawal by Subject|0|||
16890058|NCT01049360|37936901|FG001|Period 1|Withdrawal by Subject|0|||
16890059|NCT01049360|37936902|FG002|Period 1|Withdrawal by Subject|0|||
16890060|NCT01049360|37936903|FG003|Period 1|Withdrawal by Subject|0|||
16890061|NCT01049360|37936904|FG004|Period 1|Withdrawal by Subject|0|||
16890062|NCT01049360|37936905|FG005|Period 1|Withdrawal by Subject|0|||
16890063|NCT01049360|37936906|FG006|Period 1|Withdrawal by Subject|0|||
16890064|NCT01049360|37936907|FG007|Period 1|Withdrawal by Subject|0|||
16890065|NCT01049360|37936908|FG008|Period 1|Withdrawal by Subject|1|||
16890066|NCT01049360|37936909|FG009|Period 1|Withdrawal by Subject|0|||
16890067|NCT01049360|37936910|FG010|Period 1|Withdrawal by Subject|1|||
16890068|NCT01049360|37936911|FG011|Period 1|Withdrawal by Subject|0|||
16890069|NCT01049360|37936912|FG012|Period 1|Withdrawal by Subject|1|||
16890070|NCT01049360|37936913|FG013|Period 1|Withdrawal by Subject|0|||
16890071|NCT01049360|37936914|FG014|Period 1|Withdrawal by Subject|0|||
16890072|NCT01049360|37936915|FG015|Period 1|Withdrawal by Subject|0|||
16890073|NCT01049360|37936916|FG016|Period 1|Withdrawal by Subject|0|||
16890074|NCT01049360|37936917|FG017|Period 1|Withdrawal by Subject|0|||
16890075|NCT01049360|37936918|FG018|Period 1|Withdrawal by Subject|0|||
16890076|NCT01049360|37936919|FG019|Period 1|Withdrawal by Subject|0|||
16890077|NCT01049360|37936900|FG000|Period 2|Protocol Violation|0|||
16890078|NCT01049360|37936901|FG001|Period 2|Protocol Violation|0|||
16890079|NCT01049360|37936902|FG002|Period 2|Protocol Violation|0|||
16890080|NCT01049360|37936903|FG003|Period 2|Protocol Violation|1|||
16890081|NCT01049360|37936904|FG004|Period 2|Protocol Violation|0|||
16890082|NCT01049360|37936905|FG005|Period 2|Protocol Violation|0|||
16890083|NCT01049360|37936906|FG006|Period 2|Protocol Violation|0|||
16890084|NCT01049360|37936907|FG007|Period 2|Protocol Violation|0|||
16890085|NCT01049360|37936908|FG008|Period 2|Protocol Violation|0|||
16890086|NCT01049360|37936909|FG009|Period 2|Protocol Violation|0|||
16890087|NCT01049360|37936910|FG010|Period 2|Protocol Violation|0|||
16890088|NCT01049360|37936911|FG011|Period 2|Protocol Violation|0|||
16890089|NCT01049360|37936912|FG012|Period 2|Protocol Violation|0|||
16890090|NCT01049360|37936913|FG013|Period 2|Protocol Violation|0|||
16890091|NCT01049360|37936914|FG014|Period 2|Protocol Violation|1|||
16890092|NCT01049360|37936915|FG015|Period 2|Protocol Violation|1|||
16890093|NCT01049360|37936916|FG016|Period 2|Protocol Violation|0|||
16890094|NCT01049360|37936917|FG017|Period 2|Protocol Violation|0|||
16890095|NCT01049360|37936918|FG018|Period 2|Protocol Violation|0|||
16890096|NCT01049360|37936919|FG019|Period 2|Protocol Violation|0|||
16890097|NCT01049360|37936900|FG000|Period 2|Adverse Event|0|||
16890098|NCT01049360|37936901|FG001|Period 2|Adverse Event|1|||
16890099|NCT01049360|37936902|FG002|Period 2|Adverse Event|0|||
16890100|NCT01049360|37936903|FG003|Period 2|Adverse Event|0|||
16890101|NCT01049360|37936904|FG004|Period 2|Adverse Event|0|||
16890102|NCT01049360|37936905|FG005|Period 2|Adverse Event|0|||
16890103|NCT01049360|37936906|FG006|Period 2|Adverse Event|0|||
16890104|NCT01049360|37936907|FG007|Period 2|Adverse Event|0|||
16890105|NCT01049360|37936908|FG008|Period 2|Adverse Event|1|||
16890106|NCT01049360|37936909|FG009|Period 2|Adverse Event|0|||
16890107|NCT01049360|37936910|FG010|Period 2|Adverse Event|0|||
16890108|NCT01049360|37936911|FG011|Period 2|Adverse Event|0|||
16890109|NCT01049360|37936912|FG012|Period 2|Adverse Event|0|||
16890110|NCT01049360|37936913|FG013|Period 2|Adverse Event|0|||
16890111|NCT01049360|37936914|FG014|Period 2|Adverse Event|0|||
16890112|NCT01049360|37936915|FG015|Period 2|Adverse Event|0|||
16890113|NCT01049360|37936916|FG016|Period 2|Adverse Event|0|||
16890114|NCT01049360|37936917|FG017|Period 2|Adverse Event|0|||
16890115|NCT01049360|37936918|FG018|Period 2|Adverse Event|0|||
16890116|NCT01049360|37936919|FG019|Period 2|Adverse Event|1|||
16890117|NCT01049360|37936900|FG000|Period 2|Withdrawal by Subject|0|||
16890118|NCT01049360|37936901|FG001|Period 2|Withdrawal by Subject|0|||
16890119|NCT01049360|37936902|FG002|Period 2|Withdrawal by Subject|0|||
16890120|NCT01049360|37936903|FG003|Period 2|Withdrawal by Subject|1|||
16890121|NCT01049360|37936904|FG004|Period 2|Withdrawal by Subject|0|||
16890122|NCT01049360|37936905|FG005|Period 2|Withdrawal by Subject|0|||
16890123|NCT01049360|37936906|FG006|Period 2|Withdrawal by Subject|0|||
16890124|NCT01049360|37936907|FG007|Period 2|Withdrawal by Subject|0|||
16890125|NCT01049360|37936908|FG008|Period 2|Withdrawal by Subject|0|||
16890126|NCT01049360|37936909|FG009|Period 2|Withdrawal by Subject|0|||
16890127|NCT01049360|37936910|FG010|Period 2|Withdrawal by Subject|0|||
16890128|NCT01049360|37936911|FG011|Period 2|Withdrawal by Subject|0|||
16890129|NCT01049360|37936912|FG012|Period 2|Withdrawal by Subject|0|||
16890130|NCT01049360|37936913|FG013|Period 2|Withdrawal by Subject|0|||
16890131|NCT01049360|37936914|FG014|Period 2|Withdrawal by Subject|1|||
16890132|NCT01049360|37936915|FG015|Period 2|Withdrawal by Subject|0|||
16890133|NCT01049360|37936916|FG016|Period 2|Withdrawal by Subject|0|||
16890134|NCT01049360|37936917|FG017|Period 2|Withdrawal by Subject|0|||
16890135|NCT01049360|37936918|FG018|Period 2|Withdrawal by Subject|0|||
16890136|NCT01049360|37936919|FG019|Period 2|Withdrawal by Subject|1|||
16890137|NCT01049360|37936900|FG000|Period 2|Lack of Efficacy|0|||
16890138|NCT01049360|37936901|FG001|Period 2|Lack of Efficacy|0|||
16890139|NCT01049360|37936902|FG002|Period 2|Lack of Efficacy|0|||
16890140|NCT01049360|37936903|FG003|Period 2|Lack of Efficacy|0|||
16890141|NCT01049360|37936904|FG004|Period 2|Lack of Efficacy|0|||
16890142|NCT01049360|37936905|FG005|Period 2|Lack of Efficacy|1|||
16890143|NCT01049360|37936906|FG006|Period 2|Lack of Efficacy|0|||
16890144|NCT01049360|37936907|FG007|Period 2|Lack of Efficacy|0|||
16890145|NCT01049360|37936908|FG008|Period 2|Lack of Efficacy|0|||
16890146|NCT01049360|37936909|FG009|Period 2|Lack of Efficacy|0|||
16890147|NCT01049360|37936910|FG010|Period 2|Lack of Efficacy|0|||
16890148|NCT01049360|37936911|FG011|Period 2|Lack of Efficacy|0|||
16890149|NCT01049360|37936912|FG012|Period 2|Lack of Efficacy|0|||
16890150|NCT01049360|37936913|FG013|Period 2|Lack of Efficacy|0|||
16890151|NCT01049360|37936914|FG014|Period 2|Lack of Efficacy|0|||
16890152|NCT01049360|37936915|FG015|Period 2|Lack of Efficacy|0|||
16890153|NCT01049360|37936916|FG016|Period 2|Lack of Efficacy|0|||
16890154|NCT01049360|37936917|FG017|Period 2|Lack of Efficacy|0|||
16890155|NCT01049360|37936918|FG018|Period 2|Lack of Efficacy|0|||
16890156|NCT01049360|37936919|FG019|Period 2|Lack of Efficacy|0|||
16890157|NCT01049360|37936900|FG000|Period 4|Protocol Violation|0|||
16890158|NCT01049360|37936901|FG001|Period 4|Protocol Violation|0|||
16890159|NCT01049360|37936902|FG002|Period 4|Protocol Violation|0|||
16890160|NCT01049360|37936903|FG003|Period 4|Protocol Violation|0|||
16890161|NCT01049360|37936904|FG004|Period 4|Protocol Violation|0|||
16890162|NCT01049360|37936905|FG005|Period 4|Protocol Violation|0|||
16890163|NCT01049360|37936906|FG006|Period 4|Protocol Violation|0|||
16890164|NCT01049360|37936907|FG007|Period 4|Protocol Violation|0|||
16890165|NCT01049360|37936908|FG008|Period 4|Protocol Violation|0|||
16890166|NCT01049360|37936909|FG009|Period 4|Protocol Violation|0|||
16890167|NCT01049360|37936910|FG010|Period 4|Protocol Violation|0|||
16890168|NCT01049360|37936911|FG011|Period 4|Protocol Violation|0|||
16890169|NCT01049360|37936912|FG012|Period 4|Protocol Violation|0|||
16890170|NCT01049360|37936913|FG013|Period 4|Protocol Violation|0|||
16890171|NCT01049360|37936914|FG014|Period 4|Protocol Violation|0|||
16890172|NCT01049360|37936915|FG015|Period 4|Protocol Violation|0|||
16890173|NCT01049360|37936916|FG016|Period 4|Protocol Violation|0|||
16890174|NCT01049360|37936917|FG017|Period 4|Protocol Violation|1|||
16890175|NCT01049360|37936918|FG018|Period 4|Protocol Violation|0|||
16890176|NCT01049360|37936919|FG019|Period 4|Protocol Violation|0|||
16890177|NCT01049360|37936900|FG000|Period 4|Withdrawal by Subject|0|||
16890178|NCT01049360|37936901|FG001|Period 4|Withdrawal by Subject|0|||
16890179|NCT01049360|37936902|FG002|Period 4|Withdrawal by Subject|0|||
16890180|NCT01049360|37936903|FG003|Period 4|Withdrawal by Subject|1|||
16890181|NCT01049360|37936904|FG004|Period 4|Withdrawal by Subject|0|||
16890182|NCT01049360|37936905|FG005|Period 4|Withdrawal by Subject|0|||
16890183|NCT01049360|37936906|FG006|Period 4|Withdrawal by Subject|0|||
16890184|NCT01049360|37936907|FG007|Period 4|Withdrawal by Subject|0|||
16890185|NCT01049360|37936908|FG008|Period 4|Withdrawal by Subject|0|||
16890186|NCT01049360|37936909|FG009|Period 4|Withdrawal by Subject|0|||
16890187|NCT01049360|37936910|FG010|Period 4|Withdrawal by Subject|0|||
16890188|NCT01049360|37936911|FG011|Period 4|Withdrawal by Subject|0|||
16890189|NCT01049360|37936912|FG012|Period 4|Withdrawal by Subject|0|||
16890190|NCT01049360|37936913|FG013|Period 4|Withdrawal by Subject|0|||
16890191|NCT01049360|37936914|FG014|Period 4|Withdrawal by Subject|0|||
16890192|NCT01049360|37936915|FG015|Period 4|Withdrawal by Subject|0|||
16890193|NCT01049360|37936916|FG016|Period 4|Withdrawal by Subject|0|||
16890194|NCT01049360|37936917|FG017|Period 4|Withdrawal by Subject|0|||
16890195|NCT01049360|37936918|FG018|Period 4|Withdrawal by Subject|0|||
16890196|NCT01049360|37936919|FG019|Period 4|Withdrawal by Subject|0|||
16890197|NCT02494596|37936931|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16890198|NCT02494596|37936932|FG001|Overall Study|Insufficient Therapeutic Response|3|||
16890199|NCT02494596|37936933|FG002|Overall Study|Insufficient Therapeutic Response|1|||
16890200|NCT02494596|37936931|FG000|Overall Study|Adverse Event|0|||
16890201|NCT02494596|37936932|FG001|Overall Study|Adverse Event|1|||
16890202|NCT02494596|37936933|FG002|Overall Study|Adverse Event|0|||
16890203|NCT02494596|37936931|FG000|Overall Study|Refused Treatment|0|||
16890204|NCT02494596|37936932|FG001|Overall Study|Refused Treatment|1|||
16890205|NCT02494596|37936933|FG002|Overall Study|Refused Treatment|0|||
16890206|NCT02494206|37936952|FG000|Overall Study|Adverse Event|1|||
16890207|NCT02494206|37936952|FG000|Overall Study|Disease Progression|1|||
16890208|NCT01048502|37936969|FG000|Overall Study|Lost to Follow-up|2|||
16890209|NCT01048502|37936970|FG001|Overall Study|Lost to Follow-up|0|||
16890210|NCT01048502|37936971|FG002|Overall Study|Lost to Follow-up|0|||
16890211|NCT01048502|37936972|FG003|Overall Study|Lost to Follow-up|0|||
16890212|NCT01048502|37936969|FG000|Overall Study|Adverse Event|1|||
16890213|NCT01048502|37936970|FG001|Overall Study|Adverse Event|0|||
16890214|NCT01048502|37936971|FG002|Overall Study|Adverse Event|0|||
16890215|NCT01048502|37936972|FG003|Overall Study|Adverse Event|0|||
16890216|NCT01048502|37936969|FG000|Overall Study|Withdrawal by Subject|1|||
16890217|NCT01048502|37936970|FG001|Overall Study|Withdrawal by Subject|4|||
16890218|NCT01048502|37936971|FG002|Overall Study|Withdrawal by Subject|5|||
16890219|NCT01048502|37936972|FG003|Overall Study|Withdrawal by Subject|3|||
16890220|NCT01048502|37936969|FG000|Overall Study|Physician Decision|0|||
16890221|NCT01048502|37936970|FG001|Overall Study|Physician Decision|3|||
16890222|NCT01048502|37936971|FG002|Overall Study|Physician Decision|0|||
16890223|NCT01048502|37936972|FG003|Overall Study|Physician Decision|1|||
16890224|NCT02465034|37936985|FG000|Overall Study|Withdrawal by Subject|1|||
16890225|NCT02465034|37936986|FG001|Overall Study|Withdrawal by Subject|1|||
16890226|NCT02465034|37936985|FG000|Overall Study|Screen fail|2|||
16890227|NCT02465034|37936986|FG001|Overall Study|Screen fail|0|||
17002806|NCT00972179|38146983|FG003|Overall Study|Noncompliance|0|||
17002807|NCT00972179|38146984|FG004|Overall Study|Noncompliance|1|||
17002808|NCT00972179|38146985|FG005|Overall Study|Noncompliance|0|||
17002809|NCT00972179|38146986|FG006|Overall Study|Noncompliance|1|||
17002810|NCT00972179|38146980|FG000|Overall Study|Withdrawal by Subject|0|||
17002811|NCT00972179|38146981|FG001|Overall Study|Withdrawal by Subject|3|||
17002812|NCT00972179|38146982|FG002|Overall Study|Withdrawal by Subject|0|||
17002813|NCT00972179|38146983|FG003|Overall Study|Withdrawal by Subject|1|||
17002814|NCT00972179|38146984|FG004|Overall Study|Withdrawal by Subject|0|||
17002815|NCT00972179|38146985|FG005|Overall Study|Withdrawal by Subject|0|||
17002816|NCT00972179|38146986|FG006|Overall Study|Withdrawal by Subject|2|||
17002817|NCT00972179|38146980|FG000|Overall Study|Administrative Decision|0|||
16890228|NCT02465034|37936985|FG000|Overall Study|Could not be scheduled for study visit|0|||
16890229|NCT02465034|37936986|FG001|Overall Study|Could not be scheduled for study visit|5|||
16890230|NCT02516982|37937013|FG000|Overall Study|Called in to antenatal appointment|32|||
16890231|NCT02516982|37937014|FG001|Overall Study|Called in to antenatal appointment|35|||
16890232|NCT02516982|37937015|FG002|Overall Study|Called in to antenatal appointment|0|||
16890233|NCT02516982|37937016|FG003|Overall Study|Called in to antenatal appointment|0|||
16890234|NCT02516982|37937013|FG000|Overall Study|Withdrawal by Subject|0|||
16890235|NCT02516982|37937014|FG001|Overall Study|Withdrawal by Subject|0|||
16890236|NCT02516982|37937015|FG002|Overall Study|Withdrawal by Subject|1|||
16890237|NCT02516982|37937016|FG003|Overall Study|Withdrawal by Subject|2|||
17002818|NCT00972179|38146981|FG001|Overall Study|Administrative Decision|0|||
17002819|NCT00972179|38146982|FG002|Overall Study|Administrative Decision|0|||
17002820|NCT00972179|38146983|FG003|Overall Study|Administrative Decision|0|||
17002821|NCT00972179|38146984|FG004|Overall Study|Administrative Decision|1|||
17002822|NCT00972179|38146985|FG005|Overall Study|Administrative Decision|0|||
17002823|NCT00972179|38146986|FG006|Overall Study|Administrative Decision|0|||
17002824|NCT00972179|38146980|FG000|Overall Study|Lost to Follow-up|0|||
17002825|NCT00972179|38146981|FG001|Overall Study|Lost to Follow-up|0|||
16890238|NCT02516982|37937013|FG000|Overall Study|Protocol Violation|0|||
16890239|NCT02516982|37937014|FG001|Overall Study|Protocol Violation|0|||
17002826|NCT00972179|38146982|FG002|Overall Study|Lost to Follow-up|1|||
17002827|NCT00972179|38146983|FG003|Overall Study|Lost to Follow-up|0|||
17002828|NCT00972179|38146984|FG004|Overall Study|Lost to Follow-up|0|||
17002829|NCT00972179|38146985|FG005|Overall Study|Lost to Follow-up|3|||
17002830|NCT00972179|38146986|FG006|Overall Study|Lost to Follow-up|1|||
17002831|NCT00906698|38147012|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
17002832|NCT00906698|38147013|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
17002833|NCT00906698|38147014|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
17002834|NCT00906698|38147015|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
17002835|NCT00906698|38147016|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
17002836|NCT00906698|38147017|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
17002837|NCT00906698|38147012|FG000|Overall Study|Adverse Event|0|||
17002838|NCT00906698|38147013|FG001|Overall Study|Adverse Event|0|||
17002839|NCT00906698|38147014|FG002|Overall Study|Adverse Event|2|||
17002840|NCT00906698|38147015|FG003|Overall Study|Adverse Event|0|||
17002841|NCT00906698|38147016|FG004|Overall Study|Adverse Event|4|||
17002842|NCT00906698|38147017|FG005|Overall Study|Adverse Event|1|||
17002843|NCT00906698|38147012|FG000|Overall Study|Disease progression|3|||
17002844|NCT00906698|38147013|FG001|Overall Study|Disease progression|12|||
17002845|NCT00906698|38147014|FG002|Overall Study|Disease progression|4|||
17002846|NCT00906698|38147015|FG003|Overall Study|Disease progression|4|||
17002847|NCT00906698|38147016|FG004|Overall Study|Disease progression|12|||
17002848|NCT00906698|38147017|FG005|Overall Study|Disease progression|4|||
16890240|NCT02516982|37937015|FG002|Overall Study|Protocol Violation|1|||
16890241|NCT02516982|37937016|FG003|Overall Study|Protocol Violation|1|||
16890242|NCT02516982|37937013|FG000|Overall Study|Did not install the app|0|||
16890243|NCT02516982|37937014|FG001|Overall Study|Did not install the app|0|||
16890244|NCT02516982|37937015|FG002|Overall Study|Did not install the app|46|||
16890245|NCT02516982|37937016|FG003|Overall Study|Did not install the app|47|||
16890246|NCT02464410|37937061|FG000|Overall Study|Death|3|||
16890247|NCT02464410|37937062|FG001|Overall Study|Death|4|||
17002849|NCT00906698|38147012|FG000|Overall Study|Withdrawal by Subject|0|||
17002850|NCT00906698|38147013|FG001|Overall Study|Withdrawal by Subject|0|||
17002851|NCT00906698|38147014|FG002|Overall Study|Withdrawal by Subject|0|||
17002852|NCT00906698|38147015|FG003|Overall Study|Withdrawal by Subject|0|||
17002853|NCT00906698|38147016|FG004|Overall Study|Withdrawal by Subject|1|||
17002854|NCT00906698|38147017|FG005|Overall Study|Withdrawal by Subject|0|||
17002855|NCT00906698|38147012|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
17002856|NCT00906698|38147013|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
17002857|NCT00906698|38147014|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
17095371|NCT00232596|38234649|FG000|6-Week Titration Phase|Adverse Event|6|||
16890248|NCT02464410|37937061|FG000|Overall Study|Lost to Follow-up|7|||
16890249|NCT02464410|37937062|FG001|Overall Study|Lost to Follow-up|9|||
16890250|NCT02464410|37937061|FG000|Overall Study|Withdrawal by Subject|12|||
17002858|NCT00906698|38147015|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
17002859|NCT00906698|38147016|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
17002860|NCT00906698|38147017|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
17002861|NCT00972023|38147049|FG000|Overall Study|Withdrawal by Subject|1|||
17002862|NCT00971945|38147055|FG000|Overall Study|Progressive Disease|3|||
17002863|NCT00971945|38147055|FG000|Overall Study|Change in treatment policy|1|||
17002864|NCT00971945|38147055|FG000|Overall Study|Other reasons|2|||
17002865|NCT00971867|38147059|FG000|Overall Study|Adverse Event|4|||
17002866|NCT00971867|38147059|FG000|Overall Study|Participant Withdrew Consent|1|||
17002867|NCT00971867|38147059|FG000|Overall Study|Disease Progression|6|||
17002868|NCT00971321|38147065|FG000|Up to Month 7|Withdrawal by Subject|1|||
17002869|NCT00971321|38147066|FG001|Up to Month 7|Withdrawal by Subject|0|||
17002870|NCT00971321|38147065|FG000|Up to Month 7|Migrated/moved from study area|3|||
17002871|NCT00971321|38147066|FG001|Up to Month 7|Migrated/moved from study area|2|||
17002872|NCT00971321|38147065|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
17002873|NCT00971321|38147066|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
17002874|NCT00971321|38147065|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
17002875|NCT00971321|38147066|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
17002876|NCT00971321|38147065|FG000|Up to Month 11-12|Lost to Follow-up|1|||
17002877|NCT00971321|38147066|FG001|Up to Month 11-12|Lost to Follow-up|0|||
17002878|NCT00648739|38147072|FG000|Overall Study|Adverse Event|1|||
17002879|NCT00648739|38147073|FG001|Overall Study|Adverse Event|0|||
17002880|NCT00648739|38147074|FG002|Overall Study|Adverse Event|1|||
17002881|NCT00648739|38147075|FG003|Overall Study|Adverse Event|2|||
17002882|NCT00648739|38147076|FG004|Overall Study|Adverse Event|1|||
17002883|NCT00648739|38147077|FG005|Overall Study|Adverse Event|0|||
17002884|NCT00648739|38147078|FG006|Overall Study|Adverse Event|0|||
17002885|NCT00648739|38147072|FG000|Overall Study|Withdrawal by Subject|1|||
17002886|NCT00648739|38147073|FG001|Overall Study|Withdrawal by Subject|0|||
17002887|NCT00648739|38147074|FG002|Overall Study|Withdrawal by Subject|1|||
17002888|NCT00648739|38147075|FG003|Overall Study|Withdrawal by Subject|0|||
17002889|NCT00648739|38147076|FG004|Overall Study|Withdrawal by Subject|0|||
17002890|NCT00648739|38147077|FG005|Overall Study|Withdrawal by Subject|2|||
16890251|NCT02464410|37937062|FG001|Overall Study|Withdrawal by Subject|3|||
16890252|NCT01047332|37937070|FG000|Overall Study|SEMS Obstruction|11|||
16890253|NCT01047332|37937071|FG001|Overall Study|SEMS Obstruction|20|||
16890254|NCT01047332|37937070|FG000|Overall Study|Died Unobstructed|38|||
16890255|NCT01047332|37937071|FG001|Overall Study|Died Unobstructed|41|||
16890256|NCT01047332|37937070|FG000|Overall Study|Lost to Follow-up|8|||
16890257|NCT01047332|37937071|FG001|Overall Study|Lost to Follow-up|3|||
17002891|NCT00648739|38147078|FG006|Overall Study|Withdrawal by Subject|0|||
17002892|NCT00648739|38147072|FG000|Overall Study|Lack of Efficacy|0|||
17002893|NCT00648739|38147073|FG001|Overall Study|Lack of Efficacy|0|||
17002894|NCT00648739|38147074|FG002|Overall Study|Lack of Efficacy|0|||
17002895|NCT00648739|38147075|FG003|Overall Study|Lack of Efficacy|0|||
17002896|NCT00648739|38147076|FG004|Overall Study|Lack of Efficacy|1|||
17002897|NCT00648739|38147077|FG005|Overall Study|Lack of Efficacy|2|||
17002898|NCT00648739|38147078|FG006|Overall Study|Lack of Efficacy|0|||
17002899|NCT00648739|38147072|FG000|Overall Study|Investigator Considered it Advisable|0|||
17002900|NCT00648739|38147073|FG001|Overall Study|Investigator Considered it Advisable|0|||
17002901|NCT00648739|38147074|FG002|Overall Study|Investigator Considered it Advisable|0|||
17002902|NCT00648739|38147075|FG003|Overall Study|Investigator Considered it Advisable|0|||
17002903|NCT00648739|38147076|FG004|Overall Study|Investigator Considered it Advisable|0|||
17002904|NCT00648739|38147077|FG005|Overall Study|Investigator Considered it Advisable|1|||
16890258|NCT01046396|37937077|FG000|Overall Study|Withdrawal by Subject|5|||
16890259|NCT01046084|37937103|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
16890260|NCT01046084|37937104|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
16890261|NCT01045694|37937123|FG000|Overall Study|Withdrawal by Subject|2|||
16890262|NCT01044290|37937183|FG000|Follow-up 1|Death|3|||
16890263|NCT01044290|37937184|FG001|Follow-up 1|Death|3|||
16890264|NCT01044290|37937185|FG002|Follow-up 1|Death|1|||
16890265|NCT01044290|37937183|FG000|Follow-up 1|Withdrawal by Subject|2|||
16890266|NCT01044290|37937184|FG001|Follow-up 1|Withdrawal by Subject|2|||
16890267|NCT01044290|37937185|FG002|Follow-up 1|Withdrawal by Subject|0|||
16890268|NCT01044290|37937183|FG000|Follow-Up 2|Death|0|||
16890269|NCT01044290|37937184|FG001|Follow-Up 2|Death|1|||
16890270|NCT01044290|37937185|FG002|Follow-Up 2|Death|1|||
16890271|NCT01044290|37937183|FG000|Follow-Up 2|Withdrawal by Subject|0|||
16890272|NCT01044290|37937184|FG001|Follow-Up 2|Withdrawal by Subject|1|||
17002905|NCT00648739|38147078|FG006|Overall Study|Investigator Considered it Advisable|1|||
17002906|NCT00648739|38147072|FG000|Overall Study|Death|0|||
17002907|NCT00648739|38147073|FG001|Overall Study|Death|1|||
17002908|NCT00648739|38147074|FG002|Overall Study|Death|0|||
17002909|NCT00648739|38147075|FG003|Overall Study|Death|0|||
17002910|NCT00648739|38147076|FG004|Overall Study|Death|0|||
17002911|NCT00648739|38147077|FG005|Overall Study|Death|0|||
17002912|NCT00648739|38147078|FG006|Overall Study|Death|0|||
17002913|NCT00648739|38147072|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
17002914|NCT00648739|38147073|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
17002915|NCT00648739|38147074|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
17002916|NCT00648739|38147075|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
17002917|NCT00648739|38147076|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
17002918|NCT00648739|38147077|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
17002919|NCT00648739|38147078|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
17002920|NCT00648739|38147072|FG000|Overall Study|Follow-up Visits Not Completed|0|||
16890273|NCT01044290|37937185|FG002|Follow-Up 2|Withdrawal by Subject|1|||
16890274|NCT01041638|37937266|FG000|Overall Study|Adverse Event|4|||
16890275|NCT01041638|37937266|FG000|Overall Study|Death|1|||
16890276|NCT01041638|37937266|FG000|Overall Study|Lack of Efficacy|7|||
16890277|NCT01041638|37937266|FG000|Overall Study|Physician Decision|4|||
16890278|NCT01041638|37937266|FG000|Overall Study|Withdrawal by Subject|11|||
16890279|NCT01045460|37937290|FG000|Overall Study|Physician Decision|3|||
16890280|NCT01045460|37937291|FG001|Overall Study|Physician Decision|2|||
16890281|NCT01045460|37937290|FG000|Overall Study|Lost to Follow-up|0|||
16890282|NCT01045460|37937291|FG001|Overall Study|Lost to Follow-up|1|||
16890283|NCT01045460|37937290|FG000|Overall Study|Lack of Efficacy|3|||
16890284|NCT01045460|37937291|FG001|Overall Study|Lack of Efficacy|0|||
16890285|NCT05014919|37937302|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
16890286|NCT05014919|37937303|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
16890287|NCT05014919|37937304|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
16890288|NCT05014919|37937302|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
16890289|NCT05014919|37937303|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
16890290|NCT05014919|37937304|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
16890291|NCT05014919|37937302|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
16890292|NCT05014919|37937303|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
16890293|NCT05014919|37937304|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
16890294|NCT05014919|37937302|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
16890295|NCT05014919|37937303|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
16890296|NCT05014919|37937304|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
16890297|NCT05014919|37937302|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
16890298|NCT05014919|37937303|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
16890299|NCT05014919|37937304|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
16890300|NCT05014919|37937302|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
16890301|NCT05014919|37937303|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
16890302|NCT05014919|37937304|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
16890303|NCT05014919|37937302|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
16890304|NCT05014919|37937303|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
16890305|NCT05014919|37937304|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
16890306|NCT05014919|37937302|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
16890307|NCT05014919|37937303|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
16890308|NCT05014919|37937304|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
16890309|NCT03409796|37937347|FG000|Overall Study|Adverse Event|2|||
16890310|NCT03409796|37937348|FG001|Overall Study|Adverse Event|0|||
16890311|NCT03409796|37937347|FG000|Overall Study|Other|0|||
16890312|NCT03409796|37937348|FG001|Overall Study|Other|1|||
16890313|NCT02462928|37937357|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
16890314|NCT02462928|37937358|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
16890315|NCT02462928|37937359|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
16890316|NCT02462928|37937357|FG000|Overall Study|Adverse Event|47|||
16890317|NCT02462928|37937358|FG001|Overall Study|Adverse Event|51|||
16890318|NCT02462928|37937359|FG002|Overall Study|Adverse Event|25|||
16890319|NCT02462928|37937357|FG000|Overall Study|Lack of Efficacy|3|||
16890320|NCT02462928|37937358|FG001|Overall Study|Lack of Efficacy|8|||
16890321|NCT02462928|37937359|FG002|Overall Study|Lack of Efficacy|3|||
16890322|NCT02462928|37937357|FG000|Overall Study|Lost to Follow-up|4|||
16890323|NCT02462928|37937358|FG001|Overall Study|Lost to Follow-up|4|||
16890324|NCT02462928|37937359|FG002|Overall Study|Lost to Follow-up|1|||
16890325|NCT02462928|37937357|FG000|Overall Study|Withdrawal by Patient|31|||
16890326|NCT02462928|37937358|FG001|Overall Study|Withdrawal by Patient|21|||
16890327|NCT02462928|37937359|FG002|Overall Study|Withdrawal by Patient|21|||
16890328|NCT02462928|37937357|FG000|Overall Study|Protocol Violation|0|||
16890329|NCT02462928|37937358|FG001|Overall Study|Protocol Violation|1|||
16890330|NCT02462928|37937359|FG002|Overall Study|Protocol Violation|0|||
16890331|NCT02462928|37937357|FG000|Overall Study|Reason not Specified|4|||
16890332|NCT02462928|37937358|FG001|Overall Study|Reason not Specified|6|||
16890333|NCT02462928|37937359|FG002|Overall Study|Reason not Specified|5|||
16890334|NCT00019604|37937376|FG000|Overall Study|Death|1|||
16890335|NCT00019604|37937376|FG000|Overall Study|Progressive disease|23|||
16890336|NCT00019604|37937376|FG000|Overall Study|Refused treatment|1|||
16890337|NCT00019604|37937376|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
17002921|NCT00648739|38147073|FG001|Overall Study|Follow-up Visits Not Completed|1|||
17002922|NCT00648739|38147074|FG002|Overall Study|Follow-up Visits Not Completed|0|||
17002923|NCT00648739|38147075|FG003|Overall Study|Follow-up Visits Not Completed|0|||
17002924|NCT00648739|38147076|FG004|Overall Study|Follow-up Visits Not Completed|0|||
17002925|NCT00648739|38147077|FG005|Overall Study|Follow-up Visits Not Completed|0|||
17002926|NCT00648739|38147078|FG006|Overall Study|Follow-up Visits Not Completed|0|||
17002927|NCT00648037|38147099|FG000|Overall Study|Not Treated|1|||
17002928|NCT00648037|38147099|FG000|Overall Study|Withdrawal by Subject|1|||
17002929|NCT00648037|38147099|FG000|Overall Study|Adverse Event|11|||
17002930|NCT00648037|38147099|FG000|Overall Study|Relapse|2|||
17002931|NCT00648037|38147099|FG000|Overall Study|Other|1|||
17002932|NCT00627523|38147105|FG000|Overall Study|Lack of Efficacy|1|||
17002933|NCT00627523|38147106|FG001|Overall Study|Lack of Efficacy|0|||
17002934|NCT00627523|38147105|FG000|Overall Study|Withdrawal by Subject|0|||
17002935|NCT00627523|38147106|FG001|Overall Study|Withdrawal by Subject|2|||
17002936|NCT00627523|38147105|FG000|Overall Study|Other|1|||
17002937|NCT00627523|38147106|FG001|Overall Study|Other|0|||
17002938|NCT00640393|38147112|FG000|Part 1|Lost to Follow-up|2|||
17002939|NCT00640393|38147113|FG001|Part 1|Lost to Follow-up|0|||
17002940|NCT00640393|38147114|FG002|Part 1|Lost to Follow-up|0|||
17002941|NCT00640393|38147112|FG000|Part 1|Withdrawal by Subject|3|||
17002942|NCT00640393|38147113|FG001|Part 1|Withdrawal by Subject|0|||
16890338|NCT00019604|37937376|FG000|Overall Study|Going to have liver transplant|1|||
16890339|NCT00019604|37937376|FG000|Overall Study|Move to a different study|1|||
16890340|NCT00019604|37937376|FG000|Overall Study|Non compliant on systemic CH|1|||
16890341|NCT00019604|37937376|FG000|Overall Study|Non compliant|1|||
16890342|NCT00019604|37937376|FG000|Overall Study|Resectable disease|1|||
16890343|NCT00019604|37937376|FG000|Overall Study|Started new chemo regimen|1|||
17002943|NCT00640393|38147114|FG002|Part 1|Withdrawal by Subject|0|||
17002944|NCT00640393|38147112|FG000|Randomization|Withdrawn per protocol|17|||
16890344|NCT00019604|37937376|FG000|Overall Study|Pt going to immunotherapy study|1|||
16890345|NCT00019604|37937376|FG000|Overall Study|Too much disease|1|||
16890346|NCT00019604|37937376|FG000|Overall Study|Unable to evaluate|1|||
16890347|NCT00019604|37937376|FG000|Overall Study|Details for other not available|4|||
16890348|NCT02492958|37937392|FG000|Overall Study|Withdrawal by Subject|0|||
17002945|NCT00640393|38147113|FG001|Randomization|Withdrawn per protocol|0|||
16890349|NCT02492958|37937393|FG001|Overall Study|Withdrawal by Subject|0|||
17002946|NCT00640393|38147114|FG002|Randomization|Withdrawn per protocol|0|||
17002947|NCT00640393|38147112|FG000|Randomization|Never randomized by site|2|||
17002948|NCT00640393|38147113|FG001|Randomization|Never randomized by site|0|||
17002949|NCT00640393|38147114|FG002|Randomization|Never randomized by site|0|||
17002950|NCT00640393|38147112|FG000|Part 2|Lost to Follow-up|0|||
17002951|NCT00640393|38147113|FG001|Part 2|Lost to Follow-up|2|||
17002952|NCT00640393|38147114|FG002|Part 2|Lost to Follow-up|2|||
17002953|NCT00640393|38147112|FG000|Part 2|Withdrawal by Subject|0|||
17002954|NCT00640393|38147113|FG001|Part 2|Withdrawal by Subject|6|||
17002955|NCT00640393|38147114|FG002|Part 2|Withdrawal by Subject|1|||
17002956|NCT00640393|38147112|FG000|Part 2|Non-adherence|0|||
17002957|NCT00640393|38147113|FG001|Part 2|Non-adherence|1|||
17002958|NCT00640393|38147114|FG002|Part 2|Non-adherence|0|||
17002959|NCT00640393|38147112|FG000|Part 2|Adverse Event|0|||
16890350|NCT02492958|37937394|FG002|Overall Study|Withdrawal by Subject|1|||
16890351|NCT02492958|37937395|FG003|Overall Study|Withdrawal by Subject|0|||
16890352|NCT02492958|37937392|FG000|Overall Study|Adverse Event|1|||
16890353|NCT02492958|37937393|FG001|Overall Study|Adverse Event|0|||
16890354|NCT02492958|37937394|FG002|Overall Study|Adverse Event|1|||
16890355|NCT02492958|37937395|FG003|Overall Study|Adverse Event|0|||
16890356|NCT02492880|37937405|FG000|Overall Study|Lost to Follow-up|1|||
17002960|NCT00640393|38147113|FG001|Part 2|Adverse Event|1|||
17002961|NCT00640393|38147114|FG002|Part 2|Adverse Event|0|||
17002962|NCT00907478|38147125|FG000|Overall Study|Ineligibility determined|0|||
17002963|NCT00907478|38147126|FG001|Overall Study|Ineligibility determined|0|||
17002964|NCT00907478|38147127|FG002|Overall Study|Ineligibility determined|1|||
17002965|NCT00907478|38147125|FG000|Overall Study|Noncompliance|0|||
17002966|NCT00907478|38147126|FG001|Overall Study|Noncompliance|0|||
17002967|NCT00907478|38147127|FG002|Overall Study|Noncompliance|1|||
17002968|NCT00907478|38147125|FG000|Overall Study|Adverse Event|3|||
17002969|NCT00907478|38147126|FG001|Overall Study|Adverse Event|1|||
17002970|NCT00907478|38147127|FG002|Overall Study|Adverse Event|2|||
17002971|NCT00907478|38147125|FG000|Overall Study|Withdrawal by Subject|8|||
17002972|NCT00907478|38147126|FG001|Overall Study|Withdrawal by Subject|9|||
17002973|NCT00907478|38147127|FG002|Overall Study|Withdrawal by Subject|6|||
17002974|NCT00907478|38147125|FG000|Overall Study|Requirement for alternative therapy|1|||
17002975|NCT00907478|38147126|FG001|Overall Study|Requirement for alternative therapy|2|||
17002976|NCT00907478|38147127|FG002|Overall Study|Requirement for alternative therapy|3|||
16890357|NCT02492880|37937405|FG000|Overall Study|Protocol Violation|1|||
16890358|NCT02516592|37937411|FG000|Overall Study|Patient withdrew consent|5|||
16890359|NCT02516592|37937412|FG001|Overall Study|Patient withdrew consent|2|||
17002977|NCT00907478|38147125|FG000|Overall Study|Physician Decision|2|||
17002978|NCT00907478|38147126|FG001|Overall Study|Physician Decision|0|||
16890360|NCT02516592|37937411|FG000|Overall Study|Protocol deviation|4|||
16890361|NCT02516592|37937412|FG001|Overall Study|Protocol deviation|4|||
16890362|NCT02516592|37937411|FG000|Overall Study|Lost to Follow-up|2|||
16890363|NCT02516592|37937412|FG001|Overall Study|Lost to Follow-up|3|||
16890364|NCT02516592|37937411|FG000|Overall Study|Patient/guardian decision|2|||
16890365|NCT02516592|37937412|FG001|Overall Study|Patient/guardian decision|1|||
16890366|NCT02516592|37937411|FG000|Overall Study|Adverse Event|1|||
16890367|NCT02516592|37937412|FG001|Overall Study|Adverse Event|2|||
16890368|NCT02516592|37937411|FG000|Overall Study|Abnormal test procedure result|1|||
16890369|NCT02516592|37937412|FG001|Overall Study|Abnormal test procedure result|0|||
16890370|NCT02516592|37937411|FG000|Overall Study|Death|1|||
16890371|NCT02516592|37937412|FG001|Overall Study|Death|1|||
16890372|NCT02492100|37937440|FG000|Overall Study|Death|1|||
16890373|NCT02461758|37937463|FG000|Overall Study|Lost to Follow-up|0|||
16890374|NCT02461758|37937464|FG001|Overall Study|Lost to Follow-up|1|||
16890375|NCT02461758|37937465|FG002|Overall Study|Lost to Follow-up|1|||
16890376|NCT02461758|37937466|FG003|Overall Study|Lost to Follow-up|0|||
16890377|NCT02461290|37937488|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
16890378|NCT02461290|37937488|FG000|Overall Study|Lost to Follow-up|3|||
16890379|NCT02461134|37937492|FG000|Overall Study|Adverse Event|1|||
16890380|NCT02460978|37937521|FG000|Overall Study|Adverse Event|17|||
16890381|NCT02460978|37937522|FG001|Overall Study|Adverse Event|11|||
16890382|NCT02460978|37937523|FG002|Overall Study|Adverse Event|11|||
16890383|NCT02460978|37937521|FG000|Overall Study|Withdrawal by Subject|5|||
16890384|NCT02460978|37937522|FG001|Overall Study|Withdrawal by Subject|5|||
16890385|NCT02460978|37937523|FG002|Overall Study|Withdrawal by Subject|14|||
16890386|NCT02460978|37937521|FG000|Overall Study|Lost to Follow-up|2|||
16890387|NCT02460978|37937522|FG001|Overall Study|Lost to Follow-up|3|||
16890388|NCT02460978|37937523|FG002|Overall Study|Lost to Follow-up|1|||
16890389|NCT02460978|37937521|FG000|Overall Study|Protocol Violation|1|||
16890390|NCT02460978|37937522|FG001|Overall Study|Protocol Violation|1|||
16890391|NCT02460978|37937523|FG002|Overall Study|Protocol Violation|1|||
16890392|NCT02460978|37937521|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
16890393|NCT02460978|37937522|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
16890394|NCT02460978|37937523|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
16890395|NCT02460978|37937521|FG000|Overall Study|Pregnancy|0|||
16890396|NCT02460978|37937522|FG001|Overall Study|Pregnancy|0|||
16890397|NCT02460978|37937523|FG002|Overall Study|Pregnancy|2|||
16890398|NCT02489448|37937538|FG000|Overall Study|Death|3|||
16890399|NCT02489448|37937538|FG000|Overall Study|Withdrawal by Subject|2|||
16890400|NCT02488980|37937555|FG000|Overall Study|Protocol Violation|2|||
16890401|NCT02488980|37937556|FG001|Overall Study|Protocol Violation|2|||
16890402|NCT02488980|37937557|FG002|Overall Study|Protocol Violation|2|||
16890403|NCT02460822|37937569|FG000|Overall Study|Withdrawal by Subject|1|||
16890404|NCT02488824|37937575|FG000|Overall Study|Adverse Event|1|||
16890405|NCT02488824|37937576|FG001|Overall Study|Adverse Event|1|||
16890406|NCT02308241|37937679|FG000|Overall Study|Withdrawal by Subject|3|||
16890407|NCT02460198|37937718|FG000|Overall Study|Adverse Event|1|||
16890408|NCT02460198|37937719|FG001|Overall Study|Adverse Event|3|||
16890409|NCT02460198|37937718|FG000|Overall Study|Death|36|||
16890410|NCT02460198|37937719|FG001|Overall Study|Death|28|||
16890411|NCT02460198|37937718|FG000|Overall Study|Lost to Follow-up|1|||
16890412|NCT02460198|37937719|FG001|Overall Study|Lost to Follow-up|1|||
16890413|NCT02460198|37937718|FG000|Overall Study|Transferred to Extension Study|15|||
16890414|NCT02460198|37937719|FG001|Overall Study|Transferred to Extension Study|15|||
16890415|NCT02460198|37937718|FG000|Overall Study|Withdrawal by Subject|2|||
16890416|NCT02460198|37937719|FG001|Overall Study|Withdrawal by Subject|4|||
16890417|NCT02460198|37937718|FG000|Overall Study|Site Terminated By Sponsor|0|||
16890418|NCT02460198|37937719|FG001|Overall Study|Site Terminated By Sponsor|1|||
16890419|NCT02460198|37937718|FG000|Overall Study|Did Not Continue on Extension Study|6|||
16890420|NCT02460198|37937719|FG001|Overall Study|Did Not Continue on Extension Study|11|||
16890421|NCT02487810|37937739|FG000|Overall Study|Withdrawal by Subject|1|||
16890422|NCT02487810|37937740|FG001|Overall Study|Withdrawal by Subject|0|||
16890423|NCT02452320|37937748|FG000|Overall Study|Adverse Event|0|||
16890424|NCT02452320|37937749|FG001|Overall Study|Adverse Event|1|||
16890425|NCT02459964|37937758|FG000|Overall Study|Withdrawal by Subject|0|||
16890426|NCT02459964|37937759|FG001|Overall Study|Withdrawal by Subject|0|||
16890427|NCT02459964|37937760|FG002|Overall Study|Withdrawal by Subject|1|||
16890428|NCT02459964|37937758|FG000|Overall Study|Abnormal EKG changes|0|||
16890429|NCT02459964|37937759|FG001|Overall Study|Abnormal EKG changes|0|||
16890430|NCT02459964|37937760|FG002|Overall Study|Abnormal EKG changes|1|||
16890431|NCT02451930|37937837|FG000|Overall Study|Death|0|||
16890432|NCT02451930|37937838|FG001|Overall Study|Death|15|||
16890433|NCT02451930|37937837|FG000|Overall Study|Lost to Follow-up|0|||
16890434|NCT02451930|37937838|FG001|Overall Study|Lost to Follow-up|3|||
16890435|NCT02451930|37937837|FG000|Overall Study|Sponsor Decision|2|||
16890436|NCT02451930|37937838|FG001|Overall Study|Sponsor Decision|10|||
16890437|NCT02451930|37937837|FG000|Overall Study|Withdrawal by Subject|0|||
16890438|NCT02451930|37937838|FG001|Overall Study|Withdrawal by Subject|1|||
16890439|NCT02451930|37937837|FG000|Overall Study|Other|0|||
16890440|NCT02451930|37937838|FG001|Overall Study|Other|1|||
16890441|NCT02451696|37937874|FG000|Overall Study|Surgery postponed|1|||
16890442|NCT02451696|37937875|FG001|Overall Study|Surgery postponed|0|||
16890443|NCT02459418|37937898|FG000|Overall Study|Exclusion Criteria|4|||
16890444|NCT02459418|37937899|FG001|Overall Study|Exclusion Criteria|0|||
16890445|NCT02459418|37937898|FG000|Overall Study|Protocol Violation|0|||
16890446|NCT02459418|37937899|FG001|Overall Study|Protocol Violation|2|||
16890447|NCT02459418|37937898|FG000|Overall Study|Physician Decision|0|||
16890448|NCT02459418|37937899|FG001|Overall Study|Physician Decision|2|||
16890449|NCT02459418|37937898|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
16890450|NCT02459418|37937899|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
16890451|NCT02459418|37937898|FG000|Overall Study|Adverse Event|0|||
16890452|NCT02459418|37937899|FG001|Overall Study|Adverse Event|1|||
16890453|NCT02459418|37937898|FG000|Overall Study|Withdrawal by Subject|1|||
16890454|NCT02459418|37937899|FG001|Overall Study|Withdrawal by Subject|1|||
16890455|NCT02459418|37937898|FG000|Overall Study|Elevated Creatine Kinase|1|||
16890456|NCT02459418|37937899|FG001|Overall Study|Elevated Creatine Kinase|0|||
16890457|NCT02459418|37937898|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
16890458|NCT02459418|37937899|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
16890459|NCT02487498|37937929|FG000|Period: Period 1|Adverse Event|2|||
16890460|NCT02487498|37937930|FG001|Period: Period 1|Adverse Event|4|||
16890461|NCT02487498|37937929|FG000|Period: Period 1|Subject/guardian decision|2|||
16890462|NCT02487498|37937930|FG001|Period: Period 1|Subject/guardian decision|4|||
16890463|NCT02487498|37937929|FG000|Period: Period 1|Lost to Follow-up|0|||
16890464|NCT02487498|37937930|FG001|Period: Period 1|Lost to Follow-up|2|||
16890465|NCT02487498|37937929|FG000|Period: Period 1|Lack of Efficacy|1|||
16890466|NCT02487498|37937930|FG001|Period: Period 1|Lack of Efficacy|0|||
16890467|NCT02487498|37937929|FG000|Period: Period 1|Physician Decision|0|||
16890468|NCT02487498|37937930|FG001|Period: Period 1|Physician Decision|1|||
16890469|NCT02487498|37937929|FG000|Period: Period 1|Protocol deviation|1|||
16890470|NCT02487498|37937930|FG001|Period: Period 1|Protocol deviation|0|||
16890471|NCT02487498|37937929|FG000|Period: Washout|Subject/guardian decision|0|||
16890472|NCT02487498|37937930|FG001|Period: Washout|Subject/guardian decision|5|||
16890473|NCT02487498|37937929|FG000|Period: Washout|Lack of Efficacy|1|||
16890474|NCT02487498|37937930|FG001|Period: Washout|Lack of Efficacy|1|||
16890475|NCT02487498|37937929|FG000|Period: Washout|Physician Decision|1|||
16890476|NCT02487498|37937930|FG001|Period: Washout|Physician Decision|0|||
16890477|NCT02487498|37937929|FG000|Period: Washout|Non-compliance with study treatment|0|||
16890478|NCT02487498|37937930|FG001|Period: Washout|Non-compliance with study treatment|1|||
16890479|NCT02487498|37937929|FG000|Period: Period 2|Adverse Event|2|||
16890480|NCT02487498|37937930|FG001|Period: Period 2|Adverse Event|2|||
16890481|NCT02487498|37937929|FG000|Period: Period 2|Subject/guardian decision|2|||
16890482|NCT02487498|37937930|FG001|Period: Period 2|Subject/guardian decision|1|||
16890483|NCT02487498|37937929|FG000|Period: Period 2|Lost to Follow-up|1|||
16890484|NCT02487498|37937930|FG001|Period: Period 2|Lost to Follow-up|1|||
16890485|NCT02487498|37937929|FG000|Period: Period 2|Death|0|||
16890486|NCT02487498|37937930|FG001|Period: Period 2|Death|1|||
16890487|NCT02487498|37937929|FG000|Period: Period 2|Physician Decision|1|||
16890488|NCT02487498|37937930|FG001|Period: Period 2|Physician Decision|0|||
16890489|NCT02487108|37937941|FG000|Overall Study|Adverse Event|1|||
16890490|NCT02487108|37937942|FG001|Overall Study|Adverse Event|6|||
16890491|NCT02487108|37937943|FG002|Overall Study|Adverse Event|12|||
16890492|NCT02487108|37937944|FG003|Overall Study|Adverse Event|6|||
16890493|NCT02487108|37937941|FG000|Overall Study|Withdrawal by Subject|8|||
16890494|NCT02487108|37937942|FG001|Overall Study|Withdrawal by Subject|5|||
16890495|NCT02487108|37937943|FG002|Overall Study|Withdrawal by Subject|5|||
16890496|NCT02487108|37937944|FG003|Overall Study|Withdrawal by Subject|0|||
16890497|NCT02487108|37937941|FG000|Overall Study|Non-compliance to study medication|3|||
16890498|NCT02487108|37937942|FG001|Overall Study|Non-compliance to study medication|2|||
16785807|NCT02009332|37725898|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16890499|NCT02487108|37937943|FG002|Overall Study|Non-compliance to study medication|5|||
16890500|NCT02487108|37937944|FG003|Overall Study|Non-compliance to study medication|4|||
16890501|NCT02487108|37937941|FG000|Overall Study|Protocol Violation|1|||
16890502|NCT02487108|37937942|FG001|Overall Study|Protocol Violation|1|||
16890503|NCT02487108|37937943|FG002|Overall Study|Protocol Violation|2|||
16890504|NCT02487108|37937944|FG003|Overall Study|Protocol Violation|0|||
16890505|NCT02487108|37937941|FG000|Overall Study|Non-compliance to study procedures|0|||
16890506|NCT02487108|37937942|FG001|Overall Study|Non-compliance to study procedures|0|||
16785808|NCT02009332|37725899|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16890507|NCT02487108|37937943|FG002|Overall Study|Non-compliance to study procedures|0|||
16890508|NCT02487108|37937944|FG003|Overall Study|Non-compliance to study procedures|1|||
16890509|NCT02487108|37937941|FG000|Overall Study|Other than specified|3|||
16890510|NCT02487108|37937942|FG001|Overall Study|Other than specified|2|||
16890511|NCT02487108|37937943|FG002|Overall Study|Other than specified|2|||
16890512|NCT02487108|37937944|FG003|Overall Study|Other than specified|0|||
16890513|NCT02487030|37937961|FG000|Overall Study|Lack of Efficacy|2|||
16890514|NCT02487030|37937962|FG001|Overall Study|Lack of Efficacy|4|||
16890515|NCT02487030|37937963|FG002|Overall Study|Lack of Efficacy|1|||
16890516|NCT02487030|37937964|FG003|Overall Study|Lack of Efficacy|0|||
16890517|NCT02487030|37937965|FG004|Overall Study|Lack of Efficacy|1|||
16890518|NCT02487030|37937966|FG005|Overall Study|Lack of Efficacy|0|||
16890519|NCT02487030|37937967|FG006|Overall Study|Lack of Efficacy|0|||
16890520|NCT02487030|37937961|FG000|Overall Study|Lost to Follow-up|0|||
16890521|NCT02487030|37937962|FG001|Overall Study|Lost to Follow-up|0|||
16890522|NCT02487030|37937963|FG002|Overall Study|Lost to Follow-up|1|||
16890523|NCT02487030|37937964|FG003|Overall Study|Lost to Follow-up|1|||
16890524|NCT02487030|37937965|FG004|Overall Study|Lost to Follow-up|0|||
16890525|NCT02487030|37937966|FG005|Overall Study|Lost to Follow-up|1|||
16890526|NCT02487030|37937967|FG006|Overall Study|Lost to Follow-up|0|||
16890527|NCT02487030|37937961|FG000|Overall Study|Adverse Event|0|||
16890528|NCT02487030|37937962|FG001|Overall Study|Adverse Event|0|||
16890529|NCT02487030|37937963|FG002|Overall Study|Adverse Event|0|||
16890530|NCT02487030|37937964|FG003|Overall Study|Adverse Event|1|||
16890531|NCT02487030|37937965|FG004|Overall Study|Adverse Event|0|||
16890532|NCT02487030|37937966|FG005|Overall Study|Adverse Event|0|||
16890533|NCT02487030|37937967|FG006|Overall Study|Adverse Event|0|||
16890534|NCT02487030|37937961|FG000|Overall Study|Death|0|||
16890535|NCT02487030|37937962|FG001|Overall Study|Death|0|||
16890536|NCT02487030|37937963|FG002|Overall Study|Death|0|||
16890537|NCT02487030|37937964|FG003|Overall Study|Death|0|||
16890538|NCT02487030|37937965|FG004|Overall Study|Death|1|||
16890539|NCT02487030|37937966|FG005|Overall Study|Death|0|||
16890540|NCT02487030|37937967|FG006|Overall Study|Death|0|||
16890541|NCT02486952|37937984|FG000|Overall Study|Not Started Induction Therapy|3|||
16890542|NCT02486952|37937984|FG000|Overall Study|Adverse Event|1|||
16890543|NCT02486952|37937984|FG000|Overall Study|Death|15|||
16890544|NCT02486952|37937984|FG000|Overall Study|Lack of Efficacy|3|||
16890545|NCT02486952|37937984|FG000|Overall Study|Lost to Follow-up|26|||
16890546|NCT02486952|37937984|FG000|Overall Study|Other|2|||
16890547|NCT02486796|37937990|FG000|Overall Study|Withdrawal by Subject|1|||
16890548|NCT02486796|37937991|FG001|Overall Study|Withdrawal by Subject|1|||
16890549|NCT02486796|37937990|FG000|Overall Study|Physician Decision|1|||
16890550|NCT02486796|37937991|FG001|Overall Study|Physician Decision|0|||
16890551|NCT02459262|37938008|FG000|Overall Study|Withdrawal by Subject|0|||
16890552|NCT02459262|37938009|FG001|Overall Study|Withdrawal by Subject|0|||
16890553|NCT02459262|37938010|FG002|Overall Study|Withdrawal by Subject|0|||
16890554|NCT02459262|37938011|FG003|Overall Study|Withdrawal by Subject|0|||
16890555|NCT02459262|37938012|FG004|Overall Study|Withdrawal by Subject|0|||
16890556|NCT02459262|37938013|FG005|Overall Study|Withdrawal by Subject|0|||
16890557|NCT02459262|37938014|FG006|Overall Study|Withdrawal by Subject|0|||
16890558|NCT02459262|37938015|FG007|Overall Study|Withdrawal by Subject|0|||
16890559|NCT02459262|37938016|FG008|Overall Study|Withdrawal by Subject|0|||
16890560|NCT02459262|37938017|FG009|Overall Study|Withdrawal by Subject|1|||
16890561|NCT02459262|37938018|FG010|Overall Study|Withdrawal by Subject|0|||
16890562|NCT02450526|37938102|FG000|DB Period (Cycle 1)|Adverse Event|0|||
16890563|NCT02450526|37938103|FG001|DB Period (Cycle 1)|Adverse Event|0|||
16890564|NCT02450526|37938104|FG002|DB Period (Cycle 1)|Adverse Event|2|||
16890565|NCT02450526|37938105|FG003|DB Period (Cycle 1)|Adverse Event|0|||
16890566|NCT02450526|37938106|FG004|DB Period (Cycle 1)|Adverse Event|0|||
16890567|NCT02450526|37938102|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
16890568|NCT02450526|37938103|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
16890569|NCT02450526|37938104|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
16890570|NCT02450526|37938105|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
16890571|NCT02450526|37938106|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
16890572|NCT02450526|37938102|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
16890573|NCT02450526|37938103|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
16890574|NCT02450526|37938104|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
17002979|NCT00907478|38147127|FG002|Overall Study|Physician Decision|3|||
17002980|NCT00907478|38147125|FG000|Overall Study|Death|4|||
17002981|NCT00907478|38147126|FG001|Overall Study|Death|2|||
17002982|NCT00907478|38147127|FG002|Overall Study|Death|1|||
16785809|NCT02009332|37725900|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16890575|NCT02450526|37938105|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
16890576|NCT02450526|37938106|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
16890577|NCT02450526|37938102|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
16890578|NCT02450526|37938103|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
16890579|NCT02450526|37938104|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
16890580|NCT02450526|37938105|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
16890581|NCT02450526|37938106|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
16890582|NCT02450526|37938102|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
16890583|NCT02450526|37938103|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
16890584|NCT02450526|37938104|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
16890585|NCT02450526|37938105|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
17002983|NCT00907478|38147125|FG000|Overall Study|Protocol-specified criteria|5|||
17002984|NCT00907478|38147126|FG001|Overall Study|Protocol-specified criteria|2|||
17002985|NCT00907478|38147127|FG002|Overall Study|Protocol-specified criteria|3|||
17002986|NCT00907478|38147125|FG000|Overall Study|Pregnancy|0|||
17002987|NCT00907478|38147126|FG001|Overall Study|Pregnancy|1|||
17002988|NCT00907478|38147127|FG002|Overall Study|Pregnancy|1|||
17002989|NCT00907478|38147125|FG000|Overall Study|Lost to Follow-up|1|||
17002990|NCT00907478|38147126|FG001|Overall Study|Lost to Follow-up|0|||
17002991|NCT00907478|38147127|FG002|Overall Study|Lost to Follow-up|0|||
17002992|NCT00907478|38147125|FG000|Overall Study|Other|3|||
16890586|NCT02450526|37938106|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
16890587|NCT02450526|37938102|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
16890588|NCT02450526|37938103|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
16890589|NCT02450526|37938104|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
16890590|NCT02450526|37938105|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
16890591|NCT02450526|37938106|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
16890592|NCT02450526|37938102|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
16890593|NCT02450526|37938103|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
16890594|NCT02450526|37938104|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
16890595|NCT02450526|37938105|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
16890596|NCT02450526|37938106|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
16890597|NCT02450526|37938102|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
16890598|NCT02450526|37938103|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
16890599|NCT02450526|37938104|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
16890600|NCT02450526|37938105|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
16890601|NCT02450526|37938106|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
16890602|NCT02458638|37938173|FG000|Overall Study|Death|309|||
16890603|NCT02458638|37938173|FG000|Overall Study|End of Cohort/End of Study|67|||
16890604|NCT02458638|37938173|FG000|Overall Study|Lost to Follow-up|31|||
16890605|NCT02458638|37938173|FG000|Overall Study|Other Reasons|4|||
16890606|NCT02458638|37938173|FG000|Overall Study|Physician Decision|1|||
16890607|NCT02458638|37938173|FG000|Overall Study|Withdrawal by Subject|47|||
16890608|NCT02458092|37938311|FG000|Overall Study|Withdrawal by Subject|1|||
16890609|NCT02458092|37938312|FG001|Overall Study|Withdrawal by Subject|0|||
16890610|NCT02449902|37938335|FG000|Overall Study|Adverse Event|0|||
16890611|NCT02449902|37938336|FG001|Overall Study|Adverse Event|1|||
16890612|NCT02449902|37938335|FG000|Overall Study|Withdrawal by Subject|0|||
16890613|NCT02449902|37938336|FG001|Overall Study|Withdrawal by Subject|1|||
16890614|NCT02449044|37938344|FG000|Overall Study|Lost to Follow-up|2|||
16890615|NCT02449044|37938344|FG000|Overall Study|Withdrawal by Subject|13|||
16890616|NCT02449044|37938344|FG000|Overall Study|Adverse Event|30|||
16890617|NCT02449044|37938344|FG000|Overall Study|Met Withdrawal Criteria|7|||
16890618|NCT02449044|37938344|FG000|Overall Study|Physician Decision|9|||
16890619|NCT02449044|37938344|FG000|Overall Study|Sponsor Discontinued Trial|3|||
16890620|NCT02448810|37939235|FG000|Overall Study|Adverse Event|0|||
16890621|NCT02448810|37939236|FG001|Overall Study|Adverse Event|0|||
16890622|NCT02448810|37939237|FG002|Overall Study|Adverse Event|1|||
16890623|NCT02448810|37939238|FG003|Overall Study|Adverse Event|0|||
16890624|NCT02448810|37939239|FG004|Overall Study|Adverse Event|0|||
16890625|NCT02448810|37939240|FG005|Overall Study|Adverse Event|0|||
16890626|NCT02448810|37939241|FG006|Overall Study|Adverse Event|0|||
16890627|NCT02448810|37939242|FG007|Overall Study|Adverse Event|0|||
16890628|NCT02448810|37939235|FG000|Overall Study|Withdrawal by Subject|0|||
16890629|NCT02448810|37939236|FG001|Overall Study|Withdrawal by Subject|0|||
16890630|NCT02448810|37939237|FG002|Overall Study|Withdrawal by Subject|1|||
16890631|NCT02448810|37939238|FG003|Overall Study|Withdrawal by Subject|0|||
16890632|NCT02448810|37939239|FG004|Overall Study|Withdrawal by Subject|3|||
16890633|NCT02448810|37939240|FG005|Overall Study|Withdrawal by Subject|5|||
16890634|NCT02448810|37939241|FG006|Overall Study|Withdrawal by Subject|0|||
16890635|NCT02448810|37939242|FG007|Overall Study|Withdrawal by Subject|2|||
16890636|NCT02448810|37939235|FG000|Overall Study|Other (study terminated by sponsor)|0|||
16890637|NCT02448810|37939236|FG001|Overall Study|Other (study terminated by sponsor)|0|||
16890638|NCT02448810|37939237|FG002|Overall Study|Other (study terminated by sponsor)|0|||
16890639|NCT02448810|37939238|FG003|Overall Study|Other (study terminated by sponsor)|0|||
16890640|NCT02448810|37939239|FG004|Overall Study|Other (study terminated by sponsor)|4|||
16890641|NCT02448810|37939240|FG005|Overall Study|Other (study terminated by sponsor)|2|||
16890642|NCT02448810|37939241|FG006|Overall Study|Other (study terminated by sponsor)|2|||
16890643|NCT02448810|37939242|FG007|Overall Study|Other (study terminated by sponsor)|1|||
16890644|NCT02448810|37939235|FG000|Overall Study|Death|1|||
16890645|NCT02448810|37939236|FG001|Overall Study|Death|0|||
16890646|NCT02448810|37939237|FG002|Overall Study|Death|1|||
16890647|NCT02448810|37939238|FG003|Overall Study|Death|0|||
16890648|NCT02448810|37939239|FG004|Overall Study|Death|1|||
16890649|NCT02448810|37939240|FG005|Overall Study|Death|0|||
16890650|NCT02448810|37939241|FG006|Overall Study|Death|0|||
16890651|NCT02448810|37939242|FG007|Overall Study|Death|0|||
17002993|NCT00907478|38147126|FG001|Overall Study|Other|0|||
16890652|NCT02448810|37939235|FG000|Overall Study|Other (Progressive disease)|2|||
16890653|NCT02448810|37939236|FG001|Overall Study|Other (Progressive disease)|2|||
16890654|NCT02448810|37939237|FG002|Overall Study|Other (Progressive disease)|0|||
16890655|NCT02448810|37939238|FG003|Overall Study|Other (Progressive disease)|3|||
16890656|NCT02448810|37939239|FG004|Overall Study|Other (Progressive disease)|23|||
16890657|NCT02448810|37939240|FG005|Overall Study|Other (Progressive disease)|9|||
16890658|NCT02448810|37939241|FG006|Overall Study|Other (Progressive disease)|14|||
16890659|NCT02448810|37939242|FG007|Overall Study|Other (Progressive disease)|5|||
16890660|NCT02448810|37939235|FG000|Overall Study|Lost to Follow-up|0|||
16890661|NCT02448810|37939236|FG001|Overall Study|Lost to Follow-up|1|||
16890662|NCT02448810|37939237|FG002|Overall Study|Lost to Follow-up|0|||
16890663|NCT02448810|37939238|FG003|Overall Study|Lost to Follow-up|0|||
16890664|NCT02448810|37939239|FG004|Overall Study|Lost to Follow-up|0|||
16890665|NCT02448810|37939240|FG005|Overall Study|Lost to Follow-up|0|||
16890666|NCT02448810|37939241|FG006|Overall Study|Lost to Follow-up|0|||
16890667|NCT02448810|37939242|FG007|Overall Study|Lost to Follow-up|0|||
16890668|NCT02448810|37939235|FG000|Overall Study|Other (unspecified)|0|||
16890669|NCT02448810|37939236|FG001|Overall Study|Other (unspecified)|0|||
16890670|NCT02448810|37939237|FG002|Overall Study|Other (unspecified)|0|||
16890671|NCT02448810|37939238|FG003|Overall Study|Other (unspecified)|0|||
16890672|NCT02448810|37939239|FG004|Overall Study|Other (unspecified)|0|||
16890673|NCT02448810|37939240|FG005|Overall Study|Other (unspecified)|0|||
16890674|NCT02448810|37939241|FG006|Overall Study|Other (unspecified)|2|||
16890675|NCT02448810|37939242|FG007|Overall Study|Other (unspecified)|0|||
16890676|NCT02457546|37939315|FG000|Overall Study|Other reasons|4|||
16890677|NCT02457546|37939316|FG001|Overall Study|Other reasons|1|||
16890678|NCT02457546|37939315|FG000|Overall Study|Refused to complete study/procedures|1|||
16890679|NCT02457546|37939316|FG001|Overall Study|Refused to complete study/procedures|1|||
16890680|NCT02457546|37939315|FG000|Overall Study|Lost to Follow-up|4|||
16890681|NCT02457546|37939316|FG001|Overall Study|Lost to Follow-up|1|||
16890682|NCT02457546|37939315|FG000|Overall Study|Adverse Event|0|||
16890683|NCT02457546|37939316|FG001|Overall Study|Adverse Event|1|||
16890684|NCT02447952|37939337|FG000|Overall Study|Adverse Event|2|||
16890685|NCT02447952|37939337|FG000|Overall Study|Physician Decision|1|||
16890686|NCT02447952|37939337|FG000|Overall Study|Withdrawal by Subject|4|||
16890687|NCT02447718|37939371|FG000|Overall Study|Lost to Follow-up|8|||
16890688|NCT02447718|37939372|FG001|Overall Study|Lost to Follow-up|0|||
16890689|NCT02447718|37939371|FG000|Overall Study|Withdrawal by Subject|3|||
16890690|NCT02447718|37939372|FG001|Overall Study|Withdrawal by Subject|0|||
16890691|NCT02447718|37939371|FG000|Overall Study|Screen Failure|1|||
16890692|NCT02447718|37939372|FG001|Overall Study|Screen Failure|0|||
16890693|NCT02486406|37939549|FG000|Overall Study|Withdrew consent|1|||
16890694|NCT02486406|37939550|FG001|Overall Study|Withdrew consent|0|||
16890695|NCT02486406|37939551|FG002|Overall Study|Withdrew consent|0|||
16890696|NCT02486406|37939552|FG003|Overall Study|Withdrew consent|1|||
16890697|NCT02486406|37939549|FG000|Overall Study|Lost to Follow-up|1|||
16890698|NCT02486406|37939550|FG001|Overall Study|Lost to Follow-up|3|||
16890699|NCT02486406|37939551|FG002|Overall Study|Lost to Follow-up|1|||
16890700|NCT02486406|37939552|FG003|Overall Study|Lost to Follow-up|3|||
16890701|NCT02486406|37939549|FG000|Overall Study|Other, not specified|0|||
16890702|NCT02486406|37939550|FG001|Overall Study|Other, not specified|0|||
16890703|NCT02486406|37939551|FG002|Overall Study|Other, not specified|1|||
16890704|NCT02486406|37939552|FG003|Overall Study|Other, not specified|0|||
16890705|NCT02485704|37939624|FG000|Overall Study|Lost to Follow-up|4|||
16890706|NCT02485704|37939625|FG001|Overall Study|Lost to Follow-up|5|||
16890707|NCT02485704|37939624|FG000|Overall Study|Withdrawal by Subject|0|||
16890708|NCT02485704|37939625|FG001|Overall Study|Withdrawal by Subject|3|||
16890709|NCT02485704|37939624|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
16890710|NCT02485704|37939625|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
16890711|NCT02485158|37939635|FG000|Overall Study|Withdrawal by Subject|3|||
16890712|NCT02485158|37939635|FG000|Overall Study|expected drug side effect|1|||
16890713|NCT02455518|37939654|FG000|Overall Study|Protocol Violation|0|||
16890714|NCT02455518|37939655|FG001|Overall Study|Protocol Violation|1|||
16890715|NCT02455518|37939656|FG002|Overall Study|Protocol Violation|1|||
16890716|NCT02455518|37939657|FG003|Overall Study|Protocol Violation|3|||
16890717|NCT02873195|37939805|FG000|Overall Study|Ineligible|5|||
16890718|NCT02873195|37939806|FG001|Overall Study|Ineligible|0|||
16890719|NCT02435849|37939841|FG000|Overall Study|Enrolled but not infused|18|||
16890720|NCT02435849|37939841|FG000|Overall Study|Death|16|||
16890721|NCT02435849|37939841|FG000|Overall Study|Lack of Efficacy|9|||
16890722|NCT02435849|37939841|FG000|Overall Study|New therapy for study indication|7|||
16890723|NCT02435849|37939841|FG000|Overall Study|Subject/guardian decision|2|||
16890724|NCT02435849|37939841|FG000|Overall Study|Study follow-up ongoing|45|||
16890725|NCT02240069|37939888|FG000|Overall Study|Withdrawal by Subject|5|||
16890726|NCT02240069|37939889|FG001|Overall Study|Withdrawal by Subject|5|||
16890727|NCT02240069|37939890|FG002|Overall Study|Withdrawal by Subject|2|||
16890728|NCT02484690|37939976|FG000|Overall Study|Adverse Event|1|||
16890729|NCT02484690|37939977|FG001|Overall Study|Adverse Event|3|||
16890730|NCT02484690|37939978|FG002|Overall Study|Adverse Event|0|||
16890731|NCT02484690|37939979|FG003|Overall Study|Adverse Event|0|||
16890732|NCT02484690|37939980|FG004|Overall Study|Adverse Event|5|||
16890733|NCT02484690|37939976|FG000|Overall Study|Death|0|||
16890734|NCT02484690|37939977|FG001|Overall Study|Death|0|||
16890735|NCT02484690|37939978|FG002|Overall Study|Death|0|||
16890736|NCT02484690|37939979|FG003|Overall Study|Death|0|||
16890737|NCT02484690|37939980|FG004|Overall Study|Death|1|||
16890738|NCT02484690|37939976|FG000|Overall Study|Withdrawal by Subject|1|||
16890739|NCT02484690|37939977|FG001|Overall Study|Withdrawal by Subject|3|||
16890740|NCT02484690|37939978|FG002|Overall Study|Withdrawal by Subject|1|||
16890741|NCT02484690|37939979|FG003|Overall Study|Withdrawal by Subject|2|||
16890742|NCT02484690|37939980|FG004|Overall Study|Withdrawal by Subject|0|||
16890743|NCT02484690|37939976|FG000|Overall Study|Physician Decision|2|||
16890744|NCT02484690|37939977|FG001|Overall Study|Physician Decision|0|||
16890745|NCT02484690|37939978|FG002|Overall Study|Physician Decision|1|||
16890746|NCT02484690|37939979|FG003|Overall Study|Physician Decision|0|||
16890747|NCT02484690|37939980|FG004|Overall Study|Physician Decision|0|||
16890748|NCT02484690|37939976|FG000|Overall Study|Lost to Follow-up|0|||
16890749|NCT02484690|37939977|FG001|Overall Study|Lost to Follow-up|0|||
16890750|NCT02484690|37939978|FG002|Overall Study|Lost to Follow-up|1|||
16890751|NCT02484690|37939979|FG003|Overall Study|Lost to Follow-up|0|||
16890752|NCT02484690|37939980|FG004|Overall Study|Lost to Follow-up|0|||
16890753|NCT01654224|37940004|FG000|Overall Study|Lost to Follow-up|2|||
16890754|NCT01654224|37940005|FG001|Overall Study|Lost to Follow-up|2|||
16890755|NCT01654224|37940004|FG000|Overall Study|Did not receive allocation|1|||
17002994|NCT00907478|38147127|FG002|Overall Study|Other|1|||
17002995|NCT00627445|38147139|FG000|Overall Study|Adverse Event|3|||
16890756|NCT01654224|37940005|FG001|Overall Study|Did not receive allocation|8|||
16890757|NCT01654224|37940004|FG000|Overall Study|Insufficient blood sample|3|||
16890758|NCT01654224|37940005|FG001|Overall Study|Insufficient blood sample|2|||
16890759|NCT02447328|37940011|FG000|Overall Study|Withdrawal by Subject|1|||
16890760|NCT02447250|37940015|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
16890761|NCT02447250|37940015|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
16890762|NCT02447250|37940015|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
16890763|NCT02447172|37940119|FG000|Overall Study|Adverse Event|11|||
16890764|NCT02447172|37940120|FG001|Overall Study|Adverse Event|8|||
16890765|NCT02447172|37940121|FG002|Overall Study|Adverse Event|7|||
16890766|NCT02447172|37940119|FG000|Overall Study|Death|3|||
16890767|NCT02447172|37940120|FG001|Overall Study|Death|1|||
16890768|NCT02447172|37940121|FG002|Overall Study|Death|0|||
16890769|NCT02447172|37940119|FG000|Overall Study|Protocol Violation|2|||
16890770|NCT02447172|37940120|FG001|Overall Study|Protocol Violation|1|||
16890771|NCT02447172|37940121|FG002|Overall Study|Protocol Violation|2|||
16890772|NCT02447172|37940119|FG000|Overall Study|Lost to Follow-up|7|||
16890773|NCT02447172|37940120|FG001|Overall Study|Lost to Follow-up|4|||
16890774|NCT02447172|37940121|FG002|Overall Study|Lost to Follow-up|4|||
16890775|NCT02447172|37940119|FG000|Overall Study|Withdrawal by Subject|5|||
16890776|NCT02447172|37940120|FG001|Overall Study|Withdrawal by Subject|1|||
16890777|NCT02447172|37940121|FG002|Overall Study|Withdrawal by Subject|3|||
16890778|NCT02447172|37940119|FG000|Overall Study|protocol specific treatment unrelated|3|||
16890779|NCT02447172|37940120|FG001|Overall Study|protocol specific treatment unrelated|0|||
16890780|NCT02447172|37940121|FG002|Overall Study|protocol specific treatment unrelated|2|||
16890781|NCT02455050|37940154|FG000|Treatment Period 1|Lost to Follow-up|1|||
16890782|NCT02455050|37940155|FG001|Treatment Period 1|Lost to Follow-up|1|||
16890783|NCT02455050|37940156|FG002|Treatment Period 1|Lost to Follow-up|1|||
16890784|NCT02455050|37940157|FG003|Treatment Period 1|Lost to Follow-up|2|||
16890785|NCT02455050|37940154|FG000|Treatment Period 2|Lost to Follow-up|1|||
16890786|NCT02455050|37940155|FG001|Treatment Period 2|Lost to Follow-up|0|||
16890787|NCT02455050|37940156|FG002|Treatment Period 2|Lost to Follow-up|2|||
16890788|NCT02455050|37940157|FG003|Treatment Period 2|Lost to Follow-up|1|||
16890789|NCT02418468|37940197|FG000|Overall Study|Adverse Event|1|||
16890790|NCT02418468|37940198|FG001|Overall Study|Adverse Event|0|||
16890791|NCT02418468|37940197|FG000|Overall Study|Withdrawal of informed consent|1|||
16890792|NCT02418468|37940198|FG001|Overall Study|Withdrawal of informed consent|1|||
16890793|NCT02418156|37940204|FG000|Overall Study|Lost to Follow-up|12|||
16890794|NCT02418156|37940204|FG000|Overall Study|Death|2|||
16890795|NCT02418156|37940204|FG000|Overall Study|Physician Decision|1|||
16890796|NCT02418156|37940204|FG000|Overall Study|Withdrawal by Subject|1|||
16890797|NCT02418156|37940204|FG000|Overall Study|Subject refused to return|1|||
16890798|NCT02418000|37940333|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
17095372|NCT00232596|38234650|FG001|6-Week Titration Phase|Adverse Event|19|||
16890799|NCT02418000|37940334|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
16890800|NCT02418000|37940335|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
16890801|NCT02418000|37940336|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
16890802|NCT02418000|37940337|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
17002996|NCT00627445|38147140|FG001|Overall Study|Adverse Event|3|||
16890803|NCT02418000|37940333|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
16890804|NCT02418000|37940334|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
16890805|NCT02418000|37940335|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
16890806|NCT02418000|37940336|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
16890807|NCT02418000|37940337|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
16890808|NCT02418000|37940333|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
16890809|NCT02418000|37940334|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
16890810|NCT02418000|37940335|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
16890811|NCT02418000|37940336|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
16890812|NCT02418000|37940337|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
16890813|NCT02418000|37940333|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
16890814|NCT02418000|37940334|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
16890815|NCT02418000|37940335|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
16890816|NCT02418000|37940336|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
17002997|NCT00627445|38147139|FG000|Overall Study|Lack of Efficacy|0|||
17002998|NCT00627445|38147140|FG001|Overall Study|Lack of Efficacy|1|||
17002999|NCT00627445|38147139|FG000|Overall Study|Other|6|||
17003000|NCT00627445|38147140|FG001|Overall Study|Other|8|||
16890817|NCT02418000|37940337|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
16890818|NCT02418000|37940333|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
16890819|NCT02418000|37940334|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
16890820|NCT02418000|37940335|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
16890821|NCT02418000|37940336|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
16890822|NCT02418000|37940337|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
16890823|NCT02418000|37940333|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890824|NCT02418000|37940334|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890825|NCT02418000|37940335|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
16890826|NCT02418000|37940336|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
17003001|NCT00905840|38147148|FG000|Overall Study|Lost to Follow-up|11|||
17003002|NCT00905840|38147148|FG000|Overall Study|Death|3|||
17003003|NCT00905840|38147148|FG000|Overall Study|Withdrawal by Subject|1|||
17003004|NCT00905840|38147148|FG000|Overall Study|Adverse Event|1|||
17003005|NCT00626821|38147155|FG000|Overall Study|Adverse Event|44|||
17003006|NCT00626821|38147155|FG000|Overall Study|Protocol Violation|33|||
17003007|NCT00626821|38147155|FG000|Overall Study|Withdrawal by Subject|10|||
17003008|NCT00626821|38147155|FG000|Overall Study|Physician Decision|9|||
17003009|NCT00626821|38147155|FG000|Overall Study|Product dysfunction|21|||
17003010|NCT00626821|38147155|FG000|Overall Study|other/unknown reason|104|||
17003011|NCT00625183|38147159|FG000|Overall Study|Disease Progression|1|||
17003012|NCT00904982|38147169|FG000|Overall Study|Withdrawal by Subject|2|||
17003013|NCT00904982|38147170|FG001|Overall Study|Withdrawal by Subject|0|||
17003014|NCT00904982|38147171|FG002|Overall Study|Withdrawal by Subject|0|||
17003015|NCT00904982|38147172|FG003|Overall Study|Withdrawal by Subject|0|||
17003016|NCT00640315|38147184|FG000|Overall Study|Withdrawal by Subject|0|||
17003017|NCT00640315|38147185|FG001|Overall Study|Withdrawal by Subject|1|||
17003018|NCT00904748|38147191|FG000|Overall Study|Withdrawal by Subject|1|||
17003019|NCT00904748|38147192|FG001|Overall Study|Withdrawal by Subject|1|||
17003020|NCT00904748|38147193|FG002|Overall Study|Withdrawal by Subject|1|||
17003021|NCT00904748|38147194|FG003|Overall Study|Withdrawal by Subject|2|||
17003022|NCT00904748|38147195|FG004|Overall Study|Withdrawal by Subject|0|||
17003023|NCT00904748|38147196|FG005|Overall Study|Withdrawal by Subject|0|||
17003024|NCT00904748|38147191|FG000|Overall Study|Adverse Event|0|||
17003025|NCT00904748|38147192|FG001|Overall Study|Adverse Event|0|||
17003026|NCT00904748|38147193|FG002|Overall Study|Adverse Event|0|||
17003027|NCT00904748|38147194|FG003|Overall Study|Adverse Event|0|||
17003028|NCT00904748|38147195|FG004|Overall Study|Adverse Event|1|||
17003029|NCT00904748|38147196|FG005|Overall Study|Adverse Event|0|||
17003030|NCT00574405|38147207|FG000|Overall Study|Withdrawal by Subject|3|||
17003031|NCT00574405|38147208|FG001|Overall Study|Withdrawal by Subject|2|||
17003032|NCT00971243|38147219|FG000|Double Blind Period|Adverse Event|2|||
17003033|NCT00971243|38147220|FG001|Double Blind Period|Adverse Event|3|||
17003034|NCT00971243|38147221|FG002|Double Blind Period|Adverse Event|2|||
17003035|NCT00971243|38147222|FG003|Double Blind Period|Adverse Event|2|||
17003036|NCT00971243|38147223|FG004|Double Blind Period|Adverse Event|3|||
17003037|NCT00971243|38147219|FG000|Double Blind Period|Lost to Follow-up|0|||
17003038|NCT00971243|38147220|FG001|Double Blind Period|Lost to Follow-up|1|||
17003039|NCT00971243|38147221|FG002|Double Blind Period|Lost to Follow-up|1|||
17003040|NCT00971243|38147222|FG003|Double Blind Period|Lost to Follow-up|0|||
17003041|NCT00971243|38147223|FG004|Double Blind Period|Lost to Follow-up|1|||
17003042|NCT00971243|38147219|FG000|Double Blind Period|Physician Decision|10|||
17003043|NCT00971243|38147220|FG001|Double Blind Period|Physician Decision|6|||
17003044|NCT00971243|38147221|FG002|Double Blind Period|Physician Decision|7|||
17003045|NCT00971243|38147222|FG003|Double Blind Period|Physician Decision|6|||
17003046|NCT00971243|38147223|FG004|Double Blind Period|Physician Decision|7|||
17003047|NCT00971243|38147219|FG000|Double Blind Period|Protocol Violation|2|||
17003048|NCT00971243|38147220|FG001|Double Blind Period|Protocol Violation|0|||
16890827|NCT02418000|37940337|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890828|NCT02418000|37940333|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890829|NCT02418000|37940334|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890830|NCT02418000|37940335|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890831|NCT02418000|37940336|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
16890832|NCT02418000|37940337|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890833|NCT02418000|37940333|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
16890834|NCT02418000|37940334|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
16890835|NCT02418000|37940335|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
16890836|NCT02418000|37940336|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
16890837|NCT02418000|37940337|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
16890838|NCT02418000|37940333|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890839|NCT02418000|37940334|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890840|NCT02418000|37940335|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890841|NCT02418000|37940336|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16890842|NCT02418000|37940337|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
16890843|NCT02417064|37940441|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
16890844|NCT02417064|37940442|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
16890845|NCT02417064|37940443|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
16890846|NCT02417064|37940441|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
16890847|NCT02417064|37940442|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
16890848|NCT02417064|37940443|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
16890849|NCT02417064|37940441|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
16890850|NCT02417064|37940442|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
16890851|NCT02417064|37940443|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
16890852|NCT02417064|37940441|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
16890853|NCT02417064|37940442|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
16890854|NCT02417064|37940443|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
16890855|NCT02417064|37940441|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
16890856|NCT02417064|37940442|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
16890857|NCT02417064|37940443|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
16890858|NCT02417064|37940441|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
16890859|NCT02417064|37940442|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
16890860|NCT02417064|37940443|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
16890861|NCT02417064|37940441|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
16890862|NCT02417064|37940442|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
16890863|NCT02417064|37940443|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
16890864|NCT02417064|37940441|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
16890865|NCT02417064|37940442|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
16890866|NCT02417064|37940443|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
16890867|NCT02417064|37940441|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
16890868|NCT02417064|37940442|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
16890869|NCT02417064|37940443|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
16890870|NCT02417064|37940441|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
16890871|NCT02417064|37940442|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
16890872|NCT02417064|37940443|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
16890873|NCT02417064|37940441|FG000|Follow-up Phase (24 Weeks)|Other|2|||
16890874|NCT02417064|37940442|FG001|Follow-up Phase (24 Weeks)|Other|2|||
16890875|NCT02417064|37940443|FG002|Follow-up Phase (24 Weeks)|Other|3|||
16890876|NCT01653132|37940458|FG000|First Intervention|Protocol Violation|1|||
16890877|NCT01653132|37940459|FG001|First Intervention|Protocol Violation|0|||
16890878|NCT02453334|37940484|FG000|Overall Study|Death|15|||
16890879|NCT02453334|37940485|FG001|Overall Study|Death|13|||
16890880|NCT02453334|37940484|FG000|Overall Study|Adverse Event|2|||
16890881|NCT02453334|37940485|FG001|Overall Study|Adverse Event|1|||
16890882|NCT02453334|37940484|FG000|Overall Study|Lost to Follow-up|5|||
16890883|NCT02453334|37940485|FG001|Overall Study|Lost to Follow-up|9|||
16890884|NCT02453334|37940484|FG000|Overall Study|Physician Decision|1|||
16890885|NCT02453334|37940485|FG001|Overall Study|Physician Decision|0|||
16890886|NCT02453334|37940484|FG000|Overall Study|Withdrawal by Subject|17|||
16890887|NCT02453334|37940485|FG001|Overall Study|Withdrawal by Subject|13|||
16890888|NCT02453334|37940484|FG000|Overall Study|Other reason|1|||
16890889|NCT02453334|37940485|FG001|Overall Study|Other reason|4|||
16890890|NCT02443740|37940571|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
17003049|NCT00971243|38147221|FG002|Double Blind Period|Protocol Violation|3|||
17003050|NCT00971243|38147222|FG003|Double Blind Period|Protocol Violation|2|||
17003051|NCT00971243|38147223|FG004|Double Blind Period|Protocol Violation|2|||
17003052|NCT00971243|38147219|FG000|Double Blind Period|Withdrawal by Subject|4|||
17003053|NCT00971243|38147220|FG001|Double Blind Period|Withdrawal by Subject|1|||
17003054|NCT00971243|38147221|FG002|Double Blind Period|Withdrawal by Subject|4|||
17003055|NCT00971243|38147222|FG003|Double Blind Period|Withdrawal by Subject|4|||
17003056|NCT00971243|38147223|FG004|Double Blind Period|Withdrawal by Subject|4|||
17003057|NCT00971243|38147219|FG000|Double Blind Period|Other reasons|1|||
17003058|NCT00971243|38147220|FG001|Double Blind Period|Other reasons|0|||
17003059|NCT00971243|38147221|FG002|Double Blind Period|Other reasons|2|||
17003060|NCT00971243|38147222|FG003|Double Blind Period|Other reasons|0|||
17003061|NCT00971243|38147223|FG004|Double Blind Period|Other reasons|1|||
17003062|NCT00971243|38147219|FG000|Open-label Period|Adverse Event|1|||
17003063|NCT00971243|38147220|FG001|Open-label Period|Adverse Event|0|||
17003064|NCT00971243|38147221|FG002|Open-label Period|Adverse Event|1|||
17003065|NCT00971243|38147222|FG003|Open-label Period|Adverse Event|1|||
17003066|NCT00971243|38147223|FG004|Open-label Period|Adverse Event|0|||
17003067|NCT00971243|38147219|FG000|Open-label Period|Physician Decision|5|||
17003068|NCT00971243|38147220|FG001|Open-label Period|Physician Decision|9|||
17003069|NCT00971243|38147221|FG002|Open-label Period|Physician Decision|3|||
17003070|NCT00971243|38147222|FG003|Open-label Period|Physician Decision|7|||
17003071|NCT00971243|38147223|FG004|Open-label Period|Physician Decision|2|||
17003072|NCT00971243|38147219|FG000|Open-label Period|Protocol Violation|1|||
17003073|NCT00971243|38147220|FG001|Open-label Period|Protocol Violation|1|||
17192162|NCT00708435|38345286|FG001|Overall Study|Intervention by primary care physician|0|||
16890891|NCT02443740|37940572|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890892|NCT02443740|37940573|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890893|NCT02443740|37940574|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890894|NCT02443740|37940575|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890895|NCT02443740|37940576|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
16890896|NCT02443740|37940577|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890897|NCT02443740|37940578|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890898|NCT02443740|37940579|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890899|NCT02443740|37940580|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890900|NCT02443740|37940581|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
16890901|NCT02443740|37940571|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
16890902|NCT02443740|37940572|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890903|NCT02443740|37940573|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890904|NCT02443740|37940574|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890905|NCT02443740|37940575|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890906|NCT02443740|37940576|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890907|NCT02443740|37940577|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
16890908|NCT02443740|37940578|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890909|NCT02443740|37940579|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890910|NCT02443740|37940580|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890911|NCT02443740|37940581|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16890912|NCT02443740|37940571|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890913|NCT02443740|37940572|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890914|NCT02443740|37940573|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890915|NCT02443740|37940574|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890916|NCT02443740|37940575|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890917|NCT02443740|37940576|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
16890918|NCT02443740|37940577|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890919|NCT02443740|37940578|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890920|NCT02443740|37940579|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
17003074|NCT00971243|38147221|FG002|Open-label Period|Protocol Violation|1|||
17192163|NCT00708435|38345285|FG000|Overall Study|Refused hospitalization|1|||
17192164|NCT00708435|38345286|FG001|Overall Study|Refused hospitalization|0|||
17192165|NCT02841787|38345297|FG000|Overall Study|Lost to Follow-up|1|||
17192166|NCT02841787|38345298|FG001|Overall Study|Lost to Follow-up|0|||
17192167|NCT02841787|38345299|FG002|Overall Study|Lost to Follow-up|0|||
17192168|NCT02841787|38345297|FG000|Overall Study|Symptoms dropped below threshold|1|||
17192169|NCT02841787|38345298|FG001|Overall Study|Symptoms dropped below threshold|0|||
17192170|NCT02841787|38345299|FG002|Overall Study|Symptoms dropped below threshold|0|||
17192171|NCT02841787|38345297|FG000|Overall Study|Withdrawal by Subject|1|||
17192172|NCT02841787|38345298|FG001|Overall Study|Withdrawal by Subject|4|||
17192173|NCT02841787|38345299|FG002|Overall Study|Withdrawal by Subject|0|||
17192174|NCT01376037|38345309|FG000|Overall Study|Lost to Follow-up|0|||
17192175|NCT01376037|38345310|FG001|Overall Study|Lost to Follow-up|2|||
17192176|NCT02657408|38345318|FG000|Overall Study|Adverse Event|3|||
17192177|NCT02657408|38345319|FG001|Overall Study|Adverse Event|7|||
17192178|NCT02841709|38345325|FG000|5th Intervention|Adverse Event|2|||
17192179|NCT02841709|38345326|FG001|5th Intervention|Adverse Event|0|||
17192180|NCT02841709|38345327|FG002|5th Intervention|Adverse Event|0|||
17192181|NCT02841709|38345328|FG003|5th Intervention|Adverse Event|0|||
17192182|NCT02841709|38345329|FG004|5th Intervention|Adverse Event|2|||
17192183|NCT01353859|38345342|FG000|Overall Study|Adverse Event|3|||
16890921|NCT02443740|37940580|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890922|NCT02443740|37940581|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16890923|NCT02416908|37940812|FG000|Dose Escalation Phase|Adverse Event|0|||
16890924|NCT02416908|37940813|FG001|Dose Escalation Phase|Adverse Event|0|||
16890925|NCT02416908|37940814|FG002|Dose Escalation Phase|Adverse Event|3|||
16890926|NCT02416908|37940815|FG003|Dose Escalation Phase|Adverse Event|0|||
16890927|NCT02416908|37940812|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16890928|NCT02416908|37940813|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16890929|NCT02416908|37940814|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
16890930|NCT02416908|37940815|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16890931|NCT02453256|37940905|FG000|Double Blind Period|Death|1|||
16890932|NCT02453256|37940906|FG001|Double Blind Period|Death|1|||
16890933|NCT02453256|37940905|FG000|Double Blind Period|Adverse Event|3|||
16890934|NCT02453256|37940906|FG001|Double Blind Period|Adverse Event|2|||
16890935|NCT02453256|37940905|FG000|Double Blind Period|Withdrawal by Subject|9|||
16890936|NCT02453256|37940906|FG001|Double Blind Period|Withdrawal by Subject|5|||
16890937|NCT02453256|37940905|FG000|Double Blind Period|Other|0|||
16890938|NCT02453256|37940906|FG001|Double Blind Period|Other|1|||
16890939|NCT02453256|37940905|FG000|Open Label Period|Adverse Event|1|||
16890940|NCT02453256|37940906|FG001|Open Label Period|Adverse Event|3|||
16890941|NCT02453256|37940905|FG000|Open Label Period|Death|0|||
16890942|NCT02453256|37940906|FG001|Open Label Period|Death|1|||
16890943|NCT02453256|37940905|FG000|Open Label Period|Lost to Follow-up|1|||
16890944|NCT02453256|37940906|FG001|Open Label Period|Lost to Follow-up|0|||
16890945|NCT02453256|37940905|FG000|Open Label Period|Other|0|||
16890946|NCT02453256|37940906|FG001|Open Label Period|Other|2|||
16890947|NCT02453256|37940905|FG000|Open Label Period|Withdrawal by Subject|5|||
16890948|NCT02453256|37940906|FG001|Open Label Period|Withdrawal by Subject|1|||
16890949|NCT02442804|37940921|FG000|Overall Study|Withdrawal by Subject|0|||
16890950|NCT02442804|37940922|FG001|Overall Study|Withdrawal by Subject|1|||
16890951|NCT02442804|37940921|FG000|Overall Study|Adverse Event|1|||
16890952|NCT02442804|37940922|FG001|Overall Study|Adverse Event|0|||
16890953|NCT02414958|37941011|FG000|Overall Study|Adverse Event|6|||
16890954|NCT02414958|37941012|FG001|Overall Study|Adverse Event|6|||
16890955|NCT02414958|37941013|FG002|Overall Study|Adverse Event|3|||
16890956|NCT02414958|37941011|FG000|Overall Study|Protocol Violation|10|||
16890957|NCT02414958|37941012|FG001|Overall Study|Protocol Violation|3|||
16890958|NCT02414958|37941013|FG002|Overall Study|Protocol Violation|1|||
16890959|NCT02414958|37941011|FG000|Overall Study|Lost to Follow-up|7|||
16890960|NCT02414958|37941012|FG001|Overall Study|Lost to Follow-up|4|||
16890961|NCT02414958|37941013|FG002|Overall Study|Lost to Follow-up|0|||
16890962|NCT02414958|37941011|FG000|Overall Study|Withdrawal by Subject|5|||
16890963|NCT02414958|37941012|FG001|Overall Study|Withdrawal by Subject|3|||
16890964|NCT02414958|37941013|FG002|Overall Study|Withdrawal by Subject|5|||
16890965|NCT02414958|37941011|FG000|Overall Study|Other than specified|4|||
16890966|NCT02414958|37941012|FG001|Overall Study|Other than specified|4|||
16890967|NCT02414958|37941013|FG002|Overall Study|Other than specified|5|||
16890968|NCT02452476|37941086|FG000|Overall Study|Death|4|||
16890969|NCT02452476|37941087|FG001|Overall Study|Death|7|||
16890970|NCT02452476|37941086|FG000|Overall Study|Lost to Follow-up|1|||
16890971|NCT02452476|37941087|FG001|Overall Study|Lost to Follow-up|1|||
16890972|NCT02452476|37941086|FG000|Overall Study|Physician Decision|1|||
16890973|NCT02452476|37941087|FG001|Overall Study|Physician Decision|1|||
16890974|NCT02452476|37941086|FG000|Overall Study|Not treated|5|||
16890975|NCT02452476|37941087|FG001|Overall Study|Not treated|1|||
16890976|NCT02442336|37941102|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
16890977|NCT02442336|37941102|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
16890978|NCT02442336|37941102|FG000|Overall Study|Lost to Follow-up|11|||
16890979|NCT02452398|37941106|FG000|Overall Study|Adverse Event|1|||
16890980|NCT02452398|37941106|FG000|Overall Study|Lost to Follow-up|28|||
16890981|NCT02452398|37941106|FG000|Overall Study|Physician Decision|2|||
16890982|NCT02452398|37941106|FG000|Overall Study|Withdrawal by Subject|6|||
16890983|NCT02452398|37941106|FG000|Overall Study|Moved away|4|||
16890984|NCT02413398|37941112|FG000|Overall Study|Lost to Follow-up|2|||
16890985|NCT02413398|37941113|FG001|Overall Study|Lost to Follow-up|4|||
16890986|NCT02413398|37941112|FG000|Overall Study|Withdrawal by Subject|1|||
16890987|NCT02413398|37941113|FG001|Overall Study|Withdrawal by Subject|1|||
16890988|NCT02413398|37941112|FG000|Overall Study|Other Eligibility criteria|1|||
16890989|NCT02413398|37941113|FG001|Overall Study|Other Eligibility criteria|2|||
16890990|NCT02441946|37941122|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
16890991|NCT02441946|37941123|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
16890992|NCT02441946|37941124|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
16890993|NCT02441946|37941122|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
16890994|NCT02441946|37941123|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
16890995|NCT02441946|37941124|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
16890996|NCT02441946|37941122|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16890997|NCT02441946|37941123|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
16890998|NCT02441946|37941124|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16890999|NCT02441946|37941122|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
16891000|NCT02441946|37941123|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
16891001|NCT02441946|37941124|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
16891002|NCT02441946|37941122|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
16891003|NCT02441946|37941123|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
16891004|NCT02441946|37941124|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
16891005|NCT02441946|37941122|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
16891006|NCT02441946|37941123|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
16891007|NCT02441946|37941124|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
16891008|NCT02441946|37941122|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
16891009|NCT02441946|37941123|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
16891010|NCT02441946|37941124|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
16891011|NCT02441946|37941122|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
16891012|NCT02441946|37941123|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
16891013|NCT02441946|37941124|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
16891014|NCT02441946|37941122|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
16891015|NCT02441946|37941123|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
16891016|NCT02441946|37941124|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
16891017|NCT02441946|37941122|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
16891018|NCT02441946|37941123|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
16891019|NCT02441946|37941124|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
16891020|NCT02441946|37941122|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
16891021|NCT02441946|37941123|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16891022|NCT02441946|37941124|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16891023|NCT02387580|37941158|FG000|Overall Study|Withdrawal by Subject|0|||
16891024|NCT02387580|37941159|FG001|Overall Study|Withdrawal by Subject|0|||
16891025|NCT02387580|37941160|FG002|Overall Study|Withdrawal by Subject|0|||
17003075|NCT00971243|38147222|FG003|Open-label Period|Protocol Violation|0|||
17003076|NCT00971243|38147223|FG004|Open-label Period|Protocol Violation|1|||
17003077|NCT00971243|38147219|FG000|Open-label Period|Withdrawal by Subject|1|||
17003078|NCT00971243|38147220|FG001|Open-label Period|Withdrawal by Subject|0|||
17003079|NCT00971243|38147221|FG002|Open-label Period|Withdrawal by Subject|0|||
17003080|NCT00971243|38147222|FG003|Open-label Period|Withdrawal by Subject|2|||
17003081|NCT00971243|38147223|FG004|Open-label Period|Withdrawal by Subject|1|||
17003082|NCT00971243|38147219|FG000|Open-label Period|Other reason|0|||
17003083|NCT00971243|38147220|FG001|Open-label Period|Other reason|0|||
17003084|NCT00971243|38147221|FG002|Open-label Period|Other reason|0|||
17003085|NCT00971243|38147222|FG003|Open-label Period|Other reason|0|||
17003086|NCT00971243|38147223|FG004|Open-label Period|Other reason|2|||
17003087|NCT00568555|38147237|FG000|Overall Study|Withdrawal by Subject|1|||
17003088|NCT00568555|38147238|FG001|Overall Study|Withdrawal by Subject|1|||
17003089|NCT00904670|38147246|FG000|Open Label Phase|Withdrawal by Subject|2|||
17003090|NCT00904670|38147247|FG001|Open Label Phase|Withdrawal by Subject|0|||
17003091|NCT00904670|38147246|FG000|Open Label Phase|Adverse Event|2|||
17003092|NCT00904670|38147247|FG001|Open Label Phase|Adverse Event|0|||
17003093|NCT00904670|38147246|FG000|Open Label Phase|Lack of Efficacy|1|||
17003094|NCT00904670|38147247|FG001|Open Label Phase|Lack of Efficacy|0|||
17003095|NCT00904670|38147246|FG000|Open Label Phase|Lost to Follow-up|1|||
16785810|NCT02009332|37725901|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
16785811|NCT01984294|37725918|FG000|Overall Study|Randomized but Never Treated|0|||
16785812|NCT01984294|37725919|FG001|Overall Study|Randomized but Never Treated|0|||
16785813|NCT01984294|37725920|FG002|Overall Study|Randomized but Never Treated|1|||
16785814|NCT01984294|37725918|FG000|Overall Study|Lack of Efficacy|4|||
16785815|NCT01984294|37725919|FG001|Overall Study|Lack of Efficacy|2|||
16785816|NCT01984294|37725920|FG002|Overall Study|Lack of Efficacy|6|||
16785817|NCT01984294|37725918|FG000|Overall Study|Adverse Event|0|||
16785818|NCT01984294|37725919|FG001|Overall Study|Adverse Event|1|||
16785819|NCT01984294|37725920|FG002|Overall Study|Adverse Event|0|||
16785820|NCT01962298|37725933|FG000|Overall Study|Protocol Violation|1|||
16891026|NCT02387580|37941161|FG003|Overall Study|Withdrawal by Subject|1|||
16891027|NCT02387580|37941162|FG004|Overall Study|Withdrawal by Subject|0|||
16891028|NCT02387580|37941163|FG005|Overall Study|Withdrawal by Subject|0|||
16891029|NCT02440854|37941179|FG000|Overall Study|Relocation of patient|1|||
16891030|NCT02440854|37941179|FG000|Overall Study|Death|6|||
16785821|NCT01962298|37725934|FG001|Overall Study|Protocol Violation|0|||
16785822|NCT01962298|37725935|FG002|Overall Study|Protocol Violation|1|||
16785823|NCT01962298|37725936|FG003|Overall Study|Protocol Violation|1|||
16785824|NCT01962298|37725937|FG004|Overall Study|Protocol Violation|0|||
16785825|NCT01962298|37725933|FG000|Overall Study|Data quality insufficient|2|||
16785826|NCT01962298|37725934|FG001|Overall Study|Data quality insufficient|0|||
17003096|NCT00904670|38147247|FG001|Open Label Phase|Lost to Follow-up|0|||
17003097|NCT00638443|38147255|FG000|First Intervention|Adverse Event|2|||
16785827|NCT01962298|37725935|FG002|Overall Study|Data quality insufficient|3|||
16891031|NCT02440854|37941179|FG000|Overall Study|Lost to Follow-up|10|||
16891032|NCT02440854|37941179|FG000|Overall Study|Afatinib discontinuation|46|||
16891033|NCT02440854|37941179|FG000|Overall Study|stopped study at earlier timepoint|14|||
16891034|NCT02440854|37941179|FG000|Overall Study|Study medication not received|1|||
16891035|NCT02440854|37941179|FG000|Overall Study|Violation of inclusion criteria|2|||
16891036|NCT02412852|37941234|FG000|Overall Study|Withdrawal by Subject|0|||
16891037|NCT02412852|37941235|FG001|Overall Study|Withdrawal by Subject|1|||
17003098|NCT00638443|38147256|FG001|First Intervention|Adverse Event|1|||
17003099|NCT00636181|38147267|FG000|Overall Study|Withdrawal by Subject|8|||
17003100|NCT00636181|38147268|FG001|Overall Study|Withdrawal by Subject|6|||
17003101|NCT00636181|38147269|FG002|Overall Study|Withdrawal by Subject|10|||
17003102|NCT00968669|38147281|FG000|Overall Study|Lost to Follow-up|5|||
17003103|NCT00968669|38147282|FG001|Overall Study|Lost to Follow-up|2|||
17003104|NCT00968669|38147283|FG002|Overall Study|Lost to Follow-up|1|||
17003105|NCT00968669|38147284|FG003|Overall Study|Lost to Follow-up|4|||
17003106|NCT00968669|38147281|FG000|Overall Study|Withdrawal by Subject|9|||
17003107|NCT00968669|38147282|FG001|Overall Study|Withdrawal by Subject|7|||
16891038|NCT02412852|37941236|FG002|Overall Study|Withdrawal by Subject|0|||
16891039|NCT02412852|37941237|FG003|Overall Study|Withdrawal by Subject|0|||
16891040|NCT02412852|37941234|FG000|Overall Study|Physician Decision|0|||
16891041|NCT02412852|37941235|FG001|Overall Study|Physician Decision|0|||
16891042|NCT02412852|37941236|FG002|Overall Study|Physician Decision|0|||
16891043|NCT02412852|37941237|FG003|Overall Study|Physician Decision|1|||
16891044|NCT02386098|37941293|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
16891045|NCT02386098|37941294|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
16891046|NCT02386098|37941295|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
16891047|NCT02386098|37941296|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
16891048|NCT02386098|37941297|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
16891049|NCT02386098|37941293|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
16891050|NCT02386098|37941294|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
16891051|NCT02386098|37941295|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
16785828|NCT01962298|37725936|FG003|Overall Study|Data quality insufficient|1|||
16785829|NCT01962298|37725937|FG004|Overall Study|Data quality insufficient|4|||
16785830|NCT01962298|37725933|FG000|Overall Study|Insufficient data|0|||
16785831|NCT01962298|37725934|FG001|Overall Study|Insufficient data|2|||
16891052|NCT02386098|37941296|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
16891053|NCT02386098|37941297|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
16891054|NCT02386098|37941293|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
16891055|NCT02386098|37941294|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
16891056|NCT02386098|37941295|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
16891057|NCT02386098|37941296|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
16891058|NCT02386098|37941297|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
16891059|NCT02386098|37941293|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
16891060|NCT02386098|37941294|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
16891061|NCT02386098|37941295|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
16891062|NCT02386098|37941296|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
16891063|NCT02386098|37941297|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
17003108|NCT00968669|38147283|FG002|Overall Study|Withdrawal by Subject|5|||
17003109|NCT00968669|38147284|FG003|Overall Study|Withdrawal by Subject|3|||
16891064|NCT02386098|37941293|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
16891065|NCT02386098|37941294|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
16891066|NCT02386098|37941295|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
16891067|NCT02386098|37941296|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
16891068|NCT02386098|37941297|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
16891069|NCT02386098|37941293|FG000|Stage 1 (96 Weeks)|Other|1|||
17003110|NCT00968669|38147281|FG000|Overall Study|Pregnancy|0|||
17003111|NCT00968669|38147282|FG001|Overall Study|Pregnancy|0|||
17003112|NCT00968669|38147283|FG002|Overall Study|Pregnancy|2|||
16785832|NCT01962298|37725935|FG002|Overall Study|Insufficient data|1|||
16891070|NCT02386098|37941294|FG001|Stage 1 (96 Weeks)|Other|0|||
16891071|NCT02386098|37941295|FG002|Stage 1 (96 Weeks)|Other|0|||
16891072|NCT02386098|37941296|FG003|Stage 1 (96 Weeks)|Other|0|||
16891073|NCT02386098|37941297|FG004|Stage 1 (96 Weeks)|Other|0|||
16891074|NCT02386098|37941293|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
16891075|NCT02386098|37941294|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
16891076|NCT02386098|37941295|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
16891077|NCT02386098|37941296|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
16891078|NCT02386098|37941297|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
16891079|NCT02412618|37941340|FG000|Overall Study|Withdrawal by Subject|1|||
16891080|NCT02412618|37941341|FG001|Overall Study|Withdrawal by Subject|1|||
16891081|NCT02412618|37941340|FG000|Overall Study|Expulsion|1|||
16891082|NCT02412618|37941341|FG001|Overall Study|Expulsion|1|||
16891083|NCT00585195|37941538|FG000|Overall Study|Adverse Event|0|||
17003113|NCT00968669|38147284|FG003|Overall Study|Pregnancy|0|||
17003114|NCT00968669|38147281|FG000|Overall Study|AE|1|||
16891084|NCT00585195|37941539|FG001|Overall Study|Adverse Event|0|||
16891085|NCT00585195|37941540|FG002|Overall Study|Adverse Event|0|||
16891086|NCT00585195|37941541|FG003|Overall Study|Adverse Event|0|||
16891087|NCT00585195|37941542|FG004|Overall Study|Adverse Event|2|||
16891088|NCT00585195|37941543|FG005|Overall Study|Adverse Event|1|||
16891089|NCT00585195|37941544|FG006|Overall Study|Adverse Event|0|||
16891090|NCT00585195|37941545|FG007|Overall Study|Adverse Event|1|||
16891091|NCT00585195|37941546|FG008|Overall Study|Adverse Event|0|||
16891092|NCT00585195|37941547|FG009|Overall Study|Adverse Event|0|||
16891093|NCT00585195|37941548|FG010|Overall Study|Adverse Event|3|||
16891094|NCT00585195|37941549|FG011|Overall Study|Adverse Event|0|||
16891095|NCT00585195|37941550|FG012|Overall Study|Adverse Event|8|||
16891096|NCT00585195|37941551|FG013|Overall Study|Adverse Event|6|||
16891097|NCT00585195|37941552|FG014|Overall Study|Adverse Event|4|||
16891098|NCT00585195|37941553|FG015|Overall Study|Adverse Event|1|||
16891099|NCT00585195|37941554|FG016|Overall Study|Adverse Event|14|||
16891100|NCT00585195|37941555|FG017|Overall Study|Adverse Event|9|||
16891101|NCT00585195|37941556|FG018|Overall Study|Adverse Event|2|||
16891102|NCT00585195|37941557|FG019|Overall Study|Adverse Event|3|||
16891103|NCT00585195|37941558|FG020|Overall Study|Adverse Event|1|||
16891104|NCT00585195|37941538|FG000|Overall Study|Progressive Disease|2|||
16891105|NCT00585195|37941539|FG001|Overall Study|Progressive Disease|2|||
16891106|NCT00585195|37941540|FG002|Overall Study|Progressive Disease|5|||
16891107|NCT00585195|37941541|FG003|Overall Study|Progressive Disease|4|||
16891108|NCT00585195|37941542|FG004|Overall Study|Progressive Disease|6|||
16891109|NCT00585195|37941543|FG005|Overall Study|Progressive Disease|4|||
16891110|NCT00585195|37941544|FG006|Overall Study|Progressive Disease|6|||
16891111|NCT00585195|37941545|FG007|Overall Study|Progressive Disease|3|||
16891112|NCT00585195|37941546|FG008|Overall Study|Progressive Disease|0|||
16891113|NCT00585195|37941547|FG009|Overall Study|Progressive Disease|5|||
16891114|NCT00585195|37941548|FG010|Overall Study|Progressive Disease|2|||
16891115|NCT00585195|37941549|FG011|Overall Study|Progressive Disease|25|||
16891116|NCT00585195|37941550|FG012|Overall Study|Progressive Disease|29|||
16891117|NCT00585195|37941551|FG013|Overall Study|Progressive Disease|26|||
16891118|NCT00585195|37941552|FG014|Overall Study|Progressive Disease|21|||
16891119|NCT00585195|37941553|FG015|Overall Study|Progressive Disease|12|||
16891120|NCT00585195|37941554|FG016|Overall Study|Progressive Disease|94|||
16891121|NCT00585195|37941555|FG017|Overall Study|Progressive Disease|42|||
16891122|NCT00585195|37941556|FG018|Overall Study|Progressive Disease|4|||
16891123|NCT00585195|37941557|FG019|Overall Study|Progressive Disease|9|||
16891124|NCT00585195|37941558|FG020|Overall Study|Progressive Disease|8|||
16891125|NCT00585195|37941538|FG000|Overall Study|Withdrawal by Subject|1|||
16891126|NCT00585195|37941539|FG001|Overall Study|Withdrawal by Subject|1|||
16891127|NCT00585195|37941540|FG002|Overall Study|Withdrawal by Subject|2|||
16891128|NCT00585195|37941541|FG003|Overall Study|Withdrawal by Subject|2|||
16891129|NCT00585195|37941542|FG004|Overall Study|Withdrawal by Subject|0|||
16891130|NCT00585195|37941543|FG005|Overall Study|Withdrawal by Subject|0|||
16891131|NCT00585195|37941544|FG006|Overall Study|Withdrawal by Subject|0|||
16891132|NCT00585195|37941545|FG007|Overall Study|Withdrawal by Subject|1|||
16891133|NCT00585195|37941546|FG008|Overall Study|Withdrawal by Subject|0|||
16891134|NCT00585195|37941547|FG009|Overall Study|Withdrawal by Subject|0|||
16891135|NCT00585195|37941548|FG010|Overall Study|Withdrawal by Subject|3|||
16891136|NCT00585195|37941549|FG011|Overall Study|Withdrawal by Subject|8|||
16891137|NCT00585195|37941550|FG012|Overall Study|Withdrawal by Subject|15|||
16891138|NCT00585195|37941551|FG013|Overall Study|Withdrawal by Subject|0|||
16891139|NCT00585195|37941552|FG014|Overall Study|Withdrawal by Subject|3|||
16891140|NCT00585195|37941553|FG015|Overall Study|Withdrawal by Subject|0|||
16891141|NCT00585195|37941554|FG016|Overall Study|Withdrawal by Subject|7|||
16891142|NCT00585195|37941555|FG017|Overall Study|Withdrawal by Subject|1|||
16891143|NCT00585195|37941556|FG018|Overall Study|Withdrawal by Subject|2|||
16891144|NCT00585195|37941557|FG019|Overall Study|Withdrawal by Subject|2|||
16891145|NCT00585195|37941558|FG020|Overall Study|Withdrawal by Subject|0|||
16891146|NCT00585195|37941538|FG000|Overall Study|Other|0|||
16891147|NCT00585195|37941539|FG001|Overall Study|Other|1|||
16891148|NCT00585195|37941540|FG002|Overall Study|Other|1|||
16891149|NCT00585195|37941541|FG003|Overall Study|Other|1|||
16891150|NCT00585195|37941542|FG004|Overall Study|Other|0|||
16891151|NCT00585195|37941543|FG005|Overall Study|Other|1|||
16891152|NCT00585195|37941544|FG006|Overall Study|Other|0|||
16891153|NCT00585195|37941545|FG007|Overall Study|Other|0|||
17003115|NCT00968669|38147282|FG001|Overall Study|AE|0|||
17003116|NCT00968669|38147283|FG002|Overall Study|AE|0|||
17003117|NCT00968669|38147284|FG003|Overall Study|AE|0|||
16891154|NCT00585195|37941546|FG008|Overall Study|Other|2|||
16891155|NCT00585195|37941547|FG009|Overall Study|Other|1|||
16891156|NCT00585195|37941548|FG010|Overall Study|Other|0|||
16891157|NCT00585195|37941549|FG011|Overall Study|Other|19|||
16891158|NCT00585195|37941550|FG012|Overall Study|Other|24|||
16891159|NCT00585195|37941551|FG013|Overall Study|Other|7|||
16891160|NCT00585195|37941552|FG014|Overall Study|Other|11|||
17003118|NCT00968669|38147281|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
17003119|NCT00968669|38147282|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
17003120|NCT00968669|38147283|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
17003121|NCT00968669|38147284|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
17003122|NCT00968669|38147281|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
17003123|NCT00968669|38147282|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
17003124|NCT00968669|38147283|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
17003125|NCT00968669|38147284|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
17003126|NCT00968669|38147281|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
17003127|NCT00968669|38147282|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
16891161|NCT00585195|37941553|FG015|Overall Study|Other|3|||
16891162|NCT00585195|37941554|FG016|Overall Study|Other|28|||
16891163|NCT00585195|37941555|FG017|Overall Study|Other|12|||
16891164|NCT00585195|37941556|FG018|Overall Study|Other|10|||
16891165|NCT00585195|37941557|FG019|Overall Study|Other|4|||
16891166|NCT00585195|37941558|FG020|Overall Study|Other|2|||
16891167|NCT00585195|37941538|FG000|Overall Study|Randomized not treated|0|||
16891168|NCT00585195|37941539|FG001|Overall Study|Randomized not treated|0|||
16891169|NCT00585195|37941540|FG002|Overall Study|Randomized not treated|1|||
16891170|NCT00585195|37941541|FG003|Overall Study|Randomized not treated|0|||
16891171|NCT00585195|37941542|FG004|Overall Study|Randomized not treated|1|||
16891172|NCT00585195|37941543|FG005|Overall Study|Randomized not treated|0|||
16891173|NCT00585195|37941544|FG006|Overall Study|Randomized not treated|1|||
16891174|NCT00585195|37941545|FG007|Overall Study|Randomized not treated|0|||
16891175|NCT00585195|37941546|FG008|Overall Study|Randomized not treated|0|||
16891176|NCT00585195|37941547|FG009|Overall Study|Randomized not treated|0|||
16891177|NCT00585195|37941548|FG010|Overall Study|Randomized not treated|2|||
16891178|NCT00585195|37941549|FG011|Overall Study|Randomized not treated|0|||
16891179|NCT00585195|37941550|FG012|Overall Study|Randomized not treated|0|||
16891180|NCT00585195|37941551|FG013|Overall Study|Randomized not treated|0|||
16891181|NCT00585195|37941552|FG014|Overall Study|Randomized not treated|0|||
16891182|NCT00585195|37941553|FG015|Overall Study|Randomized not treated|1|||
16891183|NCT00585195|37941554|FG016|Overall Study|Randomized not treated|0|||
16891184|NCT00585195|37941555|FG017|Overall Study|Randomized not treated|1|||
16891185|NCT00585195|37941556|FG018|Overall Study|Randomized not treated|3|||
16891186|NCT00585195|37941557|FG019|Overall Study|Randomized not treated|0|||
16891187|NCT00585195|37941558|FG020|Overall Study|Randomized not treated|2|||
16891188|NCT00585195|37941538|FG000|Overall Study|Death|0|||
17003128|NCT00968669|38147283|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
17003129|NCT00968669|38147284|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
17003130|NCT00968669|38147281|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
17003131|NCT00968669|38147282|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
17003132|NCT00968669|38147283|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
17003133|NCT00968669|38147284|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
17003134|NCT00968669|38147281|FG000|Overall Study|EARLY WITHDRAWAL|0|||
17003135|NCT00968669|38147282|FG001|Overall Study|EARLY WITHDRAWAL|1|||
16891189|NCT00585195|37941539|FG001|Overall Study|Death|0|||
16891190|NCT00585195|37941540|FG002|Overall Study|Death|0|||
16891191|NCT00585195|37941541|FG003|Overall Study|Death|0|||
16891192|NCT00585195|37941542|FG004|Overall Study|Death|0|||
16891193|NCT00585195|37941543|FG005|Overall Study|Death|0|||
16891194|NCT00585195|37941544|FG006|Overall Study|Death|0|||
16891195|NCT00585195|37941545|FG007|Overall Study|Death|0|||
16891196|NCT00585195|37941546|FG008|Overall Study|Death|1|||
16891197|NCT00585195|37941547|FG009|Overall Study|Death|0|||
16891198|NCT00585195|37941548|FG010|Overall Study|Death|1|||
16891199|NCT00585195|37941549|FG011|Overall Study|Death|1|||
16891200|NCT00585195|37941550|FG012|Overall Study|Death|7|||
16891201|NCT00585195|37941551|FG013|Overall Study|Death|2|||
16891202|NCT00585195|37941552|FG014|Overall Study|Death|8|||
16891203|NCT00585195|37941553|FG015|Overall Study|Death|2|||
16891204|NCT00585195|37941554|FG016|Overall Study|Death|11|||
16891205|NCT00585195|37941555|FG017|Overall Study|Death|0|||
16891206|NCT00585195|37941556|FG018|Overall Study|Death|0|||
16891207|NCT00585195|37941557|FG019|Overall Study|Death|0|||
16891208|NCT00585195|37941558|FG020|Overall Study|Death|1|||
16891209|NCT00585195|37941538|FG000|Overall Study|Lost to Follow-up|0|||
16891210|NCT00585195|37941539|FG001|Overall Study|Lost to Follow-up|0|||
16891211|NCT00585195|37941540|FG002|Overall Study|Lost to Follow-up|0|||
16891212|NCT00585195|37941541|FG003|Overall Study|Lost to Follow-up|0|||
16891213|NCT00585195|37941542|FG004|Overall Study|Lost to Follow-up|0|||
16891214|NCT00585195|37941543|FG005|Overall Study|Lost to Follow-up|0|||
16891215|NCT00585195|37941544|FG006|Overall Study|Lost to Follow-up|0|||
16891216|NCT00585195|37941545|FG007|Overall Study|Lost to Follow-up|0|||
16891217|NCT00585195|37941546|FG008|Overall Study|Lost to Follow-up|0|||
16891218|NCT00585195|37941547|FG009|Overall Study|Lost to Follow-up|0|||
16891219|NCT00585195|37941548|FG010|Overall Study|Lost to Follow-up|0|||
16891220|NCT00585195|37941549|FG011|Overall Study|Lost to Follow-up|0|||
16891221|NCT00585195|37941550|FG012|Overall Study|Lost to Follow-up|1|||
16891222|NCT00585195|37941551|FG013|Overall Study|Lost to Follow-up|0|||
16891223|NCT00585195|37941552|FG014|Overall Study|Lost to Follow-up|0|||
16891224|NCT00585195|37941553|FG015|Overall Study|Lost to Follow-up|0|||
16891225|NCT00585195|37941554|FG016|Overall Study|Lost to Follow-up|0|||
17003136|NCT00968669|38147283|FG002|Overall Study|EARLY WITHDRAWAL|0|||
17003137|NCT00968669|38147284|FG003|Overall Study|EARLY WITHDRAWAL|0|||
16891226|NCT00585195|37941555|FG017|Overall Study|Lost to Follow-up|2|||
16891227|NCT00585195|37941556|FG018|Overall Study|Lost to Follow-up|0|||
16891228|NCT00585195|37941557|FG019|Overall Study|Lost to Follow-up|0|||
16891229|NCT00585195|37941558|FG020|Overall Study|Lost to Follow-up|0|||
16891230|NCT00585195|37941538|FG000|Overall Study|Site Terminated by Sponsor|0|||
16891231|NCT00585195|37941539|FG001|Overall Study|Site Terminated by Sponsor|0|||
16891232|NCT00585195|37941540|FG002|Overall Study|Site Terminated by Sponsor|0|||
16891233|NCT00585195|37941541|FG003|Overall Study|Site Terminated by Sponsor|0|||
16891234|NCT00585195|37941542|FG004|Overall Study|Site Terminated by Sponsor|0|||
16891235|NCT00585195|37941543|FG005|Overall Study|Site Terminated by Sponsor|0|||
16891236|NCT00585195|37941544|FG006|Overall Study|Site Terminated by Sponsor|0|||
16891237|NCT00585195|37941545|FG007|Overall Study|Site Terminated by Sponsor|0|||
17003138|NCT00968669|38147281|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
17003139|NCT00968669|38147282|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
17003140|NCT00968669|38147283|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
17003141|NCT00968669|38147284|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
17003142|NCT00968669|38147281|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
17003143|NCT00968669|38147282|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
16891238|NCT00585195|37941546|FG008|Overall Study|Site Terminated by Sponsor|0|||
16891239|NCT00585195|37941547|FG009|Overall Study|Site Terminated by Sponsor|0|||
16891240|NCT00585195|37941548|FG010|Overall Study|Site Terminated by Sponsor|0|||
16891241|NCT00585195|37941549|FG011|Overall Study|Site Terminated by Sponsor|0|||
16891242|NCT00585195|37941550|FG012|Overall Study|Site Terminated by Sponsor|1|||
16891243|NCT00585195|37941551|FG013|Overall Study|Site Terminated by Sponsor|0|||
16891244|NCT00585195|37941552|FG014|Overall Study|Site Terminated by Sponsor|0|||
16891245|NCT00585195|37941553|FG015|Overall Study|Site Terminated by Sponsor|0|||
16891246|NCT00585195|37941554|FG016|Overall Study|Site Terminated by Sponsor|0|||
16891247|NCT00585195|37941555|FG017|Overall Study|Site Terminated by Sponsor|0|||
16891248|NCT00585195|37941556|FG018|Overall Study|Site Terminated by Sponsor|0|||
16891249|NCT00585195|37941557|FG019|Overall Study|Site Terminated by Sponsor|0|||
16891250|NCT00585195|37941558|FG020|Overall Study|Site Terminated by Sponsor|0|||
16891251|NCT00585195|37941538|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
16891252|NCT00585195|37941539|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
16891253|NCT00585195|37941540|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
16891254|NCT00585195|37941541|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
16891255|NCT00585195|37941542|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
16891256|NCT00585195|37941543|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
16891257|NCT00585195|37941544|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
16891258|NCT00585195|37941545|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
16891259|NCT00585195|37941546|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
16891260|NCT00585195|37941547|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
16891261|NCT00585195|37941548|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
16891262|NCT00585195|37941549|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
16891263|NCT00585195|37941550|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
16891264|NCT00585195|37941551|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
16891265|NCT00585195|37941552|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
16891266|NCT00585195|37941553|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
16891267|NCT00585195|37941554|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
16891268|NCT00585195|37941555|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
16891269|NCT00585195|37941556|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
16891270|NCT00585195|37941557|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
16891271|NCT00585195|37941558|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
16891272|NCT02439216|37941730|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
16891273|NCT02439216|37941731|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
17003144|NCT00968669|38147283|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
17003145|NCT00968669|38147284|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
17003146|NCT00968669|38147281|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
17003147|NCT00968669|38147282|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
17003148|NCT00968669|38147283|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
17003149|NCT00968669|38147284|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
17003150|NCT00968669|38147281|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
17003151|NCT00968669|38147282|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
17003152|NCT00968669|38147283|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
17003153|NCT00968669|38147284|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
16891274|NCT02439216|37941732|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16891275|NCT02439216|37941733|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16891276|NCT02439216|37941734|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16891277|NCT02439216|37941735|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
17003154|NCT00968669|38147281|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
16891278|NCT02439216|37941736|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16891279|NCT02439216|37941737|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16891280|NCT02439216|37941738|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16891281|NCT02439216|37941730|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16891282|NCT02439216|37941731|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16891283|NCT02439216|37941732|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16891284|NCT02439216|37941733|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16891285|NCT02439216|37941734|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16891286|NCT02439216|37941735|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16891287|NCT02439216|37941736|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16891288|NCT02439216|37941737|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
16891289|NCT02439216|37941738|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16891290|NCT02439216|37941730|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16891291|NCT02439216|37941731|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16891292|NCT02439216|37941732|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16891293|NCT02439216|37941733|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16891294|NCT02439216|37941734|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16891295|NCT02439216|37941735|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16891296|NCT02439216|37941736|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16891297|NCT02439216|37941737|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
16891298|NCT02439216|37941738|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
16891299|NCT02439216|37941730|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16891300|NCT02439216|37941731|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16891301|NCT02439216|37941732|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16891302|NCT02439216|37941733|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16891303|NCT02439216|37941734|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16891304|NCT02439216|37941735|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16891305|NCT02439216|37941736|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16891306|NCT02439216|37941737|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16891307|NCT02439216|37941738|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
16891308|NCT02439216|37941730|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16891309|NCT02439216|37941731|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16891310|NCT02439216|37941732|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16891311|NCT02439216|37941733|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16891312|NCT02439216|37941734|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16891313|NCT02439216|37941735|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16891314|NCT02439216|37941736|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16891315|NCT02439216|37941737|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
16891316|NCT02439216|37941738|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
16891317|NCT02439138|37941766|FG000|Overall Study|Adverse Event|1|||
16891318|NCT02439138|37941766|FG000|Overall Study|PI decision to terminate the study|2|||
16891319|NCT02438826|37942142|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
16891320|NCT02438826|37942143|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
16891321|NCT02438826|37942144|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
16891322|NCT02438826|37942145|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
16891323|NCT02438826|37942142|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
16891324|NCT02438826|37942143|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16891325|NCT02438826|37942144|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16891326|NCT02438826|37942145|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16891327|NCT02438826|37942142|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
16891328|NCT02438826|37942143|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
16891329|NCT02438826|37942144|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16891330|NCT02438826|37942145|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16891331|NCT02438826|37942142|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
16891332|NCT02438826|37942143|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
16891333|NCT02438826|37942144|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
16891334|NCT02438826|37942145|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
16891335|NCT02438826|37942142|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
17003155|NCT00968669|38147282|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
17003156|NCT00968669|38147283|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
17003157|NCT00968669|38147284|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
17003158|NCT00968669|38147281|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
17003159|NCT00968669|38147282|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
17192184|NCT01353859|38345342|FG000|Overall Study|Lack of Efficacy|1|||
17192185|NCT02850965|38345348|FG000|Overall Study|Other than listed|3|||
17003160|NCT00968669|38147283|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
17003161|NCT00968669|38147284|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
17003162|NCT00968669|38147281|FG000|Overall Study|SPONSOR DECISION|0|||
17003163|NCT00968669|38147282|FG001|Overall Study|SPONSOR DECISION|1|||
17003164|NCT00968669|38147283|FG002|Overall Study|SPONSOR DECISION|0|||
17003165|NCT00968669|38147284|FG003|Overall Study|SPONSOR DECISION|0|||
17003166|NCT00968669|38147281|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
17003167|NCT00968669|38147282|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
17003168|NCT00968669|38147283|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
17003169|NCT00968669|38147284|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
17003170|NCT00968669|38147281|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
17003171|NCT00968669|38147282|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
17003172|NCT00968669|38147283|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
17003173|NCT00968669|38147284|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
17003174|NCT00968669|38147281|FG000|Overall Study|SUBJECT INCARCERATED|0|||
17003175|NCT00968669|38147282|FG001|Overall Study|SUBJECT INCARCERATED|1|||
17003176|NCT00968669|38147283|FG002|Overall Study|SUBJECT INCARCERATED|0|||
16891336|NCT02438826|37942143|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
16891337|NCT02438826|37942144|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
16891338|NCT02438826|37942145|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
16891339|NCT02438826|37942142|FG000|Open-Label Treatment Phase|Adverse Event|11|||
16891340|NCT02438826|37942143|FG001|Open-Label Treatment Phase|Adverse Event|6|||
16891341|NCT02438826|37942144|FG002|Open-Label Treatment Phase|Adverse Event|0|||
16891342|NCT02438826|37942145|FG003|Open-Label Treatment Phase|Adverse Event|0|||
16891343|NCT02438826|37942142|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
16891344|NCT02438826|37942143|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
16891345|NCT02438826|37942144|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
16891346|NCT02438826|37942145|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
16891347|NCT02438826|37942142|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
16891348|NCT02438826|37942143|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
16891349|NCT02438826|37942144|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
17003177|NCT00968669|38147284|FG003|Overall Study|SUBJECT INCARCERATED|0|||
17003178|NCT00968669|38147281|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
17003179|NCT00968669|38147282|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
17003180|NCT00968669|38147283|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
17003181|NCT00968669|38147284|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
17003182|NCT00968669|38147281|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
17003183|NCT00968669|38147282|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
17003184|NCT00968669|38147283|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
17003185|NCT00968669|38147284|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
17003186|NCT00568399|38147294|FG000|Overall Study|Death|2|||
17192186|NCT02850965|38345349|FG001|Overall Study|Other than listed|4|||
16891350|NCT02438826|37942145|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
16891351|NCT02438826|37942142|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
16891352|NCT02438826|37942143|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
16891353|NCT02438826|37942144|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
16891354|NCT02438826|37942145|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
16891355|NCT02438826|37942142|FG000|Post-Treatment Phase|Adverse Event|3|||
16891356|NCT02438826|37942143|FG001|Post-Treatment Phase|Adverse Event|0|||
16891357|NCT02438826|37942144|FG002|Post-Treatment Phase|Adverse Event|0|||
16891358|NCT02438826|37942145|FG003|Post-Treatment Phase|Adverse Event|0|||
16891359|NCT02438826|37942142|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
16891360|NCT02438826|37942143|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
16891361|NCT02438826|37942144|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
16891362|NCT02438826|37942145|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
16891363|NCT02438826|37942142|FG000|Post-Treatment Phase|Physician Decision|1|||
16891364|NCT02438826|37942143|FG001|Post-Treatment Phase|Physician Decision|0|||
16891365|NCT02438826|37942144|FG002|Post-Treatment Phase|Physician Decision|0|||
16891366|NCT02438826|37942145|FG003|Post-Treatment Phase|Physician Decision|0|||
16891367|NCT02438826|37942142|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
16891368|NCT02438826|37942143|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
16891369|NCT02438826|37942144|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
16891370|NCT02438826|37942145|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
16891371|NCT02438280|37942162|FG000|Overall Study|Physician Decision|1|||
16891372|NCT02438280|37942163|FG001|Overall Study|Physician Decision|0|||
16891373|NCT02385708|37942181|FG000|Overall Study|Withdrawal by Subject|0|||
16891374|NCT02385708|37942182|FG001|Overall Study|Withdrawal by Subject|2|||
16891375|NCT02385708|37942181|FG000|Overall Study|Withdrawn - surgery canceled|2|||
16891376|NCT02385708|37942182|FG001|Overall Study|Withdrawn - surgery canceled|5|||
16891377|NCT02385708|37942181|FG000|Overall Study|Investigator decision|5|||
16891378|NCT02385708|37942182|FG001|Overall Study|Investigator decision|7|||
16891379|NCT02385708|37942181|FG000|Overall Study|Protocol Violation|1|||
16891380|NCT02385708|37942182|FG001|Overall Study|Protocol Violation|1|||
16891381|NCT02411448|37942911|FG000|Overall Study|Withdrawal by Subject|1|||
16891382|NCT02411448|37942912|FG001|Overall Study|Withdrawal by Subject|14|||
16891383|NCT02411448|37942913|FG002|Overall Study|Withdrawal by Subject|9|||
16891384|NCT02411448|37942911|FG000|Overall Study|Other|0|||
16891385|NCT02411448|37942912|FG001|Overall Study|Other|2|||
16891386|NCT02411448|37942913|FG002|Overall Study|Other|0|||
16891387|NCT02411448|37942911|FG000|Overall Study|Did not receive study treatment|0|||
16891388|NCT02411448|37942912|FG001|Overall Study|Did not receive study treatment|3|||
16891389|NCT02411448|37942913|FG002|Overall Study|Did not receive study treatment|0|||
16891390|NCT02411448|37942911|FG000|Overall Study|Alive on study treatment|3|||
16891391|NCT02411448|37942912|FG001|Overall Study|Alive on study treatment|64|||
16891392|NCT02411448|37942913|FG002|Overall Study|Alive on study treatment|43|||
16891393|NCT02385084|37942938|FG000|Period 2|Protocol Violation|0|||
16891394|NCT02385084|37942939|FG001|Period 2|Protocol Violation|0|||
16891395|NCT02385084|37942940|FG002|Period 2|Protocol Violation|1|||
16891396|NCT02385084|37942941|FG003|Period 2|Protocol Violation|0|||
16891397|NCT02385084|37942942|FG004|Period 2|Protocol Violation|0|||
16891398|NCT02385084|37942943|FG005|Period 2|Protocol Violation|0|||
16891399|NCT02411292|37942952|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
16891400|NCT02411292|37942952|FG000|Overall Study|Death|2|||
16891401|NCT02411292|37942952|FG000|Overall Study|Lost to Follow-up|3|||
16891402|NCT02384850|37943015|FG000|Overall Study|Withdrawal by Subject|2|||
16891403|NCT02384850|37943016|FG001|Overall Study|Withdrawal by Subject|2|||
16891404|NCT02437890|37943238|FG000|Overall Study|Non-compliance to study drug|0|||
16891405|NCT02437890|37943239|FG001|Overall Study|Non-compliance to study drug|1|||
16891406|NCT02437890|37943240|FG002|Overall Study|Non-compliance to study drug|0|||
16891407|NCT02437890|37943241|FG003|Overall Study|Non-compliance to study drug|0|||
16891408|NCT02437890|37943242|FG004|Overall Study|Non-compliance to study drug|1|||
16891409|NCT02437890|37943238|FG000|Overall Study|Sponsor's decision|1|||
16891410|NCT02437890|37943239|FG001|Overall Study|Sponsor's decision|1|||
16891411|NCT02437890|37943240|FG002|Overall Study|Sponsor's decision|4|||
16891412|NCT02437890|37943241|FG003|Overall Study|Sponsor's decision|0|||
16891413|NCT02437890|37943242|FG004|Overall Study|Sponsor's decision|2|||
16891414|NCT02437890|37943238|FG000|Overall Study|Physician Decision|0|||
16891415|NCT02437890|37943239|FG001|Overall Study|Physician Decision|0|||
16891416|NCT02437890|37943240|FG002|Overall Study|Physician Decision|0|||
16891417|NCT02437890|37943241|FG003|Overall Study|Physician Decision|1|||
16891418|NCT02437890|37943242|FG004|Overall Study|Physician Decision|0|||
16891419|NCT02437890|37943238|FG000|Overall Study|Unable to attend visit(s)|1|||
16891420|NCT02437890|37943239|FG001|Overall Study|Unable to attend visit(s)|0|||
17003187|NCT00568399|38147294|FG000|Overall Study|Adverse Event|5|||
17003188|NCT00568399|38147294|FG000|Overall Study|Withdrawal by Subject|8|||
17003189|NCT00975143|38147300|FG000|Overall Study|Adverse Event|19|||
17003190|NCT00975143|38147301|FG001|Overall Study|Adverse Event|15|||
17003191|NCT00975143|38147300|FG000|Overall Study|Withdrawal by Subject|15|||
17003192|NCT00975143|38147301|FG001|Overall Study|Withdrawal by Subject|15|||
17003193|NCT00975143|38147300|FG000|Overall Study|Lost to Follow-up|20|||
17003194|NCT00975143|38147301|FG001|Overall Study|Lost to Follow-up|16|||
17003195|NCT00975143|38147300|FG000|Overall Study|Non-compliance|5|||
17003196|NCT00975143|38147301|FG001|Overall Study|Non-compliance|8|||
17003197|NCT00975143|38147300|FG000|Overall Study|Physician Decision|1|||
17003198|NCT00975143|38147301|FG001|Overall Study|Physician Decision|2|||
17003199|NCT00975143|38147300|FG000|Overall Study|Details not available|10|||
17003200|NCT00975143|38147301|FG001|Overall Study|Details not available|4|||
17003201|NCT00974675|38147324|FG000|Overall Study|Adverse Event|2|||
17003202|NCT00974675|38147325|FG001|Overall Study|Adverse Event|1|||
17003203|NCT00974675|38147326|FG002|Overall Study|Adverse Event|1|||
17003204|NCT00974675|38147327|FG003|Overall Study|Adverse Event|1|||
17003205|NCT00974675|38147324|FG000|Overall Study|Physician Decision|0|||
17003206|NCT00974675|38147325|FG001|Overall Study|Physician Decision|0|||
17003207|NCT00974675|38147326|FG002|Overall Study|Physician Decision|1|||
17003208|NCT00974675|38147327|FG003|Overall Study|Physician Decision|0|||
17003209|NCT00974675|38147324|FG000|Overall Study|Participant on holiday; unable to attend|0|||
17003210|NCT00974675|38147325|FG001|Overall Study|Participant on holiday; unable to attend|0|||
17003211|NCT00974675|38147326|FG002|Overall Study|Participant on holiday; unable to attend|0|||
17003212|NCT00974675|38147327|FG003|Overall Study|Participant on holiday; unable to attend|1|||
17003213|NCT03657797|38147341|FG000|Overall Study|Lost to Follow-up|0|||
17003214|NCT03657797|38147342|FG001|Overall Study|Lost to Follow-up|1|||
16891421|NCT02437890|37943240|FG002|Overall Study|Unable to attend visit(s)|0|||
16891422|NCT02437890|37943241|FG003|Overall Study|Unable to attend visit(s)|0|||
16891423|NCT02437890|37943242|FG004|Overall Study|Unable to attend visit(s)|0|||
16891424|NCT02437890|37943238|FG000|Overall Study|Lack of Efficacy|1|||
16891425|NCT02437890|37943239|FG001|Overall Study|Lack of Efficacy|3|||
16891426|NCT02437890|37943240|FG002|Overall Study|Lack of Efficacy|0|||
16891427|NCT02437890|37943241|FG003|Overall Study|Lack of Efficacy|3|||
17003215|NCT03657797|38147343|FG002|Overall Study|Lost to Follow-up|1|||
17003216|NCT03657797|38147344|FG003|Overall Study|Lost to Follow-up|0|||
17003217|NCT03657797|38147341|FG000|Overall Study|Physician Decision|0|||
17003218|NCT03657797|38147342|FG001|Overall Study|Physician Decision|1|||
17003219|NCT03657797|38147343|FG002|Overall Study|Physician Decision|0|||
17003220|NCT03657797|38147344|FG003|Overall Study|Physician Decision|0|||
17003221|NCT03657797|38147341|FG000|Overall Study|Withdrawal by Subject|0|||
17003222|NCT03657797|38147342|FG001|Overall Study|Withdrawal by Subject|1|||
17003223|NCT03657797|38147343|FG002|Overall Study|Withdrawal by Subject|2|||
17003224|NCT03657797|38147344|FG003|Overall Study|Withdrawal by Subject|0|||
17003225|NCT03657797|38147341|FG000|Overall Study|Adverse Event|0|||
17003226|NCT03657797|38147342|FG001|Overall Study|Adverse Event|0|||
17003227|NCT03657797|38147343|FG002|Overall Study|Adverse Event|2|||
17003228|NCT03657797|38147344|FG003|Overall Study|Adverse Event|0|||
17003229|NCT00634933|38147361|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
17003230|NCT00634933|38147362|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
17003231|NCT00634933|38147363|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
17003232|NCT00634933|38147364|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
17003233|NCT00634933|38147365|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
17003234|NCT00634933|38147361|FG000|Part A: Baseline to Week 24|Death|1|||
17003235|NCT00634933|38147362|FG001|Part A: Baseline to Week 24|Death|0|||
17003236|NCT00634933|38147363|FG002|Part A: Baseline to Week 24|Death|0|||
17003237|NCT00634933|38147364|FG003|Part A: Baseline to Week 24|Death|0|||
17003238|NCT00634933|38147365|FG004|Part A: Baseline to Week 24|Death|0|||
17003239|NCT00634933|38147361|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
17003240|NCT00634933|38147362|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
17003241|NCT00634933|38147363|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
17003242|NCT00634933|38147364|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
17003243|NCT00634933|38147365|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
17003244|NCT00634933|38147361|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
17003245|NCT00634933|38147362|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
17003246|NCT00634933|38147363|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
17003247|NCT00634933|38147364|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
17003248|NCT00634933|38147365|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
17003249|NCT00634933|38147361|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
17003250|NCT00634933|38147362|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
17003251|NCT00634933|38147363|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
17003252|NCT00634933|38147364|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
17003253|NCT00634933|38147365|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
17003254|NCT00634933|38147361|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
17003255|NCT00634933|38147362|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
17003256|NCT00634933|38147363|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
17003257|NCT00634933|38147364|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
17003258|NCT00634933|38147365|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
17003259|NCT00634933|38147361|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
17003260|NCT00634933|38147362|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
17003261|NCT00634933|38147363|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
17003262|NCT00634933|38147364|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
17003263|NCT00634933|38147365|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
17003264|NCT00634933|38147361|FG000|Part A: Baseline to Week 24|Other|1|||
17003265|NCT00634933|38147362|FG001|Part A: Baseline to Week 24|Other|8|||
17003266|NCT00634933|38147363|FG002|Part A: Baseline to Week 24|Other|5|||
17003267|NCT00634933|38147364|FG003|Part A: Baseline to Week 24|Other|0|||
17003268|NCT00634933|38147365|FG004|Part A: Baseline to Week 24|Other|0|||
17003269|NCT00634933|38147361|FG000|Between Part A and Part B|Physician Decision|0|||
17003270|NCT00634933|38147362|FG001|Between Part A and Part B|Physician Decision|1|||
17003271|NCT00634933|38147363|FG002|Between Part A and Part B|Physician Decision|0|||
17003272|NCT00634933|38147364|FG003|Between Part A and Part B|Physician Decision|0|||
17003273|NCT00634933|38147365|FG004|Between Part A and Part B|Physician Decision|0|||
17003274|NCT00634933|38147361|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
17003275|NCT00634933|38147362|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
17003276|NCT00634933|38147363|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
17003277|NCT00634933|38147364|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
17003278|NCT00634933|38147365|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
17003279|NCT00634933|38147361|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
17003280|NCT00634933|38147362|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
17003281|NCT00634933|38147363|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
17003282|NCT00634933|38147364|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
17003283|NCT00634933|38147365|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
17003284|NCT00634933|38147361|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
17003285|NCT00634933|38147362|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
17003286|NCT00634933|38147363|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
17003287|NCT00634933|38147364|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
17003288|NCT00634933|38147365|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
17003289|NCT00634933|38147361|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
17003290|NCT00634933|38147362|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
17003291|NCT00634933|38147363|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
17003292|NCT00634933|38147364|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
17003293|NCT00634933|38147365|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
17003294|NCT00634933|38147361|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
17003295|NCT00634933|38147362|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
17003296|NCT00634933|38147363|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
17003297|NCT00634933|38147364|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
17003298|NCT00634933|38147365|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
17003299|NCT00634933|38147361|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
17003300|NCT00634933|38147362|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
17003301|NCT00634933|38147363|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
17003302|NCT00634933|38147364|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
17003303|NCT00634933|38147365|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
17003304|NCT00634933|38147361|FG000|Part B: Week 24 to Week 52|Other|0|||
17003305|NCT00634933|38147362|FG001|Part B: Week 24 to Week 52|Other|0|||
17003306|NCT00634933|38147363|FG002|Part B: Week 24 to Week 52|Other|5|||
17003307|NCT00634933|38147364|FG003|Part B: Week 24 to Week 52|Other|0|||
17003308|NCT00634933|38147365|FG004|Part B: Week 24 to Week 52|Other|1|||
17003309|NCT00967499|38147379|FG000|Overall Study|Adverse Event|0|||
17003310|NCT00967499|38147380|FG001|Overall Study|Adverse Event|1|||
17003311|NCT00967499|38147379|FG000|Overall Study|Protocol Violation|1|||
17003312|NCT00967499|38147380|FG001|Overall Study|Protocol Violation|0|||
17003313|NCT00967499|38147379|FG000|Overall Study|Sponsor Decision|1|||
17003314|NCT00967499|38147380|FG001|Overall Study|Sponsor Decision|0|||
17003315|NCT00967499|38147379|FG000|Overall Study|Randomized but not treated|63|||
17003316|NCT00967499|38147380|FG001|Overall Study|Randomized but not treated|59|||
17003317|NCT03909971|38147388|FG000|Overall Study|Other Reasons Not Specified|0|||
17003318|NCT03909971|38147389|FG001|Overall Study|Other Reasons Not Specified|1|||
17003319|NCT03909971|38147388|FG000|Overall Study|Global Deterioration of Health Status|2|||
17003320|NCT03909971|38147389|FG001|Overall Study|Global Deterioration of Health Status|1|||
17003321|NCT03909971|38147388|FG000|Overall Study|Progressive Disease|6|||
17003322|NCT03909971|38147389|FG001|Overall Study|Progressive Disease|14|||
17003323|NCT03909971|38147388|FG000|Overall Study|Death|2|||
17003324|NCT03909971|38147389|FG001|Overall Study|Death|6|||
17003325|NCT00626275|38147396|FG000|Part A - Treatment Period 1|Adverse Event|1|||
17003326|NCT00626275|38147397|FG001|Part A - Treatment Period 1|Adverse Event|0|||
17003327|NCT00626275|38147398|FG002|Part A - Treatment Period 1|Adverse Event|0|||
17003328|NCT00626275|38147399|FG003|Part A - Treatment Period 1|Adverse Event|0|||
17003329|NCT00626275|38147400|FG004|Part A - Treatment Period 1|Adverse Event|0|||
17003330|NCT00626275|38147401|FG005|Part A - Treatment Period 1|Adverse Event|0|||
17003331|NCT00626275|38147402|FG006|Part A - Treatment Period 1|Adverse Event|0|||
17003332|NCT00626275|38147403|FG007|Part A - Treatment Period 1|Adverse Event|0|||
17003333|NCT00626275|38147396|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
17003334|NCT00626275|38147397|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
17003335|NCT00626275|38147398|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
17003336|NCT00626275|38147399|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
17003337|NCT00626275|38147400|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
16891428|NCT02437890|37943242|FG004|Overall Study|Lack of Efficacy|1|||
16891429|NCT02437890|37943238|FG000|Overall Study|Adverse Event|4|||
16891430|NCT02437890|37943239|FG001|Overall Study|Adverse Event|9|||
16891431|NCT02437890|37943240|FG002|Overall Study|Adverse Event|5|||
16891432|NCT02437890|37943241|FG003|Overall Study|Adverse Event|11|||
16891433|NCT02437890|37943242|FG004|Overall Study|Adverse Event|7|||
16891434|NCT02437890|37943238|FG000|Overall Study|Withdrawal by Subject|1|||
16891435|NCT02437890|37943239|FG001|Overall Study|Withdrawal by Subject|2|||
16891436|NCT02437890|37943240|FG002|Overall Study|Withdrawal by Subject|6|||
16891437|NCT02437890|37943241|FG003|Overall Study|Withdrawal by Subject|5|||
16891438|NCT02437890|37943242|FG004|Overall Study|Withdrawal by Subject|5|||
16891439|NCT02437890|37943238|FG000|Overall Study|Death|0|||
16891440|NCT02437890|37943239|FG001|Overall Study|Death|0|||
16891441|NCT02437890|37943240|FG002|Overall Study|Death|0|||
16891442|NCT02437890|37943241|FG003|Overall Study|Death|2|||
16891443|NCT02437890|37943242|FG004|Overall Study|Death|0|||
16891444|NCT02384538|37943303|FG000|Overall Study|Adverse Event|1|||
16891445|NCT02384538|37943304|FG001|Overall Study|Adverse Event|4|||
16891446|NCT02384538|37943303|FG000|Overall Study|Lack of Efficacy|4|||
16891447|NCT02384538|37943304|FG001|Overall Study|Lack of Efficacy|4|||
16891448|NCT02384538|37943303|FG000|Overall Study|Withdrew Consent|0|||
16891449|NCT02384538|37943304|FG001|Overall Study|Withdrew Consent|4|||
16891450|NCT02384538|37943303|FG000|Overall Study|Other|1|||
16891451|NCT02384538|37943304|FG001|Overall Study|Other|3|||
16891452|NCT02410824|37943328|FG000|First Intervention (One Week)|Headache|0|||
17003338|NCT00626275|38147401|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
17003339|NCT00626275|38147402|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
17003340|NCT00626275|38147403|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
17003341|NCT00626275|38147396|FG000|Part B|Lost to Follow-up|0|||
17003342|NCT00626275|38147397|FG001|Part B|Lost to Follow-up|0|||
16891453|NCT02410824|37943329|FG001|First Intervention (One Week)|Headache|1|||
16891454|NCT02384460|37943359|FG000|Overall Study|Protocol Violation|0|||
16891455|NCT02384460|37943360|FG001|Overall Study|Protocol Violation|1|||
16891456|NCT02384460|37943359|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
16891457|NCT02384460|37943360|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
16891458|NCT02384460|37943359|FG000|Overall Study|Adverse Event|5|||
16891459|NCT02384460|37943360|FG001|Overall Study|Adverse Event|2|||
16891460|NCT02384460|37943359|FG000|Overall Study|Withdrawal by Subject|0|||
16891461|NCT02384460|37943360|FG001|Overall Study|Withdrawal by Subject|3|||
16891462|NCT02384460|37943359|FG000|Overall Study|Elective medical treatment|1|||
16891463|NCT02384460|37943360|FG001|Overall Study|Elective medical treatment|0|||
16891464|NCT02384460|37943359|FG000|Overall Study|Non-compliance|1|||
16891465|NCT02384460|37943360|FG001|Overall Study|Non-compliance|0|||
16891466|NCT02384382|37943383|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
16891467|NCT02384382|37943383|FG000|Overall Study|Death|1|||
16891468|NCT02384382|37943383|FG000|Overall Study|Adverse Event|1|||
16891469|NCT02384382|37943383|FG000|Overall Study|Disease progression|16|||
16891470|NCT02437188|37943403|FG000|Overall Study|Randomized but did not receive surgery|4|||
16891471|NCT02437188|37943404|FG001|Overall Study|Randomized but did not receive surgery|8|||
16891472|NCT02437188|37943403|FG000|Overall Study|Adverse Event|0|||
16891473|NCT02437188|37943404|FG001|Overall Study|Adverse Event|1|||
16891474|NCT02383758|37943426|FG000|Overall Study|Withdrawal by Subject|0|||
16891475|NCT02383758|37943427|FG001|Overall Study|Withdrawal by Subject|2|||
16891476|NCT02410278|37943477|FG000|Run-in Period|Adverse Event|5|||
16891477|NCT02410278|37943478|FG001|Run-in Period|Adverse Event|0|||
16891478|NCT02410278|37943479|FG002|Run-in Period|Adverse Event|0|||
16891479|NCT02410278|37943477|FG000|Run-in Period|GSRS Threshold Not Met|30|||
16891480|NCT02410278|37943478|FG001|Run-in Period|GSRS Threshold Not Met|0|||
16891481|NCT02410278|37943479|FG002|Run-in Period|GSRS Threshold Not Met|0|||
16891482|NCT02410278|37943477|FG000|Run-in Period|Lost to Follow-up|1|||
16891483|NCT02410278|37943478|FG001|Run-in Period|Lost to Follow-up|0|||
16891484|NCT02410278|37943479|FG002|Run-in Period|Lost to Follow-up|0|||
16891485|NCT02410278|37943477|FG000|Run-in Period|Withdrawal by Subject|1|||
16891486|NCT02410278|37943478|FG001|Run-in Period|Withdrawal by Subject|0|||
16891487|NCT02410278|37943479|FG002|Run-in Period|Withdrawal by Subject|0|||
16891488|NCT02410278|37943477|FG000|Run-in Period|Pregnancy|1|||
16891489|NCT02410278|37943478|FG001|Run-in Period|Pregnancy|0|||
16891490|NCT02410278|37943479|FG002|Run-in Period|Pregnancy|0|||
16891491|NCT02410278|37943477|FG000|Study Treatment Period|Adverse Event|0|||
16891492|NCT02410278|37943478|FG001|Study Treatment Period|Adverse Event|6|||
16891493|NCT02410278|37943479|FG002|Study Treatment Period|Adverse Event|3|||
16891494|NCT02410278|37943477|FG000|Study Treatment Period|Physician Decision|0|||
16891495|NCT02410278|37943478|FG001|Study Treatment Period|Physician Decision|0|||
16891496|NCT02410278|37943479|FG002|Study Treatment Period|Physician Decision|1|||
16891497|NCT02410278|37943477|FG000|Study Treatment Period|Withdrawal by Subject|0|||
16891498|NCT02410278|37943478|FG001|Study Treatment Period|Withdrawal by Subject|1|||
16891499|NCT02410278|37943479|FG002|Study Treatment Period|Withdrawal by Subject|0|||
16891500|NCT02410278|37943477|FG000|Study Treatment Period|Other|0|||
16891501|NCT02410278|37943478|FG001|Study Treatment Period|Other|3|||
16891502|NCT02410278|37943479|FG002|Study Treatment Period|Other|0|||
16891503|NCT02410278|37943477|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
16891504|NCT02410278|37943478|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
16891505|NCT02410278|37943479|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
16891506|NCT02410200|37943512|FG000|Overall Study|Adverse Event|2|||
16891507|NCT02383056|37943531|FG000|Overall Study|Adverse Event|1|||
16891508|NCT02383056|37943532|FG001|Overall Study|Adverse Event|0|||
16891509|NCT02383056|37943531|FG000|Overall Study|Lost to Follow-up|0|||
16891510|NCT02383056|37943532|FG001|Overall Study|Lost to Follow-up|2|||
16891511|NCT02409732|37943538|FG000|Overall Study|Withdrawal by Subject|4|||
16891512|NCT02409732|37943538|FG000|Overall Study|Lost to Follow-up|2|||
16891513|NCT01650636|37943549|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
16891514|NCT01650636|37943550|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
16891515|NCT01650636|37943549|FG000|Washout up to 5 Months|Physician Decision|2|||
16891516|NCT01650636|37943550|FG001|Washout up to 5 Months|Physician Decision|2|||
16891517|NCT01650636|37943549|FG000|Washout up to 5 Months|Death|1|||
16891518|NCT01650636|37943550|FG001|Washout up to 5 Months|Death|0|||
16891519|NCT01650636|37943549|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
16891520|NCT01650636|37943550|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
16891521|NCT01650636|37943549|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
16785833|NCT01962298|37725936|FG003|Overall Study|Insufficient data|0|||
16891522|NCT01650636|37943550|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
16891523|NCT01650636|37943549|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
16891524|NCT01650636|37943550|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
16891525|NCT02436876|37943560|FG000|Overall Study|Lost to Follow-up|0|||
16891526|NCT02436876|37943561|FG001|Overall Study|Lost to Follow-up|1|||
16891527|NCT02436876|37943562|FG002|Overall Study|Lost to Follow-up|1|||
16891528|NCT02436876|37943563|FG003|Overall Study|Lost to Follow-up|1|||
16891529|NCT02436876|37943560|FG000|Overall Study|Withdrawal by Subject|1|||
16891530|NCT02436876|37943561|FG001|Overall Study|Withdrawal by Subject|0|||
16891531|NCT02436876|37943562|FG002|Overall Study|Withdrawal by Subject|0|||
16891532|NCT02436876|37943563|FG003|Overall Study|Withdrawal by Subject|1|||
16891533|NCT02436876|37943560|FG000|Overall Study|Physician Decision|0|||
16891534|NCT02436876|37943561|FG001|Overall Study|Physician Decision|2|||
16891535|NCT02436876|37943562|FG002|Overall Study|Physician Decision|1|||
16891536|NCT02436876|37943563|FG003|Overall Study|Physician Decision|0|||
16891537|NCT02436876|37943560|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
16891538|NCT02436876|37943561|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
16891539|NCT02436876|37943562|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
16891540|NCT02436876|37943563|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
16891541|NCT02382276|37943592|FG000|Overall Study|Withdrawal by Subject|4|||
16891542|NCT02382276|37943593|FG001|Overall Study|Withdrawal by Subject|8|||
16891543|NCT02382276|37943594|FG002|Overall Study|Withdrawal by Subject|5|||
16891544|NCT02382276|37943592|FG000|Overall Study|Adverse Event|7|||
16891545|NCT02382276|37943593|FG001|Overall Study|Adverse Event|2|||
16891546|NCT02382276|37943594|FG002|Overall Study|Adverse Event|32|||
16891547|NCT02382276|37943592|FG000|Overall Study|Physician Decision|0|||
16891548|NCT02382276|37943593|FG001|Overall Study|Physician Decision|0|||
16891549|NCT02382276|37943594|FG002|Overall Study|Physician Decision|2|||
16891550|NCT02436408|37943635|FG000|Overall Study|Death|1|||
16891551|NCT02436330|37943658|FG000|Cohort 1|Lost to Follow-up|5|||
16891552|NCT02436330|37943659|FG001|Cohort 1|Lost to Follow-up|2|||
16891553|NCT02436330|37943658|FG000|Cohort 1|Withdrawal by Subject|0|||
16891554|NCT02436330|37943659|FG001|Cohort 1|Withdrawal by Subject|1|||
16891555|NCT02436330|37943658|FG000|Cohort 2|Lost to Follow-up|2|||
16891556|NCT02436330|37943659|FG001|Cohort 2|Lost to Follow-up|0|||
16891557|NCT02436330|37943658|FG000|Cohort 2|Withdrawal by Subject|2|||
16891558|NCT02436330|37943659|FG001|Cohort 2|Withdrawal by Subject|3|||
16891559|NCT02436330|37943658|FG000|Cohort 3|Lost to Follow-up|1|||
16891560|NCT02436330|37943659|FG001|Cohort 3|Lost to Follow-up|0|||
16891561|NCT02436330|37943658|FG000|Cohort 3|Withdrawal by Subject|4|||
16891562|NCT02436330|37943659|FG001|Cohort 3|Withdrawal by Subject|0|||
16891563|NCT02436330|37943658|FG000|Cohort 4|Lost to Follow-up|1|||
16891564|NCT02436330|37943659|FG001|Cohort 4|Lost to Follow-up|0|||
16891565|NCT02436330|37943658|FG000|Cohort 4|Withdrawal by Subject|1|||
16891566|NCT02436330|37943659|FG001|Cohort 4|Withdrawal by Subject|0|||
16891567|NCT02436330|37943658|FG000|Cohort 5|Lost to Follow-up|3|||
16891568|NCT02436330|37943659|FG001|Cohort 5|Lost to Follow-up|2|||
16891569|NCT02436330|37943658|FG000|Cohort 5|Withdrawal by Subject|3|||
16891570|NCT02436330|37943659|FG001|Cohort 5|Withdrawal by Subject|2|||
16891571|NCT02436330|37943658|FG000|Cohort 6|Lost to Follow-up|2|||
16891572|NCT02436330|37943659|FG001|Cohort 6|Lost to Follow-up|0|||
16891573|NCT02436330|37943658|FG000|Cohort 6|Withdrawal by Subject|1|||
16891574|NCT02436330|37943659|FG001|Cohort 6|Withdrawal by Subject|1|||
16891575|NCT01650558|37943696|FG000|Overall Study|Migration out of study area|61|||
16891576|NCT01650558|37943697|FG001|Overall Study|Migration out of study area|71|||
17003343|NCT00626275|38147398|FG002|Part B|Lost to Follow-up|0|||
17003344|NCT00626275|38147399|FG003|Part B|Lost to Follow-up|0|||
17003345|NCT00626275|38147400|FG004|Part B|Lost to Follow-up|0|||
17003346|NCT00626275|38147401|FG005|Part B|Lost to Follow-up|0|||
16891577|NCT01650558|37943698|FG002|Overall Study|Migration out of study area|56|||
16891578|NCT01650558|37943696|FG000|Overall Study|Lost to Follow-up|10|||
16891579|NCT01650558|37943697|FG001|Overall Study|Lost to Follow-up|13|||
16891580|NCT01650558|37943698|FG002|Overall Study|Lost to Follow-up|6|||
17003347|NCT00626275|38147402|FG006|Part B|Lost to Follow-up|1|||
17003348|NCT00626275|38147403|FG007|Part B|Lost to Follow-up|0|||
17003349|NCT00626275|38147396|FG000|Part B|Withdrawal by Subject|0|||
17003350|NCT00626275|38147397|FG001|Part B|Withdrawal by Subject|0|||
17003351|NCT00626275|38147398|FG002|Part B|Withdrawal by Subject|0|||
17003352|NCT00626275|38147399|FG003|Part B|Withdrawal by Subject|0|||
17003353|NCT00626275|38147400|FG004|Part B|Withdrawal by Subject|0|||
16891581|NCT01650558|37943696|FG000|Overall Study|Death|10|||
16891582|NCT01650558|37943697|FG001|Overall Study|Death|6|||
16891583|NCT01650558|37943698|FG002|Overall Study|Death|8|||
16891584|NCT01650558|37943696|FG000|Overall Study|Withdrawal by Subject|1|||
16891585|NCT01650558|37943697|FG001|Overall Study|Withdrawal by Subject|1|||
16891586|NCT01650558|37943698|FG002|Overall Study|Withdrawal by Subject|3|||
16891587|NCT01650558|37943696|FG000|Overall Study|Non-compliant participant|1|||
16891588|NCT01650558|37943697|FG001|Overall Study|Non-compliant participant|0|||
16891589|NCT01650558|37943698|FG002|Overall Study|Non-compliant participant|2|||
16891590|NCT01650558|37943696|FG000|Overall Study|Physician Decision|0|||
16891591|NCT01650558|37943697|FG001|Overall Study|Physician Decision|1|||
16891592|NCT01650558|37943698|FG002|Overall Study|Physician Decision|0|||
17003354|NCT00626275|38147401|FG005|Part B|Withdrawal by Subject|0|||
17003355|NCT00626275|38147402|FG006|Part B|Withdrawal by Subject|0|||
17003356|NCT00626275|38147403|FG007|Part B|Withdrawal by Subject|1|||
17003357|NCT00967343|38147417|FG000|Overall Study|Study termination by sponsor|12|||
16891593|NCT02408484|37943737|FG000|Overall Study|Withdrawal by Subject|3|||
16891594|NCT02408484|37943737|FG000|Overall Study|Not treated during study period|1|||
16891595|NCT02380248|37943765|FG000|Overall Study|Lost to Follow-up|11|||
16891596|NCT02380248|37943765|FG000|Overall Study|Withdrawal by Subject|3|||
16891597|NCT02408016|37943812|FG000|Overall Study|Death|6|||
16891598|NCT02408016|37943813|FG001|Overall Study|Death|1|||
16891599|NCT02408016|37943814|FG002|Overall Study|Death|0|||
16891600|NCT02408016|37943812|FG000|Overall Study|Physician Decision|0|||
16891601|NCT02408016|37943813|FG001|Overall Study|Physician Decision|2|||
16891602|NCT02408016|37943814|FG002|Overall Study|Physician Decision|0|||
16891603|NCT02407704|37943888|FG000|Overall Study|Lost to Follow-up|0|||
16891604|NCT02407704|37943889|FG001|Overall Study|Lost to Follow-up|0|||
17003358|NCT00967343|38147417|FG000|Overall Study|Death|24|||
17003359|NCT00967343|38147417|FG000|Overall Study|Relapse|1|||
17003360|NCT00967343|38147417|FG000|Overall Study|Lost to Follow-up|1|||
17095373|NCT00232596|38234649|FG000|6-Week Titration Phase|Failed to Return|2|||
17095374|NCT00232596|38234650|FG001|6-Week Titration Phase|Failed to Return|1|||
16891605|NCT02407704|37943890|FG002|Overall Study|Lost to Follow-up|0|||
16891606|NCT02407704|37943891|FG003|Overall Study|Lost to Follow-up|2|||
16891607|NCT02407704|37943888|FG000|Overall Study|Protocol Violation|0|||
16891608|NCT02407704|37943889|FG001|Overall Study|Protocol Violation|0|||
16891609|NCT02407704|37943890|FG002|Overall Study|Protocol Violation|0|||
16891610|NCT02407704|37943891|FG003|Overall Study|Protocol Violation|1|||
16891611|NCT02407704|37943888|FG000|Overall Study|Withdrawal by Subject|0|||
16891612|NCT02407704|37943889|FG001|Overall Study|Withdrawal by Subject|0|||
16891613|NCT02407704|37943890|FG002|Overall Study|Withdrawal by Subject|1|||
16891614|NCT02407704|37943891|FG003|Overall Study|Withdrawal by Subject|0|||
16891615|NCT02406612|37943912|FG000|Overall Study|Screening Failure|3|||
16891616|NCT02406612|37943913|FG001|Overall Study|Screening Failure|0|||
16891617|NCT02406612|37943912|FG000|Overall Study|Intra-procedural Exclusion|1|||
16891618|NCT02406612|37943913|FG001|Overall Study|Intra-procedural Exclusion|3|||
16891619|NCT02406612|37943912|FG000|Overall Study|Guidewire Failure|0|||
16891620|NCT02406612|37943913|FG001|Overall Study|Guidewire Failure|1|||
16891621|NCT02405442|37944057|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
16891622|NCT02405442|37944058|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
16891623|NCT02405442|37944059|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
16891624|NCT02405442|37944060|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
16891625|NCT02405442|37944057|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
16891626|NCT02405442|37944058|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
16891627|NCT02405442|37944059|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
16891628|NCT02405442|37944060|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
16891629|NCT02405442|37944057|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
16891630|NCT02405442|37944058|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
16891631|NCT02405442|37944059|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
16891632|NCT02405442|37944060|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
16891633|NCT02405442|37944057|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
16891634|NCT02405442|37944058|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
16891635|NCT02405442|37944059|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
16891636|NCT02405442|37944060|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
16891637|NCT02405442|37944057|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
16891638|NCT02405442|37944058|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
16891639|NCT02405442|37944059|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
16891640|NCT02405442|37944060|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
16891641|NCT02405442|37944057|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
16891642|NCT02405442|37944058|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
16891643|NCT02405442|37944059|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
16891644|NCT02405442|37944060|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
16891645|NCT02405442|37944057|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
16891646|NCT02405442|37944058|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
16891647|NCT02405442|37944059|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
16891648|NCT02405442|37944060|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
16891649|NCT02405442|37944057|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
16891650|NCT02405442|37944058|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
16891651|NCT02405442|37944059|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
16891652|NCT02405442|37944060|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
16891653|NCT02405442|37944057|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
16891654|NCT02405442|37944058|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
16891655|NCT02405442|37944059|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
16891656|NCT02405442|37944060|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
16891657|NCT02405442|37944057|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
17003361|NCT00973973|38147423|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
16891658|NCT02405442|37944058|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
16891659|NCT02405442|37944059|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
16891660|NCT02405442|37944060|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
16891661|NCT02405442|37944057|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
16891662|NCT02405442|37944058|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
16891663|NCT02405442|37944059|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
16891664|NCT02405442|37944060|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
16891665|NCT02405442|37944057|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
16891666|NCT02405442|37944058|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
16891667|NCT02405442|37944059|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
16891668|NCT02405442|37944060|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
16891669|NCT02405442|37944057|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
16891670|NCT02405442|37944058|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
16891671|NCT02405442|37944059|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
16891672|NCT02405442|37944060|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
16891673|NCT02405442|37944057|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
16891674|NCT02405442|37944058|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
16891675|NCT02405442|37944059|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
16891676|NCT02405442|37944060|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
16891677|NCT02404350|37944176|FG000|Overall Study|Adverse Event|2|||
16891678|NCT02404350|37944177|FG001|Overall Study|Adverse Event|2|||
16891679|NCT02404350|37944178|FG002|Overall Study|Adverse Event|3|||
16891680|NCT02404350|37944179|FG003|Overall Study|Adverse Event|9|||
16891681|NCT02404350|37944176|FG000|Overall Study|Lack of Efficacy|3|||
16891682|NCT02404350|37944177|FG001|Overall Study|Lack of Efficacy|1|||
16891683|NCT02404350|37944178|FG002|Overall Study|Lack of Efficacy|0|||
16891684|NCT02404350|37944179|FG003|Overall Study|Lack of Efficacy|3|||
17003362|NCT00973973|38147424|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
17003363|NCT00973973|38147423|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
17003364|NCT00973973|38147424|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
17003365|NCT00973973|38147423|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
17003366|NCT00973973|38147424|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
17003367|NCT00973973|38147423|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
17003368|NCT00973973|38147424|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
17003369|NCT00973973|38147423|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
16891685|NCT02404350|37944176|FG000|Overall Study|Lost to Follow-up|2|||
16891686|NCT02404350|37944177|FG001|Overall Study|Lost to Follow-up|0|||
16891687|NCT02404350|37944178|FG002|Overall Study|Lost to Follow-up|0|||
16891688|NCT02404350|37944179|FG003|Overall Study|Lost to Follow-up|1|||
16891689|NCT02404350|37944176|FG000|Overall Study|Physician Decision|1|||
16891690|NCT02404350|37944177|FG001|Overall Study|Physician Decision|0|||
16891691|NCT02404350|37944178|FG002|Overall Study|Physician Decision|0|||
16891692|NCT02404350|37944179|FG003|Overall Study|Physician Decision|2|||
16891693|NCT02404350|37944176|FG000|Overall Study|Pregnancy|0|||
16891694|NCT02404350|37944177|FG001|Overall Study|Pregnancy|0|||
16891695|NCT02404350|37944178|FG002|Overall Study|Pregnancy|0|||
16891696|NCT02404350|37944179|FG003|Overall Study|Pregnancy|1|||
16891697|NCT02404350|37944176|FG000|Overall Study|Withdrawal by Subject|7|||
16891698|NCT02404350|37944177|FG001|Overall Study|Withdrawal by Subject|3|||
16891699|NCT02404350|37944178|FG002|Overall Study|Withdrawal by Subject|3|||
16891700|NCT02404350|37944179|FG003|Overall Study|Withdrawal by Subject|19|||
16891701|NCT02404350|37944176|FG000|Overall Study|Due to Non-compliance with treatment|0|||
16891702|NCT02404350|37944177|FG001|Overall Study|Due to Non-compliance with treatment|0|||
16891703|NCT02404350|37944178|FG002|Overall Study|Due to Non-compliance with treatment|0|||
16891704|NCT02404350|37944179|FG003|Overall Study|Due to Non-compliance with treatment|1|||
16891705|NCT02404350|37944176|FG000|Overall Study|Due to Technical problems|0|||
16891706|NCT02404350|37944177|FG001|Overall Study|Due to Technical problems|0|||
16891707|NCT02404350|37944178|FG002|Overall Study|Due to Technical problems|0|||
16891708|NCT02404350|37944179|FG003|Overall Study|Due to Technical problems|1|||
16891709|NCT02434770|37944478|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
16891710|NCT02434770|37944479|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
16891711|NCT02434770|37944480|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
16891712|NCT02434770|37944478|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
16891713|NCT02434770|37944479|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
16891714|NCT02434770|37944480|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
16891715|NCT02434770|37944478|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
16891716|NCT02434770|37944479|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
16891717|NCT02434770|37944480|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
16891718|NCT02434770|37944478|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
16891719|NCT02434770|37944479|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
16891720|NCT02434770|37944480|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
16891721|NCT02434770|37944478|FG000|Week 1 to Week 18|Death|1|||
16891722|NCT02434770|37944479|FG001|Week 1 to Week 18|Death|0|||
16891723|NCT02434770|37944480|FG002|Week 1 to Week 18|Death|0|||
16891724|NCT02434770|37944478|FG000|Week 18 to Week|Lost to Follow-up|2|||
16891725|NCT02434770|37944479|FG001|Week 18 to Week|Lost to Follow-up|2|||
16891726|NCT02434770|37944480|FG002|Week 18 to Week|Lost to Follow-up|1|||
16891727|NCT02434770|37944478|FG000|Week 18 to Week|Withdrawal by Subject|0|||
16891728|NCT02434770|37944479|FG001|Week 18 to Week|Withdrawal by Subject|0|||
16891729|NCT02434770|37944480|FG002|Week 18 to Week|Withdrawal by Subject|2|||
16891730|NCT02434770|37944478|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
16891731|NCT02434770|37944479|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
16891732|NCT02434770|37944480|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
16891733|NCT02433834|37944511|FG000|Overall Study|Protocol-specified criteria|7|||
16891734|NCT02433834|37944511|FG000|Overall Study|Protocol Violation|3|||
16891735|NCT02433834|37944511|FG000|Overall Study|Lost to Follow-up|6|||
16891736|NCT02433834|37944511|FG000|Overall Study|Withdrawal by Subject|14|||
16891737|NCT02433834|37944511|FG000|Overall Study|Adverse Event|6|||
16891738|NCT02433834|37944511|FG000|Overall Study|Physician Decision|1|||
16891739|NCT02433678|37944555|FG000|Overall Study|Lost to Follow-up|1|||
16891740|NCT02433678|37944556|FG001|Overall Study|Lost to Follow-up|2|||
16891741|NCT02433288|37944569|FG000|Overall Study|Severe non-compliance to protocol|13|||
16891742|NCT02433288|37944570|FG001|Overall Study|Severe non-compliance to protocol|7|||
16891743|NCT02433288|37944569|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
16891744|NCT02433288|37944570|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
16891745|NCT02433288|37944569|FG000|Overall Study|Withdrawal by Subject|101|||
16891746|NCT02433288|37944570|FG001|Overall Study|Withdrawal by Subject|99|||
16891747|NCT02433288|37944569|FG000|Overall Study|Lost to Follow-up|2|||
16891748|NCT02433288|37944570|FG001|Overall Study|Lost to Follow-up|14|||
16891749|NCT02433288|37944569|FG000|Overall Study|Death|0|||
16891750|NCT02433288|37944570|FG001|Overall Study|Death|3|||
16891751|NCT02433210|37944590|FG000|Overall Study|Physician Decision|1|||
16891752|NCT02433210|37944591|FG001|Overall Study|Physician Decision|0|||
16891753|NCT02433210|37944592|FG002|Overall Study|Physician Decision|0|||
16891754|NCT02432040|37944727|FG000|Overall Study|Lack of Efficacy|3|||
16891755|NCT02432040|37944728|FG001|Overall Study|Lack of Efficacy|0|||
16891756|NCT02432040|37944727|FG000|Overall Study|Lost to Follow-up|4|||
16891757|NCT02432040|37944728|FG001|Overall Study|Lost to Follow-up|5|||
16891758|NCT02432040|37944727|FG000|Overall Study|Physician Decision|1|||
16891759|NCT02432040|37944728|FG001|Overall Study|Physician Decision|1|||
16891760|NCT02431806|37944760|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
16891761|NCT02431806|37944761|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
16891762|NCT02431806|37944762|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
16891763|NCT02431806|37944763|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
16891764|NCT02431806|37944760|FG000|Double-blind Treatment Period|Adverse Event|4|||
16891765|NCT02431806|37944761|FG001|Double-blind Treatment Period|Adverse Event|7|||
16891766|NCT02431806|37944762|FG002|Double-blind Treatment Period|Adverse Event|11|||
16891767|NCT02431806|37944763|FG003|Double-blind Treatment Period|Adverse Event|7|||
16891768|NCT02431806|37944760|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
16891769|NCT02431806|37944761|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
16891770|NCT02431806|37944762|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
16891771|NCT02431806|37944763|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
16891772|NCT02431806|37944760|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
16891773|NCT02431806|37944761|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
16891774|NCT02431806|37944762|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
17003370|NCT00973973|38147424|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
17003371|NCT00973973|38147423|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
17095375|NCT00232596|38234649|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
16891775|NCT02431806|37944763|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
16891776|NCT02431806|37944760|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
16891777|NCT02431806|37944761|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
16891778|NCT02431806|37944762|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
16891779|NCT02431806|37944763|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
16891780|NCT02431806|37944760|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
16891781|NCT02431806|37944761|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
16891782|NCT02431806|37944762|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
16891783|NCT02431806|37944763|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
16891784|NCT02431806|37944760|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
16891785|NCT02431806|37944761|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
16891786|NCT02431806|37944762|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
16891787|NCT02431806|37944763|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
16891788|NCT01650246|37944804|FG000|Overall Study|Adverse Event|23|||
16891789|NCT01650246|37944804|FG000|Overall Study|Protocol Violation|5|||
16891790|NCT01650246|37944804|FG000|Overall Study|Sponsor terminated study|53|||
16891791|NCT01650246|37944804|FG000|Overall Study|Lost to Follow-up|5|||
16891792|NCT01650246|37944804|FG000|Overall Study|Withdrawal by Subject|26|||
16891793|NCT01650246|37944804|FG000|Overall Study|Death|1|||
16891794|NCT01650246|37944804|FG000|Overall Study|Lack of Efficacy|30|||
16891795|NCT01652664|37944823|FG000|Overall Study|Treatment Failure|5|||
16891796|NCT01652664|37944824|FG001|Overall Study|Treatment Failure|1|||
16891797|NCT01652664|37944823|FG000|Overall Study|Inadequate IOP control|1|||
16891798|NCT01652664|37944824|FG001|Overall Study|Inadequate IOP control|0|||
16891799|NCT02379390|37944864|FG000|Overall Study|Adverse Event|1|||
16891800|NCT02379390|37944865|FG001|Overall Study|Adverse Event|1|||
16891801|NCT02379390|37944864|FG000|Overall Study|Investigator's decision|1|||
16891802|NCT02379390|37944865|FG001|Overall Study|Investigator's decision|0|||
16891803|NCT02379390|37944864|FG000|Overall Study|Study Termination|0|||
16891804|NCT02379390|37944865|FG001|Overall Study|Study Termination|1|||
16891805|NCT02379078|37944876|FG000|Overall Study|Lost to Follow-up|33|||
16891806|NCT02379078|37944877|FG001|Overall Study|Lost to Follow-up|30|||
16891807|NCT02379078|37944876|FG000|Overall Study|Withdrawal by Subject|6|||
16891808|NCT02379078|37944877|FG001|Overall Study|Withdrawal by Subject|5|||
16891809|NCT01714739|37944970|FG000|Overall Study|Disease progression|3|||
16891810|NCT01714739|37944971|FG001|Overall Study|Disease progression|5|||
16891811|NCT01714739|37944972|FG002|Overall Study|Disease progression|5|||
16891812|NCT01714739|37944973|FG003|Overall Study|Disease progression|204|||
16891813|NCT01714739|37944974|FG004|Overall Study|Disease progression|1|||
16891814|NCT01714739|37944975|FG005|Overall Study|Disease progression|3|||
17003372|NCT00973973|38147424|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
17003373|NCT00973973|38147423|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
17003374|NCT00973973|38147424|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
17003375|NCT00973973|38147423|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
17003376|NCT00973973|38147424|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
17003377|NCT00973973|38147423|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
17003378|NCT00973973|38147424|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
17003379|NCT00973973|38147423|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
17003380|NCT00973973|38147424|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
17003381|NCT00973973|38147423|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
17003382|NCT00973973|38147424|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
17095376|NCT00232596|38234650|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
16891815|NCT01714739|37944976|FG006|Overall Study|Disease progression|5|||
16891816|NCT01714739|37944970|FG000|Overall Study|Study drug toxicity|1|||
16891817|NCT01714739|37944971|FG001|Overall Study|Study drug toxicity|1|||
16891818|NCT01714739|37944972|FG002|Overall Study|Study drug toxicity|1|||
16891819|NCT01714739|37944973|FG003|Overall Study|Study drug toxicity|15|||
16891820|NCT01714739|37944974|FG004|Overall Study|Study drug toxicity|0|||
16891821|NCT01714739|37944975|FG005|Overall Study|Study drug toxicity|0|||
16891822|NCT01714739|37944976|FG006|Overall Study|Study drug toxicity|5|||
16891823|NCT01714739|37944970|FG000|Overall Study|Death|0|||
16891824|NCT01714739|37944971|FG001|Overall Study|Death|0|||
16891825|NCT01714739|37944972|FG002|Overall Study|Death|0|||
16891826|NCT01714739|37944973|FG003|Overall Study|Death|1|||
16891827|NCT01714739|37944974|FG004|Overall Study|Death|0|||
16891828|NCT01714739|37944975|FG005|Overall Study|Death|0|||
16891829|NCT01714739|37944976|FG006|Overall Study|Death|0|||
16891830|NCT01714739|37944970|FG000|Overall Study|Adverse Event unrelated to drug|0|||
16891831|NCT01714739|37944971|FG001|Overall Study|Adverse Event unrelated to drug|0|||
16891832|NCT01714739|37944972|FG002|Overall Study|Adverse Event unrelated to drug|3|||
16891833|NCT01714739|37944973|FG003|Overall Study|Adverse Event unrelated to drug|21|||
16891834|NCT01714739|37944974|FG004|Overall Study|Adverse Event unrelated to drug|0|||
16891835|NCT01714739|37944975|FG005|Overall Study|Adverse Event unrelated to drug|0|||
16891836|NCT01714739|37944976|FG006|Overall Study|Adverse Event unrelated to drug|0|||
16891837|NCT01714739|37944970|FG000|Overall Study|Participant request to stop therapy|0|||
16891838|NCT01714739|37944971|FG001|Overall Study|Participant request to stop therapy|1|||
16891839|NCT01714739|37944972|FG002|Overall Study|Participant request to stop therapy|0|||
16891840|NCT01714739|37944973|FG003|Overall Study|Participant request to stop therapy|6|||
16891841|NCT01714739|37944974|FG004|Overall Study|Participant request to stop therapy|0|||
16891842|NCT01714739|37944975|FG005|Overall Study|Participant request to stop therapy|0|||
16891843|NCT01714739|37944976|FG006|Overall Study|Participant request to stop therapy|0|||
16891844|NCT01714739|37944970|FG000|Overall Study|Participant withdrew consent|0|||
16891845|NCT01714739|37944971|FG001|Overall Study|Participant withdrew consent|1|||
16891846|NCT01714739|37944972|FG002|Overall Study|Participant withdrew consent|0|||
16891847|NCT01714739|37944973|FG003|Overall Study|Participant withdrew consent|8|||
16891848|NCT01714739|37944974|FG004|Overall Study|Participant withdrew consent|0|||
16785834|NCT01962298|37725937|FG004|Overall Study|Insufficient data|1|||
16891849|NCT01714739|37944975|FG005|Overall Study|Participant withdrew consent|0|||
16891850|NCT01714739|37944976|FG006|Overall Study|Participant withdrew consent|0|||
16891851|NCT01714739|37944970|FG000|Overall Study|Lost to Follow-up|0|||
16891852|NCT01714739|37944971|FG001|Overall Study|Lost to Follow-up|0|||
16891853|NCT01714739|37944972|FG002|Overall Study|Lost to Follow-up|0|||
16891854|NCT01714739|37944973|FG003|Overall Study|Lost to Follow-up|1|||
16891855|NCT01714739|37944974|FG004|Overall Study|Lost to Follow-up|0|||
16891856|NCT01714739|37944975|FG005|Overall Study|Lost to Follow-up|0|||
16891857|NCT01714739|37944976|FG006|Overall Study|Lost to Follow-up|0|||
16891858|NCT01714739|37944970|FG000|Overall Study|Maximum clinical benefit|0|||
16891859|NCT01714739|37944971|FG001|Overall Study|Maximum clinical benefit|1|||
16891860|NCT01714739|37944972|FG002|Overall Study|Maximum clinical benefit|1|||
16891861|NCT01714739|37944973|FG003|Overall Study|Maximum clinical benefit|3|||
16891862|NCT01714739|37944974|FG004|Overall Study|Maximum clinical benefit|0|||
16891863|NCT01714739|37944975|FG005|Overall Study|Maximum clinical benefit|0|||
16891864|NCT01714739|37944976|FG006|Overall Study|Maximum clinical benefit|0|||
16891865|NCT01714739|37944970|FG000|Overall Study|Poor/non-comliance|0|||
16891866|NCT01714739|37944971|FG001|Overall Study|Poor/non-comliance|1|||
16785835|NCT01962298|37725933|FG000|Overall Study|Incorrect data recorded|0|||
16785836|NCT01962298|37725934|FG001|Overall Study|Incorrect data recorded|1|||
16785837|NCT01962298|37725935|FG002|Overall Study|Incorrect data recorded|0|||
17192187|NCT02850965|38345348|FG000|Overall Study|Protocol Violation|0|||
16891867|NCT01714739|37944972|FG002|Overall Study|Poor/non-comliance|0|||
16891868|NCT01714739|37944973|FG003|Overall Study|Poor/non-comliance|1|||
16891869|NCT01714739|37944974|FG004|Overall Study|Poor/non-comliance|0|||
16891870|NCT01714739|37944975|FG005|Overall Study|Poor/non-comliance|0|||
16891871|NCT01714739|37944976|FG006|Overall Study|Poor/non-comliance|0|||
16891872|NCT01714739|37944970|FG000|Overall Study|No longer meets study criteria|0|||
16891873|NCT01714739|37944971|FG001|Overall Study|No longer meets study criteria|0|||
16891874|NCT01714739|37944972|FG002|Overall Study|No longer meets study criteria|0|||
16891875|NCT01714739|37944973|FG003|Overall Study|No longer meets study criteria|1|||
16891876|NCT01714739|37944974|FG004|Overall Study|No longer meets study criteria|0|||
16891877|NCT01714739|37944975|FG005|Overall Study|No longer meets study criteria|0|||
16891878|NCT01714739|37944976|FG006|Overall Study|No longer meets study criteria|0|||
16891879|NCT01714739|37944970|FG000|Overall Study|Other reason|0|||
16891880|NCT01714739|37944971|FG001|Overall Study|Other reason|0|||
16891881|NCT01714739|37944972|FG002|Overall Study|Other reason|0|||
16891882|NCT01714739|37944973|FG003|Overall Study|Other reason|3|||
16891883|NCT01714739|37944974|FG004|Overall Study|Other reason|1|||
16891884|NCT01714739|37944975|FG005|Overall Study|Other reason|0|||
16891885|NCT01714739|37944976|FG006|Overall Study|Other reason|0|||
16891886|NCT00609791|37945044|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
16891887|NCT03823287|37946997|FG000|Overall Study|Withdrawal by Subject|25|||
16891888|NCT03823287|37946998|FG001|Overall Study|Withdrawal by Subject|17|||
16891889|NCT03823287|37946997|FG000|Overall Study|Death|13|||
16891890|NCT03823287|37946998|FG001|Overall Study|Death|7|||
16891891|NCT03823287|37946997|FG000|Overall Study|Lost to Follow-up|7|||
16891892|NCT03823287|37946998|FG001|Overall Study|Lost to Follow-up|8|||
16891893|NCT03823287|37946997|FG000|Overall Study|Adverse Event|6|||
16891894|NCT03823287|37946998|FG001|Overall Study|Adverse Event|8|||
16891895|NCT03823287|37946997|FG000|Overall Study|Physician Decision|5|||
16891896|NCT03823287|37946998|FG001|Overall Study|Physician Decision|2|||
16891897|NCT03823287|37946997|FG000|Overall Study|Lack of Efficacy|2|||
16891898|NCT03823287|37946998|FG001|Overall Study|Lack of Efficacy|0|||
16891899|NCT03823287|37946997|FG000|Overall Study|Other|2|||
16891900|NCT03823287|37946998|FG001|Overall Study|Other|4|||
16891901|NCT03707925|37947159|FG000|Overall Study|Inevaluable|1|||
16891902|NCT03461757|37947219|FG000|Overall Study|Adverse Event|1|||
16891903|NCT03461757|37947220|FG001|Overall Study|Adverse Event|0|||
16891904|NCT03461757|37947219|FG000|Overall Study|Lost to Follow-up|13|||
16891905|NCT03461757|37947220|FG001|Overall Study|Lost to Follow-up|7|||
16891906|NCT03461757|37947219|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
16891907|NCT03461757|37947220|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
16891908|NCT03461757|37947219|FG000|Overall Study|Non-compliance with study treatment|0|||
16891909|NCT03461757|37947220|FG001|Overall Study|Non-compliance with study treatment|1|||
16891910|NCT03461757|37947219|FG000|Overall Study|Pregnancy|2|||
16891911|NCT03461757|37947220|FG001|Overall Study|Pregnancy|0|||
16891912|NCT03461757|37947219|FG000|Overall Study|Protocol Violation|1|||
16891913|NCT03461757|37947220|FG001|Overall Study|Protocol Violation|1|||
16891914|NCT03461757|37947219|FG000|Overall Study|Withdrawal by Subject|7|||
16891915|NCT03461757|37947220|FG001|Overall Study|Withdrawal by Subject|7|||
16891916|NCT03461757|37947219|FG000|Overall Study|Other Reasons|1|||
16891917|NCT03461757|37947220|FG001|Overall Study|Other Reasons|4|||
16891918|NCT03235479|37947757|FG000|Overall Study|Lost to Follow-up|8|||
16891919|NCT03235479|37947758|FG001|Overall Study|Lost to Follow-up|11|||
16891920|NCT03235479|37947757|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
16891921|NCT03235479|37947758|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
16891922|NCT03235479|37947757|FG000|Overall Study|Pregnancy|1|||
16891923|NCT03235479|37947758|FG001|Overall Study|Pregnancy|0|||
16891924|NCT03235479|37947757|FG000|Overall Study|Protocol Deviation|1|||
16891925|NCT03235479|37947758|FG001|Overall Study|Protocol Deviation|3|||
16891926|NCT03235479|37947757|FG000|Overall Study|Technical Problems|3|||
16891927|NCT03235479|37947758|FG001|Overall Study|Technical Problems|2|||
16891928|NCT03235479|37947757|FG000|Overall Study|Withdrawal by Subject|2|||
16891929|NCT03235479|37947758|FG001|Overall Study|Withdrawal by Subject|2|||
17003383|NCT00973973|38147423|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
17192188|NCT02850965|38345349|FG001|Overall Study|Protocol Violation|2|||
17192189|NCT02850965|38345348|FG000|Overall Study|Lost to Follow-up|5|||
17192190|NCT02850965|38345349|FG001|Overall Study|Lost to Follow-up|3|||
17192191|NCT02850965|38345348|FG000|Overall Study|Lack of Efficacy|4|||
17192192|NCT02850965|38345349|FG001|Overall Study|Lack of Efficacy|8|||
17192193|NCT02850965|38345348|FG000|Overall Study|Adverse Event|3|||
17192194|NCT02850965|38345349|FG001|Overall Study|Adverse Event|2|||
17192195|NCT02850965|38345348|FG000|Overall Study|Withdrawal by Subject|3|||
17192196|NCT02850965|38345349|FG001|Overall Study|Withdrawal by Subject|4|||
17192197|NCT02850965|38345348|FG000|Overall Study|Physician Decision|0|||
17192198|NCT02850965|38345349|FG001|Overall Study|Physician Decision|1|||
17192199|NCT02850965|38345348|FG000|Overall Study|Randomized but not treated|0|||
17192200|NCT02850965|38345349|FG001|Overall Study|Randomized but not treated|1|||
17192201|NCT01375959|38345357|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
17192202|NCT01375959|38345358|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
17192203|NCT01375959|38345357|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
17192204|NCT01375959|38345358|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
17192205|NCT01375959|38345357|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
17192206|NCT01375959|38345358|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
17192207|NCT00708201|38345368|FG000|Overall Study|Adverse Event|4|||
17192208|NCT00708201|38345369|FG001|Overall Study|Adverse Event|4|||
17192209|NCT00708201|38345368|FG000|Overall Study|Withdrawal by Subject|1|||
17192210|NCT00708201|38345369|FG001|Overall Study|Withdrawal by Subject|1|||
17192211|NCT00708201|38345368|FG000|Overall Study|Lost to Follow-up|2|||
17192212|NCT00708201|38345369|FG001|Overall Study|Lost to Follow-up|0|||
17192213|NCT00708201|38345368|FG000|Overall Study|Protocol Violation|0|||
17192214|NCT00708201|38345369|FG001|Overall Study|Protocol Violation|1|||
17192215|NCT02848313|38345377|FG000|Overall Study|Adverse Event|1|||
17192216|NCT02848313|38345378|FG001|Overall Study|Adverse Event|2|||
17192217|NCT02848313|38345377|FG000|Overall Study|Lack of Efficacy|0|||
17192218|NCT02848313|38345378|FG001|Overall Study|Lack of Efficacy|1|||
17192219|NCT02848313|38345377|FG000|Overall Study|Withdrawal by Subject|1|||
17192220|NCT02848313|38345378|FG001|Overall Study|Withdrawal by Subject|1|||
17192221|NCT02848313|38345377|FG000|Overall Study|Lost to follow up|1|||
17192222|NCT02848313|38345378|FG001|Overall Study|Lost to follow up|0|||
17192223|NCT02728089|38345384|FG000|Overall Study|Physician Decision|2|||
17192224|NCT02728089|38345384|FG000|Overall Study|Withdrawal by Subject|1|||
17192225|NCT02840461|38345391|FG000|Overall Study|Adverse Event|1|||
17192226|NCT02840461|38345392|FG001|Overall Study|Adverse Event|5|||
17192227|NCT02840461|38345393|FG002|Overall Study|Adverse Event|3|||
17192228|NCT02840461|38345391|FG000|Overall Study|Lost to Follow-up|10|||
17192229|NCT02840461|38345392|FG001|Overall Study|Lost to Follow-up|7|||
17192230|NCT02840461|38345393|FG002|Overall Study|Lost to Follow-up|6|||
17192231|NCT02840461|38345391|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
17192232|NCT02840461|38345392|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
17192233|NCT02840461|38345393|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
17192234|NCT02840461|38345391|FG000|Overall Study|Protocol Violation|2|||
17192235|NCT02840461|38345392|FG001|Overall Study|Protocol Violation|3|||
17192236|NCT02840461|38345393|FG002|Overall Study|Protocol Violation|1|||
17192237|NCT02840461|38345391|FG000|Overall Study|Withdrawal by Subject|10|||
17192238|NCT02840461|38345392|FG001|Overall Study|Withdrawal by Subject|6|||
17192239|NCT02840461|38345393|FG002|Overall Study|Withdrawal by Subject|2|||
17192240|NCT02840461|38345391|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
17192241|NCT02840461|38345392|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
17192242|NCT02840461|38345393|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
17192243|NCT02839681|38345402|FG000|Overall Study|Death|2|||
17192244|NCT01676012|38345406|FG000|Overall Study|Adverse Event|2|||
17192245|NCT01676012|38345406|FG000|Overall Study|incomplete set of videos|1|||
17192246|NCT02727777|38345413|FG000|Overall Study|Screen Failure|2|||
17192247|NCT02727777|38345414|FG001|Overall Study|Screen Failure|0|||
17192248|NCT02727777|38345415|FG002|Overall Study|Screen Failure|0|||
17192249|NCT02727777|38345413|FG000|Overall Study|Progressive disease|2|||
17192250|NCT02727777|38345414|FG001|Overall Study|Progressive disease|0|||
16785838|NCT01962298|37725936|FG003|Overall Study|Incorrect data recorded|0|||
16891930|NCT03235479|37947757|FG000|Overall Study|Other Reasons|3|||
16891931|NCT03235479|37947758|FG001|Overall Study|Other Reasons|5|||
16891932|NCT03193437|37947814|FG000|Overall Study|Adverse Event|4|||
17192251|NCT02727777|38345415|FG002|Overall Study|Progressive disease|0|||
17192252|NCT00707577|38345425|FG000|Overall Study|Withdrawal by Subject|3|||
17192253|NCT00707577|38345426|FG001|Overall Study|Withdrawal by Subject|2|||
16891933|NCT03193437|37947814|FG000|Overall Study|Withdrawal by Subject|2|||
17003384|NCT00973973|38147424|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
17003385|NCT00633139|38147433|FG000|Overall Study|Non compliance|0|||
17003386|NCT00633139|38147434|FG001|Overall Study|Non compliance|0|||
17003387|NCT00633139|38147435|FG002|Overall Study|Non compliance|1|||
17003388|NCT00633139|38147433|FG000|Overall Study|Withdrawal by Subject|0|||
17003389|NCT00633139|38147434|FG001|Overall Study|Withdrawal by Subject|1|||
17003390|NCT00633139|38147435|FG002|Overall Study|Withdrawal by Subject|0|||
17003391|NCT00965081|38147445|FG000|Overall Study|Adverse Event|14|||
17003392|NCT00965081|38147446|FG001|Overall Study|Adverse Event|9|||
17003393|NCT00965081|38147445|FG000|Overall Study|Lack of Efficacy|2|||
17003394|NCT00965081|38147446|FG001|Overall Study|Lack of Efficacy|5|||
17003395|NCT00965081|38147445|FG000|Overall Study|Lost to Follow-up|4|||
17003396|NCT00965081|38147446|FG001|Overall Study|Lost to Follow-up|5|||
17003397|NCT00965081|38147445|FG000|Overall Study|Physician Decision|2|||
16891934|NCT03193437|37947814|FG000|Overall Study|Disease Progression|2|||
16891935|NCT02906787|37947867|FG000|Overall Study|Withdrawal by Subject|12|||
16891936|NCT02906787|37947868|FG001|Overall Study|Withdrawal by Subject|10|||
16891937|NCT02906787|37947867|FG000|Overall Study|Missed|24|||
16891938|NCT02906787|37947868|FG001|Overall Study|Missed|22|||
16891939|NCT02450331|37948255|FG000|Overall Study|Death|120|||
16891940|NCT02450331|37948256|FG001|Overall Study|Death|114|||
16891941|NCT02450331|37948255|FG000|Overall Study|Lost to Follow-up|9|||
16891942|NCT02450331|37948256|FG001|Overall Study|Lost to Follow-up|7|||
16891943|NCT02450331|37948255|FG000|Overall Study|Withdrawal by Subject|50|||
16891944|NCT02450331|37948256|FG001|Overall Study|Withdrawal by Subject|39|||
16891945|NCT02450331|37948255|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179|||
16891946|NCT02450331|37948256|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208|||
16891947|NCT02450331|37948255|FG000|Overall Study|On-Study Status: In Survival follow-up|45|||
16891948|NCT02450331|37948256|FG001|Overall Study|On-Study Status: In Survival follow-up|38|||
16891949|NCT02107443|37948474|FG000|Overall Study|Death|42|||
16891950|NCT02107443|37948475|FG001|Overall Study|Death|30|||
16891951|NCT02107443|37948474|FG000|Overall Study|Study Protocol Violation|3|||
16891952|NCT02107443|37948475|FG001|Overall Study|Study Protocol Violation|1|||
16891953|NCT02107443|37948474|FG000|Overall Study|Registered but Not Eligible|0|||
16891954|NCT02107443|37948475|FG001|Overall Study|Registered but Not Eligible|1|||
16891955|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
16891956|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
16891957|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
16891958|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
16891959|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Changed Mind|2|||
16891960|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Changed Mind|0|||
16891961|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
16891962|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
16891963|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
16891964|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
16891965|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
16891966|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
16891967|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
16891968|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
16891969|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Other Medical|9|||
16891970|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Other Medical|5|||
16891971|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Disease Progression|4|||
16891972|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Disease Progression|2|||
16891973|NCT02107443|37948474|FG000|Overall Study|Withdrawal: Personal Issues|0|||
16891974|NCT02107443|37948475|FG001|Overall Study|Withdrawal: Personal Issues|3|||
16891975|NCT00559949|37949392|FG000|Overall Study|Progressive Disease during cycle 1|1|||
16891976|NCT00559949|37949392|FG000|Overall Study|Adverse Event|1|||
16891977|NCT00559949|37949392|FG000|Overall Study|Withdrawal by Subject|4|||
16891978|NCT00559949|37949392|FG000|Overall Study|No disease evaluation per protocol|1|||
16891979|NCT00559637|37949448|FG000|Overall Study|Adverse Event|22|||
16891980|NCT00559637|37949448|FG000|Overall Study|Withdrawal by Subject|4|||
16891981|NCT00559637|37949448|FG000|Overall Study|Protocol Violation|6|||
16891982|NCT00559637|37949448|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
16891983|NCT00559637|37949448|FG000|Overall Study|Failure to return|6|||
16891984|NCT00559637|37949448|FG000|Overall Study|Insufficient response|3|||
16891985|NCT00559637|37949448|FG000|Overall Study|Started requiring dialysis after month 7|2|||
16891986|NCT00559637|37949448|FG000|Overall Study|Suspected lung cancer|1|||
16891987|NCT00559637|37949448|FG000|Overall Study|Participation in another study|1|||
17095377|NCT00232596|38234649|FG000|6-Week Titration Phase|Protocol Violation|1|||
17095378|NCT00232596|38234650|FG001|6-Week Titration Phase|Protocol Violation|3|||
17095379|NCT00232596|38234649|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
17003398|NCT00965081|38147446|FG001|Overall Study|Physician Decision|0|||
17003399|NCT00965081|38147445|FG000|Overall Study|Protocol Violation|2|||
17003400|NCT00965081|38147446|FG001|Overall Study|Protocol Violation|5|||
16891988|NCT00559637|37949448|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
16891989|NCT00559637|37949448|FG000|Overall Study|Change of center|1|||
16891990|NCT00559637|37949448|FG000|Overall Study|Change of home|1|||
16891991|NCT00559637|37949448|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
16891992|NCT02431260|37949550|FG000|Overall Study|Subject Decision|0|||
16891993|NCT02431260|37949551|FG001|Overall Study|Subject Decision|1|||
16891994|NCT02431260|37949552|FG002|Overall Study|Subject Decision|1|||
16891995|NCT02431260|37949553|FG003|Overall Study|Subject Decision|0|||
16891996|NCT02431260|37949554|FG004|Overall Study|Subject Decision|0|||
16891997|NCT02431260|37949555|FG005|Overall Study|Subject Decision|0|||
16891998|NCT02431260|37949556|FG006|Overall Study|Subject Decision|0|||
16891999|NCT02431260|37949557|FG007|Overall Study|Subject Decision|0|||
16892000|NCT02431260|37949558|FG008|Overall Study|Subject Decision|1|||
16892001|NCT02431260|37949559|FG009|Overall Study|Subject Decision|1|||
16892002|NCT02431260|37949560|FG010|Overall Study|Subject Decision|0|||
16892003|NCT02431260|37949561|FG011|Overall Study|Subject Decision|1|||
16892004|NCT02431260|37949562|FG012|Overall Study|Subject Decision|0|||
16892005|NCT02431260|37949563|FG013|Overall Study|Subject Decision|0|||
16892006|NCT02431260|37949550|FG000|Overall Study|Death|4|||
16892007|NCT02431260|37949551|FG001|Overall Study|Death|4|||
16892008|NCT02431260|37949552|FG002|Overall Study|Death|3|||
16892009|NCT02431260|37949553|FG003|Overall Study|Death|4|||
16892010|NCT02431260|37949554|FG004|Overall Study|Death|2|||
16892011|NCT02431260|37949555|FG005|Overall Study|Death|2|||
16892012|NCT02431260|37949556|FG006|Overall Study|Death|3|||
16892013|NCT02431260|37949557|FG007|Overall Study|Death|1|||
16892014|NCT02431260|37949558|FG008|Overall Study|Death|6|||
16892015|NCT02431260|37949559|FG009|Overall Study|Death|6|||
16892016|NCT02431260|37949560|FG010|Overall Study|Death|3|||
16892017|NCT02431260|37949561|FG011|Overall Study|Death|2|||
16892018|NCT02431260|37949562|FG012|Overall Study|Death|5|||
16892019|NCT02431260|37949563|FG013|Overall Study|Death|1|||
16892020|NCT02431260|37949550|FG000|Overall Study|Lost to Follow-up|0|||
16892021|NCT02431260|37949551|FG001|Overall Study|Lost to Follow-up|0|||
16892022|NCT02431260|37949552|FG002|Overall Study|Lost to Follow-up|0|||
16892023|NCT02431260|37949553|FG003|Overall Study|Lost to Follow-up|0|||
16892024|NCT02431260|37949554|FG004|Overall Study|Lost to Follow-up|0|||
16892025|NCT02431260|37949555|FG005|Overall Study|Lost to Follow-up|1|||
16892026|NCT02431260|37949556|FG006|Overall Study|Lost to Follow-up|0|||
16892027|NCT02431260|37949557|FG007|Overall Study|Lost to Follow-up|0|||
16892028|NCT02431260|37949558|FG008|Overall Study|Lost to Follow-up|0|||
16892029|NCT02431260|37949559|FG009|Overall Study|Lost to Follow-up|0|||
16892030|NCT02431260|37949560|FG010|Overall Study|Lost to Follow-up|0|||
16892031|NCT02431260|37949561|FG011|Overall Study|Lost to Follow-up|0|||
16892032|NCT02431260|37949562|FG012|Overall Study|Lost to Follow-up|0|||
16892033|NCT02431260|37949563|FG013|Overall Study|Lost to Follow-up|0|||
16892034|NCT02431260|37949550|FG000|Overall Study|Study Terminated by the Sponsor|0|||
16892035|NCT02431260|37949551|FG001|Overall Study|Study Terminated by the Sponsor|0|||
16892036|NCT02431260|37949552|FG002|Overall Study|Study Terminated by the Sponsor|2|||
16892037|NCT02431260|37949553|FG003|Overall Study|Study Terminated by the Sponsor|1|||
16892038|NCT02431260|37949554|FG004|Overall Study|Study Terminated by the Sponsor|1|||
16892039|NCT02431260|37949555|FG005|Overall Study|Study Terminated by the Sponsor|0|||
16892040|NCT02431260|37949556|FG006|Overall Study|Study Terminated by the Sponsor|1|||
16892041|NCT02431260|37949557|FG007|Overall Study|Study Terminated by the Sponsor|2|||
16892042|NCT02431260|37949558|FG008|Overall Study|Study Terminated by the Sponsor|1|||
16892043|NCT02431260|37949559|FG009|Overall Study|Study Terminated by the Sponsor|1|||
16892044|NCT02431260|37949560|FG010|Overall Study|Study Terminated by the Sponsor|1|||
16892045|NCT02431260|37949561|FG011|Overall Study|Study Terminated by the Sponsor|0|||
16892046|NCT02431260|37949562|FG012|Overall Study|Study Terminated by the Sponsor|4|||
16892047|NCT02431260|37949563|FG013|Overall Study|Study Terminated by the Sponsor|0|||
16892048|NCT02431260|37949550|FG000|Overall Study|Physician Decision|0|||
16892049|NCT02431260|37949551|FG001|Overall Study|Physician Decision|0|||
16892050|NCT02431260|37949552|FG002|Overall Study|Physician Decision|0|||
16892051|NCT02431260|37949553|FG003|Overall Study|Physician Decision|0|||
16892052|NCT02431260|37949554|FG004|Overall Study|Physician Decision|0|||
16892053|NCT02431260|37949555|FG005|Overall Study|Physician Decision|1|||
16892054|NCT02431260|37949556|FG006|Overall Study|Physician Decision|0|||
16892055|NCT02431260|37949557|FG007|Overall Study|Physician Decision|0|||
16892056|NCT02431260|37949558|FG008|Overall Study|Physician Decision|0|||
16892057|NCT02431260|37949559|FG009|Overall Study|Physician Decision|0|||
16892058|NCT02431260|37949560|FG010|Overall Study|Physician Decision|0|||
16892059|NCT02431260|37949561|FG011|Overall Study|Physician Decision|0|||
16892060|NCT02431260|37949562|FG012|Overall Study|Physician Decision|0|||
16892061|NCT02431260|37949563|FG013|Overall Study|Physician Decision|0|||
16892062|NCT02431260|37949550|FG000|Overall Study|Other Unspecified|0|||
16892063|NCT02431260|37949551|FG001|Overall Study|Other Unspecified|0|||
16892064|NCT02431260|37949552|FG002|Overall Study|Other Unspecified|0|||
16892065|NCT02431260|37949553|FG003|Overall Study|Other Unspecified|0|||
16892066|NCT02431260|37949554|FG004|Overall Study|Other Unspecified|0|||
16892067|NCT02431260|37949555|FG005|Overall Study|Other Unspecified|0|||
16892068|NCT02431260|37949556|FG006|Overall Study|Other Unspecified|0|||
16892069|NCT02431260|37949557|FG007|Overall Study|Other Unspecified|0|||
16892070|NCT02431260|37949558|FG008|Overall Study|Other Unspecified|0|||
16892071|NCT02431260|37949559|FG009|Overall Study|Other Unspecified|0|||
16892072|NCT02431260|37949560|FG010|Overall Study|Other Unspecified|0|||
16892073|NCT02431260|37949561|FG011|Overall Study|Other Unspecified|1|||
16892074|NCT02431260|37949562|FG012|Overall Study|Other Unspecified|1|||
16892075|NCT02431260|37949563|FG013|Overall Study|Other Unspecified|0|||
16892076|NCT02430870|37949758|FG000|Part 2|Voluntary Withdrawal|0|||
16892077|NCT02430870|37949759|FG001|Part 2|Voluntary Withdrawal|0|||
16892078|NCT02430870|37949760|FG002|Part 2|Voluntary Withdrawal|0|||
16892079|NCT02430870|37949761|FG003|Part 2|Voluntary Withdrawal|0|||
16892080|NCT02430870|37949762|FG004|Part 2|Voluntary Withdrawal|0|||
16892081|NCT02430870|37949763|FG005|Part 2|Voluntary Withdrawal|0|||
16892082|NCT02430870|37949764|FG006|Part 2|Voluntary Withdrawal|1|||
16892083|NCT02430870|37949765|FG007|Part 2|Voluntary Withdrawal|0|||
16892084|NCT02430870|37949758|FG000|Part 2|Other Reason Not Specified|0|||
16892085|NCT02430870|37949759|FG001|Part 2|Other Reason Not Specified|0|||
16892086|NCT02430870|37949760|FG002|Part 2|Other Reason Not Specified|0|||
16892087|NCT02430870|37949761|FG003|Part 2|Other Reason Not Specified|0|||
16892088|NCT02430870|37949762|FG004|Part 2|Other Reason Not Specified|0|||
16892089|NCT02430870|37949763|FG005|Part 2|Other Reason Not Specified|0|||
16892090|NCT02430870|37949764|FG006|Part 2|Other Reason Not Specified|0|||
16892091|NCT02430870|37949765|FG007|Part 2|Other Reason Not Specified|1|||
16892092|NCT02430480|37949820|FG000|Overall Study|Death|1|||
16892093|NCT02430480|37949820|FG000|Overall Study|Anesthesia concerns|1|||
16892094|NCT02430480|37949820|FG000|Overall Study|Progressed on treatment|1|||
16892095|NCT02429934|37949838|FG000|Overall Study|Withdrawal by Subject|0|||
16892096|NCT02429934|37949839|FG001|Overall Study|Withdrawal by Subject|2|||
16892097|NCT02429934|37949838|FG000|Overall Study|Adverse Event|2|||
16892098|NCT02429934|37949839|FG001|Overall Study|Adverse Event|0|||
16892099|NCT02429934|37949838|FG000|Overall Study|Lost to Follow-up|1|||
16892100|NCT02429934|37949839|FG001|Overall Study|Lost to Follow-up|1|||
16892101|NCT02429934|37949838|FG000|Overall Study|Physician Decision|1|||
16892102|NCT02429934|37949839|FG001|Overall Study|Physician Decision|0|||
16892103|NCT02429856|37949853|FG000|Overall Study|Death|12|||
16892104|NCT02429856|37949854|FG001|Overall Study|Death|13|||
16892105|NCT02429856|37949853|FG000|Overall Study|Lost to Follow-up|6|||
16892106|NCT02429856|37949854|FG001|Overall Study|Lost to Follow-up|5|||
16892107|NCT02429856|37949853|FG000|Overall Study|Withdrawal by Subject|1|||
16892108|NCT02429856|37949854|FG001|Overall Study|Withdrawal by Subject|1|||
17003401|NCT00965081|38147445|FG000|Overall Study|Sponsor Decision|1|||
17003402|NCT00965081|38147446|FG001|Overall Study|Sponsor Decision|0|||
17003403|NCT00965081|38147445|FG000|Overall Study|Withdrawal by Subject|4|||
17003404|NCT00965081|38147446|FG001|Overall Study|Withdrawal by Subject|7|||
17003405|NCT00965081|38147445|FG000|Overall Study|Switched to Rescue Arm|5|||
17003406|NCT00965081|38147446|FG001|Overall Study|Switched to Rescue Arm|12|||
17003407|NCT00961649|38147457|FG000|Overall Study|Adverse Event|4|||
17003408|NCT00961649|38147458|FG001|Overall Study|Adverse Event|0|||
17003409|NCT00961649|38147459|FG002|Overall Study|Adverse Event|0|||
17003410|NCT00961649|38147460|FG003|Overall Study|Adverse Event|2|||
17003411|NCT00961649|38147457|FG000|Overall Study|Inadequate control of IOP|0|||
17003412|NCT00961649|38147458|FG001|Overall Study|Inadequate control of IOP|0|||
17003413|NCT00961649|38147459|FG002|Overall Study|Inadequate control of IOP|0|||
17003414|NCT00961649|38147460|FG003|Overall Study|Inadequate control of IOP|1|||
17003415|NCT00961649|38147457|FG000|Overall Study|Patient has travel plans during holidays|0|||
17003416|NCT00961649|38147458|FG001|Overall Study|Patient has travel plans during holidays|0|||
17003417|NCT00961649|38147459|FG002|Overall Study|Patient has travel plans during holidays|1|||
17003418|NCT00961649|38147460|FG003|Overall Study|Patient has travel plans during holidays|0|||
17003419|NCT00961649|38147457|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
17003420|NCT00961649|38147458|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
17003421|NCT00961649|38147459|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
17003422|NCT00961649|38147460|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
17003423|NCT00961649|38147457|FG000|Overall Study|Study terminated by sponsor|4|||
17003424|NCT00961649|38147458|FG001|Overall Study|Study terminated by sponsor|4|||
17003425|NCT00961649|38147459|FG002|Overall Study|Study terminated by sponsor|4|||
17003426|NCT00961649|38147460|FG003|Overall Study|Study terminated by sponsor|1|||
16892109|NCT02429778|37949864|FG000|Overall Study|Lost to Follow-up|2|||
16892110|NCT02429778|37949865|FG001|Overall Study|Lost to Follow-up|0|||
16892111|NCT02429778|37949864|FG000|Overall Study|Withdrawal by Subject|5|||
16892112|NCT02429778|37949865|FG001|Overall Study|Withdrawal by Subject|0|||
16892113|NCT02403180|37949873|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
16892114|NCT02403180|37949874|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
16892115|NCT02403180|37949873|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
17003427|NCT00632125|38147470|FG000|Overall Study|Death|82|||
17003428|NCT00632125|38147470|FG000|Overall Study|Withdrawal by Subject|44|||
16892116|NCT02403180|37949874|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
16892117|NCT02402322|37949892|FG000|Pretreatment|Withdrawal by Subject|3|||
16892118|NCT02402322|37949893|FG001|Pretreatment|Withdrawal by Subject|1|||
16892119|NCT02402322|37949894|FG002|Pretreatment|Withdrawal by Subject|1|||
16892120|NCT02402322|37949892|FG000|Follow-up|Withdrawal by Subject|6|||
16892121|NCT02402322|37949893|FG001|Follow-up|Withdrawal by Subject|3|||
16892122|NCT02402322|37949894|FG002|Follow-up|Withdrawal by Subject|24|||
16892123|NCT00558467|37949921|FG000|Overall Study|Adverse Event|1|||
16892124|NCT00558467|37949922|FG001|Overall Study|Adverse Event|2|||
16892125|NCT00558467|37949921|FG000|Overall Study|Lack of Efficacy|0|||
16892126|NCT00558467|37949922|FG001|Overall Study|Lack of Efficacy|1|||
16892127|NCT00558467|37949921|FG000|Overall Study|Patient moving out of state|0|||
16892128|NCT00558467|37949922|FG001|Overall Study|Patient moving out of state|1|||
16892129|NCT02402166|37949928|FG000|Overall Study|Adverse Event|2|||
16892130|NCT02402166|37949928|FG000|Overall Study|Withdrawal by Subject|2|||
16892131|NCT02402166|37949928|FG000|Overall Study|Lost to Follow-up|1|||
16892132|NCT02378220|37949948|FG000|Overall Study|Death|6|||
16892133|NCT02378220|37949949|FG001|Overall Study|Death|1|||
16892134|NCT04226495|37949958|FG000|Overall Study|Withdrawal by Subject|3|||
16892135|NCT04226495|37949959|FG001|Overall Study|Withdrawal by Subject|3|||
16892136|NCT04226495|37949958|FG000|Overall Study|PI discretion|2|||
16892137|NCT04226495|37949959|FG001|Overall Study|PI discretion|4|||
16892138|NCT02401308|37949967|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
16892139|NCT02401308|37949968|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
16892140|NCT02401230|37949977|FG000|Overall Study|Adverse Event|3|||
16892141|NCT02401230|37949978|FG001|Overall Study|Adverse Event|2|||
16892142|NCT02401230|37949979|FG002|Overall Study|Adverse Event|0|||
16892143|NCT02401230|37949977|FG000|Overall Study|Withdrawal by Subject|2|||
16892144|NCT02401230|37949978|FG001|Overall Study|Withdrawal by Subject|1|||
16892145|NCT02401230|37949979|FG002|Overall Study|Withdrawal by Subject|1|||
17003429|NCT00632125|38147470|FG000|Overall Study|Adverse Event|36|||
17003430|NCT00632125|38147470|FG000|Overall Study|Renal transplantation|17|||
17003431|NCT00632125|38147470|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
17003432|NCT00632125|38147470|FG000|Overall Study|Non-compliance|8|||
17003433|NCT00632125|38147470|FG000|Overall Study|Development of uncontrolled hypertension|5|||
17003434|NCT00632125|38147470|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
16892146|NCT02401230|37949977|FG000|Overall Study|Lost to Follow-up|1|||
16892147|NCT02401230|37949978|FG001|Overall Study|Lost to Follow-up|3|||
16892148|NCT02401230|37949979|FG002|Overall Study|Lost to Follow-up|3|||
16892149|NCT02429310|37950020|FG000|Overall Study|Lost to Follow-up|1|||
16892150|NCT02429310|37950021|FG001|Overall Study|Lost to Follow-up|2|||
16892151|NCT02429310|37950020|FG000|Overall Study|Protocol Violation|1|||
16892152|NCT02429310|37950021|FG001|Overall Study|Protocol Violation|1|||
16892153|NCT02428608|37950047|FG000|Overall Study|Pregnancy|2|||
16892154|NCT02428608|37950047|FG000|Overall Study|Lost to Follow-up|37|||
16892155|NCT02428608|37950047|FG000|Overall Study|Withdrawal by Subject|2|||
16892156|NCT02428608|37950047|FG000|Overall Study|scheduling conflicts|15|||
16892157|NCT02428608|37950047|FG000|Overall Study|moved away|10|||
16892158|NCT02428608|37950047|FG000|Overall Study|Death|1|||
16892159|NCT02428608|37950047|FG000|Overall Study|various|16|||
16892160|NCT02428296|37950067|FG000|Overall Study|Adverse Event|7|||
16892161|NCT02428296|37950067|FG000|Overall Study|Withdrawal by Subject|2|||
16892162|NCT02427984|37950081|FG000|Overall Study|Lost to Follow-up|13|||
16892163|NCT02427984|37950082|FG001|Overall Study|Lost to Follow-up|5|||
16892164|NCT02427984|37950083|FG002|Overall Study|Lost to Follow-up|18|||
16892165|NCT00556673|37950322|FG000|Overall Study|Protocol deviation|3|||
16892166|NCT00556673|37950323|FG001|Overall Study|Protocol deviation|2|||
16892167|NCT00555425|37950452|FG000|Overall Study|Missed Medication > 1 wk|34|||
16892168|NCT00555425|37950453|FG001|Overall Study|Missed Medication > 1 wk|15|||
16892169|NCT00555425|37950452|FG000|Overall Study|Missed 3 physician management visits|1|||
16892170|NCT00555425|37950453|FG001|Overall Study|Missed 3 physician management visits|0|||
16892171|NCT00555425|37950452|FG000|Overall Study|Met criteria for protective transfer|16|||
16892172|NCT00555425|37950453|FG001|Overall Study|Met criteria for protective transfer|3|||
16892173|NCT00555425|37950452|FG000|Overall Study|Became pregnant and transferred care|0|||
16892174|NCT00555425|37950453|FG001|Overall Study|Became pregnant and transferred care|1|||
16892175|NCT00554099|37950634|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
16892176|NCT00554099|37950635|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
16892177|NCT00554099|37950636|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
16892178|NCT00554099|37950634|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
16892179|NCT00554099|37950635|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
16892180|NCT00554099|37950636|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
16892181|NCT00554099|37950634|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
16892182|NCT00554099|37950635|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
16892183|NCT00554099|37950636|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
16892184|NCT00554099|37950634|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
16892185|NCT00554099|37950635|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
16892186|NCT00554099|37950636|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
16892187|NCT00554099|37950634|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
16892188|NCT00554099|37950635|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
16892189|NCT00554099|37950636|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
16892190|NCT00554099|37950634|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
16892191|NCT00554099|37950635|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
16892192|NCT00554099|37950636|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
16892193|NCT00554099|37950634|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
16892194|NCT00554099|37950635|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
16892195|NCT00554099|37950636|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
16892196|NCT00554099|37950634|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
17003435|NCT00903968|38147476|FG000|Overall Study|Adverse Event|0|||
17003436|NCT00903968|38147477|FG001|Overall Study|Adverse Event|0|||
17003437|NCT00903968|38147478|FG002|Overall Study|Adverse Event|0|||
17003438|NCT00903968|38147479|FG003|Overall Study|Adverse Event|0|||
17003439|NCT00903968|38147480|FG004|Overall Study|Adverse Event|0|||
17003440|NCT00903968|38147481|FG005|Overall Study|Adverse Event|0|||
17003441|NCT00903968|38147482|FG006|Overall Study|Adverse Event|1|||
17003442|NCT00903968|38147483|FG007|Overall Study|Adverse Event|8|||
17003443|NCT00903968|38147476|FG000|Overall Study|DLT|0|||
17003444|NCT00903968|38147477|FG001|Overall Study|DLT|0|||
17003445|NCT00903968|38147478|FG002|Overall Study|DLT|0|||
17003446|NCT00903968|38147479|FG003|Overall Study|DLT|0|||
17003447|NCT00903968|38147480|FG004|Overall Study|DLT|0|||
17003448|NCT00903968|38147481|FG005|Overall Study|DLT|0|||
17003449|NCT00903968|38147482|FG006|Overall Study|DLT|2|||
17003450|NCT00903968|38147483|FG007|Overall Study|DLT|0|||
17003451|NCT00903968|38147476|FG000|Overall Study|Withdrawal by Subject|1|||
17003452|NCT00903968|38147477|FG001|Overall Study|Withdrawal by Subject|0|||
17003453|NCT00903968|38147478|FG002|Overall Study|Withdrawal by Subject|1|||
17003454|NCT00903968|38147479|FG003|Overall Study|Withdrawal by Subject|0|||
17003455|NCT00903968|38147480|FG004|Overall Study|Withdrawal by Subject|1|||
17003456|NCT00903968|38147481|FG005|Overall Study|Withdrawal by Subject|1|||
17003457|NCT00903968|38147482|FG006|Overall Study|Withdrawal by Subject|0|||
17003458|NCT00903968|38147483|FG007|Overall Study|Withdrawal by Subject|4|||
16892197|NCT00554099|37950635|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
16892198|NCT00554099|37950636|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
16892199|NCT00554099|37950634|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
16892200|NCT00554099|37950635|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
16892201|NCT00554099|37950636|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
16892202|NCT02377362|37950670|FG000|Part A Second Treatment|Protocol Violation|0|||
16892203|NCT02377362|37950671|FG001|Part A Second Treatment|Protocol Violation|0|||
16892204|NCT02377362|37950672|FG002|Part A Second Treatment|Protocol Violation|0|||
16892205|NCT02377362|37950673|FG003|Part A Second Treatment|Protocol Violation|0|||
16892206|NCT02377362|37950674|FG004|Part A Second Treatment|Protocol Violation|1|||
16892207|NCT02377362|37950675|FG005|Part A Second Treatment|Protocol Violation|0|||
16892208|NCT02377362|37950676|FG006|Part A Second Treatment|Protocol Violation|0|||
16892209|NCT02377362|37950677|FG007|Part A Second Treatment|Protocol Violation|0|||
16892210|NCT02377362|37950678|FG008|Part A Second Treatment|Protocol Violation|0|||
16892211|NCT02377362|37950679|FG009|Part A Second Treatment|Protocol Violation|0|||
16892212|NCT02377362|37950680|FG010|Part A Second Treatment|Protocol Violation|0|||
16892213|NCT02377362|37950681|FG011|Part A Second Treatment|Protocol Violation|0|||
17003459|NCT00903968|38147476|FG000|Overall Study|Non-Compliance|0|||
17003460|NCT00903968|38147477|FG001|Overall Study|Non-Compliance|0|||
17003461|NCT00903968|38147478|FG002|Overall Study|Non-Compliance|0|||
17003462|NCT00903968|38147479|FG003|Overall Study|Non-Compliance|0|||
17003463|NCT00903968|38147480|FG004|Overall Study|Non-Compliance|0|||
17003464|NCT00903968|38147481|FG005|Overall Study|Non-Compliance|1|||
17003465|NCT00903968|38147482|FG006|Overall Study|Non-Compliance|0|||
17003466|NCT00903968|38147483|FG007|Overall Study|Non-Compliance|0|||
17003467|NCT00903968|38147476|FG000|Overall Study|Physician Decision|0|||
16785839|NCT01962298|37725937|FG004|Overall Study|Incorrect data recorded|0|||
16785840|NCT01962298|37725933|FG000|Overall Study|Physician Decision|0|||
16785841|NCT01962298|37725934|FG001|Overall Study|Physician Decision|1|||
16785842|NCT01962298|37725935|FG002|Overall Study|Physician Decision|0|||
16785843|NCT01962298|37725936|FG003|Overall Study|Physician Decision|0|||
16785844|NCT01962298|37725937|FG004|Overall Study|Physician Decision|1|||
16785845|NCT02693743|37725951|FG000|Overall Study|Physician Decision|1|||
16785846|NCT02693743|37725952|FG001|Overall Study|Physician Decision|0|||
16785847|NCT02008396|37725960|FG000|Overall Study|Protocol Violation|0|||
16785848|NCT02008396|37725961|FG001|Overall Study|Protocol Violation|1|||
17003468|NCT00903968|38147477|FG001|Overall Study|Physician Decision|0|||
17003469|NCT00903968|38147478|FG002|Overall Study|Physician Decision|0|||
17003470|NCT00903968|38147479|FG003|Overall Study|Physician Decision|0|||
17003471|NCT00903968|38147480|FG004|Overall Study|Physician Decision|0|||
17003472|NCT00903968|38147481|FG005|Overall Study|Physician Decision|1|||
16785849|NCT02655887|37725968|FG000|Overall Study|Lost to Follow-up|3|||
16785850|NCT02655887|37725968|FG000|Overall Study|Death|4|||
17003473|NCT00903968|38147482|FG006|Overall Study|Physician Decision|0|||
17003474|NCT00903968|38147483|FG007|Overall Study|Physician Decision|0|||
17003475|NCT00903968|38147476|FG000|Overall Study|Progressive Disease|2|||
17003476|NCT00903968|38147477|FG001|Overall Study|Progressive Disease|3|||
17003477|NCT00903968|38147478|FG002|Overall Study|Progressive Disease|2|||
17003478|NCT00903968|38147479|FG003|Overall Study|Progressive Disease|3|||
17003479|NCT00903968|38147480|FG004|Overall Study|Progressive Disease|3|||
16892214|NCT02377362|37950682|FG012|Part A Second Treatment|Protocol Violation|0|||
16892215|NCT02377362|37950670|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892216|NCT02377362|37950671|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892217|NCT02377362|37950672|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892218|NCT02377362|37950673|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
16892219|NCT02377362|37950674|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
16892220|NCT02377362|37950675|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
16892221|NCT02377362|37950676|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892222|NCT02377362|37950677|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892223|NCT02377362|37950678|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892224|NCT02377362|37950679|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892225|NCT02377362|37950680|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892226|NCT02377362|37950681|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892227|NCT02377362|37950682|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
16892228|NCT02377362|37950670|FG000|Part B Overall|Protocol Violation|0|||
16892229|NCT02377362|37950671|FG001|Part B Overall|Protocol Violation|0|||
16892230|NCT02377362|37950672|FG002|Part B Overall|Protocol Violation|0|||
16892231|NCT02377362|37950673|FG003|Part B Overall|Protocol Violation|0|||
16892232|NCT02377362|37950674|FG004|Part B Overall|Protocol Violation|0|||
16892233|NCT02377362|37950675|FG005|Part B Overall|Protocol Violation|0|||
16892234|NCT02377362|37950676|FG006|Part B Overall|Protocol Violation|0|||
16892235|NCT02377362|37950677|FG007|Part B Overall|Protocol Violation|0|||
16892236|NCT02377362|37950678|FG008|Part B Overall|Protocol Violation|0|||
16892237|NCT02377362|37950679|FG009|Part B Overall|Protocol Violation|1|||
16892238|NCT02377362|37950680|FG010|Part B Overall|Protocol Violation|0|||
16892239|NCT02377362|37950681|FG011|Part B Overall|Protocol Violation|0|||
16892240|NCT02377362|37950682|FG012|Part B Overall|Protocol Violation|0|||
16892241|NCT02377362|37950670|FG000|Part B Overall|Adverse Event|0|||
16892242|NCT02377362|37950671|FG001|Part B Overall|Adverse Event|0|||
16892243|NCT02377362|37950672|FG002|Part B Overall|Adverse Event|0|||
16892244|NCT02377362|37950673|FG003|Part B Overall|Adverse Event|0|||
16892245|NCT02377362|37950674|FG004|Part B Overall|Adverse Event|0|||
16892246|NCT02377362|37950675|FG005|Part B Overall|Adverse Event|0|||
16892247|NCT02377362|37950676|FG006|Part B Overall|Adverse Event|1|||
16892248|NCT02377362|37950677|FG007|Part B Overall|Adverse Event|1|||
16892249|NCT02377362|37950678|FG008|Part B Overall|Adverse Event|0|||
16892250|NCT02377362|37950679|FG009|Part B Overall|Adverse Event|0|||
16892251|NCT02377362|37950680|FG010|Part B Overall|Adverse Event|0|||
16892252|NCT02377362|37950681|FG011|Part B Overall|Adverse Event|0|||
16892253|NCT02377362|37950682|FG012|Part B Overall|Adverse Event|0|||
16892254|NCT02377362|37950670|FG000|Part B Overall|Withdrawal by Subject|0|||
16892255|NCT02377362|37950671|FG001|Part B Overall|Withdrawal by Subject|0|||
16892256|NCT02377362|37950672|FG002|Part B Overall|Withdrawal by Subject|0|||
16892257|NCT02377362|37950673|FG003|Part B Overall|Withdrawal by Subject|0|||
16892258|NCT02377362|37950674|FG004|Part B Overall|Withdrawal by Subject|0|||
16892259|NCT02377362|37950675|FG005|Part B Overall|Withdrawal by Subject|0|||
16892260|NCT02377362|37950676|FG006|Part B Overall|Withdrawal by Subject|1|||
16892261|NCT02377362|37950677|FG007|Part B Overall|Withdrawal by Subject|0|||
16892262|NCT02377362|37950678|FG008|Part B Overall|Withdrawal by Subject|0|||
16892263|NCT02377362|37950679|FG009|Part B Overall|Withdrawal by Subject|0|||
16892264|NCT02377362|37950680|FG010|Part B Overall|Withdrawal by Subject|0|||
16892265|NCT02377362|37950681|FG011|Part B Overall|Withdrawal by Subject|1|||
16892266|NCT02377362|37950682|FG012|Part B Overall|Withdrawal by Subject|0|||
16892267|NCT00553631|37950722|FG000|Overall Study|Withdrawal by Subject|0|||
16892268|NCT00553631|37950723|FG001|Overall Study|Withdrawal by Subject|1|||
16892269|NCT00553631|37950722|FG000|Overall Study|Lost to Follow-up|1|||
16892270|NCT00553631|37950723|FG001|Overall Study|Lost to Follow-up|0|||
16892271|NCT00553319|37950741|FG000|Overall Study|Lost to Follow-up|10|||
16892272|NCT00553319|37950742|FG001|Overall Study|Lost to Follow-up|9|||
16892273|NCT00553319|37950743|FG002|Overall Study|Lost to Follow-up|5|||
16892274|NCT00553319|37950741|FG000|Overall Study|wanted treatment elsewhere|2|||
16892275|NCT00553319|37950742|FG001|Overall Study|wanted treatment elsewhere|1|||
16892276|NCT00553319|37950743|FG002|Overall Study|wanted treatment elsewhere|1|||
16892277|NCT00553319|37950741|FG000|Overall Study|non-compliance|0|||
16892278|NCT00553319|37950742|FG001|Overall Study|non-compliance|0|||
16892279|NCT00553319|37950743|FG002|Overall Study|non-compliance|2|||
17003480|NCT00903968|38147481|FG005|Overall Study|Progressive Disease|3|||
17003481|NCT00903968|38147482|FG006|Overall Study|Progressive Disease|0|||
17003482|NCT00903968|38147483|FG007|Overall Study|Progressive Disease|18|||
16892280|NCT00553319|37950741|FG000|Overall Study|incarceration|1|||
16892281|NCT00553319|37950742|FG001|Overall Study|incarceration|0|||
16892282|NCT00553319|37950743|FG002|Overall Study|incarceration|0|||
16892283|NCT00553319|37950741|FG000|Overall Study|moved|1|||
16892284|NCT00553319|37950742|FG001|Overall Study|moved|0|||
16892285|NCT00553319|37950743|FG002|Overall Study|moved|1|||
16892286|NCT01649856|37950929|FG000|Overall Study|Withdrawal by Subject|14|||
16892287|NCT01649856|37950930|FG001|Overall Study|Withdrawal by Subject|14|||
16892288|NCT01649856|37950929|FG000|Overall Study|Protocol Violation|4|||
16892289|NCT01649856|37950930|FG001|Overall Study|Protocol Violation|4|||
16892290|NCT01649856|37950929|FG000|Overall Study|Treatment Failure|1|||
16892291|NCT01649856|37950930|FG001|Overall Study|Treatment Failure|1|||
16892292|NCT01649856|37950929|FG000|Overall Study|Death|69|||
16892293|NCT01649856|37950930|FG001|Overall Study|Death|34|||
16892294|NCT01649856|37950929|FG000|Overall Study|Stable or Progressed Disease|5|||
16892295|NCT01649856|37950930|FG001|Overall Study|Stable or Progressed Disease|3|||
16892296|NCT01649856|37950929|FG000|Overall Study|Lost to Follow-up|20|||
16892297|NCT01649856|37950930|FG001|Overall Study|Lost to Follow-up|16|||
16892298|NCT01649856|37950929|FG000|Overall Study|Lack of Compliance|6|||
16892299|NCT01649856|37950930|FG001|Overall Study|Lack of Compliance|1|||
16892300|NCT01649856|37950929|FG000|Overall Study|Other|20|||
16892301|NCT01649856|37950930|FG001|Overall Study|Other|5|||
16892302|NCT02375724|37950951|FG000|Overall Study|Lack of Efficacy|1|||
16892303|NCT02375724|37950952|FG001|Overall Study|Lack of Efficacy|1|||
16892304|NCT02375724|37950951|FG000|Overall Study|Withdrawal by Subject|1|||
16892305|NCT02375724|37950952|FG001|Overall Study|Withdrawal by Subject|1|||
16892306|NCT02375724|37950951|FG000|Overall Study|Lost to Follow-up|1|||
16892307|NCT02375724|37950952|FG001|Overall Study|Lost to Follow-up|0|||
16892308|NCT02375724|37950951|FG000|Overall Study|Protocol Violation|1|||
16892309|NCT02375724|37950952|FG001|Overall Study|Protocol Violation|0|||
16892310|NCT02375724|37950951|FG000|Overall Study|Adverse Event|2|||
16892311|NCT02375724|37950952|FG001|Overall Study|Adverse Event|4|||
16892312|NCT02398188|37950960|FG000|Overall Study|Adverse Event|2|||
16892313|NCT02398188|37950961|FG001|Overall Study|Adverse Event|3|||
16892314|NCT02398188|37950960|FG000|Overall Study|Lost to Follow-up|5|||
16892315|NCT02398188|37950961|FG001|Overall Study|Lost to Follow-up|0|||
16892316|NCT02398188|37950960|FG000|Overall Study|Non-compliance|4|||
16892317|NCT02398188|37950961|FG001|Overall Study|Non-compliance|4|||
16892318|NCT02398188|37950960|FG000|Overall Study|Protocol Violation|6|||
16892319|NCT02398188|37950961|FG001|Overall Study|Protocol Violation|10|||
16892320|NCT02398188|37950960|FG000|Overall Study|Sponsor Decision|2|||
16892321|NCT02398188|37950961|FG001|Overall Study|Sponsor Decision|1|||
16892322|NCT02398188|37950960|FG000|Overall Study|Pregnancy|1|||
16892323|NCT02398188|37950961|FG001|Overall Study|Pregnancy|0|||
16892324|NCT02398188|37950960|FG000|Overall Study|Withdrawal by Subject|7|||
16892325|NCT02398188|37950961|FG001|Overall Study|Withdrawal by Subject|16|||
16892326|NCT02426580|37950969|FG000|Overall Study|Death|2|||
16892327|NCT02426580|37950970|FG001|Overall Study|Death|2|||
16892328|NCT02426580|37950969|FG000|Overall Study|Lost to Follow-up|0|||
16892329|NCT02426580|37950970|FG001|Overall Study|Lost to Follow-up|9|||
16892330|NCT02426580|37950969|FG000|Overall Study|transfer to hemodialysis|5|||
16892331|NCT02426580|37950970|FG001|Overall Study|transfer to hemodialysis|5|||
16892332|NCT02426580|37950969|FG000|Overall Study|Kidney transplant|3|||
16892333|NCT02426580|37950970|FG001|Overall Study|Kidney transplant|0|||
16892334|NCT02426580|37950969|FG000|Overall Study|Allergic to egg white|1|||
16892335|NCT02426580|37950970|FG001|Overall Study|Allergic to egg white|0|||
16892336|NCT01651260|37950976|FG000|Overall Study|unable to apply product|3|||
16892337|NCT02425098|37950996|FG000|Overall Study|Lost to Follow-up|7|||
16892338|NCT02425098|37950997|FG001|Overall Study|Lost to Follow-up|7|||
16892339|NCT02425098|37950996|FG000|Overall Study|Withdrawal by Subject|4|||
16892340|NCT02425098|37950997|FG001|Overall Study|Withdrawal by Subject|8|||
16892341|NCT02425098|37950996|FG000|Overall Study|Pregnancy|2|||
16892342|NCT02425098|37950997|FG001|Overall Study|Pregnancy|0|||
16892343|NCT02425098|37950996|FG000|Overall Study|Reason not Specified|0|||
16892344|NCT02425098|37950997|FG001|Overall Study|Reason not Specified|1|||
16892345|NCT02424630|37951005|FG000|Overall Study|No rotator cuff tear|1|||
16892346|NCT02424630|37951006|FG001|Overall Study|No rotator cuff tear|2|||
17003483|NCT00903968|38147476|FG000|Overall Study|Lack of Efficacy|0|||
16892347|NCT02424630|37951005|FG000|Overall Study|Open procedure|0|||
16892348|NCT02424630|37951006|FG001|Overall Study|Open procedure|1|||
16892349|NCT02397408|37951012|FG000|Overall Study|Physician Decision|4|||
16892350|NCT02397408|37951012|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
16892351|NCT02397096|37951018|FG000|Day 1 to Week 24|Adverse Event|7|||
16892352|NCT02397096|37951019|FG001|Day 1 to Week 24|Adverse Event|1|||
16892353|NCT02397096|37951018|FG000|Day 1 to Week 24|Death|1|||
16892354|NCT02397096|37951019|FG001|Day 1 to Week 24|Death|0|||
16892355|NCT02397096|37951018|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
16892356|NCT02397096|37951019|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
16892357|NCT02397096|37951018|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
16892358|NCT02397096|37951019|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
16892359|NCT02397096|37951018|FG000|Day 1 to Week 24|Physician Decision|2|||
16892360|NCT02397096|37951019|FG001|Day 1 to Week 24|Physician Decision|3|||
16892361|NCT02397096|37951018|FG000|Day 1 to Week 24|Protocol Violation|1|||
16892362|NCT02397096|37951019|FG001|Day 1 to Week 24|Protocol Violation|4|||
16892363|NCT02397096|37951018|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
16892364|NCT02397096|37951019|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
16892365|NCT02397096|37951018|FG000|Week 24 to Week 48|Adverse Event|6|||
16892366|NCT02397096|37951019|FG001|Week 24 to Week 48|Adverse Event|2|||
16892367|NCT02397096|37951018|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
16892368|NCT02397096|37951019|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
16892369|NCT02397096|37951018|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
16892370|NCT02397096|37951019|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
16892371|NCT02397096|37951018|FG000|Week 24 to Week 48|Physician Decision|2|||
16892372|NCT02397096|37951019|FG001|Week 24 to Week 48|Physician Decision|1|||
16892373|NCT02397096|37951018|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
16892374|NCT02397096|37951019|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
16892375|NCT02397096|37951018|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
16892376|NCT02397096|37951019|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
16892377|NCT02397096|37951018|FG000|Study Extensions|Ongoing|399|||
16892378|NCT02397096|37951019|FG001|Study Extensions|Ongoing|202|||
16892379|NCT02372058|37951029|FG000|Overall Study|Withdrawal by Subject|3|||
16892380|NCT02396316|37951037|FG000|Overall Study|Physician Decision|1|||
16892381|NCT02396316|37951038|FG001|Overall Study|Physician Decision|0|||
16892382|NCT02396316|37951037|FG000|Overall Study|Progressive disease|6|||
16892383|NCT02396316|37951038|FG001|Overall Study|Progressive disease|3|||
16892384|NCT02396316|37951037|FG000|Overall Study|Protocol Violation|0|||
16892385|NCT02396316|37951038|FG001|Overall Study|Protocol Violation|1|||
16892386|NCT02396316|37951037|FG000|Overall Study|Treatment unblinded|0|||
16892387|NCT02396316|37951038|FG001|Overall Study|Treatment unblinded|1|||
16892388|NCT02395536|37951048|FG000|Overall Study|Lost to Follow-up|4|||
16892389|NCT02395536|37951049|FG001|Overall Study|Lost to Follow-up|4|||
16892390|NCT02395536|37951048|FG000|Overall Study|Death|2|||
16892391|NCT02395536|37951049|FG001|Overall Study|Death|0|||
16892392|NCT02395536|37951048|FG000|Overall Study|Physician Decision|4|||
16892393|NCT02395536|37951049|FG001|Overall Study|Physician Decision|6|||
16892394|NCT02395536|37951048|FG000|Overall Study|Withdrawal by Subject|9|||
16892395|NCT02395536|37951049|FG001|Overall Study|Withdrawal by Subject|17|||
16892396|NCT02395536|37951048|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
16892397|NCT02395536|37951049|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
16892398|NCT02395536|37951048|FG000|Overall Study|Insurance issue|0|||
16892399|NCT02395536|37951049|FG001|Overall Study|Insurance issue|1|||
16892400|NCT00552929|37951065|FG000|Overall Study|Lost to Follow-up|0|||
16892401|NCT00552929|37951066|FG001|Overall Study|Lost to Follow-up|0|||
16892402|NCT00552929|37951067|FG002|Overall Study|Lost to Follow-up|0|||
16892403|NCT00552929|37951068|FG003|Overall Study|Lost to Follow-up|0|||
16892404|NCT00552929|37951069|FG004|Overall Study|Lost to Follow-up|0|||
16892405|NCT00552929|37951070|FG005|Overall Study|Lost to Follow-up|0|||
16892406|NCT00552929|37951071|FG006|Overall Study|Lost to Follow-up|0|||
16892407|NCT00552929|37951072|FG007|Overall Study|Lost to Follow-up|0|||
16892408|NCT00552929|37951073|FG008|Overall Study|Lost to Follow-up|1|||
16892409|NCT00552929|37951074|FG009|Overall Study|Lost to Follow-up|0|||
16892410|NCT00552929|37951065|FG000|Overall Study|Not Eligible|0|||
16892411|NCT00552929|37951066|FG001|Overall Study|Not Eligible|0|||
16892412|NCT00552929|37951067|FG002|Overall Study|Not Eligible|0|||
16892413|NCT00552929|37951068|FG003|Overall Study|Not Eligible|0|||
16892414|NCT00552929|37951069|FG004|Overall Study|Not Eligible|0|||
16892415|NCT00552929|37951070|FG005|Overall Study|Not Eligible|1|||
16892416|NCT00552929|37951071|FG006|Overall Study|Not Eligible|0|||
16892417|NCT00552929|37951072|FG007|Overall Study|Not Eligible|0|||
16892418|NCT00552929|37951073|FG008|Overall Study|Not Eligible|0|||
16892419|NCT00552929|37951074|FG009|Overall Study|Not Eligible|0|||
16892420|NCT02395302|37951096|FG000|Overall Study|Screen Failure|3|||
16892421|NCT02395302|37951096|FG000|Overall Study|Run In Failure|7|||
16892422|NCT02395302|37951096|FG000|Overall Study|Withdrawal by Subject|2|||
17095380|NCT00232596|38234650|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
17095381|NCT00232596|38234649|FG000|6-Week Titration Phase|Other|3|||
16892423|NCT02395302|37951096|FG000|Overall Study|Physician Decision|2|||
16892424|NCT02371980|37951130|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
16892425|NCT02371980|37951131|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
16892426|NCT02371980|37951132|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
16892427|NCT02371980|37951133|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
16892428|NCT02371980|37951134|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
16892429|NCT02371980|37951130|FG000|Open-label Period|Significant Protocol Deviation|19|||
16892430|NCT02371980|37951131|FG001|Open-label Period|Significant Protocol Deviation|0|||
16892431|NCT02371980|37951132|FG002|Open-label Period|Significant Protocol Deviation|0|||
16892432|NCT02371980|37951133|FG003|Open-label Period|Significant Protocol Deviation|0|||
16892433|NCT02371980|37951134|FG004|Open-label Period|Significant Protocol Deviation|0|||
16892434|NCT02371980|37951130|FG000|Open-label Period|Noncompliance with Study Drug|10|||
16892435|NCT02371980|37951131|FG001|Open-label Period|Noncompliance with Study Drug|0|||
16892436|NCT02371980|37951132|FG002|Open-label Period|Noncompliance with Study Drug|0|||
16892437|NCT02371980|37951133|FG003|Open-label Period|Noncompliance with Study Drug|0|||
16892438|NCT02371980|37951134|FG004|Open-label Period|Noncompliance with Study Drug|0|||
16892439|NCT02371980|37951130|FG000|Open-label Period|Lost to Follow-up|55|||
16892440|NCT02371980|37951131|FG001|Open-label Period|Lost to Follow-up|0|||
16892441|NCT02371980|37951132|FG002|Open-label Period|Lost to Follow-up|0|||
16892442|NCT02371980|37951133|FG003|Open-label Period|Lost to Follow-up|0|||
16892443|NCT02371980|37951134|FG004|Open-label Period|Lost to Follow-up|0|||
16892444|NCT02371980|37951130|FG000|Open-label Period|Voluntary Withdrawal|91|||
16892445|NCT02371980|37951131|FG001|Open-label Period|Voluntary Withdrawal|0|||
16892446|NCT02371980|37951132|FG002|Open-label Period|Voluntary Withdrawal|0|||
16892447|NCT02371980|37951133|FG003|Open-label Period|Voluntary Withdrawal|0|||
16892448|NCT02371980|37951134|FG004|Open-label Period|Voluntary Withdrawal|0|||
16892449|NCT02371980|37951130|FG000|Open-label Period|Pregnancy|1|||
16892450|NCT02371980|37951131|FG001|Open-label Period|Pregnancy|0|||
16892451|NCT02371980|37951132|FG002|Open-label Period|Pregnancy|0|||
16892452|NCT02371980|37951133|FG003|Open-label Period|Pregnancy|0|||
16892453|NCT02371980|37951134|FG004|Open-label Period|Pregnancy|0|||
16892454|NCT02371980|37951130|FG000|Open-label Period|Lack of Efficacy|116|||
16892455|NCT02371980|37951131|FG001|Open-label Period|Lack of Efficacy|0|||
16892456|NCT02371980|37951132|FG002|Open-label Period|Lack of Efficacy|0|||
16892457|NCT02371980|37951133|FG003|Open-label Period|Lack of Efficacy|0|||
16892458|NCT02371980|37951134|FG004|Open-label Period|Lack of Efficacy|0|||
16892459|NCT02371980|37951130|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
16892460|NCT02371980|37951131|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
16892461|NCT02371980|37951132|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
16892462|NCT02371980|37951133|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
16892463|NCT02371980|37951134|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
16892464|NCT02371980|37951130|FG000|Open-label Period|Reason not Specified|9|||
16892465|NCT02371980|37951131|FG001|Open-label Period|Reason not Specified|0|||
16892466|NCT02371980|37951132|FG002|Open-label Period|Reason not Specified|0|||
16892467|NCT02371980|37951133|FG003|Open-label Period|Reason not Specified|0|||
16892468|NCT02371980|37951134|FG004|Open-label Period|Reason not Specified|0|||
16892469|NCT02371980|37951130|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
16892470|NCT02371980|37951131|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
16892471|NCT02371980|37951132|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
16892472|NCT02371980|37951133|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
16892473|NCT02371980|37951134|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
16892474|NCT02371980|37951130|FG000|Double-blind Period|Significant Protocol Deviation|0|||
16892475|NCT02371980|37951131|FG001|Double-blind Period|Significant Protocol Deviation|2|||
16892476|NCT02371980|37951132|FG002|Double-blind Period|Significant Protocol Deviation|7|||
16892477|NCT02371980|37951133|FG003|Double-blind Period|Significant Protocol Deviation|3|||
16892478|NCT02371980|37951134|FG004|Double-blind Period|Significant Protocol Deviation|3|||
16892479|NCT02371980|37951130|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
16892480|NCT02371980|37951131|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
16892481|NCT02371980|37951132|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
16892482|NCT02371980|37951133|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
16892483|NCT02371980|37951134|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
16892484|NCT02371980|37951130|FG000|Double-blind Period|Lost to Follow-up|0|||
16892485|NCT02371980|37951131|FG001|Double-blind Period|Lost to Follow-up|8|||
16892486|NCT02371980|37951132|FG002|Double-blind Period|Lost to Follow-up|8|||
16892487|NCT02371980|37951133|FG003|Double-blind Period|Lost to Follow-up|6|||
16892488|NCT02371980|37951134|FG004|Double-blind Period|Lost to Follow-up|5|||
16892489|NCT02371980|37951130|FG000|Double-blind Period|Voluntary Withdrawal|0|||
16892490|NCT02371980|37951131|FG001|Double-blind Period|Voluntary Withdrawal|12|||
16892491|NCT02371980|37951132|FG002|Double-blind Period|Voluntary Withdrawal|8|||
16892492|NCT02371980|37951133|FG003|Double-blind Period|Voluntary Withdrawal|9|||
16892493|NCT02371980|37951134|FG004|Double-blind Period|Voluntary Withdrawal|11|||
16892494|NCT02371980|37951130|FG000|Double-blind Period|Relapse|0|||
16892495|NCT02371980|37951131|FG001|Double-blind Period|Relapse|50|||
16892496|NCT02371980|37951132|FG002|Double-blind Period|Relapse|25|||
16892497|NCT02371980|37951133|FG003|Double-blind Period|Relapse|25|||
16892498|NCT02371980|37951134|FG004|Double-blind Period|Relapse|26|||
17003484|NCT00903968|38147477|FG001|Overall Study|Lack of Efficacy|0|||
17003485|NCT00903968|38147478|FG002|Overall Study|Lack of Efficacy|0|||
17003486|NCT00903968|38147479|FG003|Overall Study|Lack of Efficacy|0|||
17003487|NCT00903968|38147480|FG004|Overall Study|Lack of Efficacy|0|||
17003488|NCT00903968|38147481|FG005|Overall Study|Lack of Efficacy|0|||
17003489|NCT00903968|38147482|FG006|Overall Study|Lack of Efficacy|0|||
17095382|NCT00232596|38234650|FG001|6-Week Titration Phase|Other|3|||
17003490|NCT00903968|38147483|FG007|Overall Study|Lack of Efficacy|3|||
17003491|NCT00903344|38147506|FG000|Overall Study|Pregnancy|2|||
17003492|NCT00903344|38147507|FG001|Overall Study|Pregnancy|3|||
17003493|NCT00903344|38147506|FG000|Overall Study|Lost to Follow-up|3|||
16892499|NCT02371980|37951130|FG000|Double-blind Period|Reason not Specified|0|||
16892500|NCT02371980|37951131|FG001|Double-blind Period|Reason not Specified|3|||
16892501|NCT02371980|37951132|FG002|Double-blind Period|Reason not Specified|3|||
16892502|NCT02371980|37951133|FG003|Double-blind Period|Reason not Specified|2|||
16892503|NCT02371980|37951134|FG004|Double-blind Period|Reason not Specified|1|||
16892504|NCT02371980|37951130|FG000|Double-blind Period|Missing|0|||
16892505|NCT02371980|37951131|FG001|Double-blind Period|Missing|1|||
16892506|NCT02371980|37951132|FG002|Double-blind Period|Missing|0|||
16892507|NCT02371980|37951133|FG003|Double-blind Period|Missing|0|||
16892508|NCT02371980|37951134|FG004|Double-blind Period|Missing|0|||
16892509|NCT02371746|37951274|FG000|Overall Study|Consent withdrawn|0|||
16892510|NCT02371746|37951275|FG001|Overall Study|Consent withdrawn|0|||
16892511|NCT02371746|37951276|FG002|Overall Study|Consent withdrawn|0|||
16892512|NCT02371746|37951277|FG003|Overall Study|Consent withdrawn|0|||
16892513|NCT02371746|37951278|FG004|Overall Study|Consent withdrawn|0|||
16892514|NCT02371746|37951279|FG005|Overall Study|Consent withdrawn|0|||
16892515|NCT02371746|37951280|FG006|Overall Study|Consent withdrawn|1|||
16892516|NCT02421666|37951328|FG000|6-month Follow-up|Lost to Follow-up|8|||
16892517|NCT02421666|37951329|FG001|6-month Follow-up|Lost to Follow-up|7|||
16892518|NCT02421666|37951328|FG000|6-month Follow-up|Withdrawal by Subject|5|||
16892519|NCT02421666|37951329|FG001|6-month Follow-up|Withdrawal by Subject|6|||
16892520|NCT02421666|37951328|FG000|12-month Follow-up|Lost to Follow-up|5|||
16892521|NCT02421666|37951329|FG001|12-month Follow-up|Lost to Follow-up|5|||
16892522|NCT02421666|37951328|FG000|12-month Follow-up|Withdrawal by Subject|6|||
16892523|NCT02421666|37951329|FG001|12-month Follow-up|Withdrawal by Subject|11|||
16892524|NCT02394756|37951339|FG000|Period 1|Lens Discomfort|0|||
16892525|NCT02394756|37951340|FG001|Period 1|Lens Discomfort|0|||
16892526|NCT02394756|37951341|FG002|Period 1|Lens Discomfort|0|||
16892527|NCT02394756|37951342|FG003|Period 1|Lens Discomfort|0|||
16892528|NCT02394756|37951343|FG004|Period 1|Lens Discomfort|0|||
16892529|NCT02394756|37951344|FG005|Period 1|Lens Discomfort|1|||
16892530|NCT02394756|37951339|FG000|Period 1|Withdrawal by Subject|0|||
16892531|NCT02394756|37951340|FG001|Period 1|Withdrawal by Subject|1|||
16892532|NCT02394756|37951341|FG002|Period 1|Withdrawal by Subject|1|||
16892533|NCT02394756|37951342|FG003|Period 1|Withdrawal by Subject|1|||
16892534|NCT02394756|37951343|FG004|Period 1|Withdrawal by Subject|0|||
16892535|NCT02394756|37951344|FG005|Period 1|Withdrawal by Subject|0|||
16892536|NCT02394756|37951339|FG000|Period 2|Unsatisfactory Visual Response|0|||
16892537|NCT02394756|37951340|FG001|Period 2|Unsatisfactory Visual Response|0|||
16892538|NCT02394756|37951341|FG002|Period 2|Unsatisfactory Visual Response|0|||
16892539|NCT02394756|37951342|FG003|Period 2|Unsatisfactory Visual Response|0|||
16892540|NCT02394756|37951343|FG004|Period 2|Unsatisfactory Visual Response|1|||
16892541|NCT02394756|37951344|FG005|Period 2|Unsatisfactory Visual Response|0|||
16892542|NCT02370888|37951365|FG000|Overall Study|disease progression|2|||
16892543|NCT02370888|37951365|FG000|Overall Study|did not meet chimerism criteria|6|||
16892544|NCT02394600|37951389|FG000|Overall Study|Adverse Event|3|||
16892545|NCT02394600|37951390|FG001|Overall Study|Adverse Event|0|||
16892546|NCT02394600|37951389|FG000|Overall Study|Lost to Follow-up|0|||
16892547|NCT02394600|37951390|FG001|Overall Study|Lost to Follow-up|1|||
16892548|NCT02394600|37951389|FG000|Overall Study|Withdrawal by Subject|0|||
16892549|NCT02394600|37951390|FG001|Overall Study|Withdrawal by Subject|1|||
16892550|NCT02394600|37951389|FG000|Overall Study|Protocol Violation|1|||
16892551|NCT02394600|37951390|FG001|Overall Study|Protocol Violation|0|||
16892552|NCT04685499|37951406|FG000|Overall Study|Study Terminated Early|1|||
16892553|NCT02421588|37951482|FG000|Overall Study|Non-treatment-related AE|8|||
16892554|NCT02421588|37951483|FG001|Overall Study|Non-treatment-related AE|8|||
16892555|NCT02421588|37951482|FG000|Overall Study|Progressive disease|152|||
16892556|NCT02421588|37951483|FG001|Overall Study|Progressive disease|135|||
16892557|NCT02421588|37951482|FG000|Overall Study|Death|11|||
16892558|NCT02421588|37951483|FG001|Overall Study|Death|3|||
16892559|NCT02421588|37951482|FG000|Overall Study|Physician Decision|8|||
16892560|NCT02421588|37951483|FG001|Overall Study|Physician Decision|17|||
16892561|NCT02421588|37951482|FG000|Overall Study|Other reason not specified|3|||
16892562|NCT02421588|37951483|FG001|Overall Study|Other reason not specified|1|||
16892563|NCT02421588|37951482|FG000|Overall Study|Symptomatic deterioration|13|||
16892564|NCT02421588|37951483|FG001|Overall Study|Symptomatic deterioration|19|||
16892565|NCT02421588|37951482|FG000|Overall Study|Treatment-related AE|10|||
16892566|NCT02421588|37951483|FG001|Overall Study|Treatment-related AE|14|||
16892567|NCT02421588|37951482|FG000|Overall Study|Withdrawal by Subject|14|||
16892568|NCT02421588|37951483|FG001|Overall Study|Withdrawal by Subject|16|||
16892569|NCT02421588|37951482|FG000|Overall Study|Not treated|2|||
16892570|NCT02421588|37951483|FG001|Overall Study|Not treated|8|||
16892571|NCT02421510|37951492|FG000|Overall Study|Other|4|||
16892572|NCT02421510|37951493|FG001|Overall Study|Other|2|||
16892573|NCT02421510|37951494|FG002|Overall Study|Other|3|||
16892574|NCT02421510|37951492|FG000|Overall Study|Protocol Violation|1|||
16892575|NCT02421510|37951493|FG001|Overall Study|Protocol Violation|2|||
16892576|NCT02421510|37951494|FG002|Overall Study|Protocol Violation|0|||
16892577|NCT02421510|37951492|FG000|Overall Study|Death|1|||
16892578|NCT02421510|37951493|FG001|Overall Study|Death|0|||
16892579|NCT02421510|37951494|FG002|Overall Study|Death|0|||
16892580|NCT02421510|37951492|FG000|Overall Study|Noncompliance with study drug|1|||
16892581|NCT02421510|37951493|FG001|Overall Study|Noncompliance with study drug|0|||
16892582|NCT02421510|37951494|FG002|Overall Study|Noncompliance with study drug|0|||
16892583|NCT02421510|37951492|FG000|Overall Study|Physician Decision|1|||
16892584|NCT02421510|37951493|FG001|Overall Study|Physician Decision|1|||
16892585|NCT02421510|37951494|FG002|Overall Study|Physician Decision|3|||
17003494|NCT00903344|38147507|FG001|Overall Study|Lost to Follow-up|0|||
17003495|NCT00903032|38147515|FG000|Overall Study|Withdrawal by Subject|5|||
17003496|NCT00903032|38147516|FG001|Overall Study|Withdrawal by Subject|3|||
17003497|NCT00903032|38147515|FG000|Overall Study|Lost to Follow-up|2|||
17003498|NCT00903032|38147516|FG001|Overall Study|Lost to Follow-up|2|||
17003499|NCT00902564|38147531|FG000|Overall Study|Withdrawal by Subject|2|||
17003500|NCT00626197|38147538|FG000|Overall Study|Did not cooperate|2|||
17003501|NCT00626197|38147539|FG001|Overall Study|Did not cooperate|6|||
17003502|NCT00626197|38147540|FG002|Overall Study|Did not cooperate|1|||
17003503|NCT00626197|38147538|FG000|Overall Study|Failure to return|6|||
17003504|NCT00626197|38147539|FG001|Overall Study|Failure to return|5|||
17003505|NCT00626197|38147540|FG002|Overall Study|Failure to return|6|||
16892586|NCT02421510|37951492|FG000|Overall Study|Adverse Event|9|||
16892587|NCT02421510|37951493|FG001|Overall Study|Adverse Event|10|||
16892588|NCT02421510|37951494|FG002|Overall Study|Adverse Event|18|||
16892589|NCT02421510|37951492|FG000|Overall Study|Pregnancy|1|||
16892590|NCT02421510|37951493|FG001|Overall Study|Pregnancy|1|||
16892591|NCT02421510|37951494|FG002|Overall Study|Pregnancy|0|||
16892592|NCT02421510|37951492|FG000|Overall Study|Withdrawal by Subject|14|||
16892593|NCT02421510|37951493|FG001|Overall Study|Withdrawal by Subject|18|||
16892594|NCT02421510|37951494|FG002|Overall Study|Withdrawal by Subject|12|||
16892595|NCT02421510|37951492|FG000|Overall Study|Lost to Follow-up|1|||
16892596|NCT02421510|37951493|FG001|Overall Study|Lost to Follow-up|1|||
16892597|NCT02421510|37951494|FG002|Overall Study|Lost to Follow-up|0|||
16892598|NCT00552617|37951512|FG000|Overall Study|Not Treated|0|||
16892599|NCT00552617|37951513|FG001|Overall Study|Not Treated|0|||
16892600|NCT00552617|37951514|FG002|Overall Study|Not Treated|1|||
16892601|NCT00552617|37951515|FG003|Overall Study|Not Treated|0|||
16892602|NCT00552617|37951516|FG004|Overall Study|Not Treated|0|||
16892603|NCT00552617|37951517|FG005|Overall Study|Not Treated|0|||
16892604|NCT00552617|37951518|FG006|Overall Study|Not Treated|0|||
16892605|NCT00552617|37951519|FG007|Overall Study|Not Treated|0|||
16892606|NCT00552617|37951520|FG008|Overall Study|Not Treated|0|||
16892607|NCT00552617|37951521|FG009|Overall Study|Not Treated|1|||
16892608|NCT00552617|37951512|FG000|Overall Study|Lost to Follow-up|0|||
16892609|NCT00552617|37951513|FG001|Overall Study|Lost to Follow-up|0|||
16892610|NCT00552617|37951514|FG002|Overall Study|Lost to Follow-up|0|||
16892611|NCT00552617|37951515|FG003|Overall Study|Lost to Follow-up|1|||
17003506|NCT00626197|38147538|FG000|Overall Study|Adverse event, serious fatal|3|||
17003507|NCT00626197|38147539|FG001|Overall Study|Adverse event, serious fatal|6|||
17003508|NCT00626197|38147540|FG002|Overall Study|Adverse event, serious fatal|6|||
17003509|NCT00626197|38147538|FG000|Overall Study|Adverse Event|1|||
17003510|NCT00626197|38147539|FG001|Overall Study|Adverse Event|1|||
17003511|NCT00626197|38147540|FG002|Overall Study|Adverse Event|2|||
17003512|NCT00626197|38147538|FG000|Overall Study|Withdrawal by Subject|17|||
17003513|NCT00626197|38147539|FG001|Overall Study|Withdrawal by Subject|17|||
17003514|NCT00626197|38147540|FG002|Overall Study|Withdrawal by Subject|7|||
17003515|NCT00626197|38147538|FG000|Overall Study|Administrative reasons|15|||
17003516|NCT00626197|38147539|FG001|Overall Study|Administrative reasons|19|||
17003517|NCT00626197|38147540|FG002|Overall Study|Administrative reasons|55|||
17003518|NCT00623935|38147554|FG000|Overall Study|Death|1|||
17003519|NCT00623935|38147554|FG000|Overall Study|Patient Declined Transplant|1|||
17003520|NCT00623779|38147561|FG000|Overall Study|Adverse Event|1|||
17003521|NCT00623779|38147562|FG001|Overall Study|Adverse Event|3|||
17003522|NCT00623779|38147563|FG002|Overall Study|Adverse Event|0|||
17003523|NCT00623779|38147561|FG000|Overall Study|Criteria from CSR|2|||
16892612|NCT00552617|37951516|FG004|Overall Study|Lost to Follow-up|0|||
16892613|NCT00552617|37951517|FG005|Overall Study|Lost to Follow-up|2|||
16892614|NCT00552617|37951518|FG006|Overall Study|Lost to Follow-up|0|||
16892615|NCT00552617|37951519|FG007|Overall Study|Lost to Follow-up|0|||
16892616|NCT00552617|37951520|FG008|Overall Study|Lost to Follow-up|2|||
16892617|NCT00552617|37951521|FG009|Overall Study|Lost to Follow-up|0|||
17003524|NCT00623779|38147562|FG001|Overall Study|Criteria from CSR|0|||
17003525|NCT00623779|38147563|FG002|Overall Study|Criteria from CSR|1|||
17003526|NCT00629707|38147594|FG000|Overall Study|Withdrawal by Subject|0|||
17003527|NCT00629707|38147595|FG001|Overall Study|Withdrawal by Subject|1|||
17003528|NCT00629707|38147594|FG000|Overall Study|Physician Decision|0|||
17003529|NCT00629707|38147595|FG001|Overall Study|Physician Decision|1|||
17095383|NCT00232596|38234649|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
16892618|NCT02421120|37951543|FG000|Overall Study|Adverse Event|1|||
16892619|NCT02420262|37951549|FG000|Overall Study|Adverse Event|1|||
16892620|NCT02420262|37951550|FG001|Overall Study|Adverse Event|0|||
16892621|NCT02420262|37951549|FG000|Overall Study|Withdrawal by Subject|1|||
16892622|NCT02420262|37951550|FG001|Overall Study|Withdrawal by Subject|4|||
16892623|NCT02420262|37951549|FG000|Overall Study|Unclassified|0|||
16892624|NCT02420262|37951550|FG001|Overall Study|Unclassified|1|||
16892625|NCT00552305|37951556|FG000|Overall Study|Adverse Event|43|||
16892626|NCT00552305|37951556|FG000|Overall Study|Lack of Efficacy|120|||
16892627|NCT00552305|37951556|FG000|Overall Study|Lost to Follow-up|4|||
16892628|NCT00552305|37951556|FG000|Overall Study|Protocol Violation|3|||
16892629|NCT00552305|37951556|FG000|Overall Study|Withdrawal by Subject|44|||
16892630|NCT00552305|37951556|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
16892631|NCT00552305|37951556|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
16892632|NCT00552305|37951556|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
16892633|NCT00552305|37951556|FG000|Overall Study|Unsatisfactory compliance|11|||
16892634|NCT00552305|37951556|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
16892635|NCT00552305|37951556|FG000|Overall Study|AE/Other: prohibited drug required|1|||
16892636|NCT00552305|37951556|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
16892637|NCT00552305|37951556|FG000|Overall Study|Other: Site closed|4|||
16892638|NCT00552305|37951556|FG000|Overall Study|Other: Personal problems|1|||
16892639|NCT00552305|37951556|FG000|Overall Study|Other: Unable to attend visits|1|||
16892640|NCT00552305|37951556|FG000|Overall Study|Other: Subject underwent surgery|4|||
16892641|NCT00552305|37951556|FG000|Overall Study|Other: Subject became pregnant|1|||
16892642|NCT00552305|37951556|FG000|Overall Study|Other: Health problems, not drug related|1|||
16892643|NCT00552305|37951556|FG000|Overall Study|Other: Subject moved from area|2|||
16892644|NCT00552305|37951556|FG000|Overall Study|Other: Subject incarcerated|1|||
16892645|NCT00552305|37951556|FG000|Overall Study|Other: Subject went to rehab|1|||
16892646|NCT00552071|37951582|FG000|Overall Study|Adverse Event|1|||
16892647|NCT00552071|37951583|FG001|Overall Study|Adverse Event|0|||
16892648|NCT00552071|37951582|FG000|Overall Study|Lack of Efficacy|1|||
16892649|NCT00552071|37951583|FG001|Overall Study|Lack of Efficacy|0|||
16892650|NCT00552071|37951582|FG000|Overall Study|Physician Decision|1|||
16892651|NCT00552071|37951583|FG001|Overall Study|Physician Decision|0|||
17003530|NCT00902330|38147603|FG000|Overall Study|Too overwhelmed by treatment|2|||
17003531|NCT00902330|38147604|FG001|Overall Study|Too overwhelmed by treatment|5|||
17003532|NCT00902330|38147603|FG000|Overall Study|Adverse Event|1|||
17003533|NCT00902330|38147604|FG001|Overall Study|Adverse Event|0|||
17003534|NCT00902330|38147603|FG000|Overall Study|No post baseline data|1|||
17003535|NCT00902330|38147604|FG001|Overall Study|No post baseline data|0|||
17003536|NCT00901394|38147641|FG000|Overall Study|Physician Decision|1|||
17003537|NCT00901394|38147642|FG001|Overall Study|Physician Decision|1|||
17003538|NCT00901394|38147643|FG002|Overall Study|Physician Decision|2|||
17003539|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003540|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003541|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003542|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
17003543|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003544|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
17003545|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003546|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003547|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003548|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003549|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003550|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003551|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003552|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16892652|NCT00552071|37951582|FG000|Overall Study|Pregnancy|1|||
17003553|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003554|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003555|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003556|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003557|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003558|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003559|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003560|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17003561|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
17095384|NCT00232596|38234650|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
17095385|NCT00232596|38234649|FG000|12-Week Maintenance Phase|Adverse Event|7|||
16785851|NCT02655887|37725968|FG000|Overall Study|Withdrawal by Subject|3|||
16892653|NCT00552071|37951583|FG001|Overall Study|Pregnancy|0|||
16892654|NCT00552071|37951582|FG000|Overall Study|Death|0|||
17003562|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
17003563|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
17003564|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
17003565|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
17003566|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
17003567|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
17003568|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
17003569|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003570|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003571|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003572|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003573|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003574|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003575|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003576|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003577|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003578|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003579|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003580|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16892655|NCT00552071|37951583|FG001|Overall Study|Death|1|||
16892656|NCT00552071|37951582|FG000|Overall Study|Withdrawal by Subject|0|||
16892657|NCT00552071|37951583|FG001|Overall Study|Withdrawal by Subject|1|||
16892658|NCT00551759|37951591|FG000|Overall Study|Adverse Event|7|||
16892659|NCT00551759|37951591|FG000|Overall Study|Death|5|||
16892660|NCT00551759|37951591|FG000|Overall Study|Ineligible|1|||
16892661|NCT00551525|37951595|FG000|Overall Study|Protocol Violation|5|||
16892662|NCT02370498|37951622|FG000|Overall Study|Adverse Event|10|||
16892663|NCT02370498|37951623|FG001|Overall Study|Adverse Event|8|||
16892664|NCT02370498|37951622|FG000|Overall Study|Death|263|||
16892665|NCT02370498|37951623|FG001|Overall Study|Death|265|||
16892666|NCT02370498|37951622|FG000|Overall Study|Protocol Violation|1|||
16892667|NCT02370498|37951623|FG001|Overall Study|Protocol Violation|2|||
16892668|NCT02370498|37951622|FG000|Overall Study|Withdrawal by Subject|7|||
16892669|NCT02370498|37951623|FG001|Overall Study|Withdrawal by Subject|12|||
16892670|NCT02370498|37951622|FG000|Overall Study|Sponsor's decision|15|||
16892671|NCT02370498|37951623|FG001|Overall Study|Sponsor's decision|9|||
16892672|NCT02347332|37951648|FG000|Overall Study|Not treated|5|||
16892673|NCT02347332|37951649|FG001|Overall Study|Not treated|2|||
16892674|NCT02347332|37951648|FG000|Overall Study|Progressive disease|141|||
16892675|NCT02347332|37951649|FG001|Overall Study|Progressive disease|159|||
16892676|NCT02347332|37951648|FG000|Overall Study|Adverse Event|50|||
16892677|NCT02347332|37951649|FG001|Overall Study|Adverse Event|41|||
16892678|NCT02347332|37951648|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
16892679|NCT02347332|37951649|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
16892680|NCT02347332|37951648|FG000|Overall Study|Protocol Violation|1|||
16892681|NCT02347332|37951649|FG001|Overall Study|Protocol Violation|1|||
16892682|NCT02347332|37951648|FG000|Overall Study|Lost to Follow-up|2|||
16892683|NCT02347332|37951649|FG001|Overall Study|Lost to Follow-up|1|||
16892684|NCT02347332|37951648|FG000|Overall Study|Physician Decision|4|||
16892685|NCT02347332|37951649|FG001|Overall Study|Physician Decision|3|||
16892686|NCT02347332|37951648|FG000|Overall Study|Withdrawal by Subject|20|||
16892687|NCT02347332|37951649|FG001|Overall Study|Withdrawal by Subject|14|||
16892688|NCT02347332|37951648|FG000|Overall Study|Protocol requirement|1|||
16892689|NCT02347332|37951649|FG001|Overall Study|Protocol requirement|1|||
16892690|NCT02347332|37951648|FG000|Overall Study|Switch Post-Trial program|0|||
16892691|NCT02347332|37951649|FG001|Overall Study|Switch Post-Trial program|1|||
16892692|NCT02347176|37951672|FG000|Overall Study|Lost to Follow-up|2|||
16892693|NCT02347176|37951673|FG001|Overall Study|Lost to Follow-up|3|||
16892694|NCT02347176|37951674|FG002|Overall Study|Lost to Follow-up|1|||
16892695|NCT02347176|37951675|FG003|Overall Study|Lost to Follow-up|1|||
16892696|NCT02347176|37951672|FG000|Overall Study|Withdrawal by Subject|9|||
16892697|NCT02347176|37951673|FG001|Overall Study|Withdrawal by Subject|5|||
16892698|NCT02347176|37951674|FG002|Overall Study|Withdrawal by Subject|5|||
16892699|NCT02347176|37951675|FG003|Overall Study|Withdrawal by Subject|3|||
16892700|NCT02347176|37951672|FG000|Overall Study|Other|1|||
16892701|NCT02347176|37951673|FG001|Overall Study|Other|2|||
16892702|NCT02347176|37951674|FG002|Overall Study|Other|2|||
16892703|NCT02347176|37951675|FG003|Overall Study|Other|0|||
16892704|NCT02370420|37951687|FG000|Overall Study|Physician Decision|3|||
16892705|NCT02370420|37951688|FG001|Overall Study|Physician Decision|3|||
16892706|NCT02370420|37951687|FG000|Overall Study|Lost to Follow-up|11|||
17003581|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16892707|NCT02370420|37951688|FG001|Overall Study|Lost to Follow-up|9|||
16892708|NCT02347098|37951710|FG000|Overall Study|Death|1|||
16892709|NCT02347098|37951711|FG001|Overall Study|Death|0|||
16892710|NCT02347098|37951710|FG000|Overall Study|Withdrawal by Subject|1|||
16892711|NCT02347098|37951711|FG001|Overall Study|Withdrawal by Subject|0|||
16892712|NCT02347098|37951710|FG000|Overall Study|Lost to Follow-up|2|||
16892713|NCT02347098|37951711|FG001|Overall Study|Lost to Follow-up|2|||
16892714|NCT02347098|37951710|FG000|Overall Study|Refuse Follow-up Visit|1|||
16892715|NCT02347098|37951711|FG001|Overall Study|Refuse Follow-up Visit|5|||
16892716|NCT02347098|37951710|FG000|Overall Study|no visit due to illness|2|||
16892717|NCT02347098|37951711|FG001|Overall Study|no visit due to illness|1|||
16892718|NCT02346708|37951728|FG000|Overall Study|Adverse Event|2|||
16892719|NCT02346708|37951729|FG001|Overall Study|Adverse Event|0|||
16892720|NCT02346708|37951728|FG000|Overall Study|Protocol Violation|0|||
16892721|NCT02346708|37951729|FG001|Overall Study|Protocol Violation|1|||
16892722|NCT02346240|37952219|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892723|NCT02346240|37952220|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
16892724|NCT02346240|37952221|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
16892725|NCT02346240|37952222|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
16892726|NCT02346240|37952223|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892727|NCT02346240|37952224|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892728|NCT02346240|37952225|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892729|NCT02346240|37952226|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892730|NCT02346240|37952227|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892731|NCT02346240|37952228|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892732|NCT02346240|37952229|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892733|NCT02346240|37952230|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892734|NCT02346240|37952231|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892735|NCT02346240|37952232|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892736|NCT02346240|37952233|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892737|NCT02346240|37952234|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892738|NCT02346240|37952235|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892739|NCT02346240|37952236|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892740|NCT02346240|37952237|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892741|NCT02346240|37952238|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892742|NCT02346240|37952239|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892743|NCT02346240|37952240|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892744|NCT02346240|37952241|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
17003582|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003583|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003584|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
17003585|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
17003586|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
17003587|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
17003588|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
17003589|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
17003590|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
17003591|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
17003592|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
16785852|NCT02655887|37725968|FG000|Overall Study|Missed 12-month follow-up visit|4|||
16892745|NCT02346240|37952242|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16892746|NCT02346240|37952219|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892747|NCT02346240|37952220|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
16892748|NCT02346240|37952221|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892749|NCT02346240|37952222|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892750|NCT02346240|37952223|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892751|NCT02346240|37952224|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892752|NCT02346240|37952225|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892753|NCT02346240|37952226|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892754|NCT02346240|37952227|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892755|NCT02346240|37952228|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892756|NCT02346240|37952229|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892757|NCT02346240|37952230|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892758|NCT02346240|37952231|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892759|NCT02346240|37952232|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892760|NCT02346240|37952233|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892761|NCT02346240|37952234|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892762|NCT02346240|37952235|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892763|NCT02346240|37952236|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
17003593|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003594|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16892764|NCT02346240|37952237|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892765|NCT02346240|37952238|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892766|NCT02346240|37952239|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892767|NCT02346240|37952240|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892768|NCT02346240|37952241|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892769|NCT02346240|37952242|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16892770|NCT02346240|37952219|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892771|NCT02346240|37952220|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
16892772|NCT02346240|37952221|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892773|NCT02346240|37952222|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892774|NCT02346240|37952223|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892775|NCT02346240|37952224|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892776|NCT02346240|37952225|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892777|NCT02346240|37952226|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892778|NCT02346240|37952227|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892779|NCT02346240|37952228|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892780|NCT02346240|37952229|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892781|NCT02346240|37952230|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892782|NCT02346240|37952231|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892783|NCT02346240|37952232|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
17003595|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003596|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003597|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003598|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003599|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003600|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003601|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003602|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16892784|NCT02346240|37952233|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892785|NCT02346240|37952234|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892786|NCT02346240|37952235|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892787|NCT02346240|37952236|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892788|NCT02346240|37952237|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892789|NCT02346240|37952238|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892790|NCT02346240|37952239|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892791|NCT02346240|37952240|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892792|NCT02346240|37952241|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16892793|NCT02346240|37952242|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
17003603|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003604|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003605|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17003606|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16892794|NCT02346240|37952219|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
16892795|NCT02346240|37952220|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
16892796|NCT02346240|37952221|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
16892797|NCT02346240|37952222|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
16892798|NCT02346240|37952223|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892799|NCT02346240|37952224|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892800|NCT02346240|37952225|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892801|NCT02346240|37952226|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892802|NCT02346240|37952227|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892803|NCT02346240|37952228|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892804|NCT02346240|37952229|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892805|NCT02346240|37952230|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892806|NCT02346240|37952231|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892807|NCT02346240|37952232|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892808|NCT02346240|37952233|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892809|NCT02346240|37952234|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892810|NCT02346240|37952235|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892811|NCT02346240|37952236|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892812|NCT02346240|37952237|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
17003607|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
17095386|NCT00232596|38234650|FG001|12-Week Maintenance Phase|Adverse Event|22|||
16785853|NCT02008318|37725974|FG000|Overall Study|Adverse Event|4|||
16785854|NCT02008318|37725975|FG001|Overall Study|Adverse Event|0|||
17003608|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003609|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003610|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
17003611|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003612|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
17003613|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003614|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16892813|NCT02346240|37952238|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892814|NCT02346240|37952239|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892815|NCT02346240|37952240|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892816|NCT02346240|37952241|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892817|NCT02346240|37952242|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16892818|NCT02346240|37952219|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
16892819|NCT02346240|37952220|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
16892820|NCT02346240|37952221|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
16892821|NCT02346240|37952222|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
16892822|NCT02346240|37952223|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892823|NCT02346240|37952224|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892824|NCT02346240|37952225|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892825|NCT02346240|37952226|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892826|NCT02346240|37952227|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892827|NCT02346240|37952228|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892828|NCT02346240|37952229|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892829|NCT02346240|37952230|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892830|NCT02346240|37952231|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892831|NCT02346240|37952232|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892832|NCT02346240|37952233|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892833|NCT02346240|37952234|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892834|NCT02346240|37952235|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892835|NCT02346240|37952236|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892836|NCT02346240|37952237|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892837|NCT02346240|37952238|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892838|NCT02346240|37952239|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892839|NCT02346240|37952240|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892840|NCT02346240|37952241|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892841|NCT02346240|37952242|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16892842|NCT02346240|37952219|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892843|NCT02346240|37952220|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
16892844|NCT02346240|37952221|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892845|NCT02346240|37952222|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
16892846|NCT02346240|37952223|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892847|NCT02346240|37952224|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892848|NCT02346240|37952225|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892849|NCT02346240|37952226|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892850|NCT02346240|37952227|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892851|NCT02346240|37952228|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892852|NCT02346240|37952229|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892853|NCT02346240|37952230|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892854|NCT02346240|37952231|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892855|NCT02346240|37952232|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892856|NCT02346240|37952233|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892857|NCT02346240|37952234|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
17003615|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003616|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003617|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003618|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003619|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003620|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003621|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003622|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003623|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003624|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17095387|NCT00232596|38234649|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
17003625|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003626|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003627|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003628|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003629|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003630|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
17003631|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
17003632|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003633|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003634|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
17003635|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003636|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003637|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003638|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003639|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003640|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003641|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17095388|NCT00232596|38234650|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
17192254|NCT00707577|38345425|FG000|Overall Study|Lost to Follow-up|34|||
17192255|NCT00707577|38345426|FG001|Overall Study|Lost to Follow-up|25|||
16892858|NCT02346240|37952235|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892859|NCT02346240|37952236|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892860|NCT02346240|37952237|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892861|NCT02346240|37952238|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892862|NCT02346240|37952239|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892863|NCT02346240|37952240|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892864|NCT02346240|37952241|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892865|NCT02346240|37952242|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16892866|NCT02346240|37952219|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892867|NCT02346240|37952220|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892868|NCT02346240|37952221|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
16892869|NCT02346240|37952222|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892870|NCT02346240|37952223|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892871|NCT02346240|37952224|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892872|NCT02346240|37952225|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892873|NCT02346240|37952226|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892874|NCT02346240|37952227|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892875|NCT02346240|37952228|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892876|NCT02346240|37952229|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
17003642|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17192256|NCT00707577|38345425|FG000|Overall Study|Left employment|13|||
17192257|NCT00707577|38345426|FG001|Overall Study|Left employment|10|||
17192258|NCT00707577|38345425|FG000|Overall Study|Pregnancy|4|||
17192259|NCT00707577|38345426|FG001|Overall Study|Pregnancy|1|||
17192260|NCT01675622|38345434|FG000|Overall Study|Withdrawal by Subject|2|||
17192261|NCT01675622|38345435|FG001|Overall Study|Withdrawal by Subject|2|||
17192262|NCT01675622|38345434|FG000|Overall Study|Adverse Event|12|||
17192263|NCT01675622|38345435|FG001|Overall Study|Adverse Event|10|||
17192264|NCT01675622|38345434|FG000|Overall Study|Protocol Violation|4|||
17192265|NCT01675622|38345435|FG001|Overall Study|Protocol Violation|1|||
17192266|NCT01675622|38345434|FG000|Overall Study|Lack of Efficacy|2|||
17192267|NCT01675622|38345435|FG001|Overall Study|Lack of Efficacy|4|||
17192268|NCT01675622|38345434|FG000|Overall Study|Lost to Follow-up|1|||
17192269|NCT01675622|38345435|FG001|Overall Study|Lost to Follow-up|3|||
17192270|NCT01675622|38345434|FG000|Overall Study|Other|5|||
17192271|NCT01675622|38345435|FG001|Overall Study|Other|4|||
17192272|NCT02655224|38345443|FG000|Overall Study|Adverse Event|1|||
17192273|NCT02655224|38345444|FG001|Overall Study|Adverse Event|1|||
17192274|NCT01675544|38345450|FG000|Overall Study|Withdrawal by Subject|2|||
17192275|NCT02838901|38345493|FG000|Overall Study|Withdrawal by Subject|1|||
17192276|NCT02838901|38345494|FG001|Overall Study|Withdrawal by Subject|1|||
17192277|NCT02838901|38345493|FG000|Overall Study|Lost to Follow-up|1|||
17192278|NCT02838901|38345494|FG001|Overall Study|Lost to Follow-up|1|||
17192279|NCT00706797|38345522|FG000|Overall Study|Lack of Efficacy|3|||
17192280|NCT00706797|38345523|FG001|Overall Study|Lack of Efficacy|0|||
17192281|NCT00706797|38345522|FG000|Overall Study|Adverse Event|0|||
17192282|NCT00706797|38345523|FG001|Overall Study|Adverse Event|3|||
17192283|NCT00706797|38345522|FG000|Overall Study|Withdrawal by Subject|8|||
17192284|NCT00706797|38345523|FG001|Overall Study|Withdrawal by Subject|1|||
17192285|NCT00706797|38345522|FG000|Overall Study|Death|1|||
16785855|NCT02008318|37725974|FG000|Overall Study|Physician Decision|2|||
16892877|NCT02346240|37952230|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892878|NCT02346240|37952231|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892879|NCT02346240|37952232|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892880|NCT02346240|37952233|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892881|NCT02346240|37952234|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892882|NCT02346240|37952235|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892883|NCT02346240|37952236|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892884|NCT02346240|37952237|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892885|NCT02346240|37952238|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892886|NCT02346240|37952239|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892887|NCT02346240|37952240|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892888|NCT02346240|37952241|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892889|NCT02346240|37952242|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16892890|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892891|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892892|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892893|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892894|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892895|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892896|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892897|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16892898|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
16892899|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892900|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892901|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892902|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892903|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
17003643|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003644|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003645|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003646|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003647|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003648|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003649|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003650|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003651|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003652|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003653|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
17003654|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003655|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003656|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
17003657|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003658|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003659|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003660|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003661|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003662|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003663|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003664|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003665|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003666|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003667|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003668|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003669|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003670|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003671|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003672|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003673|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003674|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17095389|NCT00232596|38234649|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
16785856|NCT02008318|37725975|FG001|Overall Study|Physician Decision|0|||
17003675|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003676|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
17003677|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003678|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003679|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
17003680|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16892904|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
16892905|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16892906|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
16892907|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892908|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892909|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892910|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892911|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892912|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892913|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16892914|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892915|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892916|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892917|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892918|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892919|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892920|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892921|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892922|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892923|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892924|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892925|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892926|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892927|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
16892928|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892929|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
16892930|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892931|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892932|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892933|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892934|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892935|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892936|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892937|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16892938|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892939|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892940|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892941|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892942|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892943|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892944|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892945|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892946|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892947|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892948|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892949|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892950|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892951|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892952|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
16892953|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892954|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892955|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892956|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892957|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892958|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892959|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892960|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892961|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16892962|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892963|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
17003681|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003682|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16892964|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892965|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892966|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892967|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16892968|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16892969|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16892970|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16892971|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892972|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16892973|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
16892974|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892975|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
16892976|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
16892977|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
16892978|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16892979|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892980|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892981|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892982|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892983|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892984|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892985|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16892986|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892987|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892988|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892989|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892990|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892991|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892992|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892993|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892994|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892995|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892996|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892997|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892998|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16892999|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
16893000|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
16893001|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
16893002|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
16893003|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16893004|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16893005|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16893006|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16893007|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16893008|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16893009|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16893010|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893011|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893012|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893013|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893014|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893015|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893016|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
16893017|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893018|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893019|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893020|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893021|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893022|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893023|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893024|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
17192286|NCT00706797|38345523|FG001|Overall Study|Death|0|||
16893025|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893026|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893027|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893028|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893029|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893030|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893031|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893032|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893033|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16893034|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893035|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893036|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893037|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893038|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893039|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893040|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893041|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893042|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
16893043|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893044|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893045|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
16893046|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893047|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
16893048|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
16893049|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893050|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893051|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893052|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893053|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893054|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893055|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893056|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893057|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16893058|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893059|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893060|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893061|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893062|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893063|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893064|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893065|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893066|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893067|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
16893068|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893069|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893070|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893071|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893072|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893073|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893074|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893075|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893076|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893077|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893078|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
17095390|NCT00232596|38234650|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
16785857|NCT02008318|37725974|FG000|Overall Study|Progressive Disease|2|||
16893079|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893080|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893081|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16893082|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893083|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893084|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893085|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893086|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893087|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893088|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893089|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893090|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893091|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893092|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
16893093|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893094|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893095|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893096|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893097|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893098|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893099|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893100|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893101|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893102|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893103|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893104|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893105|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16893106|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893107|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893108|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893109|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893110|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893111|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893112|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893113|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893114|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893115|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893116|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893117|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893118|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893119|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893120|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
16893121|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893122|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893123|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893124|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893125|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893126|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893127|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893128|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893129|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16893130|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893131|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893132|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893133|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893134|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893135|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893136|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893137|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893138|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893139|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893140|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893141|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893142|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893143|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893144|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
16893145|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893146|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893147|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893148|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893149|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893150|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893151|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893152|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893153|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16893154|NCT02346240|37952219|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893155|NCT02346240|37952220|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893156|NCT02346240|37952221|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893157|NCT02346240|37952222|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893158|NCT02346240|37952223|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893159|NCT02346240|37952224|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893160|NCT02346240|37952225|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893161|NCT02346240|37952226|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893162|NCT02346240|37952227|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893163|NCT02346240|37952228|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893164|NCT02346240|37952229|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893165|NCT02346240|37952230|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893166|NCT02346240|37952231|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893167|NCT02346240|37952232|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893168|NCT02346240|37952233|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
16893169|NCT02346240|37952234|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893170|NCT02346240|37952235|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893171|NCT02346240|37952236|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893172|NCT02346240|37952237|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893173|NCT02346240|37952238|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893174|NCT02346240|37952239|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893175|NCT02346240|37952240|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893176|NCT02346240|37952241|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893177|NCT02346240|37952242|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16893178|NCT02346240|37952219|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893179|NCT02346240|37952220|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893180|NCT02346240|37952221|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893181|NCT02346240|37952222|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893182|NCT02346240|37952223|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893183|NCT02346240|37952224|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893184|NCT02346240|37952225|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893185|NCT02346240|37952226|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893186|NCT02346240|37952227|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893187|NCT02346240|37952228|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893188|NCT02346240|37952229|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893189|NCT02346240|37952230|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893190|NCT02346240|37952231|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893191|NCT02346240|37952232|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893192|NCT02346240|37952233|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893193|NCT02346240|37952234|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16893194|NCT02346240|37952235|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16785858|NCT02008318|37725975|FG001|Overall Study|Progressive Disease|0|||
16893195|NCT02346240|37952236|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
16893196|NCT02346240|37952237|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
16893197|NCT02346240|37952238|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
16893198|NCT02346240|37952239|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
16893199|NCT02346240|37952240|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
16893200|NCT02346240|37952241|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
16893201|NCT02346240|37952242|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
16893202|NCT02346240|37952219|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893203|NCT02346240|37952220|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893204|NCT02346240|37952221|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893205|NCT02346240|37952222|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893206|NCT02346240|37952223|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893207|NCT02346240|37952224|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893208|NCT02346240|37952225|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893209|NCT02346240|37952226|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893210|NCT02346240|37952227|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893211|NCT02346240|37952228|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893212|NCT02346240|37952229|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893213|NCT02346240|37952230|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893214|NCT02346240|37952231|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893215|NCT02346240|37952232|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893216|NCT02346240|37952233|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893217|NCT02346240|37952234|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893218|NCT02346240|37952235|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893219|NCT02346240|37952236|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893220|NCT02346240|37952237|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
16893221|NCT02346240|37952238|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
16893222|NCT02346240|37952239|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893223|NCT02346240|37952240|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
16893224|NCT02346240|37952241|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893225|NCT02346240|37952242|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
16893226|NCT02346240|37952219|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893227|NCT02346240|37952220|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893228|NCT02346240|37952221|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893229|NCT02346240|37952222|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893230|NCT02346240|37952223|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893231|NCT02346240|37952224|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893232|NCT02346240|37952225|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893233|NCT02346240|37952226|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893234|NCT02346240|37952227|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893235|NCT02346240|37952228|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893236|NCT02346240|37952229|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893237|NCT02346240|37952230|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893238|NCT02346240|37952231|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893239|NCT02346240|37952232|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893240|NCT02346240|37952233|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893241|NCT02346240|37952234|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893242|NCT02346240|37952235|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893243|NCT02346240|37952236|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893244|NCT02346240|37952237|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16893245|NCT02346240|37952238|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893246|NCT02346240|37952239|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893247|NCT02346240|37952240|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16893248|NCT02346240|37952241|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893249|NCT02346240|37952242|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16893250|NCT02346240|37952219|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893251|NCT02346240|37952220|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893252|NCT02346240|37952221|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893253|NCT02346240|37952222|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893254|NCT02346240|37952223|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893255|NCT02346240|37952224|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893256|NCT02346240|37952225|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893257|NCT02346240|37952226|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
17003683|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003684|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17095391|NCT00232596|38234649|FG000|12-Week Maintenance Phase|Other|1|||
17095392|NCT00232596|38234650|FG001|12-Week Maintenance Phase|Other|3|||
16893258|NCT02346240|37952227|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893259|NCT02346240|37952228|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893260|NCT02346240|37952229|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893261|NCT02346240|37952230|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893262|NCT02346240|37952231|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893263|NCT02346240|37952232|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893264|NCT02346240|37952233|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893265|NCT02346240|37952234|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893266|NCT02346240|37952235|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893267|NCT02346240|37952236|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893268|NCT02346240|37952237|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893269|NCT02346240|37952238|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893270|NCT02346240|37952239|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893271|NCT02346240|37952240|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
16893272|NCT02346240|37952241|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893273|NCT02346240|37952242|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16893274|NCT02346240|37952219|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893275|NCT02346240|37952220|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893276|NCT02346240|37952221|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893277|NCT02346240|37952222|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893278|NCT02346240|37952223|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893279|NCT02346240|37952224|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893280|NCT02346240|37952225|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893281|NCT02346240|37952226|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893282|NCT02346240|37952227|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893283|NCT02346240|37952228|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893284|NCT02346240|37952229|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893285|NCT02346240|37952230|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893286|NCT02346240|37952231|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893287|NCT02346240|37952232|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893288|NCT02346240|37952233|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893289|NCT02346240|37952234|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893290|NCT02346240|37952235|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893291|NCT02346240|37952236|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
16893292|NCT02346240|37952237|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
16893293|NCT02346240|37952238|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
16893294|NCT02346240|37952239|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16893295|NCT02346240|37952240|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
16893296|NCT02346240|37952241|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
16893297|NCT02346240|37952242|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
16893298|NCT02346240|37952219|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893299|NCT02346240|37952220|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893300|NCT02346240|37952221|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893301|NCT02346240|37952222|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893302|NCT02346240|37952223|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893303|NCT02346240|37952224|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893304|NCT02346240|37952225|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893305|NCT02346240|37952226|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
17003685|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003686|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003687|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003688|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003689|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003690|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003691|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003692|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003693|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003694|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003695|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003696|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003697|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003698|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003699|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
17003700|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003701|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003702|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003703|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
17003704|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003705|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003706|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003707|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16893306|NCT02346240|37952227|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893307|NCT02346240|37952228|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893308|NCT02346240|37952229|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893309|NCT02346240|37952230|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893310|NCT02346240|37952231|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893311|NCT02346240|37952232|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893312|NCT02346240|37952233|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893313|NCT02346240|37952234|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893314|NCT02346240|37952235|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893315|NCT02346240|37952236|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893316|NCT02346240|37952237|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
16893317|NCT02346240|37952238|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
16893318|NCT02346240|37952239|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16893319|NCT02346240|37952240|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
16893320|NCT02346240|37952241|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
16893321|NCT02346240|37952242|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
16893322|NCT02346240|37952219|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893323|NCT02346240|37952220|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893324|NCT02346240|37952221|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893325|NCT02346240|37952222|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893326|NCT02346240|37952223|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893327|NCT02346240|37952224|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893328|NCT02346240|37952225|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893329|NCT02346240|37952226|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893330|NCT02346240|37952227|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893331|NCT02346240|37952228|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893332|NCT02346240|37952229|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893333|NCT02346240|37952230|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893334|NCT02346240|37952231|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893335|NCT02346240|37952232|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893336|NCT02346240|37952233|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893337|NCT02346240|37952234|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893338|NCT02346240|37952235|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893339|NCT02346240|37952236|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893340|NCT02346240|37952237|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
16893341|NCT02346240|37952238|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893342|NCT02346240|37952239|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16893343|NCT02346240|37952240|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
16893344|NCT02346240|37952241|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
16893345|NCT02346240|37952242|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
16893346|NCT02346240|37952219|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893347|NCT02346240|37952220|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893348|NCT02346240|37952221|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893349|NCT02346240|37952222|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893350|NCT02346240|37952223|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893351|NCT02346240|37952224|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893352|NCT02346240|37952225|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893353|NCT02346240|37952226|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893354|NCT02346240|37952227|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893355|NCT02346240|37952228|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893356|NCT02346240|37952229|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893357|NCT02346240|37952230|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893358|NCT02346240|37952231|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893359|NCT02346240|37952232|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893360|NCT02346240|37952233|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893361|NCT02346240|37952234|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893362|NCT02346240|37952235|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893363|NCT02346240|37952236|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893364|NCT02346240|37952237|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
16893365|NCT02346240|37952238|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893366|NCT02346240|37952239|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893367|NCT02346240|37952240|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893368|NCT02346240|37952241|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893369|NCT02346240|37952242|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16893370|NCT02392104|37952293|FG000|Overall Study|discontinuation of warfarin|3|||
16893371|NCT02392104|37952293|FG000|Overall Study|bleeding event|1|||
16893372|NCT02392104|37952293|FG000|Overall Study|transferred care to another doctor|2|||
16893373|NCT02392104|37952293|FG000|Overall Study|INR goal range changed|1|||
16893374|NCT02392104|37952293|FG000|Overall Study|admitted to skilled nursing facility|3|||
16893375|NCT02392104|37952293|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
16893376|NCT02391948|37952311|FG000|6-month Assessment|Death|0|||
16893377|NCT02391948|37952312|FG001|6-month Assessment|Death|0|||
16893378|NCT02391948|37952313|FG002|6-month Assessment|Death|0|||
16893379|NCT02391948|37952314|FG003|6-month Assessment|Death|0|||
16893380|NCT02391948|37952315|FG004|6-month Assessment|Death|1|||
16893381|NCT02391948|37952311|FG000|6-month Assessment|Withdrawal by Subject|0|||
16893382|NCT02391948|37952312|FG001|6-month Assessment|Withdrawal by Subject|0|||
16893383|NCT02391948|37952313|FG002|6-month Assessment|Withdrawal by Subject|1|||
16893384|NCT02391948|37952314|FG003|6-month Assessment|Withdrawal by Subject|2|||
16893385|NCT02391948|37952315|FG004|6-month Assessment|Withdrawal by Subject|0|||
16893386|NCT02391948|37952311|FG000|6-month Assessment|Lost to Follow-up|4|||
16893387|NCT02391948|37952312|FG001|6-month Assessment|Lost to Follow-up|5|||
16893388|NCT02391948|37952313|FG002|6-month Assessment|Lost to Follow-up|2|||
16893389|NCT02391948|37952314|FG003|6-month Assessment|Lost to Follow-up|3|||
16893390|NCT02391948|37952315|FG004|6-month Assessment|Lost to Follow-up|1|||
16893391|NCT02391948|37952311|FG000|6-month Assessment|Medical issue/illness|1|||
16893392|NCT02391948|37952312|FG001|6-month Assessment|Medical issue/illness|1|||
16893393|NCT02391948|37952313|FG002|6-month Assessment|Medical issue/illness|0|||
16893394|NCT02391948|37952314|FG003|6-month Assessment|Medical issue/illness|0|||
16893395|NCT02391948|37952315|FG004|6-month Assessment|Medical issue/illness|0|||
16893396|NCT02391948|37952311|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
16893397|NCT02391948|37952312|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
16893398|NCT02391948|37952313|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
16893399|NCT02391948|37952314|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
16893400|NCT02391948|37952315|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
16893401|NCT02391948|37952311|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
16893402|NCT02391948|37952312|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
16893403|NCT02391948|37952313|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
16893404|NCT02391948|37952314|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
16893405|NCT02391948|37952315|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
16893406|NCT02391948|37952311|FG000|12-month Assessment|Death|0|||
16893407|NCT02391948|37952312|FG001|12-month Assessment|Death|0|||
16893408|NCT02391948|37952313|FG002|12-month Assessment|Death|0|||
16893409|NCT02391948|37952314|FG003|12-month Assessment|Death|1|||
16893410|NCT02391948|37952315|FG004|12-month Assessment|Death|0|||
16893411|NCT02391948|37952311|FG000|12-month Assessment|Withdrawal by Subject|1|||
16893412|NCT02391948|37952312|FG001|12-month Assessment|Withdrawal by Subject|0|||
16893413|NCT02391948|37952313|FG002|12-month Assessment|Withdrawal by Subject|0|||
16893414|NCT02391948|37952314|FG003|12-month Assessment|Withdrawal by Subject|1|||
16893415|NCT02391948|37952315|FG004|12-month Assessment|Withdrawal by Subject|0|||
16893416|NCT02391948|37952311|FG000|12-month Assessment|Lost to Follow-up|5|||
16893417|NCT02391948|37952312|FG001|12-month Assessment|Lost to Follow-up|4|||
16893418|NCT02391948|37952313|FG002|12-month Assessment|Lost to Follow-up|4|||
16893419|NCT02391948|37952314|FG003|12-month Assessment|Lost to Follow-up|4|||
16893420|NCT02391948|37952315|FG004|12-month Assessment|Lost to Follow-up|5|||
16893421|NCT02391948|37952311|FG000|12-month Assessment|Medical issue/illness|0|||
16893422|NCT02391948|37952312|FG001|12-month Assessment|Medical issue/illness|1|||
16893423|NCT02391948|37952313|FG002|12-month Assessment|Medical issue/illness|0|||
16893424|NCT02391948|37952314|FG003|12-month Assessment|Medical issue/illness|1|||
16893425|NCT02391948|37952315|FG004|12-month Assessment|Medical issue/illness|0|||
16893426|NCT02391948|37952311|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
17003708|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003709|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17095393|NCT00073918|38234668|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
17003710|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003711|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003712|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003713|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003714|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003715|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003716|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003717|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003718|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16893427|NCT02391948|37952312|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
16893428|NCT02391948|37952313|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
16893429|NCT02391948|37952314|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
16893430|NCT02391948|37952315|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
16893431|NCT02391948|37952311|FG000|18-month Assessment|Death|0|||
16893432|NCT02391948|37952312|FG001|18-month Assessment|Death|0|||
17003719|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16893433|NCT02391948|37952313|FG002|18-month Assessment|Death|0|||
16893434|NCT02391948|37952314|FG003|18-month Assessment|Death|1|||
16893435|NCT02391948|37952315|FG004|18-month Assessment|Death|1|||
16893436|NCT02391948|37952311|FG000|18-month Assessment|Withdrawal by Subject|1|||
16893437|NCT02391948|37952312|FG001|18-month Assessment|Withdrawal by Subject|0|||
16893438|NCT02391948|37952313|FG002|18-month Assessment|Withdrawal by Subject|0|||
16893439|NCT02391948|37952314|FG003|18-month Assessment|Withdrawal by Subject|1|||
16893440|NCT02391948|37952315|FG004|18-month Assessment|Withdrawal by Subject|0|||
16893441|NCT02391948|37952311|FG000|18-month Assessment|Lost to Follow-up|2|||
16893442|NCT02391948|37952312|FG001|18-month Assessment|Lost to Follow-up|6|||
16893443|NCT02391948|37952313|FG002|18-month Assessment|Lost to Follow-up|2|||
16893444|NCT02391948|37952314|FG003|18-month Assessment|Lost to Follow-up|2|||
16893445|NCT02391948|37952315|FG004|18-month Assessment|Lost to Follow-up|3|||
16893446|NCT02391948|37952311|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
16893447|NCT02391948|37952312|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
16893448|NCT02391948|37952313|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
16893449|NCT02391948|37952314|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
16893450|NCT02391948|37952315|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
17003720|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003721|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003722|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
17003723|NCT00896532|38147659|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003724|NCT00896532|38147660|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
17003725|NCT00896532|38147661|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003726|NCT00896532|38147662|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
17003727|NCT00896532|38147663|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
17003728|NCT00896532|38147664|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003729|NCT00896532|38147665|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003730|NCT00896532|38147666|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003731|NCT00896532|38147667|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003732|NCT00896532|38147668|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003733|NCT00896532|38147669|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003734|NCT00896532|38147670|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003735|NCT00896532|38147671|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003736|NCT00896532|38147672|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003737|NCT00896532|38147673|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003738|NCT00896532|38147674|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003739|NCT00896532|38147675|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003740|NCT00896532|38147676|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003741|NCT00896532|38147677|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003742|NCT00896532|38147678|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003743|NCT00896532|38147679|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003744|NCT00896532|38147680|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16893451|NCT02391948|37952311|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
16893452|NCT02391948|37952312|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
16893453|NCT02391948|37952313|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
16893454|NCT02391948|37952314|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
16893455|NCT02391948|37952315|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
16893456|NCT02391948|37952311|FG000|24-month Assessment|Death|0|||
16893457|NCT02391948|37952312|FG001|24-month Assessment|Death|0|||
16893458|NCT02391948|37952313|FG002|24-month Assessment|Death|0|||
16893459|NCT02391948|37952314|FG003|24-month Assessment|Death|0|||
16893460|NCT02391948|37952315|FG004|24-month Assessment|Death|1|||
16893461|NCT02391948|37952311|FG000|24-month Assessment|Withdrawal by Subject|1|||
16893462|NCT02391948|37952312|FG001|24-month Assessment|Withdrawal by Subject|1|||
16893463|NCT02391948|37952313|FG002|24-month Assessment|Withdrawal by Subject|0|||
16893464|NCT02391948|37952314|FG003|24-month Assessment|Withdrawal by Subject|0|||
16893465|NCT02391948|37952315|FG004|24-month Assessment|Withdrawal by Subject|1|||
16893466|NCT02391948|37952311|FG000|24-month Assessment|Lost to Follow-up|5|||
16893467|NCT02391948|37952312|FG001|24-month Assessment|Lost to Follow-up|4|||
16893468|NCT02391948|37952313|FG002|24-month Assessment|Lost to Follow-up|0|||
16893469|NCT02391948|37952314|FG003|24-month Assessment|Lost to Follow-up|0|||
16893470|NCT02391948|37952315|FG004|24-month Assessment|Lost to Follow-up|0|||
16893471|NCT02391948|37952311|FG000|24-month Assessment|Medical issue/illness|0|||
16893472|NCT02391948|37952312|FG001|24-month Assessment|Medical issue/illness|0|||
16893473|NCT02391948|37952313|FG002|24-month Assessment|Medical issue/illness|1|||
16893474|NCT02391948|37952314|FG003|24-month Assessment|Medical issue/illness|0|||
16893475|NCT02391948|37952315|FG004|24-month Assessment|Medical issue/illness|0|||
16893476|NCT02391948|37952311|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
16893477|NCT02391948|37952312|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
16893478|NCT02391948|37952313|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
16893479|NCT02391948|37952314|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
16893480|NCT02391948|37952315|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
16893481|NCT02369874|37952558|FG000|Overall Study|Lost to Follow-up|2|||
16893482|NCT02369874|37952559|FG001|Overall Study|Lost to Follow-up|2|||
16893483|NCT02369874|37952560|FG002|Overall Study|Lost to Follow-up|2|||
16893484|NCT02369874|37952558|FG000|Overall Study|Withdrawal by Subject|7|||
16893485|NCT02369874|37952559|FG001|Overall Study|Withdrawal by Subject|9|||
16893486|NCT02369874|37952560|FG002|Overall Study|Withdrawal by Subject|27|||
16893487|NCT02369874|37952558|FG000|Overall Study|Miscellaneous|1|||
16893488|NCT02369874|37952559|FG001|Overall Study|Miscellaneous|1|||
16893489|NCT02369874|37952560|FG002|Overall Study|Miscellaneous|0|||
16893490|NCT02369874|37952558|FG000|Overall Study|On Treatment/Off Study|34|||
16893491|NCT02369874|37952559|FG001|Overall Study|On Treatment/Off Study|45|||
16893492|NCT02369874|37952560|FG002|Overall Study|On Treatment/Off Study|32|||
16893493|NCT02345226|37952672|FG000|Double-Blind Phase|Adverse Event|5|||
16893494|NCT02345226|37952673|FG001|Double-Blind Phase|Adverse Event|6|||
16893495|NCT02345226|37952672|FG000|Double-Blind Phase|Death|3|||
16893496|NCT02345226|37952673|FG001|Double-Blind Phase|Death|0|||
16893497|NCT02345226|37952672|FG000|Double-Blind Phase|Pregnancy|0|||
16893498|NCT02345226|37952673|FG001|Double-Blind Phase|Pregnancy|1|||
16893499|NCT02345226|37952672|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16893500|NCT02345226|37952673|FG001|Double-Blind Phase|Lack of Efficacy|0|||
16893501|NCT02345226|37952672|FG000|Double-Blind Phase|Investigator's Discretion|4|||
16893502|NCT02345226|37952673|FG001|Double-Blind Phase|Investigator's Discretion|3|||
16893503|NCT02345226|37952672|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16893504|NCT02345226|37952673|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
16893505|NCT02345226|37952672|FG000|Double-Blind Phase|Withdrew Consent|41|||
16893506|NCT02345226|37952673|FG001|Double-Blind Phase|Withdrew Consent|39|||
16893507|NCT02345226|37952672|FG000|Double-Blind Phase|Lost to Follow-up|12|||
16893508|NCT02345226|37952673|FG001|Double-Blind Phase|Lost to Follow-up|16|||
16893509|NCT02345226|37952672|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
16893510|NCT02345226|37952673|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
17003745|NCT00896532|38147681|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
17003746|NCT00896532|38147659|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003747|NCT00896532|38147660|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003748|NCT00896532|38147661|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16893511|NCT02345226|37952672|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
16893512|NCT02345226|37952673|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
17003749|NCT00896532|38147662|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003750|NCT00896532|38147663|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16893513|NCT02368314|37952723|FG000|Overall Study|Withdrawal by Subject|2|||
16893514|NCT02368314|37952724|FG001|Overall Study|Withdrawal by Subject|1|||
16893515|NCT02368314|37952723|FG000|Overall Study|Adverse Event|1|||
16893516|NCT02368314|37952724|FG001|Overall Study|Adverse Event|2|||
16893517|NCT02366910|37952734|FG000|Overall Study|Withdrawal by Subject|2|||
16893518|NCT02366910|37952734|FG000|Overall Study|Screen Failure|3|||
16893519|NCT01649232|37952752|FG000|Overall Study|Physician Decision|2|||
16893520|NCT01649232|37952753|FG001|Overall Study|Physician Decision|0|||
17003751|NCT00896532|38147664|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16893531|NCT00551369|37953650|FG000|Overall Study|Protocol Violation|5|||
16893532|NCT00551369|37953650|FG000|Overall Study|Withdrawal by Subject|1|||
16893533|NCT00551369|37953650|FG000|Overall Study|Not treated per protocol and re|1|||
16893534|NCT00551291|37953663|FG000|Overall Study|Physician Decision|1|||
16893535|NCT00551213|37953769|FG000|Overall Study|Adverse Event|6|||
16893536|NCT00551213|37953770|FG001|Overall Study|Adverse Event|3|||
16893537|NCT00551213|37953769|FG000|Overall Study|Progressive Disease|41|||
16893538|NCT00551213|37953770|FG001|Overall Study|Progressive Disease|12|||
16893539|NCT00551213|37953769|FG000|Overall Study|Withdrawal by Subject|2|||
16893540|NCT00551213|37953770|FG001|Overall Study|Withdrawal by Subject|0|||
16893541|NCT00551213|37953769|FG000|Overall Study|Not Treated|1|||
16893542|NCT00551213|37953770|FG001|Overall Study|Not Treated|2|||
16893543|NCT00550043|37953907|FG000|Overall Study|Adverse Event|0|||
16893544|NCT00550043|37953908|FG001|Overall Study|Adverse Event|0|||
16893545|NCT00550043|37953909|FG002|Overall Study|Adverse Event|0|||
16893546|NCT00550043|37953910|FG003|Overall Study|Adverse Event|1|||
16893547|NCT00550043|37953911|FG004|Overall Study|Adverse Event|1|||
16893548|NCT00550043|37953907|FG000|Overall Study|Subject Withdrew Consent|0|||
16893549|NCT00550043|37953908|FG001|Overall Study|Subject Withdrew Consent|2|||
16893550|NCT00550043|37953909|FG002|Overall Study|Subject Withdrew Consent|1|||
16893551|NCT00550043|37953910|FG003|Overall Study|Subject Withdrew Consent|0|||
16893552|NCT00550043|37953911|FG004|Overall Study|Subject Withdrew Consent|0|||
16893553|NCT00550043|37953907|FG000|Overall Study|Other Reasons- Unspecified|0|||
16893554|NCT00550043|37953908|FG001|Overall Study|Other Reasons- Unspecified|1|||
16893555|NCT00550043|37953909|FG002|Overall Study|Other Reasons- Unspecified|0|||
16893556|NCT00550043|37953910|FG003|Overall Study|Other Reasons- Unspecified|1|||
16893557|NCT00550043|37953911|FG004|Overall Study|Other Reasons- Unspecified|0|||
16893558|NCT03188822|37954639|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
16893559|NCT03188822|37954639|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
16893560|NCT04976777|37954782|FG000|Overall Study|COVID-19 Infection|1|||
16893561|NCT04976777|37954783|FG001|Overall Study|COVID-19 Infection|0|||
16893562|NCT00555971|37954966|FG000|Overall Study|Adverse Event|1|||
16893563|NCT00555971|37954967|FG001|Overall Study|Adverse Event|1|||
16893564|NCT02343120|37955843|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
16893565|NCT02343120|37955844|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
16893566|NCT02343120|37955845|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
16893567|NCT02343120|37955846|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
16893568|NCT02343120|37955847|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
16893569|NCT02343120|37955843|FG000|Part 1: Dose Escalation|Death|1|||
16893570|NCT02343120|37955844|FG001|Part 1: Dose Escalation|Death|2|||
16893571|NCT02343120|37955845|FG002|Part 1: Dose Escalation|Death|2|||
16893572|NCT02343120|37955846|FG003|Part 1: Dose Escalation|Death|2|||
16893573|NCT02343120|37955847|FG004|Part 1: Dose Escalation|Death|1|||
16893574|NCT02343120|37955843|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
16893575|NCT02343120|37955844|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
16893576|NCT02343120|37955845|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
16893577|NCT02343120|37955846|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
16893578|NCT02343120|37955847|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
16893579|NCT02343120|37955843|FG000|Part 2: Expansion|Sponsor decision|0|||
16893580|NCT02343120|37955844|FG001|Part 2: Expansion|Sponsor decision|0|||
16893581|NCT02343120|37955845|FG002|Part 2: Expansion|Sponsor decision|0|||
16893582|NCT02343120|37955846|FG003|Part 2: Expansion|Sponsor decision|165|||
16893583|NCT02343120|37955847|FG004|Part 2: Expansion|Sponsor decision|67|||
16893584|NCT02343120|37955843|FG000|Part 2: Expansion|Death|0|||
16893585|NCT02343120|37955844|FG001|Part 2: Expansion|Death|0|||
16893586|NCT02343120|37955845|FG002|Part 2: Expansion|Death|0|||
16893587|NCT02343120|37955846|FG003|Part 2: Expansion|Death|74|||
16893588|NCT02343120|37955847|FG004|Part 2: Expansion|Death|17|||
16893589|NCT02343120|37955843|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
16893590|NCT02343120|37955844|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
16893591|NCT02343120|37955845|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
16893592|NCT02343120|37955846|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
16893593|NCT02343120|37955847|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
16893594|NCT02343120|37955843|FG000|Part 2: Expansion|Lost to Follow-up|0|||
16893595|NCT02343120|37955844|FG001|Part 2: Expansion|Lost to Follow-up|0|||
16893596|NCT02343120|37955845|FG002|Part 2: Expansion|Lost to Follow-up|0|||
16893597|NCT02343120|37955846|FG003|Part 2: Expansion|Lost to Follow-up|5|||
16893598|NCT02343120|37955847|FG004|Part 2: Expansion|Lost to Follow-up|2|||
16893599|NCT02343120|37955843|FG000|Part 2: Expansion|Other|0|||
16893600|NCT02343120|37955844|FG001|Part 2: Expansion|Other|0|||
16893601|NCT02343120|37955845|FG002|Part 2: Expansion|Other|0|||
16893602|NCT02343120|37955846|FG003|Part 2: Expansion|Other|1|||
16893603|NCT02343120|37955847|FG004|Part 2: Expansion|Other|5|||
16785859|NCT02008318|37725974|FG000|Overall Study|Protocol Violation|1|||
16893604|NCT02343120|37955843|FG000|Part 2: Expansion|Adverse Event|0|||
16893605|NCT02343120|37955844|FG001|Part 2: Expansion|Adverse Event|0|||
16893606|NCT02343120|37955845|FG002|Part 2: Expansion|Adverse Event|0|||
16893607|NCT02343120|37955846|FG003|Part 2: Expansion|Adverse Event|1|||
16893608|NCT02343120|37955847|FG004|Part 2: Expansion|Adverse Event|1|||
16893609|NCT02342886|37956113|FG000|Overall Study|Treatment non-compliance|1|||
16893610|NCT02342886|37956114|FG001|Overall Study|Treatment non-compliance|0|||
16893611|NCT02342886|37956115|FG002|Overall Study|Treatment non-compliance|0|||
16893612|NCT02342886|37956116|FG003|Overall Study|Treatment non-compliance|1|||
16893613|NCT02342886|37956117|FG004|Overall Study|Treatment non-compliance|0|||
16893614|NCT02342886|37956113|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
16893615|NCT02342886|37956114|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
16893616|NCT02342886|37956115|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
16893617|NCT02342886|37956116|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
16893618|NCT02342886|37956117|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
16893619|NCT02342886|37956113|FG000|Overall Study|Adverse event/specific toxicity|4|||
16893620|NCT02342886|37956114|FG001|Overall Study|Adverse event/specific toxicity|3|||
16893621|NCT02342886|37956115|FG002|Overall Study|Adverse event/specific toxicity|11|||
16893622|NCT02342886|37956116|FG003|Overall Study|Adverse event/specific toxicity|2|||
16893623|NCT02342886|37956117|FG004|Overall Study|Adverse event/specific toxicity|1|||
16893624|NCT02342886|37956113|FG000|Overall Study|Lost to Follow-up|1|||
16893625|NCT02342886|37956114|FG001|Overall Study|Lost to Follow-up|0|||
16893626|NCT02342886|37956115|FG002|Overall Study|Lost to Follow-up|0|||
16893627|NCT02342886|37956116|FG003|Overall Study|Lost to Follow-up|0|||
16893628|NCT02342886|37956117|FG004|Overall Study|Lost to Follow-up|0|||
16893629|NCT02342886|37956113|FG000|Overall Study|Death|1|||
16893630|NCT02342886|37956114|FG001|Overall Study|Death|2|||
16893631|NCT02342886|37956115|FG002|Overall Study|Death|1|||
16893632|NCT02342886|37956116|FG003|Overall Study|Death|0|||
16893633|NCT02342886|37956117|FG004|Overall Study|Death|1|||
16893634|NCT02342886|37956113|FG000|Overall Study|Withdrawal by Subject|0|||
16893635|NCT02342886|37956114|FG001|Overall Study|Withdrawal by Subject|1|||
16893636|NCT02342886|37956115|FG002|Overall Study|Withdrawal by Subject|0|||
16893637|NCT02342886|37956116|FG003|Overall Study|Withdrawal by Subject|1|||
16893638|NCT02342886|37956117|FG004|Overall Study|Withdrawal by Subject|0|||
16893639|NCT02342886|37956113|FG000|Overall Study|Investigator/sponsor decision|0|||
16893640|NCT02342886|37956114|FG001|Overall Study|Investigator/sponsor decision|2|||
16893641|NCT02342886|37956115|FG002|Overall Study|Investigator/sponsor decision|0|||
16893642|NCT02342886|37956116|FG003|Overall Study|Investigator/sponsor decision|3|||
16893643|NCT02342886|37956117|FG004|Overall Study|Investigator/sponsor decision|1|||
16893644|NCT02342886|37956113|FG000|Overall Study|Pregnancy|0|||
16893645|NCT02342886|37956114|FG001|Overall Study|Pregnancy|0|||
16893646|NCT02342886|37956115|FG002|Overall Study|Pregnancy|2|||
16893647|NCT02342886|37956116|FG003|Overall Study|Pregnancy|0|||
16893648|NCT02342886|37956117|FG004|Overall Study|Pregnancy|0|||
16893649|NCT02342886|37956113|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
16893650|NCT02342886|37956114|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
16893651|NCT02342886|37956115|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
16893652|NCT02342886|37956116|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
16893653|NCT02342886|37956117|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
16893654|NCT02342886|37956113|FG000|Overall Study|Protocol Violation|0|||
16893655|NCT02342886|37956114|FG001|Overall Study|Protocol Violation|0|||
16893656|NCT02342886|37956115|FG002|Overall Study|Protocol Violation|0|||
16893657|NCT02342886|37956116|FG003|Overall Study|Protocol Violation|2|||
16893658|NCT02342886|37956117|FG004|Overall Study|Protocol Violation|0|||
16893659|NCT02390076|37956153|FG000|Overall Study|Lost to Follow-up|2|||
16893660|NCT02390076|37956154|FG001|Overall Study|Lost to Follow-up|1|||
16893661|NCT02390076|37956155|FG002|Overall Study|Lost to Follow-up|4|||
16893662|NCT02389998|37956174|FG000|Overall Study|car accident|1|||
16893663|NCT02389998|37956175|FG001|Overall Study|car accident|0|||
16893664|NCT02389764|37956201|FG000|Overall Study|Lack of Efficacy|9|||
16893665|NCT02366130|37956272|FG000|Overall Study|Withdrawal by Subject|3|||
16893666|NCT02366130|37956272|FG000|Overall Study|Ineligible|6|||
16893667|NCT02389452|37956334|FG000|Overall Study|Lost to Follow-up|13|||
16893668|NCT02389452|37956334|FG000|Overall Study|Adverse Event|1|||
16893669|NCT02389452|37956334|FG000|Overall Study|Withdrawal by Subject|5|||
16893670|NCT02389452|37956334|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
16893671|NCT02365584|37956372|FG000|Overall Study|Adverse Event|2|||
16893672|NCT02365584|37956373|FG001|Overall Study|Adverse Event|2|||
16893673|NCT02365584|37956372|FG000|Overall Study|Withdrawal by Subject|1|||
16893674|NCT02365584|37956373|FG001|Overall Study|Withdrawal by Subject|0|||
16893675|NCT02365584|37956372|FG000|Overall Study|Disease Progression|9|||
16893676|NCT02365584|37956373|FG001|Overall Study|Disease Progression|12|||
16893677|NCT02342418|37956385|FG000|Overall Study|Adverse Event|0|||
16893678|NCT02342418|37956386|FG001|Overall Study|Adverse Event|1|||
16893679|NCT02365506|37956427|FG000|Overall Study|Investigator's Discretion|0|||
16893680|NCT02365506|37956428|FG001|Overall Study|Investigator's Discretion|0|||
16893681|NCT02365506|37956429|FG002|Overall Study|Investigator's Discretion|1|||
16893682|NCT02312934|37956466|FG000|Overall Study|Lost to Follow-up|1|||
16893683|NCT02312934|37956467|FG001|Overall Study|Lost to Follow-up|0|||
16893684|NCT02312934|37956466|FG000|Overall Study|Physician Decision|1|||
16893685|NCT02312934|37956467|FG001|Overall Study|Physician Decision|0|||
16893686|NCT02341482|37956501|FG000|Overall Study|Adverse Event|1|||
16893687|NCT02312856|37956541|FG000|Overall Study|Death|1|||
16893688|NCT02312856|37956541|FG000|Overall Study|Lost to Follow-up|3|||
16893689|NCT01602120|37957006|FG000|Overall Study|Adverse Event|3|||
16893690|NCT01602120|37957007|FG001|Overall Study|Adverse Event|6|||
16893691|NCT01602120|37957008|FG002|Overall Study|Adverse Event|0|||
16893692|NCT01602120|37957009|FG003|Overall Study|Adverse Event|2|||
16893693|NCT01602120|37957006|FG000|Overall Study|Death|0|||
16893694|NCT01602120|37957007|FG001|Overall Study|Death|4|||
16893695|NCT01602120|37957008|FG002|Overall Study|Death|0|||
16893696|NCT01602120|37957009|FG003|Overall Study|Death|0|||
16893697|NCT01602120|37957006|FG000|Overall Study|Lost to Follow-up|0|||
16893698|NCT01602120|37957007|FG001|Overall Study|Lost to Follow-up|1|||
16893699|NCT01602120|37957008|FG002|Overall Study|Lost to Follow-up|0|||
16893700|NCT01602120|37957009|FG003|Overall Study|Lost to Follow-up|1|||
16893701|NCT01602120|37957006|FG000|Overall Study|Protocol Violation|1|||
16893702|NCT01602120|37957007|FG001|Overall Study|Protocol Violation|1|||
16893703|NCT01602120|37957008|FG002|Overall Study|Protocol Violation|0|||
16893704|NCT01602120|37957009|FG003|Overall Study|Protocol Violation|0|||
16893705|NCT01602120|37957006|FG000|Overall Study|Non-compliance|0|||
16893706|NCT01602120|37957007|FG001|Overall Study|Non-compliance|3|||
16893707|NCT01602120|37957008|FG002|Overall Study|Non-compliance|0|||
16893708|NCT01602120|37957009|FG003|Overall Study|Non-compliance|1|||
16893709|NCT01602120|37957006|FG000|Overall Study|Withdrawal by Subject|8|||
16893710|NCT01602120|37957007|FG001|Overall Study|Withdrawal by Subject|17|||
16893711|NCT01602120|37957008|FG002|Overall Study|Withdrawal by Subject|0|||
16893712|NCT01602120|37957009|FG003|Overall Study|Withdrawal by Subject|3|||
16893713|NCT01602120|37957006|FG000|Overall Study|Study Terminated by Sponsor|12|||
16893714|NCT01602120|37957007|FG001|Overall Study|Study Terminated by Sponsor|24|||
16893715|NCT01602120|37957008|FG002|Overall Study|Study Terminated by Sponsor|17|||
16893716|NCT01602120|37957009|FG003|Overall Study|Study Terminated by Sponsor|44|||
16893717|NCT01602120|37957006|FG000|Overall Study|Physician Decision|2|||
16893718|NCT01602120|37957007|FG001|Overall Study|Physician Decision|3|||
16893719|NCT01602120|37957008|FG002|Overall Study|Physician Decision|0|||
16893720|NCT01602120|37957009|FG003|Overall Study|Physician Decision|0|||
16893721|NCT01602120|37957006|FG000|Overall Study|Unspecified Reason|3|||
16893722|NCT01602120|37957007|FG001|Overall Study|Unspecified Reason|1|||
16893723|NCT01602120|37957008|FG002|Overall Study|Unspecified Reason|0|||
16893724|NCT01602120|37957009|FG003|Overall Study|Unspecified Reason|2|||
16893725|NCT02049515|37957885|FG000|Overall Study|Adverse Event|46|||
16893726|NCT02049515|37957886|FG001|Overall Study|Adverse Event|2|||
16893727|NCT02049515|37957885|FG000|Overall Study|Protocol-specified Disease Progression|23|||
16893728|NCT02049515|37957886|FG001|Overall Study|Protocol-specified Disease Progression|2|||
16893729|NCT02049515|37957885|FG000|Overall Study|Death|6|||
16893730|NCT02049515|37957886|FG001|Overall Study|Death|0|||
16893731|NCT02049515|37957885|FG000|Overall Study|Physician Decision|5|||
16893732|NCT02049515|37957886|FG001|Overall Study|Physician Decision|1|||
16893733|NCT02049515|37957885|FG000|Overall Study|Withdrawal by Subject|3|||
16893734|NCT02049515|37957886|FG001|Overall Study|Withdrawal by Subject|0|||
16893735|NCT02049515|37957885|FG000|Overall Study|Termination of the Study by Sponsor|2|||
16893736|NCT02049515|37957886|FG001|Overall Study|Termination of the Study by Sponsor|0|||
16893737|NCT02049515|37957885|FG000|Overall Study|Protocol Violation|1|||
16893738|NCT02049515|37957886|FG001|Overall Study|Protocol Violation|1|||
16893739|NCT02049515|37957885|FG000|Overall Study|Clinical Deterioration|1|||
16893740|NCT02049515|37957886|FG001|Overall Study|Clinical Deterioration|0|||
16893741|NCT02049515|37957885|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
16893742|NCT02049515|37957886|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
16893743|NCT02049515|37957885|FG000|Overall Study|Treatment Interruption >42 Days|1|||
16893744|NCT02049515|37957886|FG001|Overall Study|Treatment Interruption >42 Days|0|||
16893745|NCT02049515|37957885|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
16893746|NCT02049515|37957886|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
16893747|NCT04436744|37958421|FG000|Overall Study|Adverse Event|1|||
16893748|NCT04436744|37958422|FG001|Overall Study|Adverse Event|1|||
16893749|NCT04436744|37958421|FG000|Overall Study|Death|1|||
16893750|NCT04436744|37958422|FG001|Overall Study|Death|0|||
16893751|NCT04436744|37958421|FG000|Overall Study|Lost to Follow-up|0|||
16893752|NCT04436744|37958422|FG001|Overall Study|Lost to Follow-up|2|||
16893753|NCT04436744|37958421|FG000|Overall Study|Physician Decision|0|||
16893754|NCT04436744|37958422|FG001|Overall Study|Physician Decision|1|||
16893755|NCT04436744|37958421|FG000|Overall Study|Progressive Disease|0|||
16893756|NCT04436744|37958422|FG001|Overall Study|Progressive Disease|4|||
16893757|NCT04436744|37958421|FG000|Overall Study|Protocol Deviation|1|||
16893758|NCT04436744|37958422|FG001|Overall Study|Protocol Deviation|1|||
16893759|NCT04436744|37958421|FG000|Overall Study|Withdrawal by Subject|1|||
16893760|NCT04436744|37958422|FG001|Overall Study|Withdrawal by Subject|2|||
16893761|NCT04359758|37958462|FG000|Overall Study|Lost to Follow-up|0|||
16893762|NCT04359758|37958463|FG001|Overall Study|Lost to Follow-up|2|||
16893763|NCT04359758|37958462|FG000|Overall Study|Protocol Violation|3|||
16893764|NCT04359758|37958463|FG001|Overall Study|Protocol Violation|0|||
16893765|NCT02243306|37958578|FG000|Overall Study|Adverse Event|0|||
16893766|NCT02243306|37958579|FG001|Overall Study|Adverse Event|1|||
16893767|NCT02243306|37958578|FG000|Overall Study|Other: Reached stopping criteria|0|||
16893768|NCT02243306|37958579|FG001|Overall Study|Other: Reached stopping criteria|1|||
16893769|NCT02243306|37958578|FG000|Overall Study|Physician Decision|0|||
16893770|NCT02243306|37958579|FG001|Overall Study|Physician Decision|1|||
16893771|NCT03214679|37958739|FG000|Overall Study|Lost to Follow-up|12|||
16893772|NCT03214679|37958740|FG001|Overall Study|Lost to Follow-up|14|||
16893773|NCT03214679|37958739|FG000|Overall Study|not eligible|2|||
16893774|NCT03214679|37958740|FG001|Overall Study|not eligible|0|||
16893775|NCT01602380|37959087|FG000|Overall Study|Death|63|||
16893776|NCT01602380|37959088|FG001|Overall Study|Death|68|||
16893777|NCT01602380|37959087|FG000|Overall Study|Withdrawal by Subject|22|||
16893778|NCT01602380|37959088|FG001|Overall Study|Withdrawal by Subject|29|||
16893779|NCT01602380|37959087|FG000|Overall Study|Lost to Follow-up|6|||
16893780|NCT01602380|37959088|FG001|Overall Study|Lost to Follow-up|1|||
16893781|NCT01602380|37959087|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16893782|NCT01602380|37959088|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
16893783|NCT01242800|37959123|FG000|Overall Study|Patient refusal|0|||
16893784|NCT01242800|37959124|FG001|Overall Study|Patient refusal|10|||
16893785|NCT01242800|37959123|FG000|Overall Study|Physician Decision|0|||
16893786|NCT01242800|37959124|FG001|Overall Study|Physician Decision|1|||
16893787|NCT01242800|37959123|FG000|Overall Study|Disease progression|0|||
16893788|NCT01242800|37959124|FG001|Overall Study|Disease progression|3|||
16893789|NCT01242800|37959123|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
16893790|NCT01242800|37959124|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
16893791|NCT01242800|37959123|FG000|Overall Study|Reasons not reported|0|||
16893792|NCT01242800|37959124|FG001|Overall Study|Reasons not reported|4|||
16893793|NCT01349465|37960049|FG000|Overall Study|Adverse Event|1|||
16893794|NCT01349465|37960050|FG001|Overall Study|Adverse Event|0|||
16893795|NCT01349465|37960049|FG000|Overall Study|Death|3|||
16893796|NCT01349465|37960050|FG001|Overall Study|Death|0|||
16893797|NCT01349465|37960049|FG000|Overall Study|Lost to Follow-up|10|||
16893798|NCT01349465|37960050|FG001|Overall Study|Lost to Follow-up|1|||
16893799|NCT01349465|37960049|FG000|Overall Study|Withdrawal by Subject|4|||
16893800|NCT01349465|37960050|FG001|Overall Study|Withdrawal by Subject|2|||
16893801|NCT01349465|37960049|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
16893802|NCT01349465|37960050|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
16893803|NCT01648764|37961169|FG000|Overall Study|Progressive Disease|0|||
16893804|NCT01648764|37961170|FG001|Overall Study|Progressive Disease|1|||
16893805|NCT01648764|37961171|FG002|Overall Study|Progressive Disease|0|||
16893806|NCT01648764|37961172|FG003|Overall Study|Progressive Disease|0|||
16893807|NCT01648764|37961173|FG004|Overall Study|Progressive Disease|0|||
16893808|NCT01648764|37961174|FG005|Overall Study|Progressive Disease|1|||
16893809|NCT01648764|37961175|FG006|Overall Study|Progressive Disease|1|||
16893810|NCT01648764|37961176|FG007|Overall Study|Progressive Disease|0|||
16893811|NCT01648764|37961177|FG008|Overall Study|Progressive Disease|0|||
16893812|NCT01648764|37961178|FG009|Overall Study|Progressive Disease|2|||
16893813|NCT01648764|37961179|FG010|Overall Study|Progressive Disease|0|||
16893814|NCT01648764|37961180|FG011|Overall Study|Progressive Disease|1|||
16893815|NCT01648764|37961181|FG012|Overall Study|Progressive Disease|2|||
16893816|NCT01648764|37961182|FG013|Overall Study|Progressive Disease|1|||
16893817|NCT01648764|37961169|FG000|Overall Study|Adverse Event|0|||
16893818|NCT01648764|37961170|FG001|Overall Study|Adverse Event|0|||
16893819|NCT01648764|37961171|FG002|Overall Study|Adverse Event|0|||
16893820|NCT01648764|37961172|FG003|Overall Study|Adverse Event|0|||
16893821|NCT01648764|37961173|FG004|Overall Study|Adverse Event|0|||
16893822|NCT01648764|37961174|FG005|Overall Study|Adverse Event|1|||
16893823|NCT01648764|37961175|FG006|Overall Study|Adverse Event|0|||
16893824|NCT01648764|37961176|FG007|Overall Study|Adverse Event|0|||
16893825|NCT01648764|37961177|FG008|Overall Study|Adverse Event|0|||
16893826|NCT01648764|37961178|FG009|Overall Study|Adverse Event|1|||
16893827|NCT01648764|37961179|FG010|Overall Study|Adverse Event|0|||
16893828|NCT01648764|37961180|FG011|Overall Study|Adverse Event|3|||
16893829|NCT01648764|37961181|FG012|Overall Study|Adverse Event|1|||
16893830|NCT01648764|37961182|FG013|Overall Study|Adverse Event|1|||
16893831|NCT01648764|37961169|FG000|Overall Study|Death|0|||
16893832|NCT01648764|37961170|FG001|Overall Study|Death|0|||
16893833|NCT01648764|37961171|FG002|Overall Study|Death|0|||
16893834|NCT01648764|37961172|FG003|Overall Study|Death|0|||
16893835|NCT01648764|37961173|FG004|Overall Study|Death|0|||
16893836|NCT01648764|37961174|FG005|Overall Study|Death|0|||
16893837|NCT01648764|37961175|FG006|Overall Study|Death|1|||
16893838|NCT01648764|37961176|FG007|Overall Study|Death|0|||
16893839|NCT01648764|37961177|FG008|Overall Study|Death|0|||
16893840|NCT01648764|37961178|FG009|Overall Study|Death|0|||
16893841|NCT01648764|37961179|FG010|Overall Study|Death|0|||
16893842|NCT01648764|37961180|FG011|Overall Study|Death|0|||
16893843|NCT01648764|37961181|FG012|Overall Study|Death|0|||
16893844|NCT01648764|37961182|FG013|Overall Study|Death|1|||
16893845|NCT01648764|37961169|FG000|Overall Study|Withdrawal by Subject|0|||
16893846|NCT01648764|37961170|FG001|Overall Study|Withdrawal by Subject|0|||
16893847|NCT01648764|37961171|FG002|Overall Study|Withdrawal by Subject|0|||
16893848|NCT01648764|37961172|FG003|Overall Study|Withdrawal by Subject|0|||
16893849|NCT01648764|37961173|FG004|Overall Study|Withdrawal by Subject|0|||
16893850|NCT01648764|37961174|FG005|Overall Study|Withdrawal by Subject|0|||
16893851|NCT01648764|37961175|FG006|Overall Study|Withdrawal by Subject|2|||
16893852|NCT01648764|37961176|FG007|Overall Study|Withdrawal by Subject|0|||
16893853|NCT01648764|37961177|FG008|Overall Study|Withdrawal by Subject|0|||
16893854|NCT01648764|37961178|FG009|Overall Study|Withdrawal by Subject|0|||
16893855|NCT01648764|37961179|FG010|Overall Study|Withdrawal by Subject|0|||
16893856|NCT01648764|37961180|FG011|Overall Study|Withdrawal by Subject|0|||
16893857|NCT01648764|37961181|FG012|Overall Study|Withdrawal by Subject|1|||
16893858|NCT01648764|37961182|FG013|Overall Study|Withdrawal by Subject|0|||
16893859|NCT01648764|37961169|FG000|Overall Study|Investigator Decision|0|||
16893860|NCT01648764|37961170|FG001|Overall Study|Investigator Decision|0|||
16893861|NCT01648764|37961171|FG002|Overall Study|Investigator Decision|0|||
16893862|NCT01648764|37961172|FG003|Overall Study|Investigator Decision|0|||
16893863|NCT01648764|37961173|FG004|Overall Study|Investigator Decision|0|||
16893864|NCT01648764|37961174|FG005|Overall Study|Investigator Decision|0|||
16893865|NCT01648764|37961175|FG006|Overall Study|Investigator Decision|1|||
16893866|NCT01648764|37961176|FG007|Overall Study|Investigator Decision|0|||
16893867|NCT01648764|37961177|FG008|Overall Study|Investigator Decision|0|||
16893868|NCT01648764|37961178|FG009|Overall Study|Investigator Decision|0|||
16893869|NCT01648764|37961179|FG010|Overall Study|Investigator Decision|0|||
16893870|NCT01648764|37961180|FG011|Overall Study|Investigator Decision|1|||
16893871|NCT01648764|37961181|FG012|Overall Study|Investigator Decision|0|||
16893872|NCT01648764|37961182|FG013|Overall Study|Investigator Decision|0|||
16893873|NCT02364336|37961218|FG000|Overall Study|Adverse Event|0|||
16893874|NCT02364336|37961219|FG001|Overall Study|Adverse Event|1|||
16893875|NCT02810951|37961454|FG000|Overall Study|Adverse Event|1|||
16893876|NCT02310906|37961550|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
16893877|NCT02310906|37961551|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
16893878|NCT02310906|37961552|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
16893879|NCT02310906|37961553|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
16893880|NCT02310906|37961550|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
16893881|NCT02310906|37961551|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
16893882|NCT02310906|37961552|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
16893883|NCT02310906|37961553|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
16893884|NCT02310906|37961550|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
16893885|NCT02310906|37961551|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
16893886|NCT02310906|37961552|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
16893887|NCT02310906|37961553|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
16893888|NCT02310906|37961550|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
16893889|NCT02310906|37961551|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
16893890|NCT02310906|37961552|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
16893891|NCT02310906|37961553|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
16893892|NCT02340780|37961594|FG000|Overall Study|Ineligible|1|||
16893893|NCT02340078|37961607|FG000|Overall Study|Protocol Violation|1|||
16893894|NCT02340000|37961623|FG000|Time Period 1|Withdrawal by Subject|6|||
16893895|NCT02340000|37961624|FG001|Time Period 1|Withdrawal by Subject|8|||
16893896|NCT02340000|37961623|FG000|Time Period 1|Lost to Follow-up|6|||
16893897|NCT02340000|37961624|FG001|Time Period 1|Lost to Follow-up|7|||
16893898|NCT02340000|37961623|FG000|Time Period 2|Withdrawal by Subject|9|||
16893899|NCT02340000|37961624|FG001|Time Period 2|Withdrawal by Subject|7|||
16893900|NCT02340000|37961623|FG000|Time Period 2|Lost to Follow-up|10|||
16893901|NCT02340000|37961624|FG001|Time Period 2|Lost to Follow-up|8|||
16893902|NCT02364180|37961655|FG000|Overall Study|Screen Fail|1|||
17095394|NCT00073918|38234668|FG000|Overall Study|Rapid disease progression|2|||
17095395|NCT00073918|38234668|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
16893905|NCT02310750|37962320|FG000|HP Period 1|Lost to Follow-up|0|||
17095396|NCT00231894|38234674|FG000|Overall Study|Withdrawal by Subject|1|||
16893906|NCT02310750|37962321|FG001|HP Period 1|Lost to Follow-up|0|||
16893907|NCT02310750|37962322|FG002|HP Period 1|Lost to Follow-up|0|||
16893908|NCT02310750|37962323|FG003|HP Period 1|Lost to Follow-up|0|||
16893909|NCT02310750|37962324|FG004|HP Period 1|Lost to Follow-up|0|||
16893910|NCT02310750|37962325|FG005|HP Period 1|Lost to Follow-up|0|||
16893911|NCT02310750|37962326|FG006|HP Period 1|Lost to Follow-up|1|||
16893912|NCT02310750|37962327|FG007|HP Period 1|Lost to Follow-up|0|||
16893913|NCT02310750|37962328|FG008|HP Period 1|Lost to Follow-up|0|||
16893914|NCT02310750|37962329|FG009|HP Period 1|Lost to Follow-up|0|||
17003752|NCT00896532|38147665|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003753|NCT00896532|38147666|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003754|NCT00896532|38147667|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
17003755|NCT00896532|38147668|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003756|NCT00896532|38147669|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003757|NCT00896532|38147670|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003758|NCT00896532|38147671|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003759|NCT00896532|38147672|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16893915|NCT02310750|37962330|FG010|HP Period 1|Lost to Follow-up|0|||
16893916|NCT02310750|37962331|FG011|HP Period 1|Lost to Follow-up|0|||
16893917|NCT02310750|37962332|FG012|HP Period 1|Lost to Follow-up|0|||
16893918|NCT02310750|37962333|FG013|HP Period 1|Lost to Follow-up|0|||
16893919|NCT02310750|37962334|FG014|HP Period 1|Lost to Follow-up|0|||
16893920|NCT02310750|37962335|FG015|HP Period 1|Lost to Follow-up|0|||
16893921|NCT02310750|37962320|FG000|HP Period 1|Withdrawal by Subject|1|||
16893922|NCT02310750|37962321|FG001|HP Period 1|Withdrawal by Subject|0|||
16893923|NCT02310750|37962322|FG002|HP Period 1|Withdrawal by Subject|0|||
16893924|NCT02310750|37962323|FG003|HP Period 1|Withdrawal by Subject|1|||
16893925|NCT02310750|37962324|FG004|HP Period 1|Withdrawal by Subject|0|||
16893926|NCT02310750|37962325|FG005|HP Period 1|Withdrawal by Subject|0|||
16893927|NCT02310750|37962326|FG006|HP Period 1|Withdrawal by Subject|0|||
16893928|NCT02310750|37962327|FG007|HP Period 1|Withdrawal by Subject|0|||
16893929|NCT02310750|37962328|FG008|HP Period 1|Withdrawal by Subject|0|||
16893930|NCT02310750|37962329|FG009|HP Period 1|Withdrawal by Subject|0|||
16893931|NCT02310750|37962330|FG010|HP Period 1|Withdrawal by Subject|0|||
16893932|NCT02310750|37962331|FG011|HP Period 1|Withdrawal by Subject|0|||
16893933|NCT02310750|37962332|FG012|HP Period 1|Withdrawal by Subject|0|||
16893934|NCT02310750|37962333|FG013|HP Period 1|Withdrawal by Subject|0|||
16893935|NCT02310750|37962334|FG014|HP Period 1|Withdrawal by Subject|0|||
16893936|NCT02310750|37962335|FG015|HP Period 1|Withdrawal by Subject|0|||
16893937|NCT02310750|37962320|FG000|HP Washout 1|Lost to Follow-up|0|||
16893938|NCT02310750|37962321|FG001|HP Washout 1|Lost to Follow-up|0|||
16893939|NCT02310750|37962322|FG002|HP Washout 1|Lost to Follow-up|1|||
16893940|NCT02310750|37962323|FG003|HP Washout 1|Lost to Follow-up|1|||
16893941|NCT02310750|37962324|FG004|HP Washout 1|Lost to Follow-up|2|||
16893942|NCT02310750|37962325|FG005|HP Washout 1|Lost to Follow-up|2|||
16893943|NCT02310750|37962326|FG006|HP Washout 1|Lost to Follow-up|3|||
16893944|NCT02310750|37962327|FG007|HP Washout 1|Lost to Follow-up|0|||
16893945|NCT02310750|37962328|FG008|HP Washout 1|Lost to Follow-up|0|||
16893946|NCT02310750|37962329|FG009|HP Washout 1|Lost to Follow-up|0|||
16893947|NCT02310750|37962330|FG010|HP Washout 1|Lost to Follow-up|0|||
16893948|NCT02310750|37962331|FG011|HP Washout 1|Lost to Follow-up|0|||
16893949|NCT02310750|37962332|FG012|HP Washout 1|Lost to Follow-up|0|||
17003760|NCT00896532|38147673|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003761|NCT00896532|38147674|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003762|NCT00896532|38147675|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003763|NCT00896532|38147676|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003764|NCT00896532|38147677|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16893950|NCT02310750|37962333|FG013|HP Washout 1|Lost to Follow-up|0|||
16893951|NCT02310750|37962334|FG014|HP Washout 1|Lost to Follow-up|0|||
16893952|NCT02310750|37962335|FG015|HP Washout 1|Lost to Follow-up|0|||
16893953|NCT02310750|37962320|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893954|NCT02310750|37962321|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893955|NCT02310750|37962322|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893956|NCT02310750|37962323|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
16893957|NCT02310750|37962324|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893958|NCT02310750|37962325|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
16893959|NCT02310750|37962326|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893960|NCT02310750|37962327|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893961|NCT02310750|37962328|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
16893962|NCT02310750|37962329|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
16893963|NCT02310750|37962330|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893964|NCT02310750|37962331|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893965|NCT02310750|37962332|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893966|NCT02310750|37962333|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893967|NCT02310750|37962334|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893968|NCT02310750|37962335|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16893969|NCT02310750|37962320|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893970|NCT02310750|37962321|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893971|NCT02310750|37962322|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893972|NCT02310750|37962323|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893973|NCT02310750|37962324|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893974|NCT02310750|37962325|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893975|NCT02310750|37962326|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893976|NCT02310750|37962327|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893977|NCT02310750|37962328|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893978|NCT02310750|37962329|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
16893979|NCT02310750|37962330|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893980|NCT02310750|37962331|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893981|NCT02310750|37962332|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893982|NCT02310750|37962333|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893983|NCT02310750|37962334|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893984|NCT02310750|37962335|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16893985|NCT02310750|37962320|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893986|NCT02310750|37962321|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893987|NCT02310750|37962322|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893988|NCT02310750|37962323|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893989|NCT02310750|37962324|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893990|NCT02310750|37962325|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893991|NCT02310750|37962326|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893992|NCT02310750|37962327|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
16893993|NCT02310750|37962328|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
16893994|NCT02310750|37962329|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
16893995|NCT02310750|37962330|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893996|NCT02310750|37962331|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893997|NCT02310750|37962332|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893998|NCT02310750|37962333|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16893999|NCT02310750|37962334|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16894000|NCT02310750|37962335|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16894001|NCT02310750|37962320|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894002|NCT02310750|37962321|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894003|NCT02310750|37962322|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894004|NCT02310750|37962323|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894005|NCT02310750|37962324|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894006|NCT02310750|37962325|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894007|NCT02310750|37962326|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894008|NCT02310750|37962327|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
16894009|NCT02310750|37962328|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
16894010|NCT02310750|37962329|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894011|NCT02310750|37962330|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894012|NCT02310750|37962331|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894013|NCT02310750|37962332|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894014|NCT02310750|37962333|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894015|NCT02310750|37962334|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894016|NCT02310750|37962335|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16894017|NCT02310750|37962320|FG000|HP Washout 2|Lost to Follow-up|0|||
16894018|NCT02310750|37962321|FG001|HP Washout 2|Lost to Follow-up|0|||
16894019|NCT02310750|37962322|FG002|HP Washout 2|Lost to Follow-up|0|||
16894020|NCT02310750|37962323|FG003|HP Washout 2|Lost to Follow-up|0|||
16894021|NCT02310750|37962324|FG004|HP Washout 2|Lost to Follow-up|1|||
16894022|NCT02310750|37962325|FG005|HP Washout 2|Lost to Follow-up|0|||
16894023|NCT02310750|37962326|FG006|HP Washout 2|Lost to Follow-up|7|||
16894024|NCT02310750|37962327|FG007|HP Washout 2|Lost to Follow-up|0|||
16894025|NCT02310750|37962328|FG008|HP Washout 2|Lost to Follow-up|0|||
16894026|NCT02310750|37962329|FG009|HP Washout 2|Lost to Follow-up|0|||
16894027|NCT02310750|37962330|FG010|HP Washout 2|Lost to Follow-up|0|||
16894028|NCT02310750|37962331|FG011|HP Washout 2|Lost to Follow-up|0|||
16894029|NCT02310750|37962332|FG012|HP Washout 2|Lost to Follow-up|0|||
16894030|NCT02310750|37962333|FG013|HP Washout 2|Lost to Follow-up|0|||
16894031|NCT02310750|37962334|FG014|HP Washout 2|Lost to Follow-up|0|||
16894032|NCT02310750|37962335|FG015|HP Washout 2|Lost to Follow-up|0|||
16894033|NCT02310672|37962440|FG000|Overall Study|Death|1|||
16894034|NCT02310672|37962440|FG000|Overall Study|Lost to Follow-up|1|||
16894035|NCT02310672|37962440|FG000|Overall Study|Withdrawal by Subject|1|||
16894036|NCT02310672|37962440|FG000|Overall Study|Sponsor's decision|12|||
16894037|NCT02363946|37962594|FG000|Overall Study|Lost to Follow-up|0|||
16894038|NCT02363946|37962595|FG001|Overall Study|Lost to Follow-up|0|||
16894039|NCT02363946|37962596|FG002|Overall Study|Lost to Follow-up|0|||
16894040|NCT02363946|37962597|FG003|Overall Study|Lost to Follow-up|0|||
16894041|NCT02363946|37962598|FG004|Overall Study|Lost to Follow-up|0|||
16894042|NCT02363946|37962599|FG005|Overall Study|Lost to Follow-up|0|||
16894043|NCT02363946|37962600|FG006|Overall Study|Lost to Follow-up|0|||
16894044|NCT02363946|37962601|FG007|Overall Study|Lost to Follow-up|1|||
16894045|NCT02363946|37962602|FG008|Overall Study|Lost to Follow-up|0|||
16894046|NCT02363946|37962603|FG009|Overall Study|Lost to Follow-up|0|||
16894047|NCT02363946|37962604|FG010|Overall Study|Lost to Follow-up|0|||
16894048|NCT02363946|37962605|FG011|Overall Study|Lost to Follow-up|0|||
16894049|NCT02363946|37962606|FG012|Overall Study|Lost to Follow-up|0|||
16894050|NCT02363478|37962634|FG000|Overall Study|Lost to Follow-up|4|||
16894051|NCT02363478|37962634|FG000|Overall Study|Adverse Event|4|||
16894052|NCT02310126|37962641|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
16894053|NCT02310126|37962642|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
16894054|NCT02310126|37962641|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
16894055|NCT02310126|37962642|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
16894056|NCT02338362|37962650|FG000|Overall Study|Withdrawal by Subject|1|||
16894057|NCT02338362|37962651|FG001|Overall Study|Withdrawal by Subject|1|||
16894058|NCT02363322|37962659|FG000|Overall Study|Lost to Follow-up|1|||
16894059|NCT02363322|37962660|FG001|Overall Study|Lost to Follow-up|0|||
16894060|NCT02361762|37962668|FG000|Overall Study|Withdrawal by Subject|0|||
16894061|NCT02361762|37962669|FG001|Overall Study|Withdrawal by Subject|1|||
16894062|NCT02361762|37962668|FG000|Overall Study|Lost to Follow-up|0|||
16894063|NCT02361762|37962669|FG001|Overall Study|Lost to Follow-up|1|||
16894064|NCT02337738|37962678|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
16894065|NCT02337738|37962679|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
16894066|NCT02337738|37962680|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
16894067|NCT02337738|37962678|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16894068|NCT02337738|37962679|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
16894069|NCT02337738|37962680|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
16894070|NCT02337738|37962678|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
16894071|NCT02337738|37962679|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
16894072|NCT02337738|37962680|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
16894073|NCT02337738|37962678|FG000|Overall Study|Voluntary Withdrawal|10|||
16894074|NCT02337738|37962679|FG001|Overall Study|Voluntary Withdrawal|5|||
16894075|NCT02337738|37962680|FG002|Overall Study|Voluntary Withdrawal|2|||
16894076|NCT02337738|37962678|FG000|Overall Study|Lack of Efficacy|2|||
16894077|NCT02337738|37962679|FG001|Overall Study|Lack of Efficacy|4|||
16894078|NCT02337738|37962680|FG002|Overall Study|Lack of Efficacy|0|||
16894079|NCT02337738|37962678|FG000|Overall Study|Investigator's Judgment|1|||
16894080|NCT02337738|37962679|FG001|Overall Study|Investigator's Judgment|1|||
16894081|NCT02337738|37962680|FG002|Overall Study|Investigator's Judgment|3|||
16894082|NCT02309112|37962691|FG000|Overall Study|Withdrawal by Subject|1|||
16894083|NCT02309112|37962692|FG001|Overall Study|Withdrawal by Subject|0|||
16894084|NCT02309112|37962693|FG002|Overall Study|Withdrawal by Subject|1|||
16894085|NCT02309112|37962691|FG000|Overall Study|Lost to Follow-up|0|||
16894086|NCT02309112|37962692|FG001|Overall Study|Lost to Follow-up|1|||
16894087|NCT02309112|37962693|FG002|Overall Study|Lost to Follow-up|0|||
16894088|NCT02308488|37962703|FG000|Overall Study|Withdrawal by Subject|2|||
16894089|NCT02361216|37962709|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
16894090|NCT02361216|37962710|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
16894091|NCT02361216|37962709|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
16894092|NCT02361216|37962710|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
17003765|NCT00896532|38147678|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003766|NCT00896532|38147679|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003767|NCT00896532|38147680|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003768|NCT00896532|38147681|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
17003769|NCT00896532|38147659|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003770|NCT00896532|38147660|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003771|NCT00896532|38147661|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003772|NCT00896532|38147662|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003773|NCT00896532|38147663|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003774|NCT00896532|38147664|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003775|NCT00896532|38147665|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003776|NCT00896532|38147666|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003777|NCT00896532|38147667|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003778|NCT00896532|38147668|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003779|NCT00896532|38147669|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16894093|NCT02361216|37962709|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
16894094|NCT02361216|37962710|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
16894095|NCT02361216|37962709|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
16894096|NCT02361216|37962710|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
16894097|NCT02361216|37962709|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
16894098|NCT02361216|37962710|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
16894099|NCT02361216|37962709|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
16894100|NCT02361216|37962710|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
16894101|NCT02360280|37962721|FG000|Overall Study|Withdrawal by Subject|2|||
16894102|NCT02360280|37962722|FG001|Overall Study|Withdrawal by Subject|0|||
16894103|NCT02360280|37962721|FG000|Overall Study|Adverse Event|0|||
16894104|NCT02360280|37962722|FG001|Overall Study|Adverse Event|1|||
16894105|NCT02360280|37962721|FG000|Overall Study|Lost to Follow-up|1|||
16894106|NCT02360280|37962722|FG001|Overall Study|Lost to Follow-up|0|||
16894107|NCT00559988|37963152|FG000|Overall Study|Death|147|||
16894108|NCT00559988|37963153|FG001|Overall Study|Death|140|||
16894109|NCT00559988|37963152|FG000|Overall Study|Withdrawal by Subject|152|||
16894110|NCT00559988|37963153|FG001|Overall Study|Withdrawal by Subject|139|||
16894111|NCT00559988|37963152|FG000|Overall Study|Lost to Follow-up|42|||
16894112|NCT00559988|37963153|FG001|Overall Study|Lost to Follow-up|56|||
16894113|NCT00559988|37963152|FG000|Overall Study|ICD device explanted|10|||
16894114|NCT00559988|37963153|FG001|Overall Study|ICD device explanted|17|||
16894115|NCT00559754|37963215|FG000|Overall Study|Disease progression|1|||
16894116|NCT00559754|37963215|FG000|Overall Study|Adverse Event|5|||
16894117|NCT00559754|37963215|FG000|Overall Study|Protocol Violation|1|||
16894118|NCT00559754|37963215|FG000|Overall Study|Investigator criteria|2|||
16894119|NCT00559754|37963215|FG000|Overall Study|Withdrawal by Subject|2|||
16894120|NCT00559364|37963329|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
16894121|NCT00559364|37963330|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
16894122|NCT02308020|37963393|FG000|Overall Study|Lost to Follow-up|1|||
16894123|NCT02308020|37963394|FG001|Overall Study|Lost to Follow-up|7|||
16894124|NCT02308020|37963395|FG002|Overall Study|Lost to Follow-up|0|||
16894125|NCT02308020|37963396|FG003|Overall Study|Lost to Follow-up|0|||
16894126|NCT02308020|37963397|FG004|Overall Study|Lost to Follow-up|1|||
16894127|NCT02308020|37963398|FG005|Overall Study|Lost to Follow-up|2|||
16894128|NCT02308020|37963393|FG000|Overall Study|Sponsor Decision|0|||
16894129|NCT02308020|37963394|FG001|Overall Study|Sponsor Decision|8|||
16894130|NCT02308020|37963395|FG002|Overall Study|Sponsor Decision|0|||
16894131|NCT02308020|37963396|FG003|Overall Study|Sponsor Decision|2|||
16894132|NCT02308020|37963397|FG004|Overall Study|Sponsor Decision|2|||
16894133|NCT02308020|37963398|FG005|Overall Study|Sponsor Decision|1|||
16894134|NCT02308020|37963393|FG000|Overall Study|Withdrawal by Subject|3|||
16894135|NCT02308020|37963394|FG001|Overall Study|Withdrawal by Subject|5|||
16894136|NCT02308020|37963395|FG002|Overall Study|Withdrawal by Subject|3|||
16894137|NCT02308020|37963396|FG003|Overall Study|Withdrawal by Subject|2|||
16894138|NCT02308020|37963397|FG004|Overall Study|Withdrawal by Subject|1|||
16894139|NCT02308020|37963398|FG005|Overall Study|Withdrawal by Subject|2|||
16894140|NCT02359890|37963418|FG000|Overall Study|Not meeting eligibility|4|||
16894141|NCT02359890|37963418|FG000|Overall Study|Never treated with study catheter|6|||
16894142|NCT02306850|37963422|FG000|Overall Study|Lack of Efficacy|2|||
16894143|NCT02306694|37963427|FG000|Overall Study|Withdrawal by Subject|3|||
16894144|NCT02306694|37963427|FG000|Overall Study|Lost to Follow-up|1|||
16894145|NCT01648140|37963439|FG000|Overall Study|Physician Decision|1|||
16894146|NCT01648140|37963440|FG001|Overall Study|Physician Decision|0|||
16894147|NCT01648140|37963441|FG002|Overall Study|Physician Decision|0|||
16894148|NCT01648140|37963442|FG003|Overall Study|Physician Decision|0|||
16894149|NCT01648140|37963439|FG000|Overall Study|Lack of Efficacy|4|||
16894150|NCT01648140|37963440|FG001|Overall Study|Lack of Efficacy|7|||
16894151|NCT01648140|37963441|FG002|Overall Study|Lack of Efficacy|1|||
16894152|NCT01648140|37963442|FG003|Overall Study|Lack of Efficacy|0|||
16894153|NCT01648140|37963439|FG000|Overall Study|Adverse Event|3|||
16894154|NCT01648140|37963440|FG001|Overall Study|Adverse Event|1|||
16894155|NCT01648140|37963441|FG002|Overall Study|Adverse Event|2|||
16894156|NCT01648140|37963442|FG003|Overall Study|Adverse Event|0|||
16894157|NCT01648140|37963439|FG000|Overall Study|Withdrawal by Subject|2|||
16894158|NCT01648140|37963440|FG001|Overall Study|Withdrawal by Subject|3|||
16894159|NCT01648140|37963441|FG002|Overall Study|Withdrawal by Subject|3|||
16894160|NCT01648140|37963442|FG003|Overall Study|Withdrawal by Subject|2|||
16894161|NCT01648140|37963439|FG000|Overall Study|Lost to Follow-up|2|||
16894162|NCT01648140|37963440|FG001|Overall Study|Lost to Follow-up|1|||
16894163|NCT01648140|37963441|FG002|Overall Study|Lost to Follow-up|2|||
16894164|NCT01648140|37963442|FG003|Overall Study|Lost to Follow-up|0|||
16894165|NCT02336178|37963461|FG000|Overall Study|Lost to Follow-up|1|||
16894166|NCT02336178|37963461|FG000|Overall Study|Protocol Violation|1|||
16894167|NCT02336178|37963461|FG000|Overall Study|Withdrawal by Subject|1|||
16894168|NCT02336178|37963461|FG000|Overall Study|Other|1|||
16894169|NCT02357940|37963475|FG000|Overall Study|Adverse Event|0|||
16894170|NCT02357940|37963476|FG001|Overall Study|Adverse Event|1|||
16894171|NCT02357940|37963475|FG000|Overall Study|Investigator's judgement|0|||
16894172|NCT02357940|37963476|FG001|Overall Study|Investigator's judgement|1|||
16894173|NCT02335242|37963484|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
16894174|NCT02335242|37963485|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
16894175|NCT02335242|37963484|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
16894176|NCT02335242|37963485|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16894177|NCT02335242|37963484|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
16894178|NCT02335242|37963485|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
16894179|NCT02334384|37963497|FG000|Overall Study|Lost to Follow-up|1|||
16894180|NCT02334384|37963498|FG001|Overall Study|Lost to Follow-up|1|||
16894181|NCT02334306|37963506|FG000|Double-blind Period|Adverse Event|0|||
16894182|NCT02334306|37963507|FG001|Double-blind Period|Adverse Event|1|||
16894183|NCT02334306|37963506|FG000|Double-blind Period|Withdrawal by Subject|1|||
16894184|NCT02334306|37963507|FG001|Double-blind Period|Withdrawal by Subject|1|||
16894185|NCT02305758|37963516|FG000|Overall Study|Death|27|||
16894186|NCT02305758|37963517|FG001|Overall Study|Death|27|||
16894187|NCT02305758|37963516|FG000|Overall Study|Withdrew consent|9|||
16894188|NCT02305758|37963517|FG001|Overall Study|Withdrew consent|2|||
16894189|NCT02305758|37963516|FG000|Overall Study|Lost to Follow-up|6|||
16894190|NCT02305758|37963517|FG001|Overall Study|Lost to Follow-up|1|||
16894191|NCT02305758|37963516|FG000|Overall Study|Study Terminated by Sponsor|21|||
16894192|NCT02305758|37963517|FG001|Overall Study|Study Terminated by Sponsor|34|||
16894193|NCT02305758|37963516|FG000|Overall Study|Other, not specified|2|||
16894194|NCT02305758|37963517|FG001|Overall Study|Other, not specified|1|||
16894195|NCT02305446|37963523|FG000|Overall Study|Adverse Event|1|||
16894196|NCT02303574|37963660|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894197|NCT02303574|37963661|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894198|NCT02303574|37963662|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
16894199|NCT02303574|37963663|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894200|NCT02303574|37963664|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894201|NCT02303574|37963665|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894202|NCT02303574|37963666|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894203|NCT02303574|37963667|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894204|NCT02303574|37963668|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894205|NCT02303574|37963669|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16894206|NCT02303574|37963660|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16894207|NCT02303574|37963661|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16894208|NCT02303574|37963662|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16894209|NCT02303574|37963663|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16894210|NCT02303574|37963664|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
17192287|NCT00706797|38345522|FG000|Overall Study|Discontinuation of study by sponsor|52|||
17192288|NCT00706797|38345523|FG001|Overall Study|Discontinuation of study by sponsor|63|||
17192289|NCT00706797|38345522|FG000|Overall Study|Protocol Violation|3|||
17192290|NCT00706797|38345523|FG001|Overall Study|Protocol Violation|2|||
17192291|NCT00706797|38345522|FG000|Overall Study|Lost to Follow-up|1|||
17192292|NCT00706797|38345523|FG001|Overall Study|Lost to Follow-up|2|||
17192293|NCT00706797|38345522|FG000|Overall Study|Other|1|||
17192294|NCT00706797|38345523|FG001|Overall Study|Other|0|||
17192295|NCT00706641|38345529|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
17192296|NCT00706641|38345529|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
17192297|NCT00706641|38345529|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
17192298|NCT01362530|38345535|FG000|Base Study (Cycle 1)|Adverse Event|2|||
17192299|NCT01362530|38345536|FG001|Base Study (Cycle 1)|Adverse Event|0|||
17192300|NCT01362530|38345535|FG000|Base Study (Cycle 1)|Physician Decision|0|||
17192301|NCT01362530|38345536|FG001|Base Study (Cycle 1)|Physician Decision|1|||
17192302|NCT01362530|38345535|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
17192303|NCT01362530|38345536|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
17192304|NCT01362530|38345535|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
17192305|NCT01362530|38345536|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
17192306|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
17192307|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
17192308|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
17192309|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
17192310|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
17192311|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
17192312|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
17192313|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
17192314|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
17192315|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
17192316|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
17192317|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
17192318|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
17192319|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
17192320|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
17192321|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
17192322|NCT01362530|38345535|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
16785860|NCT02008318|37725975|FG001|Overall Study|Protocol Violation|1|||
16894211|NCT02303574|37963665|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16894212|NCT02303574|37963666|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16894213|NCT02303574|37963667|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
16894214|NCT02303574|37963668|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16894215|NCT02303574|37963669|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16894216|NCT02354976|37963705|FG000|Overall Study|Other - reason not specified|1|||
16894217|NCT02354976|37963706|FG001|Overall Study|Other - reason not specified|0|||
16894218|NCT02354976|37963707|FG002|Overall Study|Other - reason not specified|1|||
16894219|NCT02354976|37963705|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
16894220|NCT02354976|37963706|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
16894221|NCT02354976|37963707|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
16894222|NCT02354976|37963705|FG000|Overall Study|Adverse Event|1|||
16894223|NCT02354976|37963706|FG001|Overall Study|Adverse Event|0|||
16894224|NCT02354976|37963707|FG002|Overall Study|Adverse Event|2|||
16894225|NCT02303262|37963715|FG000|Overall Study|Withdrawal by Subject|2|||
16894226|NCT00558896|37963726|FG000|Overall Study|Adverse Event|1|||
16894227|NCT00558896|37963727|FG001|Overall Study|Adverse Event|1|||
16894228|NCT00558896|37963728|FG002|Overall Study|Adverse Event|1|||
16894229|NCT00558896|37963729|FG003|Overall Study|Adverse Event|3|||
16894230|NCT00558896|37963730|FG004|Overall Study|Adverse Event|4|||
16894231|NCT00558896|37963731|FG005|Overall Study|Adverse Event|10|||
16894232|NCT00558896|37963732|FG006|Overall Study|Adverse Event|3|||
16894233|NCT00558896|37963726|FG000|Overall Study|Death|3|||
16894234|NCT00558896|37963727|FG001|Overall Study|Death|0|||
16894235|NCT00558896|37963728|FG002|Overall Study|Death|2|||
16894236|NCT00558896|37963729|FG003|Overall Study|Death|3|||
16894237|NCT00558896|37963730|FG004|Overall Study|Death|2|||
16894238|NCT00558896|37963731|FG005|Overall Study|Death|2|||
16894239|NCT00558896|37963732|FG006|Overall Study|Death|6|||
16894240|NCT00558896|37963726|FG000|Overall Study|Withdrawal by Subject|2|||
16894241|NCT00558896|37963727|FG001|Overall Study|Withdrawal by Subject|1|||
16894242|NCT00558896|37963728|FG002|Overall Study|Withdrawal by Subject|1|||
16894243|NCT00558896|37963729|FG003|Overall Study|Withdrawal by Subject|1|||
16894244|NCT00558896|37963730|FG004|Overall Study|Withdrawal by Subject|1|||
16894245|NCT00558896|37963731|FG005|Overall Study|Withdrawal by Subject|5|||
16894246|NCT00558896|37963732|FG006|Overall Study|Withdrawal by Subject|5|||
16894247|NCT00558896|37963726|FG000|Overall Study|Alternative Treatment|2|||
16894248|NCT00558896|37963727|FG001|Overall Study|Alternative Treatment|2|||
16894249|NCT00558896|37963728|FG002|Overall Study|Alternative Treatment|0|||
16894250|NCT00558896|37963729|FG003|Overall Study|Alternative Treatment|2|||
16894251|NCT00558896|37963730|FG004|Overall Study|Alternative Treatment|6|||
16894252|NCT00558896|37963731|FG005|Overall Study|Alternative Treatment|7|||
16894253|NCT00558896|37963732|FG006|Overall Study|Alternative Treatment|1|||
16894254|NCT00558896|37963726|FG000|Overall Study|Physician discretion|3|||
16894255|NCT00558896|37963727|FG001|Overall Study|Physician discretion|2|||
16894256|NCT00558896|37963728|FG002|Overall Study|Physician discretion|1|||
16894257|NCT00558896|37963729|FG003|Overall Study|Physician discretion|2|||
16894258|NCT00558896|37963730|FG004|Overall Study|Physician discretion|1|||
16894259|NCT00558896|37963731|FG005|Overall Study|Physician discretion|3|||
16894260|NCT00558896|37963732|FG006|Overall Study|Physician discretion|3|||
16894261|NCT00558896|37963726|FG000|Overall Study|Continues on treatment|10|||
16894262|NCT00558896|37963727|FG001|Overall Study|Continues on treatment|1|||
16894263|NCT00558896|37963728|FG002|Overall Study|Continues on treatment|0|||
16894264|NCT00558896|37963729|FG003|Overall Study|Continues on treatment|1|||
16894265|NCT00558896|37963730|FG004|Overall Study|Continues on treatment|9|||
16894266|NCT00558896|37963731|FG005|Overall Study|Continues on treatment|25|||
16894267|NCT00558896|37963732|FG006|Overall Study|Continues on treatment|6|||
16894268|NCT00558428|37963866|FG000|Overall Study|Adverse Event|6|||
16894269|NCT00558428|37963867|FG001|Overall Study|Adverse Event|22|||
16894270|NCT00558428|37963868|FG002|Overall Study|Adverse Event|3|||
16894271|NCT00558428|37963869|FG003|Overall Study|Adverse Event|4|||
16894272|NCT00558428|37963866|FG000|Overall Study|Lost to Follow-up|0|||
16894273|NCT00558428|37963867|FG001|Overall Study|Lost to Follow-up|1|||
16894274|NCT00558428|37963868|FG002|Overall Study|Lost to Follow-up|0|||
16894275|NCT00558428|37963869|FG003|Overall Study|Lost to Follow-up|0|||
16894276|NCT00558428|37963866|FG000|Overall Study|Lack of Efficacy|0|||
16894277|NCT00558428|37963867|FG001|Overall Study|Lack of Efficacy|0|||
16894278|NCT00558428|37963868|FG002|Overall Study|Lack of Efficacy|1|||
16894279|NCT00558428|37963869|FG003|Overall Study|Lack of Efficacy|2|||
16894280|NCT00558428|37963866|FG000|Overall Study|Non compliant with protocol|1|||
16894281|NCT00558428|37963867|FG001|Overall Study|Non compliant with protocol|0|||
16894282|NCT00558428|37963868|FG002|Overall Study|Non compliant with protocol|0|||
16894283|NCT00558428|37963869|FG003|Overall Study|Non compliant with protocol|3|||
16894284|NCT00558428|37963866|FG000|Overall Study|Consent withdrawn|2|||
16785861|NCT02008318|37725974|FG000|Overall Study|Withdrawal by Subject|3|||
16894285|NCT00558428|37963867|FG001|Overall Study|Consent withdrawn|1|||
16894286|NCT00558428|37963868|FG002|Overall Study|Consent withdrawn|0|||
16894287|NCT00558428|37963869|FG003|Overall Study|Consent withdrawn|1|||
16894288|NCT00558428|37963866|FG000|Overall Study|Other|3|||
16894289|NCT00558428|37963867|FG001|Overall Study|Other|0|||
16894290|NCT00558428|37963868|FG002|Overall Study|Other|0|||
16894291|NCT00558428|37963869|FG003|Overall Study|Other|1|||
16894292|NCT00558272|37963908|FG000|Overall Study|Adverse Event|10|||
16894293|NCT00558272|37963909|FG001|Overall Study|Adverse Event|0|||
16894294|NCT00558272|37963908|FG000|Overall Study|Death|1|||
16894295|NCT00558272|37963909|FG001|Overall Study|Death|0|||
16894296|NCT00558272|37963908|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
16894297|NCT00558272|37963909|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
16894298|NCT00558272|37963908|FG000|Overall Study|AZ study team decision|0|||
16894299|NCT00558272|37963909|FG001|Overall Study|AZ study team decision|1|||
16894300|NCT00558272|37963908|FG000|Overall Study|Incorrectly enrolled|1|||
16894301|NCT00558272|37963909|FG001|Overall Study|Incorrectly enrolled|0|||
16894302|NCT00558272|37963908|FG000|Overall Study|Withdrawal by Subject|0|||
16894303|NCT00558272|37963909|FG001|Overall Study|Withdrawal by Subject|1|||
16894304|NCT00557492|37964073|FG000|Overall Study|Change in health insurance|1|||
16894305|NCT02354586|37964176|FG000|Overall Study|Death|230|||
16894306|NCT02354586|37964176|FG000|Overall Study|Withdrawal by Subject|59|||
16894307|NCT02354586|37964176|FG000|Overall Study|Lost to Follow-up|11|||
16894308|NCT02354586|37964176|FG000|Overall Study|Sponsor decision|51|||
16894309|NCT02354586|37964176|FG000|Overall Study|Site closure|2|||
16894310|NCT02354586|37964176|FG000|Overall Study|Intercurrent illness|1|||
16894311|NCT02354586|37964176|FG000|Overall Study|Protocol Violation|3|||
16894312|NCT02354586|37964176|FG000|Overall Study|Physician Decision|13|||
16894313|NCT02354586|37964176|FG000|Overall Study|Lack of Efficacy|86|||
16894314|NCT02354586|37964176|FG000|Overall Study|Adverse Event|7|||
16894315|NCT02332824|37964201|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
16894316|NCT02332824|37964202|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16894317|NCT02332824|37964203|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
16894318|NCT02332824|37964204|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
16894319|NCT02332824|37964205|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
16894320|NCT02332824|37964206|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
16894321|NCT02332824|37964201|FG000|Overall Study|Voluntary Withdrawal|1|||
16894322|NCT02332824|37964202|FG001|Overall Study|Voluntary Withdrawal|0|||
16894323|NCT02332824|37964203|FG002|Overall Study|Voluntary Withdrawal|0|||
16894324|NCT02332824|37964204|FG003|Overall Study|Voluntary Withdrawal|0|||
16894325|NCT02332824|37964205|FG004|Overall Study|Voluntary Withdrawal|0|||
16894326|NCT02332824|37964206|FG005|Overall Study|Voluntary Withdrawal|0|||
16894327|NCT02332824|37964201|FG000|Overall Study|Inconvenient schedule|1|||
16894328|NCT02332824|37964202|FG001|Overall Study|Inconvenient schedule|1|||
16894329|NCT02332824|37964203|FG002|Overall Study|Inconvenient schedule|0|||
16894330|NCT02332824|37964204|FG003|Overall Study|Inconvenient schedule|0|||
16894331|NCT02332824|37964205|FG004|Overall Study|Inconvenient schedule|0|||
16894332|NCT02332824|37964206|FG005|Overall Study|Inconvenient schedule|0|||
16894333|NCT02332824|37964201|FG000|Overall Study|Transfer|0|||
16894334|NCT02332824|37964202|FG001|Overall Study|Transfer|0|||
16894335|NCT02332824|37964203|FG002|Overall Study|Transfer|1|||
17003780|NCT00896532|38147670|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003781|NCT00896532|38147671|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
17003782|NCT00896532|38147672|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003783|NCT00896532|38147673|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003784|NCT00896532|38147674|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003785|NCT00896532|38147675|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003786|NCT00896532|38147676|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003787|NCT00896532|38147677|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003788|NCT00896532|38147678|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003789|NCT00896532|38147679|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003790|NCT00896532|38147680|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003791|NCT00896532|38147681|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
17003792|NCT00896532|38147659|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003793|NCT00896532|38147660|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003794|NCT00896532|38147661|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003795|NCT00896532|38147662|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003796|NCT00896532|38147663|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003797|NCT00896532|38147664|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003798|NCT00896532|38147665|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003799|NCT00896532|38147666|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003800|NCT00896532|38147667|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003801|NCT00896532|38147668|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16894336|NCT02332824|37964204|FG003|Overall Study|Transfer|1|||
16894337|NCT02332824|37964205|FG004|Overall Study|Transfer|0|||
16894338|NCT02332824|37964206|FG005|Overall Study|Transfer|0|||
16894339|NCT00556712|37964353|FG000|Overall Study|Adverse Event|7|||
16894340|NCT00556712|37964354|FG001|Overall Study|Adverse Event|19|||
16894341|NCT00556712|37964353|FG000|Overall Study|Death|5|||
16894342|NCT00556712|37964354|FG001|Overall Study|Death|10|||
16894343|NCT00556712|37964353|FG000|Overall Study|Progressive Disease|383|||
16894344|NCT00556712|37964354|FG001|Overall Study|Progressive Disease|320|||
16894345|NCT00556712|37964353|FG000|Overall Study|Protocol Violation|3|||
16894346|NCT00556712|37964354|FG001|Overall Study|Protocol Violation|2|||
17003802|NCT00896532|38147669|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
17003803|NCT00896532|38147670|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003804|NCT00896532|38147671|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
17003805|NCT00896532|38147672|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003806|NCT00896532|38147673|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003807|NCT00896532|38147674|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003808|NCT00896532|38147675|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003809|NCT00896532|38147676|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003810|NCT00896532|38147677|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003811|NCT00896532|38147678|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003812|NCT00896532|38147679|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003813|NCT00896532|38147680|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16894347|NCT00556712|37964353|FG000|Overall Study|Refused Treatment|17|||
16894348|NCT00556712|37964354|FG001|Overall Study|Refused Treatment|16|||
16894349|NCT00556712|37964353|FG000|Overall Study|Failure to Return|2|||
16894350|NCT00556712|37964354|FG001|Overall Study|Failure to Return|3|||
17003814|NCT00896532|38147681|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
17003815|NCT00896532|38147659|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003816|NCT00896532|38147660|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003817|NCT00896532|38147661|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003818|NCT00896532|38147662|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003819|NCT00896532|38147663|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003820|NCT00896532|38147664|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003821|NCT00896532|38147665|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003822|NCT00896532|38147666|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003823|NCT00896532|38147667|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003824|NCT00896532|38147668|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003825|NCT00896532|38147669|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003826|NCT00896532|38147670|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003827|NCT00896532|38147671|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
17003828|NCT00896532|38147672|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
17003829|NCT00896532|38147673|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003830|NCT00896532|38147674|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003831|NCT00896532|38147675|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003832|NCT00896532|38147676|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003833|NCT00896532|38147677|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003834|NCT00896532|38147678|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003835|NCT00896532|38147679|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003836|NCT00896532|38147680|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003837|NCT00896532|38147681|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
17003838|NCT00896532|38147659|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
17003839|NCT00896532|38147660|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
17095397|NCT00231894|38234675|FG001|Overall Study|Withdrawal by Subject|1|||
17095398|NCT00203424|38234687|FG000|Treatment Period|Withdrawal by Subject|4|||
17095399|NCT00203424|38234687|FG000|Treatment Period|Adverse Event|5|||
17003840|NCT00896532|38147661|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
17003841|NCT00896532|38147662|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
17003842|NCT00896532|38147663|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
17003843|NCT00896532|38147664|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
17003844|NCT00896532|38147665|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
17095400|NCT00203424|38234687|FG000|Treatment Period|progressive disease|2|||
17095401|NCT00203424|38234687|FG000|Follow-up Period|Withdrawal by Subject|1|||
17095402|NCT00203424|38234687|FG000|Follow-up Period|progressive disease|4|||
17095403|NCT00203424|38234687|FG000|Follow-up Period|Lost to Follow-up|1|||
17095404|NCT00203268|38234691|FG000|Early Treatment|only treated one headache|2|||
17095405|NCT00203268|38234691|FG000|Early Treatment|Lost to Follow-up|1|||
16894351|NCT00556712|37964353|FG000|Overall Study|Other|2|||
16894352|NCT00556712|37964354|FG001|Overall Study|Other|2|||
16894353|NCT00556712|37964353|FG000|Overall Study|Ongoing at Data Cutoff|32|||
16894354|NCT00556712|37964354|FG001|Overall Study|Ongoing at Data Cutoff|66|||
17003845|NCT00896532|38147666|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
17003846|NCT00896532|38147667|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
17003847|NCT00896532|38147668|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
17003848|NCT00896532|38147669|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
16894355|NCT00556322|37964428|FG000|Overall Study|Insufficient therapeutic response|158|||
16894356|NCT00556322|37964429|FG001|Overall Study|Insufficient therapeutic response|168|||
16894357|NCT00556322|37964428|FG000|Overall Study|Adverse Event|7|||
16894358|NCT00556322|37964429|FG001|Overall Study|Adverse Event|4|||
16894359|NCT00556322|37964428|FG000|Overall Study|Other|4|||
16894360|NCT00556322|37964429|FG001|Overall Study|Other|1|||
16894361|NCT00556322|37964428|FG000|Overall Study|Lost to Follow-up|5|||
16894362|NCT00556322|37964429|FG001|Overall Study|Lost to Follow-up|3|||
16894363|NCT00556322|37964428|FG000|Overall Study|Withdrawal by Subject|19|||
16894364|NCT00556322|37964429|FG001|Overall Study|Withdrawal by Subject|7|||
16894365|NCT00556322|37964428|FG000|Overall Study|Protocol Violation|5|||
16894366|NCT00556322|37964429|FG001|Overall Study|Protocol Violation|1|||
16894367|NCT00556322|37964428|FG000|Overall Study|Ongoing at data cutoff|3|||
16894368|NCT00556322|37964429|FG001|Overall Study|Ongoing at data cutoff|5|||
16894369|NCT00556322|37964428|FG000|Overall Study|Death|20|||
16894370|NCT00556322|37964429|FG001|Overall Study|Death|14|||
16894371|NCT00556166|37964447|FG000|Overall Study|Withdrawal by Subject|1|||
17003849|NCT00896532|38147670|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
17003850|NCT00896532|38147671|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
16894372|NCT02332590|37964607|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
16894373|NCT02332590|37964608|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
16894374|NCT02332590|37964607|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
16894375|NCT02332590|37964608|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
16894376|NCT02332590|37964607|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
16894377|NCT02332590|37964608|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
16894378|NCT02332590|37964607|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
16894379|NCT02332590|37964608|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
16894380|NCT02332590|37964607|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
16894381|NCT02332590|37964608|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
16894382|NCT02332590|37964607|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
16894383|NCT02332590|37964608|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
17003851|NCT00896532|38147672|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
17003852|NCT00896532|38147673|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
17003853|NCT00896532|38147674|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
17003854|NCT00896532|38147675|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
17003855|NCT00896532|38147676|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
17003856|NCT00896532|38147677|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
17003857|NCT00896532|38147678|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
17003858|NCT00896532|38147679|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
17003859|NCT00896532|38147680|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
17003860|NCT00896532|38147681|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
17003861|NCT00896532|38147659|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16894384|NCT02332590|37964607|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
16894385|NCT02332590|37964608|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
16894386|NCT02332590|37964607|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
16894387|NCT02332590|37964608|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
16894388|NCT02332590|37964607|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
16894389|NCT02332590|37964608|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
16894390|NCT00554840|37964679|FG000|Overall Study|Physician Decision|0|||
16894391|NCT00554840|37964680|FG001|Overall Study|Physician Decision|1|||
16894392|NCT02302716|37964705|FG000|Overall Study|Adverse Event|1|||
16894393|NCT02302716|37964706|FG001|Overall Study|Adverse Event|1|||
16894394|NCT02302716|37964705|FG000|Overall Study|Death|0|||
16894395|NCT02302716|37964706|FG001|Overall Study|Death|1|||
16894396|NCT02302716|37964705|FG000|Overall Study|Lack of Efficacy|0|||
16894397|NCT02302716|37964706|FG001|Overall Study|Lack of Efficacy|1|||
16894398|NCT02302716|37964705|FG000|Overall Study|Lost to Follow-up|2|||
16894399|NCT02302716|37964706|FG001|Overall Study|Lost to Follow-up|4|||
16894400|NCT02302716|37964705|FG000|Overall Study|Physician Decision|3|||
16894401|NCT02302716|37964706|FG001|Overall Study|Physician Decision|4|||
16894402|NCT02302716|37964705|FG000|Overall Study|Withdrawal by Subject|13|||
16894403|NCT02302716|37964706|FG001|Overall Study|Withdrawal by Subject|7|||
16894404|NCT02302716|37964705|FG000|Overall Study|Protocol Violation|0|||
16894405|NCT02302716|37964706|FG001|Overall Study|Protocol Violation|1|||
16894406|NCT00554606|37964735|FG000|Overall Study|Adverse Event|3|||
16894407|NCT00554606|37964735|FG000|Overall Study|Abnormal laboratory values|1|||
16894408|NCT00554606|37964735|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
16894409|NCT00554606|37964735|FG000|Overall Study|Subject withdrew consent|2|||
16894410|NCT00554606|37964735|FG000|Overall Study|Lost to Follow-up|2|||
16894411|NCT00554606|37964735|FG000|Overall Study|Administrative problems|60|||
16894412|NCT00554606|37964735|FG000|Overall Study|Death|1|||
16894413|NCT00554606|37964735|FG000|Overall Study|Protocol deviation|2|||
16894414|NCT02354508|37964771|FG000|Period 1: Core Phase|Adverse Event|1|||
16894415|NCT02354508|37964772|FG001|Period 1: Core Phase|Adverse Event|1|||
16894416|NCT02354508|37964773|FG002|Period 1: Core Phase|Adverse Event|2|||
16894417|NCT02354508|37964771|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
16894418|NCT02354508|37964772|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
16894419|NCT02354508|37964773|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
16894420|NCT02354508|37964771|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
16894421|NCT02354508|37964772|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
16894422|NCT02354508|37964773|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
16894423|NCT02354508|37964771|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
16894424|NCT02354508|37964772|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
16894425|NCT02354508|37964773|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
16894426|NCT02354508|37964771|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
16894427|NCT02354508|37964772|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
16894428|NCT02354508|37964773|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
16894429|NCT02354508|37964771|FG000|Period 2: Extension Phase|Physician Decision|5|||
16894430|NCT02354508|37964772|FG001|Period 2: Extension Phase|Physician Decision|0|||
16894431|NCT02354508|37964773|FG002|Period 2: Extension Phase|Physician Decision|1|||
16894432|NCT02354508|37964771|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
16894433|NCT02354508|37964772|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
16894434|NCT02354508|37964773|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
16894435|NCT02354508|37964771|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
16894436|NCT02354508|37964772|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
16894437|NCT02354508|37964773|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
16894438|NCT02354508|37964771|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
16894439|NCT02354508|37964772|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
16894440|NCT02354508|37964773|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
16894441|NCT00554216|37964825|FG000|Overall Study|Lost to Follow-up|92|||
16894442|NCT00554216|37964826|FG001|Overall Study|Lost to Follow-up|31|||
16894443|NCT00554216|37964827|FG002|Overall Study|Lost to Follow-up|63|||
16894444|NCT00554216|37964825|FG000|Overall Study|Adverse Event|16|||
16894445|NCT00554216|37964826|FG001|Overall Study|Adverse Event|16|||
16894446|NCT00554216|37964827|FG002|Overall Study|Adverse Event|36|||
16894447|NCT00554216|37964825|FG000|Overall Study|Withdrawal by Subject|92|||
16894448|NCT00554216|37964826|FG001|Overall Study|Withdrawal by Subject|31|||
16894449|NCT00554216|37964827|FG002|Overall Study|Withdrawal by Subject|43|||
16894450|NCT00554216|37964825|FG000|Overall Study|Non compliance|10|||
16894451|NCT00554216|37964826|FG001|Overall Study|Non compliance|4|||
16894452|NCT00554216|37964827|FG002|Overall Study|Non compliance|5|||
16894453|NCT00554216|37964825|FG000|Overall Study|Pregnancy|2|||
16894454|NCT00554216|37964826|FG001|Overall Study|Pregnancy|1|||
16894455|NCT00554216|37964827|FG002|Overall Study|Pregnancy|14|||
16894456|NCT00554216|37964825|FG000|Overall Study|Restricted med|3|||
16894457|NCT00554216|37964826|FG001|Overall Study|Restricted med|1|||
16894458|NCT00554216|37964827|FG002|Overall Study|Restricted med|1|||
16894459|NCT00554216|37964825|FG000|Overall Study|Other|12|||
16894460|NCT00554216|37964826|FG001|Overall Study|Other|7|||
16894461|NCT00554216|37964827|FG002|Overall Study|Other|10|||
16894462|NCT00554216|37964825|FG000|Overall Study|Lack of Efficacy|15|||
16894463|NCT00554216|37964826|FG001|Overall Study|Lack of Efficacy|3|||
16894464|NCT00554216|37964827|FG002|Overall Study|Lack of Efficacy|0|||
16894465|NCT02353572|37964852|FG000|Overall Study|Withdrawal by Subject|1|||
16894466|NCT02353572|37964852|FG000|Overall Study|Study terminated|2|||
16894467|NCT00552578|37964864|FG000|Overall Study|Lost to Follow-up|1|||
16894468|NCT00552578|37964865|FG001|Overall Study|Lost to Follow-up|1|||
16894469|NCT02301936|37964873|FG000|Overall Study|Lost to Follow-up|1|||
16894470|NCT02301936|37964874|FG001|Overall Study|Lost to Follow-up|0|||
16894471|NCT02352090|37964889|FG000|Overall Study|general malaise|1|||
16894472|NCT02352090|37964890|FG001|Overall Study|general malaise|0|||
16894473|NCT02352090|37964891|FG002|Overall Study|general malaise|0|||
16894474|NCT02352090|37964889|FG000|Overall Study|non-specified mild side-effects|0|||
16894475|NCT02352090|37964890|FG001|Overall Study|non-specified mild side-effects|0|||
16894476|NCT02352090|37964891|FG002|Overall Study|non-specified mild side-effects|2|||
16894477|NCT00552344|37964926|FG000|Overall Study|Lack of Efficacy|55|||
16894478|NCT00552344|37964926|FG000|Overall Study|Loss of efficacy|75|||
16894479|NCT00552344|37964926|FG000|Overall Study|Lost to Follow-up|8|||
16894480|NCT00552344|37964926|FG000|Overall Study|Withdrawal by Subject|48|||
16894481|NCT00552344|37964926|FG000|Overall Study|SAE, non-fatal|6|||
16894482|NCT00552344|37964926|FG000|Overall Study|AE, non-serious non-fatal|38|||
16894483|NCT00552344|37964926|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
16894484|NCT00552344|37964926|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
16894485|NCT00552344|37964926|FG000|Overall Study|Other Reason|22|||
16894486|NCT00553514|37964963|FG000|Overall Study|Protocol deviation|0|||
16894487|NCT00553514|37964964|FG001|Overall Study|Protocol deviation|0|||
16894488|NCT00553514|37964965|FG002|Overall Study|Protocol deviation|0|||
16894489|NCT00553514|37964966|FG003|Overall Study|Protocol deviation|1|||
16894490|NCT00553514|37964967|FG004|Overall Study|Protocol deviation|0|||
16894491|NCT00553514|37964963|FG000|Overall Study|Lack of ovarian response|4|||
16894492|NCT00553514|37964964|FG001|Overall Study|Lack of ovarian response|5|||
16894493|NCT00553514|37964965|FG002|Overall Study|Lack of ovarian response|5|||
16894494|NCT00553514|37964966|FG003|Overall Study|Lack of ovarian response|5|||
16894495|NCT00553514|37964967|FG004|Overall Study|Lack of ovarian response|6|||
16894496|NCT00553514|37964963|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
16894497|NCT00553514|37964964|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
16894498|NCT00553514|37964965|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
16894499|NCT00553514|37964966|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
16894500|NCT00553514|37964967|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
16894501|NCT00553514|37964963|FG000|Overall Study|Risk of multiple pregnancy|0|||
16894502|NCT00553514|37964964|FG001|Overall Study|Risk of multiple pregnancy|2|||
16894503|NCT00553514|37964965|FG002|Overall Study|Risk of multiple pregnancy|0|||
16894504|NCT00553514|37964966|FG003|Overall Study|Risk of multiple pregnancy|1|||
16894505|NCT00553514|37964967|FG004|Overall Study|Risk of multiple pregnancy|0|||
16894506|NCT00553514|37964963|FG000|Overall Study|Other|1|||
16894507|NCT00553514|37964964|FG001|Overall Study|Other|1|||
16894508|NCT00553514|37964965|FG002|Overall Study|Other|0|||
16894509|NCT00553514|37964966|FG003|Overall Study|Other|0|||
16894510|NCT00553514|37964967|FG004|Overall Study|Other|1|||
16894511|NCT00553436|37964991|FG000|Overall Study|Conversion to another procedure|1|||
16894512|NCT00553202|37965022|FG000|Overall Study|Death|16|||
16894513|NCT00553202|37965022|FG000|Overall Study|Lost to Follow-up|1|||
16894514|NCT00553202|37965022|FG000|Overall Study|Physician Decision|28|||
16894515|NCT00553202|37965022|FG000|Overall Study|Withdrawal by Subject|1|||
16894516|NCT00553202|37965022|FG000|Overall Study|No donor identified|16|||
16894517|NCT00553202|37965022|FG000|Overall Study|Fails to meet organ function|6|||
16894518|NCT00552188|37965046|FG000|Overall Study|Adverse Event|0|||
16894519|NCT00552188|37965047|FG001|Overall Study|Adverse Event|2|||
16894520|NCT00552188|37965046|FG000|Overall Study|Lost to Follow-up|2|||
16894521|NCT00552188|37965047|FG001|Overall Study|Lost to Follow-up|1|||
16894522|NCT00552188|37965046|FG000|Overall Study|Withdrawal of consent|0|||
16894523|NCT00552188|37965047|FG001|Overall Study|Withdrawal of consent|1|||
16894524|NCT00552188|37965046|FG000|Overall Study|Subject returned to home country|0|||
16894525|NCT00552188|37965047|FG001|Overall Study|Subject returned to home country|1|||
16894526|NCT00552110|37965067|FG000|Overall Study|Serious or Life-Threatening AE|0|||
16894527|NCT00552110|37965068|FG001|Overall Study|Serious or Life-Threatening AE|0|||
16894528|NCT00552110|37965069|FG002|Overall Study|Serious or Life-Threatening AE|1|||
16894529|NCT00552110|37965070|FG003|Overall Study|Serious or Life-Threatening AE|0|||
16894530|NCT00552110|37965071|FG004|Overall Study|Serious or Life-Threatening AE|0|||
16894531|NCT00552110|37965067|FG000|Overall Study|Lack of Efficacy|1|||
16894532|NCT00552110|37965068|FG001|Overall Study|Lack of Efficacy|0|||
16894533|NCT00552110|37965069|FG002|Overall Study|Lack of Efficacy|0|||
16894534|NCT00552110|37965070|FG003|Overall Study|Lack of Efficacy|1|||
16894535|NCT00552110|37965071|FG004|Overall Study|Lack of Efficacy|4|||
16894536|NCT00552110|37965067|FG000|Overall Study|Withdrawal by Subject|0|||
16894537|NCT00552110|37965068|FG001|Overall Study|Withdrawal by Subject|2|||
16894538|NCT00552110|37965069|FG002|Overall Study|Withdrawal by Subject|0|||
16894539|NCT00552110|37965070|FG003|Overall Study|Withdrawal by Subject|3|||
16894540|NCT00552110|37965071|FG004|Overall Study|Withdrawal by Subject|2|||
16894541|NCT00552110|37965067|FG000|Overall Study|Lost to Follow-up|0|||
16894542|NCT00552110|37965068|FG001|Overall Study|Lost to Follow-up|0|||
16894543|NCT00552110|37965069|FG002|Overall Study|Lost to Follow-up|0|||
16894544|NCT00552110|37965070|FG003|Overall Study|Lost to Follow-up|1|||
16894545|NCT00552110|37965071|FG004|Overall Study|Lost to Follow-up|1|||
16894546|NCT00552110|37965067|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
16894547|NCT00552110|37965068|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
16894548|NCT00552110|37965069|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
17003862|NCT00896532|38147660|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003863|NCT00896532|38147661|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003864|NCT00896532|38147662|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003865|NCT00896532|38147663|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003866|NCT00896532|38147664|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003867|NCT00896532|38147665|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16894549|NCT00552110|37965070|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
16894550|NCT00552110|37965071|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
16894551|NCT00552110|37965067|FG000|Overall Study|Withdrawn per Sponsor|0|||
16894552|NCT00552110|37965068|FG001|Overall Study|Withdrawn per Sponsor|1|||
17003868|NCT00896532|38147666|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003869|NCT00896532|38147667|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003870|NCT00896532|38147668|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003871|NCT00896532|38147669|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003872|NCT00896532|38147670|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003873|NCT00896532|38147671|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003874|NCT00896532|38147672|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003875|NCT00896532|38147673|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003876|NCT00896532|38147674|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
17003877|NCT00896532|38147675|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
17003878|NCT00896532|38147676|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003879|NCT00896532|38147677|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16894553|NCT00552110|37965069|FG002|Overall Study|Withdrawn per Sponsor|0|||
16894554|NCT00552110|37965070|FG003|Overall Study|Withdrawn per Sponsor|0|||
16894555|NCT00552110|37965071|FG004|Overall Study|Withdrawn per Sponsor|1|||
16894556|NCT00552110|37965067|FG000|Overall Study|Use of Prohibited Medication|1|||
16785862|NCT02008318|37725975|FG001|Overall Study|Withdrawal by Subject|0|||
16785863|NCT01982812|37725986|FG000|Overall Study|Death|1|||
16785864|NCT01982812|37725987|FG001|Overall Study|Death|5|||
16785865|NCT01982812|37725986|FG000|Overall Study|Adverse Event|0|||
16785866|NCT01982812|37725987|FG001|Overall Study|Adverse Event|5|||
16785867|NCT02007070|37725993|FG000|Overall Study|Adverse Event|4|||
16785868|NCT02007070|37725993|FG000|Overall Study|Clinical Progression|4|||
16785869|NCT02007070|37725993|FG000|Overall Study|Death|1|||
16785870|NCT02007070|37725993|FG000|Overall Study|Protocol Violation|2|||
16785871|NCT02007070|37725993|FG000|Overall Study|Physician Decision|1|||
16785872|NCT02007070|37725993|FG000|Overall Study|Progressive Disease|21|||
16785873|NCT02006758|37725997|FG000|Overall Study|Protocol Violation|1|||
16785874|NCT02006758|37725997|FG000|Overall Study|Death|1|||
16785875|NCT02006758|37725997|FG000|Overall Study|Lost to Follow-up|4|||
16785876|NCT02006758|37725997|FG000|Overall Study|Withdrawal by Subject|4|||
16785877|NCT02006758|37725997|FG000|Overall Study|Procedurally excluded|1|||
16785878|NCT02006758|37725997|FG000|Overall Study|Other|2|||
16785879|NCT01960816|37726002|FG000|Overall Study|Lost to Follow-up|1|||
16785880|NCT01602419|37726006|FG000|Overall Study|Not treated with Wilate|9|||
16785881|NCT01602419|37726006|FG000|Overall Study|Adverse Drug Reaction|4|||
16785882|NCT01602419|37726006|FG000|Overall Study|Insurance issues|3|||
16785883|NCT01602419|37726006|FG000|Overall Study|Changed treatment centre|1|||
16785884|NCT01602419|37726006|FG000|Overall Study|Treatment centre closed|1|||
16785885|NCT01602419|37726006|FG000|Overall Study|Withdrawal by Subject|5|||
16785886|NCT01602419|37726006|FG000|Overall Study|Lost to Follow-up|6|||
16785887|NCT01981954|37726051|FG000|Titration Period|Protocol Deviation|1|||
16785888|NCT01981954|37726051|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
16785889|NCT02693119|37726057|FG000|Open-Label Period|Withdrawal by Subject|0|||
16785890|NCT02693119|37726058|FG001|Open-Label Period|Withdrawal by Subject|1|||
16785891|NCT01960348|37726096|FG000|Overall Study|Adverse event, not serious|2|||
16785892|NCT01960348|37726097|FG001|Overall Study|Adverse event, not serious|2|||
16785893|NCT01960348|37726096|FG000|Overall Study|Adverse event, serious fatal|6|||
16785894|NCT01960348|37726097|FG001|Overall Study|Adverse event, serious fatal|5|||
16785895|NCT01960348|37726096|FG000|Overall Study|Adverse event, serious non-fatal|0|||
16785896|NCT01960348|37726097|FG001|Overall Study|Adverse event, serious non-fatal|3|||
16785897|NCT01960348|37726096|FG000|Overall Study|Withdrawal by Subject|1|||
16785898|NCT01960348|37726097|FG001|Overall Study|Withdrawal by Subject|11|||
16785899|NCT01960348|37726096|FG000|Overall Study|Physician Decision|0|||
16785900|NCT01960348|37726097|FG001|Overall Study|Physician Decision|1|||
16785901|NCT01960348|37726096|FG000|Overall Study|Protocol Violation|1|||
16785902|NCT01960348|37726097|FG001|Overall Study|Protocol Violation|0|||
16785903|NCT02653625|37726103|FG000|Overall Study|Adverse Event|1|||
16785904|NCT02653625|37726103|FG000|Overall Study|Non-compliance with Study Drug|1|||
16785905|NCT02653625|37726103|FG000|Overall Study|Protocol Violation|1|||
16785906|NCT02653625|37726103|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
16785907|NCT01981096|37726109|FG000|Overall Study|Parent illness|1|||
16785908|NCT01981096|37726110|FG001|Overall Study|Parent illness|0|||
16785909|NCT01981096|37726109|FG000|Overall Study|Withdrawal by Subject|0|||
16785910|NCT01981096|37726110|FG001|Overall Study|Withdrawal by Subject|1|||
16785911|NCT01981096|37726109|FG000|Overall Study|Lost to Follow-up|2|||
16785912|NCT01981096|37726110|FG001|Overall Study|Lost to Follow-up|0|||
16785913|NCT02652767|37726116|FG000|Overall Study|Death|2|||
16785914|NCT02652767|37726116|FG000|Overall Study|Lost to Follow-up|1|||
16785915|NCT02652767|37726116|FG000|Overall Study|Withdrawal by Subject|1|||
16785916|NCT01980940|37726130|FG000|Overall Study|Protocol Violation|0|||
16785917|NCT01980940|37726131|FG001|Overall Study|Protocol Violation|0|||
16785918|NCT01980940|37726132|FG002|Overall Study|Protocol Violation|0|||
16785919|NCT01980940|37726133|FG003|Overall Study|Protocol Violation|0|||
16785920|NCT01980940|37726134|FG004|Overall Study|Protocol Violation|0|||
16785921|NCT01980940|37726135|FG005|Overall Study|Protocol Violation|2|||
16785922|NCT01980940|37726136|FG006|Overall Study|Protocol Violation|0|||
16894557|NCT00552110|37965068|FG001|Overall Study|Use of Prohibited Medication|1|||
16894558|NCT00552110|37965069|FG002|Overall Study|Use of Prohibited Medication|0|||
16894559|NCT00552110|37965070|FG003|Overall Study|Use of Prohibited Medication|0|||
16894560|NCT00552110|37965071|FG004|Overall Study|Use of Prohibited Medication|0|||
16894561|NCT00552110|37965067|FG000|Overall Study|Delay of Study due to Relabeling|0|||
16894562|NCT00552110|37965068|FG001|Overall Study|Delay of Study due to Relabeling|0|||
16894563|NCT00552110|37965069|FG002|Overall Study|Delay of Study due to Relabeling|0|||
16894564|NCT00552110|37965070|FG003|Overall Study|Delay of Study due to Relabeling|1|||
16894565|NCT00552110|37965071|FG004|Overall Study|Delay of Study due to Relabeling|0|||
16894566|NCT00552110|37965067|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
16894567|NCT00552110|37965068|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
16894568|NCT00552110|37965069|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
16894569|NCT00552110|37965070|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
16894570|NCT00552110|37965071|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
16894571|NCT00552110|37965067|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
16894572|NCT00552110|37965068|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
16894573|NCT00552110|37965069|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
16894574|NCT00552110|37965070|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
16894575|NCT00552110|37965071|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
16894576|NCT02301624|37965094|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
16894577|NCT02301624|37965095|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
16894578|NCT02301624|37965094|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
16894579|NCT02301624|37965095|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
16894580|NCT02301624|37965094|FG000|Open-label Maintenance Phase|Adverse Event|2|||
16894581|NCT02301624|37965095|FG001|Open-label Maintenance Phase|Adverse Event|5|||
16894582|NCT02301624|37965094|FG000|Open-label Maintenance Phase|Physician Decision|3|||
16894583|NCT02301624|37965095|FG001|Open-label Maintenance Phase|Physician Decision|3|||
16894584|NCT02301624|37965094|FG000|Open-label Maintenance Phase|Death|2|||
16894585|NCT02301624|37965095|FG001|Open-label Maintenance Phase|Death|1|||
16894586|NCT02301624|37965094|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
16894587|NCT02301624|37965095|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
16894588|NCT02301546|37965136|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
16894589|NCT02301546|37965137|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
16894590|NCT02301546|37965136|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
16894591|NCT02301546|37965137|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
16894592|NCT02301546|37965136|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
16894593|NCT02301546|37965137|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
16894594|NCT02301546|37965136|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
16894595|NCT02301546|37965137|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
16894596|NCT02301546|37965136|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
16894597|NCT02301546|37965137|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
16894598|NCT02301546|37965136|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
16894599|NCT02301546|37965137|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
16894600|NCT02301546|37965136|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
16894601|NCT02301546|37965137|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
16894602|NCT02351934|37965161|FG000|Allocation|POD weight<pre-op weight|3|||
16894603|NCT02351934|37965162|FG001|Allocation|POD weight<pre-op weight|0|||
16894604|NCT02351934|37965161|FG000|Allocation|Hypotension preventing administration|2|||
16894605|NCT02351934|37965162|FG001|Allocation|Hypotension preventing administration|0|||
16894606|NCT02351934|37965161|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
16894607|NCT02351934|37965162|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
16894608|NCT02351934|37965161|FG000|Follow-Up|POD weight<pre-op weight|3|||
16894609|NCT02351934|37965162|FG001|Follow-Up|POD weight<pre-op weight|0|||
16894610|NCT02351934|37965161|FG000|Follow-Up|Acute Kidney Injury|1|||
16894611|NCT02351934|37965162|FG001|Follow-Up|Acute Kidney Injury|0|||
16894612|NCT02351934|37965161|FG000|Follow-Up|Early dismissal|3|||
16894613|NCT02351934|37965162|FG001|Follow-Up|Early dismissal|0|||
16894614|NCT02351934|37965161|FG000|Follow-Up|Hypotension|3|||
16894615|NCT02351934|37965162|FG001|Follow-Up|Hypotension|0|||
16894616|NCT02351934|37965161|FG000|Follow-Up|No documentation|2|||
16894617|NCT02351934|37965162|FG001|Follow-Up|No documentation|0|||
16894618|NCT02351934|37965161|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
16894619|NCT02351934|37965162|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
16894620|NCT02351934|37965161|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
16894621|NCT02351934|37965162|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
16894622|NCT02301390|37965170|FG000|Overall Study|Withdrawal by Subject|3|||
16894623|NCT02301390|37965171|FG001|Overall Study|Withdrawal by Subject|5|||
16894624|NCT02301390|37965170|FG000|Overall Study|Protocol Violation|1|||
16894625|NCT02301390|37965171|FG001|Overall Study|Protocol Violation|0|||
16894626|NCT02301390|37965170|FG000|Overall Study|Physician Decision|1|||
16894627|NCT02301390|37965171|FG001|Overall Study|Physician Decision|0|||
16894628|NCT02301390|37965170|FG000|Overall Study|Lost to Follow-up|0|||
16894629|NCT02301390|37965171|FG001|Overall Study|Lost to Follow-up|1|||
16894630|NCT02301390|37965170|FG000|Overall Study|Death|2|||
16894631|NCT02301390|37965171|FG001|Overall Study|Death|2|||
16894632|NCT02301390|37965170|FG000|Overall Study|Procedure not completed|0|||
16894633|NCT02301390|37965171|FG001|Overall Study|Procedure not completed|4|||
17003880|NCT00896532|38147678|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003881|NCT00896532|38147679|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003882|NCT00896532|38147680|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003883|NCT00896532|38147681|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
17003884|NCT00896532|38147659|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003885|NCT00896532|38147660|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003886|NCT00896532|38147661|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003887|NCT00896532|38147662|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003888|NCT00896532|38147663|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003889|NCT00896532|38147664|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16894634|NCT02301390|37965170|FG000|Overall Study|Missed multiple visits|1|||
16894635|NCT02301390|37965171|FG001|Overall Study|Missed multiple visits|1|||
16894636|NCT02301390|37965170|FG000|Overall Study|study terminated|2|||
16894637|NCT02301390|37965171|FG001|Overall Study|study terminated|0|||
16894638|NCT02351856|37965211|FG000|Overall Study|Adverse Event|2|||
16894639|NCT02351856|37965211|FG000|Overall Study|Physician Decision|5|||
16894640|NCT02351856|37965211|FG000|Overall Study|Study terminated by sponsor|1|||
16894641|NCT02349360|37965251|FG000|Overall Study|Withdrawal by Subject|0|||
16894642|NCT02349360|37965252|FG001|Overall Study|Withdrawal by Subject|1|||
16894643|NCT00551642|37965277|FG000|Treatment Period|Protocol Deviation|6|||
16894644|NCT00551642|37965278|FG001|Treatment Period|Protocol Deviation|11|||
16894645|NCT00551642|37965277|FG000|Treatment Period|Delivery device failure|1|||
16894646|NCT00551642|37965278|FG001|Treatment Period|Delivery device failure|3|||
16894647|NCT00551642|37965277|FG000|Treatment Period|Physician Decision|0|||
16894648|NCT00551642|37965278|FG001|Treatment Period|Physician Decision|1|||
16894649|NCT00551642|37965277|FG000|Treatment Period|Death|33|||
16894650|NCT00551642|37965278|FG001|Treatment Period|Death|31|||
16894651|NCT00551642|37965277|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
16894652|NCT00551642|37965278|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
17003890|NCT00896532|38147665|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003891|NCT00896532|38147666|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003892|NCT00896532|38147667|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003893|NCT00896532|38147668|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003894|NCT00896532|38147669|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003895|NCT00896532|38147670|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17095406|NCT00203268|38234691|FG000|Early Treatment|Withdrawal by Subject|1|||
16894653|NCT00551642|37965277|FG000|Treatment Period|Adverse Event|15|||
16894654|NCT00551642|37965278|FG001|Treatment Period|Adverse Event|12|||
16894655|NCT00551642|37965277|FG000|Treatment Period|Withdrawal by Subject|2|||
16894656|NCT00551642|37965278|FG001|Treatment Period|Withdrawal by Subject|1|||
16894657|NCT00550550|37965372|FG000|Overall Study|Adverse Event|13|||
16894658|NCT00550550|37965373|FG001|Overall Study|Adverse Event|5|||
16894659|NCT00550550|37965372|FG000|Overall Study|Treatment Failure|0|||
16894660|NCT00550550|37965373|FG001|Overall Study|Treatment Failure|1|||
16894661|NCT00550550|37965372|FG000|Overall Study|Lost to Follow-up|4|||
16894662|NCT00550550|37965373|FG001|Overall Study|Lost to Follow-up|0|||
16894663|NCT00550550|37965372|FG000|Overall Study|Withdrawal by Subject|10|||
16894664|NCT00550550|37965373|FG001|Overall Study|Withdrawal by Subject|8|||
16894665|NCT00550550|37965372|FG000|Overall Study|Protocol Violation|5|||
16894666|NCT00550550|37965373|FG001|Overall Study|Protocol Violation|14|||
16894667|NCT00550550|37965372|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
16894668|NCT00550550|37965373|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
16894669|NCT00550550|37965372|FG000|Overall Study|Randomized But Not Treated|1|||
16894670|NCT00550550|37965373|FG001|Overall Study|Randomized But Not Treated|0|||
16894671|NCT02301156|37965424|FG000|Overall Study|Adverse Event|13|||
16894672|NCT02301156|37965425|FG001|Overall Study|Adverse Event|14|||
16894673|NCT02301156|37965424|FG000|Overall Study|Death|1|||
16894674|NCT02301156|37965425|FG001|Overall Study|Death|5|||
16894675|NCT02301156|37965424|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
16894676|NCT02301156|37965425|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
16894677|NCT02301156|37965424|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
16894678|NCT02301156|37965425|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
17003896|NCT00896532|38147671|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003897|NCT00896532|38147672|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17095407|NCT00168818|38234700|FG000|Overall Study|Adverse Event|23|||
16894679|NCT02301156|37965424|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
16894680|NCT02301156|37965425|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
16894681|NCT02301156|37965424|FG000|Overall Study|Reason not Specified|6|||
16894682|NCT02301156|37965425|FG001|Overall Study|Reason not Specified|3|||
16894683|NCT02300610|37965615|FG000|Overall Study|Withdrawal by Subject|1|||
16894684|NCT02300610|37965616|FG001|Overall Study|Withdrawal by Subject|0|||
16894685|NCT02300610|37965617|FG002|Overall Study|Withdrawal by Subject|1|||
16894686|NCT02300298|37965662|FG000|Disposition for Nintedanib|Progressive disease|10|||
16894687|NCT02300298|37965663|FG001|Disposition for Nintedanib|Progressive disease|0|||
16894688|NCT02300298|37965662|FG000|Disposition for Docetaxel|Progressive disease|0|||
16894689|NCT02300298|37965663|FG001|Disposition for Docetaxel|Progressive disease|6|||
16894690|NCT02300298|37965662|FG000|Disposition for Docetaxel|other adverse event|0|||
16894691|NCT02300298|37965663|FG001|Disposition for Docetaxel|other adverse event|4|||
16894692|NCT02300220|37965669|FG000|Overall Study|Lost to Follow-up|1|||
16894693|NCT02300220|37965670|FG001|Overall Study|Lost to Follow-up|2|||
16894694|NCT02300220|37965669|FG000|Overall Study|Death|1|||
16894695|NCT02300220|37965670|FG001|Overall Study|Death|1|||
16894696|NCT02300220|37965669|FG000|Overall Study|Adverse Event|1|||
16894697|NCT02300220|37965670|FG001|Overall Study|Adverse Event|1|||
16894698|NCT02300220|37965669|FG000|Overall Study|Protocol Violation|1|||
16894699|NCT02300220|37965670|FG001|Overall Study|Protocol Violation|0|||
16894700|NCT02300220|37965669|FG000|Overall Study|Withdrawal by Subject|0|||
16894701|NCT02300220|37965670|FG001|Overall Study|Withdrawal by Subject|2|||
16894702|NCT02300220|37965669|FG000|Overall Study|Did not tolerate IMP|0|||
16894703|NCT02300220|37965670|FG001|Overall Study|Did not tolerate IMP|1|||
16894704|NCT02327130|37965694|FG000|Overall Study|Discharged in less than 5 days|5|||
16894705|NCT02327130|37965694|FG000|Overall Study|Physician Decision|2|||
16894706|NCT02327130|37965694|FG000|Overall Study|Unable to provide breath sample|1|||
16894707|NCT02327130|37965694|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
16894708|NCT02327130|37965694|FG000|Overall Study|Met exclusion criteria|3|||
16894709|NCT02326272|37965749|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894710|NCT02326272|37965750|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
16894711|NCT02326272|37965751|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
16894712|NCT02326272|37965752|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894713|NCT02326272|37965753|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894714|NCT02326272|37965754|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894715|NCT02326272|37965755|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894716|NCT02326272|37965756|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894717|NCT02326272|37965757|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894718|NCT02326272|37965758|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894719|NCT02326272|37965759|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894720|NCT02326272|37965760|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894721|NCT02326272|37965761|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894722|NCT02326272|37965762|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894723|NCT02326272|37965763|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16894724|NCT02326272|37965749|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
16894725|NCT02326272|37965750|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
16894726|NCT02326272|37965751|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894727|NCT02326272|37965752|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894728|NCT02326272|37965753|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894729|NCT02326272|37965754|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894730|NCT02326272|37965755|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894731|NCT02326272|37965756|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894732|NCT02326272|37965757|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894733|NCT02326272|37965758|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894734|NCT02326272|37965759|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894735|NCT02326272|37965760|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894736|NCT02326272|37965761|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894737|NCT02326272|37965762|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894738|NCT02326272|37965763|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16894739|NCT02326272|37965749|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
16894740|NCT02326272|37965750|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
16894741|NCT02326272|37965751|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
16894742|NCT02326272|37965752|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894743|NCT02326272|37965753|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894744|NCT02326272|37965754|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894745|NCT02326272|37965755|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894746|NCT02326272|37965756|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894747|NCT02326272|37965757|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
17095408|NCT00168818|38234701|FG001|Overall Study|Adverse Event|29|||
17095409|NCT00168818|38234702|FG002|Overall Study|Adverse Event|31|||
16894748|NCT02326272|37965758|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894749|NCT02326272|37965759|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894750|NCT02326272|37965760|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894751|NCT02326272|37965761|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
17003898|NCT00896532|38147673|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003899|NCT00896532|38147674|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
17003900|NCT00896532|38147675|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
17003901|NCT00896532|38147676|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
17003902|NCT00896532|38147677|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003903|NCT00896532|38147678|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003904|NCT00896532|38147679|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003905|NCT00896532|38147680|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003906|NCT00896532|38147681|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
17003907|NCT00896532|38147659|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003908|NCT00896532|38147660|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003909|NCT00896532|38147661|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003910|NCT00896532|38147662|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003911|NCT00896532|38147663|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003912|NCT00896532|38147664|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003913|NCT00896532|38147665|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003914|NCT00896532|38147666|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17095410|NCT00168818|38234700|FG000|Overall Study|Protocol Violation|16|||
17095411|NCT00168818|38234701|FG001|Overall Study|Protocol Violation|11|||
16894752|NCT02326272|37965762|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894753|NCT02326272|37965763|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16894754|NCT02326272|37965749|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894755|NCT02326272|37965750|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894756|NCT02326272|37965751|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
16894757|NCT02326272|37965752|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894758|NCT02326272|37965753|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894759|NCT02326272|37965754|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894760|NCT02326272|37965755|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894761|NCT02326272|37965756|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894762|NCT02326272|37965757|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894763|NCT02326272|37965758|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894764|NCT02326272|37965759|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894765|NCT02326272|37965760|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894766|NCT02326272|37965761|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894767|NCT02326272|37965762|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894768|NCT02326272|37965763|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16894769|NCT02326272|37965749|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894770|NCT02326272|37965750|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894771|NCT02326272|37965751|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
16894772|NCT02326272|37965752|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894773|NCT02326272|37965753|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894774|NCT02326272|37965754|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894775|NCT02326272|37965755|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894776|NCT02326272|37965756|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894777|NCT02326272|37965757|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894778|NCT02326272|37965758|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894779|NCT02326272|37965759|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894780|NCT02326272|37965760|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894781|NCT02326272|37965761|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894782|NCT02326272|37965762|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894783|NCT02326272|37965763|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16894784|NCT02326272|37965749|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894785|NCT02326272|37965750|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894786|NCT02326272|37965751|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
16894787|NCT02326272|37965752|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894788|NCT02326272|37965753|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894789|NCT02326272|37965754|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894790|NCT02326272|37965755|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894791|NCT02326272|37965756|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894792|NCT02326272|37965757|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894793|NCT02326272|37965758|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894794|NCT02326272|37965759|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894795|NCT02326272|37965760|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894796|NCT02326272|37965761|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894797|NCT02326272|37965762|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894798|NCT02326272|37965763|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16894799|NCT02326272|37965749|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894800|NCT02326272|37965750|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894801|NCT02326272|37965751|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
16894802|NCT02326272|37965752|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894803|NCT02326272|37965753|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894804|NCT02326272|37965754|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894805|NCT02326272|37965755|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894806|NCT02326272|37965756|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894807|NCT02326272|37965757|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894808|NCT02326272|37965758|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894809|NCT02326272|37965759|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894810|NCT02326272|37965760|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894811|NCT02326272|37965761|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894812|NCT02326272|37965762|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894813|NCT02326272|37965763|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16894814|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894815|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894816|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894817|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894818|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
16894819|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
16894820|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
16894821|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
16894822|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16894823|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894824|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894825|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894826|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894827|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894828|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16894829|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894830|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894831|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894832|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894833|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894834|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
16894835|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
16894836|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894837|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
16894838|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
16894839|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894840|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894841|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894842|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16894843|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
17003915|NCT00896532|38147667|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003916|NCT00896532|38147668|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003917|NCT00896532|38147669|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003918|NCT00896532|38147670|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003919|NCT00896532|38147671|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003920|NCT00896532|38147672|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16894844|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894845|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894846|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894847|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894848|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894849|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
16894850|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16785923|NCT01980940|37726137|FG007|Overall Study|Protocol Violation|0|||
16785924|NCT02699983|37726163|FG000|Overall Study|Withdrawal by Subject|1|||
16785925|NCT02699983|37726164|FG001|Overall Study|Withdrawal by Subject|0|||
16785926|NCT01960114|37726176|FG000|Overall Study|Adverse Event|1|||
16785927|NCT01960114|37726177|FG001|Overall Study|Adverse Event|0|||
16785928|NCT01960114|37726176|FG000|Overall Study|Could not swallow study medication|0|||
16785929|NCT01960114|37726177|FG001|Overall Study|Could not swallow study medication|1|||
16785930|NCT02005276|37726187|FG000|Overall Study|No longer interested|5|||
16785931|NCT02005276|37726188|FG001|Overall Study|No longer interested|2|||
16785932|NCT02005276|37726189|FG002|Overall Study|No longer interested|3|||
16785933|NCT02005276|37726190|FG003|Overall Study|No longer interested|3|||
16785934|NCT01980706|37726205|FG000|Overall Study|Withdrawal by Subject|9|||
16785935|NCT01980706|37726206|FG001|Overall Study|Withdrawal by Subject|6|||
16785936|NCT01980706|37726207|FG002|Overall Study|Withdrawal by Subject|2|||
16785937|NCT01980706|37726205|FG000|Overall Study|Adverse Event|1|||
16785938|NCT01980706|37726206|FG001|Overall Study|Adverse Event|2|||
16785939|NCT01980706|37726207|FG002|Overall Study|Adverse Event|5|||
16785940|NCT01980706|37726205|FG000|Overall Study|Lost to Follow-up|3|||
16785941|NCT01980706|37726206|FG001|Overall Study|Lost to Follow-up|4|||
16785942|NCT01980706|37726207|FG002|Overall Study|Lost to Follow-up|3|||
16785943|NCT01980706|37726205|FG000|Overall Study|miscellaneous|4|||
16785944|NCT01980706|37726206|FG001|Overall Study|miscellaneous|5|||
16785945|NCT01980706|37726207|FG002|Overall Study|miscellaneous|3|||
16785946|NCT02692417|37726217|FG000|Overall Study|Withdrawal by Subject|5|||
16785947|NCT02692417|37726218|FG001|Overall Study|Withdrawal by Subject|1|||
16785948|NCT02692417|37726217|FG000|Overall Study|Adverse Event|1|||
16785949|NCT02692417|37726218|FG001|Overall Study|Adverse Event|0|||
16785950|NCT02004886|37726228|FG000|Overall Study|Adverse Event|0|||
16785951|NCT02004886|37726229|FG001|Overall Study|Adverse Event|1|||
16785952|NCT02004886|37726230|FG002|Overall Study|Adverse Event|0|||
16785953|NCT02004886|37726231|FG003|Overall Study|Adverse Event|0|||
16785954|NCT02004886|37726228|FG000|Overall Study|Unable to attend future visits|1|||
16785955|NCT02004886|37726229|FG001|Overall Study|Unable to attend future visits|0|||
16785956|NCT02004886|37726230|FG002|Overall Study|Unable to attend future visits|0|||
16785957|NCT02004886|37726231|FG003|Overall Study|Unable to attend future visits|0|||
16785958|NCT01959880|37726245|FG000|Overall Study|Withdrawal by Subject|11|||
16785959|NCT01959880|37726246|FG001|Overall Study|Withdrawal by Subject|13|||
16785960|NCT01959880|37726247|FG002|Overall Study|Withdrawal by Subject|8|||
16785961|NCT01959880|37726248|FG003|Overall Study|Withdrawal by Subject|7|||
16785962|NCT01959880|37726245|FG000|Overall Study|Death|1|||
16785963|NCT01959880|37726246|FG001|Overall Study|Death|10|||
16785964|NCT01959880|37726247|FG002|Overall Study|Death|1|||
16785965|NCT01959880|37726248|FG003|Overall Study|Death|2|||
16785966|NCT01959880|37726245|FG000|Overall Study|Lost to Follow-up|95|||
16785967|NCT01959880|37726246|FG001|Overall Study|Lost to Follow-up|18|||
16785968|NCT01959880|37726247|FG002|Overall Study|Lost to Follow-up|15|||
16785969|NCT01959880|37726248|FG003|Overall Study|Lost to Follow-up|8|||
16785970|NCT01959880|37726245|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
16785971|NCT01959880|37726246|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
16785972|NCT01959880|37726247|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
16894851|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
16894852|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894853|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894854|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894855|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894856|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
17003921|NCT00896532|38147673|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003922|NCT00896532|38147674|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003923|NCT00896532|38147675|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
17003924|NCT00896532|38147676|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003925|NCT00896532|38147677|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003926|NCT00896532|38147678|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003927|NCT00896532|38147679|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17095412|NCT00168818|38234702|FG002|Overall Study|Protocol Violation|11|||
16785973|NCT01959880|37726248|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
16785974|NCT01959880|37726245|FG000|Overall Study|Study completed early-FDA approved|1003|||
16785975|NCT01959880|37726246|FG001|Overall Study|Study completed early-FDA approved|311|||
16785976|NCT01959880|37726247|FG002|Overall Study|Study completed early-FDA approved|179|||
16785977|NCT01959880|37726248|FG003|Overall Study|Study completed early-FDA approved|152|||
16785978|NCT01980628|37726258|FG000|Overall Study|Adverse Event|12|||
17003928|NCT00896532|38147680|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003929|NCT00896532|38147681|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
17003930|NCT00896532|38147659|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
17003931|NCT00896532|38147660|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
17003932|NCT00896532|38147661|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
17003933|NCT00896532|38147662|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
17003934|NCT00896532|38147663|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
17003935|NCT00896532|38147664|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
17003936|NCT00896532|38147665|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
17003937|NCT00896532|38147666|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
17003938|NCT00896532|38147667|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
17003939|NCT00896532|38147668|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
16894857|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894858|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16894859|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894860|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894861|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894862|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16894863|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894864|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
16894865|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16894866|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16894867|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894868|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16894869|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894870|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894871|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894872|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894873|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16894874|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894875|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16785979|NCT01980628|37726258|FG000|Overall Study|Physician Decision|5|||
16785980|NCT01980628|37726258|FG000|Overall Study|Withdrawal by Subject|4|||
16785981|NCT01980628|37726258|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
16894876|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894877|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894878|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894879|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894880|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894881|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
16894882|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894883|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894884|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894885|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894886|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
17003940|NCT00896532|38147669|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
17003941|NCT00896532|38147670|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
17003942|NCT00896532|38147671|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
17003943|NCT00896532|38147672|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
17003944|NCT00896532|38147673|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
17003945|NCT00896532|38147674|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
17003946|NCT00896532|38147675|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
17003947|NCT00896532|38147676|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
17003948|NCT00896532|38147677|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
17003949|NCT00896532|38147678|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
17003950|NCT00896532|38147679|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
17003951|NCT00896532|38147680|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
17003952|NCT00896532|38147681|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
17003953|NCT00896532|38147659|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003954|NCT00896532|38147660|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003955|NCT00896532|38147661|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003956|NCT00896532|38147662|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003957|NCT00896532|38147663|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003958|NCT00896532|38147664|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003959|NCT00896532|38147665|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003960|NCT00896532|38147666|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003961|NCT00896532|38147667|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003962|NCT00896532|38147668|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003963|NCT00896532|38147669|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16894887|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894888|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16894889|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894890|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
17003964|NCT00896532|38147670|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003965|NCT00896532|38147671|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003966|NCT00896532|38147672|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003967|NCT00896532|38147673|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003968|NCT00896532|38147674|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17095413|NCT00168818|38234700|FG000|Overall Study|Lost to Follow-up|13|||
17192323|NCT01362530|38345536|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
17192324|NCT02654054|38345546|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
16894891|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894892|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894893|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894894|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894895|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
16894896|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894897|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894898|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894899|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894900|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894901|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894902|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894903|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16894904|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894905|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894906|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894907|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
17192325|NCT02654054|38345547|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
17192326|NCT02654054|38345548|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
17192327|NCT02654054|38345546|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
17192328|NCT02654054|38345547|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
17192329|NCT02654054|38345548|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
17192330|NCT02654054|38345546|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
17192331|NCT02654054|38345547|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
17192332|NCT02654054|38345548|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
17192333|NCT02654054|38345546|FG000|Post-Treatment Follow-Up Period|Other|1|||
17192334|NCT02654054|38345547|FG001|Post-Treatment Follow-Up Period|Other|0|||
17192335|NCT02654054|38345548|FG002|Post-Treatment Follow-Up Period|Other|4|||
17192336|NCT02654054|38345546|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
17192337|NCT02654054|38345547|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
17192338|NCT02654054|38345548|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
17192339|NCT02653664|38345569|FG000|Post-Treatment|Withdrawal by Subject|6|||
17192340|NCT02653664|38345570|FG001|Post-Treatment|Withdrawal by Subject|5|||
17192341|NCT02653664|38345571|FG002|Post-Treatment|Withdrawal by Subject|7|||
17192342|NCT02653664|38345569|FG000|Post-Treatment|Lost to Follow-up|8|||
17192343|NCT02653664|38345570|FG001|Post-Treatment|Lost to Follow-up|1|||
17192344|NCT02653664|38345571|FG002|Post-Treatment|Lost to Follow-up|7|||
17192345|NCT02653664|38345569|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
17192346|NCT02653664|38345570|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
17192347|NCT02653664|38345571|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
17192348|NCT02653664|38345569|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
17192349|NCT02653664|38345570|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
17192350|NCT02653664|38345571|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
17192351|NCT02653664|38345569|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
17192352|NCT02653664|38345570|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
17192353|NCT02653664|38345571|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
17192354|NCT02653664|38345569|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
17192355|NCT02653664|38345570|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
17192356|NCT02653664|38345571|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
16894908|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894909|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894910|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894911|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894912|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
16894913|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894914|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894915|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894916|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894917|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894918|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16894919|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894920|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894921|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894922|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894923|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894924|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
16894925|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
16894926|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
16894927|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
16894928|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894929|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894930|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894931|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894932|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894933|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16894934|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894935|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894936|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894937|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894938|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894939|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
16894940|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894941|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894942|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894943|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894944|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894945|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894946|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894947|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894948|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16894949|NCT02326272|37965749|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894950|NCT02326272|37965750|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894951|NCT02326272|37965751|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894952|NCT02326272|37965752|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894953|NCT02326272|37965753|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894954|NCT02326272|37965754|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894955|NCT02326272|37965755|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
16894956|NCT02326272|37965756|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894957|NCT02326272|37965757|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894958|NCT02326272|37965758|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894959|NCT02326272|37965759|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894960|NCT02326272|37965760|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894961|NCT02326272|37965761|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894962|NCT02326272|37965762|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894963|NCT02326272|37965763|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16894964|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
16894965|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
17095414|NCT00168818|38234701|FG001|Overall Study|Lost to Follow-up|4|||
17095415|NCT00168818|38234702|FG002|Overall Study|Lost to Follow-up|15|||
16894966|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
16894967|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
16894968|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
16894969|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
16894970|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
16894971|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
16894972|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
16894973|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
16894974|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
16894975|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
16894976|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
16894977|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
16894978|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
16894979|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894980|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894981|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894982|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894983|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894984|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894985|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894986|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894987|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894988|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894989|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
16894990|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
16894991|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
16894992|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16894993|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
16894994|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16894995|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16894996|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16894997|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16894998|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16894999|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16895000|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16895001|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16895002|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16895003|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16895004|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16895005|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16895006|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16895007|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16895008|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16895009|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895010|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895011|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895012|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895013|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895014|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895015|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895016|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895017|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895018|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895019|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895020|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
16895021|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895022|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895023|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16895024|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895025|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895026|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895027|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895028|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895029|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895030|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895031|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895032|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895033|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895034|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
16895035|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895036|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
16895037|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16895038|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
16895039|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895040|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895041|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895042|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895043|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895044|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895045|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895046|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895047|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895048|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895049|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895050|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
16895051|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895052|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16895053|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
16895054|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895055|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895056|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895057|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895058|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895059|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895060|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895061|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895062|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895063|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895064|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895065|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
16895066|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
16895067|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16895068|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
16895069|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895070|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895071|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895072|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895073|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895074|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895075|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895076|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895077|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895078|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895079|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895080|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
16895081|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895082|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895083|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16895084|NCT02326272|37965749|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895085|NCT02326272|37965750|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895086|NCT02326272|37965751|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895087|NCT02326272|37965752|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895088|NCT02326272|37965753|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895089|NCT02326272|37965754|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895090|NCT02326272|37965755|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895091|NCT02326272|37965756|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895092|NCT02326272|37965757|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895093|NCT02326272|37965758|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895094|NCT02326272|37965759|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895095|NCT02326272|37965760|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895096|NCT02326272|37965761|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
16895097|NCT02326272|37965762|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895098|NCT02326272|37965763|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16895099|NCT02325414|37965800|FG000|Overall Study|Withdrawal by Subject|3|||
16895100|NCT02325414|37965801|FG001|Overall Study|Withdrawal by Subject|1|||
16895101|NCT02325414|37965800|FG000|Overall Study|Lost to Follow-up|5|||
16895102|NCT02325414|37965801|FG001|Overall Study|Lost to Follow-up|5|||
16895103|NCT02349048|37965819|FG000|Overall Study|Withdrawal by Subject|4|||
16895104|NCT02349048|37965820|FG001|Overall Study|Withdrawal by Subject|0|||
16895105|NCT02349048|37965819|FG000|Overall Study|Lost to Follow-up|1|||
16895106|NCT02349048|37965820|FG001|Overall Study|Lost to Follow-up|0|||
16895107|NCT02299206|37965867|FG000|Overall Study|Lost to Follow-up|1|||
16895108|NCT02299206|37965867|FG000|Overall Study|Withdrawal by Subject|1|||
16895109|NCT02298192|37965886|FG000|Overall Study|Unclassified|3|||
16895110|NCT02298192|37965887|FG001|Overall Study|Unclassified|2|||
16895111|NCT02298192|37965886|FG000|Overall Study|Withdrawal criteria|2|||
16895112|NCT02298192|37965887|FG001|Overall Study|Withdrawal criteria|0|||
16895113|NCT02298192|37965886|FG000|Overall Study|Withdrawal by Subject|6|||
16895114|NCT02298192|37965887|FG001|Overall Study|Withdrawal by Subject|1|||
16895115|NCT02298192|37965886|FG000|Overall Study|Lost to Follow-up|2|||
16895116|NCT02298192|37965887|FG001|Overall Study|Lost to Follow-up|1|||
16895117|NCT02298192|37965886|FG000|Overall Study|Adverse Event|6|||
16895118|NCT02298192|37965887|FG001|Overall Study|Adverse Event|2|||
16895119|NCT02280408|37966013|FG000|Overall Study|Lost to Follow-up|0|||
16895120|NCT02280408|37966014|FG001|Overall Study|Lost to Follow-up|2|||
16895121|NCT02280408|37966015|FG002|Overall Study|Lost to Follow-up|0|||
16895122|NCT02280408|37966016|FG003|Overall Study|Lost to Follow-up|0|||
16895123|NCT02296476|37966092|FG000|Overall Study|Disease Progression|6|||
16895124|NCT02296476|37966093|FG001|Overall Study|Disease Progression|4|||
16895125|NCT02296476|37966094|FG002|Overall Study|Disease Progression|2|||
16895126|NCT00552032|37966135|FG000|Overall Study|Withdrawal by Subject|2|||
16895127|NCT00552032|37966136|FG001|Overall Study|Withdrawal by Subject|2|||
16895128|NCT00552032|37966135|FG000|Overall Study|Protocol Violation|7|||
16895129|NCT00552032|37966136|FG001|Overall Study|Protocol Violation|12|||
16895130|NCT00552032|37966135|FG000|Overall Study|Lost to Follow-up|8|||
16895131|NCT00552032|37966136|FG001|Overall Study|Lost to Follow-up|5|||
16895132|NCT02101853|37966785|FG000|Block 1 Induction|Adverse Event|11|||
16895133|NCT02101853|37966786|FG001|Block 1 Induction|Adverse Event|0|||
16895134|NCT02101853|37966787|FG002|Block 1 Induction|Adverse Event|0|||
16895135|NCT02101853|37966788|FG003|Block 1 Induction|Adverse Event|0|||
16895136|NCT02101853|37966789|FG004|Block 1 Induction|Adverse Event|0|||
16895137|NCT02101853|37966790|FG005|Block 1 Induction|Adverse Event|0|||
16895138|NCT02101853|37966785|FG000|Block 1 Induction|Death|20|||
16895139|NCT02101853|37966786|FG001|Block 1 Induction|Death|0|||
16895140|NCT02101853|37966787|FG002|Block 1 Induction|Death|0|||
16895141|NCT02101853|37966788|FG003|Block 1 Induction|Death|0|||
16895142|NCT02101853|37966789|FG004|Block 1 Induction|Death|0|||
16895143|NCT02101853|37966790|FG005|Block 1 Induction|Death|0|||
16895144|NCT02101853|37966785|FG000|Block 1 Induction|Lack of Efficacy|6|||
16895145|NCT02101853|37966786|FG001|Block 1 Induction|Lack of Efficacy|0|||
16895146|NCT02101853|37966787|FG002|Block 1 Induction|Lack of Efficacy|0|||
16895147|NCT02101853|37966788|FG003|Block 1 Induction|Lack of Efficacy|0|||
16895148|NCT02101853|37966789|FG004|Block 1 Induction|Lack of Efficacy|0|||
16895149|NCT02101853|37966790|FG005|Block 1 Induction|Lack of Efficacy|0|||
16895150|NCT02101853|37966785|FG000|Block 1 Induction|Physician Decision|61|||
16895151|NCT02101853|37966786|FG001|Block 1 Induction|Physician Decision|0|||
16895152|NCT02101853|37966787|FG002|Block 1 Induction|Physician Decision|0|||
16895153|NCT02101853|37966788|FG003|Block 1 Induction|Physician Decision|0|||
16895154|NCT02101853|37966789|FG004|Block 1 Induction|Physician Decision|0|||
16895155|NCT02101853|37966790|FG005|Block 1 Induction|Physician Decision|0|||
16895156|NCT02101853|37966785|FG000|Block 1 Induction|Protocol Violation|2|||
16895157|NCT02101853|37966786|FG001|Block 1 Induction|Protocol Violation|0|||
16895158|NCT02101853|37966787|FG002|Block 1 Induction|Protocol Violation|0|||
16895159|NCT02101853|37966788|FG003|Block 1 Induction|Protocol Violation|0|||
16895160|NCT02101853|37966789|FG004|Block 1 Induction|Protocol Violation|0|||
16895161|NCT02101853|37966790|FG005|Block 1 Induction|Protocol Violation|0|||
16895162|NCT02101853|37966785|FG000|Block 1 Induction|Withdrawal by Subject|65|||
16895163|NCT02101853|37966786|FG001|Block 1 Induction|Withdrawal by Subject|0|||
16895164|NCT02101853|37966787|FG002|Block 1 Induction|Withdrawal by Subject|0|||
16895165|NCT02101853|37966788|FG003|Block 1 Induction|Withdrawal by Subject|0|||
16895166|NCT02101853|37966789|FG004|Block 1 Induction|Withdrawal by Subject|0|||
16895167|NCT02101853|37966790|FG005|Block 1 Induction|Withdrawal by Subject|0|||
16895168|NCT02101853|37966785|FG000|Block 1 Induction|Ineligible|8|||
16895169|NCT02101853|37966786|FG001|Block 1 Induction|Ineligible|0|||
16895170|NCT02101853|37966787|FG002|Block 1 Induction|Ineligible|0|||
16895171|NCT02101853|37966788|FG003|Block 1 Induction|Ineligible|0|||
16895172|NCT02101853|37966789|FG004|Block 1 Induction|Ineligible|0|||
16895173|NCT02101853|37966790|FG005|Block 1 Induction|Ineligible|0|||
16895174|NCT02101853|37966785|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
16895175|NCT02101853|37966786|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16895176|NCT02101853|37966787|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16895177|NCT02101853|37966788|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16895178|NCT02101853|37966789|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16895179|NCT02101853|37966790|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16895180|NCT02101853|37966785|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
16895181|NCT02101853|37966786|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895182|NCT02101853|37966787|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895183|NCT02101853|37966788|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895184|NCT02101853|37966789|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895185|NCT02101853|37966790|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895186|NCT02101853|37966785|FG000|Post Induction Randomization|Adverse Event|0|||
16895187|NCT02101853|37966786|FG001|Post Induction Randomization|Adverse Event|3|||
16895188|NCT02101853|37966787|FG002|Post Induction Randomization|Adverse Event|8|||
16895189|NCT02101853|37966788|FG003|Post Induction Randomization|Adverse Event|4|||
16895190|NCT02101853|37966789|FG004|Post Induction Randomization|Adverse Event|4|||
16895191|NCT02101853|37966790|FG005|Post Induction Randomization|Adverse Event|0|||
16895192|NCT02101853|37966785|FG000|Post Induction Randomization|Death|0|||
16895193|NCT02101853|37966786|FG001|Post Induction Randomization|Death|9|||
16895194|NCT02101853|37966787|FG002|Post Induction Randomization|Death|2|||
16895195|NCT02101853|37966788|FG003|Post Induction Randomization|Death|2|||
16895196|NCT02101853|37966789|FG004|Post Induction Randomization|Death|0|||
16895197|NCT02101853|37966790|FG005|Post Induction Randomization|Death|0|||
16895198|NCT02101853|37966785|FG000|Post Induction Randomization|Lack of Efficacy|0|||
16895199|NCT02101853|37966786|FG001|Post Induction Randomization|Lack of Efficacy|14|||
16895200|NCT02101853|37966787|FG002|Post Induction Randomization|Lack of Efficacy|23|||
16895201|NCT02101853|37966788|FG003|Post Induction Randomization|Lack of Efficacy|18|||
16895202|NCT02101853|37966789|FG004|Post Induction Randomization|Lack of Efficacy|21|||
16895203|NCT02101853|37966790|FG005|Post Induction Randomization|Lack of Efficacy|0|||
16895204|NCT02101853|37966785|FG000|Post Induction Randomization|Physician Decision|0|||
16895205|NCT02101853|37966786|FG001|Post Induction Randomization|Physician Decision|43|||
16895206|NCT02101853|37966787|FG002|Post Induction Randomization|Physician Decision|23|||
16895207|NCT02101853|37966788|FG003|Post Induction Randomization|Physician Decision|14|||
16895208|NCT02101853|37966789|FG004|Post Induction Randomization|Physician Decision|14|||
16895209|NCT02101853|37966790|FG005|Post Induction Randomization|Physician Decision|0|||
16895210|NCT02101853|37966785|FG000|Post Induction Randomization|Protocol Violation|0|||
16895211|NCT02101853|37966786|FG001|Post Induction Randomization|Protocol Violation|3|||
16895212|NCT02101853|37966787|FG002|Post Induction Randomization|Protocol Violation|0|||
16895213|NCT02101853|37966788|FG003|Post Induction Randomization|Protocol Violation|0|||
16895214|NCT02101853|37966789|FG004|Post Induction Randomization|Protocol Violation|0|||
16895215|NCT02101853|37966790|FG005|Post Induction Randomization|Protocol Violation|0|||
16895216|NCT02101853|37966785|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
16895217|NCT02101853|37966786|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
16895218|NCT02101853|37966787|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
16895219|NCT02101853|37966788|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
16895220|NCT02101853|37966789|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
16895221|NCT02101853|37966790|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
16895222|NCT02101853|37966785|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895223|NCT02101853|37966786|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895224|NCT02101853|37966787|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895225|NCT02101853|37966788|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
16895226|NCT02101853|37966789|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895227|NCT02101853|37966790|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16895228|NCT02101853|37966785|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
16895229|NCT02101853|37966786|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
16895230|NCT02101853|37966787|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
16895231|NCT02101853|37966788|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
16895232|NCT02101853|37966789|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
16895233|NCT02101853|37966790|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
16895234|NCT02101853|37966785|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16895235|NCT02101853|37966786|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
16895236|NCT02101853|37966787|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16895237|NCT02101853|37966788|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16895238|NCT02101853|37966789|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16895239|NCT02101853|37966790|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16895240|NCT02101853|37966785|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
16895241|NCT02101853|37966786|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
17095416|NCT00168818|38234700|FG000|Overall Study|Withdrawal by Subject|43|||
16785982|NCT01979614|37726265|FG000|Overall Study|Adverse Event|1|||
17003969|NCT00896532|38147675|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
17003970|NCT00896532|38147676|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17095417|NCT00168818|38234701|FG001|Overall Study|Withdrawal by Subject|41|||
16895242|NCT02101853|37966787|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
16895243|NCT02101853|37966788|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
16895244|NCT02101853|37966789|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
16895245|NCT02101853|37966790|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
16895246|NCT02101853|37966785|FG000|Blinatumomab Salvage Therapy|Death|0|||
16895247|NCT02101853|37966786|FG001|Blinatumomab Salvage Therapy|Death|0|||
16895248|NCT02101853|37966787|FG002|Blinatumomab Salvage Therapy|Death|0|||
16895249|NCT02101853|37966788|FG003|Blinatumomab Salvage Therapy|Death|0|||
16895250|NCT02101853|37966789|FG004|Blinatumomab Salvage Therapy|Death|0|||
16895251|NCT02101853|37966790|FG005|Blinatumomab Salvage Therapy|Death|2|||
16895252|NCT02101853|37966785|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16895253|NCT02101853|37966786|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16895254|NCT02101853|37966787|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16895255|NCT02101853|37966788|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16895256|NCT02101853|37966789|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16895257|NCT02101853|37966790|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
16895258|NCT02101853|37966785|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
16895259|NCT02101853|37966786|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
16895260|NCT02101853|37966787|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
16895261|NCT02101853|37966788|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
16895262|NCT02101853|37966789|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
16895263|NCT02101853|37966790|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
16895264|NCT02101853|37966785|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16895265|NCT02101853|37966786|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16895266|NCT02101853|37966787|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16895267|NCT02101853|37966788|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16895268|NCT02101853|37966789|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16895269|NCT02101853|37966790|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
16895270|NCT02988817|37966913|FG000|Overall Study|Withdrawal by Subject|1|||
16895271|NCT02988817|37966914|FG001|Overall Study|Withdrawal by Subject|0|||
16895272|NCT02988817|37966915|FG002|Overall Study|Withdrawal by Subject|0|||
16895273|NCT02988817|37966916|FG003|Overall Study|Withdrawal by Subject|1|||
16895274|NCT02988817|37966917|FG004|Overall Study|Withdrawal by Subject|3|||
16895275|NCT02988817|37966918|FG005|Overall Study|Withdrawal by Subject|1|||
16895276|NCT02988817|37966919|FG006|Overall Study|Withdrawal by Subject|2|||
16895277|NCT02988817|37966920|FG007|Overall Study|Withdrawal by Subject|1|||
16895278|NCT02988817|37966921|FG008|Overall Study|Withdrawal by Subject|1|||
16895279|NCT02988817|37966922|FG009|Overall Study|Withdrawal by Subject|1|||
16895280|NCT02988817|37966923|FG010|Overall Study|Withdrawal by Subject|1|||
16895281|NCT02988817|37966924|FG011|Overall Study|Withdrawal by Subject|12|||
16895282|NCT02988817|37966925|FG012|Overall Study|Withdrawal by Subject|6|||
16895283|NCT02988817|37966926|FG013|Overall Study|Withdrawal by Subject|6|||
16895284|NCT02988817|37966927|FG014|Overall Study|Withdrawal by Subject|4|||
16895285|NCT02988817|37966928|FG015|Overall Study|Withdrawal by Subject|5|||
16895286|NCT02988817|37966929|FG016|Overall Study|Withdrawal by Subject|4|||
16895287|NCT02988817|37966930|FG017|Overall Study|Withdrawal by Subject|11|||
16895288|NCT02988817|37966931|FG018|Overall Study|Withdrawal by Subject|4|||
16895289|NCT02988817|37966932|FG019|Overall Study|Withdrawal by Subject|2|||
16895290|NCT02988817|37966913|FG000|Overall Study|Death|0|||
16895291|NCT02988817|37966914|FG001|Overall Study|Death|1|||
16895292|NCT02988817|37966915|FG002|Overall Study|Death|3|||
16895293|NCT02988817|37966916|FG003|Overall Study|Death|1|||
16895294|NCT02988817|37966917|FG004|Overall Study|Death|6|||
16895295|NCT02988817|37966918|FG005|Overall Study|Death|10|||
16895296|NCT02988817|37966919|FG006|Overall Study|Death|1|||
16895297|NCT02988817|37966920|FG007|Overall Study|Death|2|||
16895298|NCT02988817|37966921|FG008|Overall Study|Death|1|||
17095418|NCT00168818|38234702|FG002|Overall Study|Withdrawal by Subject|37|||
16895299|NCT02988817|37966922|FG009|Overall Study|Death|5|||
16895300|NCT02988817|37966923|FG010|Overall Study|Death|1|||
16895301|NCT02988817|37966924|FG011|Overall Study|Death|8|||
16895302|NCT02988817|37966925|FG012|Overall Study|Death|9|||
16895303|NCT02988817|37966926|FG013|Overall Study|Death|17|||
16895304|NCT02988817|37966927|FG014|Overall Study|Death|18|||
16895305|NCT02988817|37966928|FG015|Overall Study|Death|30|||
16895306|NCT02988817|37966929|FG016|Overall Study|Death|17|||
16895307|NCT02988817|37966930|FG017|Overall Study|Death|38|||
16895308|NCT02988817|37966931|FG018|Overall Study|Death|14|||
16895309|NCT02988817|37966932|FG019|Overall Study|Death|16|||
16895310|NCT02988817|37966913|FG000|Overall Study|Other|0|||
16895311|NCT02988817|37966914|FG001|Overall Study|Other|0|||
16895312|NCT02988817|37966915|FG002|Overall Study|Other|0|||
16895313|NCT02988817|37966916|FG003|Overall Study|Other|1|||
16895314|NCT02988817|37966917|FG004|Overall Study|Other|1|||
16895315|NCT02988817|37966918|FG005|Overall Study|Other|0|||
16895316|NCT02988817|37966919|FG006|Overall Study|Other|0|||
16895317|NCT02988817|37966920|FG007|Overall Study|Other|0|||
16895318|NCT02988817|37966921|FG008|Overall Study|Other|0|||
16895319|NCT02988817|37966922|FG009|Overall Study|Other|0|||
16895320|NCT02988817|37966923|FG010|Overall Study|Other|0|||
16895321|NCT02988817|37966924|FG011|Overall Study|Other|0|||
16895322|NCT02988817|37966925|FG012|Overall Study|Other|0|||
16895323|NCT02988817|37966926|FG013|Overall Study|Other|0|||
16895324|NCT02988817|37966927|FG014|Overall Study|Other|0|||
16895325|NCT02988817|37966928|FG015|Overall Study|Other|1|||
16895326|NCT02988817|37966929|FG016|Overall Study|Other|0|||
16895327|NCT02988817|37966930|FG017|Overall Study|Other|0|||
16895328|NCT02988817|37966931|FG018|Overall Study|Other|0|||
16895329|NCT02988817|37966932|FG019|Overall Study|Other|0|||
16895330|NCT02988817|37966913|FG000|Overall Study|Lost to Follow-up|0|||
16895331|NCT02988817|37966914|FG001|Overall Study|Lost to Follow-up|0|||
16895332|NCT02988817|37966915|FG002|Overall Study|Lost to Follow-up|0|||
16895333|NCT02988817|37966916|FG003|Overall Study|Lost to Follow-up|0|||
16895334|NCT02988817|37966917|FG004|Overall Study|Lost to Follow-up|0|||
16895335|NCT02988817|37966918|FG005|Overall Study|Lost to Follow-up|0|||
16895336|NCT02988817|37966919|FG006|Overall Study|Lost to Follow-up|0|||
16895337|NCT02988817|37966920|FG007|Overall Study|Lost to Follow-up|0|||
16895338|NCT02988817|37966921|FG008|Overall Study|Lost to Follow-up|1|||
16895339|NCT02988817|37966922|FG009|Overall Study|Lost to Follow-up|0|||
16895340|NCT02988817|37966923|FG010|Overall Study|Lost to Follow-up|1|||
16895341|NCT02988817|37966924|FG011|Overall Study|Lost to Follow-up|1|||
16895342|NCT02988817|37966925|FG012|Overall Study|Lost to Follow-up|0|||
16895343|NCT02988817|37966926|FG013|Overall Study|Lost to Follow-up|0|||
16895344|NCT02988817|37966927|FG014|Overall Study|Lost to Follow-up|1|||
16895345|NCT02988817|37966928|FG015|Overall Study|Lost to Follow-up|1|||
16895346|NCT02988817|37966929|FG016|Overall Study|Lost to Follow-up|2|||
16895347|NCT02988817|37966930|FG017|Overall Study|Lost to Follow-up|3|||
16895348|NCT02988817|37966931|FG018|Overall Study|Lost to Follow-up|0|||
16895349|NCT02988817|37966932|FG019|Overall Study|Lost to Follow-up|0|||
16895350|NCT02988817|37966913|FG000|Overall Study|Sponsor decision|0|||
16895351|NCT02988817|37966914|FG001|Overall Study|Sponsor decision|0|||
16895352|NCT02988817|37966915|FG002|Overall Study|Sponsor decision|0|||
16895353|NCT02988817|37966916|FG003|Overall Study|Sponsor decision|0|||
16895354|NCT02988817|37966917|FG004|Overall Study|Sponsor decision|0|||
16895355|NCT02988817|37966918|FG005|Overall Study|Sponsor decision|0|||
16895356|NCT02988817|37966919|FG006|Overall Study|Sponsor decision|0|||
16895357|NCT02988817|37966920|FG007|Overall Study|Sponsor decision|0|||
16895358|NCT02988817|37966921|FG008|Overall Study|Sponsor decision|0|||
16895359|NCT02988817|37966922|FG009|Overall Study|Sponsor decision|0|||
16895360|NCT02988817|37966923|FG010|Overall Study|Sponsor decision|0|||
17095419|NCT00168818|38234700|FG000|Overall Study|Other|22|||
16895361|NCT02988817|37966924|FG011|Overall Study|Sponsor decision|1|||
16895362|NCT02988817|37966925|FG012|Overall Study|Sponsor decision|1|||
16895363|NCT02988817|37966926|FG013|Overall Study|Sponsor decision|2|||
16895364|NCT02988817|37966927|FG014|Overall Study|Sponsor decision|2|||
16895365|NCT02988817|37966928|FG015|Overall Study|Sponsor decision|6|||
16895366|NCT02988817|37966929|FG016|Overall Study|Sponsor decision|2|||
16895367|NCT02988817|37966930|FG017|Overall Study|Sponsor decision|3|||
16895368|NCT02988817|37966931|FG018|Overall Study|Sponsor decision|2|||
16895369|NCT02988817|37966932|FG019|Overall Study|Sponsor decision|7|||
16895370|NCT02988817|37966913|FG000|Overall Study|Physician Decision|0|||
16895371|NCT02988817|37966914|FG001|Overall Study|Physician Decision|0|||
16895372|NCT02988817|37966915|FG002|Overall Study|Physician Decision|0|||
16895373|NCT02988817|37966916|FG003|Overall Study|Physician Decision|0|||
16895374|NCT02988817|37966917|FG004|Overall Study|Physician Decision|0|||
16895375|NCT02988817|37966918|FG005|Overall Study|Physician Decision|0|||
16895376|NCT02988817|37966919|FG006|Overall Study|Physician Decision|0|||
16895377|NCT02988817|37966920|FG007|Overall Study|Physician Decision|0|||
16895378|NCT02988817|37966921|FG008|Overall Study|Physician Decision|0|||
16895379|NCT02988817|37966922|FG009|Overall Study|Physician Decision|0|||
16895380|NCT02988817|37966923|FG010|Overall Study|Physician Decision|0|||
16895381|NCT02988817|37966924|FG011|Overall Study|Physician Decision|0|||
16895382|NCT02988817|37966925|FG012|Overall Study|Physician Decision|0|||
16895383|NCT02988817|37966926|FG013|Overall Study|Physician Decision|0|||
16895384|NCT02988817|37966927|FG014|Overall Study|Physician Decision|0|||
16895385|NCT02988817|37966928|FG015|Overall Study|Physician Decision|1|||
16895386|NCT02988817|37966929|FG016|Overall Study|Physician Decision|0|||
16895387|NCT02988817|37966930|FG017|Overall Study|Physician Decision|0|||
16895388|NCT02988817|37966931|FG018|Overall Study|Physician Decision|1|||
16895389|NCT02988817|37966932|FG019|Overall Study|Physician Decision|1|||
16895390|NCT03312530|37967056|FG000|Overall Study|Death|5|||
16895391|NCT03312530|37967057|FG001|Overall Study|Death|5|||
16895392|NCT03312530|37967058|FG002|Overall Study|Death|4|||
16895393|NCT03312530|37967059|FG003|Overall Study|Death|10|||
16895394|NCT03312530|37967060|FG004|Overall Study|Death|8|||
16895395|NCT03312530|37967056|FG000|Overall Study|Lost to Follow-up|0|||
16895396|NCT03312530|37967057|FG001|Overall Study|Lost to Follow-up|0|||
16895397|NCT03312530|37967058|FG002|Overall Study|Lost to Follow-up|0|||
16895398|NCT03312530|37967059|FG003|Overall Study|Lost to Follow-up|1|||
16895399|NCT03312530|37967060|FG004|Overall Study|Lost to Follow-up|0|||
16785983|NCT01979614|37726266|FG001|Overall Study|Adverse Event|1|||
16785984|NCT02654717|37726274|FG000|Overall Study|Adverse Event|2|||
16785985|NCT02654717|37726275|FG001|Overall Study|Adverse Event|2|||
16785986|NCT02654717|37726274|FG000|Overall Study|Protocol Violation|1|||
16785987|NCT02654717|37726275|FG001|Overall Study|Protocol Violation|2|||
16785988|NCT02654717|37726274|FG000|Overall Study|Withdrawal by Subject|0|||
16785989|NCT02654717|37726275|FG001|Overall Study|Withdrawal by Subject|1|||
16785990|NCT02654717|37726274|FG000|Overall Study|Non-permitted medication|3|||
16785991|NCT02654717|37726275|FG001|Overall Study|Non-permitted medication|0|||
16785992|NCT03343301|37726283|FG000|Overall Study|Withdrawal by Subject|1|||
16785993|NCT03343301|37726284|FG001|Overall Study|Withdrawal by Subject|1|||
16785994|NCT03343301|37726283|FG000|Overall Study|Death|0|||
16785995|NCT03343301|37726284|FG001|Overall Study|Death|2|||
16785996|NCT03343301|37726283|FG000|Overall Study|Other|0|||
16785997|NCT03343301|37726284|FG001|Overall Study|Other|6|||
16785998|NCT03343301|37726283|FG000|Overall Study|Missing|2|||
16785999|NCT03343301|37726284|FG001|Overall Study|Missing|0|||
16786000|NCT02696785|37726294|FG000|Blinded Treatment Period|Adverse Event|0|||
16786001|NCT02696785|37726295|FG001|Blinded Treatment Period|Adverse Event|1|||
16786002|NCT02696785|37726296|FG002|Blinded Treatment Period|Adverse Event|3|||
16786003|NCT02696785|37726297|FG003|Blinded Treatment Period|Adverse Event|0|||
16786004|NCT02696785|37726294|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
16786005|NCT02696785|37726295|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
16786006|NCT02696785|37726296|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
16786007|NCT02696785|37726297|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
16786008|NCT02696785|37726294|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
16786009|NCT02696785|37726295|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
16786010|NCT02696785|37726296|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
16786011|NCT02696785|37726297|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
16786012|NCT02696785|37726294|FG000|Blinded Treatment Period|Screen Failure|1|||
16786013|NCT02696785|37726295|FG001|Blinded Treatment Period|Screen Failure|0|||
16786014|NCT02696785|37726296|FG002|Blinded Treatment Period|Screen Failure|0|||
16786015|NCT02696785|37726297|FG003|Blinded Treatment Period|Screen Failure|0|||
16786016|NCT02696785|37726294|FG000|Washout Period|Withdrawal by Subject|0|||
16786017|NCT02696785|37726295|FG001|Washout Period|Withdrawal by Subject|1|||
16786018|NCT02696785|37726296|FG002|Washout Period|Withdrawal by Subject|0|||
16786019|NCT02696785|37726297|FG003|Washout Period|Withdrawal by Subject|0|||
16786020|NCT02696785|37726294|FG000|Washout Period|Lack of Efficacy|0|||
16786021|NCT02696785|37726295|FG001|Washout Period|Lack of Efficacy|1|||
16786022|NCT02696785|37726296|FG002|Washout Period|Lack of Efficacy|0|||
16786023|NCT02696785|37726297|FG003|Washout Period|Lack of Efficacy|0|||
16786024|NCT02696785|37726294|FG000|Extended Treatment Period|Adverse Event|2|||
16786025|NCT02696785|37726295|FG001|Extended Treatment Period|Adverse Event|3|||
16786026|NCT02696785|37726296|FG002|Extended Treatment Period|Adverse Event|2|||
16786027|NCT02696785|37726297|FG003|Extended Treatment Period|Adverse Event|1|||
16786028|NCT02696785|37726294|FG000|Extended Treatment Period|Lack of Efficacy|0|||
16786029|NCT02696785|37726295|FG001|Extended Treatment Period|Lack of Efficacy|1|||
16786030|NCT02696785|37726296|FG002|Extended Treatment Period|Lack of Efficacy|0|||
16786031|NCT02696785|37726297|FG003|Extended Treatment Period|Lack of Efficacy|0|||
16786032|NCT02696785|37726294|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
16786033|NCT02696785|37726295|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
16786034|NCT02696785|37726296|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
16895400|NCT03312530|37967056|FG000|Overall Study|Participant in another sponsor study.|0|||
16895401|NCT03312530|37967057|FG001|Overall Study|Participant in another sponsor study.|0|||
16895402|NCT03312530|37967058|FG002|Overall Study|Participant in another sponsor study.|0|||
16895403|NCT03312530|37967059|FG003|Overall Study|Participant in another sponsor study.|1|||
16895404|NCT03312530|37967060|FG004|Overall Study|Participant in another sponsor study.|0|||
16895405|NCT03312530|37967056|FG000|Overall Study|Study terminated by sponsor|1|||
17095420|NCT00168818|38234701|FG001|Overall Study|Other|24|||
16895406|NCT03312530|37967057|FG001|Overall Study|Study terminated by sponsor|0|||
16895407|NCT03312530|37967058|FG002|Overall Study|Study terminated by sponsor|2|||
16895408|NCT03312530|37967059|FG003|Overall Study|Study terminated by sponsor|3|||
16895409|NCT03312530|37967060|FG004|Overall Study|Study terminated by sponsor|7|||
16895410|NCT03312530|37967056|FG000|Overall Study|Withdrawal by Subject|0|||
16895411|NCT03312530|37967057|FG001|Overall Study|Withdrawal by Subject|1|||
16895412|NCT03312530|37967058|FG002|Overall Study|Withdrawal by Subject|0|||
16895413|NCT03312530|37967059|FG003|Overall Study|Withdrawal by Subject|0|||
16895414|NCT03312530|37967060|FG004|Overall Study|Withdrawal by Subject|0|||
16895415|NCT03312530|37967056|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
16895416|NCT03312530|37967057|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
16895417|NCT03312530|37967058|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
16895418|NCT03312530|37967059|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
16895419|NCT03312530|37967060|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
16895420|NCT02296320|37967191|FG000|Overall Study|Withdrawal by Subject|4|||
16895421|NCT02296320|37967192|FG001|Overall Study|Withdrawal by Subject|0|||
16895422|NCT02296320|37967193|FG002|Overall Study|Withdrawal by Subject|2|||
16895423|NCT02296320|37967191|FG000|Overall Study|Death|24|||
16895424|NCT02296320|37967192|FG001|Overall Study|Death|3|||
16895425|NCT02296320|37967193|FG002|Overall Study|Death|27|||
16895426|NCT02296320|37967191|FG000|Overall Study|Lost to Follow-up|5|||
16895427|NCT02296320|37967192|FG001|Overall Study|Lost to Follow-up|2|||
16895428|NCT02296320|37967193|FG002|Overall Study|Lost to Follow-up|7|||
16895429|NCT02296320|37967191|FG000|Overall Study|Not treated|2|||
16895430|NCT02296320|37967192|FG001|Overall Study|Not treated|0|||
16895431|NCT02296320|37967193|FG002|Overall Study|Not treated|0|||
16895432|NCT02296320|37967191|FG000|Overall Study|Not - specified|0|||
16895433|NCT02296320|37967192|FG001|Overall Study|Not - specified|0|||
17003971|NCT00896532|38147677|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003972|NCT00896532|38147678|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003973|NCT00896532|38147679|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003974|NCT00896532|38147680|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003975|NCT00896532|38147681|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
17003976|NCT00896532|38147659|FG000|Months 48-72: Follow-on Phase|Death|0|||
17003977|NCT00896532|38147660|FG001|Months 48-72: Follow-on Phase|Death|0|||
17003978|NCT00896532|38147661|FG002|Months 48-72: Follow-on Phase|Death|0|||
17003979|NCT00896532|38147662|FG003|Months 48-72: Follow-on Phase|Death|0|||
17003980|NCT00896532|38147663|FG004|Months 48-72: Follow-on Phase|Death|0|||
17003981|NCT00896532|38147664|FG005|Months 48-72: Follow-on Phase|Death|0|||
17003982|NCT00896532|38147665|FG006|Months 48-72: Follow-on Phase|Death|0|||
17003983|NCT00896532|38147666|FG007|Months 48-72: Follow-on Phase|Death|0|||
17003984|NCT00896532|38147667|FG008|Months 48-72: Follow-on Phase|Death|0|||
17003985|NCT00896532|38147668|FG009|Months 48-72: Follow-on Phase|Death|0|||
17003986|NCT00896532|38147669|FG010|Months 48-72: Follow-on Phase|Death|0|||
17003987|NCT00896532|38147670|FG011|Months 48-72: Follow-on Phase|Death|0|||
16895434|NCT02296320|37967193|FG002|Overall Study|Not - specified|1|||
16895435|NCT02296242|37967232|FG000|Overall Study|Death|1|||
16895436|NCT02296242|37967233|FG001|Overall Study|Death|1|||
16895437|NCT02296242|37967234|FG002|Overall Study|Death|1|||
16895438|NCT02296242|37967235|FG003|Overall Study|Death|1|||
16895439|NCT02296242|37967236|FG004|Overall Study|Death|1|||
16895440|NCT02296242|37967232|FG000|Overall Study|Withdrawal by Subject|0|||
16895441|NCT02296242|37967233|FG001|Overall Study|Withdrawal by Subject|0|||
16895442|NCT02296242|37967234|FG002|Overall Study|Withdrawal by Subject|1|||
16895443|NCT02296242|37967235|FG003|Overall Study|Withdrawal by Subject|1|||
16895444|NCT02296242|37967236|FG004|Overall Study|Withdrawal by Subject|3|||
16895445|NCT02296242|37967232|FG000|Overall Study|Disease Progression|1|||
16895446|NCT02296242|37967233|FG001|Overall Study|Disease Progression|3|||
16895447|NCT02296242|37967234|FG002|Overall Study|Disease Progression|2|||
16895448|NCT02296242|37967235|FG003|Overall Study|Disease Progression|8|||
16895449|NCT02296242|37967236|FG004|Overall Study|Disease Progression|11|||
16895450|NCT02296242|37967232|FG000|Overall Study|Unacceptable Toxicity|0|||
16895451|NCT02296242|37967233|FG001|Overall Study|Unacceptable Toxicity|0|||
16895452|NCT02296242|37967234|FG002|Overall Study|Unacceptable Toxicity|0|||
16895453|NCT02296242|37967235|FG003|Overall Study|Unacceptable Toxicity|0|||
16895454|NCT02296242|37967236|FG004|Overall Study|Unacceptable Toxicity|1|||
16895455|NCT02296242|37967232|FG000|Overall Study|Patient Condition Changed|0|||
16895456|NCT02296242|37967233|FG001|Overall Study|Patient Condition Changed|0|||
16895457|NCT02296242|37967234|FG002|Overall Study|Patient Condition Changed|2|||
16895458|NCT02296242|37967235|FG003|Overall Study|Patient Condition Changed|0|||
16895459|NCT02296242|37967236|FG004|Overall Study|Patient Condition Changed|1|||
16895460|NCT02296242|37967232|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
16895461|NCT02296242|37967233|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
16895462|NCT02296242|37967234|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
16895463|NCT02296242|37967235|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
16895464|NCT02296242|37967236|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
16895465|NCT02296242|37967232|FG000|Overall Study|Lost to Follow-up|1|||
16895466|NCT02296242|37967233|FG001|Overall Study|Lost to Follow-up|0|||
16895467|NCT02296242|37967234|FG002|Overall Study|Lost to Follow-up|0|||
16895468|NCT02296242|37967235|FG003|Overall Study|Lost to Follow-up|0|||
16895469|NCT02296242|37967236|FG004|Overall Study|Lost to Follow-up|0|||
16895470|NCT02296242|37967232|FG000|Overall Study|Need for Hydroxyurea|2|||
16895471|NCT02296242|37967233|FG001|Overall Study|Need for Hydroxyurea|0|||
16895472|NCT02296242|37967234|FG002|Overall Study|Need for Hydroxyurea|0|||
16895473|NCT02296242|37967235|FG003|Overall Study|Need for Hydroxyurea|0|||
16895474|NCT02296242|37967236|FG004|Overall Study|Need for Hydroxyurea|0|||
16895475|NCT02296242|37967232|FG000|Overall Study|Screened for Other Protocol|0|||
16895476|NCT02296242|37967233|FG001|Overall Study|Screened for Other Protocol|1|||
16895477|NCT02296242|37967234|FG002|Overall Study|Screened for Other Protocol|0|||
16895478|NCT02296242|37967235|FG003|Overall Study|Screened for Other Protocol|0|||
16895479|NCT02296242|37967236|FG004|Overall Study|Screened for Other Protocol|0|||
16895480|NCT02296242|37967232|FG000|Overall Study|Physician Decision|0|||
16895481|NCT02296242|37967233|FG001|Overall Study|Physician Decision|1|||
16895482|NCT02296242|37967234|FG002|Overall Study|Physician Decision|0|||
16895483|NCT02296242|37967235|FG003|Overall Study|Physician Decision|1|||
16895484|NCT02296242|37967236|FG004|Overall Study|Physician Decision|0|||
16895485|NCT02296242|37967232|FG000|Overall Study|Alternative Treatment|0|||
16895486|NCT02296242|37967233|FG001|Overall Study|Alternative Treatment|0|||
16895487|NCT02296242|37967234|FG002|Overall Study|Alternative Treatment|0|||
16895488|NCT02296242|37967235|FG003|Overall Study|Alternative Treatment|1|||
16895489|NCT02296242|37967236|FG004|Overall Study|Alternative Treatment|0|||
16895490|NCT02296242|37967232|FG000|Overall Study|Adverse Event|0|||
16895491|NCT02296242|37967233|FG001|Overall Study|Adverse Event|0|||
16895492|NCT02296242|37967234|FG002|Overall Study|Adverse Event|0|||
16895493|NCT02296242|37967235|FG003|Overall Study|Adverse Event|1|||
16895494|NCT02296242|37967236|FG004|Overall Study|Adverse Event|0|||
16895495|NCT02296242|37967232|FG000|Overall Study|Lack of Efficacy|0|||
16895496|NCT02296242|37967233|FG001|Overall Study|Lack of Efficacy|0|||
16895497|NCT02296242|37967234|FG002|Overall Study|Lack of Efficacy|0|||
16895498|NCT02296242|37967235|FG003|Overall Study|Lack of Efficacy|0|||
16895499|NCT02296242|37967236|FG004|Overall Study|Lack of Efficacy|3|||
16895500|NCT02295774|37967256|FG000|Overall Study|Physician Decision|1|||
16895501|NCT02295774|37967256|FG000|Overall Study|Withdrawal by Subject|2|||
16895502|NCT02294682|37967271|FG000|Overall Study|Could not swallow pills|1|||
16895503|NCT02294682|37967272|FG001|Overall Study|Could not swallow pills|0|||
16895504|NCT02294604|37967281|FG000|Overall Study|Did not provide samples for culture|0|||
16895505|NCT02294604|37967282|FG001|Overall Study|Did not provide samples for culture|1|||
16895506|NCT02294604|37967283|FG002|Overall Study|Did not provide samples for culture|0|||
16895507|NCT02294604|37967281|FG000|Overall Study|Culture contamination|1|||
16895508|NCT02294604|37967282|FG001|Overall Study|Culture contamination|2|||
16895509|NCT02294604|37967283|FG002|Overall Study|Culture contamination|0|||
16895510|NCT01645176|37967302|FG000|Overall Study|Lack of Efficacy|4|||
16895511|NCT01645176|37967302|FG000|Overall Study|did not complete final MRI|1|||
16895512|NCT02322216|37967317|FG000|Overall Study|Adverse Event|1|||
16895513|NCT02322216|37967318|FG001|Overall Study|Adverse Event|0|||
16895514|NCT02322216|37967317|FG000|Overall Study|Withdrawal by Subject|1|||
16895515|NCT02322216|37967318|FG001|Overall Study|Withdrawal by Subject|4|||
16895516|NCT01647516|37967363|FG000|Induction Period (IP)|Physician Decision|2|||
16895517|NCT01647516|37967364|FG001|Induction Period (IP)|Physician Decision|0|||
16895518|NCT01647516|37967365|FG002|Induction Period (IP)|Physician Decision|0|||
16895519|NCT01647516|37967366|FG003|Induction Period (IP)|Physician Decision|0|||
16895520|NCT01647516|37967367|FG004|Induction Period (IP)|Physician Decision|0|||
16895521|NCT01647516|37967368|FG005|Induction Period (IP)|Physician Decision|0|||
17095421|NCT00168818|38234702|FG002|Overall Study|Other|30|||
16895522|NCT01647516|37967363|FG000|Induction Period (IP)|Adverse Event|1|||
16895523|NCT01647516|37967364|FG001|Induction Period (IP)|Adverse Event|2|||
16895524|NCT01647516|37967365|FG002|Induction Period (IP)|Adverse Event|0|||
16895525|NCT01647516|37967366|FG003|Induction Period (IP)|Adverse Event|0|||
16895526|NCT01647516|37967367|FG004|Induction Period (IP)|Adverse Event|0|||
16895527|NCT01647516|37967368|FG005|Induction Period (IP)|Adverse Event|0|||
16895528|NCT01647516|37967363|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
16895529|NCT01647516|37967364|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
16895530|NCT01647516|37967365|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
16895531|NCT01647516|37967366|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
16895532|NCT01647516|37967367|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
16895533|NCT01647516|37967368|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
16895534|NCT01647516|37967363|FG000|Induction Period (IP)|Participant Choice|0|||
16895535|NCT01647516|37967364|FG001|Induction Period (IP)|Participant Choice|0|||
16895536|NCT01647516|37967365|FG002|Induction Period (IP)|Participant Choice|1|||
16895537|NCT01647516|37967366|FG003|Induction Period (IP)|Participant Choice|0|||
16895538|NCT01647516|37967367|FG004|Induction Period (IP)|Participant Choice|0|||
16895539|NCT01647516|37967368|FG005|Induction Period (IP)|Participant Choice|0|||
16895540|NCT01647516|37967363|FG000|Induction Period (IP)|Lack of Efficacy|1|||
16895541|NCT01647516|37967364|FG001|Induction Period (IP)|Lack of Efficacy|0|||
16895542|NCT01647516|37967365|FG002|Induction Period (IP)|Lack of Efficacy|0|||
16895543|NCT01647516|37967366|FG003|Induction Period (IP)|Lack of Efficacy|0|||
16895544|NCT01647516|37967367|FG004|Induction Period (IP)|Lack of Efficacy|0|||
16895545|NCT01647516|37967368|FG005|Induction Period (IP)|Lack of Efficacy|0|||
16895546|NCT01647516|37967363|FG000|Induction Period (IP)|No study drug received|1|||
16895547|NCT01647516|37967364|FG001|Induction Period (IP)|No study drug received|1|||
16895548|NCT01647516|37967365|FG002|Induction Period (IP)|No study drug received|0|||
16895549|NCT01647516|37967366|FG003|Induction Period (IP)|No study drug received|0|||
16895550|NCT01647516|37967367|FG004|Induction Period (IP)|No study drug received|0|||
16895551|NCT01647516|37967368|FG005|Induction Period (IP)|No study drug received|0|||
16895552|NCT01647516|37967363|FG000|Maintenance Period (MP)|Adverse Event|2|||
16895553|NCT01647516|37967364|FG001|Maintenance Period (MP)|Adverse Event|1|||
16895554|NCT01647516|37967365|FG002|Maintenance Period (MP)|Adverse Event|0|||
16895555|NCT01647516|37967366|FG003|Maintenance Period (MP)|Adverse Event|0|||
16895556|NCT01647516|37967367|FG004|Maintenance Period (MP)|Adverse Event|0|||
16895557|NCT01647516|37967368|FG005|Maintenance Period (MP)|Adverse Event|0|||
16895558|NCT01647516|37967363|FG000|Maintenance Period (MP)|Non-compliance|1|||
16895559|NCT01647516|37967364|FG001|Maintenance Period (MP)|Non-compliance|0|||
16895560|NCT01647516|37967365|FG002|Maintenance Period (MP)|Non-compliance|0|||
16895561|NCT01647516|37967366|FG003|Maintenance Period (MP)|Non-compliance|0|||
16895562|NCT01647516|37967367|FG004|Maintenance Period (MP)|Non-compliance|0|||
16895563|NCT01647516|37967368|FG005|Maintenance Period (MP)|Non-compliance|0|||
16895564|NCT01647516|37967363|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
16895565|NCT01647516|37967364|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
16895566|NCT01647516|37967365|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
16895567|NCT01647516|37967366|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
16895568|NCT01647516|37967367|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
16895569|NCT01647516|37967368|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
16895570|NCT01647516|37967363|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
17003988|NCT00896532|38147671|FG012|Months 48-72: Follow-on Phase|Death|0|||
17003989|NCT00896532|38147672|FG013|Months 48-72: Follow-on Phase|Death|0|||
17003990|NCT00896532|38147673|FG014|Months 48-72: Follow-on Phase|Death|0|||
17003991|NCT00896532|38147674|FG015|Months 48-72: Follow-on Phase|Death|0|||
17003992|NCT00896532|38147675|FG016|Months 48-72: Follow-on Phase|Death|0|||
16895571|NCT01647516|37967364|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
16895572|NCT01647516|37967365|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
16895573|NCT01647516|37967366|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
16895574|NCT01647516|37967367|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
16895575|NCT01647516|37967368|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
16895576|NCT01647516|37967363|FG000|Open-Label Period|Adverse Event|0|||
16895577|NCT01647516|37967364|FG001|Open-Label Period|Adverse Event|0|||
16895578|NCT01647516|37967365|FG002|Open-Label Period|Adverse Event|0|||
16895579|NCT01647516|37967366|FG003|Open-Label Period|Adverse Event|5|||
16895580|NCT01647516|37967367|FG004|Open-Label Period|Adverse Event|6|||
16895581|NCT01647516|37967368|FG005|Open-Label Period|Adverse Event|3|||
17003993|NCT00896532|38147676|FG017|Months 48-72: Follow-on Phase|Death|0|||
17003994|NCT00896532|38147677|FG018|Months 48-72: Follow-on Phase|Death|1|||
17003995|NCT00896532|38147678|FG019|Months 48-72: Follow-on Phase|Death|0|||
17003996|NCT00896532|38147679|FG020|Months 48-72: Follow-on Phase|Death|0|||
16895582|NCT01647516|37967363|FG000|Open-Label Period|Pregnancy|0|||
16895583|NCT01647516|37967364|FG001|Open-Label Period|Pregnancy|0|||
16895584|NCT01647516|37967365|FG002|Open-Label Period|Pregnancy|0|||
16895585|NCT01647516|37967366|FG003|Open-Label Period|Pregnancy|0|||
16895586|NCT01647516|37967367|FG004|Open-Label Period|Pregnancy|0|||
16895587|NCT01647516|37967368|FG005|Open-Label Period|Pregnancy|1|||
17003997|NCT00896532|38147680|FG021|Months 48-72: Follow-on Phase|Death|0|||
17003998|NCT00896532|38147681|FG022|Months 48-72: Follow-on Phase|Death|0|||
16895588|NCT01647516|37967363|FG000|Open-Label Period|Non-compliance|0|||
16895589|NCT01647516|37967364|FG001|Open-Label Period|Non-compliance|0|||
16895590|NCT01647516|37967365|FG002|Open-Label Period|Non-compliance|0|||
16895591|NCT01647516|37967366|FG003|Open-Label Period|Non-compliance|1|||
16895592|NCT01647516|37967367|FG004|Open-Label Period|Non-compliance|0|||
16895593|NCT01647516|37967368|FG005|Open-Label Period|Non-compliance|1|||
16895594|NCT01647516|37967363|FG000|Open-Label Period|Physician Decision|0|||
16895595|NCT01647516|37967364|FG001|Open-Label Period|Physician Decision|0|||
16895596|NCT01647516|37967365|FG002|Open-Label Period|Physician Decision|0|||
16895597|NCT01647516|37967366|FG003|Open-Label Period|Physician Decision|1|||
16895598|NCT01647516|37967367|FG004|Open-Label Period|Physician Decision|1|||
16895599|NCT01647516|37967368|FG005|Open-Label Period|Physician Decision|0|||
17095422|NCT00168818|38234700|FG000|Treatment|Adverse Event|77|||
16895600|NCT01647516|37967363|FG000|Open-Label Period|Withdrawal by Subject|0|||
16895601|NCT01647516|37967364|FG001|Open-Label Period|Withdrawal by Subject|0|||
16895602|NCT01647516|37967365|FG002|Open-Label Period|Withdrawal by Subject|0|||
16895603|NCT01647516|37967366|FG003|Open-Label Period|Withdrawal by Subject|9|||
16895604|NCT01647516|37967367|FG004|Open-Label Period|Withdrawal by Subject|11|||
16895605|NCT01647516|37967368|FG005|Open-Label Period|Withdrawal by Subject|6|||
16895606|NCT01647516|37967363|FG000|Open-Label Period|Lost to Follow-up|0|||
16895607|NCT01647516|37967364|FG001|Open-Label Period|Lost to Follow-up|0|||
16895608|NCT01647516|37967365|FG002|Open-Label Period|Lost to Follow-up|0|||
16895609|NCT01647516|37967366|FG003|Open-Label Period|Lost to Follow-up|1|||
16895610|NCT01647516|37967367|FG004|Open-Label Period|Lost to Follow-up|0|||
16895611|NCT01647516|37967368|FG005|Open-Label Period|Lost to Follow-up|1|||
16895612|NCT01647516|37967363|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
16895613|NCT01647516|37967364|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
16895614|NCT01647516|37967365|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
16895615|NCT01647516|37967366|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
16895616|NCT01647516|37967367|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
16895617|NCT01647516|37967368|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
16895618|NCT01647516|37967363|FG000|Open-Label Period|Lack of Efficacy|0|||
16895619|NCT01647516|37967364|FG001|Open-Label Period|Lack of Efficacy|0|||
16895620|NCT01647516|37967365|FG002|Open-Label Period|Lack of Efficacy|0|||
16895621|NCT01647516|37967366|FG003|Open-Label Period|Lack of Efficacy|7|||
16895622|NCT01647516|37967367|FG004|Open-Label Period|Lack of Efficacy|9|||
16895623|NCT01647516|37967368|FG005|Open-Label Period|Lack of Efficacy|10|||
16895624|NCT01647516|37967363|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
16895625|NCT01647516|37967364|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
16895626|NCT01647516|37967365|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
16895627|NCT01647516|37967366|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
16895628|NCT01647516|37967367|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
16895629|NCT01647516|37967368|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
16895630|NCT01647516|37967363|FG000|Open-Label Period|No completion / discontinuation visit|0|||
16895631|NCT01647516|37967364|FG001|Open-Label Period|No completion / discontinuation visit|0|||
16895632|NCT01647516|37967365|FG002|Open-Label Period|No completion / discontinuation visit|0|||
17003999|NCT00896532|38147659|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004000|NCT00896532|38147660|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004001|NCT00896532|38147661|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004002|NCT00896532|38147662|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16895633|NCT01647516|37967366|FG003|Open-Label Period|No completion / discontinuation visit|0|||
16895634|NCT01647516|37967367|FG004|Open-Label Period|No completion / discontinuation visit|2|||
16895635|NCT01647516|37967368|FG005|Open-Label Period|No completion / discontinuation visit|1|||
16895636|NCT01647282|37967385|FG000|Overall Study|Physician Decision|7|||
16895637|NCT01647282|37967386|FG001|Overall Study|Physician Decision|5|||
16895638|NCT02321514|37967392|FG000|Overall Study|Death|15|||
16895639|NCT02321514|37967392|FG000|Overall Study|Missed Visit|7|||
16895640|NCT02321514|37967392|FG000|Overall Study|Study Exit|3|||
16895641|NCT02321436|37967398|FG000|Overall Study|Withdrawal by Subject|1|||
16895642|NCT02321436|37967399|FG001|Overall Study|Withdrawal by Subject|0|||
16895643|NCT02321436|37967398|FG000|Overall Study|Lost to Follow-up|0|||
16895644|NCT02321436|37967399|FG001|Overall Study|Lost to Follow-up|1|||
16895645|NCT02319642|37967408|FG000|Overall Study|Adverse Event|2|||
16895646|NCT02319642|37967409|FG001|Overall Study|Adverse Event|4|||
16895647|NCT02319642|37967408|FG000|Overall Study|Lack of Efficacy|1|||
16895648|NCT02319642|37967409|FG001|Overall Study|Lack of Efficacy|1|||
16895649|NCT02319642|37967408|FG000|Overall Study|Withdrawal by Subject|1|||
16895650|NCT02319642|37967409|FG001|Overall Study|Withdrawal by Subject|1|||
16895651|NCT02280096|37967419|FG000|Overall Study|Pregnancy|1|||
16895652|NCT02280096|37967420|FG001|Overall Study|Pregnancy|0|||
16895653|NCT02280096|37967419|FG000|Overall Study|Functional neurological disorder|1|||
16895654|NCT02280096|37967420|FG001|Overall Study|Functional neurological disorder|0|||
16895655|NCT02280096|37967419|FG000|Overall Study|Lack of attachment|0|||
16895656|NCT02280096|37967420|FG001|Overall Study|Lack of attachment|1|||
16895657|NCT02279862|37967437|FG000|Overall Study|Study drug toxicity|3|||
16895658|NCT02279862|37967438|FG001|Overall Study|Study drug toxicity|6|||
16895659|NCT02279862|37967437|FG000|Overall Study|No longer meets criteria|0|||
16895660|NCT02279862|37967438|FG001|Overall Study|No longer meets criteria|1|||
16895661|NCT02279862|37967437|FG000|Overall Study|Administrative reason by sponsor|0|||
16895662|NCT02279862|37967438|FG001|Overall Study|Administrative reason by sponsor|1|||
16895663|NCT02279862|37967437|FG000|Overall Study|Disease progression|5|||
16895664|NCT02279862|37967438|FG001|Overall Study|Disease progression|2|||
16895665|NCT02279862|37967437|FG000|Overall Study|Study closed by sponsor|16|||
16895666|NCT02279862|37967438|FG001|Overall Study|Study closed by sponsor|13|||
16895667|NCT02279862|37967437|FG000|Overall Study|Other|1|||
16895668|NCT02279862|37967438|FG001|Overall Study|Other|2|||
16895669|NCT02279862|37967437|FG000|Overall Study|Withdrawal by Subject|1|||
16895670|NCT02279862|37967438|FG001|Overall Study|Withdrawal by Subject|0|||
16895671|NCT02318940|37967446|FG000|Overall Study|lost the record|1|||
16895672|NCT02318940|37967447|FG001|Overall Study|lost the record|0|||
16895673|NCT02294058|37967456|FG000|Overall Study|Adverse Event|16|||
16895674|NCT02294058|37967457|FG001|Overall Study|Adverse Event|7|||
16895675|NCT02294058|37967458|FG002|Overall Study|Adverse Event|13|||
16895676|NCT02294058|37967456|FG000|Overall Study|Lack of Efficacy|3|||
16895677|NCT02294058|37967457|FG001|Overall Study|Lack of Efficacy|3|||
16895678|NCT02294058|37967458|FG002|Overall Study|Lack of Efficacy|0|||
16895679|NCT02294058|37967456|FG000|Overall Study|Lost to Follow-up|1|||
16895680|NCT02294058|37967457|FG001|Overall Study|Lost to Follow-up|0|||
16895681|NCT02294058|37967458|FG002|Overall Study|Lost to Follow-up|2|||
16895682|NCT02294058|37967456|FG000|Overall Study|Withdrawal by Subject|10|||
16895683|NCT02294058|37967457|FG001|Overall Study|Withdrawal by Subject|14|||
16895684|NCT02294058|37967458|FG002|Overall Study|Withdrawal by Subject|13|||
16895685|NCT02294058|37967456|FG000|Overall Study|Physician Decision|2|||
16895686|NCT02294058|37967457|FG001|Overall Study|Physician Decision|1|||
16895687|NCT02294058|37967458|FG002|Overall Study|Physician Decision|0|||
16895688|NCT02294058|37967456|FG000|Overall Study|Miscellaneous|4|||
16895689|NCT02294058|37967457|FG001|Overall Study|Miscellaneous|1|||
16895690|NCT02294058|37967458|FG002|Overall Study|Miscellaneous|1|||
16895691|NCT02293902|37967470|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
16895692|NCT02293902|37967471|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
16895693|NCT02293902|37967472|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
16895694|NCT02293902|37967473|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
16895695|NCT02293902|37967474|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
16895696|NCT02293902|37967470|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
16895697|NCT02293902|37967471|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
16895698|NCT02293902|37967472|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
16895699|NCT02293902|37967473|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
16895700|NCT02293902|37967474|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
16895701|NCT02293902|37967470|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
16895702|NCT02293902|37967471|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
16895703|NCT02293902|37967472|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
16895704|NCT02293902|37967473|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
16895705|NCT02293902|37967474|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
16895706|NCT02293902|37967470|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
16895707|NCT02293902|37967471|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
16895708|NCT02293902|37967472|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
16895709|NCT02293902|37967473|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
16895710|NCT02293902|37967474|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
16895711|NCT02293902|37967470|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
16895712|NCT02293902|37967471|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
16895713|NCT02293902|37967472|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
16895714|NCT02293902|37967473|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
16895715|NCT02293902|37967474|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
16895716|NCT02278614|37967494|FG000|Overall Study|Withdrawal by Subject|3|||
16895717|NCT02278614|37967495|FG001|Overall Study|Withdrawal by Subject|5|||
16895718|NCT02278614|37967494|FG000|Overall Study|Adverse Event|1|||
16895719|NCT02278614|37967495|FG001|Overall Study|Adverse Event|0|||
16895720|NCT02278614|37967494|FG000|Overall Study|left eye was not eligible|1|||
16895721|NCT02278614|37967495|FG001|Overall Study|left eye was not eligible|0|||
16895722|NCT02318706|37967505|FG000|Double-blind Phase|Adverse Event|7|||
17004003|NCT00896532|38147663|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004004|NCT00896532|38147664|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004005|NCT00896532|38147665|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004006|NCT00896532|38147666|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17095423|NCT00168818|38234701|FG001|Treatment|Adverse Event|89|||
16895723|NCT02318706|37967506|FG001|Double-blind Phase|Adverse Event|4|||
16895724|NCT02318706|37967507|FG002|Double-blind Phase|Adverse Event|3|||
16895725|NCT02318706|37967508|FG003|Double-blind Phase|Adverse Event|10|||
16895726|NCT02318706|37967509|FG004|Double-blind Phase|Adverse Event|0|||
16895727|NCT02318706|37967505|FG000|Double-blind Phase|Lost to Follow-up|1|||
16895728|NCT02318706|37967506|FG001|Double-blind Phase|Lost to Follow-up|0|||
16895729|NCT02318706|37967507|FG002|Double-blind Phase|Lost to Follow-up|0|||
16895730|NCT02318706|37967508|FG003|Double-blind Phase|Lost to Follow-up|0|||
16895731|NCT02318706|37967509|FG004|Double-blind Phase|Lost to Follow-up|0|||
16895732|NCT02318706|37967505|FG000|Double-blind Phase|Protocol Violation|4|||
16895733|NCT02318706|37967506|FG001|Double-blind Phase|Protocol Violation|2|||
16895734|NCT02318706|37967507|FG002|Double-blind Phase|Protocol Violation|4|||
16895735|NCT02318706|37967508|FG003|Double-blind Phase|Protocol Violation|3|||
16895736|NCT02318706|37967509|FG004|Double-blind Phase|Protocol Violation|0|||
16895737|NCT02318706|37967505|FG000|Double-blind Phase|Withdrawal by Subject|9|||
16895738|NCT02318706|37967506|FG001|Double-blind Phase|Withdrawal by Subject|5|||
16895739|NCT02318706|37967507|FG002|Double-blind Phase|Withdrawal by Subject|7|||
16895740|NCT02318706|37967508|FG003|Double-blind Phase|Withdrawal by Subject|10|||
16895741|NCT02318706|37967509|FG004|Double-blind Phase|Withdrawal by Subject|0|||
16895742|NCT02318706|37967505|FG000|Double-blind Phase|Other|4|||
16895743|NCT02318706|37967506|FG001|Double-blind Phase|Other|1|||
16895744|NCT02318706|37967507|FG002|Double-blind Phase|Other|2|||
16895745|NCT02318706|37967508|FG003|Double-blind Phase|Other|1|||
16895746|NCT02318706|37967509|FG004|Double-blind Phase|Other|0|||
16895747|NCT02318706|37967505|FG000|Double-blind Phase|Death|0|||
16895748|NCT02318706|37967506|FG001|Double-blind Phase|Death|0|||
16895749|NCT02318706|37967507|FG002|Double-blind Phase|Death|2|||
16895750|NCT02318706|37967508|FG003|Double-blind Phase|Death|0|||
16895751|NCT02318706|37967509|FG004|Double-blind Phase|Death|0|||
16895752|NCT02318706|37967505|FG000|Open-label Extension Phase|Adverse Event|0|||
16895753|NCT02318706|37967506|FG001|Open-label Extension Phase|Adverse Event|0|||
16895754|NCT02318706|37967507|FG002|Open-label Extension Phase|Adverse Event|0|||
16895755|NCT02318706|37967508|FG003|Open-label Extension Phase|Adverse Event|0|||
16895756|NCT02318706|37967509|FG004|Open-label Extension Phase|Adverse Event|21|||
16895757|NCT02318706|37967505|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
16895758|NCT02318706|37967506|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
16895759|NCT02318706|37967507|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
16895760|NCT02318706|37967508|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
16895761|NCT02318706|37967509|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
16895762|NCT02318706|37967505|FG000|Open-label Extension Phase|Death|0|||
16895763|NCT02318706|37967506|FG001|Open-label Extension Phase|Death|0|||
16895764|NCT02318706|37967507|FG002|Open-label Extension Phase|Death|0|||
16895765|NCT02318706|37967508|FG003|Open-label Extension Phase|Death|0|||
16895766|NCT02318706|37967509|FG004|Open-label Extension Phase|Death|1|||
16895767|NCT02318706|37967505|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
16895768|NCT02318706|37967506|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
16895769|NCT02318706|37967507|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
16895770|NCT02318706|37967508|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
16895771|NCT02318706|37967509|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
17095424|NCT00168818|38234702|FG002|Treatment|Adverse Event|68|||
17095425|NCT00168818|38234700|FG000|Treatment|Protocol Violation|8|||
17095426|NCT00168818|38234701|FG001|Treatment|Protocol Violation|11|||
17095427|NCT00168818|38234702|FG002|Treatment|Protocol Violation|11|||
17095428|NCT00168818|38234700|FG000|Treatment|Lost to Follow-up|0|||
17095429|NCT00168818|38234701|FG001|Treatment|Lost to Follow-up|2|||
17095430|NCT00168818|38234702|FG002|Treatment|Lost to Follow-up|1|||
17095431|NCT00168818|38234700|FG000|Treatment|Withdrawal by Subject|25|||
17095432|NCT00168818|38234701|FG001|Treatment|Withdrawal by Subject|20|||
17095433|NCT00168818|38234702|FG002|Treatment|Withdrawal by Subject|22|||
17095434|NCT00168818|38234700|FG000|Treatment|Other|23|||
17095435|NCT00168818|38234701|FG001|Treatment|Other|29|||
16895784|NCT03251924|37967876|FG000|Overall Study|Disease Progression|6|||
16895785|NCT03251924|37967877|FG001|Overall Study|Disease Progression|6|||
16895786|NCT03251924|37967878|FG002|Overall Study|Disease Progression|7|||
16895787|NCT03251924|37967879|FG003|Overall Study|Disease Progression|8|||
16895788|NCT03251924|37967880|FG004|Overall Study|Disease Progression|8|||
16895789|NCT03251924|37967881|FG005|Overall Study|Disease Progression|7|||
16895790|NCT03251924|37967882|FG006|Overall Study|Disease Progression|6|||
16895791|NCT03251924|37967883|FG007|Overall Study|Disease Progression|10|||
16895792|NCT03251924|37967884|FG008|Overall Study|Disease Progression|6|||
16895793|NCT03251924|37967876|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
16895794|NCT03251924|37967877|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
16895795|NCT03251924|37967878|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
16895796|NCT03251924|37967879|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
16895797|NCT03251924|37967880|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
16895798|NCT03251924|37967881|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
16895799|NCT03251924|37967882|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
16895800|NCT03251924|37967883|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
16895801|NCT03251924|37967884|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
16895802|NCT03251924|37967876|FG000|Overall Study|Death|0|||
16895803|NCT03251924|37967877|FG001|Overall Study|Death|1|||
16895804|NCT03251924|37967878|FG002|Overall Study|Death|0|||
16895805|NCT03251924|37967879|FG003|Overall Study|Death|1|||
16895806|NCT03251924|37967880|FG004|Overall Study|Death|1|||
16895807|NCT03251924|37967881|FG005|Overall Study|Death|1|||
16895808|NCT03251924|37967882|FG006|Overall Study|Death|0|||
16895809|NCT03251924|37967883|FG007|Overall Study|Death|0|||
16895810|NCT03251924|37967884|FG008|Overall Study|Death|0|||
16895811|NCT03251924|37967876|FG000|Overall Study|Study Drug Toxicity|0|||
16895812|NCT03251924|37967877|FG001|Overall Study|Study Drug Toxicity|0|||
16895813|NCT03251924|37967878|FG002|Overall Study|Study Drug Toxicity|0|||
16895814|NCT03251924|37967879|FG003|Overall Study|Study Drug Toxicity|1|||
17095436|NCT00168818|38234702|FG002|Treatment|Other|31|||
16895815|NCT03251924|37967880|FG004|Overall Study|Study Drug Toxicity|0|||
16895816|NCT03251924|37967881|FG005|Overall Study|Study Drug Toxicity|0|||
16895817|NCT03251924|37967882|FG006|Overall Study|Study Drug Toxicity|0|||
16895818|NCT03251924|37967883|FG007|Overall Study|Study Drug Toxicity|0|||
16895819|NCT03251924|37967884|FG008|Overall Study|Study Drug Toxicity|1|||
16895820|NCT03251924|37967876|FG000|Overall Study|Other Reasons|0|||
16895821|NCT03251924|37967877|FG001|Overall Study|Other Reasons|0|||
16895822|NCT03251924|37967878|FG002|Overall Study|Other Reasons|0|||
16895823|NCT03251924|37967879|FG003|Overall Study|Other Reasons|0|||
16895824|NCT03251924|37967880|FG004|Overall Study|Other Reasons|0|||
16895825|NCT03251924|37967881|FG005|Overall Study|Other Reasons|0|||
16895826|NCT03251924|37967882|FG006|Overall Study|Other Reasons|0|||
16895827|NCT03251924|37967883|FG007|Overall Study|Other Reasons|0|||
16895828|NCT03251924|37967884|FG008|Overall Study|Other Reasons|1|||
16895829|NCT03251924|37967876|FG000|Overall Study|Participant request to discontinue study treatment|0|||
16895830|NCT03251924|37967877|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16895831|NCT03251924|37967878|FG002|Overall Study|Participant request to discontinue study treatment|0|||
16895832|NCT03251924|37967879|FG003|Overall Study|Participant request to discontinue study treatment|0|||
16895833|NCT03251924|37967880|FG004|Overall Study|Participant request to discontinue study treatment|0|||
16895834|NCT03251924|37967881|FG005|Overall Study|Participant request to discontinue study treatment|0|||
16895835|NCT03251924|37967882|FG006|Overall Study|Participant request to discontinue study treatment|0|||
16895836|NCT03251924|37967883|FG007|Overall Study|Participant request to discontinue study treatment|1|||
16895837|NCT03251924|37967884|FG008|Overall Study|Participant request to discontinue study treatment|0|||
16895838|NCT01350141|37968080|FG000|Overall Study|Lost to Follow-up|1|||
16895839|NCT01350141|37968081|FG001|Overall Study|Lost to Follow-up|0|||
16895840|NCT01350141|37968082|FG002|Overall Study|Lost to Follow-up|1|||
16895841|NCT01350141|37968080|FG000|Overall Study|Withdrawal by Subject|1|||
16895842|NCT01350141|37968081|FG001|Overall Study|Withdrawal by Subject|0|||
16895843|NCT01350141|37968082|FG002|Overall Study|Withdrawal by Subject|0|||
16895844|NCT01350141|37968080|FG000|Overall Study|Randomized but not treated|1|||
16895845|NCT01350141|37968081|FG001|Overall Study|Randomized but not treated|0|||
16895846|NCT01350141|37968082|FG002|Overall Study|Randomized but not treated|0|||
16895847|NCT05045625|37968621|FG000|Overall Study|Lost to Follow-up|3|||
16895848|NCT04830969|37969003|FG000|Overall Study|Withdrawal by Subject|6|||
16895849|NCT04830969|37969004|FG001|Overall Study|Withdrawal by Subject|2|||
16895850|NCT04830969|37969003|FG000|Overall Study|Protocol Violation|3|||
16895851|NCT04830969|37969004|FG001|Overall Study|Protocol Violation|9|||
16895852|NCT04830969|37969003|FG000|Overall Study|Lost to Follow-up|4|||
16895853|NCT04830969|37969004|FG001|Overall Study|Lost to Follow-up|4|||
16895854|NCT03706079|37969171|FG000|Predecessor Study|Death|0|||
16895855|NCT03706079|37969172|FG001|Predecessor Study|Death|2|||
16895856|NCT03706079|37969173|FG002|Predecessor Study|Death|0|||
16895857|NCT03706079|37969174|FG003|Predecessor Study|Death|1|||
16895858|NCT03706079|37969175|FG004|Predecessor Study|Death|0|||
16895859|NCT03706079|37969176|FG005|Predecessor Study|Death|0|||
16895860|NCT03706079|37969171|FG000|Predecessor Study|Lost to Follow-up|5|||
16895861|NCT03706079|37969172|FG001|Predecessor Study|Lost to Follow-up|2|||
16895862|NCT03706079|37969173|FG002|Predecessor Study|Lost to Follow-up|0|||
16895863|NCT03706079|37969174|FG003|Predecessor Study|Lost to Follow-up|0|||
16895864|NCT03706079|37969175|FG004|Predecessor Study|Lost to Follow-up|1|||
16895865|NCT03706079|37969176|FG005|Predecessor Study|Lost to Follow-up|0|||
16895866|NCT03706079|37969171|FG000|Predecessor Study|Withdrawal by Subject|8|||
16895867|NCT03706079|37969172|FG001|Predecessor Study|Withdrawal by Subject|15|||
16895868|NCT03706079|37969173|FG002|Predecessor Study|Withdrawal by Subject|0|||
16895869|NCT03706079|37969174|FG003|Predecessor Study|Withdrawal by Subject|5|||
16895870|NCT03706079|37969175|FG004|Predecessor Study|Withdrawal by Subject|2|||
16895871|NCT03706079|37969176|FG005|Predecessor Study|Withdrawal by Subject|0|||
16895872|NCT03706079|37969171|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
16895873|NCT03706079|37969172|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
16895874|NCT03706079|37969173|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
16895875|NCT03706079|37969174|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
16895876|NCT03706079|37969175|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
16895877|NCT03706079|37969176|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
16895878|NCT03706079|37969171|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16895879|NCT03706079|37969172|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16895880|NCT03706079|37969173|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16895881|NCT03706079|37969174|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16895882|NCT03706079|37969175|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16895883|NCT03706079|37969176|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
16895884|NCT03706079|37969171|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
16895885|NCT03706079|37969172|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
16895886|NCT03706079|37969173|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
16895887|NCT03706079|37969174|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
16895888|NCT03706079|37969175|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
16895889|NCT03706079|37969176|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
16895890|NCT03706079|37969171|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
16895891|NCT03706079|37969172|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
16895892|NCT03706079|37969173|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
16895893|NCT03706079|37969174|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
16895894|NCT03706079|37969175|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
16895895|NCT03706079|37969176|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
16895896|NCT03706079|37969171|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
16895897|NCT03706079|37969172|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
16895898|NCT03706079|37969173|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
16895899|NCT03706079|37969174|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
16895900|NCT03706079|37969175|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
16895901|NCT03706079|37969176|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
16895902|NCT03706079|37969171|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
16895903|NCT03706079|37969172|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
16895904|NCT03706079|37969173|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
16895905|NCT03706079|37969174|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
16895906|NCT03706079|37969175|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
16895907|NCT03706079|37969176|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
16895908|NCT03706079|37969171|FG000|Long Term Extension (DESTINATION)|Death|8|||
16895909|NCT03706079|37969172|FG001|Long Term Extension (DESTINATION)|Death|2|||
16895910|NCT03706079|37969173|FG002|Long Term Extension (DESTINATION)|Death|2|||
16895911|NCT03706079|37969174|FG003|Long Term Extension (DESTINATION)|Death|1|||
16895912|NCT03706079|37969175|FG004|Long Term Extension (DESTINATION)|Death|0|||
16895913|NCT03706079|37969176|FG005|Long Term Extension (DESTINATION)|Death|0|||
16895914|NCT02384993|37969336|FG000|Overall Study|Adverse Event|0|||
16895915|NCT02384993|37969337|FG001|Overall Study|Adverse Event|1|||
16895916|NCT01352117|37969385|FG000|Overall Study|Death|15|||
16895917|NCT01352117|37969386|FG001|Overall Study|Death|16|||
16895918|NCT01352117|37969385|FG000|Overall Study|Withdrawal by Subject|1|||
16895919|NCT01352117|37969386|FG001|Overall Study|Withdrawal by Subject|0|||
16895920|NCT01352117|37969385|FG000|Overall Study|Lost to Follow-up|2|||
16895921|NCT01352117|37969386|FG001|Overall Study|Lost to Follow-up|7|||
16895922|NCT01352117|37969385|FG000|Overall Study|Non-adherent to study requirements|1|||
16895923|NCT01352117|37969386|FG001|Overall Study|Non-adherent to study requirements|1|||
16895924|NCT01352117|37969385|FG000|Overall Study|Did not initiate study treatment|1|||
16895925|NCT01352117|37969386|FG001|Overall Study|Did not initiate study treatment|0|||
16895926|NCT01352117|37969385|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
16895927|NCT01352117|37969386|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
17004007|NCT00896532|38147667|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004008|NCT00896532|38147668|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004009|NCT00896532|38147669|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004010|NCT00896532|38147670|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004011|NCT00896532|38147671|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004012|NCT00896532|38147672|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004013|NCT00896532|38147673|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004014|NCT00896532|38147674|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004015|NCT00896532|38147675|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004016|NCT00896532|38147676|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004017|NCT00896532|38147677|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004018|NCT00896532|38147678|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004019|NCT00896532|38147679|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004020|NCT00896532|38147680|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
16895928|NCT03578237|37969478|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
16895929|NCT03578237|37969479|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
16895930|NCT04173507|37969558|FG000|Overall Study|On Treatment|3|||
16895931|NCT04173507|37969558|FG000|Overall Study|Adverse Event|3|||
16895932|NCT04173507|37969558|FG000|Overall Study|Progression/Relapse|34|||
16895933|NCT04173507|37969558|FG000|Overall Study|Death|2|||
16895934|NCT02220725|37969566|FG000|Overall Study|Lost to Follow-up|0|||
16895935|NCT02220725|37969567|FG001|Overall Study|Lost to Follow-up|0|||
16895936|NCT02220725|37969568|FG002|Overall Study|Lost to Follow-up|0|||
16895937|NCT02220725|37969569|FG003|Overall Study|Lost to Follow-up|1|||
16895938|NCT02220725|37969566|FG000|Overall Study|Withdrawal by Subject|0|||
16895939|NCT02220725|37969567|FG001|Overall Study|Withdrawal by Subject|0|||
16895940|NCT02220725|37969568|FG002|Overall Study|Withdrawal by Subject|0|||
16895941|NCT02220725|37969569|FG003|Overall Study|Withdrawal by Subject|1|||
16895942|NCT03335475|37969601|FG000|Overall Study|Did not wear accelerometer|4|||
16895943|NCT03335475|37969602|FG001|Overall Study|Did not wear accelerometer|0|||
16895944|NCT03335475|37969601|FG000|Overall Study|Withdrawal by Subject|0|||
16895945|NCT03335475|37969602|FG001|Overall Study|Withdrawal by Subject|1|||
16895946|NCT02422615|37969610|FG000|Overall Study|Progressive disease|193|||
16895947|NCT02422615|37969611|FG001|Overall Study|Progressive disease|142|||
16895948|NCT02422615|37969610|FG000|Overall Study|Adverse Event|41|||
16895949|NCT02422615|37969611|FG001|Overall Study|Adverse Event|10|||
16895950|NCT02422615|37969610|FG000|Overall Study|Physician Decision|22|||
16895951|NCT02422615|37969611|FG001|Overall Study|Physician Decision|7|||
16895952|NCT02422615|37969610|FG000|Overall Study|Subject/guardian decision|21|||
16895953|NCT02422615|37969611|FG001|Overall Study|Subject/guardian decision|5|||
16895954|NCT02422615|37969610|FG000|Overall Study|Death|2|||
16895955|NCT02422615|37969611|FG001|Overall Study|Death|0|||
16895956|NCT02422615|37969610|FG000|Overall Study|Protocol Violation|1|||
16895957|NCT02422615|37969611|FG001|Overall Study|Protocol Violation|1|||
16895958|NCT02422615|37969610|FG000|Overall Study|Technical problems|0|||
16895959|NCT02422615|37969611|FG001|Overall Study|Technical problems|1|||
16895960|NCT02259517|37969633|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
16895961|NCT02259517|37969634|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
16895962|NCT02259517|37969635|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
16895963|NCT02259517|37969633|FG000|Overall Study|Withdrawal by Subject|0|||
16895964|NCT02259517|37969634|FG001|Overall Study|Withdrawal by Subject|0|||
16895965|NCT02259517|37969635|FG002|Overall Study|Withdrawal by Subject|3|||
16895966|NCT02277990|37969678|FG000|Overall Study|Death|170|||
16895967|NCT02277990|37969679|FG001|Overall Study|Death|188|||
16895968|NCT02277990|37969678|FG000|Overall Study|Withdrawal by Subject|64|||
16895969|NCT02277990|37969679|FG001|Overall Study|Withdrawal by Subject|53|||
16895970|NCT02277990|37969678|FG000|Overall Study|Physician Decision|40|||
16895971|NCT02277990|37969679|FG001|Overall Study|Physician Decision|34|||
16895972|NCT02277990|37969678|FG000|Overall Study|Lost to Follow-up|66|||
16895973|NCT02277990|37969679|FG001|Overall Study|Lost to Follow-up|69|||
16895974|NCT02277990|37969678|FG000|Overall Study|Had other reason|26|||
16895975|NCT02277990|37969679|FG001|Overall Study|Had other reason|32|||
16895976|NCT02317614|37969701|FG000|Overall Study|Lost to Follow-up|1|||
16895977|NCT02317614|37969702|FG001|Overall Study|Lost to Follow-up|1|||
16895978|NCT02317614|37969701|FG000|Overall Study|Withdrawal by Subject|1|||
17004021|NCT00896532|38147681|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
17004022|NCT00896532|38147659|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004023|NCT00896532|38147660|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004024|NCT00896532|38147661|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004025|NCT00896532|38147662|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004026|NCT00896532|38147663|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004027|NCT00896532|38147664|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004028|NCT00896532|38147665|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004029|NCT00896532|38147666|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004030|NCT00896532|38147667|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004031|NCT00896532|38147668|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004032|NCT00896532|38147669|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004033|NCT00896532|38147670|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004034|NCT00896532|38147671|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16895979|NCT02317614|37969702|FG001|Overall Study|Withdrawal by Subject|0|||
16895980|NCT02317614|37969701|FG000|Overall Study|Death|1|||
16895981|NCT02317614|37969702|FG001|Overall Study|Death|1|||
16895982|NCT02276040|37969715|FG000|Overall Study|Physician Decision|15|||
16895983|NCT02315664|37969721|FG000|Overall Study|Lost to Follow-up|1|||
16895984|NCT02315664|37969722|FG001|Overall Study|Lost to Follow-up|1|||
16895985|NCT02315664|37969721|FG000|Overall Study|Withdrawal by Subject|0|||
16895986|NCT02315664|37969722|FG001|Overall Study|Withdrawal by Subject|3|||
16895987|NCT02314728|37969750|FG000|Overall Study|Protocol Violation|1|||
16895988|NCT02314728|37969751|FG001|Overall Study|Protocol Violation|0|||
16895989|NCT02314728|37969750|FG000|Overall Study|Lost to Follow-up|0|||
16895990|NCT02314728|37969751|FG001|Overall Study|Lost to Follow-up|1|||
16895991|NCT02275338|37969770|FG000|Overall Study|Adverse Event|15|||
16895992|NCT02275338|37969770|FG000|Overall Study|Lack of Efficacy|3|||
16895993|NCT02275338|37969770|FG000|Overall Study|Withdrawal by Subject|4|||
16895994|NCT02275338|37969770|FG000|Overall Study|Disease progression (death)|1|||
16895995|NCT02275338|37969770|FG000|Overall Study|Ineligible to start Phase 2|4|||
16895996|NCT02275338|37969770|FG000|Overall Study|Reason not specified|5|||
16895997|NCT02275338|37969770|FG000|Overall Study|Does not meet entry criteria|1|||
16895998|NCT02313558|37969777|FG000|Overall Study|Withdrawal by Subject|2|||
16895999|NCT02313558|37969778|FG001|Overall Study|Withdrawal by Subject|0|||
16896000|NCT02313558|37969777|FG000|Overall Study|Lost to Follow-up|4|||
16896001|NCT02313558|37969778|FG001|Overall Study|Lost to Follow-up|4|||
16896002|NCT01646268|37969806|FG000|Overall Study|Adverse Event|6|||
16896003|NCT01646268|37969807|FG001|Overall Study|Adverse Event|7|||
16896004|NCT01646268|37969806|FG000|Overall Study|Lack of Efficacy|1|||
16896005|NCT01646268|37969807|FG001|Overall Study|Lack of Efficacy|3|||
16896006|NCT01646268|37969806|FG000|Overall Study|Protocol Violation|0|||
16896007|NCT01646268|37969807|FG001|Overall Study|Protocol Violation|1|||
16896008|NCT01646268|37969806|FG000|Overall Study|Withdrawal by Subject|2|||
16896009|NCT01646268|37969807|FG001|Overall Study|Withdrawal by Subject|5|||
16896010|NCT01646268|37969806|FG000|Overall Study|Other|2|||
16896011|NCT01646268|37969807|FG001|Overall Study|Other|0|||
16896012|NCT02275026|37969813|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
16896013|NCT02275026|37969813|FG000|Overall Study|Withdrawal by Subject|4|||
16896014|NCT02275026|37969813|FG000|Overall Study|Ineligible due to medical history|13|||
16896015|NCT02275026|37969813|FG000|Overall Study|MRI malfunction precluded testing|1|||
16896016|NCT02275026|37969813|FG000|Overall Study|Ineligible after MRI findings|1|||
16896017|NCT02275026|37969813|FG000|Overall Study|Lost to Follow-up|2|||
16896018|NCT02275026|37969813|FG000|Overall Study|Scanner failure|1|||
16896019|NCT02711852|37969889|FG000|Overall Study|Death|5|||
16896020|NCT02711852|37969889|FG000|Overall Study|Lost to Follow-up|1|||
16896021|NCT02711852|37969889|FG000|Overall Study|Completed follow-up|3|||
16896022|NCT02711852|37969889|FG000|Overall Study|Withdrawal by Subject|1|||
16896023|NCT04579250|37969929|FG000|Overall Study|Withdrawal by Subject|1|||
16896024|NCT04579250|37969930|FG001|Overall Study|Withdrawal by Subject|1|||
16896025|NCT04579250|37969931|FG002|Overall Study|Withdrawal by Subject|0|||
16896026|NCT04579250|37969929|FG000|Overall Study|Lost to Follow-up|1|||
16896027|NCT04579250|37969930|FG001|Overall Study|Lost to Follow-up|1|||
17004035|NCT00896532|38147672|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004036|NCT00896532|38147673|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004037|NCT00896532|38147674|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17095437|NCT00260832|38234712|FG000|Overall Study|Adverse Event|26|||
17095438|NCT00260832|38234713|FG001|Overall Study|Adverse Event|19|||
17095439|NCT00260832|38234712|FG000|Overall Study|Progression|116|||
17095440|NCT00260832|38234713|FG001|Overall Study|Progression|96|||
17095441|NCT00260832|38234712|FG000|Overall Study|Withdrawal by Subject|15|||
17095442|NCT00260832|38234713|FG001|Overall Study|Withdrawal by Subject|17|||
17095443|NCT00260832|38234712|FG000|Overall Study|Physician Decision|15|||
16896028|NCT04579250|37969931|FG002|Overall Study|Lost to Follow-up|0|||
16896029|NCT04579250|37969929|FG000|Overall Study|Moved from area|0|||
16896030|NCT04579250|37969930|FG001|Overall Study|Moved from area|1|||
16896031|NCT04579250|37969931|FG002|Overall Study|Moved from area|2|||
16896032|NCT03175367|37969958|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
16896033|NCT03175367|37969959|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
16896034|NCT03175367|37969960|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
16896035|NCT03175367|37969961|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
16896036|NCT03175367|37969962|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
16896037|NCT03175367|37969963|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
16896038|NCT03175367|37969964|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
16896039|NCT03175367|37969958|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16896040|NCT03175367|37969959|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16896041|NCT03175367|37969960|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
16896042|NCT03175367|37969961|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
16896043|NCT03175367|37969962|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
16896044|NCT03175367|37969963|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16896045|NCT03175367|37969964|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16896046|NCT03175367|37969958|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16896047|NCT03175367|37969959|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16896048|NCT03175367|37969960|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
16896049|NCT03175367|37969961|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
17095444|NCT00260832|38234713|FG001|Overall Study|Physician Decision|9|||
17095445|NCT00260832|38234712|FG000|Overall Study|Death|43|||
17095446|NCT00260832|38234713|FG001|Overall Study|Death|62|||
16896050|NCT03175367|37969962|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16896051|NCT03175367|37969963|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16896052|NCT03175367|37969964|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16896053|NCT03175367|37969958|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
16896054|NCT03175367|37969959|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
16896055|NCT03175367|37969960|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
16896056|NCT03175367|37969961|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
16896057|NCT03175367|37969962|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
16896058|NCT03175367|37969963|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
16896059|NCT03175367|37969964|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
16896060|NCT03175367|37969958|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16896061|NCT03175367|37969959|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16896062|NCT03175367|37969960|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
16896063|NCT03175367|37969961|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
17004038|NCT00896532|38147675|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004039|NCT00896532|38147676|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16896064|NCT03175367|37969962|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
16896065|NCT03175367|37969963|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16896066|NCT03175367|37969964|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16896067|NCT03175367|37969958|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16896068|NCT03175367|37969959|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16896069|NCT03175367|37969960|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16896070|NCT03175367|37969961|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16896071|NCT03175367|37969962|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16896072|NCT03175367|37969963|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16896073|NCT03175367|37969964|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
16896074|NCT03175367|37969958|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16896075|NCT03175367|37969959|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16896076|NCT03175367|37969960|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16896077|NCT03175367|37969961|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16896078|NCT03175367|37969962|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16896079|NCT03175367|37969963|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
16896080|NCT03175367|37969964|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
16896081|NCT03174275|37970021|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
16896082|NCT03174275|37970021|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
16896083|NCT03174275|37970021|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
16896084|NCT03174275|37970021|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
16896085|NCT03174275|37970021|FG000|Adjuvant Chemotherapy|Progression|1|||
16896086|NCT03174275|37970021|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
16896087|NCT03174275|37970021|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
16786035|NCT02696785|37726297|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
16896088|NCT03174275|37970021|FG000|Adjuvant Durvalumab|Progression|1|||
16896089|NCT03174275|37970021|FG000|Adjuvant Durvalumab|Adverse Event|3|||
16896090|NCT03174275|37970021|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
16896091|NCT03174275|37970021|FG000|Adjuvant Radiotherapy|Progression|1|||
16896092|NCT03174275|37970021|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
16896093|NCT03990363|37970122|FG000|Overall Study|Withdrawal by Subject|10|||
16896094|NCT03990363|37970123|FG001|Overall Study|Withdrawal by Subject|9|||
16896095|NCT03990363|37970124|FG002|Overall Study|Withdrawal by Subject|18|||
16896096|NCT03990363|37970125|FG003|Overall Study|Withdrawal by Subject|11|||
16896097|NCT03990363|37970126|FG004|Overall Study|Withdrawal by Subject|9|||
16896098|NCT03990363|37970122|FG000|Overall Study|Physician Decision|1|||
16896099|NCT03990363|37970123|FG001|Overall Study|Physician Decision|0|||
16896100|NCT03990363|37970124|FG002|Overall Study|Physician Decision|0|||
16896101|NCT03990363|37970125|FG003|Overall Study|Physician Decision|0|||
16896102|NCT03990363|37970126|FG004|Overall Study|Physician Decision|0|||
16896103|NCT03990363|37970122|FG000|Overall Study|Adverse Event|1|||
16896104|NCT03990363|37970123|FG001|Overall Study|Adverse Event|3|||
16896105|NCT03990363|37970124|FG002|Overall Study|Adverse Event|2|||
16896106|NCT03990363|37970125|FG003|Overall Study|Adverse Event|2|||
16896107|NCT03990363|37970126|FG004|Overall Study|Adverse Event|0|||
16896108|NCT03990363|37970122|FG000|Overall Study|Death|14|||
17004040|NCT00896532|38147677|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004041|NCT00896532|38147678|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004042|NCT00896532|38147679|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004043|NCT00896532|38147680|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
17004044|NCT00896532|38147681|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
17004045|NCT00574873|38147730|FG000|Overall Study|Withdrawal by Subject|18|||
17004046|NCT00574873|38147731|FG001|Overall Study|Withdrawal by Subject|19|||
17004047|NCT00574873|38147730|FG000|Overall Study|Investigator request|18|||
17004048|NCT00574873|38147731|FG001|Overall Study|Investigator request|8|||
17004049|NCT00574873|38147730|FG000|Overall Study|Death|15|||
16896109|NCT03990363|37970123|FG001|Overall Study|Death|8|||
16896110|NCT03990363|37970124|FG002|Overall Study|Death|14|||
16896111|NCT03990363|37970125|FG003|Overall Study|Death|10|||
16896112|NCT03990363|37970126|FG004|Overall Study|Death|11|||
16896113|NCT03990363|37970122|FG000|Overall Study|Failure to meet randomization criteria|0|||
16896114|NCT03990363|37970123|FG001|Overall Study|Failure to meet randomization criteria|1|||
16896115|NCT03990363|37970124|FG002|Overall Study|Failure to meet randomization criteria|1|||
16896116|NCT03990363|37970125|FG003|Overall Study|Failure to meet randomization criteria|0|||
16896117|NCT03990363|37970126|FG004|Overall Study|Failure to meet randomization criteria|0|||
16896118|NCT03990363|37970122|FG000|Overall Study|Lost to Follow-up|0|||
16896119|NCT03990363|37970123|FG001|Overall Study|Lost to Follow-up|0|||
16896120|NCT03990363|37970124|FG002|Overall Study|Lost to Follow-up|0|||
16896121|NCT03990363|37970125|FG003|Overall Study|Lost to Follow-up|1|||
16896122|NCT03990363|37970126|FG004|Overall Study|Lost to Follow-up|2|||
16896123|NCT03990363|37970122|FG000|Overall Study|Non-compliance with study drug|2|||
16896124|NCT03990363|37970123|FG001|Overall Study|Non-compliance with study drug|1|||
16896125|NCT03990363|37970124|FG002|Overall Study|Non-compliance with study drug|2|||
16896126|NCT03990363|37970125|FG003|Overall Study|Non-compliance with study drug|0|||
16896127|NCT03990363|37970126|FG004|Overall Study|Non-compliance with study drug|0|||
16896128|NCT03990363|37970122|FG000|Overall Study|Study terminated by sponsor|0|||
16896129|NCT03990363|37970123|FG001|Overall Study|Study terminated by sponsor|1|||
16896130|NCT03990363|37970124|FG002|Overall Study|Study terminated by sponsor|0|||
16896131|NCT03990363|37970125|FG003|Overall Study|Study terminated by sponsor|0|||
16896132|NCT03990363|37970126|FG004|Overall Study|Study terminated by sponsor|0|||
16896133|NCT03990363|37970122|FG000|Overall Study|Site terminated by sponsor|2|||
16896134|NCT03990363|37970123|FG001|Overall Study|Site terminated by sponsor|1|||
16896135|NCT03990363|37970124|FG002|Overall Study|Site terminated by sponsor|2|||
16896136|NCT03990363|37970125|FG003|Overall Study|Site terminated by sponsor|0|||
16896137|NCT03990363|37970126|FG004|Overall Study|Site terminated by sponsor|2|||
16896138|NCT03990363|37970122|FG000|Overall Study|Not categorized|5|||
16896139|NCT03990363|37970123|FG001|Overall Study|Not categorized|5|||
16896140|NCT03990363|37970124|FG002|Overall Study|Not categorized|3|||
16896141|NCT03990363|37970125|FG003|Overall Study|Not categorized|2|||
16896142|NCT03990363|37970126|FG004|Overall Study|Not categorized|2|||
16896143|NCT04661839|37970196|FG000|Overall Study|Not Treated|0|||
16896144|NCT04661839|37970197|FG001|Overall Study|Not Treated|0|||
16896145|NCT04661839|37970198|FG002|Overall Study|Not Treated|1|||
16896146|NCT04661839|37970199|FG003|Overall Study|Not Treated|0|||
16896147|NCT04661839|37970196|FG000|Overall Study|Lost to Follow-up|1|||
16896148|NCT04661839|37970197|FG001|Overall Study|Lost to Follow-up|0|||
16896149|NCT04661839|37970198|FG002|Overall Study|Lost to Follow-up|0|||
16896150|NCT04661839|37970199|FG003|Overall Study|Lost to Follow-up|1|||
16896151|NCT02240485|37970300|FG000|3 Months Post-admission|Lost to Follow-up|1|||
16896152|NCT02240485|37970301|FG001|3 Months Post-admission|Lost to Follow-up|5|||
16896153|NCT02240485|37970300|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
16896154|NCT02240485|37970301|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
16896155|NCT02240485|37970300|FG000|9 Months Post-admission|Lost to Follow-up|3|||
16896156|NCT02240485|37970301|FG001|9 Months Post-admission|Lost to Follow-up|1|||
16896157|NCT02240485|37970300|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
16896158|NCT02240485|37970301|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
16896159|NCT02240485|37970300|FG000|18 Months Post-admission|Lost to Follow-up|1|||
16896160|NCT02240485|37970301|FG001|18 Months Post-admission|Lost to Follow-up|1|||
16896161|NCT02240485|37970300|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
16896162|NCT02240485|37970301|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
16896163|NCT04149535|37970324|FG000|Overall Study|Death|11|||
16896164|NCT04149535|37970325|FG001|Overall Study|Death|7|||
16896165|NCT04149535|37970324|FG000|Overall Study|Physician Decision|10|||
16896166|NCT04149535|37970325|FG001|Overall Study|Physician Decision|4|||
16896167|NCT04149535|37970324|FG000|Overall Study|Withdrawal by Subject|6|||
16896168|NCT04149535|37970325|FG001|Overall Study|Withdrawal by Subject|7|||
16896169|NCT04149535|37970324|FG000|Overall Study|Not described|2|||
16896170|NCT04149535|37970325|FG001|Overall Study|Not described|0|||
16896171|NCT02210559|37970343|FG000|Overall Study|Progressive Disease|3|||
16896172|NCT02210559|37970344|FG001|Overall Study|Progressive Disease|2|||
16896173|NCT02210559|37970343|FG000|Overall Study|Adverse Event|2|||
16896174|NCT02210559|37970344|FG001|Overall Study|Adverse Event|2|||
16896175|NCT02210559|37970343|FG000|Overall Study|Physician Decision|1|||
16896176|NCT02210559|37970344|FG001|Overall Study|Physician Decision|0|||
16896177|NCT02210559|37970343|FG000|Overall Study|Withdrawal by Subject|0|||
16896178|NCT02210559|37970344|FG001|Overall Study|Withdrawal by Subject|1|||
16896179|NCT02210559|37970343|FG000|Overall Study|Other than specified|0|||
16896180|NCT02210559|37970344|FG001|Overall Study|Other than specified|1|||
16896181|NCT02073279|37970501|FG000|Double-blind Period|Adverse Event|1|||
16896182|NCT02073279|37970502|FG001|Double-blind Period|Adverse Event|1|||
16896183|NCT02073279|37970501|FG000|Double-blind Period|Switched to another treatment|1|||
16896184|NCT02073279|37970502|FG001|Double-blind Period|Switched to another treatment|2|||
16896185|NCT02073279|37970501|FG000|Double-blind Period|Protocol Violation|0|||
16896186|NCT02073279|37970502|FG001|Double-blind Period|Protocol Violation|1|||
16896187|NCT02073279|37970501|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
16896188|NCT02073279|37970502|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
16896189|NCT02073279|37970501|FG000|Double-blind Period|Withdrawal by Subject|2|||
16896190|NCT02073279|37970502|FG001|Double-blind Period|Withdrawal by Subject|2|||
16896191|NCT02073279|37970501|FG000|Open-label Extension Period|Adverse Event|1|||
16896192|NCT02073279|37970502|FG001|Open-label Extension Period|Adverse Event|0|||
16896193|NCT02073279|37970501|FG000|Open-label Extension Period|Lack of Efficacy|1|||
16896194|NCT02073279|37970502|FG001|Open-label Extension Period|Lack of Efficacy|0|||
16896195|NCT02073279|37970501|FG000|Open-label Extension Period|Lost to Follow-up|0|||
16896196|NCT02073279|37970502|FG001|Open-label Extension Period|Lost to Follow-up|4|||
16896197|NCT02073279|37970501|FG000|Open-label Extension Period|Switched to another treatment|1|||
16896198|NCT02073279|37970502|FG001|Open-label Extension Period|Switched to another treatment|4|||
16896199|NCT02073279|37970501|FG000|Open-label Extension Period|Protocol Violation|0|||
16896200|NCT02073279|37970502|FG001|Open-label Extension Period|Protocol Violation|1|||
16896201|NCT02073279|37970501|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
16896202|NCT02073279|37970502|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
16896203|NCT02073279|37970501|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
16896204|NCT02073279|37970502|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
16896205|NCT01673867|37970758|FG000|Randomization|Adverse event unrelated to study drug|1|||
16896206|NCT01673867|37970759|FG001|Randomization|Adverse event unrelated to study drug|0|||
16896207|NCT01673867|37970758|FG000|Randomization|Participant request to discontinue study treatment|0|||
16896208|NCT01673867|37970759|FG001|Randomization|Participant request to discontinue study treatment|4|||
16896209|NCT01673867|37970758|FG000|Randomization|Withdrawal by participant|0|||
17004050|NCT00574873|38147731|FG001|Overall Study|Death|14|||
17004051|NCT00574873|38147730|FG000|Overall Study|Lost to Follow-up|14|||
17004052|NCT00574873|38147731|FG001|Overall Study|Lost to Follow-up|5|||
17004053|NCT00574873|38147730|FG000|Overall Study|Other|40|||
17004054|NCT00574873|38147731|FG001|Overall Study|Other|4|||
17004055|NCT00574873|38147730|FG000|Overall Study|Discontinuation of study by sponsor|5|||
17004056|NCT00574873|38147731|FG001|Overall Study|Discontinuation of study by sponsor|199|||
17004057|NCT00574873|38147730|FG000|Overall Study|Blank, site closed per local regulations|2|||
17004058|NCT00574873|38147731|FG001|Overall Study|Blank, site closed per local regulations|2|||
17004059|NCT00574873|38147730|FG000|Overall Study|Extension Study|126|||
17004060|NCT00574873|38147731|FG001|Overall Study|Extension Study|0|||
17004061|NCT00902174|38147739|FG000|Overall Study|Adverse Event|27|||
17004062|NCT00902174|38147740|FG001|Overall Study|Adverse Event|7|||
17004063|NCT00902174|38147739|FG000|Overall Study|Lack of Efficacy|1|||
17004064|NCT00902174|38147740|FG001|Overall Study|Lack of Efficacy|5|||
17004065|NCT00902174|38147739|FG000|Overall Study|Death|2|||
17004066|NCT00902174|38147740|FG001|Overall Study|Death|2|||
17004067|NCT00902174|38147739|FG000|Overall Study|Withdrawal by Subject|2|||
17004068|NCT00902174|38147740|FG001|Overall Study|Withdrawal by Subject|1|||
17004069|NCT00902174|38147739|FG000|Overall Study|Abnormal labs|1|||
17004070|NCT00902174|38147740|FG001|Overall Study|Abnormal labs|1|||
17004071|NCT00902174|38147739|FG000|Overall Study|Protocol Violation|1|||
17004072|NCT00902174|38147740|FG001|Overall Study|Protocol Violation|1|||
17004073|NCT00902174|38147739|FG000|Overall Study|Administration problem|0|||
17004074|NCT00902174|38147740|FG001|Overall Study|Administration problem|1|||
17004075|NCT01609842|38147753|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
16896210|NCT01673867|37970759|FG001|Randomization|Withdrawal by participant|12|||
16896211|NCT01673867|37970758|FG000|Randomization|Lost to Follow-up|0|||
16896212|NCT01673867|37970759|FG001|Randomization|Lost to Follow-up|1|||
16896213|NCT01673867|37970758|FG000|Randomization|Participant no longer meets study criteria|4|||
16896214|NCT01673867|37970759|FG001|Randomization|Participant no longer meets study criteria|5|||
16896215|NCT01673867|37970758|FG000|Treatment|Disease Progression|208|||
16896216|NCT01673867|37970759|FG001|Treatment|Disease Progression|178|||
16896217|NCT01673867|37970758|FG000|Treatment|Study Drug Toxicity|23|||
16896218|NCT01673867|37970759|FG001|Treatment|Study Drug Toxicity|43|||
16896219|NCT01673867|37970758|FG000|Treatment|Death|2|||
16896220|NCT01673867|37970759|FG001|Treatment|Death|3|||
16896221|NCT01673867|37970758|FG000|Treatment|Adverse event unrelated to study drug|23|||
16896222|NCT01673867|37970759|FG001|Treatment|Adverse event unrelated to study drug|10|||
16896223|NCT01673867|37970758|FG000|Treatment|Participant request to discontinue study treatment|7|||
16896224|NCT01673867|37970759|FG001|Treatment|Participant request to discontinue study treatment|17|||
16896225|NCT01673867|37970758|FG000|Treatment|Withdrawal by participant|5|||
16896226|NCT01673867|37970759|FG001|Treatment|Withdrawal by participant|5|||
16896227|NCT01673867|37970758|FG000|Treatment|Maximum clinical benefit|1|||
16896228|NCT01673867|37970759|FG001|Treatment|Maximum clinical benefit|10|||
16896229|NCT01673867|37970758|FG000|Treatment|Participant no longer meets study criteria|2|||
16896230|NCT01673867|37970759|FG001|Treatment|Participant no longer meets study criteria|0|||
16896231|NCT01673867|37970758|FG000|Treatment|Administrative reason by sponsor|3|||
16896232|NCT01673867|37970759|FG001|Treatment|Administrative reason by sponsor|0|||
16896233|NCT01673867|37970758|FG000|Treatment|Other reason|11|||
16896234|NCT01673867|37970759|FG001|Treatment|Other reason|2|||
17004076|NCT01609842|38147754|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
17004077|NCT00623623|38147779|FG000|Overall Study|Previous enrolment into this study|1|||
17095447|NCT00260832|38234712|FG000|Overall Study|Other|10|||
16896235|NCT02041533|37970855|FG000|Pre-Treatment Period|Disease Progression|1|||
16896236|NCT02041533|37970856|FG001|Pre-Treatment Period|Disease Progression|1|||
16896237|NCT02041533|37970855|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
16896238|NCT02041533|37970856|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
16896239|NCT02041533|37970855|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
16896240|NCT02041533|37970856|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
16896241|NCT02041533|37970855|FG000|Treatment Period|Disease progression|189|||
16896242|NCT02041533|37970856|FG001|Treatment Period|Disease progression|146|||
16896243|NCT02041533|37970855|FG000|Treatment Period|Study drug toxicity|30|||
16896244|NCT02041533|37970856|FG001|Treatment Period|Study drug toxicity|34|||
16896245|NCT02041533|37970855|FG000|Treatment Period|Death|1|||
16896246|NCT02041533|37970856|FG001|Treatment Period|Death|0|||
16896247|NCT02041533|37970855|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
16896248|NCT02041533|37970856|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
16896249|NCT02041533|37970855|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
16896250|NCT02041533|37970856|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
16896251|NCT02041533|37970855|FG000|Treatment Period|Participant withdrew consent|2|||
16896252|NCT02041533|37970856|FG001|Treatment Period|Participant withdrew consent|2|||
16896253|NCT02041533|37970855|FG000|Treatment Period|Maximum clinical benefit|0|||
16896254|NCT02041533|37970856|FG001|Treatment Period|Maximum clinical benefit|18|||
16896255|NCT02041533|37970855|FG000|Treatment Period|Poor/Non-compliance|1|||
16896256|NCT02041533|37970856|FG001|Treatment Period|Poor/Non-compliance|0|||
16896257|NCT02041533|37970855|FG000|Treatment Period|Administrative reason by sponsor|1|||
17004078|NCT00623623|38147780|FG001|Overall Study|Previous enrolment into this study|1|||
17004079|NCT00896454|38147786|FG000|Overall Study|Death|10|||
17004080|NCT00896454|38147786|FG000|Overall Study|Adverse Event|8|||
17004081|NCT00896454|38147786|FG000|Overall Study|Disease Progression|5|||
17004082|NCT00896454|38147786|FG000|Overall Study|Other|4|||
17004083|NCT00896454|38147786|FG000|Overall Study|Requirement for alternative therapy|3|||
17004084|NCT00896454|38147786|FG000|Overall Study|Ongoing in study|2|||
17004085|NCT00896454|38147786|FG000|Overall Study|Withdrawal by Subject|1|||
17004086|NCT00629239|38147792|FG000|Overall Study|Adverse Event|7|||
17004087|NCT00629239|38147793|FG001|Overall Study|Adverse Event|4|||
17004088|NCT00629239|38147792|FG000|Overall Study|Physician Decision|1|||
17004089|NCT00629239|38147793|FG001|Overall Study|Physician Decision|0|||
17004090|NCT00625807|38147801|FG000|Overall Study|schedule conflict|2|||
17004091|NCT00625807|38147802|FG001|Overall Study|schedule conflict|8|||
17004092|NCT00629083|38147812|FG000|Overall Study|Adverse Event|0|||
17004093|NCT00629083|38147813|FG001|Overall Study|Adverse Event|2|||
17004094|NCT00629083|38147812|FG000|Overall Study|Lack of Efficacy|3|||
17004095|NCT00629083|38147813|FG001|Overall Study|Lack of Efficacy|1|||
17095448|NCT00260832|38234713|FG001|Overall Study|Other|7|||
16896258|NCT02041533|37970856|FG001|Treatment Period|Administrative reason by sponsor|0|||
16896259|NCT02041533|37970855|FG000|Treatment Period|Other reasons|9|||
16896260|NCT02041533|37970856|FG001|Treatment Period|Other reasons|2|||
16896261|NCT02041533|37970855|FG000|Treatment Period|Not Reported|0|||
16896262|NCT02041533|37970856|FG001|Treatment Period|Not Reported|1|||
16896263|NCT02907203|37970863|FG000|Overall Study|Death|1|||
16896264|NCT02907203|37970863|FG000|Overall Study|Lost to Follow-up|3|||
16896265|NCT02907203|37970863|FG000|Overall Study|Withdrawal by Subject|3|||
16896266|NCT02907203|37970863|FG000|Overall Study|Surgical bypass|1|||
16896267|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
16896268|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
16896269|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
16896270|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
16896271|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
16896272|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
16896273|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
16896274|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
16896275|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Death|1|||
16896276|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Death|1|||
16896277|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
16896278|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
16896279|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
16896280|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
16896281|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
16896282|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
16896283|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
16896284|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
16896285|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
16896286|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
16896287|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
17095449|NCT00260832|38234712|FG000|Overall Study|Protocol Violation|3|||
16896288|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
16896289|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
16896290|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
16896291|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
16896292|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
16896293|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
16896294|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
16896295|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
16896296|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
16896297|NCT00559585|37972047|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
16896298|NCT00559585|37972048|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
16896299|NCT00559585|37972047|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
16896300|NCT00559585|37972048|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
16896301|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
16896302|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
16896303|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
16896304|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
16896305|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
16896306|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
16896307|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
16896308|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
16896309|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
16896310|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
17004096|NCT00629083|38147812|FG000|Overall Study|Withdrawal by Subject|10|||
17004097|NCT00629083|38147813|FG001|Overall Study|Withdrawal by Subject|2|||
17004098|NCT00629083|38147812|FG000|Overall Study|Lost to Follow-up|12|||
17004099|NCT00629083|38147813|FG001|Overall Study|Lost to Follow-up|8|||
17004100|NCT00629083|38147812|FG000|Overall Study|Moved out of country/state|2|||
17004101|NCT00629083|38147813|FG001|Overall Study|Moved out of country/state|1|||
17004102|NCT00629083|38147812|FG000|Overall Study|Refused to return for 12 month visit|1|||
17004103|NCT00629083|38147813|FG001|Overall Study|Refused to return for 12 month visit|0|||
17004104|NCT00901628|38147823|FG000|Overall Study|disconnection of catheter|4|||
17004105|NCT00901628|38147824|FG001|Overall Study|disconnection of catheter|8|||
17004106|NCT00901628|38147823|FG000|Overall Study|disconnection of drain|0|||
17004107|NCT00901628|38147824|FG001|Overall Study|disconnection of drain|1|||
17004108|NCT00901628|38147823|FG000|Overall Study|peroneal nerve palsy|0|||
17004109|NCT00901628|38147824|FG001|Overall Study|peroneal nerve palsy|1|||
17004110|NCT00623545|38147830|FG000|Overall Study|Adverse Event|6|||
17004111|NCT00623545|38147830|FG000|Overall Study|Withdrawal by Subject|4|||
17004112|NCT00628927|38147837|FG000|Overall Study|Problems performing blood draw|6|||
17004113|NCT00628927|38147838|FG001|Overall Study|Problems performing blood draw|0|||
17004114|NCT00628927|38147837|FG000|Overall Study|Lost to Follow-up|1|||
17004115|NCT00628927|38147838|FG001|Overall Study|Lost to Follow-up|0|||
17004116|NCT00628927|38147837|FG000|Overall Study|Equipment failure|1|||
17004117|NCT00628927|38147838|FG001|Overall Study|Equipment failure|0|||
17004118|NCT00623467|38147849|FG000|Overall Study|Lost to Follow-up|1|||
17004119|NCT00623467|38147849|FG000|Overall Study|Protocol Violation|4|||
17004120|NCT00623467|38147849|FG000|Overall Study|Withdrawal by Subject|2|||
17192357|NCT02653664|38345569|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
17192358|NCT02653664|38345570|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
17192359|NCT02653664|38345571|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
16896311|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
16896312|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
16896313|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
16896314|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
16896315|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
16896316|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
16896317|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
16896318|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
16896319|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
16896320|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
16896321|NCT00559585|37972047|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
16896322|NCT00559585|37972048|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
16896323|NCT00559507|37972088|FG000|Overall Study|Not treated, patient ineligible|3|||
16896324|NCT00559273|37972356|FG000|Correction Period (20 Weeks)|Death|3|||
16896325|NCT00559273|37972357|FG001|Correction Period (20 Weeks)|Death|4|||
16896326|NCT00559273|37972356|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
16896327|NCT00559273|37972357|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
17004121|NCT00838539|38147867|FG000|Overall Study|Disease Progression|2|||
16896328|NCT00559273|37972356|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
16896329|NCT00559273|37972357|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
16896330|NCT00559273|37972356|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
16896331|NCT00559273|37972357|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
16896332|NCT00559273|37972356|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
16896333|NCT00559273|37972357|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
16896334|NCT00559273|37972356|FG000|Evaluation Period (8 Weeks)|Death|1|||
16896335|NCT00559273|37972357|FG001|Evaluation Period (8 Weeks)|Death|3|||
16896336|NCT00559273|37972356|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
16896337|NCT00559273|37972357|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
16896338|NCT00559273|37972356|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
16896339|NCT00559273|37972357|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
16896340|NCT00559273|37972356|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
16786036|NCT02696785|37726294|FG000|Follow-up Period|Adverse Event|0|||
16786037|NCT02696785|37726295|FG001|Follow-up Period|Adverse Event|0|||
16786038|NCT02696785|37726296|FG002|Follow-up Period|Adverse Event|8|||
16786039|NCT02696785|37726297|FG003|Follow-up Period|Adverse Event|2|||
16786040|NCT02696785|37726294|FG000|Follow-up Period|Lost to Follow-up|0|||
16786041|NCT02696785|37726295|FG001|Follow-up Period|Lost to Follow-up|0|||
16786042|NCT02696785|37726296|FG002|Follow-up Period|Lost to Follow-up|0|||
16786043|NCT02696785|37726297|FG003|Follow-up Period|Lost to Follow-up|1|||
16786044|NCT02696785|37726294|FG000|Follow-up Period|Lack of Efficacy|0|||
16786045|NCT02696785|37726295|FG001|Follow-up Period|Lack of Efficacy|0|||
16786046|NCT02696785|37726296|FG002|Follow-up Period|Lack of Efficacy|0|||
16786047|NCT02696785|37726297|FG003|Follow-up Period|Lack of Efficacy|1|||
16786048|NCT02696785|37726294|FG000|Follow-up Period|Withdrawal by Subject|1|||
16786049|NCT02696785|37726295|FG001|Follow-up Period|Withdrawal by Subject|0|||
16786050|NCT02696785|37726296|FG002|Follow-up Period|Withdrawal by Subject|5|||
16786051|NCT02696785|37726297|FG003|Follow-up Period|Withdrawal by Subject|4|||
16786052|NCT02004262|37726331|FG000|Overall Study|Death|67|||
16786053|NCT02004262|37726332|FG001|Overall Study|Death|64|||
16786054|NCT02004262|37726333|FG002|Overall Study|Death|66|||
16896341|NCT00559273|37972357|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
16896342|NCT00558259|37972412|FG000|Overall Study|Adverse Event|50|||
16896343|NCT00558259|37972413|FG001|Overall Study|Adverse Event|81|||
16896344|NCT00558259|37972412|FG000|Overall Study|Protocol Violation|9|||
16896345|NCT00558259|37972413|FG001|Overall Study|Protocol Violation|5|||
16896346|NCT00558259|37972412|FG000|Overall Study|Withdrawal by Subject|12|||
16896347|NCT00558259|37972413|FG001|Overall Study|Withdrawal by Subject|13|||
16896348|NCT00558103|37972560|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
16896349|NCT00558103|37972561|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
16896350|NCT00558103|37972562|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
16896351|NCT00558103|37972563|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
16896352|NCT00558103|37972564|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
16896353|NCT00558103|37972565|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
16896354|NCT00558103|37972560|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
16896355|NCT00558103|37972561|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
16896356|NCT00558103|37972562|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
16896357|NCT00558103|37972563|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
16896358|NCT00558103|37972564|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
16896359|NCT00558103|37972565|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
16896360|NCT00558103|37972560|FG000|Randomized Treatment Phase|Disease Progression|1|||
16896361|NCT00558103|37972561|FG001|Randomized Treatment Phase|Disease Progression|0|||
16896362|NCT00558103|37972562|FG002|Randomized Treatment Phase|Disease Progression|1|||
16896363|NCT00558103|37972563|FG003|Randomized Treatment Phase|Disease Progression|0|||
16896364|NCT00558103|37972564|FG004|Randomized Treatment Phase|Disease Progression|0|||
16896365|NCT00558103|37972565|FG005|Randomized Treatment Phase|Disease Progression|0|||
16896366|NCT00558103|37972560|FG000|Randomized Treatment Phase|Adverse Event|0|||
16896367|NCT00558103|37972561|FG001|Randomized Treatment Phase|Adverse Event|0|||
16896368|NCT00558103|37972562|FG002|Randomized Treatment Phase|Adverse Event|0|||
16896369|NCT00558103|37972563|FG003|Randomized Treatment Phase|Adverse Event|1|||
16896370|NCT00558103|37972564|FG004|Randomized Treatment Phase|Adverse Event|1|||
16896371|NCT00558103|37972565|FG005|Randomized Treatment Phase|Adverse Event|0|||
16896372|NCT00558103|37972560|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
16896373|NCT00558103|37972561|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
17004122|NCT00838539|38147868|FG001|Overall Study|Disease Progression|4|||
17004123|NCT00838539|38147869|FG002|Overall Study|Disease Progression|3|||
17004124|NCT00838539|38147870|FG003|Overall Study|Disease Progression|2|||
17004125|NCT00838539|38147871|FG004|Overall Study|Disease Progression|4|||
17004126|NCT00838539|38147872|FG005|Overall Study|Disease Progression|2|||
17004127|NCT00838539|38147873|FG006|Overall Study|Disease Progression|3|||
17004128|NCT00838539|38147874|FG007|Overall Study|Disease Progression|4|||
16786055|NCT02004262|37726334|FG003|Overall Study|Death|28|||
16786056|NCT02004262|37726335|FG004|Overall Study|Death|29|||
17004129|NCT00838539|38147875|FG008|Overall Study|Disease Progression|4|||
17004130|NCT00838539|38147876|FG009|Overall Study|Disease Progression|5|||
17004131|NCT00838539|38147877|FG010|Overall Study|Disease Progression|1|||
17004132|NCT00838539|38147878|FG011|Overall Study|Disease Progression|4|||
17004133|NCT00838539|38147867|FG000|Overall Study|Adverse Event|1|||
16896374|NCT00558103|37972562|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
16896375|NCT00558103|37972563|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
16896376|NCT00558103|37972564|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
16896377|NCT00558103|37972565|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
16896378|NCT00558103|37972560|FG000|Monotherapy Extension Phase|Disease Progression|0|||
16896379|NCT00558103|37972561|FG001|Monotherapy Extension Phase|Disease Progression|0|||
16896380|NCT00558103|37972562|FG002|Monotherapy Extension Phase|Disease Progression|0|||
16896381|NCT00558103|37972563|FG003|Monotherapy Extension Phase|Disease Progression|0|||
16896382|NCT00558103|37972564|FG004|Monotherapy Extension Phase|Disease Progression|0|||
16896383|NCT00558103|37972565|FG005|Monotherapy Extension Phase|Disease Progression|8|||
16896384|NCT00558025|37972611|FG000|Overall Study|Adverse Event|1|||
16896385|NCT00558025|37972612|FG001|Overall Study|Adverse Event|1|||
16896386|NCT00558025|37972611|FG000|Overall Study|Withdrawal by Subject|2|||
16896387|NCT00558025|37972612|FG001|Overall Study|Withdrawal by Subject|2|||
16896388|NCT00558025|37972611|FG000|Overall Study|Protocol Violation|1|||
16896389|NCT00558025|37972612|FG001|Overall Study|Protocol Violation|0|||
16896390|NCT00557323|37972665|FG000|Overall Study|Death|3|||
16896391|NCT00557323|37972665|FG000|Overall Study|Withdrawal by Subject|2|||
16896392|NCT00557323|37972665|FG000|Overall Study|Administrative change|2|||
16896393|NCT00557245|37972699|FG000|Overall Study|Lost to Follow-up|7|||
16896394|NCT00557245|37972700|FG001|Overall Study|Lost to Follow-up|8|||
16896395|NCT00557245|37972701|FG002|Overall Study|Lost to Follow-up|10|||
16896396|NCT00557245|37972699|FG000|Overall Study|Ineligible|5|||
16896397|NCT00557245|37972700|FG001|Overall Study|Ineligible|4|||
16896398|NCT00557245|37972701|FG002|Overall Study|Ineligible|2|||
16896399|NCT00556075|37972762|FG000|Overall Study|Lost to Follow-up|3|||
16896400|NCT00556075|37972763|FG001|Overall Study|Lost to Follow-up|0|||
16896401|NCT00556075|37972764|FG002|Overall Study|Lost to Follow-up|3|||
16896402|NCT00556075|37972762|FG000|Overall Study|Withdrawal by Subject|3|||
16896403|NCT00556075|37972763|FG001|Overall Study|Withdrawal by Subject|3|||
16896404|NCT00556075|37972764|FG002|Overall Study|Withdrawal by Subject|0|||
16896405|NCT00556075|37972762|FG000|Overall Study|Protocol Violation|1|||
16896406|NCT00556075|37972763|FG001|Overall Study|Protocol Violation|1|||
16896407|NCT00556075|37972764|FG002|Overall Study|Protocol Violation|3|||
16896408|NCT00556075|37972762|FG000|Overall Study|Not eligible|1|||
16896409|NCT00556075|37972763|FG001|Overall Study|Not eligible|1|||
16896410|NCT00556075|37972764|FG002|Overall Study|Not eligible|2|||
16896411|NCT00556075|37972762|FG000|Overall Study|Adverse Event|1|||
16896412|NCT00556075|37972763|FG001|Overall Study|Adverse Event|2|||
16896413|NCT00556075|37972764|FG002|Overall Study|Adverse Event|0|||
16896414|NCT00556075|37972762|FG000|Overall Study|Personal issues|4|||
16896415|NCT00556075|37972763|FG001|Overall Study|Personal issues|1|||
16896416|NCT00556075|37972764|FG002|Overall Study|Personal issues|0|||
16896417|NCT00556075|37972762|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
16896418|NCT00556075|37972763|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
16896419|NCT00556075|37972764|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
17004134|NCT00838539|38147868|FG001|Overall Study|Adverse Event|1|||
16896420|NCT00555061|37972785|FG000|Overall Study|Adverse Event|3|||
16896421|NCT00555061|37972785|FG000|Overall Study|Protocol Violation|1|||
16896422|NCT00555061|37972785|FG000|Overall Study|Lost to Follow-up|2|||
16896423|NCT00555061|37972785|FG000|Overall Study|Withdrawal by Subject|2|||
16896424|NCT00555061|37972785|FG000|Overall Study|Participant enrolled, but never treated|1|||
16896425|NCT02289690|37972799|FG000|Overall Study|Adverse Event Related to Progression|0|||
16896426|NCT02289690|37972800|FG001|Overall Study|Adverse Event Related to Progression|1|||
16896427|NCT02289690|37972801|FG002|Overall Study|Adverse Event Related to Progression|1|||
16896428|NCT02289690|37972802|FG003|Overall Study|Adverse Event Related to Progression|0|||
16896429|NCT02289690|37972803|FG004|Overall Study|Adverse Event Related to Progression|1|||
17004135|NCT00838539|38147869|FG002|Overall Study|Adverse Event|1|||
17095450|NCT00260832|38234713|FG001|Overall Study|Protocol Violation|1|||
17004136|NCT00838539|38147870|FG003|Overall Study|Adverse Event|1|||
17004137|NCT00838539|38147871|FG004|Overall Study|Adverse Event|2|||
17004138|NCT00838539|38147872|FG005|Overall Study|Adverse Event|1|||
17004139|NCT00838539|38147873|FG006|Overall Study|Adverse Event|0|||
17004140|NCT00838539|38147874|FG007|Overall Study|Adverse Event|2|||
17004141|NCT00838539|38147875|FG008|Overall Study|Adverse Event|0|||
17004142|NCT00838539|38147876|FG009|Overall Study|Adverse Event|1|||
17004143|NCT00838539|38147877|FG010|Overall Study|Adverse Event|2|||
17004144|NCT00838539|38147878|FG011|Overall Study|Adverse Event|0|||
17004145|NCT00838539|38147867|FG000|Overall Study|Withdrawal by Subject|0|||
17095451|NCT00168038|38234719|FG000|Overall Study|Adverse Event|1|||
16896430|NCT02289690|37972804|FG005|Overall Study|Adverse Event Related to Progression|0|||
16896431|NCT02289690|37972805|FG006|Overall Study|Adverse Event Related to Progression|1|||
16896432|NCT02289690|37972806|FG007|Overall Study|Adverse Event Related to Progression|0|||
16896433|NCT02289690|37972807|FG008|Overall Study|Adverse Event Related to Progression|0|||
16896434|NCT02289690|37972808|FG009|Overall Study|Adverse Event Related to Progression|0|||
16896435|NCT02289690|37972799|FG000|Overall Study|Withdrawal by Subject|1|||
16896436|NCT02289690|37972800|FG001|Overall Study|Withdrawal by Subject|0|||
16896437|NCT02289690|37972801|FG002|Overall Study|Withdrawal by Subject|0|||
16896438|NCT02289690|37972802|FG003|Overall Study|Withdrawal by Subject|0|||
16896439|NCT02289690|37972803|FG004|Overall Study|Withdrawal by Subject|1|||
16896440|NCT02289690|37972804|FG005|Overall Study|Withdrawal by Subject|1|||
16896441|NCT02289690|37972805|FG006|Overall Study|Withdrawal by Subject|0|||
16896442|NCT02289690|37972806|FG007|Overall Study|Withdrawal by Subject|0|||
16896443|NCT02289690|37972807|FG008|Overall Study|Withdrawal by Subject|4|||
16896444|NCT02289690|37972808|FG009|Overall Study|Withdrawal by Subject|2|||
16896445|NCT02289690|37972799|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
16896446|NCT02289690|37972800|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
16896447|NCT02289690|37972801|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
16896448|NCT02289690|37972802|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
16896449|NCT02289690|37972803|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
16896450|NCT02289690|37972804|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
16896451|NCT02289690|37972805|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
16896452|NCT02289690|37972806|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
16896453|NCT02289690|37972807|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
16896454|NCT02289690|37972808|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
16896455|NCT02289690|37972799|FG000|Overall Study|Lost to Follow-up|0|||
16896456|NCT02289690|37972800|FG001|Overall Study|Lost to Follow-up|0|||
16896457|NCT02289690|37972801|FG002|Overall Study|Lost to Follow-up|0|||
16896458|NCT02289690|37972802|FG003|Overall Study|Lost to Follow-up|0|||
16896459|NCT02289690|37972803|FG004|Overall Study|Lost to Follow-up|0|||
16896460|NCT02289690|37972804|FG005|Overall Study|Lost to Follow-up|0|||
16896461|NCT02289690|37972805|FG006|Overall Study|Lost to Follow-up|0|||
16896462|NCT02289690|37972806|FG007|Overall Study|Lost to Follow-up|1|||
16896463|NCT02289690|37972807|FG008|Overall Study|Lost to Follow-up|0|||
16896464|NCT02289690|37972808|FG009|Overall Study|Lost to Follow-up|2|||
16896465|NCT02289690|37972799|FG000|Overall Study|Death|0|||
16896466|NCT02289690|37972800|FG001|Overall Study|Death|0|||
16896467|NCT02289690|37972801|FG002|Overall Study|Death|0|||
16896468|NCT02289690|37972802|FG003|Overall Study|Death|0|||
16896469|NCT02289690|37972803|FG004|Overall Study|Death|0|||
16896470|NCT02289690|37972804|FG005|Overall Study|Death|0|||
16896471|NCT02289690|37972805|FG006|Overall Study|Death|0|||
16896472|NCT02289690|37972806|FG007|Overall Study|Death|49|||
16896473|NCT02289690|37972807|FG008|Overall Study|Death|45|||
16896474|NCT02289690|37972808|FG009|Overall Study|Death|41|||
16896475|NCT02289690|37972799|FG000|Overall Study|Sponsor Discontinued Study|0|||
16896476|NCT02289690|37972800|FG001|Overall Study|Sponsor Discontinued Study|0|||
16896477|NCT02289690|37972801|FG002|Overall Study|Sponsor Discontinued Study|0|||
16896478|NCT02289690|37972802|FG003|Overall Study|Sponsor Discontinued Study|0|||
16896479|NCT02289690|37972803|FG004|Overall Study|Sponsor Discontinued Study|0|||
16896480|NCT02289690|37972804|FG005|Overall Study|Sponsor Discontinued Study|0|||
16896481|NCT02289690|37972805|FG006|Overall Study|Sponsor Discontinued Study|0|||
16896482|NCT02289690|37972806|FG007|Overall Study|Sponsor Discontinued Study|9|||
16896483|NCT02289690|37972807|FG008|Overall Study|Sponsor Discontinued Study|7|||
16896484|NCT02289690|37972808|FG009|Overall Study|Sponsor Discontinued Study|15|||
16896485|NCT02289690|37972799|FG000|Overall Study|Other|0|||
16896486|NCT02289690|37972800|FG001|Overall Study|Other|0|||
16896487|NCT02289690|37972801|FG002|Overall Study|Other|0|||
16896488|NCT02289690|37972802|FG003|Overall Study|Other|1|||
16896489|NCT02289690|37972803|FG004|Overall Study|Other|1|||
16896490|NCT02289690|37972804|FG005|Overall Study|Other|0|||
16896491|NCT02289690|37972805|FG006|Overall Study|Other|1|||
16896492|NCT02289690|37972806|FG007|Overall Study|Other|2|||
16896493|NCT02289690|37972807|FG008|Overall Study|Other|3|||
16896494|NCT02289690|37972808|FG009|Overall Study|Other|1|||
16896495|NCT02289456|37972911|FG000|Induction Period|Death|2|||
16896496|NCT02289456|37972911|FG000|Induction Period|Adverse Event|11|||
16896497|NCT02289456|37972911|FG000|Induction Period|Progressive Disease (PD)|4|||
16896498|NCT02289456|37972911|FG000|Induction Period|Symptomatic Deterioration|4|||
16896499|NCT02289456|37972911|FG000|Induction Period|Withdrawal by Subject|2|||
16896500|NCT02289456|37972911|FG000|Induction Period|Miscellaneous|1|||
16896501|NCT02289456|37972911|FG000|Monotherapy Period|Death|1|||
16896502|NCT02289456|37972911|FG000|Monotherapy Period|Adverse Event|1|||
16896503|NCT02289456|37972911|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
16896504|NCT02289456|37972911|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
16896505|NCT02289456|37972911|FG000|Monotherapy Period|Withdrawal by Subject|2|||
16896506|NCT02289456|37972911|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
16896507|NCT02289456|37972911|FG000|Monotherapy Period|Miscellaneous|1|||
17095452|NCT00168038|38234719|FG000|Overall Study|Therapy failure|1|||
16896508|NCT02274948|37972960|FG000|Overall Study|Lost to Follow-up|28|||
16896509|NCT02274948|37972961|FG001|Overall Study|Lost to Follow-up|25|||
16896510|NCT02274948|37972960|FG000|Overall Study|Withdrawal by Subject|64|||
16896511|NCT02274948|37972961|FG001|Overall Study|Withdrawal by Subject|58|||
16896512|NCT02274948|37972960|FG000|Overall Study|Stopped on family Practitioner advice|2|||
16896513|NCT02274948|37972961|FG001|Overall Study|Stopped on family Practitioner advice|5|||
16896514|NCT02274948|37972960|FG000|Overall Study|Left the area|4|||
16896515|NCT02274948|37972961|FG001|Overall Study|Left the area|3|||
16896516|NCT02274792|37972977|FG000|Overall Study|Withdrawal by Subject|13|||
16896517|NCT02274792|37972977|FG000|Overall Study|Lost to Follow-up|8|||
16896518|NCT02274792|37972977|FG000|Overall Study|Protocol Specified Criteria|2|||
16896519|NCT02274792|37972977|FG000|Overall Study|Sponsor Decision|2|||
16896520|NCT02274558|37973007|FG000|Overall Study|Adverse Event|2|||
16896521|NCT02274558|37973008|FG001|Overall Study|Adverse Event|4|||
16896522|NCT02274558|37973009|FG002|Overall Study|Adverse Event|2|||
16896523|NCT02274558|37973007|FG000|Overall Study|Non-compliance|2|||
16896524|NCT02274558|37973008|FG001|Overall Study|Non-compliance|1|||
16896525|NCT02274558|37973009|FG002|Overall Study|Non-compliance|0|||
16896526|NCT02274558|37973007|FG000|Overall Study|Withdrawal by Subject|1|||
16896527|NCT02274558|37973008|FG001|Overall Study|Withdrawal by Subject|5|||
16896528|NCT02274558|37973009|FG002|Overall Study|Withdrawal by Subject|4|||
16896529|NCT02274558|37973007|FG000|Overall Study|Death|0|||
16896530|NCT02274558|37973008|FG001|Overall Study|Death|0|||
16896531|NCT02274558|37973009|FG002|Overall Study|Death|1|||
16896532|NCT02274558|37973007|FG000|Overall Study|Lost to Follow-up|2|||
16896533|NCT02274558|37973008|FG001|Overall Study|Lost to Follow-up|1|||
16896534|NCT02274558|37973009|FG002|Overall Study|Lost to Follow-up|1|||
16896535|NCT02274558|37973007|FG000|Overall Study|Physician Decision|0|||
16896536|NCT02274558|37973008|FG001|Overall Study|Physician Decision|2|||
16896537|NCT02274558|37973009|FG002|Overall Study|Physician Decision|1|||
16896538|NCT02287896|37973026|FG000|Second Injection Visit|Withdrawal by Subject|0|||
16896539|NCT02287896|37973027|FG001|Second Injection Visit|Withdrawal by Subject|1|||
16896540|NCT00553501|37973085|FG000|Overall Study|Adverse Event|2|||
16896541|NCT00553501|37973085|FG000|Overall Study|Death|1|||
16896542|NCT00553501|37973085|FG000|Overall Study|Progression|1|||
16896543|NCT02287584|37973113|FG000|the Double-blind Phase|Adverse Event|17|||
16896544|NCT02287584|37973114|FG001|the Double-blind Phase|Adverse Event|17|||
16896545|NCT02287584|37973115|FG002|the Double-blind Phase|Adverse Event|12|||
16896546|NCT02287584|37973116|FG003|the Double-blind Phase|Adverse Event|0|||
16896547|NCT02287584|37973117|FG004|the Double-blind Phase|Adverse Event|0|||
16896548|NCT02287584|37973118|FG005|the Double-blind Phase|Adverse Event|0|||
16896549|NCT02287584|37973113|FG000|the Double-blind Phase|Lack of Efficacy|18|||
16896550|NCT02287584|37973114|FG001|the Double-blind Phase|Lack of Efficacy|8|||
16896551|NCT02287584|37973115|FG002|the Double-blind Phase|Lack of Efficacy|8|||
16896552|NCT02287584|37973116|FG003|the Double-blind Phase|Lack of Efficacy|0|||
16896553|NCT02287584|37973117|FG004|the Double-blind Phase|Lack of Efficacy|0|||
16896554|NCT02287584|37973118|FG005|the Double-blind Phase|Lack of Efficacy|0|||
16896555|NCT02287584|37973113|FG000|the Double-blind Phase|Lost to Follow-up|0|||
16896556|NCT02287584|37973114|FG001|the Double-blind Phase|Lost to Follow-up|1|||
16896557|NCT02287584|37973115|FG002|the Double-blind Phase|Lost to Follow-up|1|||
16896558|NCT02287584|37973116|FG003|the Double-blind Phase|Lost to Follow-up|0|||
16896559|NCT02287584|37973117|FG004|the Double-blind Phase|Lost to Follow-up|0|||
16896560|NCT02287584|37973118|FG005|the Double-blind Phase|Lost to Follow-up|0|||
16896561|NCT02287584|37973113|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
16896562|NCT02287584|37973114|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
16896563|NCT02287584|37973115|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
16896564|NCT02287584|37973116|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
16896565|NCT02287584|37973117|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
16896566|NCT02287584|37973118|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
16896567|NCT02287584|37973113|FG000|the Double-blind Phase|Pregnancy|0|||
16896568|NCT02287584|37973114|FG001|the Double-blind Phase|Pregnancy|1|||
16896569|NCT02287584|37973115|FG002|the Double-blind Phase|Pregnancy|0|||
16896570|NCT02287584|37973116|FG003|the Double-blind Phase|Pregnancy|0|||
16896571|NCT02287584|37973117|FG004|the Double-blind Phase|Pregnancy|0|||
16896572|NCT02287584|37973118|FG005|the Double-blind Phase|Pregnancy|0|||
16896573|NCT02287584|37973113|FG000|the Double-blind Phase|Protocol Violation|0|||
16896574|NCT02287584|37973114|FG001|the Double-blind Phase|Protocol Violation|3|||
17004146|NCT00838539|38147868|FG001|Overall Study|Withdrawal by Subject|1|||
16896575|NCT02287584|37973115|FG002|the Double-blind Phase|Protocol Violation|0|||
16896576|NCT02287584|37973116|FG003|the Double-blind Phase|Protocol Violation|0|||
16896577|NCT02287584|37973117|FG004|the Double-blind Phase|Protocol Violation|0|||
16896578|NCT02287584|37973118|FG005|the Double-blind Phase|Protocol Violation|0|||
16896579|NCT02287584|37973113|FG000|the Double-blind Phase|other reasons|0|||
17004147|NCT00838539|38147869|FG002|Overall Study|Withdrawal by Subject|0|||
16896580|NCT02287584|37973114|FG001|the Double-blind Phase|other reasons|0|||
16896581|NCT02287584|37973115|FG002|the Double-blind Phase|other reasons|1|||
16896582|NCT02287584|37973116|FG003|the Double-blind Phase|other reasons|0|||
16896583|NCT02287584|37973117|FG004|the Double-blind Phase|other reasons|0|||
16896584|NCT02287584|37973118|FG005|the Double-blind Phase|other reasons|0|||
17004148|NCT00838539|38147870|FG003|Overall Study|Withdrawal by Subject|0|||
17004149|NCT00838539|38147871|FG004|Overall Study|Withdrawal by Subject|0|||
17004150|NCT00838539|38147872|FG005|Overall Study|Withdrawal by Subject|0|||
17004151|NCT00838539|38147873|FG006|Overall Study|Withdrawal by Subject|0|||
17004152|NCT00838539|38147874|FG007|Overall Study|Withdrawal by Subject|0|||
17004153|NCT00838539|38147875|FG008|Overall Study|Withdrawal by Subject|0|||
17004154|NCT00838539|38147876|FG009|Overall Study|Withdrawal by Subject|1|||
17004155|NCT00838539|38147877|FG010|Overall Study|Withdrawal by Subject|2|||
17004156|NCT00838539|38147878|FG011|Overall Study|Withdrawal by Subject|0|||
17004157|NCT00838539|38147867|FG000|Overall Study|Death|0|||
17004158|NCT00838539|38147868|FG001|Overall Study|Death|0|||
17004159|NCT00838539|38147869|FG002|Overall Study|Death|0|||
17004160|NCT00838539|38147870|FG003|Overall Study|Death|0|||
17004161|NCT00838539|38147871|FG004|Overall Study|Death|0|||
17004162|NCT00838539|38147872|FG005|Overall Study|Death|0|||
16896585|NCT02287584|37973113|FG000|the Open-label Phase|Did not receive drug|0|||
16896586|NCT02287584|37973114|FG001|the Open-label Phase|Did not receive drug|0|||
16896587|NCT02287584|37973115|FG002|the Open-label Phase|Did not receive drug|0|||
16896588|NCT02287584|37973116|FG003|the Open-label Phase|Did not receive drug|7|||
16896589|NCT02287584|37973117|FG004|the Open-label Phase|Did not receive drug|6|||
16896590|NCT02287584|37973118|FG005|the Open-label Phase|Did not receive drug|4|||
16896591|NCT02287584|37973113|FG000|the Open-label Phase|Adverse Event|0|||
16896592|NCT02287584|37973114|FG001|the Open-label Phase|Adverse Event|0|||
16896593|NCT02287584|37973115|FG002|the Open-label Phase|Adverse Event|0|||
16896594|NCT02287584|37973116|FG003|the Open-label Phase|Adverse Event|15|||
16896595|NCT02287584|37973117|FG004|the Open-label Phase|Adverse Event|12|||
16896596|NCT02287584|37973118|FG005|the Open-label Phase|Adverse Event|16|||
16896597|NCT02287584|37973113|FG000|the Open-label Phase|Lack of Efficacy|0|||
16896598|NCT02287584|37973114|FG001|the Open-label Phase|Lack of Efficacy|0|||
16896599|NCT02287584|37973115|FG002|the Open-label Phase|Lack of Efficacy|0|||
16896600|NCT02287584|37973116|FG003|the Open-label Phase|Lack of Efficacy|8|||
16896601|NCT02287584|37973117|FG004|the Open-label Phase|Lack of Efficacy|3|||
16896602|NCT02287584|37973118|FG005|the Open-label Phase|Lack of Efficacy|7|||
16896603|NCT02287584|37973113|FG000|the Open-label Phase|Lost to Follow-up|0|||
16896604|NCT02287584|37973114|FG001|the Open-label Phase|Lost to Follow-up|0|||
16896605|NCT02287584|37973115|FG002|the Open-label Phase|Lost to Follow-up|0|||
16896606|NCT02287584|37973116|FG003|the Open-label Phase|Lost to Follow-up|4|||
16896607|NCT02287584|37973117|FG004|the Open-label Phase|Lost to Follow-up|1|||
16896608|NCT02287584|37973118|FG005|the Open-label Phase|Lost to Follow-up|2|||
16896609|NCT02287584|37973113|FG000|the Open-label Phase|Withdrawal by Subject|0|||
16896610|NCT02287584|37973114|FG001|the Open-label Phase|Withdrawal by Subject|0|||
16896611|NCT02287584|37973115|FG002|the Open-label Phase|Withdrawal by Subject|0|||
16896612|NCT02287584|37973116|FG003|the Open-label Phase|Withdrawal by Subject|18|||
16896613|NCT02287584|37973117|FG004|the Open-label Phase|Withdrawal by Subject|29|||
16896614|NCT02287584|37973118|FG005|the Open-label Phase|Withdrawal by Subject|21|||
16896615|NCT02287584|37973113|FG000|the Open-label Phase|non-compliance|0|||
16896616|NCT02287584|37973114|FG001|the Open-label Phase|non-compliance|0|||
16896617|NCT02287584|37973115|FG002|the Open-label Phase|non-compliance|0|||
16896618|NCT02287584|37973116|FG003|the Open-label Phase|non-compliance|2|||
16896619|NCT02287584|37973117|FG004|the Open-label Phase|non-compliance|5|||
16896620|NCT02287584|37973118|FG005|the Open-label Phase|non-compliance|1|||
16896621|NCT02287584|37973113|FG000|the Open-label Phase|other reasons|0|||
16896622|NCT02287584|37973114|FG001|the Open-label Phase|other reasons|0|||
16896623|NCT02287584|37973115|FG002|the Open-label Phase|other reasons|0|||
16896624|NCT02287584|37973116|FG003|the Open-label Phase|other reasons|3|||
16896625|NCT02287584|37973117|FG004|the Open-label Phase|other reasons|6|||
16896626|NCT02287584|37973118|FG005|the Open-label Phase|other reasons|6|||
16896627|NCT00553267|37973151|FG000|Overall Study|Adverse Event|8|||
16896628|NCT00553267|37973152|FG001|Overall Study|Adverse Event|10|||
16896629|NCT00553267|37973153|FG002|Overall Study|Adverse Event|5|||
16896630|NCT00553267|37973151|FG000|Overall Study|Non compliant with protocol|3|||
16896631|NCT00553267|37973152|FG001|Overall Study|Non compliant with protocol|3|||
16896632|NCT00553267|37973153|FG002|Overall Study|Non compliant with protocol|2|||
16896633|NCT00553267|37973151|FG000|Overall Study|Lost to Follow-up|0|||
16896634|NCT00553267|37973152|FG001|Overall Study|Lost to Follow-up|0|||
16896635|NCT00553267|37973153|FG002|Overall Study|Lost to Follow-up|1|||
16896636|NCT00553267|37973151|FG000|Overall Study|Consent withdrawn|2|||
16896637|NCT00553267|37973152|FG001|Overall Study|Consent withdrawn|3|||
16896638|NCT00553267|37973153|FG002|Overall Study|Consent withdrawn|1|||
16896639|NCT00553267|37973151|FG000|Overall Study|Specified category|1|||
16896640|NCT00553267|37973152|FG001|Overall Study|Specified category|2|||
16896641|NCT00553267|37973153|FG002|Overall Study|Specified category|1|||
16896642|NCT02271984|37973167|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
17004163|NCT00838539|38147873|FG006|Overall Study|Death|1|||
17004164|NCT00838539|38147874|FG007|Overall Study|Death|0|||
17004165|NCT00838539|38147875|FG008|Overall Study|Death|0|||
16896643|NCT02271984|37973168|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896644|NCT02271984|37973169|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896645|NCT02271984|37973170|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896646|NCT02271984|37973171|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896647|NCT02271984|37973172|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
16896648|NCT02271984|37973173|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896649|NCT02271984|37973174|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
16896650|NCT02271984|37973175|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896651|NCT02271984|37973176|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896652|NCT02271984|37973177|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896653|NCT02271984|37973178|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16896654|NCT02287038|37973229|FG000|Overall Study|Stopped attending appointments|3|||
16896655|NCT02287038|37973230|FG001|Overall Study|Stopped attending appointments|2|||
16896656|NCT02287038|37973229|FG000|Overall Study|Anxiety after starting medication|0|||
16896657|NCT02287038|37973230|FG001|Overall Study|Anxiety after starting medication|1|||
16896658|NCT02287038|37973229|FG000|Overall Study|Nausea after starting medication|1|||
16896659|NCT02287038|37973230|FG001|Overall Study|Nausea after starting medication|0|||
16896660|NCT02287038|37973229|FG000|Overall Study|Abnormal ECG after starting medication|1|||
16896661|NCT02287038|37973230|FG001|Overall Study|Abnormal ECG after starting medication|0|||
16896662|NCT02286960|37973240|FG000|Overall Study|Lost to Follow-up|3|||
16896663|NCT02286960|37973241|FG001|Overall Study|Lost to Follow-up|3|||
16896664|NCT02286102|37973258|FG000|Overall Study|Screen Failure|1|||
16896665|NCT02286102|37973259|FG001|Overall Study|Screen Failure|1|||
16896666|NCT02285166|37973265|FG000|Overall Study|Case Report Forms Uncollected|564|||
16896667|NCT02285166|37973265|FG000|Overall Study|Protocol Deviation|402|||
16896668|NCT01642212|37973342|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
16896669|NCT01642212|37973343|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
16896670|NCT01642212|37973344|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
16896671|NCT01642212|37973345|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
16896672|NCT01642212|37973346|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
16896673|NCT01642212|37973342|FG000|Double-blind Treatment|Other|0|||
16896674|NCT01642212|37973343|FG001|Double-blind Treatment|Other|2|||
16896675|NCT01642212|37973344|FG002|Double-blind Treatment|Other|1|||
16896676|NCT01642212|37973345|FG003|Double-blind Treatment|Other|0|||
16896677|NCT01642212|37973346|FG004|Double-blind Treatment|Other|0|||
16896678|NCT01642212|37973342|FG000|Double-blind Treatment|Non-compliance|0|||
16896679|NCT01642212|37973343|FG001|Double-blind Treatment|Non-compliance|1|||
16896680|NCT01642212|37973344|FG002|Double-blind Treatment|Non-compliance|0|||
16896681|NCT01642212|37973345|FG003|Double-blind Treatment|Non-compliance|0|||
16896682|NCT01642212|37973346|FG004|Double-blind Treatment|Non-compliance|0|||
16896683|NCT01642212|37973342|FG000|Double-blind Treatment|Adverse Event|0|||
16896684|NCT01642212|37973343|FG001|Double-blind Treatment|Adverse Event|0|||
16896685|NCT01642212|37973344|FG002|Double-blind Treatment|Adverse Event|1|||
16896686|NCT01642212|37973345|FG003|Double-blind Treatment|Adverse Event|0|||
16896687|NCT01642212|37973346|FG004|Double-blind Treatment|Adverse Event|0|||
16896688|NCT01642212|37973342|FG000|Open-label Extension|Adverse Event|0|||
16896689|NCT01642212|37973343|FG001|Open-label Extension|Adverse Event|0|||
16896690|NCT01642212|37973344|FG002|Open-label Extension|Adverse Event|0|||
16896691|NCT01642212|37973345|FG003|Open-label Extension|Adverse Event|3|||
16896692|NCT01642212|37973346|FG004|Open-label Extension|Adverse Event|0|||
16896693|NCT01642212|37973342|FG000|Open-label Extension|Sponsor Decision|0|||
16896694|NCT01642212|37973343|FG001|Open-label Extension|Sponsor Decision|0|||
16896695|NCT01642212|37973344|FG002|Open-label Extension|Sponsor Decision|0|||
16896696|NCT01642212|37973345|FG003|Open-label Extension|Sponsor Decision|7|||
16896697|NCT01642212|37973346|FG004|Open-label Extension|Sponsor Decision|4|||
16896698|NCT01642212|37973342|FG000|Open-label Extension|Consent Withdrawn|0|||
16896699|NCT01642212|37973343|FG001|Open-label Extension|Consent Withdrawn|0|||
16896700|NCT01642212|37973344|FG002|Open-label Extension|Consent Withdrawn|0|||
16896701|NCT01642212|37973345|FG003|Open-label Extension|Consent Withdrawn|0|||
16896702|NCT01642212|37973346|FG004|Open-label Extension|Consent Withdrawn|2|||
16896703|NCT01642212|37973342|FG000|Open-label Extension|Lost to Follow-up|0|||
16896704|NCT01642212|37973343|FG001|Open-label Extension|Lost to Follow-up|0|||
16896705|NCT01642212|37973344|FG002|Open-label Extension|Lost to Follow-up|0|||
16896706|NCT01642212|37973345|FG003|Open-label Extension|Lost to Follow-up|0|||
16896707|NCT01642212|37973346|FG004|Open-label Extension|Lost to Follow-up|1|||
16896708|NCT01642212|37973342|FG000|Open-label Extension|Other|0|||
16896709|NCT01642212|37973343|FG001|Open-label Extension|Other|0|||
16896710|NCT01642212|37973344|FG002|Open-label Extension|Other|0|||
16896711|NCT01642212|37973345|FG003|Open-label Extension|Other|0|||
16896712|NCT01642212|37973346|FG004|Open-label Extension|Other|1|||
16896713|NCT00552175|37973371|FG000|Overall Study|Lack of Efficacy|2|||
16896714|NCT00552175|37973372|FG001|Overall Study|Lack of Efficacy|0|||
16896715|NCT00552175|37973373|FG002|Overall Study|Lack of Efficacy|1|||
16896716|NCT00552175|37973371|FG000|Overall Study|Adverse Event|9|||
16896717|NCT00552175|37973372|FG001|Overall Study|Adverse Event|9|||
16896718|NCT00552175|37973373|FG002|Overall Study|Adverse Event|10|||
16896719|NCT00552175|37973371|FG000|Overall Study|Withdrawal by Subject|2|||
16896720|NCT00552175|37973372|FG001|Overall Study|Withdrawal by Subject|2|||
16896721|NCT00552175|37973373|FG002|Overall Study|Withdrawal by Subject|1|||
16896722|NCT00552175|37973371|FG000|Overall Study|Lost to Follow-up|0|||
16896723|NCT00552175|37973372|FG001|Overall Study|Lost to Follow-up|0|||
16896724|NCT00552175|37973373|FG002|Overall Study|Lost to Follow-up|1|||
16896725|NCT00552175|37973371|FG000|Overall Study|Entry Criteria Not Met|1|||
16896726|NCT00552175|37973372|FG001|Overall Study|Entry Criteria Not Met|1|||
16896727|NCT00552175|37973373|FG002|Overall Study|Entry Criteria Not Met|0|||
16896728|NCT00552175|37973371|FG000|Overall Study|Reason Not Specified|3|||
16896729|NCT00552175|37973372|FG001|Overall Study|Reason Not Specified|1|||
16896730|NCT00552175|37973373|FG002|Overall Study|Reason Not Specified|1|||
16896731|NCT01644474|37973384|FG000|Overall Study|Poor compliance to protocol|1|||
16896732|NCT01644474|37973385|FG001|Overall Study|Poor compliance to protocol|0|||
16896733|NCT01644474|37973384|FG000|Overall Study|Consent withdrawn by participant|0|||
16896734|NCT01644474|37973385|FG001|Overall Study|Consent withdrawn by participant|1|||
16896735|NCT01644474|37973384|FG000|Overall Study|Participant moved|0|||
16896736|NCT01644474|37973385|FG001|Overall Study|Participant moved|1|||
16896737|NCT01644474|37973384|FG000|Overall Study|Adverse Event|4|||
16896738|NCT01644474|37973385|FG001|Overall Study|Adverse Event|5|||
16896739|NCT01644474|37973384|FG000|Overall Study|Site scheduling error|1|||
16896740|NCT01644474|37973385|FG001|Overall Study|Site scheduling error|1|||
16896741|NCT01644474|37973384|FG000|Overall Study|Protocol Violation|1|||
16896742|NCT01644474|37973385|FG001|Overall Study|Protocol Violation|0|||
16896743|NCT02285010|37973420|FG000|Overall Study|not abdominal hysterectomy|2|||
16896744|NCT02285010|37973421|FG001|Overall Study|not abdominal hysterectomy|0|||
16896745|NCT02285010|37973420|FG000|Overall Study|Not spinal anesthesia|3|||
16896746|NCT02285010|37973421|FG001|Overall Study|Not spinal anesthesia|1|||
16896747|NCT00551161|37973465|FG000|Overall Study|Withdrawal by Subject|1|||
16896748|NCT00550771|37973501|FG000|Overall Study|Adverse Event|11|||
16896749|NCT00550771|37973502|FG001|Overall Study|Adverse Event|3|||
16896750|NCT00550771|37973501|FG000|Overall Study|Discontinued for study-related reasons|0|||
16896751|NCT00550771|37973502|FG001|Overall Study|Discontinued for study-related reasons|1|||
16896752|NCT00550771|37973501|FG000|Overall Study|Physician Decision|2|||
17004166|NCT00838539|38147876|FG009|Overall Study|Death|0|||
17004167|NCT00838539|38147877|FG010|Overall Study|Death|0|||
17004168|NCT00838539|38147878|FG011|Overall Study|Death|0|||
17004169|NCT00838539|38147867|FG000|Overall Study|Physician Decision|0|||
17004170|NCT00838539|38147868|FG001|Overall Study|Physician Decision|0|||
16896753|NCT00550771|37973502|FG001|Overall Study|Physician Decision|0|||
16896754|NCT00550771|37973501|FG000|Overall Study|Withdrawal by Subject|0|||
16896755|NCT00550771|37973502|FG001|Overall Study|Withdrawal by Subject|1|||
16896756|NCT00550771|37973501|FG000|Overall Study|Protocol Violation|4|||
16896757|NCT00550771|37973502|FG001|Overall Study|Protocol Violation|5|||
16896758|NCT00550537|37973535|FG000|Overall Study|Death|18|||
16896759|NCT00550537|37973535|FG000|Overall Study|Adverse Event|20|||
16896760|NCT00550537|37973535|FG000|Overall Study|Disease progression before|46|||
16896761|NCT00550537|37973535|FG000|Overall Study|Withdrawal by Subject|7|||
16896762|NCT00550537|37973535|FG000|Overall Study|Change in treatment plan|4|||
16896763|NCT00550537|37973535|FG000|Overall Study|Other complicating ilness|3|||
16896764|NCT00550537|37973535|FG000|Overall Study|Declining performance status|2|||
16896765|NCT00550537|37973535|FG000|Overall Study|Treated closer to home|4|||
16896766|NCT00550147|37973553|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
17004171|NCT00838539|38147869|FG002|Overall Study|Physician Decision|0|||
16786057|NCT02004262|37726336|FG005|Overall Study|Death|22|||
16896767|NCT00550147|37973553|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
16896768|NCT00550147|37973553|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
16896769|NCT00550147|37973553|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
16786058|NCT02004262|37726331|FG000|Overall Study|Withdrawal by Subject|1|||
16786059|NCT02004262|37726332|FG001|Overall Study|Withdrawal by Subject|0|||
16786060|NCT02004262|37726333|FG002|Overall Study|Withdrawal by Subject|4|||
16786061|NCT02004262|37726334|FG003|Overall Study|Withdrawal by Subject|0|||
16786062|NCT02004262|37726335|FG004|Overall Study|Withdrawal by Subject|1|||
16786063|NCT02004262|37726336|FG005|Overall Study|Withdrawal by Subject|3|||
16786064|NCT02004262|37726331|FG000|Overall Study|Lost to Follow-up|1|||
16786065|NCT02004262|37726332|FG001|Overall Study|Lost to Follow-up|1|||
16786066|NCT02004262|37726333|FG002|Overall Study|Lost to Follow-up|0|||
16786067|NCT02004262|37726334|FG003|Overall Study|Lost to Follow-up|0|||
16786068|NCT02004262|37726335|FG004|Overall Study|Lost to Follow-up|0|||
16786069|NCT02004262|37726336|FG005|Overall Study|Lost to Follow-up|0|||
16786070|NCT02004262|37726331|FG000|Overall Study|Study Terminated by Sponsor|4|||
16786071|NCT02004262|37726332|FG001|Overall Study|Study Terminated by Sponsor|3|||
16896770|NCT00550147|37973553|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
17004172|NCT00838539|38147870|FG003|Overall Study|Physician Decision|0|||
17004173|NCT00838539|38147871|FG004|Overall Study|Physician Decision|0|||
16786072|NCT02004262|37726333|FG002|Overall Study|Study Terminated by Sponsor|2|||
16786073|NCT02004262|37726334|FG003|Overall Study|Study Terminated by Sponsor|1|||
16786074|NCT02004262|37726335|FG004|Overall Study|Study Terminated by Sponsor|1|||
16786075|NCT02004262|37726336|FG005|Overall Study|Study Terminated by Sponsor|5|||
16786076|NCT01675427|37726350|FG000|Overall Study|Withdrawal by Subject|7|||
16786077|NCT01675427|37726350|FG000|Overall Study|Participant Refused Sample Collection|18|||
16786078|NCT01675427|37726350|FG000|Overall Study|Sample not Collected by Mistake|2|||
16786079|NCT01675427|37726350|FG000|Overall Study|Lost to Follow-up|5|||
16786080|NCT01675427|37726350|FG000|Overall Study|Other|2|||
16786081|NCT01978912|37726388|FG000|Overall Study|Adverse Event|0|||
16786082|NCT01978912|37726389|FG001|Overall Study|Adverse Event|1|||
16786083|NCT01978912|37726390|FG002|Overall Study|Adverse Event|0|||
16786084|NCT01978912|37726391|FG003|Overall Study|Adverse Event|0|||
16786085|NCT01978912|37726388|FG000|Overall Study|Lost to Follow-up|1|||
16786086|NCT01978912|37726389|FG001|Overall Study|Lost to Follow-up|1|||
16786087|NCT01978912|37726390|FG002|Overall Study|Lost to Follow-up|0|||
16786088|NCT01978912|37726391|FG003|Overall Study|Lost to Follow-up|1|||
16786089|NCT01978912|37726388|FG000|Overall Study|Withdrawal by Subject|1|||
16786090|NCT01978912|37726389|FG001|Overall Study|Withdrawal by Subject|0|||
16786091|NCT01978912|37726390|FG002|Overall Study|Withdrawal by Subject|2|||
16786092|NCT01978912|37726391|FG003|Overall Study|Withdrawal by Subject|2|||
16786093|NCT01978912|37726388|FG000|Overall Study|Lumbar Surgery|1|||
16786094|NCT01978912|37726389|FG001|Overall Study|Lumbar Surgery|0|||
16786095|NCT01978912|37726390|FG002|Overall Study|Lumbar Surgery|1|||
16786096|NCT01978912|37726391|FG003|Overall Study|Lumbar Surgery|0|||
16786097|NCT01978912|37726388|FG000|Overall Study|Intradiscal Steroid Injection|0|||
16786098|NCT01978912|37726389|FG001|Overall Study|Intradiscal Steroid Injection|1|||
16786099|NCT01978912|37726390|FG002|Overall Study|Intradiscal Steroid Injection|0|||
16786100|NCT01978912|37726391|FG003|Overall Study|Intradiscal Steroid Injection|0|||
16786101|NCT01977898|37726403|FG000|Overall Study|Non functioning catheter|1|||
16786102|NCT01977898|37726404|FG001|Overall Study|Non functioning catheter|1|||
16786103|NCT02003638|37726412|FG000|Overall Study|Withdrawal by Subject|1|||
16786104|NCT02003638|37726413|FG001|Overall Study|Withdrawal by Subject|0|||
16786105|NCT02696317|37726419|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
16786106|NCT02696317|37726420|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
16786107|NCT02696317|37726419|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
16786108|NCT02696317|37726420|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
16786109|NCT01959412|37726428|FG000|Overall Study|Protocol deviation|1|||
16786110|NCT01959412|37726429|FG001|Overall Study|Protocol deviation|1|||
16896771|NCT00550459|37973764|FG000|Overall Study|Adverse Event|0|||
16896772|NCT00550459|37973765|FG001|Overall Study|Adverse Event|2|||
16896773|NCT00550459|37973764|FG000|Overall Study|Withdrawal by Subject|1|||
16896774|NCT00550459|37973765|FG001|Overall Study|Withdrawal by Subject|1|||
16896775|NCT01643928|37974064|FG000|Overall Study|Lost to Follow-up|1|||
16896776|NCT01643928|37974065|FG001|Overall Study|Lost to Follow-up|0|||
17095453|NCT00167414|38234723|FG000|Overall Study|Death|10|||
16896777|NCT01643928|37974066|FG002|Overall Study|Lost to Follow-up|2|||
16896778|NCT01643928|37974067|FG003|Overall Study|Lost to Follow-up|0|||
16896779|NCT01643928|37974068|FG004|Overall Study|Lost to Follow-up|0|||
16896780|NCT01643928|37974064|FG000|Overall Study|Withdrawal by Subject|2|||
16896781|NCT01643928|37974065|FG001|Overall Study|Withdrawal by Subject|0|||
16896782|NCT01643928|37974066|FG002|Overall Study|Withdrawal by Subject|0|||
16896783|NCT01643928|37974067|FG003|Overall Study|Withdrawal by Subject|1|||
16896784|NCT01643928|37974068|FG004|Overall Study|Withdrawal by Subject|0|||
16896785|NCT01643928|37974064|FG000|Overall Study|Pregnancy|0|||
16896786|NCT01643928|37974065|FG001|Overall Study|Pregnancy|0|||
16896787|NCT01643928|37974066|FG002|Overall Study|Pregnancy|0|||
16896788|NCT01643928|37974067|FG003|Overall Study|Pregnancy|1|||
16896789|NCT01643928|37974068|FG004|Overall Study|Pregnancy|0|||
16896790|NCT01643928|37974064|FG000|Overall Study|Other|5|||
16896791|NCT01643928|37974065|FG001|Overall Study|Other|1|||
16896792|NCT01643928|37974066|FG002|Overall Study|Other|1|||
16896793|NCT01643928|37974067|FG003|Overall Study|Other|0|||
16896794|NCT01643928|37974068|FG004|Overall Study|Other|0|||
16786111|NCT01959412|37726430|FG002|Overall Study|Protocol deviation|0|||
16786112|NCT01959412|37726431|FG003|Overall Study|Protocol deviation|1|||
16786113|NCT01959412|37726432|FG004|Overall Study|Protocol deviation|3|||
16786114|NCT01959412|37726433|FG005|Overall Study|Protocol deviation|0|||
16786115|NCT01959412|37726428|FG000|Overall Study|Adverse Event|0|||
16786116|NCT01959412|37726429|FG001|Overall Study|Adverse Event|0|||
16896795|NCT01643928|37974064|FG000|Overall Study|Adverse Event|2|||
16896796|NCT01643928|37974065|FG001|Overall Study|Adverse Event|1|||
16896797|NCT01643928|37974066|FG002|Overall Study|Adverse Event|0|||
16786117|NCT01959412|37726430|FG002|Overall Study|Adverse Event|0|||
16786118|NCT01959412|37726431|FG003|Overall Study|Adverse Event|1|||
16786119|NCT01959412|37726432|FG004|Overall Study|Adverse Event|0|||
16786120|NCT01959412|37726433|FG005|Overall Study|Adverse Event|0|||
16896798|NCT01643928|37974067|FG003|Overall Study|Adverse Event|1|||
16896799|NCT01643928|37974068|FG004|Overall Study|Adverse Event|2|||
16896800|NCT03237845|37974279|FG000|Overall Study|Adverse Event|0|||
16896801|NCT03237845|37974280|FG001|Overall Study|Adverse Event|1|||
16896802|NCT03237845|37974279|FG000|Overall Study|Lost to Follow-up|13|||
16896803|NCT03237845|37974280|FG001|Overall Study|Lost to Follow-up|10|||
16896804|NCT03237845|37974279|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
16896805|NCT03237845|37974280|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
16896806|NCT03237845|37974279|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
16896807|NCT03237845|37974280|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
16896808|NCT03237845|37974279|FG000|Overall Study|Physician Decision|1|||
16896809|NCT03237845|37974280|FG001|Overall Study|Physician Decision|2|||
16896810|NCT03237845|37974279|FG000|Overall Study|Pregnancy|1|||
16896811|NCT03237845|37974280|FG001|Overall Study|Pregnancy|0|||
16896812|NCT03237845|37974279|FG000|Overall Study|Protocol Deviation|0|||
16896813|NCT03237845|37974280|FG001|Overall Study|Protocol Deviation|1|||
16896814|NCT03237845|37974279|FG000|Overall Study|Technical Problems|8|||
16896815|NCT03237845|37974280|FG001|Overall Study|Technical Problems|1|||
16896816|NCT03237845|37974279|FG000|Overall Study|Withdrawal by Subject|3|||
16896817|NCT03237845|37974280|FG001|Overall Study|Withdrawal by Subject|3|||
16896818|NCT03237845|37974279|FG000|Overall Study|Other Reasons|4|||
16896819|NCT03237845|37974280|FG001|Overall Study|Other Reasons|0|||
16896820|NCT03007979|37974336|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
16896821|NCT01643850|37974371|FG000|Overall Study|Withdrawal by Subject|0|||
16896822|NCT01643850|37974372|FG001|Overall Study|Withdrawal by Subject|0|||
16896823|NCT01643850|37974373|FG002|Overall Study|Withdrawal by Subject|0|||
16896824|NCT01643850|37974374|FG003|Overall Study|Withdrawal by Subject|0|||
16896825|NCT01643850|37974375|FG004|Overall Study|Withdrawal by Subject|1|||
16896826|NCT01643850|37974376|FG005|Overall Study|Withdrawal by Subject|0|||
16896827|NCT01643850|37974377|FG006|Overall Study|Withdrawal by Subject|0|||
16896828|NCT01643850|37974378|FG007|Overall Study|Withdrawal by Subject|0|||
16896829|NCT01643850|37974379|FG008|Overall Study|Withdrawal by Subject|0|||
16896830|NCT01643850|37974371|FG000|Overall Study|Lost to Follow-up|0|||
16896831|NCT01643850|37974372|FG001|Overall Study|Lost to Follow-up|0|||
16896832|NCT01643850|37974373|FG002|Overall Study|Lost to Follow-up|0|||
16896833|NCT01643850|37974374|FG003|Overall Study|Lost to Follow-up|0|||
16896834|NCT01643850|37974375|FG004|Overall Study|Lost to Follow-up|0|||
16896835|NCT01643850|37974376|FG005|Overall Study|Lost to Follow-up|0|||
16896836|NCT01643850|37974377|FG006|Overall Study|Lost to Follow-up|1|||
16896837|NCT01643850|37974378|FG007|Overall Study|Lost to Follow-up|0|||
16896838|NCT01643850|37974379|FG008|Overall Study|Lost to Follow-up|1|||
16896839|NCT01643850|37974371|FG000|Overall Study|Adverse Event|0|||
16896840|NCT01643850|37974372|FG001|Overall Study|Adverse Event|0|||
16896841|NCT01643850|37974373|FG002|Overall Study|Adverse Event|0|||
16896842|NCT01643850|37974374|FG003|Overall Study|Adverse Event|0|||
16896843|NCT01643850|37974375|FG004|Overall Study|Adverse Event|1|||
16896844|NCT01643850|37974376|FG005|Overall Study|Adverse Event|0|||
16896845|NCT01643850|37974377|FG006|Overall Study|Adverse Event|0|||
16896846|NCT01643850|37974378|FG007|Overall Study|Adverse Event|0|||
16896847|NCT01643850|37974379|FG008|Overall Study|Adverse Event|0|||
16896848|NCT01643850|37974371|FG000|Overall Study|Administrative Problems|0|||
16896849|NCT01643850|37974372|FG001|Overall Study|Administrative Problems|0|||
16896850|NCT01643850|37974373|FG002|Overall Study|Administrative Problems|1|||
16896851|NCT01643850|37974374|FG003|Overall Study|Administrative Problems|0|||
17004174|NCT00838539|38147872|FG005|Overall Study|Physician Decision|0|||
17004175|NCT00838539|38147873|FG006|Overall Study|Physician Decision|0|||
17004176|NCT00838539|38147874|FG007|Overall Study|Physician Decision|0|||
17004177|NCT00838539|38147875|FG008|Overall Study|Physician Decision|1|||
17004178|NCT00838539|38147876|FG009|Overall Study|Physician Decision|0|||
17004179|NCT00838539|38147877|FG010|Overall Study|Physician Decision|0|||
17095454|NCT00166712|38234729|FG000|Overall Study|Death|0|||
17095455|NCT00166712|38234730|FG001|Overall Study|Death|1|||
17095456|NCT00166712|38234729|FG000|Overall Study|Adverse Event|1|||
17095457|NCT00166712|38234730|FG001|Overall Study|Adverse Event|0|||
17095458|NCT00166712|38234729|FG000|Overall Study|Withdrawal by Subject|1|||
17095459|NCT00166712|38234730|FG001|Overall Study|Withdrawal by Subject|2|||
17095460|NCT00166712|38234729|FG000|Overall Study|Physician Decision|0|||
17095461|NCT00166712|38234730|FG001|Overall Study|Physician Decision|2|||
17095462|NCT00073528|38234742|FG000|Overall Study|Death|488|||
17004180|NCT00838539|38147878|FG011|Overall Study|Physician Decision|0|||
17004181|NCT00838539|38147867|FG000|Overall Study|Clinical Progression|0|||
17004182|NCT00838539|38147868|FG001|Overall Study|Clinical Progression|0|||
16896852|NCT01643850|37974375|FG004|Overall Study|Administrative Problems|1|||
17004183|NCT00838539|38147869|FG002|Overall Study|Clinical Progression|0|||
17004184|NCT00838539|38147870|FG003|Overall Study|Clinical Progression|0|||
17004185|NCT00838539|38147871|FG004|Overall Study|Clinical Progression|0|||
17004186|NCT00838539|38147872|FG005|Overall Study|Clinical Progression|0|||
17004187|NCT00838539|38147873|FG006|Overall Study|Clinical Progression|1|||
16896853|NCT01643850|37974376|FG005|Overall Study|Administrative Problems|0|||
16896854|NCT01643850|37974377|FG006|Overall Study|Administrative Problems|0|||
17004188|NCT00838539|38147874|FG007|Overall Study|Clinical Progression|0|||
16786121|NCT01977820|37726449|FG000|Overall Study|Sponsor terminated the study|1|||
16786122|NCT01977820|37726450|FG001|Overall Study|Sponsor terminated the study|1|||
16786123|NCT02003014|37726456|FG000|Overall Study|Case report forms uncollected|9|||
16786124|NCT02003014|37726456|FG000|Overall Study|Treatment started after contract period|1|||
16786125|NCT02003014|37726456|FG000|Overall Study|Patient did not visit the study site|5|||
16786126|NCT02003014|37726456|FG000|Overall Study|Investigator's transfer|4|||
16786127|NCT01977352|37726462|FG000|Overall Study|Lost to Follow-up|1|||
16786128|NCT01977352|37726463|FG001|Overall Study|Lost to Follow-up|2|||
16786129|NCT02001688|37726472|FG000|Overall Study|Withdrawal by Subject|0|||
16786130|NCT02001688|37726473|FG001|Overall Study|Withdrawal by Subject|0|||
16786131|NCT02001688|37726474|FG002|Overall Study|Withdrawal by Subject|1|||
16786132|NCT02001688|37726472|FG000|Overall Study|Adverse Event|0|||
16786133|NCT02001688|37726473|FG001|Overall Study|Adverse Event|1|||
16896855|NCT01643850|37974378|FG007|Overall Study|Administrative Problems|0|||
16896856|NCT01643850|37974379|FG008|Overall Study|Administrative Problems|0|||
16896857|NCT02271594|37974447|FG000|Overall Study|Study closed; recruiting failure|19|||
16896858|NCT02271594|37974448|FG001|Overall Study|Study closed; recruiting failure|12|||
16896859|NCT02535923|37974467|FG000|Overall Study|Lost to Follow-up|5|||
16896860|NCT02535923|37974468|FG001|Overall Study|Lost to Follow-up|5|||
16896861|NCT02535923|37974467|FG000|Overall Study|Withdrawal by Subject|4|||
16896862|NCT02535923|37974468|FG001|Overall Study|Withdrawal by Subject|3|||
16896863|NCT02270736|37974477|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
16896864|NCT02270736|37974478|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
16896865|NCT02270736|37974479|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
16896866|NCT02270736|37974480|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
16896867|NCT02270736|37974481|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
16896868|NCT02270736|37974477|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
16896869|NCT02270736|37974478|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
16896870|NCT02270736|37974479|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
16896871|NCT02270736|37974480|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
16896872|NCT02270736|37974481|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
16896873|NCT02270736|37974477|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
16896874|NCT02270736|37974478|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
16896875|NCT02270736|37974479|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
16896876|NCT02270736|37974480|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
16896877|NCT02270736|37974481|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
16896878|NCT02270736|37974477|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
16896879|NCT02270736|37974478|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
16896880|NCT02270736|37974479|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
16896881|NCT02270736|37974480|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
16896882|NCT02270736|37974481|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
16896883|NCT02270736|37974477|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
16896884|NCT02270736|37974478|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
16896885|NCT02270736|37974479|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
16896886|NCT02270736|37974480|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
16896887|NCT02270736|37974481|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
16896888|NCT02270736|37974477|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
16896889|NCT02270736|37974478|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
16896890|NCT02270736|37974479|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
16896891|NCT02270736|37974480|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
16896892|NCT02270736|37974481|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
16896893|NCT02270736|37974477|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
16896894|NCT02270736|37974478|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
16896895|NCT02270736|37974479|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
16896896|NCT02270736|37974480|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
16896897|NCT02270736|37974481|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
16896898|NCT02270736|37974477|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
17004189|NCT00838539|38147875|FG008|Overall Study|Clinical Progression|0|||
17004190|NCT00838539|38147876|FG009|Overall Study|Clinical Progression|0|||
16896899|NCT02270736|37974478|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
16896900|NCT02270736|37974479|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
16896901|NCT02270736|37974480|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
16896902|NCT02270736|37974481|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
16896903|NCT02270736|37974477|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
16896904|NCT02270736|37974478|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
16896905|NCT02270736|37974479|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
17004191|NCT00838539|38147877|FG010|Overall Study|Clinical Progression|0|||
16786134|NCT02001688|37726474|FG002|Overall Study|Adverse Event|0|||
16786135|NCT02001064|37726485|FG000|Overall Study|Withdrawal by Subject|2|||
16896906|NCT02270736|37974480|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
16896907|NCT02270736|37974481|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
16896908|NCT02269098|37974496|FG000|Overall Study|Lost to Follow-up|14|||
16896909|NCT02269098|37974497|FG001|Overall Study|Lost to Follow-up|9|||
16896910|NCT02283762|37974641|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
16896911|NCT02283762|37974642|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
16896912|NCT02283762|37974641|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
16896913|NCT02283762|37974642|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
16896914|NCT02283762|37974641|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
16896915|NCT02283762|37974642|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
16896916|NCT02283762|37974641|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
16896917|NCT02283762|37974642|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
16896918|NCT02283762|37974641|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
16896919|NCT02283762|37974642|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
16896920|NCT02283762|37974641|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
16896921|NCT02283762|37974642|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
16896922|NCT02283762|37974641|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
16896923|NCT02283762|37974642|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
16896924|NCT02283762|37974641|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
16896925|NCT02283762|37974642|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
16896926|NCT02283762|37974641|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
16896927|NCT02283762|37974642|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
16896928|NCT02283762|37974641|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
16896929|NCT02283762|37974642|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
16896930|NCT02283762|37974641|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
16896931|NCT02283762|37974642|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
16896932|NCT02283762|37974641|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
16896933|NCT02283762|37974642|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
16896934|NCT02283294|37974742|FG000|Overall Study|Lost to Follow-up|1|||
16896935|NCT02283294|37974743|FG001|Overall Study|Lost to Follow-up|1|||
16896936|NCT02283294|37974742|FG000|Overall Study|Withdrawal by Subject|1|||
16896937|NCT02283294|37974743|FG001|Overall Study|Withdrawal by Subject|6|||
16896938|NCT02283294|37974742|FG000|Overall Study|Protocol Violation|1|||
16896939|NCT02283294|37974743|FG001|Overall Study|Protocol Violation|0|||
16896940|NCT02283294|37974742|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
16896941|NCT02283294|37974743|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
16896942|NCT02282982|37974759|FG000|Overall Study|Lost to Follow-up|15|||
16896943|NCT02282982|37974759|FG000|Overall Study|Withdrew consent|2|||
16896944|NCT02282982|37974759|FG000|Overall Study|Death|4|||
16896945|NCT02282982|37974759|FG000|Overall Study|Lack of product|156|||
16896946|NCT02282982|37974759|FG000|Overall Study|Palivizumab is ended|11|||
16896947|NCT02282982|37974759|FG000|Overall Study|Other, not specified|18|||
16896948|NCT02268864|37974801|FG000|Overall Study|Withdrawal by Subject|2|||
16896949|NCT02268864|37974802|FG001|Overall Study|Withdrawal by Subject|0|||
16896950|NCT02268864|37974803|FG002|Overall Study|Withdrawal by Subject|0|||
16896951|NCT02268864|37974801|FG000|Overall Study|Death|0|||
16896952|NCT02268864|37974802|FG001|Overall Study|Death|1|||
16896953|NCT02268864|37974803|FG002|Overall Study|Death|0|||
16896954|NCT02268786|37974832|FG000|Overall Study|No Euploid Embryos available|42|||
16896955|NCT02268786|37974833|FG001|Overall Study|No Euploid Embryos available|0|||
16896956|NCT02268786|37974832|FG000|Overall Study|Withdrawal by Subject|7|||
16896957|NCT02268786|37974833|FG001|Overall Study|Withdrawal by Subject|14|||
16896958|NCT02268786|37974832|FG000|Overall Study|Thaw Failure|6|||
16896959|NCT02268786|37974833|FG001|Overall Study|Thaw Failure|4|||
16896960|NCT02268786|37974832|FG000|Overall Study|Protocol Violation|1|||
16896961|NCT02268786|37974833|FG001|Overall Study|Protocol Violation|0|||
16896962|NCT02268396|37974848|FG000|Overall Study|Adverse Event|3|||
16896963|NCT02268396|37974848|FG000|Overall Study|Administrative|2|||
16896964|NCT02268396|37974848|FG000|Overall Study|Withdrawal by Subject|1|||
16896965|NCT02268396|37974848|FG000|Overall Study|Lost to Follow-up|2|||
16896966|NCT02268396|37974848|FG000|Overall Study|Protocol-Specified Criteria|2|||
17004192|NCT00838539|38147878|FG011|Overall Study|Clinical Progression|0|||
17004193|NCT00838539|38147867|FG000|Overall Study|Symptomatic Deterioration|0|||
17004194|NCT00838539|38147868|FG001|Overall Study|Symptomatic Deterioration|0|||
17004195|NCT00838539|38147869|FG002|Overall Study|Symptomatic Deterioration|1|||
17004196|NCT00838539|38147870|FG003|Overall Study|Symptomatic Deterioration|1|||
17004197|NCT00838539|38147871|FG004|Overall Study|Symptomatic Deterioration|0|||
17004198|NCT00838539|38147872|FG005|Overall Study|Symptomatic Deterioration|1|||
16896967|NCT02268396|37974848|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
16896968|NCT02268084|37974854|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
16896969|NCT02268084|37974855|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
17004199|NCT00838539|38147873|FG006|Overall Study|Symptomatic Deterioration|0|||
17004200|NCT00838539|38147874|FG007|Overall Study|Symptomatic Deterioration|0|||
16896970|NCT02268084|37974854|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
16896971|NCT02268084|37974855|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
16896972|NCT01643772|37974884|FG000|Overall Study|Protocol Violation|0|||
16896973|NCT01643772|37974885|FG001|Overall Study|Protocol Violation|0|||
16896974|NCT01643772|37974886|FG002|Overall Study|Protocol Violation|0|||
16896975|NCT01643772|37974887|FG003|Overall Study|Protocol Violation|1|||
16896976|NCT01643772|37974884|FG000|Overall Study|Adverse Event|0|||
16896977|NCT01643772|37974885|FG001|Overall Study|Adverse Event|0|||
16896978|NCT01643772|37974886|FG002|Overall Study|Adverse Event|0|||
16896979|NCT01643772|37974887|FG003|Overall Study|Adverse Event|1|||
16896980|NCT02265744|37974990|FG000|Overall Study|Poor/Non-compliance|1|||
16896981|NCT02265744|37974991|FG001|Overall Study|Poor/Non-compliance|1|||
16896982|NCT02265744|37974992|FG002|Overall Study|Poor/Non-compliance|0|||
16896983|NCT02265744|37974993|FG003|Overall Study|Poor/Non-compliance|0|||
16896984|NCT02265744|37974994|FG004|Overall Study|Poor/Non-compliance|2|||
16896985|NCT02265744|37974990|FG000|Overall Study|Lost to Follow-up|0|||
16896986|NCT02265744|37974991|FG001|Overall Study|Lost to Follow-up|0|||
16896987|NCT02265744|37974992|FG002|Overall Study|Lost to Follow-up|0|||
16896988|NCT02265744|37974993|FG003|Overall Study|Lost to Follow-up|1|||
16896989|NCT02265744|37974994|FG004|Overall Study|Lost to Follow-up|0|||
16896990|NCT02265744|37974990|FG000|Overall Study|Death|0|||
16896991|NCT02265744|37974991|FG001|Overall Study|Death|0|||
16896992|NCT02265744|37974992|FG002|Overall Study|Death|0|||
16896993|NCT02265744|37974993|FG003|Overall Study|Death|2|||
16896994|NCT02265744|37974994|FG004|Overall Study|Death|0|||
16896995|NCT02265744|37974990|FG000|Overall Study|Withdrawal by Subject|2|||
16896996|NCT02265744|37974991|FG001|Overall Study|Withdrawal by Subject|0|||
16896997|NCT02265744|37974992|FG002|Overall Study|Withdrawal by Subject|0|||
16896998|NCT02265744|37974993|FG003|Overall Study|Withdrawal by Subject|2|||
16896999|NCT02265744|37974994|FG004|Overall Study|Withdrawal by Subject|0|||
16897000|NCT02265744|37974990|FG000|Overall Study|Participant request to discontinue|2|||
16897001|NCT02265744|37974991|FG001|Overall Study|Participant request to discontinue|2|||
16897002|NCT02265744|37974992|FG002|Overall Study|Participant request to discontinue|2|||
16897003|NCT02265744|37974993|FG003|Overall Study|Participant request to discontinue|0|||
16897004|NCT02265744|37974994|FG004|Overall Study|Participant request to discontinue|0|||
16897005|NCT02265744|37974990|FG000|Overall Study|Adverse Event|8|||
16897006|NCT02265744|37974991|FG001|Overall Study|Adverse Event|4|||
16897007|NCT02265744|37974992|FG002|Overall Study|Adverse Event|9|||
16897008|NCT02265744|37974993|FG003|Overall Study|Adverse Event|8|||
16897009|NCT02265744|37974994|FG004|Overall Study|Adverse Event|2|||
16897010|NCT02265744|37974990|FG000|Overall Study|Lack of Efficacy|2|||
16897011|NCT02265744|37974991|FG001|Overall Study|Lack of Efficacy|4|||
16897012|NCT02265744|37974992|FG002|Overall Study|Lack of Efficacy|3|||
16897013|NCT02265744|37974993|FG003|Overall Study|Lack of Efficacy|4|||
16897014|NCT02265744|37974994|FG004|Overall Study|Lack of Efficacy|5|||
16897015|NCT02265744|37974990|FG000|Overall Study|Reason not provided by Investigator|1|||
16897016|NCT02265744|37974991|FG001|Overall Study|Reason not provided by Investigator|0|||
16897017|NCT02265744|37974992|FG002|Overall Study|Reason not provided by Investigator|0|||
16897018|NCT02265744|37974993|FG003|Overall Study|Reason not provided by Investigator|2|||
16897019|NCT02265744|37974994|FG004|Overall Study|Reason not provided by Investigator|0|||
16897020|NCT02265744|37974990|FG000|Overall Study|Administrative reason by sponsor|3|||
16897021|NCT02265744|37974991|FG001|Overall Study|Administrative reason by sponsor|2|||
16897022|NCT02265744|37974992|FG002|Overall Study|Administrative reason by sponsor|2|||
16897023|NCT02265744|37974993|FG003|Overall Study|Administrative reason by sponsor|3|||
16897024|NCT02265744|37974994|FG004|Overall Study|Administrative reason by sponsor|3|||
16897025|NCT02265744|37974990|FG000|Overall Study|Subject no longer meets study criteria|0|||
16897026|NCT02265744|37974991|FG001|Overall Study|Subject no longer meets study criteria|0|||
16897027|NCT02265744|37974992|FG002|Overall Study|Subject no longer meets study criteria|0|||
16897028|NCT02265744|37974993|FG003|Overall Study|Subject no longer meets study criteria|0|||
16897029|NCT02265744|37974994|FG004|Overall Study|Subject no longer meets study criteria|1|||
16897030|NCT02265744|37974990|FG000|Overall Study|Pregnancy|1|||
16897031|NCT02265744|37974991|FG001|Overall Study|Pregnancy|2|||
16897032|NCT02265744|37974992|FG002|Overall Study|Pregnancy|1|||
16897033|NCT02265744|37974993|FG003|Overall Study|Pregnancy|1|||
16897034|NCT02265744|37974994|FG004|Overall Study|Pregnancy|0|||
16897035|NCT00085735|37975023|FG000|Overall Study|Adverse Event|1|||
16897036|NCT00085735|37975024|FG001|Overall Study|Adverse Event|0|||
16897037|NCT00085735|37975025|FG002|Overall Study|Adverse Event|0|||
16897038|NCT00085735|37975026|FG003|Overall Study|Adverse Event|0|||
16897039|NCT00085735|37975027|FG004|Overall Study|Adverse Event|0|||
16897040|NCT00085735|37975028|FG005|Overall Study|Adverse Event|0|||
16897041|NCT00085735|37975023|FG000|Overall Study|Lack of Efficacy|2|||
16897042|NCT00085735|37975024|FG001|Overall Study|Lack of Efficacy|4|||
16897043|NCT00085735|37975025|FG002|Overall Study|Lack of Efficacy|6|||
16897044|NCT00085735|37975026|FG003|Overall Study|Lack of Efficacy|3|||
16897045|NCT00085735|37975027|FG004|Overall Study|Lack of Efficacy|4|||
16897046|NCT00085735|37975028|FG005|Overall Study|Lack of Efficacy|3|||
16897047|NCT00085735|37975023|FG000|Overall Study|Lost to Follow-up|0|||
16897048|NCT00085735|37975024|FG001|Overall Study|Lost to Follow-up|1|||
16897049|NCT00085735|37975025|FG002|Overall Study|Lost to Follow-up|0|||
16897050|NCT00085735|37975026|FG003|Overall Study|Lost to Follow-up|0|||
16897051|NCT00085735|37975027|FG004|Overall Study|Lost to Follow-up|1|||
16897052|NCT00085735|37975028|FG005|Overall Study|Lost to Follow-up|0|||
16897053|NCT00085735|37975023|FG000|Overall Study|Physician Decision|2|||
16897054|NCT00085735|37975024|FG001|Overall Study|Physician Decision|3|||
16897055|NCT00085735|37975025|FG002|Overall Study|Physician Decision|2|||
16897056|NCT00085735|37975026|FG003|Overall Study|Physician Decision|3|||
16897057|NCT00085735|37975027|FG004|Overall Study|Physician Decision|11|||
16897058|NCT00085735|37975028|FG005|Overall Study|Physician Decision|8|||
16897059|NCT00085735|37975023|FG000|Overall Study|Protocol Violation|1|||
16897060|NCT00085735|37975024|FG001|Overall Study|Protocol Violation|0|||
16897061|NCT00085735|37975025|FG002|Overall Study|Protocol Violation|0|||
16897062|NCT00085735|37975026|FG003|Overall Study|Protocol Violation|0|||
16897063|NCT00085735|37975027|FG004|Overall Study|Protocol Violation|0|||
16897064|NCT00085735|37975028|FG005|Overall Study|Protocol Violation|0|||
16897065|NCT00085735|37975023|FG000|Overall Study|Withdrawal by Subject|1|||
16897066|NCT00085735|37975024|FG001|Overall Study|Withdrawal by Subject|0|||
16897067|NCT00085735|37975025|FG002|Overall Study|Withdrawal by Subject|4|||
16897068|NCT00085735|37975026|FG003|Overall Study|Withdrawal by Subject|5|||
16897069|NCT00085735|37975027|FG004|Overall Study|Withdrawal by Subject|7|||
16897070|NCT00085735|37975028|FG005|Overall Study|Withdrawal by Subject|8|||
16897071|NCT00085735|37975023|FG000|Overall Study|Patient ineligible|1|||
16897072|NCT00085735|37975024|FG001|Overall Study|Patient ineligible|0|||
16897073|NCT00085735|37975025|FG002|Overall Study|Patient ineligible|3|||
16897074|NCT00085735|37975026|FG003|Overall Study|Patient ineligible|7|||
16897075|NCT00085735|37975027|FG004|Overall Study|Patient ineligible|17|||
16897076|NCT00085735|37975028|FG005|Overall Study|Patient ineligible|8|||
16897077|NCT00085735|37975023|FG000|Overall Study|Excess residual disease|2|||
16897078|NCT00085735|37975024|FG001|Overall Study|Excess residual disease|2|||
16897079|NCT00085735|37975025|FG002|Overall Study|Excess residual disease|1|||
16897080|NCT00085735|37975026|FG003|Overall Study|Excess residual disease|1|||
16897081|NCT00085735|37975027|FG004|Overall Study|Excess residual disease|1|||
16897082|NCT00085735|37975028|FG005|Overall Study|Excess residual disease|4|||
16897083|NCT00085735|37975023|FG000|Overall Study|Reason not documented|1|||
16897084|NCT00085735|37975024|FG001|Overall Study|Reason not documented|0|||
16897085|NCT00085735|37975025|FG002|Overall Study|Reason not documented|1|||
16897086|NCT00085735|37975026|FG003|Overall Study|Reason not documented|0|||
16897087|NCT00085735|37975027|FG004|Overall Study|Reason not documented|1|||
16897088|NCT00085735|37975028|FG005|Overall Study|Reason not documented|0|||
16897089|NCT00085735|37975023|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
16897090|NCT00085735|37975024|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
16897091|NCT00085735|37975025|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
16897092|NCT00085735|37975026|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
16897093|NCT00085735|37975027|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
16897094|NCT00085735|37975028|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
16897095|NCT01938001|37976608|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
16897096|NCT01938001|37976609|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
16897097|NCT01938001|37976608|FG000|Pre-Treatment|Death|1|||
16897098|NCT01938001|37976609|FG001|Pre-Treatment|Death|0|||
16897099|NCT01938001|37976608|FG000|Treatment|Death|2|||
16897100|NCT01938001|37976609|FG001|Treatment|Death|0|||
16897101|NCT01938001|37976608|FG000|Treatment|Adverse Event|14|||
16897102|NCT01938001|37976609|FG001|Treatment|Adverse Event|8|||
16897103|NCT01938001|37976608|FG000|Treatment|Progressive Disease|21|||
16897104|NCT01938001|37976609|FG001|Treatment|Progressive Disease|54|||
16897105|NCT01938001|37976608|FG000|Treatment|Withdrawal by Subject|13|||
16897106|NCT01938001|37976609|FG001|Treatment|Withdrawal by Subject|7|||
16897107|NCT01938001|37976608|FG000|Treatment|Other reasons|2|||
16897108|NCT01938001|37976609|FG001|Treatment|Other reasons|1|||
16897109|NCT02304458|37976695|FG000|Overall Study|Adverse Event|0|||
16897110|NCT02304458|37976696|FG001|Overall Study|Adverse Event|0|||
16897111|NCT02304458|37976697|FG002|Overall Study|Adverse Event|7|||
16897112|NCT02304458|37976698|FG003|Overall Study|Adverse Event|0|||
16897113|NCT02304458|37976699|FG004|Overall Study|Adverse Event|0|||
16897114|NCT02304458|37976700|FG005|Overall Study|Adverse Event|0|||
17192360|NCT02653664|38345569|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
17192361|NCT02653664|38345570|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
16897115|NCT02304458|37976701|FG006|Overall Study|Adverse Event|3|||
16897116|NCT02304458|37976702|FG007|Overall Study|Adverse Event|4|||
16897117|NCT02304458|37976695|FG000|Overall Study|Death|0|||
16897118|NCT02304458|37976696|FG001|Overall Study|Death|0|||
16897119|NCT02304458|37976697|FG002|Overall Study|Death|2|||
16897120|NCT02304458|37976698|FG003|Overall Study|Death|0|||
16897121|NCT02304458|37976699|FG004|Overall Study|Death|0|||
16897122|NCT02304458|37976700|FG005|Overall Study|Death|0|||
16897123|NCT02304458|37976701|FG006|Overall Study|Death|1|||
16897124|NCT02304458|37976702|FG007|Overall Study|Death|0|||
16897125|NCT02304458|37976695|FG000|Overall Study|Lack of Efficacy|4|||
16897126|NCT02304458|37976696|FG001|Overall Study|Lack of Efficacy|6|||
16897127|NCT02304458|37976697|FG002|Overall Study|Lack of Efficacy|38|||
16897128|NCT02304458|37976698|FG003|Overall Study|Lack of Efficacy|5|||
16897129|NCT02304458|37976699|FG004|Overall Study|Lack of Efficacy|6|||
16897130|NCT02304458|37976700|FG005|Overall Study|Lack of Efficacy|6|||
16897131|NCT02304458|37976701|FG006|Overall Study|Lack of Efficacy|21|||
16897132|NCT02304458|37976702|FG007|Overall Study|Lack of Efficacy|4|||
16897133|NCT02304458|37976695|FG000|Overall Study|Physician Decision|2|||
16897134|NCT02304458|37976696|FG001|Overall Study|Physician Decision|0|||
16897135|NCT02304458|37976697|FG002|Overall Study|Physician Decision|16|||
16897136|NCT02304458|37976698|FG003|Overall Study|Physician Decision|1|||
16897137|NCT02304458|37976699|FG004|Overall Study|Physician Decision|0|||
16897138|NCT02304458|37976700|FG005|Overall Study|Physician Decision|0|||
16897139|NCT02304458|37976701|FG006|Overall Study|Physician Decision|3|||
16897140|NCT02304458|37976702|FG007|Overall Study|Physician Decision|0|||
16897141|NCT02304458|37976695|FG000|Overall Study|Protocol Violation|0|||
16897142|NCT02304458|37976696|FG001|Overall Study|Protocol Violation|0|||
16897143|NCT02304458|37976697|FG002|Overall Study|Protocol Violation|1|||
16897144|NCT02304458|37976698|FG003|Overall Study|Protocol Violation|0|||
16897145|NCT02304458|37976699|FG004|Overall Study|Protocol Violation|0|||
16897146|NCT02304458|37976700|FG005|Overall Study|Protocol Violation|0|||
16897147|NCT02304458|37976701|FG006|Overall Study|Protocol Violation|0|||
16897148|NCT02304458|37976702|FG007|Overall Study|Protocol Violation|0|||
16897149|NCT02304458|37976695|FG000|Overall Study|Withdrawal by Subject|1|||
16897150|NCT02304458|37976696|FG001|Overall Study|Withdrawal by Subject|0|||
16897151|NCT02304458|37976697|FG002|Overall Study|Withdrawal by Subject|7|||
16897152|NCT02304458|37976698|FG003|Overall Study|Withdrawal by Subject|0|||
16897153|NCT02304458|37976699|FG004|Overall Study|Withdrawal by Subject|0|||
16897154|NCT02304458|37976700|FG005|Overall Study|Withdrawal by Subject|0|||
16897155|NCT02304458|37976701|FG006|Overall Study|Withdrawal by Subject|1|||
16897156|NCT02304458|37976702|FG007|Overall Study|Withdrawal by Subject|0|||
16897157|NCT01081951|37976793|FG000|Overall Study|Death|54|||
16897158|NCT01081951|37976794|FG001|Overall Study|Death|47|||
16897159|NCT01081951|37976793|FG000|Overall Study|Withdrawal by Subject|2|||
16897160|NCT01081951|37976794|FG001|Overall Study|Withdrawal by Subject|6|||
16897161|NCT01081951|37976793|FG000|Overall Study|Allocated treatment but did not take it|0|||
16897162|NCT01081951|37976794|FG001|Overall Study|Allocated treatment but did not take it|1|||
16897163|NCT01081951|37976793|FG000|Overall Study|Lost to Follow-up|0|||
16897164|NCT01081951|37976794|FG001|Overall Study|Lost to Follow-up|1|||
16897165|NCT01066663|37976840|FG000|Overall Study|Adverse Event|0|||
16897166|NCT01066663|37976841|FG001|Overall Study|Adverse Event|0|||
16897167|NCT01066663|37976842|FG002|Overall Study|Adverse Event|1|||
16897168|NCT03930745|37979096|FG000|Overall Study|Lost to Follow-up|10|||
16897169|NCT03930745|37979097|FG001|Overall Study|Lost to Follow-up|5|||
16897170|NCT03930745|37979096|FG000|Overall Study|Withdrawal by Subject|1|||
16897171|NCT03930745|37979097|FG001|Overall Study|Withdrawal by Subject|2|||
16897172|NCT03930745|37979096|FG000|Overall Study|Protocol Violation|2|||
16897173|NCT03930745|37979097|FG001|Overall Study|Protocol Violation|2|||
16897174|NCT03930745|37979096|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
16897175|NCT03930745|37979097|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
16897176|NCT03930745|37979096|FG000|Overall Study|Adverse Event|0|||
16897177|NCT03930745|37979097|FG001|Overall Study|Adverse Event|1|||
16897178|NCT03930745|37979096|FG000|Overall Study|Pregnancy|0|||
16897179|NCT03930745|37979097|FG001|Overall Study|Pregnancy|1|||
16897180|NCT04473326|37981882|FG000|Overall Study|Death|0|||
16897181|NCT04473326|37981883|FG001|Overall Study|Death|1|||
16897182|NCT04473326|37981882|FG000|Overall Study|Withdrawal by Subject|1|||
16897183|NCT04473326|37981883|FG001|Overall Study|Withdrawal by Subject|2|||
16897184|NCT03838484|37982482|FG000|Overall Study|Lost to Follow-up|0|||
16897185|NCT03838484|37982483|FG001|Overall Study|Lost to Follow-up|1|||
16897186|NCT03838484|37982484|FG002|Overall Study|Lost to Follow-up|0|||
16897187|NCT03838484|37982485|FG003|Overall Study|Lost to Follow-up|0|||
16897188|NCT01349192|37982700|FG000|Overall Study|Protocol Violation|0|||
16897189|NCT01349192|37982701|FG001|Overall Study|Protocol Violation|1|||
16897190|NCT01349192|37982700|FG000|Overall Study|Withdrawal by Subject|0|||
16897191|NCT01349192|37982701|FG001|Overall Study|Withdrawal by Subject|2|||
16897192|NCT01349192|37982700|FG000|Overall Study|Lost to Follow-up|1|||
16897193|NCT01349192|37982701|FG001|Overall Study|Lost to Follow-up|3|||
16897194|NCT01349192|37982700|FG000|Overall Study|Failure to adhere to Protocol|2|||
16897195|NCT01349192|37982701|FG001|Overall Study|Failure to adhere to Protocol|0|||
16897196|NCT01721876|37983056|FG000|Overall Study|Not treated|1|||
16897197|NCT01721876|37983057|FG001|Overall Study|Not treated|4|||
16897198|NCT01721876|37983056|FG000|Overall Study|Disease progression / relapse|123|||
16897199|NCT01721876|37983057|FG001|Overall Study|Disease progression / relapse|156|||
16897200|NCT01721876|37983056|FG000|Overall Study|Death|6|||
16897201|NCT01721876|37983057|FG001|Overall Study|Death|13|||
16897202|NCT01721876|37983056|FG000|Overall Study|Adverse Event|41|||
16897203|NCT01721876|37983057|FG001|Overall Study|Adverse Event|165|||
16897204|NCT01721876|37983056|FG000|Overall Study|Protocol Violation|2|||
16897205|NCT01721876|37983057|FG001|Overall Study|Protocol Violation|1|||
16897206|NCT01721876|37983056|FG000|Overall Study|Withdrawal by Subject|15|||
16897207|NCT01721876|37983057|FG001|Overall Study|Withdrawal by Subject|38|||
16897208|NCT01721876|37983056|FG000|Overall Study|Reason not listed|34|||
16897209|NCT01721876|37983057|FG001|Overall Study|Reason not listed|63|||
16897210|NCT01721876|37983056|FG000|Overall Study|Sponsor terminated trial|0|||
16897211|NCT01721876|37983057|FG001|Overall Study|Sponsor terminated trial|4|||
16897212|NCT02029443|37983089|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
16897213|NCT02029443|37983090|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
16897214|NCT02029443|37983091|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
16897215|NCT02029443|37983092|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
16897216|NCT02029443|37983093|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
16897217|NCT02029443|37983089|FG000|Overall Study|Death|13|||
16897218|NCT02029443|37983090|FG001|Overall Study|Death|2|||
16897219|NCT02029443|37983091|FG002|Overall Study|Death|2|||
16897220|NCT02029443|37983092|FG003|Overall Study|Death|11|||
16897221|NCT02029443|37983093|FG004|Overall Study|Death|2|||
16897222|NCT02029443|37983089|FG000|Overall Study|Lost to Follow-up|1|||
16897223|NCT02029443|37983090|FG001|Overall Study|Lost to Follow-up|0|||
16897224|NCT02029443|37983091|FG002|Overall Study|Lost to Follow-up|1|||
16897225|NCT02029443|37983092|FG003|Overall Study|Lost to Follow-up|1|||
16897226|NCT02029443|37983093|FG004|Overall Study|Lost to Follow-up|0|||
16897227|NCT02029443|37983089|FG000|Overall Study|Started other anti-cancer therapy|17|||
16897228|NCT02029443|37983090|FG001|Overall Study|Started other anti-cancer therapy|4|||
16897229|NCT02029443|37983091|FG002|Overall Study|Started other anti-cancer therapy|7|||
16897230|NCT02029443|37983092|FG003|Overall Study|Started other anti-cancer therapy|9|||
16897231|NCT02029443|37983093|FG004|Overall Study|Started other anti-cancer therapy|3|||
16897232|NCT02029443|37983089|FG000|Overall Study|Withdrawal by Subject|3|||
16897233|NCT02029443|37983090|FG001|Overall Study|Withdrawal by Subject|1|||
16897234|NCT02029443|37983091|FG002|Overall Study|Withdrawal by Subject|1|||
16897235|NCT02029443|37983092|FG003|Overall Study|Withdrawal by Subject|1|||
16897236|NCT02029443|37983093|FG004|Overall Study|Withdrawal by Subject|0|||
16897237|NCT02029443|37983089|FG000|Overall Study|Other|6|||
16897238|NCT02029443|37983090|FG001|Overall Study|Other|6|||
16897239|NCT02029443|37983091|FG002|Overall Study|Other|4|||
16897240|NCT02029443|37983092|FG003|Overall Study|Other|2|||
16897241|NCT02029443|37983093|FG004|Overall Study|Other|0|||
16897242|NCT02265510|37983344|FG000|Overall Study|Withdrawal by Subject|1|||
16897243|NCT02265510|37983345|FG001|Overall Study|Withdrawal by Subject|1|||
16897244|NCT02265510|37983346|FG002|Overall Study|Withdrawal by Subject|2|||
16897245|NCT02265510|37983347|FG003|Overall Study|Withdrawal by Subject|1|||
16897246|NCT02265510|37983348|FG004|Overall Study|Withdrawal by Subject|0|||
16897247|NCT02265510|37983349|FG005|Overall Study|Withdrawal by Subject|2|||
16897248|NCT02265510|37983350|FG006|Overall Study|Withdrawal by Subject|0|||
16897249|NCT02265510|37983351|FG007|Overall Study|Withdrawal by Subject|2|||
16897250|NCT02265510|37983352|FG008|Overall Study|Withdrawal by Subject|0|||
16897251|NCT02265510|37983353|FG009|Overall Study|Withdrawal by Subject|0|||
16897252|NCT02265510|37983354|FG010|Overall Study|Withdrawal by Subject|0|||
16897253|NCT02265510|37983355|FG011|Overall Study|Withdrawal by Subject|0|||
16897254|NCT02265510|37983356|FG012|Overall Study|Withdrawal by Subject|1|||
16897255|NCT02265510|37983357|FG013|Overall Study|Withdrawal by Subject|0|||
16897256|NCT02265510|37983344|FG000|Overall Study|Disease Progression|0|||
16897257|NCT02265510|37983345|FG001|Overall Study|Disease Progression|1|||
16897258|NCT02265510|37983346|FG002|Overall Study|Disease Progression|2|||
16897259|NCT02265510|37983347|FG003|Overall Study|Disease Progression|1|||
16897260|NCT02265510|37983348|FG004|Overall Study|Disease Progression|1|||
16897261|NCT02265510|37983349|FG005|Overall Study|Disease Progression|0|||
16897262|NCT02265510|37983350|FG006|Overall Study|Disease Progression|0|||
16897263|NCT02265510|37983351|FG007|Overall Study|Disease Progression|0|||
16897264|NCT02265510|37983352|FG008|Overall Study|Disease Progression|0|||
16897265|NCT02265510|37983353|FG009|Overall Study|Disease Progression|0|||
16897266|NCT02265510|37983354|FG010|Overall Study|Disease Progression|0|||
16897267|NCT02265510|37983355|FG011|Overall Study|Disease Progression|0|||
17004201|NCT00838539|38147875|FG008|Overall Study|Symptomatic Deterioration|0|||
17004202|NCT00838539|38147876|FG009|Overall Study|Symptomatic Deterioration|1|||
17004203|NCT00838539|38147877|FG010|Overall Study|Symptomatic Deterioration|0|||
17004204|NCT00838539|38147878|FG011|Overall Study|Symptomatic Deterioration|0|||
17004205|NCT00837759|38147918|FG000|Overall Study|Protocol Violation|3|||
17004206|NCT00837759|38147918|FG000|Overall Study|Lost to Follow-up|1|||
17004207|NCT00891774|38147922|FG000|Overall Study|Lost to Follow-up|5|||
17004208|NCT00891774|38147922|FG000|Overall Study|Illness (Self/Mother)|3|||
17004209|NCT00891774|38147922|FG000|Overall Study|Withdrawal by Subject|2|||
16897268|NCT02265510|37983356|FG012|Overall Study|Disease Progression|0|||
17004210|NCT00891774|38147922|FG000|Overall Study|Protocol Violation|4|||
16897269|NCT02265510|37983357|FG013|Overall Study|Disease Progression|0|||
16897270|NCT02265510|37983344|FG000|Overall Study|Death|2|||
16897271|NCT02265510|37983345|FG001|Overall Study|Death|0|||
16897272|NCT02265510|37983346|FG002|Overall Study|Death|2|||
16897273|NCT02265510|37983347|FG003|Overall Study|Death|2|||
16897274|NCT02265510|37983348|FG004|Overall Study|Death|1|||
16897275|NCT02265510|37983349|FG005|Overall Study|Death|3|||
16897276|NCT02265510|37983350|FG006|Overall Study|Death|2|||
16897277|NCT02265510|37983351|FG007|Overall Study|Death|1|||
16897278|NCT02265510|37983352|FG008|Overall Study|Death|3|||
16897279|NCT02265510|37983353|FG009|Overall Study|Death|3|||
16897280|NCT02265510|37983354|FG010|Overall Study|Death|4|||
16897281|NCT02265510|37983355|FG011|Overall Study|Death|12|||
16897282|NCT02265510|37983356|FG012|Overall Study|Death|7|||
16897283|NCT02265510|37983357|FG013|Overall Study|Death|6|||
16897284|NCT02265510|37983344|FG000|Overall Study|Lost to Follow-up|0|||
16897285|NCT02265510|37983345|FG001|Overall Study|Lost to Follow-up|0|||
16897286|NCT02265510|37983346|FG002|Overall Study|Lost to Follow-up|0|||
16897287|NCT02265510|37983347|FG003|Overall Study|Lost to Follow-up|0|||
16897288|NCT02265510|37983348|FG004|Overall Study|Lost to Follow-up|1|||
16897289|NCT02265510|37983349|FG005|Overall Study|Lost to Follow-up|0|||
16897290|NCT02265510|37983350|FG006|Overall Study|Lost to Follow-up|0|||
16897291|NCT02265510|37983351|FG007|Overall Study|Lost to Follow-up|0|||
16897292|NCT02265510|37983352|FG008|Overall Study|Lost to Follow-up|0|||
16897293|NCT02265510|37983353|FG009|Overall Study|Lost to Follow-up|2|||
16897294|NCT02265510|37983354|FG010|Overall Study|Lost to Follow-up|0|||
16897295|NCT02265510|37983355|FG011|Overall Study|Lost to Follow-up|0|||
17004211|NCT00837213|38147928|FG000|Overall Study|Lost to Follow-up|3|||
17004212|NCT00837213|38147929|FG001|Overall Study|Lost to Follow-up|2|||
17004213|NCT00837213|38147928|FG000|Overall Study|Withdrawal by Subject|2|||
17004214|NCT00837213|38147929|FG001|Overall Study|Withdrawal by Subject|2|||
16897296|NCT02265510|37983356|FG012|Overall Study|Lost to Follow-up|0|||
16897297|NCT02265510|37983357|FG013|Overall Study|Lost to Follow-up|2|||
16897298|NCT02265510|37983344|FG000|Overall Study|Other|0|||
16897299|NCT02265510|37983345|FG001|Overall Study|Other|1|||
16897300|NCT02265510|37983346|FG002|Overall Study|Other|0|||
16897301|NCT02265510|37983347|FG003|Overall Study|Other|0|||
16897302|NCT02265510|37983348|FG004|Overall Study|Other|0|||
16897303|NCT02265510|37983349|FG005|Overall Study|Other|0|||
16897304|NCT02265510|37983350|FG006|Overall Study|Other|0|||
16897305|NCT02265510|37983351|FG007|Overall Study|Other|0|||
16897306|NCT02265510|37983352|FG008|Overall Study|Other|0|||
16897307|NCT02265510|37983353|FG009|Overall Study|Other|0|||
16897308|NCT02265510|37983354|FG010|Overall Study|Other|0|||
16897309|NCT02265510|37983355|FG011|Overall Study|Other|0|||
16897310|NCT02265510|37983356|FG012|Overall Study|Other|0|||
16897311|NCT02265510|37983357|FG013|Overall Study|Other|0|||
16897312|NCT02265510|37983344|FG000|Overall Study|Study Terminated by Sponsor|0|||
16897313|NCT02265510|37983345|FG001|Overall Study|Study Terminated by Sponsor|0|||
16897314|NCT02265510|37983346|FG002|Overall Study|Study Terminated by Sponsor|0|||
16897315|NCT02265510|37983347|FG003|Overall Study|Study Terminated by Sponsor|0|||
16897316|NCT02265510|37983348|FG004|Overall Study|Study Terminated by Sponsor|0|||
16897317|NCT02265510|37983349|FG005|Overall Study|Study Terminated by Sponsor|1|||
16897318|NCT02265510|37983350|FG006|Overall Study|Study Terminated by Sponsor|1|||
16897319|NCT02265510|37983351|FG007|Overall Study|Study Terminated by Sponsor|1|||
16897320|NCT02265510|37983352|FG008|Overall Study|Study Terminated by Sponsor|1|||
16897321|NCT02265510|37983353|FG009|Overall Study|Study Terminated by Sponsor|2|||
16897322|NCT02265510|37983354|FG010|Overall Study|Study Terminated by Sponsor|1|||
16897323|NCT02265510|37983355|FG011|Overall Study|Study Terminated by Sponsor|4|||
16897324|NCT02265510|37983356|FG012|Overall Study|Study Terminated by Sponsor|1|||
16897325|NCT02265510|37983357|FG013|Overall Study|Study Terminated by Sponsor|2|||
16897326|NCT01238211|37983458|FG000|Overall Study|Continues active treatment|31|||
16897327|NCT01238211|37983458|FG000|Overall Study|Adverse Event|7|||
16897328|NCT01238211|37983458|FG000|Overall Study|Death|4|||
16897329|NCT01238211|37983458|FG000|Overall Study|Relapse/Progression|2|||
16897330|NCT01238211|37983458|FG000|Overall Study|Withdrawal by Subject|7|||
16897331|NCT01238211|37983458|FG000|Overall Study|Non-protocol treatment|4|||
16897332|NCT01238211|37983458|FG000|Overall Study|Investigator/Patient Decision|3|||
16897333|NCT02264574|37983634|FG000|Overall Study|Death|21|||
17004215|NCT00837213|38147928|FG000|Overall Study|not stated|1|||
17004216|NCT00837213|38147929|FG001|Overall Study|not stated|1|||
17004217|NCT00902486|38147939|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
17004218|NCT00902486|38147940|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
17004219|NCT00902486|38147941|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
17004220|NCT00902486|38147942|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
16897334|NCT02264574|37983635|FG001|Overall Study|Death|21|||
16897335|NCT02264574|37983634|FG000|Overall Study|Withdrawal by Subject|8|||
16897336|NCT02264574|37983635|FG001|Overall Study|Withdrawal by Subject|6|||
16897337|NCT02264574|37983634|FG000|Overall Study|Other, Not Specified|0|||
16897338|NCT02264574|37983635|FG001|Overall Study|Other, Not Specified|3|||
16897339|NCT01641900|37983675|FG000|Overall Study|Withdrawal by Subject|2|||
17004221|NCT00902486|38147943|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
17004222|NCT00902486|38147944|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
17004223|NCT00902486|38147939|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
17004224|NCT00902486|38147940|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
17004225|NCT00902486|38147941|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
17004226|NCT00902486|38147942|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
17004227|NCT00902486|38147943|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
17004228|NCT00902486|38147944|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
17192362|NCT02653664|38345571|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
16786136|NCT02001064|37726486|FG001|Overall Study|Withdrawal by Subject|1|||
16786137|NCT02000752|37726494|FG000|Overall Study|Dystocic delivery|19|||
17192363|NCT02653664|38345569|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
16897340|NCT01641900|37983676|FG001|Overall Study|Withdrawal by Subject|2|||
16897341|NCT01640808|37983749|FG000|Overall Study|Unable to continue dynamic CT|14|||
16897342|NCT01640808|37983750|FG001|Overall Study|Unable to continue dynamic CT|4|||
16897343|NCT01640808|37983749|FG000|Overall Study|Withdrawal by Subject|12|||
16897344|NCT01640808|37983750|FG001|Overall Study|Withdrawal by Subject|4|||
16897345|NCT01640808|37983749|FG000|Overall Study|Lost to Follow-up|4|||
16897346|NCT01640808|37983750|FG001|Overall Study|Lost to Follow-up|0|||
16897347|NCT01640808|37983749|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
16897348|NCT01640808|37983750|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
16897349|NCT01640808|37983749|FG000|Overall Study|Administration of anticancer drugs|2|||
16897350|NCT01640808|37983750|FG001|Overall Study|Administration of anticancer drugs|1|||
16897351|NCT01640808|37983749|FG000|Overall Study|Physician Decision|19|||
16897352|NCT01640808|37983750|FG001|Overall Study|Physician Decision|5|||
16897353|NCT01640808|37983749|FG000|Overall Study|Randomized but not treated|4|||
16897354|NCT01640808|37983750|FG001|Overall Study|Randomized but not treated|2|||
16897355|NCT02263326|37983771|FG000|Overall Study|Lost to Follow-up|1|||
16897356|NCT02263326|37983772|FG001|Overall Study|Lost to Follow-up|1|||
16897357|NCT02260986|37983883|FG000|Overall Study|Adverse Event|24|||
17192364|NCT02653664|38345570|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
17192365|NCT02653664|38345571|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
17192366|NCT02653664|38345569|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
17192367|NCT02653664|38345570|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
17192368|NCT02653664|38345571|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
17192369|NCT02727699|38345593|FG000|Overall Study|Adverse Event|2|||
17192370|NCT02727699|38345594|FG001|Overall Study|Adverse Event|0|||
17192371|NCT02727699|38345593|FG000|Overall Study|Withdrawal by Subject|5|||
17192372|NCT02727699|38345594|FG001|Overall Study|Withdrawal by Subject|3|||
17192373|NCT02727699|38345593|FG000|Overall Study|Protocol Violation|0|||
17192374|NCT02727699|38345594|FG001|Overall Study|Protocol Violation|1|||
17192375|NCT02727699|38345593|FG000|Overall Study|Physician Decision|0|||
17192376|NCT02727699|38345594|FG001|Overall Study|Physician Decision|1|||
17192377|NCT02727699|38345593|FG000|Overall Study|Lost to Follow-up|1|||
17192378|NCT02727699|38345594|FG001|Overall Study|Lost to Follow-up|0|||
17192379|NCT02727699|38345593|FG000|Overall Study|Sponsor Decision|1|||
17192380|NCT02727699|38345594|FG001|Overall Study|Sponsor Decision|0|||
17192381|NCT03576716|38345602|FG000|Overall Study|Withdrawal by Subject|0|||
17192382|NCT03576716|38345603|FG001|Overall Study|Withdrawal by Subject|1|||
17192383|NCT02847637|38345622|FG000|Overall Study|Withdrawal by Subject|0|||
17192384|NCT02847637|38345623|FG001|Overall Study|Withdrawal by Subject|1|||
17192385|NCT02847637|38345624|FG002|Overall Study|Withdrawal by Subject|1|||
17192386|NCT02847637|38345625|FG003|Overall Study|Withdrawal by Subject|0|||
17192387|NCT02847637|38345622|FG000|Overall Study|Lost to Follow-up|1|||
17192388|NCT02847637|38345623|FG001|Overall Study|Lost to Follow-up|1|||
17192389|NCT02847637|38345624|FG002|Overall Study|Lost to Follow-up|0|||
17192390|NCT02847637|38345625|FG003|Overall Study|Lost to Follow-up|0|||
17192391|NCT02652260|38345651|FG000|Overall Study|Pregnancy|0|||
17192392|NCT02652260|38345652|FG001|Overall Study|Pregnancy|1|||
17192393|NCT02652260|38345651|FG000|Overall Study|Withdrawal by Subject|0|||
17192394|NCT02652260|38345652|FG001|Overall Study|Withdrawal by Subject|1|||
17192395|NCT00706095|38345664|FG000|Overall Study|Progressive Disease|4|||
17192396|NCT00706095|38345665|FG001|Overall Study|Progressive Disease|5|||
17192397|NCT00706095|38345666|FG002|Overall Study|Progressive Disease|3|||
17192398|NCT00706095|38345664|FG000|Overall Study|Clinical Progression|1|||
17192399|NCT00706095|38345665|FG001|Overall Study|Clinical Progression|2|||
17192400|NCT00706095|38345666|FG002|Overall Study|Clinical Progression|2|||
17192401|NCT00706095|38345664|FG000|Overall Study|Withdrawal by Subject|1|||
17192402|NCT00706095|38345665|FG001|Overall Study|Withdrawal by Subject|0|||
17192403|NCT00706095|38345666|FG002|Overall Study|Withdrawal by Subject|0|||
17192404|NCT02837731|38345676|FG000|Allocation|Admitted to General Floor|3|||
17192405|NCT02837731|38345677|FG001|Allocation|Admitted to General Floor|4|||
16786138|NCT02000752|37726495|FG001|Overall Study|Dystocic delivery|8|||
17192406|NCT02837731|38345676|FG000|Allocation|Immediate surgery/withdrew|2|||
16786139|NCT02000752|37726494|FG000|Overall Study|Shift Changes|12|||
16786140|NCT02000752|37726495|FG001|Overall Study|Shift Changes|5|||
16786141|NCT02000440|37726501|FG000|Overall Study|Adverse Event|3|||
16897358|NCT02260986|37983884|FG001|Overall Study|Adverse Event|0|||
16897359|NCT02260986|37983885|FG002|Overall Study|Adverse Event|11|||
16897360|NCT02260986|37983883|FG000|Overall Study|Lack of Efficacy|27|||
16897361|NCT02260986|37983884|FG001|Overall Study|Lack of Efficacy|3|||
16897362|NCT02260986|37983885|FG002|Overall Study|Lack of Efficacy|0|||
16897363|NCT02260986|37983883|FG000|Overall Study|Protocol Violation|14|||
16897364|NCT02260986|37983884|FG001|Overall Study|Protocol Violation|5|||
16897365|NCT02260986|37983885|FG002|Overall Study|Protocol Violation|16|||
16897366|NCT02260986|37983883|FG000|Overall Study|Car accident|0|||
16897367|NCT02260986|37983884|FG001|Overall Study|Car accident|0|||
16897368|NCT02260986|37983885|FG002|Overall Study|Car accident|1|||
16897369|NCT02260986|37983883|FG000|Overall Study|Withdrawal by Subject|17|||
16897370|NCT02260986|37983884|FG001|Overall Study|Withdrawal by Subject|4|||
16897371|NCT02260986|37983885|FG002|Overall Study|Withdrawal by Subject|9|||
16897372|NCT02260986|37983883|FG000|Overall Study|Incorrect randomization|0|||
16897373|NCT02260986|37983884|FG001|Overall Study|Incorrect randomization|1|||
16897374|NCT02260986|37983885|FG002|Overall Study|Incorrect randomization|0|||
16897375|NCT02260986|37983883|FG000|Overall Study|Lack of investigation product supply|2|||
16897376|NCT02260986|37983884|FG001|Overall Study|Lack of investigation product supply|0|||
16897377|NCT02260986|37983885|FG002|Overall Study|Lack of investigation product supply|1|||
16897378|NCT02260986|37983883|FG000|Overall Study|Lost to Follow-up|4|||
16897379|NCT02260986|37983884|FG001|Overall Study|Lost to Follow-up|0|||
16897380|NCT02260986|37983885|FG002|Overall Study|Lost to Follow-up|3|||
16897381|NCT02260986|37983883|FG000|Overall Study|Pregnancy|2|||
16897382|NCT02260986|37983884|FG001|Overall Study|Pregnancy|0|||
16897383|NCT02260986|37983885|FG002|Overall Study|Pregnancy|0|||
16897384|NCT02259582|37983901|FG000|Overall Study|Physician Decision|0|||
16897385|NCT02259582|37983902|FG001|Overall Study|Physician Decision|1|||
16897386|NCT02259582|37983903|FG002|Overall Study|Physician Decision|0|||
16897387|NCT02259582|37983901|FG000|Overall Study|Death|0|||
16897388|NCT02259582|37983902|FG001|Overall Study|Death|0|||
16897389|NCT02259582|37983903|FG002|Overall Study|Death|1|||
16897390|NCT02259582|37983901|FG000|Overall Study|Adverse Event|1|||
16897391|NCT02259582|37983902|FG001|Overall Study|Adverse Event|0|||
16897392|NCT02259582|37983903|FG002|Overall Study|Adverse Event|1|||
16897393|NCT02259582|37983901|FG000|Overall Study|Withdrawal by Subject|0|||
16897394|NCT02259582|37983902|FG001|Overall Study|Withdrawal by Subject|0|||
16897395|NCT02259582|37983903|FG002|Overall Study|Withdrawal by Subject|1|||
16897396|NCT02259582|37983901|FG000|Overall Study|Disease progression|14|||
16897397|NCT02259582|37983902|FG001|Overall Study|Disease progression|15|||
16897398|NCT02259582|37983903|FG002|Overall Study|Disease progression|17|||
16897399|NCT02259582|37983901|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
16897400|NCT02259582|37983902|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
16897401|NCT02259582|37983903|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
16897402|NCT03238651|37983916|FG000|Overall Study|Other|0|||
16897403|NCT03238651|37983917|FG001|Overall Study|Other|0|||
16897404|NCT03238651|37983918|FG002|Overall Study|Other|0|||
16897405|NCT03238651|37983919|FG003|Overall Study|Other|0|||
16897406|NCT03238651|37983920|FG004|Overall Study|Other|1|||
16897407|NCT03238651|37983916|FG000|Overall Study|Progressive Disease|2|||
16897408|NCT03238651|37983917|FG001|Overall Study|Progressive Disease|2|||
16897409|NCT03238651|37983918|FG002|Overall Study|Progressive Disease|2|||
16897410|NCT03238651|37983919|FG003|Overall Study|Progressive Disease|2|||
16897411|NCT03238651|37983920|FG004|Overall Study|Progressive Disease|0|||
16897412|NCT03238651|37983916|FG000|Overall Study|Withdrawal by Subject|0|||
16897413|NCT03238651|37983917|FG001|Overall Study|Withdrawal by Subject|1|||
16897414|NCT03238651|37983918|FG002|Overall Study|Withdrawal by Subject|0|||
16897415|NCT03238651|37983919|FG003|Overall Study|Withdrawal by Subject|1|||
16897416|NCT03238651|37983920|FG004|Overall Study|Withdrawal by Subject|0|||
16897417|NCT03238651|37983916|FG000|Overall Study|Adverse Event|1|||
16897418|NCT03238651|37983917|FG001|Overall Study|Adverse Event|3|||
17192407|NCT02837731|38345677|FG001|Allocation|Immediate surgery/withdrew|0|||
17192408|NCT02837731|38345676|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
17192409|NCT02837731|38345677|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
17192410|NCT02837731|38345676|FG000|Allocation|Withdrawal by Subject|2|||
17192411|NCT02837731|38345677|FG001|Allocation|Withdrawal by Subject|0|||
16786142|NCT02000440|37726501|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
17192412|NCT02837731|38345676|FG000|Allocation|Device not available|1|||
17192413|NCT02837731|38345677|FG001|Allocation|Device not available|0|||
16786143|NCT02687815|37726507|FG000|Overall Study|Lost to Follow-up|2|||
16897419|NCT03238651|37983918|FG002|Overall Study|Adverse Event|2|||
16897420|NCT03238651|37983919|FG003|Overall Study|Adverse Event|0|||
16897421|NCT03238651|37983920|FG004|Overall Study|Adverse Event|0|||
17004229|NCT00902486|38147939|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
17004230|NCT00902486|38147940|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
17192414|NCT02837731|38345676|FG000|Allocation|Protocol not implemented|7|||
17004231|NCT00902486|38147941|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
17004232|NCT00902486|38147942|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
17004233|NCT00902486|38147943|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
17004234|NCT00902486|38147944|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
17004235|NCT00902486|38147939|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
17004236|NCT00902486|38147940|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
17004237|NCT00902486|38147941|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
17004238|NCT00902486|38147942|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
17004239|NCT00902486|38147943|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
17004240|NCT00902486|38147944|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
17004241|NCT00902486|38147939|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
17004242|NCT00902486|38147940|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
17004243|NCT00902486|38147941|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
17004244|NCT00902486|38147942|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
17095463|NCT00073528|38234743|FG001|Overall Study|Death|473|||
17095464|NCT00073528|38234742|FG000|Overall Study|Lost to Follow-up|52|||
17192415|NCT02837731|38345677|FG001|Allocation|Protocol not implemented|0|||
17192416|NCT02837731|38345676|FG000|Allocation|Moribund/Do not resuscitate|2|||
16897443|NCT02259348|37983947|FG000|Overall Study|Donors|6|||
16897444|NCT02259348|37983947|FG000|Overall Study|Death|4|||
16897445|NCT02259114|37984208|FG000|Overall Study|Progressive Disease|14|||
16897446|NCT02259114|37984209|FG001|Overall Study|Progressive Disease|2|||
16897447|NCT02259114|37984210|FG002|Overall Study|Progressive Disease|10|||
16897448|NCT02259114|37984211|FG003|Overall Study|Progressive Disease|2|||
16897449|NCT02259114|37984212|FG004|Overall Study|Progressive Disease|5|||
16897450|NCT02259114|37984208|FG000|Overall Study|Adverse Event|2|||
16897451|NCT02259114|37984209|FG001|Overall Study|Adverse Event|1|||
16897452|NCT02259114|37984210|FG002|Overall Study|Adverse Event|0|||
16897453|NCT02259114|37984211|FG003|Overall Study|Adverse Event|0|||
16897454|NCT02259114|37984212|FG004|Overall Study|Adverse Event|1|||
16897455|NCT02259114|37984208|FG000|Overall Study|Death|3|||
16897456|NCT02259114|37984209|FG001|Overall Study|Death|0|||
16897457|NCT02259114|37984210|FG002|Overall Study|Death|1|||
16897458|NCT02259114|37984211|FG003|Overall Study|Death|0|||
16897459|NCT02259114|37984212|FG004|Overall Study|Death|0|||
16897460|NCT02259114|37984208|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
16897461|NCT02259114|37984209|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
16897462|NCT02259114|37984210|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
16897463|NCT02259114|37984211|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
16897464|NCT02259114|37984212|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
16897465|NCT02259114|37984208|FG000|Overall Study|Withdrawal by Subject|0|||
16897466|NCT02259114|37984209|FG001|Overall Study|Withdrawal by Subject|0|||
16897467|NCT02259114|37984210|FG002|Overall Study|Withdrawal by Subject|1|||
16897468|NCT02259114|37984211|FG003|Overall Study|Withdrawal by Subject|1|||
16897469|NCT02259114|37984212|FG004|Overall Study|Withdrawal by Subject|0|||
16897470|NCT02259114|37984208|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
16897471|NCT02259114|37984209|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
17192417|NCT02837731|38345677|FG001|Allocation|Moribund/Do not resuscitate|0|||
17192418|NCT02837731|38345676|FG000|Allocation|Did not meet sepsis criteria|1|||
17192419|NCT02837731|38345677|FG001|Allocation|Did not meet sepsis criteria|2|||
17192420|NCT02837731|38345676|FG000|Allocation|Known aortic abnormalities|0|||
17192421|NCT02837731|38345677|FG001|Allocation|Known aortic abnormalities|1|||
17192422|NCT02836873|38345685|FG000|Overall Study|Protocol Violation|0|||
17192423|NCT02836873|38345686|FG001|Overall Study|Protocol Violation|1|||
17192424|NCT02836873|38345685|FG000|Overall Study|Adverse Event|1|||
17192425|NCT02836873|38345686|FG001|Overall Study|Adverse Event|4|||
17192426|NCT02836873|38345685|FG000|Overall Study|Withdrawal by Subject|2|||
17192427|NCT02836873|38345686|FG001|Overall Study|Withdrawal by Subject|2|||
17192428|NCT02836873|38345685|FG000|Overall Study|Lost to Follow-up|1|||
17192429|NCT02836873|38345686|FG001|Overall Study|Lost to Follow-up|3|||
17192430|NCT02836873|38345685|FG000|Overall Study|Physician Decision|0|||
17192431|NCT02836873|38345686|FG001|Overall Study|Physician Decision|1|||
17192432|NCT02836873|38345685|FG000|Overall Study|Other|1|||
17192433|NCT02836873|38345686|FG001|Overall Study|Other|0|||
17192434|NCT02836249|38345694|FG000|Overall Study|Randomized but Never Treated|0|||
17192435|NCT02836249|38345695|FG001|Overall Study|Randomized but Never Treated|1|||
17192436|NCT02836249|38345694|FG000|Overall Study|Pregnancy|2|||
17192437|NCT02836249|38345695|FG001|Overall Study|Pregnancy|0|||
17192438|NCT02836249|38345694|FG000|Overall Study|Withdrew Consent|0|||
16897472|NCT02259114|37984210|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
16897473|NCT02259114|37984211|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
17192439|NCT02836249|38345695|FG001|Overall Study|Withdrew Consent|1|||
17192440|NCT02836249|38345694|FG000|Overall Study|Lost to Follow-up|0|||
17192441|NCT02836249|38345695|FG001|Overall Study|Lost to Follow-up|1|||
17192442|NCT02836249|38345694|FG000|Overall Study|Still on Study|121|||
16897474|NCT02259114|37984212|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
16897475|NCT02259114|37984208|FG000|Overall Study|Not Treated|1|||
16897476|NCT02259114|37984209|FG001|Overall Study|Not Treated|0|||
16897477|NCT02259114|37984210|FG002|Overall Study|Not Treated|0|||
16897478|NCT02259114|37984211|FG003|Overall Study|Not Treated|0|||
16897479|NCT02259114|37984212|FG004|Overall Study|Not Treated|0|||
16897480|NCT03112603|37984226|FG000|End of Randomization Period|Lost to Follow-up|1|||
16897481|NCT03112603|37984227|FG001|End of Randomization Period|Lost to Follow-up|0|||
17004245|NCT00902486|38147943|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
17004246|NCT00902486|38147944|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
17004247|NCT00902486|38147939|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
17004248|NCT00902486|38147940|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
17004249|NCT00902486|38147941|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
17004250|NCT00902486|38147942|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
16897482|NCT03112603|37984228|FG002|End of Randomization Period|Lost to Follow-up|0|||
16897483|NCT03112603|37984226|FG000|End of Randomization Period|Subject/Guardian Decision|4|||
16897484|NCT03112603|37984227|FG001|End of Randomization Period|Subject/Guardian Decision|11|||
16897485|NCT03112603|37984228|FG002|End of Randomization Period|Subject/Guardian Decision|0|||
16897486|NCT03112603|37984226|FG000|End of Randomization Period|Physician Decision|4|||
16897487|NCT03112603|37984227|FG001|End of Randomization Period|Physician Decision|14|||
17004251|NCT00902486|38147943|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
17004252|NCT00902486|38147944|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
17004253|NCT00902486|38147939|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
17004254|NCT00902486|38147940|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
17004255|NCT00902486|38147941|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
17004256|NCT00902486|38147942|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
17004257|NCT00902486|38147943|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
17004258|NCT00902486|38147944|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
17004259|NCT00902486|38147939|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
17004260|NCT00902486|38147940|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
17004261|NCT00902486|38147941|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
17004262|NCT00902486|38147942|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
17004263|NCT00902486|38147943|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
17004264|NCT00902486|38147944|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
17004265|NCT00902486|38147939|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
17004266|NCT00902486|38147940|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
17004267|NCT00902486|38147941|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
17004268|NCT00902486|38147942|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
17004269|NCT00902486|38147943|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
17004270|NCT00902486|38147944|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
17004271|NCT00902486|38147939|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
17004272|NCT00902486|38147940|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
17004273|NCT00902486|38147941|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
17004274|NCT00902486|38147942|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
17004275|NCT00902486|38147943|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
17004276|NCT00902486|38147944|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
17004277|NCT00902486|38147939|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
17004278|NCT00902486|38147940|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
17095465|NCT00073528|38234743|FG001|Overall Study|Lost to Follow-up|45|||
17192443|NCT02836249|38345695|FG001|Overall Study|Still on Study|55|||
16897488|NCT03112603|37984228|FG002|End of Randomization Period|Physician Decision|0|||
16897489|NCT03112603|37984226|FG000|End of Randomization Period|Failure to meet protocol continuation criteria|4|||
16897490|NCT03112603|37984227|FG001|End of Randomization Period|Failure to meet protocol continuation criteria|5|||
16897491|NCT03112603|37984228|FG002|End of Randomization Period|Failure to meet protocol continuation criteria|0|||
16897492|NCT03112603|37984226|FG000|End of Randomization Period|Death|8|||
16897493|NCT03112603|37984227|FG001|End of Randomization Period|Death|7|||
16897494|NCT03112603|37984228|FG002|End of Randomization Period|Death|0|||
16897495|NCT03112603|37984226|FG000|End of Randomization Period|Disease Relapse|9|||
16897496|NCT03112603|37984227|FG001|End of Randomization Period|Disease Relapse|7|||
16897497|NCT03112603|37984228|FG002|End of Randomization Period|Disease Relapse|0|||
16897498|NCT03112603|37984226|FG000|End of Randomization Period|Lack of Efficacy|24|||
16897499|NCT03112603|37984227|FG001|End of Randomization Period|Lack of Efficacy|70|||
16897500|NCT03112603|37984228|FG002|End of Randomization Period|Lack of Efficacy|0|||
16897501|NCT03112603|37984226|FG000|End of Randomization Period|Adverse Event|28|||
16897502|NCT03112603|37984227|FG001|End of Randomization Period|Adverse Event|8|||
16897503|NCT03112603|37984228|FG002|End of Randomization Period|Adverse Event|0|||
16897504|NCT03112603|37984226|FG000|End of Randomization Period|Ongoing Treatment|83|||
16897505|NCT03112603|37984227|FG001|End of Randomization Period|Ongoing Treatment|42|||
16897506|NCT03112603|37984228|FG002|End of Randomization Period|Ongoing Treatment|0|||
16897507|NCT03112603|37984226|FG000|End of Cross Over Period|Death|0|||
16897508|NCT03112603|37984227|FG001|End of Cross Over Period|Death|0|||
16897509|NCT03112603|37984228|FG002|End of Cross Over Period|Death|1|||
16897510|NCT03112603|37984226|FG000|End of Cross Over Period|Subject/Guardian Decision|0|||
16897511|NCT03112603|37984227|FG001|End of Cross Over Period|Subject/Guardian Decision|0|||
16897512|NCT03112603|37984228|FG002|End of Cross Over Period|Subject/Guardian Decision|3|||
16897513|NCT03112603|37984226|FG000|End of Cross Over Period|Physician Decision|0|||
16897514|NCT03112603|37984227|FG001|End of Cross Over Period|Physician Decision|0|||
16897515|NCT03112603|37984228|FG002|End of Cross Over Period|Physician Decision|3|||
16897516|NCT03112603|37984226|FG000|End of Cross Over Period|Lack of Efficacy|0|||
16897517|NCT03112603|37984227|FG001|End of Cross Over Period|Lack of Efficacy|0|||
16897518|NCT03112603|37984228|FG002|End of Cross Over Period|Lack of Efficacy|4|||
16897519|NCT03112603|37984226|FG000|End of Cross Over Period|Adverse Event|0|||
16897520|NCT03112603|37984227|FG001|End of Cross Over Period|Adverse Event|0|||
16897521|NCT03112603|37984228|FG002|End of Cross Over Period|Adverse Event|4|||
16897522|NCT03112603|37984226|FG000|End of Cross Over Period|Treatment Ongoing|0|||
16897523|NCT03112603|37984227|FG001|End of Cross Over Period|Treatment Ongoing|0|||
16897524|NCT03112603|37984228|FG002|End of Cross Over Period|Treatment Ongoing|46|||
16897525|NCT02258334|37984277|FG000|Overall Study|Adverse Event|1|||
16897526|NCT02258334|37984278|FG001|Overall Study|Adverse Event|0|||
16897527|NCT02258334|37984279|FG002|Overall Study|Adverse Event|0|||
16897528|NCT02258334|37984280|FG003|Overall Study|Adverse Event|0|||
16897529|NCT04960202|37984317|FG000|Overall Study|Other|12|||
16897530|NCT04960202|37984318|FG001|Overall Study|Other|10|||
16897531|NCT04960202|37984317|FG000|Overall Study|Withdrawal by Subject|43|||
16897532|NCT04960202|37984318|FG001|Overall Study|Withdrawal by Subject|45|||
16897533|NCT04960202|37984317|FG000|Overall Study|Lost to Follow-up|20|||
16897534|NCT04960202|37984318|FG001|Overall Study|Lost to Follow-up|17|||
16897535|NCT04960202|37984317|FG000|Overall Study|Death|0|||
16897536|NCT04960202|37984318|FG001|Overall Study|Death|15|||
16897537|NCT02257632|37984388|FG000|Overall Study|Withdrawal by Subject|0|||
17004279|NCT00902486|38147941|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
17004280|NCT00902486|38147942|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
17004281|NCT00902486|38147943|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
17004282|NCT00902486|38147944|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
17004283|NCT00836745|38147974|FG000|Overall Study|Death|2|||
17004284|NCT00836745|38147974|FG000|Overall Study|Lost to Follow-up|10|||
17004285|NCT00836745|38147974|FG000|Overall Study|Adverse Event|3|||
17004286|NCT00836745|38147974|FG000|Overall Study|Objective progression or relapse|4|||
17004287|NCT00836745|38147974|FG000|Overall Study|Other|2|||
17004288|NCT00891618|38147978|FG000|Overall Study|Withdrawal by Subject|1|||
17004289|NCT00836589|38147982|FG000|Overall Study|Lost to Follow-up|246|||
17004290|NCT00836589|38147982|FG000|Overall Study|Death|429|||
17004291|NCT00836589|38147982|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
17004292|NCT00574795|38147994|FG000|Infant Series|Withdrawal by Subject|2|||
17004293|NCT00574795|38147994|FG000|Infant Series|Protocol Violation|2|||
17004294|NCT00574795|38147994|FG000|Infant Series|Adverse Event|1|||
17004295|NCT00574795|38147994|FG000|After Infant Series|Withdrawal by Subject|1|||
17004296|NCT00574795|38147994|FG000|After Infant Series|Adverse Event|2|||
17004297|NCT00574795|38147994|FG000|Toddler Dose|Withdrawal by Subject|1|||
17004298|NCT02297516|38148011|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
17004299|NCT02297516|38148012|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
17004300|NCT02297516|38148011|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
17004301|NCT02297516|38148012|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
17004302|NCT02297516|38148011|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
17004303|NCT02297516|38148012|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
17004304|NCT00836277|38148025|FG000|Overall Study|Not evaluable for response|6|||
17004305|NCT00835731|38148031|FG000|Overall Study|Withdrawal by Subject|1|||
17004306|NCT00835731|38148032|FG001|Overall Study|Withdrawal by Subject|0|||
17004307|NCT00835731|38148031|FG000|Overall Study|Physician Decision|1|||
17004308|NCT00835731|38148032|FG001|Overall Study|Physician Decision|1|||
17004309|NCT00835341|38148040|FG000|Overall Study|Lost to Follow-up|3|||
17004310|NCT00835341|38148041|FG001|Overall Study|Lost to Follow-up|12|||
17004311|NCT00574249|38148049|FG000|Overall Study|Adverse Event|6|||
17004312|NCT00574249|38148050|FG001|Overall Study|Adverse Event|18|||
17004313|NCT00574249|38148049|FG000|Overall Study|Lack of Efficacy|5|||
16897538|NCT02257632|37984389|FG001|Overall Study|Withdrawal by Subject|1|||
16897539|NCT02257632|37984388|FG000|Overall Study|Adverse Event|1|||
16897540|NCT02257632|37984389|FG001|Overall Study|Adverse Event|2|||
16897541|NCT01642914|37984436|FG000|Overall Study|Adverse Event|11|||
16897542|NCT01642914|37984437|FG001|Overall Study|Adverse Event|7|||
16897543|NCT01642914|37984438|FG002|Overall Study|Adverse Event|15|||
16897544|NCT01642914|37984436|FG000|Overall Study|Lack of Efficacy|9|||
16897545|NCT01642914|37984437|FG001|Overall Study|Lack of Efficacy|4|||
16897546|NCT01642914|37984438|FG002|Overall Study|Lack of Efficacy|2|||
16897547|NCT01642914|37984436|FG000|Overall Study|Protocol Violation|15|||
16897548|NCT01642914|37984437|FG001|Overall Study|Protocol Violation|13|||
16897549|NCT01642914|37984438|FG002|Overall Study|Protocol Violation|6|||
16897550|NCT01642914|37984436|FG000|Overall Study|Withdrawal by Subject|5|||
16897551|NCT01642914|37984437|FG001|Overall Study|Withdrawal by Subject|5|||
16897552|NCT01642914|37984438|FG002|Overall Study|Withdrawal by Subject|10|||
16897553|NCT01642914|37984436|FG000|Overall Study|Lost to Follow-up|5|||
16897554|NCT01642914|37984437|FG001|Overall Study|Lost to Follow-up|3|||
16897555|NCT01642914|37984438|FG002|Overall Study|Lost to Follow-up|7|||
16897556|NCT01642914|37984436|FG000|Overall Study|Other Reason|1|||
16897557|NCT01642914|37984437|FG001|Overall Study|Other Reason|0|||
16897558|NCT01642914|37984438|FG002|Overall Study|Other Reason|0|||
16897559|NCT01642602|37984497|FG000|Overall Study|Adverse Event|2|||
16897560|NCT02256540|37984550|FG000|Overall Study|Withdrawal by Subject|0|||
16897561|NCT02256540|37984551|FG001|Overall Study|Withdrawal by Subject|1|||
16897562|NCT02256540|37984552|FG002|Overall Study|Withdrawal by Subject|1|||
16897563|NCT02256540|37984550|FG000|Overall Study|Back pain preventing exercise|0|||
16897564|NCT02256540|37984551|FG001|Overall Study|Back pain preventing exercise|0|||
16897565|NCT02256540|37984552|FG002|Overall Study|Back pain preventing exercise|1|||
17004314|NCT00574249|38148050|FG001|Overall Study|Lack of Efficacy|3|||
17004315|NCT00574249|38148049|FG000|Overall Study|Lost to Follow-up|4|||
17004316|NCT00574249|38148050|FG001|Overall Study|Lost to Follow-up|3|||
17004317|NCT00574249|38148049|FG000|Overall Study|Protocol Violation|5|||
17004318|NCT00574249|38148050|FG001|Overall Study|Protocol Violation|2|||
17004319|NCT00574249|38148049|FG000|Overall Study|History of carcinoma|1|||
17004320|NCT00574249|38148050|FG001|Overall Study|History of carcinoma|0|||
17004321|NCT00574249|38148049|FG000|Overall Study|Withdrawal by Subject|3|||
17004322|NCT00574249|38148050|FG001|Overall Study|Withdrawal by Subject|0|||
17004323|NCT00574249|38148049|FG000|Overall Study|Physician Decision|1|||
17004324|NCT00574249|38148050|FG001|Overall Study|Physician Decision|0|||
17004325|NCT00574249|38148049|FG000|Overall Study|Pregnancy|1|||
17004326|NCT00574249|38148050|FG001|Overall Study|Pregnancy|0|||
17004327|NCT00574249|38148049|FG000|Overall Study|Excluded by company|0|||
17004328|NCT00574249|38148050|FG001|Overall Study|Excluded by company|1|||
17004329|NCT00574249|38148049|FG000|Overall Study|PPD test taken twice|0|||
17004330|NCT00574249|38148050|FG001|Overall Study|PPD test taken twice|1|||
17004331|NCT00891228|38148059|FG000|Overall Study|Adverse Event|0|||
17004332|NCT00891228|38148060|FG001|Overall Study|Adverse Event|2|||
17004333|NCT00891228|38148061|FG002|Overall Study|Adverse Event|3|||
17004334|NCT00891228|38148059|FG000|Overall Study|Withdrawal by Subject|2|||
17004335|NCT00891228|38148060|FG001|Overall Study|Withdrawal by Subject|4|||
17004336|NCT00891228|38148061|FG002|Overall Study|Withdrawal by Subject|5|||
17004337|NCT00891228|38148059|FG000|Overall Study|Protocol Violation|3|||
16897566|NCT01640184|37984576|FG000|Overall Study|Death|1|||
16897567|NCT01640184|37984577|FG001|Overall Study|Death|0|||
16897568|NCT01640184|37984578|FG002|Overall Study|Death|0|||
16897569|NCT01640184|37984576|FG000|Overall Study|Lost to Follow-up|4|||
16897570|NCT01640184|37984577|FG001|Overall Study|Lost to Follow-up|1|||
16897571|NCT01640184|37984578|FG002|Overall Study|Lost to Follow-up|0|||
16897572|NCT01640184|37984576|FG000|Overall Study|Physician Decision|3|||
16897573|NCT01640184|37984577|FG001|Overall Study|Physician Decision|0|||
16897574|NCT01640184|37984578|FG002|Overall Study|Physician Decision|0|||
16897575|NCT01640184|37984576|FG000|Overall Study|Withdrawal by Subject|0|||
16897576|NCT01640184|37984577|FG001|Overall Study|Withdrawal by Subject|1|||
16897577|NCT01640184|37984578|FG002|Overall Study|Withdrawal by Subject|1|||
16897578|NCT01640184|37984576|FG000|Overall Study|Protocol Violation|0|||
16897579|NCT01640184|37984577|FG001|Overall Study|Protocol Violation|0|||
16897580|NCT01640184|37984578|FG002|Overall Study|Protocol Violation|1|||
16897581|NCT02256384|37984598|FG000|Overall Study|Withdrawal by Subject|12|||
17004338|NCT00891228|38148060|FG001|Overall Study|Protocol Violation|1|||
17004339|NCT00891228|38148061|FG002|Overall Study|Protocol Violation|2|||
17004340|NCT00891228|38148059|FG000|Overall Study|Physician Decision|2|||
17004341|NCT00891228|38148060|FG001|Overall Study|Physician Decision|1|||
16897582|NCT02256384|37984598|FG000|Overall Study|Equipment not capturing data|2|||
16897583|NCT02255760|37984641|FG000|Overall Study|Lost to Follow-up|0|||
16897584|NCT02255760|37984642|FG001|Overall Study|Lost to Follow-up|1|||
16897585|NCT02255760|37984643|FG002|Overall Study|Lost to Follow-up|0|||
16897586|NCT02255760|37984644|FG003|Overall Study|Lost to Follow-up|0|||
16897587|NCT02255760|37984645|FG004|Overall Study|Lost to Follow-up|0|||
16897588|NCT01641822|37984741|FG000|Run-in Phase|Noncompliance with study drug|1|||
16897589|NCT01641822|37984742|FG001|Run-in Phase|Noncompliance with study drug|0|||
17004342|NCT00891228|38148061|FG002|Overall Study|Physician Decision|0|||
16897590|NCT01641822|37984743|FG002|Run-in Phase|Noncompliance with study drug|0|||
16897591|NCT01641822|37984741|FG000|Run-in Phase|Adverse Event|3|||
17004343|NCT00891228|38148059|FG000|Overall Study|Lost to Follow-up|4|||
17004344|NCT00891228|38148060|FG001|Overall Study|Lost to Follow-up|4|||
16897592|NCT01641822|37984742|FG001|Run-in Phase|Adverse Event|0|||
17004345|NCT00891228|38148061|FG002|Overall Study|Lost to Follow-up|5|||
17004346|NCT00891228|38148059|FG000|Overall Study|Pregnancy|0|||
16897593|NCT01641822|37984743|FG002|Run-in Phase|Adverse Event|0|||
16897594|NCT01641822|37984741|FG000|Run-in Phase|Withdrew consent|1|||
16897595|NCT01641822|37984742|FG001|Run-in Phase|Withdrew consent|0|||
16897596|NCT01641822|37984743|FG002|Run-in Phase|Withdrew consent|0|||
16897597|NCT01641822|37984741|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
16897598|NCT01641822|37984742|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
16897599|NCT01641822|37984743|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
16897600|NCT01641822|37984741|FG000|Comparative Phase|Noncompliance with study drug|0|||
16897601|NCT01641822|37984742|FG001|Comparative Phase|Noncompliance with study drug|1|||
16897602|NCT01641822|37984743|FG002|Comparative Phase|Noncompliance with study drug|0|||
16897603|NCT01641822|37984741|FG000|Comparative Phase|Investigator's discretion|0|||
16897604|NCT01641822|37984742|FG001|Comparative Phase|Investigator's discretion|0|||
16897605|NCT01641822|37984743|FG002|Comparative Phase|Investigator's discretion|1|||
16897606|NCT01641822|37984741|FG000|Comparative Phase|Pregnancy|0|||
16897607|NCT01641822|37984742|FG001|Comparative Phase|Pregnancy|0|||
16897608|NCT01641822|37984743|FG002|Comparative Phase|Pregnancy|1|||
16897609|NCT01641822|37984741|FG000|Comparative Phase|Adverse event, serious fatal|0|||
16897610|NCT01641822|37984742|FG001|Comparative Phase|Adverse event, serious fatal|1|||
16897611|NCT01641822|37984743|FG002|Comparative Phase|Adverse event, serious fatal|0|||
16897612|NCT01641822|37984741|FG000|Comparative Phase|Withdrew consent|0|||
16897613|NCT01641822|37984742|FG001|Comparative Phase|Withdrew consent|3|||
16897614|NCT01641822|37984743|FG002|Comparative Phase|Withdrew consent|7|||
16897615|NCT01641822|37984741|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
16897616|NCT01641822|37984742|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
16897617|NCT01641822|37984743|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
16897618|NCT01641198|37984823|FG000|After 12 Months of Function|Lost to Follow-up|3|||
16897619|NCT01641198|37984824|FG001|After 12 Months of Function|Lost to Follow-up|2|||
16897620|NCT01641198|37984825|FG002|After 12 Months of Function|Lost to Follow-up|2|||
16897621|NCT01641198|37984823|FG000|After 12 Months of Function|Protocol Violation|1|||
16897622|NCT01641198|37984824|FG001|After 12 Months of Function|Protocol Violation|0|||
16897623|NCT01641198|37984825|FG002|After 12 Months of Function|Protocol Violation|0|||
16897624|NCT01641198|37984823|FG000|After 12 Months of Function|Adverse Event|0|||
16897625|NCT01641198|37984824|FG001|After 12 Months of Function|Adverse Event|1|||
16897626|NCT01641198|37984825|FG002|After 12 Months of Function|Adverse Event|0|||
16897627|NCT01641198|37984823|FG000|After 24 Months of Function|Lost to Follow-up|4|||
16897628|NCT01641198|37984824|FG001|After 24 Months of Function|Lost to Follow-up|9|||
16897629|NCT01641198|37984825|FG002|After 24 Months of Function|Lost to Follow-up|6|||
16897630|NCT01641198|37984823|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
16897631|NCT01641198|37984824|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
16897632|NCT01641198|37984825|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
16897633|NCT01641198|37984823|FG000|At 15-20 Years of Function|Death|1|||
16897634|NCT01641198|37984824|FG001|At 15-20 Years of Function|Death|0|||
16897635|NCT01641198|37984825|FG002|At 15-20 Years of Function|Death|1|||
16897636|NCT01639560|37984910|FG000|Overall Study|Withdrawal by Subject|9|||
16897637|NCT01639560|37984911|FG001|Overall Study|Withdrawal by Subject|14|||
16897638|NCT01639560|37984910|FG000|Overall Study|Lack of Efficacy|1|||
16897639|NCT01639560|37984911|FG001|Overall Study|Lack of Efficacy|2|||
16897640|NCT01639560|37984910|FG000|Overall Study|Lost to Follow-up|9|||
16897641|NCT01639560|37984911|FG001|Overall Study|Lost to Follow-up|11|||
16897642|NCT01639560|37984910|FG000|Overall Study|Adverse Event|0|||
16897643|NCT01639560|37984911|FG001|Overall Study|Adverse Event|2|||
16897644|NCT01601652|37984933|FG000|Overall Study|Death|1|||
16897645|NCT03952130|37984971|FG000|Overall Study|Adverse Event|0|||
16897646|NCT03952130|37984972|FG001|Overall Study|Adverse Event|1|||
16897647|NCT03952130|37984971|FG000|Overall Study|Lost to Follow-up|1|||
16897648|NCT03952130|37984972|FG001|Overall Study|Lost to Follow-up|0|||
16897649|NCT03952130|37984971|FG000|Overall Study|Withdrawal by Subject|1|||
16897650|NCT03952130|37984972|FG001|Overall Study|Withdrawal by Subject|5|||
16897651|NCT01640964|37985016|FG000|Overall Study|Lost to Follow-up|0|||
16897652|NCT01640964|37985017|FG001|Overall Study|Lost to Follow-up|0|||
16897653|NCT01640964|37985018|FG002|Overall Study|Lost to Follow-up|1|||
16897654|NCT01640964|37985016|FG000|Overall Study|Protocol Deviation|1|||
16897655|NCT01640964|37985017|FG001|Overall Study|Protocol Deviation|1|||
16897656|NCT01640964|37985018|FG002|Overall Study|Protocol Deviation|2|||
16897657|NCT01638390|37985147|FG000|Overall Study|screening failures|21|||
16897658|NCT01600716|37985178|FG000|Overall Study|Other Reasons|3|||
16897659|NCT01600716|37985179|FG001|Overall Study|Other Reasons|1|||
16897660|NCT01600716|37985178|FG000|Overall Study|Personal Reasons|0|||
16897661|NCT01600716|37985179|FG001|Overall Study|Personal Reasons|2|||
16897662|NCT01600716|37985178|FG000|Overall Study|Lost to Follow-up|0|||
16897663|NCT01600716|37985179|FG001|Overall Study|Lost to Follow-up|2|||
17192444|NCT01342081|38345713|FG000|Overall Study|Did not receive allocated intervention|0|||
16897664|NCT01600716|37985178|FG000|Overall Study|Pregnancy|1|||
16897665|NCT01600716|37985179|FG001|Overall Study|Pregnancy|0|||
16897666|NCT01600716|37985178|FG000|Overall Study|Lack of Efficacy|2|||
16897667|NCT01600716|37985179|FG001|Overall Study|Lack of Efficacy|1|||
16897668|NCT01600716|37985178|FG000|Overall Study|Adverse Event|1|||
16897669|NCT01600716|37985179|FG001|Overall Study|Adverse Event|1|||
16897670|NCT01600326|37985295|FG000|Overall Study|Lost to Follow-up|1|||
16897671|NCT01600326|37985296|FG001|Overall Study|Lost to Follow-up|1|||
16897672|NCT01637142|37985432|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
16897673|NCT01636986|37985450|FG000|Overall Study|Withdrawal by Subject|0|||
16897674|NCT01636986|37985451|FG001|Overall Study|Withdrawal by Subject|1|||
16897675|NCT01636986|37985450|FG000|Overall Study|Corneal Staining|0|||
16897676|NCT01636986|37985451|FG001|Overall Study|Corneal Staining|1|||
16897677|NCT01601496|37985547|FG000|Overall Study|Physician Decision|1|||
16897678|NCT01601496|37985547|FG000|Overall Study|Withdrawal by Subject|1|||
16897679|NCT01601496|37985547|FG000|Overall Study|Lost to Follow-up|6|||
16897680|NCT01601496|37985547|FG000|Overall Study|Death|4|||
16897681|NCT01601496|37985547|FG000|Overall Study|Other: patient refusal to continue|3|||
16897682|NCT03211832|37985553|FG000|Overall Study|No longer with agency|32|||
16897683|NCT03211832|37985554|FG001|Overall Study|No longer with agency|49|||
16897684|NCT03211832|37985555|FG002|Overall Study|No longer with agency|30|||
16897685|NCT03211832|37985553|FG000|Overall Study|Declined survey|3|||
16897686|NCT03211832|37985554|FG001|Overall Study|Declined survey|3|||
16897687|NCT03211832|37985555|FG002|Overall Study|Declined survey|2|||
16897688|NCT03211832|37985553|FG000|Overall Study|Not available during data collection|1|||
16897689|NCT03211832|37985554|FG001|Overall Study|Not available during data collection|0|||
16897690|NCT03211832|37985555|FG002|Overall Study|Not available during data collection|2|||
16897691|NCT04887948|37985564|FG000|Overall Study|Death|1|||
16897692|NCT04887948|37985565|FG001|Overall Study|Death|0|||
16897693|NCT04887948|37985566|FG002|Overall Study|Death|0|||
16897694|NCT04887948|37985564|FG000|Overall Study|Lost to Follow-up|1|||
16897695|NCT04887948|37985565|FG001|Overall Study|Lost to Follow-up|0|||
16897696|NCT04887948|37985566|FG002|Overall Study|Lost to Follow-up|3|||
16897697|NCT04887948|37985564|FG000|Overall Study|Physician Decision|0|||
16897698|NCT04887948|37985565|FG001|Overall Study|Physician Decision|4|||
16897699|NCT04887948|37985566|FG002|Overall Study|Physician Decision|1|||
16897700|NCT04887948|37985564|FG000|Overall Study|Protocol Violation|1|||
16897701|NCT04887948|37985565|FG001|Overall Study|Protocol Violation|1|||
16897702|NCT04887948|37985566|FG002|Overall Study|Protocol Violation|0|||
16897703|NCT04887948|37985564|FG000|Overall Study|Withdrawal by Subject|0|||
16897704|NCT04887948|37985565|FG001|Overall Study|Withdrawal by Subject|6|||
16897705|NCT04887948|37985566|FG002|Overall Study|Withdrawal by Subject|1|||
16897706|NCT04887948|37985564|FG000|Overall Study|No longer met eligibility criteria|1|||
16897707|NCT04887948|37985565|FG001|Overall Study|No longer met eligibility criteria|2|||
16897708|NCT04887948|37985566|FG002|Overall Study|No longer met eligibility criteria|1|||
16897709|NCT04887948|37985564|FG000|Overall Study|Other|2|||
16897710|NCT04887948|37985565|FG001|Overall Study|Other|1|||
16897711|NCT04887948|37985566|FG002|Overall Study|Other|1|||
17004347|NCT00891228|38148060|FG001|Overall Study|Pregnancy|1|||
17004348|NCT00891228|38148061|FG002|Overall Study|Pregnancy|0|||
17004349|NCT00896168|38148071|FG000|Overall Study|Adverse Event|4|||
17004350|NCT00896168|38148072|FG001|Overall Study|Adverse Event|7|||
17004351|NCT00896168|38148071|FG000|Overall Study|Treatment failure|8|||
17004352|NCT00896168|38148072|FG001|Overall Study|Treatment failure|10|||
17004353|NCT00896168|38148071|FG000|Overall Study|Lost to Follow-up|1|||
16897712|NCT01638000|37985721|FG000|Overall Study|Randomized but Never Received Drug|7|||
16897713|NCT01638000|37985722|FG001|Overall Study|Randomized but Never Received Drug|10|||
16897714|NCT01638000|37985721|FG000|Overall Study|Adverse Event|14|||
16897715|NCT01638000|37985722|FG001|Overall Study|Adverse Event|16|||
16897716|NCT01638000|37985721|FG000|Overall Study|Lack of Efficacy|5|||
16897717|NCT01638000|37985722|FG001|Overall Study|Lack of Efficacy|6|||
16897718|NCT01638000|37985721|FG000|Overall Study|Protocol Violation|11|||
16897719|NCT01638000|37985722|FG001|Overall Study|Protocol Violation|13|||
16897720|NCT01638000|37985721|FG000|Overall Study|Withdrawal by Subject|21|||
16897721|NCT01638000|37985722|FG001|Overall Study|Withdrawal by Subject|24|||
16897722|NCT01638000|37985721|FG000|Overall Study|Miscellaneous|2|||
16897723|NCT01638000|37985722|FG001|Overall Study|Miscellaneous|2|||
16897724|NCT02968849|37985781|FG000|Overall Study|Death|8|||
16897725|NCT02968849|37985782|FG001|Overall Study|Death|10|||
16897726|NCT02968849|37985781|FG000|Overall Study|Lost to Follow-up|31|||
16897727|NCT02968849|37985782|FG001|Overall Study|Lost to Follow-up|29|||
16897728|NCT02968849|37985781|FG000|Overall Study|Withdrawal by Subject|73|||
16897729|NCT02968849|37985782|FG001|Overall Study|Withdrawal by Subject|64|||
16897730|NCT02968849|37985781|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
16897731|NCT02968849|37985782|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
16897732|NCT02968849|37985781|FG000|Overall Study|Physician Decision|6|||
16897733|NCT02968849|37985782|FG001|Overall Study|Physician Decision|9|||
16897734|NCT02968849|37985781|FG000|Overall Study|Other|16|||
16897735|NCT02968849|37985782|FG001|Overall Study|Other|10|||
16897736|NCT01637922|37985793|FG000|Overall Study|Adverse Event|0|||
17004354|NCT00896168|38148072|FG001|Overall Study|Lost to Follow-up|1|||
16897737|NCT01637922|37985794|FG001|Overall Study|Adverse Event|1|||
16897738|NCT01637922|37985793|FG000|Overall Study|Protocol Violation|0|||
16897739|NCT01637922|37985794|FG001|Overall Study|Protocol Violation|1|||
16897740|NCT01637922|37985793|FG000|Overall Study|Withdrawal by Subject|0|||
16897741|NCT01637922|37985794|FG001|Overall Study|Withdrawal by Subject|3|||
16897742|NCT01637922|37985793|FG000|Overall Study|Lost to Follow-up|2|||
16897743|NCT01637922|37985794|FG001|Overall Study|Lost to Follow-up|0|||
16897744|NCT02306161|37985923|FG000|Overall Study|Death|1|||
16897745|NCT02306161|37985924|FG001|Overall Study|Death|3|||
16897746|NCT02306161|37985923|FG000|Overall Study|Lack of Efficacy|20|||
16897747|NCT02306161|37985924|FG001|Overall Study|Lack of Efficacy|43|||
16897748|NCT02306161|37985923|FG000|Overall Study|Physician Decision|30|||
16897749|NCT02306161|37985924|FG001|Overall Study|Physician Decision|18|||
16897750|NCT02306161|37985923|FG000|Overall Study|Withdrawal by Subject|4|||
16897751|NCT02306161|37985924|FG001|Overall Study|Withdrawal by Subject|0|||
16897752|NCT02306161|37985923|FG000|Overall Study|Ineligible|9|||
16897753|NCT02306161|37985924|FG001|Overall Study|Ineligible|5|||
16897754|NCT01920932|37985952|FG000|Overall Study|Death|1|||
16897755|NCT01920932|37985952|FG000|Overall Study|Withdrawal of consent|1|||
16897756|NCT03496662|37986029|FG000|Overall Study|Adverse Event|1|||
16897757|NCT03496662|37986030|FG001|Overall Study|Adverse Event|0|||
16897758|NCT03496662|37986031|FG002|Overall Study|Adverse Event|1|||
16897759|NCT03496662|37986029|FG000|Overall Study|Physician Decision|1|||
16897760|NCT03496662|37986030|FG001|Overall Study|Physician Decision|0|||
16897761|NCT03496662|37986031|FG002|Overall Study|Physician Decision|3|||
16897762|NCT03496662|37986029|FG000|Overall Study|Withdrawal by Subject|0|||
16897763|NCT03496662|37986030|FG001|Overall Study|Withdrawal by Subject|0|||
16897764|NCT03496662|37986031|FG002|Overall Study|Withdrawal by Subject|2|||
16897765|NCT03496662|37986029|FG000|Overall Study|Death|0|||
16897766|NCT03496662|37986030|FG001|Overall Study|Death|0|||
16897767|NCT03496662|37986031|FG002|Overall Study|Death|2|||
16897768|NCT03496662|37986029|FG000|Overall Study|Noncompliance|0|||
16897769|NCT03496662|37986030|FG001|Overall Study|Noncompliance|0|||
16897770|NCT03496662|37986031|FG002|Overall Study|Noncompliance|1|||
16897771|NCT01638546|37986041|FG000|Overall Study|Adverse Event|1|||
16897772|NCT01638546|37986042|FG001|Overall Study|Adverse Event|3|||
16897773|NCT01000051|37986052|FG000|Overall Study|Withdrawal by Subject|1|||
16897774|NCT01000051|37986053|FG001|Overall Study|Withdrawal by Subject|1|||
16897775|NCT01000051|37986052|FG000|Overall Study|Disease Progression|1|||
16897776|NCT01000051|37986053|FG001|Overall Study|Disease Progression|0|||
16897777|NCT01000051|37986052|FG000|Overall Study|Serious noncompliance|1|||
16897778|NCT01000051|37986053|FG001|Overall Study|Serious noncompliance|0|||
16897779|NCT01593254|37986061|FG000|Treatment Period|Treatment Failure|1|||
16897780|NCT01593254|37986062|FG001|Treatment Period|Treatment Failure|2|||
17004355|NCT00896168|38148071|FG000|Overall Study|Other|1|||
17004356|NCT00896168|38148072|FG001|Overall Study|Other|1|||
17004357|NCT00833703|38148080|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
17004358|NCT00833703|38148081|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
17004359|NCT00833547|38148089|FG000|Overall Study|Withdrawal by Subject|2|||
17004360|NCT00833547|38148090|FG001|Overall Study|Withdrawal by Subject|2|||
16897781|NCT01593254|37986061|FG000|Treatment Period|Pregnancy|0|||
16897782|NCT01593254|37986062|FG001|Treatment Period|Pregnancy|1|||
16897783|NCT01593254|37986061|FG000|Treatment Period|Poor/Non-Compliance|2|||
16897784|NCT01593254|37986062|FG001|Treatment Period|Poor/Non-Compliance|1|||
16897785|NCT01593254|37986061|FG000|Treatment Period|Maximum clinical benefit|1|||
16897786|NCT01593254|37986062|FG001|Treatment Period|Maximum clinical benefit|0|||
16897787|NCT01593254|37986061|FG000|Treatment Period|Subject withdrew consent|0|||
16897788|NCT01593254|37986062|FG001|Treatment Period|Subject withdrew consent|5|||
16897789|NCT01593254|37986061|FG000|Treatment Period|Subject Request to Discontinue|1|||
16897790|NCT01593254|37986062|FG001|Treatment Period|Subject Request to Discontinue|1|||
16897791|NCT01593254|37986061|FG000|Treatment Period|AE unrelated to Study Drug|0|||
16897792|NCT01593254|37986062|FG001|Treatment Period|AE unrelated to Study Drug|1|||
16897793|NCT01593254|37986061|FG000|Treatment Period|Death|2|||
16897794|NCT01593254|37986062|FG001|Treatment Period|Death|1|||
16897795|NCT01593254|37986061|FG000|Treatment Period|Study Drug Toxicity|3|||
16897796|NCT01593254|37986062|FG001|Treatment Period|Study Drug Toxicity|9|||
16897797|NCT01593254|37986061|FG000|Treatment Period|Disease Progression|1|||
16897798|NCT01593254|37986062|FG001|Treatment Period|Disease Progression|6|||
16897799|NCT01593254|37986061|FG000|Treatment Period|Did Not Achieve RCC|0|||
16897800|NCT01593254|37986062|FG001|Treatment Period|Did Not Achieve RCC|1|||
16897801|NCT01593254|37986061|FG000|Treatment Period|Patient Refused to Return|0|||
16897802|NCT01593254|37986062|FG001|Treatment Period|Patient Refused to Return|1|||
16897803|NCT01593254|37986061|FG000|Treatment Period|No Response|1|||
16897804|NCT01593254|37986062|FG001|Treatment Period|No Response|0|||
16897805|NCT01593254|37986061|FG000|Treatment Period|T315I MUTATION|0|||
16897806|NCT01593254|37986062|FG001|Treatment Period|T315I MUTATION|1|||
16897807|NCT01593254|37986061|FG000|Treatment Period|Investigator Decision|2|||
16897808|NCT01593254|37986062|FG001|Treatment Period|Investigator Decision|1|||
16897809|NCT01593254|37986061|FG000|Follow-Up Period|Withdrawal by Subject|0|||
16897810|NCT01593254|37986062|FG001|Follow-Up Period|Withdrawal by Subject|2|||
16897811|NCT01593254|37986061|FG000|Follow-Up Period|Non-Compliance|1|||
17004361|NCT00833469|38148096|FG000|Overall Study|Withdrawal by Subject|1|||
17004362|NCT00833469|38148096|FG000|Overall Study|Lost to Follow-up|1|||
17004363|NCT00832377|38148100|FG000|Overall Study|Protocol Violation|1|||
17004364|NCT00892008|38148104|FG000|Overall Study|Death|5|||
17004365|NCT00892008|38148104|FG000|Overall Study|Lack of Efficacy|3|||
17004366|NCT00892008|38148104|FG000|Overall Study|Lost to Follow-up|142|||
17004367|NCT00892008|38148104|FG000|Overall Study|Other|378|||
17004368|NCT00892008|38148104|FG000|Overall Study|Adverse Event|37|||
17004369|NCT00623233|38148108|FG000|Overall Study|Adverse Event|10|||
17004370|NCT00623233|38148108|FG000|Overall Study|Physician Decision|10|||
17004371|NCT00623233|38148108|FG000|Overall Study|Lost to Follow-up|1|||
17004372|NCT00623233|38148108|FG000|Overall Study|Withdrawal by Subject|3|||
17095466|NCT00073528|38234742|FG000|Overall Study|Withdrawal by Subject|50|||
17095467|NCT00073528|38234743|FG001|Overall Study|Withdrawal by Subject|45|||
17095468|NCT00073528|38234742|FG000|Overall Study|Study terminated by Sponsor|10|||
17095469|NCT00073528|38234743|FG001|Overall Study|Study terminated by Sponsor|29|||
17095470|NCT00073528|38234742|FG000|Overall Study|Other|18|||
17095471|NCT00073528|38234743|FG001|Overall Study|Other|19|||
17095472|NCT00073528|38234742|FG000|Overall Study|Other|9|||
17095473|NCT00073528|38234743|FG001|Overall Study|Other|12|||
17095474|NCT00073528|38234742|FG000|Overall Study|Protocol Violation|3|||
17095475|NCT00073528|38234743|FG001|Overall Study|Protocol Violation|5|||
17095476|NCT03801148|38234753|FG000|Period 1 (2 Days)|Adverse Event|1|||
17095477|NCT03801148|38234754|FG001|Period 1 (2 Days)|Adverse Event|1|||
17095478|NCT03801148|38234755|FG002|Period 1 (2 Days)|Adverse Event|0|||
17095479|NCT03801148|38234756|FG003|Period 1 (2 Days)|Adverse Event|0|||
17004373|NCT03369236|38148114|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
17004374|NCT03369236|38148115|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
17004375|NCT03369236|38148114|FG000|Open-label Extension Period|Lack of Efficacy|2|||
17004376|NCT03369236|38148115|FG001|Open-label Extension Period|Lack of Efficacy|1|||
17004377|NCT03369236|38148114|FG000|Open-label Extension Period|Adverse Event|0|||
17004378|NCT03369236|38148115|FG001|Open-label Extension Period|Adverse Event|1|||
17004379|NCT03369236|38148114|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
17004380|NCT03369236|38148115|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
17004381|NCT00621751|38148138|FG000|Overall Study|Adverse Event|0|||
17004382|NCT00621751|38148139|FG001|Overall Study|Adverse Event|1|||
17004383|NCT00891930|38148156|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
17004384|NCT00891930|38148156|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
17004385|NCT00891930|38148156|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
17004386|NCT00891930|38148156|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
17004387|NCT00891930|38148156|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
17004388|NCT00895622|38148167|FG000|Overall Study|Protocol Violation|5|||
17004389|NCT00895622|38148168|FG001|Overall Study|Protocol Violation|4|||
17004390|NCT00895622|38148169|FG002|Overall Study|Protocol Violation|4|||
17004391|NCT00891462|38148188|FG000|Overall Study|Withdrawal by Subject|9|||
17004392|NCT00891462|38148189|FG001|Overall Study|Withdrawal by Subject|6|||
17004393|NCT00891462|38148190|FG002|Overall Study|Withdrawal by Subject|7|||
17004394|NCT00891462|38148188|FG000|Overall Study|Adverse Event|7|||
17004395|NCT00891462|38148189|FG001|Overall Study|Adverse Event|8|||
16897812|NCT01593254|37986062|FG001|Follow-Up Period|Non-Compliance|0|||
16897813|NCT01593254|37986061|FG000|Follow-Up Period|Death|2|||
16897814|NCT01593254|37986062|FG001|Follow-Up Period|Death|2|||
16897815|NCT01593254|37986061|FG000|Follow-Up Period|Subject request to Discontinue|0|||
16897816|NCT01593254|37986062|FG001|Follow-Up Period|Subject request to Discontinue|1|||
16897817|NCT01593254|37986061|FG000|Follow-Up Period|Pregnancy|0|||
16897818|NCT01593254|37986062|FG001|Follow-Up Period|Pregnancy|1|||
16897819|NCT01593254|37986061|FG000|Follow-Up Period|Study Drug Toxicity|0|||
16897820|NCT01593254|37986062|FG001|Follow-Up Period|Study Drug Toxicity|1|||
16897821|NCT01593254|37986061|FG000|Follow-Up Period|Patient refused to return|0|||
16897822|NCT01593254|37986062|FG001|Follow-Up Period|Patient refused to return|1|||
16897823|NCT01593254|37986061|FG000|Follow-Up Period|Fundus Hemorrhage|0|||
16897824|NCT01593254|37986062|FG001|Follow-Up Period|Fundus Hemorrhage|1|||
16897825|NCT01593254|37986061|FG000|Follow-Up Period|Disease Progression|0|||
16897826|NCT01593254|37986062|FG001|Follow-Up Period|Disease Progression|1|||
17004396|NCT00891462|38148190|FG002|Overall Study|Adverse Event|7|||
17004397|NCT00891462|38148188|FG000|Overall Study|Lack of Efficacy|10|||
17004398|NCT00891462|38148189|FG001|Overall Study|Lack of Efficacy|5|||
17004399|NCT00891462|38148190|FG002|Overall Study|Lack of Efficacy|1|||
17004400|NCT00891462|38148188|FG000|Overall Study|COPD exacerbation|7|||
16897827|NCT01593254|37986061|FG000|Follow-Up Period|Study Drug Side Effects|0|||
16897828|NCT01593254|37986062|FG001|Follow-Up Period|Study Drug Side Effects|1|||
16897829|NCT03172494|37986081|FG000|Overall Study|Adverse Event|5|||
17004401|NCT00891462|38148189|FG001|Overall Study|COPD exacerbation|4|||
16897830|NCT03172494|37986082|FG001|Overall Study|Adverse Event|1|||
16897831|NCT03172494|37986083|FG002|Overall Study|Adverse Event|15|||
16897832|NCT03172494|37986081|FG000|Overall Study|Protocol Violation|3|||
16897833|NCT03172494|37986082|FG001|Overall Study|Protocol Violation|2|||
16897834|NCT03172494|37986083|FG002|Overall Study|Protocol Violation|1|||
16897835|NCT03172494|37986081|FG000|Overall Study|Lack of Efficacy|0|||
16897836|NCT03172494|37986082|FG001|Overall Study|Lack of Efficacy|0|||
16897837|NCT03172494|37986083|FG002|Overall Study|Lack of Efficacy|4|||
16897838|NCT03172494|37986081|FG000|Overall Study|Pregnancy|0|||
16897839|NCT03172494|37986082|FG001|Overall Study|Pregnancy|1|||
16897840|NCT03172494|37986083|FG002|Overall Study|Pregnancy|0|||
16897841|NCT03172494|37986081|FG000|Overall Study|Withdrawal by Subject|10|||
16897842|NCT03172494|37986082|FG001|Overall Study|Withdrawal by Subject|8|||
16897843|NCT03172494|37986083|FG002|Overall Study|Withdrawal by Subject|8|||
16897844|NCT03172494|37986081|FG000|Overall Study|Severe hypoglycaemic episode|0|||
16897845|NCT03172494|37986082|FG001|Overall Study|Severe hypoglycaemic episode|0|||
16897846|NCT03172494|37986083|FG002|Overall Study|Severe hypoglycaemic episode|1|||
16897847|NCT03172494|37986081|FG000|Overall Study|Non-compliance towards treatment|2|||
16897848|NCT03172494|37986082|FG001|Overall Study|Non-compliance towards treatment|0|||
16897849|NCT03172494|37986083|FG002|Overall Study|Non-compliance towards treatment|0|||
16897850|NCT01636362|37986184|FG000|Overall Study|Physician Decision|6|||
16897851|NCT01636362|37986184|FG000|Overall Study|Subject healed, not returning|1|||
16897852|NCT01636362|37986184|FG000|Overall Study|Withdrawal by Subject|1|||
16897853|NCT02797184|37986213|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
16897854|NCT02797184|37986214|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
16897855|NCT03042468|37986256|FG000|Overall Study|Death|0|||
16897856|NCT03042468|37986257|FG001|Overall Study|Death|1|||
16897857|NCT03042468|37986258|FG002|Overall Study|Death|1|||
16897858|NCT03042468|37986259|FG003|Overall Study|Death|0|||
16897859|NCT03042468|37986260|FG004|Overall Study|Death|0|||
16897860|NCT03042468|37986261|FG005|Overall Study|Death|0|||
16897861|NCT03042468|37986256|FG000|Overall Study|Withdrawal by Subject|0|||
16897862|NCT03042468|37986257|FG001|Overall Study|Withdrawal by Subject|0|||
16897863|NCT03042468|37986258|FG002|Overall Study|Withdrawal by Subject|0|||
16897864|NCT03042468|37986259|FG003|Overall Study|Withdrawal by Subject|0|||
16897865|NCT03042468|37986260|FG004|Overall Study|Withdrawal by Subject|0|||
16897866|NCT03042468|37986261|FG005|Overall Study|Withdrawal by Subject|1|||
16897867|NCT03042468|37986256|FG000|Overall Study|Lost to Follow-up|0|||
16897868|NCT03042468|37986257|FG001|Overall Study|Lost to Follow-up|0|||
16897869|NCT03042468|37986258|FG002|Overall Study|Lost to Follow-up|0|||
16897870|NCT03042468|37986259|FG003|Overall Study|Lost to Follow-up|0|||
16897871|NCT03042468|37986260|FG004|Overall Study|Lost to Follow-up|1|||
16897872|NCT03042468|37986261|FG005|Overall Study|Lost to Follow-up|1|||
16897873|NCT01634178|37986279|FG000|Treatment Period 1|Adverse Event|0|||
16897874|NCT01634178|37986280|FG001|Treatment Period 1|Adverse Event|1|||
16897875|NCT01634178|37986279|FG000|Treatment Period 2|Adverse Event|1|||
16897876|NCT01634178|37986280|FG001|Treatment Period 2|Adverse Event|0|||
16897877|NCT04158648|37986287|FG000|Overall Study|Ongoing in the Study|69|||
16897878|NCT04158648|37986287|FG000|Overall Study|Withdrawal by Subject|4|||
16897879|NCT04382911|37986328|FG000|Overall Study|unable to be imaged prior to surgery|2|||
16897880|NCT02412306|37986337|FG000|Overall Study|Lost to Follow-up|0|||
16897881|NCT02412306|37986338|FG001|Overall Study|Lost to Follow-up|1|||
16897882|NCT02412306|37986339|FG002|Overall Study|Lost to Follow-up|0|||
16897883|NCT02412306|37986340|FG003|Overall Study|Lost to Follow-up|0|||
16897884|NCT02412306|37986341|FG004|Overall Study|Lost to Follow-up|0|||
16897885|NCT02412306|37986337|FG000|Overall Study|Withdrawal by Subject|0|||
16897886|NCT02412306|37986338|FG001|Overall Study|Withdrawal by Subject|0|||
16897887|NCT02412306|37986339|FG002|Overall Study|Withdrawal by Subject|1|||
16897888|NCT02412306|37986340|FG003|Overall Study|Withdrawal by Subject|0|||
16897889|NCT02412306|37986341|FG004|Overall Study|Withdrawal by Subject|0|||
16897890|NCT02412306|37986337|FG000|Overall Study|Death|5|||
16897891|NCT02412306|37986338|FG001|Overall Study|Death|7|||
16897892|NCT02412306|37986339|FG002|Overall Study|Death|15|||
16897893|NCT02412306|37986340|FG003|Overall Study|Death|0|||
16897894|NCT02412306|37986341|FG004|Overall Study|Death|2|||
16897895|NCT04285723|37986364|FG000|Overall Study|Subject decision|1|||
16897896|NCT04285723|37986365|FG001|Overall Study|Subject decision|2|||
16897897|NCT04285723|37986364|FG000|Overall Study|Physician Decision|1|||
16897898|NCT04285723|37986365|FG001|Overall Study|Physician Decision|0|||
16897899|NCT04285723|37986364|FG000|Overall Study|No efficiency|1|||
16897900|NCT04285723|37986365|FG001|Overall Study|No efficiency|0|||
16897901|NCT03768427|37986381|FG000|Overall Study|Death|0|||
17004402|NCT00891462|38148190|FG002|Overall Study|COPD exacerbation|1|||
17095480|NCT03801148|38234753|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
16897902|NCT03768427|37986382|FG001|Overall Study|Death|0|||
16897903|NCT03768427|37986383|FG002|Overall Study|Death|1|||
16897904|NCT03768427|37986384|FG003|Overall Study|Death|0|||
16897905|NCT03768427|37986381|FG000|Overall Study|Lost to Follow-up|2|||
16897906|NCT03768427|37986382|FG001|Overall Study|Lost to Follow-up|0|||
16897907|NCT03768427|37986383|FG002|Overall Study|Lost to Follow-up|0|||
16897908|NCT03768427|37986384|FG003|Overall Study|Lost to Follow-up|0|||
16897909|NCT03768427|37986381|FG000|Overall Study|Physician Decision|3|||
16897910|NCT03768427|37986382|FG001|Overall Study|Physician Decision|2|||
16897911|NCT03768427|37986383|FG002|Overall Study|Physician Decision|4|||
16897912|NCT03768427|37986384|FG003|Overall Study|Physician Decision|4|||
16897913|NCT03768427|37986381|FG000|Overall Study|Withdrawal by Subject|7|||
16897914|NCT03768427|37986382|FG001|Overall Study|Withdrawal by Subject|2|||
16897915|NCT03768427|37986383|FG002|Overall Study|Withdrawal by Subject|6|||
16897916|NCT03768427|37986384|FG003|Overall Study|Withdrawal by Subject|7|||
16897917|NCT03659136|37986396|FG000|Overall Study|COVID-19 related|1|||
16897918|NCT03659136|37986397|FG001|Overall Study|COVID-19 related|1|||
16897919|NCT03659136|37986396|FG000|Overall Study|Withdrawal by Subject|0|||
16897920|NCT03659136|37986397|FG001|Overall Study|Withdrawal by Subject|6|||
16897921|NCT03659136|37986396|FG000|Overall Study|Adverse Event|4|||
16897922|NCT03659136|37986397|FG001|Overall Study|Adverse Event|7|||
16897923|NCT03659136|37986396|FG000|Overall Study|Progressive disease|34|||
16897924|NCT03659136|37986397|FG001|Overall Study|Progressive disease|24|||
16897925|NCT03659136|37986396|FG000|Overall Study|Not treated|2|||
16897926|NCT03659136|37986397|FG001|Overall Study|Not treated|0|||
16897927|NCT03659136|37986396|FG000|Overall Study|Not specified above|2|||
16897928|NCT03659136|37986397|FG001|Overall Study|Not specified above|1|||
16897929|NCT01352221|37986406|FG000|Double-blind Phase|Adverse Event|6|||
16897930|NCT01352221|37986407|FG001|Double-blind Phase|Adverse Event|4|||
16897931|NCT01352221|37986408|FG002|Double-blind Phase|Adverse Event|0|||
16897932|NCT01352221|37986409|FG003|Double-blind Phase|Adverse Event|0|||
16897933|NCT01352221|37986406|FG000|Double-blind Phase|Withdrawal by Subject|3|||
16897934|NCT01352221|37986407|FG001|Double-blind Phase|Withdrawal by Subject|5|||
16897935|NCT01352221|37986408|FG002|Double-blind Phase|Withdrawal by Subject|0|||
16897936|NCT01352221|37986409|FG003|Double-blind Phase|Withdrawal by Subject|0|||
16897937|NCT01352221|37986406|FG000|Double-blind Phase|Lost to Follow-up|0|||
16897938|NCT01352221|37986407|FG001|Double-blind Phase|Lost to Follow-up|1|||
16897939|NCT01352221|37986408|FG002|Double-blind Phase|Lost to Follow-up|0|||
16897940|NCT01352221|37986409|FG003|Double-blind Phase|Lost to Follow-up|0|||
16897941|NCT01352221|37986406|FG000|Double-blind Phase|Protocol Violation|0|||
16897942|NCT01352221|37986407|FG001|Double-blind Phase|Protocol Violation|1|||
16897943|NCT01352221|37986408|FG002|Double-blind Phase|Protocol Violation|0|||
16897944|NCT01352221|37986409|FG003|Double-blind Phase|Protocol Violation|0|||
16897945|NCT01352221|37986406|FG000|Open-label Phase|Physician Decision|0|||
16897946|NCT01352221|37986407|FG001|Open-label Phase|Physician Decision|0|||
16897947|NCT01352221|37986408|FG002|Open-label Phase|Physician Decision|2|||
16897948|NCT01352221|37986409|FG003|Open-label Phase|Physician Decision|1|||
16897949|NCT01352221|37986406|FG000|Open-label Phase|Pregnancy|0|||
16897950|NCT01352221|37986407|FG001|Open-label Phase|Pregnancy|0|||
16897951|NCT01352221|37986408|FG002|Open-label Phase|Pregnancy|1|||
16897952|NCT01352221|37986409|FG003|Open-label Phase|Pregnancy|0|||
16897953|NCT01352221|37986406|FG000|Open-label Phase|Adverse Event|0|||
16897954|NCT01352221|37986407|FG001|Open-label Phase|Adverse Event|0|||
16897955|NCT01352221|37986408|FG002|Open-label Phase|Adverse Event|8|||
16897956|NCT01352221|37986409|FG003|Open-label Phase|Adverse Event|4|||
16897957|NCT01352221|37986406|FG000|Open-label Phase|Withdrawal by Subject|0|||
16897958|NCT01352221|37986407|FG001|Open-label Phase|Withdrawal by Subject|0|||
16897959|NCT01352221|37986408|FG002|Open-label Phase|Withdrawal by Subject|1|||
16897960|NCT01352221|37986409|FG003|Open-label Phase|Withdrawal by Subject|6|||
17004403|NCT00891462|38148188|FG000|Overall Study|Other Reason|2|||
17004404|NCT00891462|38148189|FG001|Overall Study|Other Reason|5|||
17004405|NCT00891462|38148190|FG002|Overall Study|Other Reason|3|||
17004406|NCT00891462|38148188|FG000|Overall Study|Protocol Violation|2|||
17004407|NCT00891462|38148189|FG001|Overall Study|Protocol Violation|1|||
17004408|NCT00891462|38148190|FG002|Overall Study|Protocol Violation|3|||
17004409|NCT00891462|38148188|FG000|Overall Study|Inclusion/exclusion criteria|0|||
17004410|NCT00891462|38148189|FG001|Overall Study|Inclusion/exclusion criteria|2|||
17004411|NCT00891462|38148190|FG002|Overall Study|Inclusion/exclusion criteria|2|||
17004412|NCT00891462|38148188|FG000|Overall Study|Lost to Follow-up|0|||
17004413|NCT00891462|38148189|FG001|Overall Study|Lost to Follow-up|2|||
17004414|NCT00891462|38148190|FG002|Overall Study|Lost to Follow-up|0|||
17004415|NCT00900146|38148205|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
17004416|NCT00900146|38148206|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
17004417|NCT00900146|38148207|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
17004418|NCT00900146|38148208|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
17004419|NCT00900146|38148209|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
17004420|NCT00900146|38148205|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
17004421|NCT00900146|38148206|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
17004422|NCT00900146|38148207|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
17004423|NCT00900146|38148208|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
16897961|NCT01352221|37986406|FG000|Open-label Phase|Worsening of IBD|0|||
16897962|NCT01352221|37986407|FG001|Open-label Phase|Worsening of IBD|0|||
17004424|NCT00900146|38148209|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
17004425|NCT00900146|38148205|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
17004426|NCT00900146|38148206|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
17004427|NCT00900146|38148207|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
17004428|NCT00900146|38148208|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
17004429|NCT00900146|38148209|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
17004430|NCT00900146|38148205|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
17004431|NCT00900146|38148206|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
17004432|NCT00900146|38148207|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
17004433|NCT00900146|38148208|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
17004434|NCT00900146|38148209|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
17004435|NCT00900146|38148205|FG000|Intermediate: Period III|Lost to Follow-up|2|||
17004436|NCT00900146|38148206|FG001|Intermediate: Period III|Lost to Follow-up|0|||
17004437|NCT00900146|38148207|FG002|Intermediate: Period III|Lost to Follow-up|0|||
17004438|NCT00900146|38148208|FG003|Intermediate: Period III|Lost to Follow-up|0|||
17004439|NCT00900146|38148209|FG004|Intermediate: Period III|Lost to Follow-up|1|||
17004440|NCT00900146|38148205|FG000|Intermediate: Period III|Administrative problems|85|||
17004441|NCT00900146|38148206|FG001|Intermediate: Period III|Administrative problems|92|||
17004442|NCT00900146|38148207|FG002|Intermediate: Period III|Administrative problems|84|||
17004443|NCT00900146|38148208|FG003|Intermediate: Period III|Administrative problems|90|||
17004444|NCT00900146|38148209|FG004|Intermediate: Period III|Administrative problems|163|||
17004445|NCT00895310|38148221|FG000|Overall Study|Withdrawal by Subject|1|||
17004446|NCT00895154|38148227|FG000|Overall Study|Lost to Follow-up|1|||
17004447|NCT00895154|38148228|FG001|Overall Study|Lost to Follow-up|1|||
17004448|NCT00895154|38148227|FG000|Overall Study|Withdrawal by Subject|0|||
17004449|NCT00895154|38148228|FG001|Overall Study|Withdrawal by Subject|1|||
17004450|NCT00888654|38148234|FG000|Overall Study|Problems swallowing oral meds.|1|||
17004451|NCT00888654|38148234|FG000|Overall Study|Not enough oral meds before surgery|3|||
17004452|NCT00888654|38148234|FG000|Overall Study|Surgery aborted|2|||
17004453|NCT00888654|38148234|FG000|Overall Study|Withdrawal by Subject|1|||
17004454|NCT00888654|38148234|FG000|Overall Study|Inelig. due to contraindication of med|1|||
17004455|NCT00888654|38148234|FG000|Overall Study|Change in surg date|1|||
17004456|NCT00888654|38148234|FG000|Overall Study|Stopped meds due to headaches|1|||
17004457|NCT00899678|38148241|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
17004458|NCT00899678|38148242|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
17004459|NCT00899678|38148243|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
16897963|NCT01352221|37986408|FG002|Open-label Phase|Worsening of IBD|1|||
16897964|NCT01352221|37986409|FG003|Open-label Phase|Worsening of IBD|0|||
16897965|NCT01634100|37986435|FG000|Overall Study|Withdrawal by Subject|1|||
16897966|NCT01634100|37986436|FG001|Overall Study|Withdrawal by Subject|0|||
16897967|NCT01634100|37986437|FG002|Overall Study|Withdrawal by Subject|1|||
16897968|NCT01634100|37986438|FG003|Overall Study|Withdrawal by Subject|0|||
16897969|NCT01634100|37986439|FG004|Overall Study|Withdrawal by Subject|0|||
16897970|NCT01634100|37986440|FG005|Overall Study|Withdrawal by Subject|0|||
16897971|NCT03662659|37986450|FG000|Pre-treatment|Participant no longer met study criteria|1|||
16897972|NCT03662659|37986451|FG001|Pre-treatment|Participant no longer met study criteria|1|||
16897973|NCT03662659|37986450|FG000|Pre-treatment|Other reasons|1|||
16897974|NCT03662659|37986451|FG001|Pre-treatment|Other reasons|0|||
16897975|NCT03662659|37986450|FG000|Treatment|Completed Treatment|0|||
16897976|NCT03662659|37986451|FG001|Treatment|Completed Treatment|3|||
16897977|NCT03662659|37986450|FG000|Treatment|Disease Progression|69|||
16897978|NCT03662659|37986451|FG001|Treatment|Disease Progression|78|||
16897979|NCT03662659|37986450|FG000|Treatment|Study Drug Toxicity|18|||
16897980|NCT03662659|37986451|FG001|Treatment|Study Drug Toxicity|8|||
16897981|NCT03662659|37986450|FG000|Treatment|Death|12|||
16897982|NCT03662659|37986451|FG001|Treatment|Death|7|||
16897983|NCT03662659|37986450|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
16897984|NCT03662659|37986451|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
16897985|NCT03662659|37986450|FG000|Treatment|Withdrawal by Subject|1|||
16897986|NCT03662659|37986451|FG001|Treatment|Withdrawal by Subject|1|||
16897987|NCT03662659|37986450|FG000|Treatment|Poor/Non-compliance|1|||
16897988|NCT03662659|37986451|FG001|Treatment|Poor/Non-compliance|0|||
16897989|NCT03662659|37986450|FG000|Treatment|Participant no longer meets study criteria|1|||
16897990|NCT03662659|37986451|FG001|Treatment|Participant no longer meets study criteria|0|||
16897991|NCT03662659|37986450|FG000|Treatment|Other reasons|6|||
16897992|NCT03662659|37986451|FG001|Treatment|Other reasons|5|||
16897993|NCT01633944|37986459|FG000|Open-label Titration Phase|Adverse Event|109|||
16897994|NCT01633944|37986460|FG001|Open-label Titration Phase|Adverse Event|0|||
16897995|NCT01633944|37986461|FG002|Open-label Titration Phase|Adverse Event|0|||
16897996|NCT01633944|37986459|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
16897997|NCT01633944|37986460|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
16897998|NCT01633944|37986461|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
16897999|NCT01633944|37986459|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
16898000|NCT01633944|37986460|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
16898001|NCT01633944|37986461|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
16898002|NCT01633944|37986459|FG000|Open-label Titration Phase|Protocol Violation|24|||
16898003|NCT01633944|37986460|FG001|Open-label Titration Phase|Protocol Violation|0|||
16898004|NCT01633944|37986461|FG002|Open-label Titration Phase|Protocol Violation|0|||
16898005|NCT01633944|37986459|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
16898006|NCT01633944|37986460|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
17095481|NCT03801148|38234754|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
17095482|NCT03801148|38234755|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
17095483|NCT03801148|38234756|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
17095484|NCT03801148|38234753|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17095485|NCT03801148|38234754|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17095486|NCT03801148|38234755|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
17095487|NCT03801148|38234756|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
17095488|NCT03801148|38234753|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
17095489|NCT03801148|38234754|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
17095490|NCT03801148|38234755|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
17095491|NCT03801148|38234756|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
17095492|NCT00072280|38234768|FG000|Treatment|Found ineligible|1|||
17095493|NCT00072280|38234769|FG001|Treatment|Found ineligible|2|||
17095494|NCT00072280|38234768|FG000|Follow-up|Early termination of study|2|||
17095495|NCT00072280|38234769|FG001|Follow-up|Early termination of study|2|||
17095496|NCT00071812|38234778|FG000|24-Week Double-Blind Period|Adverse Event|2|||
17095497|NCT00071812|38234779|FG001|24-Week Double-Blind Period|Adverse Event|3|||
17095498|NCT00071812|38234780|FG002|24-Week Double-Blind Period|Adverse Event|4|||
17095499|NCT00071812|38234781|FG003|24-Week Double-Blind Period|Adverse Event|4|||
16898007|NCT01633944|37986461|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
16898008|NCT01633944|37986459|FG000|Open-label Titration Phase|Other|68|||
16898009|NCT01633944|37986460|FG001|Open-label Titration Phase|Other|0|||
16898010|NCT01633944|37986461|FG002|Open-label Titration Phase|Other|0|||
16898011|NCT01633944|37986459|FG000|Double-blind Treatment Phase|Adverse Event|0|||
16898012|NCT01633944|37986460|FG001|Double-blind Treatment Phase|Adverse Event|13|||
16898013|NCT01633944|37986461|FG002|Double-blind Treatment Phase|Adverse Event|7|||
16898014|NCT01633944|37986459|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
16898015|NCT01633944|37986460|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
16898016|NCT01633944|37986461|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
16898017|NCT01633944|37986459|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16898018|NCT01633944|37986460|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
16898019|NCT01633944|37986461|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
16898020|NCT01633944|37986459|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
16898021|NCT01633944|37986460|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
16898022|NCT01633944|37986461|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
16898023|NCT01633944|37986459|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16898024|NCT01633944|37986460|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
16898025|NCT01633944|37986461|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
16898026|NCT01633944|37986459|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
16898027|NCT01633944|37986460|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
16898028|NCT01633944|37986461|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
16898029|NCT01633944|37986459|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
16898030|NCT01633944|37986460|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
16898031|NCT01633944|37986461|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
16898032|NCT01633944|37986459|FG000|Double-blind Treatment Phase|Other|0|||
16898033|NCT01633944|37986460|FG001|Double-blind Treatment Phase|Other|7|||
16898034|NCT01633944|37986461|FG002|Double-blind Treatment Phase|Other|0|||
16898035|NCT01633788|37986506|FG000|Overall Study|Adverse Event|1|||
16898036|NCT01633788|37986507|FG001|Overall Study|Adverse Event|3|||
16898037|NCT01633788|37986508|FG002|Overall Study|Adverse Event|3|||
16898038|NCT01633788|37986509|FG003|Overall Study|Adverse Event|3|||
16898039|NCT01633788|37986506|FG000|Overall Study|Lost to Follow-up|2|||
16898040|NCT01633788|37986507|FG001|Overall Study|Lost to Follow-up|2|||
16898041|NCT01633788|37986508|FG002|Overall Study|Lost to Follow-up|2|||
16898042|NCT01633788|37986509|FG003|Overall Study|Lost to Follow-up|0|||
16898043|NCT01633788|37986506|FG000|Overall Study|Personal Reasons|3|||
16898044|NCT01633788|37986507|FG001|Overall Study|Personal Reasons|1|||
16898045|NCT01633788|37986508|FG002|Overall Study|Personal Reasons|1|||
16898046|NCT01633788|37986509|FG003|Overall Study|Personal Reasons|3|||
16898047|NCT01633788|37986506|FG000|Overall Study|Protocol Violation|1|||
17095500|NCT00071812|38234778|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
16898048|NCT01633788|37986507|FG001|Overall Study|Protocol Violation|0|||
16898049|NCT01633788|37986508|FG002|Overall Study|Protocol Violation|1|||
16898050|NCT01633788|37986509|FG003|Overall Study|Protocol Violation|0|||
16898051|NCT01633788|37986506|FG000|Overall Study|Other Reasons|0|||
16898052|NCT01633788|37986507|FG001|Overall Study|Other Reasons|2|||
16898053|NCT01633788|37986508|FG002|Overall Study|Other Reasons|3|||
16898054|NCT01633788|37986509|FG003|Overall Study|Other Reasons|7|||
16898055|NCT00565851|37986527|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
16898056|NCT00565851|37986528|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
16898057|NCT00565851|37986529|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
16898058|NCT00565851|37986530|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
16898059|NCT00565851|37986531|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
16898060|NCT00565851|37986532|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
16898061|NCT00565851|37986533|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
16898062|NCT00565851|37986534|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
16898063|NCT00565851|37986527|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
16898064|NCT00565851|37986528|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
16898065|NCT00565851|37986529|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
16898066|NCT00565851|37986530|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
16898067|NCT00565851|37986531|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
16898068|NCT00565851|37986532|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
16898069|NCT00565851|37986533|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
16898070|NCT00565851|37986534|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
16898071|NCT04154943|37986556|FG000|Overall Study|Study Ongoing|68|||
16898072|NCT04154943|37986556|FG000|Overall Study|Lost to Follow-up|1|||
16898073|NCT04154943|37986556|FG000|Overall Study|Decision by the Investigator|1|||
16898074|NCT04154943|37986556|FG000|Overall Study|Death|5|||
16898075|NCT04154943|37986556|FG000|Overall Study|Withdrawal by Subject|4|||
16898076|NCT03476239|37986577|FG000|Overall Study|Withdrawal by Subject|10|||
16898077|NCT03476239|37986577|FG000|Overall Study|Death|80|||
16898078|NCT03476239|37986577|FG000|Overall Study|Lost to Follow-up|8|||
16898079|NCT03468985|37986585|FG000|Overall Study|Adverse Event|0|||
16898080|NCT03468985|37986586|FG001|Overall Study|Adverse Event|2|||
16898081|NCT03468985|37986587|FG002|Overall Study|Adverse Event|0|||
16898082|NCT03468985|37986588|FG003|Overall Study|Adverse Event|0|||
16898083|NCT03468985|37986585|FG000|Overall Study|Withdrawal by Subject|0|||
16898084|NCT03468985|37986586|FG001|Overall Study|Withdrawal by Subject|0|||
16898085|NCT03468985|37986587|FG002|Overall Study|Withdrawal by Subject|0|||
16898086|NCT03468985|37986588|FG003|Overall Study|Withdrawal by Subject|1|||
16898087|NCT02678312|37986603|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
16898088|NCT02678312|37986604|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
16898089|NCT02678312|37986605|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
16898090|NCT02678312|37986606|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
16898091|NCT02678312|37986607|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
16898092|NCT02678312|37986603|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
16898093|NCT02678312|37986604|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
16898094|NCT02678312|37986605|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
16898095|NCT02678312|37986606|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
17004460|NCT00899678|38148241|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
17004461|NCT00899678|38148242|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
17004462|NCT00899678|38148243|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
17004463|NCT00899678|38148241|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
17004464|NCT00899678|38148242|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
17004465|NCT00899678|38148243|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
17004466|NCT00899678|38148241|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
17004467|NCT00899678|38148242|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
17004468|NCT00899678|38148243|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
17004469|NCT00899678|38148241|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
17004470|NCT00899678|38148242|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
17004471|NCT00899678|38148243|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
17004472|NCT00899678|38148241|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
17004473|NCT00899678|38148242|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
17004474|NCT00899678|38148243|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
17004475|NCT00899678|38148241|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
17004476|NCT00899678|38148242|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
17004477|NCT00899678|38148243|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
17095501|NCT00071812|38234779|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
16898096|NCT02678312|37986607|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
16898097|NCT02678312|37986603|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
16898098|NCT02678312|37986604|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
16898099|NCT02678312|37986605|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
16898100|NCT02678312|37986606|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
16898101|NCT02678312|37986607|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
16898102|NCT02678312|37986603|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
16898103|NCT02678312|37986604|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
16898104|NCT02678312|37986605|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
16898105|NCT02678312|37986606|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
16898106|NCT02678312|37986607|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
16898107|NCT02678312|37986603|FG000|Part 2 Double Blind Epoch|Death|0|||
16898108|NCT02678312|37986604|FG001|Part 2 Double Blind Epoch|Death|0|||
16898109|NCT02678312|37986605|FG002|Part 2 Double Blind Epoch|Death|0|||
16898110|NCT02678312|37986606|FG003|Part 2 Double Blind Epoch|Death|8|||
16898111|NCT02678312|37986607|FG004|Part 2 Double Blind Epoch|Death|12|||
16898112|NCT02678312|37986603|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
16898113|NCT02678312|37986604|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
16898114|NCT02678312|37986605|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
16898115|NCT02678312|37986606|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
16898116|NCT02678312|37986607|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
16898117|NCT02678312|37986603|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
16898118|NCT02678312|37986604|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
16898119|NCT02678312|37986605|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
16898120|NCT02678312|37986606|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
16898121|NCT02678312|37986607|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
16898122|NCT02678312|37986603|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
16898123|NCT02678312|37986604|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
17004478|NCT00899678|38148241|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
17004479|NCT00899678|38148242|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
17004480|NCT00899678|38148243|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
17004481|NCT00899678|38148241|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
17004482|NCT00899678|38148242|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
17004483|NCT00899678|38148243|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
17004484|NCT00887484|38148251|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
17004485|NCT00887484|38148251|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
17004486|NCT00887484|38148251|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
17004487|NCT00886938|38148260|FG000|Overall Study|Adverse Event|1|||
17004488|NCT00886938|38148260|FG000|Overall Study|Withdrawal by Subject|1|||
17004489|NCT00620659|38148264|FG000|Treatment Period 1|Adverse Event|1|||
17004490|NCT00620659|38148265|FG001|Treatment Period 1|Adverse Event|0|||
17004491|NCT00620659|38148266|FG002|Treatment Period 1|Adverse Event|0|||
17004492|NCT00620659|38148267|FG003|Treatment Period 1|Adverse Event|3|||
17004493|NCT00620659|38148268|FG004|Treatment Period 1|Adverse Event|0|||
17004494|NCT00620659|38148269|FG005|Treatment Period 1|Adverse Event|0|||
17004495|NCT00620659|38148264|FG000|Treatment Period 1|Protocol Violation|1|||
17004496|NCT00620659|38148265|FG001|Treatment Period 1|Protocol Violation|0|||
17004497|NCT00620659|38148266|FG002|Treatment Period 1|Protocol Violation|0|||
17004498|NCT00620659|38148267|FG003|Treatment Period 1|Protocol Violation|0|||
17004499|NCT00620659|38148268|FG004|Treatment Period 1|Protocol Violation|0|||
17004500|NCT00620659|38148269|FG005|Treatment Period 1|Protocol Violation|0|||
17004501|NCT00620659|38148264|FG000|Treatment Period 1|Withdrawal by Subject|1|||
17004502|NCT00620659|38148265|FG001|Treatment Period 1|Withdrawal by Subject|0|||
17004503|NCT00620659|38148266|FG002|Treatment Period 1|Withdrawal by Subject|1|||
17004504|NCT00620659|38148267|FG003|Treatment Period 1|Withdrawal by Subject|0|||
17004505|NCT00620659|38148268|FG004|Treatment Period 1|Withdrawal by Subject|1|||
17004506|NCT00620659|38148269|FG005|Treatment Period 1|Withdrawal by Subject|0|||
17004507|NCT00620659|38148264|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
17004508|NCT00620659|38148265|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
17004509|NCT00620659|38148266|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
16898124|NCT02678312|37986605|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
16898125|NCT02678312|37986606|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
16898126|NCT02678312|37986607|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
16898127|NCT02256631|37986861|FG000|Overall Study|Lost to Follow-up|1|||
16898128|NCT02256631|37986862|FG001|Overall Study|Lost to Follow-up|1|||
16898129|NCT02256631|37986863|FG002|Overall Study|Lost to Follow-up|0|||
16898130|NCT02256631|37986864|FG003|Overall Study|Lost to Follow-up|2|||
16898131|NCT02256631|37986865|FG004|Overall Study|Lost to Follow-up|0|||
16898132|NCT02256631|37986866|FG005|Overall Study|Lost to Follow-up|4|||
16898133|NCT02256631|37986867|FG006|Overall Study|Lost to Follow-up|1|||
16898134|NCT02256631|37986861|FG000|Overall Study|Withdrawal by Subject|0|||
16898135|NCT02256631|37986862|FG001|Overall Study|Withdrawal by Subject|0|||
16898136|NCT02256631|37986863|FG002|Overall Study|Withdrawal by Subject|0|||
16898137|NCT02256631|37986864|FG003|Overall Study|Withdrawal by Subject|1|||
16898138|NCT02256631|37986865|FG004|Overall Study|Withdrawal by Subject|1|||
16898139|NCT02256631|37986866|FG005|Overall Study|Withdrawal by Subject|0|||
16898140|NCT02256631|37986867|FG006|Overall Study|Withdrawal by Subject|1|||
16898141|NCT02256631|37986861|FG000|Overall Study|Unable to get to clinic|0|||
17004510|NCT00620659|38148267|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
17004511|NCT00620659|38148268|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
16898142|NCT02256631|37986862|FG001|Overall Study|Unable to get to clinic|2|||
16898143|NCT02256631|37986863|FG002|Overall Study|Unable to get to clinic|0|||
16898144|NCT02256631|37986864|FG003|Overall Study|Unable to get to clinic|1|||
16898145|NCT02256631|37986865|FG004|Overall Study|Unable to get to clinic|0|||
16898146|NCT02256631|37986866|FG005|Overall Study|Unable to get to clinic|1|||
16898147|NCT02256631|37986867|FG006|Overall Study|Unable to get to clinic|2|||
16898148|NCT02163733|37986965|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
16898149|NCT02163733|37986966|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
16898150|NCT02163733|37986967|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
16898151|NCT02163733|37986965|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
16898152|NCT02163733|37986966|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
16898153|NCT02163733|37986967|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
16898154|NCT02279745|37986997|FG000|Overall Study|Adverse Event|7|||
16898155|NCT02279745|37986997|FG000|Overall Study|Death|6|||
16898156|NCT02279745|37986997|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
16898157|NCT02279745|37986997|FG000|Overall Study|Withdrawal by Subject|2|||
16898158|NCT02279745|37986997|FG000|Overall Study|Pregnancy|1|||
16898159|NCT02279745|37986997|FG000|Overall Study|Study Non-compliance|1|||
16898160|NCT02279745|37986997|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
16898161|NCT01761877|37987036|FG000|Overall Study|Adverse Event|7|||
16898162|NCT01761877|37987037|FG001|Overall Study|Adverse Event|0|||
16898163|NCT01761877|37987036|FG000|Overall Study|Withdrawal by Subject|6|||
16898164|NCT01761877|37987037|FG001|Overall Study|Withdrawal by Subject|4|||
16898165|NCT01761877|37987036|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
16898166|NCT01761877|37987037|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
16898167|NCT01761877|37987036|FG000|Overall Study|Death|0|||
16898168|NCT01761877|37987037|FG001|Overall Study|Death|1|||
16898169|NCT01761877|37987036|FG000|Overall Study|MRI intolerant|1|||
16898170|NCT01761877|37987037|FG001|Overall Study|MRI intolerant|6|||
16898171|NCT03093259|37987291|FG000|Overall Study|Adverse Event|1|||
16898172|NCT03093259|37987292|FG001|Overall Study|Adverse Event|0|||
16898173|NCT03093259|37987291|FG000|Overall Study|Withdrawal by Subject|1|||
16898174|NCT03093259|37987292|FG001|Overall Study|Withdrawal by Subject|0|||
16898175|NCT02997865|37987584|FG000|Overall Study|Death|2|||
16898176|NCT02997865|37987585|FG001|Overall Study|Death|1|||
16898177|NCT02997865|37987584|FG000|Overall Study|Lost to Follow-up|6|||
16898178|NCT02997865|37987585|FG001|Overall Study|Lost to Follow-up|3|||
16898179|NCT02997865|37987584|FG000|Overall Study|Withdrawal by Subject|5|||
16898180|NCT02997865|37987585|FG001|Overall Study|Withdrawal by Subject|0|||
16898181|NCT01575834|37988823|FG000|Overall Study|Withdrawal by Subject|352|||
16898182|NCT01575834|37988824|FG001|Overall Study|Withdrawal by Subject|390|||
17004512|NCT00620659|38148269|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
17004513|NCT00620659|38148264|FG000|Treatment Period 2|Adverse Event|0|||
17004514|NCT00620659|38148265|FG001|Treatment Period 2|Adverse Event|3|||
17004515|NCT00620659|38148266|FG002|Treatment Period 2|Adverse Event|0|||
17004516|NCT00620659|38148267|FG003|Treatment Period 2|Adverse Event|0|||
17004517|NCT00620659|38148268|FG004|Treatment Period 2|Adverse Event|2|||
16898183|NCT01575834|37988823|FG000|Overall Study|Death|81|||
16898184|NCT01575834|37988824|FG001|Overall Study|Death|74|||
16898185|NCT01575834|37988823|FG000|Overall Study|Other|70|||
16898186|NCT01575834|37988824|FG001|Overall Study|Other|70|||
16898187|NCT01575834|37988823|FG000|Overall Study|Adverse Event|63|||
16898188|NCT01575834|37988824|FG001|Overall Study|Adverse Event|61|||
16898189|NCT01575834|37988823|FG000|Overall Study|Lost to Follow-up|55|||
16898190|NCT01575834|37988824|FG001|Overall Study|Lost to Follow-up|68|||
16898191|NCT01575834|37988823|FG000|Overall Study|Noncompliance|52|||
16898192|NCT01575834|37988824|FG001|Overall Study|Noncompliance|27|||
16898193|NCT01575834|37988823|FG000|Overall Study|Administrative decision|15|||
16898194|NCT01575834|37988824|FG001|Overall Study|Administrative decision|33|||
16898195|NCT01575834|37988823|FG000|Overall Study|Ineligibility Determined|5|||
16898196|NCT01575834|37988824|FG001|Overall Study|Ineligibility Determined|8|||
16898197|NCT01575834|37988823|FG000|Overall Study|Protocol Deviation|4|||
16898198|NCT01575834|37988824|FG001|Overall Study|Protocol Deviation|3|||
16898199|NCT01575834|37988823|FG000|Overall Study|Requirement for Alternative Therapy|2|||
16898200|NCT01575834|37988824|FG001|Overall Study|Requirement for Alternative Therapy|4|||
16898201|NCT02254278|37988896|FG000|Overall Study|Protocol Violation|1|||
16898202|NCT02254278|37988897|FG001|Overall Study|Protocol Violation|1|||
17095502|NCT00071812|38234780|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
16898203|NCT02253654|37988948|FG000|Overall Study|Withdrawal by Subject|12|||
16898204|NCT02253654|37988949|FG001|Overall Study|Withdrawal by Subject|4|||
17004518|NCT00620659|38148269|FG005|Treatment Period 2|Adverse Event|0|||
16898205|NCT02253654|37988948|FG000|Overall Study|Decision by Sponsor|1|||
16898206|NCT02253654|37988949|FG001|Overall Study|Decision by Sponsor|1|||
16898207|NCT02253654|37988948|FG000|Overall Study|Lost to Follow-up|2|||
16898208|NCT02253654|37988949|FG001|Overall Study|Lost to Follow-up|5|||
16898209|NCT02253654|37988948|FG000|Overall Study|Death|4|||
16898210|NCT02253654|37988949|FG001|Overall Study|Death|7|||
16898211|NCT02253654|37988948|FG000|Overall Study|Did Not Receive Study Treatment|4|||
16898212|NCT02253654|37988949|FG001|Overall Study|Did Not Receive Study Treatment|1|||
16898213|NCT02252406|37988957|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
16898214|NCT02252406|37988958|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
16898215|NCT02252406|37988957|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
16898216|NCT02252406|37988958|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
16898217|NCT02252406|37988957|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
16898218|NCT02252406|37988958|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
16898219|NCT02252406|37988957|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
16898220|NCT02252406|37988958|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
16898221|NCT02252406|37988957|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
16898222|NCT02252406|37988958|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
16898223|NCT02246478|37988968|FG000|Multiple-dose Phase|Protocol Violation|1|||
16898224|NCT02246478|37988969|FG001|Multiple-dose Phase|Protocol Violation|0|||
16898225|NCT02246478|37988970|FG002|Multiple-dose Phase|Protocol Violation|0|||
16898226|NCT02246478|37988971|FG003|Multiple-dose Phase|Protocol Violation|1|||
16898227|NCT02252016|37988990|FG000|Overall Study|Lost to Follow-up|2|||
16898228|NCT02252016|37988991|FG001|Overall Study|Lost to Follow-up|1|||
16898229|NCT02252016|37988990|FG000|Overall Study|Physician Decision|1|||
16898230|NCT02252016|37988991|FG001|Overall Study|Physician Decision|0|||
16898231|NCT02252016|37988990|FG000|Overall Study|Withdrawal by Subject|0|||
16898232|NCT02252016|37988991|FG001|Overall Study|Withdrawal by Subject|2|||
16898233|NCT02249832|37988997|FG000|Overall Study|Withdrawal by Subject|3|||
16898234|NCT02249832|37988997|FG000|Overall Study|Lost to Follow-up|10|||
16898235|NCT02248974|37989008|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
16898236|NCT02248974|37989009|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
16898237|NCT02248974|37989008|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
16898238|NCT02248974|37989009|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
16898239|NCT02248974|37989008|FG000|1-Day Follow-Up|Enrolled in another study|1|||
16898240|NCT02248974|37989009|FG001|1-Day Follow-Up|Enrolled in another study|0|||
16898241|NCT02248974|37989008|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
16898242|NCT02248974|37989009|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
16898243|NCT02248974|37989008|FG000|1-Week Follow-Up|Enrolled in another study|1|||
16898244|NCT02248974|37989009|FG001|1-Week Follow-Up|Enrolled in another study|1|||
16898245|NCT02248974|37989008|FG000|1-Week Follow-Up|Transferred to another facility|1|||
16898246|NCT02248974|37989009|FG001|1-Week Follow-Up|Transferred to another facility|0|||
16898247|NCT02248974|37989008|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
16898248|NCT02248974|37989009|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
16898249|NCT02248974|37989008|FG000|1-Week Follow-Up|Death|1|||
16898250|NCT02248974|37989009|FG001|1-Week Follow-Up|Death|1|||
16898251|NCT02248974|37989008|FG000|1-Week Follow-Up|Excluded because of age|0|||
16898252|NCT02248974|37989009|FG001|1-Week Follow-Up|Excluded because of age|1|||
16898253|NCT02248974|37989008|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
16898254|NCT02248974|37989009|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
16898255|NCT02248974|37989008|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
16898256|NCT02248974|37989009|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
16898257|NCT02248974|37989008|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
16898258|NCT02248974|37989009|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
16898259|NCT02248974|37989008|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
16898260|NCT02248974|37989009|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
16898261|NCT02248974|37989008|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
16898262|NCT02248974|37989009|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
16898263|NCT02246166|37989017|FG000|Overall Study|Protocol Violation|1|||
16898264|NCT02246166|37989018|FG001|Overall Study|Protocol Violation|0|||
16898265|NCT02706847|37989027|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
16898266|NCT02706847|37989028|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
16898267|NCT02706847|37989029|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
16898268|NCT02706847|37989030|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
16898269|NCT02706847|37989027|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
16898270|NCT02706847|37989028|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
16898271|NCT02706847|37989029|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
16898272|NCT02706847|37989030|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
16898273|NCT02706847|37989027|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
16898274|NCT02706847|37989028|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
16898275|NCT02706847|37989029|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
16898276|NCT02706847|37989030|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
16898277|NCT02706847|37989027|FG000|Period 1: Day 1 to Week 12|Other|4|||
16898278|NCT02706847|37989028|FG001|Period 1: Day 1 to Week 12|Other|4|||
17095503|NCT00071812|38234781|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
17192445|NCT01342081|38345714|FG001|Overall Study|Did not receive allocated intervention|0|||
17192446|NCT01342081|38345715|FG002|Overall Study|Did not receive allocated intervention|1|||
17192447|NCT01342081|38345713|FG000|Overall Study|Adverse Event|1|||
17192448|NCT01342081|38345714|FG001|Overall Study|Adverse Event|0|||
16898279|NCT02706847|37989029|FG002|Period 1: Day 1 to Week 12|Other|2|||
16898280|NCT02706847|37989030|FG003|Period 1: Day 1 to Week 12|Other|2|||
16898281|NCT02706847|37989027|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
16898282|NCT02706847|37989028|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
16898283|NCT02706847|37989029|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
16898284|NCT02706847|37989030|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
16898285|NCT02706847|37989027|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
16898286|NCT02706847|37989028|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
16898287|NCT02706847|37989029|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
16898288|NCT02706847|37989030|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
16898289|NCT02706847|37989027|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
16898290|NCT02706847|37989028|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
16898291|NCT02706847|37989029|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
16898292|NCT02706847|37989030|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
17004519|NCT00620659|38148264|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17004520|NCT00620659|38148265|FG001|Treatment Period 2|Withdrawal by Subject|0|||
17004521|NCT00620659|38148266|FG002|Treatment Period 2|Withdrawal by Subject|1|||
17004522|NCT00620659|38148267|FG003|Treatment Period 2|Withdrawal by Subject|0|||
17004523|NCT00620659|38148268|FG004|Treatment Period 2|Withdrawal by Subject|3|||
17004524|NCT00620659|38148269|FG005|Treatment Period 2|Withdrawal by Subject|0|||
17004525|NCT00620659|38148264|FG000|Placebo Washout Period 2|Adverse Event|2|||
17004526|NCT00620659|38148265|FG001|Placebo Washout Period 2|Adverse Event|0|||
17004527|NCT00620659|38148266|FG002|Placebo Washout Period 2|Adverse Event|0|||
17004528|NCT00620659|38148267|FG003|Placebo Washout Period 2|Adverse Event|0|||
17004529|NCT00620659|38148268|FG004|Placebo Washout Period 2|Adverse Event|0|||
17004530|NCT00620659|38148269|FG005|Placebo Washout Period 2|Adverse Event|0|||
17004531|NCT00620659|38148264|FG000|Treatment Period 3|Adverse Event|0|||
17004532|NCT00620659|38148265|FG001|Treatment Period 3|Adverse Event|2|||
17004533|NCT00620659|38148266|FG002|Treatment Period 3|Adverse Event|0|||
17004534|NCT00620659|38148267|FG003|Treatment Period 3|Adverse Event|0|||
17004535|NCT00620659|38148268|FG004|Treatment Period 3|Adverse Event|0|||
17004536|NCT00620659|38148269|FG005|Treatment Period 3|Adverse Event|0|||
17004537|NCT00620659|38148264|FG000|Treatment Period 3|Withdrawal by Subject|0|||
17004538|NCT00620659|38148265|FG001|Treatment Period 3|Withdrawal by Subject|0|||
17004539|NCT00620659|38148266|FG002|Treatment Period 3|Withdrawal by Subject|0|||
17004540|NCT00620659|38148267|FG003|Treatment Period 3|Withdrawal by Subject|1|||
17004541|NCT00620659|38148268|FG004|Treatment Period 3|Withdrawal by Subject|0|||
17004542|NCT00620659|38148269|FG005|Treatment Period 3|Withdrawal by Subject|0|||
17004543|NCT00894686|38148282|FG000|Overall Study|Withdrawal by Subject|50|||
17004544|NCT00894686|38148282|FG000|Overall Study|Physician Decision|1|||
17004545|NCT00894686|38148282|FG000|Overall Study|Other|5|||
17004546|NCT00885846|38148289|FG000|Overall Study|Withdrawal by Subject|2|||
17004547|NCT00885846|38148290|FG001|Overall Study|Withdrawal by Subject|5|||
17004548|NCT00885846|38148291|FG002|Overall Study|Withdrawal by Subject|2|||
17004549|NCT00621517|38148301|FG000|Overall Study|Lost to Follow-up|3|||
17004550|NCT00621517|38148302|FG001|Overall Study|Lost to Follow-up|3|||
17004551|NCT00621517|38148301|FG000|Overall Study|Withdrawal by Subject|3|||
17004552|NCT00621517|38148302|FG001|Overall Study|Withdrawal by Subject|4|||
17004553|NCT00621517|38148301|FG000|Overall Study|Adverse Event|1|||
17004554|NCT00621517|38148302|FG001|Overall Study|Adverse Event|0|||
17004555|NCT00573937|38148310|FG000|Overall Study|Study Terminated|0|||
17004556|NCT00573937|38148311|FG001|Overall Study|Study Terminated|1|||
17004557|NCT00573859|38148317|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
17004558|NCT00573859|38148317|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
17004559|NCT00831441|38148323|FG000|Randomized|Death|82|||
17004560|NCT00831441|38148324|FG001|Randomized|Death|81|||
17004561|NCT00831441|38148323|FG000|Randomized|Adverse Event|248|||
17004562|NCT00831441|38148324|FG001|Randomized|Adverse Event|321|||
17004563|NCT00831441|38148323|FG000|Randomized|Emergency procedure|2|||
17004564|NCT00831441|38148324|FG001|Randomized|Emergency procedure|2|||
17004565|NCT00831441|38148323|FG000|Randomized|Elective procedure|26|||
17004566|NCT00831441|38148324|FG001|Randomized|Elective procedure|25|||
17004567|NCT00831441|38148323|FG000|Randomized|Physician Decision|26|||
17004568|NCT00831441|38148324|FG001|Randomized|Physician Decision|35|||
17004569|NCT00831441|38148323|FG000|Randomized|No longer met criteria|13|||
17004570|NCT00831441|38148324|FG001|Randomized|No longer met criteria|19|||
17004571|NCT00831441|38148323|FG000|Randomized|Withdrawal by Subject|178|||
17004572|NCT00831441|38148324|FG001|Randomized|Withdrawal by Subject|212|||
17004573|NCT00831441|38148323|FG000|Randomized|Lost to Follow-up|26|||
17004574|NCT00831441|38148324|FG001|Randomized|Lost to Follow-up|35|||
17004575|NCT00831441|38148323|FG000|Randomized|Administrative reason by sponsor|2780|||
17004576|NCT00831441|38148324|FG001|Randomized|Administrative reason by sponsor|2671|||
17004577|NCT00831441|38148323|FG000|Randomized|poor/non-compliance|30|||
17004578|NCT00831441|38148324|FG001|Randomized|poor/non-compliance|38|||
17004579|NCT00831441|38148323|FG000|Randomized|non-specified|276|||
17004580|NCT00831441|38148324|FG001|Randomized|non-specified|266|||
17004581|NCT00831441|38148323|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
17004582|NCT00831441|38148324|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
17004583|NCT00831441|38148323|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
17004584|NCT00831441|38148324|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
17004585|NCT00831441|38148323|FG000|Follow Up (30 Days)|Death|63|||
17004586|NCT00831441|38148324|FG001|Follow Up (30 Days)|Death|86|||
17004587|NCT00831441|38148323|FG000|Follow Up (30 Days)|non-specified|16|||
17004588|NCT00831441|38148324|FG001|Follow Up (30 Days)|non-specified|26|||
17004589|NCT00831441|38148323|FG000|Follow Up (30 Days)|missing end of study status|0|||
17004590|NCT00831441|38148324|FG001|Follow Up (30 Days)|missing end of study status|1|||
17004591|NCT00831129|38148333|FG000|Overall Study|Adverse Event|0|||
17004592|NCT00831129|38148334|FG001|Overall Study|Adverse Event|1|||
17004593|NCT00831129|38148333|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
17004594|NCT00831129|38148334|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
17004595|NCT00620113|38148344|FG000|Overall Study|Adverse Event|3|||
17004596|NCT00620113|38148345|FG001|Overall Study|Adverse Event|2|||
17004597|NCT00620113|38148346|FG002|Overall Study|Adverse Event|2|||
17004598|NCT00620113|38148347|FG003|Overall Study|Adverse Event|1|||
17004599|NCT00620113|38148344|FG000|Overall Study|Lack of Efficacy|2|||
17004600|NCT00620113|38148345|FG001|Overall Study|Lack of Efficacy|3|||
17004601|NCT00620113|38148346|FG002|Overall Study|Lack of Efficacy|0|||
17004602|NCT00620113|38148347|FG003|Overall Study|Lack of Efficacy|2|||
17004603|NCT00620113|38148344|FG000|Overall Study|Physician Decision|1|||
17004604|NCT00620113|38148345|FG001|Overall Study|Physician Decision|0|||
17004605|NCT00620113|38148346|FG002|Overall Study|Physician Decision|0|||
17004606|NCT00620113|38148347|FG003|Overall Study|Physician Decision|2|||
17004607|NCT00620113|38148344|FG000|Overall Study|Protocol Violation|2|||
17004608|NCT00620113|38148345|FG001|Overall Study|Protocol Violation|1|||
17004609|NCT00620113|38148346|FG002|Overall Study|Protocol Violation|0|||
17004610|NCT00620113|38148347|FG003|Overall Study|Protocol Violation|0|||
17004611|NCT00620113|38148344|FG000|Overall Study|Withdrawal by Subject|5|||
17004612|NCT00620113|38148345|FG001|Overall Study|Withdrawal by Subject|1|||
17004613|NCT00620113|38148346|FG002|Overall Study|Withdrawal by Subject|3|||
17004614|NCT00620113|38148347|FG003|Overall Study|Withdrawal by Subject|5|||
17004615|NCT00830115|38148357|FG000|Overall Study|Adverse Event|2|||
17004616|NCT00830115|38148357|FG000|Overall Study|Improvement/recovery|1|||
17004617|NCT00830037|38148365|FG000|Overall Study|Withdrawal by Subject|2|||
17004618|NCT00830037|38148366|FG001|Overall Study|Withdrawal by Subject|3|||
17004619|NCT00830037|38148365|FG000|Overall Study|Lost to Follow-up|1|||
17004620|NCT00830037|38148366|FG001|Overall Study|Lost to Follow-up|2|||
17004621|NCT00830037|38148365|FG000|Overall Study|Active when terminated by DSMB|15|||
17004622|NCT00830037|38148366|FG001|Overall Study|Active when terminated by DSMB|14|||
17004623|NCT00829413|38148372|FG000|Overall Study|No study drug admimnistered|13|||
17004624|NCT00829413|38148372|FG000|Overall Study|Training Patients|67|||
17004625|NCT00829413|38148372|FG000|Overall Study|No truth standard procedure available|9|||
17004626|NCT00829413|38148372|FG000|Overall Study|Technically inadequate truth standard|2|||
17004627|NCT00829413|38148372|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
17004628|NCT00829179|38148383|FG000|Overall Study|Withdrawal by Subject|1|||
17004629|NCT00591591|38148389|FG000|Overall Study|Withdrawal by Subject|1|||
16898293|NCT02706847|37989027|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
16898294|NCT02706847|37989028|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
16898295|NCT02706847|37989029|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
16898296|NCT02706847|37989030|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
16898297|NCT02706847|37989027|FG000|Period 1: Week 12 to Week 24|Other|1|||
16898298|NCT02706847|37989028|FG001|Period 1: Week 12 to Week 24|Other|0|||
16898299|NCT02706847|37989029|FG002|Period 1: Week 12 to Week 24|Other|1|||
16898300|NCT02706847|37989030|FG003|Period 1: Week 12 to Week 24|Other|4|||
16898301|NCT02706847|37989027|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
16898302|NCT02706847|37989028|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
16898303|NCT02706847|37989029|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
16898304|NCT02706847|37989030|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
16898305|NCT02706847|37989027|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
16898306|NCT02706847|37989028|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
16898307|NCT02706847|37989029|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
16898308|NCT02706847|37989030|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
16898309|NCT02706847|37989027|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
16898310|NCT02706847|37989028|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
16898311|NCT02706847|37989029|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
17004630|NCT00591591|38148390|FG001|Overall Study|Withdrawal by Subject|37|||
17004631|NCT00591591|38148389|FG000|Overall Study|Lack of Efficacy|10|||
17004632|NCT00591591|38148390|FG001|Overall Study|Lack of Efficacy|2|||
17004633|NCT00828945|38148396|FG000|Overall Study|Death|4|||
17004634|NCT00828945|38148396|FG000|Overall Study|Participant was missing|1|||
16786144|NCT02687815|37726508|FG001|Overall Study|Lost to Follow-up|4|||
17004635|NCT00828945|38148396|FG000|Overall Study|Other|36|||
17004636|NCT00966875|38148409|FG000|Part A|Adverse Event|2|||
17004637|NCT00966875|38148410|FG001|Part A|Adverse Event|1|||
16898312|NCT02706847|37989030|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
16898313|NCT02706847|37989027|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
16898314|NCT02706847|37989028|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
16898315|NCT02706847|37989029|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
16898316|NCT02706847|37989030|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
16898317|NCT02706847|37989027|FG000|Period 2: Week 24 to Week 260|Other|8|||
16898318|NCT02706847|37989028|FG001|Period 2: Week 24 to Week 260|Other|5|||
16898319|NCT02706847|37989029|FG002|Period 2: Week 24 to Week 260|Other|15|||
16898320|NCT02706847|37989030|FG003|Period 2: Week 24 to Week 260|Other|15|||
16898321|NCT02245620|37989043|FG000|Overall Study|Physician Decision|1|||
16898322|NCT02245620|37989044|FG001|Overall Study|Physician Decision|1|||
16898323|NCT02244996|37989052|FG000|Overall Study|Lack of Efficacy|2|||
16898324|NCT02244996|37989053|FG001|Overall Study|Lack of Efficacy|6|||
16898325|NCT02243280|37989088|FG000|Treated|Adverse Event|1|||
16898326|NCT02243280|37989089|FG001|Treated|Adverse Event|0|||
16898327|NCT02243280|37989090|FG002|Treated|Adverse Event|0|||
16898328|NCT02243280|37989091|FG003|Treated|Adverse Event|0|||
17004638|NCT00966875|38148411|FG002|Part A|Adverse Event|0|||
17004639|NCT00966875|38148412|FG003|Part A|Adverse Event|1|||
17004640|NCT00966875|38148413|FG004|Part A|Adverse Event|0|||
17004641|NCT00966875|38148414|FG005|Part A|Adverse Event|1|||
17004642|NCT00966875|38148415|FG006|Part A|Adverse Event|0|||
17004643|NCT00966875|38148416|FG007|Part A|Adverse Event|3|||
16898329|NCT02243280|37989092|FG004|Treated|Adverse Event|0|||
16898330|NCT02243280|37989093|FG005|Treated|Adverse Event|0|||
16898331|NCT02243280|37989094|FG006|Treated|Adverse Event|0|||
16898332|NCT02243280|37989095|FG007|Treated|Adverse Event|0|||
16898333|NCT02243280|37989096|FG008|Treated|Adverse Event|0|||
16898334|NCT02243280|37989097|FG009|Treated|Adverse Event|0|||
16898335|NCT02243280|37989098|FG010|Treated|Adverse Event|1|||
16898336|NCT02243280|37989088|FG000|Treated|Lost to Follow-up|0|||
16898337|NCT02243280|37989089|FG001|Treated|Lost to Follow-up|0|||
16898338|NCT02243280|37989090|FG002|Treated|Lost to Follow-up|0|||
16898339|NCT02243280|37989091|FG003|Treated|Lost to Follow-up|0|||
16898340|NCT02243280|37989092|FG004|Treated|Lost to Follow-up|0|||
16898341|NCT02243280|37989093|FG005|Treated|Lost to Follow-up|0|||
16898342|NCT02243280|37989094|FG006|Treated|Lost to Follow-up|0|||
16898343|NCT02243280|37989095|FG007|Treated|Lost to Follow-up|0|||
16898344|NCT02243280|37989096|FG008|Treated|Lost to Follow-up|1|||
16898345|NCT02243280|37989097|FG009|Treated|Lost to Follow-up|0|||
16898346|NCT02243280|37989098|FG010|Treated|Lost to Follow-up|2|||
16898347|NCT02248818|37989156|FG000|Screening|Protocol Violation|0|||
16898348|NCT02248818|37989157|FG001|Screening|Protocol Violation|0|||
16898349|NCT02248818|37989158|FG002|Screening|Protocol Violation|0|||
16898350|NCT02248818|37989159|FG003|Screening|Protocol Violation|0|||
16898351|NCT02248818|37989160|FG004|Screening|Protocol Violation|0|||
16898352|NCT02248818|37989161|FG005|Screening|Protocol Violation|0|||
16898353|NCT02248818|37989162|FG006|Screening|Protocol Violation|0|||
16898354|NCT02248818|37989163|FG007|Screening|Protocol Violation|0|||
16898355|NCT02248818|37989164|FG008|Screening|Protocol Violation|7|||
16898356|NCT02248818|37989156|FG000|Screening|Study fully enrolled|0|||
16898357|NCT02248818|37989157|FG001|Screening|Study fully enrolled|0|||
16898358|NCT02248818|37989158|FG002|Screening|Study fully enrolled|0|||
17004644|NCT00966875|38148417|FG008|Part A|Adverse Event|3|||
16898359|NCT02248818|37989159|FG003|Screening|Study fully enrolled|0|||
16898360|NCT02248818|37989160|FG004|Screening|Study fully enrolled|0|||
16898361|NCT02248818|37989161|FG005|Screening|Study fully enrolled|0|||
16898362|NCT02248818|37989162|FG006|Screening|Study fully enrolled|0|||
16898363|NCT02248818|37989163|FG007|Screening|Study fully enrolled|0|||
16898364|NCT02248818|37989164|FG008|Screening|Study fully enrolled|14|||
16898365|NCT02248818|37989156|FG000|Screening|Physician Decision|0|||
16898366|NCT02248818|37989157|FG001|Screening|Physician Decision|0|||
16898367|NCT02248818|37989158|FG002|Screening|Physician Decision|0|||
16898368|NCT02248818|37989159|FG003|Screening|Physician Decision|0|||
16898369|NCT02248818|37989160|FG004|Screening|Physician Decision|0|||
16898370|NCT02248818|37989161|FG005|Screening|Physician Decision|0|||
16898371|NCT02248818|37989162|FG006|Screening|Physician Decision|0|||
16898372|NCT02248818|37989163|FG007|Screening|Physician Decision|0|||
16898373|NCT02248818|37989164|FG008|Screening|Physician Decision|73|||
16898374|NCT02248818|37989156|FG000|Screening|Withdrawal by Subject|0|||
16898375|NCT02248818|37989157|FG001|Screening|Withdrawal by Subject|0|||
16898376|NCT02248818|37989158|FG002|Screening|Withdrawal by Subject|0|||
16898377|NCT02248818|37989159|FG003|Screening|Withdrawal by Subject|0|||
16898378|NCT02248818|37989160|FG004|Screening|Withdrawal by Subject|0|||
16898379|NCT02248818|37989161|FG005|Screening|Withdrawal by Subject|0|||
16898380|NCT02248818|37989162|FG006|Screening|Withdrawal by Subject|0|||
16898381|NCT02248818|37989163|FG007|Screening|Withdrawal by Subject|0|||
16898382|NCT02248818|37989164|FG008|Screening|Withdrawal by Subject|6|||
17004645|NCT00966875|38148409|FG000|Part A|Entry Criteria|0|||
17004646|NCT00966875|38148410|FG001|Part A|Entry Criteria|0|||
17004647|NCT00966875|38148411|FG002|Part A|Entry Criteria|0|||
17004648|NCT00966875|38148412|FG003|Part A|Entry Criteria|0|||
17004649|NCT00966875|38148413|FG004|Part A|Entry Criteria|0|||
17004650|NCT00966875|38148414|FG005|Part A|Entry Criteria|2|||
17004651|NCT00966875|38148415|FG006|Part A|Entry Criteria|0|||
17004652|NCT00966875|38148416|FG007|Part A|Entry Criteria|0|||
17004653|NCT00966875|38148417|FG008|Part A|Entry Criteria|0|||
17004654|NCT00966875|38148409|FG000|Part A|Lack of Efficacy|0|||
17004655|NCT00966875|38148410|FG001|Part A|Lack of Efficacy|1|||
16898383|NCT02248818|37989156|FG000|Screening|Lost to Follow-up|0|||
16898384|NCT02248818|37989157|FG001|Screening|Lost to Follow-up|0|||
16898385|NCT02248818|37989158|FG002|Screening|Lost to Follow-up|0|||
16898386|NCT02248818|37989159|FG003|Screening|Lost to Follow-up|0|||
16898387|NCT02248818|37989160|FG004|Screening|Lost to Follow-up|0|||
16898388|NCT02248818|37989161|FG005|Screening|Lost to Follow-up|0|||
16898389|NCT02248818|37989162|FG006|Screening|Lost to Follow-up|0|||
16898390|NCT02248818|37989163|FG007|Screening|Lost to Follow-up|0|||
16898391|NCT02248818|37989164|FG008|Screening|Lost to Follow-up|7|||
16898392|NCT02248818|37989156|FG000|Randomised Study|Administrative - randomization error|0|||
16898393|NCT02248818|37989157|FG001|Randomised Study|Administrative - randomization error|0|||
16898394|NCT02248818|37989158|FG002|Randomised Study|Administrative - randomization error|0|||
16898395|NCT02248818|37989159|FG003|Randomised Study|Administrative - randomization error|0|||
16898396|NCT02248818|37989160|FG004|Randomised Study|Administrative - randomization error|0|||
16898397|NCT02248818|37989161|FG005|Randomised Study|Administrative - randomization error|8|||
16898398|NCT02248818|37989162|FG006|Randomised Study|Administrative - randomization error|0|||
16898399|NCT02248818|37989163|FG007|Randomised Study|Administrative - randomization error|0|||
16898400|NCT02248818|37989164|FG008|Randomised Study|Administrative - randomization error|0|||
16898401|NCT02247960|37989193|FG000|Patient Consent and Randomization|Physician Decision|2|||
16898402|NCT02247960|37989194|FG001|Patient Consent and Randomization|Physician Decision|2|||
16898403|NCT02247960|37989193|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
16898404|NCT02247960|37989194|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
16898405|NCT02247960|37989193|FG000|Catheter Removed|Lost to Follow-up|7|||
16898406|NCT02247960|37989194|FG001|Catheter Removed|Lost to Follow-up|10|||
16898407|NCT02247804|37989283|FG000|Treatment Period 1|Adverse Event|9|||
16898408|NCT02247804|37989284|FG001|Treatment Period 1|Adverse Event|2|||
16898409|NCT02247804|37989285|FG002|Treatment Period 1|Adverse Event|0|||
16898410|NCT02247804|37989283|FG000|Treatment Period 1|Lack of Efficacy|0|||
16898411|NCT02247804|37989284|FG001|Treatment Period 1|Lack of Efficacy|0|||
16898412|NCT02247804|37989285|FG002|Treatment Period 1|Lack of Efficacy|2|||
16898413|NCT02247804|37989283|FG000|Treatment Period 1|Lost to Follow-up|1|||
16898414|NCT02247804|37989284|FG001|Treatment Period 1|Lost to Follow-up|0|||
16898415|NCT02247804|37989285|FG002|Treatment Period 1|Lost to Follow-up|2|||
16898416|NCT02247804|37989283|FG000|Treatment Period 1|Personal Reasons|7|||
16898417|NCT02247804|37989284|FG001|Treatment Period 1|Personal Reasons|1|||
16898418|NCT02247804|37989285|FG002|Treatment Period 1|Personal Reasons|2|||
16898419|NCT02247804|37989283|FG000|Treatment Period 1|Protocol Deviation|0|||
16898420|NCT02247804|37989284|FG001|Treatment Period 1|Protocol Deviation|0|||
16898421|NCT02247804|37989285|FG002|Treatment Period 1|Protocol Deviation|1|||
16898422|NCT02247804|37989283|FG000|Treatment Period 1|Randomized but not Treated|5|||
16898423|NCT02247804|37989284|FG001|Treatment Period 1|Randomized but not Treated|1|||
16898424|NCT02247804|37989285|FG002|Treatment Period 1|Randomized but not Treated|1|||
16898425|NCT02247804|37989283|FG000|Treatment Period 2|Adverse Event|6|||
16898426|NCT02247804|37989284|FG001|Treatment Period 2|Adverse Event|3|||
16898427|NCT02247804|37989285|FG002|Treatment Period 2|Adverse Event|3|||
16898428|NCT02247804|37989283|FG000|Treatment Period 2|Lack of Efficacy|0|||
16898429|NCT02247804|37989284|FG001|Treatment Period 2|Lack of Efficacy|0|||
16898430|NCT02247804|37989285|FG002|Treatment Period 2|Lack of Efficacy|1|||
16898431|NCT02247804|37989283|FG000|Treatment Period 2|Lost to Follow-up|0|||
16898432|NCT02247804|37989284|FG001|Treatment Period 2|Lost to Follow-up|1|||
16898433|NCT02247804|37989285|FG002|Treatment Period 2|Lost to Follow-up|1|||
16898434|NCT02247804|37989283|FG000|Treatment Period 2|Personal Reasons|2|||
16898435|NCT02247804|37989284|FG001|Treatment Period 2|Personal Reasons|1|||
16898436|NCT02247804|37989285|FG002|Treatment Period 2|Personal Reasons|1|||
16898437|NCT02247804|37989283|FG000|Treatment Period 2|Reason not Specified|0|||
16898438|NCT02247804|37989284|FG001|Treatment Period 2|Reason not Specified|0|||
16898439|NCT02247804|37989285|FG002|Treatment Period 2|Reason not Specified|2|||
17004656|NCT00966875|38148411|FG002|Part A|Lack of Efficacy|0|||
17004657|NCT00966875|38148412|FG003|Part A|Lack of Efficacy|0|||
17004658|NCT00966875|38148413|FG004|Part A|Lack of Efficacy|0|||
17004659|NCT00966875|38148414|FG005|Part A|Lack of Efficacy|0|||
17095504|NCT00071812|38234778|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
17192449|NCT01342081|38345715|FG002|Overall Study|Adverse Event|0|||
16898440|NCT02247804|37989283|FG000|Treatment Period 3|Adverse Event|4|||
16898441|NCT02247804|37989284|FG001|Treatment Period 3|Adverse Event|3|||
17004660|NCT00966875|38148415|FG006|Part A|Lack of Efficacy|4|||
17004661|NCT00966875|38148416|FG007|Part A|Lack of Efficacy|0|||
17004662|NCT00966875|38148417|FG008|Part A|Lack of Efficacy|0|||
17004663|NCT00966875|38148409|FG000|Part A|Lost to Follow-up|2|||
17004664|NCT00966875|38148410|FG001|Part A|Lost to Follow-up|0|||
17004665|NCT00966875|38148411|FG002|Part A|Lost to Follow-up|0|||
17004666|NCT00966875|38148412|FG003|Part A|Lost to Follow-up|0|||
17004667|NCT00966875|38148413|FG004|Part A|Lost to Follow-up|0|||
17004668|NCT00966875|38148414|FG005|Part A|Lost to Follow-up|1|||
17004669|NCT00966875|38148415|FG006|Part A|Lost to Follow-up|0|||
17004670|NCT00966875|38148416|FG007|Part A|Lost to Follow-up|0|||
17004671|NCT00966875|38148417|FG008|Part A|Lost to Follow-up|0|||
17004672|NCT00966875|38148409|FG000|Part A|Parent/Caregiver Decision|0|||
17004673|NCT00966875|38148410|FG001|Part A|Parent/Caregiver Decision|0|||
17004674|NCT00966875|38148411|FG002|Part A|Parent/Caregiver Decision|0|||
17004675|NCT00966875|38148412|FG003|Part A|Parent/Caregiver Decision|1|||
17004676|NCT00966875|38148413|FG004|Part A|Parent/Caregiver Decision|0|||
17004677|NCT00966875|38148414|FG005|Part A|Parent/Caregiver Decision|0|||
16898442|NCT02247804|37989285|FG002|Treatment Period 3|Adverse Event|3|||
16898443|NCT02247804|37989283|FG000|Treatment Period 3|Lack of Efficacy|0|||
17004678|NCT00966875|38148415|FG006|Part A|Parent/Caregiver Decision|0|||
17004679|NCT00966875|38148416|FG007|Part A|Parent/Caregiver Decision|0|||
17004680|NCT00966875|38148417|FG008|Part A|Parent/Caregiver Decision|0|||
17004681|NCT00966875|38148409|FG000|Part A|Physician Decision|0|||
17004682|NCT00966875|38148410|FG001|Part A|Physician Decision|0|||
17004683|NCT00966875|38148411|FG002|Part A|Physician Decision|0|||
17004684|NCT00966875|38148412|FG003|Part A|Physician Decision|0|||
17004685|NCT00966875|38148413|FG004|Part A|Physician Decision|1|||
17004686|NCT00966875|38148414|FG005|Part A|Physician Decision|0|||
17004687|NCT00966875|38148415|FG006|Part A|Physician Decision|1|||
16898444|NCT02247804|37989284|FG001|Treatment Period 3|Lack of Efficacy|1|||
16898445|NCT02247804|37989285|FG002|Treatment Period 3|Lack of Efficacy|0|||
16898446|NCT02247804|37989283|FG000|Treatment Period 3|Lost to Follow-up|1|||
16898447|NCT02247804|37989284|FG001|Treatment Period 3|Lost to Follow-up|2|||
16898448|NCT02247804|37989285|FG002|Treatment Period 3|Lost to Follow-up|2|||
16898449|NCT02247804|37989283|FG000|Treatment Period 3|Personal Reasons|4|||
16898450|NCT02247804|37989284|FG001|Treatment Period 3|Personal Reasons|3|||
16898451|NCT02247804|37989285|FG002|Treatment Period 3|Personal Reasons|2|||
16898452|NCT02247804|37989283|FG000|Treatment Period 3|Reason not Specified|2|||
16898453|NCT02247804|37989284|FG001|Treatment Period 3|Reason not Specified|1|||
16898454|NCT02247804|37989285|FG002|Treatment Period 3|Reason not Specified|3|||
17004688|NCT00966875|38148416|FG007|Part A|Physician Decision|0|||
17004689|NCT00966875|38148417|FG008|Part A|Physician Decision|2|||
17004690|NCT00966875|38148409|FG000|Part A|Sponsor Decision|0|||
17004691|NCT00966875|38148410|FG001|Part A|Sponsor Decision|0|||
17004692|NCT00966875|38148411|FG002|Part A|Sponsor Decision|1|||
17004693|NCT00966875|38148412|FG003|Part A|Sponsor Decision|0|||
17004694|NCT00966875|38148413|FG004|Part A|Sponsor Decision|1|||
17004695|NCT00966875|38148414|FG005|Part A|Sponsor Decision|0|||
17004696|NCT00966875|38148415|FG006|Part A|Sponsor Decision|0|||
17004697|NCT00966875|38148416|FG007|Part A|Sponsor Decision|2|||
17004698|NCT00966875|38148417|FG008|Part A|Sponsor Decision|1|||
17004699|NCT00966875|38148409|FG000|Part A|Withdrawal by Subject|2|||
17004700|NCT00966875|38148410|FG001|Part A|Withdrawal by Subject|2|||
17004701|NCT00966875|38148411|FG002|Part A|Withdrawal by Subject|1|||
17004702|NCT00966875|38148412|FG003|Part A|Withdrawal by Subject|1|||
17004703|NCT00966875|38148413|FG004|Part A|Withdrawal by Subject|3|||
17004704|NCT00966875|38148414|FG005|Part A|Withdrawal by Subject|0|||
17004705|NCT00966875|38148415|FG006|Part A|Withdrawal by Subject|5|||
17004706|NCT00966875|38148416|FG007|Part A|Withdrawal by Subject|1|||
17004707|NCT00966875|38148417|FG008|Part A|Withdrawal by Subject|1|||
17004708|NCT00966875|38148409|FG000|Part A|Protocol Violation|0|||
17004709|NCT00966875|38148410|FG001|Part A|Protocol Violation|0|||
17004710|NCT00966875|38148411|FG002|Part A|Protocol Violation|0|||
17004711|NCT00966875|38148412|FG003|Part A|Protocol Violation|0|||
17004712|NCT00966875|38148413|FG004|Part A|Protocol Violation|0|||
17004713|NCT00966875|38148414|FG005|Part A|Protocol Violation|0|||
17004714|NCT00966875|38148415|FG006|Part A|Protocol Violation|2|||
17004715|NCT00966875|38148416|FG007|Part A|Protocol Violation|1|||
17004716|NCT00966875|38148417|FG008|Part A|Protocol Violation|1|||
17004717|NCT00966875|38148409|FG000|Part B|Adverse Event|0|||
17004718|NCT00966875|38148410|FG001|Part B|Adverse Event|1|||
17004719|NCT00966875|38148411|FG002|Part B|Adverse Event|1|||
17095505|NCT00071812|38234779|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
17004720|NCT00966875|38148412|FG003|Part B|Adverse Event|0|||
17004721|NCT00966875|38148413|FG004|Part B|Adverse Event|1|||
17004722|NCT00966875|38148414|FG005|Part B|Adverse Event|0|||
17004723|NCT00966875|38148415|FG006|Part B|Adverse Event|5|||
17004724|NCT00966875|38148416|FG007|Part B|Adverse Event|2|||
17004725|NCT00966875|38148417|FG008|Part B|Adverse Event|2|||
17004726|NCT00966875|38148409|FG000|Part B|Death|0|||
17004727|NCT00966875|38148410|FG001|Part B|Death|0|||
17004728|NCT00966875|38148411|FG002|Part B|Death|1|||
17004729|NCT00966875|38148412|FG003|Part B|Death|0|||
17004730|NCT00966875|38148413|FG004|Part B|Death|0|||
17004731|NCT00966875|38148414|FG005|Part B|Death|0|||
17004732|NCT00966875|38148415|FG006|Part B|Death|0|||
17004733|NCT00966875|38148416|FG007|Part B|Death|1|||
17004734|NCT00966875|38148417|FG008|Part B|Death|0|||
17004735|NCT00966875|38148409|FG000|Part B|Lack of Efficacy|2|||
17004736|NCT00966875|38148410|FG001|Part B|Lack of Efficacy|1|||
17004737|NCT00966875|38148411|FG002|Part B|Lack of Efficacy|1|||
17004738|NCT00966875|38148412|FG003|Part B|Lack of Efficacy|1|||
16898455|NCT02243202|37989310|FG000|Overall Study|Adverse Event|5|||
16898456|NCT02243202|37989311|FG001|Overall Study|Adverse Event|6|||
16898457|NCT02243202|37989312|FG002|Overall Study|Adverse Event|10|||
16898458|NCT02243202|37989313|FG003|Overall Study|Adverse Event|4|||
16898459|NCT02243202|37989310|FG000|Overall Study|Lost to Follow-up|9|||
16898460|NCT02243202|37989311|FG001|Overall Study|Lost to Follow-up|9|||
16898461|NCT02243202|37989312|FG002|Overall Study|Lost to Follow-up|14|||
16898462|NCT02243202|37989313|FG003|Overall Study|Lost to Follow-up|11|||
16898463|NCT02243202|37989310|FG000|Overall Study|Protocol Violation|3|||
16898464|NCT02243202|37989311|FG001|Overall Study|Protocol Violation|1|||
16898465|NCT02243202|37989312|FG002|Overall Study|Protocol Violation|2|||
16898466|NCT02243202|37989313|FG003|Overall Study|Protocol Violation|1|||
16898467|NCT02243202|37989310|FG000|Overall Study|Withdrawal by Subject|7|||
16898468|NCT02243202|37989311|FG001|Overall Study|Withdrawal by Subject|6|||
16898469|NCT02243202|37989312|FG002|Overall Study|Withdrawal by Subject|4|||
16898470|NCT02243202|37989313|FG003|Overall Study|Withdrawal by Subject|4|||
16898471|NCT02243202|37989310|FG000|Overall Study|Other|1|||
16898472|NCT02243202|37989311|FG001|Overall Study|Other|3|||
16898473|NCT02243202|37989312|FG002|Overall Study|Other|1|||
16898474|NCT02243202|37989313|FG003|Overall Study|Other|2|||
16898475|NCT02243202|37989310|FG000|Overall Study|Randomized but not received treatment|0|||
16898476|NCT02243202|37989311|FG001|Overall Study|Randomized but not received treatment|0|||
16898477|NCT02243202|37989312|FG002|Overall Study|Randomized but not received treatment|0|||
16898478|NCT02243202|37989313|FG003|Overall Study|Randomized but not received treatment|1|||
16898479|NCT02243046|37989326|FG000|Overall Study|Lost to Follow-up|1|||
16898480|NCT02243046|37989327|FG001|Overall Study|Lost to Follow-up|1|||
16898481|NCT02243046|37989328|FG002|Overall Study|Lost to Follow-up|4|||
16898482|NCT02207946|37989338|FG000|Overall Study|Lost to Follow-up|1|||
16898483|NCT02207946|37989339|FG001|Overall Study|Lost to Follow-up|0|||
16898484|NCT02207946|37989338|FG000|Overall Study|Adverse Event|0|||
16898485|NCT02207946|37989339|FG001|Overall Study|Adverse Event|1|||
16898486|NCT03976076|37989346|FG000|Overall Study|Withdrawal by Subject|2|||
16898487|NCT03732638|37989493|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
16898488|NCT03732638|37989494|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
16898489|NCT03732638|37989493|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
16898490|NCT03732638|37989494|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
16898491|NCT03732638|37989493|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
16898492|NCT03732638|37989494|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
16898493|NCT03732638|37989493|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
16898494|NCT03732638|37989494|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
16898495|NCT03732638|37989493|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
16898496|NCT03732638|37989494|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
16898497|NCT03732638|37989493|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
16898498|NCT03732638|37989494|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
16898499|NCT03732638|37989493|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
16898500|NCT03732638|37989494|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
16898501|NCT03732638|37989493|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
16898502|NCT03732638|37989494|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
16898503|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
16898504|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
16898505|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
17004739|NCT00966875|38148413|FG004|Part B|Lack of Efficacy|2|||
17004740|NCT00966875|38148414|FG005|Part B|Lack of Efficacy|3|||
16898506|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
16898507|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
16898508|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
16898509|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
16898510|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
16898511|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
16898512|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
16898513|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
16898514|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
16898515|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
16898516|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
16898517|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
16898518|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
16898519|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
16898520|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
16898521|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
16898522|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
16898523|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
16898524|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
16898525|NCT03732638|37989493|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
16898526|NCT03732638|37989494|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
16898527|NCT03732638|37989493|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
16898528|NCT03732638|37989494|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
16898529|NCT03732638|37989493|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
16898530|NCT03732638|37989494|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
16898531|NCT03732638|37989493|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
16898532|NCT03732638|37989494|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
16898533|NCT03732638|37989493|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
16898534|NCT03732638|37989494|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
16898535|NCT03551210|37989561|FG000|Overall Study|Adverse Event|5|||
16898536|NCT03551210|37989562|FG001|Overall Study|Adverse Event|6|||
16898537|NCT03551210|37989561|FG000|Overall Study|Withdrawal by Subject|1|||
16898538|NCT03551210|37989562|FG001|Overall Study|Withdrawal by Subject|7|||
16898539|NCT03551210|37989561|FG000|Overall Study|Needed in other antibiotic treatment|2|||
16898540|NCT03551210|37989562|FG001|Overall Study|Needed in other antibiotic treatment|5|||
16898541|NCT03551210|37989561|FG000|Overall Study|Lost to Follow-up|1|||
16898542|NCT03551210|37989562|FG001|Overall Study|Lost to Follow-up|1|||
16898543|NCT03551210|37989561|FG000|Overall Study|Absence of visit 4 and 5|1|||
16898544|NCT03551210|37989562|FG001|Overall Study|Absence of visit 4 and 5|0|||
16898545|NCT03551210|37989561|FG000|Overall Study|No drug for dispensing|0|||
16898546|NCT03551210|37989562|FG001|Overall Study|No drug for dispensing|1|||
16898547|NCT02207634|37989708|FG000|Overall Study|Withdrawal by Subject|21|||
16898548|NCT02207634|37989709|FG001|Overall Study|Withdrawal by Subject|31|||
16898549|NCT02207634|37989708|FG000|Overall Study|Lost to Follow-up|1|||
16898550|NCT02207634|37989709|FG001|Overall Study|Lost to Follow-up|0|||
16898551|NCT03452228|37989752|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
16898552|NCT03452228|37989753|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
16898553|NCT03452228|37989754|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
16898554|NCT03452228|37989752|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
16898555|NCT03452228|37989753|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
17004741|NCT00966875|38148415|FG006|Part B|Lack of Efficacy|12|||
17004742|NCT00966875|38148416|FG007|Part B|Lack of Efficacy|9|||
17004743|NCT00966875|38148417|FG008|Part B|Lack of Efficacy|6|||
17004744|NCT00966875|38148409|FG000|Part B|Lost to Follow-up|0|||
16898556|NCT03452228|37989754|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
16898557|NCT03452228|37989752|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
17004745|NCT00966875|38148410|FG001|Part B|Lost to Follow-up|0|||
17004746|NCT00966875|38148411|FG002|Part B|Lost to Follow-up|0|||
17004747|NCT00966875|38148412|FG003|Part B|Lost to Follow-up|1|||
17004748|NCT00966875|38148413|FG004|Part B|Lost to Follow-up|0|||
17004749|NCT00966875|38148414|FG005|Part B|Lost to Follow-up|0|||
16898558|NCT03452228|37989753|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
16898559|NCT03452228|37989754|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
16898560|NCT03452228|37989752|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16898561|NCT03452228|37989753|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16898562|NCT03452228|37989754|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
16898563|NCT02207556|37989817|FG000|Overall Study|Physician Decision|1|||
16898564|NCT02207556|37989818|FG001|Overall Study|Physician Decision|0|||
16898565|NCT02207556|37989817|FG000|Overall Study|Withdrawal by Subject|1|||
16898566|NCT02207556|37989818|FG001|Overall Study|Withdrawal by Subject|0|||
16898567|NCT02207556|37989817|FG000|Overall Study|Death|0|||
16898568|NCT02207556|37989818|FG001|Overall Study|Death|5|||
16898569|NCT03266588|37989848|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
17004750|NCT00966875|38148415|FG006|Part B|Lost to Follow-up|0|||
17004751|NCT00966875|38148416|FG007|Part B|Lost to Follow-up|0|||
17004752|NCT00966875|38148417|FG008|Part B|Lost to Follow-up|1|||
17004753|NCT00966875|38148409|FG000|Part B|Physician Decision|0|||
17004754|NCT00966875|38148410|FG001|Part B|Physician Decision|0|||
17004755|NCT00966875|38148411|FG002|Part B|Physician Decision|1|||
17004756|NCT00966875|38148412|FG003|Part B|Physician Decision|0|||
17004757|NCT00966875|38148413|FG004|Part B|Physician Decision|2|||
17004758|NCT00966875|38148414|FG005|Part B|Physician Decision|1|||
17004759|NCT00966875|38148415|FG006|Part B|Physician Decision|0|||
17004760|NCT00966875|38148416|FG007|Part B|Physician Decision|0|||
17004761|NCT00966875|38148417|FG008|Part B|Physician Decision|2|||
17192450|NCT01342081|38345713|FG000|Overall Study|Physician Decision|0|||
16898570|NCT03266588|37989849|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
16898571|NCT03266588|37989850|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
16898572|NCT03266588|37989848|FG000|Observational Period|Withdrawal by Subject|44|||
17004762|NCT00966875|38148409|FG000|Part B|Sponsor Decision|1|||
17004763|NCT00966875|38148410|FG001|Part B|Sponsor Decision|0|||
17004764|NCT00966875|38148411|FG002|Part B|Sponsor Decision|0|||
17004765|NCT00966875|38148412|FG003|Part B|Sponsor Decision|0|||
17004766|NCT00966875|38148413|FG004|Part B|Sponsor Decision|0|||
17004767|NCT00966875|38148414|FG005|Part B|Sponsor Decision|1|||
16898573|NCT03266588|37989849|FG001|Observational Period|Withdrawal by Subject|22|||
16898574|NCT03266588|37989850|FG002|Observational Period|Withdrawal by Subject|13|||
16898575|NCT03266588|37989848|FG000|Observational Period|Non-compliance|18|||
16898576|NCT03266588|37989849|FG001|Observational Period|Non-compliance|12|||
16898577|NCT03266588|37989850|FG002|Observational Period|Non-compliance|10|||
16898578|NCT03266588|37989848|FG000|Observational Period|Lost to Follow-up|8|||
16898579|NCT03266588|37989849|FG001|Observational Period|Lost to Follow-up|12|||
16898580|NCT03266588|37989850|FG002|Observational Period|Lost to Follow-up|4|||
16898581|NCT03266588|37989848|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
16898582|NCT03266588|37989849|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
16898583|NCT03266588|37989850|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
16898584|NCT03266588|37989848|FG000|Observational Period|Protocol Deviation|1|||
16898585|NCT03266588|37989849|FG001|Observational Period|Protocol Deviation|0|||
16898586|NCT03266588|37989850|FG002|Observational Period|Protocol Deviation|0|||
16898587|NCT03266588|37989848|FG000|Observational Period|Other Reasons|3|||
16898588|NCT03266588|37989849|FG001|Observational Period|Other Reasons|0|||
16898589|NCT03266588|37989850|FG002|Observational Period|Other Reasons|1|||
16898590|NCT03266588|37989848|FG000|Long-term Treatment Period|Adverse Event|33|||
16898591|NCT03266588|37989849|FG001|Long-term Treatment Period|Adverse Event|17|||
16898592|NCT03266588|37989850|FG002|Long-term Treatment Period|Adverse Event|8|||
16898593|NCT03266588|37989848|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
16898594|NCT03266588|37989849|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
16898595|NCT03266588|37989850|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
16898596|NCT03266588|37989848|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
16898597|NCT03266588|37989849|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
16898598|NCT03266588|37989850|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
16898599|NCT03266588|37989848|FG000|Long-term Treatment Period|Non-Compliance|126|||
16898600|NCT03266588|37989849|FG001|Long-term Treatment Period|Non-Compliance|57|||
16898601|NCT03266588|37989850|FG002|Long-term Treatment Period|Non-Compliance|7|||
16898602|NCT03266588|37989848|FG000|Long-term Treatment Period|Pregnancy|11|||
16898603|NCT03266588|37989849|FG001|Long-term Treatment Period|Pregnancy|5|||
16898604|NCT03266588|37989850|FG002|Long-term Treatment Period|Pregnancy|0|||
16898605|NCT03266588|37989848|FG000|Long-term Treatment Period|Protocol Deviation|17|||
16898606|NCT03266588|37989849|FG001|Long-term Treatment Period|Protocol Deviation|10|||
16898607|NCT03266588|37989850|FG002|Long-term Treatment Period|Protocol Deviation|4|||
16898608|NCT03266588|37989848|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
16898609|NCT03266588|37989849|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
16898610|NCT03266588|37989850|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
16898611|NCT03266588|37989848|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
16898612|NCT03266588|37989849|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
16898613|NCT03266588|37989850|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
16898614|NCT03266588|37989848|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
16898615|NCT03266588|37989849|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
16898616|NCT03266588|37989850|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
16898617|NCT03266588|37989848|FG000|Long-term Treatment Period|Other Reasons|5|||
16898618|NCT03266588|37989849|FG001|Long-term Treatment Period|Other Reasons|0|||
17004768|NCT00966875|38148415|FG006|Part B|Sponsor Decision|0|||
17004769|NCT00966875|38148416|FG007|Part B|Sponsor Decision|2|||
17004770|NCT00966875|38148417|FG008|Part B|Sponsor Decision|1|||
17004771|NCT00966875|38148409|FG000|Part B|Withdrawal by Subject|2|||
17004772|NCT00966875|38148410|FG001|Part B|Withdrawal by Subject|1|||
17004773|NCT00966875|38148411|FG002|Part B|Withdrawal by Subject|2|||
17004774|NCT00966875|38148412|FG003|Part B|Withdrawal by Subject|1|||
17004775|NCT00966875|38148413|FG004|Part B|Withdrawal by Subject|2|||
17004776|NCT00966875|38148414|FG005|Part B|Withdrawal by Subject|1|||
17004777|NCT00966875|38148415|FG006|Part B|Withdrawal by Subject|4|||
17004778|NCT00966875|38148416|FG007|Part B|Withdrawal by Subject|5|||
17004779|NCT00966875|38148417|FG008|Part B|Withdrawal by Subject|5|||
17004780|NCT00966875|38148409|FG000|Part B|Entry Criteria|0|||
17004781|NCT00966875|38148410|FG001|Part B|Entry Criteria|0|||
17004782|NCT00966875|38148411|FG002|Part B|Entry Criteria|0|||
17004783|NCT00966875|38148412|FG003|Part B|Entry Criteria|0|||
17004784|NCT00966875|38148413|FG004|Part B|Entry Criteria|0|||
17004785|NCT00966875|38148414|FG005|Part B|Entry Criteria|0|||
17004786|NCT00966875|38148415|FG006|Part B|Entry Criteria|1|||
17004787|NCT00966875|38148416|FG007|Part B|Entry Criteria|0|||
17004788|NCT00966875|38148417|FG008|Part B|Entry Criteria|1|||
17004789|NCT00828711|38148493|FG000|Overall Study|Lost to Follow-up|1|||
16898619|NCT03266588|37989850|FG002|Long-term Treatment Period|Other Reasons|0|||
17004790|NCT00828711|38148494|FG001|Overall Study|Lost to Follow-up|0|||
17004791|NCT00828711|38148495|FG002|Overall Study|Lost to Follow-up|0|||
17004792|NCT00966719|38148505|FG000|Overall Study|Lost to Follow-up|6|||
17004793|NCT00966719|38148506|FG001|Overall Study|Lost to Follow-up|11|||
17004794|NCT00818649|38148512|FG000|Overall Study|Declining performance status|2|||
17004795|NCT00818649|38148512|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
16898620|NCT03266588|37989848|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
16898621|NCT03266588|37989849|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
16898622|NCT03266588|37989850|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
16898623|NCT03238196|37989914|FG000|Overall Study|Adverse Event|3|||
16898624|NCT03238196|37989915|FG001|Overall Study|Adverse Event|0|||
16898625|NCT03238196|37989916|FG002|Overall Study|Adverse Event|2|||
16898626|NCT03238196|37989917|FG003|Overall Study|Adverse Event|2|||
16898627|NCT03238196|37989914|FG000|Overall Study|Withdrawal by Subject|4|||
16898628|NCT03238196|37989915|FG001|Overall Study|Withdrawal by Subject|1|||
16898629|NCT03238196|37989916|FG002|Overall Study|Withdrawal by Subject|1|||
16898630|NCT03238196|37989917|FG003|Overall Study|Withdrawal by Subject|0|||
16898631|NCT03238196|37989914|FG000|Overall Study|Disease progression|14|||
16898632|NCT03238196|37989915|FG001|Overall Study|Disease progression|2|||
16898633|NCT03238196|37989916|FG002|Overall Study|Disease progression|3|||
16898634|NCT03238196|37989917|FG003|Overall Study|Disease progression|2|||
17004796|NCT00818649|38148512|FG000|Overall Study|Adverse Event|1|||
17004797|NCT00961571|38148517|FG000|Overall Study|Physician Decision|39|||
17004798|NCT00964223|38148521|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
17004799|NCT00620815|38148529|FG000|Overall Study|Adverse Event|1|||
16898635|NCT03238196|37989914|FG000|Overall Study|Still on treatment|1|||
16898636|NCT03238196|37989915|FG001|Overall Study|Still on treatment|0|||
16898637|NCT03238196|37989916|FG002|Overall Study|Still on treatment|0|||
16898638|NCT03238196|37989917|FG003|Overall Study|Still on treatment|0|||
16898639|NCT03019640|37989945|FG000|Overall Study|Screen Failures|4|||
16898640|NCT03019640|37989945|FG000|Overall Study|Adverse Event|3|||
16898641|NCT03019640|37989945|FG000|Overall Study|Participant Relapsed|1|||
16898642|NCT02240706|37990013|FG000|Overall Study|Lack of Efficacy|2|||
16898643|NCT02240706|37990014|FG001|Overall Study|Lack of Efficacy|2|||
16898644|NCT02240706|37990015|FG002|Overall Study|Lack of Efficacy|2|||
16898645|NCT02240706|37990016|FG003|Overall Study|Lack of Efficacy|2|||
16898646|NCT02240706|37990017|FG004|Overall Study|Lack of Efficacy|5|||
16898647|NCT02240706|37990018|FG005|Overall Study|Lack of Efficacy|0|||
16898648|NCT02240706|37990019|FG006|Overall Study|Lack of Efficacy|0|||
16898649|NCT02240706|37990013|FG000|Overall Study|Adverse Event|1|||
16898650|NCT02240706|37990014|FG001|Overall Study|Adverse Event|0|||
16898651|NCT02240706|37990015|FG002|Overall Study|Adverse Event|1|||
16898652|NCT02240706|37990016|FG003|Overall Study|Adverse Event|0|||
16898653|NCT02240706|37990017|FG004|Overall Study|Adverse Event|2|||
16898654|NCT02240706|37990018|FG005|Overall Study|Adverse Event|0|||
16898655|NCT02240706|37990019|FG006|Overall Study|Adverse Event|0|||
16898656|NCT02240706|37990013|FG000|Overall Study|Progressive disease|0|||
16898657|NCT02240706|37990014|FG001|Overall Study|Progressive disease|0|||
16898658|NCT02240706|37990015|FG002|Overall Study|Progressive disease|0|||
16898659|NCT02240706|37990016|FG003|Overall Study|Progressive disease|0|||
16898660|NCT02240706|37990017|FG004|Overall Study|Progressive disease|1|||
16898661|NCT02240706|37990018|FG005|Overall Study|Progressive disease|0|||
16898662|NCT02240706|37990019|FG006|Overall Study|Progressive disease|0|||
16898663|NCT02240706|37990013|FG000|Overall Study|Dose limiting toxicity|0|||
16898664|NCT02240706|37990014|FG001|Overall Study|Dose limiting toxicity|0|||
16898665|NCT02240706|37990015|FG002|Overall Study|Dose limiting toxicity|0|||
16898666|NCT02240706|37990016|FG003|Overall Study|Dose limiting toxicity|0|||
16898667|NCT02240706|37990017|FG004|Overall Study|Dose limiting toxicity|1|||
16898668|NCT02240706|37990018|FG005|Overall Study|Dose limiting toxicity|0|||
16898669|NCT02240706|37990019|FG006|Overall Study|Dose limiting toxicity|0|||
16898670|NCT02240706|37990013|FG000|Overall Study|Refused to continue taking medication|0|||
16898671|NCT02240706|37990014|FG001|Overall Study|Refused to continue taking medication|1|||
16898672|NCT02240706|37990015|FG002|Overall Study|Refused to continue taking medication|3|||
16898673|NCT02240706|37990016|FG003|Overall Study|Refused to continue taking medication|1|||
16898674|NCT02240706|37990017|FG004|Overall Study|Refused to continue taking medication|2|||
16898675|NCT02240706|37990018|FG005|Overall Study|Refused to continue taking medication|0|||
16898676|NCT02240706|37990019|FG006|Overall Study|Refused to continue taking medication|0|||
16898677|NCT02240706|37990013|FG000|Overall Study|Insurance billing concerns|0|||
16898678|NCT02240706|37990014|FG001|Overall Study|Insurance billing concerns|0|||
16898679|NCT02240706|37990015|FG002|Overall Study|Insurance billing concerns|0|||
16898680|NCT02240706|37990016|FG003|Overall Study|Insurance billing concerns|1|||
16898681|NCT02240706|37990017|FG004|Overall Study|Insurance billing concerns|0|||
16898682|NCT02240706|37990018|FG005|Overall Study|Insurance billing concerns|0|||
17004800|NCT00620815|38148530|FG001|Overall Study|Adverse Event|1|||
17004801|NCT00620815|38148531|FG002|Overall Study|Adverse Event|2|||
17004802|NCT00620815|38148529|FG000|Overall Study|Withdrawal by Subject|1|||
17004803|NCT00620815|38148530|FG001|Overall Study|Withdrawal by Subject|2|||
17004804|NCT00620815|38148531|FG002|Overall Study|Withdrawal by Subject|0|||
17004805|NCT00620815|38148529|FG000|Overall Study|Lost to Follow-up|1|||
17004806|NCT00620815|38148530|FG001|Overall Study|Lost to Follow-up|6|||
17004807|NCT00620815|38148531|FG002|Overall Study|Lost to Follow-up|3|||
17004808|NCT00620815|38148529|FG000|Overall Study|Inappropriate enrolment|0|||
17004809|NCT00620815|38148530|FG001|Overall Study|Inappropriate enrolment|0|||
17004810|NCT00620815|38148531|FG002|Overall Study|Inappropriate enrolment|1|||
17004811|NCT00620815|38148529|FG000|Overall Study|Protocol Violation|1|||
17004812|NCT00620815|38148530|FG001|Overall Study|Protocol Violation|2|||
17004813|NCT00620815|38148531|FG002|Overall Study|Protocol Violation|1|||
17004814|NCT03372941|38148557|FG000|Overall Study|Lost to Follow-up|2|||
17004815|NCT03372941|38148558|FG001|Overall Study|Lost to Follow-up|4|||
17004816|NCT00619957|38148566|FG000|Month 24 Double-Blind|Adverse Event|9|||
17004817|NCT00619957|38148567|FG001|Month 24 Double-Blind|Adverse Event|7|||
17004818|NCT00619957|38148566|FG000|Month 24 Double-Blind|Protocol Violation|1|||
17004819|NCT00619957|38148567|FG001|Month 24 Double-Blind|Protocol Violation|0|||
17004820|NCT00619957|38148566|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
17004821|NCT00619957|38148567|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
17004822|NCT00619957|38148566|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
17004823|NCT00619957|38148567|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
17004824|NCT00619957|38148566|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
16898683|NCT02240706|37990019|FG006|Overall Study|Insurance billing concerns|0|||
16898684|NCT01600092|37990044|FG000|Overall Study|Adverse Event|2|||
16898685|NCT01600092|37990045|FG001|Overall Study|Adverse Event|0|||
16898686|NCT01600092|37990044|FG000|Overall Study|Lost to Follow-up|4|||
16898687|NCT01600092|37990045|FG001|Overall Study|Lost to Follow-up|6|||
16898688|NCT01600092|37990044|FG000|Overall Study|Withdrawal by parent/guardian|8|||
16898689|NCT01600092|37990045|FG001|Overall Study|Withdrawal by parent/guardian|6|||
16898690|NCT01600092|37990044|FG000|Overall Study|Physician Decision|1|||
16898691|NCT01600092|37990045|FG001|Overall Study|Physician Decision|1|||
16898692|NCT01600092|37990044|FG000|Overall Study|Randomized but not vaccinated|3|||
16898693|NCT01600092|37990045|FG001|Overall Study|Randomized but not vaccinated|3|||
16898694|NCT02240628|37990057|FG000|Overall Study|Physician Decision|6|||
16898695|NCT02240628|37990058|FG001|Overall Study|Physician Decision|5|||
16898696|NCT02207400|37990080|FG000|Overall Study|Adverse Event|1|||
16898697|NCT02207400|37990081|FG001|Overall Study|Adverse Event|1|||
16898698|NCT02207400|37990080|FG000|Overall Study|Lost to Follow-up|6|||
16898699|NCT02207400|37990081|FG001|Overall Study|Lost to Follow-up|7|||
16898700|NCT02207400|37990080|FG000|Overall Study|Protocol Violation|1|||
16898701|NCT02207400|37990081|FG001|Overall Study|Protocol Violation|1|||
16898702|NCT02207400|37990080|FG000|Overall Study|Withdrawal by Subject|8|||
16898703|NCT02207400|37990081|FG001|Overall Study|Withdrawal by Subject|4|||
16898704|NCT02207400|37990080|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
16898705|NCT02207400|37990081|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
16898706|NCT02207244|37990474|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
16898707|NCT02207244|37990475|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
16898708|NCT02207244|37990476|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
16898709|NCT02207244|37990477|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16898710|NCT02207244|37990478|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16898711|NCT02207244|37990479|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16898712|NCT02207244|37990480|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16898713|NCT02207244|37990481|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16898714|NCT02207244|37990482|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16898715|NCT02207244|37990483|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16898716|NCT02207244|37990484|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16898717|NCT02207244|37990474|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
16898718|NCT02207244|37990475|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898719|NCT02207244|37990476|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
16898720|NCT02207244|37990477|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898721|NCT02207244|37990478|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898722|NCT02207244|37990479|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898723|NCT02207244|37990480|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898724|NCT02207244|37990481|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898725|NCT02207244|37990482|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898726|NCT02207244|37990483|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898727|NCT02207244|37990484|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16898728|NCT02207244|37990474|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
16898729|NCT02207244|37990475|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
16898730|NCT02207244|37990476|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
16898731|NCT02207244|37990477|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16898732|NCT02207244|37990478|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16898733|NCT02207244|37990479|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16898734|NCT02207244|37990480|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16898735|NCT02207244|37990481|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16898736|NCT02207244|37990482|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
17004825|NCT00619957|38148567|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
17004826|NCT00619957|38148566|FG000|Month 48 Open-Label|Adverse Event|4|||
16898737|NCT02207244|37990483|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16898738|NCT02207244|37990484|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16898739|NCT02207244|37990474|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
16898740|NCT02207244|37990475|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
16898741|NCT02207244|37990476|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898742|NCT02207244|37990477|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898743|NCT02207244|37990478|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898744|NCT02207244|37990479|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898745|NCT02207244|37990480|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898746|NCT02207244|37990481|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898747|NCT02207244|37990482|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898748|NCT02207244|37990483|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898749|NCT02207244|37990484|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16898750|NCT02207244|37990474|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
16898751|NCT02207244|37990475|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
16898752|NCT02207244|37990476|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
16898753|NCT02207244|37990477|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16898754|NCT02207244|37990478|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16898755|NCT02207244|37990479|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16898756|NCT02207244|37990480|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16898757|NCT02207244|37990481|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16898758|NCT02207244|37990482|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16898759|NCT02207244|37990483|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16898760|NCT02207244|37990484|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16898761|NCT02207244|37990474|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898762|NCT02207244|37990475|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
16898763|NCT02207244|37990476|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
16898764|NCT02207244|37990477|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898765|NCT02207244|37990478|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898766|NCT02207244|37990479|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898767|NCT02207244|37990480|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898768|NCT02207244|37990481|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898769|NCT02207244|37990482|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898770|NCT02207244|37990483|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898771|NCT02207244|37990484|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16898772|NCT02207244|37990474|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898773|NCT02207244|37990475|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
16898774|NCT02207244|37990476|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898775|NCT02207244|37990477|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898776|NCT02207244|37990478|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898777|NCT02207244|37990479|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898778|NCT02207244|37990480|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898779|NCT02207244|37990481|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898780|NCT02207244|37990482|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898781|NCT02207244|37990483|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898782|NCT02207244|37990484|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
16898783|NCT02207244|37990474|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898784|NCT02207244|37990475|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898785|NCT02207244|37990476|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898786|NCT02207244|37990477|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898787|NCT02207244|37990478|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
16898788|NCT02207244|37990479|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
16898789|NCT02207244|37990480|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898790|NCT02207244|37990481|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898791|NCT02207244|37990482|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898792|NCT02207244|37990483|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898793|NCT02207244|37990484|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16898794|NCT02207244|37990474|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898795|NCT02207244|37990475|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898796|NCT02207244|37990476|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898797|NCT02207244|37990477|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898798|NCT02207244|37990478|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898799|NCT02207244|37990479|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
16898800|NCT02207244|37990480|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898801|NCT02207244|37990481|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
17004827|NCT00619957|38148567|FG001|Month 48 Open-Label|Adverse Event|4|||
16898802|NCT02207244|37990482|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898803|NCT02207244|37990483|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898804|NCT02207244|37990484|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16898805|NCT02207244|37990474|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16898806|NCT02207244|37990475|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16898807|NCT02207244|37990476|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16898808|NCT02207244|37990477|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
16898809|NCT02207244|37990478|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
16898810|NCT02207244|37990479|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
16898811|NCT02207244|37990480|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16898812|NCT02207244|37990481|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16898813|NCT02207244|37990482|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16898814|NCT02207244|37990483|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16898815|NCT02207244|37990484|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16898816|NCT02207244|37990474|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16898817|NCT02207244|37990475|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16898818|NCT02207244|37990476|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16898819|NCT02207244|37990477|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
16898820|NCT02207244|37990478|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
16898821|NCT02207244|37990479|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
16898822|NCT02207244|37990480|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16898823|NCT02207244|37990481|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16898824|NCT02207244|37990482|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16898825|NCT02207244|37990483|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16898826|NCT02207244|37990484|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16898827|NCT02207244|37990474|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16898828|NCT02207244|37990475|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16898829|NCT02207244|37990476|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16898830|NCT02207244|37990477|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
16898831|NCT02207244|37990478|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
17004828|NCT00619957|38148566|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
17004829|NCT00619957|38148567|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
17004830|NCT00619957|38148566|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
17004831|NCT00619957|38148567|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
17004832|NCT00961415|38148577|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
17004833|NCT00961415|38148578|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
17004834|NCT00961415|38148579|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
17004835|NCT00961415|38148577|FG000|Induction Treatment Phase|Death|77|||
17004836|NCT00961415|38148578|FG001|Induction Treatment Phase|Death|0|||
17004837|NCT00961415|38148579|FG002|Induction Treatment Phase|Death|0|||
17004838|NCT00961415|38148577|FG000|Induction Treatment Phase|Protocol Violation|1|||
17004839|NCT00961415|38148578|FG001|Induction Treatment Phase|Protocol Violation|0|||
17004840|NCT00961415|38148579|FG002|Induction Treatment Phase|Protocol Violation|0|||
17004841|NCT00961415|38148577|FG000|Induction Treatment Phase|Physician Decision|2|||
17004842|NCT00961415|38148578|FG001|Induction Treatment Phase|Physician Decision|0|||
17004843|NCT00961415|38148579|FG002|Induction Treatment Phase|Physician Decision|0|||
17004844|NCT00961415|38148577|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
17004845|NCT00961415|38148578|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
17004846|NCT00961415|38148579|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
17004847|NCT00961415|38148577|FG000|Induction Treatment Phase|Other Reason|5|||
17004848|NCT00961415|38148578|FG001|Induction Treatment Phase|Other Reason|0|||
17004849|NCT00961415|38148579|FG002|Induction Treatment Phase|Other Reason|0|||
17004850|NCT00961415|38148577|FG000|Maintenance Treatment Phase|Death|0|||
17004851|NCT00961415|38148578|FG001|Maintenance Treatment Phase|Death|42|||
17004852|NCT00961415|38148579|FG002|Maintenance Treatment Phase|Death|34|||
17004853|NCT00961415|38148577|FG000|Maintenance Treatment Phase|Investigators decision|0|||
17004854|NCT00961415|38148578|FG001|Maintenance Treatment Phase|Investigators decision|2|||
17004855|NCT00961415|38148579|FG002|Maintenance Treatment Phase|Investigators decision|0|||
17004856|NCT00961415|38148577|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
17004857|NCT00961415|38148578|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
17004858|NCT00961415|38148579|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
17004859|NCT00961415|38148577|FG000|Maintenance Treatment Phase|Other reason|0|||
17004860|NCT00961415|38148578|FG001|Maintenance Treatment Phase|Other reason|1|||
17004861|NCT00961415|38148579|FG002|Maintenance Treatment Phase|Other reason|3|||
17004862|NCT00963599|38148597|FG000|Overall Study|Adverse Event|2|||
17004863|NCT00963599|38148598|FG001|Overall Study|Adverse Event|0|||
17192451|NCT01342081|38345714|FG001|Overall Study|Physician Decision|1|||
17004864|NCT00963599|38148599|FG002|Overall Study|Adverse Event|1|||
17004865|NCT00963599|38148600|FG003|Overall Study|Adverse Event|2|||
16898832|NCT02207244|37990479|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
16898833|NCT02207244|37990480|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16898834|NCT02207244|37990481|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16898835|NCT02207244|37990482|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16898836|NCT02207244|37990483|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16898837|NCT02207244|37990484|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16898838|NCT02207244|37990474|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898839|NCT02207244|37990475|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898840|NCT02207244|37990476|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898841|NCT02207244|37990477|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
16898842|NCT02207244|37990478|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898843|NCT02207244|37990479|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898844|NCT02207244|37990480|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898845|NCT02207244|37990481|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898846|NCT02207244|37990482|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898847|NCT02207244|37990483|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898848|NCT02207244|37990484|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
16898849|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16898850|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16898851|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16898852|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16898853|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16898854|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16898855|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
16898856|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
17004866|NCT00963599|38148597|FG000|Overall Study|Lack of Efficacy|0|||
17004867|NCT00963599|38148598|FG001|Overall Study|Lack of Efficacy|2|||
17004868|NCT00963599|38148599|FG002|Overall Study|Lack of Efficacy|1|||
17004869|NCT00963599|38148600|FG003|Overall Study|Lack of Efficacy|4|||
17004870|NCT00963599|38148597|FG000|Overall Study|Lost to Follow-up|0|||
17004871|NCT00963599|38148598|FG001|Overall Study|Lost to Follow-up|1|||
17004872|NCT00963599|38148599|FG002|Overall Study|Lost to Follow-up|1|||
17004873|NCT00963599|38148600|FG003|Overall Study|Lost to Follow-up|1|||
17004874|NCT00963599|38148597|FG000|Overall Study|Protocol Violation|2|||
17004875|NCT00963599|38148598|FG001|Overall Study|Protocol Violation|2|||
17004876|NCT00963599|38148599|FG002|Overall Study|Protocol Violation|3|||
17004877|NCT00963599|38148600|FG003|Overall Study|Protocol Violation|4|||
17004878|NCT00963599|38148597|FG000|Overall Study|Withdrawal by Subject|2|||
17004879|NCT00963599|38148598|FG001|Overall Study|Withdrawal by Subject|1|||
16898857|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
16898858|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
17004880|NCT00963599|38148599|FG002|Overall Study|Withdrawal by Subject|3|||
17004881|NCT00963599|38148600|FG003|Overall Study|Withdrawal by Subject|3|||
17004882|NCT00619801|38148612|FG000|Overall Study|Lack of Efficacy|0|||
17004883|NCT00619801|38148613|FG001|Overall Study|Lack of Efficacy|1|||
17004884|NCT00619801|38148612|FG000|Overall Study|Withdrawal by Subject|1|||
17004885|NCT00619801|38148613|FG001|Overall Study|Withdrawal by Subject|1|||
17004886|NCT00619801|38148612|FG000|Overall Study|Loss of efficacy|0|||
17004887|NCT00619801|38148613|FG001|Overall Study|Loss of efficacy|1|||
17004888|NCT00962741|38148619|FG000|Overall Study|Failed to return|3|||
17004889|NCT00962741|38148619|FG000|Overall Study|Lost to Follow-up|2|||
17004890|NCT00962741|38148619|FG000|Overall Study|Withdrawal by Subject|1|||
17004891|NCT00962741|38148619|FG000|Overall Study|Lack of Efficacy|1|||
17004892|NCT00962741|38148619|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
17004893|NCT00619645|38148623|FG000|Overall Study|Adverse Event|1|||
17004894|NCT00619177|38148627|FG000|Overall Study|Adverse Event|18|||
16898859|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16898860|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
17004895|NCT00619177|38148627|FG000|Overall Study|Lost to Follow-up|2|||
17004896|NCT00619177|38148627|FG000|Overall Study|Lack of Efficacy|1|||
17004897|NCT00619177|38148627|FG000|Overall Study|Missing termination information|481|||
17004898|NCT00619177|38148627|FG000|Overall Study|Not specified reasons|6|||
17004899|NCT00818259|38148638|FG000|Part I|Withdrawal by Subject|1|||
17004900|NCT00818259|38148639|FG001|Part I|Withdrawal by Subject|0|||
17004901|NCT00818259|38148640|FG002|Part I|Withdrawal by Subject|0|||
17004902|NCT00818259|38148641|FG003|Part I|Withdrawal by Subject|0|||
17004903|NCT00818259|38148642|FG004|Part I|Withdrawal by Subject|0|||
17004904|NCT00818259|38148643|FG005|Part I|Withdrawal by Subject|0|||
17004905|NCT00818259|38148644|FG006|Part I|Withdrawal by Subject|0|||
17004906|NCT00818259|38148645|FG007|Part I|Withdrawal by Subject|0|||
17004907|NCT00818259|38148646|FG008|Part I|Withdrawal by Subject|0|||
17004908|NCT00818259|38148638|FG000|Part II|Physician Decision|0|||
17004909|NCT00818259|38148639|FG001|Part II|Physician Decision|0|||
17004910|NCT00818259|38148640|FG002|Part II|Physician Decision|1|||
17004911|NCT00818259|38148641|FG003|Part II|Physician Decision|0|||
17004912|NCT00818259|38148642|FG004|Part II|Physician Decision|0|||
17004913|NCT00818259|38148643|FG005|Part II|Physician Decision|0|||
17004914|NCT00818259|38148644|FG006|Part II|Physician Decision|0|||
17004915|NCT00818259|38148645|FG007|Part II|Physician Decision|0|||
17004916|NCT00818259|38148646|FG008|Part II|Physician Decision|0|||
17004917|NCT00818259|38148638|FG000|Part II|Lack of Efficacy|0|||
17004918|NCT00818259|38148639|FG001|Part II|Lack of Efficacy|0|||
17004919|NCT00818259|38148640|FG002|Part II|Lack of Efficacy|0|||
17004920|NCT00818259|38148641|FG003|Part II|Lack of Efficacy|1|||
17004921|NCT00818259|38148642|FG004|Part II|Lack of Efficacy|0|||
17004922|NCT00818259|38148643|FG005|Part II|Lack of Efficacy|0|||
17004923|NCT00818259|38148644|FG006|Part II|Lack of Efficacy|0|||
17004924|NCT00818259|38148645|FG007|Part II|Lack of Efficacy|0|||
17004925|NCT00818259|38148646|FG008|Part II|Lack of Efficacy|0|||
17004926|NCT00818259|38148638|FG000|Part II|Not Treated|0|||
17004927|NCT00818259|38148639|FG001|Part II|Not Treated|0|||
17004928|NCT00818259|38148640|FG002|Part II|Not Treated|0|||
17004929|NCT00818259|38148641|FG003|Part II|Not Treated|1|||
17004930|NCT00818259|38148642|FG004|Part II|Not Treated|0|||
17004931|NCT00818259|38148643|FG005|Part II|Not Treated|0|||
17004932|NCT00818259|38148644|FG006|Part II|Not Treated|0|||
17004933|NCT00818259|38148645|FG007|Part II|Not Treated|0|||
17004934|NCT00818259|38148646|FG008|Part II|Not Treated|0|||
17004935|NCT00818259|38148638|FG000|Part IV|Physician Decision|0|||
17004936|NCT00818259|38148639|FG001|Part IV|Physician Decision|0|||
17004937|NCT00818259|38148640|FG002|Part IV|Physician Decision|0|||
17004938|NCT00818259|38148641|FG003|Part IV|Physician Decision|0|||
17004939|NCT00818259|38148642|FG004|Part IV|Physician Decision|0|||
17004940|NCT00818259|38148643|FG005|Part IV|Physician Decision|1|||
17095506|NCT00071812|38234780|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
16786145|NCT02687815|37726507|FG000|Overall Study|Withdrawal by Subject|2|||
16786146|NCT02687815|37726508|FG001|Overall Study|Withdrawal by Subject|4|||
16786147|NCT01959334|37726516|FG000|Second Dose|Adverse Event|1|||
16786148|NCT01959334|37726517|FG001|Second Dose|Adverse Event|0|||
16898861|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898862|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898863|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898864|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898865|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898866|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898867|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
16898868|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898869|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898870|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16898871|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16898872|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16898873|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16898874|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16898875|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16898876|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16898877|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
16898878|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
16898879|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
16898880|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
16898881|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16898882|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16898883|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16898884|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16786149|NCT01959334|37726516|FG000|Third Dose|Adverse Event|0|||
16786150|NCT01959334|37726517|FG001|Third Dose|Adverse Event|1|||
16786151|NCT02687581|37726527|FG000|Overall Study|Withdrawal by Subject|1|||
16786152|NCT02687581|37726528|FG001|Overall Study|Withdrawal by Subject|0|||
16786153|NCT02687581|37726529|FG002|Overall Study|Withdrawal by Subject|0|||
16898885|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16898886|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
17004941|NCT00818259|38148644|FG006|Part IV|Physician Decision|0|||
17004942|NCT00818259|38148645|FG007|Part IV|Physician Decision|0|||
17004943|NCT00818259|38148646|FG008|Part IV|Physician Decision|0|||
17004944|NCT00818259|38148638|FG000|Part V|Adverse Event|0|||
17004945|NCT00818259|38148639|FG001|Part V|Adverse Event|0|||
16786154|NCT02687581|37726530|FG003|Overall Study|Withdrawal by Subject|1|||
16786155|NCT02687581|37726527|FG000|Overall Study|Lost to Follow-up|2|||
16786156|NCT02687581|37726528|FG001|Overall Study|Lost to Follow-up|2|||
17004946|NCT00818259|38148640|FG002|Part V|Adverse Event|0|||
17004947|NCT00818259|38148641|FG003|Part V|Adverse Event|0|||
17004948|NCT00818259|38148642|FG004|Part V|Adverse Event|0|||
16898887|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16898888|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
16898889|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
16898890|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16898891|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
16898892|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16898893|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16898894|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16898895|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16898896|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16898897|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16898898|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16898899|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
17004949|NCT00818259|38148643|FG005|Part V|Adverse Event|0|||
17004950|NCT00818259|38148644|FG006|Part V|Adverse Event|0|||
17004951|NCT00818259|38148645|FG007|Part V|Adverse Event|1|||
17004952|NCT00818259|38148646|FG008|Part V|Adverse Event|0|||
17004953|NCT00619099|38148664|FG000|Overall Study|Progressive Disease|7|||
17004954|NCT00619099|38148665|FG001|Overall Study|Progressive Disease|5|||
17004955|NCT00619099|38148664|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
17004956|NCT00619099|38148665|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
17004957|NCT00619099|38148664|FG000|Overall Study|Adverse Event|4|||
17004958|NCT00619099|38148665|FG001|Overall Study|Adverse Event|3|||
17004959|NCT00619099|38148664|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
17004960|NCT00619099|38148665|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
17004961|NCT00619099|38148664|FG000|Overall Study|Withdrawal by Subject|10|||
17004962|NCT00619099|38148665|FG001|Overall Study|Withdrawal by Subject|2|||
17004963|NCT00619099|38148664|FG000|Overall Study|Physician Decision|9|||
17004964|NCT00619099|38148665|FG001|Overall Study|Physician Decision|6|||
17004965|NCT00962585|38148675|FG000|Overall Study|Adverse Event|0|||
17004966|NCT00962585|38148676|FG001|Overall Study|Adverse Event|2|||
17004967|NCT00962585|38148677|FG002|Overall Study|Adverse Event|1|||
17004968|NCT00962585|38148678|FG003|Overall Study|Adverse Event|0|||
17004969|NCT00962585|38148675|FG000|Overall Study|Lost to Follow-up|3|||
17004970|NCT00962585|38148676|FG001|Overall Study|Lost to Follow-up|0|||
17004971|NCT00962585|38148677|FG002|Overall Study|Lost to Follow-up|1|||
17004972|NCT00962585|38148678|FG003|Overall Study|Lost to Follow-up|0|||
17004973|NCT00962585|38148675|FG000|Overall Study|Protocol Violation|0|||
17004974|NCT00962585|38148676|FG001|Overall Study|Protocol Violation|0|||
17004975|NCT00962585|38148677|FG002|Overall Study|Protocol Violation|1|||
17004976|NCT00962585|38148678|FG003|Overall Study|Protocol Violation|0|||
17004977|NCT00962585|38148675|FG000|Overall Study|Withdrawal by Subject|1|||
17004978|NCT00962585|38148676|FG001|Overall Study|Withdrawal by Subject|0|||
17004979|NCT00962585|38148677|FG002|Overall Study|Withdrawal by Subject|0|||
17004980|NCT00962585|38148678|FG003|Overall Study|Withdrawal by Subject|0|||
17004981|NCT00962585|38148675|FG000|Overall Study|Withdrew Consent|2|||
17004982|NCT00962585|38148676|FG001|Overall Study|Withdrew Consent|0|||
17004983|NCT00962585|38148677|FG002|Overall Study|Withdrew Consent|0|||
17004984|NCT00962585|38148678|FG003|Overall Study|Withdrew Consent|0|||
17004985|NCT00621985|38148690|FG000|Dexamethasone Admission|Adverse Event|1|||
17004986|NCT00961259|38148700|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
17004987|NCT00961259|38148701|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
17004988|NCT00961259|38148702|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
17004989|NCT00961181|38148711|FG000|Overall Study|Death|2|||
17004990|NCT00961181|38148711|FG000|Overall Study|Withdrawal by Subject|2|||
17004991|NCT00961181|38148711|FG000|Overall Study|Lost to Follow-up|1|||
17004992|NCT00817635|38148720|FG000|Overall Study|Adverse Event|1|||
17004993|NCT00817635|38148721|FG001|Overall Study|Adverse Event|0|||
16898900|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
16898901|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
16898902|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
16898903|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16898904|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16898905|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
17004994|NCT00817635|38148722|FG002|Overall Study|Adverse Event|0|||
17004995|NCT00817635|38148723|FG003|Overall Study|Adverse Event|1|||
17004996|NCT00817635|38148724|FG004|Overall Study|Adverse Event|1|||
17004997|NCT00817635|38148720|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
17004998|NCT00817635|38148721|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
17004999|NCT00817635|38148722|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
17005000|NCT00817635|38148723|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
17005001|NCT00817635|38148724|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
17005002|NCT00817635|38148720|FG000|Overall Study|Withdrawal by Subject|2|||
16898906|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16898907|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16898908|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16898909|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16898910|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16898911|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
16898912|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
16898913|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16898914|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16898915|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898916|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898917|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898918|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898919|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898920|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898921|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898922|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898923|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
16898924|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898925|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16898926|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898927|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898928|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898929|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898930|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898931|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898932|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898933|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
16898934|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898935|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898936|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16898937|NCT02207244|37990474|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898938|NCT02207244|37990475|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
17005003|NCT00817635|38148721|FG001|Overall Study|Withdrawal by Subject|1|||
17005004|NCT00817635|38148722|FG002|Overall Study|Withdrawal by Subject|0|||
17005005|NCT00817635|38148723|FG003|Overall Study|Withdrawal by Subject|1|||
17005006|NCT00817635|38148724|FG004|Overall Study|Withdrawal by Subject|2|||
17005007|NCT00817635|38148720|FG000|Overall Study|Lost to Follow-up|0|||
17005008|NCT00817635|38148721|FG001|Overall Study|Lost to Follow-up|1|||
17005009|NCT00817635|38148722|FG002|Overall Study|Lost to Follow-up|0|||
17005010|NCT00817635|38148723|FG003|Overall Study|Lost to Follow-up|1|||
17005011|NCT00817635|38148724|FG004|Overall Study|Lost to Follow-up|0|||
17005012|NCT00817635|38148720|FG000|Overall Study|Administrative Problems|0|||
17005013|NCT00817635|38148721|FG001|Overall Study|Administrative Problems|0|||
17005014|NCT00817635|38148722|FG002|Overall Study|Administrative Problems|0|||
17005015|NCT00817635|38148723|FG003|Overall Study|Administrative Problems|0|||
17005016|NCT00817635|38148724|FG004|Overall Study|Administrative Problems|1|||
17005017|NCT00817635|38148720|FG000|Overall Study|Protocol Violation|5|||
17005018|NCT00817635|38148721|FG001|Overall Study|Protocol Violation|1|||
17005019|NCT00817635|38148722|FG002|Overall Study|Protocol Violation|3|||
17005020|NCT00817635|38148723|FG003|Overall Study|Protocol Violation|2|||
17005021|NCT00817635|38148724|FG004|Overall Study|Protocol Violation|3|||
17005022|NCT00817479|38148745|FG000|Overall Study|Physician Decision|1|||
17005023|NCT00817479|38148746|FG001|Overall Study|Physician Decision|1|||
17005024|NCT00961961|38148756|FG000|Phase I|Withdrawal by Subject|7|||
17005025|NCT00961961|38148757|FG001|Phase I|Withdrawal by Subject|0|||
16898939|NCT02207244|37990476|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898940|NCT02207244|37990477|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898941|NCT02207244|37990478|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898942|NCT02207244|37990479|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898943|NCT02207244|37990480|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
16898944|NCT02207244|37990481|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898945|NCT02207244|37990482|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898946|NCT02207244|37990483|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898947|NCT02207244|37990484|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16898948|NCT02207244|37990474|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
17005026|NCT00961961|38148758|FG002|Phase I|Withdrawal by Subject|0|||
16898949|NCT02207244|37990475|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16898950|NCT02207244|37990476|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16898951|NCT02207244|37990477|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16898952|NCT02207244|37990478|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16898953|NCT02207244|37990479|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16898954|NCT02207244|37990480|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16898955|NCT02207244|37990481|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16898956|NCT02207244|37990482|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
16898957|NCT02207244|37990483|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16898958|NCT02207244|37990484|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
16898959|NCT02207244|37990474|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898960|NCT02207244|37990475|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898961|NCT02207244|37990476|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898962|NCT02207244|37990477|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898963|NCT02207244|37990478|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898964|NCT02207244|37990479|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898965|NCT02207244|37990480|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898966|NCT02207244|37990481|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898967|NCT02207244|37990482|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
16898968|NCT02207244|37990483|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16898969|NCT02207244|37990484|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
16898970|NCT02207244|37990474|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898971|NCT02207244|37990475|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898972|NCT02207244|37990476|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898973|NCT02207244|37990477|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898974|NCT02207244|37990478|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898975|NCT02207244|37990479|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898976|NCT02207244|37990480|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898977|NCT02207244|37990481|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898978|NCT02207244|37990482|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
16898979|NCT02207244|37990483|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16898980|NCT02207244|37990484|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
16898981|NCT02207244|37990474|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898982|NCT02207244|37990475|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898983|NCT02207244|37990476|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898984|NCT02207244|37990477|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898985|NCT02207244|37990478|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898986|NCT02207244|37990479|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898987|NCT02207244|37990480|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898988|NCT02207244|37990481|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898989|NCT02207244|37990482|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
16898990|NCT02207244|37990483|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16898991|NCT02207244|37990484|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
16898992|NCT02207244|37990474|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
16898993|NCT02207244|37990475|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
16898994|NCT02207244|37990476|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
16898995|NCT02207244|37990477|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
16898996|NCT02207244|37990478|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
16898997|NCT02207244|37990479|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
16898998|NCT02207244|37990480|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
16898999|NCT02207244|37990481|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
16899000|NCT02207244|37990482|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
16899001|NCT02207244|37990483|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
16899002|NCT02207244|37990484|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
16899003|NCT02207244|37990474|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
16899004|NCT02207244|37990475|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
16899005|NCT02207244|37990476|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
16899006|NCT02207244|37990477|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
16899007|NCT02207244|37990478|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
16899008|NCT02207244|37990479|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
16899009|NCT02207244|37990480|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
16899010|NCT02207244|37990481|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
16899011|NCT02207244|37990482|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
16899012|NCT02207244|37990483|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
16899013|NCT02207244|37990484|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
16899014|NCT02207244|37990474|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899015|NCT02207244|37990475|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
17095507|NCT00071812|38234781|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
16899016|NCT02207244|37990476|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899017|NCT02207244|37990477|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899018|NCT02207244|37990478|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899019|NCT02207244|37990479|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899020|NCT02207244|37990480|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899021|NCT02207244|37990481|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899022|NCT02207244|37990482|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899023|NCT02207244|37990483|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16899024|NCT02207244|37990484|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
16899025|NCT02207088|37990537|FG000|Overall Study|Adverse Event|2|||
16899026|NCT02206620|37990552|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
16899027|NCT02206620|37990553|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
16899028|NCT02206620|37990552|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
16899029|NCT02206620|37990553|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
16899030|NCT02239926|37990567|FG000|Overall Study|Withdrawal by Subject|0|||
16899031|NCT02239926|37990568|FG001|Overall Study|Withdrawal by Subject|1|||
16899032|NCT02239692|37990576|FG000|Overall Study|Incomplete colonoscopy|1|||
16899033|NCT02239692|37990577|FG001|Overall Study|Incomplete colonoscopy|2|||
16899034|NCT02239692|37990576|FG000|Overall Study|Adverse Event|0|||
16899035|NCT02239692|37990577|FG001|Overall Study|Adverse Event|1|||
16899036|NCT02239692|37990576|FG000|Overall Study|Physician Decision|0|||
16899037|NCT02239692|37990577|FG001|Overall Study|Physician Decision|1|||
16899038|NCT02239692|37990576|FG000|Overall Study|Lost to Follow-up|1|||
16899039|NCT02239692|37990577|FG001|Overall Study|Lost to Follow-up|4|||
16899040|NCT02239692|37990576|FG000|Overall Study|Withdrawal by Subject|3|||
16899041|NCT02239692|37990577|FG001|Overall Study|Withdrawal by Subject|5|||
16899042|NCT02239692|37990576|FG000|Overall Study|Other reason|1|||
16899043|NCT02239692|37990577|FG001|Overall Study|Other reason|0|||
16899044|NCT02206152|37990605|FG000|Pre-Randomization|Withdrawal by Subject|2|||
16899045|NCT02204982|37990613|FG000|Overall Study|Patient ineligible-medical monitor|1|||
16899046|NCT02204982|37990614|FG001|Overall Study|Patient ineligible-medical monitor|0|||
17005027|NCT00961961|38148759|FG003|Phase I|Withdrawal by Subject|0|||
17005028|NCT00961961|38148756|FG000|Phase I|Lost to Follow-up|10|||
17005029|NCT00961961|38148757|FG001|Phase I|Lost to Follow-up|0|||
17005030|NCT00961961|38148758|FG002|Phase I|Lost to Follow-up|0|||
17005031|NCT00961961|38148759|FG003|Phase I|Lost to Follow-up|0|||
17005032|NCT00961961|38148756|FG000|Phase I|Lack of Efficacy|94|||
17005033|NCT00961961|38148757|FG001|Phase I|Lack of Efficacy|0|||
17005034|NCT00961961|38148758|FG002|Phase I|Lack of Efficacy|0|||
17005035|NCT00961961|38148759|FG003|Phase I|Lack of Efficacy|0|||
16899047|NCT02204982|37990613|FG000|Overall Study|Withdrawal by Subject|1|||
16899048|NCT02204982|37990614|FG001|Overall Study|Withdrawal by Subject|0|||
16899049|NCT02204982|37990613|FG000|Overall Study|Adverse Event|1|||
16899050|NCT02204982|37990614|FG001|Overall Study|Adverse Event|0|||
16899051|NCT02204982|37990613|FG000|Overall Study|Adverse Event and Investigator decision|1|||
16899052|NCT02204982|37990614|FG001|Overall Study|Adverse Event and Investigator decision|0|||
16899053|NCT02204982|37990613|FG000|Overall Study|Physician Decision|0|||
16899054|NCT02204982|37990614|FG001|Overall Study|Physician Decision|2|||
16899055|NCT02204982|37990613|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
16899056|NCT02204982|37990614|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
16899057|NCT02204982|37990613|FG000|Overall Study|Termination of Study bySponsor|0|||
16899058|NCT02204982|37990614|FG001|Overall Study|Termination of Study bySponsor|1|||
16899059|NCT02239536|37990622|FG000|Overall Study|Non-neoplastic polyp|23|||
16899060|NCT02239536|37990623|FG001|Overall Study|Non-neoplastic polyp|17|||
16899061|NCT02239224|37990633|FG000|Overall Study|Administrative|0|||
16899062|NCT02239224|37990634|FG001|Overall Study|Administrative|0|||
16899063|NCT02239224|37990635|FG002|Overall Study|Administrative|3|||
16899064|NCT02239224|37990636|FG003|Overall Study|Administrative|1|||
16899065|NCT01600014|37990646|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
16899066|NCT01600014|37990647|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
16899067|NCT01600014|37990646|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
16899068|NCT01600014|37990647|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
16899069|NCT01600014|37990646|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
16899070|NCT01600014|37990647|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
16899071|NCT01600014|37990646|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
16899072|NCT01600014|37990647|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
16786157|NCT02687581|37726529|FG002|Overall Study|Lost to Follow-up|0|||
16899073|NCT01600014|37990646|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
16899074|NCT01600014|37990647|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
16899075|NCT01600014|37990646|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
16899076|NCT01600014|37990647|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
17005036|NCT00961961|38148756|FG000|Phase I|Adverse Event|7|||
16786158|NCT02687581|37726530|FG003|Overall Study|Lost to Follow-up|0|||
16786159|NCT02687581|37726527|FG000|Overall Study|the device is too small for the patient.|1|||
16899077|NCT01600014|37990646|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
16899078|NCT01600014|37990647|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
16899079|NCT01600014|37990646|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
16899080|NCT01600014|37990647|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
16899081|NCT01600014|37990646|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
16899082|NCT01600014|37990647|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
16899083|NCT01600014|37990646|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
16899084|NCT01600014|37990647|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
16899085|NCT01600014|37990646|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
16899086|NCT01600014|37990647|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
16899087|NCT01600014|37990646|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
16899088|NCT01600014|37990647|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
16899089|NCT01600014|37990646|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
16899090|NCT01600014|37990647|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
16899091|NCT01600014|37990646|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
16899092|NCT01600014|37990647|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
16899093|NCT01600014|37990646|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
16899094|NCT01600014|37990647|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
16899095|NCT01600014|37990646|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
16899096|NCT01600014|37990647|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
16899097|NCT01600014|37990646|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
16899098|NCT01600014|37990647|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
16899099|NCT03330847|37990668|FG000|Overall Study|Patients ongoing study|62|||
16899100|NCT03330847|37990669|FG001|Overall Study|Patients ongoing study|65|||
16899101|NCT03330847|37990670|FG002|Overall Study|Patients ongoing study|15|||
16899102|NCT02237196|37990684|FG000|Overall Study|Adverse Event|0|||
16899103|NCT02237196|37990685|FG001|Overall Study|Adverse Event|1|||
16899104|NCT02237196|37990686|FG002|Overall Study|Adverse Event|1|||
16899105|NCT02237196|37990687|FG003|Overall Study|Adverse Event|0|||
16899106|NCT02237196|37990684|FG000|Overall Study|Lost to Follow-up|4|||
16899107|NCT02237196|37990685|FG001|Overall Study|Lost to Follow-up|2|||
16899108|NCT02237196|37990686|FG002|Overall Study|Lost to Follow-up|4|||
16899109|NCT02237196|37990687|FG003|Overall Study|Lost to Follow-up|6|||
16899110|NCT02237196|37990684|FG000|Overall Study|Physician Decision|2|||
16899111|NCT02237196|37990685|FG001|Overall Study|Physician Decision|0|||
16899112|NCT02237196|37990686|FG002|Overall Study|Physician Decision|0|||
16899113|NCT02237196|37990687|FG003|Overall Study|Physician Decision|1|||
16899114|NCT02237196|37990684|FG000|Overall Study|Pregnancy|0|||
16899115|NCT02237196|37990685|FG001|Overall Study|Pregnancy|0|||
16899116|NCT02237196|37990686|FG002|Overall Study|Pregnancy|1|||
16899117|NCT02237196|37990687|FG003|Overall Study|Pregnancy|1|||
16899118|NCT02237196|37990684|FG000|Overall Study|Withdrawal by Subject|1|||
16899119|NCT02237196|37990685|FG001|Overall Study|Withdrawal by Subject|1|||
16899120|NCT02237196|37990686|FG002|Overall Study|Withdrawal by Subject|4|||
16899121|NCT02237196|37990687|FG003|Overall Study|Withdrawal by Subject|1|||
16899122|NCT02237196|37990684|FG000|Overall Study|Site Error|1|||
16899123|NCT02237196|37990685|FG001|Overall Study|Site Error|2|||
16899124|NCT02237196|37990686|FG002|Overall Study|Site Error|0|||
16899125|NCT02237196|37990687|FG003|Overall Study|Site Error|2|||
16899126|NCT02237118|37990703|FG000|Overall Study|Protocol Violation|0|||
16899127|NCT02237118|37990704|FG001|Overall Study|Protocol Violation|1|||
16899128|NCT02237118|37990703|FG000|Overall Study|consent withdrawn|1|||
16899129|NCT02237118|37990704|FG001|Overall Study|consent withdrawn|0|||
16899130|NCT02234622|37990720|FG000|Overall Study|Withdrawal by Subject|16|||
16899131|NCT02234622|37990721|FG001|Overall Study|Withdrawal by Subject|22|||
16899132|NCT02234622|37990720|FG000|Overall Study|Lost to Follow-up|27|||
16899133|NCT02234622|37990721|FG001|Overall Study|Lost to Follow-up|14|||
16899134|NCT03250273|37990731|FG000|Overall Study|Disease Progression|2|||
16899135|NCT03250273|37990732|FG001|Overall Study|Disease Progression|11|||
16899136|NCT03250273|37990731|FG000|Overall Study|Death|0|||
16899137|NCT03250273|37990732|FG001|Overall Study|Death|1|||
16899138|NCT02203032|37990738|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
16899139|NCT02203032|37990739|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
16899140|NCT02203032|37990740|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
16899141|NCT02203032|37990741|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
16899142|NCT02203032|37990738|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
16899143|NCT02203032|37990739|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
16899144|NCT02203032|37990740|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
16899145|NCT02203032|37990741|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
16899146|NCT02203032|37990738|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
16899147|NCT02203032|37990739|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
16899148|NCT02203032|37990740|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
16899149|NCT02203032|37990741|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
16899150|NCT02203032|37990738|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
16899151|NCT02203032|37990739|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
16899152|NCT02203032|37990740|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
16899153|NCT02203032|37990741|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
16899154|NCT02203032|37990738|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
16899155|NCT02203032|37990739|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
16899156|NCT02203032|37990740|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
16899157|NCT02203032|37990741|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
16899158|NCT02203032|37990738|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
16899159|NCT02203032|37990739|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
16899160|NCT02203032|37990740|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
16899161|NCT02203032|37990741|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
16899162|NCT02203032|37990738|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
16899163|NCT02203032|37990739|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
16899164|NCT02203032|37990740|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
16899165|NCT02203032|37990741|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
16899166|NCT02203032|37990738|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
17005037|NCT00961961|38148757|FG001|Phase I|Adverse Event|0|||
17005038|NCT00961961|38148758|FG002|Phase I|Adverse Event|0|||
17005039|NCT00961961|38148759|FG003|Phase I|Adverse Event|0|||
17005040|NCT00961961|38148756|FG000|Phase I|Physician Decision|8|||
17005041|NCT00961961|38148757|FG001|Phase I|Physician Decision|0|||
17005042|NCT00961961|38148758|FG002|Phase I|Physician Decision|0|||
17005043|NCT00961961|38148759|FG003|Phase I|Physician Decision|0|||
17005044|NCT00961961|38148756|FG000|Phase II|Lost to Follow-up|0|||
17005045|NCT00961961|38148757|FG001|Phase II|Lost to Follow-up|0|||
17005046|NCT00961961|38148758|FG002|Phase II|Lost to Follow-up|10|||
17005047|NCT00961961|38148759|FG003|Phase II|Lost to Follow-up|7|||
17005048|NCT00961961|38148756|FG000|Phase II|Adverse Event|0|||
17005049|NCT00961961|38148757|FG001|Phase II|Adverse Event|0|||
17005050|NCT00961961|38148758|FG002|Phase II|Adverse Event|0|||
17192452|NCT01342081|38345715|FG002|Overall Study|Physician Decision|0|||
16899167|NCT02203032|37990739|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
17005051|NCT00961961|38148759|FG003|Phase II|Adverse Event|1|||
17005052|NCT00961961|38148756|FG000|Phase II|Physician Decision|0|||
17192453|NCT01342081|38345713|FG000|Overall Study|Withdrawal by Subject|1|||
17192454|NCT01342081|38345714|FG001|Overall Study|Withdrawal by Subject|1|||
17192455|NCT01342081|38345715|FG002|Overall Study|Withdrawal by Subject|0|||
17192456|NCT01341457|38345725|FG000|Overall Study|Adverse Event|2|||
17192457|NCT01341457|38345726|FG001|Overall Study|Adverse Event|0|||
17192458|NCT02832037|38345738|FG000|Overall Study|Administrative reasons|0|||
17192459|NCT02832037|38345739|FG001|Overall Study|Administrative reasons|0|||
17192460|NCT02832037|38345740|FG002|Overall Study|Administrative reasons|1|||
17192461|NCT02832037|38345741|FG003|Overall Study|Administrative reasons|0|||
17192462|NCT02832037|38345742|FG004|Overall Study|Administrative reasons|0|||
17192463|NCT02832037|38345738|FG000|Overall Study|Protocol Violation|3|||
17192464|NCT02832037|38345739|FG001|Overall Study|Protocol Violation|0|||
17192465|NCT02832037|38345740|FG002|Overall Study|Protocol Violation|4|||
17192466|NCT02832037|38345741|FG003|Overall Study|Protocol Violation|1|||
17192467|NCT02832037|38345742|FG004|Overall Study|Protocol Violation|2|||
17192468|NCT02832037|38345738|FG000|Overall Study|Lost to Follow-up|2|||
17192469|NCT02832037|38345739|FG001|Overall Study|Lost to Follow-up|0|||
17192470|NCT02832037|38345740|FG002|Overall Study|Lost to Follow-up|3|||
17192471|NCT02832037|38345741|FG003|Overall Study|Lost to Follow-up|0|||
17192472|NCT02832037|38345742|FG004|Overall Study|Lost to Follow-up|5|||
17192473|NCT02832037|38345738|FG000|Overall Study|Withdrawal by Subject|9|||
17192474|NCT02832037|38345739|FG001|Overall Study|Withdrawal by Subject|8|||
17192475|NCT02832037|38345740|FG002|Overall Study|Withdrawal by Subject|0|||
17192476|NCT02832037|38345741|FG003|Overall Study|Withdrawal by Subject|4|||
17192477|NCT02832037|38345742|FG004|Overall Study|Withdrawal by Subject|8|||
17192478|NCT02832037|38345738|FG000|Overall Study|Adverse Event|5|||
17192479|NCT02832037|38345739|FG001|Overall Study|Adverse Event|4|||
17192480|NCT02832037|38345740|FG002|Overall Study|Adverse Event|0|||
17192481|NCT02832037|38345741|FG003|Overall Study|Adverse Event|2|||
17192482|NCT02832037|38345742|FG004|Overall Study|Adverse Event|4|||
17192483|NCT01675154|38345758|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
17192484|NCT01675154|38345759|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
17192485|NCT01675154|38345760|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
17192486|NCT01675154|38345761|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
17192487|NCT02744755|38345785|FG000|Study Period 1|Protocol Violation|2|||
17192488|NCT02744755|38345786|FG001|Study Period 1|Protocol Violation|1|||
17192489|NCT02744755|38345785|FG000|Study Period 1|not defined|0|||
17192490|NCT02744755|38345786|FG001|Study Period 1|not defined|1|||
17192491|NCT02744755|38345785|FG000|Study Period 1|Pregnancy|1|||
16899168|NCT02203032|37990740|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
16899169|NCT02203032|37990741|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
16899170|NCT02203032|37990738|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
16899171|NCT02203032|37990739|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
16899172|NCT02203032|37990740|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
16899173|NCT02203032|37990741|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
16899174|NCT02203032|37990738|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
16899175|NCT02203032|37990739|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
16899176|NCT02203032|37990740|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
16899177|NCT02203032|37990741|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
16899178|NCT02203032|37990738|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
16899179|NCT02203032|37990739|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
16899180|NCT02203032|37990740|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
16899181|NCT02203032|37990741|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
16899182|NCT02203032|37990738|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
16899183|NCT02203032|37990739|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
16899184|NCT02203032|37990740|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
16899185|NCT02203032|37990741|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
16899186|NCT02169414|37990753|FG000|Overall Study|Withdrawal by Subject|1|||
16899187|NCT02169414|37990754|FG001|Overall Study|Withdrawal by Subject|0|||
16899188|NCT02169414|37990755|FG002|Overall Study|Withdrawal by Subject|0|||
16899189|NCT02169414|37990756|FG003|Overall Study|Withdrawal by Subject|0|||
16899190|NCT02169414|37990753|FG000|Overall Study|Adverse Event|0|||
16899191|NCT02169414|37990754|FG001|Overall Study|Adverse Event|1|||
16899192|NCT02169414|37990755|FG002|Overall Study|Adverse Event|0|||
16899193|NCT02169414|37990756|FG003|Overall Study|Adverse Event|0|||
16899194|NCT03213457|37990773|FG000|Overall Study|Not Treated|1|||
16899195|NCT03213457|37990774|FG001|Overall Study|Not Treated|1|||
16899196|NCT03213457|37990775|FG002|Overall Study|Not Treated|0|||
16899197|NCT03213457|37990773|FG000|Overall Study|Adverse Event|16|||
16899198|NCT03213457|37990774|FG001|Overall Study|Adverse Event|9|||
16899199|NCT03213457|37990775|FG002|Overall Study|Adverse Event|41|||
16899200|NCT03213457|37990773|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16899201|NCT03213457|37990774|FG001|Overall Study|Non-Compliance With Study Drug|2|||
16899202|NCT03213457|37990775|FG002|Overall Study|Non-Compliance With Study Drug|7|||
16899203|NCT03213457|37990773|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
17005053|NCT00961961|38148757|FG001|Phase II|Physician Decision|0|||
17005054|NCT00961961|38148758|FG002|Phase II|Physician Decision|1|||
17005055|NCT00961961|38148759|FG003|Phase II|Physician Decision|0|||
17005056|NCT00961961|38148756|FG000|Phase II|Withdrawal by Subject|0|||
16899204|NCT03213457|37990774|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
16899205|NCT03213457|37990775|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
16899206|NCT03213457|37990773|FG000|Overall Study|Withdrawal by Subject|18|||
16899207|NCT03213457|37990774|FG001|Overall Study|Withdrawal by Subject|7|||
16899208|NCT03213457|37990775|FG002|Overall Study|Withdrawal by Subject|35|||
16899209|NCT03213457|37990773|FG000|Overall Study|Lost to Follow-up|12|||
16899210|NCT03213457|37990774|FG001|Overall Study|Lost to Follow-up|12|||
16899211|NCT03213457|37990775|FG002|Overall Study|Lost to Follow-up|33|||
16899212|NCT03213457|37990773|FG000|Overall Study|Pregnancy|11|||
16899213|NCT03213457|37990774|FG001|Overall Study|Pregnancy|0|||
16899214|NCT03213457|37990775|FG002|Overall Study|Pregnancy|7|||
16899215|NCT03213457|37990773|FG000|Overall Study|Protocol Violation|1|||
16899216|NCT03213457|37990774|FG001|Overall Study|Protocol Violation|1|||
16899217|NCT03213457|37990775|FG002|Overall Study|Protocol Violation|6|||
16899218|NCT03213457|37990773|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
16899219|NCT03213457|37990774|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
16899220|NCT03213457|37990775|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
16899221|NCT03213457|37990773|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
16899222|NCT03213457|37990774|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
16899223|NCT03213457|37990775|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
16899224|NCT03213457|37990773|FG000|Overall Study|Lack of Efficacy|12|||
16899225|NCT03213457|37990774|FG001|Overall Study|Lack of Efficacy|2|||
16899226|NCT03213457|37990775|FG002|Overall Study|Lack of Efficacy|9|||
16899227|NCT03213457|37990773|FG000|Overall Study|Other, Not Specified|11|||
16899228|NCT03213457|37990774|FG001|Overall Study|Other, Not Specified|3|||
16899229|NCT03213457|37990775|FG002|Overall Study|Other, Not Specified|26|||
16899230|NCT02201940|37990785|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
16899231|NCT02201940|37990786|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
16899232|NCT02201940|37990785|FG000|Overall Study|Lack of Efficacy|2|||
16899233|NCT02201940|37990786|FG001|Overall Study|Lack of Efficacy|113|||
16899234|NCT02201940|37990785|FG000|Overall Study|Lost to Follow-up|5|||
16899235|NCT02201940|37990786|FG001|Overall Study|Lost to Follow-up|0|||
16899236|NCT02201940|37990785|FG000|Overall Study|Withdrew Consent|2|||
16899237|NCT02201940|37990786|FG001|Overall Study|Withdrew Consent|1|||
17005057|NCT00961961|38148757|FG001|Phase II|Withdrawal by Subject|0|||
17005058|NCT00961961|38148758|FG002|Phase II|Withdrawal by Subject|1|||
17005059|NCT00961961|38148759|FG003|Phase II|Withdrawal by Subject|0|||
17005060|NCT00817089|38148783|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
17005061|NCT00817089|38148784|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
17005062|NCT00817089|38148785|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
17005063|NCT00817089|38148786|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
16899238|NCT02201940|37990785|FG000|Overall Study|Investigator's Discretion|1|||
17095508|NCT00071812|38234778|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
16899239|NCT02201940|37990786|FG001|Overall Study|Investigator's Discretion|1|||
16899240|NCT02201940|37990785|FG000|Overall Study|Death|1|||
16899241|NCT02201940|37990786|FG001|Overall Study|Death|0|||
16899242|NCT02201940|37990785|FG000|Overall Study|Adverse Event|0|||
16899243|NCT02201940|37990786|FG001|Overall Study|Adverse Event|1|||
16899244|NCT02232984|37990792|FG000|Overall Study|Withdrawal by Subject|5|||
16899245|NCT02232984|37990792|FG000|Overall Study|Death|1|||
16899246|NCT02232984|37990792|FG000|Overall Study|Investigator withdrawal|10|||
16899247|NCT02232984|37990792|FG000|Overall Study|Device implant unsuccessful|53|||
16899248|NCT02232984|37990792|FG000|Overall Study|not disclosed by site|7|||
16899249|NCT02232984|37990792|FG000|Overall Study|Protocol Violation|1|||
16899250|NCT02169336|37990802|FG000|Overall Study|Lack of Efficacy|1|||
16899251|NCT02169336|37990803|FG001|Overall Study|Lack of Efficacy|1|||
16899252|NCT02169336|37990804|FG002|Overall Study|Lack of Efficacy|0|||
16899253|NCT02169336|37990802|FG000|Overall Study|Adverse Event|2|||
16899254|NCT02169336|37990803|FG001|Overall Study|Adverse Event|3|||
16899255|NCT02169336|37990804|FG002|Overall Study|Adverse Event|1|||
16899256|NCT02169336|37990802|FG000|Overall Study|Withdrawal by Subject|1|||
16899257|NCT02169336|37990803|FG001|Overall Study|Withdrawal by Subject|0|||
16899258|NCT02169336|37990804|FG002|Overall Study|Withdrawal by Subject|0|||
16899259|NCT02169336|37990802|FG000|Overall Study|Physician Decision|0|||
16899260|NCT02169336|37990803|FG001|Overall Study|Physician Decision|0|||
16899261|NCT02169336|37990804|FG002|Overall Study|Physician Decision|1|||
16899262|NCT02169336|37990802|FG000|Overall Study|Subject declined to continue dosing|0|||
16899263|NCT02169336|37990803|FG001|Overall Study|Subject declined to continue dosing|0|||
16899264|NCT02169336|37990804|FG002|Overall Study|Subject declined to continue dosing|1|||
16899265|NCT02609828|37990820|FG000|Overall Study|Adverse Event|8|||
16899266|NCT02609828|37990821|FG001|Overall Study|Adverse Event|1|||
16899267|NCT02609828|37990822|FG002|Overall Study|Adverse Event|0|||
16899268|NCT02609828|37990823|FG003|Overall Study|Adverse Event|6|||
16899269|NCT02609828|37990820|FG000|Overall Study|Death|15|||
16899270|NCT02609828|37990821|FG001|Overall Study|Death|1|||
16899271|NCT02609828|37990822|FG002|Overall Study|Death|1|||
16899272|NCT02609828|37990823|FG003|Overall Study|Death|19|||
16899273|NCT02609828|37990820|FG000|Overall Study|Insufficient clinical response|2|||
16899274|NCT02609828|37990821|FG001|Overall Study|Insufficient clinical response|1|||
16899275|NCT02609828|37990822|FG002|Overall Study|Insufficient clinical response|0|||
16899276|NCT02609828|37990823|FG003|Overall Study|Insufficient clinical response|0|||
16899277|NCT02609828|37990820|FG000|Overall Study|Lost to Follow-up|0|||
16899278|NCT02609828|37990821|FG001|Overall Study|Lost to Follow-up|0|||
16899279|NCT02609828|37990822|FG002|Overall Study|Lost to Follow-up|0|||
16899280|NCT02609828|37990823|FG003|Overall Study|Lost to Follow-up|1|||
16899281|NCT02609828|37990820|FG000|Overall Study|Protocol Violation|2|||
16899282|NCT02609828|37990821|FG001|Overall Study|Protocol Violation|0|||
16899283|NCT02609828|37990822|FG002|Overall Study|Protocol Violation|0|||
16899284|NCT02609828|37990823|FG003|Overall Study|Protocol Violation|1|||
16899285|NCT02609828|37990820|FG000|Overall Study|Withdrawal by Subject|12|||
16899286|NCT02609828|37990821|FG001|Overall Study|Withdrawal by Subject|1|||
16899287|NCT02609828|37990822|FG002|Overall Study|Withdrawal by Subject|0|||
16899288|NCT02609828|37990823|FG003|Overall Study|Withdrawal by Subject|10|||
16899289|NCT02609828|37990820|FG000|Overall Study|Other|3|||
16899290|NCT02609828|37990821|FG001|Overall Study|Other|0|||
16899291|NCT02609828|37990822|FG002|Overall Study|Other|0|||
16899292|NCT02609828|37990823|FG003|Overall Study|Other|6|||
16899293|NCT02609828|37990820|FG000|Overall Study|Randomized but not treated|1|||
16899294|NCT02609828|37990821|FG001|Overall Study|Randomized but not treated|0|||
16899295|NCT02609828|37990822|FG002|Overall Study|Randomized but not treated|0|||
16899296|NCT02609828|37990823|FG003|Overall Study|Randomized but not treated|0|||
16899297|NCT01632306|37990839|FG000|Overall Study|Protocol Violation|1|||
16899298|NCT01632306|37990840|FG001|Overall Study|Protocol Violation|0|||
16899299|NCT01632306|37990841|FG002|Overall Study|Protocol Violation|0|||
17192492|NCT02744755|38345786|FG001|Study Period 1|Pregnancy|0|||
16899300|NCT02201784|37990849|FG000|Overall Study|Failure to achieve adequate block|2|||
16899301|NCT02201784|37990850|FG001|Overall Study|Failure to achieve adequate block|0|||
16899302|NCT02201472|37990856|FG000|Overall Study|Lack of Efficacy|2|||
16899303|NCT02168946|37990901|FG000|Overall Study|Adverse Event|8|||
16899304|NCT02168946|37990902|FG001|Overall Study|Adverse Event|5|||
16899305|NCT02168946|37990901|FG000|Overall Study|Lost to Follow-up|3|||
16899306|NCT02168946|37990902|FG001|Overall Study|Lost to Follow-up|0|||
17005064|NCT00817089|38148783|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
16899307|NCT02168946|37990901|FG000|Overall Study|Subject unable to come back for visits|1|||
16899308|NCT02168946|37990902|FG001|Overall Study|Subject unable to come back for visits|0|||
16899309|NCT02168478|37990923|FG000|Overall Study|Withdrawal by Subject|1|||
16899310|NCT02168478|37990923|FG000|Overall Study|Did Not Consent to Participation|2|||
16899311|NCT02168478|37990923|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
16899312|NCT02200614|37992122|FG000|Double Blind Treatment|Adverse Event|86|||
16899313|NCT02200614|37992123|FG001|Double Blind Treatment|Adverse Event|48|||
16899314|NCT02200614|37992122|FG000|Double Blind Treatment|Confirmed metastasis|120|||
16899315|NCT02200614|37992123|FG001|Double Blind Treatment|Confirmed metastasis|140|||
16899316|NCT02200614|37992122|FG000|Double Blind Treatment|Judgment of the investigator|59|||
16899317|NCT02200614|37992123|FG001|Double Blind Treatment|Judgment of the investigator|99|||
16899318|NCT02200614|37992122|FG000|Double Blind Treatment|Metastasis by local reading|1|||
16899319|NCT02200614|37992123|FG001|Double Blind Treatment|Metastasis by local reading|3|||
16899320|NCT02200614|37992122|FG000|Double Blind Treatment|Other reason|6|||
16899321|NCT02200614|37992123|FG001|Double Blind Treatment|Other reason|2|||
16899322|NCT02200614|37992122|FG000|Double Blind Treatment|Personal reason|77|||
16899323|NCT02200614|37992123|FG001|Double Blind Treatment|Personal reason|85|||
16899324|NCT02200614|37992122|FG000|Double Blind Treatment|Protocol deviation|14|||
16899325|NCT02200614|37992123|FG001|Double Blind Treatment|Protocol deviation|7|||
16899326|NCT02200614|37992122|FG000|Double Blind Treatment|Not treated|1|||
16899327|NCT02200614|37992123|FG001|Double Blind Treatment|Not treated|0|||
16899328|NCT02200614|37992122|FG000|Open Label|Adverse Event|41|||
16899329|NCT02200614|37992123|FG001|Open Label|Adverse Event|11|||
16899330|NCT02200614|37992122|FG000|Open Label|Confirmed metastasis|1|||
16899331|NCT02200614|37992123|FG001|Open Label|Confirmed metastasis|0|||
16899332|NCT02200614|37992122|FG000|Open Label|Judgment of the investigator|29|||
16899333|NCT02200614|37992123|FG001|Open Label|Judgment of the investigator|2|||
16899334|NCT02200614|37992122|FG000|Open Label|Metastasis by local reading|138|||
16899335|NCT02200614|37992123|FG001|Open Label|Metastasis by local reading|27|||
16899336|NCT02200614|37992122|FG000|Open Label|Other reason|22|||
16899337|NCT02200614|37992123|FG001|Open Label|Other reason|4|||
16899338|NCT02200614|37992122|FG000|Open Label|Personal reason|60|||
16899339|NCT02200614|37992123|FG001|Open Label|Personal reason|8|||
16899340|NCT02200614|37992122|FG000|Open Label|Protocol deviation|3|||
16899341|NCT02200614|37992123|FG001|Open Label|Protocol deviation|2|||
16899342|NCT02200614|37992122|FG000|Open Label|Missing|2|||
16899343|NCT02200614|37992123|FG001|Open Label|Missing|2|||
16899344|NCT02231892|37992134|FG000|Overall Study|Lost to Follow-up|1|||
16899345|NCT02231892|37992135|FG001|Overall Study|Lost to Follow-up|0|||
16899346|NCT02231892|37992136|FG002|Overall Study|Lost to Follow-up|3|||
16899347|NCT02231892|37992134|FG000|Overall Study|Withdrawal by Subject|4|||
16899348|NCT02231892|37992135|FG001|Overall Study|Withdrawal by Subject|3|||
16899349|NCT02231892|37992136|FG002|Overall Study|Withdrawal by Subject|15|||
16899350|NCT02231892|37992134|FG000|Overall Study|Physician Decision|0|||
16899351|NCT02231892|37992135|FG001|Overall Study|Physician Decision|2|||
16899352|NCT02231892|37992136|FG002|Overall Study|Physician Decision|4|||
16899353|NCT02231892|37992134|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
16899354|NCT02231892|37992135|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
16899355|NCT02231892|37992136|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
16899356|NCT02231892|37992134|FG000|Overall Study|Participant motor threshold was >83%|0|||
16899357|NCT02231892|37992135|FG001|Overall Study|Participant motor threshold was >83%|0|||
16899358|NCT02231892|37992136|FG002|Overall Study|Participant motor threshold was >83%|9|||
16899359|NCT02231892|37992134|FG000|Overall Study|Could not find motor threshold|2|||
16899360|NCT02231892|37992135|FG001|Overall Study|Could not find motor threshold|0|||
16899361|NCT02231892|37992136|FG002|Overall Study|Could not find motor threshold|1|||
16899362|NCT02231892|37992134|FG000|Overall Study|Could not find reliable motor hotspot|0|||
16899363|NCT02231892|37992135|FG001|Overall Study|Could not find reliable motor hotspot|0|||
16899364|NCT02231892|37992136|FG002|Overall Study|Could not find reliable motor hotspot|1|||
16899365|NCT02231580|37992152|FG000|Overall Study|Adverse Event|5|||
16899366|NCT02231580|37992153|FG001|Overall Study|Adverse Event|0|||
16899367|NCT02166606|37992161|FG000|Overall Study|Adverse Event|3|||
16899368|NCT02166606|37992161|FG000|Overall Study|Death|31|||
16899369|NCT02166606|37992161|FG000|Overall Study|Protocol Violation|7|||
16899370|NCT02166606|37992161|FG000|Overall Study|Lost to Follow-up|30|||
16899371|NCT02166606|37992161|FG000|Overall Study|Withdrawal by Subject|1|||
16899372|NCT02166606|37992161|FG000|Overall Study|Physician Decision|1|||
16899373|NCT02166606|37992161|FG000|Overall Study|Device upgrade|1|||
16899374|NCT02166606|37992161|FG000|Overall Study|Enrolled after End of Enrollment|4|||
16899375|NCT02230956|37992168|FG000|Overall Study|Adverse Event|1|||
16899376|NCT02230956|37992169|FG001|Overall Study|Adverse Event|1|||
16899377|NCT02230956|37992170|FG002|Overall Study|Adverse Event|0|||
16899378|NCT02230956|37992168|FG000|Overall Study|Lack of Efficacy|1|||
16899379|NCT02230956|37992169|FG001|Overall Study|Lack of Efficacy|1|||
16899380|NCT02230956|37992170|FG002|Overall Study|Lack of Efficacy|1|||
16899381|NCT02230956|37992168|FG000|Overall Study|Lost to Follow-up|1|||
16899382|NCT02230956|37992169|FG001|Overall Study|Lost to Follow-up|1|||
16899383|NCT02230956|37992170|FG002|Overall Study|Lost to Follow-up|2|||
16899384|NCT02230956|37992168|FG000|Overall Study|Personal Reasons|2|||
16899385|NCT02230956|37992169|FG001|Overall Study|Personal Reasons|1|||
16899386|NCT02230956|37992170|FG002|Overall Study|Personal Reasons|1|||
16899387|NCT02230956|37992168|FG000|Overall Study|Protocol Violation|0|||
16899388|NCT02230956|37992169|FG001|Overall Study|Protocol Violation|1|||
16899389|NCT02230956|37992170|FG002|Overall Study|Protocol Violation|1|||
16899390|NCT02230956|37992168|FG000|Overall Study|Other Miscellaneous Reason|0|||
16899391|NCT02230956|37992169|FG001|Overall Study|Other Miscellaneous Reason|1|||
16899392|NCT02230956|37992170|FG002|Overall Study|Other Miscellaneous Reason|2|||
16899393|NCT02230410|37992178|FG000|Overall Study|Screen Failure|3|||
16899394|NCT02230332|37992184|FG000|Overall Study|Adverse Event|2|||
17005065|NCT00817089|38148784|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
17005066|NCT00817089|38148785|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
17005067|NCT00817089|38148786|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
17005068|NCT00815919|38148800|FG000|Overall Study|Unrelated Fungal Infection|1|||
17005069|NCT00815919|38148800|FG000|Overall Study|AML Relapse|1|||
17005070|NCT00815919|38148800|FG000|Overall Study|Lack of Efficacy|2|||
17005071|NCT00957905|38148806|FG000|Part B|Not Treated|0|||
17005072|NCT00957905|38148807|FG001|Part B|Not Treated|1|||
17005073|NCT00957905|38148806|FG000|Part B|Physician Decision|0|||
17005074|NCT00957905|38148807|FG001|Part B|Physician Decision|1|||
17005075|NCT00957905|38148806|FG000|Part B|Death|0|||
17005076|NCT00957905|38148807|FG001|Part B|Death|1|||
17005077|NCT00957905|38148806|FG000|Part B|Protocol Violation|0|||
17005078|NCT00957905|38148807|FG001|Part B|Protocol Violation|1|||
17005079|NCT00960323|38148813|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
17005080|NCT00617929|38148821|FG000|Overall Study|Physician Decision|1|||
17005081|NCT00815295|38148828|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
17005082|NCT00815295|38148829|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
17005083|NCT00815295|38148830|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
17005084|NCT00814983|38148840|FG000|Overall Study|Screen failure|1|||
17005085|NCT00814983|38148841|FG001|Overall Study|Screen failure|0|||
17005086|NCT00814983|38148840|FG000|Overall Study|Withdrawal by Subject|1|||
17005087|NCT00814983|38148841|FG001|Overall Study|Withdrawal by Subject|0|||
17005088|NCT00814983|38148840|FG000|Overall Study|Graft failure|1|||
16899395|NCT02230332|37992185|FG001|Overall Study|Adverse Event|1|||
16899396|NCT02230332|37992184|FG000|Overall Study|Lost to Follow-up|1|||
16899397|NCT02230332|37992185|FG001|Overall Study|Lost to Follow-up|0|||
16899398|NCT02230332|37992184|FG000|Overall Study|Protocol Violation|1|||
16899399|NCT02230332|37992185|FG001|Overall Study|Protocol Violation|0|||
16899400|NCT02230254|37992191|FG000|Overall Study|Lost to Follow-up|3|||
16899401|NCT02198664|37992197|FG000|Overall Study|Adverse Event|2|||
16899402|NCT02198664|37992198|FG001|Overall Study|Adverse Event|0|||
16899403|NCT02198664|37992197|FG000|Overall Study|Withdrawal by Subject|11|||
16899404|NCT02198664|37992198|FG001|Overall Study|Withdrawal by Subject|8|||
16899405|NCT02198664|37992197|FG000|Overall Study|Failure to tolerate|2|||
16899406|NCT02198664|37992198|FG001|Overall Study|Failure to tolerate|0|||
16899407|NCT02198664|37992197|FG000|Overall Study|Not stated|1|||
16899408|NCT02198664|37992198|FG001|Overall Study|Not stated|0|||
16899409|NCT02165826|37992209|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
16899410|NCT02165826|37992210|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
16899411|NCT02165826|37992211|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
16899412|NCT02165826|37992209|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
16899413|NCT02165826|37992210|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
16899414|NCT02165826|37992211|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
16899415|NCT02165826|37992209|FG000|Main Treatment Period|Lost to Follow-up|4|||
16899416|NCT02165826|37992210|FG001|Main Treatment Period|Lost to Follow-up|2|||
16899417|NCT02165826|37992211|FG002|Main Treatment Period|Lost to Follow-up|1|||
16899418|NCT02165826|37992209|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
16899419|NCT02165826|37992210|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
16899420|NCT02165826|37992211|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
16899421|NCT02165826|37992209|FG000|Main Treatment Period|Lack of Efficacy|2|||
16899422|NCT02165826|37992210|FG001|Main Treatment Period|Lack of Efficacy|0|||
16899423|NCT02165826|37992211|FG002|Main Treatment Period|Lack of Efficacy|0|||
16899424|NCT02165826|37992209|FG000|Main Treatment Period|Reason Not Specified|8|||
16899425|NCT02165826|37992210|FG001|Main Treatment Period|Reason Not Specified|5|||
16899426|NCT02165826|37992211|FG002|Main Treatment Period|Reason Not Specified|16|||
17005089|NCT00814983|38148841|FG001|Overall Study|Graft failure|0|||
16899427|NCT02165826|37992209|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
16899428|NCT02165826|37992210|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
16899429|NCT02165826|37992211|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
16899430|NCT02165826|37992209|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
17005090|NCT00960869|38148849|FG000|Overall Study|Adverse Event|17|||
17005091|NCT00960869|38148850|FG001|Overall Study|Adverse Event|26|||
17005092|NCT00960869|38148849|FG000|Overall Study|Withdrawal by Subject|16|||
16899431|NCT02165826|37992210|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
16899432|NCT02165826|37992211|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
16899433|NCT02165826|37992209|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
16899434|NCT02165826|37992210|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
16899435|NCT02165826|37992211|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
16899436|NCT02165826|37992209|FG000|Down-Titration Period|Reason Not Specified|1|||
16899437|NCT02165826|37992210|FG001|Down-Titration Period|Reason Not Specified|0|||
16899438|NCT02165826|37992211|FG002|Down-Titration Period|Reason Not Specified|2|||
16899439|NCT02198040|37992248|FG000|Overall Study|Work reasons|0|||
16899440|NCT02198040|37992249|FG001|Overall Study|Work reasons|1|||
16899441|NCT02198040|37992250|FG002|Overall Study|Work reasons|0|||
16899442|NCT02198040|37992248|FG000|Overall Study|Withdrawal by Subject|0|||
16899443|NCT02198040|37992249|FG001|Overall Study|Withdrawal by Subject|0|||
16899444|NCT02198040|37992250|FG002|Overall Study|Withdrawal by Subject|1|||
16899445|NCT02197806|37992264|FG000|Overall Study|Adverse Event|0|||
16899446|NCT02197806|37992265|FG001|Overall Study|Adverse Event|1|||
16899447|NCT02197806|37992266|FG002|Overall Study|Adverse Event|0|||
16899448|NCT02197806|37992267|FG003|Overall Study|Adverse Event|1|||
16899449|NCT02229864|37992314|FG000|Overall Study|Death|2|||
16899450|NCT02229864|37992314|FG000|Overall Study|Lost to Follow-up|1|||
16899451|NCT02229552|37992318|FG000|Baseline|Withdrawal by Subject|6|||
16899452|NCT02229552|37992318|FG000|1-year Follow up|Withdrawal by Subject|7|||
16899453|NCT02229552|37992318|FG000|1-year Follow up|Lost to Follow-up|18|||
16899454|NCT02229552|37992318|FG000|2-Year Follow up|Withdrawal by Subject|9|||
16899455|NCT02229552|37992318|FG000|2-Year Follow up|Lost to Follow-up|17|||
16899456|NCT02229396|37992335|FG000|Overall Study|Adverse Event|6|||
16899457|NCT02229396|37992336|FG001|Overall Study|Adverse Event|12|||
16899458|NCT02229396|37992337|FG002|Overall Study|Adverse Event|12|||
16899459|NCT02229396|37992335|FG000|Overall Study|Death|2|||
16899460|NCT02229396|37992336|FG001|Overall Study|Death|3|||
16899461|NCT02229396|37992337|FG002|Overall Study|Death|1|||
16899462|NCT02229396|37992335|FG000|Overall Study|Lost to Follow-up|14|||
16899463|NCT02229396|37992336|FG001|Overall Study|Lost to Follow-up|14|||
16899464|NCT02229396|37992337|FG002|Overall Study|Lost to Follow-up|21|||
16899465|NCT02229396|37992335|FG000|Overall Study|Protocol Violation|2|||
16899466|NCT02229396|37992336|FG001|Overall Study|Protocol Violation|1|||
16899467|NCT02229396|37992337|FG002|Overall Study|Protocol Violation|0|||
16899468|NCT02229396|37992335|FG000|Overall Study|Patient Incorrectly Randomized|0|||
16899469|NCT02229396|37992336|FG001|Overall Study|Patient Incorrectly Randomized|0|||
16899470|NCT02229396|37992337|FG002|Overall Study|Patient Incorrectly Randomized|1|||
16899471|NCT02229396|37992335|FG000|Overall Study|Other|10|||
16899472|NCT02229396|37992336|FG001|Overall Study|Other|18|||
16899473|NCT02229396|37992337|FG002|Overall Study|Other|15|||
16899474|NCT02229396|37992335|FG000|Overall Study|Withdrawal by Subject|42|||
16899475|NCT02229396|37992336|FG001|Overall Study|Withdrawal by Subject|28|||
16899476|NCT02229396|37992337|FG002|Overall Study|Withdrawal by Subject|41|||
16899477|NCT02229396|37992335|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
16899478|NCT02229396|37992336|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
16899479|NCT02229396|37992337|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
16899480|NCT02229396|37992335|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
16899481|NCT02229396|37992336|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
16899482|NCT02229396|37992337|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
16899483|NCT02197416|37992352|FG000|Overall Study|Other reasons|0|||
16899484|NCT02197416|37992353|FG001|Overall Study|Other reasons|2|||
16899485|NCT02197416|37992354|FG002|Overall Study|Other reasons|5|||
16899486|NCT02197416|37992352|FG000|Overall Study|Withdrawal by Subject|0|||
16899487|NCT02197416|37992353|FG001|Overall Study|Withdrawal by Subject|2|||
16899488|NCT02197416|37992354|FG002|Overall Study|Withdrawal by Subject|1|||
16899489|NCT02197416|37992352|FG000|Overall Study|Protocol Violation|1|||
16899490|NCT02197416|37992353|FG001|Overall Study|Protocol Violation|0|||
17005093|NCT00960869|38148850|FG001|Overall Study|Withdrawal by Subject|14|||
17005094|NCT00960869|38148849|FG000|Overall Study|Lost to Follow-up|1|||
17005095|NCT00960869|38148850|FG001|Overall Study|Lost to Follow-up|4|||
17005096|NCT00960869|38148849|FG000|Overall Study|Misc|19|||
17005097|NCT00960869|38148850|FG001|Overall Study|Misc|18|||
17005098|NCT00618787|38148858|FG000|Overall Study|Adverse Event|0|||
17005099|NCT00618787|38148859|FG001|Overall Study|Adverse Event|1|||
17005100|NCT00618787|38148858|FG000|Overall Study|Withdrawal by Subject|2|||
17005101|NCT00618787|38148859|FG001|Overall Study|Withdrawal by Subject|1|||
17005102|NCT00618787|38148858|FG000|Overall Study|Lost to Follow-up|1|||
17005103|NCT00618787|38148859|FG001|Overall Study|Lost to Follow-up|0|||
17005104|NCT00813813|38148867|FG000|Overall Study|Withdrawal by Subject|1|||
17005105|NCT00813813|38148868|FG001|Overall Study|Withdrawal by Subject|1|||
17005106|NCT00813813|38148867|FG000|Overall Study|Lost to Follow-up|2|||
16899491|NCT02197416|37992354|FG002|Overall Study|Protocol Violation|1|||
16899492|NCT02197416|37992352|FG000|Overall Study|Adverse Event|0|||
17005107|NCT00813813|38148868|FG001|Overall Study|Lost to Follow-up|7|||
16899493|NCT02197416|37992353|FG001|Overall Study|Adverse Event|0|||
16899494|NCT02197416|37992354|FG002|Overall Study|Adverse Event|1|||
16899495|NCT02165202|37992362|FG000|Oral Phase|Refused further participation|5|||
16899496|NCT02165202|37992363|FG001|Oral Phase|Refused further participation|1|||
16899497|NCT02165202|37992362|FG000|Oral Phase|Study product Related Toxicity|1|||
16899498|NCT02165202|37992363|FG001|Oral Phase|Study product Related Toxicity|0|||
16899499|NCT02165202|37992362|FG000|Oral Phase|Unable to contact Participant|1|||
16899500|NCT02165202|37992363|FG001|Oral Phase|Unable to contact Participant|1|||
16899501|NCT02165202|37992362|FG000|Oral Phase|Clinical reasons|1|||
16899502|NCT02165202|37992363|FG001|Oral Phase|Clinical reasons|0|||
16899503|NCT02165202|37992362|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
16899504|NCT02165202|37992363|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
16899505|NCT02165202|37992362|FG000|Oral Phase|CMC advised termination|1|||
16899506|NCT02165202|37992363|FG001|Oral Phase|CMC advised termination|0|||
16899507|NCT02165202|37992362|FG000|Oral Phase|Relocated, no follow-up planned|1|||
16899508|NCT02165202|37992363|FG001|Oral Phase|Relocated, no follow-up planned|0|||
16899509|NCT02165202|37992362|FG000|Oral Phase|Abnormal EKG|0|||
16899510|NCT02165202|37992363|FG001|Oral Phase|Abnormal EKG|1|||
16899511|NCT02165202|37992362|FG000|Injection Phase|Abnormal Lab Value|5|||
16899512|NCT02165202|37992363|FG001|Injection Phase|Abnormal Lab Value|1|||
16899513|NCT02165202|37992362|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
16899514|NCT02165202|37992363|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
16899515|NCT02165202|37992362|FG000|Injection Phase|Unable to attend within Visit Window|1|||
16899516|NCT02165202|37992363|FG001|Injection Phase|Unable to attend within Visit Window|0|||
16899517|NCT02165202|37992362|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
16899518|NCT02165202|37992363|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
16899519|NCT02165202|37992362|FG000|Injection Phase|End of Study|2|||
16899520|NCT02165202|37992363|FG001|Injection Phase|End of Study|1|||
16899521|NCT02165202|37992362|FG000|Injection Phase|Study Product related Toxicity|1|||
16899522|NCT02165202|37992363|FG001|Injection Phase|Study Product related Toxicity|0|||
16899523|NCT02165202|37992362|FG000|Injection Phase|No longer interested|0|||
16899524|NCT02165202|37992363|FG001|Injection Phase|No longer interested|1|||
16899525|NCT02165202|37992362|FG000|Injection Phase|Participant unwilling to comply|1|||
16899526|NCT02165202|37992363|FG001|Injection Phase|Participant unwilling to comply|0|||
16899527|NCT01628874|37992371|FG000|Overall Study|Physician Decision|1|||
16899528|NCT01628874|37992372|FG001|Overall Study|Physician Decision|1|||
16899529|NCT01628874|37992371|FG000|Overall Study|Age >4 months|4|||
16899530|NCT01628874|37992372|FG001|Overall Study|Age >4 months|2|||
16899531|NCT02196714|37992397|FG000|Overall Study|Protocol Violation|0|||
16899532|NCT02196714|37992398|FG001|Overall Study|Protocol Violation|0|||
16899533|NCT02196714|37992399|FG002|Overall Study|Protocol Violation|1|||
16899534|NCT02196714|37992400|FG003|Overall Study|Protocol Violation|0|||
16899535|NCT02196558|37992424|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
16899536|NCT02196558|37992425|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
16899537|NCT02196558|37992426|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
16899538|NCT02196558|37992424|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
16899539|NCT02196558|37992425|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
16899540|NCT02196558|37992426|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
16899541|NCT02196558|37992424|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
16899542|NCT02196558|37992425|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
16899543|NCT02196558|37992426|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
16899544|NCT02196558|37992424|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
16899545|NCT02196558|37992425|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
16899546|NCT02196558|37992426|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
16899547|NCT02196558|37992424|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
16899548|NCT02196558|37992425|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
16899549|NCT02196558|37992426|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
16899550|NCT02196324|37992447|FG000|Overall Study|Withdrawal by Subject|8|||
16899551|NCT02196324|37992448|FG001|Overall Study|Withdrawal by Subject|4|||
16899552|NCT02196324|37992447|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
16899553|NCT02196324|37992448|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
16899554|NCT02196324|37992447|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
16899555|NCT02196324|37992448|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
16899556|NCT02196324|37992447|FG000|Overall Study|Other|1|||
16899557|NCT02196324|37992448|FG001|Overall Study|Other|0|||
16899558|NCT02195700|37992456|FG000|Overall Study|Protocol Violation|0|||
16899559|NCT02195700|37992457|FG001|Overall Study|Protocol Violation|2|||
16899560|NCT02195700|37992456|FG000|Overall Study|Noncompliance|1|||
16899561|NCT02195700|37992457|FG001|Overall Study|Noncompliance|0|||
16899562|NCT02195700|37992456|FG000|Overall Study|Adverse Event|1|||
16899563|NCT02195700|37992457|FG001|Overall Study|Adverse Event|2|||
16899564|NCT02195700|37992456|FG000|Overall Study|Withdrawal by Subject|3|||
16899565|NCT02195700|37992457|FG001|Overall Study|Withdrawal by Subject|2|||
16899566|NCT02195700|37992456|FG000|Overall Study|Lost to Follow-up|1|||
16899567|NCT02195700|37992457|FG001|Overall Study|Lost to Follow-up|1|||
16899568|NCT02228460|37992472|FG000|Overall Study|Adverse Event|1|||
16899569|NCT02228460|37992472|FG000|Overall Study|Lost to Follow-up|1|||
16899570|NCT02227446|37992488|FG000|Overall Study|not eligible post randomization|18|||
16899571|NCT02227446|37992489|FG001|Overall Study|not eligible post randomization|29|||
16899572|NCT02227446|37992488|FG000|Overall Study|Withdrawal by Subject|4|||
16899573|NCT02227446|37992489|FG001|Overall Study|Withdrawal by Subject|5|||
16899574|NCT02227368|37992497|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
16899575|NCT02227368|37992498|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
17005108|NCT00813813|38148867|FG000|Overall Study|Other|0|||
17005109|NCT00813813|38148868|FG001|Overall Study|Other|1|||
17005110|NCT00960011|38148876|FG000|Overall Study|Death|5|||
17005111|NCT00960011|38148877|FG001|Overall Study|Death|0|||
17005112|NCT00960011|38148876|FG000|Overall Study|Lost to Follow-up|6|||
17005113|NCT00960011|38148877|FG001|Overall Study|Lost to Follow-up|2|||
17005114|NCT00617851|38148921|FG000|Overall Study|Death|0|||
17005115|NCT00617851|38148922|FG001|Overall Study|Death|0|||
17005116|NCT00617851|38148923|FG002|Overall Study|Death|0|||
17005117|NCT00617851|38148924|FG003|Overall Study|Death|1|||
17005118|NCT00617851|38148921|FG000|Overall Study|Withdrawal by Subject|14|||
17005119|NCT00617851|38148922|FG001|Overall Study|Withdrawal by Subject|7|||
17005120|NCT00617851|38148923|FG002|Overall Study|Withdrawal by Subject|12|||
17005121|NCT00617851|38148924|FG003|Overall Study|Withdrawal by Subject|4|||
17005122|NCT00617851|38148921|FG000|Overall Study|Lost to Follow-up|27|||
17005123|NCT00617851|38148922|FG001|Overall Study|Lost to Follow-up|29|||
16899576|NCT02227368|37992497|FG000|Overall Study|Lost to Follow-up|1|||
16899577|NCT02227368|37992498|FG001|Overall Study|Lost to Follow-up|0|||
16899578|NCT02227368|37992497|FG000|Overall Study|Adverse Event|1|||
16899579|NCT02227368|37992498|FG001|Overall Study|Adverse Event|0|||
16899580|NCT02162862|37992507|FG000|Overall Study|Lost to Follow-up|0|||
16899581|NCT02162862|37992508|FG001|Overall Study|Lost to Follow-up|11|||
16899582|NCT02162862|37992509|FG002|Overall Study|Lost to Follow-up|0|||
16899583|NCT02162862|37992507|FG000|Overall Study|Subject did not feel the med was needed|0|||
16899584|NCT02162862|37992508|FG001|Overall Study|Subject did not feel the med was needed|0|||
16899585|NCT02162862|37992509|FG002|Overall Study|Subject did not feel the med was needed|4|||
16899586|NCT02226198|37992547|FG000|Lead-in Phase|Protocol Violation|1|||
16899587|NCT02226198|37992548|FG001|Lead-in Phase|Protocol Violation|0|||
16899588|NCT02226198|37992549|FG002|Lead-in Phase|Protocol Violation|0|||
16899589|NCT02226198|37992547|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
16899590|NCT02226198|37992548|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
16899591|NCT02226198|37992549|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
16899592|NCT02226120|37992720|FG000|Overall Study|Adverse Event|60|||
16899593|NCT02226120|37992720|FG000|Overall Study|Death|172|||
16899594|NCT02226120|37992720|FG000|Overall Study|Study terminated by sponsor|1|||
16899595|NCT02226120|37992720|FG000|Overall Study|Technical problems|4|||
16899596|NCT02226120|37992720|FG000|Overall Study|Lost to Follow-up|13|||
16899597|NCT02226120|37992720|FG000|Overall Study|Physician Decision|21|||
16899598|NCT02226120|37992720|FG000|Overall Study|Withdrawal by parent/guardian|36|||
16899599|NCT02226120|37992720|FG000|Overall Study|Non-compliance with study drug|10|||
16899600|NCT02226120|37992720|FG000|Overall Study|Protocol deviation|1|||
16899601|NCT02226120|37992720|FG000|Overall Study|missing treatment disposition pages|2|||
16899602|NCT02194998|37992898|FG000|On-HCV Treatment|Did not pick up study medication|0|||
16899603|NCT02194998|37992899|FG001|On-HCV Treatment|Did not pick up study medication|1|||
16899604|NCT02194998|37992900|FG002|On-HCV Treatment|Did not pick up study medication|0|||
16899605|NCT02194998|37992901|FG003|On-HCV Treatment|Did not pick up study medication|0|||
17005124|NCT00617851|38148923|FG002|Overall Study|Lost to Follow-up|31|||
17005125|NCT00617851|38148924|FG003|Overall Study|Lost to Follow-up|19|||
17005126|NCT00617851|38148921|FG000|Overall Study|Inappropriate Enrollment|5|||
17005127|NCT00617851|38148922|FG001|Overall Study|Inappropriate Enrollment|4|||
17005128|NCT00617851|38148923|FG002|Overall Study|Inappropriate Enrollment|1|||
17005129|NCT00617851|38148924|FG003|Overall Study|Inappropriate Enrollment|1|||
17005130|NCT00617851|38148921|FG000|Overall Study|Unable to classify|1|||
17005131|NCT00617851|38148922|FG001|Overall Study|Unable to classify|0|||
17005132|NCT00617851|38148923|FG002|Overall Study|Unable to classify|1|||
17005133|NCT00617851|38148924|FG003|Overall Study|Unable to classify|0|||
17005134|NCT00812955|38148948|FG000|Overall Study|Adverse Event|7|||
17005135|NCT00812955|38148949|FG001|Overall Study|Adverse Event|6|||
17005136|NCT00812955|38148950|FG002|Overall Study|Adverse Event|3|||
17005137|NCT00812955|38148951|FG003|Overall Study|Adverse Event|4|||
17005138|NCT00812955|38148948|FG000|Overall Study|Lost to Follow-up|2|||
17005139|NCT00812955|38148949|FG001|Overall Study|Lost to Follow-up|1|||
16899606|NCT02194998|37992898|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
17005140|NCT00812955|38148950|FG002|Overall Study|Lost to Follow-up|1|||
16899607|NCT02194998|37992899|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
17005141|NCT00812955|38148951|FG003|Overall Study|Lost to Follow-up|2|||
17005142|NCT00812955|38148948|FG000|Overall Study|Withdrawal by Subject|1|||
17005143|NCT00812955|38148949|FG001|Overall Study|Withdrawal by Subject|0|||
17005144|NCT00812955|38148950|FG002|Overall Study|Withdrawal by Subject|1|||
16899608|NCT02194998|37992900|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
16899609|NCT02194998|37992901|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
16899610|NCT02194062|37992914|FG000|Overall Study|Lost to Follow-up|2|||
16899611|NCT02194062|37992915|FG001|Overall Study|Lost to Follow-up|2|||
16899612|NCT02194062|37992916|FG002|Overall Study|Lost to Follow-up|5|||
16899613|NCT02193828|37992937|FG000|Overall Study|Withdrawal by Subject|0|||
16899614|NCT02193828|37992938|FG001|Overall Study|Withdrawal by Subject|0|||
16899615|NCT02193828|37992939|FG002|Overall Study|Withdrawal by Subject|1|||
16899616|NCT02193828|37992940|FG003|Overall Study|Withdrawal by Subject|1|||
16899617|NCT02192970|37992961|FG000|Overall Study|Lost to Follow-up|6|||
16899618|NCT02192970|37992962|FG001|Overall Study|Lost to Follow-up|0|||
16899619|NCT02192190|37993154|FG000|Overall Study|Adverse Event|1|||
16899620|NCT02192190|37993155|FG001|Overall Study|Adverse Event|1|||
16899621|NCT02192190|37993156|FG002|Overall Study|Adverse Event|0|||
16899622|NCT02192190|37993157|FG003|Overall Study|Adverse Event|0|||
16899623|NCT02192190|37993158|FG004|Overall Study|Adverse Event|0|||
16899624|NCT02192190|37993159|FG005|Overall Study|Adverse Event|0|||
16899625|NCT02192190|37993154|FG000|Overall Study|Lost to Follow-up|3|||
16899626|NCT02192190|37993155|FG001|Overall Study|Lost to Follow-up|3|||
16899627|NCT02192190|37993156|FG002|Overall Study|Lost to Follow-up|2|||
16899628|NCT02192190|37993157|FG003|Overall Study|Lost to Follow-up|1|||
16899629|NCT02192190|37993158|FG004|Overall Study|Lost to Follow-up|4|||
16899630|NCT02192190|37993159|FG005|Overall Study|Lost to Follow-up|3|||
16899631|NCT02192190|37993154|FG000|Overall Study|Physician Decision|2|||
16899632|NCT02192190|37993155|FG001|Overall Study|Physician Decision|0|||
16899633|NCT02192190|37993156|FG002|Overall Study|Physician Decision|0|||
16899634|NCT02192190|37993157|FG003|Overall Study|Physician Decision|0|||
16899635|NCT02192190|37993158|FG004|Overall Study|Physician Decision|0|||
16899636|NCT02192190|37993159|FG005|Overall Study|Physician Decision|0|||
16899637|NCT02192190|37993154|FG000|Overall Study|Terminated by Sponsor|43|||
16899638|NCT02192190|37993155|FG001|Overall Study|Terminated by Sponsor|23|||
16899639|NCT02192190|37993156|FG002|Overall Study|Terminated by Sponsor|20|||
16899640|NCT02192190|37993157|FG003|Overall Study|Terminated by Sponsor|23|||
16899641|NCT02192190|37993158|FG004|Overall Study|Terminated by Sponsor|21|||
16899642|NCT02192190|37993159|FG005|Overall Study|Terminated by Sponsor|23|||
16899643|NCT02192190|37993154|FG000|Overall Study|Withdrawal by Subject|4|||
16899644|NCT02192190|37993155|FG001|Overall Study|Withdrawal by Subject|1|||
16899645|NCT02192190|37993156|FG002|Overall Study|Withdrawal by Subject|2|||
16899646|NCT02192190|37993157|FG003|Overall Study|Withdrawal by Subject|1|||
16899647|NCT02192190|37993158|FG004|Overall Study|Withdrawal by Subject|5|||
16899648|NCT02192190|37993159|FG005|Overall Study|Withdrawal by Subject|3|||
16899649|NCT02192190|37993154|FG000|Overall Study|Could not Keep Visit Schedule|1|||
16899650|NCT02192190|37993155|FG001|Overall Study|Could not Keep Visit Schedule|0|||
16899651|NCT02192190|37993156|FG002|Overall Study|Could not Keep Visit Schedule|0|||
16899652|NCT02192190|37993157|FG003|Overall Study|Could not Keep Visit Schedule|0|||
16899653|NCT02192190|37993158|FG004|Overall Study|Could not Keep Visit Schedule|0|||
16899654|NCT02192190|37993159|FG005|Overall Study|Could not Keep Visit Schedule|0|||
16899655|NCT02192190|37993154|FG000|Overall Study|Positive Drug Screen|0|||
16899656|NCT02192190|37993155|FG001|Overall Study|Positive Drug Screen|0|||
16899657|NCT02192190|37993156|FG002|Overall Study|Positive Drug Screen|0|||
16899658|NCT02192190|37993157|FG003|Overall Study|Positive Drug Screen|1|||
16899659|NCT02192190|37993158|FG004|Overall Study|Positive Drug Screen|0|||
16899660|NCT02192190|37993159|FG005|Overall Study|Positive Drug Screen|0|||
16899661|NCT02192190|37993154|FG000|Overall Study|Inadequate Pain Relief|0|||
16899662|NCT02192190|37993155|FG001|Overall Study|Inadequate Pain Relief|1|||
16899663|NCT02192190|37993156|FG002|Overall Study|Inadequate Pain Relief|1|||
16899664|NCT02192190|37993157|FG003|Overall Study|Inadequate Pain Relief|0|||
16899665|NCT02192190|37993158|FG004|Overall Study|Inadequate Pain Relief|0|||
16899666|NCT02192190|37993159|FG005|Overall Study|Inadequate Pain Relief|0|||
16899667|NCT02224638|37993187|FG000|Overall Study|Adverse Event|1|||
16899668|NCT02224638|37993188|FG001|Overall Study|Adverse Event|1|||
16899669|NCT02224560|37993203|FG000|Overall Study|Protocol Deviation|1|||
16899670|NCT02224560|37993204|FG001|Overall Study|Protocol Deviation|0|||
16899671|NCT02224560|37993205|FG002|Overall Study|Protocol Deviation|0|||
16899672|NCT02224560|37993203|FG000|Overall Study|Withdrawal by Subject|2|||
16899673|NCT02224560|37993204|FG001|Overall Study|Withdrawal by Subject|0|||
16899674|NCT02224560|37993205|FG002|Overall Study|Withdrawal by Subject|1|||
16899675|NCT02224560|37993203|FG000|Overall Study|Met Withdrawal Criteria|1|||
16899676|NCT02224560|37993204|FG001|Overall Study|Met Withdrawal Criteria|0|||
16899677|NCT02224560|37993205|FG002|Overall Study|Met Withdrawal Criteria|0|||
16899678|NCT02224560|37993203|FG000|Overall Study|Adverse Event|4|||
16899679|NCT02224560|37993204|FG001|Overall Study|Adverse Event|1|||
16899680|NCT02224560|37993205|FG002|Overall Study|Adverse Event|1|||
16899681|NCT02224560|37993203|FG000|Overall Study|Withdrawn by Investigator|1|||
16899682|NCT02224560|37993204|FG001|Overall Study|Withdrawn by Investigator|1|||
16899683|NCT02224560|37993205|FG002|Overall Study|Withdrawn by Investigator|0|||
16899684|NCT02161458|37993217|FG000|Overall Study|Withdrawal by Subject|0|||
16899685|NCT02161458|37993218|FG001|Overall Study|Withdrawal by Subject|4|||
16899686|NCT02161458|37993219|FG002|Overall Study|Withdrawal by Subject|4|||
16899687|NCT02161458|37993220|FG003|Overall Study|Withdrawal by Subject|0|||
16899688|NCT02161458|37993217|FG000|Overall Study|Lost to Follow-up|0|||
16899689|NCT02161458|37993218|FG001|Overall Study|Lost to Follow-up|2|||
16899690|NCT02161458|37993219|FG002|Overall Study|Lost to Follow-up|1|||
16899691|NCT02161458|37993220|FG003|Overall Study|Lost to Follow-up|0|||
16899692|NCT02223858|37993232|FG000|Overall Study|Death|1|||
16899693|NCT02223858|37993233|FG001|Overall Study|Death|1|||
16899694|NCT02223858|37993232|FG000|Overall Study|Lost to Follow-up|6|||
16899695|NCT02223858|37993233|FG001|Overall Study|Lost to Follow-up|11|||
16899696|NCT02223858|37993232|FG000|Overall Study|Withdrawal by Subject|8|||
16899697|NCT02223858|37993233|FG001|Overall Study|Withdrawal by Subject|5|||
16899698|NCT02223858|37993232|FG000|Overall Study|Refused|9|||
16899699|NCT02223858|37993233|FG001|Overall Study|Refused|9|||
16899700|NCT02223390|37993241|FG000|Overall Study|Lost to Follow-up|9|||
16899701|NCT02223390|37993242|FG001|Overall Study|Lost to Follow-up|4|||
16899702|NCT02222922|37997358|FG000|Overall Study|Death|0|||
16899703|NCT02222922|37997359|FG001|Overall Study|Death|0|||
16899704|NCT02222922|37997360|FG002|Overall Study|Death|0|||
16899705|NCT02222922|37997361|FG003|Overall Study|Death|0|||
16899706|NCT02222922|37997362|FG004|Overall Study|Death|13|||
16899707|NCT02222922|37997363|FG005|Overall Study|Death|0|||
16899708|NCT02222922|37997364|FG006|Overall Study|Death|0|||
16899709|NCT02222922|37997365|FG007|Overall Study|Death|0|||
16899710|NCT02222922|37997366|FG008|Overall Study|Death|2|||
16899711|NCT02222922|37997358|FG000|Overall Study|Lost to Follow-up|0|||
16899712|NCT02222922|37997359|FG001|Overall Study|Lost to Follow-up|0|||
16899713|NCT02222922|37997360|FG002|Overall Study|Lost to Follow-up|1|||
16899714|NCT02222922|37997361|FG003|Overall Study|Lost to Follow-up|0|||
16899715|NCT02222922|37997362|FG004|Overall Study|Lost to Follow-up|9|||
16899716|NCT02222922|37997363|FG005|Overall Study|Lost to Follow-up|1|||
16899717|NCT02222922|37997364|FG006|Overall Study|Lost to Follow-up|0|||
16899718|NCT02222922|37997365|FG007|Overall Study|Lost to Follow-up|0|||
16899719|NCT02222922|37997366|FG008|Overall Study|Lost to Follow-up|0|||
16899720|NCT02222922|37997358|FG000|Overall Study|Other|0|||
16899721|NCT02222922|37997359|FG001|Overall Study|Other|0|||
16899722|NCT02222922|37997360|FG002|Overall Study|Other|0|||
16899723|NCT02222922|37997361|FG003|Overall Study|Other|2|||
16899724|NCT02222922|37997362|FG004|Overall Study|Other|10|||
16899725|NCT02222922|37997363|FG005|Overall Study|Other|2|||
17005145|NCT00812955|38148951|FG003|Overall Study|Withdrawal by Subject|2|||
17005146|NCT00812955|38148948|FG000|Overall Study|randomized in error|0|||
17005147|NCT00812955|38148949|FG001|Overall Study|randomized in error|0|||
17005148|NCT00812955|38148950|FG002|Overall Study|randomized in error|1|||
17005149|NCT00812955|38148951|FG003|Overall Study|randomized in error|0|||
17005150|NCT00619489|38148967|FG000|Overall Study|Adverse Event|0|||
17005151|NCT00619489|38148968|FG001|Overall Study|Adverse Event|7|||
17005152|NCT00619489|38148967|FG000|Overall Study|Withdrawal by Subject|1|||
17005153|NCT00619489|38148968|FG001|Overall Study|Withdrawal by Subject|1|||
17005154|NCT00619489|38148967|FG000|Overall Study|Lack of Efficacy|0|||
17005155|NCT00619489|38148968|FG001|Overall Study|Lack of Efficacy|11|||
17005156|NCT00619489|38148967|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
17005157|NCT00619489|38148968|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
17005158|NCT00959699|38148976|FG000|Treatment Period|Adverse Event|3|||
17005159|NCT00959699|38148977|FG001|Treatment Period|Adverse Event|13|||
17005160|NCT00959699|38148976|FG000|Treatment Period|Lack of Efficacy|15|||
17005161|NCT00959699|38148977|FG001|Treatment Period|Lack of Efficacy|6|||
17005162|NCT00959699|38148976|FG000|Treatment Period|Lost to Follow-up|0|||
17005163|NCT00959699|38148977|FG001|Treatment Period|Lost to Follow-up|1|||
17005164|NCT00959699|38148976|FG000|Treatment Period|Withdrawal by Subject|1|||
17005165|NCT00959699|38148977|FG001|Treatment Period|Withdrawal by Subject|3|||
17005166|NCT00959699|38148976|FG000|Treatment Period|Non-Compliance with Protocol|0|||
17005167|NCT00959699|38148977|FG001|Treatment Period|Non-Compliance with Protocol|1|||
17005168|NCT00959699|38148976|FG000|Treatment Period|Did not receive treatment|0|||
17005169|NCT00959699|38148977|FG001|Treatment Period|Did not receive treatment|1|||
17005170|NCT00959699|38148976|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
17005171|NCT00959699|38148977|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
17005172|NCT00959699|38148976|FG000|Follow-up Period|Lost to Follow-up|3|||
17005173|NCT00959699|38148977|FG001|Follow-up Period|Lost to Follow-up|2|||
17005174|NCT00959699|38148976|FG000|Follow-up Period|Withdrawal by Subject|3|||
17095509|NCT00071812|38234779|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
16899726|NCT02222922|37997364|FG006|Overall Study|Other|2|||
16899727|NCT02222922|37997365|FG007|Overall Study|Other|4|||
16899728|NCT02222922|37997366|FG008|Overall Study|Other|1|||
16899729|NCT02222922|37997358|FG000|Overall Study|Participant refused further follow-up|1|||
16899730|NCT02222922|37997359|FG001|Overall Study|Participant refused further follow-up|0|||
16899731|NCT02222922|37997360|FG002|Overall Study|Participant refused further follow-up|0|||
16899732|NCT02222922|37997361|FG003|Overall Study|Participant refused further follow-up|1|||
17005175|NCT00959699|38148977|FG001|Follow-up Period|Withdrawal by Subject|4|||
17005176|NCT00617773|38148984|FG000|Overall Study|Physician Decision|1|||
17005177|NCT00617773|38148984|FG000|Overall Study|Lack of compliance with the protocol|1|||
17005178|NCT00617773|38148984|FG000|Overall Study|Withdrawal by Subject|1|||
17005179|NCT00617773|38148984|FG000|Overall Study|Death|1|||
17005180|NCT00617773|38148984|FG000|Overall Study|Progressive disease|19|||
17005181|NCT00617773|38148984|FG000|Overall Study|Protocol Violation|1|||
17005182|NCT00956813|38148990|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
17005183|NCT00956813|38148991|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
17005184|NCT00956813|38148990|FG000|Flaxseed and Placebo|Ineligible|3|||
17005185|NCT00956813|38148991|FG001|Flaxseed and Placebo|Ineligible|1|||
16899733|NCT02222922|37997362|FG004|Overall Study|Participant refused further follow-up|6|||
16899734|NCT02222922|37997363|FG005|Overall Study|Participant refused further follow-up|0|||
16899735|NCT02222922|37997364|FG006|Overall Study|Participant refused further follow-up|0|||
16899736|NCT02222922|37997365|FG007|Overall Study|Participant refused further follow-up|0|||
16899737|NCT02222922|37997366|FG008|Overall Study|Participant refused further follow-up|3|||
16899738|NCT02161146|37997418|FG000|Overall Study|Adverse Event|1|||
16899739|NCT02161146|37997419|FG001|Overall Study|Adverse Event|1|||
16899740|NCT02161146|37997420|FG002|Overall Study|Adverse Event|0|||
16899741|NCT02161146|37997421|FG003|Overall Study|Adverse Event|1|||
16899742|NCT02161146|37997422|FG004|Overall Study|Adverse Event|0|||
16899743|NCT02161146|37997418|FG000|Overall Study|Lost to Follow-up|0|||
16899744|NCT02161146|37997419|FG001|Overall Study|Lost to Follow-up|1|||
16899745|NCT02161146|37997420|FG002|Overall Study|Lost to Follow-up|0|||
16899746|NCT02161146|37997421|FG003|Overall Study|Lost to Follow-up|0|||
16899747|NCT02161146|37997422|FG004|Overall Study|Lost to Follow-up|0|||
16899748|NCT02161146|37997418|FG000|Overall Study|Personal Reasons|0|||
16899749|NCT02161146|37997419|FG001|Overall Study|Personal Reasons|1|||
16899750|NCT02161146|37997420|FG002|Overall Study|Personal Reasons|0|||
16899751|NCT02161146|37997421|FG003|Overall Study|Personal Reasons|2|||
16899752|NCT02161146|37997422|FG004|Overall Study|Personal Reasons|1|||
16899753|NCT02161146|37997418|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16899754|NCT02161146|37997419|FG001|Overall Study|Other Miscellaneous Reasons|1|||
16899755|NCT02161146|37997420|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16899756|NCT02161146|37997421|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16899757|NCT02161146|37997422|FG004|Overall Study|Other Miscellaneous Reasons|0|||
16899758|NCT02222688|37997653|FG000|Overall Study|Withdrawal by Subject|0|||
16899759|NCT02222688|37997654|FG001|Overall Study|Withdrawal by Subject|0|||
16899760|NCT02222688|37997655|FG002|Overall Study|Withdrawal by Subject|0|||
16899761|NCT02222688|37997656|FG003|Overall Study|Withdrawal by Subject|2|||
16899762|NCT02222688|37997657|FG004|Overall Study|Withdrawal by Subject|1|||
16899763|NCT02222688|37997658|FG005|Overall Study|Withdrawal by Subject|0|||
16899764|NCT02222688|37997659|FG006|Overall Study|Withdrawal by Subject|1|||
17005186|NCT00955955|38149001|FG000|Overall Study|Lost to Follow-up|2|||
17005187|NCT00955955|38149002|FG001|Overall Study|Lost to Follow-up|0|||
17005188|NCT00955955|38149003|FG002|Overall Study|Lost to Follow-up|0|||
17005189|NCT00955721|38149019|FG000|Overall Study|Physician Decision|1|||
17005190|NCT00955721|38149020|FG001|Overall Study|Physician Decision|0|||
16899765|NCT02222688|37997653|FG000|Overall Study|Disease progression|1|||
16899766|NCT02222688|37997654|FG001|Overall Study|Disease progression|0|||
16899767|NCT02222688|37997655|FG002|Overall Study|Disease progression|0|||
16899768|NCT02222688|37997656|FG003|Overall Study|Disease progression|0|||
16899769|NCT02222688|37997657|FG004|Overall Study|Disease progression|0|||
16899770|NCT02222688|37997658|FG005|Overall Study|Disease progression|0|||
16899771|NCT02222688|37997659|FG006|Overall Study|Disease progression|0|||
16899772|NCT02159352|37997711|FG000|Overall Study|Adverse Event|3|||
16899773|NCT02159352|37997712|FG001|Overall Study|Adverse Event|1|||
16899774|NCT02159352|37997711|FG000|Overall Study|Withdrawal by Subject|0|||
16899775|NCT02159352|37997712|FG001|Overall Study|Withdrawal by Subject|1|||
16899776|NCT02187744|37997749|FG000|Study|Participant refused further follow-up|1|||
16899777|NCT02187744|37997750|FG001|Study|Participant refused further follow-up|0|||
16899778|NCT02187744|37997749|FG000|Study|Other|2|||
16899779|NCT02187744|37997750|FG001|Study|Other|1|||
16899780|NCT02187744|37997749|FG000|Study|Lost to Follow-up|0|||
16899781|NCT02187744|37997750|FG001|Study|Lost to Follow-up|2|||
16899782|NCT02187744|37997749|FG000|Study|Related adverse event, not serious|0|||
16899783|NCT02187744|37997750|FG001|Study|Related adverse event, not serious|2|||
16899784|NCT02187744|37997749|FG000|Study|Death|1|||
16899785|NCT02187744|37997750|FG001|Study|Death|0|||
16899786|NCT02187744|37997749|FG000|Study|Related adverse event, serious non-fatal|0|||
16899787|NCT02187744|37997750|FG001|Study|Related adverse event, serious non-fatal|1|||
16899788|NCT02187744|37997749|FG000|Treatment|Death|1|||
16899789|NCT02187744|37997750|FG001|Treatment|Death|0|||
16899790|NCT02187744|37997749|FG000|Treatment|Related adverse event, serious non-fatal|0|||
16899791|NCT02187744|37997750|FG001|Treatment|Related adverse event, serious non-fatal|1|||
16899792|NCT02187744|37997749|FG000|Treatment|Related adverse event, not serious|0|||
17005191|NCT00955721|38149019|FG000|Overall Study|Death|1|||
17005192|NCT00955721|38149020|FG001|Overall Study|Death|0|||
16899793|NCT02187744|37997750|FG001|Treatment|Related adverse event, not serious|2|||
16899794|NCT02187744|37997749|FG000|Treatment|Lost to Follow-up|0|||
16899795|NCT02187744|37997750|FG001|Treatment|Lost to Follow-up|1|||
16899796|NCT02187744|37997749|FG000|Treatment|Other|2|||
16899797|NCT02187744|37997750|FG001|Treatment|Other|0|||
16899798|NCT02187744|37997749|FG000|Treatment|Participant refused continued treatment|1|||
16899799|NCT02187744|37997750|FG001|Treatment|Participant refused continued treatment|1|||
16899800|NCT01630434|37997786|FG000|Overall Study|Donor lungs turned down|1|||
16899801|NCT01630434|37997787|FG001|Overall Study|Donor lungs turned down|0|||
16899802|NCT01630434|37997786|FG000|Overall Study|Protocol Violation|9|||
16899803|NCT01630434|37997787|FG001|Overall Study|Protocol Violation|4|||
16899804|NCT01630434|37997786|FG000|Overall Study|Death|20|||
16899805|NCT01630434|37997787|FG001|Overall Study|Death|26|||
16899806|NCT02187042|37997925|FG000|Overall Study|Death|1|||
16899807|NCT02187042|37997926|FG001|Overall Study|Death|1|||
16899808|NCT02187042|37997925|FG000|Overall Study|Toxicity|6|||
16899809|NCT02187042|37997926|FG001|Overall Study|Toxicity|5|||
16899810|NCT02187042|37997925|FG000|Overall Study|Participant choice|1|||
16899811|NCT02187042|37997926|FG001|Overall Study|Participant choice|0|||
16899812|NCT02187042|37997925|FG000|Overall Study|Doctor choice|1|||
16899813|NCT02187042|37997926|FG001|Overall Study|Doctor choice|0|||
16899814|NCT02187042|37997925|FG000|Overall Study|Progressive disease|4|||
16899815|NCT02187042|37997926|FG001|Overall Study|Progressive disease|8|||
16899816|NCT02186652|37997935|FG000|Overall Study|Lost to Follow-up|2|||
16899817|NCT02186652|37997936|FG001|Overall Study|Lost to Follow-up|0|||
16899818|NCT02185794|37997972|FG000|Overall Study|Enrolled but Never Dosed|1|||
16899819|NCT02185794|37997973|FG001|Overall Study|Enrolled but Never Dosed|6|||
16899820|NCT02185794|37997974|FG002|Overall Study|Enrolled but Never Dosed|3|||
16899821|NCT02185794|37997975|FG003|Overall Study|Enrolled but Never Dosed|1|||
16899822|NCT02185794|37997976|FG004|Overall Study|Enrolled but Never Dosed|1|||
16899823|NCT02185794|37997977|FG005|Overall Study|Enrolled but Never Dosed|0|||
16899824|NCT02185794|37997972|FG000|Overall Study|Investigator's Discretion|1|||
16899825|NCT02185794|37997973|FG001|Overall Study|Investigator's Discretion|0|||
16899826|NCT02185794|37997974|FG002|Overall Study|Investigator's Discretion|1|||
16899827|NCT02185794|37997975|FG003|Overall Study|Investigator's Discretion|2|||
16899828|NCT02185794|37997976|FG004|Overall Study|Investigator's Discretion|2|||
16899829|NCT02185794|37997977|FG005|Overall Study|Investigator's Discretion|15|||
16899830|NCT02185794|37997972|FG000|Overall Study|Withdrew Consent|2|||
16899831|NCT02185794|37997973|FG001|Overall Study|Withdrew Consent|5|||
16899832|NCT02185794|37997974|FG002|Overall Study|Withdrew Consent|10|||
16899833|NCT02185794|37997975|FG003|Overall Study|Withdrew Consent|2|||
16899834|NCT02185794|37997976|FG004|Overall Study|Withdrew Consent|0|||
16899835|NCT02185794|37997977|FG005|Overall Study|Withdrew Consent|0|||
16899836|NCT02185794|37997972|FG000|Overall Study|Lost to Follow-up|1|||
16899837|NCT02185794|37997973|FG001|Overall Study|Lost to Follow-up|2|||
16899838|NCT02185794|37997974|FG002|Overall Study|Lost to Follow-up|2|||
16899839|NCT02185794|37997975|FG003|Overall Study|Lost to Follow-up|3|||
16899840|NCT02185794|37997976|FG004|Overall Study|Lost to Follow-up|0|||
16899841|NCT02185794|37997977|FG005|Overall Study|Lost to Follow-up|1|||
16899842|NCT02221674|37998008|FG000|Overall Study|Lost to Follow-up|1|||
16899843|NCT02221674|37998009|FG001|Overall Study|Lost to Follow-up|0|||
16899844|NCT02221674|37998010|FG002|Overall Study|Lost to Follow-up|0|||
16899845|NCT02221284|37998025|FG000|Overall Study|Case Report Forms Uncollected|56|||
16899846|NCT02221284|37998025|FG000|Overall Study|Protocol Deviation|5|||
16899847|NCT02220894|37998360|FG000|Overall Study|Adverse Event|118|||
16899848|NCT02220894|37998361|FG001|Overall Study|Adverse Event|70|||
16899849|NCT02220894|37998360|FG000|Overall Study|Death|252|||
16899850|NCT02220894|37998361|FG001|Overall Study|Death|368|||
16899851|NCT02220894|37998360|FG000|Overall Study|Lost to Follow-up|0|||
16899852|NCT02220894|37998361|FG001|Overall Study|Lost to Follow-up|2|||
16899853|NCT02220894|37998360|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16899854|NCT02220894|37998361|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16899855|NCT02220894|37998360|FG000|Overall Study|Withdrawal by Subject|2|||
16899856|NCT02220894|37998361|FG001|Overall Study|Withdrawal by Subject|13|||
16899857|NCT02220894|37998360|FG000|Overall Study|Ongoing in Study|265|||
16899858|NCT02220894|37998361|FG001|Overall Study|Ongoing in Study|183|||
16899859|NCT02219334|37998378|FG000|Overall Study|Withdrawal by Subject|1|||
16899860|NCT02219334|37998379|FG001|Overall Study|Withdrawal by Subject|0|||
16899861|NCT02219334|37998378|FG000|Overall Study|Protocol Violation|7|||
16899862|NCT02219334|37998379|FG001|Overall Study|Protocol Violation|3|||
16899863|NCT02159040|37998397|FG000|Overall Study|Death|1|||
17095510|NCT00071812|38234780|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
16899864|NCT02218008|37998422|FG000|Stage 1 (S1)|Adverse Event|6|||
16899865|NCT02218008|37998423|FG001|Stage 1 (S1)|Adverse Event|5|||
16899866|NCT02218008|37998424|FG002|Stage 1 (S1)|Adverse Event|11|||
16899867|NCT02218008|37998425|FG003|Stage 1 (S1)|Adverse Event|0|||
16899868|NCT02218008|37998426|FG004|Stage 1 (S1)|Adverse Event|0|||
16899869|NCT02218008|37998427|FG005|Stage 1 (S1)|Adverse Event|0|||
16899870|NCT02218008|37998422|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
17192493|NCT02744755|38345785|FG000|Study Period 1|Adverse Event|1|||
16899871|NCT02218008|37998423|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
17005193|NCT00955721|38149019|FG000|Overall Study|Withdrawal by Subject|1|||
17005194|NCT00955721|38149020|FG001|Overall Study|Withdrawal by Subject|0|||
17005195|NCT00573469|38149030|FG000|Overall Study|Adverse Event|1|||
17005196|NCT00573469|38149031|FG001|Overall Study|Adverse Event|1|||
17005197|NCT00573469|38149032|FG002|Overall Study|Adverse Event|1|||
17005198|NCT00573469|38149030|FG000|Overall Study|Withdrawal by Subject|0|||
17005199|NCT00573469|38149031|FG001|Overall Study|Withdrawal by Subject|2|||
17005200|NCT00573469|38149032|FG002|Overall Study|Withdrawal by Subject|0|||
17005201|NCT00573469|38149030|FG000|Overall Study|Other|5|||
17005202|NCT00573469|38149031|FG001|Overall Study|Other|1|||
17005203|NCT00573469|38149032|FG002|Overall Study|Other|3|||
17005204|NCT00812565|38149048|FG000|Overall Study|Did Not Receive Study Medication|1|||
17005205|NCT00812565|38149049|FG001|Overall Study|Did Not Receive Study Medication|1|||
17005206|NCT00812565|38149050|FG002|Overall Study|Did Not Receive Study Medication|0|||
17005207|NCT00812565|38149051|FG003|Overall Study|Did Not Receive Study Medication|0|||
17005208|NCT00812565|38149052|FG004|Overall Study|Did Not Receive Study Medication|0|||
17005209|NCT00812565|38149053|FG005|Overall Study|Did Not Receive Study Medication|0|||
17005210|NCT00812565|38149054|FG006|Overall Study|Did Not Receive Study Medication|0|||
17005211|NCT00812565|38149055|FG007|Overall Study|Did Not Receive Study Medication|0|||
17005212|NCT00812565|38149048|FG000|Overall Study|Adverse Event|0|||
17005213|NCT00812565|38149049|FG001|Overall Study|Adverse Event|0|||
17095511|NCT00071812|38234781|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
16899872|NCT02218008|37998424|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
16899873|NCT02218008|37998425|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
16899874|NCT02218008|37998426|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
16899875|NCT02218008|37998427|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
16899876|NCT02218008|37998422|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
16899877|NCT02218008|37998423|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
16899878|NCT02218008|37998424|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
16899879|NCT02218008|37998425|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
16899880|NCT02218008|37998426|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
16899881|NCT02218008|37998427|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
16899882|NCT02218008|37998422|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
16899883|NCT02218008|37998423|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
16899884|NCT02218008|37998424|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
16899885|NCT02218008|37998425|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
16899886|NCT02218008|37998426|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
16899887|NCT02218008|37998427|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
16899888|NCT02218008|37998422|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
16899889|NCT02218008|37998423|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
16899890|NCT02218008|37998424|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
16899891|NCT02218008|37998425|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
16899892|NCT02218008|37998426|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
16899893|NCT02218008|37998427|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
16899894|NCT02218008|37998422|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
16899895|NCT02218008|37998423|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
16899896|NCT02218008|37998424|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
16899897|NCT02218008|37998425|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
16899898|NCT02218008|37998426|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
16899899|NCT02218008|37998427|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
16899900|NCT02218008|37998422|FG000|Stage 1 (S1)|Pregnancy|0|||
16899901|NCT02218008|37998423|FG001|Stage 1 (S1)|Pregnancy|0|||
16899902|NCT02218008|37998424|FG002|Stage 1 (S1)|Pregnancy|1|||
16899903|NCT02218008|37998425|FG003|Stage 1 (S1)|Pregnancy|0|||
16899904|NCT02218008|37998426|FG004|Stage 1 (S1)|Pregnancy|0|||
16899905|NCT02218008|37998427|FG005|Stage 1 (S1)|Pregnancy|0|||
16899906|NCT02218008|37998422|FG000|Stage 1 (S1)|Protocol Violation|0|||
16899907|NCT02218008|37998423|FG001|Stage 1 (S1)|Protocol Violation|0|||
16899908|NCT02218008|37998424|FG002|Stage 1 (S1)|Protocol Violation|1|||
16899909|NCT02218008|37998425|FG003|Stage 1 (S1)|Protocol Violation|0|||
16899910|NCT02218008|37998426|FG004|Stage 1 (S1)|Protocol Violation|0|||
16899911|NCT02218008|37998427|FG005|Stage 1 (S1)|Protocol Violation|0|||
16899912|NCT02218008|37998422|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
16899913|NCT02218008|37998423|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16899914|NCT02218008|37998424|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16899915|NCT02218008|37998425|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16899916|NCT02218008|37998426|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16899917|NCT02218008|37998427|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16899918|NCT02218008|37998422|FG000|Stage 2 (S2)|Adverse Event|0|||
16899919|NCT02218008|37998423|FG001|Stage 2 (S2)|Adverse Event|0|||
16899920|NCT02218008|37998424|FG002|Stage 2 (S2)|Adverse Event|0|||
16899921|NCT02218008|37998425|FG003|Stage 2 (S2)|Adverse Event|2|||
16899922|NCT02218008|37998426|FG004|Stage 2 (S2)|Adverse Event|3|||
16899923|NCT02218008|37998427|FG005|Stage 2 (S2)|Adverse Event|3|||
16899924|NCT02218008|37998422|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
17005214|NCT00812565|38149050|FG002|Overall Study|Adverse Event|0|||
16899925|NCT02218008|37998423|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
16899926|NCT02218008|37998424|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
16899927|NCT02218008|37998425|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
16899928|NCT02218008|37998426|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
16899929|NCT02218008|37998427|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
16899930|NCT02218008|37998422|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
16899931|NCT02218008|37998423|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
16899932|NCT02218008|37998424|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
16899933|NCT02218008|37998425|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
16899934|NCT02218008|37998426|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
16899935|NCT02218008|37998427|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
16899936|NCT02218008|37998422|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16899937|NCT02218008|37998423|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16899938|NCT02218008|37998424|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16899939|NCT02218008|37998425|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
16899940|NCT02218008|37998426|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16899941|NCT02218008|37998427|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16899942|NCT02218008|37998422|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
16899943|NCT02218008|37998423|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
16899944|NCT02218008|37998424|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
16899945|NCT02218008|37998425|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
16899946|NCT02218008|37998426|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
16899947|NCT02218008|37998427|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
16899948|NCT01632150|37998524|FG000|Overall Study|Disease progression|27|||
16899949|NCT01632150|37998524|FG000|Overall Study|Study drug toxicity|1|||
16899950|NCT01632150|37998524|FG000|Overall Study|Unrelated adverse event|7|||
16899951|NCT01632150|37998524|FG000|Overall Study|Withdrawal by Subject|2|||
16899952|NCT01632150|37998524|FG000|Overall Study|Patient underwent autologous transplant|1|||
16899953|NCT01632150|37998524|FG000|Overall Study|Moved to compassionate program|2|||
16899954|NCT02185014|37998549|FG000|Overall Study|Adverse Event|18|||
16899955|NCT02185014|37998549|FG000|Overall Study|Withdrew Consent|8|||
16899956|NCT02185014|37998549|FG000|Overall Study|Lost to Follow-up|4|||
16899957|NCT02185014|37998549|FG000|Overall Study|Lack of Efficacy|14|||
16899958|NCT02185014|37998549|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
16899959|NCT02185014|37998549|FG000|Overall Study|Subject Noncompliance|1|||
16899960|NCT02185014|37998549|FG000|Overall Study|Other|4|||
16899961|NCT02184156|37998599|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
16899962|NCT02184156|37998600|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
16899963|NCT02184156|37998599|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
16899964|NCT02184156|37998600|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
16899965|NCT02158884|37998623|FG000|Baseline Assessment|Missed performance assessment|3|||
16899966|NCT02158884|37998623|FG000|Baseline Assessment|Missed SMFA|1|||
16899967|NCT02158884|37998623|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
16899968|NCT02158884|37998623|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
16899969|NCT02158884|37998623|FG000|6 Month Assessment|Missed SMFA|20|||
16899970|NCT02158884|37998623|FG000|12 Month Assessment|Missed SMFA|17|||
16899971|NCT02158806|37998666|FG000|Overall Study|Death|2|||
16899972|NCT02158806|37998667|FG001|Overall Study|Death|0|||
16899973|NCT02158806|37998666|FG000|Overall Study|Withdrawal by Subject|2|||
16899974|NCT02158806|37998667|FG001|Overall Study|Withdrawal by Subject|0|||
16899975|NCT02158806|37998666|FG000|Overall Study|Lost to Follow-up|0|||
16899976|NCT02158806|37998667|FG001|Overall Study|Lost to Follow-up|3|||
16899977|NCT02158806|37998666|FG000|Overall Study|Moved out of area|0|||
16899978|NCT02158806|37998667|FG001|Overall Study|Moved out of area|1|||
16899979|NCT02158806|37998666|FG000|Overall Study|Transferred to palliative care|0|||
16899980|NCT02158806|37998667|FG001|Overall Study|Transferred to palliative care|1|||
16899981|NCT02158728|37998698|FG000|Overall Study|no procedure according to CIP done|3|||
16899982|NCT02158728|37998698|FG000|Overall Study|no qualified dataset|24|||
16899983|NCT02157948|37998743|FG000|Overall Study|Withdrawal by Subject|4|||
16899984|NCT02157948|37998744|FG001|Overall Study|Withdrawal by Subject|5|||
16899985|NCT02157948|37998743|FG000|Overall Study|Lost to Follow-up|3|||
16899986|NCT02157948|37998744|FG001|Overall Study|Lost to Follow-up|2|||
16899987|NCT02157948|37998743|FG000|Overall Study|Protocol Specified Criteria|2|||
16899988|NCT02157948|37998744|FG001|Overall Study|Protocol Specified Criteria|1|||
16899989|NCT02157948|37998743|FG000|Overall Study|Decision by Sponsor|0|||
16899990|NCT02157948|37998744|FG001|Overall Study|Decision by Sponsor|1|||
16899991|NCT02182830|37998785|FG000|Overall Study|Not Treated|1|||
16899992|NCT02182830|37998786|FG001|Overall Study|Not Treated|1|||
16899993|NCT02182830|37998785|FG000|Overall Study|Trial stopped, reason missing|3|||
16899994|NCT02182830|37998786|FG001|Overall Study|Trial stopped, reason missing|3|||
16899995|NCT02182830|37998785|FG000|Overall Study|Consent withdrawn|8|||
16899996|NCT02182830|37998786|FG001|Overall Study|Consent withdrawn|8|||
16899997|NCT02182830|37998785|FG000|Overall Study|Lost to Follow-up|3|||
16899998|NCT02182830|37998786|FG001|Overall Study|Lost to Follow-up|3|||
16899999|NCT02182440|37999369|FG000|Overall Study|Adverse Event|0|||
16900000|NCT02182440|37999370|FG001|Overall Study|Adverse Event|1|||
16900001|NCT02182440|37999371|FG002|Overall Study|Adverse Event|0|||
16900002|NCT02182440|37999372|FG003|Overall Study|Adverse Event|0|||
16900003|NCT02182440|37999369|FG000|Overall Study|Death|31|||
16900004|NCT02182440|37999370|FG001|Overall Study|Death|8|||
16900005|NCT02182440|37999371|FG002|Overall Study|Death|5|||
16900006|NCT02182440|37999372|FG003|Overall Study|Death|16|||
16900007|NCT02182440|37999369|FG000|Overall Study|Protocol Violation|0|||
16900008|NCT02182440|37999370|FG001|Overall Study|Protocol Violation|1|||
16900009|NCT02182440|37999371|FG002|Overall Study|Protocol Violation|0|||
16900010|NCT02182440|37999372|FG003|Overall Study|Protocol Violation|0|||
16900011|NCT02182440|37999369|FG000|Overall Study|Physician Decision|1|||
16900012|NCT02182440|37999370|FG001|Overall Study|Physician Decision|0|||
16900013|NCT02182440|37999371|FG002|Overall Study|Physician Decision|0|||
16900014|NCT02182440|37999372|FG003|Overall Study|Physician Decision|0|||
16900015|NCT02182440|37999369|FG000|Overall Study|Withdrawal by Subject|1|||
17005215|NCT00812565|38149051|FG003|Overall Study|Adverse Event|2|||
17005216|NCT00812565|38149052|FG004|Overall Study|Adverse Event|0|||
16900016|NCT02182440|37999370|FG001|Overall Study|Withdrawal by Subject|1|||
16900017|NCT02182440|37999371|FG002|Overall Study|Withdrawal by Subject|3|||
16900018|NCT02182440|37999372|FG003|Overall Study|Withdrawal by Subject|4|||
16900019|NCT02182440|37999369|FG000|Overall Study|different, e.g adm other hospital|12|||
16900020|NCT02182440|37999370|FG001|Overall Study|different, e.g adm other hospital|3|||
16900021|NCT02182440|37999371|FG002|Overall Study|different, e.g adm other hospital|3|||
16900022|NCT02182440|37999372|FG003|Overall Study|different, e.g adm other hospital|10|||
16900023|NCT02181816|37999414|FG000|Overall Study|Case Report Forms Uncollected|38|||
17192494|NCT02744755|38345786|FG001|Study Period 1|Adverse Event|1|||
17192495|NCT02744755|38345785|FG000|Study Period 1|Lost to Follow-up|1|||
17005217|NCT00812565|38149053|FG005|Overall Study|Adverse Event|0|||
17005218|NCT00812565|38149054|FG006|Overall Study|Adverse Event|0|||
17005219|NCT00812565|38149055|FG007|Overall Study|Adverse Event|1|||
17005220|NCT00812565|38149048|FG000|Overall Study|Did Not Come to Study Visit|1|||
17005221|NCT00812565|38149049|FG001|Overall Study|Did Not Come to Study Visit|0|||
17005222|NCT00812565|38149050|FG002|Overall Study|Did Not Come to Study Visit|0|||
17005223|NCT00812565|38149051|FG003|Overall Study|Did Not Come to Study Visit|0|||
17005224|NCT00812565|38149052|FG004|Overall Study|Did Not Come to Study Visit|0|||
17005225|NCT00812565|38149053|FG005|Overall Study|Did Not Come to Study Visit|0|||
17005226|NCT00812565|38149054|FG006|Overall Study|Did Not Come to Study Visit|0|||
17005227|NCT00812565|38149055|FG007|Overall Study|Did Not Come to Study Visit|0|||
17005228|NCT00812565|38149048|FG000|Overall Study|Withdrawal of Consent|1|||
17005229|NCT00812565|38149049|FG001|Overall Study|Withdrawal of Consent|0|||
17005230|NCT00812565|38149050|FG002|Overall Study|Withdrawal of Consent|0|||
17005231|NCT00812565|38149051|FG003|Overall Study|Withdrawal of Consent|0|||
17005232|NCT00812565|38149052|FG004|Overall Study|Withdrawal of Consent|1|||
17005233|NCT00812565|38149053|FG005|Overall Study|Withdrawal of Consent|0|||
17005234|NCT00812565|38149054|FG006|Overall Study|Withdrawal of Consent|0|||
17005235|NCT00812565|38149055|FG007|Overall Study|Withdrawal of Consent|0|||
17005236|NCT00812565|38149048|FG000|Overall Study|Reason Not Specified|0|||
17005237|NCT00812565|38149049|FG001|Overall Study|Reason Not Specified|0|||
17005238|NCT00812565|38149050|FG002|Overall Study|Reason Not Specified|0|||
17005239|NCT00812565|38149051|FG003|Overall Study|Reason Not Specified|0|||
17005240|NCT00812565|38149052|FG004|Overall Study|Reason Not Specified|0|||
17005241|NCT00812565|38149053|FG005|Overall Study|Reason Not Specified|1|||
17192496|NCT02744755|38345786|FG001|Study Period 1|Lost to Follow-up|1|||
16786160|NCT02687581|37726528|FG001|Overall Study|the device is too small for the patient.|0|||
16786161|NCT02687581|37726529|FG002|Overall Study|the device is too small for the patient.|0|||
16786162|NCT02687581|37726530|FG003|Overall Study|the device is too small for the patient.|0|||
16786163|NCT01977040|37726540|FG000|Overall Study|Vasa previa not confirmed|2|||
16786164|NCT01958476|37726550|FG000|Overall Study|Parent requested exclusion from analysis|1|||
16786165|NCT01958476|37726551|FG001|Overall Study|Parent requested exclusion from analysis|0|||
16786166|NCT02695537|37726587|FG000|Overall Study|Adverse Event|3|||
16786167|NCT02695537|37726587|FG000|Overall Study|Lack of Efficacy|28|||
16786168|NCT02695537|37726587|FG000|Overall Study|Withdrawal by Subject|4|||
16786169|NCT02695537|37726587|FG000|Overall Study|Protocol Violation|3|||
16786170|NCT01353313|37726593|FG000|Overall Study|Lost to Follow-up|22|||
16900024|NCT02181816|37999414|FG000|Overall Study|Protocol Deviation|21|||
17192497|NCT02744755|38345785|FG000|Study Period 1|Lack of Efficacy|1|||
17192498|NCT02744755|38345786|FG001|Study Period 1|Lack of Efficacy|0|||
17192499|NCT02744755|38345785|FG000|Study Period 1|Withdrawal by Subject|8|||
17192500|NCT02744755|38345786|FG001|Study Period 1|Withdrawal by Subject|4|||
17192501|NCT02744755|38345785|FG000|Study Period 2|Adverse Event|5|||
17192502|NCT02744755|38345786|FG001|Study Period 2|Adverse Event|0|||
16786171|NCT01353313|37726594|FG001|Overall Study|Lost to Follow-up|23|||
16786172|NCT01353313|37726593|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
16900025|NCT02156466|37999570|FG000|Overall Study|Adverse Event|0|||
17192503|NCT02744755|38345785|FG000|Study Period 2|Protocol Violation|1|||
17192504|NCT02744755|38345786|FG001|Study Period 2|Protocol Violation|0|||
17192505|NCT02744755|38345785|FG000|Study Period 2|not defined|3|||
16900026|NCT02156466|37999571|FG001|Overall Study|Adverse Event|0|||
16900027|NCT02156466|37999572|FG002|Overall Study|Adverse Event|1|||
16900028|NCT02156466|37999573|FG003|Overall Study|Adverse Event|1|||
16900029|NCT02156466|37999574|FG004|Overall Study|Adverse Event|0|||
16900030|NCT02156466|37999570|FG000|Overall Study|Quantiferon Positivity|0|||
16900031|NCT02156466|37999571|FG001|Overall Study|Quantiferon Positivity|0|||
16900032|NCT02156466|37999572|FG002|Overall Study|Quantiferon Positivity|0|||
17005242|NCT00812565|38149054|FG006|Overall Study|Reason Not Specified|0|||
17005243|NCT00812565|38149055|FG007|Overall Study|Reason Not Specified|0|||
17005244|NCT00812487|38149075|FG000|Overall Study|Lost to Follow-up|2|||
17005245|NCT00812487|38149076|FG001|Overall Study|Lost to Follow-up|0|||
17005246|NCT00812487|38149075|FG000|Overall Study|Withdrawal by Subject|3|||
17005247|NCT00812487|38149076|FG001|Overall Study|Withdrawal by Subject|2|||
17005248|NCT00812487|38149075|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
17005249|NCT00812487|38149076|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
17005250|NCT00812487|38149075|FG000|Overall Study|Protocol Violation|0|||
17005251|NCT00812487|38149076|FG001|Overall Study|Protocol Violation|1|||
17005252|NCT00617461|38149086|FG000|First Treatment Intervention Period|Adverse Event|2|||
17005253|NCT00617461|38149087|FG001|First Treatment Intervention Period|Adverse Event|0|||
17005254|NCT00617461|38149086|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
17005255|NCT00617461|38149087|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
17005256|NCT00617461|38149086|FG000|First Treatment Intervention Period|Protocol Violation|2|||
17005257|NCT00617461|38149087|FG001|First Treatment Intervention Period|Protocol Violation|1|||
17005258|NCT00617461|38149086|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
17005259|NCT00617461|38149087|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
17005260|NCT00617461|38149086|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
17005261|NCT00617461|38149087|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
17005262|NCT00617461|38149086|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
17005263|NCT00617461|38149087|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
17005264|NCT00617461|38149086|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
17005265|NCT00617461|38149087|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
16900033|NCT02156466|37999573|FG003|Overall Study|Quantiferon Positivity|1|||
16900034|NCT02156466|37999574|FG004|Overall Study|Quantiferon Positivity|0|||
16900035|NCT02216526|37999613|FG000|Overall Study|Adverse Event|1|||
17005266|NCT00617461|38149086|FG000|Second Treatment Intervention Period|Adverse Event|0|||
17005267|NCT00617461|38149087|FG001|Second Treatment Intervention Period|Adverse Event|1|||
17005268|NCT00617461|38149086|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
17005269|NCT00617461|38149087|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
17005270|NCT00617461|38149086|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
17005271|NCT00617461|38149087|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
17005272|NCT00617461|38149086|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
17005273|NCT00617461|38149087|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
17005274|NCT00812331|38149114|FG000|Overall Study|Adverse Event|1|||
17005275|NCT00812331|38149115|FG001|Overall Study|Adverse Event|0|||
17005276|NCT00812331|38149116|FG002|Overall Study|Adverse Event|0|||
17005277|NCT00812331|38149117|FG003|Overall Study|Adverse Event|0|||
17005278|NCT00812331|38149118|FG004|Overall Study|Adverse Event|0|||
17005279|NCT00812253|38149128|FG000|Overall Study|Withdrawal by Subject|3|||
17095512|NCT00071812|38234778|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
17095513|NCT00071812|38234779|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
17095514|NCT00071812|38234780|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
17095515|NCT00071812|38234781|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
17095516|NCT00071812|38234778|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
17095517|NCT00071812|38234779|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
17095518|NCT00071812|38234780|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
17095519|NCT00071812|38234781|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
17095520|NCT00071812|38234778|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
17095521|NCT00071812|38234779|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
17095522|NCT00071812|38234780|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
17095523|NCT00071812|38234781|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
16900036|NCT02216526|37999614|FG001|Overall Study|Adverse Event|1|||
17095524|NCT00071812|38234778|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
17095525|NCT00071812|38234779|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
17095526|NCT00071812|38234780|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
17095527|NCT00071812|38234781|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
17095528|NCT00071812|38234778|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
17095529|NCT00071812|38234779|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
17095530|NCT00071812|38234780|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
17095531|NCT00071812|38234781|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
17192506|NCT02744755|38345786|FG001|Study Period 2|not defined|2|||
16900037|NCT02216526|37999615|FG002|Overall Study|Adverse Event|0|||
17095532|NCT00071812|38234778|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
17095533|NCT00071812|38234779|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
17095534|NCT00071812|38234780|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
16900038|NCT02216526|37999613|FG000|Overall Study|Death|0|||
16900039|NCT02216526|37999614|FG001|Overall Study|Death|1|||
16900040|NCT02216526|37999615|FG002|Overall Study|Death|3|||
16900041|NCT02216526|37999613|FG000|Overall Study|Protocol Violation|2|||
16900042|NCT02216526|37999614|FG001|Overall Study|Protocol Violation|0|||
16900043|NCT02216526|37999615|FG002|Overall Study|Protocol Violation|2|||
16900044|NCT02216526|37999613|FG000|Overall Study|Hospitalization|2|||
16900045|NCT02216526|37999614|FG001|Overall Study|Hospitalization|1|||
16900046|NCT02216526|37999615|FG002|Overall Study|Hospitalization|3|||
16900047|NCT02216214|37999655|FG000|Overall Study|Randomized Never Received Study Drug|1|||
16900048|NCT02216214|37999656|FG001|Overall Study|Randomized Never Received Study Drug|0|||
16900049|NCT02216214|37999655|FG000|Overall Study|Adverse Event|10|||
16900050|NCT02216214|37999656|FG001|Overall Study|Adverse Event|8|||
16900051|NCT02216214|37999655|FG000|Overall Study|Lack of Efficacy|2|||
16900052|NCT02216214|37999656|FG001|Overall Study|Lack of Efficacy|2|||
16900053|NCT02216214|37999655|FG000|Overall Study|Lost to Follow-up|3|||
16900054|NCT02216214|37999656|FG001|Overall Study|Lost to Follow-up|2|||
16900055|NCT02216214|37999655|FG000|Overall Study|Protocol Violation|4|||
16900056|NCT02216214|37999656|FG001|Overall Study|Protocol Violation|2|||
16900057|NCT02216214|37999655|FG000|Overall Study|Withdrawal by Subject|22|||
16900058|NCT02216214|37999656|FG001|Overall Study|Withdrawal by Subject|20|||
17095535|NCT00071812|38234781|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
17095536|NCT00071110|38234795|FG000|Overall Study|Protocol Violation|0|||
17095537|NCT00071110|38234796|FG001|Overall Study|Protocol Violation|4|||
17095538|NCT00071032|38234804|FG000|Overall Study|Lost to Follow-up|1|||
17095539|NCT00071032|38234805|FG001|Overall Study|Lost to Follow-up|1|||
17095540|NCT00071032|38234804|FG000|Overall Study|Withdrawal by Subject|8|||
17095541|NCT00071032|38234805|FG001|Overall Study|Withdrawal by Subject|6|||
16900059|NCT02216214|37999655|FG000|Overall Study|Study Terminated By Sponsor|0|||
16900060|NCT02216214|37999656|FG001|Overall Study|Study Terminated By Sponsor|1|||
16900061|NCT02216214|37999655|FG000|Overall Study|Miscellaneous|1|||
16900062|NCT02216214|37999656|FG001|Overall Study|Miscellaneous|1|||
16900063|NCT02214186|37999687|FG000|Overall Study|Lost to Follow-up|1|||
16900064|NCT02214186|37999688|FG001|Overall Study|Lost to Follow-up|1|||
16900065|NCT02214186|37999687|FG000|Overall Study|Protocol Violation|1|||
16900066|NCT02214186|37999688|FG001|Overall Study|Protocol Violation|1|||
16900067|NCT02181504|37999744|FG000|Overall Study|Adverse Event|1|||
16900068|NCT02181504|37999745|FG001|Overall Study|Adverse Event|1|||
16900069|NCT02181504|37999746|FG002|Overall Study|Adverse Event|1|||
16900070|NCT02179398|37999776|FG000|Overall Study|Lack of obligatory data|3|||
16900071|NCT02179398|37999777|FG001|Overall Study|Lack of obligatory data|3|||
16900072|NCT02179398|37999776|FG000|Overall Study|Lost to Follow-up|0|||
17005280|NCT00812253|38149129|FG001|Overall Study|Withdrawal by Subject|2|||
17005281|NCT00812253|38149128|FG000|Overall Study|Protocol Violation|1|||
17005282|NCT00812253|38149129|FG001|Overall Study|Protocol Violation|1|||
17005283|NCT00812253|38149128|FG000|Overall Study|Lost to Follow-up|2|||
17005284|NCT00812253|38149129|FG001|Overall Study|Lost to Follow-up|0|||
17005285|NCT00616759|38149137|FG000|Overall Study|Physician Decision|2|||
17005286|NCT00616759|38149138|FG001|Overall Study|Physician Decision|0|||
17005287|NCT00616759|38149137|FG000|Overall Study|Withdrawal by Subject|1|||
17005288|NCT00616759|38149138|FG001|Overall Study|Withdrawal by Subject|2|||
16900073|NCT02179398|37999777|FG001|Overall Study|Lost to Follow-up|1|||
16900074|NCT02156076|37999791|FG000|Treatment Period|no longer meets study criteria|0|||
17005289|NCT00812097|38149148|FG000|Overall Study|Death|3|||
17005290|NCT00812097|38149149|FG001|Overall Study|Death|10|||
17005291|NCT00812097|38149150|FG002|Overall Study|Death|3|||
17005292|NCT00812097|38149151|FG003|Overall Study|Death|3|||
17005293|NCT00812097|38149148|FG000|Overall Study|Withdrawal by Subject|14|||
17005294|NCT00812097|38149149|FG001|Overall Study|Withdrawal by Subject|12|||
17005295|NCT00812097|38149150|FG002|Overall Study|Withdrawal by Subject|8|||
17005296|NCT00812097|38149151|FG003|Overall Study|Withdrawal by Subject|2|||
16900075|NCT02156076|37999792|FG001|Treatment Period|no longer meets study criteria|0|||
16900076|NCT02156076|37999793|FG002|Treatment Period|no longer meets study criteria|1|||
16900077|NCT02156076|37999794|FG003|Treatment Period|no longer meets study criteria|0|||
16900078|NCT02156076|37999791|FG000|Treatment Period|Poor/non-compliance|0|||
16900079|NCT02156076|37999792|FG001|Treatment Period|Poor/non-compliance|1|||
16900080|NCT02156076|37999793|FG002|Treatment Period|Poor/non-compliance|0|||
16900081|NCT02156076|37999794|FG003|Treatment Period|Poor/non-compliance|0|||
16900082|NCT02156076|37999791|FG000|Treatment Period|Lost to Follow-up|0|||
16900083|NCT02156076|37999792|FG001|Treatment Period|Lost to Follow-up|0|||
16900084|NCT02156076|37999793|FG002|Treatment Period|Lost to Follow-up|0|||
16900085|NCT02156076|37999794|FG003|Treatment Period|Lost to Follow-up|1|||
17005297|NCT00812097|38149148|FG000|Overall Study|Lost to Follow-up|90|||
17005298|NCT00812097|38149149|FG001|Overall Study|Lost to Follow-up|14|||
17005299|NCT00812097|38149150|FG002|Overall Study|Lost to Follow-up|17|||
17005300|NCT00812097|38149151|FG003|Overall Study|Lost to Follow-up|5|||
17005301|NCT00812097|38149148|FG000|Overall Study|Explantation of study device(s)|27|||
17005302|NCT00812097|38149149|FG001|Overall Study|Explantation of study device(s)|29|||
17005303|NCT00812097|38149150|FG002|Overall Study|Explantation of study device(s)|14|||
17005304|NCT00812097|38149151|FG003|Overall Study|Explantation of study device(s)|20|||
17005305|NCT00812097|38149148|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
17005306|NCT00812097|38149149|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
17005307|NCT00812097|38149150|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
17005308|NCT00812097|38149151|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
17005309|NCT00811941|38149163|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
17005310|NCT00811941|38149164|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
17005311|NCT00811941|38149163|FG000|All Treated Patients|Adverse Event|2|||
17005312|NCT00811941|38149164|FG001|All Treated Patients|Adverse Event|43|||
17005313|NCT00811941|38149163|FG000|All Treated Patients|Lack of Efficacy|2|||
17005314|NCT00811941|38149164|FG001|All Treated Patients|Lack of Efficacy|3|||
17005315|NCT00811941|38149163|FG000|All Treated Patients|Non-compliance|1|||
17005316|NCT00811941|38149164|FG001|All Treated Patients|Non-compliance|8|||
17005317|NCT00811941|38149163|FG000|All Treated Patients|Protocol Violation|5|||
17005318|NCT00811941|38149164|FG001|All Treated Patients|Protocol Violation|17|||
17005319|NCT00811941|38149163|FG000|All Treated Patients|Withdrawal by Subject|35|||
17005320|NCT00811941|38149164|FG001|All Treated Patients|Withdrawal by Subject|94|||
17005321|NCT00811941|38149163|FG000|All Treated Patients|Lost to Follow-up|3|||
17005322|NCT00811941|38149164|FG001|All Treated Patients|Lost to Follow-up|12|||
17005323|NCT00811941|38149163|FG000|All Treated Patients|Other Reason|4|||
17005324|NCT00811941|38149164|FG001|All Treated Patients|Other Reason|14|||
17005325|NCT00811473|38149172|FG000|Overall Study|Adverse Event|3|||
16900086|NCT02156076|37999791|FG000|Treatment Period|Withdrawal by Subject|0|||
16900087|NCT02156076|37999792|FG001|Treatment Period|Withdrawal by Subject|0|||
16900088|NCT02156076|37999793|FG002|Treatment Period|Withdrawal by Subject|1|||
16900089|NCT02156076|37999794|FG003|Treatment Period|Withdrawal by Subject|0|||
16900090|NCT02156076|37999791|FG000|Treatment Period|Subject request to discontinue treatment|0|||
16900091|NCT02156076|37999792|FG001|Treatment Period|Subject request to discontinue treatment|1|||
16900092|NCT02156076|37999793|FG002|Treatment Period|Subject request to discontinue treatment|0|||
16900093|NCT02156076|37999794|FG003|Treatment Period|Subject request to discontinue treatment|0|||
16900094|NCT02156076|37999791|FG000|Treatment Period|Adverse Event|0|||
16900095|NCT02156076|37999792|FG001|Treatment Period|Adverse Event|0|||
16900096|NCT02156076|37999793|FG002|Treatment Period|Adverse Event|0|||
16900097|NCT02156076|37999794|FG003|Treatment Period|Adverse Event|1|||
16900098|NCT02156076|37999791|FG000|Follow-up Period|Withdrawal by Subject|1|||
16900099|NCT02156076|37999792|FG001|Follow-up Period|Withdrawal by Subject|0|||
16900100|NCT02156076|37999793|FG002|Follow-up Period|Withdrawal by Subject|0|||
16900101|NCT02156076|37999794|FG003|Follow-up Period|Withdrawal by Subject|0|||
16900102|NCT02213094|37999806|FG000|Overall Study|Adverse Event|1|||
16900103|NCT02213094|37999807|FG001|Overall Study|Adverse Event|0|||
16900104|NCT02155608|37999815|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
16900105|NCT02155608|37999816|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
16900106|NCT02155608|37999815|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
16900107|NCT02155608|37999816|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
17005326|NCT00811473|38149173|FG001|Overall Study|Adverse Event|12|||
17005327|NCT00811473|38149172|FG000|Overall Study|Lost to Follow-up|5|||
17005328|NCT00811473|38149173|FG001|Overall Study|Lost to Follow-up|1|||
17005329|NCT00811473|38149172|FG000|Overall Study|Withdrawal by Subject|2|||
17005330|NCT00811473|38149173|FG001|Overall Study|Withdrawal by Subject|4|||
17005331|NCT00811473|38149172|FG000|Overall Study|Severe non-compliance to protocol|2|||
17005332|NCT00811473|38149173|FG001|Overall Study|Severe non-compliance to protocol|4|||
17005333|NCT00811473|38149172|FG000|Overall Study|Lack of therapeutic response|4|||
17005334|NCT00811473|38149173|FG001|Overall Study|Lack of therapeutic response|1|||
17005335|NCT00811473|38149172|FG000|Overall Study|Condition under investigation worsened|1|||
17005336|NCT00811473|38149173|FG001|Overall Study|Condition under investigation worsened|3|||
17005337|NCT00811473|38149172|FG000|Overall Study|Other 2|4|||
17005338|NCT00811473|38149173|FG001|Overall Study|Other 2|1|||
17005339|NCT00811473|38149172|FG000|Overall Study|Incorrect Enrollment|1|||
17005340|NCT00811473|38149173|FG001|Overall Study|Incorrect Enrollment|0|||
17005341|NCT00811473|38149172|FG000|Overall Study|Safety Reasons|1|||
17005342|NCT00811473|38149173|FG001|Overall Study|Safety Reasons|0|||
17005343|NCT00617305|38149186|FG000|Overall Study|Adverse Event|4|||
17005344|NCT00617305|38149187|FG001|Overall Study|Adverse Event|0|||
17005345|NCT00617305|38149188|FG002|Overall Study|Adverse Event|0|||
17005346|NCT00617305|38149186|FG000|Overall Study|Death|1|||
17005347|NCT00617305|38149187|FG001|Overall Study|Death|0|||
17005348|NCT00617305|38149188|FG002|Overall Study|Death|0|||
17005349|NCT00617305|38149186|FG000|Overall Study|Physician Decision|1|||
17005350|NCT00617305|38149187|FG001|Overall Study|Physician Decision|0|||
17005351|NCT00617305|38149188|FG002|Overall Study|Physician Decision|0|||
16900108|NCT01629966|37999831|FG000|Overall Study|Pregnancy|0|||
16900109|NCT01629966|37999832|FG001|Overall Study|Pregnancy|1|||
16900110|NCT01629966|37999833|FG002|Overall Study|Pregnancy|0|||
16900111|NCT01629966|37999831|FG000|Overall Study|Lost to Follow-up|10|||
16900112|NCT01629966|37999832|FG001|Overall Study|Lost to Follow-up|13|||
16900113|NCT01629966|37999833|FG002|Overall Study|Lost to Follow-up|9|||
16900114|NCT01629966|37999831|FG000|Overall Study|Withdrawal by Subject|8|||
16900115|NCT01629966|37999832|FG001|Overall Study|Withdrawal by Subject|9|||
16900116|NCT01629966|37999833|FG002|Overall Study|Withdrawal by Subject|16|||
16900117|NCT01629966|37999831|FG000|Overall Study|Protocol Violation|7|||
16900118|NCT01629966|37999832|FG001|Overall Study|Protocol Violation|9|||
16900119|NCT01629966|37999833|FG002|Overall Study|Protocol Violation|7|||
16900120|NCT01629966|37999831|FG000|Overall Study|Lack of Efficacy|5|||
16900121|NCT01629966|37999832|FG001|Overall Study|Lack of Efficacy|2|||
16900122|NCT01629966|37999833|FG002|Overall Study|Lack of Efficacy|4|||
16900123|NCT01629966|37999831|FG000|Overall Study|Adverse Event|11|||
16900124|NCT01629966|37999832|FG001|Overall Study|Adverse Event|18|||
16900125|NCT01629966|37999833|FG002|Overall Study|Adverse Event|30|||
16900126|NCT02177838|37999873|FG000|Overall Study|Withdrawal by Subject|1|||
16900127|NCT02177838|37999873|FG000|Overall Study|Physician Decision|1|||
16900128|NCT02177838|37999873|FG000|Overall Study|Death|1|||
16900129|NCT02177136|37999970|FG000|DB Phase|Withdrawal by Subject|2|||
16900130|NCT02177136|37999971|FG001|DB Phase|Withdrawal by Subject|0|||
16900131|NCT02177136|37999972|FG002|DB Phase|Withdrawal by Subject|0|||
16900132|NCT02177136|37999973|FG003|DB Phase|Withdrawal by Subject|0|||
16900133|NCT02177136|37999970|FG000|DB Phase|Discontinued Due to Pruritus|1|||
16900134|NCT02177136|37999971|FG001|DB Phase|Discontinued Due to Pruritus|3|||
16900135|NCT02177136|37999972|FG002|DB Phase|Discontinued Due to Pruritus|0|||
16900136|NCT02177136|37999973|FG003|DB Phase|Discontinued Due to Pruritus|0|||
16900137|NCT02177136|37999970|FG000|DB Phase|Adverse Event|3|||
16900138|NCT02177136|37999971|FG001|DB Phase|Adverse Event|2|||
16900139|NCT02177136|37999972|FG002|DB Phase|Adverse Event|3|||
16900140|NCT02177136|37999973|FG003|DB Phase|Adverse Event|0|||
16900141|NCT02177136|37999970|FG000|DB Phase|Protocol Violation|0|||
16900142|NCT02177136|37999971|FG001|DB Phase|Protocol Violation|0|||
16900143|NCT02177136|37999972|FG002|DB Phase|Protocol Violation|1|||
16900144|NCT02177136|37999973|FG003|DB Phase|Protocol Violation|0|||
16900145|NCT02177136|37999970|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
16900146|NCT02177136|37999971|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
16900147|NCT02177136|37999972|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
16900148|NCT02177136|37999973|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
16900149|NCT02177136|37999970|FG000|LTSE Phase|Withdrawal by Subject|0|||
16900150|NCT02177136|37999971|FG001|LTSE Phase|Withdrawal by Subject|0|||
16900151|NCT02177136|37999972|FG002|LTSE Phase|Withdrawal by Subject|0|||
16900152|NCT02177136|37999973|FG003|LTSE Phase|Withdrawal by Subject|6|||
16900153|NCT02177136|37999970|FG000|LTSE Phase|Adverse Event|0|||
16900154|NCT02177136|37999971|FG001|LTSE Phase|Adverse Event|0|||
16900155|NCT02177136|37999972|FG002|LTSE Phase|Adverse Event|0|||
16900156|NCT02177136|37999973|FG003|LTSE Phase|Adverse Event|10|||
16900157|NCT02177136|37999970|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
16900158|NCT02177136|37999971|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
16900159|NCT02177136|37999972|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
16900160|NCT02177136|37999973|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
16900161|NCT02177136|37999970|FG000|LTSE Phase|Physician Decision|0|||
16900162|NCT02177136|37999971|FG001|LTSE Phase|Physician Decision|0|||
16900163|NCT02177136|37999972|FG002|LTSE Phase|Physician Decision|0|||
16900164|NCT02177136|37999973|FG003|LTSE Phase|Physician Decision|2|||
16900165|NCT02177136|37999970|FG000|LTSE Phase|Lost to Follow-up|0|||
16900166|NCT02177136|37999971|FG001|LTSE Phase|Lost to Follow-up|0|||
16900167|NCT02177136|37999972|FG002|LTSE Phase|Lost to Follow-up|0|||
16900168|NCT02177136|37999973|FG003|LTSE Phase|Lost to Follow-up|1|||
16900169|NCT02177136|37999970|FG000|LTSE Phase|Participant Moved|0|||
16900170|NCT02177136|37999971|FG001|LTSE Phase|Participant Moved|0|||
16900171|NCT02177136|37999972|FG002|LTSE Phase|Participant Moved|0|||
16900172|NCT02177136|37999973|FG003|LTSE Phase|Participant Moved|1|||
16900173|NCT02176356|38000001|FG000|Overall Study|Screen Failure|14|||
16900174|NCT02176356|38000001|FG000|Overall Study|Lost to Follow-up|4|||
16900175|NCT02176356|38000001|FG000|Overall Study|Personal Reasons|3|||
16900176|NCT02176356|38000001|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16900177|NCT02210208|38000011|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
16900178|NCT02210208|38000011|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
16900179|NCT02210208|38000011|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
16900180|NCT02209506|38000031|FG000|Overall Study|Withdrawal by Subject|0|||
16900181|NCT02209506|38000032|FG001|Overall Study|Withdrawal by Subject|0|||
16900182|NCT02209506|38000033|FG002|Overall Study|Withdrawal by Subject|0|||
16900183|NCT02209506|38000034|FG003|Overall Study|Withdrawal by Subject|0|||
16900184|NCT02209506|38000035|FG004|Overall Study|Withdrawal by Subject|1|||
16900185|NCT02153736|38000052|FG000|Overall Study|Lost to Follow-up|1|||
16900186|NCT02153736|38000053|FG001|Overall Study|Lost to Follow-up|0|||
17005352|NCT00617305|38149186|FG000|Overall Study|Protocol Violation|1|||
16900187|NCT02153736|38000052|FG000|Overall Study|Medical status change made ineligible|1|||
16900188|NCT02153736|38000053|FG001|Overall Study|Medical status change made ineligible|0|||
16900189|NCT02153736|38000052|FG000|Overall Study|Death|0|||
16900190|NCT02153736|38000053|FG001|Overall Study|Death|1|||
16900191|NCT02153736|38000052|FG000|Overall Study|Withdrawal by Subject|0|||
16900192|NCT02153736|38000053|FG001|Overall Study|Withdrawal by Subject|1|||
16900193|NCT02175966|38000061|FG000|Follow-up Period|Lack of Efficacy|10|||
16900194|NCT02175966|38000062|FG001|Follow-up Period|Lack of Efficacy|6|||
16900195|NCT02153346|38000068|FG000|Overall Study|Lost to Follow-up|11|||
16900196|NCT01599234|38000075|FG000|Overall Study|Adverse Event|9|||
16900197|NCT01599234|38000076|FG001|Overall Study|Adverse Event|5|||
16900198|NCT01599234|38000075|FG000|Overall Study|Withdrawal by Subject|2|||
16900199|NCT01599234|38000076|FG001|Overall Study|Withdrawal by Subject|1|||
16900200|NCT01599234|38000075|FG000|Overall Study|Lost to Follow-up|1|||
16900201|NCT01599234|38000076|FG001|Overall Study|Lost to Follow-up|2|||
16900202|NCT01599234|38000075|FG000|Overall Study|Lack of Efficacy|2|||
16900203|NCT01599234|38000076|FG001|Overall Study|Lack of Efficacy|4|||
16900204|NCT01599234|38000075|FG000|Overall Study|Unable to operate spray|1|||
16900205|NCT01599234|38000076|FG001|Overall Study|Unable to operate spray|0|||
16900206|NCT01599234|38000075|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
16900207|NCT01599234|38000076|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
16900208|NCT01599234|38000075|FG000|Overall Study|Death|1|||
16900209|NCT01599234|38000076|FG001|Overall Study|Death|0|||
16900210|NCT01599234|38000075|FG000|Overall Study|Patient would not stop driving|1|||
16900211|NCT01599234|38000076|FG001|Overall Study|Patient would not stop driving|0|||
16900212|NCT01599234|38000075|FG000|Overall Study|Contra-indication discovered|0|||
16900213|NCT01599234|38000076|FG001|Overall Study|Contra-indication discovered|1|||
16900214|NCT01599234|38000075|FG000|Overall Study|Pregnancy|0|||
16900215|NCT01599234|38000076|FG001|Overall Study|Pregnancy|1|||
16900216|NCT02174562|38000084|FG000|Overall Study|Withdrawal by Subject|7|||
16900217|NCT02174562|38000085|FG001|Overall Study|Withdrawal by Subject|2|||
16900218|NCT02174562|38000084|FG000|Overall Study|Death|2|||
16900219|NCT02174562|38000085|FG001|Overall Study|Death|0|||
16900220|NCT02174562|38000084|FG000|Overall Study|Lost to Follow-up|0|||
16900221|NCT02174562|38000085|FG001|Overall Study|Lost to Follow-up|3|||
16900222|NCT02136576|38000094|FG000|Overall Study|Lost to Follow-up|2|||
16900223|NCT02136576|38000095|FG001|Overall Study|Lost to Follow-up|0|||
16900224|NCT02136576|38000096|FG002|Overall Study|Lost to Follow-up|0|||
16900225|NCT02153112|38000368|FG000|Overall Study|Adverse Event|0|||
16900226|NCT02153112|38000369|FG001|Overall Study|Adverse Event|0|||
16900227|NCT02153112|38000370|FG002|Overall Study|Adverse Event|1|||
16900228|NCT02153112|38000371|FG003|Overall Study|Adverse Event|0|||
16900229|NCT02153112|38000372|FG004|Overall Study|Adverse Event|0|||
16900230|NCT02153112|38000373|FG005|Overall Study|Adverse Event|0|||
16900231|NCT02153112|38000374|FG006|Overall Study|Adverse Event|0|||
16900232|NCT02153112|38000375|FG007|Overall Study|Adverse Event|0|||
16900233|NCT02153112|38000376|FG008|Overall Study|Adverse Event|0|||
16900234|NCT02153112|38000377|FG009|Overall Study|Adverse Event|0|||
16900235|NCT02153112|38000368|FG000|Overall Study|Lost to Follow-up|1|||
16900236|NCT02153112|38000369|FG001|Overall Study|Lost to Follow-up|1|||
16900237|NCT02153112|38000370|FG002|Overall Study|Lost to Follow-up|0|||
16900238|NCT02153112|38000371|FG003|Overall Study|Lost to Follow-up|0|||
16900239|NCT02153112|38000372|FG004|Overall Study|Lost to Follow-up|2|||
16900240|NCT02153112|38000373|FG005|Overall Study|Lost to Follow-up|1|||
16900241|NCT02153112|38000374|FG006|Overall Study|Lost to Follow-up|1|||
16900242|NCT02153112|38000375|FG007|Overall Study|Lost to Follow-up|0|||
16900243|NCT02153112|38000376|FG008|Overall Study|Lost to Follow-up|1|||
16900244|NCT02153112|38000377|FG009|Overall Study|Lost to Follow-up|1|||
16900245|NCT02153112|38000368|FG000|Overall Study|Withdrawal by Subject|3|||
16900246|NCT02153112|38000369|FG001|Overall Study|Withdrawal by Subject|1|||
16900247|NCT02153112|38000370|FG002|Overall Study|Withdrawal by Subject|2|||
16900248|NCT02153112|38000371|FG003|Overall Study|Withdrawal by Subject|2|||
16900249|NCT02153112|38000372|FG004|Overall Study|Withdrawal by Subject|1|||
16900250|NCT02153112|38000373|FG005|Overall Study|Withdrawal by Subject|1|||
16900251|NCT02153112|38000374|FG006|Overall Study|Withdrawal by Subject|7|||
16900252|NCT02153112|38000375|FG007|Overall Study|Withdrawal by Subject|2|||
16900253|NCT02153112|38000376|FG008|Overall Study|Withdrawal by Subject|13|||
16900254|NCT02153112|38000377|FG009|Overall Study|Withdrawal by Subject|12|||
16900255|NCT02153112|38000368|FG000|Overall Study|Reason not Specified|0|||
17005353|NCT00617305|38149187|FG001|Overall Study|Protocol Violation|0|||
17005354|NCT00617305|38149188|FG002|Overall Study|Protocol Violation|1|||
17005355|NCT00617305|38149186|FG000|Overall Study|Withdrawal by Subject|1|||
17005356|NCT00617305|38149187|FG001|Overall Study|Withdrawal by Subject|0|||
16900256|NCT02153112|38000369|FG001|Overall Study|Reason not Specified|0|||
16900257|NCT02153112|38000370|FG002|Overall Study|Reason not Specified|0|||
16900258|NCT02153112|38000371|FG003|Overall Study|Reason not Specified|0|||
16900259|NCT02153112|38000372|FG004|Overall Study|Reason not Specified|0|||
16900260|NCT02153112|38000373|FG005|Overall Study|Reason not Specified|0|||
16900261|NCT02153112|38000374|FG006|Overall Study|Reason not Specified|0|||
16900262|NCT02153112|38000375|FG007|Overall Study|Reason not Specified|0|||
16900263|NCT02153112|38000376|FG008|Overall Study|Reason not Specified|1|||
16900264|NCT02153112|38000377|FG009|Overall Study|Reason not Specified|1|||
16900265|NCT02133924|38000427|FG000|Overall Study|Death|38|||
16900266|NCT02133924|38000427|FG000|Overall Study|Physician Decision|1|||
16900267|NCT02133924|38000427|FG000|Overall Study|Withdrawal by Subject|3|||
16900268|NCT02173704|38000518|FG000|Overall Study|Adverse Event|1|||
16900269|NCT02173704|38000519|FG001|Overall Study|Adverse Event|0|||
16900270|NCT02173704|38000518|FG000|Overall Study|Lost to Follow-up|1|||
16900271|NCT02173704|38000519|FG001|Overall Study|Lost to Follow-up|0|||
16900272|NCT02173704|38000518|FG000|Overall Study|Other|1|||
16900273|NCT02173704|38000519|FG001|Overall Study|Other|0|||
16900274|NCT02173704|38000518|FG000|Overall Study|Protocol Violation|1|||
16900275|NCT02173704|38000519|FG001|Overall Study|Protocol Violation|0|||
16900276|NCT02173704|38000518|FG000|Overall Study|Withdrawal by Subject|9|||
16900277|NCT02173704|38000519|FG001|Overall Study|Withdrawal by Subject|4|||
16900278|NCT02173548|38000540|FG000|Overall Study|Lost to Follow-up|0|||
16900279|NCT02173548|38000541|FG001|Overall Study|Lost to Follow-up|2|||
16900280|NCT02173548|38000540|FG000|Overall Study|Withdrawal by Subject|1|||
16900281|NCT02173548|38000541|FG001|Overall Study|Withdrawal by Subject|0|||
16900282|NCT02173158|38000557|FG000|Efficacy Phase|Adverse Event|1|||
16900283|NCT02152566|38000579|FG000|Overall Study|Lost to Follow-up|1|||
16900284|NCT02152566|38000579|FG000|Overall Study|Withdrawal by Subject|2|||
16900285|NCT02171130|38000617|FG000|Overall Study|Death|1|||
16900286|NCT02171130|38000617|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
16900287|NCT02171130|38000617|FG000|Overall Study|Discontinued; Site Termination|5|||
16900288|NCT02171130|38000617|FG000|Overall Study|Withdrawal by Subject|3|||
17192507|NCT02744755|38345785|FG000|Study Period 2|Lost to Follow-up|0|||
17192508|NCT02744755|38345786|FG001|Study Period 2|Lost to Follow-up|2|||
17192509|NCT02744755|38345785|FG000|Study Period 2|Withdrawal by Subject|2|||
17192510|NCT02744755|38345786|FG001|Study Period 2|Withdrawal by Subject|2|||
17192511|NCT02744755|38345785|FG000|Study Period 2|Lack of Efficacy|3|||
17192512|NCT02744755|38345786|FG001|Study Period 2|Lack of Efficacy|2|||
17192513|NCT01356589|38345804|FG000|Overall Study|Enrolled, but not treated|3|||
17192514|NCT01356589|38345804|FG000|Overall Study|Dose data not recorded|2|||
17192515|NCT02830087|38345814|FG000|Overall Study|No study staff to follow-up patients|4|||
17192516|NCT02830087|38345815|FG001|Overall Study|No study staff to follow-up patients|4|||
17192517|NCT02830087|38345816|FG002|Overall Study|No study staff to follow-up patients|4|||
17192518|NCT02830087|38345817|FG003|Overall Study|No study staff to follow-up patients|3|||
17192519|NCT02830087|38345818|FG004|Overall Study|No study staff to follow-up patients|3|||
17192520|NCT02830087|38345819|FG005|Overall Study|No study staff to follow-up patients|3|||
17192521|NCT02829775|38345833|FG000|Overall Study|Death|1|||
17192522|NCT02829775|38345833|FG000|Overall Study|Withdrawal by Subject|3|||
17192523|NCT02829775|38345833|FG000|Overall Study|Disease remission|1|||
17192524|NCT01355497|38345854|FG000|Overall Study|Death|19|||
17192525|NCT01355497|38345855|FG001|Overall Study|Death|18|||
17192526|NCT01355497|38345854|FG000|Overall Study|Lost to Follow-up|3|||
17192527|NCT01355497|38345855|FG001|Overall Study|Lost to Follow-up|0|||
17192528|NCT01355497|38345854|FG000|Overall Study|Protocol Violation|0|||
17192529|NCT01355497|38345855|FG001|Overall Study|Protocol Violation|1|||
17192530|NCT01355497|38345854|FG000|Overall Study|other-not provided|9|||
17192531|NCT01355497|38345855|FG001|Overall Study|other-not provided|4|||
17192532|NCT01355497|38345854|FG000|Overall Study|Withdrawal by Subject|12|||
17192533|NCT01355497|38345855|FG001|Overall Study|Withdrawal by Subject|20|||
17192534|NCT01355497|38345854|FG000|Overall Study|noncompliance|1|||
17192535|NCT01355497|38345855|FG001|Overall Study|noncompliance|2|||
17192536|NCT01355497|38345854|FG000|Overall Study|progressive disease|11|||
17192537|NCT01355497|38345855|FG001|Overall Study|progressive disease|8|||
17192538|NCT01355497|38345854|FG000|Overall Study|Adverse Event|11|||
17192539|NCT01355497|38345855|FG001|Overall Study|Adverse Event|10|||
17192540|NCT01355575|38345861|FG000|Overall Study|Withdrawal by Subject|2|||
17192541|NCT02826421|38345873|FG000|Overall Study|Adverse Event|1|||
17005357|NCT00617305|38149188|FG002|Overall Study|Withdrawal by Subject|0|||
17192542|NCT02826421|38345874|FG001|Overall Study|Adverse Event|0|||
17192543|NCT02826421|38345875|FG002|Overall Study|Adverse Event|0|||
17192544|NCT02826421|38345876|FG003|Overall Study|Adverse Event|1|||
17192545|NCT02826421|38345873|FG000|Overall Study|Withdrawal by Subject|1|||
16900289|NCT02171130|38000617|FG000|Overall Study|Physician Decision|1|||
16900290|NCT02171130|38000617|FG000|Overall Study|Lost to Follow-up|1|||
16900291|NCT02171130|38000617|FG000|Overall Study|Met Exclusion Criteria|1|||
17192546|NCT02826421|38345874|FG001|Overall Study|Withdrawal by Subject|3|||
17192547|NCT02826421|38345875|FG002|Overall Study|Withdrawal by Subject|1|||
17192548|NCT02826421|38345876|FG003|Overall Study|Withdrawal by Subject|1|||
17192549|NCT02826421|38345873|FG000|Overall Study|Reason not given|1|||
17192550|NCT02826421|38345874|FG001|Overall Study|Reason not given|0|||
17192551|NCT02826421|38345875|FG002|Overall Study|Reason not given|1|||
17192552|NCT02826421|38345876|FG003|Overall Study|Reason not given|0|||
16900292|NCT03603314|38006765|FG000|Overall Study|Lost to Follow-up|0|||
16900293|NCT03603314|38006766|FG001|Overall Study|Lost to Follow-up|3|||
16900294|NCT03603314|38006767|FG002|Overall Study|Lost to Follow-up|0|||
16900295|NCT03603314|38006765|FG000|Overall Study|Protocol Violation|0|||
16900296|NCT03603314|38006766|FG001|Overall Study|Protocol Violation|1|||
16900297|NCT03603314|38006767|FG002|Overall Study|Protocol Violation|0|||
16900298|NCT03603314|38006765|FG000|Overall Study|Adverse Event|2|||
16900299|NCT03603314|38006766|FG001|Overall Study|Adverse Event|0|||
16900300|NCT03603314|38006767|FG002|Overall Study|Adverse Event|0|||
16900301|NCT03603314|38006765|FG000|Overall Study|Physician Decision|1|||
16900302|NCT03603314|38006766|FG001|Overall Study|Physician Decision|1|||
16900303|NCT03603314|38006767|FG002|Overall Study|Physician Decision|0|||
16900304|NCT03603314|38006765|FG000|Overall Study|Withdrawal by Subject|4|||
16900305|NCT03603314|38006766|FG001|Overall Study|Withdrawal by Subject|5|||
16900306|NCT03603314|38006767|FG002|Overall Study|Withdrawal by Subject|3|||
16900307|NCT03603314|38006765|FG000|Overall Study|Other|0|||
16900308|NCT03603314|38006766|FG001|Overall Study|Other|1|||
16900309|NCT03603314|38006767|FG002|Overall Study|Other|0|||
16900310|NCT04302350|38006782|FG000|Overall Study|Physician Decision|1|||
16900311|NCT04302350|38006783|FG001|Overall Study|Physician Decision|1|||
16900312|NCT04302350|38006784|FG002|Overall Study|Physician Decision|2|||
16900313|NCT04302350|38006782|FG000|Overall Study|Lack of Efficacy|1|||
16900314|NCT04302350|38006783|FG001|Overall Study|Lack of Efficacy|1|||
16900315|NCT04302350|38006784|FG002|Overall Study|Lack of Efficacy|4|||
16900316|NCT04302350|38006782|FG000|Overall Study|Adverse Event|0|||
16900317|NCT04302350|38006783|FG001|Overall Study|Adverse Event|1|||
16900318|NCT04302350|38006784|FG002|Overall Study|Adverse Event|2|||
16900319|NCT02335424|38006815|FG000|Overall Study|Withdrawal by Subject|19|||
16900320|NCT02335424|38006815|FG000|Overall Study|Adverse Event|25|||
16900321|NCT02335424|38006815|FG000|Overall Study|Death|273|||
16900322|NCT02335424|38006815|FG000|Overall Study|Lost to Follow-up|3|||
16900323|NCT02335424|38006815|FG000|Overall Study|Physician Decision|13|||
16900324|NCT02335424|38006815|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
16900325|NCT02335424|38006815|FG000|Overall Study|Protocol Violation|1|||
16900326|NCT02335424|38006815|FG000|Overall Study|Screen failure|1|||
16900327|NCT03805412|38006822|FG000|Overall Study|Lost to Follow-up|0|||
16900328|NCT03805412|38006823|FG001|Overall Study|Lost to Follow-up|1|||
16900329|NCT04791319|38006843|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
16900330|NCT04791319|38006844|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
16900331|NCT04791319|38006845|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
16900332|NCT04791319|38006846|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
16900333|NCT04791319|38006847|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16900334|NCT04791319|38006848|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16900335|NCT04791319|38006849|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16900336|NCT04791319|38006850|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16900337|NCT04791319|38006851|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16900338|NCT04791319|38006852|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16900339|NCT04791319|38006853|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16900340|NCT04791319|38006843|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
16900341|NCT04791319|38006844|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16900342|NCT04791319|38006845|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
16900343|NCT04791319|38006846|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
16900344|NCT04791319|38006847|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16900345|NCT04791319|38006848|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16900346|NCT04791319|38006849|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16900347|NCT04791319|38006850|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16900348|NCT04791319|38006851|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16900349|NCT04791319|38006852|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16900350|NCT04791319|38006853|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16900351|NCT04791319|38006843|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
16900352|NCT04791319|38006844|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
16900353|NCT04791319|38006845|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
17192553|NCT02825251|38345889|FG000|Overall Study|Adverse Event|0|||
17192554|NCT02825251|38345890|FG001|Overall Study|Adverse Event|1|||
17192555|NCT02825251|38345889|FG000|Overall Study|Lost to Follow-up|0|||
17192556|NCT02825251|38345890|FG001|Overall Study|Lost to Follow-up|1|||
17192557|NCT02825251|38345889|FG000|Overall Study|Withdrawal by Subject|1|||
17192558|NCT02825251|38345890|FG001|Overall Study|Withdrawal by Subject|4|||
17192559|NCT02825251|38345889|FG000|Overall Study|Unclassified|2|||
17192560|NCT02825251|38345890|FG001|Overall Study|Unclassified|0|||
17192561|NCT02824627|38345898|FG000|Overall Study|Adverse Event|1|||
17192562|NCT02824627|38345899|FG001|Overall Study|Adverse Event|2|||
17192563|NCT02824627|38345898|FG000|Overall Study|Lost to Follow-up|2|||
17192564|NCT02824627|38345899|FG001|Overall Study|Lost to Follow-up|1|||
16900354|NCT04791319|38006846|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
16900355|NCT04791319|38006847|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16900356|NCT04791319|38006848|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16900357|NCT04791319|38006849|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16900358|NCT04791319|38006850|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16900359|NCT04791319|38006851|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16900360|NCT04791319|38006852|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16900361|NCT04791319|38006853|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16900362|NCT04791319|38006843|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
16900363|NCT04791319|38006844|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
16900364|NCT04791319|38006845|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
16900365|NCT04791319|38006846|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
16900366|NCT04791319|38006847|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16900367|NCT04791319|38006848|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16900368|NCT04791319|38006849|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16900369|NCT04791319|38006850|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16900370|NCT04791319|38006851|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
17005358|NCT00811395|38149205|FG000|Extension Treatment|Adverse Event|1|||
17005359|NCT00811395|38149206|FG001|Extension Treatment|Adverse Event|2|||
17005360|NCT00811395|38149207|FG002|Extension Treatment|Adverse Event|2|||
17005361|NCT00811395|38149208|FG003|Extension Treatment|Adverse Event|2|||
17005362|NCT00811395|38149209|FG004|Extension Treatment|Adverse Event|0|||
17005363|NCT00811395|38149210|FG005|Extension Treatment|Adverse Event|1|||
17005364|NCT00811395|38149205|FG000|Extension Treatment|Progressive disease|1|||
17005365|NCT00811395|38149206|FG001|Extension Treatment|Progressive disease|1|||
17005366|NCT00811395|38149207|FG002|Extension Treatment|Progressive disease|0|||
17005367|NCT00811395|38149208|FG003|Extension Treatment|Progressive disease|0|||
17005368|NCT00811395|38149209|FG004|Extension Treatment|Progressive disease|0|||
17005369|NCT00811395|38149210|FG005|Extension Treatment|Progressive disease|0|||
17005370|NCT00811395|38149205|FG000|Extension Treatment|Participant did not wish to continue|0|||
17005371|NCT00811395|38149206|FG001|Extension Treatment|Participant did not wish to continue|3|||
17005372|NCT00811395|38149207|FG002|Extension Treatment|Participant did not wish to continue|0|||
17005373|NCT00811395|38149208|FG003|Extension Treatment|Participant did not wish to continue|1|||
17005374|NCT00811395|38149209|FG004|Extension Treatment|Participant did not wish to continue|0|||
17005375|NCT00811395|38149210|FG005|Extension Treatment|Participant did not wish to continue|1|||
17005376|NCT00811395|38149205|FG000|Extension Treatment|Other than above|0|||
17005377|NCT00811395|38149206|FG001|Extension Treatment|Other than above|0|||
17005378|NCT00811395|38149207|FG002|Extension Treatment|Other than above|1|||
17005379|NCT00811395|38149208|FG003|Extension Treatment|Other than above|0|||
17005380|NCT00811395|38149209|FG004|Extension Treatment|Other than above|0|||
17005381|NCT00811395|38149210|FG005|Extension Treatment|Other than above|0|||
17005382|NCT00955409|38149237|FG000|Overall Study|Lack of Efficacy|1|||
17005383|NCT00955409|38149238|FG001|Overall Study|Lack of Efficacy|0|||
17005384|NCT00955409|38149239|FG002|Overall Study|Lack of Efficacy|0|||
17005385|NCT00955409|38149240|FG003|Overall Study|Lack of Efficacy|0|||
17005386|NCT00955409|38149241|FG004|Overall Study|Lack of Efficacy|0|||
17005387|NCT00955409|38149242|FG005|Overall Study|Lack of Efficacy|0|||
17005388|NCT00955409|38149243|FG006|Overall Study|Lack of Efficacy|0|||
17005389|NCT00955409|38149244|FG007|Overall Study|Lack of Efficacy|0|||
17005390|NCT00955409|38149245|FG008|Overall Study|Lack of Efficacy|0|||
17005391|NCT00955409|38149246|FG009|Overall Study|Lack of Efficacy|0|||
17005392|NCT00955409|38149237|FG000|Overall Study|Withdrawal by Subject|1|||
17005393|NCT00955409|38149238|FG001|Overall Study|Withdrawal by Subject|0|||
17005394|NCT00955409|38149239|FG002|Overall Study|Withdrawal by Subject|5|||
17005395|NCT00955409|38149240|FG003|Overall Study|Withdrawal by Subject|2|||
17005396|NCT00955409|38149241|FG004|Overall Study|Withdrawal by Subject|0|||
17005397|NCT00955409|38149242|FG005|Overall Study|Withdrawal by Subject|0|||
17005398|NCT00955409|38149243|FG006|Overall Study|Withdrawal by Subject|2|||
17005399|NCT00955409|38149244|FG007|Overall Study|Withdrawal by Subject|0|||
17005400|NCT00955409|38149245|FG008|Overall Study|Withdrawal by Subject|1|||
17005401|NCT00955409|38149246|FG009|Overall Study|Withdrawal by Subject|0|||
17005402|NCT00955409|38149237|FG000|Overall Study|Caregiver Request|2|||
17005403|NCT00955409|38149238|FG001|Overall Study|Caregiver Request|0|||
17005404|NCT00955409|38149239|FG002|Overall Study|Caregiver Request|6|||
17005405|NCT00955409|38149240|FG003|Overall Study|Caregiver Request|5|||
17005406|NCT00955409|38149241|FG004|Overall Study|Caregiver Request|0|||
17005407|NCT00955409|38149242|FG005|Overall Study|Caregiver Request|2|||
17005408|NCT00955409|38149243|FG006|Overall Study|Caregiver Request|3|||
17005409|NCT00955409|38149244|FG007|Overall Study|Caregiver Request|1|||
17005410|NCT00955409|38149245|FG008|Overall Study|Caregiver Request|3|||
17005411|NCT00955409|38149246|FG009|Overall Study|Caregiver Request|0|||
17192565|NCT01338493|38345905|FG000|Enrolled|Withdrawal by Subject|1|||
17192566|NCT01338493|38345905|FG000|Enrolled|Patient not implanted|4|||
17192567|NCT01338493|38345905|FG000|Discharge|Death|1|||
17192568|NCT01338493|38345905|FG000|Discharge|Missed visit|1|||
17192569|NCT01338493|38345905|FG000|6 Months Follow up|Lost to Follow-up|11|||
17192570|NCT01338493|38345905|FG000|6 Months Follow up|Missed visit|8|||
17192571|NCT01338493|38345905|FG000|12 Months Follow up|Lost to Follow-up|9|||
17192572|NCT01362296|38345911|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
17005412|NCT00955409|38149237|FG000|Overall Study|Investigator Request|0|||
17005413|NCT00955409|38149238|FG001|Overall Study|Investigator Request|0|||
17005414|NCT00955409|38149239|FG002|Overall Study|Investigator Request|1|||
17005415|NCT00955409|38149240|FG003|Overall Study|Investigator Request|0|||
17005416|NCT00955409|38149241|FG004|Overall Study|Investigator Request|0|||
17005417|NCT00955409|38149242|FG005|Overall Study|Investigator Request|0|||
17192573|NCT01362296|38345912|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
17192574|NCT01362296|38345913|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
17192575|NCT01362296|38345914|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
17192576|NCT01362296|38345911|FG000|Randomized Phase (RP)|Physician Decision|1|||
17192577|NCT01362296|38345912|FG001|Randomized Phase (RP)|Physician Decision|9|||
17192578|NCT01362296|38345913|FG002|Randomized Phase (RP)|Physician Decision|0|||
17192579|NCT01362296|38345914|FG003|Randomized Phase (RP)|Physician Decision|0|||
17192580|NCT01362296|38345911|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
17192581|NCT01362296|38345912|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
17192582|NCT01362296|38345913|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
17192583|NCT01362296|38345914|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
17192584|NCT01362296|38345911|FG000|Randomized Phase (RP)|Adverse Event|20|||
17192585|NCT01362296|38345912|FG001|Randomized Phase (RP)|Adverse Event|4|||
17192586|NCT01362296|38345913|FG002|Randomized Phase (RP)|Adverse Event|0|||
17192587|NCT01362296|38345914|FG003|Randomized Phase (RP)|Adverse Event|0|||
17192588|NCT01362296|38345911|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
17192589|NCT01362296|38345912|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
16900371|NCT04791319|38006852|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16900372|NCT04791319|38006853|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16900373|NCT04791319|38006843|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900374|NCT04791319|38006844|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900375|NCT04791319|38006845|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900376|NCT04791319|38006846|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
16900377|NCT04791319|38006847|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900378|NCT04791319|38006848|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900379|NCT04791319|38006849|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900380|NCT04791319|38006850|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900381|NCT04791319|38006851|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900382|NCT04791319|38006852|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900383|NCT04791319|38006853|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16900384|NCT04791319|38006843|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16900385|NCT04791319|38006844|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16900386|NCT04791319|38006845|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16900387|NCT04791319|38006846|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16900388|NCT04791319|38006847|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
16900389|NCT04791319|38006848|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
16900390|NCT04791319|38006849|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
16900391|NCT04791319|38006850|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16900392|NCT04791319|38006851|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16900393|NCT04791319|38006852|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16900394|NCT04791319|38006853|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
16900395|NCT04791319|38006843|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900396|NCT04791319|38006844|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900397|NCT04791319|38006845|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900398|NCT04791319|38006846|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900399|NCT04791319|38006847|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900400|NCT04791319|38006848|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900401|NCT04791319|38006849|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900402|NCT04791319|38006850|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900403|NCT04791319|38006851|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900404|NCT04791319|38006852|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
17005418|NCT00955409|38149243|FG006|Overall Study|Investigator Request|0|||
17192590|NCT01362296|38345913|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
17192591|NCT01362296|38345914|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
17192592|NCT01362296|38345911|FG000|Crossover Phase|PD including Death due to PD|0|||
16900405|NCT04791319|38006853|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16900406|NCT04791319|38006843|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16900407|NCT04791319|38006844|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16900408|NCT04791319|38006845|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16900409|NCT04791319|38006846|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16900410|NCT04791319|38006847|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
16900411|NCT04791319|38006848|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
16900412|NCT04791319|38006849|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
16900413|NCT04791319|38006850|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16900414|NCT04791319|38006851|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
16900415|NCT04791319|38006852|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
16900416|NCT04791319|38006853|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
16900417|NCT04791319|38006843|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
16900418|NCT04791319|38006844|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
16900419|NCT04791319|38006845|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
16900420|NCT04791319|38006846|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
16900421|NCT04791319|38006847|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
16900422|NCT04791319|38006848|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
16900423|NCT04791319|38006849|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
16900424|NCT04791319|38006850|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
16900425|NCT04791319|38006851|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
16900426|NCT04791319|38006852|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
16900427|NCT04791319|38006853|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
16900428|NCT03472495|38006910|FG000|Overall Study|Treatment no longer indicated|1|||
16900429|NCT03472495|38006911|FG001|Overall Study|Treatment no longer indicated|2|||
16900430|NCT03472495|38006910|FG000|Overall Study|Physician Decision|0|||
16900431|NCT03472495|38006911|FG001|Overall Study|Physician Decision|2|||
16900432|NCT03234907|38006919|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
16900433|NCT03234907|38006920|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
16900434|NCT03234907|38006921|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
16900435|NCT03234907|38006922|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
16900436|NCT03234907|38006923|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
16900437|NCT03234907|38006924|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
16900438|NCT03234907|38006919|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
16900439|NCT03234907|38006920|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
16900440|NCT03234907|38006921|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
16900441|NCT03234907|38006922|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
16900442|NCT03234907|38006923|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
16900443|NCT03234907|38006924|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
16900444|NCT03234907|38006919|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
16900445|NCT03234907|38006920|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16900446|NCT03234907|38006921|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16900447|NCT03234907|38006922|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16900448|NCT03234907|38006923|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16900449|NCT03234907|38006924|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16900450|NCT03234907|38006919|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
16900451|NCT03234907|38006920|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
16900452|NCT03234907|38006921|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
16900453|NCT03234907|38006922|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
16900454|NCT03234907|38006923|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
16900455|NCT03234907|38006924|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
16900456|NCT03234907|38006919|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
16900457|NCT03234907|38006920|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
16900458|NCT03234907|38006921|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
16900459|NCT03234907|38006922|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
16900460|NCT03234907|38006923|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
16900461|NCT03234907|38006924|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
16900462|NCT03234907|38006919|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
16900463|NCT03234907|38006920|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
17095542|NCT00071032|38234804|FG000|Overall Study|Missing Primary Outcome|0|||
17095543|NCT00071032|38234805|FG001|Overall Study|Missing Primary Outcome|1|||
16900464|NCT03234907|38006921|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
16900465|NCT03234907|38006922|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
16900466|NCT03234907|38006923|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
16900467|NCT03234907|38006924|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
16900468|NCT03234907|38006919|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
16900469|NCT03234907|38006920|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
16900470|NCT03234907|38006921|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
16900471|NCT03234907|38006922|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
16900472|NCT03234907|38006923|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
16900473|NCT03234907|38006924|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
16900474|NCT03818581|38006938|FG000|Overall Study|Adverse Event|1|||
16900475|NCT03818581|38006939|FG001|Overall Study|Adverse Event|0|||
16900476|NCT03818581|38006940|FG002|Overall Study|Adverse Event|0|||
16900477|NCT03818581|38006941|FG003|Overall Study|Adverse Event|0|||
16900478|NCT03818581|38006942|FG004|Overall Study|Adverse Event|0|||
16900479|NCT03818581|38006938|FG000|Overall Study|Covid-19|2|||
16900480|NCT03818581|38006939|FG001|Overall Study|Covid-19|0|||
16900481|NCT03818581|38006940|FG002|Overall Study|Covid-19|0|||
16900482|NCT03818581|38006941|FG003|Overall Study|Covid-19|0|||
16900483|NCT03818581|38006942|FG004|Overall Study|Covid-19|1|||
16900484|NCT03818581|38006938|FG000|Overall Study|Withdrawal by Subject|0|||
16900485|NCT03818581|38006939|FG001|Overall Study|Withdrawal by Subject|0|||
16900486|NCT03818581|38006940|FG002|Overall Study|Withdrawal by Subject|0|||
16900487|NCT03818581|38006941|FG003|Overall Study|Withdrawal by Subject|0|||
16900488|NCT03818581|38006942|FG004|Overall Study|Withdrawal by Subject|1|||
16900489|NCT03818581|38006938|FG000|Overall Study|No longer met study criteria|1|||
16900490|NCT03818581|38006939|FG001|Overall Study|No longer met study criteria|0|||
16900491|NCT03818581|38006940|FG002|Overall Study|No longer met study criteria|0|||
16900492|NCT03818581|38006941|FG003|Overall Study|No longer met study criteria|0|||
16900493|NCT03818581|38006942|FG004|Overall Study|No longer met study criteria|2|||
16900494|NCT03736447|38006956|FG000|Overall Study|Adverse Event|5|||
16900495|NCT03736447|38006957|FG001|Overall Study|Adverse Event|1|||
16900496|NCT03736447|38006956|FG000|Overall Study|Withdrawal by Subject|5|||
16900497|NCT03736447|38006957|FG001|Overall Study|Withdrawal by Subject|1|||
16900498|NCT03736447|38006956|FG000|Overall Study|Lost to Follow-up|1|||
16900499|NCT03736447|38006957|FG001|Overall Study|Lost to Follow-up|0|||
16900500|NCT03736447|38006956|FG000|Overall Study|Physician Decision|1|||
16900501|NCT03736447|38006957|FG001|Overall Study|Physician Decision|0|||
16900502|NCT03736447|38006956|FG000|Overall Study|Continued commitment to study treatment|3|||
16900503|NCT03736447|38006957|FG001|Overall Study|Continued commitment to study treatment|0|||
16900504|NCT03736447|38006956|FG000|Overall Study|Taste aversion to study product|0|||
16900505|NCT03736447|38006957|FG001|Overall Study|Taste aversion to study product|1|||
16900506|NCT01925131|38006969|FG000|Overall Study|Death|0|||
16900507|NCT01925131|38006970|FG001|Overall Study|Death|0|||
16900508|NCT01925131|38006971|FG002|Overall Study|Death|1|||
16900509|NCT01925131|38006972|FG003|Overall Study|Death|0|||
16900510|NCT01925131|38006973|FG004|Overall Study|Death|0|||
16786173|NCT01353313|37726594|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
16786174|NCT02691247|37726603|FG000|Overall Study|Withdrawal by Subject|1|||
16786175|NCT02691247|37726604|FG001|Overall Study|Withdrawal by Subject|2|||
16786176|NCT02691247|37726605|FG002|Overall Study|Withdrawal by Subject|2|||
16786177|NCT02691247|37726603|FG000|Overall Study|Lost to Follow-up|2|||
16786178|NCT02691247|37726604|FG001|Overall Study|Lost to Follow-up|0|||
16786179|NCT02691247|37726605|FG002|Overall Study|Lost to Follow-up|1|||
16786180|NCT01362491|37726616|FG000|Overall Study|Ineligible|1|||
16786181|NCT01362491|37726617|FG001|Overall Study|Ineligible|0|||
16786182|NCT01362491|37726618|FG002|Overall Study|Ineligible|0|||
16786183|NCT02687191|37726633|FG000|Overall Study|Death|0|||
16786184|NCT02687191|37726634|FG001|Overall Study|Death|1|||
16786185|NCT02687191|37726635|FG002|Overall Study|Death|1|||
16786186|NCT02687191|37726636|FG003|Overall Study|Death|0|||
16786187|NCT02687191|37726637|FG004|Overall Study|Death|1|||
16786188|NCT02687191|37726638|FG005|Overall Study|Death|1|||
16786189|NCT02687191|37726633|FG000|Overall Study|Withdrawal by Subject|0|||
16786190|NCT02687191|37726634|FG001|Overall Study|Withdrawal by Subject|0|||
16786191|NCT02687191|37726635|FG002|Overall Study|Withdrawal by Subject|0|||
16786192|NCT02687191|37726636|FG003|Overall Study|Withdrawal by Subject|1|||
16786193|NCT02687191|37726637|FG004|Overall Study|Withdrawal by Subject|0|||
16900511|NCT01925131|38006974|FG005|Overall Study|Death|0|||
16900512|NCT01925131|38006969|FG000|Overall Study|Progression/Relapse|1|||
16900513|NCT01925131|38006970|FG001|Overall Study|Progression/Relapse|1|||
16900514|NCT01925131|38006971|FG002|Overall Study|Progression/Relapse|4|||
16900515|NCT01925131|38006972|FG003|Overall Study|Progression/Relapse|0|||
16900516|NCT01925131|38006973|FG004|Overall Study|Progression/Relapse|0|||
16900517|NCT01925131|38006974|FG005|Overall Study|Progression/Relapse|1|||
16900518|NCT01925131|38006969|FG000|Overall Study|Patient Refusal|1|||
16786194|NCT02687191|37726638|FG005|Overall Study|Withdrawal by Subject|0|||
16900519|NCT01925131|38006970|FG001|Overall Study|Patient Refusal|0|||
16900520|NCT01925131|38006971|FG002|Overall Study|Patient Refusal|0|||
16900521|NCT01925131|38006972|FG003|Overall Study|Patient Refusal|0|||
16900522|NCT01925131|38006973|FG004|Overall Study|Patient Refusal|0|||
16900523|NCT01925131|38006974|FG005|Overall Study|Patient Refusal|0|||
16900524|NCT01925131|38006969|FG000|Overall Study|Adverse Event|0|||
16900525|NCT01925131|38006970|FG001|Overall Study|Adverse Event|0|||
16900526|NCT01925131|38006971|FG002|Overall Study|Adverse Event|2|||
16900527|NCT01925131|38006972|FG003|Overall Study|Adverse Event|0|||
16900528|NCT01925131|38006973|FG004|Overall Study|Adverse Event|1|||
16900529|NCT01925131|38006974|FG005|Overall Study|Adverse Event|3|||
16900530|NCT01925131|38006969|FG000|Overall Study|Other - Not Protocol Specified|3|||
16900531|NCT01925131|38006970|FG001|Overall Study|Other - Not Protocol Specified|1|||
16900532|NCT01925131|38006971|FG002|Overall Study|Other - Not Protocol Specified|2|||
16900533|NCT01925131|38006972|FG003|Overall Study|Other - Not Protocol Specified|5|||
16900534|NCT01925131|38006973|FG004|Overall Study|Other - Not Protocol Specified|10|||
16900535|NCT01925131|38006974|FG005|Overall Study|Other - Not Protocol Specified|6|||
16900536|NCT00788125|38006999|FG000|Overall Study|Death|6|||
16900537|NCT02132754|38007037|FG000|Overall Study|Adverse Event|0|||
16900538|NCT02132754|38007038|FG001|Overall Study|Adverse Event|0|||
16900539|NCT02132754|38007039|FG002|Overall Study|Adverse Event|0|||
16900540|NCT02132754|38007040|FG003|Overall Study|Adverse Event|0|||
16900541|NCT02132754|38007041|FG004|Overall Study|Adverse Event|0|||
16900542|NCT02132754|38007042|FG005|Overall Study|Adverse Event|0|||
16900543|NCT02132754|38007043|FG006|Overall Study|Adverse Event|0|||
16900544|NCT02132754|38007044|FG007|Overall Study|Adverse Event|0|||
16900545|NCT02132754|38007045|FG008|Overall Study|Adverse Event|0|||
16900546|NCT02132754|38007046|FG009|Overall Study|Adverse Event|0|||
16900547|NCT02132754|38007047|FG010|Overall Study|Adverse Event|0|||
16900548|NCT02132754|38007048|FG011|Overall Study|Adverse Event|0|||
16900549|NCT02132754|38007049|FG012|Overall Study|Adverse Event|0|||
16900550|NCT02132754|38007050|FG013|Overall Study|Adverse Event|0|||
16900551|NCT02132754|38007051|FG014|Overall Study|Adverse Event|0|||
16900552|NCT02132754|38007052|FG015|Overall Study|Adverse Event|0|||
16900553|NCT02132754|38007053|FG016|Overall Study|Adverse Event|0|||
16900554|NCT02132754|38007054|FG017|Overall Study|Adverse Event|1|||
16900555|NCT02132754|38007055|FG018|Overall Study|Adverse Event|0|||
16900556|NCT02132754|38007056|FG019|Overall Study|Adverse Event|0|||
16900557|NCT02132754|38007057|FG020|Overall Study|Adverse Event|0|||
16900558|NCT02132754|38007058|FG021|Overall Study|Adverse Event|0|||
16900559|NCT02132754|38007059|FG022|Overall Study|Adverse Event|0|||
16900560|NCT02132754|38007060|FG023|Overall Study|Adverse Event|0|||
16900561|NCT02132754|38007061|FG024|Overall Study|Adverse Event|0|||
16900562|NCT02132754|38007062|FG025|Overall Study|Adverse Event|1|||
16900563|NCT02132754|38007063|FG026|Overall Study|Adverse Event|1|||
16900564|NCT02132754|38007064|FG027|Overall Study|Adverse Event|0|||
16900565|NCT02132754|38007065|FG028|Overall Study|Adverse Event|0|||
16900566|NCT02132754|38007066|FG029|Overall Study|Adverse Event|0|||
16900567|NCT02132754|38007067|FG030|Overall Study|Adverse Event|1|||
16900568|NCT02132754|38007068|FG031|Overall Study|Adverse Event|0|||
16900569|NCT02132754|38007069|FG032|Overall Study|Adverse Event|1|||
16900570|NCT02132754|38007070|FG033|Overall Study|Adverse Event|1|||
16900571|NCT02132754|38007037|FG000|Overall Study|Clinical Progression|0|||
16900572|NCT02132754|38007038|FG001|Overall Study|Clinical Progression|0|||
16900573|NCT02132754|38007039|FG002|Overall Study|Clinical Progression|0|||
16900574|NCT02132754|38007040|FG003|Overall Study|Clinical Progression|0|||
16900575|NCT02132754|38007041|FG004|Overall Study|Clinical Progression|0|||
16900576|NCT02132754|38007042|FG005|Overall Study|Clinical Progression|0|||
16900577|NCT02132754|38007043|FG006|Overall Study|Clinical Progression|0|||
16900578|NCT02132754|38007044|FG007|Overall Study|Clinical Progression|0|||
16900579|NCT02132754|38007045|FG008|Overall Study|Clinical Progression|0|||
16900580|NCT02132754|38007046|FG009|Overall Study|Clinical Progression|1|||
16900581|NCT02132754|38007047|FG010|Overall Study|Clinical Progression|0|||
16900582|NCT02132754|38007048|FG011|Overall Study|Clinical Progression|0|||
16900583|NCT02132754|38007049|FG012|Overall Study|Clinical Progression|0|||
16900584|NCT02132754|38007050|FG013|Overall Study|Clinical Progression|0|||
16900585|NCT02132754|38007051|FG014|Overall Study|Clinical Progression|0|||
16900586|NCT02132754|38007052|FG015|Overall Study|Clinical Progression|0|||
16900587|NCT02132754|38007053|FG016|Overall Study|Clinical Progression|1|||
16900588|NCT02132754|38007054|FG017|Overall Study|Clinical Progression|1|||
16900589|NCT02132754|38007055|FG018|Overall Study|Clinical Progression|0|||
16900590|NCT02132754|38007056|FG019|Overall Study|Clinical Progression|1|||
16900591|NCT02132754|38007057|FG020|Overall Study|Clinical Progression|0|||
16900592|NCT02132754|38007058|FG021|Overall Study|Clinical Progression|0|||
16900593|NCT02132754|38007059|FG022|Overall Study|Clinical Progression|1|||
16900594|NCT02132754|38007060|FG023|Overall Study|Clinical Progression|0|||
16900595|NCT02132754|38007061|FG024|Overall Study|Clinical Progression|1|||
16900596|NCT02132754|38007062|FG025|Overall Study|Clinical Progression|1|||
17192593|NCT01362296|38345912|FG001|Crossover Phase|PD including Death due to PD|0|||
17192594|NCT01362296|38345913|FG002|Crossover Phase|PD including Death due to PD|16|||
17192595|NCT01362296|38345914|FG003|Crossover Phase|PD including Death due to PD|1|||
17192596|NCT01362296|38345911|FG000|Crossover Phase|Withdrawal by Subject|0|||
17192597|NCT01362296|38345912|FG001|Crossover Phase|Withdrawal by Subject|0|||
17192598|NCT01362296|38345913|FG002|Crossover Phase|Withdrawal by Subject|2|||
17192599|NCT01362296|38345914|FG003|Crossover Phase|Withdrawal by Subject|1|||
17192600|NCT01362296|38345911|FG000|Crossover Phase|Adverse Event|0|||
17192601|NCT01362296|38345912|FG001|Crossover Phase|Adverse Event|0|||
17192602|NCT01362296|38345913|FG002|Crossover Phase|Adverse Event|4|||
17192603|NCT01362296|38345914|FG003|Crossover Phase|Adverse Event|0|||
17192604|NCT01362296|38345911|FG000|Crossover Phase|Study Closed/Terminated|0|||
17192605|NCT01362296|38345912|FG001|Crossover Phase|Study Closed/Terminated|0|||
17192606|NCT01362296|38345913|FG002|Crossover Phase|Study Closed/Terminated|1|||
17192607|NCT01362296|38345914|FG003|Crossover Phase|Study Closed/Terminated|0|||
17192608|NCT01338415|38345926|FG000|Core + Extension|Adverse Event|8|||
17192609|NCT01338415|38345927|FG001|Core + Extension|Adverse Event|6|||
17192610|NCT01338415|38345928|FG002|Core + Extension|Adverse Event|0|||
16900597|NCT02132754|38007063|FG026|Overall Study|Clinical Progression|0|||
16900598|NCT02132754|38007064|FG027|Overall Study|Clinical Progression|1|||
16900599|NCT02132754|38007065|FG028|Overall Study|Clinical Progression|1|||
16900600|NCT02132754|38007066|FG029|Overall Study|Clinical Progression|0|||
16900601|NCT02132754|38007067|FG030|Overall Study|Clinical Progression|1|||
16900602|NCT02132754|38007068|FG031|Overall Study|Clinical Progression|0|||
16900603|NCT02132754|38007069|FG032|Overall Study|Clinical Progression|0|||
16900604|NCT02132754|38007070|FG033|Overall Study|Clinical Progression|2|||
16900605|NCT02132754|38007037|FG000|Overall Study|Death|0|||
16900606|NCT02132754|38007038|FG001|Overall Study|Death|0|||
16900607|NCT02132754|38007039|FG002|Overall Study|Death|0|||
16900608|NCT02132754|38007040|FG003|Overall Study|Death|0|||
16900609|NCT02132754|38007041|FG004|Overall Study|Death|0|||
16900610|NCT02132754|38007042|FG005|Overall Study|Death|0|||
16900611|NCT02132754|38007043|FG006|Overall Study|Death|0|||
16900612|NCT02132754|38007044|FG007|Overall Study|Death|0|||
16900613|NCT02132754|38007045|FG008|Overall Study|Death|0|||
16900614|NCT02132754|38007046|FG009|Overall Study|Death|0|||
16900615|NCT02132754|38007047|FG010|Overall Study|Death|0|||
16900616|NCT02132754|38007048|FG011|Overall Study|Death|0|||
16900617|NCT02132754|38007049|FG012|Overall Study|Death|0|||
16900618|NCT02132754|38007050|FG013|Overall Study|Death|0|||
16900619|NCT02132754|38007051|FG014|Overall Study|Death|0|||
16900620|NCT02132754|38007052|FG015|Overall Study|Death|1|||
16900621|NCT02132754|38007053|FG016|Overall Study|Death|0|||
16900622|NCT02132754|38007054|FG017|Overall Study|Death|0|||
16900623|NCT02132754|38007055|FG018|Overall Study|Death|0|||
16900624|NCT02132754|38007056|FG019|Overall Study|Death|1|||
16900625|NCT02132754|38007057|FG020|Overall Study|Death|0|||
16900626|NCT02132754|38007058|FG021|Overall Study|Death|1|||
16900627|NCT02132754|38007059|FG022|Overall Study|Death|0|||
16900628|NCT02132754|38007060|FG023|Overall Study|Death|0|||
16900629|NCT02132754|38007061|FG024|Overall Study|Death|0|||
16900630|NCT02132754|38007062|FG025|Overall Study|Death|0|||
16900631|NCT02132754|38007063|FG026|Overall Study|Death|1|||
16900632|NCT02132754|38007064|FG027|Overall Study|Death|0|||
16900633|NCT02132754|38007065|FG028|Overall Study|Death|0|||
16900634|NCT02132754|38007066|FG029|Overall Study|Death|0|||
16900635|NCT02132754|38007067|FG030|Overall Study|Death|0|||
16900636|NCT02132754|38007068|FG031|Overall Study|Death|0|||
16900637|NCT02132754|38007069|FG032|Overall Study|Death|0|||
16900638|NCT02132754|38007070|FG033|Overall Study|Death|2|||
16900639|NCT02132754|38007037|FG000|Overall Study|Excluded Medication|0|||
16900640|NCT02132754|38007038|FG001|Overall Study|Excluded Medication|0|||
16900641|NCT02132754|38007039|FG002|Overall Study|Excluded Medication|0|||
16900642|NCT02132754|38007040|FG003|Overall Study|Excluded Medication|0|||
16900643|NCT02132754|38007041|FG004|Overall Study|Excluded Medication|0|||
16900644|NCT02132754|38007042|FG005|Overall Study|Excluded Medication|0|||
17095544|NCT00259610|38234816|FG000|Overall Study|Withdrawal by Subject|33|||
16900645|NCT02132754|38007043|FG006|Overall Study|Excluded Medication|0|||
16900646|NCT02132754|38007044|FG007|Overall Study|Excluded Medication|0|||
16900647|NCT02132754|38007045|FG008|Overall Study|Excluded Medication|0|||
16900648|NCT02132754|38007046|FG009|Overall Study|Excluded Medication|0|||
16900649|NCT02132754|38007047|FG010|Overall Study|Excluded Medication|0|||
16900650|NCT02132754|38007048|FG011|Overall Study|Excluded Medication|0|||
16900651|NCT02132754|38007049|FG012|Overall Study|Excluded Medication|0|||
16900652|NCT02132754|38007050|FG013|Overall Study|Excluded Medication|0|||
16900653|NCT02132754|38007051|FG014|Overall Study|Excluded Medication|0|||
16900654|NCT02132754|38007052|FG015|Overall Study|Excluded Medication|0|||
16900655|NCT02132754|38007053|FG016|Overall Study|Excluded Medication|0|||
17192611|NCT01338415|38345926|FG000|Core + Extension|Withdrawal by Subject|1|||
16900656|NCT02132754|38007054|FG017|Overall Study|Excluded Medication|0|||
16900657|NCT02132754|38007055|FG018|Overall Study|Excluded Medication|0|||
16900658|NCT02132754|38007056|FG019|Overall Study|Excluded Medication|0|||
16900659|NCT02132754|38007057|FG020|Overall Study|Excluded Medication|1|||
16900660|NCT02132754|38007058|FG021|Overall Study|Excluded Medication|0|||
16900661|NCT02132754|38007059|FG022|Overall Study|Excluded Medication|0|||
16900662|NCT02132754|38007060|FG023|Overall Study|Excluded Medication|0|||
16900663|NCT02132754|38007061|FG024|Overall Study|Excluded Medication|0|||
16900664|NCT02132754|38007062|FG025|Overall Study|Excluded Medication|0|||
16900665|NCT02132754|38007063|FG026|Overall Study|Excluded Medication|0|||
16900666|NCT02132754|38007064|FG027|Overall Study|Excluded Medication|0|||
16900667|NCT02132754|38007065|FG028|Overall Study|Excluded Medication|0|||
16900668|NCT02132754|38007066|FG029|Overall Study|Excluded Medication|0|||
16900669|NCT02132754|38007067|FG030|Overall Study|Excluded Medication|0|||
16900670|NCT02132754|38007068|FG031|Overall Study|Excluded Medication|0|||
16900671|NCT02132754|38007069|FG032|Overall Study|Excluded Medication|0|||
16900672|NCT02132754|38007070|FG033|Overall Study|Excluded Medication|1|||
16900673|NCT02132754|38007037|FG000|Overall Study|Physician Decision|0|||
16900674|NCT02132754|38007038|FG001|Overall Study|Physician Decision|0|||
16900675|NCT02132754|38007039|FG002|Overall Study|Physician Decision|0|||
16900676|NCT02132754|38007040|FG003|Overall Study|Physician Decision|0|||
16900677|NCT02132754|38007041|FG004|Overall Study|Physician Decision|0|||
16900678|NCT02132754|38007042|FG005|Overall Study|Physician Decision|0|||
16900679|NCT02132754|38007043|FG006|Overall Study|Physician Decision|0|||
16900680|NCT02132754|38007044|FG007|Overall Study|Physician Decision|0|||
16900681|NCT02132754|38007045|FG008|Overall Study|Physician Decision|0|||
16900682|NCT02132754|38007046|FG009|Overall Study|Physician Decision|1|||
16900683|NCT02132754|38007047|FG010|Overall Study|Physician Decision|0|||
16900684|NCT02132754|38007048|FG011|Overall Study|Physician Decision|1|||
16900685|NCT02132754|38007049|FG012|Overall Study|Physician Decision|1|||
16900686|NCT02132754|38007050|FG013|Overall Study|Physician Decision|0|||
16900687|NCT02132754|38007051|FG014|Overall Study|Physician Decision|0|||
16900688|NCT02132754|38007052|FG015|Overall Study|Physician Decision|1|||
16900689|NCT02132754|38007053|FG016|Overall Study|Physician Decision|0|||
16900690|NCT02132754|38007054|FG017|Overall Study|Physician Decision|0|||
16900691|NCT02132754|38007055|FG018|Overall Study|Physician Decision|0|||
16900692|NCT02132754|38007056|FG019|Overall Study|Physician Decision|0|||
16900693|NCT02132754|38007057|FG020|Overall Study|Physician Decision|0|||
16900694|NCT02132754|38007058|FG021|Overall Study|Physician Decision|0|||
16900695|NCT02132754|38007059|FG022|Overall Study|Physician Decision|0|||
16900696|NCT02132754|38007060|FG023|Overall Study|Physician Decision|0|||
16900697|NCT02132754|38007061|FG024|Overall Study|Physician Decision|1|||
16900698|NCT02132754|38007062|FG025|Overall Study|Physician Decision|0|||
16900699|NCT02132754|38007063|FG026|Overall Study|Physician Decision|0|||
16900700|NCT02132754|38007064|FG027|Overall Study|Physician Decision|0|||
16900701|NCT02132754|38007065|FG028|Overall Study|Physician Decision|0|||
16900702|NCT02132754|38007066|FG029|Overall Study|Physician Decision|0|||
16900703|NCT02132754|38007067|FG030|Overall Study|Physician Decision|0|||
16900704|NCT02132754|38007068|FG031|Overall Study|Physician Decision|1|||
16900705|NCT02132754|38007069|FG032|Overall Study|Physician Decision|0|||
16900706|NCT02132754|38007070|FG033|Overall Study|Physician Decision|3|||
16900707|NCT02132754|38007037|FG000|Overall Study|Progressive Disease|1|||
16900708|NCT02132754|38007038|FG001|Overall Study|Progressive Disease|1|||
16900709|NCT02132754|38007039|FG002|Overall Study|Progressive Disease|1|||
16900710|NCT02132754|38007040|FG003|Overall Study|Progressive Disease|1|||
16900711|NCT02132754|38007041|FG004|Overall Study|Progressive Disease|1|||
16900712|NCT02132754|38007042|FG005|Overall Study|Progressive Disease|1|||
16900713|NCT02132754|38007043|FG006|Overall Study|Progressive Disease|1|||
16900714|NCT02132754|38007044|FG007|Overall Study|Progressive Disease|1|||
16900715|NCT02132754|38007045|FG008|Overall Study|Progressive Disease|1|||
16900716|NCT02132754|38007046|FG009|Overall Study|Progressive Disease|3|||
16900717|NCT02132754|38007047|FG010|Overall Study|Progressive Disease|3|||
16900718|NCT02132754|38007048|FG011|Overall Study|Progressive Disease|2|||
16900719|NCT02132754|38007049|FG012|Overall Study|Progressive Disease|2|||
16900720|NCT02132754|38007050|FG013|Overall Study|Progressive Disease|3|||
16900721|NCT02132754|38007051|FG014|Overall Study|Progressive Disease|2|||
16900722|NCT02132754|38007052|FG015|Overall Study|Progressive Disease|1|||
16900723|NCT02132754|38007053|FG016|Overall Study|Progressive Disease|2|||
16900724|NCT02132754|38007054|FG017|Overall Study|Progressive Disease|1|||
16900725|NCT02132754|38007055|FG018|Overall Study|Progressive Disease|3|||
16900726|NCT02132754|38007056|FG019|Overall Study|Progressive Disease|1|||
16900727|NCT02132754|38007057|FG020|Overall Study|Progressive Disease|1|||
16900728|NCT02132754|38007058|FG021|Overall Study|Progressive Disease|3|||
16900729|NCT02132754|38007059|FG022|Overall Study|Progressive Disease|2|||
16900730|NCT02132754|38007060|FG023|Overall Study|Progressive Disease|3|||
17005419|NCT00955409|38149244|FG007|Overall Study|Investigator Request|0|||
16900731|NCT02132754|38007061|FG024|Overall Study|Progressive Disease|0|||
16900732|NCT02132754|38007062|FG025|Overall Study|Progressive Disease|1|||
16900733|NCT02132754|38007063|FG026|Overall Study|Progressive Disease|2|||
16900734|NCT02132754|38007064|FG027|Overall Study|Progressive Disease|1|||
16900735|NCT02132754|38007065|FG028|Overall Study|Progressive Disease|2|||
16900736|NCT02132754|38007066|FG029|Overall Study|Progressive Disease|3|||
16900737|NCT02132754|38007067|FG030|Overall Study|Progressive Disease|1|||
16900738|NCT02132754|38007068|FG031|Overall Study|Progressive Disease|1|||
16900739|NCT02132754|38007069|FG032|Overall Study|Progressive Disease|3|||
16900740|NCT02132754|38007070|FG033|Overall Study|Progressive Disease|6|||
16900741|NCT02132754|38007037|FG000|Overall Study|Screen Failure|0|||
16900742|NCT02132754|38007038|FG001|Overall Study|Screen Failure|0|||
16900743|NCT02132754|38007039|FG002|Overall Study|Screen Failure|0|||
16900744|NCT02132754|38007040|FG003|Overall Study|Screen Failure|0|||
16900745|NCT02132754|38007041|FG004|Overall Study|Screen Failure|0|||
16900746|NCT02132754|38007042|FG005|Overall Study|Screen Failure|0|||
16900747|NCT02132754|38007043|FG006|Overall Study|Screen Failure|0|||
16900748|NCT02132754|38007044|FG007|Overall Study|Screen Failure|0|||
16900749|NCT02132754|38007045|FG008|Overall Study|Screen Failure|0|||
16900750|NCT02132754|38007046|FG009|Overall Study|Screen Failure|0|||
16900751|NCT02132754|38007047|FG010|Overall Study|Screen Failure|0|||
16900752|NCT02132754|38007048|FG011|Overall Study|Screen Failure|0|||
16900753|NCT02132754|38007049|FG012|Overall Study|Screen Failure|0|||
16900754|NCT02132754|38007050|FG013|Overall Study|Screen Failure|0|||
16900755|NCT02132754|38007051|FG014|Overall Study|Screen Failure|0|||
16900756|NCT02132754|38007052|FG015|Overall Study|Screen Failure|0|||
16900757|NCT02132754|38007053|FG016|Overall Study|Screen Failure|0|||
16900758|NCT02132754|38007054|FG017|Overall Study|Screen Failure|0|||
16900759|NCT02132754|38007055|FG018|Overall Study|Screen Failure|0|||
16900760|NCT02132754|38007056|FG019|Overall Study|Screen Failure|1|||
16900761|NCT02132754|38007057|FG020|Overall Study|Screen Failure|0|||
16900762|NCT02132754|38007058|FG021|Overall Study|Screen Failure|1|||
16900763|NCT02132754|38007059|FG022|Overall Study|Screen Failure|0|||
16900764|NCT02132754|38007060|FG023|Overall Study|Screen Failure|0|||
16900765|NCT02132754|38007061|FG024|Overall Study|Screen Failure|0|||
16900766|NCT02132754|38007062|FG025|Overall Study|Screen Failure|0|||
16900767|NCT02132754|38007063|FG026|Overall Study|Screen Failure|0|||
16900768|NCT02132754|38007064|FG027|Overall Study|Screen Failure|0|||
16900769|NCT02132754|38007065|FG028|Overall Study|Screen Failure|0|||
16900770|NCT02132754|38007066|FG029|Overall Study|Screen Failure|0|||
16900771|NCT02132754|38007067|FG030|Overall Study|Screen Failure|0|||
16900772|NCT02132754|38007068|FG031|Overall Study|Screen Failure|0|||
16900773|NCT02132754|38007069|FG032|Overall Study|Screen Failure|0|||
16900774|NCT02132754|38007070|FG033|Overall Study|Screen Failure|0|||
16900775|NCT02132754|38007037|FG000|Overall Study|Transferred to Extension Study|0|||
16900776|NCT02132754|38007038|FG001|Overall Study|Transferred to Extension Study|0|||
16900777|NCT02132754|38007039|FG002|Overall Study|Transferred to Extension Study|0|||
16900778|NCT02132754|38007040|FG003|Overall Study|Transferred to Extension Study|0|||
16900779|NCT02132754|38007041|FG004|Overall Study|Transferred to Extension Study|0|||
16900780|NCT02132754|38007042|FG005|Overall Study|Transferred to Extension Study|0|||
16900781|NCT02132754|38007043|FG006|Overall Study|Transferred to Extension Study|0|||
16900782|NCT02132754|38007044|FG007|Overall Study|Transferred to Extension Study|0|||
16900783|NCT02132754|38007045|FG008|Overall Study|Transferred to Extension Study|0|||
16900784|NCT02132754|38007046|FG009|Overall Study|Transferred to Extension Study|0|||
16900785|NCT02132754|38007047|FG010|Overall Study|Transferred to Extension Study|0|||
16900786|NCT02132754|38007048|FG011|Overall Study|Transferred to Extension Study|0|||
16900787|NCT02132754|38007049|FG012|Overall Study|Transferred to Extension Study|0|||
17005420|NCT00955409|38149245|FG008|Overall Study|Investigator Request|0|||
17005421|NCT00955409|38149246|FG009|Overall Study|Investigator Request|0|||
17005422|NCT00955409|38149237|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
17005423|NCT00955409|38149238|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
17005424|NCT00955409|38149239|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
17005425|NCT00955409|38149240|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
17005426|NCT00955409|38149241|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
17005427|NCT00955409|38149242|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
17005428|NCT00955409|38149243|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
17005429|NCT00955409|38149244|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
17005430|NCT00955409|38149245|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
17005431|NCT00955409|38149246|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
17005432|NCT00955409|38149237|FG000|Overall Study|Lost to Follow-up|0|||
17005433|NCT00955409|38149238|FG001|Overall Study|Lost to Follow-up|0|||
17005434|NCT00955409|38149239|FG002|Overall Study|Lost to Follow-up|1|||
17005435|NCT00955409|38149240|FG003|Overall Study|Lost to Follow-up|0|||
17005436|NCT00955409|38149241|FG004|Overall Study|Lost to Follow-up|0|||
17005437|NCT00955409|38149242|FG005|Overall Study|Lost to Follow-up|0|||
17005438|NCT00955409|38149243|FG006|Overall Study|Lost to Follow-up|1|||
17005439|NCT00955409|38149244|FG007|Overall Study|Lost to Follow-up|0|||
17005440|NCT00955409|38149245|FG008|Overall Study|Lost to Follow-up|0|||
17005441|NCT00955409|38149246|FG009|Overall Study|Lost to Follow-up|0|||
17005442|NCT00955409|38149237|FG000|Overall Study|Failed to Return|2|||
16900788|NCT02132754|38007050|FG013|Overall Study|Transferred to Extension Study|0|||
17005443|NCT00955409|38149238|FG001|Overall Study|Failed to Return|0|||
17005444|NCT00955409|38149239|FG002|Overall Study|Failed to Return|0|||
17005445|NCT00955409|38149240|FG003|Overall Study|Failed to Return|0|||
17005446|NCT00955409|38149241|FG004|Overall Study|Failed to Return|0|||
16900789|NCT02132754|38007051|FG014|Overall Study|Transferred to Extension Study|0|||
16900790|NCT02132754|38007052|FG015|Overall Study|Transferred to Extension Study|0|||
16900791|NCT02132754|38007053|FG016|Overall Study|Transferred to Extension Study|0|||
16900792|NCT02132754|38007054|FG017|Overall Study|Transferred to Extension Study|0|||
16900793|NCT02132754|38007055|FG018|Overall Study|Transferred to Extension Study|0|||
16900794|NCT02132754|38007056|FG019|Overall Study|Transferred to Extension Study|0|||
16900795|NCT02132754|38007057|FG020|Overall Study|Transferred to Extension Study|0|||
16900796|NCT02132754|38007058|FG021|Overall Study|Transferred to Extension Study|0|||
16900797|NCT02132754|38007059|FG022|Overall Study|Transferred to Extension Study|0|||
16900798|NCT02132754|38007060|FG023|Overall Study|Transferred to Extension Study|0|||
16900799|NCT02132754|38007061|FG024|Overall Study|Transferred to Extension Study|0|||
16900800|NCT02132754|38007062|FG025|Overall Study|Transferred to Extension Study|0|||
16900801|NCT02132754|38007063|FG026|Overall Study|Transferred to Extension Study|0|||
16900802|NCT02132754|38007064|FG027|Overall Study|Transferred to Extension Study|0|||
16900803|NCT02132754|38007065|FG028|Overall Study|Transferred to Extension Study|0|||
16900804|NCT02132754|38007066|FG029|Overall Study|Transferred to Extension Study|0|||
16900805|NCT02132754|38007067|FG030|Overall Study|Transferred to Extension Study|0|||
16900806|NCT02132754|38007068|FG031|Overall Study|Transferred to Extension Study|0|||
16900807|NCT02132754|38007069|FG032|Overall Study|Transferred to Extension Study|0|||
16900808|NCT02132754|38007070|FG033|Overall Study|Transferred to Extension Study|6|||
16900809|NCT02132754|38007037|FG000|Overall Study|Withdrawal by Subject|0|||
16900810|NCT02132754|38007038|FG001|Overall Study|Withdrawal by Subject|0|||
16900811|NCT02132754|38007039|FG002|Overall Study|Withdrawal by Subject|0|||
16900812|NCT02132754|38007040|FG003|Overall Study|Withdrawal by Subject|0|||
16900813|NCT02132754|38007041|FG004|Overall Study|Withdrawal by Subject|0|||
16900814|NCT02132754|38007042|FG005|Overall Study|Withdrawal by Subject|0|||
16900815|NCT02132754|38007043|FG006|Overall Study|Withdrawal by Subject|0|||
16900816|NCT02132754|38007044|FG007|Overall Study|Withdrawal by Subject|0|||
16900817|NCT02132754|38007045|FG008|Overall Study|Withdrawal by Subject|0|||
16900818|NCT02132754|38007046|FG009|Overall Study|Withdrawal by Subject|1|||
16900819|NCT02132754|38007047|FG010|Overall Study|Withdrawal by Subject|0|||
16900820|NCT02132754|38007048|FG011|Overall Study|Withdrawal by Subject|0|||
16900821|NCT02132754|38007049|FG012|Overall Study|Withdrawal by Subject|1|||
16900822|NCT02132754|38007050|FG013|Overall Study|Withdrawal by Subject|0|||
16900823|NCT02132754|38007051|FG014|Overall Study|Withdrawal by Subject|1|||
16900824|NCT02132754|38007052|FG015|Overall Study|Withdrawal by Subject|2|||
16900825|NCT02132754|38007053|FG016|Overall Study|Withdrawal by Subject|1|||
16900826|NCT02132754|38007054|FG017|Overall Study|Withdrawal by Subject|0|||
16900827|NCT02132754|38007055|FG018|Overall Study|Withdrawal by Subject|0|||
16900828|NCT02132754|38007056|FG019|Overall Study|Withdrawal by Subject|0|||
16900829|NCT02132754|38007057|FG020|Overall Study|Withdrawal by Subject|1|||
16900830|NCT02132754|38007058|FG021|Overall Study|Withdrawal by Subject|0|||
16900831|NCT02132754|38007059|FG022|Overall Study|Withdrawal by Subject|0|||
16900832|NCT02132754|38007060|FG023|Overall Study|Withdrawal by Subject|0|||
16900833|NCT02132754|38007061|FG024|Overall Study|Withdrawal by Subject|1|||
16900834|NCT02132754|38007062|FG025|Overall Study|Withdrawal by Subject|0|||
16900835|NCT02132754|38007063|FG026|Overall Study|Withdrawal by Subject|0|||
16900836|NCT02132754|38007064|FG027|Overall Study|Withdrawal by Subject|1|||
16900837|NCT02132754|38007065|FG028|Overall Study|Withdrawal by Subject|0|||
16900838|NCT02132754|38007066|FG029|Overall Study|Withdrawal by Subject|0|||
16900839|NCT02132754|38007067|FG030|Overall Study|Withdrawal by Subject|0|||
16900840|NCT02132754|38007068|FG031|Overall Study|Withdrawal by Subject|1|||
16900841|NCT02132754|38007069|FG032|Overall Study|Withdrawal by Subject|0|||
16900842|NCT02132754|38007070|FG033|Overall Study|Withdrawal by Subject|2|||
16900843|NCT02151786|38007180|FG000|Overall Study|Unavailability of Case Report Form|26|||
16900844|NCT02151786|38007180|FG000|Overall Study|Outside the Contract Period|1|||
16900845|NCT02151786|38007180|FG000|Overall Study|Randomized, not Treated|1|||
16900846|NCT02151786|38007180|FG000|Overall Study|Unavailability of Information|8|||
16900847|NCT02132130|38007188|FG000|Overall Study|Lost to Follow-up|0|||
16900848|NCT02132130|38007189|FG001|Overall Study|Lost to Follow-up|2|||
16900849|NCT02132130|38007190|FG002|Overall Study|Lost to Follow-up|0|||
16900850|NCT02132130|38007191|FG003|Overall Study|Lost to Follow-up|0|||
16900851|NCT02132130|38007188|FG000|Overall Study|Withdrawal by Subject|0|||
16900852|NCT02132130|38007189|FG001|Overall Study|Withdrawal by Subject|0|||
16900853|NCT02132130|38007190|FG002|Overall Study|Withdrawal by Subject|0|||
16900854|NCT02132130|38007191|FG003|Overall Study|Withdrawal by Subject|1|||
16900855|NCT02131662|38007210|FG000|Overall Study|Protocol Violation|1|||
16900856|NCT02131662|38007211|FG001|Overall Study|Protocol Violation|0|||
16900857|NCT02131662|38007212|FG002|Overall Study|Protocol Violation|0|||
16900858|NCT02131662|38007213|FG003|Overall Study|Protocol Violation|0|||
16900859|NCT02131662|38007214|FG004|Overall Study|Protocol Violation|0|||
16900860|NCT02131662|38007210|FG000|Overall Study|Other|2|||
16900861|NCT02131662|38007211|FG001|Overall Study|Other|4|||
16900862|NCT02131662|38007212|FG002|Overall Study|Other|3|||
16900863|NCT02131662|38007213|FG003|Overall Study|Other|3|||
16900864|NCT02131662|38007214|FG004|Overall Study|Other|4|||
16900865|NCT02131662|38007210|FG000|Overall Study|Adverse Event|0|||
16900866|NCT02131662|38007211|FG001|Overall Study|Adverse Event|1|||
16900867|NCT02131662|38007212|FG002|Overall Study|Adverse Event|1|||
16900868|NCT02131662|38007213|FG003|Overall Study|Adverse Event|1|||
16900869|NCT02131662|38007214|FG004|Overall Study|Adverse Event|3|||
16900870|NCT02131662|38007210|FG000|Overall Study|Pregnancy|0|||
16900871|NCT02131662|38007211|FG001|Overall Study|Pregnancy|1|||
16900872|NCT02131662|38007212|FG002|Overall Study|Pregnancy|0|||
16900873|NCT02131662|38007213|FG003|Overall Study|Pregnancy|1|||
16900874|NCT02131662|38007214|FG004|Overall Study|Pregnancy|0|||
16900875|NCT02131662|38007210|FG000|Overall Study|Wish for pregnancy|0|||
16900876|NCT02131662|38007211|FG001|Overall Study|Wish for pregnancy|0|||
16900877|NCT02131662|38007212|FG002|Overall Study|Wish for pregnancy|0|||
16900878|NCT02131662|38007213|FG003|Overall Study|Wish for pregnancy|0|||
16900879|NCT02131662|38007214|FG004|Overall Study|Wish for pregnancy|1|||
16900880|NCT02131662|38007210|FG000|Overall Study|Lack of Efficacy|1|||
16900881|NCT02131662|38007211|FG001|Overall Study|Lack of Efficacy|0|||
16900882|NCT02131662|38007212|FG002|Overall Study|Lack of Efficacy|0|||
16900883|NCT02131662|38007213|FG003|Overall Study|Lack of Efficacy|0|||
16900884|NCT02131662|38007214|FG004|Overall Study|Lack of Efficacy|1|||
16900885|NCT02131662|38007210|FG000|Overall Study|Withdrawal by Subject|1|||
16900886|NCT02131662|38007211|FG001|Overall Study|Withdrawal by Subject|5|||
16900887|NCT02131662|38007212|FG002|Overall Study|Withdrawal by Subject|1|||
16900888|NCT02131662|38007213|FG003|Overall Study|Withdrawal by Subject|5|||
16900889|NCT02131662|38007214|FG004|Overall Study|Withdrawal by Subject|6|||
16900890|NCT02131662|38007210|FG000|Overall Study|Lost to Follow-up|1|||
16900891|NCT02131662|38007211|FG001|Overall Study|Lost to Follow-up|3|||
16900892|NCT02131662|38007212|FG002|Overall Study|Lost to Follow-up|0|||
16900893|NCT02131662|38007213|FG003|Overall Study|Lost to Follow-up|9|||
16900894|NCT02131662|38007214|FG004|Overall Study|Lost to Follow-up|0|||
16900895|NCT02131662|38007210|FG000|Overall Study|Not treated|2|||
16900896|NCT02131662|38007211|FG001|Overall Study|Not treated|0|||
16900897|NCT02131662|38007212|FG002|Overall Study|Not treated|2|||
16900898|NCT02131662|38007213|FG003|Overall Study|Not treated|2|||
16900899|NCT02131662|38007214|FG004|Overall Study|Not treated|3|||
16900900|NCT02106156|38007233|FG000|Overall Study|Patient Died|19|||
16900901|NCT02106156|38007234|FG001|Overall Study|Patient Died|0|||
16900902|NCT02106156|38007235|FG002|Overall Study|Patient Died|0|||
16900903|NCT02106156|38007233|FG000|Overall Study|Lack of Tolerability|305|||
16900904|NCT02106156|38007234|FG001|Overall Study|Lack of Tolerability|3|||
16900905|NCT02106156|38007235|FG002|Overall Study|Lack of Tolerability|0|||
16900906|NCT02106156|38007233|FG000|Overall Study|Lack of Virological Response|1044|||
16900907|NCT02106156|38007234|FG001|Overall Study|Lack of Virological Response|8|||
16900908|NCT02106156|38007235|FG002|Overall Study|Lack of Virological Response|0|||
16900909|NCT02106156|38007233|FG000|Overall Study|Concomitant Disease|74|||
16900910|NCT02106156|38007234|FG001|Overall Study|Concomitant Disease|2|||
16900911|NCT02106156|38007235|FG002|Overall Study|Concomitant Disease|0|||
16900912|NCT02106156|38007233|FG000|Overall Study|Lack of Compliance|211|||
16900913|NCT02106156|38007234|FG001|Overall Study|Lack of Compliance|7|||
16900914|NCT02106156|38007235|FG002|Overall Study|Lack of Compliance|0|||
16900915|NCT02106156|38007233|FG000|Overall Study|Patients Request|307|||
16900916|NCT02106156|38007234|FG001|Overall Study|Patients Request|9|||
16900917|NCT02106156|38007235|FG002|Overall Study|Patients Request|0|||
16900918|NCT02106156|38007233|FG000|Overall Study|Lost to Follow-up|451|||
16900919|NCT02106156|38007234|FG001|Overall Study|Lost to Follow-up|8|||
16900920|NCT02106156|38007235|FG002|Overall Study|Lost to Follow-up|0|||
16900921|NCT02106156|38007233|FG000|Overall Study|Unplanned Event|82|||
16900922|NCT02106156|38007234|FG001|Overall Study|Unplanned Event|2|||
16900923|NCT02106156|38007235|FG002|Overall Study|Unplanned Event|0|||
16900924|NCT02106156|38007233|FG000|Overall Study|Change of Laboratory Parameter|10|||
16900925|NCT02106156|38007234|FG001|Overall Study|Change of Laboratory Parameter|0|||
16900926|NCT02106156|38007235|FG002|Overall Study|Change of Laboratory Parameter|0|||
16900927|NCT02106156|38007233|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
16900928|NCT02106156|38007234|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
16900929|NCT02106156|38007235|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
16900930|NCT02106156|38007233|FG000|Overall Study|Relocation/Change of Physician|40|||
16900931|NCT02106156|38007234|FG001|Overall Study|Relocation/Change of Physician|1|||
16900932|NCT02106156|38007235|FG002|Overall Study|Relocation/Change of Physician|0|||
16900933|NCT01598610|38007242|FG000|Overall Study|Adverse Event|1|||
16900934|NCT01625988|38007248|FG000|Overall Study|Lost to Follow-up|5|||
16900935|NCT01625988|38007249|FG001|Overall Study|Lost to Follow-up|6|||
16900936|NCT01625988|38007248|FG000|Overall Study|Withdrawal by Subject|8|||
16900937|NCT01625988|38007249|FG001|Overall Study|Withdrawal by Subject|3|||
16900938|NCT01625988|38007248|FG000|Overall Study|Adverse Event|0|||
16900939|NCT01625988|38007249|FG001|Overall Study|Adverse Event|1|||
16900940|NCT01625988|38007248|FG000|Overall Study|Lack of Efficacy|0|||
16900941|NCT01625988|38007249|FG001|Overall Study|Lack of Efficacy|1|||
16900942|NCT01625988|38007248|FG000|Overall Study|Randomized Inappropriately|1|||
16900943|NCT01625988|38007249|FG001|Overall Study|Randomized Inappropriately|0|||
16900944|NCT01625988|38007248|FG000|Overall Study|Protocol Violation|0|||
16900945|NCT01625988|38007249|FG001|Overall Study|Protocol Violation|2|||
16900946|NCT02131272|38007260|FG000|Overall Study|Withdrawal by parent|0|||
16900947|NCT02131272|38007261|FG001|Overall Study|Withdrawal by parent|1|||
16900948|NCT02131272|38007260|FG000|Overall Study|Withdrawal by Subject|0|||
16900949|NCT02131272|38007261|FG001|Overall Study|Withdrawal by Subject|1|||
16900950|NCT02131272|38007260|FG000|Overall Study|Withdrawal Criteria|1|||
16900951|NCT02131272|38007261|FG001|Overall Study|Withdrawal Criteria|0|||
16900952|NCT02130882|38007269|FG000|Overall Study|Withdrawal by Subject|0|||
16900953|NCT02130882|38007270|FG001|Overall Study|Withdrawal by Subject|1|||
16900954|NCT02130570|38007278|FG000|Overall Study|Death|3|||
16900955|NCT02130570|38007279|FG001|Overall Study|Death|5|||
16900956|NCT02130570|38007278|FG000|Overall Study|Withdrawal by Subject|6|||
16900957|NCT02130570|38007279|FG001|Overall Study|Withdrawal by Subject|3|||
16900958|NCT02130570|38007278|FG000|Overall Study|Part of practice that discontinued study|0|||
16900959|NCT02130570|38007279|FG001|Overall Study|Part of practice that discontinued study|5|||
16900960|NCT02149836|38007286|FG000|Overall Study|Withdrawal by Subject|1|||
16900961|NCT02130024|38007292|FG000|Overall Study|Adverse Event|10|||
16900962|NCT02130024|38007293|FG001|Overall Study|Adverse Event|11|||
16900963|NCT02130024|38007292|FG000|Overall Study|Death|2|||
16900964|NCT02130024|38007293|FG001|Overall Study|Death|2|||
16900965|NCT02130024|38007292|FG000|Overall Study|Lost to Follow-up|1|||
16900966|NCT02130024|38007293|FG001|Overall Study|Lost to Follow-up|1|||
17005447|NCT00955409|38149242|FG005|Overall Study|Failed to Return|0|||
17005448|NCT00955409|38149243|FG006|Overall Study|Failed to Return|0|||
17005449|NCT00955409|38149244|FG007|Overall Study|Failed to Return|2|||
17005450|NCT00955409|38149245|FG008|Overall Study|Failed to Return|0|||
17005451|NCT00955409|38149246|FG009|Overall Study|Failed to Return|0|||
17005452|NCT00955409|38149237|FG000|Overall Study|Adverse Event (AE)|2|||
17005453|NCT00955409|38149238|FG001|Overall Study|Adverse Event (AE)|0|||
17005454|NCT00955409|38149239|FG002|Overall Study|Adverse Event (AE)|0|||
17005455|NCT00955409|38149240|FG003|Overall Study|Adverse Event (AE)|0|||
17005456|NCT00955409|38149241|FG004|Overall Study|Adverse Event (AE)|0|||
17005457|NCT00955409|38149242|FG005|Overall Study|Adverse Event (AE)|1|||
17005458|NCT00955409|38149243|FG006|Overall Study|Adverse Event (AE)|2|||
17005459|NCT00955409|38149244|FG007|Overall Study|Adverse Event (AE)|0|||
17005460|NCT00955409|38149245|FG008|Overall Study|Adverse Event (AE)|2|||
17005461|NCT00955409|38149246|FG009|Overall Study|Adverse Event (AE)|0|||
17005462|NCT00955409|38149237|FG000|Overall Study|Reason not Specified|2|||
17005463|NCT00955409|38149238|FG001|Overall Study|Reason not Specified|1|||
17005464|NCT00955409|38149239|FG002|Overall Study|Reason not Specified|13|||
17005465|NCT00955409|38149240|FG003|Overall Study|Reason not Specified|1|||
17005466|NCT00955409|38149241|FG004|Overall Study|Reason not Specified|2|||
17005467|NCT00955409|38149242|FG005|Overall Study|Reason not Specified|0|||
17005468|NCT00955409|38149243|FG006|Overall Study|Reason not Specified|16|||
17005469|NCT00955409|38149244|FG007|Overall Study|Reason not Specified|0|||
17005470|NCT00955409|38149245|FG008|Overall Study|Reason not Specified|8|||
17005471|NCT00955409|38149246|FG009|Overall Study|Reason not Specified|1|||
17005472|NCT00615901|38149272|FG000|Overall Study|Withdrawal by Subject|2|||
17005473|NCT00615901|38149272|FG000|Overall Study|Adverse Event|7|||
17005474|NCT00616603|38149284|FG000|Overall Study|Physician Decision|2|||
17005475|NCT00616603|38149285|FG001|Overall Study|Physician Decision|0|||
17005476|NCT00616603|38149286|FG002|Overall Study|Physician Decision|2|||
17005477|NCT00810693|38149297|FG000|Treatment Period|Adverse Event|8|||
17005478|NCT00810693|38149298|FG001|Treatment Period|Adverse Event|1|||
17005479|NCT00810693|38149299|FG002|Treatment Period|Adverse Event|7|||
17005480|NCT00810693|38149297|FG000|Treatment Period|Death|0|||
17005481|NCT00810693|38149298|FG001|Treatment Period|Death|1|||
17005482|NCT00810693|38149299|FG002|Treatment Period|Death|2|||
17005483|NCT00810693|38149297|FG000|Treatment Period|Lack of Efficacy|0|||
17005484|NCT00810693|38149298|FG001|Treatment Period|Lack of Efficacy|0|||
17005485|NCT00810693|38149299|FG002|Treatment Period|Lack of Efficacy|1|||
17005486|NCT00810693|38149297|FG000|Treatment Period|Lost to Follow-up|1|||
17005487|NCT00810693|38149298|FG001|Treatment Period|Lost to Follow-up|0|||
17005488|NCT00810693|38149299|FG002|Treatment Period|Lost to Follow-up|0|||
17005489|NCT00810693|38149297|FG000|Treatment Period|Non-compliance|1|||
17005490|NCT00810693|38149298|FG001|Treatment Period|Non-compliance|0|||
17005491|NCT00810693|38149299|FG002|Treatment Period|Non-compliance|0|||
17005492|NCT00810693|38149297|FG000|Treatment Period|Protocol Violation|1|||
16900967|NCT02130024|38007292|FG000|Overall Study|Physician Decision|1|||
16900968|NCT02130024|38007293|FG001|Overall Study|Physician Decision|3|||
16900969|NCT02130024|38007292|FG000|Overall Study|Protocol Deviation|4|||
16900970|NCT02130024|38007293|FG001|Overall Study|Protocol Deviation|0|||
17005493|NCT00810693|38149298|FG001|Treatment Period|Protocol Violation|2|||
17005494|NCT00810693|38149299|FG002|Treatment Period|Protocol Violation|2|||
17005495|NCT00810693|38149297|FG000|Treatment Period|Withdrawal by Subject|6|||
17005496|NCT00810693|38149298|FG001|Treatment Period|Withdrawal by Subject|2|||
17005497|NCT00810693|38149299|FG002|Treatment Period|Withdrawal by Subject|3|||
16900971|NCT02130024|38007292|FG000|Overall Study|Site Administration Problems|1|||
16900972|NCT02130024|38007293|FG001|Overall Study|Site Administration Problems|0|||
16900973|NCT02130024|38007292|FG000|Overall Study|Subject Withdrew Consent|6|||
16900974|NCT02130024|38007293|FG001|Overall Study|Subject Withdrew Consent|14|||
16900975|NCT02105688|38007301|FG000|Part A: Double-Blind|Adverse Event|1|||
16900976|NCT02105688|38007302|FG001|Part A: Double-Blind|Adverse Event|0|||
17005498|NCT00810693|38149297|FG000|Treatment Period|Not treated|0|||
17005499|NCT00810693|38149298|FG001|Treatment Period|Not treated|1|||
17005500|NCT00810693|38149299|FG002|Treatment Period|Not treated|1|||
17005501|NCT00810693|38149297|FG000|Follow-up Period (FUP)|Adverse Event|3|||
17005502|NCT00810693|38149298|FG001|Follow-up Period (FUP)|Adverse Event|1|||
17005503|NCT00810693|38149299|FG002|Follow-up Period (FUP)|Adverse Event|1|||
17005504|NCT00810693|38149297|FG000|Follow-up Period (FUP)|Death|2|||
17005505|NCT00810693|38149298|FG001|Follow-up Period (FUP)|Death|0|||
17005506|NCT00810693|38149299|FG002|Follow-up Period (FUP)|Death|1|||
17005507|NCT00810693|38149297|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
17005508|NCT00810693|38149298|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
17005509|NCT00810693|38149299|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
17005510|NCT00810693|38149297|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
17005511|NCT00810693|38149298|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
17005512|NCT00810693|38149299|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
17005513|NCT00810693|38149297|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
17005514|NCT00810693|38149298|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
17005515|NCT00810693|38149299|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
17005516|NCT00573313|38149311|FG000|Overall Study|Protocol Violation|5|||
17005517|NCT00573313|38149312|FG001|Overall Study|Protocol Violation|0|||
17005518|NCT00573313|38149313|FG002|Overall Study|Protocol Violation|6|||
17005519|NCT00573313|38149314|FG003|Overall Study|Protocol Violation|0|||
17005520|NCT00953615|38149340|FG000|Overall Study|Adverse Event|1|||
17005521|NCT00810615|38149346|FG000|Overall Study|Withdrawal by Subject|1|||
17005522|NCT00810615|38149347|FG001|Overall Study|Withdrawal by Subject|1|||
17005523|NCT00573391|38149372|FG000|Overall Study|study stopped|2|||
17005524|NCT00573391|38149373|FG001|Overall Study|study stopped|2|||
17005525|NCT00573391|38149372|FG000|Overall Study|Death|1|||
17005526|NCT00573391|38149373|FG001|Overall Study|Death|0|||
17005527|NCT00590967|38149381|FG000|Overall Study|Withdrawal by Subject|1|||
17005528|NCT00590967|38149382|FG001|Overall Study|Withdrawal by Subject|1|||
17005529|NCT00590967|38149381|FG000|Overall Study|Ineligible|1|||
17005530|NCT00590967|38149382|FG001|Overall Study|Ineligible|0|||
17005531|NCT00590967|38149381|FG000|Overall Study|Poor performance status|0|||
17005532|NCT00590967|38149382|FG001|Overall Study|Poor performance status|1|||
17005533|NCT00590967|38149381|FG000|Overall Study|Non-compliant|0|||
17005534|NCT00590967|38149382|FG001|Overall Study|Non-compliant|2|||
17005535|NCT00590967|38149381|FG000|Overall Study|Did not sign consent form|0|||
17005536|NCT00590967|38149382|FG001|Overall Study|Did not sign consent form|1|||
17005537|NCT00590967|38149381|FG000|Overall Study|Did not receive chemo per protocol|1|||
17005538|NCT00590967|38149382|FG001|Overall Study|Did not receive chemo per protocol|0|||
17005539|NCT00590577|38149392|FG000|Overall Study|Lack of Efficacy|31|||
17005540|NCT00590577|38149393|FG001|Overall Study|Lack of Efficacy|28|||
17005541|NCT00590577|38149394|FG002|Overall Study|Lack of Efficacy|23|||
17005542|NCT00590577|38149395|FG003|Overall Study|Lack of Efficacy|45|||
17005543|NCT00590577|38149392|FG000|Overall Study|Withdrawal by Subject|23|||
17005544|NCT00590577|38149393|FG001|Overall Study|Withdrawal by Subject|28|||
17005545|NCT00590577|38149394|FG002|Overall Study|Withdrawal by Subject|30|||
17005546|NCT00590577|38149395|FG003|Overall Study|Withdrawal by Subject|26|||
17005547|NCT00590577|38149392|FG000|Overall Study|Adverse Event|10|||
17005548|NCT00590577|38149393|FG001|Overall Study|Adverse Event|10|||
17005549|NCT00590577|38149394|FG002|Overall Study|Adverse Event|13|||
17005550|NCT00590577|38149395|FG003|Overall Study|Adverse Event|11|||
17005551|NCT00590577|38149392|FG000|Overall Study|Lost to Follow-up|12|||
17005552|NCT00590577|38149393|FG001|Overall Study|Lost to Follow-up|6|||
17005553|NCT00590577|38149394|FG002|Overall Study|Lost to Follow-up|6|||
17005554|NCT00590577|38149395|FG003|Overall Study|Lost to Follow-up|9|||
17005555|NCT00590577|38149392|FG000|Overall Study|Pregnancy|0|||
17005556|NCT00590577|38149393|FG001|Overall Study|Pregnancy|1|||
17005557|NCT00590577|38149394|FG002|Overall Study|Pregnancy|0|||
17005558|NCT00590577|38149395|FG003|Overall Study|Pregnancy|0|||
17005559|NCT00590577|38149392|FG000|Overall Study|Various reasons|1|||
17005560|NCT00590577|38149393|FG001|Overall Study|Various reasons|3|||
17005561|NCT00590577|38149394|FG002|Overall Study|Various reasons|1|||
17005562|NCT00590577|38149395|FG003|Overall Study|Various reasons|2|||
17005563|NCT00614575|38149405|FG000|Overall Study|Adverse Event|106|||
17005564|NCT00614575|38149405|FG000|Overall Study|Lost to Follow-up|55|||
17005565|NCT00614575|38149405|FG000|Overall Study|Lack of Efficacy|14|||
17005566|NCT00614575|38149405|FG000|Overall Study|Withdrawal by Subject|6|||
17005567|NCT00614575|38149405|FG000|Overall Study|Death|3|||
17005568|NCT00614575|38149405|FG000|Overall Study|Physician Decision|2|||
17005569|NCT00614575|38149405|FG000|Overall Study|No data were collected.|18|||
16900977|NCT02105688|38007301|FG000|Part A: Double-Blind|Death|0|||
16900978|NCT02105688|38007302|FG001|Part A: Double-Blind|Death|1|||
16900979|NCT02105688|38007301|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
16900980|NCT02105688|38007302|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
16900981|NCT02105688|38007301|FG000|Part A: Double-Blind|Physician Decision|0|||
16900982|NCT02105688|38007302|FG001|Part A: Double-Blind|Physician Decision|1|||
16900983|NCT02105688|38007301|FG000|Part A: Double-Blind|Status Unknown|0|||
16900984|NCT02105688|38007302|FG001|Part A: Double-Blind|Status Unknown|2|||
16900985|NCT02105688|38007301|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
16900986|NCT02105688|38007302|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
16900987|NCT02105688|38007301|FG000|Part B: Observational Follow-up|Death|2|||
16900988|NCT02105688|38007302|FG001|Part B: Observational Follow-up|Death|1|||
16900989|NCT02105688|38007301|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
16900990|NCT02105688|38007302|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
16900991|NCT02105688|38007301|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
16900992|NCT02105688|38007302|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
16900993|NCT02105688|38007301|FG000|Part B: Observational Follow-up|Physician Decision|3|||
16900994|NCT02105688|38007302|FG001|Part B: Observational Follow-up|Physician Decision|1|||
16900995|NCT02105454|38007309|FG000|Overall Study|Withdrawal by Subject|1|||
16900996|NCT01625910|38007315|FG000|Overall Study|Lost to Follow-up|3|||
16900997|NCT01625910|38007316|FG001|Overall Study|Lost to Follow-up|4|||
16900998|NCT02104752|38007326|FG000|Overall Study|Withdrawal by Subject|1|||
16900999|NCT02104752|38007327|FG001|Overall Study|Withdrawal by Subject|0|||
16901000|NCT02104752|38007326|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
16901001|NCT02104752|38007327|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
16901002|NCT02102724|38007335|FG000|Overall Study|Lost to Follow-up|1|||
16901003|NCT02102724|38007336|FG001|Overall Study|Lost to Follow-up|0|||
16901004|NCT02102724|38007335|FG000|Overall Study|surgery for brain aneurysm|1|||
16901005|NCT02102724|38007336|FG001|Overall Study|surgery for brain aneurysm|1|||
16901006|NCT02102490|38007342|FG000|Overall Study|Death|6|||
16901007|NCT02102490|38007342|FG000|Overall Study|Lost to Follow-up|1|||
16901008|NCT02101554|38007349|FG000|Overall Study|Protocol Violation|0|||
16901009|NCT02101554|38007350|FG001|Overall Study|Protocol Violation|1|||
16901010|NCT02101554|38007351|FG002|Overall Study|Protocol Violation|0|||
16901011|NCT02101554|38007349|FG000|Overall Study|Insufficient Clinical Response|0|||
16901012|NCT02101554|38007350|FG001|Overall Study|Insufficient Clinical Response|2|||
16901013|NCT02101554|38007351|FG002|Overall Study|Insufficient Clinical Response|0|||
17005570|NCT00614575|38149405|FG000|Overall Study|Irregularly enrolled patients|23|||
17005571|NCT00614575|38149405|FG000|Overall Study|No treatment|1|||
17005572|NCT00805935|38149413|FG000|Overall Study|Stimulation Failure|1|||
17005573|NCT00805935|38149414|FG001|Overall Study|Stimulation Failure|5|||
17005574|NCT00805935|38149415|FG002|Overall Study|Stimulation Failure|2|||
17005575|NCT00805935|38149416|FG003|Overall Study|Stimulation Failure|2|||
17005576|NCT00805935|38149413|FG000|Overall Study|Cycle cancelled|0|||
17005577|NCT00805935|38149414|FG001|Overall Study|Cycle cancelled|0|||
17005578|NCT00805935|38149415|FG002|Overall Study|Cycle cancelled|2|||
17005579|NCT00805935|38149416|FG003|Overall Study|Cycle cancelled|0|||
17005580|NCT00805935|38149413|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
17005581|NCT00805935|38149414|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
17005582|NCT00805935|38149415|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
17005583|NCT00805935|38149416|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
16901014|NCT02101554|38007349|FG000|Overall Study|Adverse Event|2|||
16901015|NCT02101554|38007350|FG001|Overall Study|Adverse Event|1|||
16901016|NCT02101554|38007351|FG002|Overall Study|Adverse Event|1|||
16901017|NCT02101554|38007349|FG000|Overall Study|Lost to Follow-up|0|||
16901018|NCT02101554|38007350|FG001|Overall Study|Lost to Follow-up|1|||
16901019|NCT02101554|38007351|FG002|Overall Study|Lost to Follow-up|0|||
17005584|NCT00805935|38149413|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
17005585|NCT00805935|38149414|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
17005586|NCT00805935|38149415|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
17005587|NCT00805935|38149416|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
17005588|NCT00805935|38149413|FG000|Overall Study|Lost to Follow-up|1|||
17005589|NCT00805935|38149414|FG001|Overall Study|Lost to Follow-up|0|||
17005590|NCT00805935|38149415|FG002|Overall Study|Lost to Follow-up|0|||
17005591|NCT00805935|38149416|FG003|Overall Study|Lost to Follow-up|0|||
17005592|NCT00805935|38149413|FG000|Overall Study|No positive serum pregnancy|8|||
17005593|NCT00805935|38149414|FG001|Overall Study|No positive serum pregnancy|7|||
17005594|NCT00805935|38149415|FG002|Overall Study|No positive serum pregnancy|6|||
17005595|NCT00805935|38149416|FG003|Overall Study|No positive serum pregnancy|5|||
17005596|NCT00805935|38149413|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
16901020|NCT02101554|38007349|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
16901021|NCT02101554|38007350|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
16901022|NCT02101554|38007351|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
16901023|NCT02128932|38007362|FG000|Overall Study|Withdrawal by Subject|11|||
17005597|NCT00805935|38149414|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
17005598|NCT00805935|38149415|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
17005599|NCT00805935|38149416|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
17005600|NCT00805935|38149413|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
17005601|NCT00805935|38149414|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
17005602|NCT00805935|38149415|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
17005603|NCT00805935|38149416|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
17005604|NCT00805935|38149413|FG000|Overall Study|Biochemical pregnancy|0|||
17005605|NCT00805935|38149414|FG001|Overall Study|Biochemical pregnancy|1|||
17005606|NCT00805935|38149415|FG002|Overall Study|Biochemical pregnancy|0|||
17005607|NCT00805935|38149416|FG003|Overall Study|Biochemical pregnancy|0|||
17005608|NCT00805935|38149413|FG000|Overall Study|Chemical pregnancy|0|||
17005609|NCT00805935|38149414|FG001|Overall Study|Chemical pregnancy|5|||
17005610|NCT00805935|38149415|FG002|Overall Study|Chemical pregnancy|3|||
17005611|NCT00805935|38149416|FG003|Overall Study|Chemical pregnancy|2|||
17005612|NCT00805935|38149413|FG000|Overall Study|Ectopic pregnancy|0|||
17005613|NCT00805935|38149414|FG001|Overall Study|Ectopic pregnancy|0|||
17005614|NCT00805935|38149415|FG002|Overall Study|Ectopic pregnancy|1|||
17005615|NCT00805935|38149416|FG003|Overall Study|Ectopic pregnancy|0|||
17005616|NCT00805935|38149413|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
17005617|NCT00805935|38149414|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
17005618|NCT00805935|38149415|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
17005619|NCT00805935|38149416|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
17005620|NCT00805545|38149430|FG000|Overall Study|Protocol Violation|3|||
17005621|NCT00805545|38149431|FG001|Overall Study|Protocol Violation|2|||
17005622|NCT00805545|38149430|FG000|Overall Study|Protocol Violation|3|||
17005623|NCT00805545|38149431|FG001|Overall Study|Protocol Violation|1|||
17005624|NCT00590031|38149463|FG000|Overall Study|Adverse Event|3|||
17005625|NCT00590031|38149463|FG000|Overall Study|Withdrawal by Subject|1|||
17005626|NCT00590031|38149463|FG000|Overall Study|Metastatic Disease|1|||
17005627|NCT00590031|38149463|FG000|Overall Study|Admin Hold|1|||
17005628|NCT00615199|38149471|FG000|Overall Study|Adverse Event|3|||
17005629|NCT00615199|38149472|FG001|Overall Study|Adverse Event|1|||
17005630|NCT00615199|38149473|FG002|Overall Study|Adverse Event|1|||
17005631|NCT00615199|38149474|FG003|Overall Study|Adverse Event|0|||
17005632|NCT00615199|38149471|FG000|Overall Study|Lack of Efficacy|2|||
17005633|NCT00615199|38149472|FG001|Overall Study|Lack of Efficacy|0|||
17005634|NCT00615199|38149473|FG002|Overall Study|Lack of Efficacy|0|||
17005635|NCT00615199|38149474|FG003|Overall Study|Lack of Efficacy|1|||
17005636|NCT00615199|38149471|FG000|Overall Study|Lost to Follow-up|1|||
17005637|NCT00615199|38149472|FG001|Overall Study|Lost to Follow-up|0|||
17005638|NCT00615199|38149473|FG002|Overall Study|Lost to Follow-up|0|||
17005639|NCT00615199|38149474|FG003|Overall Study|Lost to Follow-up|0|||
17005640|NCT00615199|38149471|FG000|Overall Study|Other|0|||
17005641|NCT00615199|38149472|FG001|Overall Study|Other|0|||
17005642|NCT00615199|38149473|FG002|Overall Study|Other|0|||
17005643|NCT00615199|38149474|FG003|Overall Study|Other|1|||
17005644|NCT00615199|38149471|FG000|Overall Study|Withdrawal by Subject|2|||
16901024|NCT02128932|38007363|FG001|Overall Study|Withdrawal by Subject|7|||
16901025|NCT02128932|38007364|FG002|Overall Study|Withdrawal by Subject|8|||
16901026|NCT02128932|38007362|FG000|Overall Study|Death|2|||
16901027|NCT02128932|38007363|FG001|Overall Study|Death|0|||
16901028|NCT02128932|38007364|FG002|Overall Study|Death|2|||
17095545|NCT00259610|38234817|FG001|Overall Study|Withdrawal by Subject|25|||
17095546|NCT00259610|38234818|FG002|Overall Study|Withdrawal by Subject|29|||
17095547|NCT00259610|38234819|FG003|Overall Study|Withdrawal by Subject|19|||
17005645|NCT00615199|38149472|FG001|Overall Study|Withdrawal by Subject|1|||
17005646|NCT00615199|38149473|FG002|Overall Study|Withdrawal by Subject|0|||
17005647|NCT00615199|38149474|FG003|Overall Study|Withdrawal by Subject|0|||
16901029|NCT02128932|38007362|FG000|Overall Study|Lost to Follow-up|2|||
16901030|NCT02128932|38007363|FG001|Overall Study|Lost to Follow-up|1|||
16901031|NCT02128932|38007364|FG002|Overall Study|Lost to Follow-up|1|||
16901032|NCT02128932|38007362|FG000|Overall Study|No reason for withdrawal|12|||
16901033|NCT02128932|38007363|FG001|Overall Study|No reason for withdrawal|11|||
16901034|NCT02128932|38007364|FG002|Overall Study|No reason for withdrawal|7|||
17005648|NCT00613951|38149487|FG000|Overall Study|Adverse Event|1|||
17005649|NCT00613951|38149488|FG001|Overall Study|Adverse Event|0|||
17005650|NCT00613951|38149489|FG002|Overall Study|Adverse Event|1|||
17005651|NCT00613951|38149487|FG000|Overall Study|Lack of Efficacy|0|||
17005652|NCT00613951|38149488|FG001|Overall Study|Lack of Efficacy|1|||
17005653|NCT00613951|38149489|FG002|Overall Study|Lack of Efficacy|1|||
17005654|NCT00613951|38149487|FG000|Overall Study|Protocol Violation|1|||
17005655|NCT00613951|38149488|FG001|Overall Study|Protocol Violation|1|||
17005656|NCT00613951|38149489|FG002|Overall Study|Protocol Violation|1|||
17005657|NCT00613951|38149487|FG000|Overall Study|Unclassified|5|||
17005658|NCT00613951|38149488|FG001|Overall Study|Unclassified|3|||
16901035|NCT02128542|38007374|FG000|Overall Study|Lost to Follow-up|3|||
16901036|NCT02128542|38007375|FG001|Overall Study|Lost to Follow-up|0|||
16901037|NCT02128542|38007374|FG000|Overall Study|Withdrew Consent|1|||
17005659|NCT00613951|38149489|FG002|Overall Study|Unclassified|2|||
16901038|NCT02128542|38007375|FG001|Overall Study|Withdrew Consent|0|||
16901039|NCT02127372|38007385|FG000|Overall Study|Withdrawal by Subject|1|||
16901040|NCT02127372|38007386|FG001|Overall Study|Withdrawal by Subject|0|||
16901041|NCT02126826|38007400|FG000|Overall Study|Withdrawal by Subject|0|||
16901042|NCT02126826|38007401|FG001|Overall Study|Withdrawal by Subject|0|||
16901043|NCT02126826|38007402|FG002|Overall Study|Withdrawal by Subject|0|||
16901044|NCT02126826|38007403|FG003|Overall Study|Withdrawal by Subject|1|||
16901045|NCT02126826|38007404|FG004|Overall Study|Withdrawal by Subject|0|||
16901046|NCT02126826|38007405|FG005|Overall Study|Withdrawal by Subject|0|||
16901047|NCT02126826|38007406|FG006|Overall Study|Withdrawal by Subject|0|||
16901048|NCT02126670|38007431|FG000|Overall Study|Withdrawal by Subject|1|||
16901049|NCT02126670|38007432|FG001|Overall Study|Withdrawal by Subject|0|||
16901050|NCT02126670|38007433|FG002|Overall Study|Withdrawal by Subject|0|||
16901051|NCT02126670|38007434|FG003|Overall Study|Withdrawal by Subject|1|||
16901052|NCT02125734|38007446|FG000|Period 2|Adverse Event|0|||
16901053|NCT02125734|38007447|FG001|Period 2|Adverse Event|1|||
16901054|NCT02124798|38007453|FG000|Overall Study|Adverse Event|3|||
16901055|NCT02124798|38007453|FG000|Overall Study|Lost to Follow-up|1|||
16901056|NCT02146326|38007461|FG000|Overall Study|Lost to Follow-up|3|||
16901057|NCT02146326|38007462|FG001|Overall Study|Lost to Follow-up|3|||
16901058|NCT02146326|38007463|FG002|Overall Study|Lost to Follow-up|11|||
16901059|NCT02146326|38007464|FG003|Overall Study|Lost to Follow-up|19|||
16901060|NCT02146326|38007461|FG000|Overall Study|Withdrawal by Subject|2|||
16901061|NCT02146326|38007462|FG001|Overall Study|Withdrawal by Subject|1|||
16901062|NCT02146326|38007463|FG002|Overall Study|Withdrawal by Subject|15|||
16901063|NCT02146326|38007464|FG003|Overall Study|Withdrawal by Subject|11|||
16901064|NCT02146326|38007461|FG000|Overall Study|Separated from mental health center|23|||
16901065|NCT02146326|38007462|FG001|Overall Study|Separated from mental health center|33|||
16901066|NCT02146326|38007463|FG002|Overall Study|Separated from mental health center|0|||
16901067|NCT02146326|38007464|FG003|Overall Study|Separated from mental health center|0|||
16901068|NCT02146326|38007461|FG000|Overall Study|Incarcerated|0|||
16901069|NCT02146326|38007462|FG001|Overall Study|Incarcerated|0|||
16901070|NCT02146326|38007463|FG002|Overall Study|Incarcerated|3|||
16901071|NCT02146326|38007464|FG003|Overall Study|Incarcerated|8|||
16901072|NCT02146326|38007461|FG000|Overall Study|Death|0|||
16901073|NCT02146326|38007462|FG001|Overall Study|Death|0|||
16901074|NCT02146326|38007463|FG002|Overall Study|Death|4|||
16901075|NCT02146326|38007464|FG003|Overall Study|Death|4|||
16901076|NCT02146326|38007461|FG000|Overall Study|Unable to complete interview|0|||
16901077|NCT02146326|38007462|FG001|Overall Study|Unable to complete interview|0|||
16901078|NCT02146326|38007463|FG002|Overall Study|Unable to complete interview|10|||
16901079|NCT02146326|38007464|FG003|Overall Study|Unable to complete interview|6|||
16901080|NCT02146248|38007480|FG000|Overall Study|Withdrawal by Subject|2|||
16901081|NCT02145468|38007490|FG000|Overall Study|Withdrawal by Subject|5|||
16901082|NCT02145468|38007491|FG001|Overall Study|Withdrawal by Subject|8|||
16901083|NCT02124564|38007497|FG000|Treatment Period|Adverse Event|2|||
16901084|NCT02124564|38007497|FG000|Treatment Period|Lack of Efficacy|3|||
16901085|NCT02124564|38007497|FG000|Treatment Period|Withdrawal by Subject|2|||
16901086|NCT02145390|38007502|FG000|Overall Study|Withdrawal by Subject|1|||
16901087|NCT02100696|38007512|FG000|Induction Phase|Adverse Event|0|||
16901088|NCT02100696|38007513|FG001|Induction Phase|Adverse Event|0|||
16901089|NCT02100696|38007514|FG002|Induction Phase|Adverse Event|1|||
16901090|NCT02100696|38007515|FG003|Induction Phase|Adverse Event|0|||
16901091|NCT02100696|38007516|FG004|Induction Phase|Adverse Event|0|||
16901092|NCT02100696|38007517|FG005|Induction Phase|Adverse Event|0|||
16901093|NCT02100696|38007512|FG000|Induction Phase|Lost to Follow-up|1|||
16901094|NCT02100696|38007513|FG001|Induction Phase|Lost to Follow-up|0|||
16901095|NCT02100696|38007514|FG002|Induction Phase|Lost to Follow-up|1|||
16901096|NCT02100696|38007515|FG003|Induction Phase|Lost to Follow-up|0|||
16901097|NCT02100696|38007516|FG004|Induction Phase|Lost to Follow-up|0|||
16901098|NCT02100696|38007517|FG005|Induction Phase|Lost to Follow-up|0|||
16901099|NCT02100696|38007512|FG000|Induction Phase|Protocol Violation|0|||
16901100|NCT02100696|38007513|FG001|Induction Phase|Protocol Violation|1|||
16901101|NCT02100696|38007514|FG002|Induction Phase|Protocol Violation|1|||
16901102|NCT02100696|38007515|FG003|Induction Phase|Protocol Violation|0|||
16901103|NCT02100696|38007516|FG004|Induction Phase|Protocol Violation|0|||
16901104|NCT02100696|38007517|FG005|Induction Phase|Protocol Violation|0|||
16901105|NCT02100696|38007512|FG000|Induction Phase|Withdrawal by Subject|8|||
16901106|NCT02100696|38007513|FG001|Induction Phase|Withdrawal by Subject|2|||
16901107|NCT02100696|38007514|FG002|Induction Phase|Withdrawal by Subject|13|||
16901108|NCT02100696|38007515|FG003|Induction Phase|Withdrawal by Subject|0|||
16901109|NCT02100696|38007516|FG004|Induction Phase|Withdrawal by Subject|0|||
16901110|NCT02100696|38007517|FG005|Induction Phase|Withdrawal by Subject|0|||
16901111|NCT02100696|38007512|FG000|Induction Phase|Physician Decision|1|||
16901112|NCT02100696|38007513|FG001|Induction Phase|Physician Decision|0|||
16901113|NCT02100696|38007514|FG002|Induction Phase|Physician Decision|2|||
16901114|NCT02100696|38007515|FG003|Induction Phase|Physician Decision|0|||
16901115|NCT02100696|38007516|FG004|Induction Phase|Physician Decision|0|||
16901116|NCT02100696|38007517|FG005|Induction Phase|Physician Decision|0|||
16901117|NCT02100696|38007512|FG000|Induction Phase|Multiple Reasons|5|||
16901118|NCT02100696|38007513|FG001|Induction Phase|Multiple Reasons|2|||
16901119|NCT02100696|38007514|FG002|Induction Phase|Multiple Reasons|8|||
16901120|NCT02100696|38007515|FG003|Induction Phase|Multiple Reasons|0|||
16901121|NCT02100696|38007516|FG004|Induction Phase|Multiple Reasons|0|||
16901122|NCT02100696|38007517|FG005|Induction Phase|Multiple Reasons|0|||
16901123|NCT02100696|38007512|FG000|Maintenance Phase|Adverse Event|0|||
16901124|NCT02100696|38007513|FG001|Maintenance Phase|Adverse Event|0|||
17005660|NCT00805467|38149504|FG000|Overall Study|Lack of Efficacy|0|||
17005661|NCT00805467|38149505|FG001|Overall Study|Lack of Efficacy|8|||
17005662|NCT00805467|38149506|FG002|Overall Study|Lack of Efficacy|13|||
17005663|NCT00805467|38149507|FG003|Overall Study|Lack of Efficacy|86|||
17005664|NCT00805467|38149504|FG000|Overall Study|Lost to Follow-up|0|||
17005665|NCT00805467|38149505|FG001|Overall Study|Lost to Follow-up|1|||
17005666|NCT00805467|38149506|FG002|Overall Study|Lost to Follow-up|7|||
17005667|NCT00805467|38149507|FG003|Overall Study|Lost to Follow-up|21|||
17005668|NCT00805467|38149504|FG000|Overall Study|Withdrawal by Subject|0|||
17005669|NCT00805467|38149505|FG001|Overall Study|Withdrawal by Subject|6|||
16901125|NCT02100696|38007514|FG002|Maintenance Phase|Adverse Event|0|||
16901126|NCT02100696|38007515|FG003|Maintenance Phase|Adverse Event|0|||
16901127|NCT02100696|38007516|FG004|Maintenance Phase|Adverse Event|0|||
16901128|NCT02100696|38007517|FG005|Maintenance Phase|Adverse Event|2|||
16901129|NCT02100696|38007512|FG000|Maintenance Phase|Lost to Follow-up|0|||
16901130|NCT02100696|38007513|FG001|Maintenance Phase|Lost to Follow-up|0|||
16901131|NCT02100696|38007514|FG002|Maintenance Phase|Lost to Follow-up|0|||
16901132|NCT02100696|38007515|FG003|Maintenance Phase|Lost to Follow-up|0|||
16901133|NCT02100696|38007516|FG004|Maintenance Phase|Lost to Follow-up|1|||
16901134|NCT02100696|38007517|FG005|Maintenance Phase|Lost to Follow-up|0|||
16901135|NCT02100696|38007512|FG000|Maintenance Phase|Protocol Violation|0|||
16901136|NCT02100696|38007513|FG001|Maintenance Phase|Protocol Violation|0|||
16901137|NCT02100696|38007514|FG002|Maintenance Phase|Protocol Violation|0|||
16901138|NCT02100696|38007515|FG003|Maintenance Phase|Protocol Violation|0|||
16901139|NCT02100696|38007516|FG004|Maintenance Phase|Protocol Violation|1|||
16901140|NCT02100696|38007517|FG005|Maintenance Phase|Protocol Violation|0|||
16901141|NCT02100696|38007512|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16901142|NCT02100696|38007513|FG001|Maintenance Phase|Withdrawal by Subject|0|||
16901143|NCT02100696|38007514|FG002|Maintenance Phase|Withdrawal by Subject|0|||
16901144|NCT02100696|38007515|FG003|Maintenance Phase|Withdrawal by Subject|1|||
16901145|NCT02100696|38007516|FG004|Maintenance Phase|Withdrawal by Subject|4|||
16901146|NCT02100696|38007517|FG005|Maintenance Phase|Withdrawal by Subject|2|||
16901147|NCT02100696|38007512|FG000|Maintenance Phase|Physician Decision|0|||
16901148|NCT02100696|38007513|FG001|Maintenance Phase|Physician Decision|0|||
16901149|NCT02100696|38007514|FG002|Maintenance Phase|Physician Decision|0|||
16901150|NCT02100696|38007515|FG003|Maintenance Phase|Physician Decision|0|||
16901151|NCT02100696|38007516|FG004|Maintenance Phase|Physician Decision|1|||
16901152|NCT02100696|38007517|FG005|Maintenance Phase|Physician Decision|0|||
16901153|NCT02100696|38007512|FG000|Maintenance Phase|Multiple Reasons|0|||
16901154|NCT02100696|38007513|FG001|Maintenance Phase|Multiple Reasons|0|||
16901155|NCT02100696|38007514|FG002|Maintenance Phase|Multiple Reasons|0|||
16901156|NCT02100696|38007515|FG003|Maintenance Phase|Multiple Reasons|0|||
16901157|NCT02100696|38007516|FG004|Maintenance Phase|Multiple Reasons|2|||
16901158|NCT02100696|38007517|FG005|Maintenance Phase|Multiple Reasons|1|||
16901159|NCT02145156|38007541|FG000|Overall Study|No match to vaccination records|60|||
16901160|NCT02145156|38007542|FG001|Overall Study|No match to vaccination records|52|||
16901161|NCT02145156|38007543|FG002|Overall Study|No match to vaccination records|41|||
16901162|NCT02123472|38007551|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
16901163|NCT02123472|38007552|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
16901164|NCT02145078|38007558|FG000|Overall Study|Death|1|||
16901165|NCT02145078|38007558|FG000|Overall Study|Reason not given|3|||
16901166|NCT02144610|38007564|FG000|Overall Study|Physician Decision|1|||
16901167|NCT02144610|38007565|FG001|Overall Study|Physician Decision|0|||
16901168|NCT02144610|38007564|FG000|Overall Study|Withdrawal by Subject|1|||
16901169|NCT02144610|38007565|FG001|Overall Study|Withdrawal by Subject|5|||
16901170|NCT02144610|38007564|FG000|Overall Study|Death|2|||
16901171|NCT02144610|38007565|FG001|Overall Study|Death|2|||
16901172|NCT02144610|38007564|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
16901173|NCT02144610|38007565|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
16901174|NCT02144610|38007564|FG000|Overall Study|Other|0|||
16901175|NCT02144610|38007565|FG001|Overall Study|Other|1|||
16901176|NCT02100228|38007573|FG000|Overall Study|Other|19|||
16901177|NCT02100228|38007574|FG001|Overall Study|Other|19|||
16901178|NCT02100228|38007573|FG000|Overall Study|Administrative reason|0|||
16901179|NCT02100228|38007574|FG001|Overall Study|Administrative reason|1|||
16901180|NCT02100228|38007573|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
17005670|NCT00805467|38149506|FG002|Overall Study|Withdrawal by Subject|45|||
16901181|NCT02100228|38007574|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
16901182|NCT02100228|38007573|FG000|Overall Study|Non-compliance|0|||
16901183|NCT02100228|38007574|FG001|Overall Study|Non-compliance|3|||
16901184|NCT02100228|38007573|FG000|Overall Study|Lost to Follow-up|0|||
16901185|NCT02100228|38007574|FG001|Overall Study|Lost to Follow-up|1|||
16901186|NCT02100228|38007573|FG000|Overall Study|Withdrawal by Subject|27|||
16901187|NCT02100228|38007574|FG001|Overall Study|Withdrawal by Subject|37|||
16901188|NCT02100228|38007573|FG000|Overall Study|Adverse Event|16|||
16901189|NCT02100228|38007574|FG001|Overall Study|Adverse Event|12|||
16901190|NCT02100228|38007573|FG000|Overall Study|Death|1|||
16901191|NCT02100228|38007574|FG001|Overall Study|Death|1|||
16901192|NCT02099838|38007582|FG000|Overall Study|Death|1|||
16901193|NCT02099838|38007583|FG001|Overall Study|Death|0|||
16901194|NCT02099838|38007582|FG000|Overall Study|Lost to Follow-up|3|||
16901195|NCT02099838|38007583|FG001|Overall Study|Lost to Follow-up|1|||
16901196|NCT02099838|38007582|FG000|Overall Study|Withdrawal by Subject|0|||
16901197|NCT02099838|38007583|FG001|Overall Study|Withdrawal by Subject|1|||
16901198|NCT02144220|38007589|FG000|Overall Study|technology incompatibility|9|||
16901199|NCT02144220|38007589|FG000|Overall Study|Lack of Efficacy|4|||
16901200|NCT02144220|38007589|FG000|Overall Study|Physician Decision|3|||
16901201|NCT02144220|38007589|FG000|Overall Study|Withdrawal by Subject|2|||
16901202|NCT02144220|38007589|FG000|Overall Study|Protocol Violation|1|||
16901203|NCT02099682|38007593|FG000|Overall Study|Data Not Available|51|||
16901204|NCT02099682|38007593|FG000|Overall Study|Lost to Follow-up|31|||
16901205|NCT02099682|38007593|FG000|Overall Study|Other|29|||
16901206|NCT02142894|38007597|FG000|Overall Study|Protocol Violation|8|||
16901207|NCT02098746|38007601|FG000|Overall Study|Changes of Investigator|2|||
16901208|NCT02098746|38007601|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16901209|NCT02098746|38007601|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
16901210|NCT02098746|38007601|FG000|Overall Study|Data Not Available After Treatment|1|||
16901211|NCT02122770|38007609|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
16901212|NCT02122770|38007610|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
16901213|NCT02122770|38007611|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
16901214|NCT02122770|38007612|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
16901215|NCT02122770|38007613|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
16901216|NCT02122770|38007614|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
16901217|NCT02122770|38007609|FG000|Part A: Drug-drug Interaction 2|Other|0|||
16901218|NCT02122770|38007610|FG001|Part A: Drug-drug Interaction 2|Other|0|||
16901219|NCT02122770|38007611|FG002|Part A: Drug-drug Interaction 2|Other|1|||
16901220|NCT02122770|38007612|FG003|Part A: Drug-drug Interaction 2|Other|0|||
16901221|NCT02122770|38007613|FG004|Part A: Drug-drug Interaction 2|Other|0|||
16901222|NCT02122770|38007614|FG005|Part A: Drug-drug Interaction 2|Other|0|||
16901223|NCT02122770|38007609|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16901224|NCT02122770|38007610|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
16901225|NCT02122770|38007611|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16901226|NCT02122770|38007612|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16901227|NCT02122770|38007613|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16901228|NCT02122770|38007614|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16901229|NCT02122770|38007609|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
16901230|NCT02122770|38007610|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
16901231|NCT02122770|38007611|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
16901232|NCT02122770|38007612|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
16901233|NCT02122770|38007613|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
16901234|NCT02122770|38007614|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
16901235|NCT02122770|38007609|FG000|Part B: Standard of Care|Adverse Event|0|||
16901236|NCT02122770|38007610|FG001|Part B: Standard of Care|Adverse Event|0|||
16901237|NCT02122770|38007611|FG002|Part B: Standard of Care|Adverse Event|0|||
16901238|NCT02122770|38007612|FG003|Part B: Standard of Care|Adverse Event|0|||
16901239|NCT02122770|38007613|FG004|Part B: Standard of Care|Adverse Event|4|||
16901240|NCT02122770|38007614|FG005|Part B: Standard of Care|Adverse Event|1|||
16901241|NCT02122770|38007609|FG000|Part B: Standard of Care|Other|0|||
16901242|NCT02122770|38007610|FG001|Part B: Standard of Care|Other|0|||
16901243|NCT02122770|38007611|FG002|Part B: Standard of Care|Other|0|||
16901244|NCT02122770|38007612|FG003|Part B: Standard of Care|Other|0|||
16901245|NCT02122770|38007613|FG004|Part B: Standard of Care|Other|0|||
16901246|NCT02122770|38007614|FG005|Part B: Standard of Care|Other|2|||
16901247|NCT02122770|38007609|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
16901248|NCT02122770|38007610|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
16901249|NCT02122770|38007611|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
16901250|NCT02122770|38007612|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
16901251|NCT02122770|38007613|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
16901252|NCT02122770|38007614|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
17005671|NCT00805467|38149507|FG003|Overall Study|Withdrawal by Subject|50|||
17005672|NCT00805467|38149504|FG000|Overall Study|Protocol Violation|0|||
16901253|NCT02122770|38007609|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
16901254|NCT02122770|38007610|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
16901255|NCT02122770|38007611|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
16901256|NCT02122770|38007612|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
16901257|NCT02122770|38007613|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
16901258|NCT02122770|38007614|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
16901259|NCT02122770|38007609|FG000|Part B: Standard of Care|Progressive Disease|0|||
16901260|NCT02122770|38007610|FG001|Part B: Standard of Care|Progressive Disease|0|||
16901261|NCT02122770|38007611|FG002|Part B: Standard of Care|Progressive Disease|0|||
16901262|NCT02122770|38007612|FG003|Part B: Standard of Care|Progressive Disease|0|||
16901263|NCT02122770|38007613|FG004|Part B: Standard of Care|Progressive Disease|10|||
16901264|NCT02122770|38007614|FG005|Part B: Standard of Care|Progressive Disease|8|||
16901265|NCT02122380|38007639|FG000|First Intervention (30 Days)|Adverse Event|1|||
16901266|NCT02122380|38007640|FG001|First Intervention (30 Days)|Adverse Event|0|||
16901267|NCT02122380|38007639|FG000|First Intervention (30 Days)|Physician Decision|0|||
16901268|NCT02122380|38007640|FG001|First Intervention (30 Days)|Physician Decision|1|||
16901269|NCT02122380|38007639|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
16901270|NCT02122380|38007640|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
16901271|NCT02122380|38007639|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
16901272|NCT02122380|38007640|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
16901273|NCT02122380|38007639|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
16901274|NCT02122380|38007640|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
16901275|NCT02122146|38007655|FG000|Part 1: Dose Escalation|Death|0|||
16901276|NCT02122146|38007656|FG001|Part 1: Dose Escalation|Death|1|||
16901277|NCT02122146|38007657|FG002|Part 1: Dose Escalation|Death|1|||
16901278|NCT02122146|38007658|FG003|Part 1: Dose Escalation|Death|0|||
16901279|NCT02122146|38007659|FG004|Part 1: Dose Escalation|Death|0|||
16901280|NCT02122146|38007660|FG005|Part 1: Dose Escalation|Death|0|||
16901281|NCT02122146|38007661|FG006|Part 1: Dose Escalation|Death|0|||
16901282|NCT02122146|38007662|FG007|Part 1: Dose Escalation|Death|0|||
16901283|NCT02122146|38007655|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
16901284|NCT02122146|38007656|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
16901285|NCT02122146|38007657|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
16901286|NCT02122146|38007658|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
16901287|NCT02122146|38007659|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
16901288|NCT02122146|38007660|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
16901289|NCT02122146|38007661|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
16901290|NCT02122146|38007662|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
16901291|NCT02122146|38007655|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16901292|NCT02122146|38007656|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16901293|NCT02122146|38007657|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16901294|NCT02122146|38007658|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
16901295|NCT02122146|38007659|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16901296|NCT02122146|38007660|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16901297|NCT02122146|38007661|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16901298|NCT02122146|38007662|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16901299|NCT02122146|38007655|FG000|Part 1: Dose Escalation|Other|1|||
16901300|NCT02122146|38007656|FG001|Part 1: Dose Escalation|Other|0|||
16901301|NCT02122146|38007657|FG002|Part 1: Dose Escalation|Other|0|||
16901302|NCT02122146|38007658|FG003|Part 1: Dose Escalation|Other|0|||
16901303|NCT02122146|38007659|FG004|Part 1: Dose Escalation|Other|0|||
17005673|NCT00805467|38149505|FG001|Overall Study|Protocol Violation|3|||
17005674|NCT00805467|38149506|FG002|Overall Study|Protocol Violation|0|||
17005675|NCT00805467|38149507|FG003|Overall Study|Protocol Violation|5|||
17005676|NCT00805467|38149504|FG000|Overall Study|Adverse Event|0|||
17005677|NCT00805467|38149505|FG001|Overall Study|Adverse Event|13|||
17005678|NCT00805467|38149506|FG002|Overall Study|Adverse Event|26|||
17005679|NCT00805467|38149507|FG003|Overall Study|Adverse Event|57|||
17005680|NCT00805467|38149504|FG000|Overall Study|Death|0|||
17005681|NCT00805467|38149505|FG001|Overall Study|Death|2|||
16786195|NCT02687035|37726652|FG000|Overall Study|Withdrawal by Subject|1|||
16786196|NCT02687035|37726652|FG000|Overall Study|Death|87|||
16786197|NCT02687035|37726652|FG000|Overall Study|Lost to Follow-up|1|||
16786198|NCT02687035|37726652|FG000|Overall Study|Missed Visit|87|||
16786199|NCT02687035|37726652|FG000|Overall Study|Did not receive Study Device|8|||
16786200|NCT02691013|37726658|FG000|Overall Study|Withdrawal by Subject|3|||
16786201|NCT02691013|37726659|FG001|Overall Study|Withdrawal by Subject|0|||
16786202|NCT02690701|37726669|FG000|Treatment Period 1|Adverse Event|2|||
16786203|NCT02690701|37726670|FG001|Treatment Period 1|Adverse Event|2|||
16786204|NCT02690701|37726669|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16786205|NCT02690701|37726670|FG001|Treatment Period 1|Withdrawal by Subject|1|||
17005682|NCT00805467|38149506|FG002|Overall Study|Death|7|||
17005683|NCT00805467|38149507|FG003|Overall Study|Death|5|||
16786206|NCT02690701|37726669|FG000|Treatment Period 2|Adverse Event|2|||
16786207|NCT02690701|37726670|FG001|Treatment Period 2|Adverse Event|0|||
17005684|NCT00805467|38149504|FG000|Overall Study|Physician Decision|0|||
17005685|NCT00805467|38149505|FG001|Overall Study|Physician Decision|1|||
17005686|NCT00805467|38149506|FG002|Overall Study|Physician Decision|2|||
17005687|NCT00805467|38149507|FG003|Overall Study|Physician Decision|6|||
16901304|NCT02122146|38007660|FG005|Part 1: Dose Escalation|Other|1|||
16901305|NCT02122146|38007661|FG006|Part 1: Dose Escalation|Other|1|||
16901306|NCT02122146|38007662|FG007|Part 1: Dose Escalation|Other|2|||
16901307|NCT02121834|38007688|FG000|Overall Study|Protocol Violation|0|||
16901308|NCT02121834|38007689|FG001|Overall Study|Protocol Violation|1|||
16901309|NCT02121834|38007690|FG002|Overall Study|Protocol Violation|0|||
16901310|NCT02121834|38007691|FG003|Overall Study|Protocol Violation|0|||
16901311|NCT02121834|38007692|FG004|Overall Study|Protocol Violation|0|||
16901312|NCT02121834|38007693|FG005|Overall Study|Protocol Violation|0|||
16901313|NCT02121834|38007694|FG006|Overall Study|Protocol Violation|0|||
16901314|NCT02121834|38007688|FG000|Overall Study|Withdrawal by Subject|0|||
16901315|NCT02121834|38007689|FG001|Overall Study|Withdrawal by Subject|1|||
16901316|NCT02121834|38007690|FG002|Overall Study|Withdrawal by Subject|1|||
16901317|NCT02121834|38007691|FG003|Overall Study|Withdrawal by Subject|0|||
16901318|NCT02121834|38007692|FG004|Overall Study|Withdrawal by Subject|0|||
16901319|NCT02121834|38007693|FG005|Overall Study|Withdrawal by Subject|0|||
16901320|NCT02121834|38007694|FG006|Overall Study|Withdrawal by Subject|0|||
16901321|NCT02121834|38007688|FG000|Overall Study|Lost to Follow-up|0|||
16901322|NCT02121834|38007689|FG001|Overall Study|Lost to Follow-up|0|||
16901323|NCT02121834|38007690|FG002|Overall Study|Lost to Follow-up|1|||
16901324|NCT02121834|38007691|FG003|Overall Study|Lost to Follow-up|0|||
16901325|NCT02121834|38007692|FG004|Overall Study|Lost to Follow-up|0|||
16901326|NCT02121834|38007693|FG005|Overall Study|Lost to Follow-up|0|||
16901327|NCT02121834|38007694|FG006|Overall Study|Lost to Follow-up|0|||
16901328|NCT02121756|38007722|FG000|Overall Study|Adverse Event|3|||
16901329|NCT02121756|38007723|FG001|Overall Study|Adverse Event|0|||
16901330|NCT02121756|38007722|FG000|Overall Study|Protocol Violation|1|||
16901331|NCT02121756|38007723|FG001|Overall Study|Protocol Violation|1|||
16901332|NCT02121756|38007722|FG000|Overall Study|Physician Decision|2|||
16901333|NCT02121756|38007723|FG001|Overall Study|Physician Decision|1|||
16901334|NCT02142504|38007735|FG000|Overall Study|Protocol Violation|2|||
16901335|NCT02142504|38007736|FG001|Overall Study|Protocol Violation|1|||
16901336|NCT02142504|38007737|FG002|Overall Study|Protocol Violation|2|||
16901337|NCT02142504|38007735|FG000|Overall Study|Adverse Event|2|||
16901338|NCT02142504|38007736|FG001|Overall Study|Adverse Event|3|||
16901339|NCT02142504|38007737|FG002|Overall Study|Adverse Event|4|||
16901340|NCT02142504|38007735|FG000|Overall Study|Lost to Follow-up|12|||
16901341|NCT02142504|38007736|FG001|Overall Study|Lost to Follow-up|19|||
16901342|NCT02142504|38007737|FG002|Overall Study|Lost to Follow-up|17|||
16901343|NCT02142504|38007735|FG000|Overall Study|Withdrawal by Subject|7|||
16901344|NCT02142504|38007736|FG001|Overall Study|Withdrawal by Subject|9|||
16901345|NCT02142504|38007737|FG002|Overall Study|Withdrawal by Subject|11|||
16901346|NCT02142504|38007735|FG000|Overall Study|Pregnancy|4|||
16901347|NCT02142504|38007736|FG001|Overall Study|Pregnancy|4|||
16901348|NCT02142504|38007737|FG002|Overall Study|Pregnancy|2|||
17005688|NCT00805467|38149504|FG000|Overall Study|Not reported|0|||
16901349|NCT02142504|38007735|FG000|Overall Study|Physician Decision|0|||
16901350|NCT02142504|38007736|FG001|Overall Study|Physician Decision|1|||
16901351|NCT02142504|38007737|FG002|Overall Study|Physician Decision|3|||
16901352|NCT02142504|38007735|FG000|Overall Study|Reason Not Specified|4|||
16901353|NCT02142504|38007736|FG001|Overall Study|Reason Not Specified|5|||
16901354|NCT02142504|38007737|FG002|Overall Study|Reason Not Specified|4|||
16901355|NCT02121522|38007745|FG000|Overall Study|Adverse Event|1|||
16901356|NCT02121210|38007751|FG000|Overall Study|Adverse Event|5|||
16901357|NCT02121210|38007752|FG001|Overall Study|Adverse Event|7|||
16901358|NCT02121210|38007751|FG000|Overall Study|Lack of Efficacy|2|||
16901359|NCT02121210|38007752|FG001|Overall Study|Lack of Efficacy|0|||
16901360|NCT02121210|38007751|FG000|Overall Study|Other than specified above|0|||
16901361|NCT02121210|38007752|FG001|Overall Study|Other than specified above|2|||
17005689|NCT00805467|38149505|FG001|Overall Study|Not reported|0|||
17005690|NCT00805467|38149506|FG002|Overall Study|Not reported|3|||
17005691|NCT00805467|38149507|FG003|Overall Study|Not reported|7|||
16901365|NCT02141490|38007765|FG000|Overall Study|Screening failures|4|||
16901366|NCT02141490|38007766|FG001|Overall Study|Screening failures|0|||
16901367|NCT02141490|38007767|FG002|Overall Study|Screening failures|0|||
16901368|NCT02097108|38007777|FG000|Overall Study|Adverse Event|1|||
16901369|NCT02097108|38007777|FG000|Overall Study|patient was abroad for 6 months|1|||
16901370|NCT02097030|38007783|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
16901371|NCT02097030|38007784|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
16901372|NCT02097030|38007783|FG000|First Intervention (3 Days)|Visual Acuity|0|||
16901373|NCT02097030|38007784|FG001|First Intervention (3 Days)|Visual Acuity|1|||
16901374|NCT02096952|38007794|FG000|Overall Study|Adverse Event|1|||
16901375|NCT02120898|38007801|FG000|Overall Study|Withdrawal by Subject|4|||
16901376|NCT02120898|38007802|FG001|Overall Study|Withdrawal by Subject|2|||
16901377|NCT02120898|38007803|FG002|Overall Study|Withdrawal by Subject|2|||
16901378|NCT02120898|38007801|FG000|Overall Study|Non-compliance with study drug|3|||
16901379|NCT02120898|38007802|FG001|Overall Study|Non-compliance with study drug|0|||
16901380|NCT02120898|38007803|FG002|Overall Study|Non-compliance with study drug|0|||
16901381|NCT02120898|38007801|FG000|Overall Study|Adverse Event|1|||
16901382|NCT02120898|38007802|FG001|Overall Study|Adverse Event|2|||
16901383|NCT02120898|38007803|FG002|Overall Study|Adverse Event|1|||
16901384|NCT02120898|38007801|FG000|Overall Study|Protocol Violation|1|||
16901385|NCT02120898|38007802|FG001|Overall Study|Protocol Violation|2|||
16901386|NCT02120898|38007803|FG002|Overall Study|Protocol Violation|0|||
16901387|NCT02120898|38007801|FG000|Overall Study|Lost to Follow-up|0|||
16901388|NCT02120898|38007802|FG001|Overall Study|Lost to Follow-up|0|||
16901389|NCT02120898|38007803|FG002|Overall Study|Lost to Follow-up|1|||
16901390|NCT02120664|38007816|FG000|Overall Study|Withdrawal by Subject|0|||
16901391|NCT02120664|38007817|FG001|Overall Study|Withdrawal by Subject|0|||
16901392|NCT02120664|38007818|FG002|Overall Study|Withdrawal by Subject|0|||
16901393|NCT02120664|38007819|FG003|Overall Study|Withdrawal by Subject|1|||
16901394|NCT02120664|38007820|FG004|Overall Study|Withdrawal by Subject|0|||
16901395|NCT01627860|38007835|FG000|Overall Study|Adverse Event|9|||
16901396|NCT01627860|38007836|FG001|Overall Study|Adverse Event|4|||
16901397|NCT01627860|38007835|FG000|Overall Study|Withdrawal by Subject|2|||
16901398|NCT01627860|38007836|FG001|Overall Study|Withdrawal by Subject|1|||
16901399|NCT01627860|38007835|FG000|Overall Study|Seizure frequency doubled|0|||
16901400|NCT01627860|38007836|FG001|Overall Study|Seizure frequency doubled|1|||
16901401|NCT01627860|38007835|FG000|Overall Study|Protocol Violation|1|||
16901402|NCT01627860|38007836|FG001|Overall Study|Protocol Violation|0|||
16901403|NCT01627782|38007846|FG000|Overall Study|Adverse Event|1|||
16901404|NCT01627782|38007847|FG001|Overall Study|Adverse Event|2|||
16901405|NCT01627782|38007848|FG002|Overall Study|Adverse Event|0|||
16901406|NCT01627782|38007849|FG003|Overall Study|Adverse Event|1|||
16901407|NCT01627782|38007846|FG000|Overall Study|Lack of Efficacy|11|||
16901408|NCT01627782|38007847|FG001|Overall Study|Lack of Efficacy|1|||
16901409|NCT01627782|38007848|FG002|Overall Study|Lack of Efficacy|15|||
16901410|NCT01627782|38007849|FG003|Overall Study|Lack of Efficacy|2|||
16901411|NCT01627782|38007846|FG000|Overall Study|Protocol Violation|1|||
16901412|NCT01627782|38007847|FG001|Overall Study|Protocol Violation|0|||
16901413|NCT01627782|38007848|FG002|Overall Study|Protocol Violation|0|||
16901414|NCT01627782|38007849|FG003|Overall Study|Protocol Violation|0|||
16901415|NCT01627782|38007846|FG000|Overall Study|Withdrawal by Subject|2|||
16901416|NCT01627782|38007847|FG001|Overall Study|Withdrawal by Subject|1|||
16901417|NCT01627782|38007848|FG002|Overall Study|Withdrawal by Subject|0|||
17005692|NCT00958841|38149517|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17005693|NCT00958841|38149517|FG000|Overall Study|Abnormal test procedure result(s)|3|||
17005694|NCT00958841|38149517|FG000|Overall Study|Administrative problems|1|||
17005695|NCT00958841|38149517|FG000|Overall Study|Adverse Event|8|||
17005696|NCT00958841|38149517|FG000|Overall Study|New cancer therapy|5|||
17005697|NCT00958841|38149517|FG000|Overall Study|Withdrawal by Subject|1|||
17005698|NCT00958841|38149517|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
17005699|NCT00958841|38149517|FG000|Overall Study|Completed M6/did not enter extension|27|||
17005700|NCT00958841|38149517|FG000|Overall Study|Discontinued prior to M*|28|||
17005701|NCT03927105|38149580|FG000|Overall Study|Death|1|||
17005702|NCT03927105|38149580|FG000|Overall Study|In observation for potential re-treatment|2|||
17005703|NCT03927105|38149580|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
17005704|NCT00613327|38149584|FG000|Overall Study|Adverse Event|38|||
16901418|NCT01627782|38007849|FG003|Overall Study|Withdrawal by Subject|0|||
16901419|NCT01627782|38007846|FG000|Overall Study|Other|0|||
16901420|NCT01627782|38007847|FG001|Overall Study|Other|2|||
16901421|NCT01627782|38007848|FG002|Overall Study|Other|0|||
16901422|NCT01627782|38007849|FG003|Overall Study|Other|3|||
16901423|NCT01627782|38007846|FG000|Overall Study|Randomized But Not Treated|1|||
16901424|NCT01627782|38007847|FG001|Overall Study|Randomized But Not Treated|0|||
16901425|NCT01627782|38007848|FG002|Overall Study|Randomized But Not Treated|0|||
16901426|NCT01627782|38007849|FG003|Overall Study|Randomized But Not Treated|0|||
16901427|NCT01598532|38007861|FG000|Overall Study|Lost to Follow-up|3|||
16901428|NCT01598532|38007861|FG000|Overall Study|Did not meet inclusion criteria|8|||
16901429|NCT02119650|38007870|FG000|Overall Study|Adverse Event|3|||
16901430|NCT02119650|38007871|FG001|Overall Study|Adverse Event|4|||
16901431|NCT02119650|38007870|FG000|Overall Study|Subject decision|2|||
16901432|NCT02119650|38007871|FG001|Overall Study|Subject decision|3|||
16901433|NCT02119650|38007870|FG000|Overall Study|Disease progression|11|||
16901434|NCT02119650|38007871|FG001|Overall Study|Disease progression|14|||
16901435|NCT02119650|38007870|FG000|Overall Study|Death|5|||
16901436|NCT02119650|38007871|FG001|Overall Study|Death|1|||
16901437|NCT02119650|38007870|FG000|Overall Study|Noncompliance with study treatment|1|||
16901438|NCT02119650|38007871|FG001|Overall Study|Noncompliance with study treatment|1|||
16901439|NCT02119650|38007870|FG000|Overall Study|Study terminated by the sponsor|1|||
16901440|NCT02119650|38007871|FG001|Overall Study|Study terminated by the sponsor|0|||
16901441|NCT02119650|38007870|FG000|Overall Study|Physician Decision|0|||
17005705|NCT00613327|38149584|FG000|Overall Study|Lost to Follow-up|8|||
17005706|NCT00613327|38149584|FG000|Overall Study|Withdrawal by Subject|6|||
17005707|NCT00613327|38149584|FG000|Overall Study|Protocol Violation|2|||
17005708|NCT00613327|38149584|FG000|Overall Study|Other|47|||
17005709|NCT00954941|38149590|FG000|Overall Study|Received treatment at home|1|||
17005710|NCT00954941|38149591|FG001|Overall Study|Received treatment at home|0|||
17005711|NCT00954941|38149590|FG000|Overall Study|Withdrawal by Subject|1|||
17005712|NCT00954941|38149591|FG001|Overall Study|Withdrawal by Subject|0|||
17005713|NCT00954941|38149590|FG000|Overall Study|Insurance Denial|2|||
17005714|NCT00954941|38149591|FG001|Overall Study|Insurance Denial|2|||
17005715|NCT00954941|38149590|FG000|Overall Study|Physician Decision|2|||
17005716|NCT00954941|38149591|FG001|Overall Study|Physician Decision|2|||
17005717|NCT00954941|38149590|FG000|Overall Study|Ineligible|2|||
17005718|NCT00954941|38149591|FG001|Overall Study|Ineligible|2|||
17005719|NCT00954941|38149590|FG000|Overall Study|Adverse Event|0|||
17005720|NCT00954941|38149591|FG001|Overall Study|Adverse Event|1|||
17005721|NCT00954707|38149597|FG000|Overall Study|Death|34|||
17005722|NCT00954707|38149597|FG000|Overall Study|Withdrawal by Subject|100|||
17005723|NCT00954707|38149597|FG000|Overall Study|Lost to Follow-up|33|||
17005724|NCT00589797|38149603|FG000|Overall Study|Death|1|||
17005725|NCT00589797|38149604|FG001|Overall Study|Death|0|||
17005726|NCT00589797|38149603|FG000|Overall Study|Lost to Follow-up|12|||
17005727|NCT00589797|38149604|FG001|Overall Study|Lost to Follow-up|9|||
17005728|NCT00589797|38149603|FG000|Overall Study|Physician Decision|8|||
17005729|NCT00589797|38149604|FG001|Overall Study|Physician Decision|3|||
17005730|NCT00589797|38149603|FG000|Overall Study|Withdrawal by Subject|6|||
17005731|NCT00589797|38149604|FG001|Overall Study|Withdrawal by Subject|5|||
17005732|NCT00589797|38149603|FG000|Overall Study|Non-Randomized Training Subjects|46|||
17005733|NCT00589797|38149604|FG001|Overall Study|Non-Randomized Training Subjects|6|||
17005734|NCT00613171|38149610|FG000|Overall Study|Adverse Event|7|||
17005735|NCT00613171|38149610|FG000|Overall Study|Withdrawal by Subject|3|||
17005736|NCT00613171|38149610|FG000|Overall Study|Reason not Specified|4|||
17005737|NCT00896480|38149615|FG000|Overall Study|Disease progression/recurrence|21|||
17005738|NCT00953225|38149624|FG000|Overall Study|Withdrawal by Subject|2|||
17005739|NCT00953225|38149625|FG001|Overall Study|Withdrawal by Subject|0|||
17005740|NCT00613015|38149637|FG000|Overall Study|Lost to Follow-up|0|||
17005741|NCT00613015|38149638|FG001|Overall Study|Lost to Follow-up|1|||
17005742|NCT00613015|38149639|FG002|Overall Study|Lost to Follow-up|3|||
17005743|NCT00613015|38149640|FG003|Overall Study|Lost to Follow-up|3|||
17005744|NCT00613015|38149641|FG004|Overall Study|Lost to Follow-up|2|||
17005745|NCT00613015|38149642|FG005|Overall Study|Lost to Follow-up|3|||
17005746|NCT00803595|38149659|FG000|Overall Study|Adverse Event|3|||
17005747|NCT00803595|38149660|FG001|Overall Study|Adverse Event|4|||
17005748|NCT00803595|38149661|FG002|Overall Study|Adverse Event|1|||
17005749|NCT00803595|38149659|FG000|Overall Study|Protocol Violation|7|||
17005750|NCT00803595|38149660|FG001|Overall Study|Protocol Violation|2|||
17005751|NCT00803595|38149661|FG002|Overall Study|Protocol Violation|12|||
17005752|NCT00803595|38149659|FG000|Overall Study|Withdrawal by Subject|5|||
17005753|NCT00803595|38149660|FG001|Overall Study|Withdrawal by Subject|2|||
17005754|NCT00803595|38149661|FG002|Overall Study|Withdrawal by Subject|3|||
17005755|NCT00953927|38149671|FG000|Overall Study|Lost to Follow-up|61|||
17005756|NCT00953927|38149672|FG001|Overall Study|Lost to Follow-up|65|||
17005757|NCT00953927|38149671|FG000|Overall Study|Withdrawal by Subject|36|||
17005758|NCT00953927|38149672|FG001|Overall Study|Withdrawal by Subject|25|||
17005759|NCT00953927|38149671|FG000|Overall Study|Death|7|||
17005760|NCT00953927|38149672|FG001|Overall Study|Death|4|||
17005761|NCT00953927|38149671|FG000|Overall Study|Other study discontinuation|1|||
17005762|NCT00953927|38149672|FG001|Overall Study|Other study discontinuation|1|||
17005763|NCT00611767|38149680|FG000|Overall Study|Withdrawal by Subject|4|||
17005764|NCT00611767|38149681|FG001|Overall Study|Withdrawal by Subject|1|||
17005765|NCT00611767|38149680|FG000|Overall Study|Thiopental not available|3|||
17005766|NCT00611767|38149681|FG001|Overall Study|Thiopental not available|0|||
17005767|NCT00611767|38149680|FG000|Overall Study|didn't like the medication|1|||
17005768|NCT00611767|38149681|FG001|Overall Study|didn't like the medication|1|||
17005769|NCT00611767|38149680|FG000|Overall Study|Physician Decision|1|||
17005770|NCT00611767|38149681|FG001|Overall Study|Physician Decision|0|||
17005771|NCT00803361|38149689|FG000|Overall Study|Adverse Event|13|||
17005772|NCT00803361|38149690|FG001|Overall Study|Adverse Event|3|||
17005773|NCT00803361|38149689|FG000|Overall Study|Lack of Efficacy|4|||
17005774|NCT00803361|38149690|FG001|Overall Study|Lack of Efficacy|13|||
17005775|NCT00803361|38149689|FG000|Overall Study|Lost to Follow-up|1|||
17005776|NCT00803361|38149690|FG001|Overall Study|Lost to Follow-up|2|||
17005777|NCT00803361|38149689|FG000|Overall Study|Physician Decision|1|||
17005778|NCT00803361|38149690|FG001|Overall Study|Physician Decision|0|||
17005779|NCT00803361|38149689|FG000|Overall Study|Protocol Violation|2|||
17005780|NCT00803361|38149690|FG001|Overall Study|Protocol Violation|4|||
17005781|NCT00803361|38149689|FG000|Overall Study|Withdrawal by Subject|5|||
17005782|NCT00803361|38149690|FG001|Overall Study|Withdrawal by Subject|6|||
17005783|NCT00611533|38149696|FG000|First Intervention (6 Weeks)|Never started study|0|||
17005784|NCT00611533|38149697|FG001|First Intervention (6 Weeks)|Never started study|1|||
17005785|NCT00611533|38149696|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
17005786|NCT00611533|38149697|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
17005787|NCT00611533|38149696|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
17005788|NCT00611533|38149697|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
17005789|NCT00953147|38149716|FG000|Overall Study|Adverse Event|8|||
17005790|NCT00953147|38149717|FG001|Overall Study|Adverse Event|16|||
17005791|NCT00953147|38149718|FG002|Overall Study|Adverse Event|6|||
17005792|NCT00953147|38149716|FG000|Overall Study|Protocol Violation|2|||
17005793|NCT00953147|38149717|FG001|Overall Study|Protocol Violation|8|||
17005794|NCT00953147|38149718|FG002|Overall Study|Protocol Violation|4|||
17005795|NCT00953147|38149716|FG000|Overall Study|Withdrawal by Subject|13|||
17005796|NCT00953147|38149717|FG001|Overall Study|Withdrawal by Subject|15|||
17005797|NCT00953147|38149718|FG002|Overall Study|Withdrawal by Subject|12|||
17005798|NCT00953147|38149716|FG000|Overall Study|Lost to Follow-up|8|||
17005799|NCT00953147|38149717|FG001|Overall Study|Lost to Follow-up|9|||
17005800|NCT00953147|38149718|FG002|Overall Study|Lost to Follow-up|4|||
17005801|NCT00953147|38149716|FG000|Overall Study|Physician Decision|2|||
17005802|NCT00953147|38149717|FG001|Overall Study|Physician Decision|7|||
17005803|NCT00953147|38149718|FG002|Overall Study|Physician Decision|3|||
17005804|NCT00953147|38149716|FG000|Overall Study|Other|4|||
17005805|NCT00953147|38149717|FG001|Overall Study|Other|11|||
17005806|NCT00953147|38149718|FG002|Overall Study|Other|13|||
17005807|NCT00803205|38149728|FG000|Overall Study|Adverse Event|7|||
17005808|NCT00803205|38149729|FG001|Overall Study|Adverse Event|2|||
17005809|NCT00803205|38149728|FG000|Overall Study|Lost to Follow-up|1|||
17005810|NCT00803205|38149729|FG001|Overall Study|Lost to Follow-up|0|||
17005811|NCT00803205|38149728|FG000|Overall Study|Withdrawal by Subject|9|||
17005812|NCT00803205|38149729|FG001|Overall Study|Withdrawal by Subject|9|||
17005813|NCT00803205|38149728|FG000|Overall Study|Physician Decision|1|||
17005814|NCT00803205|38149729|FG001|Overall Study|Physician Decision|0|||
17005815|NCT00803205|38149728|FG000|Overall Study|Protocol Violation|1|||
17005816|NCT00803205|38149729|FG001|Overall Study|Protocol Violation|1|||
17005817|NCT00803205|38149728|FG000|Overall Study|Medical Monitor Decision|1|||
17005818|NCT00803205|38149729|FG001|Overall Study|Medical Monitor Decision|0|||
17005819|NCT00803205|38149728|FG000|Overall Study|Acquired a Lung Infection|0|||
17005820|NCT00803205|38149729|FG001|Overall Study|Acquired a Lung Infection|1|||
17005821|NCT00803205|38149728|FG000|Overall Study|Sponsor Decision|0|||
17005822|NCT00803205|38149729|FG001|Overall Study|Sponsor Decision|1|||
17005823|NCT00952523|38149735|FG000|Overall Study|Withdrawal by Subject|7|||
17005824|NCT02232737|38149744|FG000|Overall Study|Lost to Follow-up|18|||
17005825|NCT02232737|38149745|FG001|Overall Study|Lost to Follow-up|28|||
17005826|NCT02232737|38149746|FG002|Overall Study|Lost to Follow-up|33|||
17005827|NCT02232737|38149744|FG000|Overall Study|Personal reasons|7|||
17005828|NCT02232737|38149745|FG001|Overall Study|Personal reasons|8|||
17005829|NCT02232737|38149746|FG002|Overall Study|Personal reasons|14|||
17005830|NCT02232737|38149744|FG000|Overall Study|Adverse Event|6|||
17005831|NCT02232737|38149745|FG001|Overall Study|Adverse Event|3|||
17005832|NCT02232737|38149746|FG002|Overall Study|Adverse Event|8|||
17005833|NCT02232737|38149744|FG000|Overall Study|Incarcerated|2|||
17005834|NCT02232737|38149745|FG001|Overall Study|Incarcerated|1|||
17005835|NCT02232737|38149746|FG002|Overall Study|Incarcerated|2|||
17005836|NCT02232737|38149744|FG000|Overall Study|Withdrawal by Subject|0|||
17005837|NCT02232737|38149745|FG001|Overall Study|Withdrawal by Subject|1|||
17005838|NCT02232737|38149746|FG002|Overall Study|Withdrawal by Subject|2|||
17005839|NCT02232737|38149744|FG000|Overall Study|Death|0|||
17005840|NCT02232737|38149745|FG001|Overall Study|Death|1|||
17005841|NCT02232737|38149746|FG002|Overall Study|Death|1|||
17005842|NCT02232737|38149744|FG000|Overall Study|Physician Decision|1|||
17005843|NCT02232737|38149745|FG001|Overall Study|Physician Decision|3|||
17005844|NCT02232737|38149746|FG002|Overall Study|Physician Decision|1|||
17005845|NCT02232737|38149744|FG000|Overall Study|Protocol Violation|1|||
17005846|NCT02232737|38149745|FG001|Overall Study|Protocol Violation|0|||
17005847|NCT02232737|38149746|FG002|Overall Study|Protocol Violation|1|||
17005848|NCT02232737|38149744|FG000|Overall Study|Reason unknown|1|||
17005849|NCT02232737|38149745|FG001|Overall Study|Reason unknown|0|||
17005850|NCT02232737|38149746|FG002|Overall Study|Reason unknown|0|||
17005851|NCT00952367|38149754|FG000|Overall Study|Withdrawal by Subject|2|||
17005852|NCT00952367|38149754|FG000|Overall Study|Noncoordination|1|||
17005853|NCT00952367|38149754|FG000|Overall Study|Protocol Violation|3|||
17005854|NCT00948857|38149760|FG000|Overall Study|Lost to Follow-up|1|||
17005855|NCT00948857|38149761|FG001|Overall Study|Lost to Follow-up|0|||
17005856|NCT00948389|38149776|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
17005857|NCT00948389|38149777|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
17005858|NCT00948389|38149778|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
17005859|NCT00948389|38149779|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
17005860|NCT00948389|38149780|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
17005861|NCT00948389|38149776|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
17005862|NCT00948389|38149777|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
17005863|NCT00948389|38149778|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
17005864|NCT00948389|38149779|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
17005865|NCT00948389|38149780|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
17005866|NCT00948389|38149776|FG000|Overall Study|Both Progression and Toxicity|1|||
17005867|NCT00948389|38149777|FG001|Overall Study|Both Progression and Toxicity|0|||
17005868|NCT00948389|38149778|FG002|Overall Study|Both Progression and Toxicity|0|||
17005869|NCT00948389|38149779|FG003|Overall Study|Both Progression and Toxicity|0|||
17005870|NCT00948389|38149780|FG004|Overall Study|Both Progression and Toxicity|0|||
17005871|NCT00948155|38149796|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
17005872|NCT00948155|38149797|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
17005873|NCT00948155|38149796|FG000|Washout 14 Days|Lost to Follow-up|1|||
17005874|NCT00948155|38149797|FG001|Washout 14 Days|Lost to Follow-up|2|||
17005875|NCT00958217|38149807|FG000|Overall Study|Death|2|||
17005876|NCT00958217|38149808|FG001|Overall Study|Death|1|||
17005877|NCT00958217|38149807|FG000|Overall Study|Withdrawal by Subject|4|||
17005878|NCT00958217|38149808|FG001|Overall Study|Withdrawal by Subject|3|||
17005879|NCT00958217|38149807|FG000|Overall Study|Lost to Follow-up|17|||
17005880|NCT00958217|38149808|FG001|Overall Study|Lost to Follow-up|19|||
17005881|NCT00958217|38149807|FG000|Overall Study|Moved out of area|1|||
17005882|NCT00958217|38149808|FG001|Overall Study|Moved out of area|1|||
17005883|NCT00958217|38149807|FG000|Overall Study|Inpatient hospitalization|0|||
17005884|NCT00958217|38149808|FG001|Overall Study|Inpatient hospitalization|1|||
17005885|NCT00891020|38149818|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
17005886|NCT00891020|38149819|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
17005887|NCT00891020|38149820|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
17005888|NCT00891020|38149818|FG000|24 Week Treatment Period|Death|0|||
17005889|NCT00891020|38149819|FG001|24 Week Treatment Period|Death|2|||
17005890|NCT00891020|38149820|FG002|24 Week Treatment Period|Death|0|||
17005891|NCT00891020|38149818|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
17005892|NCT00891020|38149819|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
16901442|NCT02119650|38007871|FG001|Overall Study|Physician Decision|2|||
16901443|NCT02119650|38007870|FG000|Overall Study|Multiple reasons for termination|2|||
16901444|NCT02119650|38007871|FG001|Overall Study|Multiple reasons for termination|1|||
16901445|NCT02119416|38007880|FG000|Overall Study|Protocol Violation|1|||
16901446|NCT02119416|38007881|FG001|Overall Study|Protocol Violation|1|||
16901447|NCT02119416|38007882|FG002|Overall Study|Protocol Violation|1|||
16901448|NCT02119416|38007880|FG000|Overall Study|wrong pubertal stage|1|||
16901449|NCT02119416|38007881|FG001|Overall Study|wrong pubertal stage|0|||
16901450|NCT02119416|38007882|FG002|Overall Study|wrong pubertal stage|1|||
16901451|NCT02140164|38007893|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
16901452|NCT02119260|38007904|FG000|Overall Study|Adverse Event|1|||
16901453|NCT02119260|38007905|FG001|Overall Study|Adverse Event|0|||
16901454|NCT02119260|38007906|FG002|Overall Study|Adverse Event|0|||
16901455|NCT02119260|38007907|FG003|Overall Study|Adverse Event|0|||
16901456|NCT02119260|38007908|FG004|Overall Study|Adverse Event|0|||
16901457|NCT02119260|38007909|FG005|Overall Study|Adverse Event|0|||
16901458|NCT02119260|38007910|FG006|Overall Study|Adverse Event|0|||
16901459|NCT02119260|38007904|FG000|Overall Study|Withdrew consent|0|||
16901460|NCT02119260|38007905|FG001|Overall Study|Withdrew consent|1|||
16901461|NCT02119260|38007906|FG002|Overall Study|Withdrew consent|1|||
16901462|NCT02119260|38007907|FG003|Overall Study|Withdrew consent|0|||
16901463|NCT02119260|38007908|FG004|Overall Study|Withdrew consent|0|||
16901464|NCT02119260|38007909|FG005|Overall Study|Withdrew consent|0|||
16901465|NCT02119260|38007910|FG006|Overall Study|Withdrew consent|0|||
16901466|NCT02119104|38007935|FG000|Overall Study|Protocol Violation|16|||
16901467|NCT02119026|38007941|FG000|1st-line Treatment|Adverse Event|9|||
16901468|NCT02119026|38007942|FG001|1st-line Treatment|Adverse Event|14|||
16901469|NCT02119026|38007941|FG000|1st-line Treatment|Physician Decision|3|||
16901470|NCT02119026|38007942|FG001|1st-line Treatment|Physician Decision|8|||
16901471|NCT02119026|38007941|FG000|1st-line Treatment|Withdrawal by Subject|4|||
16901472|NCT02119026|38007942|FG001|1st-line Treatment|Withdrawal by Subject|10|||
16901473|NCT02119026|38007941|FG000|1st-line Treatment|Patient condition or compliance|6|||
16901474|NCT02119026|38007942|FG001|1st-line Treatment|Patient condition or compliance|4|||
16901475|NCT02119026|38007941|FG000|1st-line Treatment|Surgery of metastases|2|||
16901476|NCT02119026|38007942|FG001|1st-line Treatment|Surgery of metastases|1|||
17005893|NCT00891020|38149820|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
17005894|NCT00891020|38149818|FG000|24 Week Treatment Period|Failure to return|4|||
17005895|NCT00891020|38149819|FG001|24 Week Treatment Period|Failure to return|5|||
17005896|NCT00891020|38149820|FG002|24 Week Treatment Period|Failure to return|5|||
16901477|NCT02119026|38007941|FG000|1st-line Treatment|Death|2|||
16901478|NCT02119026|38007942|FG001|1st-line Treatment|Death|1|||
16901479|NCT02119026|38007941|FG000|2nd-line Treatment|Lost to Follow-up|2|||
16901480|NCT02119026|38007942|FG001|2nd-line Treatment|Lost to Follow-up|0|||
16901481|NCT02119026|38007941|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
16901482|NCT02119026|38007942|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
16901483|NCT02119026|38007941|FG000|2nd-line Treatment|Adverse Event|4|||
16901484|NCT02119026|38007942|FG001|2nd-line Treatment|Adverse Event|1|||
16901485|NCT02095158|38007948|FG000|Overall Study|Adverse Event|14|||
16901486|NCT02095158|38007948|FG000|Overall Study|Lack of Efficacy|3|||
16901487|NCT02095158|38007948|FG000|Overall Study|Pregnancy|1|||
16901488|NCT02095158|38007948|FG000|Overall Study|Lost to Follow-up|20|||
16901489|NCT02095158|38007948|FG000|Overall Study|Personal Reasons|35|||
16901490|NCT02095158|38007948|FG000|Overall Study|Protocol Violation|1|||
16901491|NCT02095158|38007948|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16901492|NCT02094612|38007954|FG000|Overall Study|Lost to Follow-up|47|||
16901493|NCT02094612|38007955|FG001|Overall Study|Lost to Follow-up|47|||
16901494|NCT02094612|38007954|FG000|Overall Study|Never started ADHD medication|32|||
16901495|NCT02094612|38007955|FG001|Overall Study|Never started ADHD medication|23|||
16901496|NCT02139306|38007963|FG000|Overall Study|Withdrawal by Subject|4|||
16901497|NCT02139306|38007964|FG001|Overall Study|Withdrawal by Subject|6|||
16901498|NCT02139306|38007963|FG000|Overall Study|Adverse Event|3|||
16901499|NCT02139306|38007964|FG001|Overall Study|Adverse Event|4|||
16901500|NCT02139306|38007963|FG000|Overall Study|Physician Decision|0|||
16901501|NCT02139306|38007964|FG001|Overall Study|Physician Decision|1|||
16901502|NCT02139306|38007963|FG000|Overall Study|Other Unspecified|2|||
16901503|NCT02139306|38007964|FG001|Overall Study|Other Unspecified|3|||
16901504|NCT02139306|38007963|FG000|Overall Study|Protocol Violation|4|||
16901505|NCT02139306|38007964|FG001|Overall Study|Protocol Violation|0|||
17192612|NCT01338415|38345927|FG001|Core + Extension|Withdrawal by Subject|1|||
17192613|NCT01338415|38345928|FG002|Core + Extension|Withdrawal by Subject|0|||
17192614|NCT01338415|38345926|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
17192615|NCT01338415|38345927|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
17192616|NCT01338415|38345928|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
17192617|NCT01338415|38345926|FG000|Core + Extension|Other (administrative reason)|1|||
17192618|NCT01338415|38345927|FG001|Core + Extension|Other (administrative reason)|0|||
17192619|NCT01338415|38345928|FG002|Core + Extension|Other (administrative reason)|0|||
17192620|NCT01338415|38345926|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
17192621|NCT01338415|38345927|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
17192622|NCT01338415|38345928|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
17192623|NCT01338415|38345926|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
17192624|NCT01338415|38345927|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
17192625|NCT01338415|38345928|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
17192626|NCT01338415|38345926|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
17192627|NCT01338415|38345927|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
17192628|NCT01338415|38345928|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
16786208|NCT02690701|37726669|FG000|Treatment Period 2|Lack of Efficacy|1|||
16786209|NCT02690701|37726670|FG001|Treatment Period 2|Lack of Efficacy|0|||
16786210|NCT02690701|37726669|FG000|Treatment Period 2|Lost to Follow-up|0|||
16786211|NCT02690701|37726670|FG001|Treatment Period 2|Lost to Follow-up|2|||
16786212|NCT02690701|37726669|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17192629|NCT01338415|38345926|FG000|Exceptional Use Treatment Period|Death|0|||
17192630|NCT01338415|38345927|FG001|Exceptional Use Treatment Period|Death|0|||
17192631|NCT01338415|38345928|FG002|Exceptional Use Treatment Period|Death|1|||
17192632|NCT01371643|38345938|FG000|Overall Study|Withdrawal by Subject|3|||
17192633|NCT01371643|38345939|FG001|Overall Study|Withdrawal by Subject|0|||
17192634|NCT01371565|38345945|FG000|Overall Study|Withdrawal by Subject|1|||
17192635|NCT01371565|38345945|FG000|Overall Study|Death|1|||
17192636|NCT01371565|38345945|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
17192637|NCT02821819|38345953|FG000|Overall Study|Protocol Violation|1|||
17192638|NCT03926611|38345964|FG000|Overall Study|Adverse Event|0|||
17192639|NCT03926611|38345965|FG001|Overall Study|Adverse Event|0|||
17192640|NCT03926611|38345966|FG002|Overall Study|Adverse Event|0|||
17192641|NCT03926611|38345967|FG003|Overall Study|Adverse Event|3|||
17192642|NCT03926611|38345968|FG004|Overall Study|Adverse Event|1|||
17192643|NCT03926611|38345969|FG005|Overall Study|Adverse Event|3|||
17192644|NCT03926611|38345970|FG006|Overall Study|Adverse Event|0|||
17192645|NCT03926611|38345964|FG000|Overall Study|Lack of Efficacy|1|||
17192646|NCT03926611|38345965|FG001|Overall Study|Lack of Efficacy|2|||
17192647|NCT03926611|38345966|FG002|Overall Study|Lack of Efficacy|0|||
17192648|NCT03926611|38345967|FG003|Overall Study|Lack of Efficacy|0|||
17192649|NCT03926611|38345968|FG004|Overall Study|Lack of Efficacy|1|||
17192650|NCT03926611|38345969|FG005|Overall Study|Lack of Efficacy|0|||
17192651|NCT03926611|38345970|FG006|Overall Study|Lack of Efficacy|1|||
17192652|NCT03926611|38345964|FG000|Overall Study|Physician Decision|0|||
17192653|NCT03926611|38345965|FG001|Overall Study|Physician Decision|0|||
17192654|NCT03926611|38345966|FG002|Overall Study|Physician Decision|0|||
17192655|NCT03926611|38345967|FG003|Overall Study|Physician Decision|0|||
17192656|NCT03926611|38345968|FG004|Overall Study|Physician Decision|0|||
17192657|NCT03926611|38345969|FG005|Overall Study|Physician Decision|1|||
17192658|NCT03926611|38345970|FG006|Overall Study|Physician Decision|0|||
16901506|NCT02094300|38007971|FG000|Overall Study|Death|7|||
16901507|NCT02094300|38007971|FG000|Overall Study|Lost to Follow-up|10|||
16901508|NCT02094300|38007971|FG000|Overall Study|Still be eligible for follow-up|3|||
16901509|NCT02118792|38007977|FG000|Overall Study|Withdrawal by Subject|6|||
16901510|NCT02118792|38007978|FG001|Overall Study|Withdrawal by Subject|3|||
16901511|NCT02118792|38007977|FG000|Overall Study|Lost to Follow-up|4|||
16901512|NCT02118792|38007978|FG001|Overall Study|Lost to Follow-up|4|||
16901513|NCT02118792|38007977|FG000|Overall Study|Adverse Event|5|||
16901514|NCT02118792|38007978|FG001|Overall Study|Adverse Event|4|||
16901515|NCT02118792|38007977|FG000|Overall Study|Withdrawal by parent/guardian|14|||
16901516|NCT02118792|38007978|FG001|Overall Study|Withdrawal by parent/guardian|20|||
16901517|NCT02118792|38007977|FG000|Overall Study|Other|1|||
16901518|NCT02118792|38007978|FG001|Overall Study|Other|6|||
16901519|NCT02118792|38007977|FG000|Overall Study|Randomised but not treated|1|||
16901520|NCT02118792|38007978|FG001|Overall Study|Randomised but not treated|0|||
16901521|NCT02118714|38007986|FG000|Overall Study|Lost to Follow-up|2|||
16901522|NCT02118714|38007986|FG000|Overall Study|Protocol Violation|1|||
16901523|NCT02138916|38007993|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
16901524|NCT02138916|38007994|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
16901525|NCT02138916|38007995|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
16901526|NCT02138916|38007993|FG000|Overall Study|Death|14|||
16901527|NCT02138916|38007994|FG001|Overall Study|Death|11|||
16901528|NCT02138916|38007995|FG002|Overall Study|Death|12|||
16901529|NCT02138916|38007993|FG000|Overall Study|Withdrawal by Subject|27|||
16901530|NCT02138916|38007994|FG001|Overall Study|Withdrawal by Subject|31|||
16901531|NCT02138916|38007995|FG002|Overall Study|Withdrawal by Subject|32|||
16901532|NCT02138916|38007993|FG000|Overall Study|Study specific withdrawal criteria|0|||
16901533|NCT02138916|38007994|FG001|Overall Study|Study specific withdrawal criteria|0|||
16901534|NCT02138916|38007995|FG002|Overall Study|Study specific withdrawal criteria|1|||
16901535|NCT02138916|38007993|FG000|Overall Study|incorrect enrolment|1|||
16901536|NCT02138916|38007994|FG001|Overall Study|incorrect enrolment|1|||
16901537|NCT02138916|38007995|FG002|Overall Study|incorrect enrolment|0|||
16901538|NCT02138916|38007993|FG000|Overall Study|Severe non-compliance|1|||
16901539|NCT02138916|38007994|FG001|Overall Study|Severe non-compliance|2|||
16901540|NCT02138916|38007995|FG002|Overall Study|Severe non-compliance|1|||
16901541|NCT02138916|38007993|FG000|Overall Study|Lost to Follow-up|4|||
16901542|NCT02138916|38007994|FG001|Overall Study|Lost to Follow-up|2|||
16901543|NCT02138916|38007995|FG002|Overall Study|Lost to Follow-up|3|||
16901544|NCT02138916|38007993|FG000|Overall Study|Adverse Event|4|||
16901545|NCT02138916|38007994|FG001|Overall Study|Adverse Event|4|||
16901546|NCT02138916|38007995|FG002|Overall Study|Adverse Event|3|||
16901547|NCT02118012|38008005|FG000|Overall Study|Adverse Event|0|||
16901548|NCT02118012|38008006|FG001|Overall Study|Adverse Event|1|||
16901549|NCT02118012|38008005|FG000|Overall Study|Physician Decision|0|||
16901550|NCT02118012|38008006|FG001|Overall Study|Physician Decision|1|||
16901551|NCT02093520|38008014|FG000|Overall Study|Not treated|6|||
16901552|NCT02093520|38008015|FG001|Overall Study|Not treated|22|||
16901553|NCT02138838|38008023|FG000|Overall Study|Study Closure|7|||
16901554|NCT02138838|38008024|FG001|Overall Study|Study Closure|6|||
16901555|NCT02138838|38008023|FG000|Overall Study|Withdrawal by Subject|1|||
16901556|NCT02138838|38008024|FG001|Overall Study|Withdrawal by Subject|5|||
16901557|NCT02138214|38008033|FG000|Overall Study|Withdrawal by Subject|0|||
16901558|NCT02138214|38008034|FG001|Overall Study|Withdrawal by Subject|1|||
16901559|NCT02138214|38008035|FG002|Overall Study|Withdrawal by Subject|0|||
16901560|NCT02138214|38008033|FG000|Overall Study|Lost to Follow-up|0|||
17005897|NCT00891020|38149818|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
17005898|NCT00891020|38149819|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
17005899|NCT00891020|38149820|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
17005900|NCT00891020|38149818|FG000|24 Week Treatment Period|Other protocol violation|1|||
17005901|NCT00891020|38149819|FG001|24 Week Treatment Period|Other protocol violation|1|||
17005902|NCT00891020|38149820|FG002|24 Week Treatment Period|Other protocol violation|2|||
17005903|NCT00891020|38149818|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
17005904|NCT00891020|38149819|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
17005905|NCT00891020|38149820|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
17005906|NCT00891020|38149818|FG000|24 Week Treatment Period|Withdrew consent|6|||
17005907|NCT00891020|38149819|FG001|24 Week Treatment Period|Withdrew consent|3|||
17005908|NCT00891020|38149820|FG002|24 Week Treatment Period|Withdrew consent|15|||
17005909|NCT00891020|38149818|FG000|24 Week Treatment Period|Administrative/Other|5|||
17005910|NCT00891020|38149819|FG001|24 Week Treatment Period|Administrative/Other|6|||
17005911|NCT00891020|38149820|FG002|24 Week Treatment Period|Administrative/Other|1|||
17005912|NCT00891020|38149818|FG000|Long-term Extension Period|Adverse Event|1|||
17005913|NCT00891020|38149819|FG001|Long-term Extension Period|Adverse Event|11|||
17005914|NCT00891020|38149820|FG002|Long-term Extension Period|Adverse Event|10|||
17005915|NCT00891020|38149818|FG000|Long-term Extension Period|Death|0|||
16901561|NCT02138214|38008034|FG001|Overall Study|Lost to Follow-up|2|||
16901562|NCT02138214|38008035|FG002|Overall Study|Lost to Follow-up|4|||
17005916|NCT00891020|38149819|FG001|Long-term Extension Period|Death|0|||
17005917|NCT00891020|38149820|FG002|Long-term Extension Period|Death|1|||
16901563|NCT02138214|38008033|FG000|Overall Study|Screen Failure|0|||
16901564|NCT02138214|38008034|FG001|Overall Study|Screen Failure|1|||
16901565|NCT02138214|38008035|FG002|Overall Study|Screen Failure|0|||
16901566|NCT02092662|38008044|FG000|Overall Study|Lost to Follow-up|13|||
16901567|NCT02092662|38008045|FG001|Overall Study|Lost to Follow-up|0|||
16901568|NCT02092350|38008054|FG000|Overall Study|Adverse Event|0|||
16901569|NCT02092350|38008055|FG001|Overall Study|Adverse Event|3|||
16901570|NCT02092350|38008054|FG000|Overall Study|Death|2|||
16901571|NCT02092350|38008055|FG001|Overall Study|Death|5|||
16901572|NCT02092350|38008054|FG000|Overall Study|Lost to Follow-up|3|||
16901573|NCT02092350|38008055|FG001|Overall Study|Lost to Follow-up|1|||
16901574|NCT02092350|38008054|FG000|Overall Study|Protocol Violation|1|||
17192659|NCT03926611|38345964|FG000|Overall Study|Protocol Violation|1|||
17192660|NCT03926611|38345965|FG001|Overall Study|Protocol Violation|0|||
17192661|NCT03926611|38345966|FG002|Overall Study|Protocol Violation|0|||
17192662|NCT03926611|38345967|FG003|Overall Study|Protocol Violation|1|||
17192663|NCT03926611|38345968|FG004|Overall Study|Protocol Violation|1|||
17192664|NCT03926611|38345969|FG005|Overall Study|Protocol Violation|1|||
17192665|NCT03926611|38345970|FG006|Overall Study|Protocol Violation|1|||
17192666|NCT03926611|38345964|FG000|Overall Study|Technical problems|0|||
17192667|NCT03926611|38345965|FG001|Overall Study|Technical problems|0|||
17192668|NCT03926611|38345966|FG002|Overall Study|Technical problems|0|||
17192669|NCT03926611|38345967|FG003|Overall Study|Technical problems|0|||
17192670|NCT03926611|38345968|FG004|Overall Study|Technical problems|0|||
17192671|NCT03926611|38345969|FG005|Overall Study|Technical problems|1|||
17192672|NCT03926611|38345970|FG006|Overall Study|Technical problems|0|||
17192673|NCT03926611|38345964|FG000|Overall Study|Withdrawal by Subject|1|||
17192674|NCT03926611|38345965|FG001|Overall Study|Withdrawal by Subject|1|||
17005918|NCT00891020|38149818|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
17005919|NCT00891020|38149819|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
17005920|NCT00891020|38149820|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
17005921|NCT00891020|38149818|FG000|Long-term Extension Period|Protocol Violation|0|||
17005922|NCT00891020|38149819|FG001|Long-term Extension Period|Protocol Violation|1|||
17005923|NCT00891020|38149820|FG002|Long-term Extension Period|Protocol Violation|1|||
17005924|NCT00891020|38149818|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
17005925|NCT00891020|38149819|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
17005926|NCT00891020|38149820|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
17005927|NCT00891020|38149818|FG000|Long-term Extension Period|Failure to return|0|||
17005928|NCT00891020|38149819|FG001|Long-term Extension Period|Failure to return|2|||
17005929|NCT00891020|38149820|FG002|Long-term Extension Period|Failure to return|3|||
17005930|NCT00891020|38149818|FG000|Long-term Extension Period|Administrative|1|||
17192675|NCT03926611|38345966|FG002|Overall Study|Withdrawal by Subject|1|||
17192676|NCT03926611|38345967|FG003|Overall Study|Withdrawal by Subject|0|||
17192677|NCT03926611|38345968|FG004|Overall Study|Withdrawal by Subject|0|||
17192678|NCT03926611|38345969|FG005|Overall Study|Withdrawal by Subject|1|||
17192679|NCT03926611|38345970|FG006|Overall Study|Withdrawal by Subject|3|||
16901575|NCT02092350|38008055|FG001|Overall Study|Protocol Violation|0|||
16901576|NCT02092350|38008054|FG000|Overall Study|Physician Decision|1|||
16901577|NCT02092350|38008055|FG001|Overall Study|Physician Decision|1|||
16901578|NCT02092350|38008054|FG000|Overall Study|Screen Failure|1|||
16901579|NCT02092350|38008055|FG001|Overall Study|Screen Failure|0|||
16901580|NCT02092350|38008054|FG000|Overall Study|Withdrawal by Subject|2|||
16901581|NCT02092350|38008055|FG001|Overall Study|Withdrawal by Subject|2|||
16901582|NCT02117544|38008063|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
16901583|NCT02117544|38008064|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
16901584|NCT02138136|38008071|FG000|Overall Study|Protocol Violation|4|||
16901585|NCT02138136|38008071|FG000|Overall Study|Physician Decision|7|||
16901586|NCT02138136|38008071|FG000|Overall Study|Lack of Efficacy|35|||
16901587|NCT02138136|38008071|FG000|Overall Study|Pregnancy|2|||
16901588|NCT02138136|38008071|FG000|Overall Study|Adverse Event|18|||
16901589|NCT02138136|38008071|FG000|Overall Study|Withdrawal by Subject|36|||
16901590|NCT02138136|38008071|FG000|Overall Study|Lost to Follow-up|32|||
16901591|NCT02138136|38008071|FG000|Overall Study|Withdrawn by Sponsor|5|||
16901592|NCT01626690|38008078|FG000|Overall Study|Protocol Violation|1|||
16901593|NCT01626690|38008079|FG001|Overall Study|Protocol Violation|0|||
16901594|NCT01626690|38008078|FG000|Overall Study|Adverse Event|1|||
16901595|NCT01626690|38008079|FG001|Overall Study|Adverse Event|0|||
16901596|NCT01626456|38008089|FG000|Overall Study|Withdrawal by Subject|21|||
16901597|NCT01626456|38008090|FG001|Overall Study|Withdrawal by Subject|46|||
16901598|NCT01626456|38008089|FG000|Overall Study|Adverse Event|2|||
16901599|NCT01626456|38008090|FG001|Overall Study|Adverse Event|27|||
16901600|NCT01626456|38008089|FG000|Overall Study|Lost to Follow-up|2|||
16901601|NCT01626456|38008090|FG001|Overall Study|Lost to Follow-up|27|||
17192680|NCT03926611|38345964|FG000|Overall Study|Covid-19 pandemic|0|||
17192681|NCT03926611|38345965|FG001|Overall Study|Covid-19 pandemic|0|||
16901602|NCT01626456|38008089|FG000|Overall Study|Lack of Efficacy|6|||
16901603|NCT01626456|38008090|FG001|Overall Study|Lack of Efficacy|7|||
16901604|NCT01626456|38008089|FG000|Overall Study|Physician Decision|1|||
16901605|NCT01626456|38008090|FG001|Overall Study|Physician Decision|4|||
16901606|NCT01626456|38008089|FG000|Overall Study|Protocol Violation|1|||
16901607|NCT01626456|38008090|FG001|Overall Study|Protocol Violation|1|||
16901608|NCT01626456|38008089|FG000|Overall Study|Site Closure|2|||
16901609|NCT01626456|38008090|FG001|Overall Study|Site Closure|3|||
16901610|NCT01626456|38008089|FG000|Overall Study|Incarceration|0|||
16901611|NCT01626456|38008090|FG001|Overall Study|Incarceration|2|||
16901612|NCT02116608|38008108|FG000|Overall Study|Lost to Follow-up|0|||
16901613|NCT02116608|38008109|FG001|Overall Study|Lost to Follow-up|0|||
16901614|NCT02116608|38008110|FG002|Overall Study|Lost to Follow-up|1|||
16901615|NCT02116608|38008108|FG000|Overall Study|Physician Decision|0|||
16901616|NCT02116608|38008109|FG001|Overall Study|Physician Decision|1|||
16901617|NCT02116608|38008110|FG002|Overall Study|Physician Decision|0|||
16901618|NCT02116608|38008108|FG000|Overall Study|Death|0|||
16901619|NCT02116608|38008109|FG001|Overall Study|Death|1|||
16901620|NCT02116608|38008110|FG002|Overall Study|Death|0|||
16901621|NCT02092116|38008120|FG000|Overall Study|Withdrawal by Subject|0|||
17005931|NCT00891020|38149819|FG001|Long-term Extension Period|Administrative|2|||
17005932|NCT00891020|38149820|FG002|Long-term Extension Period|Administrative|2|||
17005933|NCT00611455|38149832|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
17005934|NCT00611455|38149833|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
17005935|NCT00611455|38149834|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
17005936|NCT00611455|38149832|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
17005937|NCT00611455|38149833|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
17005938|NCT00611455|38149834|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
17005939|NCT00611455|38149832|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
17005940|NCT00611455|38149833|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
17005941|NCT00611455|38149834|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
17005942|NCT00611455|38149832|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
17005943|NCT00611455|38149833|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
17005944|NCT00611455|38149834|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
17005945|NCT00611455|38149832|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
17005946|NCT00611455|38149833|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
17005947|NCT00611455|38149834|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
17005948|NCT00611455|38149832|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
17005949|NCT00611455|38149833|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
17005950|NCT00611455|38149834|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
17005951|NCT00611455|38149832|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
17005952|NCT00611455|38149833|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
16901622|NCT02092116|38008121|FG001|Overall Study|Withdrawal by Subject|3|||
16901623|NCT02092116|38008120|FG000|Overall Study|Adverse Event|0|||
16901624|NCT02092116|38008121|FG001|Overall Study|Adverse Event|1|||
16901625|NCT02091726|38008127|FG000|Overall Study|Lost to Follow-up|6|||
16901626|NCT02091414|38008131|FG000|Overall Study|Withdrawal by Subject|2|||
16901627|NCT02091414|38008131|FG000|Overall Study|Death|2|||
16901628|NCT02116530|38008137|FG000|Overall Study|Withdrawal by Subject|1|||
16901629|NCT02116530|38008138|FG001|Overall Study|Withdrawal by Subject|2|||
16901630|NCT02116530|38008137|FG000|Overall Study|Adverse Event|4|||
16901631|NCT02116530|38008138|FG001|Overall Study|Adverse Event|0|||
16901632|NCT02116530|38008137|FG000|Overall Study|Physician Decision|1|||
16901633|NCT02116530|38008138|FG001|Overall Study|Physician Decision|0|||
16901634|NCT02116530|38008137|FG000|Overall Study|Lost to Follow-up|1|||
16901635|NCT02116530|38008138|FG001|Overall Study|Lost to Follow-up|0|||
16901636|NCT02116530|38008137|FG000|Overall Study|Other Medical Problems|2|||
16901637|NCT02116530|38008138|FG001|Overall Study|Other Medical Problems|2|||
16901638|NCT02072226|38008146|FG000|Overall Study|Lost to Follow-up|11|||
16901639|NCT02072226|38008147|FG001|Overall Study|Lost to Follow-up|7|||
16901640|NCT02072226|38008146|FG000|Overall Study|Patient Non-compliance|2|||
16901641|NCT02072226|38008147|FG001|Overall Study|Patient Non-compliance|3|||
16901642|NCT02072226|38008146|FG000|Overall Study|Death|1|||
16901643|NCT02072226|38008147|FG001|Overall Study|Death|0|||
16901644|NCT02072226|38008146|FG000|Overall Study|Patient Withdrawal of Consent|1|||
16901645|NCT02072226|38008147|FG001|Overall Study|Patient Withdrawal of Consent|0|||
16901646|NCT02071290|38008155|FG000|Overall Study|Death|1|||
16901647|NCT02071290|38008156|FG001|Overall Study|Death|0|||
16901648|NCT02071290|38008155|FG000|Overall Study|Withdrawal by Subject|0|||
16901649|NCT02071290|38008156|FG001|Overall Study|Withdrawal by Subject|1|||
16901650|NCT02071290|38008155|FG000|Overall Study|Protocol Violation|3|||
16901651|NCT02071290|38008156|FG001|Overall Study|Protocol Violation|5|||
16901652|NCT02071290|38008155|FG000|Overall Study|Physician Decision|0|||
16901653|NCT02071290|38008156|FG001|Overall Study|Physician Decision|1|||
16901654|NCT02090634|38008164|FG000|Overall Study|Lost to Follow-up|0|||
16901655|NCT02090634|38008165|FG001|Overall Study|Lost to Follow-up|1|||
16901656|NCT02090634|38008164|FG000|Overall Study|Death|0|||
16901657|NCT02090634|38008165|FG001|Overall Study|Death|1|||
16901658|NCT02090634|38008164|FG000|Overall Study|Protocol Violation|3|||
16901659|NCT02090634|38008165|FG001|Overall Study|Protocol Violation|1|||
16901660|NCT02090634|38008164|FG000|Overall Study|Adverse Event|2|||
16901661|NCT02090634|38008165|FG001|Overall Study|Adverse Event|0|||
16901662|NCT02115282|38008173|FG000|Overall Study|Disease progression during treatment|216|||
16901663|NCT02115282|38008174|FG001|Overall Study|Disease progression during treatment|229|||
16901664|NCT02115282|38008173|FG000|Overall Study|Adverse Event|49|||
16901665|NCT02115282|38008174|FG001|Overall Study|Adverse Event|23|||
16901666|NCT02115282|38008173|FG000|Overall Study|Death|1|||
16901667|NCT02115282|38008174|FG001|Overall Study|Death|3|||
16901668|NCT02115282|38008173|FG000|Overall Study|Alternative therapy|1|||
16901669|NCT02115282|38008174|FG001|Overall Study|Alternative therapy|1|||
16901670|NCT02115282|38008173|FG000|Overall Study|Complicating disease|0|||
16901671|NCT02115282|38008174|FG001|Overall Study|Complicating disease|3|||
16901672|NCT02115282|38008173|FG000|Overall Study|Withdrawal by Subject|12|||
16901673|NCT02115282|38008174|FG001|Overall Study|Withdrawal by Subject|10|||
16901674|NCT02115282|38008173|FG000|Overall Study|Symptomatic progression/deterioration|7|||
16901675|NCT02115282|38008174|FG001|Overall Study|Symptomatic progression/deterioration|18|||
16901676|NCT02115282|38008173|FG000|Overall Study|Non-compliance|5|||
16901677|NCT02115282|38008174|FG001|Overall Study|Non-compliance|1|||
16901678|NCT02115282|38008173|FG000|Overall Study|Protocol Violation|2|||
16901679|NCT02115282|38008174|FG001|Overall Study|Protocol Violation|2|||
16901680|NCT02115282|38008173|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
16901681|NCT02115282|38008174|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
16901682|NCT02115282|38008173|FG000|Overall Study|Not start protocol therapy|9|||
16901683|NCT02115282|38008174|FG001|Overall Study|Not start protocol therapy|10|||
16901684|NCT02114892|38008184|FG000|Overall Study|Lost to Follow-up|1|||
16901685|NCT02114892|38008185|FG001|Overall Study|Lost to Follow-up|2|||
16901686|NCT02070978|38008194|FG000|Overall Study|Adverse Event|6|||
16901687|NCT02070978|38008195|FG001|Overall Study|Adverse Event|2|||
16901688|NCT02070978|38008196|FG002|Overall Study|Adverse Event|0|||
16901689|NCT02070978|38008194|FG000|Overall Study|Lost to Follow-up|1|||
16901690|NCT02070978|38008195|FG001|Overall Study|Lost to Follow-up|3|||
16901691|NCT02070978|38008196|FG002|Overall Study|Lost to Follow-up|4|||
16901692|NCT02070978|38008194|FG000|Overall Study|Withdrawal by Subject|3|||
16901693|NCT02070978|38008195|FG001|Overall Study|Withdrawal by Subject|5|||
16901694|NCT02070978|38008196|FG002|Overall Study|Withdrawal by Subject|3|||
16901695|NCT02070978|38008194|FG000|Overall Study|Protocol Violation|1|||
16901696|NCT02070978|38008195|FG001|Overall Study|Protocol Violation|0|||
16901697|NCT02070978|38008196|FG002|Overall Study|Protocol Violation|3|||
16901698|NCT02070978|38008194|FG000|Overall Study|Lack of Efficacy|0|||
16901699|NCT02070978|38008195|FG001|Overall Study|Lack of Efficacy|1|||
16901700|NCT02070978|38008196|FG002|Overall Study|Lack of Efficacy|0|||
16901701|NCT02070978|38008194|FG000|Overall Study|Death|0|||
16901702|NCT02070978|38008195|FG001|Overall Study|Death|0|||
16901703|NCT02070978|38008196|FG002|Overall Study|Death|2|||
16901704|NCT02070978|38008194|FG000|Overall Study|Un-specified|3|||
16901705|NCT02070978|38008195|FG001|Overall Study|Un-specified|2|||
16901706|NCT02070978|38008196|FG002|Overall Study|Un-specified|2|||
16901707|NCT02070978|38008194|FG000|Overall Study|Terminated by Sponsor|33|||
16901708|NCT02070978|38008195|FG001|Overall Study|Terminated by Sponsor|40|||
16901709|NCT02070978|38008196|FG002|Overall Study|Terminated by Sponsor|39|||
16901710|NCT02114268|38008210|FG000|Overall Study|Lost to Follow-up|4|||
16901711|NCT02114268|38008211|FG001|Overall Study|Lost to Follow-up|1|||
16901712|NCT02114268|38008212|FG002|Overall Study|Lost to Follow-up|1|||
16901713|NCT02114268|38008213|FG003|Overall Study|Lost to Follow-up|0|||
16901714|NCT02114268|38008214|FG004|Overall Study|Lost to Follow-up|0|||
16901715|NCT02114268|38008215|FG005|Overall Study|Lost to Follow-up|2|||
16901716|NCT02114268|38008210|FG000|Overall Study|Withdrawal by Subject|1|||
16901717|NCT02114268|38008211|FG001|Overall Study|Withdrawal by Subject|0|||
16901718|NCT02114268|38008212|FG002|Overall Study|Withdrawal by Subject|0|||
16901719|NCT02114268|38008213|FG003|Overall Study|Withdrawal by Subject|0|||
16901720|NCT02114268|38008214|FG004|Overall Study|Withdrawal by Subject|0|||
16901721|NCT02114268|38008215|FG005|Overall Study|Withdrawal by Subject|1|||
16901722|NCT02114268|38008210|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
16901723|NCT02114268|38008211|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
16901724|NCT02114268|38008212|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
16901725|NCT02114268|38008213|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
16901726|NCT02114268|38008214|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
16901727|NCT02114268|38008215|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
16901728|NCT02089230|38008237|FG000|Overall Study|Death|0|||
16901729|NCT02089230|38008238|FG001|Overall Study|Death|0|||
16901730|NCT02089230|38008239|FG002|Overall Study|Death|2|||
16901731|NCT02089230|38008237|FG000|Overall Study|Seeking Alternative Therapy|0|||
16901732|NCT02089230|38008238|FG001|Overall Study|Seeking Alternative Therapy|0|||
16901733|NCT02089230|38008239|FG002|Overall Study|Seeking Alternative Therapy|4|||
16901734|NCT02070744|38008251|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
16901735|NCT02070744|38008252|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
16901736|NCT02070744|38008253|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
16901737|NCT02070744|38008254|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
16901738|NCT02070744|38008255|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
16901739|NCT02070744|38008251|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
16901740|NCT02070744|38008252|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
16901741|NCT02070744|38008253|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
16901742|NCT02070744|38008254|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
16901743|NCT02070744|38008255|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
16901744|NCT02070744|38008251|FG000|OLE Phase (48 Weeks)|Other|0|||
16901745|NCT02070744|38008252|FG001|OLE Phase (48 Weeks)|Other|0|||
16901746|NCT02070744|38008253|FG002|OLE Phase (48 Weeks)|Other|0|||
16901747|NCT02070744|38008254|FG003|OLE Phase (48 Weeks)|Other|0|||
16901748|NCT02070744|38008255|FG004|OLE Phase (48 Weeks)|Other|1|||
16901749|NCT02113956|38008272|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
16901750|NCT02113956|38008273|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
16901751|NCT02113956|38008272|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
16901752|NCT02113956|38008273|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
16901753|NCT02113956|38008272|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
16901754|NCT02113956|38008273|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
16901755|NCT02070588|38008282|FG000|Overall Study|Withdrawal by Subject|29|||
16901756|NCT02070588|38008283|FG001|Overall Study|Withdrawal by Subject|1|||
16901757|NCT02070588|38008284|FG002|Overall Study|Withdrawal by Subject|0|||
16901758|NCT02070588|38008282|FG000|Overall Study|Writhdrawal due to early termination|9|||
16901759|NCT02070588|38008283|FG001|Overall Study|Writhdrawal due to early termination|0|||
16901760|NCT02070588|38008284|FG002|Overall Study|Writhdrawal due to early termination|0|||
16901761|NCT02070588|38008282|FG000|Overall Study|Adverse Event|1|||
16901762|NCT02070588|38008283|FG001|Overall Study|Adverse Event|0|||
16901763|NCT02070588|38008284|FG002|Overall Study|Adverse Event|0|||
16901764|NCT02111850|38008303|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901765|NCT02111850|38008304|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901766|NCT02111850|38008305|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901767|NCT02111850|38008306|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901768|NCT02111850|38008307|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
16901769|NCT02111850|38008308|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901770|NCT02111850|38008309|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901771|NCT02111850|38008310|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901772|NCT02111850|38008311|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901773|NCT02111850|38008312|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901774|NCT02111850|38008313|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16901775|NCT02087904|38008343|FG000|Overall Study|Did Not Receive Study Drug|0|||
16901776|NCT02087904|38008344|FG001|Overall Study|Did Not Receive Study Drug|0|||
16901777|NCT02087904|38008345|FG002|Overall Study|Did Not Receive Study Drug|2|||
16901778|NCT02087904|38008346|FG003|Overall Study|Did Not Receive Study Drug|1|||
16901779|NCT02087904|38008343|FG000|Overall Study|Adverse Event|8|||
16901780|NCT02087904|38008344|FG001|Overall Study|Adverse Event|4|||
16901781|NCT02087904|38008345|FG002|Overall Study|Adverse Event|4|||
16901782|NCT02087904|38008346|FG003|Overall Study|Adverse Event|12|||
16901783|NCT02087904|38008343|FG000|Overall Study|Lack of Efficacy|3|||
16901784|NCT02087904|38008344|FG001|Overall Study|Lack of Efficacy|6|||
16901785|NCT02087904|38008345|FG002|Overall Study|Lack of Efficacy|3|||
16901786|NCT02087904|38008346|FG003|Overall Study|Lack of Efficacy|2|||
16901787|NCT02087904|38008343|FG000|Overall Study|Other|6|||
16901788|NCT02087904|38008344|FG001|Overall Study|Other|2|||
16901789|NCT02087904|38008345|FG002|Overall Study|Other|4|||
16901790|NCT02087904|38008346|FG003|Overall Study|Other|4|||
16901791|NCT02087904|38008343|FG000|Overall Study|Withdrawal by Subject|8|||
16901792|NCT02087904|38008344|FG001|Overall Study|Withdrawal by Subject|3|||
16901793|NCT02087904|38008345|FG002|Overall Study|Withdrawal by Subject|7|||
16901794|NCT02087904|38008346|FG003|Overall Study|Withdrawal by Subject|4|||
16901795|NCT02087904|38008343|FG000|Overall Study|Lost to Follow-up|0|||
16901796|NCT02087904|38008344|FG001|Overall Study|Lost to Follow-up|4|||
16901797|NCT02087904|38008345|FG002|Overall Study|Lost to Follow-up|2|||
16901798|NCT02087904|38008346|FG003|Overall Study|Lost to Follow-up|2|||
16901799|NCT02087670|38008358|FG000|Overall Study|Withdrawal by Subject|3|||
16901800|NCT02087670|38008359|FG001|Overall Study|Withdrawal by Subject|2|||
16901801|NCT02087046|38008365|FG000|Overall Study|Adverse Event|4|||
16901802|NCT02087046|38008365|FG000|Overall Study|Death|1|||
16901803|NCT02087046|38008365|FG000|Overall Study|Lost to Follow-up|3|||
16901804|NCT02087046|38008365|FG000|Overall Study|Withdrawal by Subject|2|||
16901805|NCT02087046|38008365|FG000|Overall Study|Physician Decision|1|||
16901806|NCT02086968|38008372|FG000|Overall Study|Adverse Event|1|||
16901807|NCT02086968|38008373|FG001|Overall Study|Adverse Event|5|||
16901808|NCT02086968|38008372|FG000|Overall Study|Lost to Follow-up|2|||
16901809|NCT02086968|38008373|FG001|Overall Study|Lost to Follow-up|3|||
16901810|NCT02086968|38008372|FG000|Overall Study|Study drug received outside protocol|0|||
16901811|NCT02086968|38008373|FG001|Overall Study|Study drug received outside protocol|1|||
16901812|NCT02086968|38008372|FG000|Overall Study|Physician Decision|4|||
16901813|NCT02086968|38008373|FG001|Overall Study|Physician Decision|0|||
16901814|NCT02086968|38008372|FG000|Overall Study|Withdrawal by Subject|1|||
16901815|NCT02086968|38008373|FG001|Overall Study|Withdrawal by Subject|4|||
16901816|NCT02086110|38008381|FG000|Overall Study|Withdrawal by Subject|1|||
16901817|NCT02086110|38008382|FG001|Overall Study|Withdrawal by Subject|1|||
16901818|NCT02085252|38008391|FG000|Overall Study|Withdrawal of Consent|1|||
16901819|NCT02085252|38008392|FG001|Overall Study|Withdrawal of Consent|0|||
16901820|NCT02085252|38008391|FG000|Overall Study|Adverse Event|0|||
16901821|NCT02085252|38008392|FG001|Overall Study|Adverse Event|1|||
16901822|NCT02085252|38008391|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
16901823|NCT02085252|38008392|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
16901824|NCT02085252|38008391|FG000|Overall Study|Reason Not Specified|0|||
16901825|NCT02085252|38008392|FG001|Overall Study|Reason Not Specified|1|||
16901826|NCT02085252|38008391|FG000|Overall Study|Reason Unknown|0|||
16901827|NCT02085252|38008392|FG001|Overall Study|Reason Unknown|1|||
16901828|NCT02084238|38008398|FG000|Overall Study|Lost to Follow-up|2|||
16901829|NCT02084082|38008411|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
16901830|NCT02084082|38008412|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
16901831|NCT02084082|38008413|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
16901832|NCT02084082|38008414|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
16901833|NCT02084082|38008411|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16901834|NCT02084082|38008412|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16901835|NCT02084082|38008413|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16901836|NCT02084082|38008414|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
16901837|NCT02083926|38008426|FG000|Overall Study|Withdrawal by Subject|1|||
16901838|NCT02083926|38008427|FG001|Overall Study|Withdrawal by Subject|0|||
16901839|NCT02083380|38008437|FG000|Overall Study|Lack of Efficacy|68|||
16901840|NCT02083380|38008438|FG001|Overall Study|Lack of Efficacy|79|||
16901841|NCT02083380|38008439|FG002|Overall Study|Lack of Efficacy|64|||
16901842|NCT02083380|38008437|FG000|Overall Study|Withdrawal by Subject|9|||
16901843|NCT02083380|38008438|FG001|Overall Study|Withdrawal by Subject|3|||
16901844|NCT02083380|38008439|FG002|Overall Study|Withdrawal by Subject|7|||
16901845|NCT02083380|38008437|FG000|Overall Study|Physician Decision|1|||
16901846|NCT02083380|38008438|FG001|Overall Study|Physician Decision|6|||
16901847|NCT02083380|38008439|FG002|Overall Study|Physician Decision|3|||
16901848|NCT02083380|38008437|FG000|Overall Study|Adverse Event|0|||
16901849|NCT02083380|38008438|FG001|Overall Study|Adverse Event|0|||
16901850|NCT02083380|38008439|FG002|Overall Study|Adverse Event|1|||
16901851|NCT02083380|38008437|FG000|Overall Study|Lost to Follow-up|5|||
16901852|NCT02083380|38008438|FG001|Overall Study|Lost to Follow-up|3|||
16901853|NCT02083380|38008439|FG002|Overall Study|Lost to Follow-up|3|||
16901854|NCT02083380|38008437|FG000|Overall Study|Other|8|||
16901855|NCT02083380|38008438|FG001|Overall Study|Other|4|||
16901856|NCT02083380|38008439|FG002|Overall Study|Other|6|||
16901857|NCT02109744|38008454|FG000|Overall Study|Death|1|||
16901858|NCT02109744|38008455|FG001|Overall Study|Death|1|||
16901859|NCT02109744|38008454|FG000|Overall Study|no marrow exam|1|||
16901860|NCT02109744|38008455|FG001|Overall Study|no marrow exam|0|||
16901861|NCT02109432|38008461|FG000|Overall Study|Withdrawal by Subject|1|||
17005953|NCT00611455|38149834|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
17005954|NCT00611455|38149832|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
17005955|NCT00611455|38149833|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
17005956|NCT00611455|38149834|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
17005957|NCT00611455|38149832|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
17005958|NCT00611455|38149833|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
17005959|NCT00611455|38149834|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
17005960|NCT00611455|38149832|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
17005961|NCT00611455|38149833|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
17005962|NCT00611455|38149834|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
17005963|NCT00611455|38149832|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
17095548|NCT00259610|38234816|FG000|Overall Study|Lost to Follow-up|19|||
16901862|NCT02109042|38008465|FG000|Overall Study|Sponsor Decision|15|||
16901863|NCT02066922|38008470|FG000|Overall Study|Adverse Event|1|||
16901864|NCT02108964|38008485|FG000|Overall Study|Progressive disease|12|||
16901865|NCT02108964|38008486|FG001|Overall Study|Progressive disease|25|||
16901866|NCT02108964|38008487|FG002|Overall Study|Progressive disease|50|||
16901867|NCT02108964|38008488|FG003|Overall Study|Progressive disease|6|||
17005964|NCT00611455|38149833|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
17005965|NCT00611455|38149834|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
17005966|NCT00611455|38149832|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
17005967|NCT00611455|38149833|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
17005968|NCT00611455|38149834|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
17005969|NCT00611455|38149832|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
17005970|NCT00611455|38149833|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
17005971|NCT00611455|38149834|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
17005972|NCT00611455|38149832|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
17005973|NCT00611455|38149833|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
17005974|NCT00611455|38149834|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
17005975|NCT00611455|38149832|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
17005976|NCT00611455|38149833|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
17005977|NCT00611455|38149834|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
17005978|NCT00611455|38149832|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
17005979|NCT00611455|38149833|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
17005980|NCT00611455|38149834|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
17005981|NCT00611455|38149832|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
17005982|NCT00611455|38149833|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
17005983|NCT00611455|38149834|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
17005984|NCT00611455|38149832|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
17005985|NCT00611455|38149833|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
17005986|NCT00611455|38149834|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
17005987|NCT00611455|38149832|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
17005988|NCT00611455|38149833|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
17005989|NCT00611455|38149834|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
17005990|NCT00611455|38149832|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
17005991|NCT00611455|38149833|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
17005992|NCT00611455|38149834|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
17005993|NCT00611455|38149832|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
17005994|NCT00611455|38149833|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
17005995|NCT00611455|38149834|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
17005996|NCT00952289|38149846|FG000|All Participants|Death|9|||
16901868|NCT02108964|38008489|FG004|Overall Study|Progressive disease|18|||
16901869|NCT02108964|38008490|FG005|Overall Study|Progressive disease|5|||
16901870|NCT02108964|38008491|FG006|Overall Study|Progressive disease|7|||
16901871|NCT02108964|38008492|FG007|Overall Study|Progressive disease|9|||
16901872|NCT02108964|38008485|FG000|Overall Study|Physician Decision|1|||
16901873|NCT02108964|38008486|FG001|Overall Study|Physician Decision|5|||
16901874|NCT02108964|38008487|FG002|Overall Study|Physician Decision|6|||
16901875|NCT02108964|38008488|FG003|Overall Study|Physician Decision|0|||
16901876|NCT02108964|38008489|FG004|Overall Study|Physician Decision|1|||
16901877|NCT02108964|38008490|FG005|Overall Study|Physician Decision|0|||
16901878|NCT02108964|38008491|FG006|Overall Study|Physician Decision|0|||
16901879|NCT02108964|38008492|FG007|Overall Study|Physician Decision|0|||
16901880|NCT02108964|38008485|FG000|Overall Study|Adverse Event|0|||
16901881|NCT02108964|38008486|FG001|Overall Study|Adverse Event|0|||
16901882|NCT02108964|38008487|FG002|Overall Study|Adverse Event|4|||
16901883|NCT02108964|38008488|FG003|Overall Study|Adverse Event|0|||
16901884|NCT02108964|38008489|FG004|Overall Study|Adverse Event|1|||
16901885|NCT02108964|38008490|FG005|Overall Study|Adverse Event|0|||
16901886|NCT02108964|38008491|FG006|Overall Study|Adverse Event|3|||
16901887|NCT02108964|38008492|FG007|Overall Study|Adverse Event|1|||
16901888|NCT02108964|38008485|FG000|Overall Study|Death|1|||
17005997|NCT00952289|38149847|FG001|All Participants|Death|9|||
17005998|NCT00952289|38149846|FG000|All Participants|Adverse Event|8|||
17005999|NCT00952289|38149847|FG001|All Participants|Adverse Event|8|||
17006000|NCT00952289|38149846|FG000|All Participants|Disease progression|3|||
17006001|NCT00952289|38149847|FG001|All Participants|Disease progression|12|||
17006002|NCT00952289|38149846|FG000|All Participants|Withdrawal by Subject|1|||
17006003|NCT00952289|38149847|FG001|All Participants|Withdrawal by Subject|10|||
17006004|NCT00952289|38149846|FG000|All Participants|Data lost during site relocation|0|||
17006005|NCT00952289|38149847|FG001|All Participants|Data lost during site relocation|1|||
17006006|NCT00952289|38149846|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
17006007|NCT00952289|38149847|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
17006008|NCT00952289|38149846|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
17006009|NCT00952289|38149847|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
16901889|NCT02108964|38008486|FG001|Overall Study|Death|1|||
16901890|NCT02108964|38008487|FG002|Overall Study|Death|2|||
16901891|NCT02108964|38008488|FG003|Overall Study|Death|0|||
17006010|NCT00952289|38149846|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
17006011|NCT00952289|38149847|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
17006012|NCT00952289|38149846|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
17006013|NCT00952289|38149847|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
17006014|NCT00952289|38149846|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
17006015|NCT00952289|38149847|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
17006016|NCT00947531|38149855|FG000|Overall Study|Withdrawal by Subject|10|||
17006017|NCT00947531|38149856|FG001|Overall Study|Withdrawal by Subject|7|||
17006018|NCT00947531|38149855|FG000|Overall Study|Administrative Reason|0|||
17006019|NCT00947531|38149856|FG001|Overall Study|Administrative Reason|1|||
17006020|NCT00947531|38149855|FG000|Overall Study|Adverse Event|2|||
17006021|NCT00947531|38149856|FG001|Overall Study|Adverse Event|2|||
17006022|NCT00947531|38149855|FG000|Overall Study|Lack of Efficacy|1|||
17006023|NCT00947531|38149856|FG001|Overall Study|Lack of Efficacy|0|||
17006024|NCT00947531|38149855|FG000|Overall Study|Other|1|||
17006025|NCT00947531|38149856|FG001|Overall Study|Other|1|||
17006026|NCT00612313|38149864|FG000|Overall Study|Withdrawal by Subject|6|||
17006027|NCT00612313|38149865|FG001|Overall Study|Withdrawal by Subject|9|||
17006028|NCT00612313|38149864|FG000|Overall Study|Lost to Follow-up|11|||
17006029|NCT00612313|38149865|FG001|Overall Study|Lost to Follow-up|4|||
17006030|NCT00890552|38149877|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
17006031|NCT00890552|38149877|FG000|On-treatment|Early prog disease/ death|10|||
17006032|NCT00946985|38149881|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
17006033|NCT00946985|38149881|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
17006034|NCT00946985|38149881|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
17006035|NCT00946985|38149881|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
17006036|NCT00946985|38149881|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
17006037|NCT00946985|38149881|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
17006038|NCT00946985|38149881|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
17006039|NCT00946985|38149881|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
17006040|NCT00946985|38149881|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
17006041|NCT00611923|38149887|FG000|Overall Study|Withdrawal by Subject|2|||
17006042|NCT00611923|38149888|FG001|Overall Study|Withdrawal by Subject|2|||
17006043|NCT00609973|38149898|FG000|Overall Study|Adverse Event|2|||
17006044|NCT00609973|38149899|FG001|Overall Study|Adverse Event|1|||
17006045|NCT00609973|38149898|FG000|Overall Study|Protocol Violation|4|||
17006046|NCT00609973|38149899|FG001|Overall Study|Protocol Violation|3|||
17006047|NCT00609973|38149898|FG000|Overall Study|Lost to Follow-up|2|||
17006048|NCT00609973|38149899|FG001|Overall Study|Lost to Follow-up|1|||
17006049|NCT00609973|38149898|FG000|Overall Study|Withdrawal by Subject|0|||
17006050|NCT00609973|38149899|FG001|Overall Study|Withdrawal by Subject|1|||
17006051|NCT00803049|38149909|FG000|Overall Study|Adverse Event|21|||
17006052|NCT00803049|38149910|FG001|Overall Study|Adverse Event|33|||
17006053|NCT00803049|38149911|FG002|Overall Study|Adverse Event|13|||
17006054|NCT00803049|38149912|FG003|Overall Study|Adverse Event|27|||
17006055|NCT00803049|38149909|FG000|Overall Study|Lack of Efficacy|10|||
17006056|NCT00803049|38149910|FG001|Overall Study|Lack of Efficacy|19|||
17006057|NCT00803049|38149911|FG002|Overall Study|Lack of Efficacy|6|||
17006058|NCT00803049|38149912|FG003|Overall Study|Lack of Efficacy|13|||
17006059|NCT00803049|38149909|FG000|Overall Study|Lost to Follow-up|0|||
17006060|NCT00803049|38149910|FG001|Overall Study|Lost to Follow-up|2|||
17006061|NCT00803049|38149911|FG002|Overall Study|Lost to Follow-up|0|||
17006062|NCT00803049|38149912|FG003|Overall Study|Lost to Follow-up|3|||
17006063|NCT00803049|38149909|FG000|Overall Study|Death|2|||
17006064|NCT00803049|38149910|FG001|Overall Study|Death|1|||
17006065|NCT00803049|38149911|FG002|Overall Study|Death|0|||
17006066|NCT00803049|38149912|FG003|Overall Study|Death|2|||
16901892|NCT02108964|38008489|FG004|Overall Study|Death|3|||
16901893|NCT02108964|38008490|FG005|Overall Study|Death|0|||
16901894|NCT02108964|38008491|FG006|Overall Study|Death|0|||
16901895|NCT02108964|38008492|FG007|Overall Study|Death|1|||
16901896|NCT02108964|38008485|FG000|Overall Study|Subject/Guardian decision|0|||
16901897|NCT02108964|38008486|FG001|Overall Study|Subject/Guardian decision|1|||
16901898|NCT02108964|38008487|FG002|Overall Study|Subject/Guardian decision|3|||
16901899|NCT02108964|38008488|FG003|Overall Study|Subject/Guardian decision|0|||
16901900|NCT02108964|38008489|FG004|Overall Study|Subject/Guardian decision|2|||
16901901|NCT02108964|38008490|FG005|Overall Study|Subject/Guardian decision|0|||
16901902|NCT02108964|38008491|FG006|Overall Study|Subject/Guardian decision|1|||
17095549|NCT00259610|38234817|FG001|Overall Study|Lost to Follow-up|8|||
16901903|NCT02108964|38008492|FG007|Overall Study|Subject/Guardian decision|1|||
17006067|NCT00803049|38149909|FG000|Overall Study|Progressive Disease|6|||
17006068|NCT00803049|38149910|FG001|Overall Study|Progressive Disease|10|||
17006069|NCT00803049|38149911|FG002|Overall Study|Progressive Disease|6|||
17006070|NCT00803049|38149912|FG003|Overall Study|Progressive Disease|6|||
17006071|NCT00803049|38149909|FG000|Overall Study|Withdrawal by Subject|19|||
17006072|NCT00803049|38149910|FG001|Overall Study|Withdrawal by Subject|43|||
16901904|NCT02108262|38008515|FG000|Overall Study|Non-compliance|0|||
16901905|NCT02108262|38008516|FG001|Overall Study|Non-compliance|2|||
16901906|NCT02108262|38008517|FG002|Overall Study|Non-compliance|1|||
16901907|NCT02108262|38008518|FG003|Overall Study|Non-compliance|1|||
16901908|NCT02108262|38008515|FG000|Overall Study|Randomized by error/screen failure|0|||
16901909|NCT02108262|38008516|FG001|Overall Study|Randomized by error/screen failure|0|||
16901910|NCT02108262|38008517|FG002|Overall Study|Randomized by error/screen failure|1|||
16901911|NCT02108262|38008518|FG003|Overall Study|Randomized by error/screen failure|0|||
16901912|NCT02108262|38008515|FG000|Overall Study|Distance to center|0|||
16901913|NCT02108262|38008516|FG001|Overall Study|Distance to center|1|||
16901914|NCT02108262|38008517|FG002|Overall Study|Distance to center|1|||
16901915|NCT02108262|38008518|FG003|Overall Study|Distance to center|0|||
16901916|NCT02108262|38008515|FG000|Overall Study|Adverse Event|0|||
16901917|NCT02108262|38008516|FG001|Overall Study|Adverse Event|11|||
16901918|NCT02108262|38008517|FG002|Overall Study|Adverse Event|6|||
16901919|NCT02108262|38008518|FG003|Overall Study|Adverse Event|12|||
16901920|NCT02108262|38008515|FG000|Overall Study|Death|0|||
16901921|NCT02108262|38008516|FG001|Overall Study|Death|2|||
16901922|NCT02108262|38008517|FG002|Overall Study|Death|2|||
16901923|NCT02108262|38008518|FG003|Overall Study|Death|1|||
16901924|NCT02108262|38008515|FG000|Overall Study|Lost to Follow-up|0|||
16901925|NCT02108262|38008516|FG001|Overall Study|Lost to Follow-up|0|||
16901926|NCT02108262|38008517|FG002|Overall Study|Lost to Follow-up|1|||
16901927|NCT02108262|38008518|FG003|Overall Study|Lost to Follow-up|0|||
17006073|NCT00803049|38149911|FG002|Overall Study|Withdrawal by Subject|16|||
17006074|NCT00803049|38149912|FG003|Overall Study|Withdrawal by Subject|44|||
17006075|NCT00803049|38149909|FG000|Overall Study|Protocol Violation|0|||
17006076|NCT00803049|38149910|FG001|Overall Study|Protocol Violation|1|||
17006077|NCT00803049|38149911|FG002|Overall Study|Protocol Violation|1|||
17006078|NCT00803049|38149912|FG003|Overall Study|Protocol Violation|0|||
17006079|NCT00803049|38149909|FG000|Overall Study|Randomized and Not Treated|0|||
17006080|NCT00803049|38149910|FG001|Overall Study|Randomized and Not Treated|0|||
16901928|NCT02108262|38008515|FG000|Overall Study|Physician Decision|0|||
16901929|NCT02108262|38008516|FG001|Overall Study|Physician Decision|0|||
16901930|NCT02108262|38008517|FG002|Overall Study|Physician Decision|2|||
16901931|NCT02108262|38008518|FG003|Overall Study|Physician Decision|0|||
16901932|NCT02108262|38008515|FG000|Overall Study|Withdrawal by Subject|0|||
16901933|NCT02108262|38008516|FG001|Overall Study|Withdrawal by Subject|7|||
16901934|NCT02108262|38008517|FG002|Overall Study|Withdrawal by Subject|3|||
16901935|NCT02108262|38008518|FG003|Overall Study|Withdrawal by Subject|4|||
16901936|NCT02108262|38008515|FG000|Overall Study|Due to key hepatic values|0|||
16901937|NCT02108262|38008516|FG001|Overall Study|Due to key hepatic values|1|||
16901938|NCT02108262|38008517|FG002|Overall Study|Due to key hepatic values|0|||
16901939|NCT02108262|38008518|FG003|Overall Study|Due to key hepatic values|0|||
16901940|NCT02108262|38008515|FG000|Overall Study|Unable to contact patient|0|||
16901941|NCT02108262|38008516|FG001|Overall Study|Unable to contact patient|3|||
16901942|NCT02108262|38008517|FG002|Overall Study|Unable to contact patient|1|||
16901943|NCT02108262|38008518|FG003|Overall Study|Unable to contact patient|2|||
16901944|NCT02108262|38008515|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
16901945|NCT02108262|38008516|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
16901946|NCT02108262|38008517|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
16901947|NCT02108262|38008518|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
16901948|NCT02108262|38008515|FG000|Overall Study|Patient did not want another infusion|0|||
16901949|NCT02108262|38008516|FG001|Overall Study|Patient did not want another infusion|3|||
16901950|NCT02108262|38008517|FG002|Overall Study|Patient did not want another infusion|3|||
16901951|NCT02108262|38008518|FG003|Overall Study|Patient did not want another infusion|2|||
16901952|NCT02108262|38008515|FG000|Overall Study|Vacation|0|||
16901953|NCT02108262|38008516|FG001|Overall Study|Vacation|1|||
16901954|NCT02108262|38008517|FG002|Overall Study|Vacation|0|||
16901955|NCT02108262|38008518|FG003|Overall Study|Vacation|0|||
16901956|NCT02108262|38008515|FG000|Overall Study|Patient decision|0|||
16901957|NCT02108262|38008516|FG001|Overall Study|Patient decision|7|||
16901958|NCT02108262|38008517|FG002|Overall Study|Patient decision|9|||
16901959|NCT02108262|38008518|FG003|Overall Study|Patient decision|14|||
16901960|NCT02108262|38008515|FG000|Overall Study|Missed IV due to pharmacy error|0|||
16901961|NCT02108262|38008516|FG001|Overall Study|Missed IV due to pharmacy error|0|||
16901962|NCT02108262|38008517|FG002|Overall Study|Missed IV due to pharmacy error|1|||
16901963|NCT02108262|38008518|FG003|Overall Study|Missed IV due to pharmacy error|0|||
16901964|NCT02107482|38008527|FG000|Overall Study|inconveinence|2|||
16901965|NCT02107482|38008527|FG000|Overall Study|Lost to Follow-up|1|||
16901966|NCT02107482|38008527|FG000|Overall Study|Lack of Efficacy|1|||
16901967|NCT02066298|38008537|FG000|Overall Study|Lost to Follow-up|3|||
16901968|NCT02066298|38008538|FG001|Overall Study|Lost to Follow-up|2|||
16901969|NCT02066298|38008539|FG002|Overall Study|Lost to Follow-up|3|||
16901970|NCT02066298|38008540|FG003|Overall Study|Lost to Follow-up|2|||
16901971|NCT02066298|38008541|FG004|Overall Study|Lost to Follow-up|3|||
16901972|NCT02066298|38008542|FG005|Overall Study|Lost to Follow-up|4|||
16901973|NCT02066298|38008537|FG000|Overall Study|Withdrawal by Subject|6|||
16901974|NCT02066298|38008538|FG001|Overall Study|Withdrawal by Subject|6|||
16901975|NCT02066298|38008539|FG002|Overall Study|Withdrawal by Subject|6|||
16901976|NCT02066298|38008540|FG003|Overall Study|Withdrawal by Subject|4|||
16901977|NCT02066298|38008541|FG004|Overall Study|Withdrawal by Subject|5|||
16901978|NCT02066298|38008542|FG005|Overall Study|Withdrawal by Subject|8|||
16901979|NCT02066298|38008537|FG000|Overall Study|Physician Decision|0|||
16901980|NCT02066298|38008538|FG001|Overall Study|Physician Decision|0|||
16901981|NCT02066298|38008539|FG002|Overall Study|Physician Decision|1|||
16901982|NCT02066298|38008540|FG003|Overall Study|Physician Decision|0|||
16901983|NCT02066298|38008541|FG004|Overall Study|Physician Decision|1|||
16901984|NCT02066298|38008542|FG005|Overall Study|Physician Decision|0|||
16901985|NCT02082912|38008556|FG000|Overall Study|Physician Decision|0|||
16901986|NCT02082912|38008557|FG001|Overall Study|Physician Decision|1|||
16901987|NCT02082522|38008565|FG000|Overall Study|Sponsor termination|5|||
16901988|NCT02082522|38008566|FG001|Overall Study|Sponsor termination|3|||
16901989|NCT02082522|38008565|FG000|Overall Study|Withdrawal by Subject|2|||
16901990|NCT02082522|38008566|FG001|Overall Study|Withdrawal by Subject|4|||
16901991|NCT02082522|38008565|FG000|Overall Study|Death|1|||
16901992|NCT02082522|38008566|FG001|Overall Study|Death|0|||
16901993|NCT02082522|38008565|FG000|Overall Study|Lost to Follow-up|1|||
16901994|NCT02082522|38008566|FG001|Overall Study|Lost to Follow-up|0|||
16901995|NCT02082522|38008565|FG000|Overall Study|Physician Decision|3|||
16901996|NCT02082522|38008566|FG001|Overall Study|Physician Decision|1|||
16901997|NCT02082522|38008565|FG000|Overall Study|Disease progression|2|||
16901998|NCT02082522|38008566|FG001|Overall Study|Disease progression|2|||
16901999|NCT02082522|38008565|FG000|Overall Study|Chemotherapy change|1|||
16902000|NCT02082522|38008566|FG001|Overall Study|Chemotherapy change|3|||
16902001|NCT02082210|38008578|FG000|Overall Study|Death|0|||
16902002|NCT02082210|38008579|FG001|Overall Study|Death|0|||
16902003|NCT02082210|38008580|FG002|Overall Study|Death|1|||
16902004|NCT02082210|38008581|FG003|Overall Study|Death|1|||
16902005|NCT02082210|38008582|FG004|Overall Study|Death|1|||
16902006|NCT02082210|38008583|FG005|Overall Study|Death|0|||
16902007|NCT02082210|38008578|FG000|Overall Study|Withdrawal by Subject|0|||
16902008|NCT02082210|38008579|FG001|Overall Study|Withdrawal by Subject|0|||
16902009|NCT02082210|38008580|FG002|Overall Study|Withdrawal by Subject|0|||
16902010|NCT02082210|38008581|FG003|Overall Study|Withdrawal by Subject|1|||
16902011|NCT02082210|38008582|FG004|Overall Study|Withdrawal by Subject|2|||
16902012|NCT02082210|38008583|FG005|Overall Study|Withdrawal by Subject|2|||
16902013|NCT02082210|38008578|FG000|Overall Study|Clinical Progression|0|||
16902014|NCT02082210|38008579|FG001|Overall Study|Clinical Progression|0|||
16902015|NCT02082210|38008580|FG002|Overall Study|Clinical Progression|0|||
16902016|NCT02082210|38008581|FG003|Overall Study|Clinical Progression|1|||
16902017|NCT02082210|38008582|FG004|Overall Study|Clinical Progression|0|||
16902018|NCT02082210|38008583|FG005|Overall Study|Clinical Progression|0|||
16902019|NCT02082210|38008578|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
16902020|NCT02082210|38008579|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
17006081|NCT00803049|38149911|FG002|Overall Study|Randomized and Not Treated|0|||
17006082|NCT00803049|38149912|FG003|Overall Study|Randomized and Not Treated|2|||
17006083|NCT00803049|38149909|FG000|Overall Study|Other than Specified Above|3|||
17006084|NCT00803049|38149910|FG001|Overall Study|Other than Specified Above|9|||
17006085|NCT00803049|38149911|FG002|Overall Study|Other than Specified Above|2|||
17006086|NCT00803049|38149912|FG003|Overall Study|Other than Specified Above|5|||
17006087|NCT00890084|38149922|FG000|Overall Study|Adverse Event|16|||
17006088|NCT00890084|38149922|FG000|Overall Study|Lost to Follow-up|126|||
17006089|NCT00802893|38149935|FG000|Overall Study|study terminated|3|||
17006090|NCT00608569|38149956|FG000|Overall Study|Death|4|||
17006091|NCT00608569|38149957|FG001|Overall Study|Death|3|||
17006092|NCT00608569|38149956|FG000|Overall Study|Lost to Follow-up|4|||
17006093|NCT00608569|38149957|FG001|Overall Study|Lost to Follow-up|5|||
17006094|NCT00608569|38149956|FG000|Overall Study|Withdrawal by Subject|1|||
17006095|NCT00608569|38149957|FG001|Overall Study|Withdrawal by Subject|0|||
17006096|NCT00608569|38149956|FG000|Overall Study|Adverse Event|1|||
17006097|NCT00608569|38149957|FG001|Overall Study|Adverse Event|0|||
17006098|NCT00608569|38149956|FG000|Overall Study|Unable to adhere with study requirements|0|||
17006099|NCT00608569|38149957|FG001|Overall Study|Unable to adhere with study requirements|1|||
17006100|NCT00610675|38149963|FG000|Overall Study|Untreated|4|||
17006101|NCT00610675|38149963|FG000|Overall Study|Adverse Event|67|||
17006102|NCT00610675|38149963|FG000|Overall Study|Insufficient Effect|31|||
17006103|NCT00610675|38149963|FG000|Overall Study|Withdrawal by Subject|28|||
17006104|NCT00610675|38149963|FG000|Overall Study|Reasons unrelated to trial|27|||
17006105|NCT00610675|38149963|FG000|Overall Study|Lack of Compliance|7|||
16902021|NCT02082210|38008580|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
16902022|NCT02082210|38008581|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
17006106|NCT00610675|38149963|FG000|Overall Study|Lost to Follow-up|31|||
17006107|NCT00610675|38149963|FG000|Overall Study|Other reason (not specified)|25|||
17006108|NCT00888134|38149967|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
17006109|NCT00888134|38149967|FG000|Follow-up|being followed for long-term survival|1|||
17006110|NCT00573157|38149974|FG000|Overall Study|Adverse Event|3|||
16902023|NCT02082210|38008582|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
16902024|NCT02082210|38008583|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
16902025|NCT02082210|38008578|FG000|Overall Study|Physician Decision|0|||
16902026|NCT02082210|38008579|FG001|Overall Study|Physician Decision|0|||
16902027|NCT02082210|38008580|FG002|Overall Study|Physician Decision|1|||
16902028|NCT02082210|38008581|FG003|Overall Study|Physician Decision|1|||
16902029|NCT02082210|38008582|FG004|Overall Study|Physician Decision|0|||
16902030|NCT02082210|38008583|FG005|Overall Study|Physician Decision|0|||
16902031|NCT02107092|38008609|FG000|Overall Study|Miscellaneous|3|||
16902032|NCT02107092|38008609|FG000|Overall Study|Subject compliance|3|||
16902033|NCT02107092|38008609|FG000|Overall Study|Hypo-or hyperkalemia|2|||
16902034|NCT02107092|38008609|FG000|Overall Study|Met ECG withdrawal criteria|3|||
16902035|NCT02107092|38008609|FG000|Overall Study|Physician Decision|3|||
16902036|NCT02107092|38008609|FG000|Overall Study|Lost to Follow-up|2|||
16902037|NCT02107092|38008609|FG000|Overall Study|Withdrawal by Subject|9|||
16902038|NCT02107092|38008609|FG000|Overall Study|Adverse Event|7|||
16902039|NCT02107092|38008609|FG000|Overall Study|Expected progression of CKD|12|||
17192682|NCT03926611|38345966|FG002|Overall Study|Covid-19 pandemic|1|||
17192683|NCT03926611|38345967|FG003|Overall Study|Covid-19 pandemic|0|||
17192684|NCT03926611|38345968|FG004|Overall Study|Covid-19 pandemic|1|||
17192685|NCT03926611|38345969|FG005|Overall Study|Covid-19 pandemic|2|||
17192686|NCT03926611|38345970|FG006|Overall Study|Covid-19 pandemic|0|||
17192687|NCT02818777|38345990|FG000|Overall Study|Adverse Event|3|||
17192688|NCT02817841|38346004|FG000|Overall Study|Lost to Follow-up|287|||
16902040|NCT02107014|38008613|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
16902041|NCT01624974|38008619|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
16902042|NCT01624974|38008620|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
16902043|NCT01624974|38008619|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
16902044|NCT01624974|38008620|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
16902045|NCT01624974|38008619|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
16902046|NCT01624974|38008620|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
16902047|NCT01624974|38008619|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
16902048|NCT01624974|38008620|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
16902049|NCT01624974|38008619|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
16902050|NCT01624974|38008620|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
16902051|NCT01624974|38008619|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
16902052|NCT01624974|38008620|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
16902053|NCT01624974|38008619|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
16902054|NCT01624974|38008620|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
16902055|NCT01624974|38008619|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
16902056|NCT01624974|38008620|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
16902057|NCT01624974|38008619|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
16902058|NCT01624974|38008620|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
16902059|NCT01624974|38008619|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
16902060|NCT01624974|38008620|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
16902061|NCT01624974|38008619|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
16902062|NCT01624974|38008620|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
16902063|NCT01624974|38008619|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
16902064|NCT01624974|38008620|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
16902065|NCT02065518|38008631|FG000|Overall Study|Lost to Follow-up|3|||
16902066|NCT02065518|38008632|FG001|Overall Study|Lost to Follow-up|4|||
16902067|NCT02065518|38008633|FG002|Overall Study|Lost to Follow-up|0|||
16902068|NCT02065518|38008634|FG003|Overall Study|Lost to Follow-up|3|||
16902069|NCT02065518|38008631|FG000|Overall Study|Withdrawal by Subject|3|||
16902070|NCT02065518|38008632|FG001|Overall Study|Withdrawal by Subject|4|||
16902071|NCT02065518|38008633|FG002|Overall Study|Withdrawal by Subject|9|||
16902072|NCT02065518|38008634|FG003|Overall Study|Withdrawal by Subject|2|||
16902073|NCT01624662|38008648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
17006111|NCT00573157|38149975|FG001|Overall Study|Adverse Event|1|||
17006112|NCT00573157|38149974|FG000|Overall Study|Other|1|||
17006113|NCT00573157|38149975|FG001|Overall Study|Other|1|||
17006114|NCT00802737|38149984|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
17006115|NCT00802737|38149985|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
17006116|NCT00802737|38149986|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
17006117|NCT00802737|38149984|FG000|Overall Study|Death|6|||
17006118|NCT00802737|38149985|FG001|Overall Study|Death|5|||
17006119|NCT00802737|38149986|FG002|Overall Study|Death|1|||
17006120|NCT00802737|38149984|FG000|Overall Study|Adverse Event|1|||
17006121|NCT00802737|38149985|FG001|Overall Study|Adverse Event|0|||
17006122|NCT00802737|38149986|FG002|Overall Study|Adverse Event|0|||
17006123|NCT00802737|38149984|FG000|Overall Study|Received Prohibited Therapy|1|||
17192689|NCT02817841|38346004|FG000|Overall Study|Withdrawal by Subject|183|||
17006124|NCT00802737|38149985|FG001|Overall Study|Received Prohibited Therapy|0|||
17006125|NCT00802737|38149986|FG002|Overall Study|Received Prohibited Therapy|0|||
17006126|NCT00802737|38149984|FG000|Overall Study|Ongoing CLL-Treatment|0|||
17006127|NCT00802737|38149985|FG001|Overall Study|Ongoing CLL-Treatment|1|||
17006128|NCT00802737|38149986|FG002|Overall Study|Ongoing CLL-Treatment|0|||
17006129|NCT00802737|38149984|FG000|Overall Study|Participant too Unwell|0|||
17006130|NCT00802737|38149985|FG001|Overall Study|Participant too Unwell|2|||
17006131|NCT00802737|38149986|FG002|Overall Study|Participant too Unwell|0|||
17006132|NCT00588861|38149997|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
17006133|NCT00588861|38149998|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
16902074|NCT01624662|38008649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
16902075|NCT01624662|38008650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
16902076|NCT01624662|38008651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
16902077|NCT01624662|38008648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
16902078|NCT01624662|38008649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
16902079|NCT01624662|38008650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
16902080|NCT01624662|38008651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
16902081|NCT01624662|38008648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16902082|NCT01624662|38008649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
16902083|NCT01624662|38008650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16902084|NCT01624662|38008651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16902085|NCT01624662|38008648|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
16902086|NCT01624662|38008649|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
16902087|NCT01624662|38008650|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
16902088|NCT01624662|38008651|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
16902089|NCT01624662|38008648|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
16902090|NCT01624662|38008649|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
16902091|NCT01624662|38008650|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
16902092|NCT01624662|38008651|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
16902093|NCT01624662|38008648|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16902094|NCT01624662|38008649|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
16902095|NCT01624662|38008650|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16902096|NCT01624662|38008651|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16902097|NCT01624662|38008648|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
16902098|NCT01624662|38008649|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
16902099|NCT01624662|38008650|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
16902100|NCT01624662|38008651|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
16902101|NCT01624506|38008674|FG000|Overall Study|Lost to Follow-up|29|||
16902102|NCT01624506|38008675|FG001|Overall Study|Lost to Follow-up|15|||
16902103|NCT01624506|38008674|FG000|Overall Study|Withdrawal by Subject|9|||
16902104|NCT01624506|38008675|FG001|Overall Study|Withdrawal by Subject|2|||
16902105|NCT01624506|38008674|FG000|Overall Study|Death|1|||
16902106|NCT01624506|38008675|FG001|Overall Study|Death|0|||
16902107|NCT01624506|38008674|FG000|Overall Study|LINX explants|23|||
16902108|NCT01624506|38008675|FG001|Overall Study|LINX explants|0|||
16902109|NCT01624506|38008674|FG000|Overall Study|Adverse Event|3|||
16902110|NCT01624506|38008675|FG001|Overall Study|Adverse Event|0|||
16902111|NCT02106390|38008684|FG000|Overall Study|Withdrawal by Subject|15|||
16902112|NCT02106390|38008685|FG001|Overall Study|Withdrawal by Subject|16|||
16902113|NCT02106390|38008686|FG002|Overall Study|Withdrawal by Subject|15|||
16902114|NCT02106390|38008684|FG000|Overall Study|Lost to Follow-up|25|||
16902115|NCT02106390|38008685|FG001|Overall Study|Lost to Follow-up|20|||
16902116|NCT02106390|38008686|FG002|Overall Study|Lost to Follow-up|13|||
16902117|NCT02106390|38008684|FG000|Overall Study|Other: Administrative Reason|8|||
16902118|NCT02106390|38008685|FG001|Overall Study|Other: Administrative Reason|5|||
16902119|NCT02106390|38008686|FG002|Overall Study|Other: Administrative Reason|12|||
16902120|NCT02106390|38008684|FG000|Overall Study|Other: Unspecified|1|||
16902121|NCT02106390|38008685|FG001|Overall Study|Other: Unspecified|4|||
16902122|NCT02106390|38008686|FG002|Overall Study|Other: Unspecified|2|||
16902123|NCT02106390|38008684|FG000|Overall Study|Adverse Event|0|||
16902124|NCT02106390|38008685|FG001|Overall Study|Adverse Event|2|||
16902125|NCT02106390|38008686|FG002|Overall Study|Adverse Event|1|||
16902126|NCT02106390|38008684|FG000|Overall Study|Protocol Violation|0|||
16902127|NCT02106390|38008685|FG001|Overall Study|Protocol Violation|1|||
16902128|NCT02106390|38008686|FG002|Overall Study|Protocol Violation|0|||
16902129|NCT02064894|38008700|FG000|Overall Study|Withdrawal by Subject|43|||
16902130|NCT02064894|38008701|FG001|Overall Study|Withdrawal by Subject|102|||
17006134|NCT00588861|38149997|FG000|6 Months|Patients did not return for follow-up|98|||
17006135|NCT00588861|38149998|FG001|6 Months|Patients did not return for follow-up|73|||
17006136|NCT00588861|38149997|FG000|1 Year|Patients did not return for follow-up|89|||
17006137|NCT00588861|38149998|FG001|1 Year|Patients did not return for follow-up|82|||
17006138|NCT00588861|38149997|FG000|2 Years|Patients did not return for follow-up|92|||
17006139|NCT00588861|38149998|FG001|2 Years|Patients did not return for follow-up|87|||
17006140|NCT00588861|38149997|FG000|4 Years|Patients did not return for follow-up|91|||
17006141|NCT00588861|38149998|FG001|4 Years|Patients did not return for follow-up|103|||
17006142|NCT00588861|38149997|FG000|6 Years|Patients did not return for follow-up|104|||
17006143|NCT00588861|38149998|FG001|6 Years|Patients did not return for follow-up|109|||
17006144|NCT00588861|38149997|FG000|8 Years|Patients did not return for follow-up|105|||
17006145|NCT00588861|38149998|FG001|8 Years|Patients did not return for follow-up|114|||
17006146|NCT00588861|38149997|FG000|10 Years|Incomplete due to study termination|107|||
17006147|NCT00588861|38149998|FG001|10 Years|Incomplete due to study termination|114|||
17006148|NCT00887978|38150006|FG000|Overall Study|Adverse Event|18|||
17006149|NCT00887978|38150007|FG001|Overall Study|Adverse Event|5|||
17006150|NCT00887978|38150006|FG000|Overall Study|Clinical Worsening|4|||
17006151|NCT00887978|38150007|FG001|Overall Study|Clinical Worsening|4|||
17006152|NCT00887978|38150006|FG000|Overall Study|Death|2|||
17006153|NCT00887978|38150007|FG001|Overall Study|Death|3|||
17006154|NCT00887978|38150006|FG000|Overall Study|Withdrawal by Subject|1|||
16902131|NCT02064894|38008702|FG002|Overall Study|Withdrawal by Subject|115|||
16902132|NCT02081586|38008714|FG000|Overall Study|Lost to Follow-up|0|||
16902133|NCT02081586|38008715|FG001|Overall Study|Lost to Follow-up|1|||
16902134|NCT02081586|38008716|FG002|Overall Study|Lost to Follow-up|0|||
16902135|NCT02081586|38008717|FG003|Overall Study|Lost to Follow-up|1|||
16902136|NCT02081586|38008714|FG000|Overall Study|Head injury not related to study|0|||
16902137|NCT02081586|38008715|FG001|Overall Study|Head injury not related to study|0|||
16902138|NCT02081586|38008716|FG002|Overall Study|Head injury not related to study|1|||
16902139|NCT02081586|38008717|FG003|Overall Study|Head injury not related to study|0|||
16902140|NCT02081196|38008729|FG000|Overall Study|Lost to Follow-up|1|||
16902141|NCT02064816|38008737|FG000|Overall Study|Adverse Event|3|||
16902142|NCT02064816|38008738|FG001|Overall Study|Adverse Event|2|||
16902143|NCT02064816|38008737|FG000|Overall Study|Withdrawal by Subject|2|||
16902144|NCT02064816|38008738|FG001|Overall Study|Withdrawal by Subject|1|||
17006155|NCT00887978|38150007|FG001|Overall Study|Withdrawal by Subject|2|||
17006156|NCT00887978|38150006|FG000|Overall Study|Lost to Follow-up|0|||
17006157|NCT00887978|38150007|FG001|Overall Study|Lost to Follow-up|1|||
17006158|NCT00608023|38150016|FG000|Overall Study|Withdrawal by Subject|8|||
17006159|NCT00608023|38150017|FG001|Overall Study|Withdrawal by Subject|10|||
17006160|NCT00608023|38150018|FG002|Overall Study|Withdrawal by Subject|7|||
17006161|NCT00608023|38150016|FG000|Overall Study|Adverse Event|1|||
16902145|NCT02064816|38008737|FG000|Overall Study|Lost to Follow-up|2|||
16902146|NCT02064816|38008738|FG001|Overall Study|Lost to Follow-up|1|||
16902147|NCT02064816|38008737|FG000|Overall Study|Therapeutic failure|0|||
16902148|NCT02064816|38008738|FG001|Overall Study|Therapeutic failure|1|||
16902149|NCT02064816|38008737|FG000|Overall Study|Other|1|||
16902150|NCT02064816|38008738|FG001|Overall Study|Other|3|||
16902151|NCT02080260|38008744|FG000|Overall Study|Death|18|||
16902152|NCT02080260|38008744|FG000|Overall Study|Withdrawal by Subject|1|||
16902153|NCT01624194|38008750|FG000|Overall Study|Lost to Follow-up|1|||
16902154|NCT01624194|38008751|FG001|Overall Study|Lost to Follow-up|0|||
16902155|NCT01624194|38008750|FG000|Overall Study|Withdrawal by Subject|1|||
16902156|NCT01624194|38008751|FG001|Overall Study|Withdrawal by Subject|0|||
16902157|NCT02079636|38008773|FG000|Overall Study|Death|2|||
16902158|NCT02079636|38008774|FG001|Overall Study|Death|1|||
16902159|NCT02079636|38008775|FG002|Overall Study|Death|0|||
16902160|NCT02079636|38008776|FG003|Overall Study|Death|5|||
16902161|NCT02079636|38008777|FG004|Overall Study|Death|1|||
16902162|NCT02079636|38008778|FG005|Overall Study|Death|2|||
16902163|NCT02079636|38008779|FG006|Overall Study|Death|1|||
16902164|NCT02079636|38008780|FG007|Overall Study|Death|0|||
16902165|NCT02079636|38008781|FG008|Overall Study|Death|0|||
16902166|NCT02079636|38008782|FG009|Overall Study|Death|0|||
16902167|NCT02079636|38008783|FG010|Overall Study|Death|0|||
16902168|NCT02079636|38008784|FG011|Overall Study|Death|1|||
16902169|NCT02079636|38008785|FG012|Overall Study|Death|1|||
16902170|NCT02079636|38008786|FG013|Overall Study|Death|0|||
16902171|NCT02079636|38008787|FG014|Overall Study|Death|2|||
16902172|NCT02079636|38008773|FG000|Overall Study|Adverse Event|1|||
16902173|NCT02079636|38008774|FG001|Overall Study|Adverse Event|1|||
16902174|NCT02079636|38008775|FG002|Overall Study|Adverse Event|0|||
16902175|NCT02079636|38008776|FG003|Overall Study|Adverse Event|1|||
16902176|NCT02079636|38008777|FG004|Overall Study|Adverse Event|1|||
17006162|NCT00608023|38150017|FG001|Overall Study|Adverse Event|4|||
17006163|NCT00608023|38150018|FG002|Overall Study|Adverse Event|5|||
17006164|NCT00608023|38150016|FG000|Overall Study|Lost to Follow-up|2|||
16902177|NCT02079636|38008778|FG005|Overall Study|Adverse Event|2|||
16902178|NCT02079636|38008779|FG006|Overall Study|Adverse Event|0|||
16902179|NCT02079636|38008780|FG007|Overall Study|Adverse Event|0|||
16902180|NCT02079636|38008781|FG008|Overall Study|Adverse Event|0|||
16902181|NCT02079636|38008782|FG009|Overall Study|Adverse Event|0|||
16902182|NCT02079636|38008783|FG010|Overall Study|Adverse Event|0|||
16902183|NCT02079636|38008784|FG011|Overall Study|Adverse Event|0|||
16902184|NCT02079636|38008785|FG012|Overall Study|Adverse Event|0|||
16902185|NCT02079636|38008786|FG013|Overall Study|Adverse Event|0|||
16902186|NCT02079636|38008787|FG014|Overall Study|Adverse Event|0|||
16902187|NCT02079636|38008773|FG000|Overall Study|Progressive disease|0|||
16902188|NCT02079636|38008774|FG001|Overall Study|Progressive disease|0|||
16902189|NCT02079636|38008775|FG002|Overall Study|Progressive disease|0|||
16902190|NCT02079636|38008776|FG003|Overall Study|Progressive disease|2|||
16902191|NCT02079636|38008777|FG004|Overall Study|Progressive disease|0|||
16902192|NCT02079636|38008778|FG005|Overall Study|Progressive disease|0|||
16902193|NCT02079636|38008779|FG006|Overall Study|Progressive disease|0|||
16902194|NCT02079636|38008780|FG007|Overall Study|Progressive disease|0|||
16902195|NCT02079636|38008781|FG008|Overall Study|Progressive disease|0|||
16902196|NCT02079636|38008782|FG009|Overall Study|Progressive disease|0|||
16902197|NCT02079636|38008783|FG010|Overall Study|Progressive disease|0|||
16902198|NCT02079636|38008784|FG011|Overall Study|Progressive disease|0|||
16902199|NCT02079636|38008785|FG012|Overall Study|Progressive disease|1|||
16902200|NCT02079636|38008786|FG013|Overall Study|Progressive disease|0|||
16902201|NCT02079636|38008787|FG014|Overall Study|Progressive disease|0|||
16902202|NCT02079636|38008773|FG000|Overall Study|Withdrawal by Subject|0|||
17006165|NCT00608023|38150017|FG001|Overall Study|Lost to Follow-up|2|||
17006166|NCT00608023|38150018|FG002|Overall Study|Lost to Follow-up|1|||
17006167|NCT00608023|38150016|FG000|Overall Study|Protocol Violation|1|||
16902203|NCT02079636|38008774|FG001|Overall Study|Withdrawal by Subject|0|||
16902204|NCT02079636|38008775|FG002|Overall Study|Withdrawal by Subject|0|||
16902205|NCT02079636|38008776|FG003|Overall Study|Withdrawal by Subject|4|||
16902206|NCT02079636|38008777|FG004|Overall Study|Withdrawal by Subject|0|||
16902207|NCT02079636|38008778|FG005|Overall Study|Withdrawal by Subject|1|||
16902208|NCT02079636|38008779|FG006|Overall Study|Withdrawal by Subject|0|||
17006168|NCT00608023|38150017|FG001|Overall Study|Protocol Violation|3|||
17006169|NCT00608023|38150018|FG002|Overall Study|Protocol Violation|1|||
17006170|NCT00608023|38150016|FG000|Overall Study|Unknown reason|0|||
17006171|NCT00608023|38150017|FG001|Overall Study|Unknown reason|3|||
17006172|NCT00608023|38150018|FG002|Overall Study|Unknown reason|0|||
17006173|NCT00802659|38150033|FG000|Overall Study|Physician Decision|0|||
17006174|NCT00802659|38150034|FG001|Overall Study|Physician Decision|1|||
17006175|NCT00802659|38150035|FG002|Overall Study|Physician Decision|0|||
17006176|NCT00802659|38150036|FG003|Overall Study|Physician Decision|0|||
17006177|NCT00607789|38150048|FG000|Overall Study|Adverse Event|3|||
17006178|NCT00607789|38150049|FG001|Overall Study|Adverse Event|0|||
17006179|NCT00607789|38150048|FG000|Overall Study|Lack of Efficacy|0|||
17006180|NCT00607789|38150049|FG001|Overall Study|Lack of Efficacy|1|||
17006181|NCT00607789|38150048|FG000|Overall Study|Inadequate adherence|3|||
16902209|NCT02079636|38008780|FG007|Overall Study|Withdrawal by Subject|0|||
16902210|NCT02079636|38008781|FG008|Overall Study|Withdrawal by Subject|0|||
16902211|NCT02079636|38008782|FG009|Overall Study|Withdrawal by Subject|2|||
16902212|NCT02079636|38008783|FG010|Overall Study|Withdrawal by Subject|1|||
16902213|NCT02079636|38008784|FG011|Overall Study|Withdrawal by Subject|1|||
16902214|NCT02079636|38008785|FG012|Overall Study|Withdrawal by Subject|1|||
16902215|NCT02079636|38008786|FG013|Overall Study|Withdrawal by Subject|0|||
16902216|NCT02079636|38008787|FG014|Overall Study|Withdrawal by Subject|2|||
16902217|NCT02079636|38008773|FG000|Overall Study|Physician Decision|0|||
16902218|NCT02079636|38008774|FG001|Overall Study|Physician Decision|0|||
16902219|NCT02079636|38008775|FG002|Overall Study|Physician Decision|0|||
16902220|NCT02079636|38008776|FG003|Overall Study|Physician Decision|0|||
16902221|NCT02079636|38008777|FG004|Overall Study|Physician Decision|0|||
16902222|NCT02079636|38008778|FG005|Overall Study|Physician Decision|1|||
16902223|NCT02079636|38008779|FG006|Overall Study|Physician Decision|0|||
16902224|NCT02079636|38008780|FG007|Overall Study|Physician Decision|0|||
16902225|NCT02079636|38008781|FG008|Overall Study|Physician Decision|0|||
16902226|NCT02079636|38008782|FG009|Overall Study|Physician Decision|1|||
16902227|NCT02079636|38008783|FG010|Overall Study|Physician Decision|1|||
16902228|NCT02079636|38008784|FG011|Overall Study|Physician Decision|0|||
16902229|NCT02079636|38008785|FG012|Overall Study|Physician Decision|0|||
16902230|NCT02079636|38008786|FG013|Overall Study|Physician Decision|0|||
16902231|NCT02079636|38008787|FG014|Overall Study|Physician Decision|1|||
16902232|NCT02079636|38008773|FG000|Overall Study|Lost to Follow-up|0|||
16902233|NCT02079636|38008774|FG001|Overall Study|Lost to Follow-up|0|||
16902234|NCT02079636|38008775|FG002|Overall Study|Lost to Follow-up|0|||
16902235|NCT02079636|38008776|FG003|Overall Study|Lost to Follow-up|0|||
16902236|NCT02079636|38008777|FG004|Overall Study|Lost to Follow-up|0|||
16902237|NCT02079636|38008778|FG005|Overall Study|Lost to Follow-up|0|||
17006182|NCT00607789|38150049|FG001|Overall Study|Inadequate adherence|0|||
16902238|NCT02079636|38008779|FG006|Overall Study|Lost to Follow-up|0|||
16902239|NCT02079636|38008780|FG007|Overall Study|Lost to Follow-up|1|||
16902240|NCT02079636|38008781|FG008|Overall Study|Lost to Follow-up|0|||
16902241|NCT02079636|38008782|FG009|Overall Study|Lost to Follow-up|0|||
16902242|NCT02079636|38008783|FG010|Overall Study|Lost to Follow-up|0|||
16902243|NCT02079636|38008784|FG011|Overall Study|Lost to Follow-up|0|||
16902244|NCT02079636|38008785|FG012|Overall Study|Lost to Follow-up|0|||
17006183|NCT00607789|38150048|FG000|Overall Study|Lost to Follow-up|0|||
16902245|NCT02079636|38008786|FG013|Overall Study|Lost to Follow-up|0|||
16902246|NCT02079636|38008787|FG014|Overall Study|Lost to Follow-up|0|||
16902247|NCT02079246|38008851|FG000|OLEX|Withdrawal before treatment|1|||
16902248|NCT02079246|38008852|FG001|OLEX|Withdrawal before treatment|0|||
16902249|NCT02079246|38008851|FG000|OLEX|Death|11|||
16902250|NCT02079246|38008852|FG001|OLEX|Death|0|||
16902251|NCT02079246|38008851|FG000|OLEX|Adverse Event|66|||
16902252|NCT02079246|38008852|FG001|OLEX|Adverse Event|0|||
16902253|NCT02079246|38008851|FG000|OLEX|Withdrawal by Subject|60|||
16902254|NCT02079246|38008852|FG001|OLEX|Withdrawal by Subject|0|||
16902255|NCT02079246|38008851|FG000|OLEX|Lost to Follow-up|6|||
16902256|NCT02079246|38008852|FG001|OLEX|Lost to Follow-up|0|||
16902257|NCT02079246|38008851|FG000|OLEX|Protocol Violation|6|||
16902258|NCT02079246|38008852|FG001|OLEX|Protocol Violation|0|||
16902259|NCT02079246|38008851|FG000|OLEX|Lack of Efficacy|3|||
16902260|NCT02079246|38008852|FG001|OLEX|Lack of Efficacy|0|||
16902261|NCT02079246|38008851|FG000|OLEX|Results of the lead-in studies|58|||
16902262|NCT02079246|38008852|FG001|OLEX|Results of the lead-in studies|0|||
16902263|NCT02079246|38008851|FG000|OLEX|Other: Disallowed medication|8|||
16902264|NCT02079246|38008852|FG001|OLEX|Other: Disallowed medication|0|||
16902265|NCT02079246|38008851|FG000|OLEX|Other: Insufficient compliance|2|||
16902266|NCT02079246|38008852|FG001|OLEX|Other: Insufficient compliance|0|||
16902267|NCT02079246|38008851|FG000|OLEX|Other: Caregiver unavailable|3|||
16902268|NCT02079246|38008852|FG001|OLEX|Other: Caregiver unavailable|0|||
16902269|NCT02079246|38008851|FG000|OLEX|Other: Coordinator decision|1|||
16902270|NCT02079246|38008852|FG001|OLEX|Other: Coordinator decision|0|||
16902271|NCT02079246|38008851|FG000|OLEX|Other: Worsening of condition|1|||
16902272|NCT02079246|38008852|FG001|OLEX|Other: Worsening of condition|0|||
16902273|NCT02079246|38008851|FG000|OLEX|Other: Moved to nursing home|1|||
16902274|NCT02079246|38008852|FG001|OLEX|Other: Moved to nursing home|0|||
16902275|NCT02079246|38008851|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
16902276|NCT02079246|38008852|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
16902277|NCT02079246|38008851|FG000|OLEX-MEM|Adverse Event|0|||
16902278|NCT02079246|38008852|FG001|OLEX-MEM|Adverse Event|6|||
16902279|NCT02079246|38008851|FG000|OLEX-MEM|Withdrawal by Subject|0|||
16902280|NCT02079246|38008852|FG001|OLEX-MEM|Withdrawal by Subject|7|||
16902281|NCT02079246|38008851|FG000|OLEX-MEM|Protocol Violation|0|||
16902282|NCT02079246|38008852|FG001|OLEX-MEM|Protocol Violation|2|||
16902283|NCT02079246|38008851|FG000|OLEX-MEM|Lost to Follow-up|0|||
16902284|NCT02079246|38008852|FG001|OLEX-MEM|Lost to Follow-up|1|||
16902285|NCT02079246|38008851|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
16902286|NCT02079246|38008852|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
16902287|NCT02077374|38008863|FG000|Overall Study|Withdrawal by Subject|0|||
16902288|NCT02077374|38008864|FG001|Overall Study|Withdrawal by Subject|1|||
16902289|NCT02077374|38008863|FG000|Overall Study|Protocol Violation|0|||
16902290|NCT02077374|38008864|FG001|Overall Study|Protocol Violation|1|||
16902291|NCT02077140|38008878|FG000|Overall Study|Lost to Follow-up|4|||
16902292|NCT02077140|38008879|FG001|Overall Study|Lost to Follow-up|1|||
16902293|NCT02077140|38008880|FG002|Overall Study|Lost to Follow-up|2|||
16902294|NCT02077140|38008881|FG003|Overall Study|Lost to Follow-up|2|||
16902295|NCT02077140|38008882|FG004|Overall Study|Lost to Follow-up|3|||
16902296|NCT02077140|38008878|FG000|Overall Study|Withdrawal by Subject|0|||
16902297|NCT02077140|38008879|FG001|Overall Study|Withdrawal by Subject|1|||
16902298|NCT02077140|38008880|FG002|Overall Study|Withdrawal by Subject|0|||
16902299|NCT02077140|38008881|FG003|Overall Study|Withdrawal by Subject|2|||
16902300|NCT02077140|38008882|FG004|Overall Study|Withdrawal by Subject|2|||
16902301|NCT02047110|38008901|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
16902302|NCT02047110|38008902|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
16902303|NCT02047110|38008903|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
16902304|NCT02047110|38008904|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
16902305|NCT02047110|38008901|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
16902306|NCT02047110|38008902|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
16902307|NCT02047110|38008903|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
16902308|NCT02047110|38008904|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
16902309|NCT02047110|38008901|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
16902310|NCT02047110|38008902|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
17006184|NCT00607789|38150049|FG001|Overall Study|Lost to Follow-up|5|||
17192690|NCT02817841|38346004|FG000|Overall Study|Adverse event not related to bleeding|131|||
16902311|NCT02047110|38008903|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
16902312|NCT02047110|38008904|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
16902313|NCT02047110|38008901|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
17192691|NCT02817841|38346004|FG000|Overall Study|Adverse event related to bleeding|51|||
16902314|NCT02047110|38008902|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
16902315|NCT02047110|38008903|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
16902316|NCT02047110|38008904|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
16902317|NCT02047110|38008901|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
17006185|NCT00607789|38150048|FG000|Overall Study|Withdrawal by Subject|1|||
16902318|NCT02047110|38008902|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
16902319|NCT02047110|38008903|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
16902320|NCT02047110|38008904|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
16902321|NCT02047110|38008901|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
16902322|NCT02047110|38008902|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
16902323|NCT02047110|38008903|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
16902324|NCT02047110|38008904|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
16902325|NCT02047110|38008901|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
16902326|NCT02047110|38008902|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
16902327|NCT02047110|38008903|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
16902328|NCT02047110|38008904|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
16902329|NCT02047110|38008901|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
16902330|NCT02047110|38008902|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
16902331|NCT02047110|38008903|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
16902332|NCT02047110|38008904|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
16902333|NCT02047110|38008901|FG000|Escape Treatment Period|Adverse Event|1|||
16902334|NCT02047110|38008902|FG001|Escape Treatment Period|Adverse Event|2|||
16902335|NCT02047110|38008903|FG002|Escape Treatment Period|Adverse Event|2|||
16902336|NCT02047110|38008904|FG003|Escape Treatment Period|Adverse Event|0|||
16902337|NCT02047110|38008901|FG000|Escape Treatment Period|Other than specified|1|||
16902338|NCT02047110|38008902|FG001|Escape Treatment Period|Other than specified|2|||
16902339|NCT02047110|38008903|FG002|Escape Treatment Period|Other than specified|0|||
16902340|NCT02047110|38008904|FG003|Escape Treatment Period|Other than specified|1|||
16902341|NCT02047110|38008901|FG000|OLE Treatment Period|Other than specified|0|||
16902342|NCT02047110|38008902|FG001|OLE Treatment Period|Other than specified|0|||
16902343|NCT02047110|38008903|FG002|OLE Treatment Period|Other than specified|1|||
16902344|NCT02047110|38008904|FG003|OLE Treatment Period|Other than specified|0|||
16902345|NCT02046564|38008923|FG000|Overall Study|Adverse Event|6|||
16902346|NCT02046564|38008924|FG001|Overall Study|Adverse Event|3|||
16902347|NCT02046564|38008923|FG000|Overall Study|Physician Decision|0|||
16902348|NCT02046564|38008924|FG001|Overall Study|Physician Decision|1|||
16902349|NCT02046564|38008923|FG000|Overall Study|Protocol Violation|3|||
16902350|NCT02046564|38008924|FG001|Overall Study|Protocol Violation|1|||
16902351|NCT02046564|38008923|FG000|Overall Study|Withdrawal by Subject|4|||
16902352|NCT02046564|38008924|FG001|Overall Study|Withdrawal by Subject|10|||
16902353|NCT02046564|38008923|FG000|Overall Study|Subject met withdrawal criteria|2|||
16902354|NCT02046564|38008924|FG001|Overall Study|Subject met withdrawal criteria|5|||
16902355|NCT02046174|38008930|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
16902356|NCT02046174|38008931|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
16902357|NCT02045862|38009019|FG000|Overall Study|Death|0|||
16902358|NCT02045862|38009020|FG001|Overall Study|Death|0|||
16902359|NCT02045862|38009021|FG002|Overall Study|Death|1|||
16902360|NCT02045862|38009019|FG000|Overall Study|Miscellaneous|5|||
16902361|NCT02045862|38009020|FG001|Overall Study|Miscellaneous|0|||
16902362|NCT02045862|38009021|FG002|Overall Study|Miscellaneous|8|||
16902363|NCT02045862|38009019|FG000|Overall Study|Withdrawal by Patient|18|||
16902364|NCT02045862|38009020|FG001|Overall Study|Withdrawal by Patient|27|||
16902365|NCT02045862|38009021|FG002|Overall Study|Withdrawal by Patient|57|||
16902366|NCT02045862|38009019|FG000|Overall Study|Protocol Violation|0|||
17192692|NCT02817841|38346004|FG000|Overall Study|Pregnancy|32|||
17192693|NCT02817841|38346004|FG000|Overall Study|Pregnancy wish|17|||
17006186|NCT00607789|38150049|FG001|Overall Study|Withdrawal by Subject|0|||
17006187|NCT00887822|38150057|FG000|Overall Study|Insufficient therapeutic response|53|||
17006188|NCT00887822|38150058|FG001|Overall Study|Insufficient therapeutic response|55|||
17006189|NCT00887822|38150057|FG000|Overall Study|Adverse Event|14|||
17006190|NCT00887822|38150058|FG001|Overall Study|Adverse Event|17|||
17006191|NCT00887822|38150057|FG000|Overall Study|Failure to return|11|||
17006192|NCT00887822|38150058|FG001|Overall Study|Failure to return|11|||
17006193|NCT00887822|38150057|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
16902367|NCT02045862|38009020|FG001|Overall Study|Protocol Violation|0|||
16902368|NCT02045862|38009021|FG002|Overall Study|Protocol Violation|6|||
16902369|NCT02045862|38009019|FG000|Overall Study|Lack of Efficacy|8|||
16902370|NCT02045862|38009020|FG001|Overall Study|Lack of Efficacy|4|||
16902371|NCT02045862|38009021|FG002|Overall Study|Lack of Efficacy|13|||
16902372|NCT02045862|38009019|FG000|Overall Study|Randomized but not Received Study Drug|0|||
16902373|NCT02045862|38009020|FG001|Overall Study|Randomized but not Received Study Drug|2|||
16902374|NCT02045862|38009021|FG002|Overall Study|Randomized but not Received Study Drug|8|||
16902375|NCT02045862|38009019|FG000|Overall Study|Adverse Event|7|||
16902376|NCT02045862|38009020|FG001|Overall Study|Adverse Event|5|||
16902377|NCT02045862|38009021|FG002|Overall Study|Adverse Event|27|||
16902378|NCT02045862|38009019|FG000|Overall Study|Lost to Follow-up|1|||
16902379|NCT02045862|38009020|FG001|Overall Study|Lost to Follow-up|2|||
16902380|NCT02045862|38009021|FG002|Overall Study|Lost to Follow-up|6|||
16902381|NCT02075658|38009031|FG000|Overall Study|Physician Decision|2|||
17192694|NCT02817841|38346004|FG000|Overall Study|Other reasons|53|||
16902382|NCT02075658|38009032|FG001|Overall Study|Physician Decision|2|||
16902383|NCT02063880|38009040|FG000|Overall Study|Death|21|||
16902384|NCT02063880|38009041|FG001|Overall Study|Death|18|||
16902385|NCT02063880|38009040|FG000|Overall Study|Lost to Follow-up|7|||
16902386|NCT02063880|38009041|FG001|Overall Study|Lost to Follow-up|7|||
16902387|NCT02063880|38009040|FG000|Overall Study|Ineligible|0|||
16902388|NCT02063880|38009041|FG001|Overall Study|Ineligible|2|||
17095550|NCT00259610|38234818|FG002|Overall Study|Lost to Follow-up|18|||
17095551|NCT00259610|38234819|FG003|Overall Study|Lost to Follow-up|15|||
17095552|NCT00259610|38234816|FG000|Overall Study|Physician Decision|6|||
17095553|NCT00259610|38234817|FG001|Overall Study|Physician Decision|4|||
17095554|NCT00259610|38234818|FG002|Overall Study|Physician Decision|7|||
17095555|NCT00259610|38234819|FG003|Overall Study|Physician Decision|2|||
17095556|NCT00259610|38234816|FG000|Overall Study|Death|1|||
17095557|NCT00259610|38234817|FG001|Overall Study|Death|1|||
17095558|NCT00259610|38234818|FG002|Overall Study|Death|2|||
17095559|NCT00259610|38234819|FG003|Overall Study|Death|0|||
16902389|NCT02044848|38009049|FG000|Overall Study|Administrative Problems|2|||
16902390|NCT02044848|38009050|FG001|Overall Study|Administrative Problems|3|||
16902391|NCT02044458|38009058|FG000|Overall Study|Protocol Violation|3|||
16902392|NCT02044458|38009059|FG001|Overall Study|Protocol Violation|8|||
16902393|NCT02044302|38009067|FG000|Overall Study|study terminated|2|||
16902394|NCT02044302|38009068|FG001|Overall Study|study terminated|0|||
16902395|NCT02062944|38009072|FG000|Overall Study|Lost to Follow-up|1|||
16902396|NCT02062944|38009072|FG000|Overall Study|New hemotological disorder identified|1|||
16902397|NCT02062944|38009072|FG000|Overall Study|Uncontrolled Hypertension|1|||
16902398|NCT02062944|38009072|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
16902399|NCT02062632|38009077|FG000|Overall Study|No treatment data|1|||
16902400|NCT02062398|38009081|FG000|Overall Study|Implant removal|1|||
16902401|NCT02061540|38009085|FG000|Overall Study|Adverse Event|2|||
16902402|NCT02061540|38009085|FG000|Overall Study|Withdrawal by Subject|2|||
16902403|NCT02043366|38009100|FG000|Overall Study|Lost to Follow-up|2|||
16902404|NCT02043366|38009101|FG001|Overall Study|Lost to Follow-up|2|||
16902405|NCT02043366|38009102|FG002|Overall Study|Lost to Follow-up|2|||
16902406|NCT02043366|38009103|FG003|Overall Study|Lost to Follow-up|2|||
16902407|NCT02043366|38009104|FG004|Overall Study|Lost to Follow-up|2|||
16902408|NCT02043366|38009105|FG005|Overall Study|Lost to Follow-up|2|||
16902409|NCT02060370|38009121|FG000|Overall Study|Physician Decision|1|||
16902410|NCT01622088|38009125|FG000|Overall Study|Adverse Event|20|||
16902411|NCT01622088|38009125|FG000|Overall Study|Lost to Follow-up|1|||
16902412|NCT01622088|38009125|FG000|Overall Study|Withdrawal by Subject|20|||
16902413|NCT01622088|38009125|FG000|Overall Study|Investigator Decision|1|||
16902414|NCT01622088|38009125|FG000|Overall Study|Death|53|||
16902415|NCT01622088|38009125|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
16902416|NCT01621542|38009136|FG000|Overall Study|Adverse Event|0|||
16902417|NCT01621542|38009137|FG001|Overall Study|Adverse Event|0|||
16902418|NCT01621542|38009138|FG002|Overall Study|Adverse Event|1|||
16902419|NCT01621542|38009139|FG003|Overall Study|Adverse Event|3|||
16902420|NCT01621542|38009140|FG004|Overall Study|Adverse Event|0|||
16902421|NCT01621542|38009141|FG005|Overall Study|Adverse Event|0|||
16902422|NCT01621542|38009136|FG000|Overall Study|Death|0|||
16902423|NCT01621542|38009137|FG001|Overall Study|Death|1|||
16902424|NCT01621542|38009138|FG002|Overall Study|Death|0|||
16902425|NCT01621542|38009139|FG003|Overall Study|Death|0|||
16902426|NCT01621542|38009140|FG004|Overall Study|Death|0|||
16902427|NCT01621542|38009141|FG005|Overall Study|Death|0|||
16902428|NCT01621542|38009136|FG000|Overall Study|Physician Decision|1|||
17095560|NCT00259610|38234816|FG000|Overall Study|non medical reason|6|||
16902429|NCT01621542|38009137|FG001|Overall Study|Physician Decision|0|||
16902430|NCT01621542|38009138|FG002|Overall Study|Physician Decision|1|||
16902431|NCT01621542|38009139|FG003|Overall Study|Physician Decision|13|||
16902432|NCT01621542|38009140|FG004|Overall Study|Physician Decision|3|||
16902433|NCT01621542|38009141|FG005|Overall Study|Physician Decision|1|||
16902434|NCT01621542|38009136|FG000|Overall Study|Withdrawal by Subject|2|||
16902435|NCT01621542|38009137|FG001|Overall Study|Withdrawal by Subject|0|||
16902436|NCT01621542|38009138|FG002|Overall Study|Withdrawal by Subject|1|||
16902437|NCT01621542|38009139|FG003|Overall Study|Withdrawal by Subject|3|||
16902438|NCT01621542|38009140|FG004|Overall Study|Withdrawal by Subject|3|||
16902439|NCT01621542|38009141|FG005|Overall Study|Withdrawal by Subject|3|||
16902440|NCT01621542|38009136|FG000|Overall Study|progression/treatment failure|2|||
16902441|NCT01621542|38009137|FG001|Overall Study|progression/treatment failure|4|||
16902442|NCT01621542|38009138|FG002|Overall Study|progression/treatment failure|3|||
16902443|NCT01621542|38009139|FG003|Overall Study|progression/treatment failure|7|||
16902444|NCT01621542|38009140|FG004|Overall Study|progression/treatment failure|3|||
16902445|NCT01621542|38009141|FG005|Overall Study|progression/treatment failure|5|||
16902446|NCT01621542|38009136|FG000|Overall Study|Protocol Violation|0|||
16902447|NCT01621542|38009137|FG001|Overall Study|Protocol Violation|0|||
16902448|NCT01621542|38009138|FG002|Overall Study|Protocol Violation|0|||
17095561|NCT00259610|38234817|FG001|Overall Study|non medical reason|2|||
17095562|NCT00259610|38234818|FG002|Overall Study|non medical reason|10|||
17095563|NCT00259610|38234819|FG003|Overall Study|non medical reason|3|||
17095564|NCT00259610|38234816|FG000|Overall Study|Adverse Event|3|||
17095565|NCT00259610|38234817|FG001|Overall Study|Adverse Event|4|||
17095566|NCT00259610|38234818|FG002|Overall Study|Adverse Event|5|||
17095567|NCT00259610|38234819|FG003|Overall Study|Adverse Event|2|||
17095568|NCT00259610|38234816|FG000|Overall Study|Serious Adverse Event|8|||
17095569|NCT00259610|38234817|FG001|Overall Study|Serious Adverse Event|2|||
17095570|NCT00259610|38234818|FG002|Overall Study|Serious Adverse Event|2|||
17095571|NCT00259610|38234819|FG003|Overall Study|Serious Adverse Event|2|||
17095572|NCT00165776|38234833|FG000|Overall Study|Lack of Efficacy|0|||
17095573|NCT00165776|38234834|FG001|Overall Study|Lack of Efficacy|0|||
17095574|NCT00165776|38234835|FG002|Overall Study|Lack of Efficacy|0|||
17095575|NCT00165776|38234836|FG003|Overall Study|Lack of Efficacy|1|||
17095576|NCT00165776|38234833|FG000|Overall Study|Withdrawal by Subject|4|||
17095577|NCT00165776|38234834|FG001|Overall Study|Withdrawal by Subject|1|||
17095578|NCT00165776|38234835|FG002|Overall Study|Withdrawal by Subject|2|||
17095579|NCT00165776|38234836|FG003|Overall Study|Withdrawal by Subject|0|||
17095580|NCT00165776|38234833|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
17095581|NCT00165776|38234834|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
17095582|NCT00165776|38234835|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
17095583|NCT00165776|38234836|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
17095584|NCT00165698|38234848|FG000|Overall Study|Adverse Event|2|||
17095585|NCT00165698|38234849|FG001|Overall Study|Adverse Event|10|||
17095586|NCT00165698|38234848|FG000|Overall Study|Lost to Follow-up|2|||
17095587|NCT00165698|38234849|FG001|Overall Study|Lost to Follow-up|2|||
17095588|NCT00165698|38234848|FG000|Overall Study|Withdrawal by Subject|2|||
17095589|NCT00165698|38234849|FG001|Overall Study|Withdrawal by Subject|1|||
17095590|NCT00165698|38234848|FG000|Overall Study|Protocol Violation|1|||
17095591|NCT00165698|38234849|FG001|Overall Study|Protocol Violation|0|||
17095592|NCT00165698|38234848|FG000|Overall Study|Not Taken/Lost the medicine|1|||
16902449|NCT01621542|38009139|FG003|Overall Study|Protocol Violation|1|||
16902450|NCT01621542|38009140|FG004|Overall Study|Protocol Violation|0|||
16902451|NCT01621542|38009141|FG005|Overall Study|Protocol Violation|0|||
16902452|NCT01621542|38009136|FG000|Overall Study|study stopped by sponsor|0|||
16902453|NCT01621542|38009137|FG001|Overall Study|study stopped by sponsor|0|||
16902454|NCT01621542|38009138|FG002|Overall Study|study stopped by sponsor|0|||
16902455|NCT01621542|38009139|FG003|Overall Study|study stopped by sponsor|1|||
16902456|NCT01621542|38009140|FG004|Overall Study|study stopped by sponsor|0|||
16902457|NCT01621542|38009141|FG005|Overall Study|study stopped by sponsor|0|||
16902458|NCT02021292|38009157|FG000|Overall Study|Physician Decision|0|||
16902459|NCT02021292|38009158|FG001|Overall Study|Physician Decision|1|||
16902460|NCT02021292|38009157|FG000|Overall Study|Lost to Follow-up|0|||
16902461|NCT02021292|38009158|FG001|Overall Study|Lost to Follow-up|1|||
16902462|NCT02021292|38009157|FG000|Overall Study|Death|0|||
16902463|NCT02021292|38009158|FG001|Overall Study|Death|1|||
16902464|NCT02059980|38009168|FG000|Overall Study|Lost to Follow-up|2|||
16902465|NCT02059980|38009169|FG001|Overall Study|Lost to Follow-up|1|||
16902466|NCT02043132|38009177|FG000|Overall Study|Lost to Follow-up|1|||
16902467|NCT02043132|38009178|FG001|Overall Study|Lost to Follow-up|1|||
16902468|NCT02043132|38009177|FG000|Overall Study|screen failures|4|||
16902469|NCT02043132|38009178|FG001|Overall Study|screen failures|8|||
16902470|NCT02059434|38009193|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
16902471|NCT02059434|38009194|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
16902472|NCT02059434|38009195|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
16902473|NCT02059434|38009196|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
16902474|NCT02059434|38009197|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
16902475|NCT02059434|38009198|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
16902476|NCT02059434|38009199|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
16902477|NCT02059434|38009200|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
16902478|NCT02059434|38009201|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
16902479|NCT02059434|38009193|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
16902480|NCT02059434|38009194|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
16902481|NCT02059434|38009195|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
16902482|NCT02059434|38009196|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
16902483|NCT02059434|38009197|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
16902484|NCT02059434|38009198|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
16902485|NCT02059434|38009199|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
16902486|NCT02059434|38009200|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
16902487|NCT02059434|38009201|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
16902488|NCT02059434|38009193|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
16902489|NCT02059434|38009194|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
16902490|NCT02059434|38009195|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
17006194|NCT00887822|38150058|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
17095593|NCT00165698|38234849|FG001|Overall Study|Not Taken/Lost the medicine|2|||
17095594|NCT00225758|38234855|FG000|Overall Study|Adverse Event|4|||
16902491|NCT02059434|38009196|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
16902492|NCT02059434|38009197|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
16902493|NCT02059434|38009198|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
16902494|NCT02059434|38009199|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
16902495|NCT02059434|38009200|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
16902496|NCT02059434|38009201|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
16902497|NCT02059434|38009193|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
16902498|NCT02059434|38009194|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
16902499|NCT02059434|38009195|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
16902500|NCT02059434|38009196|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
16902501|NCT02059434|38009197|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
16902502|NCT02059434|38009198|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
16902503|NCT02059434|38009199|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
16902504|NCT02059434|38009200|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
16902505|NCT02059434|38009201|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
16902506|NCT02059434|38009193|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16902507|NCT02059434|38009194|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16902508|NCT02059434|38009195|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
17006195|NCT00887822|38150057|FG000|Overall Study|Administrative/Other than specified|5|||
17006196|NCT00887822|38150058|FG001|Overall Study|Administrative/Other than specified|4|||
17006197|NCT00887822|38150057|FG000|Overall Study|Death|2|||
17006198|NCT00887822|38150058|FG001|Overall Study|Death|3|||
17006199|NCT00887822|38150057|FG000|Overall Study|Protocol Violation|0|||
17006200|NCT00887822|38150058|FG001|Overall Study|Protocol Violation|1|||
17006201|NCT00887822|38150057|FG000|Overall Study|Randomized but not treated|0|||
17006202|NCT00887822|38150058|FG001|Overall Study|Randomized but not treated|1|||
17006203|NCT00951665|38150070|FG000|Phase 1b|Adverse Event|2|||
17192695|NCT02817841|38346004|FG000|Overall Study|Protocol Violation|94|||
17192696|NCT02814565|38346014|FG000|Overall Study|Lack of Efficacy|0|||
17192697|NCT02814565|38346015|FG001|Overall Study|Lack of Efficacy|1|||
17192698|NCT02814565|38346014|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
17192699|NCT02814565|38346015|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
17192700|NCT02650466|38346021|FG000|Overall Study|Physician Decision|1|||
17192701|NCT02650466|38346021|FG000|Overall Study|Withdrawal by Subject|5|||
17192702|NCT02650466|38346021|FG000|Overall Study|Lost to Follow-up|1|||
17192703|NCT02815735|38346027|FG000|First Intervention (4 Weeks)|Discomfort|1|||
17192704|NCT02815735|38346028|FG001|First Intervention (4 Weeks)|Discomfort|0|||
17192705|NCT02815735|38346027|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
17192706|NCT02815735|38346028|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
17192707|NCT02815735|38346027|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
17192708|NCT02815735|38346028|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
17192709|NCT02815735|38346027|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
17192710|NCT02815735|38346028|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
17192711|NCT02814643|38346045|FG000|Overall Study|Lost to Follow-up|0|||
17192712|NCT02814643|38346046|FG001|Overall Study|Lost to Follow-up|1|||
17192713|NCT02814643|38346045|FG000|Overall Study|Withdrawal by Subject|1|||
17192714|NCT02814643|38346046|FG001|Overall Study|Withdrawal by Subject|2|||
17192715|NCT02724111|38346054|FG000|Overall Study|Protocol Violation|2|||
17192716|NCT02724111|38346055|FG001|Overall Study|Protocol Violation|5|||
17192717|NCT02649218|38346061|FG000|Overall Study|Adverse Event|8|||
17192718|NCT02649218|38346061|FG000|Overall Study|Lack of Efficacy|8|||
17192719|NCT02649218|38346061|FG000|Overall Study|Pregnancy|3|||
17192720|NCT02649218|38346061|FG000|Overall Study|Protocol Violation|3|||
17192721|NCT02649218|38346061|FG000|Overall Study|Physician Decision|1|||
17192722|NCT02649218|38346061|FG000|Overall Study|Withdrawal by Subject|2|||
17192723|NCT02814175|38346068|FG000|Part 1|Adverse Event|2|||
17192724|NCT02814175|38346069|FG001|Part 1|Adverse Event|3|||
17192725|NCT02814175|38346070|FG002|Part 1|Adverse Event|0|||
17192726|NCT02814175|38346071|FG003|Part 1|Adverse Event|0|||
17192727|NCT02814175|38346072|FG004|Part 1|Adverse Event|0|||
17192728|NCT02814175|38346073|FG005|Part 1|Adverse Event|0|||
17192729|NCT02814175|38346068|FG000|Part 1|Withdrawal Consent|8|||
17192730|NCT02814175|38346069|FG001|Part 1|Withdrawal Consent|1|||
17192731|NCT02814175|38346070|FG002|Part 1|Withdrawal Consent|0|||
17192732|NCT02814175|38346071|FG003|Part 1|Withdrawal Consent|0|||
17192733|NCT02814175|38346072|FG004|Part 1|Withdrawal Consent|0|||
17192734|NCT02814175|38346073|FG005|Part 1|Withdrawal Consent|0|||
17192735|NCT02814175|38346068|FG000|Part 1|Lost to Follow-up|1|||
17192736|NCT02814175|38346069|FG001|Part 1|Lost to Follow-up|0|||
17192737|NCT02814175|38346070|FG002|Part 1|Lost to Follow-up|0|||
17192738|NCT02814175|38346071|FG003|Part 1|Lost to Follow-up|0|||
17192739|NCT02814175|38346072|FG004|Part 1|Lost to Follow-up|0|||
17192740|NCT02814175|38346073|FG005|Part 1|Lost to Follow-up|0|||
17192741|NCT02814175|38346068|FG000|Part 1|Lack of Efficacy|1|||
17192742|NCT02814175|38346069|FG001|Part 1|Lack of Efficacy|2|||
17192743|NCT02814175|38346070|FG002|Part 1|Lack of Efficacy|0|||
17192744|NCT02814175|38346071|FG003|Part 1|Lack of Efficacy|0|||
16902509|NCT02059434|38009196|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16902510|NCT02059434|38009197|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16902511|NCT02059434|38009198|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16902512|NCT02059434|38009199|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16902513|NCT02059434|38009200|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16902514|NCT02059434|38009201|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
16902515|NCT02059278|38009231|FG000|Overall Study|Adverse Event|1|||
16902516|NCT02059278|38009232|FG001|Overall Study|Adverse Event|1|||
16902517|NCT02059278|38009231|FG000|Overall Study|Lost to Follow-up|1|||
16902518|NCT02059278|38009232|FG001|Overall Study|Lost to Follow-up|0|||
16902519|NCT02059278|38009231|FG000|Overall Study|Withdrawal by Subject|0|||
16902520|NCT02059278|38009232|FG001|Overall Study|Withdrawal by Subject|3|||
16902521|NCT02059278|38009231|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
16902522|NCT02059278|38009232|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
16902523|NCT02020512|38009238|FG000|Overall Study|Adverse Event|1|||
16902524|NCT02020512|38009238|FG000|Overall Study|Lost to Follow-up|3|||
16902525|NCT02020512|38009238|FG000|Overall Study|Protocol Violation|4|||
16902526|NCT02041962|38009244|FG000|Overall Study|Lost Aetna Coverage|43|||
16902527|NCT02041962|38009245|FG001|Overall Study|Lost Aetna Coverage|40|||
16902528|NCT02041962|38009244|FG000|Overall Study|Death|1|||
16902529|NCT02041962|38009245|FG001|Overall Study|Death|1|||
16902530|NCT02041962|38009244|FG000|Overall Study|Lost to Follow-up|37|||
16902531|NCT02041962|38009245|FG001|Overall Study|Lost to Follow-up|32|||
16902532|NCT02041962|38009244|FG000|Overall Study|Withdrawal by Subject|0|||
16902533|NCT02041962|38009245|FG001|Overall Study|Withdrawal by Subject|11|||
16902534|NCT02041494|38009253|FG000|Overall Study|Death|1|||
16902535|NCT02041494|38009254|FG001|Overall Study|Death|3|||
16902536|NCT02041494|38009253|FG000|Overall Study|Lost to Follow-up|2|||
16902537|NCT02041494|38009254|FG001|Overall Study|Lost to Follow-up|6|||
16902538|NCT02041494|38009253|FG000|Overall Study|study terminated|16|||
16902539|NCT02041494|38009254|FG001|Overall Study|study terminated|11|||
16902540|NCT02041104|38009285|FG000|Overall Study|Lost to Follow-up|1|||
16902541|NCT02041104|38009286|FG001|Overall Study|Lost to Follow-up|4|||
16902542|NCT02041104|38009285|FG000|Overall Study|discomfort during OGTT|0|||
16902543|NCT02041104|38009286|FG001|Overall Study|discomfort during OGTT|3|||
16902544|NCT02019420|38009296|FG000|Overall Study|Did not receive study drug|2|||
16902545|NCT02019420|38009297|FG001|Overall Study|Did not receive study drug|2|||
16902546|NCT02019420|38009296|FG000|Overall Study|Withdrawal by Subject|1|||
16902547|NCT02019420|38009297|FG001|Overall Study|Withdrawal by Subject|3|||
16902548|NCT02019420|38009296|FG000|Overall Study|At request of sponsor or investigator|0|||
16902549|NCT02019420|38009297|FG001|Overall Study|At request of sponsor or investigator|1|||
16902550|NCT02019420|38009296|FG000|Overall Study|Death|104|||
16902551|NCT02019420|38009297|FG001|Overall Study|Death|99|||
16902552|NCT02019420|38009296|FG000|Overall Study|Transferred to other care facility|1|||
16902553|NCT02019420|38009297|FG001|Overall Study|Transferred to other care facility|1|||
16902554|NCT02019264|38009305|FG000|Overall Study|Not treated|6|||
16902555|NCT02019264|38009306|FG001|Overall Study|Not treated|4|||
16902556|NCT02019264|38009305|FG000|Overall Study|Lost to Follow-up|50|||
16902557|NCT02019264|38009306|FG001|Overall Study|Lost to Follow-up|47|||
16902558|NCT02019264|38009305|FG000|Overall Study|Withdrawal by Subject|142|||
16902559|NCT02019264|38009306|FG001|Overall Study|Withdrawal by Subject|117|||
16902560|NCT02019264|38009305|FG000|Overall Study|Administrative reason|36|||
16902561|NCT02019264|38009306|FG001|Overall Study|Administrative reason|28|||
16902562|NCT02019264|38009305|FG000|Overall Study|Missing|14|||
16902563|NCT02019264|38009306|FG001|Overall Study|Missing|11|||
16902564|NCT02019108|38009314|FG000|Overall Study|Lost to Follow-up|5|||
16902565|NCT02019108|38009315|FG001|Overall Study|Lost to Follow-up|7|||
16902566|NCT02018562|38009323|FG000|Overall Study|Withdrawal by Subject|2|||
16902567|NCT02018562|38009324|FG001|Overall Study|Withdrawal by Subject|0|||
16902568|NCT02018562|38009323|FG000|Overall Study|Discharged prior to study completion|1|||
16902569|NCT02018562|38009324|FG001|Overall Study|Discharged prior to study completion|0|||
16902570|NCT02058966|38009330|FG000|Open-Label Methamphetamine|Adverse Event|1|||
16902571|NCT02058966|38009330|FG000|First Intervention|Withdrawal by Subject|1|||
16902572|NCT02017860|38009342|FG000|Overall Study|Adverse Event|1|||
16902573|NCT02017860|38009342|FG000|Overall Study|Withdrawal by Subject|1|||
16902574|NCT02040870|38009346|FG000|Overall Study|Completed treatment phase|6|||
16902575|NCT02040870|38009346|FG000|Overall Study|Adverse Event|7|||
16902576|NCT02040870|38009346|FG000|Overall Study|Progressive disease|58|||
16902577|NCT02040870|38009346|FG000|Overall Study|Physician Decision|6|||
16902578|NCT02040870|38009346|FG000|Overall Study|Subject/guardian decision|10|||
16902579|NCT02040870|38009346|FG000|Overall Study|Lost to Follow-up|3|||
16902580|NCT02040870|38009346|FG000|Overall Study|Death|13|||
16902581|NCT02016690|38009350|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
16902582|NCT02016690|38009350|FG000|Overall Study|Excluded from SAS: Duplication|2|||
16902583|NCT02016690|38009350|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
16902584|NCT02016690|38009350|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
16902585|NCT02016690|38009350|FG000|Overall Study|Did not meet inclusion criteria|13|||
16902586|NCT02016690|38009350|FG000|Overall Study|Hospitalized for RSV at study start|3|||
16902587|NCT02016300|38009356|FG000|Overall Study|Lost to Follow-up|0|||
16902588|NCT02016300|38009357|FG001|Overall Study|Lost to Follow-up|3|||
16902589|NCT02040090|38009365|FG000|Overall Study|Adverse Event|2|||
16902590|NCT02040090|38009366|FG001|Overall Study|Adverse Event|0|||
16902591|NCT02040090|38009365|FG000|Overall Study|Physician Decision|1|||
16902592|NCT02040090|38009366|FG001|Overall Study|Physician Decision|0|||
16902593|NCT02040090|38009365|FG000|Overall Study|Withdrawal by Subject|0|||
16902594|NCT02040090|38009366|FG001|Overall Study|Withdrawal by Subject|1|||
16902595|NCT02040090|38009365|FG000|Overall Study|Lost to Follow-up|0|||
16902596|NCT02040090|38009366|FG001|Overall Study|Lost to Follow-up|1|||
16902597|NCT02058498|38009372|FG000|Overall Study|Withdrawal by Subject|4|||
16902598|NCT02039856|38009378|FG000|Overall Study|Death|5|||
16902599|NCT02039856|38009379|FG001|Overall Study|Death|3|||
16902600|NCT02039856|38009378|FG000|Overall Study|Partial survey completion|61|||
16902601|NCT02039856|38009379|FG001|Overall Study|Partial survey completion|26|||
16902602|NCT02039856|38009378|FG000|Overall Study|Lost to Follow-up|388|||
16902603|NCT02039856|38009379|FG001|Overall Study|Lost to Follow-up|206|||
16902604|NCT02039856|38009378|FG000|Overall Study|Withdrawal by Subject|1573|||
16902605|NCT02039856|38009379|FG001|Overall Study|Withdrawal by Subject|618|||
16902606|NCT02039778|38009387|FG000|Overall Study|Death|2|||
16902607|NCT02039778|38009387|FG000|Overall Study|Withdrawal by Subject|1|||
16902608|NCT02039778|38009387|FG000|Overall Study|Never started the protocol treatment|1|||
16902609|NCT02015754|38009391|FG000|Overall Study|Disease progression|5|||
16902610|NCT02015754|38009391|FG000|Overall Study|Change in treatment modality|5|||
16902611|NCT02015754|38009391|FG000|Overall Study|Lost to Follow-up|1|||
16902612|NCT02015676|38009398|FG000|Overall Study|Adverse Event|2|||
16902613|NCT02015676|38009399|FG001|Overall Study|Adverse Event|18|||
16902614|NCT02015676|38009400|FG002|Overall Study|Adverse Event|0|||
16902615|NCT02015676|38009398|FG000|Overall Study|Lack of Efficacy|2|||
16902616|NCT02015676|38009399|FG001|Overall Study|Lack of Efficacy|4|||
16902617|NCT02015676|38009400|FG002|Overall Study|Lack of Efficacy|0|||
16902618|NCT02015676|38009398|FG000|Overall Study|Protocol Violation|1|||
16902619|NCT02015676|38009399|FG001|Overall Study|Protocol Violation|0|||
16902620|NCT02015676|38009400|FG002|Overall Study|Protocol Violation|0|||
16902621|NCT02015676|38009398|FG000|Overall Study|Withdrawal by Subject|1|||
16902622|NCT02015676|38009399|FG001|Overall Study|Withdrawal by Subject|7|||
16902623|NCT02015676|38009400|FG002|Overall Study|Withdrawal by Subject|1|||
16902624|NCT02015676|38009398|FG000|Overall Study|Administrative reasons|0|||
16902625|NCT02015676|38009399|FG001|Overall Study|Administrative reasons|3|||
16786213|NCT02690701|37726670|FG001|Treatment Period 2|Withdrawal by Subject|2|||
16786214|NCT02690701|37726669|FG000|Treatment Period 2|Protocol Violation|0|||
16786215|NCT02690701|37726670|FG001|Treatment Period 2|Protocol Violation|1|||
16786216|NCT02694757|37726677|FG000|Overall Study|Lack of Efficacy|3|||
16902626|NCT02015676|38009400|FG002|Overall Study|Administrative reasons|1|||
16902627|NCT02015676|38009398|FG000|Overall Study|Death|0|||
16902628|NCT02015676|38009399|FG001|Overall Study|Death|1|||
16902629|NCT02015676|38009400|FG002|Overall Study|Death|0|||
16902630|NCT02015676|38009398|FG000|Overall Study|Disease progression|3|||
16902631|NCT02015676|38009399|FG001|Overall Study|Disease progression|1|||
16902632|NCT02015676|38009400|FG002|Overall Study|Disease progression|1|||
16902633|NCT02015520|38009408|FG000|Overall Study|Lack of Efficacy|1|||
16902634|NCT02015520|38009409|FG001|Overall Study|Lack of Efficacy|0|||
16902635|NCT02015520|38009410|FG002|Overall Study|Lack of Efficacy|3|||
16902636|NCT02015520|38009411|FG003|Overall Study|Lack of Efficacy|2|||
16902637|NCT02015520|38009408|FG000|Overall Study|Adverse Event|0|||
16902638|NCT02015520|38009409|FG001|Overall Study|Adverse Event|0|||
16902639|NCT02015520|38009410|FG002|Overall Study|Adverse Event|0|||
16902640|NCT02015520|38009411|FG003|Overall Study|Adverse Event|1|||
16902641|NCT02015520|38009408|FG000|Overall Study|Withdrawal by Subject|2|||
16902642|NCT02015520|38009409|FG001|Overall Study|Withdrawal by Subject|2|||
16902643|NCT02015520|38009410|FG002|Overall Study|Withdrawal by Subject|1|||
16902644|NCT02015520|38009411|FG003|Overall Study|Withdrawal by Subject|0|||
16902645|NCT02015520|38009408|FG000|Overall Study|Death|1|||
16902646|NCT02015520|38009409|FG001|Overall Study|Death|0|||
16902647|NCT02015520|38009410|FG002|Overall Study|Death|0|||
16902648|NCT02015520|38009411|FG003|Overall Study|Death|0|||
16902649|NCT02015520|38009408|FG000|Overall Study|Lost to Follow-up|0|||
16902650|NCT02015520|38009409|FG001|Overall Study|Lost to Follow-up|0|||
16902651|NCT02015520|38009410|FG002|Overall Study|Lost to Follow-up|1|||
16902652|NCT02015520|38009411|FG003|Overall Study|Lost to Follow-up|0|||
16902653|NCT02015520|38009408|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
16902654|NCT02015520|38009409|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
16902655|NCT02015520|38009410|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
16902656|NCT02015520|38009411|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
16902657|NCT02015520|38009408|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
16902658|NCT02015520|38009409|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
16902659|NCT02015520|38009410|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
16902660|NCT02015520|38009411|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
16902661|NCT02058108|38009423|FG000|Overall Study|Abnormal Laboratory Values|0|||
16902662|NCT02058108|38009424|FG001|Overall Study|Abnormal Laboratory Values|1|||
16902663|NCT02058108|38009423|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
16902664|NCT02058108|38009424|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
16902665|NCT02058108|38009423|FG000|Overall Study|No longer requires study drug|0|||
16902666|NCT02058108|38009424|FG001|Overall Study|No longer requires study drug|1|||
16902667|NCT02058108|38009423|FG000|Overall Study|Withdrawal by Subject|1|||
16902668|NCT02058108|38009424|FG001|Overall Study|Withdrawal by Subject|0|||
16902669|NCT02058108|38009423|FG000|Overall Study|Administrative problems|3|||
16902670|NCT02058108|38009424|FG001|Overall Study|Administrative problems|3|||
16902671|NCT02058108|38009423|FG000|Overall Study|Protocol Violation|0|||
16902672|NCT02058108|38009424|FG001|Overall Study|Protocol Violation|1|||
16902673|NCT02057874|38009432|FG000|Overall Study|participant did not return for scan|1|||
16902674|NCT02038920|38009439|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
16902675|NCT02038920|38009440|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
16902676|NCT02038920|38009441|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
16902677|NCT02038920|38009442|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
17006204|NCT00951665|38150071|FG001|Phase 1b|Adverse Event|1|||
17006205|NCT00951665|38150072|FG002|Phase 1b|Adverse Event|0|||
17006206|NCT00951665|38150073|FG003|Phase 1b|Adverse Event|1|||
17006207|NCT00951665|38150074|FG004|Phase 1b|Adverse Event|0|||
17006208|NCT00951665|38150075|FG005|Phase 1b|Adverse Event|0|||
16902678|NCT02038920|38009443|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
16902679|NCT02038920|38009444|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
16902680|NCT02038920|38009439|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
16902681|NCT02038920|38009440|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16902682|NCT02038920|38009441|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16902683|NCT02038920|38009442|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16902684|NCT02038920|38009443|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16902685|NCT02038920|38009444|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16902686|NCT02038920|38009439|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
16902687|NCT02038920|38009440|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
16902688|NCT02038920|38009441|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
16902689|NCT02038920|38009442|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
16902690|NCT02038920|38009443|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
16902691|NCT02038920|38009444|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
16902692|NCT02038920|38009439|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
16902693|NCT02038920|38009440|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
16902694|NCT02038920|38009441|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
16902695|NCT02038920|38009442|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
16902696|NCT02038920|38009443|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
16902697|NCT02038920|38009444|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
16902698|NCT02038920|38009439|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16902699|NCT02038920|38009440|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16902700|NCT02038920|38009441|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
16902701|NCT02038920|38009442|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
17006209|NCT00951665|38150070|FG000|Phase 1b|Death|1|||
17006210|NCT00951665|38150071|FG001|Phase 1b|Death|0|||
17006211|NCT00951665|38150072|FG002|Phase 1b|Death|2|||
17006212|NCT00951665|38150073|FG003|Phase 1b|Death|0|||
17006213|NCT00951665|38150074|FG004|Phase 1b|Death|0|||
17006214|NCT00951665|38150075|FG005|Phase 1b|Death|0|||
17006215|NCT00951665|38150070|FG000|Phase 1b|Physician Decision|4|||
17006216|NCT00951665|38150071|FG001|Phase 1b|Physician Decision|0|||
17006217|NCT00951665|38150072|FG002|Phase 1b|Physician Decision|1|||
17006218|NCT00951665|38150073|FG003|Phase 1b|Physician Decision|0|||
17095595|NCT00259298|38234861|FG000|Overall Study|Withdrawal by Subject|1|||
17095596|NCT00259298|38234861|FG000|Overall Study|Physician Decision|2|||
17095597|NCT03789292|38234871|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
17095598|NCT03789292|38234872|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
17095599|NCT03789292|38234873|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
17095600|NCT03789292|38234871|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
17095601|NCT03789292|38234872|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
17095602|NCT03789292|38234873|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
17095603|NCT03789292|38234871|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
17095604|NCT03789292|38234872|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
17095605|NCT03789292|38234873|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
17095606|NCT03789292|38234871|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
17192745|NCT02814175|38346072|FG004|Part 1|Lack of Efficacy|0|||
17006219|NCT00951665|38150074|FG004|Phase 1b|Physician Decision|0|||
17006220|NCT00951665|38150075|FG005|Phase 1b|Physician Decision|0|||
17006221|NCT00951665|38150070|FG000|Phase 1b|Withdrawal by Subject|0|||
17006222|NCT00951665|38150071|FG001|Phase 1b|Withdrawal by Subject|1|||
17006223|NCT00951665|38150072|FG002|Phase 1b|Withdrawal by Subject|0|||
17006224|NCT00951665|38150073|FG003|Phase 1b|Withdrawal by Subject|0|||
16902702|NCT02038920|38009443|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16902703|NCT02038920|38009444|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16902704|NCT02038920|38009439|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
16902705|NCT02038920|38009440|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
16902706|NCT02038920|38009441|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
16902707|NCT02038920|38009442|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
16902708|NCT02038920|38009443|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
16902709|NCT02038920|38009444|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
16902710|NCT02038920|38009439|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16902711|NCT02038920|38009440|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16902712|NCT02038920|38009441|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16902713|NCT02038920|38009442|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16902714|NCT02038920|38009443|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16902715|NCT02038920|38009444|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
16902716|NCT02038920|38009439|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16902717|NCT02038920|38009440|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16902718|NCT02038920|38009441|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16902719|NCT02038920|38009442|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16902720|NCT02038920|38009443|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16902721|NCT02038920|38009444|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
16902722|NCT02038920|38009439|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16902723|NCT02038920|38009440|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16902724|NCT02038920|38009441|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16902725|NCT02038920|38009442|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16902726|NCT02038920|38009443|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16902727|NCT02038920|38009444|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
16902728|NCT02038920|38009439|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16902729|NCT02038920|38009440|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16902730|NCT02038920|38009441|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16902731|NCT02038920|38009442|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16902732|NCT02038920|38009443|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16902733|NCT02038920|38009444|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
16902734|NCT02038920|38009439|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16902735|NCT02038920|38009440|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16902736|NCT02038920|38009441|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16902737|NCT02038920|38009442|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16902738|NCT02038920|38009443|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16902739|NCT02038920|38009444|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
16902740|NCT02038920|38009439|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16902741|NCT02038920|38009440|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16902742|NCT02038920|38009441|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16902743|NCT02038920|38009442|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16902744|NCT02038920|38009443|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16902745|NCT02038920|38009444|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
16902746|NCT02038764|38009466|FG000|Overall Study|Adverse Event|0|||
17006225|NCT00951665|38150074|FG004|Phase 1b|Withdrawal by Subject|0|||
17006226|NCT00951665|38150075|FG005|Phase 1b|Withdrawal by Subject|0|||
17006227|NCT00951665|38150070|FG000|Phase 1b|Disease Progression|13|||
17006228|NCT00951665|38150071|FG001|Phase 1b|Disease Progression|2|||
17006229|NCT00951665|38150072|FG002|Phase 1b|Disease Progression|14|||
17006230|NCT00951665|38150073|FG003|Phase 1b|Disease Progression|0|||
17006231|NCT00951665|38150074|FG004|Phase 1b|Disease Progression|0|||
17006232|NCT00951665|38150075|FG005|Phase 1b|Disease Progression|0|||
17006233|NCT00951665|38150070|FG000|Phase 1b|Protocol Violation|2|||
17095607|NCT03789292|38234872|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
17095608|NCT03789292|38234873|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
17095609|NCT03789292|38234871|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
17095610|NCT03789292|38234872|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
17095611|NCT03789292|38234873|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
17095612|NCT03789292|38234871|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
17095613|NCT03789292|38234872|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
17006234|NCT00951665|38150071|FG001|Phase 1b|Protocol Violation|0|||
16902747|NCT02038764|38009467|FG001|Overall Study|Adverse Event|0|||
16902748|NCT02038764|38009468|FG002|Overall Study|Adverse Event|1|||
16902749|NCT02038764|38009469|FG003|Overall Study|Adverse Event|0|||
16902750|NCT02038764|38009470|FG004|Overall Study|Adverse Event|0|||
16902751|NCT02038764|38009466|FG000|Overall Study|Lost to Follow-up|0|||
16902752|NCT02038764|38009467|FG001|Overall Study|Lost to Follow-up|1|||
16902753|NCT02038764|38009468|FG002|Overall Study|Lost to Follow-up|0|||
16902754|NCT02038764|38009469|FG003|Overall Study|Lost to Follow-up|0|||
16902755|NCT02038764|38009470|FG004|Overall Study|Lost to Follow-up|0|||
16902756|NCT02038764|38009466|FG000|Overall Study|Withdrawal by Subject|0|||
16902757|NCT02038764|38009467|FG001|Overall Study|Withdrawal by Subject|0|||
16902758|NCT02038764|38009468|FG002|Overall Study|Withdrawal by Subject|0|||
16902759|NCT02038764|38009469|FG003|Overall Study|Withdrawal by Subject|0|||
16902760|NCT02038764|38009470|FG004|Overall Study|Withdrawal by Subject|1|||
16902761|NCT02038764|38009466|FG000|Overall Study|Other|1|||
16902762|NCT02038764|38009467|FG001|Overall Study|Other|0|||
16902763|NCT02038764|38009468|FG002|Overall Study|Other|1|||
16902764|NCT02038764|38009469|FG003|Overall Study|Other|0|||
16902765|NCT02038764|38009470|FG004|Overall Study|Other|0|||
16902766|NCT02057718|38009488|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
16902767|NCT02057718|38009489|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
16902768|NCT02057718|38009488|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
16902769|NCT02057718|38009489|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
16902770|NCT02057718|38009488|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
16902771|NCT02057718|38009489|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
16902772|NCT02057718|38009488|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
16902773|NCT02057718|38009489|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
16902774|NCT02057718|38009488|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
16902775|NCT02057718|38009489|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
16902776|NCT02057718|38009488|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
16902777|NCT02057718|38009489|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
17006235|NCT00951665|38150072|FG002|Phase 1b|Protocol Violation|0|||
17006236|NCT00951665|38150073|FG003|Phase 1b|Protocol Violation|0|||
17006237|NCT00951665|38150074|FG004|Phase 1b|Protocol Violation|0|||
17095614|NCT03789292|38234873|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
16902778|NCT02057718|38009488|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
16902779|NCT02057718|38009489|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
16902780|NCT02057718|38009488|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
16902781|NCT02057718|38009489|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
16902782|NCT02057718|38009488|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
16902783|NCT02057718|38009489|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
16902784|NCT02057718|38009488|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
16902785|NCT02057718|38009489|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
16902786|NCT02057718|38009488|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
16902787|NCT02057718|38009489|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
16902788|NCT01622868|38009497|FG000|Overall Study|Protocol Violation|7|||
16902789|NCT01622868|38009498|FG001|Overall Study|Protocol Violation|0|||
16902790|NCT02014740|38009506|FG000|Overall Study|Lost to Follow-up|4|||
16902791|NCT02014740|38009507|FG001|Overall Study|Lost to Follow-up|4|||
16902792|NCT02014740|38009506|FG000|Overall Study|Withdrawal by Subject|2|||
16902793|NCT02014740|38009507|FG001|Overall Study|Withdrawal by Subject|1|||
16902794|NCT02014584|38009515|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16902795|NCT02014584|38009516|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
16902796|NCT02014584|38009517|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16902797|NCT02014584|38009518|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16902798|NCT02014584|38009519|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16902799|NCT02014584|38009520|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16902800|NCT02014584|38009515|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
16902801|NCT02014584|38009516|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
16902802|NCT02014584|38009517|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
17095615|NCT03789292|38234871|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
17095616|NCT03789292|38234872|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
17095617|NCT03789292|38234873|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
17095618|NCT03789292|38234871|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
17095619|NCT03789292|38234872|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
17095620|NCT03789292|38234873|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
16902803|NCT02014584|38009518|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
16902804|NCT02014584|38009519|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
16902805|NCT02014584|38009520|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
17006238|NCT00951665|38150075|FG005|Phase 1b|Protocol Violation|0|||
17095621|NCT03789292|38234871|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
17095622|NCT03789292|38234872|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
16902806|NCT02014584|38009515|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16902807|NCT02014584|38009516|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16902808|NCT02014584|38009517|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
17095623|NCT03789292|38234873|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
17095624|NCT03789292|38234871|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
17095625|NCT03789292|38234872|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
17095626|NCT03789292|38234873|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
17095627|NCT03789292|38234871|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
17095628|NCT03789292|38234872|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
17095629|NCT03789292|38234873|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
17095630|NCT03789292|38234871|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
17095631|NCT03789292|38234872|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
17095632|NCT03789292|38234873|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
17095633|NCT03789292|38234871|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
17095634|NCT03789292|38234872|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
17095635|NCT03789292|38234873|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
17095636|NCT03781336|38234889|FG000|Overall Study|Withdrawal by Subject|2|||
17095637|NCT03781336|38234890|FG001|Overall Study|Withdrawal by Subject|2|||
17095638|NCT03780400|38234896|FG000|Overall Study|Lost to Follow-up|5|||
17095639|NCT03780400|38234896|FG000|Overall Study|Withdrawal by Subject|2|||
17095640|NCT03780244|38234902|FG000|Overall Study|Lost to Follow-up|1|||
17095641|NCT03780244|38234903|FG001|Overall Study|Lost to Follow-up|0|||
17095642|NCT03786718|38234909|FG000|Overall Study|Lost to Follow-up|3|||
17095643|NCT03786718|38234909|FG000|Overall Study|Withdrawal by Subject|1|||
17095644|NCT03786718|38234909|FG000|Overall Study|Did not use the intervention|2|||
17095645|NCT03786718|38234909|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
17095646|NCT03785548|38234916|FG000|Overall Study|age > 80|1|||
17095647|NCT03785548|38234917|FG001|Overall Study|age > 80|0|||
17095648|NCT03785548|38234916|FG000|Overall Study|no Postop queries|1|||
17095649|NCT03785548|38234917|FG001|Overall Study|no Postop queries|0|||
17095650|NCT00141297|38234925|FG000|Overall Study|Adverse Event|0|||
17095651|NCT00141297|38234926|FG001|Overall Study|Adverse Event|0|||
17095652|NCT00141297|38234927|FG002|Overall Study|Adverse Event|1|||
17095653|NCT00141297|38234928|FG003|Overall Study|Adverse Event|0|||
17095654|NCT00141297|38234929|FG004|Overall Study|Adverse Event|1|||
17095655|NCT00141297|38234930|FG005|Overall Study|Adverse Event|1|||
17095656|NCT00141297|38234931|FG006|Overall Study|Adverse Event|0|||
17095657|NCT00141297|38234932|FG007|Overall Study|Adverse Event|1|||
17095658|NCT00141297|38234933|FG008|Overall Study|Adverse Event|1|||
17095659|NCT00141297|38234934|FG009|Overall Study|Adverse Event|0|||
17095660|NCT00141297|38234925|FG000|Overall Study|Death|1|||
17095661|NCT00141297|38234926|FG001|Overall Study|Death|0|||
17095662|NCT00141297|38234927|FG002|Overall Study|Death|0|||
17095663|NCT00141297|38234928|FG003|Overall Study|Death|0|||
17095664|NCT00141297|38234929|FG004|Overall Study|Death|0|||
17095665|NCT00141297|38234930|FG005|Overall Study|Death|0|||
17095666|NCT00141297|38234931|FG006|Overall Study|Death|0|||
17095667|NCT00141297|38234932|FG007|Overall Study|Death|0|||
17095668|NCT00141297|38234933|FG008|Overall Study|Death|1|||
17095669|NCT00141297|38234934|FG009|Overall Study|Death|0|||
17095670|NCT00141297|38234925|FG000|Overall Study|Withdrawal by Subject|0|||
17095671|NCT00141297|38234926|FG001|Overall Study|Withdrawal by Subject|0|||
17095672|NCT00141297|38234927|FG002|Overall Study|Withdrawal by Subject|0|||
17095673|NCT00141297|38234928|FG003|Overall Study|Withdrawal by Subject|0|||
17095674|NCT00141297|38234929|FG004|Overall Study|Withdrawal by Subject|0|||
17095675|NCT00141297|38234930|FG005|Overall Study|Withdrawal by Subject|0|||
17095676|NCT00141297|38234931|FG006|Overall Study|Withdrawal by Subject|0|||
17095677|NCT00141297|38234932|FG007|Overall Study|Withdrawal by Subject|0|||
17095678|NCT00141297|38234933|FG008|Overall Study|Withdrawal by Subject|1|||
17095679|NCT00141297|38234934|FG009|Overall Study|Withdrawal by Subject|0|||
17095680|NCT00141297|38234925|FG000|Overall Study|Other|0|||
17095681|NCT00141297|38234926|FG001|Overall Study|Other|0|||
17095682|NCT00141297|38234927|FG002|Overall Study|Other|0|||
17095683|NCT00141297|38234928|FG003|Overall Study|Other|1|||
17095684|NCT00141297|38234929|FG004|Overall Study|Other|5|||
17095685|NCT00141297|38234930|FG005|Overall Study|Other|0|||
17095686|NCT00141297|38234931|FG006|Overall Study|Other|0|||
17095687|NCT00141297|38234932|FG007|Overall Study|Other|0|||
17095688|NCT00141297|38234933|FG008|Overall Study|Other|2|||
17095689|NCT00141297|38234934|FG009|Overall Study|Other|0|||
17095690|NCT00141297|38234925|FG000|Overall Study|Progressive Disease|2|||
17095691|NCT00141297|38234926|FG001|Overall Study|Progressive Disease|3|||
17095692|NCT00141297|38234927|FG002|Overall Study|Progressive Disease|6|||
16902809|NCT02014584|38009518|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16902810|NCT02014584|38009519|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16902811|NCT02014584|38009520|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16902812|NCT02014584|38009515|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
16902813|NCT02014584|38009516|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
16902814|NCT02014584|38009517|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
16902815|NCT02014584|38009518|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
16902816|NCT02014584|38009519|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
16902817|NCT02014584|38009520|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
16902818|NCT02014584|38009515|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16902819|NCT02014584|38009516|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16902820|NCT02014584|38009517|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16902821|NCT02014584|38009518|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16902822|NCT02014584|38009519|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
16902823|NCT02014584|38009520|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16902824|NCT02014272|38009532|FG000|Intervention Period 1|Withdrawal by Subject|1|||
16902825|NCT02014272|38009533|FG001|Intervention Period 1|Withdrawal by Subject|0|||
16902826|NCT02014272|38009532|FG000|Intervention Period 1|Adverse Event|0|||
16902827|NCT02014272|38009533|FG001|Intervention Period 1|Adverse Event|1|||
16902828|NCT02037984|38009547|FG000|Overall Study|Lack of Efficacy|0|||
16902829|NCT02037984|38009548|FG001|Overall Study|Lack of Efficacy|0|||
16902830|NCT02037984|38009549|FG002|Overall Study|Lack of Efficacy|3|||
16902831|NCT02037984|38009550|FG003|Overall Study|Lack of Efficacy|10|||
16902832|NCT02037984|38009551|FG004|Overall Study|Lack of Efficacy|2|||
16902833|NCT02037984|38009552|FG005|Overall Study|Lack of Efficacy|2|||
16902834|NCT02037984|38009553|FG006|Overall Study|Lack of Efficacy|4|||
16902835|NCT02037984|38009554|FG007|Overall Study|Lack of Efficacy|3|||
16902836|NCT02037984|38009547|FG000|Overall Study|Lost to Follow-up|1|||
16902837|NCT02037984|38009548|FG001|Overall Study|Lost to Follow-up|0|||
16902838|NCT02037984|38009549|FG002|Overall Study|Lost to Follow-up|3|||
16902839|NCT02037984|38009550|FG003|Overall Study|Lost to Follow-up|5|||
16902840|NCT02037984|38009551|FG004|Overall Study|Lost to Follow-up|2|||
16902841|NCT02037984|38009552|FG005|Overall Study|Lost to Follow-up|2|||
16902842|NCT02037984|38009553|FG006|Overall Study|Lost to Follow-up|2|||
17006239|NCT00951665|38150070|FG000|Phase 2a|Adverse Event|0|||
17006240|NCT00951665|38150071|FG001|Phase 2a|Adverse Event|0|||
17006241|NCT00951665|38150072|FG002|Phase 2a|Adverse Event|0|||
17006242|NCT00951665|38150073|FG003|Phase 2a|Adverse Event|0|||
17006243|NCT00951665|38150074|FG004|Phase 2a|Adverse Event|2|||
17006244|NCT00951665|38150075|FG005|Phase 2a|Adverse Event|0|||
17006245|NCT00951665|38150070|FG000|Phase 2a|Death|0|||
17006246|NCT00951665|38150071|FG001|Phase 2a|Death|0|||
16902843|NCT02037984|38009554|FG007|Overall Study|Lost to Follow-up|4|||
16902844|NCT02037984|38009547|FG000|Overall Study|Physician Decision|0|||
16902845|NCT02037984|38009548|FG001|Overall Study|Physician Decision|0|||
16902846|NCT02037984|38009549|FG002|Overall Study|Physician Decision|0|||
16902847|NCT02037984|38009550|FG003|Overall Study|Physician Decision|0|||
16902848|NCT02037984|38009551|FG004|Overall Study|Physician Decision|0|||
16902849|NCT02037984|38009552|FG005|Overall Study|Physician Decision|0|||
16902850|NCT02037984|38009553|FG006|Overall Study|Physician Decision|1|||
16902851|NCT02037984|38009554|FG007|Overall Study|Physician Decision|0|||
16902852|NCT02037984|38009547|FG000|Overall Study|Protocol Violation|0|||
16902853|NCT02037984|38009548|FG001|Overall Study|Protocol Violation|0|||
16902854|NCT02037984|38009549|FG002|Overall Study|Protocol Violation|0|||
16902855|NCT02037984|38009550|FG003|Overall Study|Protocol Violation|0|||
16902856|NCT02037984|38009551|FG004|Overall Study|Protocol Violation|0|||
16902857|NCT02037984|38009552|FG005|Overall Study|Protocol Violation|1|||
16902858|NCT02037984|38009553|FG006|Overall Study|Protocol Violation|2|||
16902859|NCT02037984|38009554|FG007|Overall Study|Protocol Violation|0|||
16902860|NCT02037984|38009547|FG000|Overall Study|Technical Problems|0|||
16902861|NCT02037984|38009548|FG001|Overall Study|Technical Problems|0|||
16902862|NCT02037984|38009549|FG002|Overall Study|Technical Problems|3|||
16902863|NCT02037984|38009550|FG003|Overall Study|Technical Problems|3|||
16902864|NCT02037984|38009551|FG004|Overall Study|Technical Problems|2|||
16902865|NCT02037984|38009552|FG005|Overall Study|Technical Problems|3|||
16902866|NCT02037984|38009553|FG006|Overall Study|Technical Problems|4|||
16902867|NCT02037984|38009554|FG007|Overall Study|Technical Problems|2|||
16902868|NCT02037984|38009547|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16902869|NCT02037984|38009548|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16902870|NCT02037984|38009549|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
17006247|NCT00951665|38150072|FG002|Phase 2a|Death|0|||
17006248|NCT00951665|38150073|FG003|Phase 2a|Death|0|||
16902871|NCT02037984|38009550|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
16902872|NCT02037984|38009551|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
16902873|NCT02037984|38009552|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
17006249|NCT00951665|38150074|FG004|Phase 2a|Death|1|||
17006250|NCT00951665|38150075|FG005|Phase 2a|Death|1|||
16902874|NCT02037984|38009553|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
16902875|NCT02037984|38009554|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
16902876|NCT02037984|38009547|FG000|Overall Study|Withdrawal by Subject|0|||
16902877|NCT02037984|38009548|FG001|Overall Study|Withdrawal by Subject|0|||
16902878|NCT02037984|38009549|FG002|Overall Study|Withdrawal by Subject|0|||
16902879|NCT02037984|38009550|FG003|Overall Study|Withdrawal by Subject|1|||
16902880|NCT02037984|38009551|FG004|Overall Study|Withdrawal by Subject|1|||
16902881|NCT02037984|38009552|FG005|Overall Study|Withdrawal by Subject|3|||
16902882|NCT02037984|38009553|FG006|Overall Study|Withdrawal by Subject|0|||
16902883|NCT02037984|38009554|FG007|Overall Study|Withdrawal by Subject|1|||
16902884|NCT02057406|38009585|FG000|Overall Study|Physician Decision|0|||
16902885|NCT02057406|38009586|FG001|Overall Study|Physician Decision|0|||
16902886|NCT02057406|38009587|FG002|Overall Study|Physician Decision|2|||
16902887|NCT02057406|38009585|FG000|Overall Study|Withdrawal by Subject|0|||
16902888|NCT02057406|38009586|FG001|Overall Study|Withdrawal by Subject|2|||
16902889|NCT02057406|38009587|FG002|Overall Study|Withdrawal by Subject|0|||
16902890|NCT02057406|38009585|FG000|Overall Study|Lost to Follow-up|0|||
16902891|NCT02057406|38009586|FG001|Overall Study|Lost to Follow-up|0|||
16902892|NCT02057406|38009587|FG002|Overall Study|Lost to Follow-up|1|||
16902893|NCT02057406|38009585|FG000|Overall Study|Death|1|||
16902894|NCT02057406|38009586|FG001|Overall Study|Death|0|||
16902895|NCT02057406|38009587|FG002|Overall Study|Death|0|||
16902896|NCT02057406|38009585|FG000|Overall Study|Protocol Violation|0|||
16902897|NCT02057406|38009586|FG001|Overall Study|Protocol Violation|1|||
16902898|NCT02057406|38009587|FG002|Overall Study|Protocol Violation|0|||
16902899|NCT02057406|38009585|FG000|Overall Study|Patient transportation issues|0|||
16902900|NCT02057406|38009586|FG001|Overall Study|Patient transportation issues|0|||
16902901|NCT02057406|38009587|FG002|Overall Study|Patient transportation issues|1|||
16902902|NCT02036580|38009598|FG000|Overall Study|Withdrawal by Subject|0|||
16902903|NCT02036580|38009599|FG001|Overall Study|Withdrawal by Subject|1|||
16902904|NCT02036580|38009600|FG002|Overall Study|Withdrawal by Subject|0|||
16902905|NCT02036580|38009598|FG000|Overall Study|Adverse Event|1|||
16902906|NCT02036580|38009599|FG001|Overall Study|Adverse Event|0|||
16902907|NCT02036580|38009600|FG002|Overall Study|Adverse Event|0|||
16902908|NCT02014116|38009617|FG000|Overall Study|Progressive Disease|3|||
16902909|NCT02014116|38009618|FG001|Overall Study|Progressive Disease|4|||
16902910|NCT02014116|38009619|FG002|Overall Study|Progressive Disease|2|||
16902911|NCT02014116|38009620|FG003|Overall Study|Progressive Disease|6|||
16902912|NCT02014116|38009621|FG004|Overall Study|Progressive Disease|1|||
16902913|NCT02014116|38009622|FG005|Overall Study|Progressive Disease|13|||
16902914|NCT02014116|38009623|FG006|Overall Study|Progressive Disease|1|||
16902915|NCT02014116|38009624|FG007|Overall Study|Progressive Disease|3|||
16902916|NCT02014116|38009625|FG008|Overall Study|Progressive Disease|7|||
16902917|NCT02014116|38009617|FG000|Overall Study|Adverse Event|0|||
16902918|NCT02014116|38009618|FG001|Overall Study|Adverse Event|0|||
16902919|NCT02014116|38009619|FG002|Overall Study|Adverse Event|0|||
16902920|NCT02014116|38009620|FG003|Overall Study|Adverse Event|0|||
16902921|NCT02014116|38009621|FG004|Overall Study|Adverse Event|1|||
16902922|NCT02014116|38009622|FG005|Overall Study|Adverse Event|0|||
16902923|NCT02014116|38009623|FG006|Overall Study|Adverse Event|0|||
16902924|NCT02014116|38009624|FG007|Overall Study|Adverse Event|1|||
16902925|NCT02014116|38009625|FG008|Overall Study|Adverse Event|0|||
16902926|NCT02014116|38009617|FG000|Overall Study|Lost to Follow-up|0|||
16902927|NCT02014116|38009618|FG001|Overall Study|Lost to Follow-up|0|||
16902928|NCT02014116|38009619|FG002|Overall Study|Lost to Follow-up|0|||
16902929|NCT02014116|38009620|FG003|Overall Study|Lost to Follow-up|0|||
16902930|NCT02014116|38009621|FG004|Overall Study|Lost to Follow-up|0|||
16902931|NCT02014116|38009622|FG005|Overall Study|Lost to Follow-up|1|||
16902932|NCT02014116|38009623|FG006|Overall Study|Lost to Follow-up|0|||
16902933|NCT02014116|38009624|FG007|Overall Study|Lost to Follow-up|0|||
16902934|NCT02014116|38009625|FG008|Overall Study|Lost to Follow-up|1|||
16902935|NCT02014116|38009617|FG000|Overall Study|Death|0|||
16902936|NCT02014116|38009618|FG001|Overall Study|Death|0|||
16902937|NCT02014116|38009619|FG002|Overall Study|Death|0|||
16902938|NCT02014116|38009620|FG003|Overall Study|Death|0|||
16902939|NCT02014116|38009621|FG004|Overall Study|Death|0|||
16902940|NCT02014116|38009622|FG005|Overall Study|Death|0|||
16902941|NCT02014116|38009623|FG006|Overall Study|Death|0|||
16902942|NCT02014116|38009624|FG007|Overall Study|Death|1|||
16902943|NCT02014116|38009625|FG008|Overall Study|Death|1|||
16902944|NCT02014116|38009617|FG000|Overall Study|Withdrawal by Subject|0|||
16902945|NCT02014116|38009618|FG001|Overall Study|Withdrawal by Subject|0|||
16902946|NCT02014116|38009619|FG002|Overall Study|Withdrawal by Subject|1|||
16902947|NCT02014116|38009620|FG003|Overall Study|Withdrawal by Subject|1|||
16902948|NCT02014116|38009621|FG004|Overall Study|Withdrawal by Subject|0|||
16902949|NCT02014116|38009622|FG005|Overall Study|Withdrawal by Subject|1|||
16902950|NCT02014116|38009623|FG006|Overall Study|Withdrawal by Subject|0|||
16902951|NCT02014116|38009624|FG007|Overall Study|Withdrawal by Subject|0|||
16902952|NCT02014116|38009625|FG008|Overall Study|Withdrawal by Subject|0|||
17006251|NCT00951665|38150070|FG000|Phase 2a|Lost to Follow-up|0|||
16902953|NCT02014116|38009617|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
16902954|NCT02014116|38009618|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
16902955|NCT02014116|38009619|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
16902956|NCT02014116|38009620|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
16902957|NCT02014116|38009621|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
16902958|NCT02014116|38009622|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
16902959|NCT02014116|38009623|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
16902960|NCT02014116|38009624|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
16902961|NCT02014116|38009625|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
16902962|NCT02014116|38009617|FG000|Overall Study|Physician Decision|0|||
16902963|NCT02014116|38009618|FG001|Overall Study|Physician Decision|0|||
16902964|NCT02014116|38009619|FG002|Overall Study|Physician Decision|0|||
16902965|NCT02014116|38009620|FG003|Overall Study|Physician Decision|0|||
16902966|NCT02014116|38009621|FG004|Overall Study|Physician Decision|0|||
16902967|NCT02014116|38009622|FG005|Overall Study|Physician Decision|0|||
16902968|NCT02014116|38009623|FG006|Overall Study|Physician Decision|0|||
16902969|NCT02014116|38009624|FG007|Overall Study|Physician Decision|0|||
16902970|NCT02014116|38009625|FG008|Overall Study|Physician Decision|1|||
16902971|NCT02057250|38009652|FG000|AID Assessment Phase|Adverse Event|3|||
16902972|NCT02057250|38009653|FG001|AID Assessment Phase|Adverse Event|2|||
16902973|NCT02057250|38009654|FG002|AID Assessment Phase|Adverse Event|6|||
16902974|NCT02057250|38009655|FG003|AID Assessment Phase|Adverse Event|1|||
16902975|NCT02057250|38009656|FG004|AID Assessment Phase|Adverse Event|0|||
16902976|NCT02057250|38009652|FG000|AID Assessment Phase|Other than specified above|1|||
16902977|NCT02057250|38009653|FG001|AID Assessment Phase|Other than specified above|1|||
16902978|NCT02057250|38009654|FG002|AID Assessment Phase|Other than specified above|1|||
16902979|NCT02057250|38009655|FG003|AID Assessment Phase|Other than specified above|1|||
16902980|NCT02057250|38009656|FG004|AID Assessment Phase|Other than specified above|0|||
16902981|NCT02057250|38009652|FG000|Extension Phase|Adverse Event|0|||
16902982|NCT02057250|38009653|FG001|Extension Phase|Adverse Event|0|||
16902983|NCT02057250|38009654|FG002|Extension Phase|Adverse Event|0|||
16902984|NCT02057250|38009655|FG003|Extension Phase|Adverse Event|0|||
16902985|NCT02057250|38009656|FG004|Extension Phase|Adverse Event|15|||
16902986|NCT02057250|38009652|FG000|Extension Phase|Lack of Efficacy|0|||
16902987|NCT02057250|38009653|FG001|Extension Phase|Lack of Efficacy|0|||
16902988|NCT02057250|38009654|FG002|Extension Phase|Lack of Efficacy|0|||
16902989|NCT02057250|38009655|FG003|Extension Phase|Lack of Efficacy|0|||
16902990|NCT02057250|38009656|FG004|Extension Phase|Lack of Efficacy|10|||
16902991|NCT02057250|38009652|FG000|Extension Phase|Entered in this period but not treated|0|||
16902992|NCT02057250|38009653|FG001|Extension Phase|Entered in this period but not treated|0|||
16902993|NCT02057250|38009654|FG002|Extension Phase|Entered in this period but not treated|0|||
16902994|NCT02057250|38009655|FG003|Extension Phase|Entered in this period but not treated|0|||
16902995|NCT02057250|38009656|FG004|Extension Phase|Entered in this period but not treated|4|||
16902996|NCT02057250|38009652|FG000|Extension Phase|Other than specified above|0|||
16902997|NCT02057250|38009653|FG001|Extension Phase|Other than specified above|0|||
16902998|NCT02057250|38009654|FG002|Extension Phase|Other than specified above|0|||
16902999|NCT02057250|38009655|FG003|Extension Phase|Other than specified above|0|||
16903000|NCT02057250|38009656|FG004|Extension Phase|Other than specified above|7|||
16903001|NCT02036502|38009676|FG000|Part 1:Dose Determination/Escalation|Death|3|||
16903002|NCT02036502|38009677|FG001|Part 1:Dose Determination/Escalation|Death|2|||
16903003|NCT02036502|38009678|FG002|Part 1:Dose Determination/Escalation|Death|0|||
16903004|NCT02036502|38009679|FG003|Part 1:Dose Determination/Escalation|Death|0|||
16903005|NCT02036502|38009680|FG004|Part 1:Dose Determination/Escalation|Death|0|||
16903006|NCT02036502|38009681|FG005|Part 1:Dose Determination/Escalation|Death|0|||
16903007|NCT02036502|38009682|FG006|Part 1:Dose Determination/Escalation|Death|0|||
16903008|NCT02036502|38009683|FG007|Part 1:Dose Determination/Escalation|Death|0|||
16903009|NCT02036502|38009676|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
16903010|NCT02036502|38009677|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16903011|NCT02036502|38009678|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16903012|NCT02036502|38009679|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16903013|NCT02036502|38009680|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16903014|NCT02036502|38009681|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16903015|NCT02036502|38009682|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16903016|NCT02036502|38009683|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16903017|NCT02036502|38009676|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16903018|NCT02036502|38009677|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
16903019|NCT02036502|38009678|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16903020|NCT02036502|38009679|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16903021|NCT02036502|38009680|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16903022|NCT02036502|38009681|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16903023|NCT02036502|38009682|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16903024|NCT02036502|38009683|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16903025|NCT02036502|38009676|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
16903026|NCT02036502|38009677|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
17006252|NCT00951665|38150071|FG001|Phase 2a|Lost to Follow-up|0|||
17006253|NCT00951665|38150072|FG002|Phase 2a|Lost to Follow-up|0|||
17006254|NCT00951665|38150073|FG003|Phase 2a|Lost to Follow-up|0|||
17006255|NCT00951665|38150074|FG004|Phase 2a|Lost to Follow-up|1|||
17006256|NCT00951665|38150075|FG005|Phase 2a|Lost to Follow-up|0|||
17006257|NCT00951665|38150070|FG000|Phase 2a|Physician Decision|0|||
17006258|NCT00951665|38150071|FG001|Phase 2a|Physician Decision|0|||
17006259|NCT00951665|38150072|FG002|Phase 2a|Physician Decision|0|||
16903027|NCT02036502|38009678|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
16903028|NCT02036502|38009679|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
16903029|NCT02036502|38009680|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
16903030|NCT02036502|38009681|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
16903031|NCT02036502|38009682|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
16903032|NCT02036502|38009683|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
16903033|NCT02036502|38009676|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16903034|NCT02036502|38009677|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16903035|NCT02036502|38009678|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
16903036|NCT02036502|38009679|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
16903037|NCT02036502|38009680|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
16903038|NCT02036502|38009681|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16903039|NCT02036502|38009682|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16903040|NCT02036502|38009683|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16903041|NCT02036502|38009676|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16903042|NCT02036502|38009677|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16903043|NCT02036502|38009678|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
16903044|NCT02036502|38009679|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16903045|NCT02036502|38009680|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16903046|NCT02036502|38009681|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16903047|NCT02036502|38009682|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16903048|NCT02036502|38009683|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16903049|NCT02036502|38009676|FG000|Part 2:Dose Confirmation|Death|0|||
16903050|NCT02036502|38009677|FG001|Part 2:Dose Confirmation|Death|0|||
16903051|NCT02036502|38009678|FG002|Part 2:Dose Confirmation|Death|1|||
16903052|NCT02036502|38009679|FG003|Part 2:Dose Confirmation|Death|0|||
16903053|NCT02036502|38009680|FG004|Part 2:Dose Confirmation|Death|0|||
16903054|NCT02036502|38009681|FG005|Part 2:Dose Confirmation|Death|0|||
16903055|NCT02036502|38009682|FG006|Part 2:Dose Confirmation|Death|0|||
16903056|NCT02036502|38009683|FG007|Part 2:Dose Confirmation|Death|0|||
16903057|NCT02036502|38009676|FG000|Part 2:Dose Confirmation|Not treated|0|||
16903058|NCT02036502|38009677|FG001|Part 2:Dose Confirmation|Not treated|0|||
16903059|NCT02036502|38009678|FG002|Part 2:Dose Confirmation|Not treated|0|||
16903060|NCT02036502|38009679|FG003|Part 2:Dose Confirmation|Not treated|1|||
16903061|NCT02036502|38009680|FG004|Part 2:Dose Confirmation|Not treated|0|||
16903062|NCT02036502|38009681|FG005|Part 2:Dose Confirmation|Not treated|0|||
16903063|NCT02036502|38009682|FG006|Part 2:Dose Confirmation|Not treated|0|||
16903064|NCT02036502|38009683|FG007|Part 2:Dose Confirmation|Not treated|0|||
16903065|NCT02036502|38009676|FG000|Part 3:Dose Expansion|Adverse Event|0|||
16903066|NCT02036502|38009677|FG001|Part 3:Dose Expansion|Adverse Event|0|||
16903067|NCT02036502|38009678|FG002|Part 3:Dose Expansion|Adverse Event|0|||
16903068|NCT02036502|38009679|FG003|Part 3:Dose Expansion|Adverse Event|0|||
16903069|NCT02036502|38009680|FG004|Part 3:Dose Expansion|Adverse Event|0|||
16903070|NCT02036502|38009681|FG005|Part 3:Dose Expansion|Adverse Event|4|||
16903071|NCT02036502|38009682|FG006|Part 3:Dose Expansion|Adverse Event|0|||
16903072|NCT02036502|38009683|FG007|Part 3:Dose Expansion|Adverse Event|2|||
16903073|NCT02036502|38009676|FG000|Part 3:Dose Expansion|Death|0|||
16903074|NCT02036502|38009677|FG001|Part 3:Dose Expansion|Death|0|||
16903075|NCT02036502|38009678|FG002|Part 3:Dose Expansion|Death|0|||
16903076|NCT02036502|38009679|FG003|Part 3:Dose Expansion|Death|0|||
16903077|NCT02036502|38009680|FG004|Part 3:Dose Expansion|Death|0|||
16903078|NCT02036502|38009681|FG005|Part 3:Dose Expansion|Death|24|||
16903079|NCT02036502|38009682|FG006|Part 3:Dose Expansion|Death|0|||
16903080|NCT02036502|38009683|FG007|Part 3:Dose Expansion|Death|3|||
16903081|NCT02036502|38009676|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
16903082|NCT02036502|38009677|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
16903083|NCT02036502|38009678|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
17006260|NCT00951665|38150073|FG003|Phase 2a|Physician Decision|0|||
17006261|NCT00951665|38150074|FG004|Phase 2a|Physician Decision|0|||
17006262|NCT00951665|38150075|FG005|Phase 2a|Physician Decision|1|||
17006263|NCT00951665|38150070|FG000|Phase 2a|Withdrawal by Subject|0|||
17006264|NCT00951665|38150071|FG001|Phase 2a|Withdrawal by Subject|0|||
17006265|NCT00951665|38150072|FG002|Phase 2a|Withdrawal by Subject|0|||
17006266|NCT00951665|38150073|FG003|Phase 2a|Withdrawal by Subject|0|||
17006267|NCT00951665|38150074|FG004|Phase 2a|Withdrawal by Subject|2|||
17006268|NCT00951665|38150075|FG005|Phase 2a|Withdrawal by Subject|0|||
17006269|NCT00951665|38150070|FG000|Phase 2a|Disease Progression|0|||
17006270|NCT00951665|38150071|FG001|Phase 2a|Disease Progression|0|||
17006271|NCT00951665|38150072|FG002|Phase 2a|Disease Progression|0|||
17006272|NCT00951665|38150073|FG003|Phase 2a|Disease Progression|0|||
17006273|NCT00951665|38150074|FG004|Phase 2a|Disease Progression|6|||
17006274|NCT00951665|38150075|FG005|Phase 2a|Disease Progression|5|||
17006275|NCT00801099|38150109|FG000|Overall Study|Lost to Follow-up|101|||
17006276|NCT00887744|38150113|FG000|Overall Study|Adverse Event|3|||
17006277|NCT00887744|38150113|FG000|Overall Study|Death|1|||
17006278|NCT00887744|38150113|FG000|Overall Study|Lost to Follow-up|3|||
17006279|NCT00887744|38150113|FG000|Overall Study|Withdrawal by Subject|18|||
17006280|NCT00887744|38150113|FG000|Overall Study|Various reasons|9|||
16903084|NCT02036502|38009679|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
16903085|NCT02036502|38009680|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
16903086|NCT02036502|38009681|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
16903087|NCT02036502|38009682|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
16903088|NCT02036502|38009683|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
16903089|NCT02036502|38009676|FG000|Part 3:Dose Expansion|Physician Decision|0|||
16903090|NCT02036502|38009677|FG001|Part 3:Dose Expansion|Physician Decision|0|||
16903091|NCT02036502|38009678|FG002|Part 3:Dose Expansion|Physician Decision|0|||
16903092|NCT02036502|38009679|FG003|Part 3:Dose Expansion|Physician Decision|0|||
16903093|NCT02036502|38009680|FG004|Part 3:Dose Expansion|Physician Decision|0|||
16903094|NCT02036502|38009681|FG005|Part 3:Dose Expansion|Physician Decision|1|||
16903095|NCT02036502|38009682|FG006|Part 3:Dose Expansion|Physician Decision|0|||
16903096|NCT02036502|38009683|FG007|Part 3:Dose Expansion|Physician Decision|0|||
16903097|NCT02036502|38009676|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
16903098|NCT02036502|38009677|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
16903099|NCT02036502|38009678|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
16903100|NCT02036502|38009679|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
16903101|NCT02036502|38009680|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
16903102|NCT02036502|38009681|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
16903103|NCT02036502|38009682|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
16903104|NCT02036502|38009683|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
16903105|NCT02036502|38009676|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16903106|NCT02036502|38009677|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16903107|NCT02036502|38009678|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16903108|NCT02036502|38009679|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16903109|NCT02036502|38009680|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16903110|NCT02036502|38009681|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
16903111|NCT02036502|38009682|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16903112|NCT02036502|38009683|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
16903113|NCT02036502|38009676|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16903114|NCT02036502|38009677|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16903115|NCT02036502|38009678|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16903116|NCT02036502|38009679|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16903117|NCT02036502|38009680|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16903118|NCT02036502|38009681|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
16903119|NCT02036502|38009682|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
16903120|NCT02036502|38009683|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
16903121|NCT02036502|38009676|FG000|Part 3:Dose Expansion|Not Treated|0|||
16903122|NCT02036502|38009677|FG001|Part 3:Dose Expansion|Not Treated|0|||
16903123|NCT02036502|38009678|FG002|Part 3:Dose Expansion|Not Treated|0|||
16903124|NCT02036502|38009679|FG003|Part 3:Dose Expansion|Not Treated|0|||
16903125|NCT02036502|38009680|FG004|Part 3:Dose Expansion|Not Treated|0|||
16903126|NCT02036502|38009681|FG005|Part 3:Dose Expansion|Not Treated|2|||
16903127|NCT02036502|38009682|FG006|Part 3:Dose Expansion|Not Treated|0|||
16903128|NCT02036502|38009683|FG007|Part 3:Dose Expansion|Not Treated|0|||
16903129|NCT02056626|38009707|FG000|Overall Study|patient did not follow directions|3|||
16903130|NCT02056626|38009708|FG001|Overall Study|patient did not follow directions|1|||
16903131|NCT02056626|38009709|FG002|Overall Study|patient did not follow directions|0|||
16903132|NCT02056626|38009710|FG003|Overall Study|patient did not follow directions|0|||
16903133|NCT02035332|38009720|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
16903134|NCT02056392|38009730|FG000|Overall Study|Lost to Follow-up|0|||
16903135|NCT02056392|38009731|FG001|Overall Study|Lost to Follow-up|1|||
16903136|NCT02056392|38009732|FG002|Overall Study|Lost to Follow-up|2|||
16903137|NCT02056392|38009733|FG003|Overall Study|Lost to Follow-up|0|||
16903138|NCT02056392|38009734|FG004|Overall Study|Lost to Follow-up|0|||
16903139|NCT02056392|38009735|FG005|Overall Study|Lost to Follow-up|0|||
16903140|NCT02056392|38009730|FG000|Overall Study|Protocol Violation|1|||
17006281|NCT04280081|38150117|FG000|Overall Study|Adverse Event|4|||
16903141|NCT02056392|38009731|FG001|Overall Study|Protocol Violation|0|||
16903142|NCT02056392|38009732|FG002|Overall Study|Protocol Violation|1|||
16903143|NCT02056392|38009733|FG003|Overall Study|Protocol Violation|0|||
16903144|NCT02056392|38009734|FG004|Overall Study|Protocol Violation|0|||
16903145|NCT02056392|38009735|FG005|Overall Study|Protocol Violation|0|||
16903146|NCT02056392|38009730|FG000|Overall Study|Withdrawal by Subject|1|||
16903147|NCT02056392|38009731|FG001|Overall Study|Withdrawal by Subject|0|||
16903148|NCT02056392|38009732|FG002|Overall Study|Withdrawal by Subject|0|||
16903149|NCT02056392|38009733|FG003|Overall Study|Withdrawal by Subject|0|||
16903150|NCT02056392|38009734|FG004|Overall Study|Withdrawal by Subject|1|||
16903151|NCT02056392|38009735|FG005|Overall Study|Withdrawal by Subject|0|||
16903152|NCT02034708|38009745|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
16903153|NCT02034708|38009746|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
16903154|NCT02034708|38009745|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
16903155|NCT02034708|38009746|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
16903156|NCT02034708|38009745|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
16903157|NCT02034708|38009746|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
16903158|NCT02034708|38009745|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
16903159|NCT02034708|38009746|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
16903160|NCT02034552|38009760|FG000|Overall Study|Never treated|3|||
16903161|NCT02034552|38009761|FG001|Overall Study|Never treated|2|||
16903162|NCT02034552|38009762|FG002|Overall Study|Never treated|0|||
16903163|NCT02034552|38009760|FG000|Overall Study|Radiological progression|3|||
16903164|NCT02034552|38009761|FG001|Overall Study|Radiological progression|5|||
16903165|NCT02034552|38009762|FG002|Overall Study|Radiological progression|4|||
16903166|NCT02034552|38009760|FG000|Overall Study|AE not assoc. with disease progression|1|||
16903167|NCT02034552|38009761|FG001|Overall Study|AE not assoc. with disease progression|4|||
16903168|NCT02034552|38009762|FG002|Overall Study|AE not assoc. with disease progression|2|||
16903169|NCT02034552|38009760|FG000|Overall Study|AE associated with disease progression|0|||
16903170|NCT02034552|38009761|FG001|Overall Study|AE associated with disease progression|1|||
16903171|NCT02034552|38009762|FG002|Overall Study|AE associated with disease progression|0|||
16903172|NCT02034552|38009760|FG000|Overall Study|Withdrawal by Subject|2|||
16903173|NCT02034552|38009761|FG001|Overall Study|Withdrawal by Subject|1|||
16903174|NCT02034552|38009762|FG002|Overall Study|Withdrawal by Subject|1|||
16903175|NCT02034552|38009760|FG000|Overall Study|Non-compliance with study drug|0|||
16903176|NCT02034552|38009761|FG001|Overall Study|Non-compliance with study drug|0|||
16903177|NCT02034552|38009762|FG002|Overall Study|Non-compliance with study drug|1|||
16903178|NCT02034552|38009760|FG000|Overall Study|Clinical progression|5|||
16903179|NCT02034552|38009761|FG001|Overall Study|Clinical progression|7|||
16903180|NCT02034552|38009762|FG002|Overall Study|Clinical progression|9|||
16903181|NCT02034474|38009772|FG000|Overall Study|Adverse Event|3|||
16903182|NCT02034474|38009773|FG001|Overall Study|Adverse Event|2|||
16903183|NCT02034474|38009772|FG000|Overall Study|Withdrawal by Subject|1|||
16903184|NCT02034474|38009773|FG001|Overall Study|Withdrawal by Subject|2|||
16903185|NCT02011542|38009781|FG000|Overall Study|Physician Decision|1|||
16903186|NCT02011386|38009785|FG000|Overall Study|Non-compliance|2|||
16903187|NCT02011386|38009785|FG000|Overall Study|Lack of Efficacy|3|||
16903188|NCT02010684|38009791|FG000|Overall Study|Lost to Follow-up|8|||
16903189|NCT02010684|38009792|FG001|Overall Study|Lost to Follow-up|18|||
16903190|NCT02010684|38009791|FG000|Overall Study|Withdrawal by Subject|4|||
16903191|NCT02010684|38009792|FG001|Overall Study|Withdrawal by Subject|5|||
16903192|NCT02034162|38009800|FG000|Double-blind|Lost to Follow-up|3|||
16903193|NCT02034162|38009801|FG001|Double-blind|Lost to Follow-up|0|||
16903194|NCT02034162|38009802|FG002|Double-blind|Lost to Follow-up|0|||
16903195|NCT02034162|38009800|FG000|Double-blind|Physician Decision|1|||
16903196|NCT02034162|38009801|FG001|Double-blind|Physician Decision|0|||
16903197|NCT02034162|38009802|FG002|Double-blind|Physician Decision|0|||
16903198|NCT02034162|38009800|FG000|Double-blind|Protocol Violation|0|||
16903199|NCT02034162|38009801|FG001|Double-blind|Protocol Violation|1|||
16903200|NCT02034162|38009802|FG002|Double-blind|Protocol Violation|0|||
16903201|NCT02034162|38009800|FG000|Double-blind|Withdrawal by Subject|5|||
16903202|NCT02034162|38009801|FG001|Double-blind|Withdrawal by Subject|7|||
16903203|NCT02034162|38009802|FG002|Double-blind|Withdrawal by Subject|0|||
16903204|NCT02034006|38009815|FG000|Overall Study|Withdrawal by Subject|7|||
16903205|NCT02034006|38009815|FG000|Overall Study|Lost to Follow-up|5|||
16903206|NCT02034006|38009815|FG000|Overall Study|Death|1|||
16903207|NCT02034006|38009815|FG000|Overall Study|Pregnancy|1|||
16903208|NCT02054910|38009824|FG000|Overall Study|Lost to Follow-up|4|||
16903209|NCT02054910|38009825|FG001|Overall Study|Lost to Follow-up|1|||
16903210|NCT02033850|38009835|FG000|Overall Study|Death|1|||
16903211|NCT02033850|38009836|FG001|Overall Study|Death|0|||
16903212|NCT02033850|38009835|FG000|Overall Study|unrelated medical reason|1|||
16903213|NCT02033850|38009836|FG001|Overall Study|unrelated medical reason|1|||
16903214|NCT02054520|38009848|FG000|Overall Study|Adverse Event|1|||
16903215|NCT02054520|38009849|FG001|Overall Study|Adverse Event|4|||
16903216|NCT02054520|38009850|FG002|Overall Study|Adverse Event|2|||
16903217|NCT02054520|38009851|FG003|Overall Study|Adverse Event|1|||
16903218|NCT02054520|38009852|FG004|Overall Study|Adverse Event|1|||
16903219|NCT02054520|38009853|FG005|Overall Study|Adverse Event|0|||
16903220|NCT02054520|38009848|FG000|Overall Study|Lack of Efficacy|7|||
16903221|NCT02054520|38009849|FG001|Overall Study|Lack of Efficacy|0|||
16903222|NCT02054520|38009850|FG002|Overall Study|Lack of Efficacy|2|||
16903223|NCT02054520|38009851|FG003|Overall Study|Lack of Efficacy|1|||
16903224|NCT02054520|38009852|FG004|Overall Study|Lack of Efficacy|3|||
16903225|NCT02054520|38009853|FG005|Overall Study|Lack of Efficacy|2|||
16903226|NCT02054520|38009848|FG000|Overall Study|Withdrawal by Subject|1|||
16903227|NCT02054520|38009849|FG001|Overall Study|Withdrawal by Subject|0|||
16903228|NCT02054520|38009850|FG002|Overall Study|Withdrawal by Subject|0|||
16903229|NCT02054520|38009851|FG003|Overall Study|Withdrawal by Subject|2|||
16903230|NCT02054520|38009852|FG004|Overall Study|Withdrawal by Subject|1|||
16903231|NCT02054520|38009853|FG005|Overall Study|Withdrawal by Subject|0|||
16903232|NCT02054520|38009848|FG000|Overall Study|Physician Decision|0|||
16903233|NCT02054520|38009849|FG001|Overall Study|Physician Decision|1|||
16903234|NCT02054520|38009850|FG002|Overall Study|Physician Decision|0|||
16903235|NCT02054520|38009851|FG003|Overall Study|Physician Decision|1|||
16903236|NCT02054520|38009852|FG004|Overall Study|Physician Decision|0|||
16903237|NCT02054520|38009853|FG005|Overall Study|Physician Decision|1|||
17006282|NCT04280081|38150117|FG000|Overall Study|Death|2|||
17006283|NCT04280081|38150117|FG000|Overall Study|Progressive Disease|6|||
17095693|NCT00141297|38234928|FG003|Overall Study|Progressive Disease|2|||
16903238|NCT02054520|38009848|FG000|Overall Study|Study terminated by Sponsor|0|||
16903239|NCT02054520|38009849|FG001|Overall Study|Study terminated by Sponsor|0|||
16903240|NCT02054520|38009850|FG002|Overall Study|Study terminated by Sponsor|2|||
16903241|NCT02054520|38009851|FG003|Overall Study|Study terminated by Sponsor|1|||
16903242|NCT02054520|38009852|FG004|Overall Study|Study terminated by Sponsor|0|||
16903243|NCT02054520|38009853|FG005|Overall Study|Study terminated by Sponsor|0|||
16903244|NCT02054130|38009871|FG000|Overall Study|Withdrawal by Subject|4|||
16903245|NCT02054130|38009872|FG001|Overall Study|Withdrawal by Subject|4|||
16903246|NCT02054130|38009873|FG002|Overall Study|Withdrawal by Subject|7|||
16903247|NCT02054130|38009874|FG003|Overall Study|Withdrawal by Subject|10|||
16903248|NCT02054130|38009871|FG000|Overall Study|Death|0|||
16903249|NCT02054130|38009872|FG001|Overall Study|Death|1|||
16903250|NCT02054130|38009873|FG002|Overall Study|Death|0|||
16903251|NCT02054130|38009874|FG003|Overall Study|Death|0|||
16903252|NCT02054130|38009871|FG000|Overall Study|Lost to Follow-up|0|||
16903253|NCT02054130|38009872|FG001|Overall Study|Lost to Follow-up|0|||
16903254|NCT02054130|38009873|FG002|Overall Study|Lost to Follow-up|1|||
16903255|NCT02054130|38009874|FG003|Overall Study|Lost to Follow-up|2|||
16903256|NCT02054130|38009871|FG000|Overall Study|Missed dose|4|||
16903257|NCT02054130|38009872|FG001|Overall Study|Missed dose|6|||
16903258|NCT02054130|38009873|FG002|Overall Study|Missed dose|7|||
16903259|NCT02054130|38009874|FG003|Overall Study|Missed dose|10|||
16903260|NCT02053350|38009887|FG000|Overall Study|Withdrawal by Subject|1|||
16903261|NCT02053350|38009887|FG000|Overall Study|Adverse Event|4|||
16903262|NCT02009046|38009893|FG000|Overall Study|Lost to Follow-up|256|||
16903263|NCT02009046|38009894|FG001|Overall Study|Lost to Follow-up|206|||
16903264|NCT02052960|38009910|FG000|Overall Study|Adverse Event|19|||
16903265|NCT02052960|38009911|FG001|Overall Study|Adverse Event|17|||
16903266|NCT02052960|38009910|FG000|Overall Study|Protocol Violation|4|||
16903267|NCT02052960|38009911|FG001|Overall Study|Protocol Violation|3|||
16903268|NCT02052960|38009910|FG000|Overall Study|Withdrawal by Subject|6|||
16903269|NCT02052960|38009911|FG001|Overall Study|Withdrawal by Subject|11|||
16903270|NCT02052960|38009910|FG000|Overall Study|Other|25|||
16903271|NCT02052960|38009911|FG001|Overall Study|Other|15|||
16903272|NCT02008890|38009923|FG000|Period 1|Withdrawal by Subject|7|||
16903273|NCT02008890|38009924|FG001|Period 1|Withdrawal by Subject|7|||
16903274|NCT02008890|38009925|FG002|Period 1|Withdrawal by Subject|5|||
16903275|NCT02008890|38009926|FG003|Period 1|Withdrawal by Subject|0|||
16903276|NCT02008890|38009927|FG004|Period 1|Withdrawal by Subject|0|||
16903277|NCT02008890|38009923|FG000|Period 1|Pregnancy|1|||
16903278|NCT02008890|38009924|FG001|Period 1|Pregnancy|0|||
16903279|NCT02008890|38009925|FG002|Period 1|Pregnancy|0|||
16903280|NCT02008890|38009926|FG003|Period 1|Pregnancy|0|||
16903281|NCT02008890|38009927|FG004|Period 1|Pregnancy|0|||
16903282|NCT02008890|38009923|FG000|Period 1|Physician Decision|1|||
16903283|NCT02008890|38009924|FG001|Period 1|Physician Decision|0|||
17095694|NCT00141297|38234929|FG004|Overall Study|Progressive Disease|15|||
16786217|NCT02684617|37726684|FG000|Overall Study|Adverse Event|1|||
16903284|NCT02008890|38009925|FG002|Period 1|Physician Decision|1|||
16903285|NCT02008890|38009926|FG003|Period 1|Physician Decision|0|||
16903286|NCT02008890|38009927|FG004|Period 1|Physician Decision|0|||
16903287|NCT02008890|38009923|FG000|Period 1|Adverse Event|6|||
16903288|NCT02008890|38009924|FG001|Period 1|Adverse Event|8|||
16903289|NCT02008890|38009925|FG002|Period 1|Adverse Event|6|||
16903290|NCT02008890|38009926|FG003|Period 1|Adverse Event|0|||
16903291|NCT02008890|38009927|FG004|Period 1|Adverse Event|0|||
16903292|NCT02008890|38009923|FG000|Period 2|Adverse Event|12|||
16903293|NCT02008890|38009924|FG001|Period 2|Adverse Event|7|||
16903294|NCT02008890|38009925|FG002|Period 2|Adverse Event|0|||
16903295|NCT02008890|38009926|FG003|Period 2|Adverse Event|5|||
16903296|NCT02008890|38009927|FG004|Period 2|Adverse Event|5|||
16903297|NCT02008890|38009923|FG000|Period 2|Withdrawal by Subject|11|||
16903298|NCT02008890|38009924|FG001|Period 2|Withdrawal by Subject|8|||
16903299|NCT02008890|38009925|FG002|Period 2|Withdrawal by Subject|0|||
16903300|NCT02008890|38009926|FG003|Period 2|Withdrawal by Subject|7|||
16903301|NCT02008890|38009927|FG004|Period 2|Withdrawal by Subject|2|||
17006284|NCT00951509|38150130|FG000|Overall Study|Withdrawal by Subject|2|||
17006285|NCT00610441|38150142|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
16903302|NCT02008890|38009923|FG000|Period 2|Physician Decision|4|||
16903303|NCT02008890|38009924|FG001|Period 2|Physician Decision|0|||
16903304|NCT02008890|38009925|FG002|Period 2|Physician Decision|0|||
16903305|NCT02008890|38009926|FG003|Period 2|Physician Decision|2|||
16903306|NCT02008890|38009927|FG004|Period 2|Physician Decision|1|||
16903307|NCT02008890|38009923|FG000|Period 2|Lost to Follow-up|0|||
16903308|NCT02008890|38009924|FG001|Period 2|Lost to Follow-up|0|||
16903309|NCT02008890|38009925|FG002|Period 2|Lost to Follow-up|1|||
16903310|NCT02008890|38009926|FG003|Period 2|Lost to Follow-up|0|||
16903311|NCT02008890|38009927|FG004|Period 2|Lost to Follow-up|0|||
16903312|NCT02008890|38009923|FG000|Extension Period|Withdrawal by Subject|3|||
16903313|NCT02008890|38009924|FG001|Extension Period|Withdrawal by Subject|2|||
17006286|NCT00610441|38150143|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
17006287|NCT00610441|38150144|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
17006288|NCT00610441|38150145|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
17006289|NCT00610441|38150142|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
17006290|NCT00610441|38150143|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
17006291|NCT00610441|38150144|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
17006292|NCT00610441|38150145|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
17006293|NCT00610441|38150142|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
17006294|NCT00610441|38150143|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
17006295|NCT00610441|38150144|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
17006296|NCT00610441|38150145|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
17006297|NCT00610441|38150142|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
17006298|NCT00610441|38150143|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
17006299|NCT00610441|38150144|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
17006300|NCT00610441|38150145|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
17006301|NCT00610441|38150142|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
17006302|NCT00610441|38150143|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
17006303|NCT00610441|38150144|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
17006304|NCT00610441|38150145|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
17006305|NCT00610441|38150142|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
17006306|NCT00610441|38150143|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
17006307|NCT00610441|38150144|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
16903314|NCT02008890|38009925|FG002|Extension Period|Withdrawal by Subject|0|||
16903315|NCT02008890|38009926|FG003|Extension Period|Withdrawal by Subject|4|||
16903316|NCT02008890|38009927|FG004|Extension Period|Withdrawal by Subject|2|||
16903317|NCT02008890|38009923|FG000|Extension Period|Lost to Follow-up|1|||
16903318|NCT02008890|38009924|FG001|Extension Period|Lost to Follow-up|0|||
16903319|NCT02008890|38009925|FG002|Extension Period|Lost to Follow-up|0|||
16903320|NCT02008890|38009926|FG003|Extension Period|Lost to Follow-up|0|||
16903321|NCT02008890|38009927|FG004|Extension Period|Lost to Follow-up|0|||
16903322|NCT02008890|38009923|FG000|Extension Period|Adverse Event|1|||
16903323|NCT02008890|38009924|FG001|Extension Period|Adverse Event|3|||
16903324|NCT02008890|38009925|FG002|Extension Period|Adverse Event|0|||
16903325|NCT02008890|38009926|FG003|Extension Period|Adverse Event|0|||
17006308|NCT00610441|38150145|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
17006309|NCT00610441|38150142|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
17006310|NCT00610441|38150143|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
17006311|NCT00610441|38150144|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
17006312|NCT00610441|38150145|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
17006313|NCT00610441|38150142|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
17006314|NCT00610441|38150143|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
17006315|NCT00610441|38150144|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
17095695|NCT00141297|38234930|FG005|Overall Study|Progressive Disease|2|||
17095696|NCT00141297|38234931|FG006|Overall Study|Progressive Disease|3|||
17095697|NCT00141297|38234932|FG007|Overall Study|Progressive Disease|3|||
17095698|NCT00141297|38234933|FG008|Overall Study|Progressive Disease|15|||
17095699|NCT00141297|38234934|FG009|Overall Study|Progressive Disease|6|||
17095700|NCT00141297|38234925|FG000|Overall Study|Transitioned|0|||
17095701|NCT00141297|38234926|FG001|Overall Study|Transitioned|0|||
17095702|NCT00141297|38234927|FG002|Overall Study|Transitioned|0|||
16903326|NCT02008890|38009927|FG004|Extension Period|Adverse Event|2|||
16903327|NCT02052414|38009942|FG000|Overall Study|Adverse Event|12|||
16903328|NCT02052414|38009942|FG000|Overall Study|Lack of Efficacy|2|||
16903329|NCT02052414|38009942|FG000|Overall Study|Withdrawal by Subject|3|||
16903330|NCT02007954|38009947|FG000|Overall Study|Received liver transplant|3|||
16903331|NCT02007954|38009947|FG000|Overall Study|Switch in treatment modality|2|||
16903332|NCT02007954|38009947|FG000|Overall Study|Disease progression and unrelated AE|1|||
16903333|NCT02007954|38009947|FG000|Overall Study|Death|1|||
16903334|NCT02049450|38009951|FG000|Overall Study|Adverse Event|2|||
16903335|NCT02049450|38009951|FG000|Overall Study|Withdrawal by Subject|1|||
17006316|NCT00610441|38150145|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
17006317|NCT00610441|38150142|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
17006318|NCT00610441|38150143|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
16903336|NCT02049450|38009951|FG000|Overall Study|Patients/guardian decision|1|||
16903337|NCT02031432|38009962|FG000|Overall Study|Protocol Violation|1|||
16903338|NCT02031432|38009962|FG000|Overall Study|Lack of Efficacy|5|||
16903339|NCT02031432|38009962|FG000|Overall Study|Cancer Progression|2|||
16903340|NCT02031432|38009962|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
16903341|NCT02031432|38009962|FG000|Overall Study|Adverse Event|8|||
16903342|NCT02031432|38009962|FG000|Overall Study|Withdrawal by Subject|5|||
16903343|NCT02031432|38009962|FG000|Overall Study|Lost to Follow-up|1|||
16903344|NCT02031432|38009962|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
16903345|NCT02031432|38009962|FG000|Overall Study|Death|10|||
16903346|NCT02031276|38009969|FG000|Period 1 Double-blind IV|Adverse Event|6|||
16903347|NCT02031276|38009970|FG001|Period 1 Double-blind IV|Adverse Event|5|||
16903348|NCT02031276|38009971|FG002|Period 1 Double-blind IV|Adverse Event|1|||
16903349|NCT02031276|38009969|FG000|Period 1 Double-blind IV|Other|0|||
16903350|NCT02031276|38009970|FG001|Period 1 Double-blind IV|Other|1|||
16903351|NCT02031276|38009971|FG002|Period 1 Double-blind IV|Other|0|||
16903352|NCT02031276|38009969|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
16903353|NCT02031276|38009970|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
16903354|NCT02031276|38009971|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
16903355|NCT02031276|38009969|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
16903356|NCT02031276|38009970|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
16903357|NCT02031276|38009971|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
16903358|NCT02031276|38009969|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
16903359|NCT02031276|38009970|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
16903360|NCT02031276|38009971|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
16903361|NCT02031276|38009969|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
16903362|NCT02031276|38009970|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
16903363|NCT02031276|38009971|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
16903364|NCT02031276|38009969|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
16903365|NCT02031276|38009970|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
16903366|NCT02031276|38009971|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
16903367|NCT02031276|38009969|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
16903368|NCT02031276|38009970|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
16903369|NCT02031276|38009971|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
16903370|NCT02031276|38009969|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
16903371|NCT02031276|38009970|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
16903372|NCT02031276|38009971|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
16903373|NCT02007720|38009985|FG000|Overall Study|Withdrawal by Subject|9|||
16903374|NCT02007720|38009986|FG001|Overall Study|Withdrawal by Subject|11|||
16903375|NCT02007720|38009985|FG000|Overall Study|study terminated by sponsor|58|||
16903376|NCT02007720|38009986|FG001|Overall Study|study terminated by sponsor|54|||
16903377|NCT02007720|38009985|FG000|Overall Study|technical problem|4|||
16903378|NCT02007720|38009986|FG001|Overall Study|technical problem|2|||
16903379|NCT02007720|38009985|FG000|Overall Study|patient followd less than 165 days|11|||
16903380|NCT02007720|38009986|FG001|Overall Study|patient followd less than 165 days|5|||
16903381|NCT01363440|38009996|FG000|Overall Study|Adverse Event|5|||
16903382|NCT01363440|38009997|FG001|Overall Study|Adverse Event|4|||
16903383|NCT01363440|38009998|FG002|Overall Study|Adverse Event|4|||
16903384|NCT01363440|38009996|FG000|Overall Study|Death|3|||
16903385|NCT01363440|38009997|FG001|Overall Study|Death|7|||
16903386|NCT01363440|38009998|FG002|Overall Study|Death|5|||
16903387|NCT01363440|38009996|FG000|Overall Study|Withdrawal by Subject|9|||
16903388|NCT01363440|38009997|FG001|Overall Study|Withdrawal by Subject|11|||
16903389|NCT01363440|38009998|FG002|Overall Study|Withdrawal by Subject|11|||
17006319|NCT00610441|38150144|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
17006320|NCT00610441|38150145|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
16903390|NCT01363440|38009996|FG000|Overall Study|Lost to Follow-up|2|||
16903391|NCT01363440|38009997|FG001|Overall Study|Lost to Follow-up|4|||
16903392|NCT01363440|38009998|FG002|Overall Study|Lost to Follow-up|5|||
16903393|NCT01363440|38009996|FG000|Overall Study|Other|4|||
16903394|NCT01363440|38009997|FG001|Overall Study|Other|5|||
16903395|NCT01363440|38009998|FG002|Overall Study|Other|2|||
16903396|NCT02007252|38010011|FG000|Overall Study|Administrative problems|3|||
16903397|NCT02007252|38010012|FG001|Overall Study|Administrative problems|7|||
16903398|NCT02007252|38010011|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16903399|NCT02007252|38010012|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16903400|NCT02007252|38010011|FG000|Overall Study|Adverse Event|7|||
16903401|NCT02007252|38010012|FG001|Overall Study|Adverse Event|4|||
16903402|NCT02007096|38010020|FG000|Overall Study|medication not available|2|||
16903403|NCT02007096|38010021|FG001|Overall Study|medication not available|0|||
16903404|NCT02007096|38010020|FG000|Overall Study|did not inject saline|0|||
16903405|NCT02007096|38010021|FG001|Overall Study|did not inject saline|3|||
16903406|NCT02007096|38010020|FG000|Overall Study|did not follow postoperative protocol|8|||
16903407|NCT02007096|38010021|FG001|Overall Study|did not follow postoperative protocol|11|||
16903408|NCT02007096|38010020|FG000|Overall Study|converted to open surgery|1|||
16903409|NCT02007096|38010021|FG001|Overall Study|converted to open surgery|1|||
16903410|NCT02007096|38010020|FG000|Overall Study|no mesh placed|0|||
16903411|NCT02007096|38010021|FG001|Overall Study|no mesh placed|1|||
16903412|NCT02006706|38010027|FG000|Overall Study|Lost to Follow-up|1|||
16903413|NCT02049138|38010034|FG000|Overall Study|Adverse Event|46|||
16903414|NCT02049138|38010035|FG001|Overall Study|Adverse Event|25|||
16903415|NCT02049138|38010036|FG002|Overall Study|Adverse Event|1|||
16903416|NCT02049138|38010034|FG000|Overall Study|Withdrawal by Subject|57|||
16903417|NCT02049138|38010035|FG001|Overall Study|Withdrawal by Subject|21|||
16903418|NCT02049138|38010036|FG002|Overall Study|Withdrawal by Subject|5|||
16903419|NCT02049138|38010034|FG000|Overall Study|Lost to Follow-up|18|||
16903420|NCT02049138|38010035|FG001|Overall Study|Lost to Follow-up|5|||
16903421|NCT02049138|38010036|FG002|Overall Study|Lost to Follow-up|1|||
16903422|NCT02049138|38010034|FG000|Overall Study|Lack of Efficacy|10|||
16903423|NCT02049138|38010035|FG001|Overall Study|Lack of Efficacy|26|||
16903424|NCT02049138|38010036|FG002|Overall Study|Lack of Efficacy|1|||
16903425|NCT02049138|38010034|FG000|Overall Study|Non-Compliance|15|||
16903426|NCT02049138|38010035|FG001|Overall Study|Non-Compliance|6|||
16903427|NCT02049138|38010036|FG002|Overall Study|Non-Compliance|0|||
16903428|NCT02049138|38010034|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
16903429|NCT02049138|38010035|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
16903430|NCT02049138|38010036|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
16903431|NCT02049138|38010034|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
16903432|NCT02049138|38010035|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
16903433|NCT02049138|38010036|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
16903434|NCT02049138|38010034|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
16903435|NCT02049138|38010035|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
16903436|NCT02049138|38010036|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
16903437|NCT02049138|38010034|FG000|Overall Study|Other|15|||
16903438|NCT02049138|38010035|FG001|Overall Study|Other|13|||
16903439|NCT02049138|38010036|FG002|Overall Study|Other|0|||
16903440|NCT02049138|38010034|FG000|Overall Study|Missing|0|||
16903441|NCT02049138|38010035|FG001|Overall Study|Missing|1|||
16903442|NCT02049138|38010036|FG002|Overall Study|Missing|0|||
16903443|NCT02048904|38010047|FG000|Overall Study|Withdrawal by Subject|7|||
16903444|NCT02048904|38010047|FG000|Overall Study|Physician Decision|70|||
16903445|NCT02006628|38010053|FG000|Overall Study|Adverse Event|1|||
16903446|NCT02006628|38010054|FG001|Overall Study|Adverse Event|1|||
16903447|NCT02006628|38010053|FG000|Overall Study|Withdrawal by Subject|2|||
16903448|NCT02006628|38010054|FG001|Overall Study|Withdrawal by Subject|1|||
16903449|NCT02048826|38010062|FG000|Overall Study|Withdrawal by Subject|1|||
16903450|NCT02048826|38010063|FG001|Overall Study|Withdrawal by Subject|0|||
16903451|NCT02006472|38010074|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
16903452|NCT02006472|38010075|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
16903453|NCT02006472|38010076|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
16903454|NCT02006472|38010077|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
16903455|NCT02006472|38010078|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
16903456|NCT02006472|38010074|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
16903457|NCT02006472|38010075|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
16903458|NCT02006472|38010076|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
16903459|NCT02006472|38010077|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
16903460|NCT02006472|38010078|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
16903461|NCT02006472|38010074|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
16903462|NCT02006472|38010075|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
16903463|NCT02006472|38010076|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
17006321|NCT00799617|38150159|FG000|Main Testosterone Trial|Randomized in error|1|||
17095703|NCT00141297|38234928|FG003|Overall Study|Transitioned|0|||
16903464|NCT02006472|38010077|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
16903465|NCT02006472|38010078|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
16903466|NCT02006472|38010074|FG000|Period 1 (Through Week 26)|Other|1|||
16903467|NCT02006472|38010075|FG001|Period 1 (Through Week 26)|Other|5|||
16903468|NCT02006472|38010076|FG002|Period 1 (Through Week 26)|Other|0|||
16903469|NCT02006472|38010077|FG003|Period 1 (Through Week 26)|Other|2|||
16903470|NCT02006472|38010078|FG004|Period 1 (Through Week 26)|Other|3|||
16903471|NCT02006472|38010074|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
16903472|NCT02006472|38010075|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
16903473|NCT02006472|38010076|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
16903474|NCT02006472|38010077|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
16903475|NCT02006472|38010078|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
16903476|NCT02006472|38010074|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
16903477|NCT02006472|38010075|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
16903478|NCT02006472|38010076|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
16903479|NCT02006472|38010077|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
16903480|NCT02006472|38010078|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
16903481|NCT02006472|38010074|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
16903482|NCT02006472|38010075|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
16903483|NCT02006472|38010076|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
16903484|NCT02006472|38010077|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
16903485|NCT02006472|38010078|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
16903486|NCT02006472|38010074|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
16903487|NCT02006472|38010075|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
16903488|NCT02006472|38010076|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
16903489|NCT02006472|38010077|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
16903490|NCT02006472|38010078|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
16903491|NCT02006472|38010074|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
16903492|NCT02006472|38010075|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
16903493|NCT02006472|38010076|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
16903494|NCT02006472|38010077|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
16903495|NCT02006472|38010078|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
16903496|NCT02006472|38010074|FG000|Period 2 (Through Week 52)|Other|0|||
16903497|NCT02006472|38010075|FG001|Period 2 (Through Week 52)|Other|1|||
16903498|NCT02006472|38010076|FG002|Period 2 (Through Week 52)|Other|0|||
16903499|NCT02006472|38010077|FG003|Period 2 (Through Week 52)|Other|1|||
16903500|NCT02006472|38010078|FG004|Period 2 (Through Week 52)|Other|0|||
16903501|NCT02006472|38010074|FG000|Period 2 (Through Week 52)|Not treated|0|||
16903502|NCT02006472|38010075|FG001|Period 2 (Through Week 52)|Not treated|0|||
16903503|NCT02006472|38010076|FG002|Period 2 (Through Week 52)|Not treated|2|||
16903504|NCT02006472|38010077|FG003|Period 2 (Through Week 52)|Not treated|0|||
16903505|NCT02006472|38010078|FG004|Period 2 (Through Week 52)|Not treated|0|||
16903506|NCT02006472|38010074|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
16903507|NCT02006472|38010075|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
16903508|NCT02006472|38010076|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
16903509|NCT02006472|38010077|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
16903510|NCT02006472|38010078|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
16903511|NCT02006472|38010074|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
16903512|NCT02006472|38010075|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
16903513|NCT02006472|38010076|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
16903514|NCT02006472|38010077|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
16903515|NCT02006472|38010078|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
16903516|NCT02005692|38010095|FG000|Overall Study|Protocol Violation|1|||
16903517|NCT02005692|38010095|FG000|Overall Study|Withdrawal by Subject|1|||
16903518|NCT02005692|38010095|FG000|Overall Study|Discharged earlier than anticipated|5|||
16903519|NCT02029638|38010103|FG000|Overall Study|Death|0|||
16903520|NCT02029638|38010104|FG001|Overall Study|Death|0|||
16903521|NCT02029638|38010105|FG002|Overall Study|Death|1|||
16903522|NCT02029638|38010103|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
16903523|NCT02029638|38010104|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
16903524|NCT02029638|38010105|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
16903525|NCT02047734|38010116|FG000|Overall Study|Adverse Event|18|||
16903526|NCT02047734|38010117|FG001|Overall Study|Adverse Event|13|||
16903527|NCT02047734|38010118|FG002|Overall Study|Adverse Event|13|||
16903528|NCT02047734|38010116|FG000|Overall Study|Lack of Efficacy|4|||
16903529|NCT02047734|38010117|FG001|Overall Study|Lack of Efficacy|5|||
16903530|NCT02047734|38010118|FG002|Overall Study|Lack of Efficacy|1|||
16903531|NCT02047734|38010116|FG000|Overall Study|Protocol Violation|3|||
16903532|NCT02047734|38010117|FG001|Overall Study|Protocol Violation|1|||
16903533|NCT02047734|38010118|FG002|Overall Study|Protocol Violation|1|||
16903534|NCT02047734|38010116|FG000|Overall Study|Lost to Follow-up|1|||
16903535|NCT02047734|38010117|FG001|Overall Study|Lost to Follow-up|4|||
16903536|NCT02047734|38010118|FG002|Overall Study|Lost to Follow-up|0|||
16903537|NCT02047734|38010116|FG000|Overall Study|Death|0|||
16903538|NCT02047734|38010117|FG001|Overall Study|Death|1|||
16903539|NCT02047734|38010118|FG002|Overall Study|Death|0|||
16903540|NCT02047734|38010116|FG000|Overall Study|Withdrawal by Subject|30|||
16903541|NCT02047734|38010117|FG001|Overall Study|Withdrawal by Subject|31|||
16903542|NCT02047734|38010118|FG002|Overall Study|Withdrawal by Subject|19|||
16903543|NCT02047734|38010116|FG000|Overall Study|Physician Decision|7|||
16903544|NCT02047734|38010117|FG001|Overall Study|Physician Decision|6|||
16903545|NCT02047734|38010118|FG002|Overall Study|Physician Decision|5|||
16903546|NCT02047734|38010116|FG000|Overall Study|Miscellaneous|2|||
16903547|NCT02047734|38010117|FG001|Overall Study|Miscellaneous|4|||
16903548|NCT02047734|38010118|FG002|Overall Study|Miscellaneous|6|||
16903549|NCT02047734|38010116|FG000|Overall Study|Did Not Receive Study Drug|2|||
16903550|NCT02047734|38010117|FG001|Overall Study|Did Not Receive Study Drug|4|||
16903551|NCT02047734|38010118|FG002|Overall Study|Did Not Receive Study Drug|1|||
16903552|NCT01994850|38010126|FG000|Overall Study|Physician Decision|1|||
16903553|NCT01994850|38010126|FG000|Overall Study|Withdrawal by Subject|1|||
16903554|NCT02027844|38010133|FG000|Overall Study|Withdrawal by Subject|3|||
16903555|NCT02027844|38010134|FG001|Overall Study|Withdrawal by Subject|2|||
16903556|NCT02027844|38010135|FG002|Overall Study|Withdrawal by Subject|1|||
16903557|NCT02027844|38010133|FG000|Overall Study|Lost to Follow-up|0|||
16903558|NCT02027844|38010134|FG001|Overall Study|Lost to Follow-up|2|||
16903559|NCT02027844|38010135|FG002|Overall Study|Lost to Follow-up|1|||
16903560|NCT02027844|38010133|FG000|Overall Study|Protocol Violation|0|||
16903561|NCT02027844|38010134|FG001|Overall Study|Protocol Violation|2|||
16903562|NCT02027844|38010135|FG002|Overall Study|Protocol Violation|0|||
16903563|NCT02027844|38010133|FG000|Overall Study|Incomlete data|2|||
16903564|NCT02027844|38010134|FG001|Overall Study|Incomlete data|0|||
16903565|NCT02027844|38010135|FG002|Overall Study|Incomlete data|0|||
16903566|NCT01994382|38010160|FG000|Overall Study|Informed consent withdrawn|0|||
16903567|NCT01994382|38010161|FG001|Overall Study|Informed consent withdrawn|0|||
16903568|NCT01994382|38010162|FG002|Overall Study|Informed consent withdrawn|0|||
16903569|NCT01994382|38010163|FG003|Overall Study|Informed consent withdrawn|0|||
16903570|NCT01994382|38010164|FG004|Overall Study|Informed consent withdrawn|0|||
16903571|NCT01994382|38010165|FG005|Overall Study|Informed consent withdrawn|0|||
16903572|NCT01994382|38010166|FG006|Overall Study|Informed consent withdrawn|1|||
16903573|NCT01994382|38010167|FG007|Overall Study|Informed consent withdrawn|0|||
16903574|NCT01994382|38010168|FG008|Overall Study|Informed consent withdrawn|0|||
16903575|NCT01994382|38010169|FG009|Overall Study|Informed consent withdrawn|0|||
16903576|NCT01994382|38010170|FG010|Overall Study|Informed consent withdrawn|0|||
16903577|NCT01994382|38010171|FG011|Overall Study|Informed consent withdrawn|0|||
16903578|NCT01994382|38010172|FG012|Overall Study|Informed consent withdrawn|0|||
16903579|NCT01994382|38010173|FG013|Overall Study|Informed consent withdrawn|0|||
16903580|NCT01994382|38010174|FG014|Overall Study|Informed consent withdrawn|0|||
16903581|NCT01994382|38010175|FG015|Overall Study|Informed consent withdrawn|0|||
16903582|NCT01994382|38010176|FG016|Overall Study|Informed consent withdrawn|0|||
16903583|NCT01994382|38010160|FG000|Overall Study|Progressive disease|3|||
16903584|NCT01994382|38010161|FG001|Overall Study|Progressive disease|4|||
16903585|NCT01994382|38010162|FG002|Overall Study|Progressive disease|4|||
16903586|NCT01994382|38010163|FG003|Overall Study|Progressive disease|3|||
16903587|NCT01994382|38010164|FG004|Overall Study|Progressive disease|2|||
16903588|NCT01994382|38010165|FG005|Overall Study|Progressive disease|3|||
16903589|NCT01994382|38010166|FG006|Overall Study|Progressive disease|3|||
16903590|NCT01994382|38010167|FG007|Overall Study|Progressive disease|6|||
16903591|NCT01994382|38010168|FG008|Overall Study|Progressive disease|2|||
16903592|NCT01994382|38010169|FG009|Overall Study|Progressive disease|2|||
16903593|NCT01994382|38010170|FG010|Overall Study|Progressive disease|13|||
16903594|NCT01994382|38010171|FG011|Overall Study|Progressive disease|8|||
16903595|NCT01994382|38010172|FG012|Overall Study|Progressive disease|7|||
16903596|NCT01994382|38010173|FG013|Overall Study|Progressive disease|3|||
16903597|NCT01994382|38010174|FG014|Overall Study|Progressive disease|6|||
16903598|NCT01994382|38010175|FG015|Overall Study|Progressive disease|44|||
16903599|NCT01994382|38010176|FG016|Overall Study|Progressive disease|28|||
16903600|NCT01994382|38010160|FG000|Overall Study|Physician Decision|0|||
16903601|NCT01994382|38010161|FG001|Overall Study|Physician Decision|1|||
16903602|NCT01994382|38010162|FG002|Overall Study|Physician Decision|0|||
16903603|NCT01994382|38010163|FG003|Overall Study|Physician Decision|0|||
16903604|NCT01994382|38010164|FG004|Overall Study|Physician Decision|0|||
16903605|NCT01994382|38010165|FG005|Overall Study|Physician Decision|0|||
16903606|NCT01994382|38010166|FG006|Overall Study|Physician Decision|0|||
16903607|NCT01994382|38010167|FG007|Overall Study|Physician Decision|0|||
16903608|NCT01994382|38010168|FG008|Overall Study|Physician Decision|0|||
16903609|NCT01994382|38010169|FG009|Overall Study|Physician Decision|0|||
16903610|NCT01994382|38010170|FG010|Overall Study|Physician Decision|3|||
16903611|NCT01994382|38010171|FG011|Overall Study|Physician Decision|1|||
16903612|NCT01994382|38010172|FG012|Overall Study|Physician Decision|1|||
16903613|NCT01994382|38010173|FG013|Overall Study|Physician Decision|0|||
16903614|NCT01994382|38010174|FG014|Overall Study|Physician Decision|1|||
16903615|NCT01994382|38010175|FG015|Overall Study|Physician Decision|4|||
16903616|NCT01994382|38010176|FG016|Overall Study|Physician Decision|2|||
16903617|NCT01994382|38010160|FG000|Overall Study|Death|0|||
16903618|NCT01994382|38010161|FG001|Overall Study|Death|0|||
16903619|NCT01994382|38010162|FG002|Overall Study|Death|0|||
16903620|NCT01994382|38010163|FG003|Overall Study|Death|0|||
16903621|NCT01994382|38010164|FG004|Overall Study|Death|1|||
16903622|NCT01994382|38010165|FG005|Overall Study|Death|0|||
16903623|NCT01994382|38010166|FG006|Overall Study|Death|0|||
16903624|NCT01994382|38010167|FG007|Overall Study|Death|0|||
16903625|NCT01994382|38010168|FG008|Overall Study|Death|1|||
16903626|NCT01994382|38010169|FG009|Overall Study|Death|1|||
16903627|NCT01994382|38010170|FG010|Overall Study|Death|0|||
16903628|NCT01994382|38010171|FG011|Overall Study|Death|0|||
16903629|NCT01994382|38010172|FG012|Overall Study|Death|0|||
16903630|NCT01994382|38010173|FG013|Overall Study|Death|0|||
16903631|NCT01994382|38010174|FG014|Overall Study|Death|0|||
16903632|NCT01994382|38010175|FG015|Overall Study|Death|1|||
16903633|NCT01994382|38010176|FG016|Overall Study|Death|0|||
16903634|NCT01994382|38010160|FG000|Overall Study|Adverse Event|0|||
16903635|NCT01994382|38010161|FG001|Overall Study|Adverse Event|1|||
16903636|NCT01994382|38010162|FG002|Overall Study|Adverse Event|2|||
16903637|NCT01994382|38010163|FG003|Overall Study|Adverse Event|0|||
16903638|NCT01994382|38010164|FG004|Overall Study|Adverse Event|0|||
16903639|NCT01994382|38010165|FG005|Overall Study|Adverse Event|0|||
16903640|NCT01994382|38010166|FG006|Overall Study|Adverse Event|0|||
16903641|NCT01994382|38010167|FG007|Overall Study|Adverse Event|0|||
16903642|NCT01994382|38010168|FG008|Overall Study|Adverse Event|0|||
16903643|NCT01994382|38010169|FG009|Overall Study|Adverse Event|0|||
16903644|NCT01994382|38010170|FG010|Overall Study|Adverse Event|15|||
16903645|NCT01994382|38010171|FG011|Overall Study|Adverse Event|2|||
16903646|NCT01994382|38010172|FG012|Overall Study|Adverse Event|7|||
16903647|NCT01994382|38010173|FG013|Overall Study|Adverse Event|3|||
16903648|NCT01994382|38010174|FG014|Overall Study|Adverse Event|17|||
16903649|NCT01994382|38010175|FG015|Overall Study|Adverse Event|6|||
16903650|NCT01994382|38010176|FG016|Overall Study|Adverse Event|3|||
16903651|NCT01994382|38010160|FG000|Overall Study|Other than specified|0|||
16903652|NCT01994382|38010161|FG001|Overall Study|Other than specified|0|||
16903653|NCT01994382|38010162|FG002|Overall Study|Other than specified|0|||
16903654|NCT01994382|38010163|FG003|Overall Study|Other than specified|0|||
16903655|NCT01994382|38010164|FG004|Overall Study|Other than specified|0|||
16903656|NCT01994382|38010165|FG005|Overall Study|Other than specified|0|||
16903657|NCT01994382|38010166|FG006|Overall Study|Other than specified|0|||
16903658|NCT01994382|38010167|FG007|Overall Study|Other than specified|0|||
16903659|NCT01994382|38010168|FG008|Overall Study|Other than specified|0|||
16903660|NCT01994382|38010169|FG009|Overall Study|Other than specified|0|||
16903661|NCT01994382|38010170|FG010|Overall Study|Other than specified|2|||
16903662|NCT01994382|38010171|FG011|Overall Study|Other than specified|0|||
16903663|NCT01994382|38010172|FG012|Overall Study|Other than specified|2|||
16903664|NCT01994382|38010173|FG013|Overall Study|Other than specified|0|||
16903665|NCT01994382|38010174|FG014|Overall Study|Other than specified|0|||
16903666|NCT01994382|38010175|FG015|Overall Study|Other than specified|4|||
16903667|NCT01994382|38010176|FG016|Overall Study|Other than specified|4|||
16903668|NCT01994382|38010160|FG000|Overall Study|Withdrawal by Subject|0|||
16903669|NCT01994382|38010161|FG001|Overall Study|Withdrawal by Subject|0|||
16903670|NCT01994382|38010162|FG002|Overall Study|Withdrawal by Subject|0|||
16903671|NCT01994382|38010163|FG003|Overall Study|Withdrawal by Subject|0|||
16903672|NCT01994382|38010164|FG004|Overall Study|Withdrawal by Subject|0|||
16903673|NCT01994382|38010165|FG005|Overall Study|Withdrawal by Subject|0|||
16903674|NCT01994382|38010166|FG006|Overall Study|Withdrawal by Subject|0|||
16903675|NCT01994382|38010167|FG007|Overall Study|Withdrawal by Subject|0|||
16903676|NCT01994382|38010168|FG008|Overall Study|Withdrawal by Subject|0|||
16903677|NCT01994382|38010169|FG009|Overall Study|Withdrawal by Subject|0|||
16903678|NCT01994382|38010170|FG010|Overall Study|Withdrawal by Subject|6|||
16903679|NCT01994382|38010171|FG011|Overall Study|Withdrawal by Subject|0|||
16903680|NCT01994382|38010172|FG012|Overall Study|Withdrawal by Subject|2|||
16903681|NCT01994382|38010173|FG013|Overall Study|Withdrawal by Subject|0|||
16903682|NCT01994382|38010174|FG014|Overall Study|Withdrawal by Subject|4|||
16903683|NCT01994382|38010175|FG015|Overall Study|Withdrawal by Subject|3|||
16903684|NCT01994382|38010176|FG016|Overall Study|Withdrawal by Subject|0|||
16903685|NCT01994382|38010160|FG000|Overall Study|Lost to Follow-up|0|||
16903686|NCT01994382|38010161|FG001|Overall Study|Lost to Follow-up|0|||
16903687|NCT01994382|38010162|FG002|Overall Study|Lost to Follow-up|0|||
16903688|NCT01994382|38010163|FG003|Overall Study|Lost to Follow-up|0|||
16903689|NCT01994382|38010164|FG004|Overall Study|Lost to Follow-up|0|||
16903690|NCT01994382|38010165|FG005|Overall Study|Lost to Follow-up|0|||
16903691|NCT01994382|38010166|FG006|Overall Study|Lost to Follow-up|0|||
16903692|NCT01994382|38010167|FG007|Overall Study|Lost to Follow-up|0|||
16903693|NCT01994382|38010168|FG008|Overall Study|Lost to Follow-up|0|||
16903694|NCT01994382|38010169|FG009|Overall Study|Lost to Follow-up|0|||
16903695|NCT01994382|38010170|FG010|Overall Study|Lost to Follow-up|1|||
16903696|NCT01994382|38010171|FG011|Overall Study|Lost to Follow-up|0|||
16903697|NCT01994382|38010172|FG012|Overall Study|Lost to Follow-up|0|||
16903698|NCT01994382|38010173|FG013|Overall Study|Lost to Follow-up|0|||
16903699|NCT01994382|38010174|FG014|Overall Study|Lost to Follow-up|0|||
16903700|NCT01994382|38010175|FG015|Overall Study|Lost to Follow-up|0|||
16903701|NCT01994382|38010176|FG016|Overall Study|Lost to Follow-up|0|||
16903702|NCT01994382|38010160|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903703|NCT01994382|38010161|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903704|NCT01994382|38010162|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903705|NCT01994382|38010163|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903706|NCT01994382|38010164|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903707|NCT01994382|38010165|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903708|NCT01994382|38010166|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903709|NCT01994382|38010167|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903710|NCT01994382|38010168|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903711|NCT01994382|38010169|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903712|NCT01994382|38010170|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
16903713|NCT01994382|38010171|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903714|NCT01994382|38010172|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
16903715|NCT01994382|38010173|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16903716|NCT01994382|38010174|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
17006322|NCT00799617|38150160|FG001|Main Testosterone Trial|Randomized in error|1|||
17006323|NCT00799617|38150159|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
17006324|NCT00799617|38150160|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
17006325|NCT00799617|38150159|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
16903717|NCT01994382|38010175|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
16903718|NCT01994382|38010176|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
16903719|NCT01994382|38010160|FG000|Overall Study|Protocol violation/noncompliance|0|||
16903720|NCT01994382|38010161|FG001|Overall Study|Protocol violation/noncompliance|0|||
16903721|NCT01994382|38010162|FG002|Overall Study|Protocol violation/noncompliance|0|||
16903722|NCT01994382|38010163|FG003|Overall Study|Protocol violation/noncompliance|0|||
16903723|NCT01994382|38010164|FG004|Overall Study|Protocol violation/noncompliance|0|||
16903724|NCT01994382|38010165|FG005|Overall Study|Protocol violation/noncompliance|0|||
16903725|NCT01994382|38010166|FG006|Overall Study|Protocol violation/noncompliance|0|||
16903726|NCT01994382|38010167|FG007|Overall Study|Protocol violation/noncompliance|0|||
16903727|NCT01994382|38010168|FG008|Overall Study|Protocol violation/noncompliance|0|||
17006326|NCT00799617|38150160|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
17006327|NCT00799617|38150159|FG000|Sexual Funtion Trial|No Baseline Data|4|||
17006328|NCT00799617|38150160|FG001|Sexual Funtion Trial|No Baseline Data|7|||
17006329|NCT00799617|38150159|FG000|Physical Function Trial|Lost to Follow-up|6|||
17095704|NCT00141297|38234929|FG004|Overall Study|Transitioned|1|||
17095705|NCT00141297|38234930|FG005|Overall Study|Transitioned|0|||
17095706|NCT00141297|38234931|FG006|Overall Study|Transitioned|0|||
17192746|NCT02814175|38346073|FG005|Part 1|Lack of Efficacy|0|||
17192747|NCT02814175|38346068|FG000|Part 2|Adverse Event|0|||
17192748|NCT02814175|38346069|FG001|Part 2|Adverse Event|0|||
17192749|NCT02814175|38346070|FG002|Part 2|Adverse Event|0|||
17192750|NCT02814175|38346071|FG003|Part 2|Adverse Event|1|||
17192751|NCT02814175|38346072|FG004|Part 2|Adverse Event|1|||
17192752|NCT02814175|38346073|FG005|Part 2|Adverse Event|2|||
17192753|NCT02814175|38346068|FG000|Part 2|Withdrawal Consent|0|||
17192754|NCT02814175|38346069|FG001|Part 2|Withdrawal Consent|0|||
17192755|NCT02814175|38346070|FG002|Part 2|Withdrawal Consent|0|||
17192756|NCT02814175|38346071|FG003|Part 2|Withdrawal Consent|2|||
17192757|NCT02814175|38346072|FG004|Part 2|Withdrawal Consent|1|||
17192758|NCT02814175|38346073|FG005|Part 2|Withdrawal Consent|1|||
17192759|NCT02814175|38346068|FG000|Part 2|Lost to Follow-up|0|||
17192760|NCT02814175|38346069|FG001|Part 2|Lost to Follow-up|0|||
17192761|NCT02814175|38346070|FG002|Part 2|Lost to Follow-up|0|||
17192762|NCT02814175|38346071|FG003|Part 2|Lost to Follow-up|1|||
17192763|NCT02814175|38346072|FG004|Part 2|Lost to Follow-up|0|||
17192764|NCT02814175|38346073|FG005|Part 2|Lost to Follow-up|0|||
17192765|NCT02814175|38346068|FG000|Part 2|Lack of Efficacy|0|||
17192766|NCT02814175|38346069|FG001|Part 2|Lack of Efficacy|0|||
17095707|NCT00141297|38234932|FG007|Overall Study|Transitioned|0|||
17095708|NCT00141297|38234933|FG008|Overall Study|Transitioned|0|||
17095709|NCT00141297|38234934|FG009|Overall Study|Transitioned|0|||
17095710|NCT00141219|38234969|FG000|Overall Study|Protocol violations|5|||
17095711|NCT00141219|38234970|FG001|Overall Study|Protocol violations|4|||
17095712|NCT00141219|38234969|FG000|Overall Study|Adverse Event|8|||
17095713|NCT00141219|38234970|FG001|Overall Study|Adverse Event|6|||
17095714|NCT00141219|38234969|FG000|Overall Study|Lack of Efficacy|5|||
17095715|NCT00141219|38234970|FG001|Overall Study|Lack of Efficacy|4|||
17095716|NCT00141219|38234969|FG000|Overall Study|Withdrawal by Subject|6|||
17095717|NCT00141219|38234970|FG001|Overall Study|Withdrawal by Subject|2|||
17095718|NCT00162266|38234979|FG000|Double-Blind Period|Adverse Event|5|||
17095719|NCT00162266|38234980|FG001|Double-Blind Period|Adverse Event|9|||
17095720|NCT00162266|38234981|FG002|Double-Blind Period|Adverse Event|11|||
17095721|NCT00162266|38234982|FG003|Double-Blind Period|Adverse Event|0|||
17095722|NCT00162266|38234979|FG000|Double-Blind Period|Death|0|||
17095723|NCT00162266|38234980|FG001|Double-Blind Period|Death|1|||
17095724|NCT00162266|38234981|FG002|Double-Blind Period|Death|0|||
17192767|NCT02814175|38346070|FG002|Part 2|Lack of Efficacy|0|||
17192768|NCT02814175|38346071|FG003|Part 2|Lack of Efficacy|0|||
17192769|NCT02814175|38346072|FG004|Part 2|Lack of Efficacy|0|||
17192770|NCT02814175|38346073|FG005|Part 2|Lack of Efficacy|3|||
17192771|NCT01335997|38346089|FG000|Period I and II|Adverse Event|63|||
17192772|NCT01335997|38346090|FG001|Period I and II|Adverse Event|43|||
16903728|NCT01994382|38010169|FG009|Overall Study|Protocol violation/noncompliance|0|||
16903729|NCT01994382|38010170|FG010|Overall Study|Protocol violation/noncompliance|0|||
16903730|NCT01994382|38010171|FG011|Overall Study|Protocol violation/noncompliance|1|||
16903731|NCT01994382|38010172|FG012|Overall Study|Protocol violation/noncompliance|0|||
16903732|NCT01994382|38010173|FG013|Overall Study|Protocol violation/noncompliance|0|||
16903733|NCT01994382|38010174|FG014|Overall Study|Protocol violation/noncompliance|0|||
16903734|NCT01994382|38010175|FG015|Overall Study|Protocol violation/noncompliance|0|||
16903735|NCT01994382|38010176|FG016|Overall Study|Protocol violation/noncompliance|2|||
16903736|NCT01994382|38010160|FG000|Overall Study|Rolled over to Phase 2a|0|||
16903737|NCT01994382|38010161|FG001|Overall Study|Rolled over to Phase 2a|0|||
16903738|NCT01994382|38010162|FG002|Overall Study|Rolled over to Phase 2a|1|||
16903739|NCT01994382|38010163|FG003|Overall Study|Rolled over to Phase 2a|0|||
16903740|NCT01994382|38010164|FG004|Overall Study|Rolled over to Phase 2a|0|||
16903741|NCT01994382|38010165|FG005|Overall Study|Rolled over to Phase 2a|0|||
16903742|NCT01994382|38010166|FG006|Overall Study|Rolled over to Phase 2a|0|||
16903743|NCT01994382|38010167|FG007|Overall Study|Rolled over to Phase 2a|0|||
16903744|NCT01994382|38010168|FG008|Overall Study|Rolled over to Phase 2a|0|||
16903745|NCT01994382|38010169|FG009|Overall Study|Rolled over to Phase 2a|2|||
16903746|NCT01994382|38010170|FG010|Overall Study|Rolled over to Phase 2a|0|||
16903747|NCT01994382|38010171|FG011|Overall Study|Rolled over to Phase 2a|0|||
16903748|NCT01994382|38010172|FG012|Overall Study|Rolled over to Phase 2a|0|||
16903749|NCT01994382|38010173|FG013|Overall Study|Rolled over to Phase 2a|0|||
16903750|NCT01994382|38010174|FG014|Overall Study|Rolled over to Phase 2a|0|||
16903751|NCT01994382|38010175|FG015|Overall Study|Rolled over to Phase 2a|0|||
16903752|NCT01994382|38010176|FG016|Overall Study|Rolled over to Phase 2a|0|||
16903753|NCT02003898|38010219|FG000|Overall Study|Death|3|||
16903754|NCT02003898|38010219|FG000|Overall Study|Lost to Follow-up|12|||
16903755|NCT02003898|38010219|FG000|Overall Study|Withdrawal by Subject|52|||
16903756|NCT02027376|38010223|FG000|Overall Study|Death|1|||
16903757|NCT02027376|38010224|FG001|Overall Study|Death|0|||
16903758|NCT02027376|38010225|FG002|Overall Study|Death|0|||
16903759|NCT01994226|38010237|FG000|Overall Study|Protocol Violation|13|||
16903760|NCT01994226|38010238|FG001|Overall Study|Protocol Violation|10|||
16903761|NCT01994226|38010237|FG000|Overall Study|Early Cessation of treatment|6|||
16903762|NCT01994226|38010238|FG001|Overall Study|Early Cessation of treatment|11|||
16903763|NCT02002884|38010247|FG000|Main Period (MP)|Other|0|||
16903764|NCT02002884|38010248|FG001|Main Period (MP)|Other|3|||
16903765|NCT02002884|38010249|FG002|Main Period (MP)|Other|3|||
16903766|NCT02002884|38010250|FG003|Main Period (MP)|Other|0|||
16903767|NCT02002884|38010247|FG000|Main Period (MP)|Adverse Event|0|||
16903768|NCT02002884|38010248|FG001|Main Period (MP)|Adverse Event|1|||
16903769|NCT02002884|38010249|FG002|Main Period (MP)|Adverse Event|1|||
16903770|NCT02002884|38010250|FG003|Main Period (MP)|Adverse Event|0|||
16903771|NCT02002884|38010247|FG000|Main Period (MP)|Withdrawal by Subject|6|||
16903772|NCT02002884|38010248|FG001|Main Period (MP)|Withdrawal by Subject|2|||
16903773|NCT02002884|38010249|FG002|Main Period (MP)|Withdrawal by Subject|2|||
16903774|NCT02002884|38010250|FG003|Main Period (MP)|Withdrawal by Subject|0|||
16903775|NCT02002884|38010247|FG000|Main Period (MP)|Lost to Follow-up|0|||
16903776|NCT02002884|38010248|FG001|Main Period (MP)|Lost to Follow-up|0|||
16903777|NCT02002884|38010249|FG002|Main Period (MP)|Lost to Follow-up|2|||
16903778|NCT02002884|38010250|FG003|Main Period (MP)|Lost to Follow-up|0|||
16903779|NCT02002884|38010247|FG000|Open-Label Extension Period (OLEX)|Other|0|||
16903780|NCT02002884|38010248|FG001|Open-Label Extension Period (OLEX)|Other|0|||
16903781|NCT02002884|38010249|FG002|Open-Label Extension Period (OLEX)|Other|0|||
16903782|NCT02002884|38010250|FG003|Open-Label Extension Period (OLEX)|Other|24|||
16903783|NCT02002884|38010247|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
16903784|NCT02002884|38010248|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
16903785|NCT02002884|38010249|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
16903786|NCT02002884|38010250|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
16903787|NCT02002884|38010247|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
16903788|NCT02002884|38010248|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
16903789|NCT02002884|38010249|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
16903790|NCT02002884|38010250|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
16903791|NCT02002884|38010247|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
16903792|NCT02002884|38010248|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
16903793|NCT02002884|38010249|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
16903794|NCT02002884|38010250|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
16903795|NCT02002884|38010247|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
16903796|NCT02002884|38010248|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
16903797|NCT02002884|38010249|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
16903798|NCT02002884|38010250|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
16903799|NCT02002182|38010262|FG000|Overall Study|Withdraw from study|3|||
16903800|NCT02002182|38010263|FG001|Overall Study|Withdraw from study|1|||
17095725|NCT00162266|38234982|FG003|Double-Blind Period|Death|0|||
16903801|NCT02002182|38010262|FG000|Overall Study|Health Reasons|1|||
16903802|NCT02002182|38010263|FG001|Overall Study|Health Reasons|0|||
16903803|NCT02002182|38010262|FG000|Overall Study|Death|1|||
16903804|NCT02002182|38010263|FG001|Overall Study|Death|0|||
16903805|NCT01990950|38010269|FG000|Overall Study|Death|3|||
16903806|NCT01990950|38010269|FG000|Overall Study|Lost to Follow-up|2|||
16903807|NCT01990950|38010269|FG000|Overall Study|Withdrawal by Subject|6|||
16903808|NCT02001558|38010275|FG000|Overall Study|Lost to Follow-up|8|||
16903809|NCT02001558|38010276|FG001|Overall Study|Lost to Follow-up|14|||
16903810|NCT02023866|38010282|FG000|Overall Study|Non-compliance|2|||
16903811|NCT02023866|38010282|FG000|Overall Study|Adverse Event|3|||
16903812|NCT02023866|38010282|FG000|Overall Study|Withdrawal by Subject|1|||
16903813|NCT02023242|38010288|FG000|Overall Study|Lost to Follow-up|3|||
16903814|NCT02023242|38010289|FG001|Overall Study|Lost to Follow-up|1|||
16903815|NCT02023242|38010288|FG000|Overall Study|Death|0|||
16903816|NCT02023242|38010289|FG001|Overall Study|Death|1|||
16903817|NCT01967940|38010298|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
16903818|NCT01967940|38010299|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
16903819|NCT01967940|38010300|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
16903820|NCT01967940|38010301|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
16903821|NCT01967940|38010298|FG000|Part 2|Adverse Event|0|||
16903822|NCT01967940|38010299|FG001|Part 2|Adverse Event|0|||
16903823|NCT01967940|38010300|FG002|Part 2|Adverse Event|0|||
16903824|NCT01967940|38010301|FG003|Part 2|Adverse Event|1|||
16903825|NCT01967940|38010298|FG000|Part 2|Unknown Reason|0|||
16903826|NCT01967940|38010299|FG001|Part 2|Unknown Reason|0|||
16903827|NCT01967940|38010300|FG002|Part 2|Unknown Reason|0|||
16903828|NCT01967940|38010301|FG003|Part 2|Unknown Reason|1|||
16903829|NCT01990560|38010311|FG000|Overall Study|Withdrawal by Subject|1|||
16903830|NCT01999218|38010318|FG000|Overall Study|Hyperglycemia|18|||
16903831|NCT01999218|38010319|FG001|Overall Study|Hyperglycemia|17|||
16903832|NCT01999218|38010320|FG002|Overall Study|Hyperglycemia|17|||
16903833|NCT01999218|38010318|FG000|Overall Study|Lack of Efficacy|1|||
16903834|NCT01999218|38010319|FG001|Overall Study|Lack of Efficacy|0|||
16903835|NCT01999218|38010320|FG002|Overall Study|Lack of Efficacy|1|||
16903836|NCT01999218|38010318|FG000|Overall Study|Lost to Follow-up|22|||
16903837|NCT01999218|38010319|FG001|Overall Study|Lost to Follow-up|17|||
16903838|NCT01999218|38010320|FG002|Overall Study|Lost to Follow-up|18|||
16903839|NCT01999218|38010318|FG000|Overall Study|Non-Compliance With Study Drug|6|||
16903840|NCT01999218|38010319|FG001|Overall Study|Non-Compliance With Study Drug|4|||
16903841|NCT01999218|38010320|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16903842|NCT01999218|38010318|FG000|Overall Study|Physician Decision|1|||
16903843|NCT01999218|38010319|FG001|Overall Study|Physician Decision|4|||
16903844|NCT01999218|38010320|FG002|Overall Study|Physician Decision|6|||
16903845|NCT01999218|38010318|FG000|Overall Study|Protocol Violation|4|||
16903846|NCT01999218|38010319|FG001|Overall Study|Protocol Violation|5|||
16903847|NCT01999218|38010320|FG002|Overall Study|Protocol Violation|4|||
16903848|NCT01999218|38010318|FG000|Overall Study|Screen failure|0|||
16903849|NCT01999218|38010319|FG001|Overall Study|Screen failure|1|||
16903850|NCT01999218|38010320|FG002|Overall Study|Screen failure|0|||
16903851|NCT01999218|38010318|FG000|Overall Study|Study Terminated By Sponsor|7|||
16903852|NCT01999218|38010319|FG001|Overall Study|Study Terminated By Sponsor|5|||
16903853|NCT01999218|38010320|FG002|Overall Study|Study Terminated By Sponsor|12|||
16903854|NCT01999218|38010318|FG000|Overall Study|Participant moves|2|||
16903855|NCT01999218|38010319|FG001|Overall Study|Participant moves|5|||
16903856|NCT01999218|38010320|FG002|Overall Study|Participant moves|3|||
16903857|NCT01999218|38010318|FG000|Overall Study|Withdrawal by Subject|28|||
16903858|NCT01999218|38010319|FG001|Overall Study|Withdrawal by Subject|29|||
16903859|NCT01999218|38010320|FG002|Overall Study|Withdrawal by Subject|34|||
16903860|NCT01999218|38010318|FG000|Overall Study|Creatinine/eGFR|0|||
16903861|NCT01999218|38010319|FG001|Overall Study|Creatinine/eGFR|0|||
17006330|NCT00799617|38150160|FG001|Physical Function Trial|Lost to Follow-up|11|||
17006331|NCT00799617|38150159|FG000|Vitality Trial|Lost to Follow-up|7|||
17006332|NCT00799617|38150160|FG001|Vitality Trial|Lost to Follow-up|22|||
16903862|NCT01999218|38010320|FG002|Overall Study|Creatinine/eGFR|1|||
16903863|NCT01999218|38010318|FG000|Overall Study|Death|7|||
16903864|NCT01999218|38010319|FG001|Overall Study|Death|1|||
16903865|NCT01999218|38010320|FG002|Overall Study|Death|2|||
16903866|NCT01999218|38010318|FG000|Overall Study|Excluded Medication|1|||
16903867|NCT01999218|38010319|FG001|Overall Study|Excluded Medication|1|||
16903868|NCT01999218|38010320|FG002|Overall Study|Excluded Medication|2|||
16903869|NCT01999218|38010318|FG000|Overall Study|Adverse Event|9|||
16903870|NCT01999218|38010319|FG001|Overall Study|Adverse Event|7|||
16903871|NCT01999218|38010320|FG002|Overall Study|Adverse Event|7|||
16903872|NCT01999218|38010318|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
16903873|NCT01999218|38010319|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
16903874|NCT01999218|38010320|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
16903875|NCT01998984|38010332|FG000|Overall Study|Adverse Event|0|||
17006333|NCT00799617|38150159|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
17006334|NCT00799617|38150160|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
16903876|NCT01998984|38010333|FG001|Overall Study|Adverse Event|0|||
16903877|NCT01998984|38010334|FG002|Overall Study|Adverse Event|0|||
16903878|NCT01998984|38010335|FG003|Overall Study|Adverse Event|1|||
16903879|NCT01998984|38010332|FG000|Overall Study|Lost to Follow-up|0|||
16903880|NCT01998984|38010333|FG001|Overall Study|Lost to Follow-up|1|||
16903881|NCT01998984|38010334|FG002|Overall Study|Lost to Follow-up|0|||
16903882|NCT01998984|38010335|FG003|Overall Study|Lost to Follow-up|1|||
16903883|NCT01998984|38010332|FG000|Overall Study|Withdrawal by Subject|0|||
16903884|NCT01998984|38010333|FG001|Overall Study|Withdrawal by Subject|0|||
16903885|NCT01998984|38010334|FG002|Overall Study|Withdrawal by Subject|1|||
16903886|NCT01998984|38010335|FG003|Overall Study|Withdrawal by Subject|0|||
16903887|NCT01998984|38010332|FG000|Overall Study|Other|0|||
16903888|NCT01998984|38010333|FG001|Overall Study|Other|0|||
16903889|NCT01998984|38010334|FG002|Overall Study|Other|0|||
16903890|NCT01998984|38010335|FG003|Overall Study|Other|1|||
16903891|NCT01967706|38010347|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
16903892|NCT01967706|38010348|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
16903893|NCT01967706|38010349|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16903894|NCT01967706|38010350|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
16903895|NCT01967628|38010361|FG000|Overall Study|Withdrawal by Subject|2|||
16903896|NCT01967628|38010362|FG001|Overall Study|Withdrawal by Subject|0|||
16903897|NCT01967628|38010361|FG000|Overall Study|Unable to complete bronchoscopy|4|||
16903898|NCT01967628|38010362|FG001|Overall Study|Unable to complete bronchoscopy|6|||
16903899|NCT01967628|38010361|FG000|Overall Study|Lost to Follow-up|1|||
16903900|NCT01967628|38010362|FG001|Overall Study|Lost to Follow-up|0|||
16903901|NCT01967628|38010361|FG000|Overall Study|Low protein concentration in sample|20|||
16903902|NCT01967628|38010362|FG001|Overall Study|Low protein concentration in sample|25|||
16903903|NCT01998906|38010371|FG000|Overall Study|Participants ongoing in follow-up|77|||
16903904|NCT01998906|38010372|FG001|Overall Study|Participants ongoing in follow-up|60|||
16903905|NCT01998906|38010373|FG002|Overall Study|Participants ongoing in follow-up|58|||
16903906|NCT01998906|38010371|FG000|Overall Study|Death|21|||
16903907|NCT01998906|38010372|FG001|Overall Study|Death|30|||
16903908|NCT01998906|38010373|FG002|Overall Study|Death|17|||
16903909|NCT01998906|38010371|FG000|Overall Study|Lack of Efficacy|10|||
16903910|NCT01998906|38010372|FG001|Overall Study|Lack of Efficacy|9|||
16903911|NCT01998906|38010373|FG002|Overall Study|Lack of Efficacy|8|||
16903912|NCT01998906|38010371|FG000|Overall Study|Failure to return|0|||
16903913|NCT01998906|38010372|FG001|Overall Study|Failure to return|2|||
16903914|NCT01998906|38010373|FG002|Overall Study|Failure to return|4|||
16903915|NCT01998906|38010371|FG000|Overall Study|Violation of Selection Criteria|0|||
16903916|NCT01998906|38010372|FG001|Overall Study|Violation of Selection Criteria|0|||
16903917|NCT01998906|38010373|FG002|Overall Study|Violation of Selection Criteria|1|||
17006335|NCT00799617|38150159|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
17006336|NCT00799617|38150160|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
17006337|NCT00799617|38150159|FG000|Bone Trial|Month 12 scan not available|6|||
17006338|NCT00799617|38150160|FG001|Bone Trial|Month 12 scan not available|16|||
17006339|NCT00799617|38150159|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
17006340|NCT00799617|38150160|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
16903918|NCT01998906|38010371|FG000|Overall Study|Withdrawal by Subject|1|||
16786218|NCT02684617|37726685|FG001|Overall Study|Adverse Event|0|||
16903919|NCT01998906|38010372|FG001|Overall Study|Withdrawal by Subject|4|||
16903920|NCT01998906|38010373|FG002|Overall Study|Withdrawal by Subject|3|||
16903921|NCT01998906|38010371|FG000|Overall Study|Administrative/Other|2|||
16903922|NCT01998906|38010372|FG001|Overall Study|Administrative/Other|1|||
16903923|NCT01998906|38010373|FG002|Overall Study|Administrative/Other|3|||
16903924|NCT01998906|38010371|FG000|Overall Study|Other|3|||
16903925|NCT01998906|38010372|FG001|Overall Study|Other|8|||
16903926|NCT01998906|38010373|FG002|Overall Study|Other|4|||
16903927|NCT01967550|38010386|FG000|Overall Study|Withdrawal by Subject|1|||
16903928|NCT01967550|38010387|FG001|Overall Study|Withdrawal by Subject|0|||
16903929|NCT01967550|38010386|FG000|Overall Study|Adverse Event|2|||
16903930|NCT01967550|38010387|FG001|Overall Study|Adverse Event|0|||
16903931|NCT01967550|38010386|FG000|Overall Study|Protocol Violation|2|||
16903932|NCT01967550|38010387|FG001|Overall Study|Protocol Violation|1|||
16786219|NCT02684617|37726686|FG002|Overall Study|Adverse Event|1|||
16786220|NCT02684617|37726684|FG000|Overall Study|Death|8|||
16903933|NCT01967550|38010386|FG000|Overall Study|Non Compliance|0|||
16903934|NCT01967550|38010387|FG001|Overall Study|Non Compliance|1|||
16903935|NCT01989546|38010393|FG000|Overall Study|Clinical Progression|1|||
16903936|NCT01989546|38010393|FG000|Overall Study|Disease progression on study|8|||
16903937|NCT01997892|38010397|FG000|Overall Study|Physician Decision|2|||
16903938|NCT01997892|38010397|FG000|Overall Study|Lost to Follow-up|6|||
16903939|NCT01997892|38010397|FG000|Overall Study|Death|14|||
16903940|NCT01997892|38010397|FG000|Overall Study|Renal transplant|8|||
16903941|NCT01997892|38010397|FG000|Overall Study|Other|3|||
16903942|NCT01997892|38010397|FG000|Overall Study|Study completion data not recorded|35|||
16903943|NCT01989468|38010409|FG000|Overall Study|Adverse Event|10|||
16903944|NCT01989468|38010410|FG001|Overall Study|Adverse Event|15|||
16903945|NCT01989468|38010411|FG002|Overall Study|Adverse Event|4|||
16903946|NCT01989468|38010412|FG003|Overall Study|Adverse Event|5|||
16903947|NCT01989468|38010413|FG004|Overall Study|Adverse Event|4|||
16903948|NCT01989468|38010409|FG000|Overall Study|Lack of Efficacy|11|||
16903949|NCT01989468|38010410|FG001|Overall Study|Lack of Efficacy|11|||
16903950|NCT01989468|38010411|FG002|Overall Study|Lack of Efficacy|7|||
16903951|NCT01989468|38010412|FG003|Overall Study|Lack of Efficacy|4|||
16903952|NCT01989468|38010413|FG004|Overall Study|Lack of Efficacy|2|||
16903953|NCT01989468|38010409|FG000|Overall Study|Lost to Follow-up|5|||
16903954|NCT01989468|38010410|FG001|Overall Study|Lost to Follow-up|2|||
16903955|NCT01989468|38010411|FG002|Overall Study|Lost to Follow-up|0|||
16903956|NCT01989468|38010412|FG003|Overall Study|Lost to Follow-up|1|||
16903957|NCT01989468|38010413|FG004|Overall Study|Lost to Follow-up|1|||
16903958|NCT01989468|38010409|FG000|Overall Study|Physician Decision|4|||
16903959|NCT01989468|38010410|FG001|Overall Study|Physician Decision|1|||
16903960|NCT01989468|38010411|FG002|Overall Study|Physician Decision|0|||
16903961|NCT01989468|38010412|FG003|Overall Study|Physician Decision|1|||
16903962|NCT01989468|38010413|FG004|Overall Study|Physician Decision|0|||
16903963|NCT01989468|38010409|FG000|Overall Study|Pregnancy|0|||
16903964|NCT01989468|38010410|FG001|Overall Study|Pregnancy|1|||
16903965|NCT01989468|38010411|FG002|Overall Study|Pregnancy|0|||
16903966|NCT01989468|38010412|FG003|Overall Study|Pregnancy|0|||
16903967|NCT01989468|38010413|FG004|Overall Study|Pregnancy|0|||
16903968|NCT01989468|38010409|FG000|Overall Study|Technical Problems|3|||
16903969|NCT01989468|38010410|FG001|Overall Study|Technical Problems|1|||
16903970|NCT01989468|38010411|FG002|Overall Study|Technical Problems|3|||
16903971|NCT01989468|38010412|FG003|Overall Study|Technical Problems|1|||
16903972|NCT01989468|38010413|FG004|Overall Study|Technical Problems|0|||
16903973|NCT01989468|38010409|FG000|Overall Study|Subject Guardian Decision|11|||
16903974|NCT01989468|38010410|FG001|Overall Study|Subject Guardian Decision|6|||
16903975|NCT01989468|38010411|FG002|Overall Study|Subject Guardian Decision|4|||
16903976|NCT01989468|38010412|FG003|Overall Study|Subject Guardian Decision|4|||
16903977|NCT01989468|38010413|FG004|Overall Study|Subject Guardian Decision|1|||
16903978|NCT01989468|38010409|FG000|Overall Study|Death|3|||
16903979|NCT01989468|38010410|FG001|Overall Study|Death|0|||
16903980|NCT01989468|38010411|FG002|Overall Study|Death|1|||
16903981|NCT01989468|38010412|FG003|Overall Study|Death|0|||
16903982|NCT01989468|38010413|FG004|Overall Study|Death|0|||
16903983|NCT01989156|38010429|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
16903984|NCT01989156|38010430|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
16903985|NCT01989156|38010431|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
16903986|NCT01989156|38010429|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
16903987|NCT01989156|38010430|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
16903988|NCT01989156|38010431|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
16903989|NCT01989156|38010429|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
16903990|NCT01989156|38010430|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
16903991|NCT01989156|38010431|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
16903992|NCT01989156|38010429|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
16903993|NCT01989156|38010430|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
16903994|NCT01989156|38010431|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
16903995|NCT01989156|38010429|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
16903996|NCT01989156|38010430|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
16903997|NCT01989156|38010431|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
16903998|NCT01989156|38010429|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
16903999|NCT01989156|38010430|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
16904000|NCT01989156|38010431|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
16904001|NCT01989156|38010429|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
16904002|NCT01989156|38010430|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
16904003|NCT01989156|38010431|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
16904004|NCT01989156|38010429|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
16904005|NCT01989156|38010430|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
16904006|NCT01989156|38010431|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
16904007|NCT01620762|38010442|FG000|Overall Study|Protocol Violation|1|||
16904008|NCT01620762|38010443|FG001|Overall Study|Protocol Violation|1|||
16904009|NCT01620762|38010444|FG002|Overall Study|Protocol Violation|1|||
16904010|NCT01620762|38010442|FG000|Overall Study|Adverse Event|9|||
16904011|NCT01620762|38010443|FG001|Overall Study|Adverse Event|5|||
17095726|NCT00162266|38234979|FG000|Double-Blind Period|Lost to Follow-up|1|||
16904012|NCT01620762|38010444|FG002|Overall Study|Adverse Event|2|||
17006341|NCT00799617|38150159|FG000|Anemia Trial|Withdrawal by Subject|3|||
16904013|NCT01620762|38010442|FG000|Overall Study|Withdrawal by Subject|23|||
16904014|NCT01620762|38010443|FG001|Overall Study|Withdrawal by Subject|26|||
16904015|NCT01620762|38010444|FG002|Overall Study|Withdrawal by Subject|27|||
16904016|NCT01620762|38010442|FG000|Overall Study|Lost to Follow-up|11|||
16904017|NCT01620762|38010443|FG001|Overall Study|Lost to Follow-up|17|||
16904018|NCT01620762|38010444|FG002|Overall Study|Lost to Follow-up|10|||
16904019|NCT01620762|38010442|FG000|Overall Study|Protocol deviation|1|||
16904020|NCT01620762|38010443|FG001|Overall Study|Protocol deviation|1|||
16904021|NCT01620762|38010444|FG002|Overall Study|Protocol deviation|6|||
16904022|NCT01620762|38010442|FG000|Overall Study|Subject deterioration|0|||
16904023|NCT01620762|38010443|FG001|Overall Study|Subject deterioration|1|||
16904024|NCT01620762|38010444|FG002|Overall Study|Subject deterioration|1|||
16904025|NCT01620762|38010442|FG000|Overall Study|Non-specified|3|||
16904026|NCT01620762|38010443|FG001|Overall Study|Non-specified|6|||
16904027|NCT01620762|38010444|FG002|Overall Study|Non-specified|5|||
16904028|NCT01620762|38010442|FG000|Overall Study|Use of prohibted therapies|0|||
16904029|NCT01620762|38010443|FG001|Overall Study|Use of prohibted therapies|1|||
16904030|NCT01620762|38010444|FG002|Overall Study|Use of prohibted therapies|1|||
16904031|NCT01966068|38010454|FG000|Overall Study|Withdrawal by Subject|57|||
16904032|NCT01966068|38010454|FG000|Overall Study|Lost to Follow-up|81|||
16904033|NCT01620528|38010462|FG000|Treatment Period|Did Not Receive Study Drug|0|||
17006342|NCT00799617|38150160|FG001|Anemia Trial|Withdrawal by Subject|3|||
17006343|NCT00607087|38150169|FG000|Overall Study|Withdrawal by Subject|9|||
16904034|NCT01620528|38010463|FG001|Treatment Period|Did Not Receive Study Drug|0|||
16904035|NCT01620528|38010464|FG002|Treatment Period|Did Not Receive Study Drug|1|||
16904036|NCT01620528|38010462|FG000|Treatment Period|Withdrawal by Subject|35|||
16904037|NCT01620528|38010463|FG001|Treatment Period|Withdrawal by Subject|21|||
16904038|NCT01620528|38010464|FG002|Treatment Period|Withdrawal by Subject|16|||
16904039|NCT01620528|38010462|FG000|Treatment Period|Adverse Event|17|||
16904040|NCT01620528|38010463|FG001|Treatment Period|Adverse Event|13|||
16904041|NCT01620528|38010464|FG002|Treatment Period|Adverse Event|21|||
16904042|NCT01620528|38010462|FG000|Treatment Period|Lost to Follow-up|16|||
16904043|NCT01620528|38010463|FG001|Treatment Period|Lost to Follow-up|8|||
16904044|NCT01620528|38010464|FG002|Treatment Period|Lost to Follow-up|14|||
16904045|NCT01620528|38010462|FG000|Treatment Period|Other|9|||
16904046|NCT01620528|38010463|FG001|Treatment Period|Other|5|||
16904047|NCT01620528|38010464|FG002|Treatment Period|Other|7|||
16904048|NCT01620528|38010462|FG000|Treatment Period|Subject Noncompliant|11|||
16904049|NCT01620528|38010463|FG001|Treatment Period|Subject Noncompliant|2|||
16904050|NCT01620528|38010464|FG002|Treatment Period|Subject Noncompliant|2|||
16904051|NCT01620528|38010462|FG000|Treatment Period|Pregnancy|7|||
16904052|NCT01620528|38010463|FG001|Treatment Period|Pregnancy|2|||
16904053|NCT01620528|38010464|FG002|Treatment Period|Pregnancy|2|||
16904054|NCT01620528|38010462|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
16904055|NCT01620528|38010463|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
16904056|NCT01620528|38010464|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
16904057|NCT01620528|38010462|FG000|Treatment Period|Exclusionary Medication Received|0|||
16904058|NCT01620528|38010463|FG001|Treatment Period|Exclusionary Medication Received|1|||
16904059|NCT01620528|38010464|FG002|Treatment Period|Exclusionary Medication Received|0|||
16904060|NCT01620528|38010462|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
17006344|NCT00607087|38150170|FG001|Overall Study|Withdrawal by Subject|4|||
17006345|NCT00607087|38150171|FG002|Overall Study|Withdrawal by Subject|4|||
17006346|NCT00607087|38150169|FG000|Overall Study|Adverse Event|3|||
17006347|NCT00607087|38150170|FG001|Overall Study|Adverse Event|2|||
16904061|NCT01620528|38010463|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
16904062|NCT01620528|38010464|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
16904063|NCT01620528|38010462|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
16904064|NCT01620528|38010463|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
16904065|NCT01620528|38010464|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
16904066|NCT01620528|38010462|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
16904067|NCT01620528|38010463|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
16904068|NCT01620528|38010464|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
16904069|NCT01620528|38010462|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
16904070|NCT01620528|38010463|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
16904071|NCT01620528|38010464|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
16904072|NCT01620528|38010462|FG000|Post-Treatment Follow-Up Period|Other|6|||
16904073|NCT01620528|38010463|FG001|Post-Treatment Follow-Up Period|Other|4|||
16904074|NCT01620528|38010464|FG002|Post-Treatment Follow-Up Period|Other|2|||
16904075|NCT01965834|38010472|FG000|Overall Study|Lack of Efficacy|4|||
16904076|NCT01965600|38010476|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
16904077|NCT01965600|38010477|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
16904078|NCT01965600|38010478|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
16904079|NCT01965600|38010479|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
16904080|NCT01965600|38010476|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
16904081|NCT01965600|38010477|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
16904082|NCT01965600|38010478|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
17006348|NCT00607087|38150171|FG002|Overall Study|Adverse Event|3|||
16904083|NCT01965600|38010479|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
16904084|NCT01965600|38010476|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
16904085|NCT01965600|38010477|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
16904086|NCT01965600|38010478|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
16904087|NCT01965600|38010479|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
16904088|NCT01965600|38010476|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
16904089|NCT01965600|38010477|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
16904090|NCT01965600|38010478|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
16904091|NCT01965600|38010479|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
16904092|NCT01965600|38010476|FG000|Second Intervention|Study terminated by Sponsor|0|||
16904093|NCT01965600|38010477|FG001|Second Intervention|Study terminated by Sponsor|0|||
17006349|NCT00607087|38150169|FG000|Overall Study|Other reason|1|||
17006350|NCT00607087|38150170|FG001|Overall Study|Other reason|5|||
17006351|NCT00607087|38150171|FG002|Overall Study|Other reason|2|||
17006352|NCT00607087|38150169|FG000|Overall Study|Poor compliance to protocol|1|||
17006353|NCT00607087|38150170|FG001|Overall Study|Poor compliance to protocol|0|||
17006354|NCT00607087|38150171|FG002|Overall Study|Poor compliance to protocol|1|||
17006355|NCT00607087|38150169|FG000|Overall Study|Lost to Follow-up|1|||
17006356|NCT00607087|38150170|FG001|Overall Study|Lost to Follow-up|0|||
17006357|NCT00607087|38150171|FG002|Overall Study|Lost to Follow-up|0|||
17006358|NCT00607087|38150169|FG000|Period 1|Withdrawal by Subject|7|||
17006359|NCT00607087|38150170|FG001|Period 1|Withdrawal by Subject|2|||
17006360|NCT00607087|38150171|FG002|Period 1|Withdrawal by Subject|3|||
17006361|NCT00607087|38150169|FG000|Period 1|Adverse Event|3|||
17006362|NCT00607087|38150170|FG001|Period 1|Adverse Event|0|||
17095727|NCT00162266|38234980|FG001|Double-Blind Period|Lost to Follow-up|2|||
16904094|NCT01965600|38010478|FG002|Second Intervention|Study terminated by Sponsor|2|||
16904095|NCT01965600|38010479|FG003|Second Intervention|Study terminated by Sponsor|2|||
16904096|NCT01996332|38010487|FG000|Overall Study|Adverse Event|117|||
16904097|NCT01996332|38010487|FG000|Overall Study|Lack of Efficacy|1245|||
16904098|NCT01996332|38010487|FG000|Overall Study|Death|264|||
16904099|NCT01996332|38010487|FG000|Overall Study|Protocol Violation|9|||
16904100|NCT01996332|38010487|FG000|Overall Study|Withdrawal by Subject|71|||
16904101|NCT01996332|38010487|FG000|Overall Study|Other|20|||
16904102|NCT01996332|38010487|FG000|Overall Study|Clinical Deterioration|28|||
16904103|NCT01996332|38010487|FG000|Overall Study|Physician Decision|17|||
16904104|NCT01996332|38010487|FG000|Overall Study|Lost to Follow-up|34|||
16904105|NCT01996254|38010493|FG000|Overall Study|Change in Eligibility|0|||
16904106|NCT01996254|38010494|FG001|Overall Study|Change in Eligibility|2|||
16904107|NCT01996254|38010495|FG002|Overall Study|Change in Eligibility|0|||
16904108|NCT01996254|38010493|FG000|Overall Study|Withdrawal by Subject|0|||
16904109|NCT01996254|38010494|FG001|Overall Study|Withdrawal by Subject|3|||
16904110|NCT01996254|38010495|FG002|Overall Study|Withdrawal by Subject|4|||
16904111|NCT01996254|38010493|FG000|Overall Study|Lost to Follow-up|1|||
16904112|NCT01996254|38010494|FG001|Overall Study|Lost to Follow-up|0|||
16904113|NCT01996254|38010495|FG002|Overall Study|Lost to Follow-up|4|||
16904114|NCT01987986|38010509|FG000|Overall Study|Lost to Follow-up|1|||
16904115|NCT01987986|38010510|FG001|Overall Study|Lost to Follow-up|0|||
16904116|NCT01987986|38010511|FG002|Overall Study|Lost to Follow-up|0|||
16904117|NCT01987986|38010512|FG003|Overall Study|Lost to Follow-up|0|||
16904118|NCT01987986|38010509|FG000|Overall Study|Adverse Event|1|||
16904119|NCT01987986|38010510|FG001|Overall Study|Adverse Event|0|||
16904120|NCT01987986|38010511|FG002|Overall Study|Adverse Event|2|||
16904121|NCT01987986|38010512|FG003|Overall Study|Adverse Event|0|||
16904122|NCT01987908|38010522|FG000|Placebo Lead-in Period|Adverse Event|2|||
16904123|NCT01987908|38010523|FG001|Placebo Lead-in Period|Adverse Event|0|||
16904124|NCT01987908|38010524|FG002|Placebo Lead-in Period|Adverse Event|0|||
16904125|NCT01987908|38010522|FG000|Placebo Lead-in Period|Physician Decision|2|||
16904126|NCT01987908|38010523|FG001|Placebo Lead-in Period|Physician Decision|0|||
16904127|NCT01987908|38010524|FG002|Placebo Lead-in Period|Physician Decision|0|||
16904128|NCT01987908|38010522|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
16904129|NCT01987908|38010523|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
16904130|NCT01987908|38010524|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
16904131|NCT01987908|38010522|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
16904132|NCT01987908|38010523|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
16904133|NCT01987908|38010524|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
16904134|NCT01987908|38010522|FG000|Treatment Period|Adverse Event|0|||
16904135|NCT01987908|38010523|FG001|Treatment Period|Adverse Event|1|||
16904136|NCT01987908|38010524|FG002|Treatment Period|Adverse Event|1|||
16904137|NCT01987908|38010522|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
16904138|NCT01987908|38010523|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
17006363|NCT00607087|38150171|FG002|Period 1|Adverse Event|0|||
17006364|NCT00607087|38150169|FG000|Period 1|Poor compliance to protocol|1|||
17006365|NCT00607087|38150170|FG001|Period 1|Poor compliance to protocol|0|||
16904139|NCT01987908|38010524|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
16904140|NCT01987908|38010522|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
16904141|NCT01987908|38010523|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
16904142|NCT01987908|38010524|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
16904143|NCT01995552|38010548|FG000|Overall Study|Protocol Violation|1|||
16904144|NCT01995552|38010548|FG000|Overall Study|Lack of Efficacy|15|||
16904145|NCT01995552|38010548|FG000|Overall Study|Death|1|||
16904146|NCT01987830|38010554|FG000|Overall Study|Never received baseline scan|1|||
16904147|NCT01987596|38010560|FG000|Overall Study|Physician Decision|1|||
16904148|NCT01987596|38010561|FG001|Overall Study|Physician Decision|0|||
16904149|NCT01987596|38010560|FG000|Overall Study|Progressive Disease; missing all period|0|||
16904150|NCT01987596|38010561|FG001|Overall Study|Progressive Disease; missing all period|1|||
16904151|NCT01964976|38010575|FG000|Overall Study|Protocol Violation|31|||
16904152|NCT01964898|38010584|FG000|Overall Study|ineligible post-randomization|1|||
16904153|NCT01964898|38010585|FG001|Overall Study|ineligible post-randomization|1|||
16904154|NCT01964898|38010584|FG000|Overall Study|did not receive the allocated interventi|2|||
16904155|NCT01964898|38010585|FG001|Overall Study|did not receive the allocated interventi|1|||
16904156|NCT01964898|38010584|FG000|Overall Study|Lost to Follow-up|3|||
16904157|NCT01964898|38010585|FG001|Overall Study|Lost to Follow-up|5|||
16904158|NCT01964898|38010584|FG000|Overall Study|Withdrawal by Subject|1|||
16904159|NCT01964898|38010585|FG001|Overall Study|Withdrawal by Subject|0|||
16904160|NCT01964352|38010595|FG000|Overall Study|Adverse Event|13|||
16904161|NCT01964352|38010596|FG001|Overall Study|Adverse Event|3|||
16904162|NCT01964352|38010597|FG002|Overall Study|Adverse Event|4|||
16904163|NCT01964352|38010598|FG003|Overall Study|Adverse Event|3|||
16904164|NCT01964352|38010595|FG000|Overall Study|Lack of Efficacy|6|||
16904165|NCT01964352|38010596|FG001|Overall Study|Lack of Efficacy|0|||
16904166|NCT01964352|38010597|FG002|Overall Study|Lack of Efficacy|0|||
16904167|NCT01964352|38010598|FG003|Overall Study|Lack of Efficacy|0|||
16904168|NCT01964352|38010595|FG000|Overall Study|Protocol Violation|2|||
16904169|NCT01964352|38010596|FG001|Overall Study|Protocol Violation|4|||
16904170|NCT01964352|38010597|FG002|Overall Study|Protocol Violation|0|||
16904171|NCT01964352|38010598|FG003|Overall Study|Protocol Violation|2|||
16904172|NCT01964352|38010595|FG000|Overall Study|Lost to Follow-up|1|||
16904173|NCT01964352|38010596|FG001|Overall Study|Lost to Follow-up|0|||
16904174|NCT01964352|38010597|FG002|Overall Study|Lost to Follow-up|0|||
16904175|NCT01964352|38010598|FG003|Overall Study|Lost to Follow-up|1|||
16904176|NCT01964352|38010595|FG000|Overall Study|Withdrawal by Subject|4|||
16904177|NCT01964352|38010596|FG001|Overall Study|Withdrawal by Subject|2|||
16904178|NCT01964352|38010597|FG002|Overall Study|Withdrawal by Subject|1|||
16904179|NCT01964352|38010598|FG003|Overall Study|Withdrawal by Subject|0|||
16904180|NCT01964352|38010595|FG000|Overall Study|Other than stated above|0|||
16904181|NCT01964352|38010596|FG001|Overall Study|Other than stated above|2|||
16904182|NCT01964352|38010597|FG002|Overall Study|Other than stated above|1|||
16904183|NCT01964352|38010598|FG003|Overall Study|Other than stated above|2|||
16904184|NCT01946412|38010608|FG000|Overall Study|Adverse Event|1|||
16904185|NCT01946412|38010608|FG000|Overall Study|Non-Compliance|1|||
16904186|NCT01946412|38010608|FG000|Overall Study|Continued with commercial Kalydeco|2|||
16904187|NCT01946412|38010608|FG000|Overall Study|Difficulty in swallowing|1|||
16904188|NCT01946178|38010614|FG000|Overall Study|Pregnancy|1|||
16904189|NCT01946178|38010614|FG000|Overall Study|Lost to Follow-up|1|||
16904190|NCT01945944|38010624|FG000|Overall Study|Adverse Event|0|||
16904191|NCT01945944|38010625|FG001|Overall Study|Adverse Event|2|||
16904192|NCT01945944|38010624|FG000|Overall Study|Physician Decision|1|||
16904193|NCT01945944|38010625|FG001|Overall Study|Physician Decision|0|||
16904194|NCT01945944|38010624|FG000|Overall Study|Withdrawal by Subject|0|||
16904195|NCT01945944|38010625|FG001|Overall Study|Withdrawal by Subject|1|||
16904196|NCT01945866|38010635|FG000|Overall Study|Eyes did not complete or were dropped|2|||
16904197|NCT01945866|38010636|FG001|Overall Study|Eyes did not complete or were dropped|0|||
16904198|NCT01986114|38010643|FG000|Overall Study|Adverse Event|59|||
16904199|NCT01986114|38010643|FG000|Overall Study|Lack of Efficacy|23|||
16904200|NCT01986114|38010643|FG000|Overall Study|Withdrawal by Subject|58|||
16904201|NCT01986114|38010643|FG000|Overall Study|Noncompliance|3|||
16904202|NCT01986114|38010643|FG000|Overall Study|Protocol Violation|1|||
16904203|NCT01986114|38010643|FG000|Overall Study|Lost to Follow-up|5|||
16904204|NCT01986114|38010643|FG000|Overall Study|Other reason|7|||
16904205|NCT01945710|38010656|FG000|Overall Study|Progressive Disease|5|||
16904206|NCT01945710|38010657|FG001|Overall Study|Progressive Disease|4|||
16904207|NCT01945710|38010658|FG002|Overall Study|Progressive Disease|3|||
16904208|NCT01945710|38010659|FG003|Overall Study|Progressive Disease|2|||
16904209|NCT01945710|38010660|FG004|Overall Study|Progressive Disease|7|||
16904210|NCT01945710|38010661|FG005|Overall Study|Progressive Disease|3|||
16904211|NCT01945710|38010662|FG006|Overall Study|Progressive Disease|19|||
16904212|NCT01945710|38010656|FG000|Overall Study|Adverse Event|0|||
16904213|NCT01945710|38010657|FG001|Overall Study|Adverse Event|1|||
16904214|NCT01945710|38010658|FG002|Overall Study|Adverse Event|0|||
16904215|NCT01945710|38010659|FG003|Overall Study|Adverse Event|0|||
16904216|NCT01945710|38010660|FG004|Overall Study|Adverse Event|0|||
16904217|NCT01945710|38010661|FG005|Overall Study|Adverse Event|0|||
16904218|NCT01945710|38010662|FG006|Overall Study|Adverse Event|0|||
16904219|NCT01945710|38010656|FG000|Overall Study|Other|2|||
16904220|NCT01945710|38010657|FG001|Overall Study|Other|0|||
16904221|NCT01945710|38010658|FG002|Overall Study|Other|3|||
16904222|NCT01945710|38010659|FG003|Overall Study|Other|1|||
16904223|NCT01945710|38010660|FG004|Overall Study|Other|1|||
16904224|NCT01945710|38010661|FG005|Overall Study|Other|0|||
16904225|NCT01945710|38010662|FG006|Overall Study|Other|4|||
16904226|NCT01945710|38010656|FG000|Overall Study|Withdrawal by Subject|0|||
16904227|NCT01945710|38010657|FG001|Overall Study|Withdrawal by Subject|1|||
16904228|NCT01945710|38010658|FG002|Overall Study|Withdrawal by Subject|1|||
16904229|NCT01945710|38010659|FG003|Overall Study|Withdrawal by Subject|0|||
16904230|NCT01945710|38010660|FG004|Overall Study|Withdrawal by Subject|1|||
16904231|NCT01945710|38010661|FG005|Overall Study|Withdrawal by Subject|0|||
16904232|NCT01945710|38010662|FG006|Overall Study|Withdrawal by Subject|0|||
16904233|NCT01945242|38010682|FG000|Overall Study|Physician Decision|3|||
16904234|NCT01945242|38010683|FG001|Overall Study|Physician Decision|3|||
16904235|NCT01945086|38010693|FG000|Overall Study|Withdrawal by Subject|1|||
16904236|NCT01945086|38010694|FG001|Overall Study|Withdrawal by Subject|0|||
16904237|NCT01945086|38010695|FG002|Overall Study|Withdrawal by Subject|1|||
16904238|NCT01945086|38010693|FG000|Overall Study|Adverse Event|0|||
16904239|NCT01945086|38010694|FG001|Overall Study|Adverse Event|0|||
16904240|NCT01945086|38010695|FG002|Overall Study|Adverse Event|1|||
16904241|NCT01963728|38010705|FG000|Overall Study|Study terminated early|0|||
16904242|NCT01963728|38010706|FG001|Overall Study|Study terminated early|1|||
16904243|NCT01963260|38010722|FG000|Overall Study|Withdrawal by Subject|2|||
16904244|NCT01963260|38010723|FG001|Overall Study|Withdrawal by Subject|0|||
16904245|NCT01963260|38010724|FG002|Overall Study|Withdrawal by Subject|0|||
16904246|NCT01963260|38010725|FG003|Overall Study|Withdrawal by Subject|1|||
16904247|NCT01963260|38010726|FG004|Overall Study|Withdrawal by Subject|2|||
16904248|NCT01963260|38010727|FG005|Overall Study|Withdrawal by Subject|0|||
16904249|NCT01963260|38010728|FG006|Overall Study|Withdrawal by Subject|0|||
16904250|NCT01963260|38010729|FG007|Overall Study|Withdrawal by Subject|0|||
16904251|NCT01963260|38010730|FG008|Overall Study|Withdrawal by Subject|0|||
16904252|NCT01963260|38010731|FG009|Overall Study|Withdrawal by Subject|0|||
16904253|NCT01962948|38010764|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
16904254|NCT01962948|38010765|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
16904255|NCT01962948|38010766|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
16904256|NCT01962948|38010767|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
16904257|NCT01985334|38010782|FG000|Overall Study|Administrative problems|1|||
16904258|NCT01985334|38010783|FG001|Overall Study|Administrative problems|1|||
16904259|NCT01985334|38010784|FG002|Overall Study|Administrative problems|0|||
16904260|NCT01985334|38010785|FG003|Overall Study|Administrative problems|2|||
16904261|NCT01985334|38010786|FG004|Overall Study|Administrative problems|0|||
16904262|NCT01985334|38010787|FG005|Overall Study|Administrative problems|1|||
16904263|NCT01985334|38010788|FG006|Overall Study|Administrative problems|1|||
16904264|NCT01985334|38010789|FG007|Overall Study|Administrative problems|3|||
16904265|NCT01985334|38010782|FG000|Overall Study|Death|1|||
16904266|NCT01985334|38010783|FG001|Overall Study|Death|0|||
16904267|NCT01985334|38010784|FG002|Overall Study|Death|0|||
16904268|NCT01985334|38010785|FG003|Overall Study|Death|3|||
16904269|NCT01985334|38010786|FG004|Overall Study|Death|0|||
16904270|NCT01985334|38010787|FG005|Overall Study|Death|0|||
16904271|NCT01985334|38010788|FG006|Overall Study|Death|1|||
16904272|NCT01985334|38010789|FG007|Overall Study|Death|2|||
16904273|NCT01985334|38010782|FG000|Overall Study|Worsening of disease|0|||
16904274|NCT01985334|38010783|FG001|Overall Study|Worsening of disease|0|||
16904275|NCT01985334|38010784|FG002|Overall Study|Worsening of disease|0|||
16904276|NCT01985334|38010785|FG003|Overall Study|Worsening of disease|1|||
16904277|NCT01985334|38010786|FG004|Overall Study|Worsening of disease|0|||
16904278|NCT01985334|38010787|FG005|Overall Study|Worsening of disease|3|||
16904279|NCT01985334|38010788|FG006|Overall Study|Worsening of disease|0|||
16904280|NCT01985334|38010789|FG007|Overall Study|Worsening of disease|1|||
16904281|NCT01985334|38010782|FG000|Overall Study|Other|2|||
16904282|NCT01985334|38010783|FG001|Overall Study|Other|9|||
16904283|NCT01985334|38010784|FG002|Overall Study|Other|7|||
16904284|NCT01985334|38010785|FG003|Overall Study|Other|17|||
16904285|NCT01985334|38010786|FG004|Overall Study|Other|4|||
16904286|NCT01985334|38010787|FG005|Overall Study|Other|8|||
16904287|NCT01985334|38010788|FG006|Overall Study|Other|4|||
16904288|NCT01985334|38010789|FG007|Overall Study|Other|7|||
16904289|NCT01985334|38010782|FG000|Overall Study|Protocol deviation|6|||
16904290|NCT01985334|38010783|FG001|Overall Study|Protocol deviation|31|||
16904291|NCT01985334|38010784|FG002|Overall Study|Protocol deviation|25|||
16904292|NCT01985334|38010785|FG003|Overall Study|Protocol deviation|84|||
16904293|NCT01985334|38010786|FG004|Overall Study|Protocol deviation|17|||
16904294|NCT01985334|38010787|FG005|Overall Study|Protocol deviation|47|||
16904295|NCT01985334|38010788|FG006|Overall Study|Protocol deviation|15|||
16904296|NCT01985334|38010789|FG007|Overall Study|Protocol deviation|42|||
16904297|NCT01985334|38010782|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
16904298|NCT01985334|38010783|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
16904299|NCT01985334|38010784|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
16904300|NCT01985334|38010785|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
16904301|NCT01985334|38010786|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
16904302|NCT01985334|38010787|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
16904303|NCT01985334|38010788|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
16904304|NCT01985334|38010789|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
16904305|NCT01985334|38010782|FG000|Overall Study|Subject withdrawal of consent|3|||
16904306|NCT01985334|38010783|FG001|Overall Study|Subject withdrawal of consent|6|||
16904307|NCT01985334|38010784|FG002|Overall Study|Subject withdrawal of consent|2|||
16904308|NCT01985334|38010785|FG003|Overall Study|Subject withdrawal of consent|28|||
16904309|NCT01985334|38010786|FG004|Overall Study|Subject withdrawal of consent|4|||
16904310|NCT01985334|38010787|FG005|Overall Study|Subject withdrawal of consent|19|||
16904311|NCT01985334|38010788|FG006|Overall Study|Subject withdrawal of consent|0|||
16904312|NCT01985334|38010789|FG007|Overall Study|Subject withdrawal of consent|20|||
16904313|NCT01985334|38010782|FG000|Overall Study|Adverse Event|0|||
16904314|NCT01985334|38010783|FG001|Overall Study|Adverse Event|8|||
16904315|NCT01985334|38010784|FG002|Overall Study|Adverse Event|2|||
16904316|NCT01985334|38010785|FG003|Overall Study|Adverse Event|26|||
16904317|NCT01985334|38010786|FG004|Overall Study|Adverse Event|3|||
16904318|NCT01985334|38010787|FG005|Overall Study|Adverse Event|18|||
16904319|NCT01985334|38010788|FG006|Overall Study|Adverse Event|3|||
16904320|NCT01985334|38010789|FG007|Overall Study|Adverse Event|15|||
16904321|NCT01985334|38010782|FG000|Overall Study|Other|4|||
16904322|NCT01985334|38010783|FG001|Overall Study|Other|2|||
16904323|NCT01985334|38010784|FG002|Overall Study|Other|3|||
16904324|NCT01985334|38010785|FG003|Overall Study|Other|10|||
16904325|NCT01985334|38010786|FG004|Overall Study|Other|1|||
16904326|NCT01985334|38010787|FG005|Overall Study|Other|6|||
16904327|NCT01985334|38010788|FG006|Overall Study|Other|2|||
16904328|NCT01985334|38010789|FG007|Overall Study|Other|2|||
16904329|NCT01985334|38010782|FG000|Overall Study|Medication non-compliance|0|||
16904330|NCT01985334|38010783|FG001|Overall Study|Medication non-compliance|4|||
16904331|NCT01985334|38010784|FG002|Overall Study|Medication non-compliance|1|||
16904332|NCT01985334|38010785|FG003|Overall Study|Medication non-compliance|6|||
16904333|NCT01985334|38010786|FG004|Overall Study|Medication non-compliance|2|||
16904334|NCT01985334|38010787|FG005|Overall Study|Medication non-compliance|3|||
16904335|NCT01985334|38010788|FG006|Overall Study|Medication non-compliance|1|||
16904336|NCT01985334|38010789|FG007|Overall Study|Medication non-compliance|3|||
16904337|NCT01985334|38010782|FG000|Overall Study|Use of prohibited treatment|1|||
16904338|NCT01985334|38010783|FG001|Overall Study|Use of prohibited treatment|4|||
16904339|NCT01985334|38010784|FG002|Overall Study|Use of prohibited treatment|1|||
16904340|NCT01985334|38010785|FG003|Overall Study|Use of prohibited treatment|2|||
16904341|NCT01985334|38010786|FG004|Overall Study|Use of prohibited treatment|1|||
16904342|NCT01985334|38010787|FG005|Overall Study|Use of prohibited treatment|6|||
16904343|NCT01985334|38010788|FG006|Overall Study|Use of prohibited treatment|2|||
16904344|NCT01985334|38010789|FG007|Overall Study|Use of prohibited treatment|0|||
16904345|NCT01985334|38010782|FG000|Overall Study|Investigator decision|0|||
16904346|NCT01985334|38010783|FG001|Overall Study|Investigator decision|3|||
16904347|NCT01985334|38010784|FG002|Overall Study|Investigator decision|0|||
16904348|NCT01985334|38010785|FG003|Overall Study|Investigator decision|7|||
16904349|NCT01985334|38010786|FG004|Overall Study|Investigator decision|1|||
16904350|NCT01985334|38010787|FG005|Overall Study|Investigator decision|1|||
16904351|NCT01985334|38010788|FG006|Overall Study|Investigator decision|0|||
16904352|NCT01985334|38010789|FG007|Overall Study|Investigator decision|4|||
16904353|NCT01985334|38010782|FG000|Overall Study|Lost to Follow-up|0|||
16904354|NCT01985334|38010783|FG001|Overall Study|Lost to Follow-up|2|||
16904355|NCT01985334|38010784|FG002|Overall Study|Lost to Follow-up|0|||
16904356|NCT01985334|38010785|FG003|Overall Study|Lost to Follow-up|3|||
16904357|NCT01985334|38010786|FG004|Overall Study|Lost to Follow-up|1|||
16904358|NCT01985334|38010787|FG005|Overall Study|Lost to Follow-up|4|||
16904359|NCT01985334|38010788|FG006|Overall Study|Lost to Follow-up|0|||
16904360|NCT01985334|38010789|FG007|Overall Study|Lost to Follow-up|3|||
16904361|NCT01944774|38010824|FG000|Overall Study|Withdrawal by Subject|2|||
16904362|NCT01944774|38010825|FG001|Overall Study|Withdrawal by Subject|3|||
16904363|NCT01944774|38010826|FG002|Overall Study|Withdrawal by Subject|3|||
16904364|NCT01944774|38010824|FG000|Overall Study|Adverse Event|3|||
16904365|NCT01944774|38010825|FG001|Overall Study|Adverse Event|2|||
16904366|NCT01944774|38010826|FG002|Overall Study|Adverse Event|3|||
16904367|NCT01944774|38010824|FG000|Overall Study|Lack of Efficacy|1|||
16904368|NCT01944774|38010825|FG001|Overall Study|Lack of Efficacy|2|||
16904369|NCT01944774|38010826|FG002|Overall Study|Lack of Efficacy|2|||
16904370|NCT01944774|38010824|FG000|Overall Study|Lost to Follow-up|0|||
16904371|NCT01944774|38010825|FG001|Overall Study|Lost to Follow-up|1|||
16904372|NCT01944774|38010826|FG002|Overall Study|Lost to Follow-up|0|||
16904373|NCT01944462|38010837|FG000|PPPP Educational Program|Lost to Follow-up|60|||
17006366|NCT00607087|38150171|FG002|Period 1|Poor compliance to protocol|0|||
17006367|NCT00607087|38150169|FG000|Period 1|Lost to Follow-up|1|||
17006368|NCT00607087|38150170|FG001|Period 1|Lost to Follow-up|0|||
17006369|NCT00607087|38150171|FG002|Period 1|Lost to Follow-up|0|||
17006370|NCT00607087|38150169|FG000|Period 1|Other reason|0|||
16904374|NCT01943292|38010845|FG000|Overall Study|Withdrawal by Subject|1|||
16904375|NCT01943292|38010846|FG001|Overall Study|Withdrawal by Subject|0|||
16904376|NCT01943292|38010847|FG002|Overall Study|Withdrawal by Subject|0|||
17006371|NCT00607087|38150170|FG001|Period 1|Other reason|4|||
17006372|NCT00607087|38150171|FG002|Period 1|Other reason|2|||
17006373|NCT00607087|38150169|FG000|Period 2|Withdrawal by Subject|0|||
17006374|NCT00607087|38150170|FG001|Period 2|Withdrawal by Subject|1|||
17006375|NCT00607087|38150171|FG002|Period 2|Withdrawal by Subject|1|||
17006376|NCT00607087|38150169|FG000|Period 2|Other reason|1|||
17006377|NCT00607087|38150170|FG001|Period 2|Other reason|1|||
17006378|NCT00607087|38150171|FG002|Period 2|Other reason|0|||
17006379|NCT00607087|38150169|FG000|Period 2|Adverse Event|0|||
17006380|NCT00607087|38150170|FG001|Period 2|Adverse Event|1|||
17006381|NCT00607087|38150171|FG002|Period 2|Adverse Event|3|||
17006382|NCT00607087|38150169|FG000|Period 2|Poor compliance to protocol|0|||
17006383|NCT00607087|38150170|FG001|Period 2|Poor compliance to protocol|0|||
17006384|NCT00607087|38150171|FG002|Period 2|Poor compliance to protocol|1|||
17006385|NCT00607087|38150169|FG000|Period 3|Withdrawal by Subject|2|||
17006386|NCT00607087|38150170|FG001|Period 3|Withdrawal by Subject|1|||
17006387|NCT00607087|38150171|FG002|Period 3|Withdrawal by Subject|0|||
17006388|NCT00607087|38150169|FG000|Period 3|Adverse Event|0|||
16904377|NCT01961544|38010855|FG000|Overall Study|Protocol Violation|1|||
16904378|NCT01961544|38010855|FG000|Overall Study|Withdrawal by Subject|7|||
16904379|NCT01961544|38010855|FG000|Overall Study|Adverse Event|1|||
16904380|NCT01961544|38010855|FG000|Overall Study|Physician Decision|2|||
16904381|NCT01961544|38010855|FG000|Overall Study|Poor Tolerance|1|||
16904382|NCT01961544|38010855|FG000|Overall Study|Aggravation of Steral Pain|1|||
16904383|NCT01942590|38010861|FG000|Overall Study|Withdrawal by Subject|0|||
16904384|NCT01942590|38010862|FG001|Overall Study|Withdrawal by Subject|1|||
16904385|NCT01942590|38010861|FG000|Overall Study|Adverse Event|1|||
16904386|NCT01942590|38010862|FG001|Overall Study|Adverse Event|0|||
16904387|NCT01984242|38010872|FG000|Overall Study|Death|52|||
16904388|NCT01984242|38010873|FG001|Overall Study|Death|50|||
16904389|NCT01984242|38010874|FG002|Overall Study|Death|52|||
16904390|NCT01984242|38010872|FG000|Overall Study|Withdrawal by Subject|5|||
16904391|NCT01984242|38010873|FG001|Overall Study|Withdrawal by Subject|3|||
16904392|NCT01984242|38010874|FG002|Overall Study|Withdrawal by Subject|10|||
16904393|NCT01984242|38010872|FG000|Overall Study|Physician Decision|0|||
16904394|NCT01984242|38010873|FG001|Overall Study|Physician Decision|0|||
16904395|NCT01984242|38010874|FG002|Overall Study|Physician Decision|1|||
16904396|NCT01984242|38010872|FG000|Overall Study|Lost to Follow-up|4|||
16904397|NCT01984242|38010873|FG001|Overall Study|Lost to Follow-up|0|||
16904398|NCT01984242|38010874|FG002|Overall Study|Lost to Follow-up|3|||
16904399|NCT01984242|38010872|FG000|Overall Study|Sponsor Decision|1|||
16904400|NCT01984242|38010873|FG001|Overall Study|Sponsor Decision|0|||
16904401|NCT01984242|38010874|FG002|Overall Study|Sponsor Decision|0|||
16904402|NCT01984242|38010872|FG000|Overall Study|Non-Compliance|1|||
16904403|NCT01984242|38010873|FG001|Overall Study|Non-Compliance|0|||
16904404|NCT01984242|38010874|FG002|Overall Study|Non-Compliance|0|||
16904405|NCT01984242|38010872|FG000|Overall Study|Study terminated by Sponsor|38|||
16904406|NCT01984242|38010873|FG001|Overall Study|Study terminated by Sponsor|50|||
16904407|NCT01984242|38010874|FG002|Overall Study|Study terminated by Sponsor|34|||
16904408|NCT01984242|38010872|FG000|Overall Study|Disease Progression|0|||
16904409|NCT01984242|38010873|FG001|Overall Study|Disease Progression|0|||
16904410|NCT01984242|38010874|FG002|Overall Study|Disease Progression|1|||
16904411|NCT01941498|38010890|FG000|Overall Study|Relocated out of state|1|||
16904412|NCT01960998|38010911|FG000|Overall Study|Lost to Follow-up|3|||
16904413|NCT01960998|38010912|FG001|Overall Study|Lost to Follow-up|7|||
16904414|NCT01960998|38010911|FG000|Overall Study|Death|0|||
16904415|NCT01960998|38010912|FG001|Overall Study|Death|1|||
16904416|NCT01960998|38010911|FG000|Overall Study|Withdrawal by Subject|8|||
16904417|NCT01960998|38010912|FG001|Overall Study|Withdrawal by Subject|2|||
16904418|NCT01960998|38010911|FG000|Overall Study|lost computer access|0|||
16904419|NCT01960998|38010912|FG001|Overall Study|lost computer access|1|||
16904420|NCT01941186|38010922|FG000|Follow-up|Lost to Follow-up|1|||
16904421|NCT01941186|38010923|FG001|Follow-up|Lost to Follow-up|0|||
16904422|NCT01960842|38010942|FG000|Overall Study|Adverse Event|1|||
16904423|NCT01960842|38010942|FG000|Overall Study|Withdrawal by Subject|2|||
17006389|NCT00607087|38150170|FG001|Period 3|Adverse Event|1|||
17006390|NCT00607087|38150171|FG002|Period 3|Adverse Event|0|||
17006391|NCT00610363|38150181|FG000|Overall Study|Non-compliance with protocol|0|||
16904424|NCT01984164|38010948|FG000|Overall Study|Withdrawal by Subject|4|||
16904425|NCT01984164|38010949|FG001|Overall Study|Withdrawal by Subject|3|||
16904426|NCT01984164|38010948|FG000|Overall Study|Adverse Event|5|||
16904427|NCT01984164|38010949|FG001|Overall Study|Adverse Event|19|||
16904428|NCT01984164|38010948|FG000|Overall Study|Lost to Follow-up|1|||
16904429|NCT01984164|38010949|FG001|Overall Study|Lost to Follow-up|3|||
16904430|NCT01941030|38010957|FG000|Overall Study|Death|3|||
16904431|NCT01941030|38010958|FG001|Overall Study|Death|2|||
16904432|NCT01941030|38010957|FG000|Overall Study|Lost to Follow-up|6|||
16904433|NCT01941030|38010958|FG001|Overall Study|Lost to Follow-up|5|||
16904434|NCT01941030|38010957|FG000|Overall Study|Withdrawal by Subject|4|||
16904435|NCT01941030|38010958|FG001|Overall Study|Withdrawal by Subject|6|||
16904436|NCT01983930|38010966|FG000|Overall Study|Withdrawal by Subject|9|||
16904437|NCT01983930|38010967|FG001|Overall Study|Withdrawal by Subject|8|||
16904438|NCT01983930|38010966|FG000|Overall Study|Adverse Event|0|||
16904439|NCT01983930|38010967|FG001|Overall Study|Adverse Event|1|||
16904440|NCT01983774|38010980|FG000|Overall Study|Lung Transplant|0|||
16904441|NCT01983774|38010981|FG001|Overall Study|Lung Transplant|1|||
16904442|NCT01983774|38010980|FG000|Overall Study|Lost to Follow-up|1|||
16904443|NCT01983774|38010981|FG001|Overall Study|Lost to Follow-up|0|||
16904444|NCT01982682|38010989|FG000|Overall Study|Physician Decision|1|||
16904445|NCT01940484|38010994|FG000|Overall Study|Withdrawal by Subject|3|||
16904446|NCT01940484|38010994|FG000|Overall Study|Underwent transplantation|4|||
16904447|NCT01940484|38010994|FG000|Overall Study|Death|2|||
16904448|NCT01940484|38010994|FG000|Overall Study|Adverse Event|1|||
16904449|NCT01939548|38011001|FG000|Overall Study|Non compliance|0|||
16904450|NCT01939548|38011002|FG001|Overall Study|Non compliance|2|||
16904451|NCT01939548|38011003|FG002|Overall Study|Non compliance|0|||
16904452|NCT01939548|38011001|FG000|Overall Study|Study Terminated by Sponsor|17|||
16904453|NCT01939548|38011002|FG001|Overall Study|Study Terminated by Sponsor|19|||
16904454|NCT01939548|38011003|FG002|Overall Study|Study Terminated by Sponsor|12|||
16904455|NCT01939548|38011001|FG000|Overall Study|Insufficient Clinical Response|1|||
16904456|NCT01939548|38011002|FG001|Overall Study|Insufficient Clinical Response|0|||
16904457|NCT01939548|38011003|FG002|Overall Study|Insufficient Clinical Response|0|||
16904458|NCT01939548|38011001|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16904459|NCT01939548|38011002|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
16904460|NCT01939548|38011003|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
16904461|NCT01939548|38011001|FG000|Overall Study|Withdrawal by Subject|4|||
16904462|NCT01939548|38011002|FG001|Overall Study|Withdrawal by Subject|4|||
16904463|NCT01939548|38011003|FG002|Overall Study|Withdrawal by Subject|1|||
16904464|NCT01939548|38011001|FG000|Overall Study|Protocol Violation|7|||
16904465|NCT01939548|38011002|FG001|Overall Study|Protocol Violation|6|||
16904466|NCT01939548|38011003|FG002|Overall Study|Protocol Violation|5|||
16904467|NCT01939548|38011001|FG000|Overall Study|Lost to Follow-up|5|||
16904468|NCT01939548|38011002|FG001|Overall Study|Lost to Follow-up|5|||
16904469|NCT01939548|38011003|FG002|Overall Study|Lost to Follow-up|3|||
16904470|NCT01939548|38011001|FG000|Overall Study|Adverse Event|2|||
16904471|NCT01939548|38011002|FG001|Overall Study|Adverse Event|9|||
16904472|NCT01939548|38011003|FG002|Overall Study|Adverse Event|7|||
16904473|NCT01939548|38011001|FG000|Overall Study|Death|0|||
16904474|NCT01939548|38011002|FG001|Overall Study|Death|0|||
16904475|NCT01939548|38011003|FG002|Overall Study|Death|1|||
16904476|NCT01939548|38011001|FG000|Overall Study|Participant dropped|0|||
16904477|NCT01939548|38011002|FG001|Overall Study|Participant dropped|0|||
16904478|NCT01939548|38011003|FG002|Overall Study|Participant dropped|1|||
16904479|NCT01939548|38011001|FG000|Overall Study|Participant unwilling to continue|0|||
16904480|NCT01939548|38011002|FG001|Overall Study|Participant unwilling to continue|1|||
16904481|NCT01939548|38011003|FG002|Overall Study|Participant unwilling to continue|0|||
16904482|NCT01939548|38011001|FG000|Overall Study|Participant withdrew consent|0|||
16904483|NCT01939548|38011002|FG001|Overall Study|Participant withdrew consent|2|||
16904484|NCT01939548|38011003|FG002|Overall Study|Participant withdrew consent|0|||
16904485|NCT01939548|38011001|FG000|Overall Study|Did not complete follow-up|0|||
16904486|NCT01939548|38011002|FG001|Overall Study|Did not complete follow-up|1|||
16904487|NCT01939548|38011003|FG002|Overall Study|Did not complete follow-up|0|||
16904488|NCT01960296|38011013|FG000|Overall Study|Postponed surgery|1|||
16904489|NCT01960296|38011014|FG001|Overall Study|Postponed surgery|0|||
16904490|NCT01960296|38011013|FG000|Overall Study|Received different procedure|1|||
16904491|NCT01960296|38011014|FG001|Overall Study|Received different procedure|3|||
16904492|NCT01982292|38011022|FG000|Overall Study|Adverse Event|2|||
16904493|NCT01982292|38011023|FG001|Overall Study|Adverse Event|0|||
16904494|NCT01982292|38011022|FG000|Overall Study|Death|1|||
16904495|NCT01982292|38011023|FG001|Overall Study|Death|0|||
16904496|NCT01982292|38011022|FG000|Overall Study|Lost to Follow-up|2|||
16904497|NCT01982292|38011023|FG001|Overall Study|Lost to Follow-up|0|||
16904498|NCT01982292|38011022|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
16904499|NCT01982292|38011023|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
16904500|NCT01982292|38011022|FG000|Overall Study|Protocol Deviation|1|||
16904501|NCT01982292|38011023|FG001|Overall Study|Protocol Deviation|0|||
17006392|NCT00610363|38150182|FG001|Overall Study|Non-compliance with protocol|1|||
17006393|NCT00610363|38150181|FG000|Overall Study|Adverse Event|3|||
17006394|NCT00610363|38150182|FG001|Overall Study|Adverse Event|1|||
17006395|NCT00610363|38150181|FG000|Overall Study|Lack of Efficacy|2|||
17006396|NCT00610363|38150182|FG001|Overall Study|Lack of Efficacy|0|||
17006397|NCT00610363|38150181|FG000|Overall Study|Lost to Follow-up|4|||
17006398|NCT00610363|38150182|FG001|Overall Study|Lost to Follow-up|0|||
17006399|NCT00610363|38150181|FG000|Overall Study|Withdrawal by Subject|1|||
17006400|NCT00610363|38150182|FG001|Overall Study|Withdrawal by Subject|0|||
17006401|NCT00610363|38150181|FG000|Overall Study|Other than specified above|1|||
17006402|NCT00610363|38150182|FG001|Overall Study|Other than specified above|1|||
17006403|NCT00887588|38150191|FG000|Core Period|Death|1|||
17006404|NCT00887588|38150192|FG001|Core Period|Death|1|||
17006405|NCT00887588|38150191|FG000|Core Period|Lost to Follow-up|3|||
17006406|NCT00887588|38150192|FG001|Core Period|Lost to Follow-up|1|||
17006407|NCT00887588|38150191|FG000|Core Period|Withdrawal by Subject|6|||
16904502|NCT01982292|38011022|FG000|Overall Study|Patient/Guardian Decision|3|||
16904503|NCT01982292|38011023|FG001|Overall Study|Patient/Guardian Decision|1|||
16904504|NCT01982292|38011022|FG000|Overall Study|Technical Problems|2|||
16904505|NCT01982292|38011023|FG001|Overall Study|Technical Problems|0|||
16904506|NCT01939314|38011031|FG000|Overall Study|Withdrawal by Subject|3|||
16904507|NCT01939314|38011032|FG001|Overall Study|Withdrawal by Subject|1|||
16904508|NCT01939314|38011031|FG000|Overall Study|Protocol Violation|1|||
16904509|NCT01939314|38011032|FG001|Overall Study|Protocol Violation|0|||
16904510|NCT01939314|38011031|FG000|Overall Study|Pregnancy|0|||
16904511|NCT01939314|38011032|FG001|Overall Study|Pregnancy|1|||
16904512|NCT01939314|38011031|FG000|Overall Study|Lost to Follow-up|5|||
16904513|NCT01939314|38011032|FG001|Overall Study|Lost to Follow-up|6|||
16904514|NCT01939158|38011044|FG000|Overall Study|Adverse Event|1|||
16904515|NCT01939158|38011045|FG001|Overall Study|Adverse Event|0|||
16904516|NCT01939158|38011046|FG002|Overall Study|Adverse Event|0|||
16904517|NCT01939158|38011047|FG003|Overall Study|Adverse Event|0|||
16904518|NCT01939158|38011044|FG000|Overall Study|Withdrawal by Subject|22|||
16904519|NCT01939158|38011045|FG001|Overall Study|Withdrawal by Subject|25|||
16904520|NCT01939158|38011046|FG002|Overall Study|Withdrawal by Subject|15|||
16904521|NCT01939158|38011047|FG003|Overall Study|Withdrawal by Subject|17|||
16904522|NCT01939158|38011044|FG000|Overall Study|Migrated/moved from study area|5|||
16904523|NCT01939158|38011045|FG001|Overall Study|Migrated/moved from study area|7|||
16904524|NCT01939158|38011046|FG002|Overall Study|Migrated/moved from study area|3|||
16904525|NCT01939158|38011047|FG003|Overall Study|Migrated/moved from study area|6|||
17006408|NCT00887588|38150192|FG001|Core Period|Withdrawal by Subject|8|||
17006409|NCT00887588|38150191|FG000|Core Period|Adverse Event|9|||
17006410|NCT00887588|38150192|FG001|Core Period|Adverse Event|11|||
17006411|NCT00887588|38150191|FG000|Extension Period|Adverse Event|4|||
17006412|NCT00887588|38150192|FG001|Extension Period|Adverse Event|4|||
17006413|NCT00887588|38150191|FG000|Extension Period|Death|0|||
17006414|NCT00887588|38150192|FG001|Extension Period|Death|1|||
17006415|NCT00887588|38150191|FG000|Extension Period|Protocol deviation|1|||
17006416|NCT00887588|38150192|FG001|Extension Period|Protocol deviation|0|||
17006417|NCT00887588|38150191|FG000|Extension Period|Lost to Follow-up|1|||
17006418|NCT00887588|38150192|FG001|Extension Period|Lost to Follow-up|0|||
17006419|NCT00945893|38150200|FG000|Overall Study|Lost to Follow-up|2|||
17006420|NCT00945893|38150201|FG001|Overall Study|Lost to Follow-up|8|||
17006421|NCT00945893|38150200|FG000|Overall Study|Withdrawal of consent|1|||
16904526|NCT01939158|38011044|FG000|Overall Study|Lost to Follow-up|18|||
17006422|NCT00945893|38150201|FG001|Overall Study|Withdrawal of consent|2|||
17006423|NCT00799383|38150213|FG000|Overall Study|Protocol Violation|1|||
17006424|NCT00799383|38150214|FG001|Overall Study|Protocol Violation|1|||
17006425|NCT00799383|38150213|FG000|Overall Study|Adverse Event|0|||
17006426|NCT00799383|38150214|FG001|Overall Study|Adverse Event|1|||
17006427|NCT00799383|38150213|FG000|Overall Study|Lost to Follow-up|1|||
17006428|NCT00799383|38150214|FG001|Overall Study|Lost to Follow-up|2|||
17006429|NCT00799383|38150213|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
17006430|NCT00799383|38150214|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
17006431|NCT00799383|38150213|FG000|Overall Study|Withdrawal by Subject|0|||
17006432|NCT00799383|38150214|FG001|Overall Study|Withdrawal by Subject|1|||
17006433|NCT00610207|38150220|FG000|Overall Study|Lost to Follow-up|3|||
17006434|NCT00798759|38150226|FG000|Overall Study|Adverse Event|3|||
17006435|NCT00798759|38150227|FG001|Overall Study|Adverse Event|3|||
17006436|NCT00798759|38150226|FG000|Overall Study|Lost to Follow-up|1|||
17006437|NCT00798759|38150227|FG001|Overall Study|Lost to Follow-up|1|||
17006438|NCT00798759|38150226|FG000|Overall Study|Protocol Violation|4|||
17006439|NCT00798759|38150227|FG001|Overall Study|Protocol Violation|8|||
17095728|NCT00162266|38234981|FG002|Double-Blind Period|Lost to Follow-up|0|||
17095729|NCT00162266|38234982|FG003|Double-Blind Period|Lost to Follow-up|0|||
16904527|NCT01939158|38011045|FG001|Overall Study|Lost to Follow-up|17|||
17006440|NCT00798759|38150226|FG000|Overall Study|Other|0|||
17006441|NCT00798759|38150227|FG001|Overall Study|Other|1|||
17095730|NCT00162266|38234979|FG000|Double-Blind Period|Other Reason|1|||
17006442|NCT00887432|38150235|FG000|Overall Study|Start Excluded Therapy|3|||
17006443|NCT00887432|38150236|FG001|Overall Study|Start Excluded Therapy|0|||
16904528|NCT01939158|38011046|FG002|Overall Study|Lost to Follow-up|17|||
16904529|NCT01939158|38011047|FG003|Overall Study|Lost to Follow-up|17|||
16904530|NCT01939158|38011044|FG000|Overall Study|Death|0|||
17006444|NCT00887432|38150235|FG000|Overall Study|Did not complete treatment|6|||
17006445|NCT00887432|38150236|FG001|Overall Study|Did not complete treatment|8|||
17006446|NCT00887432|38150235|FG000|Overall Study|Protocol Violation|2|||
17006447|NCT00887432|38150236|FG001|Overall Study|Protocol Violation|3|||
17006448|NCT00887432|38150235|FG000|Overall Study|Withdrawal by Subject|3|||
17006449|NCT00887432|38150236|FG001|Overall Study|Withdrawal by Subject|2|||
17006450|NCT00887432|38150235|FG000|Overall Study|Lost to Follow-up|1|||
17006451|NCT00887432|38150236|FG001|Overall Study|Lost to Follow-up|0|||
17006452|NCT00887432|38150235|FG000|Overall Study|No reason provided|0|||
17006453|NCT00887432|38150236|FG001|Overall Study|No reason provided|1|||
17006454|NCT00951275|38150242|FG000|Overall Study|Administrative Reason|1|||
17006455|NCT00951275|38150242|FG000|Overall Study|Adverse Event|7|||
17006456|NCT00951275|38150242|FG000|Overall Study|Withdrawal by Subject|4|||
17006457|NCT00951275|38150242|FG000|Overall Study|Protocol Violation|1|||
17006458|NCT00798603|38150246|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
17006459|NCT00798603|38150246|FG000|Overall Study|Withdrawal by Subject|10|||
17006460|NCT00798603|38150246|FG000|Overall Study|Adverse Event|22|||
17006461|NCT00798603|38150246|FG000|Overall Study|Physician Decision|1|||
17006462|NCT00798603|38150246|FG000|Overall Study|Lack of insurance coverage|1|||
17006463|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
17006464|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
17006465|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
17006466|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
17006467|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
17006468|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
17006469|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
17006470|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
17006471|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
17006472|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
17006473|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
17006474|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
17006475|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
17006476|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
17006477|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
17006478|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
17006479|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
17006480|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
17006481|NCT00887354|38150252|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
17006482|NCT00887354|38150253|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
17006483|NCT00887354|38150252|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
17006484|NCT00887354|38150253|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
17006485|NCT00887354|38150252|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
17006486|NCT00887354|38150253|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
17006487|NCT00887354|38150252|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
17006488|NCT00887354|38150253|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
17006489|NCT00887354|38150252|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
17006490|NCT00887354|38150253|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
17006491|NCT00887354|38150252|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
17006492|NCT00887354|38150253|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
17006493|NCT00951041|38150262|FG000|Overall Study|Withdrawal by Subject|1|||
17006494|NCT00951041|38150263|FG001|Overall Study|Withdrawal by Subject|1|||
17006495|NCT00951041|38150262|FG000|Overall Study|Lost to Follow-up|1|||
17006496|NCT00951041|38150263|FG001|Overall Study|Lost to Follow-up|0|||
17006497|NCT00951041|38150262|FG000|Overall Study|Other|3|||
17006498|NCT00951041|38150263|FG001|Overall Study|Other|0|||
17006499|NCT02763462|38150270|FG000|Overall Study|Protocol Violation|6|||
17006500|NCT00610129|38150274|FG000|Overall Study|Not treated since patients ineligible|3|||
17006501|NCT00945815|38150278|FG000|Overall Study|Death|3|||
17006502|NCT00945815|38150278|FG000|Overall Study|Not protocol specified|1|||
17006503|NCT00945815|38150278|FG000|Overall Study|Ineligible|3|||
17006504|NCT00945815|38150278|FG000|Overall Study|Did not begin protocol therapy|1|||
17006505|NCT00606307|38150282|FG000|Overall Study|Adverse Event|2|||
16904531|NCT01939158|38011045|FG001|Overall Study|Death|0|||
16904532|NCT01939158|38011046|FG002|Overall Study|Death|1|||
16904533|NCT01939158|38011047|FG003|Overall Study|Death|1|||
16904534|NCT01939158|38011044|FG000|Overall Study|No longer meets eligibility criteria|0|||
16904535|NCT01939158|38011045|FG001|Overall Study|No longer meets eligibility criteria|0|||
16904536|NCT01939158|38011046|FG002|Overall Study|No longer meets eligibility criteria|1|||
16904537|NCT01939158|38011047|FG003|Overall Study|No longer meets eligibility criteria|0|||
16904538|NCT01939158|38011044|FG000|Overall Study|Other|1|||
16904539|NCT01939158|38011045|FG001|Overall Study|Other|3|||
16904540|NCT01939158|38011046|FG002|Overall Study|Other|4|||
16904541|NCT01939158|38011047|FG003|Overall Study|Other|3|||
16904542|NCT01939002|38011063|FG000|Overall Study|Adverse Event|13|||
16904543|NCT01939002|38011064|FG001|Overall Study|Adverse Event|13|||
16904544|NCT01939002|38011063|FG000|Overall Study|Withdrawal by Subject|5|||
16904545|NCT01939002|38011064|FG001|Overall Study|Withdrawal by Subject|3|||
16904546|NCT01939002|38011063|FG000|Overall Study|Other|1|||
16904547|NCT01939002|38011064|FG001|Overall Study|Other|2|||
16904548|NCT01938846|38011078|FG000|Overall Study|Progressive disease|26|||
16904549|NCT01938846|38011079|FG001|Overall Study|Progressive disease|18|||
16904550|NCT01938846|38011080|FG002|Overall Study|Progressive disease|16|||
16904551|NCT01938846|38011078|FG000|Overall Study|Adverse Event|8|||
16904552|NCT01938846|38011079|FG001|Overall Study|Adverse Event|4|||
16904553|NCT01938846|38011080|FG002|Overall Study|Adverse Event|3|||
16904554|NCT01938846|38011078|FG000|Overall Study|Withdrawal by Subject|2|||
16904555|NCT01938846|38011079|FG001|Overall Study|Withdrawal by Subject|2|||
16904556|NCT01938846|38011080|FG002|Overall Study|Withdrawal by Subject|1|||
16904557|NCT01938846|38011078|FG000|Overall Study|Other than listed|5|||
16904558|NCT01938846|38011079|FG001|Overall Study|Other than listed|1|||
16904559|NCT01938846|38011080|FG002|Overall Study|Other than listed|4|||
16904560|NCT01960140|38011121|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
16904561|NCT01981356|38011131|FG000|Overall Study|Lost to Follow-up|4|||
16904562|NCT01981356|38011132|FG001|Overall Study|Lost to Follow-up|1|||
16904563|NCT01981356|38011131|FG000|Overall Study|Withdrawal by Subject|1|||
16904564|NCT01981356|38011132|FG001|Overall Study|Withdrawal by Subject|1|||
16904565|NCT01981356|38011131|FG000|Overall Study|Protocol Violation|2|||
16904566|NCT01981356|38011132|FG001|Overall Study|Protocol Violation|0|||
16904567|NCT01981122|38011141|FG000|Overall Study|Withdrawal by Subject|0|||
16904568|NCT01981122|38011142|FG001|Overall Study|Withdrawal by Subject|2|||
16904569|NCT01981122|38011141|FG000|Overall Study|Protocol Violation|0|||
16904570|NCT01981122|38011142|FG001|Overall Study|Protocol Violation|1|||
16904571|NCT01981122|38011141|FG000|Overall Study|Lost to Follow-up|0|||
16904572|NCT01981122|38011142|FG001|Overall Study|Lost to Follow-up|1|||
16904573|NCT01981122|38011141|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
16904574|NCT01981122|38011142|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
16904575|NCT01981122|38011141|FG000|Overall Study|Death|14|||
16904576|NCT01981122|38011142|FG001|Overall Study|Death|15|||
16904577|NCT01959672|38011148|FG000|Overall Study|Death|1|||
16904578|NCT01980888|38011157|FG000|Overall Study|Study Terminated by Sponsor|116|||
16904579|NCT01980888|38011158|FG001|Overall Study|Study Terminated by Sponsor|122|||
16904580|NCT01980888|38011157|FG000|Overall Study|Withdrew Consent|17|||
16904581|NCT01980888|38011158|FG001|Overall Study|Withdrew Consent|6|||
16904582|NCT01980888|38011157|FG000|Overall Study|Investigator's Discretion|8|||
16904583|NCT01980888|38011158|FG001|Overall Study|Investigator's Discretion|3|||
16904584|NCT01980888|38011157|FG000|Overall Study|Non-Compliance with Study Drug|3|||
16904585|NCT01980888|38011158|FG001|Overall Study|Non-Compliance with Study Drug|2|||
16904586|NCT01937364|38011175|FG000|Overall Study|Adverse Event|2|||
16904587|NCT01937364|38011176|FG001|Overall Study|Adverse Event|1|||
16904588|NCT01979952|38011184|FG000|Overall Study|Adverse Event|4|||
16904589|NCT01979952|38011185|FG001|Overall Study|Adverse Event|5|||
16904590|NCT01979952|38011184|FG000|Overall Study|Protocol Violation|1|||
16904591|NCT01979952|38011185|FG001|Overall Study|Protocol Violation|0|||
16786221|NCT02684617|37726685|FG001|Overall Study|Death|16|||
16786222|NCT02684617|37726686|FG002|Overall Study|Death|28|||
16786223|NCT02684617|37726684|FG000|Overall Study|Withdrawal by Subject|2|||
16786224|NCT02684617|37726685|FG001|Overall Study|Withdrawal by Subject|0|||
16786225|NCT02684617|37726686|FG002|Overall Study|Withdrawal by Subject|4|||
16786226|NCT02684617|37726684|FG000|Overall Study|Screen Failure|1|||
16786227|NCT02684617|37726685|FG001|Overall Study|Screen Failure|0|||
16786228|NCT02684617|37726686|FG002|Overall Study|Screen Failure|2|||
16786229|NCT02684617|37726684|FG000|Overall Study|Study Terminated by Sponsor|6|||
16786230|NCT02684617|37726685|FG001|Overall Study|Study Terminated by Sponsor|1|||
16904592|NCT01979952|38011184|FG000|Overall Study|Withdrawal by Subject|2|||
16904593|NCT01979952|38011185|FG001|Overall Study|Withdrawal by Subject|1|||
16904594|NCT01979952|38011184|FG000|Overall Study|Other than specified above|1|||
16904595|NCT01979952|38011185|FG001|Overall Study|Other than specified above|0|||
16904596|NCT01937130|38011195|FG000|Overall Study|Withdrawal by Subject|0|||
16904597|NCT01937130|38011196|FG001|Overall Study|Withdrawal by Subject|0|||
16904598|NCT01937130|38011197|FG002|Overall Study|Withdrawal by Subject|0|||
16904599|NCT01937130|38011198|FG003|Overall Study|Withdrawal by Subject|1|||
16786231|NCT02684617|37726686|FG002|Overall Study|Study Terminated by Sponsor|5|||
16904600|NCT01937130|38011195|FG000|Overall Study|Adverse Event|0|||
16904601|NCT01937130|38011196|FG001|Overall Study|Adverse Event|1|||
16904602|NCT01937130|38011197|FG002|Overall Study|Adverse Event|0|||
16904603|NCT01937130|38011198|FG003|Overall Study|Adverse Event|1|||
16904604|NCT01937130|38011195|FG000|Overall Study|Death|1|||
16904605|NCT01937130|38011196|FG001|Overall Study|Death|1|||
16904606|NCT01937130|38011197|FG002|Overall Study|Death|1|||
16904607|NCT01937130|38011198|FG003|Overall Study|Death|0|||
16904608|NCT01937130|38011195|FG000|Overall Study|Lost to Follow-up|2|||
16904609|NCT01937130|38011196|FG001|Overall Study|Lost to Follow-up|0|||
16904610|NCT01937130|38011197|FG002|Overall Study|Lost to Follow-up|2|||
16904611|NCT01937130|38011198|FG003|Overall Study|Lost to Follow-up|0|||
16904612|NCT01937130|38011195|FG000|Overall Study|Physician Decision|0|||
16904613|NCT01937130|38011196|FG001|Overall Study|Physician Decision|1|||
16904614|NCT01937130|38011197|FG002|Overall Study|Physician Decision|0|||
16904615|NCT01937130|38011198|FG003|Overall Study|Physician Decision|0|||
16904616|NCT01937130|38011195|FG000|Overall Study|Patients unable to swallow|0|||
16904617|NCT01937130|38011196|FG001|Overall Study|Patients unable to swallow|1|||
16904618|NCT01937130|38011197|FG002|Overall Study|Patients unable to swallow|0|||
16904619|NCT01937130|38011198|FG003|Overall Study|Patients unable to swallow|0|||
16904620|NCT01937130|38011195|FG000|Overall Study|Patient lost to FU due to death|2|||
16904621|NCT01937130|38011196|FG001|Overall Study|Patient lost to FU due to death|0|||
16904622|NCT01937130|38011197|FG002|Overall Study|Patient lost to FU due to death|0|||
16904623|NCT01937130|38011198|FG003|Overall Study|Patient lost to FU due to death|0|||
16904624|NCT01936974|38011210|FG000|Overall Study|Physician Decision|2|||
16904625|NCT01936974|38011211|FG001|Overall Study|Physician Decision|5|||
16904626|NCT01959516|38011217|FG000|Epoch 1|Adverse Event|4|||
16904627|NCT01959516|38011218|FG001|Epoch 1|Adverse Event|1|||
16904628|NCT01959516|38011217|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
16904629|NCT01959516|38011218|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
16904630|NCT01959516|38011217|FG000|Epoch 1|Subject withdrew consent|3|||
16904631|NCT01959516|38011218|FG001|Epoch 1|Subject withdrew consent|2|||
16904632|NCT01959516|38011217|FG000|Epoch 1|Administrative problems|1|||
16904633|NCT01959516|38011218|FG001|Epoch 1|Administrative problems|0|||
16904634|NCT01959516|38011217|FG000|Epoch 1|Use of prohibited treatment|1|||
16904635|NCT01959516|38011218|FG001|Epoch 1|Use of prohibited treatment|0|||
16904636|NCT01959516|38011217|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
16904637|NCT01959516|38011218|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
16904638|NCT01959516|38011217|FG000|Epoch 1|Protocol deviation|0|||
16904639|NCT01959516|38011218|FG001|Epoch 1|Protocol deviation|1|||
16904640|NCT01959516|38011217|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
16904641|NCT01959516|38011218|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
16904642|NCT01959516|38011217|FG000|Epoch 2|Subject withdrew consent|1|||
16904643|NCT01959516|38011218|FG001|Epoch 2|Subject withdrew consent|0|||
16904644|NCT01959516|38011217|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
16904645|NCT01959516|38011218|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
16904646|NCT01979016|38011226|FG000|Overall Study|Withdrawal by Subject|2|||
16904647|NCT01979016|38011227|FG001|Overall Study|Withdrawal by Subject|0|||
16904648|NCT01979016|38011226|FG000|Overall Study|Adverse Event|0|||
16904649|NCT01979016|38011227|FG001|Overall Study|Adverse Event|1|||
16904650|NCT01935336|38011237|FG000|Overall Study|Adverse Event|1|||
16904651|NCT01935336|38011238|FG001|Overall Study|Adverse Event|0|||
16904652|NCT01935336|38011239|FG002|Overall Study|Adverse Event|0|||
16904653|NCT01935336|38011240|FG003|Overall Study|Adverse Event|0|||
16904654|NCT01935336|38011237|FG000|Overall Study|Progressive disease|5|||
16904655|NCT01935336|38011238|FG001|Overall Study|Progressive disease|3|||
16904656|NCT01935336|38011239|FG002|Overall Study|Progressive disease|47|||
16904657|NCT01935336|38011240|FG003|Overall Study|Progressive disease|66|||
16904658|NCT01978236|38011256|FG000|Overall Study|Discontinued due to study close|2|||
16904659|NCT01977846|38011262|FG000|Total Study - Prospective|Death|0|||
16904660|NCT01977846|38011263|FG001|Total Study - Prospective|Death|1|||
16904661|NCT01977846|38011262|FG000|Total Study - Prospective|Lost to Follow-up|0|||
16904662|NCT01977846|38011263|FG001|Total Study - Prospective|Lost to Follow-up|8|||
16904663|NCT01977846|38011262|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
16904664|NCT01977846|38011263|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
16904665|NCT01977846|38011262|FG000|Total Study - Prospective|Not available at time of visit|0|||
16904666|NCT01977846|38011263|FG001|Total Study - Prospective|Not available at time of visit|5|||
16904667|NCT01977846|38011262|FG000|Total Study - Prospective|No show|0|||
16904668|NCT01977846|38011263|FG001|Total Study - Prospective|No show|1|||
16904669|NCT01977846|38011262|FG000|Total Study - Prospective|Protocol Violation|0|||
16904670|NCT01977846|38011263|FG001|Total Study - Prospective|Protocol Violation|1|||
16904671|NCT01934790|38011270|FG000|Treatment|Adverse Event|3|||
16904672|NCT01934790|38011270|FG000|Treatment|Clinical progression|6|||
16904673|NCT01934790|38011270|FG000|Treatment|Radiological progression|4|||
16904674|NCT01934790|38011270|FG000|Treatment|Withdrawal by Subject|2|||
16904675|NCT01934790|38011270|FG000|Treatment|Study drug never administered|1|||
16904676|NCT01934790|38011270|FG000|Active Follow up|Death|20|||
16904677|NCT01934790|38011270|FG000|Active Follow up|Physician Decision|2|||
16904678|NCT01934790|38011270|FG000|Active Follow up|Progressive disease|1|||
16904679|NCT01934790|38011270|FG000|Active Follow up|Other reason|1|||
16904680|NCT01934556|38011277|FG000|Overall Study|Withdrawal by Subject|0|||
16904681|NCT01934556|38011278|FG001|Overall Study|Withdrawal by Subject|1|||
16904682|NCT01934556|38011279|FG002|Overall Study|Withdrawal by Subject|1|||
16904683|NCT01934556|38011277|FG000|Overall Study|Lost to Follow-up|4|||
16904684|NCT01934556|38011278|FG001|Overall Study|Lost to Follow-up|10|||
16904685|NCT01934556|38011279|FG002|Overall Study|Lost to Follow-up|7|||
16904686|NCT01934556|38011277|FG000|Overall Study|Death|1|||
16904687|NCT01934556|38011278|FG001|Overall Study|Death|5|||
16904688|NCT01934556|38011279|FG002|Overall Study|Death|2|||
16904689|NCT01977690|38011289|FG000|Overall Study|Withdrawal by Subject|0|||
16904690|NCT01977690|38011290|FG001|Overall Study|Withdrawal by Subject|4|||
16904691|NCT01934010|38011365|FG000|Overall Study|Adverse Event|1|||
16904692|NCT01934010|38011366|FG001|Overall Study|Adverse Event|1|||
16904693|NCT01934010|38011367|FG002|Overall Study|Adverse Event|0|||
16904694|NCT01934010|38011365|FG000|Overall Study|Withdrawal by Subject|15|||
16904695|NCT01934010|38011366|FG001|Overall Study|Withdrawal by Subject|6|||
16904696|NCT01934010|38011367|FG002|Overall Study|Withdrawal by Subject|2|||
16904697|NCT01934010|38011365|FG000|Overall Study|Lost to Follow-up|7|||
16904698|NCT01934010|38011366|FG001|Overall Study|Lost to Follow-up|4|||
16904699|NCT01934010|38011367|FG002|Overall Study|Lost to Follow-up|0|||
16904700|NCT01620138|38011386|FG000|Overall Study|Withdrawal by Subject|3|||
16904701|NCT01620138|38011387|FG001|Overall Study|Withdrawal by Subject|0|||
16904702|NCT01620138|38011386|FG000|Overall Study|Lack of Efficacy|1|||
16904703|NCT01620138|38011387|FG001|Overall Study|Lack of Efficacy|0|||
16904704|NCT01620138|38011386|FG000|Overall Study|Adverse Event|2|||
16904705|NCT01620138|38011387|FG001|Overall Study|Adverse Event|0|||
16904706|NCT01977612|38011395|FG000|Overall Study|Lost to Follow-up|1|||
16904707|NCT01977612|38011396|FG001|Overall Study|Lost to Follow-up|1|||
16904708|NCT01932996|38011404|FG000|Overall Study|Protocol Violation|2|||
16904709|NCT01932996|38011405|FG001|Overall Study|Protocol Violation|0|||
16904710|NCT01932762|38011415|FG000|Overall Study|Withdrawal by Subject|1|||
16904711|NCT01932762|38011416|FG001|Overall Study|Withdrawal by Subject|2|||
16904712|NCT01932762|38011417|FG002|Overall Study|Withdrawal by Subject|0|||
16904713|NCT01932762|38011418|FG003|Overall Study|Withdrawal by Subject|0|||
16904714|NCT01932762|38011415|FG000|Overall Study|Lost to Follow-up|4|||
16904715|NCT01932762|38011416|FG001|Overall Study|Lost to Follow-up|0|||
16904716|NCT01932762|38011417|FG002|Overall Study|Lost to Follow-up|0|||
16904717|NCT01932762|38011418|FG003|Overall Study|Lost to Follow-up|1|||
16904718|NCT01932762|38011415|FG000|Overall Study|Physician Decision|1|||
16904719|NCT01932762|38011416|FG001|Overall Study|Physician Decision|0|||
16904720|NCT01932762|38011417|FG002|Overall Study|Physician Decision|0|||
16904721|NCT01932762|38011418|FG003|Overall Study|Physician Decision|0|||
16904722|NCT01618968|38011432|FG000|Overall Study|Adverse Event|1|||
16904723|NCT01618968|38011433|FG001|Overall Study|Adverse Event|0|||
16904724|NCT01618968|38011434|FG002|Overall Study|Adverse Event|0|||
16904725|NCT01618968|38011435|FG003|Overall Study|Adverse Event|0|||
17006506|NCT00606307|38150282|FG000|Overall Study|Withdrawal by Subject|2|||
17006507|NCT00606307|38150282|FG000|Overall Study|Disease progression|6|||
17006508|NCT00606307|38150282|FG000|Overall Study|QTc prolongation|1|||
17006509|NCT00798369|38150292|FG000|Overall Study|Subject withdrew consent|0|||
17006510|NCT00798369|38150293|FG001|Overall Study|Subject withdrew consent|0|||
17006511|NCT00798369|38150294|FG002|Overall Study|Subject withdrew consent|1|||
17006512|NCT00798369|38150295|FG003|Overall Study|Subject withdrew consent|1|||
17006513|NCT00798369|38150296|FG004|Overall Study|Subject withdrew consent|0|||
17006514|NCT00798369|38150297|FG005|Overall Study|Subject withdrew consent|2|||
17006515|NCT00798369|38150292|FG000|Overall Study|Lost to Follow-up|1|||
17006516|NCT00798369|38150293|FG001|Overall Study|Lost to Follow-up|1|||
17006517|NCT00798369|38150294|FG002|Overall Study|Lost to Follow-up|1|||
17006518|NCT00798369|38150295|FG003|Overall Study|Lost to Follow-up|0|||
17006519|NCT00798369|38150296|FG004|Overall Study|Lost to Follow-up|1|||
17006520|NCT00798369|38150297|FG005|Overall Study|Lost to Follow-up|0|||
17095731|NCT00162266|38234980|FG001|Double-Blind Period|Other Reason|0|||
16904726|NCT01618968|38011432|FG000|Overall Study|Death|0|||
16904727|NCT01618968|38011433|FG001|Overall Study|Death|0|||
16904728|NCT01618968|38011434|FG002|Overall Study|Death|0|||
16904729|NCT01618968|38011435|FG003|Overall Study|Death|1|||
16904730|NCT01932294|38011444|FG000|Overall Study|Death|43|||
16904731|NCT01932294|38011444|FG000|Overall Study|Lost to Follow-up|8|||
16904732|NCT01932294|38011444|FG000|Overall Study|VAD Implantation|20|||
16904733|NCT01932294|38011444|FG000|Overall Study|Heart Transplantation|16|||
16904734|NCT01932294|38011444|FG000|Overall Study|Transferred to other hospitals|12|||
17006521|NCT00798369|38150292|FG000|Overall Study|Adminstrative problems|0|||
16904735|NCT01931670|38011452|FG000|Treatment Period|Exclusionary Medication Received|1|||
16904736|NCT01931670|38011453|FG001|Treatment Period|Exclusionary Medication Received|1|||
16904737|NCT01931670|38011454|FG002|Treatment Period|Exclusionary Medication Received|1|||
16904738|NCT01931670|38011452|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
16904739|NCT01931670|38011453|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
16904740|NCT01931670|38011454|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
16904741|NCT01931670|38011452|FG000|Treatment Period|Subject Noncompliant|4|||
16904742|NCT01931670|38011453|FG001|Treatment Period|Subject Noncompliant|9|||
16904743|NCT01931670|38011454|FG002|Treatment Period|Subject Noncompliant|5|||
16904744|NCT01931670|38011452|FG000|Treatment Period|Adverse Event|19|||
16904745|NCT01931670|38011453|FG001|Treatment Period|Adverse Event|8|||
16904746|NCT01931670|38011454|FG002|Treatment Period|Adverse Event|21|||
16904747|NCT01931670|38011452|FG000|Treatment Period|Lack of Efficacy|11|||
16904748|NCT01931670|38011453|FG001|Treatment Period|Lack of Efficacy|2|||
16904749|NCT01931670|38011454|FG002|Treatment Period|Lack of Efficacy|2|||
16904750|NCT01931670|38011452|FG000|Treatment Period|Pregnancy|7|||
16904751|NCT01931670|38011453|FG001|Treatment Period|Pregnancy|2|||
16904752|NCT01931670|38011454|FG002|Treatment Period|Pregnancy|0|||
16904753|NCT01931670|38011452|FG000|Treatment Period|Other|8|||
16904754|NCT01931670|38011453|FG001|Treatment Period|Other|7|||
16904755|NCT01931670|38011454|FG002|Treatment Period|Other|2|||
16904756|NCT01931670|38011452|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
16904757|NCT01931670|38011453|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
16904758|NCT01931670|38011454|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
16904759|NCT01931670|38011452|FG000|Treatment Period|Lost to Follow-up|19|||
16904760|NCT01931670|38011453|FG001|Treatment Period|Lost to Follow-up|5|||
16904761|NCT01931670|38011454|FG002|Treatment Period|Lost to Follow-up|7|||
16904762|NCT01931670|38011452|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
16904763|NCT01931670|38011453|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
16904764|NCT01931670|38011454|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
16904765|NCT01931670|38011452|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
16904766|NCT01931670|38011453|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
16904767|NCT01931670|38011454|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
16904768|NCT01931670|38011452|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
16904769|NCT01931670|38011453|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
16904770|NCT01931670|38011454|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
16904771|NCT01931670|38011452|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
16904772|NCT01931670|38011453|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
16904773|NCT01931670|38011454|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
16904774|NCT01931670|38011452|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
17006522|NCT00798369|38150293|FG001|Overall Study|Adminstrative problems|0|||
17006523|NCT00798369|38150294|FG002|Overall Study|Adminstrative problems|0|||
17006524|NCT00798369|38150295|FG003|Overall Study|Adminstrative problems|0|||
17006525|NCT00798369|38150296|FG004|Overall Study|Adminstrative problems|0|||
17006526|NCT00798369|38150297|FG005|Overall Study|Adminstrative problems|1|||
17006527|NCT00950963|38150314|FG000|Overall Study|Lost to Follow-up|29|||
17006528|NCT00950963|38150315|FG001|Overall Study|Lost to Follow-up|24|||
17006529|NCT00608959|38150323|FG000|Part 1|Did not meet eligibility criteria|1|||
17006530|NCT00945659|38150336|FG000|Overall Study|Lost to Follow-up|7|||
17006531|NCT00945659|38150337|FG001|Overall Study|Lost to Follow-up|20|||
17006532|NCT00945659|38150338|FG002|Overall Study|Lost to Follow-up|17|||
17006533|NCT00798135|38150346|FG000|Overall Study|Disease progression, relapse|11|||
17006534|NCT00798135|38150346|FG000|Overall Study|Disease progression, refractory|1|||
17006535|NCT00798135|38150346|FG000|Overall Study|Physician Decision|1|||
17006536|NCT00941603|38150356|FG000|Overall Study|Adverse Event|10|||
17006537|NCT00941603|38150357|FG001|Overall Study|Adverse Event|15|||
17006538|NCT00941603|38150358|FG002|Overall Study|Adverse Event|5|||
17006539|NCT00941603|38150359|FG003|Overall Study|Adverse Event|1|||
17006540|NCT00941603|38150360|FG004|Overall Study|Adverse Event|4|||
17006541|NCT00941603|38150361|FG005|Overall Study|Adverse Event|0|||
17006542|NCT00941603|38150356|FG000|Overall Study|Lost to Follow-up|0|||
17006543|NCT00941603|38150357|FG001|Overall Study|Lost to Follow-up|0|||
17006544|NCT00941603|38150358|FG002|Overall Study|Lost to Follow-up|0|||
17006545|NCT00941603|38150359|FG003|Overall Study|Lost to Follow-up|1|||
17006546|NCT00941603|38150360|FG004|Overall Study|Lost to Follow-up|0|||
17006547|NCT00941603|38150361|FG005|Overall Study|Lost to Follow-up|2|||
17006548|NCT00941603|38150356|FG000|Overall Study|Withdrawal by Subject|0|||
17006549|NCT00941603|38150357|FG001|Overall Study|Withdrawal by Subject|0|||
17006550|NCT00941603|38150358|FG002|Overall Study|Withdrawal by Subject|0|||
17006551|NCT00941603|38150359|FG003|Overall Study|Withdrawal by Subject|2|||
17006552|NCT00941603|38150360|FG004|Overall Study|Withdrawal by Subject|0|||
17006553|NCT00941603|38150361|FG005|Overall Study|Withdrawal by Subject|1|||
17006554|NCT00941603|38150356|FG000|Overall Study|Protocol Violation|0|||
17006555|NCT00941603|38150357|FG001|Overall Study|Protocol Violation|1|||
16904775|NCT01931670|38011453|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
17006556|NCT00941603|38150358|FG002|Overall Study|Protocol Violation|0|||
17006557|NCT00941603|38150359|FG003|Overall Study|Protocol Violation|0|||
17006558|NCT00941603|38150360|FG004|Overall Study|Protocol Violation|0|||
17006559|NCT00941603|38150361|FG005|Overall Study|Protocol Violation|0|||
17006560|NCT00941603|38150356|FG000|Overall Study|Did not meet protocol eligibility|1|||
17006561|NCT00941603|38150357|FG001|Overall Study|Did not meet protocol eligibility|0|||
17006562|NCT00941603|38150358|FG002|Overall Study|Did not meet protocol eligibility|0|||
17006563|NCT00941603|38150359|FG003|Overall Study|Did not meet protocol eligibility|0|||
17006564|NCT00941603|38150360|FG004|Overall Study|Did not meet protocol eligibility|0|||
17006565|NCT00941603|38150361|FG005|Overall Study|Did not meet protocol eligibility|0|||
17006566|NCT04533438|38150377|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
17006567|NCT04533438|38150378|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
17006568|NCT00797823|38150388|FG000|First Period (Initial Randomization)|Physician Decision|1|||
17006569|NCT00797823|38150389|FG001|First Period (Initial Randomization)|Physician Decision|0|||
17006570|NCT00797823|38150390|FG002|First Period (Initial Randomization)|Physician Decision|0|||
17006571|NCT00797667|38150400|FG000|Overall Study|Lack of Efficacy|0|||
17006572|NCT00797667|38150401|FG001|Overall Study|Lack of Efficacy|1|||
17006573|NCT00797667|38150402|FG002|Overall Study|Lack of Efficacy|0|||
17006574|NCT00797667|38150400|FG000|Overall Study|Lost to Follow-up|8|||
17006575|NCT00797667|38150401|FG001|Overall Study|Lost to Follow-up|12|||
17006576|NCT00797667|38150402|FG002|Overall Study|Lost to Follow-up|2|||
17006577|NCT00797667|38150400|FG000|Overall Study|Physician Decision|3|||
17006578|NCT00797667|38150401|FG001|Overall Study|Physician Decision|1|||
17006579|NCT00797667|38150402|FG002|Overall Study|Physician Decision|0|||
17006580|NCT00797667|38150400|FG000|Overall Study|Pregnancy|2|||
17006581|NCT00797667|38150401|FG001|Overall Study|Pregnancy|0|||
17006582|NCT00797667|38150402|FG002|Overall Study|Pregnancy|0|||
17006583|NCT00797667|38150400|FG000|Overall Study|Protocol Violation|2|||
17006584|NCT00797667|38150401|FG001|Overall Study|Protocol Violation|7|||
17006585|NCT00797667|38150402|FG002|Overall Study|Protocol Violation|0|||
17006586|NCT00797667|38150400|FG000|Overall Study|Study Terminated by Sponsor|217|||
17006587|NCT00797667|38150401|FG001|Overall Study|Study Terminated by Sponsor|216|||
17006588|NCT00797667|38150402|FG002|Overall Study|Study Terminated by Sponsor|115|||
17006589|NCT00797667|38150400|FG000|Overall Study|Withdrawal by Subject|9|||
17006590|NCT00797667|38150401|FG001|Overall Study|Withdrawal by Subject|14|||
17006591|NCT00797667|38150402|FG002|Overall Study|Withdrawal by Subject|2|||
17006592|NCT00797667|38150400|FG000|Overall Study|Adverse Event|19|||
17006593|NCT00797667|38150401|FG001|Overall Study|Adverse Event|8|||
17006594|NCT00797667|38150402|FG002|Overall Study|Adverse Event|8|||
17006595|NCT00950807|38150410|FG000|Treatment Period 1|Lack of Efficacy|1|||
17006596|NCT00950807|38150411|FG001|Treatment Period 1|Lack of Efficacy|0|||
17006597|NCT00950807|38150412|FG002|Treatment Period 1|Lack of Efficacy|0|||
17006598|NCT00950807|38150413|FG003|Treatment Period 1|Lack of Efficacy|0|||
17006599|NCT00950807|38150414|FG004|Treatment Period 1|Lack of Efficacy|0|||
17006600|NCT00950807|38150415|FG005|Treatment Period 1|Lack of Efficacy|1|||
17006601|NCT00950807|38150416|FG006|Treatment Period 1|Lack of Efficacy|0|||
17006602|NCT00950807|38150417|FG007|Treatment Period 1|Lack of Efficacy|0|||
17006603|NCT00950807|38150418|FG008|Treatment Period 1|Lack of Efficacy|0|||
17006604|NCT00950807|38150419|FG009|Treatment Period 1|Lack of Efficacy|0|||
17006605|NCT00950807|38150410|FG000|Treatment Period 1|Protocol Violation|1|||
17006606|NCT00950807|38150411|FG001|Treatment Period 1|Protocol Violation|0|||
17006607|NCT00950807|38150412|FG002|Treatment Period 1|Protocol Violation|0|||
17006608|NCT00950807|38150413|FG003|Treatment Period 1|Protocol Violation|0|||
17006609|NCT00950807|38150414|FG004|Treatment Period 1|Protocol Violation|0|||
17006610|NCT00950807|38150415|FG005|Treatment Period 1|Protocol Violation|0|||
17006611|NCT00950807|38150416|FG006|Treatment Period 1|Protocol Violation|0|||
17006612|NCT00950807|38150417|FG007|Treatment Period 1|Protocol Violation|0|||
17006613|NCT00950807|38150418|FG008|Treatment Period 1|Protocol Violation|0|||
17006614|NCT00950807|38150419|FG009|Treatment Period 1|Protocol Violation|0|||
17006615|NCT00950807|38150410|FG000|Treatment Period 1|Lost to Follow-up|0|||
17006616|NCT00950807|38150411|FG001|Treatment Period 1|Lost to Follow-up|0|||
16904776|NCT01931670|38011454|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
16904777|NCT01931670|38011452|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
16904778|NCT01931670|38011453|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
16904779|NCT01931670|38011454|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
16904780|NCT01977456|38011462|FG000|Overall Study|Death|5|||
16904781|NCT01957644|38011471|FG000|Overall Study|Adverse Event|4|||
16904782|NCT01957644|38011472|FG001|Overall Study|Adverse Event|2|||
16904783|NCT01957644|38011473|FG002|Overall Study|Adverse Event|0|||
16904784|NCT01957644|38011474|FG003|Overall Study|Adverse Event|0|||
16904785|NCT01957644|38011475|FG004|Overall Study|Adverse Event|1|||
16904786|NCT01957644|38011471|FG000|Overall Study|Progressive disease / relapse|0|||
16904787|NCT01957644|38011472|FG001|Overall Study|Progressive disease / relapse|1|||
16904788|NCT01957644|38011473|FG002|Overall Study|Progressive disease / relapse|0|||
17006617|NCT00950807|38150412|FG002|Treatment Period 1|Lost to Follow-up|1|||
17006618|NCT00950807|38150413|FG003|Treatment Period 1|Lost to Follow-up|0|||
17095732|NCT00162266|38234981|FG002|Double-Blind Period|Other Reason|1|||
17095733|NCT00162266|38234982|FG003|Double-Blind Period|Other Reason|0|||
17095734|NCT00162266|38234979|FG000|Double-Blind Period|Lack of Efficacy|13|||
17095735|NCT00162266|38234980|FG001|Double-Blind Period|Lack of Efficacy|17|||
17095736|NCT00162266|38234981|FG002|Double-Blind Period|Lack of Efficacy|30|||
17095737|NCT00162266|38234982|FG003|Double-Blind Period|Lack of Efficacy|0|||
17095738|NCT00162266|38234979|FG000|Double-Blind Period|Withdrawal by Subject|5|||
17095739|NCT00162266|38234980|FG001|Double-Blind Period|Withdrawal by Subject|2|||
17006619|NCT00950807|38150414|FG004|Treatment Period 1|Lost to Follow-up|0|||
16904789|NCT01957644|38011474|FG003|Overall Study|Progressive disease / relapse|1|||
16904790|NCT01957644|38011475|FG004|Overall Study|Progressive disease / relapse|0|||
16904791|NCT01957644|38011471|FG000|Overall Study|Other reason|1|||
16904792|NCT01957644|38011472|FG001|Overall Study|Other reason|2|||
16904793|NCT01957644|38011473|FG002|Overall Study|Other reason|1|||
16904794|NCT01957644|38011474|FG003|Overall Study|Other reason|1|||
16904795|NCT01957644|38011475|FG004|Overall Study|Other reason|0|||
16904796|NCT01957644|38011471|FG000|Overall Study|Withdrawal by Subject|1|||
16904797|NCT01957644|38011472|FG001|Overall Study|Withdrawal by Subject|0|||
16904798|NCT01957644|38011473|FG002|Overall Study|Withdrawal by Subject|0|||
16904799|NCT01957644|38011474|FG003|Overall Study|Withdrawal by Subject|0|||
16904800|NCT01957644|38011475|FG004|Overall Study|Withdrawal by Subject|0|||
16904801|NCT01957644|38011471|FG000|Overall Study|Protocol Violation|0|||
16904802|NCT01957644|38011472|FG001|Overall Study|Protocol Violation|1|||
16904803|NCT01957644|38011473|FG002|Overall Study|Protocol Violation|0|||
16904804|NCT01957644|38011474|FG003|Overall Study|Protocol Violation|0|||
16904805|NCT01957644|38011475|FG004|Overall Study|Protocol Violation|0|||
16904806|NCT01931202|38011492|FG000|Overall Study|Withdrawal by Subject|0|||
16904807|NCT01931202|38011493|FG001|Overall Study|Withdrawal by Subject|0|||
16904808|NCT01931202|38011494|FG002|Overall Study|Withdrawal by Subject|2|||
16904809|NCT01931202|38011492|FG000|Overall Study|Lost to Follow-up|0|||
16904810|NCT01931202|38011493|FG001|Overall Study|Lost to Follow-up|5|||
16904811|NCT01931202|38011494|FG002|Overall Study|Lost to Follow-up|2|||
16904812|NCT01930890|38011509|FG000|Overall Study|Study Termination|14|||
16904813|NCT01930890|38011510|FG001|Overall Study|Study Termination|28|||
16904814|NCT01930890|38011511|FG002|Overall Study|Study Termination|13|||
16904815|NCT01930890|38011512|FG003|Overall Study|Study Termination|25|||
16904816|NCT01930890|38011509|FG000|Overall Study|Death|0|||
16904817|NCT01930890|38011510|FG001|Overall Study|Death|0|||
16904818|NCT01930890|38011511|FG002|Overall Study|Death|0|||
16904819|NCT01930890|38011512|FG003|Overall Study|Death|1|||
16904820|NCT01930890|38011509|FG000|Overall Study|Investigator Decision|0|||
16904821|NCT01930890|38011510|FG001|Overall Study|Investigator Decision|1|||
16904822|NCT01930890|38011511|FG002|Overall Study|Investigator Decision|0|||
16904823|NCT01930890|38011512|FG003|Overall Study|Investigator Decision|0|||
17006620|NCT00950807|38150415|FG005|Treatment Period 1|Lost to Follow-up|0|||
16904824|NCT01930890|38011509|FG000|Overall Study|Consent Withdrawn|0|||
16904825|NCT01930890|38011510|FG001|Overall Study|Consent Withdrawn|3|||
16904826|NCT01930890|38011511|FG002|Overall Study|Consent Withdrawn|0|||
16904827|NCT01930890|38011512|FG003|Overall Study|Consent Withdrawn|1|||
16904828|NCT01930890|38011509|FG000|Overall Study|Adverse Event|0|||
16904829|NCT01930890|38011510|FG001|Overall Study|Adverse Event|1|||
16904830|NCT01930890|38011511|FG002|Overall Study|Adverse Event|0|||
16904831|NCT01930890|38011512|FG003|Overall Study|Adverse Event|0|||
16904832|NCT01930188|38011525|FG000|Overall Study|unclassified|4|||
16904833|NCT01930188|38011526|FG001|Overall Study|unclassified|5|||
16904834|NCT01930188|38011527|FG002|Overall Study|unclassified|3|||
16904835|NCT01930188|38011525|FG000|Overall Study|Missing follow-up information|2|||
16904836|NCT01930188|38011526|FG001|Overall Study|Missing follow-up information|2|||
16904837|NCT01930188|38011527|FG002|Overall Study|Missing follow-up information|3|||
16904838|NCT01930188|38011525|FG000|Overall Study|Lost to Follow-up|5|||
16904839|NCT01930188|38011526|FG001|Overall Study|Lost to Follow-up|2|||
16904840|NCT01930188|38011527|FG002|Overall Study|Lost to Follow-up|2|||
16904841|NCT01930188|38011525|FG000|Overall Study|Death|2|||
16904842|NCT01930188|38011526|FG001|Overall Study|Death|1|||
16904843|NCT01930188|38011527|FG002|Overall Study|Death|3|||
16904844|NCT01930188|38011525|FG000|Overall Study|Withdrawal by Subject|9|||
16904845|NCT01930188|38011526|FG001|Overall Study|Withdrawal by Subject|11|||
16904846|NCT01930188|38011527|FG002|Overall Study|Withdrawal by Subject|8|||
16904847|NCT01977222|38011536|FG000|Overall Study|Withdrawal by Subject|1|||
16904848|NCT01957488|38011540|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
16904849|NCT01957488|38011541|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
16904850|NCT01957488|38011542|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
16904851|NCT01957488|38011543|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
16904852|NCT01957488|38011544|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
16904853|NCT01957488|38011545|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
16904854|NCT01957488|38011540|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
16904855|NCT01957488|38011541|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
16904856|NCT01957488|38011542|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
16904857|NCT01957488|38011543|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
16904858|NCT01957488|38011544|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
16904859|NCT01957488|38011545|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
16904860|NCT01957488|38011540|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
16904861|NCT01957488|38011541|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
16904862|NCT01957488|38011542|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
16904863|NCT01957488|38011543|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
16904864|NCT01957488|38011544|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
16904865|NCT01957488|38011545|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
16904866|NCT01957488|38011540|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16904867|NCT01957488|38011541|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16904868|NCT01957488|38011542|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16904869|NCT01957488|38011543|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
16904870|NCT01957488|38011544|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
16904871|NCT01957488|38011545|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
16904872|NCT01957488|38011540|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16904873|NCT01957488|38011541|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16904874|NCT01957488|38011542|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16904875|NCT01957488|38011543|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16904876|NCT01957488|38011544|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
16904877|NCT01957488|38011545|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16904878|NCT01957488|38011540|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
16904879|NCT01957488|38011541|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
16904880|NCT01957488|38011542|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
16904881|NCT01957488|38011543|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
16904882|NCT01957488|38011544|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
16904883|NCT01957488|38011545|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
16904884|NCT01957488|38011540|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
16904885|NCT01957488|38011541|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
16904886|NCT01957488|38011542|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
16904887|NCT01957488|38011543|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
16904888|NCT01957488|38011544|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
16904889|NCT01957488|38011545|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
16904890|NCT01957488|38011540|FG000|Test Period 2 (2 Weeks)|Other|1|||
16904891|NCT01957488|38011541|FG001|Test Period 2 (2 Weeks)|Other|0|||
16904892|NCT01957488|38011542|FG002|Test Period 2 (2 Weeks)|Other|0|||
16904893|NCT01957488|38011543|FG003|Test Period 2 (2 Weeks)|Other|0|||
16904894|NCT01957488|38011544|FG004|Test Period 2 (2 Weeks)|Other|0|||
16904895|NCT01957488|38011545|FG005|Test Period 2 (2 Weeks)|Other|0|||
16904896|NCT01957488|38011540|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16904897|NCT01957488|38011541|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
16904898|NCT01957488|38011542|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16904899|NCT01957488|38011543|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16904900|NCT01957488|38011544|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16904901|NCT01957488|38011545|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16904902|NCT01957488|38011540|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
16904903|NCT01957488|38011541|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
16904904|NCT01957488|38011542|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
16904905|NCT01957488|38011543|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
16904906|NCT01957488|38011544|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
16904907|NCT01957488|38011545|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
16904908|NCT01957488|38011540|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16904909|NCT01957488|38011541|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16904910|NCT01957488|38011542|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16904911|NCT01957488|38011543|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16904912|NCT01957488|38011544|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16904913|NCT01957488|38011545|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
16904914|NCT01957488|38011540|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
16904915|NCT01957488|38011541|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16904916|NCT01957488|38011542|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16904917|NCT01957488|38011543|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16904918|NCT01957488|38011544|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16904919|NCT01957488|38011545|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16904920|NCT01957488|38011540|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16904921|NCT01957488|38011541|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
16904922|NCT01957488|38011542|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16904923|NCT01957488|38011543|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16904924|NCT01957488|38011544|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16904925|NCT01957488|38011545|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16904926|NCT01976364|38011553|FG000|Main Study (36 Months)|Adverse Event|63|||
16904927|NCT01976364|38011554|FG001|Main Study (36 Months)|Adverse Event|0|||
16904928|NCT01976364|38011555|FG002|Main Study (36 Months)|Adverse Event|0|||
16904929|NCT01976364|38011553|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
16904930|NCT01976364|38011554|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
16904931|NCT01976364|38011555|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
16904932|NCT01976364|38011553|FG000|Main Study (36 Months)|Other|13|||
17006621|NCT00950807|38150416|FG006|Treatment Period 1|Lost to Follow-up|0|||
17192773|NCT01335997|38346089|FG000|Period I and II|Noncompliance with Study Drug|1|||
16904933|NCT01976364|38011554|FG001|Main Study (36 Months)|Other|0|||
16904934|NCT01976364|38011555|FG002|Main Study (36 Months)|Other|0|||
16904935|NCT01976364|38011553|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
16904936|NCT01976364|38011554|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
16904937|NCT01976364|38011555|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
16904938|NCT01976364|38011553|FG000|Main Study (36 Months)|Medication error|1|||
16904939|NCT01976364|38011554|FG001|Main Study (36 Months)|Medication error|0|||
16904940|NCT01976364|38011555|FG002|Main Study (36 Months)|Medication error|0|||
16904941|NCT01976364|38011553|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
16904942|NCT01976364|38011554|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
16904943|NCT01976364|38011555|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
16904944|NCT01976364|38011553|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
16904945|NCT01976364|38011554|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
16904946|NCT01976364|38011555|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
16904947|NCT01976364|38011553|FG000|Main Study (36 Months)|Protocol Violation|13|||
16904948|NCT01976364|38011554|FG001|Main Study (36 Months)|Protocol Violation|0|||
16904949|NCT01976364|38011555|FG002|Main Study (36 Months)|Protocol Violation|0|||
16904950|NCT01976364|38011553|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
16904951|NCT01976364|38011554|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
16904952|NCT01976364|38011555|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
16904953|NCT01976364|38011553|FG000|Main Study (36 Months)|Death|5|||
16904954|NCT01976364|38011554|FG001|Main Study (36 Months)|Death|0|||
16904955|NCT01976364|38011555|FG002|Main Study (36 Months)|Death|0|||
16904956|NCT01976364|38011553|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
16904957|NCT01976364|38011554|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
16904958|NCT01976364|38011555|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
16904959|NCT01976364|38011553|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
16904960|NCT01976364|38011554|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
16904961|NCT01976364|38011555|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
16904962|NCT01976364|38011553|FG000|Sub-study (12 Months)|Protocol Violation|0|||
16904963|NCT01976364|38011554|FG001|Sub-study (12 Months)|Protocol Violation|1|||
16904964|NCT01976364|38011555|FG002|Sub-study (12 Months)|Protocol Violation|1|||
16904965|NCT01976364|38011553|FG000|Sub-study (12 Months)|Adverse Event|0|||
16904966|NCT01976364|38011554|FG001|Sub-study (12 Months)|Adverse Event|4|||
16904967|NCT01976364|38011555|FG002|Sub-study (12 Months)|Adverse Event|3|||
16904968|NCT01956240|38011566|FG000|Overall Study|Lost to Follow-up|6|||
16904969|NCT01956240|38011567|FG001|Overall Study|Lost to Follow-up|20|||
16904970|NCT01956240|38011566|FG000|Overall Study|Adverse Event|17|||
16904971|NCT01956240|38011567|FG001|Overall Study|Adverse Event|4|||
16904972|NCT01929876|38011573|FG000|Period 2|Non-Compliance|1|||
16904973|NCT01929408|38011577|FG000|Overall Study|received HCT as initial treatment|8|||
16904974|NCT01975428|38011583|FG000|Overall Study|Lost to Follow-up|17|||
16904975|NCT01975428|38011584|FG001|Overall Study|Lost to Follow-up|4|||
16904976|NCT01975428|38011583|FG000|Overall Study|Withdrawal by Subject|3|||
16904977|NCT01975428|38011584|FG001|Overall Study|Withdrawal by Subject|10|||
16904978|NCT01929018|38011592|FG000|Overall Study|Lost to Follow-up|1|||
16904979|NCT01929018|38011593|FG001|Overall Study|Lost to Follow-up|0|||
16904980|NCT01929018|38011592|FG000|Overall Study|Hospitalization|0|||
16904981|NCT01929018|38011593|FG001|Overall Study|Hospitalization|1|||
16904982|NCT01928940|38011601|FG000|Overall Study|Adverse Event|0|||
16904983|NCT01928940|38011602|FG001|Overall Study|Adverse Event|1|||
16904984|NCT01928862|38011614|FG000|Overall Study|Lost to Follow-up|1|||
16904985|NCT01928862|38011615|FG001|Overall Study|Lost to Follow-up|0|||
16904986|NCT01928862|38011616|FG002|Overall Study|Lost to Follow-up|0|||
16904987|NCT01928862|38011617|FG003|Overall Study|Lost to Follow-up|0|||
16904988|NCT01928862|38011618|FG004|Overall Study|Lost to Follow-up|1|||
16904989|NCT01954056|38011633|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
16904990|NCT01954056|38011634|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
16904991|NCT01953354|38011642|FG000|Overall Study|Withdrawal by Subject|0|||
16904992|NCT01953354|38011643|FG001|Overall Study|Withdrawal by Subject|1|||
16904993|NCT01953354|38011642|FG000|Overall Study|Decision of Sponsor|0|||
16904994|NCT01953354|38011643|FG001|Overall Study|Decision of Sponsor|1|||
16904995|NCT01953354|38011642|FG000|Overall Study|Disease Exacerbation|1|||
16904996|NCT01953354|38011643|FG001|Overall Study|Disease Exacerbation|0|||
16904997|NCT01975272|38011652|FG000|Overall Study|Excluded after protocol amendment|1|||
16904998|NCT01975272|38011653|FG001|Overall Study|Excluded after protocol amendment|1|||
16904999|NCT01975272|38011654|FG002|Overall Study|Excluded after protocol amendment|2|||
16905000|NCT01951638|38011667|FG000|Treatment Period|Protocol Violation|0|||
16905001|NCT01951638|38011668|FG001|Treatment Period|Protocol Violation|0|||
16905002|NCT01951638|38011669|FG002|Treatment Period|Protocol Violation|0|||
16905003|NCT01951638|38011670|FG003|Treatment Period|Protocol Violation|2|||
16905004|NCT01951638|38011671|FG004|Treatment Period|Protocol Violation|0|||
16905005|NCT01951638|38011667|FG000|Treatment Period|Protocol-driven decision point|1|||
16905006|NCT01951638|38011668|FG001|Treatment Period|Protocol-driven decision point|3|||
16905007|NCT01951638|38011669|FG002|Treatment Period|Protocol-driven decision point|0|||
16905008|NCT01951638|38011670|FG003|Treatment Period|Protocol-driven decision point|0|||
16905009|NCT01951638|38011671|FG004|Treatment Period|Protocol-driven decision point|0|||
16905010|NCT01951638|38011667|FG000|Treatment Period|Logistical difficulties|0|||
16905011|NCT01951638|38011668|FG001|Treatment Period|Logistical difficulties|1|||
16905012|NCT01951638|38011669|FG002|Treatment Period|Logistical difficulties|1|||
16905013|NCT01951638|38011670|FG003|Treatment Period|Logistical difficulties|0|||
16905014|NCT01951638|38011671|FG004|Treatment Period|Logistical difficulties|0|||
16905015|NCT01951638|38011667|FG000|Treatment Period|Withdrawal by Subject|9|||
16905016|NCT01951638|38011668|FG001|Treatment Period|Withdrawal by Subject|6|||
16905017|NCT01951638|38011669|FG002|Treatment Period|Withdrawal by Subject|4|||
16905018|NCT01951638|38011670|FG003|Treatment Period|Withdrawal by Subject|5|||
16905019|NCT01951638|38011671|FG004|Treatment Period|Withdrawal by Subject|4|||
16905020|NCT01951638|38011667|FG000|Treatment Period|Death|0|||
16905021|NCT01951638|38011668|FG001|Treatment Period|Death|0|||
16905022|NCT01951638|38011669|FG002|Treatment Period|Death|0|||
16905023|NCT01951638|38011670|FG003|Treatment Period|Death|3|||
16905024|NCT01951638|38011671|FG004|Treatment Period|Death|1|||
16905025|NCT01951638|38011667|FG000|Treatment Period|Adverse Event|3|||
16905026|NCT01951638|38011668|FG001|Treatment Period|Adverse Event|4|||
16905027|NCT01951638|38011669|FG002|Treatment Period|Adverse Event|8|||
16905028|NCT01951638|38011670|FG003|Treatment Period|Adverse Event|6|||
16905029|NCT01951638|38011671|FG004|Treatment Period|Adverse Event|5|||
17006622|NCT00950807|38150417|FG007|Treatment Period 1|Lost to Follow-up|0|||
17006623|NCT00950807|38150418|FG008|Treatment Period 1|Lost to Follow-up|0|||
17006624|NCT00950807|38150419|FG009|Treatment Period 1|Lost to Follow-up|0|||
17006625|NCT00950807|38150410|FG000|Treatment Period 1|Withdrawal by Subject|1|||
17006626|NCT00950807|38150411|FG001|Treatment Period 1|Withdrawal by Subject|0|||
17006627|NCT00950807|38150412|FG002|Treatment Period 1|Withdrawal by Subject|0|||
17006628|NCT00950807|38150413|FG003|Treatment Period 1|Withdrawal by Subject|0|||
17006629|NCT00950807|38150414|FG004|Treatment Period 1|Withdrawal by Subject|1|||
17006630|NCT00950807|38150415|FG005|Treatment Period 1|Withdrawal by Subject|0|||
17006631|NCT00950807|38150416|FG006|Treatment Period 1|Withdrawal by Subject|0|||
17006632|NCT00950807|38150417|FG007|Treatment Period 1|Withdrawal by Subject|0|||
17006633|NCT00950807|38150418|FG008|Treatment Period 1|Withdrawal by Subject|1|||
17006634|NCT00950807|38150419|FG009|Treatment Period 1|Withdrawal by Subject|0|||
17006635|NCT00950807|38150410|FG000|Treatment Period 1|Adverse Event|0|||
17006636|NCT00950807|38150411|FG001|Treatment Period 1|Adverse Event|0|||
17006637|NCT00950807|38150412|FG002|Treatment Period 1|Adverse Event|0|||
17006638|NCT00950807|38150413|FG003|Treatment Period 1|Adverse Event|0|||
17006639|NCT00950807|38150414|FG004|Treatment Period 1|Adverse Event|0|||
17006640|NCT00950807|38150415|FG005|Treatment Period 1|Adverse Event|1|||
17006641|NCT00950807|38150416|FG006|Treatment Period 1|Adverse Event|0|||
16905030|NCT01951638|38011667|FG000|Follow-up Period|Protocol Violation|0|||
16905031|NCT01951638|38011668|FG001|Follow-up Period|Protocol Violation|0|||
16905032|NCT01951638|38011669|FG002|Follow-up Period|Protocol Violation|0|||
16905033|NCT01951638|38011670|FG003|Follow-up Period|Protocol Violation|1|||
16905034|NCT01951638|38011671|FG004|Follow-up Period|Protocol Violation|0|||
16905035|NCT01951638|38011667|FG000|Follow-up Period|Logistical difficulties|0|||
16905036|NCT01951638|38011668|FG001|Follow-up Period|Logistical difficulties|2|||
16905037|NCT01951638|38011669|FG002|Follow-up Period|Logistical difficulties|0|||
16905038|NCT01951638|38011670|FG003|Follow-up Period|Logistical difficulties|0|||
16905039|NCT01951638|38011671|FG004|Follow-up Period|Logistical difficulties|1|||
16905040|NCT01951638|38011667|FG000|Follow-up Period|Withdrawal by Subject|1|||
16905041|NCT01951638|38011668|FG001|Follow-up Period|Withdrawal by Subject|5|||
16905042|NCT01951638|38011669|FG002|Follow-up Period|Withdrawal by Subject|2|||
16905043|NCT01951638|38011670|FG003|Follow-up Period|Withdrawal by Subject|1|||
16905044|NCT01951638|38011671|FG004|Follow-up Period|Withdrawal by Subject|2|||
16905045|NCT01951638|38011667|FG000|Follow-up Period|Lost to Follow-up|0|||
16905046|NCT01951638|38011668|FG001|Follow-up Period|Lost to Follow-up|1|||
16905047|NCT01951638|38011669|FG002|Follow-up Period|Lost to Follow-up|0|||
16905048|NCT01951638|38011670|FG003|Follow-up Period|Lost to Follow-up|1|||
16905049|NCT01951638|38011671|FG004|Follow-up Period|Lost to Follow-up|0|||
16905050|NCT01951638|38011667|FG000|Follow-up Period|Death|1|||
16905051|NCT01951638|38011668|FG001|Follow-up Period|Death|0|||
16905052|NCT01951638|38011669|FG002|Follow-up Period|Death|1|||
16905053|NCT01951638|38011670|FG003|Follow-up Period|Death|4|||
16905054|NCT01951638|38011671|FG004|Follow-up Period|Death|1|||
16905055|NCT01951638|38011667|FG000|Follow-up Period|Adverse Event|0|||
16905056|NCT01951638|38011668|FG001|Follow-up Period|Adverse Event|1|||
16905057|NCT01951638|38011669|FG002|Follow-up Period|Adverse Event|2|||
16905058|NCT01951638|38011670|FG003|Follow-up Period|Adverse Event|1|||
16905059|NCT01951638|38011671|FG004|Follow-up Period|Adverse Event|1|||
16905060|NCT01928472|38011687|FG000|Overall Study|Death|0|||
16905061|NCT01928472|38011688|FG001|Overall Study|Death|0|||
16905062|NCT01928472|38011689|FG002|Overall Study|Death|1|||
16905063|NCT01928472|38011690|FG003|Overall Study|Death|0|||
16905064|NCT01928472|38011687|FG000|Overall Study|Withdrawal by Subject|4|||
17006642|NCT00950807|38150417|FG007|Treatment Period 1|Adverse Event|0|||
16905065|NCT01928472|38011688|FG001|Overall Study|Withdrawal by Subject|4|||
16905066|NCT01928472|38011689|FG002|Overall Study|Withdrawal by Subject|1|||
16905067|NCT01928472|38011690|FG003|Overall Study|Withdrawal by Subject|2|||
16905068|NCT01928472|38011687|FG000|Overall Study|Lost to Follow-up|2|||
16905069|NCT01928472|38011688|FG001|Overall Study|Lost to Follow-up|3|||
16905070|NCT01928472|38011689|FG002|Overall Study|Lost to Follow-up|4|||
16905071|NCT01928472|38011690|FG003|Overall Study|Lost to Follow-up|0|||
16905072|NCT01928472|38011687|FG000|Overall Study|Administrative Reason|2|||
16905073|NCT01928472|38011688|FG001|Overall Study|Administrative Reason|1|||
16905074|NCT01928472|38011689|FG002|Overall Study|Administrative Reason|0|||
16905075|NCT01928472|38011690|FG003|Overall Study|Administrative Reason|0|||
16905076|NCT01928472|38011687|FG000|Overall Study|Unclassified|0|||
16905077|NCT01928472|38011688|FG001|Overall Study|Unclassified|0|||
16905078|NCT01928472|38011689|FG002|Overall Study|Unclassified|1|||
16905079|NCT01928472|38011690|FG003|Overall Study|Unclassified|0|||
16905080|NCT01351415|38013560|FG000|Overall Study|Withdrawal by Subject|15|||
16905081|NCT01351415|38013561|FG001|Overall Study|Withdrawal by Subject|17|||
16905082|NCT01351415|38013560|FG000|Overall Study|Trial termination by the Sponsor|28|||
16905083|NCT01351415|38013561|FG001|Overall Study|Trial termination by the Sponsor|19|||
16905084|NCT01351415|38013560|FG000|Overall Study|Lost to Follow-up|5|||
16905085|NCT01351415|38013561|FG001|Overall Study|Lost to Follow-up|7|||
16905086|NCT01351415|38013560|FG000|Overall Study|Death|190|||
16905087|NCT01351415|38013561|FG001|Overall Study|Death|187|||
16905088|NCT01351415|38013560|FG000|Overall Study|Physician Decision|2|||
16905089|NCT01351415|38013561|FG001|Overall Study|Physician Decision|3|||
16905090|NCT01351415|38013560|FG000|Overall Study|Reason unknown|0|||
16905091|NCT01351415|38013561|FG001|Overall Study|Reason unknown|2|||
16905092|NCT01351415|38013560|FG000|Overall Study|Never Started|5|||
16905093|NCT01351415|38013561|FG001|Overall Study|Never Started|5|||
16905094|NCT04811339|38013669|FG000|Overall Study|lack of transportation not wanting to return|4|||
16905095|NCT04811339|38013670|FG001|Overall Study|lack of transportation not wanting to return|8|||
16905096|NCT04811339|38013671|FG002|Overall Study|lack of transportation not wanting to return|0|||
16905097|NCT04811339|38013669|FG000|Overall Study|Adverse Event|3|||
16905098|NCT04811339|38013670|FG001|Overall Study|Adverse Event|0|||
16905099|NCT04811339|38013671|FG002|Overall Study|Adverse Event|0|||
16905100|NCT04811339|38013669|FG000|Overall Study|Lost to Follow-up|1|||
16905101|NCT04811339|38013670|FG001|Overall Study|Lost to Follow-up|0|||
16905102|NCT04811339|38013671|FG002|Overall Study|Lost to Follow-up|0|||
16905103|NCT04811339|38013669|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
16905104|NCT04811339|38013670|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
16905105|NCT04811339|38013671|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
16905106|NCT04811339|38013669|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
16905107|NCT04811339|38013670|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
16905108|NCT04811339|38013671|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
16905109|NCT04811339|38013669|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
16905110|NCT04811339|38013670|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
16905111|NCT04811339|38013671|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
16905112|NCT04811339|38013669|FG000|Overall Study|Withdrawal by Subject|0|||
16905113|NCT04811339|38013670|FG001|Overall Study|Withdrawal by Subject|3|||
16905114|NCT04811339|38013671|FG002|Overall Study|Withdrawal by Subject|0|||
16905115|NCT04811339|38013669|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
16905116|NCT04811339|38013670|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
16905117|NCT04811339|38013671|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
16905118|NCT04811339|38013669|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
16905119|NCT04811339|38013670|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
16905120|NCT04811339|38013671|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
16905121|NCT04652453|38013684|FG000|Overall Study|Death|8|||
16905122|NCT04652453|38013685|FG001|Overall Study|Death|2|||
16905123|NCT04652453|38013686|FG002|Overall Study|Death|0|||
16905124|NCT04652453|38013684|FG000|Overall Study|Hospice|5|||
16905125|NCT04652453|38013685|FG001|Overall Study|Hospice|5|||
16905126|NCT04652453|38013686|FG002|Overall Study|Hospice|0|||
16905127|NCT04652453|38013684|FG000|Overall Study|Withdrawal by Subject|2|||
16905128|NCT04652453|38013685|FG001|Overall Study|Withdrawal by Subject|0|||
16905129|NCT04652453|38013686|FG002|Overall Study|Withdrawal by Subject|0|||
16905130|NCT04332107|38013694|FG000|Day 3|Lost to Follow-up|23|||
16905131|NCT04332107|38013695|FG001|Day 3|Lost to Follow-up|14|||
16905132|NCT04332107|38013694|FG000|Day 3|Missing outcome data|3|||
16905133|NCT04332107|38013695|FG001|Day 3|Missing outcome data|6|||
16905134|NCT04332107|38013694|FG000|Day 14|Lost to Follow-up|13|||
16905135|NCT04332107|38013695|FG001|Day 14|Lost to Follow-up|4|||
16905136|NCT04332107|38013694|FG000|Day 14|Missing outcome data|4|||
16905137|NCT04332107|38013695|FG001|Day 14|Missing outcome data|4|||
16905138|NCT04332107|38013694|FG000|Day 21|Lost to Follow-up|10|||
16905139|NCT04332107|38013695|FG001|Day 21|Lost to Follow-up|2|||
16905140|NCT03375203|38013710|FG000|Overall Study|Protocol Violation|0|||
16905141|NCT03375203|38013711|FG001|Overall Study|Protocol Violation|0|||
16905142|NCT03375203|38013712|FG002|Overall Study|Protocol Violation|1|||
16905143|NCT03375203|38013713|FG003|Overall Study|Protocol Violation|0|||
16905144|NCT03375203|38013714|FG004|Overall Study|Protocol Violation|0|||
16905145|NCT03375203|38013710|FG000|Overall Study|Adverse Event|2|||
16905146|NCT03375203|38013711|FG001|Overall Study|Adverse Event|3|||
16905147|NCT03375203|38013712|FG002|Overall Study|Adverse Event|0|||
16905148|NCT03375203|38013713|FG003|Overall Study|Adverse Event|2|||
16905149|NCT03375203|38013714|FG004|Overall Study|Adverse Event|2|||
16905150|NCT03375203|38013710|FG000|Overall Study|Withdrawal by Subject|3|||
16905151|NCT03375203|38013711|FG001|Overall Study|Withdrawal by Subject|0|||
16905152|NCT03375203|38013712|FG002|Overall Study|Withdrawal by Subject|1|||
16905153|NCT03375203|38013713|FG003|Overall Study|Withdrawal by Subject|0|||
16905154|NCT03375203|38013714|FG004|Overall Study|Withdrawal by Subject|2|||
16905155|NCT03375203|38013710|FG000|Overall Study|Non-compliance with study drug|1|||
16905156|NCT03375203|38013711|FG001|Overall Study|Non-compliance with study drug|0|||
16905157|NCT03375203|38013712|FG002|Overall Study|Non-compliance with study drug|0|||
16905158|NCT03375203|38013713|FG003|Overall Study|Non-compliance with study drug|0|||
16905159|NCT03375203|38013714|FG004|Overall Study|Non-compliance with study drug|0|||
16905160|NCT03375203|38013710|FG000|Overall Study|Randomized, not treated.|0|||
16905161|NCT03375203|38013711|FG001|Overall Study|Randomized, not treated.|1|||
16905162|NCT03375203|38013712|FG002|Overall Study|Randomized, not treated.|0|||
16905163|NCT03375203|38013713|FG003|Overall Study|Randomized, not treated.|0|||
16905164|NCT03375203|38013714|FG004|Overall Study|Randomized, not treated.|0|||
16905165|NCT03075839|38013736|FG000|Overall Study|Lost to Follow-up|4|||
16905166|NCT02919683|38013742|FG000|Post-Surgery Follow-Up|Death|2|||
16905167|NCT02919683|38013743|FG001|Post-Surgery Follow-Up|Death|2|||
16905168|NCT02919683|38013742|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
16905169|NCT02919683|38013743|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
16905170|NCT01928394|38013773|FG000|Treatment Period|Disease progression|17|||
16905171|NCT01928394|38013774|FG001|Treatment Period|Disease progression|2|||
16905172|NCT01928394|38013775|FG002|Treatment Period|Disease progression|12|||
16905173|NCT01928394|38013776|FG003|Treatment Period|Disease progression|48|||
16905174|NCT01928394|38013777|FG004|Treatment Period|Disease progression|3|||
16905175|NCT01928394|38013778|FG005|Treatment Period|Disease progression|25|||
16905176|NCT01928394|38013779|FG006|Treatment Period|Disease progression|38|||
16905177|NCT01928394|38013780|FG007|Treatment Period|Disease progression|16|||
16905178|NCT01928394|38013781|FG008|Treatment Period|Disease progression|3|||
16905179|NCT01928394|38013782|FG009|Treatment Period|Disease progression|11|||
16905180|NCT01928394|38013783|FG010|Treatment Period|Disease progression|22|||
16905181|NCT01928394|38013784|FG011|Treatment Period|Disease progression|73|||
16905182|NCT01928394|38013785|FG012|Treatment Period|Disease progression|38|||
16905183|NCT01928394|38013786|FG013|Treatment Period|Disease progression|118|||
16905184|NCT01928394|38013787|FG014|Treatment Period|Disease progression|59|||
16905185|NCT01928394|38013788|FG015|Treatment Period|Disease progression|1|||
16905186|NCT01928394|38013789|FG016|Treatment Period|Disease progression|43|||
16905187|NCT01928394|38013790|FG017|Treatment Period|Disease progression|56|||
16905188|NCT01928394|38013791|FG018|Treatment Period|Disease progression|50|||
16905189|NCT01928394|38013792|FG019|Treatment Period|Disease progression|71|||
16905190|NCT01928394|38013793|FG020|Treatment Period|Disease progression|30|||
16905191|NCT01928394|38013794|FG021|Treatment Period|Disease progression|31|||
16905192|NCT01928394|38013795|FG022|Treatment Period|Disease progression|31|||
16905193|NCT01928394|38013773|FG000|Treatment Period|Study drug toxicity|1|||
16905194|NCT01928394|38013774|FG001|Treatment Period|Study drug toxicity|1|||
16905195|NCT01928394|38013775|FG002|Treatment Period|Study drug toxicity|3|||
16905196|NCT01928394|38013776|FG003|Treatment Period|Study drug toxicity|3|||
16905197|NCT01928394|38013777|FG004|Treatment Period|Study drug toxicity|0|||
16905198|NCT01928394|38013778|FG005|Treatment Period|Study drug toxicity|9|||
16905199|NCT01928394|38013779|FG006|Treatment Period|Study drug toxicity|7|||
16905200|NCT01928394|38013780|FG007|Treatment Period|Study drug toxicity|1|||
16905201|NCT01928394|38013781|FG008|Treatment Period|Study drug toxicity|0|||
16905202|NCT01928394|38013782|FG009|Treatment Period|Study drug toxicity|5|||
16905203|NCT01928394|38013783|FG010|Treatment Period|Study drug toxicity|2|||
16905204|NCT01928394|38013784|FG011|Treatment Period|Study drug toxicity|3|||
16905205|NCT01928394|38013785|FG012|Treatment Period|Study drug toxicity|7|||
16905206|NCT01928394|38013786|FG013|Treatment Period|Study drug toxicity|5|||
16905207|NCT01928394|38013787|FG014|Treatment Period|Study drug toxicity|12|||
16905208|NCT01928394|38013788|FG015|Treatment Period|Study drug toxicity|0|||
16905209|NCT01928394|38013789|FG016|Treatment Period|Study drug toxicity|3|||
16905210|NCT01928394|38013790|FG017|Treatment Period|Study drug toxicity|3|||
16905211|NCT01928394|38013791|FG018|Treatment Period|Study drug toxicity|12|||
16905212|NCT01928394|38013792|FG019|Treatment Period|Study drug toxicity|15|||
16905213|NCT01928394|38013793|FG020|Treatment Period|Study drug toxicity|4|||
17006643|NCT00950807|38150418|FG008|Treatment Period 1|Adverse Event|0|||
16905214|NCT01928394|38013794|FG021|Treatment Period|Study drug toxicity|7|||
16905215|NCT01928394|38013795|FG022|Treatment Period|Study drug toxicity|4|||
16905216|NCT01928394|38013773|FG000|Treatment Period|AE unrelated to study drug|0|||
16905217|NCT01928394|38013774|FG001|Treatment Period|AE unrelated to study drug|0|||
16905218|NCT01928394|38013775|FG002|Treatment Period|AE unrelated to study drug|2|||
16905219|NCT01928394|38013776|FG003|Treatment Period|AE unrelated to study drug|3|||
16905220|NCT01928394|38013777|FG004|Treatment Period|AE unrelated to study drug|0|||
16905221|NCT01928394|38013778|FG005|Treatment Period|AE unrelated to study drug|5|||
16905222|NCT01928394|38013779|FG006|Treatment Period|AE unrelated to study drug|1|||
16905223|NCT01928394|38013780|FG007|Treatment Period|AE unrelated to study drug|0|||
16905224|NCT01928394|38013781|FG008|Treatment Period|AE unrelated to study drug|0|||
16905225|NCT01928394|38013782|FG009|Treatment Period|AE unrelated to study drug|2|||
16905226|NCT01928394|38013783|FG010|Treatment Period|AE unrelated to study drug|0|||
16905227|NCT01928394|38013784|FG011|Treatment Period|AE unrelated to study drug|12|||
16905228|NCT01928394|38013785|FG012|Treatment Period|AE unrelated to study drug|6|||
16905229|NCT01928394|38013786|FG013|Treatment Period|AE unrelated to study drug|13|||
16905230|NCT01928394|38013787|FG014|Treatment Period|AE unrelated to study drug|6|||
16905231|NCT01928394|38013788|FG015|Treatment Period|AE unrelated to study drug|1|||
16905232|NCT01928394|38013789|FG016|Treatment Period|AE unrelated to study drug|1|||
16905233|NCT01928394|38013790|FG017|Treatment Period|AE unrelated to study drug|6|||
16905234|NCT01928394|38013791|FG018|Treatment Period|AE unrelated to study drug|3|||
16905235|NCT01928394|38013792|FG019|Treatment Period|AE unrelated to study drug|5|||
16905236|NCT01928394|38013793|FG020|Treatment Period|AE unrelated to study drug|1|||
16905237|NCT01928394|38013794|FG021|Treatment Period|AE unrelated to study drug|1|||
16905238|NCT01928394|38013795|FG022|Treatment Period|AE unrelated to study drug|0|||
16905239|NCT01928394|38013773|FG000|Treatment Period|Participant request to stop therapy|0|||
16905240|NCT01928394|38013774|FG001|Treatment Period|Participant request to stop therapy|0|||
16905241|NCT01928394|38013775|FG002|Treatment Period|Participant request to stop therapy|0|||
16905242|NCT01928394|38013776|FG003|Treatment Period|Participant request to stop therapy|0|||
16905243|NCT01928394|38013777|FG004|Treatment Period|Participant request to stop therapy|0|||
16905244|NCT01928394|38013778|FG005|Treatment Period|Participant request to stop therapy|3|||
16905245|NCT01928394|38013779|FG006|Treatment Period|Participant request to stop therapy|3|||
16905246|NCT01928394|38013780|FG007|Treatment Period|Participant request to stop therapy|0|||
16905247|NCT01928394|38013781|FG008|Treatment Period|Participant request to stop therapy|0|||
16905248|NCT01928394|38013782|FG009|Treatment Period|Participant request to stop therapy|0|||
16905249|NCT01928394|38013783|FG010|Treatment Period|Participant request to stop therapy|3|||
16905250|NCT01928394|38013784|FG011|Treatment Period|Participant request to stop therapy|2|||
16905251|NCT01928394|38013785|FG012|Treatment Period|Participant request to stop therapy|1|||
16905252|NCT01928394|38013786|FG013|Treatment Period|Participant request to stop therapy|2|||
16905253|NCT01928394|38013787|FG014|Treatment Period|Participant request to stop therapy|4|||
16905254|NCT01928394|38013788|FG015|Treatment Period|Participant request to stop therapy|0|||
16905255|NCT01928394|38013789|FG016|Treatment Period|Participant request to stop therapy|1|||
16905256|NCT01928394|38013790|FG017|Treatment Period|Participant request to stop therapy|3|||
16905257|NCT01928394|38013791|FG018|Treatment Period|Participant request to stop therapy|1|||
16905258|NCT01928394|38013792|FG019|Treatment Period|Participant request to stop therapy|1|||
16905259|NCT01928394|38013793|FG020|Treatment Period|Participant request to stop therapy|3|||
16905260|NCT01928394|38013794|FG021|Treatment Period|Participant request to stop therapy|1|||
16905261|NCT01928394|38013795|FG022|Treatment Period|Participant request to stop therapy|3|||
16905262|NCT01928394|38013773|FG000|Treatment Period|Participant withdrew consent|0|||
16905263|NCT01928394|38013774|FG001|Treatment Period|Participant withdrew consent|0|||
16905264|NCT01928394|38013775|FG002|Treatment Period|Participant withdrew consent|1|||
16905265|NCT01928394|38013776|FG003|Treatment Period|Participant withdrew consent|1|||
16905266|NCT01928394|38013777|FG004|Treatment Period|Participant withdrew consent|0|||
17192774|NCT01335997|38346090|FG001|Period I and II|Noncompliance with Study Drug|1|||
17192775|NCT01335997|38346089|FG000|Period I and II|Lost to Follow-up|3|||
17192776|NCT01335997|38346090|FG001|Period I and II|Lost to Follow-up|5|||
17192777|NCT01335997|38346089|FG000|Period I and II|Withdrawal by Subject|9|||
17192778|NCT01335997|38346090|FG001|Period I and II|Withdrawal by Subject|4|||
17192779|NCT01335997|38346089|FG000|Period I and II|Study Terminated by Sponsor|406|||
17192780|NCT01335997|38346090|FG001|Period I and II|Study Terminated by Sponsor|415|||
17192781|NCT01335997|38346089|FG000|Period I and II|Protocol Violation|9|||
17192782|NCT01335997|38346090|FG001|Period I and II|Protocol Violation|10|||
17192783|NCT01335997|38346089|FG000|Period I and II|Physician Decision|2|||
17192784|NCT01335997|38346090|FG001|Period I and II|Physician Decision|1|||
17192785|NCT01335997|38346089|FG000|Period III|Adverse Event|0|||
17192786|NCT01335997|38346090|FG001|Period III|Adverse Event|2|||
17192787|NCT01335997|38346089|FG000|Period III|Study Terminated by Sponsor|77|||
17192788|NCT01335997|38346090|FG001|Period III|Study Terminated by Sponsor|76|||
17192789|NCT01335997|38346089|FG000|Period III|Protocol Violation|0|||
17192790|NCT01335997|38346090|FG001|Period III|Protocol Violation|1|||
17006644|NCT00950807|38150419|FG009|Treatment Period 1|Adverse Event|0|||
17006645|NCT00950807|38150410|FG000|Washout Period 1|Lack of Efficacy|0|||
16905267|NCT01928394|38013778|FG005|Treatment Period|Participant withdrew consent|1|||
16905268|NCT01928394|38013779|FG006|Treatment Period|Participant withdrew consent|0|||
16905269|NCT01928394|38013780|FG007|Treatment Period|Participant withdrew consent|1|||
16905270|NCT01928394|38013781|FG008|Treatment Period|Participant withdrew consent|0|||
16905271|NCT01928394|38013782|FG009|Treatment Period|Participant withdrew consent|0|||
16905272|NCT01928394|38013783|FG010|Treatment Period|Participant withdrew consent|1|||
16905273|NCT01928394|38013784|FG011|Treatment Period|Participant withdrew consent|1|||
16905274|NCT01928394|38013785|FG012|Treatment Period|Participant withdrew consent|1|||
16905275|NCT01928394|38013786|FG013|Treatment Period|Participant withdrew consent|0|||
16905276|NCT01928394|38013787|FG014|Treatment Period|Participant withdrew consent|2|||
16905277|NCT01928394|38013788|FG015|Treatment Period|Participant withdrew consent|0|||
16905278|NCT01928394|38013789|FG016|Treatment Period|Participant withdrew consent|2|||
16905279|NCT01928394|38013790|FG017|Treatment Period|Participant withdrew consent|1|||
16905280|NCT01928394|38013791|FG018|Treatment Period|Participant withdrew consent|1|||
16905281|NCT01928394|38013792|FG019|Treatment Period|Participant withdrew consent|1|||
16905282|NCT01928394|38013793|FG020|Treatment Period|Participant withdrew consent|0|||
16905283|NCT01928394|38013794|FG021|Treatment Period|Participant withdrew consent|2|||
16905284|NCT01928394|38013795|FG022|Treatment Period|Participant withdrew consent|0|||
16905285|NCT01928394|38013773|FG000|Treatment Period|Poor/non-compliance|0|||
16905286|NCT01928394|38013774|FG001|Treatment Period|Poor/non-compliance|0|||
16905287|NCT01928394|38013775|FG002|Treatment Period|Poor/non-compliance|0|||
16905288|NCT01928394|38013776|FG003|Treatment Period|Poor/non-compliance|1|||
16905289|NCT01928394|38013777|FG004|Treatment Period|Poor/non-compliance|0|||
16905290|NCT01928394|38013778|FG005|Treatment Period|Poor/non-compliance|0|||
16905291|NCT01928394|38013779|FG006|Treatment Period|Poor/non-compliance|0|||
16905292|NCT01928394|38013780|FG007|Treatment Period|Poor/non-compliance|0|||
16905293|NCT01928394|38013781|FG008|Treatment Period|Poor/non-compliance|0|||
16905294|NCT01928394|38013782|FG009|Treatment Period|Poor/non-compliance|0|||
16905295|NCT01928394|38013783|FG010|Treatment Period|Poor/non-compliance|0|||
16905296|NCT01928394|38013784|FG011|Treatment Period|Poor/non-compliance|0|||
16905297|NCT01928394|38013785|FG012|Treatment Period|Poor/non-compliance|1|||
16905298|NCT01928394|38013786|FG013|Treatment Period|Poor/non-compliance|0|||
16905299|NCT01928394|38013787|FG014|Treatment Period|Poor/non-compliance|1|||
16905300|NCT01928394|38013788|FG015|Treatment Period|Poor/non-compliance|0|||
16905301|NCT01928394|38013789|FG016|Treatment Period|Poor/non-compliance|0|||
16905302|NCT01928394|38013790|FG017|Treatment Period|Poor/non-compliance|1|||
16905303|NCT01928394|38013791|FG018|Treatment Period|Poor/non-compliance|0|||
16905304|NCT01928394|38013792|FG019|Treatment Period|Poor/non-compliance|1|||
16905305|NCT01928394|38013793|FG020|Treatment Period|Poor/non-compliance|0|||
16905306|NCT01928394|38013794|FG021|Treatment Period|Poor/non-compliance|0|||
16905307|NCT01928394|38013795|FG022|Treatment Period|Poor/non-compliance|0|||
16905308|NCT01928394|38013773|FG000|Treatment Period|other reason|0|||
16905309|NCT01928394|38013774|FG001|Treatment Period|other reason|0|||
16905310|NCT01928394|38013775|FG002|Treatment Period|other reason|0|||
16905311|NCT01928394|38013776|FG003|Treatment Period|other reason|0|||
16905312|NCT01928394|38013777|FG004|Treatment Period|other reason|0|||
16905313|NCT01928394|38013778|FG005|Treatment Period|other reason|0|||
16905314|NCT01928394|38013779|FG006|Treatment Period|other reason|0|||
16905315|NCT01928394|38013780|FG007|Treatment Period|other reason|0|||
16905316|NCT01928394|38013781|FG008|Treatment Period|other reason|0|||
16905317|NCT01928394|38013782|FG009|Treatment Period|other reason|0|||
16905318|NCT01928394|38013783|FG010|Treatment Period|other reason|1|||
16905319|NCT01928394|38013784|FG011|Treatment Period|other reason|1|||
16905320|NCT01928394|38013785|FG012|Treatment Period|other reason|1|||
16905321|NCT01928394|38013786|FG013|Treatment Period|other reason|0|||
16905322|NCT01928394|38013787|FG014|Treatment Period|other reason|1|||
16905323|NCT01928394|38013788|FG015|Treatment Period|other reason|0|||
16905324|NCT01928394|38013789|FG016|Treatment Period|other reason|0|||
16905325|NCT01928394|38013790|FG017|Treatment Period|other reason|0|||
16905326|NCT01928394|38013791|FG018|Treatment Period|other reason|2|||
16905327|NCT01928394|38013792|FG019|Treatment Period|other reason|2|||
16905328|NCT01928394|38013793|FG020|Treatment Period|other reason|0|||
16905329|NCT01928394|38013794|FG021|Treatment Period|other reason|0|||
16905330|NCT01928394|38013795|FG022|Treatment Period|other reason|0|||
16905331|NCT01928394|38013773|FG000|Treatment Period|Maximum clinical benefit|0|||
16905332|NCT01928394|38013774|FG001|Treatment Period|Maximum clinical benefit|0|||
16905333|NCT01928394|38013775|FG002|Treatment Period|Maximum clinical benefit|0|||
16905334|NCT01928394|38013776|FG003|Treatment Period|Maximum clinical benefit|0|||
16905335|NCT01928394|38013777|FG004|Treatment Period|Maximum clinical benefit|0|||
16905336|NCT01928394|38013778|FG005|Treatment Period|Maximum clinical benefit|0|||
17006646|NCT00950807|38150411|FG001|Washout Period 1|Lack of Efficacy|0|||
16905337|NCT01928394|38013779|FG006|Treatment Period|Maximum clinical benefit|0|||
16905338|NCT01928394|38013780|FG007|Treatment Period|Maximum clinical benefit|0|||
16905339|NCT01928394|38013781|FG008|Treatment Period|Maximum clinical benefit|0|||
16905340|NCT01928394|38013782|FG009|Treatment Period|Maximum clinical benefit|0|||
16905341|NCT01928394|38013783|FG010|Treatment Period|Maximum clinical benefit|1|||
16905342|NCT01928394|38013784|FG011|Treatment Period|Maximum clinical benefit|1|||
16905343|NCT01928394|38013785|FG012|Treatment Period|Maximum clinical benefit|0|||
16905344|NCT01928394|38013786|FG013|Treatment Period|Maximum clinical benefit|0|||
16905345|NCT01928394|38013787|FG014|Treatment Period|Maximum clinical benefit|1|||
16905346|NCT01928394|38013788|FG015|Treatment Period|Maximum clinical benefit|0|||
16905347|NCT01928394|38013789|FG016|Treatment Period|Maximum clinical benefit|0|||
16905348|NCT01928394|38013790|FG017|Treatment Period|Maximum clinical benefit|1|||
16905349|NCT01928394|38013791|FG018|Treatment Period|Maximum clinical benefit|1|||
16905350|NCT01928394|38013792|FG019|Treatment Period|Maximum clinical benefit|0|||
16905351|NCT01928394|38013793|FG020|Treatment Period|Maximum clinical benefit|2|||
16905352|NCT01928394|38013794|FG021|Treatment Period|Maximum clinical benefit|0|||
16905353|NCT01928394|38013795|FG022|Treatment Period|Maximum clinical benefit|0|||
16905354|NCT01928394|38013773|FG000|Treatment Period|Lost to Follow-up|0|||
16905355|NCT01928394|38013774|FG001|Treatment Period|Lost to Follow-up|0|||
16905356|NCT01928394|38013775|FG002|Treatment Period|Lost to Follow-up|0|||
16905357|NCT01928394|38013776|FG003|Treatment Period|Lost to Follow-up|0|||
16905358|NCT01928394|38013777|FG004|Treatment Period|Lost to Follow-up|0|||
16905359|NCT01928394|38013778|FG005|Treatment Period|Lost to Follow-up|0|||
16905360|NCT01928394|38013779|FG006|Treatment Period|Lost to Follow-up|0|||
16905361|NCT01928394|38013780|FG007|Treatment Period|Lost to Follow-up|0|||
16905362|NCT01928394|38013781|FG008|Treatment Period|Lost to Follow-up|0|||
16905363|NCT01928394|38013782|FG009|Treatment Period|Lost to Follow-up|0|||
16905364|NCT01928394|38013783|FG010|Treatment Period|Lost to Follow-up|0|||
16905365|NCT01928394|38013784|FG011|Treatment Period|Lost to Follow-up|0|||
16905366|NCT01928394|38013785|FG012|Treatment Period|Lost to Follow-up|0|||
16905367|NCT01928394|38013786|FG013|Treatment Period|Lost to Follow-up|0|||
16905368|NCT01928394|38013787|FG014|Treatment Period|Lost to Follow-up|0|||
16905369|NCT01928394|38013788|FG015|Treatment Period|Lost to Follow-up|0|||
16905370|NCT01928394|38013789|FG016|Treatment Period|Lost to Follow-up|0|||
16905371|NCT01928394|38013790|FG017|Treatment Period|Lost to Follow-up|0|||
16905372|NCT01928394|38013791|FG018|Treatment Period|Lost to Follow-up|0|||
16905373|NCT01928394|38013792|FG019|Treatment Period|Lost to Follow-up|0|||
16905374|NCT01928394|38013793|FG020|Treatment Period|Lost to Follow-up|0|||
16905375|NCT01928394|38013794|FG021|Treatment Period|Lost to Follow-up|0|||
16905376|NCT01928394|38013795|FG022|Treatment Period|Lost to Follow-up|1|||
16905377|NCT01928394|38013773|FG000|Treatment Period|Death|0|||
16905378|NCT01928394|38013774|FG001|Treatment Period|Death|0|||
16905379|NCT01928394|38013775|FG002|Treatment Period|Death|0|||
16905380|NCT01928394|38013776|FG003|Treatment Period|Death|0|||
16905381|NCT01928394|38013777|FG004|Treatment Period|Death|0|||
16905382|NCT01928394|38013778|FG005|Treatment Period|Death|0|||
16905383|NCT01928394|38013779|FG006|Treatment Period|Death|0|||
16905384|NCT01928394|38013780|FG007|Treatment Period|Death|0|||
16905385|NCT01928394|38013781|FG008|Treatment Period|Death|0|||
16905386|NCT01928394|38013782|FG009|Treatment Period|Death|0|||
16905387|NCT01928394|38013783|FG010|Treatment Period|Death|0|||
16905388|NCT01928394|38013784|FG011|Treatment Period|Death|0|||
16905389|NCT01928394|38013785|FG012|Treatment Period|Death|0|||
16905390|NCT01928394|38013786|FG013|Treatment Period|Death|1|||
17006647|NCT00950807|38150412|FG002|Washout Period 1|Lack of Efficacy|0|||
17006648|NCT00950807|38150413|FG003|Washout Period 1|Lack of Efficacy|0|||
17006649|NCT00950807|38150414|FG004|Washout Period 1|Lack of Efficacy|0|||
17006650|NCT00950807|38150415|FG005|Washout Period 1|Lack of Efficacy|0|||
17006651|NCT00950807|38150416|FG006|Washout Period 1|Lack of Efficacy|1|||
17006652|NCT00950807|38150417|FG007|Washout Period 1|Lack of Efficacy|0|||
17006653|NCT00950807|38150418|FG008|Washout Period 1|Lack of Efficacy|0|||
17006654|NCT00950807|38150419|FG009|Washout Period 1|Lack of Efficacy|0|||
17006655|NCT00950807|38150410|FG000|Washout Period 1|Withdrawal by Subject|0|||
17006656|NCT00950807|38150411|FG001|Washout Period 1|Withdrawal by Subject|0|||
17006657|NCT00950807|38150412|FG002|Washout Period 1|Withdrawal by Subject|0|||
17006658|NCT00950807|38150413|FG003|Washout Period 1|Withdrawal by Subject|0|||
17006659|NCT00950807|38150414|FG004|Washout Period 1|Withdrawal by Subject|0|||
17006660|NCT00950807|38150415|FG005|Washout Period 1|Withdrawal by Subject|0|||
17006661|NCT00950807|38150416|FG006|Washout Period 1|Withdrawal by Subject|0|||
17006662|NCT00950807|38150417|FG007|Washout Period 1|Withdrawal by Subject|0|||
17006663|NCT00950807|38150418|FG008|Washout Period 1|Withdrawal by Subject|1|||
17006664|NCT00950807|38150419|FG009|Washout Period 1|Withdrawal by Subject|0|||
17006665|NCT00950807|38150410|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
16905391|NCT01928394|38013787|FG014|Treatment Period|Death|2|||
16905392|NCT01928394|38013788|FG015|Treatment Period|Death|0|||
16905393|NCT01928394|38013789|FG016|Treatment Period|Death|0|||
16905394|NCT01928394|38013790|FG017|Treatment Period|Death|0|||
16905395|NCT01928394|38013791|FG018|Treatment Period|Death|0|||
16905396|NCT01928394|38013792|FG019|Treatment Period|Death|0|||
16905397|NCT01928394|38013793|FG020|Treatment Period|Death|0|||
16905398|NCT01928394|38013794|FG021|Treatment Period|Death|0|||
17006666|NCT00950807|38150411|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16905399|NCT01928394|38013795|FG022|Treatment Period|Death|0|||
16905400|NCT01928394|38013773|FG000|Follow-up Period|Participant withdrew consent|3|||
16905401|NCT01928394|38013774|FG001|Follow-up Period|Participant withdrew consent|0|||
16905402|NCT01928394|38013775|FG002|Follow-up Period|Participant withdrew consent|1|||
16905403|NCT01928394|38013776|FG003|Follow-up Period|Participant withdrew consent|4|||
16905404|NCT01928394|38013777|FG004|Follow-up Period|Participant withdrew consent|0|||
16905405|NCT01928394|38013778|FG005|Follow-up Period|Participant withdrew consent|2|||
16905406|NCT01928394|38013779|FG006|Follow-up Period|Participant withdrew consent|5|||
16905407|NCT01928394|38013780|FG007|Follow-up Period|Participant withdrew consent|1|||
16905408|NCT01928394|38013781|FG008|Follow-up Period|Participant withdrew consent|0|||
16905409|NCT01928394|38013782|FG009|Follow-up Period|Participant withdrew consent|0|||
16905410|NCT01928394|38013783|FG010|Follow-up Period|Participant withdrew consent|5|||
16905411|NCT01928394|38013784|FG011|Follow-up Period|Participant withdrew consent|8|||
16905412|NCT01928394|38013785|FG012|Follow-up Period|Participant withdrew consent|2|||
16905413|NCT01928394|38013786|FG013|Follow-up Period|Participant withdrew consent|12|||
16905414|NCT01928394|38013787|FG014|Follow-up Period|Participant withdrew consent|7|||
16905415|NCT01928394|38013788|FG015|Follow-up Period|Participant withdrew consent|0|||
16905416|NCT01928394|38013789|FG016|Follow-up Period|Participant withdrew consent|5|||
16905417|NCT01928394|38013790|FG017|Follow-up Period|Participant withdrew consent|3|||
16905418|NCT01928394|38013791|FG018|Follow-up Period|Participant withdrew consent|2|||
16905419|NCT01928394|38013792|FG019|Follow-up Period|Participant withdrew consent|7|||
16905420|NCT01928394|38013793|FG020|Follow-up Period|Participant withdrew consent|4|||
16905421|NCT01928394|38013794|FG021|Follow-up Period|Participant withdrew consent|6|||
16905422|NCT01928394|38013795|FG022|Follow-up Period|Participant withdrew consent|2|||
16905423|NCT01928394|38013773|FG000|Follow-up Period|Death|0|||
16905424|NCT01928394|38013774|FG001|Follow-up Period|Death|0|||
16905425|NCT01928394|38013775|FG002|Follow-up Period|Death|2|||
16905426|NCT01928394|38013776|FG003|Follow-up Period|Death|6|||
16905427|NCT01928394|38013777|FG004|Follow-up Period|Death|0|||
16905428|NCT01928394|38013778|FG005|Follow-up Period|Death|6|||
16905429|NCT01928394|38013779|FG006|Follow-up Period|Death|6|||
16905430|NCT01928394|38013780|FG007|Follow-up Period|Death|2|||
16905431|NCT01928394|38013781|FG008|Follow-up Period|Death|1|||
16905432|NCT01928394|38013782|FG009|Follow-up Period|Death|2|||
16905433|NCT01928394|38013783|FG010|Follow-up Period|Death|4|||
16905434|NCT01928394|38013784|FG011|Follow-up Period|Death|12|||
16905435|NCT01928394|38013785|FG012|Follow-up Period|Death|11|||
16905436|NCT01928394|38013786|FG013|Follow-up Period|Death|25|||
16905437|NCT01928394|38013787|FG014|Follow-up Period|Death|18|||
16905438|NCT01928394|38013788|FG015|Follow-up Period|Death|0|||
16905439|NCT01928394|38013789|FG016|Follow-up Period|Death|6|||
16905440|NCT01928394|38013790|FG017|Follow-up Period|Death|5|||
16905441|NCT01928394|38013791|FG018|Follow-up Period|Death|13|||
16905442|NCT01928394|38013792|FG019|Follow-up Period|Death|13|||
16905443|NCT01928394|38013793|FG020|Follow-up Period|Death|5|||
16905444|NCT01928394|38013794|FG021|Follow-up Period|Death|3|||
16905445|NCT01928394|38013795|FG022|Follow-up Period|Death|2|||
16905446|NCT01928394|38013773|FG000|Follow-up Period|other reason|0|||
16905447|NCT01928394|38013774|FG001|Follow-up Period|other reason|0|||
16905448|NCT01928394|38013775|FG002|Follow-up Period|other reason|0|||
16905449|NCT01928394|38013776|FG003|Follow-up Period|other reason|0|||
16905450|NCT01928394|38013777|FG004|Follow-up Period|other reason|0|||
16905451|NCT01928394|38013778|FG005|Follow-up Period|other reason|0|||
16905452|NCT01928394|38013779|FG006|Follow-up Period|other reason|1|||
16905453|NCT01928394|38013780|FG007|Follow-up Period|other reason|3|||
16905454|NCT01928394|38013781|FG008|Follow-up Period|other reason|0|||
16905455|NCT01928394|38013782|FG009|Follow-up Period|other reason|0|||
16905456|NCT01928394|38013783|FG010|Follow-up Period|other reason|2|||
16905457|NCT01928394|38013784|FG011|Follow-up Period|other reason|1|||
16905458|NCT01928394|38013785|FG012|Follow-up Period|other reason|0|||
16905459|NCT01928394|38013786|FG013|Follow-up Period|other reason|1|||
16905460|NCT01928394|38013787|FG014|Follow-up Period|other reason|4|||
16905461|NCT01928394|38013788|FG015|Follow-up Period|other reason|0|||
16905462|NCT01928394|38013789|FG016|Follow-up Period|other reason|2|||
16905463|NCT01928394|38013790|FG017|Follow-up Period|other reason|0|||
16905464|NCT01928394|38013791|FG018|Follow-up Period|other reason|1|||
17006667|NCT00950807|38150412|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
17006668|NCT00950807|38150413|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16905465|NCT01928394|38013792|FG019|Follow-up Period|other reason|1|||
17006669|NCT00950807|38150414|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
17006670|NCT00950807|38150415|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
17006671|NCT00950807|38150416|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
17006672|NCT00950807|38150417|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
17006673|NCT00950807|38150418|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16905466|NCT01928394|38013793|FG020|Follow-up Period|other reason|0|||
16905467|NCT01928394|38013794|FG021|Follow-up Period|other reason|0|||
16905468|NCT01928394|38013795|FG022|Follow-up Period|other reason|1|||
16905469|NCT01928394|38013773|FG000|Follow-up Period|Lost to Follow-up|0|||
16905470|NCT01928394|38013774|FG001|Follow-up Period|Lost to Follow-up|0|||
16905471|NCT01928394|38013775|FG002|Follow-up Period|Lost to Follow-up|0|||
16905472|NCT01928394|38013776|FG003|Follow-up Period|Lost to Follow-up|0|||
16905473|NCT01928394|38013777|FG004|Follow-up Period|Lost to Follow-up|0|||
16905474|NCT01928394|38013778|FG005|Follow-up Period|Lost to Follow-up|0|||
16905475|NCT01928394|38013779|FG006|Follow-up Period|Lost to Follow-up|0|||
16905476|NCT01928394|38013780|FG007|Follow-up Period|Lost to Follow-up|0|||
16905477|NCT01928394|38013781|FG008|Follow-up Period|Lost to Follow-up|0|||
16905478|NCT01928394|38013782|FG009|Follow-up Period|Lost to Follow-up|0|||
16905479|NCT01928394|38013783|FG010|Follow-up Period|Lost to Follow-up|0|||
16905480|NCT01928394|38013784|FG011|Follow-up Period|Lost to Follow-up|1|||
16905481|NCT01928394|38013785|FG012|Follow-up Period|Lost to Follow-up|1|||
16905482|NCT01928394|38013786|FG013|Follow-up Period|Lost to Follow-up|0|||
16905483|NCT01928394|38013787|FG014|Follow-up Period|Lost to Follow-up|1|||
16905484|NCT01928394|38013788|FG015|Follow-up Period|Lost to Follow-up|0|||
16905485|NCT01928394|38013789|FG016|Follow-up Period|Lost to Follow-up|1|||
16905486|NCT01928394|38013790|FG017|Follow-up Period|Lost to Follow-up|0|||
16905487|NCT01928394|38013791|FG018|Follow-up Period|Lost to Follow-up|0|||
16905488|NCT01928394|38013792|FG019|Follow-up Period|Lost to Follow-up|0|||
16905489|NCT01928394|38013793|FG020|Follow-up Period|Lost to Follow-up|0|||
16905490|NCT01928394|38013794|FG021|Follow-up Period|Lost to Follow-up|0|||
16905491|NCT01928394|38013795|FG022|Follow-up Period|Lost to Follow-up|1|||
16905492|NCT01928082|38013843|FG000|Overall Study|Study terminated.|1|||
16905493|NCT01972776|38013853|FG000|Part 1|Withdrawal by Subject|0|||
16905494|NCT01972776|38013854|FG001|Part 1|Withdrawal by Subject|0|||
16905495|NCT01972776|38013855|FG002|Part 1|Withdrawal by Subject|1|||
16905496|NCT01972776|38013856|FG003|Part 1|Withdrawal by Subject|0|||
16905497|NCT01972776|38013857|FG004|Part 1|Withdrawal by Subject|0|||
16905498|NCT01972776|38013858|FG005|Part 1|Withdrawal by Subject|0|||
16905499|NCT01972776|38013853|FG000|Part 1|Adverse Event|0|||
16905500|NCT01972776|38013854|FG001|Part 1|Adverse Event|0|||
16905501|NCT01972776|38013855|FG002|Part 1|Adverse Event|1|||
16905502|NCT01972776|38013856|FG003|Part 1|Adverse Event|1|||
16905503|NCT01972776|38013857|FG004|Part 1|Adverse Event|0|||
16905504|NCT01972776|38013858|FG005|Part 1|Adverse Event|0|||
16905505|NCT01972776|38013853|FG000|Part 2|Adverse Event|0|||
16905506|NCT01972776|38013854|FG001|Part 2|Adverse Event|0|||
16905507|NCT01972776|38013855|FG002|Part 2|Adverse Event|0|||
16905508|NCT01972776|38013856|FG003|Part 2|Adverse Event|0|||
16905509|NCT01972776|38013857|FG004|Part 2|Adverse Event|3|||
16905510|NCT01972776|38013858|FG005|Part 2|Adverse Event|0|||
16905511|NCT01972776|38013853|FG000|Part 2|Administrative problems|0|||
16905512|NCT01972776|38013854|FG001|Part 2|Administrative problems|0|||
16905513|NCT01972776|38013855|FG002|Part 2|Administrative problems|0|||
16905514|NCT01972776|38013856|FG003|Part 2|Administrative problems|0|||
16905515|NCT01972776|38013857|FG004|Part 2|Administrative problems|10|||
16905516|NCT01972776|38013858|FG005|Part 2|Administrative problems|7|||
16905517|NCT02908685|38013884|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
16905518|NCT02908685|38013885|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
16905519|NCT02908685|38013886|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
16905520|NCT02908685|38013887|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
16905521|NCT02908685|38013888|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
16905522|NCT02908685|38013889|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
16905523|NCT02908685|38013890|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
16905524|NCT02908685|38013891|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
16905525|NCT02908685|38013892|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
16905526|NCT02908685|38013893|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
16905527|NCT02908685|38013894|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
16905528|NCT02908685|38013895|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
16905529|NCT02908685|38013884|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
16905530|NCT02908685|38013885|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
17006674|NCT00950807|38150419|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
17006675|NCT00950807|38150410|FG000|Washout Period 1|Adverse Event|2|||
17006676|NCT00950807|38150411|FG001|Washout Period 1|Adverse Event|0|||
17006677|NCT00950807|38150412|FG002|Washout Period 1|Adverse Event|0|||
17006678|NCT00950807|38150413|FG003|Washout Period 1|Adverse Event|1|||
17006679|NCT00950807|38150414|FG004|Washout Period 1|Adverse Event|1|||
17095740|NCT00162266|38234981|FG002|Double-Blind Period|Withdrawal by Subject|6|||
16905531|NCT02908685|38013886|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
17006680|NCT00950807|38150415|FG005|Washout Period 1|Adverse Event|0|||
17006681|NCT00950807|38150416|FG006|Washout Period 1|Adverse Event|0|||
16905532|NCT02908685|38013887|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
17006682|NCT00950807|38150417|FG007|Washout Period 1|Adverse Event|0|||
16905533|NCT02908685|38013888|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
16905534|NCT02908685|38013889|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
16905535|NCT02908685|38013890|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
16905536|NCT02908685|38013891|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
16905537|NCT02908685|38013892|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
16905538|NCT02908685|38013893|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
16905539|NCT02908685|38013894|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
16905540|NCT02908685|38013895|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
16905541|NCT02908685|38013884|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
16905542|NCT02908685|38013885|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
16905543|NCT02908685|38013886|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
16905544|NCT02908685|38013887|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
16905545|NCT02908685|38013888|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
16905546|NCT02908685|38013889|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
16905547|NCT02908685|38013890|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
16905548|NCT02908685|38013891|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
16905549|NCT02908685|38013892|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
16905550|NCT02908685|38013893|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
16905551|NCT02908685|38013894|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
16905552|NCT02908685|38013895|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
16905553|NCT03763331|38013914|FG000|Overall Study|Lost to Follow-up|1|||
16905554|NCT03763331|38013915|FG001|Overall Study|Lost to Follow-up|0|||
16905555|NCT03763331|38013914|FG000|Overall Study|Withdrawal by Subject|1|||
16905556|NCT03763331|38013915|FG001|Overall Study|Withdrawal by Subject|0|||
16905557|NCT03763331|38013914|FG000|Overall Study|Non-compliance|0|||
16905558|NCT03763331|38013915|FG001|Overall Study|Non-compliance|3|||
16905559|NCT01958021|38013923|FG000|Overall Study|Progressive disease|87|||
16905560|NCT01958021|38013924|FG001|Overall Study|Progressive disease|146|||
16905561|NCT01958021|38013923|FG000|Overall Study|Adverse Event|25|||
16905562|NCT01958021|38013924|FG001|Overall Study|Adverse Event|7|||
16905563|NCT01958021|38013923|FG000|Overall Study|Subject/guardian decision|12|||
16905564|NCT01958021|38013924|FG001|Overall Study|Subject/guardian decision|13|||
16905565|NCT01958021|38013923|FG000|Overall Study|Physician Decision|10|||
16905566|NCT01958021|38013924|FG001|Overall Study|Physician Decision|13|||
16905567|NCT01958021|38013923|FG000|Overall Study|Protocol Violation|3|||
16905568|NCT01958021|38013924|FG001|Overall Study|Protocol Violation|1|||
16905569|NCT01958021|38013923|FG000|Overall Study|Death|2|||
16905570|NCT01958021|38013924|FG001|Overall Study|Death|0|||
16905571|NCT01660451|38013933|FG000|Overall Study|Protocol Violation|0|||
16905572|NCT01660451|38013934|FG001|Overall Study|Protocol Violation|1|||
16905573|NCT01660451|38013935|FG002|Overall Study|Protocol Violation|1|||
16905574|NCT01660451|38013933|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
16905575|NCT01660451|38013934|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
16905576|NCT01660451|38013935|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
16905577|NCT01660451|38013933|FG000|Overall Study|AE with Clinical PD|1|||
16905578|NCT01660451|38013934|FG001|Overall Study|AE with Clinical PD|3|||
16905579|NCT01660451|38013935|FG002|Overall Study|AE with Clinical PD|9|||
16905580|NCT01660451|38013933|FG000|Overall Study|Sponsor Decision|0|||
16905581|NCT01660451|38013934|FG001|Overall Study|Sponsor Decision|0|||
16905582|NCT01660451|38013935|FG002|Overall Study|Sponsor Decision|1|||
16905583|NCT01660451|38013933|FG000|Overall Study|Protocol Deviation|0|||
16905584|NCT01660451|38013934|FG001|Overall Study|Protocol Deviation|0|||
16905585|NCT01660451|38013935|FG002|Overall Study|Protocol Deviation|1|||
16905586|NCT01660451|38013933|FG000|Overall Study|Physician Decision|1|||
16905587|NCT01660451|38013934|FG001|Overall Study|Physician Decision|2|||
16905588|NCT01660451|38013935|FG002|Overall Study|Physician Decision|5|||
16905589|NCT01660451|38013933|FG000|Overall Study|Withdrawal by Subject|1|||
16905590|NCT01660451|38013934|FG001|Overall Study|Withdrawal by Subject|0|||
16905591|NCT01660451|38013935|FG002|Overall Study|Withdrawal by Subject|16|||
16905592|NCT01660451|38013933|FG000|Overall Study|Ongoing with treatment|3|||
16905593|NCT01660451|38013934|FG001|Overall Study|Ongoing with treatment|3|||
16905594|NCT01660451|38013935|FG002|Overall Study|Ongoing with treatment|46|||
16905595|NCT00001259|38013965|FG000|Study 2|Adverse Event|0|||
16905596|NCT00001259|38013966|FG001|Study 2|Adverse Event|0|||
16905597|NCT00001259|38013967|FG002|Study 2|Adverse Event|0|||
16905598|NCT00001259|38013968|FG003|Study 2|Adverse Event|0|||
16905599|NCT00001259|38013969|FG004|Study 2|Adverse Event|2|||
16905600|NCT00001259|38013970|FG005|Study 2|Adverse Event|0|||
16905601|NCT00001259|38013971|FG006|Study 2|Adverse Event|0|||
16905602|NCT01926444|38013985|FG000|Overall Study|Colonoscopy not performed|0|||
16905603|NCT01926444|38013986|FG001|Overall Study|Colonoscopy not performed|0|||
16905604|NCT01926444|38013987|FG002|Overall Study|Colonoscopy not performed|4|||
16905605|NCT01926444|38013988|FG003|Overall Study|Colonoscopy not performed|2|||
16905606|NCT01597908|38014004|FG000|Randomized Phase|Death|217|||
16905607|NCT01597908|38014005|FG001|Randomized Phase|Death|238|||
16905608|NCT01597908|38014006|FG002|Randomized Phase|Death|0|||
16905609|NCT01597908|38014004|FG000|Randomized Phase|Sponsor Decision|93|||
16905610|NCT01597908|38014005|FG001|Randomized Phase|Sponsor Decision|39|||
16905611|NCT01597908|38014006|FG002|Randomized Phase|Sponsor Decision|0|||
16905612|NCT01597908|38014004|FG000|Randomized Phase|Lost to Follow-up|9|||
16905613|NCT01597908|38014005|FG001|Randomized Phase|Lost to Follow-up|16|||
16905614|NCT01597908|38014006|FG002|Randomized Phase|Lost to Follow-up|0|||
16905615|NCT01597908|38014004|FG000|Randomized Phase|Physician Decision|6|||
16905616|NCT01597908|38014005|FG001|Randomized Phase|Physician Decision|3|||
16905617|NCT01597908|38014006|FG002|Randomized Phase|Physician Decision|0|||
16905618|NCT01597908|38014004|FG000|Randomized Phase|Withdrawal by Subject|26|||
16905619|NCT01597908|38014005|FG001|Randomized Phase|Withdrawal by Subject|22|||
16905620|NCT01597908|38014006|FG002|Randomized Phase|Withdrawal by Subject|0|||
16905621|NCT01597908|38014004|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
16905622|NCT01597908|38014005|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
16905623|NCT01597908|38014006|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
16905624|NCT01597908|38014004|FG000|Crossover Phase|Death|0|||
16905625|NCT01597908|38014005|FG001|Crossover Phase|Death|0|||
16905626|NCT01597908|38014006|FG002|Crossover Phase|Death|11|||
16905627|NCT01597908|38014004|FG000|Crossover Phase|Withdrawal by Subject|0|||
16905628|NCT01597908|38014005|FG001|Crossover Phase|Withdrawal by Subject|0|||
16905629|NCT01597908|38014006|FG002|Crossover Phase|Withdrawal by Subject|3|||
16905630|NCT01597908|38014004|FG000|Crossover Phase|Sponsor Decision|0|||
17006683|NCT00950807|38150418|FG008|Washout Period 1|Adverse Event|0|||
17006684|NCT00950807|38150419|FG009|Washout Period 1|Adverse Event|0|||
17006685|NCT00950807|38150410|FG000|Treatment Period 2|Lack of Efficacy|1|||
17006686|NCT00950807|38150411|FG001|Treatment Period 2|Lack of Efficacy|0|||
17006687|NCT00950807|38150412|FG002|Treatment Period 2|Lack of Efficacy|0|||
17006688|NCT00950807|38150413|FG003|Treatment Period 2|Lack of Efficacy|0|||
17006689|NCT00950807|38150414|FG004|Treatment Period 2|Lack of Efficacy|0|||
17006690|NCT00950807|38150415|FG005|Treatment Period 2|Lack of Efficacy|0|||
16905631|NCT01597908|38014005|FG001|Crossover Phase|Sponsor Decision|0|||
16905632|NCT01597908|38014006|FG002|Crossover Phase|Sponsor Decision|20|||
16905633|NCT01951170|38014015|FG000|Overall Study|Investigator decision|1|||
16905634|NCT01951092|38014019|FG000|Overall Study|Lost to Follow-up|10|||
16905635|NCT01951092|38014019|FG000|Overall Study|Incarceration|1|||
16905636|NCT01951092|38014019|FG000|Overall Study|Transfer of Care|1|||
16905637|NCT01949532|38014025|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
16905638|NCT01949532|38014026|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
16905639|NCT01949142|38014034|FG000|Overall Study|Withdrawal of consent|1|||
16905640|NCT01949142|38014035|FG001|Overall Study|Withdrawal of consent|0|||
16905641|NCT01949142|38014034|FG000|Overall Study|Lost to Follow-up|1|||
16905642|NCT01949142|38014035|FG001|Overall Study|Lost to Follow-up|1|||
16905643|NCT01949142|38014034|FG000|Overall Study|Parent changed their mind|1|||
16905644|NCT01949142|38014035|FG001|Overall Study|Parent changed their mind|0|||
16905645|NCT01948908|38014045|FG000|Overall Study|Protocol Violation|1|||
16905646|NCT01948908|38014046|FG001|Overall Study|Protocol Violation|0|||
16905647|NCT01948908|38014047|FG002|Overall Study|Protocol Violation|2|||
16905648|NCT01925274|38014058|FG000|Overall Study|Death|1|||
16905649|NCT01925274|38014059|FG001|Overall Study|Death|0|||
16905650|NCT01925274|38014060|FG002|Overall Study|Death|0|||
16905651|NCT01925274|38014058|FG000|Overall Study|Lost to Follow-up|0|||
16905652|NCT01925274|38014059|FG001|Overall Study|Lost to Follow-up|1|||
16905653|NCT01925274|38014060|FG002|Overall Study|Lost to Follow-up|0|||
16905654|NCT01925274|38014058|FG000|Overall Study|Withdrawal by Subject|1|||
16905655|NCT01925274|38014059|FG001|Overall Study|Withdrawal by Subject|2|||
16905656|NCT01925274|38014060|FG002|Overall Study|Withdrawal by Subject|0|||
16905657|NCT01925274|38014058|FG000|Overall Study|Study terminated by sponsor|4|||
16905658|NCT01925274|38014059|FG001|Overall Study|Study terminated by sponsor|0|||
16905659|NCT01925274|38014060|FG002|Overall Study|Study terminated by sponsor|0|||
16905660|NCT01925274|38014058|FG000|Overall Study|Protocol amendment|1|||
16905661|NCT01925274|38014059|FG001|Overall Study|Protocol amendment|3|||
16905662|NCT01925274|38014060|FG002|Overall Study|Protocol amendment|6|||
16905663|NCT01948830|38014072|FG000|Overall Study|Physician Decision|1|||
16905664|NCT01948830|38014073|FG001|Overall Study|Physician Decision|3|||
16905665|NCT01948830|38014072|FG000|Overall Study|Protocol deviation|1|||
16905666|NCT01948830|38014073|FG001|Overall Study|Protocol deviation|2|||
16905667|NCT01948830|38014072|FG000|Overall Study|Lost to Follow-up|5|||
16905668|NCT01948830|38014073|FG001|Overall Study|Lost to Follow-up|4|||
16905669|NCT01948830|38014072|FG000|Overall Study|Withdrawal by Subject|14|||
16905670|NCT01948830|38014073|FG001|Overall Study|Withdrawal by Subject|17|||
16905671|NCT01948830|38014072|FG000|Overall Study|Adverse Event|9|||
16905672|NCT01948830|38014073|FG001|Overall Study|Adverse Event|2|||
16905673|NCT01948830|38014072|FG000|Overall Study|Death|3|||
16905674|NCT01948830|38014073|FG001|Overall Study|Death|4|||
16905675|NCT01972464|38014081|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
16905676|NCT01972464|38014082|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
16905677|NCT01972464|38014081|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
16905678|NCT01972464|38014082|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
16905679|NCT01972464|38014081|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
16905680|NCT01972464|38014082|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
17006691|NCT00950807|38150416|FG006|Treatment Period 2|Lack of Efficacy|0|||
17006692|NCT00950807|38150417|FG007|Treatment Period 2|Lack of Efficacy|0|||
17006693|NCT00950807|38150418|FG008|Treatment Period 2|Lack of Efficacy|0|||
17006694|NCT00950807|38150419|FG009|Treatment Period 2|Lack of Efficacy|0|||
17006695|NCT00950807|38150410|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17006696|NCT00950807|38150411|FG001|Treatment Period 2|Withdrawal by Subject|0|||
17006697|NCT00950807|38150412|FG002|Treatment Period 2|Withdrawal by Subject|0|||
17006698|NCT00950807|38150413|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16905681|NCT01972464|38014081|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
16905682|NCT01972464|38014082|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
16905683|NCT01948050|38014091|FG000|Overall Study|Withdrawal by Subject|0|||
16905684|NCT01948050|38014092|FG001|Overall Study|Withdrawal by Subject|1|||
16905685|NCT01947894|38014101|FG000|Overall Study|Other|3|||
16905686|NCT01947894|38014102|FG001|Overall Study|Other|4|||
16905687|NCT01947894|38014103|FG002|Overall Study|Other|3|||
16905688|NCT01947894|38014101|FG000|Overall Study|Withdrawal by Subject|12|||
16905689|NCT01947894|38014102|FG001|Overall Study|Withdrawal by Subject|4|||
16905690|NCT01947894|38014103|FG002|Overall Study|Withdrawal by Subject|1|||
16905691|NCT01947894|38014101|FG000|Overall Study|Death|12|||
16905692|NCT01947894|38014102|FG001|Overall Study|Death|1|||
16905693|NCT01947894|38014103|FG002|Overall Study|Death|0|||
16905694|NCT01947894|38014101|FG000|Overall Study|Physician Decision|2|||
16905695|NCT01947894|38014102|FG001|Overall Study|Physician Decision|0|||
16905696|NCT01947894|38014103|FG002|Overall Study|Physician Decision|0|||
16905697|NCT01947894|38014101|FG000|Overall Study|Adverse Event|5|||
16905698|NCT01947894|38014102|FG001|Overall Study|Adverse Event|1|||
16905699|NCT01947894|38014103|FG002|Overall Study|Adverse Event|0|||
16905700|NCT01947894|38014101|FG000|Overall Study|Switched to other growth hormone brand|53|||
16905701|NCT01947894|38014102|FG001|Overall Study|Switched to other growth hormone brand|8|||
16905702|NCT01947894|38014103|FG002|Overall Study|Switched to other growth hormone brand|23|||
16905703|NCT01947582|38014111|FG000|Overall Study|Withdrawal by Subject|1|||
17006699|NCT00950807|38150414|FG004|Treatment Period 2|Withdrawal by Subject|0|||
17006700|NCT00950807|38150415|FG005|Treatment Period 2|Withdrawal by Subject|0|||
17006701|NCT00950807|38150416|FG006|Treatment Period 2|Withdrawal by Subject|1|||
17006702|NCT00950807|38150417|FG007|Treatment Period 2|Withdrawal by Subject|2|||
17006703|NCT00950807|38150418|FG008|Treatment Period 2|Withdrawal by Subject|0|||
17006704|NCT00950807|38150419|FG009|Treatment Period 2|Withdrawal by Subject|0|||
17006705|NCT00950807|38150410|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
17006706|NCT00950807|38150411|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
17006707|NCT00950807|38150412|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
17006708|NCT00950807|38150413|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
17006709|NCT00950807|38150414|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
17006710|NCT00950807|38150415|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
17006711|NCT00950807|38150416|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16905704|NCT01924806|38014117|FG000|Overall Study|Physician Decision|2|||
16905705|NCT01924806|38014118|FG001|Overall Study|Physician Decision|1|||
16905706|NCT01924182|38014126|FG000|Overall Study|Withdrawal by Subject|1|||
16905707|NCT01924182|38014127|FG001|Overall Study|Withdrawal by Subject|0|||
16905708|NCT01972308|38014135|FG000|Overall Study|Withdrawal by Subject|0|||
16905709|NCT01972308|38014136|FG001|Overall Study|Withdrawal by Subject|1|||
16905710|NCT01972308|38014135|FG000|Overall Study|Lost to Follow-up|4|||
16905711|NCT01972308|38014136|FG001|Overall Study|Lost to Follow-up|6|||
16905712|NCT01972308|38014135|FG000|Overall Study|Death|4|||
16905713|NCT01972308|38014136|FG001|Overall Study|Death|1|||
16905714|NCT01946880|38014146|FG000|Overall Study|Lost to Follow-up|1|||
16905715|NCT01946880|38014147|FG001|Overall Study|Lost to Follow-up|0|||
16905716|NCT01946880|38014146|FG000|Overall Study|Physician Decision|1|||
16905717|NCT01946880|38014147|FG001|Overall Study|Physician Decision|1|||
16905718|NCT01946880|38014146|FG000|Overall Study|Withdrawal by Subject|3|||
16905719|NCT01946880|38014147|FG001|Overall Study|Withdrawal by Subject|2|||
16905720|NCT01946880|38014146|FG000|Overall Study|Met Primary Endpoint|1|||
16905721|NCT01946880|38014147|FG001|Overall Study|Met Primary Endpoint|0|||
16905722|NCT01946880|38014146|FG000|Overall Study|Personal and Family Issues|1|||
16905723|NCT01946880|38014147|FG001|Overall Study|Personal and Family Issues|0|||
16905724|NCT01972152|38014153|FG000|First Treatment Visit|Lost to Follow-up|0|||
16905725|NCT01972152|38014154|FG001|First Treatment Visit|Lost to Follow-up|1|||
16905726|NCT01972152|38014155|FG002|First Treatment Visit|Lost to Follow-up|0|||
16905727|NCT01972152|38014156|FG003|First Treatment Visit|Lost to Follow-up|0|||
16905728|NCT01972152|38014157|FG004|First Treatment Visit|Lost to Follow-up|0|||
16905729|NCT01972152|38014158|FG005|First Treatment Visit|Lost to Follow-up|0|||
16905730|NCT01972152|38014153|FG000|Second Treatment Visit|Protocol Violation|0|||
16905731|NCT01972152|38014154|FG001|Second Treatment Visit|Protocol Violation|1|||
16905732|NCT01972152|38014155|FG002|Second Treatment Visit|Protocol Violation|0|||
16905733|NCT01972152|38014156|FG003|Second Treatment Visit|Protocol Violation|0|||
16905734|NCT01972152|38014157|FG004|Second Treatment Visit|Protocol Violation|0|||
16905735|NCT01972152|38014158|FG005|Second Treatment Visit|Protocol Violation|0|||
16905736|NCT01972074|38014172|FG000|Overall Study|Adverse Event|4|||
17006712|NCT00950807|38150417|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
17006713|NCT00950807|38150418|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16905737|NCT01972074|38014173|FG001|Overall Study|Adverse Event|1|||
16905738|NCT01972074|38014174|FG002|Overall Study|Adverse Event|0|||
16905739|NCT01972074|38014172|FG000|Overall Study|Lack of Efficacy|1|||
16905740|NCT01972074|38014173|FG001|Overall Study|Lack of Efficacy|1|||
16905741|NCT01972074|38014174|FG002|Overall Study|Lack of Efficacy|0|||
16905742|NCT01972074|38014172|FG000|Overall Study|Lost to Follow-up|0|||
16905743|NCT01972074|38014173|FG001|Overall Study|Lost to Follow-up|1|||
16905744|NCT01972074|38014174|FG002|Overall Study|Lost to Follow-up|1|||
16905745|NCT01972074|38014172|FG000|Overall Study|Withdrawal by Subject|1|||
16905746|NCT01972074|38014173|FG001|Overall Study|Withdrawal by Subject|1|||
16905747|NCT01972074|38014174|FG002|Overall Study|Withdrawal by Subject|1|||
16905748|NCT01972074|38014172|FG000|Overall Study|Scanner Unavailable|0|||
16905749|NCT01972074|38014173|FG001|Overall Study|Scanner Unavailable|0|||
16905750|NCT01972074|38014174|FG002|Overall Study|Scanner Unavailable|1|||
16905751|NCT01970982|38014184|FG000|Overall Study|Withdrawal by Subject|0|||
16905752|NCT01970982|38014185|FG001|Overall Study|Withdrawal by Subject|0|||
16905753|NCT01970982|38014186|FG002|Overall Study|Withdrawal by Subject|2|||
16905754|NCT01946802|38014195|FG000|Overall Study|Death|1|||
16905755|NCT01946802|38014195|FG000|Overall Study|Withdrawal by Subject|2|||
16905756|NCT01946802|38014195|FG000|Overall Study|Combined septic shock|1|||
16905757|NCT01946802|38014195|FG000|Overall Study|Protocol Violation|1|||
16905758|NCT01618266|38014199|FG000|Overall Study|Lost to Follow-up|9|||
16905759|NCT01618266|38014199|FG000|Overall Study|Treatment satisfaction|10|||
16905760|NCT01618266|38014199|FG000|Overall Study|Other reasons|11|||
16905761|NCT01618266|38014199|FG000|Overall Study|Lack of Efficacy|23|||
16905762|NCT01618266|38014199|FG000|Overall Study|Protocol Violation|43|||
16905763|NCT01919112|38014206|FG000|Secondary Analysis-day 30|Death|1|||
16905764|NCT01919112|38014207|FG001|Secondary Analysis-day 30|Death|1|||
16905765|NCT01919112|38014208|FG002|Secondary Analysis-day 30|Death|1|||
16905766|NCT01919112|38014206|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
16905767|NCT01919112|38014207|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
16905768|NCT01919112|38014208|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
16905769|NCT01918332|38014220|FG000|Overall Study|Adverse Event|0|||
16905770|NCT01918332|38014221|FG001|Overall Study|Adverse Event|0|||
16905771|NCT01918332|38014222|FG002|Overall Study|Adverse Event|0|||
16905772|NCT01918332|38014223|FG003|Overall Study|Adverse Event|1|||
16905773|NCT01918332|38014220|FG000|Overall Study|Withdrawal by Subject|2|||
16905774|NCT01918332|38014221|FG001|Overall Study|Withdrawal by Subject|3|||
16905775|NCT01918332|38014222|FG002|Overall Study|Withdrawal by Subject|2|||
16905776|NCT01918332|38014223|FG003|Overall Study|Withdrawal by Subject|3|||
16905777|NCT01918332|38014220|FG000|Overall Study|Protocol Violation|6|||
16905778|NCT01918332|38014221|FG001|Overall Study|Protocol Violation|2|||
16905779|NCT01918332|38014222|FG002|Overall Study|Protocol Violation|6|||
17006714|NCT00950807|38150419|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
17006715|NCT00950807|38150410|FG000|Treatment Period 2|Adverse Event|0|||
17006716|NCT00950807|38150411|FG001|Treatment Period 2|Adverse Event|1|||
17006717|NCT00950807|38150412|FG002|Treatment Period 2|Adverse Event|0|||
17006718|NCT00950807|38150413|FG003|Treatment Period 2|Adverse Event|1|||
17006719|NCT00950807|38150414|FG004|Treatment Period 2|Adverse Event|0|||
17006720|NCT00950807|38150415|FG005|Treatment Period 2|Adverse Event|1|||
17006721|NCT00950807|38150416|FG006|Treatment Period 2|Adverse Event|0|||
17006722|NCT00950807|38150417|FG007|Treatment Period 2|Adverse Event|1|||
17006723|NCT00950807|38150418|FG008|Treatment Period 2|Adverse Event|0|||
17006724|NCT00950807|38150419|FG009|Treatment Period 2|Adverse Event|0|||
17006725|NCT00950807|38150410|FG000|Washout Period 2|Lack of Efficacy|1|||
17006726|NCT00950807|38150411|FG001|Washout Period 2|Lack of Efficacy|0|||
17006727|NCT00950807|38150412|FG002|Washout Period 2|Lack of Efficacy|0|||
17006728|NCT00950807|38150413|FG003|Washout Period 2|Lack of Efficacy|0|||
17006729|NCT00950807|38150414|FG004|Washout Period 2|Lack of Efficacy|0|||
17006730|NCT00950807|38150415|FG005|Washout Period 2|Lack of Efficacy|0|||
17006731|NCT00950807|38150416|FG006|Washout Period 2|Lack of Efficacy|0|||
17006732|NCT00950807|38150417|FG007|Washout Period 2|Lack of Efficacy|0|||
17006733|NCT00950807|38150418|FG008|Washout Period 2|Lack of Efficacy|0|||
17006734|NCT00950807|38150419|FG009|Washout Period 2|Lack of Efficacy|0|||
17006735|NCT00950807|38150410|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
17006736|NCT00950807|38150411|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
17006737|NCT00950807|38150412|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
17006738|NCT00950807|38150413|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
17006739|NCT00950807|38150414|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
17006740|NCT00950807|38150415|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
17006741|NCT00950807|38150416|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
17095741|NCT00162266|38234982|FG003|Double-Blind Period|Withdrawal by Subject|0|||
17006742|NCT00950807|38150417|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
17006743|NCT00950807|38150418|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
16905780|NCT01918332|38014223|FG003|Overall Study|Protocol Violation|3|||
16905781|NCT01918332|38014220|FG000|Overall Study|lipid result by central lab did not meet|0|||
16905782|NCT01918332|38014221|FG001|Overall Study|lipid result by central lab did not meet|0|||
16905783|NCT01918332|38014222|FG002|Overall Study|lipid result by central lab did not meet|1|||
16905784|NCT01918332|38014223|FG003|Overall Study|lipid result by central lab did not meet|0|||
16905785|NCT01922934|38014235|FG000|Eligible Patients|Death|0|||
16905786|NCT01922934|38014236|FG001|Eligible Patients|Death|7|||
16905787|NCT01922934|38014235|FG000|Eligible Patients|Physician Decision|17|||
16905788|NCT01922934|38014236|FG001|Eligible Patients|Physician Decision|0|||
16905789|NCT01922934|38014235|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
16905790|NCT01922934|38014236|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
16905791|NCT01922934|38014235|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
16905792|NCT01922934|38014236|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
16905793|NCT01922934|38014235|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
16905794|NCT01922934|38014236|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
16905795|NCT01922934|38014235|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
16905796|NCT01922934|38014236|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
16905797|NCT01970592|38014244|FG000|Overall Study|Withdrawal by Subject|4|||
16905798|NCT01970592|38014244|FG000|Overall Study|Physician Decision|1|||
16905799|NCT01970592|38014244|FG000|Overall Study|Adverse Event|1|||
16905800|NCT01920594|38014250|FG000|Overall Study|Adverse Event|4|||
16905801|NCT01920594|38014251|FG001|Overall Study|Adverse Event|2|||
16905802|NCT01920594|38014250|FG000|Overall Study|Lost to Follow-up|1|||
16905803|NCT01920594|38014251|FG001|Overall Study|Lost to Follow-up|0|||
16905804|NCT01920594|38014250|FG000|Overall Study|Recovery|2|||
16905805|NCT01920594|38014251|FG001|Overall Study|Recovery|0|||
16905806|NCT01920594|38014250|FG000|Overall Study|Investigator discretion|0|||
16905807|NCT01920594|38014251|FG001|Overall Study|Investigator discretion|1|||
16905808|NCT01917084|38014257|FG000|Overall Study|Withdrawal by Subject|1|||
16905809|NCT01917006|38014268|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
16905810|NCT01917006|38014269|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
16905811|NCT01917006|38014270|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
16905812|NCT01917006|38014271|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
16905813|NCT01917006|38014272|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
16905814|NCT01917006|38014273|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
16905815|NCT01917006|38014274|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
16905816|NCT01917006|38014275|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
16905817|NCT01917006|38014268|FG000|Randomized-treatment Period|Personal Reasons|0|||
16905818|NCT01917006|38014269|FG001|Randomized-treatment Period|Personal Reasons|0|||
16905819|NCT01917006|38014270|FG002|Randomized-treatment Period|Personal Reasons|0|||
16905820|NCT01917006|38014271|FG003|Randomized-treatment Period|Personal Reasons|0|||
16905821|NCT01917006|38014272|FG004|Randomized-treatment Period|Personal Reasons|0|||
16905822|NCT01917006|38014273|FG005|Randomized-treatment Period|Personal Reasons|1|||
16905823|NCT01917006|38014274|FG006|Randomized-treatment Period|Personal Reasons|0|||
17006744|NCT00950807|38150419|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
17006745|NCT00950807|38150410|FG000|Washout Period 2|Adverse Event|3|||
17006746|NCT00950807|38150411|FG001|Washout Period 2|Adverse Event|0|||
17006747|NCT00950807|38150412|FG002|Washout Period 2|Adverse Event|0|||
17006748|NCT00950807|38150413|FG003|Washout Period 2|Adverse Event|1|||
17006749|NCT00950807|38150414|FG004|Washout Period 2|Adverse Event|0|||
17006750|NCT00950807|38150415|FG005|Washout Period 2|Adverse Event|0|||
17006751|NCT00950807|38150416|FG006|Washout Period 2|Adverse Event|0|||
17006752|NCT00950807|38150417|FG007|Washout Period 2|Adverse Event|0|||
17006753|NCT00950807|38150418|FG008|Washout Period 2|Adverse Event|0|||
17006754|NCT00950807|38150419|FG009|Washout Period 2|Adverse Event|0|||
17006755|NCT00950807|38150410|FG000|Treatment Period 3|Withdrawal by Subject|0|||
17006756|NCT00950807|38150411|FG001|Treatment Period 3|Withdrawal by Subject|0|||
17006757|NCT00950807|38150412|FG002|Treatment Period 3|Withdrawal by Subject|0|||
17006758|NCT00950807|38150413|FG003|Treatment Period 3|Withdrawal by Subject|0|||
17006759|NCT00950807|38150414|FG004|Treatment Period 3|Withdrawal by Subject|0|||
17006760|NCT00950807|38150415|FG005|Treatment Period 3|Withdrawal by Subject|0|||
17006761|NCT00950807|38150416|FG006|Treatment Period 3|Withdrawal by Subject|0|||
17006762|NCT00950807|38150417|FG007|Treatment Period 3|Withdrawal by Subject|0|||
17006763|NCT00950807|38150418|FG008|Treatment Period 3|Withdrawal by Subject|0|||
17006764|NCT00950807|38150419|FG009|Treatment Period 3|Withdrawal by Subject|1|||
17006765|NCT00950807|38150410|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
17006766|NCT00950807|38150411|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
17006767|NCT00950807|38150412|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
17006768|NCT00950807|38150413|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
17006769|NCT00950807|38150414|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
17006770|NCT00950807|38150415|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
17006771|NCT00950807|38150416|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
17006772|NCT00950807|38150417|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
17095742|NCT00162266|38234979|FG000|Open-Label Period|Death|0|||
17095743|NCT00162266|38234980|FG001|Open-Label Period|Death|0|||
17095744|NCT00162266|38234981|FG002|Open-Label Period|Death|0|||
16905824|NCT01917006|38014275|FG007|Randomized-treatment Period|Personal Reasons|0|||
16905825|NCT01917006|38014268|FG000|Randomized-treatment Period|Protocol Violation|1|||
16905826|NCT01917006|38014269|FG001|Randomized-treatment Period|Protocol Violation|0|||
16905827|NCT01917006|38014270|FG002|Randomized-treatment Period|Protocol Violation|0|||
16905828|NCT01917006|38014271|FG003|Randomized-treatment Period|Protocol Violation|0|||
16905829|NCT01917006|38014272|FG004|Randomized-treatment Period|Protocol Violation|0|||
16905830|NCT01917006|38014273|FG005|Randomized-treatment Period|Protocol Violation|0|||
16905831|NCT01917006|38014274|FG006|Randomized-treatment Period|Protocol Violation|0|||
16905832|NCT01917006|38014275|FG007|Randomized-treatment Period|Protocol Violation|0|||
16905833|NCT01917006|38014268|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16905834|NCT01917006|38014269|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16905835|NCT01917006|38014270|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16905836|NCT01917006|38014271|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16905837|NCT01917006|38014272|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16905838|NCT01917006|38014273|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16905839|NCT01917006|38014274|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
17095745|NCT00162266|38234982|FG003|Open-Label Period|Death|7|||
17095746|NCT00162266|38234979|FG000|Open-Label Period|Adverse Event|0|||
17095747|NCT00162266|38234980|FG001|Open-Label Period|Adverse Event|0|||
17095748|NCT00162266|38234981|FG002|Open-Label Period|Adverse Event|0|||
17095749|NCT00162266|38234982|FG003|Open-Label Period|Adverse Event|46|||
17095750|NCT00162266|38234979|FG000|Open-Label Period|Lack of Efficacy|0|||
17095751|NCT00162266|38234980|FG001|Open-Label Period|Lack of Efficacy|0|||
17095752|NCT00162266|38234981|FG002|Open-Label Period|Lack of Efficacy|0|||
17095753|NCT00162266|38234982|FG003|Open-Label Period|Lack of Efficacy|26|||
17095754|NCT00162266|38234979|FG000|Open-Label Period|Lost to Follow-up|0|||
16905840|NCT01917006|38014275|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16905841|NCT01917006|38014268|FG000|Open-label Period|Adverse Event|0|||
16905842|NCT01917006|38014269|FG001|Open-label Period|Adverse Event|0|||
16905843|NCT01917006|38014270|FG002|Open-label Period|Adverse Event|0|||
16905844|NCT01917006|38014271|FG003|Open-label Period|Adverse Event|0|||
16905845|NCT01917006|38014272|FG004|Open-label Period|Adverse Event|0|||
16905846|NCT01917006|38014273|FG005|Open-label Period|Adverse Event|0|||
16905847|NCT01917006|38014274|FG006|Open-label Period|Adverse Event|0|||
16905848|NCT01917006|38014275|FG007|Open-label Period|Adverse Event|1|||
16905849|NCT01917006|38014268|FG000|Open-label Period|Lost to Follow-up|0|||
16905850|NCT01917006|38014269|FG001|Open-label Period|Lost to Follow-up|0|||
16905851|NCT01917006|38014270|FG002|Open-label Period|Lost to Follow-up|0|||
16905852|NCT01917006|38014271|FG003|Open-label Period|Lost to Follow-up|0|||
16905853|NCT01917006|38014272|FG004|Open-label Period|Lost to Follow-up|0|||
16905854|NCT01917006|38014273|FG005|Open-label Period|Lost to Follow-up|0|||
16905855|NCT01917006|38014274|FG006|Open-label Period|Lost to Follow-up|0|||
16905856|NCT01917006|38014275|FG007|Open-label Period|Lost to Follow-up|1|||
16905857|NCT01916304|38014292|FG000|Overall Study|Screening failure|17|||
16905858|NCT01916226|38014300|FG000|Overall Study|Adverse Event|1|||
16905859|NCT01916226|38014301|FG001|Overall Study|Adverse Event|0|||
16905860|NCT01916226|38014302|FG002|Overall Study|Adverse Event|1|||
16905861|NCT01916226|38014303|FG003|Overall Study|Adverse Event|1|||
16905862|NCT01916226|38014300|FG000|Overall Study|Lack of Efficacy|0|||
16905863|NCT01916226|38014301|FG001|Overall Study|Lack of Efficacy|0|||
16905864|NCT01916226|38014302|FG002|Overall Study|Lack of Efficacy|2|||
16905865|NCT01916226|38014303|FG003|Overall Study|Lack of Efficacy|1|||
16905866|NCT01916226|38014300|FG000|Overall Study|Protocol Violation|0|||
16905867|NCT01916226|38014301|FG001|Overall Study|Protocol Violation|1|||
16905868|NCT01916226|38014302|FG002|Overall Study|Protocol Violation|0|||
16905869|NCT01916226|38014303|FG003|Overall Study|Protocol Violation|1|||
16905870|NCT01916226|38014300|FG000|Overall Study|Physician Decision|0|||
16905871|NCT01916226|38014301|FG001|Overall Study|Physician Decision|0|||
16905872|NCT01916226|38014302|FG002|Overall Study|Physician Decision|0|||
16905873|NCT01916226|38014303|FG003|Overall Study|Physician Decision|1|||
16905874|NCT01969500|38014316|FG000|Overall Study|Death|0|||
16905875|NCT01969500|38014317|FG001|Overall Study|Death|1|||
16905876|NCT01969500|38014316|FG000|Overall Study|extended hospitalization|1|||
16905877|NCT01969500|38014317|FG001|Overall Study|extended hospitalization|1|||
16905878|NCT01915914|38014323|FG000|Acute Phase|Withdrawal by Subject|4|||
16905879|NCT01915914|38014324|FG001|Acute Phase|Withdrawal by Subject|0|||
16905880|NCT01915914|38014325|FG002|Acute Phase|Withdrawal by Subject|0|||
16905881|NCT01915914|38014326|FG003|Acute Phase|Withdrawal by Subject|0|||
16905882|NCT01915914|38014323|FG000|Acute Phase|Lost to Follow-up|4|||
16905883|NCT01915914|38014324|FG001|Acute Phase|Lost to Follow-up|0|||
17095755|NCT00162266|38234980|FG001|Open-Label Period|Lost to Follow-up|0|||
17095756|NCT00162266|38234981|FG002|Open-Label Period|Lost to Follow-up|0|||
16905884|NCT01915914|38014325|FG002|Acute Phase|Lost to Follow-up|0|||
16905885|NCT01915914|38014326|FG003|Acute Phase|Lost to Follow-up|0|||
16905886|NCT01915914|38014323|FG000|Acute Phase|Physician Decision|1|||
16905887|NCT01915914|38014324|FG001|Acute Phase|Physician Decision|0|||
16905888|NCT01915914|38014325|FG002|Acute Phase|Physician Decision|0|||
16905889|NCT01915914|38014326|FG003|Acute Phase|Physician Decision|0|||
16905890|NCT01915914|38014323|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
16905891|NCT01915914|38014324|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
16905892|NCT01915914|38014325|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
16905893|NCT01915914|38014326|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
16905894|NCT01915914|38014323|FG000|Acute Phase|"Not Achieved treatment success"|1|||
16905895|NCT01915914|38014324|FG001|Acute Phase|"Not Achieved treatment success"|0|||
16905896|NCT01915914|38014325|FG002|Acute Phase|"Not Achieved treatment success"|0|||
16905897|NCT01915914|38014326|FG003|Acute Phase|"Not Achieved treatment success"|0|||
16905898|NCT01915914|38014323|FG000|Acute Phase|Missing|1|||
16905899|NCT01915914|38014324|FG001|Acute Phase|Missing|0|||
16905900|NCT01915914|38014325|FG002|Acute Phase|Missing|0|||
16905901|NCT01915914|38014326|FG003|Acute Phase|Missing|0|||
16905902|NCT01915914|38014323|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16905903|NCT01915914|38014324|FG001|Maintenance Phase|Withdrawal by Subject|1|||
16905904|NCT01915914|38014325|FG002|Maintenance Phase|Withdrawal by Subject|1|||
16905905|NCT01915914|38014326|FG003|Maintenance Phase|Withdrawal by Subject|0|||
16905906|NCT01915914|38014323|FG000|Maintenance Phase|Lost to Follow-up|0|||
16905907|NCT01915914|38014324|FG001|Maintenance Phase|Lost to Follow-up|4|||
16905908|NCT01915914|38014325|FG002|Maintenance Phase|Lost to Follow-up|1|||
16905909|NCT01915914|38014326|FG003|Maintenance Phase|Lost to Follow-up|0|||
16905910|NCT01915914|38014323|FG000|Maintenance Phase|Missing|0|||
16905911|NCT01915914|38014324|FG001|Maintenance Phase|Missing|1|||
16905912|NCT01915914|38014325|FG002|Maintenance Phase|Missing|0|||
16905913|NCT01915914|38014326|FG003|Maintenance Phase|Missing|0|||
16905914|NCT01915914|38014323|FG000|Follow-up Phase|Withdrawal by Subject|0|||
16905915|NCT01915914|38014324|FG001|Follow-up Phase|Withdrawal by Subject|0|||
16905916|NCT01915914|38014325|FG002|Follow-up Phase|Withdrawal by Subject|0|||
16905917|NCT01915914|38014326|FG003|Follow-up Phase|Withdrawal by Subject|1|||
16905918|NCT01915914|38014323|FG000|Follow-up Phase|Physician Decision|0|||
16905919|NCT01915914|38014324|FG001|Follow-up Phase|Physician Decision|0|||
16905920|NCT01915914|38014325|FG002|Follow-up Phase|Physician Decision|0|||
16905921|NCT01915914|38014326|FG003|Follow-up Phase|Physician Decision|1|||
16905922|NCT01919970|38014346|FG000|Overall Study|Withdrawal by Subject|3|||
16905923|NCT01919970|38014347|FG001|Overall Study|Withdrawal by Subject|0|||
16905924|NCT01919814|38014353|FG000|Overall Study|Adverse Event|1|||
16905925|NCT01919814|38014354|FG001|Overall Study|Adverse Event|0|||
16905926|NCT01919814|38014353|FG000|Overall Study|Protocol Violation|1|||
16905927|NCT01919814|38014354|FG001|Overall Study|Protocol Violation|0|||
16905928|NCT01919814|38014353|FG000|Overall Study|Withdrawal by Subject|1|||
16905929|NCT01919814|38014354|FG001|Overall Study|Withdrawal by Subject|0|||
16905930|NCT01968954|38014362|FG000|Overall Study|Adverse Event|6|||
16905931|NCT01968954|38014363|FG001|Overall Study|Adverse Event|3|||
16905932|NCT01968954|38014362|FG000|Overall Study|Death|1|||
16905933|NCT01968954|38014363|FG001|Overall Study|Death|2|||
16905934|NCT01968954|38014362|FG000|Overall Study|Lost to Follow-up|6|||
16905935|NCT01968954|38014363|FG001|Overall Study|Lost to Follow-up|4|||
16905936|NCT01968954|38014362|FG000|Overall Study|Withdrawal by Subject|20|||
16905937|NCT01968954|38014363|FG001|Overall Study|Withdrawal by Subject|23|||
16905938|NCT01968954|38014362|FG000|Overall Study|Other|7|||
16905939|NCT01968954|38014363|FG001|Overall Study|Other|8|||
16905940|NCT01968954|38014362|FG000|Overall Study|Protocol Violation|0|||
16905941|NCT01968954|38014363|FG001|Overall Study|Protocol Violation|1|||
16905942|NCT01968954|38014362|FG000|Overall Study|Did not met inclusion criteria|0|||
16905943|NCT01968954|38014363|FG001|Overall Study|Did not met inclusion criteria|2|||
16905944|NCT01919190|38014372|FG000|Overall Study|Intra-op findings, etc.|3|||
16905945|NCT01919190|38014373|FG001|Overall Study|Intra-op findings, etc.|0|||
16905946|NCT01620060|38014380|FG000|Overall Study|Adverse Event|9|||
16905947|NCT01620060|38014380|FG000|Overall Study|Protocol Violation|1|||
16905948|NCT01620060|38014380|FG000|Overall Study|Withdrawal by Subject|1|||
16905949|NCT01620060|38014380|FG000|Overall Study|Did not comply with Study Produre|1|||
16905950|NCT01620060|38014380|FG000|Overall Study|Family emergency|1|||
16905951|NCT01620060|38014380|FG000|Overall Study|Per Sponsor Decision|2|||
16905952|NCT01914666|38014387|FG000|Treatment Period|Lack of Efficacy|0|||
16905953|NCT01914666|38014388|FG001|Treatment Period|Lack of Efficacy|0|||
16905954|NCT01914666|38014389|FG002|Treatment Period|Lack of Efficacy|2|||
16905955|NCT01914666|38014387|FG000|Treatment Period|Adverse Event|10|||
16905956|NCT01914666|38014388|FG001|Treatment Period|Adverse Event|4|||
16905957|NCT01914666|38014389|FG002|Treatment Period|Adverse Event|2|||
16905958|NCT01914666|38014387|FG000|Treatment Period|Withdrawal by Subject|3|||
16905959|NCT01914666|38014388|FG001|Treatment Period|Withdrawal by Subject|2|||
16905960|NCT01914666|38014389|FG002|Treatment Period|Withdrawal by Subject|2|||
17095757|NCT00162266|38234982|FG003|Open-Label Period|Lost to Follow-up|3|||
17095758|NCT00162266|38234979|FG000|Open-Label Period|Withdrawal by Subject|0|||
16905961|NCT01914666|38014387|FG000|Treatment Period|Physician Decision|0|||
16905962|NCT01914666|38014388|FG001|Treatment Period|Physician Decision|0|||
16905963|NCT01914666|38014389|FG002|Treatment Period|Physician Decision|2|||
16905964|NCT01913340|38014397|FG000|Overall Study|Death|2|||
16905965|NCT01913340|38014398|FG001|Overall Study|Death|5|||
16905966|NCT01913340|38014397|FG000|Overall Study|Lost to Follow-up|1|||
16905967|NCT01913340|38014398|FG001|Overall Study|Lost to Follow-up|1|||
16905968|NCT01864200|38014406|FG000|Overall Study|Lost to Follow-up|1|||
16905969|NCT01864200|38014407|FG001|Overall Study|Lost to Follow-up|3|||
16905970|NCT01864200|38014406|FG000|Overall Study|Protocol Violation|1|||
16905971|NCT01864200|38014407|FG001|Overall Study|Protocol Violation|0|||
16905972|NCT01912872|38014417|FG000|Overall Study|Lost to Follow-up|2|||
16905973|NCT01912872|38014418|FG001|Overall Study|Lost to Follow-up|3|||
16905974|NCT01912872|38014419|FG002|Overall Study|Lost to Follow-up|5|||
16905975|NCT01912872|38014420|FG003|Overall Study|Lost to Follow-up|5|||
16905976|NCT01912872|38014417|FG000|Overall Study|Other unspecified|3|||
16905977|NCT01912872|38014418|FG001|Overall Study|Other unspecified|1|||
16905978|NCT01912872|38014419|FG002|Overall Study|Other unspecified|3|||
16905979|NCT01912872|38014420|FG003|Overall Study|Other unspecified|0|||
16905980|NCT01912872|38014417|FG000|Overall Study|Informed consent withdrawn|0|||
16905981|NCT01912872|38014418|FG001|Overall Study|Informed consent withdrawn|0|||
16905982|NCT01912872|38014419|FG002|Overall Study|Informed consent withdrawn|1|||
16905983|NCT01912872|38014420|FG003|Overall Study|Informed consent withdrawn|1|||
16905984|NCT01912872|38014417|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
16905985|NCT01912872|38014418|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
16905986|NCT01912872|38014419|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
16905987|NCT01912872|38014420|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
16905988|NCT01912872|38014417|FG000|Overall Study|Protocol Violation|0|||
16905989|NCT01912872|38014418|FG001|Overall Study|Protocol Violation|0|||
16905990|NCT01912872|38014419|FG002|Overall Study|Protocol Violation|1|||
16905991|NCT01912872|38014420|FG003|Overall Study|Protocol Violation|0|||
16905992|NCT01912872|38014417|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16905993|NCT01912872|38014418|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16905994|NCT01912872|38014419|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16905995|NCT01912872|38014420|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
16905996|NCT01912872|38014417|FG000|Overall Study|Withdrawal of study medication|0|||
16905997|NCT01912872|38014418|FG001|Overall Study|Withdrawal of study medication|0|||
16905998|NCT01912872|38014419|FG002|Overall Study|Withdrawal of study medication|0|||
16905999|NCT01912872|38014420|FG003|Overall Study|Withdrawal of study medication|2|||
16906000|NCT01912872|38014417|FG000|Overall Study|Missing|0|||
16906001|NCT01912872|38014418|FG001|Overall Study|Missing|0|||
16906002|NCT01912872|38014419|FG002|Overall Study|Missing|0|||
16906003|NCT01912872|38014420|FG003|Overall Study|Missing|1|||
16906004|NCT01912404|38014433|FG000|Overall Study|Due to personal reasons|1|||
16906005|NCT01912404|38014434|FG001|Overall Study|Due to personal reasons|0|||
16906006|NCT01911780|38014442|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
16906007|NCT01911780|38014443|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
16906008|NCT01911780|38014442|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
16906009|NCT01911780|38014443|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
16906010|NCT01911780|38014442|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
16906011|NCT01911780|38014443|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
16906012|NCT01911780|38014442|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
16906013|NCT01911780|38014443|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
16906014|NCT01911780|38014442|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
16906015|NCT01911780|38014443|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
16906016|NCT01911780|38014442|FG000|Extension Period (52 Weeks)|Personal reason|1|||
16906017|NCT01911780|38014443|FG001|Extension Period (52 Weeks)|Personal reason|1|||
16906018|NCT01911546|38014453|FG000|Overall Study|Lost to Follow-up|1|||
16906019|NCT01911546|38014453|FG000|Overall Study|Everolimus was discontinued|5|||
16906020|NCT01910298|38014459|FG000|Overall Study|Adverse Event|1|||
16906021|NCT01910298|38014460|FG001|Overall Study|Adverse Event|0|||
16906022|NCT01910298|38014459|FG000|Overall Study|Withdrawal by Subject|2|||
16906023|NCT01910298|38014460|FG001|Overall Study|Withdrawal by Subject|7|||
16906024|NCT01910298|38014459|FG000|Overall Study|Protocol Deviation|0|||
16906025|NCT01910298|38014460|FG001|Overall Study|Protocol Deviation|5|||
16906026|NCT01910298|38014459|FG000|Overall Study|Lost to Follow-up|1|||
16906027|NCT01910298|38014460|FG001|Overall Study|Lost to Follow-up|1|||
16906028|NCT01910298|38014459|FG000|Overall Study|Study Terminated by Sponsor|1|||
16906029|NCT01910298|38014460|FG001|Overall Study|Study Terminated by Sponsor|17|||
16906030|NCT01910298|38014459|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16906031|NCT01910298|38014460|FG001|Overall Study|Other Miscellaneous Reasons|2|||
16906032|NCT01909674|38014468|FG000|Overall Study|Withdrawal by Subject|5|||
16906033|NCT01909674|38014469|FG001|Overall Study|Withdrawal by Subject|2|||
16906034|NCT01908816|38014479|FG000|Overall Study|Subject's no longer requires study drug|0|||
16906035|NCT01908816|38014480|FG001|Overall Study|Subject's no longer requires study drug|0|||
16906036|NCT01908816|38014481|FG002|Overall Study|Subject's no longer requires study drug|0|||
16906037|NCT01908816|38014482|FG003|Overall Study|Subject's no longer requires study drug|1|||
16906038|NCT01908816|38014479|FG000|Overall Study|Protocol deviation|1|||
16906039|NCT01908816|38014480|FG001|Overall Study|Protocol deviation|2|||
16906040|NCT01908816|38014481|FG002|Overall Study|Protocol deviation|1|||
16906041|NCT01908816|38014482|FG003|Overall Study|Protocol deviation|1|||
17006773|NCT00950807|38150418|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
17006774|NCT00950807|38150419|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
17006775|NCT00950807|38150410|FG000|Treatment Period 3|Adverse Event|0|||
17006776|NCT00950807|38150411|FG001|Treatment Period 3|Adverse Event|0|||
16906042|NCT01908816|38014479|FG000|Overall Study|Withdrawal by Subject|0|||
16906043|NCT01908816|38014480|FG001|Overall Study|Withdrawal by Subject|4|||
16906044|NCT01908816|38014481|FG002|Overall Study|Withdrawal by Subject|2|||
16906045|NCT01908816|38014482|FG003|Overall Study|Withdrawal by Subject|2|||
16906046|NCT01908816|38014479|FG000|Overall Study|Lost to Follow-up|3|||
16906047|NCT01908816|38014480|FG001|Overall Study|Lost to Follow-up|5|||
16906048|NCT01908816|38014481|FG002|Overall Study|Lost to Follow-up|4|||
16906049|NCT01908816|38014482|FG003|Overall Study|Lost to Follow-up|2|||
16906050|NCT01908816|38014479|FG000|Overall Study|Death|1|||
16906051|NCT01908816|38014480|FG001|Overall Study|Death|0|||
16906052|NCT01908816|38014481|FG002|Overall Study|Death|7|||
16906053|NCT01908816|38014482|FG003|Overall Study|Death|1|||
16906054|NCT01908816|38014479|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16906055|NCT01908816|38014480|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
16906056|NCT01908816|38014481|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
16906057|NCT01908816|38014482|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16906058|NCT01908816|38014479|FG000|Overall Study|Early termination|87|||
16906059|NCT01908816|38014480|FG001|Overall Study|Early termination|60|||
16906060|NCT01908816|38014481|FG002|Overall Study|Early termination|43|||
16906061|NCT01908816|38014482|FG003|Overall Study|Early termination|28|||
16906062|NCT01908582|38014495|FG000|Period 2|Physician Decision|1|||
16906063|NCT01908582|38014495|FG000|Period 2|Withdrawal by Subject|1|||
16906064|NCT01908426|38014504|FG000|Overall Study|Adverse Event|98|||
16906065|NCT01908426|38014505|FG001|Overall Study|Adverse Event|11|||
16906066|NCT01908426|38014504|FG000|Overall Study|Clinical Deterioration|72|||
16906067|NCT01908426|38014505|FG001|Overall Study|Clinical Deterioration|38|||
16906068|NCT01908426|38014504|FG000|Overall Study|Lack of Efficacy|3|||
16906069|NCT01908426|38014505|FG001|Overall Study|Lack of Efficacy|0|||
16906070|NCT01908426|38014504|FG000|Overall Study|Lost to Follow-up|0|||
16906071|NCT01908426|38014505|FG001|Overall Study|Lost to Follow-up|1|||
16906072|NCT01908426|38014504|FG000|Overall Study|Physician Decision|3|||
16906073|NCT01908426|38014505|FG001|Overall Study|Physician Decision|3|||
16906074|NCT01908426|38014504|FG000|Overall Study|Withdrawal by Subject|11|||
16906075|NCT01908426|38014505|FG001|Overall Study|Withdrawal by Subject|6|||
16906076|NCT01908426|38014504|FG000|Overall Study|Progressive Disease|206|||
16906077|NCT01908426|38014505|FG001|Overall Study|Progressive Disease|152|||
16906078|NCT01908426|38014504|FG000|Overall Study|Protocol Violation|1|||
16906079|NCT01908426|38014505|FG001|Overall Study|Protocol Violation|0|||
16906080|NCT01908426|38014504|FG000|Overall Study|No Study Treatment Given|3|||
16906081|NCT01908426|38014505|FG001|Overall Study|No Study Treatment Given|0|||
16906082|NCT01907100|38014515|FG000|Overall Study|PD based on modified RECIST criteria|31|||
16906083|NCT01907100|38014516|FG001|Overall Study|PD based on modified RECIST criteria|32|||
16906084|NCT01907100|38014517|FG002|Overall Study|PD based on modified RECIST criteria|95|||
16906085|NCT01907100|38014518|FG003|Overall Study|PD based on modified RECIST criteria|92|||
16906086|NCT01907100|38014515|FG000|Overall Study|Withdrawal by Subject|2|||
16906087|NCT01907100|38014516|FG001|Overall Study|Withdrawal by Subject|5|||
16906088|NCT01907100|38014517|FG002|Overall Study|Withdrawal by Subject|10|||
16906089|NCT01907100|38014518|FG003|Overall Study|Withdrawal by Subject|13|||
16906090|NCT01907100|38014515|FG000|Overall Study|Protocol Violation|0|||
16906091|NCT01907100|38014516|FG001|Overall Study|Protocol Violation|0|||
16906092|NCT01907100|38014517|FG002|Overall Study|Protocol Violation|1|||
16906093|NCT01907100|38014518|FG003|Overall Study|Protocol Violation|1|||
16906094|NCT01907100|38014515|FG000|Overall Study|Lost to Follow-up|0|||
16906095|NCT01907100|38014516|FG001|Overall Study|Lost to Follow-up|0|||
16906096|NCT01907100|38014517|FG002|Overall Study|Lost to Follow-up|0|||
16906097|NCT01907100|38014518|FG003|Overall Study|Lost to Follow-up|1|||
16906098|NCT01907100|38014515|FG000|Overall Study|Not treated|2|||
16906099|NCT01907100|38014516|FG001|Overall Study|Not treated|0|||
16906100|NCT01907100|38014517|FG002|Overall Study|Not treated|1|||
16906101|NCT01907100|38014518|FG003|Overall Study|Not treated|2|||
16906102|NCT01907100|38014515|FG000|Overall Study|Other than reasons specified|1|||
16906103|NCT01907100|38014516|FG001|Overall Study|Other than reasons specified|0|||
16906104|NCT01907100|38014517|FG002|Overall Study|Other than reasons specified|10|||
16906105|NCT01907100|38014518|FG003|Overall Study|Other than reasons specified|6|||
16906106|NCT01907100|38014515|FG000|Overall Study|Adverse event (AE)|6|||
16906107|NCT01907100|38014516|FG001|Overall Study|Adverse event (AE)|3|||
16906108|NCT01907100|38014517|FG002|Overall Study|Adverse event (AE)|22|||
16906109|NCT01907100|38014518|FG003|Overall Study|Adverse event (AE)|23|||
16906110|NCT01907100|38014515|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
16906111|NCT01907100|38014516|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
16906112|NCT01907100|38014517|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
16906113|NCT01907100|38014518|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
16906114|NCT01889862|38014526|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
16906115|NCT01889862|38014527|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
16906116|NCT01889862|38014528|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
16906117|NCT01889862|38014529|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
16906118|NCT01889862|38014530|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
16906119|NCT01889862|38014526|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
16906120|NCT01889862|38014527|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
16906121|NCT01889862|38014528|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
16906122|NCT01889862|38014529|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
16906123|NCT01889862|38014530|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
16906124|NCT01889862|38014526|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
16906125|NCT01889862|38014527|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
16906126|NCT01889862|38014528|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
16906127|NCT01889862|38014529|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
16906128|NCT01889862|38014530|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
16906129|NCT01889862|38014526|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
16906130|NCT01889862|38014527|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
16906131|NCT01889862|38014528|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
16906132|NCT01889862|38014529|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
16906133|NCT01889862|38014530|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
16906134|NCT01889862|38014526|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
16906135|NCT01889862|38014527|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
16906136|NCT01889862|38014528|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
16906137|NCT01889862|38014529|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
16906138|NCT01889862|38014530|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
16906139|NCT01889862|38014526|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
16906140|NCT01889862|38014527|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
16906141|NCT01889862|38014528|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
16906142|NCT01889862|38014529|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
16906143|NCT01889862|38014530|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
16906144|NCT01889862|38014526|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
16906145|NCT01889862|38014527|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
16906146|NCT01889862|38014528|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
16906147|NCT01889862|38014529|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
16906148|NCT01889862|38014530|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
16906149|NCT01889862|38014526|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
16906150|NCT01889862|38014527|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
17006777|NCT00950807|38150412|FG002|Treatment Period 3|Adverse Event|0|||
17006778|NCT00950807|38150413|FG003|Treatment Period 3|Adverse Event|0|||
16906151|NCT01889862|38014528|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
16906152|NCT01889862|38014529|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
16906153|NCT01889862|38014530|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
16906154|NCT01889862|38014526|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
17006779|NCT00950807|38150414|FG004|Treatment Period 3|Adverse Event|0|||
17006780|NCT00950807|38150415|FG005|Treatment Period 3|Adverse Event|0|||
17006781|NCT00950807|38150416|FG006|Treatment Period 3|Adverse Event|1|||
17006782|NCT00950807|38150417|FG007|Treatment Period 3|Adverse Event|0|||
17006783|NCT00950807|38150418|FG008|Treatment Period 3|Adverse Event|0|||
17006784|NCT00950807|38150419|FG009|Treatment Period 3|Adverse Event|0|||
17006785|NCT00797511|38150441|FG000|Overall Study|Withdrawal by Subject|1|||
17006786|NCT00608881|38150448|FG000|Overall Study|Death|22|||
17006787|NCT00608881|38150449|FG001|Overall Study|Death|13|||
17006788|NCT00608881|38150448|FG000|Overall Study|Adverse Event|5|||
16906155|NCT01889862|38014527|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
16906156|NCT01889862|38014528|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
16906157|NCT01889862|38014529|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
16906158|NCT01889862|38014530|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
16906159|NCT01889862|38014526|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
16906160|NCT01889862|38014527|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
16906161|NCT01889862|38014528|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
16906162|NCT01889862|38014529|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
16906163|NCT01889862|38014530|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
16906164|NCT01887912|38014557|FG000|Overall Study|Serious adverse event|400|||
16906165|NCT01887912|38014558|FG001|Overall Study|Serious adverse event|198|||
16906166|NCT01887912|38014557|FG000|Overall Study|Other Adverse Event|34|||
16906167|NCT01887912|38014558|FG001|Overall Study|Other Adverse Event|15|||
16906168|NCT01887912|38014557|FG000|Overall Study|Protocol Violation|67|||
16906169|NCT01887912|38014558|FG001|Overall Study|Protocol Violation|37|||
16906170|NCT01887912|38014557|FG000|Overall Study|Lost to Follow-up|163|||
16906171|NCT01887912|38014558|FG001|Overall Study|Lost to Follow-up|74|||
16906172|NCT01887912|38014557|FG000|Overall Study|Withdrawal by Subject|606|||
17006789|NCT00608881|38150449|FG001|Overall Study|Adverse Event|3|||
17006790|NCT00608881|38150448|FG000|Overall Study|Lost to Follow-up|28|||
16906173|NCT01887912|38014558|FG001|Overall Study|Withdrawal by Subject|349|||
16906174|NCT01887912|38014557|FG000|Overall Study|Other|122|||
16906175|NCT01887912|38014558|FG001|Overall Study|Other|58|||
16906176|NCT01887678|38014566|FG000|Overall Study|Adverse Event|4|||
16906177|NCT01887678|38014567|FG001|Overall Study|Adverse Event|6|||
16906178|NCT01887678|38014566|FG000|Overall Study|Exceeded rescue medication dosage|4|||
16906179|NCT01887678|38014567|FG001|Overall Study|Exceeded rescue medication dosage|5|||
16906180|NCT01887678|38014566|FG000|Overall Study|Withdrawal of consent|3|||
16906181|NCT01887678|38014567|FG001|Overall Study|Withdrawal of consent|4|||
16906182|NCT01887678|38014566|FG000|Overall Study|Lost to Follow-up|4|||
16906183|NCT01887678|38014567|FG001|Overall Study|Lost to Follow-up|2|||
16906184|NCT01887678|38014566|FG000|Overall Study|Deterioration of clinical condition|0|||
16906185|NCT01887678|38014567|FG001|Overall Study|Deterioration of clinical condition|4|||
16906186|NCT01887678|38014566|FG000|Overall Study|Lack of Efficacy|1|||
16906187|NCT01887678|38014567|FG001|Overall Study|Lack of Efficacy|2|||
16906188|NCT01887678|38014566|FG000|Overall Study|Non-compliance|0|||
16906189|NCT01887678|38014567|FG001|Overall Study|Non-compliance|3|||
16906190|NCT01887678|38014566|FG000|Overall Study|Specified|1|||
16906191|NCT01887678|38014567|FG001|Overall Study|Specified|2|||
16906192|NCT01887600|38014575|FG000|Overall Study|Death|39|||
16906193|NCT01887600|38014576|FG001|Overall Study|Death|16|||
16906194|NCT01887600|38014575|FG000|Overall Study|Lack of Efficacy|3|||
16906195|NCT01887600|38014576|FG001|Overall Study|Lack of Efficacy|26|||
16906196|NCT01887600|38014575|FG000|Overall Study|Lost to Follow-up|5|||
16906197|NCT01887600|38014576|FG001|Overall Study|Lost to Follow-up|1|||
16906198|NCT01887600|38014575|FG000|Overall Study|Physician Decision|7|||
16906199|NCT01887600|38014576|FG001|Overall Study|Physician Decision|8|||
16906200|NCT01887600|38014575|FG000|Overall Study|Protocol Deviation|3|||
16906201|NCT01887600|38014576|FG001|Overall Study|Protocol Deviation|0|||
16906202|NCT01887600|38014575|FG000|Overall Study|Withdrawal by Subject|58|||
16906203|NCT01887600|38014576|FG001|Overall Study|Withdrawal by Subject|52|||
17006791|NCT00608881|38150449|FG001|Overall Study|Lost to Follow-up|14|||
17006792|NCT00608881|38150448|FG000|Overall Study|Withdrawal by Subject|18|||
17006793|NCT00608881|38150449|FG001|Overall Study|Withdrawal by Subject|29|||
16906204|NCT01887600|38014575|FG000|Overall Study|Adverse Event|21|||
16906205|NCT01887600|38014576|FG001|Overall Study|Adverse Event|9|||
16906206|NCT01887600|38014575|FG000|Overall Study|Non-compliance with study drug|3|||
16906207|NCT01887600|38014576|FG001|Overall Study|Non-compliance with study drug|0|||
16906208|NCT01887600|38014575|FG000|Overall Study|Miscellaneous|6|||
16906209|NCT01887600|38014576|FG001|Overall Study|Miscellaneous|2|||
16906210|NCT01887600|38014575|FG000|Overall Study|Progressive Disease|1|||
16906211|NCT01887600|38014576|FG001|Overall Study|Progressive Disease|0|||
16906212|NCT01887288|38014583|FG000|Overall Study|The study was terminated and the PI has|16|||
16906213|NCT01887210|38014589|FG000|Overall Study|Withdrawal by Subject|1|||
16906214|NCT01887210|38014590|FG001|Overall Study|Withdrawal by Subject|3|||
16906215|NCT01887210|38014589|FG000|Overall Study|Lost to Follow-up|0|||
16906216|NCT01887210|38014590|FG001|Overall Study|Lost to Follow-up|1|||
16906217|NCT01885182|38014621|FG000|Overall Study|Adverse Event|11|||
16906218|NCT01885182|38014622|FG001|Overall Study|Adverse Event|13|||
16906219|NCT01885182|38014621|FG000|Overall Study|Withdrawal by Subject|13|||
16906220|NCT01885182|38014622|FG001|Overall Study|Withdrawal by Subject|6|||
16906221|NCT01885182|38014621|FG000|Overall Study|Lost to Follow-up|2|||
16906222|NCT01885182|38014622|FG001|Overall Study|Lost to Follow-up|2|||
16906223|NCT01885182|38014621|FG000|Overall Study|Lack of Efficacy|8|||
16906224|NCT01885182|38014622|FG001|Overall Study|Lack of Efficacy|1|||
16906225|NCT01885104|38014632|FG000|Overall Study|Withdrawal of Consent|1|||
17006794|NCT00608881|38150448|FG000|Overall Study|Physician Decision|5|||
17006795|NCT00608881|38150449|FG001|Overall Study|Physician Decision|5|||
17006796|NCT00608881|38150448|FG000|Overall Study|Institutionalized|1|||
17006797|NCT00608881|38150449|FG001|Overall Study|Institutionalized|2|||
17006798|NCT00945191|38150455|FG000|Overall Study|Did not achieve a complete response|18|||
17006799|NCT00945191|38150455|FG000|Overall Study|Participant relocated to another state|1|||
17192791|NCT01335997|38346089|FG000|Period III|Lost to Follow-up|1|||
16906226|NCT01885104|38014633|FG001|Overall Study|Withdrawal of Consent|0|||
16906227|NCT01885104|38014632|FG000|Overall Study|Lost to Follow-up|0|||
16906228|NCT01885104|38014633|FG001|Overall Study|Lost to Follow-up|1|||
16906229|NCT01885104|38014632|FG000|Overall Study|Physician Decision|1|||
16906230|NCT01885104|38014633|FG001|Overall Study|Physician Decision|0|||
16906231|NCT01881750|38014641|FG000|Overall Study|Changes in concomitant therapies|2|||
16906232|NCT01881750|38014642|FG001|Overall Study|Changes in concomitant therapies|3|||
16906233|NCT01881750|38014641|FG000|Overall Study|Lost to Follow-up|0|||
16906234|NCT01881750|38014642|FG001|Overall Study|Lost to Follow-up|1|||
16906235|NCT01906008|38014652|FG000|Overall Study|Lost to Follow-up|2|||
16906236|NCT01906008|38014653|FG001|Overall Study|Lost to Follow-up|0|||
16906237|NCT01906008|38014652|FG000|Overall Study|Oxaliplatin toxicity|2|||
16906238|NCT01906008|38014653|FG001|Overall Study|Oxaliplatin toxicity|0|||
16906239|NCT01906008|38014652|FG000|Overall Study|Protocol Violation|0|||
16906240|NCT01906008|38014653|FG001|Overall Study|Protocol Violation|1|||
17006800|NCT00945191|38150455|FG000|Overall Study|Disease progression|3|||
16906241|NCT01906008|38014652|FG000|Overall Study|Withdrawal by Subject|1|||
16906242|NCT01906008|38014653|FG001|Overall Study|Withdrawal by Subject|5|||
16906243|NCT01906008|38014652|FG000|Overall Study|Did not start study med|3|||
16906244|NCT01906008|38014653|FG001|Overall Study|Did not start study med|4|||
16906245|NCT01906008|38014652|FG000|Overall Study|Oxaliplatin stops|10|||
16906246|NCT01906008|38014653|FG001|Overall Study|Oxaliplatin stops|8|||
16906247|NCT01906008|38014652|FG000|Overall Study|Hospice|1|||
16906248|NCT01906008|38014653|FG001|Overall Study|Hospice|0|||
16906249|NCT01906008|38014652|FG000|Overall Study|Physician Decision|3|||
16906250|NCT01906008|38014653|FG001|Overall Study|Physician Decision|3|||
17006801|NCT00945191|38150455|FG000|Overall Study|Serious adverse event or adverse event|1|||
17006802|NCT00945191|38150455|FG000|Overall Study|Investigator's discretion|1|||
17006803|NCT01030523|38150461|FG000|Overall Study|Death|1|||
17006804|NCT01030523|38150462|FG001|Overall Study|Death|0|||
17006805|NCT01030523|38150461|FG000|Overall Study|Lost to Follow-up|4|||
17006806|NCT01030523|38150462|FG001|Overall Study|Lost to Follow-up|4|||
17006807|NCT01030523|38150461|FG000|Overall Study|Implant failure|1|||
17006808|NCT01030523|38150462|FG001|Overall Study|Implant failure|0|||
17006809|NCT01030523|38150461|FG000|Overall Study|Withdrawal by Subject|0|||
17006810|NCT01030523|38150462|FG001|Overall Study|Withdrawal by Subject|1|||
17006811|NCT00606931|38150468|FG000|Overall Study|Withdrawal by Subject|3|||
17006812|NCT00792909|38150475|FG000|Overall Study|Withdrawal by Subject|0|||
17006813|NCT00792909|38150476|FG001|Overall Study|Withdrawal by Subject|1|||
17006814|NCT00792909|38150477|FG002|Overall Study|Withdrawal by Subject|0|||
17006815|NCT00944645|38150488|FG000|Period 2|Adverse Event|1|||
17006816|NCT00944645|38150489|FG001|Period 2|Adverse Event|0|||
17006817|NCT00944645|38150488|FG000|Period 2|Lost to Follow-up|0|||
17006818|NCT00944645|38150489|FG001|Period 2|Lost to Follow-up|3|||
17006819|NCT00944645|38150488|FG000|Period 2|Withdrawal by Subject|7|||
17006820|NCT00944645|38150489|FG001|Period 2|Withdrawal by Subject|6|||
17006821|NCT00606229|38150495|FG000|Overall Study|Adverse Event|11|||
17006822|NCT00606229|38150495|FG000|Overall Study|Lack of Efficacy|1|||
17006823|NCT00606229|38150495|FG000|Overall Study|Withdrawal by Subject|4|||
17006824|NCT00606229|38150495|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
17006825|NCT00606229|38150495|FG000|Overall Study|change of residence or other commitments|2|||
17006826|NCT00950651|38150501|FG000|Overall Study|Adverse Event|17|||
17006827|NCT00950651|38150502|FG001|Overall Study|Adverse Event|20|||
17006828|NCT00950651|38150501|FG000|Overall Study|Death|1|||
16906251|NCT01906008|38014652|FG000|Overall Study|Lack of compliance of study med|5|||
16906252|NCT01906008|38014653|FG001|Overall Study|Lack of compliance of study med|3|||
16906253|NCT01906008|38014652|FG000|Overall Study|Adverse Event|0|||
16906254|NCT01906008|38014653|FG001|Overall Study|Adverse Event|3|||
16906255|NCT01863732|38014663|FG000|Overall Study|Adverse Event|2|||
16906256|NCT01863732|38014664|FG001|Overall Study|Adverse Event|0|||
16906257|NCT01863732|38014665|FG002|Overall Study|Adverse Event|3|||
16906258|NCT01863732|38014666|FG003|Overall Study|Adverse Event|3|||
16906259|NCT01863732|38014663|FG000|Overall Study|Lack of Efficacy|1|||
16906260|NCT01863732|38014664|FG001|Overall Study|Lack of Efficacy|0|||
16906261|NCT01863732|38014665|FG002|Overall Study|Lack of Efficacy|2|||
16906262|NCT01863732|38014666|FG003|Overall Study|Lack of Efficacy|1|||
16906263|NCT01863732|38014663|FG000|Overall Study|Lost to Follow-up|2|||
16906264|NCT01863732|38014664|FG001|Overall Study|Lost to Follow-up|2|||
16906265|NCT01863732|38014665|FG002|Overall Study|Lost to Follow-up|1|||
16906266|NCT01863732|38014666|FG003|Overall Study|Lost to Follow-up|1|||
16906267|NCT01863732|38014663|FG000|Overall Study|Physician Decision|1|||
16906268|NCT01863732|38014664|FG001|Overall Study|Physician Decision|0|||
16906269|NCT01863732|38014665|FG002|Overall Study|Physician Decision|1|||
16906270|NCT01863732|38014666|FG003|Overall Study|Physician Decision|0|||
16906271|NCT01863732|38014663|FG000|Overall Study|Pregnancy|0|||
16906272|NCT01863732|38014664|FG001|Overall Study|Pregnancy|0|||
16906273|NCT01863732|38014665|FG002|Overall Study|Pregnancy|0|||
16906274|NCT01863732|38014666|FG003|Overall Study|Pregnancy|1|||
16906275|NCT01863732|38014663|FG000|Overall Study|Technical problems|0|||
16906276|NCT01863732|38014664|FG001|Overall Study|Technical problems|1|||
16906277|NCT01863732|38014665|FG002|Overall Study|Technical problems|1|||
16906278|NCT01863732|38014666|FG003|Overall Study|Technical problems|0|||
16906279|NCT01863732|38014663|FG000|Overall Study|Subject/guardian decision|6|||
16906280|NCT01863732|38014664|FG001|Overall Study|Subject/guardian decision|9|||
16906281|NCT01863732|38014665|FG002|Overall Study|Subject/guardian decision|3|||
16906282|NCT01863732|38014666|FG003|Overall Study|Subject/guardian decision|1|||
16906283|NCT01863732|38014663|FG000|Overall Study|Death|1|||
16906284|NCT01863732|38014664|FG001|Overall Study|Death|0|||
16906285|NCT01863732|38014665|FG002|Overall Study|Death|0|||
16906286|NCT01863732|38014666|FG003|Overall Study|Death|1|||
16906287|NCT01905540|38014679|FG000|Period 3|Other|1|||
17006829|NCT00950651|38150502|FG001|Overall Study|Death|0|||
17006830|NCT00950651|38150501|FG000|Overall Study|Lack of Efficacy|2|||
17006831|NCT00950651|38150502|FG001|Overall Study|Lack of Efficacy|2|||
16906288|NCT01905540|38014680|FG001|Period 3|Other|0|||
17006832|NCT00950651|38150501|FG000|Overall Study|Protocol Violation|3|||
16906289|NCT01905540|38014681|FG002|Period 3|Other|1|||
16906290|NCT01905540|38014682|FG003|Period 3|Other|1|||
16906291|NCT01904760|38014694|FG000|Overall Study|Protocol Violation|1|||
16906292|NCT01904760|38014695|FG001|Overall Study|Protocol Violation|0|||
16906293|NCT01904604|38014704|FG000|Overall Study|Withdrew before receiving dosing|0|||
16906294|NCT01904604|38014705|FG001|Overall Study|Withdrew before receiving dosing|1|||
16906295|NCT01904604|38014706|FG002|Overall Study|Withdrew before receiving dosing|0|||
16906296|NCT01904604|38014704|FG000|Overall Study|Non-compliance|1|||
16906297|NCT01904604|38014705|FG001|Overall Study|Non-compliance|0|||
16906298|NCT01904604|38014706|FG002|Overall Study|Non-compliance|0|||
16906299|NCT01904604|38014704|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
16906300|NCT01904604|38014705|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
16906301|NCT01904604|38014706|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
16906302|NCT01904604|38014704|FG000|Overall Study|Patch site reactions|1|||
16906303|NCT01904604|38014705|FG001|Overall Study|Patch site reactions|1|||
16906304|NCT01904604|38014706|FG002|Overall Study|Patch site reactions|0|||
16906305|NCT01904604|38014704|FG000|Overall Study|Increased syncope|0|||
16906306|NCT01904604|38014705|FG001|Overall Study|Increased syncope|1|||
16906307|NCT01904604|38014706|FG002|Overall Study|Increased syncope|0|||
16906308|NCT01904604|38014704|FG000|Overall Study|Unrelated illness|0|||
16906309|NCT01904604|38014705|FG001|Overall Study|Unrelated illness|1|||
16906310|NCT01904604|38014706|FG002|Overall Study|Unrelated illness|0|||
16906311|NCT01904604|38014704|FG000|Overall Study|Passed Week 52 OFC|1|||
16906312|NCT01904604|38014705|FG001|Overall Study|Passed Week 52 OFC|0|||
16906313|NCT01904604|38014706|FG002|Overall Study|Passed Week 52 OFC|0|||
16906314|NCT01904604|38014704|FG000|Overall Study|Withdrawal by Subject|1|||
16906315|NCT01904604|38014705|FG001|Overall Study|Withdrawal by Subject|2|||
16906316|NCT01904604|38014706|FG002|Overall Study|Withdrawal by Subject|0|||
16906317|NCT01904604|38014704|FG000|Overall Study|Participant Relocated|1|||
16906318|NCT01904604|38014705|FG001|Overall Study|Participant Relocated|1|||
16906319|NCT01904604|38014706|FG002|Overall Study|Participant Relocated|1|||
16906320|NCT01904604|38014704|FG000|Overall Study|Lost to Follow-up|0|||
16906321|NCT01904604|38014705|FG001|Overall Study|Lost to Follow-up|0|||
16906322|NCT01904604|38014706|FG002|Overall Study|Lost to Follow-up|1|||
16906323|NCT01904058|38014721|FG000|Overall Study|Adverse Event|2|||
16906324|NCT01904058|38014722|FG001|Overall Study|Adverse Event|0|||
16906325|NCT01904058|38014723|FG002|Overall Study|Adverse Event|0|||
16906326|NCT01904058|38014724|FG003|Overall Study|Adverse Event|0|||
16906327|NCT01904058|38014721|FG000|Overall Study|Withdrawal by Subject|1|||
16906328|NCT01904058|38014722|FG001|Overall Study|Withdrawal by Subject|0|||
16906329|NCT01904058|38014723|FG002|Overall Study|Withdrawal by Subject|1|||
17006833|NCT00950651|38150502|FG001|Overall Study|Protocol Violation|4|||
17006834|NCT00950651|38150501|FG000|Overall Study|Withdrawal by Subject|8|||
17095759|NCT00162266|38234980|FG001|Open-Label Period|Withdrawal by Subject|0|||
17095760|NCT00162266|38234981|FG002|Open-Label Period|Withdrawal by Subject|0|||
17095761|NCT00162266|38234982|FG003|Open-Label Period|Withdrawal by Subject|31|||
16906330|NCT01904058|38014724|FG003|Overall Study|Withdrawal by Subject|0|||
16906331|NCT01904058|38014721|FG000|Overall Study|Pregnancy|0|||
17006835|NCT00950651|38150502|FG001|Overall Study|Withdrawal by Subject|9|||
17006836|NCT00605293|38150510|FG000|Overall Study|Death|2|||
17006837|NCT00605293|38150511|FG001|Overall Study|Death|1|||
17006838|NCT00605293|38150510|FG000|Overall Study|Insufficient Therapeutic Response|2|||
17006839|NCT00605293|38150511|FG001|Overall Study|Insufficient Therapeutic Response|0|||
17006840|NCT00605293|38150510|FG000|Overall Study|Adverse Event|1|||
17006841|NCT00605293|38150511|FG001|Overall Study|Adverse Event|0|||
17006842|NCT00605293|38150510|FG000|Overall Study|Holidays Dialysis Out|1|||
17006843|NCT00605293|38150511|FG001|Overall Study|Holidays Dialysis Out|0|||
17006844|NCT00605293|38150510|FG000|Overall Study|Blood Transfusion|7|||
17006845|NCT00605293|38150511|FG001|Overall Study|Blood Transfusion|1|||
17006846|NCT00605293|38150510|FG000|Overall Study|Renal Transplantation|3|||
17006847|NCT00605293|38150511|FG001|Overall Study|Renal Transplantation|1|||
17006848|NCT00605293|38150510|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
17006849|NCT00605293|38150511|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
17006850|NCT00605293|38150510|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
17006851|NCT00605293|38150511|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
17006852|NCT00605293|38150510|FG000|Overall Study|Principal Investigator Decision|0|||
17006853|NCT00605293|38150511|FG001|Overall Study|Principal Investigator Decision|1|||
17006854|NCT00572533|38150519|FG000|Overall Study|Death|4|||
17006855|NCT00572533|38150520|FG001|Overall Study|Death|1|||
17006856|NCT00572533|38150519|FG000|Overall Study|Received Kidney Transplant|2|||
17006857|NCT00572533|38150520|FG001|Overall Study|Received Kidney Transplant|1|||
16906332|NCT01904058|38014722|FG001|Overall Study|Pregnancy|0|||
17006858|NCT00572533|38150519|FG000|Overall Study|Social Issues|1|||
17006859|NCT00572533|38150520|FG001|Overall Study|Social Issues|0|||
17006860|NCT00572533|38150519|FG000|Overall Study|Transfer out of Facility|0|||
17006861|NCT00572533|38150520|FG001|Overall Study|Transfer out of Facility|1|||
17192792|NCT01335997|38346090|FG001|Period III|Lost to Follow-up|0|||
17192793|NCT02725671|38346098|FG000|Overall Study|Lost to Follow-up|1|||
16906333|NCT01904058|38014723|FG002|Overall Study|Pregnancy|0|||
16906334|NCT01904058|38014724|FG003|Overall Study|Pregnancy|1|||
16906335|NCT01881126|38014742|FG000|Overall Study|Non-compliance|1|||
16906336|NCT01881126|38014743|FG001|Overall Study|Non-compliance|1|||
16906337|NCT01881126|38014742|FG000|Overall Study|Adverse Event|0|||
16906338|NCT01881126|38014743|FG001|Overall Study|Adverse Event|1|||
16906339|NCT01614600|38014749|FG000|Overall Study|Unacceptable fit|1|||
16906340|NCT01614600|38014749|FG000|Overall Study|Discomfort|1|||
16906341|NCT01614600|38014749|FG000|Overall Study|Unable to remove lens at the end of day|1|||
16906342|NCT01614600|38014749|FG000|Overall Study|Protocol deviation|1|||
16906343|NCT01880736|38014757|FG000|Overall Study|Adverse Event|0|||
16906344|NCT01880736|38014758|FG001|Overall Study|Adverse Event|0|||
16906345|NCT01880736|38014759|FG002|Overall Study|Adverse Event|0|||
16906346|NCT01880736|38014760|FG003|Overall Study|Adverse Event|1|||
16906347|NCT01880736|38014757|FG000|Overall Study|Withdrawal Criteria|1|||
16906348|NCT01880736|38014758|FG001|Overall Study|Withdrawal Criteria|2|||
16906349|NCT01880736|38014759|FG002|Overall Study|Withdrawal Criteria|1|||
16906350|NCT01880736|38014760|FG003|Overall Study|Withdrawal Criteria|5|||
16906351|NCT01880424|38014772|FG000|Overall Study|Adverse Event|7|||
16906352|NCT01880424|38014773|FG001|Overall Study|Adverse Event|6|||
16906353|NCT01880424|38014772|FG000|Overall Study|Lack of Efficacy|1|||
16906354|NCT01880424|38014773|FG001|Overall Study|Lack of Efficacy|4|||
16906355|NCT01880424|38014772|FG000|Overall Study|Lost to Follow-up|3|||
16906356|NCT01880424|38014773|FG001|Overall Study|Lost to Follow-up|2|||
16906357|NCT01880424|38014772|FG000|Overall Study|Protocol Violation|11|||
16906358|NCT01880424|38014773|FG001|Overall Study|Protocol Violation|13|||
16906359|NCT01880424|38014772|FG000|Overall Study|Withdrawal by Subject|10|||
16906360|NCT01880424|38014773|FG001|Overall Study|Withdrawal by Subject|30|||
16906361|NCT01880424|38014772|FG000|Overall Study|Other|1|||
16906362|NCT01880424|38014773|FG001|Overall Study|Other|0|||
16906363|NCT01862874|38014781|FG000|Overall Study|Randomized not treated|1|||
16906364|NCT01862874|38014782|FG001|Overall Study|Randomized not treated|0|||
16906365|NCT01862874|38014781|FG000|Overall Study|Adverse Event|0|||
16906366|NCT01862874|38014782|FG001|Overall Study|Adverse Event|3|||
16906367|NCT01862874|38014781|FG000|Overall Study|Lost to Follow-up|26|||
16906368|NCT01862874|38014782|FG001|Overall Study|Lost to Follow-up|29|||
16906369|NCT01862874|38014781|FG000|Overall Study|Physician Decision|5|||
16906370|NCT01862874|38014782|FG001|Overall Study|Physician Decision|3|||
16906371|NCT01862874|38014781|FG000|Overall Study|Withdrawn by parent/guardian|1|||
16906372|NCT01862874|38014782|FG001|Overall Study|Withdrawn by parent/guardian|1|||
16906373|NCT01862874|38014781|FG000|Overall Study|Withdrawal by Subject|46|||
16906374|NCT01862874|38014782|FG001|Overall Study|Withdrawal by Subject|40|||
16906375|NCT01862874|38014781|FG000|Overall Study|Death|0|||
16906376|NCT01862874|38014782|FG001|Overall Study|Death|1|||
16906377|NCT01879722|38014798|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16906378|NCT01879722|38014799|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16906379|NCT01879722|38014800|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16906380|NCT01879722|38014801|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
16906381|NCT01879722|38014802|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
16906382|NCT01879722|38014803|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
16906383|NCT01879722|38014804|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
16906384|NCT01879722|38014805|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
16906385|NCT01879722|38014806|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
16906386|NCT01879722|38014807|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
16906387|NCT01879722|38014798|FG000|Overall Study|Voluntary Withdrawal|0|||
16906388|NCT01879722|38014799|FG001|Overall Study|Voluntary Withdrawal|0|||
16906389|NCT01879722|38014800|FG002|Overall Study|Voluntary Withdrawal|0|||
16906390|NCT01879722|38014801|FG003|Overall Study|Voluntary Withdrawal|0|||
16906391|NCT01879722|38014802|FG004|Overall Study|Voluntary Withdrawal|0|||
16906392|NCT01879722|38014803|FG005|Overall Study|Voluntary Withdrawal|0|||
16906393|NCT01879722|38014804|FG006|Overall Study|Voluntary Withdrawal|0|||
16906394|NCT01879722|38014805|FG007|Overall Study|Voluntary Withdrawal|0|||
16906395|NCT01879722|38014806|FG008|Overall Study|Voluntary Withdrawal|1|||
16906396|NCT01879722|38014807|FG009|Overall Study|Voluntary Withdrawal|0|||
16906397|NCT01879410|38014834|FG000|Overall Study|Adverse Event|9|||
16906398|NCT01879410|38014835|FG001|Overall Study|Adverse Event|14|||
16906399|NCT01879410|38014834|FG000|Overall Study|Lack of Efficacy|4|||
16906400|NCT01879410|38014835|FG001|Overall Study|Lack of Efficacy|6|||
16906401|NCT01879410|38014834|FG000|Overall Study|Protocol Violation|1|||
16906402|NCT01879410|38014835|FG001|Overall Study|Protocol Violation|7|||
16906403|NCT01879410|38014834|FG000|Overall Study|Lost to Follow-up|2|||
16906404|NCT01879410|38014835|FG001|Overall Study|Lost to Follow-up|1|||
16906405|NCT01879410|38014834|FG000|Overall Study|Withdrawal by Subject|7|||
16906406|NCT01879410|38014835|FG001|Overall Study|Withdrawal by Subject|8|||
16906407|NCT01879410|38014834|FG000|Overall Study|Randomised in Error|1|||
16906408|NCT01879410|38014835|FG001|Overall Study|Randomised in Error|2|||
16906409|NCT01903434|38014841|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
16906410|NCT01903434|38014842|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
16906411|NCT01903434|38014841|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
16906412|NCT01903434|38014842|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
16906413|NCT01903356|38014848|FG000|Overall Study|Lost to Follow-up|7|||
16906414|NCT01903356|38014848|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
16906415|NCT01903356|38014848|FG000|Overall Study|Violated the dosage and administration|3|||
16906416|NCT01862796|38014855|FG000|Overall Study|Prohibited medications|0|||
16906417|NCT01862796|38014856|FG001|Overall Study|Prohibited medications|0|||
16906418|NCT01862796|38014857|FG002|Overall Study|Prohibited medications|1|||
16906419|NCT01878084|38014865|FG000|Overall Study|Physician Decision|2|||
16906420|NCT01862640|38014874|FG000|Overall Study|Adverse Event|4|||
16906421|NCT01862640|38014875|FG001|Overall Study|Adverse Event|10|||
16906422|NCT01862640|38014876|FG002|Overall Study|Adverse Event|6|||
16906423|NCT01862640|38014877|FG003|Overall Study|Adverse Event|8|||
16906424|NCT01862640|38014874|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
16906425|NCT01862640|38014875|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
16906426|NCT01862640|38014876|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
16906427|NCT01862640|38014877|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
16906428|NCT01862640|38014874|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
16906429|NCT01862640|38014875|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
16906430|NCT01862640|38014876|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
16906431|NCT01862640|38014877|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
16906432|NCT01862640|38014874|FG000|Overall Study|Withdrawal by Subject|2|||
16906433|NCT01862640|38014875|FG001|Overall Study|Withdrawal by Subject|4|||
16906434|NCT01862640|38014876|FG002|Overall Study|Withdrawal by Subject|8|||
16906435|NCT01862640|38014877|FG003|Overall Study|Withdrawal by Subject|5|||
16906436|NCT01862640|38014874|FG000|Overall Study|Protocol Deviation|0|||
16906437|NCT01862640|38014875|FG001|Overall Study|Protocol Deviation|0|||
16906438|NCT01862640|38014876|FG002|Overall Study|Protocol Deviation|1|||
16906439|NCT01862640|38014877|FG003|Overall Study|Protocol Deviation|0|||
16906440|NCT01902966|38014886|FG000|Overall Study|Death|1|||
16906441|NCT01902966|38014886|FG000|Overall Study|Physician Decision|1|||
16906442|NCT01902966|38014886|FG000|Overall Study|Withdrawal by Subject|1|||
16906443|NCT01862484|38014892|FG000|Overall Study|Lack of Efficacy|1|||
16906444|NCT01862484|38014893|FG001|Overall Study|Lack of Efficacy|1|||
16906445|NCT01862484|38014892|FG000|Overall Study|Lost to Follow-up|1|||
16906446|NCT01862484|38014893|FG001|Overall Study|Lost to Follow-up|2|||
16906447|NCT01862484|38014892|FG000|Overall Study|Protocol Violation|0|||
16906448|NCT01862484|38014893|FG001|Overall Study|Protocol Violation|2|||
16906449|NCT01862484|38014892|FG000|Overall Study|Withdrawal by Subject|0|||
16906450|NCT01862484|38014893|FG001|Overall Study|Withdrawal by Subject|3|||
16906451|NCT01902888|38014899|FG000|Overall Study|Study Terminated|3|||
16906452|NCT01862328|38014910|FG000|Overall Study|Progressive Disease|3|||
16906453|NCT01862328|38014911|FG001|Overall Study|Progressive Disease|11|||
16906454|NCT01862328|38014912|FG002|Overall Study|Progressive Disease|5|||
16906455|NCT01862328|38014913|FG003|Overall Study|Progressive Disease|6|||
16906456|NCT01862328|38014914|FG004|Overall Study|Progressive Disease|7|||
16906457|NCT01862328|38014915|FG005|Overall Study|Progressive Disease|4|||
16906458|NCT01862328|38014916|FG006|Overall Study|Progressive Disease|3|||
16906459|NCT01862328|38014910|FG000|Overall Study|Adverse Event|0|||
16906460|NCT01862328|38014911|FG001|Overall Study|Adverse Event|4|||
16906461|NCT01862328|38014912|FG002|Overall Study|Adverse Event|0|||
16906462|NCT01862328|38014913|FG003|Overall Study|Adverse Event|1|||
16906463|NCT01862328|38014914|FG004|Overall Study|Adverse Event|0|||
16906464|NCT01862328|38014915|FG005|Overall Study|Adverse Event|2|||
16906465|NCT01862328|38014916|FG006|Overall Study|Adverse Event|4|||
16906466|NCT01862328|38014910|FG000|Overall Study|Other|0|||
16906467|NCT01862328|38014911|FG001|Overall Study|Other|2|||
16906468|NCT01862328|38014912|FG002|Overall Study|Other|1|||
16906469|NCT01862328|38014913|FG003|Overall Study|Other|0|||
16906470|NCT01862328|38014914|FG004|Overall Study|Other|4|||
16906471|NCT01862328|38014915|FG005|Overall Study|Other|0|||
16906472|NCT01862328|38014916|FG006|Overall Study|Other|1|||
16906473|NCT01862328|38014910|FG000|Overall Study|Withdrawal by Subject|1|||
16906474|NCT01862328|38014911|FG001|Overall Study|Withdrawal by Subject|1|||
16906475|NCT01862328|38014912|FG002|Overall Study|Withdrawal by Subject|0|||
16906476|NCT01862328|38014913|FG003|Overall Study|Withdrawal by Subject|0|||
16906477|NCT01862328|38014914|FG004|Overall Study|Withdrawal by Subject|1|||
16906478|NCT01862328|38014915|FG005|Overall Study|Withdrawal by Subject|1|||
16906479|NCT01862328|38014916|FG006|Overall Study|Withdrawal by Subject|1|||
16906480|NCT01862328|38014910|FG000|Overall Study|Symptomatic Deterioration|0|||
16906481|NCT01862328|38014911|FG001|Overall Study|Symptomatic Deterioration|0|||
16906482|NCT01862328|38014912|FG002|Overall Study|Symptomatic Deterioration|0|||
16906483|NCT01862328|38014913|FG003|Overall Study|Symptomatic Deterioration|0|||
16906484|NCT01862328|38014914|FG004|Overall Study|Symptomatic Deterioration|0|||
16906485|NCT01862328|38014915|FG005|Overall Study|Symptomatic Deterioration|0|||
16906486|NCT01862328|38014916|FG006|Overall Study|Symptomatic Deterioration|1|||
16906487|NCT01862250|38014938|FG000|Overall Study|Adverse Event|4|||
16906488|NCT01860846|38014942|FG000|Overall Study|Lost to Follow-up|33|||
16906489|NCT01901874|38014946|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
16906490|NCT01901874|38014946|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
16906491|NCT01901874|38014946|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
16906492|NCT01901874|38014946|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
16906493|NCT01901874|38014946|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
16906494|NCT01901874|38014946|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
16906495|NCT01860534|38014952|FG000|ROP #1|Needed treatment for ROP|0|||
16906496|NCT01860534|38014953|FG001|ROP #1|Needed treatment for ROP|1|||
16906497|NCT01860534|38014952|FG000|ROP #2|discharged prior to ROP #2|1|||
16906498|NCT01860534|38014953|FG001|ROP #2|discharged prior to ROP #2|0|||
16906499|NCT01901328|38014963|FG000|Overall Study|Lost to Follow-up|1|||
16906500|NCT01901328|38014964|FG001|Overall Study|Lost to Follow-up|0|||
16906501|NCT01901328|38014963|FG000|Overall Study|Physician Decision|0|||
16906502|NCT01901328|38014964|FG001|Overall Study|Physician Decision|1|||
16906503|NCT01901328|38014963|FG000|Overall Study|Protocol Violation|1|||
16906504|NCT01901328|38014964|FG001|Overall Study|Protocol Violation|1|||
16906505|NCT01901328|38014963|FG000|Overall Study|Study Terminated by Sponsor|19|||
16906506|NCT01901328|38014964|FG001|Overall Study|Study Terminated by Sponsor|16|||
16906507|NCT01901328|38014963|FG000|Overall Study|Withdrawal by Subject|1|||
16906508|NCT01901328|38014964|FG001|Overall Study|Withdrawal by Subject|2|||
16906509|NCT01901328|38014963|FG000|Overall Study|Lack of Efficacy|0|||
16906510|NCT01901328|38014964|FG001|Overall Study|Lack of Efficacy|1|||
16906511|NCT01859988|38014977|FG000|Overall Study|Withdrawal by Subject|6|||
16906512|NCT01859988|38014978|FG001|Overall Study|Withdrawal by Subject|3|||
16906513|NCT01859988|38014979|FG002|Overall Study|Withdrawal by Subject|4|||
17006862|NCT00949715|38150528|FG000|Overall Study|Physician Decision|1|||
17006863|NCT00949715|38150529|FG001|Overall Study|Physician Decision|0|||
17006864|NCT00949715|38150528|FG000|Overall Study|Lost to Follow-up|1|||
17006865|NCT00949715|38150529|FG001|Overall Study|Lost to Follow-up|0|||
17006866|NCT00949715|38150528|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
17006867|NCT00949715|38150529|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
17006868|NCT00791661|38150537|FG000|7 Day Wash-out|Adverse Event|0|||
17006869|NCT00791661|38150538|FG001|7 Day Wash-out|Adverse Event|0|||
17006870|NCT00791661|38150539|FG002|7 Day Wash-out|Adverse Event|1|||
17006871|NCT00791661|38150537|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
17006872|NCT00791661|38150538|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
17006873|NCT00791661|38150539|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
17006874|NCT00943787|38150563|FG000|Overall Study|Physician Decision|4|||
17006875|NCT00943787|38150563|FG000|Overall Study|Withdrawal by Subject|3|||
17006876|NCT00949325|38150567|FG000|Overall Study|Adverse Event|0|||
17006877|NCT00949325|38150568|FG001|Overall Study|Adverse Event|2|||
17006878|NCT00949325|38150569|FG002|Overall Study|Adverse Event|0|||
17006879|NCT00943319|38150585|FG000|Overall Study|Death|1|||
17006880|NCT00790647|38150589|FG000|Overall Study|Adverse Event|1|||
17006881|NCT00790569|38150598|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
17006882|NCT00790569|38150599|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
17006883|NCT00790569|38150600|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
17006884|NCT00790569|38150598|FG000|End of Treatment (6 Month Interview)|Death|0|||
17006885|NCT00790569|38150599|FG001|End of Treatment (6 Month Interview)|Death|2|||
17006886|NCT00790569|38150600|FG002|End of Treatment (6 Month Interview)|Death|1|||
17006887|NCT00790569|38150598|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
17006888|NCT00790569|38150599|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
17006889|NCT00790569|38150600|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
17006890|NCT00790569|38150598|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
17006891|NCT00790569|38150599|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
17006892|NCT00790569|38150600|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
17006893|NCT00790569|38150598|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
17006894|NCT00790569|38150599|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
17006895|NCT00790569|38150600|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
17006896|NCT00790569|38150598|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
17006897|NCT00790569|38150599|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
17006898|NCT00790569|38150600|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
17006899|NCT00939029|38150610|FG000|Overall Study|Withdrawal by Subject|3|||
17006900|NCT00939029|38150611|FG001|Overall Study|Withdrawal by Subject|7|||
17006901|NCT00939029|38150610|FG000|Overall Study|Lost to Follow-up|3|||
17006902|NCT00939029|38150611|FG001|Overall Study|Lost to Follow-up|4|||
17006903|NCT00939029|38150610|FG000|Overall Study|Adverse Event|0|||
17006904|NCT00939029|38150611|FG001|Overall Study|Adverse Event|1|||
17006905|NCT00587847|38150617|FG000|Overall Study|Lack of Efficacy|5|||
17006906|NCT00587847|38150617|FG000|Overall Study|Adverse Event|2|||
17006907|NCT00784563|38150625|FG000|Years 1 & 2|Withdrawal by Subject|3|||
17006908|NCT00784563|38150626|FG001|Years 1 & 2|Withdrawal by Subject|2|||
16906514|NCT01859988|38014980|FG003|Overall Study|Withdrawal by Subject|3|||
17006909|NCT00784563|38150627|FG002|Years 1 & 2|Withdrawal by Subject|0|||
17006910|NCT00784563|38150625|FG000|Years 1 & 2|Adverse Event|0|||
17006911|NCT00784563|38150626|FG001|Years 1 & 2|Adverse Event|3|||
17006912|NCT00784563|38150627|FG002|Years 1 & 2|Adverse Event|0|||
17006913|NCT00784563|38150625|FG000|Year 3|Withdrawal by Subject|0|||
17192794|NCT02446990|38346106|FG000|Overall Study|Death|485|||
17192795|NCT02446990|38346107|FG001|Overall Study|Death|458|||
17192796|NCT02446990|38346106|FG000|Overall Study|Lost to Follow-up|3|||
17192797|NCT02446990|38346107|FG001|Overall Study|Lost to Follow-up|1|||
17192798|NCT02446990|38346106|FG000|Overall Study|Physician Decision|1|||
17192799|NCT02446990|38346107|FG001|Overall Study|Physician Decision|0|||
17192800|NCT02446990|38346106|FG000|Overall Study|Withdrawal by Subject|231|||
17192801|NCT02446990|38346107|FG001|Overall Study|Withdrawal by Subject|199|||
17192802|NCT02725515|38346115|FG000|Overall Study|Refused infusion (no study treatment)|1|||
17192803|NCT02725515|38346116|FG001|Overall Study|Refused infusion (no study treatment)|0|||
17192804|NCT02725515|38346115|FG000|Overall Study|Loss of Improvement per Protocol|14|||
17192805|NCT02725515|38346116|FG001|Overall Study|Loss of Improvement per Protocol|25|||
17192806|NCT02725515|38346115|FG000|Overall Study|Withdrawal by Subject|2|||
17192807|NCT02725515|38346116|FG001|Overall Study|Withdrawal by Subject|1|||
17192808|NCT02725515|38346115|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17192809|NCT02725515|38346116|FG001|Overall Study|Non-Compliance With Study Drug|3|||
17192810|NCT02725515|38346115|FG000|Overall Study|Lost to Follow-up|1|||
17192811|NCT02725515|38346116|FG001|Overall Study|Lost to Follow-up|1|||
17192812|NCT02725515|38346115|FG000|Overall Study|Adverse Event|7|||
17192813|NCT02725515|38346116|FG001|Overall Study|Adverse Event|2|||
17192814|NCT02725515|38346115|FG000|Overall Study|No Documented Disease Improvement|0|||
17192815|NCT02725515|38346116|FG001|Overall Study|No Documented Disease Improvement|1|||
17192816|NCT02725515|38346115|FG000|Overall Study|Completed Study Under Original Protocol|0|||
17192817|NCT02725515|38346116|FG001|Overall Study|Completed Study Under Original Protocol|1|||
17192818|NCT02725515|38346115|FG000|Overall Study|Lack of Response|0|||
17192819|NCT02725515|38346116|FG001|Overall Study|Lack of Response|1|||
17192820|NCT02416180|38346122|FG000|Overall Study|Withdrawal by Subject|1|||
17192821|NCT02473510|38346128|FG000|Overall Study|Lost to Follow-up|1|||
17192822|NCT02473510|38346129|FG001|Overall Study|Lost to Follow-up|2|||
17192823|NCT02445586|38346135|FG000|Overall Study|Death|14|||
17192824|NCT02445586|38346135|FG000|Overall Study|Withdrawal by Subject|13|||
17192825|NCT02445586|38346135|FG000|Overall Study|Disease Progression|10|||
17192826|NCT02445586|38346135|FG000|Overall Study|Protocol Violation|1|||
17192827|NCT02445586|38346135|FG000|Overall Study|Medical Condition|1|||
17192828|NCT01674062|38346141|FG000|Overall Study|Insufficient Therapeutic Response|56|||
17192829|NCT01674062|38346142|FG001|Overall Study|Insufficient Therapeutic Response|26|||
17192830|NCT01674062|38346141|FG000|Overall Study|Other|8|||
17192831|NCT01674062|38346142|FG001|Overall Study|Other|1|||
17192832|NCT01674062|38346141|FG000|Overall Study|Adverse Event|1|||
17192833|NCT01674062|38346142|FG001|Overall Study|Adverse Event|1|||
17192834|NCT01674062|38346141|FG000|Overall Study|Death|0|||
17192835|NCT01674062|38346142|FG001|Overall Study|Death|1|||
17192836|NCT01674062|38346141|FG000|Overall Study|Programming Error|1|||
17192837|NCT01674062|38346142|FG001|Overall Study|Programming Error|0|||
17192838|NCT02472886|38346151|FG000|Overall Study|Lack of Efficacy|0|||
17192839|NCT02472886|38346152|FG001|Overall Study|Lack of Efficacy|2|||
17192840|NCT02472886|38346153|FG002|Overall Study|Lack of Efficacy|1|||
17192841|NCT02472652|38346166|FG000|Overall Study|Lost to Follow-up|1|||
17192842|NCT02807857|38346170|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
17192843|NCT02807857|38346170|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
17192844|NCT02807857|38346170|FG000|Follow-Up Set|Withdrawal by Subject|8|||
17192845|NCT02807857|38346170|FG000|Follow-Up Set|Lost to Follow-up|7|||
17192846|NCT02807857|38346170|FG000|Follow-Up Set|Physician Decision|6|||
17192847|NCT02807857|38346170|FG000|Follow-Up Set|Adverse Event|3|||
17192848|NCT02807857|38346170|FG000|Follow-Up Set|Death|27|||
17192849|NCT02807857|38346170|FG000|Follow-Up Set|Relocation|2|||
17192850|NCT02648438|38346183|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
17192851|NCT02648438|38346184|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
17192852|NCT02648438|38346185|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
17006914|NCT00784563|38150626|FG001|Year 3|Withdrawal by Subject|0|||
17192853|NCT02648438|38346183|FG000|Overall Study|Protocol Violation|2|||
17192854|NCT02648438|38346184|FG001|Overall Study|Protocol Violation|0|||
17192855|NCT02648438|38346185|FG002|Overall Study|Protocol Violation|0|||
17192856|NCT02648438|38346183|FG000|Overall Study|Withdrawal by Subject|1|||
17192857|NCT02648438|38346184|FG001|Overall Study|Withdrawal by Subject|1|||
17192858|NCT02648438|38346185|FG002|Overall Study|Withdrawal by Subject|0|||
17192859|NCT02415556|38346205|FG000|Overall Study|Adverse Event|3|||
17192860|NCT02415556|38346206|FG001|Overall Study|Adverse Event|4|||
17192861|NCT02415556|38346207|FG002|Overall Study|Adverse Event|2|||
17192862|NCT02415556|38346208|FG003|Overall Study|Adverse Event|4|||
17192863|NCT02415556|38346205|FG000|Overall Study|Lost to Follow-up|4|||
17192864|NCT02415556|38346206|FG001|Overall Study|Lost to Follow-up|5|||
17192865|NCT02415556|38346207|FG002|Overall Study|Lost to Follow-up|4|||
17192866|NCT02415556|38346208|FG003|Overall Study|Lost to Follow-up|1|||
17006915|NCT00784563|38150627|FG002|Year 3|Withdrawal by Subject|2|||
17006916|NCT00784563|38150625|FG000|Year 3|Adverse Event|0|||
17006917|NCT00784563|38150626|FG001|Year 3|Adverse Event|0|||
16906515|NCT01859988|38014981|FG004|Overall Study|Withdrawal by Subject|2|||
16906516|NCT01859988|38014982|FG005|Overall Study|Withdrawal by Subject|2|||
16906517|NCT01859988|38014977|FG000|Overall Study|Lack of Efficacy|1|||
16906518|NCT01859988|38014978|FG001|Overall Study|Lack of Efficacy|1|||
16906519|NCT01859988|38014979|FG002|Overall Study|Lack of Efficacy|5|||
16906520|NCT01859988|38014980|FG003|Overall Study|Lack of Efficacy|0|||
16906521|NCT01859988|38014981|FG004|Overall Study|Lack of Efficacy|7|||
16906522|NCT01859988|38014982|FG005|Overall Study|Lack of Efficacy|9|||
16906523|NCT01859988|38014977|FG000|Overall Study|Physician Decision|1|||
16906524|NCT01859988|38014978|FG001|Overall Study|Physician Decision|3|||
16906525|NCT01859988|38014979|FG002|Overall Study|Physician Decision|1|||
16906526|NCT01859988|38014980|FG003|Overall Study|Physician Decision|3|||
16906527|NCT01859988|38014981|FG004|Overall Study|Physician Decision|4|||
17006918|NCT00784563|38150627|FG002|Year 3|Adverse Event|1|||
17006919|NCT00938717|38150635|FG000|Overall Study|Adverse Event|10|||
17006920|NCT00938717|38150636|FG001|Overall Study|Adverse Event|41|||
17006921|NCT00938717|38150635|FG000|Overall Study|Protocol Violation|11|||
17006922|NCT00938717|38150636|FG001|Overall Study|Protocol Violation|8|||
17006923|NCT00938717|38150635|FG000|Overall Study|Withdrawal by Subject|26|||
17006924|NCT00938717|38150636|FG001|Overall Study|Withdrawal by Subject|24|||
17006925|NCT00938717|38150635|FG000|Overall Study|Lost to Follow-up|13|||
16906528|NCT01859988|38014982|FG005|Overall Study|Physician Decision|1|||
16906529|NCT01859988|38014977|FG000|Overall Study|Adverse Event|2|||
16906530|NCT01859988|38014978|FG001|Overall Study|Adverse Event|1|||
16906531|NCT01859988|38014979|FG002|Overall Study|Adverse Event|3|||
16906532|NCT01859988|38014980|FG003|Overall Study|Adverse Event|1|||
16906533|NCT01859988|38014981|FG004|Overall Study|Adverse Event|2|||
16906534|NCT01859988|38014982|FG005|Overall Study|Adverse Event|2|||
16906535|NCT01859988|38014977|FG000|Overall Study|Lost to Follow-up|1|||
16906536|NCT01859988|38014978|FG001|Overall Study|Lost to Follow-up|2|||
16906537|NCT01859988|38014979|FG002|Overall Study|Lost to Follow-up|3|||
16906538|NCT01859988|38014980|FG003|Overall Study|Lost to Follow-up|0|||
16906539|NCT01859988|38014981|FG004|Overall Study|Lost to Follow-up|3|||
17006926|NCT00938717|38150636|FG001|Overall Study|Lost to Follow-up|18|||
17006927|NCT00938717|38150635|FG000|Overall Study|Lack of Efficacy|33|||
17006928|NCT00938717|38150636|FG001|Overall Study|Lack of Efficacy|15|||
17006929|NCT00938717|38150635|FG000|Overall Study|Other reason|5|||
17006930|NCT00938717|38150636|FG001|Overall Study|Other reason|2|||
17006931|NCT00587223|38150642|FG000|Overall Study|Adverse Event|1|||
16906540|NCT01859988|38014982|FG005|Overall Study|Lost to Follow-up|2|||
16906541|NCT01859988|38014977|FG000|Overall Study|Protocol Violation|0|||
16906542|NCT01859988|38014978|FG001|Overall Study|Protocol Violation|0|||
16906543|NCT01859988|38014979|FG002|Overall Study|Protocol Violation|1|||
16906544|NCT01859988|38014980|FG003|Overall Study|Protocol Violation|0|||
16906545|NCT01859988|38014981|FG004|Overall Study|Protocol Violation|0|||
16906546|NCT01859988|38014982|FG005|Overall Study|Protocol Violation|0|||
16906547|NCT01859988|38014977|FG000|Overall Study|Other than specified above|0|||
16906548|NCT01859988|38014978|FG001|Overall Study|Other than specified above|2|||
16906549|NCT01859988|38014979|FG002|Overall Study|Other than specified above|11|||
16906550|NCT01859988|38014980|FG003|Overall Study|Other than specified above|3|||
16906551|NCT01859988|38014981|FG004|Overall Study|Other than specified above|5|||
16906552|NCT01859988|38014982|FG005|Overall Study|Other than specified above|3|||
16906553|NCT01859598|38014996|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
16906554|NCT01876446|38015004|FG000|Overall Study|Death|0|||
16906555|NCT01876446|38015005|FG001|Overall Study|Death|1|||
16906556|NCT01876446|38015004|FG000|Overall Study|Withdrawal by Subject|1|||
16906557|NCT01876446|38015005|FG001|Overall Study|Withdrawal by Subject|2|||
16906558|NCT01876446|38015004|FG000|Overall Study|Physician Decision|1|||
16906559|NCT01876446|38015005|FG001|Overall Study|Physician Decision|3|||
17006932|NCT00938639|38150651|FG000|Overall Study|Moved away from study area|0|||
17006933|NCT00938639|38150652|FG001|Overall Study|Moved away from study area|1|||
17006934|NCT00938639|38150651|FG000|Overall Study|Lost to Follow-up|1|||
17006935|NCT00938639|38150652|FG001|Overall Study|Lost to Follow-up|2|||
17006936|NCT00938639|38150651|FG000|Overall Study|Family issues|1|||
17006937|NCT00938639|38150652|FG001|Overall Study|Family issues|1|||
17006938|NCT00938639|38150651|FG000|Overall Study|Participant noncompliance|1|||
17006939|NCT00938639|38150652|FG001|Overall Study|Participant noncompliance|0|||
16906560|NCT01900626|38015013|FG000|Overall Study|study was closed due to low enrollment|1|||
17095762|NCT00162266|38234979|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
16906561|NCT01900626|38015014|FG001|Overall Study|study was closed due to low enrollment|1|||
16906562|NCT01900314|38015024|FG000|Overall Study|Lost to Follow-up|1|||
16906563|NCT01900314|38015025|FG001|Overall Study|Lost to Follow-up|0|||
16906564|NCT01900314|38015024|FG000|Overall Study|Protocol Violation|0|||
16906565|NCT01900314|38015025|FG001|Overall Study|Protocol Violation|1|||
16906566|NCT01900314|38015024|FG000|Overall Study|Withdrawal by Subject|3|||
17095763|NCT00162266|38234980|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
16906567|NCT01900314|38015025|FG001|Overall Study|Withdrawal by Subject|3|||
16906568|NCT01899768|38015032|FG000|Part A|Adverse Event|2|||
16906569|NCT01899768|38015032|FG000|Part A|Withdrawal by Subject|1|||
16906570|NCT01899768|38015032|FG000|Part B|Adverse Event|1|||
16906571|NCT01899768|38015032|FG000|Part B|Withdrawal by Subject|1|||
16906572|NCT01898598|38015042|FG000|Overall Study|Adverse Event|1|||
16906573|NCT01898598|38015043|FG001|Overall Study|Adverse Event|0|||
16906574|NCT01898598|38015042|FG000|Overall Study|Withdrawal by Subject|3|||
16906575|NCT01898598|38015043|FG001|Overall Study|Withdrawal by Subject|0|||
16906576|NCT01898598|38015042|FG000|Overall Study|Lost to Follow-up|0|||
16906577|NCT01898598|38015043|FG001|Overall Study|Lost to Follow-up|1|||
16906578|NCT01898598|38015042|FG000|Overall Study|Other|0|||
16906579|NCT01898598|38015043|FG001|Overall Study|Other|1|||
16906580|NCT01898442|38015052|FG000|Overall Study|Hemolysis/technical problems|1|||
16906581|NCT01898442|38015053|FG001|Overall Study|Hemolysis/technical problems|2|||
16906582|NCT01898442|38015054|FG002|Overall Study|Hemolysis/technical problems|2|||
16906583|NCT01898442|38015052|FG000|Overall Study|Patient vomited pills|0|||
16906584|NCT01898442|38015053|FG001|Overall Study|Patient vomited pills|0|||
16906585|NCT01898442|38015054|FG002|Overall Study|Patient vomited pills|1|||
16906586|NCT01898286|38015062|FG000|Overall Study|Withdrawal by Subject|1|||
16906587|NCT01898286|38015062|FG000|Overall Study|Protocol Violation|1|||
16906588|NCT01898286|38015062|FG000|Overall Study|Lost to Follow-up|1|||
16906589|NCT01898208|38015069|FG000|Overall Study|Positive blood culture|17|||
16906590|NCT01898208|38015070|FG001|Overall Study|Positive blood culture|23|||
16906591|NCT01898208|38015071|FG002|Overall Study|Positive blood culture|15|||
16906592|NCT01898208|38015069|FG000|Overall Study|Death/comfort care within 24 hours|10|||
16906593|NCT01898208|38015070|FG001|Overall Study|Death/comfort care within 24 hours|9|||
16906594|NCT01898208|38015071|FG002|Overall Study|Death/comfort care within 24 hours|8|||
16906595|NCT01898208|38015069|FG000|Overall Study|Negative Gram Stain|6|||
16906596|NCT01898208|38015070|FG001|Overall Study|Negative Gram Stain|9|||
16906597|NCT01898208|38015071|FG002|Overall Study|Negative Gram Stain|6|||
16906598|NCT01898208|38015069|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
16906599|NCT01898208|38015070|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
16906600|NCT01898208|38015071|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
16906601|NCT01898208|38015069|FG000|Overall Study|System/Technical Error|1|||
16906602|NCT01898208|38015070|FG001|Overall Study|System/Technical Error|2|||
16906603|NCT01898208|38015071|FG002|Overall Study|System/Technical Error|3|||
16906604|NCT01898208|38015069|FG000|Overall Study|Lost to Follow-up|3|||
16906605|NCT01898208|38015070|FG001|Overall Study|Lost to Follow-up|1|||
16906606|NCT01898208|38015071|FG002|Overall Study|Lost to Follow-up|1|||
16906607|NCT01898130|38015079|FG000|Treatment|Withdrawal by Subject|2|||
16906608|NCT01898130|38015079|FG000|Treatment|Progressive Disease|4|||
16906609|NCT01898130|38015079|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
16906610|NCT01876368|38015085|FG000|Overall Study|Adverse Event|2|||
16906611|NCT01876368|38015086|FG001|Overall Study|Adverse Event|5|||
16906612|NCT01876368|38015085|FG000|Overall Study|Lack of Efficacy|1|||
16906613|NCT01876368|38015086|FG001|Overall Study|Lack of Efficacy|0|||
16906614|NCT01876368|38015085|FG000|Overall Study|Lost to Follow-up|0|||
16906615|NCT01876368|38015086|FG001|Overall Study|Lost to Follow-up|1|||
16906616|NCT01876368|38015085|FG000|Overall Study|Non-compliance with study treatment|0|||
16906617|NCT01876368|38015086|FG001|Overall Study|Non-compliance with study treatment|1|||
16906618|NCT01876368|38015085|FG000|Overall Study|Physician Decision|0|||
16906619|NCT01876368|38015086|FG001|Overall Study|Physician Decision|2|||
16906620|NCT01876368|38015085|FG000|Overall Study|Protocol deviation|3|||
16906621|NCT01876368|38015086|FG001|Overall Study|Protocol deviation|3|||
16906622|NCT01876368|38015085|FG000|Overall Study|Subject/guardian decision|3|||
16906623|NCT01876368|38015086|FG001|Overall Study|Subject/guardian decision|1|||
16906624|NCT01874340|38015096|FG000|Overall Study|Study terminated by Sponsor|6|||
16906625|NCT01874340|38015097|FG001|Overall Study|Study terminated by Sponsor|8|||
16906626|NCT01874340|38015098|FG002|Overall Study|Study terminated by Sponsor|8|||
16906627|NCT01874340|38015099|FG003|Overall Study|Study terminated by Sponsor|4|||
16906628|NCT01874340|38015096|FG000|Overall Study|Withdrawal by Subject|0|||
16906629|NCT01874340|38015097|FG001|Overall Study|Withdrawal by Subject|0|||
16906630|NCT01874340|38015098|FG002|Overall Study|Withdrawal by Subject|0|||
16906631|NCT01874340|38015099|FG003|Overall Study|Withdrawal by Subject|1|||
16906632|NCT01897896|38015111|FG000|Overall Study|Death|1|||
16906633|NCT01897896|38015112|FG001|Overall Study|Death|0|||
16906634|NCT01897896|38015111|FG000|Overall Study|Adverse Event|11|||
16906635|NCT01897896|38015112|FG001|Overall Study|Adverse Event|1|||
16906636|NCT01897896|38015111|FG000|Overall Study|Lost to Follow-up|1|||
16906637|NCT01897896|38015112|FG001|Overall Study|Lost to Follow-up|0|||
16906638|NCT01897896|38015111|FG000|Overall Study|Non-compliance with study drug dosing|1|||
16906639|NCT01897896|38015112|FG001|Overall Study|Non-compliance with study drug dosing|1|||
16906640|NCT01897896|38015111|FG000|Overall Study|Withdrawal by Subject|7|||
16906641|NCT01897896|38015112|FG001|Overall Study|Withdrawal by Subject|1|||
16906642|NCT01897896|38015111|FG000|Overall Study|Require drug that interfere with study|1|||
16906643|NCT01897896|38015112|FG001|Overall Study|Require drug that interfere with study|4|||
16906644|NCT01897896|38015111|FG000|Overall Study|Protocol Violation|1|||
16906645|NCT01897896|38015112|FG001|Overall Study|Protocol Violation|1|||
16906646|NCT01897896|38015111|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
16906647|NCT01897896|38015112|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
16906648|NCT01897896|38015111|FG000|Overall Study|Caregiver can no longer participate|0|||
16906649|NCT01897896|38015112|FG001|Overall Study|Caregiver can no longer participate|2|||
16906650|NCT01897896|38015111|FG000|Overall Study|Other than specified|2|||
16906651|NCT01897896|38015112|FG001|Overall Study|Other than specified|1|||
16906652|NCT01858194|38015122|FG000|Overall Study|Total Artificial Heart Implant|0|||
16906653|NCT01858194|38015123|FG001|Overall Study|Total Artificial Heart Implant|1|||
16906654|NCT01858194|38015122|FG000|Overall Study|Lost to Follow-up|0|||
16906655|NCT01858194|38015123|FG001|Overall Study|Lost to Follow-up|1|||
16906656|NCT01873950|38015131|FG000|Period 5|Withdrawal by Subject|0|||
16906657|NCT01873950|38015132|FG001|Period 5|Withdrawal by Subject|0|||
16906658|NCT01873950|38015133|FG002|Period 5|Withdrawal by Subject|0|||
16906659|NCT01873950|38015134|FG003|Period 5|Withdrawal by Subject|1|||
16906660|NCT01873950|38015135|FG004|Period 5|Withdrawal by Subject|0|||
16906661|NCT01857102|38015149|FG000|Period 1|No longer meets Eligibility Criteria|0|||
16906662|NCT01857102|38015150|FG001|Period 1|No longer meets Eligibility Criteria|2|||
16906663|NCT01857102|38015149|FG000|Period 1|Lost to Follow-up|0|||
16906664|NCT01857102|38015150|FG001|Period 1|Lost to Follow-up|3|||
16906665|NCT01857102|38015149|FG000|Period 1|Unsatisfactory Lens Fit|1|||
16906666|NCT01857102|38015150|FG001|Period 1|Unsatisfactory Lens Fit|0|||
16906667|NCT01857102|38015149|FG000|Period 1|Unsatisfactory Visual Response|1|||
16906668|NCT01857102|38015150|FG001|Period 1|Unsatisfactory Visual Response|0|||
16906669|NCT01857102|38015149|FG000|Period 1|Physician Decision|1|||
16906670|NCT01857102|38015150|FG001|Period 1|Physician Decision|0|||
16906671|NCT01857102|38015149|FG000|Period 2|Lens Discomfort|1|||
16906672|NCT01857102|38015150|FG001|Period 2|Lens Discomfort|0|||
16906673|NCT01857102|38015149|FG000|Period 2|Unsatisfactory Lens Fit|1|||
16906674|NCT01857102|38015150|FG001|Period 2|Unsatisfactory Lens Fit|0|||
16906675|NCT01872078|38015162|FG000|Overall Study|Adverse Event|0|||
16906676|NCT01872078|38015163|FG001|Overall Study|Adverse Event|0|||
16906677|NCT01872078|38015164|FG002|Overall Study|Adverse Event|1|||
16906678|NCT01872078|38015165|FG003|Overall Study|Adverse Event|0|||
16906679|NCT01872078|38015162|FG000|Overall Study|Dose administration non-compliance|0|||
16906680|NCT01872078|38015163|FG001|Overall Study|Dose administration non-compliance|0|||
16906681|NCT01872078|38015164|FG002|Overall Study|Dose administration non-compliance|0|||
16906682|NCT01872078|38015165|FG003|Overall Study|Dose administration non-compliance|1|||
16906683|NCT01872078|38015162|FG000|Overall Study|Protocol Violation|0|||
16906684|NCT01872078|38015163|FG001|Overall Study|Protocol Violation|0|||
16906685|NCT01872078|38015164|FG002|Overall Study|Protocol Violation|1|||
16906686|NCT01872078|38015165|FG003|Overall Study|Protocol Violation|0|||
17006940|NCT00783705|38150664|FG000|Overall Study|Adverse Event|2|||
17006941|NCT00783705|38150665|FG001|Overall Study|Adverse Event|0|||
17006942|NCT00783705|38150664|FG000|Overall Study|Withdrawal by Subject|3|||
17006943|NCT00783705|38150665|FG001|Overall Study|Withdrawal by Subject|2|||
17006944|NCT00783705|38150664|FG000|Overall Study|Lost to Follow-up|1|||
17006945|NCT00783705|38150665|FG001|Overall Study|Lost to Follow-up|3|||
17006946|NCT00604669|38150671|FG000|Overall Study|lack of information in chart|7|||
17006947|NCT00938327|38150675|FG000|Overall Study|Adverse Event|2|||
17006948|NCT00938327|38150675|FG000|Overall Study|Protocol Violation|1|||
17006949|NCT00938327|38150675|FG000|Overall Study|Withdrawal by Subject|4|||
17006950|NCT00938327|38150675|FG000|Overall Study|Lost to Follow-up|37|||
17006951|NCT00938327|38150675|FG000|Overall Study|2nd dose received outside of the study|7|||
17006952|NCT00938327|38150675|FG000|Overall Study|Vaccine not received as out of stock|9|||
17006953|NCT00887198|38150681|FG000|Randomized Period|Ongoing|42|||
17006954|NCT00887198|38150682|FG001|Randomized Period|Ongoing|0|||
17006955|NCT00887198|38150683|FG002|Randomized Period|Ongoing|0|||
17006956|NCT00887198|38150681|FG000|Randomized Period|Adverse Event|50|||
17006957|NCT00887198|38150682|FG001|Randomized Period|Adverse Event|33|||
17006958|NCT00887198|38150683|FG002|Randomized Period|Adverse Event|0|||
17006959|NCT00887198|38150681|FG000|Randomized Period|Lost to Follow-up|1|||
16906687|NCT01872078|38015162|FG000|Overall Study|Withdrawal by Subject|0|||
16906688|NCT01872078|38015163|FG001|Overall Study|Withdrawal by Subject|0|||
16906689|NCT01872078|38015164|FG002|Overall Study|Withdrawal by Subject|1|||
16906690|NCT01872078|38015165|FG003|Overall Study|Withdrawal by Subject|0|||
16906691|NCT01872078|38015162|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
16906692|NCT01872078|38015163|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
16906693|NCT01872078|38015164|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
16906694|NCT01872078|38015165|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
16906695|NCT01896726|38015175|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
16906696|NCT01896726|38015175|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
16906697|NCT01856790|38015182|FG000|Closed Loop Control|Withdrawal by Subject|2|||
17006960|NCT00887198|38150682|FG001|Randomized Period|Lost to Follow-up|0|||
17006961|NCT00887198|38150683|FG002|Randomized Period|Lost to Follow-up|0|||
17006962|NCT00887198|38150681|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
17006963|NCT00887198|38150682|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
17006964|NCT00887198|38150683|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
17006965|NCT00887198|38150681|FG000|Randomized Period|Withdrawal by Subject|41|||
17006966|NCT00887198|38150682|FG001|Randomized Period|Withdrawal by Subject|56|||
17006967|NCT00887198|38150683|FG002|Randomized Period|Withdrawal by Subject|0|||
17006968|NCT00887198|38150681|FG000|Randomized Period|Progressive disease|366|||
17006969|NCT00887198|38150682|FG001|Randomized Period|Progressive disease|370|||
17006970|NCT00887198|38150683|FG002|Randomized Period|Progressive disease|0|||
17006971|NCT00887198|38150681|FG000|Randomized Period|Other|42|||
17006972|NCT00887198|38150682|FG001|Randomized Period|Other|30|||
17006973|NCT00887198|38150683|FG002|Randomized Period|Other|0|||
17006974|NCT00887198|38150681|FG000|Randomized Period|Randomized, Not treated|4|||
17006975|NCT00887198|38150682|FG001|Randomized Period|Randomized, Not treated|2|||
17006976|NCT00887198|38150683|FG002|Randomized Period|Randomized, Not treated|0|||
17006977|NCT00887198|38150681|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
17006978|NCT00887198|38150682|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
17006979|NCT00887198|38150683|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
16906698|NCT01856790|38015182|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
16906699|NCT01856322|38015196|FG000|Overall Study|off study due to lack of accrual|0|||
16906700|NCT01856322|38015197|FG001|Overall Study|off study due to lack of accrual|0|||
16906701|NCT01856322|38015198|FG002|Overall Study|off study due to lack of accrual|3|||
16906702|NCT01896102|38015205|FG000|Overall Study|Death|1|||
16906703|NCT01896102|38015205|FG000|Overall Study|Participant to receive allogenic transplant|2|||
16906704|NCT01871532|38015212|FG000|Overall Study|Withdrawal by Subject|1|||
16906705|NCT01871532|38015213|FG001|Overall Study|Withdrawal by Subject|2|||
16906706|NCT01855074|38015219|FG000|Overall Study|Adverse Event|1|||
16906707|NCT01855074|38015219|FG000|Overall Study|Lost to Follow-up|4|||
16906708|NCT01855074|38015219|FG000|Overall Study|Withdrawal by Subject|8|||
16906709|NCT01855074|38015219|FG000|Overall Study|Started but not treated|1|||
16906710|NCT01871142|38015223|FG000|Overall Study|Adverse Event|1|||
16906711|NCT01895322|38015237|FG000|Overall Study|Adverse Event|1|||
16906712|NCT01895322|38015237|FG000|Overall Study|Withdrawal by Subject|2|||
16906713|NCT01895322|38015237|FG000|Overall Study|Protocol Violation|10|||
16906714|NCT01894776|38015242|FG000|Overall Study|Withdrawal by Subject|1|||
16906715|NCT01894620|38015248|FG000|Overall Study|Withdrawal by Subject|0|||
16906716|NCT01894620|38015249|FG001|Overall Study|Withdrawal by Subject|1|||
16906717|NCT01854918|38015259|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
16906718|NCT01854918|38015260|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
16906719|NCT01854918|38015259|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
16906720|NCT01854918|38015260|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
16906721|NCT01854918|38015259|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
16906722|NCT01854918|38015260|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
16906723|NCT01854918|38015259|FG000|SOC-controlled Period (Year 1)|Death|5|||
16906724|NCT01854918|38015260|FG001|SOC-controlled Period (Year 1)|Death|5|||
16906725|NCT01854918|38015259|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
16906726|NCT01854918|38015260|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
16906727|NCT01854918|38015259|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
16906728|NCT01854918|38015260|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
16906729|NCT01854918|38015259|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
16906730|NCT01854918|38015260|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
16906731|NCT01854918|38015259|FG000|All-IP Period (Years 2 and 3)|Death|5|||
16906732|NCT01854918|38015260|FG001|All-IP Period (Years 2 and 3)|Death|16|||
16906733|NCT01894230|38015275|FG000|Overall Study|Lost to Follow-up|2|||
16906734|NCT01894230|38015276|FG001|Overall Study|Lost to Follow-up|2|||
16906735|NCT01894230|38015275|FG000|Overall Study|Withdrawal by Subject|4|||
16906736|NCT01894230|38015276|FG001|Overall Study|Withdrawal by Subject|4|||
16906737|NCT01894230|38015275|FG000|Overall Study|Non-adherent|0|||
16906738|NCT01894230|38015276|FG001|Overall Study|Non-adherent|1|||
16906739|NCT01894230|38015275|FG000|Overall Study|Death|1|||
17006980|NCT00887198|38150681|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
16906740|NCT01894230|38015276|FG001|Overall Study|Death|0|||
16906741|NCT01894152|38015282|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
16906742|NCT01854528|38015288|FG000|Overall Study|Adverse Event|0|||
16906743|NCT01854528|38015289|FG001|Overall Study|Adverse Event|4|||
16906744|NCT01854528|38015288|FG000|Overall Study|Withdrawal by Subject|0|||
16906745|NCT01854528|38015289|FG001|Overall Study|Withdrawal by Subject|2|||
16906746|NCT01854528|38015288|FG000|Overall Study|Virologic Failure|0|||
16906747|NCT01854528|38015289|FG001|Overall Study|Virologic Failure|9|||
16906748|NCT01853982|38015297|FG000|Overall Study|Withdrawal by Subject|1|||
16906749|NCT01853982|38015298|FG001|Overall Study|Withdrawal by Subject|0|||
16906750|NCT01853982|38015297|FG000|Overall Study|Death|1|||
16906751|NCT01853982|38015298|FG001|Overall Study|Death|0|||
17006981|NCT00887198|38150682|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
16906752|NCT01853982|38015297|FG000|Overall Study|Lost to Follow-up|0|||
16906753|NCT01853982|38015298|FG001|Overall Study|Lost to Follow-up|1|||
16906754|NCT01853280|38015306|FG000|Overall Study|Lack of Efficacy|2|||
16906755|NCT01853280|38015307|FG001|Overall Study|Lack of Efficacy|2|||
16906756|NCT01853280|38015306|FG000|Overall Study|Lost to Follow-up|0|||
16906757|NCT01853280|38015307|FG001|Overall Study|Lost to Follow-up|1|||
16906758|NCT01853280|38015306|FG000|Overall Study|Physician Decision|0|||
16906759|NCT01853280|38015307|FG001|Overall Study|Physician Decision|1|||
16906760|NCT01853280|38015306|FG000|Overall Study|Withdrawal by Subject|0|||
16906761|NCT01853280|38015307|FG001|Overall Study|Withdrawal by Subject|1|||
16906762|NCT01853280|38015306|FG000|Overall Study|Ineligible|0|||
16906763|NCT01853280|38015307|FG001|Overall Study|Ineligible|1|||
16906764|NCT01892436|38015317|FG000|Overall Study|Withdrawal by Subject|8|||
16906765|NCT01892436|38015318|FG001|Overall Study|Withdrawal by Subject|15|||
16906766|NCT01892436|38015319|FG002|Overall Study|Withdrawal by Subject|4|||
16906767|NCT01892436|38015320|FG003|Overall Study|Withdrawal by Subject|4|||
16906768|NCT01892436|38015317|FG000|Overall Study|Death|1|||
16906769|NCT01892436|38015318|FG001|Overall Study|Death|1|||
16906770|NCT01892436|38015319|FG002|Overall Study|Death|0|||
16906771|NCT01892436|38015320|FG003|Overall Study|Death|0|||
16906772|NCT01892436|38015317|FG000|Overall Study|Physician Decision|2|||
16906773|NCT01892436|38015318|FG001|Overall Study|Physician Decision|1|||
16906774|NCT01892436|38015319|FG002|Overall Study|Physician Decision|0|||
16906775|NCT01892436|38015320|FG003|Overall Study|Physician Decision|1|||
16906776|NCT01892436|38015317|FG000|Overall Study|Pregnancy|0|||
16906777|NCT01892436|38015318|FG001|Overall Study|Pregnancy|2|||
16906778|NCT01892436|38015319|FG002|Overall Study|Pregnancy|1|||
16906779|NCT01892436|38015320|FG003|Overall Study|Pregnancy|0|||
16906780|NCT01892436|38015317|FG000|Overall Study|Technical problems|2|||
16906781|NCT01892436|38015318|FG001|Overall Study|Technical problems|1|||
16906782|NCT01892436|38015319|FG002|Overall Study|Technical problems|1|||
16906783|NCT01892436|38015320|FG003|Overall Study|Technical problems|1|||
16906784|NCT01892436|38015317|FG000|Overall Study|Lack of Efficacy|1|||
16906785|NCT01892436|38015318|FG001|Overall Study|Lack of Efficacy|2|||
16906786|NCT01892436|38015319|FG002|Overall Study|Lack of Efficacy|2|||
16906787|NCT01892436|38015320|FG003|Overall Study|Lack of Efficacy|2|||
16906788|NCT01892436|38015317|FG000|Overall Study|Lost to Follow-up|1|||
16906789|NCT01892436|38015318|FG001|Overall Study|Lost to Follow-up|1|||
16906790|NCT01892436|38015319|FG002|Overall Study|Lost to Follow-up|1|||
16906791|NCT01892436|38015320|FG003|Overall Study|Lost to Follow-up|3|||
16906792|NCT01892436|38015317|FG000|Overall Study|non-compliance with treatment|1|||
16906793|NCT01892436|38015318|FG001|Overall Study|non-compliance with treatment|0|||
16906794|NCT01892436|38015319|FG002|Overall Study|non-compliance with treatment|0|||
16906795|NCT01892436|38015320|FG003|Overall Study|non-compliance with treatment|0|||
16906796|NCT01892436|38015317|FG000|Overall Study|Adverse Event|7|||
16906797|NCT01892436|38015318|FG001|Overall Study|Adverse Event|6|||
16906798|NCT01892436|38015319|FG002|Overall Study|Adverse Event|2|||
16906799|NCT01892436|38015320|FG003|Overall Study|Adverse Event|3|||
16906800|NCT01853046|38015332|FG000|Overall Study|Withdrawal by Subject|1|||
16906801|NCT01853046|38015333|FG001|Overall Study|Withdrawal by Subject|1|||
16906802|NCT01853046|38015332|FG000|Overall Study|Adverse Event|4|||
16906803|NCT01853046|38015333|FG001|Overall Study|Adverse Event|2|||
16906804|NCT01853046|38015332|FG000|Overall Study|Disease progression|13|||
16906805|NCT01853046|38015333|FG001|Overall Study|Disease progression|3|||
16906806|NCT01891890|38015343|FG000|Overall Study|Lost to Follow-up|0|||
16906807|NCT01891890|38015344|FG001|Overall Study|Lost to Follow-up|0|||
16906808|NCT01891890|38015345|FG002|Overall Study|Lost to Follow-up|1|||
16906809|NCT01891890|38015343|FG000|Overall Study|Study ended before endpoint reached|7|||
16906810|NCT01891890|38015344|FG001|Overall Study|Study ended before endpoint reached|3|||
16906811|NCT01891890|38015345|FG002|Overall Study|Study ended before endpoint reached|6|||
16906812|NCT01852812|38015356|FG000|Overall Study|Adverse Event|0|||
16906813|NCT01852812|38015357|FG001|Overall Study|Adverse Event|0|||
16906814|NCT01852812|38015358|FG002|Overall Study|Adverse Event|1|||
16906815|NCT01852812|38015356|FG000|Overall Study|Non-compliance With Study Drug|0|||
16906816|NCT01852812|38015357|FG001|Overall Study|Non-compliance With Study Drug|1|||
16906817|NCT01852812|38015358|FG002|Overall Study|Non-compliance With Study Drug|0|||
16906818|NCT01869348|38015368|FG000|Overall Study|Withdrawal by Subject|1|||
16906819|NCT01869348|38015369|FG001|Overall Study|Withdrawal by Subject|1|||
16906820|NCT01869192|38015377|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
16906821|NCT01869192|38015378|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
16906822|NCT01869192|38015377|FG000|Postoperative Chemotherapy|Physician Decision|0|||
16906823|NCT01869192|38015378|FG001|Postoperative Chemotherapy|Physician Decision|2|||
16906824|NCT01868646|38015386|FG000|Overall Study|Do not meet inclusion criteria|3|||
16906825|NCT01868646|38015387|FG001|Overall Study|Do not meet inclusion criteria|5|||
16906826|NCT01852110|38015395|FG000|Overall Study|Adverse Event|12|||
16906827|NCT01852110|38015396|FG001|Overall Study|Adverse Event|5|||
16906828|NCT01852110|38015397|FG002|Overall Study|Adverse Event|0|||
16906829|NCT01852110|38015398|FG003|Overall Study|Adverse Event|0|||
16906830|NCT01852110|38015399|FG004|Overall Study|Adverse Event|0|||
16906831|NCT01852110|38015400|FG005|Overall Study|Adverse Event|0|||
16906832|NCT01852110|38015395|FG000|Overall Study|Lost to Follow-up|1|||
16906833|NCT01852110|38015396|FG001|Overall Study|Lost to Follow-up|3|||
16906834|NCT01852110|38015397|FG002|Overall Study|Lost to Follow-up|0|||
16906835|NCT01852110|38015398|FG003|Overall Study|Lost to Follow-up|0|||
16906836|NCT01852110|38015399|FG004|Overall Study|Lost to Follow-up|0|||
16906837|NCT01852110|38015400|FG005|Overall Study|Lost to Follow-up|0|||
16906838|NCT01852110|38015395|FG000|Overall Study|Non-compliance with Study Drug|2|||
16906839|NCT01852110|38015396|FG001|Overall Study|Non-compliance with Study Drug|1|||
16906840|NCT01852110|38015397|FG002|Overall Study|Non-compliance with Study Drug|0|||
16906841|NCT01852110|38015398|FG003|Overall Study|Non-compliance with Study Drug|0|||
16906842|NCT01852110|38015399|FG004|Overall Study|Non-compliance with Study Drug|0|||
16906843|NCT01852110|38015400|FG005|Overall Study|Non-compliance with Study Drug|0|||
16906844|NCT01852110|38015395|FG000|Overall Study|Physician Decision|1|||
16906845|NCT01852110|38015396|FG001|Overall Study|Physician Decision|0|||
16906846|NCT01852110|38015397|FG002|Overall Study|Physician Decision|0|||
16906847|NCT01852110|38015398|FG003|Overall Study|Physician Decision|0|||
16906848|NCT01852110|38015399|FG004|Overall Study|Physician Decision|0|||
16906849|NCT01852110|38015400|FG005|Overall Study|Physician Decision|0|||
16906850|NCT01852110|38015395|FG000|Overall Study|Protocol Violation|0|||
16906851|NCT01852110|38015396|FG001|Overall Study|Protocol Violation|1|||
16906852|NCT01852110|38015397|FG002|Overall Study|Protocol Violation|0|||
16906853|NCT01852110|38015398|FG003|Overall Study|Protocol Violation|0|||
16906854|NCT01852110|38015399|FG004|Overall Study|Protocol Violation|0|||
16906855|NCT01852110|38015400|FG005|Overall Study|Protocol Violation|0|||
16906856|NCT01852110|38015395|FG000|Overall Study|Study Terminated by Sponsor|30|||
16906857|NCT01852110|38015396|FG001|Overall Study|Study Terminated by Sponsor|32|||
16906858|NCT01852110|38015397|FG002|Overall Study|Study Terminated by Sponsor|0|||
16906859|NCT01852110|38015398|FG003|Overall Study|Study Terminated by Sponsor|0|||
16906860|NCT01852110|38015399|FG004|Overall Study|Study Terminated by Sponsor|0|||
16906861|NCT01852110|38015400|FG005|Overall Study|Study Terminated by Sponsor|0|||
16906862|NCT01852110|38015395|FG000|Overall Study|Withdrawal by Subject|4|||
17006982|NCT00887198|38150683|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
17006983|NCT00887198|38150681|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
17006984|NCT00887198|38150682|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
17006985|NCT00887198|38150683|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
17006986|NCT00887198|38150681|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
17006987|NCT00887198|38150682|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
17006988|NCT00887198|38150683|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
17006989|NCT00887198|38150681|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
17006990|NCT00887198|38150682|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
17006991|NCT00887198|38150683|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
17006992|NCT00887198|38150681|FG000|Cross Over (Placebo to AA)|Other|0|||
17006993|NCT00887198|38150682|FG001|Cross Over (Placebo to AA)|Other|0|||
17006994|NCT00887198|38150683|FG002|Cross Over (Placebo to AA)|Other|19|||
17006995|NCT00782067|38150691|FG000|Overall Study|Adverse Event|35|||
17006996|NCT00782067|38150691|FG000|Overall Study|Subject withdrew consent|11|||
16906863|NCT01852110|38015396|FG001|Overall Study|Withdrawal by Subject|4|||
16906864|NCT01852110|38015397|FG002|Overall Study|Withdrawal by Subject|0|||
16906865|NCT01852110|38015398|FG003|Overall Study|Withdrawal by Subject|0|||
16906866|NCT01852110|38015399|FG004|Overall Study|Withdrawal by Subject|0|||
16906867|NCT01852110|38015400|FG005|Overall Study|Withdrawal by Subject|0|||
16906868|NCT01851720|38015416|FG000|Overall Study|Lost to Follow-up|0|||
16906869|NCT01851720|38015417|FG001|Overall Study|Lost to Follow-up|1|||
16906870|NCT01851330|38015426|FG000|Overall Study|Lack of Efficacy|10|||
16906871|NCT01851330|38015427|FG001|Overall Study|Lack of Efficacy|9|||
16906872|NCT01851330|38015428|FG002|Overall Study|Lack of Efficacy|2|||
16906873|NCT01851330|38015426|FG000|Overall Study|Lost to Follow-up|1|||
16906874|NCT01851330|38015427|FG001|Overall Study|Lost to Follow-up|6|||
16906875|NCT01851330|38015428|FG002|Overall Study|Lost to Follow-up|9|||
16906876|NCT01851330|38015426|FG000|Overall Study|Withdrew Consent|2|||
16906877|NCT01851330|38015427|FG001|Overall Study|Withdrew Consent|1|||
16906878|NCT01851330|38015428|FG002|Overall Study|Withdrew Consent|0|||
16906879|NCT01851330|38015426|FG000|Overall Study|Investigator's Discretion|0|||
16906880|NCT01851330|38015427|FG001|Overall Study|Investigator's Discretion|0|||
17006997|NCT00782067|38150691|FG000|Overall Study|Lost to Follow-up|2|||
17006998|NCT00782067|38150691|FG000|Overall Study|Administrative problems|14|||
17006999|NCT00782067|38150691|FG000|Overall Study|Death|9|||
16906881|NCT01851330|38015428|FG002|Overall Study|Investigator's Discretion|1|||
16906882|NCT01868022|38015445|FG000|Overall Study|Withdrawal by Subject|0|||
16906883|NCT01868022|38015446|FG001|Overall Study|Withdrawal by Subject|0|||
16906884|NCT01868022|38015447|FG002|Overall Study|Withdrawal by Subject|1|||
16906885|NCT01868022|38015448|FG003|Overall Study|Withdrawal by Subject|1|||
16906886|NCT01868022|38015449|FG004|Overall Study|Withdrawal by Subject|0|||
16906887|NCT01868022|38015450|FG005|Overall Study|Withdrawal by Subject|0|||
16906888|NCT01868022|38015451|FG006|Overall Study|Withdrawal by Subject|0|||
16906889|NCT01868022|38015452|FG007|Overall Study|Withdrawal by Subject|1|||
16906890|NCT01868022|38015453|FG008|Overall Study|Withdrawal by Subject|0|||
16906891|NCT01868022|38015445|FG000|Overall Study|Adverse Event|0|||
17007000|NCT00782067|38150691|FG000|Overall Study|Disease progression|43|||
17007001|NCT00782067|38150691|FG000|Overall Study|Protocol deviation|2|||
17007002|NCT00886340|38150697|FG000|Overall Study|Withdrawal by Subject|0|||
17007003|NCT00886340|38150698|FG001|Overall Study|Withdrawal by Subject|7|||
17007004|NCT00605215|38150707|FG000|Overall Study|Death|0|||
17007005|NCT00605215|38150708|FG001|Overall Study|Death|0|||
17007006|NCT00605215|38150709|FG002|Overall Study|Death|1|||
17007007|NCT00605215|38150707|FG000|Overall Study|Adverse Event|19|||
16906892|NCT01868022|38015446|FG001|Overall Study|Adverse Event|0|||
16906893|NCT01868022|38015447|FG002|Overall Study|Adverse Event|0|||
16906894|NCT01868022|38015448|FG003|Overall Study|Adverse Event|0|||
16906895|NCT01868022|38015449|FG004|Overall Study|Adverse Event|2|||
16906896|NCT01868022|38015450|FG005|Overall Study|Adverse Event|0|||
16906897|NCT01868022|38015451|FG006|Overall Study|Adverse Event|0|||
16906898|NCT01868022|38015452|FG007|Overall Study|Adverse Event|2|||
16906899|NCT01868022|38015453|FG008|Overall Study|Adverse Event|2|||
16906900|NCT01868022|38015445|FG000|Overall Study|Physician Decision|0|||
16906901|NCT01868022|38015446|FG001|Overall Study|Physician Decision|0|||
16906902|NCT01868022|38015447|FG002|Overall Study|Physician Decision|0|||
16906903|NCT01868022|38015448|FG003|Overall Study|Physician Decision|0|||
16906904|NCT01868022|38015449|FG004|Overall Study|Physician Decision|0|||
16906905|NCT01868022|38015450|FG005|Overall Study|Physician Decision|1|||
16906906|NCT01868022|38015451|FG006|Overall Study|Physician Decision|0|||
16906907|NCT01868022|38015452|FG007|Overall Study|Physician Decision|2|||
16906908|NCT01868022|38015453|FG008|Overall Study|Physician Decision|0|||
16906909|NCT01868022|38015445|FG000|Overall Study|Study closed/terminated|0|||
16906910|NCT01868022|38015446|FG001|Overall Study|Study closed/terminated|0|||
16906911|NCT01868022|38015447|FG002|Overall Study|Study closed/terminated|0|||
16906912|NCT01868022|38015448|FG003|Overall Study|Study closed/terminated|0|||
16906913|NCT01868022|38015449|FG004|Overall Study|Study closed/terminated|0|||
16906914|NCT01868022|38015450|FG005|Overall Study|Study closed/terminated|0|||
16906915|NCT01868022|38015451|FG006|Overall Study|Study closed/terminated|0|||
16906916|NCT01868022|38015452|FG007|Overall Study|Study closed/terminated|1|||
16906917|NCT01868022|38015453|FG008|Overall Study|Study closed/terminated|0|||
16906918|NCT01868022|38015445|FG000|Overall Study|Ongoing|0|||
16906919|NCT01868022|38015446|FG001|Overall Study|Ongoing|0|||
16906920|NCT01868022|38015447|FG002|Overall Study|Ongoing|0|||
16906921|NCT01868022|38015448|FG003|Overall Study|Ongoing|0|||
16906922|NCT01868022|38015449|FG004|Overall Study|Ongoing|0|||
16906923|NCT01868022|38015450|FG005|Overall Study|Ongoing|0|||
16906924|NCT01868022|38015451|FG006|Overall Study|Ongoing|0|||
16906925|NCT01868022|38015452|FG007|Overall Study|Ongoing|3|||
16906926|NCT01868022|38015453|FG008|Overall Study|Ongoing|0|||
16906927|NCT01850004|38015479|FG000|Overall Study|Poor/Non-compliance|1|||
16906928|NCT01850004|38015479|FG000|Overall Study|Participant Withdrew Consent|9|||
16906929|NCT01850004|38015479|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
16906930|NCT01850004|38015479|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
16906931|NCT01850004|38015479|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
16906932|NCT01850004|38015479|FG000|Overall Study|Other Reasons|2|||
16906933|NCT01850004|38015479|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
16906934|NCT01850004|38015479|FG000|Overall Study|Maximum Clinical Benefit|4|||
16906935|NCT01867710|38015487|FG000|Overall Study|Death|25|||
16906936|NCT01867710|38015488|FG001|Overall Study|Death|15|||
16906937|NCT01867710|38015489|FG002|Overall Study|Death|27|||
16906938|NCT01867710|38015490|FG003|Overall Study|Death|20|||
16906939|NCT01867710|38015487|FG000|Overall Study|Lost to Follow-up|3|||
16906940|NCT01867710|38015488|FG001|Overall Study|Lost to Follow-up|4|||
16906941|NCT01867710|38015489|FG002|Overall Study|Lost to Follow-up|3|||
16906942|NCT01867710|38015490|FG003|Overall Study|Lost to Follow-up|2|||
16906943|NCT01867710|38015487|FG000|Overall Study|Withdrawal of consent|2|||
16906944|NCT01867710|38015488|FG001|Overall Study|Withdrawal of consent|5|||
16906945|NCT01867710|38015489|FG002|Overall Study|Withdrawal of consent|1|||
16906946|NCT01867710|38015490|FG003|Overall Study|Withdrawal of consent|2|||
16906947|NCT01867710|38015487|FG000|Overall Study|Study Terminated by Sponsor|9|||
16906948|NCT01867710|38015488|FG001|Overall Study|Study Terminated by Sponsor|13|||
16906949|NCT01867710|38015489|FG002|Overall Study|Study Terminated by Sponsor|8|||
16906950|NCT01867710|38015490|FG003|Overall Study|Study Terminated by Sponsor|16|||
16906951|NCT01867710|38015487|FG000|Overall Study|Biochemical progression|0|||
16906952|NCT01867710|38015488|FG001|Overall Study|Biochemical progression|1|||
17007008|NCT00605215|38150708|FG001|Overall Study|Adverse Event|21|||
17192867|NCT02415556|38346205|FG000|Overall Study|Withdrawal by Subject|13|||
16906953|NCT01867710|38015489|FG002|Overall Study|Biochemical progression|0|||
16906954|NCT01867710|38015490|FG003|Overall Study|Biochemical progression|0|||
16906955|NCT01867710|38015487|FG000|Overall Study|Clinical progression|0|||
16906956|NCT01867710|38015488|FG001|Overall Study|Clinical progression|0|||
16906957|NCT01867710|38015489|FG002|Overall Study|Clinical progression|1|||
16906958|NCT01867710|38015490|FG003|Overall Study|Clinical progression|0|||
17007009|NCT00605215|38150709|FG002|Overall Study|Adverse Event|26|||
17007010|NCT00605215|38150707|FG000|Overall Study|Refusal to sign the re-consent form|8|||
17007011|NCT00605215|38150708|FG001|Overall Study|Refusal to sign the re-consent form|3|||
17007012|NCT00605215|38150709|FG002|Overall Study|Refusal to sign the re-consent form|3|||
17007013|NCT00605215|38150707|FG000|Overall Study|Withdrawal by Subject|39|||
17007014|NCT00605215|38150708|FG001|Overall Study|Withdrawal by Subject|37|||
17007015|NCT00605215|38150709|FG002|Overall Study|Withdrawal by Subject|27|||
17007016|NCT00605215|38150707|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
17007017|NCT00605215|38150708|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
17007018|NCT00605215|38150709|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
17007019|NCT00605215|38150707|FG000|Overall Study|Protocol Violation|3|||
17007020|NCT00605215|38150708|FG001|Overall Study|Protocol Violation|4|||
17007021|NCT00605215|38150709|FG002|Overall Study|Protocol Violation|1|||
17007022|NCT00605215|38150707|FG000|Overall Study|Pregnancy|8|||
17007023|NCT00605215|38150708|FG001|Overall Study|Pregnancy|5|||
16906959|NCT01867710|38015487|FG000|Overall Study|Disease progression|1|||
16906960|NCT01867710|38015488|FG001|Overall Study|Disease progression|0|||
16906961|NCT01867710|38015489|FG002|Overall Study|Disease progression|0|||
16906962|NCT01867710|38015490|FG003|Overall Study|Disease progression|0|||
16906963|NCT01867710|38015487|FG000|Overall Study|Patient decision|0|||
16906964|NCT01867710|38015488|FG001|Overall Study|Patient decision|0|||
16906965|NCT01867710|38015489|FG002|Overall Study|Patient decision|0|||
16906966|NCT01867710|38015490|FG003|Overall Study|Patient decision|1|||
16906967|NCT01867710|38015487|FG000|Overall Study|Patient to follow subsequent treatment|0|||
16906968|NCT01867710|38015488|FG001|Overall Study|Patient to follow subsequent treatment|1|||
16906969|NCT01867710|38015489|FG002|Overall Study|Patient to follow subsequent treatment|0|||
16906970|NCT01867710|38015490|FG003|Overall Study|Patient to follow subsequent treatment|0|||
16906971|NCT01867710|38015487|FG000|Overall Study|Progressive disease|1|||
16906972|NCT01867710|38015488|FG001|Overall Study|Progressive disease|0|||
16906973|NCT01867710|38015489|FG002|Overall Study|Progressive disease|0|||
16906974|NCT01867710|38015490|FG003|Overall Study|Progressive disease|0|||
16906975|NCT01867710|38015487|FG000|Overall Study|Protocol Violation|0|||
16906976|NCT01867710|38015488|FG001|Overall Study|Protocol Violation|0|||
16906977|NCT01867710|38015489|FG002|Overall Study|Protocol Violation|0|||
16906978|NCT01867710|38015490|FG003|Overall Study|Protocol Violation|1|||
16906979|NCT01867710|38015487|FG000|Overall Study|PSA-progression|0|||
16906980|NCT01867710|38015488|FG001|Overall Study|PSA-progression|1|||
16906981|NCT01867710|38015489|FG002|Overall Study|PSA-progression|0|||
16906982|NCT01867710|38015490|FG003|Overall Study|PSA-progression|0|||
16906983|NCT01867710|38015487|FG000|Overall Study|Study medication no longer effective|0|||
16906984|NCT01867710|38015488|FG001|Overall Study|Study medication no longer effective|1|||
16906985|NCT01867710|38015489|FG002|Overall Study|Study medication no longer effective|0|||
16906986|NCT01867710|38015490|FG003|Overall Study|Study medication no longer effective|0|||
16906987|NCT01849848|38015500|FG000|Overall Study|Physician Decision|1|||
16906988|NCT01849848|38015500|FG000|Overall Study|Progression of the primary disease|3|||
16906989|NCT01849458|38015504|FG000|Overall Study|Lost to Follow-up|4|||
16906990|NCT01832766|38015508|FG000|Washout|Lost to Follow-up|0|||
16906991|NCT01832766|38015509|FG001|Washout|Lost to Follow-up|1|||
16906992|NCT01832532|38015517|FG000|Overall Study|Withdrawal by Subject|5|||
16906993|NCT01832532|38015518|FG001|Overall Study|Withdrawal by Subject|2|||
16906994|NCT01848990|38015527|FG000|Overall Study|Adverse Event|6|||
16906995|NCT01848990|38015528|FG001|Overall Study|Adverse Event|2|||
16906996|NCT01848990|38015529|FG002|Overall Study|Adverse Event|0|||
16906997|NCT01848990|38015527|FG000|Overall Study|Lost to Follow-up|6|||
16906998|NCT01848990|38015528|FG001|Overall Study|Lost to Follow-up|2|||
16906999|NCT01848990|38015529|FG002|Overall Study|Lost to Follow-up|2|||
16907000|NCT01848990|38015527|FG000|Overall Study|Protocol Violation|1|||
16907001|NCT01848990|38015528|FG001|Overall Study|Protocol Violation|1|||
16907002|NCT01848990|38015529|FG002|Overall Study|Protocol Violation|0|||
16907003|NCT01848990|38015527|FG000|Overall Study|Withdrawal by Subject|29|||
16907004|NCT01848990|38015528|FG001|Overall Study|Withdrawal by Subject|10|||
16907005|NCT01848990|38015529|FG002|Overall Study|Withdrawal by Subject|11|||
16907006|NCT01848990|38015527|FG000|Overall Study|Physician Decision|1|||
16907007|NCT01848990|38015528|FG001|Overall Study|Physician Decision|1|||
16907008|NCT01848990|38015529|FG002|Overall Study|Physician Decision|0|||
16907009|NCT01848990|38015527|FG000|Overall Study|Non Compliance|1|||
16907010|NCT01848990|38015528|FG001|Overall Study|Non Compliance|0|||
16907011|NCT01848990|38015529|FG002|Overall Study|Non Compliance|0|||
16907012|NCT01848990|38015527|FG000|Overall Study|Death|1|||
16907013|NCT01848990|38015528|FG001|Overall Study|Death|0|||
16907014|NCT01848990|38015529|FG002|Overall Study|Death|1|||
17007024|NCT00605215|38150709|FG002|Overall Study|Pregnancy|4|||
16907015|NCT01848990|38015527|FG000|Overall Study|Other|1|||
16907016|NCT01848990|38015528|FG001|Overall Study|Other|4|||
16907017|NCT01848990|38015529|FG002|Overall Study|Other|2|||
16907018|NCT01867086|38015541|FG000|Overall Study|Disease Progression|1|||
16907019|NCT01831596|38015545|FG000|Overall Study|Other|8|||
16907020|NCT01848834|38015554|FG000|Overall Study|Adverse Event|3|||
16907021|NCT01848834|38015555|FG001|Overall Study|Adverse Event|11|||
16907022|NCT01848834|38015556|FG002|Overall Study|Adverse Event|3|||
16907023|NCT01848834|38015557|FG003|Overall Study|Adverse Event|5|||
16907024|NCT01848834|38015558|FG004|Overall Study|Adverse Event|9|||
16907025|NCT01848834|38015554|FG000|Overall Study|Death|2|||
16907026|NCT01848834|38015555|FG001|Overall Study|Death|11|||
16907027|NCT01848834|38015556|FG002|Overall Study|Death|1|||
16907028|NCT01848834|38015557|FG003|Overall Study|Death|8|||
16907029|NCT01848834|38015558|FG004|Overall Study|Death|27|||
16907030|NCT01848834|38015554|FG000|Overall Study|Excluded Medication|5|||
16907031|NCT01848834|38015555|FG001|Overall Study|Excluded Medication|4|||
16907032|NCT01848834|38015556|FG002|Overall Study|Excluded Medication|3|||
16907033|NCT01848834|38015557|FG003|Overall Study|Excluded Medication|6|||
16907034|NCT01848834|38015558|FG004|Overall Study|Excluded Medication|6|||
16907035|NCT01848834|38015554|FG000|Overall Study|Lost to Follow-up|5|||
16907036|NCT01848834|38015555|FG001|Overall Study|Lost to Follow-up|5|||
16907037|NCT01848834|38015556|FG002|Overall Study|Lost to Follow-up|3|||
16907038|NCT01848834|38015557|FG003|Overall Study|Lost to Follow-up|0|||
16907039|NCT01848834|38015558|FG004|Overall Study|Lost to Follow-up|3|||
16907040|NCT01848834|38015554|FG000|Overall Study|Physician Decision|1|||
16907041|NCT01848834|38015555|FG001|Overall Study|Physician Decision|3|||
16907042|NCT01848834|38015556|FG002|Overall Study|Physician Decision|4|||
16907043|NCT01848834|38015557|FG003|Overall Study|Physician Decision|0|||
16907044|NCT01848834|38015558|FG004|Overall Study|Physician Decision|11|||
16907045|NCT01848834|38015554|FG000|Overall Study|Protocol Violation|0|||
16907046|NCT01848834|38015555|FG001|Overall Study|Protocol Violation|0|||
16907047|NCT01848834|38015556|FG002|Overall Study|Protocol Violation|0|||
16907048|NCT01848834|38015557|FG003|Overall Study|Protocol Violation|0|||
16907049|NCT01848834|38015558|FG004|Overall Study|Protocol Violation|1|||
16907050|NCT01848834|38015554|FG000|Overall Study|Sponsor Decision|1|||
16907051|NCT01848834|38015555|FG001|Overall Study|Sponsor Decision|1|||
16907052|NCT01848834|38015556|FG002|Overall Study|Sponsor Decision|0|||
16907053|NCT01848834|38015557|FG003|Overall Study|Sponsor Decision|1|||
16907054|NCT01848834|38015558|FG004|Overall Study|Sponsor Decision|1|||
16907055|NCT01848834|38015554|FG000|Overall Study|Withdrawal by Subject|2|||
16907056|NCT01848834|38015555|FG001|Overall Study|Withdrawal by Subject|13|||
16907057|NCT01848834|38015556|FG002|Overall Study|Withdrawal by Subject|10|||
16907058|NCT01848834|38015557|FG003|Overall Study|Withdrawal by Subject|6|||
16907059|NCT01848834|38015558|FG004|Overall Study|Withdrawal by Subject|36|||
16907060|NCT01867008|38015574|FG000|Overall Study|Withdrawal by Subject|1|||
16907061|NCT01848756|38015578|FG000|Overall Study|Adverse Event|1|||
16907062|NCT01848756|38015578|FG000|Overall Study|Withdrawal by Subject|1|||
16907063|NCT01848756|38015578|FG000|Overall Study|Enrolled in Error|1|||
16907064|NCT01830972|38015585|FG000|Part II|Withdrawal by Subject|2|||
16907065|NCT01830972|38015586|FG001|Part II|Withdrawal by Subject|2|||
16907066|NCT01830972|38015585|FG000|Part III|Withdrawal by Subject|1|||
16907067|NCT01830972|38015586|FG001|Part III|Withdrawal by Subject|0|||
17007025|NCT00605215|38150707|FG000|Overall Study|Lost to Follow-up|8|||
17007026|NCT00605215|38150708|FG001|Overall Study|Lost to Follow-up|5|||
17007027|NCT00605215|38150709|FG002|Overall Study|Lost to Follow-up|2|||
17007028|NCT00605215|38150707|FG000|Overall Study|Other than specified|0|||
17007029|NCT00605215|38150708|FG001|Overall Study|Other than specified|2|||
17007030|NCT00605215|38150709|FG002|Overall Study|Other than specified|1|||
17007031|NCT00604279|38150719|FG000|Overall Study|Lack of Efficacy|22|||
17007032|NCT00604279|38150720|FG001|Overall Study|Lack of Efficacy|9|||
17007033|NCT00604279|38150719|FG000|Overall Study|Lost to Follow-up|9|||
17007034|NCT00604279|38150720|FG001|Overall Study|Lost to Follow-up|14|||
17007035|NCT00604279|38150719|FG000|Overall Study|Pregnancy|2|||
17007036|NCT00604279|38150720|FG001|Overall Study|Pregnancy|0|||
17007037|NCT00604279|38150719|FG000|Overall Study|Protocol Violation|3|||
17007038|NCT00604279|38150720|FG001|Overall Study|Protocol Violation|1|||
17007039|NCT00604279|38150719|FG000|Overall Study|Withdrawal by Subject|16|||
17007040|NCT00604279|38150720|FG001|Overall Study|Withdrawal by Subject|5|||
17095764|NCT00162266|38234981|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
17095765|NCT00162266|38234982|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
17095766|NCT00162266|38234979|FG000|Open-Label Period|Other Reasons|0|||
17095767|NCT00162266|38234980|FG001|Open-Label Period|Other Reasons|0|||
17095768|NCT00162266|38234981|FG002|Open-Label Period|Other Reasons|0|||
17095769|NCT00162266|38234982|FG003|Open-Label Period|Other Reasons|15|||
16907068|NCT01830972|38015585|FG000|Part III|Noncompliance|1|||
16907069|NCT01830972|38015586|FG001|Part III|Noncompliance|0|||
16907070|NCT01830972|38015585|FG000|Part IV|Withdrawal by Subject|2|||
16907071|NCT01830972|38015586|FG001|Part IV|Withdrawal by Subject|1|||
16907072|NCT01830972|38015585|FG000|Part IV|Non-Compliance|1|||
16907073|NCT01830972|38015586|FG001|Part IV|Non-Compliance|0|||
16907074|NCT01848288|38015602|FG000|Overall Study|Death|1|||
16907075|NCT01848288|38015602|FG000|Overall Study|Protocol Violation|1|||
16907076|NCT01848288|38015602|FG000|Overall Study|Withdrawal by Subject|1|||
17007041|NCT00604279|38150719|FG000|Overall Study|Adverse Event|4|||
17095770|NCT00225212|38235034|FG000|Overall Study|Disease progression|2|||
16907077|NCT01848210|38015609|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
16907078|NCT01848210|38015610|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
16907079|NCT01848210|38015609|FG000|Overall Study|Lost to Follow-up|24|||
16907080|NCT01848210|38015610|FG001|Overall Study|Lost to Follow-up|12|||
16907081|NCT01848210|38015609|FG000|Overall Study|Protocol Violation|3|||
16907082|NCT01848210|38015610|FG001|Overall Study|Protocol Violation|5|||
16907083|NCT01848210|38015609|FG000|Overall Study|Use of Forbidden Drugs|9|||
16907084|NCT01848210|38015610|FG001|Overall Study|Use of Forbidden Drugs|10|||
16907085|NCT01848210|38015609|FG000|Overall Study|Impedition Condition|5|||
16907086|NCT01848210|38015610|FG001|Overall Study|Impedition Condition|9|||
16907087|NCT01848210|38015609|FG000|Overall Study|Adverse Event|7|||
16907088|NCT01848210|38015610|FG001|Overall Study|Adverse Event|9|||
16907089|NCT01848210|38015609|FG000|Overall Study|Discontinuation Criterion|5|||
16907090|NCT01848210|38015610|FG001|Overall Study|Discontinuation Criterion|7|||
16907091|NCT01848210|38015609|FG000|Overall Study|Hypesensitivity|1|||
16907092|NCT01848210|38015610|FG001|Overall Study|Hypesensitivity|0|||
16786232|NCT01999972|37726700|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
16786233|NCT01999972|37726701|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
16786234|NCT01999972|37726702|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
16786235|NCT01999972|37726703|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
16786236|NCT01999972|37726704|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
16786237|NCT01999972|37726705|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
16786238|NCT01999972|37726700|FG000|Dose Escalation Part|Death|0|||
16786239|NCT01999972|37726701|FG001|Dose Escalation Part|Death|1|||
16786240|NCT01999972|37726702|FG002|Dose Escalation Part|Death|0|||
16786241|NCT01999972|37726703|FG003|Dose Escalation Part|Death|0|||
16786242|NCT01999972|37726704|FG004|Dose Escalation Part|Death|0|||
16786243|NCT01999972|37726705|FG005|Dose Escalation Part|Death|0|||
16786244|NCT01999972|37726700|FG000|Dose Escalation Part|Enrolled but not treated|0|||
16786245|NCT01999972|37726701|FG001|Dose Escalation Part|Enrolled but not treated|0|||
16786246|NCT01999972|37726702|FG002|Dose Escalation Part|Enrolled but not treated|1|||
16786247|NCT01999972|37726703|FG003|Dose Escalation Part|Enrolled but not treated|1|||
16786248|NCT01999972|37726704|FG004|Dose Escalation Part|Enrolled but not treated|0|||
16786249|NCT01999972|37726705|FG005|Dose Escalation Part|Enrolled but not treated|0|||
16786250|NCT01999972|37726700|FG000|Dose Escalation Part|Disease progression|3|||
16786251|NCT01999972|37726701|FG001|Dose Escalation Part|Disease progression|2|||
16786252|NCT01999972|37726702|FG002|Dose Escalation Part|Disease progression|3|||
16786253|NCT01999972|37726703|FG003|Dose Escalation Part|Disease progression|6|||
16786254|NCT01999972|37726704|FG004|Dose Escalation Part|Disease progression|0|||
16907093|NCT01848210|38015609|FG000|Overall Study|Hepatic Function Alteration|4|||
16907094|NCT01848210|38015610|FG001|Overall Study|Hepatic Function Alteration|0|||
16907095|NCT01848210|38015609|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
16907096|NCT01848210|38015610|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
16907097|NCT01848210|38015609|FG000|Overall Study|Administrative|1|||
16907098|NCT01848210|38015610|FG001|Overall Study|Administrative|0|||
16907099|NCT01830816|38015619|FG000|Overall Study|Progressive Disease|12|||
16907100|NCT01830816|38015620|FG001|Overall Study|Progressive Disease|7|||
16907101|NCT01830816|38015621|FG002|Overall Study|Progressive Disease|7|||
16907102|NCT01830816|38015619|FG000|Overall Study|Adverse Event|3|||
16907103|NCT01830816|38015620|FG001|Overall Study|Adverse Event|4|||
16907104|NCT01830816|38015621|FG002|Overall Study|Adverse Event|0|||
16907105|NCT01830816|38015619|FG000|Overall Study|Study Terminated by Sponsor|1|||
16907106|NCT01830816|38015620|FG001|Overall Study|Study Terminated by Sponsor|1|||
16907107|NCT01830816|38015621|FG002|Overall Study|Study Terminated by Sponsor|0|||
16907108|NCT01830816|38015619|FG000|Overall Study|Withdrawal by Subject|1|||
16907109|NCT01830816|38015620|FG001|Overall Study|Withdrawal by Subject|1|||
16907110|NCT01830816|38015621|FG002|Overall Study|Withdrawal by Subject|0|||
16907111|NCT01830816|38015619|FG000|Overall Study|Lost to Follow-up|0|||
16907112|NCT01830816|38015620|FG001|Overall Study|Lost to Follow-up|1|||
16907113|NCT01830816|38015621|FG002|Overall Study|Lost to Follow-up|0|||
16907114|NCT01830816|38015619|FG000|Overall Study|Symptomatic Deterioration|1|||
16907115|NCT01830816|38015620|FG001|Overall Study|Symptomatic Deterioration|0|||
16907116|NCT01830816|38015621|FG002|Overall Study|Symptomatic Deterioration|0|||
16907117|NCT01830816|38015619|FG000|Overall Study|Reason not Specified|2|||
16907118|NCT01830816|38015620|FG001|Overall Study|Reason not Specified|0|||
16907119|NCT01830816|38015621|FG002|Overall Study|Reason not Specified|0|||
16907120|NCT01846416|38015635|FG000|Treatment Phase|Death|2|||
17095771|NCT00225212|38235034|FG000|Overall Study|Death|1|||
16786255|NCT01999972|37726705|FG005|Dose Escalation Part|Disease progression|0|||
16786256|NCT01999972|37726700|FG000|Dose Escalation Part|Adverse Event|0|||
16907121|NCT01846416|38015636|FG001|Treatment Phase|Death|9|||
16907122|NCT01846416|38015637|FG002|Treatment Phase|Death|1|||
16907123|NCT01846416|38015635|FG000|Treatment Phase|Withdrawal by Subject|2|||
16907124|NCT01846416|38015636|FG001|Treatment Phase|Withdrawal by Subject|4|||
17007042|NCT00604279|38150720|FG001|Overall Study|Adverse Event|5|||
16907125|NCT01846416|38015637|FG002|Treatment Phase|Withdrawal by Subject|2|||
16907126|NCT01846416|38015635|FG000|Treatment Phase|Other|1|||
16907127|NCT01846416|38015636|FG001|Treatment Phase|Other|5|||
16907128|NCT01846416|38015637|FG002|Treatment Phase|Other|1|||
16907129|NCT01846416|38015635|FG000|Treatment Phase|Physician Decision|1|||
16907130|NCT01846416|38015636|FG001|Treatment Phase|Physician Decision|2|||
16907131|NCT01846416|38015637|FG002|Treatment Phase|Physician Decision|0|||
16907132|NCT01846416|38015635|FG000|Treatment Phase|Adverse Event|3|||
16907133|NCT01846416|38015636|FG001|Treatment Phase|Adverse Event|4|||
16907134|NCT01846416|38015637|FG002|Treatment Phase|Adverse Event|0|||
16907135|NCT01846416|38015635|FG000|Treatment Phase|Non-compliance|0|||
16907136|NCT01846416|38015636|FG001|Treatment Phase|Non-compliance|2|||
16907137|NCT01846416|38015637|FG002|Treatment Phase|Non-compliance|0|||
16907138|NCT01846416|38015635|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
16907139|NCT01846416|38015636|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
16907140|NCT01846416|38015637|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
16907141|NCT01846416|38015635|FG000|Treatment Phase|Progressive Disease|21|||
16907142|NCT01846416|38015636|FG001|Treatment Phase|Progressive Disease|63|||
16907143|NCT01846416|38015637|FG002|Treatment Phase|Progressive Disease|9|||
16907144|NCT01846416|38015635|FG000|Survival Follow-up|Death|21|||
16907145|NCT01846416|38015636|FG001|Survival Follow-up|Death|62|||
16907146|NCT01846416|38015637|FG002|Survival Follow-up|Death|9|||
16907147|NCT01846416|38015635|FG000|Survival Follow-up|Lost to Follow-up|0|||
16907148|NCT01846416|38015636|FG001|Survival Follow-up|Lost to Follow-up|2|||
16907149|NCT01846416|38015637|FG002|Survival Follow-up|Lost to Follow-up|2|||
17007043|NCT00604279|38150719|FG000|Overall Study|Other|8|||
17007044|NCT00604279|38150720|FG001|Overall Study|Other|4|||
17007045|NCT00938015|38150726|FG000|Overall Study|Death|2|||
17007046|NCT00938015|38150726|FG000|Overall Study|Lost to Follow-up|32|||
17007047|NCT00938015|38150726|FG000|Overall Study|Adverse Event|32|||
17007048|NCT00938015|38150726|FG000|Overall Study|Non-responder|52|||
17007049|NCT00938015|38150726|FG000|Overall Study|Reason not related to Etanercept|29|||
17007050|NCT00781911|38150732|FG000|Overall Study|Adverse Event|4|||
17007051|NCT00781911|38150733|FG001|Overall Study|Adverse Event|4|||
17007052|NCT00781911|38150732|FG000|Overall Study|Withdrawal by Subject|1|||
16907150|NCT01846416|38015635|FG000|Survival Follow-up|Withdrawal by Subject|2|||
16907151|NCT01846416|38015636|FG001|Survival Follow-up|Withdrawal by Subject|7|||
16907152|NCT01846416|38015637|FG002|Survival Follow-up|Withdrawal by Subject|0|||
16907153|NCT01846416|38015635|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
16907154|NCT01846416|38015636|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
17007053|NCT00781911|38150733|FG001|Overall Study|Withdrawal by Subject|2|||
17007054|NCT00781911|38150732|FG000|Overall Study|Physician Decision|0|||
17007055|NCT00781911|38150733|FG001|Overall Study|Physician Decision|2|||
17007056|NCT00781911|38150732|FG000|Overall Study|Sponsor Decision|1|||
17095772|NCT00225212|38235034|FG000|Overall Study|Adverse Event|2|||
17095773|NCT00225212|38235034|FG000|Overall Study|Intercurrent illness|1|||
17095774|NCT00162032|38235040|FG000|Overall Study|Lost to Follow-up|4|||
17095775|NCT00162032|38235041|FG001|Overall Study|Lost to Follow-up|2|||
17095776|NCT00162032|38235040|FG000|Overall Study|Reason not specified|1|||
17095777|NCT00162032|38235041|FG001|Overall Study|Reason not specified|0|||
17095778|NCT00258674|38235055|FG000|Overall Study|Death|32|||
17095779|NCT00258674|38235056|FG001|Overall Study|Death|53|||
17095780|NCT00258674|38235057|FG002|Overall Study|Death|34|||
17095781|NCT00258440|38235068|FG000|Overall Study|Withdrawal by Subject|0|||
17095782|NCT00258440|38235069|FG001|Overall Study|Withdrawal by Subject|0|||
17095783|NCT00258440|38235070|FG002|Overall Study|Withdrawal by Subject|1|||
17095784|NCT00224120|38235080|FG000|Overall Study|Adverse Event|10|||
17095785|NCT00224120|38235081|FG001|Overall Study|Adverse Event|4|||
17095786|NCT00224120|38235080|FG000|Overall Study|Protocol Violation|1|||
17095787|NCT00224120|38235081|FG001|Overall Study|Protocol Violation|0|||
17095788|NCT00224120|38235080|FG000|Overall Study|Withdrawal by Subject|5|||
17095789|NCT00224120|38235081|FG001|Overall Study|Withdrawal by Subject|10|||
17095790|NCT00224120|38235080|FG000|Overall Study|Lack of Efficacy|0|||
17095791|NCT00224120|38235081|FG001|Overall Study|Lack of Efficacy|2|||
17095792|NCT00224120|38235080|FG000|Overall Study|Lost to Follow-up|2|||
17095793|NCT00224120|38235081|FG001|Overall Study|Lost to Follow-up|3|||
17095794|NCT00224120|38235080|FG000|Overall Study|Other|4|||
17095795|NCT00224120|38235081|FG001|Overall Study|Other|5|||
17095796|NCT00257660|38235089|FG000|Overall Study|Lack of Efficacy|5|||
17095797|NCT00257660|38235090|FG001|Overall Study|Lack of Efficacy|23|||
17095798|NCT00257660|38235089|FG000|Overall Study|Withdrawal by Subject|2|||
17095799|NCT00257660|38235090|FG001|Overall Study|Withdrawal by Subject|0|||
17095800|NCT00257660|38235089|FG000|Overall Study|Lost to Follow-up|1|||
16907155|NCT01846416|38015637|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
16907156|NCT01846416|38015635|FG000|Survival Follow-up|Other|3|||
16907157|NCT01846416|38015636|FG001|Survival Follow-up|Other|1|||
16907158|NCT01846416|38015637|FG002|Survival Follow-up|Other|1|||
17007057|NCT00781911|38150733|FG001|Overall Study|Sponsor Decision|0|||
17095801|NCT00257660|38235090|FG001|Overall Study|Lost to Follow-up|0|||
17007058|NCT00605917|38150741|FG000|Overall Study|Protocol Violation|79|||
17007059|NCT00781599|38150778|FG000|Overall Study|Lost to Follow-up|7|||
17007060|NCT00781599|38150779|FG001|Overall Study|Lost to Follow-up|4|||
16907159|NCT01865448|38015648|FG000|Overall Study|Adverse Event|1|||
16907160|NCT01865448|38015649|FG001|Overall Study|Adverse Event|1|||
16907161|NCT01865448|38015648|FG000|Overall Study|Pregnancy|0|||
16907162|NCT01865448|38015649|FG001|Overall Study|Pregnancy|1|||
16907163|NCT01865448|38015648|FG000|Overall Study|dropout unrelated to study|1|||
16907164|NCT01865448|38015649|FG001|Overall Study|dropout unrelated to study|1|||
16907165|NCT01804140|38015656|FG000|Overall Study|No sampling or biopsy procedures done|114|||
16907166|NCT01846104|38015660|FG000|Overall Study|Withdrawal by Subject|1|||
16907167|NCT01803282|38015676|FG000|Overall Study|Progressive Disease|4|||
16907168|NCT01803282|38015677|FG001|Overall Study|Progressive Disease|3|||
16907169|NCT01803282|38015678|FG002|Overall Study|Progressive Disease|6|||
16907170|NCT01803282|38015679|FG003|Overall Study|Progressive Disease|22|||
16907171|NCT01803282|38015680|FG004|Overall Study|Progressive Disease|5|||
16907172|NCT01803282|38015681|FG005|Overall Study|Progressive Disease|8|||
16907173|NCT01803282|38015682|FG006|Overall Study|Progressive Disease|23|||
16907174|NCT01803282|38015683|FG007|Overall Study|Progressive Disease|24|||
16907175|NCT01803282|38015684|FG008|Overall Study|Progressive Disease|3|||
16907176|NCT01803282|38015685|FG009|Overall Study|Progressive Disease|29|||
16907177|NCT01803282|38015686|FG010|Overall Study|Progressive Disease|6|||
16907178|NCT01803282|38015687|FG011|Overall Study|Progressive Disease|11|||
16907179|NCT01803282|38015676|FG000|Overall Study|Death|0|||
16907180|NCT01803282|38015677|FG001|Overall Study|Death|0|||
16907181|NCT01803282|38015678|FG002|Overall Study|Death|0|||
16907182|NCT01803282|38015679|FG003|Overall Study|Death|0|||
16907183|NCT01803282|38015680|FG004|Overall Study|Death|2|||
16907184|NCT01803282|38015681|FG005|Overall Study|Death|1|||
16907185|NCT01803282|38015682|FG006|Overall Study|Death|1|||
16907186|NCT01803282|38015683|FG007|Overall Study|Death|5|||
17007061|NCT00605839|38150797|FG000|Overall Study|Protocol Violation|1|||
17007062|NCT00605839|38150798|FG001|Overall Study|Protocol Violation|0|||
16907187|NCT01803282|38015684|FG008|Overall Study|Death|1|||
16907188|NCT01803282|38015685|FG009|Overall Study|Death|1|||
16907189|NCT01803282|38015686|FG010|Overall Study|Death|0|||
17007063|NCT00605839|38150799|FG002|Overall Study|Protocol Violation|0|||
17007064|NCT00781365|38150809|FG000|Overall Study|Withdrawal by Subject|13|||
17007065|NCT00781365|38150810|FG001|Overall Study|Withdrawal by Subject|8|||
17007066|NCT00781365|38150809|FG000|Overall Study|Did Not Attend Visit|20|||
17007067|NCT00781365|38150810|FG001|Overall Study|Did Not Attend Visit|28|||
17007068|NCT00781365|38150809|FG000|Overall Study|Language barrier|1|||
17007069|NCT00781365|38150810|FG001|Overall Study|Language barrier|0|||
17007070|NCT00937547|38150819|FG000|Overall Study|misdiagnosis|1|||
17007071|NCT00937547|38150820|FG001|Overall Study|misdiagnosis|6|||
17007072|NCT00937547|38150821|FG002|Overall Study|misdiagnosis|7|||
17007073|NCT00780975|38150829|FG000|Overall Study|Progressive disease|3|||
17007074|NCT00780975|38150829|FG000|Overall Study|Toxicity|5|||
17007075|NCT00780273|38150833|FG000|Overall Study|Death|1|||
17007076|NCT00780273|38150833|FG000|Overall Study|Lost to Follow-up|1|||
17007077|NCT00779259|38150838|FG000|Quinine Alone|Adverse Event|2|||
17007078|NCT00779025|38150856|FG000|Overall Study|Withdrawal by Subject|1|||
17007079|NCT00936065|38150864|FG000|Overall Study|Adverse Event|1|||
17007080|NCT00936065|38150865|FG001|Overall Study|Adverse Event|0|||
17007081|NCT00936065|38150866|FG002|Overall Study|Adverse Event|1|||
17007082|NCT00936065|38150864|FG000|Overall Study|Lack of Efficacy|1|||
17007083|NCT00936065|38150865|FG001|Overall Study|Lack of Efficacy|0|||
17007084|NCT00936065|38150866|FG002|Overall Study|Lack of Efficacy|1|||
17007085|NCT00936065|38150864|FG000|Overall Study|Lost to Follow-up|1|||
17007086|NCT00936065|38150865|FG001|Overall Study|Lost to Follow-up|0|||
17007087|NCT00936065|38150866|FG002|Overall Study|Lost to Follow-up|0|||
17007088|NCT00936065|38150864|FG000|Overall Study|Protocol Violation|1|||
16907190|NCT01803282|38015687|FG011|Overall Study|Death|0|||
16907191|NCT01803282|38015676|FG000|Overall Study|Withdrew Consent|0|||
16907192|NCT01803282|38015677|FG001|Overall Study|Withdrew Consent|0|||
16907193|NCT01803282|38015678|FG002|Overall Study|Withdrew Consent|0|||
16907194|NCT01803282|38015679|FG003|Overall Study|Withdrew Consent|6|||
16907195|NCT01803282|38015680|FG004|Overall Study|Withdrew Consent|1|||
16907196|NCT01803282|38015681|FG005|Overall Study|Withdrew Consent|0|||
16907197|NCT01803282|38015682|FG006|Overall Study|Withdrew Consent|8|||
16907198|NCT01803282|38015683|FG007|Overall Study|Withdrew Consent|3|||
16907199|NCT01803282|38015684|FG008|Overall Study|Withdrew Consent|1|||
16907200|NCT01803282|38015685|FG009|Overall Study|Withdrew Consent|5|||
16907201|NCT01803282|38015686|FG010|Overall Study|Withdrew Consent|0|||
16907202|NCT01803282|38015687|FG011|Overall Study|Withdrew Consent|1|||
16907203|NCT01803282|38015676|FG000|Overall Study|Investigator's Discretion|0|||
17007089|NCT00936065|38150865|FG001|Overall Study|Protocol Violation|2|||
17007090|NCT00936065|38150866|FG002|Overall Study|Protocol Violation|1|||
16907204|NCT01803282|38015677|FG001|Overall Study|Investigator's Discretion|0|||
16907205|NCT01803282|38015678|FG002|Overall Study|Investigator's Discretion|0|||
17007091|NCT00936065|38150864|FG000|Overall Study|Withdrawal by Subject|0|||
16907206|NCT01803282|38015679|FG003|Overall Study|Investigator's Discretion|7|||
16907207|NCT01803282|38015680|FG004|Overall Study|Investigator's Discretion|2|||
16907208|NCT01803282|38015681|FG005|Overall Study|Investigator's Discretion|1|||
16907209|NCT01803282|38015682|FG006|Overall Study|Investigator's Discretion|7|||
16907210|NCT01803282|38015683|FG007|Overall Study|Investigator's Discretion|10|||
16907211|NCT01803282|38015684|FG008|Overall Study|Investigator's Discretion|6|||
16907212|NCT01803282|38015685|FG009|Overall Study|Investigator's Discretion|7|||
16907213|NCT01803282|38015686|FG010|Overall Study|Investigator's Discretion|1|||
16907214|NCT01803282|38015687|FG011|Overall Study|Investigator's Discretion|0|||
16907215|NCT01803282|38015676|FG000|Overall Study|Adverse Event|0|||
16907216|NCT01803282|38015677|FG001|Overall Study|Adverse Event|0|||
16907217|NCT01803282|38015678|FG002|Overall Study|Adverse Event|0|||
16907218|NCT01803282|38015679|FG003|Overall Study|Adverse Event|0|||
16907219|NCT01803282|38015680|FG004|Overall Study|Adverse Event|0|||
16907220|NCT01803282|38015681|FG005|Overall Study|Adverse Event|0|||
16907221|NCT01803282|38015682|FG006|Overall Study|Adverse Event|1|||
16907222|NCT01803282|38015683|FG007|Overall Study|Adverse Event|2|||
16907223|NCT01803282|38015684|FG008|Overall Study|Adverse Event|0|||
16907224|NCT01803282|38015685|FG009|Overall Study|Adverse Event|1|||
16907225|NCT01803282|38015686|FG010|Overall Study|Adverse Event|0|||
16907226|NCT01803282|38015687|FG011|Overall Study|Adverse Event|3|||
16907227|NCT01803282|38015676|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16907228|NCT01803282|38015677|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16907229|NCT01803282|38015678|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16907230|NCT01803282|38015679|FG003|Overall Study|Non-Compliance with Study Drug|1|||
16907231|NCT01803282|38015680|FG004|Overall Study|Non-Compliance with Study Drug|0|||
16907232|NCT01803282|38015681|FG005|Overall Study|Non-Compliance with Study Drug|0|||
16907233|NCT01803282|38015682|FG006|Overall Study|Non-Compliance with Study Drug|0|||
16907234|NCT01803282|38015683|FG007|Overall Study|Non-Compliance with Study Drug|0|||
16907235|NCT01803282|38015684|FG008|Overall Study|Non-Compliance with Study Drug|0|||
16907236|NCT01803282|38015685|FG009|Overall Study|Non-Compliance with Study Drug|0|||
16907237|NCT01803282|38015686|FG010|Overall Study|Non-Compliance with Study Drug|0|||
16907238|NCT01803282|38015687|FG011|Overall Study|Non-Compliance with Study Drug|0|||
16907239|NCT01803282|38015676|FG000|Overall Study|Unknown Reason|0|||
16907240|NCT01803282|38015677|FG001|Overall Study|Unknown Reason|0|||
16907241|NCT01803282|38015678|FG002|Overall Study|Unknown Reason|0|||
16907242|NCT01803282|38015679|FG003|Overall Study|Unknown Reason|0|||
16907243|NCT01803282|38015680|FG004|Overall Study|Unknown Reason|0|||
16907244|NCT01803282|38015681|FG005|Overall Study|Unknown Reason|0|||
16907245|NCT01803282|38015682|FG006|Overall Study|Unknown Reason|0|||
16907246|NCT01803282|38015683|FG007|Overall Study|Unknown Reason|1|||
16907247|NCT01803282|38015684|FG008|Overall Study|Unknown Reason|0|||
16907248|NCT01803282|38015685|FG009|Overall Study|Unknown Reason|0|||
16907249|NCT01803282|38015686|FG010|Overall Study|Unknown Reason|0|||
16907250|NCT01803282|38015687|FG011|Overall Study|Unknown Reason|0|||
16907251|NCT01803282|38015676|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
16907252|NCT01803282|38015677|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
16907253|NCT01803282|38015678|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
16907254|NCT01803282|38015679|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
17007092|NCT00936065|38150865|FG001|Overall Study|Withdrawal by Subject|2|||
17007093|NCT00936065|38150866|FG002|Overall Study|Withdrawal by Subject|4|||
17007094|NCT04441788|38150877|FG000|Overall Study|Voluntary Withdrawl|0|||
17007095|NCT04441788|38150878|FG001|Overall Study|Voluntary Withdrawl|1|||
17007096|NCT04441788|38150879|FG002|Overall Study|Voluntary Withdrawl|0|||
17007097|NCT04441788|38150877|FG000|Overall Study|Ineligibility|1|||
17007098|NCT04441788|38150878|FG001|Overall Study|Ineligibility|0|||
17007099|NCT04441788|38150879|FG002|Overall Study|Ineligibility|0|||
17007100|NCT04441788|38150877|FG000|Overall Study|Adverse Event|0|||
17007101|NCT04441788|38150878|FG001|Overall Study|Adverse Event|0|||
17007102|NCT04441788|38150879|FG002|Overall Study|Adverse Event|4|||
17007103|NCT04441788|38150877|FG000|Overall Study|Study Terminated by Sponsor|16|||
16907255|NCT01803282|38015680|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
16907256|NCT01803282|38015681|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
16907257|NCT01803282|38015682|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
16907258|NCT01803282|38015683|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
16907259|NCT01803282|38015684|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
16907260|NCT01803282|38015685|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
17095802|NCT00257660|38235089|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
17192868|NCT02415556|38346206|FG001|Overall Study|Withdrawal by Subject|4|||
17192869|NCT02415556|38346207|FG002|Overall Study|Withdrawal by Subject|14|||
16907261|NCT01803282|38015686|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
16907262|NCT01803282|38015687|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
16907263|NCT01803282|38015676|FG000|Overall Study|Enrolled but Never Treated|0|||
16907264|NCT01803282|38015677|FG001|Overall Study|Enrolled but Never Treated|0|||
17007104|NCT04441788|38150878|FG001|Overall Study|Study Terminated by Sponsor|16|||
16907265|NCT01803282|38015678|FG002|Overall Study|Enrolled but Never Treated|0|||
16907266|NCT01803282|38015679|FG003|Overall Study|Enrolled but Never Treated|0|||
16907267|NCT01803282|38015680|FG004|Overall Study|Enrolled but Never Treated|1|||
16907268|NCT01803282|38015681|FG005|Overall Study|Enrolled but Never Treated|0|||
16907269|NCT01803282|38015682|FG006|Overall Study|Enrolled but Never Treated|1|||
16907270|NCT01803282|38015683|FG007|Overall Study|Enrolled but Never Treated|1|||
16907271|NCT01803282|38015684|FG008|Overall Study|Enrolled but Never Treated|0|||
16907272|NCT01803282|38015685|FG009|Overall Study|Enrolled but Never Treated|1|||
16907273|NCT01803282|38015686|FG010|Overall Study|Enrolled but Never Treated|0|||
17007105|NCT04441788|38150879|FG002|Overall Study|Study Terminated by Sponsor|12|||
17007106|NCT00604825|38150895|FG000|Overall Study|Adverse Event|2|||
16907274|NCT01803282|38015687|FG011|Overall Study|Enrolled but Never Treated|0|||
16907275|NCT01844778|38015716|FG000|Overall Study|Protocol deviation|0|||
16907276|NCT01844778|38015717|FG001|Overall Study|Protocol deviation|1|||
16907277|NCT01844778|38015718|FG002|Overall Study|Protocol deviation|2|||
16907278|NCT01844778|38015716|FG000|Overall Study|Withdrawal by Subject|2|||
16907279|NCT01844778|38015717|FG001|Overall Study|Withdrawal by Subject|0|||
16907280|NCT01844778|38015718|FG002|Overall Study|Withdrawal by Subject|0|||
16907281|NCT01844778|38015716|FG000|Overall Study|Adverse Event|0|||
17007107|NCT00604825|38150896|FG001|Overall Study|Adverse Event|6|||
17007108|NCT00604825|38150897|FG002|Overall Study|Adverse Event|7|||
17007109|NCT00604825|38150898|FG003|Overall Study|Adverse Event|4|||
17007110|NCT00604825|38150895|FG000|Overall Study|Lost to Follow-up|0|||
17007111|NCT00604825|38150896|FG001|Overall Study|Lost to Follow-up|3|||
17007112|NCT00604825|38150897|FG002|Overall Study|Lost to Follow-up|1|||
17007113|NCT00604825|38150898|FG003|Overall Study|Lost to Follow-up|0|||
17007114|NCT00604825|38150895|FG000|Overall Study|Protocol Violation|0|||
17007115|NCT00604825|38150896|FG001|Overall Study|Protocol Violation|1|||
17007116|NCT00604825|38150897|FG002|Overall Study|Protocol Violation|0|||
17007117|NCT00604825|38150898|FG003|Overall Study|Protocol Violation|0|||
17007118|NCT00604825|38150895|FG000|Overall Study|Withdrawal by Subject|4|||
17007119|NCT00604825|38150896|FG001|Overall Study|Withdrawal by Subject|3|||
17007120|NCT00604825|38150897|FG002|Overall Study|Withdrawal by Subject|5|||
17007121|NCT00604825|38150898|FG003|Overall Study|Withdrawal by Subject|5|||
17007122|NCT00604825|38150895|FG000|Overall Study|Lack of Efficacy|3|||
17007123|NCT00604825|38150896|FG001|Overall Study|Lack of Efficacy|2|||
17007124|NCT00604825|38150897|FG002|Overall Study|Lack of Efficacy|1|||
17007125|NCT00604825|38150898|FG003|Overall Study|Lack of Efficacy|0|||
17007126|NCT00604825|38150895|FG000|Overall Study|Did not meet eligibility criteria|0|||
17007127|NCT00604825|38150896|FG001|Overall Study|Did not meet eligibility criteria|0|||
17007128|NCT00604825|38150897|FG002|Overall Study|Did not meet eligibility criteria|2|||
17007129|NCT00604825|38150898|FG003|Overall Study|Did not meet eligibility criteria|0|||
17007130|NCT00604825|38150895|FG000|Overall Study|Physician Decision|0|||
17007131|NCT00604825|38150896|FG001|Overall Study|Physician Decision|0|||
17007132|NCT00604825|38150897|FG002|Overall Study|Physician Decision|0|||
17007133|NCT00604825|38150898|FG003|Overall Study|Physician Decision|1|||
17007134|NCT00604825|38150895|FG000|Overall Study|Exclusion criterion met|0|||
17007135|NCT00604825|38150896|FG001|Overall Study|Exclusion criterion met|0|||
16907282|NCT01844778|38015717|FG001|Overall Study|Adverse Event|2|||
16907283|NCT01844778|38015718|FG002|Overall Study|Adverse Event|2|||
16907284|NCT01802580|38015732|FG000|Overall Study|Physician Decision|1|||
16907285|NCT01802580|38015733|FG001|Overall Study|Physician Decision|0|||
16907286|NCT01802580|38015732|FG000|Overall Study|Protocol Violation|2|||
16907287|NCT01802580|38015733|FG001|Overall Study|Protocol Violation|0|||
16907288|NCT01802580|38015732|FG000|Overall Study|Withdrawal by Subject|5|||
16907289|NCT01802580|38015733|FG001|Overall Study|Withdrawal by Subject|6|||
16907290|NCT01802580|38015732|FG000|Overall Study|Other|1|||
16907291|NCT01802580|38015733|FG001|Overall Study|Other|3|||
16907292|NCT01802580|38015732|FG000|Overall Study|Lack of Efficacy|0|||
16907293|NCT01802580|38015733|FG001|Overall Study|Lack of Efficacy|2|||
16907294|NCT01611090|38015741|FG000|Randomized Period|Lost to Follow-up|8|||
16907295|NCT01611090|38015742|FG001|Randomized Period|Lost to Follow-up|3|||
16907296|NCT01611090|38015743|FG002|Randomized Period|Lost to Follow-up|0|||
16907297|NCT01611090|38015741|FG000|Randomized Period|Withdrawal by Subject|22|||
16907298|NCT01611090|38015742|FG001|Randomized Period|Withdrawal by Subject|26|||
16907299|NCT01611090|38015743|FG002|Randomized Period|Withdrawal by Subject|0|||
16907300|NCT01611090|38015741|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
16907301|NCT01611090|38015742|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
16907302|NCT01611090|38015743|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
16907303|NCT01611090|38015741|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
16907304|NCT01611090|38015742|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
16907305|NCT01611090|38015743|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
16907306|NCT01844700|38015752|FG000|Overall Study|Lack of Efficacy|1|||
16907307|NCT01844700|38015753|FG001|Overall Study|Lack of Efficacy|0|||
16907308|NCT01844700|38015752|FG000|Overall Study|refused medication switch|1|||
16907309|NCT01844700|38015753|FG001|Overall Study|refused medication switch|0|||
17007136|NCT00604825|38150897|FG002|Overall Study|Exclusion criterion met|0|||
17007137|NCT00604825|38150898|FG003|Overall Study|Exclusion criterion met|1|||
16907310|NCT01844700|38015752|FG000|Overall Study|Withdrawal by Subject|1|||
16907311|NCT01844700|38015753|FG001|Overall Study|Withdrawal by Subject|0|||
16907312|NCT01844700|38015752|FG000|Overall Study|stopped taking meds|0|||
16907313|NCT01844700|38015753|FG001|Overall Study|stopped taking meds|1|||
16907314|NCT01827384|38015773|FG000|Overall Study|Switched to alternative treatment|0|||
16907315|NCT01827384|38015774|FG001|Overall Study|Switched to alternative treatment|0|||
16907316|NCT01827384|38015775|FG002|Overall Study|Switched to alternative treatment|0|||
16907317|NCT01827384|38015776|FG003|Overall Study|Switched to alternative treatment|0|||
16907318|NCT01827384|38015777|FG004|Overall Study|Switched to alternative treatment|0|||
16907319|NCT01827384|38015778|FG005|Overall Study|Switched to alternative treatment|0|||
16907320|NCT01827384|38015779|FG006|Overall Study|Switched to alternative treatment|0|||
16907321|NCT01827384|38015780|FG007|Overall Study|Switched to alternative treatment|0|||
16907322|NCT01827384|38015781|FG008|Overall Study|Switched to alternative treatment|0|||
16907323|NCT01827384|38015782|FG009|Overall Study|Switched to alternative treatment|0|||
16907324|NCT01827384|38015783|FG010|Overall Study|Switched to alternative treatment|0|||
16907325|NCT01827384|38015784|FG011|Overall Study|Switched to alternative treatment|0|||
16907326|NCT01827384|38015785|FG012|Overall Study|Switched to alternative treatment|0|||
16907327|NCT01827384|38015786|FG013|Overall Study|Switched to alternative treatment|2|||
16907328|NCT01827384|38015773|FG000|Overall Study|Disease progression before treatment|0|||
16907329|NCT01827384|38015774|FG001|Overall Study|Disease progression before treatment|0|||
16907330|NCT01827384|38015775|FG002|Overall Study|Disease progression before treatment|0|||
16907331|NCT01827384|38015776|FG003|Overall Study|Disease progression before treatment|0|||
16907332|NCT01827384|38015777|FG004|Overall Study|Disease progression before treatment|0|||
16907333|NCT01827384|38015778|FG005|Overall Study|Disease progression before treatment|0|||
16907334|NCT01827384|38015779|FG006|Overall Study|Disease progression before treatment|0|||
16907335|NCT01827384|38015780|FG007|Overall Study|Disease progression before treatment|0|||
16907336|NCT01827384|38015781|FG008|Overall Study|Disease progression before treatment|0|||
16907337|NCT01827384|38015782|FG009|Overall Study|Disease progression before treatment|0|||
16907338|NCT01827384|38015783|FG010|Overall Study|Disease progression before treatment|0|||
16907339|NCT01827384|38015784|FG011|Overall Study|Disease progression before treatment|0|||
16907340|NCT01827384|38015785|FG012|Overall Study|Disease progression before treatment|0|||
16907341|NCT01827384|38015786|FG013|Overall Study|Disease progression before treatment|4|||
16907342|NCT01827384|38015773|FG000|Overall Study|Ineligible|0|||
16907343|NCT01827384|38015774|FG001|Overall Study|Ineligible|0|||
16907344|NCT01827384|38015775|FG002|Overall Study|Ineligible|0|||
16907345|NCT01827384|38015776|FG003|Overall Study|Ineligible|0|||
16907346|NCT01827384|38015777|FG004|Overall Study|Ineligible|0|||
16907347|NCT01827384|38015778|FG005|Overall Study|Ineligible|0|||
16907348|NCT01827384|38015779|FG006|Overall Study|Ineligible|0|||
16907349|NCT01827384|38015780|FG007|Overall Study|Ineligible|0|||
16907350|NCT01827384|38015781|FG008|Overall Study|Ineligible|0|||
16907351|NCT01827384|38015782|FG009|Overall Study|Ineligible|0|||
16907352|NCT01827384|38015783|FG010|Overall Study|Ineligible|0|||
16907353|NCT01827384|38015784|FG011|Overall Study|Ineligible|0|||
16907354|NCT01827384|38015785|FG012|Overall Study|Ineligible|0|||
16907355|NCT01827384|38015786|FG013|Overall Study|Ineligible|19|||
16907356|NCT01827384|38015773|FG000|Overall Study|Participant died before treatment|0|||
16907357|NCT01827384|38015774|FG001|Overall Study|Participant died before treatment|0|||
16907358|NCT01827384|38015775|FG002|Overall Study|Participant died before treatment|0|||
16907359|NCT01827384|38015776|FG003|Overall Study|Participant died before treatment|0|||
16907360|NCT01827384|38015777|FG004|Overall Study|Participant died before treatment|0|||
16907361|NCT01827384|38015778|FG005|Overall Study|Participant died before treatment|0|||
16907362|NCT01827384|38015779|FG006|Overall Study|Participant died before treatment|0|||
16907363|NCT01827384|38015780|FG007|Overall Study|Participant died before treatment|0|||
16907364|NCT01827384|38015781|FG008|Overall Study|Participant died before treatment|0|||
16907365|NCT01827384|38015782|FG009|Overall Study|Participant died before treatment|0|||
16907366|NCT01827384|38015783|FG010|Overall Study|Participant died before treatment|0|||
16907367|NCT01827384|38015784|FG011|Overall Study|Participant died before treatment|0|||
16907368|NCT01827384|38015785|FG012|Overall Study|Participant died before treatment|0|||
16907369|NCT01827384|38015786|FG013|Overall Study|Participant died before treatment|5|||
16907370|NCT01827384|38015773|FG000|Overall Study|Insufficient tumor cells|0|||
16907371|NCT01827384|38015774|FG001|Overall Study|Insufficient tumor cells|0|||
16907372|NCT01827384|38015775|FG002|Overall Study|Insufficient tumor cells|0|||
16907373|NCT01827384|38015776|FG003|Overall Study|Insufficient tumor cells|0|||
16907374|NCT01827384|38015777|FG004|Overall Study|Insufficient tumor cells|0|||
16907375|NCT01827384|38015778|FG005|Overall Study|Insufficient tumor cells|0|||
16907376|NCT01827384|38015779|FG006|Overall Study|Insufficient tumor cells|0|||
16907377|NCT01827384|38015780|FG007|Overall Study|Insufficient tumor cells|0|||
16907378|NCT01827384|38015781|FG008|Overall Study|Insufficient tumor cells|0|||
16907379|NCT01827384|38015782|FG009|Overall Study|Insufficient tumor cells|0|||
17095803|NCT00257660|38235090|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
16907380|NCT01827384|38015783|FG010|Overall Study|Insufficient tumor cells|0|||
16907381|NCT01827384|38015784|FG011|Overall Study|Insufficient tumor cells|0|||
16907382|NCT01827384|38015785|FG012|Overall Study|Insufficient tumor cells|0|||
16907383|NCT01827384|38015786|FG013|Overall Study|Insufficient tumor cells|13|||
16907384|NCT01827384|38015773|FG000|Overall Study|No actionable mutation|0|||
16907385|NCT01827384|38015774|FG001|Overall Study|No actionable mutation|0|||
16907386|NCT01827384|38015775|FG002|Overall Study|No actionable mutation|0|||
16907387|NCT01827384|38015776|FG003|Overall Study|No actionable mutation|0|||
16907388|NCT01827384|38015777|FG004|Overall Study|No actionable mutation|0|||
16907389|NCT01827384|38015778|FG005|Overall Study|No actionable mutation|0|||
16907390|NCT01827384|38015779|FG006|Overall Study|No actionable mutation|0|||
16907391|NCT01827384|38015780|FG007|Overall Study|No actionable mutation|0|||
16907392|NCT01827384|38015781|FG008|Overall Study|No actionable mutation|0|||
16907393|NCT01827384|38015782|FG009|Overall Study|No actionable mutation|0|||
16907394|NCT01827384|38015783|FG010|Overall Study|No actionable mutation|0|||
16907395|NCT01827384|38015784|FG011|Overall Study|No actionable mutation|0|||
16907396|NCT01827384|38015785|FG012|Overall Study|No actionable mutation|0|||
16907397|NCT01827384|38015786|FG013|Overall Study|No actionable mutation|73|||
16907398|NCT01827384|38015773|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
16907399|NCT01827384|38015774|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
16907400|NCT01827384|38015775|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
16907401|NCT01827384|38015776|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
16907402|NCT01827384|38015777|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
16907403|NCT01827384|38015778|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
16907404|NCT01827384|38015779|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
16907405|NCT01827384|38015780|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
16907406|NCT01827384|38015781|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
16907407|NCT01827384|38015782|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
16907408|NCT01827384|38015783|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
16907409|NCT01827384|38015784|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
16907410|NCT01827384|38015785|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
16907411|NCT01827384|38015786|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
16907412|NCT01844076|38015820|FG000|Overall Study|Adverse Event|1|||
16907413|NCT01844076|38015821|FG001|Overall Study|Adverse Event|0|||
16907414|NCT01844076|38015822|FG002|Overall Study|Adverse Event|0|||
16907415|NCT01844076|38015823|FG003|Overall Study|Adverse Event|0|||
16907416|NCT01844076|38015820|FG000|Overall Study|Withdrawal by Subject|1|||
16907417|NCT01844076|38015821|FG001|Overall Study|Withdrawal by Subject|0|||
16907418|NCT01844076|38015822|FG002|Overall Study|Withdrawal by Subject|0|||
16907419|NCT01844076|38015823|FG003|Overall Study|Withdrawal by Subject|0|||
16907420|NCT01826604|38015835|FG000|Overall Study|Lost to Follow-up|8|||
16907421|NCT01826604|38015836|FG001|Overall Study|Lost to Follow-up|9|||
16907422|NCT01843842|38015844|FG000|Overall Study|Do not meet inclusion criteria|1|||
16907423|NCT01843842|38015845|FG001|Overall Study|Do not meet inclusion criteria|1|||
16907424|NCT01826448|38015853|FG000|Overall Study|Adverse Event|1|||
16907425|NCT01826448|38015854|FG001|Overall Study|Adverse Event|3|||
16907426|NCT01826448|38015853|FG000|Overall Study|Disease progression|2|||
16907427|NCT01826448|38015854|FG001|Overall Study|Disease progression|4|||
16907428|NCT01826448|38015853|FG000|Overall Study|Withdrawal by Subject|1|||
16907429|NCT01826448|38015854|FG001|Overall Study|Withdrawal by Subject|0|||
16907430|NCT01826448|38015853|FG000|Overall Study|Physician Decision|0|||
16907431|NCT01826448|38015854|FG001|Overall Study|Physician Decision|1|||
16907432|NCT01826448|38015853|FG000|Overall Study|2 active cancers|0|||
17007138|NCT00937391|38150910|FG000|Stage 2|Withdrawal by Subject|1|||
17007139|NCT00937157|38150927|FG000|Overall Study|Pregnancy|1|||
17007140|NCT00937157|38150927|FG000|Overall Study|Lost to Follow-up|3|||
17007141|NCT00777153|38150934|FG000|Overall Study|Lost to Follow-up|1|||
17007142|NCT00777153|38150935|FG001|Overall Study|Lost to Follow-up|1|||
17007143|NCT00777153|38150936|FG002|Overall Study|Lost to Follow-up|0|||
17007144|NCT00777153|38150934|FG000|Overall Study|Death|85|||
17007145|NCT00777153|38150935|FG001|Overall Study|Death|73|||
17007146|NCT00777153|38150936|FG002|Overall Study|Death|33|||
16907433|NCT01826448|38015854|FG001|Overall Study|2 active cancers|1|||
16907434|NCT01826370|38015860|FG000|Overall Study|Protocol Violation|6|||
16907435|NCT01826370|38015860|FG000|Overall Study|Lost to Follow-up|12|||
16907436|NCT01826370|38015860|FG000|Overall Study|Other reason not defined above|2|||
16907437|NCT01826214|38015866|FG000|Overall Study|Adverse Event|7|||
16907438|NCT01826214|38015867|FG001|Overall Study|Adverse Event|6|||
16907439|NCT01826214|38015866|FG000|Overall Study|Death|3|||
16907440|NCT01826214|38015867|FG001|Overall Study|Death|1|||
16907441|NCT01826214|38015866|FG000|Overall Study|Lost to Follow-up|1|||
16907442|NCT01826214|38015867|FG001|Overall Study|Lost to Follow-up|0|||
16907443|NCT01826214|38015866|FG000|Overall Study|Physician Decision|0|||
16907444|NCT01826214|38015867|FG001|Overall Study|Physician Decision|2|||
17007147|NCT00777153|38150934|FG000|Overall Study|Withdrawal by Subject|3|||
16907445|NCT01826214|38015866|FG000|Overall Study|Progressive disease|22|||
16907446|NCT01826214|38015867|FG001|Overall Study|Progressive disease|21|||
16907447|NCT01826214|38015866|FG000|Overall Study|Study terminated by Sponsor|0|||
16907448|NCT01826214|38015867|FG001|Overall Study|Study terminated by Sponsor|1|||
16907449|NCT01826214|38015866|FG000|Overall Study|Subject/guardian decision|2|||
16907450|NCT01826214|38015867|FG001|Overall Study|Subject/guardian decision|3|||
16907451|NCT01843062|38015875|FG000|Overall Study|Protocol Violation|1|||
16907452|NCT01843062|38015876|FG001|Overall Study|Protocol Violation|0|||
16907453|NCT01843062|38015875|FG000|Overall Study|New treatment following progression|2|||
16907454|NCT01843062|38015876|FG001|Overall Study|New treatment following progression|0|||
16907455|NCT01843062|38015875|FG000|Overall Study|Pregnancy|1|||
16907456|NCT01843062|38015876|FG001|Overall Study|Pregnancy|0|||
16907457|NCT01843062|38015875|FG000|Overall Study|Adverse Event|2|||
16907458|NCT01843062|38015876|FG001|Overall Study|Adverse Event|0|||
16907459|NCT01843062|38015875|FG000|Overall Study|Incorrect randomisation|1|||
16907460|NCT01843062|38015876|FG001|Overall Study|Incorrect randomisation|0|||
16907461|NCT01843062|38015875|FG000|Overall Study|Withdrawal by Subject|12|||
16907462|NCT01843062|38015876|FG001|Overall Study|Withdrawal by Subject|3|||
16907463|NCT01843062|38015875|FG000|Overall Study|Death|1|||
16907464|NCT01843062|38015876|FG001|Overall Study|Death|2|||
16907465|NCT01843062|38015875|FG000|Overall Study|Lost to Follow-up|2|||
16907466|NCT01843062|38015876|FG001|Overall Study|Lost to Follow-up|4|||
16907467|NCT01842438|38015884|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
16907468|NCT01842438|38015885|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
16907469|NCT01842438|38015884|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
16907470|NCT01842438|38015885|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
16907471|NCT01842438|38015884|FG000|T2: 6month Follow-up|Death|0|||
16907472|NCT01842438|38015885|FG001|T2: 6month Follow-up|Death|1|||
16907473|NCT01799226|38015897|FG000|Overall Study|Withdrawal by Subject|1|||
16907474|NCT01799226|38015898|FG001|Overall Study|Withdrawal by Subject|0|||
16907475|NCT01799226|38015897|FG000|Overall Study|Disqualified at Day 14|1|||
16907476|NCT01799226|38015898|FG001|Overall Study|Disqualified at Day 14|0|||
16907477|NCT01798992|38015908|FG000|Overall Study|Administrative withdrawal|0|||
16907478|NCT01798992|38015909|FG001|Overall Study|Administrative withdrawal|1|||
16907479|NCT01798992|38015910|FG002|Overall Study|Administrative withdrawal|0|||
16907480|NCT01798992|38015911|FG003|Overall Study|Administrative withdrawal|1|||
16907481|NCT01798992|38015908|FG000|Overall Study|Lost to Follow-up|0|||
16907482|NCT01798992|38015909|FG001|Overall Study|Lost to Follow-up|1|||
16907483|NCT01798992|38015910|FG002|Overall Study|Lost to Follow-up|1|||
16907484|NCT01798992|38015911|FG003|Overall Study|Lost to Follow-up|0|||
16907485|NCT01798992|38015908|FG000|Overall Study|Insufficient biopsy tissue|0|||
16907486|NCT01798992|38015909|FG001|Overall Study|Insufficient biopsy tissue|0|||
16907487|NCT01798992|38015910|FG002|Overall Study|Insufficient biopsy tissue|1|||
16907488|NCT01798992|38015911|FG003|Overall Study|Insufficient biopsy tissue|0|||
16907489|NCT01825200|38015922|FG000|Overall Study|Lost to Follow-up|5|||
16907490|NCT01825200|38015923|FG001|Overall Study|Lost to Follow-up|6|||
16907491|NCT01825200|38015922|FG000|Overall Study|Withdrawal by Subject|0|||
16907492|NCT01825200|38015923|FG001|Overall Study|Withdrawal by Subject|1|||
16907493|NCT01824576|38015929|FG000|Overall Study|Device deficiency|2|||
16907494|NCT01824498|38015939|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
16907495|NCT01824498|38015940|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
16907496|NCT01824498|38015941|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
16907497|NCT01824498|38015942|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
16907498|NCT01824498|38015943|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
16907499|NCT01824498|38015944|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
16907500|NCT01798134|38015952|FG000|Overall Study|Lost to Follow-up|1|||
16907501|NCT01798134|38015952|FG000|Overall Study|Withdrawal by Subject|3|||
16907502|NCT01798134|38015952|FG000|Overall Study|Death|2|||
16907503|NCT01798134|38015952|FG000|Overall Study|Adverse Event|3|||
16907504|NCT01798134|38015952|FG000|Overall Study|Physician Decision|3|||
16907505|NCT01798134|38015952|FG000|Overall Study|Liver transplant/surgery|4|||
16907506|NCT01798056|38015958|FG000|Overall Study|Serious Adverse Event|13|||
16907507|NCT01798056|38015959|FG001|Overall Study|Serious Adverse Event|12|||
16907508|NCT01798056|38015958|FG000|Overall Study|Withdrawal by Subject|12|||
16907509|NCT01798056|38015959|FG001|Overall Study|Withdrawal by Subject|9|||
16907510|NCT01798056|38015958|FG000|Overall Study|Migrated/moved from study area|1|||
16907511|NCT01798056|38015959|FG001|Overall Study|Migrated/moved from study area|1|||
16907512|NCT01798056|38015958|FG000|Overall Study|Lost to Follow-up|1|||
16907513|NCT01798056|38015959|FG001|Overall Study|Lost to Follow-up|1|||
16907514|NCT01798056|38015958|FG000|Overall Study|Other|0|||
16907515|NCT01798056|38015959|FG001|Overall Study|Other|2|||
16907516|NCT01824342|38015969|FG000|Overall Study|Withdrawal by Subject|0|||
16907517|NCT01824342|38015970|FG001|Overall Study|Withdrawal by Subject|3|||
17095804|NCT00257660|38235089|FG000|Overall Study|No longer wanted to do blood draws|1|||
16907518|NCT01824342|38015969|FG000|Overall Study|Adverse Event|1|||
16907519|NCT01824342|38015970|FG001|Overall Study|Adverse Event|1|||
16907520|NCT01824342|38015969|FG000|Overall Study|Disease Progression|1|||
16907521|NCT01824342|38015970|FG001|Overall Study|Disease Progression|1|||
16907522|NCT01824342|38015969|FG000|Overall Study|Physician Decision|5|||
16907523|NCT01824342|38015970|FG001|Overall Study|Physician Decision|0|||
16907524|NCT01824342|38015969|FG000|Overall Study|Death|2|||
16907525|NCT01824342|38015970|FG001|Overall Study|Death|0|||
16907526|NCT01841970|38015976|FG000|Overall Study|Withdrawal by Subject|1|||
16907527|NCT01841970|38015976|FG000|Overall Study|Physician Decision|2|||
16907528|NCT01841970|38015976|FG000|Overall Study|Lost to Follow-up|8|||
16907529|NCT01823328|38015985|FG000|Overall Study|Withdrawal by Subject|8|||
16907530|NCT01823328|38015986|FG001|Overall Study|Withdrawal by Subject|6|||
16907531|NCT01840410|38015994|FG000|Overall Study|Physician Decision|1|||
16907532|NCT01840410|38015995|FG001|Overall Study|Physician Decision|2|||
16907533|NCT01840410|38015994|FG000|Overall Study|Pregnancy|1|||
16907534|NCT01840410|38015995|FG001|Overall Study|Pregnancy|0|||
16907535|NCT01840410|38015994|FG000|Overall Study|Protocol deviation|1|||
16907536|NCT01840410|38015995|FG001|Overall Study|Protocol deviation|0|||
16907537|NCT01840410|38015994|FG000|Overall Study|Lost to Follow-up|1|||
16907538|NCT01840410|38015995|FG001|Overall Study|Lost to Follow-up|0|||
16907539|NCT01840410|38015994|FG000|Overall Study|Withdrawal by Subject|2|||
16907540|NCT01840410|38015995|FG001|Overall Study|Withdrawal by Subject|1|||
16907541|NCT01840410|38015994|FG000|Overall Study|Adverse Event|1|||
16907542|NCT01840410|38015995|FG001|Overall Study|Adverse Event|1|||
16907543|NCT01797432|38016003|FG000|Overall Study|Lost to Follow-up|1|||
16907544|NCT01797432|38016003|FG000|Overall Study|Adverse Event|1|||
16907545|NCT01797432|38016003|FG000|Overall Study|Withdrawal by Subject|1|||
16907546|NCT01797432|38016003|FG000|Overall Study|lived too far from study site|1|||
16907547|NCT01797120|38016009|FG000|Overall Study|Disesae progression|37|||
16907548|NCT01797120|38016010|FG001|Overall Study|Disesae progression|49|||
16907549|NCT01797120|38016009|FG000|Overall Study|Adverse Event|13|||
16907550|NCT01797120|38016010|FG001|Overall Study|Adverse Event|5|||
16907551|NCT01797120|38016009|FG000|Overall Study|Withdrawal by Subject|6|||
16907552|NCT01797120|38016010|FG001|Overall Study|Withdrawal by Subject|6|||
16907553|NCT01797120|38016009|FG000|Overall Study|Symptomatic progression|2|||
16907554|NCT01797120|38016010|FG001|Overall Study|Symptomatic progression|1|||
16907555|NCT01797120|38016009|FG000|Overall Study|Non-compliance|1|||
16907556|NCT01797120|38016010|FG001|Overall Study|Non-compliance|0|||
16907557|NCT01797120|38016009|FG000|Overall Study|Physician Decision|3|||
16907558|NCT01797120|38016010|FG001|Overall Study|Physician Decision|0|||
16907559|NCT01797120|38016009|FG000|Overall Study|still on treatment|2|||
16907560|NCT01797120|38016010|FG001|Overall Study|still on treatment|4|||
16907561|NCT01797120|38016009|FG000|Overall Study|never start protocol therapy|2|||
16907562|NCT01797120|38016010|FG001|Overall Study|never start protocol therapy|0|||
16907563|NCT01796964|38016018|FG000|Overall Study|Adverse Event|1|||
16907564|NCT01796964|38016019|FG001|Overall Study|Adverse Event|1|||
16907565|NCT01796964|38016018|FG000|Overall Study|Death|1|||
16907566|NCT01796964|38016019|FG001|Overall Study|Death|0|||
16907567|NCT01796964|38016018|FG000|Overall Study|Protocol Violation|0|||
16907568|NCT01796964|38016019|FG001|Overall Study|Protocol Violation|1|||
16907569|NCT01796964|38016018|FG000|Overall Study|Withdrawal by Subject|1|||
16907570|NCT01796964|38016019|FG001|Overall Study|Withdrawal by Subject|1|||
16907571|NCT01838694|38016028|FG000|Overall Study|Adverse Event|0|||
16907572|NCT01838694|38016029|FG001|Overall Study|Adverse Event|1|||
16907573|NCT01795638|38016040|FG000|Overall Study|Death|0|||
16907574|NCT01795638|38016041|FG001|Overall Study|Death|3|||
16907575|NCT01795638|38016040|FG000|Overall Study|transferred to quaternary hospital|2|||
16907576|NCT01795638|38016041|FG001|Overall Study|transferred to quaternary hospital|3|||
16907577|NCT01795638|38016040|FG000|Overall Study|Protocol Violation|3|||
16907578|NCT01795638|38016041|FG001|Overall Study|Protocol Violation|0|||
16907579|NCT01795638|38016040|FG000|Overall Study|discharged from hospital|7|||
16907580|NCT01795638|38016041|FG001|Overall Study|discharged from hospital|5|||
16907581|NCT01795638|38016040|FG000|Overall Study|Withdrawal by Subject|1|||
16907582|NCT01795638|38016041|FG001|Overall Study|Withdrawal by Subject|0|||
16907583|NCT01794780|38016055|FG000|Overall Study|Adverse Event|0|||
16907584|NCT01794780|38016056|FG001|Overall Study|Adverse Event|1|||
16907585|NCT01794780|38016057|FG002|Overall Study|Adverse Event|2|||
16907586|NCT01794780|38016058|FG003|Overall Study|Adverse Event|0|||
16907587|NCT01794780|38016059|FG004|Overall Study|Adverse Event|0|||
17095805|NCT00257660|38235090|FG001|Overall Study|No longer wanted to do blood draws|0|||
16907588|NCT01794780|38016060|FG005|Overall Study|Adverse Event|0|||
16907589|NCT01794780|38016061|FG006|Overall Study|Adverse Event|0|||
16907590|NCT01794780|38016062|FG007|Overall Study|Adverse Event|0|||
16907591|NCT01794780|38016055|FG000|Overall Study|Death|0|||
16907592|NCT01794780|38016056|FG001|Overall Study|Death|2|||
16907593|NCT01794780|38016057|FG002|Overall Study|Death|14|||
16907594|NCT01794780|38016058|FG003|Overall Study|Death|1|||
16907595|NCT01794780|38016059|FG004|Overall Study|Death|0|||
16907596|NCT01794780|38016060|FG005|Overall Study|Death|9|||
16907597|NCT01794780|38016061|FG006|Overall Study|Death|4|||
16907598|NCT01794780|38016062|FG007|Overall Study|Death|0|||
16907599|NCT01794780|38016055|FG000|Overall Study|Lost to Follow-up|10|||
16907600|NCT01794780|38016056|FG001|Overall Study|Lost to Follow-up|64|||
16907601|NCT01794780|38016057|FG002|Overall Study|Lost to Follow-up|165|||
16907602|NCT01794780|38016058|FG003|Overall Study|Lost to Follow-up|53|||
16907603|NCT01794780|38016059|FG004|Overall Study|Lost to Follow-up|2|||
16907604|NCT01794780|38016060|FG005|Overall Study|Lost to Follow-up|99|||
16907605|NCT01794780|38016061|FG006|Overall Study|Lost to Follow-up|30|||
16907606|NCT01794780|38016062|FG007|Overall Study|Lost to Follow-up|5|||
16907607|NCT01794780|38016055|FG000|Overall Study|Withdrew informed consent|7|||
16907608|NCT01794780|38016056|FG001|Overall Study|Withdrew informed consent|17|||
16907609|NCT01794780|38016057|FG002|Overall Study|Withdrew informed consent|36|||
16907610|NCT01794780|38016058|FG003|Overall Study|Withdrew informed consent|9|||
16907611|NCT01794780|38016059|FG004|Overall Study|Withdrew informed consent|0|||
16907612|NCT01794780|38016060|FG005|Overall Study|Withdrew informed consent|48|||
16907613|NCT01794780|38016061|FG006|Overall Study|Withdrew informed consent|4|||
16907614|NCT01794780|38016062|FG007|Overall Study|Withdrew informed consent|3|||
16907615|NCT01794780|38016055|FG000|Overall Study|Other|0|||
16907616|NCT01794780|38016056|FG001|Overall Study|Other|12|||
16907617|NCT01794780|38016057|FG002|Overall Study|Other|25|||
16907618|NCT01794780|38016058|FG003|Overall Study|Other|20|||
16907619|NCT01794780|38016059|FG004|Overall Study|Other|1|||
16907620|NCT01794780|38016060|FG005|Overall Study|Other|24|||
16907621|NCT01794780|38016061|FG006|Overall Study|Other|4|||
16907622|NCT01794780|38016062|FG007|Overall Study|Other|1|||
16907623|NCT01838616|38016089|FG000|Titration Period|Adverse Event|18|||
16907624|NCT01838616|38016090|FG001|Titration Period|Adverse Event|48|||
16907625|NCT01838616|38016089|FG000|Titration Period|Lack of Efficacy|5|||
16907626|NCT01838616|38016090|FG001|Titration Period|Lack of Efficacy|12|||
16907627|NCT01838616|38016089|FG000|Titration Period|Withdrawal by Subject|5|||
16907628|NCT01838616|38016090|FG001|Titration Period|Withdrawal by Subject|5|||
16907629|NCT01838616|38016089|FG000|Titration Period|Technical problems|1|||
16907630|NCT01838616|38016090|FG001|Titration Period|Technical problems|0|||
16907631|NCT01838616|38016089|FG000|Titration Period|Other|1|||
16907632|NCT01838616|38016090|FG001|Titration Period|Other|0|||
16907633|NCT01838616|38016089|FG000|Titration Period|Protocol Violation|0|||
16907634|NCT01838616|38016090|FG001|Titration Period|Protocol Violation|1|||
16907635|NCT01838616|38016089|FG000|Continuation Period|Lack of Efficacy|3|||
16907636|NCT01838616|38016090|FG001|Continuation Period|Lack of Efficacy|5|||
16907637|NCT01838616|38016089|FG000|Continuation Period|Adverse Event|8|||
16907638|NCT01838616|38016090|FG001|Continuation Period|Adverse Event|4|||
16907639|NCT01838616|38016089|FG000|Continuation Period|Protocol Violation|2|||
16907640|NCT01838616|38016090|FG001|Continuation Period|Protocol Violation|0|||
16907641|NCT01838616|38016089|FG000|Continuation Period|Lost to Follow-up|1|||
16907642|NCT01838616|38016090|FG001|Continuation Period|Lost to Follow-up|0|||
16907643|NCT01838616|38016089|FG000|Continuation Period|Withdrawal by Subject|0|||
16907644|NCT01838616|38016090|FG001|Continuation Period|Withdrawal by Subject|4|||
16907645|NCT01838616|38016089|FG000|Continuation Period|Technical problems|0|||
16907646|NCT01838616|38016090|FG001|Continuation Period|Technical problems|1|||
16907647|NCT01838616|38016089|FG000|Pick-up Arm|Lack of Efficacy|4|||
16907648|NCT01838616|38016090|FG001|Pick-up Arm|Lack of Efficacy|0|||
16907649|NCT01838616|38016089|FG000|Pick-up Arm|Adverse Event|9|||
16907650|NCT01838616|38016090|FG001|Pick-up Arm|Adverse Event|0|||
16907651|NCT01838616|38016089|FG000|Pick-up Arm|Withdrawal by Subject|1|||
16907652|NCT01838616|38016090|FG001|Pick-up Arm|Withdrawal by Subject|0|||
16907653|NCT01838616|38016089|FG000|Pick-up Arm|Technical problems|1|||
16907654|NCT01838616|38016090|FG001|Pick-up Arm|Technical problems|0|||
16907655|NCT01611792|38016103|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
16907656|NCT01611792|38016104|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
16907657|NCT01611792|38016103|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
16907658|NCT01611792|38016104|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
16907659|NCT01820364|38016111|FG000|Part I: LGX818|Death|1|||
16907660|NCT01820364|38016112|FG001|Part I: LGX818|Death|0|||
16907661|NCT01820364|38016111|FG000|Part I: LGX818|Administrative Problems|3|||
16907662|NCT01820364|38016112|FG001|Part I: LGX818|Administrative Problems|0|||
16907663|NCT01820364|38016111|FG000|Part I: LGX818|Adverse Event|6|||
16907664|NCT01820364|38016112|FG001|Part I: LGX818|Adverse Event|0|||
16907665|NCT01820364|38016111|FG000|Part I: LGX818|Disease Progression|4|||
16907666|NCT01820364|38016112|FG001|Part I: LGX818|Disease Progression|0|||
16907667|NCT01820364|38016111|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
16907668|NCT01820364|38016112|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
16907669|NCT01819506|38016120|FG000|Overall Study|Physician Decision|5|||
16907670|NCT01819506|38016121|FG001|Overall Study|Physician Decision|2|||
16907671|NCT01819506|38016120|FG000|Overall Study|Withdrawal by Subject|3|||
16907672|NCT01819506|38016121|FG001|Overall Study|Withdrawal by Subject|3|||
16907673|NCT01794000|38016129|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
16907674|NCT01794000|38016130|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
16907675|NCT01794000|38016129|FG000|Double-Blind Phase (DBP)|Death|1|||
16907676|NCT01794000|38016130|FG001|Double-Blind Phase (DBP)|Death|2|||
16907677|NCT01794000|38016129|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
16907678|NCT01794000|38016130|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
16907679|NCT01794000|38016129|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
16907680|NCT01794000|38016130|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
16907681|NCT01794000|38016129|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
16907682|NCT01794000|38016130|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
16907683|NCT01794000|38016129|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
16907684|NCT01794000|38016130|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
16907685|NCT01794000|38016129|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
16907686|NCT01794000|38016130|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
16907687|NCT01794000|38016129|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
16907688|NCT01794000|38016130|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16907689|NCT01609296|38016137|FG000|Overall Study|Death|253|||
16907690|NCT01609296|38016137|FG000|Overall Study|Withdrawal by Subject|151|||
16907691|NCT01609296|38016137|FG000|Overall Study|Lost to Follow-up|21|||
16907692|NCT01609296|38016137|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
16907693|NCT01609296|38016137|FG000|Overall Study|missed visit but known to be alive|28|||
16907694|NCT01609218|38016145|FG000|Period 1|Adverse Event|3|||
16907695|NCT01609218|38016146|FG001|Period 1|Adverse Event|5|||
16907696|NCT01609218|38016145|FG000|Period 1|Sponsor Decision|0|||
16907697|NCT01609218|38016146|FG001|Period 1|Sponsor Decision|1|||
16907698|NCT01609218|38016145|FG000|Period 2|Adverse Event|1|||
16907699|NCT01609218|38016146|FG001|Period 2|Adverse Event|0|||
16907700|NCT01609062|38016154|FG000|Extension Phase|Terminated by Sponsor|14|||
16907701|NCT01609062|38016155|FG001|Extension Phase|Terminated by Sponsor|9|||
16907702|NCT01609062|38016154|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
16907703|NCT01609062|38016155|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
16907704|NCT01609062|38016154|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
16907705|NCT01609062|38016155|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
16907706|NCT01819272|38016168|FG000|Overall Study|Adverse Event|1|||
16907707|NCT01819272|38016169|FG001|Overall Study|Adverse Event|0|||
16907708|NCT01819272|38016170|FG002|Overall Study|Adverse Event|0|||
16907709|NCT01819272|38016171|FG003|Overall Study|Adverse Event|2|||
16907710|NCT01819272|38016172|FG004|Overall Study|Adverse Event|0|||
16907711|NCT01819272|38016173|FG005|Overall Study|Adverse Event|0|||
16907712|NCT01819272|38016168|FG000|Overall Study|Lost to Follow-up|3|||
16907713|NCT01819272|38016169|FG001|Overall Study|Lost to Follow-up|0|||
16907714|NCT01819272|38016170|FG002|Overall Study|Lost to Follow-up|1|||
16907715|NCT01819272|38016171|FG003|Overall Study|Lost to Follow-up|0|||
16907716|NCT01819272|38016172|FG004|Overall Study|Lost to Follow-up|0|||
16907717|NCT01819272|38016173|FG005|Overall Study|Lost to Follow-up|3|||
16907718|NCT01819272|38016168|FG000|Overall Study|Protocol Violation|0|||
16907719|NCT01819272|38016169|FG001|Overall Study|Protocol Violation|0|||
16907720|NCT01819272|38016170|FG002|Overall Study|Protocol Violation|0|||
16907721|NCT01819272|38016171|FG003|Overall Study|Protocol Violation|1|||
16907722|NCT01819272|38016172|FG004|Overall Study|Protocol Violation|2|||
16907723|NCT01819272|38016173|FG005|Overall Study|Protocol Violation|3|||
16907724|NCT01819272|38016168|FG000|Overall Study|Physician Decision|0|||
16907725|NCT01819272|38016169|FG001|Overall Study|Physician Decision|1|||
16907726|NCT01819272|38016170|FG002|Overall Study|Physician Decision|0|||
16907727|NCT01819272|38016171|FG003|Overall Study|Physician Decision|0|||
16907728|NCT01819272|38016172|FG004|Overall Study|Physician Decision|0|||
16907729|NCT01819272|38016173|FG005|Overall Study|Physician Decision|0|||
16907730|NCT01819272|38016168|FG000|Overall Study|Withdrawal of Consent|0|||
16907731|NCT01819272|38016169|FG001|Overall Study|Withdrawal of Consent|1|||
16907732|NCT01819272|38016170|FG002|Overall Study|Withdrawal of Consent|2|||
16907733|NCT01819272|38016171|FG003|Overall Study|Withdrawal of Consent|1|||
16907734|NCT01819272|38016172|FG004|Overall Study|Withdrawal of Consent|0|||
16907735|NCT01819272|38016173|FG005|Overall Study|Withdrawal of Consent|1|||
16907736|NCT01819272|38016168|FG000|Overall Study|Loss of Glucose Control|2|||
16907737|NCT01819272|38016169|FG001|Overall Study|Loss of Glucose Control|1|||
16907738|NCT01819272|38016170|FG002|Overall Study|Loss of Glucose Control|0|||
16907739|NCT01819272|38016171|FG003|Overall Study|Loss of Glucose Control|1|||
16907740|NCT01819272|38016172|FG004|Overall Study|Loss of Glucose Control|2|||
16907741|NCT01819272|38016173|FG005|Overall Study|Loss of Glucose Control|0|||
16907742|NCT01819194|38016187|FG000|Overall Study|Loss of study articles|2|||
16907743|NCT01611558|38016191|FG000|Induction Phase|Study drug toxicity|15|||
16907744|NCT01611558|38016191|FG000|Induction Phase|Disease progression|18|||
16907745|NCT01611558|38016191|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
17007148|NCT00777153|38150935|FG001|Overall Study|Withdrawal by Subject|4|||
16907746|NCT01611558|38016191|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
16907747|NCT01611558|38016191|FG000|Induction Phase|Death|1|||
16907748|NCT01611558|38016191|FG000|Maintenance Phase|Withdrawal by Subject|1|||
16907749|NCT01611558|38016191|FG000|Maintenance Phase|Elevated Uric acid|1|||
16907750|NCT01818726|38016198|FG000|Overall Study|Administrative reasons|5|||
16907751|NCT01818726|38016199|FG001|Overall Study|Administrative reasons|1|||
16907752|NCT01818726|38016198|FG000|Overall Study|Withdrawal by Subject|0|||
16907753|NCT01818726|38016199|FG001|Overall Study|Withdrawal by Subject|1|||
16907754|NCT01818726|38016198|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
16907755|NCT01818726|38016199|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
16907756|NCT01818336|38016205|FG000|Overall Study|Declined retest visit|0|||
16907757|NCT01818336|38016206|FG001|Overall Study|Declined retest visit|11|||
16907758|NCT01818336|38016205|FG000|Overall Study|Lost to Follow-up|0|||
16907759|NCT01818336|38016206|FG001|Overall Study|Lost to Follow-up|1|||
16907760|NCT01818258|38016214|FG000|Overall Study|Death|3|||
16907761|NCT01818258|38016215|FG001|Overall Study|Death|0|||
16907762|NCT01818258|38016214|FG000|Overall Study|Withdrawal by Subject|0|||
16907763|NCT01818258|38016215|FG001|Overall Study|Withdrawal by Subject|1|||
16907764|NCT01818258|38016214|FG000|Overall Study|Lost to Follow-up|0|||
16907765|NCT01818258|38016215|FG001|Overall Study|Lost to Follow-up|1|||
16907766|NCT01818258|38016214|FG000|Overall Study|Unable to Travel to Clinic|0|||
16907767|NCT01818258|38016215|FG001|Overall Study|Unable to Travel to Clinic|1|||
16907768|NCT01817790|38016224|FG000|Overall Study|Adverse Event|0|||
16907769|NCT01817790|38016225|FG001|Overall Study|Adverse Event|2|||
16907770|NCT01817790|38016224|FG000|Overall Study|Lost to Follow-up|0|||
16907771|NCT01817790|38016225|FG001|Overall Study|Lost to Follow-up|1|||
16907772|NCT01817790|38016224|FG000|Overall Study|Protocol Violation|2|||
16907773|NCT01817790|38016225|FG001|Overall Study|Protocol Violation|1|||
16907774|NCT01817790|38016224|FG000|Overall Study|Withdrawal by Subject|1|||
17007149|NCT00777153|38150936|FG002|Overall Study|Withdrawal by Subject|3|||
17007150|NCT00777153|38150934|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
17007151|NCT00777153|38150935|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
17007152|NCT00777153|38150936|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
17007153|NCT00567541|38150950|FG000|Overall Study|Adverse Event|0|||
17007154|NCT00567541|38150951|FG001|Overall Study|Adverse Event|1|||
17007155|NCT00776997|38150957|FG000|Overall Study|Adverse Event|2|||
17007156|NCT00940823|38150963|FG000|Overall Study|Death|8|||
17007157|NCT00940823|38150964|FG001|Overall Study|Death|12|||
17007158|NCT00940823|38150963|FG000|Overall Study|Lost to Follow-up|27|||
16907775|NCT01817790|38016225|FG001|Overall Study|Withdrawal by Subject|3|||
16907776|NCT01817790|38016224|FG000|Overall Study|Other: Could not attend appointment|1|||
16907777|NCT01817790|38016225|FG001|Overall Study|Other: Could not attend appointment|1|||
16907778|NCT01793688|38016233|FG000|Overall Study|Protocol Violation|2|||
16907779|NCT01793610|38016240|FG000|Overall Study|Withdrawal by Subject|1|||
16907780|NCT01793610|38016241|FG001|Overall Study|Withdrawal by Subject|0|||
16907781|NCT01793610|38016242|FG002|Overall Study|Withdrawal by Subject|1|||
16907782|NCT01793142|38016254|FG000|Overall Study|Randomized not treated|7|||
16907783|NCT01792830|38016269|FG000|Overall Study|Withdrawal by Subject|22|||
16907784|NCT01792830|38016270|FG001|Overall Study|Withdrawal by Subject|0|||
16907785|NCT01792830|38016271|FG002|Overall Study|Withdrawal by Subject|0|||
16907786|NCT01792830|38016272|FG003|Overall Study|Withdrawal by Subject|2|||
16907787|NCT01792830|38016273|FG004|Overall Study|Withdrawal by Subject|1|||
16907788|NCT01792830|38016274|FG005|Overall Study|Withdrawal by Subject|1|||
16907789|NCT01792830|38016275|FG006|Overall Study|Withdrawal by Subject|1|||
16907790|NCT01792830|38016276|FG007|Overall Study|Withdrawal by Subject|1|||
16907791|NCT01792830|38016277|FG008|Overall Study|Withdrawal by Subject|7|||
16907792|NCT01792830|38016278|FG009|Overall Study|Withdrawal by Subject|0|||
16907793|NCT01792830|38016279|FG010|Overall Study|Withdrawal by Subject|2|||
16907794|NCT01792830|38016269|FG000|Overall Study|Death|3|||
16907795|NCT01792830|38016270|FG001|Overall Study|Death|0|||
16907796|NCT01792830|38016271|FG002|Overall Study|Death|0|||
16907797|NCT01792830|38016272|FG003|Overall Study|Death|1|||
16907798|NCT01792830|38016273|FG004|Overall Study|Death|0|||
16907799|NCT01792830|38016274|FG005|Overall Study|Death|0|||
16907800|NCT01792830|38016275|FG006|Overall Study|Death|1|||
16907801|NCT01792830|38016276|FG007|Overall Study|Death|0|||
16907802|NCT01792830|38016277|FG008|Overall Study|Death|1|||
16907803|NCT01792830|38016278|FG009|Overall Study|Death|0|||
16907804|NCT01792830|38016279|FG010|Overall Study|Death|1|||
17007159|NCT00940823|38150964|FG001|Overall Study|Lost to Follow-up|20|||
17007160|NCT00936611|38150972|FG000|Overall Study|Progressive Disease|3|||
17095806|NCT00224042|38235098|FG000|Overall Study|Adverse Event|2|||
17007161|NCT00936611|38150972|FG000|Overall Study|New Systemic Therapy|22|||
17007162|NCT00936611|38150972|FG000|Overall Study|Lost to Follow-up|1|||
16907805|NCT01792830|38016269|FG000|Overall Study|Adverse Event|0|||
16907806|NCT01792830|38016270|FG001|Overall Study|Adverse Event|0|||
16907807|NCT01792830|38016271|FG002|Overall Study|Adverse Event|0|||
16907808|NCT01792830|38016272|FG003|Overall Study|Adverse Event|0|||
16907809|NCT01792830|38016273|FG004|Overall Study|Adverse Event|0|||
16907810|NCT01792830|38016274|FG005|Overall Study|Adverse Event|0|||
16907811|NCT01792830|38016275|FG006|Overall Study|Adverse Event|0|||
16907812|NCT01792830|38016276|FG007|Overall Study|Adverse Event|0|||
16907813|NCT01792830|38016277|FG008|Overall Study|Adverse Event|1|||
17007163|NCT00936611|38150972|FG000|Overall Study|Withdrawal by Subject|2|||
17007164|NCT00936611|38150972|FG000|Overall Study|Still on Follow-up|1|||
16907814|NCT01792830|38016278|FG009|Overall Study|Adverse Event|0|||
16907815|NCT01792830|38016279|FG010|Overall Study|Adverse Event|0|||
16907816|NCT01792518|38016311|FG000|Overall Study|Adverse Event|3|||
16907817|NCT01792518|38016312|FG001|Overall Study|Adverse Event|4|||
16907818|NCT01792518|38016311|FG000|Overall Study|Protocol Violation|0|||
16907819|NCT01792518|38016312|FG001|Overall Study|Protocol Violation|1|||
16907820|NCT01792518|38016311|FG000|Overall Study|Lost to Follow-up|3|||
16907821|NCT01792518|38016312|FG001|Overall Study|Lost to Follow-up|1|||
16907822|NCT01792518|38016311|FG000|Overall Study|Withdrawal by Subject|2|||
16907823|NCT01792518|38016312|FG001|Overall Study|Withdrawal by Subject|0|||
16907824|NCT01792518|38016311|FG000|Overall Study|Other Reason|0|||
16907825|NCT01792518|38016312|FG001|Overall Study|Other Reason|1|||
16907826|NCT01792284|38016318|FG000|Lead-in Period|Adverse Event|15|||
16907827|NCT01792284|38016319|FG001|Lead-in Period|Adverse Event|0|||
16907828|NCT01792284|38016320|FG002|Lead-in Period|Adverse Event|0|||
16907829|NCT01792284|38016318|FG000|Lead-in Period|Lost to Follow-up|2|||
16907830|NCT01792284|38016319|FG001|Lead-in Period|Lost to Follow-up|0|||
16907831|NCT01792284|38016320|FG002|Lead-in Period|Lost to Follow-up|0|||
16907832|NCT01792284|38016318|FG000|Lead-in Period|Protocol Violation|1|||
16907833|NCT01792284|38016319|FG001|Lead-in Period|Protocol Violation|0|||
16907834|NCT01792284|38016320|FG002|Lead-in Period|Protocol Violation|0|||
16907835|NCT01792284|38016318|FG000|Lead-in Period|Withdrawal by Subject|10|||
16907836|NCT01792284|38016319|FG001|Lead-in Period|Withdrawal by Subject|0|||
16907837|NCT01792284|38016320|FG002|Lead-in Period|Withdrawal by Subject|0|||
16907838|NCT01792284|38016318|FG000|Lead-in Period|Physician Decision|1|||
16907839|NCT01792284|38016319|FG001|Lead-in Period|Physician Decision|0|||
16907840|NCT01792284|38016320|FG002|Lead-in Period|Physician Decision|0|||
16907841|NCT01792284|38016318|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
16907842|NCT01792284|38016319|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
16907843|NCT01792284|38016320|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
16907844|NCT01792284|38016318|FG000|Randomization Period 1|Withdrawal by Subject|0|||
16907845|NCT01792284|38016319|FG001|Randomization Period 1|Withdrawal by Subject|1|||
16907846|NCT01792284|38016320|FG002|Randomization Period 1|Withdrawal by Subject|1|||
16907847|NCT01792284|38016318|FG000|Randomization Period 1|Physician Decision|0|||
16907848|NCT01792284|38016319|FG001|Randomization Period 1|Physician Decision|1|||
16907849|NCT01792284|38016320|FG002|Randomization Period 1|Physician Decision|1|||
16907850|NCT01792284|38016318|FG000|Randomization Period 1|Adverse Event|0|||
16907851|NCT01792284|38016319|FG001|Randomization Period 1|Adverse Event|0|||
17007165|NCT00936611|38150972|FG000|Overall Study|Still on Active Therapy|7|||
17007166|NCT00936611|38150972|FG000|Overall Study|Ineligible for Study Drug|3|||
17007167|NCT00936221|38150995|FG000|Overall Study|Withdrawal by Subject|1|||
17007168|NCT00936221|38150996|FG001|Overall Study|Withdrawal by Subject|1|||
17007169|NCT00776919|38151006|FG000|Overall Study|Withdrawal by Subject|16|||
17007170|NCT00776919|38151007|FG001|Overall Study|Withdrawal by Subject|14|||
16907852|NCT01792284|38016320|FG002|Randomization Period 1|Adverse Event|2|||
16907853|NCT01792284|38016318|FG000|Randomization Period 1|Lost to Follow-up|0|||
16907854|NCT01792284|38016319|FG001|Randomization Period 1|Lost to Follow-up|0|||
16907855|NCT01792284|38016320|FG002|Randomization Period 1|Lost to Follow-up|1|||
16907856|NCT01792284|38016318|FG000|Randomization Period 2|Protocol Violation|0|||
16907857|NCT01792284|38016319|FG001|Randomization Period 2|Protocol Violation|1|||
16907858|NCT01792284|38016320|FG002|Randomization Period 2|Protocol Violation|0|||
16907859|NCT01792284|38016318|FG000|Randomization Period 2|Withdrawal by Subject|0|||
16907860|NCT01792284|38016319|FG001|Randomization Period 2|Withdrawal by Subject|2|||
16907861|NCT01792284|38016320|FG002|Randomization Period 2|Withdrawal by Subject|0|||
17007171|NCT00776919|38151008|FG002|Overall Study|Withdrawal by Subject|15|||
17007172|NCT00776919|38151009|FG003|Overall Study|Withdrawal by Subject|26|||
17007173|NCT00776919|38151006|FG000|Overall Study|Lost to Follow-up|8|||
17007174|NCT00776919|38151007|FG001|Overall Study|Lost to Follow-up|12|||
17007175|NCT00776919|38151008|FG002|Overall Study|Lost to Follow-up|11|||
17007176|NCT00776919|38151009|FG003|Overall Study|Lost to Follow-up|8|||
17007177|NCT00776919|38151006|FG000|Overall Study|Adverse Event|1|||
17007178|NCT00776919|38151007|FG001|Overall Study|Adverse Event|0|||
17007179|NCT00776919|38151008|FG002|Overall Study|Adverse Event|2|||
17007180|NCT00776919|38151009|FG003|Overall Study|Adverse Event|2|||
17007181|NCT00776919|38151006|FG000|Overall Study|Protocol Violation|1|||
17007182|NCT00776919|38151007|FG001|Overall Study|Protocol Violation|2|||
17007183|NCT00776919|38151008|FG002|Overall Study|Protocol Violation|0|||
17007184|NCT00776919|38151009|FG003|Overall Study|Protocol Violation|1|||
16907862|NCT01791894|38016328|FG000|Overall Study|Adverse Event|1|||
16907863|NCT01837680|38016335|FG000|Overall Study|Lost to Follow-up|2|||
16907864|NCT01837680|38016336|FG001|Overall Study|Lost to Follow-up|2|||
16907865|NCT01837680|38016335|FG000|Overall Study|lack of insurance|0|||
16907866|NCT01837680|38016336|FG001|Overall Study|lack of insurance|2|||
16907867|NCT01837680|38016335|FG000|Overall Study|allergic reaction|6|||
16907868|NCT01837680|38016336|FG001|Overall Study|allergic reaction|0|||
16907869|NCT01837680|38016335|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
16907870|NCT01837680|38016336|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
16907871|NCT01836276|38016344|FG000|Overall Study|Lost to Follow-up|28|||
16907872|NCT01836276|38016345|FG001|Overall Study|Lost to Follow-up|51|||
16907873|NCT01790568|38016351|FG000|Overall Study|Progression prior to transplant|0|||
16907874|NCT01790568|38016352|FG001|Overall Study|Progression prior to transplant|1|||
16907875|NCT01610076|38016358|FG000|Overall Study|Technical issue with video|0|||
16907876|NCT01610076|38016359|FG001|Overall Study|Technical issue with video|1|||
16907877|NCT01610076|38016358|FG000|Overall Study|Lost to Follow-up|3|||
16907878|NCT01610076|38016359|FG001|Overall Study|Lost to Follow-up|4|||
16907879|NCT01836198|38016368|FG000|Part A, Period 2|Protocol Violation|0|||
16907880|NCT01836198|38016369|FG001|Part A, Period 2|Protocol Violation|1|||
16907881|NCT01836198|38016370|FG002|Part A, Period 2|Protocol Violation|0|||
16907882|NCT01816074|38016390|FG000|Phase 1|Time commitment issues|0|||
16907883|NCT01816074|38016391|FG001|Phase 1|Time commitment issues|0|||
16907884|NCT01816074|38016392|FG002|Phase 1|Time commitment issues|1|||
16907885|NCT01816074|38016393|FG003|Phase 1|Time commitment issues|0|||
16907886|NCT01816074|38016390|FG000|Phase 2|Time commitment Issues|0|||
16907887|NCT01816074|38016391|FG001|Phase 2|Time commitment Issues|2|||
16907888|NCT01816074|38016392|FG002|Phase 2|Time commitment Issues|0|||
16907889|NCT01816074|38016393|FG003|Phase 2|Time commitment Issues|0|||
16907890|NCT01816074|38016390|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
16907891|NCT01816074|38016391|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
16907892|NCT01816074|38016392|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
16907893|NCT01816074|38016393|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
16907894|NCT01816074|38016390|FG000|Phase 2|Physician Decision|0|||
16907895|NCT01816074|38016391|FG001|Phase 2|Physician Decision|0|||
16907896|NCT01816074|38016392|FG002|Phase 2|Physician Decision|0|||
16907897|NCT01816074|38016393|FG003|Phase 2|Physician Decision|1|||
16907898|NCT01816074|38016390|FG000|Phase 2|Withdrawal by Subject|1|||
16907899|NCT01816074|38016391|FG001|Phase 2|Withdrawal by Subject|0|||
16907900|NCT01816074|38016392|FG002|Phase 2|Withdrawal by Subject|0|||
16907901|NCT01816074|38016393|FG003|Phase 2|Withdrawal by Subject|0|||
16907902|NCT01815918|38016419|FG000|Overall Study|Patient samples not analyzable|3|||
16907903|NCT01815918|38016420|FG001|Overall Study|Patient samples not analyzable|4|||
16907904|NCT01815918|38016419|FG000|Overall Study|Lack of Efficacy|15|||
16907905|NCT01815918|38016420|FG001|Overall Study|Lack of Efficacy|15|||
16907906|NCT01789476|38016432|FG000|Overall Study|Lack of Efficacy|6|||
16907907|NCT01789476|38016433|FG001|Overall Study|Lack of Efficacy|2|||
16907908|NCT01789476|38016432|FG000|Overall Study|Adverse Event|1|||
16907909|NCT01789476|38016433|FG001|Overall Study|Adverse Event|0|||
16907910|NCT01789476|38016432|FG000|Overall Study|Unable to get IV access|1|||
16907911|NCT01789476|38016433|FG001|Overall Study|Unable to get IV access|0|||
16907912|NCT01789320|38016439|FG000|Overall Study|Re-enrolled into study|1|||
16907913|NCT01789320|38016439|FG000|Overall Study|Lost to Follow-up|1|||
16907914|NCT01815840|38016445|FG000|Overall Study|Missing|1|||
16907915|NCT01815840|38016446|FG001|Overall Study|Missing|0|||
16907916|NCT01815840|38016445|FG000|Overall Study|Withdrew Consent|31|||
16907917|NCT01815840|38016446|FG001|Overall Study|Withdrew Consent|30|||
16907918|NCT01815840|38016445|FG000|Overall Study|Administrative/Other|1|||
16907919|NCT01815840|38016446|FG001|Overall Study|Administrative/Other|3|||
16907920|NCT01815840|38016445|FG000|Overall Study|Adverse Event|10|||
16907921|NCT01815840|38016446|FG001|Overall Study|Adverse Event|16|||
16907922|NCT01815840|38016445|FG000|Overall Study|Death|2|||
16907923|NCT01815840|38016446|FG001|Overall Study|Death|2|||
16907924|NCT01815840|38016445|FG000|Overall Study|Disease progression|3|||
16907925|NCT01815840|38016446|FG001|Overall Study|Disease progression|2|||
16907926|NCT01815840|38016445|FG000|Overall Study|Investigators Decision|2|||
16907927|NCT01815840|38016446|FG001|Overall Study|Investigators Decision|3|||
16907928|NCT01815840|38016445|FG000|Overall Study|Lost to Follow-up|3|||
16907929|NCT01815840|38016446|FG001|Overall Study|Lost to Follow-up|6|||
16907930|NCT01815840|38016445|FG000|Overall Study|Refused Treatment|5|||
16907931|NCT01815840|38016446|FG001|Overall Study|Refused Treatment|1|||
16907932|NCT01815840|38016445|FG000|Overall Study|Sponsor Termination Treatment|1|||
16907933|NCT01815840|38016446|FG001|Overall Study|Sponsor Termination Treatment|0|||
16907934|NCT01774110|38016452|FG000|Overall Study|Lost to Follow-up|7|||
16907935|NCT01788228|38016459|FG000|Overall Study|Migrated/moved from study area|1|||
16907936|NCT01788228|38016460|FG001|Overall Study|Migrated/moved from study area|0|||
16907937|NCT01607346|38016469|FG000|Overall Study|Adverse Event|3|||
17007185|NCT00776919|38151006|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
16907938|NCT01787838|38016473|FG000|Overall Study|refused|1413|||
16907939|NCT01787760|38016480|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
16907940|NCT01787760|38016481|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
16907941|NCT01787760|38016482|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
16907942|NCT01787760|38016480|FG000|Overall Study|Decompensated on left exotropia|0|||
16907943|NCT01787760|38016481|FG001|Overall Study|Decompensated on left exotropia|0|||
16907944|NCT01787760|38016482|FG002|Overall Study|Decompensated on left exotropia|1|||
16907945|NCT01787760|38016480|FG000|Overall Study|Dryness|0|||
16907946|NCT01787760|38016481|FG001|Overall Study|Dryness|1|||
16907947|NCT01787760|38016482|FG002|Overall Study|Dryness|0|||
16907948|NCT01787760|38016480|FG000|Overall Study|Relocation|1|||
16907949|NCT01787760|38016481|FG001|Overall Study|Relocation|1|||
16907950|NCT01787760|38016482|FG002|Overall Study|Relocation|0|||
16907951|NCT01787760|38016480|FG000|Overall Study|Lens discomfort|3|||
16907952|NCT01787760|38016481|FG001|Overall Study|Lens discomfort|0|||
16907953|NCT01787760|38016482|FG002|Overall Study|Lens discomfort|0|||
16907954|NCT01787760|38016480|FG000|Overall Study|Lens handling difficulty|1|||
16907955|NCT01787760|38016481|FG001|Overall Study|Lens handling difficulty|2|||
16907956|NCT01787760|38016482|FG002|Overall Study|Lens handling difficulty|0|||
16907957|NCT01787760|38016480|FG000|Overall Study|Protocol Violation|6|||
16907958|NCT01787760|38016481|FG001|Overall Study|Protocol Violation|0|||
16907959|NCT01787760|38016482|FG002|Overall Study|Protocol Violation|1|||
16907960|NCT01787760|38016480|FG000|Overall Study|Withdrawal by Subject|5|||
16907961|NCT01787760|38016481|FG001|Overall Study|Withdrawal by Subject|1|||
16907962|NCT01787760|38016482|FG002|Overall Study|Withdrawal by Subject|2|||
16907963|NCT01787760|38016480|FG000|Overall Study|Lost to Follow-up|1|||
16907964|NCT01787760|38016481|FG001|Overall Study|Lost to Follow-up|0|||
16907965|NCT01787760|38016482|FG002|Overall Study|Lost to Follow-up|1|||
16907966|NCT01787760|38016480|FG000|Overall Study|Stroke|1|||
16907967|NCT01787760|38016481|FG001|Overall Study|Stroke|0|||
16907968|NCT01787760|38016482|FG002|Overall Study|Stroke|0|||
16907969|NCT01787760|38016480|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
16907970|NCT01787760|38016481|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
16907971|NCT01787760|38016482|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
16907972|NCT01787760|38016480|FG000|Overall Study|Unsatisfactory physiological response|2|||
16907973|NCT01787760|38016481|FG001|Overall Study|Unsatisfactory physiological response|4|||
16907974|NCT01787760|38016482|FG002|Overall Study|Unsatisfactory physiological response|0|||
16907975|NCT01787760|38016480|FG000|Overall Study|Unsatisfactory visual response|1|||
16907976|NCT01787760|38016481|FG001|Overall Study|Unsatisfactory visual response|1|||
16907977|NCT01787760|38016482|FG002|Overall Study|Unsatisfactory visual response|0|||
16907978|NCT01787760|38016480|FG000|Overall Study|Near vision blur|1|||
16907979|NCT01787760|38016481|FG001|Overall Study|Near vision blur|0|||
16907980|NCT01787760|38016482|FG002|Overall Study|Near vision blur|0|||
16907981|NCT01815138|38016493|FG000|Overall Study|Withdrawal by Subject|0|||
16907982|NCT01815138|38016494|FG001|Overall Study|Withdrawal by Subject|1|||
16907983|NCT01815138|38016493|FG000|Overall Study|Physician Decision|8|||
16907984|NCT01815138|38016494|FG001|Overall Study|Physician Decision|5|||
16907985|NCT01606800|38016502|FG000|Overall Study|Adverse Event|3|||
16907986|NCT01606800|38016503|FG001|Overall Study|Adverse Event|1|||
16907987|NCT01606800|38016502|FG000|Overall Study|Participant withdrew consent|0|||
16907988|NCT01606800|38016503|FG001|Overall Study|Participant withdrew consent|1|||
16907989|NCT01606800|38016502|FG000|Overall Study|Missing completion status|2|||
16907990|NCT01606800|38016503|FG001|Overall Study|Missing completion status|0|||
17007186|NCT00776919|38151007|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
17007187|NCT00776919|38151008|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
17007188|NCT00776919|38151009|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
17007189|NCT00775983|38151036|FG000|Overall Study|Protocol Violation|1|||
17007190|NCT00775983|38151037|FG001|Overall Study|Protocol Violation|2|||
17007191|NCT00775593|38151043|FG000|Overall Study|Unmet eligibility criteria|6|||
17007192|NCT00775593|38151043|FG000|Overall Study|Death|1|||
17007193|NCT00939809|38151047|FG000|Overall Study|Adverse Event|2|||
17007194|NCT00939809|38151047|FG000|Overall Study|Death|1|||
17007195|NCT00934661|38151053|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
17007196|NCT00934661|38151054|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
17007197|NCT00775437|38151060|FG000|Overall Study|Loss of efficacy|2|||
17007198|NCT00775437|38151060|FG000|Overall Study|Withdrawal by Subject|3|||
17007199|NCT00775437|38151060|FG000|Overall Study|Lost to Follow-up|1|||
17007200|NCT00775203|38151066|FG000|Overall Study|Adverse Event|25|||
17007201|NCT00775203|38151067|FG001|Overall Study|Adverse Event|6|||
17007202|NCT00775203|38151066|FG000|Overall Study|Lack of Efficacy|8|||
17007203|NCT00775203|38151067|FG001|Overall Study|Lack of Efficacy|9|||
17007204|NCT00775203|38151066|FG000|Overall Study|Withdrawal by Subject|11|||
17007205|NCT00775203|38151067|FG001|Overall Study|Withdrawal by Subject|9|||
17007206|NCT00775203|38151066|FG000|Overall Study|Lost to Follow-up|11|||
17007207|NCT00775203|38151067|FG001|Overall Study|Lost to Follow-up|15|||
17007208|NCT00775203|38151066|FG000|Overall Study|Administrative reason|2|||
17007209|NCT00775203|38151067|FG001|Overall Study|Administrative reason|0|||
17007210|NCT00775203|38151066|FG000|Overall Study|Noncompliance|4|||
17007211|NCT00775203|38151067|FG001|Overall Study|Noncompliance|2|||
16907991|NCT01772550|38016512|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
16907992|NCT01772550|38016513|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
16907993|NCT01772550|38016514|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
16907994|NCT01772550|38016512|FG000|Overall Study|Adverse Event|0|||
16907995|NCT01772550|38016513|FG001|Overall Study|Adverse Event|0|||
16907996|NCT01772550|38016514|FG002|Overall Study|Adverse Event|1|||
16907997|NCT01787292|38016522|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
17007212|NCT00775203|38151066|FG000|Overall Study|Protocol Violation|0|||
17007213|NCT00775203|38151067|FG001|Overall Study|Protocol Violation|1|||
17007214|NCT00775203|38151066|FG000|Overall Study|Entered other study|1|||
17007215|NCT00775203|38151067|FG001|Overall Study|Entered other study|0|||
16907998|NCT01787292|38016523|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
16907999|NCT01787292|38016522|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
16908000|NCT01787292|38016523|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
16908001|NCT01814748|38016536|FG000|Overall Study|Lost to Follow-up|1|||
16908002|NCT01814748|38016537|FG001|Overall Study|Lost to Follow-up|2|||
16908003|NCT01814748|38016536|FG000|Overall Study|Study site terminated by sponsor|1|||
16908004|NCT01814748|38016537|FG001|Overall Study|Study site terminated by sponsor|1|||
16908005|NCT01814748|38016536|FG000|Overall Study|Withdrawal by Subject|6|||
16908006|NCT01814748|38016537|FG001|Overall Study|Withdrawal by Subject|4|||
16908007|NCT01814670|38016543|FG000|Overall Study|Protocol Violation|12|||
16908008|NCT01814046|38016549|FG000|Drug Administration|Death due to complications of RSV|1|||
16908009|NCT01814046|38016550|FG001|Drug Administration|Death due to complications of RSV|0|||
16908010|NCT01814046|38016551|FG002|Drug Administration|Death due to complications of RSV|0|||
16908011|NCT01813890|38016561|FG000|Overall Study|Adverse Event|0|||
16908012|NCT01813890|38016562|FG001|Overall Study|Adverse Event|3|||
16908013|NCT01813890|38016563|FG002|Overall Study|Adverse Event|4|||
16908014|NCT01813890|38016561|FG000|Overall Study|Lack of Efficacy|9|||
16908015|NCT01813890|38016562|FG001|Overall Study|Lack of Efficacy|1|||
16908016|NCT01813890|38016563|FG002|Overall Study|Lack of Efficacy|2|||
16908017|NCT01772316|38016571|FG000|Overall Study|Serious adverse event|1|||
16908018|NCT01772316|38016571|FG000|Overall Study|Inform consent withdrawn|1|||
16908019|NCT01772316|38016571|FG000|Overall Study|Withdrawn by sponsor decision|5|||
16908020|NCT01813422|38016577|FG000|Overall Study|Withdrawal by Subject|14|||
16908021|NCT01813422|38016578|FG001|Overall Study|Withdrawal by Subject|8|||
16908022|NCT01813422|38016577|FG000|Overall Study|Death|2|||
16908023|NCT01813422|38016578|FG001|Overall Study|Death|3|||
16908024|NCT01813422|38016577|FG000|Overall Study|Sponsor Decision|2|||
16908025|NCT01813422|38016578|FG001|Overall Study|Sponsor Decision|1|||
16908026|NCT01813422|38016577|FG000|Overall Study|Lost to Follow-up|2|||
16908027|NCT01813422|38016578|FG001|Overall Study|Lost to Follow-up|4|||
16908028|NCT01786668|38016588|FG000|Overall Study|Adverse Event|0|||
16908029|NCT01786668|38016589|FG001|Overall Study|Adverse Event|1|||
16908030|NCT01786668|38016590|FG002|Overall Study|Adverse Event|1|||
16908031|NCT01786668|38016591|FG003|Overall Study|Adverse Event|2|||
16908032|NCT01786668|38016588|FG000|Overall Study|Withdrawal by Subject|0|||
16908033|NCT01786668|38016589|FG001|Overall Study|Withdrawal by Subject|0|||
16908034|NCT01786668|38016590|FG002|Overall Study|Withdrawal by Subject|3|||
16908035|NCT01786668|38016591|FG003|Overall Study|Withdrawal by Subject|1|||
16908036|NCT01786668|38016588|FG000|Overall Study|Pregnancy|0|||
16908037|NCT01786668|38016589|FG001|Overall Study|Pregnancy|0|||
16908038|NCT01786668|38016590|FG002|Overall Study|Pregnancy|0|||
16908039|NCT01786668|38016591|FG003|Overall Study|Pregnancy|1|||
16908040|NCT01786668|38016588|FG000|Overall Study|Lost to Follow-up|1|||
16908041|NCT01786668|38016589|FG001|Overall Study|Lost to Follow-up|0|||
16908042|NCT01786668|38016590|FG002|Overall Study|Lost to Follow-up|1|||
16908043|NCT01786668|38016591|FG003|Overall Study|Lost to Follow-up|0|||
16908044|NCT01786512|38016612|FG000|Overall Study|Lost to Follow-up|0|||
16908045|NCT01786512|38016613|FG001|Overall Study|Lost to Follow-up|0|||
16908046|NCT01786512|38016614|FG002|Overall Study|Lost to Follow-up|0|||
16908047|NCT01786512|38016615|FG003|Overall Study|Lost to Follow-up|0|||
16908048|NCT01786512|38016616|FG004|Overall Study|Lost to Follow-up|0|||
16908049|NCT01786512|38016617|FG005|Overall Study|Lost to Follow-up|0|||
16908050|NCT01786512|38016618|FG006|Overall Study|Lost to Follow-up|0|||
16908051|NCT01786512|38016619|FG007|Overall Study|Lost to Follow-up|0|||
16908052|NCT01786512|38016620|FG008|Overall Study|Lost to Follow-up|0|||
16908053|NCT01786512|38016621|FG009|Overall Study|Lost to Follow-up|1|||
16908054|NCT01786512|38016622|FG010|Overall Study|Lost to Follow-up|0|||
16908055|NCT01786512|38016612|FG000|Overall Study|Decision by sponsor|0|||
16908056|NCT01786512|38016613|FG001|Overall Study|Decision by sponsor|0|||
16908057|NCT01786512|38016614|FG002|Overall Study|Decision by sponsor|0|||
16908058|NCT01786512|38016615|FG003|Overall Study|Decision by sponsor|0|||
16908059|NCT01786512|38016616|FG004|Overall Study|Decision by sponsor|0|||
16908060|NCT01786512|38016617|FG005|Overall Study|Decision by sponsor|0|||
16908061|NCT01786512|38016618|FG006|Overall Study|Decision by sponsor|0|||
16908062|NCT01786512|38016619|FG007|Overall Study|Decision by sponsor|0|||
16908063|NCT01786512|38016620|FG008|Overall Study|Decision by sponsor|0|||
16908064|NCT01786512|38016621|FG009|Overall Study|Decision by sponsor|0|||
16908065|NCT01786512|38016622|FG010|Overall Study|Decision by sponsor|2|||
16908066|NCT01786512|38016612|FG000|Overall Study|Withdrawal by Subject|0|||
16908067|NCT01786512|38016613|FG001|Overall Study|Withdrawal by Subject|1|||
17007216|NCT00775203|38151066|FG000|Overall Study|Physician Decision|0|||
17007217|NCT00775203|38151067|FG001|Overall Study|Physician Decision|1|||
16908068|NCT01786512|38016614|FG002|Overall Study|Withdrawal by Subject|0|||
16908069|NCT01786512|38016615|FG003|Overall Study|Withdrawal by Subject|0|||
16908070|NCT01786512|38016616|FG004|Overall Study|Withdrawal by Subject|0|||
16908071|NCT01786512|38016617|FG005|Overall Study|Withdrawal by Subject|0|||
16908072|NCT01786512|38016618|FG006|Overall Study|Withdrawal by Subject|1|||
16908073|NCT01786512|38016619|FG007|Overall Study|Withdrawal by Subject|0|||
16908074|NCT01786512|38016620|FG008|Overall Study|Withdrawal by Subject|0|||
16908075|NCT01786512|38016621|FG009|Overall Study|Withdrawal by Subject|3|||
16908076|NCT01786512|38016622|FG010|Overall Study|Withdrawal by Subject|7|||
16908077|NCT01786512|38016612|FG000|Overall Study|Death|0|||
16908078|NCT01786512|38016613|FG001|Overall Study|Death|0|||
16908079|NCT01786512|38016614|FG002|Overall Study|Death|0|||
16908080|NCT01786512|38016615|FG003|Overall Study|Death|0|||
17007218|NCT00568321|38151076|FG000|Overall Study|Adverse Event|1|||
17007219|NCT00568321|38151077|FG001|Overall Study|Adverse Event|0|||
16908081|NCT01786512|38016616|FG004|Overall Study|Death|0|||
16908082|NCT01786512|38016617|FG005|Overall Study|Death|0|||
16908083|NCT01786512|38016618|FG006|Overall Study|Death|0|||
16908084|NCT01786512|38016619|FG007|Overall Study|Death|0|||
16908085|NCT01786512|38016620|FG008|Overall Study|Death|4|||
16908086|NCT01786512|38016621|FG009|Overall Study|Death|1|||
16908087|NCT01786512|38016622|FG010|Overall Study|Death|3|||
16908088|NCT01772160|38016654|FG000|Overall Study|Death|3|||
16908089|NCT01772160|38016654|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
16908090|NCT01772160|38016654|FG000|Overall Study|Consent withdrawal|3|||
16908091|NCT01772160|38016654|FG000|Overall Study|Migrated / moved from the study area|4|||
16908092|NCT01772160|38016654|FG000|Overall Study|Lost to Follow-up|30|||
16908093|NCT01772160|38016654|FG000|Overall Study|Other|5|||
16908094|NCT01770912|38016660|FG000|Overall Study|Lost to Follow-up|2|||
16908095|NCT01770912|38016661|FG001|Overall Study|Lost to Follow-up|0|||
16908096|NCT01811706|38016667|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
16908097|NCT01811706|38016668|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
16908098|NCT01811472|38016679|FG000|Overall Study|Adverse Event|1|||
16908099|NCT01811472|38016680|FG001|Overall Study|Adverse Event|0|||
16908100|NCT01811472|38016681|FG002|Overall Study|Adverse Event|4|||
16908101|NCT01811472|38016679|FG000|Overall Study|Lost to Follow-up|0|||
16908102|NCT01811472|38016680|FG001|Overall Study|Lost to Follow-up|0|||
16908103|NCT01811472|38016681|FG002|Overall Study|Lost to Follow-up|1|||
16908104|NCT01811472|38016679|FG000|Overall Study|Subject/guardian decision|1|||
16908105|NCT01811472|38016680|FG001|Overall Study|Subject/guardian decision|0|||
16908106|NCT01811472|38016681|FG002|Overall Study|Subject/guardian decision|0|||
16908107|NCT01811238|38016690|FG000|Overall Study|Withdrawal by Subject|42|||
16908108|NCT01811238|38016690|FG000|Overall Study|Adverse Event|25|||
16908109|NCT01811238|38016690|FG000|Overall Study|Protocol Violation|4|||
16908110|NCT01811238|38016690|FG000|Overall Study|Lack of Efficacy|4|||
16908111|NCT01811238|38016690|FG000|Overall Study|subject refused study medication|6|||
16908112|NCT01769508|38016695|FG000|Overall Study|Death|3|||
16908113|NCT01769508|38016695|FG000|Overall Study|Withdrawal by Subject|1|||
16908114|NCT01769508|38016695|FG000|Overall Study|Adverse Event|1|||
16908115|NCT01769508|38016695|FG000|Overall Study|Lost to Follow-up|1|||
16908116|NCT01810380|38016702|FG000|Overall Study|Randomised not treated|2|||
16908117|NCT01810380|38016703|FG001|Overall Study|Randomised not treated|1|||
16908118|NCT01810380|38016704|FG002|Overall Study|Randomised not treated|1|||
16908119|NCT01810380|38016702|FG000|Overall Study|Adverse Event|11|||
16908120|NCT01810380|38016703|FG001|Overall Study|Adverse Event|14|||
16908121|NCT01810380|38016704|FG002|Overall Study|Adverse Event|4|||
16908122|NCT01810380|38016702|FG000|Overall Study|Lack of Efficacy|24|||
16908123|NCT01810380|38016703|FG001|Overall Study|Lack of Efficacy|10|||
16908124|NCT01810380|38016704|FG002|Overall Study|Lack of Efficacy|11|||
16908125|NCT01810380|38016702|FG000|Overall Study|Protocol Violation|1|||
16908126|NCT01810380|38016703|FG001|Overall Study|Protocol Violation|0|||
16908127|NCT01810380|38016704|FG002|Overall Study|Protocol Violation|1|||
16908128|NCT01810380|38016702|FG000|Overall Study|Withdrawal by Subject|6|||
16908129|NCT01810380|38016703|FG001|Overall Study|Withdrawal by Subject|0|||
16908130|NCT01810380|38016704|FG002|Overall Study|Withdrawal by Subject|6|||
16908131|NCT01810380|38016702|FG000|Overall Study|Administrative or other reasons|11|||
16908132|NCT01810380|38016703|FG001|Overall Study|Administrative or other reasons|13|||
16908133|NCT01810380|38016704|FG002|Overall Study|Administrative or other reasons|9|||
16908134|NCT01769196|38016714|FG000|Overall Study|Adverse Event|24|||
16908135|NCT01769196|38016715|FG001|Overall Study|Adverse Event|20|||
16908136|NCT01769196|38016714|FG000|Overall Study|Death|21|||
16908137|NCT01769196|38016715|FG001|Overall Study|Death|26|||
16908138|NCT01769196|38016714|FG000|Overall Study|Investigator Discretion|7|||
16908139|NCT01769196|38016715|FG001|Overall Study|Investigator Discretion|3|||
16908140|NCT01769196|38016714|FG000|Overall Study|Lack of Efficacy|3|||
16908141|NCT01769196|38016715|FG001|Overall Study|Lack of Efficacy|2|||
16908142|NCT01769196|38016714|FG000|Overall Study|Progressive disease|11|||
16908143|NCT01769196|38016715|FG001|Overall Study|Progressive disease|6|||
17192870|NCT02415556|38346208|FG003|Overall Study|Withdrawal by Subject|12|||
16908144|NCT01769196|38016714|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
17007220|NCT00568321|38151078|FG002|Overall Study|Adverse Event|0|||
16908145|NCT01769196|38016715|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
16908146|NCT01769196|38016714|FG000|Overall Study|Protocol Violation|0|||
16908147|NCT01769196|38016715|FG001|Overall Study|Protocol Violation|3|||
16908148|NCT01769196|38016714|FG000|Overall Study|Study terminated by sponsor|160|||
16908149|NCT01769196|38016715|FG001|Overall Study|Study terminated by sponsor|161|||
16908150|NCT01769196|38016714|FG000|Overall Study|Participant never dosed with study drug|1|||
16908151|NCT01769196|38016715|FG001|Overall Study|Participant never dosed with study drug|0|||
16908152|NCT01769196|38016714|FG000|Overall Study|Withdrew consent|36|||
16908153|NCT01769196|38016715|FG001|Overall Study|Withdrew consent|40|||
16908154|NCT01810302|38016723|FG000|Overall Study|Death|1|||
16908155|NCT01810302|38016724|FG001|Overall Study|Death|0|||
16908156|NCT01810302|38016723|FG000|Overall Study|Physician Decision|0|||
16908157|NCT01810302|38016724|FG001|Overall Study|Physician Decision|1|||
16908158|NCT01783938|38016732|FG000|Overall Study|Disease Progression|18|||
16908159|NCT01783938|38016733|FG001|Overall Study|Disease Progression|41|||
16908160|NCT01783938|38016732|FG000|Overall Study|Study Drug Toxicity|27|||
16908161|NCT01783938|38016733|FG001|Overall Study|Study Drug Toxicity|14|||
16908162|NCT01783938|38016732|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
17007221|NCT00568321|38151076|FG000|Overall Study|Lack of Efficacy|8|||
17007222|NCT00568321|38151077|FG001|Overall Study|Lack of Efficacy|5|||
17007223|NCT00568321|38151078|FG002|Overall Study|Lack of Efficacy|6|||
17007224|NCT00568321|38151076|FG000|Overall Study|Lost to Follow-up|0|||
17007225|NCT00568321|38151077|FG001|Overall Study|Lost to Follow-up|0|||
17007226|NCT00568321|38151078|FG002|Overall Study|Lost to Follow-up|1|||
17007227|NCT00568321|38151076|FG000|Overall Study|Withdrawal by Subject|2|||
17007228|NCT00568321|38151077|FG001|Overall Study|Withdrawal by Subject|0|||
17007229|NCT00568321|38151078|FG002|Overall Study|Withdrawal by Subject|0|||
17007230|NCT00568321|38151076|FG000|Overall Study|Protocol Violation|0|||
17007231|NCT00568321|38151077|FG001|Overall Study|Protocol Violation|0|||
17007232|NCT00568321|38151078|FG002|Overall Study|Protocol Violation|1|||
17007233|NCT00568321|38151076|FG000|Overall Study|Randomized, not treated|2|||
17007234|NCT00568321|38151077|FG001|Overall Study|Randomized, not treated|0|||
17007235|NCT00568321|38151078|FG002|Overall Study|Randomized, not treated|1|||
17007236|NCT00774345|38151090|FG000|Pre-treatment|Other reasons|2|||
17095807|NCT00224042|38235099|FG001|Overall Study|Adverse Event|1|||
17095808|NCT00224042|38235098|FG000|Overall Study|Protocol Violation|0|||
17095809|NCT00224042|38235099|FG001|Overall Study|Protocol Violation|1|||
17095810|NCT00224042|38235098|FG000|Overall Study|Physician Decision|0|||
17095811|NCT00224042|38235099|FG001|Overall Study|Physician Decision|1|||
17095812|NCT00224042|38235098|FG000|Overall Study|Did not meet lab incusion criteria|2|||
17007237|NCT00774345|38151091|FG001|Pre-treatment|Other reasons|0|||
17007238|NCT00774345|38151090|FG000|Treatment|Adverse Event|61|||
17007239|NCT00774345|38151091|FG001|Treatment|Adverse Event|15|||
17007240|NCT00774345|38151090|FG000|Treatment|Progressive Disease without histologic transformation|51|||
17007241|NCT00774345|38151091|FG001|Treatment|Progressive Disease without histologic transformation|111|||
17007242|NCT00774345|38151090|FG000|Treatment|Progressive Disease with histologic transformation|4|||
17095813|NCT00224042|38235099|FG001|Overall Study|Did not meet lab incusion criteria|3|||
17095814|NCT00224042|38235098|FG000|Overall Study|Other|2|||
17095815|NCT00224042|38235099|FG001|Overall Study|Other|0|||
17095816|NCT03772522|38235107|FG000|Pre-intervention|Withdrawal by Subject|3|||
17095817|NCT03772522|38235108|FG001|Pre-intervention|Withdrawal by Subject|4|||
17095818|NCT03772522|38235107|FG000|Intervention|Withdrawal by Subject|1|||
17095819|NCT03772522|38235108|FG001|Intervention|Withdrawal by Subject|0|||
17095820|NCT03772522|38235107|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
17095821|NCT03772522|38235108|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
17095822|NCT00160706|38235118|FG000|Overall Study|Adverse Event|53|||
17095823|NCT00160706|38235118|FG000|Overall Study|Adverse Event and Other Reason|105|||
17095824|NCT00160706|38235118|FG000|Overall Study|Protocol Violation|3|||
17095825|NCT00160706|38235118|FG000|Overall Study|Withdrawal by Subject|41|||
17095826|NCT00160706|38235118|FG000|Overall Study|Withdrawal by Subject and Other|12|||
17095827|NCT00160706|38235118|FG000|Overall Study|Physician Decision|10|||
17095828|NCT00160706|38235118|FG000|Overall Study|Physician Decision and Other|3|||
17095829|NCT00160706|38235118|FG000|Overall Study|Lost to Follow-up|4|||
17095830|NCT00160706|38235118|FG000|Overall Study|Lost to Follow-up and Other|1|||
17095831|NCT00160706|38235118|FG000|Overall Study|Lack of Efficacy|42|||
17095832|NCT00160706|38235118|FG000|Overall Study|Lack of Efficacy and Other|1|||
17095833|NCT00160706|38235118|FG000|Overall Study|Other Reason|11|||
17095834|NCT00257192|38235124|FG000|Overall Study|Adverse Event|21|||
17095835|NCT00257192|38235125|FG001|Overall Study|Adverse Event|10|||
17095836|NCT00257192|38235124|FG000|Overall Study|Laboratory abnormality|1|||
17007243|NCT00774345|38151091|FG001|Treatment|Progressive Disease with histologic transformation|2|||
17007244|NCT00774345|38151090|FG000|Treatment|Withdrawal by Subject|5|||
17007245|NCT00774345|38151091|FG001|Treatment|Withdrawal by Subject|2|||
17007246|NCT00774345|38151090|FG000|Treatment|Lost to Follow-up|1|||
17095837|NCT00257192|38235125|FG001|Overall Study|Laboratory abnormality|1|||
17095838|NCT00257192|38235124|FG000|Overall Study|Lost to Follow-up|3|||
17095839|NCT00257192|38235125|FG001|Overall Study|Lost to Follow-up|3|||
17095840|NCT00257192|38235124|FG000|Overall Study|Insufficient clinical response|18|||
16908163|NCT01783938|38016733|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16908164|NCT01783938|38016732|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
16908165|NCT01783938|38016733|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
16908166|NCT01783938|38016732|FG000|Overall Study|Participant Withdrew Consent|2|||
16908167|NCT01783938|38016733|FG001|Overall Study|Participant Withdrew Consent|0|||
16908168|NCT01783938|38016732|FG000|Overall Study|Maximum Clinical Benefit|1|||
16908169|NCT01783938|38016733|FG001|Overall Study|Maximum Clinical Benefit|0|||
17007247|NCT00774345|38151091|FG001|Treatment|Lost to Follow-up|1|||
16908170|NCT01783938|38016732|FG000|Overall Study|Other Reasons|3|||
16908171|NCT01783938|38016733|FG001|Overall Study|Other Reasons|1|||
16908172|NCT01768572|38016742|FG000|Overall Study|Adverse Event|7|||
16908173|NCT01768572|38016743|FG001|Overall Study|Adverse Event|8|||
16908174|NCT01768572|38016744|FG002|Overall Study|Adverse Event|4|||
16908175|NCT01768572|38016742|FG000|Overall Study|Lack of Efficacy|1|||
16908176|NCT01768572|38016743|FG001|Overall Study|Lack of Efficacy|3|||
16908177|NCT01768572|38016744|FG002|Overall Study|Lack of Efficacy|1|||
16908178|NCT01768572|38016742|FG000|Overall Study|Other, Not due to an adverse event|1|||
16908179|NCT01768572|38016743|FG001|Overall Study|Other, Not due to an adverse event|1|||
16908180|NCT01768572|38016744|FG002|Overall Study|Other, Not due to an adverse event|1|||
16908181|NCT01783548|38016754|FG000|Overall Study|Adverse Event|8|||
16908182|NCT01783548|38016755|FG001|Overall Study|Adverse Event|4|||
16908183|NCT01783548|38016754|FG000|Overall Study|Withdrawal by Subject|11|||
16908184|NCT01783548|38016755|FG001|Overall Study|Withdrawal by Subject|8|||
16908185|NCT01783548|38016754|FG000|Overall Study|Non-compliance|4|||
16908186|NCT01783548|38016755|FG001|Overall Study|Non-compliance|0|||
16908187|NCT01783548|38016754|FG000|Overall Study|Protocol Violation|2|||
16908188|NCT01783548|38016755|FG001|Overall Study|Protocol Violation|2|||
16908189|NCT01783548|38016754|FG000|Overall Study|Lost to Follow-up|8|||
16908190|NCT01783548|38016755|FG001|Overall Study|Lost to Follow-up|3|||
16908191|NCT01783548|38016754|FG000|Overall Study|Lack of Efficacy|1|||
16908192|NCT01783548|38016755|FG001|Overall Study|Lack of Efficacy|1|||
16908193|NCT01809210|38016768|FG000|Overall Study|Withdrawal by Subject|0|||
16908194|NCT01809210|38016769|FG001|Overall Study|Withdrawal by Subject|0|||
16908195|NCT01809210|38016770|FG002|Overall Study|Withdrawal by Subject|1|||
16908196|NCT01809210|38016771|FG003|Overall Study|Withdrawal by Subject|1|||
16908197|NCT01809210|38016772|FG004|Overall Study|Withdrawal by Subject|1|||
16908198|NCT01809210|38016773|FG005|Overall Study|Withdrawal by Subject|0|||
16908199|NCT01809210|38016774|FG006|Overall Study|Withdrawal by Subject|4|||
16908200|NCT01809210|38016768|FG000|Overall Study|Death|1|||
16908201|NCT01809210|38016769|FG001|Overall Study|Death|1|||
16908202|NCT01809210|38016770|FG002|Overall Study|Death|2|||
16908203|NCT01809210|38016771|FG003|Overall Study|Death|0|||
16908204|NCT01809210|38016772|FG004|Overall Study|Death|1|||
16908205|NCT01809210|38016773|FG005|Overall Study|Death|3|||
16908206|NCT01809210|38016774|FG006|Overall Study|Death|1|||
16908207|NCT01809132|38016793|FG000|Overall Study|Withdrawal by Subject|0|||
16908208|NCT01809132|38016794|FG001|Overall Study|Withdrawal by Subject|0|||
16908209|NCT01809132|38016795|FG002|Overall Study|Withdrawal by Subject|1|||
16908210|NCT01808508|38016806|FG000|Overall Study|Lost to Follow-up|1|||
16908211|NCT01808508|38016807|FG001|Overall Study|Lost to Follow-up|0|||
16908212|NCT01808508|38016808|FG002|Overall Study|Lost to Follow-up|0|||
16908213|NCT01766778|38016818|FG000|Overall Study|Adverse Event|4|||
16908214|NCT01766778|38016819|FG001|Overall Study|Adverse Event|4|||
16908215|NCT01766778|38016818|FG000|Overall Study|Withdrawal by Subject|1|||
16908216|NCT01766778|38016819|FG001|Overall Study|Withdrawal by Subject|0|||
16908217|NCT01808196|38016825|FG000|Overall Study|Lost to Follow-up|1|||
16908218|NCT01808118|38016829|FG000|Period 1|Adverse Event|15|||
16908219|NCT01808118|38016830|FG001|Period 1|Adverse Event|0|||
16908220|NCT01808118|38016831|FG002|Period 1|Adverse Event|0|||
16908221|NCT01808118|38016829|FG000|Period 1|Withdrew consent|24|||
16908222|NCT01808118|38016830|FG001|Period 1|Withdrew consent|0|||
16908223|NCT01808118|38016831|FG002|Period 1|Withdrew consent|0|||
16908224|NCT01808118|38016829|FG000|Period 1|Lost to Follow-up|9|||
16908225|NCT01808118|38016830|FG001|Period 1|Lost to Follow-up|0|||
16908226|NCT01808118|38016831|FG002|Period 1|Lost to Follow-up|0|||
16908227|NCT01808118|38016829|FG000|Period 1|Did not meet criteria for remission|303|||
16908228|NCT01808118|38016830|FG001|Period 1|Did not meet criteria for remission|0|||
16908229|NCT01808118|38016831|FG002|Period 1|Did not meet criteria for remission|0|||
16908230|NCT01808118|38016829|FG000|Period 1|Enrolled in error|7|||
16908231|NCT01808118|38016830|FG001|Period 1|Enrolled in error|0|||
16908232|NCT01808118|38016831|FG002|Period 1|Enrolled in error|0|||
16908233|NCT01808118|38016829|FG000|Period 1|Did not meet inclusion criteria|3|||
16908234|NCT01808118|38016830|FG001|Period 1|Did not meet inclusion criteria|0|||
16908235|NCT01808118|38016831|FG002|Period 1|Did not meet inclusion criteria|0|||
16908236|NCT01808118|38016829|FG000|Period 1|Non-conformance with inclusion criteria|3|||
16908237|NCT01808118|38016830|FG001|Period 1|Non-conformance with inclusion criteria|0|||
16908238|NCT01808118|38016831|FG002|Period 1|Non-conformance with inclusion criteria|0|||
16908239|NCT01808118|38016829|FG000|Period 1|Investigator decision: site closure|2|||
16908240|NCT01808118|38016830|FG001|Period 1|Investigator decision: site closure|0|||
16908241|NCT01808118|38016831|FG002|Period 1|Investigator decision: site closure|0|||
16908242|NCT01808118|38016829|FG000|Period 1|Non-compliance per sponsor|1|||
16908243|NCT01808118|38016830|FG001|Period 1|Non-compliance per sponsor|0|||
16908244|NCT01808118|38016831|FG002|Period 1|Non-compliance per sponsor|0|||
16908245|NCT01808118|38016829|FG000|Period 1|Lack of Efficacy|1|||
16908246|NCT01808118|38016830|FG001|Period 1|Lack of Efficacy|0|||
16908247|NCT01808118|38016831|FG002|Period 1|Lack of Efficacy|0|||
16908248|NCT01808118|38016829|FG000|Period 2|Adverse Event|0|||
16908249|NCT01808118|38016830|FG001|Period 2|Adverse Event|4|||
16908250|NCT01808118|38016831|FG002|Period 2|Adverse Event|0|||
16908251|NCT01808118|38016829|FG000|Period 2|Withdrew consent|0|||
16908252|NCT01808118|38016830|FG001|Period 2|Withdrew consent|7|||
16908253|NCT01808118|38016831|FG002|Period 2|Withdrew consent|6|||
16908254|NCT01808118|38016829|FG000|Period 2|Lost to Follow-up|0|||
16908255|NCT01808118|38016830|FG001|Period 2|Lost to Follow-up|0|||
16908256|NCT01808118|38016831|FG002|Period 2|Lost to Follow-up|2|||
16908257|NCT01808118|38016829|FG000|Period 2|Investigator no longer conducting trials|0|||
16908258|NCT01808118|38016830|FG001|Period 2|Investigator no longer conducting trials|1|||
16908259|NCT01808118|38016831|FG002|Period 2|Investigator no longer conducting trials|0|||
16908260|NCT01808118|38016829|FG000|Period 2|Switched to other therapy|0|||
16908261|NCT01808118|38016830|FG001|Period 2|Switched to other therapy|1|||
16908262|NCT01808118|38016831|FG002|Period 2|Switched to other therapy|0|||
16908263|NCT01807650|38016845|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
16908264|NCT01807650|38016845|FG000|Overall Study|Adverse Event|5|||
16908265|NCT01807650|38016845|FG000|Overall Study|Other|2|||
16908266|NCT01782690|38016886|FG000|Overall Study|Not reported|7|||
16908267|NCT01782690|38016886|FG000|Overall Study|Toxicity of gemcitabine|1|||
16908268|NCT01782690|38016886|FG000|Overall Study|Toxicity of erlotinib|1|||
16908269|NCT01782690|38016886|FG000|Overall Study|Lost to Follow-up|31|||
16908270|NCT01782690|38016886|FG000|Overall Study|Withdrawal of informed consent|2|||
16908271|NCT01782690|38016886|FG000|Overall Study|Absent rash|9|||
16908272|NCT01782690|38016886|FG000|Overall Study|Physician Decision|13|||
16908273|NCT01782690|38016886|FG000|Overall Study|Patient's wish|21|||
16908274|NCT01782690|38016886|FG000|Overall Study|Tumor progression|74|||
16908275|NCT01782690|38016886|FG000|Overall Study|Death|133|||
16908276|NCT01782690|38016886|FG000|Overall Study|Study completion unknown|7|||
16908277|NCT01782378|38016892|FG000|First Series|Lost to Follow-up|7|||
16908278|NCT01782378|38016893|FG001|First Series|Lost to Follow-up|8|||
16908279|NCT01782378|38016892|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
16908280|NCT01782378|38016893|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
16908281|NCT01782378|38016892|FG000|Second Series|Lost to Follow-up|8|||
16908282|NCT01782378|38016893|FG001|Second Series|Lost to Follow-up|7|||
16908283|NCT01782378|38016892|FG000|Second Series|Did not choose to complete S2 Optional|18|||
16908284|NCT01782378|38016893|FG001|Second Series|Did not choose to complete S2 Optional|0|||
16908285|NCT01766310|38016901|FG000|Overall Study|Lost to Follow-up|1|||
16908286|NCT01766310|38016902|FG001|Overall Study|Lost to Follow-up|3|||
16908287|NCT01765920|38016910|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
16908288|NCT01765920|38016911|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
16908289|NCT01765920|38016910|FG000|Overall Study|Patient code disclosure|0|||
16908290|NCT01765920|38016911|FG001|Overall Study|Patient code disclosure|1|||
16908291|NCT01782222|38016920|FG000|Overall Study|Adverse Event|4|||
16908292|NCT01782222|38016921|FG001|Overall Study|Adverse Event|5|||
16908293|NCT01782222|38016922|FG002|Overall Study|Adverse Event|3|||
16908294|NCT01782222|38016920|FG000|Overall Study|Lack of Efficacy|2|||
16908295|NCT01782222|38016921|FG001|Overall Study|Lack of Efficacy|1|||
16908296|NCT01782222|38016922|FG002|Overall Study|Lack of Efficacy|0|||
16908297|NCT01782222|38016920|FG000|Overall Study|Protocol Violation|1|||
16908298|NCT01782222|38016921|FG001|Overall Study|Protocol Violation|0|||
16908299|NCT01782222|38016922|FG002|Overall Study|Protocol Violation|0|||
16908300|NCT01782222|38016920|FG000|Overall Study|Withdrawal by Subject|1|||
16908301|NCT01782222|38016921|FG001|Overall Study|Withdrawal by Subject|4|||
16908302|NCT01782222|38016922|FG002|Overall Study|Withdrawal by Subject|1|||
16908303|NCT01782222|38016920|FG000|Overall Study|Moved to other state|0|||
16908304|NCT01782222|38016921|FG001|Overall Study|Moved to other state|1|||
16908305|NCT01782222|38016922|FG002|Overall Study|Moved to other state|0|||
16908306|NCT01781832|38016930|FG000|Overall Study|Withdrawal by Subject|1|||
16908307|NCT01807182|38016934|FG000|Overall Study|Death|1|||
16908308|NCT01807182|38016934|FG000|Overall Study|New therapy|1|||
16908309|NCT01807182|38016934|FG000|Overall Study|Moved to hospice care|1|||
16908310|NCT01806714|38016940|FG000|Overall Study|No functioning phone number|200|||
16908311|NCT01806714|38016941|FG001|Overall Study|No functioning phone number|170|||
16908312|NCT01765764|38016950|FG000|Treatment Period|Adverse Event|1|||
16908313|NCT01765764|38016951|FG001|Treatment Period|Adverse Event|2|||
16908314|NCT01765764|38016952|FG002|Treatment Period|Adverse Event|1|||
16908315|NCT01765764|38016950|FG000|Treatment Period|Lost to Follow-up|0|||
16908316|NCT01765764|38016951|FG001|Treatment Period|Lost to Follow-up|3|||
16908317|NCT01765764|38016952|FG002|Treatment Period|Lost to Follow-up|2|||
16908318|NCT01765764|38016950|FG000|Treatment Period|Personal Reasons|1|||
16908319|NCT01765764|38016951|FG001|Treatment Period|Personal Reasons|2|||
16908320|NCT01765764|38016952|FG002|Treatment Period|Personal Reasons|1|||
16908321|NCT01765764|38016950|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
16908322|NCT01765764|38016951|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
16908323|NCT01765764|38016952|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
16908324|NCT01806168|38016963|FG000|Overall Study|Adverse Event|1|||
16908325|NCT01806168|38016964|FG001|Overall Study|Adverse Event|0|||
16908326|NCT01806168|38016965|FG002|Overall Study|Adverse Event|0|||
16908327|NCT01806168|38016963|FG000|Overall Study|Withdrawal by Subject|0|||
16908328|NCT01806168|38016964|FG001|Overall Study|Withdrawal by Subject|1|||
16908329|NCT01806168|38016965|FG002|Overall Study|Withdrawal by Subject|2|||
16908330|NCT01806168|38016963|FG000|Overall Study|Protocol Violation|0|||
16908331|NCT01806168|38016964|FG001|Overall Study|Protocol Violation|0|||
16908332|NCT01806168|38016965|FG002|Overall Study|Protocol Violation|1|||
16908333|NCT01804842|38016979|FG000|Overall Study|Adverse Event|1|||
16908334|NCT01804842|38016980|FG001|Overall Study|Adverse Event|1|||
16908335|NCT01804842|38016981|FG002|Overall Study|Adverse Event|0|||
16908336|NCT01804842|38016979|FG000|Overall Study|Lost to Follow-up|1|||
16908337|NCT01804842|38016980|FG001|Overall Study|Lost to Follow-up|0|||
16908338|NCT01804842|38016981|FG002|Overall Study|Lost to Follow-up|0|||
16908339|NCT01804842|38016979|FG000|Overall Study|Non-Compliance|1|||
16908340|NCT01804842|38016980|FG001|Overall Study|Non-Compliance|1|||
16908341|NCT01804842|38016981|FG002|Overall Study|Non-Compliance|0|||
16908342|NCT01804842|38016979|FG000|Overall Study|Personal Reason|0|||
16908343|NCT01804842|38016980|FG001|Overall Study|Personal Reason|0|||
16908344|NCT01804842|38016981|FG002|Overall Study|Personal Reason|1|||
16908345|NCT01781286|38016989|FG000|Overall Study|Lost to Follow-up|0|||
16908346|NCT01781286|38016990|FG001|Overall Study|Lost to Follow-up|0|||
16908347|NCT01781286|38016991|FG002|Overall Study|Lost to Follow-up|0|||
16908348|NCT01781286|38016992|FG003|Overall Study|Lost to Follow-up|0|||
16908349|NCT01781286|38016993|FG004|Overall Study|Lost to Follow-up|0|||
16908350|NCT01781286|38016994|FG005|Overall Study|Lost to Follow-up|1|||
16908351|NCT01781286|38016989|FG000|Overall Study|Time Constraints|2|||
16908352|NCT01781286|38016990|FG001|Overall Study|Time Constraints|0|||
16908353|NCT01781286|38016991|FG002|Overall Study|Time Constraints|2|||
16908354|NCT01781286|38016992|FG003|Overall Study|Time Constraints|0|||
16908355|NCT01781286|38016993|FG004|Overall Study|Time Constraints|0|||
16908356|NCT01781286|38016994|FG005|Overall Study|Time Constraints|0|||
16908357|NCT01781286|38016989|FG000|Overall Study|Noncompliance|0|||
16908358|NCT01781286|38016990|FG001|Overall Study|Noncompliance|0|||
16908359|NCT01781286|38016991|FG002|Overall Study|Noncompliance|0|||
16908360|NCT01781286|38016992|FG003|Overall Study|Noncompliance|1|||
17007248|NCT00774345|38151090|FG000|Treatment|Death|4|||
17007249|NCT00774345|38151091|FG001|Treatment|Death|0|||
17007250|NCT00774345|38151090|FG000|Treatment|Other Reasons|32|||
17007251|NCT00774345|38151091|FG001|Treatment|Other Reasons|26|||
17007252|NCT00773253|38151103|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
17007253|NCT00773253|38151104|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
17007254|NCT00773175|38151114|FG000|Overall Study|Adverse Event|2|||
17007255|NCT00773175|38151115|FG001|Overall Study|Adverse Event|0|||
17007256|NCT00773175|38151114|FG000|Overall Study|Consent Withdrawn|0|||
17007257|NCT00773175|38151115|FG001|Overall Study|Consent Withdrawn|2|||
17007258|NCT00566527|38151129|FG000|Overall Study|Reason not provided|3|||
17007259|NCT00566527|38151130|FG001|Overall Study|Reason not provided|11|||
17095841|NCT00257192|38235125|FG001|Overall Study|Insufficient clinical response|18|||
17095842|NCT00257192|38235124|FG000|Overall Study|Withdrawal by Subject|14|||
17007260|NCT00566527|38151131|FG002|Overall Study|Reason not provided|10|||
17007261|NCT00566527|38151129|FG000|Overall Study|Adverse Event|2|||
17007262|NCT00566527|38151130|FG001|Overall Study|Adverse Event|0|||
17007263|NCT00566527|38151131|FG002|Overall Study|Adverse Event|1|||
17007264|NCT00566527|38151129|FG000|Overall Study|Physician Decision|3|||
17007265|NCT00566527|38151130|FG001|Overall Study|Physician Decision|8|||
17007266|NCT00566527|38151131|FG002|Overall Study|Physician Decision|20|||
17007267|NCT00566527|38151129|FG000|Overall Study|Lost to Follow-up|3|||
17007268|NCT00566527|38151130|FG001|Overall Study|Lost to Follow-up|4|||
17007269|NCT00566527|38151131|FG002|Overall Study|Lost to Follow-up|4|||
17007270|NCT00566527|38151129|FG000|Overall Study|Withdrawal by Subject|6|||
17007271|NCT00566527|38151130|FG001|Overall Study|Withdrawal by Subject|43|||
17007272|NCT00566527|38151131|FG002|Overall Study|Withdrawal by Subject|43|||
16908361|NCT01781286|38016993|FG004|Overall Study|Noncompliance|0|||
16908362|NCT01781286|38016994|FG005|Overall Study|Noncompliance|0|||
16908363|NCT01780974|38017006|FG000|Overall Study|Death|1|||
16908364|NCT01780974|38017007|FG001|Overall Study|Death|0|||
16908365|NCT01780974|38017006|FG000|Overall Study|Adverse Event|1|||
17007273|NCT00773097|38151141|FG000|Overall Study|Withdrawal by Subject|1|||
17007274|NCT00773097|38151141|FG000|Overall Study|Physician Decision|6|||
17007275|NCT00933335|38151147|FG000|Overall Study|Lost to Follow-up|1|||
17095843|NCT00257192|38235125|FG001|Overall Study|Withdrawal by Subject|2|||
16908366|NCT01780974|38017007|FG001|Overall Study|Adverse Event|3|||
17007276|NCT00933335|38151148|FG001|Overall Study|Lost to Follow-up|3|||
17007277|NCT00933335|38151147|FG000|Overall Study|Withdrawal by Subject|0|||
17007278|NCT00933335|38151148|FG001|Overall Study|Withdrawal by Subject|1|||
17007279|NCT00933335|38151147|FG000|Overall Study|Progressive Disease|0|||
17007280|NCT00933335|38151148|FG001|Overall Study|Progressive Disease|11|||
17007281|NCT00933335|38151147|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
17007282|NCT00933335|38151148|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
17007283|NCT00933335|38151147|FG000|Overall Study|Co-morbid Illness|1|||
17007284|NCT00933335|38151148|FG001|Overall Study|Co-morbid Illness|0|||
17007285|NCT00772941|38151160|FG000|Overall Study|CRFs not available|195|||
17007286|NCT00772941|38151160|FG000|Overall Study|Study not completed|16|||
17007287|NCT00772941|38151160|FG000|Overall Study|Missed Visits|374|||
17007288|NCT00772941|38151160|FG000|Overall Study|Poor Compliance|7|||
17007289|NCT00772941|38151160|FG000|Overall Study|GPSP Violation|90|||
17095844|NCT00257192|38235124|FG000|Overall Study|Randomized but not treated|0|||
17095845|NCT00257192|38235125|FG001|Overall Study|Randomized but not treated|1|||
17007290|NCT00772707|38151187|FG000|Overall Study|Withdrawn|3|||
17007291|NCT00772629|38151193|FG000|Overall Study|Subject was not vaccinated|1|||
17007292|NCT00772629|38151194|FG001|Overall Study|Subject was not vaccinated|0|||
17007293|NCT00939341|38151200|FG000|Overall Study|Adverse Event|15|||
17007294|NCT00939341|38151200|FG000|Overall Study|Pregnancy|1|||
17007295|NCT00939341|38151200|FG000|Overall Study|Lost to Follow-up|23|||
17007296|NCT00939341|38151200|FG000|Overall Study|Withdrawal by Subject|13|||
17007297|NCT00939341|38151200|FG000|Overall Study|Protocol Violation|6|||
17007298|NCT00939341|38151200|FG000|Overall Study|Incorrect enrolment|8|||
17007299|NCT04292470|38151229|FG000|Overall Study|Withdrawal by Subject|0|||
17007300|NCT04292470|38151230|FG001|Overall Study|Withdrawal by Subject|1|||
17007301|NCT04217590|38151238|FG000|Overall Study|Other|1|||
17007302|NCT04217590|38151239|FG001|Overall Study|Other|1|||
17007303|NCT04217590|38151238|FG000|Overall Study|Withdrawal by Subject|3|||
17007304|NCT04217590|38151239|FG001|Overall Study|Withdrawal by Subject|1|||
17007305|NCT04217590|38151238|FG000|Overall Study|Death|0|||
17007306|NCT04217590|38151239|FG001|Overall Study|Death|1|||
17007307|NCT03963232|38151320|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
17007308|NCT03963232|38151321|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
17007309|NCT03963232|38151320|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
17007310|NCT03963232|38151321|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
17007311|NCT03963232|38151320|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
17007312|NCT03963232|38151321|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
17007313|NCT03963232|38151320|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
17007314|NCT03963232|38151321|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
17007315|NCT03963232|38151320|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
17007316|NCT03963232|38151321|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
17007317|NCT03963232|38151320|FG000|Open-Label Treatment Phase|Adverse Event|1|||
17007318|NCT03963232|38151321|FG001|Open-Label Treatment Phase|Adverse Event|2|||
17007319|NCT03963232|38151320|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
17007320|NCT03963232|38151321|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
17007321|NCT03963232|38151320|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
17007322|NCT03963232|38151321|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
17007323|NCT03963232|38151320|FG000|Open-Label Treatment Phase|Pregnancy|1|||
17007324|NCT03963232|38151321|FG001|Open-Label Treatment Phase|Pregnancy|0|||
17007325|NCT03963232|38151320|FG000|Follow-up Phase|Withdrawal by Subject|7|||
17007326|NCT03963232|38151321|FG001|Follow-up Phase|Withdrawal by Subject|5|||
17007327|NCT03963232|38151320|FG000|Follow-up Phase|Protocol Violation|0|||
17007328|NCT03963232|38151321|FG001|Follow-up Phase|Protocol Violation|2|||
17007329|NCT03963232|38151320|FG000|Follow-up Phase|Adverse Event|0|||
17007330|NCT03963232|38151321|FG001|Follow-up Phase|Adverse Event|1|||
17007331|NCT03963232|38151320|FG000|Follow-up Phase|Lost to Follow-up|0|||
17007332|NCT03963232|38151321|FG001|Follow-up Phase|Lost to Follow-up|1|||
17007333|NCT03934216|38151345|FG000|Randomization|Randomized in Error|1|||
17007334|NCT03934216|38151346|FG001|Randomization|Randomized in Error|1|||
17007335|NCT03934216|38151345|FG000|Treatment Period|Adverse Event|10|||
17007336|NCT03934216|38151346|FG001|Treatment Period|Adverse Event|3|||
17007337|NCT03934216|38151345|FG000|Treatment Period|Withdrawal by Participant|6|||
17007338|NCT03934216|38151346|FG001|Treatment Period|Withdrawal by Participant|2|||
17007339|NCT03934216|38151345|FG000|Treatment Period|Other Reasons|2|||
17007340|NCT03934216|38151346|FG001|Treatment Period|Other Reasons|2|||
17007341|NCT03856593|38151354|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
17007342|NCT03856593|38151355|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
17007343|NCT03845296|38151365|FG000|Overall Study|On Treatment|2|||
17007344|NCT03845296|38151366|FG001|Overall Study|On Treatment|1|||
17095846|NCT00257192|38235124|FG000|Overall Study|Study terminated by sponsor|1|||
17007345|NCT03845296|38151365|FG000|Overall Study|Adverse Event|4|||
17007346|NCT03845296|38151366|FG001|Overall Study|Adverse Event|11|||
17007347|NCT03845296|38151365|FG000|Overall Study|Refusal unrelated to adverse event|0|||
17007348|NCT03845296|38151366|FG001|Overall Study|Refusal unrelated to adverse event|1|||
17007349|NCT03845296|38151365|FG000|Overall Study|Progression/relapse|14|||
17007350|NCT03845296|38151366|FG001|Overall Study|Progression/relapse|18|||
17007351|NCT03845296|38151365|FG000|Overall Study|Death|4|||
17007352|NCT03845296|38151366|FG001|Overall Study|Death|0|||
17095847|NCT00257192|38235125|FG001|Overall Study|Study terminated by sponsor|0|||
17095848|NCT00257192|38235124|FG000|Overall Study|Miscellaneous|0|||
17095849|NCT00257192|38235125|FG001|Overall Study|Miscellaneous|4|||
17095850|NCT00256724|38235133|FG000|Overall Study|Physician Decision|2|||
17095851|NCT00256724|38235134|FG001|Overall Study|Physician Decision|5|||
17095852|NCT00256724|38235133|FG000|Overall Study|Protocol Violation|3|||
17095853|NCT00256724|38235134|FG001|Overall Study|Protocol Violation|3|||
17095854|NCT00157820|38235143|FG000|Randomized|Physician Decision|4|||
17095855|NCT00157820|38235144|FG001|Randomized|Physician Decision|2|||
17095856|NCT00157820|38235145|FG002|Randomized|Physician Decision|3|||
17007353|NCT03845296|38151365|FG000|Overall Study|Other - not protocol specified|1|||
17007354|NCT03845296|38151366|FG001|Overall Study|Other - not protocol specified|3|||
17007355|NCT03785925|38151372|FG000|Overall Study|Withdrawal by Subject|15|||
17007356|NCT03785925|38151372|FG000|Overall Study|Lost to Follow-up|1|||
17007357|NCT03427411|38151390|FG000|Overall Study|Screen failure - platelets too low|0|||
17095857|NCT00157820|38235143|FG000|Randomized|Withdrawal by Subject|1|||
17095858|NCT00157820|38235144|FG001|Randomized|Withdrawal by Subject|2|||
17095859|NCT00157820|38235145|FG002|Randomized|Withdrawal by Subject|3|||
17095860|NCT00157820|38235143|FG000|Randomized|Protocol Violation|2|||
17007358|NCT03427411|38151391|FG001|Overall Study|Screen failure - platelets too low|1|||
17007359|NCT03330106|38151399|FG000|Part A|Withdrawal by Subject|1|||
17007360|NCT03330106|38151400|FG001|Part A|Withdrawal by Subject|1|||
17007361|NCT03330106|38151401|FG002|Part A|Withdrawal by Subject|0|||
17007362|NCT03330106|38151402|FG003|Part A|Withdrawal by Subject|0|||
17007363|NCT03330106|38151399|FG000|Part A|Death|2|||
17007364|NCT03330106|38151400|FG001|Part A|Death|1|||
17007365|NCT03330106|38151401|FG002|Part A|Death|0|||
17007366|NCT03330106|38151402|FG003|Part A|Death|0|||
17007367|NCT03330106|38151399|FG000|Part A|Adverse Event|0|||
17007368|NCT03330106|38151400|FG001|Part A|Adverse Event|1|||
17007369|NCT03330106|38151401|FG002|Part A|Adverse Event|0|||
17007370|NCT03330106|38151402|FG003|Part A|Adverse Event|0|||
17007371|NCT03330106|38151399|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
17095861|NCT00157820|38235144|FG001|Randomized|Protocol Violation|1|||
17095862|NCT00157820|38235145|FG002|Randomized|Protocol Violation|2|||
17095863|NCT00157820|38235143|FG000|1st 8 Month|Death|7|||
17095864|NCT00157820|38235144|FG001|1st 8 Month|Death|8|||
17095865|NCT00157820|38235145|FG002|1st 8 Month|Death|3|||
17095866|NCT00157820|38235143|FG000|1st 8 Month|Lost to Follow-up|1|||
17095867|NCT00157820|38235144|FG001|1st 8 Month|Lost to Follow-up|2|||
17095868|NCT00157820|38235145|FG002|1st 8 Month|Lost to Follow-up|1|||
17095869|NCT00157820|38235143|FG000|1st 8 Month|Premature cross-over|0|||
17095870|NCT00157820|38235144|FG001|1st 8 Month|Premature cross-over|2|||
17007372|NCT03330106|38151400|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
17007373|NCT03330106|38151401|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
17007374|NCT03330106|38151402|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
17007375|NCT03330106|38151399|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
17007376|NCT03330106|38151400|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
17007377|NCT03330106|38151401|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
17007378|NCT03330106|38151402|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
17007379|NCT03330106|38151399|FG000|Part A|Progressive Disease|0|||
17007380|NCT03330106|38151400|FG001|Part A|Progressive Disease|1|||
17007381|NCT03330106|38151401|FG002|Part A|Progressive Disease|0|||
17095871|NCT00157820|38235145|FG002|1st 8 Month|Premature cross-over|2|||
17007382|NCT03330106|38151402|FG003|Part A|Progressive Disease|0|||
17007383|NCT03330106|38151399|FG000|Part B|Lost to Follow-up|0|||
17007384|NCT03330106|38151400|FG001|Part B|Lost to Follow-up|0|||
17007385|NCT03330106|38151401|FG002|Part B|Lost to Follow-up|0|||
17007386|NCT03330106|38151402|FG003|Part B|Lost to Follow-up|1|||
17007387|NCT03330106|38151399|FG000|Part B|Withdrawal by Subject|0|||
17007388|NCT03330106|38151400|FG001|Part B|Withdrawal by Subject|0|||
17007389|NCT03330106|38151401|FG002|Part B|Withdrawal by Subject|4|||
17007390|NCT03330106|38151402|FG003|Part B|Withdrawal by Subject|0|||
17007391|NCT03330106|38151399|FG000|Part B|Death|0|||
17007392|NCT03330106|38151400|FG001|Part B|Death|0|||
17007393|NCT03330106|38151401|FG002|Part B|Death|2|||
17007394|NCT03330106|38151402|FG003|Part B|Death|0|||
17007395|NCT03330106|38151399|FG000|Part B|Clinical Progression|0|||
17007396|NCT03330106|38151400|FG001|Part B|Clinical Progression|0|||
17007397|NCT03330106|38151401|FG002|Part B|Clinical Progression|1|||
17007398|NCT03330106|38151402|FG003|Part B|Clinical Progression|1|||
17095872|NCT00157820|38235143|FG000|2nd 8 Months|Death|3|||
17095873|NCT00157820|38235144|FG001|2nd 8 Months|Death|1|||
17095874|NCT00157820|38235145|FG002|2nd 8 Months|Death|3|||
17007399|NCT03330106|38151399|FG000|Part B|Symptomatic Deterioration|0|||
17007400|NCT03330106|38151400|FG001|Part B|Symptomatic Deterioration|0|||
17007401|NCT03330106|38151401|FG002|Part B|Symptomatic Deterioration|0|||
17007402|NCT03330106|38151402|FG003|Part B|Symptomatic Deterioration|1|||
17007403|NCT03330106|38151399|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
17007404|NCT03330106|38151400|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
17007405|NCT03330106|38151401|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
17007406|NCT03330106|38151402|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
17007407|NCT03330106|38151399|FG000|Part B|Progressive Disease|0|||
17007408|NCT03330106|38151400|FG001|Part B|Progressive Disease|0|||
17007409|NCT03330106|38151401|FG002|Part B|Progressive Disease|11|||
17007410|NCT03330106|38151402|FG003|Part B|Progressive Disease|4|||
17007411|NCT03164564|38151414|FG000|Overall Study|Death|3|||
17007412|NCT03164564|38151415|FG001|Overall Study|Death|0|||
17007413|NCT03164564|38151414|FG000|Overall Study|Withdrawal by Subject|20|||
17007414|NCT03164564|38151415|FG001|Overall Study|Withdrawal by Subject|15|||
17007415|NCT03164564|38151414|FG000|Overall Study|Lost to Follow-up|2|||
17007416|NCT03164564|38151415|FG001|Overall Study|Lost to Follow-up|0|||
17007417|NCT03164564|38151414|FG000|Overall Study|Physician Decision|0|||
17007418|NCT03164564|38151415|FG001|Overall Study|Physician Decision|1|||
17007419|NCT03164564|38151414|FG000|Overall Study|Adverse Event|0|||
17007420|NCT03164564|38151415|FG001|Overall Study|Adverse Event|1|||
17007421|NCT03164564|38151414|FG000|Overall Study|Ongoing|1586|||
17007422|NCT03164564|38151415|FG001|Overall Study|Ongoing|1586|||
17007423|NCT02821754|38151439|FG000|Overall Study|Procedure not required prior to amendment change|13|||
17007424|NCT02821754|38151440|FG001|Overall Study|Procedure not required prior to amendment change|11|||
17007425|NCT02821754|38151441|FG002|Overall Study|Procedure not required prior to amendment change|0|||
17007426|NCT02821754|38151439|FG000|Overall Study|Participant's Clinical status|2|||
17007427|NCT02821754|38151440|FG001|Overall Study|Participant's Clinical status|0|||
17007428|NCT02821754|38151441|FG002|Overall Study|Participant's Clinical status|0|||
17007429|NCT02821754|38151439|FG000|Overall Study|Participant removed for noncompliance|1|||
17007430|NCT02821754|38151440|FG001|Overall Study|Participant removed for noncompliance|0|||
17007431|NCT02821754|38151441|FG002|Overall Study|Participant removed for noncompliance|0|||
17007432|NCT02821754|38151439|FG000|Overall Study|Drug not available.|0|||
17007433|NCT02821754|38151440|FG001|Overall Study|Drug not available.|0|||
17007434|NCT02821754|38151441|FG002|Overall Study|Drug not available.|1|||
17007435|NCT02821754|38151439|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
17007436|NCT02821754|38151440|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
17007437|NCT02821754|38151441|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
17007438|NCT02742246|38151450|FG000|Overall Study|Never initiated treatment|5|||
17007439|NCT02742246|38151451|FG001|Overall Study|Never initiated treatment|3|||
17007440|NCT02742246|38151452|FG002|Overall Study|Never initiated treatment|1|||
17007441|NCT02742246|38151450|FG000|Overall Study|dropped out during treatment|14|||
17007442|NCT02742246|38151451|FG001|Overall Study|dropped out during treatment|14|||
17007443|NCT02742246|38151452|FG002|Overall Study|dropped out during treatment|11|||
17007444|NCT02742246|38151450|FG000|Overall Study|Death|1|||
17007445|NCT02742246|38151451|FG001|Overall Study|Death|0|||
17007446|NCT02742246|38151452|FG002|Overall Study|Death|0|||
17007447|NCT02708108|38151462|FG000|Overall Study|Death|1|||
17007448|NCT02708108|38151463|FG001|Overall Study|Death|2|||
17007449|NCT02708108|38151462|FG000|Overall Study|Regimen change|1|||
17007450|NCT02708108|38151463|FG001|Overall Study|Regimen change|0|||
17007451|NCT02708108|38151462|FG000|Overall Study|No MRD and no imaging available|0|||
17007452|NCT02708108|38151463|FG001|Overall Study|No MRD and no imaging available|1|||
17007453|NCT02619682|38151470|FG000|Overall Study|Withdrawal by Subject|3|||
17007454|NCT02619682|38151470|FG000|Overall Study|Lack of Efficacy|8|||
17007455|NCT02619682|38151470|FG000|Overall Study|new secondary cancer|1|||
17007456|NCT02619682|38151470|FG000|Overall Study|post surgery complications|2|||
17007457|NCT02617589|38151476|FG000|Randomization|Request to Discontinue Study Treatment|1|||
17007458|NCT02617589|38151477|FG001|Randomization|Request to Discontinue Study Treatment|3|||
17007459|NCT02617589|38151476|FG000|Randomization|Participant Withdrew Consent|1|||
17007460|NCT02617589|38151477|FG001|Randomization|Participant Withdrew Consent|2|||
17007461|NCT02617589|38151476|FG000|Treatment|Other Reasons|3|||
17007462|NCT02617589|38151477|FG001|Treatment|Other Reasons|3|||
17007463|NCT02617589|38151476|FG000|Treatment|Poor/Non Compliance|1|||
17007464|NCT02617589|38151477|FG001|Treatment|Poor/Non Compliance|1|||
17007465|NCT02617589|38151476|FG000|Treatment|Maximum Clinical Benefit|0|||
17007466|NCT02617589|38151477|FG001|Treatment|Maximum Clinical Benefit|2|||
17007467|NCT02617589|38151476|FG000|Treatment|Participant Withdrew Consent|2|||
17007468|NCT02617589|38151477|FG001|Treatment|Participant Withdrew Consent|6|||
17007469|NCT02617589|38151476|FG000|Treatment|Participant Request to Discontinue|12|||
17007470|NCT02617589|38151477|FG001|Treatment|Participant Request to Discontinue|21|||
17007471|NCT02617589|38151476|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
17007472|NCT02617589|38151477|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
17007473|NCT02617589|38151476|FG000|Treatment|Death|1|||
17007474|NCT02617589|38151477|FG001|Treatment|Death|1|||
17007475|NCT02617589|38151476|FG000|Treatment|Study Drug Toxicity|27|||
17007476|NCT02617589|38151477|FG001|Treatment|Study Drug Toxicity|20|||
17007477|NCT02617589|38151476|FG000|Treatment|Disease Progression|216|||
17007478|NCT02617589|38151477|FG001|Treatment|Disease Progression|136|||
17007479|NCT02500797|38151495|FG000|Overall Study|Cancel (rapid disease progression)|0|||
17007480|NCT02500797|38151496|FG001|Overall Study|Cancel (rapid disease progression)|0|||
17007481|NCT02500797|38151497|FG002|Overall Study|Cancel (rapid disease progression)|0|||
17007482|NCT02500797|38151498|FG003|Overall Study|Cancel (rapid disease progression)|0|||
17007483|NCT02500797|38151499|FG004|Overall Study|Cancel (rapid disease progression)|1|||
17007484|NCT02500797|38151500|FG005|Overall Study|Cancel (rapid disease progression)|1|||
17007485|NCT02500797|38151501|FG006|Overall Study|Cancel (rapid disease progression)|0|||
17007486|NCT02500797|38151502|FG007|Overall Study|Cancel (rapid disease progression)|0|||
17007487|NCT02500797|38151495|FG000|Overall Study|Withdrawal by Subject|1|||
17007488|NCT02500797|38151496|FG001|Overall Study|Withdrawal by Subject|0|||
17007489|NCT02500797|38151497|FG002|Overall Study|Withdrawal by Subject|0|||
17007490|NCT02500797|38151498|FG003|Overall Study|Withdrawal by Subject|0|||
17007491|NCT02500797|38151499|FG004|Overall Study|Withdrawal by Subject|0|||
17007492|NCT02500797|38151500|FG005|Overall Study|Withdrawal by Subject|0|||
17007493|NCT02500797|38151501|FG006|Overall Study|Withdrawal by Subject|0|||
17007494|NCT02500797|38151502|FG007|Overall Study|Withdrawal by Subject|0|||
17007495|NCT02471807|38151527|FG000|Overall Study|Death|14|||
17007496|NCT02471807|38151527|FG000|Overall Study|Withdrawal by Subject|2|||
17007497|NCT02471807|38151527|FG000|Overall Study|Explant|5|||
17007498|NCT02471807|38151527|FG000|Overall Study|Lost to Follow-up|1|||
17007499|NCT02395666|38151533|FG000|Overall Study|Physician Decision|3|||
17007500|NCT02395666|38151534|FG001|Overall Study|Physician Decision|0|||
17007501|NCT02395666|38151533|FG000|Overall Study|Lost to Follow-up|1|||
17007502|NCT02395666|38151534|FG001|Overall Study|Lost to Follow-up|0|||
17007503|NCT02395666|38151533|FG000|Overall Study|Withdrawal by Subject|2|||
17007504|NCT02395666|38151534|FG001|Overall Study|Withdrawal by Subject|1|||
17007505|NCT02364557|38151546|FG000|Overall Study|Protocol Violation|3|||
17007506|NCT02364557|38151547|FG001|Overall Study|Protocol Violation|1|||
17007507|NCT02337829|38151583|FG000|Overall Study|Death|0|||
17007508|NCT02337829|38151584|FG001|Overall Study|Death|1|||
17007509|NCT02337829|38151585|FG002|Overall Study|Death|0|||
17007510|NCT02337829|38151586|FG003|Overall Study|Death|0|||
17007511|NCT02337829|38151583|FG000|Overall Study|Study terminated by sponsor|12|||
17007512|NCT02337829|38151584|FG001|Overall Study|Study terminated by sponsor|10|||
17007513|NCT02337829|38151585|FG002|Overall Study|Study terminated by sponsor|5|||
17007514|NCT02337829|38151586|FG003|Overall Study|Study terminated by sponsor|6|||
17007515|NCT02337829|38151583|FG000|Overall Study|discontinued for other reasons|6|||
17007516|NCT02337829|38151584|FG001|Overall Study|discontinued for other reasons|3|||
17007517|NCT02337829|38151585|FG002|Overall Study|discontinued for other reasons|1|||
17007518|NCT02337829|38151586|FG003|Overall Study|discontinued for other reasons|4|||
17007519|NCT02257528|38151598|FG000|Overall Study|Never received study treatment|1|||
17007520|NCT01899326|38151602|FG000|Overall Study|Withdrawal by Subject|1|||
17007521|NCT01899326|38151602|FG000|Overall Study|Adverse Event|2|||
17007522|NCT01899326|38151602|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
17095875|NCT00157820|38235143|FG000|2nd 8 Months|Lost to Follow-up|1|||
17095876|NCT00157820|38235144|FG001|2nd 8 Months|Lost to Follow-up|5|||
17095877|NCT00157820|38235145|FG002|2nd 8 Months|Lost to Follow-up|2|||
17095878|NCT00157820|38235143|FG000|2nd 8 Months|Premature cross-over|1|||
17095879|NCT00157820|38235144|FG001|2nd 8 Months|Premature cross-over|7|||
17095880|NCT00157820|38235145|FG002|2nd 8 Months|Premature cross-over|9|||
17095881|NCT00223808|38235157|FG000|Overall Study|<5 hrs therapy before discharge|3|||
17095882|NCT00223808|38235158|FG001|Overall Study|<5 hrs therapy before discharge|5|||
17095883|NCT00223808|38235159|FG002|Overall Study|<5 hrs therapy before discharge|5|||
17095884|NCT00154310|38235169|FG000|Overall Study|Adverse Event|19|||
17095885|NCT00154310|38235170|FG001|Overall Study|Adverse Event|9|||
17095886|NCT00154310|38235169|FG000|Overall Study|Lack of Efficacy|5|||
17095887|NCT00154310|38235170|FG001|Overall Study|Lack of Efficacy|4|||
17095888|NCT00154310|38235169|FG000|Overall Study|Protocol Violation|4|||
17095889|NCT00154310|38235170|FG001|Overall Study|Protocol Violation|2|||
17095890|NCT00154310|38235169|FG000|Overall Study|Withdrawal by Subject|9|||
17095891|NCT00154310|38235170|FG001|Overall Study|Withdrawal by Subject|3|||
17095892|NCT00154310|38235169|FG000|Overall Study|Lost to Follow-up|0|||
17095893|NCT00154310|38235170|FG001|Overall Study|Lost to Follow-up|8|||
17095894|NCT00154310|38235169|FG000|Overall Study|Administrative problems|0|||
17095895|NCT00154310|38235170|FG001|Overall Study|Administrative problems|1|||
17095896|NCT00154310|38235169|FG000|Overall Study|Death|0|||
17095897|NCT00154310|38235170|FG001|Overall Study|Death|1|||
17095898|NCT03771664|38235178|FG000|Overall Study|Adverse Event|1|||
17007523|NCT01856192|38151609|FG000|Overall Study|Adverse Event|12|||
17007524|NCT01856192|38151610|FG001|Overall Study|Adverse Event|4|||
17007525|NCT01856192|38151609|FG000|Overall Study|Alternative therapy|0|||
17007526|NCT01856192|38151610|FG001|Overall Study|Alternative therapy|3|||
17007527|NCT01856192|38151609|FG000|Overall Study|Death|3|||
17007528|NCT01856192|38151610|FG001|Overall Study|Death|5|||
17007529|NCT01856192|38151609|FG000|Overall Study|Lack of Efficacy|0|||
17007530|NCT01856192|38151610|FG001|Overall Study|Lack of Efficacy|5|||
17007531|NCT01856192|38151609|FG000|Overall Study|Withdrawal by Subject|1|||
17007532|NCT01856192|38151610|FG001|Overall Study|Withdrawal by Subject|1|||
17007533|NCT01856192|38151609|FG000|Overall Study|Other diseases|1|||
17007534|NCT01856192|38151610|FG001|Overall Study|Other diseases|0|||
17007535|NCT01856192|38151609|FG000|Overall Study|Never started treatment|7|||
17007536|NCT01856192|38151610|FG001|Overall Study|Never started treatment|5|||
17095899|NCT03771664|38235179|FG001|Overall Study|Adverse Event|0|||
17095900|NCT03771664|38235178|FG000|Overall Study|Lost to Follow-up|1|||
17095901|NCT03771664|38235179|FG001|Overall Study|Lost to Follow-up|0|||
17095902|NCT03771664|38235178|FG000|Overall Study|Withdrawal by Participant|1|||
17095903|NCT03771664|38235179|FG001|Overall Study|Withdrawal by Participant|4|||
17007537|NCT01856192|38151609|FG000|Overall Study|Path ineligible|20|||
17007538|NCT01856192|38151610|FG001|Overall Study|Path ineligible|34|||
17007539|NCT01856192|38151609|FG000|Overall Study|Non-path ineligible|2|||
17007540|NCT01856192|38151610|FG001|Overall Study|Non-path ineligible|2|||
17007541|NCT01856192|38151609|FG000|Overall Study|Physician Decision|1|||
17007542|NCT01856192|38151610|FG001|Overall Study|Physician Decision|1|||
17007543|NCT01856192|38151609|FG000|Overall Study|Suspicion of progressive disease|1|||
17007544|NCT01856192|38151610|FG001|Overall Study|Suspicion of progressive disease|0|||
17007545|NCT01856192|38151609|FG000|Overall Study|Non-compliance|1|||
17007546|NCT01856192|38151610|FG001|Overall Study|Non-compliance|0|||
17007547|NCT01572480|38151621|FG000|Participants Enrolled|Withdrawal by Subject|1|||
17007548|NCT01572480|38151621|FG000|Drug Administration|Discontinued drug/Off Study|1|||
17007549|NCT01572480|38151621|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
17007550|NCT01572480|38151621|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
17007551|NCT01126190|38151628|FG000|Double-Blind Phase|Death|0|||
17007552|NCT01126190|38151629|FG001|Double-Blind Phase|Death|1|||
17007553|NCT01126190|38151630|FG002|Double-Blind Phase|Death|0|||
17007554|NCT01126190|38151628|FG000|Double-Blind Phase|Adverse Event|1|||
17007555|NCT01126190|38151629|FG001|Double-Blind Phase|Adverse Event|2|||
17095904|NCT03771664|38235178|FG000|Overall Study|Randomized but not Treated|0|||
17095905|NCT03771664|38235179|FG001|Overall Study|Randomized but not Treated|1|||
17095906|NCT03771352|38235185|FG000|Overall Study|Screen failure|2|||
17095907|NCT03771352|38235185|FG000|Overall Study|Withdrawal by Subject|2|||
17095908|NCT03770728|38235193|FG000|Overall Study|Adverse Event|1|||
17095909|NCT03770728|38235194|FG001|Overall Study|Adverse Event|0|||
17095910|NCT03770728|38235195|FG002|Overall Study|Adverse Event|1|||
17095911|NCT03770728|38235196|FG003|Overall Study|Adverse Event|0|||
17095912|NCT03770728|38235193|FG000|Overall Study|Poor compliance to protocol|0|||
17095913|NCT03770728|38235194|FG001|Overall Study|Poor compliance to protocol|0|||
17095914|NCT03770728|38235195|FG002|Overall Study|Poor compliance to protocol|1|||
17095915|NCT03770728|38235196|FG003|Overall Study|Poor compliance to protocol|0|||
17095916|NCT03770728|38235193|FG000|Overall Study|Withdrawal by Subject|13|||
17095917|NCT03770728|38235194|FG001|Overall Study|Withdrawal by Subject|8|||
16786257|NCT01999972|37726701|FG001|Dose Escalation Part|Adverse Event|0|||
17007556|NCT01126190|38151630|FG002|Double-Blind Phase|Adverse Event|0|||
17007557|NCT01126190|38151628|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
17007558|NCT01126190|38151629|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
17007559|NCT01126190|38151630|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
17007560|NCT01126190|38151628|FG000|Double-Blind Phase|Request of Investigator|1|||
17007561|NCT01126190|38151629|FG001|Double-Blind Phase|Request of Investigator|0|||
17007562|NCT01126190|38151630|FG002|Double-Blind Phase|Request of Investigator|0|||
17007563|NCT01126190|38151628|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
17007564|NCT01126190|38151629|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
17007565|NCT01126190|38151630|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
17007566|NCT01126190|38151628|FG000|Double-Blind Phase|Non-compliance|1|||
17007567|NCT01126190|38151629|FG001|Double-Blind Phase|Non-compliance|0|||
17007568|NCT01126190|38151630|FG002|Double-Blind Phase|Non-compliance|0|||
17007569|NCT01126190|38151628|FG000|Double-Blind Phase|Lost to Follow-up|1|||
17007570|NCT01126190|38151629|FG001|Double-Blind Phase|Lost to Follow-up|3|||
17007571|NCT01126190|38151630|FG002|Double-Blind Phase|Lost to Follow-up|0|||
17007572|NCT01126190|38151628|FG000|Open-Label Phase|Death|0|||
17007573|NCT01126190|38151629|FG001|Open-Label Phase|Death|0|||
17007574|NCT01126190|38151630|FG002|Open-Label Phase|Death|1|||
17007575|NCT01126190|38151628|FG000|Open-Label Phase|Adverse Event|0|||
17007576|NCT01126190|38151629|FG001|Open-Label Phase|Adverse Event|0|||
17007577|NCT01126190|38151630|FG002|Open-Label Phase|Adverse Event|4|||
17007578|NCT01126190|38151628|FG000|Open-Label Phase|Withdrawal by Subject|0|||
17007579|NCT01126190|38151629|FG001|Open-Label Phase|Withdrawal by Subject|0|||
17095918|NCT03770728|38235195|FG002|Overall Study|Withdrawal by Subject|9|||
17095919|NCT03770728|38235196|FG003|Overall Study|Withdrawal by Subject|13|||
17192871|NCT02415556|38346205|FG000|Overall Study|Physician Decision|1|||
17007580|NCT01126190|38151630|FG002|Open-Label Phase|Withdrawal by Subject|6|||
17095920|NCT03770728|38235193|FG000|Overall Study|Other than specified|24|||
17095921|NCT03770728|38235194|FG001|Overall Study|Other than specified|23|||
17095922|NCT03770728|38235195|FG002|Overall Study|Other than specified|21|||
17095923|NCT03770728|38235196|FG003|Overall Study|Other than specified|22|||
17095924|NCT03769090|38235211|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
17095925|NCT03769090|38235212|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
17095926|NCT03769090|38235213|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
17095927|NCT03769090|38235211|FG000|Overall Study|Withdrawal by Subject|52|||
17095928|NCT03769090|38235212|FG001|Overall Study|Withdrawal by Subject|62|||
17095929|NCT03769090|38235213|FG002|Overall Study|Withdrawal by Subject|74|||
17095930|NCT03769090|38235211|FG000|Overall Study|Death|4|||
17095931|NCT03769090|38235212|FG001|Overall Study|Death|2|||
17095932|NCT03769090|38235213|FG002|Overall Study|Death|2|||
17095933|NCT03769090|38235211|FG000|Overall Study|Adverse Event|7|||
17095934|NCT03769090|38235212|FG001|Overall Study|Adverse Event|7|||
17095935|NCT03769090|38235213|FG002|Overall Study|Adverse Event|8|||
17095936|NCT03769090|38235211|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
17095937|NCT03769090|38235212|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
17095938|NCT03769090|38235213|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
17095939|NCT03769090|38235211|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
17095940|NCT03769090|38235212|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
17095941|NCT03769090|38235213|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
17095942|NCT03769090|38235211|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
17095943|NCT03769090|38235212|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
17095944|NCT03769090|38235213|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
17095945|NCT03769090|38235211|FG000|Overall Study|Protocol Violation|5|||
17095946|NCT03769090|38235212|FG001|Overall Study|Protocol Violation|6|||
17095947|NCT03769090|38235213|FG002|Overall Study|Protocol Violation|8|||
17095948|NCT03769090|38235211|FG000|Overall Study|Pregnancy|1|||
17095949|NCT03769090|38235212|FG001|Overall Study|Pregnancy|0|||
17095950|NCT03769090|38235213|FG002|Overall Study|Pregnancy|3|||
17095951|NCT03769090|38235211|FG000|Overall Study|Lost to Follow-up|19|||
17095952|NCT03769090|38235212|FG001|Overall Study|Lost to Follow-up|25|||
17095953|NCT03769090|38235213|FG002|Overall Study|Lost to Follow-up|21|||
17095954|NCT03769090|38235211|FG000|Overall Study|Condition under investigation worsened|2|||
17095955|NCT03769090|38235212|FG001|Overall Study|Condition under investigation worsened|0|||
17095956|NCT03769090|38235213|FG002|Overall Study|Condition under investigation worsened|1|||
17095957|NCT03769090|38235211|FG000|Overall Study|Lack of Efficacy|1|||
17095958|NCT03769090|38235212|FG001|Overall Study|Lack of Efficacy|2|||
17095959|NCT03769090|38235213|FG002|Overall Study|Lack of Efficacy|2|||
17095960|NCT03769090|38235211|FG000|Overall Study|Other reasons|8|||
17095961|NCT03769090|38235212|FG001|Overall Study|Other reasons|12|||
17095962|NCT03769090|38235213|FG002|Overall Study|Other reasons|15|||
17095963|NCT03559270|38235237|FG000|Overall Study|Adverse Event|6|||
17095964|NCT03559270|38235238|FG001|Overall Study|Adverse Event|5|||
17192872|NCT02415556|38346206|FG001|Overall Study|Physician Decision|3|||
17095965|NCT03559270|38235239|FG002|Overall Study|Adverse Event|3|||
17095966|NCT03559270|38235240|FG003|Overall Study|Adverse Event|0|||
17095967|NCT03559270|38235237|FG000|Overall Study|Lack of Efficacy|34|||
17095968|NCT03559270|38235238|FG001|Overall Study|Lack of Efficacy|52|||
17095969|NCT03559270|38235239|FG002|Overall Study|Lack of Efficacy|37|||
17095970|NCT03559270|38235240|FG003|Overall Study|Lack of Efficacy|2|||
17095971|NCT03559270|38235237|FG000|Overall Study|Death|0|||
17095972|NCT03559270|38235238|FG001|Overall Study|Death|2|||
17095973|NCT03559270|38235239|FG002|Overall Study|Death|0|||
17095974|NCT03559270|38235240|FG003|Overall Study|Death|0|||
17095975|NCT03559270|38235237|FG000|Overall Study|Lost to Follow-up|16|||
17095976|NCT03559270|38235238|FG001|Overall Study|Lost to Follow-up|4|||
17095977|NCT03559270|38235239|FG002|Overall Study|Lost to Follow-up|12|||
17095978|NCT03559270|38235240|FG003|Overall Study|Lost to Follow-up|3|||
17095979|NCT03559270|38235237|FG000|Overall Study|Sponsor Decision|38|||
17095980|NCT03559270|38235238|FG001|Overall Study|Sponsor Decision|31|||
17095981|NCT03559270|38235239|FG002|Overall Study|Sponsor Decision|35|||
17095982|NCT03559270|38235240|FG003|Overall Study|Sponsor Decision|18|||
17095983|NCT03559270|38235237|FG000|Overall Study|Withdrawal by Subject|19|||
17095984|NCT03559270|38235238|FG001|Overall Study|Withdrawal by Subject|21|||
17095985|NCT03559270|38235239|FG002|Overall Study|Withdrawal by Subject|18|||
17095986|NCT03559270|38235240|FG003|Overall Study|Withdrawal by Subject|7|||
17095987|NCT03559270|38235237|FG000|Overall Study|Physician Decision|3|||
17095988|NCT03559270|38235238|FG001|Overall Study|Physician Decision|2|||
17095989|NCT03559270|38235239|FG002|Overall Study|Physician Decision|1|||
17095990|NCT03559270|38235240|FG003|Overall Study|Physician Decision|0|||
17095991|NCT03559270|38235237|FG000|Overall Study|Pregnancy|0|||
17095992|NCT03559270|38235238|FG001|Overall Study|Pregnancy|1|||
17095993|NCT03559270|38235239|FG002|Overall Study|Pregnancy|0|||
17095994|NCT03559270|38235240|FG003|Overall Study|Pregnancy|0|||
17007581|NCT00939185|38151663|FG000|Overall Study|Adverse Event|3|||
17007582|NCT00939185|38151663|FG000|Overall Study|Lack of Efficacy|1|||
17007583|NCT00939185|38151663|FG000|Overall Study|Lost to Follow-up|6|||
17007584|NCT00939185|38151663|FG000|Overall Study|Other|3|||
17007585|NCT00939185|38151663|FG000|Overall Study|Withdrawal by Subject|2|||
17007586|NCT00939185|38151663|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
17007587|NCT03977155|38151670|FG000|Overall Study|Adverse Event|3|||
17007588|NCT03977155|38151671|FG001|Overall Study|Adverse Event|0|||
17007589|NCT03977155|38151672|FG002|Overall Study|Adverse Event|0|||
17007590|NCT03977155|38151670|FG000|Overall Study|Lost to Follow-up|0|||
17007591|NCT03977155|38151671|FG001|Overall Study|Lost to Follow-up|1|||
17007592|NCT03977155|38151672|FG002|Overall Study|Lost to Follow-up|0|||
17007593|NCT03977155|38151670|FG000|Overall Study|Withdrawal by Subject|1|||
17007594|NCT03977155|38151671|FG001|Overall Study|Withdrawal by Subject|1|||
17007595|NCT03977155|38151672|FG002|Overall Study|Withdrawal by Subject|2|||
17007596|NCT03977155|38151670|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
17007597|NCT03977155|38151671|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
17007598|NCT03977155|38151672|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
17007599|NCT00930059|38151697|FG000|Overall Study|Death|1|||
17007600|NCT00930059|38151698|FG001|Overall Study|Death|0|||
17007601|NCT00930059|38151697|FG000|Overall Study|Did not meet entrance criteria|1|||
17007602|NCT00930059|38151698|FG001|Overall Study|Did not meet entrance criteria|1|||
17007603|NCT00930059|38151697|FG000|Overall Study|Withdrawal by Subject|3|||
17007604|NCT00930059|38151698|FG001|Overall Study|Withdrawal by Subject|4|||
17007605|NCT00930059|38151697|FG000|Overall Study|Other|1|||
17007606|NCT00930059|38151698|FG001|Overall Study|Other|0|||
17007607|NCT00930059|38151697|FG000|Overall Study|1 site terminated by sponsor|1|||
17007608|NCT00930059|38151698|FG001|Overall Study|1 site terminated by sponsor|1|||
17007609|NCT00930059|38151697|FG000|Overall Study|Adverse Event|1|||
17007610|NCT00930059|38151698|FG001|Overall Study|Adverse Event|6|||
17007611|NCT00772005|38151717|FG000|Overall Study|Adverse Event|9|||
17007612|NCT00772005|38151718|FG001|Overall Study|Adverse Event|14|||
17007613|NCT00772005|38151719|FG002|Overall Study|Adverse Event|10|||
17007614|NCT00772005|38151720|FG003|Overall Study|Adverse Event|13|||
17007615|NCT00772005|38151717|FG000|Overall Study|Lack of Efficacy|0|||
17007616|NCT00772005|38151718|FG001|Overall Study|Lack of Efficacy|1|||
17007617|NCT00772005|38151719|FG002|Overall Study|Lack of Efficacy|0|||
17007618|NCT00772005|38151720|FG003|Overall Study|Lack of Efficacy|0|||
17007619|NCT00772005|38151717|FG000|Overall Study|Withdrawal by Subject|3|||
17007620|NCT00772005|38151718|FG001|Overall Study|Withdrawal by Subject|7|||
17007621|NCT00772005|38151719|FG002|Overall Study|Withdrawal by Subject|10|||
17007622|NCT00772005|38151720|FG003|Overall Study|Withdrawal by Subject|2|||
17007623|NCT00772005|38151717|FG000|Overall Study|Protocol Violation|2|||
17007624|NCT00772005|38151718|FG001|Overall Study|Protocol Violation|4|||
17007625|NCT00772005|38151719|FG002|Overall Study|Protocol Violation|1|||
17007626|NCT00772005|38151720|FG003|Overall Study|Protocol Violation|6|||
17007627|NCT00772005|38151717|FG000|Overall Study|Lost to Follow-up|7|||
17007628|NCT00772005|38151718|FG001|Overall Study|Lost to Follow-up|3|||
17007629|NCT00772005|38151719|FG002|Overall Study|Lost to Follow-up|6|||
17007630|NCT00772005|38151720|FG003|Overall Study|Lost to Follow-up|3|||
17007631|NCT00772005|38151717|FG000|Overall Study|Non-compliance with study procedures|1|||
17007632|NCT00772005|38151718|FG001|Overall Study|Non-compliance with study procedures|1|||
17007633|NCT00772005|38151719|FG002|Overall Study|Non-compliance with study procedures|0|||
17007634|NCT00772005|38151720|FG003|Overall Study|Non-compliance with study procedures|1|||
17007635|NCT00772005|38151717|FG000|Overall Study|Non-compliance with drug administration|3|||
17007636|NCT00772005|38151718|FG001|Overall Study|Non-compliance with drug administration|0|||
17007637|NCT00772005|38151719|FG002|Overall Study|Non-compliance with drug administration|1|||
17007638|NCT00772005|38151720|FG003|Overall Study|Non-compliance with drug administration|1|||
17007639|NCT00939107|38151732|FG000|Overall Study|Lost to Follow-up|14|||
17007640|NCT00939107|38151733|FG001|Overall Study|Lost to Follow-up|12|||
17007641|NCT00927485|38151741|FG000|Overall Study|Adverse Event|4|||
17007642|NCT00927485|38151742|FG001|Overall Study|Adverse Event|2|||
17007643|NCT00927485|38151741|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
17007644|NCT00927485|38151742|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
17007645|NCT00927251|38151748|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
17007646|NCT00927095|38151755|FG000|Overall Study|Adverse Event|3|||
17007647|NCT00927095|38151756|FG001|Overall Study|Adverse Event|1|||
17007648|NCT00927095|38151757|FG002|Overall Study|Adverse Event|0|||
17007649|NCT00927095|38151755|FG000|Overall Study|Withdrawal by Subject|2|||
17007650|NCT00927095|38151756|FG001|Overall Study|Withdrawal by Subject|1|||
17007651|NCT00927095|38151757|FG002|Overall Study|Withdrawal by Subject|1|||
17007652|NCT00927095|38151755|FG000|Overall Study|Physician Decision|1|||
17007653|NCT00927095|38151756|FG001|Overall Study|Physician Decision|2|||
17007654|NCT00927095|38151757|FG002|Overall Study|Physician Decision|1|||
17007655|NCT00932165|38151765|FG000|Overall Study|Lost to Follow-up|1|||
17007656|NCT00926783|38151772|FG000|Overall Study|Incomplete CFAE Procedures|3|||
17007657|NCT00926783|38151773|FG001|Overall Study|Incomplete CFAE Procedures|3|||
17007658|NCT00929669|38151779|FG000|Overall Study|elevated glucose levels|1|||
17007659|NCT00566995|38151783|FG000|Overall Study|Toxicity|4|||
17007660|NCT00566995|38151783|FG000|Overall Study|Withdrew consent|3|||
17007661|NCT00926393|38151789|FG000|Overall Study|Withdrawal by Subject|1|||
17007662|NCT00926393|38151790|FG001|Overall Study|Withdrawal by Subject|2|||
17007663|NCT00926393|38151789|FG000|Overall Study|Adverse Event|1|||
17007664|NCT00926393|38151790|FG001|Overall Study|Adverse Event|1|||
17007665|NCT00926237|38151796|FG000|Overall Study|Withdrawal by Subject|2|||
17007666|NCT00926237|38151797|FG001|Overall Study|Withdrawal by Subject|1|||
17007667|NCT00931463|38151809|FG000|Overall Study|Death|8|||
17007668|NCT00931463|38151810|FG001|Overall Study|Death|4|||
17007669|NCT00931463|38151809|FG000|Overall Study|Withdrawal by Subject|5|||
17007670|NCT00931463|38151810|FG001|Overall Study|Withdrawal by Subject|0|||
17007671|NCT00931463|38151809|FG000|Overall Study|Lost to Follow-up|4|||
17007672|NCT00931463|38151810|FG001|Overall Study|Lost to Follow-up|1|||
17007673|NCT00929201|38151816|FG000|Period 1|Withdrawal by Subject|0|||
17007674|NCT00929201|38151817|FG001|Period 1|Withdrawal by Subject|1|||
17007675|NCT00926003|38151827|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
17007676|NCT00926003|38151828|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
17007677|NCT00926003|38151829|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
17007678|NCT00926003|38151827|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
17007679|NCT00926003|38151828|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
17007680|NCT00926003|38151829|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
17007681|NCT00928889|38151839|FG000|Overall Study|Lost to Follow-up|3|||
17007682|NCT00928889|38151840|FG001|Overall Study|Lost to Follow-up|1|||
17007683|NCT00928889|38151839|FG000|Overall Study|Protocol Violation|0|||
17007684|NCT00928889|38151840|FG001|Overall Study|Protocol Violation|1|||
17007685|NCT00928889|38151839|FG000|Overall Study|Adverse Event|1|||
17007686|NCT00928889|38151840|FG001|Overall Study|Adverse Event|0|||
17007687|NCT00928889|38151839|FG000|Overall Study|Other|1|||
17007688|NCT00928889|38151840|FG001|Overall Study|Other|0|||
17007689|NCT03978091|38151852|FG000|Overall Study|Lost to Follow-up|0|||
17007690|NCT03978091|38151853|FG001|Overall Study|Lost to Follow-up|0|||
17007691|NCT03978091|38151854|FG002|Overall Study|Lost to Follow-up|1|||
17007692|NCT03978091|38151855|FG003|Overall Study|Lost to Follow-up|0|||
17007693|NCT03978091|38151856|FG004|Overall Study|Lost to Follow-up|0|||
17007694|NCT03978091|38151857|FG005|Overall Study|Lost to Follow-up|0|||
17007695|NCT03978091|38151852|FG000|Overall Study|Withdrawal by Subject|0|||
17007696|NCT03978091|38151853|FG001|Overall Study|Withdrawal by Subject|0|||
17007697|NCT03978091|38151854|FG002|Overall Study|Withdrawal by Subject|0|||
17007698|NCT03978091|38151855|FG003|Overall Study|Withdrawal by Subject|1|||
17007699|NCT03978091|38151856|FG004|Overall Study|Withdrawal by Subject|1|||
17007700|NCT03978091|38151857|FG005|Overall Study|Withdrawal by Subject|0|||
17007701|NCT00564733|38151880|FG000|Overall Study|Withdrawal by Subject|4|||
17007702|NCT00564733|38151880|FG000|Overall Study|Ineligible|5|||
17007703|NCT00931385|38151884|FG000|Overall Study|Adverse Event|2|||
17007704|NCT00931385|38151885|FG001|Overall Study|Adverse Event|1|||
17007705|NCT00931385|38151886|FG002|Overall Study|Adverse Event|0|||
17007706|NCT00931385|38151887|FG003|Overall Study|Adverse Event|3|||
17007707|NCT00931385|38151884|FG000|Overall Study|Protocol Violation|0|||
17007708|NCT00931385|38151885|FG001|Overall Study|Protocol Violation|0|||
17007709|NCT00931385|38151886|FG002|Overall Study|Protocol Violation|1|||
17007710|NCT00931385|38151887|FG003|Overall Study|Protocol Violation|0|||
17007711|NCT00931385|38151884|FG000|Overall Study|Withdrawal by Subject|0|||
17007712|NCT00931385|38151885|FG001|Overall Study|Withdrawal by Subject|1|||
17007713|NCT00931385|38151886|FG002|Overall Study|Withdrawal by Subject|0|||
17007714|NCT00931385|38151887|FG003|Overall Study|Withdrawal by Subject|1|||
17007715|NCT00931385|38151884|FG000|Overall Study|Lost to Follow-up|0|||
17007716|NCT00931385|38151885|FG001|Overall Study|Lost to Follow-up|0|||
17007717|NCT00931385|38151886|FG002|Overall Study|Lost to Follow-up|0|||
17007718|NCT00931385|38151887|FG003|Overall Study|Lost to Follow-up|1|||
17007719|NCT00565747|38151903|FG000|Overall Study|No embryo transfer|67|||
17007720|NCT00565747|38151904|FG001|Overall Study|No embryo transfer|73|||
17007721|NCT00563797|38151912|FG000|Overall Study|Lost to Follow-up|7|||
17007722|NCT00563797|38151913|FG001|Overall Study|Lost to Follow-up|2|||
17007723|NCT00771927|38151932|FG000|Overall Study|Adverse Event|100|||
17007724|NCT00771927|38151933|FG001|Overall Study|Adverse Event|105|||
17007725|NCT00771927|38151932|FG000|Overall Study|Lack of Efficacy|70|||
17007726|NCT00771927|38151933|FG001|Overall Study|Lack of Efficacy|42|||
17007727|NCT00771927|38151932|FG000|Overall Study|Lost to Follow-up|46|||
17007728|NCT00771927|38151933|FG001|Overall Study|Lost to Follow-up|46|||
17007729|NCT00771927|38151932|FG000|Overall Study|Withdrawal by Subject|16|||
17007730|NCT00771927|38151933|FG001|Overall Study|Withdrawal by Subject|17|||
17007731|NCT00771927|38151932|FG000|Overall Study|Other reason|23|||
17007732|NCT00771927|38151933|FG001|Overall Study|Other reason|27|||
17007733|NCT00771849|38151941|FG000|Overall Study|Lost to Follow-up|1|||
17007734|NCT00771849|38151942|FG001|Overall Study|Lost to Follow-up|2|||
17007735|NCT00771849|38151941|FG000|Overall Study|Withdrawal by Subject|1|||
17007736|NCT00771849|38151942|FG001|Overall Study|Withdrawal by Subject|1|||
17007737|NCT00771849|38151941|FG000|Overall Study|Not vaccinated|0|||
17007738|NCT00771849|38151942|FG001|Overall Study|Not vaccinated|1|||
17007739|NCT00564889|38151948|FG000|Overall Study|Death|7|||
17007740|NCT00564889|38151948|FG000|Overall Study|Adverse Event|12|||
17007741|NCT00564889|38151948|FG000|Overall Study|Alternative treatment|3|||
17007742|NCT00564889|38151948|FG000|Overall Study|Disease progression|3|||
17007743|NCT00564889|38151948|FG000|Overall Study|Other, not specified|4|||
17192873|NCT02415556|38346207|FG002|Overall Study|Physician Decision|1|||
17095995|NCT03559270|38235237|FG000|Overall Study|Protocol Violation|1|||
17095996|NCT03559270|38235238|FG001|Overall Study|Protocol Violation|0|||
17095997|NCT03559270|38235239|FG002|Overall Study|Protocol Violation|2|||
17095998|NCT03559270|38235240|FG003|Overall Study|Protocol Violation|0|||
17095999|NCT02685826|38235295|FG000|Overall Study|Adverse Event|2|||
17096000|NCT02685826|38235296|FG001|Overall Study|Adverse Event|0|||
17192874|NCT02415556|38346208|FG003|Overall Study|Physician Decision|2|||
17192875|NCT02415556|38346205|FG000|Overall Study|Censored - study completion|4|||
17192876|NCT02415556|38346206|FG001|Overall Study|Censored - study completion|5|||
17192877|NCT02415556|38346207|FG002|Overall Study|Censored - study completion|1|||
17192878|NCT02415556|38346208|FG003|Overall Study|Censored - study completion|0|||
17192879|NCT02415556|38346205|FG000|Overall Study|Family-related issues|0|||
17192880|NCT02415556|38346206|FG001|Overall Study|Family-related issues|0|||
17192881|NCT02415556|38346207|FG002|Overall Study|Family-related issues|0|||
17192882|NCT02415556|38346208|FG003|Overall Study|Family-related issues|1|||
17192883|NCT02807623|38346221|FG000|Overall Study|Lost to Follow-up|23|||
17192884|NCT02807623|38346222|FG001|Overall Study|Lost to Follow-up|18|||
17192885|NCT02807623|38346223|FG002|Overall Study|Lost to Follow-up|22|||
17192886|NCT02807623|38346221|FG000|Overall Study|Drug intolerance|0|||
17192887|NCT02807623|38346222|FG001|Overall Study|Drug intolerance|1|||
17192888|NCT02807623|38346223|FG002|Overall Study|Drug intolerance|0|||
17192889|NCT02807623|38346221|FG000|Overall Study|incomplete blood draw|0|||
17192890|NCT02807623|38346222|FG001|Overall Study|incomplete blood draw|2|||
17192891|NCT02807623|38346223|FG002|Overall Study|incomplete blood draw|1|||
17192892|NCT02805907|38346242|FG000|Overall Study|Lost to Follow-up|3|||
17192893|NCT02805907|38346243|FG001|Overall Study|Lost to Follow-up|3|||
17192894|NCT02723175|38346251|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
17192895|NCT02723175|38346252|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
17192896|NCT02723175|38346251|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
17192897|NCT02723175|38346252|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
17192898|NCT02801617|38346260|FG000|Overall Study|Protocol Violation|2|||
17192899|NCT02801617|38346261|FG001|Overall Study|Protocol Violation|6|||
17192900|NCT01334515|38346273|FG000|Overall Study|Adverse Event|1|||
17192901|NCT01334515|38346274|FG001|Overall Study|Adverse Event|6|||
17192902|NCT01334515|38346273|FG000|Overall Study|Death|1|||
17192903|NCT01334515|38346274|FG001|Overall Study|Death|0|||
17192904|NCT01334515|38346273|FG000|Overall Study|Lack of Efficacy|8|||
17192905|NCT01334515|38346274|FG001|Overall Study|Lack of Efficacy|21|||
17192906|NCT01334515|38346273|FG000|Overall Study|Physician Decision|1|||
17192907|NCT01334515|38346274|FG001|Overall Study|Physician Decision|1|||
17192908|NCT01334515|38346273|FG000|Overall Study|Withdrawal by Subject|1|||
17192909|NCT01334515|38346274|FG001|Overall Study|Withdrawal by Subject|1|||
17192910|NCT02802319|38346282|FG000|Overall Study|Physician Decision|2|||
17096001|NCT02685826|38235297|FG002|Overall Study|Adverse Event|1|||
17096002|NCT02685826|38235295|FG000|Overall Study|Progressive Disease|2|||
17096003|NCT02685826|38235296|FG001|Overall Study|Progressive Disease|1|||
17096004|NCT02685826|38235297|FG002|Overall Study|Progressive Disease|0|||
17096005|NCT02685826|38235295|FG000|Overall Study|Withdrawal by Subject|2|||
17096006|NCT02685826|38235296|FG001|Overall Study|Withdrawal by Subject|0|||
17192911|NCT02802319|38346283|FG001|Overall Study|Physician Decision|1|||
17192912|NCT02802319|38346282|FG000|Overall Study|Lost to Follow-up|0|||
17192913|NCT02802319|38346283|FG001|Overall Study|Lost to Follow-up|4|||
17192914|NCT02415400|38346293|FG000|Overall Study|Adverse Event|0|||
16786258|NCT01999972|37726702|FG002|Dose Escalation Part|Adverse Event|0|||
17192915|NCT02415400|38346294|FG001|Overall Study|Adverse Event|1|||
17192916|NCT02415400|38346295|FG002|Overall Study|Adverse Event|1|||
17096007|NCT02685826|38235297|FG002|Overall Study|Withdrawal by Subject|0|||
17096008|NCT02685826|38235295|FG000|Overall Study|Full Clinical Hold by FDA|19|||
17192917|NCT02415400|38346296|FG003|Overall Study|Adverse Event|2|||
17192918|NCT02415400|38346293|FG000|Overall Study|Participant request to stop therapy|4|||
16786259|NCT01999972|37726703|FG003|Dose Escalation Part|Adverse Event|2|||
17007744|NCT04143594|38151956|FG000|Overall Study|Still on study|48|||
17007745|NCT04143594|38151957|FG001|Overall Study|Still on study|42|||
17096009|NCT02685826|38235296|FG001|Overall Study|Full Clinical Hold by FDA|9|||
17096010|NCT02685826|38235297|FG002|Overall Study|Full Clinical Hold by FDA|20|||
17096011|NCT00114777|38235308|FG000|Randomization to Month 36|Death|10|||
17096012|NCT00114777|38235309|FG001|Randomization to Month 36|Death|4|||
17096013|NCT00114777|38235310|FG002|Randomization to Month 36|Death|3|||
17192919|NCT02415400|38346294|FG001|Overall Study|Participant request to stop therapy|3|||
17192920|NCT02415400|38346295|FG002|Overall Study|Participant request to stop therapy|8|||
17007746|NCT04143594|38151958|FG002|Overall Study|Still on study|48|||
17007747|NCT04143594|38151959|FG003|Overall Study|Still on study|18|||
17007748|NCT04143594|38151956|FG000|Overall Study|Withdrew consent|0|||
17007749|NCT04143594|38151957|FG001|Overall Study|Withdrew consent|6|||
17007750|NCT04143594|38151958|FG002|Overall Study|Withdrew consent|1|||
17007751|NCT04143594|38151959|FG003|Overall Study|Withdrew consent|1|||
17007752|NCT04143594|38151956|FG000|Overall Study|Lost to Follow-up|2|||
17007753|NCT04143594|38151957|FG001|Overall Study|Lost to Follow-up|2|||
17007754|NCT04143594|38151958|FG002|Overall Study|Lost to Follow-up|3|||
17007755|NCT04143594|38151959|FG003|Overall Study|Lost to Follow-up|0|||
17007756|NCT04143594|38151956|FG000|Overall Study|Investigator's discretion|1|||
17007757|NCT04143594|38151957|FG001|Overall Study|Investigator's discretion|2|||
17007758|NCT04143594|38151958|FG002|Overall Study|Investigator's discretion|0|||
17007759|NCT04143594|38151959|FG003|Overall Study|Investigator's discretion|0|||
17007760|NCT04143594|38151956|FG000|Overall Study|Lack of Efficacy|0|||
17007761|NCT04143594|38151957|FG001|Overall Study|Lack of Efficacy|1|||
17007762|NCT04143594|38151958|FG002|Overall Study|Lack of Efficacy|0|||
17007763|NCT04143594|38151959|FG003|Overall Study|Lack of Efficacy|0|||
17007764|NCT04143594|38151956|FG000|Overall Study|Protocol Violation|0|||
17007765|NCT04143594|38151957|FG001|Overall Study|Protocol Violation|0|||
17007766|NCT04143594|38151958|FG002|Overall Study|Protocol Violation|0|||
17007767|NCT04143594|38151959|FG003|Overall Study|Protocol Violation|1|||
17007768|NCT00560833|38151986|FG000|Overall Study|Adverse Event|16|||
17007769|NCT00560833|38151987|FG001|Overall Study|Adverse Event|10|||
17007770|NCT00560833|38151988|FG002|Overall Study|Adverse Event|25|||
17007771|NCT00560833|38151989|FG003|Overall Study|Adverse Event|23|||
17007772|NCT00560833|38151990|FG004|Overall Study|Adverse Event|35|||
17007773|NCT00560833|38151986|FG000|Overall Study|Lost to Follow-up|0|||
17007774|NCT00560833|38151987|FG001|Overall Study|Lost to Follow-up|0|||
17007775|NCT00560833|38151988|FG002|Overall Study|Lost to Follow-up|1|||
17007776|NCT00560833|38151989|FG003|Overall Study|Lost to Follow-up|0|||
17007777|NCT00560833|38151990|FG004|Overall Study|Lost to Follow-up|0|||
17007778|NCT00560833|38151986|FG000|Overall Study|Lack of Efficacy|22|||
17007779|NCT00560833|38151987|FG001|Overall Study|Lack of Efficacy|9|||
17007780|NCT00560833|38151988|FG002|Overall Study|Lack of Efficacy|6|||
17007781|NCT00560833|38151989|FG003|Overall Study|Lack of Efficacy|4|||
17007782|NCT00560833|38151990|FG004|Overall Study|Lack of Efficacy|4|||
17007783|NCT00560833|38151986|FG000|Overall Study|Participant uncooperative|5|||
17007784|NCT00560833|38151987|FG001|Overall Study|Participant uncooperative|5|||
17007785|NCT00560833|38151988|FG002|Overall Study|Participant uncooperative|4|||
17007786|NCT00560833|38151989|FG003|Overall Study|Participant uncooperative|4|||
17007787|NCT00560833|38151990|FG004|Overall Study|Participant uncooperative|2|||
17007788|NCT00560833|38151986|FG000|Overall Study|Other|1|||
17007789|NCT00560833|38151987|FG001|Overall Study|Other|1|||
17007790|NCT00560833|38151988|FG002|Overall Study|Other|3|||
17007791|NCT00560833|38151989|FG003|Overall Study|Other|0|||
17007792|NCT00560833|38151990|FG004|Overall Study|Other|0|||
17007793|NCT00560833|38151986|FG000|Overall Study|Never received drug|0|||
17007794|NCT00560833|38151987|FG001|Overall Study|Never received drug|1|||
17007795|NCT00560833|38151988|FG002|Overall Study|Never received drug|0|||
17007796|NCT00560833|38151989|FG003|Overall Study|Never received drug|0|||
17007797|NCT00560833|38151990|FG004|Overall Study|Never received drug|1|||
17007798|NCT00771615|38152011|FG000|Overall Study|Withdrawal by Subject|0|||
17007799|NCT00771615|38152012|FG001|Overall Study|Withdrawal by Subject|1|||
17007800|NCT00771615|38152013|FG002|Overall Study|Withdrawal by Subject|0|||
17007801|NCT00771615|38152014|FG003|Overall Study|Withdrawal by Subject|0|||
17007802|NCT00771615|38152015|FG004|Overall Study|Withdrawal by Subject|0|||
17007803|NCT00771615|38152016|FG005|Overall Study|Withdrawal by Subject|0|||
17007804|NCT00771615|38152017|FG006|Overall Study|Withdrawal by Subject|0|||
17007805|NCT00771615|38152018|FG007|Overall Study|Withdrawal by Subject|1|||
17007806|NCT00771615|38152019|FG008|Overall Study|Withdrawal by Subject|0|||
17007807|NCT00771615|38152011|FG000|Overall Study|Lost to Follow-up|1|||
17007808|NCT00771615|38152012|FG001|Overall Study|Lost to Follow-up|1|||
17007809|NCT00771615|38152013|FG002|Overall Study|Lost to Follow-up|1|||
17007810|NCT00771615|38152014|FG003|Overall Study|Lost to Follow-up|1|||
17007811|NCT00771615|38152015|FG004|Overall Study|Lost to Follow-up|0|||
17007812|NCT00771615|38152016|FG005|Overall Study|Lost to Follow-up|1|||
17007813|NCT00771615|38152017|FG006|Overall Study|Lost to Follow-up|1|||
17007814|NCT00771615|38152018|FG007|Overall Study|Lost to Follow-up|0|||
17007815|NCT00771615|38152019|FG008|Overall Study|Lost to Follow-up|0|||
17007816|NCT02723604|38152048|FG000|Overall Study|ineligible|1|||
17007817|NCT02723604|38152048|FG000|Overall Study|never received treatment|1|||
17007818|NCT00560755|38152052|FG000|Overall Study|Protocol Violation|15|||
17007819|NCT00560755|38152052|FG000|Overall Study|Withdrawal by Subject|26|||
17007820|NCT00560755|38152052|FG000|Overall Study|Lost to Follow-up|9|||
17007821|NCT00560755|38152052|FG000|Overall Study|Adverse Event|8|||
17007822|NCT00560755|38152052|FG000|Overall Study|Physician Decision|2|||
17007823|NCT00770991|38152059|FG000|Overall Study|Physician Decision|2|||
17007824|NCT00770991|38152060|FG001|Overall Study|Physician Decision|0|||
17007825|NCT00770991|38152059|FG000|Overall Study|Withdrawal by Subject|1|||
17007826|NCT00770991|38152060|FG001|Overall Study|Withdrawal by Subject|0|||
17007827|NCT00770991|38152059|FG000|Overall Study|Adverse Event|1|||
17007828|NCT00770991|38152060|FG001|Overall Study|Adverse Event|5|||
17007829|NCT00770991|38152059|FG000|Overall Study|Pregnancy|1|||
17007830|NCT00770991|38152060|FG001|Overall Study|Pregnancy|0|||
17007831|NCT00925769|38152071|FG000|Overall Study|Major toxicity|1|||
17007832|NCT00925769|38152072|FG001|Overall Study|Major toxicity|0|||
17007833|NCT00925769|38152073|FG002|Overall Study|Major toxicity|1|||
17007834|NCT00925769|38152074|FG003|Overall Study|Major toxicity|1|||
17007835|NCT00925769|38152075|FG004|Overall Study|Major toxicity|0|||
17007836|NCT00925769|38152076|FG005|Overall Study|Major toxicity|0|||
17007837|NCT00925769|38152071|FG000|Overall Study|Disease progression|4|||
17007838|NCT00925769|38152072|FG001|Overall Study|Disease progression|5|||
17007839|NCT00925769|38152073|FG002|Overall Study|Disease progression|3|||
17007840|NCT00925769|38152074|FG003|Overall Study|Disease progression|4|||
17007841|NCT00925769|38152075|FG004|Overall Study|Disease progression|2|||
17007842|NCT00925769|38152076|FG005|Overall Study|Disease progression|3|||
17007843|NCT00925769|38152071|FG000|Overall Study|Death|0|||
17007844|NCT00925769|38152072|FG001|Overall Study|Death|0|||
17007845|NCT00925769|38152073|FG002|Overall Study|Death|1|||
17007846|NCT00925769|38152074|FG003|Overall Study|Death|0|||
17007847|NCT00925769|38152075|FG004|Overall Study|Death|0|||
17007848|NCT00925769|38152076|FG005|Overall Study|Death|0|||
17007849|NCT00925769|38152071|FG000|Overall Study|Physician Decision|1|||
17007850|NCT00925769|38152072|FG001|Overall Study|Physician Decision|0|||
17007851|NCT00925769|38152073|FG002|Overall Study|Physician Decision|0|||
17007852|NCT00925769|38152074|FG003|Overall Study|Physician Decision|0|||
17007853|NCT00925769|38152075|FG004|Overall Study|Physician Decision|0|||
17007854|NCT00925769|38152076|FG005|Overall Study|Physician Decision|0|||
17007855|NCT00925769|38152071|FG000|Overall Study|Missing documentation|0|||
17007856|NCT00925769|38152072|FG001|Overall Study|Missing documentation|1|||
17007857|NCT00925769|38152073|FG002|Overall Study|Missing documentation|0|||
17007858|NCT00925769|38152074|FG003|Overall Study|Missing documentation|0|||
17007859|NCT00925769|38152075|FG004|Overall Study|Missing documentation|0|||
17007860|NCT00925769|38152076|FG005|Overall Study|Missing documentation|0|||
17007861|NCT00925769|38152071|FG000|Overall Study|End of study visit not done|0|||
17007862|NCT00925769|38152072|FG001|Overall Study|End of study visit not done|0|||
17007863|NCT00925769|38152073|FG002|Overall Study|End of study visit not done|1|||
17007864|NCT00925769|38152074|FG003|Overall Study|End of study visit not done|0|||
17007865|NCT00925769|38152075|FG004|Overall Study|End of study visit not done|0|||
17007866|NCT00925769|38152076|FG005|Overall Study|End of study visit not done|0|||
17007867|NCT00925769|38152071|FG000|Overall Study|Participant is unable to swallow drug|0|||
17007868|NCT00925769|38152072|FG001|Overall Study|Participant is unable to swallow drug|0|||
17007869|NCT00925769|38152073|FG002|Overall Study|Participant is unable to swallow drug|0|||
17007870|NCT00925769|38152074|FG003|Overall Study|Participant is unable to swallow drug|1|||
17096014|NCT00114777|38235308|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
17096015|NCT00114777|38235309|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
17096016|NCT00114777|38235310|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
17096017|NCT00114777|38235308|FG000|Randomization to Month 36|Lack of Efficacy|19|||
17096018|NCT00114777|38235309|FG001|Randomization to Month 36|Lack of Efficacy|15|||
17096019|NCT00114777|38235310|FG002|Randomization to Month 36|Lack of Efficacy|17|||
17096020|NCT00114777|38235308|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
17096021|NCT00114777|38235309|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
17096022|NCT00114777|38235310|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
17096023|NCT00114777|38235308|FG000|Randomization to Month 36|Adverse Event|34|||
17096024|NCT00114777|38235309|FG001|Randomization to Month 36|Adverse Event|35|||
17096025|NCT00114777|38235310|FG002|Randomization to Month 36|Adverse Event|44|||
17096026|NCT00114777|38235308|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
17096027|NCT00114777|38235309|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
17096028|NCT00114777|38235310|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
17096029|NCT00114777|38235308|FG000|Randomization to Month 36|Other|9|||
17096030|NCT00114777|38235309|FG001|Randomization to Month 36|Other|3|||
17096031|NCT00114777|38235310|FG002|Randomization to Month 36|Other|12|||
17096032|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|Death|8|||
17096033|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|Death|13|||
17096034|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|Death|7|||
17007871|NCT00925769|38152075|FG004|Overall Study|Participant is unable to swallow drug|0|||
17007872|NCT00925769|38152076|FG005|Overall Study|Participant is unable to swallow drug|0|||
17007873|NCT00925769|38152071|FG000|Overall Study|Adverse Event|0|||
17096035|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
17096036|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
17096037|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
17096038|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
17096039|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
16786260|NCT01999972|37726704|FG004|Dose Escalation Part|Adverse Event|0|||
17096040|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
17096041|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
17096042|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
17096043|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
17096044|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
17096045|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
17096046|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
17096047|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
17096048|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
17096049|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
17096050|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
17096051|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
17096052|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
17096053|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
17096054|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
17096055|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
17096056|NCT00114777|38235308|FG000|Long-Term Extension to Month 84|Other|2|||
17096057|NCT00114777|38235309|FG001|Long-Term Extension to Month 84|Other|0|||
17096058|NCT00114777|38235310|FG002|Long-Term Extension to Month 84|Other|2|||
17096059|NCT00139737|38235319|FG000|Overall Study|Withdrawal by Subject|190|||
17096060|NCT00139737|38235319|FG000|Overall Study|Adverse Event|58|||
17096061|NCT00139737|38235319|FG000|Overall Study|Lack of Efficacy|40|||
17096062|NCT00139737|38235319|FG000|Overall Study|Lost to Follow-up|8|||
17096063|NCT00139737|38235319|FG000|Overall Study|Death|3|||
17096064|NCT00139737|38235319|FG000|Overall Study|Laboratory Abnormality|2|||
17096065|NCT00139737|38235319|FG000|Overall Study|Protocol Violation|18|||
17096066|NCT00139737|38235319|FG000|Overall Study|Withdrew During Screening Phase|8|||
17096067|NCT00139737|38235319|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
17096068|NCT00139737|38235319|FG000|Overall Study|Screened, Not Treated|13|||
17096069|NCT00122187|38235325|FG000|Overall Study|Withdrew because of resource limitations|2|||
17096070|NCT00122187|38235326|FG001|Overall Study|Withdrew because of resource limitations|2|||
17096071|NCT00139659|38235336|FG000|Overall Study|Adverse Event|12|||
17096072|NCT00139659|38235337|FG001|Overall Study|Adverse Event|1|||
17096073|NCT00139659|38235336|FG000|Overall Study|Lack of Efficacy|1|||
17096074|NCT00139659|38235337|FG001|Overall Study|Lack of Efficacy|1|||
17096075|NCT00139659|38235336|FG000|Overall Study|Lost to Follow-up|7|||
17096076|NCT00139659|38235337|FG001|Overall Study|Lost to Follow-up|3|||
17096077|NCT00139659|38235336|FG000|Overall Study|Reason not Specified|6|||
17096078|NCT00139659|38235337|FG001|Overall Study|Reason not Specified|3|||
17096079|NCT00139659|38235336|FG000|Overall Study|Withdrawal by Subject|14|||
17096080|NCT00139659|38235337|FG001|Overall Study|Withdrawal by Subject|10|||
17096081|NCT00137631|38235349|FG000|Overall Study|Lost to Follow-up|37|||
17096082|NCT00137631|38235350|FG001|Overall Study|Lost to Follow-up|41|||
17096083|NCT00114231|38235358|FG000|Overall Study|No consent|2|||
17096084|NCT00114231|38235359|FG001|Overall Study|No consent|0|||
17096085|NCT00114231|38235358|FG000|Overall Study|QARC requirement not met|1|||
17096086|NCT00114231|38235359|FG001|Overall Study|QARC requirement not met|0|||
16786261|NCT01999972|37726705|FG005|Dose Escalation Part|Adverse Event|0|||
16786262|NCT01999972|37726700|FG000|Dose Escalation Part|Global deterioration of health status|1|||
16786263|NCT01999972|37726701|FG001|Dose Escalation Part|Global deterioration of health status|0|||
16786264|NCT01999972|37726702|FG002|Dose Escalation Part|Global deterioration of health status|0|||
16786265|NCT01999972|37726703|FG003|Dose Escalation Part|Global deterioration of health status|1|||
16786266|NCT01999972|37726704|FG004|Dose Escalation Part|Global deterioration of health status|0|||
16786267|NCT01999972|37726705|FG005|Dose Escalation Part|Global deterioration of health status|0|||
17007874|NCT00925769|38152072|FG001|Overall Study|Adverse Event|0|||
17007875|NCT00925769|38152073|FG002|Overall Study|Adverse Event|0|||
17007876|NCT00925769|38152074|FG003|Overall Study|Adverse Event|0|||
17096087|NCT00114231|38235358|FG000|Overall Study|Suspected metastatic disease|1|||
17096088|NCT00114231|38235359|FG001|Overall Study|Suspected metastatic disease|0|||
17096089|NCT00114231|38235358|FG000|Overall Study|No adenocarcinoma|1|||
17096090|NCT00114231|38235359|FG001|Overall Study|No adenocarcinoma|0|||
17096091|NCT00114231|38235358|FG000|Overall Study|Low creatinine clearance|0|||
17096092|NCT00114231|38235359|FG001|Overall Study|Low creatinine clearance|1|||
17096093|NCT00114231|38235358|FG000|Overall Study|Tumor size > 4cm|1|||
17096094|NCT00114231|38235359|FG001|Overall Study|Tumor size > 4cm|0|||
17096095|NCT00114231|38235358|FG000|Overall Study|Tumor fixed on digital exam|0|||
17096096|NCT00114231|38235359|FG001|Overall Study|Tumor fixed on digital exam|1|||
17096097|NCT00114231|38235358|FG000|Overall Study|No Absolute Neutrophil Count|2|||
17096098|NCT00114231|38235359|FG001|Overall Study|No Absolute Neutrophil Count|0|||
17096099|NCT00114231|38235358|FG000|Overall Study|Biopsy done after registration|1|||
17096100|NCT00114231|38235359|FG001|Overall Study|Biopsy done after registration|0|||
17096101|NCT00113919|38235364|FG000|Overall Study|Physician Decision|8|||
17096102|NCT00113919|38235364|FG000|Overall Study|Death|6|||
17096103|NCT00113841|38235370|FG000|Overall Study|Disease progression|0|||
17096104|NCT00113841|38235371|FG001|Overall Study|Disease progression|2|||
17096105|NCT00113841|38235370|FG000|Overall Study|Non-compliant|1|||
17096106|NCT00113841|38235371|FG001|Overall Study|Non-compliant|0|||
17096107|NCT00113607|38235379|FG000|Overall Study|Adverse Event|40|||
17096108|NCT00113607|38235380|FG001|Overall Study|Adverse Event|71|||
17096109|NCT00113607|38235379|FG000|Overall Study|Death|8|||
17096110|NCT00113607|38235380|FG001|Overall Study|Death|8|||
17096111|NCT00113607|38235379|FG000|Overall Study|Withdrawal by Subject|50|||
17096112|NCT00113607|38235380|FG001|Overall Study|Withdrawal by Subject|58|||
17096113|NCT00113607|38235379|FG000|Overall Study|Lost to Follow-up|0|||
17096114|NCT00113607|38235380|FG001|Overall Study|Lost to Follow-up|2|||
17096115|NCT00113607|38235379|FG000|Overall Study|Disease Progression|180|||
17096116|NCT00113607|38235380|FG001|Overall Study|Disease Progression|142|||
17096117|NCT00113607|38235379|FG000|Overall Study|Complete Response (Confirmed)|14|||
17096118|NCT00113607|38235380|FG001|Overall Study|Complete Response (Confirmed)|24|||
17096119|NCT00113607|38235379|FG000|Overall Study|Other|43|||
17096120|NCT00113607|38235380|FG001|Overall Study|Other|32|||
17096121|NCT00113529|38235387|FG000|Overall Study|Adverse Event|4|||
17096122|NCT00113529|38235387|FG000|Overall Study|Lack of Efficacy|20|||
17096123|NCT00113529|38235387|FG000|Overall Study|Decision of sponsor|6|||
17096124|NCT00113529|38235387|FG000|Overall Study|Withdrawal by Subject|4|||
17096125|NCT00134901|38235393|FG000|Overall Study|Lost to Follow-up|5|||
17096126|NCT00134901|38235394|FG001|Overall Study|Lost to Follow-up|5|||
17096127|NCT00134901|38235393|FG000|Overall Study|discontinued intervention|12|||
17096128|NCT00134901|38235394|FG001|Overall Study|discontinued intervention|10|||
17096129|NCT00122109|38235404|FG000|Overall Study|Did not meet criteria|6|||
17096130|NCT00122109|38235405|FG001|Overall Study|Did not meet criteria|7|||
17096131|NCT00113373|38235414|FG000|Overall Study|Ineligible: wrong primary|1|||
17096132|NCT00113373|38235414|FG000|Overall Study|Ineligible: second primary|1|||
17096133|NCT00113373|38235414|FG000|Overall Study|Never Treated|1|||
17096134|NCT00113295|38235425|FG000|Overall Study|Adverse Event|4|||
17096135|NCT00113295|38235426|FG001|Overall Study|Adverse Event|1|||
17096136|NCT00113295|38235425|FG000|Overall Study|Unrelated Medical Illness|1|||
17096137|NCT00113295|38235426|FG001|Overall Study|Unrelated Medical Illness|0|||
17096138|NCT00112905|38235434|FG000|Overall Study|Adverse Event|4|||
17096139|NCT00112905|38235434|FG000|Overall Study|Death|1|||
17096140|NCT00112905|38235434|FG000|Overall Study|Ineligibility|5|||
17096141|NCT00112905|38235434|FG000|Overall Study|Alternative treatment|1|||
17096142|NCT00112905|38235434|FG000|Overall Study|performance status was deteiorating|1|||
17096143|NCT00427895|38235442|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
17096144|NCT00427895|38235443|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
17096145|NCT00427895|38235444|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
17096146|NCT00427895|38235445|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
17096147|NCT00427895|38235446|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
17096148|NCT00427895|38235447|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
17096149|NCT00427895|38235448|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
17096150|NCT00427895|38235449|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
17096151|NCT00427895|38235442|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
17096152|NCT00427895|38235443|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
17096153|NCT00427895|38235444|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
17096154|NCT00427895|38235445|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
17096155|NCT00427895|38235446|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
17096156|NCT00427895|38235447|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
17096157|NCT00427895|38235448|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
17096158|NCT00427895|38235449|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
17096159|NCT00427895|38235442|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
17096160|NCT00427895|38235443|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
17096161|NCT00427895|38235444|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
17096162|NCT00427895|38235445|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
17096163|NCT00427895|38235446|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
17096164|NCT00427895|38235447|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
17096165|NCT00427895|38235448|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
17096166|NCT00427895|38235449|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
17192921|NCT02415400|38346296|FG003|Overall Study|Participant request to stop therapy|6|||
17096167|NCT00427895|38235442|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
17096168|NCT00427895|38235443|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
17096169|NCT00427895|38235444|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
17096170|NCT00427895|38235445|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
17096171|NCT00427895|38235446|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
17096172|NCT00427895|38235447|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
17096173|NCT00427895|38235448|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
17096174|NCT00427895|38235449|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
17096175|NCT00427895|38235442|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
17096176|NCT00427895|38235443|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
17096177|NCT00427895|38235444|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
17096178|NCT00427895|38235445|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
17096179|NCT00427895|38235446|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
17096180|NCT00427895|38235447|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
17096181|NCT00427895|38235448|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
17096182|NCT00427895|38235449|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
17096183|NCT00427895|38235442|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
17096184|NCT00427895|38235443|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
17096185|NCT00427895|38235444|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
17096186|NCT00427895|38235445|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
17096187|NCT00427895|38235446|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
17096188|NCT00427895|38235447|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
17096189|NCT00427895|38235448|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
17096190|NCT00427895|38235449|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
17096191|NCT00427895|38235442|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
17096192|NCT00427895|38235443|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
17096193|NCT00427895|38235444|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
17096194|NCT00427895|38235445|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
17096195|NCT00427895|38235446|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
17096196|NCT00427895|38235447|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
17096197|NCT00427895|38235448|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
17096198|NCT00427895|38235449|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
17096199|NCT00427895|38235442|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
17096200|NCT00427895|38235443|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
17096201|NCT00427895|38235444|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
17096202|NCT00427895|38235445|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
17096203|NCT00427895|38235446|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
17096204|NCT00427895|38235447|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
17096205|NCT00427895|38235448|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
17096206|NCT00427895|38235449|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
17096207|NCT00427895|38235442|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
17096208|NCT00427895|38235443|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
17096209|NCT00427895|38235444|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
17096210|NCT00427895|38235445|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
17096211|NCT00427895|38235446|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
17096212|NCT00427895|38235447|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
17096213|NCT00427895|38235448|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
17096214|NCT00427895|38235449|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
17096215|NCT00427895|38235442|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
17096216|NCT00427895|38235443|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
17096217|NCT00427895|38235444|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
17096218|NCT00427895|38235445|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
17096219|NCT00427895|38235446|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
17096220|NCT00427895|38235447|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
17096221|NCT00427895|38235448|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
17096222|NCT00427895|38235449|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
17096223|NCT00427895|38235442|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
17096224|NCT00427895|38235443|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
17096225|NCT00427895|38235444|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
17096226|NCT00427895|38235445|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
17096227|NCT00427895|38235446|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
17096228|NCT00427895|38235447|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
17096229|NCT00427895|38235448|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
17096230|NCT00427895|38235449|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
17096231|NCT00427895|38235442|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
17096232|NCT00427895|38235443|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
17096233|NCT00427895|38235444|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
17096234|NCT00427895|38235445|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
17096235|NCT00427895|38235446|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
17096236|NCT00427895|38235447|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
17096237|NCT00427895|38235448|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
17096238|NCT00427895|38235449|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
17096239|NCT00427895|38235442|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
17096240|NCT00427895|38235443|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
17096241|NCT00427895|38235444|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
17096242|NCT00427895|38235445|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
17096243|NCT00427895|38235446|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
17096244|NCT00427895|38235447|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
17096245|NCT00427895|38235448|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
17096246|NCT00427895|38235449|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
17096247|NCT00427895|38235442|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
17096248|NCT00427895|38235443|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
17096249|NCT00427895|38235444|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
17096250|NCT00427895|38235445|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
17096251|NCT00427895|38235446|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
17096252|NCT00427895|38235447|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
17096253|NCT00427895|38235448|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
17096254|NCT00427895|38235449|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
17096255|NCT00427895|38235442|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
17096256|NCT00427895|38235443|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
17096257|NCT00427895|38235444|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
17096258|NCT00427895|38235445|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
17096259|NCT00427895|38235446|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
17096260|NCT00427895|38235447|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
17096261|NCT00427895|38235448|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
17096262|NCT00427895|38235449|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
17096263|NCT00427895|38235442|FG000|Vax 1/Year 1 Follow-up|Death|1|||
17096264|NCT00427895|38235443|FG001|Vax 1/Year 1 Follow-up|Death|0|||
17096265|NCT00427895|38235444|FG002|Vax 1/Year 1 Follow-up|Death|0|||
17096266|NCT00427895|38235445|FG003|Vax 1/Year 1 Follow-up|Death|0|||
17096267|NCT00427895|38235446|FG004|Vax 1/Year 1 Follow-up|Death|0|||
17096268|NCT00427895|38235447|FG005|Vax 1/Year 1 Follow-up|Death|0|||
17096269|NCT00427895|38235448|FG006|Vax 1/Year 1 Follow-up|Death|0|||
17096270|NCT00427895|38235449|FG007|Vax 1/Year 1 Follow-up|Death|0|||
17096271|NCT00427895|38235442|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
17096272|NCT00427895|38235443|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
17096273|NCT00427895|38235444|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
17096274|NCT00427895|38235445|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
17096275|NCT00427895|38235446|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
17096276|NCT00427895|38235447|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
17096277|NCT00427895|38235448|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
17096278|NCT00427895|38235449|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
17096279|NCT00427895|38235442|FG000|Vax 1/Year 1 Follow-up|Other|0|||
17096280|NCT00427895|38235443|FG001|Vax 1/Year 1 Follow-up|Other|0|||
17096281|NCT00427895|38235444|FG002|Vax 1/Year 1 Follow-up|Other|0|||
17096282|NCT00427895|38235445|FG003|Vax 1/Year 1 Follow-up|Other|2|||
17096283|NCT00427895|38235446|FG004|Vax 1/Year 1 Follow-up|Other|0|||
17096284|NCT00427895|38235447|FG005|Vax 1/Year 1 Follow-up|Other|0|||
17096285|NCT00427895|38235448|FG006|Vax 1/Year 1 Follow-up|Other|0|||
17096286|NCT00427895|38235449|FG007|Vax 1/Year 1 Follow-up|Other|0|||
17096287|NCT00427895|38235442|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
17096288|NCT00427895|38235443|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
17096289|NCT00427895|38235444|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
17096290|NCT00427895|38235445|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
17096291|NCT00427895|38235446|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
17096292|NCT00427895|38235447|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
17096293|NCT00427895|38235448|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
17096294|NCT00427895|38235449|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
17096295|NCT00427349|38235488|FG000|Overall Study|Lack of Efficacy|23|||
17096296|NCT00427349|38235488|FG000|Overall Study|Adverse Event|14|||
17096297|NCT00427349|38235488|FG000|Overall Study|Death|1|||
17096298|NCT00427349|38235488|FG000|Overall Study|Withdrawal by Subject|3|||
17096299|NCT00427349|38235488|FG000|Overall Study|Alternative therapy|1|||
17096300|NCT00427349|38235488|FG000|Overall Study|Other|2|||
17096301|NCT00427349|38235488|FG000|Overall Study|Ineligible|1|||
17096302|NCT00427349|38235488|FG000|Overall Study|Never started therapy|1|||
17096303|NCT00425945|38235494|FG000|Overall Study|Concern about Supplement|2|||
17096304|NCT00425945|38235495|FG001|Overall Study|Concern about Supplement|0|||
17096305|NCT00425945|38235494|FG000|Overall Study|Inconvenience|0|||
17096306|NCT00425945|38235495|FG001|Overall Study|Inconvenience|2|||
17096307|NCT00425945|38235494|FG000|Overall Study|Lost to Follow-up|0|||
17096308|NCT00425945|38235495|FG001|Overall Study|Lost to Follow-up|2|||
17192922|NCT02415400|38346293|FG000|Overall Study|Participant withdrew consent|14|||
17096309|NCT00425945|38235494|FG000|Overall Study|Began hypertension medication|1|||
17096310|NCT00425945|38235495|FG001|Overall Study|Began hypertension medication|0|||
17096311|NCT00425945|38235494|FG000|Overall Study|Began cancer treatments|1|||
17096312|NCT00425945|38235495|FG001|Overall Study|Began cancer treatments|0|||
17096313|NCT00425945|38235494|FG000|Overall Study|Moved from area|0|||
17096314|NCT00425945|38235495|FG001|Overall Study|Moved from area|1|||
17096315|NCT00416195|38235505|FG000|Overall Study|Adverse Event|1|||
17096316|NCT00416195|38235506|FG001|Overall Study|Adverse Event|2|||
17096317|NCT00416195|38235505|FG000|Overall Study|Protocol Violation|1|||
17096318|NCT00416195|38235506|FG001|Overall Study|Protocol Violation|1|||
17096319|NCT00416195|38235505|FG000|Overall Study|Other|0|||
17096320|NCT00416195|38235506|FG001|Overall Study|Other|1|||
17096321|NCT00121641|38235516|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
17096322|NCT00121641|38235517|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
17096323|NCT00121641|38235518|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
17096324|NCT00121641|38235519|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
17096325|NCT00121641|38235520|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
17096326|NCT00121641|38235516|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
17096327|NCT00121641|38235517|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
17096328|NCT00121641|38235518|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
17096329|NCT00121641|38235519|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
17096330|NCT00121641|38235520|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
17096331|NCT00121641|38235516|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
17096332|NCT00121641|38235517|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
17007877|NCT00925769|38152075|FG004|Overall Study|Adverse Event|1|||
17007878|NCT00925769|38152076|FG005|Overall Study|Adverse Event|0|||
17007879|NCT00770913|38152095|FG000|Overall Study|Adverse Event|1|||
17007880|NCT00770913|38152096|FG001|Overall Study|Adverse Event|3|||
17007881|NCT00770913|38152097|FG002|Overall Study|Adverse Event|6|||
17007882|NCT00770913|38152095|FG000|Overall Study|Refusal to continue participation|6|||
17007883|NCT00770913|38152096|FG001|Overall Study|Refusal to continue participation|4|||
17007884|NCT00770913|38152097|FG002|Overall Study|Refusal to continue participation|5|||
17007885|NCT00770913|38152095|FG000|Overall Study|Physician Decision|0|||
17007886|NCT00770913|38152096|FG001|Overall Study|Physician Decision|1|||
17096333|NCT00121641|38235518|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
17096334|NCT00121641|38235519|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
17096335|NCT00121641|38235520|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
17096336|NCT00121641|38235516|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
17007887|NCT00770913|38152097|FG002|Overall Study|Physician Decision|1|||
17007888|NCT00770913|38152095|FG000|Overall Study|Protocol Violation|3|||
17007889|NCT00770913|38152096|FG001|Overall Study|Protocol Violation|0|||
17007890|NCT00770913|38152097|FG002|Overall Study|Protocol Violation|1|||
17007891|NCT00770913|38152095|FG000|Overall Study|Incorrect drug was allocated|1|||
17007892|NCT00770913|38152096|FG001|Overall Study|Incorrect drug was allocated|0|||
17007893|NCT00770913|38152097|FG002|Overall Study|Incorrect drug was allocated|0|||
17007894|NCT00562861|38152107|FG000|Overall Study|Adverse Event|1|||
17007895|NCT00562861|38152108|FG001|Overall Study|Adverse Event|1|||
17007896|NCT00562861|38152107|FG000|Overall Study|Lack of Efficacy|5|||
17007897|NCT00562861|38152108|FG001|Overall Study|Lack of Efficacy|5|||
17007898|NCT00562861|38152107|FG000|Overall Study|noncompliance, moved|7|||
17007899|NCT00562861|38152108|FG001|Overall Study|noncompliance, moved|2|||
17192923|NCT02415400|38346294|FG001|Overall Study|Participant withdrew consent|12|||
17192924|NCT02415400|38346295|FG002|Overall Study|Participant withdrew consent|30|||
17192925|NCT02415400|38346296|FG003|Overall Study|Participant withdrew consent|21|||
17192926|NCT02415400|38346293|FG000|Overall Study|Death|39|||
17192927|NCT02415400|38346294|FG001|Overall Study|Death|41|||
17192928|NCT02415400|38346295|FG002|Overall Study|Death|35|||
17192929|NCT02415400|38346296|FG003|Overall Study|Death|42|||
17192930|NCT02415400|38346293|FG000|Overall Study|Lost to Follow-up|3|||
17192931|NCT02415400|38346294|FG001|Overall Study|Lost to Follow-up|3|||
17192932|NCT02415400|38346295|FG002|Overall Study|Lost to Follow-up|2|||
17192933|NCT02415400|38346296|FG003|Overall Study|Lost to Follow-up|5|||
17192934|NCT02415400|38346293|FG000|Overall Study|Poor/Non-Compliance|0|||
17192935|NCT02415400|38346294|FG001|Overall Study|Poor/Non-Compliance|1|||
17192936|NCT02415400|38346295|FG002|Overall Study|Poor/Non-Compliance|3|||
17192937|NCT02415400|38346296|FG003|Overall Study|Poor/Non-Compliance|4|||
17192938|NCT02415400|38346293|FG000|Overall Study|Participant no longer meets criteria|2|||
17192939|NCT02415400|38346294|FG001|Overall Study|Participant no longer meets criteria|0|||
17192940|NCT02415400|38346295|FG002|Overall Study|Participant no longer meets criteria|0|||
17192941|NCT02415400|38346296|FG003|Overall Study|Participant no longer meets criteria|1|||
17192942|NCT02415400|38346293|FG000|Overall Study|Participant doesn't answer phone|1|||
17192943|NCT02415400|38346294|FG001|Overall Study|Participant doesn't answer phone|0|||
17192944|NCT02415400|38346295|FG002|Overall Study|Participant doesn't answer phone|0|||
17192945|NCT02415400|38346296|FG003|Overall Study|Participant doesn't answer phone|0|||
16786268|NCT01999972|37726700|FG000|Dose Expansion Part|Death|0|||
16786269|NCT01999972|37726701|FG001|Dose Expansion Part|Death|0|||
16786270|NCT01999972|37726702|FG002|Dose Expansion Part|Death|0|||
17007900|NCT00562861|38152107|FG000|Overall Study|Lost to Follow-up|7|||
17007901|NCT00562861|38152108|FG001|Overall Study|Lost to Follow-up|3|||
17007902|NCT00770679|38152114|FG000|Overall Study|Lost to Follow-up|3|||
17096337|NCT00121641|38235517|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
17096338|NCT00121641|38235518|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
17007903|NCT00770679|38152114|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
17007904|NCT00770601|38152118|FG000|Overall Study|Withdrawal by Subject|1|||
17007905|NCT00770367|38152124|FG000|First Intervention|Withdrawal by Subject|0|||
17007906|NCT00770367|38152125|FG001|First Intervention|Withdrawal by Subject|2|||
17007907|NCT00770367|38152124|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
17007908|NCT00770367|38152125|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
17007909|NCT00770367|38152124|FG000|Second Intervention|Lost to Follow-up|2|||
17007910|NCT00770367|38152125|FG001|Second Intervention|Lost to Follow-up|0|||
17007911|NCT00931307|38152133|FG000|Overall Study|Lack of Efficacy|12|||
17096339|NCT00121641|38235519|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
17096340|NCT00121641|38235520|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
17096341|NCT00121641|38235516|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
17096342|NCT00121641|38235517|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
17096343|NCT00121641|38235518|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
17096344|NCT00121641|38235519|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
17096345|NCT00121641|38235520|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
17096346|NCT00121641|38235516|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
17096347|NCT00121641|38235517|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
17096348|NCT00121641|38235518|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
17096349|NCT00121641|38235519|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
17096350|NCT00121641|38235520|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
17096351|NCT00121641|38235516|FG000|24-week Short-term Treatment Period|Other Reason|1|||
17096352|NCT00121641|38235517|FG001|24-week Short-term Treatment Period|Other Reason|0|||
17007912|NCT00931307|38152133|FG000|Overall Study|Biomicroscopy|1|||
17007913|NCT00930761|38152152|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
17007914|NCT00930761|38152153|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
17007915|NCT00930761|38152152|FG000|Overall Study|less than 3 music therapy sessions|0|||
17007916|NCT00930761|38152153|FG001|Overall Study|less than 3 music therapy sessions|3|||
17007917|NCT00770289|38152159|FG000|Overall Study|Other|6|||
17007918|NCT00556933|38152172|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
17007919|NCT00556933|38152173|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
17007920|NCT00556933|38152174|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
17007921|NCT00556933|38152175|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
17007922|NCT00556933|38152172|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
17007923|NCT00556933|38152173|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
17007924|NCT00556933|38152174|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
17007925|NCT00556933|38152175|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
17007926|NCT00556933|38152172|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
17007927|NCT00556933|38152173|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
17007928|NCT00556933|38152174|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
17007929|NCT00556933|38152175|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
17007930|NCT00556933|38152172|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
17007931|NCT00556933|38152173|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
17007932|NCT00556933|38152174|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
17007933|NCT00556933|38152175|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
17007934|NCT00556933|38152172|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
17007935|NCT00556933|38152173|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
17007936|NCT00556933|38152174|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
17007937|NCT00556933|38152175|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
17007938|NCT00556933|38152172|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
17007939|NCT00556933|38152173|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
17007940|NCT00556933|38152174|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
17007941|NCT00556933|38152175|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
17007942|NCT00556933|38152172|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
17007943|NCT00556933|38152173|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
17007944|NCT00556933|38152174|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
17007945|NCT00556933|38152175|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
17007946|NCT00556933|38152172|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
17007947|NCT00556933|38152173|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
17007948|NCT00556933|38152174|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
17007949|NCT00556933|38152175|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
17007950|NCT00556933|38152172|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
17007951|NCT00556933|38152173|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
17007952|NCT00556933|38152174|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
17007953|NCT00556933|38152175|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
17007954|NCT00556933|38152172|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
17007955|NCT00556933|38152173|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
17007956|NCT00556933|38152174|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
17007957|NCT00556933|38152175|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
17007958|NCT00556933|38152172|FG000|CNI Withdrawal vs. Minimization|Death|0|||
17007959|NCT00556933|38152173|FG001|CNI Withdrawal vs. Minimization|Death|0|||
17007960|NCT00556933|38152174|FG002|CNI Withdrawal vs. Minimization|Death|0|||
17007961|NCT00556933|38152175|FG003|CNI Withdrawal vs. Minimization|Death|1|||
17007962|NCT00770211|38152196|FG000|Overall Study|Lost to Follow-up|1|||
17007963|NCT00770211|38152197|FG001|Overall Study|Lost to Follow-up|0|||
17007964|NCT00770211|38152196|FG000|Overall Study|Withdrawal by Subject|0|||
17007965|NCT00770211|38152197|FG001|Overall Study|Withdrawal by Subject|2|||
17007966|NCT00928187|38152206|FG000|Overall Study|Death|1|||
17007967|NCT00928187|38152207|FG001|Overall Study|Death|2|||
17007968|NCT00928187|38152208|FG002|Overall Study|Death|3|||
17007969|NCT00928187|38152206|FG000|Overall Study|Lost to Follow-up|1|||
17007970|NCT00928187|38152207|FG001|Overall Study|Lost to Follow-up|2|||
17007971|NCT00928187|38152208|FG002|Overall Study|Lost to Follow-up|1|||
17007972|NCT00928187|38152206|FG000|Overall Study|Withdrawal by Subject|0|||
17007973|NCT00928187|38152207|FG001|Overall Study|Withdrawal by Subject|1|||
17007974|NCT00928187|38152208|FG002|Overall Study|Withdrawal by Subject|1|||
17007975|NCT00928187|38152206|FG000|Overall Study|Protocol Violation|0|||
17007976|NCT00928187|38152207|FG001|Overall Study|Protocol Violation|1|||
17007977|NCT00928187|38152208|FG002|Overall Study|Protocol Violation|0|||
17007978|NCT00769119|38152218|FG000|Overall Study|Voluntary discontinuation|0|||
17007979|NCT00769119|38152219|FG001|Overall Study|Voluntary discontinuation|2|||
17007980|NCT00769119|38152218|FG000|Overall Study|Adverse Event|1|||
17007981|NCT00769119|38152219|FG001|Overall Study|Adverse Event|1|||
17007982|NCT00769119|38152218|FG000|Overall Study|Disallowed medication|1|||
17007983|NCT00769119|38152219|FG001|Overall Study|Disallowed medication|0|||
17007984|NCT00927953|38152227|FG000|Overall Study|Death|2|||
17007985|NCT00927953|38152228|FG001|Overall Study|Death|1|||
17007986|NCT00768651|38152235|FG000|Overall Study|Withdrawal by Subject|1|||
17007987|NCT00756717|38152240|FG000|Overall Study|Withdrawal by Subject|2|||
17007988|NCT03962101|38152244|FG000|Overall Study|Adverse Event|1|||
17007989|NCT03962101|38152244|FG000|Overall Study|Physician Decision|2|||
17007990|NCT03962101|38152244|FG000|Overall Study|Not related to medical events|1|||
17007991|NCT00923351|38152251|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
17007992|NCT00923351|38152252|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
17007993|NCT00923351|38152253|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
17007994|NCT00755937|38152259|FG000|Recruitment|Unknown if infliximab received|164|||
17007995|NCT00755937|38152259|FG000|Observational Follow-up|Lost to Follow-up|148|||
17007996|NCT00755079|38152265|FG000|Overall Study|Lost to Follow-up|1|||
17007997|NCT00755079|38152266|FG001|Overall Study|Lost to Follow-up|3|||
17007998|NCT00755079|38152265|FG000|Overall Study|Adverse Event|0|||
17007999|NCT00755079|38152266|FG001|Overall Study|Adverse Event|1|||
17008000|NCT00755079|38152265|FG000|Overall Study|Withdrawal by Subject|0|||
17008001|NCT00755079|38152266|FG001|Overall Study|Withdrawal by Subject|2|||
17008002|NCT00925301|38152274|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
17008003|NCT00925301|38152275|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
17008004|NCT00925301|38152276|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
17008005|NCT00925301|38152277|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
17008006|NCT00925301|38152274|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
17008007|NCT00925301|38152275|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
17008008|NCT00925301|38152276|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
17008009|NCT00925301|38152277|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
17008010|NCT00925301|38152274|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
17008011|NCT00925301|38152275|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
17008012|NCT00925301|38152276|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
17008013|NCT00925301|38152277|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
17008014|NCT00925301|38152274|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
17008015|NCT00925301|38152275|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
17008016|NCT00925301|38152276|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
17008017|NCT00925301|38152277|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
17008018|NCT00925301|38152274|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
17008019|NCT00925301|38152275|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
17008020|NCT00925301|38152276|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
17008021|NCT00925301|38152277|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
17008022|NCT00925301|38152274|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
17008023|NCT00925301|38152275|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
17008024|NCT00925301|38152276|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
17008025|NCT00925301|38152277|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
17008026|NCT00925301|38152274|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
17008027|NCT00925301|38152275|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
17008028|NCT00925301|38152276|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
17008029|NCT00925301|38152277|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
17008030|NCT00754065|38152290|FG000|Overall Study|Never received treatment|12|||
17008031|NCT00754065|38152291|FG001|Overall Study|Never received treatment|2|||
17008032|NCT00754065|38152290|FG000|Overall Study|Adverse Event|19|||
17008033|NCT00754065|38152291|FG001|Overall Study|Adverse Event|25|||
17008034|NCT00754065|38152290|FG000|Overall Study|Lost to Follow-up|7|||
17008035|NCT00754065|38152291|FG001|Overall Study|Lost to Follow-up|11|||
17008036|NCT00754065|38152290|FG000|Overall Study|Protocol Violation|12|||
17008037|NCT00754065|38152291|FG001|Overall Study|Protocol Violation|10|||
17008038|NCT00754065|38152290|FG000|Overall Study|Withdrawal by Subject|4|||
17008039|NCT00754065|38152291|FG001|Overall Study|Withdrawal by Subject|5|||
17008040|NCT00754065|38152290|FG000|Overall Study|Pregnancy|6|||
17008041|NCT00754065|38152291|FG001|Overall Study|Pregnancy|0|||
17008042|NCT00754065|38152290|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
17008043|NCT00754065|38152291|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
17008044|NCT04138056|38152311|FG000|Primary Study|Lost to Follow-up|3|||
17008045|NCT04138056|38152312|FG001|Primary Study|Lost to Follow-up|4|||
17008046|NCT04138056|38152313|FG002|Primary Study|Lost to Follow-up|1|||
17008047|NCT04138056|38152314|FG003|Primary Study|Lost to Follow-up|1|||
17008048|NCT04138056|38152315|FG004|Primary Study|Lost to Follow-up|4|||
17008049|NCT04138056|38152311|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
17008050|NCT04138056|38152312|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
17008051|NCT04138056|38152313|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
17008052|NCT04138056|38152314|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
17008053|NCT04138056|38152315|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
17008054|NCT04138056|38152311|FG000|Extension Study|Lost to Follow-up|1|||
16786271|NCT01999972|37726703|FG003|Dose Expansion Part|Death|0|||
16786272|NCT01999972|37726704|FG004|Dose Expansion Part|Death|2|||
16786273|NCT01999972|37726705|FG005|Dose Expansion Part|Death|1|||
17096353|NCT00121641|38235518|FG002|24-week Short-term Treatment Period|Other Reason|0|||
17096354|NCT00121641|38235519|FG003|24-week Short-term Treatment Period|Other Reason|0|||
17096355|NCT00121641|38235520|FG004|24-week Short-term Treatment Period|Other Reason|0|||
17192946|NCT02415400|38346293|FG000|Overall Study|Participant wanted home visits|1|||
17192947|NCT02415400|38346294|FG001|Overall Study|Participant wanted home visits|0|||
17192948|NCT02415400|38346295|FG002|Overall Study|Participant wanted home visits|0|||
17192949|NCT02415400|38346296|FG003|Overall Study|Participant wanted home visits|0|||
17192950|NCT02415400|38346293|FG000|Overall Study|Randomized in error|2|||
17192951|NCT02415400|38346294|FG001|Overall Study|Randomized in error|0|||
17192952|NCT02415400|38346295|FG002|Overall Study|Randomized in error|0|||
17192953|NCT02415400|38346296|FG003|Overall Study|Randomized in error|0|||
17192954|NCT02415400|38346293|FG000|Overall Study|No study drug on site|0|||
17192955|NCT02415400|38346294|FG001|Overall Study|No study drug on site|1|||
17192956|NCT02415400|38346295|FG002|Overall Study|No study drug on site|0|||
17192957|NCT02415400|38346296|FG003|Overall Study|No study drug on site|0|||
17192958|NCT02415400|38346293|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
17192959|NCT02415400|38346294|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
17192960|NCT02415400|38346295|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
16786274|NCT01999972|37726700|FG000|Dose Expansion Part|Disease progression|0|||
17008055|NCT04138056|38152312|FG001|Extension Study|Lost to Follow-up|2|||
17096356|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
17096357|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
17096358|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
17096359|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
17096360|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
17096361|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
17096362|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
17096363|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
17096364|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
17096365|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
17096366|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
17096367|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
17096368|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
17096369|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
17096370|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
17096371|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
17096372|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
17192961|NCT02415400|38346296|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
17008056|NCT04138056|38152313|FG002|Extension Study|Lost to Follow-up|1|||
17008057|NCT04138056|38152314|FG003|Extension Study|Lost to Follow-up|0|||
17008058|NCT04138056|38152315|FG004|Extension Study|Lost to Follow-up|1|||
16786275|NCT01999972|37726701|FG001|Dose Expansion Part|Disease progression|0|||
16786276|NCT01999972|37726702|FG002|Dose Expansion Part|Disease progression|0|||
16786277|NCT01999972|37726703|FG003|Dose Expansion Part|Disease progression|0|||
16786278|NCT01999972|37726704|FG004|Dose Expansion Part|Disease progression|9|||
16786279|NCT01999972|37726705|FG005|Dose Expansion Part|Disease progression|3|||
16786280|NCT01999972|37726700|FG000|Dose Expansion Part|Sponsor decision|0|||
16786281|NCT01999972|37726701|FG001|Dose Expansion Part|Sponsor decision|0|||
16786282|NCT01999972|37726702|FG002|Dose Expansion Part|Sponsor decision|0|||
16786283|NCT01999972|37726703|FG003|Dose Expansion Part|Sponsor decision|0|||
16786284|NCT01999972|37726704|FG004|Dose Expansion Part|Sponsor decision|1|||
16786285|NCT01999972|37726705|FG005|Dose Expansion Part|Sponsor decision|0|||
16786286|NCT01999972|37726700|FG000|Dose Expansion Part|Adverse Event|0|||
17008059|NCT00753675|38152361|FG000|Overall Study|other reason|11|||
17008060|NCT00753675|38152362|FG001|Overall Study|other reason|12|||
17008061|NCT00753675|38152363|FG002|Overall Study|other reason|13|||
17008062|NCT00753675|38152361|FG000|Overall Study|Death|1|||
17008063|NCT00753675|38152362|FG001|Overall Study|Death|2|||
17008064|NCT00753675|38152363|FG002|Overall Study|Death|4|||
17008065|NCT00753675|38152361|FG000|Overall Study|Adverse Event|11|||
17008066|NCT00753675|38152362|FG001|Overall Study|Adverse Event|9|||
17008067|NCT00753675|38152363|FG002|Overall Study|Adverse Event|4|||
17008068|NCT00753675|38152361|FG000|Overall Study|Objective progression of disease|35|||
17008069|NCT00753675|38152362|FG001|Overall Study|Objective progression of disease|35|||
17008070|NCT00753675|38152363|FG002|Overall Study|Objective progression of disease|35|||
17008071|NCT00753675|38152361|FG000|Overall Study|Withdrawal by Subject|0|||
17008072|NCT00753675|38152362|FG001|Overall Study|Withdrawal by Subject|1|||
17008073|NCT00753675|38152363|FG002|Overall Study|Withdrawal by Subject|0|||
17008074|NCT00753675|38152361|FG000|Overall Study|Lost to Follow-up|1|||
17008075|NCT00753675|38152362|FG001|Overall Study|Lost to Follow-up|0|||
17008076|NCT00753675|38152363|FG002|Overall Study|Lost to Follow-up|0|||
17008077|NCT00586521|38152371|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
17008078|NCT00923273|38152380|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
17008079|NCT00923273|38152381|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
17008080|NCT00923273|38152382|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
17008081|NCT00923273|38152383|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
17008082|NCT00923273|38152384|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
17008083|NCT00923273|38152380|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
17008084|NCT00923273|38152381|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
17008085|NCT00923273|38152382|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
17008086|NCT00923273|38152383|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
17008087|NCT00923273|38152384|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
17008088|NCT00923195|38152404|FG000|Overall Study|Death|0|||
17008089|NCT00923195|38152405|FG001|Overall Study|Death|1|||
17008090|NCT00753519|38152413|FG000|Overall Study|Withdrawal by Subject|0|||
17008091|NCT00753519|38152414|FG001|Overall Study|Withdrawal by Subject|2|||
17008092|NCT00919061|38152422|FG000|Overall Study|Adverse Event|1|||
17008093|NCT00919061|38152422|FG000|Overall Study|Withdrawal by Subject|1|||
17008094|NCT00747435|38152426|FG000|Overall Study|Lost to Follow-up|2|||
17008095|NCT00747435|38152426|FG000|Overall Study|Withdrawal by Subject|3|||
17008096|NCT00747435|38152426|FG000|Overall Study|Still undergoing follow up|1|||
17008097|NCT00918749|38152433|FG000|Overall Study|Adverse Event|1|||
17008098|NCT00918749|38152434|FG001|Overall Study|Adverse Event|0|||
17008099|NCT00918749|38152435|FG002|Overall Study|Adverse Event|1|||
17008100|NCT00918749|38152433|FG000|Overall Study|Lost to Follow-up|0|||
17008101|NCT00918749|38152434|FG001|Overall Study|Lost to Follow-up|0|||
17008102|NCT00918749|38152435|FG002|Overall Study|Lost to Follow-up|1|||
17008103|NCT00918749|38152433|FG000|Overall Study|Withdrawal by Subject|5|||
17008104|NCT00918749|38152434|FG001|Overall Study|Withdrawal by Subject|3|||
17008105|NCT00918749|38152435|FG002|Overall Study|Withdrawal by Subject|5|||
17008106|NCT00918749|38152433|FG000|Overall Study|No Study Medication Taken|1|||
17008107|NCT00918749|38152434|FG001|Overall Study|No Study Medication Taken|0|||
17008108|NCT00918749|38152435|FG002|Overall Study|No Study Medication Taken|0|||
17008109|NCT00746733|38152443|FG000|Second Intervention|Adverse Event|1|||
17008110|NCT00746733|38152444|FG001|Second Intervention|Adverse Event|0|||
17008111|NCT00746733|38152443|FG000|Third Intervention|Withdrawal by Subject|1|||
17008112|NCT00746733|38152444|FG001|Third Intervention|Withdrawal by Subject|1|||
17008113|NCT00745875|38152459|FG000|Overall Study|Continuing study treatment|4|||
17008114|NCT00745875|38152460|FG001|Overall Study|Continuing study treatment|4|||
17008115|NCT00555217|38152468|FG000|Overall Study|Withdrawal by Subject|35|||
17008116|NCT00555217|38152469|FG001|Overall Study|Withdrawal by Subject|31|||
17008117|NCT00555217|38152468|FG000|Overall Study|Lost to Follow-up|19|||
17008118|NCT00555217|38152469|FG001|Overall Study|Lost to Follow-up|20|||
17008119|NCT00555217|38152468|FG000|Overall Study|close out sites|21|||
16786287|NCT01999972|37726701|FG001|Dose Expansion Part|Adverse Event|0|||
17008120|NCT00555217|38152469|FG001|Overall Study|close out sites|17|||
17008121|NCT00745251|38152477|FG000|Overall Study|Adverse Event|1|||
17008122|NCT00745251|38152478|FG001|Overall Study|Adverse Event|2|||
17008123|NCT00745251|38152477|FG000|Overall Study|Withdrawal by Subject|1|||
17008124|NCT00745251|38152478|FG001|Overall Study|Withdrawal by Subject|1|||
17008125|NCT00745095|38152490|FG000|Overall Study|Declined to participate|1|||
17008126|NCT00745095|38152491|FG001|Overall Study|Declined to participate|0|||
17008127|NCT00745095|38152492|FG002|Overall Study|Declined to participate|0|||
17008128|NCT00745095|38152493|FG003|Overall Study|Declined to participate|0|||
17008129|NCT00745095|38152494|FG004|Overall Study|Declined to participate|92|||
17008130|NCT00745095|38152495|FG005|Overall Study|Declined to participate|95|||
17008131|NCT00745095|38152490|FG000|Overall Study|Ineligible due to GFR criteria|0|||
17008132|NCT00745095|38152491|FG001|Overall Study|Ineligible due to GFR criteria|2|||
17008133|NCT00745095|38152492|FG002|Overall Study|Ineligible due to GFR criteria|3|||
17008134|NCT00745095|38152493|FG003|Overall Study|Ineligible due to GFR criteria|3|||
17008135|NCT00745095|38152494|FG004|Overall Study|Ineligible due to GFR criteria|30|||
17008136|NCT00745095|38152495|FG005|Overall Study|Ineligible due to GFR criteria|28|||
17008137|NCT00744939|38152516|FG000|Overall Study|Withdrawal by Subject|9|||
17008138|NCT00744939|38152516|FG000|Overall Study|Protocol Violation|13|||
17008139|NCT00744939|38152516|FG000|Overall Study|Death|24|||
17008140|NCT00744939|38152516|FG000|Overall Study|distance|4|||
17008141|NCT00744939|38152516|FG000|Overall Study|Lost to Follow-up|12|||
17008142|NCT00744939|38152516|FG000|Overall Study|Medical history exclusionary|1|||
17008143|NCT00744939|38152516|FG000|Overall Study|Did not receive Magnevist|7|||
17008144|NCT00744939|38152516|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
17008145|NCT00744939|38152516|FG000|Overall Study|coma|1|||
17008146|NCT00744939|38152516|FG000|Overall Study|incorrect race|1|||
17008147|NCT00554515|38152528|FG000|Overall Study|Withdrawal by Subject|3|||
17008148|NCT00554515|38152528|FG000|Overall Study|Disease progression|52|||
17008149|NCT00554515|38152528|FG000|Overall Study|Physician Decision|18|||
17008150|NCT00554515|38152528|FG000|Overall Study|Withdrawal by Subject|11|||
17008151|NCT00554515|38152528|FG000|Overall Study|Adverse Event|9|||
17008152|NCT00554515|38152528|FG000|Overall Study|Death|2|||
17008153|NCT00554515|38152528|FG000|Overall Study|Achieved Stable Disease|7|||
17008154|NCT00554515|38152528|FG000|Overall Study|Other|1|||
17008155|NCT00554515|38152528|FG000|Overall Study|Misc|15|||
17008156|NCT00744861|38152557|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
17008157|NCT00744861|38152558|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
17008158|NCT00744861|38152559|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
17008159|NCT00744861|38152560|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
17008160|NCT00744861|38152557|FG000|Feasibility Stage 1|Pregnancy|0|||
17008161|NCT00744861|38152558|FG001|Feasibility Stage 1|Pregnancy|1|||
17008162|NCT00744861|38152559|FG002|Feasibility Stage 1|Pregnancy|0|||
17008163|NCT00744861|38152560|FG003|Feasibility Stage 1|Pregnancy|0|||
17008164|NCT00744861|38152557|FG000|Pivotal Stage 2|Adverse Event|0|||
17008165|NCT00744861|38152558|FG001|Pivotal Stage 2|Adverse Event|0|||
17008166|NCT00744861|38152559|FG002|Pivotal Stage 2|Adverse Event|6|||
17008167|NCT00744861|38152560|FG003|Pivotal Stage 2|Adverse Event|11|||
17008168|NCT00744861|38152557|FG000|Pivotal Stage 2|Death|0|||
17008169|NCT00744861|38152558|FG001|Pivotal Stage 2|Death|0|||
17008170|NCT00744861|38152559|FG002|Pivotal Stage 2|Death|0|||
17008171|NCT00744861|38152560|FG003|Pivotal Stage 2|Death|1|||
17008172|NCT00744861|38152557|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
17008173|NCT00744861|38152558|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
17008174|NCT00744861|38152559|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
17008175|NCT00744861|38152560|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
17008176|NCT00744861|38152557|FG000|Pivotal Stage 2|Physician Decision|0|||
17008177|NCT00744861|38152558|FG001|Pivotal Stage 2|Physician Decision|0|||
17008178|NCT00744861|38152559|FG002|Pivotal Stage 2|Physician Decision|3|||
17008179|NCT00744861|38152560|FG003|Pivotal Stage 2|Physician Decision|1|||
17008180|NCT00744861|38152557|FG000|Pivotal Stage 2|Protocol Violation|0|||
17008181|NCT00744861|38152558|FG001|Pivotal Stage 2|Protocol Violation|0|||
17008182|NCT00744861|38152559|FG002|Pivotal Stage 2|Protocol Violation|0|||
17008183|NCT00744861|38152560|FG003|Pivotal Stage 2|Protocol Violation|1|||
17008184|NCT00744861|38152557|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
17008185|NCT00744861|38152558|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
17008186|NCT00744861|38152559|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
17008187|NCT00744861|38152560|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
17008188|NCT00744861|38152557|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
17008189|NCT00744861|38152558|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
17008190|NCT00744861|38152559|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
17008191|NCT00744861|38152560|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
17008192|NCT03969589|38152570|FG000|Overall Study|Lost to Follow-up|3|||
17008193|NCT03969589|38152571|FG001|Overall Study|Lost to Follow-up|2|||
17008194|NCT03969589|38152570|FG000|Overall Study|Declined Follow-Up|0|||
17008195|NCT03969589|38152571|FG001|Overall Study|Declined Follow-Up|1|||
17008196|NCT00744627|38152579|FG000|Overall Study|Adverse Event|6|||
17008197|NCT00744627|38152580|FG001|Overall Study|Adverse Event|9|||
17008198|NCT00744627|38152579|FG000|Overall Study|Lack of Efficacy|7|||
17008199|NCT00744627|38152580|FG001|Overall Study|Lack of Efficacy|3|||
17008200|NCT00744627|38152579|FG000|Overall Study|Noncompliance|0|||
17008201|NCT00744627|38152580|FG001|Overall Study|Noncompliance|1|||
17192962|NCT02415400|38346293|FG000|Overall Study|Coagulation values cannot be set|0|||
17192963|NCT02415400|38346294|FG001|Overall Study|Coagulation values cannot be set|0|||
16908367|NCT01780662|38017016|FG000|Overall Study|Adverse Event|1|||
17008202|NCT00744627|38152579|FG000|Overall Study|Protocol Deviations|0|||
17008203|NCT00744627|38152580|FG001|Overall Study|Protocol Deviations|2|||
17008204|NCT00744627|38152579|FG000|Overall Study|Voluntary Withdrawal|9|||
17008205|NCT00744627|38152580|FG001|Overall Study|Voluntary Withdrawal|6|||
17008206|NCT00744627|38152579|FG000|Overall Study|Lost to Follow-up|2|||
17008207|NCT00744627|38152580|FG001|Overall Study|Lost to Follow-up|1|||
17008208|NCT00744627|38152579|FG000|Overall Study|Other|1|||
17008209|NCT00744627|38152580|FG001|Overall Study|Other|0|||
17008210|NCT03959137|38152586|FG000|Overall Study|Protocol Violation|6|||
17008211|NCT00562627|38152593|FG000|Overall Study|Protocol Violation|1|||
17008212|NCT00562627|38152594|FG001|Overall Study|Protocol Violation|1|||
17008213|NCT00562627|38152595|FG002|Overall Study|Protocol Violation|1|||
17008214|NCT00562159|38152605|FG000|Overall Study|Adverse Event|11|||
17008215|NCT00562159|38152606|FG001|Overall Study|Adverse Event|8|||
17008216|NCT00562159|38152605|FG000|Overall Study|Lost to Follow-up|5|||
17008217|NCT00562159|38152606|FG001|Overall Study|Lost to Follow-up|4|||
17008218|NCT00562159|38152605|FG000|Overall Study|Withdrawal by Subject|9|||
17008219|NCT00562159|38152606|FG001|Overall Study|Withdrawal by Subject|8|||
17008220|NCT00562159|38152605|FG000|Overall Study|Protocol Violation|12|||
17008221|NCT00562159|38152606|FG001|Overall Study|Protocol Violation|12|||
17008222|NCT00562159|38152605|FG000|Overall Study|Did not meet protocol eligibility|1|||
17008223|NCT00562159|38152606|FG001|Overall Study|Did not meet protocol eligibility|1|||
17008224|NCT04223778|38152615|FG000|Overall Study|Ongoing|322|||
17008225|NCT04223778|38152616|FG001|Overall Study|Ongoing|326|||
17008226|NCT04223778|38152615|FG000|Overall Study|Death|0|||
17008227|NCT04223778|38152616|FG001|Overall Study|Death|1|||
17008228|NCT04223778|38152615|FG000|Overall Study|Lost to Follow-up|1|||
17008229|NCT04223778|38152616|FG001|Overall Study|Lost to Follow-up|5|||
17008230|NCT04223778|38152615|FG000|Overall Study|Physician Decision|3|||
17008231|NCT04223778|38152616|FG001|Overall Study|Physician Decision|1|||
17008232|NCT04223778|38152615|FG000|Overall Study|Withdrawal by Subject|10|||
17008233|NCT04223778|38152616|FG001|Overall Study|Withdrawal by Subject|1|||
17008234|NCT04223778|38152615|FG000|Overall Study|Lack of Efficacy|0|||
17008235|NCT04223778|38152616|FG001|Overall Study|Lack of Efficacy|2|||
17008236|NCT00921557|38152625|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
17008237|NCT00921557|38152626|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
17008238|NCT00921557|38152627|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
17008239|NCT00921557|38152625|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
17008240|NCT00921557|38152626|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
17008241|NCT00921557|38152627|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
17008242|NCT00921557|38152625|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
17008243|NCT00921557|38152626|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
17008244|NCT00921557|38152627|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
17008245|NCT00921557|38152625|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
17008246|NCT00921557|38152626|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
17008247|NCT00921557|38152627|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
17008248|NCT00921557|38152625|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
17008249|NCT00921557|38152626|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
17008250|NCT00921557|38152627|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
17008251|NCT00550615|38152642|FG000|Overall Study|Withdrawal by Subject|0|||
16908368|NCT01780662|38017017|FG001|Overall Study|Adverse Event|0|||
16908369|NCT01780662|38017018|FG002|Overall Study|Adverse Event|2|||
16908370|NCT01780662|38017016|FG000|Overall Study|Physician Decision|0|||
16908371|NCT01780662|38017017|FG001|Overall Study|Physician Decision|5|||
16908372|NCT01780662|38017018|FG002|Overall Study|Physician Decision|7|||
16908373|NCT01780662|38017016|FG000|Overall Study|Protocol Violation|0|||
16908374|NCT01780662|38017017|FG001|Overall Study|Protocol Violation|1|||
16908375|NCT01780662|38017018|FG002|Overall Study|Protocol Violation|0|||
16908376|NCT01780662|38017016|FG000|Overall Study|Ineligible|0|||
16908377|NCT01780662|38017017|FG001|Overall Study|Ineligible|0|||
16908378|NCT01780662|38017018|FG002|Overall Study|Ineligible|1|||
16908379|NCT01780584|38017030|FG000|Overall Study|Death|1|||
16908380|NCT01780584|38017031|FG001|Overall Study|Death|0|||
16908381|NCT01780584|38017032|FG002|Overall Study|Death|1|||
16908382|NCT01780584|38017030|FG000|Overall Study|Adverse Event|0|||
16908383|NCT01780584|38017031|FG001|Overall Study|Adverse Event|1|||
16908384|NCT01780584|38017032|FG002|Overall Study|Adverse Event|0|||
16908385|NCT01780584|38017030|FG000|Overall Study|Protocol Violation|0|||
16908386|NCT01780584|38017031|FG001|Overall Study|Protocol Violation|0|||
16908387|NCT01780584|38017032|FG002|Overall Study|Protocol Violation|1|||
17008252|NCT00550615|38152643|FG001|Overall Study|Withdrawal by Subject|0|||
17008253|NCT00550615|38152644|FG002|Overall Study|Withdrawal by Subject|2|||
17008254|NCT00550615|38152645|FG003|Overall Study|Withdrawal by Subject|3|||
17008255|NCT00550615|38152642|FG000|Overall Study|Not evaluable|0|||
17008256|NCT00550615|38152643|FG001|Overall Study|Not evaluable|0|||
17008257|NCT00550615|38152644|FG002|Overall Study|Not evaluable|2|||
17008258|NCT00550615|38152645|FG003|Overall Study|Not evaluable|7|||
17008259|NCT00744471|38152655|FG000|Overall Study|Randomized but not treated|1|||
17008260|NCT00744471|38152656|FG001|Overall Study|Randomized but not treated|1|||
17008261|NCT00744471|38152657|FG002|Overall Study|Randomized but not treated|4|||
17008262|NCT00744471|38152658|FG003|Overall Study|Randomized but not treated|0|||
17008263|NCT00744471|38152655|FG000|Overall Study|Death|0|||
17008264|NCT00744471|38152656|FG001|Overall Study|Death|0|||
17008265|NCT00744471|38152657|FG002|Overall Study|Death|0|||
17008266|NCT00744471|38152658|FG003|Overall Study|Death|1|||
17008267|NCT00744471|38152655|FG000|Overall Study|Adverse Event|6|||
17008268|NCT00744471|38152656|FG001|Overall Study|Adverse Event|7|||
17008269|NCT00744471|38152657|FG002|Overall Study|Adverse Event|5|||
17008270|NCT00744471|38152658|FG003|Overall Study|Adverse Event|9|||
17008271|NCT00744471|38152655|FG000|Overall Study|Withdrawal by Subject|9|||
17008272|NCT00744471|38152656|FG001|Overall Study|Withdrawal by Subject|9|||
17008273|NCT00744471|38152657|FG002|Overall Study|Withdrawal by Subject|15|||
17008274|NCT00744471|38152658|FG003|Overall Study|Withdrawal by Subject|12|||
17008275|NCT00744471|38152655|FG000|Overall Study|Protocol Violation|1|||
17008276|NCT00744471|38152656|FG001|Overall Study|Protocol Violation|4|||
17008277|NCT00744471|38152657|FG002|Overall Study|Protocol Violation|1|||
17008278|NCT00744471|38152658|FG003|Overall Study|Protocol Violation|2|||
17008279|NCT00744471|38152655|FG000|Overall Study|Entered extension study|41|||
17008280|NCT00744471|38152656|FG001|Overall Study|Entered extension study|84|||
17008281|NCT00744471|38152657|FG002|Overall Study|Entered extension study|100|||
17008282|NCT00744471|38152658|FG003|Overall Study|Entered extension study|91|||
17008283|NCT00744471|38152655|FG000|Overall Study|Other|2|||
17008284|NCT00744471|38152656|FG001|Overall Study|Other|3|||
17008285|NCT00744471|38152657|FG002|Overall Study|Other|6|||
17008286|NCT00744471|38152658|FG003|Overall Study|Other|2|||
17008287|NCT00744471|38152655|FG000|Overall Study|Lack of Efficacy|83|||
17008288|NCT00744471|38152656|FG001|Overall Study|Lack of Efficacy|37|||
17008289|NCT00744471|38152657|FG002|Overall Study|Lack of Efficacy|19|||
17008290|NCT00744471|38152658|FG003|Overall Study|Lack of Efficacy|31|||
17008291|NCT00744471|38152655|FG000|Overall Study|Lost to Follow-up|0|||
17008292|NCT00744471|38152656|FG001|Overall Study|Lost to Follow-up|0|||
17008293|NCT00744471|38152657|FG002|Overall Study|Lost to Follow-up|2|||
17008294|NCT00744471|38152658|FG003|Overall Study|Lost to Follow-up|0|||
17008295|NCT00744237|38152671|FG000|Overall Study|Lack of Efficacy|1|||
17008296|NCT00744237|38152672|FG001|Overall Study|Lack of Efficacy|1|||
17008297|NCT00744237|38152673|FG002|Overall Study|Lack of Efficacy|0|||
17008298|NCT00744237|38152671|FG000|Overall Study|Withdrawal by Subject|9|||
17008299|NCT00744237|38152672|FG001|Overall Study|Withdrawal by Subject|5|||
17008300|NCT00744237|38152673|FG002|Overall Study|Withdrawal by Subject|3|||
17008301|NCT00744237|38152671|FG000|Overall Study|Lost to Follow-up|1|||
17008302|NCT00744237|38152672|FG001|Overall Study|Lost to Follow-up|1|||
17008303|NCT00744237|38152673|FG002|Overall Study|Lost to Follow-up|1|||
17008304|NCT00744237|38152671|FG000|Overall Study|Protocol Violation|3|||
17008305|NCT00744237|38152672|FG001|Overall Study|Protocol Violation|4|||
17008306|NCT00744237|38152673|FG002|Overall Study|Protocol Violation|3|||
17008307|NCT00744237|38152671|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
17008308|NCT00744237|38152672|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
17008309|NCT00744237|38152673|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
17008310|NCT00744237|38152671|FG000|Overall Study|Dosing Error|1|||
17008311|NCT00744237|38152672|FG001|Overall Study|Dosing Error|0|||
17008312|NCT00744237|38152673|FG002|Overall Study|Dosing Error|1|||
17008313|NCT00744237|38152671|FG000|Overall Study|Study Drug Error|1|||
17008314|NCT00744237|38152672|FG001|Overall Study|Study Drug Error|0|||
17008315|NCT00744237|38152673|FG002|Overall Study|Study Drug Error|0|||
17008316|NCT00744237|38152671|FG000|Overall Study|Prohibited Concomitant Medication|0|||
17008317|NCT00744237|38152672|FG001|Overall Study|Prohibited Concomitant Medication|0|||
17008318|NCT00744237|38152673|FG002|Overall Study|Prohibited Concomitant Medication|1|||
17008319|NCT00744237|38152671|FG000|Overall Study|Poor Compliance|0|||
17008320|NCT00744237|38152672|FG001|Overall Study|Poor Compliance|2|||
17008321|NCT00744237|38152673|FG002|Overall Study|Poor Compliance|0|||
17008322|NCT00744237|38152671|FG000|Overall Study|Administrative. Site Closed|1|||
17008323|NCT00744237|38152672|FG001|Overall Study|Administrative. Site Closed|1|||
17008324|NCT00744237|38152673|FG002|Overall Study|Administrative. Site Closed|1|||
17008325|NCT00744237|38152671|FG000|Overall Study|Adverse Event|9|||
17008326|NCT00744237|38152672|FG001|Overall Study|Adverse Event|13|||
17008327|NCT00744237|38152673|FG002|Overall Study|Adverse Event|5|||
17008328|NCT00743145|38152681|FG000|Overall Study|Withdrawal by Subject|1|||
17008329|NCT00743145|38152681|FG000|Overall Study|Adverse Event|2|||
17008330|NCT00743145|38152681|FG000|Overall Study|Pregnancy|1|||
17008331|NCT00920855|38152698|FG000|Overall Study|Adverse Event|1|||
17008332|NCT00920855|38152699|FG001|Overall Study|Adverse Event|1|||
17008333|NCT00920855|38152700|FG002|Overall Study|Adverse Event|4|||
17008334|NCT00920855|38152698|FG000|Overall Study|Withdrawal by Subject|2|||
17008335|NCT00920855|38152699|FG001|Overall Study|Withdrawal by Subject|1|||
17008336|NCT00920855|38152700|FG002|Overall Study|Withdrawal by Subject|6|||
17008337|NCT00920855|38152698|FG000|Overall Study|Disease progression|2|||
17008338|NCT00920855|38152699|FG001|Overall Study|Disease progression|1|||
17008339|NCT00920855|38152700|FG002|Overall Study|Disease progression|10|||
17008340|NCT00920855|38152698|FG000|Overall Study|Noncompliance to study medication|0|||
17008341|NCT00920855|38152699|FG001|Overall Study|Noncompliance to study medication|0|||
17008342|NCT00920855|38152700|FG002|Overall Study|Noncompliance to study medication|1|||
17008343|NCT00920855|38152698|FG000|Overall Study|Response plateau; started maintenance|0|||
17008344|NCT00920855|38152699|FG001|Overall Study|Response plateau; started maintenance|0|||
17008345|NCT00920855|38152700|FG002|Overall Study|Response plateau; started maintenance|1|||
17008346|NCT00742209|38152714|FG000|Overall Study|Adverse Event|11|||
17008347|NCT00742209|38152715|FG001|Overall Study|Adverse Event|4|||
17008348|NCT00742209|38152716|FG002|Overall Study|Adverse Event|17|||
17008349|NCT00742209|38152717|FG003|Overall Study|Adverse Event|16|||
17008350|NCT00742209|38152718|FG004|Overall Study|Adverse Event|13|||
17008351|NCT00742209|38152714|FG000|Overall Study|Participant Withdrew Consent|8|||
17008352|NCT00742209|38152715|FG001|Overall Study|Participant Withdrew Consent|4|||
17008353|NCT00742209|38152716|FG002|Overall Study|Participant Withdrew Consent|14|||
17008354|NCT00742209|38152717|FG003|Overall Study|Participant Withdrew Consent|7|||
17008355|NCT00742209|38152718|FG004|Overall Study|Participant Withdrew Consent|4|||
17008356|NCT00742209|38152714|FG000|Overall Study|Protocol Violation|6|||
17008357|NCT00742209|38152715|FG001|Overall Study|Protocol Violation|5|||
17008358|NCT00742209|38152716|FG002|Overall Study|Protocol Violation|4|||
17008359|NCT00742209|38152717|FG003|Overall Study|Protocol Violation|5|||
17008360|NCT00742209|38152718|FG004|Overall Study|Protocol Violation|3|||
17008361|NCT00742209|38152714|FG000|Overall Study|Lost to Follow-up|3|||
17008362|NCT00742209|38152715|FG001|Overall Study|Lost to Follow-up|4|||
17008363|NCT00742209|38152716|FG002|Overall Study|Lost to Follow-up|5|||
17008364|NCT00742209|38152717|FG003|Overall Study|Lost to Follow-up|5|||
17008365|NCT00742209|38152718|FG004|Overall Study|Lost to Follow-up|3|||
17008366|NCT00742209|38152714|FG000|Overall Study|Lack of Efficacy|6|||
17008367|NCT00742209|38152715|FG001|Overall Study|Lack of Efficacy|1|||
17008368|NCT00742209|38152716|FG002|Overall Study|Lack of Efficacy|1|||
17008369|NCT00742209|38152717|FG003|Overall Study|Lack of Efficacy|3|||
17008370|NCT00742209|38152718|FG004|Overall Study|Lack of Efficacy|1|||
17008371|NCT00742209|38152714|FG000|Overall Study|Investigator Discretion|0|||
17008372|NCT00742209|38152715|FG001|Overall Study|Investigator Discretion|0|||
17008373|NCT00742209|38152716|FG002|Overall Study|Investigator Discretion|5|||
17008374|NCT00742209|38152717|FG003|Overall Study|Investigator Discretion|1|||
17008375|NCT00742209|38152718|FG004|Overall Study|Investigator Discretion|1|||
17008376|NCT00741819|38152731|FG000|Overall Study|Adverse Event|3|||
17008377|NCT00741819|38152731|FG000|Overall Study|Withdrawal by Subject|3|||
17008378|NCT00741819|38152731|FG000|Overall Study|Death|1|||
17008379|NCT00741819|38152731|FG000|Overall Study|Disease progression|1|||
17008380|NCT00924443|38152737|FG000|Overall Study|Physician Decision|2|||
17192964|NCT02415400|38346295|FG002|Overall Study|Coagulation values cannot be set|1|||
17192965|NCT02415400|38346296|FG003|Overall Study|Coagulation values cannot be set|0|||
17192966|NCT02415400|38346293|FG000|Overall Study|State regulations prevent participation|0|||
17192967|NCT02415400|38346294|FG001|Overall Study|State regulations prevent participation|0|||
17192968|NCT02415400|38346295|FG002|Overall Study|State regulations prevent participation|1|||
17192969|NCT02415400|38346296|FG003|Overall Study|State regulations prevent participation|0|||
17192970|NCT02415400|38346293|FG000|Overall Study|Poor treatment monitoring|0|||
17192971|NCT02415400|38346294|FG001|Overall Study|Poor treatment monitoring|0|||
17192972|NCT02415400|38346295|FG002|Overall Study|Poor treatment monitoring|1|||
17192973|NCT02415400|38346296|FG003|Overall Study|Poor treatment monitoring|0|||
17192974|NCT02415400|38346293|FG000|Overall Study|Participant in jail|0|||
17192975|NCT02415400|38346294|FG001|Overall Study|Participant in jail|0|||
17192976|NCT02415400|38346295|FG002|Overall Study|Participant in jail|1|||
17192977|NCT02415400|38346296|FG003|Overall Study|Participant in jail|0|||
17192978|NCT02415400|38346293|FG000|Overall Study|Investigator decision|0|||
16786288|NCT01999972|37726702|FG002|Dose Expansion Part|Adverse Event|0|||
17008381|NCT00924443|38152737|FG000|Overall Study|Protocol Violation|1|||
17008382|NCT03693300|38152743|FG000|Overall Study|Patients ongoing study|43|||
17008383|NCT03693300|38152744|FG001|Overall Study|Patients ongoing study|1|||
17008384|NCT00924287|38152752|FG000|Overall Study|Death|1|||
17008385|NCT00923975|38152756|FG000|Overall Study|Did not meet inclusion criteria|1|||
17008386|NCT00918203|38152792|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
17008387|NCT00918203|38152793|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
17008388|NCT00918203|38152794|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
17192979|NCT02415400|38346294|FG001|Overall Study|Investigator decision|0|||
17192980|NCT02415400|38346295|FG002|Overall Study|Investigator decision|1|||
17008389|NCT00918203|38152792|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
17008390|NCT00918203|38152793|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
17008391|NCT00918203|38152794|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
17008392|NCT00918203|38152792|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
17008393|NCT00918203|38152793|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
17008394|NCT00918203|38152794|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
17008395|NCT00918203|38152792|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
17008396|NCT00918203|38152793|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
17008397|NCT00918203|38152794|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
17008398|NCT00918281|38152806|FG000|Overall Study|Physician Decision|29|||
17008399|NCT02770716|38152815|FG000|Overall Study|Death|101|||
17008400|NCT02770716|38152816|FG001|Overall Study|Death|45|||
17008401|NCT02770716|38152815|FG000|Overall Study|Withdrawal by Subject|4|||
17008402|NCT02770716|38152816|FG001|Overall Study|Withdrawal by Subject|2|||
17008403|NCT02770716|38152815|FG000|Overall Study|Lost to Follow-up|1|||
17008404|NCT02770716|38152816|FG001|Overall Study|Lost to Follow-up|0|||
17008405|NCT02770716|38152815|FG000|Overall Study|Various reasons|6|||
17008406|NCT02770716|38152816|FG001|Overall Study|Various reasons|2|||
17008407|NCT00917579|38152822|FG000|Washout >= 2 Weeks|Adverse Event|1|||
17008408|NCT00917579|38152823|FG001|Washout >= 2 Weeks|Adverse Event|0|||
17008409|NCT00917579|38152822|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
17008410|NCT00917579|38152823|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
17008411|NCT00915551|38152831|FG000|Overall Study|Withdrawal by Subject|0|||
17008412|NCT00915551|38152832|FG001|Overall Study|Withdrawal by Subject|1|||
17008413|NCT00915473|38152840|FG000|Screening|Withdrawal by Subject|1|||
17008414|NCT00915473|38152841|FG001|Screening|Withdrawal by Subject|0|||
17008415|NCT00915473|38152840|FG000|4-week Follow Up|Lost to Follow-up|1|||
17008416|NCT00915473|38152841|FG001|4-week Follow Up|Lost to Follow-up|5|||
17008417|NCT00917501|38152849|FG000|Overall Study|Lost to Follow-up|4|||
17008418|NCT00917501|38152850|FG001|Overall Study|Lost to Follow-up|1|||
17008419|NCT00917501|38152849|FG000|Overall Study|Withdrawal by Subject|3|||
17008420|NCT00917501|38152850|FG001|Overall Study|Withdrawal by Subject|1|||
17008421|NCT00917501|38152849|FG000|Overall Study|Lack of Efficacy|1|||
17008422|NCT00917501|38152850|FG001|Overall Study|Lack of Efficacy|2|||
17008423|NCT00917501|38152849|FG000|Overall Study|trouble swollowing capsules|0|||
17008424|NCT00917501|38152850|FG001|Overall Study|trouble swollowing capsules|1|||
17008425|NCT00917267|38152869|FG000|Overall Study|Adverse Event|15|||
17008426|NCT00917267|38152870|FG001|Overall Study|Adverse Event|36|||
17008427|NCT00917267|38152869|FG000|Overall Study|Physician Decision|2|||
17008428|NCT00917267|38152870|FG001|Overall Study|Physician Decision|4|||
17008429|NCT00917267|38152869|FG000|Overall Study|Protocol Violation|9|||
17008430|NCT00917267|38152870|FG001|Overall Study|Protocol Violation|18|||
17008431|NCT00917267|38152869|FG000|Overall Study|Withdrawal by Subject|5|||
17008432|NCT00917267|38152870|FG001|Overall Study|Withdrawal by Subject|12|||
17008433|NCT00917267|38152869|FG000|Overall Study|Lost to follow up|0|||
17008434|NCT00917267|38152870|FG001|Overall Study|Lost to follow up|2|||
17008435|NCT00917267|38152869|FG000|Overall Study|Entry Criteria Not Met|1|||
17008436|NCT00917267|38152870|FG001|Overall Study|Entry Criteria Not Met|0|||
17008437|NCT00917267|38152869|FG000|Overall Study|Sponsor Decision|5|||
17008438|NCT00917267|38152870|FG001|Overall Study|Sponsor Decision|5|||
17008439|NCT00917267|38152869|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
17008440|NCT00917267|38152870|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
17008441|NCT00920699|38152883|FG000|Overall Study|Withdrawal by Subject|2|||
17008442|NCT00920699|38152884|FG001|Overall Study|Withdrawal by Subject|0|||
17008443|NCT00920699|38152885|FG002|Overall Study|Withdrawal by Subject|2|||
17008444|NCT00920699|38152883|FG000|Overall Study|no longer met eligibility|0|||
17008445|NCT00920699|38152884|FG001|Overall Study|no longer met eligibility|1|||
17008446|NCT00920699|38152885|FG002|Overall Study|no longer met eligibility|0|||
17008447|NCT00920699|38152883|FG000|Overall Study|Lost to Follow-up|0|||
17008448|NCT00920699|38152884|FG001|Overall Study|Lost to Follow-up|0|||
17008449|NCT00920699|38152885|FG002|Overall Study|Lost to Follow-up|2|||
17008450|NCT00920387|38152895|FG000|Stage 1|Adverse Event|1|||
17008451|NCT00920387|38152896|FG001|Stage 1|Adverse Event|0|||
17008452|NCT00920387|38152897|FG002|Stage 1|Adverse Event|0|||
17008453|NCT03462576|38152907|FG000|Overall Study|Protocol Violation|5|||
17008454|NCT03462576|38152908|FG001|Overall Study|Protocol Violation|11|||
17008455|NCT03462576|38152909|FG002|Overall Study|Protocol Violation|7|||
17008456|NCT03462576|38152907|FG000|Overall Study|Device Malfunction|0|||
17008457|NCT03462576|38152908|FG001|Overall Study|Device Malfunction|0|||
17008458|NCT03462576|38152909|FG002|Overall Study|Device Malfunction|1|||
17008459|NCT00916721|38152919|FG000|Overall Study|Lost to Follow-up|0|||
17008460|NCT00916721|38152920|FG001|Overall Study|Lost to Follow-up|1|||
17008461|NCT00916721|38152919|FG000|Overall Study|Adverse Event|6|||
17008462|NCT00916721|38152920|FG001|Overall Study|Adverse Event|3|||
17008463|NCT00916721|38152919|FG000|Overall Study|Withdrawal by Subject|2|||
17008464|NCT00916721|38152920|FG001|Overall Study|Withdrawal by Subject|2|||
17008465|NCT00916721|38152919|FG000|Overall Study|Protocol Violation|2|||
17008466|NCT00916721|38152920|FG001|Overall Study|Protocol Violation|4|||
17008467|NCT00915005|38152928|FG000|Overall Study|Withdrawal by Subject|4|||
17008468|NCT00915005|38152929|FG001|Overall Study|Withdrawal by Subject|4|||
17008469|NCT00915005|38152928|FG000|Overall Study|Patient preferred protons therapy|6|||
17008470|NCT00915005|38152929|FG001|Overall Study|Patient preferred protons therapy|0|||
17008471|NCT00915005|38152928|FG000|Overall Study|Insurance denial|3|||
17008472|NCT00915005|38152929|FG001|Overall Study|Insurance denial|15|||
17008473|NCT01143246|38152937|FG000|Overall Study|Adverse Event|24|||
17008474|NCT01143246|38152938|FG001|Overall Study|Adverse Event|28|||
17008475|NCT01143246|38152937|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
17008476|NCT01143246|38152938|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
17008477|NCT01143246|38152937|FG000|Overall Study|Lost to Follow-up|0|||
17008478|NCT01143246|38152938|FG001|Overall Study|Lost to Follow-up|1|||
17008479|NCT01143246|38152937|FG000|Overall Study|Death|16|||
17008480|NCT01143246|38152938|FG001|Overall Study|Death|15|||
17008481|NCT01143246|38152937|FG000|Overall Study|Reason not Specified|3|||
17008482|NCT01143246|38152938|FG001|Overall Study|Reason not Specified|5|||
17008483|NCT00561925|38152952|FG000|14 Day Lead-In Period|Adverse Event|38|||
17008484|NCT00561925|38152953|FG001|14 Day Lead-In Period|Adverse Event|0|||
17008485|NCT00561925|38152954|FG002|14 Day Lead-In Period|Adverse Event|0|||
17008486|NCT00561925|38152955|FG003|14 Day Lead-In Period|Adverse Event|0|||
17008487|NCT00561925|38152956|FG004|14 Day Lead-In Period|Adverse Event|0|||
17008488|NCT00561925|38152952|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
17008489|NCT00561925|38152953|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
17008490|NCT00561925|38152954|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
17008491|NCT00561925|38152955|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
17008492|NCT00561925|38152956|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
17008493|NCT00561925|38152952|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
17008494|NCT00561925|38152953|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
17008495|NCT00561925|38152954|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
17008496|NCT00561925|38152955|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
17008497|NCT00561925|38152956|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
17008498|NCT00561925|38152952|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
17008499|NCT00561925|38152953|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
17008500|NCT00561925|38152954|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
17008501|NCT00561925|38152955|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
17008502|NCT00561925|38152956|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
17008503|NCT00561925|38152952|FG000|14 Day Lead-In Period|Other|5|||
16908388|NCT01780506|38017042|FG000|Double-Blind Phase|Randomized but not Treated|3|||
16908389|NCT01780506|38017043|FG001|Double-Blind Phase|Randomized but not Treated|2|||
16908390|NCT01780506|38017042|FG000|Double-Blind Phase|Adverse Event|4|||
16908391|NCT01780506|38017043|FG001|Double-Blind Phase|Adverse Event|14|||
16908392|NCT01780506|38017042|FG000|Double-Blind Phase|Death|1|||
16908393|NCT01780506|38017043|FG001|Double-Blind Phase|Death|2|||
16908394|NCT01780506|38017042|FG000|Double-Blind Phase|Pregnancy|2|||
16908395|NCT01780506|38017043|FG001|Double-Blind Phase|Pregnancy|1|||
16908396|NCT01780506|38017042|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16908397|NCT01780506|38017043|FG001|Double-Blind Phase|Lack of Efficacy|1|||
16908398|NCT01780506|38017042|FG000|Double-Blind Phase|Investigator's Discretion|5|||
16908399|NCT01780506|38017043|FG001|Double-Blind Phase|Investigator's Discretion|2|||
16908400|NCT01780506|38017042|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
16908401|NCT01780506|38017043|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
16908402|NCT01780506|38017042|FG000|Double-Blind Phase|Protocol Violation|4|||
16908403|NCT01780506|38017043|FG001|Double-Blind Phase|Protocol Violation|3|||
16908404|NCT01780506|38017042|FG000|Double-Blind Phase|Withdrew Consent|23|||
16908405|NCT01780506|38017043|FG001|Double-Blind Phase|Withdrew Consent|24|||
16908406|NCT01780506|38017042|FG000|Double-Blind Phase|Lost to Follow-up|23|||
16908407|NCT01780506|38017043|FG001|Double-Blind Phase|Lost to Follow-up|26|||
16908408|NCT01780506|38017042|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
16908409|NCT01780506|38017043|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
16908410|NCT01779648|38017053|FG000|Overall Study|Protocol Violation|1|||
16908411|NCT01779648|38017054|FG001|Overall Study|Protocol Violation|0|||
16908412|NCT01762800|38017062|FG000|Overall Study|Adverse Event|8|||
16908413|NCT01762800|38017063|FG001|Overall Study|Adverse Event|13|||
16908414|NCT01762800|38017062|FG000|Overall Study|Lack of Efficacy|3|||
16908415|NCT01762800|38017063|FG001|Overall Study|Lack of Efficacy|2|||
16908416|NCT01762800|38017062|FG000|Overall Study|Study Closed/Terminated|0|||
16908417|NCT01762800|38017063|FG001|Overall Study|Study Closed/Terminated|1|||
16908418|NCT01762800|38017062|FG000|Overall Study|Physician Decision|1|||
16908419|NCT01762800|38017063|FG001|Overall Study|Physician Decision|1|||
16908420|NCT01762800|38017062|FG000|Overall Study|Withdrawal by Subject|7|||
16908421|NCT01762800|38017063|FG001|Overall Study|Withdrawal by Subject|4|||
16908422|NCT01597596|38017077|FG000|Overall Study|Study terminated by sponsor|1|||
16908423|NCT01597596|38017078|FG001|Overall Study|Study terminated by sponsor|0|||
16908424|NCT01597596|38017077|FG000|Overall Study|Physician Decision|0|||
16908425|NCT01597596|38017078|FG001|Overall Study|Physician Decision|1|||
16908426|NCT01778556|38017086|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
16908427|NCT01778556|38017087|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
16908428|NCT01778556|38017086|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
16908429|NCT01778556|38017087|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
16908430|NCT01778556|38017086|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
16908431|NCT01778556|38017087|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
16908432|NCT01778556|38017086|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
16908433|NCT01778556|38017087|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
16786289|NCT01999972|37726703|FG003|Dose Expansion Part|Adverse Event|0|||
17008504|NCT00561925|38152953|FG001|14 Day Lead-In Period|Other|0|||
17008505|NCT00561925|38152954|FG002|14 Day Lead-In Period|Other|0|||
17008506|NCT00561925|38152955|FG003|14 Day Lead-In Period|Other|0|||
17008507|NCT00561925|38152956|FG004|14 Day Lead-In Period|Other|0|||
17008508|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
17008509|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
17008510|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
17008511|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
17008512|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
17008513|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
17008514|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
17008515|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
17008516|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
17008517|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
17008518|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
17008519|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
17008520|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
17008521|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
17008522|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
17008523|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
17008524|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
17008525|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
17008526|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
17008527|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
17008528|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
17008529|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
17008530|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
17008531|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
17008532|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
17008533|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
17008534|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
17008535|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
17008536|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
17008537|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
17008538|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Death|0|||
17008539|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Death|6|||
17008540|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Death|3|||
17008541|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Death|0|||
17008542|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Death|0|||
17008543|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
17008544|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
17008545|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
17008546|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
17008547|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
17008548|NCT00561925|38152952|FG000|144-week Double-blind, Double-dummy|Other|0|||
17008549|NCT00561925|38152953|FG001|144-week Double-blind, Double-dummy|Other|8|||
17008550|NCT00561925|38152954|FG002|144-week Double-blind, Double-dummy|Other|11|||
17008551|NCT00561925|38152955|FG003|144-week Double-blind, Double-dummy|Other|0|||
17008552|NCT00561925|38152956|FG004|144-week Double-blind, Double-dummy|Other|0|||
17008553|NCT00561925|38152952|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
17008554|NCT00561925|38152953|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
17008555|NCT00561925|38152954|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
17008556|NCT00561925|38152955|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
17008557|NCT00561925|38152956|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
17008558|NCT00549445|38152976|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
17008559|NCT00549445|38152977|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
17008560|NCT00601107|38152987|FG000|Overall Study|Adverse Event|0|||
16786290|NCT01999972|37726704|FG004|Dose Expansion Part|Adverse Event|4|||
16908434|NCT01761162|38017096|FG000|Overall Study|Withdrawal by Subject|3|||
17008561|NCT00601107|38152988|FG001|Overall Study|Adverse Event|1|||
17008562|NCT00601107|38152989|FG002|Overall Study|Adverse Event|3|||
17008563|NCT00601107|38152990|FG003|Overall Study|Adverse Event|0|||
17008564|NCT00601107|38152987|FG000|Overall Study|Withdrawal by Subject|5|||
17008565|NCT00601107|38152988|FG001|Overall Study|Withdrawal by Subject|4|||
17008566|NCT00601107|38152989|FG002|Overall Study|Withdrawal by Subject|7|||
17008567|NCT00601107|38152990|FG003|Overall Study|Withdrawal by Subject|4|||
17008568|NCT00601107|38152987|FG000|Overall Study|Lost to Follow-up|3|||
17008569|NCT00601107|38152988|FG001|Overall Study|Lost to Follow-up|3|||
17008570|NCT00601107|38152989|FG002|Overall Study|Lost to Follow-up|0|||
17008571|NCT00601107|38152990|FG003|Overall Study|Lost to Follow-up|3|||
17008572|NCT00601107|38152987|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
17008573|NCT00601107|38152988|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
17008574|NCT00601107|38152989|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
17008575|NCT00601107|38152990|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
17008576|NCT00601107|38152987|FG000|Overall Study|Worsening of Psoriasis|4|||
17008577|NCT00601107|38152988|FG001|Overall Study|Worsening of Psoriasis|1|||
17008578|NCT00601107|38152989|FG002|Overall Study|Worsening of Psoriasis|1|||
17008579|NCT00601107|38152990|FG003|Overall Study|Worsening of Psoriasis|4|||
17008580|NCT00601107|38152987|FG000|Overall Study|Undefined|1|||
17008581|NCT00601107|38152988|FG001|Overall Study|Undefined|0|||
17008582|NCT00601107|38152989|FG002|Overall Study|Undefined|1|||
17008583|NCT00601107|38152990|FG003|Overall Study|Undefined|0|||
17008584|NCT00914927|38153016|FG000|Overall Study|Adverse Event|0|||
17008585|NCT00914927|38153017|FG001|Overall Study|Adverse Event|0|||
17008586|NCT00914927|38153018|FG002|Overall Study|Adverse Event|0|||
17008587|NCT00914927|38153019|FG003|Overall Study|Adverse Event|0|||
17008588|NCT00914927|38153020|FG004|Overall Study|Adverse Event|1|||
17008589|NCT00914927|38153021|FG005|Overall Study|Adverse Event|0|||
17008590|NCT00914927|38153022|FG006|Overall Study|Adverse Event|0|||
17008591|NCT00914927|38153016|FG000|Overall Study|Withdrawal by Subject|0|||
17008592|NCT00914927|38153017|FG001|Overall Study|Withdrawal by Subject|1|||
17008593|NCT00914927|38153018|FG002|Overall Study|Withdrawal by Subject|0|||
17008594|NCT00914927|38153019|FG003|Overall Study|Withdrawal by Subject|1|||
17008595|NCT00914927|38153020|FG004|Overall Study|Withdrawal by Subject|0|||
17008596|NCT00914927|38153021|FG005|Overall Study|Withdrawal by Subject|0|||
17008597|NCT00914927|38153022|FG006|Overall Study|Withdrawal by Subject|0|||
17008598|NCT00914927|38153016|FG000|Overall Study|Lost to Follow-up|0|||
17008599|NCT00914927|38153017|FG001|Overall Study|Lost to Follow-up|0|||
17008600|NCT00914927|38153018|FG002|Overall Study|Lost to Follow-up|0|||
17008601|NCT00914927|38153019|FG003|Overall Study|Lost to Follow-up|1|||
17008602|NCT00914927|38153020|FG004|Overall Study|Lost to Follow-up|0|||
17008603|NCT00914927|38153021|FG005|Overall Study|Lost to Follow-up|0|||
17008604|NCT00914927|38153022|FG006|Overall Study|Lost to Follow-up|0|||
17008605|NCT00914927|38153016|FG000|Overall Study|Administrative/Other|2|||
17008606|NCT00914927|38153017|FG001|Overall Study|Administrative/Other|1|||
17008607|NCT00914927|38153018|FG002|Overall Study|Administrative/Other|0|||
17008608|NCT00914927|38153019|FG003|Overall Study|Administrative/Other|0|||
17008609|NCT00914927|38153020|FG004|Overall Study|Administrative/Other|1|||
17008610|NCT00914927|38153021|FG005|Overall Study|Administrative/Other|0|||
17008611|NCT00914927|38153022|FG006|Overall Study|Administrative/Other|0|||
17008612|NCT00914849|38153049|FG000|Overall Study|Withdrawal by Subject|1|||
16908435|NCT01778010|38017100|FG000|Overall Study|Withdrawal by Subject|2|||
16908436|NCT01778010|38017100|FG000|Overall Study|abnormal ECG before meds|1|||
16908437|NCT01778010|38017100|FG000|Overall Study|Arrested|1|||
16908438|NCT01778010|38017100|FG000|Overall Study|rash while on placebo|1|||
16908439|NCT01777932|38017117|FG000|Overall Study|Disease progression|136|||
16908440|NCT01777932|38017117|FG000|Overall Study|Death|3|||
16908441|NCT01777932|38017117|FG000|Overall Study|Adverse Event|34|||
16908442|NCT01777932|38017117|FG000|Overall Study|Lost to Follow-up|3|||
16908443|NCT01777932|38017117|FG000|Overall Study|Investigator decision|10|||
16908444|NCT01777932|38017117|FG000|Overall Study|Reimbursement limit|9|||
16908445|NCT01777932|38017117|FG000|Overall Study|Patient refused further treatment|10|||
16908446|NCT01777854|38017121|FG000|Overall Study|Physician Decision|3|||
16908447|NCT01777854|38017122|FG001|Overall Study|Physician Decision|3|||
16908448|NCT01777776|38017130|FG000|Overall Study|Adverse Event|2|||
16908449|NCT01777776|38017131|FG001|Overall Study|Adverse Event|4|||
16908450|NCT01777776|38017132|FG002|Overall Study|Adverse Event|0|||
16908451|NCT01777776|38017133|FG003|Overall Study|Adverse Event|0|||
16908452|NCT01777776|38017130|FG000|Overall Study|Disease Progression|4|||
16908453|NCT01777776|38017131|FG001|Overall Study|Disease Progression|8|||
16908454|NCT01777776|38017132|FG002|Overall Study|Disease Progression|6|||
16908455|NCT01777776|38017133|FG003|Overall Study|Disease Progression|3|||
16908456|NCT01777776|38017130|FG000|Overall Study|Withdrawal by Subject|0|||
16908457|NCT01777776|38017131|FG001|Overall Study|Withdrawal by Subject|0|||
16908458|NCT01777776|38017132|FG002|Overall Study|Withdrawal by Subject|0|||
16908459|NCT01777776|38017133|FG003|Overall Study|Withdrawal by Subject|1|||
16908460|NCT01777620|38017154|FG000|Overall Study|Subject Withdrawal|1|||
17008613|NCT00914849|38153050|FG001|Overall Study|Withdrawal by Subject|0|||
17008614|NCT00914849|38153049|FG000|Overall Study|Not eligible|0|||
17008615|NCT00914849|38153050|FG001|Overall Study|Not eligible|1|||
17008616|NCT00912743|38153058|FG000|Overall Study|Adverse Event|3|||
17008617|NCT00912743|38153059|FG001|Overall Study|Adverse Event|1|||
17008618|NCT00912743|38153058|FG000|Overall Study|Lack of Efficacy|9|||
17008619|NCT00912743|38153059|FG001|Overall Study|Lack of Efficacy|18|||
17008620|NCT00912743|38153058|FG000|Overall Study|Toxicity|0|||
17008621|NCT00912743|38153059|FG001|Overall Study|Toxicity|1|||
17008622|NCT00912743|38153058|FG000|Overall Study|End of treatment form was not collected|1|||
17008623|NCT00912743|38153059|FG001|Overall Study|End of treatment form was not collected|0|||
17008624|NCT00914459|38153067|FG000|Overall Study|Protocol Violation|0|||
17008625|NCT00914459|38153068|FG001|Overall Study|Protocol Violation|1|||
17008626|NCT00914459|38153067|FG000|Overall Study|Parent/Legal guardian request|1|||
17008627|NCT00914459|38153068|FG001|Overall Study|Parent/Legal guardian request|0|||
17008628|NCT00912509|38153078|FG000|Overall Study|Lost to Follow-up|1|||
17008629|NCT00912509|38153079|FG001|Overall Study|Lost to Follow-up|0|||
17008630|NCT00912509|38153078|FG000|Overall Study|Lack of Efficacy|4|||
17008631|NCT00912509|38153079|FG001|Overall Study|Lack of Efficacy|3|||
17008632|NCT00913835|38153099|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
17008633|NCT00913835|38153100|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
17008634|NCT00913835|38153099|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
17008635|NCT00913835|38153100|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
17008636|NCT00913835|38153099|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
17008637|NCT00913835|38153100|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
17008638|NCT00913835|38153099|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
17008639|NCT00913835|38153100|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
17008640|NCT00913835|38153099|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
17008641|NCT00913835|38153100|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
17008642|NCT00913523|38153125|FG000|Overall Study|Withdrawal by Subject|3|||
17008643|NCT00913523|38153126|FG001|Overall Study|Withdrawal by Subject|2|||
17008644|NCT00913523|38153127|FG002|Overall Study|Withdrawal by Subject|2|||
17008645|NCT00913523|38153125|FG000|Overall Study|Lost to Follow-up|1|||
17008646|NCT00913523|38153126|FG001|Overall Study|Lost to Follow-up|1|||
17008647|NCT00913523|38153127|FG002|Overall Study|Lost to Follow-up|1|||
17008648|NCT00913523|38153125|FG000|Overall Study|Adverse Event|1|||
17008649|NCT00913523|38153126|FG001|Overall Study|Adverse Event|0|||
17008650|NCT00913523|38153127|FG002|Overall Study|Adverse Event|0|||
17008651|NCT00913523|38153125|FG000|Overall Study|Protocol Violation|5|||
17008652|NCT00913523|38153126|FG001|Overall Study|Protocol Violation|8|||
17008653|NCT00913523|38153127|FG002|Overall Study|Protocol Violation|8|||
17008654|NCT00913523|38153125|FG000|Overall Study|Pregnancy|1|||
17008655|NCT00913523|38153126|FG001|Overall Study|Pregnancy|3|||
17008656|NCT00913523|38153127|FG002|Overall Study|Pregnancy|0|||
17008657|NCT00913523|38153125|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
17008658|NCT00913523|38153126|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
17008659|NCT00913523|38153127|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
17008660|NCT00912197|38153137|FG000|Overall Study|Withdrawal by Subject|3|||
17008661|NCT00912197|38153138|FG001|Overall Study|Withdrawal by Subject|3|||
17008662|NCT00910247|38153146|FG000|Overall Study|Adverse Event|15|||
17008663|NCT00910247|38153146|FG000|Overall Study|Death|2|||
17008664|NCT00910247|38153146|FG000|Overall Study|Lost to Follow-up|10|||
17008665|NCT00910247|38153146|FG000|Overall Study|Physician Decision|3|||
17008666|NCT00910247|38153146|FG000|Overall Study|Protocol Violation|10|||
17008667|NCT00910247|38153146|FG000|Overall Study|Withdrawal by Subject|25|||
17008668|NCT00910247|38153146|FG000|Overall Study|Not collected|4|||
17008669|NCT00659334|38153157|FG000|Overall Study|Screen Failure|8|||
17008670|NCT00659334|38153158|FG001|Overall Study|Screen Failure|5|||
17008671|NCT00659334|38153159|FG002|Overall Study|Screen Failure|0|||
17008672|NCT00659334|38153160|FG003|Overall Study|Screen Failure|0|||
17008673|NCT00659334|38153161|FG004|Overall Study|Screen Failure|0|||
17008674|NCT00659334|38153162|FG005|Overall Study|Screen Failure|0|||
17008675|NCT00659334|38153163|FG006|Overall Study|Screen Failure|1|||
17008676|NCT00910091|38153185|FG000|Pre-assignment|Withdrawal by Subject|0|||
17008677|NCT00910091|38153186|FG001|Pre-assignment|Withdrawal by Subject|2|||
17008678|NCT00910091|38153185|FG000|Treatment and Survival|Withdrawal by Subject|3|||
17008679|NCT00910091|38153186|FG001|Treatment and Survival|Withdrawal by Subject|4|||
17008680|NCT00910091|38153185|FG000|Treatment and Survival|Adverse Event|1|||
17008681|NCT00910091|38153186|FG001|Treatment and Survival|Adverse Event|0|||
17008682|NCT00909857|38153195|FG000|Overall Study|Withdrawal by Subject|6|||
17008683|NCT00909857|38153196|FG001|Overall Study|Withdrawal by Subject|10|||
17008684|NCT00909857|38153195|FG000|Overall Study|Adverse Event|5|||
17008685|NCT00909857|38153196|FG001|Overall Study|Adverse Event|5|||
17008686|NCT00909857|38153195|FG000|Overall Study|Lost to Follow-up|2|||
17008687|NCT00909857|38153196|FG001|Overall Study|Lost to Follow-up|5|||
17008688|NCT00909857|38153195|FG000|Overall Study|Protocol Violation|2|||
17008689|NCT00909857|38153196|FG001|Overall Study|Protocol Violation|1|||
17008690|NCT00909857|38153195|FG000|Overall Study|Pregnancy|1|||
17008691|NCT00909857|38153196|FG001|Overall Study|Pregnancy|0|||
17008692|NCT00909857|38153195|FG000|Overall Study|Other|1|||
17008693|NCT00909857|38153196|FG001|Overall Study|Other|0|||
17008694|NCT00909857|38153195|FG000|Overall Study|Did not receive study medication|19|||
17008695|NCT00909857|38153196|FG001|Overall Study|Did not receive study medication|24|||
17008696|NCT00911807|38153205|FG000|Overall Study|Adverse Event|2|||
17008697|NCT00911807|38153206|FG001|Overall Study|Adverse Event|1|||
17008698|NCT00911807|38153207|FG002|Overall Study|Adverse Event|5|||
17008699|NCT00911807|38153205|FG000|Overall Study|Death|0|||
17008700|NCT00911807|38153206|FG001|Overall Study|Death|0|||
17008701|NCT00911807|38153207|FG002|Overall Study|Death|1|||
17008702|NCT00911807|38153205|FG000|Overall Study|Protocol Violation|6|||
17008703|NCT00911807|38153206|FG001|Overall Study|Protocol Violation|4|||
17008704|NCT00911807|38153207|FG002|Overall Study|Protocol Violation|9|||
17008705|NCT00911807|38153205|FG000|Overall Study|Withdrawal by Subject|8|||
17008706|NCT00911807|38153206|FG001|Overall Study|Withdrawal by Subject|10|||
17008707|NCT00911807|38153207|FG002|Overall Study|Withdrawal by Subject|7|||
17008708|NCT00911807|38153205|FG000|Overall Study|Organizational reasons|1|||
17008709|NCT00911807|38153206|FG001|Overall Study|Organizational reasons|3|||
17008710|NCT00911807|38153207|FG002|Overall Study|Organizational reasons|1|||
17008711|NCT04287920|38153234|FG000|Overall Study|Lost to Follow-up|1|||
17008712|NCT04287920|38153235|FG001|Overall Study|Lost to Follow-up|1|||
17008713|NCT04287920|38153234|FG000|Overall Study|Withdrawal by Subject|0|||
17008714|NCT04287920|38153235|FG001|Overall Study|Withdrawal by Subject|3|||
17008715|NCT00909779|38153243|FG000|Overall Study|Adverse Event|53|||
17008716|NCT00909779|38153244|FG001|Overall Study|Adverse Event|55|||
17008717|NCT00909779|38153243|FG000|Overall Study|Lack of Efficacy|7|||
17008718|NCT00909779|38153244|FG001|Overall Study|Lack of Efficacy|4|||
17008719|NCT00909779|38153243|FG000|Overall Study|Lost to Follow-up|19|||
17008720|NCT00909779|38153244|FG001|Overall Study|Lost to Follow-up|15|||
17008721|NCT00909779|38153243|FG000|Overall Study|Physician Decision|8|||
17008722|NCT00909779|38153244|FG001|Overall Study|Physician Decision|2|||
17008723|NCT00909779|38153243|FG000|Overall Study|Protocol Violation|2|||
17008724|NCT00909779|38153244|FG001|Overall Study|Protocol Violation|5|||
17008725|NCT00909779|38153243|FG000|Overall Study|Withdrawal by Subject|116|||
17008726|NCT00909779|38153244|FG001|Overall Study|Withdrawal by Subject|80|||
17008727|NCT00909779|38153243|FG000|Overall Study|Site Ceasing Operation|2|||
17008728|NCT00909779|38153244|FG001|Overall Study|Site Ceasing Operation|2|||
17008729|NCT00909779|38153243|FG000|Overall Study|Medical Monitor Decision|1|||
17008730|NCT00909779|38153244|FG001|Overall Study|Medical Monitor Decision|0|||
17008731|NCT00909779|38153243|FG000|Overall Study|Noncompliance|1|||
17008732|NCT00909779|38153244|FG001|Overall Study|Noncompliance|1|||
17008733|NCT00909779|38153243|FG000|Overall Study|Randomized in error|1|||
17008734|NCT00909779|38153244|FG001|Overall Study|Randomized in error|1|||
17008735|NCT00910871|38153252|FG000|Overall Study|Adverse Event|5|||
17008736|NCT00910871|38153252|FG000|Overall Study|Death|12|||
17008737|NCT00910871|38153252|FG000|Overall Study|Lost to Follow-up|8|||
17008738|NCT00910871|38153252|FG000|Overall Study|Protocol Violation|11|||
17008739|NCT00910871|38153252|FG000|Overall Study|Withdrawal by Subject|12|||
17008740|NCT00910871|38153252|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
17008741|NCT00910871|38153252|FG000|Overall Study|Undefined|1|||
17008742|NCT02631941|38153277|FG000|Overall Study|Physician Decision|0|||
17008743|NCT02631941|38153278|FG001|Overall Study|Physician Decision|1|||
17008744|NCT02631941|38153279|FG002|Overall Study|Physician Decision|0|||
17008745|NCT02631941|38153280|FG003|Overall Study|Physician Decision|0|||
17008746|NCT02631941|38153281|FG004|Overall Study|Physician Decision|0|||
17008747|NCT02631941|38153282|FG005|Overall Study|Physician Decision|0|||
17008748|NCT02631941|38153283|FG006|Overall Study|Physician Decision|0|||
17008749|NCT02631941|38153284|FG007|Overall Study|Physician Decision|0|||
17008750|NCT02631941|38153285|FG008|Overall Study|Physician Decision|0|||
17008751|NCT02631941|38153286|FG009|Overall Study|Physician Decision|0|||
17008752|NCT02631941|38153277|FG000|Overall Study|Adverse Event|0|||
17008753|NCT02631941|38153278|FG001|Overall Study|Adverse Event|1|||
17008754|NCT02631941|38153279|FG002|Overall Study|Adverse Event|0|||
17008755|NCT02631941|38153280|FG003|Overall Study|Adverse Event|0|||
17008756|NCT02631941|38153281|FG004|Overall Study|Adverse Event|0|||
17008757|NCT02631941|38153282|FG005|Overall Study|Adverse Event|0|||
17008758|NCT02631941|38153283|FG006|Overall Study|Adverse Event|0|||
17008759|NCT02631941|38153284|FG007|Overall Study|Adverse Event|0|||
17008760|NCT02631941|38153285|FG008|Overall Study|Adverse Event|0|||
17192981|NCT02415400|38346296|FG003|Overall Study|Investigator decision|1|||
17008761|NCT02631941|38153286|FG009|Overall Study|Adverse Event|0|||
17008762|NCT02631941|38153277|FG000|Overall Study|Withdrawal by Subject|0|||
17008763|NCT02631941|38153278|FG001|Overall Study|Withdrawal by Subject|0|||
17008764|NCT02631941|38153279|FG002|Overall Study|Withdrawal by Subject|0|||
17008765|NCT02631941|38153280|FG003|Overall Study|Withdrawal by Subject|0|||
17008766|NCT02631941|38153281|FG004|Overall Study|Withdrawal by Subject|1|||
17008767|NCT02631941|38153282|FG005|Overall Study|Withdrawal by Subject|0|||
17008768|NCT02631941|38153283|FG006|Overall Study|Withdrawal by Subject|0|||
17008769|NCT02631941|38153284|FG007|Overall Study|Withdrawal by Subject|1|||
17008770|NCT02631941|38153285|FG008|Overall Study|Withdrawal by Subject|0|||
17008771|NCT02631941|38153286|FG009|Overall Study|Withdrawal by Subject|0|||
17008772|NCT02631941|38153277|FG000|Overall Study|Lost to Follow-up|0|||
17008773|NCT02631941|38153278|FG001|Overall Study|Lost to Follow-up|0|||
17008774|NCT02631941|38153279|FG002|Overall Study|Lost to Follow-up|0|||
17008775|NCT02631941|38153280|FG003|Overall Study|Lost to Follow-up|0|||
17008776|NCT02631941|38153281|FG004|Overall Study|Lost to Follow-up|0|||
17008777|NCT02631941|38153282|FG005|Overall Study|Lost to Follow-up|0|||
17008778|NCT02631941|38153283|FG006|Overall Study|Lost to Follow-up|0|||
17008779|NCT02631941|38153284|FG007|Overall Study|Lost to Follow-up|0|||
17008780|NCT02631941|38153285|FG008|Overall Study|Lost to Follow-up|1|||
17008781|NCT02631941|38153286|FG009|Overall Study|Lost to Follow-up|0|||
17008782|NCT00908375|38153298|FG000|Overall Study|Withdrawal by Subject|2|||
17008783|NCT00908375|38153299|FG001|Overall Study|Withdrawal by Subject|4|||
17008784|NCT00908375|38153298|FG000|Overall Study|Lost to Follow-up|8|||
17096373|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
17096374|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
17096375|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
17192982|NCT02415400|38346293|FG000|Overall Study|Site closure; participant won't transfer|0|||
17192983|NCT02415400|38346294|FG001|Overall Study|Site closure; participant won't transfer|0|||
17192984|NCT02415400|38346295|FG002|Overall Study|Site closure; participant won't transfer|0|||
17192985|NCT02415400|38346296|FG003|Overall Study|Site closure; participant won't transfer|1|||
17192986|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
17192987|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
17192988|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
17192989|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
17192990|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
17192991|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
17192992|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
17192993|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
17192994|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
17192995|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
17192996|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
17192997|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
17192998|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
17192999|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
17193000|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
17193001|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
17193002|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
17193003|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
17193004|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
17193005|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
17193006|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
17193007|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
17193008|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
17193009|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
17193010|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
17193011|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
17193012|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
17193013|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
17193014|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
17193015|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
17193016|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
17193017|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
17008785|NCT00908375|38153299|FG001|Overall Study|Lost to Follow-up|6|||
17008786|NCT00909389|38153305|FG000|Overall Study|Adverse Event|6|||
17096376|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
17096377|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
17096378|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
17096379|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
17096380|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
17096381|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
17008787|NCT00909389|38153305|FG000|Overall Study|Death|4|||
17008788|NCT00909389|38153305|FG000|Overall Study|Poor Compliance|16|||
17008789|NCT00909389|38153305|FG000|Overall Study|Lost to Follow-up|4|||
17008790|NCT00909389|38153305|FG000|Overall Study|No Information|103|||
17008791|NCT00910715|38153312|FG000|Overall Study|Lost to Follow-up|22|||
17008792|NCT00910715|38153313|FG001|Overall Study|Lost to Follow-up|26|||
17008793|NCT00910715|38153314|FG002|Overall Study|Lost to Follow-up|0|||
17008794|NCT00600483|38153403|FG000|Overall Study|Lost to Follow-up|26|||
17008795|NCT00600483|38153404|FG001|Overall Study|Lost to Follow-up|47|||
17008796|NCT00600483|38153403|FG000|Overall Study|Randomized but not treated|10|||
17008797|NCT00600483|38153404|FG001|Overall Study|Randomized but not treated|0|||
17008798|NCT00600171|38153416|FG000|Overall Study|Adverse Event|0|||
17008799|NCT00600171|38153417|FG001|Overall Study|Adverse Event|1|||
17008800|NCT00600171|38153418|FG002|Overall Study|Adverse Event|0|||
17008801|NCT00600171|38153419|FG003|Overall Study|Adverse Event|0|||
17008802|NCT00600171|38153420|FG004|Overall Study|Adverse Event|1|||
17008803|NCT00600171|38153421|FG005|Overall Study|Adverse Event|0|||
17008804|NCT00600171|38153416|FG000|Overall Study|Lack of Efficacy|9|||
17008805|NCT00600171|38153417|FG001|Overall Study|Lack of Efficacy|12|||
17008806|NCT00600171|38153418|FG002|Overall Study|Lack of Efficacy|3|||
17008807|NCT00600171|38153419|FG003|Overall Study|Lack of Efficacy|5|||
17008808|NCT00600171|38153420|FG004|Overall Study|Lack of Efficacy|4|||
17008809|NCT00600171|38153421|FG005|Overall Study|Lack of Efficacy|0|||
17008810|NCT00600171|38153416|FG000|Overall Study|Protocol Violation|1|||
17008811|NCT00600171|38153417|FG001|Overall Study|Protocol Violation|2|||
17008812|NCT00600171|38153418|FG002|Overall Study|Protocol Violation|0|||
17008813|NCT00600171|38153419|FG003|Overall Study|Protocol Violation|1|||
17008814|NCT00600171|38153420|FG004|Overall Study|Protocol Violation|0|||
17008815|NCT00600171|38153421|FG005|Overall Study|Protocol Violation|0|||
17008816|NCT00600171|38153416|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
17008817|NCT00600171|38153417|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
17008818|NCT00600171|38153418|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
17008819|NCT00600171|38153419|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
17008820|NCT00600171|38153420|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
17008821|NCT00600171|38153421|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
17008822|NCT00600171|38153416|FG000|Overall Study|Withdrawal by Subject|3|||
17008823|NCT00600171|38153417|FG001|Overall Study|Withdrawal by Subject|0|||
17008824|NCT00600171|38153418|FG002|Overall Study|Withdrawal by Subject|0|||
17008825|NCT00600171|38153419|FG003|Overall Study|Withdrawal by Subject|1|||
17008826|NCT00600171|38153420|FG004|Overall Study|Withdrawal by Subject|1|||
17008827|NCT00600171|38153421|FG005|Overall Study|Withdrawal by Subject|1|||
17008828|NCT00600171|38153416|FG000|Overall Study|Physician Decision|0|||
17008829|NCT00600171|38153417|FG001|Overall Study|Physician Decision|1|||
17008830|NCT00600171|38153418|FG002|Overall Study|Physician Decision|0|||
17008831|NCT00600171|38153419|FG003|Overall Study|Physician Decision|1|||
17008832|NCT00600171|38153420|FG004|Overall Study|Physician Decision|0|||
17008833|NCT00600171|38153421|FG005|Overall Study|Physician Decision|2|||
17008834|NCT00600171|38153416|FG000|Overall Study|Lost to Follow-up|0|||
17008835|NCT00600171|38153417|FG001|Overall Study|Lost to Follow-up|0|||
17008836|NCT00600171|38153418|FG002|Overall Study|Lost to Follow-up|0|||
17008837|NCT00600171|38153419|FG003|Overall Study|Lost to Follow-up|1|||
17008838|NCT00600171|38153420|FG004|Overall Study|Lost to Follow-up|0|||
17008839|NCT00600171|38153421|FG005|Overall Study|Lost to Follow-up|0|||
17008840|NCT04035668|38153440|FG000|Overall Study|Adverse Event|3|||
17008841|NCT04035668|38153441|FG001|Overall Study|Adverse Event|4|||
17008842|NCT04035668|38153442|FG002|Overall Study|Adverse Event|2|||
17096382|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
17096383|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
17096384|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
17096385|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
17096386|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
17096387|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
17096388|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
17096389|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
17096390|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
17096391|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
17193018|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
17193019|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
17193020|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
17193021|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
17008843|NCT04035668|38153440|FG000|Overall Study|Lost to Follow-up|0|||
17008844|NCT04035668|38153441|FG001|Overall Study|Lost to Follow-up|1|||
17008845|NCT04035668|38153442|FG002|Overall Study|Lost to Follow-up|0|||
17008846|NCT04035668|38153440|FG000|Overall Study|Physician Decision|2|||
17008847|NCT04035668|38153441|FG001|Overall Study|Physician Decision|1|||
17008848|NCT04035668|38153442|FG002|Overall Study|Physician Decision|1|||
17008849|NCT04035668|38153440|FG000|Overall Study|Subject Decision|2|||
17008850|NCT04035668|38153441|FG001|Overall Study|Subject Decision|2|||
17008851|NCT04035668|38153442|FG002|Overall Study|Subject Decision|0|||
17008852|NCT00602667|38153463|FG000|Overall Study|Still on Therapy|0|||
17008853|NCT00602667|38153464|FG001|Overall Study|Still on Therapy|2|||
17008854|NCT00602667|38153465|FG002|Overall Study|Still on Therapy|2|||
17008855|NCT00602667|38153463|FG000|Overall Study|Death|0|||
17008856|NCT00602667|38153464|FG001|Overall Study|Death|1|||
17008857|NCT00602667|38153465|FG002|Overall Study|Death|1|||
17008858|NCT00602667|38153463|FG000|Overall Study|Family request|3|||
17008859|NCT00602667|38153464|FG001|Overall Study|Family request|25|||
17008860|NCT00602667|38153465|FG002|Overall Study|Family request|6|||
17008861|NCT00602667|38153463|FG000|Overall Study|Excessive toxicity|1|||
17008862|NCT00602667|38153464|FG001|Overall Study|Excessive toxicity|1|||
17008863|NCT00602667|38153465|FG002|Overall Study|Excessive toxicity|0|||
17008864|NCT00602667|38153463|FG000|Overall Study|Second malignancy|0|||
17008865|NCT00602667|38153464|FG001|Overall Study|Second malignancy|1|||
17008866|NCT00602667|38153465|FG002|Overall Study|Second malignancy|0|||
17008867|NCT00602667|38153463|FG000|Overall Study|Physician Decision|2|||
17008868|NCT00602667|38153464|FG001|Overall Study|Physician Decision|3|||
17008869|NCT00602667|38153465|FG002|Overall Study|Physician Decision|8|||
17008870|NCT00602667|38153463|FG000|Overall Study|Progressive disease|13|||
17008871|NCT00602667|38153464|FG001|Overall Study|Progressive disease|48|||
17008872|NCT00602667|38153465|FG002|Overall Study|Progressive disease|45|||
17008873|NCT00602667|38153463|FG000|Overall Study|Progressive disease prior to therapy|0|||
17008874|NCT00602667|38153464|FG001|Overall Study|Progressive disease prior to therapy|0|||
17008875|NCT00602667|38153465|FG002|Overall Study|Progressive disease prior to therapy|1|||
17008876|NCT00885495|38153504|FG000|Overall Study|Adverse Event|1|||
17008877|NCT00885495|38153505|FG001|Overall Study|Adverse Event|2|||
16786291|NCT01999972|37726705|FG005|Dose Expansion Part|Adverse Event|2|||
17008878|NCT00885495|38153504|FG000|Overall Study|Protocol Violation|0|||
17008879|NCT00885495|38153505|FG001|Overall Study|Protocol Violation|1|||
17096392|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
17096393|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
17096394|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
17096395|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
17008880|NCT00885495|38153504|FG000|Overall Study|Withdrawal by Subject|1|||
17008881|NCT00885495|38153505|FG001|Overall Study|Withdrawal by Subject|0|||
17008882|NCT00885105|38153518|FG000|Overall Study|Withdrawal by Subject|0|||
17008883|NCT00885105|38153519|FG001|Overall Study|Withdrawal by Subject|8|||
17008884|NCT00885105|38153518|FG000|Overall Study|Adverse Event|1|||
17008885|NCT00885105|38153519|FG001|Overall Study|Adverse Event|0|||
17008886|NCT00885105|38153518|FG000|Overall Study|Protocol Violation|0|||
17008887|NCT00885105|38153519|FG001|Overall Study|Protocol Violation|2|||
17008888|NCT03945188|38153527|FG000|Overall Study|Protocol Violation|1|||
17008889|NCT03945188|38153528|FG001|Overall Study|Protocol Violation|0|||
17008890|NCT03945188|38153527|FG000|Overall Study|Disease worsening|79|||
17008891|NCT03945188|38153528|FG001|Overall Study|Disease worsening|73|||
17008892|NCT03945188|38153527|FG000|Overall Study|Physician Decision|2|||
17008893|NCT03945188|38153528|FG001|Overall Study|Physician Decision|2|||
17008894|NCT03945188|38153527|FG000|Overall Study|Lack of Efficacy|7|||
17008895|NCT03945188|38153528|FG001|Overall Study|Lack of Efficacy|4|||
17008896|NCT03945188|38153527|FG000|Overall Study|Pregnancy|2|||
17008897|NCT03945188|38153528|FG001|Overall Study|Pregnancy|0|||
17008898|NCT03945188|38153527|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
17008899|NCT03945188|38153528|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
17008900|NCT03945188|38153527|FG000|Overall Study|Adverse Event|10|||
17008901|NCT03945188|38153528|FG001|Overall Study|Adverse Event|5|||
17008902|NCT03945188|38153527|FG000|Overall Study|Other|2|||
17008903|NCT03945188|38153528|FG001|Overall Study|Other|2|||
17008904|NCT03945188|38153527|FG000|Overall Study|Lost to Follow-up|1|||
17008905|NCT03945188|38153528|FG001|Overall Study|Lost to Follow-up|2|||
17008906|NCT00884949|38153534|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
17008907|NCT00884949|38153534|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
17008908|NCT00884793|38153547|FG000|Overall Study|Withdrawal by Subject|1|||
17008909|NCT00884325|38153553|FG000|Overall Study|Lost to Follow-up|1|||
17008910|NCT00884325|38153554|FG001|Overall Study|Lost to Follow-up|2|||
17008911|NCT00884325|38153553|FG000|Overall Study|Lack of Efficacy|0|||
17008912|NCT00884325|38153554|FG001|Overall Study|Lack of Efficacy|1|||
17008913|NCT00884325|38153553|FG000|Overall Study|Withdrawal by Subject|1|||
17008914|NCT00884325|38153554|FG001|Overall Study|Withdrawal by Subject|1|||
17008915|NCT00884325|38153553|FG000|Overall Study|Not provided|1|||
17008916|NCT00884325|38153554|FG001|Overall Study|Not provided|0|||
17008917|NCT00883779|38153562|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
17008918|NCT00883779|38153563|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
17096396|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Death|0|||
17096397|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Death|0|||
17008919|NCT00883779|38153562|FG000|Primary Study Treatment Phase|Disease progression|75|||
17008920|NCT00883779|38153563|FG001|Primary Study Treatment Phase|Disease progression|59|||
17008921|NCT00883779|38153562|FG000|Primary Study Treatment Phase|Adverse Event|16|||
17008922|NCT00883779|38153563|FG001|Primary Study Treatment Phase|Adverse Event|16|||
17008923|NCT00883779|38153562|FG000|Primary Study Treatment Phase|Death|2|||
17008924|NCT00883779|38153563|FG001|Primary Study Treatment Phase|Death|3|||
17008925|NCT00883779|38153562|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
17008926|NCT00883779|38153563|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
17008927|NCT00883779|38153562|FG000|Primary Study Treatment Phase|Other|3|||
17008928|NCT00883779|38153563|FG001|Primary Study Treatment Phase|Other|0|||
17008929|NCT00883779|38153562|FG000|Post-Study Treatment Phase|Adverse Event|2|||
17008930|NCT00883779|38153563|FG001|Post-Study Treatment Phase|Adverse Event|3|||
17008931|NCT00883779|38153562|FG000|Post-Study Treatment Phase|Death|1|||
17008932|NCT00883779|38153563|FG001|Post-Study Treatment Phase|Death|3|||
17008933|NCT00883779|38153562|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
17008934|NCT00883779|38153563|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
17008935|NCT00883779|38153562|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
17008936|NCT00883779|38153563|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
17008937|NCT00883779|38153562|FG000|Post-Study Treatment Phase|Disease progression|103|||
17008938|NCT00883779|38153563|FG001|Post-Study Treatment Phase|Disease progression|122|||
17008939|NCT00883779|38153562|FG000|Post-Study Treatment Phase|Other|3|||
17008940|NCT00883779|38153563|FG001|Post-Study Treatment Phase|Other|0|||
17008941|NCT00883779|38153562|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
17008942|NCT00883779|38153563|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
17008943|NCT00883779|38153562|FG000|Off-study Phase|Death|185|||
17008944|NCT00883779|38153563|FG001|Off-study Phase|Death|174|||
17008945|NCT00883779|38153562|FG000|Off-study Phase|Refused treatment|1|||
17008946|NCT00883779|38153563|FG001|Off-study Phase|Refused treatment|1|||
17008947|NCT00883779|38153562|FG000|Off-study Phase|Failure to return|5|||
17008948|NCT00883779|38153563|FG001|Off-study Phase|Failure to return|6|||
17008949|NCT00883779|38153562|FG000|Off-study Phase|Other|18|||
17008950|NCT00883779|38153563|FG001|Off-study Phase|Other|21|||
17008951|NCT04159701|38153571|FG000|Period 1: Treatment Period|Pregnancy|1|||
17008952|NCT04159701|38153572|FG001|Period 1: Treatment Period|Pregnancy|0|||
17008953|NCT04159701|38153571|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
17008954|NCT04159701|38153572|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
17008955|NCT04159701|38153571|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
17008956|NCT04159701|38153572|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
17008957|NCT04159701|38153571|FG000|Washout Period|site terminated by sponsor|0|||
17008958|NCT04159701|38153572|FG001|Washout Period|site terminated by sponsor|1|||
17008959|NCT04159701|38153571|FG000|Washout Period|study terminated by sponsor|10|||
17008960|NCT04159701|38153572|FG001|Washout Period|study terminated by sponsor|3|||
17008961|NCT04159701|38153571|FG000|Washout Period|Withdrawal by Subject|1|||
17008962|NCT04159701|38153572|FG001|Washout Period|Withdrawal by Subject|0|||
17008963|NCT04159701|38153571|FG000|Washout Period|Inadvertent Enrollment|1|||
17008964|NCT04159701|38153572|FG001|Washout Period|Inadvertent Enrollment|0|||
17008965|NCT04159701|38153571|FG000|Washout Period|Miscellaneous|1|||
17008966|NCT04159701|38153572|FG001|Washout Period|Miscellaneous|0|||
17008967|NCT04159701|38153571|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
17008968|NCT04159701|38153572|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
17008969|NCT04159701|38153571|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
17008970|NCT04159701|38153572|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
17008971|NCT04159701|38153571|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
17008972|NCT04159701|38153572|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
17008973|NCT04159701|38153571|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
17008974|NCT04159701|38153572|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
17008975|NCT04159701|38153571|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
17008976|NCT04159701|38153572|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
17008977|NCT00880269|38153584|FG000|Overall Study|Protocol Violation|1|||
17008978|NCT00880269|38153585|FG001|Overall Study|Protocol Violation|0|||
17008979|NCT00880269|38153584|FG000|Overall Study|Disease Progression|13|||
17008980|NCT00880269|38153585|FG001|Overall Study|Disease Progression|11|||
17008981|NCT00880269|38153584|FG000|Overall Study|New Cancer Therapy|1|||
17008982|NCT00880269|38153585|FG001|Overall Study|New Cancer Therapy|0|||
17008983|NCT00880269|38153584|FG000|Overall Study|Death|4|||
17008984|NCT00880269|38153585|FG001|Overall Study|Death|2|||
17008985|NCT00880269|38153584|FG000|Overall Study|Lost to Follow-up|0|||
17008986|NCT00880269|38153585|FG001|Overall Study|Lost to Follow-up|1|||
17008987|NCT00880269|38153584|FG000|Overall Study|Withdrawal by Subject|3|||
17008988|NCT00880269|38153585|FG001|Overall Study|Withdrawal by Subject|4|||
17008989|NCT00880269|38153584|FG000|Overall Study|Adverse Event|10|||
17008990|NCT00880269|38153585|FG001|Overall Study|Adverse Event|9|||
17008991|NCT00880191|38153593|FG000|Overall Study|Refused further treatment|4|||
17008992|NCT00880191|38153594|FG001|Overall Study|Refused further treatment|1|||
17008993|NCT00880191|38153593|FG000|Overall Study|Adverse Event|8|||
17008994|NCT00880191|38153594|FG001|Overall Study|Adverse Event|6|||
17008995|NCT00880191|38153593|FG000|Overall Study|Hospitalization/efficacy|1|||
17008996|NCT00880191|38153594|FG001|Overall Study|Hospitalization/efficacy|1|||
17008997|NCT00597519|38153600|FG000|Overall Study|Death|1|||
17008998|NCT00879333|38153606|FG000|Overall Study|Adverse Event|94|||
17008999|NCT00879333|38153607|FG001|Overall Study|Adverse Event|34|||
17009000|NCT00879333|38153606|FG000|Overall Study|Abnormal Laboratory Value|1|||
17009001|NCT00879333|38153607|FG001|Overall Study|Abnormal Laboratory Value|0|||
17009002|NCT00879333|38153606|FG000|Overall Study|Withdrawal by Subject|20|||
17009003|NCT00879333|38153607|FG001|Overall Study|Withdrawal by Subject|7|||
17009004|NCT00879333|38153606|FG000|Overall Study|Lost to Follow-up|2|||
17009005|NCT00879333|38153607|FG001|Overall Study|Lost to Follow-up|1|||
17009006|NCT00879333|38153606|FG000|Overall Study|Administrative Problems|2|||
17009007|NCT00879333|38153607|FG001|Overall Study|Administrative Problems|0|||
17009008|NCT00879333|38153606|FG000|Overall Study|Death|16|||
17009009|NCT00879333|38153607|FG001|Overall Study|Death|5|||
17009010|NCT00879333|38153606|FG000|Overall Study|Disease Progression|292|||
17009011|NCT00879333|38153607|FG001|Overall Study|Disease Progression|169|||
17009012|NCT00879333|38153606|FG000|Overall Study|Protocol Violation|1|||
17009013|NCT00879333|38153607|FG001|Overall Study|Protocol Violation|1|||
17009014|NCT03481556|38153619|FG000|Overall Study|Adverse Event|1|||
17009015|NCT03481556|38153620|FG001|Overall Study|Adverse Event|0|||
17009016|NCT03481556|38153621|FG002|Overall Study|Adverse Event|0|||
17009017|NCT03481556|38153622|FG003|Overall Study|Adverse Event|0|||
17009018|NCT03481556|38153619|FG000|Overall Study|Death|4|||
17009019|NCT03481556|38153620|FG001|Overall Study|Death|2|||
17009020|NCT03481556|38153621|FG002|Overall Study|Death|3|||
17009021|NCT03481556|38153622|FG003|Overall Study|Death|16|||
17009022|NCT03481556|38153619|FG000|Overall Study|Study Terminated by Sponsor|10|||
17009023|NCT03481556|38153620|FG001|Overall Study|Study Terminated by Sponsor|5|||
17009024|NCT03481556|38153621|FG002|Overall Study|Study Terminated by Sponsor|2|||
17009025|NCT03481556|38153622|FG003|Overall Study|Study Terminated by Sponsor|9|||
17009026|NCT00596427|38153640|FG000|Overall Study|Withdrawal by Subject|2|||
17009027|NCT00596427|38153641|FG001|Overall Study|Withdrawal by Subject|2|||
17009028|NCT00596427|38153640|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
17009029|NCT00596427|38153641|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
17009030|NCT00596427|38153640|FG000|Overall Study|Protocol Violation|1|||
17009031|NCT00596427|38153641|FG001|Overall Study|Protocol Violation|0|||
17009032|NCT02732210|38153650|FG000|Overall Study|Site Closed|0|||
17009033|NCT02732210|38153651|FG001|Overall Study|Site Closed|11|||
17009034|NCT02732210|38153650|FG000|Overall Study|Study Ended|13|||
17009035|NCT02732210|38153651|FG001|Overall Study|Study Ended|13|||
17009036|NCT02732210|38153650|FG000|Overall Study|Withdrawal by Subject|28|||
17009037|NCT02732210|38153651|FG001|Overall Study|Withdrawal by Subject|87|||
17009038|NCT02732210|38153650|FG000|Overall Study|Lost to Follow-up|5|||
17009039|NCT02732210|38153651|FG001|Overall Study|Lost to Follow-up|57|||
17009040|NCT02732210|38153650|FG000|Overall Study|Death|4|||
17009041|NCT02732210|38153651|FG001|Overall Study|Death|15|||
17009042|NCT02732210|38153650|FG000|Overall Study|Other|35|||
17009043|NCT02732210|38153651|FG001|Overall Study|Other|103|||
17009044|NCT02732210|38153650|FG000|Overall Study|Missing|0|||
17009045|NCT02732210|38153651|FG001|Overall Study|Missing|8|||
17009046|NCT00595959|38153657|FG000|Overall Study|Withdrawal by Subject|1|||
17009047|NCT00595959|38153657|FG000|Overall Study|Lost to Follow-up|1|||
17009048|NCT00436748|38153695|FG000|Overall Study|Ineligibility Determined|1|||
17009049|NCT00436748|38153696|FG001|Overall Study|Ineligibility Determined|1|||
17009050|NCT00436748|38153695|FG000|Overall Study|Adverse Event|0|||
17009051|NCT00436748|38153696|FG001|Overall Study|Adverse Event|2|||
17009052|NCT00436748|38153695|FG000|Overall Study|Consent Withdrawn|1|||
17009053|NCT00436748|38153696|FG001|Overall Study|Consent Withdrawn|4|||
17009054|NCT00436748|38153695|FG000|Overall Study|Administrative Decision|1|||
17009055|NCT00436748|38153696|FG001|Overall Study|Administrative Decision|0|||
17009056|NCT00436748|38153695|FG000|Overall Study|Lost to Follow-up|0|||
17009057|NCT00436748|38153696|FG001|Overall Study|Lost to Follow-up|1|||
17009058|NCT00436748|38153695|FG000|Overall Study|Protocol-specified Criteria|5|||
17009059|NCT00436748|38153696|FG001|Overall Study|Protocol-specified Criteria|4|||
17009060|NCT00436748|38153695|FG000|Overall Study|Other|3|||
17009061|NCT00436748|38153696|FG001|Overall Study|Other|0|||
17009062|NCT03342404|38153704|FG000|Overall Study|Withdrawal by Subject|9|||
17009063|NCT03342404|38153705|FG001|Overall Study|Withdrawal by Subject|10|||
17009064|NCT03342404|38153704|FG000|Overall Study|Lack of Efficacy|1|||
17009065|NCT03342404|38153705|FG001|Overall Study|Lack of Efficacy|17|||
17009066|NCT03342404|38153704|FG000|Overall Study|Adverse Event|3|||
17009067|NCT03342404|38153705|FG001|Overall Study|Adverse Event|4|||
17009068|NCT03342404|38153704|FG000|Overall Study|Noncompliance with study drug|1|||
17009069|NCT03342404|38153705|FG001|Overall Study|Noncompliance with study drug|0|||
17009070|NCT03342404|38153704|FG000|Overall Study|Other reasons|1|||
17009071|NCT03342404|38153705|FG001|Overall Study|Other reasons|0|||
17009072|NCT02703272|38153715|FG000|Overall Study|Death|4|||
17009073|NCT02703272|38153716|FG001|Overall Study|Death|9|||
17009074|NCT02703272|38153717|FG002|Overall Study|Death|19|||
17009075|NCT02703272|38153718|FG003|Overall Study|Death|10|||
17009076|NCT02703272|38153715|FG000|Overall Study|Withdrawal by Subject|0|||
17009077|NCT02703272|38153716|FG001|Overall Study|Withdrawal by Subject|0|||
17009078|NCT02703272|38153717|FG002|Overall Study|Withdrawal by Subject|4|||
17009079|NCT02703272|38153718|FG003|Overall Study|Withdrawal by Subject|2|||
17009080|NCT02703272|38153715|FG000|Overall Study|Study Terminated by Sponsor|6|||
17009081|NCT02703272|38153716|FG001|Overall Study|Study Terminated by Sponsor|1|||
17009082|NCT02703272|38153717|FG002|Overall Study|Study Terminated by Sponsor|12|||
17009083|NCT02703272|38153718|FG003|Overall Study|Study Terminated by Sponsor|4|||
17009084|NCT02703272|38153715|FG000|Overall Study|Other|1|||
17009085|NCT02703272|38153716|FG001|Overall Study|Other|0|||
17009086|NCT02703272|38153717|FG002|Overall Study|Other|0|||
17009087|NCT02703272|38153718|FG003|Overall Study|Other|0|||
17009088|NCT02568215|38153758|FG000|Overall Study|Death|1|||
17009089|NCT02568215|38153759|FG001|Overall Study|Death|2|||
17009090|NCT02568215|38153760|FG002|Overall Study|Death|0|||
17009091|NCT02568215|38153758|FG000|Overall Study|Physician Decision|2|||
17009092|NCT02568215|38153759|FG001|Overall Study|Physician Decision|2|||
17009093|NCT02568215|38153760|FG002|Overall Study|Physician Decision|2|||
17009094|NCT02568215|38153758|FG000|Overall Study|Lost to Follow-up|29|||
17009095|NCT02568215|38153759|FG001|Overall Study|Lost to Follow-up|32|||
17009096|NCT02568215|38153760|FG002|Overall Study|Lost to Follow-up|41|||
17009097|NCT02568215|38153758|FG000|Overall Study|Withdrawal by Subject|21|||
17009098|NCT02568215|38153759|FG001|Overall Study|Withdrawal by Subject|19|||
17009099|NCT02568215|38153760|FG002|Overall Study|Withdrawal by Subject|22|||
17009100|NCT02568215|38153758|FG000|Overall Study|Protocol Violation|1|||
17009101|NCT02568215|38153759|FG001|Overall Study|Protocol Violation|1|||
17009102|NCT02568215|38153760|FG002|Overall Study|Protocol Violation|0|||
17009103|NCT02568215|38153758|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
17009104|NCT02568215|38153759|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
17009105|NCT02568215|38153760|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
17009106|NCT02568215|38153758|FG000|Overall Study|Other|0|||
17009107|NCT02568215|38153759|FG001|Overall Study|Other|1|||
17009108|NCT02568215|38153760|FG002|Overall Study|Other|4|||
17009109|NCT00908141|38153797|FG000|Overall Study|Withdrawal by Subject|0|||
17009110|NCT00908141|38153798|FG001|Overall Study|Withdrawal by Subject|1|||
17009111|NCT00906347|38153806|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
17009112|NCT00906347|38153807|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
17009113|NCT00906347|38153806|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
17009114|NCT00906347|38153807|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
17009115|NCT00906347|38153806|FG000|Received Study Drug|Refused study drug|1|||
17009116|NCT00906347|38153807|FG001|Received Study Drug|Refused study drug|0|||
17009117|NCT00906347|38153806|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
17009118|NCT00906347|38153807|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
17009119|NCT00906035|38153816|FG000|Overall Study|Withdrawal by Subject|2|||
17009120|NCT00906035|38153817|FG001|Overall Study|Withdrawal by Subject|3|||
17009121|NCT00906035|38153818|FG002|Overall Study|Withdrawal by Subject|0|||
17009122|NCT00905489|38153826|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
17009123|NCT00905489|38153826|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
17009124|NCT00905489|38153826|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
17009125|NCT02704754|38153837|FG000|Overall Study|Lost to Follow-up|1|||
17009126|NCT02704754|38153838|FG001|Overall Study|Lost to Follow-up|1|||
17009127|NCT02704754|38153837|FG000|Overall Study|Lack of Efficacy|1|||
17009128|NCT02704754|38153838|FG001|Overall Study|Lack of Efficacy|0|||
17009129|NCT02704754|38153837|FG000|Overall Study|Withdrawal by Subject|1|||
17009130|NCT02704754|38153838|FG001|Overall Study|Withdrawal by Subject|0|||
17009131|NCT03170882|38153846|FG000|Overall Study|Death|17|||
17009132|NCT03170882|38153847|FG001|Overall Study|Death|29|||
17009133|NCT03170882|38153846|FG000|Overall Study|Lost to Follow-up|0|||
17009134|NCT03170882|38153847|FG001|Overall Study|Lost to Follow-up|1|||
17009135|NCT03170882|38153846|FG000|Overall Study|Withdrawal by Subject|4|||
17009136|NCT03170882|38153847|FG001|Overall Study|Withdrawal by Subject|7|||
17009137|NCT03170882|38153846|FG000|Overall Study|Reason not Specified|28|||
17009138|NCT03170882|38153847|FG001|Overall Study|Reason not Specified|36|||
17009139|NCT00907517|38153871|FG000|Overall Study|Progressive Disease|3|||
17009140|NCT00907517|38153872|FG001|Overall Study|Progressive Disease|3|||
17009141|NCT00907517|38153873|FG002|Overall Study|Progressive Disease|4|||
17009142|NCT00907517|38153874|FG003|Overall Study|Progressive Disease|4|||
17009143|NCT00907517|38153875|FG004|Overall Study|Progressive Disease|4|||
17009144|NCT00907517|38153871|FG000|Overall Study|Symptomatic Deterioration|0|||
17009145|NCT00907517|38153872|FG001|Overall Study|Symptomatic Deterioration|0|||
17009146|NCT00907517|38153873|FG002|Overall Study|Symptomatic Deterioration|0|||
17009147|NCT00907517|38153874|FG003|Overall Study|Symptomatic Deterioration|0|||
17009148|NCT00907517|38153875|FG004|Overall Study|Symptomatic Deterioration|1|||
17009149|NCT00905255|38153889|FG000|Overall Study|Adverse Event|7|||
17009150|NCT00905255|38153890|FG001|Overall Study|Adverse Event|5|||
17009151|NCT00905255|38153889|FG000|Overall Study|Withdrawal by Subject|5|||
17009152|NCT00905255|38153890|FG001|Overall Study|Withdrawal by Subject|4|||
17009153|NCT00905255|38153889|FG000|Overall Study|Familial and Personal Reasons|1|||
17009154|NCT00905255|38153890|FG001|Overall Study|Familial and Personal Reasons|0|||
17009155|NCT00905021|38153897|FG000|Overall Study|Adverse Event|2|||
17009156|NCT00906971|38153904|FG000|Overall Study|Withdrawal by Subject|8|||
17009157|NCT00906971|38153905|FG001|Overall Study|Withdrawal by Subject|2|||
17009158|NCT00906971|38153904|FG000|Overall Study|Lost to Follow-up|0|||
17009159|NCT00906971|38153905|FG001|Overall Study|Lost to Follow-up|1|||
17009160|NCT00903929|38153911|FG000|Overall Study|Withdrawal by Subject|0|||
17009161|NCT00903929|38153912|FG001|Overall Study|Withdrawal by Subject|0|||
17009162|NCT00903929|38153913|FG002|Overall Study|Withdrawal by Subject|1|||
17009163|NCT00903929|38153914|FG003|Overall Study|Withdrawal by Subject|2|||
17009164|NCT00903929|38153911|FG000|Overall Study|Adverse Event|0|||
17009165|NCT00903929|38153912|FG001|Overall Study|Adverse Event|0|||
17009166|NCT00903929|38153913|FG002|Overall Study|Adverse Event|0|||
17009167|NCT00903929|38153914|FG003|Overall Study|Adverse Event|1|||
17009168|NCT00903695|38153921|FG000|Overall Study|medical exclusion after 1st testing|1|||
17009169|NCT00903695|38153922|FG001|Overall Study|medical exclusion after 1st testing|0|||
17009170|NCT00903695|38153921|FG000|Overall Study|lung cancer|1|||
17009171|NCT00903695|38153922|FG001|Overall Study|lung cancer|0|||
17009172|NCT02432274|38153938|FG000|Overall Study|Radiological Disease Progression|3|||
17009173|NCT02432274|38153939|FG001|Overall Study|Radiological Disease Progression|4|||
17009174|NCT02432274|38153940|FG002|Overall Study|Radiological Disease Progression|7|||
17009175|NCT02432274|38153941|FG003|Overall Study|Radiological Disease Progression|0|||
17009176|NCT02432274|38153942|FG004|Overall Study|Radiological Disease Progression|24|||
17009177|NCT02432274|38153943|FG005|Overall Study|Radiological Disease Progression|6|||
17009178|NCT02432274|38153944|FG006|Overall Study|Radiological Disease Progression|11|||
17009179|NCT02432274|38153945|FG007|Overall Study|Radiological Disease Progression|9|||
17009180|NCT02432274|38153938|FG000|Overall Study|Clinical Disease Progression|0|||
17009181|NCT02432274|38153939|FG001|Overall Study|Clinical Disease Progression|4|||
17009182|NCT02432274|38153940|FG002|Overall Study|Clinical Disease Progression|1|||
17009183|NCT02432274|38153941|FG003|Overall Study|Clinical Disease Progression|0|||
17009184|NCT02432274|38153942|FG004|Overall Study|Clinical Disease Progression|1|||
17009185|NCT02432274|38153943|FG005|Overall Study|Clinical Disease Progression|0|||
17009186|NCT02432274|38153944|FG006|Overall Study|Clinical Disease Progression|0|||
17009187|NCT02432274|38153945|FG007|Overall Study|Clinical Disease Progression|1|||
17009188|NCT02432274|38153938|FG000|Overall Study|Adverse Event|0|||
17009189|NCT02432274|38153939|FG001|Overall Study|Adverse Event|0|||
17009190|NCT02432274|38153940|FG002|Overall Study|Adverse Event|1|||
17009191|NCT02432274|38153941|FG003|Overall Study|Adverse Event|0|||
17009192|NCT02432274|38153942|FG004|Overall Study|Adverse Event|1|||
17009193|NCT02432274|38153943|FG005|Overall Study|Adverse Event|0|||
17009194|NCT02432274|38153944|FG006|Overall Study|Adverse Event|2|||
17009195|NCT02432274|38153945|FG007|Overall Study|Adverse Event|0|||
17009196|NCT02432274|38153938|FG000|Overall Study|Withdrawal by Subject|0|||
17009197|NCT02432274|38153939|FG001|Overall Study|Withdrawal by Subject|0|||
17009198|NCT02432274|38153940|FG002|Overall Study|Withdrawal by Subject|0|||
17009199|NCT02432274|38153941|FG003|Overall Study|Withdrawal by Subject|0|||
17009200|NCT02432274|38153942|FG004|Overall Study|Withdrawal by Subject|2|||
17009201|NCT02432274|38153943|FG005|Overall Study|Withdrawal by Subject|0|||
17009202|NCT02432274|38153944|FG006|Overall Study|Withdrawal by Subject|1|||
17096398|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Death|0|||
17096399|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Death|1|||
17096400|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Death|0|||
17096401|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Missing|0|||
17096402|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Missing|0|||
17096403|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Missing|1|||
17096404|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Missing|0|||
17096405|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Missing|0|||
17096406|NCT00121641|38235516|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
17096407|NCT00121641|38235517|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
17096408|NCT00121641|38235518|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
17096409|NCT00121641|38235519|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
17096410|NCT00121641|38235520|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
17096411|NCT00425555|38235536|FG000|Overall Study|Withdrawal by Subject|11|||
17096412|NCT00425555|38235537|FG001|Overall Study|Withdrawal by Subject|8|||
17096413|NCT00425555|38235536|FG000|Overall Study|Lost to Follow-up|0|||
17096414|NCT00425555|38235537|FG001|Overall Study|Lost to Follow-up|1|||
17096415|NCT00425555|38235536|FG000|Overall Study|Administrative problems|3|||
17009203|NCT02432274|38153945|FG007|Overall Study|Withdrawal by Subject|2|||
17009204|NCT02432274|38153938|FG000|Overall Study|Participant Choice|0|||
17009205|NCT02432274|38153939|FG001|Overall Study|Participant Choice|0|||
17009206|NCT02432274|38153940|FG002|Overall Study|Participant Choice|1|||
17009207|NCT02432274|38153941|FG003|Overall Study|Participant Choice|0|||
17009208|NCT02432274|38153942|FG004|Overall Study|Participant Choice|0|||
17009209|NCT02432274|38153943|FG005|Overall Study|Participant Choice|0|||
17009210|NCT02432274|38153944|FG006|Overall Study|Participant Choice|1|||
17009211|NCT02432274|38153945|FG007|Overall Study|Participant Choice|0|||
17009212|NCT02432274|38153938|FG000|Overall Study|Other than specified|0|||
17009213|NCT02432274|38153939|FG001|Overall Study|Other than specified|1|||
17009214|NCT02432274|38153940|FG002|Overall Study|Other than specified|0|||
17009215|NCT02432274|38153941|FG003|Overall Study|Other than specified|0|||
17009216|NCT02432274|38153942|FG004|Overall Study|Other than specified|0|||
17009217|NCT02432274|38153943|FG005|Overall Study|Other than specified|1|||
17009218|NCT02432274|38153944|FG006|Overall Study|Other than specified|0|||
17009219|NCT02432274|38153945|FG007|Overall Study|Other than specified|1|||
17009220|NCT02432274|38153938|FG000|Overall Study|Ongoing|0|||
17009221|NCT02432274|38153939|FG001|Overall Study|Ongoing|0|||
17009222|NCT02432274|38153940|FG002|Overall Study|Ongoing|1|||
17009223|NCT02432274|38153941|FG003|Overall Study|Ongoing|1|||
17009224|NCT02432274|38153942|FG004|Overall Study|Ongoing|3|||
17009225|NCT02432274|38153943|FG005|Overall Study|Ongoing|0|||
17009226|NCT02432274|38153944|FG006|Overall Study|Ongoing|0|||
17009227|NCT02432274|38153945|FG007|Overall Study|Ongoing|7|||
17009228|NCT00903617|38153979|FG000|Overall Study|Adverse Event|0|||
17009229|NCT00903617|38153980|FG001|Overall Study|Adverse Event|1|||
17009230|NCT00903617|38153981|FG002|Overall Study|Adverse Event|1|||
17009231|NCT00903617|38153982|FG003|Overall Study|Adverse Event|0|||
17009232|NCT00903617|38153979|FG000|Overall Study|Protocol-defined stopping criteria|0|||
17009233|NCT00903617|38153980|FG001|Overall Study|Protocol-defined stopping criteria|2|||
17009234|NCT00903617|38153981|FG002|Overall Study|Protocol-defined stopping criteria|0|||
17009235|NCT00903617|38153982|FG003|Overall Study|Protocol-defined stopping criteria|0|||
17009236|NCT00903617|38153979|FG000|Overall Study|Lost to Follow-up|2|||
17009237|NCT00903617|38153980|FG001|Overall Study|Lost to Follow-up|0|||
17009238|NCT00903617|38153981|FG002|Overall Study|Lost to Follow-up|1|||
17009239|NCT00903617|38153982|FG003|Overall Study|Lost to Follow-up|1|||
17009240|NCT00903617|38153979|FG000|Overall Study|Withdrawal by Subject|1|||
17009241|NCT00903617|38153980|FG001|Overall Study|Withdrawal by Subject|2|||
17009242|NCT00903617|38153981|FG002|Overall Study|Withdrawal by Subject|3|||
17009243|NCT00903617|38153982|FG003|Overall Study|Withdrawal by Subject|0|||
17009244|NCT00903383|38153997|FG000|Overall Study|Adverse Event|1|||
17009245|NCT00903383|38153998|FG001|Overall Study|Adverse Event|2|||
17009246|NCT00903383|38153999|FG002|Overall Study|Adverse Event|3|||
17009247|NCT00903383|38154000|FG003|Overall Study|Adverse Event|1|||
17009248|NCT00903383|38153997|FG000|Overall Study|Physician Decision|1|||
17009249|NCT00903383|38153998|FG001|Overall Study|Physician Decision|2|||
17009250|NCT00903383|38153999|FG002|Overall Study|Physician Decision|0|||
17009251|NCT00903383|38154000|FG003|Overall Study|Physician Decision|0|||
17009252|NCT00903383|38153997|FG000|Overall Study|Lost to Follow-up|0|||
17009253|NCT00903383|38153998|FG001|Overall Study|Lost to Follow-up|0|||
17009254|NCT00903383|38153999|FG002|Overall Study|Lost to Follow-up|0|||
17009255|NCT00903383|38154000|FG003|Overall Study|Lost to Follow-up|1|||
17009256|NCT00903383|38153997|FG000|Overall Study|Decision of Sponsor|1|||
17009257|NCT00903383|38153998|FG001|Overall Study|Decision of Sponsor|0|||
17009258|NCT00903383|38153999|FG002|Overall Study|Decision of Sponsor|0|||
17009259|NCT00903383|38154000|FG003|Overall Study|Decision of Sponsor|0|||
17009260|NCT00903383|38153997|FG000|Overall Study|Withdrawal by Subject|4|||
17009261|NCT00903383|38153998|FG001|Overall Study|Withdrawal by Subject|1|||
17009262|NCT00903383|38153999|FG002|Overall Study|Withdrawal by Subject|0|||
17009263|NCT00903383|38154000|FG003|Overall Study|Withdrawal by Subject|2|||
17009264|NCT00903383|38153997|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
17009265|NCT00903383|38153998|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
17009266|NCT00903383|38153999|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
17009267|NCT00903383|38154000|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
17009268|NCT00903383|38153997|FG000|Overall Study|Patient Decision|0|||
17009269|NCT00903383|38153998|FG001|Overall Study|Patient Decision|0|||
17009270|NCT00903383|38153999|FG002|Overall Study|Patient Decision|0|||
17009271|NCT00903383|38154000|FG003|Overall Study|Patient Decision|1|||
17009272|NCT02314026|38154010|FG000|Overall Study|Protocol Violation|28|||
17009273|NCT01617096|38154020|FG000|Overall Study|Withdrawal by Subject|96|||
17009274|NCT01617096|38154021|FG001|Overall Study|Withdrawal by Subject|81|||
17009275|NCT01617096|38154020|FG000|Overall Study|Lost to Follow-up|37|||
17009276|NCT01617096|38154021|FG001|Overall Study|Lost to Follow-up|32|||
17009277|NCT01617096|38154020|FG000|Overall Study|Physician Decision|10|||
17009278|NCT01617096|38154021|FG001|Overall Study|Physician Decision|18|||
17009279|NCT01617096|38154020|FG000|Overall Study|Death|4|||
16908461|NCT01777620|38017155|FG001|Overall Study|Subject Withdrawal|0|||
17009280|NCT01617096|38154021|FG001|Overall Study|Death|3|||
17009281|NCT01617096|38154020|FG000|Overall Study|Other|1|||
17009282|NCT01617096|38154021|FG001|Overall Study|Other|3|||
17009283|NCT00900731|38154050|FG000|Overall Study|Adverse Event|31|||
17009284|NCT00900731|38154051|FG001|Overall Study|Adverse Event|27|||
17009285|NCT00900731|38154050|FG000|Overall Study|Withdrawal by Subject|8|||
17009286|NCT00900731|38154051|FG001|Overall Study|Withdrawal by Subject|7|||
17009287|NCT00900731|38154050|FG000|Overall Study|Protocol Deviation|8|||
17009288|NCT00900731|38154051|FG001|Overall Study|Protocol Deviation|11|||
17009289|NCT00900731|38154050|FG000|Overall Study|Administrative Problems|5|||
17009290|NCT00900731|38154051|FG001|Overall Study|Administrative Problems|4|||
17009291|NCT00900731|38154050|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
17009292|NCT00900731|38154051|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
17009293|NCT00900731|38154050|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
17009294|NCT00900731|38154051|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
17009295|NCT00900731|38154050|FG000|Overall Study|Lost to Follow-up|2|||
17009296|NCT00900731|38154051|FG001|Overall Study|Lost to Follow-up|3|||
17009297|NCT00900731|38154050|FG000|Overall Study|Lack of Efficacy|1|||
17009298|NCT00900731|38154051|FG001|Overall Study|Lack of Efficacy|3|||
17009299|NCT00900731|38154050|FG000|Overall Study|Death|0|||
17009300|NCT00900731|38154051|FG001|Overall Study|Death|2|||
17009301|NCT03635489|38154059|FG000|Overall Study|Death|6|||
17009302|NCT03635489|38154060|FG001|Overall Study|Death|3|||
17009303|NCT03635489|38154059|FG000|Overall Study|Lost to Follow-up|0|||
17009304|NCT03635489|38154060|FG001|Overall Study|Lost to Follow-up|1|||
17009305|NCT03635489|38154059|FG000|Overall Study|Withdrawal by Subject|1|||
17009306|NCT03635489|38154060|FG001|Overall Study|Withdrawal by Subject|2|||
17009307|NCT03842436|38154066|FG000|Overall Study|Lost to Follow-up|1|||
17009308|NCT02702414|38154098|FG000|Overall Study|Death|77|||
17009309|NCT02702414|38154099|FG001|Overall Study|Death|34|||
17009310|NCT02702414|38154098|FG000|Overall Study|Lost to Follow-up|0|||
17009311|NCT02702414|38154099|FG001|Overall Study|Lost to Follow-up|1|||
17009312|NCT02702414|38154098|FG000|Overall Study|Withdrawal by Subject|0|||
17009313|NCT02702414|38154099|FG001|Overall Study|Withdrawal by Subject|1|||
17009314|NCT02702414|38154098|FG000|Overall Study|Participants Ongoing in Study|27|||
17009315|NCT02702414|38154099|FG001|Overall Study|Participants Ongoing in Study|15|||
17009316|NCT02702414|38154098|FG000|Overall Study|Not Treated|1|||
17009317|NCT02702414|38154099|FG001|Overall Study|Not Treated|0|||
17009318|NCT00602472|38154117|FG000|Overall Study|Adverse Event|5|||
17009319|NCT00602472|38154118|FG001|Overall Study|Adverse Event|23|||
17009320|NCT00602472|38154117|FG000|Overall Study|Protocol Violation|4|||
17009321|NCT00602472|38154118|FG001|Overall Study|Protocol Violation|19|||
17009322|NCT00602472|38154117|FG000|Overall Study|Withdrawal by Subject|8|||
17009323|NCT00602472|38154118|FG001|Overall Study|Withdrawal by Subject|14|||
17009324|NCT00602472|38154117|FG000|Overall Study|Other incl. lack of efficacy|4|||
17009325|NCT00602472|38154118|FG001|Overall Study|Other incl. lack of efficacy|2|||
17009326|NCT01832402|38154126|FG000|Overall Study|Lost to Follow-up|2|||
17009327|NCT01832402|38154127|FG001|Overall Study|Lost to Follow-up|0|||
17009328|NCT01832402|38154126|FG000|Overall Study|Withdrawal by Subject|3|||
17009329|NCT01832402|38154127|FG001|Overall Study|Withdrawal by Subject|3|||
17009330|NCT01832402|38154126|FG000|Overall Study|Declining Performance status|2|||
17009331|NCT01832402|38154127|FG001|Overall Study|Declining Performance status|1|||
17009332|NCT01828112|38154149|FG000|Overall Study|Adverse Event|6|||
17009333|NCT01828112|38154150|FG001|Overall Study|Adverse Event|8|||
17009334|NCT01828112|38154149|FG000|Overall Study|Death|9|||
17009335|NCT01828112|38154150|FG001|Overall Study|Death|5|||
17009336|NCT01828112|38154149|FG000|Overall Study|Physician Decision|5|||
17009337|NCT01828112|38154150|FG001|Overall Study|Physician Decision|5|||
17009338|NCT01828112|38154149|FG000|Overall Study|Progressive disease|56|||
17009339|NCT01828112|38154150|FG001|Overall Study|Progressive disease|82|||
17009340|NCT01828112|38154149|FG000|Overall Study|Subject/guardian decision|6|||
17009341|NCT01828112|38154150|FG001|Overall Study|Subject/guardian decision|8|||
17009342|NCT00901901|38154175|FG000|Treatment Period|Adverse Event|120|||
17009343|NCT00901901|38154176|FG001|Treatment Period|Adverse Event|128|||
17009344|NCT00901901|38154175|FG000|Treatment Period|Withdrawal by Subject|26|||
17009345|NCT00901901|38154176|FG001|Treatment Period|Withdrawal by Subject|24|||
17009346|NCT00901901|38154175|FG000|Treatment Period|Physician Decision|2|||
17009347|NCT00901901|38154176|FG001|Treatment Period|Physician Decision|2|||
17009348|NCT00901901|38154175|FG000|Treatment Period|Lost to Follow-up|3|||
17009349|NCT00901901|38154176|FG001|Treatment Period|Lost to Follow-up|5|||
17009350|NCT00901901|38154175|FG000|Treatment Period|Noncompliance with study medication|4|||
17009351|NCT00901901|38154176|FG001|Treatment Period|Noncompliance with study medication|1|||
17009352|NCT00901901|38154175|FG000|Treatment Period|Missing|1|||
17009353|NCT00901901|38154176|FG001|Treatment Period|Missing|0|||
17009354|NCT00901901|38154175|FG000|Treatment Period|Never treated|0|||
17009355|NCT00901901|38154176|FG001|Treatment Period|Never treated|3|||
17009356|NCT00901901|38154175|FG000|Treatment Period|Protocol driven decision point|0|||
17009357|NCT00901901|38154176|FG001|Treatment Period|Protocol driven decision point|2|||
17009358|NCT00901901|38154175|FG000|Treatment Period|Study terminated by sponsor|2|||
17009359|NCT00901901|38154176|FG001|Treatment Period|Study terminated by sponsor|0|||
17009360|NCT00901901|38154175|FG000|Treatment Period|Protocol Violation|5|||
17009361|NCT00901901|38154176|FG001|Treatment Period|Protocol Violation|9|||
17009362|NCT00901901|38154175|FG000|Treatment Period|Switch to commercial drug|1|||
17009363|NCT00901901|38154176|FG001|Treatment Period|Switch to commercial drug|1|||
17009364|NCT00901901|38154175|FG000|Treatment Period|Transfer to treatment continuation study|5|||
17009365|NCT00901901|38154176|FG001|Treatment Period|Transfer to treatment continuation study|2|||
17009366|NCT00901901|38154175|FG000|Follow-up Period|Death|181|||
17009367|NCT00901901|38154176|FG001|Follow-up Period|Death|208|||
17009368|NCT00901901|38154175|FG000|Follow-up Period|Protocol driven decision point|47|||
17009369|NCT00901901|38154176|FG001|Follow-up Period|Protocol driven decision point|36|||
17009370|NCT00901901|38154175|FG000|Follow-up Period|Withdrawal by Subject|6|||
17009371|NCT00901901|38154176|FG001|Follow-up Period|Withdrawal by Subject|9|||
17009372|NCT00901901|38154175|FG000|Follow-up Period|Lost to Follow-up|12|||
17009373|NCT00901901|38154176|FG001|Follow-up Period|Lost to Follow-up|8|||
17009374|NCT00901901|38154175|FG000|Follow-up Period|Missing|94|||
17009375|NCT00901901|38154176|FG001|Follow-up Period|Missing|80|||
17009376|NCT02143778|38154184|FG000|Overall Study|Withdrawal by Subject|2|||
17009377|NCT02143778|38154184|FG000|Overall Study|Device malfunction|1|||
17009378|NCT00896363|38154228|FG000|Overall Study|Adverse Event|3|||
17009379|NCT00896363|38154229|FG001|Overall Study|Adverse Event|4|||
17009380|NCT00896363|38154230|FG002|Overall Study|Adverse Event|2|||
17009381|NCT00896363|38154228|FG000|Overall Study|Lack of Efficacy|0|||
17009382|NCT00896363|38154229|FG001|Overall Study|Lack of Efficacy|2|||
17009383|NCT00896363|38154230|FG002|Overall Study|Lack of Efficacy|1|||
17009384|NCT00896363|38154228|FG000|Overall Study|Withdrawal by Subject|3|||
17009385|NCT00896363|38154229|FG001|Overall Study|Withdrawal by Subject|5|||
17009386|NCT00896363|38154230|FG002|Overall Study|Withdrawal by Subject|5|||
17009387|NCT00900029|38154246|FG000|Overall Study|Lost to Follow-up|0|||
17009388|NCT00900029|38154247|FG001|Overall Study|Lost to Follow-up|2|||
17009389|NCT00900029|38154248|FG002|Overall Study|Lost to Follow-up|1|||
17009390|NCT00900029|38154249|FG003|Overall Study|Lost to Follow-up|4|||
17009391|NCT00900029|38154250|FG004|Overall Study|Lost to Follow-up|4|||
17009392|NCT00900029|38154246|FG000|Overall Study|Withdrawal by Subject|2|||
17009393|NCT00900029|38154247|FG001|Overall Study|Withdrawal by Subject|2|||
17009394|NCT00900029|38154248|FG002|Overall Study|Withdrawal by Subject|1|||
17009395|NCT00900029|38154249|FG003|Overall Study|Withdrawal by Subject|1|||
17009396|NCT00900029|38154250|FG004|Overall Study|Withdrawal by Subject|1|||
17009397|NCT00900029|38154246|FG000|Overall Study|Adverse Event|0|||
17009398|NCT00900029|38154247|FG001|Overall Study|Adverse Event|0|||
17009399|NCT00900029|38154248|FG002|Overall Study|Adverse Event|1|||
17009400|NCT00900029|38154249|FG003|Overall Study|Adverse Event|1|||
17009401|NCT00900029|38154250|FG004|Overall Study|Adverse Event|1|||
17009402|NCT00900029|38154246|FG000|Overall Study|Death|1|||
17009403|NCT00900029|38154247|FG001|Overall Study|Death|0|||
17009404|NCT00900029|38154248|FG002|Overall Study|Death|0|||
17009405|NCT00900029|38154249|FG003|Overall Study|Death|1|||
17009406|NCT00900029|38154250|FG004|Overall Study|Death|0|||
17009407|NCT00896051|38154268|FG000|Overall Study|Adverse Event|2|||
17009408|NCT00896051|38154269|FG001|Overall Study|Adverse Event|1|||
17009409|NCT00896051|38154268|FG000|Overall Study|Lost to Follow-up|3|||
17009410|NCT00896051|38154269|FG001|Overall Study|Lost to Follow-up|2|||
17009411|NCT00896051|38154268|FG000|Overall Study|Withdrawal by Subject|3|||
17009412|NCT00896051|38154269|FG001|Overall Study|Withdrawal by Subject|2|||
17009413|NCT00896051|38154268|FG000|Overall Study|Subject noncompliant|1|||
17009414|NCT00896051|38154269|FG001|Overall Study|Subject noncompliant|3|||
17009415|NCT00896051|38154268|FG000|Overall Study|Other|1|||
17009416|NCT00896051|38154269|FG001|Overall Study|Other|1|||
17009417|NCT00894647|38154286|FG000|Overall Study|Adverse Event|5|||
17009418|NCT00894647|38154287|FG001|Overall Study|Adverse Event|4|||
16786292|NCT01999972|37726700|FG000|Dose Expansion Part|Participant's non-compliance|0|||
16786293|NCT01999972|37726701|FG001|Dose Expansion Part|Participant's non-compliance|0|||
16908462|NCT01777542|38017161|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
16908463|NCT01777542|38017162|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
16908464|NCT01736124|38017171|FG000|Post-intervention Assessment|Death|2|||
16908465|NCT01736124|38017172|FG001|Post-intervention Assessment|Death|2|||
16908466|NCT01736124|38017171|FG000|Post-intervention Assessment|lost computer access|1|||
16908467|NCT01736124|38017172|FG001|Post-intervention Assessment|lost computer access|1|||
16908468|NCT01736124|38017171|FG000|Post-intervention Assessment|Moved away|3|||
16908469|NCT01736124|38017172|FG001|Post-intervention Assessment|Moved away|1|||
16908470|NCT01736124|38017171|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
16908471|NCT01736124|38017172|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
16908472|NCT01736124|38017171|FG000|Post-intervention Assessment|Illness|3|||
16908473|NCT01736124|38017172|FG001|Post-intervention Assessment|Illness|2|||
16908474|NCT01736124|38017171|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
17009419|NCT00894647|38154286|FG000|Overall Study|Withdrawal by Subject|4|||
17009420|NCT00894647|38154287|FG001|Overall Study|Withdrawal by Subject|4|||
17009421|NCT00894647|38154286|FG000|Overall Study|Lost to Follow-up|0|||
17009422|NCT00894647|38154287|FG001|Overall Study|Lost to Follow-up|2|||
17009423|NCT00894647|38154286|FG000|Overall Study|Non-compliance with study procedures|0|||
17009424|NCT00894647|38154287|FG001|Overall Study|Non-compliance with study procedures|2|||
17009425|NCT00894647|38154286|FG000|Overall Study|Other, not due to AE|1|||
17009426|NCT00894647|38154287|FG001|Overall Study|Other, not due to AE|2|||
17009427|NCT00892775|38154295|FG000|Overall Study|Protocol Violation|1|||
17009428|NCT00892775|38154296|FG001|Overall Study|Protocol Violation|0|||
17009429|NCT00892775|38154295|FG000|Overall Study|Subject difficulties with blood drawing|1|||
17009430|NCT00892775|38154296|FG001|Overall Study|Subject difficulties with blood drawing|0|||
17009431|NCT00892775|38154295|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
17009432|NCT00892775|38154296|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
17009433|NCT00892775|38154295|FG000|Overall Study|Migrated/ moved from study area|1|||
17009434|NCT00892775|38154296|FG001|Overall Study|Migrated/ moved from study area|0|||
17009435|NCT00892775|38154295|FG000|Overall Study|Withdrawal by Subject|0|||
17009436|NCT00892775|38154296|FG001|Overall Study|Withdrawal by Subject|1|||
17009437|NCT00892775|38154295|FG000|Overall Study|Lost to Follow-up|1|||
17009438|NCT00892775|38154296|FG001|Overall Study|Lost to Follow-up|0|||
17009439|NCT00895895|38154307|FG000|Period 1|Adverse Event|7|||
17009440|NCT00895895|38154308|FG001|Period 1|Adverse Event|6|||
17009441|NCT00895895|38154309|FG002|Period 1|Adverse Event|4|||
17009442|NCT00895895|38154310|FG003|Period 1|Adverse Event|6|||
17009443|NCT00895895|38154311|FG004|Period 1|Adverse Event|7|||
17009444|NCT00895895|38154307|FG000|Period 1|Death|0|||
17009445|NCT00895895|38154308|FG001|Period 1|Death|0|||
17009446|NCT00895895|38154309|FG002|Period 1|Death|0|||
17009447|NCT00895895|38154310|FG003|Period 1|Death|0|||
17009448|NCT00895895|38154311|FG004|Period 1|Death|1|||
17009449|NCT00895895|38154307|FG000|Period 1|discontinued by sponsor|2|||
17009450|NCT00895895|38154308|FG001|Period 1|discontinued by sponsor|1|||
17009451|NCT00895895|38154309|FG002|Period 1|discontinued by sponsor|2|||
17009452|NCT00895895|38154310|FG003|Period 1|discontinued by sponsor|1|||
17193022|NCT04194801|38346313|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
17193023|NCT04194801|38346314|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
17193024|NCT04194801|38346315|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
17193025|NCT04194801|38346313|FG000|Part Ib/II End of Study|Death|2|||
17193026|NCT04194801|38346314|FG001|Part Ib/II End of Study|Death|3|||
17193027|NCT04194801|38346315|FG002|Part Ib/II End of Study|Death|3|||
17193028|NCT04194801|38346313|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
17193029|NCT04194801|38346314|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
17193030|NCT04194801|38346315|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
17193031|NCT04194801|38346313|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
17193032|NCT04194801|38346314|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
17193033|NCT04194801|38346315|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
17193034|NCT04194801|38346313|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
17193035|NCT04194801|38346314|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
17193036|NCT04194801|38346315|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
17193037|NCT04194801|38346313|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
17193038|NCT04194801|38346314|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
17193039|NCT04194801|38346315|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
17193040|NCT02802865|38346339|FG000|Overall Study|Pregnancy|1|||
17193041|NCT02802865|38346340|FG001|Overall Study|Pregnancy|1|||
17193042|NCT02802865|38346339|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
16908475|NCT01736124|38017172|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
16908476|NCT01736124|38017171|FG000|Post-intervention Assessment|Temporarily away|3|||
16908477|NCT01736124|38017172|FG001|Post-intervention Assessment|Temporarily away|1|||
16908478|NCT01736124|38017171|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
16908479|NCT01736124|38017172|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
16908480|NCT01736124|38017171|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
16908481|NCT01736124|38017172|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
16908482|NCT01736124|38017171|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
16908483|NCT01736124|38017172|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
16908484|NCT01736124|38017171|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
16908485|NCT01736124|38017172|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
16908486|NCT01736124|38017171|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
16908487|NCT01736124|38017172|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
16908488|NCT01736124|38017171|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
16908489|NCT01736124|38017172|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
16908490|NCT01736124|38017171|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
16908491|NCT01736124|38017172|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
16908492|NCT01736124|38017171|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
16908493|NCT01736124|38017172|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
16908494|NCT01736124|38017171|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
16908495|NCT01736124|38017172|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
17009453|NCT00895895|38154311|FG004|Period 1|discontinued by sponsor|1|||
17009454|NCT00895895|38154307|FG000|Period 1|failed to return|0|||
17009455|NCT00895895|38154308|FG001|Period 1|failed to return|0|||
17193043|NCT02802865|38346340|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
17193044|NCT02414932|38346348|FG000|Overall Study|Withdrawal by Subject|2|||
17009456|NCT00895895|38154309|FG002|Period 1|failed to return|1|||
17009457|NCT00895895|38154310|FG003|Period 1|failed to return|0|||
17009458|NCT00895895|38154311|FG004|Period 1|failed to return|1|||
17009459|NCT00895895|38154307|FG000|Period 1|investigator request|0|||
17009460|NCT00895895|38154308|FG001|Period 1|investigator request|1|||
17009461|NCT00895895|38154309|FG002|Period 1|investigator request|0|||
17009462|NCT00895895|38154310|FG003|Period 1|investigator request|0|||
17009463|NCT00895895|38154311|FG004|Period 1|investigator request|0|||
17009464|NCT00895895|38154307|FG000|Period 1|Lost to Follow-up|2|||
17193045|NCT02414932|38346349|FG001|Overall Study|Withdrawal by Subject|3|||
17193046|NCT02414932|38346348|FG000|Overall Study|Adverse Event|1|||
17193047|NCT02414932|38346349|FG001|Overall Study|Adverse Event|0|||
17193048|NCT00704535|38346355|FG000|Overall Study|Adverse Event|2|||
17193049|NCT00704535|38346355|FG000|Overall Study|Death|2|||
17193050|NCT00704535|38346355|FG000|Overall Study|Lost to Follow-up|8|||
17193051|NCT00704535|38346355|FG000|Overall Study|Protocol Violation|10|||
17193052|NCT00704535|38346355|FG000|Overall Study|Completed status not on Case Report Form|124|||
17193053|NCT01740687|38346359|FG000|Overall Study|Lost to Follow-up|11|||
17193054|NCT01740687|38346359|FG000|Overall Study|Withdrawal by Subject|2|||
17193055|NCT01740687|38346359|FG000|Overall Study|other reason|22|||
17009465|NCT00895895|38154308|FG001|Period 1|Lost to Follow-up|1|||
17009466|NCT00895895|38154309|FG002|Period 1|Lost to Follow-up|3|||
16786294|NCT01999972|37726702|FG002|Dose Expansion Part|Participant's non-compliance|0|||
17009467|NCT00895895|38154310|FG003|Period 1|Lost to Follow-up|2|||
17009468|NCT00895895|38154311|FG004|Period 1|Lost to Follow-up|3|||
17009469|NCT00895895|38154307|FG000|Period 1|Other|1|||
17009470|NCT00895895|38154308|FG001|Period 1|Other|2|||
17009471|NCT00895895|38154309|FG002|Period 1|Other|1|||
17009472|NCT00895895|38154310|FG003|Period 1|Other|1|||
17009473|NCT00895895|38154311|FG004|Period 1|Other|1|||
17009474|NCT00895895|38154307|FG000|Period 1|Protocol Violation|0|||
17009475|NCT00895895|38154308|FG001|Period 1|Protocol Violation|1|||
17009476|NCT00895895|38154309|FG002|Period 1|Protocol Violation|0|||
17009477|NCT00895895|38154310|FG003|Period 1|Protocol Violation|0|||
17009478|NCT00895895|38154311|FG004|Period 1|Protocol Violation|0|||
17009479|NCT00895895|38154307|FG000|Period 1|Withdrawal by Subject|6|||
17009480|NCT00895895|38154308|FG001|Period 1|Withdrawal by Subject|6|||
17009481|NCT00895895|38154309|FG002|Period 1|Withdrawal by Subject|8|||
17009482|NCT00895895|38154310|FG003|Period 1|Withdrawal by Subject|2|||
17009483|NCT00895895|38154311|FG004|Period 1|Withdrawal by Subject|4|||
17009484|NCT00895895|38154307|FG000|Period 1|unsatisfactory response-efficacy|2|||
17009485|NCT00895895|38154308|FG001|Period 1|unsatisfactory response-efficacy|0|||
17009486|NCT00895895|38154309|FG002|Period 1|unsatisfactory response-efficacy|0|||
17009487|NCT00895895|38154310|FG003|Period 1|unsatisfactory response-efficacy|0|||
17009488|NCT00895895|38154311|FG004|Period 1|unsatisfactory response-efficacy|0|||
17009489|NCT00895895|38154307|FG000|Period 1|randomized and not treated|1|||
17009490|NCT00895895|38154308|FG001|Period 1|randomized and not treated|3|||
17009491|NCT00895895|38154309|FG002|Period 1|randomized and not treated|1|||
17009492|NCT00895895|38154310|FG003|Period 1|randomized and not treated|1|||
17009493|NCT00895895|38154311|FG004|Period 1|randomized and not treated|2|||
17009494|NCT00895895|38154307|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
17009495|NCT00895895|38154308|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
17009496|NCT00895895|38154309|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
17009497|NCT00895895|38154310|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
17009498|NCT00895895|38154311|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
17009499|NCT00895895|38154307|FG000|After Period 1, Prior to Period 2|Other|0|||
17009500|NCT00895895|38154308|FG001|After Period 1, Prior to Period 2|Other|0|||
17009501|NCT00895895|38154309|FG002|After Period 1, Prior to Period 2|Other|1|||
17096416|NCT00425555|38235537|FG001|Overall Study|Administrative problems|0|||
17096417|NCT00425555|38235536|FG000|Overall Study|Death|1|||
17096418|NCT00425555|38235537|FG001|Overall Study|Death|2|||
17096419|NCT00425555|38235536|FG000|Overall Study|New cancer therapy|2|||
17096420|NCT00425555|38235537|FG001|Overall Study|New cancer therapy|1|||
17096421|NCT00425555|38235536|FG000|Overall Study|Disease progression|36|||
17096422|NCT00425555|38235537|FG001|Overall Study|Disease progression|33|||
17096423|NCT00425555|38235536|FG000|Overall Study|Adverse Event|25|||
17096424|NCT00425555|38235537|FG001|Overall Study|Adverse Event|15|||
17096425|NCT00425555|38235536|FG000|Overall Study|Protocol Violation|1|||
17096426|NCT00425555|38235537|FG001|Overall Study|Protocol Violation|0|||
17096427|NCT00424775|38235546|FG000|Overall Study|Adverse Event|2|||
17193056|NCT01740687|38346359|FG000|Overall Study|treatment not received|2|||
17193057|NCT02648204|38346367|FG000|Overall Study|Withdrawal by Subject|12|||
17193058|NCT02648204|38346368|FG001|Overall Study|Withdrawal by Subject|8|||
17193059|NCT02648204|38346369|FG002|Overall Study|Withdrawal by Subject|2|||
17009502|NCT00895895|38154310|FG003|After Period 1, Prior to Period 2|Other|0|||
17009503|NCT00895895|38154311|FG004|After Period 1, Prior to Period 2|Other|0|||
17009504|NCT00895895|38154307|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
17009505|NCT00895895|38154308|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
17096428|NCT00424775|38235547|FG001|Overall Study|Adverse Event|0|||
17009506|NCT00895895|38154309|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
17009507|NCT00895895|38154310|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
17009508|NCT00895895|38154311|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
17009509|NCT00895895|38154307|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
17009510|NCT00895895|38154308|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
17009511|NCT00895895|38154309|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
17009512|NCT00895895|38154310|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
17009513|NCT00895895|38154311|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
17009514|NCT00895895|38154307|FG000|Period 2|Adverse Event|3|||
17009515|NCT00895895|38154308|FG001|Period 2|Adverse Event|3|||
17009516|NCT00895895|38154309|FG002|Period 2|Adverse Event|5|||
17009517|NCT00895895|38154310|FG003|Period 2|Adverse Event|2|||
17009518|NCT00895895|38154311|FG004|Period 2|Adverse Event|5|||
17009519|NCT00895895|38154307|FG000|Period 2|Death|0|||
17009520|NCT00895895|38154308|FG001|Period 2|Death|0|||
17009521|NCT00895895|38154309|FG002|Period 2|Death|1|||
17009522|NCT00895895|38154310|FG003|Period 2|Death|0|||
17009523|NCT00895895|38154311|FG004|Period 2|Death|0|||
17009524|NCT00895895|38154307|FG000|Period 2|discontinued by sponsor|44|||
17009525|NCT00895895|38154308|FG001|Period 2|discontinued by sponsor|44|||
17009526|NCT00895895|38154309|FG002|Period 2|discontinued by sponsor|38|||
17009527|NCT00895895|38154310|FG003|Period 2|discontinued by sponsor|46|||
17009528|NCT00895895|38154311|FG004|Period 2|discontinued by sponsor|37|||
17009529|NCT00895895|38154307|FG000|Period 2|failed to return|2|||
17096429|NCT00424775|38235546|FG000|Overall Study|Lack of Efficacy|1|||
17096430|NCT00424775|38235547|FG001|Overall Study|Lack of Efficacy|0|||
17096431|NCT00121485|38235553|FG000|Overall Study|Not implanted|1|||
17096432|NCT00121485|38235554|FG001|Overall Study|Not implanted|5|||
17096433|NCT00121485|38235553|FG000|Overall Study|Crossover|0|||
17096434|NCT00121485|38235554|FG001|Overall Study|Crossover|2|||
17096435|NCT01763866|38235585|FG000|Overall Study|Withdrawal by Subject|2|||
17096436|NCT01763866|38235586|FG001|Overall Study|Withdrawal by Subject|1|||
17096437|NCT01763866|38235587|FG002|Overall Study|Withdrawal by Subject|4|||
17096438|NCT01763866|38235588|FG003|Overall Study|Withdrawal by Subject|0|||
17096439|NCT01763866|38235589|FG004|Overall Study|Withdrawal by Subject|0|||
17096440|NCT01763866|38235590|FG005|Overall Study|Withdrawal by Subject|3|||
17096441|NCT01763866|38235591|FG006|Overall Study|Withdrawal by Subject|4|||
17096442|NCT01763866|38235592|FG007|Overall Study|Withdrawal by Subject|0|||
17096443|NCT01763866|38235593|FG008|Overall Study|Withdrawal by Subject|1|||
17096444|NCT01763866|38235594|FG009|Overall Study|Withdrawal by Subject|1|||
17096445|NCT01763866|38235595|FG010|Overall Study|Withdrawal by Subject|2|||
17096446|NCT01763866|38235596|FG011|Overall Study|Withdrawal by Subject|2|||
17096447|NCT01763866|38235597|FG012|Overall Study|Withdrawal by Subject|2|||
17096448|NCT01763866|38235598|FG013|Overall Study|Withdrawal by Subject|0|||
17096449|NCT01763866|38235599|FG014|Overall Study|Withdrawal by Subject|6|||
17096450|NCT01763866|38235600|FG015|Overall Study|Withdrawal by Subject|3|||
17096451|NCT01763866|38235601|FG016|Overall Study|Withdrawal by Subject|0|||
17096452|NCT01763866|38235602|FG017|Overall Study|Withdrawal by Subject|1|||
17096453|NCT01763866|38235603|FG018|Overall Study|Withdrawal by Subject|1|||
17096454|NCT01763866|38235604|FG019|Overall Study|Withdrawal by Subject|1|||
17096455|NCT01763866|38235605|FG020|Overall Study|Withdrawal by Subject|2|||
17096456|NCT01763866|38235606|FG021|Overall Study|Withdrawal by Subject|1|||
17096457|NCT01763866|38235607|FG022|Overall Study|Withdrawal by Subject|2|||
17009530|NCT00895895|38154308|FG001|Period 2|failed to return|0|||
17009531|NCT00895895|38154309|FG002|Period 2|failed to return|0|||
17009532|NCT00895895|38154310|FG003|Period 2|failed to return|0|||
17009533|NCT00895895|38154311|FG004|Period 2|failed to return|0|||
17009534|NCT00895895|38154307|FG000|Period 2|investigator request|2|||
17009535|NCT00895895|38154308|FG001|Period 2|investigator request|0|||
17009536|NCT00895895|38154309|FG002|Period 2|investigator request|0|||
17009537|NCT00895895|38154310|FG003|Period 2|investigator request|0|||
17009538|NCT00895895|38154311|FG004|Period 2|investigator request|0|||
17009539|NCT00895895|38154307|FG000|Period 2|Lost to Follow-up|1|||
17009540|NCT00895895|38154308|FG001|Period 2|Lost to Follow-up|2|||
17009541|NCT00895895|38154309|FG002|Period 2|Lost to Follow-up|1|||
17096458|NCT01763866|38235608|FG023|Overall Study|Withdrawal by Subject|1|||
17096459|NCT01763866|38235585|FG000|Overall Study|Decision by sponsor|0|||
17096460|NCT01763866|38235586|FG001|Overall Study|Decision by sponsor|0|||
17009542|NCT00895895|38154310|FG003|Period 2|Lost to Follow-up|1|||
17009543|NCT00895895|38154311|FG004|Period 2|Lost to Follow-up|0|||
17009544|NCT00895895|38154307|FG000|Period 2|Other|1|||
17009545|NCT00895895|38154308|FG001|Period 2|Other|1|||
17096461|NCT01763866|38235587|FG002|Overall Study|Decision by sponsor|1|||
17096462|NCT01763866|38235588|FG003|Overall Study|Decision by sponsor|0|||
17009546|NCT00895895|38154309|FG002|Period 2|Other|3|||
17009547|NCT00895895|38154310|FG003|Period 2|Other|1|||
17009548|NCT00895895|38154311|FG004|Period 2|Other|1|||
17009549|NCT00895895|38154307|FG000|Period 2|Protocol Violation|1|||
17096463|NCT01763866|38235589|FG004|Overall Study|Decision by sponsor|2|||
17096464|NCT01763866|38235590|FG005|Overall Study|Decision by sponsor|0|||
17009550|NCT00895895|38154308|FG001|Period 2|Protocol Violation|0|||
17009551|NCT00895895|38154309|FG002|Period 2|Protocol Violation|1|||
17009552|NCT00895895|38154310|FG003|Period 2|Protocol Violation|1|||
17009553|NCT00895895|38154311|FG004|Period 2|Protocol Violation|1|||
17009554|NCT00895895|38154307|FG000|Period 2|Withdrawal by Subject|0|||
17009555|NCT00895895|38154308|FG001|Period 2|Withdrawal by Subject|2|||
17009556|NCT00895895|38154309|FG002|Period 2|Withdrawal by Subject|0|||
17009557|NCT00895895|38154310|FG003|Period 2|Withdrawal by Subject|3|||
17009558|NCT00895895|38154311|FG004|Period 2|Withdrawal by Subject|5|||
17009559|NCT00895895|38154307|FG000|Period 2|unsatisfactory response-efficacy|2|||
17009560|NCT00895895|38154308|FG001|Period 2|unsatisfactory response-efficacy|1|||
17009561|NCT00895895|38154309|FG002|Period 2|unsatisfactory response-efficacy|0|||
17009562|NCT00895895|38154310|FG003|Period 2|unsatisfactory response-efficacy|0|||
17009563|NCT00895895|38154311|FG004|Period 2|unsatisfactory response-efficacy|0|||
17009564|NCT00895661|38154329|FG000|Overall Study|Death|1|||
17009565|NCT00895661|38154329|FG000|Overall Study|reason unknown|2|||
17009566|NCT00895583|38154335|FG000|Overall Study|Adverse Event|28|||
17009567|NCT00895583|38154336|FG001|Overall Study|Adverse Event|4|||
17009568|NCT00895583|38154335|FG000|Overall Study|Death|2|||
17009569|NCT00895583|38154336|FG001|Overall Study|Death|1|||
17009570|NCT00895583|38154335|FG000|Overall Study|Physician Decision|3|||
17009571|NCT00895583|38154336|FG001|Overall Study|Physician Decision|1|||
17009572|NCT00895583|38154335|FG000|Overall Study|Lost to Follow-up|1|||
17009573|NCT00895583|38154336|FG001|Overall Study|Lost to Follow-up|3|||
17009574|NCT00895583|38154335|FG000|Overall Study|Protocol Violation|1|||
17009575|NCT00895583|38154336|FG001|Overall Study|Protocol Violation|0|||
17009576|NCT00895583|38154335|FG000|Overall Study|Withdrawal by Subject|4|||
17009577|NCT00895583|38154336|FG001|Overall Study|Withdrawal by Subject|2|||
17009578|NCT00895583|38154335|FG000|Overall Study|Lack of Efficacy|5|||
17009579|NCT00895583|38154336|FG001|Overall Study|Lack of Efficacy|0|||
17009580|NCT00895583|38154335|FG000|Overall Study|Other|0|||
17009581|NCT00895583|38154336|FG001|Overall Study|Other|1|||
17009582|NCT00894413|38154353|FG000|Overall Study|Physician Decision|0|||
17009583|NCT00894413|38154354|FG001|Overall Study|Physician Decision|2|||
17009584|NCT00894413|38154353|FG000|Overall Study|Adverse Event|0|||
17009585|NCT00894413|38154354|FG001|Overall Study|Adverse Event|2|||
17009586|NCT00894413|38154353|FG000|Overall Study|Withdrawal by Subject|0|||
17009587|NCT00894413|38154354|FG001|Overall Study|Withdrawal by Subject|4|||
17009588|NCT00895037|38154363|FG000|Overall Study|Death|0|||
17009589|NCT00895037|38154364|FG001|Overall Study|Death|2|||
17009590|NCT00895037|38154365|FG002|Overall Study|Death|1|||
17009591|NCT00892151|38154373|FG000|Overall Study|Protocol Violation|1|||
17009592|NCT01706705|38154377|FG000|Overall Study|Death|1|||
17009593|NCT01706705|38154377|FG000|Overall Study|Lack of Efficacy|13|||
17009594|NCT01706705|38154377|FG000|Overall Study|Non-clinical|6|||
17009595|NCT00894803|38154393|FG000|Overall Study|Death|20|||
17009596|NCT00894803|38154394|FG001|Overall Study|Death|4|||
17009597|NCT00894803|38154393|FG000|Overall Study|Lost to Follow-up|0|||
17009598|NCT00894803|38154394|FG001|Overall Study|Lost to Follow-up|1|||
17009599|NCT00601458|38154403|FG000|Overall Study|Dosing Error|1|||
17009600|NCT00601458|38154404|FG001|Overall Study|Dosing Error|0|||
17009601|NCT00601458|38154405|FG002|Overall Study|Dosing Error|0|||
17009602|NCT00601458|38154403|FG000|Overall Study|Incomplete Data|0|||
17009603|NCT00601458|38154404|FG001|Overall Study|Incomplete Data|2|||
17009604|NCT00601458|38154405|FG002|Overall Study|Incomplete Data|0|||
17009605|NCT00601458|38154403|FG000|Overall Study|Protocol Violation|3|||
17009606|NCT00601458|38154404|FG001|Overall Study|Protocol Violation|2|||
17009607|NCT00601458|38154405|FG002|Overall Study|Protocol Violation|1|||
17009608|NCT00601458|38154403|FG000|Overall Study|Early Termination|0|||
17009609|NCT00601458|38154404|FG001|Overall Study|Early Termination|1|||
17009610|NCT00601458|38154405|FG002|Overall Study|Early Termination|1|||
17009611|NCT02141282|38154417|FG000|Overall Study|Adverse event, not related to progression|8|||
16908496|NCT01759446|38017185|FG000|Overall Study|Protocol Violation|1|||
16908497|NCT01759446|38017186|FG001|Overall Study|Protocol Violation|0|||
16908498|NCT01759446|38017187|FG002|Overall Study|Protocol Violation|1|||
16908499|NCT01759446|38017188|FG003|Overall Study|Protocol Violation|0|||
16908500|NCT01759446|38017189|FG004|Overall Study|Protocol Violation|0|||
16908501|NCT01759446|38017185|FG000|Overall Study|Withdrawal by Subject|0|||
16908502|NCT01759446|38017186|FG001|Overall Study|Withdrawal by Subject|1|||
16908503|NCT01759446|38017187|FG002|Overall Study|Withdrawal by Subject|0|||
16908504|NCT01759446|38017188|FG003|Overall Study|Withdrawal by Subject|1|||
16908505|NCT01759446|38017189|FG004|Overall Study|Withdrawal by Subject|0|||
16908506|NCT01777308|38017203|FG000|Overall Study|Withdrawal by Subject|5|||
16908507|NCT01777308|38017204|FG001|Overall Study|Withdrawal by Subject|1|||
16908508|NCT01777308|38017203|FG000|Overall Study|Migrated/moved from study area|1|||
17009612|NCT02141282|38154418|FG001|Overall Study|Adverse event, not related to progression|1|||
17009613|NCT02141282|38154419|FG002|Overall Study|Adverse event, not related to progression|3|||
17009614|NCT02141282|38154420|FG003|Overall Study|Adverse event, not related to progression|1|||
17009615|NCT02141282|38154417|FG000|Overall Study|Adverse event, related to progression|1|||
17009616|NCT02141282|38154418|FG001|Overall Study|Adverse event, related to progression|0|||
17009617|NCT02141282|38154419|FG002|Overall Study|Adverse event, related to progression|2|||
17009618|NCT02141282|38154420|FG003|Overall Study|Adverse event, related to progression|0|||
17009619|NCT02141282|38154417|FG000|Overall Study|COVID-19 infection|1|||
17009620|NCT02141282|38154418|FG001|Overall Study|COVID-19 infection|0|||
17009621|NCT02141282|38154419|FG002|Overall Study|COVID-19 infection|0|||
17009622|NCT02141282|38154420|FG003|Overall Study|COVID-19 infection|0|||
17009623|NCT02141282|38154417|FG000|Overall Study|Lost to Follow-up|0|||
17009624|NCT02141282|38154418|FG001|Overall Study|Lost to Follow-up|0|||
17009625|NCT02141282|38154419|FG002|Overall Study|Lost to Follow-up|4|||
17009626|NCT02141282|38154420|FG003|Overall Study|Lost to Follow-up|2|||
17009627|NCT02141282|38154417|FG000|Overall Study|Other, not specified|14|||
17009628|NCT02141282|38154418|FG001|Overall Study|Other, not specified|11|||
17009629|NCT02141282|38154419|FG002|Overall Study|Other, not specified|23|||
17009630|NCT02141282|38154420|FG003|Overall Study|Other, not specified|9|||
17009631|NCT02141282|38154417|FG000|Overall Study|Progressive disease, Richter's|4|||
17009632|NCT02141282|38154418|FG001|Overall Study|Progressive disease, Richter's|1|||
17009633|NCT02141282|38154419|FG002|Overall Study|Progressive disease, Richter's|1|||
17009634|NCT02141282|38154420|FG003|Overall Study|Progressive disease, Richter's|1|||
17009635|NCT02141282|38154417|FG000|Overall Study|Progressive disease per protocol|12|||
17009636|NCT02141282|38154418|FG001|Overall Study|Progressive disease per protocol|7|||
17009637|NCT02141282|38154419|FG002|Overall Study|Progressive disease per protocol|9|||
17009638|NCT02141282|38154420|FG003|Overall Study|Progressive disease per protocol|2|||
17009639|NCT02141282|38154417|FG000|Overall Study|Stem cell transplant|1|||
17009640|NCT02141282|38154418|FG001|Overall Study|Stem cell transplant|0|||
17009641|NCT02141282|38154419|FG002|Overall Study|Stem cell transplant|1|||
17009642|NCT02141282|38154420|FG003|Overall Study|Stem cell transplant|0|||
17009643|NCT02141282|38154417|FG000|Overall Study|Study terminated by Sponsor|0|||
17009644|NCT02141282|38154418|FG001|Overall Study|Study terminated by Sponsor|1|||
17009645|NCT02141282|38154419|FG002|Overall Study|Study terminated by Sponsor|0|||
17009646|NCT02141282|38154420|FG003|Overall Study|Study terminated by Sponsor|0|||
17009647|NCT02141282|38154417|FG000|Overall Study|Subject non-compliance|0|||
17009648|NCT02141282|38154418|FG001|Overall Study|Subject non-compliance|0|||
17009649|NCT02141282|38154419|FG002|Overall Study|Subject non-compliance|1|||
17009650|NCT02141282|38154420|FG003|Overall Study|Subject non-compliance|0|||
17009651|NCT02141282|38154417|FG000|Overall Study|Withdrew consent|2|||
17009652|NCT02141282|38154418|FG001|Overall Study|Withdrew consent|0|||
17009653|NCT02141282|38154419|FG002|Overall Study|Withdrew consent|4|||
17009654|NCT02141282|38154420|FG003|Overall Study|Withdrew consent|0|||
17009655|NCT00003479|38154433|FG000|Overall Study|Not evaluable|3|||
17009656|NCT00891839|38154437|FG000|Overall Study|Adverse Event|2|||
17009657|NCT00891839|38154437|FG000|Overall Study|Withdrawal by Subject|2|||
17009658|NCT00891839|38154437|FG000|Overall Study|Disease progression|3|||
17009659|NCT00600756|38154443|FG000|Analysis After 6 Months|Adverse Event|43|||
17009660|NCT00600756|38154444|FG001|Analysis After 6 Months|Adverse Event|33|||
17009661|NCT00600756|38154443|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
17009662|NCT00600756|38154444|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
17009663|NCT00600756|38154443|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
17009664|NCT00600756|38154444|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
17009665|NCT00600756|38154443|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
17009666|NCT00600756|38154444|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
17009667|NCT00600756|38154443|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
17009668|NCT00600756|38154444|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
17009669|NCT00600756|38154443|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
17009670|NCT00600756|38154444|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
17009671|NCT00600756|38154443|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
17009672|NCT00600756|38154444|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
17009673|NCT00600756|38154443|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
17009674|NCT00600756|38154444|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
17009675|NCT00600756|38154443|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
17009676|NCT00600756|38154444|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
17009677|NCT00600756|38154443|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
17009678|NCT00600756|38154444|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
17009679|NCT00600756|38154443|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
17009680|NCT00600756|38154444|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
17009681|NCT00600756|38154443|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
17009682|NCT00600756|38154444|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
17096465|NCT01763866|38235591|FG006|Overall Study|Decision by sponsor|2|||
17096466|NCT01763866|38235592|FG007|Overall Study|Decision by sponsor|0|||
17096467|NCT01763866|38235593|FG008|Overall Study|Decision by sponsor|2|||
17009683|NCT00600756|38154443|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
17009684|NCT00600756|38154444|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
17009685|NCT00600756|38154443|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
17009686|NCT00600756|38154444|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
17009687|NCT00890825|38154456|FG000|Overall Study|Withdrawal by Subject|1|||
17009688|NCT00890825|38154457|FG001|Overall Study|Withdrawal by Subject|0|||
17009689|NCT00890825|38154456|FG000|Overall Study|Alive at data cut off (DCO)|13|||
17009690|NCT00890825|38154457|FG001|Overall Study|Alive at data cut off (DCO)|14|||
17009691|NCT00890201|38154465|FG000|Overall Study|Protocol Violation|5|||
17009692|NCT00890201|38154466|FG001|Overall Study|Protocol Violation|56|||
17009693|NCT00891527|38154472|FG000|Overall Study|Withdrawal by Subject|2|||
17009694|NCT03861078|38154477|FG000|Overall Study|COVID-19 shut down|4|||
17009695|NCT03861078|38154477|FG000|Overall Study|Lost to Follow-up|1|||
17009696|NCT03861078|38154477|FG000|Overall Study|Protocol Violation|2|||
17009697|NCT03861078|38154477|FG000|Overall Study|lack of venous access|1|||
17009698|NCT00891371|38154485|FG000|Pre-assignment|Inclusion/exclusion|5|||
17009699|NCT00891371|38154485|FG000|Pre-assignment|Consent withdrawal|1|||
17009700|NCT00891371|38154485|FG000|Treatment|Lack of Efficacy|5|||
17009701|NCT00891371|38154485|FG000|Treatment|Adverse Event|2|||
17009702|NCT00891371|38154485|FG000|Treatment|Death|1|||
17009703|NCT00891371|38154485|FG000|Treatment|Lost to Follow-up|1|||
17009704|NCT00890045|38154491|FG000|Overall Study|Death|0|||
17009705|NCT00890045|38154492|FG001|Overall Study|Death|1|||
17009706|NCT00890045|38154491|FG000|Overall Study|Did not receive HeRO Graft|0|||
17009707|NCT00890045|38154492|FG001|Overall Study|Did not receive HeRO Graft|2|||
17009708|NCT00890045|38154491|FG000|Overall Study|Lost to Follow-up|5|||
17009709|NCT00890045|38154492|FG001|Overall Study|Lost to Follow-up|7|||
17009710|NCT00891293|38154498|FG000|Overall Study|Adverse Event|2|||
17009711|NCT00891293|38154498|FG000|Overall Study|Protocol Violation|2|||
17009712|NCT00891293|38154498|FG000|Overall Study|Laboratory abnormality|4|||
17009713|NCT00891293|38154498|FG000|Overall Study|Lost to Follow-up|7|||
17009714|NCT00891293|38154498|FG000|Overall Study|Subject withdrew consent|7|||
17009715|NCT00891293|38154498|FG000|Overall Study|Sponsor termination|62|||
17009716|NCT00889421|38154522|FG000|Overall Study|Lack of Efficacy|3|||
17009717|NCT00889265|38154526|FG000|Overall Study|Adverse Event|1|||
17009718|NCT00889265|38154526|FG000|Overall Study|Lost to Follow-up|5|||
17009719|NCT00889265|38154526|FG000|Overall Study|Protocol Violation|1|||
17009720|NCT00603746|38154536|FG000|Overall Study|Adverse Event|2|||
17009721|NCT00603746|38154537|FG001|Overall Study|Adverse Event|3|||
17009722|NCT00603746|38154538|FG002|Overall Study|Adverse Event|0|||
17009723|NCT00603746|38154539|FG003|Overall Study|Adverse Event|1|||
17009724|NCT00603746|38154540|FG004|Overall Study|Adverse Event|0|||
17096468|NCT01763866|38235594|FG009|Overall Study|Decision by sponsor|0|||
17096469|NCT01763866|38235595|FG010|Overall Study|Decision by sponsor|6|||
17096470|NCT01763866|38235596|FG011|Overall Study|Decision by sponsor|0|||
17096471|NCT01763866|38235597|FG012|Overall Study|Decision by sponsor|1|||
17096472|NCT01763866|38235598|FG013|Overall Study|Decision by sponsor|0|||
17096473|NCT01763866|38235599|FG014|Overall Study|Decision by sponsor|5|||
17096474|NCT01763866|38235600|FG015|Overall Study|Decision by sponsor|0|||
17096475|NCT01763866|38235601|FG016|Overall Study|Decision by sponsor|0|||
17096476|NCT01763866|38235602|FG017|Overall Study|Decision by sponsor|0|||
17096477|NCT01763866|38235603|FG018|Overall Study|Decision by sponsor|4|||
17096478|NCT01763866|38235604|FG019|Overall Study|Decision by sponsor|0|||
17096479|NCT01763866|38235605|FG020|Overall Study|Decision by sponsor|2|||
17096480|NCT01763866|38235606|FG021|Overall Study|Decision by sponsor|0|||
17096481|NCT01763866|38235607|FG022|Overall Study|Decision by sponsor|1|||
17096482|NCT01763866|38235608|FG023|Overall Study|Decision by sponsor|0|||
17096483|NCT01763866|38235585|FG000|Overall Study|Lost to Follow-up|0|||
17096484|NCT01763866|38235586|FG001|Overall Study|Lost to Follow-up|0|||
17096485|NCT01763866|38235587|FG002|Overall Study|Lost to Follow-up|0|||
17096486|NCT01763866|38235588|FG003|Overall Study|Lost to Follow-up|0|||
17096487|NCT01763866|38235589|FG004|Overall Study|Lost to Follow-up|0|||
17096488|NCT01763866|38235590|FG005|Overall Study|Lost to Follow-up|0|||
17096489|NCT01763866|38235591|FG006|Overall Study|Lost to Follow-up|1|||
17096490|NCT01763866|38235592|FG007|Overall Study|Lost to Follow-up|0|||
17096491|NCT01763866|38235593|FG008|Overall Study|Lost to Follow-up|0|||
17096492|NCT01763866|38235594|FG009|Overall Study|Lost to Follow-up|0|||
17096493|NCT01763866|38235595|FG010|Overall Study|Lost to Follow-up|0|||
17009725|NCT00603746|38154541|FG005|Overall Study|Adverse Event|4|||
17009726|NCT00603746|38154536|FG000|Overall Study|Lack of Efficacy|34|||
17009727|NCT00603746|38154537|FG001|Overall Study|Lack of Efficacy|11|||
17009728|NCT00603746|38154538|FG002|Overall Study|Lack of Efficacy|6|||
17009729|NCT00603746|38154539|FG003|Overall Study|Lack of Efficacy|11|||
17009730|NCT00603746|38154540|FG004|Overall Study|Lack of Efficacy|12|||
17009731|NCT00603746|38154541|FG005|Overall Study|Lack of Efficacy|8|||
17009732|NCT00603746|38154536|FG000|Overall Study|Protocol Violation|0|||
17009733|NCT00603746|38154537|FG001|Overall Study|Protocol Violation|3|||
17009734|NCT00603746|38154538|FG002|Overall Study|Protocol Violation|1|||
17009735|NCT00603746|38154539|FG003|Overall Study|Protocol Violation|0|||
17009736|NCT00603746|38154540|FG004|Overall Study|Protocol Violation|1|||
17096494|NCT01763866|38235596|FG011|Overall Study|Lost to Follow-up|0|||
17009737|NCT00603746|38154541|FG005|Overall Study|Protocol Violation|0|||
17009738|NCT00603746|38154536|FG000|Overall Study|Lost to Follow-up|0|||
17009739|NCT00603746|38154537|FG001|Overall Study|Lost to Follow-up|1|||
17009740|NCT00603746|38154538|FG002|Overall Study|Lost to Follow-up|1|||
17009741|NCT00603746|38154539|FG003|Overall Study|Lost to Follow-up|0|||
17009742|NCT00603746|38154540|FG004|Overall Study|Lost to Follow-up|0|||
17009743|NCT00603746|38154541|FG005|Overall Study|Lost to Follow-up|0|||
17009744|NCT00603746|38154536|FG000|Overall Study|Physician Decision|1|||
17009745|NCT00603746|38154537|FG001|Overall Study|Physician Decision|0|||
17009746|NCT00603746|38154538|FG002|Overall Study|Physician Decision|0|||
17009747|NCT00603746|38154539|FG003|Overall Study|Physician Decision|0|||
17009748|NCT00603746|38154540|FG004|Overall Study|Physician Decision|1|||
17009749|NCT00603746|38154541|FG005|Overall Study|Physician Decision|0|||
17009750|NCT00603746|38154536|FG000|Overall Study|Withdrawal by Subject|1|||
17009751|NCT00603746|38154537|FG001|Overall Study|Withdrawal by Subject|0|||
17009752|NCT00603746|38154538|FG002|Overall Study|Withdrawal by Subject|0|||
17009753|NCT00603746|38154539|FG003|Overall Study|Withdrawal by Subject|1|||
17009754|NCT00603746|38154540|FG004|Overall Study|Withdrawal by Subject|3|||
17009755|NCT00603746|38154541|FG005|Overall Study|Withdrawal by Subject|1|||
17009756|NCT00888329|38154557|FG000|Overall Study|Physician Decision|6|||
17009757|NCT00888329|38154558|FG001|Overall Study|Physician Decision|9|||
17009758|NCT00603590|38154566|FG000|Overall Study|Did not attend study clinic|39|||
17009759|NCT00603590|38154567|FG001|Overall Study|Did not attend study clinic|30|||
17009760|NCT00603590|38154566|FG000|Overall Study|Refused blood test|5|||
17009761|NCT00603590|38154567|FG001|Overall Study|Refused blood test|1|||
17009762|NCT00603590|38154566|FG000|Overall Study|Patient discontinued study drug|22|||
17009763|NCT00603590|38154567|FG001|Overall Study|Patient discontinued study drug|15|||
17009764|NCT00603590|38154566|FG000|Overall Study|Adverse Event|2|||
17009765|NCT00603590|38154567|FG001|Overall Study|Adverse Event|0|||
17009766|NCT00603590|38154566|FG000|Overall Study|Lost to Follow-up|8|||
17009767|NCT00603590|38154567|FG001|Overall Study|Lost to Follow-up|4|||
17009768|NCT00603590|38154566|FG000|Overall Study|Cardiovascular event|0|||
17009769|NCT00603590|38154567|FG001|Overall Study|Cardiovascular event|1|||
17009770|NCT00888173|38154573|FG000|Overall Study|Wrong Primary|1|||
17009771|NCT00888173|38154573|FG000|Overall Study|Ineligible: required test not done|1|||
17009772|NCT00887549|38154586|FG000|Induction Therapy|Adverse Event|8|||
17009773|NCT00887549|38154586|FG000|Induction Therapy|Physician Decision|1|||
17009774|NCT00887549|38154586|FG000|Induction Therapy|Progressive Disease|13|||
17009775|NCT00887549|38154586|FG000|Induction Therapy|Death due to Study Disease|4|||
17009776|NCT00887549|38154586|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
17009777|NCT00887549|38154586|FG000|Maintenance Therapy|Adverse Event|16|||
17009778|NCT00887549|38154586|FG000|Maintenance Therapy|Physician Decision|1|||
17009779|NCT00887549|38154586|FG000|Maintenance Therapy|Progressive Disease|25|||
17009780|NCT00887549|38154586|FG000|Maintenance Therapy|Death due to adverse event|1|||
17009781|NCT00887315|38154596|FG000|Overall Study|Study termination|7|||
17009782|NCT00887315|38154597|FG001|Overall Study|Study termination|4|||
17009783|NCT03608826|38154603|FG000|Overall Study|Death|3|||
17009784|NCT03608826|38154603|FG000|Overall Study|Heart Transplant|3|||
17009785|NCT03608826|38154603|FG000|Overall Study|Physician Decision|4|||
17009786|NCT00887159|38154610|FG000|Overall Study|Disease progression|6|||
17009787|NCT00887159|38154611|FG001|Overall Study|Disease progression|39|||
17009788|NCT00887159|38154612|FG002|Overall Study|Disease progression|33|||
17009789|NCT00887159|38154610|FG000|Overall Study|Adverse Event|3|||
17009790|NCT00887159|38154611|FG001|Overall Study|Adverse Event|4|||
17009791|NCT00887159|38154612|FG002|Overall Study|Adverse Event|17|||
17009792|NCT00887159|38154610|FG000|Overall Study|Death|2|||
17009793|NCT00887159|38154611|FG001|Overall Study|Death|2|||
17009794|NCT00887159|38154612|FG002|Overall Study|Death|0|||
17009795|NCT00887159|38154610|FG000|Overall Study|Withdrawal by Subject|4|||
17009796|NCT00887159|38154611|FG001|Overall Study|Withdrawal by Subject|4|||
17009797|NCT00887159|38154612|FG002|Overall Study|Withdrawal by Subject|2|||
17009798|NCT00887159|38154610|FG000|Overall Study|Alternative therapy|2|||
17009799|NCT00887159|38154611|FG001|Overall Study|Alternative therapy|0|||
17009800|NCT00887159|38154612|FG002|Overall Study|Alternative therapy|0|||
17009801|NCT00887159|38154610|FG000|Overall Study|Physician Decision|1|||
17009802|NCT00887159|38154611|FG001|Overall Study|Physician Decision|1|||
17096495|NCT01763866|38235597|FG012|Overall Study|Lost to Follow-up|1|||
17096496|NCT01763866|38235598|FG013|Overall Study|Lost to Follow-up|0|||
17009803|NCT00887159|38154612|FG002|Overall Study|Physician Decision|0|||
17009804|NCT00887159|38154610|FG000|Overall Study|Sympomatic deterioration|1|||
17009805|NCT00887159|38154611|FG001|Overall Study|Sympomatic deterioration|0|||
17009806|NCT00887159|38154612|FG002|Overall Study|Sympomatic deterioration|0|||
17009807|NCT00887159|38154610|FG000|Overall Study|Treatment delayed|1|||
17009808|NCT00887159|38154611|FG001|Overall Study|Treatment delayed|1|||
17009809|NCT00887159|38154612|FG002|Overall Study|Treatment delayed|0|||
17009810|NCT00887159|38154610|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
17009811|NCT00887159|38154611|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
17009812|NCT00887159|38154612|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
17009813|NCT00887159|38154610|FG000|Overall Study|Received more tx instead of observation|1|||
17009814|NCT00887159|38154611|FG001|Overall Study|Received more tx instead of observation|0|||
17009815|NCT00887159|38154612|FG002|Overall Study|Received more tx instead of observation|0|||
17009816|NCT00887159|38154610|FG000|Overall Study|Ineligible|5|||
17009817|NCT00887159|38154611|FG001|Overall Study|Ineligible|1|||
17009818|NCT00887159|38154612|FG002|Overall Study|Ineligible|0|||
17009819|NCT00887159|38154610|FG000|Overall Study|Never started assigned therapy|3|||
17009820|NCT00887159|38154611|FG001|Overall Study|Never started assigned therapy|3|||
17009821|NCT00887159|38154612|FG002|Overall Study|Never started assigned therapy|4|||
17009822|NCT00886769|38154624|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
17009823|NCT00886769|38154625|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
17009824|NCT00886613|38154634|FG000|Overall Study|Protocol deviation (Part B)|1|||
17009825|NCT00886613|38154635|FG001|Overall Study|Protocol deviation (Part B)|0|||
17009826|NCT00886613|38154636|FG002|Overall Study|Protocol deviation (Part B)|0|||
17009827|NCT00886613|38154634|FG000|Overall Study|Lost to follow-up (Part B)|1|||
17009828|NCT00886613|38154635|FG001|Overall Study|Lost to follow-up (Part B)|0|||
17009829|NCT00886613|38154636|FG002|Overall Study|Lost to follow-up (Part B)|1|||
17009830|NCT00886613|38154634|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
17009831|NCT00886613|38154635|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
17009832|NCT00886613|38154636|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
17009833|NCT00886379|38154652|FG000|Overall Study|Transferred Schools|0|||
17009834|NCT00886379|38154653|FG001|Overall Study|Transferred Schools|0|||
17009835|NCT00886379|38154654|FG002|Overall Study|Transferred Schools|2|||
17009836|NCT00886379|38154655|FG003|Overall Study|Transferred Schools|1|||
17009837|NCT00886379|38154656|FG004|Overall Study|Transferred Schools|1|||
17009838|NCT00886379|38154652|FG000|Overall Study|Final blood draw not obtained|3|||
17009839|NCT00886379|38154653|FG001|Overall Study|Final blood draw not obtained|3|||
17009840|NCT00886379|38154654|FG002|Overall Study|Final blood draw not obtained|4|||
17009841|NCT00886379|38154655|FG003|Overall Study|Final blood draw not obtained|2|||
17009842|NCT00886379|38154656|FG004|Overall Study|Final blood draw not obtained|2|||
17009843|NCT00599196|38154668|FG000|Overall Study|Lack of Efficacy|22|||
17009844|NCT00599196|38154668|FG000|Overall Study|Adverse Event|93|||
17009845|NCT00599196|38154668|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
17009846|NCT00599196|38154668|FG000|Overall Study|Subject withdrew consent|43|||
17009847|NCT00599196|38154668|FG000|Overall Study|Study ended per sponsor|197|||
17009848|NCT00599196|38154668|FG000|Overall Study|Lost to Follow-up|17|||
17009849|NCT00599196|38154668|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
17009850|NCT00599196|38154668|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
17009851|NCT00599196|38154668|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
17009852|NCT00599196|38154668|FG000|Overall Study|Other: Pt Moved To Australia|1|||
17009853|NCT00599196|38154668|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
17009854|NCT00599196|38154668|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
17009855|NCT00603512|38154677|FG000|Overall Study|Adverse Event|0|||
17009856|NCT00603512|38154678|FG001|Overall Study|Adverse Event|2|||
17009857|NCT00603512|38154679|FG002|Overall Study|Adverse Event|4|||
17009858|NCT00603512|38154680|FG003|Overall Study|Adverse Event|4|||
17009859|NCT00603512|38154681|FG004|Overall Study|Adverse Event|2|||
17009860|NCT00603512|38154677|FG000|Overall Study|Lack of Efficacy|0|||
17009861|NCT00603512|38154678|FG001|Overall Study|Lack of Efficacy|1|||
17009862|NCT00603512|38154679|FG002|Overall Study|Lack of Efficacy|0|||
17009863|NCT00603512|38154680|FG003|Overall Study|Lack of Efficacy|0|||
17009864|NCT00603512|38154681|FG004|Overall Study|Lack of Efficacy|1|||
17009865|NCT00603512|38154677|FG000|Overall Study|Other|2|||
17009866|NCT00603512|38154678|FG001|Overall Study|Other|1|||
17009867|NCT00603512|38154679|FG002|Overall Study|Other|0|||
17009868|NCT00603512|38154680|FG003|Overall Study|Other|1|||
17009869|NCT00603512|38154681|FG004|Overall Study|Other|1|||
17009870|NCT00603512|38154677|FG000|Overall Study|Withdrawal by Subject|0|||
17009871|NCT00603512|38154678|FG001|Overall Study|Withdrawal by Subject|0|||
17009872|NCT00603512|38154679|FG002|Overall Study|Withdrawal by Subject|0|||
17009873|NCT00603512|38154680|FG003|Overall Study|Withdrawal by Subject|0|||
17009874|NCT00603512|38154681|FG004|Overall Study|Withdrawal by Subject|1|||
17009875|NCT00603512|38154677|FG000|Overall Study|Randomized but not treated|0|||
17009876|NCT00603512|38154678|FG001|Overall Study|Randomized but not treated|1|||
17009877|NCT00603512|38154679|FG002|Overall Study|Randomized but not treated|1|||
17009878|NCT00603512|38154680|FG003|Overall Study|Randomized but not treated|2|||
17009879|NCT00603512|38154681|FG004|Overall Study|Randomized but not treated|0|||
17009880|NCT04242875|38154693|FG000|Overall Study|Adverse Event|2|||
17009881|NCT00603278|38154707|FG000|Overall Study|Lack of Efficacy|35|||
17009882|NCT00603278|38154708|FG001|Overall Study|Lack of Efficacy|10|||
17009883|NCT00603278|38154709|FG002|Overall Study|Lack of Efficacy|11|||
17009884|NCT00603278|38154710|FG003|Overall Study|Lack of Efficacy|8|||
17009885|NCT00603278|38154711|FG004|Overall Study|Lack of Efficacy|7|||
17009886|NCT00603278|38154712|FG005|Overall Study|Lack of Efficacy|14|||
17009887|NCT00603278|38154707|FG000|Overall Study|Adverse Event|0|||
17009888|NCT00603278|38154708|FG001|Overall Study|Adverse Event|3|||
17009889|NCT00603278|38154709|FG002|Overall Study|Adverse Event|1|||
17009890|NCT00603278|38154710|FG003|Overall Study|Adverse Event|0|||
17009891|NCT00603278|38154711|FG004|Overall Study|Adverse Event|2|||
17009892|NCT00603278|38154712|FG005|Overall Study|Adverse Event|1|||
17009893|NCT00603278|38154707|FG000|Overall Study|Withdrawal by Subject|2|||
17009894|NCT00603278|38154708|FG001|Overall Study|Withdrawal by Subject|3|||
17009895|NCT00603278|38154709|FG002|Overall Study|Withdrawal by Subject|1|||
17009896|NCT00603278|38154710|FG003|Overall Study|Withdrawal by Subject|2|||
17009897|NCT00603278|38154711|FG004|Overall Study|Withdrawal by Subject|1|||
17009898|NCT00603278|38154712|FG005|Overall Study|Withdrawal by Subject|2|||
17009899|NCT00603278|38154707|FG000|Overall Study|Protocol Violation|3|||
17009900|NCT00603278|38154708|FG001|Overall Study|Protocol Violation|0|||
17009901|NCT00603278|38154709|FG002|Overall Study|Protocol Violation|1|||
17009902|NCT00603278|38154710|FG003|Overall Study|Protocol Violation|1|||
17009903|NCT00603278|38154711|FG004|Overall Study|Protocol Violation|0|||
17009904|NCT00603278|38154712|FG005|Overall Study|Protocol Violation|1|||
17009905|NCT00603278|38154707|FG000|Overall Study|Physician Decision|0|||
17009906|NCT00603278|38154708|FG001|Overall Study|Physician Decision|1|||
17009907|NCT00603278|38154709|FG002|Overall Study|Physician Decision|0|||
17009908|NCT00603278|38154710|FG003|Overall Study|Physician Decision|0|||
17009909|NCT00603278|38154711|FG004|Overall Study|Physician Decision|2|||
17009910|NCT00603278|38154712|FG005|Overall Study|Physician Decision|1|||
17009911|NCT00603278|38154707|FG000|Overall Study|Lost to Follow-up|1|||
17009912|NCT00603278|38154708|FG001|Overall Study|Lost to Follow-up|0|||
17009913|NCT00603278|38154709|FG002|Overall Study|Lost to Follow-up|0|||
17009914|NCT00603278|38154710|FG003|Overall Study|Lost to Follow-up|0|||
17009915|NCT00603278|38154711|FG004|Overall Study|Lost to Follow-up|1|||
17009916|NCT00603278|38154712|FG005|Overall Study|Lost to Follow-up|0|||
17009917|NCT00876447|38154732|FG000|Overall Study|Other miscellaneous reasons|3|||
17009918|NCT00876447|38154733|FG001|Overall Study|Other miscellaneous reasons|8|||
17009919|NCT00876447|38154732|FG000|Overall Study|Site closure|19|||
17009920|NCT00876447|38154733|FG001|Overall Study|Site closure|14|||
17009921|NCT00876447|38154732|FG000|Overall Study|Protocol Violation|9|||
17009922|NCT00876447|38154733|FG001|Overall Study|Protocol Violation|3|||
17009923|NCT00876447|38154732|FG000|Overall Study|Personal reasons|30|||
17009924|NCT00876447|38154733|FG001|Overall Study|Personal reasons|28|||
17009925|NCT00876447|38154732|FG000|Overall Study|Lost to Follow-up|6|||
17009926|NCT00876447|38154733|FG001|Overall Study|Lost to Follow-up|15|||
17009927|NCT00876447|38154732|FG000|Overall Study|Pregnancy|4|||
17009928|NCT00876447|38154733|FG001|Overall Study|Pregnancy|2|||
17009929|NCT00876447|38154732|FG000|Overall Study|Lack of Efficacy|5|||
17009930|NCT00876447|38154733|FG001|Overall Study|Lack of Efficacy|3|||
17009931|NCT00876447|38154732|FG000|Overall Study|Adverse Event|4|||
17009932|NCT00876447|38154733|FG001|Overall Study|Adverse Event|8|||
17009933|NCT00598650|38154763|FG000|Overall Study|Withdrawal by Subject|3|||
17009934|NCT00598650|38154763|FG000|Overall Study|Adverse Event|18|||
17009935|NCT00598650|38154763|FG000|Overall Study|No treatment for 3 weeks|1|||
17009936|NCT00598650|38154763|FG000|Overall Study|Not eligible|1|||
17009937|NCT00598650|38154763|FG000|Overall Study|Prohibited Concomitant Medication|2|||
17009938|NCT00598650|38154763|FG000|Overall Study|Physician Decision|2|||
17009939|NCT04249076|38154770|FG000|Overall Study|Adverse Event|1|||
17009940|NCT04249076|38154771|FG001|Overall Study|Adverse Event|1|||
17009941|NCT04249076|38154770|FG000|Overall Study|Protocol Violation|1|||
17009942|NCT04249076|38154771|FG001|Overall Study|Protocol Violation|2|||
17009943|NCT04249076|38154770|FG000|Overall Study|Lack of Efficacy|0|||
17009944|NCT04249076|38154771|FG001|Overall Study|Lack of Efficacy|1|||
17009945|NCT04249076|38154770|FG000|Overall Study|Withdrawal by Subject|0|||
17009946|NCT04249076|38154771|FG001|Overall Study|Withdrawal by Subject|1|||
17009947|NCT04150107|38154779|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
17009948|NCT04150107|38154780|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
17009949|NCT04150107|38154779|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
17009950|NCT04150107|38154780|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
17009951|NCT04173494|38154790|FG000|Randomized Double-Blind Treatment Period|Adverse Event|16|||
17009952|NCT04173494|38154791|FG001|Randomized Double-Blind Treatment Period|Adverse Event|11|||
17009953|NCT04173494|38154790|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|6|||
17009954|NCT04173494|38154791|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|5|||
17009955|NCT04173494|38154790|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|6|||
17009956|NCT04173494|38154791|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|3|||
17009957|NCT04173494|38154790|FG000|Randomized Double-Blind Treatment Period|Death|4|||
17009958|NCT04173494|38154791|FG001|Randomized Double-Blind Treatment Period|Death|3|||
17009959|NCT04173494|38154790|FG000|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
17009960|NCT04173494|38154791|FG001|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
17009961|NCT04173494|38154790|FG000|Randomized Double-Blind Treatment Period|Disease Progression|1|||
17009962|NCT04173494|38154791|FG001|Randomized Double-Blind Treatment Period|Disease Progression|2|||
17009963|NCT04173494|38154790|FG000|Randomized Double-Blind Treatment Period|Lost to Follow-up|1|||
17096497|NCT01763866|38235599|FG014|Overall Study|Lost to Follow-up|1|||
17009964|NCT04173494|38154791|FG001|Randomized Double-Blind Treatment Period|Lost to Follow-up|0|||
17009965|NCT04173494|38154790|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
17009966|NCT04173494|38154791|FG001|Randomized Double-Blind Treatment Period|Physician Decision|1|||
17009967|NCT04173494|38154790|FG000|Open-Label Extended Treatment Period|Open-label treatment ongoing|52|||
17009968|NCT04173494|38154791|FG001|Open-Label Extended Treatment Period|Open-label treatment ongoing|22|||
17009969|NCT04173494|38154790|FG000|Open-Label Extended Treatment Period|Continuing in MMB extension study|24|||
17009970|NCT04173494|38154791|FG001|Open-Label Extended Treatment Period|Continuing in MMB extension study|9|||
17009971|NCT04173494|38154790|FG000|Open-Label Extended Treatment Period|Adverse Event|8|||
17009972|NCT04173494|38154791|FG001|Open-Label Extended Treatment Period|Adverse Event|1|||
17009973|NCT04173494|38154790|FG000|Open-Label Extended Treatment Period|Withdrawal by Subject|2|||
17009974|NCT04173494|38154791|FG001|Open-Label Extended Treatment Period|Withdrawal by Subject|3|||
17009975|NCT04173494|38154790|FG000|Open-Label Extended Treatment Period|Death|3|||
17009976|NCT04173494|38154791|FG001|Open-Label Extended Treatment Period|Death|1|||
17009977|NCT04173494|38154790|FG000|Open-Label Extended Treatment Period|Physician Decision|2|||
17009978|NCT04173494|38154791|FG001|Open-Label Extended Treatment Period|Physician Decision|2|||
17096498|NCT01763866|38235600|FG015|Overall Study|Lost to Follow-up|0|||
17096499|NCT01763866|38235601|FG016|Overall Study|Lost to Follow-up|0|||
17096500|NCT01763866|38235602|FG017|Overall Study|Lost to Follow-up|0|||
17096501|NCT01763866|38235603|FG018|Overall Study|Lost to Follow-up|1|||
17096502|NCT01763866|38235604|FG019|Overall Study|Lost to Follow-up|1|||
17096503|NCT01763866|38235605|FG020|Overall Study|Lost to Follow-up|0|||
17096504|NCT01763866|38235606|FG021|Overall Study|Lost to Follow-up|0|||
17096505|NCT01763866|38235607|FG022|Overall Study|Lost to Follow-up|0|||
17096506|NCT01763866|38235608|FG023|Overall Study|Lost to Follow-up|1|||
17096507|NCT01763866|38235585|FG000|Overall Study|Death|0|||
17096508|NCT01763866|38235586|FG001|Overall Study|Death|0|||
17096509|NCT01763866|38235587|FG002|Overall Study|Death|0|||
17096510|NCT01763866|38235588|FG003|Overall Study|Death|0|||
17096511|NCT01763866|38235589|FG004|Overall Study|Death|0|||
17096512|NCT01763866|38235590|FG005|Overall Study|Death|0|||
17096513|NCT01763866|38235591|FG006|Overall Study|Death|0|||
17096514|NCT01763866|38235592|FG007|Overall Study|Death|0|||
17096515|NCT01763866|38235593|FG008|Overall Study|Death|0|||
17096516|NCT01763866|38235594|FG009|Overall Study|Death|0|||
17096517|NCT01763866|38235595|FG010|Overall Study|Death|0|||
17096518|NCT01763866|38235596|FG011|Overall Study|Death|0|||
17096519|NCT01763866|38235597|FG012|Overall Study|Death|0|||
17096520|NCT01763866|38235598|FG013|Overall Study|Death|0|||
17096521|NCT01763866|38235599|FG014|Overall Study|Death|0|||
17096522|NCT01763866|38235600|FG015|Overall Study|Death|0|||
17096523|NCT01763866|38235601|FG016|Overall Study|Death|1|||
17096524|NCT01763866|38235602|FG017|Overall Study|Death|0|||
17096525|NCT01763866|38235603|FG018|Overall Study|Death|0|||
17096526|NCT01763866|38235604|FG019|Overall Study|Death|0|||
17096527|NCT01763866|38235605|FG020|Overall Study|Death|0|||
17096528|NCT01763866|38235606|FG021|Overall Study|Death|0|||
17096529|NCT01763866|38235607|FG022|Overall Study|Death|0|||
17096530|NCT01763866|38235608|FG023|Overall Study|Death|0|||
17096531|NCT00132873|38235658|FG000|Overall Study|Adverse Event|3|||
17096532|NCT00132873|38235658|FG000|Overall Study|Lost to Follow-up|1|||
17096533|NCT00132873|38235658|FG000|Overall Study|Lack of Efficacy|1|||
17096534|NCT00132873|38235658|FG000|Overall Study|Withdrawal by Subject|3|||
17096535|NCT00132873|38235658|FG000|Overall Study|Planned Pregnancy|1|||
17096536|NCT00120627|38235664|FG000|Overall Study|Withdrawal by Subject|5|||
17096537|NCT00120627|38235665|FG001|Overall Study|Withdrawal by Subject|5|||
17096538|NCT03762616|38235680|FG000|Overall Study|Protocol Violation|2|||
17096539|NCT04246996|38235688|FG000|Overall Study|Physician Decision|1|||
17096540|NCT04246996|38235689|FG001|Overall Study|Physician Decision|1|||
17096541|NCT04246996|38235688|FG000|Overall Study|Did not meet eligibility criteria|1|||
17096542|NCT04246996|38235689|FG001|Overall Study|Did not meet eligibility criteria|4|||
17096543|NCT00424463|38235698|FG000|Overall Study|Adverse Event|2|||
17096544|NCT00424463|38235699|FG001|Overall Study|Adverse Event|3|||
17096545|NCT00424463|38235700|FG002|Overall Study|Adverse Event|2|||
17096546|NCT00424463|38235698|FG000|Overall Study|Physician Decision|0|||
17096547|NCT00424463|38235699|FG001|Overall Study|Physician Decision|2|||
17096548|NCT00424463|38235700|FG002|Overall Study|Physician Decision|2|||
17096549|NCT00424463|38235698|FG000|Overall Study|Withdrawal by Subject|4|||
17096550|NCT00424463|38235699|FG001|Overall Study|Withdrawal by Subject|2|||
17193060|NCT02648204|38346370|FG003|Overall Study|Withdrawal by Subject|6|||
17193061|NCT02648204|38346367|FG000|Overall Study|Lost to Follow-up|5|||
17193062|NCT02648204|38346368|FG001|Overall Study|Lost to Follow-up|8|||
17096551|NCT00424463|38235700|FG002|Overall Study|Withdrawal by Subject|5|||
17096552|NCT00424463|38235698|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
17096553|NCT00424463|38235699|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
17096554|NCT00424463|38235700|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
17096555|NCT00424463|38235698|FG000|Overall Study|Patient's convenience|0|||
17193063|NCT02648204|38346369|FG002|Overall Study|Lost to Follow-up|4|||
17009979|NCT04173494|38154790|FG000|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
17009980|NCT04173494|38154791|FG001|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
17009981|NCT04173494|38154790|FG000|Open-Label Extended Treatment Period|Leukemic transformation|0|||
17009982|NCT04173494|38154791|FG001|Open-Label Extended Treatment Period|Leukemic transformation|1|||
17009983|NCT00875979|38154799|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
17009984|NCT00875979|38154800|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
17009985|NCT00875979|38154799|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
16908509|NCT01777308|38017204|FG001|Overall Study|Migrated/moved from study area|0|||
17009986|NCT00875979|38154800|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
17009987|NCT00875979|38154799|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
17009988|NCT00875979|38154800|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
17009989|NCT00875979|38154799|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
17009990|NCT00875979|38154800|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
17009991|NCT00875979|38154799|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
17009992|NCT00875979|38154800|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
17009993|NCT00875979|38154799|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
17009994|NCT00875979|38154800|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
17009995|NCT00875979|38154799|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
17096556|NCT00424463|38235699|FG001|Overall Study|Patient's convenience|0|||
17096557|NCT00424463|38235700|FG002|Overall Study|Patient's convenience|1|||
17096558|NCT00424385|38235708|FG000|Cohort 0|Withdrawal by Subject|5|||
17096559|NCT00424385|38235708|FG000|Cohort 0|Physician Decision|1|||
17096560|NCT00424385|38235708|FG000|Cohort 1|Withdrawal by Subject|1|||
17096561|NCT00423917|38235714|FG000|Overall Study|Cancel|2|||
17096562|NCT00423917|38235714|FG000|Overall Study|Ineligible|1|||
17096563|NCT00845026|38235720|FG000|Study Period III|Adverse Event|23|||
17096564|NCT00845026|38235721|FG001|Study Period III|Adverse Event|19|||
17096565|NCT00845026|38235720|FG000|Study Period III|Perceived lack of efficacy|27|||
17096566|NCT00845026|38235721|FG001|Study Period III|Perceived lack of efficacy|15|||
17096567|NCT00845026|38235720|FG000|Study Period III|Withdrawal by Subject|19|||
17096568|NCT00845026|38235721|FG001|Study Period III|Withdrawal by Subject|15|||
17096569|NCT00845026|38235720|FG000|Study Period III|Entry Criteria not met|8|||
17096570|NCT00845026|38235721|FG001|Study Period III|Entry Criteria not met|11|||
17096571|NCT00845026|38235720|FG000|Study Period III|Lost to Follow-up|4|||
17096572|NCT00845026|38235721|FG001|Study Period III|Lost to Follow-up|5|||
17096573|NCT00845026|38235720|FG000|Study Period III|Protocol Violation|8|||
17096574|NCT00845026|38235721|FG001|Study Period III|Protocol Violation|1|||
17096575|NCT00845026|38235720|FG000|Study Period III|Scheduled conflict|3|||
17096576|NCT00845026|38235721|FG001|Study Period III|Scheduled conflict|1|||
17096577|NCT00845026|38235720|FG000|Study Period III|Subject is moving or has moved|2|||
17096578|NCT00845026|38235721|FG001|Study Period III|Subject is moving or has moved|4|||
17096579|NCT00845026|38235720|FG000|Study Period III|Transportation issues|1|||
17096580|NCT00845026|38235721|FG001|Study Period III|Transportation issues|1|||
17096581|NCT00845026|38235720|FG000|Study Period IV|Adverse Event|4|||
17096582|NCT00845026|38235721|FG001|Study Period IV|Adverse Event|0|||
17096583|NCT00845026|38235720|FG000|Study Period IV|Perceived lack of efficacy|2|||
17096584|NCT00845026|38235721|FG001|Study Period IV|Perceived lack of efficacy|1|||
17096585|NCT00845026|38235720|FG000|Study Period IV|Protocol Violation|3|||
17096586|NCT00845026|38235721|FG001|Study Period IV|Protocol Violation|1|||
17096587|NCT00845026|38235720|FG000|Study Period IV|Lost to Follow-up|1|||
17096588|NCT00845026|38235721|FG001|Study Period IV|Lost to Follow-up|0|||
17096589|NCT00845026|38235720|FG000|Study Period IV|Withdrawal by Subject|4|||
17096590|NCT00845026|38235721|FG001|Study Period IV|Withdrawal by Subject|1|||
17096591|NCT00845026|38235720|FG000|Study Period IV|Entry Criteria Not Met|1|||
17096592|NCT00845026|38235721|FG001|Study Period IV|Entry Criteria Not Met|0|||
17096593|NCT00845026|38235720|FG000|Study Period IV|Subject is moving or has moved|0|||
17096594|NCT00845026|38235721|FG001|Study Period IV|Subject is moving or has moved|1|||
17096595|NCT00845026|38235720|FG000|Study Period IV|Scheduling conflict|1|||
17096596|NCT00845026|38235721|FG001|Study Period IV|Scheduling conflict|0|||
17096597|NCT00691678|38235729|FG000|Overall Study|Adverse Event|5|||
17096598|NCT00691678|38235729|FG000|Overall Study|life events, pain|11|||
17096599|NCT00423605|38235733|FG000|Overall Study|Adverse Event|129|||
17096600|NCT00423605|38235733|FG000|Overall Study|Withdrawal by Subject|36|||
17096601|NCT00423605|38235733|FG000|Overall Study|Lost to Follow-up|15|||
17096602|NCT00423605|38235733|FG000|Overall Study|Lack of Efficacy|38|||
17096603|NCT00423605|38235733|FG000|Overall Study|Sponsor Decision|3|||
17096604|NCT00423605|38235733|FG000|Overall Study|Physician Decision|8|||
17096605|NCT00423605|38235733|FG000|Overall Study|Protocol Violation|7|||
17096606|NCT00423605|38235733|FG000|Overall Study|Not one of the pre-specified options|5|||
17096607|NCT00003838|38235740|FG000|Overall Study|Death|0|||
17096608|NCT00003838|38235741|FG001|Overall Study|Death|12|||
17096609|NCT00003838|38235742|FG002|Overall Study|Death|7|||
17096610|NCT00003838|38235740|FG000|Overall Study|Lost to Follow-up|0|||
17096611|NCT00003838|38235741|FG001|Overall Study|Lost to Follow-up|1|||
17009996|NCT00875979|38154800|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
17009997|NCT00875979|38154799|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
17009998|NCT00875979|38154800|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
17009999|NCT00875979|38154799|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
17010000|NCT00875979|38154800|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
17010001|NCT00602420|38154808|FG000|Overall Study|Death|1|||
17010002|NCT00602420|38154809|FG001|Overall Study|Death|4|||
17010003|NCT00602420|38154808|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
17010004|NCT00602420|38154809|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
17010005|NCT00602420|38154808|FG000|Overall Study|Withdrawal by Subject|18|||
17010006|NCT00602420|38154809|FG001|Overall Study|Withdrawal by Subject|17|||
17010007|NCT00602420|38154808|FG000|Overall Study|Adverse Event|1|||
17010008|NCT00602420|38154809|FG001|Overall Study|Adverse Event|0|||
17010009|NCT00875667|38154823|FG000|Overall Study|Adverse Event|29|||
17010010|NCT00875667|38154824|FG001|Overall Study|Adverse Event|10|||
17010011|NCT00875667|38154823|FG000|Overall Study|Withdrawal by Subject|17|||
17010012|NCT00875667|38154824|FG001|Overall Study|Withdrawal by Subject|5|||
17010013|NCT00875667|38154823|FG000|Overall Study|Death|7|||
17010014|NCT00875667|38154824|FG001|Overall Study|Death|2|||
17010015|NCT00875667|38154823|FG000|Overall Study|Protocol Violation|2|||
17010016|NCT00875667|38154824|FG001|Overall Study|Protocol Violation|0|||
17010017|NCT00875667|38154823|FG000|Overall Study|Disease Progression|100|||
17010018|NCT00875667|38154824|FG001|Overall Study|Disease Progression|49|||
17010019|NCT00875667|38154823|FG000|Overall Study|Miscellaneous|12|||
17010020|NCT00875667|38154824|FG001|Overall Study|Miscellaneous|6|||
17010021|NCT00875667|38154823|FG000|Overall Study|Randomized but no Study Drug Given|3|||
17010022|NCT00875667|38154824|FG001|Overall Study|Randomized but no Study Drug Given|1|||
17010023|NCT00602030|38154834|FG000|Lead-in Phase|Disease Progression|2|||
17010024|NCT00602030|38154835|FG001|Lead-in Phase|Disease Progression|3|||
17010025|NCT00602030|38154836|FG002|Lead-in Phase|Disease Progression|0|||
17010026|NCT00602030|38154837|FG003|Lead-in Phase|Disease Progression|0|||
17010027|NCT00602030|38154838|FG004|Lead-in Phase|Disease Progression|0|||
17010028|NCT00602030|38154834|FG000|Lead-in Phase|Adverse Event|0|||
17010029|NCT00602030|38154835|FG001|Lead-in Phase|Adverse Event|2|||
17010030|NCT00602030|38154836|FG002|Lead-in Phase|Adverse Event|0|||
17010031|NCT00602030|38154837|FG003|Lead-in Phase|Adverse Event|0|||
17010032|NCT00602030|38154838|FG004|Lead-in Phase|Adverse Event|0|||
17010033|NCT00602030|38154834|FG000|Double-blind Phase|Disease progression|0|||
17010034|NCT00602030|38154835|FG001|Double-blind Phase|Disease progression|0|||
17010035|NCT00602030|38154836|FG002|Double-blind Phase|Disease progression|33|||
17010036|NCT00602030|38154837|FG003|Double-blind Phase|Disease progression|30|||
17010037|NCT00602030|38154838|FG004|Double-blind Phase|Disease progression|0|||
17010038|NCT00602030|38154834|FG000|Double-blind Phase|Adverse Event|0|||
17010039|NCT00602030|38154835|FG001|Double-blind Phase|Adverse Event|0|||
17010040|NCT00602030|38154836|FG002|Double-blind Phase|Adverse Event|9|||
17010041|NCT00602030|38154837|FG003|Double-blind Phase|Adverse Event|18|||
17010042|NCT00602030|38154838|FG004|Double-blind Phase|Adverse Event|0|||
17010043|NCT00602030|38154834|FG000|Double-blind Phase|Consent withdrawal|0|||
17010044|NCT00602030|38154835|FG001|Double-blind Phase|Consent withdrawal|0|||
17010045|NCT00602030|38154836|FG002|Double-blind Phase|Consent withdrawal|4|||
17010046|NCT00602030|38154837|FG003|Double-blind Phase|Consent withdrawal|3|||
17010047|NCT00602030|38154838|FG004|Double-blind Phase|Consent withdrawal|0|||
17010048|NCT00602030|38154834|FG000|Double-blind Phase|Death|0|||
17010049|NCT00602030|38154835|FG001|Double-blind Phase|Death|0|||
17010050|NCT00602030|38154836|FG002|Double-blind Phase|Death|3|||
17010051|NCT00602030|38154837|FG003|Double-blind Phase|Death|3|||
17010052|NCT00602030|38154838|FG004|Double-blind Phase|Death|0|||
17010053|NCT00602030|38154834|FG000|Double-blind Phase|Administrative decision|0|||
17010054|NCT00602030|38154835|FG001|Double-blind Phase|Administrative decision|0|||
17010055|NCT00602030|38154836|FG002|Double-blind Phase|Administrative decision|0|||
17010056|NCT00602030|38154837|FG003|Double-blind Phase|Administrative decision|2|||
17010057|NCT00602030|38154838|FG004|Double-blind Phase|Administrative decision|0|||
17010058|NCT00602030|38154834|FG000|Double-blind Phase|Ineligibility|0|||
17010059|NCT00602030|38154835|FG001|Double-blind Phase|Ineligibility|0|||
17010060|NCT00602030|38154836|FG002|Double-blind Phase|Ineligibility|0|||
17010061|NCT00602030|38154837|FG003|Double-blind Phase|Ineligibility|1|||
17010062|NCT00602030|38154838|FG004|Double-blind Phase|Ineligibility|0|||
17010063|NCT00602030|38154834|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
17010064|NCT00602030|38154835|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
17010065|NCT00602030|38154836|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
17010066|NCT00602030|38154837|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
17010067|NCT00602030|38154838|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
17010068|NCT00602030|38154834|FG000|Double-blind Phase|Reason not specified|0|||
17010069|NCT00602030|38154835|FG001|Double-blind Phase|Reason not specified|0|||
17010070|NCT00602030|38154836|FG002|Double-blind Phase|Reason not specified|4|||
17010071|NCT00602030|38154837|FG003|Double-blind Phase|Reason not specified|2|||
17096612|NCT00003838|38235742|FG002|Overall Study|Lost to Follow-up|1|||
17010072|NCT00602030|38154838|FG004|Double-blind Phase|Reason not specified|0|||
17010073|NCT00602030|38154834|FG000|Crossover Phase|Disease Progression|0|||
17010074|NCT00602030|38154835|FG001|Crossover Phase|Disease Progression|0|||
17010075|NCT00602030|38154836|FG002|Crossover Phase|Disease Progression|0|||
17010076|NCT00602030|38154837|FG003|Crossover Phase|Disease Progression|0|||
17010077|NCT00602030|38154838|FG004|Crossover Phase|Disease Progression|11|||
17010078|NCT00602030|38154834|FG000|Crossover Phase|Adverse Event|0|||
17010079|NCT00602030|38154835|FG001|Crossover Phase|Adverse Event|0|||
17010080|NCT00602030|38154836|FG002|Crossover Phase|Adverse Event|0|||
17010081|NCT00602030|38154837|FG003|Crossover Phase|Adverse Event|0|||
17010082|NCT00602030|38154838|FG004|Crossover Phase|Adverse Event|3|||
17010083|NCT00602030|38154834|FG000|Crossover Phase|Consent withdrawal|0|||
17010084|NCT00602030|38154835|FG001|Crossover Phase|Consent withdrawal|0|||
17010085|NCT00602030|38154836|FG002|Crossover Phase|Consent withdrawal|0|||
17010086|NCT00602030|38154837|FG003|Crossover Phase|Consent withdrawal|0|||
17010087|NCT00602030|38154838|FG004|Crossover Phase|Consent withdrawal|2|||
17010088|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
17010089|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
17010090|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
17010091|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
17010092|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
17010093|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
17010094|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
17010095|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
17010096|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
17010097|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
17010098|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
17010099|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
17010100|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
17010101|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
17010102|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
17010103|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
17010104|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
17010105|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
17010106|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
17010107|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
17010108|NCT00549757|38154852|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
17010109|NCT00549757|38154853|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
17010110|NCT00549757|38154852|FG000|Extension Period (in Average 9 Months)|Death|143|||
17010111|NCT00549757|38154853|FG001|Extension Period (in Average 9 Months)|Death|136|||
17010112|NCT00549757|38154852|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
17010113|NCT00549757|38154853|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
17010114|NCT00549757|38154852|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
17010115|NCT00549757|38154853|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
17010116|NCT00549757|38154852|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
17010117|NCT00549757|38154853|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
17010118|NCT00549601|38154868|FG000|Randomized|Protocol Violation|0|||
17010119|NCT00549601|38154869|FG001|Randomized|Protocol Violation|0|||
17010120|NCT00549601|38154870|FG002|Randomized|Protocol Violation|1|||
17010121|NCT00549601|38154868|FG000|Randomized|Withdrawal by Subject|0|||
17010122|NCT00549601|38154869|FG001|Randomized|Withdrawal by Subject|1|||
17010123|NCT00549601|38154870|FG002|Randomized|Withdrawal by Subject|1|||
17010124|NCT00549601|38154868|FG000|Received Study Drug|Adverse Event|2|||
17010125|NCT00549601|38154869|FG001|Received Study Drug|Adverse Event|5|||
17010126|NCT00549601|38154870|FG002|Received Study Drug|Adverse Event|1|||
17010127|NCT00549601|38154868|FG000|Received Study Drug|Death|0|||
17010128|NCT00549601|38154869|FG001|Received Study Drug|Death|1|||
17010129|NCT00549601|38154870|FG002|Received Study Drug|Death|0|||
17010130|NCT00549601|38154868|FG000|Received Study Drug|Lost to Follow-up|0|||
17010131|NCT00549601|38154869|FG001|Received Study Drug|Lost to Follow-up|1|||
17010132|NCT00549601|38154870|FG002|Received Study Drug|Lost to Follow-up|1|||
17010133|NCT00549601|38154868|FG000|Received Study Drug|Protocol Violation|3|||
17010134|NCT00549601|38154869|FG001|Received Study Drug|Protocol Violation|4|||
17010135|NCT00549601|38154870|FG002|Received Study Drug|Protocol Violation|1|||
17010136|NCT00549601|38154868|FG000|Received Study Drug|Withdrawal by Subject|2|||
17010137|NCT00549601|38154869|FG001|Received Study Drug|Withdrawal by Subject|0|||
17010138|NCT00549601|38154870|FG002|Received Study Drug|Withdrawal by Subject|1|||
17010139|NCT00601640|38154896|FG000|Overall Study|Withdrawal by Subject|3|||
17010140|NCT00601640|38154897|FG001|Overall Study|Withdrawal by Subject|0|||
17010141|NCT00601640|38154898|FG002|Overall Study|Withdrawal by Subject|7|||
17010142|NCT00601640|38154896|FG000|Overall Study|Death|1|||
17010143|NCT00601640|38154897|FG001|Overall Study|Death|0|||
17010144|NCT00601640|38154898|FG002|Overall Study|Death|0|||
17010145|NCT00601640|38154896|FG000|Overall Study|Adverse Event|0|||
17010146|NCT00601640|38154897|FG001|Overall Study|Adverse Event|4|||
17010147|NCT00601640|38154898|FG002|Overall Study|Adverse Event|2|||
17010148|NCT00601640|38154896|FG000|Overall Study|intercurrent illness|1|||
17010149|NCT00601640|38154897|FG001|Overall Study|intercurrent illness|0|||
17010150|NCT00601640|38154898|FG002|Overall Study|intercurrent illness|0|||
17096613|NCT00003838|38235740|FG000|Overall Study|Disease Progression|0|||
17096614|NCT00003838|38235741|FG001|Overall Study|Disease Progression|12|||
17096615|NCT00003838|38235742|FG002|Overall Study|Disease Progression|0|||
17096616|NCT00423449|38235749|FG000|Overall Study|Clinical Adverse Event|1|||
17096617|NCT00423449|38235750|FG001|Overall Study|Clinical Adverse Event|0|||
17096618|NCT00423449|38235751|FG002|Overall Study|Clinical Adverse Event|1|||
17096619|NCT00423449|38235752|FG003|Overall Study|Clinical Adverse Event|8|||
17096620|NCT00423449|38235753|FG004|Overall Study|Clinical Adverse Event|2|||
17096621|NCT00423449|38235749|FG000|Overall Study|Death|1|||
17096622|NCT00423449|38235750|FG001|Overall Study|Death|0|||
17096623|NCT00423449|38235751|FG002|Overall Study|Death|2|||
17096624|NCT00423449|38235752|FG003|Overall Study|Death|1|||
17096625|NCT00423449|38235753|FG004|Overall Study|Death|1|||
17096626|NCT00423449|38235749|FG000|Overall Study|Progressive Disease|1|||
17010151|NCT00601640|38154896|FG000|Overall Study|change in eligibility status|0|||
17010152|NCT00601640|38154897|FG001|Overall Study|change in eligibility status|1|||
17010153|NCT00601640|38154898|FG002|Overall Study|change in eligibility status|1|||
17010154|NCT02805725|38154913|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
17010155|NCT02805725|38154914|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
17010156|NCT02805725|38154915|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
17010157|NCT02805725|38154916|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
17010158|NCT02805725|38154917|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
17010159|NCT02805725|38154913|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
17010160|NCT02805725|38154914|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
17010161|NCT02805725|38154915|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
17010162|NCT02805725|38154916|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
17010163|NCT02805725|38154917|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
17010164|NCT02805725|38154913|FG000|Phase II|Protocol Violation|0|||
17010165|NCT02805725|38154914|FG001|Phase II|Protocol Violation|0|||
17010166|NCT02805725|38154915|FG002|Phase II|Protocol Violation|0|||
17010167|NCT02805725|38154916|FG003|Phase II|Protocol Violation|0|||
17010168|NCT02805725|38154917|FG004|Phase II|Protocol Violation|6|||
17010169|NCT00546871|38154934|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
17010170|NCT00546871|38154935|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
17010171|NCT00546871|38154934|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
17010172|NCT00546871|38154935|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
17010173|NCT00546871|38154934|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
17010174|NCT00546871|38154935|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
17010175|NCT00546871|38154934|FG000|Study Extension Period|Protocol Violation|1|||
17010176|NCT00546871|38154935|FG001|Study Extension Period|Protocol Violation|0|||
17010177|NCT00546871|38154934|FG000|Study Extension Period|Withdrawal by Subject|0|||
17010178|NCT00546871|38154935|FG001|Study Extension Period|Withdrawal by Subject|1|||
17010179|NCT03951805|38154968|FG000|Overall Study|Adverse Event|1|||
17010180|NCT03951805|38154969|FG001|Overall Study|Adverse Event|0|||
17010181|NCT03951805|38154970|FG002|Overall Study|Adverse Event|0|||
17010182|NCT03951805|38154971|FG003|Overall Study|Adverse Event|0|||
17010183|NCT03944707|38154983|FG000|Overall Study|Adverse Event|0|||
17010184|NCT03944707|38154984|FG001|Overall Study|Adverse Event|2|||
17010185|NCT03944707|38154983|FG000|Overall Study|Study terminated by sponsor|12|||
17010186|NCT03944707|38154984|FG001|Overall Study|Study terminated by sponsor|7|||
17010187|NCT03944707|38154983|FG000|Overall Study|Subject decision|0|||
17010188|NCT03944707|38154984|FG001|Overall Study|Subject decision|1|||
17010189|NCT00549055|38154990|FG000|Overall Study|Adverse Event|4|||
17010190|NCT00549055|38154990|FG000|Overall Study|Lack of Efficacy|18|||
17010191|NCT00549055|38154990|FG000|Overall Study|Stabilization|5|||
17010192|NCT00549055|38154990|FG000|Overall Study|Progression to fibrosis|2|||
17010193|NCT00549055|38154990|FG000|Overall Study|Decrease of size|1|||
17010194|NCT00549055|38154990|FG000|Overall Study|Active choroidal neovascula increased|1|||
17010195|NCT00549055|38154990|FG000|Overall Study|Vitreous hemorrhage|1|||
17010196|NCT00549055|38154990|FG000|Overall Study|Growth choroidal neovascularisation|1|||
17010197|NCT00549055|38154990|FG000|Overall Study|Choroidal neovascularization|1|||
17010198|NCT00549055|38154990|FG000|Overall Study|Very low visual acuity (VA)|1|||
17010199|NCT00883116|38154996|FG000|Overall Study|Adverse event unrelated to study drug|5|||
17096627|NCT00423449|38235750|FG001|Overall Study|Progressive Disease|3|||
17096628|NCT00423449|38235751|FG002|Overall Study|Progressive Disease|8|||
17096629|NCT00423449|38235752|FG003|Overall Study|Progressive Disease|11|||
17096630|NCT00423449|38235753|FG004|Overall Study|Progressive Disease|4|||
17096631|NCT00423449|38235749|FG000|Overall Study|Laboratory Adverse Event|0|||
17010200|NCT00883116|38154997|FG001|Overall Study|Adverse event unrelated to study drug|10|||
17010201|NCT00883116|38154996|FG000|Overall Study|Death|6|||
17010202|NCT00883116|38154997|FG001|Overall Study|Death|2|||
17010203|NCT00883116|38154996|FG000|Overall Study|Disease progression|130|||
17010204|NCT00883116|38154997|FG001|Overall Study|Disease progression|128|||
17010205|NCT00883116|38154996|FG000|Overall Study|Lost to Follow-up|0|||
17010206|NCT00883116|38154997|FG001|Overall Study|Lost to Follow-up|1|||
17010207|NCT00883116|38154996|FG000|Overall Study|Maximum clinical benefit|13|||
17010208|NCT00883116|38154997|FG001|Overall Study|Maximum clinical benefit|46|||
17010209|NCT00883116|38154996|FG000|Overall Study|Not identified|3|||
17010210|NCT00883116|38154997|FG001|Overall Study|Not identified|6|||
17010211|NCT00883116|38154996|FG000|Overall Study|Study drug toxicity|36|||
17010212|NCT00883116|38154997|FG001|Overall Study|Study drug toxicity|16|||
17010213|NCT00883116|38154996|FG000|Overall Study|Withdrawal by Subject|14|||
17010214|NCT00883116|38154997|FG001|Overall Study|Withdrawal by Subject|8|||
17010215|NCT00883116|38154996|FG000|Overall Study|No longer meets study criteria|2|||
17010216|NCT00883116|38154997|FG001|Overall Study|No longer meets study criteria|2|||
17010217|NCT00594399|38155016|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
17010218|NCT00594399|38155017|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
17010219|NCT00594399|38155018|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
17010220|NCT00594399|38155016|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
17010221|NCT00594399|38155017|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
17010222|NCT00594399|38155018|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
17010223|NCT00594399|38155016|FG000|Initial 3 Month Counseling|Personal issues|2|||
17010224|NCT00594399|38155017|FG001|Initial 3 Month Counseling|Personal issues|0|||
17010225|NCT00594399|38155018|FG002|Initial 3 Month Counseling|Personal issues|0|||
17096632|NCT00423449|38235750|FG001|Overall Study|Laboratory Adverse Event|1|||
17096633|NCT00423449|38235751|FG002|Overall Study|Laboratory Adverse Event|2|||
17010226|NCT00594399|38155016|FG000|Initial 3 Month Counseling|Too busy|7|||
17010227|NCT00594399|38155017|FG001|Initial 3 Month Counseling|Too busy|1|||
17010228|NCT00594399|38155018|FG002|Initial 3 Month Counseling|Too busy|0|||
17010229|NCT00594399|38155016|FG000|Initial 3 Month Counseling|Pain|2|||
17010230|NCT00594399|38155017|FG001|Initial 3 Month Counseling|Pain|0|||
17010231|NCT00594399|38155018|FG002|Initial 3 Month Counseling|Pain|0|||
17010232|NCT00594399|38155016|FG000|Initial 3 Month Counseling|Moved|1|||
17010233|NCT00594399|38155017|FG001|Initial 3 Month Counseling|Moved|0|||
17010234|NCT00594399|38155018|FG002|Initial 3 Month Counseling|Moved|0|||
17010235|NCT00594399|38155016|FG000|Initial 3 Month Counseling|Family illness|1|||
17010236|NCT00594399|38155017|FG001|Initial 3 Month Counseling|Family illness|0|||
17010237|NCT00594399|38155018|FG002|Initial 3 Month Counseling|Family illness|0|||
17010238|NCT00594399|38155016|FG000|Rerandomization Arm 1 Only|Death|2|||
17010239|NCT00594399|38155017|FG001|Rerandomization Arm 1 Only|Death|1|||
17010240|NCT00594399|38155018|FG002|Rerandomization Arm 1 Only|Death|0|||
17010241|NCT00594399|38155016|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
17010242|NCT00594399|38155017|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
17010243|NCT00594399|38155018|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
17010244|NCT00546715|38155028|FG000|Overall Study|Withdrawal by Subject|0|||
17010245|NCT00546715|38155029|FG001|Overall Study|Withdrawal by Subject|1|||
17010246|NCT00546715|38155030|FG002|Overall Study|Withdrawal by Subject|0|||
17010247|NCT00546715|38155031|FG003|Overall Study|Withdrawal by Subject|0|||
17010248|NCT00874029|38155041|FG000|Overall Study|Withdrawal by Subject|10|||
17010249|NCT00874029|38155041|FG000|Overall Study|Pregnancy|4|||
17096634|NCT00423449|38235752|FG003|Overall Study|Laboratory Adverse Event|0|||
17096635|NCT00423449|38235753|FG004|Overall Study|Laboratory Adverse Event|0|||
17096636|NCT00423449|38235749|FG000|Overall Study|Other|0|||
17096637|NCT00423449|38235750|FG001|Overall Study|Other|0|||
17096638|NCT00423449|38235751|FG002|Overall Study|Other|0|||
17096639|NCT00423449|38235752|FG003|Overall Study|Other|1|||
17096640|NCT00423449|38235753|FG004|Overall Study|Other|0|||
17096641|NCT00423449|38235749|FG000|Overall Study|Protocol Violation|0|||
17096642|NCT00423449|38235750|FG001|Overall Study|Protocol Violation|0|||
17096643|NCT00423449|38235751|FG002|Overall Study|Protocol Violation|2|||
17096644|NCT00423449|38235752|FG003|Overall Study|Protocol Violation|1|||
17096645|NCT00423449|38235753|FG004|Overall Study|Protocol Violation|0|||
17096646|NCT00423293|38235766|FG000|Overall Study|Ineligible / No protocol treatment|11|||
17096647|NCT00423137|38235774|FG000|Overall Study|Lost to Follow-up|0|||
17096648|NCT00423137|38235775|FG001|Overall Study|Lost to Follow-up|0|||
17096649|NCT00423137|38235776|FG002|Overall Study|Lost to Follow-up|1|||
17010250|NCT00874029|38155041|FG000|Overall Study|Physician Decision|1|||
17010251|NCT00874029|38155041|FG000|Overall Study|Adverse Event|1|||
17010252|NCT00874029|38155041|FG000|Overall Study|Lost to Follow-up|5|||
17010253|NCT00546637|38155057|FG000|Overall Study|Adverse Event|46|||
17010254|NCT00546637|38155058|FG001|Overall Study|Adverse Event|20|||
17010255|NCT00546637|38155057|FG000|Overall Study|Lack of Efficacy|5|||
17010256|NCT00546637|38155058|FG001|Overall Study|Lack of Efficacy|5|||
17010257|NCT00546637|38155057|FG000|Overall Study|Lost to Follow-up|2|||
17010258|NCT00546637|38155058|FG001|Overall Study|Lost to Follow-up|2|||
17010259|NCT00546637|38155057|FG000|Overall Study|Other|10|||
17010260|NCT00546637|38155058|FG001|Overall Study|Other|12|||
17010261|NCT00546637|38155057|FG000|Overall Study|Withdrawal by Subject|7|||
17010262|NCT00546637|38155058|FG001|Overall Study|Withdrawal by Subject|9|||
17010263|NCT00546637|38155057|FG000|Overall Study|Randomized, but not treated|3|||
17010264|NCT00546637|38155058|FG001|Overall Study|Randomized, but not treated|1|||
17096650|NCT00423137|38235777|FG003|Overall Study|Lost to Follow-up|0|||
17096651|NCT00423137|38235774|FG000|Overall Study|Protocol Violation|0|||
17096652|NCT00423137|38235775|FG001|Overall Study|Protocol Violation|0|||
17096653|NCT00423137|38235776|FG002|Overall Study|Protocol Violation|0|||
17096654|NCT00423137|38235777|FG003|Overall Study|Protocol Violation|1|||
17096655|NCT00423137|38235774|FG000|Overall Study|Adverse Event Study disease worse|1|||
17096656|NCT00423137|38235775|FG001|Overall Study|Adverse Event Study disease worse|0|||
17096657|NCT00423137|38235776|FG002|Overall Study|Adverse Event Study disease worse|3|||
17096658|NCT00423137|38235777|FG003|Overall Study|Adverse Event Study disease worse|1|||
17096659|NCT00423137|38235774|FG000|Overall Study|Adverse Event Other|0|||
17096660|NCT00423137|38235775|FG001|Overall Study|Adverse Event Other|0|||
17096661|NCT00423137|38235776|FG002|Overall Study|Adverse Event Other|2|||
17096662|NCT00423137|38235777|FG003|Overall Study|Adverse Event Other|0|||
17096663|NCT00422903|38235792|FG000|Overall Study|Disease Progression|3|||
17096664|NCT00422903|38235793|FG001|Overall Study|Disease Progression|1|||
17096665|NCT00422903|38235792|FG000|Overall Study|Adverse Event|0|||
17096666|NCT00422903|38235793|FG001|Overall Study|Adverse Event|2|||
17096667|NCT00422903|38235792|FG000|Overall Study|Informed Consent Withdrawn|1|||
17096668|NCT00422903|38235793|FG001|Overall Study|Informed Consent Withdrawn|2|||
17096669|NCT00422669|38235802|FG000|Overall Study|The study was terminated early.|98|||
17096670|NCT00422669|38235803|FG001|Overall Study|The study was terminated early.|100|||
17096671|NCT00422669|38235804|FG002|Overall Study|The study was terminated early.|7|||
17096672|NCT00422591|38235810|FG000|Overall Study|Physician Decision|4|||
17096673|NCT00422591|38235810|FG000|Overall Study|Withdrawal by Subject|2|||
17096674|NCT00422513|38235816|FG000|Overall Study|Lack of Efficacy|4|||
17096675|NCT00422513|38235817|FG001|Overall Study|Lack of Efficacy|5|||
17096676|NCT00422513|38235816|FG000|Overall Study|Protocol Violation|23|||
17096677|NCT00422513|38235817|FG001|Overall Study|Protocol Violation|7|||
17096678|NCT00422513|38235816|FG000|Overall Study|Refused Treatment|4|||
17096679|NCT00422513|38235817|FG001|Overall Study|Refused Treatment|2|||
17096680|NCT00422513|38235816|FG000|Overall Study|Withdrawal by Subject|2|||
17096681|NCT00422513|38235817|FG001|Overall Study|Withdrawal by Subject|1|||
17096682|NCT00422513|38235816|FG000|Overall Study|early termination of the study|67|||
17096683|NCT00422513|38235817|FG001|Overall Study|early termination of the study|80|||
17096684|NCT00422513|38235816|FG000|Overall Study|Adverse Event|4|||
17096685|NCT00422513|38235817|FG001|Overall Study|Adverse Event|4|||
17096686|NCT00422513|38235816|FG000|Overall Study|Death|3|||
17096687|NCT00422513|38235817|FG001|Overall Study|Death|7|||
17096688|NCT00202878|38235825|FG000|Overall Study|Death|964|||
17096689|NCT00202878|38235826|FG001|Overall Study|Death|968|||
17193064|NCT02648204|38346370|FG003|Overall Study|Lost to Follow-up|6|||
17193065|NCT02648204|38346367|FG000|Overall Study|Missing follow-up information|4|||
17193066|NCT02648204|38346368|FG001|Overall Study|Missing follow-up information|4|||
17193067|NCT02648204|38346369|FG002|Overall Study|Missing follow-up information|4|||
17193068|NCT02648204|38346370|FG003|Overall Study|Missing follow-up information|2|||
17193069|NCT02648204|38346367|FG000|Overall Study|Death|1|||
17193070|NCT02648204|38346368|FG001|Overall Study|Death|1|||
17193071|NCT02648204|38346369|FG002|Overall Study|Death|2|||
17193072|NCT02648204|38346370|FG003|Overall Study|Death|2|||
17193073|NCT02648204|38346367|FG000|Overall Study|Adverse Event|0|||
17193074|NCT02648204|38346368|FG001|Overall Study|Adverse Event|0|||
17193075|NCT02648204|38346369|FG002|Overall Study|Adverse Event|1|||
17193076|NCT02648204|38346370|FG003|Overall Study|Adverse Event|0|||
17193077|NCT02799745|38346382|FG000|Overall Study|Participant moved out of state|1|||
17193078|NCT02799745|38346383|FG001|Overall Study|Participant moved out of state|0|||
17193079|NCT02799745|38346382|FG000|Overall Study|Discontinued due to planned surgery|1|||
17193080|NCT02799745|38346383|FG001|Overall Study|Discontinued due to planned surgery|0|||
17193081|NCT02799745|38346382|FG000|Overall Study|Withdrawal by Subject|16|||
17193082|NCT02799745|38346383|FG001|Overall Study|Withdrawal by Subject|25|||
17193083|NCT02799745|38346382|FG000|Overall Study|Protocol Deviation|4|||
17193084|NCT02799745|38346383|FG001|Overall Study|Protocol Deviation|5|||
17193085|NCT02799745|38346382|FG000|Overall Study|Progressive Disease|28|||
17193086|NCT02799745|38346383|FG001|Overall Study|Progressive Disease|38|||
17193087|NCT02799745|38346382|FG000|Overall Study|Lost to Follow-up|3|||
17096690|NCT00202878|38235825|FG000|Overall Study|Only Vital Status Known|357|||
17193088|NCT02799745|38346383|FG001|Overall Study|Lost to Follow-up|2|||
17193089|NCT02799745|38346382|FG000|Overall Study|Death|3|||
17096691|NCT00202878|38235826|FG001|Overall Study|Only Vital Status Known|356|||
17096692|NCT00202878|38235825|FG000|Overall Study|Lost to Follow-up|44|||
17096693|NCT00202878|38235826|FG001|Overall Study|Lost to Follow-up|49|||
17096694|NCT00202878|38235825|FG000|Overall Study|Site Closure|39|||
17096695|NCT00202878|38235826|FG001|Overall Study|Site Closure|36|||
17096696|NCT00202878|38235825|FG000|Overall Study|Withdrawal by Subject|795|||
17096697|NCT00202878|38235826|FG001|Overall Study|Withdrawal by Subject|808|||
17096698|NCT00414011|38235832|FG000|Overall Study|Physician Decision|3|||
17096699|NCT00414011|38235832|FG000|Overall Study|Withdrawal by Subject|2|||
17096700|NCT00231816|38235839|FG000|Overall Study|Adverse Event|1|||
17096701|NCT00231816|38235840|FG001|Overall Study|Adverse Event|0|||
17096702|NCT00231816|38235839|FG000|Overall Study|Lost to Follow-up|8|||
17096703|NCT00231816|38235840|FG001|Overall Study|Lost to Follow-up|5|||
17096704|NCT00231816|38235839|FG000|Overall Study|Protocol Violation|2|||
17096705|NCT00231816|38235840|FG001|Overall Study|Protocol Violation|3|||
17010265|NCT00546481|38155066|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
17096706|NCT00231816|38235839|FG000|Overall Study|Withdrawal by Subject|3|||
17096707|NCT00231816|38235840|FG001|Overall Study|Withdrawal by Subject|3|||
17096708|NCT00231816|38235839|FG000|Overall Study|Other|2|||
17096709|NCT00231816|38235840|FG001|Overall Study|Other|1|||
17096710|NCT00260208|38235849|FG000|Overall Study|Subject withdrew consent|11|||
17096711|NCT00260208|38235850|FG001|Overall Study|Subject withdrew consent|7|||
17096712|NCT00260208|38235849|FG000|Overall Study|Lost to Follow-up|6|||
16908510|NCT01777308|38017203|FG000|Overall Study|Lost to Follow-up|7|||
16908511|NCT01777308|38017204|FG001|Overall Study|Lost to Follow-up|2|||
16908512|NCT01777308|38017203|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
16908513|NCT01777308|38017204|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
16908514|NCT01759368|38017213|FG000|Overall Study|Lost to Follow-up|1|||
17010266|NCT00546481|38155067|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
17010267|NCT00546481|38155068|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
17010268|NCT00546481|38155066|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
17010269|NCT00546481|38155067|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
17010270|NCT00546481|38155068|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
17010271|NCT00546481|38155066|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
17010272|NCT00546481|38155067|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
17010273|NCT00546481|38155068|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
17010274|NCT00546481|38155066|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
17010275|NCT00546481|38155067|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
17010276|NCT00546481|38155068|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
17010277|NCT00546481|38155066|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
17010278|NCT00546481|38155067|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
17010279|NCT00546481|38155068|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
17010280|NCT00546481|38155066|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
17010281|NCT00546481|38155067|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
17010282|NCT00546481|38155068|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
17010283|NCT00546481|38155066|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
17010284|NCT00546481|38155067|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
17010285|NCT00546481|38155068|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
17010286|NCT00546481|38155066|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
17010287|NCT00546481|38155067|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
17010288|NCT00546481|38155068|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
17010289|NCT00546481|38155066|FG000|Maintenance Phase (CERA)|Other Reason|0|||
17010290|NCT00546481|38155067|FG001|Maintenance Phase (CERA)|Other Reason|0|||
17010291|NCT00546481|38155068|FG002|Maintenance Phase (CERA)|Other Reason|1|||
17010292|NCT00880698|38155080|FG000|Overall Study|Death|0|||
17010293|NCT00880698|38155081|FG001|Overall Study|Death|0|||
17010294|NCT00880698|38155082|FG002|Overall Study|Death|1|||
17010295|NCT00880698|38155083|FG003|Overall Study|Death|2|||
17010296|NCT00880698|38155080|FG000|Overall Study|Lost to Follow-up|1|||
17010297|NCT00880698|38155081|FG001|Overall Study|Lost to Follow-up|3|||
17010298|NCT00880698|38155082|FG002|Overall Study|Lost to Follow-up|0|||
17010299|NCT00880698|38155083|FG003|Overall Study|Lost to Follow-up|1|||
17010300|NCT00880620|38155099|FG000|Overall Study|Adverse Event|4|||
17010301|NCT00880620|38155100|FG001|Overall Study|Adverse Event|5|||
17010302|NCT00880620|38155101|FG002|Overall Study|Adverse Event|15|||
17010303|NCT00880620|38155102|FG003|Overall Study|Adverse Event|15|||
17010304|NCT00880620|38155099|FG000|Overall Study|Death|0|||
17010305|NCT00880620|38155100|FG001|Overall Study|Death|0|||
17010306|NCT00880620|38155101|FG002|Overall Study|Death|1|||
17010307|NCT00880620|38155102|FG003|Overall Study|Death|0|||
17010308|NCT00880620|38155099|FG000|Overall Study|Lack of Efficacy|12|||
17010309|NCT00880620|38155100|FG001|Overall Study|Lack of Efficacy|4|||
17010310|NCT00880620|38155101|FG002|Overall Study|Lack of Efficacy|0|||
17010311|NCT00880620|38155102|FG003|Overall Study|Lack of Efficacy|1|||
17096713|NCT00260208|38235850|FG001|Overall Study|Lost to Follow-up|1|||
17010312|NCT00880620|38155099|FG000|Overall Study|Lost to Follow-up|0|||
17010313|NCT00880620|38155100|FG001|Overall Study|Lost to Follow-up|1|||
17010314|NCT00880620|38155101|FG002|Overall Study|Lost to Follow-up|1|||
17010315|NCT00880620|38155102|FG003|Overall Study|Lost to Follow-up|0|||
17010316|NCT00880620|38155099|FG000|Overall Study|Protocol Violation|0|||
17010317|NCT00880620|38155100|FG001|Overall Study|Protocol Violation|1|||
17010318|NCT00880620|38155101|FG002|Overall Study|Protocol Violation|0|||
17010319|NCT00880620|38155102|FG003|Overall Study|Protocol Violation|2|||
17010320|NCT00880620|38155099|FG000|Overall Study|Withdrawal by Subject|4|||
17010321|NCT00880620|38155100|FG001|Overall Study|Withdrawal by Subject|3|||
17010322|NCT00880620|38155101|FG002|Overall Study|Withdrawal by Subject|1|||
17010323|NCT00880620|38155102|FG003|Overall Study|Withdrawal by Subject|3|||
17010324|NCT00880620|38155099|FG000|Overall Study|Noncompliance|0|||
17010325|NCT00880620|38155100|FG001|Overall Study|Noncompliance|0|||
17010326|NCT00880620|38155101|FG002|Overall Study|Noncompliance|1|||
17010327|NCT00880620|38155102|FG003|Overall Study|Noncompliance|1|||
17010328|NCT00880620|38155099|FG000|Overall Study|Other|1|||
17010329|NCT00880620|38155100|FG001|Overall Study|Other|1|||
17010330|NCT00880620|38155101|FG002|Overall Study|Other|2|||
17010331|NCT00880620|38155102|FG003|Overall Study|Other|2|||
17010332|NCT00881868|38155128|FG000|Overall Study|Adverse Event|0|||
17010333|NCT00881868|38155129|FG001|Overall Study|Adverse Event|1|||
17010334|NCT00881868|38155128|FG000|Overall Study|Lost to Follow-up|2|||
17010335|NCT00881868|38155129|FG001|Overall Study|Lost to Follow-up|1|||
17010336|NCT00881868|38155128|FG000|Overall Study|Physician Decision|4|||
17010337|NCT00881868|38155129|FG001|Overall Study|Physician Decision|0|||
17010338|NCT00881868|38155128|FG000|Overall Study|Protocol Violation|2|||
17010339|NCT00881868|38155129|FG001|Overall Study|Protocol Violation|0|||
17010340|NCT00881712|38155138|FG000|Overall Study|Death|1|||
17010341|NCT00881712|38155139|FG001|Overall Study|Death|0|||
17010342|NCT00881712|38155140|FG002|Overall Study|Death|0|||
17010343|NCT00881712|38155138|FG000|Overall Study|Withdrawal by Subject|1|||
17010344|NCT00881712|38155139|FG001|Overall Study|Withdrawal by Subject|0|||
17010345|NCT00881712|38155140|FG002|Overall Study|Withdrawal by Subject|0|||
17010346|NCT03955471|38155148|FG000|Overall Study|Death|22|||
17010347|NCT03955471|38155148|FG000|Overall Study|Lost to Follow-up|1|||
17010348|NCT03955471|38155148|FG000|Overall Study|Withdrawal by Subject|6|||
17010349|NCT03955471|38155148|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
17010350|NCT00880542|38155152|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
17010351|NCT00880542|38155152|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
17010352|NCT00880542|38155152|FG000|REP: Surgical Resection|progressive disease|1|||
17010353|NCT00885534|38155156|FG000|Overall Study|Patient deemed ineligible|1|||
17010354|NCT00885378|38155162|FG000|Overall Study|Lack of Efficacy|2|||
17010355|NCT00885378|38155163|FG001|Overall Study|Lack of Efficacy|2|||
17010356|NCT00885378|38155162|FG000|Overall Study|Withdrawal by Subject|1|||
17010357|NCT00885378|38155163|FG001|Overall Study|Withdrawal by Subject|2|||
17010358|NCT00885378|38155162|FG000|Overall Study|Lost to Follow-up|1|||
17010359|NCT00885378|38155163|FG001|Overall Study|Lost to Follow-up|2|||
17010360|NCT00885378|38155162|FG000|Overall Study|Poor/Noncompliance|2|||
17010361|NCT00885378|38155163|FG001|Overall Study|Poor/Noncompliance|2|||
17010362|NCT00885378|38155162|FG000|Overall Study|Protocol Violation|2|||
17010363|NCT00885378|38155163|FG001|Overall Study|Protocol Violation|0|||
17010364|NCT00545779|38155169|FG000|Overall Study|Violation of selection criteria at entry|8|||
17010365|NCT00545779|38155169|FG000|Overall Study|Other protocol violation|1|||
17010366|NCT00545779|38155169|FG000|Overall Study|Did not cooperate|7|||
17010367|NCT00545779|38155169|FG000|Overall Study|Withdrawal by Subject|20|||
17010368|NCT00545779|38155169|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
17010369|NCT00545779|38155169|FG000|Overall Study|Failure to return|3|||
17010370|NCT00597714|38155179|FG000|Overall Study|Death|56|||
17010371|NCT00597714|38155180|FG001|Overall Study|Death|46|||
17010372|NCT00597714|38155181|FG002|Overall Study|Death|0|||
17010373|NCT00597714|38155179|FG000|Overall Study|Recipient death|0|||
17010374|NCT00597714|38155180|FG001|Overall Study|Recipient death|0|||
17010375|NCT00597714|38155181|FG002|Overall Study|Recipient death|10|||
17010376|NCT03938857|38155194|FG000|Overall Study|Physician Decision|1|||
17010377|NCT03938857|38155195|FG001|Overall Study|Physician Decision|0|||
17010378|NCT03938857|38155196|FG002|Overall Study|Physician Decision|0|||
17010379|NCT03938857|38155197|FG003|Overall Study|Physician Decision|0|||
17010380|NCT00884832|38155209|FG000|Overall Study|Withdrawal by Subject|0|||
17010381|NCT00884832|38155210|FG001|Overall Study|Withdrawal by Subject|1|||
17010382|NCT03938545|38155220|FG000|Overall Study|Lost to Follow-up|0|||
17010383|NCT03938545|38155221|FG001|Overall Study|Lost to Follow-up|0|||
16908515|NCT01759368|38017214|FG001|Overall Study|Lost to Follow-up|0|||
17010384|NCT03938545|38155222|FG002|Overall Study|Lost to Follow-up|0|||
17010385|NCT03938545|38155223|FG003|Overall Study|Lost to Follow-up|1|||
17010386|NCT03938545|38155220|FG000|Overall Study|Non-compliance with study drug|0|||
17010387|NCT03938545|38155221|FG001|Overall Study|Non-compliance with study drug|0|||
17010388|NCT03938545|38155222|FG002|Overall Study|Non-compliance with study drug|1|||
17010389|NCT03938545|38155223|FG003|Overall Study|Non-compliance with study drug|0|||
17010390|NCT03938545|38155220|FG000|Overall Study|Pregnancy|1|||
17010391|NCT03938545|38155221|FG001|Overall Study|Pregnancy|0|||
17010392|NCT03938545|38155222|FG002|Overall Study|Pregnancy|0|||
17010393|NCT03938545|38155223|FG003|Overall Study|Pregnancy|0|||
17010394|NCT03938545|38155220|FG000|Overall Study|Study terminated by sponsor|6|||
17010395|NCT03938545|38155221|FG001|Overall Study|Study terminated by sponsor|4|||
17010396|NCT03938545|38155222|FG002|Overall Study|Study terminated by sponsor|2|||
17010397|NCT03938545|38155223|FG003|Overall Study|Study terminated by sponsor|4|||
17010398|NCT03938545|38155220|FG000|Overall Study|Withdrawal by Subject|0|||
17010399|NCT03938545|38155221|FG001|Overall Study|Withdrawal by Subject|1|||
17010400|NCT03938545|38155222|FG002|Overall Study|Withdrawal by Subject|0|||
17010401|NCT03938545|38155223|FG003|Overall Study|Withdrawal by Subject|0|||
17010402|NCT03938545|38155220|FG000|Overall Study|Adverse Event|1|||
17010403|NCT03938545|38155221|FG001|Overall Study|Adverse Event|0|||
17096714|NCT00260208|38235849|FG000|Overall Study|Death|12|||
17096715|NCT00260208|38235850|FG001|Overall Study|Death|10|||
17096716|NCT00260208|38235849|FG000|Overall Study|Missing|18|||
17096717|NCT00260208|38235850|FG001|Overall Study|Missing|16|||
17096718|NCT00202644|38235858|FG000|Overall Study|Adverse Event|12|||
17096719|NCT00202644|38235859|FG001|Overall Study|Adverse Event|13|||
17096720|NCT00202644|38235858|FG000|Overall Study|Withdrawal by Subject|8|||
17096721|NCT00202644|38235859|FG001|Overall Study|Withdrawal by Subject|6|||
17010404|NCT03938545|38155222|FG002|Overall Study|Adverse Event|0|||
17010405|NCT03938545|38155223|FG003|Overall Study|Adverse Event|0|||
17010406|NCT00879996|38155235|FG000|Overall Study|Lost to Follow-up|7|||
17010407|NCT00879996|38155236|FG001|Overall Study|Lost to Follow-up|6|||
17010408|NCT00879996|38155235|FG000|Overall Study|non-compliance|6|||
17010409|NCT00879996|38155236|FG001|Overall Study|non-compliance|4|||
17010410|NCT00879996|38155235|FG000|Overall Study|Physician Decision|1|||
17010411|NCT00879996|38155236|FG001|Overall Study|Physician Decision|2|||
17010412|NCT00879996|38155235|FG000|Overall Study|psychiatric problem|0|||
17010413|NCT00879996|38155236|FG001|Overall Study|psychiatric problem|1|||
17010414|NCT00879996|38155235|FG000|Overall Study|put on parole|1|||
17096722|NCT00202644|38235858|FG000|Overall Study|Lack of Efficacy|6|||
17096723|NCT00202644|38235859|FG001|Overall Study|Lack of Efficacy|6|||
17010415|NCT00879996|38155236|FG001|Overall Study|put on parole|0|||
17010416|NCT00873093|38155249|FG000|Overall Study|Adverse Event|0|||
17010417|NCT00873093|38155250|FG001|Overall Study|Adverse Event|2|||
17010418|NCT00873093|38155251|FG002|Overall Study|Adverse Event|0|||
17010419|NCT00873093|38155252|FG003|Overall Study|Adverse Event|0|||
17010420|NCT00873093|38155253|FG004|Overall Study|Adverse Event|0|||
17010421|NCT00873093|38155249|FG000|Overall Study|Death|0|||
17010422|NCT00873093|38155250|FG001|Overall Study|Death|3|||
17010423|NCT00873093|38155251|FG002|Overall Study|Death|2|||
17010424|NCT00873093|38155252|FG003|Overall Study|Death|0|||
17010425|NCT00873093|38155253|FG004|Overall Study|Death|0|||
17010426|NCT00873093|38155249|FG000|Overall Study|Physician Decision|0|||
17010427|NCT00873093|38155250|FG001|Overall Study|Physician Decision|17|||
17010428|NCT00873093|38155251|FG002|Overall Study|Physician Decision|10|||
17010429|NCT00873093|38155252|FG003|Overall Study|Physician Decision|10|||
17010430|NCT00873093|38155253|FG004|Overall Study|Physician Decision|2|||
17010431|NCT00873093|38155249|FG000|Overall Study|Withdrawal by Subject|1|||
17010432|NCT00873093|38155250|FG001|Overall Study|Withdrawal by Subject|4|||
17010433|NCT00873093|38155251|FG002|Overall Study|Withdrawal by Subject|4|||
17010434|NCT00873093|38155252|FG003|Overall Study|Withdrawal by Subject|0|||
17010435|NCT00873093|38155253|FG004|Overall Study|Withdrawal by Subject|0|||
17010436|NCT00873093|38155249|FG000|Overall Study|Ineligible|0|||
17010437|NCT00873093|38155250|FG001|Overall Study|Ineligible|1|||
17010438|NCT00873093|38155251|FG002|Overall Study|Ineligible|0|||
17193090|NCT02799745|38346383|FG001|Overall Study|Death|0|||
17193091|NCT02799745|38346382|FG000|Overall Study|Adverse Event|0|||
17096724|NCT00202644|38235858|FG000|Overall Study|Lost to Follow-up|0|||
17096725|NCT00202644|38235859|FG001|Overall Study|Lost to Follow-up|1|||
17096726|NCT00202644|38235858|FG000|Overall Study|Other|9|||
17096727|NCT00202644|38235859|FG001|Overall Study|Other|1|||
17096728|NCT01235962|38235869|FG000|Overall Study|Withdrawal by Subject|20|||
17096729|NCT01235962|38235870|FG001|Overall Study|Withdrawal by Subject|19|||
17096730|NCT01235962|38235871|FG002|Overall Study|Withdrawal by Subject|62|||
17096731|NCT01235962|38235872|FG003|Overall Study|Withdrawal by Subject|49|||
17010439|NCT00873093|38155252|FG003|Overall Study|Ineligible|1|||
17010440|NCT00873093|38155253|FG004|Overall Study|Ineligible|0|||
17010441|NCT00545077|38155277|FG000|Overall Study|Treatment not received|5|||
17010442|NCT00545077|38155278|FG001|Overall Study|Treatment not received|1|||
17010443|NCT00545077|38155277|FG000|Overall Study|Disease Progression|131|||
17010444|NCT00545077|38155278|FG001|Overall Study|Disease Progression|98|||
17010445|NCT00545077|38155277|FG000|Overall Study|Withdrawal by Subject|3|||
17096732|NCT01235962|38235869|FG000|Overall Study|Lost to Follow-up|21|||
17096733|NCT01235962|38235870|FG001|Overall Study|Lost to Follow-up|16|||
17096734|NCT01235962|38235871|FG002|Overall Study|Lost to Follow-up|47|||
17096735|NCT01235962|38235872|FG003|Overall Study|Lost to Follow-up|32|||
17096736|NCT01235962|38235869|FG000|Overall Study|Physician Decision|5|||
17010446|NCT00545077|38155278|FG001|Overall Study|Withdrawal by Subject|14|||
17010447|NCT00545077|38155277|FG000|Overall Study|Physician Decision|6|||
17010448|NCT00545077|38155278|FG001|Overall Study|Physician Decision|3|||
17010449|NCT00545077|38155277|FG000|Overall Study|Lost to Follow-up|2|||
17010450|NCT00545077|38155278|FG001|Overall Study|Lost to Follow-up|0|||
17010451|NCT00545077|38155277|FG000|Overall Study|Protocol Violation|1|||
17010452|NCT00545077|38155278|FG001|Overall Study|Protocol Violation|0|||
17010453|NCT00545077|38155277|FG000|Overall Study|Adverse Event|0|||
17010454|NCT00545077|38155278|FG001|Overall Study|Adverse Event|31|||
17010455|NCT00545077|38155277|FG000|Overall Study|Death|0|||
17010456|NCT00545077|38155278|FG001|Overall Study|Death|8|||
17010457|NCT00884286|38155286|FG000|Overall Study|Progressive disease|21|||
17010458|NCT00884286|38155287|FG001|Overall Study|Progressive disease|28|||
17010459|NCT00884286|38155286|FG000|Overall Study|Toxicity|4|||
17096737|NCT01235962|38235870|FG001|Overall Study|Physician Decision|0|||
17096738|NCT01235962|38235871|FG002|Overall Study|Physician Decision|9|||
17096739|NCT01235962|38235872|FG003|Overall Study|Physician Decision|5|||
17096740|NCT00259740|38235892|FG000|Overall Study|Physician Decision|1|||
17096741|NCT00259740|38235893|FG001|Overall Study|Physician Decision|1|||
17096742|NCT00259740|38235892|FG000|Overall Study|Adverse Event|0|||
17096743|NCT00259740|38235893|FG001|Overall Study|Adverse Event|2|||
17096744|NCT00259740|38235892|FG000|Overall Study|Withdrawal by Subject|2|||
17096745|NCT00259740|38235893|FG001|Overall Study|Withdrawal by Subject|6|||
17096746|NCT00259740|38235892|FG000|Overall Study|Death|1|||
17096747|NCT00259740|38235893|FG001|Overall Study|Death|1|||
17096748|NCT00259740|38235892|FG000|Overall Study|Disease progression|19|||
17096749|NCT00259740|38235893|FG001|Overall Study|Disease progression|36|||
17096750|NCT00259740|38235892|FG000|Overall Study|Ongoing|17|||
17096751|NCT00259740|38235893|FG001|Overall Study|Ongoing|3|||
17096752|NCT00259740|38235892|FG000|Overall Study|Other|3|||
17096753|NCT00259740|38235893|FG001|Overall Study|Other|0|||
17096754|NCT00259740|38235892|FG000|Overall Study|Requirement for alternative therapy|0|||
17096755|NCT00259740|38235893|FG001|Overall Study|Requirement for alternative therapy|4|||
17096756|NCT00201006|38235902|FG000|Overall Study|Withdrawal by Subject|7|||
17096757|NCT00201006|38235903|FG001|Overall Study|Withdrawal by Subject|2|||
17096758|NCT00201006|38235904|FG002|Overall Study|Withdrawal by Subject|3|||
17096759|NCT00201006|38235902|FG000|Overall Study|Adverse Event|1|||
17096760|NCT00201006|38235903|FG001|Overall Study|Adverse Event|0|||
17010460|NCT00884286|38155287|FG001|Overall Study|Toxicity|1|||
17010461|NCT00884286|38155286|FG000|Overall Study|Death|2|||
17010462|NCT00884286|38155287|FG001|Overall Study|Death|2|||
17010463|NCT00884286|38155286|FG000|Overall Study|Physician Decision|1|||
17096761|NCT00201006|38235904|FG002|Overall Study|Adverse Event|1|||
17096762|NCT00200850|38235915|FG000|Overall Study|relocation|1|||
17096763|NCT00200850|38235916|FG001|Overall Study|relocation|0|||
17096764|NCT00200850|38235917|FG002|Overall Study|relocation|1|||
17096765|NCT00200850|38235915|FG000|Overall Study|too busy|1|||
17096766|NCT00200850|38235916|FG001|Overall Study|too busy|0|||
17096767|NCT00200850|38235917|FG002|Overall Study|too busy|0|||
17096768|NCT00200850|38235915|FG000|Overall Study|Pregnancy|0|||
17096769|NCT00200850|38235916|FG001|Overall Study|Pregnancy|0|||
17096770|NCT00200850|38235917|FG002|Overall Study|Pregnancy|1|||
17096771|NCT00200850|38235915|FG000|Overall Study|Poor adherence|0|||
17096772|NCT00200850|38235916|FG001|Overall Study|Poor adherence|0|||
17096773|NCT00200850|38235917|FG002|Overall Study|Poor adherence|1|||
17096774|NCT00200850|38235915|FG000|Overall Study|optic neuritis|0|||
17010464|NCT00884286|38155287|FG001|Overall Study|Physician Decision|0|||
17010465|NCT00884286|38155286|FG000|Overall Study|Septic shock|1|||
17096775|NCT00200850|38235916|FG001|Overall Study|optic neuritis|0|||
17096776|NCT00200850|38235917|FG002|Overall Study|optic neuritis|1|||
17096777|NCT00200850|38235915|FG000|Overall Study|Adverse Event|1|||
17096778|NCT00200850|38235916|FG001|Overall Study|Adverse Event|1|||
17096779|NCT00200850|38235917|FG002|Overall Study|Adverse Event|2|||
17096780|NCT03812224|38235927|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
17096781|NCT03812224|38235928|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
17096782|NCT03812224|38235927|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
17096783|NCT03812224|38235928|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
17096784|NCT03812224|38235927|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
17096785|NCT03812224|38235928|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
17096786|NCT03812224|38235927|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
17096787|NCT03812224|38235928|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
17096788|NCT00231114|38235937|FG000|Randomized|Withdrawal by Subject|6|||
17096789|NCT00231114|38235938|FG001|Randomized|Withdrawal by Subject|3|||
17193092|NCT02799745|38346383|FG001|Overall Study|Adverse Event|1|||
17010466|NCT00884286|38155287|FG001|Overall Study|Septic shock|0|||
17010467|NCT00884286|38155286|FG000|Overall Study|Thrombus in right auricle|1|||
17096790|NCT00231114|38235937|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
17096791|NCT00231114|38235938|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
17096792|NCT00231114|38235937|FG000|Post-Treatment Period|Lost to Follow-up|6|||
17096793|NCT00231114|38235938|FG001|Post-Treatment Period|Lost to Follow-up|1|||
17010468|NCT00884286|38155287|FG001|Overall Study|Thrombus in right auricle|0|||
17010469|NCT00884286|38155286|FG000|Overall Study|Not treated|2|||
17010470|NCT00884286|38155287|FG001|Overall Study|Not treated|1|||
17010471|NCT00884286|38155286|FG000|Overall Study|Comprised lung carcinoma|0|||
17010472|NCT00884286|38155287|FG001|Overall Study|Comprised lung carcinoma|1|||
17010473|NCT00873015|38155298|FG000|Overall Study|Withdrawal by Subject|0|||
17010474|NCT00873015|38155299|FG001|Overall Study|Withdrawal by Subject|1|||
17010475|NCT00873015|38155300|FG002|Overall Study|Withdrawal by Subject|0|||
17010476|NCT00873015|38155301|FG003|Overall Study|Withdrawal by Subject|0|||
17010477|NCT03921151|38155316|FG000|Overall Study|Withdrawal by Subject|11|||
17010478|NCT03921151|38155317|FG001|Overall Study|Withdrawal by Subject|16|||
17010479|NCT00872001|38155329|FG000|Overall Study|Adverse Event|34|||
17010480|NCT00872001|38155330|FG001|Overall Study|Adverse Event|23|||
17010481|NCT00872001|38155329|FG000|Overall Study|Protocol Defined Clinical Event|5|||
17010482|NCT00872001|38155330|FG001|Overall Study|Protocol Defined Clinical Event|7|||
17010483|NCT00872001|38155329|FG000|Overall Study|Lost to Follow-up|13|||
17010484|NCT00872001|38155330|FG001|Overall Study|Lost to Follow-up|12|||
17010485|NCT00872001|38155329|FG000|Overall Study|Withdrawal by Subject|18|||
17010486|NCT00872001|38155330|FG001|Overall Study|Withdrawal by Subject|30|||
17010487|NCT00872001|38155329|FG000|Overall Study|Protocol Violation|5|||
17010488|NCT00872001|38155330|FG001|Overall Study|Protocol Violation|8|||
17010489|NCT00872001|38155329|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
17010490|NCT00872001|38155330|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
17010491|NCT00872001|38155329|FG000|Overall Study|Administrative|23|||
17010492|NCT00872001|38155330|FG001|Overall Study|Administrative|15|||
17010493|NCT00871923|38155338|FG000|Overall Study|Death|1|||
17010494|NCT00871923|38155338|FG000|Overall Study|Withdrawal by Subject|1|||
17010495|NCT03922945|38155345|FG000|Overall Study|Adverse Event|1|||
17010496|NCT03922945|38155346|FG001|Overall Study|Adverse Event|1|||
17010497|NCT03922945|38155347|FG002|Overall Study|Adverse Event|2|||
17010498|NCT03922945|38155345|FG000|Overall Study|Lost to Follow-up|13|||
17010499|NCT03922945|38155346|FG001|Overall Study|Lost to Follow-up|9|||
17010500|NCT03922945|38155347|FG002|Overall Study|Lost to Follow-up|20|||
17010501|NCT03922945|38155345|FG000|Overall Study|Lack of Efficacy|2|||
17010502|NCT03922945|38155346|FG001|Overall Study|Lack of Efficacy|0|||
17010503|NCT03922945|38155347|FG002|Overall Study|Lack of Efficacy|1|||
17010504|NCT03922945|38155345|FG000|Overall Study|Protocol Non-Compliance|0|||
17010505|NCT03922945|38155346|FG001|Overall Study|Protocol Non-Compliance|0|||
17010506|NCT03922945|38155347|FG002|Overall Study|Protocol Non-Compliance|1|||
17010507|NCT03922945|38155345|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
17010508|NCT03922945|38155346|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
17010509|NCT03922945|38155347|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
17010510|NCT03922945|38155345|FG000|Overall Study|All Other Personal Reasons|1|||
17010511|NCT03922945|38155346|FG001|Overall Study|All Other Personal Reasons|1|||
17010512|NCT03922945|38155347|FG002|Overall Study|All Other Personal Reasons|2|||
17010513|NCT03922477|38155358|FG000|Overall Study|Death|9|||
17010514|NCT03922477|38155358|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
17010515|NCT03922477|38155358|FG000|Overall Study|Physician Decision|1|||
17010516|NCT03922477|38155358|FG000|Overall Study|Withdrawal by Subject|2|||
17010517|NCT00867165|38155364|FG000|Overall Study|Adverse Event|3|||
17010518|NCT00867165|38155365|FG001|Overall Study|Adverse Event|0|||
17010519|NCT00867165|38155364|FG000|Overall Study|Withdrawal by Subject|1|||
17010520|NCT00867165|38155365|FG001|Overall Study|Withdrawal by Subject|0|||
17010521|NCT00867087|38155371|FG000|Overall Study|Other|1|||
17010522|NCT00867087|38155371|FG000|Overall Study|Withdrawal by Subject|4|||
17010523|NCT00867087|38155371|FG000|Overall Study|Death|37|||
17010524|NCT00545233|38155377|FG000|Overall Study|Adverse Event|10|||
17010525|NCT00545233|38155378|FG001|Overall Study|Adverse Event|5|||
17010526|NCT00545233|38155377|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
17010527|NCT00545233|38155378|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
17010528|NCT00545233|38155377|FG000|Overall Study|Protocol Violation|2|||
17010529|NCT00545233|38155378|FG001|Overall Study|Protocol Violation|0|||
17010530|NCT00545233|38155377|FG000|Overall Study|Refused Treatment|9|||
17010531|NCT00545233|38155378|FG001|Overall Study|Refused Treatment|7|||
17010532|NCT00545233|38155377|FG000|Overall Study|Failure to Return|4|||
17010533|NCT00545233|38155378|FG001|Overall Study|Failure to Return|6|||
17010534|NCT00545233|38155377|FG000|Overall Study|Insufficient response|14|||
17010535|NCT00545233|38155378|FG001|Overall Study|Insufficient response|15|||
17010536|NCT00545233|38155377|FG000|Overall Study|Physician Decision|2|||
17010537|NCT00545233|38155378|FG001|Overall Study|Physician Decision|1|||
17010538|NCT02393248|38155410|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010539|NCT02393248|38155411|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
17010540|NCT02393248|38155412|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010541|NCT02393248|38155413|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010542|NCT02393248|38155414|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010543|NCT02393248|38155415|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
17010544|NCT02393248|38155416|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
17010545|NCT02393248|38155417|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010546|NCT02393248|38155418|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010547|NCT02393248|38155419|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010548|NCT02393248|38155420|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010549|NCT02393248|38155421|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010550|NCT02393248|38155422|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010551|NCT02393248|38155423|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010552|NCT02393248|38155424|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010553|NCT02393248|38155425|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010554|NCT02393248|38155426|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010555|NCT02393248|38155427|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17096794|NCT00231114|38235937|FG000|Post-Treatment Period|Physician Decision|1|||
17096795|NCT00231114|38235938|FG001|Post-Treatment Period|Physician Decision|0|||
17096796|NCT00231114|38235937|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
17096797|NCT00231114|38235938|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
17096798|NCT03543046|38235948|FG000|Overall Study|Adverse Event|1|||
17096799|NCT03543046|38235949|FG001|Overall Study|Adverse Event|1|||
17096800|NCT03543046|38235948|FG000|Overall Study|Physician Decision|1|||
17096801|NCT03543046|38235949|FG001|Overall Study|Physician Decision|1|||
17096802|NCT03543046|38235948|FG000|Overall Study|Protocol Violation|1|||
17096803|NCT03543046|38235949|FG001|Overall Study|Protocol Violation|0|||
17096804|NCT00259272|38235968|FG000|Overall Study|Adverse Event|2|||
17096805|NCT00259272|38235969|FG001|Overall Study|Adverse Event|1|||
17096806|NCT00259272|38235970|FG002|Overall Study|Adverse Event|0|||
17096807|NCT00259272|38235971|FG003|Overall Study|Adverse Event|3|||
17096808|NCT00259272|38235968|FG000|Overall Study|Lack of Efficacy|5|||
17096809|NCT00259272|38235969|FG001|Overall Study|Lack of Efficacy|1|||
17096810|NCT00259272|38235970|FG002|Overall Study|Lack of Efficacy|2|||
17096811|NCT00259272|38235971|FG003|Overall Study|Lack of Efficacy|6|||
17096812|NCT00259272|38235968|FG000|Overall Study|Physician Decision|1|||
17096813|NCT00259272|38235969|FG001|Overall Study|Physician Decision|2|||
17096814|NCT00259272|38235970|FG002|Overall Study|Physician Decision|1|||
17193093|NCT00705159|38346393|FG000|Overall Study|Withdrawal by Subject|0|||
17193094|NCT00705159|38346394|FG001|Overall Study|Withdrawal by Subject|1|||
17193095|NCT00705159|38346395|FG002|Overall Study|Withdrawal by Subject|1|||
17193096|NCT00705159|38346396|FG003|Overall Study|Withdrawal by Subject|1|||
17193097|NCT00705159|38346393|FG000|Overall Study|Protocol Violation|0|||
17193098|NCT00705159|38346394|FG001|Overall Study|Protocol Violation|1|||
17193099|NCT00705159|38346395|FG002|Overall Study|Protocol Violation|0|||
17193100|NCT00705159|38346396|FG003|Overall Study|Protocol Violation|0|||
17193101|NCT00705159|38346393|FG000|Overall Study|Adverse Event|0|||
17193102|NCT00705159|38346394|FG001|Overall Study|Adverse Event|0|||
17193103|NCT00705159|38346395|FG002|Overall Study|Adverse Event|1|||
17193104|NCT00705159|38346396|FG003|Overall Study|Adverse Event|0|||
17193105|NCT00705159|38346393|FG000|Overall Study|Lost to Follow-up|0|||
17193106|NCT00705159|38346394|FG001|Overall Study|Lost to Follow-up|0|||
17193107|NCT00705159|38346395|FG002|Overall Study|Lost to Follow-up|3|||
17193108|NCT00705159|38346396|FG003|Overall Study|Lost to Follow-up|2|||
17193109|NCT00705159|38346393|FG000|Overall Study|Screen Failure|0|||
17193110|NCT00705159|38346394|FG001|Overall Study|Screen Failure|0|||
17193111|NCT00705159|38346395|FG002|Overall Study|Screen Failure|0|||
17193112|NCT00705159|38346396|FG003|Overall Study|Screen Failure|1|||
17193113|NCT01673984|38346408|FG000|Overall Study|Adverse Event|1|||
17193114|NCT01673984|38346409|FG001|Overall Study|Adverse Event|0|||
17193115|NCT01673984|38346408|FG000|Overall Study|Study termination|9|||
17193116|NCT01673984|38346409|FG001|Overall Study|Study termination|6|||
17193117|NCT02332928|38346428|FG000|Overall Study|Withdrawal by Subject|0|||
17193118|NCT02332928|38346429|FG001|Overall Study|Withdrawal by Subject|2|||
17193119|NCT02332928|38346428|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
17193120|NCT02332928|38346429|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
17193121|NCT02647658|38346437|FG000|Overall Study|Consent refusal|15|||
17193122|NCT02647658|38346438|FG001|Overall Study|Consent refusal|24|||
17193123|NCT00703677|38346444|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
17193124|NCT00703911|38346452|FG000|Overall Study|Death|1|||
17193125|NCT00703911|38346452|FG000|Overall Study|Physician Decision|6|||
17096815|NCT00259272|38235971|FG003|Overall Study|Physician Decision|3|||
17096816|NCT00259272|38235968|FG000|Overall Study|Protocol Violation|2|||
17096817|NCT00259272|38235969|FG001|Overall Study|Protocol Violation|0|||
17096818|NCT00259272|38235970|FG002|Overall Study|Protocol Violation|0|||
17096819|NCT00259272|38235971|FG003|Overall Study|Protocol Violation|1|||
17193126|NCT00703911|38346452|FG000|Overall Study|Lost to Follow-up|1|||
17193127|NCT00703911|38346452|FG000|Overall Study|Withdrawal by Subject|2|||
17193128|NCT02055547|38346456|FG000|Overall Study|Protocol Violation|0|||
17193129|NCT02055547|38346457|FG001|Overall Study|Protocol Violation|0|||
17096820|NCT00259272|38235968|FG000|Overall Study|Sponsor Decision|0|||
17096821|NCT00259272|38235969|FG001|Overall Study|Sponsor Decision|1|||
17010556|NCT02393248|38155428|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010557|NCT02393248|38155429|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010558|NCT02393248|38155430|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010559|NCT02393248|38155431|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010560|NCT02393248|38155432|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010561|NCT02393248|38155433|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010562|NCT02393248|38155434|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
17010563|NCT02393248|38155410|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010564|NCT02393248|38155411|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
17010565|NCT02393248|38155412|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010566|NCT02393248|38155413|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010567|NCT02393248|38155414|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010568|NCT02393248|38155415|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010569|NCT02393248|38155416|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010570|NCT02393248|38155417|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010571|NCT02393248|38155418|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010572|NCT02393248|38155419|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010573|NCT02393248|38155420|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010574|NCT02393248|38155421|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010575|NCT02393248|38155422|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010576|NCT02393248|38155423|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010577|NCT02393248|38155424|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010578|NCT02393248|38155425|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010579|NCT02393248|38155426|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010580|NCT02393248|38155427|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010581|NCT02393248|38155428|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010582|NCT02393248|38155429|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010583|NCT02393248|38155430|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010584|NCT02393248|38155431|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010585|NCT02393248|38155432|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010586|NCT02393248|38155433|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010587|NCT02393248|38155434|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
17010588|NCT02393248|38155410|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
17010589|NCT02393248|38155411|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
17010590|NCT02393248|38155412|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
17010591|NCT02393248|38155413|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
17010592|NCT02393248|38155414|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
17010593|NCT02393248|38155415|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
17010594|NCT02393248|38155416|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
17010595|NCT02393248|38155417|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
17010596|NCT02393248|38155418|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
17010597|NCT02393248|38155419|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
17010598|NCT02393248|38155420|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
17010599|NCT02393248|38155421|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
17010600|NCT02393248|38155422|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
17010601|NCT02393248|38155423|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
17010602|NCT02393248|38155424|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
17010603|NCT02393248|38155425|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
17010604|NCT02393248|38155426|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
17010605|NCT02393248|38155427|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
17010606|NCT02393248|38155428|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
17010607|NCT02393248|38155429|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
17010608|NCT02393248|38155430|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
17010609|NCT02393248|38155431|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
17010610|NCT02393248|38155432|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
17010611|NCT02393248|38155433|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
17010612|NCT02393248|38155434|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
17010613|NCT02393248|38155410|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
17010614|NCT02393248|38155411|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010615|NCT02393248|38155412|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010616|NCT02393248|38155413|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010617|NCT02393248|38155414|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010618|NCT02393248|38155415|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010619|NCT02393248|38155416|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010620|NCT02393248|38155417|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010621|NCT02393248|38155418|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010622|NCT02393248|38155419|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010623|NCT02393248|38155420|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010624|NCT02393248|38155421|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010625|NCT02393248|38155422|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010626|NCT02393248|38155423|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010627|NCT02393248|38155424|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010628|NCT02393248|38155425|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010629|NCT02393248|38155426|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010630|NCT02393248|38155427|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010631|NCT02393248|38155428|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010632|NCT02393248|38155429|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010633|NCT02393248|38155430|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010634|NCT02393248|38155431|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010635|NCT02393248|38155432|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010636|NCT02393248|38155433|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010637|NCT02393248|38155434|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
17010638|NCT02393248|38155410|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010639|NCT02393248|38155411|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010640|NCT02393248|38155412|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010641|NCT02393248|38155413|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010642|NCT02393248|38155414|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010643|NCT02393248|38155415|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
17010644|NCT02393248|38155416|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
17010645|NCT02393248|38155417|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010646|NCT02393248|38155418|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010647|NCT02393248|38155419|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
17010648|NCT02393248|38155420|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010649|NCT02393248|38155421|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010650|NCT02393248|38155422|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010651|NCT02393248|38155423|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010652|NCT02393248|38155424|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010653|NCT02393248|38155425|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010654|NCT02393248|38155426|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010655|NCT02393248|38155427|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010656|NCT02393248|38155428|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010657|NCT02393248|38155429|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010658|NCT02393248|38155430|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010659|NCT02393248|38155431|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010660|NCT02393248|38155432|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010661|NCT02393248|38155433|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010662|NCT02393248|38155434|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
17010663|NCT02393248|38155410|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010664|NCT02393248|38155411|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010665|NCT02393248|38155412|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010666|NCT02393248|38155413|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010667|NCT02393248|38155414|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010668|NCT02393248|38155415|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010669|NCT02393248|38155416|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
17010670|NCT02393248|38155417|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010671|NCT02393248|38155418|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010672|NCT02393248|38155419|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010673|NCT02393248|38155420|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010674|NCT02393248|38155421|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010675|NCT02393248|38155422|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010676|NCT02393248|38155423|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010677|NCT02393248|38155424|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010678|NCT02393248|38155425|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010679|NCT02393248|38155426|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010680|NCT02393248|38155427|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010681|NCT02393248|38155428|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16786295|NCT01999972|37726703|FG003|Dose Expansion Part|Participant's non-compliance|0|||
16786296|NCT01999972|37726704|FG004|Dose Expansion Part|Participant's non-compliance|0|||
16786297|NCT01999972|37726705|FG005|Dose Expansion Part|Participant's non-compliance|1|||
17010682|NCT02393248|38155429|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010683|NCT02393248|38155430|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010684|NCT02393248|38155431|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010685|NCT02393248|38155432|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010686|NCT02393248|38155433|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010687|NCT02393248|38155434|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
17010688|NCT02393248|38155410|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010689|NCT02393248|38155411|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010690|NCT02393248|38155412|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010691|NCT02393248|38155413|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010692|NCT02393248|38155414|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010693|NCT02393248|38155415|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010694|NCT02393248|38155416|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010695|NCT02393248|38155417|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010696|NCT02393248|38155418|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010697|NCT02393248|38155419|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010698|NCT02393248|38155420|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010699|NCT02393248|38155421|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
17010700|NCT02393248|38155422|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
17010701|NCT02393248|38155423|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
17010702|NCT02393248|38155424|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
17010703|NCT02393248|38155425|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010704|NCT02393248|38155426|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010705|NCT02393248|38155427|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010706|NCT02393248|38155428|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010707|NCT02393248|38155429|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010708|NCT02393248|38155430|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010709|NCT02393248|38155431|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010710|NCT02393248|38155432|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010711|NCT02393248|38155433|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010712|NCT02393248|38155434|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
17010713|NCT02393248|38155410|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010714|NCT02393248|38155411|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010715|NCT02393248|38155412|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010716|NCT02393248|38155413|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010717|NCT02393248|38155414|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010718|NCT02393248|38155415|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010719|NCT02393248|38155416|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010720|NCT02393248|38155417|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010721|NCT02393248|38155418|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010722|NCT02393248|38155419|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010723|NCT02393248|38155420|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
17010724|NCT02393248|38155421|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
17010725|NCT02393248|38155422|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010726|NCT02393248|38155423|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010727|NCT02393248|38155424|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010728|NCT02393248|38155425|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010729|NCT02393248|38155426|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010730|NCT02393248|38155427|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010731|NCT02393248|38155428|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010732|NCT02393248|38155429|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010733|NCT02393248|38155430|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010734|NCT02393248|38155431|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010735|NCT02393248|38155432|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010736|NCT02393248|38155433|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010737|NCT02393248|38155434|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
17010738|NCT02393248|38155410|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
17010739|NCT02393248|38155411|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
17010740|NCT02393248|38155412|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
17010741|NCT02393248|38155413|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
17010742|NCT02393248|38155414|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
17010743|NCT02393248|38155415|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
17010744|NCT02393248|38155416|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
17010745|NCT02393248|38155417|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
17010746|NCT02393248|38155418|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
17010747|NCT02393248|38155419|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
17010748|NCT02393248|38155420|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
17010749|NCT02393248|38155421|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
17010750|NCT02393248|38155422|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
17010751|NCT02393248|38155423|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
17010752|NCT02393248|38155424|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
17010753|NCT02393248|38155425|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
17010754|NCT02393248|38155426|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
17010755|NCT02393248|38155427|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
17010756|NCT02393248|38155428|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
17010757|NCT02393248|38155429|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
17010758|NCT02393248|38155430|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
17010759|NCT02393248|38155431|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
17010760|NCT02393248|38155432|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
17010761|NCT02393248|38155433|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
17010762|NCT02393248|38155434|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
17010763|NCT02393248|38155410|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010764|NCT02393248|38155411|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010765|NCT02393248|38155412|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010766|NCT02393248|38155413|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010767|NCT02393248|38155414|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010768|NCT02393248|38155415|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010769|NCT02393248|38155416|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010770|NCT02393248|38155417|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010771|NCT02393248|38155418|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010772|NCT02393248|38155419|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010773|NCT02393248|38155420|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010774|NCT02393248|38155421|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
17010775|NCT02393248|38155422|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010776|NCT02393248|38155423|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
17010777|NCT02393248|38155424|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010778|NCT02393248|38155425|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010779|NCT02393248|38155426|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010780|NCT02393248|38155427|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010781|NCT02393248|38155428|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010782|NCT02393248|38155429|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010783|NCT02393248|38155430|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010784|NCT02393248|38155431|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010785|NCT02393248|38155432|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010786|NCT02393248|38155433|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010787|NCT02393248|38155434|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
17010788|NCT02393248|38155410|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010789|NCT02393248|38155411|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010790|NCT02393248|38155412|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010791|NCT02393248|38155413|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010792|NCT02393248|38155414|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010793|NCT02393248|38155415|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010794|NCT02393248|38155416|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010795|NCT02393248|38155417|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010796|NCT02393248|38155418|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010797|NCT02393248|38155419|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010798|NCT02393248|38155420|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010799|NCT02393248|38155421|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010800|NCT02393248|38155422|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010801|NCT02393248|38155423|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010802|NCT02393248|38155424|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010803|NCT02393248|38155425|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010804|NCT02393248|38155426|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010805|NCT02393248|38155427|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010806|NCT02393248|38155428|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
17010807|NCT02393248|38155429|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010808|NCT02393248|38155430|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
17096822|NCT00259272|38235970|FG002|Overall Study|Sponsor Decision|0|||
17096823|NCT00259272|38235971|FG003|Overall Study|Sponsor Decision|0|||
17096824|NCT00259272|38235968|FG000|Overall Study|Withdrawal by Subject|4|||
17096825|NCT00259272|38235969|FG001|Overall Study|Withdrawal by Subject|2|||
17096826|NCT00259272|38235970|FG002|Overall Study|Withdrawal by Subject|2|||
17096827|NCT00259272|38235971|FG003|Overall Study|Withdrawal by Subject|7|||
17096828|NCT00259272|38235968|FG000|Overall Study|Lost to Follow-up|1|||
17096829|NCT00259272|38235969|FG001|Overall Study|Lost to Follow-up|0|||
17010809|NCT02393248|38155431|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
17010810|NCT02393248|38155432|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010811|NCT02393248|38155433|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
17010812|NCT02393248|38155434|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
17010813|NCT02393248|38155410|FG000|Part 3: Combination Therapy|Death|0|||
17010814|NCT02393248|38155411|FG001|Part 3: Combination Therapy|Death|0|||
17010815|NCT02393248|38155412|FG002|Part 3: Combination Therapy|Death|0|||
17010816|NCT02393248|38155413|FG003|Part 3: Combination Therapy|Death|0|||
17010817|NCT02393248|38155414|FG004|Part 3: Combination Therapy|Death|0|||
17010818|NCT02393248|38155415|FG005|Part 3: Combination Therapy|Death|0|||
17010819|NCT02393248|38155416|FG006|Part 3: Combination Therapy|Death|0|||
17096830|NCT00259272|38235970|FG002|Overall Study|Lost to Follow-up|0|||
17010820|NCT02393248|38155417|FG007|Part 3: Combination Therapy|Death|0|||
17010821|NCT02393248|38155418|FG008|Part 3: Combination Therapy|Death|0|||
17010822|NCT02393248|38155419|FG009|Part 3: Combination Therapy|Death|0|||
17010823|NCT02393248|38155420|FG010|Part 3: Combination Therapy|Death|0|||
17010824|NCT02393248|38155421|FG011|Part 3: Combination Therapy|Death|0|||
17010825|NCT02393248|38155422|FG012|Part 3: Combination Therapy|Death|0|||
17010826|NCT02393248|38155423|FG013|Part 3: Combination Therapy|Death|0|||
17010827|NCT02393248|38155424|FG014|Part 3: Combination Therapy|Death|0|||
17096831|NCT00259272|38235971|FG003|Overall Study|Lost to Follow-up|1|||
17096832|NCT00421889|38236004|FG000|Overall Study|Adverse Event|1|||
17096833|NCT00421889|38236005|FG001|Overall Study|Adverse Event|0|||
17096834|NCT00421889|38236006|FG002|Overall Study|Adverse Event|1|||
17096835|NCT00421889|38236007|FG003|Overall Study|Adverse Event|1|||
17010828|NCT02393248|38155425|FG015|Part 3: Combination Therapy|Death|1|||
17010829|NCT02393248|38155426|FG016|Part 3: Combination Therapy|Death|7|||
17010830|NCT02393248|38155427|FG017|Part 3: Combination Therapy|Death|5|||
17010831|NCT02393248|38155428|FG018|Part 3: Combination Therapy|Death|5|||
17010832|NCT02393248|38155429|FG019|Part 3: Combination Therapy|Death|3|||
17010833|NCT02393248|38155430|FG020|Part 3: Combination Therapy|Death|7|||
17096836|NCT00421889|38236008|FG004|Overall Study|Adverse Event|1|||
17096837|NCT00421889|38236009|FG005|Overall Study|Adverse Event|4|||
17096838|NCT00421889|38236010|FG006|Overall Study|Adverse Event|1|||
17193130|NCT02055547|38346458|FG002|Overall Study|Protocol Violation|1|||
17010834|NCT02393248|38155431|FG021|Part 3: Combination Therapy|Death|5|||
17010835|NCT02393248|38155432|FG022|Part 3: Combination Therapy|Death|6|||
17010836|NCT02393248|38155433|FG023|Part 3: Combination Therapy|Death|3|||
17010837|NCT02393248|38155434|FG024|Part 3: Combination Therapy|Death|0|||
17010838|NCT02393248|38155410|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010839|NCT02393248|38155411|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010840|NCT02393248|38155412|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010841|NCT02393248|38155413|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010842|NCT02393248|38155414|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010843|NCT02393248|38155415|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010844|NCT02393248|38155416|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010845|NCT02393248|38155417|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010846|NCT02393248|38155418|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010847|NCT02393248|38155419|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010848|NCT02393248|38155420|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010849|NCT02393248|38155421|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010850|NCT02393248|38155422|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010851|NCT02393248|38155423|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010852|NCT02393248|38155424|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010853|NCT02393248|38155425|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010854|NCT02393248|38155426|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010855|NCT02393248|38155427|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
17010856|NCT02393248|38155428|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
17010857|NCT02393248|38155429|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
17010858|NCT02393248|38155430|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
17010859|NCT02393248|38155431|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
17010860|NCT02393248|38155432|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
17096839|NCT00421889|38236011|FG007|Overall Study|Adverse Event|0|||
17193131|NCT02055547|38346459|FG003|Overall Study|Protocol Violation|0|||
17193132|NCT02055547|38346460|FG004|Overall Study|Protocol Violation|0|||
17193133|NCT02055547|38346461|FG005|Overall Study|Protocol Violation|0|||
17193134|NCT02055547|38346462|FG006|Overall Study|Protocol Violation|1|||
17193135|NCT02055547|38346463|FG007|Overall Study|Protocol Violation|0|||
17193136|NCT02055547|38346464|FG008|Overall Study|Protocol Violation|0|||
17193137|NCT02055547|38346465|FG009|Overall Study|Protocol Violation|0|||
17193138|NCT02055547|38346466|FG010|Overall Study|Protocol Violation|0|||
17193139|NCT02055547|38346467|FG011|Overall Study|Protocol Violation|0|||
17193140|NCT02055547|38346468|FG012|Overall Study|Protocol Violation|0|||
17193141|NCT02055547|38346469|FG013|Overall Study|Protocol Violation|0|||
17010861|NCT02393248|38155433|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
17010862|NCT02393248|38155434|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
17010863|NCT02393248|38155410|FG000|Part 3: Combination Therapy|Disease Progression|0|||
17010864|NCT02393248|38155411|FG001|Part 3: Combination Therapy|Disease Progression|0|||
17010865|NCT02393248|38155412|FG002|Part 3: Combination Therapy|Disease Progression|0|||
17010866|NCT02393248|38155413|FG003|Part 3: Combination Therapy|Disease Progression|0|||
17010867|NCT02393248|38155414|FG004|Part 3: Combination Therapy|Disease Progression|0|||
17010868|NCT02393248|38155415|FG005|Part 3: Combination Therapy|Disease Progression|0|||
17010869|NCT02393248|38155416|FG006|Part 3: Combination Therapy|Disease Progression|0|||
17010870|NCT02393248|38155417|FG007|Part 3: Combination Therapy|Disease Progression|0|||
17010871|NCT02393248|38155418|FG008|Part 3: Combination Therapy|Disease Progression|0|||
17010872|NCT02393248|38155419|FG009|Part 3: Combination Therapy|Disease Progression|0|||
17010873|NCT02393248|38155420|FG010|Part 3: Combination Therapy|Disease Progression|0|||
17010874|NCT02393248|38155421|FG011|Part 3: Combination Therapy|Disease Progression|0|||
17010875|NCT02393248|38155422|FG012|Part 3: Combination Therapy|Disease Progression|0|||
17010876|NCT02393248|38155423|FG013|Part 3: Combination Therapy|Disease Progression|0|||
17010877|NCT02393248|38155424|FG014|Part 3: Combination Therapy|Disease Progression|0|||
17010878|NCT02393248|38155425|FG015|Part 3: Combination Therapy|Disease Progression|0|||
17010879|NCT02393248|38155426|FG016|Part 3: Combination Therapy|Disease Progression|0|||
17010880|NCT02393248|38155427|FG017|Part 3: Combination Therapy|Disease Progression|0|||
17010881|NCT02393248|38155428|FG018|Part 3: Combination Therapy|Disease Progression|0|||
17010882|NCT02393248|38155429|FG019|Part 3: Combination Therapy|Disease Progression|0|||
17096840|NCT00421889|38236012|FG008|Overall Study|Adverse Event|2|||
17096841|NCT00421889|38236004|FG000|Overall Study|Withdrawal by Subject|1|||
17096842|NCT00421889|38236005|FG001|Overall Study|Withdrawal by Subject|3|||
17096843|NCT00421889|38236006|FG002|Overall Study|Withdrawal by Subject|0|||
17096844|NCT00421889|38236007|FG003|Overall Study|Withdrawal by Subject|0|||
17096845|NCT00421889|38236008|FG004|Overall Study|Withdrawal by Subject|2|||
17096846|NCT00421889|38236009|FG005|Overall Study|Withdrawal by Subject|0|||
17010883|NCT02393248|38155430|FG020|Part 3: Combination Therapy|Disease Progression|2|||
17010884|NCT02393248|38155431|FG021|Part 3: Combination Therapy|Disease Progression|1|||
17010885|NCT02393248|38155432|FG022|Part 3: Combination Therapy|Disease Progression|0|||
17010886|NCT02393248|38155433|FG023|Part 3: Combination Therapy|Disease Progression|0|||
17010887|NCT02393248|38155434|FG024|Part 3: Combination Therapy|Disease Progression|0|||
17010888|NCT02393248|38155410|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010889|NCT02393248|38155411|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010890|NCT02393248|38155412|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010891|NCT02393248|38155413|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010892|NCT02393248|38155414|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010893|NCT02393248|38155415|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010894|NCT02393248|38155416|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010895|NCT02393248|38155417|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010896|NCT02393248|38155418|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010897|NCT02393248|38155419|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010898|NCT02393248|38155420|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010899|NCT02393248|38155421|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010900|NCT02393248|38155422|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010901|NCT02393248|38155423|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010902|NCT02393248|38155424|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010903|NCT02393248|38155425|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010904|NCT02393248|38155426|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010905|NCT02393248|38155427|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010906|NCT02393248|38155428|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
17096847|NCT00421889|38236010|FG006|Overall Study|Withdrawal by Subject|0|||
17096848|NCT00421889|38236011|FG007|Overall Study|Withdrawal by Subject|0|||
17096849|NCT00421889|38236012|FG008|Overall Study|Withdrawal by Subject|0|||
17096850|NCT00421889|38236004|FG000|Overall Study|Death|0|||
17096851|NCT00421889|38236005|FG001|Overall Study|Death|0|||
17096852|NCT00421889|38236006|FG002|Overall Study|Death|0|||
17096853|NCT00421889|38236007|FG003|Overall Study|Death|0|||
17096854|NCT00421889|38236008|FG004|Overall Study|Death|1|||
17096855|NCT00421889|38236009|FG005|Overall Study|Death|1|||
17096856|NCT00421889|38236010|FG006|Overall Study|Death|0|||
17096857|NCT00421889|38236011|FG007|Overall Study|Death|0|||
17096858|NCT00421889|38236012|FG008|Overall Study|Death|0|||
17096859|NCT00421889|38236004|FG000|Overall Study|Progressive disease|3|||
17096860|NCT00421889|38236005|FG001|Overall Study|Progressive disease|2|||
17096861|NCT00421889|38236006|FG002|Overall Study|Progressive disease|2|||
17096862|NCT00421889|38236007|FG003|Overall Study|Progressive disease|3|||
17096863|NCT00421889|38236008|FG004|Overall Study|Progressive disease|2|||
17096864|NCT00421889|38236009|FG005|Overall Study|Progressive disease|21|||
17096865|NCT00421889|38236010|FG006|Overall Study|Progressive disease|3|||
17096866|NCT00421889|38236011|FG007|Overall Study|Progressive disease|1|||
17096867|NCT00421889|38236012|FG008|Overall Study|Progressive disease|5|||
17010907|NCT02393248|38155429|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010908|NCT02393248|38155430|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
17010909|NCT02393248|38155431|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
17010910|NCT02393248|38155432|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010911|NCT02393248|38155433|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010912|NCT02393248|38155434|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
17010913|NCT02393248|38155410|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010914|NCT02393248|38155411|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010915|NCT02393248|38155412|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010916|NCT02393248|38155413|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010917|NCT02393248|38155414|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010918|NCT02393248|38155415|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010919|NCT02393248|38155416|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010920|NCT02393248|38155417|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010921|NCT02393248|38155418|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010922|NCT02393248|38155419|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010923|NCT02393248|38155420|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010924|NCT02393248|38155421|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010925|NCT02393248|38155422|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010926|NCT02393248|38155423|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010927|NCT02393248|38155424|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010928|NCT02393248|38155425|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010929|NCT02393248|38155426|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010930|NCT02393248|38155427|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010931|NCT02393248|38155428|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010932|NCT02393248|38155429|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010933|NCT02393248|38155430|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
17010934|NCT02393248|38155431|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010935|NCT02393248|38155432|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010936|NCT02393248|38155433|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010937|NCT02393248|38155434|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
17010938|NCT02393248|38155410|FG000|Part 3: Combination Therapy|Adverse Event|0|||
17010939|NCT02393248|38155411|FG001|Part 3: Combination Therapy|Adverse Event|0|||
17010940|NCT02393248|38155412|FG002|Part 3: Combination Therapy|Adverse Event|0|||
17010941|NCT02393248|38155413|FG003|Part 3: Combination Therapy|Adverse Event|0|||
17010942|NCT02393248|38155414|FG004|Part 3: Combination Therapy|Adverse Event|0|||
17010943|NCT02393248|38155415|FG005|Part 3: Combination Therapy|Adverse Event|0|||
17010944|NCT02393248|38155416|FG006|Part 3: Combination Therapy|Adverse Event|0|||
17010945|NCT02393248|38155417|FG007|Part 3: Combination Therapy|Adverse Event|0|||
17010946|NCT02393248|38155418|FG008|Part 3: Combination Therapy|Adverse Event|0|||
17010947|NCT02393248|38155419|FG009|Part 3: Combination Therapy|Adverse Event|0|||
17010948|NCT02393248|38155420|FG010|Part 3: Combination Therapy|Adverse Event|0|||
17010949|NCT02393248|38155421|FG011|Part 3: Combination Therapy|Adverse Event|0|||
17010950|NCT02393248|38155422|FG012|Part 3: Combination Therapy|Adverse Event|0|||
17010951|NCT02393248|38155423|FG013|Part 3: Combination Therapy|Adverse Event|0|||
17010952|NCT02393248|38155424|FG014|Part 3: Combination Therapy|Adverse Event|0|||
17010953|NCT02393248|38155425|FG015|Part 3: Combination Therapy|Adverse Event|0|||
17010954|NCT02393248|38155426|FG016|Part 3: Combination Therapy|Adverse Event|0|||
17010955|NCT02393248|38155427|FG017|Part 3: Combination Therapy|Adverse Event|0|||
17010956|NCT02393248|38155428|FG018|Part 3: Combination Therapy|Adverse Event|0|||
17010957|NCT02393248|38155429|FG019|Part 3: Combination Therapy|Adverse Event|0|||
17193142|NCT02055547|38346470|FG014|Overall Study|Protocol Violation|0|||
17193143|NCT02055547|38346471|FG015|Overall Study|Protocol Violation|0|||
17193144|NCT02055547|38346472|FG016|Overall Study|Protocol Violation|0|||
17193145|NCT02055547|38346473|FG017|Overall Study|Protocol Violation|0|||
17193146|NCT02055547|38346474|FG018|Overall Study|Protocol Violation|0|||
17193147|NCT02055547|38346456|FG000|Overall Study|Physician Decision|0|||
17193148|NCT02055547|38346457|FG001|Overall Study|Physician Decision|1|||
17193149|NCT02055547|38346458|FG002|Overall Study|Physician Decision|1|||
17193150|NCT02055547|38346459|FG003|Overall Study|Physician Decision|0|||
17193151|NCT02055547|38346460|FG004|Overall Study|Physician Decision|1|||
17193152|NCT02055547|38346461|FG005|Overall Study|Physician Decision|0|||
17193153|NCT02055547|38346462|FG006|Overall Study|Physician Decision|0|||
17010958|NCT02393248|38155430|FG020|Part 3: Combination Therapy|Adverse Event|0|||
17010959|NCT02393248|38155431|FG021|Part 3: Combination Therapy|Adverse Event|0|||
17010960|NCT02393248|38155432|FG022|Part 3: Combination Therapy|Adverse Event|0|||
17010961|NCT02393248|38155433|FG023|Part 3: Combination Therapy|Adverse Event|1|||
17010962|NCT02393248|38155434|FG024|Part 3: Combination Therapy|Adverse Event|0|||
17010963|NCT02393248|38155410|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010964|NCT02393248|38155411|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010965|NCT02393248|38155412|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010966|NCT02393248|38155413|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010967|NCT02393248|38155414|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010968|NCT02393248|38155415|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010969|NCT02393248|38155416|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010970|NCT02393248|38155417|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010971|NCT02393248|38155418|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010972|NCT02393248|38155419|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010973|NCT02393248|38155420|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010974|NCT02393248|38155421|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010975|NCT02393248|38155422|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010976|NCT02393248|38155423|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010977|NCT02393248|38155424|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010978|NCT02393248|38155425|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010979|NCT02393248|38155426|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010980|NCT02393248|38155427|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010981|NCT02393248|38155428|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010982|NCT02393248|38155429|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010983|NCT02393248|38155430|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010984|NCT02393248|38155431|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010985|NCT02393248|38155432|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010986|NCT02393248|38155433|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
17010987|NCT02393248|38155434|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
17010988|NCT00601484|38155497|FG000|Overall Study|Adverse Event|0|||
17010989|NCT00601484|38155498|FG001|Overall Study|Adverse Event|1|||
17010990|NCT00601484|38155497|FG000|Overall Study|Lost to Follow-up|4|||
17010991|NCT00601484|38155498|FG001|Overall Study|Lost to Follow-up|3|||
17010992|NCT00601484|38155497|FG000|Overall Study|Lack of Efficacy|0|||
17010993|NCT00601484|38155498|FG001|Overall Study|Lack of Efficacy|2|||
17010994|NCT00601484|38155497|FG000|Overall Study|Withdrawal by Subject|1|||
17010995|NCT00601484|38155498|FG001|Overall Study|Withdrawal by Subject|1|||
17010996|NCT00601484|38155497|FG000|Overall Study|Randomized, but not treated|0|||
17010997|NCT00601484|38155498|FG001|Overall Study|Randomized, but not treated|1|||
17010998|NCT00883896|38155508|FG000|Overall Study|Lost to Follow-up|0|||
17010999|NCT00883896|38155509|FG001|Overall Study|Lost to Follow-up|0|||
17011000|NCT00883896|38155510|FG002|Overall Study|Lost to Follow-up|0|||
17011001|NCT00883896|38155511|FG003|Overall Study|Lost to Follow-up|2|||
17011002|NCT00883896|38155508|FG000|Overall Study|Withdrawal by Subject|5|||
17011003|NCT00883896|38155509|FG001|Overall Study|Withdrawal by Subject|0|||
17011004|NCT00883896|38155510|FG002|Overall Study|Withdrawal by Subject|1|||
17011005|NCT00883896|38155511|FG003|Overall Study|Withdrawal by Subject|3|||
17011006|NCT00883896|38155508|FG000|Overall Study|Lack of Efficacy|0|||
17011007|NCT00883896|38155509|FG001|Overall Study|Lack of Efficacy|0|||
17011008|NCT00883896|38155510|FG002|Overall Study|Lack of Efficacy|0|||
17011009|NCT00883896|38155511|FG003|Overall Study|Lack of Efficacy|2|||
17011010|NCT00883896|38155508|FG000|Overall Study|Other|1|||
17011011|NCT00883896|38155509|FG001|Overall Study|Other|0|||
17011012|NCT00883896|38155510|FG002|Overall Study|Other|0|||
17011013|NCT00883896|38155511|FG003|Overall Study|Other|0|||
17011014|NCT03920293|38155523|FG000|Overall Study|Withdrawal by Subject|2|||
17011015|NCT03920293|38155524|FG001|Overall Study|Withdrawal by Subject|1|||
17011016|NCT03920293|38155523|FG000|Overall Study|Physician Decision|1|||
17011017|NCT03920293|38155524|FG001|Overall Study|Physician Decision|2|||
17011018|NCT03920293|38155523|FG000|Overall Study|Adverse Event|0|||
17011019|NCT03920293|38155524|FG001|Overall Study|Adverse Event|2|||
17011020|NCT03920293|38155523|FG000|Overall Study|Sponsor Decision|0|||
17011021|NCT03920293|38155524|FG001|Overall Study|Sponsor Decision|1|||
17011022|NCT03920293|38155523|FG000|Overall Study|Death|2|||
17011023|NCT03920293|38155524|FG001|Overall Study|Death|0|||
17011024|NCT03920293|38155523|FG000|Overall Study|Protocol Violation|1|||
17011025|NCT03920293|38155524|FG001|Overall Study|Protocol Violation|0|||
17011026|NCT03920293|38155523|FG000|Overall Study|Noncompliance|1|||
17011027|NCT03920293|38155524|FG001|Overall Study|Noncompliance|0|||
17011028|NCT00867009|38155530|FG000|Induction Period|Nonserious Adverse Event|5|||
17011029|NCT00867009|38155530|FG000|Induction Period|Serious Adverse Event|10|||
17011030|NCT00867009|38155530|FG000|Induction Period|Death due to serious adverse event|6|||
17011031|NCT00867009|38155530|FG000|Induction Period|Death due to Study Disease|4|||
17011032|NCT00867009|38155530|FG000|Induction Period|Protocol Violation|1|||
17011033|NCT00867009|38155530|FG000|Induction Period|Withdrawal by Subject|8|||
17011034|NCT00867009|38155530|FG000|Induction Period|Physician Decision|3|||
17011035|NCT00867009|38155530|FG000|Induction Period|Progressive Disease (PD)|25|||
17011036|NCT00867009|38155530|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
17011037|NCT00601250|38155536|FG000|Overall Study|Adverse Event|3|||
17011038|NCT00601250|38155537|FG001|Overall Study|Adverse Event|9|||
17011039|NCT00601250|38155536|FG000|Overall Study|Protocol Violation|3|||
17011040|NCT00601250|38155537|FG001|Overall Study|Protocol Violation|2|||
17011041|NCT00601250|38155536|FG000|Overall Study|Lost to Follow-up|2|||
17011042|NCT00601250|38155537|FG001|Overall Study|Lost to Follow-up|6|||
17011043|NCT00601250|38155536|FG000|Overall Study|Withdrawal by Subject|4|||
17011044|NCT00601250|38155537|FG001|Overall Study|Withdrawal by Subject|13|||
17011045|NCT00601250|38155536|FG000|Overall Study|Other incl. lack of efficacy|2|||
17011046|NCT00601250|38155537|FG001|Overall Study|Other incl. lack of efficacy|9|||
17011047|NCT00866775|38155545|FG000|Overall Study|Adverse Event|5|||
17011048|NCT00866775|38155546|FG001|Overall Study|Adverse Event|19|||
17011049|NCT00866775|38155545|FG000|Overall Study|Death|1|||
17011050|NCT00866775|38155546|FG001|Overall Study|Death|0|||
17011051|NCT00866775|38155545|FG000|Overall Study|Lost to Follow-up|0|||
17011052|NCT00866775|38155546|FG001|Overall Study|Lost to Follow-up|4|||
17011053|NCT00866775|38155545|FG000|Overall Study|Physician Decision|0|||
17011054|NCT00866775|38155546|FG001|Overall Study|Physician Decision|3|||
17011055|NCT00866775|38155545|FG000|Overall Study|Protocol Violation|3|||
17011056|NCT00866775|38155546|FG001|Overall Study|Protocol Violation|4|||
17011057|NCT00866775|38155545|FG000|Overall Study|Withdrawal by Subject|4|||
17011058|NCT00866775|38155546|FG001|Overall Study|Withdrawal by Subject|4|||
17011059|NCT00866775|38155545|FG000|Overall Study|met exit criteria|23|||
17011060|NCT00866775|38155546|FG001|Overall Study|met exit criteria|17|||
17011061|NCT00866775|38155545|FG000|Overall Study|discontinued due to communication error|0|||
17011062|NCT00866775|38155546|FG001|Overall Study|discontinued due to communication error|1|||
17011063|NCT03265210|38155556|FG000|Overall Study|Withdrawal by Subject|7|||
17011064|NCT03265210|38155557|FG001|Overall Study|Withdrawal by Subject|9|||
17011065|NCT03265210|38155556|FG000|Overall Study|Lost to Follow-up|2|||
17011066|NCT03265210|38155557|FG001|Overall Study|Lost to Follow-up|0|||
17011067|NCT03265210|38155556|FG000|Overall Study|Physician Decision|2|||
17011068|NCT03265210|38155557|FG001|Overall Study|Physician Decision|0|||
17011069|NCT03265210|38155556|FG000|Overall Study|Adverse Event|1|||
17011070|NCT03265210|38155557|FG001|Overall Study|Adverse Event|0|||
17011071|NCT00543985|38155563|FG000|Overall Study|Withdrawal by Subject|4|||
17011072|NCT00582556|38155578|FG000|Overall Study|Withdrawal by Subject|0|||
17011073|NCT00582556|38155579|FG001|Overall Study|Withdrawal by Subject|1|||
17011074|NCT00582556|38155580|FG002|Overall Study|Withdrawal by Subject|1|||
17011075|NCT00582556|38155578|FG000|Overall Study|Physician Decision|0|||
17011076|NCT00582556|38155579|FG001|Overall Study|Physician Decision|0|||
17011077|NCT00582556|38155580|FG002|Overall Study|Physician Decision|1|||
17011078|NCT00542269|38155592|FG000|Overall Study|Adverse Event|10|||
17011079|NCT00542269|38155593|FG001|Overall Study|Adverse Event|4|||
17096868|NCT00421889|38236004|FG000|Overall Study|Patient/Investigator request|0|||
17096869|NCT00421889|38236005|FG001|Overall Study|Patient/Investigator request|0|||
17096870|NCT00421889|38236006|FG002|Overall Study|Patient/Investigator request|0|||
17096871|NCT00421889|38236007|FG003|Overall Study|Patient/Investigator request|0|||
17096872|NCT00421889|38236008|FG004|Overall Study|Patient/Investigator request|0|||
17096873|NCT00421889|38236009|FG005|Overall Study|Patient/Investigator request|9|||
17096874|NCT00421889|38236010|FG006|Overall Study|Patient/Investigator request|0|||
17096875|NCT00421889|38236011|FG007|Overall Study|Patient/Investigator request|1|||
17096876|NCT00421889|38236012|FG008|Overall Study|Patient/Investigator request|3|||
17011080|NCT00542269|38155594|FG002|Overall Study|Adverse Event|5|||
17011081|NCT00542269|38155592|FG000|Overall Study|Protocol Violation|1|||
17011082|NCT00542269|38155593|FG001|Overall Study|Protocol Violation|1|||
17011083|NCT00542269|38155594|FG002|Overall Study|Protocol Violation|0|||
17011084|NCT00542269|38155592|FG000|Overall Study|Withdrawal by Subject|1|||
17011085|NCT00542269|38155593|FG001|Overall Study|Withdrawal by Subject|0|||
17011086|NCT00542269|38155594|FG002|Overall Study|Withdrawal by Subject|0|||
17011087|NCT00542269|38155592|FG000|Overall Study|Administrative problems|1|||
17011088|NCT00542269|38155593|FG001|Overall Study|Administrative problems|1|||
17011089|NCT00542269|38155594|FG002|Overall Study|Administrative problems|1|||
17011090|NCT00866697|38155606|FG000|Overall Study|Study closed/terminated|156|||
17011091|NCT00866697|38155607|FG001|Overall Study|Study closed/terminated|138|||
17011092|NCT00866697|38155606|FG000|Overall Study|Lost to Follow-up|22|||
17011093|NCT00866697|38155607|FG001|Overall Study|Lost to Follow-up|28|||
17011094|NCT00866697|38155606|FG000|Overall Study|Physician Decision|3|||
17096877|NCT00421889|38236004|FG000|Overall Study|Lost to Follow-up|0|||
17096878|NCT00421889|38236005|FG001|Overall Study|Lost to Follow-up|0|||
17096879|NCT00421889|38236006|FG002|Overall Study|Lost to Follow-up|0|||
17096880|NCT00421889|38236007|FG003|Overall Study|Lost to Follow-up|0|||
17096881|NCT00421889|38236008|FG004|Overall Study|Lost to Follow-up|0|||
17096882|NCT00421889|38236009|FG005|Overall Study|Lost to Follow-up|0|||
17096883|NCT00421889|38236010|FG006|Overall Study|Lost to Follow-up|0|||
17096884|NCT00421889|38236011|FG007|Overall Study|Lost to Follow-up|0|||
17096885|NCT00421889|38236012|FG008|Overall Study|Lost to Follow-up|1|||
17096886|NCT00421733|38236039|FG000|Overall Study|Adverse Event|4|||
17011095|NCT00866697|38155607|FG001|Overall Study|Physician Decision|5|||
17011096|NCT00866697|38155606|FG000|Overall Study|Withdrawal by Subject|33|||
17011097|NCT00866697|38155607|FG001|Overall Study|Withdrawal by Subject|57|||
17011098|NCT00542191|38155613|FG000|Overall Study|Death|3|||
17011099|NCT00600938|38155619|FG000|Core Study|Abnormal test procedure result(s)|3|||
17011100|NCT00600938|38155620|FG001|Core Study|Abnormal test procedure result(s)|2|||
17011101|NCT00600938|38155621|FG002|Core Study|Abnormal test procedure result(s)|0|||
17011102|NCT00600938|38155622|FG003|Core Study|Abnormal test procedure result(s)|0|||
17011103|NCT00600938|38155619|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
17011104|NCT00600938|38155620|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
17011105|NCT00600938|38155621|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
17011106|NCT00600938|38155622|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
17011107|NCT00600938|38155619|FG000|Core Study|Patient withdrew consent|7|||
17011108|NCT00600938|38155620|FG001|Core Study|Patient withdrew consent|12|||
17011109|NCT00600938|38155621|FG002|Core Study|Patient withdrew consent|0|||
17011110|NCT00600938|38155622|FG003|Core Study|Patient withdrew consent|0|||
17011111|NCT00600938|38155619|FG000|Core Study|Lost to Follow-up|3|||
17011112|NCT00600938|38155620|FG001|Core Study|Lost to Follow-up|2|||
17011113|NCT00600938|38155621|FG002|Core Study|Lost to Follow-up|0|||
17011114|NCT00600938|38155622|FG003|Core Study|Lost to Follow-up|0|||
17011115|NCT00600938|38155619|FG000|Core Study|Death|1|||
17011116|NCT00600938|38155620|FG001|Core Study|Death|1|||
17011117|NCT00600938|38155621|FG002|Core Study|Death|0|||
17011118|NCT00600938|38155622|FG003|Core Study|Death|0|||
17011119|NCT00600938|38155619|FG000|Core Study|Protocol Violation|1|||
17011120|NCT00600938|38155620|FG001|Core Study|Protocol Violation|2|||
17011121|NCT00600938|38155621|FG002|Core Study|Protocol Violation|0|||
17011122|NCT00600938|38155622|FG003|Core Study|Protocol Violation|0|||
17011123|NCT00600938|38155619|FG000|Extension Study|Adverse Event|1|||
17011124|NCT00600938|38155620|FG001|Extension Study|Adverse Event|0|||
17011125|NCT00600938|38155621|FG002|Extension Study|Adverse Event|2|||
17011126|NCT00600938|38155622|FG003|Extension Study|Adverse Event|0|||
17011127|NCT00600938|38155619|FG000|Extension Study|Abnormal test procedure results|0|||
17011128|NCT00600938|38155620|FG001|Extension Study|Abnormal test procedure results|1|||
17011129|NCT00600938|38155621|FG002|Extension Study|Abnormal test procedure results|1|||
17011130|NCT00600938|38155622|FG003|Extension Study|Abnormal test procedure results|1|||
17011131|NCT00600938|38155619|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
17011132|NCT00600938|38155620|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
17011133|NCT00600938|38155621|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
17011134|NCT00600938|38155622|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
17011135|NCT00600938|38155619|FG000|Extension Study|Withdrawal by Subject|2|||
17011136|NCT00600938|38155620|FG001|Extension Study|Withdrawal by Subject|2|||
17011137|NCT00600938|38155621|FG002|Extension Study|Withdrawal by Subject|3|||
17011138|NCT00600938|38155622|FG003|Extension Study|Withdrawal by Subject|0|||
17011139|NCT00600938|38155619|FG000|Extension Study|Lost to Follow-up|1|||
17011140|NCT00600938|38155620|FG001|Extension Study|Lost to Follow-up|1|||
17011141|NCT00600938|38155621|FG002|Extension Study|Lost to Follow-up|2|||
17011142|NCT00600938|38155622|FG003|Extension Study|Lost to Follow-up|0|||
17011143|NCT00600938|38155619|FG000|Extension Study|Death|1|||
17011144|NCT00600938|38155620|FG001|Extension Study|Death|0|||
17011145|NCT00600938|38155621|FG002|Extension Study|Death|0|||
17011146|NCT00600938|38155622|FG003|Extension Study|Death|0|||
17096887|NCT00421733|38236040|FG001|Overall Study|Adverse Event|9|||
17096888|NCT00421733|38236041|FG002|Overall Study|Adverse Event|2|||
17011147|NCT00543439|38155663|FG000|Period 1|Adverse Event|0|||
17011148|NCT00543439|38155664|FG001|Period 1|Adverse Event|2|||
17011149|NCT00543439|38155665|FG002|Period 1|Adverse Event|1|||
17011150|NCT00543439|38155663|FG000|Period 1|Withdrawal by Subject|1|||
17011151|NCT00543439|38155664|FG001|Period 1|Withdrawal by Subject|1|||
17011152|NCT00543439|38155665|FG002|Period 1|Withdrawal by Subject|0|||
17011153|NCT00543439|38155663|FG000|Period 1|Physician Decision|0|||
17011154|NCT00543439|38155664|FG001|Period 1|Physician Decision|0|||
17011155|NCT00543439|38155665|FG002|Period 1|Physician Decision|1|||
17011156|NCT00543439|38155663|FG000|Period 2|Protocol Violation|1|||
17011157|NCT00543439|38155664|FG001|Period 2|Protocol Violation|0|||
17011158|NCT00543439|38155665|FG002|Period 2|Protocol Violation|1|||
17011159|NCT00543439|38155663|FG000|Period 2|Adverse Event|0|||
17011160|NCT00543439|38155664|FG001|Period 2|Adverse Event|1|||
17011161|NCT00543439|38155665|FG002|Period 2|Adverse Event|1|||
17011162|NCT00582166|38155682|FG000|Overall Study|Death|1|||
17011163|NCT00582166|38155682|FG000|Overall Study|Ineligible pathology|1|||
17011164|NCT00601172|38155688|FG000|Overall Study|Adverse Event|43|||
17011165|NCT00601172|38155689|FG001|Overall Study|Adverse Event|32|||
17011166|NCT00601172|38155688|FG000|Overall Study|Lack of Efficacy|11|||
17011167|NCT00601172|38155689|FG001|Overall Study|Lack of Efficacy|12|||
17011168|NCT00601172|38155688|FG000|Overall Study|Protocol Violation|2|||
17011169|NCT00601172|38155689|FG001|Overall Study|Protocol Violation|5|||
17011170|NCT00601172|38155688|FG000|Overall Study|Lost to Follow-up|4|||
17011171|NCT00601172|38155689|FG001|Overall Study|Lost to Follow-up|3|||
17011172|NCT00601172|38155688|FG000|Overall Study|Physician Decision|27|||
17011173|NCT00601172|38155689|FG001|Overall Study|Physician Decision|28|||
17011174|NCT00601172|38155688|FG000|Overall Study|Withdrawal by Subject|35|||
17011175|NCT00601172|38155689|FG001|Overall Study|Withdrawal by Subject|27|||
17011176|NCT00601172|38155688|FG000|Overall Study|Did not meet continuation criteria|19|||
17011177|NCT00601172|38155689|FG001|Overall Study|Did not meet continuation criteria|20|||
17011178|NCT00582010|38155698|FG000|Overall Study|Death|0|||
17011179|NCT00582010|38155699|FG001|Overall Study|Death|1|||
17011180|NCT03920215|38155713|FG000|Overall Study|Lost to Follow-up|1|||
17011181|NCT03920215|38155714|FG001|Overall Study|Lost to Follow-up|2|||
17011182|NCT03920215|38155715|FG002|Overall Study|Lost to Follow-up|0|||
17011183|NCT03920215|38155716|FG003|Overall Study|Lost to Follow-up|0|||
17011184|NCT03920215|38155713|FG000|Overall Study|Death|0|||
17011185|NCT03920215|38155714|FG001|Overall Study|Death|0|||
17011186|NCT03920215|38155715|FG002|Overall Study|Death|0|||
17011187|NCT03920215|38155716|FG003|Overall Study|Death|1|||
17011188|NCT00580840|38155726|FG000|Run-in|Adverse Event|17|||
17011189|NCT00580840|38155727|FG001|Run-in|Adverse Event|0|||
17011190|NCT00580840|38155728|FG002|Run-in|Adverse Event|0|||
17011191|NCT00580840|38155729|FG003|Run-in|Adverse Event|0|||
17011192|NCT00580840|38155726|FG000|Run-in|Lack of Efficacy|93|||
17011193|NCT00580840|38155727|FG001|Run-in|Lack of Efficacy|0|||
17011194|NCT00580840|38155728|FG002|Run-in|Lack of Efficacy|0|||
17011195|NCT00580840|38155729|FG003|Run-in|Lack of Efficacy|0|||
17011196|NCT00580840|38155726|FG000|Run-in|Loss of Efficacy|1|||
17011197|NCT00580840|38155727|FG001|Run-in|Loss of Efficacy|0|||
17011198|NCT00580840|38155728|FG002|Run-in|Loss of Efficacy|0|||
17096889|NCT00421733|38236039|FG000|Overall Study|Lost to Follow-up|1|||
17096890|NCT00421733|38236040|FG001|Overall Study|Lost to Follow-up|2|||
17011199|NCT00580840|38155729|FG003|Run-in|Loss of Efficacy|0|||
17011200|NCT00580840|38155726|FG000|Run-in|Lost to Follow-up|4|||
17011201|NCT00580840|38155727|FG001|Run-in|Lost to Follow-up|0|||
17011202|NCT00580840|38155728|FG002|Run-in|Lost to Follow-up|0|||
17011203|NCT00580840|38155729|FG003|Run-in|Lost to Follow-up|0|||
17011204|NCT00580840|38155726|FG000|Run-in|Withdrawal by Subject|5|||
17011205|NCT00580840|38155727|FG001|Run-in|Withdrawal by Subject|0|||
17011206|NCT00580840|38155728|FG002|Run-in|Withdrawal by Subject|0|||
17011207|NCT00580840|38155729|FG003|Run-in|Withdrawal by Subject|0|||
17011208|NCT00580840|38155726|FG000|Run-in|Other: Per Sponsor Request|2|||
17011209|NCT00580840|38155727|FG001|Run-in|Other: Per Sponsor Request|0|||
17011210|NCT00580840|38155728|FG002|Run-in|Other: Per Sponsor Request|0|||
17011211|NCT00580840|38155729|FG003|Run-in|Other: Per Sponsor Request|0|||
17011212|NCT00580840|38155726|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
17011213|NCT00580840|38155727|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
17011214|NCT00580840|38155728|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
17011215|NCT00580840|38155729|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
17011216|NCT00580840|38155726|FG000|Run-in|Other: Exclusionary Lab Value|1|||
17011217|NCT00580840|38155727|FG001|Run-in|Other: Exclusionary Lab Value|0|||
17011218|NCT00580840|38155728|FG002|Run-in|Other: Exclusionary Lab Value|0|||
17011219|NCT00580840|38155729|FG003|Run-in|Other: Exclusionary Lab Value|0|||
17011220|NCT00580840|38155726|FG000|Double-Blind|Adverse Event|0|||
17011221|NCT00580840|38155727|FG001|Double-Blind|Adverse Event|3|||
17011222|NCT00580840|38155728|FG002|Double-Blind|Adverse Event|4|||
17011223|NCT00580840|38155729|FG003|Double-Blind|Adverse Event|1|||
17011224|NCT00580840|38155726|FG000|Double-Blind|Loss of Efficacy|0|||
17011225|NCT00580840|38155727|FG001|Double-Blind|Loss of Efficacy|1|||
17011226|NCT00580840|38155728|FG002|Double-Blind|Loss of Efficacy|2|||
17011227|NCT00580840|38155729|FG003|Double-Blind|Loss of Efficacy|10|||
17011228|NCT00580840|38155726|FG000|Double-Blind|Lost to Follow-up|0|||
17011229|NCT00580840|38155727|FG001|Double-Blind|Lost to Follow-up|1|||
17011230|NCT00580840|38155728|FG002|Double-Blind|Lost to Follow-up|0|||
17011231|NCT00580840|38155729|FG003|Double-Blind|Lost to Follow-up|2|||
17011232|NCT00580840|38155726|FG000|Double-Blind|Withdrawal by Subject|0|||
17011233|NCT00580840|38155727|FG001|Double-Blind|Withdrawal by Subject|1|||
17011234|NCT00580840|38155728|FG002|Double-Blind|Withdrawal by Subject|2|||
17011235|NCT00580840|38155729|FG003|Double-Blind|Withdrawal by Subject|2|||
17011236|NCT00580840|38155726|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
17011237|NCT00580840|38155727|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
17011238|NCT00580840|38155728|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
17011239|NCT00580840|38155729|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
17096891|NCT00421733|38236041|FG002|Overall Study|Lost to Follow-up|4|||
17011240|NCT00580840|38155726|FG000|Double-Blind|Other: Forbidden Medication|0|||
17011241|NCT00580840|38155727|FG001|Double-Blind|Other: Forbidden Medication|0|||
17011242|NCT00580840|38155728|FG002|Double-Blind|Other: Forbidden Medication|1|||
17011243|NCT00580840|38155729|FG003|Double-Blind|Other: Forbidden Medication|0|||
17011244|NCT00879684|38155739|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
17011245|NCT00879684|38155740|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
17011246|NCT00879684|38155741|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
17011247|NCT00879684|38155742|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
17011248|NCT00879684|38155743|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
17011249|NCT00879684|38155744|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
17011250|NCT00879684|38155745|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
17011251|NCT00879684|38155739|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
17011252|NCT00879684|38155740|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
17011253|NCT00879684|38155741|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
17011254|NCT00879684|38155742|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
17011255|NCT00879684|38155743|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
17011256|NCT00879684|38155744|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
17011257|NCT00879684|38155745|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
17011258|NCT00879684|38155739|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
17011259|NCT00879684|38155740|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
17011260|NCT00879684|38155741|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
17011261|NCT00879684|38155742|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
17011262|NCT00879684|38155743|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
17011263|NCT00879684|38155744|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
17011264|NCT00879684|38155745|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
17011265|NCT00879684|38155739|FG000|Stage 1: Dose Escalation|Death|0|||
17011266|NCT00879684|38155740|FG001|Stage 1: Dose Escalation|Death|0|||
17011267|NCT00879684|38155741|FG002|Stage 1: Dose Escalation|Death|1|||
17011268|NCT00879684|38155742|FG003|Stage 1: Dose Escalation|Death|0|||
17011269|NCT00879684|38155743|FG004|Stage 1: Dose Escalation|Death|0|||
17011270|NCT00879684|38155744|FG005|Stage 1: Dose Escalation|Death|0|||
17011271|NCT00879684|38155745|FG006|Stage 1: Dose Escalation|Death|0|||
17011272|NCT00879684|38155739|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
17011273|NCT00879684|38155740|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
17011274|NCT00879684|38155741|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
17011275|NCT00879684|38155742|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
17011276|NCT00879684|38155743|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
17011277|NCT00879684|38155744|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
17011278|NCT00879684|38155745|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
17011279|NCT00879684|38155739|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
17011280|NCT00879684|38155740|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
17011281|NCT00879684|38155741|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
17011282|NCT00879684|38155742|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
17011283|NCT00879684|38155743|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
17011284|NCT00879684|38155744|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
17011285|NCT00879684|38155745|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
17011286|NCT00879684|38155739|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
17011287|NCT00879684|38155740|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
17011288|NCT00879684|38155741|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
17011289|NCT00879684|38155742|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
17011290|NCT00879684|38155743|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
17096892|NCT00421733|38236039|FG000|Overall Study|Withdrawal by Subject|1|||
17096893|NCT00421733|38236040|FG001|Overall Study|Withdrawal by Subject|2|||
17096894|NCT00421733|38236041|FG002|Overall Study|Withdrawal by Subject|7|||
17096895|NCT00421733|38236039|FG000|Overall Study|Death|0|||
17096896|NCT00421733|38236040|FG001|Overall Study|Death|3|||
17096897|NCT00421733|38236041|FG002|Overall Study|Death|0|||
17096898|NCT00421733|38236039|FG000|Overall Study|Required dialysis|1|||
17096899|NCT00421733|38236040|FG001|Overall Study|Required dialysis|0|||
17193154|NCT02055547|38346463|FG007|Overall Study|Physician Decision|0|||
17193155|NCT02055547|38346464|FG008|Overall Study|Physician Decision|0|||
17193156|NCT02055547|38346465|FG009|Overall Study|Physician Decision|1|||
17193157|NCT02055547|38346466|FG010|Overall Study|Physician Decision|1|||
17193158|NCT02055547|38346467|FG011|Overall Study|Physician Decision|0|||
17096900|NCT00421733|38236041|FG002|Overall Study|Required dialysis|0|||
17193159|NCT02055547|38346468|FG012|Overall Study|Physician Decision|0|||
17193160|NCT02055547|38346469|FG013|Overall Study|Physician Decision|0|||
17193161|NCT02055547|38346470|FG014|Overall Study|Physician Decision|0|||
17193162|NCT02055547|38346471|FG015|Overall Study|Physician Decision|0|||
17193163|NCT02055547|38346472|FG016|Overall Study|Physician Decision|0|||
17011291|NCT00879684|38155744|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
17096901|NCT00421733|38236039|FG000|Overall Study|Administrative|2|||
17096902|NCT00421733|38236040|FG001|Overall Study|Administrative|0|||
17011292|NCT00879684|38155745|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
17011293|NCT00581776|38155764|FG000|Overall Study|Disease progression or no response|3|||
17011294|NCT00883740|38155768|FG000|First Intervention|Lost to Follow-up|1|||
17011295|NCT00883740|38155769|FG001|First Intervention|Lost to Follow-up|0|||
17096903|NCT00421733|38236041|FG002|Overall Study|Administrative|0|||
17096904|NCT00421733|38236039|FG000|Overall Study|Did not satisfy entry criteria|1|||
17096905|NCT00421733|38236040|FG001|Overall Study|Did not satisfy entry criteria|3|||
17096906|NCT00421733|38236041|FG002|Overall Study|Did not satisfy entry criteria|2|||
17096907|NCT00421733|38236039|FG000|Overall Study|Sponsor request|1|||
17096908|NCT00421733|38236040|FG001|Overall Study|Sponsor request|0|||
17096909|NCT00421733|38236041|FG002|Overall Study|Sponsor request|3|||
17096910|NCT00421733|38236039|FG000|Overall Study|Protocol deviation|4|||
17096911|NCT00421733|38236040|FG001|Overall Study|Protocol deviation|7|||
17096912|NCT00421733|38236041|FG002|Overall Study|Protocol deviation|2|||
17096913|NCT00421343|38236053|FG000|Overall Study|Death|1|||
17096914|NCT00421343|38236053|FG000|Overall Study|Withdrawal by Subject|2|||
17096915|NCT00421343|38236053|FG000|Overall Study|Lost to Follow-up|3|||
17096916|NCT00230178|38236060|FG000|Overall Study|Adverse Event|1|||
17096917|NCT00230178|38236061|FG001|Overall Study|Adverse Event|5|||
17096918|NCT00230178|38236062|FG002|Overall Study|Adverse Event|2|||
17096919|NCT00230178|38236060|FG000|Overall Study|Withdrawal by Subject|0|||
17096920|NCT00230178|38236061|FG001|Overall Study|Withdrawal by Subject|0|||
17096921|NCT00230178|38236062|FG002|Overall Study|Withdrawal by Subject|1|||
17096922|NCT00230178|38236060|FG000|Overall Study|Various other reasons|3|||
17096923|NCT00230178|38236061|FG001|Overall Study|Various other reasons|2|||
17096924|NCT00230178|38236062|FG002|Overall Study|Various other reasons|4|||
17096925|NCT00413777|38236072|FG000|Fixed-dose Period|Lost to Follow-up|1|||
17096926|NCT00413777|38236073|FG001|Fixed-dose Period|Lost to Follow-up|1|||
17096927|NCT00413777|38236072|FG000|Fixed-dose Period|Adverse Event|2|||
17096928|NCT00413777|38236073|FG001|Fixed-dose Period|Adverse Event|1|||
17096929|NCT00413777|38236072|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
17096930|NCT00413777|38236073|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
17096931|NCT00413777|38236072|FG000|Fixed-dose Period|Withdrew Consent|0|||
17096932|NCT00413777|38236073|FG001|Fixed-dose Period|Withdrew Consent|1|||
17011296|NCT00883740|38155768|FG000|First Intervention|No longer willing to participate|2|||
17011297|NCT00883740|38155769|FG001|First Intervention|No longer willing to participate|0|||
17011298|NCT00883740|38155768|FG000|First Intervention|Protocol Violation|3|||
17011299|NCT00883740|38155769|FG001|First Intervention|Protocol Violation|6|||
17011300|NCT00883740|38155768|FG000|First Intervention|Adverse Event|1|||
17011301|NCT00883740|38155769|FG001|First Intervention|Adverse Event|2|||
17096933|NCT00197028|38236081|FG000|Overall Study|Adverse Event|2|||
17096934|NCT00197028|38236082|FG001|Overall Study|Adverse Event|2|||
17011302|NCT00883740|38155768|FG000|Second Intervention|Protocol Violation|1|||
17011303|NCT00883740|38155769|FG001|Second Intervention|Protocol Violation|0|||
17096935|NCT00197028|38236081|FG000|Overall Study|Protocol Violation|2|||
17096936|NCT00197028|38236082|FG001|Overall Study|Protocol Violation|1|||
17096937|NCT00197028|38236081|FG000|Overall Study|Withdrawal by Subject|8|||
17096938|NCT00197028|38236082|FG001|Overall Study|Withdrawal by Subject|12|||
17096939|NCT00197028|38236081|FG000|Overall Study|Lost to Follow-up|1|||
17096940|NCT00197028|38236082|FG001|Overall Study|Lost to Follow-up|0|||
17096941|NCT00197028|38236081|FG000|Overall Study|Other|3|||
17096942|NCT00197028|38236082|FG001|Overall Study|Other|6|||
17096943|NCT00258960|38236088|FG000|Overall Study|Death|2|||
17096944|NCT00258960|38236088|FG000|Overall Study|Disease Progression|7|||
17096945|NCT00258960|38236088|FG000|Overall Study|Adverse Event|4|||
17096946|NCT00258960|38236088|FG000|Overall Study|Physician Decision|1|||
17096947|NCT00258960|38236088|FG000|Overall Study|Withdrawal by Subject|1|||
17096948|NCT00258960|38236088|FG000|Overall Study|Mistake|2|||
17096949|NCT00420641|38236095|FG000|Overall Study|Adverse Event|3|||
17096950|NCT00420641|38236096|FG001|Overall Study|Adverse Event|25|||
17096951|NCT00420641|38236097|FG002|Overall Study|Adverse Event|10|||
17096952|NCT00420641|38236095|FG000|Overall Study|Lost to Follow-up|2|||
17096953|NCT00420641|38236096|FG001|Overall Study|Lost to Follow-up|4|||
17096954|NCT00420641|38236097|FG002|Overall Study|Lost to Follow-up|2|||
17096955|NCT00420641|38236095|FG000|Overall Study|Protocol Violation|8|||
17096956|NCT00420641|38236096|FG001|Overall Study|Protocol Violation|8|||
17096957|NCT00420641|38236097|FG002|Overall Study|Protocol Violation|7|||
17096958|NCT00420641|38236095|FG000|Overall Study|Withdrawal by Subject|15|||
17096959|NCT00420641|38236096|FG001|Overall Study|Withdrawal by Subject|21|||
17096960|NCT00420641|38236097|FG002|Overall Study|Withdrawal by Subject|14|||
17096961|NCT00420641|38236095|FG000|Overall Study|Lack of Efficacy|6|||
17096962|NCT00420641|38236096|FG001|Overall Study|Lack of Efficacy|5|||
17096963|NCT00420641|38236097|FG002|Overall Study|Lack of Efficacy|4|||
17096964|NCT00420641|38236095|FG000|Overall Study|Non-compliance|7|||
17096965|NCT00420641|38236096|FG001|Overall Study|Non-compliance|5|||
17096966|NCT00420641|38236097|FG002|Overall Study|Non-compliance|4|||
17096967|NCT00420641|38236095|FG000|Overall Study|Other|4|||
17096968|NCT00420641|38236096|FG001|Overall Study|Other|4|||
17096969|NCT00420641|38236097|FG002|Overall Study|Other|3|||
17096970|NCT00257556|38236107|FG000|Overall Study|Adverse Event|1|||
17096971|NCT00257556|38236108|FG001|Overall Study|Adverse Event|4|||
17096972|NCT00257556|38236107|FG000|Overall Study|Physician Decision|6|||
17096973|NCT00257556|38236108|FG001|Overall Study|Physician Decision|0|||
17096974|NCT00257556|38236107|FG000|Overall Study|Did not meet hCG criterion|3|||
17096975|NCT00257556|38236108|FG001|Overall Study|Did not meet hCG criterion|0|||
17096976|NCT00257556|38236107|FG000|Overall Study|other reason|4|||
17096977|NCT00257556|38236108|FG001|Overall Study|other reason|6|||
17096978|NCT00228384|38236116|FG000|Overall Study|Death|9|||
17096979|NCT00228384|38236117|FG001|Overall Study|Death|3|||
17096980|NCT00228384|38236116|FG000|Overall Study|Lost to Follow-up|6|||
17096981|NCT00228384|38236117|FG001|Overall Study|Lost to Follow-up|10|||
17096982|NCT00228384|38236116|FG000|Overall Study|Surgical Intervention (bypass)|5|||
17096983|NCT00228384|38236117|FG001|Overall Study|Surgical Intervention (bypass)|5|||
17096984|NCT00228384|38236116|FG000|Overall Study|Withdrawal by Subject|9|||
17096985|NCT00228384|38236117|FG001|Overall Study|Withdrawal by Subject|10|||
17096986|NCT00228384|38236116|FG000|Overall Study|Physician Decision|0|||
17096987|NCT00228384|38236117|FG001|Overall Study|Physician Decision|1|||
17096988|NCT00257166|38236125|FG000|Overall Study|Adverse Event|18|||
17096989|NCT00257166|38236126|FG001|Overall Study|Adverse Event|13|||
17096990|NCT00257166|38236125|FG000|Overall Study|Laboratory abnormality|1|||
17096991|NCT00257166|38236126|FG001|Overall Study|Laboratory abnormality|0|||
17096992|NCT00257166|38236125|FG000|Overall Study|Lost to Follow-up|8|||
17096993|NCT00257166|38236126|FG001|Overall Study|Lost to Follow-up|1|||
17096994|NCT00257166|38236125|FG000|Overall Study|Withdrawal by Subject|9|||
17096995|NCT00257166|38236126|FG001|Overall Study|Withdrawal by Subject|2|||
17096996|NCT00257166|38236125|FG000|Overall Study|Other|16|||
17096997|NCT00257166|38236126|FG001|Overall Study|Other|21|||
17096998|NCT00257166|38236125|FG000|Overall Study|Randomized, but not treated|1|||
17096999|NCT00257166|38236126|FG001|Overall Study|Randomized, but not treated|0|||
17097000|NCT00227370|38236134|FG000|Overall Study|Withdrawal by Subject|1|||
17097001|NCT00227370|38236135|FG001|Overall Study|Withdrawal by Subject|2|||
17097002|NCT00227370|38236134|FG000|Overall Study|Death|3|||
17097003|NCT00227370|38236135|FG001|Overall Study|Death|4|||
17097004|NCT00227370|38236134|FG000|Overall Study|Adverse Event|6|||
17097005|NCT00227370|38236135|FG001|Overall Study|Adverse Event|11|||
17097006|NCT00227370|38236134|FG000|Overall Study|Physician Decision|9|||
17097007|NCT00227370|38236135|FG001|Overall Study|Physician Decision|6|||
17097008|NCT00227370|38236134|FG000|Overall Study|Other reasons|2|||
17097009|NCT00227370|38236135|FG001|Overall Study|Other reasons|1|||
17097010|NCT00191100|38236143|FG000|Overall Study|Adverse Event|18|||
17097011|NCT00191100|38236144|FG001|Overall Study|Adverse Event|1|||
17097012|NCT00191100|38236143|FG000|Overall Study|Lost to Follow-up|2|||
17097013|NCT00191100|38236144|FG001|Overall Study|Lost to Follow-up|0|||
17097014|NCT00191100|38236143|FG000|Overall Study|Patient Moved|0|||
17097015|NCT00191100|38236144|FG001|Overall Study|Patient Moved|1|||
17097016|NCT00191100|38236143|FG000|Overall Study|Withdrawal by Subject|9|||
17097017|NCT00191100|38236144|FG001|Overall Study|Withdrawal by Subject|3|||
17097018|NCT00191100|38236143|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
17097019|NCT00191100|38236144|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
17097020|NCT00191100|38236143|FG000|Overall Study|Clinical Relapse|2|||
17097021|NCT00191100|38236144|FG001|Overall Study|Clinical Relapse|1|||
17097022|NCT00191100|38236143|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
17097023|NCT00191100|38236144|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
17097024|NCT00191100|38236143|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
17097025|NCT00191100|38236144|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
17097026|NCT00191100|38236143|FG000|Overall Study|Physician Decision|3|||
17097027|NCT00191100|38236144|FG001|Overall Study|Physician Decision|1|||
17097028|NCT00191100|38236143|FG000|Overall Study|Death from Study Drug Toxicity|2|||
17097029|NCT00191100|38236144|FG001|Overall Study|Death from Study Drug Toxicity|0|||
17097030|NCT00191100|38236143|FG000|Overall Study|Protocol Violation|1|||
17097031|NCT00191100|38236144|FG001|Overall Study|Protocol Violation|1|||
17097032|NCT00191100|38236143|FG000|Overall Study|Death from Other Cause|1|||
17097033|NCT00191100|38236144|FG001|Overall Study|Death from Other Cause|0|||
17097034|NCT00191100|38236143|FG000|Overall Study|Reason Not Specified|0|||
17097035|NCT00191100|38236144|FG001|Overall Study|Reason Not Specified|1|||
17097036|NCT00189540|38236152|FG000|Overall Study|Withdrawal by Subject|3|||
17097037|NCT00189540|38236153|FG001|Overall Study|Withdrawal by Subject|0|||
17097038|NCT00189540|38236152|FG000|Overall Study|Death|4|||
17097039|NCT00189540|38236153|FG001|Overall Study|Death|1|||
17097040|NCT00257010|38236159|FG000|Overall Study|Lack of Efficacy|11|||
17097041|NCT00257010|38236159|FG000|Overall Study|Lost to Follow-up|53|||
17097042|NCT00257010|38236159|FG000|Overall Study|Withdrawal by Subject|34|||
17097043|NCT00257010|38236159|FG000|Overall Study|Adverse Event|10|||
17097044|NCT00257010|38236159|FG000|Overall Study|various|11|||
17097045|NCT00257010|38236159|FG000|Overall Study|no headache reported|9|||
17097046|NCT00256854|38236169|FG000|Overall Study|Withdrawal by Subject|2|||
17097047|NCT00256854|38236170|FG001|Overall Study|Withdrawal by Subject|3|||
17097048|NCT00256854|38236171|FG002|Overall Study|Withdrawal by Subject|0|||
17097049|NCT00256854|38236172|FG003|Overall Study|Withdrawal by Subject|0|||
17097050|NCT00256854|38236173|FG004|Overall Study|Withdrawal by Subject|0|||
17097051|NCT00256854|38236174|FG005|Overall Study|Withdrawal by Subject|0|||
17097052|NCT00256854|38236169|FG000|Overall Study|Lack of Efficacy|1|||
17097053|NCT00256854|38236170|FG001|Overall Study|Lack of Efficacy|0|||
17097054|NCT00256854|38236171|FG002|Overall Study|Lack of Efficacy|0|||
17097055|NCT00256854|38236172|FG003|Overall Study|Lack of Efficacy|0|||
17097056|NCT00256854|38236173|FG004|Overall Study|Lack of Efficacy|0|||
17097057|NCT00256854|38236174|FG005|Overall Study|Lack of Efficacy|0|||
17097058|NCT00256854|38236169|FG000|Overall Study|Protocol Violation|0|||
17097059|NCT00256854|38236170|FG001|Overall Study|Protocol Violation|1|||
17097060|NCT00256854|38236171|FG002|Overall Study|Protocol Violation|1|||
17097061|NCT00256854|38236172|FG003|Overall Study|Protocol Violation|1|||
17097062|NCT00256854|38236173|FG004|Overall Study|Protocol Violation|0|||
17097063|NCT00256854|38236174|FG005|Overall Study|Protocol Violation|0|||
17097064|NCT00256854|38236169|FG000|Overall Study|Adverse Event|0|||
17097065|NCT00256854|38236170|FG001|Overall Study|Adverse Event|0|||
17097066|NCT00256854|38236171|FG002|Overall Study|Adverse Event|2|||
17097067|NCT00256854|38236172|FG003|Overall Study|Adverse Event|2|||
17097068|NCT00256854|38236173|FG004|Overall Study|Adverse Event|0|||
17097069|NCT00256854|38236174|FG005|Overall Study|Adverse Event|1|||
17097070|NCT00256854|38236169|FG000|Overall Study|Not compliant with the study drug|0|||
17097071|NCT00256854|38236170|FG001|Overall Study|Not compliant with the study drug|0|||
17097072|NCT00256854|38236171|FG002|Overall Study|Not compliant with the study drug|0|||
17097073|NCT00256854|38236172|FG003|Overall Study|Not compliant with the study drug|0|||
17097074|NCT00256854|38236173|FG004|Overall Study|Not compliant with the study drug|1|||
17097075|NCT00256854|38236174|FG005|Overall Study|Not compliant with the study drug|0|||
17097076|NCT00189462|38236191|FG000|Overall Study|Lack of Efficacy|5|||
17097077|NCT00189462|38236192|FG001|Overall Study|Lack of Efficacy|1|||
17097078|NCT00189462|38236191|FG000|Overall Study|Lost to Follow-up|18|||
17097079|NCT00189462|38236192|FG001|Overall Study|Lost to Follow-up|20|||
17097080|NCT00256698|38236200|FG000|Overall Study|Withdrawal by Subject|7|||
17097081|NCT00256698|38236201|FG001|Overall Study|Withdrawal by Subject|7|||
17097082|NCT00256698|38236200|FG000|Overall Study|Adverse Event|13|||
17097083|NCT00256698|38236201|FG001|Overall Study|Adverse Event|6|||
17097084|NCT00256698|38236200|FG000|Overall Study|Protocol Violation|6|||
17097085|NCT00256698|38236201|FG001|Overall Study|Protocol Violation|5|||
17097086|NCT00256698|38236200|FG000|Overall Study|Lost to Follow-up|1|||
17097087|NCT00256698|38236201|FG001|Overall Study|Lost to Follow-up|3|||
17097088|NCT00256698|38236200|FG000|Overall Study|disease progression|97|||
17097089|NCT00256698|38236201|FG001|Overall Study|disease progression|105|||
17097090|NCT00256698|38236200|FG000|Overall Study|still ongoing at data cut-off|41|||
17097091|NCT00256698|38236201|FG001|Overall Study|still ongoing at data cut-off|46|||
17097092|NCT00256698|38236200|FG000|Overall Study|withdrawn due to osteoporosis|1|||
17097093|NCT00256698|38236201|FG001|Overall Study|withdrawn due to osteoporosis|0|||
17097094|NCT00256698|38236200|FG000|Overall Study|Prematurely Discontinued|1|||
17097095|NCT00256698|38236201|FG001|Overall Study|Prematurely Discontinued|0|||
17097096|NCT00189306|38236207|FG000|Treatment Period|Withdrawal by Subject|2|||
17097097|NCT00189306|38236207|FG000|Treatment Period|Adverse Event|2|||
17097098|NCT00189306|38236207|FG000|Treatment Period|Protocol Violation|1|||
17097099|NCT00189306|38236207|FG000|Posttreatment Period|Death|1|||
17097100|NCT00189306|38236207|FG000|Posttreatment Period|Withdrawal by Subject|2|||
17097101|NCT00189306|38236207|FG000|Posttreatment Period|Noncompliance|1|||
17097102|NCT00189306|38236207|FG000|Posttreatment Period|Target lesion excised|1|||
17097103|NCT00189306|38236207|FG000|Posttreatment Period|Protocol Violation|1|||
17097104|NCT00189306|38236207|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
17097105|NCT00189306|38236207|FG000|Posttreatment Period|Local skin reaction/sign|1|||
17097106|NCT00189306|38236207|FG000|Long-Term Follow-up|Adverse Event|2|||
17097107|NCT00189306|38236207|FG000|Long-Term Follow-up|Death|4|||
17097108|NCT00189306|38236207|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
17097109|NCT00189306|38236207|FG000|Long-Term Follow-up|Intercurrent disease|2|||
17097110|NCT00189306|38236207|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
17097111|NCT00189306|38236207|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
17097112|NCT00187278|38236213|FG000|Overall Study|Protocol Violation|10|||
17097113|NCT00187278|38236214|FG001|Overall Study|Protocol Violation|13|||
17097114|NCT00256308|38236222|FG000|Overall Study|Death|2|||
17097115|NCT00255840|38236228|FG000|Overall Study|Lost to Follow-up|10|||
17097116|NCT00255840|38236229|FG001|Overall Study|Lost to Follow-up|14|||
17097117|NCT00255840|38236228|FG000|Overall Study|Discontinued intervention|53|||
17097118|NCT00255840|38236229|FG001|Overall Study|Discontinued intervention|56|||
17097119|NCT00224874|38236239|FG000|Overall Study|Withdrawal by Subject|0|||
17097120|NCT00224874|38236240|FG001|Overall Study|Withdrawal by Subject|0|||
17097121|NCT00224874|38236241|FG002|Overall Study|Withdrawal by Subject|1|||
17097122|NCT00224874|38236242|FG003|Overall Study|Withdrawal by Subject|0|||
17097123|NCT00186186|38236252|FG000|Overall Study|Lack of Efficacy|3|||
17097124|NCT00186186|38236252|FG000|Overall Study|Withdrawal by Subject|3|||
17097125|NCT00186186|38236252|FG000|Overall Study|Not reported as to reason|2|||
17097126|NCT00185640|38236257|FG000|Overall Study|Not Eligible|4|||
17097127|NCT00185640|38236257|FG000|Overall Study|Withdrawal by Subject|3|||
17097128|NCT00185640|38236257|FG000|Overall Study|Death|138|||
17097129|NCT03760666|38236264|FG000|Overall Study|Adverse Event|2|||
17097130|NCT03760666|38236265|FG001|Overall Study|Adverse Event|4|||
17097131|NCT03760666|38236266|FG002|Overall Study|Adverse Event|1|||
17097132|NCT03760666|38236264|FG000|Overall Study|AML Disease Progression|3|||
17097133|NCT03760666|38236265|FG001|Overall Study|AML Disease Progression|3|||
17097134|NCT03760666|38236266|FG002|Overall Study|AML Disease Progression|0|||
17097135|NCT03760666|38236264|FG000|Overall Study|Physician Decision|0|||
17097136|NCT03760666|38236265|FG001|Overall Study|Physician Decision|3|||
17097137|NCT03760666|38236266|FG002|Overall Study|Physician Decision|0|||
17097138|NCT03760666|38236264|FG000|Overall Study|Withdrawal by Subject|0|||
17097139|NCT03760666|38236265|FG001|Overall Study|Withdrawal by Subject|1|||
17097140|NCT03760666|38236266|FG002|Overall Study|Withdrawal by Subject|0|||
17097141|NCT03760510|38236279|FG000|Overall Study|Not ventilated for 24 hours|105|||
17097142|NCT03760510|38236280|FG001|Overall Study|Not ventilated for 24 hours|97|||
17097143|NCT00224484|38236289|FG000|Overall Study|Serious Adverse Event|1|||
17097144|NCT00224484|38236290|FG001|Overall Study|Serious Adverse Event|1|||
17097145|NCT00224484|38236291|FG002|Overall Study|Serious Adverse Event|0|||
17097146|NCT00224484|38236289|FG000|Overall Study|Non-Serious Adverse Event|5|||
17097147|NCT00224484|38236290|FG001|Overall Study|Non-Serious Adverse Event|7|||
17097148|NCT00224484|38236291|FG002|Overall Study|Non-Serious Adverse Event|3|||
17097149|NCT00224484|38236289|FG000|Overall Study|Protocol Violation|2|||
17097150|NCT00224484|38236290|FG001|Overall Study|Protocol Violation|2|||
17097151|NCT00224484|38236291|FG002|Overall Study|Protocol Violation|0|||
17097152|NCT00224484|38236289|FG000|Overall Study|Withdrawal by Subject|49|||
17097153|NCT00224484|38236290|FG001|Overall Study|Withdrawal by Subject|18|||
17097154|NCT00224484|38236291|FG002|Overall Study|Withdrawal by Subject|16|||
17097155|NCT00224484|38236289|FG000|Overall Study|Migrated/moved from study area|18|||
17097156|NCT00224484|38236290|FG001|Overall Study|Migrated/moved from study area|5|||
17097157|NCT00224484|38236291|FG002|Overall Study|Migrated/moved from study area|5|||
17097158|NCT00224484|38236289|FG000|Overall Study|Lost to Follow-up|66|||
17097159|NCT00224484|38236290|FG001|Overall Study|Lost to Follow-up|28|||
17097160|NCT00224484|38236291|FG002|Overall Study|Lost to Follow-up|36|||
17097161|NCT00224484|38236289|FG000|Overall Study|Reason not specified|5|||
17097162|NCT00224484|38236290|FG001|Overall Study|Reason not specified|4|||
17097163|NCT00224484|38236291|FG002|Overall Study|Reason not specified|2|||
17097164|NCT00254982|38236304|FG000|Overall Study|Other|2|||
17097165|NCT00254982|38236305|FG001|Overall Study|Other|1|||
17097166|NCT00254982|38236304|FG000|Overall Study|Lack of Efficacy|5|||
17097167|NCT00254982|38236305|FG001|Overall Study|Lack of Efficacy|3|||
17097168|NCT00254982|38236304|FG000|Overall Study|Lost to Follow-up|5|||
17097169|NCT00254982|38236305|FG001|Overall Study|Lost to Follow-up|3|||
17097170|NCT00254982|38236304|FG000|Overall Study|Adverse Event|18|||
17097171|NCT00254982|38236305|FG001|Overall Study|Adverse Event|16|||
17097172|NCT00254982|38236304|FG000|Overall Study|Withdrawal by Subject|1|||
17097173|NCT00254982|38236305|FG001|Overall Study|Withdrawal by Subject|1|||
17097174|NCT00254982|38236304|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
17097175|NCT00254982|38236305|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
17097176|NCT00254982|38236304|FG000|Overall Study|Protocol deviation|1|||
17097177|NCT00254982|38236305|FG001|Overall Study|Protocol deviation|1|||
17097178|NCT00254982|38236304|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
17097179|NCT00254982|38236305|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
17097180|NCT00254982|38236304|FG000|Overall Study|Malignancy|0|||
17097181|NCT00254982|38236305|FG001|Overall Study|Malignancy|2|||
17097182|NCT00254982|38236304|FG000|Overall Study|Opportunistic infection|1|||
17097183|NCT00254982|38236305|FG001|Overall Study|Opportunistic infection|0|||
17097184|NCT00254982|38236304|FG000|Overall Study|Abnormal liver function tests|2|||
17097185|NCT00254982|38236305|FG001|Overall Study|Abnormal liver function tests|1|||
17097186|NCT03759340|38236311|FG000|Overall Study|Adverse Event|2|||
17097187|NCT03759340|38236311|FG000|Overall Study|Lost to Follow-up|1|||
17097188|NCT03759340|38236311|FG000|Overall Study|Withdrawal by Subject|15|||
17097189|NCT03759340|38236311|FG000|Overall Study|Study Terminated by Sponsor|38|||
17097190|NCT00224016|38236317|FG000|Titration Period|Withdrawal by Subject|0|||
17097191|NCT00224016|38236318|FG001|Titration Period|Withdrawal by Subject|1|||
17097192|NCT00224016|38236317|FG000|Titration Period|Lost to Follow-up|1|||
17097193|NCT00224016|38236318|FG001|Titration Period|Lost to Follow-up|0|||
17097194|NCT00224016|38236317|FG000|Maintenance Period|Withdrawal by Subject|2|||
17097195|NCT00224016|38236318|FG001|Maintenance Period|Withdrawal by Subject|0|||
17097196|NCT00224016|38236317|FG000|Maintenance Period|Lost to Follow-up|0|||
17097197|NCT00224016|38236318|FG001|Maintenance Period|Lost to Follow-up|1|||
17097198|NCT03757234|38236329|FG000|Overall Study|Adverse Event|0|||
17097199|NCT03757234|38236330|FG001|Overall Study|Adverse Event|0|||
17097200|NCT03757234|38236331|FG002|Overall Study|Adverse Event|0|||
17097201|NCT03757234|38236332|FG003|Overall Study|Adverse Event|0|||
17097202|NCT03757234|38236333|FG004|Overall Study|Adverse Event|1|||
17097203|NCT03757234|38236329|FG000|Overall Study|Lost to Follow-up|1|||
17097204|NCT03757234|38236330|FG001|Overall Study|Lost to Follow-up|0|||
17097205|NCT03757234|38236331|FG002|Overall Study|Lost to Follow-up|0|||
17097206|NCT03757234|38236332|FG003|Overall Study|Lost to Follow-up|0|||
17097207|NCT03757234|38236333|FG004|Overall Study|Lost to Follow-up|1|||
17097208|NCT03757234|38236329|FG000|Overall Study|Withdrawal by Subject|1|||
17097209|NCT03757234|38236330|FG001|Overall Study|Withdrawal by Subject|1|||
17097210|NCT03757234|38236331|FG002|Overall Study|Withdrawal by Subject|0|||
17097211|NCT03757234|38236332|FG003|Overall Study|Withdrawal by Subject|1|||
17097212|NCT03757234|38236333|FG004|Overall Study|Withdrawal by Subject|2|||
17097213|NCT03757234|38236329|FG000|Overall Study|Other|1|||
17097214|NCT03757234|38236330|FG001|Overall Study|Other|1|||
17097215|NCT03757234|38236331|FG002|Overall Study|Other|0|||
17097216|NCT03757234|38236332|FG003|Overall Study|Other|0|||
17097217|NCT03757234|38236333|FG004|Overall Study|Other|0|||
17097218|NCT00223080|38236347|FG000|Overall Study|Withdrawal by Subject|253|||
17097219|NCT00223080|38236348|FG001|Overall Study|Withdrawal by Subject|232|||
17097220|NCT00223080|38236347|FG000|Overall Study|Required contraindicated med|0|||
17097221|NCT00223080|38236348|FG001|Overall Study|Required contraindicated med|1|||
17097222|NCT00223080|38236347|FG000|Overall Study|Non-compliant|7|||
17097223|NCT00223080|38236348|FG001|Overall Study|Non-compliant|7|||
17097224|NCT00223080|38236347|FG000|Overall Study|Moved from study area|37|||
17097225|NCT00223080|38236348|FG001|Overall Study|Moved from study area|47|||
17011304|NCT00883740|38155768|FG000|Second Intervention|No longer willing to participate|0|||
17011305|NCT00883740|38155769|FG001|Second Intervention|No longer willing to participate|1|||
17011306|NCT00597012|38155777|FG000|Overall Study|Death|1|||
17011307|NCT00597012|38155778|FG001|Overall Study|Death|1|||
17011308|NCT00597012|38155777|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
17011309|NCT00597012|38155778|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
17011310|NCT00597012|38155777|FG000|Overall Study|Withdrawal by Subject|7|||
17011311|NCT00597012|38155778|FG001|Overall Study|Withdrawal by Subject|4|||
17011312|NCT00597012|38155777|FG000|Overall Study|Ineligible|2|||
17011313|NCT00597012|38155778|FG001|Overall Study|Ineligible|0|||
17011314|NCT00597012|38155777|FG000|Overall Study|Lost to Follow-up|0|||
17011315|NCT00597012|38155778|FG001|Overall Study|Lost to Follow-up|2|||
17011316|NCT00542815|38155789|FG000|Overall Study|Adverse Event|19|||
17011317|NCT00542815|38155790|FG001|Overall Study|Adverse Event|6|||
17011318|NCT00542815|38155791|FG002|Overall Study|Adverse Event|9|||
17011319|NCT00542815|38155789|FG000|Overall Study|Death|10|||
17011320|NCT00542815|38155790|FG001|Overall Study|Death|7|||
17011321|NCT00542815|38155791|FG002|Overall Study|Death|3|||
17011322|NCT00542815|38155789|FG000|Overall Study|Lack of Efficacy|9|||
17011323|NCT00542815|38155790|FG001|Overall Study|Lack of Efficacy|2|||
17011324|NCT00542815|38155791|FG002|Overall Study|Lack of Efficacy|0|||
17011325|NCT00542815|38155789|FG000|Overall Study|Physician Decision|2|||
17011326|NCT00542815|38155790|FG001|Overall Study|Physician Decision|1|||
17011327|NCT00542815|38155791|FG002|Overall Study|Physician Decision|0|||
17011328|NCT00542815|38155789|FG000|Overall Study|Protocol Violation|1|||
17011329|NCT00542815|38155790|FG001|Overall Study|Protocol Violation|1|||
17011330|NCT00542815|38155791|FG002|Overall Study|Protocol Violation|2|||
17011331|NCT00542815|38155789|FG000|Overall Study|Withdrawal by Subject|41|||
17011332|NCT00542815|38155790|FG001|Overall Study|Withdrawal by Subject|5|||
17011333|NCT00542815|38155791|FG002|Overall Study|Withdrawal by Subject|8|||
17011334|NCT00542815|38155789|FG000|Overall Study|Other reasons|24|||
17011335|NCT00542815|38155790|FG001|Overall Study|Other reasons|10|||
17011336|NCT00542815|38155791|FG002|Overall Study|Other reasons|10|||
17011337|NCT00542425|38155804|FG000|Initial 24 Weeks|Administrative reasons|0|||
17011338|NCT00542425|38155805|FG001|Initial 24 Weeks|Administrative reasons|0|||
17011339|NCT00542425|38155806|FG002|Initial 24 Weeks|Administrative reasons|1|||
17011340|NCT00542425|38155807|FG003|Initial 24 Weeks|Administrative reasons|1|||
17011341|NCT00542425|38155808|FG004|Initial 24 Weeks|Administrative reasons|0|||
17097226|NCT00223080|38236347|FG000|Overall Study|Lost to Follow-up|259|||
17011342|NCT00542425|38155804|FG000|Initial 24 Weeks|Adverse Event|0|||
17011343|NCT00542425|38155805|FG001|Initial 24 Weeks|Adverse Event|1|||
17011344|NCT00542425|38155806|FG002|Initial 24 Weeks|Adverse Event|1|||
17011345|NCT00542425|38155807|FG003|Initial 24 Weeks|Adverse Event|3|||
17011346|NCT00542425|38155808|FG004|Initial 24 Weeks|Adverse Event|2|||
17011347|NCT00542425|38155804|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
17011348|NCT00542425|38155805|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
17011349|NCT00542425|38155806|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
17011350|NCT00542425|38155807|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
17097227|NCT00223080|38236348|FG001|Overall Study|Lost to Follow-up|284|||
17097228|NCT00223080|38236347|FG000|Overall Study|Death|85|||
17097229|NCT00223080|38236348|FG001|Overall Study|Death|74|||
17097230|NCT00223080|38236347|FG000|Overall Study|Other|14|||
17097231|NCT00223080|38236348|FG001|Overall Study|Other|11|||
17097232|NCT00223080|38236347|FG000|Overall Study|Reason not provided|141|||
17011351|NCT00542425|38155808|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
17011352|NCT00542425|38155804|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
17011353|NCT00542425|38155805|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
17011354|NCT00542425|38155806|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
17011355|NCT00542425|38155807|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
17011356|NCT00542425|38155808|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
17011357|NCT00542425|38155804|FG000|Initial 24 Weeks|Non-compliance|0|||
17011358|NCT00542425|38155805|FG001|Initial 24 Weeks|Non-compliance|0|||
17011359|NCT00542425|38155806|FG002|Initial 24 Weeks|Non-compliance|0|||
17011360|NCT00542425|38155807|FG003|Initial 24 Weeks|Non-compliance|1|||
17011361|NCT00542425|38155808|FG004|Initial 24 Weeks|Non-compliance|1|||
17011362|NCT00542425|38155804|FG000|Initial 24 Weeks|Protocol Violation|0|||
17011363|NCT00542425|38155805|FG001|Initial 24 Weeks|Protocol Violation|0|||
17011364|NCT00542425|38155806|FG002|Initial 24 Weeks|Protocol Violation|0|||
17011365|NCT00542425|38155807|FG003|Initial 24 Weeks|Protocol Violation|1|||
17011366|NCT00542425|38155808|FG004|Initial 24 Weeks|Protocol Violation|0|||
17011367|NCT00542425|38155804|FG000|Initial 24 Weeks|Refusal of treatment|2|||
17011368|NCT00542425|38155805|FG001|Initial 24 Weeks|Refusal of treatment|2|||
17011369|NCT00542425|38155806|FG002|Initial 24 Weeks|Refusal of treatment|1|||
17011370|NCT00542425|38155807|FG003|Initial 24 Weeks|Refusal of treatment|4|||
17011371|NCT00542425|38155808|FG004|Initial 24 Weeks|Refusal of treatment|1|||
17011372|NCT00542425|38155804|FG000|Initial 24 Weeks|Other|0|||
17011373|NCT00542425|38155805|FG001|Initial 24 Weeks|Other|2|||
17011374|NCT00542425|38155806|FG002|Initial 24 Weeks|Other|1|||
17011375|NCT00542425|38155807|FG003|Initial 24 Weeks|Other|0|||
17011376|NCT00542425|38155808|FG004|Initial 24 Weeks|Other|0|||
17011377|NCT00542425|38155804|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
17011378|NCT00542425|38155805|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
17011379|NCT00542425|38155806|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
17011380|NCT00542425|38155807|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
17011381|NCT00542425|38155808|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
17011382|NCT00542425|38155804|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
17011383|NCT00542425|38155805|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
17011384|NCT00542425|38155806|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
17011385|NCT00542425|38155807|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
17011386|NCT00542425|38155808|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
17011387|NCT00542425|38155804|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
17011388|NCT00542425|38155805|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
17011389|NCT00542425|38155806|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
17011390|NCT00542425|38155807|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
17011391|NCT00542425|38155808|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
17011392|NCT00542425|38155804|FG000|Extended 24 Weeks of Treatment|Other|1|||
17011393|NCT00542425|38155805|FG001|Extended 24 Weeks of Treatment|Other|1|||
17011394|NCT00542425|38155806|FG002|Extended 24 Weeks of Treatment|Other|0|||
17011395|NCT00542425|38155807|FG003|Extended 24 Weeks of Treatment|Other|0|||
17011396|NCT00542425|38155808|FG004|Extended 24 Weeks of Treatment|Other|1|||
17011397|NCT00541099|38155820|FG000|Overall Study|Ineligible|3|||
17011398|NCT00580606|38155826|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
17011399|NCT00580606|38155827|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
17011400|NCT00580606|38155826|FG000|Open Label (OL)|Withdrawal by Subject|4|||
17011401|NCT00580606|38155827|FG001|Open Label (OL)|Withdrawal by Subject|6|||
17011402|NCT00580606|38155826|FG000|Open Label (OL)|Dosing Symptoms|0|||
17011403|NCT00580606|38155827|FG001|Open Label (OL)|Dosing Symptoms|1|||
17011404|NCT00580606|38155826|FG000|Open Label (OL)|Lost to Follow-up|0|||
17011405|NCT00580606|38155827|FG001|Open Label (OL)|Lost to Follow-up|1|||
17011406|NCT00580606|38155826|FG000|Open Label (OL)|Pregnancy|0|||
17011407|NCT00580606|38155827|FG001|Open Label (OL)|Pregnancy|1|||
17011408|NCT00580606|38155826|FG000|Open Label (OL)|Non-compliance|2|||
17011409|NCT00580606|38155827|FG001|Open Label (OL)|Non-compliance|0|||
17011410|NCT00580606|38155826|FG000|Open Label (OL)|Physician Decision|1|||
17011411|NCT00580606|38155827|FG001|Open Label (OL)|Physician Decision|1|||
17011412|NCT00580606|38155826|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
17011413|NCT00580606|38155827|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
17011414|NCT00579982|38155841|FG000|Overall Study|Adverse Event|4|||
17011415|NCT00579982|38155841|FG000|Overall Study|Protocol Violation|4|||
17011416|NCT00596466|38155845|FG000|Overall Study|Lack of Efficacy|5|||
17011417|NCT00596466|38155845|FG000|Overall Study|Adverse Event|4|||
17011418|NCT00596466|38155845|FG000|Overall Study|Withdrawal by Subject|2|||
17011419|NCT00596466|38155845|FG000|Overall Study|Protocol Violation|2|||
17011420|NCT00596466|38155845|FG000|Overall Study|Unpecified|2|||
17011421|NCT00596466|38155845|FG000|Overall Study|Enrolled, not treated|2|||
17011422|NCT00596934|38155849|FG000|Overall Study|Protocol Violation|1|||
17011423|NCT00596934|38155849|FG000|Overall Study|Withdrawal by Subject|1|||
17011424|NCT03911401|38155858|FG000|Overall Study|Adverse Event|1|||
17011425|NCT03911401|38155859|FG001|Overall Study|Adverse Event|2|||
17011426|NCT03911401|38155860|FG002|Overall Study|Adverse Event|5|||
17011427|NCT03911401|38155858|FG000|Overall Study|Lack of Efficacy|1|||
17011428|NCT03911401|38155859|FG001|Overall Study|Lack of Efficacy|1|||
17011429|NCT03911401|38155860|FG002|Overall Study|Lack of Efficacy|8|||
17011430|NCT03911401|38155858|FG000|Overall Study|Physician Decision|0|||
17011431|NCT03911401|38155859|FG001|Overall Study|Physician Decision|0|||
17011432|NCT03911401|38155860|FG002|Overall Study|Physician Decision|1|||
17011433|NCT03911401|38155858|FG000|Overall Study|Withdrawal by Subject|1|||
17011434|NCT03911401|38155859|FG001|Overall Study|Withdrawal by Subject|2|||
17011435|NCT03911401|38155860|FG002|Overall Study|Withdrawal by Subject|0|||
17011436|NCT03911401|38155858|FG000|Overall Study|Withdrawal by parent/guardian|4|||
17011437|NCT03911401|38155859|FG001|Overall Study|Withdrawal by parent/guardian|4|||
17097233|NCT00223080|38236348|FG001|Overall Study|Reason not provided|140|||
17097234|NCT00223080|38236347|FG000|Overall Study|Adverse Event|0|||
17097235|NCT00223080|38236348|FG001|Overall Study|Adverse Event|1|||
17097236|NCT00220740|38236356|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
17097237|NCT00220740|38236357|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
17097238|NCT00220740|38236356|FG000|Efficacy Period|Adverse Event|1|||
17097239|NCT00220740|38236357|FG001|Efficacy Period|Adverse Event|1|||
17097240|NCT00220740|38236356|FG000|Efficacy Period|Withdrawal by Subject|1|||
17011438|NCT03911401|38155860|FG002|Overall Study|Withdrawal by parent/guardian|11|||
17011439|NCT00579670|38155873|FG000|Overall Study|Death|1|||
17011440|NCT00579670|38155874|FG001|Overall Study|Death|0|||
17011441|NCT00579670|38155875|FG002|Overall Study|Death|0|||
17011442|NCT00579670|38155876|FG003|Overall Study|Death|0|||
17011443|NCT00579670|38155877|FG004|Overall Study|Death|0|||
17011444|NCT00579670|38155873|FG000|Overall Study|Adverse Event|1|||
17011445|NCT00579670|38155874|FG001|Overall Study|Adverse Event|0|||
17011446|NCT00579670|38155875|FG002|Overall Study|Adverse Event|1|||
17011447|NCT00579670|38155876|FG003|Overall Study|Adverse Event|2|||
17011448|NCT00579670|38155877|FG004|Overall Study|Adverse Event|0|||
17011449|NCT00579670|38155873|FG000|Overall Study|Lack of Efficacy|0|||
17011450|NCT00579670|38155874|FG001|Overall Study|Lack of Efficacy|0|||
17011451|NCT00579670|38155875|FG002|Overall Study|Lack of Efficacy|1|||
17011452|NCT00579670|38155876|FG003|Overall Study|Lack of Efficacy|14|||
17011453|NCT00579670|38155877|FG004|Overall Study|Lack of Efficacy|0|||
17011454|NCT00579670|38155873|FG000|Overall Study|Lost to Follow-up|0|||
17011455|NCT00579670|38155874|FG001|Overall Study|Lost to Follow-up|1|||
17011456|NCT00579670|38155875|FG002|Overall Study|Lost to Follow-up|0|||
17011457|NCT00579670|38155876|FG003|Overall Study|Lost to Follow-up|4|||
17011458|NCT00579670|38155877|FG004|Overall Study|Lost to Follow-up|0|||
17011459|NCT00579670|38155873|FG000|Overall Study|Other|0|||
17011460|NCT00579670|38155874|FG001|Overall Study|Other|0|||
17011461|NCT00579670|38155875|FG002|Overall Study|Other|1|||
17011462|NCT00579670|38155876|FG003|Overall Study|Other|2|||
17011463|NCT00579670|38155877|FG004|Overall Study|Other|0|||
17011464|NCT00579670|38155873|FG000|Overall Study|Withdrawal by Subject|0|||
17011465|NCT00579670|38155874|FG001|Overall Study|Withdrawal by Subject|0|||
17011466|NCT00579670|38155875|FG002|Overall Study|Withdrawal by Subject|1|||
17011467|NCT00579670|38155876|FG003|Overall Study|Withdrawal by Subject|0|||
17011468|NCT00579670|38155877|FG004|Overall Study|Withdrawal by Subject|0|||
17011469|NCT03909295|38155901|FG000|Overall Study|Adverse Event|2|||
17011470|NCT03909295|38155901|FG000|Overall Study|Study terminated by sponsor|50|||
17011471|NCT00599924|38155912|FG000|Overall Study|Lack of Efficacy|3|||
17011472|NCT00599924|38155913|FG001|Overall Study|Lack of Efficacy|5|||
17011473|NCT00599924|38155914|FG002|Overall Study|Lack of Efficacy|1|||
17011474|NCT00599924|38155915|FG003|Overall Study|Lack of Efficacy|2|||
17011475|NCT00599924|38155916|FG004|Overall Study|Lack of Efficacy|3|||
17011476|NCT00599924|38155917|FG005|Overall Study|Lack of Efficacy|2|||
17011477|NCT00599924|38155918|FG006|Overall Study|Lack of Efficacy|0|||
17097241|NCT00220740|38236357|FG001|Efficacy Period|Withdrawal by Subject|0|||
17097242|NCT00220740|38236356|FG000|Efficacy Period|Protocol Violation|1|||
17097243|NCT00220740|38236357|FG001|Efficacy Period|Protocol Violation|0|||
17097244|NCT00220740|38236356|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
17097245|NCT00220740|38236357|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
17097246|NCT00184002|38236365|FG000|Overall Study|Adverse Event|9|||
17097247|NCT00184002|38236365|FG000|Overall Study|Death|3|||
17097248|NCT00184002|38236365|FG000|Overall Study|Physician Decision|1|||
17097249|NCT00184002|38236365|FG000|Overall Study|Withdrawal by Subject|4|||
17097250|NCT00165672|38236371|FG000|Overall Study|Adverse Event|0|||
17097251|NCT00165672|38236372|FG001|Overall Study|Adverse Event|1|||
17097252|NCT00180414|38236380|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
17097253|NCT00180414|38236381|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
17097254|NCT00174252|38236387|FG000|Overall Study|Protocol Violation|2|||
17097255|NCT00169104|38236395|FG000|Overall Study|Withdrawal by Subject|2|||
17097256|NCT00169104|38236396|FG001|Overall Study|Withdrawal by Subject|0|||
17011478|NCT00599924|38155912|FG000|Overall Study|Adverse Event|0|||
17011479|NCT00599924|38155913|FG001|Overall Study|Adverse Event|0|||
17011480|NCT00599924|38155914|FG002|Overall Study|Adverse Event|0|||
17097257|NCT00169104|38236395|FG000|Overall Study|Protocol Violation|0|||
17097258|NCT00169104|38236396|FG001|Overall Study|Protocol Violation|1|||
17097259|NCT00169104|38236395|FG000|Overall Study|Physician Decision|0|||
17011481|NCT00599924|38155915|FG003|Overall Study|Adverse Event|2|||
17011482|NCT00599924|38155916|FG004|Overall Study|Adverse Event|0|||
17011483|NCT00599924|38155917|FG005|Overall Study|Adverse Event|0|||
17011484|NCT00599924|38155918|FG006|Overall Study|Adverse Event|2|||
17011485|NCT00599924|38155912|FG000|Overall Study|Death|0|||
17097260|NCT00169104|38236396|FG001|Overall Study|Physician Decision|1|||
17097261|NCT00163020|38236405|FG000|Overall Study|Lost to Follow-up|0|||
17097262|NCT00163020|38236406|FG001|Overall Study|Lost to Follow-up|2|||
17097263|NCT00252720|38236416|FG000|Overall Study|Withdrawal by Subject|95|||
17097264|NCT00252720|38236417|FG001|Overall Study|Withdrawal by Subject|97|||
17097265|NCT00252720|38236416|FG000|Overall Study|Death|7|||
17097266|NCT00252720|38236417|FG001|Overall Study|Death|8|||
17097267|NCT00252720|38236416|FG000|Overall Study|Moving|23|||
17097268|NCT00252720|38236417|FG001|Overall Study|Moving|42|||
17097269|NCT00252720|38236416|FG000|Overall Study|Mainly patients lost to follow-up|7|||
17097270|NCT00252720|38236417|FG001|Overall Study|Mainly patients lost to follow-up|18|||
17097271|NCT00167778|38236423|FG000|Overall Study|Withdrawal by Subject|1|||
17097272|NCT00167310|38236430|FG000|Overall Study|Protocol Violation|5|||
17097273|NCT00167310|38236431|FG001|Overall Study|Protocol Violation|3|||
17097274|NCT00167310|38236430|FG000|Overall Study|Withdrawal by Subject|3|||
17097275|NCT00167310|38236431|FG001|Overall Study|Withdrawal by Subject|7|||
17097276|NCT03754582|38236437|FG000|Treatment Phase|Adverse Event|0|||
17097277|NCT03754582|38236438|FG001|Treatment Phase|Adverse Event|1|||
17097278|NCT03754582|38236439|FG002|Treatment Phase|Adverse Event|0|||
17097279|NCT03754582|38236437|FG000|Follow-up Phase|Other|0|||
17097280|NCT03754582|38236438|FG001|Follow-up Phase|Other|0|||
17097281|NCT03754582|38236439|FG002|Follow-up Phase|Other|1|||
17097282|NCT00161616|38236457|FG000|Overall Study|Withdrawal by Subject|6|||
17097283|NCT00161616|38236458|FG001|Overall Study|Withdrawal by Subject|5|||
17097284|NCT00161616|38236457|FG000|Overall Study|Physician Decision|1|||
17097285|NCT00161616|38236458|FG001|Overall Study|Physician Decision|0|||
17097286|NCT00161616|38236457|FG000|Overall Study|Death|1|||
17097287|NCT00161616|38236458|FG001|Overall Study|Death|1|||
17097288|NCT00161616|38236457|FG000|Overall Study|Lost to Follow-up|17|||
17097289|NCT00161616|38236458|FG001|Overall Study|Lost to Follow-up|13|||
17097290|NCT00161616|38236457|FG000|Overall Study|Protocol deviation|1|||
17097291|NCT00161616|38236458|FG001|Overall Study|Protocol deviation|0|||
17097292|NCT00252564|38236466|FG000|Overall Study|Adverse Event|17|||
17097293|NCT00252564|38236467|FG001|Overall Study|Adverse Event|13|||
17097294|NCT00252564|38236466|FG000|Overall Study|Unrelated Complication|2|||
17097295|NCT00252564|38236467|FG001|Overall Study|Unrelated Complication|1|||
17097296|NCT00252564|38236466|FG000|Overall Study|Disease Progression|14|||
17097297|NCT00252564|38236467|FG001|Overall Study|Disease Progression|20|||
17097298|NCT00252564|38236466|FG000|Overall Study|Death|0|||
17097299|NCT00252564|38236467|FG001|Overall Study|Death|3|||
17097300|NCT00252564|38236466|FG000|Overall Study|Physician Decision|1|||
17097301|NCT00252564|38236467|FG001|Overall Study|Physician Decision|0|||
17097302|NCT00252564|38236466|FG000|Overall Study|Lost to Follow-up|1|||
17097303|NCT00252564|38236467|FG001|Overall Study|Lost to Follow-up|0|||
17097304|NCT00252564|38236466|FG000|Overall Study|Patient Request|4|||
17011486|NCT00599924|38155913|FG001|Overall Study|Death|0|||
17011487|NCT00599924|38155914|FG002|Overall Study|Death|0|||
17011488|NCT00599924|38155915|FG003|Overall Study|Death|2|||
17011489|NCT00599924|38155916|FG004|Overall Study|Death|0|||
17011490|NCT00599924|38155917|FG005|Overall Study|Death|2|||
17011491|NCT00599924|38155918|FG006|Overall Study|Death|1|||
17011492|NCT00599924|38155912|FG000|Overall Study|Protocol Violation|0|||
17011493|NCT00599924|38155913|FG001|Overall Study|Protocol Violation|0|||
17011494|NCT00599924|38155914|FG002|Overall Study|Protocol Violation|0|||
17011495|NCT00599924|38155915|FG003|Overall Study|Protocol Violation|1|||
17011496|NCT00599924|38155916|FG004|Overall Study|Protocol Violation|0|||
17011497|NCT00599924|38155917|FG005|Overall Study|Protocol Violation|0|||
17011498|NCT00599924|38155918|FG006|Overall Study|Protocol Violation|0|||
17011499|NCT00599924|38155912|FG000|Overall Study|Withdrawal by Subject|0|||
17011500|NCT00599924|38155913|FG001|Overall Study|Withdrawal by Subject|0|||
17011501|NCT00599924|38155914|FG002|Overall Study|Withdrawal by Subject|1|||
17011502|NCT00599924|38155915|FG003|Overall Study|Withdrawal by Subject|0|||
17011503|NCT00599924|38155916|FG004|Overall Study|Withdrawal by Subject|1|||
17097305|NCT00252564|38236467|FG001|Overall Study|Patient Request|5|||
17097306|NCT00252564|38236466|FG000|Overall Study|Withdrawal by Subject|0|||
17097307|NCT00252564|38236467|FG001|Overall Study|Withdrawal by Subject|2|||
17097308|NCT00166296|38236475|FG000|Overall Study|Withdrawal by Subject|1|||
17097309|NCT00166296|38236476|FG001|Overall Study|Withdrawal by Subject|3|||
17097310|NCT00166296|38236475|FG000|Overall Study|Adverse Event|2|||
17097311|NCT00166296|38236476|FG001|Overall Study|Adverse Event|4|||
17097312|NCT00166296|38236475|FG000|Overall Study|Lost to Follow-up|4|||
17097313|NCT00166296|38236476|FG001|Overall Study|Lost to Follow-up|2|||
17097314|NCT00252174|38236485|FG000|Overall Study|Withdrawal by Subject|0|||
17097315|NCT00252174|38236486|FG001|Overall Study|Withdrawal by Subject|1|||
17011504|NCT00599924|38155917|FG005|Overall Study|Withdrawal by Subject|0|||
17011505|NCT00599924|38155918|FG006|Overall Study|Withdrawal by Subject|0|||
17011506|NCT00599924|38155912|FG000|Overall Study|Other|0|||
17011507|NCT00599924|38155913|FG001|Overall Study|Other|0|||
17011508|NCT00599924|38155914|FG002|Overall Study|Other|0|||
17011509|NCT00599924|38155915|FG003|Overall Study|Other|1|||
17011510|NCT00599924|38155916|FG004|Overall Study|Other|2|||
17011511|NCT00599924|38155917|FG005|Overall Study|Other|0|||
17011512|NCT00599924|38155918|FG006|Overall Study|Other|2|||
17011513|NCT00581542|38155941|FG000|Overall Study|they met an exclusion criteria|2|||
17011514|NCT00581542|38155942|FG001|Overall Study|they met an exclusion criteria|2|||
17011515|NCT00581542|38155941|FG000|Overall Study|Lost to Follow-up|9|||
17011516|NCT00581542|38155942|FG001|Overall Study|Lost to Follow-up|21|||
17011517|NCT01385176|38155952|FG000|Randomization Phase|Death|1|||
17011518|NCT01385176|38155953|FG001|Randomization Phase|Death|2|||
17011519|NCT01385176|38155952|FG000|6-18 Month All VNS Active|Death|1|||
17011520|NCT01385176|38155953|FG001|6-18 Month All VNS Active|Death|2|||
17011521|NCT01385176|38155952|FG000|6-18 Month All VNS Active|Physician Decision|0|||
17011522|NCT01385176|38155953|FG001|6-18 Month All VNS Active|Physician Decision|1|||
17011523|NCT01385176|38155952|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
17011524|NCT01385176|38155953|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
17011525|NCT01385176|38155952|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
17011526|NCT01385176|38155953|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
17011527|NCT03912337|38155966|FG000|Overall Study|Withdrawal of Consent From Study|1|||
17011528|NCT03912337|38155967|FG001|Overall Study|Withdrawal of Consent From Study|0|||
17011529|NCT03912337|38155966|FG000|Overall Study|Lost to Follow-up|1|||
17011530|NCT03912337|38155967|FG001|Overall Study|Lost to Follow-up|1|||
17011531|NCT03912259|38155975|FG000|Overall Study|Adverse Event (AE)|2|||
17011532|NCT03912259|38155976|FG001|Overall Study|Adverse Event (AE)|4|||
17011533|NCT03912259|38155975|FG000|Overall Study|Lack of Efficacy|4|||
17011534|NCT03912259|38155976|FG001|Overall Study|Lack of Efficacy|1|||
17011535|NCT03912259|38155975|FG000|Overall Study|Withdrawal by Subject|11|||
17011536|NCT03912259|38155976|FG001|Overall Study|Withdrawal by Subject|1|||
17011537|NCT02121652|38155985|FG000|Overall Study|Lost to Follow-up|2|||
17011538|NCT02121652|38155986|FG001|Overall Study|Lost to Follow-up|1|||
17011539|NCT02121652|38155985|FG000|Overall Study|Death|1|||
17011540|NCT02121652|38155986|FG001|Overall Study|Death|0|||
17011541|NCT02121652|38155985|FG000|Overall Study|Withdrawal by Subject|3|||
17011542|NCT02121652|38155986|FG001|Overall Study|Withdrawal by Subject|3|||
17011543|NCT00595920|38156005|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
17011544|NCT00595764|38156011|FG000|Overall Study|Protocol Violation|24|||
17011545|NCT00595764|38156012|FG001|Overall Study|Protocol Violation|19|||
17011546|NCT00595764|38156011|FG000|Overall Study|Missed Medication >1 week|10|||
17011547|NCT00595764|38156012|FG001|Overall Study|Missed Medication >1 week|17|||
17011548|NCT00595764|38156011|FG000|Overall Study|Missed 3 PM visits|1|||
17011549|NCT00595764|38156012|FG001|Overall Study|Missed 3 PM visits|7|||
17011550|NCT00595764|38156011|FG000|Overall Study|Withdrawal by Subject|4|||
17011551|NCT00595764|38156012|FG001|Overall Study|Withdrawal by Subject|0|||
17011552|NCT00581308|38156032|FG000|Pre Discharge|Lost to Follow-up|1|||
17011553|NCT00581308|38156032|FG000|Pre Discharge|Device Removed|1|||
17011554|NCT00581308|38156032|FG000|Month 1|Lost to Follow-up|3|||
17011555|NCT00581308|38156032|FG000|Month 1|Withdrawal by Subject|2|||
17011556|NCT00581308|38156032|FG000|Month 1|Device Removed|2|||
17011557|NCT00581308|38156032|FG000|Month 1|Uknown|1|||
17011558|NCT00581308|38156032|FG000|Month 6|Lost to Follow-up|1|||
17011559|NCT00581308|38156032|FG000|Month 6|Withdrawal by Subject|2|||
17011560|NCT00581308|38156032|FG000|Month 12|Death|1|||
17011561|NCT00581308|38156032|FG000|Month 12|Lost to Follow-up|14|||
17011562|NCT00581308|38156032|FG000|Month 12|Withdrawal by Subject|3|||
17011563|NCT00581308|38156032|FG000|Month 12|Device Removed|1|||
17011564|NCT00581308|38156032|FG000|Month 12|Other|1|||
17011565|NCT00877890|38156041|FG000|Overall Study|Adverse Event|6|||
17011566|NCT00877890|38156042|FG001|Overall Study|Adverse Event|6|||
17011567|NCT00877890|38156041|FG000|Overall Study|Lost to Follow-up|5|||
17011568|NCT00877890|38156042|FG001|Overall Study|Lost to Follow-up|5|||
17011569|NCT00877890|38156041|FG000|Overall Study|Protocol Violation|0|||
17011570|NCT00877890|38156042|FG001|Overall Study|Protocol Violation|1|||
17011571|NCT00877890|38156041|FG000|Overall Study|Withdrawal of Consent|6|||
17011572|NCT00877890|38156042|FG001|Overall Study|Withdrawal of Consent|12|||
17011573|NCT00877890|38156041|FG000|Overall Study|Investigator Decision|0|||
17011574|NCT00877890|38156042|FG001|Overall Study|Investigator Decision|2|||
17011575|NCT00877890|38156041|FG000|Overall Study|Loss of Glucose Control|3|||
17011576|NCT00877890|38156042|FG001|Overall Study|Loss of Glucose Control|4|||
17011577|NCT03474679|38156052|FG000|Overall Study|Death|7|||
17011578|NCT03474679|38156052|FG000|Overall Study|Withdrawal by Subject|1|||
17011579|NCT03472885|38156056|FG000|Overall Study|Adverse Event|1|||
17011580|NCT03905863|38156062|FG000|Overall Study|Adverse Event|2|||
17011581|NCT03905863|38156063|FG001|Overall Study|Adverse Event|4|||
17011582|NCT03905863|38156062|FG000|Overall Study|Withdrawal by Subject|2|||
17011583|NCT03905863|38156063|FG001|Overall Study|Withdrawal by Subject|2|||
17011584|NCT03905863|38156062|FG000|Overall Study|Physician Decision|0|||
17011585|NCT03905863|38156063|FG001|Overall Study|Physician Decision|3|||
17011586|NCT03905863|38156062|FG000|Overall Study|Lost to Follow-up|1|||
17011587|NCT03905863|38156063|FG001|Overall Study|Lost to Follow-up|0|||
17011588|NCT03905863|38156062|FG000|Overall Study|Protocol Violation|0|||
17011589|NCT03905863|38156063|FG001|Overall Study|Protocol Violation|2|||
17011590|NCT03905863|38156062|FG000|Overall Study|Death|0|||
17011591|NCT03905863|38156063|FG001|Overall Study|Death|1|||
17011592|NCT04067011|38156072|FG000|Overall Study|Not Treated|8|||
17011593|NCT04067011|38156073|FG001|Overall Study|Not Treated|7|||
17011594|NCT04067011|38156074|FG002|Overall Study|Not Treated|5|||
17011595|NCT04067011|38156072|FG000|Overall Study|Adverse Event|2|||
17011596|NCT04067011|38156073|FG001|Overall Study|Adverse Event|1|||
17011597|NCT04067011|38156074|FG002|Overall Study|Adverse Event|0|||
17011598|NCT04067011|38156072|FG000|Overall Study|Withdrawal by Subject|6|||
17097316|NCT00252174|38236487|FG002|Overall Study|Withdrawal by Subject|0|||
17097317|NCT00165984|38236495|FG000|Overall Study|Death|15|||
17097318|NCT00160680|38236504|FG000|Overall Study|Adverse Event|0|||
17097319|NCT00160680|38236505|FG001|Overall Study|Adverse Event|1|||
17097320|NCT00160680|38236504|FG000|Overall Study|Lack of Efficacy|2|||
17097321|NCT00160680|38236505|FG001|Overall Study|Lack of Efficacy|1|||
17011599|NCT04067011|38156073|FG001|Overall Study|Withdrawal by Subject|2|||
17011600|NCT04067011|38156074|FG002|Overall Study|Withdrawal by Subject|1|||
16786298|NCT01999972|37726700|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
17011601|NCT04067011|38156072|FG000|Overall Study|Lost to Follow-up|0|||
17011602|NCT04067011|38156073|FG001|Overall Study|Lost to Follow-up|0|||
17011603|NCT04067011|38156074|FG002|Overall Study|Lost to Follow-up|1|||
17011604|NCT04067011|38156072|FG000|Overall Study|Physician Decision|1|||
17011605|NCT04067011|38156073|FG001|Overall Study|Physician Decision|1|||
17011606|NCT04067011|38156074|FG002|Overall Study|Physician Decision|0|||
17011607|NCT04067011|38156072|FG000|Overall Study|Other Reasons|2|||
17011608|NCT04067011|38156073|FG001|Overall Study|Other Reasons|0|||
17011609|NCT04067011|38156074|FG002|Overall Study|Other Reasons|1|||
17011610|NCT04067011|38156072|FG000|Overall Study|Missing|0|||
17097322|NCT00160680|38236504|FG000|Overall Study|Lost to Follow-up|3|||
17097323|NCT00160680|38236505|FG001|Overall Study|Lost to Follow-up|2|||
17097324|NCT00160680|38236504|FG000|Overall Study|Withdrawal by Subject|4|||
17097325|NCT00160680|38236505|FG001|Overall Study|Withdrawal by Subject|9|||
17097326|NCT00160524|38236511|FG000|Overall Study|Adverse Event|119|||
17097327|NCT00160524|38236511|FG000|Overall Study|Adverse Event and Other|94|||
17097328|NCT00160524|38236511|FG000|Overall Study|Protocol Violation|16|||
17097329|NCT00160524|38236511|FG000|Overall Study|Protocol Violation and Other|2|||
17097330|NCT00160524|38236511|FG000|Overall Study|Withdrawal by Subject|141|||
17097331|NCT00160524|38236511|FG000|Overall Study|Withdrawal by Subject and Other|17|||
17011611|NCT04067011|38156073|FG001|Overall Study|Missing|2|||
17011612|NCT04067011|38156074|FG002|Overall Study|Missing|0|||
17011613|NCT00539305|38156118|FG000|Overall Study|Adverse Event|1|||
17011614|NCT00539305|38156119|FG001|Overall Study|Adverse Event|0|||
17011615|NCT00539305|38156118|FG000|Overall Study|Substance Use|0|||
17011616|NCT00539305|38156119|FG001|Overall Study|Substance Use|1|||
17011617|NCT00539305|38156118|FG000|Overall Study|Withdrawal by Subject|0|||
17011618|NCT00539305|38156119|FG001|Overall Study|Withdrawal by Subject|1|||
17011619|NCT00877032|38156151|FG000|Overall Study|Did not meet entrance criteria|0|||
17011620|NCT00877032|38156152|FG001|Overall Study|Did not meet entrance criteria|0|||
17011621|NCT00877032|38156153|FG002|Overall Study|Did not meet entrance criteria|0|||
17011622|NCT00877032|38156154|FG003|Overall Study|Did not meet entrance criteria|1|||
17011623|NCT00877032|38156155|FG004|Overall Study|Did not meet entrance criteria|0|||
17011624|NCT00877032|38156156|FG005|Overall Study|Did not meet entrance criteria|0|||
17011625|NCT00877032|38156157|FG006|Overall Study|Did not meet entrance criteria|2|||
17011626|NCT00538681|38156187|FG000|Overall Study|Progressive Disease|7|||
17011627|NCT00538681|38156188|FG001|Overall Study|Progressive Disease|0|||
17011628|NCT00538681|38156189|FG002|Overall Study|Progressive Disease|1|||
17011629|NCT00538681|38156190|FG003|Overall Study|Progressive Disease|0|||
17011630|NCT00538681|38156187|FG000|Overall Study|Sponsor Decision|1|||
17011631|NCT00538681|38156188|FG001|Overall Study|Sponsor Decision|3|||
17011632|NCT00538681|38156189|FG002|Overall Study|Sponsor Decision|8|||
17011633|NCT00538681|38156190|FG003|Overall Study|Sponsor Decision|9|||
17011634|NCT00538681|38156187|FG000|Overall Study|Adverse Event|1|||
17011635|NCT00538681|38156188|FG001|Overall Study|Adverse Event|1|||
17011636|NCT00538681|38156189|FG002|Overall Study|Adverse Event|1|||
17011637|NCT00538681|38156190|FG003|Overall Study|Adverse Event|0|||
17011638|NCT00538681|38156187|FG000|Overall Study|Death|0|||
17011639|NCT00538681|38156188|FG001|Overall Study|Death|0|||
17011640|NCT00538681|38156189|FG002|Overall Study|Death|1|||
17097332|NCT00160524|38236511|FG000|Overall Study|Physician Decision|27|||
17097333|NCT00160524|38236511|FG000|Overall Study|Physician Decision and Other|6|||
17097334|NCT00160524|38236511|FG000|Overall Study|Lost to Follow-up|13|||
17097335|NCT00160524|38236511|FG000|Overall Study|Lost to Follow-up and Other|1|||
17097336|NCT00160524|38236511|FG000|Overall Study|Lack of Efficacy|21|||
17011641|NCT00538681|38156190|FG003|Overall Study|Death|1|||
17011642|NCT00538681|38156187|FG000|Overall Study|Investigator Decision|0|||
17011643|NCT00538681|38156188|FG001|Overall Study|Investigator Decision|0|||
17011644|NCT00538681|38156189|FG002|Overall Study|Investigator Decision|0|||
17011645|NCT00538681|38156190|FG003|Overall Study|Investigator Decision|1|||
17011646|NCT00876018|38156204|FG000|Overall Study|Lost to Follow-up|0|||
17011647|NCT00876018|38156205|FG001|Overall Study|Lost to Follow-up|1|||
17011648|NCT00876018|38156206|FG002|Overall Study|Lost to Follow-up|1|||
17011649|NCT00876018|38156204|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
17011650|NCT00876018|38156205|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
17011651|NCT00876018|38156206|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
17011652|NCT03885934|38156231|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
17011653|NCT03885934|38156232|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
17011654|NCT03885934|38156233|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
17011655|NCT03885934|38156234|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
17011656|NCT03885934|38156235|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
17011657|NCT03885934|38156236|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
17011658|NCT00875706|38156253|FG000|Overall Study|Withdrawal by Subject|1|||
17011659|NCT00875706|38156254|FG001|Overall Study|Withdrawal by Subject|0|||
17011660|NCT00875706|38156255|FG002|Overall Study|Withdrawal by Subject|0|||
17097337|NCT00160524|38236511|FG000|Overall Study|Lack of Efficacy and Other|1|||
17097338|NCT00160524|38236511|FG000|Overall Study|Other|20|||
17097339|NCT00159822|38236515|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
17097340|NCT00159822|38236515|FG000|Voriconazole Treatment Period|Adverse Event|9|||
17097341|NCT00159822|38236515|FG000|Voriconazole Treatment Period|Death|4|||
17097342|NCT00159822|38236515|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
17097343|NCT00159822|38236515|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
17097344|NCT00159822|38236515|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
17097345|NCT00159822|38236515|FG000|Post-treatment Follow-up Period|Death|1|||
17097346|NCT00159822|38236515|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
17097347|NCT00159822|38236515|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
17097348|NCT00158262|38236521|FG000|Overall Study|Lost to Follow-up|1|||
17097349|NCT00158262|38236522|FG001|Overall Study|Lost to Follow-up|1|||
17097350|NCT00157950|38236530|FG000|Overall Study|Death|1|||
17097351|NCT00157950|38236531|FG001|Overall Study|Death|0|||
17097352|NCT03745768|38236539|FG000|Overall Study|discontinued study|2|||
17097353|NCT03745768|38236540|FG001|Overall Study|discontinued study|0|||
17097354|NCT03745222|38236549|FG000|Overall Study|Withdrawal by Subject|0|||
17097355|NCT03745222|38236550|FG001|Overall Study|Withdrawal by Subject|1|||
17097356|NCT03745222|38236551|FG002|Overall Study|Withdrawal by Subject|0|||
17097357|NCT03743038|38236559|FG000|Overall Study|Physician Decision|1|||
17097358|NCT00153816|38236571|FG000|Overall Study|Death|6|||
17097359|NCT00153816|38236572|FG001|Overall Study|Death|5|||
17097360|NCT00153816|38236573|FG002|Overall Study|Death|4|||
17097361|NCT00153816|38236574|FG003|Overall Study|Death|6|||
17097362|NCT00153816|38236575|FG004|Overall Study|Death|0|||
17097363|NCT00153816|38236576|FG005|Overall Study|Death|2|||
17097364|NCT00153816|38236571|FG000|Overall Study|Lost to Follow-up|7|||
17097365|NCT00153816|38236572|FG001|Overall Study|Lost to Follow-up|8|||
17097366|NCT00153816|38236573|FG002|Overall Study|Lost to Follow-up|5|||
17097367|NCT00153816|38236574|FG003|Overall Study|Lost to Follow-up|8|||
17097368|NCT00153816|38236575|FG004|Overall Study|Lost to Follow-up|7|||
17097369|NCT00153816|38236576|FG005|Overall Study|Lost to Follow-up|9|||
17097370|NCT00153816|38236571|FG000|Overall Study|Withdrawal by Subject|9|||
17097371|NCT00153816|38236572|FG001|Overall Study|Withdrawal by Subject|9|||
17097372|NCT00153816|38236573|FG002|Overall Study|Withdrawal by Subject|9|||
17097373|NCT00153816|38236574|FG003|Overall Study|Withdrawal by Subject|4|||
17097374|NCT00153816|38236575|FG004|Overall Study|Withdrawal by Subject|1|||
17097375|NCT00153816|38236576|FG005|Overall Study|Withdrawal by Subject|5|||
17097376|NCT00153816|38236571|FG000|Overall Study|Follow-up exam not done|8|||
17097377|NCT00153816|38236572|FG001|Overall Study|Follow-up exam not done|7|||
17097378|NCT00153816|38236573|FG002|Overall Study|Follow-up exam not done|11|||
17011661|NCT04399889|38156266|FG000|Overall Study|Death|5|||
17011662|NCT04399889|38156267|FG001|Overall Study|Death|1|||
17011663|NCT04399889|38156268|FG002|Overall Study|Death|1|||
17097379|NCT00153816|38236574|FG003|Overall Study|Follow-up exam not done|10|||
17097380|NCT00153816|38236575|FG004|Overall Study|Follow-up exam not done|8|||
17097381|NCT00153816|38236576|FG005|Overall Study|Follow-up exam not done|9|||
17097382|NCT00153816|38236571|FG000|Overall Study|Follow-up exam done, histology missing|2|||
17097383|NCT00153816|38236572|FG001|Overall Study|Follow-up exam done, histology missing|3|||
17097384|NCT00153816|38236573|FG002|Overall Study|Follow-up exam done, histology missing|3|||
17097385|NCT00153816|38236574|FG003|Overall Study|Follow-up exam done, histology missing|3|||
17097386|NCT00153816|38236575|FG004|Overall Study|Follow-up exam done, histology missing|1|||
17097387|NCT00153816|38236576|FG005|Overall Study|Follow-up exam done, histology missing|2|||
17097388|NCT00151476|38236593|FG000|FAP Identified Subjects|Protocol Violation|0|||
17193164|NCT02055547|38346473|FG017|Overall Study|Physician Decision|0|||
17011664|NCT00837265|38156283|FG000|Pilot Phase|Withdrawal by Subject|0|||
17011665|NCT00837265|38156284|FG001|Pilot Phase|Withdrawal by Subject|2|||
17011666|NCT00837265|38156285|FG002|Pilot Phase|Withdrawal by Subject|3|||
17011667|NCT00837265|38156286|FG003|Pilot Phase|Withdrawal by Subject|2|||
17011668|NCT00837265|38156287|FG004|Pilot Phase|Withdrawal by Subject|0|||
17011669|NCT00837265|38156288|FG005|Pilot Phase|Withdrawal by Subject|0|||
17011670|NCT00837265|38156289|FG006|Pilot Phase|Withdrawal by Subject|0|||
17011671|NCT00837265|38156283|FG000|Pilot Phase|Decision of the investigator|2|||
17011672|NCT00837265|38156284|FG001|Pilot Phase|Decision of the investigator|1|||
17011673|NCT00837265|38156285|FG002|Pilot Phase|Decision of the investigator|0|||
17011674|NCT00837265|38156286|FG003|Pilot Phase|Decision of the investigator|0|||
17011675|NCT00837265|38156287|FG004|Pilot Phase|Decision of the investigator|0|||
17011676|NCT00837265|38156288|FG005|Pilot Phase|Decision of the investigator|0|||
17011677|NCT00837265|38156289|FG006|Pilot Phase|Decision of the investigator|0|||
17011678|NCT00837265|38156283|FG000|Pilot Phase|Adverse Event|1|||
17011679|NCT00837265|38156284|FG001|Pilot Phase|Adverse Event|0|||
17011680|NCT00837265|38156285|FG002|Pilot Phase|Adverse Event|0|||
17011681|NCT00837265|38156286|FG003|Pilot Phase|Adverse Event|0|||
17011682|NCT00837265|38156287|FG004|Pilot Phase|Adverse Event|0|||
17011683|NCT00837265|38156288|FG005|Pilot Phase|Adverse Event|0|||
17011684|NCT00837265|38156289|FG006|Pilot Phase|Adverse Event|0|||
17011685|NCT00837265|38156283|FG000|Pilot Phase|Disease progression|0|||
17011686|NCT00837265|38156284|FG001|Pilot Phase|Disease progression|0|||
17011687|NCT00837265|38156285|FG002|Pilot Phase|Disease progression|0|||
17011688|NCT00837265|38156286|FG003|Pilot Phase|Disease progression|1|||
17011689|NCT00837265|38156287|FG004|Pilot Phase|Disease progression|0|||
17011690|NCT00837265|38156288|FG005|Pilot Phase|Disease progression|0|||
17011691|NCT00837265|38156289|FG006|Pilot Phase|Disease progression|0|||
17011692|NCT00837265|38156283|FG000|Pilot Phase|Participant left the city|0|||
17011693|NCT00837265|38156284|FG001|Pilot Phase|Participant left the city|0|||
17011694|NCT00837265|38156285|FG002|Pilot Phase|Participant left the city|0|||
17011695|NCT00837265|38156286|FG003|Pilot Phase|Participant left the city|1|||
17011696|NCT00837265|38156287|FG004|Pilot Phase|Participant left the city|0|||
17011697|NCT00837265|38156288|FG005|Pilot Phase|Participant left the city|0|||
17011698|NCT00837265|38156289|FG006|Pilot Phase|Participant left the city|0|||
17011699|NCT00837265|38156283|FG000|Main Phase|Withdrawal by Subject|0|||
17011700|NCT00837265|38156284|FG001|Main Phase|Withdrawal by Subject|0|||
17011701|NCT00837265|38156285|FG002|Main Phase|Withdrawal by Subject|0|||
17011702|NCT00837265|38156286|FG003|Main Phase|Withdrawal by Subject|0|||
17011703|NCT00837265|38156287|FG004|Main Phase|Withdrawal by Subject|4|||
17011704|NCT00837265|38156288|FG005|Main Phase|Withdrawal by Subject|2|||
17011705|NCT00837265|38156289|FG006|Main Phase|Withdrawal by Subject|1|||
17011706|NCT00837265|38156283|FG000|Main Phase|Decision of the investigator|0|||
17011707|NCT00837265|38156284|FG001|Main Phase|Decision of the investigator|0|||
17011708|NCT00837265|38156285|FG002|Main Phase|Decision of the investigator|0|||
17011709|NCT00837265|38156286|FG003|Main Phase|Decision of the investigator|0|||
17011710|NCT00837265|38156287|FG004|Main Phase|Decision of the investigator|0|||
17011711|NCT00837265|38156288|FG005|Main Phase|Decision of the investigator|2|||
17011712|NCT00837265|38156289|FG006|Main Phase|Decision of the investigator|1|||
17011713|NCT00837265|38156283|FG000|Main Phase|Adverse Event|0|||
17011714|NCT00837265|38156284|FG001|Main Phase|Adverse Event|0|||
17011715|NCT00837265|38156285|FG002|Main Phase|Adverse Event|0|||
17011716|NCT00837265|38156286|FG003|Main Phase|Adverse Event|0|||
17011717|NCT00837265|38156287|FG004|Main Phase|Adverse Event|0|||
17011718|NCT00837265|38156288|FG005|Main Phase|Adverse Event|1|||
17011719|NCT00837265|38156289|FG006|Main Phase|Adverse Event|0|||
17011720|NCT00837265|38156283|FG000|Main Phase|Death|0|||
17011721|NCT00837265|38156284|FG001|Main Phase|Death|0|||
17011722|NCT00837265|38156285|FG002|Main Phase|Death|0|||
17011723|NCT00837265|38156286|FG003|Main Phase|Death|0|||
17011724|NCT00837265|38156287|FG004|Main Phase|Death|2|||
17011725|NCT00837265|38156288|FG005|Main Phase|Death|0|||
17011726|NCT00837265|38156289|FG006|Main Phase|Death|1|||
17011727|NCT00837265|38156283|FG000|Main Phase|Lost to Follow-up|0|||
17011728|NCT00837265|38156284|FG001|Main Phase|Lost to Follow-up|0|||
17011729|NCT00837265|38156285|FG002|Main Phase|Lost to Follow-up|0|||
17011730|NCT00837265|38156286|FG003|Main Phase|Lost to Follow-up|0|||
17011731|NCT00837265|38156287|FG004|Main Phase|Lost to Follow-up|1|||
17011732|NCT00837265|38156288|FG005|Main Phase|Lost to Follow-up|0|||
17011733|NCT00837265|38156289|FG006|Main Phase|Lost to Follow-up|0|||
17011734|NCT00837265|38156283|FG000|Main Phase|Principal investigator resignation|0|||
17011735|NCT00837265|38156284|FG001|Main Phase|Principal investigator resignation|0|||
17011736|NCT00837265|38156285|FG002|Main Phase|Principal investigator resignation|0|||
17011737|NCT00837265|38156286|FG003|Main Phase|Principal investigator resignation|0|||
17011738|NCT00837265|38156287|FG004|Main Phase|Principal investigator resignation|2|||
17011739|NCT00837265|38156288|FG005|Main Phase|Principal investigator resignation|0|||
17011740|NCT00837265|38156289|FG006|Main Phase|Principal investigator resignation|0|||
17011741|NCT00837265|38156283|FG000|Main Phase|Participant's personal reason|0|||
17011742|NCT00837265|38156284|FG001|Main Phase|Participant's personal reason|0|||
17011743|NCT00837265|38156285|FG002|Main Phase|Participant's personal reason|0|||
17011744|NCT00837265|38156286|FG003|Main Phase|Participant's personal reason|0|||
17011745|NCT00837265|38156287|FG004|Main Phase|Participant's personal reason|1|||
17011746|NCT00837265|38156288|FG005|Main Phase|Participant's personal reason|0|||
17011747|NCT00837265|38156289|FG006|Main Phase|Participant's personal reason|0|||
17011748|NCT00594516|38156302|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
16908516|NCT01777152|38017224|FG000|Overall Study|Withdrawal by Subject|22|||
16908517|NCT01777152|38017225|FG001|Overall Study|Withdrawal by Subject|16|||
16908518|NCT01777152|38017224|FG000|Overall Study|Lost to Follow-up|3|||
16908519|NCT01777152|38017225|FG001|Overall Study|Lost to Follow-up|5|||
16908520|NCT01777152|38017224|FG000|Overall Study|Death|68|||
16908521|NCT01777152|38017225|FG001|Overall Study|Death|89|||
16908522|NCT01777152|38017224|FG000|Overall Study|Not eligible, no study drug received|1|||
16908523|NCT01777152|38017225|FG001|Overall Study|Not eligible, no study drug received|0|||
16908524|NCT01777152|38017224|FG000|Overall Study|Change of diagnosis|1|||
16908525|NCT01777152|38017225|FG001|Overall Study|Change of diagnosis|0|||
16908526|NCT01759290|38017232|FG000|Overall Study|Subjects withdrawn consent|5|||
16908527|NCT01759290|38017232|FG000|Overall Study|Physician Decision|2|||
17011749|NCT00594516|38156303|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
17011750|NCT00594516|38156304|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
17193165|NCT02055547|38346474|FG018|Overall Study|Physician Decision|0|||
17193166|NCT02055547|38346456|FG000|Overall Study|Adverse Event|0|||
17193167|NCT02055547|38346457|FG001|Overall Study|Adverse Event|0|||
17193168|NCT02055547|38346458|FG002|Overall Study|Adverse Event|0|||
17193169|NCT02055547|38346459|FG003|Overall Study|Adverse Event|0|||
17193170|NCT02055547|38346460|FG004|Overall Study|Adverse Event|0|||
17193171|NCT02055547|38346461|FG005|Overall Study|Adverse Event|0|||
17193172|NCT02055547|38346462|FG006|Overall Study|Adverse Event|1|||
17193173|NCT02055547|38346463|FG007|Overall Study|Adverse Event|0|||
17193174|NCT02055547|38346464|FG008|Overall Study|Adverse Event|1|||
17193175|NCT02055547|38346465|FG009|Overall Study|Adverse Event|0|||
17193176|NCT02055547|38346466|FG010|Overall Study|Adverse Event|0|||
17193177|NCT02055547|38346467|FG011|Overall Study|Adverse Event|0|||
17011751|NCT00594516|38156302|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
17011752|NCT00594516|38156303|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
17011753|NCT00594516|38156304|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
17011754|NCT00594516|38156302|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
17011755|NCT00594516|38156303|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
17011756|NCT00594516|38156304|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
17011757|NCT00594516|38156302|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
17011758|NCT00594516|38156303|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
17011759|NCT00594516|38156304|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
17011760|NCT00594516|38156302|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
17011761|NCT00594516|38156303|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
17011762|NCT00594516|38156304|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
17011763|NCT00594516|38156302|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
17011764|NCT00594516|38156303|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
17011765|NCT00594516|38156304|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
17011766|NCT00594516|38156302|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
17011767|NCT00594516|38156303|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
17011768|NCT00594516|38156304|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
17011769|NCT00594516|38156302|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
17011770|NCT00594516|38156303|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
17011771|NCT00594516|38156304|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
17011772|NCT00594516|38156302|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
17011773|NCT00594516|38156303|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
17011774|NCT00594516|38156304|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
17011775|NCT00538291|38156308|FG000|Overall Study|Adverse Event|2|||
17011776|NCT00538291|38156308|FG000|Overall Study|Withdrawal by Subject|1|||
17011777|NCT00594906|38156314|FG000|Overall Study|Physician Decision|1|||
17011778|NCT00594906|38156315|FG001|Overall Study|Physician Decision|0|||
17011779|NCT00594906|38156314|FG000|Overall Study|Physician Decision|0|||
17011780|NCT00594906|38156315|FG001|Overall Study|Physician Decision|1|||
17097389|NCT00151476|38236594|FG001|FAP Identified Subjects|Protocol Violation|1|||
17097390|NCT00151476|38236593|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
17097391|NCT00151476|38236594|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
17097392|NCT00151476|38236593|FG000|FAP Analyzed Subjects|Other study participation|0|||
17097393|NCT00151476|38236594|FG001|FAP Analyzed Subjects|Other study participation|1|||
17097394|NCT00149994|38236603|FG000|Overall Study|Administrative problems:|1|||
16908528|NCT01759290|38017232|FG000|Overall Study|Death|17|||
17011781|NCT00594906|38156314|FG000|Overall Study|Death|0|||
17011782|NCT00594906|38156315|FG001|Overall Study|Death|1|||
17011783|NCT00537979|38156323|FG000|Overall Study|Adverse Event|2|||
17097395|NCT00149994|38236604|FG001|Overall Study|Administrative problems:|0|||
17193178|NCT02055547|38346468|FG012|Overall Study|Adverse Event|0|||
17011784|NCT00537979|38156324|FG001|Overall Study|Adverse Event|2|||
17011785|NCT00537979|38156323|FG000|Overall Study|Withdrawal by Subject|1|||
17011786|NCT00537979|38156324|FG001|Overall Study|Withdrawal by Subject|4|||
17011787|NCT00537979|38156323|FG000|Overall Study|Lost to Follow-up|1|||
17011788|NCT00537979|38156324|FG001|Overall Study|Lost to Follow-up|4|||
17011789|NCT00537979|38156323|FG000|Overall Study|Lack of Efficacy|0|||
17011790|NCT00537979|38156324|FG001|Overall Study|Lack of Efficacy|1|||
17011791|NCT00537979|38156323|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
17011792|NCT00537979|38156324|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
17011793|NCT00537979|38156323|FG000|Overall Study|Death|0|||
17011794|NCT00537979|38156324|FG001|Overall Study|Death|3|||
17011795|NCT00537979|38156323|FG000|Overall Study|Kidney transplant|0|||
17011796|NCT00537979|38156324|FG001|Overall Study|Kidney transplant|3|||
17011797|NCT00537979|38156323|FG000|Overall Study|Heart failure|0|||
17011798|NCT00537979|38156324|FG001|Overall Study|Heart failure|1|||
17011799|NCT00537823|38156333|FG000|Overall Study|Adverse Event|2|||
17011800|NCT00537823|38156334|FG001|Overall Study|Adverse Event|0|||
17011801|NCT00537277|38156341|FG000|Overall Study|Adverse Event|1|||
17011802|NCT00537277|38156341|FG000|Overall Study|Lack of Efficacy|2|||
17011803|NCT00537277|38156341|FG000|Overall Study|Lost to Follow-up|12|||
17011804|NCT00537277|38156341|FG000|Overall Study|Protocol Violation|11|||
17011805|NCT00537277|38156341|FG000|Overall Study|Unclassified|4|||
17011806|NCT00537277|38156341|FG000|Overall Study|Inability to tolerate trial medication|4|||
17011807|NCT00537277|38156341|FG000|Overall Study|Non-compliance with trial procedures|15|||
17011808|NCT00537199|38156345|FG000|Overall Study|Study Terminated|1|||
17011809|NCT03898063|38156351|FG000|Overall Study|Withdrawal by Subject|10|||
17011810|NCT03898063|38156352|FG001|Overall Study|Withdrawal by Subject|8|||
17011811|NCT00873912|38156360|FG000|Overall Study|Withdrawal by Subject|1|||
17011812|NCT00873912|38156361|FG001|Overall Study|Withdrawal by Subject|0|||
17097396|NCT00149994|38236603|FG000|Overall Study|Protocol Violation|0|||
17097397|NCT00149994|38236604|FG001|Overall Study|Protocol Violation|1|||
17097398|NCT00149214|38236612|FG000|Overall Study|Adverse Event|12|||
17097399|NCT00149214|38236613|FG001|Overall Study|Adverse Event|9|||
17097400|NCT00149214|38236612|FG000|Overall Study|Withdrawal by Subject|4|||
17097401|NCT00149214|38236613|FG001|Overall Study|Withdrawal by Subject|1|||
17097402|NCT00149214|38236612|FG000|Overall Study|Physician Decision|3|||
17097403|NCT00149214|38236613|FG001|Overall Study|Physician Decision|3|||
17097404|NCT00149214|38236612|FG000|Overall Study|Sponsor Decision|0|||
17097405|NCT00149214|38236613|FG001|Overall Study|Sponsor Decision|1|||
17097406|NCT00149214|38236612|FG000|Overall Study|Progressive Disease|7|||
17097407|NCT00149214|38236613|FG001|Overall Study|Progressive Disease|3|||
17097408|NCT00114972|38236630|FG000|Overall Study|Withdrawal by Subject|40|||
17097409|NCT00114972|38236631|FG001|Overall Study|Withdrawal by Subject|7|||
17097410|NCT00114972|38236630|FG000|Overall Study|Lost to Follow-up|8|||
17097411|NCT00114972|38236631|FG001|Overall Study|Lost to Follow-up|5|||
17097412|NCT00129402|38236639|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
17097413|NCT00129402|38236640|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
17097414|NCT00129402|38236641|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
17097415|NCT00129402|38236642|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
17097416|NCT00129402|38236643|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
17097417|NCT00129402|38236644|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
17097418|NCT00129402|38236645|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
17097419|NCT00129402|38236639|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
17097420|NCT00129402|38236640|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
17097421|NCT00129402|38236641|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
17097422|NCT00129402|38236642|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
17097423|NCT00129402|38236643|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
17097424|NCT00129402|38236644|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
17097425|NCT00129402|38236645|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
17097426|NCT00129402|38236639|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
17097427|NCT00129402|38236640|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
17097428|NCT00129402|38236641|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
17097429|NCT00129402|38236642|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
17097430|NCT00129402|38236643|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
17097431|NCT00129402|38236644|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
17097432|NCT00129402|38236645|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
17097433|NCT00129402|38236639|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
17097434|NCT00129402|38236640|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
17097435|NCT00129402|38236641|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
17097436|NCT00129402|38236642|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
17097437|NCT00129402|38236643|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
17097438|NCT00129402|38236644|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
17011813|NCT00873912|38156360|FG000|Overall Study|Lost to Follow-up|2|||
17011814|NCT00873912|38156361|FG001|Overall Study|Lost to Follow-up|0|||
17011815|NCT03823300|38156373|FG000|Overall Study|Withdrawal by Subject|16|||
17011816|NCT03823300|38156374|FG001|Overall Study|Withdrawal by Subject|22|||
17011817|NCT03823300|38156373|FG000|Overall Study|Death|10|||
17011818|NCT03823300|38156374|FG001|Overall Study|Death|14|||
17011819|NCT03823300|38156373|FG000|Overall Study|Adverse Event|3|||
17011820|NCT03823300|38156374|FG001|Overall Study|Adverse Event|5|||
17011821|NCT03823300|38156373|FG000|Overall Study|Physician Decision|1|||
17011822|NCT03823300|38156374|FG001|Overall Study|Physician Decision|7|||
17011823|NCT03823300|38156373|FG000|Overall Study|Lost to Follow-up|1|||
17011824|NCT03823300|38156374|FG001|Overall Study|Lost to Follow-up|3|||
17011825|NCT03823300|38156373|FG000|Overall Study|Protocol Violation|1|||
17011826|NCT03823300|38156374|FG001|Overall Study|Protocol Violation|1|||
17011827|NCT03823300|38156373|FG000|Overall Study|Lack of Efficacy|1|||
17011828|NCT03823300|38156374|FG001|Overall Study|Lack of Efficacy|1|||
17011829|NCT03823300|38156373|FG000|Overall Study|Not Eligible|0|||
17011830|NCT03823300|38156374|FG001|Overall Study|Not Eligible|1|||
17011831|NCT03823300|38156373|FG000|Overall Study|Other|1|||
17011832|NCT03823300|38156374|FG001|Overall Study|Other|0|||
17011833|NCT00537745|38156380|FG000|Overall Study|Did not meet eligibility criteria|2|||
17011834|NCT00537745|38156380|FG000|Overall Study|Withdrawal by Subject|2|||
17011835|NCT00537745|38156380|FG000|Overall Study|Subject unable to provide Interlock info|1|||
17011836|NCT00874848|38156387|FG000|Overall Study|Adverse Event|13|||
17011837|NCT00874848|38156388|FG001|Overall Study|Adverse Event|2|||
17011838|NCT00874848|38156387|FG000|Overall Study|Progressive neoplastic disease|38|||
17011839|NCT00874848|38156388|FG001|Overall Study|Progressive neoplastic disease|18|||
17011840|NCT00874848|38156387|FG000|Overall Study|Withdrawal by Subject|7|||
17011841|NCT00874848|38156388|FG001|Overall Study|Withdrawal by Subject|4|||
17011842|NCT00874848|38156387|FG000|Overall Study|Noncompliance|1|||
17011843|NCT00874848|38156388|FG001|Overall Study|Noncompliance|1|||
17011844|NCT00874848|38156387|FG000|Overall Study|Failure to comply with protocol|0|||
17011845|NCT00874848|38156388|FG001|Overall Study|Failure to comply with protocol|1|||
17011846|NCT00874848|38156387|FG000|Overall Study|Physician Decision|0|||
17011847|NCT00874848|38156388|FG001|Overall Study|Physician Decision|2|||
17011848|NCT00578812|38156396|FG000|Overall Study|Not treated|6|||
17011849|NCT00578812|38156397|FG001|Overall Study|Not treated|7|||
17011850|NCT00536809|38156404|FG000|Phase II|Adverse Event|1|||
17011851|NCT00536809|38156404|FG000|Phase II|Referred for surgical resection|1|||
17011852|NCT00536731|38156415|FG000|Overall Study|Adverse Event|3|||
17011853|NCT00536731|38156416|FG001|Overall Study|Adverse Event|2|||
17011854|NCT00536731|38156417|FG002|Overall Study|Adverse Event|3|||
17011855|NCT00536731|38156415|FG000|Overall Study|Withdrawal by Subject|0|||
17011856|NCT00536731|38156416|FG001|Overall Study|Withdrawal by Subject|2|||
17011857|NCT00536731|38156417|FG002|Overall Study|Withdrawal by Subject|0|||
17011858|NCT00536731|38156415|FG000|Overall Study|Intake of prohibited conc. medication|0|||
17011859|NCT00536731|38156416|FG001|Overall Study|Intake of prohibited conc. medication|0|||
17011860|NCT00536731|38156417|FG002|Overall Study|Intake of prohibited conc. medication|1|||
17011861|NCT00536731|38156415|FG000|Overall Study|Safety reasons|0|||
17011862|NCT00536731|38156416|FG001|Overall Study|Safety reasons|0|||
17011863|NCT00536731|38156417|FG002|Overall Study|Safety reasons|1|||
17011864|NCT00536731|38156415|FG000|Overall Study|Other|1|||
17011865|NCT00536731|38156416|FG001|Overall Study|Other|1|||
17011866|NCT00536731|38156417|FG002|Overall Study|Other|0|||
17011867|NCT00536575|38156425|FG000|Overall Study|Withdrawal by Subject|1|||
17011868|NCT00536575|38156425|FG000|Overall Study|Death|1|||
17011869|NCT03214250|38156436|FG000|Overall Study|Death|5|||
17011870|NCT03214250|38156437|FG001|Overall Study|Death|5|||
17011871|NCT03214250|38156438|FG002|Overall Study|Death|7|||
17011872|NCT03214250|38156439|FG003|Overall Study|Death|4|||
17011873|NCT03214250|38156440|FG004|Overall Study|Death|23|||
17011874|NCT03214250|38156441|FG005|Overall Study|Death|23|||
17011875|NCT03214250|38156442|FG006|Overall Study|Death|24|||
17011876|NCT03214250|38156436|FG000|Overall Study|Lost to Follow-up|0|||
17011877|NCT03214250|38156437|FG001|Overall Study|Lost to Follow-up|0|||
17011878|NCT03214250|38156438|FG002|Overall Study|Lost to Follow-up|0|||
17011879|NCT03214250|38156439|FG003|Overall Study|Lost to Follow-up|1|||
17011880|NCT03214250|38156440|FG004|Overall Study|Lost to Follow-up|1|||
17011881|NCT03214250|38156441|FG005|Overall Study|Lost to Follow-up|2|||
17011882|NCT03214250|38156442|FG006|Overall Study|Lost to Follow-up|0|||
17011883|NCT03214250|38156436|FG000|Overall Study|Other|0|||
17193179|NCT02055547|38346469|FG013|Overall Study|Adverse Event|0|||
17011884|NCT03214250|38156437|FG001|Overall Study|Other|0|||
17011885|NCT03214250|38156438|FG002|Overall Study|Other|0|||
17011886|NCT03214250|38156439|FG003|Overall Study|Other|0|||
17011887|NCT03214250|38156440|FG004|Overall Study|Other|1|||
17011888|NCT03214250|38156441|FG005|Overall Study|Other|1|||
17011889|NCT03214250|38156442|FG006|Overall Study|Other|2|||
17011890|NCT03214250|38156436|FG000|Overall Study|Remains on Study|2|||
17011891|NCT03214250|38156437|FG001|Overall Study|Remains on Study|2|||
17011892|NCT03214250|38156438|FG002|Overall Study|Remains on Study|0|||
17011893|NCT03214250|38156439|FG003|Overall Study|Remains on Study|1|||
17011894|NCT03214250|38156440|FG004|Overall Study|Remains on Study|7|||
17011895|NCT03214250|38156441|FG005|Overall Study|Remains on Study|5|||
17011896|NCT03214250|38156442|FG006|Overall Study|Remains on Study|3|||
17011897|NCT03214250|38156436|FG000|Overall Study|Withdrawal by Subject|0|||
17011898|NCT03214250|38156437|FG001|Overall Study|Withdrawal by Subject|0|||
17011899|NCT03214250|38156438|FG002|Overall Study|Withdrawal by Subject|1|||
17011900|NCT03214250|38156439|FG003|Overall Study|Withdrawal by Subject|2|||
17011901|NCT03214250|38156440|FG004|Overall Study|Withdrawal by Subject|5|||
17011902|NCT03214250|38156441|FG005|Overall Study|Withdrawal by Subject|0|||
17011903|NCT03214250|38156442|FG006|Overall Study|Withdrawal by Subject|2|||
17011904|NCT00874770|38156466|FG000|Overall Study|Lack of Efficacy|2|||
17011905|NCT00874770|38156467|FG001|Overall Study|Lack of Efficacy|0|||
17011906|NCT00874770|38156468|FG002|Overall Study|Lack of Efficacy|0|||
17011907|NCT00874770|38156469|FG003|Overall Study|Lack of Efficacy|2|||
17011908|NCT00874770|38156466|FG000|Overall Study|Adverse Event|1|||
17011909|NCT00874770|38156467|FG001|Overall Study|Adverse Event|1|||
17011910|NCT00874770|38156468|FG002|Overall Study|Adverse Event|4|||
17011911|NCT00874770|38156469|FG003|Overall Study|Adverse Event|2|||
17011912|NCT00874770|38156466|FG000|Overall Study|Lost to Follow-up|1|||
17011913|NCT00874770|38156467|FG001|Overall Study|Lost to Follow-up|0|||
17011914|NCT00874770|38156468|FG002|Overall Study|Lost to Follow-up|0|||
17011915|NCT00874770|38156469|FG003|Overall Study|Lost to Follow-up|1|||
17011916|NCT00874770|38156466|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
17011917|NCT00874770|38156467|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
17011918|NCT00874770|38156468|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
17011919|NCT00874770|38156469|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
17011920|NCT00536263|38156492|FG000|Overall Study|Adverse Event|5|||
17011921|NCT00536263|38156493|FG001|Overall Study|Adverse Event|5|||
17011922|NCT00536263|38156494|FG002|Overall Study|Adverse Event|7|||
17011923|NCT00536263|38156492|FG000|Overall Study|Lost to Follow-up|3|||
17011924|NCT00536263|38156493|FG001|Overall Study|Lost to Follow-up|4|||
17011925|NCT00536263|38156494|FG002|Overall Study|Lost to Follow-up|4|||
17011926|NCT00536263|38156492|FG000|Overall Study|Subject withdrew - not treatment related|2|||
17011927|NCT00536263|38156493|FG001|Overall Study|Subject withdrew - not treatment related|0|||
17011928|NCT00536263|38156494|FG002|Overall Study|Subject withdrew - not treatment related|5|||
17011929|NCT00536263|38156492|FG000|Overall Study|Subject withdrew - treatment related|0|||
17011930|NCT00536263|38156493|FG001|Overall Study|Subject withdrew - treatment related|3|||
17097439|NCT00129402|38236645|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
17097440|NCT00129402|38236639|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
17097441|NCT00129402|38236640|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
17097442|NCT00129402|38236641|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
17097443|NCT00129402|38236642|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
17097444|NCT00129402|38236643|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
17097445|NCT00129402|38236644|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
17097446|NCT00129402|38236645|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
17097447|NCT00129402|38236639|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
17097448|NCT00129402|38236640|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
17097449|NCT00129402|38236641|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
17097450|NCT00129402|38236642|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
17097451|NCT00129402|38236643|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
17097452|NCT00129402|38236644|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
17097453|NCT00129402|38236645|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
17097454|NCT00129402|38236639|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
17097455|NCT00129402|38236640|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
17097456|NCT00129402|38236641|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
17097457|NCT00129402|38236642|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
17097458|NCT00129402|38236643|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
17097459|NCT00129402|38236644|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
17097460|NCT00129402|38236645|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
17097461|NCT00129402|38236639|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
17097462|NCT00129402|38236640|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
17097463|NCT00129402|38236641|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
17011931|NCT00536263|38156494|FG002|Overall Study|Subject withdrew - treatment related|2|||
17011932|NCT00536263|38156492|FG000|Overall Study|Noncompliance with protocol|0|||
17011933|NCT00536263|38156493|FG001|Overall Study|Noncompliance with protocol|0|||
17011934|NCT00536263|38156494|FG002|Overall Study|Noncompliance with protocol|1|||
17011935|NCT00536263|38156492|FG000|Overall Study|Did not meet protocol eligibility|1|||
17011936|NCT00536263|38156493|FG001|Overall Study|Did not meet protocol eligibility|2|||
17011937|NCT00536263|38156494|FG002|Overall Study|Did not meet protocol eligibility|2|||
17011938|NCT00578344|38156502|FG000|Overall Study|Insurance problems|1|||
17011939|NCT00578344|38156502|FG000|Overall Study|Graft failure|1|||
17011940|NCT00873366|38156506|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
17011941|NCT00873366|38156506|FG000|Overall Study|Off tamoxifen due to side effects|2|||
17011942|NCT00873366|38156506|FG000|Overall Study|Refused to continue DM-BT testing|3|||
17011943|NCT00536107|38156512|FG000|Overall Study|Death|5|||
17011944|NCT00536107|38156513|FG001|Overall Study|Death|1|||
17011945|NCT00536107|38156512|FG000|Overall Study|Incorrect enrolment|1|||
17011946|NCT00536107|38156513|FG001|Overall Study|Incorrect enrolment|0|||
17011947|NCT00536107|38156512|FG000|Overall Study|Withdrawal by Subject|0|||
17011948|NCT00536107|38156513|FG001|Overall Study|Withdrawal by Subject|1|||
17011949|NCT00536107|38156512|FG000|Overall Study|Study Termination|2|||
17011950|NCT00536107|38156513|FG001|Overall Study|Study Termination|4|||
17011951|NCT00885482|38156542|FG000|Overall Study|Pregnancy|1|||
17011952|NCT00885482|38156542|FG000|Overall Study|Lack of Efficacy|1|||
17011953|NCT00885482|38156542|FG000|Overall Study|Death|1|||
17011954|NCT00885482|38156542|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
17011955|NCT00885170|38156566|FG000|Overall Study|Adverse Event|12|||
17011956|NCT00885170|38156567|FG001|Overall Study|Adverse Event|4|||
17011957|NCT00885170|38156566|FG000|Overall Study|Excessive bone loss|6|||
17011958|NCT00885170|38156567|FG001|Overall Study|Excessive bone loss|3|||
17011959|NCT00885170|38156566|FG000|Overall Study|Lost to Follow-up|2|||
17011960|NCT00885170|38156567|FG001|Overall Study|Lost to Follow-up|1|||
17011961|NCT00885170|38156566|FG000|Overall Study|Physician Decision|2|||
17011962|NCT00885170|38156567|FG001|Overall Study|Physician Decision|1|||
17011963|NCT00885170|38156566|FG000|Overall Study|Protocol Violation|3|||
17011964|NCT00885170|38156567|FG001|Overall Study|Protocol Violation|1|||
17011965|NCT00885170|38156566|FG000|Overall Study|Withdrawal by Subject|13|||
17011966|NCT00885170|38156567|FG001|Overall Study|Withdrawal by Subject|13|||
17011967|NCT00866619|38156594|FG000|Overall Study|Adverse Event|112|||
17011968|NCT00866619|38156595|FG001|Overall Study|Adverse Event|106|||
17011969|NCT00866619|38156596|FG002|Overall Study|Adverse Event|47|||
17011970|NCT00866619|38156597|FG003|Overall Study|Adverse Event|44|||
17011971|NCT00866619|38156594|FG000|Overall Study|Protocol Violation|2|||
17011972|NCT00866619|38156595|FG001|Overall Study|Protocol Violation|39|||
17011973|NCT00866619|38156596|FG002|Overall Study|Protocol Violation|2|||
17011974|NCT00866619|38156597|FG003|Overall Study|Protocol Violation|17|||
17011975|NCT00866619|38156594|FG000|Overall Study|Withdrawal by Subject|587|||
17011976|NCT00866619|38156595|FG001|Overall Study|Withdrawal by Subject|295|||
17011977|NCT00866619|38156596|FG002|Overall Study|Withdrawal by Subject|272|||
17011978|NCT00866619|38156597|FG003|Overall Study|Withdrawal by Subject|144|||
17011979|NCT00866619|38156594|FG000|Overall Study|Lost to Follow-up|1145|||
17011980|NCT00866619|38156595|FG001|Overall Study|Lost to Follow-up|830|||
17011981|NCT00866619|38156596|FG002|Overall Study|Lost to Follow-up|568|||
17011982|NCT00866619|38156597|FG003|Overall Study|Lost to Follow-up|425|||
17011983|NCT00884390|38156644|FG000|Overall Study|Adverse Event|0|||
17011984|NCT00884390|38156645|FG001|Overall Study|Adverse Event|1|||
17011985|NCT00884390|38156644|FG000|Overall Study|Lost to Follow-up|0|||
17011986|NCT00884390|38156645|FG001|Overall Study|Lost to Follow-up|1|||
17011987|NCT00884390|38156644|FG000|Overall Study|Physician Decision|2|||
17011988|NCT00884390|38156645|FG001|Overall Study|Physician Decision|1|||
17011989|NCT00884390|38156644|FG000|Overall Study|Protocol Violation|4|||
17011990|NCT00884390|38156645|FG001|Overall Study|Protocol Violation|1|||
17011991|NCT00884390|38156644|FG000|Overall Study|Withdrawal by Subject|4|||
17011992|NCT00884390|38156645|FG001|Overall Study|Withdrawal by Subject|1|||
17011993|NCT00884390|38156644|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
17011994|NCT00884390|38156645|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
17011995|NCT00884390|38156644|FG000|Overall Study|Other|11|||
17011996|NCT00884390|38156645|FG001|Overall Study|Other|1|||
17011997|NCT00872898|38156682|FG000|Part Two - Double Blind|Adverse Event|4|||
17011998|NCT00872898|38156683|FG001|Part Two - Double Blind|Adverse Event|3|||
17011999|NCT00872898|38156682|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
17012000|NCT00872898|38156683|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
17012001|NCT00872898|38156682|FG000|Part Two - Double Blind|Protocol Violation|1|||
17012002|NCT00872898|38156683|FG001|Part Two - Double Blind|Protocol Violation|0|||
17012003|NCT00872898|38156682|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
17012004|NCT00872898|38156683|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
17012005|NCT00872898|38156682|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
17012006|NCT00872898|38156683|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
17012007|NCT00872898|38156682|FG000|Part Two - Double Blind|Other reasons|2|||
17012008|NCT00872898|38156683|FG001|Part Two - Double Blind|Other reasons|0|||
17012009|NCT00884312|38156694|FG000|Overall Study|Non-fatal Progressive Disease|0|||
17012010|NCT00884312|38156695|FG001|Overall Study|Non-fatal Progressive Disease|8|||
17012011|NCT00884312|38156694|FG000|Overall Study|Fatal Progressive Disease|0|||
17012012|NCT00884312|38156695|FG001|Overall Study|Fatal Progressive Disease|1|||
17012013|NCT00884312|38156694|FG000|Overall Study|Non-fatal Adverse Event|1|||
17012014|NCT00884312|38156695|FG001|Overall Study|Non-fatal Adverse Event|0|||
17012015|NCT00884312|38156694|FG000|Overall Study|Fatal Adverse Event|1|||
17012016|NCT00884312|38156695|FG001|Overall Study|Fatal Adverse Event|4|||
17012017|NCT00884312|38156694|FG000|Overall Study|Withdrawal by Subject|0|||
17012018|NCT00884312|38156695|FG001|Overall Study|Withdrawal by Subject|6|||
17012019|NCT00884312|38156694|FG000|Overall Study|Physician Decision|0|||
17012020|NCT00884312|38156695|FG001|Overall Study|Physician Decision|1|||
17012021|NCT00884312|38156694|FG000|Overall Study|Other|0|||
17012022|NCT00884312|38156695|FG001|Overall Study|Other|4|||
17012023|NCT00884312|38156694|FG000|Overall Study|Did Not Receive Study Drug|0|||
17012024|NCT00884312|38156695|FG001|Overall Study|Did Not Receive Study Drug|1|||
17012025|NCT00534313|38156705|FG000|Short-term Period|Adverse Event|1|||
17012026|NCT00534313|38156706|FG001|Short-term Period|Adverse Event|2|||
17012027|NCT00534313|38156707|FG002|Short-term Period|Adverse Event|1|||
17012028|NCT00534313|38156708|FG003|Short-term Period|Adverse Event|3|||
17012029|NCT00534313|38156705|FG000|Short-term Period|Lack of Efficacy|3|||
17012030|NCT00534313|38156706|FG001|Short-term Period|Lack of Efficacy|4|||
17012031|NCT00534313|38156707|FG002|Short-term Period|Lack of Efficacy|0|||
17012032|NCT00534313|38156708|FG003|Short-term Period|Lack of Efficacy|3|||
17012033|NCT00534313|38156705|FG000|Short-term Period|Participant not meeting study criteria|0|||
17012034|NCT00534313|38156706|FG001|Short-term Period|Participant not meeting study criteria|0|||
17012035|NCT00534313|38156707|FG002|Short-term Period|Participant not meeting study criteria|0|||
17012036|NCT00534313|38156708|FG003|Short-term Period|Participant not meeting study criteria|1|||
17012037|NCT00534313|38156705|FG000|Short-term Period|Participant withdrew consent|2|||
17012038|NCT00534313|38156706|FG001|Short-term Period|Participant withdrew consent|0|||
17012039|NCT00534313|38156707|FG002|Short-term Period|Participant withdrew consent|0|||
17012040|NCT00534313|38156708|FG003|Short-term Period|Participant withdrew consent|2|||
17012041|NCT00534313|38156705|FG000|Short-term Period|Pregnancy|0|||
17012042|NCT00534313|38156706|FG001|Short-term Period|Pregnancy|0|||
17012043|NCT00534313|38156707|FG002|Short-term Period|Pregnancy|1|||
17012044|NCT00534313|38156708|FG003|Short-term Period|Pregnancy|0|||
17012045|NCT00534313|38156705|FG000|Long-term Period|Adverse Event|2|||
17012046|NCT00534313|38156706|FG001|Long-term Period|Adverse Event|1|||
17012047|NCT00534313|38156707|FG002|Long-term Period|Adverse Event|0|||
17012048|NCT00534313|38156708|FG003|Long-term Period|Adverse Event|1|||
17012049|NCT00534313|38156705|FG000|Long-term Period|Lack of Efficacy|14|||
17012050|NCT00534313|38156706|FG001|Long-term Period|Lack of Efficacy|10|||
17012051|NCT00534313|38156707|FG002|Long-term Period|Lack of Efficacy|14|||
17012052|NCT00534313|38156708|FG003|Long-term Period|Lack of Efficacy|12|||
17012053|NCT00534313|38156705|FG000|Long-term Period|Lost to Follow-up|1|||
17012054|NCT00534313|38156706|FG001|Long-term Period|Lost to Follow-up|2|||
17012055|NCT00534313|38156707|FG002|Long-term Period|Lost to Follow-up|0|||
17012056|NCT00534313|38156708|FG003|Long-term Period|Lost to Follow-up|0|||
17012057|NCT00534313|38156705|FG000|Long-term Period|Withdrawal by Subject|2|||
17012058|NCT00534313|38156706|FG001|Long-term Period|Withdrawal by Subject|2|||
17012059|NCT00534313|38156707|FG002|Long-term Period|Withdrawal by Subject|0|||
17012060|NCT00534313|38156708|FG003|Long-term Period|Withdrawal by Subject|0|||
17012061|NCT00534313|38156705|FG000|Long-term Period|No longer meets study criteria|0|||
17012062|NCT00534313|38156706|FG001|Long-term Period|No longer meets study criteria|1|||
17012063|NCT00534313|38156707|FG002|Long-term Period|No longer meets study criteria|0|||
17012064|NCT00534313|38156708|FG003|Long-term Period|No longer meets study criteria|0|||
17012065|NCT00534313|38156705|FG000|Long-term Period|Poor compliance/noncompliance|0|||
17012066|NCT00534313|38156706|FG001|Long-term Period|Poor compliance/noncompliance|1|||
17012067|NCT00534313|38156707|FG002|Long-term Period|Poor compliance/noncompliance|1|||
17012068|NCT00534313|38156708|FG003|Long-term Period|Poor compliance/noncompliance|0|||
17012069|NCT00534313|38156705|FG000|Long-term Period|Administrative reason by sponsor|17|||
17012070|NCT00534313|38156706|FG001|Long-term Period|Administrative reason by sponsor|15|||
17012071|NCT00534313|38156707|FG002|Long-term Period|Administrative reason by sponsor|26|||
17012072|NCT00534313|38156708|FG003|Long-term Period|Administrative reason by sponsor|18|||
17012073|NCT00534313|38156705|FG000|Long-term Period|Other|1|||
17012074|NCT00534313|38156706|FG001|Long-term Period|Other|2|||
17012075|NCT00534313|38156707|FG002|Long-term Period|Other|2|||
17012076|NCT00534313|38156708|FG003|Long-term Period|Other|2|||
17012077|NCT02611960|38156755|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7|||
17012078|NCT02611960|38156756|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8|||
17097464|NCT00129402|38236642|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
17097465|NCT00129402|38236643|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
17097466|NCT00129402|38236644|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
17097467|NCT00129402|38236645|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
17097468|NCT00129402|38236639|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
17097469|NCT00129402|38236640|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
17012079|NCT02611960|38156755|FG000|Overall Study|Death|87|||
17012080|NCT02611960|38156756|FG001|Overall Study|Death|85|||
17012081|NCT02611960|38156755|FG000|Overall Study|Withdrawal by Subject|0|||
17012082|NCT02611960|38156756|FG001|Overall Study|Withdrawal by Subject|1|||
17012083|NCT02611960|38156755|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1|||
17012084|NCT02611960|38156756|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4|||
17012085|NCT02611960|38156755|FG000|Overall Study|Participants Ongoing|22|||
17012086|NCT02611960|38156756|FG001|Overall Study|Participants Ongoing|18|||
17012087|NCT03888391|38156763|FG000|Overall Study|Lost to Follow-up|15|||
17012088|NCT00594204|38156769|FG000|Overall Study|Adverse Event|15|||
17012089|NCT00594204|38156770|FG001|Overall Study|Adverse Event|3|||
17012090|NCT00594204|38156769|FG000|Overall Study|Lost to Follow-up|9|||
17012091|NCT00594204|38156770|FG001|Overall Study|Lost to Follow-up|5|||
17012092|NCT00594204|38156769|FG000|Overall Study|Withdrawal by Subject|23|||
17012093|NCT00594204|38156770|FG001|Overall Study|Withdrawal by Subject|29|||
17012094|NCT00594204|38156769|FG000|Overall Study|Other|4|||
17012095|NCT00594204|38156770|FG001|Overall Study|Other|3|||
17012096|NCT00594204|38156769|FG000|Overall Study|Lack of Efficacy|3|||
17012097|NCT00594204|38156770|FG001|Overall Study|Lack of Efficacy|4|||
17012098|NCT00594204|38156769|FG000|Overall Study|Randomized but not treated|4|||
17012099|NCT00594204|38156770|FG001|Overall Study|Randomized but not treated|1|||
17012100|NCT03888235|38156788|FG000|Overall Study|Lost to Follow-up|1|||
17012101|NCT03888235|38156789|FG001|Overall Study|Lost to Follow-up|1|||
17012102|NCT03888235|38156790|FG002|Overall Study|Lost to Follow-up|0|||
17012103|NCT00866307|38156821|FG000|Induction|Adverse Event|5|||
17012104|NCT00866307|38156822|FG001|Induction|Adverse Event|0|||
17012105|NCT00866307|38156823|FG002|Induction|Adverse Event|0|||
17012106|NCT00866307|38156821|FG000|Induction|Death|2|||
17012107|NCT00866307|38156822|FG001|Induction|Death|0|||
17012108|NCT00866307|38156823|FG002|Induction|Death|0|||
17012109|NCT00866307|38156821|FG000|Induction|Physician Decision|5|||
17012110|NCT00866307|38156822|FG001|Induction|Physician Decision|0|||
17012111|NCT00866307|38156823|FG002|Induction|Physician Decision|0|||
17012112|NCT00866307|38156821|FG000|Induction|Progressive Disease|1|||
17012113|NCT00866307|38156822|FG001|Induction|Progressive Disease|0|||
17012114|NCT00866307|38156823|FG002|Induction|Progressive Disease|0|||
17012115|NCT00866307|38156821|FG000|Induction|Identification of Patients with Day 29 M|3|||
17012116|NCT00866307|38156822|FG001|Induction|Identification of Patients with Day 29 M|0|||
17012117|NCT00866307|38156823|FG002|Induction|Identification of Patients with Day 29 M|0|||
17012118|NCT00866307|38156821|FG000|Induction|Inadequate cytognetic samples th|1|||
17012119|NCT00866307|38156822|FG001|Induction|Inadequate cytognetic samples th|0|||
17012120|NCT00866307|38156823|FG002|Induction|Inadequate cytognetic samples th|0|||
17012121|NCT00866307|38156821|FG000|Induction|Improper post-induction consent|2|||
17012122|NCT00866307|38156822|FG001|Induction|Improper post-induction consent|0|||
17012123|NCT00866307|38156823|FG002|Induction|Improper post-induction consent|0|||
17012124|NCT00866307|38156821|FG000|Induction|Study was closed at the time|1|||
17012125|NCT00866307|38156822|FG001|Induction|Study was closed at the time|0|||
17012126|NCT00866307|38156823|FG002|Induction|Study was closed at the time|0|||
17012127|NCT00866307|38156821|FG000|Consolidation/Maintenance|Adverse Event|0|||
17012128|NCT00866307|38156822|FG001|Consolidation/Maintenance|Adverse Event|0|||
17012129|NCT00866307|38156823|FG002|Consolidation/Maintenance|Adverse Event|8|||
17012130|NCT00866307|38156821|FG000|Consolidation/Maintenance|Death|0|||
17012131|NCT00866307|38156822|FG001|Consolidation/Maintenance|Death|0|||
17012132|NCT00866307|38156823|FG002|Consolidation/Maintenance|Death|1|||
17012133|NCT00866307|38156821|FG000|Consolidation/Maintenance|Physician Decision|0|||
17012134|NCT00866307|38156822|FG001|Consolidation/Maintenance|Physician Decision|3|||
17012135|NCT00866307|38156823|FG002|Consolidation/Maintenance|Physician Decision|2|||
17012136|NCT00866307|38156821|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
17012137|NCT00866307|38156822|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
17012138|NCT00866307|38156823|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
17012139|NCT00866307|38156821|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
17012140|NCT00866307|38156822|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
17012141|NCT00866307|38156823|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
17012142|NCT00866307|38156821|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
17012143|NCT00866307|38156822|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
17012144|NCT00866307|38156823|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
17012145|NCT00866307|38156821|FG000|Consolidation/Maintenance|Therapy error|0|||
17012146|NCT00866307|38156822|FG001|Consolidation/Maintenance|Therapy error|1|||
17012147|NCT00866307|38156823|FG002|Consolidation/Maintenance|Therapy error|0|||
17012148|NCT00866307|38156821|FG000|Consolidation/Maintenance|Non-compliance|0|||
17012149|NCT00866307|38156822|FG001|Consolidation/Maintenance|Non-compliance|0|||
17012150|NCT00866307|38156823|FG002|Consolidation/Maintenance|Non-compliance|1|||
17012151|NCT00866307|38156821|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
17012152|NCT00866307|38156822|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
17012153|NCT00866307|38156823|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
17012154|NCT00531427|38156831|FG000|Overall Study|Withdrawal by Subject|7|||
17012155|NCT00531427|38156832|FG001|Overall Study|Withdrawal by Subject|13|||
17012156|NCT00531427|38156831|FG000|Overall Study|Adverse Event|44|||
17012157|NCT00531427|38156832|FG001|Overall Study|Adverse Event|30|||
17012158|NCT00531427|38156831|FG000|Overall Study|Lost to Follow-up|4|||
17012159|NCT00531427|38156832|FG001|Overall Study|Lost to Follow-up|3|||
17012160|NCT00531427|38156831|FG000|Overall Study|Lack of Efficacy|14|||
17012161|NCT00531427|38156832|FG001|Overall Study|Lack of Efficacy|39|||
17012162|NCT00531427|38156831|FG000|Overall Study|Administrative|4|||
17012163|NCT00531427|38156832|FG001|Overall Study|Administrative|9|||
17012164|NCT00871728|38156839|FG000|Overall Study|Adverse Event|1|||
17012165|NCT00871728|38156839|FG000|Overall Study|Protocol Violation|7|||
17012166|NCT00871728|38156839|FG000|Overall Study|Lost to Follow-up|2|||
17012167|NCT00871728|38156839|FG000|Overall Study|Failed to Visit Hospital|4|||
17012168|NCT00871728|38156839|FG000|Overall Study|Participant Non-compliance|1|||
17012169|NCT00871728|38156839|FG000|Overall Study|Withdrawal of Informed Consent|5|||
17012170|NCT00868998|38156843|FG000|Overall Study|Screen Failure|1|||
17012171|NCT00868998|38156843|FG000|Overall Study|Withdrawal by Subject|1|||
17012172|NCT00868998|38156843|FG000|Overall Study|Progression of disease|2|||
17012173|NCT00868998|38156843|FG000|Overall Study|Death|1|||
17012174|NCT00533845|38156858|FG000|Overall Study|Physician Decision|1|||
17012175|NCT00533845|38156859|FG001|Overall Study|Physician Decision|0|||
17012176|NCT00857649|38156867|FG000|Overall Study|Adverse Event|15|||
17012177|NCT00857649|38156868|FG001|Overall Study|Adverse Event|10|||
17012178|NCT00857649|38156867|FG000|Overall Study|Non-compliance|1|||
17012179|NCT00857649|38156868|FG001|Overall Study|Non-compliance|1|||
17012180|NCT00857649|38156867|FG000|Overall Study|Protocol Violation|2|||
17012181|NCT00857649|38156868|FG001|Overall Study|Protocol Violation|2|||
17012182|NCT00857649|38156867|FG000|Overall Study|Withdrawal of Consent|10|||
17012183|NCT00857649|38156868|FG001|Overall Study|Withdrawal of Consent|7|||
17012184|NCT00857649|38156867|FG000|Overall Study|Nursing Home Placement|2|||
17012185|NCT00857649|38156868|FG001|Overall Study|Nursing Home Placement|9|||
17012186|NCT00857649|38156867|FG000|Overall Study|Other Reasons|1|||
17012187|NCT00857649|38156868|FG001|Overall Study|Other Reasons|3|||
17012188|NCT00857415|38156876|FG000|Overall Study|Image acquisition failure|2|||
17012189|NCT00857415|38156877|FG001|Overall Study|Image acquisition failure|0|||
17012190|NCT00857415|38156876|FG000|Overall Study|Invalid image or not imaged|3|||
17012191|NCT00857415|38156877|FG001|Overall Study|Invalid image or not imaged|0|||
17012192|NCT00857415|38156876|FG000|Overall Study|Subject still living at end of study|110|||
17012193|NCT00857415|38156877|FG001|Overall Study|Subject still living at end of study|0|||
17012194|NCT00857415|38156876|FG000|Overall Study|Deceased with no autopsy|2|||
17012195|NCT00857415|38156877|FG001|Overall Study|Deceased with no autopsy|0|||
17012196|NCT00532441|38156883|FG000|Overall Study|Death|1|||
17012197|NCT00532441|38156884|FG001|Overall Study|Death|0|||
17012198|NCT00857259|38156905|FG000|Overall Study|Protocol Violation|1|||
17012199|NCT00857259|38156906|FG001|Overall Study|Protocol Violation|0|||
17012200|NCT00857259|38156907|FG002|Overall Study|Protocol Violation|1|||
17012201|NCT00868608|38156920|FG000|Overall Study|Withdrawal by Subject|3|||
17012202|NCT00868608|38156921|FG001|Overall Study|Withdrawal by Subject|1|||
17012203|NCT00868608|38156922|FG002|Overall Study|Withdrawal by Subject|0|||
17012204|NCT00868608|38156920|FG000|Overall Study|Lost to Follow-up|3|||
17012205|NCT00868608|38156921|FG001|Overall Study|Lost to Follow-up|0|||
17012206|NCT00868608|38156922|FG002|Overall Study|Lost to Follow-up|1|||
17012207|NCT00868608|38156920|FG000|Overall Study|Death|16|||
17012208|NCT00868608|38156921|FG001|Overall Study|Death|2|||
17012209|NCT00868608|38156922|FG002|Overall Study|Death|4|||
17012210|NCT00868608|38156920|FG000|Overall Study|Other - Unspecified|1|||
17012211|NCT00868608|38156921|FG001|Overall Study|Other - Unspecified|0|||
17012212|NCT00868608|38156922|FG002|Overall Study|Other - Unspecified|0|||
17012213|NCT00856635|38156932|FG000|Overall Study|Lost to Follow-up|2|||
17012214|NCT00856635|38156933|FG001|Overall Study|Lost to Follow-up|5|||
17012215|NCT00856635|38156932|FG000|Overall Study|Pregnancy|1|||
17012216|NCT00856635|38156933|FG001|Overall Study|Pregnancy|0|||
17012217|NCT00856635|38156932|FG000|Overall Study|Withdrawal by Subject|3|||
17012218|NCT00856635|38156933|FG001|Overall Study|Withdrawal by Subject|1|||
17012219|NCT00856635|38156932|FG000|Overall Study|Serious Adverse Event|1|||
17012220|NCT00856635|38156933|FG001|Overall Study|Serious Adverse Event|0|||
17012221|NCT00856635|38156932|FG000|Overall Study|Other|1|||
17012222|NCT00856635|38156933|FG001|Overall Study|Other|0|||
17012223|NCT00856635|38156932|FG000|Overall Study|Discontinued at Randomization|2|||
17012224|NCT00856635|38156933|FG001|Overall Study|Discontinued at Randomization|2|||
17012225|NCT00856557|38156943|FG000|Overall Study|No patients with contextual flags|12|||
17012226|NCT00856557|38156944|FG001|Overall Study|No patients with contextual flags|16|||
17012227|NCT00856323|38156950|FG000|Overall Study|Withdrawal by Subject|2|||
17012228|NCT00856245|38156958|FG000|Overall Study|Was not transplanted|5|||
17012229|NCT00855933|38156964|FG000|Overall Study|Withdrawal by Subject|0|||
17012230|NCT00855933|38156965|FG001|Overall Study|Withdrawal by Subject|1|||
17012231|NCT00871572|38156975|FG000|Overall Study|Adverse Event|0|||
17012232|NCT00871572|38156976|FG001|Overall Study|Adverse Event|2|||
17012233|NCT00871572|38156977|FG002|Overall Study|Adverse Event|0|||
17012234|NCT00871572|38156978|FG003|Overall Study|Adverse Event|3|||
17012235|NCT00871572|38156975|FG000|Overall Study|Investigator Decision|0|||
17012236|NCT00871572|38156976|FG001|Overall Study|Investigator Decision|1|||
17193180|NCT02055547|38346470|FG014|Overall Study|Adverse Event|0|||
17012237|NCT00871572|38156977|FG002|Overall Study|Investigator Decision|0|||
17012238|NCT00871572|38156978|FG003|Overall Study|Investigator Decision|1|||
17012239|NCT00871572|38156975|FG000|Overall Study|Lost to Follow-up|0|||
17012240|NCT00871572|38156976|FG001|Overall Study|Lost to Follow-up|1|||
17012241|NCT00871572|38156977|FG002|Overall Study|Lost to Follow-up|0|||
17012242|NCT00871572|38156978|FG003|Overall Study|Lost to Follow-up|1|||
17012243|NCT00871572|38156975|FG000|Overall Study|Protocol Violation|0|||
17012244|NCT00871572|38156976|FG001|Overall Study|Protocol Violation|0|||
17012245|NCT00871572|38156977|FG002|Overall Study|Protocol Violation|1|||
17012246|NCT00871572|38156978|FG003|Overall Study|Protocol Violation|1|||
17012247|NCT00871572|38156975|FG000|Overall Study|Sponsor Decision|1|||
17012248|NCT00871572|38156976|FG001|Overall Study|Sponsor Decision|0|||
17012249|NCT00871572|38156977|FG002|Overall Study|Sponsor Decision|0|||
17012250|NCT00871572|38156978|FG003|Overall Study|Sponsor Decision|0|||
17012251|NCT00871572|38156975|FG000|Overall Study|Withdrawal by Subject|1|||
17012252|NCT00871572|38156976|FG001|Overall Study|Withdrawal by Subject|2|||
17012253|NCT00871572|38156977|FG002|Overall Study|Withdrawal by Subject|3|||
17012254|NCT00871572|38156978|FG003|Overall Study|Withdrawal by Subject|1|||
17012255|NCT03885661|38156990|FG000|Overall Study|Withdrawal by Subject|0|||
17012256|NCT03885661|38156991|FG001|Overall Study|Withdrawal by Subject|1|||
17012257|NCT03885661|38156990|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
17012258|NCT03885661|38156991|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
17012259|NCT00868530|38156997|FG000|Overall Study|Adverse Event|3|||
17012260|NCT00868530|38156997|FG000|Overall Study|Lost to Follow-up|1|||
17012261|NCT00855465|38157003|FG000|Treatment Period|Adverse Event|4|||
17012262|NCT00855465|38157004|FG001|Treatment Period|Adverse Event|2|||
17012263|NCT00855465|38157003|FG000|Treatment Period|Death|2|||
17012264|NCT00855465|38157004|FG001|Treatment Period|Death|2|||
17012265|NCT00855465|38157003|FG000|Treatment Period|Lack of Efficacy|2|||
17012266|NCT00855465|38157004|FG001|Treatment Period|Lack of Efficacy|1|||
17012267|NCT00855465|38157003|FG000|Treatment Period|Non-compliance|1|||
17012268|NCT00855465|38157004|FG001|Treatment Period|Non-compliance|0|||
17012269|NCT00855465|38157003|FG000|Treatment Period|Protocol Violation|2|||
17012270|NCT00855465|38157004|FG001|Treatment Period|Protocol Violation|0|||
17012271|NCT00855465|38157003|FG000|Treatment Period|Withdrawal by Subject|2|||
17012272|NCT00855465|38157004|FG001|Treatment Period|Withdrawal by Subject|0|||
17012273|NCT00855465|38157003|FG000|Treatment Period|Not treated|1|||
17012274|NCT00855465|38157004|FG001|Treatment Period|Not treated|0|||
17012275|NCT00855465|38157003|FG000|Follow-up Period (FUP)|Adverse Event|0|||
17012276|NCT00855465|38157004|FG001|Follow-up Period (FUP)|Adverse Event|1|||
17012277|NCT00855465|38157003|FG000|Follow-up Period (FUP)|Death|0|||
17012278|NCT00855465|38157004|FG001|Follow-up Period (FUP)|Death|1|||
17012279|NCT00855465|38157003|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
17012280|NCT00855465|38157004|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
17012281|NCT00855465|38157003|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
17012282|NCT00855465|38157004|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
17012283|NCT00855465|38157003|FG000|Follow-up Period (FUP)|Missing|1|||
17012284|NCT00855465|38157004|FG001|Follow-up Period (FUP)|Missing|0|||
17012285|NCT00598442|38157013|FG000|Overall Study|Adverse Event|3|||
17097470|NCT00129402|38236641|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
17097471|NCT00129402|38236642|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
17097472|NCT00129402|38236643|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
17012286|NCT00598442|38157014|FG001|Overall Study|Adverse Event|0|||
17012287|NCT00598442|38157015|FG002|Overall Study|Adverse Event|0|||
17012288|NCT00598442|38157013|FG000|Overall Study|Death|19|||
17012289|NCT00598442|38157014|FG001|Overall Study|Death|11|||
17012290|NCT00598442|38157015|FG002|Overall Study|Death|11|||
17012291|NCT00598442|38157013|FG000|Overall Study|Lost to Follow-up|4|||
17012292|NCT00598442|38157014|FG001|Overall Study|Lost to Follow-up|3|||
17012293|NCT00598442|38157015|FG002|Overall Study|Lost to Follow-up|3|||
17012294|NCT00598442|38157013|FG000|Overall Study|Physician Decision|2|||
17012295|NCT00598442|38157014|FG001|Overall Study|Physician Decision|1|||
17012296|NCT00598442|38157015|FG002|Overall Study|Physician Decision|1|||
17012297|NCT00598442|38157013|FG000|Overall Study|Withdrawal by Subject|8|||
17097473|NCT00129402|38236644|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
17097474|NCT00129402|38236645|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
17097475|NCT00129402|38236639|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
17097476|NCT00129402|38236640|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
17097477|NCT00129402|38236641|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
17097478|NCT00129402|38236642|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
17097479|NCT00129402|38236643|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
17012298|NCT00598442|38157014|FG001|Overall Study|Withdrawal by Subject|16|||
17012299|NCT00598442|38157015|FG002|Overall Study|Withdrawal by Subject|6|||
17012300|NCT00598442|38157013|FG000|Overall Study|Noncompliance|0|||
17012301|NCT00598442|38157014|FG001|Overall Study|Noncompliance|2|||
17012302|NCT00598442|38157015|FG002|Overall Study|Noncompliance|1|||
17012303|NCT00598442|38157013|FG000|Overall Study|Relocation|1|||
17012304|NCT00598442|38157014|FG001|Overall Study|Relocation|4|||
17012305|NCT00598442|38157015|FG002|Overall Study|Relocation|0|||
17012306|NCT00598442|38157013|FG000|Overall Study|Renal transplant|0|||
17012307|NCT00598442|38157014|FG001|Overall Study|Renal transplant|0|||
17012308|NCT00598442|38157015|FG002|Overall Study|Renal transplant|1|||
17012309|NCT00598442|38157013|FG000|Overall Study|Site closed by sponsor|5|||
17012310|NCT00598442|38157014|FG001|Overall Study|Site closed by sponsor|2|||
17012311|NCT00598442|38157015|FG002|Overall Study|Site closed by sponsor|1|||
17097480|NCT00129402|38236644|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
17097481|NCT00129402|38236645|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
17097482|NCT00129402|38236639|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
17097483|NCT00129402|38236640|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
17097484|NCT00129402|38236641|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
17097485|NCT00129402|38236642|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
17097486|NCT00129402|38236643|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
17097487|NCT00129402|38236644|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
17097488|NCT00129402|38236645|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
17097489|NCT00129402|38236639|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
17097490|NCT00129402|38236640|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
17097491|NCT00129402|38236641|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
17097492|NCT00129402|38236642|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
17097493|NCT00129402|38236643|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
17097494|NCT00129402|38236644|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
17097495|NCT00129402|38236645|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
17097496|NCT00129402|38236639|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
17193181|NCT02055547|38346471|FG015|Overall Study|Adverse Event|0|||
17193182|NCT02055547|38346472|FG016|Overall Study|Adverse Event|0|||
17193183|NCT02055547|38346473|FG017|Overall Study|Adverse Event|0|||
17193184|NCT02055547|38346474|FG018|Overall Study|Adverse Event|0|||
17193185|NCT02055547|38346456|FG000|Overall Study|Withdrawal by Subject|0|||
17193186|NCT02055547|38346457|FG001|Overall Study|Withdrawal by Subject|0|||
17193187|NCT02055547|38346458|FG002|Overall Study|Withdrawal by Subject|0|||
17193188|NCT02055547|38346459|FG003|Overall Study|Withdrawal by Subject|0|||
17193189|NCT02055547|38346460|FG004|Overall Study|Withdrawal by Subject|0|||
17193190|NCT02055547|38346461|FG005|Overall Study|Withdrawal by Subject|1|||
17193191|NCT02055547|38346462|FG006|Overall Study|Withdrawal by Subject|0|||
17193192|NCT02055547|38346463|FG007|Overall Study|Withdrawal by Subject|0|||
17193193|NCT02055547|38346464|FG008|Overall Study|Withdrawal by Subject|1|||
17193194|NCT02055547|38346465|FG009|Overall Study|Withdrawal by Subject|0|||
17193195|NCT02055547|38346466|FG010|Overall Study|Withdrawal by Subject|0|||
17193196|NCT02055547|38346467|FG011|Overall Study|Withdrawal by Subject|0|||
17193197|NCT02055547|38346468|FG012|Overall Study|Withdrawal by Subject|0|||
17193198|NCT02055547|38346469|FG013|Overall Study|Withdrawal by Subject|1|||
17193199|NCT02055547|38346470|FG014|Overall Study|Withdrawal by Subject|0|||
17193200|NCT02055547|38346471|FG015|Overall Study|Withdrawal by Subject|1|||
17193201|NCT02055547|38346472|FG016|Overall Study|Withdrawal by Subject|0|||
17193202|NCT02055547|38346473|FG017|Overall Study|Withdrawal by Subject|0|||
17193203|NCT02055547|38346474|FG018|Overall Study|Withdrawal by Subject|0|||
17193204|NCT02055547|38346456|FG000|Overall Study|Lost to Follow-up|0|||
17193205|NCT02055547|38346457|FG001|Overall Study|Lost to Follow-up|0|||
17193206|NCT02055547|38346458|FG002|Overall Study|Lost to Follow-up|1|||
17193207|NCT02055547|38346459|FG003|Overall Study|Lost to Follow-up|0|||
17193208|NCT02055547|38346460|FG004|Overall Study|Lost to Follow-up|0|||
17193209|NCT02055547|38346461|FG005|Overall Study|Lost to Follow-up|0|||
17193210|NCT02055547|38346462|FG006|Overall Study|Lost to Follow-up|0|||
17193211|NCT02055547|38346463|FG007|Overall Study|Lost to Follow-up|0|||
17193212|NCT02055547|38346464|FG008|Overall Study|Lost to Follow-up|0|||
17193213|NCT02055547|38346465|FG009|Overall Study|Lost to Follow-up|0|||
17193214|NCT02055547|38346466|FG010|Overall Study|Lost to Follow-up|0|||
17193215|NCT02055547|38346467|FG011|Overall Study|Lost to Follow-up|0|||
17193216|NCT02055547|38346468|FG012|Overall Study|Lost to Follow-up|0|||
17193217|NCT02055547|38346469|FG013|Overall Study|Lost to Follow-up|0|||
17193218|NCT02055547|38346470|FG014|Overall Study|Lost to Follow-up|0|||
17193219|NCT02055547|38346471|FG015|Overall Study|Lost to Follow-up|0|||
17193220|NCT02055547|38346472|FG016|Overall Study|Lost to Follow-up|0|||
17193221|NCT02055547|38346473|FG017|Overall Study|Lost to Follow-up|0|||
17193222|NCT02055547|38346474|FG018|Overall Study|Lost to Follow-up|0|||
17193223|NCT02414854|38346512|FG000|Overall Study|Adverse Event|9|||
17193224|NCT02414854|38346513|FG001|Overall Study|Adverse Event|7|||
17193225|NCT02414854|38346514|FG002|Overall Study|Adverse Event|1|||
17193226|NCT02414854|38346515|FG003|Overall Study|Adverse Event|12|||
17193227|NCT02414854|38346512|FG000|Overall Study|Poor compliance to protocol|1|||
17012312|NCT00598442|38157013|FG000|Overall Study|Started dialysis|1|||
17012313|NCT00598442|38157014|FG001|Overall Study|Started dialysis|0|||
17012314|NCT00598442|38157015|FG002|Overall Study|Started dialysis|0|||
17012315|NCT00593814|38157025|FG000|Overall Study|Death|7|||
17012316|NCT00593814|38157026|FG001|Overall Study|Death|0|||
17012317|NCT00593814|38157025|FG000|Overall Study|Withdrawal by Subject|7|||
17012318|NCT00593814|38157026|FG001|Overall Study|Withdrawal by Subject|0|||
17012319|NCT00593814|38157025|FG000|Overall Study|Lost to Follow-up|7|||
17012320|NCT00593814|38157026|FG001|Overall Study|Lost to Follow-up|0|||
17012321|NCT00593814|38157025|FG000|Overall Study|Physician Decision|3|||
17012322|NCT00593814|38157026|FG001|Overall Study|Physician Decision|0|||
17012323|NCT00855309|38157034|FG000|Overall Study|patient never recieved drug|1|||
17012324|NCT00855309|38157035|FG001|Overall Study|patient never recieved drug|0|||
17012325|NCT00532129|38157041|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
17012326|NCT00532129|38157041|FG000|Treatment Period|Physician Decision|15|||
17012327|NCT00532129|38157041|FG000|Treatment Period|Disease progression|3|||
17012328|NCT00532129|38157041|FG000|Treatment Period|Protocol Violation|1|||
17012329|NCT00532129|38157041|FG000|Treatment Period|Other|5|||
17012330|NCT00532129|38157041|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
17012331|NCT00532129|38157041|FG000|Follow-up Period|Disease progression|57|||
17012332|NCT00532129|38157041|FG000|Follow-up Period|Lost to Follow-up|1|||
17012333|NCT00532129|38157041|FG000|Follow-up Period|Other|6|||
17012334|NCT00854607|38157045|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
17012335|NCT00854373|38157058|FG000|Overall Study|Withdrawal by Subject|1|||
17012336|NCT00854373|38157059|FG001|Overall Study|Withdrawal by Subject|3|||
17012337|NCT00854373|38157058|FG000|Overall Study|Forgot to take study drug|1|||
17012338|NCT00854373|38157059|FG001|Overall Study|Forgot to take study drug|1|||
17012339|NCT00853905|38157067|FG000|Overall Study|Lost to Follow-up|1|||
17012340|NCT00853905|38157068|FG001|Overall Study|Lost to Follow-up|3|||
17012341|NCT00853905|38157067|FG000|Overall Study|Withdrawal by Subject|0|||
17012342|NCT00853905|38157068|FG001|Overall Study|Withdrawal by Subject|1|||
17012343|NCT00853905|38157067|FG000|Overall Study|never had surgery|1|||
17012344|NCT00853905|38157068|FG001|Overall Study|never had surgery|0|||
17012345|NCT00868296|38157079|FG000|Overall Study|Adverse Event|0|||
17012346|NCT00868296|38157080|FG001|Overall Study|Adverse Event|2|||
17012347|NCT00868296|38157079|FG000|Overall Study|Withdrawal by Subject|0|||
17012348|NCT00868296|38157080|FG001|Overall Study|Withdrawal by Subject|1|||
17012349|NCT00867360|38157088|FG000|Overall Study|Withdrawal by Subject|1|||
17012350|NCT00867360|38157089|FG001|Overall Study|Withdrawal by Subject|0|||
17012351|NCT00867360|38157088|FG000|Overall Study|Physician Decision|0|||
17012352|NCT00867360|38157089|FG001|Overall Study|Physician Decision|1|||
17012353|NCT00593736|38157100|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
17012354|NCT00593736|38157101|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
17012355|NCT00593736|38157102|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
17012356|NCT00593736|38157103|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
17012357|NCT00593736|38157100|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
17012358|NCT00593736|38157101|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
17012359|NCT00593736|38157102|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
17012360|NCT00593736|38157103|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
17012361|NCT00593736|38157100|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
17012362|NCT00593736|38157101|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
17012363|NCT00593736|38157102|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
17012364|NCT00593736|38157103|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
17012365|NCT00593736|38157100|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
17012366|NCT00593736|38157101|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
17012367|NCT00593736|38157102|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
17012368|NCT00593736|38157103|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
17012369|NCT00593736|38157100|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
17012370|NCT00593736|38157101|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
17012371|NCT00593736|38157102|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
17012372|NCT00593736|38157103|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
17012373|NCT00593736|38157100|FG000|Screening Period and Placebo Run-in|Various|0|||
17012374|NCT00593736|38157101|FG001|Screening Period and Placebo Run-in|Various|0|||
17012375|NCT00593736|38157102|FG002|Screening Period and Placebo Run-in|Various|0|||
17012376|NCT00593736|38157103|FG003|Screening Period and Placebo Run-in|Various|25|||
17012377|NCT00593736|38157100|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
17012378|NCT00593736|38157101|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
17012379|NCT00593736|38157102|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
17012380|NCT00593736|38157103|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
17012381|NCT00593736|38157100|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
17012382|NCT00593736|38157101|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
17012383|NCT00593736|38157102|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
17012384|NCT00593736|38157103|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
17012385|NCT00593736|38157100|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
17012386|NCT00593736|38157101|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
17012387|NCT00593736|38157102|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
17012388|NCT00593736|38157103|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
17012389|NCT00593736|38157100|FG000|Treatment Period and Placebo Run-out|Various|1|||
17012390|NCT00593736|38157101|FG001|Treatment Period and Placebo Run-out|Various|1|||
17012391|NCT00593736|38157102|FG002|Treatment Period and Placebo Run-out|Various|1|||
17012392|NCT00593736|38157103|FG003|Treatment Period and Placebo Run-out|Various|0|||
17012393|NCT00883688|38157113|FG000|Overall Study|Ineligible|2|||
17012394|NCT03883477|38157119|FG000|Overall Study|Death|1|||
17012395|NCT03883477|38157120|FG001|Overall Study|Death|0|||
17012396|NCT03883477|38157119|FG000|Overall Study|Protocol Violation|0|||
17193228|NCT02414854|38346513|FG001|Overall Study|Poor compliance to protocol|1|||
17193229|NCT02414854|38346514|FG002|Overall Study|Poor compliance to protocol|2|||
17193230|NCT02414854|38346515|FG003|Overall Study|Poor compliance to protocol|2|||
17193231|NCT02414854|38346512|FG000|Overall Study|Other than specified above|12|||
17193232|NCT02414854|38346513|FG001|Overall Study|Other than specified above|37|||
17193233|NCT02414854|38346514|FG002|Overall Study|Other than specified above|17|||
17193234|NCT02414854|38346515|FG003|Overall Study|Other than specified above|37|||
17193235|NCT03332498|38346528|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
17193236|NCT03332498|38346529|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
17193237|NCT03332498|38346530|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
17193238|NCT01334125|38346539|FG000|Overall Study|Lost to Follow-up|3|||
17193239|NCT01334125|38346540|FG001|Overall Study|Lost to Follow-up|3|||
17193240|NCT02414152|38346547|FG000|Overall Study|Withdrawal by Subject|1|||
17193241|NCT02414152|38346547|FG000|Overall Study|Lack of Efficacy|1|||
17193242|NCT02413996|38346553|FG000|Overall Study|not comfortable with the intervention|9|||
17193243|NCT02413996|38346554|FG001|Overall Study|not comfortable with the intervention|2|||
17193244|NCT01333501|38346562|FG000|Overall Study|Adverse Event|3|||
17193245|NCT01333501|38346563|FG001|Overall Study|Adverse Event|1|||
17193246|NCT01333501|38346562|FG000|Overall Study|Abnormal laboratory value|2|||
17193247|NCT01333501|38346563|FG001|Overall Study|Abnormal laboratory value|1|||
17193248|NCT01333501|38346562|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17193249|NCT01333501|38346563|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
17193250|NCT01333501|38346562|FG000|Overall Study|Withdrawn consent|3|||
17193251|NCT01333501|38346563|FG001|Overall Study|Withdrawn consent|12|||
17193252|NCT01362140|38346571|FG000|Overall Study|Noncompliance|1|||
17193253|NCT01362140|38346572|FG001|Overall Study|Noncompliance|0|||
17193254|NCT01362140|38346571|FG000|Overall Study|Adverse Event|2|||
17193255|NCT01362140|38346572|FG001|Overall Study|Adverse Event|2|||
17193256|NCT01362140|38346571|FG000|Overall Study|Withdrawal by Subject|3|||
17193257|NCT01362140|38346572|FG001|Overall Study|Withdrawal by Subject|3|||
17193258|NCT01362140|38346571|FG000|Overall Study|Administrative Decision|0|||
17193259|NCT01362140|38346572|FG001|Overall Study|Administrative Decision|1|||
17193260|NCT01362140|38346571|FG000|Overall Study|Death|2|||
17193261|NCT01362140|38346572|FG001|Overall Study|Death|1|||
17193262|NCT01362140|38346571|FG000|Overall Study|Other|1|||
17193263|NCT01362140|38346572|FG001|Overall Study|Other|1|||
17193264|NCT01362140|38346571|FG000|Overall Study|Protocol-specified Criteria|1|||
17193265|NCT01362140|38346572|FG001|Overall Study|Protocol-specified Criteria|2|||
17193266|NCT01362140|38346571|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
17193267|NCT01362140|38346572|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
17193268|NCT01333189|38346580|FG000|Overall Study|Time constraints|1|||
17193269|NCT01333189|38346581|FG001|Overall Study|Time constraints|0|||
17193270|NCT01333189|38346580|FG000|Overall Study|Adverse Event|1|||
17193271|NCT01333189|38346581|FG001|Overall Study|Adverse Event|0|||
17193272|NCT01333189|38346580|FG000|Overall Study|Transportation difficulties|0|||
17193273|NCT01333189|38346581|FG001|Overall Study|Transportation difficulties|1|||
17193274|NCT01333189|38346580|FG000|Overall Study|Moved from region|0|||
17193275|NCT01333189|38346581|FG001|Overall Study|Moved from region|1|||
17193276|NCT01333111|38346590|FG000|Overall Study|patient undergoing major surgery|0|||
17193277|NCT01333111|38346591|FG001|Overall Study|patient undergoing major surgery|2|||
17193278|NCT01333111|38346592|FG002|Overall Study|patient undergoing major surgery|0|||
17193279|NCT01333111|38346590|FG000|Overall Study|personal reasons|0|||
17193280|NCT01333111|38346591|FG001|Overall Study|personal reasons|0|||
17193281|NCT01333111|38346592|FG002|Overall Study|personal reasons|1|||
17193282|NCT01333111|38346590|FG000|Overall Study|unclassified|1|||
17193283|NCT01333111|38346591|FG001|Overall Study|unclassified|0|||
17193284|NCT01333111|38346592|FG002|Overall Study|unclassified|0|||
17193285|NCT01333111|38346590|FG000|Overall Study|withdrawal criteria|0|||
17193286|NCT01333111|38346591|FG001|Overall Study|withdrawal criteria|1|||
17193287|NCT01333111|38346592|FG002|Overall Study|withdrawal criteria|0|||
17193288|NCT01333111|38346590|FG000|Overall Study|Non-compliance|1|||
17193289|NCT01333111|38346591|FG001|Overall Study|Non-compliance|0|||
17193290|NCT01333111|38346592|FG002|Overall Study|Non-compliance|0|||
17193291|NCT01333111|38346590|FG000|Overall Study|Ineffective therapy|0|||
17193292|NCT01333111|38346591|FG001|Overall Study|Ineffective therapy|0|||
17012397|NCT03883477|38157120|FG001|Overall Study|Protocol Violation|1|||
17012398|NCT00853827|38157128|FG000|Single Blind Period (1 Week)|Other|4|||
17012399|NCT00853827|38157129|FG001|Single Blind Period (1 Week)|Other|0|||
17012400|NCT00853827|38157128|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
17012401|NCT00853827|38157129|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
17012402|NCT00853827|38157128|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
17012403|NCT00853827|38157129|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
17012404|NCT00853827|38157128|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
17012405|NCT00853827|38157129|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
17012406|NCT00853827|38157128|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
17012407|NCT00853827|38157129|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
17012408|NCT00853827|38157128|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
17012409|NCT00853827|38157129|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
17012410|NCT00853827|38157128|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
17012411|NCT00853827|38157129|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
17012412|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
17012413|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
17012414|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
17012415|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
17012416|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
17012417|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
17012418|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
17012419|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
17012420|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
17012421|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
17012422|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
17012423|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
17012424|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
17012425|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
17012426|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
17012427|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
17012428|NCT00853827|38157128|FG000|Double Blind Period (103 Weeks)|Death|1|||
17012429|NCT00853827|38157129|FG001|Double Blind Period (103 Weeks)|Death|6|||
17012430|NCT00853749|38157137|FG000|Overall Study|Lost to Follow-up|0|||
17012431|NCT00853749|38157138|FG001|Overall Study|Lost to Follow-up|1|||
17012432|NCT00592839|38157147|FG000|Overall Study|Withdrawal by Subject|1|||
17012433|NCT00592839|38157148|FG001|Overall Study|Withdrawal by Subject|1|||
17012434|NCT00592839|38157149|FG002|Overall Study|Withdrawal by Subject|3|||
17012435|NCT00592839|38157147|FG000|Overall Study|Protocol Violation|1|||
17012436|NCT00592839|38157148|FG001|Overall Study|Protocol Violation|1|||
17012437|NCT00592839|38157149|FG002|Overall Study|Protocol Violation|2|||
17012438|NCT00592839|38157147|FG000|Overall Study|Adverse Event|0|||
17012439|NCT00592839|38157148|FG001|Overall Study|Adverse Event|1|||
17012440|NCT00592839|38157149|FG002|Overall Study|Adverse Event|0|||
17097497|NCT00129402|38236640|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
17097498|NCT00129402|38236641|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
17097499|NCT00129402|38236642|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
17097500|NCT00129402|38236643|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
17193293|NCT01333111|38346592|FG002|Overall Study|Ineffective therapy|1|||
17193294|NCT00702507|38346600|FG000|Initial Treatment Phase|Adverse Event|2|||
17193295|NCT00702507|38346600|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
17193296|NCT00702507|38346600|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
17193297|NCT00702507|38346600|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
17193298|NCT00702507|38346600|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
17097501|NCT00129402|38236644|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
17193299|NCT00702507|38346600|FG000|Follow-up Phase|Protocol Violation|2|||
17193300|NCT00702507|38346600|FG000|Follow-up Phase|Lost to Follow-up|23|||
17193301|NCT00702507|38346600|FG000|Follow-up Phase|Late Enrollment|1|||
17193302|NCT01673594|38346616|FG000|Overall Study|Adverse Event|3|||
17097502|NCT00129402|38236645|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
17097503|NCT03739528|38236655|FG000|Overall Study|Not treated|8|||
17097504|NCT03739528|38236656|FG001|Overall Study|Not treated|12|||
17097505|NCT03739528|38236655|FG000|Overall Study|Treatment and study discontinued|6|||
17097506|NCT03739528|38236656|FG001|Overall Study|Treatment and study discontinued|2|||
17097507|NCT03739528|38236655|FG000|Overall Study|Treatment discontinued + study completed|1|||
17097508|NCT03739528|38236656|FG001|Overall Study|Treatment discontinued + study completed|3|||
17097509|NCT00114738|38236665|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
17097510|NCT00114738|38236666|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
17097511|NCT00114738|38236667|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
17193303|NCT01673594|38346617|FG001|Overall Study|Adverse Event|1|||
17012441|NCT00592839|38157147|FG000|Overall Study|Lost to Follow-up|0|||
17012442|NCT00592839|38157148|FG001|Overall Study|Lost to Follow-up|1|||
17012443|NCT00592839|38157149|FG002|Overall Study|Lost to Follow-up|1|||
17012444|NCT00598832|38157159|FG000|Overall Study|Lack of Efficacy|3|||
17012445|NCT00598832|38157160|FG001|Overall Study|Lack of Efficacy|7|||
17012446|NCT00598832|38157159|FG000|Overall Study|Adverse Event|6|||
17012447|NCT00598832|38157160|FG001|Overall Study|Adverse Event|2|||
17012448|NCT00598832|38157159|FG000|Overall Study|Withdrawal by Subject|25|||
17012449|NCT00598832|38157160|FG001|Overall Study|Withdrawal by Subject|36|||
17012450|NCT00598832|38157159|FG000|Overall Study|Protocol Violation|0|||
17012451|NCT00598832|38157160|FG001|Overall Study|Protocol Violation|2|||
17012452|NCT00598832|38157159|FG000|Overall Study|Lost to Follow-up|24|||
17012453|NCT00598832|38157160|FG001|Overall Study|Lost to Follow-up|29|||
17012454|NCT00598832|38157159|FG000|Overall Study|Pregnancy|2|||
17012455|NCT00598832|38157160|FG001|Overall Study|Pregnancy|2|||
17012456|NCT00598832|38157159|FG000|Overall Study|Physician Decision|1|||
17012457|NCT00598832|38157160|FG001|Overall Study|Physician Decision|4|||
17012458|NCT00598832|38157159|FG000|Overall Study|Non compliance|1|||
17012459|NCT00598832|38157160|FG001|Overall Study|Non compliance|0|||
17012460|NCT00853593|38157166|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
17012461|NCT00853593|38157166|FG000|Overall Study|Model 4396 lead not attempted|29|||
17012462|NCT00853593|38157166|FG000|Overall Study|Implant not attempted|4|||
17012463|NCT00853125|38157187|FG000|Overall Study|Study participant's donor was CMV +|1|||
17012464|NCT00530023|38157194|FG000|Overall Study|Withdrawal by Subject|0|||
17012465|NCT00530023|38157195|FG001|Overall Study|Withdrawal by Subject|1|||
17012466|NCT02253316|38157201|FG000|Consolidation|Progression|4|||
17012467|NCT02253316|38157202|FG001|Consolidation|Progression|0|||
17012468|NCT02253316|38157203|FG002|Consolidation|Progression|0|||
17012469|NCT02253316|38157201|FG000|Consolidation|Non-Compliance|1|||
17012470|NCT02253316|38157202|FG001|Consolidation|Non-Compliance|0|||
17012471|NCT02253316|38157203|FG002|Consolidation|Non-Compliance|0|||
17012472|NCT02253316|38157201|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
17012473|NCT02253316|38157202|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
17012474|NCT02253316|38157203|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
17012475|NCT02253316|38157201|FG000|Consolidation|Secondary Malignancy|2|||
17012476|NCT02253316|38157202|FG001|Consolidation|Secondary Malignancy|0|||
17012477|NCT02253316|38157203|FG002|Consolidation|Secondary Malignancy|0|||
17012478|NCT02253316|38157201|FG000|Consolidation|Adverse Event|7|||
17012479|NCT02253316|38157202|FG001|Consolidation|Adverse Event|0|||
17012480|NCT02253316|38157203|FG002|Consolidation|Adverse Event|0|||
17012481|NCT02253316|38157201|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
17012482|NCT02253316|38157202|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
17012483|NCT02253316|38157203|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
17012484|NCT02253316|38157201|FG000|Maintenance|Physician Decision|0|||
17012485|NCT02253316|38157202|FG001|Maintenance|Physician Decision|5|||
17012486|NCT02253316|38157203|FG002|Maintenance|Physician Decision|16|||
17012487|NCT02253316|38157201|FG000|Maintenance|Non-Compliance|0|||
17012488|NCT02253316|38157202|FG001|Maintenance|Non-Compliance|1|||
17012489|NCT02253316|38157203|FG002|Maintenance|Non-Compliance|0|||
17012490|NCT02253316|38157201|FG000|Maintenance|Secondary Malignancy|0|||
17012491|NCT02253316|38157202|FG001|Maintenance|Secondary Malignancy|1|||
17012492|NCT02253316|38157203|FG002|Maintenance|Secondary Malignancy|5|||
17012493|NCT02253316|38157201|FG000|Maintenance|Adverse Event|0|||
17012494|NCT02253316|38157202|FG001|Maintenance|Adverse Event|8|||
17012495|NCT02253316|38157203|FG002|Maintenance|Adverse Event|12|||
17012496|NCT02253316|38157201|FG000|Maintenance|Still receiving active treatment|0|||
17012497|NCT02253316|38157202|FG001|Maintenance|Still receiving active treatment|23|||
17012498|NCT02253316|38157203|FG002|Maintenance|Still receiving active treatment|26|||
17012499|NCT00529087|38157214|FG000|Overall Study|Adverse Event|10|||
17012500|NCT00529087|38157215|FG001|Overall Study|Adverse Event|13|||
17012501|NCT00529087|38157216|FG002|Overall Study|Adverse Event|4|||
17012502|NCT00529087|38157214|FG000|Overall Study|Lost to Follow-up|6|||
17012503|NCT00529087|38157215|FG001|Overall Study|Lost to Follow-up|4|||
17012504|NCT00529087|38157216|FG002|Overall Study|Lost to Follow-up|1|||
17012505|NCT00529087|38157214|FG000|Overall Study|Protocol Violation|8|||
17012506|NCT00529087|38157215|FG001|Overall Study|Protocol Violation|7|||
17012507|NCT00529087|38157216|FG002|Overall Study|Protocol Violation|6|||
17012508|NCT00529087|38157214|FG000|Overall Study|Withdrawal by Subject|3|||
17097512|NCT00114738|38236665|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
17012509|NCT00529087|38157215|FG001|Overall Study|Withdrawal by Subject|3|||
17012510|NCT00529087|38157216|FG002|Overall Study|Withdrawal by Subject|3|||
17012511|NCT00529087|38157214|FG000|Overall Study|Protocol deviation|1|||
17012512|NCT00529087|38157215|FG001|Overall Study|Protocol deviation|1|||
17012513|NCT00529087|38157216|FG002|Overall Study|Protocol deviation|2|||
17012514|NCT00870870|38157251|FG000|Overall Study|Withdrawal by Subject|0|||
17012515|NCT00870870|38157252|FG001|Overall Study|Withdrawal by Subject|1|||
17012516|NCT00870870|38157253|FG002|Overall Study|Withdrawal by Subject|1|||
17012517|NCT00870870|38157254|FG003|Overall Study|Withdrawal by Subject|3|||
17012518|NCT00870870|38157251|FG000|Overall Study|Adverse Event|0|||
17012519|NCT00870870|38157252|FG001|Overall Study|Adverse Event|0|||
17012520|NCT00870870|38157253|FG002|Overall Study|Adverse Event|2|||
17012521|NCT00870870|38157254|FG003|Overall Study|Adverse Event|2|||
17012522|NCT03877237|38157271|FG000|Overall Study|Adverse Event|1|||
17012523|NCT03877237|38157272|FG001|Overall Study|Adverse Event|2|||
17012524|NCT03877237|38157271|FG000|Overall Study|Death|3|||
17097513|NCT00114738|38236666|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
17097514|NCT00114738|38236667|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
17097515|NCT00114738|38236665|FG000|Screening for Randomization|Neuropathy|17|||
17097516|NCT00114738|38236666|FG001|Screening for Randomization|Neuropathy|0|||
17097517|NCT00114738|38236667|FG002|Screening for Randomization|Neuropathy|0|||
17097518|NCT00114738|38236665|FG000|Screening for Randomization|Progressive disease|2|||
17097519|NCT00114738|38236666|FG001|Screening for Randomization|Progressive disease|0|||
17097520|NCT00114738|38236667|FG002|Screening for Randomization|Progressive disease|0|||
17097521|NCT00114738|38236665|FG000|Screening for Randomization|CNS Hemorrhage|1|||
17097522|NCT00114738|38236666|FG001|Screening for Randomization|CNS Hemorrhage|0|||
17097523|NCT00114738|38236667|FG002|Screening for Randomization|CNS Hemorrhage|0|||
17097524|NCT00114738|38236665|FG000|Screening for Randomization|Other|1|||
17097525|NCT00114738|38236666|FG001|Screening for Randomization|Other|0|||
17097526|NCT00114738|38236667|FG002|Screening for Randomization|Other|0|||
17097527|NCT00148122|38236674|FG000|Overall Study|Withdrawal by Subject|2|||
17097528|NCT00147498|38236682|FG000|Overall Study|Adverse Event|1|||
17097529|NCT00147498|38236683|FG001|Overall Study|Adverse Event|6|||
17097530|NCT00147498|38236684|FG002|Overall Study|Adverse Event|7|||
17193304|NCT01673594|38346616|FG000|Overall Study|Lost to Follow-up|1|||
17193305|NCT01673594|38346617|FG001|Overall Study|Lost to Follow-up|0|||
17193306|NCT01673594|38346616|FG000|Overall Study|Physician Decision|2|||
17193307|NCT01673594|38346617|FG001|Overall Study|Physician Decision|4|||
17193308|NCT01673594|38346616|FG000|Overall Study|Withdrawal by Subject|0|||
17193309|NCT01673594|38346617|FG001|Overall Study|Withdrawal by Subject|1|||
17193310|NCT02721147|38346626|FG000|Overall Study|Lost to Follow-up|2|||
17193311|NCT02721147|38346627|FG001|Overall Study|Lost to Follow-up|0|||
17193312|NCT02721147|38346628|FG002|Overall Study|Lost to Follow-up|0|||
17193313|NCT02720757|38346636|FG000|Overall Study|Other reason|5|||
17193314|NCT02720757|38346636|FG000|Overall Study|Loss of contact|4|||
17193315|NCT02720757|38346636|FG000|Overall Study|Informed consent withdrawal|1|||
17193316|NCT02720757|38346636|FG000|Overall Study|Patients wish to withdraw|2|||
17193317|NCT02720757|38346636|FG000|Overall Study|Missing|3|||
17193318|NCT02720757|38346636|FG000|Overall Study|General exclusion|3|||
17193319|NCT02646566|38346666|FG000|Overall Study|Lost to Follow-up|5|||
17193320|NCT02646566|38346667|FG001|Overall Study|Lost to Follow-up|4|||
17193321|NCT02646566|38346668|FG002|Overall Study|Lost to Follow-up|5|||
17193322|NCT02646566|38346666|FG000|Overall Study|Treatment failure|1|||
17193323|NCT02646566|38346667|FG001|Overall Study|Treatment failure|0|||
17193324|NCT02646566|38346668|FG002|Overall Study|Treatment failure|0|||
17193325|NCT01333033|38346682|FG000|Overall Study|Ineligible|0|||
17193326|NCT01333033|38346683|FG001|Overall Study|Ineligible|0|||
17193327|NCT01333033|38346684|FG002|Overall Study|Ineligible|0|||
17193328|NCT01333033|38346685|FG003|Overall Study|Ineligible|0|||
17193329|NCT01333033|38346686|FG004|Overall Study|Ineligible|6|||
17193330|NCT01333033|38346687|FG005|Overall Study|Ineligible|8|||
17193331|NCT01333033|38346682|FG000|Overall Study|Withdrawal by Subject|0|||
17193332|NCT01333033|38346683|FG001|Overall Study|Withdrawal by Subject|0|||
17193333|NCT01333033|38346684|FG002|Overall Study|Withdrawal by Subject|0|||
17193334|NCT01333033|38346685|FG003|Overall Study|Withdrawal by Subject|0|||
17193335|NCT01333033|38346686|FG004|Overall Study|Withdrawal by Subject|4|||
17193336|NCT01333033|38346687|FG005|Overall Study|Withdrawal by Subject|2|||
17193337|NCT01333033|38346682|FG000|Overall Study|PET inevaluable|0|||
17193338|NCT01333033|38346683|FG001|Overall Study|PET inevaluable|0|||
17193339|NCT01333033|38346684|FG002|Overall Study|PET inevaluable|0|||
17193340|NCT01333033|38346685|FG003|Overall Study|PET inevaluable|0|||
17193341|NCT01333033|38346686|FG004|Overall Study|PET inevaluable|2|||
17193342|NCT01333033|38346687|FG005|Overall Study|PET inevaluable|4|||
17193343|NCT01333033|38346682|FG000|Overall Study|Adverse Event|0|||
17193344|NCT01333033|38346683|FG001|Overall Study|Adverse Event|0|||
17193345|NCT01333033|38346684|FG002|Overall Study|Adverse Event|0|||
17193346|NCT01333033|38346685|FG003|Overall Study|Adverse Event|0|||
17193347|NCT01333033|38346686|FG004|Overall Study|Adverse Event|2|||
17193348|NCT01333033|38346687|FG005|Overall Study|Adverse Event|1|||
17193349|NCT01333033|38346682|FG000|Overall Study|Progression|0|||
16786299|NCT01999972|37726701|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
17012525|NCT03877237|38157272|FG001|Overall Study|Death|2|||
17012526|NCT03877237|38157271|FG000|Overall Study|Physician Decision|1|||
17012527|NCT03877237|38157272|FG001|Overall Study|Physician Decision|0|||
17012528|NCT03877237|38157271|FG000|Overall Study|Withdrawal by Subject|0|||
17012529|NCT03877237|38157272|FG001|Overall Study|Withdrawal by Subject|2|||
17097531|NCT00147498|38236685|FG003|Overall Study|Adverse Event|3|||
17097532|NCT00147498|38236682|FG000|Overall Study|Lack of Efficacy|1|||
17012530|NCT00528931|38157278|FG000|Overall Study|Lost to Follow-up|1|||
17012531|NCT00866814|38157283|FG000|Overall Study|Lost to Follow-up|12|||
17012532|NCT00866814|38157283|FG000|Overall Study|Adverse Event|2|||
17012533|NCT00866814|38157283|FG000|Overall Study|Physician Decision|1|||
17012534|NCT00866814|38157283|FG000|Overall Study|Death|1|||
17193350|NCT01333033|38346683|FG001|Overall Study|Progression|0|||
17193351|NCT01333033|38346684|FG002|Overall Study|Progression|0|||
17193352|NCT01333033|38346685|FG003|Overall Study|Progression|0|||
17193353|NCT01333033|38346686|FG004|Overall Study|Progression|0|||
17193354|NCT01333033|38346687|FG005|Overall Study|Progression|1|||
17193355|NCT01333033|38346682|FG000|Overall Study|MD Decision|0|||
17193356|NCT01333033|38346683|FG001|Overall Study|MD Decision|0|||
17193357|NCT01333033|38346684|FG002|Overall Study|MD Decision|0|||
17193358|NCT01333033|38346685|FG003|Overall Study|MD Decision|0|||
17193359|NCT01333033|38346686|FG004|Overall Study|MD Decision|0|||
17193360|NCT01333033|38346687|FG005|Overall Study|MD Decision|2|||
17193361|NCT02720523|38346709|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
17193362|NCT02720523|38346710|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
17193363|NCT02720523|38346711|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
17193364|NCT02720523|38346712|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
17193365|NCT02720523|38346713|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
17193366|NCT02720523|38346714|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
17193367|NCT02720523|38346715|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
17193368|NCT02720523|38346709|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
17097533|NCT00147498|38236683|FG001|Overall Study|Lack of Efficacy|1|||
17097534|NCT00147498|38236684|FG002|Overall Study|Lack of Efficacy|1|||
17097535|NCT00147498|38236685|FG003|Overall Study|Lack of Efficacy|8|||
17097536|NCT00147498|38236682|FG000|Overall Study|Laboratory abnormality|0|||
17097537|NCT00147498|38236683|FG001|Overall Study|Laboratory abnormality|0|||
17097538|NCT00147498|38236684|FG002|Overall Study|Laboratory abnormality|2|||
17193369|NCT02720523|38346710|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
17193370|NCT02720523|38346711|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
17193371|NCT02720523|38346712|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
17193372|NCT02720523|38346713|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
17097539|NCT00147498|38236685|FG003|Overall Study|Laboratory abnormality|0|||
17097540|NCT00147498|38236682|FG000|Overall Study|Participant defaulted|0|||
17097541|NCT00147498|38236683|FG001|Overall Study|Participant defaulted|1|||
17097542|NCT00147498|38236684|FG002|Overall Study|Participant defaulted|4|||
17097543|NCT00147498|38236685|FG003|Overall Study|Participant defaulted|3|||
17097544|NCT00147498|38236682|FG000|Overall Study|Other|1|||
17097545|NCT00147498|38236683|FG001|Overall Study|Other|1|||
17097546|NCT00147498|38236684|FG002|Overall Study|Other|3|||
17097547|NCT00147498|38236685|FG003|Overall Study|Other|3|||
17097548|NCT00113568|38236695|FG000|Overall Study|Adverse Event|97|||
17097549|NCT00113568|38236695|FG000|Overall Study|Death|1|||
17097550|NCT00113568|38236695|FG000|Overall Study|Lack of Efficacy|30|||
17097551|NCT00113568|38236695|FG000|Overall Study|Lost to Follow-up|156|||
17097552|NCT00113568|38236695|FG000|Overall Study|Protocol Violation|32|||
17097553|NCT00113568|38236695|FG000|Overall Study|Withdrawal by Subject|117|||
17097554|NCT00113568|38236695|FG000|Overall Study|Other|112|||
17097555|NCT00113490|38236701|FG000|Overall Study|Withdrawal by Subject|1|||
17193373|NCT02720523|38346714|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
17193374|NCT02720523|38346715|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
17193375|NCT02720523|38346709|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
17193376|NCT02720523|38346710|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
17193377|NCT02720523|38346711|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
17193378|NCT02720523|38346712|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
17193379|NCT02720523|38346713|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
17193380|NCT02720523|38346714|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
17193381|NCT02720523|38346715|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
17193382|NCT02720523|38346709|FG000|Period 1: Placebo-controlled Period|Other|0|||
17193383|NCT02720523|38346710|FG001|Period 1: Placebo-controlled Period|Other|0|||
16786300|NCT01999972|37726702|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
17012535|NCT00866814|38157283|FG000|Overall Study|No longer wished to participate|1|||
17012536|NCT00866814|38157283|FG000|Overall Study|Unable to meet follow-up requirements|2|||
17012537|NCT00866814|38157283|FG000|Overall Study|Moved to area without study site|1|||
17012538|NCT00871494|38157287|FG000|Overall Study|Protocol Violation|5|||
17012539|NCT00871494|38157287|FG000|Overall Study|Lack of Efficacy|4|||
17012540|NCT00871494|38157287|FG000|Overall Study|Adverse Event|4|||
17012541|NCT00871494|38157287|FG000|Overall Study|Lost to Follow-up|1|||
17012542|NCT00529789|38157291|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
17012543|NCT00529789|38157291|FG000|Study Period II/III|Adverse Event|3|||
17012544|NCT00529789|38157291|FG000|Study Period II/III|Lack of Efficacy|2|||
17097556|NCT00113490|38236702|FG001|Overall Study|Withdrawal by Subject|3|||
17097557|NCT00113490|38236701|FG000|Overall Study|Lost to Follow-up|1|||
17097558|NCT00113490|38236702|FG001|Overall Study|Lost to Follow-up|0|||
17012545|NCT00529789|38157291|FG000|Study Period II/III|Withdrawal by Subject|1|||
17012546|NCT00529789|38157291|FG000|Study Period II/III|Protocol Violation|3|||
17012547|NCT00529789|38157291|FG000|Study Period II/III|Physician Decision|3|||
17012548|NCT00529789|38157291|FG000|Study Period II/III|Lost to Follow-up|3|||
17012549|NCT00529789|38157291|FG000|Study Period IV|Parent/Caregiver Decision|1|||
17012550|NCT00529789|38157291|FG000|Study Period IV|Adverse Event|1|||
17012551|NCT00529789|38157291|FG000|Study Period IV|Lack of Efficacy|1|||
17012552|NCT00529789|38157291|FG000|Study Period IV|Lost to Follow-up|3|||
17012553|NCT00577642|38157301|FG000|Overall Study|Clinical Disease Progression|1|||
17012554|NCT00866658|38157307|FG000|Overall Study|Adverse Event|5|||
17012555|NCT00866658|38157308|FG001|Overall Study|Adverse Event|14|||
17097559|NCT00146640|38236710|FG000|Overall Study|Adverse Event|12|||
17097560|NCT00146640|38236711|FG001|Overall Study|Adverse Event|10|||
17097561|NCT00146640|38236710|FG000|Overall Study|Medical Reasons|3|||
17097562|NCT00146640|38236711|FG001|Overall Study|Medical Reasons|0|||
17097563|NCT00146640|38236710|FG000|Overall Study|Non-Medical Reasons|8|||
17097564|NCT00146640|38236711|FG001|Overall Study|Non-Medical Reasons|4|||
17097565|NCT03737110|38236728|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
17097566|NCT03737110|38236729|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
17097567|NCT03737110|38236730|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
17097568|NCT03737110|38236728|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
17097569|NCT03737110|38236729|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
17097570|NCT03737110|38236730|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
17097571|NCT03737110|38236728|FG000|Run-in (RI) Period|Adverse Event|4|||
17097572|NCT03737110|38236729|FG001|Run-in (RI) Period|Adverse Event|0|||
17097573|NCT03737110|38236730|FG002|Run-in (RI) Period|Adverse Event|0|||
17097574|NCT03737110|38236728|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
17097575|NCT03737110|38236729|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
17097576|NCT03737110|38236730|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
17097577|NCT03737110|38236728|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
17097578|NCT03737110|38236729|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
17097579|NCT03737110|38236730|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
17097580|NCT00146328|38236751|FG000|Overall Study|Adverse Event|39|||
17097581|NCT00146328|38236752|FG001|Overall Study|Adverse Event|48|||
17097582|NCT00146328|38236753|FG002|Overall Study|Adverse Event|79|||
17097583|NCT00146328|38236751|FG000|Overall Study|Protocol Violation|11|||
17097584|NCT00146328|38236752|FG001|Overall Study|Protocol Violation|6|||
17097585|NCT00146328|38236753|FG002|Overall Study|Protocol Violation|12|||
17097586|NCT00146328|38236751|FG000|Overall Study|Lost to Follow-up|7|||
17097587|NCT00146328|38236752|FG001|Overall Study|Lost to Follow-up|4|||
17097588|NCT00146328|38236753|FG002|Overall Study|Lost to Follow-up|7|||
17097589|NCT00146328|38236751|FG000|Overall Study|Withdrawal by Subject|16|||
17097590|NCT00146328|38236752|FG001|Overall Study|Withdrawal by Subject|16|||
17097591|NCT00146328|38236753|FG002|Overall Study|Withdrawal by Subject|22|||
17097592|NCT00146328|38236751|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
17097593|NCT00146328|38236752|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
17097594|NCT00146328|38236753|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
17097595|NCT00146328|38236751|FG000|Overall Study|Trial ended/site closed|8|||
17097596|NCT00146328|38236752|FG001|Overall Study|Trial ended/site closed|2|||
17097597|NCT00146328|38236753|FG002|Overall Study|Trial ended/site closed|19|||
17097598|NCT00146328|38236751|FG000|Overall Study|Patient decision to end|0|||
17097599|NCT00146328|38236752|FG001|Overall Study|Patient decision to end|1|||
17097600|NCT00146328|38236753|FG002|Overall Study|Patient decision to end|6|||
17097601|NCT00146328|38236751|FG000|Overall Study|Enroll into other trial|2|||
17097602|NCT00146328|38236752|FG001|Overall Study|Enroll into other trial|4|||
17097603|NCT00146328|38236753|FG002|Overall Study|Enroll into other trial|2|||
17097604|NCT00146328|38236751|FG000|Overall Study|Death|0|||
17097605|NCT00146328|38236752|FG001|Overall Study|Death|1|||
17097606|NCT00146328|38236753|FG002|Overall Study|Death|1|||
17097607|NCT00146328|38236751|FG000|Overall Study|Moved|2|||
17012556|NCT00866658|38157307|FG000|Overall Study|Lack of Efficacy|2|||
17012557|NCT00866658|38157308|FG001|Overall Study|Lack of Efficacy|1|||
17097608|NCT00146328|38236752|FG001|Overall Study|Moved|0|||
17097609|NCT00146328|38236753|FG002|Overall Study|Moved|0|||
17097610|NCT00146328|38236751|FG000|Overall Study|Interaction with other medication|2|||
17097611|NCT00146328|38236752|FG001|Overall Study|Interaction with other medication|0|||
17097612|NCT00146328|38236753|FG002|Overall Study|Interaction with other medication|1|||
17097613|NCT03733444|38236764|FG000|Overall Study|Adverse Event|8|||
17097614|NCT03733444|38236765|FG001|Overall Study|Adverse Event|10|||
17097615|NCT03733444|38236766|FG002|Overall Study|Adverse Event|5|||
17097616|NCT03733444|38236764|FG000|Overall Study|Death|20|||
17097617|NCT03733444|38236765|FG001|Overall Study|Death|19|||
17097618|NCT03733444|38236766|FG002|Overall Study|Death|11|||
17097619|NCT03733444|38236764|FG000|Overall Study|Lost to Follow-up|3|||
17097620|NCT03733444|38236765|FG001|Overall Study|Lost to Follow-up|0|||
17097621|NCT03733444|38236766|FG002|Overall Study|Lost to Follow-up|1|||
17012558|NCT00866658|38157307|FG000|Overall Study|Withdrawal by Subject|1|||
17012559|NCT00866658|38157308|FG001|Overall Study|Withdrawal by Subject|0|||
17012560|NCT00866658|38157307|FG000|Overall Study|Protocol Violation|1|||
17012561|NCT00866658|38157308|FG001|Overall Study|Protocol Violation|1|||
17012562|NCT00866658|38157307|FG000|Overall Study|Familial and Personal Reasons|4|||
17012563|NCT00866658|38157308|FG001|Overall Study|Familial and Personal Reasons|5|||
17012564|NCT03872453|38157318|FG000|Overall Study|Adverse Event|1|||
17012565|NCT03872453|38157319|FG001|Overall Study|Adverse Event|1|||
17012566|NCT03872453|38157320|FG002|Overall Study|Adverse Event|0|||
17012567|NCT03872453|38157321|FG003|Overall Study|Adverse Event|0|||
17012568|NCT03872453|38157318|FG000|Overall Study|Lost to Follow-up|8|||
17012569|NCT03872453|38157319|FG001|Overall Study|Lost to Follow-up|7|||
17012570|NCT03872453|38157320|FG002|Overall Study|Lost to Follow-up|4|||
17012571|NCT03872453|38157321|FG003|Overall Study|Lost to Follow-up|4|||
17012572|NCT03872453|38157318|FG000|Overall Study|Never Treated Migraine|19|||
17012573|NCT03872453|38157319|FG001|Overall Study|Never Treated Migraine|17|||
17012574|NCT03872453|38157320|FG002|Overall Study|Never Treated Migraine|13|||
17012575|NCT03872453|38157321|FG003|Overall Study|Never Treated Migraine|12|||
17012576|NCT03872453|38157318|FG000|Overall Study|Pregnancy|1|||
17012577|NCT03872453|38157319|FG001|Overall Study|Pregnancy|0|||
17012578|NCT03872453|38157320|FG002|Overall Study|Pregnancy|0|||
17012579|NCT03872453|38157321|FG003|Overall Study|Pregnancy|0|||
17012580|NCT03872453|38157318|FG000|Overall Study|Protocol Deviation|2|||
17012581|NCT03872453|38157319|FG001|Overall Study|Protocol Deviation|0|||
17012582|NCT03872453|38157320|FG002|Overall Study|Protocol Deviation|0|||
17012583|NCT03872453|38157321|FG003|Overall Study|Protocol Deviation|2|||
17012584|NCT03872453|38157318|FG000|Overall Study|Withdrawal by Subject|0|||
17012585|NCT03872453|38157319|FG001|Overall Study|Withdrawal by Subject|1|||
17012586|NCT03872453|38157320|FG002|Overall Study|Withdrawal by Subject|2|||
17012587|NCT03872453|38157321|FG003|Overall Study|Withdrawal by Subject|0|||
17012588|NCT03872453|38157318|FG000|Overall Study|Other Than Specified|1|||
17012589|NCT03872453|38157319|FG001|Overall Study|Other Than Specified|0|||
17012590|NCT03872453|38157320|FG002|Overall Study|Other Than Specified|0|||
17012591|NCT03872453|38157321|FG003|Overall Study|Other Than Specified|0|||
17012592|NCT00597584|38157333|FG000|Overall Study|Adverse Event|4|||
17012593|NCT00597584|38157334|FG001|Overall Study|Adverse Event|2|||
17012594|NCT00597584|38157333|FG000|Overall Study|Death|53|||
17012595|NCT00597584|38157334|FG001|Overall Study|Death|30|||
17012596|NCT00597584|38157333|FG000|Overall Study|Lack of Efficacy|1|||
17012597|NCT00597584|38157334|FG001|Overall Study|Lack of Efficacy|0|||
17012598|NCT00597584|38157333|FG000|Overall Study|Lost to Follow-up|2|||
17012599|NCT00597584|38157334|FG001|Overall Study|Lost to Follow-up|4|||
17012600|NCT00597584|38157333|FG000|Overall Study|Physician Decision|3|||
17012601|NCT00597584|38157334|FG001|Overall Study|Physician Decision|0|||
17012602|NCT00597584|38157333|FG000|Overall Study|Pregnancy|2|||
17012603|NCT00597584|38157334|FG001|Overall Study|Pregnancy|0|||
17012604|NCT00597584|38157333|FG000|Overall Study|Withdrawal by Subject|44|||
17012605|NCT00597584|38157334|FG001|Overall Study|Withdrawal by Subject|12|||
17012606|NCT00597584|38157333|FG000|Overall Study|Discontinued Dialysis|0|||
17012607|NCT00597584|38157334|FG001|Overall Study|Discontinued Dialysis|1|||
17012608|NCT00597584|38157333|FG000|Overall Study|Lost ability to consent|1|||
17012609|NCT00597584|38157334|FG001|Overall Study|Lost ability to consent|1|||
17012610|NCT00597584|38157333|FG000|Overall Study|Never dosed|1|||
17012611|NCT00597584|38157334|FG001|Overall Study|Never dosed|0|||
17012612|NCT00597584|38157333|FG000|Overall Study|Relocation|8|||
17012613|NCT00597584|38157334|FG001|Overall Study|Relocation|6|||
17012614|NCT00597584|38157333|FG000|Overall Study|Renal transplant|9|||
17012615|NCT00597584|38157334|FG001|Overall Study|Renal transplant|7|||
17012616|NCT00529633|38157342|FG000|Overall Study|Withdrawal by Subject|1|||
17012617|NCT00529633|38157343|FG001|Overall Study|Withdrawal by Subject|1|||
17012618|NCT00530335|38157349|FG000|Overall Study|Adverse Event|3|||
17012619|NCT00530335|38157349|FG000|Overall Study|Protocol Violation|1|||
17012620|NCT00530335|38157349|FG000|Overall Study|Withdrawal by Subject|1|||
17012621|NCT00530335|38157349|FG000|Overall Study|Physician Decision|1|||
17012622|NCT00712270|38157356|FG000|Overall Study|Withdrawal by Subject|11|||
17012623|NCT00712270|38157356|FG000|Overall Study|Screen Failure|3|||
17012624|NCT00530257|38157382|FG000|Overall Study|Lost to Follow-up|1|||
17012625|NCT00869778|38157392|FG000|Overall Study|Adverse Event|2|||
17012626|NCT00869778|38157393|FG001|Overall Study|Adverse Event|0|||
17012627|NCT00869778|38157394|FG002|Overall Study|Adverse Event|0|||
17012628|NCT00869778|38157392|FG000|Overall Study|Withdrawal by Subject|3|||
17097622|NCT03733444|38236764|FG000|Overall Study|Lack of Efficacy|0|||
17012629|NCT00869778|38157393|FG001|Overall Study|Withdrawal by Subject|4|||
17012630|NCT00869778|38157394|FG002|Overall Study|Withdrawal by Subject|5|||
17012631|NCT00869778|38157392|FG000|Overall Study|Pregnancy|1|||
17012632|NCT00869778|38157393|FG001|Overall Study|Pregnancy|0|||
17012633|NCT00869778|38157394|FG002|Overall Study|Pregnancy|0|||
17012634|NCT00869778|38157392|FG000|Overall Study|Protocol Violation|5|||
17012635|NCT00869778|38157393|FG001|Overall Study|Protocol Violation|3|||
17097623|NCT03733444|38236765|FG001|Overall Study|Lack of Efficacy|1|||
17012636|NCT00869778|38157394|FG002|Overall Study|Protocol Violation|5|||
17012637|NCT00869778|38157392|FG000|Overall Study|Unblinding|1|||
17012638|NCT00869778|38157393|FG001|Overall Study|Unblinding|0|||
17012639|NCT00869778|38157394|FG002|Overall Study|Unblinding|0|||
17012640|NCT00711958|38157425|FG000|Overall Study|Withdrawal by Subject|6|||
17012641|NCT00711958|38157426|FG001|Overall Study|Withdrawal by Subject|8|||
17012642|NCT00711958|38157425|FG000|Overall Study|Lack of Efficacy|3|||
17012643|NCT00711958|38157426|FG001|Overall Study|Lack of Efficacy|1|||
17012644|NCT00711958|38157425|FG000|Overall Study|Clinical deterioration|1|||
17012645|NCT00711958|38157426|FG001|Overall Study|Clinical deterioration|0|||
17012646|NCT00711958|38157425|FG000|Overall Study|Adverse Event|9|||
17012647|NCT00711958|38157426|FG001|Overall Study|Adverse Event|7|||
17012648|NCT00711958|38157425|FG000|Overall Study|Protocol Violation|1|||
17012649|NCT00711958|38157426|FG001|Overall Study|Protocol Violation|0|||
17012650|NCT00711958|38157425|FG000|Overall Study|Lost to Follow-up|2|||
17012651|NCT00711958|38157426|FG001|Overall Study|Lost to Follow-up|2|||
17012652|NCT00711958|38157425|FG000|Overall Study|Death|10|||
17012653|NCT00711958|38157426|FG001|Overall Study|Death|5|||
17012654|NCT00711958|38157425|FG000|Overall Study|Progression of disease|1|||
17012655|NCT00711958|38157426|FG001|Overall Study|Progression of disease|0|||
17012656|NCT00711880|38157434|FG000|Overall Study|Adverse Event|11|||
17012657|NCT00711880|38157435|FG001|Overall Study|Adverse Event|2|||
17012658|NCT00711880|38157434|FG000|Overall Study|Patient non-compliance|1|||
17012659|NCT00711880|38157435|FG001|Overall Study|Patient non-compliance|0|||
17012660|NCT00711880|38157434|FG000|Overall Study|Lack of Efficacy|1|||
17012661|NCT00711880|38157435|FG001|Overall Study|Lack of Efficacy|5|||
17012662|NCT00528775|38157441|FG000|Overall Study|Other not specified|1|||
17012663|NCT00853047|38157450|FG000|Core Phase|Participant Request|0|||
17012664|NCT00853047|38157451|FG001|Core Phase|Participant Request|0|||
17012665|NCT00853047|38157452|FG002|Core Phase|Participant Request|0|||
17012666|NCT00853047|38157453|FG003|Core Phase|Participant Request|1|||
17012667|NCT00853047|38157454|FG004|Core Phase|Participant Request|0|||
17012668|NCT00853047|38157455|FG005|Core Phase|Participant Request|0|||
17012669|NCT00853047|38157450|FG000|Open-Label Extension Phase|Participant Request|0|||
17012670|NCT00853047|38157451|FG001|Open-Label Extension Phase|Participant Request|0|||
17012671|NCT00853047|38157452|FG002|Open-Label Extension Phase|Participant Request|0|||
17012672|NCT00853047|38157453|FG003|Open-Label Extension Phase|Participant Request|0|||
17012673|NCT00853047|38157454|FG004|Open-Label Extension Phase|Participant Request|0|||
17012674|NCT00853047|38157455|FG005|Open-Label Extension Phase|Participant Request|7|||
17012675|NCT00853047|38157450|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
17012676|NCT00853047|38157451|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
17012677|NCT00853047|38157452|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
17012678|NCT00853047|38157453|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
17012679|NCT00853047|38157454|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
17012680|NCT00853047|38157455|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
17012681|NCT00853047|38157450|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
17012682|NCT00853047|38157451|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
17012683|NCT00853047|38157452|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
17012684|NCT00853047|38157453|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
16786301|NCT01999972|37726703|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
16786302|NCT01999972|37726704|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
16786303|NCT01999972|37726705|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
16786304|NCT01999972|37726700|FG000|Dose Expansion Part|Changed to standard of care|0|||
16786305|NCT01999972|37726701|FG001|Dose Expansion Part|Changed to standard of care|0|||
16786306|NCT01999972|37726702|FG002|Dose Expansion Part|Changed to standard of care|0|||
16786307|NCT01999972|37726703|FG003|Dose Expansion Part|Changed to standard of care|0|||
16786308|NCT01999972|37726704|FG004|Dose Expansion Part|Changed to standard of care|1|||
16786309|NCT01999972|37726705|FG005|Dose Expansion Part|Changed to standard of care|0|||
16786310|NCT01999894|37726721|FG000|Overall Study|Adverse Event|9|||
16786311|NCT01999894|37726721|FG000|Overall Study|Lack of Efficacy|5|||
16786312|NCT01999894|37726721|FG000|Overall Study|Protocol Violation|1|||
16786313|NCT01999894|37726721|FG000|Overall Study|Withdrawal by Subject|7|||
16786314|NCT01999894|37726721|FG000|Overall Study|Lost to Follow-up|10|||
17012685|NCT00853047|38157454|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
17012686|NCT00853047|38157455|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
17012687|NCT00853047|38157450|FG000|Open-Label Extension Phase|Investigator Decision|0|||
17012688|NCT00853047|38157451|FG001|Open-Label Extension Phase|Investigator Decision|0|||
17012689|NCT00853047|38157452|FG002|Open-Label Extension Phase|Investigator Decision|0|||
17012690|NCT00853047|38157453|FG003|Open-Label Extension Phase|Investigator Decision|0|||
17012691|NCT00853047|38157454|FG004|Open-Label Extension Phase|Investigator Decision|0|||
17012692|NCT00853047|38157455|FG005|Open-Label Extension Phase|Investigator Decision|1|||
17012693|NCT00853047|38157450|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
17012694|NCT00853047|38157451|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
17012695|NCT00853047|38157452|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
17012696|NCT00853047|38157453|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
17012697|NCT00853047|38157454|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
17012698|NCT00853047|38157455|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
17012699|NCT00529399|38157473|FG000|Overall Study|Lost to Follow-up|1|||
17012700|NCT00529399|38157474|FG001|Overall Study|Lost to Follow-up|0|||
17012701|NCT00529399|38157475|FG002|Overall Study|Lost to Follow-up|1|||
17012702|NCT00529399|38157473|FG000|Overall Study|Withdrawal by Subject|1|||
17012703|NCT00529399|38157474|FG001|Overall Study|Withdrawal by Subject|0|||
17012704|NCT00529399|38157475|FG002|Overall Study|Withdrawal by Subject|1|||
17012705|NCT00529399|38157473|FG000|Overall Study|Non-compliant|0|||
17012706|NCT00529399|38157474|FG001|Overall Study|Non-compliant|1|||
17012707|NCT00529399|38157475|FG002|Overall Study|Non-compliant|0|||
17012708|NCT00852969|38157485|FG000|Overall Study|Adverse Event|0|||
17012709|NCT00852969|38157486|FG001|Overall Study|Adverse Event|1|||
17012710|NCT00852969|38157485|FG000|Overall Study|Lost to Follow-up|0|||
17012711|NCT00852969|38157486|FG001|Overall Study|Lost to Follow-up|1|||
17012712|NCT03870997|38157498|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
17012713|NCT03870997|38157499|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
17012714|NCT03870997|38157500|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
17012715|NCT03870997|38157501|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
17012716|NCT03870997|38157502|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
17012717|NCT03870997|38157503|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
17012718|NCT00521365|38157512|FG000|Overall Study|Adverse Event|3|||
17012719|NCT00521365|38157512|FG000|Overall Study|Lost to Follow-up|6|||
17012720|NCT00521365|38157512|FG000|Overall Study|Protocol deviation|2|||
17012721|NCT00521365|38157512|FG000|Overall Study|Drug compliance|3|||
17012722|NCT00521365|38157512|FG000|Overall Study|Usage of not allowed drugs|6|||
17012723|NCT00711802|38157524|FG000|Overall Study|Not treated (no further detail)|2|||
17012724|NCT00711802|38157525|FG001|Overall Study|Not treated (no further detail)|1|||
17012725|NCT00711802|38157526|FG002|Overall Study|Not treated (no further detail)|2|||
17012726|NCT00711802|38157527|FG003|Overall Study|Not treated (no further detail)|0|||
17012727|NCT00711802|38157528|FG004|Overall Study|Not treated (no further detail)|2|||
17012728|NCT00711802|38157529|FG005|Overall Study|Not treated (no further detail)|0|||
17012729|NCT00711802|38157530|FG006|Overall Study|Not treated (no further detail)|0|||
17012730|NCT00711802|38157531|FG007|Overall Study|Not treated (no further detail)|0|||
17012731|NCT00711802|38157524|FG000|Overall Study|Adverse Event|0|||
17012732|NCT00711802|38157525|FG001|Overall Study|Adverse Event|0|||
17012733|NCT00711802|38157526|FG002|Overall Study|Adverse Event|0|||
17012734|NCT00711802|38157527|FG003|Overall Study|Adverse Event|0|||
17012735|NCT00711802|38157528|FG004|Overall Study|Adverse Event|1|||
17012736|NCT00711802|38157529|FG005|Overall Study|Adverse Event|1|||
17012737|NCT00711802|38157530|FG006|Overall Study|Adverse Event|0|||
17012738|NCT00711802|38157531|FG007|Overall Study|Adverse Event|0|||
17012739|NCT00711802|38157524|FG000|Overall Study|Microbiological failure|0|||
17012740|NCT00711802|38157525|FG001|Overall Study|Microbiological failure|1|||
17012741|NCT00711802|38157526|FG002|Overall Study|Microbiological failure|0|||
17012742|NCT00711802|38157527|FG003|Overall Study|Microbiological failure|0|||
17012743|NCT00711802|38157528|FG004|Overall Study|Microbiological failure|0|||
17012744|NCT00711802|38157529|FG005|Overall Study|Microbiological failure|1|||
17012745|NCT00711802|38157530|FG006|Overall Study|Microbiological failure|0|||
17012746|NCT00711802|38157531|FG007|Overall Study|Microbiological failure|0|||
17012747|NCT00711802|38157524|FG000|Overall Study|Protocol Violation|0|||
17012748|NCT00711802|38157525|FG001|Overall Study|Protocol Violation|0|||
17012749|NCT00711802|38157526|FG002|Overall Study|Protocol Violation|0|||
17012750|NCT00711802|38157527|FG003|Overall Study|Protocol Violation|1|||
17012751|NCT00711802|38157528|FG004|Overall Study|Protocol Violation|0|||
17012752|NCT00711802|38157529|FG005|Overall Study|Protocol Violation|0|||
17012753|NCT00711802|38157530|FG006|Overall Study|Protocol Violation|0|||
17012754|NCT00711802|38157531|FG007|Overall Study|Protocol Violation|0|||
17012755|NCT00711802|38157524|FG000|Overall Study|Physician Decision|0|||
17012756|NCT00711802|38157525|FG001|Overall Study|Physician Decision|2|||
17012757|NCT00711802|38157526|FG002|Overall Study|Physician Decision|0|||
17012758|NCT00711802|38157527|FG003|Overall Study|Physician Decision|0|||
17012759|NCT00711802|38157528|FG004|Overall Study|Physician Decision|0|||
17012760|NCT00711802|38157529|FG005|Overall Study|Physician Decision|0|||
17012761|NCT00711802|38157530|FG006|Overall Study|Physician Decision|0|||
17012762|NCT00711802|38157531|FG007|Overall Study|Physician Decision|0|||
17012763|NCT00711802|38157524|FG000|Overall Study|Withdrawal by Subject|0|||
17012764|NCT00711802|38157525|FG001|Overall Study|Withdrawal by Subject|1|||
17012765|NCT00711802|38157526|FG002|Overall Study|Withdrawal by Subject|0|||
17012766|NCT00711802|38157527|FG003|Overall Study|Withdrawal by Subject|1|||
17012767|NCT00711802|38157528|FG004|Overall Study|Withdrawal by Subject|0|||
17012768|NCT00711802|38157529|FG005|Overall Study|Withdrawal by Subject|0|||
17097624|NCT03733444|38236766|FG002|Overall Study|Lack of Efficacy|1|||
17012769|NCT00711802|38157530|FG006|Overall Study|Withdrawal by Subject|0|||
17012770|NCT00711802|38157531|FG007|Overall Study|Withdrawal by Subject|0|||
17012771|NCT00711802|38157524|FG000|Overall Study|Lost to Follow-up|0|||
17097625|NCT03733444|38236764|FG000|Overall Study|Physician Decision|2|||
17012772|NCT00711802|38157525|FG001|Overall Study|Lost to Follow-up|0|||
17012773|NCT00711802|38157526|FG002|Overall Study|Lost to Follow-up|3|||
17012774|NCT00711802|38157527|FG003|Overall Study|Lost to Follow-up|1|||
17012775|NCT00711802|38157528|FG004|Overall Study|Lost to Follow-up|10|||
17012776|NCT00711802|38157529|FG005|Overall Study|Lost to Follow-up|6|||
17012777|NCT00711802|38157530|FG006|Overall Study|Lost to Follow-up|4|||
17012778|NCT00711802|38157531|FG007|Overall Study|Lost to Follow-up|2|||
17012779|NCT00711802|38157524|FG000|Overall Study|Reason not reported|0|||
17012780|NCT00711802|38157525|FG001|Overall Study|Reason not reported|1|||
17012781|NCT00711802|38157526|FG002|Overall Study|Reason not reported|1|||
17012782|NCT00711802|38157527|FG003|Overall Study|Reason not reported|0|||
17012783|NCT00711802|38157528|FG004|Overall Study|Reason not reported|1|||
17012784|NCT00711802|38157529|FG005|Overall Study|Reason not reported|0|||
17012785|NCT00711802|38157530|FG006|Overall Study|Reason not reported|1|||
17012786|NCT00711802|38157531|FG007|Overall Study|Reason not reported|0|||
17012787|NCT00851877|38157552|FG000|Phase I-1|Death|1|||
17012788|NCT00851877|38157553|FG001|Phase I-1|Death|0|||
17012789|NCT00851877|38157554|FG002|Phase I-1|Death|0|||
17012790|NCT00851877|38157552|FG000|Phase II|Withdrawal by Subject|0|||
17012791|NCT00851877|38157553|FG001|Phase II|Withdrawal by Subject|0|||
17012792|NCT00851877|38157554|FG002|Phase II|Withdrawal by Subject|3|||
17012793|NCT00882908|38157565|FG000|Overall Study|Adverse Event|0|||
17012794|NCT00882908|38157566|FG001|Overall Study|Adverse Event|0|||
17012795|NCT00882908|38157567|FG002|Overall Study|Adverse Event|1|||
17012796|NCT00882908|38157568|FG003|Overall Study|Adverse Event|0|||
17012797|NCT00882908|38157569|FG004|Overall Study|Adverse Event|1|||
17012798|NCT00882908|38157565|FG000|Overall Study|Lost to Follow-up|3|||
17012799|NCT00882908|38157566|FG001|Overall Study|Lost to Follow-up|5|||
17012800|NCT00882908|38157567|FG002|Overall Study|Lost to Follow-up|3|||
17012801|NCT00882908|38157568|FG003|Overall Study|Lost to Follow-up|1|||
17012802|NCT00882908|38157569|FG004|Overall Study|Lost to Follow-up|2|||
17012803|NCT00882908|38157565|FG000|Overall Study|Protocol Violation|0|||
17012804|NCT00882908|38157566|FG001|Overall Study|Protocol Violation|1|||
17012805|NCT00882908|38157567|FG002|Overall Study|Protocol Violation|0|||
17012806|NCT00882908|38157568|FG003|Overall Study|Protocol Violation|0|||
17012807|NCT00882908|38157569|FG004|Overall Study|Protocol Violation|0|||
17012808|NCT00882908|38157565|FG000|Overall Study|Withdrawal by Subject|0|||
17012809|NCT00882908|38157566|FG001|Overall Study|Withdrawal by Subject|0|||
17012810|NCT00882908|38157567|FG002|Overall Study|Withdrawal by Subject|3|||
17012811|NCT00882908|38157568|FG003|Overall Study|Withdrawal by Subject|5|||
17012812|NCT00882908|38157569|FG004|Overall Study|Withdrawal by Subject|2|||
17012813|NCT00882908|38157565|FG000|Overall Study|Subject reached a virologic endpoint|0|||
17012814|NCT00882908|38157566|FG001|Overall Study|Subject reached a virologic endpoint|0|||
17012815|NCT00882908|38157567|FG002|Overall Study|Subject reached a virologic endpoint|0|||
17012816|NCT00882908|38157568|FG003|Overall Study|Subject reached a virologic endpoint|0|||
17012817|NCT00882908|38157569|FG004|Overall Study|Subject reached a virologic endpoint|1|||
17012818|NCT00882908|38157565|FG000|Overall Study|Study terminated in error|0|||
17012819|NCT00882908|38157566|FG001|Overall Study|Study terminated in error|0|||
17012820|NCT00882908|38157567|FG002|Overall Study|Study terminated in error|0|||
17012821|NCT00882908|38157568|FG003|Overall Study|Study terminated in error|1|||
17012822|NCT00882908|38157569|FG004|Overall Study|Study terminated in error|0|||
17012823|NCT00851799|38157585|FG000|Overall Study|Death|1|||
17012824|NCT00851799|38157586|FG001|Overall Study|Death|0|||
17012825|NCT00851799|38157587|FG002|Overall Study|Death|1|||
17012826|NCT00851799|38157585|FG000|Overall Study|Lost to Follow-up|5|||
17012827|NCT00851799|38157586|FG001|Overall Study|Lost to Follow-up|3|||
17012828|NCT00851799|38157587|FG002|Overall Study|Lost to Follow-up|10|||
17012829|NCT00851799|38157585|FG000|Overall Study|Not able to get to clinic|8|||
17012830|NCT00851799|38157586|FG001|Overall Study|Not able to get to clinic|5|||
17012831|NCT00851799|38157587|FG002|Overall Study|Not able to get to clinic|9|||
17012832|NCT00851799|38157585|FG000|Overall Study|Not willing to adhere to requirements|1|||
17012833|NCT00851799|38157586|FG001|Overall Study|Not willing to adhere to requirements|2|||
17012834|NCT00851799|38157587|FG002|Overall Study|Not willing to adhere to requirements|2|||
17097626|NCT03733444|38236765|FG001|Overall Study|Physician Decision|1|||
17097627|NCT03733444|38236766|FG002|Overall Study|Physician Decision|0|||
17097628|NCT03733444|38236764|FG000|Overall Study|Protocol Violation|2|||
17097629|NCT03733444|38236765|FG001|Overall Study|Protocol Violation|1|||
17097630|NCT03733444|38236766|FG002|Overall Study|Protocol Violation|0|||
17097631|NCT03733444|38236764|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
17012835|NCT00851799|38157585|FG000|Overall Study|Withdrew consent prior study completion|1|||
17012836|NCT00851799|38157586|FG001|Overall Study|Withdrew consent prior study completion|2|||
17012837|NCT00851799|38157587|FG002|Overall Study|Withdrew consent prior study completion|1|||
17012838|NCT00851799|38157585|FG000|Overall Study|Severe Debilitation|0|||
17097632|NCT03733444|38236765|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
17097633|NCT03733444|38236766|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
17012839|NCT00851799|38157586|FG001|Overall Study|Severe Debilitation|1|||
17097634|NCT03733444|38236764|FG000|Overall Study|Study Terminated by Sponsor|203|||
17012840|NCT00851799|38157587|FG002|Overall Study|Severe Debilitation|0|||
17012841|NCT00851799|38157585|FG000|Overall Study|Completed protocol due to pregnancy|0|||
17012842|NCT00851799|38157586|FG001|Overall Study|Completed protocol due to pregnancy|0|||
17012843|NCT00851799|38157587|FG002|Overall Study|Completed protocol due to pregnancy|1|||
17012844|NCT00521053|38157595|FG000|Observation Phase|Disease Progression|55|||
17012845|NCT00521053|38157595|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
17012846|NCT00521053|38157595|FG000|Observation Phase|Death|2|||
17012847|NCT00521053|38157595|FG000|Observation Phase|Adverse Event|1|||
17012848|NCT00521053|38157595|FG000|Observation Phase|Other non-study melanoma treatment|1|||
17012849|NCT00521053|38157595|FG000|Observation Phase|Physician Decision|1|||
17012850|NCT00711646|38157604|FG000|Overall Study|Adverse Event|6|||
17012851|NCT00711646|38157605|FG001|Overall Study|Adverse Event|1|||
17012852|NCT00711646|38157604|FG000|Overall Study|Withdrawal by Subject|4|||
17012853|NCT00711646|38157605|FG001|Overall Study|Withdrawal by Subject|0|||
17012854|NCT00711646|38157604|FG000|Overall Study|Protocol Violation|0|||
17012855|NCT00711646|38157605|FG001|Overall Study|Protocol Violation|1|||
17012856|NCT00711646|38157604|FG000|Overall Study|Lost to Follow-up|1|||
17012857|NCT00711646|38157605|FG001|Overall Study|Lost to Follow-up|0|||
17012858|NCT00711646|38157604|FG000|Overall Study|administrative decision|0|||
17012859|NCT00711646|38157605|FG001|Overall Study|administrative decision|1|||
17012860|NCT00711646|38157604|FG000|Overall Study|patient non-compliance|1|||
17012861|NCT00711646|38157605|FG001|Overall Study|patient non-compliance|0|||
17097635|NCT03733444|38236765|FG001|Overall Study|Study Terminated by Sponsor|209|||
17097636|NCT03733444|38236766|FG002|Overall Study|Study Terminated by Sponsor|221|||
17097637|NCT03733444|38236764|FG000|Overall Study|Withdrawal by Subject|19|||
17097638|NCT03733444|38236765|FG001|Overall Study|Withdrawal by Subject|18|||
17097639|NCT03733444|38236766|FG002|Overall Study|Withdrawal by Subject|16|||
17097640|NCT03733444|38236764|FG000|Overall Study|Miscellaneous|1|||
17097641|NCT03733444|38236765|FG001|Overall Study|Miscellaneous|0|||
17097642|NCT03733444|38236766|FG002|Overall Study|Miscellaneous|1|||
17097643|NCT03733444|38236764|FG000|Overall Study|Not Treated|1|||
17097644|NCT03733444|38236765|FG001|Overall Study|Not Treated|2|||
17097645|NCT03733444|38236766|FG002|Overall Study|Not Treated|1|||
17097646|NCT03731182|38236786|FG000|Overall Study|Lost to Follow-up|2|||
17097647|NCT03731182|38236787|FG001|Overall Study|Lost to Follow-up|0|||
17097648|NCT03731182|38236786|FG000|Overall Study|Physician Decision|1|||
17097649|NCT03731182|38236787|FG001|Overall Study|Physician Decision|0|||
17097650|NCT03731182|38236786|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
17097651|NCT03731182|38236787|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
17097652|NCT03730012|38236796|FG000|Overall Study|Adverse Event|0|||
17097653|NCT03730012|38236797|FG001|Overall Study|Adverse Event|1|||
17097654|NCT03730012|38236796|FG000|Overall Study|Lack of Efficacy|1|||
17012862|NCT00520975|38157613|FG000|Overall Study|Disease progression|31|||
17012863|NCT00520975|38157614|FG001|Overall Study|Disease progression|23|||
17012864|NCT00520975|38157613|FG000|Overall Study|Adverse Event|7|||
17012865|NCT00520975|38157614|FG001|Overall Study|Adverse Event|10|||
17012866|NCT00520975|38157613|FG000|Overall Study|Death|0|||
17012867|NCT00520975|38157614|FG001|Overall Study|Death|2|||
17012868|NCT00520975|38157613|FG000|Overall Study|Withdrawal by Subject|3|||
17012869|NCT00520975|38157614|FG001|Overall Study|Withdrawal by Subject|5|||
17012870|NCT00520975|38157613|FG000|Overall Study|Other therapy|2|||
17012871|NCT00520975|38157614|FG001|Overall Study|Other therapy|4|||
17012872|NCT00520975|38157613|FG000|Overall Study|Other reasons|4|||
17012873|NCT00520975|38157614|FG001|Overall Study|Other reasons|2|||
17012874|NCT00520975|38157613|FG000|Overall Study|Not start protocol therapy|1|||
17012875|NCT00520975|38157614|FG001|Overall Study|Not start protocol therapy|2|||
17097655|NCT03730012|38236797|FG001|Overall Study|Lack of Efficacy|5|||
17097656|NCT03730012|38236796|FG000|Overall Study|Withdrawal by Subject|0|||
17097657|NCT03730012|38236797|FG001|Overall Study|Withdrawal by Subject|1|||
17097658|NCT03730012|38236796|FG000|Overall Study|Miscellaneous|2|||
17097659|NCT03730012|38236797|FG001|Overall Study|Miscellaneous|1|||
17097660|NCT03728140|38236808|FG000|Overall Study|Abnormal embryo transfer operation|10|||
17097661|NCT03728140|38236809|FG001|Overall Study|Abnormal embryo transfer operation|7|||
17097662|NCT03725722|38236834|FG000|Overall Study|Lack of Efficacy|2|||
17097663|NCT03725722|38236835|FG001|Overall Study|Lack of Efficacy|1|||
17097664|NCT03725722|38236836|FG002|Overall Study|Lack of Efficacy|2|||
17097665|NCT03725722|38236837|FG003|Overall Study|Lack of Efficacy|0|||
17097666|NCT03725722|38236838|FG004|Overall Study|Lack of Efficacy|2|||
16786315|NCT01999894|37726721|FG000|Overall Study|Other Reason|3|||
17012876|NCT00851721|38157622|FG000|Overall Study|planned surgery|1|||
17012877|NCT00851721|38157623|FG001|Overall Study|planned surgery|0|||
17012878|NCT00851721|38157622|FG000|Overall Study|Death|1|||
17097667|NCT03725722|38236834|FG000|Overall Study|Adverse Event|2|||
17097668|NCT03725722|38236835|FG001|Overall Study|Adverse Event|2|||
17097669|NCT03725722|38236836|FG002|Overall Study|Adverse Event|1|||
17097670|NCT03725722|38236837|FG003|Overall Study|Adverse Event|0|||
17097671|NCT03725722|38236838|FG004|Overall Study|Adverse Event|6|||
17097672|NCT03725722|38236834|FG000|Overall Study|Withdrawal by Subject|4|||
17097673|NCT03725722|38236835|FG001|Overall Study|Withdrawal by Subject|1|||
17097674|NCT03725722|38236836|FG002|Overall Study|Withdrawal by Subject|0|||
17097675|NCT03725722|38236837|FG003|Overall Study|Withdrawal by Subject|4|||
17097676|NCT03725722|38236838|FG004|Overall Study|Withdrawal by Subject|4|||
17097677|NCT03725722|38236834|FG000|Overall Study|Lost to Follow-up|3|||
17097678|NCT03725722|38236835|FG001|Overall Study|Lost to Follow-up|1|||
17097679|NCT03725722|38236836|FG002|Overall Study|Lost to Follow-up|2|||
17097680|NCT03725722|38236837|FG003|Overall Study|Lost to Follow-up|2|||
17097681|NCT03725722|38236838|FG004|Overall Study|Lost to Follow-up|1|||
17097682|NCT03725722|38236834|FG000|Overall Study|Personal reasons|0|||
17097683|NCT03725722|38236835|FG001|Overall Study|Personal reasons|0|||
17097684|NCT03725722|38236836|FG002|Overall Study|Personal reasons|1|||
17097685|NCT03725722|38236837|FG003|Overall Study|Personal reasons|0|||
17097686|NCT03725722|38236838|FG004|Overall Study|Personal reasons|1|||
17097687|NCT03725722|38236834|FG000|Overall Study|COVID-19 situation|0|||
17097688|NCT03725722|38236835|FG001|Overall Study|COVID-19 situation|1|||
17097689|NCT03725722|38236836|FG002|Overall Study|COVID-19 situation|0|||
17097690|NCT03725722|38236837|FG003|Overall Study|COVID-19 situation|0|||
17097691|NCT03725722|38236838|FG004|Overall Study|COVID-19 situation|0|||
17097692|NCT02966314|38236852|FG000|Overall Study|Lost to Follow-up|1|||
17097693|NCT02966314|38236853|FG001|Overall Study|Lost to Follow-up|0|||
17097694|NCT03723070|38236859|FG000|Overall Study|Lost to Follow-up|2|||
17012879|NCT00851721|38157623|FG001|Overall Study|Death|0|||
17012880|NCT00851721|38157622|FG000|Overall Study|Adverse Event|0|||
17012881|NCT00851721|38157623|FG001|Overall Study|Adverse Event|1|||
17012882|NCT00520741|38157637|FG000|Overall Study|Adverse Event|16|||
17012883|NCT00520741|38157638|FG001|Overall Study|Adverse Event|56|||
17012884|NCT00520741|38157637|FG000|Overall Study|Lack of Efficacy|11|||
17012885|NCT00520741|38157638|FG001|Overall Study|Lack of Efficacy|30|||
17012886|NCT00520741|38157637|FG000|Overall Study|Withdrawal by Subject|0|||
17012887|NCT00520741|38157638|FG001|Overall Study|Withdrawal by Subject|11|||
17012888|NCT00520741|38157637|FG000|Overall Study|Protocol Violation|2|||
17012889|NCT00520741|38157638|FG001|Overall Study|Protocol Violation|15|||
17012890|NCT00520741|38157637|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
17012891|NCT00520741|38157638|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
17012892|NCT00520741|38157637|FG000|Overall Study|Lost to Follow-up|4|||
17012893|NCT00520741|38157638|FG001|Overall Study|Lost to Follow-up|4|||
17012894|NCT00520741|38157637|FG000|Overall Study|Other reasons for premature termination|0|||
17012895|NCT00520741|38157638|FG001|Overall Study|Other reasons for premature termination|6|||
17012896|NCT00882518|38157648|FG000|Overall Study|Adverse Event|9|||
17012897|NCT00882518|38157649|FG001|Overall Study|Adverse Event|18|||
17012898|NCT00882518|38157648|FG000|Overall Study|Withdrawal by Subject|9|||
17012899|NCT00882518|38157649|FG001|Overall Study|Withdrawal by Subject|13|||
17012900|NCT00882518|38157648|FG000|Overall Study|Lack of Efficacy|12|||
17012901|NCT00882518|38157649|FG001|Overall Study|Lack of Efficacy|9|||
17012902|NCT00882518|38157648|FG000|Overall Study|Severe non-compliance to protocol|3|||
17012903|NCT00882518|38157649|FG001|Overall Study|Severe non-compliance to protocol|1|||
17012904|NCT00882518|38157648|FG000|Overall Study|Incorrect enrolment|4|||
17097695|NCT03723070|38236859|FG000|Overall Study|Physician Decision|1|||
17097696|NCT03723070|38236859|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
17097697|NCT03722524|38236867|FG000|Overall Study|Protocol Violation|86|||
17097698|NCT03722524|38236867|FG000|Overall Study|Adverse Event|7|||
17097699|NCT03722524|38236867|FG000|Overall Study|Lost to Follow-up|1|||
17097700|NCT03722524|38236867|FG000|Overall Study|Reason is not stated|1|||
17012905|NCT00882518|38157649|FG001|Overall Study|Incorrect enrolment|2|||
17012906|NCT00882518|38157648|FG000|Overall Study|Central lab closure for National day|1|||
17097701|NCT03722524|38236867|FG000|Overall Study|Physician Decision|1|||
17097702|NCT03722524|38236867|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
17097703|NCT03722446|38236873|FG000|Overall Study|Protocol Violation|15|||
17097704|NCT03722446|38236874|FG001|Overall Study|Protocol Violation|2|||
17097705|NCT00146172|38236888|FG000|Overall Study|Adverse Event|0|||
17097706|NCT00146172|38236889|FG001|Overall Study|Adverse Event|0|||
17193384|NCT02720523|38346711|FG002|Period 1: Placebo-controlled Period|Other|1|||
17193385|NCT02720523|38346712|FG003|Period 1: Placebo-controlled Period|Other|1|||
17193386|NCT02720523|38346713|FG004|Period 1: Placebo-controlled Period|Other|0|||
17193387|NCT02720523|38346714|FG005|Period 1: Placebo-controlled Period|Other|0|||
17193388|NCT02720523|38346715|FG006|Period 1: Placebo-controlled Period|Other|0|||
17193389|NCT02720523|38346709|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
17193390|NCT02720523|38346710|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
17193391|NCT02720523|38346711|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
17012907|NCT00882518|38157649|FG001|Overall Study|Central lab closure for National day|0|||
17012908|NCT00882518|38157648|FG000|Overall Study|Allocating random number by mistake|0|||
17012909|NCT00882518|38157649|FG001|Overall Study|Allocating random number by mistake|1|||
17097707|NCT00146172|38236890|FG002|Overall Study|Adverse Event|1|||
17097708|NCT00146172|38236891|FG003|Overall Study|Adverse Event|1|||
17097709|NCT00146172|38236892|FG004|Overall Study|Adverse Event|0|||
17097710|NCT00146172|38236893|FG005|Overall Study|Adverse Event|2|||
17097711|NCT00146172|38236894|FG006|Overall Study|Adverse Event|3|||
17097712|NCT00146172|38236895|FG007|Overall Study|Adverse Event|10|||
17097713|NCT00146172|38236888|FG000|Overall Study|Lost to Follow-up|0|||
17097714|NCT00146172|38236889|FG001|Overall Study|Lost to Follow-up|0|||
17097715|NCT00146172|38236890|FG002|Overall Study|Lost to Follow-up|0|||
17097716|NCT00146172|38236891|FG003|Overall Study|Lost to Follow-up|0|||
17097717|NCT00146172|38236892|FG004|Overall Study|Lost to Follow-up|0|||
17097718|NCT00146172|38236893|FG005|Overall Study|Lost to Follow-up|0|||
17097719|NCT00146172|38236894|FG006|Overall Study|Lost to Follow-up|0|||
17097720|NCT00146172|38236895|FG007|Overall Study|Lost to Follow-up|1|||
17097721|NCT00146172|38236888|FG000|Overall Study|Disease Progression|2|||
17097722|NCT00146172|38236889|FG001|Overall Study|Disease Progression|4|||
17097723|NCT00146172|38236890|FG002|Overall Study|Disease Progression|2|||
17097724|NCT00146172|38236891|FG003|Overall Study|Disease Progression|5|||
17097725|NCT00146172|38236892|FG004|Overall Study|Disease Progression|2|||
17097726|NCT00146172|38236893|FG005|Overall Study|Disease Progression|2|||
17097727|NCT00146172|38236894|FG006|Overall Study|Disease Progression|1|||
17097728|NCT00146172|38236895|FG007|Overall Study|Disease Progression|22|||
17097729|NCT00146172|38236888|FG000|Overall Study|Death|0|||
17097730|NCT00146172|38236889|FG001|Overall Study|Death|0|||
17012910|NCT00882362|38157666|FG000|Overall Study|Adverse Event|13|||
17012911|NCT00882362|38157667|FG001|Overall Study|Adverse Event|10|||
17012912|NCT00882362|38157666|FG000|Overall Study|Withdrawal by Subject|13|||
17012913|NCT00882362|38157667|FG001|Overall Study|Withdrawal by Subject|10|||
17012914|NCT00882362|38157666|FG000|Overall Study|Lack of Efficacy|3|||
17012915|NCT00882362|38157667|FG001|Overall Study|Lack of Efficacy|0|||
17012916|NCT00882362|38157666|FG000|Overall Study|Protocol Violation|7|||
17012917|NCT00882362|38157667|FG001|Overall Study|Protocol Violation|2|||
17012918|NCT00882362|38157666|FG000|Overall Study|Pregnancy|1|||
17012919|NCT00882362|38157667|FG001|Overall Study|Pregnancy|0|||
17012920|NCT00882362|38157666|FG000|Overall Study|Physician Decision|5|||
17012921|NCT00882362|38157667|FG001|Overall Study|Physician Decision|1|||
17012922|NCT00882362|38157666|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
17012923|NCT00882362|38157667|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
17012924|NCT00882362|38157666|FG000|Overall Study|change of residence or other commitments|5|||
17012925|NCT00882362|38157667|FG001|Overall Study|change of residence or other commitments|0|||
17012926|NCT00851643|38157679|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
17012927|NCT00851643|38157680|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
17012928|NCT00851643|38157681|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
17012929|NCT00851643|38157682|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
17012930|NCT00851643|38157683|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
17097731|NCT00146172|38236890|FG002|Overall Study|Death|0|||
17097732|NCT00146172|38236891|FG003|Overall Study|Death|0|||
17097733|NCT00146172|38236892|FG004|Overall Study|Death|0|||
17097734|NCT00146172|38236893|FG005|Overall Study|Death|0|||
17097735|NCT00146172|38236894|FG006|Overall Study|Death|1|||
17097736|NCT00146172|38236895|FG007|Overall Study|Death|0|||
17097737|NCT00146172|38236888|FG000|Overall Study|Physician Decision|0|||
17097738|NCT00146172|38236889|FG001|Overall Study|Physician Decision|0|||
17097739|NCT00146172|38236890|FG002|Overall Study|Physician Decision|0|||
17097740|NCT00146172|38236891|FG003|Overall Study|Physician Decision|0|||
17097741|NCT00146172|38236892|FG004|Overall Study|Physician Decision|0|||
17097742|NCT00146172|38236893|FG005|Overall Study|Physician Decision|0|||
17097743|NCT00146172|38236894|FG006|Overall Study|Physician Decision|0|||
17097744|NCT00146172|38236895|FG007|Overall Study|Physician Decision|1|||
17097745|NCT00146172|38236888|FG000|Overall Study|Withdrawal by Subject|0|||
17097746|NCT00146172|38236889|FG001|Overall Study|Withdrawal by Subject|0|||
17097747|NCT00146172|38236890|FG002|Overall Study|Withdrawal by Subject|0|||
17097748|NCT00146172|38236891|FG003|Overall Study|Withdrawal by Subject|0|||
17097749|NCT00146172|38236892|FG004|Overall Study|Withdrawal by Subject|0|||
17097750|NCT00146172|38236893|FG005|Overall Study|Withdrawal by Subject|1|||
17193392|NCT02720523|38346712|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
17193393|NCT02720523|38346713|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
17097751|NCT00146172|38236894|FG006|Overall Study|Withdrawal by Subject|1|||
17097752|NCT00146172|38236895|FG007|Overall Study|Withdrawal by Subject|4|||
17097753|NCT00146172|38236888|FG000|Overall Study|Symptomatic Deterioration|1|||
17097754|NCT00146172|38236889|FG001|Overall Study|Symptomatic Deterioration|0|||
17097755|NCT00146172|38236890|FG002|Overall Study|Symptomatic Deterioration|1|||
17097756|NCT00146172|38236891|FG003|Overall Study|Symptomatic Deterioration|0|||
17097757|NCT00146172|38236892|FG004|Overall Study|Symptomatic Deterioration|1|||
17097758|NCT00146172|38236893|FG005|Overall Study|Symptomatic Deterioration|2|||
17097759|NCT00146172|38236894|FG006|Overall Study|Symptomatic Deterioration|0|||
17097760|NCT00146172|38236895|FG007|Overall Study|Symptomatic Deterioration|2|||
17097761|NCT00145626|38236923|FG000|Overall Study|Did not have NK infusions|2|||
17097762|NCT00145626|38236923|FG000|Overall Study|Turned 2 years old before treatment|1|||
17097763|NCT00145626|38236923|FG000|Overall Study|Death|1|||
17097764|NCT00145626|38236923|FG000|Overall Study|Withdrawal by Subject|1|||
17012931|NCT00851643|38157684|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
17012932|NCT00851643|38157679|FG000|Base Study (Up to 12 Months)|Other|0|||
17012933|NCT00851643|38157680|FG001|Base Study (Up to 12 Months)|Other|0|||
17012934|NCT00851643|38157681|FG002|Base Study (Up to 12 Months)|Other|0|||
17012935|NCT00851643|38157682|FG003|Base Study (Up to 12 Months)|Other|0|||
17097765|NCT00153062|38236947|FG000|Overall Study|Death|360|||
17097766|NCT00153062|38236948|FG001|Overall Study|Death|352|||
17097767|NCT00153062|38236949|FG002|Overall Study|Death|369|||
17097768|NCT00153062|38236950|FG003|Overall Study|Death|365|||
17012936|NCT00851643|38157683|FG004|Base Study (Up to 12 Months)|Other|0|||
17012937|NCT00851643|38157684|FG005|Base Study (Up to 12 Months)|Other|1|||
17012938|NCT00851643|38157679|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
17012939|NCT00851643|38157680|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
17012940|NCT00851643|38157681|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
17012941|NCT00851643|38157682|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
17012942|NCT00851643|38157683|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
17012943|NCT00851643|38157684|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
17012944|NCT00851643|38157679|FG000|Extension Study (Up to 36 Months)|Moved|0|||
17012945|NCT00851643|38157680|FG001|Extension Study (Up to 36 Months)|Moved|2|||
17012946|NCT00851643|38157681|FG002|Extension Study (Up to 36 Months)|Moved|1|||
17012947|NCT00851643|38157682|FG003|Extension Study (Up to 36 Months)|Moved|1|||
17012948|NCT00851643|38157683|FG004|Extension Study (Up to 36 Months)|Moved|0|||
17097769|NCT00153062|38236947|FG000|Overall Study|Withdrawal by Subject|14|||
17097770|NCT00153062|38236948|FG001|Overall Study|Withdrawal by Subject|30|||
17097771|NCT00153062|38236949|FG002|Overall Study|Withdrawal by Subject|27|||
17097772|NCT00153062|38236950|FG003|Overall Study|Withdrawal by Subject|28|||
17097773|NCT00153062|38236947|FG000|Overall Study|Lost to Follow-up|12|||
17097774|NCT00153062|38236948|FG001|Overall Study|Lost to Follow-up|20|||
17097775|NCT00153062|38236949|FG002|Overall Study|Lost to Follow-up|15|||
17097776|NCT00153062|38236950|FG003|Overall Study|Lost to Follow-up|16|||
17097777|NCT00153062|38236947|FG000|Overall Study|Adverse Event|0|||
17097778|NCT00153062|38236948|FG001|Overall Study|Adverse Event|1|||
17097779|NCT00153062|38236949|FG002|Overall Study|Adverse Event|1|||
17097780|NCT00153062|38236950|FG003|Overall Study|Adverse Event|0|||
17097781|NCT00153062|38236947|FG000|Overall Study|Protocol Violation|0|||
17097782|NCT00153062|38236948|FG001|Overall Study|Protocol Violation|2|||
17097783|NCT00153062|38236949|FG002|Overall Study|Protocol Violation|1|||
17097784|NCT00153062|38236950|FG003|Overall Study|Protocol Violation|1|||
17097785|NCT00153062|38236947|FG000|Overall Study|No disposition data available|1|||
17097786|NCT00153062|38236948|FG001|Overall Study|No disposition data available|1|||
17097787|NCT00153062|38236949|FG002|Overall Study|No disposition data available|1|||
17097788|NCT00153062|38236950|FG003|Overall Study|No disposition data available|1|||
17097789|NCT00153062|38236947|FG000|Overall Study|Other|0|||
17097790|NCT00153062|38236948|FG001|Overall Study|Other|0|||
17097791|NCT00153062|38236949|FG002|Overall Study|Other|1|||
17097792|NCT00153062|38236950|FG003|Overall Study|Other|0|||
17097793|NCT00145470|38236962|FG000|Overall Study|Adverse Event|19|||
17097794|NCT00145470|38236963|FG001|Overall Study|Adverse Event|25|||
17097795|NCT00145470|38236962|FG000|Overall Study|Lack of Efficacy|27|||
17097796|NCT00145470|38236963|FG001|Overall Study|Lack of Efficacy|13|||
17012949|NCT00851643|38157684|FG005|Extension Study (Up to 36 Months)|Moved|1|||
17012950|NCT00529243|38157697|FG000|Overall Study|Adverse Event|1|||
17012951|NCT00529243|38157697|FG000|Overall Study|Death|1|||
17012952|NCT00529243|38157697|FG000|Overall Study|Relocated|1|||
17012953|NCT03728309|38157703|FG000|Overall Study|Randomized but not Treated|0|||
17012954|NCT03728309|38157704|FG001|Overall Study|Randomized but not Treated|1|||
17012955|NCT03728309|38157703|FG000|Overall Study|Adverse Event|0|||
17012956|NCT03728309|38157704|FG001|Overall Study|Adverse Event|1|||
17012957|NCT03728309|38157703|FG000|Overall Study|Withdrawal by Subject|2|||
17012958|NCT03728309|38157704|FG001|Overall Study|Withdrawal by Subject|8|||
17012959|NCT03728309|38157703|FG000|Overall Study|Lost to Follow-up|9|||
17012960|NCT03728309|38157704|FG001|Overall Study|Lost to Follow-up|10|||
17012961|NCT03728309|38157703|FG000|Overall Study|Protocol Deviation|0|||
17012962|NCT03728309|38157704|FG001|Overall Study|Protocol Deviation|1|||
17012963|NCT03728309|38157703|FG000|Overall Study|Due to COVID|1|||
17012964|NCT03728309|38157704|FG001|Overall Study|Due to COVID|3|||
17012965|NCT03683719|38157721|FG000|Overall Study|Lack of Efficacy|1|||
17012966|NCT03683719|38157722|FG001|Overall Study|Lack of Efficacy|3|||
17097797|NCT00145470|38236962|FG000|Overall Study|Withdrawal by Subject|36|||
17097798|NCT00145470|38236963|FG001|Overall Study|Withdrawal by Subject|34|||
17097799|NCT00145470|38236962|FG000|Overall Study|Lost to Follow-up|21|||
17097800|NCT00145470|38236963|FG001|Overall Study|Lost to Follow-up|17|||
17097801|NCT00145470|38236962|FG000|Overall Study|Reason Not Reported|9|||
17097802|NCT00145470|38236963|FG001|Overall Study|Reason Not Reported|9|||
17097803|NCT00152516|38236969|FG000|Overall Study|Adverse Event|18|||
17097804|NCT00152516|38236969|FG000|Overall Study|Lack and Loss of Efficacy|30|||
17097805|NCT00152516|38236969|FG000|Overall Study|Lost to Follow-up|5|||
17097806|NCT00152516|38236969|FG000|Overall Study|Withdrawal by Subject|8|||
17012967|NCT03683719|38157723|FG002|Overall Study|Lack of Efficacy|4|||
17012968|NCT03683719|38157724|FG003|Overall Study|Lack of Efficacy|0|||
17193394|NCT02720523|38346714|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
17193395|NCT02720523|38346715|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
17193396|NCT02720523|38346709|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
17193397|NCT02720523|38346710|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
17193398|NCT02720523|38346711|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
17097807|NCT00152516|38236969|FG000|Overall Study|Protocol Violation|3|||
17097808|NCT00152516|38236969|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
17193399|NCT02720523|38346712|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
17193400|NCT02720523|38346713|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
17193401|NCT02720523|38346714|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
17193402|NCT02720523|38346715|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
17193403|NCT02720523|38346709|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
17193404|NCT02720523|38346710|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
17193405|NCT02720523|38346711|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
17193406|NCT02720523|38346712|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
17193407|NCT02720523|38346713|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
17193408|NCT02720523|38346714|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
17193409|NCT02720523|38346715|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
17193410|NCT02720523|38346709|FG000|Period 2: Long-term Extension Period|Other|0|||
17193411|NCT02720523|38346710|FG001|Period 2: Long-term Extension Period|Other|0|||
17193412|NCT02720523|38346711|FG002|Period 2: Long-term Extension Period|Other|0|||
17193413|NCT02720523|38346712|FG003|Period 2: Long-term Extension Period|Other|0|||
17193414|NCT02720523|38346713|FG004|Period 2: Long-term Extension Period|Other|2|||
17193415|NCT02720523|38346714|FG005|Period 2: Long-term Extension Period|Other|0|||
17193416|NCT02720523|38346715|FG006|Period 2: Long-term Extension Period|Other|3|||
17193417|NCT02646332|38346730|FG000|Overall Study|Lost to Follow-up|0|||
17193418|NCT02646332|38346731|FG001|Overall Study|Lost to Follow-up|3|||
17193419|NCT02471716|38346742|FG000|Overall Study|Withdrawal by Subject|0|||
17193420|NCT02471716|38346743|FG001|Overall Study|Withdrawal by Subject|1|||
17193421|NCT02471716|38346744|FG002|Overall Study|Withdrawal by Subject|0|||
17193422|NCT02471716|38346745|FG003|Overall Study|Withdrawal by Subject|2|||
17097809|NCT00152516|38236969|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
17097810|NCT00152516|38236969|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
17097811|NCT00152516|38236969|FG000|Overall Study|Other: Non-Compliance|2|||
17097812|NCT00152516|38236969|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
17193423|NCT02471716|38346746|FG004|Overall Study|Withdrawal by Subject|5|||
17193424|NCT02471716|38346742|FG000|Overall Study|Study Terminiated by sponsor|0|||
17193425|NCT02471716|38346743|FG001|Overall Study|Study Terminiated by sponsor|0|||
17193426|NCT02471716|38346744|FG002|Overall Study|Study Terminiated by sponsor|0|||
17193427|NCT02471716|38346745|FG003|Overall Study|Study Terminiated by sponsor|1|||
17193428|NCT02471716|38346746|FG004|Overall Study|Study Terminiated by sponsor|0|||
17193429|NCT02471716|38346742|FG000|Overall Study|Lost to Follow-up|0|||
17193430|NCT02471716|38346743|FG001|Overall Study|Lost to Follow-up|0|||
17193431|NCT02471716|38346744|FG002|Overall Study|Lost to Follow-up|0|||
17193432|NCT02471716|38346745|FG003|Overall Study|Lost to Follow-up|3|||
17193433|NCT02471716|38346746|FG004|Overall Study|Lost to Follow-up|2|||
17193434|NCT02471716|38346742|FG000|Overall Study|Death|0|||
17193435|NCT02471716|38346743|FG001|Overall Study|Death|0|||
17193436|NCT02471716|38346744|FG002|Overall Study|Death|0|||
17193437|NCT02471716|38346745|FG003|Overall Study|Death|1|||
17193438|NCT02471716|38346746|FG004|Overall Study|Death|0|||
17193439|NCT02471716|38346742|FG000|Overall Study|Other|0|||
17193440|NCT02471716|38346743|FG001|Overall Study|Other|0|||
17193441|NCT02471716|38346744|FG002|Overall Study|Other|0|||
17193442|NCT02471716|38346745|FG003|Overall Study|Other|8|||
17193443|NCT02471716|38346746|FG004|Overall Study|Other|9|||
17012969|NCT03683719|38157725|FG004|Overall Study|Lack of Efficacy|4|||
17012970|NCT03683719|38157721|FG000|Overall Study|Adverse Event|6|||
17012971|NCT03683719|38157722|FG001|Overall Study|Adverse Event|6|||
17012972|NCT03683719|38157723|FG002|Overall Study|Adverse Event|0|||
17012973|NCT03683719|38157724|FG003|Overall Study|Adverse Event|1|||
17012974|NCT03683719|38157725|FG004|Overall Study|Adverse Event|3|||
17012975|NCT03683719|38157721|FG000|Overall Study|Withdrawal by Subject|4|||
17012976|NCT03683719|38157722|FG001|Overall Study|Withdrawal by Subject|4|||
17097813|NCT00152516|38236969|FG000|Overall Study|Other: Moved Out Of State|1|||
17097814|NCT00152516|38236969|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
17097815|NCT00152516|38236969|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
17097816|NCT00145158|38236975|FG000|Overall Study|premature withdrawal|2|||
17193444|NCT01370863|38346762|FG000|Overall Study|Adverse Event|1|||
17193445|NCT01370863|38346763|FG001|Overall Study|Adverse Event|1|||
17012977|NCT03683719|38157723|FG002|Overall Study|Withdrawal by Subject|3|||
17012978|NCT03683719|38157724|FG003|Overall Study|Withdrawal by Subject|5|||
17012979|NCT03683719|38157725|FG004|Overall Study|Withdrawal by Subject|5|||
17012980|NCT03683719|38157721|FG000|Overall Study|Lost to Follow-up|1|||
17012981|NCT03683719|38157722|FG001|Overall Study|Lost to Follow-up|0|||
17012982|NCT03683719|38157723|FG002|Overall Study|Lost to Follow-up|0|||
17012983|NCT03683719|38157724|FG003|Overall Study|Lost to Follow-up|1|||
17012984|NCT03683719|38157725|FG004|Overall Study|Lost to Follow-up|1|||
17097817|NCT00145158|38236976|FG001|Overall Study|premature withdrawal|3|||
17097818|NCT00150800|38236983|FG000|Overall Study|Adverse Event|89|||
17097819|NCT00150800|38236983|FG000|Overall Study|Death|18|||
17097820|NCT00150800|38236983|FG000|Overall Study|Lack of Efficacy|166|||
17097821|NCT00150800|38236983|FG000|Overall Study|Lost to Follow-up|58|||
17097822|NCT00150800|38236983|FG000|Overall Study|Subject's choice|90|||
17097823|NCT00150800|38236983|FG000|Overall Study|No compliance|18|||
17097824|NCT00150800|38236983|FG000|Overall Study|IP misshandling|1|||
17097825|NCT00150800|38236983|FG000|Overall Study|Site closure|24|||
17097826|NCT00150800|38236983|FG000|Overall Study|Protocol non-adherence|2|||
17097827|NCT00150800|38236983|FG000|Overall Study|Nobody to accompany patient|1|||
17097828|NCT00150800|38236983|FG000|Overall Study|Distance too long for patient|1|||
17097829|NCT00150800|38236983|FG000|Overall Study|Neurosurgery|2|||
17097830|NCT00150800|38236983|FG000|Overall Study|BRV monotherapy|1|||
17097831|NCT00150800|38236983|FG000|Overall Study|Visit refusal|3|||
17097832|NCT00150800|38236983|FG000|Overall Study|Sponsor's request|2|||
17097833|NCT00150800|38236983|FG000|Overall Study|Generalized Epilepsy|1|||
17097834|NCT00150800|38236983|FG000|Overall Study|Moved from area/country|8|||
17012985|NCT03683719|38157721|FG000|Overall Study|Other personal reasons|0|||
17012986|NCT03683719|38157722|FG001|Overall Study|Other personal reasons|0|||
17012987|NCT03683719|38157723|FG002|Overall Study|Other personal reasons|1|||
17012988|NCT03683719|38157724|FG003|Overall Study|Other personal reasons|0|||
17012989|NCT03683719|38157725|FG004|Overall Study|Other personal reasons|1|||
17012990|NCT00851253|38157739|FG000|Overall Study|Disease Progression|1|||
17012991|NCT00851253|38157740|FG001|Overall Study|Disease Progression|0|||
17012992|NCT00520351|38157748|FG000|First Intervention|Withdrawal by Subject|1|||
17012993|NCT00520351|38157749|FG001|First Intervention|Withdrawal by Subject|1|||
17012994|NCT00850395|38157759|FG000|Overall Study|Death|1|||
17012995|NCT00850395|38157759|FG000|Overall Study|Adverse Event|1|||
17012996|NCT00850395|38157759|FG000|Overall Study|Insufficient clinical response|3|||
17012997|NCT00850395|38157759|FG000|Overall Study|Other|5|||
17012998|NCT00520039|38157765|FG000|Overall Study|Exclusion criteria met at first visit|7|||
17012999|NCT00520039|38157766|FG001|Overall Study|Exclusion criteria met at first visit|5|||
17013000|NCT00577720|38157778|FG000|Overall Study|Adverse Event|2|||
17013001|NCT00577720|38157779|FG001|Overall Study|Adverse Event|1|||
17013002|NCT00577720|38157780|FG002|Overall Study|Adverse Event|0|||
17013003|NCT00577720|38157781|FG003|Overall Study|Adverse Event|4|||
17013004|NCT00577720|38157778|FG000|Overall Study|Lost to Follow-up|0|||
17013005|NCT00577720|38157779|FG001|Overall Study|Lost to Follow-up|0|||
17013006|NCT00577720|38157780|FG002|Overall Study|Lost to Follow-up|1|||
17013007|NCT00577720|38157781|FG003|Overall Study|Lost to Follow-up|0|||
17013008|NCT00577720|38157778|FG000|Overall Study|Protocol Violation|0|||
17097835|NCT00150800|38236983|FG000|Overall Study|PI retiring|2|||
17097836|NCT00150800|38236983|FG000|Overall Study|PI leaving site|2|||
17097837|NCT00150800|38236983|FG000|Overall Study|Patient insurance|1|||
17097838|NCT00150800|38236983|FG000|Overall Study|Surgical intervention|4|||
17013009|NCT00577720|38157779|FG001|Overall Study|Protocol Violation|0|||
17013010|NCT00577720|38157780|FG002|Overall Study|Protocol Violation|0|||
17013011|NCT00577720|38157781|FG003|Overall Study|Protocol Violation|1|||
17013012|NCT00577720|38157778|FG000|Overall Study|Withdrawal by Subject|2|||
17013013|NCT00577720|38157779|FG001|Overall Study|Withdrawal by Subject|0|||
17013014|NCT00577720|38157780|FG002|Overall Study|Withdrawal by Subject|0|||
17013015|NCT00577720|38157781|FG003|Overall Study|Withdrawal by Subject|2|||
17013016|NCT00519649|38157791|FG000|Overall Study|Withdrawal by Subject|1|||
17013017|NCT00512707|38157809|FG000|Overall Study|Lost to Follow-up|5|||
17013018|NCT00512707|38157810|FG001|Overall Study|Lost to Follow-up|11|||
17013019|NCT00512707|38157809|FG000|Overall Study|Developed skin irritation|2|||
17013020|NCT00512707|38157810|FG001|Overall Study|Developed skin irritation|1|||
17013021|NCT00512707|38157809|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
17013022|NCT00512707|38157810|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
17013023|NCT00512707|38157809|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
17013024|NCT00512707|38157810|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
17013025|NCT03471767|38157818|FG000|Overall Study|Withdrawal by Subject|3|||
17013026|NCT03471767|38157819|FG001|Overall Study|Withdrawal by Subject|1|||
17013027|NCT03471767|38157818|FG000|Overall Study|Adverse Event|1|||
17013028|NCT03471767|38157819|FG001|Overall Study|Adverse Event|0|||
17013029|NCT03471767|38157818|FG000|Overall Study|Lost to Follow-up|1|||
17013030|NCT03471767|38157819|FG001|Overall Study|Lost to Follow-up|0|||
17013031|NCT03471767|38157818|FG000|Overall Study|PI Withdrawal|1|||
17097839|NCT00150800|38236983|FG000|Overall Study|Pregnancy planned|1|||
17097840|NCT00150800|38236983|FG000|Overall Study|PI discontinuation request|1|||
17013032|NCT03471767|38157819|FG001|Overall Study|PI Withdrawal|3|||
17013033|NCT00849693|38157829|FG000|Acute Treatment Phase|Adverse Event|12|||
17013034|NCT00849693|38157830|FG001|Acute Treatment Phase|Adverse Event|7|||
17013035|NCT00849693|38157831|FG002|Acute Treatment Phase|Adverse Event|6|||
17013036|NCT00849693|38157832|FG003|Acute Treatment Phase|Adverse Event|4|||
17013037|NCT00849693|38157829|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
17097841|NCT00144300|38236990|FG000|Overall Study|Adverse Event|18|||
17097842|NCT00144300|38236991|FG001|Overall Study|Adverse Event|16|||
17097843|NCT00144300|38236990|FG000|Overall Study|Protocol Violation|1|||
17097844|NCT00144300|38236991|FG001|Overall Study|Protocol Violation|3|||
17097845|NCT00144300|38236990|FG000|Overall Study|Lost to Follow-up|3|||
17097846|NCT00144300|38236991|FG001|Overall Study|Lost to Follow-up|0|||
17097847|NCT00144300|38236990|FG000|Overall Study|Withdrawal by Subject|6|||
17097848|NCT00144300|38236991|FG001|Overall Study|Withdrawal by Subject|6|||
17097849|NCT00144300|38236990|FG000|Overall Study|Other reason (not specified)|1|||
17097850|NCT00144300|38236991|FG001|Overall Study|Other reason (not specified)|3|||
17097851|NCT00149630|38236999|FG000|Overall Study|Incarceration|2|||
17097852|NCT00149630|38237000|FG001|Overall Study|Incarceration|0|||
17097853|NCT00149630|38236999|FG000|Overall Study|Treatment Programs|4|||
17097854|NCT00149630|38237000|FG001|Overall Study|Treatment Programs|5|||
17097855|NCT00149630|38236999|FG000|Overall Study|Adverse Event|2|||
17097856|NCT00149630|38237000|FG001|Overall Study|Adverse Event|0|||
17097857|NCT00127842|38237010|FG000|Overall Study|Adverse Event|15|||
17013038|NCT00849693|38157830|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
17013039|NCT00849693|38157831|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
17013040|NCT00849693|38157832|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
17193446|NCT01370863|38346762|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
17193447|NCT01370863|38346763|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
17193448|NCT01370863|38346762|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
17193449|NCT01370863|38346763|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
17193450|NCT02444182|38346771|FG000|Overall Study|non-compliance|2|||
17193451|NCT02444182|38346772|FG001|Overall Study|non-compliance|1|||
17193452|NCT02444182|38346771|FG000|Overall Study|Lost to Follow-up|0|||
17193453|NCT02444182|38346772|FG001|Overall Study|Lost to Follow-up|4|||
17193454|NCT02471404|38346781|FG000|Overall Study|Adverse Event|7|||
17193455|NCT02471404|38346782|FG001|Overall Study|Adverse Event|1|||
17193456|NCT02471404|38346783|FG002|Overall Study|Adverse Event|2|||
17193457|NCT02471404|38346781|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
17193458|NCT02471404|38346782|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
17193459|NCT02471404|38346783|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
17193460|NCT02471404|38346781|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
17193461|NCT02471404|38346782|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
17193462|NCT02471404|38346783|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
17193463|NCT02471404|38346781|FG000|Overall Study|Lost to Follow-up|1|||
17193464|NCT02471404|38346782|FG001|Overall Study|Lost to Follow-up|1|||
17193465|NCT02471404|38346783|FG002|Overall Study|Lost to Follow-up|3|||
17193466|NCT02471404|38346781|FG000|Overall Study|Protocol Violation|1|||
17193467|NCT02471404|38346782|FG001|Overall Study|Protocol Violation|0|||
17193468|NCT02471404|38346783|FG002|Overall Study|Protocol Violation|0|||
17193469|NCT02471404|38346781|FG000|Overall Study|Withdrawal by Subject|8|||
16786316|NCT01999894|37726721|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
17097858|NCT00127842|38237010|FG000|Overall Study|Withdrawal by Subject|3|||
17097859|NCT00127842|38237010|FG000|Overall Study|Lost to Follow-up|1|||
17097860|NCT00127842|38237010|FG000|Overall Study|Lack of Efficacy|12|||
17097861|NCT00127842|38237010|FG000|Overall Study|Noncompliance|2|||
17097862|NCT00127842|38237010|FG000|Overall Study|Protocol Violation|1|||
17097863|NCT00127842|38237010|FG000|Overall Study|Other|5|||
17097864|NCT03720652|38237016|FG000|Overall Study|Withdrawal by Subject|2|||
17097865|NCT03720652|38237017|FG001|Overall Study|Withdrawal by Subject|7|||
16908529|NCT01759290|38017232|FG000|Overall Study|Lost to Follow-up|53|||
16908530|NCT01759290|38017232|FG000|Overall Study|Unknown reason|4|||
16908531|NCT01758900|38017238|FG000|Overall Study|difficulty for further intubation|7|||
17097866|NCT03720652|38237016|FG000|Overall Study|Lost to Follow-up|0|||
17097867|NCT03720652|38237017|FG001|Overall Study|Lost to Follow-up|4|||
17097868|NCT00112866|38237027|FG000|Overall Study|Protocol Violation|1|||
17097869|NCT00112866|38237028|FG001|Overall Study|Protocol Violation|0|||
17097870|NCT00112866|38237027|FG000|Overall Study|did not start treatment post-op|1|||
16786317|NCT02679235|37726726|FG000|Overall Study|Withdrawal by Subject|3|||
17097871|NCT00112866|38237028|FG001|Overall Study|did not start treatment post-op|2|||
17013041|NCT00849693|38157829|FG000|Acute Treatment Phase|Protocol Violation|1|||
17013042|NCT00849693|38157830|FG001|Acute Treatment Phase|Protocol Violation|5|||
17097872|NCT00127608|38237042|FG000|Overall Study|VZV DNA negative|1|||
17097873|NCT00149396|38237046|FG000|Overall Study|Death|15|||
17097874|NCT00149396|38237046|FG000|Overall Study|Withdrawal by Subject|1|||
17097875|NCT00149396|38237046|FG000|Overall Study|Subject noncompliance|2|||
17097876|NCT00149396|38237046|FG000|Overall Study|other treatment|5|||
17097877|NCT00223496|38237057|FG000|Overall Study|screen failure|9|||
17013043|NCT00849693|38157831|FG002|Acute Treatment Phase|Protocol Violation|2|||
17013044|NCT00849693|38157832|FG003|Acute Treatment Phase|Protocol Violation|6|||
17013045|NCT00849693|38157829|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
17013046|NCT00849693|38157830|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
17013047|NCT00849693|38157831|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
17013048|NCT00849693|38157832|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
17013049|NCT00849693|38157829|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
17097878|NCT00223496|38237057|FG000|Overall Study|Lost to Follow-up|4|||
17097879|NCT00223496|38237057|FG000|Overall Study|Lack of Efficacy|6|||
17097880|NCT00223496|38237057|FG000|Overall Study|Withdrawal by Subject|1|||
17097881|NCT00223496|38237057|FG000|Overall Study|Physician Decision|2|||
17097882|NCT00255944|38237063|FG000|Overall Study|Lost to Follow-up|797|||
17097883|NCT00255944|38237064|FG001|Overall Study|Lost to Follow-up|834|||
17097884|NCT00143598|38237072|FG000|Overall Study|Lost to Follow-up|23|||
17097885|NCT00143598|38237073|FG001|Overall Study|Lost to Follow-up|21|||
17097886|NCT00143598|38237072|FG000|Overall Study|Withdrawal by Subject|33|||
17097887|NCT00143598|38237073|FG001|Overall Study|Withdrawal by Subject|37|||
17097888|NCT00143598|38237072|FG000|Overall Study|Death|36|||
17097889|NCT00143598|38237073|FG001|Overall Study|Death|36|||
17097890|NCT00126672|38237079|FG000|Overall Study|Adverse Event|4|||
17097891|NCT00126672|38237079|FG000|Overall Study|Lost to Follow-up|4|||
17193470|NCT02471404|38346782|FG001|Overall Study|Withdrawal by Subject|4|||
17193471|NCT02471404|38346783|FG002|Overall Study|Withdrawal by Subject|5|||
17193472|NCT02471404|38346781|FG000|Overall Study|Other reasons not specified|10|||
17193473|NCT02471404|38346782|FG001|Overall Study|Other reasons not specified|7|||
17193474|NCT02471404|38346783|FG002|Overall Study|Other reasons not specified|12|||
17097892|NCT00145574|38237086|FG000|Double Blind|Adverse Event|0|||
17097893|NCT00145574|38237087|FG001|Double Blind|Adverse Event|3|||
17097894|NCT00145574|38237088|FG002|Double Blind|Adverse Event|1|||
17097895|NCT00145574|38237086|FG000|Double Blind|Withdrawal by Subject|1|||
17097896|NCT00145574|38237087|FG001|Double Blind|Withdrawal by Subject|1|||
17097897|NCT00145574|38237088|FG002|Double Blind|Withdrawal by Subject|1|||
17193475|NCT02471014|38346793|FG000|Overall Study|Lost to Follow-up|2|||
17193476|NCT02471014|38346794|FG001|Overall Study|Lost to Follow-up|2|||
17193477|NCT02413372|38346803|FG000|Treatment|Lost to Follow-up|0|||
17193478|NCT02413372|38346804|FG001|Treatment|Lost to Follow-up|2|||
17193479|NCT02413372|38346805|FG002|Treatment|Lost to Follow-up|1|||
17193480|NCT02413372|38346803|FG000|Treatment|Withdrawal by Subject|1|||
17193481|NCT02413372|38346804|FG001|Treatment|Withdrawal by Subject|0|||
17193482|NCT02413372|38346805|FG002|Treatment|Withdrawal by Subject|0|||
17193483|NCT02413372|38346803|FG000|Follow-up|Lost to Follow-up|1|||
17193484|NCT02413372|38346804|FG001|Follow-up|Lost to Follow-up|1|||
17193485|NCT02413372|38346805|FG002|Follow-up|Lost to Follow-up|0|||
17193486|NCT02413372|38346803|FG000|Follow-up|Subject Withdrew Consent|1|||
17193487|NCT02413372|38346804|FG001|Follow-up|Subject Withdrew Consent|0|||
17193488|NCT02413372|38346805|FG002|Follow-up|Subject Withdrew Consent|1|||
17193489|NCT02413372|38346803|FG000|Follow-up|Subject unable to return for visit|0|||
17193490|NCT02413372|38346804|FG001|Follow-up|Subject unable to return for visit|0|||
17193491|NCT02413372|38346805|FG002|Follow-up|Subject unable to return for visit|1|||
17193492|NCT02413294|38346813|FG000|Overall Study|Withdrawal by Subject|1|||
17193493|NCT02719353|38346826|FG000|First Intervention|Physician Decision|0|||
17193494|NCT02719353|38346827|FG001|First Intervention|Physician Decision|1|||
17193495|NCT01362062|38346836|FG000|Overall Study|Adverse Event|1|||
17193496|NCT01362062|38346837|FG001|Overall Study|Adverse Event|0|||
17097898|NCT00145574|38237086|FG000|Double Blind|required restricted medicine|0|||
17097899|NCT00145574|38237087|FG001|Double Blind|required restricted medicine|1|||
17097900|NCT00145574|38237088|FG002|Double Blind|required restricted medicine|0|||
17097901|NCT00145574|38237086|FG000|Open Label Long-term Extension|Adverse Event|0|||
17097902|NCT00145574|38237087|FG001|Open Label Long-term Extension|Adverse Event|0|||
17097903|NCT00145574|38237088|FG002|Open Label Long-term Extension|Adverse Event|5|||
17097904|NCT00145574|38237086|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
17097905|NCT00145574|38237087|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
17097906|NCT00145574|38237088|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
17097907|NCT00145574|38237086|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
17097908|NCT00145574|38237087|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
17097909|NCT00145574|38237088|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
17097910|NCT00145574|38237086|FG000|Open Label Long-term Extension|required restricted medicine|0|||
17097911|NCT00145574|38237087|FG001|Open Label Long-term Extension|required restricted medicine|0|||
17097912|NCT00145574|38237088|FG002|Open Label Long-term Extension|required restricted medicine|1|||
17097913|NCT00145496|38237103|FG000|Overall Study|Adverse Event|42|||
17097914|NCT00145496|38237104|FG001|Overall Study|Adverse Event|30|||
17097915|NCT00145496|38237103|FG000|Overall Study|Lack of Efficacy|12|||
17097916|NCT00145496|38237104|FG001|Overall Study|Lack of Efficacy|7|||
17097917|NCT00145496|38237103|FG000|Overall Study|Withdrawal by Subject|32|||
17193497|NCT01362062|38346836|FG000|Overall Study|Lost to Follow-up|11|||
17193498|NCT01362062|38346837|FG001|Overall Study|Lost to Follow-up|0|||
17013050|NCT00849693|38157830|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
17013051|NCT00849693|38157831|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
17013052|NCT00849693|38157832|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
17013053|NCT00849693|38157829|FG000|Acute Treatment Phase|Physician Decision|2|||
17013054|NCT00849693|38157830|FG001|Acute Treatment Phase|Physician Decision|1|||
17013055|NCT00849693|38157831|FG002|Acute Treatment Phase|Physician Decision|2|||
17013056|NCT00849693|38157832|FG003|Acute Treatment Phase|Physician Decision|1|||
17013057|NCT00849693|38157829|FG000|Acute Treatment Phase|Sponsor decision|0|||
17013058|NCT00849693|38157830|FG001|Acute Treatment Phase|Sponsor decision|0|||
17013059|NCT00849693|38157831|FG002|Acute Treatment Phase|Sponsor decision|1|||
17013060|NCT00849693|38157832|FG003|Acute Treatment Phase|Sponsor decision|0|||
17013061|NCT00849693|38157829|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
17013062|NCT00849693|38157830|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
17013063|NCT00849693|38157831|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
17013064|NCT00849693|38157832|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
17013065|NCT00849693|38157829|FG000|Extension Phase|Adverse Event|4|||
17013066|NCT00849693|38157830|FG001|Extension Phase|Adverse Event|6|||
17013067|NCT00849693|38157831|FG002|Extension Phase|Adverse Event|3|||
17013068|NCT00849693|38157832|FG003|Extension Phase|Adverse Event|7|||
17013069|NCT00849693|38157829|FG000|Extension Phase|Lost to Follow-up|7|||
17013070|NCT00849693|38157830|FG001|Extension Phase|Lost to Follow-up|5|||
17013071|NCT00849693|38157831|FG002|Extension Phase|Lost to Follow-up|6|||
17013072|NCT00849693|38157832|FG003|Extension Phase|Lost to Follow-up|6|||
17013073|NCT00849693|38157829|FG000|Extension Phase|Protocol Violation|0|||
17013074|NCT00849693|38157830|FG001|Extension Phase|Protocol Violation|3|||
17013075|NCT00849693|38157831|FG002|Extension Phase|Protocol Violation|2|||
17013076|NCT00849693|38157832|FG003|Extension Phase|Protocol Violation|3|||
17013077|NCT00849693|38157829|FG000|Extension Phase|Withdrawal by Subject|6|||
17013078|NCT00849693|38157830|FG001|Extension Phase|Withdrawal by Subject|9|||
17013079|NCT00849693|38157831|FG002|Extension Phase|Withdrawal by Subject|10|||
17013080|NCT00849693|38157832|FG003|Extension Phase|Withdrawal by Subject|15|||
17013081|NCT00849693|38157829|FG000|Extension Phase|Parent or caregiver decision|9|||
17013082|NCT00849693|38157830|FG001|Extension Phase|Parent or caregiver decision|4|||
17013083|NCT00849693|38157831|FG002|Extension Phase|Parent or caregiver decision|10|||
17013084|NCT00849693|38157832|FG003|Extension Phase|Parent or caregiver decision|5|||
17013085|NCT00849693|38157829|FG000|Extension Phase|Physician Decision|1|||
17013086|NCT00849693|38157830|FG001|Extension Phase|Physician Decision|1|||
17013087|NCT00849693|38157831|FG002|Extension Phase|Physician Decision|2|||
17013088|NCT00849693|38157832|FG003|Extension Phase|Physician Decision|0|||
17013089|NCT00849693|38157829|FG000|Extension Phase|Sponsor decision|1|||
17013090|NCT00849693|38157830|FG001|Extension Phase|Sponsor decision|0|||
17013091|NCT00849693|38157831|FG002|Extension Phase|Sponsor decision|0|||
17013092|NCT00849693|38157832|FG003|Extension Phase|Sponsor decision|1|||
17013093|NCT00849693|38157829|FG000|Extension Phase|Lack of Efficacy|2|||
17013094|NCT00849693|38157830|FG001|Extension Phase|Lack of Efficacy|2|||
17013095|NCT00849693|38157831|FG002|Extension Phase|Lack of Efficacy|2|||
17013096|NCT00849693|38157832|FG003|Extension Phase|Lack of Efficacy|1|||
17013097|NCT00527605|38157856|FG000|Overall Study|Adverse Event|3|||
17013098|NCT00527605|38157857|FG001|Overall Study|Adverse Event|0|||
17013099|NCT00527605|38157856|FG000|Overall Study|Withdrawal by Subject|3|||
17013100|NCT00527605|38157857|FG001|Overall Study|Withdrawal by Subject|7|||
17013101|NCT00527605|38157856|FG000|Overall Study|Lost to Follow-up|6|||
17013102|NCT00527605|38157857|FG001|Overall Study|Lost to Follow-up|2|||
17013103|NCT00527605|38157856|FG000|Overall Study|Protocol Violation|1|||
17013104|NCT00527605|38157857|FG001|Overall Study|Protocol Violation|2|||
17013105|NCT00849381|38157863|FG000|Overall Study|Adverse Event|1|||
17013106|NCT00849381|38157863|FG000|Overall Study|Lost to Follow-up|129|||
17013107|NCT00849381|38157863|FG000|Overall Study|Protocol Violation|5|||
17013108|NCT00849381|38157863|FG000|Overall Study|Withdrawal by Subject|6|||
17013109|NCT00849381|38157863|FG000|Overall Study|Other|4|||
17013110|NCT00711412|38157867|FG000|Induction Treatment|Death|2|||
17013111|NCT00711412|38157867|FG000|Induction Treatment|Adverse Event|1|||
17013112|NCT00711412|38157867|FG000|Induction Treatment|Other|1|||
17013113|NCT00711412|38157867|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
17013114|NCT00711412|38157867|FG000|Evaluated for Combination Treatment|Death|1|||
17013115|NCT00711412|38157867|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
17013116|NCT00711412|38157867|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
17013117|NCT00711412|38157867|FG000|Combination Treatment|Progressive Disease|1|||
17013118|NCT00711412|38157867|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
17013119|NCT00711412|38157867|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
17013120|NCT00711412|38157867|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
17013121|NCT00711412|38157867|FG000|Evaluation for Response and Surgery|Death|1|||
17013122|NCT00711412|38157867|FG000|Survival Follow up Until Death|Other|12|||
17013123|NCT00577408|38157883|FG000|Overall Study|Stopped attending study visits|9|||
17013124|NCT00577408|38157884|FG001|Overall Study|Stopped attending study visits|11|||
17013125|NCT00577408|38157883|FG000|Overall Study|Continued opioid use|3|||
17013126|NCT00577408|38157884|FG001|Overall Study|Continued opioid use|2|||
17013127|NCT00577408|38157883|FG000|Overall Study|Non-compliance with study meds|0|||
17013128|NCT00577408|38157884|FG001|Overall Study|Non-compliance with study meds|3|||
17013129|NCT00577408|38157883|FG000|Overall Study|Refused Oral Naltrexone|0|||
17013130|NCT00577408|38157884|FG001|Overall Study|Refused Oral Naltrexone|1|||
17013131|NCT00577408|38157883|FG000|Overall Study|Moved out of state|0|||
17013132|NCT00577408|38157884|FG001|Overall Study|Moved out of state|1|||
17013133|NCT00577408|38157883|FG000|Overall Study|Scheduling Issues|0|||
17013134|NCT00577408|38157884|FG001|Overall Study|Scheduling Issues|3|||
17013135|NCT00577408|38157883|FG000|Overall Study|Death|0|||
17013136|NCT00577408|38157884|FG001|Overall Study|Death|1|||
17013137|NCT00577408|38157883|FG000|Overall Study|Psychiatric hospitalization|0|||
17013138|NCT00577408|38157884|FG001|Overall Study|Psychiatric hospitalization|1|||
17097918|NCT00145496|38237104|FG001|Overall Study|Withdrawal by Subject|26|||
17097919|NCT00145496|38237103|FG000|Overall Study|Lost to Follow-up|12|||
17097920|NCT00145496|38237104|FG001|Overall Study|Lost to Follow-up|5|||
17097921|NCT00145496|38237103|FG000|Overall Study|Other|25|||
17097922|NCT00145496|38237104|FG001|Overall Study|Other|13|||
17097923|NCT00255164|38237113|FG000|Overall Study|Adverse Event|10|||
17097924|NCT00255164|38237114|FG001|Overall Study|Adverse Event|6|||
17097925|NCT00255164|38237115|FG002|Overall Study|Adverse Event|9|||
17097926|NCT00255164|38237113|FG000|Overall Study|Lost to Follow-up|4|||
17097927|NCT00255164|38237114|FG001|Overall Study|Lost to Follow-up|3|||
17097928|NCT00255164|38237115|FG002|Overall Study|Lost to Follow-up|4|||
17097929|NCT00255164|38237113|FG000|Overall Study|Withdrawal by Subject|18|||
17097930|NCT00255164|38237114|FG001|Overall Study|Withdrawal by Subject|17|||
17097931|NCT00255164|38237115|FG002|Overall Study|Withdrawal by Subject|8|||
17097932|NCT00255164|38237113|FG000|Overall Study|Noncompliance|0|||
17097933|NCT00255164|38237114|FG001|Overall Study|Noncompliance|1|||
17097934|NCT00255164|38237115|FG002|Overall Study|Noncompliance|2|||
17097935|NCT00255164|38237113|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
17097936|NCT00255164|38237114|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
17097937|NCT00255164|38237115|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
17097938|NCT00255164|38237113|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
17097939|NCT00255164|38237114|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
17097940|NCT00255164|38237115|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
17097941|NCT00255164|38237113|FG000|Overall Study|Possible Barrett's Esophagus|1|||
17097942|NCT00255164|38237114|FG001|Overall Study|Possible Barrett's Esophagus|3|||
17097943|NCT00255164|38237115|FG002|Overall Study|Possible Barrett's Esophagus|8|||
17097944|NCT00255164|38237113|FG000|Overall Study|Esophageal Stricture|0|||
17097945|NCT00255164|38237114|FG001|Overall Study|Esophageal Stricture|0|||
17097946|NCT00255164|38237115|FG002|Overall Study|Esophageal Stricture|1|||
17097947|NCT00255164|38237113|FG000|Overall Study|Therapeutic Failure|11|||
17097948|NCT00255164|38237114|FG001|Overall Study|Therapeutic Failure|2|||
17097949|NCT00255164|38237115|FG002|Overall Study|Therapeutic Failure|3|||
17097950|NCT00126594|38237125|FG000|Overall Study|Ineligible|2|||
17013139|NCT00828009|38157890|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
17013140|NCT00828009|38157890|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
17013141|NCT00828009|38157890|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
17013142|NCT00828009|38157890|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
17013143|NCT00828009|38157890|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
17013144|NCT00828009|38157890|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
17013145|NCT00828009|38157890|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
17013146|NCT00828009|38157890|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
17013147|NCT00828009|38157890|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
17013148|NCT00828009|38157890|FG000|Step 2 - Maintenance Therapy|Death|1|||
17013149|NCT00828009|38157890|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
17013150|NCT00828009|38157890|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
17013151|NCT00828009|38157890|FG000|Step 2 - Maintenance Therapy|Other|1|||
17013152|NCT00713596|38157898|FG000|Overall Study|Study was terminated|2|||
17013153|NCT00713596|38157899|FG001|Overall Study|Study was terminated|3|||
17097951|NCT00126594|38237126|FG001|Overall Study|Ineligible|0|||
17013154|NCT00713596|38157900|FG002|Overall Study|Study was terminated|2|||
17013155|NCT00880568|38157917|FG000|Overall Study|Disease progression|3|||
17013156|NCT00880568|38157918|FG001|Overall Study|Disease progression|3|||
17013157|NCT00880568|38157919|FG002|Overall Study|Disease progression|3|||
17013158|NCT00880568|38157920|FG003|Overall Study|Disease progression|1|||
17013159|NCT00880568|38157921|FG004|Overall Study|Disease progression|3|||
17013160|NCT00880568|38157922|FG005|Overall Study|Disease progression|3|||
17013161|NCT00880568|38157923|FG006|Overall Study|Disease progression|5|||
17013162|NCT00880568|38157924|FG007|Overall Study|Disease progression|0|||
17013163|NCT00880568|38157925|FG008|Overall Study|Disease progression|3|||
17013164|NCT00880568|38157917|FG000|Overall Study|Adverse Event|0|||
17013165|NCT00880568|38157918|FG001|Overall Study|Adverse Event|0|||
17097952|NCT00126594|38237125|FG000|Overall Study|Withdrawal by Subject|0|||
17013166|NCT00880568|38157919|FG002|Overall Study|Adverse Event|0|||
17013167|NCT00880568|38157920|FG003|Overall Study|Adverse Event|0|||
17013168|NCT00880568|38157921|FG004|Overall Study|Adverse Event|0|||
17013169|NCT00880568|38157922|FG005|Overall Study|Adverse Event|0|||
17013170|NCT00880568|38157923|FG006|Overall Study|Adverse Event|1|||
17097953|NCT00126594|38237126|FG001|Overall Study|Withdrawal by Subject|4|||
17097954|NCT00126594|38237125|FG000|Overall Study|Physician Decision|1|||
17097955|NCT00126594|38237126|FG001|Overall Study|Physician Decision|3|||
17097956|NCT00126594|38237125|FG000|Overall Study|Adverse Event|7|||
17097957|NCT00126594|38237126|FG001|Overall Study|Adverse Event|5|||
17097958|NCT00126594|38237125|FG000|Overall Study|Non-compliance|0|||
17097959|NCT00126594|38237126|FG001|Overall Study|Non-compliance|1|||
17097960|NCT00126594|38237125|FG000|Overall Study|Disease Progression|29|||
17097961|NCT00126594|38237126|FG001|Overall Study|Disease Progression|24|||
17097962|NCT00126438|38237135|FG000|Overall Study|Withdrawal due to adverse event|1|||
17097963|NCT00126438|38237136|FG001|Overall Study|Withdrawal due to adverse event|0|||
17097964|NCT00126438|38237135|FG000|Overall Study|Lost to Follow-up|22|||
17097965|NCT00126438|38237136|FG001|Overall Study|Lost to Follow-up|0|||
17097966|NCT00126438|38237135|FG000|Overall Study|Protocol Violation|8|||
17097967|NCT00126438|38237136|FG001|Overall Study|Protocol Violation|8|||
17097968|NCT00126438|38237135|FG000|Overall Study|Withdrawal by Subject|3|||
17097969|NCT00126438|38237136|FG001|Overall Study|Withdrawal by Subject|2|||
17097970|NCT00142584|38237144|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
17097971|NCT00142584|38237145|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
17097972|NCT00142584|38237144|FG000|Overall Study|Withdrawal by Subject|30|||
17097973|NCT00142584|38237145|FG001|Overall Study|Withdrawal by Subject|16|||
17097974|NCT00142584|38237144|FG000|Overall Study|Lost to Follow-up|22|||
17097975|NCT00142584|38237145|FG001|Overall Study|Lost to Follow-up|12|||
17193499|NCT01362062|38346836|FG000|Overall Study|Withdrawal by Subject|2|||
17193500|NCT01362062|38346837|FG001|Overall Study|Withdrawal by Subject|0|||
17193501|NCT01362062|38346836|FG000|Overall Study|Non-compliant participant|2|||
17193502|NCT01362062|38346837|FG001|Overall Study|Non-compliant participant|0|||
17193503|NCT01362062|38346836|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
17193504|NCT01362062|38346837|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
17193505|NCT01362062|38346836|FG000|Overall Study|Had significant improvement|9|||
17193506|NCT01362062|38346837|FG001|Overall Study|Had significant improvement|0|||
17193507|NCT01361594|38346844|FG000|Overall Study|Withdrawal by Subject|1|||
17013171|NCT00880568|38157924|FG007|Overall Study|Adverse Event|1|||
17013172|NCT00880568|38157925|FG008|Overall Study|Adverse Event|0|||
17013173|NCT00880568|38157917|FG000|Overall Study|Withdrawal by Subject|0|||
17193508|NCT01361594|38346845|FG001|Overall Study|Withdrawal by Subject|2|||
17193509|NCT02642432|38346851|FG000|Overall Study|Adverse Event|2|||
17193510|NCT02642432|38346851|FG000|Overall Study|Withdrew Consent|1|||
17193511|NCT02642432|38346851|FG000|Overall Study|Lost to Follow-up|2|||
17193512|NCT02642432|38346851|FG000|Overall Study|Other|3|||
17193513|NCT02640482|38346857|FG000|Overall Study|Lost to Follow-up|3|||
17193514|NCT02640482|38346858|FG001|Overall Study|Lost to Follow-up|0|||
17193515|NCT02719743|38346869|FG000|Overall Study|Consent withdrawal|0|||
17193516|NCT02719743|38346870|FG001|Overall Study|Consent withdrawal|2|||
17193517|NCT02719743|38346871|FG002|Overall Study|Consent withdrawal|0|||
17193518|NCT02719743|38346872|FG003|Overall Study|Consent withdrawal|1|||
17193519|NCT02719743|38346873|FG004|Overall Study|Consent withdrawal|0|||
17193520|NCT02719743|38346869|FG000|Overall Study|Migrated/moved from study area|0|||
17193521|NCT02719743|38346870|FG001|Overall Study|Migrated/moved from study area|0|||
17193522|NCT02719743|38346871|FG002|Overall Study|Migrated/moved from study area|0|||
17193523|NCT02719743|38346872|FG003|Overall Study|Migrated/moved from study area|0|||
17193524|NCT02719743|38346873|FG004|Overall Study|Migrated/moved from study area|2|||
17193525|NCT02719743|38346869|FG000|Overall Study|Lost to Follow-up|1|||
17193526|NCT02719743|38346870|FG001|Overall Study|Lost to Follow-up|1|||
17193527|NCT02719743|38346871|FG002|Overall Study|Lost to Follow-up|0|||
17193528|NCT02719743|38346872|FG003|Overall Study|Lost to Follow-up|0|||
17193529|NCT02719743|38346873|FG004|Overall Study|Lost to Follow-up|0|||
17193530|NCT02641730|38346888|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
17193531|NCT02641730|38346889|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
17193532|NCT02641730|38346890|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
17193533|NCT02641730|38346891|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
17193534|NCT02641730|38346892|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
17013174|NCT00880568|38157918|FG001|Overall Study|Withdrawal by Subject|0|||
17193535|NCT02641730|38346888|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
17193536|NCT02641730|38346889|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
17193537|NCT02641730|38346890|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
17193538|NCT02641730|38346891|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
17193539|NCT02641730|38346892|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
17097976|NCT00142584|38237144|FG000|Overall Study|Adverse Event|14|||
17097977|NCT00142584|38237145|FG001|Overall Study|Adverse Event|5|||
17097978|NCT00142584|38237144|FG000|Overall Study|Protocol Violation|4|||
17013175|NCT00880568|38157919|FG002|Overall Study|Withdrawal by Subject|0|||
17013176|NCT00880568|38157920|FG003|Overall Study|Withdrawal by Subject|0|||
17013177|NCT00880568|38157921|FG004|Overall Study|Withdrawal by Subject|0|||
17013178|NCT00880568|38157922|FG005|Overall Study|Withdrawal by Subject|0|||
17013179|NCT00880568|38157923|FG006|Overall Study|Withdrawal by Subject|0|||
17013180|NCT00880568|38157924|FG007|Overall Study|Withdrawal by Subject|1|||
17013181|NCT00880568|38157925|FG008|Overall Study|Withdrawal by Subject|0|||
17013182|NCT00881894|38157952|FG000|Overall Study|Consent withdrawn|0|||
17013183|NCT00881894|38157953|FG001|Overall Study|Consent withdrawn|1|||
17013184|NCT00881894|38157952|FG000|Overall Study|Other reasons for premature termination|1|||
17013185|NCT00881894|38157953|FG001|Overall Study|Other reasons for premature termination|2|||
17013186|NCT00711100|38157959|FG000|Overall Study|Lack of Efficacy|5|||
17013187|NCT00711100|38157959|FG000|Overall Study|Withdrawal by Subject|8|||
17013188|NCT00827931|38157977|FG000|Overall Study|Death|3|||
17013189|NCT00827931|38157978|FG001|Overall Study|Death|5|||
17097979|NCT00142584|38237145|FG001|Overall Study|Protocol Violation|7|||
17097980|NCT00142584|38237144|FG000|Overall Study|Treatment Failure|2|||
17097981|NCT00142584|38237145|FG001|Overall Study|Treatment Failure|0|||
17097982|NCT00126126|38237155|FG000|Overall Study|Lost to Follow-up|0|||
17097983|NCT00126126|38237156|FG001|Overall Study|Lost to Follow-up|2|||
17097984|NCT00125268|38237164|FG000|Overall Study|Withdrawal by Subject|1|||
17097985|NCT00125268|38237165|FG001|Overall Study|Withdrawal by Subject|1|||
17013190|NCT00827931|38157977|FG000|Overall Study|Adverse Event|1|||
17013191|NCT00827931|38157978|FG001|Overall Study|Adverse Event|0|||
17013192|NCT00827931|38157977|FG000|Overall Study|Lost to Follow-up|1|||
17013193|NCT00827931|38157978|FG001|Overall Study|Lost to Follow-up|0|||
17013194|NCT00827931|38157977|FG000|Overall Study|Withdrawal by Subject|0|||
17013195|NCT00827931|38157978|FG001|Overall Study|Withdrawal by Subject|1|||
17013196|NCT00827931|38157977|FG000|Overall Study|Other|1|||
17013197|NCT00827931|38157978|FG001|Overall Study|Other|0|||
17013198|NCT00526669|38157984|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
17013199|NCT00526669|38157985|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
17013200|NCT00526669|38157984|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
17097986|NCT00125190|38237171|FG000|Overall Study|Subject/Parent Decision|7|||
17097987|NCT00125190|38237171|FG000|Overall Study|Non-compliance|2|||
17097988|NCT00125190|38237171|FG000|Overall Study|Adverse Event|1|||
17013201|NCT00526669|38157985|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
17013202|NCT00526669|38157984|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
17013203|NCT00526669|38157985|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
17013204|NCT00526669|38157984|FG000|Combined Treatment Phase|Death|0|||
17013205|NCT00526669|38157985|FG001|Combined Treatment Phase|Death|2|||
17013206|NCT00710866|38157997|FG000|Overall Study|Protocol Violation|5|||
17013207|NCT00710866|38157998|FG001|Overall Study|Protocol Violation|4|||
17013208|NCT00710866|38157997|FG000|Overall Study|Withdrawal by Subject|2|||
17013209|NCT00710866|38157998|FG001|Overall Study|Withdrawal by Subject|1|||
17013210|NCT00710866|38157997|FG000|Overall Study|Lost to Follow-up|1|||
17013211|NCT00710866|38157998|FG001|Overall Study|Lost to Follow-up|0|||
17013212|NCT00710866|38157997|FG000|Overall Study|Failed to meet eligibility|1|||
17013213|NCT00710866|38157998|FG001|Overall Study|Failed to meet eligibility|1|||
17013214|NCT00827775|38158015|FG000|Overall Study|Withdrawal by Subject|0|||
17013215|NCT00827775|38158016|FG001|Overall Study|Withdrawal by Subject|5|||
17013216|NCT00827541|38158024|FG000|Overall Study|Exitus|1|||
17013217|NCT00827541|38158025|FG001|Overall Study|Exitus|8|||
17013218|NCT00827541|38158024|FG000|Overall Study|Other|1|||
17013219|NCT00827541|38158025|FG001|Overall Study|Other|3|||
17013220|NCT00827541|38158024|FG000|Overall Study|Pathogen not susceptible|1|||
17013221|NCT00827541|38158025|FG001|Overall Study|Pathogen not susceptible|0|||
17013222|NCT00827541|38158024|FG000|Overall Study|Lack of effectiveness|1|||
17013223|NCT00827541|38158025|FG001|Overall Study|Lack of effectiveness|0|||
17013224|NCT00518323|38158035|FG000|Overall Study|Lack of Efficacy|14|||
17013225|NCT00518323|38158036|FG001|Overall Study|Lack of Efficacy|2|||
17013226|NCT00518323|38158037|FG002|Overall Study|Lack of Efficacy|4|||
17013227|NCT00518323|38158038|FG003|Overall Study|Lack of Efficacy|20|||
17013228|NCT00518323|38158035|FG000|Overall Study|Withdrawal by Subject|1|||
17013229|NCT00518323|38158036|FG001|Overall Study|Withdrawal by Subject|2|||
17013230|NCT00518323|38158037|FG002|Overall Study|Withdrawal by Subject|4|||
17013231|NCT00518323|38158038|FG003|Overall Study|Withdrawal by Subject|2|||
17013232|NCT00518323|38158035|FG000|Overall Study|Lost to Follow-up|0|||
17013233|NCT00518323|38158036|FG001|Overall Study|Lost to Follow-up|2|||
17013234|NCT00518323|38158037|FG002|Overall Study|Lost to Follow-up|1|||
17013235|NCT00518323|38158038|FG003|Overall Study|Lost to Follow-up|3|||
17013236|NCT00518323|38158035|FG000|Overall Study|Adverse Event|1|||
17013237|NCT00518323|38158036|FG001|Overall Study|Adverse Event|1|||
17013238|NCT00518323|38158037|FG002|Overall Study|Adverse Event|1|||
17013239|NCT00518323|38158038|FG003|Overall Study|Adverse Event|0|||
17013240|NCT00518323|38158035|FG000|Overall Study|Prohibited medication and others|3|||
17097989|NCT00125190|38237171|FG000|Overall Study|Other|1|||
17097990|NCT00125190|38237171|FG000|Overall Study|Lost to Follow-up|4|||
17013241|NCT00518323|38158036|FG001|Overall Study|Prohibited medication and others|1|||
17013242|NCT00518323|38158037|FG002|Overall Study|Prohibited medication and others|1|||
17013243|NCT00518323|38158038|FG003|Overall Study|Prohibited medication and others|0|||
17013244|NCT00826449|38158050|FG000|Overall Study|Disease Progression|4|||
17013245|NCT00826449|38158050|FG000|Overall Study|Withdrawal by Subject|1|||
17013246|NCT00825825|38158055|FG000|First Medication Period (14 Days)|Adverse Event|1|||
17013247|NCT00825825|38158056|FG001|First Medication Period (14 Days)|Adverse Event|0|||
17013248|NCT00825825|38158057|FG002|First Medication Period (14 Days)|Adverse Event|0|||
17013249|NCT00825825|38158058|FG003|First Medication Period (14 Days)|Adverse Event|0|||
17013250|NCT00825825|38158059|FG004|First Medication Period (14 Days)|Adverse Event|0|||
17013251|NCT00825825|38158060|FG005|First Medication Period (14 Days)|Adverse Event|1|||
17013252|NCT00825825|38158055|FG000|First Medication Period (14 Days)|Physician Decision|2|||
17013253|NCT00825825|38158056|FG001|First Medication Period (14 Days)|Physician Decision|0|||
17013254|NCT00825825|38158057|FG002|First Medication Period (14 Days)|Physician Decision|1|||
17013255|NCT00825825|38158058|FG003|First Medication Period (14 Days)|Physician Decision|0|||
17013256|NCT00825825|38158059|FG004|First Medication Period (14 Days)|Physician Decision|0|||
17013257|NCT00825825|38158060|FG005|First Medication Period (14 Days)|Physician Decision|1|||
17013258|NCT00825825|38158055|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
17013259|NCT00825825|38158056|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
17013260|NCT00825825|38158057|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
17013261|NCT00825825|38158058|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
17013262|NCT00825825|38158059|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
17013263|NCT00825825|38158060|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
17013264|NCT00825825|38158055|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
17013265|NCT00825825|38158056|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
17097991|NCT00141726|38237176|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
17097992|NCT00111228|38237183|FG000|Overall Study|Withdrawal by Subject|5|||
17097993|NCT00111228|38237184|FG001|Overall Study|Withdrawal by Subject|1|||
17097994|NCT00111228|38237185|FG002|Overall Study|Withdrawal by Subject|0|||
17097995|NCT00110994|38237195|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
17097996|NCT00110994|38237196|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
17097997|NCT00110994|38237195|FG000|Double-blind (DB) Treatment|Death|1|||
17097998|NCT00110994|38237196|FG001|Double-blind (DB) Treatment|Death|0|||
17097999|NCT00110994|38237195|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
17098000|NCT00110994|38237196|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
17098001|NCT00110994|38237195|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
17098002|NCT00110994|38237196|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
17098003|NCT00110994|38237195|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
17098004|NCT00110994|38237196|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
17013266|NCT00825825|38158057|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
17013267|NCT00825825|38158058|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
17013268|NCT00825825|38158059|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
17013269|NCT00825825|38158060|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
17013270|NCT00825825|38158055|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
17013271|NCT00825825|38158056|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
17013272|NCT00825825|38158057|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
17013273|NCT00825825|38158058|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
17013274|NCT00825825|38158059|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
17013275|NCT00825825|38158060|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
17013276|NCT00825825|38158055|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
17013277|NCT00825825|38158056|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
17013278|NCT00825825|38158057|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
17013279|NCT00825825|38158058|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
17013280|NCT00825825|38158059|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
17013281|NCT00825825|38158060|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
17013282|NCT00825825|38158055|FG000|Third Medication Period (14 Days)|poor data quality|0|||
17013283|NCT00825825|38158056|FG001|Third Medication Period (14 Days)|poor data quality|1|||
17013284|NCT00825825|38158057|FG002|Third Medication Period (14 Days)|poor data quality|0|||
17013285|NCT00825825|38158058|FG003|Third Medication Period (14 Days)|poor data quality|0|||
17013286|NCT00825825|38158059|FG004|Third Medication Period (14 Days)|poor data quality|0|||
17013287|NCT00825825|38158060|FG005|Third Medication Period (14 Days)|poor data quality|0|||
17013288|NCT00710710|38158069|FG000|Overall Study|Consent withdrawn|2|||
17013289|NCT00710710|38158070|FG001|Overall Study|Consent withdrawn|2|||
17013290|NCT00710710|38158069|FG000|Overall Study|Protocol Violation|0|||
17013291|NCT00710710|38158070|FG001|Overall Study|Protocol Violation|1|||
17013292|NCT00710710|38158069|FG000|Overall Study|Adverse Event|3|||
17013293|NCT00710710|38158070|FG001|Overall Study|Adverse Event|3|||
17098005|NCT00110994|38237195|FG000|Double-blind (DB) Treatment|other reasons|2|||
17098006|NCT00110994|38237196|FG001|Double-blind (DB) Treatment|other reasons|3|||
17013294|NCT00710710|38158069|FG000|Overall Study|Progressive disease|40|||
17013295|NCT00710710|38158070|FG001|Overall Study|Progressive disease|38|||
17013296|NCT00880334|38158078|FG000|Randomized Phase|Physician Decision|1|||
17013297|NCT00880334|38158079|FG001|Randomized Phase|Physician Decision|0|||
17013298|NCT00880334|38158078|FG000|Randomized Phase|Withdrawal by Subject|2|||
17013299|NCT00880334|38158079|FG001|Randomized Phase|Withdrawal by Subject|1|||
17013300|NCT00880334|38158078|FG000|Randomized Phase|Inadequate Labs|1|||
17013301|NCT00880334|38158079|FG001|Randomized Phase|Inadequate Labs|1|||
17013302|NCT00880334|38158078|FG000|Randomized Phase|Brain Metastasis|0|||
17013303|NCT00880334|38158079|FG001|Randomized Phase|Brain Metastasis|1|||
17013304|NCT00880334|38158078|FG000|Randomized Phase|Crossover Participants|0|||
17013305|NCT00880334|38158079|FG001|Randomized Phase|Crossover Participants|37|||
17013306|NCT00865566|38158095|FG000|Overall Study|Death|1|||
17013307|NCT00865566|38158096|FG001|Overall Study|Death|11|||
17013308|NCT00865566|38158095|FG000|Overall Study|Lost to Follow-up|314|||
17013309|NCT00865566|38158096|FG001|Overall Study|Lost to Follow-up|315|||
17013310|NCT00865566|38158095|FG000|Overall Study|Withdrawal by Subject|45|||
17013311|NCT00865566|38158096|FG001|Overall Study|Withdrawal by Subject|65|||
17013312|NCT00865566|38158095|FG000|Overall Study|Physician Decision|0|||
17013313|NCT00865566|38158096|FG001|Overall Study|Physician Decision|1|||
17013314|NCT00865566|38158095|FG000|Overall Study|Participant relocated|78|||
17098007|NCT00110994|38237195|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
17098008|NCT00110994|38237196|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
17098009|NCT00110994|38237195|FG000|Active Follow-up|Other reasons|0|||
17098010|NCT00110994|38237196|FG001|Active Follow-up|Other reasons|2|||
17098011|NCT00110994|38237195|FG000|Long Term Follow-up|Death|19|||
17098012|NCT00110994|38237196|FG001|Long Term Follow-up|Death|17|||
17098013|NCT00144170|38237204|FG000|Overall Study|Adverse Event|84|||
17098014|NCT00144170|38237205|FG001|Overall Study|Adverse Event|41|||
17098015|NCT00144170|38237204|FG000|Overall Study|Protocol Violation|23|||
17098016|NCT00144170|38237205|FG001|Overall Study|Protocol Violation|16|||
17098017|NCT00144170|38237204|FG000|Overall Study|Lost to Follow-up|5|||
17098018|NCT00144170|38237205|FG001|Overall Study|Lost to Follow-up|10|||
17098019|NCT00144170|38237204|FG000|Overall Study|Withdrawal by Subject|29|||
17098020|NCT00144170|38237205|FG001|Overall Study|Withdrawal by Subject|13|||
17098021|NCT00144170|38237204|FG000|Overall Study|Other reason not defined above|211|||
17098022|NCT00144170|38237205|FG001|Overall Study|Other reason not defined above|316|||
17013315|NCT00865566|38158096|FG001|Overall Study|Participant relocated|107|||
17013316|NCT00865566|38158095|FG000|Overall Study|Participant unable to adhere|27|||
17013317|NCT00865566|38158096|FG001|Overall Study|Participant unable to adhere|42|||
17013318|NCT00865566|38158095|FG000|Overall Study|Other; N=245 due to early study closure|154|||
17013319|NCT00865566|38158096|FG001|Overall Study|Other; N=245 due to early study closure|139|||
17013320|NCT00865566|38158095|FG000|Overall Study|HIV infection|5|||
17013321|NCT00865566|38158096|FG001|Overall Study|HIV infection|7|||
17013322|NCT03866473|38158104|FG000|Phase 1|Death|1|||
17013323|NCT03866473|38158105|FG001|Phase 1|Death|0|||
17013324|NCT03866473|38158104|FG000|Phase 2|Death|0|||
17013325|NCT03866473|38158105|FG001|Phase 2|Death|2|||
17013326|NCT03866473|38158104|FG000|Phase 2|Dropped|1|||
17098023|NCT00255086|38237213|FG000|Overall Study|Adverse Event|1|||
17098024|NCT00255086|38237214|FG001|Overall Study|Adverse Event|1|||
17098025|NCT00255086|38237213|FG000|Overall Study|Protocol Violation|1|||
17098026|NCT00255086|38237214|FG001|Overall Study|Protocol Violation|1|||
17098027|NCT00110214|38237223|FG000|Overall Study|Never started treatment|21|||
17098028|NCT00110214|38237224|FG001|Overall Study|Never started treatment|20|||
17098029|NCT00110214|38237223|FG000|Overall Study|Disease progression or death|260|||
17098030|NCT00110214|38237224|FG001|Overall Study|Disease progression or death|151|||
17098031|NCT00110214|38237223|FG000|Overall Study|Adverse Event|115|||
17098032|NCT00110214|38237224|FG001|Overall Study|Adverse Event|192|||
17013327|NCT03866473|38158105|FG001|Phase 2|Dropped|1|||
17013328|NCT03866473|38158104|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
17013329|NCT03866473|38158105|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
17013330|NCT00710554|38158117|FG000|Overall Study|Adverse Event|24|||
17013331|NCT00710554|38158118|FG001|Overall Study|Adverse Event|7|||
17013332|NCT00710554|38158117|FG000|Overall Study|Withdrawal by Subject|7|||
17013333|NCT00710554|38158118|FG001|Overall Study|Withdrawal by Subject|3|||
17013334|NCT00710554|38158117|FG000|Overall Study|Lost to Follow-up|7|||
17013335|NCT00710554|38158118|FG001|Overall Study|Lost to Follow-up|1|||
17013336|NCT00710554|38158117|FG000|Overall Study|Lack of Efficacy|11|||
17013337|NCT00710554|38158118|FG001|Overall Study|Lack of Efficacy|12|||
17013338|NCT00710554|38158117|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
17013339|NCT00710554|38158118|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
17098033|NCT00110214|38237223|FG000|Overall Study|Refused further treatment|52|||
17013340|NCT00525499|38158128|FG000|Overall Study|Lost to Follow-up|2|||
17013341|NCT00525499|38158129|FG001|Overall Study|Lost to Follow-up|4|||
17013342|NCT00525499|38158130|FG002|Overall Study|Lost to Follow-up|1|||
17013343|NCT00525499|38158131|FG003|Overall Study|Lost to Follow-up|4|||
17013344|NCT00525499|38158128|FG000|Overall Study|Adverse Event|0|||
17013345|NCT00525499|38158129|FG001|Overall Study|Adverse Event|1|||
17013346|NCT00525499|38158130|FG002|Overall Study|Adverse Event|0|||
17013347|NCT00525499|38158131|FG003|Overall Study|Adverse Event|1|||
17013348|NCT00525499|38158128|FG000|Overall Study|Withdrawal by Subject|5|||
17013349|NCT00525499|38158129|FG001|Overall Study|Withdrawal by Subject|1|||
17013350|NCT00525499|38158130|FG002|Overall Study|Withdrawal by Subject|5|||
17013351|NCT00525499|38158131|FG003|Overall Study|Withdrawal by Subject|2|||
17013352|NCT00525499|38158128|FG000|Overall Study|Protocol Violation|0|||
17013353|NCT00525499|38158129|FG001|Overall Study|Protocol Violation|1|||
17013354|NCT00525499|38158130|FG002|Overall Study|Protocol Violation|1|||
17013355|NCT00525499|38158131|FG003|Overall Study|Protocol Violation|0|||
17013356|NCT00824655|38158143|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
17013357|NCT00824655|38158144|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
17013358|NCT00824655|38158143|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
17098034|NCT00110214|38237224|FG001|Overall Study|Refused further treatment|65|||
17098035|NCT00110214|38237223|FG000|Overall Study|Other (not specified)|61|||
17098036|NCT00110214|38237224|FG001|Overall Study|Other (not specified)|75|||
17098037|NCT00124020|38237232|FG000|Overall Study|Death|67|||
17098038|NCT00124020|38237233|FG001|Overall Study|Death|71|||
17098039|NCT00124020|38237232|FG000|Overall Study|Withdrawal by Subject|13|||
17098040|NCT00124020|38237233|FG001|Overall Study|Withdrawal by Subject|11|||
17098041|NCT00124020|38237232|FG000|Overall Study|Lost to Follow-up|5|||
17098042|NCT00124020|38237233|FG001|Overall Study|Lost to Follow-up|8|||
17098043|NCT00124020|38237232|FG000|Overall Study|Other|1|||
17098044|NCT00124020|38237233|FG001|Overall Study|Other|1|||
17098045|NCT00124020|38237232|FG000|Overall Study|Transfer to another hospital|2|||
17098046|NCT00124020|38237233|FG001|Overall Study|Transfer to another hospital|0|||
17098047|NCT00215540|38237242|FG000|Overall Study|Withdrew from study medication|1|||
17098048|NCT00215540|38237243|FG001|Overall Study|Withdrew from study medication|0|||
17098049|NCT00215540|38237244|FG002|Overall Study|Withdrew from study medication|0|||
17098050|NCT00143390|38237254|FG000|Overall Study|Death|2|||
17098051|NCT00143390|38237255|FG001|Overall Study|Death|0|||
17098052|NCT00143390|38237254|FG000|Overall Study|Not meeting entry criteria|2|||
17098053|NCT00143390|38237255|FG001|Overall Study|Not meeting entry criteria|5|||
17098054|NCT00143390|38237254|FG000|Overall Study|Withdrawal by Subject|4|||
17098055|NCT00143390|38237255|FG001|Overall Study|Withdrawal by Subject|4|||
17098056|NCT00143390|38237254|FG000|Overall Study|Progressive disease|119|||
17098057|NCT00143390|38237255|FG001|Overall Study|Progressive disease|115|||
17098058|NCT00143390|38237254|FG000|Overall Study|Protocol Violation|2|||
17098059|NCT00143390|38237255|FG001|Overall Study|Protocol Violation|0|||
17098060|NCT00143390|38237254|FG000|Overall Study|Study termination|10|||
17098061|NCT00143390|38237255|FG001|Overall Study|Study termination|15|||
17098062|NCT00143390|38237254|FG000|Overall Study|Adverse Event|9|||
17098063|NCT00143390|38237255|FG001|Overall Study|Adverse Event|8|||
17098064|NCT00143390|38237254|FG000|Overall Study|Other|1|||
17098065|NCT00143390|38237255|FG001|Overall Study|Other|2|||
17098066|NCT00141102|38237263|FG000|Overall Study|Adverse Event|233|||
17098067|NCT00141102|38237264|FG001|Overall Study|Adverse Event|305|||
17098068|NCT00141102|38237263|FG000|Overall Study|Laboratory Abnormality|9|||
17098069|NCT00141102|38237264|FG001|Overall Study|Laboratory Abnormality|33|||
17098070|NCT00141102|38237263|FG000|Overall Study|Lack of Efficacy|21|||
17098071|NCT00141102|38237264|FG001|Overall Study|Lack of Efficacy|26|||
17098072|NCT00141102|38237263|FG000|Overall Study|Lost to Follow-up|29|||
17098073|NCT00141102|38237264|FG001|Overall Study|Lost to Follow-up|32|||
17098074|NCT00141102|38237263|FG000|Overall Study|Other|87|||
17098075|NCT00141102|38237264|FG001|Overall Study|Other|76|||
17098076|NCT00141102|38237263|FG000|Overall Study|Withdrawal by Subject|112|||
17098077|NCT00141102|38237264|FG001|Overall Study|Withdrawal by Subject|142|||
17098078|NCT00141102|38237263|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
17098079|NCT00141102|38237264|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
17098080|NCT00141102|38237263|FG000|Overall Study|Death|2|||
17098081|NCT00141102|38237264|FG001|Overall Study|Death|2|||
17098082|NCT00255008|38237275|FG000|Overall Study|Adverse Event|1|||
17098083|NCT00255008|38237276|FG001|Overall Study|Adverse Event|1|||
17098084|NCT00255008|38237277|FG002|Overall Study|Adverse Event|2|||
17098085|NCT00255008|38237278|FG003|Overall Study|Adverse Event|0|||
17098086|NCT00255008|38237275|FG000|Overall Study|Lost to Follow-up|1|||
17098087|NCT00255008|38237276|FG001|Overall Study|Lost to Follow-up|0|||
17098088|NCT00255008|38237277|FG002|Overall Study|Lost to Follow-up|1|||
17098089|NCT00255008|38237278|FG003|Overall Study|Lost to Follow-up|2|||
17098090|NCT00255008|38237275|FG000|Overall Study|Did not meet viral reduction criteria|4|||
17098091|NCT00255008|38237276|FG001|Overall Study|Did not meet viral reduction criteria|5|||
17098092|NCT00255008|38237277|FG002|Overall Study|Did not meet viral reduction criteria|0|||
17098093|NCT00255008|38237278|FG003|Overall Study|Did not meet viral reduction criteria|1|||
17098094|NCT00255008|38237275|FG000|Overall Study|Withdrew consent|0|||
17098095|NCT00255008|38237276|FG001|Overall Study|Withdrew consent|0|||
17098096|NCT00255008|38237277|FG002|Overall Study|Withdrew consent|2|||
17013359|NCT00824655|38158144|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
17013360|NCT00525265|38158154|FG000|Overall Study|Protocol Violation|1|||
17013361|NCT00525265|38158155|FG001|Overall Study|Protocol Violation|0|||
17013362|NCT00880256|38158161|FG000|Overall Study|Lost to Follow-up|28|||
17013363|NCT03865381|38158170|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
17013364|NCT03865381|38158170|FG000|Overall Study|Withdrawal by Subject|2|||
17013365|NCT00713206|38158176|FG000|Overall Study|Lost to Follow-up|4|||
17013366|NCT00713206|38158177|FG001|Overall Study|Lost to Follow-up|4|||
17013367|NCT00713206|38158176|FG000|Overall Study|Death|1|||
17013368|NCT00713206|38158177|FG001|Overall Study|Death|0|||
17013369|NCT00865098|38158183|FG000|Overall Study|Progressive disease|1|||
17013370|NCT00880100|38158187|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
17013371|NCT00880100|38158187|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
17013372|NCT00880100|38158187|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
17013373|NCT00518011|38158193|FG000|Overall Study|Death|1|||
17013374|NCT00518011|38158194|FG001|Overall Study|Death|1|||
17013375|NCT00518011|38158193|FG000|Overall Study|Adverse Event|2|||
17013376|NCT00518011|38158194|FG001|Overall Study|Adverse Event|3|||
17013377|NCT00518011|38158193|FG000|Overall Study|Disease Progression|2|||
17013378|NCT00518011|38158194|FG001|Overall Study|Disease Progression|2|||
17013379|NCT00518011|38158193|FG000|Overall Study|Other Reasons|3|||
17013380|NCT00518011|38158194|FG001|Overall Study|Other Reasons|2|||
17013381|NCT00518011|38158193|FG000|Overall Study|Withdrawal by Subject|1|||
17013382|NCT00518011|38158194|FG001|Overall Study|Withdrawal by Subject|0|||
17013383|NCT00865020|38158203|FG000|Overall Study|Withdrawal by Subject|22|||
17013384|NCT00865020|38158204|FG001|Overall Study|Withdrawal by Subject|16|||
17013385|NCT00865020|38158203|FG000|Overall Study|Adverse Event|9|||
17013386|NCT00865020|38158204|FG001|Overall Study|Adverse Event|14|||
17013387|NCT00865020|38158203|FG000|Overall Study|Abnormal test procedure result(s)|6|||
17013388|NCT00865020|38158204|FG001|Overall Study|Abnormal test procedure result(s)|8|||
17013389|NCT00865020|38158203|FG000|Overall Study|Lost to Follow-up|6|||
17013390|NCT00865020|38158204|FG001|Overall Study|Lost to Follow-up|4|||
17013391|NCT00865020|38158203|FG000|Overall Study|Protocol deviation|4|||
17013392|NCT00865020|38158204|FG001|Overall Study|Protocol deviation|1|||
17098097|NCT00255008|38237278|FG003|Overall Study|Withdrew consent|0|||
17098098|NCT00255008|38237275|FG000|Overall Study|Sponsor request|18|||
17098099|NCT00255008|38237276|FG001|Overall Study|Sponsor request|3|||
17098100|NCT00255008|38237277|FG002|Overall Study|Sponsor request|8|||
17098101|NCT00255008|38237278|FG003|Overall Study|Sponsor request|17|||
17098102|NCT00255008|38237275|FG000|Overall Study|Adverse lab experience|1|||
17098103|NCT00255008|38237276|FG001|Overall Study|Adverse lab experience|0|||
17098104|NCT00255008|38237277|FG002|Overall Study|Adverse lab experience|0|||
17098105|NCT00255008|38237278|FG003|Overall Study|Adverse lab experience|0|||
17098106|NCT00255008|38237275|FG000|Overall Study|Other|7|||
17098107|NCT00255008|38237276|FG001|Overall Study|Other|0|||
17098108|NCT00255008|38237277|FG002|Overall Study|Other|3|||
17098109|NCT00255008|38237278|FG003|Overall Study|Other|2|||
17098110|NCT03714022|38237290|FG000|Overall Study|Adverse Event|1|||
17098111|NCT03714022|38237291|FG001|Overall Study|Adverse Event|0|||
17098112|NCT03714022|38237290|FG000|Overall Study|Consent withdrawal|0|||
17013393|NCT00865020|38158203|FG000|Overall Study|Administrative problems|0|||
17013394|NCT00865020|38158204|FG001|Overall Study|Administrative problems|2|||
17013395|NCT00865020|38158203|FG000|Overall Study|Abnormal laboratory value(s)|0|||
17013396|NCT00865020|38158204|FG001|Overall Study|Abnormal laboratory value(s)|1|||
17013397|NCT00865020|38158203|FG000|Overall Study|Death|0|||
17013398|NCT00865020|38158204|FG001|Overall Study|Death|1|||
17013399|NCT00865020|38158203|FG000|Overall Study|Randomized but discontinued|2|||
17013400|NCT00865020|38158204|FG001|Overall Study|Randomized but discontinued|4|||
17013401|NCT00517933|38158212|FG000|Period 1|Death|2|||
17013402|NCT00517933|38158213|FG001|Period 1|Death|1|||
17013403|NCT00517933|38158212|FG000|Period 1|Adverse Event|4|||
17013404|NCT00517933|38158213|FG001|Period 1|Adverse Event|4|||
17013405|NCT00517933|38158212|FG000|Period 1|Lost to Follow-up|2|||
17013406|NCT00517933|38158213|FG001|Period 1|Lost to Follow-up|0|||
17013407|NCT00517933|38158212|FG000|Period 1|Underwent lung transplant|0|||
17013408|NCT00517933|38158213|FG001|Period 1|Underwent lung transplant|1|||
17013409|NCT00517933|38158212|FG000|Period 2|Death|2|||
17013410|NCT00517933|38158213|FG001|Period 2|Death|4|||
17013411|NCT00517933|38158212|FG000|Period 2|Adverse Event|2|||
17013412|NCT00517933|38158213|FG001|Period 2|Adverse Event|4|||
17013413|NCT00517933|38158212|FG000|Period 2|Physician Decision|1|||
16786318|NCT02679235|37726726|FG000|Overall Study|Adverse Event|1|||
17098113|NCT03714022|38237291|FG001|Overall Study|Consent withdrawal|1|||
17013414|NCT00517933|38158213|FG001|Period 2|Physician Decision|0|||
17013415|NCT00517933|38158212|FG000|Period 2|Withdrawal by Subject|1|||
17013416|NCT00517933|38158213|FG001|Period 2|Withdrawal by Subject|3|||
17013417|NCT00517933|38158212|FG000|Period 2|Underwent lung transplant|0|||
17013418|NCT00517933|38158213|FG001|Period 2|Underwent lung transplant|2|||
17013419|NCT00701038|38158224|FG000|Overall Study|study amended pilot group of patients|4|||
17098114|NCT03714022|38237290|FG000|Overall Study|Lost to Follow-up|3|||
17013420|NCT00701038|38158225|FG001|Overall Study|study amended pilot group of patients|4|||
17013421|NCT00857766|38158244|FG000|Overall Study|Adverse Event|13|||
17013422|NCT00857766|38158245|FG001|Overall Study|Adverse Event|12|||
17013423|NCT00857766|38158244|FG000|Overall Study|Protocol Violation|11|||
17013424|NCT00857766|38158245|FG001|Overall Study|Protocol Violation|11|||
17013425|NCT00857766|38158244|FG000|Overall Study|Lost to Follow-up|1|||
17013426|NCT00857766|38158245|FG001|Overall Study|Lost to Follow-up|0|||
17013427|NCT00857766|38158244|FG000|Overall Study|Investigator Discretion|2|||
17013428|NCT00857766|38158245|FG001|Overall Study|Investigator Discretion|3|||
17013429|NCT00857766|38158244|FG000|Overall Study|Participant Withdrew Consent|4|||
17098115|NCT03714022|38237291|FG001|Overall Study|Lost to Follow-up|2|||
17098116|NCT00143312|38237297|FG000|Overall Study|Death|11|||
17098117|NCT00143312|38237297|FG000|Overall Study|Adverse Event|2|||
17098118|NCT00143312|38237297|FG000|Overall Study|Lost to Follow-up|1|||
17098119|NCT00143312|38237297|FG000|Overall Study|Other|1|||
17098120|NCT00143312|38237297|FG000|Overall Study|Withdrawal by Subject|1|||
17013430|NCT00857766|38158245|FG001|Overall Study|Participant Withdrew Consent|4|||
17013431|NCT00517699|38158251|FG000|Overall Study|Withdrawal by Subject|1|||
17013432|NCT00517699|38158251|FG000|Overall Study|Lack of Efficacy|1|||
17013433|NCT00517699|38158251|FG000|Overall Study|Administrative error|1|||
17013434|NCT00517699|38158251|FG000|Overall Study|Study terminated by Sponsor|2|||
17013435|NCT00857454|38158255|FG000|Overall Study|Withdrawal by Subject|2|||
17013436|NCT00857454|38158255|FG000|Overall Study|Lost to Follow-up|1|||
17013437|NCT00857454|38158255|FG000|Overall Study|Adverse Event|2|||
17013438|NCT00857454|38158255|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
17013439|NCT00857454|38158255|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
17013440|NCT00857454|38158255|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
17013441|NCT00525031|38158261|FG000|Overall Study|Disease Progression|1|||
17013442|NCT00525031|38158262|FG001|Overall Study|Disease Progression|1|||
17013443|NCT00524485|38158269|FG000|Overall Study|Withdrawal by Subject|5|||
17013444|NCT00857220|38158273|FG000|Overall Study|Adverse Event|35|||
17013445|NCT00857220|38158273|FG000|Overall Study|Death|1|||
17013446|NCT00857220|38158273|FG000|Overall Study|Lack of Efficacy|11|||
17013447|NCT00857220|38158273|FG000|Overall Study|Lost to Follow-up|30|||
17098121|NCT00254540|38237303|FG000|Overall Study|Adverse Event|6|||
17098122|NCT00254540|38237304|FG001|Overall Study|Adverse Event|7|||
17098123|NCT00254540|38237303|FG000|Overall Study|Lack of Efficacy|13|||
17098124|NCT00254540|38237304|FG001|Overall Study|Lack of Efficacy|13|||
17098125|NCT00254540|38237303|FG000|Overall Study|Death|0|||
17098126|NCT00254540|38237304|FG001|Overall Study|Death|1|||
17013448|NCT00857220|38158273|FG000|Overall Study|Physician Decision|4|||
17098127|NCT00254540|38237303|FG000|Overall Study|Laboratory Test Abnormality|0|||
17098128|NCT00254540|38237304|FG001|Overall Study|Laboratory Test Abnormality|1|||
17098129|NCT00139776|38237313|FG000|Period I|Did not enter Period II|575|||
17098130|NCT00139776|38237314|FG001|Period I|Did not enter Period II|0|||
17098131|NCT00139776|38237315|FG002|Period I|Did not enter Period II|0|||
17098132|NCT00139776|38237316|FG003|Period I|Did not enter Period II|0|||
17013449|NCT00857220|38158273|FG000|Overall Study|Protocol Violation|16|||
17013450|NCT00857220|38158273|FG000|Overall Study|Withdrawal by Subject|67|||
17013451|NCT00857220|38158273|FG000|Overall Study|Clinical Hold|6|||
17013452|NCT00857220|38158273|FG000|Overall Study|Site Closed|5|||
17013453|NCT00857220|38158273|FG000|Overall Study|Miscellaneous|8|||
17013454|NCT00524173|38158279|FG000|Overall Study|Lost to Follow-up|0|||
17013455|NCT00524173|38158280|FG001|Overall Study|Lost to Follow-up|1|||
17013456|NCT00524173|38158279|FG000|Overall Study|Death|1|||
17013457|NCT00524173|38158280|FG001|Overall Study|Death|0|||
17013458|NCT00524173|38158279|FG000|Overall Study|Had not reached endpoint at study close|4|||
17013459|NCT00524173|38158280|FG001|Overall Study|Had not reached endpoint at study close|1|||
17013460|NCT00879710|38158288|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
17013461|NCT00879710|38158289|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
17013462|NCT00879710|38158290|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
17013463|NCT00879710|38158291|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
17013464|NCT00879710|38158288|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
17013465|NCT00879710|38158289|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
17098133|NCT00139776|38237313|FG000|Period II|Not Randomized into Period III|0|||
17098134|NCT00139776|38237314|FG001|Period II|Not Randomized into Period III|322|||
17098135|NCT00139776|38237315|FG002|Period II|Not Randomized into Period III|0|||
17013466|NCT00879710|38158290|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
17013467|NCT00879710|38158291|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
17013468|NCT00597506|38158299|FG000|Overall Study|Subject is being followed for survival|1|||
17013469|NCT00708682|38158312|FG000|Infant Series|Adverse Event|1|||
17013470|NCT00708682|38158312|FG000|Infant Series|Lost to Follow-up|4|||
17013471|NCT00708682|38158312|FG000|Infant Series|Protocol Violation|1|||
17013472|NCT00708682|38158312|FG000|Infant Series|Parent/legal guardian request|6|||
17013473|NCT00708682|38158312|FG000|Infant Series|Failed to return|2|||
17013474|NCT00708682|38158312|FG000|Infant Series|Other|19|||
17013475|NCT00708682|38158312|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
17013476|NCT00708682|38158312|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
17013477|NCT00708682|38158312|FG000|Toddler Dose|Lost to Follow-up|3|||
17013478|NCT00708682|38158312|FG000|Toddler Dose|Failed to Return|4|||
17013479|NCT00712348|38158318|FG000|Overall Study|Withdrawal by Subject|1|||
17013480|NCT00881504|38158322|FG000|Overall Study|Withdrawal by Subject|1|||
17013481|NCT01936831|38158339|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
17013482|NCT01936831|38158340|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
17013483|NCT01936831|38158341|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
17013484|NCT01936831|38158342|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
17013485|NCT01936831|38158343|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
17013486|NCT01936831|38158344|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
17013487|NCT01936831|38158345|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
17013488|NCT01936831|38158346|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
17013489|NCT01936831|38158347|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
17013490|NCT03863353|38158364|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
17013491|NCT03863353|38158365|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
17013492|NCT00523705|38158373|FG000|Overall Study|No time for study.|0|||
17013493|NCT00523705|38158374|FG001|Overall Study|No time for study.|1|||
17013494|NCT00523549|38158387|FG000|Overall Study|Adverse Event|6|||
17013495|NCT00523549|38158388|FG001|Overall Study|Adverse Event|3|||
17013496|NCT00523549|38158387|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
17013497|NCT00523549|38158388|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
17013498|NCT00523549|38158387|FG000|Overall Study|Protocol Deviation|3|||
17013499|NCT00523549|38158388|FG001|Overall Study|Protocol Deviation|1|||
17013500|NCT00523549|38158387|FG000|Overall Study|Patient withdrew consent|7|||
17013501|NCT00523549|38158388|FG001|Overall Study|Patient withdrew consent|6|||
17013502|NCT00523549|38158387|FG000|Overall Study|Lost to Follow-up|3|||
17013503|NCT00523549|38158388|FG001|Overall Study|Lost to Follow-up|5|||
17013504|NCT03504085|38158396|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
17013505|NCT03504085|38158397|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
17013506|NCT03504085|38158396|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
17013507|NCT03504085|38158397|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
17013508|NCT00700102|38158405|FG000|Overall Study|Died|394|||
17013509|NCT00700102|38158406|FG001|Overall Study|Died|385|||
17013510|NCT00700102|38158405|FG000|Overall Study|Lost to Follow-up|8|||
17013511|NCT00700102|38158406|FG001|Overall Study|Lost to Follow-up|10|||
17013512|NCT00595478|38158414|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
17013513|NCT00595478|38158415|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
17013514|NCT00595478|38158414|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
17013515|NCT00595478|38158415|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
17013516|NCT00516295|38158424|FG000|Overall Study|Lack of Efficacy|2|||
17013517|NCT00516295|38158425|FG001|Overall Study|Lack of Efficacy|0|||
17013518|NCT00516295|38158426|FG002|Overall Study|Lack of Efficacy|0|||
17013519|NCT00516295|38158424|FG000|Overall Study|Ineligible|1|||
17013520|NCT00516295|38158425|FG001|Overall Study|Ineligible|0|||
17013521|NCT00516295|38158426|FG002|Overall Study|Ineligible|0|||
17013522|NCT03861559|38158436|FG000|Overall Study|Adverse Event|0|||
17098136|NCT00139776|38237316|FG003|Period II|Not Randomized into Period III|0|||
17098137|NCT00139776|38237313|FG000|Period III|Adverse Event|0|||
17098138|NCT00139776|38237314|FG001|Period III|Adverse Event|0|||
17098139|NCT00139776|38237315|FG002|Period III|Adverse Event|22|||
17098140|NCT00139776|38237316|FG003|Period III|Adverse Event|23|||
17098141|NCT00139776|38237313|FG000|Period III|Other|0|||
17098142|NCT00139776|38237314|FG001|Period III|Other|0|||
17098143|NCT00139776|38237315|FG002|Period III|Other|23|||
17098144|NCT00139776|38237316|FG003|Period III|Other|34|||
17098145|NCT00139776|38237313|FG000|Period III|Lack of Efficacy|0|||
17098146|NCT00139776|38237314|FG001|Period III|Lack of Efficacy|0|||
17098147|NCT00139776|38237315|FG002|Period III|Lack of Efficacy|10|||
17098148|NCT00139776|38237316|FG003|Period III|Lack of Efficacy|24|||
17098149|NCT00139776|38237313|FG000|Period III|Lost to Follow-up|0|||
17193540|NCT02641730|38346888|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
17013523|NCT03861559|38158437|FG001|Overall Study|Adverse Event|2|||
17013524|NCT03861559|38158436|FG000|Overall Study|Treatment failure|0|||
17013525|NCT03861559|38158437|FG001|Overall Study|Treatment failure|2|||
17013526|NCT03861559|38158436|FG000|Overall Study|Noncompliance|1|||
17098150|NCT00139776|38237314|FG001|Period III|Lost to Follow-up|0|||
17098151|NCT00139776|38237315|FG002|Period III|Lost to Follow-up|5|||
17193541|NCT02641730|38346889|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
17193542|NCT02641730|38346890|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
17013527|NCT03861559|38158437|FG001|Overall Study|Noncompliance|1|||
17013528|NCT03861559|38158436|FG000|Overall Study|Did not meet eligibility requirements|1|||
17013529|NCT03861559|38158437|FG001|Overall Study|Did not meet eligibility requirements|0|||
17013530|NCT00516139|38158443|FG000|Overall Study|Adverse Event|27|||
17013531|NCT00516139|38158443|FG000|Overall Study|Lost to Follow-up|1|||
17013532|NCT00516139|38158443|FG000|Overall Study|Protocol Violation|1|||
17098152|NCT00139776|38237316|FG003|Period III|Lost to Follow-up|4|||
17098153|NCT00139776|38237313|FG000|Period III|Withdrawal by Subject|0|||
17013533|NCT00516139|38158443|FG000|Overall Study|Withdrawal by Subject|8|||
17013534|NCT00516139|38158443|FG000|Overall Study|Lack of Efficacy|1|||
17013535|NCT00879086|38158453|FG000|Overall Study|Adverse Event|3|||
17013536|NCT00879086|38158454|FG001|Overall Study|Adverse Event|15|||
17013537|NCT00879086|38158453|FG000|Overall Study|Participant choice|2|||
17013538|NCT00879086|38158454|FG001|Overall Study|Participant choice|2|||
17013539|NCT00879086|38158453|FG000|Overall Study|Progression of disease|40|||
17013540|NCT00879086|38158454|FG001|Overall Study|Progression of disease|26|||
17013541|NCT00879086|38158453|FG000|Overall Study|Withdrawal of consent|2|||
17013542|NCT00879086|38158454|FG001|Overall Study|Withdrawal of consent|1|||
17013543|NCT00879086|38158453|FG000|Overall Study|Other|4|||
17013544|NCT00879086|38158454|FG001|Overall Study|Other|6|||
17013545|NCT00879086|38158453|FG000|Overall Study|Death|1|||
17013546|NCT00879086|38158454|FG001|Overall Study|Death|2|||
17013547|NCT00515827|38158462|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
17098154|NCT00139776|38237314|FG001|Period III|Withdrawal by Subject|0|||
17098155|NCT00139776|38237315|FG002|Period III|Withdrawal by Subject|16|||
17013548|NCT00515827|38158463|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
17013549|NCT00515827|38158462|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
17013550|NCT00515827|38158463|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
17013551|NCT00522457|38158471|FG000|Overall Study|Due to disease progression|16|||
17013552|NCT00522457|38158471|FG000|Overall Study|Adverse Event|2|||
17013553|NCT00856986|38158480|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
17013554|NCT00856986|38158481|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
17098156|NCT00139776|38237316|FG003|Period III|Withdrawal by Subject|21|||
17098157|NCT00413699|38237325|FG000|Initial Period|Death|25|||
17098158|NCT00413699|38237326|FG001|Initial Period|Death|30|||
17098159|NCT00413699|38237327|FG002|Initial Period|Death|0|||
17098160|NCT00413699|38237325|FG000|Initial Period|Lack of Efficacy|59|||
17098161|NCT00413699|38237326|FG001|Initial Period|Lack of Efficacy|115|||
17098162|NCT00413699|38237327|FG002|Initial Period|Lack of Efficacy|0|||
17098163|NCT00413699|38237325|FG000|Initial Period|Lost to Follow-up|31|||
17098164|NCT00413699|38237326|FG001|Initial Period|Lost to Follow-up|101|||
17098165|NCT00413699|38237327|FG002|Initial Period|Lost to Follow-up|0|||
17098166|NCT00413699|38237325|FG000|Initial Period|Protocol Violation|38|||
17098167|NCT00413699|38237326|FG001|Initial Period|Protocol Violation|89|||
17098168|NCT00413699|38237327|FG002|Initial Period|Protocol Violation|0|||
17098169|NCT00413699|38237325|FG000|Initial Period|Pregnancy|10|||
17098170|NCT00413699|38237326|FG001|Initial Period|Pregnancy|8|||
17098171|NCT00413699|38237327|FG002|Initial Period|Pregnancy|0|||
17013555|NCT00856986|38158482|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
17013556|NCT00856986|38158483|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
17013557|NCT00856986|38158484|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
17013558|NCT00856986|38158480|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
17013559|NCT00856986|38158481|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
17013560|NCT00856986|38158482|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
17098172|NCT00413699|38237325|FG000|Initial Period|Did not meet entrance criteria|2|||
17098173|NCT00413699|38237326|FG001|Initial Period|Did not meet entrance criteria|2|||
17098174|NCT00413699|38237327|FG002|Initial Period|Did not meet entrance criteria|0|||
17098175|NCT00413699|38237325|FG000|Initial Period|Medication error without adverse event|0|||
17013561|NCT00856986|38158483|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
17013562|NCT00856986|38158484|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
17013563|NCT00856986|38158480|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
17013564|NCT00856986|38158481|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
17013565|NCT00856986|38158482|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
17013566|NCT00856986|38158483|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
17013567|NCT00856986|38158484|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
17013568|NCT00856986|38158480|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
17098176|NCT00413699|38237326|FG001|Initial Period|Medication error without adverse event|1|||
17098177|NCT00413699|38237327|FG002|Initial Period|Medication error without adverse event|0|||
17013569|NCT00856986|38158481|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
17013570|NCT00856986|38158482|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
17013571|NCT00856986|38158483|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
17013572|NCT00856986|38158484|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
17013573|NCT00856986|38158480|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
17013574|NCT00856986|38158481|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
17013575|NCT00856986|38158482|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
17013576|NCT00856986|38158483|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
17013577|NCT00856986|38158484|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
17013578|NCT00856986|38158480|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
17098178|NCT00413699|38237325|FG000|Initial Period|Study terminated by Sponsor|0|||
17098179|NCT00413699|38237326|FG001|Initial Period|Study terminated by Sponsor|1|||
17098180|NCT00413699|38237327|FG002|Initial Period|Study terminated by Sponsor|0|||
17098181|NCT00413699|38237325|FG000|Initial Period|Other|67|||
17098182|NCT00413699|38237326|FG001|Initial Period|Other|211|||
17098183|NCT00413699|38237327|FG002|Initial Period|Other|0|||
17098184|NCT00413699|38237325|FG000|Initial Period|Adverse event related to study drug|178|||
17098185|NCT00413699|38237326|FG001|Initial Period|Adverse event related to study drug|527|||
17098186|NCT00413699|38237327|FG002|Initial Period|Adverse event related to study drug|0|||
17098187|NCT00413699|38237325|FG000|Initial Period|Adverse event not related to study drug|113|||
17098188|NCT00413699|38237326|FG001|Initial Period|Adverse event not related to study drug|248|||
17098189|NCT00413699|38237327|FG002|Initial Period|Adverse event not related to study drug|0|||
17098190|NCT00413699|38237325|FG000|Initial Period|Missing end of study page|0|||
17098191|NCT00413699|38237326|FG001|Initial Period|Missing end of study page|4|||
17098192|NCT00413699|38237327|FG002|Initial Period|Missing end of study page|0|||
17098193|NCT00413699|38237325|FG000|Initial Period|No longer willing to participate|116|||
17098194|NCT00413699|38237326|FG001|Initial Period|No longer willing to participate|368|||
17193543|NCT02641730|38346891|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
17193544|NCT02641730|38346892|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
17193545|NCT02641730|38346888|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
17193546|NCT02641730|38346889|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
17193547|NCT02641730|38346890|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
17193548|NCT02641730|38346891|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
17193549|NCT02641730|38346892|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
17193550|NCT02641730|38346888|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
17193551|NCT02641730|38346889|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
17013579|NCT00856986|38158481|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
17193552|NCT02641730|38346890|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
17193553|NCT02641730|38346891|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
17193554|NCT02641730|38346892|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
17193555|NCT02641730|38346888|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
17193556|NCT02641730|38346889|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
17193557|NCT02641730|38346890|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
17193558|NCT02641730|38346891|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
17193559|NCT02641730|38346892|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
17193560|NCT02797171|38346912|FG000|Overall Study|Lost to Follow-up|2|||
17193561|NCT02797171|38346913|FG001|Overall Study|Lost to Follow-up|0|||
17193562|NCT02797171|38346914|FG002|Overall Study|Lost to Follow-up|2|||
17193563|NCT02797171|38346915|FG003|Overall Study|Lost to Follow-up|1|||
17193564|NCT02797171|38346916|FG004|Overall Study|Lost to Follow-up|2|||
17193565|NCT02797171|38346917|FG005|Overall Study|Lost to Follow-up|0|||
17193566|NCT02797171|38346912|FG000|Overall Study|Withdrawal by Subject|1|||
17193567|NCT02797171|38346913|FG001|Overall Study|Withdrawal by Subject|1|||
17193568|NCT02797171|38346914|FG002|Overall Study|Withdrawal by Subject|0|||
17193569|NCT02797171|38346915|FG003|Overall Study|Withdrawal by Subject|0|||
17193570|NCT02797171|38346916|FG004|Overall Study|Withdrawal by Subject|0|||
17193571|NCT02797171|38346917|FG005|Overall Study|Withdrawal by Subject|0|||
17193572|NCT02797171|38346912|FG000|Overall Study|Protocol Violation|1|||
17193573|NCT02797171|38346913|FG001|Overall Study|Protocol Violation|0|||
17193574|NCT02797171|38346914|FG002|Overall Study|Protocol Violation|0|||
17193575|NCT02797171|38346915|FG003|Overall Study|Protocol Violation|0|||
17193576|NCT02797171|38346916|FG004|Overall Study|Protocol Violation|0|||
17193577|NCT02797171|38346917|FG005|Overall Study|Protocol Violation|0|||
17193578|NCT02797171|38346912|FG000|Overall Study|Participant unable to adhere|0|||
17013580|NCT00856986|38158482|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
17013581|NCT00856986|38158483|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
17013582|NCT00856986|38158484|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
17013583|NCT00856986|38158480|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
17013584|NCT00856986|38158481|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
17013585|NCT00856986|38158482|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
17013586|NCT00856986|38158483|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
17013587|NCT00856986|38158484|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
17013588|NCT00856986|38158480|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
17013589|NCT00856986|38158481|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
17013590|NCT00856986|38158482|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
17013591|NCT00856986|38158483|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
17013592|NCT00856986|38158484|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
17013593|NCT00856986|38158480|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
17013594|NCT00856986|38158481|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
17013595|NCT00856986|38158482|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
17013596|NCT00856986|38158483|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
17013597|NCT00856986|38158484|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
17013598|NCT00856986|38158480|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
17013599|NCT00856986|38158481|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
17013600|NCT00856986|38158482|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
17013601|NCT00856986|38158483|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
17013602|NCT00856986|38158484|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
17013603|NCT00856986|38158480|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
17013604|NCT00856986|38158481|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
17013605|NCT00856986|38158482|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
17013606|NCT00856986|38158483|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
17013607|NCT00856986|38158484|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
17013608|NCT00856986|38158480|FG000|Main Period, Weeks 0-26|Unclassified|7|||
17013609|NCT00856986|38158481|FG001|Main Period, Weeks 0-26|Unclassified|6|||
17013610|NCT00856986|38158482|FG002|Main Period, Weeks 0-26|Unclassified|7|||
17013611|NCT00856986|38158483|FG003|Main Period, Weeks 0-26|Unclassified|0|||
17013612|NCT00856986|38158484|FG004|Main Period, Weeks 0-26|Unclassified|0|||
17013613|NCT00856986|38158480|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
17013614|NCT00856986|38158481|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
17013615|NCT00856986|38158482|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
17013616|NCT00856986|38158483|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
17013617|NCT00856986|38158484|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
17013618|NCT00856986|38158480|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
17013619|NCT00856986|38158481|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
17013620|NCT00856986|38158482|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
17013621|NCT00856986|38158483|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
17013622|NCT00856986|38158484|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
17013623|NCT00856986|38158480|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
17013624|NCT00856986|38158481|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
17013625|NCT00856986|38158482|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
17013626|NCT00856986|38158483|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
17013627|NCT00856986|38158484|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
17013628|NCT00856986|38158480|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
17098195|NCT00413699|38237327|FG002|Initial Period|No longer willing to participate|0|||
17098196|NCT00413699|38237325|FG000|Extension Period|No Longer Willing to Participate|0|||
17098197|NCT00413699|38237326|FG001|Extension Period|No Longer Willing to Participate|0|||
17098198|NCT00413699|38237327|FG002|Extension Period|No Longer Willing to Participate|2|||
17013629|NCT00856986|38158481|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
17013630|NCT00856986|38158482|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
17013631|NCT00856986|38158483|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
17098199|NCT00413699|38237325|FG000|Extension Period|Protocol Violation|0|||
17098200|NCT00413699|38237326|FG001|Extension Period|Protocol Violation|0|||
17098201|NCT00413699|38237327|FG002|Extension Period|Protocol Violation|1|||
17098202|NCT00413699|38237325|FG000|Extension Period|Adverse Event|0|||
17098203|NCT00413699|38237326|FG001|Extension Period|Adverse Event|0|||
17098204|NCT00413699|38237327|FG002|Extension Period|Adverse Event|2|||
17013632|NCT00856986|38158484|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
17013633|NCT00856986|38158480|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
17013634|NCT00856986|38158481|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
17013635|NCT00856986|38158482|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
17013636|NCT00856986|38158483|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
17013637|NCT00856986|38158484|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
17013638|NCT00856986|38158480|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
17013639|NCT00856986|38158481|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
17013640|NCT00856986|38158482|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
17013641|NCT00856986|38158483|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
17013642|NCT00856986|38158484|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
17013643|NCT00707746|38158498|FG000|Treatment Period|Adverse Event|2|||
17193579|NCT02797171|38346913|FG001|Overall Study|Participant unable to adhere|1|||
17193580|NCT02797171|38346914|FG002|Overall Study|Participant unable to adhere|0|||
17193581|NCT02797171|38346915|FG003|Overall Study|Participant unable to adhere|0|||
17193582|NCT02797171|38346916|FG004|Overall Study|Participant unable to adhere|0|||
17193583|NCT02797171|38346917|FG005|Overall Study|Participant unable to adhere|0|||
17193584|NCT02797171|38346912|FG000|Overall Study|Not Randomized|0|||
17193585|NCT02797171|38346913|FG001|Overall Study|Not Randomized|0|||
17193586|NCT02797171|38346914|FG002|Overall Study|Not Randomized|0|||
17193587|NCT02797171|38346915|FG003|Overall Study|Not Randomized|0|||
17193588|NCT02797171|38346916|FG004|Overall Study|Not Randomized|0|||
17193589|NCT02797171|38346917|FG005|Overall Study|Not Randomized|1|||
17193590|NCT02797951|38346931|FG000|Overall Study|Adverse Event|4|||
17193591|NCT02797951|38346931|FG000|Overall Study|Death|1|||
17193592|NCT02797951|38346931|FG000|Overall Study|Lack of Efficacy|19|||
17193593|NCT02797951|38346931|FG000|Overall Study|Lost to Follow-up|4|||
17193594|NCT02797951|38346931|FG000|Overall Study|Physician Decision|6|||
17193595|NCT02797951|38346931|FG000|Overall Study|Withdrawal by Subject|15|||
17013644|NCT00707746|38158499|FG001|Treatment Period|Adverse Event|4|||
17013645|NCT00707746|38158498|FG000|Treatment Period|Ineligibility|0|||
17013646|NCT00707746|38158499|FG001|Treatment Period|Ineligibility|1|||
17013647|NCT00856908|38158507|FG000|Overall Study|Lost to Follow-up|1|||
17013648|NCT00856908|38158508|FG001|Overall Study|Lost to Follow-up|0|||
17013649|NCT00522379|38158519|FG000|Overall Study|Adverse Event|12|||
17013650|NCT00522379|38158520|FG001|Overall Study|Adverse Event|15|||
17013651|NCT00522379|38158521|FG002|Overall Study|Adverse Event|12|||
17013652|NCT00522379|38158522|FG003|Overall Study|Adverse Event|5|||
17193596|NCT00701805|38346939|FG000|Overall Study|Withdrawal by Subject|3|||
17193597|NCT00701805|38346940|FG001|Overall Study|Withdrawal by Subject|1|||
17193598|NCT00701805|38346941|FG002|Overall Study|Withdrawal by Subject|4|||
17193599|NCT00701805|38346942|FG003|Overall Study|Withdrawal by Subject|3|||
17098205|NCT03713320|38237355|FG000|Randomized Period|Adverse Event|1|||
17193600|NCT00701805|38346939|FG000|Overall Study|Adverse Event|0|||
17193601|NCT00701805|38346940|FG001|Overall Study|Adverse Event|1|||
17193602|NCT00701805|38346941|FG002|Overall Study|Adverse Event|1|||
17193603|NCT00701805|38346942|FG003|Overall Study|Adverse Event|0|||
17193604|NCT00701805|38346939|FG000|Overall Study|Missed 7 consecutive doses|0|||
17193605|NCT00701805|38346940|FG001|Overall Study|Missed 7 consecutive doses|1|||
17193606|NCT00701805|38346941|FG002|Overall Study|Missed 7 consecutive doses|0|||
17193607|NCT00701805|38346942|FG003|Overall Study|Missed 7 consecutive doses|0|||
17193608|NCT00701805|38346939|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
17193609|NCT00701805|38346940|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
17193610|NCT00701805|38346941|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
17193611|NCT00701805|38346942|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
17098206|NCT03713320|38237356|FG001|Randomized Period|Adverse Event|5|||
17098207|NCT03713320|38237357|FG002|Randomized Period|Adverse Event|0|||
17193612|NCT00701805|38346939|FG000|Overall Study|Physician decision, change of therapy|0|||
17193613|NCT00701805|38346940|FG001|Overall Study|Physician decision, change of therapy|0|||
17193614|NCT00701805|38346941|FG002|Overall Study|Physician decision, change of therapy|0|||
17193615|NCT00701805|38346942|FG003|Overall Study|Physician decision, change of therapy|1|||
17193616|NCT00701805|38346939|FG000|Overall Study|Difficult to travel to dialysis site|0|||
17193617|NCT00701805|38346940|FG001|Overall Study|Difficult to travel to dialysis site|0|||
17193618|NCT00701805|38346941|FG002|Overall Study|Difficult to travel to dialysis site|1|||
17193619|NCT00701805|38346942|FG003|Overall Study|Difficult to travel to dialysis site|0|||
17193620|NCT00701805|38346939|FG000|Overall Study|Resumption criteria were not met|0|||
17193621|NCT00701805|38346940|FG001|Overall Study|Resumption criteria were not met|1|||
17193622|NCT00701805|38346941|FG002|Overall Study|Resumption criteria were not met|0|||
17193623|NCT00701805|38346942|FG003|Overall Study|Resumption criteria were not met|0|||
17193624|NCT02715765|38346955|FG000|Overall Study|Study Termination|3|||
17193625|NCT02715765|38346956|FG001|Overall Study|Study Termination|0|||
17193626|NCT02715765|38346957|FG002|Overall Study|Study Termination|0|||
17193627|NCT04542291|38346965|FG000|Overall Study|Adverse Event|1|||
17193628|NCT04542291|38346965|FG000|Overall Study|Physician Decision|2|||
17193629|NCT02795767|38346972|FG000|Overall Study|Received Commercial Emicizumab|1|||
17193630|NCT02795767|38346973|FG001|Overall Study|Received Commercial Emicizumab|0|||
17193631|NCT02795767|38346974|FG002|Overall Study|Received Commercial Emicizumab|0|||
17193632|NCT02639559|38346988|FG000|Overall Study|Mobilization failure|0|||
17193633|NCT02639559|38346989|FG001|Overall Study|Mobilization failure|3|||
17193634|NCT02639559|38346988|FG000|Overall Study|Issues with vascular acess|1|||
17193635|NCT02639559|38346989|FG001|Overall Study|Issues with vascular acess|0|||
17193636|NCT02796391|38347010|FG000|Overall Study|Lost to Follow-up|2|||
17193637|NCT02796391|38347011|FG001|Overall Study|Lost to Follow-up|2|||
17193638|NCT02796391|38347012|FG002|Overall Study|Lost to Follow-up|13|||
17193639|NCT02796391|38347013|FG003|Overall Study|Lost to Follow-up|8|||
17193640|NCT02796391|38347014|FG004|Overall Study|Lost to Follow-up|14|||
17193641|NCT02796391|38347015|FG005|Overall Study|Lost to Follow-up|13|||
17193642|NCT02796391|38347010|FG000|Overall Study|COVID|0|||
17193643|NCT02796391|38347011|FG001|Overall Study|COVID|0|||
17193644|NCT02796391|38347012|FG002|Overall Study|COVID|5|||
17193645|NCT02796391|38347013|FG003|Overall Study|COVID|5|||
17193646|NCT02796391|38347014|FG004|Overall Study|COVID|2|||
17193647|NCT02796391|38347015|FG005|Overall Study|COVID|4|||
17193648|NCT02796391|38347010|FG000|Overall Study|Participant did not like study cigarettes|0|||
17193649|NCT02796391|38347011|FG001|Overall Study|Participant did not like study cigarettes|0|||
17193650|NCT02796391|38347012|FG002|Overall Study|Participant did not like study cigarettes|3|||
17013653|NCT00522379|38158523|FG004|Overall Study|Adverse Event|17|||
17013654|NCT00522379|38158519|FG000|Overall Study|Lack of Efficacy|3|||
17013655|NCT00522379|38158520|FG001|Overall Study|Lack of Efficacy|0|||
17013656|NCT00522379|38158521|FG002|Overall Study|Lack of Efficacy|2|||
17013657|NCT00522379|38158522|FG003|Overall Study|Lack of Efficacy|2|||
17013658|NCT00522379|38158523|FG004|Overall Study|Lack of Efficacy|7|||
17013659|NCT00522379|38158519|FG000|Overall Study|Withdrawal by Subject|2|||
17098208|NCT03713320|38237355|FG000|Randomized Period|Physician Decision|1|||
17098209|NCT03713320|38237356|FG001|Randomized Period|Physician Decision|1|||
17098210|NCT03713320|38237357|FG002|Randomized Period|Physician Decision|0|||
17098211|NCT03713320|38237355|FG000|Randomized Period|Withdrawal by Subject|4|||
17098212|NCT03713320|38237356|FG001|Randomized Period|Withdrawal by Subject|0|||
17098213|NCT03713320|38237357|FG002|Randomized Period|Withdrawal by Subject|0|||
17098214|NCT03713320|38237355|FG000|Randomized Period|Participant decision|3|||
17098215|NCT03713320|38237356|FG001|Randomized Period|Participant decision|1|||
17013660|NCT00522379|38158520|FG001|Overall Study|Withdrawal by Subject|3|||
17013661|NCT00522379|38158521|FG002|Overall Study|Withdrawal by Subject|1|||
17013662|NCT00522379|38158522|FG003|Overall Study|Withdrawal by Subject|2|||
17013663|NCT00522379|38158523|FG004|Overall Study|Withdrawal by Subject|0|||
17013664|NCT00522379|38158519|FG000|Overall Study|Protocol Violation|1|||
17013665|NCT00522379|38158520|FG001|Overall Study|Protocol Violation|1|||
17013666|NCT00522379|38158521|FG002|Overall Study|Protocol Violation|2|||
17013667|NCT00522379|38158522|FG003|Overall Study|Protocol Violation|0|||
17013668|NCT00522379|38158523|FG004|Overall Study|Protocol Violation|0|||
17013669|NCT00522379|38158519|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
17013670|NCT00522379|38158520|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
17013671|NCT00522379|38158521|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
17013672|NCT00522379|38158522|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
17013673|NCT00522379|38158523|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
17013674|NCT00522379|38158519|FG000|Overall Study|Lost to Follow-up|1|||
17013675|NCT00522379|38158520|FG001|Overall Study|Lost to Follow-up|0|||
17013676|NCT00522379|38158521|FG002|Overall Study|Lost to Follow-up|4|||
17013677|NCT00522379|38158522|FG003|Overall Study|Lost to Follow-up|2|||
17013678|NCT00522379|38158523|FG004|Overall Study|Lost to Follow-up|2|||
17013679|NCT00522379|38158519|FG000|Overall Study|Randomization error|0|||
17013680|NCT00522379|38158520|FG001|Overall Study|Randomization error|0|||
17098216|NCT03713320|38237357|FG002|Randomized Period|Participant decision|0|||
17098217|NCT03713320|38237355|FG000|Randomized Period|Study terminated by sponsor|6|||
17098218|NCT03713320|38237356|FG001|Randomized Period|Study terminated by sponsor|3|||
17098219|NCT03713320|38237357|FG002|Randomized Period|Study terminated by sponsor|0|||
17098220|NCT03713320|38237355|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
17098221|NCT03713320|38237356|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
17098222|NCT03713320|38237357|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
17098223|NCT03713320|38237355|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
17013681|NCT00522379|38158521|FG002|Overall Study|Randomization error|0|||
17013682|NCT00522379|38158522|FG003|Overall Study|Randomization error|0|||
17013683|NCT00522379|38158523|FG004|Overall Study|Randomization error|1|||
17013684|NCT00522379|38158519|FG000|Overall Study|Dispensing error|1|||
17013685|NCT00522379|38158520|FG001|Overall Study|Dispensing error|0|||
17013686|NCT00522379|38158521|FG002|Overall Study|Dispensing error|0|||
17013687|NCT00522379|38158522|FG003|Overall Study|Dispensing error|1|||
17013688|NCT00522379|38158523|FG004|Overall Study|Dispensing error|0|||
17013689|NCT00522379|38158519|FG000|Overall Study|Subject Moved|1|||
17013690|NCT00522379|38158520|FG001|Overall Study|Subject Moved|1|||
17013691|NCT00522379|38158521|FG002|Overall Study|Subject Moved|0|||
17013692|NCT00522379|38158522|FG003|Overall Study|Subject Moved|0|||
17013693|NCT00522379|38158523|FG004|Overall Study|Subject Moved|0|||
17013694|NCT00522379|38158519|FG000|Overall Study|Sponsor Request|0|||
17013695|NCT00522379|38158520|FG001|Overall Study|Sponsor Request|1|||
17013696|NCT00522379|38158521|FG002|Overall Study|Sponsor Request|0|||
17013697|NCT00522379|38158522|FG003|Overall Study|Sponsor Request|0|||
17013698|NCT00522379|38158523|FG004|Overall Study|Sponsor Request|0|||
17098224|NCT03713320|38237356|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
17098225|NCT03713320|38237357|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
17098226|NCT03712930|38237364|FG000|Overall Study|Death|7|||
17098227|NCT03712930|38237364|FG000|Overall Study|Physician Decision|1|||
17098228|NCT03712930|38237364|FG000|Overall Study|Study Terminated by Sponsor|3|||
17013699|NCT00522379|38158519|FG000|Overall Study|Family Problem|0|||
17013700|NCT00522379|38158520|FG001|Overall Study|Family Problem|0|||
17013701|NCT00522379|38158521|FG002|Overall Study|Family Problem|1|||
17013702|NCT00522379|38158522|FG003|Overall Study|Family Problem|0|||
17013703|NCT00522379|38158523|FG004|Overall Study|Family Problem|0|||
17013704|NCT00522379|38158519|FG000|Overall Study|Site Closed|0|||
17013705|NCT00522379|38158520|FG001|Overall Study|Site Closed|0|||
17013706|NCT00522379|38158521|FG002|Overall Study|Site Closed|0|||
17013707|NCT00522379|38158522|FG003|Overall Study|Site Closed|1|||
17013708|NCT00522379|38158523|FG004|Overall Study|Site Closed|0|||
17013709|NCT00522379|38158519|FG000|Overall Study|Subject Withdrawal|0|||
17013710|NCT00522379|38158520|FG001|Overall Study|Subject Withdrawal|0|||
17013711|NCT00522379|38158521|FG002|Overall Study|Subject Withdrawal|0|||
17013712|NCT00522379|38158522|FG003|Overall Study|Subject Withdrawal|1|||
17013713|NCT00522379|38158523|FG004|Overall Study|Subject Withdrawal|0|||
17013714|NCT00856830|38158539|FG000|Irinotecan & Bendamustine|Death|0|||
17013715|NCT00856830|38158540|FG001|Irinotecan & Bendamustine|Death|0|||
17013716|NCT00856830|38158541|FG002|Irinotecan & Bendamustine|Death|0|||
17013717|NCT00856830|38158542|FG003|Irinotecan & Bendamustine|Death|2|||
17013718|NCT00856830|38158539|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
17013719|NCT00856830|38158540|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
17013720|NCT00856830|38158541|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
17013721|NCT00856830|38158542|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
17013722|NCT00522301|38158547|FG000|Overall Study|Withdrawal by Subject|1|||
17013723|NCT00522301|38158547|FG000|Overall Study|Adverse Event|5|||
17013724|NCT00863928|38158553|FG000|Overall Study|Protocol Violation|26|||
17193651|NCT02796391|38347013|FG003|Overall Study|Participant did not like study cigarettes|0|||
17193652|NCT02796391|38347014|FG004|Overall Study|Participant did not like study cigarettes|0|||
17193653|NCT02796391|38347015|FG005|Overall Study|Participant did not like study cigarettes|0|||
17193654|NCT02796391|38347010|FG000|Overall Study|Withdrawal by Subject|1|||
17193655|NCT02796391|38347011|FG001|Overall Study|Withdrawal by Subject|1|||
17193656|NCT02796391|38347012|FG002|Overall Study|Withdrawal by Subject|4|||
17193657|NCT02796391|38347013|FG003|Overall Study|Withdrawal by Subject|3|||
17193658|NCT02796391|38347014|FG004|Overall Study|Withdrawal by Subject|4|||
17193659|NCT02796391|38347015|FG005|Overall Study|Withdrawal by Subject|3|||
17193660|NCT02796391|38347010|FG000|Overall Study|Adverse Event|0|||
17193661|NCT02796391|38347011|FG001|Overall Study|Adverse Event|0|||
17193662|NCT02796391|38347012|FG002|Overall Study|Adverse Event|0|||
17193663|NCT02796391|38347013|FG003|Overall Study|Adverse Event|1|||
17193664|NCT02796391|38347014|FG004|Overall Study|Adverse Event|0|||
17193665|NCT02796391|38347015|FG005|Overall Study|Adverse Event|0|||
17193666|NCT02796391|38347010|FG000|Overall Study|Protocol Violation|0|||
17193667|NCT02796391|38347011|FG001|Overall Study|Protocol Violation|0|||
17193668|NCT02796391|38347012|FG002|Overall Study|Protocol Violation|0|||
17193669|NCT02796391|38347013|FG003|Overall Study|Protocol Violation|1|||
17193670|NCT02796391|38347014|FG004|Overall Study|Protocol Violation|0|||
17193671|NCT02796391|38347015|FG005|Overall Study|Protocol Violation|0|||
17193672|NCT01370317|38347031|FG000|Overall Study|Participant withdrew consent|1|||
17193673|NCT01370317|38347032|FG001|Overall Study|Participant withdrew consent|0|||
17193674|NCT01370317|38347031|FG000|Overall Study|Protocol deviation|0|||
17193675|NCT01370317|38347032|FG001|Overall Study|Protocol deviation|1|||
17193676|NCT01370083|38347040|FG000|Overall Study|Lost to Follow-up|2|||
17193677|NCT01370083|38347041|FG001|Overall Study|Lost to Follow-up|0|||
17193678|NCT01370083|38347040|FG000|Overall Study|Adverse Event|0|||
17193679|NCT01370083|38347041|FG001|Overall Study|Adverse Event|1|||
17193680|NCT03350815|38347047|FG000|Period 1|Adverse Event|10|||
17193681|NCT03350815|38347048|FG001|Period 1|Adverse Event|0|||
17193682|NCT03350815|38347049|FG002|Period 1|Adverse Event|0|||
17193683|NCT03350815|38347050|FG003|Period 1|Adverse Event|0|||
17193684|NCT03350815|38347047|FG000|Period 1|Technical problems|1|||
17193685|NCT03350815|38347048|FG001|Period 1|Technical problems|0|||
17193686|NCT03350815|38347049|FG002|Period 1|Technical problems|0|||
17193687|NCT03350815|38347050|FG003|Period 1|Technical problems|0|||
17193688|NCT03350815|38347047|FG000|Period 1|Lost to Follow-up|3|||
17193689|NCT03350815|38347048|FG001|Period 1|Lost to Follow-up|0|||
17193690|NCT03350815|38347049|FG002|Period 1|Lost to Follow-up|0|||
17193691|NCT03350815|38347050|FG003|Period 1|Lost to Follow-up|0|||
17193692|NCT03350815|38347047|FG000|Period 1|Physician Decision|1|||
17193693|NCT03350815|38347048|FG001|Period 1|Physician Decision|0|||
17193694|NCT03350815|38347049|FG002|Period 1|Physician Decision|0|||
17193695|NCT03350815|38347050|FG003|Period 1|Physician Decision|0|||
17193696|NCT03350815|38347047|FG000|Period 1|Withdrawal by Subject|8|||
17193697|NCT03350815|38347048|FG001|Period 1|Withdrawal by Subject|0|||
17193698|NCT03350815|38347049|FG002|Period 1|Withdrawal by Subject|0|||
17193699|NCT03350815|38347050|FG003|Period 1|Withdrawal by Subject|0|||
17193700|NCT03350815|38347047|FG000|Period 1|Lack of Efficacy|15|||
17193701|NCT03350815|38347048|FG001|Period 1|Lack of Efficacy|0|||
17193702|NCT03350815|38347049|FG002|Period 1|Lack of Efficacy|0|||
17193703|NCT03350815|38347050|FG003|Period 1|Lack of Efficacy|0|||
17193704|NCT03350815|38347047|FG000|Period 1|Non-compliance with study treatment|2|||
17193705|NCT03350815|38347048|FG001|Period 1|Non-compliance with study treatment|0|||
17193706|NCT03350815|38347049|FG002|Period 1|Non-compliance with study treatment|0|||
17193707|NCT03350815|38347050|FG003|Period 1|Non-compliance with study treatment|0|||
17193708|NCT03350815|38347047|FG000|Period 1|Protocol Violation|3|||
17193709|NCT03350815|38347048|FG001|Period 1|Protocol Violation|0|||
17193710|NCT03350815|38347049|FG002|Period 1|Protocol Violation|0|||
17193711|NCT03350815|38347050|FG003|Period 1|Protocol Violation|0|||
17193712|NCT03350815|38347047|FG000|Period 2|Adverse Event|0|||
17193713|NCT03350815|38347048|FG001|Period 2|Adverse Event|3|||
17193714|NCT03350815|38347049|FG002|Period 2|Adverse Event|5|||
17193715|NCT03350815|38347050|FG003|Period 2|Adverse Event|0|||
17193716|NCT03350815|38347047|FG000|Period 2|Technical problem|0|||
17193717|NCT03350815|38347048|FG001|Period 2|Technical problem|1|||
17193718|NCT03350815|38347049|FG002|Period 2|Technical problem|0|||
17193719|NCT03350815|38347050|FG003|Period 2|Technical problem|0|||
17193720|NCT03350815|38347047|FG000|Period 2|Lost to Follow-up|0|||
17193721|NCT03350815|38347048|FG001|Period 2|Lost to Follow-up|3|||
17193722|NCT03350815|38347049|FG002|Period 2|Lost to Follow-up|3|||
17193723|NCT03350815|38347050|FG003|Period 2|Lost to Follow-up|0|||
17193724|NCT03350815|38347047|FG000|Period 2|Physician Decision|0|||
17193725|NCT03350815|38347048|FG001|Period 2|Physician Decision|0|||
17193726|NCT03350815|38347049|FG002|Period 2|Physician Decision|1|||
17193727|NCT03350815|38347050|FG003|Period 2|Physician Decision|0|||
17193728|NCT03350815|38347047|FG000|Period 2|Withdrawal by Subject|0|||
17193729|NCT03350815|38347048|FG001|Period 2|Withdrawal by Subject|3|||
17193730|NCT03350815|38347049|FG002|Period 2|Withdrawal by Subject|4|||
17013725|NCT00863928|38158554|FG001|Overall Study|Protocol Violation|0|||
17013726|NCT00863928|38158553|FG000|Overall Study|Withdrawal by Subject|3|||
17013727|NCT00863928|38158554|FG001|Overall Study|Withdrawal by Subject|0|||
17013728|NCT00863928|38158553|FG000|Overall Study|surgery cancellation|4|||
17013729|NCT00863928|38158554|FG001|Overall Study|surgery cancellation|0|||
17098229|NCT03712930|38237364|FG000|Overall Study|Progressive Disease|2|||
17098230|NCT00420407|38237370|FG000|Overall Study|Lost to Follow-up|0|||
17098231|NCT00420407|38237371|FG001|Overall Study|Lost to Follow-up|3|||
17013730|NCT00863928|38158553|FG000|Overall Study|medication allergy|3|||
17013731|NCT00863928|38158554|FG001|Overall Study|medication allergy|0|||
17013732|NCT00856518|38158562|FG000|Overall Study|Lost to Follow-up|4|||
17013733|NCT00856518|38158563|FG001|Overall Study|Lost to Follow-up|2|||
17013734|NCT00506389|38158574|FG000|In-treatment Period|Other|3|||
17013735|NCT00506389|38158575|FG001|In-treatment Period|Other|3|||
17013736|NCT00506389|38158576|FG002|In-treatment Period|Other|4|||
17013737|NCT00506389|38158574|FG000|In-treatment Period|Lost to Follow-up|0|||
17013738|NCT00506389|38158575|FG001|In-treatment Period|Lost to Follow-up|0|||
17098232|NCT00420407|38237370|FG000|Overall Study|Physician Decision|2|||
17098233|NCT00420407|38237371|FG001|Overall Study|Physician Decision|1|||
17098234|NCT00420407|38237370|FG000|Overall Study|subject identified as detainee|1|||
17098235|NCT00420407|38237371|FG001|Overall Study|subject identified as detainee|0|||
17098236|NCT00420407|38237370|FG000|Overall Study|subject identified as Jehovah's witness|1|||
17098237|NCT00420407|38237371|FG001|Overall Study|subject identified as Jehovah's witness|0|||
17098238|NCT00420407|38237370|FG000|Overall Study|Withdrawal by Subject|0|||
17098239|NCT00420407|38237371|FG001|Overall Study|Withdrawal by Subject|2|||
17098240|NCT00420095|38237380|FG000|Overall Study|Adverse Event|1|||
17098241|NCT00420095|38237381|FG001|Overall Study|Adverse Event|0|||
17098242|NCT00420095|38237380|FG000|Overall Study|Protocol Violation|1|||
17098243|NCT00420095|38237381|FG001|Overall Study|Protocol Violation|1|||
17098244|NCT00420095|38237380|FG000|Overall Study|Lost to Follow-up|1|||
17098245|NCT00420095|38237381|FG001|Overall Study|Lost to Follow-up|0|||
17013739|NCT00506389|38158576|FG002|In-treatment Period|Lost to Follow-up|1|||
17013740|NCT00506389|38158574|FG000|In-treatment Period|Lack of compliance|1|||
17013741|NCT00506389|38158575|FG001|In-treatment Period|Lack of compliance|0|||
17013742|NCT00506389|38158576|FG002|In-treatment Period|Lack of compliance|0|||
17013743|NCT00506389|38158574|FG000|In-treatment Period|Reasons not related to trial|4|||
17013744|NCT00506389|38158575|FG001|In-treatment Period|Reasons not related to trial|1|||
17013745|NCT00506389|38158576|FG002|In-treatment Period|Reasons not related to trial|0|||
17013746|NCT00506389|38158574|FG000|In-treatment Period|Withdrawal by Subject|3|||
17013747|NCT00506389|38158575|FG001|In-treatment Period|Withdrawal by Subject|3|||
17013748|NCT00506389|38158576|FG002|In-treatment Period|Withdrawal by Subject|4|||
17013749|NCT00506389|38158574|FG000|In-treatment Period|Lack of Efficacy|0|||
17098246|NCT00419393|38237387|FG000|Overall Study|Adverse Event|5|||
17098247|NCT00419393|38237387|FG000|Overall Study|Protocol Violation|5|||
17098248|NCT00419393|38237387|FG000|Overall Study|Withdrawal by Subject|7|||
17098249|NCT00419393|38237387|FG000|Overall Study|Other: Sponsor request|3|||
17098250|NCT00419393|38237387|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
17098251|NCT00419393|38237387|FG000|Overall Study|Other: Site closure|1|||
17098252|NCT00419393|38237387|FG000|Overall Study|Other: Other health problems|1|||
17098253|NCT00419393|38237387|FG000|Overall Study|Other: Investigator decision|1|||
17193731|NCT03350815|38347050|FG003|Period 2|Withdrawal by Subject|0|||
17193732|NCT03350815|38347047|FG000|Period 2|Lack of Efficacy|0|||
17193733|NCT03350815|38347048|FG001|Period 2|Lack of Efficacy|6|||
17193734|NCT03350815|38347049|FG002|Period 2|Lack of Efficacy|2|||
17193735|NCT03350815|38347050|FG003|Period 2|Lack of Efficacy|0|||
17193736|NCT03350815|38347047|FG000|Period 2|Protocol Violation|0|||
17193737|NCT03350815|38347048|FG001|Period 2|Protocol Violation|0|||
17193738|NCT03350815|38347049|FG002|Period 2|Protocol Violation|1|||
17193739|NCT03350815|38347050|FG003|Period 2|Protocol Violation|0|||
17193740|NCT03350815|38347047|FG000|Period 2|New therapy for study indication|0|||
17193741|NCT03350815|38347048|FG001|Period 2|New therapy for study indication|0|||
17193742|NCT03350815|38347049|FG002|Period 2|New therapy for study indication|1|||
17193743|NCT03350815|38347050|FG003|Period 2|New therapy for study indication|0|||
17193744|NCT00854295|38347065|FG000|Overall Study|Death|7|||
17193745|NCT00854295|38347066|FG001|Overall Study|Death|0|||
17193746|NCT00854295|38347067|FG002|Overall Study|Death|1|||
17193747|NCT00854295|38347068|FG003|Overall Study|Death|1|||
17193748|NCT00854295|38347065|FG000|Overall Study|Adverse Event|6|||
17193749|NCT00854295|38347066|FG001|Overall Study|Adverse Event|1|||
17193750|NCT00854295|38347067|FG002|Overall Study|Adverse Event|1|||
17193751|NCT00854295|38347068|FG003|Overall Study|Adverse Event|3|||
17193752|NCT00854295|38347065|FG000|Overall Study|Lost to Follow-up|18|||
17193753|NCT00854295|38347066|FG001|Overall Study|Lost to Follow-up|5|||
17193754|NCT00854295|38347067|FG002|Overall Study|Lost to Follow-up|21|||
17013750|NCT00506389|38158575|FG001|In-treatment Period|Lack of Efficacy|2|||
17013751|NCT00506389|38158576|FG002|In-treatment Period|Lack of Efficacy|0|||
17013752|NCT00506389|38158574|FG000|In-treatment Period|Adverse Event|11|||
17013753|NCT00506389|38158575|FG001|In-treatment Period|Adverse Event|5|||
17098254|NCT00419159|38237393|FG000|Overall Study|Adverse Event|7|||
17098255|NCT00419159|38237394|FG001|Overall Study|Adverse Event|15|||
17098256|NCT00419159|38237393|FG000|Overall Study|Abnormal laboratory value(s)|0|||
17098257|NCT00419159|38237394|FG001|Overall Study|Abnormal laboratory value(s)|2|||
17098258|NCT00419159|38237393|FG000|Overall Study|Subject's no longer requires study drug|0|||
17098259|NCT00419159|38237394|FG001|Overall Study|Subject's no longer requires study drug|1|||
17098260|NCT00419159|38237393|FG000|Overall Study|Protocol Violation|1|||
17098261|NCT00419159|38237394|FG001|Overall Study|Protocol Violation|0|||
17013754|NCT00506389|38158576|FG002|In-treatment Period|Adverse Event|2|||
17013755|NCT00506389|38158574|FG000|In-treatment Period|Randomized but not treated|4|||
17013756|NCT00506389|38158575|FG001|In-treatment Period|Randomized but not treated|1|||
17013757|NCT00506389|38158576|FG002|In-treatment Period|Randomized but not treated|1|||
17013758|NCT00871338|38158589|FG000|Prior to Booster|Withdrawal by Subject|1|||
17013759|NCT00871338|38158590|FG001|Prior to Booster|Withdrawal by Subject|3|||
17013760|NCT00871338|38158589|FG000|Prior to Booster|Lost to Follow-up|1|||
17098262|NCT00419159|38237393|FG000|Overall Study|Withdrawal by Subject|10|||
17098263|NCT00419159|38237394|FG001|Overall Study|Withdrawal by Subject|3|||
17098264|NCT00419159|38237393|FG000|Overall Study|Lost to Follow-up|0|||
17098265|NCT00419159|38237394|FG001|Overall Study|Lost to Follow-up|1|||
17098266|NCT00419159|38237393|FG000|Overall Study|Death|2|||
17098267|NCT00419159|38237394|FG001|Overall Study|Death|2|||
17098268|NCT00419159|38237393|FG000|Overall Study|Disease progression|79|||
17098269|NCT00419159|38237394|FG001|Overall Study|Disease progression|76|||
17098270|NCT03717064|38237408|FG000|Period 2|Adverse Event|1|||
17098271|NCT03716050|38237420|FG000|Overall Study|Lost to Follow-up|0|||
17098272|NCT03716050|38237421|FG001|Overall Study|Lost to Follow-up|0|||
17098273|NCT03716050|38237422|FG002|Overall Study|Lost to Follow-up|1|||
17098274|NCT03716050|38237423|FG003|Overall Study|Lost to Follow-up|0|||
17098275|NCT03716050|38237424|FG004|Overall Study|Lost to Follow-up|0|||
17098276|NCT03716050|38237425|FG005|Overall Study|Lost to Follow-up|0|||
17098277|NCT03716050|38237426|FG006|Overall Study|Lost to Follow-up|0|||
17098278|NCT03716050|38237427|FG007|Overall Study|Lost to Follow-up|0|||
17013761|NCT00871338|38158590|FG001|Prior to Booster|Lost to Follow-up|0|||
17013762|NCT00824421|38158599|FG000|Overall Study|Adverse Event|6|||
17013763|NCT00824421|38158600|FG001|Overall Study|Adverse Event|6|||
17013764|NCT00824421|38158601|FG002|Overall Study|Adverse Event|6|||
17013765|NCT00824421|38158599|FG000|Overall Study|Death|0|||
17193755|NCT00854295|38347068|FG003|Overall Study|Lost to Follow-up|21|||
17098279|NCT03716050|38237420|FG000|Overall Study|Physician Decision|0|||
17098280|NCT03716050|38237421|FG001|Overall Study|Physician Decision|0|||
17098281|NCT03716050|38237422|FG002|Overall Study|Physician Decision|0|||
17098282|NCT03716050|38237423|FG003|Overall Study|Physician Decision|1|||
17098283|NCT03716050|38237424|FG004|Overall Study|Physician Decision|0|||
17098284|NCT03716050|38237425|FG005|Overall Study|Physician Decision|0|||
17193756|NCT00854295|38347065|FG000|Overall Study|Physician Decision|10|||
17193757|NCT00854295|38347066|FG001|Overall Study|Physician Decision|0|||
17193758|NCT00854295|38347067|FG002|Overall Study|Physician Decision|0|||
17193759|NCT00854295|38347068|FG003|Overall Study|Physician Decision|0|||
17193760|NCT02792959|38347079|FG000|Overall Study|Protocol Violation|1|||
17193761|NCT01652872|38347085|FG000|Overall Study|Death|36|||
17193762|NCT01652872|38347086|FG001|Overall Study|Death|39|||
17193763|NCT01652872|38347085|FG000|Overall Study|Lost to Follow-up|28|||
17193764|NCT01652872|38347086|FG001|Overall Study|Lost to Follow-up|23|||
17193765|NCT01652872|38347085|FG000|Overall Study|Decision by sponsor|5|||
17193766|NCT01652872|38347086|FG001|Overall Study|Decision by sponsor|7|||
17193767|NCT01652872|38347085|FG000|Overall Study|Withdrawal by Subject|76|||
17193768|NCT01652872|38347086|FG001|Overall Study|Withdrawal by Subject|84|||
17193769|NCT04251273|38347094|FG000|Overall Study|Lost to Follow-up|331|||
17193770|NCT04251273|38347095|FG001|Overall Study|Lost to Follow-up|290|||
17193771|NCT02443402|38347103|FG000|Overall Study|Withdrawal by Subject|3|||
17193772|NCT02443402|38347104|FG001|Overall Study|Withdrawal by Subject|1|||
17193773|NCT02443402|38347103|FG000|Overall Study|Screen Failure|1|||
17193774|NCT02443402|38347104|FG001|Overall Study|Screen Failure|2|||
17193775|NCT02412670|38347112|FG000|Overall Study|Adverse Event|4|||
17098285|NCT03716050|38237426|FG006|Overall Study|Physician Decision|0|||
17098286|NCT03716050|38237427|FG007|Overall Study|Physician Decision|0|||
17013766|NCT00824421|38158600|FG001|Overall Study|Death|1|||
17013767|NCT00824421|38158601|FG002|Overall Study|Death|0|||
17013768|NCT00824421|38158599|FG000|Overall Study|Lack of Efficacy|5|||
17013769|NCT00824421|38158600|FG001|Overall Study|Lack of Efficacy|7|||
17098287|NCT03716050|38237420|FG000|Overall Study|Protocol Violation|0|||
17098288|NCT03716050|38237421|FG001|Overall Study|Protocol Violation|0|||
17193776|NCT02412670|38347113|FG001|Overall Study|Adverse Event|1|||
17193777|NCT02412670|38347112|FG000|Overall Study|Physician Decision|1|||
17193778|NCT02412670|38347113|FG001|Overall Study|Physician Decision|0|||
17193779|NCT02412670|38347112|FG000|Overall Study|Withdrawal by Subject|1|||
17193780|NCT02412670|38347113|FG001|Overall Study|Withdrawal by Subject|0|||
17193781|NCT02412670|38347112|FG000|Overall Study|Ineligible|1|||
17193782|NCT02412670|38347113|FG001|Overall Study|Ineligible|0|||
17193783|NCT01370005|38347122|FG000|Overall Study|Not treated|1|||
17013770|NCT00824421|38158601|FG002|Overall Study|Lack of Efficacy|4|||
17013771|NCT00824421|38158599|FG000|Overall Study|Lost to Follow-up|2|||
17013772|NCT00824421|38158600|FG001|Overall Study|Lost to Follow-up|3|||
17013773|NCT00824421|38158601|FG002|Overall Study|Lost to Follow-up|0|||
17013774|NCT00824421|38158599|FG000|Overall Study|Pregnancy|1|||
17013775|NCT00824421|38158600|FG001|Overall Study|Pregnancy|0|||
17013776|NCT00824421|38158601|FG002|Overall Study|Pregnancy|1|||
17013777|NCT00824421|38158599|FG000|Overall Study|Withdrawal by Subject|2|||
17013778|NCT00824421|38158600|FG001|Overall Study|Withdrawal by Subject|3|||
17193784|NCT01370005|38347123|FG001|Overall Study|Not treated|0|||
17193785|NCT01370005|38347124|FG002|Overall Study|Not treated|0|||
17193786|NCT01370005|38347122|FG000|Overall Study|Adverse Event|5|||
17193787|NCT01370005|38347123|FG001|Overall Study|Adverse Event|5|||
17193788|NCT01370005|38347124|FG002|Overall Study|Adverse Event|6|||
17193789|NCT01370005|38347122|FG000|Overall Study|Lack of Efficacy|1|||
17193790|NCT01370005|38347123|FG001|Overall Study|Lack of Efficacy|0|||
17193791|NCT01370005|38347124|FG002|Overall Study|Lack of Efficacy|0|||
17193792|NCT01370005|38347122|FG000|Overall Study|Non compliant with protocol|0|||
17193793|NCT01370005|38347123|FG001|Overall Study|Non compliant with protocol|1|||
17193794|NCT01370005|38347124|FG002|Overall Study|Non compliant with protocol|2|||
17193795|NCT01370005|38347122|FG000|Overall Study|Lost to Follow-up|1|||
17193796|NCT01370005|38347123|FG001|Overall Study|Lost to Follow-up|1|||
17193797|NCT01370005|38347124|FG002|Overall Study|Lost to Follow-up|1|||
17193798|NCT01370005|38347122|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
17193799|NCT01370005|38347123|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
17193800|NCT01370005|38347124|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
17193801|NCT01370005|38347122|FG000|Overall Study|Other reason not defined above|3|||
17193802|NCT01370005|38347123|FG001|Overall Study|Other reason not defined above|0|||
17193803|NCT01370005|38347124|FG002|Overall Study|Other reason not defined above|2|||
17193804|NCT02442778|38347135|FG000|Overall Study|Adverse Event|2|||
17193805|NCT02442778|38347136|FG001|Overall Study|Adverse Event|6|||
17193806|NCT02442778|38347137|FG002|Overall Study|Adverse Event|6|||
17193807|NCT02442778|38347135|FG000|Overall Study|Death|0|||
17193808|NCT02442778|38347136|FG001|Overall Study|Death|2|||
17193809|NCT02442778|38347137|FG002|Overall Study|Death|0|||
17193810|NCT02442778|38347135|FG000|Overall Study|Lack of Efficacy|1|||
17193811|NCT02442778|38347136|FG001|Overall Study|Lack of Efficacy|0|||
17193812|NCT02442778|38347137|FG002|Overall Study|Lack of Efficacy|0|||
17193813|NCT02442778|38347135|FG000|Overall Study|Lost to Follow-up|1|||
17193814|NCT02442778|38347136|FG001|Overall Study|Lost to Follow-up|1|||
17193815|NCT02442778|38347137|FG002|Overall Study|Lost to Follow-up|1|||
17193816|NCT02442778|38347135|FG000|Overall Study|Non-compliance with study drug|2|||
17193817|NCT02442778|38347136|FG001|Overall Study|Non-compliance with study drug|0|||
17193818|NCT02442778|38347137|FG002|Overall Study|Non-compliance with study drug|1|||
17193819|NCT02442778|38347135|FG000|Overall Study|Physician Decision|1|||
17193820|NCT02442778|38347136|FG001|Overall Study|Physician Decision|1|||
17193821|NCT02442778|38347137|FG002|Overall Study|Physician Decision|1|||
17193822|NCT02442778|38347135|FG000|Overall Study|Protocol Deviation|3|||
17193823|NCT02442778|38347136|FG001|Overall Study|Protocol Deviation|0|||
17193824|NCT02442778|38347137|FG002|Overall Study|Protocol Deviation|1|||
17193825|NCT02442778|38347135|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
17193826|NCT02442778|38347136|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
17193827|NCT02442778|38347137|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
17193828|NCT02442778|38347135|FG000|Overall Study|Withdrawal by Subject|4|||
17193829|NCT02442778|38347136|FG001|Overall Study|Withdrawal by Subject|4|||
17193830|NCT02442778|38347137|FG002|Overall Study|Withdrawal by Subject|3|||
17193831|NCT02442778|38347135|FG000|Overall Study|Reason not specified|1|||
17193832|NCT02442778|38347136|FG001|Overall Study|Reason not specified|4|||
17193833|NCT02442778|38347137|FG002|Overall Study|Reason not specified|0|||
17193834|NCT02412436|38347145|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
17193835|NCT02412436|38347145|FG000|Overall Study|Lost to Follow-up|6|||
17193836|NCT02412436|38347145|FG000|Overall Study|Unable to get to clinic|3|||
17193837|NCT02412436|38347145|FG000|Overall Study|Death|1|||
17193838|NCT02412436|38347145|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
17193839|NCT01651000|38347151|FG000|Overall Study|Adverse Event|2|||
17193840|NCT01651000|38347152|FG001|Overall Study|Adverse Event|8|||
17193841|NCT01651000|38347151|FG000|Overall Study|Lost to Follow-up|3|||
17193842|NCT01651000|38347152|FG001|Overall Study|Lost to Follow-up|2|||
17193843|NCT01651000|38347151|FG000|Overall Study|Protocol Violation|0|||
17193844|NCT01651000|38347152|FG001|Overall Study|Protocol Violation|3|||
17193845|NCT01651000|38347151|FG000|Overall Study|Withdrawal by Subject|2|||
17193846|NCT01651000|38347152|FG001|Overall Study|Withdrawal by Subject|10|||
17013779|NCT00824421|38158601|FG002|Overall Study|Withdrawal by Subject|3|||
17193847|NCT01651000|38347151|FG000|Overall Study|Subject noncompliance|0|||
17193848|NCT01651000|38347152|FG001|Overall Study|Subject noncompliance|3|||
17193849|NCT01651000|38347151|FG000|Overall Study|Lack of Efficacy|1|||
17193850|NCT01651000|38347152|FG001|Overall Study|Lack of Efficacy|1|||
17193851|NCT01651000|38347151|FG000|Overall Study|Physician Decision|1|||
17098289|NCT03716050|38237422|FG002|Overall Study|Protocol Violation|0|||
17098290|NCT03716050|38237423|FG003|Overall Study|Protocol Violation|1|||
17098291|NCT03716050|38237424|FG004|Overall Study|Protocol Violation|0|||
17098292|NCT03716050|38237425|FG005|Overall Study|Protocol Violation|0|||
17098293|NCT03716050|38237426|FG006|Overall Study|Protocol Violation|0|||
17098294|NCT03716050|38237427|FG007|Overall Study|Protocol Violation|2|||
17098295|NCT00413231|38237444|FG000|0 to 30-day Post Treatment|Death|5|||
17098296|NCT00413231|38237444|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
17098297|NCT00413231|38237444|FG000|30-day to 365-day Post Treatment|Death|13|||
17098298|NCT00413231|38237444|FG000|365-day to 60-month Post Treatment|Death|36|||
17098299|NCT00413231|38237444|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
17098300|NCT00413231|38237444|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
17098301|NCT00413231|38237444|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
17098302|NCT00413153|38237464|FG000|Overall Study|Withdrawal by Subject|1|||
17098303|NCT00413153|38237465|FG001|Overall Study|Withdrawal by Subject|1|||
17098304|NCT00413153|38237464|FG000|Overall Study|Adverse Event|1|||
17098305|NCT00413153|38237465|FG001|Overall Study|Adverse Event|0|||
17098306|NCT00412607|38237471|FG000|Overall Study|Withdrawal by Subject|9|||
17193852|NCT01651000|38347152|FG001|Overall Study|Physician Decision|0|||
17193853|NCT01651000|38347151|FG000|Overall Study|Administrative reason|1|||
17193854|NCT01651000|38347152|FG001|Overall Study|Administrative reason|0|||
17193855|NCT01651000|38347151|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
17193856|NCT01651000|38347152|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
17193857|NCT02469610|38347160|FG000|Overall Study|Death|1|||
17193858|NCT02469610|38347161|FG001|Overall Study|Death|0|||
17193859|NCT02469610|38347160|FG000|Overall Study|Lost to Follow-up|1|||
17193860|NCT02469610|38347161|FG001|Overall Study|Lost to Follow-up|0|||
17193861|NCT02469610|38347160|FG000|Overall Study|exclusion criteria|2|||
17193862|NCT02469610|38347161|FG001|Overall Study|exclusion criteria|1|||
17193863|NCT02469298|38347171|FG000|Overall Study|Protocol Violation|0|||
17193864|NCT02469298|38347172|FG001|Overall Study|Protocol Violation|1|||
17193865|NCT02469298|38347173|FG002|Overall Study|Protocol Violation|1|||
17193866|NCT02469298|38347174|FG003|Overall Study|Protocol Violation|0|||
17193867|NCT02469298|38347171|FG000|Overall Study|Lost to Follow-up|1|||
17193868|NCT02469298|38347172|FG001|Overall Study|Lost to Follow-up|0|||
17193869|NCT02469298|38347173|FG002|Overall Study|Lost to Follow-up|1|||
17193870|NCT02469298|38347174|FG003|Overall Study|Lost to Follow-up|0|||
17193871|NCT02469298|38347171|FG000|Overall Study|Physician Decision|0|||
17193872|NCT02469298|38347172|FG001|Overall Study|Physician Decision|0|||
17193873|NCT02469298|38347173|FG002|Overall Study|Physician Decision|0|||
17193874|NCT02469298|38347174|FG003|Overall Study|Physician Decision|1|||
17193875|NCT02469298|38347171|FG000|Overall Study|Withdrawal by Subject|0|||
17193876|NCT02469298|38347172|FG001|Overall Study|Withdrawal by Subject|0|||
17193877|NCT02469298|38347173|FG002|Overall Study|Withdrawal by Subject|0|||
17193878|NCT02469298|38347174|FG003|Overall Study|Withdrawal by Subject|1|||
17193879|NCT04163991|38347196|FG000|Overall Study|Adverse Event|0|||
17193880|NCT04163991|38347197|FG001|Overall Study|Adverse Event|0|||
17193881|NCT04163991|38347198|FG002|Overall Study|Adverse Event|0|||
17193882|NCT04163991|38347199|FG003|Overall Study|Adverse Event|1|||
17193883|NCT04163991|38347200|FG004|Overall Study|Adverse Event|0|||
17193884|NCT04163991|38347196|FG000|Overall Study|Death|0|||
17193885|NCT04163991|38347197|FG001|Overall Study|Death|0|||
17193886|NCT04163991|38347198|FG002|Overall Study|Death|1|||
17193887|NCT04163991|38347199|FG003|Overall Study|Death|0|||
17193888|NCT04163991|38347200|FG004|Overall Study|Death|0|||
17193889|NCT04163991|38347196|FG000|Overall Study|Lost to Follow-up|0|||
17193890|NCT04163991|38347197|FG001|Overall Study|Lost to Follow-up|1|||
17193891|NCT04163991|38347198|FG002|Overall Study|Lost to Follow-up|0|||
17193892|NCT04163991|38347199|FG003|Overall Study|Lost to Follow-up|0|||
17193893|NCT04163991|38347200|FG004|Overall Study|Lost to Follow-up|0|||
17193894|NCT04163991|38347196|FG000|Overall Study|Withdrawal by Subject|1|||
17193895|NCT04163991|38347197|FG001|Overall Study|Withdrawal by Subject|1|||
17193896|NCT04163991|38347198|FG002|Overall Study|Withdrawal by Subject|3|||
17193897|NCT04163991|38347199|FG003|Overall Study|Withdrawal by Subject|1|||
17193898|NCT04163991|38347200|FG004|Overall Study|Withdrawal by Subject|1|||
17193899|NCT04163991|38347196|FG000|Overall Study|Other, Not Specified|0|||
17193900|NCT04163991|38347197|FG001|Overall Study|Other, Not Specified|1|||
17193901|NCT04163991|38347198|FG002|Overall Study|Other, Not Specified|1|||
17193902|NCT04163991|38347199|FG003|Overall Study|Other, Not Specified|1|||
17193903|NCT04163991|38347200|FG004|Overall Study|Other, Not Specified|0|||
17193904|NCT02442622|38347218|FG000|Overall Study|Withdrawal by Subject|3|||
17193905|NCT02442622|38347219|FG001|Overall Study|Withdrawal by Subject|1|||
17193906|NCT02411578|38347227|FG000|Crossover Trial Phase|Pregnancy|0|||
17193907|NCT02411578|38347228|FG001|Crossover Trial Phase|Pregnancy|1|||
17193908|NCT02442310|38347236|FG000|Overall Study|Adverse Event|2|||
17193909|NCT02442310|38347236|FG000|Overall Study|Withdrawal by Subject|1|||
17193910|NCT02411110|38347248|FG000|Treatment Period 1|Adverse Event|4|||
17193911|NCT02411110|38347249|FG001|Treatment Period 1|Adverse Event|2|||
17013780|NCT00824421|38158599|FG000|Overall Study|Randomized but not Treated|1|||
17013781|NCT00824421|38158600|FG001|Overall Study|Randomized but not Treated|1|||
17013782|NCT00824421|38158601|FG002|Overall Study|Randomized but not Treated|0|||
17013783|NCT00824421|38158599|FG000|Overall Study|Other|0|||
17013784|NCT00824421|38158600|FG001|Overall Study|Other|1|||
17098307|NCT00412607|38237471|FG000|Overall Study|Lost to Follow-up|19|||
17013785|NCT00824421|38158601|FG002|Overall Study|Other|0|||
17013786|NCT00514813|38158615|FG000|Overall Study|Study terminated|14|||
17013787|NCT00514813|38158616|FG001|Overall Study|Study terminated|74|||
17013788|NCT00514813|38158617|FG002|Overall Study|Study terminated|40|||
17013789|NCT00514813|38158618|FG003|Overall Study|Study terminated|2|||
17013790|NCT00514813|38158615|FG000|Overall Study|Adverse Event|0|||
17013791|NCT00514813|38158616|FG001|Overall Study|Adverse Event|2|||
17013792|NCT00514813|38158617|FG002|Overall Study|Adverse Event|2|||
17013793|NCT00514813|38158618|FG003|Overall Study|Adverse Event|0|||
17013794|NCT00514813|38158615|FG000|Overall Study|Protocol Violation|1|||
17013795|NCT00514813|38158616|FG001|Overall Study|Protocol Violation|0|||
17013796|NCT00514813|38158617|FG002|Overall Study|Protocol Violation|0|||
17013797|NCT00514813|38158618|FG003|Overall Study|Protocol Violation|0|||
17013798|NCT00514813|38158615|FG000|Overall Study|Withdrawal by Subject|0|||
17013799|NCT00514813|38158616|FG001|Overall Study|Withdrawal by Subject|1|||
17013800|NCT00514813|38158617|FG002|Overall Study|Withdrawal by Subject|0|||
17013801|NCT00514813|38158618|FG003|Overall Study|Withdrawal by Subject|0|||
17013802|NCT00514813|38158615|FG000|Overall Study|Lack of Efficacy|0|||
17013803|NCT00514813|38158616|FG001|Overall Study|Lack of Efficacy|1|||
17013804|NCT00514813|38158617|FG002|Overall Study|Lack of Efficacy|0|||
17098308|NCT00412607|38237471|FG000|Overall Study|Death|61|||
17193912|NCT02411110|38347248|FG000|Treatment Period 1|Lost to Follow-up|1|||
17193913|NCT02411110|38347249|FG001|Treatment Period 1|Lost to Follow-up|0|||
17193914|NCT02411110|38347248|FG000|Treatment Period 1|Personal Reasons|2|||
17193915|NCT02411110|38347249|FG001|Treatment Period 1|Personal Reasons|5|||
17193916|NCT02411110|38347248|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
17193917|NCT02411110|38347249|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
17193918|NCT02411110|38347248|FG000|Treatment Period 2|Adverse Event|1|||
17193919|NCT02411110|38347249|FG001|Treatment Period 2|Adverse Event|0|||
17193920|NCT02411110|38347248|FG000|Treatment Period 2|Lost to Follow-up|0|||
17193921|NCT02411110|38347249|FG001|Treatment Period 2|Lost to Follow-up|2|||
17193922|NCT02411110|38347248|FG000|Treatment Period 2|Personal Reasons|0|||
17193923|NCT02411110|38347249|FG001|Treatment Period 2|Personal Reasons|2|||
17193924|NCT01369849|38347260|FG000|Overall Study|Ineligible prior to treatment|0|||
17193925|NCT01369849|38347261|FG001|Overall Study|Ineligible prior to treatment|0|||
17193926|NCT01369849|38347262|FG002|Overall Study|Ineligible prior to treatment|1|||
17193927|NCT01369849|38347260|FG000|Overall Study|Ineligible after receiving treatment|0|||
17193928|NCT01369849|38347261|FG001|Overall Study|Ineligible after receiving treatment|1|||
17193929|NCT01369849|38347262|FG002|Overall Study|Ineligible after receiving treatment|0|||
17193930|NCT02716779|38347275|FG000|Monotherapy|Adverse Event|0|||
17193931|NCT02716779|38347276|FG001|Monotherapy|Adverse Event|1|||
17193932|NCT02716779|38347277|FG002|Monotherapy|Adverse Event|1|||
17193933|NCT02716779|38347275|FG000|Combination Therapy|Adverse Event|0|||
17193934|NCT02716779|38347276|FG001|Combination Therapy|Adverse Event|2|||
17193935|NCT02716779|38347277|FG002|Combination Therapy|Adverse Event|1|||
17193936|NCT01369615|38347293|FG000|Overall Study|Withdrawal by Subject|0|||
17193937|NCT01369615|38347294|FG001|Overall Study|Withdrawal by Subject|1|||
17193938|NCT01369615|38347293|FG000|Overall Study|Lost to Follow-up|0|||
17193939|NCT01369615|38347294|FG001|Overall Study|Lost to Follow-up|1|||
17193940|NCT02468674|38347318|FG000|Overall Study|Adverse Event|0|||
17193941|NCT02468674|38347319|FG001|Overall Study|Adverse Event|0|||
17193942|NCT02468674|38347320|FG002|Overall Study|Adverse Event|0|||
17193943|NCT02468674|38347321|FG003|Overall Study|Adverse Event|1|||
17193944|NCT02468674|38347322|FG004|Overall Study|Adverse Event|0|||
17193945|NCT02468674|38347323|FG005|Overall Study|Adverse Event|1|||
17193946|NCT02468674|38347324|FG006|Overall Study|Adverse Event|0|||
17193947|NCT02468674|38347325|FG007|Overall Study|Adverse Event|0|||
17193948|NCT02468674|38347326|FG008|Overall Study|Adverse Event|0|||
17193949|NCT02468674|38347318|FG000|Overall Study|Lost to Follow-up|1|||
17193950|NCT02468674|38347319|FG001|Overall Study|Lost to Follow-up|0|||
17193951|NCT02468674|38347320|FG002|Overall Study|Lost to Follow-up|0|||
17193952|NCT02468674|38347321|FG003|Overall Study|Lost to Follow-up|0|||
17193953|NCT02468674|38347322|FG004|Overall Study|Lost to Follow-up|0|||
17193954|NCT02468674|38347323|FG005|Overall Study|Lost to Follow-up|0|||
17193955|NCT02468674|38347324|FG006|Overall Study|Lost to Follow-up|0|||
17098309|NCT00412607|38237471|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
17098310|NCT00419003|38237480|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
17098311|NCT00419003|38237481|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
17098312|NCT00419003|38237480|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
17098313|NCT00419003|38237481|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
17098314|NCT00418691|38237493|FG000|Overall Study|Lost to Follow-up|1|||
17098315|NCT00418691|38237494|FG001|Overall Study|Lost to Follow-up|2|||
17013805|NCT00514813|38158618|FG003|Overall Study|Lack of Efficacy|0|||
17013806|NCT00514813|38158615|FG000|Overall Study|Kidney transplant|0|||
17013807|NCT00514813|38158616|FG001|Overall Study|Kidney transplant|6|||
17013808|NCT00514813|38158617|FG002|Overall Study|Kidney transplant|2|||
17013809|NCT00514813|38158618|FG003|Overall Study|Kidney transplant|0|||
17013810|NCT00514813|38158615|FG000|Overall Study|Death|0|||
17013811|NCT00514813|38158616|FG001|Overall Study|Death|2|||
17013812|NCT00514813|38158617|FG002|Overall Study|Death|3|||
17013813|NCT00514813|38158618|FG003|Overall Study|Death|2|||
17013814|NCT00597116|38158630|FG000|Overall Study|Adverse Event|2|||
17013815|NCT00597116|38158631|FG001|Overall Study|Adverse Event|1|||
17013816|NCT00597116|38158630|FG000|Overall Study|Withdrawal by Subject|0|||
17013817|NCT00597116|38158631|FG001|Overall Study|Withdrawal by Subject|2|||
17013818|NCT00597116|38158630|FG000|Overall Study|Physician Decision|0|||
17013819|NCT00597116|38158631|FG001|Overall Study|Physician Decision|1|||
17013820|NCT00597116|38158630|FG000|Overall Study|Death|0|||
17013821|NCT00597116|38158631|FG001|Overall Study|Death|1|||
17013822|NCT00597116|38158630|FG000|Overall Study|Lost to Follow-up|1|||
17013823|NCT00597116|38158631|FG001|Overall Study|Lost to Follow-up|0|||
17013824|NCT00597116|38158630|FG000|Overall Study|Progressive disease|11|||
17013825|NCT00597116|38158631|FG001|Overall Study|Progressive disease|6|||
17013826|NCT00514735|38158639|FG000|Overall Study|Withdrawal by Subject|13|||
17013827|NCT00514735|38158640|FG001|Overall Study|Withdrawal by Subject|5|||
17013828|NCT00514735|38158639|FG000|Overall Study|Death|1|||
17013829|NCT00514735|38158640|FG001|Overall Study|Death|0|||
17013830|NCT00514735|38158639|FG000|Overall Study|Lost to Follow-up|0|||
17013831|NCT00514735|38158640|FG001|Overall Study|Lost to Follow-up|1|||
17013832|NCT03252587|38158652|FG000|Overall Study|Adverse Event|3|||
17013833|NCT03252587|38158653|FG001|Overall Study|Adverse Event|8|||
17013834|NCT03252587|38158654|FG002|Overall Study|Adverse Event|6|||
17013835|NCT03252587|38158655|FG003|Overall Study|Adverse Event|12|||
17098316|NCT00418691|38237495|FG002|Overall Study|Lost to Follow-up|3|||
17098317|NCT00418691|38237493|FG000|Overall Study|Started new medication voiding entry|0|||
17098318|NCT00418691|38237494|FG001|Overall Study|Started new medication voiding entry|0|||
17098319|NCT00418691|38237495|FG002|Overall Study|Started new medication voiding entry|1|||
17013836|NCT03252587|38158652|FG000|Overall Study|Lack of Efficacy|7|||
17013837|NCT03252587|38158653|FG001|Overall Study|Lack of Efficacy|2|||
17013838|NCT03252587|38158654|FG002|Overall Study|Lack of Efficacy|2|||
17013839|NCT03252587|38158655|FG003|Overall Study|Lack of Efficacy|4|||
17013840|NCT03252587|38158652|FG000|Overall Study|Lost to Follow-up|2|||
17013841|NCT03252587|38158653|FG001|Overall Study|Lost to Follow-up|0|||
17013842|NCT03252587|38158654|FG002|Overall Study|Lost to Follow-up|0|||
17013843|NCT03252587|38158655|FG003|Overall Study|Lost to Follow-up|2|||
17013844|NCT03252587|38158652|FG000|Overall Study|Pregnancy|2|||
17013845|NCT03252587|38158653|FG001|Overall Study|Pregnancy|1|||
17013846|NCT03252587|38158654|FG002|Overall Study|Pregnancy|0|||
17013847|NCT03252587|38158655|FG003|Overall Study|Pregnancy|1|||
17013848|NCT03252587|38158652|FG000|Overall Study|Withdrawal by Subject|8|||
17013849|NCT03252587|38158653|FG001|Overall Study|Withdrawal by Subject|4|||
17013850|NCT03252587|38158654|FG002|Overall Study|Withdrawal by Subject|4|||
17013851|NCT03252587|38158655|FG003|Overall Study|Withdrawal by Subject|4|||
17013852|NCT03252587|38158652|FG000|Overall Study|Other Reasons|2|||
17013853|NCT03252587|38158653|FG001|Overall Study|Other Reasons|5|||
17013854|NCT03252587|38158654|FG002|Overall Study|Other Reasons|5|||
17013855|NCT03252587|38158655|FG003|Overall Study|Other Reasons|4|||
17013856|NCT00511147|38158668|FG000|Overall Study|Withdrawal by Subject|1|||
17013857|NCT00511147|38158668|FG000|Overall Study|Disease progression|5|||
17098320|NCT00418691|38237493|FG000|Overall Study|Progressive Disease|1|||
17098321|NCT00418691|38237494|FG001|Overall Study|Progressive Disease|0|||
17013858|NCT00511147|38158668|FG000|Overall Study|Required platelet transfusion|1|||
17013859|NCT00510835|38158675|FG000|Overall Study|Withdrawal by Subject|6|||
17013860|NCT00510835|38158676|FG001|Overall Study|Withdrawal by Subject|2|||
17013861|NCT00510835|38158677|FG002|Overall Study|Withdrawal by Subject|2|||
17098322|NCT00418691|38237495|FG002|Overall Study|Progressive Disease|1|||
17098323|NCT00412373|38237505|FG000|Overall Study|Adverse Event|8|||
17098324|NCT00412373|38237506|FG001|Overall Study|Adverse Event|13|||
17098325|NCT00412373|38237505|FG000|Overall Study|Lack of Efficacy|16|||
17098326|NCT00412373|38237506|FG001|Overall Study|Lack of Efficacy|22|||
17098327|NCT00412373|38237505|FG000|Overall Study|Lost to Follow-up|7|||
17098328|NCT00412373|38237506|FG001|Overall Study|Lost to Follow-up|13|||
17098329|NCT00412373|38237505|FG000|Overall Study|Withdrawal by Subject|8|||
17098330|NCT00412373|38237506|FG001|Overall Study|Withdrawal by Subject|27|||
17098331|NCT00412373|38237505|FG000|Overall Study|Other|2|||
17098332|NCT00412373|38237506|FG001|Overall Study|Other|2|||
17098333|NCT00418379|38237515|FG000|Year 1|Adverse Event|9|||
17098334|NCT00418379|38237516|FG001|Year 1|Adverse Event|15|||
17098335|NCT00418379|38237517|FG002|Year 1|Adverse Event|3|||
17013862|NCT00506077|38158687|FG000|Treatment Period 1|Adverse Event|2|||
17013863|NCT00506077|38158688|FG001|Treatment Period 1|Adverse Event|1|||
17013864|NCT00506077|38158687|FG000|Treatment Period 1|Lost to Follow-up|0|||
17098336|NCT00418379|38237515|FG000|Year 1|Withdrawal by Subject|7|||
17098337|NCT00418379|38237516|FG001|Year 1|Withdrawal by Subject|8|||
17098338|NCT00418379|38237517|FG002|Year 1|Withdrawal by Subject|5|||
17098339|NCT00418379|38237515|FG000|Year 1|Any other reason not above-mentioned|2|||
17098340|NCT00418379|38237516|FG001|Year 1|Any other reason not above-mentioned|5|||
17013865|NCT00506077|38158688|FG001|Treatment Period 1|Lost to Follow-up|2|||
17098341|NCT00418379|38237517|FG002|Year 1|Any other reason not above-mentioned|7|||
17098342|NCT00418379|38237515|FG000|Year 2|Adverse Event|5|||
17098343|NCT00418379|38237516|FG001|Year 2|Adverse Event|2|||
17098344|NCT00418379|38237517|FG002|Year 2|Adverse Event|1|||
17098345|NCT00418379|38237515|FG000|Year 2|Withdrawal by Subject|1|||
17098346|NCT00418379|38237516|FG001|Year 2|Withdrawal by Subject|1|||
17098347|NCT00418379|38237517|FG002|Year 2|Withdrawal by Subject|3|||
17098348|NCT00418379|38237515|FG000|Year 2|Any other reason not above-mentioned|2|||
17098349|NCT00418379|38237516|FG001|Year 2|Any other reason not above-mentioned|1|||
17098350|NCT00418379|38237517|FG002|Year 2|Any other reason not above-mentioned|6|||
17098351|NCT00418379|38237515|FG000|Year 3|Withdrawal by Subject|1|||
17098352|NCT00418379|38237516|FG001|Year 3|Withdrawal by Subject|1|||
17098353|NCT00418379|38237517|FG002|Year 3|Withdrawal by Subject|2|||
17098354|NCT00418379|38237515|FG000|Year 3|Any other reason not above-mentioned|2|||
17193956|NCT02468674|38347325|FG007|Overall Study|Lost to Follow-up|1|||
17193957|NCT02468674|38347326|FG008|Overall Study|Lost to Follow-up|1|||
17193958|NCT02468674|38347318|FG000|Overall Study|Physician Decision|0|||
17013866|NCT00506077|38158687|FG000|Treatment Period 1|Withdrawal by Subject|2|||
17013867|NCT00506077|38158688|FG001|Treatment Period 1|Withdrawal by Subject|0|||
17193959|NCT02468674|38347319|FG001|Overall Study|Physician Decision|0|||
17193960|NCT02468674|38347320|FG002|Overall Study|Physician Decision|0|||
17193961|NCT02468674|38347321|FG003|Overall Study|Physician Decision|0|||
17193962|NCT02468674|38347322|FG004|Overall Study|Physician Decision|0|||
17193963|NCT02468674|38347323|FG005|Overall Study|Physician Decision|0|||
17193964|NCT02468674|38347324|FG006|Overall Study|Physician Decision|1|||
17193965|NCT02468674|38347325|FG007|Overall Study|Physician Decision|0|||
17193966|NCT02468674|38347326|FG008|Overall Study|Physician Decision|0|||
17193967|NCT02468674|38347318|FG000|Overall Study|Patient/Guardian Decision|0|||
17193968|NCT02468674|38347319|FG001|Overall Study|Patient/Guardian Decision|0|||
17193969|NCT02468674|38347320|FG002|Overall Study|Patient/Guardian Decision|0|||
17193970|NCT02468674|38347321|FG003|Overall Study|Patient/Guardian Decision|0|||
17193971|NCT02468674|38347322|FG004|Overall Study|Patient/Guardian Decision|1|||
17193972|NCT02468674|38347323|FG005|Overall Study|Patient/Guardian Decision|0|||
17193973|NCT02468674|38347324|FG006|Overall Study|Patient/Guardian Decision|0|||
17193974|NCT02468674|38347325|FG007|Overall Study|Patient/Guardian Decision|2|||
17193975|NCT02468674|38347326|FG008|Overall Study|Patient/Guardian Decision|1|||
17193976|NCT02468674|38347318|FG000|Overall Study|Protocol Deviation|0|||
17193977|NCT02468674|38347319|FG001|Overall Study|Protocol Deviation|0|||
17193978|NCT02468674|38347320|FG002|Overall Study|Protocol Deviation|0|||
17193979|NCT02468674|38347321|FG003|Overall Study|Protocol Deviation|0|||
17193980|NCT02468674|38347322|FG004|Overall Study|Protocol Deviation|0|||
17193981|NCT02468674|38347323|FG005|Overall Study|Protocol Deviation|0|||
17193982|NCT02468674|38347324|FG006|Overall Study|Protocol Deviation|0|||
17193983|NCT02468674|38347325|FG007|Overall Study|Protocol Deviation|1|||
17193984|NCT02468674|38347326|FG008|Overall Study|Protocol Deviation|1|||
17193985|NCT02467192|38347346|FG000|Overall Study|Death|1|||
17193986|NCT02467192|38347346|FG000|Overall Study|revealed to have pneumonia before|2|||
17193987|NCT02410954|38347356|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
17193988|NCT02410954|38347357|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
17193989|NCT02410954|38347356|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
17193990|NCT02410954|38347357|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
17193991|NCT02689453|38347366|FG000|Overall Study|Progressive disease|0|||
17193992|NCT02689453|38347367|FG001|Overall Study|Progressive disease|1|||
17193993|NCT02689453|38347368|FG002|Overall Study|Progressive disease|1|||
17193994|NCT00701103|38347399|FG000|Overall Study|Adverse Event|0|||
17193995|NCT00701103|38347400|FG001|Overall Study|Adverse Event|0|||
17193996|NCT00701103|38347401|FG002|Overall Study|Adverse Event|1|||
17193997|NCT00701103|38347402|FG003|Overall Study|Adverse Event|1|||
17193998|NCT00701103|38347403|FG004|Overall Study|Adverse Event|0|||
17193999|NCT00701103|38347404|FG005|Overall Study|Adverse Event|1|||
17194000|NCT00701103|38347405|FG006|Overall Study|Adverse Event|1|||
17013868|NCT00506077|38158687|FG000|Treatment Period 2|Adverse Event|0|||
17013869|NCT00506077|38158688|FG001|Treatment Period 2|Adverse Event|1|||
17013870|NCT00506077|38158687|FG000|Treatment Period 2|Withdrawal by Subject|1|||
17013871|NCT00506077|38158688|FG001|Treatment Period 2|Withdrawal by Subject|0|||
17013872|NCT00505921|38158694|FG000|Overall Study|Ineligible|1|||
17013873|NCT00505921|38158694|FG000|Overall Study|Failed to Mobilize|8|||
17013874|NCT00596960|38158700|FG000|Overall Study|Death|1|||
17013875|NCT00596960|38158701|FG001|Overall Study|Death|2|||
17013876|NCT00596960|38158700|FG000|Overall Study|Lost to Follow-up|6|||
17013877|NCT00596960|38158701|FG001|Overall Study|Lost to Follow-up|5|||
17098355|NCT00418379|38237516|FG001|Year 3|Any other reason not above-mentioned|1|||
17013878|NCT00596960|38158700|FG000|Overall Study|Withdrawal by Subject|1|||
17013879|NCT00596960|38158701|FG001|Overall Study|Withdrawal by Subject|0|||
17013880|NCT00596960|38158700|FG000|Overall Study|Incarcerated|2|||
17098356|NCT00418379|38237517|FG002|Year 3|Any other reason not above-mentioned|1|||
17098357|NCT00418379|38237515|FG000|Year 4|Adverse Event|0|||
17098358|NCT00418379|38237516|FG001|Year 4|Adverse Event|1|||
17098359|NCT00418379|38237517|FG002|Year 4|Adverse Event|0|||
17098360|NCT00418379|38237515|FG000|Year 4|Withdrawal by Subject|2|||
17098361|NCT00418379|38237516|FG001|Year 4|Withdrawal by Subject|3|||
17013881|NCT00596960|38158701|FG001|Overall Study|Incarcerated|0|||
17013882|NCT00596960|38158700|FG000|Overall Study|Physician Decision|1|||
17013883|NCT00596960|38158701|FG001|Overall Study|Physician Decision|0|||
17013884|NCT00596960|38158700|FG000|Overall Study|Protocol Violation|0|||
17098362|NCT00418379|38237517|FG002|Year 4|Withdrawal by Subject|2|||
17098363|NCT00418379|38237515|FG000|Year 4|Any other reason not above-mentioned|1|||
17098364|NCT00418379|38237516|FG001|Year 4|Any other reason not above-mentioned|1|||
17098365|NCT00418379|38237517|FG002|Year 4|Any other reason not above-mentioned|0|||
17098366|NCT00418379|38237515|FG000|Year 5|Adverse Event|0|||
17098367|NCT00418379|38237516|FG001|Year 5|Adverse Event|1|||
17098368|NCT00418379|38237517|FG002|Year 5|Adverse Event|0|||
17098369|NCT00418379|38237515|FG000|Year 5|Any other reason not above-mentioned|2|||
17098370|NCT00418379|38237516|FG001|Year 5|Any other reason not above-mentioned|4|||
17098371|NCT00418379|38237517|FG002|Year 5|Any other reason not above-mentioned|3|||
17013885|NCT00596960|38158701|FG001|Overall Study|Protocol Violation|1|||
17013886|NCT00596960|38158700|FG000|Overall Study|No alcohol use data|0|||
17013887|NCT00596960|38158701|FG001|Overall Study|No alcohol use data|1|||
17013888|NCT00505765|38158710|FG000|Overall Study|Withdrawal by Subject|1|||
17098372|NCT00418145|38237525|FG000|Overall Study|study terminated|6|||
17098373|NCT00417989|38237533|FG000|Overall Study|Withdrawal by Subject|13|||
17098374|NCT00417989|38237534|FG001|Overall Study|Withdrawal by Subject|13|||
17098375|NCT00417989|38237533|FG000|Overall Study|Lost to Follow-up|1|||
17098376|NCT00417989|38237534|FG001|Overall Study|Lost to Follow-up|6|||
17098377|NCT00417989|38237533|FG000|Overall Study|Protocol Violation|1|||
17098378|NCT00417989|38237534|FG001|Overall Study|Protocol Violation|0|||
17098379|NCT00417989|38237533|FG000|Overall Study|Death|0|||
17098380|NCT00417989|38237534|FG001|Overall Study|Death|1|||
17098381|NCT00417989|38237533|FG000|Overall Study|Physician Decision|5|||
17098382|NCT00417989|38237534|FG001|Overall Study|Physician Decision|2|||
17098383|NCT00412217|38237544|FG000|Overall Study|Insufficient Data Available|8|||
17098384|NCT00412217|38237545|FG001|Overall Study|Insufficient Data Available|3|||
17098385|NCT00412217|38237544|FG000|Overall Study|Death|5|||
17098386|NCT00412217|38237545|FG001|Overall Study|Death|4|||
17098387|NCT00412217|38237544|FG000|Overall Study|Disease Progression|2|||
17098388|NCT00412217|38237545|FG001|Overall Study|Disease Progression|3|||
17098389|NCT00412217|38237544|FG000|Overall Study|Investigator Decision|1|||
17098390|NCT00412217|38237545|FG001|Overall Study|Investigator Decision|0|||
17098391|NCT00412217|38237544|FG000|Overall Study|Withdrawal by Subject|2|||
17098392|NCT00412217|38237545|FG001|Overall Study|Withdrawal by Subject|0|||
17098393|NCT00412217|38237544|FG000|Overall Study|Lost to Follow-up|1|||
17098394|NCT00412217|38237545|FG001|Overall Study|Lost to Follow-up|4|||
17194001|NCT00701103|38347406|FG007|Overall Study|Adverse Event|0|||
17194002|NCT00701103|38347407|FG008|Overall Study|Adverse Event|0|||
17194003|NCT00701103|38347408|FG009|Overall Study|Adverse Event|2|||
17194004|NCT00701103|38347409|FG010|Overall Study|Adverse Event|0|||
17194005|NCT00701103|38347399|FG000|Overall Study|Progressive Disease|5|||
17194006|NCT00701103|38347400|FG001|Overall Study|Progressive Disease|2|||
17194007|NCT00701103|38347401|FG002|Overall Study|Progressive Disease|6|||
17194008|NCT00701103|38347402|FG003|Overall Study|Progressive Disease|5|||
17194009|NCT00701103|38347403|FG004|Overall Study|Progressive Disease|6|||
17194010|NCT00701103|38347404|FG005|Overall Study|Progressive Disease|5|||
17194011|NCT00701103|38347405|FG006|Overall Study|Progressive Disease|7|||
17194012|NCT00701103|38347406|FG007|Overall Study|Progressive Disease|7|||
17194013|NCT00701103|38347407|FG008|Overall Study|Progressive Disease|8|||
17194014|NCT00701103|38347408|FG009|Overall Study|Progressive Disease|8|||
17194015|NCT00701103|38347409|FG010|Overall Study|Progressive Disease|11|||
17194016|NCT00701103|38347399|FG000|Overall Study|Withdrawal by Subject|0|||
17194017|NCT00701103|38347400|FG001|Overall Study|Withdrawal by Subject|1|||
17194018|NCT00701103|38347401|FG002|Overall Study|Withdrawal by Subject|1|||
17194019|NCT00701103|38347402|FG003|Overall Study|Withdrawal by Subject|0|||
17194020|NCT00701103|38347403|FG004|Overall Study|Withdrawal by Subject|0|||
17194021|NCT00701103|38347404|FG005|Overall Study|Withdrawal by Subject|0|||
17194022|NCT00701103|38347405|FG006|Overall Study|Withdrawal by Subject|0|||
17194023|NCT00701103|38347406|FG007|Overall Study|Withdrawal by Subject|0|||
17013889|NCT00505765|38158711|FG001|Overall Study|Withdrawal by Subject|0|||
17194024|NCT00701103|38347407|FG008|Overall Study|Withdrawal by Subject|0|||
16786319|NCT01976806|37726732|FG000|Overall Study|Lost to Follow-up|1|||
17013890|NCT00505765|38158712|FG002|Overall Study|Withdrawal by Subject|0|||
17013891|NCT00505765|38158710|FG000|Overall Study|Adverse Event|1|||
17013892|NCT00505765|38158711|FG001|Overall Study|Adverse Event|2|||
17013893|NCT00505765|38158712|FG002|Overall Study|Adverse Event|0|||
17013894|NCT00505765|38158710|FG000|Overall Study|Noncompliance|0|||
17013895|NCT00505765|38158711|FG001|Overall Study|Noncompliance|1|||
17013896|NCT00505765|38158712|FG002|Overall Study|Noncompliance|3|||
17013897|NCT00505687|38158720|FG000|Overall Study|Important protocol violation|2|||
17013898|NCT00505687|38158720|FG000|Overall Study|Lack of Efficacy|15|||
17013899|NCT00505687|38158720|FG000|Overall Study|Adverse Event|48|||
17013900|NCT00505687|38158720|FG000|Overall Study|Subject withdrew consent|15|||
17194025|NCT00701103|38347408|FG009|Overall Study|Withdrawal by Subject|0|||
17194026|NCT00701103|38347409|FG010|Overall Study|Withdrawal by Subject|0|||
17194027|NCT00701103|38347399|FG000|Overall Study|Other|0|||
17194028|NCT00701103|38347400|FG001|Overall Study|Other|0|||
17194029|NCT00701103|38347401|FG002|Overall Study|Other|0|||
17194030|NCT00701103|38347402|FG003|Overall Study|Other|0|||
17194031|NCT00701103|38347403|FG004|Overall Study|Other|0|||
17194032|NCT00701103|38347404|FG005|Overall Study|Other|0|||
17194033|NCT00701103|38347405|FG006|Overall Study|Other|0|||
17194034|NCT00701103|38347406|FG007|Overall Study|Other|0|||
17194035|NCT00701103|38347407|FG008|Overall Study|Other|1|||
17194036|NCT00701103|38347408|FG009|Overall Study|Other|1|||
17194037|NCT00701103|38347409|FG010|Overall Study|Other|0|||
17194038|NCT01369225|38347443|FG000|Overall Study|Withdrawal by Subject|1|||
17194039|NCT01369225|38347444|FG001|Overall Study|Withdrawal by Subject|0|||
17194040|NCT01369225|38347445|FG002|Overall Study|Withdrawal by Subject|2|||
17194041|NCT01369225|38347446|FG003|Overall Study|Withdrawal by Subject|1|||
17194042|NCT01369225|38347447|FG004|Overall Study|Withdrawal by Subject|0|||
17194043|NCT01369225|38347448|FG005|Overall Study|Withdrawal by Subject|0|||
17194044|NCT01369225|38347443|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
17194045|NCT01369225|38347444|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
17194046|NCT01369225|38347445|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
17194047|NCT01369225|38347446|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
17194048|NCT01369225|38347447|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
17194049|NCT01369225|38347448|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
17194050|NCT01369225|38347443|FG000|Overall Study|Other|1|||
17194051|NCT01369225|38347444|FG001|Overall Study|Other|0|||
17194052|NCT01369225|38347445|FG002|Overall Study|Other|0|||
17194053|NCT01369225|38347446|FG003|Overall Study|Other|0|||
17194054|NCT01369225|38347447|FG004|Overall Study|Other|1|||
17194055|NCT01369225|38347448|FG005|Overall Study|Other|0|||
17194056|NCT01369225|38347443|FG000|Overall Study|Adverse Event|0|||
17194057|NCT01369225|38347444|FG001|Overall Study|Adverse Event|0|||
17194058|NCT01369225|38347445|FG002|Overall Study|Adverse Event|0|||
16786320|NCT01976806|37726733|FG001|Overall Study|Lost to Follow-up|4|||
17013901|NCT00505687|38158720|FG000|Overall Study|Lost to Follow-up|1|||
17013902|NCT00505687|38158720|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
17013903|NCT00505687|38158720|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
17013904|NCT00505687|38158720|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
17013905|NCT00505687|38158720|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
17013906|NCT00505687|38158720|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
17013907|NCT00505687|38158720|FG000|Overall Study|Other: Disease Progression|1|||
17013908|NCT00505687|38158720|FG000|Overall Study|Other: As Per Sponsor|8|||
17098395|NCT00412217|38237544|FG000|Overall Study|Study Terminated by Sponsor|26|||
17098396|NCT00412217|38237545|FG001|Overall Study|Study Terminated by Sponsor|33|||
17013909|NCT00505375|38158726|FG000|Overall Study|Death|1|||
17013910|NCT00505375|38158727|FG001|Overall Study|Death|0|||
17013911|NCT00505375|38158726|FG000|Overall Study|Withdrawal by Subject|2|||
17013912|NCT00505375|38158727|FG001|Overall Study|Withdrawal by Subject|2|||
17013913|NCT00505375|38158726|FG000|Overall Study|Lost to Follow-up|0|||
17013914|NCT00505375|38158727|FG001|Overall Study|Lost to Follow-up|2|||
17013915|NCT00505375|38158726|FG000|Overall Study|Pregnancy|1|||
17013916|NCT00505375|38158727|FG001|Overall Study|Pregnancy|0|||
17013917|NCT00505375|38158726|FG000|Overall Study|Travel issues|0|||
17013918|NCT00505375|38158727|FG001|Overall Study|Travel issues|1|||
17013919|NCT00594932|38158735|FG000|First 3 Months|Withdrawal by Subject|1|||
17013920|NCT00594932|38158736|FG001|First 3 Months|Withdrawal by Subject|3|||
17013921|NCT00594932|38158735|FG000|Final 3 Months|Withdrawal by Subject|4|||
17098397|NCT00412217|38237544|FG000|Overall Study|Other|1|||
17098398|NCT00412217|38237545|FG001|Overall Study|Other|1|||
17098399|NCT05000164|38237551|FG000|Overall Study|Adverse Event|1|||
17098400|NCT05000164|38237551|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
17098401|NCT05000164|38237551|FG000|Overall Study|Lens Discomfort|3|||
17098402|NCT05000164|38237551|FG000|Overall Study|Withdrew Consent during Study|2|||
17098403|NCT05000164|38237551|FG000|Overall Study|Subject Withdrawn by PI|2|||
17098404|NCT05000164|38237551|FG000|Overall Study|Other Fractured Test Article|1|||
17194059|NCT01369225|38347446|FG003|Overall Study|Adverse Event|1|||
17194060|NCT01369225|38347447|FG004|Overall Study|Adverse Event|1|||
17194061|NCT01369225|38347448|FG005|Overall Study|Adverse Event|0|||
17194062|NCT02639546|38347470|FG000|Overall Study|Death|2|||
17194063|NCT02639546|38347471|FG001|Overall Study|Death|2|||
17013922|NCT00594932|38158736|FG001|Final 3 Months|Withdrawal by Subject|3|||
17013923|NCT00504829|38158745|FG000|Overall Study|Protocol Violation|6|||
17013924|NCT00504829|38158746|FG001|Overall Study|Protocol Violation|4|||
17013925|NCT00504829|38158747|FG002|Overall Study|Protocol Violation|10|||
17013926|NCT00504595|38158759|FG000|Overall Study|Lack of Efficacy|1|||
17013927|NCT00504595|38158760|FG001|Overall Study|Lack of Efficacy|0|||
17013928|NCT00504595|38158761|FG002|Overall Study|Lack of Efficacy|0|||
17013929|NCT00504595|38158762|FG003|Overall Study|Lack of Efficacy|0|||
17098405|NCT00123474|38237559|FG000|Randomized to Treatment|Randomized, never treated|1|||
17098406|NCT00123474|38237560|FG001|Randomized to Treatment|Randomized, never treated|4|||
17098407|NCT00123474|38237561|FG002|Randomized to Treatment|Randomized, never treated|2|||
17098408|NCT00123474|38237562|FG003|Randomized to Treatment|Randomized, never treated|1|||
17098409|NCT00123474|38237559|FG000|As Treated at Study Closure|not reported when site closed|1|||
17098410|NCT00123474|38237560|FG001|As Treated at Study Closure|not reported when site closed|0|||
17098411|NCT00123474|38237561|FG002|As Treated at Study Closure|not reported when site closed|1|||
17098412|NCT00123474|38237562|FG003|As Treated at Study Closure|not reported when site closed|0|||
17013930|NCT00504595|38158759|FG000|Overall Study|Other|0|||
17013931|NCT00504595|38158760|FG001|Overall Study|Other|0|||
17013932|NCT00504595|38158761|FG002|Overall Study|Other|2|||
17013933|NCT00504595|38158762|FG003|Overall Study|Other|0|||
17013934|NCT00513409|38158774|FG000|Overall Study|Adverse Event|0|||
17013935|NCT00513409|38158775|FG001|Overall Study|Adverse Event|1|||
17013936|NCT00513409|38158774|FG000|Overall Study|Withdrawal by Subject|0|||
17013937|NCT00513409|38158775|FG001|Overall Study|Withdrawal by Subject|2|||
17013938|NCT00513409|38158774|FG000|Overall Study|Lost to Follow-up|0|||
17013939|NCT00513409|38158775|FG001|Overall Study|Lost to Follow-up|1|||
17013940|NCT00513409|38158774|FG000|Overall Study|Physician Decision|1|||
17013941|NCT00513409|38158775|FG001|Overall Study|Physician Decision|0|||
17098413|NCT00123474|38237559|FG000|As Treated at Study Closure|Adverse Event|10|||
17013942|NCT00513409|38158774|FG000|Overall Study|Visit 3 not done|1|||
17013943|NCT00513409|38158775|FG001|Overall Study|Visit 3 not done|2|||
17013944|NCT03150095|38158783|FG000|Overall Study|Death|0|||
17013945|NCT03150095|38158784|FG001|Overall Study|Death|1|||
17013946|NCT03150095|38158783|FG000|Overall Study|Lost to Follow-up|1|||
17013947|NCT03150095|38158784|FG001|Overall Study|Lost to Follow-up|1|||
17013948|NCT03150095|38158783|FG000|Overall Study|Withdrawal by Subject|4|||
17013949|NCT03150095|38158784|FG001|Overall Study|Withdrawal by Subject|0|||
17013950|NCT03150095|38158783|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
17013951|NCT03150095|38158784|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
17013952|NCT00705016|38158793|FG000|Overall Study|Adverse Event|6|||
17013953|NCT00705016|38158794|FG001|Overall Study|Adverse Event|11|||
17013954|NCT00705016|38158795|FG002|Overall Study|Adverse Event|10|||
17013955|NCT00705016|38158793|FG000|Overall Study|Death|5|||
17013956|NCT00705016|38158794|FG001|Overall Study|Death|7|||
17013957|NCT00705016|38158795|FG002|Overall Study|Death|5|||
17013958|NCT00705016|38158793|FG000|Overall Study|Protocol Violation|0|||
17013959|NCT00705016|38158794|FG001|Overall Study|Protocol Violation|1|||
17013960|NCT00705016|38158795|FG002|Overall Study|Protocol Violation|1|||
17013961|NCT00705016|38158793|FG000|Overall Study|Withdrawal by Subject|4|||
17013962|NCT00705016|38158794|FG001|Overall Study|Withdrawal by Subject|3|||
17013963|NCT00705016|38158795|FG002|Overall Study|Withdrawal by Subject|2|||
17013964|NCT00705016|38158793|FG000|Overall Study|Progressive Disease|33|||
17013965|NCT00705016|38158794|FG001|Overall Study|Progressive Disease|29|||
17013966|NCT00705016|38158795|FG002|Overall Study|Progressive Disease|33|||
17013967|NCT00705016|38158793|FG000|Overall Study|Symptomatic Deterioration|3|||
17013968|NCT00705016|38158794|FG001|Overall Study|Symptomatic Deterioration|1|||
17013969|NCT00705016|38158795|FG002|Overall Study|Symptomatic Deterioration|1|||
17013970|NCT00705016|38158793|FG000|Overall Study|Other|9|||
17013971|NCT00705016|38158794|FG001|Overall Study|Other|6|||
17013972|NCT00705016|38158795|FG002|Overall Study|Other|6|||
17013973|NCT00595868|38158805|FG000|Overall Study|Lost to Follow-up|45|||
17013974|NCT00595868|38158806|FG001|Overall Study|Lost to Follow-up|50|||
17013975|NCT00856284|38158836|FG000|Overall Study|Hyperglycemic rescue|231|||
17013976|NCT00856284|38158837|FG001|Overall Study|Hyperglycemic rescue|201|||
17013977|NCT00856284|38158838|FG002|Overall Study|Hyperglycemic rescue|235|||
17013978|NCT00856284|38158836|FG000|Overall Study|Adverse Event|60|||
17013979|NCT00856284|38158837|FG001|Overall Study|Adverse Event|74|||
17013980|NCT00856284|38158838|FG002|Overall Study|Adverse Event|82|||
17013981|NCT00856284|38158836|FG000|Overall Study|Major protocol deviation|24|||
17013982|NCT00856284|38158837|FG001|Overall Study|Major protocol deviation|16|||
17013983|NCT00856284|38158838|FG002|Overall Study|Major protocol deviation|15|||
17013984|NCT00856284|38158836|FG000|Overall Study|Lost to Follow-up|20|||
17013985|NCT00856284|38158837|FG001|Overall Study|Lost to Follow-up|22|||
17013986|NCT00856284|38158838|FG002|Overall Study|Lost to Follow-up|28|||
17013987|NCT00856284|38158836|FG000|Overall Study|Voluntary withdrawal|48|||
17013988|NCT00856284|38158837|FG001|Overall Study|Voluntary withdrawal|52|||
17013989|NCT00856284|38158838|FG002|Overall Study|Voluntary withdrawal|62|||
17013990|NCT00856284|38158836|FG000|Overall Study|Pregnancy|1|||
17013991|NCT00856284|38158837|FG001|Overall Study|Pregnancy|2|||
17013992|NCT00856284|38158838|FG002|Overall Study|Pregnancy|0|||
17013993|NCT00856284|38158836|FG000|Overall Study|Investigator discretion|9|||
17013994|NCT00856284|38158837|FG001|Overall Study|Investigator discretion|8|||
17013995|NCT00856284|38158838|FG002|Overall Study|Investigator discretion|10|||
17013996|NCT00856284|38158836|FG000|Overall Study|Other|15|||
17013997|NCT00856284|38158837|FG001|Overall Study|Other|17|||
17013998|NCT00856284|38158838|FG002|Overall Study|Other|14|||
17013999|NCT00856284|38158836|FG000|Overall Study|Randomized in error|0|||
17014000|NCT00856284|38158837|FG001|Overall Study|Randomized in error|0|||
17014001|NCT00856284|38158838|FG002|Overall Study|Randomized in error|1|||
17014002|NCT00510289|38158846|FG000|Overall Study|Withdrawal by Subject|7|||
17014003|NCT00510289|38158846|FG000|Overall Study|Refused bone marrow biopsy|2|||
17014004|NCT00510289|38158846|FG000|Overall Study|Lost to Follow-up|1|||
17014005|NCT00510289|38158846|FG000|Overall Study|Progressed prior to starting drug|2|||
17014006|NCT00492115|38158853|FG000|Overall Study|Withdrawal by Subject|3|||
17014007|NCT00492115|38158854|FG001|Overall Study|Withdrawal by Subject|4|||
17014008|NCT00856206|38158862|FG000|Overall Study|Protocol Violation|6|||
17014009|NCT00856206|38158863|FG001|Overall Study|Protocol Violation|18|||
17014010|NCT00856206|38158862|FG000|Overall Study|Adverse Event|10|||
17014011|NCT00856206|38158863|FG001|Overall Study|Adverse Event|46|||
17014012|NCT00856206|38158862|FG000|Overall Study|Lack of Efficacy|1|||
17014013|NCT00856206|38158863|FG001|Overall Study|Lack of Efficacy|2|||
17014014|NCT00856206|38158862|FG000|Overall Study|Withdrawal by Subject|15|||
17014015|NCT00856206|38158863|FG001|Overall Study|Withdrawal by Subject|36|||
17014016|NCT00856206|38158862|FG000|Overall Study|Lost to Follow-up|13|||
17014017|NCT00856206|38158863|FG001|Overall Study|Lost to Follow-up|39|||
17014018|NCT00856206|38158862|FG000|Overall Study|Death|2|||
17014019|NCT00856206|38158863|FG001|Overall Study|Death|2|||
17014020|NCT00856206|38158862|FG000|Overall Study|Decision by the Sponsor|4|||
17014021|NCT00856206|38158863|FG001|Overall Study|Decision by the Sponsor|8|||
17014022|NCT00856206|38158862|FG000|Overall Study|Other than specified above|3|||
17014023|NCT00856206|38158863|FG001|Overall Study|Other than specified above|10|||
17014024|NCT00593112|38158871|FG000|Overall Study|Scan Anxiety|3|||
17014025|NCT00593112|38158872|FG001|Overall Study|Scan Anxiety|0|||
17194064|NCT02639546|38347472|FG002|Overall Study|Death|1|||
17194065|NCT02639546|38347473|FG003|Overall Study|Death|2|||
17194066|NCT02639546|38347474|FG004|Overall Study|Death|2|||
17194067|NCT02639546|38347475|FG005|Overall Study|Death|2|||
17194068|NCT02639546|38347476|FG006|Overall Study|Death|0|||
17194069|NCT02639546|38347477|FG007|Overall Study|Death|0|||
17194070|NCT02639546|38347470|FG000|Overall Study|Lost to Follow-up|0|||
17194071|NCT02639546|38347471|FG001|Overall Study|Lost to Follow-up|0|||
17194072|NCT02639546|38347472|FG002|Overall Study|Lost to Follow-up|1|||
17194073|NCT02639546|38347473|FG003|Overall Study|Lost to Follow-up|0|||
17194074|NCT02639546|38347474|FG004|Overall Study|Lost to Follow-up|1|||
17194075|NCT02639546|38347475|FG005|Overall Study|Lost to Follow-up|1|||
17194076|NCT02639546|38347476|FG006|Overall Study|Lost to Follow-up|0|||
17194077|NCT02639546|38347477|FG007|Overall Study|Lost to Follow-up|1|||
17194078|NCT02639546|38347470|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
17194079|NCT02639546|38347471|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
17194080|NCT02639546|38347472|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
17194081|NCT02639546|38347473|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
17194082|NCT02639546|38347474|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
17194083|NCT02639546|38347475|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
17194084|NCT02639546|38347476|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
17194085|NCT02639546|38347477|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
17194086|NCT02639546|38347470|FG000|Overall Study|Study Terminated By Sponsor|0|||
17014026|NCT00593112|38158871|FG000|Overall Study|Abnormal Scan|1|||
17014027|NCT00593112|38158872|FG001|Overall Study|Abnormal Scan|0|||
17098414|NCT00123474|38237560|FG001|As Treated at Study Closure|Adverse Event|4|||
17098415|NCT00123474|38237561|FG002|As Treated at Study Closure|Adverse Event|10|||
17098416|NCT00123474|38237562|FG003|As Treated at Study Closure|Adverse Event|8|||
17098417|NCT00123474|38237559|FG000|As Treated at Study Closure|Disease Progression|35|||
17098418|NCT00123474|38237560|FG001|As Treated at Study Closure|Disease Progression|42|||
17098419|NCT00123474|38237561|FG002|As Treated at Study Closure|Disease Progression|29|||
17098420|NCT00123474|38237562|FG003|As Treated at Study Closure|Disease Progression|27|||
17098421|NCT00123474|38237559|FG000|As Treated at Study Closure|Investigator Request|12|||
17098422|NCT00123474|38237560|FG001|As Treated at Study Closure|Investigator Request|6|||
17098423|NCT00123474|38237561|FG002|As Treated at Study Closure|Investigator Request|7|||
17098424|NCT00123474|38237562|FG003|As Treated at Study Closure|Investigator Request|5|||
17098425|NCT00123474|38237559|FG000|As Treated at Study Closure|non-specified|54|||
17194087|NCT02639546|38347471|FG001|Overall Study|Study Terminated By Sponsor|2|||
17194088|NCT02639546|38347472|FG002|Overall Study|Study Terminated By Sponsor|3|||
17194089|NCT02639546|38347473|FG003|Overall Study|Study Terminated By Sponsor|4|||
17014028|NCT00593112|38158871|FG000|Overall Study|Unreadable Scan|1|||
17014029|NCT00593112|38158872|FG001|Overall Study|Unreadable Scan|0|||
17014030|NCT00593112|38158871|FG000|Overall Study|Withdrawal by Subject|5|||
17014031|NCT00593112|38158872|FG001|Overall Study|Withdrawal by Subject|0|||
17014032|NCT00491179|38158880|FG000|Overall Study|Adverse Event|5|||
17014033|NCT00491179|38158881|FG001|Overall Study|Adverse Event|1|||
17014034|NCT00491179|38158880|FG000|Overall Study|Withdrawal by Subject|2|||
17014035|NCT00491179|38158881|FG001|Overall Study|Withdrawal by Subject|1|||
17098426|NCT00123474|38237560|FG001|As Treated at Study Closure|non-specified|47|||
17098427|NCT00123474|38237561|FG002|As Treated at Study Closure|non-specified|57|||
17098428|NCT00123474|38237562|FG003|As Treated at Study Closure|non-specified|60|||
17098429|NCT00123474|38237559|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
17098430|NCT00123474|38237560|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
17098431|NCT00123474|38237561|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
17098432|NCT00123474|38237562|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
17098433|NCT00123474|38237559|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
17098434|NCT00123474|38237560|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
17098435|NCT00123474|38237561|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
17098436|NCT00123474|38237562|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
17098437|NCT00142298|38237603|FG000|Overall Study|Adverse Event|10|||
17098438|NCT00142298|38237604|FG001|Overall Study|Adverse Event|10|||
17098439|NCT00142298|38237605|FG002|Overall Study|Adverse Event|1|||
17098440|NCT00142298|38237606|FG003|Overall Study|Adverse Event|5|||
17098441|NCT00142298|38237607|FG004|Overall Study|Adverse Event|2|||
17098442|NCT00142298|38237608|FG005|Overall Study|Adverse Event|2|||
17098443|NCT00142298|38237609|FG006|Overall Study|Adverse Event|0|||
17098444|NCT00142298|38237610|FG007|Overall Study|Adverse Event|0|||
17194090|NCT02639546|38347474|FG004|Overall Study|Study Terminated By Sponsor|4|||
17194091|NCT02639546|38347475|FG005|Overall Study|Study Terminated By Sponsor|3|||
17194092|NCT02639546|38347476|FG006|Overall Study|Study Terminated By Sponsor|3|||
17194093|NCT02639546|38347477|FG007|Overall Study|Study Terminated By Sponsor|9|||
17194094|NCT02639546|38347470|FG000|Overall Study|Withdrawal by Subject|2|||
17194095|NCT02639546|38347471|FG001|Overall Study|Withdrawal by Subject|2|||
17194096|NCT02639546|38347472|FG002|Overall Study|Withdrawal by Subject|1|||
17194097|NCT02639546|38347473|FG003|Overall Study|Withdrawal by Subject|0|||
17194098|NCT02639546|38347474|FG004|Overall Study|Withdrawal by Subject|0|||
17194099|NCT02639546|38347475|FG005|Overall Study|Withdrawal by Subject|1|||
17194100|NCT02639546|38347476|FG006|Overall Study|Withdrawal by Subject|2|||
17194101|NCT02639546|38347477|FG007|Overall Study|Withdrawal by Subject|1|||
17194102|NCT02639390|38347511|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
17194103|NCT02639390|38347512|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
17194104|NCT02718417|38347521|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
17194105|NCT02718417|38347522|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
17194106|NCT02718417|38347523|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
17194107|NCT02718417|38347521|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
17194108|NCT02718417|38347522|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
17194109|NCT02718417|38347523|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
17194110|NCT02718417|38347521|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
17194111|NCT02718417|38347522|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
17194112|NCT02718417|38347523|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
17194113|NCT02718417|38347521|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
17194114|NCT02718417|38347522|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
17194115|NCT02718417|38347523|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
17194116|NCT02718417|38347521|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
17194117|NCT02718417|38347522|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
17194118|NCT02718417|38347523|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
17194119|NCT02718417|38347521|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
17194120|NCT02718417|38347522|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
17194121|NCT02718417|38347523|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
17194122|NCT02718417|38347521|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
17194123|NCT02718417|38347522|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
17194124|NCT02718417|38347523|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
17014036|NCT00503581|38158890|FG000|Overall Study|Study closed|3|||
17014037|NCT00503581|38158891|FG001|Overall Study|Study closed|4|||
17014038|NCT00503581|38158892|FG002|Overall Study|Study closed|2|||
17014039|NCT00703534|38158902|FG000|Overall Study|Adverse Event|14|||
17014040|NCT00703534|38158903|FG001|Overall Study|Adverse Event|3|||
17014041|NCT00703534|38158902|FG000|Overall Study|Withdrawal by Subject|8|||
17014042|NCT00703534|38158903|FG001|Overall Study|Withdrawal by Subject|7|||
17014043|NCT00703534|38158902|FG000|Overall Study|Incorrect Enrollment|6|||
17014044|NCT00703534|38158903|FG001|Overall Study|Incorrect Enrollment|6|||
17014045|NCT00703534|38158902|FG000|Overall Study|Lost to Follow-up|1|||
17014046|NCT00703534|38158903|FG001|Overall Study|Lost to Follow-up|4|||
17014047|NCT00703534|38158902|FG000|Overall Study|Severe Non Compliance|1|||
17098445|NCT00142298|38237611|FG008|Overall Study|Adverse Event|0|||
17098446|NCT00142298|38237612|FG009|Overall Study|Adverse Event|0|||
17098447|NCT00142298|38237603|FG000|Overall Study|Clinical disease progression|1|||
17098448|NCT00142298|38237604|FG001|Overall Study|Clinical disease progression|0|||
17098449|NCT00142298|38237605|FG002|Overall Study|Clinical disease progression|0|||
17098450|NCT00142298|38237606|FG003|Overall Study|Clinical disease progression|0|||
17098451|NCT00142298|38237607|FG004|Overall Study|Clinical disease progression|0|||
17098452|NCT00142298|38237608|FG005|Overall Study|Clinical disease progression|0|||
17098453|NCT00142298|38237609|FG006|Overall Study|Clinical disease progression|0|||
17098454|NCT00142298|38237610|FG007|Overall Study|Clinical disease progression|0|||
17098455|NCT00142298|38237611|FG008|Overall Study|Clinical disease progression|0|||
17098456|NCT00142298|38237612|FG009|Overall Study|Clinical disease progression|0|||
17098457|NCT00142298|38237603|FG000|Overall Study|Death|1|||
17098458|NCT00142298|38237604|FG001|Overall Study|Death|1|||
17098459|NCT00142298|38237605|FG002|Overall Study|Death|1|||
17098460|NCT00142298|38237606|FG003|Overall Study|Death|0|||
17098461|NCT00142298|38237607|FG004|Overall Study|Death|0|||
17098462|NCT00142298|38237608|FG005|Overall Study|Death|6|||
17098463|NCT00142298|38237609|FG006|Overall Study|Death|0|||
17098464|NCT00142298|38237610|FG007|Overall Study|Death|0|||
17098465|NCT00142298|38237611|FG008|Overall Study|Death|0|||
17098466|NCT00142298|38237612|FG009|Overall Study|Death|0|||
17098467|NCT00142298|38237603|FG000|Overall Study|Lack of Efficacy|44|||
17098468|NCT00142298|38237604|FG001|Overall Study|Lack of Efficacy|62|||
17098469|NCT00142298|38237605|FG002|Overall Study|Lack of Efficacy|9|||
17098470|NCT00142298|38237606|FG003|Overall Study|Lack of Efficacy|12|||
17098471|NCT00142298|38237607|FG004|Overall Study|Lack of Efficacy|1|||
17098472|NCT00142298|38237608|FG005|Overall Study|Lack of Efficacy|0|||
17098473|NCT00142298|38237609|FG006|Overall Study|Lack of Efficacy|0|||
17098474|NCT00142298|38237610|FG007|Overall Study|Lack of Efficacy|1|||
17098475|NCT00142298|38237611|FG008|Overall Study|Lack of Efficacy|0|||
17098476|NCT00142298|38237612|FG009|Overall Study|Lack of Efficacy|0|||
17098477|NCT00142298|38237603|FG000|Overall Study|Non-compliance|15|||
17098478|NCT00142298|38237604|FG001|Overall Study|Non-compliance|13|||
17098479|NCT00142298|38237605|FG002|Overall Study|Non-compliance|0|||
17098480|NCT00142298|38237606|FG003|Overall Study|Non-compliance|6|||
17194125|NCT02718417|38347521|FG000|Chemotherapy Phase (CP)|Other|2|||
17194126|NCT02718417|38347522|FG001|Chemotherapy Phase (CP)|Other|0|||
17194127|NCT02718417|38347523|FG002|Chemotherapy Phase (CP)|Other|1|||
17194128|NCT02718417|38347521|FG000|Maintenance Phase (MP)|Adverse Event|21|||
17194129|NCT02718417|38347522|FG001|Maintenance Phase (MP)|Adverse Event|26|||
17194130|NCT02718417|38347523|FG002|Maintenance Phase (MP)|Adverse Event|0|||
17194131|NCT02718417|38347521|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
17194132|NCT02718417|38347522|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
17194133|NCT02718417|38347523|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
17194134|NCT02718417|38347521|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
17194135|NCT02718417|38347522|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
17194136|NCT02718417|38347523|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
17194137|NCT02718417|38347521|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
17194138|NCT02718417|38347522|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
17194139|NCT02718417|38347523|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
17194140|NCT02718417|38347521|FG000|Maintenance Phase (MP)|Physician's decision|6|||
17194141|NCT02718417|38347522|FG001|Maintenance Phase (MP)|Physician's decision|7|||
17194142|NCT02718417|38347523|FG002|Maintenance Phase (MP)|Physician's decision|0|||
17194143|NCT02718417|38347521|FG000|Maintenance Phase (MP)|Progressive disease|100|||
17194144|NCT02718417|38347522|FG001|Maintenance Phase (MP)|Progressive disease|88|||
17194145|NCT02718417|38347523|FG002|Maintenance Phase (MP)|Progressive disease|0|||
17194146|NCT02718417|38347521|FG000|Maintenance Phase (MP)|Other|2|||
17194147|NCT02718417|38347522|FG001|Maintenance Phase (MP)|Other|1|||
17194148|NCT02718417|38347523|FG002|Maintenance Phase (MP)|Other|0|||
17194149|NCT02718417|38347521|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
17194150|NCT02718417|38347522|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
17194151|NCT02718417|38347523|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
17194152|NCT02718417|38347521|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
17194153|NCT02718417|38347522|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
17194154|NCT02718417|38347523|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
17194155|NCT02718417|38347521|FG000|Observation Phase (OP)|Adverse Event|0|||
17194156|NCT02718417|38347522|FG001|Observation Phase (OP)|Adverse Event|0|||
17194157|NCT02718417|38347523|FG002|Observation Phase (OP)|Adverse Event|1|||
17194158|NCT02718417|38347521|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
17098481|NCT00142298|38237607|FG004|Overall Study|Non-compliance|1|||
17098482|NCT00142298|38237608|FG005|Overall Study|Non-compliance|0|||
17098483|NCT00142298|38237609|FG006|Overall Study|Non-compliance|0|||
17098484|NCT00142298|38237610|FG007|Overall Study|Non-compliance|3|||
17098485|NCT00142298|38237611|FG008|Overall Study|Non-compliance|3|||
17098486|NCT00142298|38237612|FG009|Overall Study|Non-compliance|0|||
17098487|NCT00142298|38237603|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
17098488|NCT00142298|38237604|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
17098489|NCT00142298|38237605|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
17098490|NCT00142298|38237606|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
17098491|NCT00142298|38237607|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
17098492|NCT00142298|38237608|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
17098493|NCT00142298|38237609|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
17098494|NCT00142298|38237610|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
17098495|NCT00142298|38237611|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
17098496|NCT00142298|38237612|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
17098497|NCT00142298|38237603|FG000|Overall Study|Pregnancy|4|||
17098498|NCT00142298|38237604|FG001|Overall Study|Pregnancy|4|||
17098499|NCT00142298|38237605|FG002|Overall Study|Pregnancy|2|||
17098500|NCT00142298|38237606|FG003|Overall Study|Pregnancy|3|||
17098501|NCT00142298|38237607|FG004|Overall Study|Pregnancy|0|||
17098502|NCT00142298|38237608|FG005|Overall Study|Pregnancy|0|||
17098503|NCT00142298|38237609|FG006|Overall Study|Pregnancy|0|||
17098504|NCT00142298|38237610|FG007|Overall Study|Pregnancy|0|||
17098505|NCT00142298|38237611|FG008|Overall Study|Pregnancy|1|||
17098506|NCT00142298|38237612|FG009|Overall Study|Pregnancy|0|||
17098507|NCT00142298|38237603|FG000|Overall Study|Virologic breakthrough|19|||
17098508|NCT00142298|38237604|FG001|Overall Study|Virologic breakthrough|23|||
17098509|NCT00142298|38237605|FG002|Overall Study|Virologic breakthrough|9|||
17098510|NCT00142298|38237606|FG003|Overall Study|Virologic breakthrough|7|||
17098511|NCT00142298|38237607|FG004|Overall Study|Virologic breakthrough|2|||
17098512|NCT00142298|38237608|FG005|Overall Study|Virologic breakthrough|3|||
17098513|NCT00142298|38237609|FG006|Overall Study|Virologic breakthrough|3|||
17098514|NCT00142298|38237610|FG007|Overall Study|Virologic breakthrough|0|||
17098515|NCT00142298|38237611|FG008|Overall Study|Virologic breakthrough|0|||
17098516|NCT00142298|38237612|FG009|Overall Study|Virologic breakthrough|0|||
17098517|NCT00142298|38237603|FG000|Overall Study|Other- not specified|0|||
17098518|NCT00142298|38237604|FG001|Overall Study|Other- not specified|3|||
17098519|NCT00142298|38237605|FG002|Overall Study|Other- not specified|0|||
17098520|NCT00142298|38237606|FG003|Overall Study|Other- not specified|1|||
17098521|NCT00142298|38237607|FG004|Overall Study|Other- not specified|0|||
17098522|NCT00142298|38237608|FG005|Overall Study|Other- not specified|0|||
17098523|NCT00142298|38237609|FG006|Overall Study|Other- not specified|0|||
17098524|NCT00142298|38237610|FG007|Overall Study|Other- not specified|0|||
17098525|NCT00142298|38237611|FG008|Overall Study|Other- not specified|0|||
17098526|NCT00142298|38237612|FG009|Overall Study|Other- not specified|0|||
17098527|NCT00142298|38237603|FG000|Overall Study|Lost to Follow-up|0|||
17098528|NCT00142298|38237604|FG001|Overall Study|Lost to Follow-up|0|||
17098529|NCT00142298|38237605|FG002|Overall Study|Lost to Follow-up|0|||
17098530|NCT00142298|38237606|FG003|Overall Study|Lost to Follow-up|0|||
17098531|NCT00142298|38237607|FG004|Overall Study|Lost to Follow-up|0|||
17098532|NCT00142298|38237608|FG005|Overall Study|Lost to Follow-up|0|||
17098533|NCT00142298|38237609|FG006|Overall Study|Lost to Follow-up|2|||
17098534|NCT00142298|38237610|FG007|Overall Study|Lost to Follow-up|0|||
17098535|NCT00142298|38237611|FG008|Overall Study|Lost to Follow-up|0|||
17098536|NCT00142298|38237612|FG009|Overall Study|Lost to Follow-up|0|||
17098537|NCT00142298|38237603|FG000|Overall Study|Treatment Failure|0|||
17098538|NCT00142298|38237604|FG001|Overall Study|Treatment Failure|0|||
17098539|NCT00142298|38237605|FG002|Overall Study|Treatment Failure|0|||
17098540|NCT00142298|38237606|FG003|Overall Study|Treatment Failure|0|||
17098541|NCT00142298|38237607|FG004|Overall Study|Treatment Failure|0|||
17098542|NCT00142298|38237608|FG005|Overall Study|Treatment Failure|2|||
17098543|NCT00142298|38237609|FG006|Overall Study|Treatment Failure|2|||
17098544|NCT00142298|38237610|FG007|Overall Study|Treatment Failure|0|||
17098545|NCT00142298|38237611|FG008|Overall Study|Treatment Failure|0|||
17098546|NCT00142298|38237612|FG009|Overall Study|Treatment Failure|0|||
17098547|NCT03709654|38237636|FG000|Overall Study|Lost to Follow-up|1|||
17098548|NCT03709654|38237637|FG001|Overall Study|Lost to Follow-up|1|||
17098549|NCT03709654|38237636|FG000|Overall Study|Withdrawal by Subject|1|||
17098550|NCT03709654|38237637|FG001|Overall Study|Withdrawal by Subject|1|||
17098551|NCT03709654|38237636|FG000|Overall Study|Adverse Event|1|||
17098552|NCT03709654|38237637|FG001|Overall Study|Adverse Event|0|||
17098553|NCT00412061|38237645|FG000|Double Blind Phase|Disease Progression|101|||
17098554|NCT00412061|38237646|FG001|Double Blind Phase|Disease Progression|154|||
17098555|NCT00412061|38237645|FG000|Double Blind Phase|Adverse Event|61|||
17098556|NCT00412061|38237646|FG001|Double Blind Phase|Adverse Event|16|||
17098557|NCT00412061|38237645|FG000|Double Blind Phase|Final Primary Analysis|26|||
17098558|NCT00412061|38237646|FG001|Double Blind Phase|Final Primary Analysis|14|||
17098559|NCT00412061|38237645|FG000|Double Blind Phase|Withdrawal by Subject|18|||
17098560|NCT00412061|38237646|FG001|Double Blind Phase|Withdrawal by Subject|20|||
17098561|NCT00412061|38237645|FG000|Double Blind Phase|Death|6|||
17098562|NCT00412061|38237646|FG001|Double Blind Phase|Death|3|||
17098563|NCT00412061|38237645|FG000|Double Blind Phase|Protocol Violation|3|||
17098564|NCT00412061|38237646|FG001|Double Blind Phase|Protocol Violation|4|||
17098565|NCT00412061|38237645|FG000|Double Blind Phase|New Cander Therapy|1|||
17098566|NCT00412061|38237646|FG001|Double Blind Phase|New Cander Therapy|1|||
17098567|NCT00412061|38237645|FG000|Double Blind Phase|Lost to Follow-up|0|||
17098568|NCT00412061|38237646|FG001|Double Blind Phase|Lost to Follow-up|1|||
17098569|NCT00412061|38237645|FG000|Open Label Phase|Disease Progression|0|||
17098570|NCT00412061|38237646|FG001|Open Label Phase|Disease Progression|86|||
17098571|NCT00412061|38237645|FG000|Open Label Phase|Adverse Event|0|||
17014048|NCT00703534|38158903|FG001|Overall Study|Severe Non Compliance|5|||
17014049|NCT00503425|38158909|FG000|Overall Study|Participant files lost|6|||
17014050|NCT00503425|38158909|FG000|Overall Study|Adverse Event|5|||
17014051|NCT00503425|38158909|FG000|Overall Study|Lack of Efficacy|25|||
17014052|NCT00503425|38158909|FG000|Overall Study|Withdrawal by Subject|8|||
17014053|NCT00503425|38158909|FG000|Overall Study|Lost to Follow-up|3|||
17014054|NCT00503425|38158909|FG000|Overall Study|Death|3|||
17014055|NCT00503425|38158909|FG000|Overall Study|Missing Data/Unknown|4|||
17014056|NCT00863772|38158917|FG000|Overall Study|Adverse Event|1|||
17014057|NCT00863772|38158918|FG001|Overall Study|Adverse Event|4|||
17014058|NCT00863772|38158919|FG002|Overall Study|Adverse Event|0|||
17014059|NCT00863772|38158917|FG000|Overall Study|Lack of Efficacy|4|||
17014060|NCT00863772|38158918|FG001|Overall Study|Lack of Efficacy|2|||
17014061|NCT00863772|38158919|FG002|Overall Study|Lack of Efficacy|4|||
17014062|NCT00863772|38158917|FG000|Overall Study|Lost to Follow-up|5|||
17014063|NCT00863772|38158918|FG001|Overall Study|Lost to Follow-up|1|||
17014064|NCT00863772|38158919|FG002|Overall Study|Lost to Follow-up|1|||
17014065|NCT00863772|38158917|FG000|Overall Study|Protocol Violation|2|||
17014066|NCT00863772|38158918|FG001|Overall Study|Protocol Violation|0|||
17014067|NCT00863772|38158919|FG002|Overall Study|Protocol Violation|2|||
17098572|NCT00412061|38237646|FG001|Open Label Phase|Adverse Event|46|||
17098573|NCT00412061|38237645|FG000|Open Label Phase|Withdrawal by Subject|0|||
17098574|NCT00412061|38237646|FG001|Open Label Phase|Withdrawal by Subject|15|||
17098575|NCT00412061|38237645|FG000|Open Label Phase|Administrative Problems|0|||
17098576|NCT00412061|38237646|FG001|Open Label Phase|Administrative Problems|13|||
17098577|NCT00412061|38237645|FG000|Open Label Phase|Death|0|||
17098578|NCT00412061|38237646|FG001|Open Label Phase|Death|7|||
17098579|NCT00412061|38237645|FG000|Open Label Phase|Lost to Follow-up|0|||
17098580|NCT00412061|38237646|FG001|Open Label Phase|Lost to Follow-up|2|||
17098581|NCT00412061|38237645|FG000|Open Label Phase|New Cancer Therapy|0|||
17098582|NCT00412061|38237646|FG001|Open Label Phase|New Cancer Therapy|1|||
17098583|NCT00411671|38237664|FG000|Overall Study|Adverse Event|15|||
17098584|NCT00411671|38237664|FG000|Overall Study|Death|2|||
17098585|NCT00411671|38237664|FG000|Overall Study|Lost to Follow-up|3|||
17098586|NCT03835481|38237673|FG000|Double-blind Period|Other not stated below|0|||
17098587|NCT03835481|38237674|FG001|Double-blind Period|Other not stated below|0|||
17098588|NCT03835481|38237675|FG002|Double-blind Period|Other not stated below|0|||
17098589|NCT03835481|38237676|FG003|Double-blind Period|Other not stated below|1|||
17098590|NCT03835481|38237677|FG004|Double-blind Period|Other not stated below|1|||
17098591|NCT03835481|38237673|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
17098592|NCT03835481|38237674|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
17098593|NCT03835481|38237675|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
17098594|NCT03835481|38237676|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
17098595|NCT03835481|38237677|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
17098596|NCT03835481|38237673|FG000|Double-blind Period|Withdrawal by Subject|0|||
17098597|NCT03835481|38237674|FG001|Double-blind Period|Withdrawal by Subject|0|||
17194159|NCT02718417|38347522|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
17194160|NCT02718417|38347523|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
17194161|NCT02718417|38347521|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
17194162|NCT02718417|38347522|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
17194163|NCT02718417|38347523|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
17194164|NCT02718417|38347521|FG000|Observation Phase (OP)|Physician Decision|0|||
17194165|NCT02718417|38347522|FG001|Observation Phase (OP)|Physician Decision|0|||
17194166|NCT02718417|38347523|FG002|Observation Phase (OP)|Physician Decision|9|||
17194167|NCT02718417|38347521|FG000|Observation Phase (OP)|Progressive disease|0|||
17194168|NCT02718417|38347522|FG001|Observation Phase (OP)|Progressive disease|0|||
17194169|NCT02718417|38347523|FG002|Observation Phase (OP)|Progressive disease|92|||
17194170|NCT02718417|38347521|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
17194171|NCT02718417|38347522|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
17194172|NCT02718417|38347523|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
17194173|NCT02718417|38347521|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
17194174|NCT02718417|38347522|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
17194175|NCT02718417|38347523|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
17014068|NCT00863772|38158917|FG000|Overall Study|Withdrawal by Subject|4|||
17014069|NCT00863772|38158918|FG001|Overall Study|Withdrawal by Subject|7|||
17014070|NCT00863772|38158919|FG002|Overall Study|Withdrawal by Subject|5|||
17014071|NCT00863772|38158917|FG000|Overall Study|Study terminated by sponsor|44|||
17014072|NCT00863772|38158918|FG001|Overall Study|Study terminated by sponsor|45|||
17014073|NCT00863772|38158919|FG002|Overall Study|Study terminated by sponsor|36|||
17014074|NCT00863772|38158917|FG000|Overall Study|Entered extension study|6|||
17014075|NCT00863772|38158918|FG001|Overall Study|Entered extension study|4|||
17014076|NCT00863772|38158919|FG002|Overall Study|Entered extension study|9|||
17014077|NCT00863772|38158917|FG000|Overall Study|Other|1|||
17014078|NCT00863772|38158918|FG001|Overall Study|Other|2|||
17014079|NCT00863772|38158919|FG002|Overall Study|Other|4|||
17098598|NCT03835481|38237675|FG002|Double-blind Period|Withdrawal by Subject|1|||
17098599|NCT03835481|38237676|FG003|Double-blind Period|Withdrawal by Subject|0|||
17098600|NCT03835481|38237677|FG004|Double-blind Period|Withdrawal by Subject|5|||
17098601|NCT03835481|38237673|FG000|Double-blind Period|Lost to Follow-up|0|||
17014080|NCT00863772|38158917|FG000|Overall Study|Randomized but not Treated|1|||
17014081|NCT00863772|38158918|FG001|Overall Study|Randomized but not Treated|0|||
17014082|NCT00863772|38158919|FG002|Overall Study|Randomized but not Treated|0|||
17014083|NCT00502801|38158927|FG000|Treatment Period|Withdrawal by Subject|3|||
17014084|NCT00502801|38158927|FG000|Treatment Period|Adverse Event|7|||
17014085|NCT00502801|38158927|FG000|Treatment Period|Death|14|||
17014086|NCT00502801|38158927|FG000|Treatment Period|OTHER|30|||
17014087|NCT00502801|38158927|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
17014088|NCT00502801|38158927|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
17014089|NCT00502801|38158927|FG000|End of Therapy to Test of Cure|Death|3|||
17098602|NCT03835481|38237674|FG001|Double-blind Period|Lost to Follow-up|0|||
17098603|NCT03835481|38237675|FG002|Double-blind Period|Lost to Follow-up|0|||
17098604|NCT03835481|38237676|FG003|Double-blind Period|Lost to Follow-up|1|||
17098605|NCT03835481|38237677|FG004|Double-blind Period|Lost to Follow-up|0|||
17098606|NCT03835481|38237673|FG000|Double-blind Period|Protocol Violation|0|||
17098607|NCT03835481|38237674|FG001|Double-blind Period|Protocol Violation|2|||
17014090|NCT00502801|38158927|FG000|End of Therapy to Test of Cure|OTHER|2|||
17014091|NCT00824265|38158933|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
17014092|NCT00824265|38158934|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
17014093|NCT00824265|38158933|FG000|Treatment Phase|Protocol Violation|1|||
17014094|NCT00824265|38158934|FG001|Treatment Phase|Protocol Violation|0|||
17014095|NCT00824265|38158933|FG000|Treatment Phase|Lost to Follow-up|1|||
17014096|NCT00824265|38158934|FG001|Treatment Phase|Lost to Follow-up|1|||
17014097|NCT00824265|38158933|FG000|Treatment Phase|Physician Decision|6|||
17014098|NCT00824265|38158934|FG001|Treatment Phase|Physician Decision|12|||
17098608|NCT03835481|38237675|FG002|Double-blind Period|Protocol Violation|0|||
17194176|NCT02718417|38347521|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
17194177|NCT02718417|38347522|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
17194178|NCT02718417|38347523|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
17098609|NCT03835481|38237676|FG003|Double-blind Period|Protocol Violation|1|||
17098610|NCT03835481|38237677|FG004|Double-blind Period|Protocol Violation|0|||
17098611|NCT03835481|38237673|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
17098612|NCT03835481|38237674|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
17098613|NCT03835481|38237675|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
17194179|NCT02718417|38347521|FG000|Observation Phase (OP)|Other|0|||
17194180|NCT02718417|38347522|FG001|Observation Phase (OP)|Other|0|||
17194181|NCT02718417|38347523|FG002|Observation Phase (OP)|Other|7|||
17194182|NCT02718417|38347521|FG000|Follow-up Phase|Adverse Event|3|||
17194183|NCT02718417|38347522|FG001|Follow-up Phase|Adverse Event|1|||
17194184|NCT02718417|38347523|FG002|Follow-up Phase|Adverse Event|1|||
17194185|NCT02718417|38347521|FG000|Follow-up Phase|Other|4|||
17194186|NCT02718417|38347522|FG001|Follow-up Phase|Other|6|||
17194187|NCT02718417|38347523|FG002|Follow-up Phase|Other|4|||
17194188|NCT02718417|38347521|FG000|Follow-up Phase|Withdrawal by Subject|19|||
17194189|NCT02718417|38347522|FG001|Follow-up Phase|Withdrawal by Subject|17|||
17194190|NCT02718417|38347523|FG002|Follow-up Phase|Withdrawal by Subject|5|||
17194191|NCT02718417|38347521|FG000|Follow-up Phase|Study terminated by sponsor|100|||
17194192|NCT02718417|38347522|FG001|Follow-up Phase|Study terminated by sponsor|138|||
17194193|NCT02718417|38347523|FG002|Follow-up Phase|Study terminated by sponsor|6|||
17194194|NCT02718417|38347521|FG000|Follow-up Phase|Lost to Follow-up|2|||
17194195|NCT02718417|38347522|FG001|Follow-up Phase|Lost to Follow-up|3|||
17194196|NCT02718417|38347523|FG002|Follow-up Phase|Lost to Follow-up|0|||
17194197|NCT02718417|38347521|FG000|Follow-up Phase|Death leading to discontinuation|7|||
17194198|NCT02718417|38347522|FG001|Follow-up Phase|Death leading to discontinuation|7|||
17194199|NCT02718417|38347523|FG002|Follow-up Phase|Death leading to discontinuation|3|||
17194200|NCT02718417|38347521|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
17194201|NCT02718417|38347522|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
17194202|NCT02718417|38347523|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
17194203|NCT02718417|38347521|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
17014099|NCT00824265|38158933|FG000|Treatment Phase|Withdrawal by Subject|6|||
17014100|NCT00824265|38158934|FG001|Treatment Phase|Withdrawal by Subject|15|||
17014101|NCT00824265|38158933|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
17014102|NCT00824265|38158934|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
17014103|NCT00824265|38158933|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
17014104|NCT00824265|38158934|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
17014105|NCT00855894|38158944|FG000|Overall Study|Death|31|||
17014106|NCT00855894|38158944|FG000|Overall Study|Patient's decision|1|||
17014107|NCT00855894|38158944|FG000|Overall Study|Disease progression|1|||
17014108|NCT00855816|38158950|FG000|Overall Study|Withdrawal by Subject|22|||
17014109|NCT00855816|38158951|FG001|Overall Study|Withdrawal by Subject|15|||
17098614|NCT03835481|38237676|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
17098615|NCT03835481|38237677|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
17098616|NCT03835481|38237673|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
17014110|NCT00855816|38158950|FG000|Overall Study|Lost to Follow-up|3|||
17014111|NCT00855816|38158951|FG001|Overall Study|Lost to Follow-up|5|||
17014112|NCT00855816|38158950|FG000|Overall Study|Death|1|||
17014113|NCT00855816|38158951|FG001|Overall Study|Death|0|||
17014114|NCT00855816|38158950|FG000|Overall Study|Became ineligible|0|||
17014115|NCT00855816|38158951|FG001|Overall Study|Became ineligible|1|||
17014116|NCT00855738|38158957|FG000|Overall Study|Lost to Follow-up|2|||
17014117|NCT00855738|38158957|FG000|Overall Study|Adverse Event|1|||
17014118|NCT00855738|38158957|FG000|Overall Study|Subject Defaulted|1|||
17014119|NCT00855738|38158957|FG000|Overall Study|Death|1|||
17014120|NCT00490945|38158968|FG000|Overall Study|Adverse Event|0|||
17014121|NCT00490945|38158969|FG001|Overall Study|Adverse Event|1|||
17014122|NCT00490945|38158970|FG002|Overall Study|Adverse Event|0|||
17014123|NCT00490945|38158971|FG003|Overall Study|Adverse Event|0|||
17014124|NCT00490945|38158972|FG004|Overall Study|Adverse Event|0|||
17014125|NCT00879398|38158990|FG000|Overall Study|Visit Stop|399|||
17014126|NCT00879398|38158990|FG000|Overall Study|Lack of Efficacy|64|||
17014127|NCT00879398|38158990|FG000|Overall Study|Adverse Event|41|||
17014128|NCT00879398|38158990|FG000|Overall Study|Other Reasons|171|||
17014129|NCT00696436|38158999|FG000|Overall Study|Adverse Event|7|||
17014130|NCT00696436|38159000|FG001|Overall Study|Adverse Event|9|||
17014131|NCT00696436|38159001|FG002|Overall Study|Adverse Event|8|||
17014132|NCT00696436|38159002|FG003|Overall Study|Adverse Event|6|||
17014133|NCT00696436|38159003|FG004|Overall Study|Adverse Event|4|||
17014134|NCT00696436|38158999|FG000|Overall Study|Protocol Violation|3|||
17014135|NCT00696436|38159000|FG001|Overall Study|Protocol Violation|2|||
17098617|NCT03835481|38237674|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
17098618|NCT03835481|38237675|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
17098619|NCT03835481|38237676|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
17098620|NCT03835481|38237677|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
17098621|NCT03835481|38237673|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
17098622|NCT03835481|38237674|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
17098623|NCT03835481|38237675|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
17098624|NCT03835481|38237676|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
17194204|NCT02718417|38347522|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
17194205|NCT02718417|38347523|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
17194206|NCT02718417|38347521|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
17194207|NCT02718417|38347522|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
17194208|NCT02718417|38347523|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
17194209|NCT02718417|38347521|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
17194210|NCT02718417|38347522|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
17194211|NCT02718417|38347523|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
17194212|NCT02718417|38347521|FG000|Long-term Follow-up Phase|Other|0|||
17194213|NCT02718417|38347522|FG001|Long-term Follow-up Phase|Other|2|||
17194214|NCT02718417|38347523|FG002|Long-term Follow-up Phase|Other|0|||
17194215|NCT02640404|38347540|FG000|Overall Study|Protocol Violation|1|||
17194216|NCT02640404|38347541|FG001|Overall Study|Protocol Violation|0|||
17194217|NCT02640404|38347540|FG000|Overall Study|Withdrawal by Subject|1|||
17194218|NCT02640404|38347541|FG001|Overall Study|Withdrawal by Subject|0|||
17194219|NCT00701727|38347547|FG000|First Treatment Period|Adverse Event|0|||
17194220|NCT00701727|38347548|FG001|First Treatment Period|Adverse Event|0|||
17194221|NCT00701727|38347547|FG000|First Treatment Period|Withdrawal by Subject|1|||
17194222|NCT00701727|38347548|FG001|First Treatment Period|Withdrawal by Subject|0|||
17194223|NCT00701727|38347547|FG000|First Treatment Period|sponsor decision|0|||
17194224|NCT00701727|38347548|FG001|First Treatment Period|sponsor decision|1|||
17194225|NCT00701727|38347547|FG000|First Treatment Period|Lost to Follow-up|0|||
17194226|NCT00701727|38347548|FG001|First Treatment Period|Lost to Follow-up|1|||
17194227|NCT00701727|38347547|FG000|Second Treatment Period|Withdrawal by Subject|2|||
17194228|NCT00701727|38347548|FG001|Second Treatment Period|Withdrawal by Subject|0|||
17014136|NCT00696436|38159001|FG002|Overall Study|Protocol Violation|2|||
17014137|NCT00696436|38159002|FG003|Overall Study|Protocol Violation|0|||
17014138|NCT00696436|38159003|FG004|Overall Study|Protocol Violation|1|||
17014139|NCT00696436|38158999|FG000|Overall Study|Lost to Follow-up|1|||
17014140|NCT00696436|38159000|FG001|Overall Study|Lost to Follow-up|6|||
17014141|NCT00696436|38159001|FG002|Overall Study|Lost to Follow-up|2|||
17014142|NCT00696436|38159002|FG003|Overall Study|Lost to Follow-up|4|||
17194229|NCT01369069|38347565|FG000|Overall Study|Lost to Follow-up|8|||
17194230|NCT01369069|38347566|FG001|Overall Study|Lost to Follow-up|9|||
17194231|NCT01369069|38347565|FG000|Overall Study|Withdrawal by Subject|9|||
17098625|NCT03835481|38237677|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
17098626|NCT03835481|38237673|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
17098627|NCT03835481|38237674|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
17098628|NCT03835481|38237675|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
17098629|NCT03835481|38237676|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
17098630|NCT03835481|38237677|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
17098631|NCT03835481|38237673|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
17098632|NCT03835481|38237674|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
17098633|NCT03835481|38237675|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
17194232|NCT01369069|38347566|FG001|Overall Study|Withdrawal by Subject|7|||
17194233|NCT02441218|38347574|FG000|Overall Study|Death|503|||
17194234|NCT02441218|38347575|FG001|Overall Study|Death|553|||
17194235|NCT02441218|38347574|FG000|Overall Study|Withdrawal by Subject|73|||
17194236|NCT02441218|38347575|FG001|Overall Study|Withdrawal by Subject|58|||
17194237|NCT02441218|38347574|FG000|Overall Study|Lost to Follow-up|2|||
17194238|NCT02441218|38347575|FG001|Overall Study|Lost to Follow-up|1|||
17194239|NCT02410252|38347581|FG000|Overall Study|Withdrawal by Subject|4|||
17194240|NCT02410252|38347581|FG000|Overall Study|Physician Decision|2|||
17194241|NCT02440594|38347595|FG000|Overall Study|Lost to Follow-up|34|||
17194242|NCT02440594|38347596|FG001|Overall Study|Lost to Follow-up|33|||
17194243|NCT02440594|38347597|FG002|Overall Study|Lost to Follow-up|54|||
17194244|NCT02440594|38347598|FG003|Overall Study|Lost to Follow-up|47|||
17194245|NCT02440594|38347599|FG004|Overall Study|Lost to Follow-up|5|||
17194246|NCT02440594|38347600|FG005|Overall Study|Lost to Follow-up|4|||
17194247|NCT02440594|38347601|FG006|Overall Study|Lost to Follow-up|28|||
17194248|NCT02440594|38347602|FG007|Overall Study|Lost to Follow-up|48|||
17194249|NCT02440594|38347595|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
17194250|NCT02440594|38347596|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
17194251|NCT02440594|38347597|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
17194252|NCT02440594|38347598|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
17194253|NCT02440594|38347599|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
17194254|NCT02440594|38347600|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
17194255|NCT02440594|38347601|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
17194256|NCT02440594|38347602|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
17194257|NCT02440594|38347595|FG000|Overall Study|Withdrawal by Subject|81|||
17194258|NCT02440594|38347596|FG001|Overall Study|Withdrawal by Subject|67|||
17194259|NCT02440594|38347597|FG002|Overall Study|Withdrawal by Subject|59|||
17194260|NCT02440594|38347598|FG003|Overall Study|Withdrawal by Subject|38|||
17194261|NCT02440594|38347599|FG004|Overall Study|Withdrawal by Subject|2|||
17194262|NCT02440594|38347600|FG005|Overall Study|Withdrawal by Subject|2|||
17194263|NCT02440594|38347601|FG006|Overall Study|Withdrawal by Subject|7|||
17194264|NCT02440594|38347602|FG007|Overall Study|Withdrawal by Subject|7|||
17194265|NCT02440594|38347595|FG000|Overall Study|Administratively w/drawn|3|||
17194266|NCT02440594|38347596|FG001|Overall Study|Administratively w/drawn|2|||
17194267|NCT02440594|38347597|FG002|Overall Study|Administratively w/drawn|0|||
17194268|NCT02440594|38347598|FG003|Overall Study|Administratively w/drawn|0|||
17194269|NCT02440594|38347599|FG004|Overall Study|Administratively w/drawn|0|||
17194270|NCT02440594|38347600|FG005|Overall Study|Administratively w/drawn|0|||
17194271|NCT02440594|38347601|FG006|Overall Study|Administratively w/drawn|2|||
17194272|NCT02440594|38347602|FG007|Overall Study|Administratively w/drawn|1|||
17194273|NCT03836001|38347629|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
17194274|NCT03836001|38347630|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
17194275|NCT03836001|38347631|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
17014143|NCT00696436|38159003|FG004|Overall Study|Lost to Follow-up|3|||
17014144|NCT00696436|38158999|FG000|Overall Study|Withdrawal by Subject|4|||
17014145|NCT00696436|38159000|FG001|Overall Study|Withdrawal by Subject|11|||
17014146|NCT00696436|38159001|FG002|Overall Study|Withdrawal by Subject|5|||
17014147|NCT00696436|38159002|FG003|Overall Study|Withdrawal by Subject|7|||
17014148|NCT00696436|38159003|FG004|Overall Study|Withdrawal by Subject|1|||
17014149|NCT00696436|38158999|FG000|Overall Study|Lack of Efficacy|3|||
17014150|NCT00696436|38159000|FG001|Overall Study|Lack of Efficacy|1|||
17014151|NCT00696436|38159001|FG002|Overall Study|Lack of Efficacy|5|||
17014152|NCT00696436|38159002|FG003|Overall Study|Lack of Efficacy|2|||
17014153|NCT00696436|38159003|FG004|Overall Study|Lack of Efficacy|4|||
17014154|NCT00696436|38158999|FG000|Overall Study|Participant Unavailability|2|||
17014155|NCT00696436|38159000|FG001|Overall Study|Participant Unavailability|0|||
17014156|NCT00696436|38159001|FG002|Overall Study|Participant Unavailability|2|||
17014157|NCT00696436|38159002|FG003|Overall Study|Participant Unavailability|1|||
17014158|NCT00696436|38159003|FG004|Overall Study|Participant Unavailability|0|||
17014159|NCT00696436|38158999|FG000|Overall Study|Administrative Error|2|||
17014160|NCT00696436|38159000|FG001|Overall Study|Administrative Error|0|||
17014161|NCT00696436|38159001|FG002|Overall Study|Administrative Error|2|||
17014162|NCT00696436|38159002|FG003|Overall Study|Administrative Error|0|||
17014163|NCT00696436|38159003|FG004|Overall Study|Administrative Error|0|||
17014164|NCT00696436|38158999|FG000|Overall Study|Participant Non-compliance|0|||
17014165|NCT00696436|38159000|FG001|Overall Study|Participant Non-compliance|0|||
17014166|NCT00696436|38159001|FG002|Overall Study|Participant Non-compliance|1|||
17014167|NCT00696436|38159002|FG003|Overall Study|Participant Non-compliance|2|||
17014168|NCT00696436|38159003|FG004|Overall Study|Participant Non-compliance|0|||
17014169|NCT00696436|38158999|FG000|Overall Study|Administrative Decision|1|||
17014170|NCT00696436|38159000|FG001|Overall Study|Administrative Decision|0|||
17014171|NCT00696436|38159001|FG002|Overall Study|Administrative Decision|0|||
17014172|NCT00696436|38159002|FG003|Overall Study|Administrative Decision|0|||
17014173|NCT00696436|38159003|FG004|Overall Study|Administrative Decision|0|||
17014174|NCT00696436|38158999|FG000|Overall Study|Missing|0|||
17014175|NCT00696436|38159000|FG001|Overall Study|Missing|1|||
17014176|NCT00696436|38159001|FG002|Overall Study|Missing|1|||
17014177|NCT00696436|38159002|FG003|Overall Study|Missing|0|||
17014178|NCT00696436|38159003|FG004|Overall Study|Missing|0|||
17014179|NCT00878072|38159015|FG000|Overall Study|Withdrew consent|2|||
17014180|NCT00594854|38159043|FG000|Overall Study|Study terminated|7|||
17014181|NCT00594854|38159044|FG001|Overall Study|Study terminated|10|||
17014182|NCT00855582|38159053|FG000|Overall Study|Adverse Event|2|||
17014183|NCT00855582|38159054|FG001|Overall Study|Adverse Event|6|||
17014184|NCT00855582|38159055|FG002|Overall Study|Adverse Event|3|||
17014185|NCT00855582|38159053|FG000|Overall Study|Death|1|||
17014186|NCT00855582|38159054|FG001|Overall Study|Death|0|||
17014187|NCT00855582|38159055|FG002|Overall Study|Death|0|||
17014188|NCT00855582|38159053|FG000|Overall Study|Lack of Efficacy|1|||
17014189|NCT00855582|38159054|FG001|Overall Study|Lack of Efficacy|3|||
17014190|NCT00855582|38159055|FG002|Overall Study|Lack of Efficacy|8|||
17014191|NCT00855582|38159053|FG000|Overall Study|Lost to Follow-up|1|||
17014192|NCT00855582|38159054|FG001|Overall Study|Lost to Follow-up|3|||
17014193|NCT00855582|38159055|FG002|Overall Study|Lost to Follow-up|1|||
17014194|NCT00855582|38159053|FG000|Overall Study|Physician Decision|0|||
17014195|NCT00855582|38159054|FG001|Overall Study|Physician Decision|0|||
17014196|NCT00855582|38159055|FG002|Overall Study|Physician Decision|1|||
17014197|NCT00855582|38159053|FG000|Overall Study|Protocol Violation|6|||
17014198|NCT00855582|38159054|FG001|Overall Study|Protocol Violation|2|||
17014199|NCT00855582|38159055|FG002|Overall Study|Protocol Violation|6|||
17014200|NCT00855582|38159053|FG000|Overall Study|Entry Criteria Not Met|8|||
17014201|NCT00855582|38159054|FG001|Overall Study|Entry Criteria Not Met|6|||
17014202|NCT00855582|38159055|FG002|Overall Study|Entry Criteria Not Met|3|||
17014203|NCT00855582|38159053|FG000|Overall Study|Withdrawal by Subject|7|||
17014204|NCT00855582|38159054|FG001|Overall Study|Withdrawal by Subject|4|||
17014205|NCT00855582|38159055|FG002|Overall Study|Withdrawal by Subject|8|||
17014206|NCT00854724|38159068|FG000|First Intervention|Withdrawal by Subject|1|||
17014207|NCT00854724|38159069|FG001|First Intervention|Withdrawal by Subject|1|||
17014208|NCT00854724|38159068|FG000|Washout|Protocol Violation|1|||
17014209|NCT00854724|38159069|FG001|Washout|Protocol Violation|0|||
17014210|NCT00854724|38159068|FG000|Washout|Withdrawal by Subject|0|||
17014211|NCT00854724|38159069|FG001|Washout|Withdrawal by Subject|1|||
17014212|NCT00854724|38159068|FG000|Second Intervention|Protocol Violation|1|||
17098634|NCT03835481|38237676|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
17098635|NCT03835481|38237677|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
17098636|NCT03835481|38237673|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
17098637|NCT03835481|38237674|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
17098638|NCT03835481|38237675|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
17098639|NCT03835481|38237676|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
17098640|NCT03835481|38237677|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
17098641|NCT03709576|38237724|FG000|Overall Study|progression prior to enrollment|1|||
17098642|NCT00122460|38237731|FG000|Overall Study|investigational study phase ongoing|7|||
17098643|NCT00122460|38237732|FG001|Overall Study|investigational study phase ongoing|1|||
17014213|NCT00854724|38159069|FG001|Second Intervention|Protocol Violation|0|||
17014214|NCT00854724|38159068|FG000|Second Intervention|Physician Decision|0|||
17014215|NCT00854724|38159069|FG001|Second Intervention|Physician Decision|1|||
17014216|NCT00698932|38159107|FG000|Overall Study|Adverse Event|0|||
17014217|NCT00698932|38159108|FG001|Overall Study|Adverse Event|2|||
17014218|NCT00698932|38159107|FG000|Overall Study|Incorrect enrollment|0|||
17014219|NCT00698932|38159108|FG001|Overall Study|Incorrect enrollment|2|||
17014220|NCT00698932|38159107|FG000|Overall Study|Study specific discontinuation criteria|3|||
17014221|NCT00698932|38159108|FG001|Overall Study|Study specific discontinuation criteria|4|||
17014222|NCT00698932|38159107|FG000|Overall Study|Withdrawal by Subject|11|||
17014223|NCT00698932|38159108|FG001|Overall Study|Withdrawal by Subject|23|||
17014224|NCT00698932|38159107|FG000|Overall Study|Lost to Follow-up|6|||
17014225|NCT00698932|38159108|FG001|Overall Study|Lost to Follow-up|1|||
17014226|NCT00698932|38159107|FG000|Overall Study|Severe non-compliance to protocol|1|||
17014227|NCT00698932|38159108|FG001|Overall Study|Severe non-compliance to protocol|2|||
17014228|NCT00698932|38159107|FG000|Overall Study|Safety reasons|0|||
17014229|NCT00698932|38159108|FG001|Overall Study|Safety reasons|2|||
17014230|NCT00698932|38159107|FG000|Overall Study|Death|1|||
17014231|NCT00698932|38159108|FG001|Overall Study|Death|0|||
17014232|NCT00823719|38159116|FG000|Overall Study|Adverse Event|1|||
17014233|NCT00823719|38159117|FG001|Overall Study|Adverse Event|2|||
17194276|NCT03836001|38347629|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
17194277|NCT03836001|38347630|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
17194278|NCT03836001|38347631|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
17194279|NCT03836001|38347629|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
17194280|NCT03836001|38347630|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
17194281|NCT03836001|38347631|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
17194282|NCT03836001|38347629|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
17194283|NCT03836001|38347630|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
17194284|NCT03836001|38347631|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
17194285|NCT02465866|38347638|FG000|Period 3|Withdrawal by Subject|0|||
17194286|NCT02465866|38347639|FG001|Period 3|Withdrawal by Subject|1|||
17194287|NCT02465866|38347640|FG002|Period 3|Withdrawal by Subject|0|||
17194288|NCT02465866|38347641|FG003|Period 3|Withdrawal by Subject|0|||
17194289|NCT02439970|38347653|FG000|Overall Study|Study Terminated|2|||
17194290|NCT02439970|38347654|FG001|Overall Study|Study Terminated|3|||
17194291|NCT02437864|38347662|FG000|Overall Study|Protocol Violation|4|||
17194292|NCT02437864|38347663|FG001|Overall Study|Protocol Violation|0|||
17194293|NCT02408068|38347669|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
17194294|NCT02408068|38347670|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
17194295|NCT02408068|38347671|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
17194296|NCT02408068|38347672|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
17194297|NCT02408068|38347673|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
17194298|NCT02408068|38347674|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
17194299|NCT01361126|38347687|FG000|Overall Study|Sponsor decision|0|||
17194300|NCT01361126|38347688|FG001|Overall Study|Sponsor decision|2|||
17194301|NCT04428645|38347695|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
17194302|NCT01368835|38347699|FG000|Overall Study|Inclusion criteria/photography quality|22|||
17194303|NCT01368835|38347699|FG000|Overall Study|Lost to Follow-up|11|||
17194304|NCT02407990|38347718|FG000|Overall Study|Death|2|||
17194305|NCT02407990|38347719|FG001|Overall Study|Death|22|||
17194306|NCT02407990|38347720|FG002|Overall Study|Death|23|||
17194307|NCT02407990|38347721|FG003|Overall Study|Death|7|||
17194308|NCT02407990|38347722|FG004|Overall Study|Death|17|||
17194309|NCT02407990|38347723|FG005|Overall Study|Death|16|||
17194310|NCT02407990|38347724|FG006|Overall Study|Death|10|||
17194311|NCT02407990|38347725|FG007|Overall Study|Death|248|||
17194312|NCT02407990|38347718|FG000|Overall Study|Lost to Follow-up|0|||
17194313|NCT02407990|38347719|FG001|Overall Study|Lost to Follow-up|1|||
17194314|NCT02407990|38347720|FG002|Overall Study|Lost to Follow-up|0|||
17194315|NCT02407990|38347721|FG003|Overall Study|Lost to Follow-up|0|||
17194316|NCT02407990|38347722|FG004|Overall Study|Lost to Follow-up|0|||
17194317|NCT02407990|38347723|FG005|Overall Study|Lost to Follow-up|0|||
17194318|NCT02407990|38347724|FG006|Overall Study|Lost to Follow-up|0|||
17194319|NCT02407990|38347725|FG007|Overall Study|Lost to Follow-up|17|||
17194320|NCT02407990|38347718|FG000|Overall Study|Progressive Disease|0|||
17194321|NCT02407990|38347719|FG001|Overall Study|Progressive Disease|0|||
17194322|NCT02407990|38347720|FG002|Overall Study|Progressive Disease|0|||
17194323|NCT02407990|38347721|FG003|Overall Study|Progressive Disease|0|||
17194324|NCT02407990|38347722|FG004|Overall Study|Progressive Disease|0|||
17194325|NCT02407990|38347723|FG005|Overall Study|Progressive Disease|0|||
17194326|NCT02407990|38347724|FG006|Overall Study|Progressive Disease|0|||
17194327|NCT02407990|38347725|FG007|Overall Study|Progressive Disease|1|||
17194328|NCT02407990|38347718|FG000|Overall Study|Withdrawal by Subject|0|||
17194329|NCT02407990|38347719|FG001|Overall Study|Withdrawal by Subject|0|||
17194330|NCT02407990|38347720|FG002|Overall Study|Withdrawal by Subject|0|||
17194331|NCT02407990|38347721|FG003|Overall Study|Withdrawal by Subject|0|||
17194332|NCT02407990|38347722|FG004|Overall Study|Withdrawal by Subject|1|||
17194333|NCT02407990|38347723|FG005|Overall Study|Withdrawal by Subject|0|||
17194334|NCT02407990|38347724|FG006|Overall Study|Withdrawal by Subject|0|||
17194335|NCT02407990|38347725|FG007|Overall Study|Withdrawal by Subject|30|||
17014234|NCT00823719|38159116|FG000|Overall Study|Physician Decision|1|||
17014235|NCT00823719|38159117|FG001|Overall Study|Physician Decision|4|||
17014236|NCT00823719|38159116|FG000|Overall Study|Withdrawal by Subject|0|||
17194336|NCT02407990|38347718|FG000|Overall Study|Study Terminated by Sponsor|1|||
17194337|NCT02407990|38347719|FG001|Overall Study|Study Terminated by Sponsor|3|||
17098644|NCT00137436|38237738|FG000|Overall Study|Adverse Event|13|||
17014237|NCT00823719|38159117|FG001|Overall Study|Withdrawal by Subject|1|||
17014238|NCT00823719|38159116|FG000|Overall Study|Disease Progression|4|||
17098645|NCT00137436|38237738|FG000|Overall Study|Death|2|||
17098646|NCT00137436|38237738|FG000|Overall Study|Lack of Efficacy|17|||
17098647|NCT00137436|38237738|FG000|Overall Study|Withdrawal by Subject|6|||
17098648|NCT00137436|38237738|FG000|Overall Study|Other|5|||
17098649|NCT03834623|38237744|FG000|Overall Study|Progression|0|||
17098650|NCT03834623|38237745|FG001|Overall Study|Progression|1|||
17098651|NCT00410813|38237753|FG000|Overall Study|Adverse Event|6|||
17098652|NCT00410813|38237754|FG001|Overall Study|Adverse Event|11|||
17014239|NCT00823719|38159117|FG001|Overall Study|Disease Progression|4|||
17098653|NCT00410813|38237753|FG000|Overall Study|Progression|32|||
17098654|NCT00410813|38237754|FG001|Overall Study|Progression|21|||
17098655|NCT00410813|38237753|FG000|Overall Study|Not protocol specified|3|||
17098656|NCT00410813|38237754|FG001|Overall Study|Not protocol specified|4|||
17014240|NCT00875420|38159130|FG000|Overall Study|Adverse Event|0|||
17014241|NCT00875420|38159131|FG001|Overall Study|Adverse Event|1|||
17014242|NCT00875420|38159132|FG002|Overall Study|Adverse Event|1|||
17014243|NCT00875420|38159133|FG003|Overall Study|Adverse Event|0|||
17014244|NCT00875420|38159134|FG004|Overall Study|Adverse Event|0|||
17014245|NCT00875420|38159130|FG000|Overall Study|Inability to complete study procedures|1|||
17014246|NCT00875420|38159131|FG001|Overall Study|Inability to complete study procedures|0|||
17014247|NCT00875420|38159132|FG002|Overall Study|Inability to complete study procedures|1|||
17014248|NCT00875420|38159133|FG003|Overall Study|Inability to complete study procedures|1|||
17014249|NCT00875420|38159134|FG004|Overall Study|Inability to complete study procedures|1|||
17014250|NCT00875420|38159130|FG000|Overall Study|Lost to Follow-up|1|||
17014251|NCT00875420|38159131|FG001|Overall Study|Lost to Follow-up|0|||
17014252|NCT00875420|38159132|FG002|Overall Study|Lost to Follow-up|0|||
17014253|NCT00875420|38159133|FG003|Overall Study|Lost to Follow-up|0|||
17014254|NCT00875420|38159134|FG004|Overall Study|Lost to Follow-up|0|||
17014255|NCT00875420|38159130|FG000|Overall Study|Personal reason|0|||
17014256|NCT00875420|38159131|FG001|Overall Study|Personal reason|0|||
17014257|NCT00875420|38159132|FG002|Overall Study|Personal reason|0|||
17014258|NCT00875420|38159133|FG003|Overall Study|Personal reason|0|||
17014259|NCT00875420|38159134|FG004|Overall Study|Personal reason|1|||
17014260|NCT00875420|38159130|FG000|Overall Study|Prohibited medication|0|||
17014261|NCT00875420|38159131|FG001|Overall Study|Prohibited medication|0|||
17014262|NCT00875420|38159132|FG002|Overall Study|Prohibited medication|0|||
17014263|NCT00875420|38159133|FG003|Overall Study|Prohibited medication|1|||
17014264|NCT00875420|38159134|FG004|Overall Study|Prohibited medication|0|||
17014265|NCT00875420|38159130|FG000|Overall Study|Sponsor decision|0|||
17014266|NCT00875420|38159131|FG001|Overall Study|Sponsor decision|1|||
17014267|NCT00875420|38159132|FG002|Overall Study|Sponsor decision|0|||
17014268|NCT00875420|38159133|FG003|Overall Study|Sponsor decision|0|||
17014269|NCT00875420|38159134|FG004|Overall Study|Sponsor decision|0|||
17014270|NCT00875420|38159130|FG000|Overall Study|Withdrawal by Subject|0|||
17014271|NCT00875420|38159131|FG001|Overall Study|Withdrawal by Subject|0|||
17014272|NCT00875420|38159132|FG002|Overall Study|Withdrawal by Subject|1|||
17014273|NCT00875420|38159133|FG003|Overall Study|Withdrawal by Subject|0|||
17014274|NCT00875420|38159134|FG004|Overall Study|Withdrawal by Subject|0|||
17194338|NCT02407990|38347720|FG002|Overall Study|Study Terminated by Sponsor|3|||
17098657|NCT00410813|38237753|FG000|Overall Study|Ineligible|2|||
17098658|NCT00410813|38237754|FG001|Overall Study|Ineligible|4|||
17098659|NCT00410813|38237753|FG000|Overall Study|Death|0|||
17098660|NCT00410813|38237754|FG001|Overall Study|Death|2|||
17098661|NCT03704194|38237785|FG000|Overall Study|Withdrawal by Subject|0|||
17098662|NCT03704194|38237786|FG001|Overall Study|Withdrawal by Subject|1|||
17098663|NCT00405821|38237796|FG000|Overall Study|Death|5|||
17194339|NCT02407990|38347721|FG003|Overall Study|Study Terminated by Sponsor|0|||
17194340|NCT02407990|38347722|FG004|Overall Study|Study Terminated by Sponsor|3|||
17194341|NCT02407990|38347723|FG005|Overall Study|Study Terminated by Sponsor|4|||
17194342|NCT02407990|38347724|FG006|Overall Study|Study Terminated by Sponsor|3|||
17194343|NCT02407990|38347725|FG007|Overall Study|Study Terminated by Sponsor|37|||
16786321|NCT01976806|37726732|FG000|Overall Study|Adverse Event|1|||
17098664|NCT00405821|38237797|FG001|Overall Study|Death|7|||
17098665|NCT00405821|38237796|FG000|Overall Study|Lost to Follow-up|7|||
17098666|NCT00405821|38237797|FG001|Overall Study|Lost to Follow-up|7|||
17098667|NCT00405821|38237796|FG000|Overall Study|Protocol Violation|1|||
17014275|NCT00822237|38159148|FG000|Dose 1 Vaccination|Not vaccinated|3|||
17014276|NCT00822237|38159149|FG001|Dose 1 Vaccination|Not vaccinated|0|||
17014277|NCT00822237|38159148|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
17098668|NCT00405821|38237797|FG001|Overall Study|Protocol Violation|0|||
17098669|NCT00405821|38237796|FG000|Overall Study|initiated ART|9|||
17014278|NCT00822237|38159149|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
17014279|NCT00822237|38159148|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
17014280|NCT00822237|38159149|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
17014281|NCT00822237|38159148|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
17014282|NCT00822237|38159149|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
17098670|NCT00405821|38237797|FG001|Overall Study|initiated ART|8|||
17014283|NCT00822237|38159148|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
17014284|NCT00822237|38159149|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
17014285|NCT00577096|38159156|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
17014286|NCT00577096|38159157|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
17014287|NCT00577096|38159156|FG000|Short Term Participation|Withdrawal by Subject|3|||
17014288|NCT00577096|38159157|FG001|Short Term Participation|Withdrawal by Subject|5|||
17014289|NCT00577096|38159156|FG000|Short Term Participation|Death|1|||
17014290|NCT00577096|38159157|FG001|Short Term Participation|Death|1|||
17014291|NCT00863304|38159167|FG000|Overall Study|Adverse Event|10|||
17014292|NCT00863304|38159168|FG001|Overall Study|Adverse Event|4|||
17014293|NCT00863304|38159169|FG002|Overall Study|Adverse Event|14|||
17014294|NCT00863304|38159170|FG003|Overall Study|Adverse Event|16|||
17014295|NCT00863304|38159167|FG000|Overall Study|Lost to Follow-up|1|||
17014296|NCT00863304|38159168|FG001|Overall Study|Lost to Follow-up|5|||
17014297|NCT00863304|38159169|FG002|Overall Study|Lost to Follow-up|4|||
17014298|NCT00863304|38159170|FG003|Overall Study|Lost to Follow-up|2|||
17014299|NCT00863304|38159167|FG000|Overall Study|Lack of Efficacy|57|||
17014300|NCT00863304|38159168|FG001|Overall Study|Lack of Efficacy|26|||
17014301|NCT00863304|38159169|FG002|Overall Study|Lack of Efficacy|30|||
17014302|NCT00863304|38159170|FG003|Overall Study|Lack of Efficacy|28|||
17014303|NCT00863304|38159167|FG000|Overall Study|Withdrawal by Subject|19|||
17014304|NCT00863304|38159168|FG001|Overall Study|Withdrawal by Subject|14|||
17014305|NCT00863304|38159169|FG002|Overall Study|Withdrawal by Subject|20|||
17014306|NCT00863304|38159170|FG003|Overall Study|Withdrawal by Subject|18|||
17014307|NCT00863304|38159167|FG000|Overall Study|Other|1|||
17014308|NCT00863304|38159168|FG001|Overall Study|Other|0|||
17014309|NCT00863304|38159169|FG002|Overall Study|Other|0|||
17014310|NCT00863304|38159170|FG003|Overall Study|Other|1|||
17014311|NCT00863304|38159167|FG000|Overall Study|Protocol Violation|2|||
17014312|NCT00863304|38159168|FG001|Overall Study|Protocol Violation|6|||
17014313|NCT00863304|38159169|FG002|Overall Study|Protocol Violation|2|||
17014314|NCT00863304|38159170|FG003|Overall Study|Protocol Violation|0|||
17014315|NCT00863304|38159167|FG000|Overall Study|Randomized, but not Treated|3|||
17014316|NCT00863304|38159168|FG001|Overall Study|Randomized, but not Treated|1|||
17014317|NCT00863304|38159169|FG002|Overall Study|Randomized, but not Treated|4|||
17014318|NCT00863304|38159170|FG003|Overall Study|Randomized, but not Treated|1|||
17014319|NCT00863304|38159167|FG000|Overall Study|Entered extension study|101|||
17014320|NCT00863304|38159168|FG001|Overall Study|Entered extension study|129|||
17014321|NCT00863304|38159169|FG002|Overall Study|Entered extension study|113|||
17014322|NCT00863304|38159170|FG003|Overall Study|Entered extension study|125|||
17014323|NCT00695110|38159182|FG000|Treatment Period 1|Adverse Event|1|||
17014324|NCT00695110|38159182|FG000|Treatment Period 1|Withdrawal by Subject|2|||
17014325|NCT00695110|38159182|FG000|Treatment Period 3|Withdrawal by Subject|1|||
17014326|NCT00695110|38159182|FG000|Treatment Period 4|Adverse Event|1|||
17014327|NCT00594386|38159189|FG000|Overall Study|Major protocol violation|2|||
17014328|NCT00594386|38159189|FG000|Overall Study|Lack of Efficacy|12|||
17014329|NCT00594386|38159189|FG000|Overall Study|Adverse Event|68|||
17014330|NCT00594386|38159189|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
17014331|NCT00594386|38159189|FG000|Overall Study|Subject withdrew consent|35|||
17014332|NCT00594386|38159189|FG000|Overall Study|Study ended per sponsor|115|||
17014333|NCT00594386|38159189|FG000|Overall Study|Lost to Follow-up|6|||
17014334|NCT00594386|38159189|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
17014335|NCT00594386|38159189|FG000|Overall Study|Other: Subject moved to Seattle|1|||
17014336|NCT00594386|38159189|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
17014337|NCT00594386|38159189|FG000|Overall Study|Other: Study terminated per investigator|2|||
17014338|NCT00594386|38159189|FG000|Overall Study|Other: Sponsor closure of study|1|||
17014339|NCT00594386|38159189|FG000|Overall Study|Other: Site terminated participation|1|||
17014340|NCT00594386|38159189|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
17014341|NCT00594386|38159189|FG000|Overall Study|Other: Loss of drivers license|1|||
17098671|NCT01446016|38237803|FG000|Overall Study|Lost to Follow-up|3|||
17098672|NCT01446016|38237803|FG000|Overall Study|Withdrawal by Subject|1|||
17098673|NCT01446016|38237803|FG000|Overall Study|Toxicity|3|||
17098674|NCT00137046|38237809|FG000|Overall Study|Death|2|||
17098675|NCT00137046|38237810|FG001|Overall Study|Death|1|||
17098676|NCT00137046|38237809|FG000|Overall Study|Adverse Event|16|||
17014342|NCT00862992|38159196|FG000|Overall Study|Adverse Event|2|||
17014343|NCT00862992|38159197|FG001|Overall Study|Adverse Event|1|||
17014344|NCT00862992|38159198|FG002|Overall Study|Adverse Event|1|||
17014345|NCT00862992|38159196|FG000|Overall Study|Physician Decision|1|||
17014346|NCT00862992|38159197|FG001|Overall Study|Physician Decision|0|||
17014347|NCT00862992|38159198|FG002|Overall Study|Physician Decision|0|||
17014348|NCT00862992|38159196|FG000|Overall Study|Withdrawal by Subject|0|||
17014349|NCT00862992|38159197|FG001|Overall Study|Withdrawal by Subject|0|||
17014350|NCT00862992|38159198|FG002|Overall Study|Withdrawal by Subject|2|||
17014351|NCT00694096|38159206|FG000|Overall Study|Withdrawal by Subject|5|||
17014352|NCT00854100|38159213|FG000|Overall Study|Inability to complete the study visits|0|||
17098677|NCT00137046|38237810|FG001|Overall Study|Adverse Event|5|||
17014353|NCT00854100|38159214|FG001|Overall Study|Inability to complete the study visits|0|||
17014354|NCT00854100|38159215|FG002|Overall Study|Inability to complete the study visits|1|||
17014355|NCT00854100|38159213|FG000|Overall Study|Lost to Follow-up|2|||
17014356|NCT00854100|38159214|FG001|Overall Study|Lost to Follow-up|0|||
17014357|NCT00854100|38159215|FG002|Overall Study|Lost to Follow-up|3|||
17014358|NCT00854100|38159213|FG000|Overall Study|Withdrawal by Subject|3|||
17014359|NCT00854100|38159214|FG001|Overall Study|Withdrawal by Subject|1|||
17014360|NCT00854100|38159215|FG002|Overall Study|Withdrawal by Subject|2|||
17014361|NCT00854100|38159213|FG000|Overall Study|Protocol Violation|2|||
17014362|NCT00854100|38159214|FG001|Overall Study|Protocol Violation|4|||
17014363|NCT00854100|38159215|FG002|Overall Study|Protocol Violation|3|||
17014364|NCT00854100|38159213|FG000|Overall Study|Adverse Event|2|||
17014365|NCT00854100|38159214|FG001|Overall Study|Adverse Event|1|||
17014366|NCT00854100|38159215|FG002|Overall Study|Adverse Event|2|||
17014367|NCT00509899|38159232|FG000|Overall Study|Progressive disease|1|||
17014368|NCT00509899|38159233|FG001|Overall Study|Progressive disease|3|||
17014369|NCT00509899|38159234|FG002|Overall Study|Progressive disease|5|||
17014370|NCT00509899|38159235|FG003|Overall Study|Progressive disease|1|||
17014371|NCT00509899|38159236|FG004|Overall Study|Progressive disease|0|||
17014372|NCT00509899|38159237|FG005|Overall Study|Progressive disease|1|||
17014373|NCT00509899|38159238|FG006|Overall Study|Progressive disease|0|||
17014374|NCT00509899|38159239|FG007|Overall Study|Progressive disease|0|||
17014375|NCT00509899|38159232|FG000|Overall Study|Unacceptable Toxicity|1|||
17014376|NCT00509899|38159233|FG001|Overall Study|Unacceptable Toxicity|0|||
17098678|NCT00137046|38237809|FG000|Overall Study|Laboratory Abnormality|2|||
17194344|NCT02407990|38347718|FG000|Overall Study|Logistics|0|||
17194345|NCT02407990|38347719|FG001|Overall Study|Logistics|0|||
17194346|NCT02407990|38347720|FG002|Overall Study|Logistics|0|||
17194347|NCT02407990|38347721|FG003|Overall Study|Logistics|0|||
17194348|NCT02407990|38347722|FG004|Overall Study|Logistics|0|||
17194349|NCT02407990|38347723|FG005|Overall Study|Logistics|0|||
17194350|NCT02407990|38347724|FG006|Overall Study|Logistics|0|||
17098679|NCT00137046|38237810|FG001|Overall Study|Laboratory Abnormality|0|||
17098680|NCT00137046|38237809|FG000|Overall Study|Lack of Efficacy|13|||
17098681|NCT00137046|38237810|FG001|Overall Study|Lack of Efficacy|1|||
17098682|NCT00137046|38237809|FG000|Overall Study|Lost to Follow-up|8|||
17098683|NCT00137046|38237810|FG001|Overall Study|Lost to Follow-up|24|||
17098684|NCT00137046|38237809|FG000|Overall Study|Other|23|||
17098685|NCT00137046|38237810|FG001|Overall Study|Other|19|||
17098686|NCT00137046|38237809|FG000|Overall Study|Withdrawal by Subject|33|||
17098687|NCT00137046|38237810|FG001|Overall Study|Withdrawal by Subject|42|||
17098688|NCT00137046|38237809|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
17098689|NCT00137046|38237810|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
17098690|NCT00137046|38237809|FG000|Overall Study|Withdrew prior to study treatment|1|||
17098691|NCT00137046|38237810|FG001|Overall Study|Withdrew prior to study treatment|1|||
17098692|NCT00122382|38237822|FG000|Double-Blind Study|Adverse Event|9|||
17098693|NCT00122382|38237823|FG001|Double-Blind Study|Adverse Event|11|||
17098694|NCT00122382|38237824|FG002|Double-Blind Study|Adverse Event|0|||
17098695|NCT00122382|38237822|FG000|Double-Blind Study|Death|2|||
17098696|NCT00122382|38237823|FG001|Double-Blind Study|Death|2|||
17098697|NCT00122382|38237824|FG002|Double-Blind Study|Death|0|||
17098698|NCT00122382|38237822|FG000|Double-Blind Study|Lack of Efficacy|0|||
17194351|NCT02407990|38347725|FG007|Overall Study|Logistics|1|||
17194352|NCT02407990|38347718|FG000|Overall Study|Rolled into long-term extension study|0|||
17194353|NCT02407990|38347719|FG001|Overall Study|Rolled into long-term extension study|0|||
17194354|NCT02407990|38347720|FG002|Overall Study|Rolled into long-term extension study|0|||
17194355|NCT02407990|38347721|FG003|Overall Study|Rolled into long-term extension study|0|||
17194356|NCT02407990|38347722|FG004|Overall Study|Rolled into long-term extension study|0|||
17194357|NCT02407990|38347723|FG005|Overall Study|Rolled into long-term extension study|0|||
17194358|NCT02407990|38347724|FG006|Overall Study|Rolled into long-term extension study|0|||
17194359|NCT02407990|38347725|FG007|Overall Study|Rolled into long-term extension study|1|||
17194360|NCT03288129|38347749|FG000|Overall Study|Adverse Event|10|||
17194361|NCT03288129|38347749|FG000|Overall Study|Lost to Follow-up|3|||
17194362|NCT03288129|38347749|FG000|Overall Study|Withdrawal by Subject|3|||
17194363|NCT03288129|38347749|FG000|Overall Study|Withdrawal of consent/assent|1|||
17194364|NCT03288129|38347749|FG000|Overall Study|Other|5|||
17194365|NCT02437318|38347755|FG000|Overall Study|Progressive disease|173|||
17194366|NCT02437318|38347756|FG001|Overall Study|Progressive disease|208|||
17014377|NCT00509899|38159234|FG002|Overall Study|Unacceptable Toxicity|0|||
17014378|NCT00509899|38159235|FG003|Overall Study|Unacceptable Toxicity|2|||
17014379|NCT00509899|38159236|FG004|Overall Study|Unacceptable Toxicity|0|||
17014380|NCT00509899|38159237|FG005|Overall Study|Unacceptable Toxicity|0|||
17098699|NCT00122382|38237823|FG001|Double-Blind Study|Lack of Efficacy|8|||
17098700|NCT00122382|38237824|FG002|Double-Blind Study|Lack of Efficacy|0|||
17098701|NCT00122382|38237822|FG000|Double-Blind Study|Lost to Follow-up|2|||
17194367|NCT02437318|38347755|FG000|Overall Study|Subject/guardian decision|22|||
16786322|NCT01976806|37726733|FG001|Overall Study|Adverse Event|1|||
17014381|NCT00509899|38159238|FG006|Overall Study|Unacceptable Toxicity|0|||
17014382|NCT00509899|38159239|FG007|Overall Study|Unacceptable Toxicity|0|||
17014383|NCT00509899|38159232|FG000|Overall Study|Withdrawal by Subject|6|||
17014384|NCT00509899|38159233|FG001|Overall Study|Withdrawal by Subject|2|||
17014385|NCT00509899|38159234|FG002|Overall Study|Withdrawal by Subject|3|||
17014386|NCT00509899|38159235|FG003|Overall Study|Withdrawal by Subject|0|||
17014387|NCT00509899|38159236|FG004|Overall Study|Withdrawal by Subject|3|||
17014388|NCT00509899|38159237|FG005|Overall Study|Withdrawal by Subject|2|||
17014389|NCT00509899|38159238|FG006|Overall Study|Withdrawal by Subject|0|||
17014390|NCT00509899|38159239|FG007|Overall Study|Withdrawal by Subject|0|||
17014391|NCT00509899|38159232|FG000|Overall Study|Physician Decision|4|||
17014392|NCT00509899|38159233|FG001|Overall Study|Physician Decision|2|||
17014393|NCT00509899|38159234|FG002|Overall Study|Physician Decision|7|||
17014394|NCT00509899|38159235|FG003|Overall Study|Physician Decision|0|||
17014395|NCT00509899|38159236|FG004|Overall Study|Physician Decision|1|||
17014396|NCT00509899|38159237|FG005|Overall Study|Physician Decision|4|||
17014397|NCT00509899|38159238|FG006|Overall Study|Physician Decision|0|||
17014398|NCT00509899|38159239|FG007|Overall Study|Physician Decision|0|||
17014399|NCT00509899|38159232|FG000|Overall Study|Intercurrent Illness|1|||
17014400|NCT00509899|38159233|FG001|Overall Study|Intercurrent Illness|0|||
17014401|NCT00509899|38159234|FG002|Overall Study|Intercurrent Illness|0|||
17014402|NCT00509899|38159235|FG003|Overall Study|Intercurrent Illness|1|||
17014403|NCT00509899|38159236|FG004|Overall Study|Intercurrent Illness|0|||
17014404|NCT00509899|38159237|FG005|Overall Study|Intercurrent Illness|1|||
17014405|NCT00509899|38159238|FG006|Overall Study|Intercurrent Illness|0|||
17014406|NCT00509899|38159239|FG007|Overall Study|Intercurrent Illness|0|||
17014407|NCT00509899|38159232|FG000|Overall Study|Death|2|||
17014408|NCT00509899|38159233|FG001|Overall Study|Death|2|||
17014409|NCT00509899|38159234|FG002|Overall Study|Death|3|||
17014410|NCT00509899|38159235|FG003|Overall Study|Death|0|||
17014411|NCT00509899|38159236|FG004|Overall Study|Death|1|||
17014412|NCT00509899|38159237|FG005|Overall Study|Death|1|||
17014413|NCT00509899|38159238|FG006|Overall Study|Death|1|||
17014414|NCT00509899|38159239|FG007|Overall Study|Death|1|||
17014415|NCT00509899|38159232|FG000|Overall Study|Lack of Efficacy|1|||
17014416|NCT00509899|38159233|FG001|Overall Study|Lack of Efficacy|0|||
17014417|NCT00509899|38159234|FG002|Overall Study|Lack of Efficacy|2|||
17014418|NCT00509899|38159235|FG003|Overall Study|Lack of Efficacy|0|||
17014419|NCT00509899|38159236|FG004|Overall Study|Lack of Efficacy|0|||
17014420|NCT00509899|38159237|FG005|Overall Study|Lack of Efficacy|1|||
17014421|NCT00509899|38159238|FG006|Overall Study|Lack of Efficacy|0|||
17014422|NCT00509899|38159239|FG007|Overall Study|Lack of Efficacy|0|||
17014423|NCT00862836|38159253|FG000|Overall Study|Withdrawal by Subject|1|||
17014424|NCT00820755|38159257|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
17014425|NCT00820755|38159258|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
17014426|NCT00820755|38159259|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
17014427|NCT00820755|38159257|FG000|Period 1: Combination Therapy Phase|Death|28|||
17014428|NCT00820755|38159258|FG001|Period 1: Combination Therapy Phase|Death|0|||
17014429|NCT00820755|38159259|FG002|Period 1: Combination Therapy Phase|Death|0|||
17014430|NCT00820755|38159257|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
17014431|NCT00820755|38159258|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
17014432|NCT00820755|38159259|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
17014433|NCT00820755|38159257|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
17014434|NCT00820755|38159258|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
17014435|NCT00820755|38159259|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
17014436|NCT00820755|38159257|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
17014437|NCT00820755|38159258|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
17014438|NCT00820755|38159259|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
17014439|NCT00820755|38159257|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
17014440|NCT00820755|38159258|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
17014441|NCT00820755|38159259|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
17014442|NCT00820755|38159257|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
17014443|NCT00820755|38159258|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
17014444|NCT00820755|38159259|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
17014445|NCT00820755|38159257|FG000|Period 1: Combination Therapy Phase|Other|11|||
17014446|NCT00820755|38159258|FG001|Period 1: Combination Therapy Phase|Other|0|||
17014447|NCT00820755|38159259|FG002|Period 1: Combination Therapy Phase|Other|0|||
17014448|NCT00820755|38159257|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
17014449|NCT00820755|38159258|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
17014450|NCT00820755|38159259|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
17014451|NCT00820599|38159267|FG000|Overall Study|Death|129|||
17014452|NCT00820599|38159267|FG000|Overall Study|Withdrawal by Subject|2|||
17014453|NCT00819741|38159273|FG000|Overall Study|Adverse Event|5|||
17014454|NCT00819741|38159274|FG001|Overall Study|Adverse Event|2|||
17014455|NCT00819741|38159273|FG000|Overall Study|Lack of Efficacy|0|||
17014456|NCT00819741|38159274|FG001|Overall Study|Lack of Efficacy|2|||
17014457|NCT00819741|38159273|FG000|Overall Study|Lost to Follow-up|3|||
17014458|NCT00819741|38159274|FG001|Overall Study|Lost to Follow-up|1|||
17014459|NCT00819741|38159273|FG000|Overall Study|Protocol Violation|3|||
17014460|NCT00819741|38159274|FG001|Overall Study|Protocol Violation|4|||
17014461|NCT00819741|38159273|FG000|Overall Study|Withdrawal by Subject|2|||
17014462|NCT00819741|38159274|FG001|Overall Study|Withdrawal by Subject|2|||
17194368|NCT02437318|38347756|FG001|Overall Study|Subject/guardian decision|10|||
17194369|NCT02437318|38347755|FG000|Overall Study|Physician Decision|11|||
17194370|NCT02437318|38347756|FG001|Overall Study|Physician Decision|10|||
17194371|NCT02437318|38347755|FG000|Overall Study|Adverse Event|14|||
17194372|NCT02437318|38347756|FG001|Overall Study|Adverse Event|3|||
17194373|NCT02437318|38347755|FG000|Overall Study|Death|4|||
17194374|NCT02437318|38347756|FG001|Overall Study|Death|4|||
17194375|NCT02437318|38347755|FG000|Overall Study|Protocol Violation|5|||
17194376|NCT02437318|38347756|FG001|Overall Study|Protocol Violation|6|||
17194377|NCT02437318|38347755|FG000|Overall Study|Untreated|0|||
17194378|NCT02437318|38347756|FG001|Overall Study|Untreated|1|||
17194379|NCT01673282|38347764|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
17194380|NCT01673282|38347765|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
17194381|NCT01673282|38347764|FG000|Overall Study|Lack of Efficacy|9|||
17194382|NCT01673282|38347765|FG001|Overall Study|Lack of Efficacy|2|||
17098702|NCT00122382|38237823|FG001|Double-Blind Study|Lost to Follow-up|1|||
17098703|NCT00122382|38237824|FG002|Double-Blind Study|Lost to Follow-up|0|||
17098704|NCT00122382|38237822|FG000|Double-Blind Study|Pregnancy|2|||
17098705|NCT00122382|38237823|FG001|Double-Blind Study|Pregnancy|0|||
17098706|NCT00122382|38237824|FG002|Double-Blind Study|Pregnancy|0|||
17098707|NCT00122382|38237822|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
17098708|NCT00122382|38237823|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
17098709|NCT00122382|38237824|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
17098710|NCT00122382|38237822|FG000|Double-Blind Study|Withdrawal of Consent|7|||
17098711|NCT00122382|38237823|FG001|Double-Blind Study|Withdrawal of Consent|3|||
17098712|NCT00122382|38237824|FG002|Double-Blind Study|Withdrawal of Consent|0|||
17098713|NCT00122382|38237822|FG000|Double-Blind Study|Protocol Violation|1|||
17194383|NCT01673282|38347764|FG000|Overall Study|Lost to Follow-up|11|||
17194384|NCT01673282|38347765|FG001|Overall Study|Lost to Follow-up|10|||
17194385|NCT01673282|38347764|FG000|Overall Study|Withdrawal by Subject|3|||
17098714|NCT00122382|38237823|FG001|Double-Blind Study|Protocol Violation|0|||
17098715|NCT00122382|38237824|FG002|Double-Blind Study|Protocol Violation|0|||
17098716|NCT00122382|38237822|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
17098717|NCT00122382|38237823|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
17098718|NCT00122382|38237824|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
17098719|NCT00122382|38237822|FG000|Double-Blind Study|Randomized but not treated|0|||
17098720|NCT00122382|38237823|FG001|Double-Blind Study|Randomized but not treated|2|||
17098721|NCT00122382|38237824|FG002|Double-Blind Study|Randomized but not treated|0|||
17098722|NCT00122382|38237822|FG000|Open-Label Study|Adverse Event|0|||
17098723|NCT00122382|38237823|FG001|Open-Label Study|Adverse Event|0|||
17098724|NCT00122382|38237824|FG002|Open-Label Study|Adverse Event|11|||
17098725|NCT00122382|38237822|FG000|Open-Label Study|Death|0|||
17098726|NCT00122382|38237823|FG001|Open-Label Study|Death|0|||
17098727|NCT00122382|38237824|FG002|Open-Label Study|Death|2|||
17098728|NCT00122382|38237822|FG000|Open-Label Study|Lack of Efficacy|0|||
17098729|NCT00122382|38237823|FG001|Open-Label Study|Lack of Efficacy|0|||
17098730|NCT00122382|38237824|FG002|Open-Label Study|Lack of Efficacy|3|||
17098731|NCT00122382|38237822|FG000|Open-Label Study|Lost to Follow-up|0|||
17098732|NCT00122382|38237823|FG001|Open-Label Study|Lost to Follow-up|0|||
17098733|NCT00122382|38237824|FG002|Open-Label Study|Lost to Follow-up|3|||
17098734|NCT00122382|38237822|FG000|Open-Label Study|Pregnancy|0|||
17098735|NCT00122382|38237823|FG001|Open-Label Study|Pregnancy|0|||
17098736|NCT00122382|38237824|FG002|Open-Label Study|Pregnancy|2|||
17098737|NCT00122382|38237822|FG000|Open-Label Study|Poor/Non-Compliance|0|||
17098738|NCT00122382|38237823|FG001|Open-Label Study|Poor/Non-Compliance|0|||
17098739|NCT00122382|38237824|FG002|Open-Label Study|Poor/Non-Compliance|1|||
17098740|NCT00122382|38237822|FG000|Open-Label Study|Withdrawal of Consent|0|||
17098741|NCT00122382|38237823|FG001|Open-Label Study|Withdrawal of Consent|0|||
17098742|NCT00122382|38237824|FG002|Open-Label Study|Withdrawal of Consent|4|||
17098743|NCT01028716|38237842|FG000|Overall Study|Physician Decision|1|||
17098744|NCT00106704|38237849|FG000|Overall Study|Adverse Event|10|||
17098745|NCT00106704|38237850|FG001|Overall Study|Adverse Event|7|||
17098746|NCT00106704|38237849|FG000|Overall Study|Death|2|||
17014463|NCT00819741|38159273|FG000|Overall Study|Unclassified|6|||
17014464|NCT00819741|38159274|FG001|Overall Study|Unclassified|0|||
17194386|NCT01673282|38347765|FG001|Overall Study|Withdrawal by Subject|3|||
17014465|NCT00819741|38159273|FG000|Overall Study|Reasons unknown|3|||
17194387|NCT01673282|38347764|FG000|Overall Study|Other|1|||
17194388|NCT01673282|38347765|FG001|Overall Study|Other|6|||
17194389|NCT04157751|38347773|FG000|Overall Study|Withdrawal by Subject|12|||
17014466|NCT00819741|38159274|FG001|Overall Study|Reasons unknown|3|||
17014467|NCT00862134|38159282|FG000|Overall Study|Death|1|||
17014468|NCT00862134|38159283|FG001|Overall Study|Death|0|||
17014469|NCT00862134|38159282|FG000|Overall Study|Physician Decision|0|||
17014470|NCT00862134|38159283|FG001|Overall Study|Physician Decision|1|||
17014471|NCT00862134|38159282|FG000|Overall Study|Withdrawal by Subject|1|||
17014472|NCT00862134|38159283|FG001|Overall Study|Withdrawal by Subject|2|||
17014473|NCT00862134|38159282|FG000|Overall Study|Sponsor terminated study|5|||
17014474|NCT00862134|38159283|FG001|Overall Study|Sponsor terminated study|7|||
17014475|NCT00862134|38159282|FG000|Overall Study|Adverse Event|2|||
17014476|NCT00862134|38159283|FG001|Overall Study|Adverse Event|2|||
17014477|NCT00862134|38159282|FG000|Overall Study|Withdrew prior to dosing|2|||
17014478|NCT00862134|38159283|FG001|Overall Study|Withdrew prior to dosing|0|||
17014479|NCT00848484|38159291|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
17014480|NCT00848484|38159292|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
17014481|NCT00848484|38159291|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
17014482|NCT00848484|38159292|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
17014483|NCT00848484|38159291|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
17014484|NCT00848484|38159292|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
17014485|NCT00848484|38159291|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
17014486|NCT00848484|38159292|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
17014487|NCT00848484|38159291|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
17014488|NCT00848484|38159292|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
17014489|NCT00509821|38159300|FG000|Study Period 1 (Induction)|Death|0|||
17014490|NCT00509821|38159301|FG001|Study Period 1 (Induction)|Death|1|||
17098747|NCT00106704|38237850|FG001|Overall Study|Death|1|||
17098748|NCT00106704|38237849|FG000|Overall Study|Lack of Efficacy|67|||
17098749|NCT00106704|38237850|FG001|Overall Study|Lack of Efficacy|69|||
17098750|NCT00106704|38237849|FG000|Overall Study|Lost to Follow-up|7|||
17098751|NCT00106704|38237850|FG001|Overall Study|Lost to Follow-up|3|||
17098752|NCT00106704|38237849|FG000|Overall Study|Pregnancy|1|||
17098753|NCT00106704|38237850|FG001|Overall Study|Pregnancy|0|||
17098754|NCT00106704|38237849|FG000|Overall Study|Protocol Violation|4|||
17098755|NCT00106704|38237850|FG001|Overall Study|Protocol Violation|7|||
17098756|NCT00106704|38237849|FG000|Overall Study|Withdrawal by Subject|14|||
17098757|NCT00106704|38237850|FG001|Overall Study|Withdrawal by Subject|21|||
17098758|NCT00106704|38237849|FG000|Overall Study|Patient moved|1|||
17014491|NCT00509821|38159300|FG000|Study Period 1 (Induction)|Adverse Event|0|||
17014492|NCT00509821|38159301|FG001|Study Period 1 (Induction)|Adverse Event|2|||
17014493|NCT00509821|38159300|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
17014494|NCT00509821|38159301|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
17014495|NCT00508651|38159314|FG000|Overall Study|Lost to Follow-up|3|||
17014496|NCT00508651|38159315|FG001|Overall Study|Lost to Follow-up|1|||
17014497|NCT00508651|38159314|FG000|Overall Study|Withdrawal by Subject|1|||
17014498|NCT00508651|38159315|FG001|Overall Study|Withdrawal by Subject|1|||
17014499|NCT00490555|38159325|FG000|Overall Study|noncompliant with drug administration|0|||
17014500|NCT00490555|38159326|FG001|Overall Study|noncompliant with drug administration|0|||
17014501|NCT00490555|38159327|FG002|Overall Study|noncompliant with drug administration|2|||
17014502|NCT00490555|38159328|FG003|Overall Study|noncompliant with drug administration|0|||
17014503|NCT00501085|38159338|FG000|Overall Study|Lost to Follow-up|195|||
17014504|NCT00501085|38159338|FG000|Overall Study|Withdrawal by Subject|34|||
17014505|NCT00501085|38159338|FG000|Overall Study|Subject Decision|1|||
17014506|NCT00501085|38159338|FG000|Overall Study|Revision Surgery|7|||
17014507|NCT00501085|38159338|FG000|Overall Study|Explantation Surgery|26|||
17014508|NCT00501085|38159338|FG000|Overall Study|Adverse Event|4|||
17014509|NCT00501085|38159338|FG000|Overall Study|Non-Compliance|24|||
17014510|NCT00501085|38159338|FG000|Overall Study|Study closed by sponsor|109|||
17014511|NCT00501085|38159338|FG000|Overall Study|Other loss to follow-up|32|||
17014512|NCT00501007|38159342|FG000|Overall Study|Inclusion criteria not met.|29|||
17014513|NCT00501007|38159343|FG001|Overall Study|Inclusion criteria not met.|25|||
17014514|NCT00873860|38159353|FG000|Overall Study|Lost to Follow-up|1|||
17098759|NCT00106704|38237850|FG001|Overall Study|Patient moved|0|||
17014515|NCT00873860|38159354|FG001|Overall Study|Lost to Follow-up|0|||
17014516|NCT00873860|38159355|FG002|Overall Study|Lost to Follow-up|0|||
17014517|NCT00873860|38159356|FG003|Overall Study|Lost to Follow-up|1|||
17014518|NCT00873860|38159353|FG000|Overall Study|Withdrawal by Subject|1|||
17014519|NCT00873860|38159354|FG001|Overall Study|Withdrawal by Subject|0|||
17014520|NCT00873860|38159355|FG002|Overall Study|Withdrawal by Subject|2|||
17014521|NCT00873860|38159356|FG003|Overall Study|Withdrawal by Subject|0|||
17014522|NCT00873860|38159353|FG000|Overall Study|Death|1|||
17014523|NCT00873860|38159354|FG001|Overall Study|Death|0|||
17014524|NCT00873860|38159355|FG002|Overall Study|Death|0|||
17014525|NCT00873860|38159356|FG003|Overall Study|Death|0|||
17014526|NCT00873860|38159353|FG000|Overall Study|Other|1|||
17098760|NCT00106704|38237849|FG000|Overall Study|Site terminated|0|||
17098761|NCT00106704|38237850|FG001|Overall Study|Site terminated|1|||
17098762|NCT00106704|38237849|FG000|Overall Study|Planned major surgery|1|||
17098763|NCT00106704|38237850|FG001|Overall Study|Planned major surgery|0|||
17098764|NCT00106704|38237849|FG000|Overall Study|Patient Received Glycemic Medication|22|||
17098765|NCT00106704|38237850|FG001|Overall Study|Patient Received Glycemic Medication|41|||
17098766|NCT00106704|38237849|FG000|Overall Study|Unable to re-enter US|1|||
17098767|NCT00106704|38237850|FG001|Overall Study|Unable to re-enter US|0|||
17098768|NCT00106704|38237849|FG000|Overall Study|Laboratory test|1|||
17014527|NCT00873860|38159354|FG001|Overall Study|Other|0|||
17014528|NCT00873860|38159355|FG002|Overall Study|Other|1|||
17014529|NCT00873860|38159356|FG003|Overall Study|Other|0|||
17014530|NCT03853291|38159379|FG000|Overall Study|Lost to Follow-up|1|||
17014531|NCT03853291|38159380|FG001|Overall Study|Lost to Follow-up|2|||
17014532|NCT03853291|38159381|FG002|Overall Study|Lost to Follow-up|0|||
17014533|NCT03853291|38159382|FG003|Overall Study|Lost to Follow-up|0|||
17014534|NCT03853291|38159383|FG004|Overall Study|Lost to Follow-up|0|||
17014535|NCT03853291|38159384|FG005|Overall Study|Lost to Follow-up|0|||
17014536|NCT03853291|38159379|FG000|Overall Study|Determined to be ineligible|1|||
17014537|NCT03853291|38159380|FG001|Overall Study|Determined to be ineligible|1|||
17014538|NCT03853291|38159381|FG002|Overall Study|Determined to be ineligible|0|||
17014539|NCT03853291|38159382|FG003|Overall Study|Determined to be ineligible|0|||
17014540|NCT03853291|38159383|FG004|Overall Study|Determined to be ineligible|0|||
17014541|NCT03853291|38159384|FG005|Overall Study|Determined to be ineligible|0|||
17014542|NCT03853213|38159397|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
17014543|NCT03853213|38159398|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
17014544|NCT03853213|38159397|FG000|Overall Study|Other (e.g., too busy)|0|||
17014545|NCT03853213|38159398|FG001|Overall Study|Other (e.g., too busy)|2|||
17014546|NCT00819585|38159431|FG000|Core Study|Adverse Event|2|||
17014547|NCT00819585|38159432|FG001|Core Study|Adverse Event|1|||
17014548|NCT00819585|38159433|FG002|Core Study|Adverse Event|1|||
17014549|NCT00819585|38159434|FG003|Core Study|Adverse Event|4|||
17014550|NCT00819585|38159435|FG004|Core Study|Adverse Event|1|||
17014551|NCT00819585|38159436|FG005|Core Study|Adverse Event|0|||
17014552|NCT00819585|38159437|FG006|Core Study|Adverse Event|2|||
17014553|NCT00819585|38159438|FG007|Core Study|Adverse Event|0|||
17014554|NCT00819585|38159439|FG008|Core Study|Adverse Event|0|||
17014555|NCT00819585|38159440|FG009|Core Study|Adverse Event|0|||
17014556|NCT00819585|38159441|FG010|Core Study|Adverse Event|0|||
17194390|NCT04157751|38347774|FG001|Overall Study|Withdrawal by Subject|17|||
17194391|NCT04157751|38347773|FG000|Overall Study|Lost to Follow-up|6|||
17194392|NCT04157751|38347774|FG001|Overall Study|Lost to Follow-up|2|||
17194393|NCT04157751|38347773|FG000|Overall Study|Adverse Event|34|||
17194394|NCT04157751|38347774|FG001|Overall Study|Adverse Event|23|||
17194395|NCT04157751|38347773|FG000|Overall Study|Not treated|1|||
17194396|NCT04157751|38347774|FG001|Overall Study|Not treated|5|||
17194397|NCT04157751|38347773|FG000|Overall Study|Other reason not stated above|10|||
17194398|NCT04157751|38347774|FG001|Overall Study|Other reason not stated above|10|||
17194399|NCT01673126|38347782|FG000|Overall Study|change of diagnosis|4|||
17194400|NCT01673126|38347783|FG001|Overall Study|change of diagnosis|3|||
17194401|NCT02407054|38347792|FG000|Overall Study|Adverse Event|1|||
17194402|NCT02407054|38347793|FG001|Overall Study|Adverse Event|4|||
17194403|NCT02407054|38347794|FG002|Overall Study|Adverse Event|1|||
17194404|NCT02407054|38347792|FG000|Overall Study|Non-compliance with Study|0|||
17194405|NCT02407054|38347793|FG001|Overall Study|Non-compliance with Study|2|||
17194406|NCT02407054|38347794|FG002|Overall Study|Non-compliance with Study|1|||
17194407|NCT02407054|38347792|FG000|Overall Study|Physician Decision|1|||
17194408|NCT02407054|38347793|FG001|Overall Study|Physician Decision|3|||
17194409|NCT02407054|38347794|FG002|Overall Study|Physician Decision|3|||
17194410|NCT02407054|38347792|FG000|Overall Study|Withdrawal by Subject|5|||
17194411|NCT02407054|38347793|FG001|Overall Study|Withdrawal by Subject|9|||
17194412|NCT02407054|38347794|FG002|Overall Study|Withdrawal by Subject|2|||
17194413|NCT01652716|38347805|FG000|Overall Study|Loss of glucose control|1|||
17194414|NCT01652716|38347806|FG001|Overall Study|Loss of glucose control|0|||
17194415|NCT01652716|38347805|FG000|Overall Study|Administrative|0|||
17194416|NCT01652716|38347806|FG001|Overall Study|Administrative|2|||
17194417|NCT01652716|38347805|FG000|Overall Study|Investigator decision|1|||
17194418|NCT01652716|38347806|FG001|Overall Study|Investigator decision|4|||
16786323|NCT01976806|37726732|FG000|Overall Study|Withdrawal by Subject|1|||
16786324|NCT01976806|37726733|FG001|Overall Study|Withdrawal by Subject|1|||
16786325|NCT02679079|37726742|FG000|Overall Study|Adverse Event|2|||
17098769|NCT00106704|38237850|FG001|Overall Study|Laboratory test|1|||
17098770|NCT00105066|38237858|FG000|Overall Study|Adverse Event|2|||
17098771|NCT00105066|38237859|FG001|Overall Study|Adverse Event|5|||
17098772|NCT00104520|38237867|FG000|Overall Study|Unrelated adverse event|34|||
17098773|NCT00104520|38237868|FG001|Overall Study|Unrelated adverse event|47|||
17098774|NCT00104520|38237867|FG000|Overall Study|Study drug intolerance|0|||
17014557|NCT00819585|38159431|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
17014558|NCT00819585|38159432|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
17194419|NCT01652716|38347805|FG000|Overall Study|Lost to Follow-up|12|||
17194420|NCT01652716|38347806|FG001|Overall Study|Lost to Follow-up|11|||
17014559|NCT00819585|38159433|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
17098775|NCT00104520|38237868|FG001|Overall Study|Study drug intolerance|1|||
17098776|NCT00104520|38237867|FG000|Overall Study|Related adverse event|13|||
17098777|NCT00104520|38237868|FG001|Overall Study|Related adverse event|15|||
17098778|NCT00104520|38237867|FG000|Overall Study|Lost to Follow-up|1|||
17098779|NCT00104520|38237868|FG001|Overall Study|Lost to Follow-up|0|||
17098780|NCT00104520|38237867|FG000|Overall Study|Noncompliance|0|||
17098781|NCT00104520|38237868|FG001|Overall Study|Noncompliance|2|||
17098782|NCT00104520|38237867|FG000|Overall Study|Personal/administrative|1|||
17014560|NCT00819585|38159434|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
17014561|NCT00819585|38159435|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
17098783|NCT00104520|38237868|FG001|Overall Study|Personal/administrative|1|||
17014562|NCT00819585|38159436|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
17014563|NCT00819585|38159437|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
17014564|NCT00819585|38159438|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
17014565|NCT00819585|38159439|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
17014566|NCT00819585|38159440|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
17014567|NCT00819585|38159441|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
17014568|NCT00819585|38159431|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014569|NCT00819585|38159432|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
17014570|NCT00819585|38159433|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014571|NCT00819585|38159434|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014572|NCT00819585|38159435|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014573|NCT00819585|38159436|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014574|NCT00819585|38159437|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
17098784|NCT00104520|38237867|FG000|Overall Study|Other|1|||
17098785|NCT00104520|38237868|FG001|Overall Study|Other|5|||
17098786|NCT00135330|38237877|FG000|Overall Study|Adverse Event|2|||
17098787|NCT00135330|38237878|FG001|Overall Study|Adverse Event|5|||
17098788|NCT00135330|38237879|FG002|Overall Study|Adverse Event|1|||
17098789|NCT00135330|38237877|FG000|Overall Study|Lost to Follow-up|0|||
17098790|NCT00135330|38237878|FG001|Overall Study|Lost to Follow-up|2|||
17098791|NCT00135330|38237879|FG002|Overall Study|Lost to Follow-up|3|||
17098792|NCT00135330|38237877|FG000|Overall Study|Physician Decision|1|||
17098793|NCT00135330|38237878|FG001|Overall Study|Physician Decision|1|||
17098794|NCT00135330|38237879|FG002|Overall Study|Physician Decision|0|||
17098795|NCT00135330|38237877|FG000|Overall Study|Protocol Violation|4|||
17098796|NCT00135330|38237878|FG001|Overall Study|Protocol Violation|3|||
17098797|NCT00135330|38237879|FG002|Overall Study|Protocol Violation|3|||
17098798|NCT00135330|38237877|FG000|Overall Study|Patient Decision|5|||
17098799|NCT00135330|38237878|FG001|Overall Study|Patient Decision|1|||
17098800|NCT00135330|38237879|FG002|Overall Study|Patient Decision|4|||
17098801|NCT00135330|38237877|FG000|Overall Study|Sponsor Decision|0|||
17098802|NCT00135330|38237878|FG001|Overall Study|Sponsor Decision|1|||
17098803|NCT00135330|38237879|FG002|Overall Study|Sponsor Decision|0|||
17098804|NCT00134784|38237891|FG000|Overall Study|Withdrawal by Subject|2|||
17098805|NCT00134784|38237892|FG001|Overall Study|Withdrawal by Subject|2|||
17098806|NCT00134784|38237893|FG002|Overall Study|Withdrawal by Subject|2|||
17098807|NCT00134784|38237894|FG003|Overall Study|Withdrawal by Subject|1|||
17098808|NCT00134082|38237901|FG000|Overall Study|Adverse Event|2|||
17098809|NCT00134082|38237901|FG000|Overall Study|Death|1|||
17098810|NCT03703336|38237907|FG000|Overall Study|Parent withdrew consent|29|||
17098811|NCT03703336|38237908|FG001|Overall Study|Parent withdrew consent|8|||
17098812|NCT03703336|38237907|FG000|Overall Study|Migration|3|||
17098813|NCT03703336|38237908|FG001|Overall Study|Migration|3|||
17098814|NCT03703336|38237907|FG000|Overall Study|Protocol Violation|3|||
17098815|NCT03703336|38237908|FG001|Overall Study|Protocol Violation|1|||
17098816|NCT03703336|38237907|FG000|Overall Study|Physician Decision|2|||
17098817|NCT03703336|38237908|FG001|Overall Study|Physician Decision|0|||
17098818|NCT03703336|38237907|FG000|Overall Study|Adverse Event|0|||
17098819|NCT03703336|38237908|FG001|Overall Study|Adverse Event|2|||
17098820|NCT03703336|38237907|FG000|Overall Study|Lost to Follow-up|1|||
17098821|NCT03703336|38237908|FG001|Overall Study|Lost to Follow-up|0|||
17098822|NCT03702166|38237914|FG000|Overall Study|Lost to Follow-up|1|||
17098823|NCT03702166|38237914|FG000|Overall Study|Withdrawal by Subject|1|||
17098824|NCT00132678|38237921|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
17098825|NCT00132678|38237922|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
17098826|NCT00132678|38237923|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
17098827|NCT00132678|38237921|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
17098828|NCT00132678|38237922|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
17098829|NCT00132678|38237923|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
17098830|NCT00132678|38237921|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
17098831|NCT00132678|38237922|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
17098832|NCT00132678|38237923|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
17098833|NCT00132678|38237921|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
17098834|NCT00132678|38237922|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
17014575|NCT00819585|38159438|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014576|NCT00819585|38159439|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014577|NCT00819585|38159440|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014578|NCT00819585|38159441|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
17014579|NCT00819585|38159431|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
17014580|NCT00819585|38159432|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
17014581|NCT00819585|38159433|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
17014582|NCT00819585|38159434|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
17098835|NCT00132678|38237923|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
17014583|NCT00819585|38159435|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
17014584|NCT00819585|38159436|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
17014585|NCT00819585|38159437|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
17014586|NCT00819585|38159438|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
17098836|NCT00132678|38237921|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
17098837|NCT00132678|38237922|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
17098838|NCT00132678|38237923|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
17098839|NCT00132678|38237921|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
17098840|NCT00132678|38237922|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
17098841|NCT00132678|38237923|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
17014587|NCT00819585|38159439|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
17014588|NCT00819585|38159440|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
17014589|NCT00819585|38159441|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
17014590|NCT00819585|38159431|FG000|Core Study|Subject Withdrew Consent|0|||
17014591|NCT00819585|38159432|FG001|Core Study|Subject Withdrew Consent|3|||
17014592|NCT00819585|38159433|FG002|Core Study|Subject Withdrew Consent|2|||
17014593|NCT00819585|38159434|FG003|Core Study|Subject Withdrew Consent|1|||
17014594|NCT00819585|38159435|FG004|Core Study|Subject Withdrew Consent|0|||
17014595|NCT00819585|38159436|FG005|Core Study|Subject Withdrew Consent|0|||
17014596|NCT00819585|38159437|FG006|Core Study|Subject Withdrew Consent|3|||
17014597|NCT00819585|38159438|FG007|Core Study|Subject Withdrew Consent|0|||
17014598|NCT00819585|38159439|FG008|Core Study|Subject Withdrew Consent|0|||
17014599|NCT00819585|38159440|FG009|Core Study|Subject Withdrew Consent|0|||
17014600|NCT00819585|38159441|FG010|Core Study|Subject Withdrew Consent|0|||
17014601|NCT00819585|38159431|FG000|Core Study|Lost to Follow-up|2|||
17014602|NCT00819585|38159432|FG001|Core Study|Lost to Follow-up|1|||
17098842|NCT00132678|38237921|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
17098843|NCT00132678|38237922|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
17098844|NCT00132678|38237923|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
17098845|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Death|2|||
17098846|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Death|0|||
17098847|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Death|0|||
17098848|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
17098849|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
17098850|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
17098851|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
17098852|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
17098853|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
17194421|NCT01652716|38347805|FG000|Overall Study|Protocol Violation|2|||
17014603|NCT00819585|38159433|FG002|Core Study|Lost to Follow-up|2|||
17014604|NCT00819585|38159434|FG003|Core Study|Lost to Follow-up|0|||
17014605|NCT00819585|38159435|FG004|Core Study|Lost to Follow-up|1|||
17014606|NCT00819585|38159436|FG005|Core Study|Lost to Follow-up|1|||
17014607|NCT00819585|38159437|FG006|Core Study|Lost to Follow-up|1|||
17014608|NCT00819585|38159438|FG007|Core Study|Lost to Follow-up|0|||
17014609|NCT00819585|38159439|FG008|Core Study|Lost to Follow-up|0|||
17194422|NCT01652716|38347806|FG001|Overall Study|Protocol Violation|1|||
17194423|NCT01652716|38347805|FG000|Overall Study|Adverse Event|7|||
17194424|NCT01652716|38347806|FG001|Overall Study|Adverse Event|10|||
17194425|NCT01652716|38347805|FG000|Overall Study|Withdrawal by Subject|33|||
17194426|NCT01652716|38347806|FG001|Overall Study|Withdrawal by Subject|18|||
17194427|NCT02790073|38347812|FG000|Overall Study|Death|1|||
17194428|NCT02790073|38347812|FG000|Overall Study|Withdrawal from HD|1|||
17194429|NCT02790073|38347812|FG000|Overall Study|Withdrawal by Subject|1|||
17194430|NCT02789137|38347816|FG000|Overall Study|Dropped out/Died|58|||
17194431|NCT01672970|38347821|FG000|Overall Study|Lack of Efficacy|12|||
17194432|NCT01672970|38347821|FG000|Overall Study|Adverse Event|18|||
17194433|NCT01672970|38347821|FG000|Overall Study|Withdrawal by Subject|2|||
17194434|NCT01672970|38347821|FG000|Overall Study|Lost to Follow-up|5|||
17194435|NCT01672970|38347821|FG000|Overall Study|Other|9|||
17194436|NCT01672970|38347821|FG000|Overall Study|Enrolled but not treated|1|||
17194437|NCT02788747|38347845|FG000|Overall Study|Adverse Event|1|||
17194438|NCT02788747|38347846|FG001|Overall Study|Adverse Event|0|||
17014610|NCT00819585|38159440|FG009|Core Study|Lost to Follow-up|0|||
17014611|NCT00819585|38159441|FG010|Core Study|Lost to Follow-up|0|||
17014612|NCT00819585|38159431|FG000|Core Study|Administrative Problems|0|||
17098854|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
17194439|NCT02788747|38347847|FG002|Overall Study|Adverse Event|0|||
17194440|NCT02406742|38347861|FG000|Overall Study|Progression of Disease|5|||
17194441|NCT02406742|38347862|FG001|Overall Study|Progression of Disease|1|||
17194442|NCT02406742|38347863|FG002|Overall Study|Progression of Disease|6|||
17194443|NCT02406742|38347861|FG000|Overall Study|Adverse Event|3|||
17194444|NCT02406742|38347862|FG001|Overall Study|Adverse Event|0|||
17194445|NCT02406742|38347863|FG002|Overall Study|Adverse Event|2|||
17194446|NCT02406742|38347861|FG000|Overall Study|Death|1|||
17194447|NCT02406742|38347862|FG001|Overall Study|Death|0|||
17194448|NCT02406742|38347863|FG002|Overall Study|Death|0|||
17194449|NCT02406742|38347861|FG000|Overall Study|Lack of Efficacy|0|||
17194450|NCT02406742|38347862|FG001|Overall Study|Lack of Efficacy|0|||
17194451|NCT02406742|38347863|FG002|Overall Study|Lack of Efficacy|1|||
17194452|NCT02406742|38347861|FG000|Overall Study|Withdrawal by Participant|1|||
17194453|NCT02406742|38347862|FG001|Overall Study|Withdrawal by Participant|2|||
17194454|NCT02406742|38347863|FG002|Overall Study|Withdrawal by Participant|0|||
17194455|NCT02406742|38347861|FG000|Overall Study|Physician Decision|1|||
17194456|NCT02406742|38347862|FG001|Overall Study|Physician Decision|2|||
17194457|NCT02406742|38347863|FG002|Overall Study|Physician Decision|1|||
17194458|NCT02406742|38347861|FG000|Overall Study|Transition to other treatment|2|||
17194459|NCT02406742|38347862|FG001|Overall Study|Transition to other treatment|0|||
17194460|NCT02406742|38347863|FG002|Overall Study|Transition to other treatment|1|||
17194461|NCT02406742|38347861|FG000|Overall Study|Other Reasons|1|||
17194462|NCT02406742|38347862|FG001|Overall Study|Other Reasons|11|||
17194463|NCT02406742|38347863|FG002|Overall Study|Other Reasons|5|||
17194464|NCT02714595|38347873|FG000|Overall Study|Lost to Follow-up|1|||
17194465|NCT02714595|38347874|FG001|Overall Study|Lost to Follow-up|0|||
17194466|NCT02714595|38347873|FG000|Overall Study|Withdrawal by Subject|1|||
17194467|NCT02714595|38347874|FG001|Overall Study|Withdrawal by Subject|2|||
17194468|NCT02714595|38347873|FG000|Overall Study|Lack of Efficacy|0|||
17194469|NCT02714595|38347874|FG001|Overall Study|Lack of Efficacy|1|||
17194470|NCT02714595|38347873|FG000|Overall Study|Death|30|||
17194471|NCT02714595|38347874|FG001|Overall Study|Death|9|||
17194472|NCT02714595|38347873|FG000|Overall Study|Other-Miscellaneous|0|||
17194473|NCT02714595|38347874|FG001|Overall Study|Other-Miscellaneous|1|||
17194474|NCT02437162|38347901|FG000|Overall Study|Protocol Violation|0|||
17194475|NCT02437162|38347902|FG001|Overall Study|Protocol Violation|1|||
17194476|NCT02437162|38347903|FG002|Overall Study|Protocol Violation|0|||
17194477|NCT02437162|38347901|FG000|Overall Study|Randomized but not treated|0|||
17194478|NCT02437162|38347902|FG001|Overall Study|Randomized but not treated|0|||
17194479|NCT02437162|38347903|FG002|Overall Study|Randomized but not treated|1|||
17194480|NCT02437162|38347901|FG000|Overall Study|Study discontinued by Sponsor|93|||
17194481|NCT02437162|38347902|FG001|Overall Study|Study discontinued by Sponsor|98|||
17194482|NCT02437162|38347903|FG002|Overall Study|Study discontinued by Sponsor|97|||
17194483|NCT02437162|38347901|FG000|Overall Study|Withdrawal by Subject|13|||
17194484|NCT02437162|38347902|FG001|Overall Study|Withdrawal by Subject|7|||
17194485|NCT02437162|38347903|FG002|Overall Study|Withdrawal by Subject|9|||
17194486|NCT02437162|38347901|FG000|Overall Study|Adverse Event|0|||
17194487|NCT02437162|38347902|FG001|Overall Study|Adverse Event|1|||
17194488|NCT02437162|38347903|FG002|Overall Study|Adverse Event|0|||
17194489|NCT02437162|38347901|FG000|Overall Study|Lost to Follow-up|1|||
17194490|NCT02437162|38347902|FG001|Overall Study|Lost to Follow-up|0|||
17194491|NCT02437162|38347903|FG002|Overall Study|Lost to Follow-up|1|||
17194492|NCT02437162|38347901|FG000|Overall Study|Death|0|||
17014613|NCT00819585|38159432|FG001|Core Study|Administrative Problems|0|||
17014614|NCT00819585|38159433|FG002|Core Study|Administrative Problems|0|||
17014615|NCT00819585|38159434|FG003|Core Study|Administrative Problems|0|||
17014616|NCT00819585|38159435|FG004|Core Study|Administrative Problems|0|||
17014617|NCT00819585|38159436|FG005|Core Study|Administrative Problems|0|||
17014618|NCT00819585|38159437|FG006|Core Study|Administrative Problems|2|||
17098855|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
17098856|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
17098857|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
17098858|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
17098859|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
17098860|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
17098861|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
17098862|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
17098863|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
17098864|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
17098865|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
17194493|NCT02437162|38347902|FG001|Overall Study|Death|1|||
17014619|NCT00819585|38159438|FG007|Core Study|Administrative Problems|0|||
17014620|NCT00819585|38159439|FG008|Core Study|Administrative Problems|0|||
17014621|NCT00819585|38159440|FG009|Core Study|Administrative Problems|0|||
17014622|NCT00819585|38159441|FG010|Core Study|Administrative Problems|0|||
17014623|NCT00819585|38159431|FG000|Core Study|Death|0|||
17014624|NCT00819585|38159432|FG001|Core Study|Death|0|||
17014625|NCT00819585|38159433|FG002|Core Study|Death|0|||
17014626|NCT00819585|38159434|FG003|Core Study|Death|0|||
17014627|NCT00819585|38159435|FG004|Core Study|Death|0|||
17014628|NCT00819585|38159436|FG005|Core Study|Death|0|||
17014629|NCT00819585|38159437|FG006|Core Study|Death|1|||
17014630|NCT00819585|38159438|FG007|Core Study|Death|0|||
17014631|NCT00819585|38159439|FG008|Core Study|Death|0|||
17014632|NCT00819585|38159440|FG009|Core Study|Death|0|||
17014633|NCT00819585|38159441|FG010|Core Study|Death|0|||
17014634|NCT00819585|38159431|FG000|Core Study|Protocol Violation|0|||
17014635|NCT00819585|38159432|FG001|Core Study|Protocol Violation|0|||
17014636|NCT00819585|38159433|FG002|Core Study|Protocol Violation|1|||
17014637|NCT00819585|38159434|FG003|Core Study|Protocol Violation|0|||
17194494|NCT02437162|38347903|FG002|Overall Study|Death|0|||
17194495|NCT02437162|38347901|FG000|Overall Study|Other|0|||
17194496|NCT02437162|38347902|FG001|Overall Study|Other|0|||
17194497|NCT02437162|38347903|FG002|Overall Study|Other|1|||
17194498|NCT01368211|38347918|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
17194499|NCT01368211|38347919|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
17194500|NCT02437084|38347925|FG000|Overall Study|Withdrawal by Subject|2|||
17194501|NCT02437084|38347925|FG000|Overall Study|Physician Decision|1|||
17194502|NCT02406586|38347932|FG000|Overall Study|Lost to Follow-up|0|||
17194503|NCT02406586|38347933|FG001|Overall Study|Lost to Follow-up|4|||
17194504|NCT02406586|38347934|FG002|Overall Study|Lost to Follow-up|2|||
17194505|NCT02406586|38347932|FG000|Overall Study|Withdrawal by Subject|1|||
17194506|NCT02406586|38347933|FG001|Overall Study|Withdrawal by Subject|0|||
17194507|NCT02406586|38347934|FG002|Overall Study|Withdrawal by Subject|0|||
17014638|NCT00819585|38159435|FG004|Core Study|Protocol Violation|0|||
17098866|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
17098867|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
17098868|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
17098869|NCT00132678|38237921|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
17014639|NCT00819585|38159436|FG005|Core Study|Protocol Violation|1|||
17098870|NCT00132678|38237922|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
17098871|NCT00132678|38237923|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
17098872|NCT00132678|38237921|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
17098873|NCT00132678|38237922|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
17098874|NCT00132678|38237923|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
17098875|NCT00132678|38237921|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
17098876|NCT00132678|38237922|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
17098877|NCT00132678|38237923|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
17098878|NCT00132678|38237921|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
17098879|NCT00132678|38237922|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
17098880|NCT00132678|38237923|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
17098881|NCT00132678|38237921|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
17098882|NCT00132678|38237922|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
17098883|NCT00132678|38237923|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
17098884|NCT00132678|38237921|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
17098885|NCT00132678|38237922|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
17098886|NCT00132678|38237923|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
17098887|NCT00132678|38237921|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
17098888|NCT00132678|38237922|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
17098889|NCT00132678|38237923|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
17098890|NCT00132678|38237921|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
17098891|NCT00132678|38237922|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
17098892|NCT00132678|38237923|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
17098893|NCT00101868|38237933|FG000|Overall Study|Death|10|||
17098894|NCT00101868|38237934|FG001|Overall Study|Death|10|||
17098895|NCT00101868|38237933|FG000|Overall Study|Withdrawal by Subject|8|||
17098896|NCT00101868|38237934|FG001|Overall Study|Withdrawal by Subject|9|||
17098897|NCT00101868|38237933|FG000|Overall Study|Protocol Violation|3|||
17098898|NCT00101868|38237934|FG001|Overall Study|Protocol Violation|0|||
17098899|NCT00101868|38237933|FG000|Overall Study|Lost to Follow-up|8|||
17194508|NCT02460562|38347947|FG000|Overall Study|Lost to Follow-up|15|||
17194509|NCT02460562|38347948|FG001|Overall Study|Lost to Follow-up|16|||
17014640|NCT00819585|38159437|FG006|Core Study|Protocol Violation|3|||
17194510|NCT02788357|38347956|FG000|Overall Study|Lost to Follow-up|3|||
17014641|NCT00819585|38159438|FG007|Core Study|Protocol Violation|0|||
17014642|NCT00819585|38159439|FG008|Core Study|Protocol Violation|0|||
17014643|NCT00819585|38159440|FG009|Core Study|Protocol Violation|0|||
17014644|NCT00819585|38159441|FG010|Core Study|Protocol Violation|0|||
17014645|NCT00819585|38159431|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
17014646|NCT00819585|38159432|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
17014647|NCT00819585|38159433|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
17014648|NCT00819585|38159434|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
17014649|NCT00819585|38159435|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
17014650|NCT00819585|38159436|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
17014651|NCT00819585|38159437|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
17014652|NCT00819585|38159438|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
17014653|NCT00819585|38159439|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
17014654|NCT00819585|38159440|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
17014655|NCT00819585|38159441|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
17014656|NCT00819585|38159431|FG000|Extension Study|Subject Withdrew Consent|0|||
17014657|NCT00819585|38159432|FG001|Extension Study|Subject Withdrew Consent|0|||
17014658|NCT00819585|38159433|FG002|Extension Study|Subject Withdrew Consent|0|||
17014659|NCT00819585|38159434|FG003|Extension Study|Subject Withdrew Consent|0|||
17014660|NCT00819585|38159435|FG004|Extension Study|Subject Withdrew Consent|0|||
17014661|NCT00819585|38159436|FG005|Extension Study|Subject Withdrew Consent|0|||
17014662|NCT00819585|38159437|FG006|Extension Study|Subject Withdrew Consent|0|||
17014663|NCT00819585|38159438|FG007|Extension Study|Subject Withdrew Consent|0|||
17014664|NCT00819585|38159439|FG008|Extension Study|Subject Withdrew Consent|3|||
17014665|NCT00819585|38159440|FG009|Extension Study|Subject Withdrew Consent|0|||
17014666|NCT00819585|38159441|FG010|Extension Study|Subject Withdrew Consent|1|||
17014667|NCT00819585|38159431|FG000|Extension Study|Lost to Follow-up|0|||
17014668|NCT00819585|38159432|FG001|Extension Study|Lost to Follow-up|0|||
17014669|NCT00819585|38159433|FG002|Extension Study|Lost to Follow-up|0|||
17014670|NCT00819585|38159434|FG003|Extension Study|Lost to Follow-up|0|||
17014671|NCT00819585|38159435|FG004|Extension Study|Lost to Follow-up|0|||
17014672|NCT00819585|38159436|FG005|Extension Study|Lost to Follow-up|0|||
17014673|NCT00819585|38159437|FG006|Extension Study|Lost to Follow-up|0|||
17014674|NCT00819585|38159438|FG007|Extension Study|Lost to Follow-up|0|||
17014675|NCT00819585|38159439|FG008|Extension Study|Lost to Follow-up|2|||
17014676|NCT00819585|38159440|FG009|Extension Study|Lost to Follow-up|1|||
17014677|NCT00819585|38159441|FG010|Extension Study|Lost to Follow-up|1|||
17014678|NCT00819585|38159431|FG000|Extension Study|Death|0|||
17014679|NCT00819585|38159432|FG001|Extension Study|Death|0|||
17014680|NCT00819585|38159433|FG002|Extension Study|Death|0|||
17014681|NCT00819585|38159434|FG003|Extension Study|Death|0|||
17014682|NCT00819585|38159435|FG004|Extension Study|Death|0|||
17014683|NCT00819585|38159436|FG005|Extension Study|Death|0|||
17014684|NCT00819585|38159437|FG006|Extension Study|Death|0|||
17014685|NCT00819585|38159438|FG007|Extension Study|Death|0|||
17014686|NCT00819585|38159439|FG008|Extension Study|Death|2|||
17014687|NCT00819585|38159440|FG009|Extension Study|Death|0|||
17014688|NCT00819585|38159441|FG010|Extension Study|Death|0|||
17014689|NCT00508261|38159473|FG000|Overall Study|Other|0|||
17014690|NCT00508261|38159474|FG001|Overall Study|Other|1|||
17014691|NCT00508261|38159475|FG002|Overall Study|Other|1|||
17014692|NCT00508261|38159476|FG003|Overall Study|Other|0|||
17014693|NCT00508261|38159473|FG000|Overall Study|Serious Adverse Event|0|||
17014694|NCT00508261|38159474|FG001|Overall Study|Serious Adverse Event|1|||
17014695|NCT00508261|38159475|FG002|Overall Study|Serious Adverse Event|0|||
17014696|NCT00508261|38159476|FG003|Overall Study|Serious Adverse Event|0|||
17014697|NCT00508261|38159473|FG000|Overall Study|Withdrawal by Subject|3|||
17014698|NCT00508261|38159474|FG001|Overall Study|Withdrawal by Subject|4|||
17014699|NCT00508261|38159475|FG002|Overall Study|Withdrawal by Subject|4|||
17014700|NCT00508261|38159476|FG003|Overall Study|Withdrawal by Subject|0|||
17014701|NCT00508261|38159473|FG000|Overall Study|Migrated/ moved from study area|0|||
17014702|NCT00508261|38159474|FG001|Overall Study|Migrated/ moved from study area|1|||
17014703|NCT00508261|38159475|FG002|Overall Study|Migrated/ moved from study area|0|||
17014704|NCT00508261|38159476|FG003|Overall Study|Migrated/ moved from study area|0|||
17014705|NCT00508261|38159473|FG000|Overall Study|Lost to Follow-up|0|||
17014706|NCT00508261|38159474|FG001|Overall Study|Lost to Follow-up|1|||
17014707|NCT00508261|38159475|FG002|Overall Study|Lost to Follow-up|1|||
17014708|NCT00508261|38159476|FG003|Overall Study|Lost to Follow-up|1|||
17014709|NCT00819039|38159515|FG000|Overall Study|Physician Decision|1|||
17014710|NCT00819039|38159516|FG001|Overall Study|Physician Decision|0|||
17014711|NCT00819039|38159517|FG002|Overall Study|Physician Decision|1|||
17014712|NCT00819039|38159515|FG000|Overall Study|Protocol Violation|1|||
17014713|NCT00819039|38159516|FG001|Overall Study|Protocol Violation|0|||
17014714|NCT00819039|38159517|FG002|Overall Study|Protocol Violation|0|||
17014715|NCT00500539|38159527|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
17014716|NCT00500539|38159527|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
17014717|NCT00500539|38159527|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
17014718|NCT00500539|38159527|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
17014719|NCT00500539|38159527|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
17014720|NCT00500539|38159527|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
17014721|NCT00500539|38159527|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
17014722|NCT00500539|38159527|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
17014723|NCT00500539|38159527|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
17014724|NCT00500539|38159527|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
17014725|NCT00500539|38159527|FG000|Follow-up Period (16 Weeks)|Death|1|||
17014726|NCT00500539|38159527|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
17098900|NCT00101868|38237934|FG001|Overall Study|Lost to Follow-up|13|||
17098901|NCT00101400|38237942|FG000|Survival Follow-Up|Alive|7|||
17098902|NCT03821064|38237946|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
17194511|NCT02788357|38347957|FG001|Overall Study|Lost to Follow-up|0|||
17194512|NCT02457910|38347969|FG000|Overall Study|Withdrawal by Subject|0|||
17194513|NCT02457910|38347970|FG001|Overall Study|Withdrawal by Subject|0|||
17194514|NCT02457910|38347971|FG002|Overall Study|Withdrawal by Subject|0|||
17194515|NCT02457910|38347972|FG003|Overall Study|Withdrawal by Subject|0|||
17194516|NCT02457910|38347973|FG004|Overall Study|Withdrawal by Subject|0|||
17194517|NCT02457910|38347974|FG005|Overall Study|Withdrawal by Subject|1|||
17194518|NCT02457910|38347969|FG000|Overall Study|Adverse Event|0|||
17194519|NCT02457910|38347970|FG001|Overall Study|Adverse Event|2|||
17194520|NCT02457910|38347971|FG002|Overall Study|Adverse Event|1|||
17194521|NCT02457910|38347972|FG003|Overall Study|Adverse Event|1|||
17194522|NCT02457910|38347973|FG004|Overall Study|Adverse Event|1|||
17194523|NCT02457910|38347974|FG005|Overall Study|Adverse Event|3|||
17194524|NCT02457910|38347969|FG000|Overall Study|Disease progression|3|||
17194525|NCT02457910|38347970|FG001|Overall Study|Disease progression|3|||
17194526|NCT02457910|38347971|FG002|Overall Study|Disease progression|1|||
17194527|NCT02457910|38347972|FG003|Overall Study|Disease progression|1|||
17194528|NCT02457910|38347973|FG004|Overall Study|Disease progression|4|||
17194529|NCT02457910|38347974|FG005|Overall Study|Disease progression|6|||
17194530|NCT02457910|38347969|FG000|Overall Study|Other complicating illness|0|||
17194531|NCT02457910|38347970|FG001|Overall Study|Other complicating illness|0|||
17098903|NCT00121992|38237952|FG000|Overall Study|Treatment not received|2|||
17098904|NCT00121992|38237953|FG001|Overall Study|Treatment not received|11|||
17194532|NCT02457910|38347971|FG002|Overall Study|Other complicating illness|0|||
17194533|NCT02457910|38347972|FG003|Overall Study|Other complicating illness|0|||
17194534|NCT02457910|38347973|FG004|Overall Study|Other complicating illness|0|||
17194535|NCT02457910|38347974|FG005|Overall Study|Other complicating illness|1|||
17194536|NCT02457910|38347969|FG000|Overall Study|Death|0|||
17194537|NCT02457910|38347970|FG001|Overall Study|Death|0|||
17194538|NCT02457910|38347971|FG002|Overall Study|Death|1|||
17194539|NCT02457910|38347972|FG003|Overall Study|Death|0|||
17194540|NCT02457910|38347973|FG004|Overall Study|Death|0|||
17194541|NCT02457910|38347974|FG005|Overall Study|Death|0|||
17194542|NCT02405962|38347993|FG000|Overall Study|Lost to Follow-up|1|||
17194543|NCT02405962|38347994|FG001|Overall Study|Lost to Follow-up|4|||
17194544|NCT02405962|38347993|FG000|Overall Study|A participant has moved to another place|0|||
17194545|NCT02405962|38347994|FG001|Overall Study|A participant has moved to another place|1|||
17194546|NCT02436304|38348003|FG000|Overall Study|Lost to Follow-up|0|||
17194547|NCT02436304|38348004|FG001|Overall Study|Lost to Follow-up|1|||
17194548|NCT02436304|38348005|FG002|Overall Study|Lost to Follow-up|0|||
17194549|NCT02436304|38348003|FG000|Overall Study|Withdrawal by Subject|0|||
17194550|NCT02436304|38348004|FG001|Overall Study|Withdrawal by Subject|1|||
17194551|NCT02436304|38348005|FG002|Overall Study|Withdrawal by Subject|0|||
17194552|NCT02436304|38348003|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
17194553|NCT02436304|38348004|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
17194554|NCT02436304|38348005|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
17194555|NCT02402218|38348017|FG000|Overall Study|Did not pickup study medication|12|||
17194556|NCT02402218|38348018|FG001|Overall Study|Did not pickup study medication|9|||
17194557|NCT02402218|38348019|FG002|Overall Study|Did not pickup study medication|13|||
17194558|NCT02402218|38348017|FG000|Overall Study|Lack of Efficacy|0|||
17194559|NCT02402218|38348018|FG001|Overall Study|Lack of Efficacy|1|||
17194560|NCT02402218|38348019|FG002|Overall Study|Lack of Efficacy|1|||
17194561|NCT02402218|38348017|FG000|Overall Study|Death|1|||
17194562|NCT02402218|38348018|FG001|Overall Study|Death|0|||
17194563|NCT02402218|38348019|FG002|Overall Study|Death|0|||
17194564|NCT02402218|38348017|FG000|Overall Study|Reinfection|0|||
17194565|NCT02402218|38348018|FG001|Overall Study|Reinfection|0|||
17194566|NCT02402218|38348019|FG002|Overall Study|Reinfection|1|||
17194567|NCT02402218|38348017|FG000|Overall Study|Adverse Event|0|||
17194568|NCT02402218|38348018|FG001|Overall Study|Adverse Event|2|||
17194569|NCT02402218|38348019|FG002|Overall Study|Adverse Event|1|||
17194570|NCT02402218|38348017|FG000|Overall Study|Withdrawal by Subject|1|||
17098905|NCT00141518|38237962|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
17194571|NCT02402218|38348018|FG001|Overall Study|Withdrawal by Subject|1|||
17014727|NCT00500539|38159527|FG000|Follow-up Period (16 Weeks)|Missing|3|||
17098906|NCT00141518|38237963|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
17194572|NCT02402218|38348019|FG002|Overall Study|Withdrawal by Subject|1|||
17194573|NCT02457520|38348027|FG000|Active Treatment Phase|Adverse Event|10|||
17014728|NCT00818883|38159536|FG000|Overall Study|Adverse Event|28|||
17014729|NCT00818883|38159537|FG001|Overall Study|Adverse Event|19|||
17014730|NCT00818883|38159536|FG000|Overall Study|Protocol Violation|2|||
17014731|NCT00818883|38159537|FG001|Overall Study|Protocol Violation|2|||
17014732|NCT00818883|38159536|FG000|Overall Study|Lost to Follow-up|3|||
17014733|NCT00818883|38159537|FG001|Overall Study|Lost to Follow-up|2|||
17014734|NCT00818883|38159536|FG000|Overall Study|Withdrawal by Subject|16|||
17014735|NCT00818883|38159537|FG001|Overall Study|Withdrawal by Subject|14|||
17014736|NCT00818883|38159536|FG000|Overall Study|Lack of Efficacy|0|||
17014737|NCT00818883|38159537|FG001|Overall Study|Lack of Efficacy|2|||
17014738|NCT00818883|38159536|FG000|Overall Study|Other|2|||
17014739|NCT00818883|38159537|FG001|Overall Study|Other|7|||
17014740|NCT00508027|38159543|FG000|Dose Level 1|Lost to Follow-up|4|||
17014741|NCT00508027|38159543|FG000|Dose Level 1|Withdrawal by Subject|2|||
17014742|NCT00508027|38159543|FG000|Dose Level 1|Physician Decision|2|||
17014743|NCT00508027|38159543|FG000|Dose Level 2|Lost to Follow-up|2|||
17014744|NCT00508027|38159543|FG000|Dose Level 2|Withdrawal by Subject|2|||
17014745|NCT00500149|38159572|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
17014746|NCT00500149|38159573|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
17014747|NCT00500149|38159572|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
17014748|NCT00500149|38159573|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
17014749|NCT00500149|38159572|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
17014750|NCT00500149|38159573|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
17014751|NCT00500149|38159572|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
17014752|NCT00500149|38159573|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
17014753|NCT00500149|38159572|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
17014754|NCT00500149|38159573|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
17098907|NCT00141518|38237964|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
17098908|NCT00141518|38237962|FG000|Overall Study|Adverse Event|7|||
17098909|NCT00141518|38237963|FG001|Overall Study|Adverse Event|5|||
17098910|NCT00141518|38237964|FG002|Overall Study|Adverse Event|2|||
17098911|NCT00141518|38237962|FG000|Overall Study|Withdrawal by Subject|2|||
17098912|NCT00141518|38237963|FG001|Overall Study|Withdrawal by Subject|0|||
17098913|NCT00141518|38237964|FG002|Overall Study|Withdrawal by Subject|2|||
17098914|NCT00141518|38237962|FG000|Overall Study|Protocol Violation|1|||
17098915|NCT00141518|38237963|FG001|Overall Study|Protocol Violation|1|||
17098916|NCT00141518|38237964|FG002|Overall Study|Protocol Violation|2|||
17098917|NCT00141518|38237962|FG000|Overall Study|Lack of Efficacy|5|||
17098918|NCT00141518|38237963|FG001|Overall Study|Lack of Efficacy|0|||
17014755|NCT00500149|38159572|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
17014756|NCT00500149|38159573|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
17098919|NCT00141518|38237964|FG002|Overall Study|Lack of Efficacy|0|||
17098920|NCT00253448|38237974|FG000|Overall Study|Withdrawal by Subject|1|||
17098921|NCT00098748|38237981|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
17098922|NCT00098748|38237982|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
17098923|NCT00098748|38237983|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
17098924|NCT00098748|38237981|FG000|Received Study Treatment|Death|2|||
17098925|NCT00098748|38237982|FG001|Received Study Treatment|Death|1|||
17098926|NCT00098748|38237983|FG002|Received Study Treatment|Death|2|||
17014757|NCT00500149|38159572|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
17014758|NCT00500149|38159573|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
17014759|NCT00489853|38159579|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
17014760|NCT00489853|38159580|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
17014761|NCT00489853|38159581|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
17014762|NCT00489853|38159579|FG000|Wash-out Period 1|Adverse Event|0|||
17014763|NCT00489853|38159580|FG001|Wash-out Period 1|Adverse Event|1|||
17014764|NCT00489853|38159581|FG002|Wash-out Period 1|Adverse Event|1|||
17014765|NCT00489853|38159579|FG000|Wash-out Period 1|Protocol Violation|0|||
17014766|NCT00489853|38159580|FG001|Wash-out Period 1|Protocol Violation|1|||
17014767|NCT00489853|38159581|FG002|Wash-out Period 1|Protocol Violation|1|||
17014768|NCT00489853|38159579|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
17014769|NCT00489853|38159580|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
17014770|NCT00489853|38159581|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
17098927|NCT00098748|38237981|FG000|Received Study Treatment|Adverse Event|1|||
17098928|NCT00098748|38237982|FG001|Received Study Treatment|Adverse Event|2|||
17098929|NCT00098748|38237983|FG002|Received Study Treatment|Adverse Event|5|||
17098930|NCT00098748|38237981|FG000|Received Study Treatment|Lack of Efficacy|40|||
17194574|NCT02457520|38348027|FG000|Active Treatment Phase|Lost to Follow-up|8|||
17194575|NCT02457520|38348027|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
17194576|NCT02457520|38348027|FG000|Active Treatment Phase|other|4|||
17194577|NCT02457520|38348027|FG000|Active Treatment Phase|Physician Decision|1|||
17014771|NCT00489853|38159579|FG000|Wash-out Period 2|Adverse Event|1|||
17014772|NCT00489853|38159580|FG001|Wash-out Period 2|Adverse Event|1|||
17014773|NCT00489853|38159581|FG002|Wash-out Period 2|Adverse Event|0|||
17014774|NCT00489853|38159579|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
17014775|NCT00489853|38159580|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
17014776|NCT00489853|38159581|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
17014777|NCT00489853|38159579|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
17014778|NCT00489853|38159580|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
17014779|NCT00489853|38159581|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
17014780|NCT00499681|38159591|FG000|Overall Study|toxicity|0|||
17014781|NCT00499681|38159592|FG001|Overall Study|toxicity|1|||
17014782|NCT00499681|38159591|FG000|Overall Study|disease progression|0|||
17014783|NCT00499681|38159592|FG001|Overall Study|disease progression|1|||
17014784|NCT00875810|38159603|FG000|Overall Study|Withdrawal by Subject|1|||
17014785|NCT00875810|38159603|FG000|Overall Study|Physician Decision|3|||
17014786|NCT00875810|38159603|FG000|Overall Study|Lost to Follow-up|39|||
17014787|NCT00875810|38159603|FG000|Overall Study|Patient enroled but not implanted|2|||
17014788|NCT00875810|38159603|FG000|Overall Study|Device explanted|1|||
17014789|NCT00499603|38159609|FG000|Overall Study|Adverse Event|0|||
17014790|NCT00499603|38159610|FG001|Overall Study|Adverse Event|1|||
17014791|NCT00810069|38159629|FG000|Lead-in Period I|Adverse Event|43|||
17014792|NCT00810069|38159630|FG001|Lead-in Period I|Adverse Event|0|||
17014793|NCT00810069|38159631|FG002|Lead-in Period I|Adverse Event|0|||
17014794|NCT00810069|38159629|FG000|Lead-in Period I|Lack of Efficacy|1|||
17014795|NCT00810069|38159630|FG001|Lead-in Period I|Lack of Efficacy|0|||
17014796|NCT00810069|38159631|FG002|Lead-in Period I|Lack of Efficacy|0|||
17014797|NCT00810069|38159629|FG000|Lead-in Period I|Lost to Follow-up|19|||
17014798|NCT00810069|38159630|FG001|Lead-in Period I|Lost to Follow-up|0|||
17014799|NCT00810069|38159631|FG002|Lead-in Period I|Lost to Follow-up|0|||
17014800|NCT00810069|38159629|FG000|Lead-in Period I|Physician Decision|1|||
17014801|NCT00810069|38159630|FG001|Lead-in Period I|Physician Decision|0|||
17098931|NCT00098748|38237982|FG001|Received Study Treatment|Lack of Efficacy|27|||
17098932|NCT00098748|38237983|FG002|Received Study Treatment|Lack of Efficacy|27|||
17098933|NCT00098748|38237981|FG000|Received Study Treatment|Other|2|||
17098934|NCT00098748|38237982|FG001|Received Study Treatment|Other|2|||
17098935|NCT00098748|38237983|FG002|Received Study Treatment|Other|6|||
17098936|NCT00098748|38237981|FG000|Received Study Treatment|Subject defaulted|3|||
17098937|NCT00098748|38237982|FG001|Received Study Treatment|Subject defaulted|4|||
17098938|NCT00098748|38237983|FG002|Received Study Treatment|Subject defaulted|4|||
17098939|NCT00098748|38237981|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
17098940|NCT00098748|38237982|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
17194578|NCT02457520|38348027|FG000|Active Treatment Phase|Protocol Violation|1|||
17194579|NCT02457520|38348027|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
17194580|NCT02457520|38348027|FG000|Post-treatment Period|Other: Retreatment Required|7|||
17194581|NCT02457520|38348027|FG000|Post-treatment Period|Lost to Follow-up|23|||
17194582|NCT02457520|38348027|FG000|Post-treatment Period|Other|3|||
17194583|NCT02457520|38348027|FG000|Post-treatment Period|Physician Decision|1|||
17194584|NCT02457520|38348027|FG000|Post-treatment Period|Withdrawal by Subject|14|||
17194585|NCT02788279|38348060|FG000|Overall Study|Death|62|||
17194586|NCT02788279|38348061|FG001|Overall Study|Death|136|||
17194587|NCT02788279|38348062|FG002|Overall Study|Death|72|||
17194588|NCT02788279|38348060|FG000|Overall Study|Withdrawal by Subject|10|||
17194589|NCT02788279|38348061|FG001|Overall Study|Withdrawal by Subject|15|||
17194590|NCT02788279|38348062|FG002|Overall Study|Withdrawal by Subject|5|||
17194591|NCT02788279|38348060|FG000|Overall Study|Lost to Follow-up|0|||
17194592|NCT02788279|38348061|FG001|Overall Study|Lost to Follow-up|3|||
17194593|NCT02788279|38348062|FG002|Overall Study|Lost to Follow-up|2|||
17194594|NCT02788279|38348060|FG000|Overall Study|Sponsor decision|18|||
17194595|NCT02788279|38348061|FG001|Overall Study|Sponsor decision|29|||
17194596|NCT02788279|38348062|FG002|Overall Study|Sponsor decision|11|||
17194597|NCT02435992|38348078|FG000|Overall Study|non compliance with protocol|2|||
17194598|NCT02435992|38348079|FG001|Overall Study|non compliance with protocol|0|||
17194599|NCT02435992|38348080|FG002|Overall Study|non compliance with protocol|1|||
17194600|NCT02435992|38348081|FG003|Overall Study|non compliance with protocol|0|||
17194601|NCT02435992|38348082|FG004|Overall Study|non compliance with protocol|0|||
17194602|NCT02435992|38348078|FG000|Overall Study|Adverse Event|11|||
17194603|NCT02435992|38348079|FG001|Overall Study|Adverse Event|6|||
17194604|NCT02435992|38348080|FG002|Overall Study|Adverse Event|12|||
17194605|NCT02435992|38348081|FG003|Overall Study|Adverse Event|0|||
17194606|NCT02435992|38348082|FG004|Overall Study|Adverse Event|0|||
17194607|NCT02435992|38348078|FG000|Overall Study|Lack of Efficacy|4|||
17194608|NCT02435992|38348079|FG001|Overall Study|Lack of Efficacy|10|||
17098941|NCT00098748|38237983|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
17098942|NCT00098748|38237981|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
17098943|NCT00098748|38237982|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
17098944|NCT00098748|38237983|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
17194609|NCT02435992|38348080|FG002|Overall Study|Lack of Efficacy|9|||
17194610|NCT02435992|38348081|FG003|Overall Study|Lack of Efficacy|0|||
17194611|NCT02435992|38348082|FG004|Overall Study|Lack of Efficacy|0|||
17194612|NCT02435992|38348078|FG000|Overall Study|Withdrawal by Subject|10|||
17194613|NCT02435992|38348079|FG001|Overall Study|Withdrawal by Subject|8|||
17194614|NCT02435992|38348080|FG002|Overall Study|Withdrawal by Subject|20|||
17194615|NCT02435992|38348081|FG003|Overall Study|Withdrawal by Subject|0|||
17194616|NCT02435992|38348082|FG004|Overall Study|Withdrawal by Subject|0|||
17098945|NCT00098748|38237981|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
17098946|NCT00098748|38237982|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
17098947|NCT00098748|38237983|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
17194617|NCT02435992|38348078|FG000|Overall Study|Other Reason|1|||
17194618|NCT02435992|38348079|FG001|Overall Study|Other Reason|0|||
17194619|NCT02435992|38348080|FG002|Overall Study|Other Reason|0|||
17194620|NCT02435992|38348081|FG003|Overall Study|Other Reason|0|||
17098948|NCT00098748|38237981|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
17098949|NCT00098748|38237982|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
17098950|NCT00098748|38237983|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
17098951|NCT00098748|38237981|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
17098952|NCT00098748|38237982|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
17098953|NCT00098748|38237983|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
17098954|NCT00130520|38237991|FG000|Overall Study|Adverse Event|11|||
17194621|NCT02435992|38348082|FG004|Overall Study|Other Reason|0|||
17194622|NCT02435992|38348078|FG000|Overall Study|Physician Decision|0|||
17194623|NCT02435992|38348079|FG001|Overall Study|Physician Decision|0|||
17194624|NCT02435992|38348080|FG002|Overall Study|Physician Decision|1|||
17194625|NCT02435992|38348081|FG003|Overall Study|Physician Decision|0|||
17194626|NCT02435992|38348082|FG004|Overall Study|Physician Decision|0|||
17194627|NCT02788513|38348099|FG000|Overall Study|Withdrawal by Subject|3|||
17194628|NCT02788513|38348100|FG001|Overall Study|Withdrawal by Subject|0|||
17194629|NCT02788513|38348101|FG002|Overall Study|Withdrawal by Subject|2|||
17194630|NCT02788513|38348102|FG003|Overall Study|Withdrawal by Subject|3|||
17194631|NCT02788513|38348103|FG004|Overall Study|Withdrawal by Subject|1|||
17194632|NCT02788513|38348099|FG000|Overall Study|Lost to Follow-up|1|||
17194633|NCT02788513|38348100|FG001|Overall Study|Lost to Follow-up|0|||
17194634|NCT02788513|38348101|FG002|Overall Study|Lost to Follow-up|0|||
17194635|NCT02788513|38348102|FG003|Overall Study|Lost to Follow-up|0|||
17194636|NCT02788513|38348103|FG004|Overall Study|Lost to Follow-up|1|||
17194637|NCT02788513|38348099|FG000|Overall Study|Adverse Event|5|||
17194638|NCT02788513|38348100|FG001|Overall Study|Adverse Event|8|||
17194639|NCT02788513|38348101|FG002|Overall Study|Adverse Event|4|||
17194640|NCT02788513|38348102|FG003|Overall Study|Adverse Event|2|||
17194641|NCT02788513|38348103|FG004|Overall Study|Adverse Event|2|||
17194642|NCT02788513|38348099|FG000|Overall Study|Protocol Violation|0|||
17194643|NCT02788513|38348100|FG001|Overall Study|Protocol Violation|0|||
17194644|NCT02788513|38348101|FG002|Overall Study|Protocol Violation|1|||
17194645|NCT02788513|38348102|FG003|Overall Study|Protocol Violation|1|||
17194646|NCT02788513|38348103|FG004|Overall Study|Protocol Violation|0|||
17194647|NCT02788513|38348099|FG000|Overall Study|Subject decided to stop taking treatment|0|||
17194648|NCT02788513|38348100|FG001|Overall Study|Subject decided to stop taking treatment|0|||
17194649|NCT02788513|38348101|FG002|Overall Study|Subject decided to stop taking treatment|1|||
17194650|NCT02788513|38348102|FG003|Overall Study|Subject decided to stop taking treatment|0|||
17194651|NCT02788513|38348103|FG004|Overall Study|Subject decided to stop taking treatment|0|||
17194652|NCT02788513|38348099|FG000|Overall Study|Decision by the study team|0|||
17194653|NCT02788513|38348100|FG001|Overall Study|Decision by the study team|0|||
17194654|NCT02788513|38348101|FG002|Overall Study|Decision by the study team|0|||
17194655|NCT02788513|38348102|FG003|Overall Study|Decision by the study team|0|||
17194656|NCT02788513|38348103|FG004|Overall Study|Decision by the study team|1|||
17194657|NCT02401672|38348117|FG000|Overall Study|Withdrawal by Subject|1|||
17194658|NCT02401672|38348118|FG001|Overall Study|Withdrawal by Subject|3|||
17194659|NCT02435914|38348128|FG000|Overall Study|Ocular Adverse Event|1|||
17194660|NCT02435914|38348129|FG001|Overall Study|Ocular Adverse Event|0|||
17194661|NCT02435914|38348130|FG002|Overall Study|Ocular Adverse Event|0|||
17194662|NCT02435914|38348131|FG003|Overall Study|Ocular Adverse Event|0|||
17194663|NCT02435914|38348128|FG000|Overall Study|Withdrawal by Subject|0|||
17194664|NCT02435914|38348129|FG001|Overall Study|Withdrawal by Subject|1|||
17194665|NCT02435914|38348130|FG002|Overall Study|Withdrawal by Subject|0|||
17194666|NCT02435914|38348131|FG003|Overall Study|Withdrawal by Subject|0|||
17194667|NCT02435914|38348128|FG000|Overall Study|Other Miscellaneous Reason|0|||
17194668|NCT02435914|38348129|FG001|Overall Study|Other Miscellaneous Reason|0|||
17194669|NCT02435914|38348130|FG002|Overall Study|Other Miscellaneous Reason|1|||
17194670|NCT02435914|38348131|FG003|Overall Study|Other Miscellaneous Reason|0|||
17194671|NCT02786953|38348143|FG000|Overall Study|Withdrawal by Subject|3|||
17194672|NCT02786953|38348144|FG001|Overall Study|Withdrawal by Subject|0|||
17194673|NCT02786953|38348143|FG000|Overall Study|Physician Decision|0|||
17194674|NCT02786953|38348144|FG001|Overall Study|Physician Decision|1|||
17194675|NCT02435836|38348150|FG000|Overall Study|Lost to Follow-up|21|||
17194676|NCT02435836|38348150|FG000|Overall Study|Lack of Efficacy|1|||
17194677|NCT02435836|38348150|FG000|Overall Study|Withdrawal by Subject|236|||
17194678|NCT02435836|38348150|FG000|Overall Study|Insufficient Clinical Response|26|||
17194679|NCT02435836|38348150|FG000|Overall Study|Adverse Event|44|||
17194680|NCT02435836|38348150|FG000|Overall Study|Sponsor discontinued trial|167|||
17194681|NCT02435836|38348150|FG000|Overall Study|Noncompliance|27|||
17194682|NCT02435836|38348150|FG000|Overall Study|Protocol Violation|6|||
17194683|NCT02435836|38348150|FG000|Overall Study|Met Withdrawal Criteria|7|||
17194684|NCT02435836|38348150|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
17014802|NCT00810069|38159631|FG002|Lead-in Period I|Physician Decision|0|||
17014803|NCT00810069|38159629|FG000|Lead-in Period I|Protocol Violation|1|||
17014804|NCT00810069|38159630|FG001|Lead-in Period I|Protocol Violation|0|||
17014805|NCT00810069|38159631|FG002|Lead-in Period I|Protocol Violation|0|||
17014806|NCT00810069|38159629|FG000|Lead-in Period I|Withdrawal by Subject|46|||
17014807|NCT00810069|38159630|FG001|Lead-in Period I|Withdrawal by Subject|0|||
17014808|NCT00810069|38159631|FG002|Lead-in Period I|Withdrawal by Subject|0|||
17014809|NCT00810069|38159629|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
17014810|NCT00810069|38159630|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
17014811|NCT00810069|38159631|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
17014812|NCT00810069|38159629|FG000|Lead-in Period I|Randomization criteria not met|158|||
17014813|NCT00810069|38159630|FG001|Lead-in Period I|Randomization criteria not met|0|||
17014814|NCT00810069|38159631|FG002|Lead-in Period I|Randomization criteria not met|0|||
17098955|NCT00130520|38237991|FG000|Overall Study|Death|1|||
17098956|NCT00130520|38237991|FG000|Overall Study|Physician Decision|1|||
17098957|NCT00130520|38237991|FG000|Overall Study|Withdrawal by Subject|1|||
17098958|NCT00130520|38237991|FG000|Overall Study|Disease Progression|23|||
17098959|NCT00130520|38237991|FG000|Overall Study|Protocol non-compliance|1|||
17098960|NCT00130520|38237991|FG000|Overall Study|Did not meet re-treatment criteria|1|||
17098961|NCT00132132|38237997|FG000|Overall Study|Lost to Follow-up|7|||
17098962|NCT00132132|38237998|FG001|Overall Study|Lost to Follow-up|2|||
17098963|NCT00130442|38238006|FG000|Overall Study|Withdrawal by Subject|0|||
17098964|NCT00130442|38238007|FG001|Overall Study|Withdrawal by Subject|1|||
17098965|NCT00130442|38238006|FG000|Overall Study|did not meet criteria|1|||
17098966|NCT00130442|38238007|FG001|Overall Study|did not meet criteria|1|||
17098967|NCT00130208|38238017|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
17098968|NCT00130208|38238018|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
17098969|NCT00130208|38238017|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
17098970|NCT00130208|38238018|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
17098971|NCT00130208|38238017|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
17098972|NCT00130208|38238018|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
17098973|NCT00130208|38238017|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
17098974|NCT00130208|38238018|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
17098975|NCT00130208|38238017|FG000|Maintenance Period (26 Weeks)|Other|1|||
17098976|NCT00130208|38238018|FG001|Maintenance Period (26 Weeks)|Other|1|||
17098977|NCT00130208|38238017|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
17098978|NCT00130208|38238018|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
17098979|NCT00130208|38238017|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
17098980|NCT00130208|38238018|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
17098981|NCT00130208|38238017|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
17098982|NCT00130208|38238018|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
17098983|NCT00130208|38238017|FG000|Washout Period (8 Weeks)|Other|1|||
17098984|NCT00130208|38238018|FG001|Washout Period (8 Weeks)|Other|1|||
17098985|NCT00253370|38238024|FG000|Overall Study|Adverse Event|18|||
17098986|NCT00253370|38238024|FG000|Overall Study|Disease progression|13|||
17098987|NCT00253370|38238024|FG000|Overall Study|Death|2|||
17098988|NCT00253370|38238024|FG000|Overall Study|Withdrawal by Subject|6|||
17014815|NCT00810069|38159629|FG000|Double-Blind Period II|Adverse Event|0|||
17014816|NCT00810069|38159630|FG001|Double-Blind Period II|Adverse Event|9|||
17014817|NCT00810069|38159631|FG002|Double-Blind Period II|Adverse Event|8|||
17014818|NCT00810069|38159629|FG000|Double-Blind Period II|Lack of Efficacy|0|||
17014819|NCT00810069|38159630|FG001|Double-Blind Period II|Lack of Efficacy|7|||
17014820|NCT00810069|38159631|FG002|Double-Blind Period II|Lack of Efficacy|12|||
17014821|NCT00810069|38159629|FG000|Double-Blind Period II|Lost to Follow-up|0|||
17014822|NCT00810069|38159630|FG001|Double-Blind Period II|Lost to Follow-up|9|||
17014823|NCT00810069|38159631|FG002|Double-Blind Period II|Lost to Follow-up|9|||
17098989|NCT00253370|38238024|FG000|Overall Study|Non-protocol therapy|1|||
17098990|NCT00253370|38238024|FG000|Overall Study|Physician Decision|1|||
17098991|NCT00253370|38238024|FG000|Overall Study|Protocol Violation|1|||
17098992|NCT00253370|38238024|FG000|Overall Study|Abdominal pain due to disease|1|||
17098993|NCT00140426|38238031|FG000|Overall Study|Withdrawal by Subject|0|||
17098994|NCT00140426|38238032|FG001|Overall Study|Withdrawal by Subject|3|||
17098995|NCT00121134|38238047|FG000|Overall Study|Progression of Disease|5|||
17194685|NCT02788201|38348160|FG000|Overall Study|Death|1|||
17194686|NCT02788201|38348161|FG001|Overall Study|Death|1|||
17014824|NCT00810069|38159629|FG000|Double-Blind Period II|Physician Decision|0|||
17194687|NCT02788201|38348162|FG002|Overall Study|Death|1|||
17194688|NCT02788201|38348163|FG003|Overall Study|Death|1|||
17194689|NCT02788201|38348164|FG004|Overall Study|Death|0|||
17194690|NCT02788201|38348165|FG005|Overall Study|Death|1|||
17194691|NCT02788201|38348160|FG000|Overall Study|Ineligible|0|||
17194692|NCT02788201|38348161|FG001|Overall Study|Ineligible|0|||
17194693|NCT02788201|38348162|FG002|Overall Study|Ineligible|0|||
17194694|NCT02788201|38348163|FG003|Overall Study|Ineligible|0|||
17194695|NCT02788201|38348164|FG004|Overall Study|Ineligible|0|||
17194696|NCT02788201|38348165|FG005|Overall Study|Ineligible|1|||
17194697|NCT02788201|38348160|FG000|Overall Study|Withdrawal by Subject|0|||
17194698|NCT02788201|38348161|FG001|Overall Study|Withdrawal by Subject|0|||
17194699|NCT02788201|38348162|FG002|Overall Study|Withdrawal by Subject|0|||
17194700|NCT02788201|38348163|FG003|Overall Study|Withdrawal by Subject|0|||
17194701|NCT02788201|38348164|FG004|Overall Study|Withdrawal by Subject|0|||
17194702|NCT02788201|38348165|FG005|Overall Study|Withdrawal by Subject|1|||
17194703|NCT02456740|38348184|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
17194704|NCT02456740|38348185|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
17194705|NCT02456740|38348186|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
17194706|NCT02456740|38348187|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
17194707|NCT02456740|38348188|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
17194708|NCT02456740|38348189|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
17194709|NCT02456740|38348190|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
17194710|NCT02456740|38348191|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
17194711|NCT02456740|38348192|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
17194712|NCT02456740|38348184|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
17194713|NCT02456740|38348185|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
17194714|NCT02456740|38348186|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
17194715|NCT02456740|38348187|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
17194716|NCT02456740|38348188|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
17194717|NCT02456740|38348189|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
17194718|NCT02456740|38348190|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
17194719|NCT02456740|38348191|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
17194720|NCT02456740|38348192|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
17194721|NCT02456740|38348184|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
17194722|NCT02456740|38348185|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
17194723|NCT02456740|38348186|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
17194724|NCT02456740|38348187|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
17098996|NCT00121134|38238048|FG001|Overall Study|Progression of Disease|3|||
17098997|NCT00121134|38238049|FG002|Overall Study|Progression of Disease|4|||
17098998|NCT00121134|38238050|FG003|Overall Study|Progression of Disease|2|||
17098999|NCT00121134|38238047|FG000|Overall Study|Toxicity|4|||
17099000|NCT00121134|38238048|FG001|Overall Study|Toxicity|7|||
17099001|NCT00121134|38238049|FG002|Overall Study|Toxicity|13|||
17099002|NCT00121134|38238050|FG003|Overall Study|Toxicity|5|||
17099003|NCT00121134|38238047|FG000|Overall Study|Physician Decision|6|||
17099004|NCT00121134|38238048|FG001|Overall Study|Physician Decision|4|||
17099005|NCT00121134|38238049|FG002|Overall Study|Physician Decision|4|||
17099006|NCT00121134|38238050|FG003|Overall Study|Physician Decision|1|||
17099007|NCT00121134|38238047|FG000|Overall Study|Treatment Delay|1|||
17099008|NCT00121134|38238048|FG001|Overall Study|Treatment Delay|0|||
17099009|NCT00121134|38238049|FG002|Overall Study|Treatment Delay|0|||
17099010|NCT00121134|38238050|FG003|Overall Study|Treatment Delay|0|||
17099011|NCT00121134|38238047|FG000|Overall Study|Intercurrent Illness|0|||
17099012|NCT00121134|38238048|FG001|Overall Study|Intercurrent Illness|0|||
17099013|NCT00121134|38238049|FG002|Overall Study|Intercurrent Illness|0|||
17099014|NCT00121134|38238050|FG003|Overall Study|Intercurrent Illness|1|||
17099015|NCT00121134|38238047|FG000|Overall Study|Patient Personal Reasons|0|||
17099016|NCT00121134|38238048|FG001|Overall Study|Patient Personal Reasons|1|||
17099017|NCT00121134|38238049|FG002|Overall Study|Patient Personal Reasons|0|||
17099018|NCT00121134|38238050|FG003|Overall Study|Patient Personal Reasons|0|||
17099019|NCT02657434|38238062|FG000|Overall Study|On-Going in Study|77|||
17099020|NCT02657434|38238063|FG001|Overall Study|On-Going in Study|91|||
17099021|NCT02657434|38238062|FG000|Overall Study|Death|177|||
17099022|NCT02657434|38238063|FG001|Overall Study|Death|183|||
17099023|NCT02657434|38238062|FG000|Overall Study|Lost to Follow-up|2|||
17099024|NCT02657434|38238063|FG001|Overall Study|Lost to Follow-up|2|||
17099025|NCT02657434|38238062|FG000|Overall Study|Randomization by Error|2|||
17099026|NCT02657434|38238063|FG001|Overall Study|Randomization by Error|0|||
17099027|NCT02657434|38238062|FG000|Overall Study|Withdrawal by Subject|27|||
17099028|NCT02657434|38238063|FG001|Overall Study|Withdrawal by Subject|16|||
17099029|NCT02657434|38238062|FG000|Overall Study|Protocol Violation|1|||
17099030|NCT02657434|38238063|FG001|Overall Study|Protocol Violation|0|||
17099031|NCT00119262|38238072|FG000|Overall Study|Lack of Efficacy|0|||
17099032|NCT00119262|38238073|FG001|Overall Study|Lack of Efficacy|3|||
17194725|NCT02456740|38348188|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
17194726|NCT02456740|38348189|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
17194727|NCT02456740|38348190|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
17194728|NCT02456740|38348191|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
17194729|NCT02456740|38348192|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
17194730|NCT02456740|38348184|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
17194731|NCT02456740|38348185|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
17194732|NCT02456740|38348186|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
17194733|NCT02456740|38348187|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
17194734|NCT02456740|38348188|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
17194735|NCT02456740|38348189|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
17194736|NCT02456740|38348190|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
17194737|NCT02456740|38348191|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
17194738|NCT02456740|38348192|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
17194739|NCT02456740|38348184|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
17194740|NCT02456740|38348185|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
17194741|NCT02456740|38348186|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
17194742|NCT02456740|38348187|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
17194743|NCT02456740|38348188|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
17194744|NCT02456740|38348189|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
17194745|NCT02456740|38348190|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
17194746|NCT02456740|38348191|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
17194747|NCT02456740|38348192|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
17194748|NCT02456740|38348184|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
17099033|NCT00119262|38238072|FG000|Overall Study|Withdrawal by Subject|12|||
17099034|NCT00119262|38238073|FG001|Overall Study|Withdrawal by Subject|11|||
17099035|NCT00119262|38238072|FG000|Overall Study|Adverse Event|33|||
17099036|NCT00119262|38238073|FG001|Overall Study|Adverse Event|35|||
17099037|NCT00119262|38238072|FG000|Overall Study|other disease|0|||
17099038|NCT00119262|38238073|FG001|Overall Study|other disease|2|||
17099039|NCT00119262|38238072|FG000|Overall Study|ineligble|1|||
17099040|NCT00119262|38238073|FG001|Overall Study|ineligble|2|||
17099041|NCT00119262|38238072|FG000|Overall Study|others|0|||
17099042|NCT00119262|38238073|FG001|Overall Study|others|5|||
17099043|NCT03703882|38238081|FG000|Overall Study|Adverse Event|1|||
17099044|NCT03703882|38238082|FG001|Overall Study|Adverse Event|0|||
17194749|NCT02456740|38348185|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
17194750|NCT02456740|38348186|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
17194751|NCT02456740|38348187|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
17194752|NCT02456740|38348188|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
17194753|NCT02456740|38348189|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
17194754|NCT02456740|38348190|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
17194755|NCT02456740|38348191|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
17194756|NCT02456740|38348192|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
17194757|NCT02456740|38348184|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
17194758|NCT02456740|38348185|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
17194759|NCT02456740|38348186|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
17194760|NCT02456740|38348187|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
17194761|NCT02456740|38348188|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
17194762|NCT02456740|38348189|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
17194763|NCT02456740|38348190|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
17194764|NCT02456740|38348191|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
17194765|NCT02456740|38348192|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
17194766|NCT02400580|38348204|FG000|Overall Study|Withdrawal by Subject|1|||
17194767|NCT02400580|38348205|FG001|Overall Study|Withdrawal by Subject|1|||
17194768|NCT02400580|38348204|FG000|Overall Study|Adverse Event|1|||
17194769|NCT02400580|38348205|FG001|Overall Study|Adverse Event|0|||
17194770|NCT01367119|38348213|FG000|Overall Study|Adverse Event|1|||
17194771|NCT01367119|38348214|FG001|Overall Study|Adverse Event|0|||
17194772|NCT01367119|38348213|FG000|Overall Study|Withdrawal by Subject|1|||
17194773|NCT01367119|38348214|FG001|Overall Study|Withdrawal by Subject|1|||
17194774|NCT02635724|38348223|FG000|Overall Study|Withdrawal by Subject|0|||
17194775|NCT02635724|38348224|FG001|Overall Study|Withdrawal by Subject|1|||
17194776|NCT02635724|38348225|FG002|Overall Study|Withdrawal by Subject|0|||
17194777|NCT02635646|38348235|FG000|Overall Study|Lost to Follow-up|24|||
17194778|NCT02635646|38348236|FG001|Overall Study|Lost to Follow-up|25|||
17099045|NCT03703882|38238081|FG000|Overall Study|Lost to Follow-up|0|||
17099046|NCT03703882|38238082|FG001|Overall Study|Lost to Follow-up|2|||
17099047|NCT03703882|38238081|FG000|Overall Study|Non-compliance with study drug|0|||
17194779|NCT02635646|38348235|FG000|Overall Study|Pregnancy|1|||
17194780|NCT02635646|38348236|FG001|Overall Study|Pregnancy|1|||
17194781|NCT00408005|38348250|FG000|Induction|Adverse Event|19|||
17194782|NCT00408005|38348251|FG001|Induction|Adverse Event|3|||
17194783|NCT00408005|38348252|FG002|Induction|Adverse Event|0|||
17194784|NCT00408005|38348253|FG003|Induction|Adverse Event|0|||
17194785|NCT00408005|38348254|FG004|Induction|Adverse Event|0|||
17194786|NCT00408005|38348255|FG005|Induction|Adverse Event|0|||
17194787|NCT00408005|38348256|FG006|Induction|Adverse Event|0|||
17194788|NCT00408005|38348257|FG007|Induction|Adverse Event|0|||
17194789|NCT00408005|38348250|FG000|Induction|Death|6|||
17194790|NCT00408005|38348251|FG001|Induction|Death|0|||
17194791|NCT00408005|38348252|FG002|Induction|Death|0|||
17194792|NCT00408005|38348253|FG003|Induction|Death|0|||
17194793|NCT00408005|38348254|FG004|Induction|Death|0|||
17194794|NCT00408005|38348255|FG005|Induction|Death|0|||
17194795|NCT00408005|38348256|FG006|Induction|Death|0|||
17194796|NCT00408005|38348257|FG007|Induction|Death|0|||
17194797|NCT00408005|38348250|FG000|Induction|Physician Decision|83|||
17194798|NCT00408005|38348251|FG001|Induction|Physician Decision|9|||
17194799|NCT00408005|38348252|FG002|Induction|Physician Decision|0|||
17194800|NCT00408005|38348253|FG003|Induction|Physician Decision|0|||
17194801|NCT00408005|38348254|FG004|Induction|Physician Decision|0|||
17194802|NCT00408005|38348255|FG005|Induction|Physician Decision|0|||
17194803|NCT00408005|38348256|FG006|Induction|Physician Decision|0|||
17194804|NCT00408005|38348257|FG007|Induction|Physician Decision|0|||
17194805|NCT00408005|38348250|FG000|Induction|Withdrawal by Subject|2|||
17194806|NCT00408005|38348251|FG001|Induction|Withdrawal by Subject|4|||
17194807|NCT00408005|38348252|FG002|Induction|Withdrawal by Subject|0|||
17194808|NCT00408005|38348253|FG003|Induction|Withdrawal by Subject|0|||
17194809|NCT00408005|38348254|FG004|Induction|Withdrawal by Subject|0|||
17194810|NCT00408005|38348255|FG005|Induction|Withdrawal by Subject|0|||
17194811|NCT00408005|38348256|FG006|Induction|Withdrawal by Subject|0|||
17194812|NCT00408005|38348257|FG007|Induction|Withdrawal by Subject|0|||
17194813|NCT00408005|38348250|FG000|Induction|Ineligible|33|||
17194814|NCT00408005|38348251|FG001|Induction|Ineligible|14|||
17099048|NCT03703882|38238082|FG001|Overall Study|Non-compliance with study drug|1|||
17099049|NCT03703882|38238081|FG000|Overall Study|Physician Decision|0|||
17099050|NCT03703882|38238082|FG001|Overall Study|Physician Decision|1|||
17099051|NCT03703882|38238081|FG000|Overall Study|Progressive disease|1|||
17099052|NCT03703882|38238082|FG001|Overall Study|Progressive disease|0|||
17099053|NCT03703882|38238081|FG000|Overall Study|Withdrawal by parent/guardian|1|||
17099054|NCT03703882|38238082|FG001|Overall Study|Withdrawal by parent/guardian|0|||
17099055|NCT03703882|38238081|FG000|Overall Study|Starting another treatment|0|||
17099056|NCT03703882|38238082|FG001|Overall Study|Starting another treatment|1|||
17099057|NCT03703882|38238081|FG000|Overall Study|noncompliance with study procedures|0|||
17099058|NCT03703882|38238082|FG001|Overall Study|noncompliance with study procedures|1|||
17099059|NCT00131664|38238091|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
17194815|NCT00408005|38348252|FG002|Induction|Ineligible|0|||
17194816|NCT00408005|38348253|FG003|Induction|Ineligible|0|||
17194817|NCT00408005|38348254|FG004|Induction|Ineligible|0|||
17194818|NCT00408005|38348255|FG005|Induction|Ineligible|0|||
17194819|NCT00408005|38348256|FG006|Induction|Ineligible|0|||
17194820|NCT00408005|38348257|FG007|Induction|Ineligible|0|||
17194821|NCT00408005|38348250|FG000|Induction|Refusal of Further Protocol Therapy|225|||
17194822|NCT00408005|38348251|FG001|Induction|Refusal of Further Protocol Therapy|44|||
17194823|NCT00408005|38348252|FG002|Induction|Refusal of Further Protocol Therapy|0|||
17194824|NCT00408005|38348253|FG003|Induction|Refusal of Further Protocol Therapy|0|||
17194825|NCT00408005|38348254|FG004|Induction|Refusal of Further Protocol Therapy|0|||
17194826|NCT00408005|38348255|FG005|Induction|Refusal of Further Protocol Therapy|0|||
17194827|NCT00408005|38348256|FG006|Induction|Refusal of Further Protocol Therapy|0|||
17194828|NCT00408005|38348257|FG007|Induction|Refusal of Further Protocol Therapy|0|||
17194829|NCT00408005|38348250|FG000|Induction|Entered another COG therapeutic protocol|4|||
17194830|NCT00408005|38348251|FG001|Induction|Entered another COG therapeutic protocol|0|||
17194831|NCT00408005|38348252|FG002|Induction|Entered another COG therapeutic protocol|0|||
17194832|NCT00408005|38348253|FG003|Induction|Entered another COG therapeutic protocol|0|||
17194833|NCT00408005|38348254|FG004|Induction|Entered another COG therapeutic protocol|0|||
17194834|NCT00408005|38348255|FG005|Induction|Entered another COG therapeutic protocol|0|||
17194835|NCT00408005|38348256|FG006|Induction|Entered another COG therapeutic protocol|0|||
17194836|NCT00408005|38348257|FG007|Induction|Entered another COG therapeutic protocol|0|||
17194837|NCT00408005|38348250|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
17194838|NCT00408005|38348251|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
17099060|NCT00131664|38238092|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
17099061|NCT00131664|38238093|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
17194839|NCT00408005|38348252|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
17194840|NCT00408005|38348253|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
17194841|NCT00408005|38348254|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
17194842|NCT00408005|38348255|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
17194843|NCT00408005|38348256|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
17194844|NCT00408005|38348257|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
17194845|NCT00408005|38348250|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
17194846|NCT00408005|38348251|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
17194847|NCT00408005|38348252|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
17194848|NCT00408005|38348253|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
17194849|NCT00408005|38348254|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
17194850|NCT00408005|38348255|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
17194851|NCT00408005|38348256|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
17194852|NCT00408005|38348257|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
17194853|NCT00408005|38348250|FG000|Induction|Progressive Disease|0|||
17194854|NCT00408005|38348251|FG001|Induction|Progressive Disease|1|||
17194855|NCT00408005|38348252|FG002|Induction|Progressive Disease|0|||
17194856|NCT00408005|38348253|FG003|Induction|Progressive Disease|0|||
17194857|NCT00408005|38348254|FG004|Induction|Progressive Disease|0|||
17194858|NCT00408005|38348255|FG005|Induction|Progressive Disease|0|||
17194859|NCT00408005|38348256|FG006|Induction|Progressive Disease|0|||
17194860|NCT00408005|38348257|FG007|Induction|Progressive Disease|0|||
17194861|NCT00408005|38348250|FG000|Induction|Inevaluable|18|||
17194862|NCT00408005|38348251|FG001|Induction|Inevaluable|14|||
17194863|NCT00408005|38348252|FG002|Induction|Inevaluable|0|||
17194864|NCT00408005|38348253|FG003|Induction|Inevaluable|0|||
17099062|NCT00131664|38238094|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
17099063|NCT00131664|38238095|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
17099064|NCT00131664|38238096|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
17099065|NCT00131664|38238091|FG000|First Period (First 6 Months)|Death|0|||
17099066|NCT00131664|38238092|FG001|First Period (First 6 Months)|Death|1|||
17099067|NCT00131664|38238093|FG002|First Period (First 6 Months)|Death|0|||
17099068|NCT00131664|38238094|FG003|First Period (First 6 Months)|Death|0|||
17099069|NCT00131664|38238095|FG004|First Period (First 6 Months)|Death|0|||
17099070|NCT00131664|38238096|FG005|First Period (First 6 Months)|Death|0|||
17099071|NCT00131664|38238091|FG000|First Period (First 6 Months)|Protocol Violation|2|||
17099072|NCT00131664|38238092|FG001|First Period (First 6 Months)|Protocol Violation|2|||
17099073|NCT00131664|38238093|FG002|First Period (First 6 Months)|Protocol Violation|1|||
17099074|NCT00131664|38238094|FG003|First Period (First 6 Months)|Protocol Violation|0|||
17099075|NCT00131664|38238095|FG004|First Period (First 6 Months)|Protocol Violation|0|||
17099076|NCT00131664|38238096|FG005|First Period (First 6 Months)|Protocol Violation|0|||
17099077|NCT00131664|38238091|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
17099078|NCT00131664|38238092|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
17099079|NCT00131664|38238093|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
17099080|NCT00131664|38238094|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
17099081|NCT00131664|38238095|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
17099082|NCT00131664|38238096|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
17194865|NCT00408005|38348254|FG004|Induction|Inevaluable|0|||
17194866|NCT00408005|38348255|FG005|Induction|Inevaluable|0|||
17099083|NCT00131664|38238091|FG000|First Period (First 6 Months)|Adverse Event|9|||
17099084|NCT00131664|38238092|FG001|First Period (First 6 Months)|Adverse Event|4|||
17099085|NCT00131664|38238093|FG002|First Period (First 6 Months)|Adverse Event|5|||
17099086|NCT00131664|38238094|FG003|First Period (First 6 Months)|Adverse Event|0|||
17099087|NCT00131664|38238095|FG004|First Period (First 6 Months)|Adverse Event|0|||
17099088|NCT00131664|38238096|FG005|First Period (First 6 Months)|Adverse Event|0|||
17099089|NCT00131664|38238091|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
17099090|NCT00131664|38238092|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
17099091|NCT00131664|38238093|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
17099092|NCT00131664|38238094|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
17099093|NCT00131664|38238095|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
17099094|NCT00131664|38238096|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
17099095|NCT00131664|38238091|FG000|First Period (First 6 Months)|Administrative reasons|2|||
17099096|NCT00131664|38238092|FG001|First Period (First 6 Months)|Administrative reasons|0|||
17099097|NCT00131664|38238093|FG002|First Period (First 6 Months)|Administrative reasons|5|||
17099098|NCT00131664|38238094|FG003|First Period (First 6 Months)|Administrative reasons|0|||
17099099|NCT00131664|38238095|FG004|First Period (First 6 Months)|Administrative reasons|0|||
17099100|NCT00131664|38238096|FG005|First Period (First 6 Months)|Administrative reasons|0|||
17099101|NCT00131664|38238091|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
17099102|NCT00131664|38238092|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
17099103|NCT00131664|38238093|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
17099104|NCT00131664|38238094|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
17099105|NCT00131664|38238095|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
17194867|NCT00408005|38348256|FG006|Induction|Inevaluable|0|||
17194868|NCT00408005|38348257|FG007|Induction|Inevaluable|0|||
17194869|NCT00408005|38348250|FG000|Induction|Failed to Complete Randomization|3|||
17194870|NCT00408005|38348251|FG001|Induction|Failed to Complete Randomization|2|||
17194871|NCT00408005|38348252|FG002|Induction|Failed to Complete Randomization|0|||
17194872|NCT00408005|38348253|FG003|Induction|Failed to Complete Randomization|0|||
17194873|NCT00408005|38348254|FG004|Induction|Failed to Complete Randomization|0|||
17194874|NCT00408005|38348255|FG005|Induction|Failed to Complete Randomization|0|||
17194875|NCT00408005|38348256|FG006|Induction|Failed to Complete Randomization|0|||
17194876|NCT00408005|38348257|FG007|Induction|Failed to Complete Randomization|0|||
17194877|NCT00408005|38348250|FG000|Induction|Protocol Deviation|3|||
17194878|NCT00408005|38348251|FG001|Induction|Protocol Deviation|1|||
17194879|NCT00408005|38348252|FG002|Induction|Protocol Deviation|0|||
17194880|NCT00408005|38348253|FG003|Induction|Protocol Deviation|0|||
17194881|NCT00408005|38348254|FG004|Induction|Protocol Deviation|0|||
17194882|NCT00408005|38348255|FG005|Induction|Protocol Deviation|0|||
17194883|NCT00408005|38348256|FG006|Induction|Protocol Deviation|0|||
17194884|NCT00408005|38348257|FG007|Induction|Protocol Deviation|0|||
17194885|NCT00408005|38348250|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
17194886|NCT00408005|38348251|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
17194887|NCT00408005|38348252|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
17194888|NCT00408005|38348253|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
17194889|NCT00408005|38348254|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
17194890|NCT00408005|38348255|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
17014825|NCT00810069|38159630|FG001|Double-Blind Period II|Physician Decision|0|||
17014826|NCT00810069|38159631|FG002|Double-Blind Period II|Physician Decision|1|||
17014827|NCT00810069|38159629|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
17014828|NCT00810069|38159630|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
17194891|NCT00408005|38348256|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
17194892|NCT00408005|38348257|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
17194893|NCT00408005|38348250|FG000|Induction|Recurrent leukemia|1|||
17194894|NCT00408005|38348251|FG001|Induction|Recurrent leukemia|0|||
17194895|NCT00408005|38348252|FG002|Induction|Recurrent leukemia|0|||
17194896|NCT00408005|38348253|FG003|Induction|Recurrent leukemia|0|||
17194897|NCT00408005|38348254|FG004|Induction|Recurrent leukemia|0|||
17194898|NCT00408005|38348255|FG005|Induction|Recurrent leukemia|0|||
17194899|NCT00408005|38348256|FG006|Induction|Recurrent leukemia|0|||
17194900|NCT00408005|38348257|FG007|Induction|Recurrent leukemia|0|||
17194901|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
17194902|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
17194903|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
17194904|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
17194905|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
17194906|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
17194907|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
17194908|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
17194909|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
17194910|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
17194911|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
17194912|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
17194913|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
17194914|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
17194915|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
17194916|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
17194917|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
17194918|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
17194919|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
17194920|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
17194921|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
17194922|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
17194923|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
17194924|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
17194925|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
17194926|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
17194927|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
17014829|NCT00810069|38159631|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
17014830|NCT00810069|38159629|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
17014831|NCT00810069|38159630|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
17014832|NCT00810069|38159631|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
17014833|NCT00810069|38159629|FG000|Double-Blind Period II|Clinical relapse|0|||
17014834|NCT00810069|38159630|FG001|Double-Blind Period II|Clinical relapse|3|||
17014835|NCT00810069|38159631|FG002|Double-Blind Period II|Clinical relapse|0|||
17194928|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
17194929|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
17194930|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
17194931|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
17194932|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
17194933|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
17194934|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
17194935|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
17194936|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
17194937|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
17194938|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
17194939|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
17194940|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
17194941|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
17194942|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
17194943|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
17194944|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
17194945|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
17194946|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
17194947|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
17194948|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
17194949|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
17194950|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
17194951|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
17194952|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
17194953|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
17194954|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
17194955|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
17194956|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
17194957|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
17194958|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
17194959|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
17194960|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
17194961|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
17194962|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
17194963|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
17194964|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
17194965|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
17194966|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
17194967|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
17194968|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
17194969|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
17194970|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
17194971|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
17194972|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
17194973|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
17194974|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
17194975|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
17194976|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
17194977|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
17194978|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
17194979|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
17194980|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
17194981|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
17194982|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
17194983|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
17194984|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
17194985|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
17194986|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
17194987|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
17194988|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
17194989|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
17194990|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
17194991|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
17194992|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
17194993|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
17194994|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
17194995|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
17194996|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
17194997|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
17194998|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
17194999|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
17195000|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
17195001|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
17195002|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
17195003|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
17195004|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
17195005|NCT00408005|38348250|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
17195006|NCT00408005|38348251|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
17195007|NCT00408005|38348252|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
17195008|NCT00408005|38348253|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
17195009|NCT00408005|38348254|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
17195010|NCT00408005|38348255|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
17195011|NCT00408005|38348256|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
17195012|NCT00408005|38348257|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
17195013|NCT02634788|38348281|FG000|Overall Study|Adverse Event|0|||
17195014|NCT02634788|38348282|FG001|Overall Study|Adverse Event|8|||
17195015|NCT02634788|38348283|FG002|Overall Study|Adverse Event|3|||
17195016|NCT02634788|38348284|FG003|Overall Study|Adverse Event|1|||
17195017|NCT02634788|38348281|FG000|Overall Study|Lack of Efficacy|4|||
17195018|NCT02634788|38348282|FG001|Overall Study|Lack of Efficacy|0|||
17195019|NCT02634788|38348283|FG002|Overall Study|Lack of Efficacy|1|||
17195020|NCT02634788|38348284|FG003|Overall Study|Lack of Efficacy|4|||
17099106|NCT00131664|38238096|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
17099107|NCT00131664|38238091|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
17195021|NCT02634788|38348281|FG000|Overall Study|Lost to Follow-up|0|||
17195022|NCT02634788|38348282|FG001|Overall Study|Lost to Follow-up|1|||
17195023|NCT02634788|38348283|FG002|Overall Study|Lost to Follow-up|0|||
17195024|NCT02634788|38348284|FG003|Overall Study|Lost to Follow-up|0|||
17195025|NCT02634788|38348281|FG000|Overall Study|Withdrawal by Subject|0|||
17195026|NCT02634788|38348282|FG001|Overall Study|Withdrawal by Subject|1|||
17195027|NCT02634788|38348283|FG002|Overall Study|Withdrawal by Subject|1|||
17099108|NCT00131664|38238092|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
17099109|NCT00131664|38238093|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
17099110|NCT00131664|38238094|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
17099111|NCT00131664|38238095|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
17099112|NCT00131664|38238096|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
17099113|NCT00131664|38238091|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
17099114|NCT00131664|38238092|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
17099115|NCT00131664|38238093|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
17099116|NCT00131664|38238094|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
17099117|NCT00131664|38238095|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
17099118|NCT00131664|38238096|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
17099119|NCT00131664|38238091|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
17099120|NCT00131664|38238092|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
17099121|NCT00131664|38238093|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
17099122|NCT00131664|38238094|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
17099123|NCT00131664|38238095|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
17099124|NCT00131664|38238096|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
17099125|NCT00131664|38238091|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
17099126|NCT00131664|38238092|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
17099127|NCT00131664|38238093|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
17195028|NCT02634788|38348284|FG003|Overall Study|Withdrawal by Subject|0|||
17195029|NCT02785939|38348296|FG000|Overall Study|Progression|25|||
17195030|NCT02785939|38348297|FG001|Overall Study|Progression|8|||
17195031|NCT02785939|38348296|FG000|Overall Study|Adverse Event|3|||
17195032|NCT02785939|38348297|FG001|Overall Study|Adverse Event|1|||
17195033|NCT02785939|38348296|FG000|Overall Study|Death|1|||
17195034|NCT02785939|38348297|FG001|Overall Study|Death|0|||
17195035|NCT02785939|38348296|FG000|Overall Study|Refusal|1|||
17195036|NCT02785939|38348297|FG001|Overall Study|Refusal|0|||
17195037|NCT02785939|38348296|FG000|Overall Study|Deteriorating health|1|||
17195038|NCT02785939|38348297|FG001|Overall Study|Deteriorating health|0|||
17195039|NCT02785939|38348296|FG000|Overall Study|Not protocol specified|0|||
17195040|NCT02785939|38348297|FG001|Overall Study|Not protocol specified|1|||
17195041|NCT02634320|38348311|FG000|Overall Study|Adverse Event|2|||
17195042|NCT02634320|38348311|FG000|Overall Study|Lost to Follow-up|3|||
17195043|NCT02634320|38348311|FG000|Overall Study|Moved out of area|2|||
17195044|NCT02634320|38348311|FG000|Overall Study|Out of window for study visits|1|||
17195045|NCT02634320|38348311|FG000|Overall Study|Protocol Violation|1|||
17195046|NCT02634320|38348311|FG000|Overall Study|Withdrawal by Subject|5|||
17195047|NCT02634320|38348311|FG000|Overall Study|Lack of Efficacy|2|||
17195048|NCT02435680|38348318|FG000|Overall Study|Physician Decision|3|||
17195049|NCT02435680|38348319|FG001|Overall Study|Physician Decision|0|||
17195050|NCT02435680|38348320|FG002|Overall Study|Physician Decision|0|||
17195051|NCT02435680|38348318|FG000|Overall Study|subject / guardian decision|0|||
17195052|NCT02435680|38348319|FG001|Overall Study|subject / guardian decision|3|||
17195053|NCT02435680|38348320|FG002|Overall Study|subject / guardian decision|2|||
17195054|NCT02435680|38348318|FG000|Overall Study|Adverse Event|8|||
17195055|NCT02435680|38348319|FG001|Overall Study|Adverse Event|3|||
17195056|NCT02435680|38348320|FG002|Overall Study|Adverse Event|2|||
17195057|NCT02435680|38348318|FG000|Overall Study|progressive disease|10|||
17195058|NCT02435680|38348319|FG001|Overall Study|progressive disease|7|||
17195059|NCT02435680|38348320|FG002|Overall Study|progressive disease|11|||
17195060|NCT02435680|38348318|FG000|Overall Study|not treated|0|||
17195061|NCT02435680|38348319|FG001|Overall Study|not treated|0|||
17195062|NCT02435680|38348320|FG002|Overall Study|not treated|1|||
17195063|NCT03371732|38348334|FG000|Overall Study|Withdrawal by Subject|9|||
17195064|NCT03371732|38348335|FG001|Overall Study|Withdrawal by Subject|3|||
17195065|NCT03371732|38348334|FG000|Overall Study|Refusal to continue|3|||
17195066|NCT03371732|38348335|FG001|Overall Study|Refusal to continue|4|||
17195067|NCT02745119|38348347|FG000|Overall Study|Adverse Event|1|||
17195068|NCT02745119|38348348|FG001|Overall Study|Adverse Event|0|||
17195069|NCT02745119|38348349|FG002|Overall Study|Adverse Event|1|||
17195070|NCT02745119|38348350|FG003|Overall Study|Adverse Event|3|||
17195071|NCT02745119|38348347|FG000|Overall Study|Death|3|||
17195072|NCT02745119|38348348|FG001|Overall Study|Death|3|||
17195073|NCT02745119|38348349|FG002|Overall Study|Death|0|||
17195074|NCT02745119|38348350|FG003|Overall Study|Death|4|||
17195075|NCT02745119|38348347|FG000|Overall Study|Lost to Follow-up|0|||
17195076|NCT02745119|38348348|FG001|Overall Study|Lost to Follow-up|0|||
17195077|NCT02745119|38348349|FG002|Overall Study|Lost to Follow-up|0|||
17195078|NCT02745119|38348350|FG003|Overall Study|Lost to Follow-up|1|||
17195079|NCT02745119|38348347|FG000|Overall Study|Protocol Deviation|0|||
17195080|NCT02745119|38348348|FG001|Overall Study|Protocol Deviation|0|||
17195081|NCT02745119|38348349|FG002|Overall Study|Protocol Deviation|0|||
17195082|NCT02745119|38348350|FG003|Overall Study|Protocol Deviation|1|||
17195083|NCT02745119|38348347|FG000|Overall Study|Withdrawal by Subject|7|||
17195084|NCT02745119|38348348|FG001|Overall Study|Withdrawal by Subject|15|||
17195085|NCT02745119|38348349|FG002|Overall Study|Withdrawal by Subject|8|||
17195086|NCT02745119|38348350|FG003|Overall Study|Withdrawal by Subject|14|||
17195087|NCT02745119|38348347|FG000|Overall Study|Study Terminated by Sponsor|134|||
17195088|NCT02745119|38348348|FG001|Overall Study|Study Terminated by Sponsor|252|||
17195089|NCT02745119|38348349|FG002|Overall Study|Study Terminated by Sponsor|135|||
17195090|NCT02745119|38348350|FG003|Overall Study|Study Terminated by Sponsor|251|||
17195091|NCT02745119|38348347|FG000|Overall Study|Physician Decision|0|||
17195092|NCT02745119|38348348|FG001|Overall Study|Physician Decision|2|||
17195093|NCT02745119|38348349|FG002|Overall Study|Physician Decision|2|||
17195094|NCT02745119|38348350|FG003|Overall Study|Physician Decision|2|||
17195095|NCT02745119|38348347|FG000|Overall Study|Reason Not Specified|0|||
17195096|NCT02745119|38348348|FG001|Overall Study|Reason Not Specified|2|||
17014836|NCT00810069|38159629|FG000|Double-Blind Period II|Protocol Violation|0|||
17014837|NCT00810069|38159630|FG001|Double-Blind Period II|Protocol Violation|7|||
17014838|NCT00810069|38159631|FG002|Double-Blind Period II|Protocol Violation|6|||
17014839|NCT00489541|38159642|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
17014840|NCT00489541|38159643|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
17014841|NCT00489541|38159642|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
17014842|NCT00489541|38159643|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
17014843|NCT00489541|38159642|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
17014844|NCT00489541|38159643|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
17195097|NCT02745119|38348349|FG002|Overall Study|Reason Not Specified|0|||
17195098|NCT02745119|38348350|FG003|Overall Study|Reason Not Specified|1|||
17195099|NCT01367665|38348364|FG000|Overall Study|Death|102|||
17195100|NCT01367665|38348365|FG001|Overall Study|Death|19|||
17195101|NCT01367665|38348364|FG000|Overall Study|Lost to Follow-up|222|||
17195102|NCT01367665|38348365|FG001|Overall Study|Lost to Follow-up|22|||
17195103|NCT01367665|38348364|FG000|Overall Study|Not Done|118|||
17195104|NCT01367665|38348365|FG001|Overall Study|Not Done|14|||
17195105|NCT02576847|38348372|FG000|Overall Study|Adverse Event|27|||
17195106|NCT02576847|38348372|FG000|Overall Study|Lost to Follow-up|22|||
17099128|NCT00131664|38238094|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
17099129|NCT00131664|38238095|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
17099130|NCT00131664|38238096|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
17099131|NCT00131664|38238091|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
17195107|NCT02576847|38348372|FG000|Overall Study|Physician Decision|1|||
17195108|NCT02576847|38348372|FG000|Overall Study|Pregnancy|1|||
17195109|NCT02576847|38348372|FG000|Overall Study|Protocol Violation|3|||
17195110|NCT02576847|38348372|FG000|Overall Study|Withdrawal by Subject|78|||
17099132|NCT00131664|38238092|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
17099133|NCT00131664|38238093|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
17099134|NCT00131664|38238094|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
17099135|NCT00131664|38238095|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
17099136|NCT00131664|38238096|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
17099137|NCT00131508|38238109|FG000|Overall Study|Disease progression|0|||
17195111|NCT02576847|38348372|FG000|Overall Study|Other|5|||
17195112|NCT02135029|38348388|FG000|Overall Study|Adverse Event|2|||
17195113|NCT02135029|38348389|FG001|Overall Study|Adverse Event|2|||
17195114|NCT02135029|38348390|FG002|Overall Study|Adverse Event|2|||
17195115|NCT02135029|38348388|FG000|Overall Study|Lost to Follow-up|0|||
17195116|NCT02135029|38348389|FG001|Overall Study|Lost to Follow-up|1|||
17195117|NCT02135029|38348390|FG002|Overall Study|Lost to Follow-up|0|||
17195118|NCT02135029|38348388|FG000|Overall Study|Withdrawal by Subject|2|||
17195119|NCT02135029|38348389|FG001|Overall Study|Withdrawal by Subject|0|||
17195120|NCT02135029|38348390|FG002|Overall Study|Withdrawal by Subject|1|||
17195121|NCT02135029|38348388|FG000|Overall Study|Other|0|||
17195122|NCT02135029|38348389|FG001|Overall Study|Other|1|||
17195123|NCT02135029|38348390|FG002|Overall Study|Other|0|||
17195124|NCT02135029|38348388|FG000|Overall Study|Death|0|||
17195125|NCT02135029|38348389|FG001|Overall Study|Death|1|||
17195126|NCT02135029|38348390|FG002|Overall Study|Death|0|||
17195127|NCT02842151|38348399|FG000|Overall Study|Adverse Event|1|||
17195128|NCT02842151|38348399|FG000|Overall Study|Subject moved too far away|1|||
17195129|NCT02842073|38348405|FG000|Overall Study|Withdrawal by Subject|1|||
17099138|NCT00131508|38238110|FG001|Overall Study|Disease progression|2|||
17195130|NCT02784535|38348409|FG000|Overall Study|Adverse Event|1|||
17195131|NCT02784535|38348410|FG001|Overall Study|Adverse Event|0|||
17195132|NCT02784535|38348409|FG000|Overall Study|Withdrawal by Subject|0|||
17195133|NCT02784535|38348410|FG001|Overall Study|Withdrawal by Subject|1|||
17195134|NCT02784535|38348409|FG000|Overall Study|Physician Decision|0|||
17195135|NCT02784535|38348410|FG001|Overall Study|Physician Decision|1|||
17195136|NCT01367275|38348419|FG000|Overall Study|Ineligible|1|||
17195137|NCT01367275|38348419|FG000|Overall Study|Disease Progression|2|||
17195138|NCT02842853|38348427|FG000|Overall Study|Non-compliance with the protocol|3|||
17195139|NCT02842853|38348428|FG001|Overall Study|Non-compliance with the protocol|7|||
17195140|NCT02842853|38348429|FG002|Overall Study|Non-compliance with the protocol|2|||
17195141|NCT02842853|38348430|FG003|Overall Study|Non-compliance with the protocol|5|||
17195142|NCT02842853|38348427|FG000|Overall Study|Subject met exclusion criteria|0|||
17195143|NCT02842853|38348428|FG001|Overall Study|Subject met exclusion criteria|1|||
17195144|NCT02842853|38348429|FG002|Overall Study|Subject met exclusion criteria|0|||
17195145|NCT02842853|38348430|FG003|Overall Study|Subject met exclusion criteria|0|||
17195146|NCT02842853|38348427|FG000|Overall Study|Withdrawal by Subject|11|||
17195147|NCT02842853|38348428|FG001|Overall Study|Withdrawal by Subject|13|||
17195148|NCT02842853|38348429|FG002|Overall Study|Withdrawal by Subject|9|||
17195149|NCT02842853|38348430|FG003|Overall Study|Withdrawal by Subject|8|||
17195150|NCT02842853|38348427|FG000|Overall Study|Lost to Follow-up|9|||
17195151|NCT02842853|38348428|FG001|Overall Study|Lost to Follow-up|13|||
17195152|NCT02842853|38348429|FG002|Overall Study|Lost to Follow-up|10|||
17195153|NCT02842853|38348430|FG003|Overall Study|Lost to Follow-up|11|||
17195154|NCT02433340|38348446|FG000|Overall Study|Adverse Event|0|||
17195155|NCT02433340|38348447|FG001|Overall Study|Adverse Event|0|||
17195156|NCT02433340|38348448|FG002|Overall Study|Adverse Event|1|||
17195157|NCT02433340|38348449|FG003|Overall Study|Adverse Event|0|||
17195158|NCT02433340|38348446|FG000|Overall Study|Withdrawal by Subject|1|||
17195159|NCT02433340|38348447|FG001|Overall Study|Withdrawal by Subject|0|||
17195160|NCT02433340|38348448|FG002|Overall Study|Withdrawal by Subject|1|||
17195161|NCT02433340|38348449|FG003|Overall Study|Withdrawal by Subject|2|||
17195162|NCT02433340|38348446|FG000|Overall Study|Lost to Follow-up|0|||
17195163|NCT02433340|38348447|FG001|Overall Study|Lost to Follow-up|1|||
17195164|NCT02433340|38348448|FG002|Overall Study|Lost to Follow-up|0|||
17195165|NCT02433340|38348449|FG003|Overall Study|Lost to Follow-up|0|||
17195166|NCT02433340|38348446|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
17195167|NCT02433340|38348447|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
17195168|NCT02433340|38348448|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
17195169|NCT02433340|38348449|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
17195170|NCT02433340|38348446|FG000|Overall Study|Other|0|||
17195171|NCT02433340|38348447|FG001|Overall Study|Other|1|||
17195172|NCT02433340|38348448|FG002|Overall Study|Other|0|||
17014845|NCT00489541|38159642|FG000|12-Month Clinical Follow-up|Death|3|||
17014846|NCT00489541|38159643|FG001|12-Month Clinical Follow-up|Death|2|||
17099139|NCT00131508|38238109|FG000|Overall Study|Non-Compliance|2|||
17099140|NCT00131508|38238110|FG001|Overall Study|Non-Compliance|4|||
17099141|NCT00131508|38238109|FG000|Overall Study|Withdrawal by Subject|1|||
17099142|NCT00131508|38238110|FG001|Overall Study|Withdrawal by Subject|2|||
17099143|NCT05050318|38238119|FG000|Overall Study|Protocol Deviation|1|||
17099144|NCT05050318|38238120|FG001|Overall Study|Protocol Deviation|0|||
17099145|NCT05050318|38238121|FG002|Overall Study|Protocol Deviation|0|||
17099146|NCT03699124|38238132|FG000|Overall Study|Adverse Event|6|||
17099147|NCT03699124|38238133|FG001|Overall Study|Adverse Event|5|||
17099148|NCT03699124|38238134|FG002|Overall Study|Adverse Event|2|||
17099149|NCT03699124|38238132|FG000|Overall Study|Death|0|||
17099150|NCT03699124|38238133|FG001|Overall Study|Death|2|||
17099151|NCT03699124|38238134|FG002|Overall Study|Death|0|||
17099152|NCT03699124|38238132|FG000|Overall Study|Lost to Follow-up|20|||
17099153|NCT03699124|38238133|FG001|Overall Study|Lost to Follow-up|16|||
17099154|NCT03699124|38238134|FG002|Overall Study|Lost to Follow-up|15|||
17099155|NCT03699124|38238132|FG000|Overall Study|Protocol Violation|1|||
17099156|NCT03699124|38238133|FG001|Overall Study|Protocol Violation|0|||
17099157|NCT03699124|38238134|FG002|Overall Study|Protocol Violation|0|||
17099158|NCT03699124|38238132|FG000|Overall Study|Withdrawal by Subject|13|||
17099159|NCT03699124|38238133|FG001|Overall Study|Withdrawal by Subject|14|||
17099160|NCT03699124|38238134|FG002|Overall Study|Withdrawal by Subject|13|||
17099161|NCT03699124|38238132|FG000|Overall Study|Other reasons|5|||
17099162|NCT03699124|38238133|FG001|Overall Study|Other reasons|3|||
17099163|NCT03699124|38238134|FG002|Overall Study|Other reasons|10|||
17099164|NCT05002972|38238142|FG000|Overall Study|Withdrawal by Subject|2|||
17099165|NCT04651114|38238146|FG000|Overall Study|Withdrawal by Subject|8|||
17099166|NCT04980040|38238150|FG000|Overall Study|Violated the Inclusion Criteria|260|||
17099167|NCT04980040|38238150|FG000|Overall Study|Violated the Administration & Dosage|225|||
17099168|NCT04980040|38238150|FG000|Overall Study|Lost to Safety-Follow-up|4|||
17099169|NCT04980040|38238150|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
17099170|NCT00131352|38238156|FG000|Initial Treatment Period|Adverse Event|1|||
17099171|NCT00131352|38238157|FG001|Initial Treatment Period|Adverse Event|3|||
17099172|NCT00131352|38238156|FG000|Initial Treatment Period|Non-compliant|1|||
17099173|NCT00131352|38238157|FG001|Initial Treatment Period|Non-compliant|2|||
17099174|NCT00131352|38238156|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
17099175|NCT00131352|38238157|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
17099176|NCT00131352|38238156|FG000|Initial Treatment Period|Lack of Efficacy|6|||
17099177|NCT00131352|38238157|FG001|Initial Treatment Period|Lack of Efficacy|4|||
17014847|NCT00489541|38159642|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
17014848|NCT00489541|38159643|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
17014849|NCT00489541|38159642|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
17014850|NCT00489541|38159643|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
17014851|NCT00809835|38159653|FG000|Overall Study|Lost to Follow-up|7|||
17014852|NCT00809835|38159654|FG001|Overall Study|Lost to Follow-up|6|||
17014853|NCT00809835|38159655|FG002|Overall Study|Lost to Follow-up|10|||
17014854|NCT00809835|38159656|FG003|Overall Study|Lost to Follow-up|2|||
17099178|NCT00131352|38238156|FG000|Initial Treatment Period|Other|0|||
17099179|NCT00131352|38238157|FG001|Initial Treatment Period|Other|2|||
17099180|NCT00131352|38238156|FG000|Repeat Treatment Period|Adverse Event|1|||
17099181|NCT00131352|38238157|FG001|Repeat Treatment Period|Adverse Event|0|||
17099182|NCT00131352|38238156|FG000|Repeat Treatment Period|Other|1|||
17099183|NCT00131352|38238157|FG001|Repeat Treatment Period|Other|0|||
17099184|NCT04633642|38238167|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
17099185|NCT04633642|38238168|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
17099186|NCT00136916|38238176|FG000|Overall Study|Never received study treatment|3|||
17099187|NCT00136916|38238177|FG001|Overall Study|Never received study treatment|5|||
17099188|NCT00136916|38238176|FG000|Overall Study|Death|1|||
17099189|NCT00136916|38238177|FG001|Overall Study|Death|3|||
17099190|NCT00136916|38238176|FG000|Overall Study|Adverse Event|27|||
17099191|NCT00136916|38238177|FG001|Overall Study|Adverse Event|8|||
17099192|NCT00136916|38238176|FG000|Overall Study|Laboratory abnormality|0|||
16786326|NCT02679079|37726743|FG001|Overall Study|Adverse Event|0|||
17099193|NCT00136916|38238177|FG001|Overall Study|Laboratory abnormality|1|||
17099194|NCT00136916|38238176|FG000|Overall Study|Lack of Efficacy|13|||
17099195|NCT00136916|38238177|FG001|Overall Study|Lack of Efficacy|3|||
17099196|NCT00136916|38238176|FG000|Overall Study|Lost to Follow-up|12|||
17099197|NCT00136916|38238177|FG001|Overall Study|Lost to Follow-up|14|||
17099198|NCT00136916|38238176|FG000|Overall Study|Withdrawal by Subject|44|||
17099199|NCT00136916|38238177|FG001|Overall Study|Withdrawal by Subject|46|||
17099200|NCT00136916|38238176|FG000|Overall Study|Other|22|||
17099201|NCT00136916|38238177|FG001|Overall Study|Other|24|||
17099202|NCT00136916|38238176|FG000|Overall Study|Discontinued in follow up period|3|||
17099203|NCT00136916|38238177|FG001|Overall Study|Discontinued in follow up period|0|||
17099204|NCT04633564|38238187|FG000|Period 1|Adverse Event|28|||
17099205|NCT04633564|38238188|FG001|Period 1|Adverse Event|19|||
17099206|NCT04633564|38238187|FG000|Period 1|Death|8|||
17099207|NCT04633564|38238188|FG001|Period 1|Death|7|||
17099208|NCT04633564|38238187|FG000|Period 1|Lost to Follow-up|3|||
17099209|NCT04633564|38238188|FG001|Period 1|Lost to Follow-up|5|||
17099210|NCT04633564|38238187|FG000|Period 1|Physician Decision|4|||
17099211|NCT04633564|38238188|FG001|Period 1|Physician Decision|12|||
17099212|NCT04633564|38238187|FG000|Period 1|Protocol Violation|0|||
17195173|NCT02433340|38348449|FG003|Overall Study|Other|0|||
17195174|NCT02400346|38348461|FG000|Overall Study|Adverse Event|24|||
17195175|NCT02400346|38348461|FG000|Overall Study|Lack of Efficacy|9|||
17195176|NCT02400346|38348461|FG000|Overall Study|Non-compliance with IMP|1|||
17195177|NCT02400346|38348461|FG000|Overall Study|Withdrawal by Subject|7|||
17195178|NCT02400346|38348461|FG000|Overall Study|Administrative or other reason(s)|2|||
17195179|NCT02400346|38348461|FG000|Overall Study|Lost to Follow-up|1|||
17195180|NCT02399254|38348465|FG000|Overall Study|Physician Decision|2|||
17195181|NCT02456662|38348472|FG000|Overall Study|Lost to Follow-up|2|||
17195182|NCT02456662|38348473|FG001|Overall Study|Lost to Follow-up|1|||
17195183|NCT01653262|38348479|FG000|Overall Study|Lack of Efficacy|1|||
17195184|NCT01653262|38348479|FG000|Overall Study|SAE, non-fatal|1|||
17195185|NCT01653262|38348479|FG000|Overall Study|AE, non-serious non-fatal|1|||
17195186|NCT02455336|38348485|FG000|Overall Study|Withdrawal by Subject|0|||
17195187|NCT02455336|38348486|FG001|Overall Study|Withdrawal by Subject|2|||
17195188|NCT02455336|38348485|FG000|Overall Study|Adverse Event|3|||
17195189|NCT02455336|38348486|FG001|Overall Study|Adverse Event|0|||
17195190|NCT02455336|38348485|FG000|Overall Study|Non-responder to treatment|2|||
17195191|NCT02455336|38348486|FG001|Overall Study|Non-responder to treatment|0|||
17195192|NCT02397694|38348494|FG000|Double-Blinded Phase|Adverse Event|1|||
17195193|NCT02397694|38348495|FG001|Double-Blinded Phase|Adverse Event|0|||
17195194|NCT02397694|38348494|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
17195195|NCT02397694|38348495|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
17195196|NCT02397694|38348494|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
17195197|NCT02397694|38348495|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
17195198|NCT02397694|38348494|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
17195199|NCT02397694|38348495|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
17195200|NCT02397694|38348494|FG000|Open Label Extension Phase|Protocol Violation|1|||
17195201|NCT02397694|38348495|FG001|Open Label Extension Phase|Protocol Violation|0|||
17195202|NCT02397694|38348494|FG000|Open Label Extension Phase|Withdrew Consent|3|||
17195203|NCT02397694|38348495|FG001|Open Label Extension Phase|Withdrew Consent|1|||
17195204|NCT02397694|38348494|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
17195205|NCT02397694|38348495|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
17195206|NCT02783599|38348505|FG000|Overall Study|Progressive disease|23|||
17195207|NCT02783599|38348505|FG000|Overall Study|Surgical Resection|10|||
17195208|NCT02783599|38348505|FG000|Overall Study|Adverse Event|4|||
17195209|NCT02783599|38348505|FG000|Overall Study|Physician Decision|2|||
17099213|NCT04633564|38238188|FG001|Period 1|Protocol Violation|1|||
17099214|NCT04633564|38238187|FG000|Period 1|Withdrawal by Subject|10|||
17099215|NCT04633564|38238188|FG001|Period 1|Withdrawal by Subject|8|||
17099216|NCT04633564|38238187|FG000|Period 1|Progressive disease|47|||
17099217|NCT04633564|38238188|FG001|Period 1|Progressive disease|51|||
17099218|NCT04633564|38238187|FG000|Period 1|Terminated by Sponsor|8|||
17099219|NCT04633564|38238188|FG001|Period 1|Terminated by Sponsor|6|||
17099220|NCT04633564|38238187|FG000|Period 2|Adverse Event|3|||
17099221|NCT04633564|38238188|FG001|Period 2|Adverse Event|4|||
17099222|NCT04633564|38238187|FG000|Period 2|Death|0|||
17195210|NCT02783599|38348505|FG000|Overall Study|Death|1|||
17195211|NCT02838017|38348518|FG000|Overall Study|Lost to Follow-up|14|||
17099223|NCT04633564|38238188|FG001|Period 2|Death|2|||
17099224|NCT04633564|38238187|FG000|Period 2|Lost to Follow-up|0|||
17099225|NCT04633564|38238188|FG001|Period 2|Lost to Follow-up|1|||
17195212|NCT02838017|38348519|FG001|Overall Study|Lost to Follow-up|11|||
17195213|NCT03188666|38348527|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
17195214|NCT03188666|38348528|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
17195215|NCT03188666|38348529|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
17099226|NCT04633564|38238187|FG000|Period 2|Physician Decision|2|||
17099227|NCT04633564|38238188|FG001|Period 2|Physician Decision|4|||
17099228|NCT04633564|38238187|FG000|Period 2|Withdrawal by Subject|5|||
17099229|NCT04633564|38238188|FG001|Period 2|Withdrawal by Subject|1|||
17099230|NCT04633564|38238187|FG000|Period 2|Progressive Disease|74|||
17099231|NCT04633564|38238188|FG001|Period 2|Progressive Disease|82|||
17195216|NCT03188666|38348530|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
17195217|NCT03188666|38348527|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
17195218|NCT03188666|38348528|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
17195219|NCT03188666|38348529|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
17195220|NCT03188666|38348530|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
17195221|NCT03188666|38348527|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
17195222|NCT03188666|38348528|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
17195223|NCT03188666|38348529|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
17195224|NCT03188666|38348530|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
17195225|NCT03188666|38348527|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
17195226|NCT03188666|38348528|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
17195227|NCT03188666|38348529|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
17195228|NCT03188666|38348530|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
17195229|NCT02836769|38348544|FG000|Overall Study|Lost to Follow-up|10|||
17195230|NCT02836769|38348544|FG000|Overall Study|Medical withdrawal|2|||
17195231|NCT02836769|38348544|FG000|Overall Study|Withdrawal by Subject|3|||
17195232|NCT02836613|38348550|FG000|Overall Study|Accidental drowning|1|||
17195233|NCT02836613|38348551|FG001|Overall Study|Accidental drowning|0|||
17195234|NCT02836613|38348550|FG000|Overall Study|Lost to Follow-up|0|||
17195235|NCT02836613|38348551|FG001|Overall Study|Lost to Follow-up|1|||
17099232|NCT04633564|38238187|FG000|Period 2|Terminated by Sponsor|9|||
17099233|NCT04633564|38238188|FG001|Period 2|Terminated by Sponsor|3|||
17099234|NCT04960228|38238196|FG000|Overall Study|Withdrawal by Subject|216|||
17195236|NCT02836613|38348550|FG000|Overall Study|Withdrawal by Subject|0|||
17195237|NCT02836613|38348551|FG001|Overall Study|Withdrawal by Subject|2|||
17099235|NCT04960228|38238197|FG001|Overall Study|Withdrawal by Subject|35|||
17099236|NCT04960228|38238196|FG000|Overall Study|Failed attention check|69|||
17099237|NCT04960228|38238197|FG001|Overall Study|Failed attention check|148|||
17099238|NCT04960228|38238196|FG000|Overall Study|Flagged for response quality by Dynata|3|||
17099239|NCT04960228|38238197|FG001|Overall Study|Flagged for response quality by Dynata|3|||
17099240|NCT04619992|38238205|FG000|Overall Study|Withdrawal by Subject|1|||
17099241|NCT04619992|38238206|FG001|Overall Study|Withdrawal by Subject|0|||
17099242|NCT00136604|38238217|FG000|Overall Study|Lost to Follow-up|1|||
17195238|NCT02397460|38348565|FG000|Treatment Period 2|Adverse Event|0|||
17195239|NCT02397460|38348566|FG001|Treatment Period 2|Adverse Event|0|||
17195240|NCT02397460|38348567|FG002|Treatment Period 2|Adverse Event|0|||
17195241|NCT02397460|38348568|FG003|Treatment Period 2|Adverse Event|0|||
17195242|NCT02397460|38348569|FG004|Treatment Period 2|Adverse Event|0|||
17195243|NCT02397460|38348570|FG005|Treatment Period 2|Adverse Event|0|||
17195244|NCT02397460|38348571|FG006|Treatment Period 2|Adverse Event|0|||
17195245|NCT02397460|38348572|FG007|Treatment Period 2|Adverse Event|1|||
17195246|NCT02397460|38348565|FG000|Treatment Period 4|Adverse Event|0|||
17195247|NCT02397460|38348566|FG001|Treatment Period 4|Adverse Event|1|||
17195248|NCT02397460|38348567|FG002|Treatment Period 4|Adverse Event|0|||
17195249|NCT02397460|38348568|FG003|Treatment Period 4|Adverse Event|0|||
17195250|NCT02397460|38348569|FG004|Treatment Period 4|Adverse Event|0|||
17195251|NCT02397460|38348570|FG005|Treatment Period 4|Adverse Event|0|||
17195252|NCT02397460|38348571|FG006|Treatment Period 4|Adverse Event|0|||
17195253|NCT02397460|38348572|FG007|Treatment Period 4|Adverse Event|0|||
17195254|NCT02397460|38348565|FG000|Treatment Period 4|Physician Decision|0|||
17195255|NCT02397460|38348566|FG001|Treatment Period 4|Physician Decision|0|||
17195256|NCT02397460|38348567|FG002|Treatment Period 4|Physician Decision|0|||
17195257|NCT02397460|38348568|FG003|Treatment Period 4|Physician Decision|0|||
17195258|NCT02397460|38348569|FG004|Treatment Period 4|Physician Decision|1|||
17195259|NCT02397460|38348570|FG005|Treatment Period 4|Physician Decision|0|||
17195260|NCT02397460|38348571|FG006|Treatment Period 4|Physician Decision|0|||
17195261|NCT02397460|38348572|FG007|Treatment Period 4|Physician Decision|0|||
17195262|NCT02768870|38348646|FG000|Overall Study|Not Implanted with Device|2|||
17195263|NCT02768870|38348646|FG000|Overall Study|Death|1|||
17195264|NCT02768870|38348646|FG000|Overall Study|Reoperation|4|||
17195265|NCT02768870|38348646|FG000|Overall Study|On Study|19|||
17195266|NCT02834819|38348652|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
17195267|NCT02834819|38348653|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
17195268|NCT02454478|38348659|FG000|Overall Study|Incomplete DLT Evaluation|1|||
16786327|NCT02679079|37726744|FG002|Overall Study|Adverse Event|2|||
16786328|NCT02679079|37726742|FG000|Overall Study|Protocol Violation|0|||
16786329|NCT02679079|37726743|FG001|Overall Study|Protocol Violation|1|||
16786330|NCT02679079|37726744|FG002|Overall Study|Protocol Violation|0|||
16786331|NCT02679079|37726742|FG000|Overall Study|Withdrawal by Subject|2|||
17195269|NCT01341587|38348665|FG000|Overall Study|Lost to Follow-up|2|||
17195270|NCT01341587|38348666|FG001|Overall Study|Lost to Follow-up|0|||
17195271|NCT01341587|38348665|FG000|Overall Study|stopped using the meters|2|||
17195272|NCT01341587|38348666|FG001|Overall Study|stopped using the meters|10|||
17099243|NCT00136604|38238218|FG001|Overall Study|Lost to Follow-up|0|||
17099244|NCT00136604|38238219|FG002|Overall Study|Lost to Follow-up|0|||
17099245|NCT00136604|38238220|FG003|Overall Study|Lost to Follow-up|0|||
17099246|NCT00136604|38238221|FG004|Overall Study|Lost to Follow-up|1|||
17099247|NCT00136604|38238217|FG000|Overall Study|Migrated/moved from study area|0|||
17099248|NCT00136604|38238218|FG001|Overall Study|Migrated/moved from study area|1|||
17099249|NCT00136604|38238219|FG002|Overall Study|Migrated/moved from study area|0|||
17099250|NCT00136604|38238220|FG003|Overall Study|Migrated/moved from study area|0|||
17099251|NCT00136604|38238221|FG004|Overall Study|Migrated/moved from study area|0|||
17099252|NCT00135512|38238237|FG000|Overall Study|Adverse Event|56|||
17099253|NCT00135512|38238237|FG000|Overall Study|Lack of Efficacy|25|||
17099254|NCT00135512|38238237|FG000|Overall Study|Other|42|||
17099255|NCT00130728|38238243|FG000|Overall Study|Death|258|||
17099256|NCT00130728|38238244|FG001|Overall Study|Death|258|||
17099257|NCT00130728|38238243|FG000|Overall Study|Lost to Follow-up|4|||
17099258|NCT00130728|38238244|FG001|Overall Study|Lost to Follow-up|0|||
17099259|NCT00130728|38238243|FG000|Overall Study|Withdrawal by Subject|0|||
17099260|NCT00130728|38238244|FG001|Overall Study|Withdrawal by Subject|2|||
17099261|NCT00129974|38238250|FG000|Overall Study|Other|1|||
17099262|NCT04947436|38238257|FG000|Overall Study|Lost to Follow-up|3|||
17099263|NCT04947436|38238258|FG001|Overall Study|Lost to Follow-up|7|||
17099264|NCT04947436|38238259|FG002|Overall Study|Lost to Follow-up|5|||
17099265|NCT04947436|38238257|FG000|Overall Study|Death|1|||
17099266|NCT04947436|38238258|FG001|Overall Study|Death|1|||
17099267|NCT04947436|38238259|FG002|Overall Study|Death|1|||
17099268|NCT00119106|38238269|FG000|Overall Study|HIV infected at baseline|179|||
17099269|NCT00119106|38238270|FG001|Overall Study|HIV infected at baseline|178|||
17099270|NCT00135356|38238286|FG000|Overall Study|Adverse Event|6|||
17099271|NCT00135356|38238287|FG001|Overall Study|Adverse Event|2|||
17099272|NCT00135356|38238286|FG000|Overall Study|Lack of Efficacy|2|||
17099273|NCT00135356|38238287|FG001|Overall Study|Lack of Efficacy|0|||
17099274|NCT00135356|38238286|FG000|Overall Study|Lost to Follow-up|3|||
17099275|NCT00135356|38238287|FG001|Overall Study|Lost to Follow-up|1|||
17099276|NCT00135356|38238286|FG000|Overall Study|Surgery for abdominal fat|1|||
17099277|NCT00135356|38238287|FG001|Overall Study|Surgery for abdominal fat|0|||
17099278|NCT00135356|38238286|FG000|Overall Study|Change in antiviral regimen|0|||
17099279|NCT00135356|38238287|FG001|Overall Study|Change in antiviral regimen|1|||
17099280|NCT00135356|38238286|FG000|Overall Study|Poor/noncompliance|1|||
17099281|NCT00135356|38238287|FG001|Overall Study|Poor/noncompliance|1|||
17099282|NCT00135356|38238286|FG000|Overall Study|No longer meets study criteria|2|||
17099283|NCT00135356|38238287|FG001|Overall Study|No longer meets study criteria|0|||
17099284|NCT00135356|38238286|FG000|Overall Study|Withdrawal by Subject|2|||
17099285|NCT00135356|38238287|FG001|Overall Study|Withdrawal by Subject|4|||
17099286|NCT00118716|38238295|FG000|Overall Study|Adverse Event|2|||
17099287|NCT00118716|38238296|FG001|Overall Study|Adverse Event|7|||
17099288|NCT00118716|38238295|FG000|Overall Study|Protocol Violation|5|||
17099289|NCT00118716|38238296|FG001|Overall Study|Protocol Violation|4|||
17099290|NCT00118716|38238295|FG000|Overall Study|Withdrawal by Subject|0|||
17099291|NCT00118716|38238296|FG001|Overall Study|Withdrawal by Subject|1|||
17099292|NCT00118716|38238295|FG000|Overall Study|Exacerbation|2|||
17099293|NCT00118716|38238296|FG001|Overall Study|Exacerbation|2|||
17099294|NCT00118716|38238295|FG000|Overall Study|Discontinued by sponsor|1|||
17099295|NCT00118716|38238296|FG001|Overall Study|Discontinued by sponsor|1|||
17099296|NCT00118716|38238295|FG000|Overall Study|Non-compliance|1|||
17099297|NCT00118716|38238296|FG001|Overall Study|Non-compliance|3|||
17099298|NCT00118716|38238295|FG000|Overall Study|misrandomized|1|||
17099299|NCT00118716|38238296|FG001|Overall Study|misrandomized|1|||
17099300|NCT00118716|38238295|FG000|Overall Study|Expired drug use|1|||
17099301|NCT00118716|38238296|FG001|Overall Study|Expired drug use|2|||
17099302|NCT00118716|38238295|FG000|Overall Study|Investigator discretion|0|||
17099303|NCT00118716|38238296|FG001|Overall Study|Investigator discretion|1|||
17099304|NCT04584346|38238304|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
17099305|NCT04584346|38238305|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
17099306|NCT00118482|38238315|FG000|Overall Study|Lost to Follow-up|7|||
17099307|NCT00118482|38238316|FG001|Overall Study|Lost to Follow-up|7|||
17099308|NCT00118482|38238315|FG000|Overall Study|Withdrawal by Subject|23|||
17099309|NCT00118482|38238316|FG001|Overall Study|Withdrawal by Subject|22|||
17099310|NCT00129272|38238324|FG000|Overall Study|Lost to Follow-up|12|||
17099311|NCT00129272|38238325|FG001|Overall Study|Lost to Follow-up|11|||
17099312|NCT00129272|38238324|FG000|Overall Study|Withdrawal by Subject|5|||
17099313|NCT00129272|38238325|FG001|Overall Study|Withdrawal by Subject|11|||
17099314|NCT04899232|38238334|FG000|Screening Period|Physician Decision|1|||
17099315|NCT04899232|38238335|FG001|Screening Period|Physician Decision|0|||
17099316|NCT04899232|38238336|FG002|Screening Period|Physician Decision|0|||
17099317|NCT04899232|38238334|FG000|Screening Period|Withdrawal by Subject|1|||
17099318|NCT04899232|38238335|FG001|Screening Period|Withdrawal by Subject|0|||
17099319|NCT04899232|38238336|FG002|Screening Period|Withdrawal by Subject|0|||
17099320|NCT04899232|38238334|FG000|Screening Period|Participant discharged before receiving intervention|3|||
17195273|NCT01358825|38348674|FG000|Overall Study|Blood sample not drawn|0|||
17195274|NCT01358825|38348675|FG001|Overall Study|Blood sample not drawn|1|||
17195275|NCT02453386|38348684|FG000|Overall Study|Adverse Event|22|||
17195276|NCT02453386|38348685|FG001|Overall Study|Adverse Event|30|||
17195277|NCT02453386|38348686|FG002|Overall Study|Adverse Event|15|||
17195278|NCT02453386|38348684|FG000|Overall Study|Protocol Violation|1|||
17195279|NCT02453386|38348685|FG001|Overall Study|Protocol Violation|0|||
17195280|NCT02453386|38348686|FG002|Overall Study|Protocol Violation|1|||
17195281|NCT02453386|38348684|FG000|Overall Study|Withdrawal by Subject|10|||
17195282|NCT02453386|38348685|FG001|Overall Study|Withdrawal by Subject|9|||
17195283|NCT02453386|38348686|FG002|Overall Study|Withdrawal by Subject|9|||
17195284|NCT02453386|38348684|FG000|Overall Study|Sponsor Terminated Study|14|||
17195285|NCT02453386|38348685|FG001|Overall Study|Sponsor Terminated Study|8|||
17195286|NCT02453386|38348686|FG002|Overall Study|Sponsor Terminated Study|11|||
17195287|NCT02453386|38348684|FG000|Overall Study|Subject Terminated by Sponsor|1|||
17195288|NCT02453386|38348685|FG001|Overall Study|Subject Terminated by Sponsor|1|||
17195289|NCT02453386|38348686|FG002|Overall Study|Subject Terminated by Sponsor|1|||
17195290|NCT02453386|38348684|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
17195291|NCT02453386|38348685|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
17195292|NCT02453386|38348686|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
17195293|NCT02453386|38348684|FG000|Overall Study|Lost to Follow-up|0|||
17195294|NCT02453386|38348685|FG001|Overall Study|Lost to Follow-up|0|||
17195295|NCT02453386|38348686|FG002|Overall Study|Lost to Follow-up|1|||
17195296|NCT02453386|38348684|FG000|Overall Study|Other|1|||
17195297|NCT02453386|38348685|FG001|Overall Study|Other|0|||
17099321|NCT04899232|38238335|FG001|Screening Period|Participant discharged before receiving intervention|0|||
17099322|NCT04899232|38238336|FG002|Screening Period|Participant discharged before receiving intervention|0|||
17099323|NCT00096174|38238353|FG000|Overall Study|Lack of Efficacy|9|||
17099324|NCT00096174|38238353|FG000|Overall Study|Adverse Event|15|||
17195298|NCT02453386|38348686|FG002|Overall Study|Other|1|||
17195299|NCT02431468|38348704|FG000|Overall Study|Adverse Event|2|||
17195300|NCT02431468|38348705|FG001|Overall Study|Adverse Event|4|||
17195301|NCT02431468|38348706|FG002|Overall Study|Adverse Event|5|||
17195302|NCT02431468|38348704|FG000|Overall Study|Withdrawal by Subject|4|||
17195303|NCT02431468|38348705|FG001|Overall Study|Withdrawal by Subject|12|||
17195304|NCT02431468|38348706|FG002|Overall Study|Withdrawal by Subject|2|||
17195305|NCT02431468|38348704|FG000|Overall Study|noncompliance, investigator termination,|2|||
17195306|NCT02431468|38348705|FG001|Overall Study|noncompliance, investigator termination,|2|||
17195307|NCT02431468|38348706|FG002|Overall Study|noncompliance, investigator termination,|2|||
17195308|NCT02452762|38348722|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
17195309|NCT02452762|38348723|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
17195310|NCT02452762|38348722|FG000|Overall Study|Withdrawal by Subject|1|||
17195311|NCT02452762|38348723|FG001|Overall Study|Withdrawal by Subject|0|||
17195312|NCT02631746|38348730|FG000|Overall Study|Lack of Efficacy|3|||
17195313|NCT02633306|38348734|FG000|Overall Study|Withdrawal by Subject|3|||
17195314|NCT02396758|38348743|FG000|Overall Study|Withdrawal by Subject|2|||
17195315|NCT02396758|38348744|FG001|Overall Study|Withdrawal by Subject|0|||
17195316|NCT02396758|38348745|FG002|Overall Study|Withdrawal by Subject|0|||
17195317|NCT02396758|38348746|FG003|Overall Study|Withdrawal by Subject|1|||
17195318|NCT02396758|38348743|FG000|Overall Study|Lost to Follow-up|8|||
17195319|NCT02396758|38348744|FG001|Overall Study|Lost to Follow-up|5|||
17195320|NCT02396758|38348745|FG002|Overall Study|Lost to Follow-up|3|||
17195321|NCT02396758|38348746|FG003|Overall Study|Lost to Follow-up|3|||
17195322|NCT02396758|38348743|FG000|Overall Study|Death|1|||
17099325|NCT00096174|38238353|FG000|Overall Study|Death|6|||
17099326|NCT00096174|38238353|FG000|Overall Study|Withdrawal by Subject|15|||
17099327|NCT00096174|38238353|FG000|Overall Study|Not started protocol therapy|3|||
17099328|NCT00096174|38238353|FG000|Overall Study|Ineligible|6|||
17099329|NCT00096174|38238353|FG000|Overall Study|other reason|8|||
17099330|NCT04559698|38238359|FG000|Overall Study|Lost to Follow-up|14|||
17099331|NCT04559698|38238360|FG001|Overall Study|Lost to Follow-up|15|||
17099332|NCT04559698|38238359|FG000|Overall Study|Withdrawal by Subject|0|||
17099333|NCT04559698|38238360|FG001|Overall Study|Withdrawal by Subject|1|||
17099334|NCT00133952|38238368|FG000|Overall Study|Adverse Event|1|||
17099335|NCT00133952|38238369|FG001|Overall Study|Adverse Event|2|||
17099336|NCT00133952|38238368|FG000|Overall Study|Death|3|||
17099337|NCT00133952|38238369|FG001|Overall Study|Death|2|||
17099338|NCT00133952|38238368|FG000|Overall Study|Lost to Follow-up|9|||
17099339|NCT00133952|38238369|FG001|Overall Study|Lost to Follow-up|14|||
17099340|NCT00133952|38238368|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
17099341|NCT00133952|38238369|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
17099342|NCT00133952|38238368|FG000|Overall Study|Protocol Violation|1|||
17099343|NCT00133952|38238369|FG001|Overall Study|Protocol Violation|1|||
17195323|NCT02396758|38348744|FG001|Overall Study|Death|1|||
17195324|NCT02396758|38348745|FG002|Overall Study|Death|0|||
17195325|NCT02396758|38348746|FG003|Overall Study|Death|1|||
17195326|NCT02396758|38348743|FG000|Overall Study|Randomized but not treated|1|||
17195327|NCT02396758|38348744|FG001|Overall Study|Randomized but not treated|0|||
17195328|NCT02396758|38348745|FG002|Overall Study|Randomized but not treated|1|||
17195329|NCT02396758|38348746|FG003|Overall Study|Randomized but not treated|0|||
17195330|NCT02632838|38348758|FG000|Overall Study|Withdrawal by Subject|3|||
17195331|NCT02632838|38348759|FG001|Overall Study|Withdrawal by Subject|0|||
17195332|NCT02632838|38348758|FG000|Overall Study|Lost to Follow-up|0|||
17195333|NCT02632838|38348759|FG001|Overall Study|Lost to Follow-up|2|||
17195334|NCT02396212|38348769|FG000|Overall Study|Adverse Event|1|||
17195335|NCT02396212|38348769|FG000|Overall Study|Lack of Efficacy|2|||
17195336|NCT02395822|38348773|FG000|Overall Study|Withdrawal by Subject|1|||
17195337|NCT02395822|38348773|FG000|Overall Study|Death|1|||
17195338|NCT01651936|38348779|FG000|Base Study|Adverse Event|3|||
17195339|NCT01651936|38348780|FG001|Base Study|Adverse Event|0|||
17195340|NCT01651936|38348781|FG002|Base Study|Adverse Event|0|||
17195341|NCT01651936|38348779|FG000|Base Study|Withdrawal by Subject|1|||
17195342|NCT01651936|38348780|FG001|Base Study|Withdrawal by Subject|1|||
17195343|NCT01651936|38348781|FG002|Base Study|Withdrawal by Subject|0|||
17195344|NCT01651936|38348779|FG000|Base Study|Early Escape|2|||
17195345|NCT01651936|38348780|FG001|Base Study|Early Escape|8|||
17195346|NCT01651936|38348781|FG002|Base Study|Early Escape|0|||
17195347|NCT01651936|38348779|FG000|Base Study|Study terminated by sponsor|21|||
17195348|NCT01651936|38348780|FG001|Base Study|Study terminated by sponsor|16|||
17195349|NCT01651936|38348781|FG002|Base Study|Study terminated by sponsor|0|||
17195350|NCT01651936|38348779|FG000|Extension Study|Lack of Efficacy|0|||
17195351|NCT01651936|38348780|FG001|Extension Study|Lack of Efficacy|0|||
17195352|NCT01651936|38348781|FG002|Extension Study|Lack of Efficacy|1|||
17195353|NCT01651936|38348779|FG000|Extension Study|Study terminated by sponsor|0|||
17195354|NCT01651936|38348780|FG001|Extension Study|Study terminated by sponsor|0|||
17195355|NCT01651936|38348781|FG002|Extension Study|Study terminated by sponsor|13|||
17195356|NCT02395042|38348791|FG000|Treatment 1 Period|Adverse Event|1|||
17195357|NCT02395042|38348792|FG001|Treatment 1 Period|Adverse Event|3|||
17195358|NCT02395042|38348793|FG002|Treatment 1 Period|Adverse Event|1|||
17195359|NCT02395042|38348791|FG000|Treatment 1 Period|Lack of Efficacy|1|||
17195360|NCT02395042|38348792|FG001|Treatment 1 Period|Lack of Efficacy|1|||
17195361|NCT02395042|38348793|FG002|Treatment 1 Period|Lack of Efficacy|0|||
17195362|NCT02395042|38348791|FG000|Treatment 1 Period|Lost to Follow-up|1|||
17195363|NCT02395042|38348792|FG001|Treatment 1 Period|Lost to Follow-up|0|||
17195364|NCT02395042|38348793|FG002|Treatment 1 Period|Lost to Follow-up|0|||
17195365|NCT02395042|38348791|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
17195366|NCT02395042|38348792|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
17195367|NCT02395042|38348793|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
17195368|NCT02395042|38348791|FG000|Treatment 2 Period|Lack of Efficacy|1|||
17195369|NCT02395042|38348792|FG001|Treatment 2 Period|Lack of Efficacy|1|||
17195370|NCT02395042|38348793|FG002|Treatment 2 Period|Lack of Efficacy|0|||
17195371|NCT02394808|38348804|FG000|Period 1|Unsatisfactory lens fitting|0|||
17195372|NCT02394808|38348805|FG001|Period 1|Unsatisfactory lens fitting|1|||
17195373|NCT02394808|38348804|FG000|Period 2|Lost to Follow-up|1|||
17195374|NCT02394808|38348805|FG001|Period 2|Lost to Follow-up|0|||
17195375|NCT02630966|38348813|FG000|Overall Study|Adverse Event|1|||
17195376|NCT02630966|38348814|FG001|Overall Study|Adverse Event|3|||
17195377|NCT02630966|38348813|FG000|Overall Study|Significant Protocol Deviation|0|||
17195378|NCT02630966|38348814|FG001|Overall Study|Significant Protocol Deviation|2|||
17195379|NCT02630966|38348813|FG000|Overall Study|Voluntary Withdrawal|1|||
17195380|NCT02630966|38348814|FG001|Overall Study|Voluntary Withdrawal|1|||
17195381|NCT02630966|38348813|FG000|Overall Study|Lack of Efficacy|0|||
17195382|NCT02630966|38348814|FG001|Overall Study|Lack of Efficacy|2|||
17195383|NCT01651780|38348822|FG000|Overall Study|Physician decision: No 30-day visit|2|||
17195384|NCT01651780|38348823|FG001|Overall Study|Physician decision: No 30-day visit|1|||
17195385|NCT01651780|38348822|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
17195386|NCT01651780|38348823|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
17195387|NCT01651780|38348822|FG000|Overall Study|Withdrawal by Subject|2|||
17195388|NCT01651780|38348823|FG001|Overall Study|Withdrawal by Subject|0|||
17195389|NCT01651780|38348822|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
17195390|NCT01651780|38348823|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17195391|NCT01651780|38348822|FG000|Overall Study|Lost to Follow-up|1|||
17195392|NCT01651780|38348823|FG001|Overall Study|Lost to Follow-up|2|||
17195393|NCT01651780|38348822|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
17195394|NCT01651780|38348823|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
17195395|NCT02394730|38348835|FG000|Overall Study|Lost to Follow-up|1|||
17195396|NCT02394730|38348836|FG001|Overall Study|Lost to Follow-up|0|||
17195397|NCT02394730|38348835|FG000|Overall Study|Withdrawal by Subject|0|||
17195398|NCT02394730|38348836|FG001|Overall Study|Withdrawal by Subject|1|||
17195399|NCT02430532|38348844|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
17195400|NCT02430532|38348845|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
17195401|NCT02430532|38348844|FG000|Overall Study|Consent Withdrawn|0|||
17195402|NCT02430532|38348845|FG001|Overall Study|Consent Withdrawn|2|||
17195403|NCT02430532|38348844|FG000|Overall Study|Adverse Event|0|||
17195404|NCT02430532|38348845|FG001|Overall Study|Adverse Event|1|||
17195405|NCT02394340|38348853|FG000|Overall Study|Failed drug screen test|1|||
17195406|NCT02394340|38348853|FG000|Overall Study|Adverse Event|1|||
17195407|NCT01672736|38348857|FG000|Overall Study|Available drug expired on 31 May 16|3|||
17195408|NCT01560637|38348861|FG000|Overall Study|Adverse Event|63|||
17195409|NCT01560637|38348861|FG000|Overall Study|Death|69|||
17195410|NCT01560637|38348861|FG000|Overall Study|Lost to Follow-up|8|||
17195411|NCT01560637|38348861|FG000|Overall Study|Protocol Violation|8|||
17195412|NCT01560637|38348861|FG000|Overall Study|Withdrawal by Subject|24|||
17195413|NCT01560637|38348861|FG000|Overall Study|Progressive Disease|20|||
17195414|NCT01560637|38348861|FG000|Overall Study|Other Reason Not Specified|6|||
17195415|NCT01353911|38348873|FG000|Overall Study|Lost to Follow-up|2|||
17195416|NCT01353911|38348874|FG001|Overall Study|Lost to Follow-up|6|||
17195417|NCT01353911|38348875|FG002|Overall Study|Lost to Follow-up|4|||
17195418|NCT01353911|38348876|FG003|Overall Study|Lost to Follow-up|0|||
17195419|NCT01353911|38348877|FG004|Overall Study|Lost to Follow-up|4|||
17195420|NCT01353911|38348878|FG005|Overall Study|Lost to Follow-up|4|||
17195421|NCT01353911|38348879|FG006|Overall Study|Lost to Follow-up|3|||
17195422|NCT01353911|38348880|FG007|Overall Study|Lost to Follow-up|6|||
17195423|NCT01353911|38348873|FG000|Overall Study|Withdrawal by Subject|2|||
17195424|NCT01353911|38348874|FG001|Overall Study|Withdrawal by Subject|3|||
17195425|NCT01353911|38348875|FG002|Overall Study|Withdrawal by Subject|4|||
17195426|NCT01353911|38348876|FG003|Overall Study|Withdrawal by Subject|2|||
17195427|NCT01353911|38348877|FG004|Overall Study|Withdrawal by Subject|2|||
17195428|NCT01353911|38348878|FG005|Overall Study|Withdrawal by Subject|3|||
17195429|NCT01353911|38348879|FG006|Overall Study|Withdrawal by Subject|3|||
17195430|NCT01353911|38348880|FG007|Overall Study|Withdrawal by Subject|9|||
17195431|NCT01353911|38348873|FG000|Overall Study|Status Not Recorded|4|||
17195432|NCT01353911|38348874|FG001|Overall Study|Status Not Recorded|0|||
17195433|NCT01353911|38348875|FG002|Overall Study|Status Not Recorded|1|||
17195434|NCT01353911|38348876|FG003|Overall Study|Status Not Recorded|0|||
17195435|NCT01353911|38348877|FG004|Overall Study|Status Not Recorded|0|||
17195436|NCT01353911|38348878|FG005|Overall Study|Status Not Recorded|0|||
17195437|NCT01353911|38348879|FG006|Overall Study|Status Not Recorded|0|||
17195438|NCT01353911|38348880|FG007|Overall Study|Status Not Recorded|0|||
17195439|NCT01671488|38348898|FG000|Overall Study|Withdrawal by Subject|1|||
17195440|NCT02783911|38348904|FG000|Overall Study|Lost to Follow-up|3|||
17195441|NCT02783911|38348905|FG001|Overall Study|Lost to Follow-up|32|||
17195442|NCT01358357|38348913|FG000|Open Label Phase|Adverse Event|0|||
17195443|NCT01358357|38348914|FG001|Open Label Phase|Adverse Event|0|||
17195444|NCT01358357|38348915|FG002|Open Label Phase|Adverse Event|59|||
17195445|NCT01358357|38348913|FG000|Open Label Phase|Lack of Efficacy|0|||
17195446|NCT01358357|38348914|FG001|Open Label Phase|Lack of Efficacy|0|||
17195447|NCT01358357|38348915|FG002|Open Label Phase|Lack of Efficacy|107|||
16786332|NCT02679079|37726743|FG001|Overall Study|Withdrawal by Subject|1|||
16786333|NCT02679079|37726744|FG002|Overall Study|Withdrawal by Subject|0|||
16786334|NCT02678923|37726754|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
16786335|NCT02678923|37726755|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
16786336|NCT02678923|37726754|FG000|Overall Study|Withdrawal by Subject|3|||
16786337|NCT02678923|37726755|FG001|Overall Study|Withdrawal by Subject|2|||
16786338|NCT02678923|37726754|FG000|Overall Study|Lost to Follow-up|1|||
16786339|NCT02678923|37726755|FG001|Overall Study|Lost to Follow-up|0|||
16786340|NCT02678923|37726754|FG000|Overall Study|Did Not Return for Study Visits|1|||
16786341|NCT02678923|37726755|FG001|Overall Study|Did Not Return for Study Visits|0|||
16786342|NCT01976728|37726765|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
16786343|NCT01976728|37726766|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
16786344|NCT01976728|37726767|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
16786345|NCT01976728|37726768|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
16786346|NCT02689219|37726796|FG000|Overall Study|Death|1|||
16786347|NCT02689219|37726797|FG001|Overall Study|Death|1|||
16786348|NCT02689219|37726796|FG000|Overall Study|Disease Progression|10|||
16786349|NCT02689219|37726797|FG001|Overall Study|Disease Progression|6|||
16786350|NCT02683525|37726803|FG000|Overall Study|Lost to Follow-up|1|||
17195448|NCT01358357|38348913|FG000|Open Label Phase|Lost to Follow-up|0|||
17195449|NCT01358357|38348914|FG001|Open Label Phase|Lost to Follow-up|0|||
16786351|NCT02683525|37726803|FG000|Overall Study|Physician Decision|1|||
17195450|NCT01358357|38348915|FG002|Open Label Phase|Lost to Follow-up|76|||
17195451|NCT01358357|38348913|FG000|Open Label Phase|Protocol Violation|0|||
17195452|NCT01358357|38348914|FG001|Open Label Phase|Protocol Violation|0|||
17195453|NCT01358357|38348915|FG002|Open Label Phase|Protocol Violation|45|||
17195454|NCT01358357|38348913|FG000|Open Label Phase|Withdrawal by Subject|0|||
17195455|NCT01358357|38348914|FG001|Open Label Phase|Withdrawal by Subject|0|||
17195456|NCT01358357|38348915|FG002|Open Label Phase|Withdrawal by Subject|112|||
17195457|NCT01358357|38348913|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
17195458|NCT01358357|38348914|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
17195459|NCT01358357|38348915|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
17195460|NCT01358357|38348913|FG000|Open Label Phase|Terminated at study completion|0|||
17195461|NCT01358357|38348914|FG001|Open Label Phase|Terminated at study completion|0|||
17195462|NCT01358357|38348915|FG002|Open Label Phase|Terminated at study completion|5|||
17195463|NCT01358357|38348913|FG000|Open Label Phase|Mood episode|0|||
17195464|NCT01358357|38348914|FG001|Open Label Phase|Mood episode|0|||
17195465|NCT01358357|38348915|FG002|Open Label Phase|Mood episode|42|||
17195466|NCT01358357|38348913|FG000|Double-Blind Phase|Adverse Event|8|||
17195467|NCT01358357|38348914|FG001|Double-Blind Phase|Adverse Event|5|||
17195468|NCT01358357|38348915|FG002|Double-Blind Phase|Adverse Event|0|||
17195469|NCT01358357|38348913|FG000|Double-Blind Phase|Lost to Follow-up|5|||
17195470|NCT01358357|38348914|FG001|Double-Blind Phase|Lost to Follow-up|7|||
17195471|NCT01358357|38348915|FG002|Double-Blind Phase|Lost to Follow-up|0|||
17195472|NCT01358357|38348913|FG000|Double-Blind Phase|Protocol Violation|1|||
17195473|NCT01358357|38348914|FG001|Double-Blind Phase|Protocol Violation|11|||
17195474|NCT01358357|38348915|FG002|Double-Blind Phase|Protocol Violation|0|||
17195475|NCT01358357|38348913|FG000|Double-Blind Phase|Protocol Violation|16|||
17195476|NCT01358357|38348914|FG001|Double-Blind Phase|Protocol Violation|12|||
17195477|NCT01358357|38348915|FG002|Double-Blind Phase|Protocol Violation|0|||
17195478|NCT01358357|38348913|FG000|Double-Blind Phase|Terminated at study completion|2|||
17195479|NCT01358357|38348914|FG001|Double-Blind Phase|Terminated at study completion|0|||
17195480|NCT01358357|38348915|FG002|Double-Blind Phase|Terminated at study completion|0|||
17195481|NCT01358357|38348913|FG000|Double-Blind Phase|Recurrence of mood event|48|||
17195482|NCT01358357|38348914|FG001|Double-Blind Phase|Recurrence of mood event|64|||
17195483|NCT01358357|38348915|FG002|Double-Blind Phase|Recurrence of mood event|0|||
17195484|NCT01358357|38348913|FG000|Double-Blind Phase|Administrative|0|||
17195485|NCT01358357|38348914|FG001|Double-Blind Phase|Administrative|1|||
17195486|NCT01358357|38348915|FG002|Double-Blind Phase|Administrative|0|||
17195487|NCT02831387|38348924|FG000|Overall Study|Withdrawal by Subject|1|||
17195488|NCT02831387|38348925|FG001|Overall Study|Withdrawal by Subject|1|||
17195489|NCT02831387|38348924|FG000|Overall Study|Discontinued due to stock recovery|0|||
17195490|NCT02831387|38348925|FG001|Overall Study|Discontinued due to stock recovery|1|||
17195491|NCT02831855|38348931|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
17195492|NCT02831855|38348932|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
17195493|NCT02831855|38348933|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
17195494|NCT02831855|38348931|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
17195495|NCT02831855|38348932|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
17195496|NCT02831855|38348933|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
17195497|NCT02831855|38348931|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
17195498|NCT02831855|38348932|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
17099344|NCT00133952|38238368|FG000|Overall Study|Withdrawal by Subject|20|||
17099345|NCT00133952|38238369|FG001|Overall Study|Withdrawal by Subject|4|||
17099346|NCT00133952|38238368|FG000|Overall Study|Physician Decision|4|||
17099347|NCT00133952|38238369|FG001|Overall Study|Physician Decision|3|||
17099348|NCT00133952|38238368|FG000|Overall Study|Sponsor Decision|0|||
17099349|NCT00133952|38238369|FG001|Overall Study|Sponsor Decision|1|||
17099350|NCT00118092|38238375|FG000|Overall Study|Withdrawal by Subject|1|||
17099351|NCT00118092|38238375|FG000|Overall Study|Protocol Violation|1|||
17099352|NCT04555096|38238382|FG000|Overall Study|Death|4|||
17099353|NCT04555096|38238383|FG001|Overall Study|Death|4|||
17099354|NCT04555096|38238382|FG000|Overall Study|Withdrawal by Subject|1|||
17099355|NCT04555096|38238383|FG001|Overall Study|Withdrawal by Subject|0|||
17099356|NCT04555096|38238382|FG000|Overall Study|Other|0|||
17099357|NCT04555096|38238383|FG001|Overall Study|Other|1|||
17099358|NCT00097500|38238391|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
17099359|NCT00097500|38238392|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
17099360|NCT00097500|38238391|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
17099361|NCT00097500|38238392|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
17099362|NCT00097500|38238391|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
17099363|NCT00097500|38238392|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
17099364|NCT00097500|38238391|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
17195499|NCT02831855|38348933|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
17195500|NCT02831855|38348931|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
17195501|NCT02831855|38348932|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
17195502|NCT02831855|38348933|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
17195503|NCT02831855|38348931|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
17195504|NCT02831855|38348932|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
17195505|NCT02831855|38348933|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
17099365|NCT00097500|38238392|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
17099366|NCT00097500|38238391|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
17195506|NCT02831855|38348931|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
17195507|NCT02831855|38348932|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
17099367|NCT00097500|38238392|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
17099368|NCT00097500|38238391|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
17099369|NCT00097500|38238392|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
17099370|NCT00097500|38238391|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
17099371|NCT00097500|38238392|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
17099372|NCT04551898|38238402|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
17099373|NCT04551898|38238403|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
17099374|NCT04551898|38238404|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
17099375|NCT04551898|38238405|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
17195508|NCT02831855|38348933|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
16786352|NCT02683525|37726803|FG000|Overall Study|Disease Progression|6|||
17099376|NCT04551898|38238402|FG000|Overall Study|Withdrawal by Subject|5|||
17099377|NCT04551898|38238403|FG001|Overall Study|Withdrawal by Subject|1|||
17099378|NCT04551898|38238404|FG002|Overall Study|Withdrawal by Subject|2|||
17099379|NCT04551898|38238405|FG003|Overall Study|Withdrawal by Subject|2|||
17099380|NCT04551898|38238402|FG000|Overall Study|Lost to Follow-up|2|||
17099381|NCT04551898|38238403|FG001|Overall Study|Lost to Follow-up|1|||
17099382|NCT04551898|38238404|FG002|Overall Study|Lost to Follow-up|2|||
16786353|NCT01976338|37726809|FG000|Overall Study|Physician Decision|0|||
16786354|NCT01976338|37726810|FG001|Overall Study|Physician Decision|1|||
16786355|NCT01976338|37726809|FG000|Overall Study|Lost to Follow-up|3|||
16786356|NCT01976338|37726810|FG001|Overall Study|Lost to Follow-up|0|||
16786357|NCT01976338|37726809|FG000|Overall Study|Withdrawal by Subject|5|||
16786358|NCT01976338|37726810|FG001|Overall Study|Withdrawal by Subject|2|||
16786359|NCT01976338|37726809|FG000|Overall Study|Adverse Event|5|||
16786360|NCT01976338|37726810|FG001|Overall Study|Adverse Event|1|||
16786361|NCT02674633|37726819|FG000|Overall Study|Lost to Follow-up|3|||
16786362|NCT02674633|37726820|FG001|Overall Study|Lost to Follow-up|2|||
16786363|NCT02674633|37726819|FG000|Overall Study|Physician Decision|1|||
16786364|NCT02674633|37726820|FG001|Overall Study|Physician Decision|0|||
16786365|NCT02674633|37726819|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16786366|NCT02674633|37726820|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
16786367|NCT02651987|37726828|FG000|Overall Study|Adverse Event|2|||
16786368|NCT02651987|37726829|FG001|Overall Study|Adverse Event|2|||
16786369|NCT02651987|37726828|FG000|Overall Study|Consent Withdrawn|2|||
16786370|NCT02651987|37726829|FG001|Overall Study|Consent Withdrawn|0|||
16786371|NCT02651987|37726828|FG000|Overall Study|Local PD|0|||
16786372|NCT02651987|37726829|FG001|Overall Study|Local PD|2|||
16786373|NCT02651987|37726828|FG000|Overall Study|Investigator Decision|1|||
16786374|NCT02651987|37726829|FG001|Overall Study|Investigator Decision|1|||
16786375|NCT02677987|37726840|FG000|Overall Study|Withdrawal by Subject|3|||
16786376|NCT02677987|37726841|FG001|Overall Study|Withdrawal by Subject|0|||
16786377|NCT02677987|37726840|FG000|Overall Study|Lost to Follow-up|1|||
16786378|NCT02677987|37726841|FG001|Overall Study|Lost to Follow-up|0|||
16786379|NCT01999114|37726860|FG000|Overall Study|Adverse Event|8|||
16786380|NCT01999114|37726861|FG001|Overall Study|Adverse Event|7|||
16786381|NCT01999114|37726862|FG002|Overall Study|Adverse Event|2|||
16786382|NCT01999114|37726863|FG003|Overall Study|Adverse Event|2|||
16786383|NCT01999114|37726864|FG004|Overall Study|Adverse Event|1|||
16786384|NCT01999114|37726860|FG000|Overall Study|Withdrawal by Subject|0|||
16786385|NCT01999114|37726861|FG001|Overall Study|Withdrawal by Subject|0|||
16786386|NCT01999114|37726862|FG002|Overall Study|Withdrawal by Subject|1|||
16786387|NCT01999114|37726863|FG003|Overall Study|Withdrawal by Subject|0|||
16786388|NCT01999114|37726864|FG004|Overall Study|Withdrawal by Subject|1|||
16786389|NCT01999114|37726860|FG000|Overall Study|Lost to Follow-up|0|||
16786390|NCT01999114|37726861|FG001|Overall Study|Lost to Follow-up|0|||
16786391|NCT01999114|37726862|FG002|Overall Study|Lost to Follow-up|1|||
16786392|NCT01999114|37726863|FG003|Overall Study|Lost to Follow-up|0|||
16786393|NCT01999114|37726864|FG004|Overall Study|Lost to Follow-up|0|||
16786394|NCT01999114|37726860|FG000|Overall Study|Administrative|0|||
16786395|NCT01999114|37726861|FG001|Overall Study|Administrative|0|||
16786396|NCT01999114|37726862|FG002|Overall Study|Administrative|1|||
16786397|NCT01999114|37726863|FG003|Overall Study|Administrative|1|||
16786398|NCT01999114|37726864|FG004|Overall Study|Administrative|2|||
16786399|NCT02682823|37726895|FG000|Overall Study|Withdrawal by Subject|0|||
16786400|NCT02682823|37726896|FG001|Overall Study|Withdrawal by Subject|0|||
16786401|NCT02682823|37726897|FG002|Overall Study|Withdrawal by Subject|1|||
16786402|NCT02682823|37726898|FG003|Overall Study|Withdrawal by Subject|0|||
16786403|NCT02682823|37726899|FG004|Overall Study|Withdrawal by Subject|1|||
16786404|NCT02682823|37726895|FG000|Overall Study|Protocol Deviation|0|||
16786405|NCT02682823|37726896|FG001|Overall Study|Protocol Deviation|1|||
16786406|NCT02682823|37726897|FG002|Overall Study|Protocol Deviation|0|||
16786407|NCT02682823|37726898|FG003|Overall Study|Protocol Deviation|0|||
16786408|NCT02682823|37726899|FG004|Overall Study|Protocol Deviation|0|||
16786409|NCT02682823|37726895|FG000|Overall Study|Adverse Event|0|||
17099383|NCT04551898|38238405|FG003|Overall Study|Lost to Follow-up|2|||
17099384|NCT04551898|38238402|FG000|Overall Study|Death|1|||
17099385|NCT04551898|38238403|FG001|Overall Study|Death|0|||
17099386|NCT04551898|38238404|FG002|Overall Study|Death|0|||
17099387|NCT04551898|38238405|FG003|Overall Study|Death|0|||
17099388|NCT04551898|38238402|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
17099389|NCT04551898|38238403|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
17099390|NCT04551898|38238404|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
17099391|NCT04551898|38238405|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
17099392|NCT04849780|38238423|FG000|Period 1|Covid-19 Related|1|||
17099393|NCT04849780|38238424|FG001|Period 1|Covid-19 Related|0|||
17099394|NCT04849780|38238423|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
17099395|NCT04849780|38238424|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
17099396|NCT04849780|38238423|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
17099397|NCT04849780|38238424|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
17099398|NCT04823494|38238438|FG000|Overall Study|Programming software malfunction.|1|||
17099399|NCT04823494|38238439|FG001|Overall Study|Programming software malfunction.|0|||
17099400|NCT04823494|38238438|FG000|Overall Study|Withdrawal by Subject|1|||
17099401|NCT04823494|38238439|FG001|Overall Study|Withdrawal by Subject|0|||
17099402|NCT04823494|38238438|FG000|Overall Study|Devices lost|0|||
17099403|NCT04823494|38238439|FG001|Overall Study|Devices lost|1|||
17099404|NCT04542694|38238449|FG000|Overall Study|The need for prohibited therapy|2|||
17099405|NCT04542694|38238450|FG001|Overall Study|The need for prohibited therapy|0|||
17099406|NCT04542694|38238449|FG000|Overall Study|Adverse Event|1|||
17099407|NCT04542694|38238450|FG001|Overall Study|Adverse Event|0|||
17099408|NCT04542694|38238449|FG000|Overall Study|Protocol Violation|1|||
17099409|NCT04542694|38238450|FG001|Overall Study|Protocol Violation|0|||
17195509|NCT02831855|38348931|FG000|Open Label Phase (24 Weeks)|Other|4|||
17195510|NCT02831855|38348932|FG001|Open Label Phase (24 Weeks)|Other|0|||
17195511|NCT02831855|38348933|FG002|Open Label Phase (24 Weeks)|Other|0|||
17195512|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
17195513|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
17195514|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
17195515|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Death|0|||
17195516|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Death|0|||
17195517|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Death|2|||
17195518|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
17195519|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
17195520|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
17195521|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
17195522|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
17195523|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
17195524|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
17195525|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
16786410|NCT02682823|37726896|FG001|Overall Study|Adverse Event|0|||
16786411|NCT02682823|37726897|FG002|Overall Study|Adverse Event|0|||
16786412|NCT02682823|37726898|FG003|Overall Study|Adverse Event|1|||
16786413|NCT02682823|37726899|FG004|Overall Study|Adverse Event|0|||
16786414|NCT01374451|37726913|FG000|Overall Study|Administrative problems|1|||
16786415|NCT01374451|37726914|FG001|Overall Study|Administrative problems|0|||
16786416|NCT02674477|37726922|FG000|Overall Study|Protocol Violation|8|||
16786417|NCT02674477|37726923|FG001|Overall Study|Protocol Violation|2|||
17195526|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
17195527|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Other|0|||
17195528|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Other|2|||
17195529|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Other|5|||
17195530|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
17195531|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
17195532|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
17195533|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
17195534|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
17195535|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
17195536|NCT02831855|38348931|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
17195537|NCT02831855|38348932|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
17195538|NCT02831855|38348933|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
17195539|NCT02628938|38348946|FG000|Overall Study|Did not attend the follow up recall|2|||
17195540|NCT02628938|38348947|FG001|Overall Study|Did not attend the follow up recall|2|||
17195541|NCT02628938|38348948|FG002|Overall Study|Did not attend the follow up recall|1|||
17195542|NCT02628938|38348946|FG000|Overall Study|Failure to comply with the instructions|3|||
17195543|NCT02628938|38348947|FG001|Overall Study|Failure to comply with the instructions|0|||
17099410|NCT00117312|38238460|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
16786418|NCT01352845|37726931|FG000|Overall Study|Lost to Follow-up|313|||
16786419|NCT01352845|37726932|FG001|Overall Study|Lost to Follow-up|92|||
16786420|NCT01352845|37726931|FG000|Overall Study|No Longer Willing to Participate|205|||
16786421|NCT01352845|37726932|FG001|Overall Study|No Longer Willing to Participate|58|||
17099411|NCT00117312|38238461|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
17099412|NCT00117312|38238462|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
17099413|NCT00117312|38238463|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
17099414|NCT00117312|38238460|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
17099415|NCT00117312|38238461|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
17099416|NCT00117312|38238462|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
16786422|NCT01352845|37726931|FG000|Overall Study|Withdrawal by Subject|48|||
16786423|NCT01352845|37726932|FG001|Overall Study|Withdrawal by Subject|16|||
16786424|NCT01352845|37726931|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
16786425|NCT01352845|37726932|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
16786426|NCT01352845|37726931|FG000|Overall Study|Pregnancy|27|||
16786427|NCT01352845|37726932|FG001|Overall Study|Pregnancy|7|||
16786428|NCT01352845|37726931|FG000|Overall Study|Adverse Event|22|||
16786429|NCT01352845|37726932|FG001|Overall Study|Adverse Event|6|||
16786430|NCT01352845|37726931|FG000|Overall Study|Other|17|||
16786431|NCT01352845|37726932|FG001|Overall Study|Other|7|||
16786432|NCT01352845|37726931|FG000|Overall Study|Protocol Violation|12|||
16786433|NCT01352845|37726932|FG001|Overall Study|Protocol Violation|6|||
16786434|NCT01352845|37726931|FG000|Overall Study|Death|3|||
16786435|NCT01352845|37726932|FG001|Overall Study|Death|0|||
16786436|NCT02674399|37726940|FG000|Overall Study|Lost to Follow-up|2|||
16786437|NCT02674399|37726941|FG001|Overall Study|Lost to Follow-up|0|||
16786438|NCT02676895|37726950|FG000|Overall Study|Administrative reason|1|||
16786439|NCT02676895|37726951|FG001|Overall Study|Administrative reason|0|||
16786440|NCT02676895|37726952|FG002|Overall Study|Administrative reason|0|||
16786441|NCT02676895|37726950|FG000|Overall Study|Protocol Violation|1|||
16786442|NCT02676895|37726951|FG001|Overall Study|Protocol Violation|0|||
16786443|NCT02676895|37726952|FG002|Overall Study|Protocol Violation|0|||
16786444|NCT02676895|37726950|FG000|Overall Study|Adverse Event|0|||
16786445|NCT02676895|37726951|FG001|Overall Study|Adverse Event|3|||
16786446|NCT02676895|37726952|FG002|Overall Study|Adverse Event|1|||
16786447|NCT02676895|37726950|FG000|Overall Study|Lost to Follow-up|0|||
16786448|NCT02676895|37726951|FG001|Overall Study|Lost to Follow-up|0|||
16786449|NCT02676895|37726952|FG002|Overall Study|Lost to Follow-up|1|||
16786450|NCT02676895|37726950|FG000|Overall Study|Withdrawal by Subject|0|||
16786451|NCT02676895|37726951|FG001|Overall Study|Withdrawal by Subject|0|||
16786452|NCT02676895|37726952|FG002|Overall Study|Withdrawal by Subject|1|||
16786453|NCT02673697|37726963|FG000|Overall Study|Adverse Event|2|||
16786454|NCT02673697|37726964|FG001|Overall Study|Adverse Event|0|||
16786455|NCT02673697|37726963|FG000|Overall Study|Death|32|||
16786456|NCT02673697|37726964|FG001|Overall Study|Death|24|||
16786457|NCT02673697|37726963|FG000|Overall Study|Lost to Follow-up|5|||
16786458|NCT02673697|37726964|FG001|Overall Study|Lost to Follow-up|2|||
16786459|NCT02673697|37726963|FG000|Overall Study|Physician Decision|2|||
16786460|NCT02673697|37726964|FG001|Overall Study|Physician Decision|1|||
16786461|NCT02673697|37726963|FG000|Overall Study|Withdrawal by Subject|10|||
16786462|NCT02673697|37726964|FG001|Overall Study|Withdrawal by Subject|7|||
16786463|NCT02673697|37726963|FG000|Overall Study|Change subj medical status|1|||
16786464|NCT02673697|37726964|FG001|Overall Study|Change subj medical status|2|||
17099417|NCT00117312|38238463|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
17099418|NCT00117312|38238460|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
17099419|NCT00117312|38238461|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
17099420|NCT00117312|38238462|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
17099421|NCT00117312|38238463|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
17099422|NCT00117312|38238460|FG000|Overall Study|Other|0|||
17099423|NCT00117312|38238461|FG001|Overall Study|Other|1|||
17099424|NCT00117312|38238462|FG002|Overall Study|Other|3|||
17099425|NCT00117312|38238463|FG003|Overall Study|Other|1|||
17099426|NCT00117312|38238460|FG000|Overall Study|Patient choice|0|||
17099427|NCT00117312|38238461|FG001|Overall Study|Patient choice|0|||
17099428|NCT00117312|38238462|FG002|Overall Study|Patient choice|2|||
17099429|NCT00117312|38238463|FG003|Overall Study|Patient choice|1|||
17099430|NCT00117312|38238460|FG000|Overall Study|Adverse Event|0|||
17099431|NCT00117312|38238461|FG001|Overall Study|Adverse Event|2|||
17099432|NCT00117312|38238462|FG002|Overall Study|Adverse Event|0|||
17099433|NCT00117312|38238463|FG003|Overall Study|Adverse Event|0|||
17099434|NCT00117312|38238460|FG000|Overall Study|Protocol Violation|0|||
16786465|NCT02673697|37726963|FG000|Overall Study|Explant|10|||
16786466|NCT02673697|37726964|FG001|Overall Study|Explant|5|||
16786467|NCT02673697|37726963|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
16786468|NCT02673697|37726964|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
16786469|NCT02673619|37726974|FG000|Overall Study|Lost to Follow-up|1|||
16786470|NCT02673619|37726975|FG001|Overall Study|Lost to Follow-up|0|||
16786471|NCT02673619|37726976|FG002|Overall Study|Lost to Follow-up|0|||
16786472|NCT02673619|37726977|FG003|Overall Study|Lost to Follow-up|0|||
17099435|NCT00117312|38238461|FG001|Overall Study|Protocol Violation|1|||
17099436|NCT00117312|38238462|FG002|Overall Study|Protocol Violation|3|||
17195544|NCT02628938|38348948|FG002|Overall Study|Failure to comply with the instructions|3|||
17195545|NCT01356407|38348962|FG000|Overall Study|Lost to Follow-up|2|||
17195546|NCT01356407|38348963|FG001|Overall Study|Lost to Follow-up|0|||
17195547|NCT01356407|38348962|FG000|Overall Study|Patient Withdrew Consent|2|||
17195548|NCT01356407|38348963|FG001|Overall Study|Patient Withdrew Consent|1|||
17195549|NCT01356407|38348962|FG000|Overall Study|Could not afford IMP administration|0|||
17195550|NCT01356407|38348963|FG001|Overall Study|Could not afford IMP administration|1|||
17195551|NCT01356407|38348962|FG000|Overall Study|Not complete Endoscopy|2|||
17195552|NCT01356407|38348963|FG001|Overall Study|Not complete Endoscopy|2|||
17195553|NCT00109837|38348969|FG000|Overall Study|Adverse Event|2|||
17195554|NCT00109837|38348969|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
17195555|NCT00109837|38348969|FG000|Overall Study|Death|1|||
17195556|NCT00109837|38348969|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
17195557|NCT00109837|38348969|FG000|Overall Study|Not treated|1|||
17195558|NCT00109837|38348969|FG000|Overall Study|Ineligible|1|||
17195559|NCT02828111|38348982|FG000|Overall Study|Withdrawal by Subject|0|||
17195560|NCT02828111|38348983|FG001|Overall Study|Withdrawal by Subject|0|||
17195561|NCT02828111|38348984|FG002|Overall Study|Withdrawal by Subject|2|||
17195562|NCT02828111|38348985|FG003|Overall Study|Withdrawal by Subject|0|||
17195563|NCT02828111|38348986|FG004|Overall Study|Withdrawal by Subject|0|||
17195564|NCT02828111|38348982|FG000|Overall Study|Lost to Follow-up|0|||
17195565|NCT02828111|38348983|FG001|Overall Study|Lost to Follow-up|0|||
17195566|NCT02828111|38348984|FG002|Overall Study|Lost to Follow-up|0|||
17195567|NCT02828111|38348985|FG003|Overall Study|Lost to Follow-up|1|||
17195568|NCT02828111|38348986|FG004|Overall Study|Lost to Follow-up|1|||
17195569|NCT01671332|38349009|FG000|Overall Study|Withdrawal by Subject|1|||
17195570|NCT01671332|38349010|FG001|Overall Study|Withdrawal by Subject|1|||
17195571|NCT01355627|38349023|FG000|Overall Study|Request By the Patient to Discontinue|5|||
17195572|NCT01355627|38349024|FG001|Overall Study|Request By the Patient to Discontinue|7|||
17195573|NCT01355627|38349023|FG000|Overall Study|Lost to Follow-up|8|||
17195574|NCT01355627|38349024|FG001|Overall Study|Lost to Follow-up|7|||
17195575|NCT01355627|38349023|FG000|Overall Study|Fatal Adverse Event|19|||
17195576|NCT01355627|38349024|FG001|Overall Study|Fatal Adverse Event|23|||
17195577|NCT01355627|38349023|FG000|Overall Study|Other|1|||
17195578|NCT01355627|38349024|FG001|Overall Study|Other|1|||
17195579|NCT00100802|38349030|FG000|Overall Study|Adverse Event|9|||
17195580|NCT00100802|38349030|FG000|Overall Study|Death|1|||
17195581|NCT00100802|38349030|FG000|Overall Study|Lack of Efficacy|47|||
17195582|NCT00100802|38349030|FG000|Overall Study|Physician Decision|5|||
17195583|NCT00100802|38349030|FG000|Overall Study|Protocol Violation|1|||
17195584|NCT00100802|38349030|FG000|Overall Study|Withdrawal by Subject|5|||
17195585|NCT00100802|38349030|FG000|Overall Study|Ineligible|12|||
17195586|NCT01355159|38349036|FG000|Overall Study|Withdrew consent|39|||
16786473|NCT02673619|37726974|FG000|Overall Study|Withdrawal by Subject|1|||
16786474|NCT02673619|37726975|FG001|Overall Study|Withdrawal by Subject|1|||
16786475|NCT02673619|37726976|FG002|Overall Study|Withdrawal by Subject|1|||
16786476|NCT02673619|37726977|FG003|Overall Study|Withdrawal by Subject|0|||
16786477|NCT02673619|37726974|FG000|Overall Study|Adverse Event|0|||
16786478|NCT02673619|37726975|FG001|Overall Study|Adverse Event|0|||
16786479|NCT02673619|37726976|FG002|Overall Study|Adverse Event|1|||
16786480|NCT02673619|37726977|FG003|Overall Study|Adverse Event|0|||
16786481|NCT02673619|37726974|FG000|Overall Study|Lack of Efficacy|0|||
16786482|NCT02673619|37726975|FG001|Overall Study|Lack of Efficacy|0|||
16786483|NCT02673619|37726976|FG002|Overall Study|Lack of Efficacy|1|||
16786484|NCT02673619|37726977|FG003|Overall Study|Lack of Efficacy|0|||
16786485|NCT02680639|37726999|FG000|Screening Period|Screen Failure|7|||
16786486|NCT02680639|37727000|FG001|Screening Period|Screen Failure|0|||
16786487|NCT02680639|37727001|FG002|Screening Period|Screen Failure|0|||
16786488|NCT01674725|37727013|FG000|Overall Study|Adverse Event|1|||
16786489|NCT01674725|37727014|FG001|Overall Study|Adverse Event|0|||
16786490|NCT01674725|37727013|FG000|Overall Study|Did not receive study drug|1|||
16786491|NCT01674725|37727014|FG001|Overall Study|Did not receive study drug|0|||
16786492|NCT01674725|37727013|FG000|Overall Study|Withdrawal by Subject|1|||
16786493|NCT01674725|37727014|FG001|Overall Study|Withdrawal by Subject|0|||
17099437|NCT00117312|38238463|FG003|Overall Study|Protocol Violation|0|||
17099438|NCT00117312|38238460|FG000|Overall Study|PSA decrease <=50%|0|||
17099439|NCT00117312|38238461|FG001|Overall Study|PSA decrease <=50%|2|||
17099440|NCT00117312|38238462|FG002|Overall Study|PSA decrease <=50%|2|||
17099441|NCT00117312|38238463|FG003|Overall Study|PSA decrease <=50%|4|||
17099442|NCT00117312|38238460|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
17099443|NCT00117312|38238461|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
17099444|NCT00117312|38238462|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
17195587|NCT01355159|38349037|FG001|Overall Study|Withdrew consent|47|||
16786494|NCT01674725|37727013|FG000|Overall Study|Lost to Follow-up|0|||
16786495|NCT01674725|37727014|FG001|Overall Study|Lost to Follow-up|1|||
16786496|NCT01674569|37727020|FG000|Overall Study|Adverse Event|0|||
16786497|NCT01674569|37727021|FG001|Overall Study|Adverse Event|2|||
17014855|NCT00809835|38159653|FG000|Overall Study|Withdrawal by Subject|1|||
17014856|NCT00809835|38159654|FG001|Overall Study|Withdrawal by Subject|1|||
17014857|NCT00809835|38159655|FG002|Overall Study|Withdrawal by Subject|1|||
17014858|NCT00809835|38159656|FG003|Overall Study|Withdrawal by Subject|0|||
17014859|NCT00853242|38159673|FG000|Overall Study|Adverse Event|0|||
17014860|NCT00853242|38159674|FG001|Overall Study|Adverse Event|1|||
17014861|NCT00853242|38159675|FG002|Overall Study|Adverse Event|1|||
17014862|NCT00853242|38159676|FG003|Overall Study|Adverse Event|0|||
17014863|NCT00853242|38159677|FG004|Overall Study|Adverse Event|3|||
17014864|NCT00853242|38159678|FG005|Overall Study|Adverse Event|1|||
17014865|NCT00853242|38159679|FG006|Overall Study|Adverse Event|1|||
17014866|NCT00853242|38159673|FG000|Overall Study|Noncompliant|0|||
17099445|NCT00117312|38238463|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
17099446|NCT00117312|38238460|FG000|Overall Study|Hepatic abnormality|0|||
17099447|NCT00117312|38238461|FG001|Overall Study|Hepatic abnormality|1|||
17099448|NCT00117312|38238462|FG002|Overall Study|Hepatic abnormality|0|||
17099449|NCT00117312|38238463|FG003|Overall Study|Hepatic abnormality|1|||
17099450|NCT00117312|38238460|FG000|Overall Study|Withdrawal by Subject|0|||
17099451|NCT00117312|38238461|FG001|Overall Study|Withdrawal by Subject|2|||
17099452|NCT00117312|38238462|FG002|Overall Study|Withdrawal by Subject|0|||
17099453|NCT00117312|38238463|FG003|Overall Study|Withdrawal by Subject|0|||
17099454|NCT00129116|38238478|FG000|Primary Phase|Lost to Follow-up|1|||
17099455|NCT00129116|38238479|FG001|Primary Phase|Lost to Follow-up|1|||
17099456|NCT00129116|38238480|FG002|Primary Phase|Lost to Follow-up|0|||
17099457|NCT00129116|38238481|FG003|Primary Phase|Lost to Follow-up|1|||
17099458|NCT00129116|38238482|FG004|Primary Phase|Lost to Follow-up|1|||
17099459|NCT00129116|38238478|FG000|Primary Phase|Protocol Violation|0|||
17099460|NCT00129116|38238479|FG001|Primary Phase|Protocol Violation|1|||
17099461|NCT00129116|38238480|FG002|Primary Phase|Protocol Violation|0|||
17099462|NCT00129116|38238481|FG003|Primary Phase|Protocol Violation|0|||
17099463|NCT00129116|38238482|FG004|Primary Phase|Protocol Violation|0|||
17099464|NCT00129116|38238478|FG000|Primary Phase|Adverse Event|1|||
17099465|NCT00129116|38238479|FG001|Primary Phase|Adverse Event|1|||
17099466|NCT00129116|38238480|FG002|Primary Phase|Adverse Event|0|||
17099467|NCT00129116|38238481|FG003|Primary Phase|Adverse Event|0|||
17099468|NCT00129116|38238482|FG004|Primary Phase|Adverse Event|0|||
17099469|NCT00129116|38238478|FG000|Primary Phase|Withdrawal by Subject|0|||
17099470|NCT00129116|38238479|FG001|Primary Phase|Withdrawal by Subject|1|||
17099471|NCT00129116|38238480|FG002|Primary Phase|Withdrawal by Subject|0|||
17099472|NCT00129116|38238481|FG003|Primary Phase|Withdrawal by Subject|0|||
17099473|NCT00129116|38238482|FG004|Primary Phase|Withdrawal by Subject|0|||
17099474|NCT00129116|38238478|FG000|Primary Phase|Other|0|||
17099475|NCT00129116|38238479|FG001|Primary Phase|Other|0|||
17099476|NCT00129116|38238480|FG002|Primary Phase|Other|1|||
17099477|NCT00129116|38238481|FG003|Primary Phase|Other|0|||
17099478|NCT00129116|38238482|FG004|Primary Phase|Other|0|||
17099479|NCT00129116|38238478|FG000|Booster Phase|Lost to Follow-up|2|||
17099480|NCT00129116|38238479|FG001|Booster Phase|Lost to Follow-up|0|||
17099481|NCT00129116|38238480|FG002|Booster Phase|Lost to Follow-up|0|||
17099482|NCT00129116|38238481|FG003|Booster Phase|Lost to Follow-up|0|||
17099483|NCT00129116|38238482|FG004|Booster Phase|Lost to Follow-up|1|||
17099484|NCT00117156|38238494|FG000|Overall Study|Adverse Event|9|||
17099485|NCT00117156|38238494|FG000|Overall Study|Physician Decision|1|||
17099486|NCT00117156|38238494|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
17099487|NCT00096954|38238500|FG000|Overall Study|Adverse Event|3|||
17099488|NCT00096954|38238501|FG001|Overall Study|Adverse Event|1|||
17099489|NCT00096954|38238500|FG000|Overall Study|Withdrawal by Subject|9|||
17099490|NCT00096954|38238501|FG001|Overall Study|Withdrawal by Subject|8|||
17099491|NCT00096954|38238500|FG000|Overall Study|Physician Decision|1|||
17099492|NCT00096954|38238501|FG001|Overall Study|Physician Decision|1|||
17099493|NCT00096954|38238500|FG000|Overall Study|Sponsors Decision|1|||
17099494|NCT00096954|38238501|FG001|Overall Study|Sponsors Decision|1|||
17099495|NCT00096954|38238500|FG000|Overall Study|Pregnancy|1|||
17099496|NCT00096954|38238501|FG001|Overall Study|Pregnancy|1|||
17099497|NCT00096954|38238500|FG000|Overall Study|Initiation of immunotherapy|1|||
17099498|NCT00096954|38238501|FG001|Overall Study|Initiation of immunotherapy|0|||
17099499|NCT00096954|38238500|FG000|Overall Study|Non-compliance|0|||
17099500|NCT00096954|38238501|FG001|Overall Study|Non-compliance|3|||
17099501|NCT00096954|38238500|FG000|Overall Study|Lost to Follow-up|8|||
17099502|NCT00096954|38238501|FG001|Overall Study|Lost to Follow-up|5|||
17099503|NCT00096486|38238511|FG000|Overall Study|Withdrawal by Subject|0|||
17099504|NCT00096486|38238512|FG001|Overall Study|Withdrawal by Subject|0|||
17099505|NCT00096486|38238513|FG002|Overall Study|Withdrawal by Subject|1|||
17099506|NCT00096486|38238514|FG003|Overall Study|Withdrawal by Subject|1|||
17099507|NCT00096486|38238511|FG000|Overall Study|Not Treated|0|||
17099508|NCT00096486|38238512|FG001|Overall Study|Not Treated|0|||
17099509|NCT00096486|38238513|FG002|Overall Study|Not Treated|1|||
17099510|NCT00096486|38238514|FG003|Overall Study|Not Treated|1|||
17099511|NCT00116844|38238526|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
17099512|NCT00116844|38238527|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
17195588|NCT01355159|38349036|FG000|Overall Study|No primary outcome data|17|||
17195589|NCT01355159|38349037|FG001|Overall Study|No primary outcome data|11|||
17195590|NCT01355159|38349036|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
17195591|NCT01355159|38349037|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
17195592|NCT01355159|38349036|FG000|Overall Study|Early intrauterine fetal death|6|||
17195593|NCT01355159|38349037|FG001|Overall Study|Early intrauterine fetal death|6|||
17195594|NCT02630186|38349043|FG000|Overall Study|Withdrawal by Subject|1|||
17195595|NCT01669928|38349049|FG000|First Intervention|Withdrawal by Subject|3|||
17195596|NCT01669928|38349050|FG001|First Intervention|Withdrawal by Subject|5|||
17195597|NCT01355081|38349061|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
17195598|NCT01355081|38349062|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
17195599|NCT01355081|38349063|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
17195600|NCT01355081|38349061|FG000|Overall Study|Major Protocol Deviation|0|||
17195601|NCT01355081|38349062|FG001|Overall Study|Major Protocol Deviation|1|||
17195602|NCT01355081|38349063|FG002|Overall Study|Major Protocol Deviation|0|||
17195603|NCT01355081|38349061|FG000|Overall Study|Lost to Follow-up|0|||
17195604|NCT01355081|38349062|FG001|Overall Study|Lost to Follow-up|0|||
17195605|NCT01355081|38349063|FG002|Overall Study|Lost to Follow-up|1|||
17195606|NCT01355081|38349061|FG000|Overall Study|Withdrawal of Consent|2|||
17195607|NCT01355081|38349062|FG001|Overall Study|Withdrawal of Consent|3|||
17195608|NCT01355081|38349063|FG002|Overall Study|Withdrawal of Consent|3|||
17195609|NCT01355081|38349061|FG000|Overall Study|Lack of Efficacy|2|||
17195610|NCT01355081|38349062|FG001|Overall Study|Lack of Efficacy|1|||
17195611|NCT01355081|38349063|FG002|Overall Study|Lack of Efficacy|1|||
17195612|NCT01355081|38349061|FG000|Overall Study|Non Compliance with Study Medication|0|||
17195613|NCT01355081|38349062|FG001|Overall Study|Non Compliance with Study Medication|1|||
17195614|NCT01355081|38349063|FG002|Overall Study|Non Compliance with Study Medication|0|||
17195615|NCT01354223|38349073|FG000|Overall Study|Withdrawal by Subject|3|||
17195616|NCT01354223|38349074|FG001|Overall Study|Withdrawal by Subject|1|||
17195617|NCT04043455|38349084|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
17195618|NCT04043455|38349085|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
17195619|NCT04043455|38349086|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
17195620|NCT04043455|38349087|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
17195621|NCT04043455|38349088|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
17195622|NCT04043455|38349089|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
17195623|NCT04043455|38349084|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
17195624|NCT04043455|38349085|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
17195625|NCT04043455|38349086|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
17195626|NCT04043455|38349087|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
17195627|NCT04043455|38349088|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
17195628|NCT04043455|38349089|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
17195629|NCT04043455|38349084|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
17195630|NCT04043455|38349085|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
17195631|NCT04043455|38349086|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
17195632|NCT04043455|38349087|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
17195633|NCT04043455|38349088|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
17195634|NCT04043455|38349089|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
17195635|NCT04043455|38349084|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
17195636|NCT04043455|38349085|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
17195637|NCT04043455|38349086|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
17195638|NCT04043455|38349087|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
17195639|NCT04043455|38349088|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
17195640|NCT04043455|38349089|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
17195641|NCT04043455|38349084|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
17195642|NCT04043455|38349085|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
16786498|NCT01674569|37727022|FG002|Overall Study|Adverse Event|0|||
16786499|NCT01674569|37727023|FG003|Overall Study|Adverse Event|1|||
16786500|NCT01674569|37727024|FG004|Overall Study|Adverse Event|2|||
16786501|NCT01674569|37727025|FG005|Overall Study|Adverse Event|2|||
17195643|NCT04043455|38349086|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
17195644|NCT04043455|38349087|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
17195645|NCT04043455|38349088|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
17195646|NCT04043455|38349089|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
17195647|NCT04043455|38349084|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
17195648|NCT04043455|38349085|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
17195649|NCT04043455|38349086|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
17195650|NCT04043455|38349087|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
17195651|NCT04043455|38349088|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
17195652|NCT04043455|38349089|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
17099513|NCT00116844|38238526|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
17099514|NCT00116844|38238527|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
17099515|NCT00116844|38238526|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
17099516|NCT00116844|38238527|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
17099517|NCT00116844|38238526|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
17099518|NCT00116844|38238527|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
17099519|NCT00116844|38238526|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
17099520|NCT00116844|38238527|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
17099521|NCT00116844|38238526|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
17099522|NCT00116844|38238527|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
17099523|NCT00116844|38238526|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
17099524|NCT00116844|38238527|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
17099525|NCT00116844|38238526|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
17099526|NCT00116844|38238527|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
17099527|NCT00116844|38238526|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
17099528|NCT00116844|38238527|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
17099529|NCT00128492|38238535|FG000|Overall Study|AE unrelated to study|2|||
17099530|NCT00128492|38238536|FG001|Overall Study|AE unrelated to study|9|||
16786502|NCT01674569|37727020|FG000|Overall Study|Protocol Violation|0|||
16786503|NCT01674569|37727021|FG001|Overall Study|Protocol Violation|1|||
17195653|NCT04043455|38349084|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
17195654|NCT04043455|38349085|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
17195655|NCT04043455|38349086|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
17195656|NCT04043455|38349087|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
17195657|NCT04043455|38349088|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
17195658|NCT04043455|38349089|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
17195659|NCT04043455|38349084|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
17195660|NCT04043455|38349085|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
17195661|NCT04043455|38349086|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
17195662|NCT04043455|38349087|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
17195663|NCT04043455|38349088|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
17195664|NCT04043455|38349089|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
17195665|NCT04043455|38349084|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
17195666|NCT04043455|38349085|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
17195667|NCT04043455|38349086|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
17195668|NCT04043455|38349087|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
17195669|NCT04043455|38349088|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
17195670|NCT04043455|38349089|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
17195671|NCT04043455|38349084|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
17195672|NCT04043455|38349085|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
17195673|NCT04043455|38349086|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
17195674|NCT04043455|38349087|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
17195675|NCT04043455|38349088|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
17195676|NCT04043455|38349089|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
17195677|NCT04043455|38349084|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
17195678|NCT04043455|38349085|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
17195679|NCT04043455|38349086|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
17195680|NCT04043455|38349087|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
17195681|NCT04043455|38349088|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
17195682|NCT04043455|38349089|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
17195683|NCT02627144|38349107|FG000|Overall Study|Serious adverse event|32|||
17195684|NCT02627144|38349107|FG000|Overall Study|Cancer progression|171|||
17195685|NCT02627144|38349107|FG000|Overall Study|Death from cancer|20|||
17195686|NCT02627144|38349107|FG000|Overall Study|Death from other cause|8|||
17195687|NCT02627144|38349107|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
17195688|NCT02627144|38349107|FG000|Overall Study|Administrative reasons|65|||
17195689|NCT02627144|38349107|FG000|Overall Study|Lost to Follow-up|8|||
17195690|NCT02627144|38349107|FG000|Overall Study|Enrolled, not treated|6|||
17195691|NCT02627144|38349107|FG000|Overall Study|Other|17|||
17195692|NCT02626520|38349113|FG000|Overall Study|Physician Decision|1|||
17195693|NCT02626520|38349114|FG001|Overall Study|Physician Decision|1|||
17195694|NCT02626520|38349113|FG000|Overall Study|Adverse Event|0|||
17195695|NCT02626520|38349114|FG001|Overall Study|Adverse Event|4|||
17195696|NCT02626520|38349113|FG000|Overall Study|Lack of Efficacy|0|||
17195697|NCT02626520|38349114|FG001|Overall Study|Lack of Efficacy|2|||
17195698|NCT02626520|38349113|FG000|Overall Study|Did not start protocol therapy|0|||
17195699|NCT02626520|38349114|FG001|Overall Study|Did not start protocol therapy|2|||
17195700|NCT02626520|38349113|FG000|Overall Study|Study terminated|0|||
17195701|NCT02626520|38349114|FG001|Overall Study|Study terminated|1|||
17195702|NCT04522141|38349122|FG000|Overall Study|Withdrawal by Subject|1|||
17195703|NCT04522141|38349123|FG001|Overall Study|Withdrawal by Subject|0|||
17195704|NCT01329029|38349146|FG000|Overall Study|Withdrawal by Subject|117|||
17195705|NCT01329029|38349147|FG001|Overall Study|Withdrawal by Subject|87|||
17195706|NCT01329029|38349146|FG000|Overall Study|Adverse Event|82|||
17099531|NCT00128492|38238535|FG000|Overall Study|Study drug intolerance (AE)|2|||
17099532|NCT00128492|38238536|FG001|Overall Study|Study drug intolerance (AE)|8|||
17099533|NCT00128492|38238535|FG000|Overall Study|AE related to study|1|||
17099534|NCT00128492|38238536|FG001|Overall Study|AE related to study|4|||
17099535|NCT00128492|38238535|FG000|Overall Study|Death|1|||
17099536|NCT00128492|38238536|FG001|Overall Study|Death|0|||
17099537|NCT00128492|38238535|FG000|Overall Study|Lost to Follow-up|1|||
17099538|NCT00128492|38238536|FG001|Overall Study|Lost to Follow-up|5|||
17099539|NCT00128492|38238535|FG000|Overall Study|Noncompliance|0|||
17099540|NCT00128492|38238536|FG001|Overall Study|Noncompliance|5|||
17099541|NCT00128492|38238535|FG000|Overall Study|Personal or administrative|10|||
17099542|NCT00128492|38238536|FG001|Overall Study|Personal or administrative|22|||
17099543|NCT00128492|38238535|FG000|Overall Study|Withdrawal by Subject|3|||
17099544|NCT00128492|38238536|FG001|Overall Study|Withdrawal by Subject|5|||
17099545|NCT00128492|38238535|FG000|Overall Study|Pregnancy|0|||
17099546|NCT00128492|38238536|FG001|Overall Study|Pregnancy|1|||
17099547|NCT00132314|38238544|FG000|Overall Study|Lost to Follow-up|70|||
17195707|NCT01329029|38349147|FG001|Overall Study|Adverse Event|29|||
17195708|NCT01329029|38349146|FG000|Overall Study|Death|16|||
17195709|NCT01329029|38349147|FG001|Overall Study|Death|19|||
17195710|NCT01329029|38349146|FG000|Overall Study|Other|14|||
17195711|NCT01329029|38349147|FG001|Overall Study|Other|20|||
17195712|NCT01329029|38349146|FG000|Overall Study|COPD Exacerbation|11|||
17195713|NCT01329029|38349147|FG001|Overall Study|COPD Exacerbation|18|||
17195714|NCT01329029|38349146|FG000|Overall Study|Physician Decision|16|||
17195715|NCT01329029|38349147|FG001|Overall Study|Physician Decision|13|||
17195716|NCT01329029|38349146|FG000|Overall Study|Lost to Follow-up|8|||
17195717|NCT01329029|38349147|FG001|Overall Study|Lost to Follow-up|5|||
17195718|NCT01329029|38349146|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
17195719|NCT01329029|38349147|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
17195720|NCT01372085|38349163|FG000|Washout Period 2|Physician Decision|0|||
17195721|NCT01372085|38349164|FG001|Washout Period 2|Physician Decision|0|||
17195722|NCT01372085|38349165|FG002|Washout Period 2|Physician Decision|0|||
17195723|NCT01372085|38349166|FG003|Washout Period 2|Physician Decision|0|||
17099548|NCT00132314|38238545|FG001|Overall Study|Lost to Follow-up|62|||
17099549|NCT00132314|38238544|FG000|Overall Study|Lacked SSN|1|||
17099550|NCT00132314|38238545|FG001|Overall Study|Lacked SSN|3|||
17099551|NCT00132314|38238544|FG000|Overall Study|Refused intervention at baseline|2|||
17099552|NCT00132314|38238545|FG001|Overall Study|Refused intervention at baseline|7|||
17195724|NCT01372085|38349167|FG004|Washout Period 2|Physician Decision|1|||
17195725|NCT01372085|38349168|FG005|Washout Period 2|Physician Decision|0|||
17195726|NCT01372085|38349169|FG006|Washout Period 2|Physician Decision|0|||
17195727|NCT01372085|38349170|FG007|Washout Period 2|Physician Decision|0|||
17195728|NCT01372085|38349171|FG008|Washout Period 2|Physician Decision|0|||
17195729|NCT01372085|38349172|FG009|Washout Period 2|Physician Decision|0|||
17195730|NCT01372085|38349163|FG000|Washout Period 3|Withdrawal by Subject|0|||
17195731|NCT01372085|38349164|FG001|Washout Period 3|Withdrawal by Subject|0|||
17195732|NCT01372085|38349165|FG002|Washout Period 3|Withdrawal by Subject|0|||
17195733|NCT01372085|38349166|FG003|Washout Period 3|Withdrawal by Subject|0|||
17195734|NCT01372085|38349167|FG004|Washout Period 3|Withdrawal by Subject|0|||
17195735|NCT01372085|38349168|FG005|Washout Period 3|Withdrawal by Subject|2|||
17195736|NCT01372085|38349169|FG006|Washout Period 3|Withdrawal by Subject|0|||
17195737|NCT01372085|38349170|FG007|Washout Period 3|Withdrawal by Subject|0|||
17195738|NCT01372085|38349171|FG008|Washout Period 3|Withdrawal by Subject|0|||
17195739|NCT01372085|38349172|FG009|Washout Period 3|Withdrawal by Subject|0|||
17195740|NCT02941549|38349199|FG000|Overall Study|Adverse Event|1|||
17195741|NCT02941549|38349200|FG001|Overall Study|Adverse Event|0|||
17195742|NCT02941549|38349201|FG002|Overall Study|Adverse Event|0|||
17195743|NCT02941549|38349199|FG000|Overall Study|Withdrawal by Subject|2|||
17195744|NCT02941549|38349200|FG001|Overall Study|Withdrawal by Subject|1|||
17195745|NCT02941549|38349201|FG002|Overall Study|Withdrawal by Subject|2|||
17195746|NCT02394028|38349223|FG000|Induction Phase|Adverse Event|2|||
17195747|NCT02394028|38349224|FG001|Induction Phase|Adverse Event|4|||
17195748|NCT02394028|38349225|FG002|Induction Phase|Adverse Event|1|||
17195749|NCT02394028|38349226|FG003|Induction Phase|Adverse Event|2|||
17195750|NCT02394028|38349227|FG004|Induction Phase|Adverse Event|5|||
17195751|NCT02394028|38349228|FG005|Induction Phase|Adverse Event|2|||
17195752|NCT02394028|38349229|FG006|Induction Phase|Adverse Event|0|||
17195753|NCT02394028|38349230|FG007|Induction Phase|Adverse Event|0|||
17195754|NCT02394028|38349231|FG008|Induction Phase|Adverse Event|0|||
17195755|NCT02394028|38349232|FG009|Induction Phase|Adverse Event|0|||
17195756|NCT02394028|38349233|FG010|Induction Phase|Adverse Event|0|||
17195757|NCT02394028|38349223|FG000|Induction Phase|Lack of Efficacy|3|||
17195758|NCT02394028|38349224|FG001|Induction Phase|Lack of Efficacy|6|||
17195759|NCT02394028|38349225|FG002|Induction Phase|Lack of Efficacy|2|||
17195760|NCT02394028|38349226|FG003|Induction Phase|Lack of Efficacy|17|||
17195761|NCT02394028|38349227|FG004|Induction Phase|Lack of Efficacy|14|||
17195762|NCT02394028|38349228|FG005|Induction Phase|Lack of Efficacy|8|||
17195763|NCT02394028|38349229|FG006|Induction Phase|Lack of Efficacy|17|||
17195764|NCT02394028|38349230|FG007|Induction Phase|Lack of Efficacy|23|||
17195765|NCT02394028|38349231|FG008|Induction Phase|Lack of Efficacy|0|||
17195766|NCT02394028|38349232|FG009|Induction Phase|Lack of Efficacy|0|||
17099553|NCT04539262|38238559|FG000|Overall Study|Adverse Event|0|||
17099554|NCT04539262|38238560|FG001|Overall Study|Adverse Event|0|||
17099555|NCT04539262|38238561|FG002|Overall Study|Adverse Event|1|||
17099556|NCT04539262|38238562|FG003|Overall Study|Adverse Event|0|||
17099557|NCT04539262|38238563|FG004|Overall Study|Adverse Event|0|||
17099558|NCT04539262|38238564|FG005|Overall Study|Adverse Event|0|||
17099559|NCT04539262|38238565|FG006|Overall Study|Adverse Event|0|||
17099560|NCT04539262|38238566|FG007|Overall Study|Adverse Event|0|||
17099561|NCT04539262|38238559|FG000|Overall Study|Withdrew Consent|0|||
17099562|NCT04539262|38238560|FG001|Overall Study|Withdrew Consent|0|||
17099563|NCT04539262|38238561|FG002|Overall Study|Withdrew Consent|0|||
17099564|NCT04539262|38238562|FG003|Overall Study|Withdrew Consent|1|||
17099565|NCT04539262|38238563|FG004|Overall Study|Withdrew Consent|0|||
17195767|NCT02394028|38349233|FG010|Induction Phase|Lack of Efficacy|0|||
17195768|NCT02394028|38349223|FG000|Induction Phase|Lost to Follow-up|1|||
17195769|NCT02394028|38349224|FG001|Induction Phase|Lost to Follow-up|0|||
17195770|NCT02394028|38349225|FG002|Induction Phase|Lost to Follow-up|0|||
17195771|NCT02394028|38349226|FG003|Induction Phase|Lost to Follow-up|1|||
17195772|NCT02394028|38349227|FG004|Induction Phase|Lost to Follow-up|0|||
17195773|NCT02394028|38349228|FG005|Induction Phase|Lost to Follow-up|0|||
17099566|NCT04539262|38238564|FG005|Overall Study|Withdrew Consent|0|||
17099567|NCT04539262|38238565|FG006|Overall Study|Withdrew Consent|0|||
17099568|NCT04539262|38238566|FG007|Overall Study|Withdrew Consent|0|||
17099569|NCT04539262|38238559|FG000|Overall Study|Randomized, Not treated|0|||
17099570|NCT04539262|38238560|FG001|Overall Study|Randomized, Not treated|1|||
17099571|NCT04539262|38238561|FG002|Overall Study|Randomized, Not treated|0|||
17099572|NCT04539262|38238562|FG003|Overall Study|Randomized, Not treated|0|||
17099573|NCT04539262|38238563|FG004|Overall Study|Randomized, Not treated|0|||
17099574|NCT04539262|38238564|FG005|Overall Study|Randomized, Not treated|0|||
17099575|NCT04539262|38238565|FG006|Overall Study|Randomized, Not treated|1|||
17099576|NCT04539262|38238566|FG007|Overall Study|Randomized, Not treated|0|||
17099577|NCT03702010|38238589|FG000|Follow-up (30days)|Lack of Efficacy|2|||
17099578|NCT03702010|38238590|FG001|Follow-up (30days)|Lack of Efficacy|2|||
17099579|NCT04538170|38238604|FG000|Overall Study|Withdrawal by Subject|104|||
17099580|NCT04538170|38238605|FG001|Overall Study|Withdrawal by Subject|210|||
17099581|NCT04537234|38238617|FG000|Overall Study|Withdrawal by Subject|2|||
17099582|NCT04537234|38238618|FG001|Overall Study|Withdrawal by Subject|0|||
17099583|NCT04537078|38238626|FG000|Overall Study|Protocol Violation|3|||
17099584|NCT04537078|38238627|FG001|Overall Study|Protocol Violation|2|||
17099585|NCT04537078|38238626|FG000|Overall Study|Lost to Follow-up|1|||
17099586|NCT04537078|38238627|FG001|Overall Study|Lost to Follow-up|0|||
17099587|NCT04537078|38238626|FG000|Overall Study|Withdrawal by Subject|0|||
17099588|NCT04537078|38238627|FG001|Overall Study|Withdrawal by Subject|1|||
17099589|NCT04532164|38238640|FG000|Overall Study|Adverse Event|1|||
17099590|NCT04532164|38238640|FG000|Overall Study|Protocol Violation|5|||
17099591|NCT04532164|38238640|FG000|Overall Study|Lost to Follow-up|1|||
17099592|NCT04532164|38238640|FG000|Overall Study|Found to be Ineligible|3|||
17099593|NCT04532164|38238640|FG000|Overall Study|Withdrawal by Subject|14|||
17195774|NCT02394028|38349229|FG006|Induction Phase|Lost to Follow-up|1|||
17195775|NCT02394028|38349230|FG007|Induction Phase|Lost to Follow-up|0|||
17195776|NCT02394028|38349231|FG008|Induction Phase|Lost to Follow-up|0|||
17195777|NCT02394028|38349232|FG009|Induction Phase|Lost to Follow-up|0|||
17195778|NCT02394028|38349233|FG010|Induction Phase|Lost to Follow-up|0|||
17195779|NCT02394028|38349223|FG000|Induction Phase|Non-compliance|0|||
17195780|NCT02394028|38349224|FG001|Induction Phase|Non-compliance|1|||
17195781|NCT02394028|38349225|FG002|Induction Phase|Non-compliance|3|||
17195782|NCT02394028|38349226|FG003|Induction Phase|Non-compliance|1|||
17195783|NCT02394028|38349227|FG004|Induction Phase|Non-compliance|3|||
17195784|NCT02394028|38349228|FG005|Induction Phase|Non-compliance|0|||
17195785|NCT02394028|38349229|FG006|Induction Phase|Non-compliance|1|||
17195786|NCT02394028|38349230|FG007|Induction Phase|Non-compliance|1|||
17195787|NCT02394028|38349231|FG008|Induction Phase|Non-compliance|0|||
17195788|NCT02394028|38349232|FG009|Induction Phase|Non-compliance|0|||
17195789|NCT02394028|38349233|FG010|Induction Phase|Non-compliance|0|||
17195790|NCT02394028|38349223|FG000|Induction Phase|Physician Decision|0|||
17195791|NCT02394028|38349224|FG001|Induction Phase|Physician Decision|0|||
17195792|NCT02394028|38349225|FG002|Induction Phase|Physician Decision|1|||
17195793|NCT02394028|38349226|FG003|Induction Phase|Physician Decision|4|||
17195794|NCT02394028|38349227|FG004|Induction Phase|Physician Decision|0|||
17195795|NCT02394028|38349228|FG005|Induction Phase|Physician Decision|2|||
17195796|NCT02394028|38349229|FG006|Induction Phase|Physician Decision|1|||
17195797|NCT02394028|38349230|FG007|Induction Phase|Physician Decision|0|||
17195798|NCT02394028|38349231|FG008|Induction Phase|Physician Decision|0|||
17099594|NCT00116688|38238647|FG000|Overall Study|Protocol deviation|1|||
17099595|NCT00116688|38238648|FG001|Overall Study|Protocol deviation|0|||
17195799|NCT02394028|38349232|FG009|Induction Phase|Physician Decision|0|||
17195800|NCT02394028|38349233|FG010|Induction Phase|Physician Decision|0|||
17195801|NCT02394028|38349223|FG000|Induction Phase|Protocol Violation|0|||
17195802|NCT02394028|38349224|FG001|Induction Phase|Protocol Violation|2|||
17195803|NCT02394028|38349225|FG002|Induction Phase|Protocol Violation|0|||
17195804|NCT02394028|38349226|FG003|Induction Phase|Protocol Violation|3|||
17195805|NCT02394028|38349227|FG004|Induction Phase|Protocol Violation|0|||
17195806|NCT02394028|38349228|FG005|Induction Phase|Protocol Violation|1|||
17195807|NCT02394028|38349229|FG006|Induction Phase|Protocol Violation|1|||
17195808|NCT02394028|38349230|FG007|Induction Phase|Protocol Violation|0|||
17195809|NCT02394028|38349231|FG008|Induction Phase|Protocol Violation|0|||
17195810|NCT02394028|38349232|FG009|Induction Phase|Protocol Violation|0|||
17195811|NCT02394028|38349233|FG010|Induction Phase|Protocol Violation|0|||
17195812|NCT02394028|38349223|FG000|Induction Phase|Withdrawal by Subject|1|||
17099596|NCT00116688|38238647|FG000|Overall Study|Noncompliance|3|||
17099597|NCT00116688|38238648|FG001|Overall Study|Noncompliance|1|||
17195813|NCT02394028|38349224|FG001|Induction Phase|Withdrawal by Subject|2|||
17195814|NCT02394028|38349225|FG002|Induction Phase|Withdrawal by Subject|4|||
17195815|NCT02394028|38349226|FG003|Induction Phase|Withdrawal by Subject|6|||
17195816|NCT02394028|38349227|FG004|Induction Phase|Withdrawal by Subject|7|||
17099598|NCT00116688|38238647|FG000|Overall Study|Adverse Event|11|||
17099599|NCT00116688|38238648|FG001|Overall Study|Adverse Event|0|||
17099600|NCT00116688|38238647|FG000|Overall Study|Withdrawal by Subject|26|||
17099601|NCT00116688|38238648|FG001|Overall Study|Withdrawal by Subject|2|||
17099602|NCT00116688|38238647|FG000|Overall Study|Requirement for alternative therapy|11|||
17099603|NCT00116688|38238648|FG001|Overall Study|Requirement for alternative therapy|1|||
17099604|NCT00116688|38238647|FG000|Overall Study|Physician Decision|7|||
17099605|NCT00116688|38238648|FG001|Overall Study|Physician Decision|0|||
17099606|NCT00116688|38238647|FG000|Overall Study|Lost to Follow-up|3|||
17099607|NCT00116688|38238648|FG001|Overall Study|Lost to Follow-up|0|||
17099608|NCT00116688|38238647|FG000|Overall Study|Death|15|||
17099609|NCT00116688|38238648|FG001|Overall Study|Death|0|||
17099610|NCT00116688|38238647|FG000|Overall Study|Protocol-specified criteria|3|||
17099611|NCT00116688|38238648|FG001|Overall Study|Protocol-specified criteria|0|||
17099612|NCT00116688|38238647|FG000|Overall Study|Pregnancy|1|||
17099613|NCT00116688|38238648|FG001|Overall Study|Pregnancy|0|||
17099614|NCT00116688|38238647|FG000|Overall Study|Other|11|||
17099615|NCT00116688|38238648|FG001|Overall Study|Other|0|||
17099616|NCT04531540|38238654|FG000|Overall Study|Adverse Event|1|||
17099617|NCT04531540|38238654|FG000|Overall Study|Protocol Violation|3|||
17099618|NCT04531540|38238654|FG000|Overall Study|Withdrawal by Subject|4|||
17099619|NCT04531540|38238654|FG000|Overall Study|Found to be Ineligible|1|||
17099620|NCT04799782|38238658|FG000|Washout|Physician Decision|2|||
17099621|NCT04799782|38238659|FG001|Washout|Physician Decision|0|||
17099622|NCT04799782|38238658|FG000|Washout|Withdrawal by Subject|0|||
17099623|NCT04799782|38238659|FG001|Washout|Withdrawal by Subject|2|||
17099624|NCT04799782|38238658|FG000|Washout|Lost to Follow-up|0|||
17099625|NCT04799782|38238659|FG001|Washout|Lost to Follow-up|1|||
17099626|NCT03697252|38238667|FG000|Overall Study|Adverse Event|3|||
17099627|NCT03697252|38238668|FG001|Overall Study|Adverse Event|2|||
17099628|NCT03697252|38238667|FG000|Overall Study|Withdrawal by Subject|14|||
17099629|NCT03697252|38238668|FG001|Overall Study|Withdrawal by Subject|14|||
17099630|NCT03697252|38238667|FG000|Overall Study|Lost to Follow-up|0|||
17099631|NCT03697252|38238668|FG001|Overall Study|Lost to Follow-up|1|||
17099632|NCT03697252|38238667|FG000|Overall Study|Physician Decision|1|||
17099633|NCT03697252|38238668|FG001|Overall Study|Physician Decision|1|||
17099634|NCT03697252|38238667|FG000|Overall Study|Other|0|||
17099635|NCT03697252|38238668|FG001|Overall Study|Other|1|||
17099636|NCT03701074|38238676|FG000|Overall Study|Physician Decision|1|||
17099637|NCT03701074|38238677|FG001|Overall Study|Physician Decision|0|||
17099638|NCT04728802|38238685|FG000|Overall Study|Withdrawal by Subject|4|||
17099639|NCT04728802|38238686|FG001|Overall Study|Withdrawal by Subject|20|||
17099640|NCT04728802|38238685|FG000|Overall Study|Physician Decision|7|||
17099641|NCT04728802|38238686|FG001|Overall Study|Physician Decision|7|||
17099642|NCT04728802|38238685|FG000|Overall Study|Protocol Violation|10|||
17099643|NCT04728802|38238686|FG001|Overall Study|Protocol Violation|4|||
17099644|NCT04728802|38238685|FG000|Overall Study|Transfer|1|||
17099645|NCT04728802|38238686|FG001|Overall Study|Transfer|0|||
17099646|NCT04728802|38238685|FG000|Overall Study|Death|4|||
17099647|NCT04728802|38238686|FG001|Overall Study|Death|5|||
17195817|NCT02394028|38349228|FG005|Induction Phase|Withdrawal by Subject|4|||
17099648|NCT04728802|38238685|FG000|Overall Study|Other|3|||
17099649|NCT04728802|38238686|FG001|Overall Study|Other|0|||
17099650|NCT00114530|38238694|FG000|Overall Study|Death|3|||
17099651|NCT00114530|38238695|FG001|Overall Study|Death|11|||
17099652|NCT00114530|38238694|FG000|Overall Study|Lost to Follow-up|1|||
17099653|NCT00114530|38238695|FG001|Overall Study|Lost to Follow-up|1|||
17099654|NCT00114530|38238694|FG000|Overall Study|Physician Decision|1|||
17099655|NCT00114530|38238695|FG001|Overall Study|Physician Decision|1|||
17099656|NCT00114530|38238694|FG000|Overall Study|Withdrawal by Subject|2|||
17099657|NCT00114530|38238695|FG001|Overall Study|Withdrawal by Subject|6|||
17099658|NCT00114530|38238694|FG000|Overall Study|Breast Cancer|1|||
17099659|NCT00114530|38238695|FG001|Overall Study|Breast Cancer|0|||
17099660|NCT00114530|38238694|FG000|Overall Study|Subject decision after endpoint failure|0|||
17099661|NCT00114530|38238695|FG001|Overall Study|Subject decision after endpoint failure|1|||
17099662|NCT00114530|38238694|FG000|Overall Study|Ineligible|1|||
17099663|NCT00114530|38238695|FG001|Overall Study|Ineligible|0|||
17099664|NCT04426318|38238707|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
17195818|NCT02394028|38349229|FG006|Induction Phase|Withdrawal by Subject|3|||
17195819|NCT02394028|38349230|FG007|Induction Phase|Withdrawal by Subject|6|||
17195820|NCT02394028|38349231|FG008|Induction Phase|Withdrawal by Subject|0|||
17195821|NCT02394028|38349232|FG009|Induction Phase|Withdrawal by Subject|0|||
17195822|NCT02394028|38349233|FG010|Induction Phase|Withdrawal by Subject|0|||
17195823|NCT02394028|38349223|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
17195824|NCT02394028|38349224|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
17195825|NCT02394028|38349225|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
17099665|NCT04426318|38238708|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
17099666|NCT04715932|38238716|FG000|Overall Study|Lost to Follow-up|1|||
17099667|NCT04715932|38238717|FG001|Overall Study|Lost to Follow-up|0|||
17099668|NCT00130832|38238725|FG000|Overall Study|Adverse Event|1|||
17099669|NCT00130832|38238726|FG001|Overall Study|Adverse Event|1|||
17099670|NCT00130832|38238725|FG000|Overall Study|Lost to Follow-up|1|||
17099671|NCT00130832|38238726|FG001|Overall Study|Lost to Follow-up|2|||
17099672|NCT00130832|38238725|FG000|Overall Study|Protocol Violation|6|||
17099673|NCT00130832|38238726|FG001|Overall Study|Protocol Violation|8|||
17099674|NCT00130832|38238725|FG000|Overall Study|Withdrawal by Subject|6|||
17195826|NCT02394028|38349226|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
17195827|NCT02394028|38349227|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
17195828|NCT02394028|38349228|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
17195829|NCT02394028|38349229|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
17099675|NCT00130832|38238726|FG001|Overall Study|Withdrawal by Subject|1|||
17099676|NCT00130832|38238725|FG000|Overall Study|Moved|2|||
17195830|NCT02394028|38349230|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
17195831|NCT02394028|38349231|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
17195832|NCT02394028|38349232|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
17195833|NCT02394028|38349233|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
17099677|NCT00130832|38238726|FG001|Overall Study|Moved|2|||
17099678|NCT00130832|38238725|FG000|Overall Study|Other|0|||
17099679|NCT00130832|38238726|FG001|Overall Study|Other|3|||
17099680|NCT00096018|38238734|FG000|Overall Study|Became Ineligible (not treated)|0|||
17099681|NCT00096018|38238735|FG001|Overall Study|Became Ineligible (not treated)|3|||
17099682|NCT00096018|38238734|FG000|Overall Study|Miscellaneous (not treated)|0|||
17099683|NCT00096018|38238735|FG001|Overall Study|Miscellaneous (not treated)|2|||
17099684|NCT00096018|38238734|FG000|Overall Study|Adverse Event|0|||
17099685|NCT00096018|38238735|FG001|Overall Study|Adverse Event|5|||
17099686|NCT00096018|38238734|FG000|Overall Study|Death|0|||
17099687|NCT00096018|38238735|FG001|Overall Study|Death|1|||
17099688|NCT00096018|38238734|FG000|Overall Study|Withdrawal by Subject|0|||
17099689|NCT00096018|38238735|FG001|Overall Study|Withdrawal by Subject|2|||
17099690|NCT00096018|38238734|FG000|Overall Study|Miscellaneous|2|||
17099691|NCT00096018|38238735|FG001|Overall Study|Miscellaneous|1|||
17099692|NCT04713748|38238741|FG000|Overall Study|Not enough kits allocated|35|||
17195834|NCT02394028|38349223|FG000|Induction Phase|Sponsor decision|0|||
17195835|NCT02394028|38349224|FG001|Induction Phase|Sponsor decision|1|||
17099693|NCT04706416|38238747|FG000|Overall Study|Lost to Follow-up|2|||
17099694|NCT04706416|38238748|FG001|Overall Study|Lost to Follow-up|0|||
17099695|NCT04702984|38238757|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
17195836|NCT02394028|38349225|FG002|Induction Phase|Sponsor decision|2|||
17195837|NCT02394028|38349226|FG003|Induction Phase|Sponsor decision|0|||
17195838|NCT02394028|38349227|FG004|Induction Phase|Sponsor decision|0|||
17195839|NCT02394028|38349228|FG005|Induction Phase|Sponsor decision|0|||
17195840|NCT02394028|38349229|FG006|Induction Phase|Sponsor decision|0|||
17195841|NCT02394028|38349230|FG007|Induction Phase|Sponsor decision|0|||
17195842|NCT02394028|38349231|FG008|Induction Phase|Sponsor decision|0|||
17099696|NCT04701658|38238763|FG000|Overall Study|Lost to Follow-up|6|||
17099697|NCT00128102|38238769|FG000|Overall Study|Site Discontinued|3|||
17099698|NCT00128102|38238770|FG001|Overall Study|Site Discontinued|6|||
17099699|NCT00128102|38238769|FG000|Overall Study|Other|0|||
17099700|NCT00128102|38238770|FG001|Overall Study|Other|1|||
17099701|NCT00128102|38238769|FG000|Overall Study|Progressive Disease|255|||
17099702|NCT00128102|38238770|FG001|Overall Study|Progressive Disease|285|||
17099703|NCT00128102|38238769|FG000|Overall Study|Adverse Event|34|||
17099704|NCT00128102|38238770|FG001|Overall Study|Adverse Event|11|||
17099705|NCT00128102|38238769|FG000|Overall Study|Death|12|||
17099706|NCT00128102|38238770|FG001|Overall Study|Death|13|||
17099707|NCT00128102|38238769|FG000|Overall Study|Physician Decision|3|||
17195843|NCT02394028|38349232|FG009|Induction Phase|Sponsor decision|0|||
17195844|NCT02394028|38349233|FG010|Induction Phase|Sponsor decision|0|||
17195845|NCT02394028|38349223|FG000|Induction Phase|Technical reason|0|||
17195846|NCT02394028|38349224|FG001|Induction Phase|Technical reason|0|||
17195847|NCT02394028|38349225|FG002|Induction Phase|Technical reason|0|||
17099708|NCT00128102|38238770|FG001|Overall Study|Physician Decision|3|||
17099709|NCT00128102|38238769|FG000|Overall Study|Withdrawal by Subject|19|||
17099710|NCT00128102|38238770|FG001|Overall Study|Withdrawal by Subject|11|||
17099711|NCT00128102|38238769|FG000|Overall Study|Protocol Violation|2|||
17099712|NCT00128102|38238770|FG001|Overall Study|Protocol Violation|2|||
17099713|NCT04668274|38238776|FG000|Part 1 Study Period 1|Adverse Event|3|||
17099714|NCT04668274|38238777|FG001|Part 1 Study Period 1|Adverse Event|0|||
17099715|NCT04668274|38238778|FG002|Part 1 Study Period 1|Adverse Event|0|||
17099716|NCT04668274|38238779|FG003|Part 1 Study Period 1|Adverse Event|0|||
17099717|NCT04668274|38238776|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
17099718|NCT04668274|38238777|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
17099719|NCT04668274|38238778|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
17099720|NCT04668274|38238779|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
17099721|NCT04668274|38238776|FG000|Part 1 Study Period 2|Other|0|||
17099722|NCT04668274|38238777|FG001|Part 1 Study Period 2|Other|1|||
17099723|NCT04668274|38238778|FG002|Part 1 Study Period 2|Other|0|||
17099724|NCT04668274|38238779|FG003|Part 1 Study Period 2|Other|0|||
17099725|NCT04668274|38238776|FG000|Part 1 Study Period 3|Adverse Event|0|||
17099726|NCT04668274|38238777|FG001|Part 1 Study Period 3|Adverse Event|0|||
17099727|NCT04668274|38238778|FG002|Part 1 Study Period 3|Adverse Event|1|||
17195848|NCT02394028|38349226|FG003|Induction Phase|Technical reason|1|||
17195849|NCT02394028|38349227|FG004|Induction Phase|Technical reason|0|||
17195850|NCT02394028|38349228|FG005|Induction Phase|Technical reason|0|||
17195851|NCT02394028|38349229|FG006|Induction Phase|Technical reason|0|||
17195852|NCT02394028|38349230|FG007|Induction Phase|Technical reason|0|||
17195853|NCT02394028|38349231|FG008|Induction Phase|Technical reason|0|||
17014867|NCT00853242|38159674|FG001|Overall Study|Noncompliant|0|||
17014868|NCT00853242|38159675|FG002|Overall Study|Noncompliant|0|||
17014869|NCT00853242|38159676|FG003|Overall Study|Noncompliant|0|||
17014870|NCT00853242|38159677|FG004|Overall Study|Noncompliant|1|||
17014871|NCT00853242|38159678|FG005|Overall Study|Noncompliant|0|||
17014872|NCT00853242|38159679|FG006|Overall Study|Noncompliant|0|||
17099728|NCT04668274|38238779|FG003|Part 1 Study Period 3|Adverse Event|0|||
17099729|NCT04668274|38238776|FG000|Part 1 Study Period 3|Other|0|||
17099730|NCT04668274|38238777|FG001|Part 1 Study Period 3|Other|0|||
17099731|NCT04668274|38238778|FG002|Part 1 Study Period 3|Other|2|||
17099732|NCT04668274|38238779|FG003|Part 1 Study Period 3|Other|0|||
17099733|NCT04668274|38238776|FG000|Part 2 Study Period 4|Other|0|||
17099734|NCT04668274|38238777|FG001|Part 2 Study Period 4|Other|0|||
17099735|NCT04668274|38238778|FG002|Part 2 Study Period 4|Other|0|||
17099736|NCT04668274|38238779|FG003|Part 2 Study Period 4|Other|1|||
17099737|NCT04406194|38238794|FG000|Period 1|Withdrawal by Subject|0|||
17099738|NCT04406194|38238795|FG001|Period 1|Withdrawal by Subject|1|||
17099739|NCT03822884|38238810|FG000|Overall Study|Withdrawal by Subject|0|||
17099740|NCT03822884|38238811|FG001|Overall Study|Withdrawal by Subject|0|||
17099741|NCT03822884|38238812|FG002|Overall Study|Withdrawal by Subject|0|||
17099742|NCT03822884|38238813|FG003|Overall Study|Withdrawal by Subject|0|||
17099743|NCT03822884|38238814|FG004|Overall Study|Withdrawal by Subject|1|||
17014873|NCT00853242|38159673|FG000|Overall Study|Withdrawal by Subject|1|||
17014874|NCT00853242|38159674|FG001|Overall Study|Withdrawal by Subject|2|||
17014875|NCT00853242|38159675|FG002|Overall Study|Withdrawal by Subject|0|||
17014876|NCT00853242|38159676|FG003|Overall Study|Withdrawal by Subject|4|||
17014877|NCT00853242|38159677|FG004|Overall Study|Withdrawal by Subject|0|||
17014878|NCT00853242|38159678|FG005|Overall Study|Withdrawal by Subject|0|||
17014879|NCT00853242|38159679|FG006|Overall Study|Withdrawal by Subject|2|||
17014880|NCT00853242|38159673|FG000|Overall Study|Other|2|||
17014881|NCT00853242|38159674|FG001|Overall Study|Other|0|||
17014882|NCT00853242|38159675|FG002|Overall Study|Other|2|||
17099744|NCT03822884|38238815|FG005|Overall Study|Withdrawal by Subject|0|||
17099745|NCT03822416|38238825|FG000|Overall Study|Lost to Follow-up|1|||
17099746|NCT03822416|38238826|FG001|Overall Study|Lost to Follow-up|0|||
17195854|NCT02394028|38349232|FG009|Induction Phase|Technical reason|0|||
17195855|NCT02394028|38349233|FG010|Induction Phase|Technical reason|0|||
17195856|NCT02394028|38349223|FG000|Induction Phase|:ack of calculation|0|||
17195857|NCT02394028|38349224|FG001|Induction Phase|:ack of calculation|0|||
17195858|NCT02394028|38349225|FG002|Induction Phase|:ack of calculation|0|||
17195859|NCT02394028|38349226|FG003|Induction Phase|:ack of calculation|0|||
17195860|NCT02394028|38349227|FG004|Induction Phase|:ack of calculation|0|||
17014883|NCT00853242|38159676|FG003|Overall Study|Other|0|||
17014884|NCT00853242|38159677|FG004|Overall Study|Other|0|||
17014885|NCT00853242|38159678|FG005|Overall Study|Other|1|||
17099747|NCT03822416|38238825|FG000|Overall Study|Withdrawal by Subject|0|||
17099748|NCT03822416|38238826|FG001|Overall Study|Withdrawal by Subject|1|||
17195861|NCT02394028|38349228|FG005|Induction Phase|:ack of calculation|0|||
17195862|NCT02394028|38349229|FG006|Induction Phase|:ack of calculation|0|||
17195863|NCT02394028|38349230|FG007|Induction Phase|:ack of calculation|1|||
17195864|NCT02394028|38349231|FG008|Induction Phase|:ack of calculation|0|||
17195865|NCT02394028|38349232|FG009|Induction Phase|:ack of calculation|0|||
17195866|NCT02394028|38349233|FG010|Induction Phase|:ack of calculation|0|||
17195867|NCT02394028|38349223|FG000|Maintenance Phase|Protocol Violation|0|||
17195868|NCT02394028|38349224|FG001|Maintenance Phase|Protocol Violation|0|||
17195869|NCT02394028|38349225|FG002|Maintenance Phase|Protocol Violation|0|||
17195870|NCT02394028|38349226|FG003|Maintenance Phase|Protocol Violation|0|||
17195871|NCT02394028|38349227|FG004|Maintenance Phase|Protocol Violation|0|||
17195872|NCT02394028|38349228|FG005|Maintenance Phase|Protocol Violation|0|||
17195873|NCT02394028|38349229|FG006|Maintenance Phase|Protocol Violation|0|||
17099749|NCT04405570|38238836|FG000|Overall Study|Adverse Event|0|||
17099750|NCT04405570|38238837|FG001|Overall Study|Adverse Event|1|||
17099751|NCT04405570|38238838|FG002|Overall Study|Adverse Event|1|||
17099752|NCT04405570|38238839|FG003|Overall Study|Adverse Event|1|||
17195874|NCT02394028|38349230|FG007|Maintenance Phase|Protocol Violation|0|||
17195875|NCT02394028|38349231|FG008|Maintenance Phase|Protocol Violation|0|||
17195876|NCT02394028|38349232|FG009|Maintenance Phase|Protocol Violation|0|||
17195877|NCT02394028|38349233|FG010|Maintenance Phase|Protocol Violation|1|||
17195878|NCT02394028|38349223|FG000|Maintenance Phase|Physician Decision|0|||
17195879|NCT02394028|38349224|FG001|Maintenance Phase|Physician Decision|0|||
17195880|NCT02394028|38349225|FG002|Maintenance Phase|Physician Decision|0|||
17195881|NCT02394028|38349226|FG003|Maintenance Phase|Physician Decision|0|||
17195882|NCT02394028|38349227|FG004|Maintenance Phase|Physician Decision|0|||
17195883|NCT02394028|38349228|FG005|Maintenance Phase|Physician Decision|0|||
17195884|NCT02394028|38349229|FG006|Maintenance Phase|Physician Decision|0|||
17195885|NCT02394028|38349230|FG007|Maintenance Phase|Physician Decision|0|||
17195886|NCT02394028|38349231|FG008|Maintenance Phase|Physician Decision|1|||
17195887|NCT02394028|38349232|FG009|Maintenance Phase|Physician Decision|3|||
17195888|NCT02394028|38349233|FG010|Maintenance Phase|Physician Decision|2|||
17195889|NCT02394028|38349223|FG000|Maintenance Phase|Lack of Efficacy|0|||
17195890|NCT02394028|38349224|FG001|Maintenance Phase|Lack of Efficacy|0|||
17195891|NCT02394028|38349225|FG002|Maintenance Phase|Lack of Efficacy|0|||
17195892|NCT02394028|38349226|FG003|Maintenance Phase|Lack of Efficacy|0|||
17099753|NCT04405570|38238836|FG000|Overall Study|Lost to Follow-up|0|||
17099754|NCT04405570|38238837|FG001|Overall Study|Lost to Follow-up|1|||
17099755|NCT04405570|38238838|FG002|Overall Study|Lost to Follow-up|0|||
17099756|NCT04405570|38238839|FG003|Overall Study|Lost to Follow-up|0|||
17099757|NCT04405570|38238836|FG000|Overall Study|Physician Decision|0|||
17099758|NCT04405570|38238837|FG001|Overall Study|Physician Decision|0|||
17195893|NCT02394028|38349227|FG004|Maintenance Phase|Lack of Efficacy|0|||
17195894|NCT02394028|38349228|FG005|Maintenance Phase|Lack of Efficacy|0|||
17195895|NCT02394028|38349229|FG006|Maintenance Phase|Lack of Efficacy|0|||
17195896|NCT02394028|38349230|FG007|Maintenance Phase|Lack of Efficacy|0|||
17195897|NCT02394028|38349231|FG008|Maintenance Phase|Lack of Efficacy|7|||
17099759|NCT04405570|38238838|FG002|Overall Study|Physician Decision|1|||
17099760|NCT04405570|38238839|FG003|Overall Study|Physician Decision|0|||
17099761|NCT04405570|38238836|FG000|Overall Study|Withdrawal by Subject|0|||
17099762|NCT04405570|38238837|FG001|Overall Study|Withdrawal by Subject|1|||
17195898|NCT02394028|38349232|FG009|Maintenance Phase|Lack of Efficacy|25|||
17195899|NCT02394028|38349233|FG010|Maintenance Phase|Lack of Efficacy|33|||
17195900|NCT02394028|38349223|FG000|Maintenance Phase|Death|0|||
17195901|NCT02394028|38349224|FG001|Maintenance Phase|Death|0|||
17099763|NCT04405570|38238838|FG002|Overall Study|Withdrawal by Subject|1|||
17099764|NCT04405570|38238839|FG003|Overall Study|Withdrawal by Subject|0|||
17099765|NCT04405570|38238836|FG000|Overall Study|Randomized not dosed|0|||
17099766|NCT04405570|38238837|FG001|Overall Study|Randomized not dosed|2|||
17099767|NCT04405570|38238838|FG002|Overall Study|Randomized not dosed|0|||
17099768|NCT04405570|38238839|FG003|Overall Study|Randomized not dosed|0|||
17195902|NCT02394028|38349225|FG002|Maintenance Phase|Death|0|||
17195903|NCT02394028|38349226|FG003|Maintenance Phase|Death|0|||
17195904|NCT02394028|38349227|FG004|Maintenance Phase|Death|0|||
17195905|NCT02394028|38349228|FG005|Maintenance Phase|Death|0|||
17195906|NCT02394028|38349229|FG006|Maintenance Phase|Death|0|||
17195907|NCT02394028|38349230|FG007|Maintenance Phase|Death|0|||
17195908|NCT02394028|38349231|FG008|Maintenance Phase|Death|0|||
17099769|NCT00127712|38238854|FG000|Overall Study|Adverse Event|3|||
17099770|NCT00127712|38238855|FG001|Overall Study|Adverse Event|0|||
17099771|NCT00127712|38238854|FG000|Overall Study|Lack of GI access to continue|2|||
17195909|NCT02394028|38349232|FG009|Maintenance Phase|Death|0|||
17195910|NCT02394028|38349233|FG010|Maintenance Phase|Death|1|||
17195911|NCT02394028|38349223|FG000|Maintenance Phase|Adverse Event|0|||
17099772|NCT00127712|38238855|FG001|Overall Study|Lack of GI access to continue|0|||
17195912|NCT02394028|38349224|FG001|Maintenance Phase|Adverse Event|0|||
17195913|NCT02394028|38349225|FG002|Maintenance Phase|Adverse Event|0|||
17195914|NCT02394028|38349226|FG003|Maintenance Phase|Adverse Event|0|||
17014886|NCT00853242|38159679|FG006|Overall Study|Other|2|||
17014887|NCT00848250|38159703|FG000|Overall Study|surgery was completed without cardiopulm|0|||
17014888|NCT00848250|38159704|FG001|Overall Study|surgery was completed without cardiopulm|1|||
17014889|NCT00809757|38159714|FG000|Overall Study|Adverse Event|2|||
17014890|NCT00809757|38159715|FG001|Overall Study|Adverse Event|3|||
17014891|NCT00809757|38159716|FG002|Overall Study|Adverse Event|3|||
17014892|NCT00809757|38159714|FG000|Overall Study|Lost to Follow-up|0|||
17014893|NCT00809757|38159715|FG001|Overall Study|Lost to Follow-up|0|||
17014894|NCT00809757|38159716|FG002|Overall Study|Lost to Follow-up|1|||
17014895|NCT00809757|38159714|FG000|Overall Study|Protocol Violation|1|||
17014896|NCT00809757|38159715|FG001|Overall Study|Protocol Violation|1|||
17014897|NCT00809757|38159716|FG002|Overall Study|Protocol Violation|1|||
17014898|NCT00809757|38159714|FG000|Overall Study|Withdrawal by Subject|2|||
17014899|NCT00809757|38159715|FG001|Overall Study|Withdrawal by Subject|1|||
17014900|NCT00809757|38159716|FG002|Overall Study|Withdrawal by Subject|3|||
17014901|NCT00809757|38159714|FG000|Overall Study|Subject Uncooperative|1|||
17014902|NCT00809757|38159715|FG001|Overall Study|Subject Uncooperative|0|||
17014903|NCT00809757|38159716|FG002|Overall Study|Subject Uncooperative|2|||
17014904|NCT00809757|38159714|FG000|Overall Study|Noncompliance with Medication|0|||
17014905|NCT00809757|38159715|FG001|Overall Study|Noncompliance with Medication|0|||
17014906|NCT00809757|38159716|FG002|Overall Study|Noncompliance with Medication|1|||
17099773|NCT04404010|38238863|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
17099774|NCT04404010|38238864|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
17099775|NCT04401202|38238874|FG000|Overall Study|Lost to Follow-up|2|||
17099776|NCT04401202|38238875|FG001|Overall Study|Lost to Follow-up|2|||
17099777|NCT04401202|38238874|FG000|Overall Study|Adverse Event|0|||
17099778|NCT04401202|38238875|FG001|Overall Study|Adverse Event|1|||
17099779|NCT04401202|38238874|FG000|Overall Study|Hospitalized|4|||
17099780|NCT04401202|38238875|FG001|Overall Study|Hospitalized|1|||
17099781|NCT00096356|38238884|FG000|Overall Study|Adverse Event|11|||
17099782|NCT00096356|38238885|FG001|Overall Study|Adverse Event|9|||
17099783|NCT00096356|38238884|FG000|Overall Study|Physician Decision|5|||
17099784|NCT00096356|38238885|FG001|Overall Study|Physician Decision|3|||
17099785|NCT00096356|38238884|FG000|Overall Study|Withdrawal by Subject|17|||
17099786|NCT00096356|38238885|FG001|Overall Study|Withdrawal by Subject|23|||
17099787|NCT00096356|38238884|FG000|Overall Study|Lack of Efficacy|1|||
17099788|NCT00096356|38238885|FG001|Overall Study|Lack of Efficacy|0|||
17099789|NCT00096356|38238884|FG000|Overall Study|multiple reasons|10|||
17099790|NCT00096356|38238885|FG001|Overall Study|multiple reasons|18|||
17099791|NCT04391842|38238892|FG000|Overall Study|Withdrawal by Subject|2|||
17099792|NCT04358068|38238898|FG000|Overall Study|Did not initiate study treatment|2|||
17099793|NCT04358068|38238899|FG001|Overall Study|Did not initiate study treatment|2|||
17099794|NCT03694210|38238905|FG000|Overall Study|Death|1|||
17099795|NCT03694210|38238905|FG000|Overall Study|Screen Failure|7|||
17099796|NCT04339972|38238913|FG000|Overall Study|Scheduling Issues|3|||
17099797|NCT04339972|38238914|FG001|Overall Study|Scheduling Issues|3|||
17099798|NCT04339972|38238913|FG000|Overall Study|dropout|1|||
17099799|NCT04339972|38238914|FG001|Overall Study|dropout|1|||
17099800|NCT04339972|38238913|FG000|Overall Study|Technical issues|1|||
17099801|NCT04339972|38238914|FG001|Overall Study|Technical issues|0|||
17099802|NCT04339972|38238913|FG000|Overall Study|Claustraphobia|0|||
17099803|NCT04339972|38238914|FG001|Overall Study|Claustraphobia|1|||
17099804|NCT00096278|38238922|FG000|Overall Study|No follow-up data|15|||
17099805|NCT00096278|38238923|FG001|Overall Study|No follow-up data|18|||
17099806|NCT00096278|38238922|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
17099807|NCT00096278|38238923|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
17099808|NCT00095940|38238938|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
17195915|NCT02394028|38349227|FG004|Maintenance Phase|Adverse Event|0|||
17195916|NCT02394028|38349228|FG005|Maintenance Phase|Adverse Event|0|||
17195917|NCT02394028|38349229|FG006|Maintenance Phase|Adverse Event|0|||
17195918|NCT02394028|38349230|FG007|Maintenance Phase|Adverse Event|0|||
17195919|NCT02394028|38349231|FG008|Maintenance Phase|Adverse Event|1|||
17195920|NCT02394028|38349232|FG009|Maintenance Phase|Adverse Event|1|||
17195921|NCT02394028|38349233|FG010|Maintenance Phase|Adverse Event|3|||
17195922|NCT02394028|38349223|FG000|Maintenance Phase|Site closure|0|||
17195923|NCT02394028|38349224|FG001|Maintenance Phase|Site closure|0|||
17195924|NCT02394028|38349225|FG002|Maintenance Phase|Site closure|0|||
17195925|NCT02394028|38349226|FG003|Maintenance Phase|Site closure|0|||
17195926|NCT02394028|38349227|FG004|Maintenance Phase|Site closure|0|||
17195927|NCT02394028|38349228|FG005|Maintenance Phase|Site closure|0|||
17195928|NCT02394028|38349229|FG006|Maintenance Phase|Site closure|0|||
17195929|NCT02394028|38349230|FG007|Maintenance Phase|Site closure|0|||
17195930|NCT02394028|38349231|FG008|Maintenance Phase|Site closure|0|||
17195931|NCT02394028|38349232|FG009|Maintenance Phase|Site closure|1|||
17195932|NCT02394028|38349233|FG010|Maintenance Phase|Site closure|0|||
17195933|NCT02394028|38349223|FG000|Maintenance Phase|Withdrawal by Subject|0|||
17195934|NCT02394028|38349224|FG001|Maintenance Phase|Withdrawal by Subject|0|||
17195935|NCT02394028|38349225|FG002|Maintenance Phase|Withdrawal by Subject|0|||
17195936|NCT02394028|38349226|FG003|Maintenance Phase|Withdrawal by Subject|0|||
17195937|NCT02394028|38349227|FG004|Maintenance Phase|Withdrawal by Subject|0|||
17195938|NCT02394028|38349228|FG005|Maintenance Phase|Withdrawal by Subject|0|||
17195939|NCT02394028|38349229|FG006|Maintenance Phase|Withdrawal by Subject|0|||
17195940|NCT02394028|38349230|FG007|Maintenance Phase|Withdrawal by Subject|0|||
17195941|NCT02394028|38349231|FG008|Maintenance Phase|Withdrawal by Subject|3|||
17195942|NCT02394028|38349232|FG009|Maintenance Phase|Withdrawal by Subject|12|||
17195943|NCT02394028|38349233|FG010|Maintenance Phase|Withdrawal by Subject|12|||
17195944|NCT01371539|38349287|FG000|Period One: One Week|Lost to Follow-up|0|||
17195945|NCT01371539|38349288|FG001|Period One: One Week|Lost to Follow-up|1|||
17195946|NCT01371539|38349287|FG000|Period Two: One Week|Lost to Follow-up|0|||
17195947|NCT01371539|38349288|FG001|Period Two: One Week|Lost to Follow-up|1|||
17195948|NCT01371539|38349287|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
17195949|NCT01371539|38349288|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
17195950|NCT01371539|38349287|FG000|Period Two: One Week|Time/job conflict|0|||
17195951|NCT01371539|38349288|FG001|Period Two: One Week|Time/job conflict|1|||
17099809|NCT00095940|38238939|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
17099810|NCT00095940|38238940|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
17195952|NCT03320330|38349297|FG000|Overall Study|Lack of Efficacy|5|||
17195953|NCT03320330|38349298|FG001|Overall Study|Lack of Efficacy|5|||
17195954|NCT03320330|38349299|FG002|Overall Study|Lack of Efficacy|14|||
17195955|NCT03320330|38349297|FG000|Overall Study|Physician Decision|1|||
17195956|NCT03320330|38349298|FG001|Overall Study|Physician Decision|0|||
17195957|NCT03320330|38349299|FG002|Overall Study|Physician Decision|0|||
17099811|NCT00095940|38238941|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
17099812|NCT00095940|38238942|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
17195958|NCT02819297|38349310|FG000|Overall Study|Withdrawal by Subject|25|||
17195959|NCT02819297|38349311|FG001|Overall Study|Withdrawal by Subject|13|||
17195960|NCT02819297|38349310|FG000|Overall Study|Lost to Follow-up|12|||
17195961|NCT02819297|38349311|FG001|Overall Study|Lost to Follow-up|14|||
17195962|NCT02819297|38349310|FG000|Overall Study|Adverse Event|12|||
17195963|NCT02819297|38349311|FG001|Overall Study|Adverse Event|10|||
17195964|NCT02819297|38349310|FG000|Overall Study|Physician Decision|5|||
17195965|NCT02819297|38349311|FG001|Overall Study|Physician Decision|5|||
17195966|NCT02819297|38349310|FG000|Overall Study|Lack of Efficacy|5|||
17195967|NCT02819297|38349311|FG001|Overall Study|Lack of Efficacy|8|||
17195968|NCT02819297|38349310|FG000|Overall Study|Protocol Violation|1|||
17195969|NCT02819297|38349311|FG001|Overall Study|Protocol Violation|2|||
17195970|NCT02429830|38349317|FG000|Overall Study|Lost to Follow-up|1|||
17195971|NCT02429830|38349317|FG000|Overall Study|Device Explant|2|||
17195972|NCT02821715|38349321|FG000|Overall Study|Protocol Violation|1|||
17195973|NCT02821715|38349322|FG001|Overall Study|Protocol Violation|0|||
17195974|NCT02821715|38349323|FG002|Overall Study|Protocol Violation|0|||
16786504|NCT01674569|37727022|FG002|Overall Study|Protocol Violation|1|||
16786505|NCT01674569|37727023|FG003|Overall Study|Protocol Violation|0|||
16786506|NCT01674569|37727024|FG004|Overall Study|Protocol Violation|0|||
17014907|NCT00594464|38159730|FG000|Overall Study|Withdrawal by Subject|1|||
17014908|NCT00594464|38159730|FG000|Overall Study|Delay in operation|2|||
17014909|NCT00809445|38159743|FG000|1 Month Follow-up|Lost contact|1|||
17014910|NCT00809445|38159744|FG001|1 Month Follow-up|Lost contact|2|||
17014911|NCT00809445|38159745|FG002|1 Month Follow-up|Lost contact|1|||
17014912|NCT00809445|38159743|FG000|1 Month Follow-up|Withdrew consent|1|||
17014913|NCT00809445|38159744|FG001|1 Month Follow-up|Withdrew consent|1|||
17014914|NCT00809445|38159745|FG002|1 Month Follow-up|Withdrew consent|1|||
17014915|NCT00809445|38159743|FG000|1 Month Follow-up|Death|0|||
17014916|NCT00809445|38159744|FG001|1 Month Follow-up|Death|1|||
17014917|NCT00809445|38159745|FG002|1 Month Follow-up|Death|1|||
16786507|NCT01674569|37727025|FG005|Overall Study|Protocol Violation|0|||
16786508|NCT01674569|37727020|FG000|Overall Study|Withdrawal by Subject|0|||
16786509|NCT01674569|37727021|FG001|Overall Study|Withdrawal by Subject|0|||
16786510|NCT01674569|37727022|FG002|Overall Study|Withdrawal by Subject|1|||
16786511|NCT01674569|37727023|FG003|Overall Study|Withdrawal by Subject|0|||
16786512|NCT01674569|37727024|FG004|Overall Study|Withdrawal by Subject|0|||
16786513|NCT01674569|37727025|FG005|Overall Study|Withdrawal by Subject|0|||
16786514|NCT01374217|37727029|FG000|Overall Study|Lack of Efficacy|13|||
16786515|NCT01674647|37727035|FG000|Treatment Period|Death|4|||
16786516|NCT01674647|37727036|FG001|Treatment Period|Death|1|||
17099813|NCT00095940|38238943|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
17099814|NCT00095940|38238944|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
17099815|NCT00095940|38238945|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
17099816|NCT00095940|38238946|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
17099817|NCT00095940|38238938|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
17099818|NCT00095940|38238939|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
17099819|NCT00095940|38238940|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
17099820|NCT00095940|38238941|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
17099821|NCT00095940|38238942|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
17099822|NCT00095940|38238943|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
17099823|NCT00095940|38238944|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
17099824|NCT00095940|38238945|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
17099825|NCT00095940|38238946|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
17099826|NCT00095940|38238938|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
17099827|NCT00095940|38238939|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
17099828|NCT00095940|38238940|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
17099829|NCT00095940|38238941|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
17099830|NCT00095940|38238942|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
17099831|NCT00095940|38238943|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
17099832|NCT00095940|38238944|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
17099833|NCT00095940|38238945|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
17099834|NCT00095940|38238946|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
17099835|NCT00114218|38238964|FG000|Overall Study|Wrong Cell Type|2|||
17099836|NCT00114218|38238964|FG000|Overall Study|Wrong Primary|1|||
17099837|NCT00114218|38238964|FG000|Overall Study|Never Treated|1|||
17099838|NCT04380688|38238970|FG000|Overall Study|Death|2|||
17099839|NCT04380688|38238971|FG001|Overall Study|Death|2|||
17099840|NCT04380688|38238970|FG000|Overall Study|Lost to Follow-up|2|||
17099841|NCT04380688|38238971|FG001|Overall Study|Lost to Follow-up|4|||
17099842|NCT04380688|38238970|FG000|Overall Study|Withdrawal by Subject|3|||
17099843|NCT04380688|38238971|FG001|Overall Study|Withdrawal by Subject|3|||
17099844|NCT00095628|38238977|FG000|Overall Study|Disease progression prior to treatment|1|||
17099845|NCT04380142|38238983|FG000|LD/CD Stabilization Period|Adverse Event|3|||
17099846|NCT04380142|38238984|FG001|LD/CD Stabilization Period|Adverse Event|0|||
17099847|NCT04380142|38238985|FG002|LD/CD Stabilization Period|Adverse Event|0|||
17099848|NCT04380142|38238983|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
17099849|NCT04380142|38238984|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
17099850|NCT04380142|38238985|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
17099851|NCT04380142|38238983|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
17099852|NCT04380142|38238984|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
17099853|NCT04380142|38238985|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
17099854|NCT04380142|38238983|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
17099855|NCT04380142|38238984|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
17099856|NCT04380142|38238985|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
17099857|NCT04380142|38238983|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
17099858|NCT04380142|38238984|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
17099859|NCT04380142|38238985|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
17099860|NCT04380142|38238983|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
17099861|NCT04380142|38238984|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
17099862|NCT04380142|38238985|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
17099863|NCT04380142|38238983|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16786517|NCT01674647|37727035|FG000|Treatment Period|Efficacy outcome reached|0|||
16786518|NCT01674647|37727036|FG001|Treatment Period|Efficacy outcome reached|1|||
17014918|NCT00809445|38159743|FG000|1 Month Follow-up|Incarcerated|0|||
17014919|NCT00809445|38159744|FG001|1 Month Follow-up|Incarcerated|0|||
17014920|NCT00809445|38159745|FG002|1 Month Follow-up|Incarcerated|1|||
17014921|NCT00809445|38159743|FG000|6 Month Follow-up|Lost contact|16|||
17014922|NCT00809445|38159744|FG001|6 Month Follow-up|Lost contact|14|||
17014923|NCT00809445|38159745|FG002|6 Month Follow-up|Lost contact|14|||
17014924|NCT00809445|38159743|FG000|6 Month Follow-up|Death|2|||
17014925|NCT00809445|38159744|FG001|6 Month Follow-up|Death|1|||
17014926|NCT00809445|38159745|FG002|6 Month Follow-up|Death|1|||
17099864|NCT04380142|38238984|FG001|Double-Blind Treatment Period|Adverse Event|1|||
17099865|NCT04380142|38238985|FG002|Double-Blind Treatment Period|Adverse Event|14|||
17099866|NCT04380142|38238983|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
17099867|NCT04380142|38238984|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
17099868|NCT04380142|38238985|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
17099869|NCT04380142|38238983|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
17099870|NCT04380142|38238984|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
17099871|NCT04380142|38238985|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
17195975|NCT02821715|38349324|FG003|Overall Study|Protocol Violation|0|||
17195976|NCT02821715|38349325|FG004|Overall Study|Protocol Violation|0|||
17195977|NCT02821715|38349326|FG005|Overall Study|Protocol Violation|0|||
17195978|NCT02813681|38349337|FG000|Overall Study|Physician Decision|5|||
17195979|NCT02813681|38349338|FG001|Overall Study|Physician Decision|5|||
17195980|NCT02813681|38349339|FG002|Overall Study|Physician Decision|0|||
17195981|NCT02813681|38349337|FG000|Overall Study|Lost to Follow-up|0|||
17195982|NCT02813681|38349338|FG001|Overall Study|Lost to Follow-up|1|||
17195983|NCT02813681|38349339|FG002|Overall Study|Lost to Follow-up|0|||
17195984|NCT02393950|38349351|FG000|Overall Study|Adverse Event|1|||
17195985|NCT02393950|38349352|FG001|Overall Study|Adverse Event|0|||
17195986|NCT02393950|38349351|FG000|Overall Study|Withdrawal by Subject|0|||
17195987|NCT02393950|38349352|FG001|Overall Study|Withdrawal by Subject|1|||
17195988|NCT02815397|38349387|FG000|Overall Study|Physician Decision|2|||
17195989|NCT02427958|38349391|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
17195990|NCT02427958|38349391|FG000|Overall Study|Lost to Follow-up|6|||
17195991|NCT02427958|38349391|FG000|Overall Study|Withdrawal by Subject|14|||
17195992|NCT02427958|38349391|FG000|Overall Study|Lack of Efficacy|1|||
17195993|NCT02392624|38349398|FG000|Overall Study|Withdrawal by Subject|15|||
17195994|NCT02392624|38349399|FG001|Overall Study|Withdrawal by Subject|12|||
17195995|NCT02392624|38349400|FG002|Overall Study|Withdrawal by Subject|9|||
17195996|NCT02392624|38349398|FG000|Overall Study|Adverse Event|4|||
17195997|NCT02392624|38349399|FG001|Overall Study|Adverse Event|1|||
17195998|NCT02392624|38349400|FG002|Overall Study|Adverse Event|2|||
17195999|NCT02392624|38349398|FG000|Overall Study|Pregnancy|1|||
17196000|NCT02392624|38349399|FG001|Overall Study|Pregnancy|0|||
17196001|NCT02392624|38349400|FG002|Overall Study|Pregnancy|0|||
17196002|NCT02392624|38349398|FG000|Overall Study|Protocol Violation|0|||
17196003|NCT02392624|38349399|FG001|Overall Study|Protocol Violation|0|||
17196004|NCT02392624|38349400|FG002|Overall Study|Protocol Violation|1|||
17196005|NCT02392624|38349398|FG000|Overall Study|Sponsor/Investigator Decision|2|||
17196006|NCT02392624|38349399|FG001|Overall Study|Sponsor/Investigator Decision|1|||
17196007|NCT02392624|38349400|FG002|Overall Study|Sponsor/Investigator Decision|0|||
17196008|NCT02392624|38349398|FG000|Overall Study|Other|49|||
17196009|NCT02392624|38349399|FG001|Overall Study|Other|1|||
17196010|NCT02392624|38349400|FG002|Overall Study|Other|1|||
17196011|NCT04325828|38349408|FG000|Overall Study|Ongoing|26|||
17196012|NCT02387164|38349414|FG000|Overall Study|Lost to Follow-up|2|||
17196013|NCT02387164|38349415|FG001|Overall Study|Lost to Follow-up|0|||
17196014|NCT02387164|38349414|FG000|Overall Study|Diagnosed|1|||
17196015|NCT02387164|38349415|FG001|Overall Study|Diagnosed|2|||
17196016|NCT02392234|38349433|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
16786519|NCT01674647|37727035|FG000|Treatment Period|Physician Decision|3|||
16786520|NCT01674647|37727036|FG001|Treatment Period|Physician Decision|1|||
16786521|NCT01674647|37727035|FG000|Treatment Period|Adverse Event|60|||
16786522|NCT01674647|37727036|FG001|Treatment Period|Adverse Event|22|||
16786523|NCT01674647|37727035|FG000|Treatment Period|Non-compliance with study drug|3|||
16786524|NCT01674647|37727036|FG001|Treatment Period|Non-compliance with study drug|0|||
16786525|NCT01674647|37727035|FG000|Treatment Period|Lost to Follow-up|1|||
16786526|NCT01674647|37727036|FG001|Treatment Period|Lost to Follow-up|1|||
16786527|NCT01674647|37727035|FG000|Treatment Period|Withdrawal by Subject|19|||
16786528|NCT01674647|37727036|FG001|Treatment Period|Withdrawal by Subject|16|||
16786529|NCT01674647|37727035|FG000|Treatment Period|Switching to other therapy|5|||
16786530|NCT01674647|37727036|FG001|Treatment Period|Switching to other therapy|2|||
16786531|NCT01674647|37727035|FG000|Treatment Period|Logistical difficulties|5|||
16786532|NCT01674647|37727036|FG001|Treatment Period|Logistical difficulties|8|||
16786533|NCT01674647|37727035|FG000|Treatment Period|Treatment failure|0|||
16786534|NCT01674647|37727036|FG001|Treatment Period|Treatment failure|14|||
16786535|NCT01674647|37727035|FG000|Treatment Period|Protocol Violation|56|||
16786536|NCT01674647|37727036|FG001|Treatment Period|Protocol Violation|36|||
16786537|NCT01674647|37727035|FG000|30-day Safety Follow-up Period|Death|3|||
16786538|NCT01674647|37727036|FG001|30-day Safety Follow-up Period|Death|2|||
17099872|NCT04380142|38238983|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
17196017|NCT02392234|38349434|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
17196018|NCT02392234|38349435|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
16786539|NCT01674647|37727035|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
16786540|NCT01674647|37727036|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
16786541|NCT01674647|37727035|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
17196019|NCT02392234|38349436|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
17196020|NCT02392234|38349437|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
17196021|NCT02392234|38349438|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
17196022|NCT02392234|38349433|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
17196023|NCT02392234|38349434|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
17196024|NCT02392234|38349435|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
17196025|NCT02392234|38349436|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
17196026|NCT02392234|38349437|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
17196027|NCT02392234|38349438|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
17196028|NCT02392234|38349433|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
17196029|NCT02392234|38349434|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
17196030|NCT02392234|38349435|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
17196031|NCT02392234|38349436|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
17196032|NCT02392234|38349437|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
17196033|NCT02392234|38349438|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
17196034|NCT02392234|38349433|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
17196035|NCT02392234|38349434|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
17196036|NCT02392234|38349435|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
17196037|NCT02392234|38349436|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
17196038|NCT02392234|38349437|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
17196039|NCT02392234|38349438|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
17196040|NCT02392234|38349433|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
17196041|NCT02392234|38349434|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
17196042|NCT02392234|38349435|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
17196043|NCT02392234|38349436|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
17196044|NCT02392234|38349437|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
17196045|NCT02392234|38349438|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
17196046|NCT02392234|38349433|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
17196047|NCT02392234|38349434|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
17196048|NCT02392234|38349435|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
17196049|NCT02392234|38349436|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
17196050|NCT02392234|38349437|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
17196051|NCT02392234|38349438|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
17196052|NCT02392234|38349433|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
17196053|NCT02392234|38349434|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
17196054|NCT02392234|38349435|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
17196055|NCT02392234|38349436|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
17196056|NCT02392234|38349437|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
17196057|NCT02392234|38349438|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
17196058|NCT02392234|38349433|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
17196059|NCT02392234|38349434|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
17196060|NCT02392234|38349435|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
17196061|NCT02392234|38349436|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
17196062|NCT02392234|38349437|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
17196063|NCT02392234|38349438|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
17196064|NCT02963090|38349452|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
17196065|NCT02963090|38349453|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
17196066|NCT02427802|38349465|FG000|Overall Study|Adverse Event|11|||
17196067|NCT02427802|38349466|FG001|Overall Study|Adverse Event|3|||
17196068|NCT02427802|38349467|FG002|Overall Study|Adverse Event|7|||
17196069|NCT02427802|38349465|FG000|Overall Study|Death|0|||
17196070|NCT02427802|38349466|FG001|Overall Study|Death|4|||
17196071|NCT02427802|38349467|FG002|Overall Study|Death|1|||
17196072|NCT02427802|38349465|FG000|Overall Study|Lost to Follow-up|13|||
17196073|NCT02427802|38349466|FG001|Overall Study|Lost to Follow-up|8|||
17196074|NCT02427802|38349467|FG002|Overall Study|Lost to Follow-up|8|||
17196075|NCT02427802|38349465|FG000|Overall Study|Physician Decision|4|||
17196076|NCT02427802|38349466|FG001|Overall Study|Physician Decision|2|||
17196077|NCT02427802|38349467|FG002|Overall Study|Physician Decision|4|||
17196078|NCT02427802|38349465|FG000|Overall Study|Withdrawal by Subject|10|||
17196079|NCT02427802|38349466|FG001|Overall Study|Withdrawal by Subject|5|||
17196080|NCT02427802|38349467|FG002|Overall Study|Withdrawal by Subject|11|||
17014927|NCT00809445|38159743|FG000|6 Month Follow-up|Incarcerated|6|||
17014928|NCT00809445|38159744|FG001|6 Month Follow-up|Incarcerated|8|||
17014929|NCT00809445|38159745|FG002|6 Month Follow-up|Incarcerated|8|||
17014930|NCT00809445|38159743|FG000|6 Month Follow-up|Withdrew consent|0|||
17014931|NCT00809445|38159744|FG001|6 Month Follow-up|Withdrew consent|0|||
17099873|NCT04380142|38238984|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
17099874|NCT04380142|38238985|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
17014932|NCT00809445|38159745|FG002|6 Month Follow-up|Withdrew consent|1|||
17014933|NCT00593918|38159768|FG000|Overall Study|Withdrawal by Subject|5|||
17014934|NCT00593918|38159769|FG001|Overall Study|Withdrawal by Subject|24|||
17196081|NCT02427802|38349465|FG000|Overall Study|Protocol Violation|3|||
17099875|NCT04380142|38238983|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
17099876|NCT04380142|38238984|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
17099877|NCT04380142|38238985|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
17099878|NCT04380142|38238983|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
17099879|NCT04380142|38238984|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
17099880|NCT04380142|38238985|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
17099881|NCT04045132|38238995|FG000|Overall Study|Lost to Follow-up|3|||
17099882|NCT04045132|38238996|FG001|Overall Study|Lost to Follow-up|6|||
17196082|NCT02427802|38349466|FG001|Overall Study|Protocol Violation|1|||
16786542|NCT01674647|37727036|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
16786543|NCT01674647|37727035|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
16786544|NCT01674647|37727036|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
16786545|NCT01674647|37727035|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
16786546|NCT01674647|37727036|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
16786547|NCT01674647|37727035|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
16786548|NCT01674647|37727036|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
16786549|NCT02669407|37727042|FG000|Overall Study|Physician Decision|3|||
16786550|NCT02667457|37727048|FG000|Overall Study|Withdrawal by Subject|1|||
16786551|NCT02667457|37727049|FG001|Overall Study|Withdrawal by Subject|0|||
16786552|NCT02667457|37727048|FG000|Overall Study|Other Reason|0|||
16786553|NCT02667457|37727049|FG001|Overall Study|Other Reason|2|||
16786554|NCT02669095|37727058|FG000|Overall Study|Adverse Event|1|||
16786555|NCT02669095|37727059|FG001|Overall Study|Adverse Event|0|||
16786556|NCT02669095|37727058|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
16786557|NCT02669095|37727059|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
16786558|NCT02669095|37727058|FG000|Overall Study|Torn Lens|0|||
16786559|NCT02669095|37727059|FG001|Overall Study|Torn Lens|1|||
16786560|NCT02669095|37727058|FG000|Overall Study|Visit 5 assessments not completed|0|||
16786561|NCT02669095|37727059|FG001|Overall Study|Visit 5 assessments not completed|1|||
16786562|NCT02667301|37727065|FG000|Overall Study|Adverse Event|1|||
16786563|NCT02667301|37727065|FG000|Overall Study|Lack of Efficacy|1|||
16786564|NCT04209725|37727071|FG000|Overall Study|Adverse Event|1|||
16786565|NCT02644967|37727164|FG000|Overall Study|Death|26|||
16786566|NCT02644967|37727164|FG000|Overall Study|Physician Decision|1|||
16786567|NCT02644967|37727164|FG000|Overall Study|Withdrawal by Subject|2|||
16786568|NCT02644967|37727164|FG000|Overall Study|Protocol Violation|1|||
16786569|NCT02644967|37727164|FG000|Overall Study|Progressive Disease|1|||
16786570|NCT02644967|37727164|FG000|Overall Study|Study Terminated by Sponsor|4|||
16786571|NCT02644343|37727168|FG000|Overall Study|Withdrawal by Subject|1|||
16786572|NCT02644109|37727174|FG000|Overall Study|Adverse Event|0|||
16786573|NCT02644109|37727175|FG001|Overall Study|Adverse Event|4|||
16786574|NCT02642159|37727183|FG000|Overall Study|Randomized but not treated|1|||
16786575|NCT02642159|37727184|FG001|Overall Study|Randomized but not treated|0|||
16786576|NCT02642159|37727183|FG000|Overall Study|Adverse Event|10|||
16786577|NCT02642159|37727184|FG001|Overall Study|Adverse Event|4|||
16786578|NCT02642159|37727183|FG000|Overall Study|Withdrawal by Subject|9|||
16786579|NCT02642159|37727184|FG001|Overall Study|Withdrawal by Subject|1|||
16786580|NCT02642159|37727183|FG000|Overall Study|Poor compliance to study protocol|1|||
16786581|NCT02642159|37727184|FG001|Overall Study|Poor compliance to study protocol|0|||
16786582|NCT02642159|37727183|FG000|Overall Study|Other than specified above|10|||
16786583|NCT02642159|37727184|FG001|Overall Study|Other than specified above|3|||
16786584|NCT02669017|37727200|FG000|Overall Study|Death|1|||
16786585|NCT02669017|37727201|FG001|Overall Study|Death|2|||
16786586|NCT02669017|37727202|FG002|Overall Study|Death|2|||
16786587|NCT02669017|37727203|FG003|Overall Study|Death|3|||
16786588|NCT02669017|37727204|FG004|Overall Study|Death|8|||
16786589|NCT02669017|37727205|FG005|Overall Study|Death|18|||
16786590|NCT02669017|37727206|FG006|Overall Study|Death|10|||
16786591|NCT02669017|37727207|FG007|Overall Study|Death|47|||
16786592|NCT02669017|37727208|FG008|Overall Study|Death|20|||
16786593|NCT02669017|37727200|FG000|Overall Study|Withdrawal by Subject|0|||
17014935|NCT00593840|38159775|FG000|Overall Study|Withdrawal by Subject|1|||
17014936|NCT00499369|38159784|FG000|Overall Study|Adverse Event|2|||
17014937|NCT00499369|38159785|FG001|Overall Study|Adverse Event|2|||
17196083|NCT02427802|38349467|FG002|Overall Study|Protocol Violation|1|||
16786594|NCT02669017|37727201|FG001|Overall Study|Withdrawal by Subject|0|||
16786595|NCT02669017|37727202|FG002|Overall Study|Withdrawal by Subject|0|||
16786596|NCT02669017|37727203|FG003|Overall Study|Withdrawal by Subject|1|||
16786597|NCT02669017|37727204|FG004|Overall Study|Withdrawal by Subject|2|||
16786598|NCT02669017|37727205|FG005|Overall Study|Withdrawal by Subject|0|||
16786599|NCT02669017|37727206|FG006|Overall Study|Withdrawal by Subject|0|||
16786600|NCT02669017|37727207|FG007|Overall Study|Withdrawal by Subject|2|||
16786601|NCT02669017|37727208|FG008|Overall Study|Withdrawal by Subject|2|||
16786602|NCT02669017|37727200|FG000|Overall Study|Lost to Follow-up|0|||
16786603|NCT02669017|37727201|FG001|Overall Study|Lost to Follow-up|0|||
16786604|NCT02669017|37727202|FG002|Overall Study|Lost to Follow-up|0|||
17196084|NCT02427802|38349465|FG000|Overall Study|protocol specific treatment unrelated|18|||
17196085|NCT02427802|38349466|FG001|Overall Study|protocol specific treatment unrelated|11|||
17196086|NCT02427802|38349467|FG002|Overall Study|protocol specific treatment unrelated|11|||
17196087|NCT02392000|38349475|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
17196088|NCT02392000|38349475|FG000|Overall Study|Withdrawal by Subject|1|||
17196089|NCT02392000|38349475|FG000|Overall Study|Lost to Follow-up|8|||
17099883|NCT04335136|38239006|FG000|Overall Study|Death|8|||
17099884|NCT04335136|38239007|FG001|Overall Study|Death|4|||
17099885|NCT04335136|38239006|FG000|Overall Study|Lost to Follow-up|2|||
17099886|NCT04335136|38239007|FG001|Overall Study|Lost to Follow-up|0|||
17099887|NCT04335136|38239006|FG000|Overall Study|Protocol Violation|1|||
17099888|NCT04335136|38239007|FG001|Overall Study|Protocol Violation|0|||
17099889|NCT04335136|38239006|FG000|Overall Study|Withdrawal by Subject|1|||
17099890|NCT04335136|38239007|FG001|Overall Study|Withdrawal by Subject|1|||
17099891|NCT04335136|38239006|FG000|Overall Study|Health-threatening condition|0|||
17099892|NCT04335136|38239007|FG001|Overall Study|Health-threatening condition|1|||
17099893|NCT04335136|38239006|FG000|Overall Study|Adverse Event|0|||
17099894|NCT04335136|38239007|FG001|Overall Study|Adverse Event|1|||
17099895|NCT04335136|38239006|FG000|Overall Study|Erroneously randomized|2|||
17099896|NCT04335136|38239007|FG001|Overall Study|Erroneously randomized|0|||
17196090|NCT02427646|38349482|FG000|Overall Study|Lack of Efficacy|2|||
17099897|NCT04171414|38239013|FG000|Overall Study|Death|1|||
17099898|NCT04171414|38239013|FG000|Overall Study|Withdrawal by Subject|1|||
17099899|NCT04167670|38239020|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
17099900|NCT04167670|38239021|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
17099901|NCT04167670|38239022|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
17099902|NCT04167670|38239020|FG000|Overall Study|Significant protocol deviation|3|||
17099903|NCT04167670|38239021|FG001|Overall Study|Significant protocol deviation|1|||
17099904|NCT04167670|38239022|FG002|Overall Study|Significant protocol deviation|0|||
17099905|NCT04167670|38239020|FG000|Overall Study|Lost to Follow-up|0|||
17099906|NCT04167670|38239021|FG001|Overall Study|Lost to Follow-up|3|||
17099907|NCT04167670|38239022|FG002|Overall Study|Lost to Follow-up|3|||
17099908|NCT04167670|38239020|FG000|Overall Study|Voluntary Withdrawal|0|||
17099909|NCT04167670|38239021|FG001|Overall Study|Voluntary Withdrawal|1|||
17099910|NCT04167670|38239022|FG002|Overall Study|Voluntary Withdrawal|1|||
17099911|NCT04167670|38239020|FG000|Overall Study|Withdrawal of Consent|4|||
17099912|NCT04167670|38239021|FG001|Overall Study|Withdrawal of Consent|1|||
17099913|NCT04167670|38239022|FG002|Overall Study|Withdrawal of Consent|3|||
17099914|NCT04167670|38239020|FG000|Overall Study|Miscellaneous|7|||
17099915|NCT04167670|38239021|FG001|Overall Study|Miscellaneous|5|||
17099916|NCT04167670|38239022|FG002|Overall Study|Miscellaneous|3|||
17099917|NCT00113516|38239030|FG000|Part 1|Adverse Event|6|||
17099918|NCT00113516|38239031|FG001|Part 1|Adverse Event|0|||
17099919|NCT00113516|38239030|FG000|Part 1|Death|3|||
17099920|NCT00113516|38239031|FG001|Part 1|Death|0|||
17099921|NCT00113516|38239030|FG000|Part 1|Other|3|||
17099922|NCT00113516|38239031|FG001|Part 1|Other|0|||
17099923|NCT00113516|38239030|FG000|Part 1|Withdrawal by Subject|2|||
17099924|NCT00113516|38239031|FG001|Part 1|Withdrawal by Subject|0|||
17099925|NCT00113516|38239030|FG000|Part 1|Lack of Efficacy|2|||
17099926|NCT00113516|38239031|FG001|Part 1|Lack of Efficacy|0|||
17099927|NCT00113516|38239030|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
17099928|NCT00113516|38239031|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
17099929|NCT00113516|38239030|FG000|Part 1|Laboratory Abnormality|1|||
17099930|NCT00113516|38239031|FG001|Part 1|Laboratory Abnormality|0|||
17099931|NCT00113516|38239030|FG000|Part 1|Ongoing|1|||
17099932|NCT00113516|38239031|FG001|Part 1|Ongoing|0|||
17099933|NCT00113516|38239030|FG000|Part 1|Missing|65|||
17099934|NCT00113516|38239031|FG001|Part 1|Missing|0|||
17099935|NCT00113516|38239030|FG000|Part 2|Adverse Event|0|||
17099936|NCT00113516|38239031|FG001|Part 2|Adverse Event|16|||
17099937|NCT00113516|38239030|FG000|Part 2|Death|0|||
17099938|NCT00113516|38239031|FG001|Part 2|Death|5|||
17196091|NCT02427646|38349483|FG001|Overall Study|Lack of Efficacy|3|||
17196092|NCT02427646|38349482|FG000|Overall Study|Physician Decision|1|||
17196093|NCT02427646|38349483|FG001|Overall Study|Physician Decision|4|||
17196094|NCT02427646|38349482|FG000|Overall Study|Protocol Violation|3|||
17196095|NCT02427646|38349483|FG001|Overall Study|Protocol Violation|3|||
16908532|NCT01758900|38017239|FG001|Overall Study|difficulty for further intubation|8|||
16908533|NCT01757184|38017247|FG000|Double-blind Period|Adverse Event|1|||
17099939|NCT00113516|38239030|FG000|Part 2|Lack of Efficacy|0|||
17099940|NCT00113516|38239031|FG001|Part 2|Lack of Efficacy|37|||
17099941|NCT00113516|38239030|FG000|Part 2|Withdrawal by Subject|0|||
17099942|NCT00113516|38239031|FG001|Part 2|Withdrawal by Subject|3|||
17099943|NCT00113516|38239030|FG000|Part 2|Other|0|||
17099944|NCT00113516|38239031|FG001|Part 2|Other|3|||
17099945|NCT00113516|38239030|FG000|Part 2|Laboratory Abnormality|0|||
17099946|NCT00113516|38239031|FG001|Part 2|Laboratory Abnormality|1|||
17099947|NCT00113516|38239030|FG000|Part 2|Ongoing|0|||
17099948|NCT00113516|38239031|FG001|Part 2|Ongoing|1|||
17196096|NCT02427646|38349482|FG000|Overall Study|Bothersome hand weakness|2|||
17196097|NCT02427646|38349483|FG001|Overall Study|Bothersome hand weakness|4|||
17099949|NCT04142242|38239043|FG000|Overall Study|Non-compliance with the protocol|1|||
17099950|NCT04142242|38239044|FG001|Overall Study|Non-compliance with the protocol|0|||
17099951|NCT04142242|38239045|FG002|Overall Study|Non-compliance with the protocol|0|||
17099952|NCT04142242|38239046|FG003|Overall Study|Non-compliance with the protocol|0|||
17099953|NCT04142242|38239047|FG004|Overall Study|Non-compliance with the protocol|0|||
17099954|NCT04142242|38239048|FG005|Overall Study|Non-compliance with the protocol|1|||
17099955|NCT04142242|38239043|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
17099956|NCT04142242|38239044|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1|||
17099957|NCT04142242|38239045|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
17099958|NCT04142242|38239046|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
17099959|NCT04142242|38239047|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
17099960|NCT04142242|38239048|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
17099961|NCT04142242|38239043|FG000|Overall Study|Ongoing|0|||
17099962|NCT04142242|38239044|FG001|Overall Study|Ongoing|0|||
17099963|NCT04142242|38239045|FG002|Overall Study|Ongoing|31|||
17099964|NCT04142242|38239046|FG003|Overall Study|Ongoing|39|||
17099965|NCT04142242|38239047|FG004|Overall Study|Ongoing|0|||
17099966|NCT04142242|38239048|FG005|Overall Study|Ongoing|0|||
17099967|NCT04140292|38239076|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
17099968|NCT04140292|38239077|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
17099969|NCT04138810|38239086|FG000|Overall Study|Withdrawal by Subject|0|||
17196098|NCT02385526|38349494|FG000|Overall Study|Withdrawal by Subject|0|||
17196099|NCT02385526|38349495|FG001|Overall Study|Withdrawal by Subject|2|||
17196100|NCT02385526|38349496|FG002|Overall Study|Withdrawal by Subject|0|||
17196101|NCT02385526|38349494|FG000|Overall Study|Lost to Follow-up|0|||
17196102|NCT02385526|38349495|FG001|Overall Study|Lost to Follow-up|1|||
17196103|NCT02385526|38349496|FG002|Overall Study|Lost to Follow-up|0|||
17196104|NCT02385526|38349494|FG000|Overall Study|Physician Decision|1|||
17014938|NCT00499369|38159786|FG002|Overall Study|Adverse Event|3|||
17014939|NCT00499369|38159787|FG003|Overall Study|Adverse Event|1|||
17014940|NCT00499369|38159788|FG004|Overall Study|Adverse Event|2|||
17014941|NCT00499369|38159784|FG000|Overall Study|Withdrawal by Subject|0|||
17014942|NCT00499369|38159785|FG001|Overall Study|Withdrawal by Subject|1|||
17014943|NCT00499369|38159786|FG002|Overall Study|Withdrawal by Subject|1|||
17014944|NCT00499369|38159787|FG003|Overall Study|Withdrawal by Subject|0|||
17014945|NCT00499369|38159788|FG004|Overall Study|Withdrawal by Subject|0|||
17014946|NCT00499369|38159784|FG000|Overall Study|Progression|10|||
17014947|NCT00499369|38159785|FG001|Overall Study|Progression|12|||
17014948|NCT00499369|38159786|FG002|Overall Study|Progression|9|||
17014949|NCT00499369|38159787|FG003|Overall Study|Progression|6|||
17099970|NCT04138810|38239087|FG001|Overall Study|Withdrawal by Subject|1|||
17099971|NCT04138810|38239086|FG000|Overall Study|Subject cancelled surgery|1|||
17099972|NCT04138810|38239087|FG001|Overall Study|Subject cancelled surgery|0|||
17099973|NCT00127166|38239095|FG000|Period I|Protocol Violation|0|||
17099974|NCT00127166|38239096|FG001|Period I|Protocol Violation|2|||
17099975|NCT00127166|38239095|FG000|Period I|Withdrawal by Subject|2|||
17099976|NCT00127166|38239096|FG001|Period I|Withdrawal by Subject|0|||
17099977|NCT00127166|38239095|FG000|Period I|Patient did not meet inclusion criteria|1|||
17099978|NCT00127166|38239096|FG001|Period I|Patient did not meet inclusion criteria|0|||
17099979|NCT00127166|38239095|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
17099980|NCT00127166|38239096|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
17099981|NCT00127166|38239095|FG000|Period II|Withdrawal by Subject|2|||
17099982|NCT00127166|38239096|FG001|Period II|Withdrawal by Subject|0|||
17014950|NCT00499369|38159788|FG004|Overall Study|Progression|10|||
17014951|NCT00499369|38159784|FG000|Overall Study|Death|0|||
17014952|NCT00499369|38159785|FG001|Overall Study|Death|1|||
17014953|NCT00499369|38159786|FG002|Overall Study|Death|0|||
17014954|NCT00499369|38159787|FG003|Overall Study|Death|0|||
17014955|NCT00499369|38159788|FG004|Overall Study|Death|0|||
17014956|NCT00499369|38159784|FG000|Overall Study|Not protocol specified|2|||
17014957|NCT00499369|38159785|FG001|Overall Study|Not protocol specified|0|||
17014958|NCT00499369|38159786|FG002|Overall Study|Not protocol specified|3|||
17014959|NCT00499369|38159787|FG003|Overall Study|Not protocol specified|1|||
17099983|NCT00127166|38239095|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
17099984|NCT00127166|38239096|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
17099985|NCT00125138|38239106|FG000|Overall Study|Adverse Event|1|||
17099986|NCT00125138|38239107|FG001|Overall Study|Adverse Event|0|||
17099987|NCT00125138|38239108|FG002|Overall Study|Adverse Event|3|||
17196105|NCT02385526|38349495|FG001|Overall Study|Physician Decision|0|||
17196106|NCT02385526|38349496|FG002|Overall Study|Physician Decision|0|||
17014960|NCT00499369|38159788|FG004|Overall Study|Not protocol specified|0|||
17196107|NCT02385526|38349494|FG000|Overall Study|Protocol Violation|1|||
17014961|NCT00499369|38159784|FG000|Overall Study|Ineligible|2|||
17014962|NCT00499369|38159785|FG001|Overall Study|Ineligible|2|||
17196108|NCT02385526|38349495|FG001|Overall Study|Protocol Violation|0|||
17196109|NCT02385526|38349496|FG002|Overall Study|Protocol Violation|0|||
17196110|NCT02808143|38349506|FG000|Maintenance Phase|Disease recurrence|1|||
17196111|NCT02808143|38349507|FG001|Maintenance Phase|Disease recurrence|3|||
17196112|NCT02808143|38349506|FG000|Maintenance Phase|Disease progression|1|||
17196113|NCT02808143|38349507|FG001|Maintenance Phase|Disease progression|2|||
17196114|NCT02808143|38349506|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
17196115|NCT02808143|38349507|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
17196116|NCT02808143|38349506|FG000|Survival Follow-Up|Disease recurrence|0|||
17099988|NCT00125138|38239109|FG003|Overall Study|Adverse Event|2|||
17099989|NCT00125138|38239106|FG000|Overall Study|Withdrawal by Subject|2|||
17099990|NCT00125138|38239107|FG001|Overall Study|Withdrawal by Subject|3|||
17099991|NCT00125138|38239108|FG002|Overall Study|Withdrawal by Subject|1|||
17099992|NCT00125138|38239109|FG003|Overall Study|Withdrawal by Subject|1|||
17099993|NCT00125138|38239106|FG000|Overall Study|Lack of Efficacy|0|||
17099994|NCT00125138|38239107|FG001|Overall Study|Lack of Efficacy|0|||
17099995|NCT00125138|38239108|FG002|Overall Study|Lack of Efficacy|0|||
17099996|NCT00125138|38239109|FG003|Overall Study|Lack of Efficacy|1|||
17099997|NCT00125138|38239106|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
17099998|NCT00125138|38239107|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
17099999|NCT00125138|38239108|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
17100000|NCT00125138|38239109|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
17100001|NCT04132336|38239126|FG000|Overall Study|Investigator Decision|0|||
17100002|NCT04132336|38239127|FG001|Overall Study|Investigator Decision|1|||
17100003|NCT04132336|38239128|FG002|Overall Study|Investigator Decision|0|||
17100004|NCT04132336|38239129|FG003|Overall Study|Investigator Decision|0|||
17100005|NCT04132336|38239130|FG004|Overall Study|Investigator Decision|0|||
17100006|NCT04132336|38239131|FG005|Overall Study|Investigator Decision|0|||
17100007|NCT04132336|38239132|FG006|Overall Study|Investigator Decision|0|||
17196117|NCT02808143|38349507|FG001|Survival Follow-Up|Disease recurrence|2|||
17196118|NCT02808143|38349506|FG000|Survival Follow-Up|Adverse Event|0|||
17196119|NCT02808143|38349507|FG001|Survival Follow-Up|Adverse Event|1|||
17196120|NCT02808143|38349506|FG000|Survival Follow-Up|Death|1|||
17196121|NCT02808143|38349507|FG001|Survival Follow-Up|Death|0|||
17196122|NCT02427100|38349517|FG000|Overall Study|Lost to Follow-up|0|||
17196123|NCT02427100|38349518|FG001|Overall Study|Lost to Follow-up|2|||
17196124|NCT02806973|38349524|FG000|Period 1|Withdrawal by Subject|0|||
17196125|NCT02806973|38349525|FG001|Period 1|Withdrawal by Subject|2|||
17196126|NCT02806973|38349526|FG002|Period 1|Withdrawal by Subject|1|||
17196127|NCT02806973|38349527|FG003|Period 1|Withdrawal by Subject|1|||
17196128|NCT02806973|38349524|FG000|Period 1|Adverse Event|0|||
17196129|NCT02806973|38349525|FG001|Period 1|Adverse Event|0|||
17196130|NCT02806973|38349526|FG002|Period 1|Adverse Event|0|||
17196131|NCT02806973|38349527|FG003|Period 1|Adverse Event|1|||
17196132|NCT02806973|38349524|FG000|Period 3|Withdrawal by Subject|0|||
17196133|NCT02806973|38349525|FG001|Period 3|Withdrawal by Subject|0|||
17196134|NCT02806973|38349526|FG002|Period 3|Withdrawal by Subject|0|||
17196135|NCT02806973|38349527|FG003|Period 3|Withdrawal by Subject|3|||
17196136|NCT02806973|38349524|FG000|Period 3|Adverse Event|0|||
17196137|NCT02806973|38349525|FG001|Period 3|Adverse Event|0|||
17196138|NCT02806973|38349526|FG002|Period 3|Adverse Event|1|||
17196139|NCT02806973|38349527|FG003|Period 3|Adverse Event|0|||
17196140|NCT02806505|38349539|FG000|Overall Study|Adverse event/intercurrent illness|1|||
17196141|NCT02806505|38349540|FG001|Overall Study|Adverse event/intercurrent illness|3|||
17196142|NCT02806505|38349539|FG000|Overall Study|Death|4|||
17196143|NCT02806505|38349540|FG001|Overall Study|Death|0|||
17196144|NCT02806505|38349539|FG000|Overall Study|Did not cooperate/refused treatment|3|||
17196145|NCT02806505|38349540|FG001|Overall Study|Did not cooperate/refused treatment|3|||
17196146|NCT02806505|38349539|FG000|Overall Study|Failure to return|0|||
17196147|NCT02806505|38349540|FG001|Overall Study|Failure to return|1|||
17196148|NCT02806505|38349539|FG000|Overall Study|Insufficient therapeutic response|2|||
17196149|NCT02806505|38349540|FG001|Overall Study|Insufficient therapeutic response|4|||
17196150|NCT02807363|38349550|FG000|Dosing Period|Adverse Event|0|||
17196151|NCT02807363|38349551|FG001|Dosing Period|Adverse Event|1|||
17196152|NCT02807363|38349552|FG002|Dosing Period|Adverse Event|0|||
17196153|NCT02807363|38349553|FG003|Dosing Period|Adverse Event|0|||
17196154|NCT02426086|38349567|FG000|Overall Study|Death|33|||
17014963|NCT00499369|38159786|FG002|Overall Study|Ineligible|1|||
17014964|NCT00499369|38159787|FG003|Overall Study|Ineligible|1|||
17014965|NCT00499369|38159788|FG004|Overall Study|Ineligible|0|||
17014966|NCT00869258|38159800|FG000|Overall Study|Physician Decision|1|||
17014967|NCT00693784|38159804|FG000|Overall Study|Lost to Follow-up|2|||
17014968|NCT00693784|38159804|FG000|Overall Study|Withdrawal by Subject|2|||
17014969|NCT00693706|38159810|FG000|Overall Study|Protocol Violation|0|||
17014970|NCT00693706|38159811|FG001|Overall Study|Protocol Violation|1|||
17014971|NCT00488683|38159820|FG000|Overall Study|Withdrawal by Subject|1|||
17014972|NCT00488683|38159821|FG001|Overall Study|Withdrawal by Subject|2|||
17014973|NCT00488683|38159822|FG002|Overall Study|Withdrawal by Subject|2|||
17100008|NCT04131556|38239148|FG000|Overall Study|Adverse Event|1|||
17100009|NCT04131556|38239148|FG000|Overall Study|Withdrawal by Subject|1|||
17100010|NCT04295356|38239157|FG000|Overall Study|Physician Decision|1|||
17100011|NCT04295356|38239158|FG001|Overall Study|Physician Decision|0|||
17100012|NCT04295356|38239157|FG000|Overall Study|Lost to Follow-up|0|||
17100013|NCT04295356|38239158|FG001|Overall Study|Lost to Follow-up|3|||
17100014|NCT04295356|38239157|FG000|Overall Study|Protocol Violation|0|||
17100015|NCT04295356|38239158|FG001|Overall Study|Protocol Violation|1|||
17100016|NCT03691948|38239166|FG000|Overall Study|Lost to Follow-up|1|||
17100017|NCT03691948|38239167|FG001|Overall Study|Lost to Follow-up|3|||
17100018|NCT04126174|38239174|FG000|Overall Study|Lost to Follow-up|3|||
17196155|NCT02426086|38349568|FG001|Overall Study|Death|36|||
17196156|NCT02426086|38349567|FG000|Overall Study|Lost to Follow-up|2|||
17196157|NCT02426086|38349568|FG001|Overall Study|Lost to Follow-up|0|||
17196158|NCT02426086|38349567|FG000|Overall Study|Study Terminated by Sponsor|5|||
17196159|NCT02426086|38349568|FG001|Overall Study|Study Terminated by Sponsor|14|||
17014974|NCT00488683|38159820|FG000|Overall Study|Lost to Follow-up|5|||
17014975|NCT00488683|38159821|FG001|Overall Study|Lost to Follow-up|3|||
17196160|NCT02426086|38349567|FG000|Overall Study|Withdrawal by Subject|8|||
17196161|NCT02426086|38349568|FG001|Overall Study|Withdrawal by Subject|9|||
17196162|NCT02383966|38349581|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
17196163|NCT02383966|38349582|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
17196164|NCT02383966|38349581|FG000|Overall Study|Randomized, but not treated|1|||
17196165|NCT02383966|38349582|FG001|Overall Study|Randomized, but not treated|3|||
17196166|NCT02383576|38349590|FG000|Overall Study|Death|53|||
17196167|NCT02383576|38349591|FG001|Overall Study|Death|33|||
17196168|NCT02383576|38349590|FG000|Overall Study|Lost to Follow-up|7|||
17196169|NCT02383576|38349591|FG001|Overall Study|Lost to Follow-up|1|||
17196170|NCT02383576|38349590|FG000|Overall Study|Withdrew Consent|1|||
17196171|NCT02383576|38349591|FG001|Overall Study|Withdrew Consent|6|||
17196172|NCT02383576|38349590|FG000|Overall Study|Investigator's Decision|0|||
17196173|NCT02383576|38349591|FG001|Overall Study|Investigator's Decision|1|||
17196174|NCT02383576|38349590|FG000|Overall Study|Administrative/Other|2|||
17196175|NCT02383576|38349591|FG001|Overall Study|Administrative/Other|4|||
17196176|NCT02748317|38349597|FG000|Overall Study|Withdrawal by Subject|14|||
17196177|NCT02748317|38349597|FG000|Overall Study|Lost to Follow-up|8|||
17196178|NCT02748317|38349597|FG000|Overall Study|Death|1|||
17196179|NCT02422264|38349603|FG000|Overall Study|Serious Adverse Event|1|||
17196180|NCT02422264|38349604|FG001|Overall Study|Serious Adverse Event|0|||
17196181|NCT02422264|38349603|FG000|Overall Study|Withdrawal by Subject|1|||
17196182|NCT02422264|38349604|FG001|Overall Study|Withdrawal by Subject|2|||
17014976|NCT00488683|38159822|FG002|Overall Study|Lost to Follow-up|0|||
17014977|NCT00488683|38159820|FG000|Overall Study|Protocol Violation|5|||
17014978|NCT00488683|38159821|FG001|Overall Study|Protocol Violation|1|||
17014979|NCT00488683|38159822|FG002|Overall Study|Protocol Violation|0|||
17014980|NCT00488683|38159820|FG000|Overall Study|Unable to Classify|1|||
17014981|NCT00488683|38159821|FG001|Overall Study|Unable to Classify|0|||
17014982|NCT00488683|38159822|FG002|Overall Study|Unable to Classify|0|||
17014983|NCT00693472|38159856|FG000|Part 1|Adverse Event|1|||
17014984|NCT00693472|38159857|FG001|Part 1|Adverse Event|1|||
17014985|NCT00693472|38159858|FG002|Part 1|Adverse Event|0|||
17014986|NCT00693472|38159859|FG003|Part 1|Adverse Event|0|||
17014987|NCT00693472|38159856|FG000|Part 1|Lost to Follow-up|0|||
17014988|NCT00693472|38159857|FG001|Part 1|Lost to Follow-up|1|||
17014989|NCT00693472|38159858|FG002|Part 1|Lost to Follow-up|0|||
17014990|NCT00693472|38159859|FG003|Part 1|Lost to Follow-up|0|||
17014991|NCT00693472|38159856|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
17014992|NCT00693472|38159857|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
17014993|NCT00693472|38159858|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
17014994|NCT00693472|38159859|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
17014995|NCT00693472|38159856|FG000|Part 2|Adverse Event|0|||
17014996|NCT00693472|38159857|FG001|Part 2|Adverse Event|0|||
17014997|NCT00693472|38159858|FG002|Part 2|Adverse Event|1|||
17014998|NCT00693472|38159859|FG003|Part 2|Adverse Event|0|||
17014999|NCT00693472|38159856|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
17015000|NCT00693472|38159857|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
17015001|NCT00693472|38159858|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
17015002|NCT00693472|38159859|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
17015003|NCT00498433|38159872|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
17015004|NCT00498433|38159873|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
17015005|NCT00498433|38159874|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
17015006|NCT00498433|38159872|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
17015007|NCT00498433|38159873|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
17015008|NCT00498433|38159874|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
17015009|NCT00498433|38159872|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
17015010|NCT00498433|38159873|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
17100019|NCT04126174|38239175|FG001|Overall Study|Lost to Follow-up|3|||
17196183|NCT02422264|38349603|FG000|Overall Study|Migrated/moved from study area|3|||
17196184|NCT02422264|38349604|FG001|Overall Study|Migrated/moved from study area|1|||
17196185|NCT02422264|38349603|FG000|Overall Study|Subject vaccinated outside of the study|0|||
17196186|NCT02422264|38349604|FG001|Overall Study|Subject vaccinated outside of the study|1|||
17196187|NCT02390362|38349612|FG000|Overall Study|Withdrawal by Subject|0|||
17196188|NCT02390362|38349613|FG001|Overall Study|Withdrawal by Subject|1|||
17196189|NCT02389894|38349622|FG000|Overall Study|Death|4|||
17196190|NCT02389894|38349623|FG001|Overall Study|Death|5|||
17196191|NCT02389894|38349624|FG002|Overall Study|Death|3|||
17196192|NCT02389894|38349622|FG000|Overall Study|Withdrawal by Subject|2|||
17196193|NCT02389894|38349623|FG001|Overall Study|Withdrawal by Subject|4|||
17196194|NCT02389894|38349624|FG002|Overall Study|Withdrawal by Subject|5|||
17196195|NCT02389894|38349622|FG000|Overall Study|Lost to Follow-up|2|||
17196196|NCT02389894|38349623|FG001|Overall Study|Lost to Follow-up|1|||
17196197|NCT02389894|38349624|FG002|Overall Study|Lost to Follow-up|1|||
17100020|NCT04124926|38239183|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
17100021|NCT04124926|38239184|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
17100022|NCT04124926|38239185|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
17196198|NCT02389816|38349635|FG000|Overall Study|Randomized but Not Treated|1|||
17196199|NCT02389816|38349636|FG001|Overall Study|Randomized but Not Treated|0|||
17196200|NCT02389816|38349637|FG002|Overall Study|Randomized but Not Treated|0|||
17196201|NCT02389816|38349635|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
17196202|NCT02389816|38349636|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
17196203|NCT02389816|38349637|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
17196204|NCT02389816|38349635|FG000|Overall Study|Major Protocol Deviation|1|||
17196205|NCT02389816|38349636|FG001|Overall Study|Major Protocol Deviation|0|||
17100023|NCT04124926|38239186|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
17100024|NCT04124926|38239187|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
17100025|NCT04124926|38239183|FG000|Healing Phase|Protocol Violation|0|||
17100026|NCT04124926|38239184|FG001|Healing Phase|Protocol Violation|1|||
17196206|NCT02389816|38349637|FG002|Overall Study|Major Protocol Deviation|0|||
17196207|NCT02389816|38349635|FG000|Overall Study|Lost to Follow-up|1|||
17196208|NCT02389816|38349636|FG001|Overall Study|Lost to Follow-up|0|||
17196209|NCT02389816|38349637|FG002|Overall Study|Lost to Follow-up|0|||
17196210|NCT02389816|38349635|FG000|Overall Study|Withdrawal of Consent|6|||
17196211|NCT02389816|38349636|FG001|Overall Study|Withdrawal of Consent|4|||
17196212|NCT02389816|38349637|FG002|Overall Study|Withdrawal of Consent|4|||
17196213|NCT02389816|38349635|FG000|Overall Study|Lack of Efficacy|1|||
17196214|NCT02389816|38349636|FG001|Overall Study|Lack of Efficacy|0|||
17196215|NCT02389816|38349637|FG002|Overall Study|Lack of Efficacy|0|||
17196216|NCT02389816|38349635|FG000|Overall Study|Non Compliance with Study Drug|1|||
17196217|NCT02389816|38349636|FG001|Overall Study|Non Compliance with Study Drug|1|||
17196218|NCT02389816|38349637|FG002|Overall Study|Non Compliance with Study Drug|1|||
17196219|NCT02389816|38349635|FG000|Overall Study|Reason not Specified|0|||
17196220|NCT02389816|38349636|FG001|Overall Study|Reason not Specified|2|||
17196221|NCT02389816|38349637|FG002|Overall Study|Reason not Specified|0|||
17196222|NCT02388724|38349647|FG000|Overall Study|Reason not Specified|0|||
17196223|NCT02388724|38349648|FG001|Overall Study|Reason not Specified|1|||
17196224|NCT02388724|38349647|FG000|Overall Study|Major Protocol Deviation|3|||
17196225|NCT02388724|38349648|FG001|Overall Study|Major Protocol Deviation|3|||
17196226|NCT02388724|38349647|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
17196227|NCT02388724|38349648|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
17196228|NCT02388724|38349647|FG000|Overall Study|Voluntary Withdrawal|6|||
17196229|NCT02388724|38349648|FG001|Overall Study|Voluntary Withdrawal|5|||
17196230|NCT02388724|38349647|FG000|Overall Study|Randomized but not Treated|0|||
17196231|NCT02388724|38349648|FG001|Overall Study|Randomized but not Treated|2|||
17196232|NCT02382796|38349654|FG000|Overall Study|Global deterioration of health status|1|||
17196233|NCT02382796|38349654|FG000|Overall Study|Objective progression or relapse|3|||
17196234|NCT02382796|38349654|FG000|Overall Study|Commercial dacomitinib became available|3|||
17196235|NCT02382640|38349662|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
17196236|NCT02382640|38349663|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
17196237|NCT02382640|38349664|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
17196238|NCT02382640|38349665|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
17196239|NCT02801669|38349677|FG000|Overall Study|Death|66|||
17196240|NCT02801669|38349678|FG001|Overall Study|Death|69|||
17196241|NCT02801669|38349677|FG000|Overall Study|Withdrawal by Subject|81|||
17196242|NCT02801669|38349678|FG001|Overall Study|Withdrawal by Subject|77|||
17196243|NCT02801669|38349677|FG000|Overall Study|Other|4|||
17196244|NCT02801669|38349678|FG001|Overall Study|Other|6|||
17196245|NCT02804399|38349684|FG000|Period 2|Adverse Event|0|||
17196246|NCT02804399|38349685|FG001|Period 2|Adverse Event|1|||
17196247|NCT01333943|38349696|FG000|Overall Study|Known neuropathy|1|||
17196248|NCT01333943|38349697|FG001|Overall Study|Known neuropathy|0|||
17196249|NCT01333865|38349703|FG000|Overall Study|Adverse Event|2|||
16786605|NCT02669017|37727203|FG003|Overall Study|Lost to Follow-up|0|||
17196250|NCT01333475|38349709|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
17100027|NCT04124926|38239185|FG002|Healing Phase|Protocol Violation|0|||
17196251|NCT01333475|38349710|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
17196252|NCT01333475|38349709|FG000|Overall Study|Toxicity|1|||
17100028|NCT04124926|38239186|FG003|Healing Phase|Protocol Violation|0|||
17100029|NCT04124926|38239187|FG004|Healing Phase|Protocol Violation|0|||
17100030|NCT04124926|38239183|FG000|Healing Phase|Lost to Follow-up|5|||
17100031|NCT04124926|38239184|FG001|Healing Phase|Lost to Follow-up|4|||
17100032|NCT04124926|38239185|FG002|Healing Phase|Lost to Follow-up|0|||
17100033|NCT04124926|38239186|FG003|Healing Phase|Lost to Follow-up|0|||
17100034|NCT04124926|38239187|FG004|Healing Phase|Lost to Follow-up|0|||
17100035|NCT04124926|38239183|FG000|Healing Phase|Voluntary Withdrawal|10|||
17100036|NCT04124926|38239184|FG001|Healing Phase|Voluntary Withdrawal|7|||
17100037|NCT04124926|38239185|FG002|Healing Phase|Voluntary Withdrawal|0|||
17100038|NCT04124926|38239186|FG003|Healing Phase|Voluntary Withdrawal|0|||
17100039|NCT04124926|38239187|FG004|Healing Phase|Voluntary Withdrawal|0|||
17100040|NCT04124926|38239183|FG000|Healing Phase|Withdrawal of Consent|5|||
17100041|NCT04124926|38239184|FG001|Healing Phase|Withdrawal of Consent|3|||
17100042|NCT04124926|38239185|FG002|Healing Phase|Withdrawal of Consent|0|||
17100043|NCT04124926|38239186|FG003|Healing Phase|Withdrawal of Consent|0|||
17100044|NCT04124926|38239187|FG004|Healing Phase|Withdrawal of Consent|0|||
17100045|NCT04124926|38239183|FG000|Healing Phase|Miscellaneous|8|||
17100046|NCT04124926|38239184|FG001|Healing Phase|Miscellaneous|7|||
17100047|NCT04124926|38239185|FG002|Healing Phase|Miscellaneous|0|||
17100048|NCT04124926|38239186|FG003|Healing Phase|Miscellaneous|0|||
17100049|NCT04124926|38239187|FG004|Healing Phase|Miscellaneous|0|||
17100050|NCT04124926|38239183|FG000|Healing Phase|Randomized but not Treated|0|||
17100051|NCT04124926|38239184|FG001|Healing Phase|Randomized but not Treated|3|||
17100052|NCT04124926|38239185|FG002|Healing Phase|Randomized but not Treated|0|||
17100053|NCT04124926|38239186|FG003|Healing Phase|Randomized but not Treated|0|||
17100054|NCT04124926|38239187|FG004|Healing Phase|Randomized but not Treated|0|||
17100055|NCT04124926|38239183|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
17100056|NCT04124926|38239184|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
17100057|NCT04124926|38239185|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
17100058|NCT04124926|38239186|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
17100059|NCT04124926|38239187|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
17100060|NCT04124926|38239183|FG000|Maintenance Phase|Protocol Violation|0|||
17100061|NCT04124926|38239184|FG001|Maintenance Phase|Protocol Violation|0|||
17100062|NCT04124926|38239185|FG002|Maintenance Phase|Protocol Violation|3|||
17100063|NCT04124926|38239186|FG003|Maintenance Phase|Protocol Violation|0|||
17100064|NCT04124926|38239187|FG004|Maintenance Phase|Protocol Violation|0|||
17100065|NCT04124926|38239183|FG000|Maintenance Phase|Lost to Follow-up|0|||
17100066|NCT04124926|38239184|FG001|Maintenance Phase|Lost to Follow-up|0|||
17100067|NCT04124926|38239185|FG002|Maintenance Phase|Lost to Follow-up|7|||
17100068|NCT04124926|38239186|FG003|Maintenance Phase|Lost to Follow-up|8|||
17100069|NCT04124926|38239187|FG004|Maintenance Phase|Lost to Follow-up|9|||
17100070|NCT04124926|38239183|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
17100071|NCT04124926|38239184|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
17100072|NCT04124926|38239185|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
17100073|NCT04124926|38239186|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
17196253|NCT01333475|38349710|FG001|Overall Study|Toxicity|3|||
17196254|NCT01333397|38349722|FG000|Overall Study|Lost to Follow-up|1|||
17196255|NCT01333397|38349723|FG001|Overall Study|Lost to Follow-up|0|||
17196256|NCT01333397|38349724|FG002|Overall Study|Lost to Follow-up|0|||
17196257|NCT01333397|38349725|FG003|Overall Study|Lost to Follow-up|1|||
17196258|NCT01333397|38349726|FG004|Overall Study|Lost to Follow-up|0|||
17196259|NCT02798861|38349747|FG000|Overall Study|Lost to Follow-up|22|||
17196260|NCT02798861|38349747|FG000|Overall Study|Withdrawal by Subject|1|||
17196261|NCT02798315|38349751|FG000|Overall Study|Failure to return|1|||
17196262|NCT02796755|38349757|FG000|Overall Study|Adverse Event|2|||
17196263|NCT02796755|38349758|FG001|Overall Study|Adverse Event|0|||
17196264|NCT02382016|38349766|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
17196265|NCT02382016|38349767|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
17196266|NCT02382016|38349766|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
17015011|NCT00498433|38159874|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
17015012|NCT00498433|38159872|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
17015013|NCT00498433|38159873|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
17015014|NCT00498433|38159874|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
17015015|NCT00498355|38159891|FG000|Overall Study|Lost to Follow-up|1|||
17015016|NCT04327271|38159898|FG000|Overall Study|Death|1|||
17015017|NCT04327271|38159899|FG001|Overall Study|Death|0|||
17015018|NCT04327271|38159898|FG000|Overall Study|Withdrawal by Subject|1|||
17015019|NCT04327271|38159899|FG001|Overall Study|Withdrawal by Subject|0|||
17015020|NCT04327271|38159898|FG000|Overall Study|randomization error (data capture)|4|||
17015021|NCT04327271|38159899|FG001|Overall Study|randomization error (data capture)|3|||
17015022|NCT00688636|38159916|FG000|Overall Study|Adverse Event|2|||
17100074|NCT04124926|38239187|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
17100075|NCT04124926|38239183|FG000|Maintenance Phase|Pregnancy|0|||
17100076|NCT04124926|38239184|FG001|Maintenance Phase|Pregnancy|0|||
17100077|NCT04124926|38239185|FG002|Maintenance Phase|Pregnancy|0|||
17100078|NCT04124926|38239186|FG003|Maintenance Phase|Pregnancy|1|||
17100079|NCT04124926|38239187|FG004|Maintenance Phase|Pregnancy|0|||
17100080|NCT04124926|38239183|FG000|Maintenance Phase|Lack of Efficacy|0|||
17100081|NCT04124926|38239184|FG001|Maintenance Phase|Lack of Efficacy|0|||
17100082|NCT04124926|38239185|FG002|Maintenance Phase|Lack of Efficacy|0|||
17100083|NCT04124926|38239186|FG003|Maintenance Phase|Lack of Efficacy|0|||
17100084|NCT04124926|38239187|FG004|Maintenance Phase|Lack of Efficacy|1|||
17100085|NCT04124926|38239183|FG000|Maintenance Phase|Withdrawal of Consent|0|||
17100086|NCT04124926|38239184|FG001|Maintenance Phase|Withdrawal of Consent|0|||
17100087|NCT04124926|38239185|FG002|Maintenance Phase|Withdrawal of Consent|5|||
17100088|NCT04124926|38239186|FG003|Maintenance Phase|Withdrawal of Consent|5|||
17100089|NCT04124926|38239187|FG004|Maintenance Phase|Withdrawal of Consent|5|||
17100090|NCT04124926|38239183|FG000|Maintenance Phase|Miscellaneous|0|||
17196267|NCT02382016|38349767|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
17196268|NCT02382016|38349766|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
17196269|NCT02382016|38349767|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
17196270|NCT02382016|38349766|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
17196271|NCT02382016|38349767|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
17196272|NCT02382016|38349766|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
17196273|NCT02382016|38349767|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
17196274|NCT02382016|38349766|FG000|Open-label (OL) Treatment Period|Death|4|||
17196275|NCT02382016|38349767|FG001|Open-label (OL) Treatment Period|Death|0|||
17196276|NCT02382016|38349766|FG000|OL Extension Period|Physician Decision|3|||
17196277|NCT02382016|38349767|FG001|OL Extension Period|Physician Decision|0|||
17100091|NCT04124926|38239184|FG001|Maintenance Phase|Miscellaneous|0|||
17100092|NCT04124926|38239185|FG002|Maintenance Phase|Miscellaneous|1|||
17100093|NCT04124926|38239186|FG003|Maintenance Phase|Miscellaneous|2|||
17100094|NCT04124926|38239187|FG004|Maintenance Phase|Miscellaneous|4|||
17100095|NCT04124926|38239183|FG000|Maintenance Phase|Randomized but not Treated|0|||
17100096|NCT04124926|38239184|FG001|Maintenance Phase|Randomized but not Treated|0|||
17100097|NCT04124926|38239185|FG002|Maintenance Phase|Randomized but not Treated|2|||
17100098|NCT04124926|38239186|FG003|Maintenance Phase|Randomized but not Treated|2|||
17100099|NCT04124926|38239187|FG004|Maintenance Phase|Randomized but not Treated|0|||
17100100|NCT04274686|38239199|FG000|Overall Study|Physician Decision|1|||
17100101|NCT04274686|38239200|FG001|Overall Study|Physician Decision|0|||
17100102|NCT04113694|38239208|FG000|Overall Study|Adverse Event|2|||
17100103|NCT04113694|38239208|FG000|Overall Study|Lost to Follow-up|2|||
17100104|NCT04113694|38239208|FG000|Overall Study|Withdrawal by Subject|6|||
17100105|NCT04113694|38239208|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
17100106|NCT04105972|38239217|FG000|Overall Study|Adverse Event|2|||
17100107|NCT04105972|38239218|FG001|Overall Study|Adverse Event|1|||
17100108|NCT04102540|38239224|FG000|Overall Study|Withdrawn by PI|2|||
17100109|NCT04102540|38239224|FG000|Overall Study|Lost to Follow-up|6|||
17100110|NCT00124982|38239230|FG000|Short-term Period|Death|1|||
17100111|NCT00124982|38239231|FG001|Short-term Period|Death|1|||
17100112|NCT00124982|38239232|FG002|Short-term Period|Death|0|||
17100113|NCT00124982|38239230|FG000|Short-term Period|Adverse Event|17|||
17100114|NCT00124982|38239231|FG001|Short-term Period|Adverse Event|22|||
17100115|NCT00124982|38239232|FG002|Short-term Period|Adverse Event|0|||
17100116|NCT00124982|38239230|FG000|Short-term Period|Lack of Efficacy|32|||
17100117|NCT00124982|38239231|FG001|Short-term Period|Lack of Efficacy|73|||
17100118|NCT00124982|38239232|FG002|Short-term Period|Lack of Efficacy|0|||
17100119|NCT00124982|38239230|FG000|Short-term Period|Lost to Follow-up|8|||
17100120|NCT00124982|38239231|FG001|Short-term Period|Lost to Follow-up|5|||
17100121|NCT00124982|38239232|FG002|Short-term Period|Lost to Follow-up|0|||
17100122|NCT00124982|38239230|FG000|Short-term Period|Withdrawal of Consent|7|||
17100123|NCT00124982|38239231|FG001|Short-term Period|Withdrawal of Consent|9|||
17100124|NCT00124982|38239232|FG002|Short-term Period|Withdrawal of Consent|0|||
17100125|NCT00124982|38239230|FG000|Short-term Period|Poor/Non-compliance|3|||
17100126|NCT00124982|38239231|FG001|Short-term Period|Poor/Non-compliance|1|||
17100127|NCT00124982|38239232|FG002|Short-term Period|Poor/Non-compliance|0|||
17100128|NCT00124982|38239230|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
17100129|NCT00124982|38239231|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
17100130|NCT00124982|38239232|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
17100131|NCT00124982|38239230|FG000|Short-term Period|Participant Decision|1|||
17100132|NCT00124982|38239231|FG001|Short-term Period|Participant Decision|0|||
17100133|NCT00124982|38239232|FG002|Short-term Period|Participant Decision|0|||
17100134|NCT00124982|38239230|FG000|Short-term Period|Participant Chose Own Doctor|0|||
17100135|NCT00124982|38239231|FG001|Short-term Period|Participant Chose Own Doctor|1|||
17196278|NCT02382016|38349766|FG000|OL Extension Period|Death|2|||
17100136|NCT00124982|38239232|FG002|Short-term Period|Participant Chose Own Doctor|0|||
17100137|NCT00124982|38239230|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
17100138|NCT00124982|38239231|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
17100139|NCT00124982|38239232|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
17100140|NCT00124982|38239230|FG000|Short-term Period|Participant Had Lymphopenia|1|||
17100141|NCT00124982|38239231|FG001|Short-term Period|Participant Had Lymphopenia|0|||
17100142|NCT00124982|38239232|FG002|Short-term Period|Participant Had Lymphopenia|0|||
17100143|NCT00124982|38239230|FG000|Long-term Period|Death|0|||
17100144|NCT00124982|38239231|FG001|Long-term Period|Death|0|||
17196279|NCT02382016|38349767|FG001|OL Extension Period|Death|0|||
17196280|NCT02382016|38349766|FG000|OL Extension Period|Withdrawal by Subject|1|||
17196281|NCT02382016|38349767|FG001|OL Extension Period|Withdrawal by Subject|0|||
17196282|NCT02380690|38349777|FG000|Overall Study|Lost to Follow-up|14|||
17196283|NCT02380690|38349778|FG001|Overall Study|Lost to Follow-up|4|||
17196284|NCT02380690|38349777|FG000|Overall Study|Withdrawal by Subject|20|||
17196285|NCT02380690|38349778|FG001|Overall Study|Withdrawal by Subject|8|||
17196286|NCT02422186|38349786|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
17196287|NCT02422186|38349787|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
17196288|NCT02422186|38349786|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
17196289|NCT02422186|38349787|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
17196290|NCT02422186|38349786|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
17196291|NCT02422186|38349787|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
17196292|NCT02422186|38349786|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
17196293|NCT02422186|38349787|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
17196294|NCT02422186|38349786|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
17196295|NCT02422186|38349787|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
17196296|NCT02422186|38349786|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
17196297|NCT02422186|38349787|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
17196298|NCT02422186|38349786|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
17196299|NCT02422186|38349787|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
17196300|NCT02422186|38349786|FG000|Follow-up Phase (2 Weeks)|Other|3|||
17196301|NCT02422186|38349787|FG001|Follow-up Phase (2 Weeks)|Other|0|||
17196302|NCT02421952|38349795|FG000|Overall Study|Diary Not Returned|93|||
17196303|NCT02421952|38349795|FG000|Overall Study|Failed seriation task|13|||
17196304|NCT02421952|38349795|FG000|Overall Study|Subject uncooperative for baseline test|2|||
17196305|NCT02421952|38349795|FG000|Overall Study|Surgery cancelled|1|||
17100145|NCT00124982|38239232|FG002|Long-term Period|Death|1|||
17100146|NCT00124982|38239230|FG000|Long-term Period|Adverse Event|0|||
17100147|NCT00124982|38239231|FG001|Long-term Period|Adverse Event|0|||
17100148|NCT00124982|38239232|FG002|Long-term Period|Adverse Event|17|||
17196306|NCT02796677|38349806|FG000|Overall Study|Adverse Event|11|||
17196307|NCT02796677|38349807|FG001|Overall Study|Adverse Event|22|||
17196308|NCT02796677|38349808|FG002|Overall Study|Adverse Event|14|||
17196309|NCT02796677|38349809|FG003|Overall Study|Adverse Event|14|||
17196310|NCT02796677|38349806|FG000|Overall Study|Protocol Violation|7|||
17196311|NCT02796677|38349807|FG001|Overall Study|Protocol Violation|5|||
17196312|NCT02796677|38349808|FG002|Overall Study|Protocol Violation|4|||
17196313|NCT02796677|38349809|FG003|Overall Study|Protocol Violation|8|||
17196314|NCT02796677|38349806|FG000|Overall Study|Lost to Follow-up|1|||
17196315|NCT02796677|38349807|FG001|Overall Study|Lost to Follow-up|5|||
17196316|NCT02796677|38349808|FG002|Overall Study|Lost to Follow-up|2|||
17196317|NCT02796677|38349809|FG003|Overall Study|Lost to Follow-up|2|||
17196318|NCT02796677|38349806|FG000|Overall Study|Lack of Efficacy|7|||
17015023|NCT00688636|38159917|FG001|Overall Study|Adverse Event|1|||
17015027|NCT00870740|38159933|FG000|Overall Study|Adverse Event|2|||
17015028|NCT00870740|38159934|FG001|Overall Study|Adverse Event|1|||
17015029|NCT00870740|38159935|FG002|Overall Study|Adverse Event|3|||
17015030|NCT00870740|38159936|FG003|Overall Study|Adverse Event|2|||
17015031|NCT00870740|38159937|FG004|Overall Study|Adverse Event|1|||
17015032|NCT00870740|38159938|FG005|Overall Study|Adverse Event|6|||
17015033|NCT00870740|38159933|FG000|Overall Study|Consent Withdrawn|6|||
17015034|NCT00870740|38159934|FG001|Overall Study|Consent Withdrawn|3|||
17015035|NCT00870740|38159935|FG002|Overall Study|Consent Withdrawn|4|||
17015036|NCT00870740|38159936|FG003|Overall Study|Consent Withdrawn|6|||
17015037|NCT00870740|38159937|FG004|Overall Study|Consent Withdrawn|6|||
17015038|NCT00870740|38159938|FG005|Overall Study|Consent Withdrawn|5|||
17015039|NCT00870740|38159933|FG000|Overall Study|Investigator Decision|2|||
17015040|NCT00870740|38159934|FG001|Overall Study|Investigator Decision|0|||
17100149|NCT00124982|38239230|FG000|Long-term Period|Lack of Efficacy|0|||
17196319|NCT02796677|38349807|FG001|Overall Study|Lack of Efficacy|9|||
17196320|NCT02796677|38349808|FG002|Overall Study|Lack of Efficacy|14|||
17196321|NCT02796677|38349809|FG003|Overall Study|Lack of Efficacy|20|||
17196322|NCT02796677|38349806|FG000|Overall Study|Withdrawal by Subject|4|||
17196323|NCT02796677|38349807|FG001|Overall Study|Withdrawal by Subject|14|||
17196324|NCT02796677|38349808|FG002|Overall Study|Withdrawal by Subject|6|||
17196325|NCT02796677|38349809|FG003|Overall Study|Withdrawal by Subject|7|||
17196326|NCT02796677|38349806|FG000|Overall Study|Progressive disease|6|||
17196327|NCT02796677|38349807|FG001|Overall Study|Progressive disease|15|||
17196328|NCT02796677|38349808|FG002|Overall Study|Progressive disease|13|||
17196329|NCT02796677|38349809|FG003|Overall Study|Progressive disease|18|||
17196330|NCT02796677|38349806|FG000|Overall Study|Reason not mentioned|2|||
17015041|NCT00870740|38159935|FG002|Overall Study|Investigator Decision|1|||
17015042|NCT00870740|38159936|FG003|Overall Study|Investigator Decision|0|||
17015043|NCT00870740|38159937|FG004|Overall Study|Investigator Decision|0|||
17015044|NCT00870740|38159938|FG005|Overall Study|Investigator Decision|0|||
17015045|NCT00870740|38159933|FG000|Overall Study|Subject Non-compliance|0|||
17015046|NCT00870740|38159934|FG001|Overall Study|Subject Non-compliance|0|||
17015047|NCT00870740|38159935|FG002|Overall Study|Subject Non-compliance|0|||
17015048|NCT00870740|38159936|FG003|Overall Study|Subject Non-compliance|0|||
17015049|NCT00870740|38159937|FG004|Overall Study|Subject Non-compliance|0|||
17015050|NCT00870740|38159938|FG005|Overall Study|Subject Non-compliance|1|||
17015051|NCT00870740|38159933|FG000|Overall Study|Death|0|||
17015052|NCT00870740|38159934|FG001|Overall Study|Death|0|||
17015053|NCT00870740|38159935|FG002|Overall Study|Death|0|||
16908534|NCT01757184|38017248|FG001|Double-blind Period|Adverse Event|0|||
16908535|NCT01757184|38017249|FG002|Double-blind Period|Adverse Event|0|||
16908536|NCT01757184|38017250|FG003|Double-blind Period|Adverse Event|0|||
16908537|NCT01757184|38017247|FG000|Open-label Period|Lost to Follow-up|0|||
16908538|NCT01757184|38017248|FG001|Open-label Period|Lost to Follow-up|0|||
16908539|NCT01757184|38017249|FG002|Open-label Period|Lost to Follow-up|2|||
16908540|NCT01757184|38017250|FG003|Open-label Period|Lost to Follow-up|0|||
16908541|NCT01757184|38017247|FG000|Open-label Period|Withdrawal by Subject|0|||
16908542|NCT01757184|38017248|FG001|Open-label Period|Withdrawal by Subject|0|||
16908543|NCT01757184|38017249|FG002|Open-label Period|Withdrawal by Subject|1|||
16908544|NCT01757184|38017250|FG003|Open-label Period|Withdrawal by Subject|1|||
16908545|NCT01757184|38017247|FG000|Open-label Period|Discontinued by Sponsor|0|||
16908546|NCT01757184|38017248|FG001|Open-label Period|Discontinued by Sponsor|0|||
16908547|NCT01757184|38017249|FG002|Open-label Period|Discontinued by Sponsor|1|||
16908548|NCT01757184|38017250|FG003|Open-label Period|Discontinued by Sponsor|2|||
16908549|NCT01775904|38017264|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
16908550|NCT01775904|38017264|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
16908551|NCT01775670|38017276|FG000|Overall Study|Lost to Follow-up|1|||
16908552|NCT01775670|38017277|FG001|Overall Study|Lost to Follow-up|1|||
16908553|NCT01775124|38017285|FG000|Core Period|Disease Progression|0|||
16908554|NCT01775124|38017286|FG001|Core Period|Disease Progression|1|||
16908555|NCT01775124|38017285|FG000|Core Period|Physician Decision|1|||
16908556|NCT01775124|38017286|FG001|Core Period|Physician Decision|1|||
16908557|NCT01775124|38017285|FG000|Core Period|Death|0|||
16908558|NCT01775124|38017286|FG001|Core Period|Death|1|||
16908559|NCT01775124|38017285|FG000|Core Period|Administrative problems|1|||
16908560|NCT01775124|38017286|FG001|Core Period|Administrative problems|0|||
16908561|NCT01775124|38017285|FG000|Core Period|Withdrawal by Subject|4|||
16908562|NCT01775124|38017286|FG001|Core Period|Withdrawal by Subject|2|||
16908563|NCT01775124|38017285|FG000|Core Period|Adverse Event|5|||
16908564|NCT01775124|38017286|FG001|Core Period|Adverse Event|5|||
16908565|NCT01775124|38017285|FG000|Extension Period|Adverse Event|3|||
16908566|NCT01775124|38017286|FG001|Extension Period|Adverse Event|2|||
16908567|NCT01775124|38017285|FG000|Extension Period|Physician Decision|0|||
16908568|NCT01775124|38017286|FG001|Extension Period|Physician Decision|2|||
16908569|NCT01775124|38017285|FG000|Extension Period|Administrative problems|0|||
16908570|NCT01775124|38017286|FG001|Extension Period|Administrative problems|1|||
16908571|NCT01775124|38017285|FG000|Extension Period|Lost to Follow-up|0|||
16908572|NCT01775124|38017286|FG001|Extension Period|Lost to Follow-up|1|||
16908573|NCT01775124|38017285|FG000|Extension Period|Withdrawal by Subject|9|||
16908574|NCT01775124|38017286|FG001|Extension Period|Withdrawal by Subject|12|||
16908575|NCT01733316|38017293|FG000|RP103 Phase|Non-compliance|1|||
16908576|NCT01733316|38017293|FG000|Long Term Extension Phase|Adverse Event|1|||
16908577|NCT01733316|38017293|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
16908578|NCT01733316|38017293|FG000|Long Term Extension Phase|Sponsor Decision|2|||
16908579|NCT01732926|38017306|FG000|Overall Study|Study Terminated by Sponsor|168|||
16908580|NCT01732926|38017307|FG001|Overall Study|Study Terminated by Sponsor|80|||
16908581|NCT01732926|38017306|FG000|Overall Study|Withdrawal by Subject|46|||
16908582|NCT01732926|38017307|FG001|Overall Study|Withdrawal by Subject|8|||
16908583|NCT01732926|38017306|FG000|Overall Study|Physician Decision|24|||
16908584|NCT01732926|38017307|FG001|Overall Study|Physician Decision|11|||
16908585|NCT01732926|38017306|FG000|Overall Study|Other Reason|21|||
16908586|NCT01732926|38017307|FG001|Overall Study|Other Reason|4|||
16908587|NCT01732926|38017306|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
16908588|NCT01732926|38017307|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
17015054|NCT00870740|38159936|FG003|Overall Study|Death|0|||
17196331|NCT02796677|38349807|FG001|Overall Study|Reason not mentioned|3|||
17196332|NCT02796677|38349808|FG002|Overall Study|Reason not mentioned|0|||
17196333|NCT02796677|38349809|FG003|Overall Study|Reason not mentioned|5|||
17196334|NCT02007512|38349825|FG000|Double Blind Treatment Period|Adverse Event|4|||
17196335|NCT02007512|38349826|FG001|Double Blind Treatment Period|Adverse Event|2|||
17196336|NCT02007512|38349827|FG002|Double Blind Treatment Period|Adverse Event|6|||
17196337|NCT02007512|38349828|FG003|Double Blind Treatment Period|Adverse Event|2|||
17196338|NCT02007512|38349825|FG000|Double Blind Treatment Period|Death|1|||
17196339|NCT02007512|38349826|FG001|Double Blind Treatment Period|Death|0|||
17196340|NCT02007512|38349827|FG002|Double Blind Treatment Period|Death|0|||
17196341|NCT02007512|38349828|FG003|Double Blind Treatment Period|Death|0|||
17196342|NCT02007512|38349825|FG000|Double Blind Treatment Period|Disease progression|44|||
17196343|NCT02007512|38349826|FG001|Double Blind Treatment Period|Disease progression|49|||
17196344|NCT02007512|38349827|FG002|Double Blind Treatment Period|Disease progression|45|||
17196345|NCT02007512|38349828|FG003|Double Blind Treatment Period|Disease progression|51|||
17196346|NCT02007512|38349825|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
17196347|NCT02007512|38349826|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
17196348|NCT02007512|38349827|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
17196349|NCT02007512|38349828|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
17196350|NCT02007512|38349825|FG000|Double Blind Treatment Period|Protocol Violation|0|||
17196351|NCT02007512|38349826|FG001|Double Blind Treatment Period|Protocol Violation|0|||
17196352|NCT02007512|38349827|FG002|Double Blind Treatment Period|Protocol Violation|0|||
17196353|NCT02007512|38349828|FG003|Double Blind Treatment Period|Protocol Violation|1|||
17196354|NCT02007512|38349825|FG000|Double Blind Treatment Period|Other|0|||
17196355|NCT02007512|38349826|FG001|Double Blind Treatment Period|Other|0|||
17196356|NCT02007512|38349827|FG002|Double Blind Treatment Period|Other|1|||
17196357|NCT02007512|38349828|FG003|Double Blind Treatment Period|Other|2|||
17196358|NCT02007512|38349825|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
17196359|NCT02007512|38349826|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
17196360|NCT02007512|38349827|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
17196361|NCT02007512|38349828|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
17196362|NCT02007512|38349825|FG000|Open Label Treatment Period|Adverse Event|0|||
17196363|NCT02007512|38349826|FG001|Open Label Treatment Period|Adverse Event|1|||
17196364|NCT02007512|38349827|FG002|Open Label Treatment Period|Adverse Event|0|||
17196365|NCT02007512|38349828|FG003|Open Label Treatment Period|Adverse Event|0|||
17196366|NCT02007512|38349825|FG000|Open Label Treatment Period|Other|0|||
17196367|NCT02007512|38349826|FG001|Open Label Treatment Period|Other|0|||
17196368|NCT02007512|38349827|FG002|Open Label Treatment Period|Other|0|||
17196369|NCT02007512|38349828|FG003|Open Label Treatment Period|Other|1|||
17196370|NCT02007512|38349825|FG000|Open Label Treatment Period|Disease progression|0|||
17196371|NCT02007512|38349826|FG001|Open Label Treatment Period|Disease progression|17|||
17196372|NCT02007512|38349827|FG002|Open Label Treatment Period|Disease progression|0|||
17196373|NCT02007512|38349828|FG003|Open Label Treatment Period|Disease progression|11|||
17196374|NCT02007512|38349825|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
17196375|NCT02007512|38349826|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
17196376|NCT02007512|38349827|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
17196377|NCT02007512|38349828|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
17196378|NCT02421172|38349843|FG000|Period 1|Adverse Event|1|||
17196379|NCT02421172|38349844|FG001|Period 1|Adverse Event|0|||
17196380|NCT02421172|38349845|FG002|Period 1|Adverse Event|0|||
17196381|NCT02421172|38349846|FG003|Period 1|Adverse Event|0|||
17196382|NCT02421172|38349847|FG004|Period 1|Adverse Event|0|||
17196383|NCT02421172|38349843|FG000|Period 1|Lost to Follow-up|3|||
17196384|NCT02421172|38349844|FG001|Period 1|Lost to Follow-up|1|||
17196385|NCT02421172|38349845|FG002|Period 1|Lost to Follow-up|0|||
17196386|NCT02421172|38349846|FG003|Period 1|Lost to Follow-up|0|||
17196387|NCT02421172|38349847|FG004|Period 1|Lost to Follow-up|0|||
17196388|NCT02421172|38349843|FG000|Period 1|Patient/guardian decision|0|||
17196389|NCT02421172|38349844|FG001|Period 1|Patient/guardian decision|1|||
17196390|NCT02421172|38349845|FG002|Period 1|Patient/guardian decision|0|||
17196391|NCT02421172|38349846|FG003|Period 1|Patient/guardian decision|0|||
17196392|NCT02421172|38349847|FG004|Period 1|Patient/guardian decision|0|||
17196393|NCT02421172|38349843|FG000|Period 2|Adverse Event|0|||
17196394|NCT02421172|38349844|FG001|Period 2|Adverse Event|0|||
17196395|NCT02421172|38349845|FG002|Period 2|Adverse Event|4|||
17196396|NCT02421172|38349846|FG003|Period 2|Adverse Event|0|||
17196397|NCT02421172|38349847|FG004|Period 2|Adverse Event|0|||
17196398|NCT02421172|38349843|FG000|Period 2|Lost to Follow-up|0|||
17196399|NCT02421172|38349844|FG001|Period 2|Lost to Follow-up|0|||
17196400|NCT02421172|38349845|FG002|Period 2|Lost to Follow-up|0|||
17196401|NCT02421172|38349846|FG003|Period 2|Lost to Follow-up|1|||
17196402|NCT02421172|38349847|FG004|Period 2|Lost to Follow-up|0|||
17196403|NCT02421172|38349843|FG000|Period 2|Patient/guardian decision|0|||
17196404|NCT02421172|38349844|FG001|Period 2|Patient/guardian decision|0|||
17196405|NCT02421172|38349845|FG002|Period 2|Patient/guardian decision|3|||
17196406|NCT02421172|38349846|FG003|Period 2|Patient/guardian decision|2|||
17196407|NCT02421172|38349847|FG004|Period 2|Patient/guardian decision|1|||
17196408|NCT02379052|38349860|FG000|Overall Study|Protocol Violation|0|||
17196409|NCT02379052|38349861|FG001|Overall Study|Protocol Violation|1|||
17196410|NCT02379052|38349860|FG000|Overall Study|Adverse Event|0|||
17196411|NCT02379052|38349861|FG001|Overall Study|Adverse Event|1|||
17196412|NCT02379052|38349860|FG000|Overall Study|Physician Decision|1|||
17196413|NCT02379052|38349861|FG001|Overall Study|Physician Decision|1|||
17196414|NCT02379052|38349860|FG000|Overall Study|Withdrawal by Subject|2|||
17196415|NCT02379052|38349861|FG001|Overall Study|Withdrawal by Subject|0|||
17196416|NCT02379052|38349860|FG000|Overall Study|Lost to Follow-up|2|||
17196417|NCT02379052|38349861|FG001|Overall Study|Lost to Follow-up|1|||
17196418|NCT02379052|38349860|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
17196419|NCT02379052|38349861|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
17196420|NCT02379052|38349860|FG000|Overall Study|Subject was Incarcerated|0|||
17196421|NCT02379052|38349861|FG001|Overall Study|Subject was Incarcerated|1|||
17196422|NCT02378662|38349869|FG000|Overall Study|Early Discontinuation|2|||
17196423|NCT02378662|38349870|FG001|Overall Study|Early Discontinuation|0|||
17015055|NCT00870740|38159937|FG004|Overall Study|Death|1|||
17015056|NCT00870740|38159938|FG005|Overall Study|Death|0|||
17100150|NCT00124982|38239231|FG001|Long-term Period|Lack of Efficacy|0|||
17100151|NCT00124982|38239232|FG002|Long-term Period|Lack of Efficacy|46|||
17100152|NCT00124982|38239230|FG000|Long-term Period|Lost to Follow-up|0|||
17100153|NCT00124982|38239231|FG001|Long-term Period|Lost to Follow-up|0|||
17100154|NCT00124982|38239232|FG002|Long-term Period|Lost to Follow-up|4|||
17100155|NCT00124982|38239230|FG000|Long-term Period|Withdrawal by Subject|0|||
17100156|NCT00124982|38239231|FG001|Long-term Period|Withdrawal by Subject|0|||
17100157|NCT00124982|38239232|FG002|Long-term Period|Withdrawal by Subject|16|||
17100158|NCT00124982|38239230|FG000|Long-term Period|Pregnancy|0|||
17100159|NCT00124982|38239231|FG001|Long-term Period|Pregnancy|0|||
17100160|NCT00124982|38239232|FG002|Long-term Period|Pregnancy|1|||
17100161|NCT00124982|38239230|FG000|Long-term Period|Poor/Non-compliance|0|||
17100162|NCT00124982|38239231|FG001|Long-term Period|Poor/Non-compliance|0|||
17100163|NCT00124982|38239232|FG002|Long-term Period|Poor/Non-compliance|2|||
17100164|NCT00124982|38239230|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
17100165|NCT00124982|38239231|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
17100166|NCT00124982|38239232|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
17100167|NCT00124982|38239230|FG000|Long-term Period|Neurologist Recommendation|0|||
17100168|NCT00124982|38239231|FG001|Long-term Period|Neurologist Recommendation|0|||
17100169|NCT00124982|38239232|FG002|Long-term Period|Neurologist Recommendation|1|||
17100170|NCT04263142|38239246|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
17100171|NCT04263142|38239247|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
17100172|NCT04263142|38239248|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
17100173|NCT04263142|38239249|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
17100174|NCT04263142|38239250|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
17100175|NCT04263142|38239246|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
17100176|NCT04263142|38239247|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
17100177|NCT04263142|38239248|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
17100178|NCT04263142|38239249|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
17100179|NCT04263142|38239250|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
17100180|NCT04095286|38239263|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100181|NCT04095286|38239264|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
17100182|NCT04095286|38239265|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100183|NCT04095286|38239266|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100184|NCT04095286|38239267|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100185|NCT04095286|38239268|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100186|NCT04095286|38239263|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
17100187|NCT04095286|38239264|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
17100188|NCT04095286|38239265|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
17100189|NCT04095286|38239266|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
17015057|NCT00870740|38159933|FG000|Overall Study|Other|2|||
17015058|NCT00870740|38159934|FG001|Overall Study|Other|5|||
17015059|NCT00870740|38159935|FG002|Overall Study|Other|2|||
17015060|NCT00870740|38159936|FG003|Overall Study|Other|4|||
17015061|NCT00870740|38159937|FG004|Overall Study|Other|3|||
17015062|NCT00870740|38159938|FG005|Overall Study|Other|5|||
17015063|NCT00869024|38159965|FG000|Overall Study|Death|2|||
17015064|NCT00869024|38159966|FG001|Overall Study|Death|3|||
17015065|NCT00869024|38159965|FG000|Overall Study|Lost to Follow-up|0|||
17196424|NCT02378506|38349876|FG000|Overall Study|Lack of Efficacy|3|||
17015066|NCT00869024|38159966|FG001|Overall Study|Lost to Follow-up|1|||
17015067|NCT00869024|38159965|FG000|Overall Study|Protocol Violation|0|||
17015068|NCT00869024|38159966|FG001|Overall Study|Protocol Violation|1|||
17100190|NCT04095286|38239267|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
17100191|NCT04095286|38239268|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
17100192|NCT04095286|38239263|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
17100193|NCT04095286|38239264|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
17100194|NCT04095286|38239265|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
17100195|NCT04095286|38239266|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
17100196|NCT04095286|38239267|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
17100197|NCT04095286|38239268|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
17100198|NCT04095286|38239263|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100199|NCT04095286|38239264|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100200|NCT04095286|38239265|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
17100201|NCT04095286|38239266|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100202|NCT04095286|38239267|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100203|NCT04095286|38239268|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
17100204|NCT04095286|38239263|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
17100205|NCT04095286|38239264|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
17100206|NCT04095286|38239265|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
17100207|NCT04095286|38239266|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
17100208|NCT04095286|38239267|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
17100209|NCT04095286|38239268|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
17100210|NCT04093414|38239278|FG000|3 Month Follow up|Physician Decision|0|||
17100211|NCT04093414|38239279|FG001|3 Month Follow up|Physician Decision|1|||
17100212|NCT04093414|38239278|FG000|6month Follow up|Physician Decision|1|||
17100213|NCT04093414|38239279|FG001|6month Follow up|Physician Decision|3|||
17100214|NCT04093258|38239285|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
17100215|NCT04093258|38239286|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
17100216|NCT04253236|38239294|FG000|Overall Study|Adverse Event|1|||
17100217|NCT04253236|38239295|FG001|Overall Study|Adverse Event|0|||
17100218|NCT04253236|38239294|FG000|Overall Study|Safety Concerns|1|||
17100219|NCT04253236|38239295|FG001|Overall Study|Safety Concerns|0|||
17100220|NCT04253236|38239294|FG000|Overall Study|Study Terminated by Sponsor|1|||
17100221|NCT04253236|38239295|FG001|Overall Study|Study Terminated by Sponsor|0|||
17100222|NCT04087720|38239301|FG000|Overall Study|Withdrawal by Subject|2|||
17100223|NCT04087720|38239301|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
17100224|NCT04086472|38239310|FG000|Overall Study|Lost to Follow-up|1|||
17100225|NCT04086472|38239311|FG001|Overall Study|Lost to Follow-up|0|||
17100226|NCT04086472|38239312|FG002|Overall Study|Lost to Follow-up|0|||
17100227|NCT04086472|38239313|FG003|Overall Study|Lost to Follow-up|0|||
17100228|NCT04086472|38239314|FG004|Overall Study|Lost to Follow-up|1|||
17100229|NCT04086472|38239310|FG000|Overall Study|Physician Decision|0|||
17100230|NCT04086472|38239311|FG001|Overall Study|Physician Decision|1|||
17100231|NCT04086472|38239312|FG002|Overall Study|Physician Decision|1|||
17100232|NCT04086472|38239313|FG003|Overall Study|Physician Decision|0|||
17100233|NCT04086472|38239314|FG004|Overall Study|Physician Decision|0|||
17100234|NCT04086472|38239310|FG000|Overall Study|Withdrawal by Subject|1|||
17100235|NCT04086472|38239311|FG001|Overall Study|Withdrawal by Subject|1|||
17100236|NCT04086472|38239312|FG002|Overall Study|Withdrawal by Subject|1|||
17100237|NCT04086472|38239313|FG003|Overall Study|Withdrawal by Subject|0|||
17100238|NCT04086472|38239314|FG004|Overall Study|Withdrawal by Subject|0|||
17100239|NCT04086472|38239310|FG000|Overall Study|Various reasons|2|||
17100240|NCT04086472|38239311|FG001|Overall Study|Various reasons|0|||
17100241|NCT04086472|38239312|FG002|Overall Study|Various reasons|0|||
17100242|NCT04086472|38239313|FG003|Overall Study|Various reasons|3|||
17100243|NCT04086472|38239314|FG004|Overall Study|Various reasons|1|||
17100244|NCT04249336|38239330|FG000|Overall Study|Lost to Follow-up|3|||
17100245|NCT04249336|38239331|FG001|Overall Study|Lost to Follow-up|3|||
17100246|NCT04249336|38239332|FG002|Overall Study|Lost to Follow-up|3|||
17100247|NCT04249336|38239333|FG003|Overall Study|Lost to Follow-up|3|||
17100248|NCT04245202|38239345|FG000|Overall Study|Lack of Efficacy|10|||
17100249|NCT04245202|38239346|FG001|Overall Study|Lack of Efficacy|1|||
17100250|NCT04079842|38239353|FG000|Overall Study|Request of subject|2|||
17100251|NCT04079842|38239353|FG000|Overall Study|Unable to draw Arterial samples|1|||
17100252|NCT04078126|38239357|FG000|Washout|Study put on hold due to COVID-19|0|||
17100253|NCT04078126|38239358|FG001|Washout|Study put on hold due to COVID-19|2|||
17100254|NCT04078126|38239357|FG000|Period 2|Study put on hold due to COVID-19|1|||
17100255|NCT04078126|38239358|FG001|Period 2|Study put on hold due to COVID-19|1|||
17196425|NCT02378506|38349876|FG000|Overall Study|Withdrawal by Subject|4|||
17196426|NCT02378506|38349876|FG000|Overall Study|Protocol Violation|2|||
17100256|NCT04073368|38239368|FG000|Overall Study|Adverse Event|2|||
17100257|NCT04073368|38239369|FG001|Overall Study|Adverse Event|0|||
17100258|NCT04073368|38239370|FG002|Overall Study|Adverse Event|1|||
17100259|NCT04073368|38239371|FG003|Overall Study|Adverse Event|1|||
17100260|NCT04073368|38239368|FG000|Overall Study|Withdrawal by Subject|2|||
17196427|NCT02378506|38349876|FG000|Overall Study|Death|1|||
17196428|NCT02378506|38349876|FG000|Overall Study|Adverse Event|14|||
17196429|NCT02378506|38349876|FG000|Overall Study|Randomized But Not Treated|1|||
17196430|NCT02347774|38349883|FG000|Study Participation|Lost to Follow-up|3|||
17196431|NCT02347774|38349884|FG001|Study Participation|Lost to Follow-up|6|||
17196432|NCT02347774|38349885|FG002|Study Participation|Lost to Follow-up|2|||
17196433|NCT02347774|38349883|FG000|Study Participation|Withdrawal by Subject|8|||
17196434|NCT02347774|38349884|FG001|Study Participation|Withdrawal by Subject|9|||
17196435|NCT02347774|38349885|FG002|Study Participation|Withdrawal by Subject|15|||
17196436|NCT02347774|38349883|FG000|Study Participation|Adverse Event|1|||
17196437|NCT02347774|38349884|FG001|Study Participation|Adverse Event|4|||
17196438|NCT02347774|38349885|FG002|Study Participation|Adverse Event|6|||
17196439|NCT02347774|38349883|FG000|Study Participation|withdrew consent|1|||
17196440|NCT02347774|38349884|FG001|Study Participation|withdrew consent|1|||
17196441|NCT02347774|38349885|FG002|Study Participation|withdrew consent|1|||
17196442|NCT02347774|38349883|FG000|Study Participation|Met Prolonged QT criteria|1|||
17196443|NCT02347774|38349884|FG001|Study Participation|Met Prolonged QT criteria|0|||
17015069|NCT00506779|38159974|FG000|Overall Study|Withdrawal by Subject|1|||
17015070|NCT00506779|38159975|FG001|Overall Study|Withdrawal by Subject|0|||
17015071|NCT00506779|38159976|FG002|Overall Study|Withdrawal by Subject|1|||
17015072|NCT00506779|38159977|FG003|Overall Study|Withdrawal by Subject|0|||
17015073|NCT00506779|38159974|FG000|Overall Study|Adverse Event|0|||
17015074|NCT00506779|38159975|FG001|Overall Study|Adverse Event|1|||
17015075|NCT00506779|38159976|FG002|Overall Study|Adverse Event|1|||
17015076|NCT00506779|38159977|FG003|Overall Study|Adverse Event|1|||
17015077|NCT00488293|38159990|FG000|Overall Study|Lost to Follow-up|28|||
17015078|NCT00488293|38159991|FG001|Overall Study|Lost to Follow-up|25|||
17015079|NCT00488293|38159990|FG000|Overall Study|Withdrawal by Subject|5|||
17015080|NCT00488293|38159991|FG001|Overall Study|Withdrawal by Subject|3|||
17015081|NCT00488293|38159990|FG000|Overall Study|Death|2|||
17015082|NCT00488293|38159991|FG001|Overall Study|Death|1|||
17015083|NCT00488293|38159990|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
17015084|NCT00488293|38159991|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
17015085|NCT00868790|38159997|FG000|Period 1|Adverse Event|1|||
17015086|NCT00868790|38159998|FG001|Period 1|Adverse Event|0|||
17015087|NCT00868790|38159999|FG002|Period 1|Adverse Event|0|||
17015088|NCT00868790|38160000|FG003|Period 1|Adverse Event|0|||
17015089|NCT00868790|38160001|FG004|Period 1|Adverse Event|0|||
17015090|NCT00868790|38160002|FG005|Period 1|Adverse Event|0|||
17015091|NCT00868790|38160003|FG006|Period 1|Adverse Event|0|||
17015092|NCT00868790|38160004|FG007|Period 1|Adverse Event|3|||
17015093|NCT00868790|38160005|FG008|Period 1|Adverse Event|1|||
17015094|NCT00868790|38160006|FG009|Period 1|Adverse Event|0|||
17015095|NCT00868790|38160007|FG010|Period 1|Adverse Event|0|||
17015096|NCT00868790|38160008|FG011|Period 1|Adverse Event|0|||
17015097|NCT00868790|38160009|FG012|Period 1|Adverse Event|0|||
17015098|NCT00868790|38160010|FG013|Period 1|Adverse Event|1|||
17015099|NCT00868790|38159997|FG000|Period 1|Protocol Violation|1|||
17015100|NCT00868790|38159998|FG001|Period 1|Protocol Violation|0|||
17015101|NCT00868790|38159999|FG002|Period 1|Protocol Violation|0|||
17015102|NCT00868790|38160000|FG003|Period 1|Protocol Violation|0|||
17015103|NCT00868790|38160001|FG004|Period 1|Protocol Violation|0|||
17015104|NCT00868790|38160002|FG005|Period 1|Protocol Violation|0|||
17015105|NCT00868790|38160003|FG006|Period 1|Protocol Violation|0|||
17015106|NCT00868790|38160004|FG007|Period 1|Protocol Violation|0|||
17015107|NCT00868790|38160005|FG008|Period 1|Protocol Violation|0|||
17015108|NCT00868790|38160006|FG009|Period 1|Protocol Violation|0|||
17015109|NCT00868790|38160007|FG010|Period 1|Protocol Violation|0|||
17015110|NCT00868790|38160008|FG011|Period 1|Protocol Violation|0|||
17196444|NCT02347774|38349885|FG002|Study Participation|Met Prolonged QT criteria|0|||
16786606|NCT02669017|37727204|FG004|Overall Study|Lost to Follow-up|0|||
16786607|NCT02669017|37727205|FG005|Overall Study|Lost to Follow-up|0|||
16786608|NCT02669017|37727206|FG006|Overall Study|Lost to Follow-up|0|||
16786609|NCT02669017|37727207|FG007|Overall Study|Lost to Follow-up|0|||
16786610|NCT02669017|37727208|FG008|Overall Study|Lost to Follow-up|1|||
16786611|NCT02669017|37727200|FG000|Overall Study|Miscellaneous|0|||
16786612|NCT02669017|37727201|FG001|Overall Study|Miscellaneous|0|||
16908589|NCT01732926|38017306|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
17015111|NCT00868790|38160009|FG012|Period 1|Protocol Violation|0|||
16786613|NCT02669017|37727202|FG002|Overall Study|Miscellaneous|0|||
16786614|NCT02669017|37727203|FG003|Overall Study|Miscellaneous|0|||
16786615|NCT02669017|37727204|FG004|Overall Study|Miscellaneous|2|||
17015112|NCT00868790|38160010|FG013|Period 1|Protocol Violation|0|||
17015113|NCT00868790|38159997|FG000|Period 1|Withdrawal by Subject|0|||
17015114|NCT00868790|38159998|FG001|Period 1|Withdrawal by Subject|1|||
17015115|NCT00868790|38159999|FG002|Period 1|Withdrawal by Subject|0|||
17015116|NCT00868790|38160000|FG003|Period 1|Withdrawal by Subject|0|||
17015117|NCT00868790|38160001|FG004|Period 1|Withdrawal by Subject|0|||
17015118|NCT00868790|38160002|FG005|Period 1|Withdrawal by Subject|0|||
17015119|NCT00868790|38160003|FG006|Period 1|Withdrawal by Subject|0|||
17196445|NCT02347774|38349883|FG000|Study Participation|non-compliance with study drug|0|||
17196446|NCT02347774|38349884|FG001|Study Participation|non-compliance with study drug|1|||
17196447|NCT02347774|38349885|FG002|Study Participation|non-compliance with study drug|0|||
17196448|NCT02347774|38349883|FG000|Study Participation|incarceration|1|||
17196449|NCT02347774|38349884|FG001|Study Participation|incarceration|0|||
17196450|NCT02347774|38349885|FG002|Study Participation|incarceration|0|||
17196451|NCT02347774|38349883|FG000|Study Participation|randomized in error|0|||
17196452|NCT02347774|38349884|FG001|Study Participation|randomized in error|0|||
17196453|NCT02347774|38349885|FG002|Study Participation|randomized in error|1|||
17196454|NCT02347774|38349883|FG000|On Study Treatment|Adverse Event|9|||
17196455|NCT02347774|38349884|FG001|On Study Treatment|Adverse Event|15|||
17100261|NCT04073368|38239369|FG001|Overall Study|Withdrawal by Subject|2|||
17100262|NCT04073368|38239370|FG002|Overall Study|Withdrawal by Subject|1|||
17100263|NCT04073368|38239371|FG003|Overall Study|Withdrawal by Subject|1|||
17100264|NCT04073368|38239368|FG000|Overall Study|Lost to Follow-up|1|||
17100265|NCT04073368|38239369|FG001|Overall Study|Lost to Follow-up|1|||
17100266|NCT04073368|38239370|FG002|Overall Study|Lost to Follow-up|1|||
17100267|NCT04073368|38239371|FG003|Overall Study|Lost to Follow-up|0|||
17100268|NCT04073368|38239368|FG000|Overall Study|Protocol Violation|0|||
17100269|NCT04073368|38239369|FG001|Overall Study|Protocol Violation|1|||
17100270|NCT04073368|38239370|FG002|Overall Study|Protocol Violation|0|||
17100271|NCT04073368|38239371|FG003|Overall Study|Protocol Violation|0|||
17100272|NCT04073368|38239368|FG000|Overall Study|Subject noncompliance|7|||
17100273|NCT04073368|38239369|FG001|Overall Study|Subject noncompliance|4|||
17100274|NCT04073368|38239370|FG002|Overall Study|Subject noncompliance|0|||
17100275|NCT04073368|38239371|FG003|Overall Study|Subject noncompliance|0|||
17100276|NCT00124748|38239383|FG000|Overall Study|Adverse Event|8|||
17100277|NCT00124748|38239384|FG001|Overall Study|Adverse Event|39|||
17100278|NCT00124748|38239383|FG000|Overall Study|Abnormal laboratory Value|2|||
17100279|NCT00124748|38239384|FG001|Overall Study|Abnormal laboratory Value|2|||
17100280|NCT00124748|38239383|FG000|Overall Study|Abnormal Procedure|0|||
17100281|NCT00124748|38239384|FG001|Overall Study|Abnormal Procedure|1|||
17100282|NCT00124748|38239383|FG000|Overall Study|Lack of Efficacy|20|||
17100283|NCT00124748|38239384|FG001|Overall Study|Lack of Efficacy|41|||
17100284|NCT00124748|38239383|FG000|Overall Study|No longer requires study drug|1|||
17100285|NCT00124748|38239384|FG001|Overall Study|No longer requires study drug|1|||
17100286|NCT00124748|38239383|FG000|Overall Study|Protocol Violation|3|||
17100287|NCT00124748|38239384|FG001|Overall Study|Protocol Violation|1|||
17100288|NCT00124748|38239383|FG000|Overall Study|Withdrawal by Subject|5|||
17100289|NCT00124748|38239384|FG001|Overall Study|Withdrawal by Subject|15|||
17100290|NCT00124748|38239383|FG000|Overall Study|Lost to Follow-up|2|||
17100291|NCT00124748|38239384|FG001|Overall Study|Lost to Follow-up|7|||
17100292|NCT00124748|38239383|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
17100293|NCT00124748|38239384|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
17100294|NCT00124748|38239383|FG000|Overall Study|Death|1|||
17196456|NCT02347774|38349885|FG002|On Study Treatment|Adverse Event|19|||
17196457|NCT02347774|38349883|FG000|On Study Treatment|Lack of Efficacy|3|||
17196458|NCT02347774|38349884|FG001|On Study Treatment|Lack of Efficacy|0|||
17196459|NCT02347774|38349885|FG002|On Study Treatment|Lack of Efficacy|2|||
17196460|NCT02347774|38349883|FG000|On Study Treatment|non-complicance with study medication|0|||
16786616|NCT02669017|37727205|FG005|Overall Study|Miscellaneous|1|||
16786617|NCT02669017|37727206|FG006|Overall Study|Miscellaneous|1|||
16786618|NCT02669017|37727207|FG007|Overall Study|Miscellaneous|13|||
16786619|NCT02669017|37727208|FG008|Overall Study|Miscellaneous|2|||
16786620|NCT02668393|37727238|FG000|Overall Study|Progressive disease|6|||
16786621|NCT02668393|37727239|FG001|Overall Study|Progressive disease|3|||
16786622|NCT02668393|37727238|FG000|Overall Study|Adverse Event|0|||
16786623|NCT02668393|37727239|FG001|Overall Study|Adverse Event|2|||
16786624|NCT02668393|37727238|FG000|Overall Study|Withdrawal from the trial|0|||
16786625|NCT02668393|37727239|FG001|Overall Study|Withdrawal from the trial|1|||
16786626|NCT02668393|37727238|FG000|Overall Study|Lack of benefit and side effects|1|||
16786627|NCT02668393|37727239|FG001|Overall Study|Lack of benefit and side effects|0|||
16786628|NCT01998958|37727253|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786629|NCT01998958|37727254|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
16786630|NCT01998958|37727255|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786631|NCT01998958|37727256|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786632|NCT01998958|37727257|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786633|NCT01998958|37727258|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16908590|NCT01732926|38017307|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
16908591|NCT01755858|38017315|FG000|Overall Study|Adverse Event|1|||
16786634|NCT01998958|37727259|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786635|NCT01998958|37727260|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786636|NCT01998958|37727261|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
17100295|NCT00124748|38239384|FG001|Overall Study|Death|3|||
17100296|NCT04070326|38239392|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
17196461|NCT02347774|38349884|FG001|On Study Treatment|non-complicance with study medication|2|||
17196462|NCT02347774|38349885|FG002|On Study Treatment|non-complicance with study medication|0|||
17196463|NCT02347774|38349883|FG000|On Study Treatment|Protocol Violation|0|||
17196464|NCT02347774|38349884|FG001|On Study Treatment|Protocol Violation|0|||
17196465|NCT02347774|38349885|FG002|On Study Treatment|Protocol Violation|1|||
17196466|NCT02347774|38349883|FG000|On Study Treatment|withdrew consent|9|||
17196467|NCT02347774|38349884|FG001|On Study Treatment|withdrew consent|8|||
17196468|NCT02347774|38349885|FG002|On Study Treatment|withdrew consent|12|||
17196469|NCT02347774|38349883|FG000|On Study Treatment|Lost to Follow-up|2|||
17196470|NCT02347774|38349884|FG001|On Study Treatment|Lost to Follow-up|6|||
17196471|NCT02347774|38349885|FG002|On Study Treatment|Lost to Follow-up|1|||
17196472|NCT02347774|38349883|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
17196473|NCT02347774|38349884|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
17196474|NCT02347774|38349885|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
17196475|NCT02347774|38349883|FG000|On Study Treatment|ranomized in error|0|||
17196476|NCT02347774|38349884|FG001|On Study Treatment|ranomized in error|0|||
17196477|NCT02347774|38349885|FG002|On Study Treatment|ranomized in error|1|||
17196478|NCT02794883|38349896|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
17100297|NCT04070326|38239393|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
17100298|NCT03689452|38239403|FG000|Overall Study|Lost to Follow-up|1|||
17100299|NCT03689452|38239404|FG001|Overall Study|Lost to Follow-up|1|||
17100300|NCT04067050|38239412|FG000|One Month|Lost to Follow-up|4|||
17100301|NCT04067050|38239413|FG001|One Month|Lost to Follow-up|0|||
17100302|NCT04067050|38239412|FG000|Two Month|Lost to Follow-up|1|||
17100303|NCT04067050|38239413|FG001|Two Month|Lost to Follow-up|0|||
17100304|NCT04067050|38239412|FG000|Two Month|Adverse Event|1|||
17100305|NCT04067050|38239413|FG001|Two Month|Adverse Event|0|||
17100306|NCT04060654|38239419|FG000|Overall Study|Withdrawal by Subject|1|||
17100307|NCT04060654|38239419|FG000|Overall Study|Lost to Follow-up|5|||
17100308|NCT00096200|38239426|FG000|Overall Study|Adverse Event|0|||
17100309|NCT00096200|38239427|FG001|Overall Study|Adverse Event|4|||
17100310|NCT00096200|38239428|FG002|Overall Study|Adverse Event|0|||
17100311|NCT00096200|38239426|FG000|Overall Study|Withdrawal by Subject|1|||
17100312|NCT00096200|38239427|FG001|Overall Study|Withdrawal by Subject|2|||
17100313|NCT00096200|38239428|FG002|Overall Study|Withdrawal by Subject|0|||
17100314|NCT00096200|38239426|FG000|Overall Study|Ineligible pathology|0|||
17100315|NCT00096200|38239427|FG001|Overall Study|Ineligible pathology|1|||
17100316|NCT00096200|38239428|FG002|Overall Study|Ineligible pathology|0|||
17100317|NCT04059094|38239441|FG000|Overall Study|Adverse Event|0|||
17196479|NCT02794883|38349897|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
17196480|NCT02794883|38349898|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
17196481|NCT02794883|38349896|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
17196482|NCT02794883|38349897|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
17196483|NCT02794883|38349898|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
17196484|NCT02794883|38349896|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
17196485|NCT02794883|38349897|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
17196486|NCT02794883|38349898|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
17196487|NCT02794883|38349896|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
17196488|NCT02794883|38349897|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
17196489|NCT02794883|38349898|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
17196490|NCT02794883|38349896|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
17100318|NCT04059094|38239442|FG001|Overall Study|Adverse Event|0|||
17100319|NCT04059094|38239443|FG002|Overall Study|Adverse Event|0|||
17100320|NCT04059094|38239444|FG003|Overall Study|Adverse Event|0|||
17100321|NCT04059094|38239445|FG004|Overall Study|Adverse Event|1|||
17100322|NCT04059094|38239441|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
17100323|NCT04059094|38239442|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
17100324|NCT04059094|38239443|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
17100325|NCT04059094|38239444|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
17100326|NCT04059094|38239445|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
17100327|NCT00096044|38239461|FG000|Overall Study|Withdrawal by Subject|9|||
17100328|NCT00096044|38239461|FG000|Overall Study|Adverse Event|21|||
17100329|NCT00096044|38239461|FG000|Overall Study|Disease Progression|4|||
17100330|NCT03689374|38239467|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
17196491|NCT02794883|38349897|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
17196492|NCT02794883|38349898|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
17196493|NCT02794883|38349896|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
17196494|NCT02794883|38349897|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
17196495|NCT02794883|38349898|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
17196496|NCT02794883|38349896|FG000|Follow-up Period (up to 2 Years)|Death|12|||
17196497|NCT02794883|38349897|FG001|Follow-up Period (up to 2 Years)|Death|10|||
17196498|NCT02794883|38349898|FG002|Follow-up Period (up to 2 Years)|Death|10|||
17196499|NCT01370603|38349908|FG000|Period 1|Adverse Event|5|||
17196500|NCT01370603|38349909|FG001|Period 1|Adverse Event|3|||
17196501|NCT01370603|38349908|FG000|Period 1|Lost to Follow-up|2|||
17196502|NCT01370603|38349909|FG001|Period 1|Lost to Follow-up|0|||
17100331|NCT03689374|38239468|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
17100332|NCT03689374|38239469|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
17100333|NCT03689374|38239467|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
17100334|NCT03689374|38239468|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
17100335|NCT03689374|38239469|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
17100336|NCT03689374|38239467|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
17100337|NCT03689374|38239468|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
17100338|NCT03689374|38239469|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
17100339|NCT03689374|38239467|FG000|Treatment Period (Week 0 to 52)|Death|0|||
17100340|NCT03689374|38239468|FG001|Treatment Period (Week 0 to 52)|Death|11|||
17100341|NCT03689374|38239469|FG002|Treatment Period (Week 0 to 52)|Death|1|||
17100342|NCT00113360|38239475|FG000|Overall Study|Adverse Event|3|||
17100343|NCT00113360|38239475|FG000|Overall Study|Subject required surgery|1|||
17100344|NCT00113360|38239475|FG000|Overall Study|Did not meet eligibility criteria|3|||
17100345|NCT00123734|38239479|FG000|Overall Study|Death|3|||
17100346|NCT00123734|38239479|FG000|Overall Study|Lost to Follow-up|3|||
17196503|NCT01370603|38349908|FG000|Period 1|Protocol Violation|2|||
17196504|NCT01370603|38349909|FG001|Period 1|Protocol Violation|2|||
17100347|NCT00123734|38239479|FG000|Overall Study|Dropout|1|||
17100348|NCT00123734|38239479|FG000|Overall Study|Withdrawal by Subject|1|||
17100349|NCT00112736|38239489|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
17100350|NCT00112736|38239490|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
17100351|NCT00123422|38239505|FG000|Overall Study|Physician Decision|2|||
17100352|NCT00123422|38239506|FG001|Overall Study|Physician Decision|2|||
17196505|NCT01370603|38349908|FG000|Period 1|Withdrawal by Subject|5|||
17196506|NCT01370603|38349909|FG001|Period 1|Withdrawal by Subject|5|||
17196507|NCT01370603|38349908|FG000|Crossover Washout|Adverse Event|2|||
17196508|NCT01370603|38349909|FG001|Crossover Washout|Adverse Event|1|||
17196509|NCT01370603|38349908|FG000|Crossover Washout|Lost to Follow-up|2|||
17196510|NCT01370603|38349909|FG001|Crossover Washout|Lost to Follow-up|0|||
17196511|NCT01370603|38349908|FG000|Crossover Washout|Protocol Violation|1|||
17196512|NCT01370603|38349909|FG001|Crossover Washout|Protocol Violation|0|||
17196513|NCT01370603|38349908|FG000|Crossover Washout|Withdrawal by Subject|4|||
17196514|NCT01370603|38349909|FG001|Crossover Washout|Withdrawal by Subject|1|||
17196515|NCT01370603|38349908|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
17196516|NCT01370603|38349909|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
17196517|NCT01370603|38349908|FG000|Period 2|Adverse Event|1|||
17196518|NCT01370603|38349909|FG001|Period 2|Adverse Event|4|||
17196519|NCT01370603|38349908|FG000|Period 2|Lost to Follow-up|1|||
17196520|NCT01370603|38349909|FG001|Period 2|Lost to Follow-up|0|||
17196521|NCT01370603|38349908|FG000|Period 2|Withdrawal by Subject|1|||
17196522|NCT01370603|38349909|FG001|Period 2|Withdrawal by Subject|0|||
17196523|NCT02312206|38349917|FG000|Overall Study|Adverse Event|3|||
17196524|NCT02312206|38349918|FG001|Overall Study|Adverse Event|6|||
17196525|NCT02312206|38349917|FG000|Overall Study|Withdrawal by Subject|7|||
17196526|NCT02312206|38349918|FG001|Overall Study|Withdrawal by Subject|6|||
17196527|NCT02312206|38349917|FG000|Overall Study|Physician Decision|7|||
17196528|NCT02312206|38349918|FG001|Overall Study|Physician Decision|6|||
17196529|NCT02312206|38349917|FG000|Overall Study|Death|30|||
17196530|NCT02312206|38349918|FG001|Overall Study|Death|36|||
17196531|NCT02312206|38349917|FG000|Overall Study|Study Terminated by Sponsor|81|||
17196532|NCT02312206|38349918|FG001|Overall Study|Study Terminated by Sponsor|74|||
17196533|NCT02312206|38349917|FG000|Overall Study|Disease Progression|1|||
17196534|NCT02312206|38349918|FG001|Overall Study|Disease Progression|0|||
17196535|NCT02312206|38349917|FG000|Overall Study|Patient progression and new therapy|1|||
17196536|NCT02312206|38349918|FG001|Overall Study|Patient progression and new therapy|0|||
17196537|NCT02312206|38349917|FG000|Overall Study|Patient transferred to hospice|0|||
17196538|NCT02312206|38349918|FG001|Overall Study|Patient transferred to hospice|1|||
17196539|NCT02312206|38349917|FG000|Overall Study|Subject missed 3 consecutive tx visits|0|||
17196540|NCT02312206|38349918|FG001|Overall Study|Subject missed 3 consecutive tx visits|1|||
17100353|NCT00123422|38239507|FG002|Overall Study|Physician Decision|6|||
17196541|NCT02347072|38349924|FG000|Overall Study|Adverse Event|2|||
17196542|NCT02347072|38349924|FG000|Overall Study|Withdrawal by Subject|6|||
17196543|NCT02347072|38349924|FG000|Overall Study|Physician Decision|1|||
17196544|NCT02347072|38349924|FG000|Overall Study|Lost to Follow-up|2|||
17196545|NCT02347072|38349924|FG000|Overall Study|Protocol Violation|1|||
17196546|NCT02347072|38349924|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
17196547|NCT02794103|38349932|FG000|Overall Study|Loss to follow up due to high sedation|3|||
17196548|NCT02346370|38349939|FG000|Overall Study|Not treated|1|||
17196549|NCT02346370|38349940|FG001|Overall Study|Not treated|0|||
17196550|NCT02346370|38349941|FG002|Overall Study|Not treated|0|||
17100354|NCT00123422|38239505|FG000|Overall Study|Withdrawal by Subject|1|||
17100355|NCT00123422|38239506|FG001|Overall Study|Withdrawal by Subject|2|||
17100356|NCT00123422|38239507|FG002|Overall Study|Withdrawal by Subject|2|||
17100357|NCT00123422|38239505|FG000|Overall Study|Lost to Follow-up|1|||
17100358|NCT00123422|38239506|FG001|Overall Study|Lost to Follow-up|2|||
17100359|NCT00123422|38239507|FG002|Overall Study|Lost to Follow-up|2|||
17100360|NCT04052620|38239517|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
17100361|NCT04052620|38239518|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
17100362|NCT04052620|38239517|FG000|Overall Study|Withdrawal by Subject|1|||
17100363|NCT04052620|38239518|FG001|Overall Study|Withdrawal by Subject|0|||
17100364|NCT04052620|38239517|FG000|Overall Study|Lost to Follow-up|1|||
17100365|NCT04052620|38239518|FG001|Overall Study|Lost to Follow-up|1|||
17100366|NCT04052620|38239517|FG000|Overall Study|Adverse Event|1|||
17100367|NCT04052620|38239518|FG001|Overall Study|Adverse Event|0|||
17100368|NCT04052620|38239517|FG000|Overall Study|Subject did not meet study Criteria|0|||
17100369|NCT04052620|38239518|FG001|Overall Study|Subject did not meet study Criteria|1|||
17100370|NCT04052620|38239517|FG000|Overall Study|Screened failure, randomized by mistake|0|||
17100371|NCT04052620|38239518|FG001|Overall Study|Screened failure, randomized by mistake|1|||
17100372|NCT04052620|38239517|FG000|Overall Study|Personal reasons|2|||
17100373|NCT04052620|38239518|FG001|Overall Study|Personal reasons|4|||
17100374|NCT04052620|38239517|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
17100375|NCT04052620|38239518|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
17100376|NCT00112580|38239526|FG000|Overall Study|Adverse Event|1|||
17100377|NCT00112580|38239527|FG001|Overall Study|Adverse Event|2|||
17100378|NCT00112580|38239526|FG000|Overall Study|Disease progression|5|||
17100379|NCT00112580|38239527|FG001|Overall Study|Disease progression|16|||
17100380|NCT00112580|38239526|FG000|Overall Study|Participant withdrew consent|2|||
17100381|NCT00112580|38239527|FG001|Overall Study|Participant withdrew consent|1|||
17100382|NCT04238650|38239534|FG000|Overall Study|Withdrawal by Subject|0|||
17100383|NCT04238650|38239535|FG001|Overall Study|Withdrawal by Subject|1|||
17100384|NCT00095576|38239543|FG000|Overall Study|Adverse Event|5|||
17100385|NCT00095576|38239544|FG001|Overall Study|Adverse Event|3|||
17100386|NCT00095576|38239543|FG000|Overall Study|Lost to Follow-up|233|||
17100387|NCT00095576|38239544|FG001|Overall Study|Lost to Follow-up|229|||
17100388|NCT00095576|38239543|FG000|Overall Study|Protocol Violation|1|||
17100389|NCT00095576|38239544|FG001|Overall Study|Protocol Violation|0|||
17100390|NCT00095576|38239543|FG000|Overall Study|Withdrawal by Subject|34|||
17100391|NCT00095576|38239544|FG001|Overall Study|Withdrawal by Subject|47|||
17100392|NCT00095576|38239543|FG000|Overall Study|Option to switch to a rollover study|1097|||
17100393|NCT00095576|38239544|FG001|Overall Study|Option to switch to a rollover study|1099|||
17100394|NCT00095576|38239543|FG000|Overall Study|Site terminated|75|||
17100395|NCT00095576|38239544|FG001|Overall Study|Site terminated|67|||
17100396|NCT00095576|38239543|FG000|Overall Study|Subject moved|30|||
17100397|NCT00095576|38239544|FG001|Overall Study|Subject moved|36|||
17100398|NCT04049578|38239550|FG000|Overall Study|Physician Decision|1|||
17100399|NCT04044352|38239554|FG000|Overall Study|Lost to Follow-up|9|||
17100400|NCT04044352|38239554|FG000|Overall Study|Withdrawal by Subject|2|||
17100401|NCT04043962|38239559|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
17100402|NCT04043962|38239559|FG000|Post-Treatment|Withdrawal by Subject|5|||
17100403|NCT04043962|38239559|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
17100404|NCT04043728|38239566|FG000|Overall Study|Lost to Follow-up|1|||
17100405|NCT04043728|38239567|FG001|Overall Study|Lost to Follow-up|2|||
17100406|NCT04043728|38239568|FG002|Overall Study|Lost to Follow-up|0|||
17100407|NCT04043416|38239578|FG000|Washout|Change in health condition|0|||
17100408|NCT04043416|38239579|FG001|Washout|Change in health condition|1|||
17100409|NCT00095498|38239591|FG000|Overall Study|Physician Decision|9|||
17100410|NCT00095498|38239592|FG001|Overall Study|Physician Decision|10|||
17100411|NCT00095498|38239593|FG002|Overall Study|Physician Decision|8|||
17100412|NCT00095498|38239591|FG000|Overall Study|Adverse Event|1|||
17100413|NCT00095498|38239592|FG001|Overall Study|Adverse Event|0|||
17100414|NCT00095498|38239593|FG002|Overall Study|Adverse Event|1|||
17100415|NCT00095498|38239591|FG000|Overall Study|Withdrawal by Subject|15|||
17100416|NCT00095498|38239592|FG001|Overall Study|Withdrawal by Subject|16|||
17100417|NCT00095498|38239593|FG002|Overall Study|Withdrawal by Subject|15|||
17100418|NCT00095498|38239591|FG000|Overall Study|Disease progression|0|||
17100419|NCT00095498|38239592|FG001|Overall Study|Disease progression|1|||
17100420|NCT00095498|38239593|FG002|Overall Study|Disease progression|1|||
17100421|NCT00095498|38239591|FG000|Overall Study|Ineligibility determined|3|||
17100422|NCT00095498|38239592|FG001|Overall Study|Ineligibility determined|0|||
17100423|NCT00095498|38239593|FG002|Overall Study|Ineligibility determined|2|||
17100424|NCT00095498|38239591|FG000|Overall Study|Lost to Follow-up|1|||
17100425|NCT00095498|38239592|FG001|Overall Study|Lost to Follow-up|1|||
17100426|NCT00095498|38239593|FG002|Overall Study|Lost to Follow-up|2|||
17100427|NCT00095498|38239591|FG000|Overall Study|Noncompliance|1|||
17100428|NCT00095498|38239592|FG001|Overall Study|Noncompliance|0|||
17196551|NCT02346370|38349939|FG000|Overall Study|Withdrawal of consent|1|||
17196552|NCT02346370|38349940|FG001|Overall Study|Withdrawal of consent|0|||
17196553|NCT02346370|38349941|FG002|Overall Study|Withdrawal of consent|0|||
17196554|NCT02346370|38349939|FG000|Overall Study|Death|1|||
17196555|NCT02346370|38349940|FG001|Overall Study|Death|3|||
17196556|NCT02346370|38349941|FG002|Overall Study|Death|1|||
17196557|NCT02346370|38349939|FG000|Overall Study|Sponsor discontinued study|5|||
17196558|NCT02346370|38349940|FG001|Overall Study|Sponsor discontinued study|0|||
17196559|NCT02346370|38349941|FG002|Overall Study|Sponsor discontinued study|2|||
17196560|NCT02346370|38349939|FG000|Overall Study|Radiologic progression|0|||
17196561|NCT02346370|38349940|FG001|Overall Study|Radiologic progression|0|||
17196562|NCT02346370|38349941|FG002|Overall Study|Radiologic progression|1|||
17196563|NCT02346370|38349939|FG000|Overall Study|Physician Decision|0|||
17196564|NCT02346370|38349940|FG001|Overall Study|Physician Decision|1|||
17196565|NCT02346370|38349941|FG002|Overall Study|Physician Decision|0|||
17196566|NCT02346136|38349953|FG000|Overall Study|Withdrawal by Subject|7|||
17196567|NCT02346136|38349954|FG001|Overall Study|Withdrawal by Subject|5|||
17196568|NCT02346136|38349953|FG000|Overall Study|Death|1|||
17196569|NCT02346136|38349954|FG001|Overall Study|Death|0|||
17196570|NCT02346136|38349953|FG000|Overall Study|Study termination|14|||
17196571|NCT02346136|38349954|FG001|Overall Study|Study termination|18|||
17196572|NCT02793947|38349962|FG000|Overall Study|Death|1|||
17196573|NCT02793947|38349963|FG001|Overall Study|Death|0|||
17196574|NCT02793947|38349962|FG000|Overall Study|Physician Decision|1|||
17196575|NCT02793947|38349963|FG001|Overall Study|Physician Decision|5|||
17196576|NCT02345512|38349969|FG000|Overall Study|Adverse Event|1|||
17196577|NCT02345512|38349969|FG000|Overall Study|Withdrawal by Subject|1|||
17196578|NCT02345434|38349980|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
17196579|NCT02345434|38349981|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
17196580|NCT01370213|38349990|FG000|Overall Study|Early Death|1|||
17196581|NCT01370213|38349991|FG001|Overall Study|Early Death|0|||
17196582|NCT01370213|38349992|FG002|Overall Study|Early Death|0|||
17196583|NCT01370213|38349990|FG000|Overall Study|Not evaluable|0|||
17196584|NCT01370213|38349991|FG001|Overall Study|Not evaluable|2|||
17196585|NCT01370213|38349992|FG002|Overall Study|Not evaluable|0|||
17196586|NCT01370525|38350001|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
17196587|NCT01370525|38350002|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
17196588|NCT01370525|38350001|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
17196589|NCT01370525|38350002|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
17196590|NCT01370525|38350001|FG000|Overall Study|Adverse Event|0|||
17196591|NCT01370525|38350002|FG001|Overall Study|Adverse Event|1|||
17196592|NCT01370525|38350001|FG000|Overall Study|Protocol Violation|2|||
17196593|NCT01370525|38350002|FG001|Overall Study|Protocol Violation|1|||
17196594|NCT01370525|38350001|FG000|Overall Study|Lost to follow up|2|||
17196595|NCT01370525|38350002|FG001|Overall Study|Lost to follow up|6|||
17196596|NCT02792777|38350010|FG000|Overall Study|Withdrawal by Subject|2|||
17196597|NCT02792777|38350011|FG001|Overall Study|Withdrawal by Subject|0|||
17196598|NCT02792777|38350010|FG000|Overall Study|Recording malfunction|2|||
17196599|NCT02792777|38350011|FG001|Overall Study|Recording malfunction|0|||
17196600|NCT02792777|38350010|FG000|Overall Study|Later determined to be ineligible|2|||
17196601|NCT02792777|38350011|FG001|Overall Study|Later determined to be ineligible|0|||
17196602|NCT02792777|38350010|FG000|Overall Study|Participant interviewed twice|1|||
17196603|NCT02792777|38350011|FG001|Overall Study|Participant interviewed twice|0|||
17196604|NCT02625974|38350020|FG000|Overall Study|Adverse Event|12|||
17196605|NCT02625974|38350021|FG001|Overall Study|Adverse Event|2|||
17196606|NCT02625974|38350020|FG000|Overall Study|Withdrawal by Subject|3|||
17196607|NCT02625974|38350021|FG001|Overall Study|Withdrawal by Subject|1|||
17196608|NCT02625974|38350020|FG000|Overall Study|positive parasitemia|1|||
17196609|NCT02625974|38350021|FG001|Overall Study|positive parasitemia|0|||
17196610|NCT02625974|38350020|FG000|Overall Study|non-compliance with study drug|0|||
17196611|NCT02625974|38350021|FG001|Overall Study|non-compliance with study drug|2|||
17196612|NCT02625974|38350020|FG000|Overall Study|Protocol Violation|0|||
17196613|NCT02625974|38350021|FG001|Overall Study|Protocol Violation|1|||
17196614|NCT02792699|38350066|FG000|Overall Study|Adverse Event|1|||
17196615|NCT02792699|38350067|FG001|Overall Study|Adverse Event|2|||
17196616|NCT02792699|38350068|FG002|Overall Study|Adverse Event|4|||
17196617|NCT02792699|38350066|FG000|Overall Study|Withdrawal by Subject|4|||
17196618|NCT02792699|38350067|FG001|Overall Study|Withdrawal by Subject|4|||
17196619|NCT02792699|38350068|FG002|Overall Study|Withdrawal by Subject|3|||
17196620|NCT02792699|38350066|FG000|Overall Study|Lost to Follow-up|0|||
17196621|NCT02792699|38350067|FG001|Overall Study|Lost to Follow-up|1|||
17015120|NCT00868790|38160004|FG007|Period 1|Withdrawal by Subject|0|||
17196622|NCT02792699|38350068|FG002|Overall Study|Lost to Follow-up|2|||
17196623|NCT02792699|38350066|FG000|Overall Study|Physician Decision|2|||
17196624|NCT02792699|38350067|FG001|Overall Study|Physician Decision|0|||
17196625|NCT02792699|38350068|FG002|Overall Study|Physician Decision|0|||
17196626|NCT02792699|38350066|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
17196627|NCT02792699|38350067|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
17196628|NCT02792699|38350068|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
17196629|NCT02792699|38350066|FG000|Overall Study|Other|1|||
17196630|NCT02792699|38350067|FG001|Overall Study|Other|0|||
17196631|NCT02792699|38350068|FG002|Overall Study|Other|0|||
17196632|NCT03010319|38350085|FG000|Overall Study|Adverse Event|15|||
17015121|NCT00868790|38160005|FG008|Period 1|Withdrawal by Subject|0|||
17015122|NCT00868790|38160006|FG009|Period 1|Withdrawal by Subject|0|||
17196633|NCT03010319|38350086|FG001|Overall Study|Adverse Event|9|||
17196634|NCT03010319|38350085|FG000|Overall Study|Withdrawal by Subject|1|||
17196635|NCT03010319|38350086|FG001|Overall Study|Withdrawal by Subject|6|||
17196636|NCT03010319|38350085|FG000|Overall Study|Physician Decision|2|||
17196637|NCT03010319|38350086|FG001|Overall Study|Physician Decision|4|||
17196638|NCT03010319|38350085|FG000|Overall Study|Sponsor requested withdrawal|2|||
17196639|NCT03010319|38350086|FG001|Overall Study|Sponsor requested withdrawal|2|||
17196640|NCT03010319|38350085|FG000|Overall Study|Death|1|||
17196641|NCT03010319|38350086|FG001|Overall Study|Death|0|||
17196642|NCT03010319|38350085|FG000|Overall Study|Lost to Follow-up|0|||
17196643|NCT03010319|38350086|FG001|Overall Study|Lost to Follow-up|1|||
17196644|NCT03010319|38350085|FG000|Overall Study|Other Reason|5|||
17196645|NCT03010319|38350086|FG001|Overall Study|Other Reason|7|||
17196646|NCT01369511|38350096|FG000|Overall Study|Adverse Event|1|||
17196647|NCT01369511|38350097|FG001|Overall Study|Adverse Event|1|||
17196648|NCT01369511|38350098|FG002|Overall Study|Adverse Event|5|||
17196649|NCT01369511|38350099|FG003|Overall Study|Adverse Event|0|||
17196650|NCT01369511|38350096|FG000|Overall Study|Entry criteria not met|2|||
17196651|NCT01369511|38350097|FG001|Overall Study|Entry criteria not met|0|||
17196652|NCT01369511|38350098|FG002|Overall Study|Entry criteria not met|0|||
17196653|NCT01369511|38350099|FG003|Overall Study|Entry criteria not met|1|||
17196654|NCT01369511|38350096|FG000|Overall Study|Lost to Follow-up|0|||
17196655|NCT01369511|38350097|FG001|Overall Study|Lost to Follow-up|1|||
17196656|NCT01369511|38350098|FG002|Overall Study|Lost to Follow-up|1|||
17100429|NCT00095498|38239593|FG002|Overall Study|Noncompliance|1|||
17100430|NCT00095498|38239591|FG000|Overall Study|Other|6|||
17100431|NCT00095498|38239592|FG001|Overall Study|Other|7|||
17100432|NCT00095498|38239593|FG002|Overall Study|Other|6|||
17100433|NCT00095498|38239591|FG000|Overall Study|Protocol Violation|0|||
17100434|NCT00095498|38239592|FG001|Overall Study|Protocol Violation|0|||
17100435|NCT00095498|38239593|FG002|Overall Study|Protocol Violation|1|||
17100436|NCT00095498|38239591|FG000|Overall Study|Requirement for alternative therapy|1|||
17100437|NCT00095498|38239592|FG001|Overall Study|Requirement for alternative therapy|0|||
17100438|NCT00095498|38239593|FG002|Overall Study|Requirement for alternative therapy|2|||
17196657|NCT01369511|38350099|FG003|Overall Study|Lost to Follow-up|2|||
17196658|NCT01369511|38350096|FG000|Overall Study|Protocol Violation|0|||
17196659|NCT01369511|38350097|FG001|Overall Study|Protocol Violation|1|||
17196660|NCT01369511|38350098|FG002|Overall Study|Protocol Violation|0|||
17196661|NCT01369511|38350099|FG003|Overall Study|Protocol Violation|2|||
17196662|NCT01369511|38350096|FG000|Overall Study|Physician Decision|3|||
17196663|NCT01369511|38350097|FG001|Overall Study|Physician Decision|4|||
17196664|NCT01369511|38350098|FG002|Overall Study|Physician Decision|0|||
17196665|NCT01369511|38350099|FG003|Overall Study|Physician Decision|0|||
17100439|NCT04237792|38239607|FG000|Treatment (Day 1)|Adverse Event|1|||
17100440|NCT04237792|38239608|FG001|Treatment (Day 1)|Adverse Event|0|||
17100441|NCT04237792|38239609|FG002|Treatment (Day 1)|Adverse Event|0|||
17196666|NCT01369511|38350096|FG000|Overall Study|Sponsor decision|2|||
17196667|NCT01369511|38350097|FG001|Overall Study|Sponsor decision|0|||
17196668|NCT01369511|38350098|FG002|Overall Study|Sponsor decision|1|||
17196669|NCT01369511|38350099|FG003|Overall Study|Sponsor decision|0|||
17196670|NCT01369511|38350096|FG000|Overall Study|Withdrawal by Subject|5|||
17196671|NCT01369511|38350097|FG001|Overall Study|Withdrawal by Subject|6|||
17196672|NCT01369511|38350098|FG002|Overall Study|Withdrawal by Subject|4|||
17196673|NCT01369511|38350099|FG003|Overall Study|Withdrawal by Subject|6|||
17196674|NCT02315703|38350117|FG000|Overall Study|Adverse Event|0|||
17015123|NCT00868790|38160007|FG010|Period 1|Withdrawal by Subject|0|||
17196675|NCT02315703|38350118|FG001|Overall Study|Adverse Event|0|||
17196676|NCT02315703|38350119|FG002|Overall Study|Adverse Event|0|||
17196677|NCT02315703|38350120|FG003|Overall Study|Adverse Event|1|||
17196678|NCT02315703|38350121|FG004|Overall Study|Adverse Event|1|||
17196679|NCT02315703|38350122|FG005|Overall Study|Adverse Event|0|||
17196680|NCT02315703|38350123|FG006|Overall Study|Adverse Event|1|||
17196681|NCT02315703|38350124|FG007|Overall Study|Adverse Event|0|||
17196682|NCT02315703|38350117|FG000|Overall Study|Lost to Follow-up|1|||
17196683|NCT02315703|38350118|FG001|Overall Study|Lost to Follow-up|5|||
16908592|NCT01755858|38017316|FG001|Overall Study|Adverse Event|1|||
17100442|NCT04237792|38239610|FG003|Treatment (Day 1)|Adverse Event|0|||
17100443|NCT04237792|38239611|FG004|Treatment (Day 1)|Adverse Event|1|||
17196684|NCT02315703|38350119|FG002|Overall Study|Lost to Follow-up|3|||
17196685|NCT02315703|38350120|FG003|Overall Study|Lost to Follow-up|3|||
17196686|NCT02315703|38350121|FG004|Overall Study|Lost to Follow-up|2|||
17196687|NCT02315703|38350122|FG005|Overall Study|Lost to Follow-up|1|||
17196688|NCT02315703|38350123|FG006|Overall Study|Lost to Follow-up|2|||
17196689|NCT02315703|38350124|FG007|Overall Study|Lost to Follow-up|2|||
17196690|NCT02315703|38350117|FG000|Overall Study|Pregnancy|0|||
17196691|NCT02315703|38350118|FG001|Overall Study|Pregnancy|0|||
17196692|NCT02315703|38350119|FG002|Overall Study|Pregnancy|0|||
17196693|NCT02315703|38350120|FG003|Overall Study|Pregnancy|0|||
17196694|NCT02315703|38350121|FG004|Overall Study|Pregnancy|0|||
17196695|NCT02315703|38350122|FG005|Overall Study|Pregnancy|0|||
17196696|NCT02315703|38350123|FG006|Overall Study|Pregnancy|0|||
17196697|NCT02315703|38350124|FG007|Overall Study|Pregnancy|1|||
17196698|NCT02315703|38350117|FG000|Overall Study|Withdrawal by Subject|1|||
17196699|NCT02315703|38350118|FG001|Overall Study|Withdrawal by Subject|3|||
16786637|NCT01998958|37727262|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786638|NCT01998958|37727263|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786639|NCT01998958|37727264|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786640|NCT01998958|37727265|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786641|NCT01998958|37727266|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786642|NCT01998958|37727267|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786643|NCT01998958|37727268|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786644|NCT01998958|37727269|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786645|NCT01998958|37727270|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786646|NCT01998958|37727271|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786647|NCT01998958|37727272|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786648|NCT01998958|37727273|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786649|NCT01998958|37727274|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786650|NCT01998958|37727275|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786651|NCT01998958|37727276|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786652|NCT01998958|37727277|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786653|NCT01998958|37727278|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786654|NCT01998958|37727279|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786655|NCT01998958|37727280|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786656|NCT01998958|37727281|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786657|NCT01998958|37727282|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786658|NCT01998958|37727283|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786659|NCT01998958|37727284|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16786660|NCT01998958|37727253|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786661|NCT01998958|37727254|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
16786662|NCT01998958|37727255|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786663|NCT01998958|37727256|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786664|NCT01998958|37727257|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786665|NCT01998958|37727258|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786666|NCT01998958|37727259|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786667|NCT01998958|37727260|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786668|NCT01998958|37727261|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786669|NCT01998958|37727262|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786670|NCT01998958|37727263|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786671|NCT01998958|37727264|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786672|NCT01998958|37727265|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786673|NCT01998958|37727266|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786674|NCT01998958|37727267|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786675|NCT01998958|37727268|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786676|NCT01998958|37727269|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786677|NCT01998958|37727270|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786678|NCT01998958|37727271|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786679|NCT01998958|37727272|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786680|NCT01998958|37727273|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786681|NCT01998958|37727274|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786682|NCT01998958|37727275|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786683|NCT01998958|37727276|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786684|NCT01998958|37727277|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786685|NCT01998958|37727278|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786686|NCT01998958|37727279|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
17015124|NCT00868790|38160008|FG011|Period 1|Withdrawal by Subject|0|||
17196700|NCT02315703|38350119|FG002|Overall Study|Withdrawal by Subject|0|||
17196701|NCT02315703|38350120|FG003|Overall Study|Withdrawal by Subject|3|||
17196702|NCT02315703|38350121|FG004|Overall Study|Withdrawal by Subject|4|||
17196703|NCT02315703|38350122|FG005|Overall Study|Withdrawal by Subject|1|||
17196704|NCT02315703|38350123|FG006|Overall Study|Withdrawal by Subject|1|||
17196705|NCT02315703|38350124|FG007|Overall Study|Withdrawal by Subject|2|||
17196706|NCT02315703|38350117|FG000|Overall Study|Physician Decision|0|||
16786687|NCT01998958|37727280|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786688|NCT01998958|37727281|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786689|NCT01998958|37727282|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786690|NCT01998958|37727283|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
17196707|NCT02315703|38350118|FG001|Overall Study|Physician Decision|0|||
17196708|NCT02315703|38350119|FG002|Overall Study|Physician Decision|0|||
17015125|NCT00868790|38160009|FG012|Period 1|Withdrawal by Subject|0|||
17015126|NCT00868790|38160010|FG013|Period 1|Withdrawal by Subject|1|||
17015127|NCT00868790|38159997|FG000|Period 1|Abnormal Triglycerides|0|||
17015128|NCT00868790|38159998|FG001|Period 1|Abnormal Triglycerides|0|||
17015129|NCT00868790|38159999|FG002|Period 1|Abnormal Triglycerides|0|||
17015130|NCT00868790|38160000|FG003|Period 1|Abnormal Triglycerides|0|||
17015131|NCT00868790|38160001|FG004|Period 1|Abnormal Triglycerides|1|||
17015132|NCT00868790|38160002|FG005|Period 1|Abnormal Triglycerides|0|||
17015133|NCT00868790|38160003|FG006|Period 1|Abnormal Triglycerides|0|||
17015134|NCT00868790|38160004|FG007|Period 1|Abnormal Triglycerides|0|||
17015135|NCT00868790|38160005|FG008|Period 1|Abnormal Triglycerides|0|||
17015136|NCT00868790|38160006|FG009|Period 1|Abnormal Triglycerides|0|||
17015137|NCT00868790|38160007|FG010|Period 1|Abnormal Triglycerides|0|||
17015138|NCT00868790|38160008|FG011|Period 1|Abnormal Triglycerides|0|||
17015139|NCT00868790|38160009|FG012|Period 1|Abnormal Triglycerides|0|||
17015140|NCT00868790|38160010|FG013|Period 1|Abnormal Triglycerides|0|||
17015141|NCT00868790|38159997|FG000|Period 1|Lost to Follow-up|0|||
17015142|NCT00868790|38159998|FG001|Period 1|Lost to Follow-up|0|||
17015143|NCT00868790|38159999|FG002|Period 1|Lost to Follow-up|0|||
17015144|NCT00868790|38160000|FG003|Period 1|Lost to Follow-up|0|||
17015145|NCT00868790|38160001|FG004|Period 1|Lost to Follow-up|0|||
17015146|NCT00868790|38160002|FG005|Period 1|Lost to Follow-up|1|||
17015147|NCT00868790|38160003|FG006|Period 1|Lost to Follow-up|0|||
17015148|NCT00868790|38160004|FG007|Period 1|Lost to Follow-up|0|||
17015149|NCT00868790|38160005|FG008|Period 1|Lost to Follow-up|0|||
17015150|NCT00868790|38160006|FG009|Period 1|Lost to Follow-up|0|||
17015151|NCT00868790|38160007|FG010|Period 1|Lost to Follow-up|0|||
17015152|NCT00868790|38160008|FG011|Period 1|Lost to Follow-up|0|||
17015153|NCT00868790|38160009|FG012|Period 1|Lost to Follow-up|0|||
17015154|NCT00868790|38160010|FG013|Period 1|Lost to Follow-up|0|||
17015155|NCT00868790|38159997|FG000|Period 2|Adverse Event|0|||
17015156|NCT00868790|38159998|FG001|Period 2|Adverse Event|0|||
17015157|NCT00868790|38159999|FG002|Period 2|Adverse Event|0|||
17015158|NCT00868790|38160000|FG003|Period 2|Adverse Event|0|||
17015159|NCT00868790|38160001|FG004|Period 2|Adverse Event|0|||
17015160|NCT00868790|38160002|FG005|Period 2|Adverse Event|0|||
17015161|NCT00868790|38160003|FG006|Period 2|Adverse Event|0|||
17015162|NCT00868790|38160004|FG007|Period 2|Adverse Event|0|||
17015163|NCT00868790|38160005|FG008|Period 2|Adverse Event|1|||
17015164|NCT00868790|38160006|FG009|Period 2|Adverse Event|0|||
17015165|NCT00868790|38160007|FG010|Period 2|Adverse Event|0|||
17015166|NCT00868790|38160008|FG011|Period 2|Adverse Event|0|||
17015167|NCT00868790|38160009|FG012|Period 2|Adverse Event|0|||
17015168|NCT00868790|38160010|FG013|Period 2|Adverse Event|0|||
17015169|NCT00868790|38159997|FG000|Period 2|Lost to Follow-up|0|||
17015170|NCT00868790|38159998|FG001|Period 2|Lost to Follow-up|1|||
17015171|NCT00868790|38159999|FG002|Period 2|Lost to Follow-up|0|||
17015172|NCT00868790|38160000|FG003|Period 2|Lost to Follow-up|0|||
17015173|NCT00868790|38160001|FG004|Period 2|Lost to Follow-up|0|||
17015174|NCT00868790|38160002|FG005|Period 2|Lost to Follow-up|1|||
17015175|NCT00868790|38160003|FG006|Period 2|Lost to Follow-up|0|||
17015176|NCT00868790|38160004|FG007|Period 2|Lost to Follow-up|0|||
17015177|NCT00868790|38160005|FG008|Period 2|Lost to Follow-up|0|||
17015178|NCT00868790|38160006|FG009|Period 2|Lost to Follow-up|0|||
17015179|NCT00868790|38160007|FG010|Period 2|Lost to Follow-up|0|||
17015180|NCT00868790|38160008|FG011|Period 2|Lost to Follow-up|0|||
17015181|NCT00868790|38160009|FG012|Period 2|Lost to Follow-up|0|||
17015182|NCT00868790|38160010|FG013|Period 2|Lost to Follow-up|0|||
17015183|NCT00868790|38159997|FG000|Period 2|Withdrawal by Subject|0|||
17015184|NCT00868790|38159998|FG001|Period 2|Withdrawal by Subject|0|||
17196709|NCT02315703|38350120|FG003|Overall Study|Physician Decision|0|||
17196710|NCT02315703|38350121|FG004|Overall Study|Physician Decision|0|||
17196711|NCT02315703|38350122|FG005|Overall Study|Physician Decision|2|||
17196712|NCT02315703|38350123|FG006|Overall Study|Physician Decision|1|||
17196713|NCT02315703|38350124|FG007|Overall Study|Physician Decision|0|||
17196714|NCT02315703|38350117|FG000|Overall Study|Other|4|||
17196715|NCT02315703|38350118|FG001|Overall Study|Other|2|||
17196716|NCT02315703|38350119|FG002|Overall Study|Other|2|||
17196717|NCT02315703|38350120|FG003|Overall Study|Other|2|||
17196718|NCT02315703|38350121|FG004|Overall Study|Other|1|||
17196719|NCT02315703|38350122|FG005|Overall Study|Other|2|||
17196720|NCT02315703|38350123|FG006|Overall Study|Other|8|||
17196721|NCT02315703|38350124|FG007|Overall Study|Other|2|||
17015185|NCT00868790|38159999|FG002|Period 2|Withdrawal by Subject|0|||
17015186|NCT00868790|38160000|FG003|Period 2|Withdrawal by Subject|0|||
17015187|NCT00868790|38160001|FG004|Period 2|Withdrawal by Subject|0|||
17015188|NCT00868790|38160002|FG005|Period 2|Withdrawal by Subject|0|||
17015189|NCT00868790|38160003|FG006|Period 2|Withdrawal by Subject|0|||
17015190|NCT00868790|38160004|FG007|Period 2|Withdrawal by Subject|0|||
17196722|NCT01369433|38350144|FG000|Overall Study|Adverse Event|31|||
17196723|NCT01369433|38350145|FG001|Overall Study|Adverse Event|1|||
17196724|NCT01369433|38350144|FG000|Overall Study|Required significant surgical procedure|1|||
17196725|NCT01369433|38350145|FG001|Overall Study|Required significant surgical procedure|0|||
17196726|NCT01369433|38350144|FG000|Overall Study|Non-compliance|1|||
17196727|NCT01369433|38350145|FG001|Overall Study|Non-compliance|0|||
17196728|NCT01369433|38350144|FG000|Overall Study|Withdrawal by Subject|5|||
17196729|NCT01369433|38350145|FG001|Overall Study|Withdrawal by Subject|2|||
17196730|NCT01369433|38350144|FG000|Overall Study|Study terminated by Sponsor|67|||
17196731|NCT01369433|38350145|FG001|Overall Study|Study terminated by Sponsor|0|||
17196732|NCT01369433|38350144|FG000|Overall Study|Lost to Follow-up|1|||
17196733|NCT01369433|38350145|FG001|Overall Study|Lost to Follow-up|0|||
17196734|NCT01369433|38350144|FG000|Overall Study|Death|5|||
17196735|NCT01369433|38350145|FG001|Overall Study|Death|0|||
17196736|NCT01369433|38350144|FG000|Overall Study|Investigator discretion|6|||
17196737|NCT01369433|38350145|FG001|Overall Study|Investigator discretion|1|||
17196738|NCT01369433|38350144|FG000|Overall Study|Progressive Disease|92|||
17196739|NCT01369433|38350145|FG001|Overall Study|Progressive Disease|12|||
17196740|NCT02624492|38350154|FG000|Overall Study|Adverse Event|2|||
17196741|NCT02624492|38350155|FG001|Overall Study|Adverse Event|2|||
17196742|NCT02624492|38350156|FG002|Overall Study|Adverse Event|2|||
17196743|NCT02624492|38350154|FG000|Overall Study|Progressive disease|0|||
17196744|NCT02624492|38350155|FG001|Overall Study|Progressive disease|2|||
17196745|NCT02624492|38350156|FG002|Overall Study|Progressive disease|3|||
17196746|NCT01975831|38350173|FG000|Overall Study|Adverse Event|1|||
17196747|NCT01975831|38350174|FG001|Overall Study|Adverse Event|2|||
17196748|NCT01975831|38350175|FG002|Overall Study|Adverse Event|2|||
17196749|NCT01975831|38350176|FG003|Overall Study|Adverse Event|0|||
17196750|NCT01975831|38350177|FG004|Overall Study|Adverse Event|1|||
17196751|NCT01975831|38350178|FG005|Overall Study|Adverse Event|1|||
17196752|NCT01975831|38350179|FG006|Overall Study|Adverse Event|3|||
17196753|NCT01975831|38350180|FG007|Overall Study|Adverse Event|4|||
17196754|NCT01975831|38350181|FG008|Overall Study|Adverse Event|1|||
17196755|NCT01975831|38350173|FG000|Overall Study|Death|1|||
17196756|NCT01975831|38350174|FG001|Overall Study|Death|1|||
17196757|NCT01975831|38350175|FG002|Overall Study|Death|0|||
17196758|NCT01975831|38350176|FG003|Overall Study|Death|0|||
17196759|NCT01975831|38350177|FG004|Overall Study|Death|1|||
17196760|NCT01975831|38350178|FG005|Overall Study|Death|0|||
17196761|NCT01975831|38350179|FG006|Overall Study|Death|1|||
17015191|NCT00868790|38160005|FG008|Period 2|Withdrawal by Subject|1|||
17015192|NCT00868790|38160006|FG009|Period 2|Withdrawal by Subject|0|||
17015193|NCT00868790|38160007|FG010|Period 2|Withdrawal by Subject|0|||
17015194|NCT00868790|38160008|FG011|Period 2|Withdrawal by Subject|0|||
17015195|NCT00868790|38160009|FG012|Period 2|Withdrawal by Subject|0|||
17015196|NCT00868790|38160010|FG013|Period 2|Withdrawal by Subject|1|||
17015197|NCT00868790|38159997|FG000|Period 3|Adverse Event|0|||
17015198|NCT00868790|38159998|FG001|Period 3|Adverse Event|0|||
17015199|NCT00868790|38159999|FG002|Period 3|Adverse Event|0|||
17015200|NCT00868790|38160000|FG003|Period 3|Adverse Event|0|||
17015201|NCT00868790|38160001|FG004|Period 3|Adverse Event|0|||
17015202|NCT00868790|38160002|FG005|Period 3|Adverse Event|0|||
17015203|NCT00868790|38160003|FG006|Period 3|Adverse Event|0|||
17015204|NCT00868790|38160004|FG007|Period 3|Adverse Event|0|||
17015205|NCT00868790|38160005|FG008|Period 3|Adverse Event|0|||
17015206|NCT00868790|38160006|FG009|Period 3|Adverse Event|1|||
17015207|NCT00868790|38160007|FG010|Period 3|Adverse Event|0|||
17015208|NCT00868790|38160008|FG011|Period 3|Adverse Event|0|||
17015209|NCT00868790|38160009|FG012|Period 3|Adverse Event|0|||
17015210|NCT00868790|38160010|FG013|Period 3|Adverse Event|0|||
17015211|NCT00868790|38159997|FG000|Period 3|Protocol Violation|0|||
17015212|NCT00868790|38159998|FG001|Period 3|Protocol Violation|0|||
17015213|NCT00868790|38159999|FG002|Period 3|Protocol Violation|0|||
17015214|NCT00868790|38160000|FG003|Period 3|Protocol Violation|0|||
17015215|NCT00868790|38160001|FG004|Period 3|Protocol Violation|0|||
17015216|NCT00868790|38160002|FG005|Period 3|Protocol Violation|0|||
17015217|NCT00868790|38160003|FG006|Period 3|Protocol Violation|0|||
17015218|NCT00868790|38160004|FG007|Period 3|Protocol Violation|0|||
17015219|NCT00868790|38160005|FG008|Period 3|Protocol Violation|0|||
17015220|NCT00868790|38160006|FG009|Period 3|Protocol Violation|0|||
17015221|NCT00868790|38160007|FG010|Period 3|Protocol Violation|1|||
17015222|NCT00868790|38160008|FG011|Period 3|Protocol Violation|0|||
17015223|NCT00868790|38160009|FG012|Period 3|Protocol Violation|0|||
17015224|NCT00868790|38160010|FG013|Period 3|Protocol Violation|0|||
17015225|NCT00868790|38159997|FG000|Period 3|Study Terminated by Sponsor|0|||
16908593|NCT01732770|38017326|FG000|Overall Study|Lost to Follow-up|2|||
17015226|NCT00868790|38159998|FG001|Period 3|Study Terminated by Sponsor|0|||
17015227|NCT00868790|38159999|FG002|Period 3|Study Terminated by Sponsor|0|||
17100444|NCT04237792|38239612|FG005|Treatment (Day 1)|Adverse Event|1|||
17015228|NCT00868790|38160000|FG003|Period 3|Study Terminated by Sponsor|1|||
17100445|NCT04237792|38239607|FG000|Treatment (Day 1)|Other|0|||
17196762|NCT01975831|38350180|FG007|Overall Study|Death|0|||
17196763|NCT01975831|38350181|FG008|Overall Study|Death|0|||
17196764|NCT01975831|38350173|FG000|Overall Study|Progressive Disease|1|||
17196765|NCT01975831|38350174|FG001|Overall Study|Progressive Disease|3|||
17196766|NCT01975831|38350175|FG002|Overall Study|Progressive Disease|2|||
17015229|NCT00868790|38160001|FG004|Period 3|Study Terminated by Sponsor|0|||
17015230|NCT00868790|38160002|FG005|Period 3|Study Terminated by Sponsor|0|||
17015231|NCT00868790|38160003|FG006|Period 3|Study Terminated by Sponsor|0|||
17015232|NCT00868790|38160004|FG007|Period 3|Study Terminated by Sponsor|0|||
17015233|NCT00868790|38160005|FG008|Period 3|Study Terminated by Sponsor|0|||
17015234|NCT00868790|38160006|FG009|Period 3|Study Terminated by Sponsor|0|||
17015235|NCT00868790|38160007|FG010|Period 3|Study Terminated by Sponsor|0|||
17015236|NCT00868790|38160008|FG011|Period 3|Study Terminated by Sponsor|0|||
17015237|NCT00868790|38160009|FG012|Period 3|Study Terminated by Sponsor|0|||
17015238|NCT00868790|38160010|FG013|Period 3|Study Terminated by Sponsor|0|||
17015239|NCT00868790|38159997|FG000|Period 4|Adverse Event|0|||
17015240|NCT00868790|38159998|FG001|Period 4|Adverse Event|0|||
17015241|NCT00868790|38159999|FG002|Period 4|Adverse Event|0|||
17015242|NCT00868790|38160000|FG003|Period 4|Adverse Event|0|||
17015243|NCT00868790|38160001|FG004|Period 4|Adverse Event|0|||
17015244|NCT00868790|38160002|FG005|Period 4|Adverse Event|0|||
17015245|NCT00868790|38160003|FG006|Period 4|Adverse Event|0|||
17015246|NCT00868790|38160004|FG007|Period 4|Adverse Event|1|||
17015247|NCT00868790|38160005|FG008|Period 4|Adverse Event|0|||
17015248|NCT00868790|38160006|FG009|Period 4|Adverse Event|0|||
17015249|NCT00868790|38160007|FG010|Period 4|Adverse Event|1|||
17015250|NCT00868790|38160008|FG011|Period 4|Adverse Event|0|||
17015251|NCT00868790|38160009|FG012|Period 4|Adverse Event|1|||
17015252|NCT00868790|38160010|FG013|Period 4|Adverse Event|0|||
17015253|NCT00868790|38159997|FG000|Period 4|Lost to Follow-up|0|||
17015254|NCT00868790|38159998|FG001|Period 4|Lost to Follow-up|0|||
17015255|NCT00868790|38159999|FG002|Period 4|Lost to Follow-up|0|||
17015256|NCT00868790|38160000|FG003|Period 4|Lost to Follow-up|0|||
17015257|NCT00868790|38160001|FG004|Period 4|Lost to Follow-up|0|||
17015258|NCT00868790|38160002|FG005|Period 4|Lost to Follow-up|0|||
17015259|NCT00868790|38160003|FG006|Period 4|Lost to Follow-up|0|||
17015260|NCT00868790|38160004|FG007|Period 4|Lost to Follow-up|1|||
17015261|NCT00868790|38160005|FG008|Period 4|Lost to Follow-up|0|||
17015262|NCT00868790|38160006|FG009|Period 4|Lost to Follow-up|0|||
17015263|NCT00868790|38160007|FG010|Period 4|Lost to Follow-up|0|||
17015264|NCT00868790|38160008|FG011|Period 4|Lost to Follow-up|0|||
17015265|NCT00868790|38160009|FG012|Period 4|Lost to Follow-up|0|||
17015266|NCT00868790|38160010|FG013|Period 4|Lost to Follow-up|0|||
17015267|NCT00868790|38159997|FG000|Period 4|Study Terminated by Sponsor|2|||
17015268|NCT00868790|38159998|FG001|Period 4|Study Terminated by Sponsor|0|||
17015269|NCT00868790|38159999|FG002|Period 4|Study Terminated by Sponsor|0|||
17015270|NCT00868790|38160000|FG003|Period 4|Study Terminated by Sponsor|0|||
17196767|NCT01975831|38350176|FG003|Overall Study|Progressive Disease|4|||
17196768|NCT01975831|38350177|FG004|Overall Study|Progressive Disease|13|||
17196769|NCT01975831|38350178|FG005|Overall Study|Progressive Disease|9|||
17196770|NCT01975831|38350179|FG006|Overall Study|Progressive Disease|10|||
17196771|NCT01975831|38350180|FG007|Overall Study|Progressive Disease|8|||
17015271|NCT00868790|38160001|FG004|Period 4|Study Terminated by Sponsor|0|||
17015272|NCT00868790|38160002|FG005|Period 4|Study Terminated by Sponsor|0|||
17015273|NCT00868790|38160003|FG006|Period 4|Study Terminated by Sponsor|0|||
17015274|NCT00868790|38160004|FG007|Period 4|Study Terminated by Sponsor|1|||
17100446|NCT04237792|38239608|FG001|Treatment (Day 1)|Other|0|||
17015275|NCT00868790|38160005|FG008|Period 4|Study Terminated by Sponsor|2|||
17015276|NCT00868790|38160006|FG009|Period 4|Study Terminated by Sponsor|0|||
17015277|NCT00868790|38160007|FG010|Period 4|Study Terminated by Sponsor|2|||
17015278|NCT00868790|38160008|FG011|Period 4|Study Terminated by Sponsor|1|||
17015279|NCT00868790|38160009|FG012|Period 4|Study Terminated by Sponsor|0|||
17015280|NCT00868790|38160010|FG013|Period 4|Study Terminated by Sponsor|1|||
17015281|NCT00868790|38159997|FG000|Period 4|Abnormal ALT/AST|0|||
17015282|NCT00868790|38159998|FG001|Period 4|Abnormal ALT/AST|0|||
17015283|NCT00868790|38159999|FG002|Period 4|Abnormal ALT/AST|1|||
17100447|NCT04237792|38239609|FG002|Treatment (Day 1)|Other|1|||
17100448|NCT04237792|38239610|FG003|Treatment (Day 1)|Other|0|||
17100449|NCT04237792|38239611|FG004|Treatment (Day 1)|Other|0|||
17100450|NCT04237792|38239612|FG005|Treatment (Day 1)|Other|1|||
17100451|NCT04237792|38239607|FG000|Treatment (Day 1)|Not treated|1|||
17100452|NCT04237792|38239608|FG001|Treatment (Day 1)|Not treated|1|||
17100453|NCT04237792|38239609|FG002|Treatment (Day 1)|Not treated|2|||
17100454|NCT04237792|38239610|FG003|Treatment (Day 1)|Not treated|1|||
17100455|NCT04237792|38239611|FG004|Treatment (Day 1)|Not treated|0|||
17100456|NCT04237792|38239612|FG005|Treatment (Day 1)|Not treated|1|||
17015284|NCT00868790|38160000|FG003|Period 4|Abnormal ALT/AST|0|||
17100457|NCT04233580|38239643|FG000|Overall Study|Adverse Event|3|||
17100458|NCT04233580|38239644|FG001|Overall Study|Adverse Event|3|||
17015285|NCT00868790|38160001|FG004|Period 4|Abnormal ALT/AST|0|||
17100459|NCT04233580|38239643|FG000|Overall Study|Withdrawal by Subject|2|||
17015286|NCT00868790|38160002|FG005|Period 4|Abnormal ALT/AST|0|||
17196772|NCT01975831|38350181|FG008|Overall Study|Progressive Disease|10|||
17196773|NCT01975831|38350173|FG000|Overall Study|Withdrawal by Subject|0|||
17100460|NCT04233580|38239644|FG001|Overall Study|Withdrawal by Subject|1|||
17100461|NCT00122954|38239652|FG000|Overall Study|Withdrawal by Subject|2|||
17100462|NCT00122954|38239653|FG001|Overall Study|Withdrawal by Subject|2|||
17100463|NCT00122954|38239652|FG000|Overall Study|Protocol Violation|0|||
17100464|NCT00122954|38239653|FG001|Overall Study|Protocol Violation|1|||
17100465|NCT04491994|38239661|FG000|Overall Study|Withdrawal by Subject|10|||
17100466|NCT04491994|38239662|FG001|Overall Study|Withdrawal by Subject|5|||
17100467|NCT04491994|38239661|FG000|Overall Study|developed fever > 3 days|4|||
17196774|NCT01975831|38350174|FG001|Overall Study|Withdrawal by Subject|3|||
17196775|NCT01975831|38350175|FG002|Overall Study|Withdrawal by Subject|0|||
17196776|NCT01975831|38350176|FG003|Overall Study|Withdrawal by Subject|0|||
17196777|NCT01975831|38350177|FG004|Overall Study|Withdrawal by Subject|3|||
17196778|NCT01975831|38350178|FG005|Overall Study|Withdrawal by Subject|1|||
17196779|NCT01975831|38350179|FG006|Overall Study|Withdrawal by Subject|1|||
17196780|NCT01975831|38350180|FG007|Overall Study|Withdrawal by Subject|0|||
17196781|NCT01975831|38350181|FG008|Overall Study|Withdrawal by Subject|0|||
17196782|NCT01975831|38350173|FG000|Overall Study|Physician Decision|0|||
17196783|NCT01975831|38350174|FG001|Overall Study|Physician Decision|0|||
17100468|NCT04491994|38239662|FG001|Overall Study|developed fever > 3 days|1|||
17100469|NCT04491994|38239661|FG000|Overall Study|Protocol Violation|11|||
17196784|NCT01975831|38350175|FG002|Overall Study|Physician Decision|0|||
17196785|NCT01975831|38350176|FG003|Overall Study|Physician Decision|0|||
17196786|NCT01975831|38350177|FG004|Overall Study|Physician Decision|0|||
17196787|NCT01975831|38350178|FG005|Overall Study|Physician Decision|1|||
17196788|NCT01975831|38350179|FG006|Overall Study|Physician Decision|0|||
17196789|NCT01975831|38350180|FG007|Overall Study|Physician Decision|1|||
17196790|NCT01975831|38350181|FG008|Overall Study|Physician Decision|0|||
17196791|NCT01975831|38350173|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
17196792|NCT01975831|38350174|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
17196793|NCT01975831|38350175|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
17196794|NCT01975831|38350176|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
17196795|NCT01975831|38350177|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
17196796|NCT01975831|38350178|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
17196797|NCT01975831|38350179|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
17196798|NCT01975831|38350180|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
17196799|NCT01975831|38350181|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
17196800|NCT01975831|38350173|FG000|Overall Study|Entered Hospice|0|||
17196801|NCT01975831|38350174|FG001|Overall Study|Entered Hospice|0|||
17100470|NCT04491994|38239662|FG001|Overall Study|Protocol Violation|2|||
17100471|NCT04491994|38239661|FG000|Overall Study|Lost to Follow-up|4|||
17100472|NCT04491994|38239662|FG001|Overall Study|Lost to Follow-up|3|||
17100473|NCT04041700|38239668|FG000|Overall Study|Pregnancy|1|||
17196802|NCT01975831|38350175|FG002|Overall Study|Entered Hospice|0|||
17196803|NCT01975831|38350176|FG003|Overall Study|Entered Hospice|0|||
17196804|NCT01975831|38350177|FG004|Overall Study|Entered Hospice|0|||
17196805|NCT01975831|38350178|FG005|Overall Study|Entered Hospice|1|||
17196806|NCT01975831|38350179|FG006|Overall Study|Entered Hospice|0|||
17196807|NCT01975831|38350180|FG007|Overall Study|Entered Hospice|0|||
17196808|NCT01975831|38350181|FG008|Overall Study|Entered Hospice|0|||
17196809|NCT01975831|38350173|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
17196810|NCT01975831|38350174|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
17196811|NCT01975831|38350175|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
17196812|NCT01975831|38350176|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
17196813|NCT01975831|38350177|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
17196814|NCT01975831|38350178|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
17196815|NCT01975831|38350179|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
17196816|NCT01975831|38350180|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
17196817|NCT01975831|38350181|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
17196818|NCT00700713|38350204|FG000|Overall Study|Protocol Violation|1|||
17196819|NCT00700713|38350205|FG001|Overall Study|Protocol Violation|0|||
17196820|NCT00700713|38350206|FG002|Overall Study|Protocol Violation|1|||
17196821|NCT00700713|38350204|FG000|Overall Study|Withdrawal by Subject|0|||
17196822|NCT00700713|38350205|FG001|Overall Study|Withdrawal by Subject|0|||
17196823|NCT00700713|38350206|FG002|Overall Study|Withdrawal by Subject|1|||
17196824|NCT02622386|38350214|FG000|First Assignment|Withdrawal by Subject|3|||
17196825|NCT02622386|38350215|FG001|First Assignment|Withdrawal by Subject|2|||
17196826|NCT02622386|38350214|FG000|Washout|Withdrawal by Subject|4|||
17196827|NCT02622386|38350215|FG001|Washout|Withdrawal by Subject|4|||
17100474|NCT04041700|38239668|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
17100475|NCT04227340|38239674|FG000|Overall Study|Withdrawal by Subject|3|||
17100476|NCT04033432|38239681|FG000|Overall Study|Progressive Disease|8|||
17196828|NCT02622386|38350214|FG000|Second Assignment|Withdrawal by Subject|0|||
17196829|NCT02622386|38350215|FG001|Second Assignment|Withdrawal by Subject|2|||
17196830|NCT02792231|38350223|FG000|Overall Study|Patient/guardian decision|32|||
17196831|NCT02792231|38350224|FG001|Overall Study|Patient/guardian decision|42|||
17100477|NCT04033432|38239681|FG000|Overall Study|Adverse Event|4|||
17100478|NCT04033432|38239681|FG000|Overall Study|Death|1|||
17100479|NCT04223830|38239686|FG000|Overall Study|Lost to Follow-up|9|||
17100480|NCT04223830|38239686|FG000|Overall Study|Adverse Event|1|||
17100481|NCT04032652|38239693|FG000|Overall Study|The study was terminated and the PI has|1|||
17100482|NCT04032652|38239694|FG001|Overall Study|The study was terminated and the PI has|1|||
17100483|NCT04031404|38239700|FG000|Baseline|Lost to Follow-up|0|||
17100484|NCT04031404|38239701|FG001|Baseline|Lost to Follow-up|1|||
17100485|NCT04031404|38239700|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
17100486|NCT04031404|38239701|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
17100487|NCT04031404|38239700|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
17100488|NCT04031404|38239701|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
17100489|NCT04031404|38239700|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
17100490|NCT04031404|38239701|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
17196832|NCT02792231|38350223|FG000|Overall Study|Adverse Event|15|||
17196833|NCT02792231|38350224|FG001|Overall Study|Adverse Event|11|||
17196834|NCT02792231|38350223|FG000|Overall Study|Physician Decision|14|||
17196835|NCT02792231|38350224|FG001|Overall Study|Physician Decision|12|||
17196836|NCT02792231|38350223|FG000|Overall Study|Lack of Efficacy|7|||
17196837|NCT02792231|38350224|FG001|Overall Study|Lack of Efficacy|9|||
17196838|NCT02792231|38350223|FG000|Overall Study|Lost to Follow-up|9|||
17196839|NCT02792231|38350224|FG001|Overall Study|Lost to Follow-up|5|||
17196840|NCT02792231|38350223|FG000|Overall Study|Pregnancy|1|||
17196841|NCT02792231|38350224|FG001|Overall Study|Pregnancy|3|||
17196842|NCT02792231|38350223|FG000|Overall Study|Non-compliance with study treatment|2|||
17196843|NCT02792231|38350224|FG001|Overall Study|Non-compliance with study treatment|1|||
17196844|NCT02792231|38350223|FG000|Overall Study|Protocol deviation|2|||
17196845|NCT02792231|38350224|FG001|Overall Study|Protocol deviation|0|||
17196846|NCT02792231|38350223|FG000|Overall Study|Technical problems|0|||
17196847|NCT02792231|38350224|FG001|Overall Study|Technical problems|1|||
17196848|NCT00700401|38350230|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
17196849|NCT00700401|38350230|FG000|Overall Study|Adverse Event|5|||
17196850|NCT00700401|38350230|FG000|Overall Study|Refused Treatment|2|||
17196851|NCT00700401|38350230|FG000|Overall Study|Lost to Follow-up|1|||
17196852|NCT00700401|38350230|FG000|Overall Study|Treatment never started|1|||
17196853|NCT00700401|38350230|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
17196854|NCT00700401|38350230|FG000|Overall Study|Withdrawal by Subject|2|||
17100491|NCT04031404|38239700|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
17100492|NCT04031404|38239701|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
17100493|NCT04476784|38239717|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
17100494|NCT04476784|38239718|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
17100495|NCT04026568|38239729|FG000|Overall Study|study terminated|0|||
17100496|NCT04026568|38239730|FG001|Overall Study|study terminated|1|||
17100497|NCT04025632|38239738|FG000|Overall Study|Adverse Event|1|||
17100498|NCT04025632|38239739|FG001|Overall Study|Adverse Event|1|||
17100499|NCT04025632|38239738|FG000|Overall Study|Withdrawal by Subject|1|||
16908594|NCT01732770|38017327|FG001|Overall Study|Lost to Follow-up|3|||
17015287|NCT00868790|38160003|FG006|Period 4|Abnormal ALT/AST|0|||
17015288|NCT00868790|38160004|FG007|Period 4|Abnormal ALT/AST|0|||
17015289|NCT00868790|38160005|FG008|Period 4|Abnormal ALT/AST|0|||
17100500|NCT04025632|38239739|FG001|Overall Study|Withdrawal by Subject|1|||
17100501|NCT04025632|38239738|FG000|Overall Study|Study Terminated by Sponsor|10|||
17015290|NCT00868790|38160006|FG009|Period 4|Abnormal ALT/AST|0|||
17015291|NCT00868790|38160007|FG010|Period 4|Abnormal ALT/AST|0|||
17015292|NCT00868790|38160008|FG011|Period 4|Abnormal ALT/AST|0|||
17015293|NCT00868790|38160009|FG012|Period 4|Abnormal ALT/AST|0|||
17015294|NCT00868790|38160010|FG013|Period 4|Abnormal ALT/AST|0|||
17015295|NCT00868790|38159997|FG000|Post-study|Withdrawal by Subject|0|||
17015296|NCT00868790|38159998|FG001|Post-study|Withdrawal by Subject|0|||
17015297|NCT00868790|38159999|FG002|Post-study|Withdrawal by Subject|0|||
17196855|NCT02621606|38350237|FG000|Overall Study|Withdrawal by Subject|0|||
17196856|NCT02621606|38350238|FG001|Overall Study|Withdrawal by Subject|1|||
17196857|NCT02621606|38350239|FG002|Overall Study|Withdrawal by Subject|0|||
17196858|NCT02871401|38350249|FG000|Overall Study|Adverse Event|1|||
17196859|NCT02871401|38350250|FG001|Overall Study|Adverse Event|0|||
17196860|NCT02576509|38350258|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
17196861|NCT02576509|38350259|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
17196862|NCT02576509|38350258|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
17196863|NCT02576509|38350259|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
17196864|NCT02576509|38350258|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
17196865|NCT02576509|38350259|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
17196866|NCT02576509|38350258|FG000|Treatment Period|Disease progression|245|||
16908595|NCT01732770|38017326|FG000|Overall Study|Withdrawal by Subject|5|||
17015298|NCT00868790|38160000|FG003|Post-study|Withdrawal by Subject|0|||
17015299|NCT00868790|38160001|FG004|Post-study|Withdrawal by Subject|1|||
17015300|NCT00868790|38160002|FG005|Post-study|Withdrawal by Subject|0|||
17015301|NCT00868790|38160003|FG006|Post-study|Withdrawal by Subject|0|||
17196867|NCT02576509|38350259|FG001|Treatment Period|Disease progression|240|||
17196868|NCT02576509|38350258|FG000|Treatment Period|Study drug toxicity|32|||
17196869|NCT02576509|38350259|FG001|Treatment Period|Study drug toxicity|41|||
17196870|NCT02576509|38350258|FG000|Treatment Period|Death|1|||
17196871|NCT02576509|38350259|FG001|Treatment Period|Death|1|||
17100502|NCT04025632|38239739|FG001|Overall Study|Study Terminated by Sponsor|9|||
17100503|NCT04025632|38239738|FG000|Overall Study|Physician Decision|3|||
17100504|NCT04025632|38239739|FG001|Overall Study|Physician Decision|1|||
17100505|NCT04024228|38239750|FG000|Overall Study|Adverse Event|1|||
17100506|NCT04024228|38239751|FG001|Overall Study|Adverse Event|0|||
17100507|NCT04024228|38239750|FG000|Overall Study|Protocol Deviation|0|||
17100508|NCT04024228|38239751|FG001|Overall Study|Protocol Deviation|2|||
17100509|NCT04024228|38239750|FG000|Overall Study|Withdrawal by Subject|3|||
17100510|NCT04024228|38239751|FG001|Overall Study|Withdrawal by Subject|4|||
17100511|NCT04023994|38239765|FG000|Overall Study|Lost to Follow-up|0|||
17100512|NCT04023994|38239766|FG001|Overall Study|Lost to Follow-up|1|||
17100513|NCT04023994|38239767|FG002|Overall Study|Lost to Follow-up|2|||
17100514|NCT04023994|38239768|FG003|Overall Study|Lost to Follow-up|0|||
17100515|NCT04023994|38239769|FG004|Overall Study|Lost to Follow-up|0|||
17100516|NCT04023994|38239770|FG005|Overall Study|Lost to Follow-up|0|||
17100517|NCT04023994|38239765|FG000|Overall Study|Withdrawal by Subject|0|||
17100518|NCT04023994|38239766|FG001|Overall Study|Withdrawal by Subject|0|||
17100519|NCT04023994|38239767|FG002|Overall Study|Withdrawal by Subject|0|||
17196872|NCT02576509|38350258|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
17196873|NCT02576509|38350259|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
17196874|NCT02576509|38350258|FG000|Treatment Period|Participant request to stop treatment|8|||
17196875|NCT02576509|38350259|FG001|Treatment Period|Participant request to stop treatment|17|||
17196876|NCT02576509|38350258|FG000|Treatment Period|Participant withdrew consent|2|||
17196877|NCT02576509|38350259|FG001|Treatment Period|Participant withdrew consent|7|||
17196878|NCT02576509|38350258|FG000|Treatment Period|Lost to Follow-up|0|||
17196879|NCT02576509|38350259|FG001|Treatment Period|Lost to Follow-up|1|||
17196880|NCT02576509|38350258|FG000|Treatment Period|Maximum clinical benefit|1|||
17196881|NCT02576509|38350259|FG001|Treatment Period|Maximum clinical benefit|0|||
17196882|NCT02576509|38350258|FG000|Treatment Period|Poor/non-compliance|0|||
17196883|NCT02576509|38350259|FG001|Treatment Period|Poor/non-compliance|1|||
17196884|NCT02576509|38350258|FG000|Treatment Period|Participant no longer meets criteria|1|||
17196885|NCT02576509|38350259|FG001|Treatment Period|Participant no longer meets criteria|0|||
17196886|NCT02576509|38350258|FG000|Treatment Period|Other reason|2|||
17196887|NCT02576509|38350259|FG001|Treatment Period|Other reason|7|||
17196888|NCT02576509|38350258|FG000|Follow-up Period|Death|41|||
17196889|NCT02576509|38350259|FG001|Follow-up Period|Death|35|||
17196890|NCT02576509|38350258|FG000|Follow-up Period|Participant withdrew consent|7|||
17196891|NCT02576509|38350259|FG001|Follow-up Period|Participant withdrew consent|14|||
17196892|NCT02576509|38350258|FG000|Follow-up Period|Lost to Follow-up|0|||
17196893|NCT02576509|38350259|FG001|Follow-up Period|Lost to Follow-up|1|||
17196894|NCT02576509|38350258|FG000|Follow-up Period|Other reason|1|||
17100520|NCT04023994|38239768|FG003|Overall Study|Withdrawal by Subject|1|||
17100521|NCT04023994|38239769|FG004|Overall Study|Withdrawal by Subject|0|||
17100522|NCT04023994|38239770|FG005|Overall Study|Withdrawal by Subject|0|||
17100523|NCT04023682|38239789|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
17100524|NCT04018612|38239800|FG000|Overall Study|Withdrawal by Subject|1|||
17100525|NCT04018612|38239801|FG001|Overall Study|Withdrawal by Subject|0|||
17100526|NCT04018612|38239802|FG002|Overall Study|Withdrawal by Subject|1|||
17100527|NCT04018066|38239810|FG000|Overall Study|participants started taking medications during the study period|3|||
17100528|NCT04018066|38239810|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
17100529|NCT04209400|38239817|FG000|Overall Study|Withdrawal by Subject|0|||
17100530|NCT04209400|38239818|FG001|Overall Study|Withdrawal by Subject|1|||
17100531|NCT04207840|38239824|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
17100532|NCT04207840|38239825|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
17100533|NCT04207840|38239826|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
17100534|NCT04207840|38239824|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
17100535|NCT04207840|38239825|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
17100536|NCT04207840|38239826|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
17100537|NCT04006366|38239834|FG000|Overall Study|Withdrawal by Subject|1|||
17100538|NCT04191148|38239840|FG000|Overall Study|Withdrawal by Subject|1|||
17100539|NCT04191148|38239841|FG001|Overall Study|Withdrawal by Subject|0|||
17100540|NCT04191148|38239840|FG000|Overall Study|Adverse Event|1|||
17100541|NCT04191148|38239841|FG001|Overall Study|Adverse Event|0|||
17100542|NCT04004260|38239851|FG000|Overall Study|Withdrawal by Subject|7|||
17100543|NCT04004260|38239852|FG001|Overall Study|Withdrawal by Subject|3|||
17100544|NCT04004260|38239851|FG000|Overall Study|Lost to Follow-up|22|||
17100545|NCT04004260|38239852|FG001|Overall Study|Lost to Follow-up|12|||
17196895|NCT02576509|38350259|FG001|Follow-up Period|Other reason|2|||
17196896|NCT02619812|38350269|FG000|Overall Study|Withdrawal by Subject|0|||
17196897|NCT02619812|38350270|FG001|Overall Study|Withdrawal by Subject|0|||
17196898|NCT02619812|38350271|FG002|Overall Study|Withdrawal by Subject|1|||
17196899|NCT02619812|38350272|FG003|Overall Study|Withdrawal by Subject|2|||
17196900|NCT02623322|38350285|FG000|Overall Study|Lost to Follow-up|2|||
17196901|NCT02623322|38350286|FG001|Overall Study|Lost to Follow-up|1|||
17196902|NCT02623322|38350287|FG002|Overall Study|Lost to Follow-up|0|||
17196903|NCT00105157|38350301|FG000|Double-Blind (DB)|Never Treated|1|||
17196904|NCT00105157|38350302|FG001|Double-Blind (DB)|Never Treated|0|||
17196905|NCT00105157|38350303|FG002|Double-Blind (DB)|Never Treated|0|||
17100546|NCT04004260|38239851|FG000|Overall Study|Did not engage in intervention|13|||
17100547|NCT04004260|38239852|FG001|Overall Study|Did not engage in intervention|17|||
17100548|NCT04470622|38239860|FG000|Overall Study|Withdrawal by Subject|0|||
17100549|NCT04470622|38239861|FG001|Overall Study|Withdrawal by Subject|1|||
17196906|NCT00105157|38350304|FG003|Double-Blind (DB)|Never Treated|0|||
17196907|NCT00105157|38350301|FG000|Double-Blind (DB)|Adverse Event|2|||
17196908|NCT00105157|38350302|FG001|Double-Blind (DB)|Adverse Event|0|||
17196909|NCT00105157|38350303|FG002|Double-Blind (DB)|Adverse Event|1|||
17196910|NCT00105157|38350304|FG003|Double-Blind (DB)|Adverse Event|1|||
17196911|NCT00105157|38350301|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
17015302|NCT00868790|38160004|FG007|Post-study|Withdrawal by Subject|0|||
17100550|NCT04470622|38239860|FG000|Overall Study|Screen Failure|0|||
17100551|NCT04470622|38239861|FG001|Overall Study|Screen Failure|1|||
17100552|NCT04470622|38239860|FG000|Overall Study|Death|0|||
17100553|NCT04470622|38239861|FG001|Overall Study|Death|1|||
17100554|NCT04465630|38239867|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
17100555|NCT04465630|38239867|FG000|Overall Study|Screen failure|8|||
17100556|NCT04465630|38239867|FG000|Overall Study|Baseline failure|16|||
17100557|NCT04182880|38239874|FG000|Overall Study|Pregnancy|1|||
17100558|NCT04182880|38239875|FG001|Overall Study|Pregnancy|0|||
17100559|NCT04465396|38239885|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
17100560|NCT04465396|38239886|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
17015303|NCT00868790|38160005|FG008|Post-study|Withdrawal by Subject|0|||
17015304|NCT00868790|38160006|FG009|Post-study|Withdrawal by Subject|0|||
17015305|NCT00868790|38160007|FG010|Post-study|Withdrawal by Subject|0|||
17015306|NCT00868790|38160008|FG011|Post-study|Withdrawal by Subject|0|||
17100561|NCT04465396|38239887|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
17100562|NCT04465396|38239888|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
17100563|NCT03999892|38239913|FG000|Overall Study|Lost to Follow-up|1|||
17015307|NCT00868790|38160009|FG012|Post-study|Withdrawal by Subject|0|||
17015308|NCT00868790|38160010|FG013|Post-study|Withdrawal by Subject|0|||
17015309|NCT00868790|38159997|FG000|Post-study|Excluded Medication|0|||
17015310|NCT00868790|38159998|FG001|Post-study|Excluded Medication|0|||
17015311|NCT00868790|38159999|FG002|Post-study|Excluded Medication|0|||
17015312|NCT00868790|38160000|FG003|Post-study|Excluded Medication|0|||
17015313|NCT00868790|38160001|FG004|Post-study|Excluded Medication|0|||
17015314|NCT00868790|38160002|FG005|Post-study|Excluded Medication|0|||
17015315|NCT00868790|38160003|FG006|Post-study|Excluded Medication|0|||
17015316|NCT00868790|38160004|FG007|Post-study|Excluded Medication|2|||
17015317|NCT00868790|38160005|FG008|Post-study|Excluded Medication|0|||
17015318|NCT00868790|38160006|FG009|Post-study|Excluded Medication|1|||
17015319|NCT00868790|38160007|FG010|Post-study|Excluded Medication|0|||
17015320|NCT00868790|38160008|FG011|Post-study|Excluded Medication|0|||
17015321|NCT00868790|38160009|FG012|Post-study|Excluded Medication|0|||
17015322|NCT00868790|38160010|FG013|Post-study|Excluded Medication|0|||
17015323|NCT00496483|38160026|FG000|Overall Study|Not dosed|9|||
17015324|NCT00496483|38160026|FG000|Overall Study|Adverse Event|2|||
17015325|NCT00496483|38160026|FG000|Overall Study|Lack of Efficacy|1|||
17015326|NCT03528551|38160036|FG000|Overall Study|Lost to Follow-up|0|||
17015327|NCT03528551|38160037|FG001|Overall Study|Lost to Follow-up|1|||
17015328|NCT03528551|38160038|FG002|Overall Study|Lost to Follow-up|0|||
17015329|NCT03528551|38160036|FG000|Overall Study|Transferred to other arm/group|2|||
17015330|NCT03528551|38160037|FG001|Overall Study|Transferred to other arm/group|3|||
17015331|NCT03528551|38160038|FG002|Overall Study|Transferred to other arm/group|0|||
17015332|NCT03528551|38160036|FG000|Overall Study|Withdrawal by parent/guardian|0|||
17015333|NCT03528551|38160037|FG001|Overall Study|Withdrawal by parent/guardian|5|||
17015334|NCT03528551|38160038|FG002|Overall Study|Withdrawal by parent/guardian|0|||
17015335|NCT03528551|38160036|FG000|Overall Study|Protocol Violation|0|||
17015336|NCT03528551|38160037|FG001|Overall Study|Protocol Violation|3|||
17015337|NCT03528551|38160038|FG002|Overall Study|Protocol Violation|0|||
17100564|NCT03996694|38239917|FG000|First Washout (7 Days)|positive urine drug screen|0|||
17100565|NCT03996694|38239918|FG001|First Washout (7 Days)|positive urine drug screen|0|||
17015338|NCT03528551|38160036|FG000|Overall Study|Withdrawal by Subject|0|||
17100566|NCT03996694|38239919|FG002|First Washout (7 Days)|positive urine drug screen|1|||
17100567|NCT03996694|38239920|FG003|First Washout (7 Days)|positive urine drug screen|0|||
17100568|NCT03996694|38239921|FG004|First Washout (7 Days)|positive urine drug screen|0|||
17015339|NCT03528551|38160037|FG001|Overall Study|Withdrawal by Subject|7|||
17015340|NCT03528551|38160038|FG002|Overall Study|Withdrawal by Subject|0|||
17196912|NCT00105157|38350302|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
17196913|NCT00105157|38350303|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
17196914|NCT00105157|38350304|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
17196915|NCT00105157|38350301|FG000|Open-Label Continuation of DB|Adverse Event|3|||
17196916|NCT00105157|38350302|FG001|Open-Label Continuation of DB|Adverse Event|1|||
17196917|NCT00105157|38350303|FG002|Open-Label Continuation of DB|Adverse Event|0|||
17196918|NCT00105157|38350304|FG003|Open-Label Continuation of DB|Adverse Event|0|||
17196919|NCT00105157|38350301|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
17196920|NCT00105157|38350302|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
17196921|NCT00105157|38350303|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
17196922|NCT00105157|38350304|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
17196923|NCT00105157|38350301|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
17196924|NCT00105157|38350302|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
17196925|NCT00105157|38350303|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
17196926|NCT00105157|38350304|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
17196927|NCT00105157|38350301|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
17196928|NCT00105157|38350302|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
17196929|NCT00105157|38350303|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
17196930|NCT00105157|38350304|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
17100569|NCT03996694|38239922|FG005|First Washout (7 Days)|positive urine drug screen|0|||
17100570|NCT03996694|38239917|FG000|First Washout (7 Days)|Adverse Event|0|||
17100571|NCT03996694|38239918|FG001|First Washout (7 Days)|Adverse Event|1|||
17100572|NCT03996694|38239919|FG002|First Washout (7 Days)|Adverse Event|0|||
17100573|NCT03996694|38239920|FG003|First Washout (7 Days)|Adverse Event|0|||
17100574|NCT03996694|38239921|FG004|First Washout (7 Days)|Adverse Event|0|||
17100575|NCT03996694|38239922|FG005|First Washout (7 Days)|Adverse Event|0|||
17100576|NCT03996694|38239917|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
17100577|NCT03996694|38239918|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
17100578|NCT03996694|38239919|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
17100579|NCT03996694|38239920|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
16908596|NCT01732770|38017327|FG001|Overall Study|Withdrawal by Subject|3|||
16908597|NCT01732770|38017326|FG000|Overall Study|Decision by Sponsor|2|||
17100580|NCT03996694|38239921|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
17100581|NCT03996694|38239922|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
17100582|NCT03996694|38239917|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
17100583|NCT03996694|38239918|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
17100584|NCT03996694|38239919|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
17100585|NCT03996694|38239920|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
17100586|NCT03996694|38239921|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
17100587|NCT03996694|38239922|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
17100588|NCT04179838|38239938|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
17100589|NCT04179838|38239939|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
17100590|NCT04179838|38239938|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
17100591|NCT04179838|38239939|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
17100592|NCT03994120|38239947|FG000|Overall Study|Lost to Follow-up|3|||
17100593|NCT03994120|38239948|FG001|Overall Study|Lost to Follow-up|1|||
17100594|NCT04178590|38239954|FG000|Overall Study|Pregnancy|1|||
17100595|NCT04178590|38239954|FG000|Overall Study|Lost to Follow-up|1|||
17100596|NCT04175392|38239982|FG000|Overall Study|Withdrawal by Subject|3|||
17100597|NCT04175392|38239983|FG001|Overall Study|Withdrawal by Subject|2|||
17100598|NCT03986866|38239991|FG000|Overall Study|Withdrawal by Subject|0|||
17100599|NCT03986866|38239992|FG001|Overall Study|Withdrawal by Subject|3|||
17100600|NCT03986866|38239991|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
17100601|NCT03986866|38239992|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
17100602|NCT03980938|38240000|FG000|Treatment Period 1|Study Terminated|1|||
17100603|NCT03980938|38240001|FG001|Treatment Period 1|Study Terminated|1|||
17100604|NCT03980938|38240000|FG000|Treatment Period 2|Study Terminated|2|||
17100605|NCT03980938|38240001|FG001|Treatment Period 2|Study Terminated|2|||
17100606|NCT03656692|38240007|FG000|Overall Study|Worsening of disease activity|2|||
17100607|NCT03656692|38240007|FG000|Overall Study|Physician Decision|1|||
17100608|NCT04439266|38240011|FG000|Overall Study|Ineligible|1|||
17100609|NCT04439266|38240011|FG000|Overall Study|Adverse Event|1|||
17100610|NCT04439266|38240011|FG000|Overall Study|Death|1|||
17100611|NCT04439266|38240011|FG000|Overall Study|Disease progression|1|||
17100612|NCT04439266|38240011|FG000|Overall Study|Still on treatment|1|||
17100613|NCT03682120|38240019|FG000|Overall Study|Lost to Follow-up|11|||
17100614|NCT03682120|38240020|FG001|Overall Study|Lost to Follow-up|4|||
17100615|NCT03682120|38240021|FG002|Overall Study|Lost to Follow-up|5|||
17100616|NCT03682120|38240022|FG003|Overall Study|Lost to Follow-up|2|||
17100617|NCT03682120|38240019|FG000|Overall Study|Physician Decision|1|||
17100618|NCT03682120|38240020|FG001|Overall Study|Physician Decision|0|||
17100619|NCT03682120|38240021|FG002|Overall Study|Physician Decision|0|||
17100620|NCT03682120|38240022|FG003|Overall Study|Physician Decision|0|||
17100621|NCT03682120|38240019|FG000|Overall Study|Withdrawal by Subject|1|||
17196931|NCT00105157|38350301|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
17100622|NCT03682120|38240020|FG001|Overall Study|Withdrawal by Subject|2|||
17100623|NCT03682120|38240021|FG002|Overall Study|Withdrawal by Subject|3|||
17100624|NCT03682120|38240022|FG003|Overall Study|Withdrawal by Subject|0|||
17100625|NCT03682120|38240019|FG000|Overall Study|Death|0|||
17100626|NCT03682120|38240020|FG001|Overall Study|Death|1|||
17100627|NCT03682120|38240021|FG002|Overall Study|Death|0|||
17100628|NCT03682120|38240022|FG003|Overall Study|Death|0|||
17100629|NCT03682120|38240019|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
17100630|NCT03682120|38240020|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
17100631|NCT03682120|38240021|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
17100632|NCT03682120|38240022|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
17100633|NCT04428502|38240034|FG000|Overall Study|Did not meet entrance criteria|14|||
17100634|NCT04428424|38240039|FG000|Overall Study|Does not meet entrance criteria|132|||
17100635|NCT04428424|38240039|FG000|Overall Study|Lost to Follow-up|115|||
17100636|NCT03655756|38240043|FG000|Overall Study|Death|1|||
17100637|NCT00095238|38240049|FG000|Overall Study|Lack of Efficacy|9|||
17100638|NCT00095238|38240050|FG001|Overall Study|Lack of Efficacy|9|||
17100639|NCT00095238|38240049|FG000|Overall Study|Adverse Event|331|||
17100640|NCT00095238|38240050|FG001|Overall Study|Adverse Event|287|||
17100641|NCT00095238|38240049|FG000|Overall Study|Subject Withdrew Consent|208|||
17100642|NCT00095238|38240050|FG001|Overall Study|Subject Withdrew Consent|223|||
17100643|NCT00095238|38240049|FG000|Overall Study|Death|154|||
17100644|NCT00095238|38240050|FG001|Overall Study|Death|170|||
17100645|NCT00095238|38240049|FG000|Overall Study|Lost to Follow-up|19|||
17100646|NCT00095238|38240050|FG001|Overall Study|Lost to Follow-up|24|||
17100647|NCT00095238|38240049|FG000|Overall Study|Noncompliance|44|||
17100648|NCT00095238|38240050|FG001|Overall Study|Noncompliance|45|||
17100649|NCT00095238|38240049|FG000|Overall Study|No longer met study criteria|4|||
17100650|NCT00095238|38240050|FG001|Overall Study|No longer met study criteria|5|||
17100651|NCT00095238|38240049|FG000|Overall Study|Study terminated by sponsor|0|||
17100652|NCT00095238|38240050|FG001|Overall Study|Study terminated by sponsor|1|||
17100653|NCT00095238|38240049|FG000|Overall Study|Missing|1|||
17100654|NCT00095238|38240050|FG001|Overall Study|Missing|0|||
17100655|NCT00095238|38240049|FG000|Overall Study|Other Reasons|87|||
17100656|NCT00095238|38240050|FG001|Overall Study|Other Reasons|88|||
17100657|NCT00082368|38240088|FG000|Overall Study|Not treated-pt had poor IV access|1|||
17100658|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
17100659|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
17100660|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
17100661|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
17100662|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
17100663|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
17100664|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
17100665|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
17100666|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
17100667|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
17100668|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
17100669|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
17100670|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
17100671|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
17100672|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
17100673|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
17100674|NCT00094770|38240094|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
17100675|NCT00094770|38240095|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
17100676|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
17100677|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
17196932|NCT00105157|38350302|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
17196933|NCT00105157|38350303|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
17196934|NCT00105157|38350304|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
17196935|NCT00105157|38350301|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
17100678|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
17100679|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
16908598|NCT01732770|38017327|FG001|Overall Study|Decision by Sponsor|2|||
17015341|NCT00487981|38160047|FG000|Overall Study|Hypothyroidism diagnosis|1|||
17015342|NCT00861744|38160055|FG000|Overall Study|Adverse Event|0|||
17015343|NCT00861744|38160056|FG001|Overall Study|Adverse Event|0|||
17015344|NCT00861744|38160057|FG002|Overall Study|Adverse Event|0|||
17015345|NCT00861744|38160058|FG003|Overall Study|Adverse Event|1|||
17015346|NCT00861744|38160055|FG000|Overall Study|Lost to Follow-up|7|||
17015347|NCT00861744|38160056|FG001|Overall Study|Lost to Follow-up|19|||
17015348|NCT00861744|38160057|FG002|Overall Study|Lost to Follow-up|17|||
17015349|NCT00861744|38160058|FG003|Overall Study|Lost to Follow-up|12|||
17015350|NCT00861744|38160055|FG000|Overall Study|Withdrawal by Subject|10|||
17015351|NCT00861744|38160056|FG001|Overall Study|Withdrawal by Subject|6|||
17100680|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
17100681|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
17100682|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
17100683|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
17100684|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
17100685|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
17100686|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
17100687|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
17100688|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
17100689|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
17100690|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
17100691|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
17100692|NCT00094770|38240094|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
17100693|NCT00094770|38240095|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
17100694|NCT00069576|38240103|FG000|Original Trial|Lost to Follow-up|25|||
17100695|NCT00069576|38240104|FG001|Original Trial|Lost to Follow-up|33|||
17100696|NCT00069576|38240103|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
17100697|NCT00069576|38240104|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
17100698|NCT00069264|38240110|FG000|Overall Study|Adverse Event|3|||
17100699|NCT00069264|38240110|FG000|Overall Study|Progressive Disease|23|||
17100700|NCT00069264|38240110|FG000|Overall Study|Withdrawal by Subject|3|||
17196936|NCT00105157|38350302|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
17196937|NCT00105157|38350303|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
17196938|NCT00105157|38350304|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
17196939|NCT00105157|38350301|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
17196940|NCT00105157|38350302|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
17196941|NCT00105157|38350303|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
17196942|NCT00105157|38350304|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
17196943|NCT00105157|38350301|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
17196944|NCT00105157|38350302|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
17196945|NCT00105157|38350303|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
17196946|NCT00105157|38350304|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
17196947|NCT00105157|38350301|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
17196948|NCT00105157|38350302|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
17196949|NCT00105157|38350303|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
17196950|NCT00105157|38350304|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
17196951|NCT00105157|38350301|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
17196952|NCT00105157|38350302|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
17100701|NCT00069264|38240110|FG000|Overall Study|Discon Therapy|3|||
17100702|NCT00069108|38240116|FG000|Overall Study|Withdrawal by Subject|5|||
17100703|NCT00069108|38240117|FG001|Overall Study|Withdrawal by Subject|9|||
17100704|NCT00069108|38240116|FG000|Overall Study|Adverse Event|64|||
17100705|NCT00069108|38240117|FG001|Overall Study|Adverse Event|42|||
17100706|NCT00069108|38240116|FG000|Overall Study|Death|6|||
17100707|NCT00069108|38240117|FG001|Overall Study|Death|6|||
17100708|NCT00069108|38240116|FG000|Overall Study|Administration|15|||
17100709|NCT00069108|38240117|FG001|Overall Study|Administration|4|||
17100710|NCT00069108|38240116|FG000|Overall Study|Insufficient therapy|117|||
17100711|NCT00069108|38240117|FG001|Overall Study|Insufficient therapy|144|||
17100712|NCT00069108|38240116|FG000|Overall Study|Violation criteria|1|||
17100713|NCT00069108|38240117|FG001|Overall Study|Violation criteria|4|||
17100714|NCT00069108|38240116|FG000|Overall Study|Refused treatment|5|||
17100715|NCT00069108|38240117|FG001|Overall Study|Refused treatment|10|||
17100716|NCT00094536|38240124|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
16908599|NCT01732770|38017326|FG000|Overall Study|Death|1|||
16908600|NCT01732770|38017327|FG001|Overall Study|Death|0|||
16908601|NCT01732692|38017335|FG000|Overall Study|Adverse Event|0|||
17015352|NCT00861744|38160057|FG002|Overall Study|Withdrawal by Subject|6|||
17015353|NCT00861744|38160058|FG003|Overall Study|Withdrawal by Subject|19|||
17015354|NCT00861744|38160055|FG000|Overall Study|Protocol Violation|0|||
17015355|NCT00861744|38160056|FG001|Overall Study|Protocol Violation|1|||
17015356|NCT00861744|38160057|FG002|Overall Study|Protocol Violation|0|||
17015357|NCT00861744|38160058|FG003|Overall Study|Protocol Violation|0|||
17015358|NCT00861744|38160055|FG000|Overall Study|Migration from study area|0|||
17015359|NCT00861744|38160056|FG001|Overall Study|Migration from study area|3|||
17015360|NCT00861744|38160057|FG002|Overall Study|Migration from study area|1|||
17015361|NCT00861744|38160058|FG003|Overall Study|Migration from study area|0|||
17015362|NCT00861744|38160055|FG000|Overall Study|Blood draws|0|||
16908602|NCT01732692|38017336|FG001|Overall Study|Adverse Event|1|||
16908603|NCT01774968|38017344|FG000|Overall Study|Adverse Event|4|||
17100717|NCT00094536|38240124|FG000|Treatment and Follow-up|Adverse Event|4|||
17100718|NCT00094536|38240124|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
17015363|NCT00861744|38160056|FG001|Overall Study|Blood draws|0|||
17100719|NCT00094536|38240124|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
17100720|NCT00094536|38240124|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
17100721|NCT00094536|38240124|FG000|Treatment and Follow-up|Subject non-compliance|9|||
17100722|NCT00094536|38240124|FG000|Treatment and Follow-up|Unable to attend visits|1|||
17100723|NCT00405587|38240132|FG000|Overall Study|Death|0|||
17100724|NCT00405587|38240133|FG001|Overall Study|Death|0|||
17100725|NCT00405587|38240134|FG002|Overall Study|Death|0|||
17100726|NCT00405587|38240135|FG003|Overall Study|Death|1|||
17100727|NCT00405587|38240132|FG000|Overall Study|Disease Progression|22|||
17100728|NCT00405587|38240133|FG001|Overall Study|Disease Progression|23|||
17100729|NCT00405587|38240134|FG002|Overall Study|Disease Progression|21|||
17100730|NCT00405587|38240135|FG003|Overall Study|Disease Progression|17|||
17100731|NCT00405587|38240132|FG000|Overall Study|Physician Decision|3|||
17100732|NCT00405587|38240133|FG001|Overall Study|Physician Decision|2|||
17100733|NCT00405587|38240134|FG002|Overall Study|Physician Decision|0|||
17100734|NCT00405587|38240135|FG003|Overall Study|Physician Decision|0|||
17100735|NCT00405587|38240132|FG000|Overall Study|Adverse Event|1|||
17100736|NCT00405587|38240133|FG001|Overall Study|Adverse Event|0|||
17100737|NCT00405587|38240134|FG002|Overall Study|Adverse Event|0|||
17015364|NCT00861744|38160057|FG002|Overall Study|Blood draws|0|||
17015365|NCT00861744|38160058|FG003|Overall Study|Blood draws|1|||
17015366|NCT00603239|38160070|FG000|Overall Study|Adverse Event|4|||
17015367|NCT00603239|38160071|FG001|Overall Study|Adverse Event|1|||
17015368|NCT00603239|38160070|FG000|Overall Study|Entry criteria not met|0|||
17015369|NCT00603239|38160071|FG001|Overall Study|Entry criteria not met|1|||
17015370|NCT00603239|38160070|FG000|Overall Study|Loss of glucose control|3|||
17015371|NCT00603239|38160071|FG001|Overall Study|Loss of glucose control|0|||
17015372|NCT00603239|38160070|FG000|Overall Study|Lost to Follow-up|2|||
17015373|NCT00603239|38160071|FG001|Overall Study|Lost to Follow-up|1|||
17015374|NCT00603239|38160070|FG000|Overall Study|Physician Decision|2|||
17100738|NCT00405587|38240135|FG003|Overall Study|Adverse Event|0|||
17100739|NCT00405587|38240132|FG000|Overall Study|Lost to Follow-up|0|||
17100740|NCT00405587|38240133|FG001|Overall Study|Lost to Follow-up|1|||
17015375|NCT00603239|38160071|FG001|Overall Study|Physician Decision|0|||
17015376|NCT00603239|38160070|FG000|Overall Study|Protocol Violation|2|||
17015377|NCT00603239|38160071|FG001|Overall Study|Protocol Violation|0|||
17015378|NCT00603239|38160070|FG000|Overall Study|Subject decision|2|||
17015379|NCT00603239|38160071|FG001|Overall Study|Subject decision|1|||
17015380|NCT00852930|38160080|FG000|Overall Study|Withdrawal by Subject|1|||
17015381|NCT00852930|38160081|FG001|Overall Study|Withdrawal by Subject|1|||
17015382|NCT00852930|38160082|FG002|Overall Study|Withdrawal by Subject|1|||
17015383|NCT00852930|38160080|FG000|Overall Study|Physician Decision|0|||
17015384|NCT00852930|38160081|FG001|Overall Study|Physician Decision|0|||
17015385|NCT00852930|38160082|FG002|Overall Study|Physician Decision|1|||
17015386|NCT00852540|38160093|FG000|Overall Study|Adverse Event|10|||
17015387|NCT00852540|38160094|FG001|Overall Study|Adverse Event|3|||
17015388|NCT00852540|38160093|FG000|Overall Study|Lack of Efficacy|15|||
17015389|NCT00852540|38160094|FG001|Overall Study|Lack of Efficacy|3|||
17015390|NCT00852540|38160093|FG000|Overall Study|Protocol Violation|1|||
17015391|NCT00852540|38160094|FG001|Overall Study|Protocol Violation|2|||
17015392|NCT00852540|38160093|FG000|Overall Study|Lost to Follow-up|2|||
17015393|NCT00852540|38160094|FG001|Overall Study|Lost to Follow-up|3|||
17015394|NCT00852540|38160093|FG000|Overall Study|Investigator Discretion|2|||
17015395|NCT00852540|38160094|FG001|Overall Study|Investigator Discretion|3|||
17015396|NCT00852540|38160093|FG000|Overall Study|Withdrawal by Subject|3|||
17015397|NCT00852540|38160094|FG001|Overall Study|Withdrawal by Subject|1|||
17015398|NCT00852540|38160093|FG000|Overall Study|Did Not Receive Study Drug|3|||
17015399|NCT00852540|38160094|FG001|Overall Study|Did Not Receive Study Drug|3|||
17015400|NCT00861198|38160101|FG000|Overall Study|SpyGlass Failed|5|||
17015401|NCT00847704|38160105|FG000|Overall Study|Withdrawal by Subject|1|||
17015402|NCT00860574|38160109|FG000|Overall Study|Death|2|||
17015403|NCT00860574|38160109|FG000|Overall Study|Relapse|1|||
17015404|NCT00496015|38160118|FG000|Overall Study|Other|1|||
17015405|NCT00496015|38160119|FG001|Overall Study|Other|0|||
17015406|NCT00496015|38160120|FG002|Overall Study|Other|0|||
17015407|NCT00496015|38160121|FG003|Overall Study|Other|1|||
17015408|NCT00496015|38160122|FG004|Overall Study|Other|0|||
17015409|NCT00487825|38160144|FG000|Overall Study|Adverse Event|2|||
17015410|NCT00487825|38160145|FG001|Overall Study|Adverse Event|2|||
17015411|NCT00487825|38160144|FG000|Overall Study|Lack of Efficacy|1|||
17015412|NCT00487825|38160145|FG001|Overall Study|Lack of Efficacy|1|||
17015413|NCT00487825|38160144|FG000|Overall Study|Other|3|||
17015414|NCT00487825|38160145|FG001|Overall Study|Other|2|||
17100741|NCT00405587|38240134|FG002|Overall Study|Lost to Follow-up|1|||
17100742|NCT00405587|38240135|FG003|Overall Study|Lost to Follow-up|0|||
17100743|NCT00405587|38240132|FG000|Overall Study|Radiation induced necrosis|0|||
17015415|NCT00487747|38160151|FG000|Overall Study|Adverse Event|1|||
17015416|NCT00487747|38160151|FG000|Overall Study|Lost to Follow-up|9|||
17015417|NCT00487747|38160151|FG000|Overall Study|Lack of Efficacy|1|||
17015418|NCT00487435|38160155|FG000|Overall Study|Adverse Event|146|||
17100744|NCT00405587|38240133|FG001|Overall Study|Radiation induced necrosis|1|||
17100745|NCT00405587|38240134|FG002|Overall Study|Radiation induced necrosis|0|||
17100746|NCT00405587|38240135|FG003|Overall Study|Radiation induced necrosis|0|||
17100747|NCT00405587|38240132|FG000|Overall Study|Withdrawal by Subject|0|||
17196953|NCT00105157|38350303|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
17100748|NCT00405587|38240133|FG001|Overall Study|Withdrawal by Subject|0|||
17100749|NCT00405587|38240134|FG002|Overall Study|Withdrawal by Subject|0|||
17100750|NCT00405587|38240135|FG003|Overall Study|Withdrawal by Subject|2|||
17100751|NCT00405587|38240132|FG000|Overall Study|Participant not dosed|0|||
17100752|NCT00405587|38240133|FG001|Overall Study|Participant not dosed|1|||
17100753|NCT00405587|38240134|FG002|Overall Study|Participant not dosed|0|||
17100754|NCT00405587|38240135|FG003|Overall Study|Participant not dosed|0|||
17100755|NCT00405275|38240173|FG000|Overall Study|Death|1|||
17100756|NCT00405275|38240174|FG001|Overall Study|Death|0|||
17100757|NCT00405275|38240173|FG000|Overall Study|Lost to Follow-up|5|||
17100758|NCT00405275|38240174|FG001|Overall Study|Lost to Follow-up|1|||
17100759|NCT00405275|38240173|FG000|Overall Study|Withdrawal by Subject|7|||
17100760|NCT00405275|38240174|FG001|Overall Study|Withdrawal by Subject|9|||
17100761|NCT00405275|38240173|FG000|Overall Study|Unwilling to continue|10|||
17100762|NCT00405275|38240174|FG001|Overall Study|Unwilling to continue|9|||
17100763|NCT00404651|38240184|FG000|Overall Study|Serious Adverse Event|0|||
17100764|NCT00404651|38240185|FG001|Overall Study|Serious Adverse Event|0|||
17100765|NCT00404651|38240186|FG002|Overall Study|Serious Adverse Event|2|||
17100766|NCT00404651|38240187|FG003|Overall Study|Serious Adverse Event|0|||
17100767|NCT00404651|38240184|FG000|Overall Study|Protocol Violation|10|||
17196954|NCT00105157|38350304|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
17196955|NCT00105157|38350301|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
17196956|NCT00105157|38350302|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
17196957|NCT00105157|38350303|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
17196958|NCT00105157|38350304|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
17196959|NCT02148133|38350325|FG000|Overall Study|Investigator discretion|1|||
17196960|NCT02148133|38350325|FG000|Overall Study|Lack of Efficacy|1|||
17196961|NCT02148133|38350325|FG000|Overall Study|Protocol deviation|1|||
17196962|NCT02148133|38350325|FG000|Overall Study|Protocol-defined stopping criteria|2|||
17196963|NCT00803569|38350329|FG000|Overall Study|Progressive Disease|3|||
17196964|NCT00803569|38350329|FG000|Overall Study|Noncompliance|1|||
17196965|NCT00112957|38350333|FG000|Overall Study|Progressive disease|18|||
17196966|NCT00112957|38350333|FG000|Overall Study|Physician Decision|1|||
17196967|NCT02376790|38350340|FG000|Overall Study|Withdrawal by Subject|43|||
17196968|NCT02376790|38350341|FG001|Overall Study|Withdrawal by Subject|36|||
17100768|NCT00404651|38240185|FG001|Overall Study|Protocol Violation|5|||
17100769|NCT00404651|38240186|FG002|Overall Study|Protocol Violation|14|||
17100770|NCT00404651|38240187|FG003|Overall Study|Protocol Violation|5|||
17100771|NCT00404651|38240184|FG000|Overall Study|Lost to Follow-up|15|||
17100772|NCT00404651|38240185|FG001|Overall Study|Lost to Follow-up|11|||
17100773|NCT00404651|38240186|FG002|Overall Study|Lost to Follow-up|13|||
17100774|NCT00404651|38240187|FG003|Overall Study|Lost to Follow-up|10|||
17100775|NCT00404651|38240184|FG000|Overall Study|Withdrawal by Subject|14|||
17100776|NCT00404651|38240185|FG001|Overall Study|Withdrawal by Subject|12|||
17100777|NCT00404651|38240186|FG002|Overall Study|Withdrawal by Subject|16|||
17100778|NCT00404651|38240187|FG003|Overall Study|Withdrawal by Subject|6|||
17100779|NCT00404495|38240199|FG000|Overall Study|Death|37|||
17100780|NCT00404495|38240200|FG001|Overall Study|Death|11|||
17100781|NCT00404495|38240199|FG000|Overall Study|Lost to Follow-up|5|||
17100782|NCT00404495|38240200|FG001|Overall Study|Lost to Follow-up|0|||
17100783|NCT00404495|38240199|FG000|Overall Study|Other|1|||
17100784|NCT00404495|38240200|FG001|Overall Study|Other|0|||
17100785|NCT00404495|38240199|FG000|Overall Study|Withdrawal by Subject|1|||
17100786|NCT00404495|38240200|FG001|Overall Study|Withdrawal by Subject|0|||
17100787|NCT00409409|38240208|FG000|Overall Study|Adverse Event|7|||
17100788|NCT00409409|38240209|FG001|Overall Study|Adverse Event|2|||
17196969|NCT02376790|38350342|FG002|Overall Study|Withdrawal by Subject|37|||
17196970|NCT02376790|38350340|FG000|Overall Study|Decision by Sponsor|2|||
17100789|NCT00409409|38240208|FG000|Overall Study|Withdrawal by Subject|1|||
17100790|NCT00409409|38240209|FG001|Overall Study|Withdrawal by Subject|1|||
17100791|NCT00409409|38240208|FG000|Overall Study|Any other reason not above-mentioned|0|||
17015419|NCT00487435|38160155|FG000|Overall Study|Death|2|||
17015420|NCT00487435|38160155|FG000|Overall Study|Lack of Efficacy|33|||
17015421|NCT00487435|38160155|FG000|Overall Study|Lost to Follow-up|54|||
17015422|NCT00487435|38160155|FG000|Overall Study|Pregnancy|2|||
17015423|NCT00487435|38160155|FG000|Overall Study|Withdrawal by Subject|132|||
17015424|NCT00487435|38160155|FG000|Overall Study|Resolution Of Pain|1|||
17015425|NCT00487435|38160155|FG000|Overall Study|Study Medication Non-Compliant|32|||
17100792|NCT00409409|38240209|FG001|Overall Study|Any other reason not above-mentioned|1|||
17015426|NCT00487435|38160155|FG000|Overall Study|Other|83|||
17015427|NCT00487279|38160161|FG000|Overall Study|Death|1|||
17015428|NCT00487279|38160162|FG001|Overall Study|Death|0|||
17196971|NCT02376790|38350341|FG001|Overall Study|Decision by Sponsor|1|||
17100793|NCT00409331|38240215|FG000|Overall Study|Physician Decision|1|||
17100794|NCT00409175|38240221|FG000|Overall Study|Adverse Event|4|||
17100795|NCT00409175|38240222|FG001|Overall Study|Adverse Event|3|||
17100796|NCT00409175|38240221|FG000|Overall Study|Withdrawal by Subject|1|||
17100797|NCT00409175|38240222|FG001|Overall Study|Withdrawal by Subject|2|||
17196972|NCT02376790|38350342|FG002|Overall Study|Decision by Sponsor|4|||
17196973|NCT02376790|38350340|FG000|Overall Study|Lost to Follow-up|15|||
17196974|NCT02376790|38350341|FG001|Overall Study|Lost to Follow-up|10|||
17196975|NCT02376790|38350342|FG002|Overall Study|Lost to Follow-up|12|||
17196976|NCT02376166|38350350|FG000|Overall Study|Adverse Event|1|||
17196977|NCT02376166|38350350|FG000|Overall Study|Discontinued metformin early|2|||
17196978|NCT02311894|38350354|FG000|Overall Study|Discontinued in error|1|||
17196979|NCT02311894|38350354|FG000|Overall Study|Lost to Follow-up|1|||
17196980|NCT02311894|38350354|FG000|Overall Study|Adverse Event|1|||
17196981|NCT02311894|38350354|FG000|Overall Study|Withdrawal by Subject|1|||
17196982|NCT02310646|38350360|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
17196983|NCT02310646|38350361|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
17196984|NCT02310646|38350360|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
17196985|NCT02310646|38350361|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
17196986|NCT02375698|38350385|FG000|Overall Study|Withdrawal by Subject|0|||
17196987|NCT02375698|38350386|FG001|Overall Study|Withdrawal by Subject|2|||
17196988|NCT02375698|38350385|FG000|Overall Study|Physician Decision|2|||
17196989|NCT02375698|38350386|FG001|Overall Study|Physician Decision|0|||
17196990|NCT02374918|38350396|FG000|Overall Study|Protocol Violation|2|||
17196991|NCT02374918|38350397|FG001|Overall Study|Protocol Violation|0|||
17196992|NCT02374918|38350398|FG002|Overall Study|Protocol Violation|2|||
17196993|NCT02374918|38350399|FG003|Overall Study|Protocol Violation|1|||
17196994|NCT02374918|38350396|FG000|Overall Study|Withdrawal by Subject|1|||
17196995|NCT02374918|38350397|FG001|Overall Study|Withdrawal by Subject|1|||
17196996|NCT02374918|38350398|FG002|Overall Study|Withdrawal by Subject|1|||
17196997|NCT02374918|38350399|FG003|Overall Study|Withdrawal by Subject|0|||
17196998|NCT02374918|38350396|FG000|Overall Study|Lack of Efficacy|0|||
17196999|NCT02374918|38350397|FG001|Overall Study|Lack of Efficacy|0|||
17197000|NCT02374918|38350398|FG002|Overall Study|Lack of Efficacy|1|||
17197001|NCT02374918|38350399|FG003|Overall Study|Lack of Efficacy|1|||
17197002|NCT02344576|38350411|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
17197003|NCT02344576|38350412|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
17197004|NCT02344576|38350413|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
17100798|NCT00409175|38240221|FG000|Overall Study|Negative genotype|0|||
17100799|NCT00409175|38240222|FG001|Overall Study|Negative genotype|1|||
17100800|NCT00409175|38240221|FG000|Overall Study|Liver transplantation|13|||
17100801|NCT00409175|38240222|FG001|Overall Study|Liver transplantation|13|||
17197005|NCT02344576|38350414|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
17197006|NCT02344576|38350411|FG000|1-Month Follow-Up|Death|13|||
17197007|NCT02344576|38350412|FG001|1-Month Follow-Up|Death|8|||
17197008|NCT02344576|38350413|FG002|1-Month Follow-Up|Death|0|||
17197009|NCT02344576|38350414|FG003|1-Month Follow-Up|Death|0|||
17197010|NCT02344576|38350411|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
17197011|NCT02344576|38350412|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
17197012|NCT02344576|38350413|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
17197013|NCT02344576|38350414|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
17197014|NCT02344576|38350411|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
17197015|NCT02344576|38350412|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
17197016|NCT02344576|38350413|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
17197017|NCT02344576|38350414|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
17197018|NCT02344576|38350411|FG000|6-Month Follow-Up|Death|14|||
17197019|NCT02344576|38350412|FG001|6-Month Follow-Up|Death|14|||
17197020|NCT02344576|38350413|FG002|6-Month Follow-Up|Death|0|||
17197021|NCT02344576|38350414|FG003|6-Month Follow-Up|Death|0|||
17197022|NCT02344576|38350411|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
17197023|NCT02344576|38350412|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
17197024|NCT02344576|38350413|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
17197025|NCT02344576|38350414|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
17197026|NCT02344576|38350411|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
17197027|NCT02344576|38350412|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
17100802|NCT00408629|38240230|FG000|Overall Study|Adverse Event|13|||
17100803|NCT00408629|38240231|FG001|Overall Study|Adverse Event|27|||
17100804|NCT00408629|38240230|FG000|Overall Study|Withdrawal by Subject|8|||
17100805|NCT00408629|38240231|FG001|Overall Study|Withdrawal by Subject|4|||
17100806|NCT00408629|38240230|FG000|Overall Study|Lost to Follow-up|1|||
17100807|NCT00408629|38240231|FG001|Overall Study|Lost to Follow-up|1|||
17100808|NCT00408629|38240230|FG000|Overall Study|Lack of Efficacy|63|||
17197028|NCT02344576|38350413|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
17197029|NCT02344576|38350414|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
17197030|NCT02344342|38350430|FG000|Overall Study|Industry partner dropped out|11|||
17197031|NCT02344342|38350431|FG001|Overall Study|Industry partner dropped out|9|||
17100809|NCT00408629|38240231|FG001|Overall Study|Lack of Efficacy|73|||
17100810|NCT00408629|38240230|FG000|Overall Study|Protocol Violation|1|||
17100811|NCT00408629|38240231|FG001|Overall Study|Protocol Violation|5|||
17100812|NCT00408629|38240230|FG000|Overall Study|Miscellaneous|11|||
17100813|NCT00408629|38240231|FG001|Overall Study|Miscellaneous|15|||
17100814|NCT00408317|38240238|FG000|First Intervention Period|Adverse Event|0|||
17100815|NCT00408317|38240239|FG001|First Intervention Period|Adverse Event|1|||
17100816|NCT00408317|38240238|FG000|Second Intervention Period|Adverse Event|2|||
17100817|NCT00408317|38240239|FG001|Second Intervention Period|Adverse Event|0|||
17100818|NCT00408317|38240238|FG000|Second Intervention Period|Protocol Violation|0|||
17100819|NCT00408317|38240239|FG001|Second Intervention Period|Protocol Violation|1|||
17100820|NCT00408317|38240238|FG000|Second Intervention Period|Withdrawal of consent|0|||
17100821|NCT00408317|38240239|FG001|Second Intervention Period|Withdrawal of consent|1|||
17100822|NCT00112502|38240253|FG000|Overall Study|Withdrawal by Subject|0|||
17100823|NCT00112502|38240254|FG001|Overall Study|Withdrawal by Subject|1|||
17100824|NCT00112502|38240255|FG002|Overall Study|Withdrawal by Subject|1|||
17100825|NCT00112502|38240256|FG003|Overall Study|Withdrawal by Subject|4|||
17100826|NCT00112502|38240257|FG004|Overall Study|Withdrawal by Subject|2|||
17100827|NCT00112502|38240258|FG005|Overall Study|Withdrawal by Subject|5|||
17100828|NCT00112502|38240259|FG006|Overall Study|Withdrawal by Subject|3|||
17100829|NCT00112502|38240260|FG007|Overall Study|Withdrawal by Subject|7|||
17100830|NCT03822182|38240291|FG000|Overall Study|Protocol Violation|0|||
17100831|NCT03822182|38240292|FG001|Overall Study|Protocol Violation|1|||
17100832|NCT03822182|38240293|FG002|Overall Study|Protocol Violation|1|||
17100833|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
17100834|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
17100835|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
17100836|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
17100837|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
17100838|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
17100839|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
17197032|NCT02344342|38350432|FG002|Overall Study|Industry partner dropped out|14|||
17197033|NCT02344342|38350433|FG003|Overall Study|Industry partner dropped out|10|||
17197034|NCT02343952|38350447|FG000|Study Treatment|Disease Progression|23|||
17197035|NCT02343952|38350447|FG000|Study Treatment|Death|3|||
17197036|NCT02343952|38350447|FG000|Study Treatment|Adverse Event|19|||
17197037|NCT02343952|38350447|FG000|Study Treatment|Withdrawal by Subject|7|||
17197038|NCT02343952|38350447|FG000|Study Treatment|other complicating Diseases|1|||
17197039|NCT02343952|38350447|FG000|Follow up|Withdrawal by Subject|3|||
17197040|NCT02343952|38350447|FG000|Follow up|Death|33|||
17015429|NCT00487279|38160161|FG000|Overall Study|Withdrawal by Subject|0|||
17100840|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
17100841|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
17100842|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
17100843|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
17100844|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
17100845|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
17100846|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
17100847|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
17100848|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
17100849|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
17100850|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
17100851|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
17100852|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
17100853|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
17100854|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
17100855|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
17100856|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
17100857|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
17100858|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
17100859|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
17197041|NCT02343952|38350447|FG000|Follow up|Patient does not meet eligibility for study.|1|||
17015430|NCT00487279|38160162|FG001|Overall Study|Withdrawal by Subject|2|||
17015431|NCT00495625|38160168|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
17015432|NCT00847626|38160183|FG000|Overall Study|Adverse Event|10|||
17015433|NCT00847626|38160184|FG001|Overall Study|Adverse Event|10|||
17015434|NCT00847626|38160185|FG002|Overall Study|Adverse Event|6|||
17015435|NCT00847626|38160186|FG003|Overall Study|Adverse Event|19|||
17015436|NCT00847626|38160187|FG004|Overall Study|Adverse Event|11|||
17015437|NCT00847626|38160188|FG005|Overall Study|Adverse Event|22|||
17015438|NCT00847626|38160189|FG006|Overall Study|Adverse Event|4|||
17015439|NCT00847626|38160190|FG007|Overall Study|Adverse Event|6|||
17015440|NCT00847626|38160191|FG008|Overall Study|Adverse Event|3|||
17197042|NCT02343952|38350447|FG000|Follow up|Research department closed by the practice.|5|||
17197043|NCT02343952|38350447|FG000|Follow up|Patient went home to Russia|1|||
17197044|NCT02343952|38350447|FG000|Follow up|Disease Progression|1|||
17197045|NCT02343952|38350447|FG000|Follow up|study terminated|1|||
17197046|NCT02310568|38350456|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
17197047|NCT02310568|38350457|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
17197048|NCT02310568|38350458|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
17197049|NCT02310568|38350459|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
17197050|NCT02310568|38350460|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
17197051|NCT02310568|38350456|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
17197052|NCT02310568|38350457|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
17197053|NCT02310568|38350458|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
17197054|NCT02310568|38350459|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
17197055|NCT02310568|38350460|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
17197056|NCT02310568|38350456|FG000|Stage 1 ( 4 Weeks)|Other|1|||
17197057|NCT02310568|38350457|FG001|Stage 1 ( 4 Weeks)|Other|1|||
17197058|NCT02310568|38350458|FG002|Stage 1 ( 4 Weeks)|Other|0|||
17197059|NCT02310568|38350459|FG003|Stage 1 ( 4 Weeks)|Other|0|||
17197060|NCT02310568|38350460|FG004|Stage 1 ( 4 Weeks)|Other|0|||
17197061|NCT02310568|38350456|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
17197062|NCT02310568|38350457|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
17197063|NCT02310568|38350458|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
17197064|NCT02310568|38350459|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
17197065|NCT02310568|38350460|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
17197066|NCT02310568|38350456|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
17197067|NCT02310568|38350457|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
17197068|NCT02310568|38350458|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
17197069|NCT02310568|38350459|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
17197070|NCT02310568|38350460|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
17197071|NCT02310568|38350456|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
17197072|NCT02310568|38350457|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
17197073|NCT02310568|38350458|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
17197074|NCT02310568|38350459|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
17197075|NCT02310568|38350460|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
17197076|NCT02310568|38350456|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
17197077|NCT02310568|38350457|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
17197078|NCT02310568|38350458|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
17197079|NCT02310568|38350459|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
17197080|NCT02310568|38350460|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
17197081|NCT02310568|38350456|FG000|Stage 2 (4 Weeks)|Other|0|||
17197082|NCT02310568|38350457|FG001|Stage 2 (4 Weeks)|Other|1|||
17197083|NCT02310568|38350458|FG002|Stage 2 (4 Weeks)|Other|1|||
17197084|NCT02310568|38350459|FG003|Stage 2 (4 Weeks)|Other|0|||
17197085|NCT02310568|38350460|FG004|Stage 2 (4 Weeks)|Other|0|||
17197086|NCT02310568|38350456|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
17197087|NCT02310568|38350457|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
17197088|NCT02310568|38350458|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
17197089|NCT02310568|38350459|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
17197090|NCT02310568|38350460|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
17197091|NCT02310568|38350456|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
17197092|NCT02310568|38350457|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
17197093|NCT02310568|38350458|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
17197094|NCT02310568|38350459|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
17197095|NCT02310568|38350460|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
17197096|NCT02310568|38350456|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
17197097|NCT02310568|38350457|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
17197098|NCT02310568|38350458|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
17197099|NCT02310568|38350459|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
17197100|NCT02310568|38350460|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
17197101|NCT02310100|38350478|FG000|Overall Study|Physician Decision|3|||
17197102|NCT02310100|38350478|FG000|Overall Study|Withdrawal by Subject|10|||
17197103|NCT02310100|38350478|FG000|Overall Study|Enrollment closure|1|||
17197104|NCT02310100|38350478|FG000|Overall Study|Unapproved ablation operator|1|||
17197105|NCT02310100|38350478|FG000|Overall Study|Visit compliance|1|||
17197106|NCT02310100|38350478|FG000|Overall Study|Lost to Follow-up|2|||
17197107|NCT02780167|38350488|FG000|Overall Study|Adverse Event|9|||
17197108|NCT02780167|38350489|FG001|Overall Study|Adverse Event|8|||
17197109|NCT02780167|38350490|FG002|Overall Study|Adverse Event|8|||
17197110|NCT02780167|38350491|FG003|Overall Study|Adverse Event|12|||
17197111|NCT02780167|38350492|FG004|Overall Study|Adverse Event|8|||
17197112|NCT02780167|38350488|FG000|Overall Study|Lack of Efficacy|6|||
17197113|NCT02780167|38350489|FG001|Overall Study|Lack of Efficacy|5|||
17197114|NCT02780167|38350490|FG002|Overall Study|Lack of Efficacy|6|||
17197115|NCT02780167|38350491|FG003|Overall Study|Lack of Efficacy|1|||
17197116|NCT02780167|38350492|FG004|Overall Study|Lack of Efficacy|0|||
17197117|NCT02780167|38350488|FG000|Overall Study|Lost to Follow-up|2|||
17197118|NCT02780167|38350489|FG001|Overall Study|Lost to Follow-up|0|||
17197119|NCT02780167|38350490|FG002|Overall Study|Lost to Follow-up|1|||
17100860|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
17197120|NCT02780167|38350491|FG003|Overall Study|Lost to Follow-up|0|||
17197121|NCT02780167|38350492|FG004|Overall Study|Lost to Follow-up|0|||
17015441|NCT00847626|38160192|FG009|Overall Study|Adverse Event|6|||
17015442|NCT00847626|38160193|FG010|Overall Study|Adverse Event|6|||
17015443|NCT00847626|38160183|FG000|Overall Study|Protocol Violation|2|||
17015444|NCT00847626|38160184|FG001|Overall Study|Protocol Violation|1|||
17015445|NCT00847626|38160185|FG002|Overall Study|Protocol Violation|2|||
17015446|NCT00847626|38160186|FG003|Overall Study|Protocol Violation|1|||
17015447|NCT00847626|38160187|FG004|Overall Study|Protocol Violation|1|||
17015448|NCT00847626|38160188|FG005|Overall Study|Protocol Violation|1|||
17015449|NCT00847626|38160189|FG006|Overall Study|Protocol Violation|1|||
17015450|NCT00847626|38160190|FG007|Overall Study|Protocol Violation|1|||
17015451|NCT00847626|38160191|FG008|Overall Study|Protocol Violation|0|||
17015452|NCT00847626|38160192|FG009|Overall Study|Protocol Violation|1|||
17015453|NCT00847626|38160193|FG010|Overall Study|Protocol Violation|1|||
17015454|NCT00847626|38160183|FG000|Overall Study|Lost to Follow-up|0|||
17015455|NCT00847626|38160184|FG001|Overall Study|Lost to Follow-up|1|||
17015456|NCT00847626|38160185|FG002|Overall Study|Lost to Follow-up|1|||
17015457|NCT00847626|38160186|FG003|Overall Study|Lost to Follow-up|1|||
17015458|NCT00847626|38160187|FG004|Overall Study|Lost to Follow-up|0|||
17015459|NCT00847626|38160188|FG005|Overall Study|Lost to Follow-up|3|||
17015460|NCT00847626|38160189|FG006|Overall Study|Lost to Follow-up|1|||
17015461|NCT00847626|38160190|FG007|Overall Study|Lost to Follow-up|3|||
17015462|NCT00847626|38160191|FG008|Overall Study|Lost to Follow-up|1|||
17015463|NCT00847626|38160192|FG009|Overall Study|Lost to Follow-up|0|||
17015464|NCT00847626|38160193|FG010|Overall Study|Lost to Follow-up|1|||
17015465|NCT00847626|38160183|FG000|Overall Study|Withdrawal by Subject|5|||
17015466|NCT00847626|38160184|FG001|Overall Study|Withdrawal by Subject|5|||
17015467|NCT00847626|38160185|FG002|Overall Study|Withdrawal by Subject|3|||
17015468|NCT00847626|38160186|FG003|Overall Study|Withdrawal by Subject|8|||
17015469|NCT00847626|38160187|FG004|Overall Study|Withdrawal by Subject|12|||
17015470|NCT00847626|38160188|FG005|Overall Study|Withdrawal by Subject|9|||
17015471|NCT00847626|38160189|FG006|Overall Study|Withdrawal by Subject|8|||
17015472|NCT00847626|38160190|FG007|Overall Study|Withdrawal by Subject|4|||
17015473|NCT00847626|38160191|FG008|Overall Study|Withdrawal by Subject|4|||
17015474|NCT00847626|38160192|FG009|Overall Study|Withdrawal by Subject|5|||
17015475|NCT00847626|38160193|FG010|Overall Study|Withdrawal by Subject|2|||
17015476|NCT00847626|38160183|FG000|Overall Study|Lack of Efficacy|3|||
17015477|NCT00847626|38160184|FG001|Overall Study|Lack of Efficacy|1|||
17015478|NCT00847626|38160185|FG002|Overall Study|Lack of Efficacy|0|||
17015479|NCT00847626|38160186|FG003|Overall Study|Lack of Efficacy|1|||
17015480|NCT00847626|38160187|FG004|Overall Study|Lack of Efficacy|2|||
17015481|NCT00847626|38160188|FG005|Overall Study|Lack of Efficacy|0|||
17015482|NCT00847626|38160189|FG006|Overall Study|Lack of Efficacy|6|||
17015483|NCT00847626|38160190|FG007|Overall Study|Lack of Efficacy|2|||
17015484|NCT00847626|38160191|FG008|Overall Study|Lack of Efficacy|5|||
17015485|NCT00847626|38160192|FG009|Overall Study|Lack of Efficacy|1|||
17015486|NCT00847626|38160193|FG010|Overall Study|Lack of Efficacy|7|||
17015487|NCT00847626|38160183|FG000|Overall Study|Other|1|||
17015488|NCT00847626|38160184|FG001|Overall Study|Other|5|||
17015489|NCT00847626|38160185|FG002|Overall Study|Other|4|||
17197122|NCT02780167|38350488|FG000|Overall Study|Does not meet entrance criteria|0|||
17015490|NCT00847626|38160186|FG003|Overall Study|Other|1|||
17015491|NCT00847626|38160187|FG004|Overall Study|Other|2|||
17100861|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
17100862|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
17100863|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
17100864|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
17100865|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
17100866|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
17100867|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
17100868|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
17100869|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
17100870|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
17100871|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
17100872|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
17100873|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
17197123|NCT02780167|38350489|FG001|Overall Study|Does not meet entrance criteria|0|||
17015492|NCT00847626|38160188|FG005|Overall Study|Other|2|||
17015493|NCT00847626|38160189|FG006|Overall Study|Other|2|||
17015494|NCT00847626|38160190|FG007|Overall Study|Other|3|||
17015495|NCT00847626|38160191|FG008|Overall Study|Other|1|||
17015496|NCT00847626|38160192|FG009|Overall Study|Other|1|||
17015497|NCT00847626|38160193|FG010|Overall Study|Other|3|||
17197124|NCT02780167|38350490|FG002|Overall Study|Does not meet entrance criteria|1|||
17197125|NCT02780167|38350491|FG003|Overall Study|Does not meet entrance criteria|0|||
17100874|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
17100875|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
17100876|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
17100877|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
17100878|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
17100879|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
17197126|NCT02780167|38350492|FG004|Overall Study|Does not meet entrance criteria|0|||
17197127|NCT02780167|38350488|FG000|Overall Study|No longer meets eligibility criteria|0|||
17197128|NCT02780167|38350489|FG001|Overall Study|No longer meets eligibility criteria|0|||
17197129|NCT02780167|38350490|FG002|Overall Study|No longer meets eligibility criteria|0|||
17197130|NCT02780167|38350491|FG003|Overall Study|No longer meets eligibility criteria|1|||
17197131|NCT02780167|38350492|FG004|Overall Study|No longer meets eligibility criteria|1|||
17197132|NCT02780167|38350488|FG000|Overall Study|Protocol Violation|5|||
17197133|NCT02780167|38350489|FG001|Overall Study|Protocol Violation|5|||
17197134|NCT02780167|38350490|FG002|Overall Study|Protocol Violation|1|||
17197135|NCT02780167|38350491|FG003|Overall Study|Protocol Violation|1|||
17197136|NCT02780167|38350492|FG004|Overall Study|Protocol Violation|2|||
17197137|NCT02780167|38350488|FG000|Overall Study|Withdrawal by Subject|6|||
17197138|NCT02780167|38350489|FG001|Overall Study|Withdrawal by Subject|4|||
17197139|NCT02780167|38350490|FG002|Overall Study|Withdrawal by Subject|4|||
17100880|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
17100881|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
17100882|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
17100883|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
17100884|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
17100885|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
17197140|NCT02780167|38350491|FG003|Overall Study|Withdrawal by Subject|3|||
17197141|NCT02780167|38350492|FG004|Overall Study|Withdrawal by Subject|4|||
17197142|NCT02780167|38350488|FG000|Overall Study|Other|0|||
17197143|NCT02780167|38350489|FG001|Overall Study|Other|0|||
17100886|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
17100887|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
17100888|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
17197144|NCT02780167|38350490|FG002|Overall Study|Other|3|||
17197145|NCT02780167|38350491|FG003|Overall Study|Other|1|||
17197146|NCT02780167|38350492|FG004|Overall Study|Other|2|||
17197147|NCT02779855|38350507|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
17197148|NCT02779855|38350508|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
17197149|NCT02779855|38350509|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
17197150|NCT02779075|38350518|FG000|Overall Study|Withdrawal by Subject|1|||
17197151|NCT02779075|38350519|FG001|Overall Study|Withdrawal by Subject|3|||
17015498|NCT00851682|38160222|FG000|Overall Study|screen failure|5|||
17015499|NCT00851682|38160223|FG001|Overall Study|screen failure|0|||
17015500|NCT00860262|38160232|FG000|Overall Study|Adverse Event|9|||
17015501|NCT00860262|38160233|FG001|Overall Study|Adverse Event|6|||
17015502|NCT00860262|38160234|FG002|Overall Study|Adverse Event|7|||
17015503|NCT00860262|38160232|FG000|Overall Study|Protocol Violation|0|||
17015504|NCT00860262|38160233|FG001|Overall Study|Protocol Violation|1|||
17015505|NCT00860262|38160234|FG002|Overall Study|Protocol Violation|0|||
17015506|NCT00860262|38160232|FG000|Overall Study|Lost to Follow-up|2|||
17015507|NCT00860262|38160233|FG001|Overall Study|Lost to Follow-up|0|||
17015508|NCT00860262|38160234|FG002|Overall Study|Lost to Follow-up|1|||
17015509|NCT00860262|38160232|FG000|Overall Study|Withdrawal by Subject|4|||
17015510|NCT00860262|38160233|FG001|Overall Study|Withdrawal by Subject|8|||
17015511|NCT00860262|38160234|FG002|Overall Study|Withdrawal by Subject|6|||
17015512|NCT00860262|38160232|FG000|Overall Study|Lack of Efficacy|0|||
17015513|NCT00860262|38160233|FG001|Overall Study|Lack of Efficacy|4|||
17015514|NCT00860262|38160234|FG002|Overall Study|Lack of Efficacy|3|||
17015515|NCT00860262|38160232|FG000|Overall Study|Other|5|||
17015516|NCT00860262|38160233|FG001|Overall Study|Other|3|||
17015517|NCT00860262|38160234|FG002|Overall Study|Other|1|||
17015518|NCT00860028|38160246|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
17015519|NCT00860028|38160247|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
17015520|NCT00859638|38160257|FG000|Overall Study|Lost to Follow-up|6|||
17015521|NCT00859638|38160258|FG001|Overall Study|Lost to Follow-up|1|||
17015522|NCT00859638|38160257|FG000|Overall Study|Withdrawal by Subject|3|||
17015523|NCT00859638|38160258|FG001|Overall Study|Withdrawal by Subject|2|||
16908604|NCT01774968|38017345|FG001|Overall Study|Adverse Event|4|||
16786691|NCT01998958|37727284|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16786692|NCT01998958|37727253|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
17197152|NCT02779075|38350518|FG000|Overall Study|IV lost during 2nd study|1|||
17197153|NCT02779075|38350519|FG001|Overall Study|IV lost during 2nd study|0|||
17197154|NCT00105079|38350531|FG000|Overall Study|Adverse Event|5|||
17100889|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
17100890|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
17100891|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
17100892|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
17100893|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
17100894|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
17197155|NCT00105079|38350532|FG001|Overall Study|Adverse Event|12|||
17197156|NCT00105079|38350531|FG000|Overall Study|Death|3|||
17197157|NCT00105079|38350532|FG001|Overall Study|Death|1|||
17197158|NCT00105079|38350531|FG000|Overall Study|Lost to Follow-up|12|||
17197159|NCT00105079|38350532|FG001|Overall Study|Lost to Follow-up|12|||
17197160|NCT00105079|38350531|FG000|Overall Study|Lack of Efficacy|9|||
17197161|NCT00105079|38350532|FG001|Overall Study|Lack of Efficacy|3|||
17197162|NCT00105079|38350531|FG000|Overall Study|Refused treatment|6|||
17197163|NCT00105079|38350532|FG001|Overall Study|Refused treatment|4|||
17197164|NCT00105079|38350531|FG000|Overall Study|Violation of selection criteria at entry|0|||
17197165|NCT00105079|38350532|FG001|Overall Study|Violation of selection criteria at entry|2|||
17197166|NCT00105079|38350531|FG000|Overall Study|Protocol Violation|1|||
17197167|NCT00105079|38350532|FG001|Overall Study|Protocol Violation|0|||
17197168|NCT00105079|38350531|FG000|Overall Study|Other|3|||
17197169|NCT00105079|38350532|FG001|Overall Study|Other|1|||
17197170|NCT02777827|38350538|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
17197171|NCT02777827|38350539|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
17197172|NCT02777827|38350540|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
17197173|NCT02777827|38350541|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
17197174|NCT02777827|38350542|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
17197175|NCT02777827|38350543|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
17197176|NCT02712333|38350559|FG000|First Period|Withdrawal by Subject|3|||
17197177|NCT02712333|38350560|FG001|First Period|Withdrawal by Subject|2|||
17197178|NCT02343406|38350576|FG000|Overall Study|Progressive disease|72|||
17197179|NCT02343406|38350577|FG001|Overall Study|Progressive disease|70|||
17197180|NCT02343406|38350578|FG002|Overall Study|Progressive disease|43|||
17197181|NCT02343406|38350579|FG003|Overall Study|Progressive disease|15|||
17197182|NCT02343406|38350580|FG004|Overall Study|Progressive disease|5|||
17197183|NCT02343406|38350576|FG000|Overall Study|Adverse Event|6|||
17197184|NCT02343406|38350577|FG001|Overall Study|Adverse Event|8|||
17197185|NCT02343406|38350578|FG002|Overall Study|Adverse Event|6|||
17197186|NCT02343406|38350579|FG003|Overall Study|Adverse Event|3|||
17197187|NCT02343406|38350580|FG004|Overall Study|Adverse Event|0|||
16786693|NCT01998958|37727254|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
16786694|NCT01998958|37727255|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
16786695|NCT01998958|37727256|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
16786696|NCT01998958|37727257|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
16786697|NCT01998958|37727258|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
16786698|NCT01998958|37727259|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
16786699|NCT01998958|37727260|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
16786700|NCT01998958|37727261|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
16786701|NCT01998958|37727262|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
16786702|NCT01998958|37727263|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
16786703|NCT01998958|37727264|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
16786704|NCT01998958|37727265|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
16786705|NCT01998958|37727266|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
16786706|NCT01998958|37727267|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
16786707|NCT01998958|37727268|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
16786708|NCT01998958|37727269|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
16786709|NCT01998958|37727270|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
16786710|NCT01998958|37727271|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
16786711|NCT01998958|37727272|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
16786712|NCT01998958|37727273|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
16786713|NCT01998958|37727274|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
16786714|NCT01998958|37727275|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
16786715|NCT01998958|37727276|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
16786716|NCT01998958|37727277|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
16786717|NCT01998958|37727278|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
17100895|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
17197188|NCT02343406|38350576|FG000|Overall Study|Withdrawal by Subject|6|||
17197189|NCT02343406|38350577|FG001|Overall Study|Withdrawal by Subject|4|||
16786718|NCT01998958|37727279|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
16786719|NCT01998958|37727280|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
16786720|NCT01998958|37727281|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
16786721|NCT01998958|37727282|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
17100896|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
17100897|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
17100898|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
16786722|NCT01998958|37727283|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
16786723|NCT01998958|37727284|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
16786724|NCT01998958|37727253|FG000|Period 1 (Panel A and B)|Other|1|||
16786725|NCT01998958|37727254|FG001|Period 1 (Panel A and B)|Other|0|||
16786726|NCT01998958|37727255|FG002|Period 1 (Panel A and B)|Other|0|||
16786727|NCT01998958|37727256|FG003|Period 1 (Panel A and B)|Other|0|||
16786728|NCT01998958|37727257|FG004|Period 1 (Panel A and B)|Other|0|||
16786729|NCT01998958|37727258|FG005|Period 1 (Panel A and B)|Other|0|||
16786730|NCT01998958|37727259|FG006|Period 1 (Panel A and B)|Other|0|||
16786731|NCT01998958|37727260|FG007|Period 1 (Panel A and B)|Other|0|||
16786732|NCT01998958|37727261|FG008|Period 1 (Panel A and B)|Other|0|||
16786733|NCT01998958|37727262|FG009|Period 1 (Panel A and B)|Other|0|||
16786734|NCT01998958|37727263|FG010|Period 1 (Panel A and B)|Other|0|||
16786735|NCT01998958|37727264|FG011|Period 1 (Panel A and B)|Other|0|||
16786736|NCT01998958|37727265|FG012|Period 1 (Panel A and B)|Other|0|||
16786737|NCT01998958|37727266|FG013|Period 1 (Panel A and B)|Other|0|||
16786738|NCT01998958|37727267|FG014|Period 1 (Panel A and B)|Other|0|||
16786739|NCT01998958|37727268|FG015|Period 1 (Panel A and B)|Other|0|||
16786740|NCT01998958|37727269|FG016|Period 1 (Panel A and B)|Other|0|||
16908605|NCT01774968|38017344|FG000|Overall Study|Death|0|||
16908606|NCT01774968|38017345|FG001|Overall Study|Death|1|||
16908607|NCT01774968|38017344|FG000|Overall Study|Lost to Follow-up|1|||
16908608|NCT01774968|38017345|FG001|Overall Study|Lost to Follow-up|3|||
16908609|NCT01774968|38017344|FG000|Overall Study|Physician Decision|5|||
16908610|NCT01774968|38017345|FG001|Overall Study|Physician Decision|1|||
16908611|NCT01774968|38017344|FG000|Overall Study|Protocol Violation|14|||
17015524|NCT00859638|38160257|FG000|Overall Study|Ill health|1|||
16786741|NCT01998958|37727270|FG017|Period 1 (Panel A and B)|Other|0|||
16786742|NCT01998958|37727271|FG018|Period 1 (Panel A and B)|Other|0|||
16786743|NCT01998958|37727272|FG019|Period 1 (Panel A and B)|Other|0|||
16786744|NCT01998958|37727273|FG020|Period 1 (Panel A and B)|Other|0|||
16786745|NCT01998958|37727274|FG021|Period 1 (Panel A and B)|Other|0|||
16786746|NCT01998958|37727275|FG022|Period 1 (Panel A and B)|Other|0|||
16786747|NCT01998958|37727276|FG023|Period 1 (Panel A and B)|Other|0|||
16786748|NCT01998958|37727277|FG024|Period 1 (Panel A and B)|Other|0|||
16786749|NCT01998958|37727278|FG025|Period 1 (Panel A and B)|Other|0|||
16786750|NCT01998958|37727279|FG026|Period 1 (Panel A and B)|Other|0|||
16786751|NCT01998958|37727280|FG027|Period 1 (Panel A and B)|Other|0|||
16786752|NCT01998958|37727281|FG028|Period 1 (Panel A and B)|Other|0|||
16786753|NCT01998958|37727282|FG029|Period 1 (Panel A and B)|Other|0|||
16786754|NCT01998958|37727283|FG030|Period 1 (Panel A and B)|Other|0|||
16786755|NCT01998958|37727284|FG031|Period 1 (Panel A and B)|Other|0|||
16786756|NCT01998958|37727253|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
16786757|NCT01998958|37727254|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
16786758|NCT01998958|37727255|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
16786759|NCT01998958|37727256|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
16786760|NCT01998958|37727257|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
16786761|NCT01998958|37727258|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
16786762|NCT01998958|37727259|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
16786763|NCT01998958|37727260|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
16786764|NCT01998958|37727261|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
16786765|NCT01998958|37727262|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
16786766|NCT01998958|37727263|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
16786767|NCT01998958|37727264|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
16786768|NCT01998958|37727265|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
16786769|NCT01998958|37727266|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
16786770|NCT01998958|37727267|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
16786771|NCT01998958|37727268|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
16786772|NCT01998958|37727269|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
16786773|NCT01998958|37727270|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
16786774|NCT01998958|37727271|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
16786775|NCT01998958|37727272|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
16786776|NCT01998958|37727273|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
16786777|NCT01998958|37727274|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
17015525|NCT00859638|38160258|FG001|Overall Study|Ill health|1|||
17100899|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
17100900|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
17100901|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
17100902|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
16908612|NCT01774968|38017345|FG001|Overall Study|Protocol Violation|13|||
16908613|NCT01774968|38017344|FG000|Overall Study|Sponsor Decision|0|||
17100903|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
16786778|NCT01998958|37727275|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
17015526|NCT00846846|38160264|FG000|Overall Study|Death|56|||
17197190|NCT02343406|38350578|FG002|Overall Study|Withdrawal by Subject|8|||
17197191|NCT02343406|38350579|FG003|Overall Study|Withdrawal by Subject|3|||
17197192|NCT02343406|38350580|FG004|Overall Study|Withdrawal by Subject|0|||
17197193|NCT02343406|38350576|FG000|Overall Study|Death|2|||
17197194|NCT02343406|38350577|FG001|Overall Study|Death|1|||
17100904|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
17100905|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
17100906|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
17100907|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
17100908|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
17100909|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
17100910|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
16786779|NCT01998958|37727276|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
16786780|NCT01998958|37727277|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
16786781|NCT01998958|37727278|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
16786782|NCT01998958|37727279|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
16786783|NCT01998958|37727280|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
16786784|NCT01998958|37727281|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
16786785|NCT01998958|37727282|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
16786786|NCT01998958|37727283|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
16786787|NCT01998958|37727284|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
17100911|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
17100912|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
17100913|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
17100914|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
17100915|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
17100916|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
17100917|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
17100918|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
17197195|NCT02343406|38350578|FG002|Overall Study|Death|0|||
17015527|NCT00846846|38160264|FG000|Overall Study|Withdrawal by Subject|19|||
17015528|NCT00846768|38160268|FG000|Overall Study|Adverse Event|0|||
17015529|NCT00846768|38160269|FG001|Overall Study|Adverse Event|1|||
17015530|NCT00846768|38160270|FG002|Overall Study|Adverse Event|0|||
17015531|NCT00846768|38160271|FG003|Overall Study|Adverse Event|0|||
17015532|NCT00863798|38160284|FG000|Overall Study|Adverse Event|5|||
17015533|NCT00863798|38160285|FG001|Overall Study|Adverse Event|2|||
17015534|NCT00863798|38160286|FG002|Overall Study|Adverse Event|4|||
17015535|NCT00863798|38160284|FG000|Overall Study|Participant failed to return|2|||
17015536|NCT00863798|38160285|FG001|Overall Study|Participant failed to return|1|||
17015537|NCT00863798|38160286|FG002|Overall Study|Participant failed to return|0|||
17015538|NCT00863798|38160284|FG000|Overall Study|Investigator request|1|||
17015539|NCT00863798|38160285|FG001|Overall Study|Investigator request|2|||
17015540|NCT00863798|38160286|FG002|Overall Study|Investigator request|1|||
17015541|NCT00863798|38160284|FG000|Overall Study|Lack of Efficacy|4|||
17015542|NCT00863798|38160285|FG001|Overall Study|Lack of Efficacy|3|||
17015543|NCT00863798|38160286|FG002|Overall Study|Lack of Efficacy|6|||
17015544|NCT00863798|38160284|FG000|Overall Study|Lost to Follow-up|6|||
17015545|NCT00863798|38160285|FG001|Overall Study|Lost to Follow-up|9|||
17015546|NCT00863798|38160286|FG002|Overall Study|Lost to Follow-up|5|||
17015547|NCT00863798|38160284|FG000|Overall Study|Other|2|||
17015548|NCT00863798|38160285|FG001|Overall Study|Other|3|||
17015549|NCT00863798|38160286|FG002|Overall Study|Other|1|||
17015550|NCT00863798|38160284|FG000|Overall Study|Protocol Violation|0|||
17015551|NCT00863798|38160285|FG001|Overall Study|Protocol Violation|1|||
17015552|NCT00863798|38160286|FG002|Overall Study|Protocol Violation|1|||
17015553|NCT00863798|38160284|FG000|Overall Study|Withdrawal by Subject|8|||
17015554|NCT00863798|38160285|FG001|Overall Study|Withdrawal by Subject|7|||
17015555|NCT00863798|38160286|FG002|Overall Study|Withdrawal by Subject|4|||
17015556|NCT00863798|38160284|FG000|Overall Study|Randomized not treated|4|||
17015557|NCT00863798|38160285|FG001|Overall Study|Randomized not treated|2|||
17015558|NCT00863798|38160286|FG002|Overall Study|Randomized not treated|3|||
17015559|NCT00859014|38160294|FG000|Overall Study|Death|4|||
17015560|NCT00859014|38160294|FG000|Overall Study|Lost to Follow-up|1|||
17015561|NCT00593606|38160298|FG000|Overall Study|Adverse Event|13|||
17015562|NCT00593606|38160298|FG000|Overall Study|Withdrawal by Subject|1|||
17015563|NCT00593606|38160298|FG000|Overall Study|Protocol Violation|3|||
17015564|NCT00593606|38160298|FG000|Overall Study|Lost to Follow-up|2|||
17015565|NCT00593606|38160298|FG000|Overall Study|Run-In Failure|5|||
17015566|NCT00593606|38160298|FG000|Overall Study|Screen Failure|3|||
17015567|NCT00870584|38160304|FG000|Overall Study|Adverse Event|3|||
17015568|NCT00870584|38160305|FG001|Overall Study|Adverse Event|3|||
16786788|NCT01998958|37727253|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
17015569|NCT00870584|38160304|FG000|Overall Study|Withdrawal by Subject|6|||
17100919|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
17100920|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
17100921|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
17100922|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
17100923|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
17100924|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
17100925|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
17100926|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
17100927|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
17100928|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
17100929|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
17100930|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
17100931|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
17100932|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
17100933|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
17100934|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
17100935|NCT00111800|38240308|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
17100936|NCT00111800|38240309|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
17100937|NCT00111800|38240310|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
17100938|NCT00111800|38240311|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
17100939|NCT00111800|38240312|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
17100940|NCT00111800|38240313|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
17100941|NCT00111800|38240308|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
17100942|NCT00111800|38240309|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
17100943|NCT00111800|38240310|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
17100944|NCT00111800|38240311|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
17100945|NCT00111800|38240312|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
17100946|NCT00111800|38240313|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
17100947|NCT00111800|38240308|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
17100948|NCT00111800|38240309|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
17100949|NCT00111800|38240310|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
17100950|NCT00111800|38240311|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
17100951|NCT00111800|38240312|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
17100952|NCT00111800|38240313|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
17100953|NCT00111800|38240308|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
17100954|NCT00111800|38240309|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
17100955|NCT00111800|38240310|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
17100956|NCT00111800|38240311|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
17100957|NCT00111800|38240312|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
17100958|NCT00111800|38240313|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
17100959|NCT00111800|38240308|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
17100960|NCT00111800|38240309|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
17197196|NCT02343406|38350579|FG003|Overall Study|Death|0|||
17197197|NCT02343406|38350580|FG004|Overall Study|Death|0|||
17197198|NCT02343406|38350576|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
17197199|NCT02343406|38350577|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
17197200|NCT02343406|38350578|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
17197201|NCT02343406|38350579|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
17197202|NCT02343406|38350580|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
17197203|NCT02343406|38350576|FG000|Overall Study|Other primary malignancy|0|||
17197204|NCT02343406|38350577|FG001|Overall Study|Other primary malignancy|1|||
17015570|NCT00870584|38160305|FG001|Overall Study|Withdrawal by Subject|7|||
17015571|NCT00870584|38160304|FG000|Overall Study|Lost to Follow-up|5|||
17015572|NCT00870584|38160305|FG001|Overall Study|Lost to Follow-up|1|||
17015573|NCT00870584|38160304|FG000|Overall Study|Protocol Deviation|2|||
17015574|NCT00870584|38160305|FG001|Overall Study|Protocol Deviation|2|||
17015575|NCT00870194|38160313|FG000|Overall Study|Adverse Event|10|||
17015576|NCT00870194|38160314|FG001|Overall Study|Adverse Event|5|||
17015577|NCT00870194|38160313|FG000|Overall Study|Lack of Efficacy|0|||
17015578|NCT00870194|38160314|FG001|Overall Study|Lack of Efficacy|1|||
17015579|NCT00870194|38160313|FG000|Overall Study|Lost to Follow-up|2|||
17015580|NCT00870194|38160314|FG001|Overall Study|Lost to Follow-up|0|||
17015581|NCT00870194|38160313|FG000|Overall Study|Physician Decision|3|||
17015582|NCT00870194|38160314|FG001|Overall Study|Physician Decision|1|||
17015583|NCT00870194|38160313|FG000|Overall Study|Protocol Violation|3|||
17015584|NCT00870194|38160314|FG001|Overall Study|Protocol Violation|3|||
17197205|NCT02343406|38350578|FG002|Overall Study|Other primary malignancy|0|||
17197206|NCT02343406|38350579|FG003|Overall Study|Other primary malignancy|0|||
17197207|NCT02343406|38350580|FG004|Overall Study|Other primary malignancy|0|||
17197208|NCT02343406|38350576|FG000|Overall Study|Other, not specified|2|||
17197209|NCT02343406|38350577|FG001|Overall Study|Other, not specified|1|||
17197210|NCT02343406|38350578|FG002|Overall Study|Other, not specified|1|||
17100961|NCT00111800|38240310|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
17100962|NCT00111800|38240311|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
17100963|NCT00111800|38240312|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
17100964|NCT00111800|38240313|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
17100965|NCT00111800|38240308|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
17100966|NCT00111800|38240309|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
17100967|NCT00111800|38240310|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
17100968|NCT00111800|38240311|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
17100969|NCT00111800|38240312|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
17100970|NCT00111800|38240313|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
17100971|NCT00111800|38240308|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
17100972|NCT00111800|38240309|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
17100973|NCT00111800|38240310|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
17197211|NCT02343406|38350579|FG003|Overall Study|Other, not specified|4|||
17197212|NCT02343406|38350580|FG004|Overall Study|Other, not specified|0|||
17197213|NCT02710071|38350593|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
17197214|NCT02710071|38350594|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
17197215|NCT02710071|38350593|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
17197216|NCT02710071|38350594|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
17197217|NCT02373202|38350605|FG000|Overall Study|Adverse Event|2|||
17100974|NCT00111800|38240311|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
17100975|NCT00111800|38240312|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
17100976|NCT00111800|38240313|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
17197218|NCT02373202|38350606|FG001|Overall Study|Adverse Event|5|||
17197219|NCT02373202|38350607|FG002|Overall Study|Adverse Event|2|||
17197220|NCT02373202|38350608|FG003|Overall Study|Adverse Event|1|||
17197221|NCT02373202|38350605|FG000|Overall Study|Lack of Efficacy|0|||
17197222|NCT02373202|38350606|FG001|Overall Study|Lack of Efficacy|0|||
17197223|NCT02373202|38350607|FG002|Overall Study|Lack of Efficacy|1|||
17197224|NCT02373202|38350608|FG003|Overall Study|Lack of Efficacy|0|||
17197225|NCT02373202|38350605|FG000|Overall Study|Other|0|||
17197226|NCT02373202|38350606|FG001|Overall Study|Other|1|||
17197227|NCT02373202|38350607|FG002|Overall Study|Other|0|||
17197228|NCT02373202|38350608|FG003|Overall Study|Other|0|||
17197229|NCT02622074|38350624|FG000|Overall Study|Death|4|||
17197230|NCT02622074|38350625|FG001|Overall Study|Death|0|||
17197231|NCT02622074|38350626|FG002|Overall Study|Death|0|||
17197232|NCT02622074|38350627|FG003|Overall Study|Death|1|||
17197233|NCT02622074|38350628|FG004|Overall Study|Death|1|||
17197234|NCT02622074|38350629|FG005|Overall Study|Death|0|||
17197235|NCT02622074|38350624|FG000|Overall Study|Withdrawal by Subject|0|||
17197236|NCT02622074|38350625|FG001|Overall Study|Withdrawal by Subject|1|||
17197237|NCT02622074|38350626|FG002|Overall Study|Withdrawal by Subject|0|||
17197238|NCT02622074|38350627|FG003|Overall Study|Withdrawal by Subject|0|||
17197239|NCT02622074|38350628|FG004|Overall Study|Withdrawal by Subject|0|||
17197240|NCT02622074|38350629|FG005|Overall Study|Withdrawal by Subject|0|||
17197241|NCT02308696|38350645|FG000|Overall Study|Lost to Follow-up|28|||
17197242|NCT02308696|38350646|FG001|Overall Study|Lost to Follow-up|21|||
17197243|NCT02308696|38350645|FG000|Overall Study|Death|8|||
17197244|NCT02308696|38350646|FG001|Overall Study|Death|4|||
17197245|NCT02308696|38350645|FG000|Overall Study|Moved to a Higher Level of Care|17|||
17197246|NCT02308696|38350646|FG001|Overall Study|Moved to a Higher Level of Care|6|||
17197247|NCT02342704|38350654|FG000|Overall Study|Physician Decision|0|||
17197248|NCT02342704|38350655|FG001|Overall Study|Physician Decision|3|||
17197249|NCT02342704|38350654|FG000|Overall Study|Sponsor Termination|49|||
17197250|NCT02342704|38350655|FG001|Overall Study|Sponsor Termination|43|||
17197251|NCT02342704|38350654|FG000|Overall Study|Other|0|||
17197252|NCT02342704|38350655|FG001|Overall Study|Other|1|||
17197253|NCT02342704|38350654|FG000|Overall Study|Withdrawal by Subject|1|||
17197254|NCT02342704|38350655|FG001|Overall Study|Withdrawal by Subject|0|||
17015585|NCT00870194|38160313|FG000|Overall Study|Entry Criteria Not Met|1|||
17015586|NCT00870194|38160314|FG001|Overall Study|Entry Criteria Not Met|2|||
17015587|NCT00870194|38160313|FG000|Overall Study|Subject Decision|7|||
17015588|NCT00870194|38160314|FG001|Overall Study|Subject Decision|2|||
17015589|NCT00690430|38160322|FG000|Core Phase|Abnormal Laboratory value|0|||
17015590|NCT00690430|38160323|FG001|Core Phase|Abnormal Laboratory value|1|||
17015591|NCT00690430|38160324|FG002|Core Phase|Abnormal Laboratory value|0|||
17015592|NCT00690430|38160322|FG000|Core Phase|Adverse Event|5|||
17197255|NCT02342704|38350654|FG000|Overall Study|Lost to Follow-up|2|||
17197256|NCT02342704|38350655|FG001|Overall Study|Lost to Follow-up|1|||
17197257|NCT02342704|38350654|FG000|Overall Study|Adverse Event|1|||
17197258|NCT02342704|38350655|FG001|Overall Study|Adverse Event|3|||
17197259|NCT01359956|38350665|FG000|Overall Study|Death|61|||
17197260|NCT01359956|38350666|FG001|Overall Study|Death|64|||
17197261|NCT01359956|38350667|FG002|Overall Study|Death|67|||
17197262|NCT01359956|38350668|FG003|Overall Study|Death|58|||
17197263|NCT02342548|38350681|FG000|Overall Study|Adverse Event|12|||
17197264|NCT02342548|38350682|FG001|Overall Study|Adverse Event|17|||
17197265|NCT02342548|38350683|FG002|Overall Study|Adverse Event|13|||
17197266|NCT02342548|38350681|FG000|Overall Study|Lost to Follow-up|0|||
17197267|NCT02342548|38350682|FG001|Overall Study|Lost to Follow-up|1|||
17197268|NCT02342548|38350683|FG002|Overall Study|Lost to Follow-up|0|||
17197269|NCT02342548|38350681|FG000|Overall Study|Study terminated by sponsor|20|||
17197270|NCT02342548|38350682|FG001|Overall Study|Study terminated by sponsor|39|||
17197271|NCT02342548|38350683|FG002|Overall Study|Study terminated by sponsor|25|||
17197272|NCT02342548|38350681|FG000|Overall Study|Protocol Violation|0|||
17197273|NCT02342548|38350682|FG001|Overall Study|Protocol Violation|1|||
17197274|NCT02342548|38350683|FG002|Overall Study|Protocol Violation|0|||
17197275|NCT02342548|38350681|FG000|Overall Study|Withdrawal by Subject|1|||
17197276|NCT02342548|38350682|FG001|Overall Study|Withdrawal by Subject|3|||
17197277|NCT02342548|38350683|FG002|Overall Study|Withdrawal by Subject|4|||
17197278|NCT02342548|38350681|FG000|Overall Study|Other|1|||
17197279|NCT02342548|38350682|FG001|Overall Study|Other|1|||
17197280|NCT02342548|38350683|FG002|Overall Study|Other|1|||
17197281|NCT02617628|38350693|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
17100977|NCT00111800|38240308|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
17100978|NCT00111800|38240309|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
17100979|NCT00111800|38240310|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
17100980|NCT00111800|38240311|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
17197282|NCT02617628|38350694|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
17197283|NCT02308540|38350710|FG000|Overall Study|Lost to Follow-up|0|||
17197284|NCT02308540|38350711|FG001|Overall Study|Lost to Follow-up|0|||
17197285|NCT02308540|38350712|FG002|Overall Study|Lost to Follow-up|0|||
17197286|NCT02308540|38350713|FG003|Overall Study|Lost to Follow-up|0|||
17197287|NCT02308540|38350714|FG004|Overall Study|Lost to Follow-up|0|||
17197288|NCT02308540|38350715|FG005|Overall Study|Lost to Follow-up|1|||
17197289|NCT02308228|38350766|FG000|Overall Study|Adverse Event|3|||
17197290|NCT02308228|38350767|FG001|Overall Study|Adverse Event|4|||
17197291|NCT02308228|38350766|FG000|Overall Study|Withdrawal by Subject|5|||
17197292|NCT02308228|38350767|FG001|Overall Study|Withdrawal by Subject|3|||
17197293|NCT02616614|38350785|FG000|Overall Study|Withdrawal by Subject|10|||
17197294|NCT02616614|38350786|FG001|Overall Study|Withdrawal by Subject|5|||
17197295|NCT02616614|38350787|FG002|Overall Study|Withdrawal by Subject|6|||
17197296|NCT02616614|38350785|FG000|Overall Study|Physician Decision|2|||
17197297|NCT02616614|38350786|FG001|Overall Study|Physician Decision|1|||
17197298|NCT02616614|38350787|FG002|Overall Study|Physician Decision|0|||
17197299|NCT02616614|38350785|FG000|Overall Study|Adverse Event|1|||
17197300|NCT02616614|38350786|FG001|Overall Study|Adverse Event|4|||
17197301|NCT02616614|38350787|FG002|Overall Study|Adverse Event|1|||
17197302|NCT02616614|38350785|FG000|Overall Study|Protocol Violation|0|||
17197303|NCT02616614|38350786|FG001|Overall Study|Protocol Violation|3|||
17197304|NCT02616614|38350787|FG002|Overall Study|Protocol Violation|1|||
17197305|NCT02616614|38350785|FG000|Overall Study|Prohibited Medication|12|||
17100981|NCT00111800|38240312|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
17100982|NCT00111800|38240313|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
17100983|NCT00111800|38240308|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
17100984|NCT00111800|38240309|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
17100985|NCT00111800|38240310|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
17100986|NCT00111800|38240311|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
17100987|NCT00111800|38240312|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
17100988|NCT00111800|38240313|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
17100989|NCT00094328|38240336|FG000|Overall Study|Lost to Follow-up|1|||
17100990|NCT00094172|38240342|FG000|Overall Study|Adverse Event|0|||
17100991|NCT00094172|38240343|FG001|Overall Study|Adverse Event|1|||
17100992|NCT00094172|38240342|FG000|Overall Study|Lost to Follow-up|2|||
17015593|NCT00690430|38160323|FG001|Core Phase|Adverse Event|1|||
17015594|NCT00690430|38160324|FG002|Core Phase|Adverse Event|0|||
17015595|NCT00690430|38160322|FG000|Core Phase|Death|0|||
17015596|NCT00690430|38160323|FG001|Core Phase|Death|2|||
17015597|NCT00690430|38160324|FG002|Core Phase|Death|0|||
17015598|NCT00690430|38160322|FG000|Core Phase|Protocol Violation|1|||
17015599|NCT00690430|38160323|FG001|Core Phase|Protocol Violation|0|||
17015600|NCT00690430|38160324|FG002|Core Phase|Protocol Violation|0|||
17015601|NCT00690430|38160322|FG000|Core Phase|Withdrawal by Subject|3|||
17100993|NCT00094172|38240343|FG001|Overall Study|Lost to Follow-up|0|||
17100994|NCT00094172|38240342|FG000|Overall Study|Protocol Violation|0|||
17100995|NCT00094172|38240343|FG001|Overall Study|Protocol Violation|1|||
17100996|NCT00094172|38240342|FG000|Overall Study|Withdrawal by Subject|10|||
17100997|NCT00094172|38240343|FG001|Overall Study|Withdrawal by Subject|5|||
17100998|NCT00094172|38240342|FG000|Overall Study|Primary endpoint met.|1|||
17100999|NCT00094172|38240343|FG001|Overall Study|Primary endpoint met.|0|||
17101000|NCT00094172|38240342|FG000|Overall Study|Started other MS therapy due to disease|1|||
17101001|NCT00094172|38240343|FG001|Overall Study|Started other MS therapy due to disease|0|||
17101002|NCT00094094|38240349|FG000|Overall Study|Death|2|||
17101003|NCT00094094|38240349|FG000|Overall Study|Lack of Efficacy|23|||
17101004|NCT00094094|38240349|FG000|Overall Study|Adverse Event|7|||
17101005|NCT00110396|38240353|FG000|Overall Study|Adverse Event|15|||
17101006|NCT00110396|38240353|FG000|Overall Study|Lost to Follow-up|1|||
17101007|NCT00110396|38240353|FG000|Overall Study|Administration of plasmapheresis|1|||
17101008|NCT00110396|38240353|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
17101009|NCT00110396|38240353|FG000|Overall Study|Lack of Efficacy|1|||
17101010|NCT00110396|38240353|FG000|Overall Study|Decided not to continue treatment|1|||
17101011|NCT00110396|38240353|FG000|Overall Study|Patient non-compliance|1|||
17101012|NCT00110396|38240353|FG000|Overall Study|Patient refused to continue|1|||
17101013|NCT00110396|38240353|FG000|Overall Study|Patient refused to participate|1|||
17101014|NCT00110396|38240353|FG000|Overall Study|Patient will|1|||
17101015|NCT00110396|38240353|FG000|Overall Study|Patient's decision|1|||
17101016|NCT00110396|38240353|FG000|Overall Study|Participation in MS vaccine study|1|||
17101017|NCT00110396|38240353|FG000|Overall Study|Pregnancy|1|||
17015602|NCT00690430|38160323|FG001|Core Phase|Withdrawal by Subject|3|||
17015603|NCT00690430|38160324|FG002|Core Phase|Withdrawal by Subject|0|||
17015604|NCT00690430|38160322|FG000|Core Phase|Subject no longer requires study drug|1|||
17015605|NCT00690430|38160323|FG001|Core Phase|Subject no longer requires study drug|0|||
17015606|NCT00690430|38160324|FG002|Core Phase|Subject no longer requires study drug|0|||
17101018|NCT00110396|38240353|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
17101019|NCT00110396|38240353|FG000|Overall Study|Protocol Violation|2|||
17015607|NCT00690430|38160322|FG000|Core Phase|Lack of Efficacy|8|||
17015608|NCT00690430|38160323|FG001|Core Phase|Lack of Efficacy|10|||
17015609|NCT00690430|38160324|FG002|Core Phase|Lack of Efficacy|0|||
17015610|NCT00690430|38160322|FG000|Core Phase|Administrative Problems|0|||
17015611|NCT00690430|38160323|FG001|Core Phase|Administrative Problems|1|||
17015612|NCT00690430|38160324|FG002|Core Phase|Administrative Problems|0|||
17015613|NCT00690430|38160322|FG000|Core Phase|Early Termination|0|||
17015614|NCT00690430|38160323|FG001|Core Phase|Early Termination|5|||
17015615|NCT00690430|38160324|FG002|Core Phase|Early Termination|0|||
17015616|NCT00690430|38160322|FG000|Extension Phase|Lack of Efficacy|3|||
17015617|NCT00690430|38160323|FG001|Extension Phase|Lack of Efficacy|1|||
17015618|NCT00690430|38160324|FG002|Extension Phase|Lack of Efficacy|4|||
17015619|NCT00690430|38160322|FG000|Extension Phase|Abnormal Lab Values|1|||
17015620|NCT00690430|38160323|FG001|Extension Phase|Abnormal Lab Values|0|||
17015621|NCT00690430|38160324|FG002|Extension Phase|Abnormal Lab Values|0|||
17015622|NCT00690430|38160322|FG000|Extension Phase|Abnormal test procedure results|1|||
17015623|NCT00690430|38160323|FG001|Extension Phase|Abnormal test procedure results|0|||
17015624|NCT00690430|38160324|FG002|Extension Phase|Abnormal test procedure results|0|||
17015625|NCT00690430|38160322|FG000|Extension Phase|Administrative Problems|0|||
17015626|NCT00690430|38160323|FG001|Extension Phase|Administrative Problems|1|||
17015627|NCT00690430|38160324|FG002|Extension Phase|Administrative Problems|1|||
17015628|NCT00690430|38160322|FG000|Extension Phase|Adverse Event|2|||
17015629|NCT00690430|38160323|FG001|Extension Phase|Adverse Event|1|||
17015630|NCT00690430|38160324|FG002|Extension Phase|Adverse Event|2|||
17015631|NCT00690430|38160322|FG000|Extension Phase|Death|1|||
17015632|NCT00690430|38160323|FG001|Extension Phase|Death|1|||
17015633|NCT00690430|38160324|FG002|Extension Phase|Death|1|||
17015634|NCT00690430|38160322|FG000|Extension Phase|Withdrawal by Subject|0|||
17015635|NCT00690430|38160323|FG001|Extension Phase|Withdrawal by Subject|0|||
17015636|NCT00690430|38160324|FG002|Extension Phase|Withdrawal by Subject|2|||
17015637|NCT00690430|38160322|FG000|Extension Phase|Early Termination|10|||
17015638|NCT00690430|38160323|FG001|Extension Phase|Early Termination|1|||
17015639|NCT00690430|38160324|FG002|Extension Phase|Early Termination|3|||
17015640|NCT00863330|38160333|FG000|Overall Study|study terminated early due to administra|6|||
17015641|NCT00688324|38160337|FG000|Overall Study|Withdrawal by Subject|2|||
17015642|NCT00688324|38160337|FG000|Overall Study|Physician Decision|5|||
17015643|NCT00688324|38160337|FG000|Overall Study|Lost to Follow-up|1|||
17015644|NCT00862940|38160344|FG000|Overall Study|Adverse Event|15|||
17015645|NCT00862940|38160345|FG001|Overall Study|Adverse Event|12|||
17015646|NCT00862940|38160344|FG000|Overall Study|Lack of Efficacy|1|||
17015647|NCT00862940|38160345|FG001|Overall Study|Lack of Efficacy|3|||
17015648|NCT00862940|38160344|FG000|Overall Study|Protocol Violation|2|||
17015649|NCT00862940|38160345|FG001|Overall Study|Protocol Violation|5|||
17101020|NCT00110396|38240353|FG000|Overall Study|Patient refused to come back|1|||
17101021|NCT00110396|38240353|FG000|Overall Study|The patient has refused|2|||
17101022|NCT00110396|38240353|FG000|Overall Study|The patient has refused to visit site|1|||
17101023|NCT00110396|38240353|FG000|Overall Study|Patient is to be administered copaxone|1|||
17101024|NCT03819218|38240357|FG000|Overall Study|Protocol Violation|1|||
17101025|NCT00093470|38240363|FG000|Overall Study|Disease progression|39|||
17101026|NCT00093470|38240364|FG001|Overall Study|Disease progression|0|||
17015650|NCT00862940|38160344|FG000|Overall Study|Withdrawal by Subject|4|||
17015651|NCT00862940|38160345|FG001|Overall Study|Withdrawal by Subject|6|||
17015652|NCT00862940|38160344|FG000|Overall Study|Non-compliance|4|||
17015653|NCT00862940|38160345|FG001|Overall Study|Non-compliance|0|||
17015654|NCT00862940|38160344|FG000|Overall Study|Lost to Follow-up|0|||
17015655|NCT00862940|38160345|FG001|Overall Study|Lost to Follow-up|1|||
17015656|NCT00862940|38160344|FG000|Overall Study|Administrative or other reason(s)|4|||
17015657|NCT00862940|38160345|FG001|Overall Study|Administrative or other reason(s)|3|||
17015658|NCT00868166|38160353|FG000|Overall Study|Death|58|||
17015659|NCT00868166|38160354|FG001|Overall Study|Death|65|||
17015660|NCT00868166|38160353|FG000|Overall Study|Withdrawal by Subject|33|||
17015661|NCT00868166|38160354|FG001|Overall Study|Withdrawal by Subject|25|||
17015662|NCT00868166|38160353|FG000|Overall Study|Protocol Violation|1|||
17015663|NCT00868166|38160354|FG001|Overall Study|Protocol Violation|0|||
17015664|NCT00868166|38160353|FG000|Overall Study|Lost to Follow-up|1|||
17015665|NCT00868166|38160354|FG001|Overall Study|Lost to Follow-up|3|||
17015666|NCT00868166|38160353|FG000|Overall Study|Adverse Event|9|||
17015667|NCT00868166|38160354|FG001|Overall Study|Adverse Event|10|||
17015668|NCT00868166|38160353|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
17015669|NCT00868166|38160354|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
17015670|NCT00868166|38160353|FG000|Overall Study|Non-compliance with IMP|1|||
17015671|NCT00868166|38160354|FG001|Overall Study|Non-compliance with IMP|1|||
17015672|NCT00858780|38160360|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
17015673|NCT00858780|38160361|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
17015674|NCT00858780|38160362|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
17015675|NCT00858780|38160363|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
17015676|NCT00858780|38160364|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
17015677|NCT00858780|38160360|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
17015678|NCT00858780|38160361|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
17015679|NCT00858780|38160362|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
17015680|NCT00858780|38160363|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
17015681|NCT00858780|38160364|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
17015682|NCT00858780|38160360|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
17015683|NCT00858780|38160361|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
17015684|NCT00858780|38160362|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
17015685|NCT00858780|38160363|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
17015686|NCT00858780|38160364|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
17015687|NCT00858780|38160360|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
17015688|NCT00858780|38160361|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
17015689|NCT00858780|38160362|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
17015690|NCT00858780|38160363|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
17015691|NCT00858780|38160364|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
17015692|NCT00858780|38160360|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
17015693|NCT00858780|38160361|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
17015694|NCT00858780|38160362|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
17015695|NCT00858780|38160363|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
17015696|NCT00858780|38160364|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
17015697|NCT00858780|38160360|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
17015698|NCT00858780|38160361|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
17015699|NCT00858780|38160362|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
17015700|NCT00858780|38160363|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
17015701|NCT00858780|38160364|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
17015702|NCT00850200|38160374|FG000|Overall Study|Physician Decision|2|||
17015703|NCT00850200|38160374|FG000|Overall Study|Did not recieve treatment|2|||
17015704|NCT00850200|38160374|FG000|Overall Study|Withdrawal by Subject|1|||
17015705|NCT00858234|38160381|FG000|Overall Study|Adverse Event|6|||
17015706|NCT00858234|38160381|FG000|Overall Study|Progressive disease|2|||
17015707|NCT00858234|38160381|FG000|Overall Study|Status unknown|1|||
17015708|NCT00862082|38160387|FG000|Overall Study|Sponsor decision to terminate the study|5|||
17015709|NCT00862082|38160388|FG001|Overall Study|Sponsor decision to terminate the study|0|||
17015710|NCT00862082|38160387|FG000|Overall Study|Withdrawal by Subject|0|||
17015711|NCT00862082|38160388|FG001|Overall Study|Withdrawal by Subject|1|||
17015712|NCT00849186|38160401|FG000|Overall Study|Adverse Event|2|||
17101027|NCT00093470|38240363|FG000|Overall Study|Adverse Event|15|||
17101028|NCT00093470|38240364|FG001|Overall Study|Adverse Event|0|||
17101029|NCT00093470|38240363|FG000|Overall Study|Death|2|||
17101030|NCT00093470|38240364|FG001|Overall Study|Death|0|||
17101031|NCT00093470|38240363|FG000|Overall Study|Withdrawal by Subject|8|||
17101032|NCT00093470|38240364|FG001|Overall Study|Withdrawal by Subject|0|||
17101033|NCT00093470|38240363|FG000|Overall Study|Alternative therapy|2|||
17101034|NCT00093470|38240364|FG001|Overall Study|Alternative therapy|0|||
17101035|NCT00093470|38240363|FG000|Overall Study|Other complicating disease|3|||
17101036|NCT00093470|38240364|FG001|Overall Study|Other complicating disease|0|||
17101037|NCT00093470|38240363|FG000|Overall Study|Physician Decision|2|||
17101038|NCT00093470|38240364|FG001|Overall Study|Physician Decision|0|||
17101039|NCT00093470|38240363|FG000|Overall Study|Never started treatment|1|||
17101040|NCT00093470|38240364|FG001|Overall Study|Never started treatment|0|||
17101041|NCT00093470|38240363|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
17101042|NCT00093470|38240364|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
17101043|NCT00407537|38240372|FG000|Overall Study|Death|5|||
17101044|NCT00407537|38240373|FG001|Overall Study|Death|2|||
17101045|NCT00407537|38240372|FG000|Overall Study|Adverse Event|36|||
17101046|NCT00407537|38240373|FG001|Overall Study|Adverse Event|0|||
17101047|NCT00407537|38240372|FG000|Overall Study|Lost to Follow-up|12|||
17101048|NCT00407537|38240373|FG001|Overall Study|Lost to Follow-up|19|||
17101049|NCT00407537|38240372|FG000|Overall Study|Other|6|||
17101050|NCT00407537|38240373|FG001|Overall Study|Other|7|||
17101051|NCT00407537|38240372|FG000|Overall Study|Withdrawal by Subject|34|||
17101052|NCT00407537|38240373|FG001|Overall Study|Withdrawal by Subject|16|||
17101053|NCT00094458|38240382|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
17101054|NCT00094458|38240383|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
17101055|NCT00094458|38240384|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
17101056|NCT00094458|38240385|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
17101057|NCT00094458|38240386|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
17101058|NCT00094458|38240387|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
17101059|NCT00094458|38240382|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
17101060|NCT00094458|38240383|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
17101061|NCT00094458|38240384|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
17101062|NCT00094458|38240385|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
17101063|NCT00094458|38240386|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
17101064|NCT00094458|38240387|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
17101065|NCT00094458|38240382|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
17101066|NCT00094458|38240383|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
17101067|NCT00094458|38240384|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
17101068|NCT00094458|38240385|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
17101069|NCT00094458|38240386|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
17101070|NCT00094458|38240387|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
17101071|NCT00094458|38240382|FG000|Main Study: Through Week 30|Adverse Event|38|||
17101072|NCT00094458|38240383|FG001|Main Study: Through Week 30|Adverse Event|20|||
17101073|NCT00094458|38240384|FG002|Main Study: Through Week 30|Adverse Event|28|||
17101074|NCT00094458|38240385|FG003|Main Study: Through Week 30|Adverse Event|0|||
17101075|NCT00094458|38240386|FG004|Main Study: Through Week 30|Adverse Event|0|||
17101076|NCT00094458|38240387|FG005|Main Study: Through Week 30|Adverse Event|0|||
17101077|NCT00094458|38240382|FG000|Main Study: Through Week 30|Death|1|||
17101078|NCT00094458|38240383|FG001|Main Study: Through Week 30|Death|0|||
17101079|NCT00094458|38240384|FG002|Main Study: Through Week 30|Death|0|||
17101080|NCT00094458|38240385|FG003|Main Study: Through Week 30|Death|0|||
17101081|NCT00094458|38240386|FG004|Main Study: Through Week 30|Death|0|||
17101082|NCT00094458|38240387|FG005|Main Study: Through Week 30|Death|0|||
17101083|NCT00094458|38240382|FG000|Main Study: Through Week 30|Other|19|||
17101084|NCT00094458|38240383|FG001|Main Study: Through Week 30|Other|16|||
17101085|NCT00094458|38240384|FG002|Main Study: Through Week 30|Other|9|||
17101086|NCT00094458|38240385|FG003|Main Study: Through Week 30|Other|0|||
17101087|NCT00094458|38240386|FG004|Main Study: Through Week 30|Other|0|||
17101088|NCT00094458|38240387|FG005|Main Study: Through Week 30|Other|0|||
17101089|NCT00094458|38240382|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
17101090|NCT00094458|38240383|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
17101091|NCT00094458|38240384|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
17101092|NCT00094458|38240385|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
17101093|NCT00094458|38240386|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
17101094|NCT00094458|38240387|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
17101095|NCT00094458|38240382|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
17101096|NCT00094458|38240383|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
17101097|NCT00094458|38240384|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
17101098|NCT00094458|38240385|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
17101099|NCT00094458|38240386|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
17101100|NCT00094458|38240387|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
17101101|NCT00094458|38240382|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
17197306|NCT02616614|38350786|FG001|Overall Study|Prohibited Medication|9|||
17101102|NCT00094458|38240383|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
17101103|NCT00094458|38240384|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
17101104|NCT00094458|38240385|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
17101105|NCT00094458|38240386|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
17101106|NCT00094458|38240387|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
17101107|NCT00094458|38240382|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
17101108|NCT00094458|38240383|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
17101109|NCT00094458|38240384|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
17101110|NCT00094458|38240385|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
17101111|NCT00094458|38240386|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
17197307|NCT02616614|38350787|FG002|Overall Study|Prohibited Medication|5|||
17197308|NCT02616614|38350785|FG000|Overall Study|More than 3 applications missed|6|||
17101112|NCT00094458|38240387|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
17101113|NCT00094458|38240382|FG000|OLE: Open-Label Extension|Adverse Event|0|||
17101114|NCT00094458|38240383|FG001|OLE: Open-Label Extension|Adverse Event|0|||
17101115|NCT00094458|38240384|FG002|OLE: Open-Label Extension|Adverse Event|0|||
17101116|NCT00094458|38240385|FG003|OLE: Open-Label Extension|Adverse Event|0|||
17101117|NCT00094458|38240386|FG004|OLE: Open-Label Extension|Adverse Event|3|||
17101118|NCT00094458|38240387|FG005|OLE: Open-Label Extension|Adverse Event|4|||
17101119|NCT00094458|38240382|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
17197309|NCT02616614|38350786|FG001|Overall Study|More than 3 applications missed|8|||
17197310|NCT02616614|38350787|FG002|Overall Study|More than 3 applications missed|1|||
17197311|NCT02616614|38350785|FG000|Overall Study|Lost to Follow-up|31|||
17197312|NCT02616614|38350786|FG001|Overall Study|Lost to Follow-up|28|||
17197313|NCT02616614|38350787|FG002|Overall Study|Lost to Follow-up|13|||
17197314|NCT02616614|38350785|FG000|Overall Study|Pregnancy|2|||
17197315|NCT02616614|38350786|FG001|Overall Study|Pregnancy|0|||
17197316|NCT02616614|38350787|FG002|Overall Study|Pregnancy|1|||
17197317|NCT02616614|38350785|FG000|Overall Study|Other|1|||
17197318|NCT02616614|38350786|FG001|Overall Study|Other|2|||
17197319|NCT02616614|38350787|FG002|Overall Study|Other|1|||
17101120|NCT00094458|38240383|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
17197320|NCT02616380|38350813|FG000|Overall Study|Lost to Follow-up|1|||
17197321|NCT02616380|38350813|FG000|Overall Study|Other|2|||
17197322|NCT01596062|38350824|FG000|Overall Study|Adverse Event|1|||
17197323|NCT01596062|38350825|FG001|Overall Study|Adverse Event|0|||
17197324|NCT01596062|38350826|FG002|Overall Study|Adverse Event|2|||
17197325|NCT01596062|38350824|FG000|Overall Study|Lack of Efficacy|0|||
17197326|NCT01596062|38350825|FG001|Overall Study|Lack of Efficacy|0|||
17197327|NCT01596062|38350826|FG002|Overall Study|Lack of Efficacy|1|||
17101121|NCT00094458|38240384|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
17101122|NCT00094458|38240385|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
17101123|NCT00094458|38240386|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
17101124|NCT00094458|38240387|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
17101125|NCT00094458|38240382|FG000|OLE: Open-Label Extension|Patient decision|0|||
17101126|NCT00094458|38240383|FG001|OLE: Open-Label Extension|Patient decision|0|||
17101127|NCT00094458|38240384|FG002|OLE: Open-Label Extension|Patient decision|0|||
17101128|NCT00094458|38240385|FG003|OLE: Open-Label Extension|Patient decision|0|||
17101129|NCT00094458|38240386|FG004|OLE: Open-Label Extension|Patient decision|1|||
17101130|NCT00094458|38240387|FG005|OLE: Open-Label Extension|Patient decision|0|||
17101131|NCT00406367|38240403|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
17101132|NCT00406367|38240404|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
17197328|NCT02614898|38350845|FG000|Overall Study|Participated until study termination|10|||
17197329|NCT02614898|38350846|FG001|Overall Study|Participated until study termination|26|||
17197330|NCT02614898|38350845|FG000|Overall Study|Lost to Follow-up|0|||
17197331|NCT02614898|38350846|FG001|Overall Study|Lost to Follow-up|2|||
17197332|NCT02614898|38350845|FG000|Overall Study|Physician Decision|1|||
17197333|NCT02614898|38350846|FG001|Overall Study|Physician Decision|8|||
17197334|NCT02614898|38350845|FG000|Overall Study|Study Terminated by Sponsor|3|||
17197335|NCT02614898|38350846|FG001|Overall Study|Study Terminated by Sponsor|0|||
17197336|NCT02614898|38350845|FG000|Overall Study|Withdrawal by Subject|0|||
17197337|NCT02614898|38350846|FG001|Overall Study|Withdrawal by Subject|2|||
17197338|NCT02614898|38350845|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
17197339|NCT02614898|38350846|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
17197340|NCT02614898|38350845|FG000|Overall Study|Other-Additional Information Unavailable|0|||
17197341|NCT02614898|38350846|FG001|Overall Study|Other-Additional Information Unavailable|11|||
17101133|NCT00406367|38240403|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
17101134|NCT00406367|38240404|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
17101135|NCT00406367|38240403|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
17101136|NCT00406367|38240404|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
17101137|NCT00406367|38240403|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
17197342|NCT02614898|38350845|FG000|Overall Study|Missing|0|||
17101138|NCT00406367|38240404|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
17101139|NCT00406367|38240403|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
17101140|NCT00406367|38240404|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
17101141|NCT00406367|38240403|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
17101142|NCT00406367|38240404|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
17101143|NCT00406367|38240403|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
17101144|NCT00406367|38240404|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
17101145|NCT00406367|38240403|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
17101146|NCT00406367|38240404|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
17101147|NCT00406367|38240403|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
17101148|NCT00406367|38240404|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
17101149|NCT00406367|38240403|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
17101150|NCT00406367|38240404|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
17101151|NCT00406367|38240403|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
17101152|NCT00406367|38240404|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
17101153|NCT00406367|38240403|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
17101154|NCT00406367|38240404|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
17101155|NCT00394589|38240413|FG000|Overall Study|Adverse Event|2|||
17101156|NCT00394589|38240414|FG001|Overall Study|Adverse Event|1|||
17101157|NCT00394589|38240415|FG002|Overall Study|Adverse Event|2|||
17101158|NCT00394589|38240413|FG000|Overall Study|Lack of Efficacy|2|||
17101159|NCT00394589|38240414|FG001|Overall Study|Lack of Efficacy|2|||
17101160|NCT00394589|38240415|FG002|Overall Study|Lack of Efficacy|3|||
17101161|NCT00394589|38240413|FG000|Overall Study|Protocol Violation|4|||
17101162|NCT00394589|38240414|FG001|Overall Study|Protocol Violation|0|||
17101163|NCT00394589|38240415|FG002|Overall Study|Protocol Violation|2|||
17101164|NCT00068406|38240423|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
17101165|NCT00068406|38240423|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
17101166|NCT00403559|38240429|FG000|Overall Study|Adverse Event|0|||
17101167|NCT00403559|38240430|FG001|Overall Study|Adverse Event|1|||
17101168|NCT00403559|38240429|FG000|Overall Study|Lost to Follow-up|3|||
17101169|NCT00403559|38240430|FG001|Overall Study|Lost to Follow-up|3|||
17101170|NCT00403559|38240429|FG000|Overall Study|Withdrawal by Subject|1|||
17101171|NCT00403559|38240430|FG001|Overall Study|Withdrawal by Subject|0|||
17101172|NCT00403481|38240438|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
17101173|NCT00403481|38240438|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
17101174|NCT00403481|38240438|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
17101175|NCT00403481|38240438|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
17101176|NCT00403481|38240438|FG000|Olm 40 mg|Adverse Event|2|||
17101177|NCT00403481|38240438|FG000|Olm 40 mg|Protocol Violation|1|||
17101178|NCT00403481|38240438|FG000|Olm 40 mg|Withdrawal by Subject|1|||
17101179|NCT00403481|38240438|FG000|Olm 40 mg|Other|1|||
17101180|NCT00403481|38240438|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
17101181|NCT00403481|38240438|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
17101182|NCT00403481|38240438|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
17101183|NCT00403481|38240438|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
17101184|NCT00403481|38240438|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
17197343|NCT02614898|38350846|FG001|Overall Study|Missing|1|||
17197344|NCT02777593|38350858|FG000|Overall Study|Still in study|66|||
17197345|NCT02777593|38350859|FG001|Overall Study|Still in study|105|||
17197346|NCT02777593|38350860|FG002|Overall Study|Still in study|10|||
17197347|NCT02777593|38350861|FG003|Overall Study|Still in study|8|||
17197348|NCT02777593|38350862|FG004|Overall Study|Still in study|6|||
17197349|NCT02777593|38350858|FG000|Overall Study|Death|11|||
17197350|NCT02777593|38350859|FG001|Overall Study|Death|19|||
17197351|NCT02777593|38350860|FG002|Overall Study|Death|0|||
17197352|NCT02777593|38350861|FG003|Overall Study|Death|4|||
17101185|NCT00403481|38240438|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
17197353|NCT02777593|38350862|FG004|Overall Study|Death|0|||
17197354|NCT02777593|38350858|FG000|Overall Study|Withdrawal by Subject|5|||
17197355|NCT02777593|38350859|FG001|Overall Study|Withdrawal by Subject|1|||
17197356|NCT02777593|38350860|FG002|Overall Study|Withdrawal by Subject|0|||
17197357|NCT02777593|38350861|FG003|Overall Study|Withdrawal by Subject|1|||
17197358|NCT02777593|38350862|FG004|Overall Study|Withdrawal by Subject|0|||
17197359|NCT02777593|38350858|FG000|Overall Study|Lost to Follow-up|1|||
17197360|NCT02777593|38350859|FG001|Overall Study|Lost to Follow-up|6|||
17197361|NCT02777593|38350860|FG002|Overall Study|Lost to Follow-up|0|||
17197362|NCT02777593|38350861|FG003|Overall Study|Lost to Follow-up|0|||
17197363|NCT02777593|38350862|FG004|Overall Study|Lost to Follow-up|0|||
17197364|NCT02777593|38350858|FG000|Overall Study|Physician Decision|0|||
17197365|NCT02777593|38350859|FG001|Overall Study|Physician Decision|1|||
17197366|NCT02777593|38350860|FG002|Overall Study|Physician Decision|0|||
17197367|NCT02777593|38350861|FG003|Overall Study|Physician Decision|0|||
17197368|NCT02777593|38350862|FG004|Overall Study|Physician Decision|0|||
17197369|NCT02777593|38350858|FG000|Overall Study|Discontinued due to Other|2|||
17197370|NCT02777593|38350859|FG001|Overall Study|Discontinued due to Other|0|||
17197371|NCT02777593|38350860|FG002|Overall Study|Discontinued due to Other|0|||
17197372|NCT02777593|38350861|FG003|Overall Study|Discontinued due to Other|0|||
17101186|NCT00402779|38240447|FG000|Overall Study|Screen Failure|77|||
17101187|NCT00402779|38240448|FG001|Overall Study|Screen Failure|76|||
17101188|NCT00394433|38240454|FG000|Overall Study|Adverse Event|2|||
17101189|NCT00394433|38240454|FG000|Overall Study|Alternative Therapy|1|||
17197373|NCT02777593|38350862|FG004|Overall Study|Discontinued due to Other|0|||
17197374|NCT02776033|38350887|FG000|Overall Study|Withdrawal by Subject|0|||
17197375|NCT02776033|38350888|FG001|Overall Study|Withdrawal by Subject|0|||
17197376|NCT02776033|38350889|FG002|Overall Study|Withdrawal by Subject|2|||
17197377|NCT02776033|38350887|FG000|Overall Study|Physician Decision|2|||
17197378|NCT02776033|38350888|FG001|Overall Study|Physician Decision|0|||
17197379|NCT02776033|38350889|FG002|Overall Study|Physician Decision|0|||
17197380|NCT02776033|38350887|FG000|Overall Study|Lost to Follow-up|1|||
17197381|NCT02776033|38350888|FG001|Overall Study|Lost to Follow-up|0|||
17197382|NCT02776033|38350889|FG002|Overall Study|Lost to Follow-up|0|||
17197383|NCT02776033|38350887|FG000|Overall Study|Adverse Event|1|||
17197384|NCT02776033|38350888|FG001|Overall Study|Adverse Event|2|||
17197385|NCT02776033|38350889|FG002|Overall Study|Adverse Event|0|||
17197386|NCT02777125|38350905|FG000|Overall Study|Consent form violation|14|||
17197387|NCT02777125|38350906|FG001|Overall Study|Consent form violation|12|||
17197388|NCT02777125|38350905|FG000|Overall Study|Assent form violation|21|||
17197389|NCT02777125|38350906|FG001|Overall Study|Assent form violation|23|||
17197390|NCT02777125|38350905|FG000|Overall Study|Protocol Violation|8|||
17197391|NCT02777125|38350906|FG001|Overall Study|Protocol Violation|12|||
17197392|NCT02769481|38350931|FG000|Overall Study|Protocol Violation|1|||
17197393|NCT02769481|38350932|FG001|Overall Study|Protocol Violation|0|||
17197394|NCT02769481|38350931|FG000|Overall Study|Adverse Event|3|||
17197395|NCT02769481|38350932|FG001|Overall Study|Adverse Event|6|||
17015713|NCT00849186|38160401|FG000|Overall Study|Withdrawal by Subject|1|||
17015714|NCT00849186|38160401|FG000|Overall Study|not treated|6|||
17015715|NCT00849186|38160401|FG000|Overall Study|Other|1|||
17015716|NCT00692770|38160408|FG000|Overall Study|Protocol Violation|2|||
17015717|NCT00692770|38160409|FG001|Overall Study|Protocol Violation|7|||
17015718|NCT00692770|38160408|FG000|Overall Study|Withdrawal by Subject|97|||
17015719|NCT00692770|38160409|FG001|Overall Study|Withdrawal by Subject|36|||
17015720|NCT00692770|38160408|FG000|Overall Study|Adverse Event|136|||
17015721|NCT00692770|38160409|FG001|Overall Study|Adverse Event|41|||
17015722|NCT00692770|38160408|FG000|Overall Study|Death|10|||
17015723|NCT00692770|38160409|FG001|Overall Study|Death|5|||
17015724|NCT00692770|38160408|FG000|Overall Study|Lost to Follow-up|7|||
17015725|NCT00692770|38160409|FG001|Overall Study|Lost to Follow-up|3|||
17015726|NCT00692770|38160408|FG000|Overall Study|Non-compliant with study medication|11|||
17015727|NCT00692770|38160409|FG001|Overall Study|Non-compliant with study medication|5|||
17015728|NCT00692770|38160408|FG000|Overall Study|Progression by clinical judgment|2|||
17015729|NCT00692770|38160409|FG001|Overall Study|Progression by clinical judgment|3|||
17015730|NCT00692770|38160408|FG000|Overall Study|Physician decision not protocol driven|10|||
17015731|NCT00692770|38160409|FG001|Overall Study|Physician decision not protocol driven|14|||
17101190|NCT00092534|38240460|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
17101191|NCT00092534|38240461|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
17101192|NCT00092534|38240462|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
17101193|NCT00092534|38240463|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
17101194|NCT00092534|38240464|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
17101195|NCT00092534|38240460|FG000|Base Study Vaccination Period|Adverse Event|3|||
17101196|NCT00092534|38240461|FG001|Base Study Vaccination Period|Adverse Event|1|||
17101197|NCT00092534|38240462|FG002|Base Study Vaccination Period|Adverse Event|0|||
17101198|NCT00092534|38240463|FG003|Base Study Vaccination Period|Adverse Event|0|||
17101199|NCT00092534|38240464|FG004|Base Study Vaccination Period|Adverse Event|0|||
17101200|NCT00092534|38240460|FG000|Base Study Vaccination Period|Death|5|||
17101201|NCT00092534|38240461|FG001|Base Study Vaccination Period|Death|4|||
17101202|NCT00092534|38240462|FG002|Base Study Vaccination Period|Death|0|||
17101203|NCT00092534|38240463|FG003|Base Study Vaccination Period|Death|0|||
17101204|NCT00092534|38240464|FG004|Base Study Vaccination Period|Death|0|||
17101205|NCT00092534|38240460|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
17101206|NCT00092534|38240461|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
17101207|NCT00092534|38240462|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
17101208|NCT00092534|38240463|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
17101209|NCT00092534|38240464|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
17101210|NCT00092534|38240460|FG000|Base Study Vaccination Period|Physician Decision|1|||
17197396|NCT02769481|38350931|FG000|Overall Study|Entry Criteria Not Met|1|||
17015732|NCT00692770|38160408|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
17197397|NCT02769481|38350932|FG001|Overall Study|Entry Criteria Not Met|2|||
17197398|NCT02769481|38350931|FG000|Overall Study|Withdrawal by Subject|14|||
17197399|NCT02769481|38350932|FG001|Overall Study|Withdrawal by Subject|16|||
17197400|NCT02769481|38350931|FG000|Overall Study|Lost to Follow-up|9|||
17197401|NCT02769481|38350932|FG001|Overall Study|Lost to Follow-up|9|||
17197402|NCT02769481|38350931|FG000|Overall Study|Physician Decision|0|||
17197403|NCT02769481|38350932|FG001|Overall Study|Physician Decision|1|||
17197404|NCT02769481|38350931|FG000|Overall Study|Terminated by Sponsor|1|||
17197405|NCT02769481|38350932|FG001|Overall Study|Terminated by Sponsor|0|||
17197406|NCT02769481|38350931|FG000|Overall Study|Death|0|||
17197407|NCT02769481|38350932|FG001|Overall Study|Death|1|||
17197408|NCT02769481|38350931|FG000|Overall Study|Undefined|4|||
17197409|NCT02769481|38350932|FG001|Overall Study|Undefined|1|||
17197410|NCT02769247|38350942|FG000|Overall Study|Withdrawal by Subject|1|||
17197411|NCT02769247|38350943|FG001|Overall Study|Withdrawal by Subject|0|||
17197412|NCT02769247|38350944|FG002|Overall Study|Withdrawal by Subject|0|||
17197413|NCT02769247|38350945|FG003|Overall Study|Withdrawal by Subject|1|||
17197414|NCT02769247|38350942|FG000|Overall Study|Protocol Violation|0|||
17197415|NCT02769247|38350943|FG001|Overall Study|Protocol Violation|0|||
17197416|NCT02769247|38350944|FG002|Overall Study|Protocol Violation|1|||
17197417|NCT02769247|38350945|FG003|Overall Study|Protocol Violation|0|||
17197418|NCT02769247|38350942|FG000|Overall Study|Physician Decision|1|||
17197419|NCT02769247|38350943|FG001|Overall Study|Physician Decision|0|||
17197420|NCT02769247|38350944|FG002|Overall Study|Physician Decision|0|||
17197421|NCT02769247|38350945|FG003|Overall Study|Physician Decision|0|||
17197422|NCT02773537|38350962|FG000|Overall Study|Lost to Follow-up|0|||
17197423|NCT02773537|38350963|FG001|Overall Study|Lost to Follow-up|1|||
17197424|NCT02773537|38350964|FG002|Overall Study|Lost to Follow-up|4|||
17197425|NCT02780713|38350972|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
17197426|NCT02780713|38350973|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
17197427|NCT02780713|38350974|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
17197428|NCT02780713|38350975|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
17197429|NCT02780713|38350976|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
17197430|NCT02767765|38350995|FG000|Overall Study|Adverse Event|4|||
17197431|NCT02767765|38350995|FG000|Overall Study|Death|1|||
17197432|NCT02767765|38350995|FG000|Overall Study|Insufficient response|1|||
17197433|NCT02767765|38350995|FG000|Overall Study|Lost to Follow-up|2|||
17197434|NCT02767765|38350995|FG000|Overall Study|Investigator decision|1|||
17197435|NCT02767765|38350995|FG000|Overall Study|Non-Compliance|1|||
17197436|NCT02767765|38350995|FG000|Overall Study|Withdrawal by Subject|1|||
17197437|NCT02772757|38351002|FG000|Overall Study|Withdrawal by Subject|1|||
17197438|NCT02772757|38351003|FG001|Overall Study|Withdrawal by Subject|0|||
17197439|NCT02772757|38351004|FG002|Overall Study|Withdrawal by Subject|1|||
17197440|NCT02772757|38351002|FG000|Overall Study|Protocol Violation|0|||
17197441|NCT02772757|38351003|FG001|Overall Study|Protocol Violation|0|||
17197442|NCT02772757|38351004|FG002|Overall Study|Protocol Violation|1|||
17197443|NCT02772757|38351002|FG000|Overall Study|Physician Decision|0|||
17197444|NCT02772757|38351003|FG001|Overall Study|Physician Decision|3|||
17197445|NCT02772757|38351004|FG002|Overall Study|Physician Decision|3|||
17197446|NCT00103207|38351013|FG000|Overall Study|Adverse Event|3|||
17197447|NCT00103207|38351013|FG000|Overall Study|Death|1|||
17197448|NCT00103207|38351013|FG000|Overall Study|Withdrawal by Subject|2|||
17197449|NCT00103207|38351013|FG000|Overall Study|Other complicating disease|1|||
17197450|NCT00103207|38351013|FG000|Overall Study|Ineligible|4|||
17197451|NCT00103207|38351013|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
17197452|NCT02771275|38351019|FG000|Overall Study|Reoperation|2|||
17197453|NCT02771275|38351019|FG000|Overall Study|On Study|11|||
17197454|NCT01369355|38351029|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
17197455|NCT01369355|38351030|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
17197456|NCT01369355|38351031|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
17197457|NCT01369355|38351032|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
17197458|NCT01369355|38351033|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
17197459|NCT01369355|38351034|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
17197460|NCT01369355|38351035|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
17197461|NCT01369355|38351036|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
17101211|NCT00092534|38240461|FG001|Base Study Vaccination Period|Physician Decision|0|||
17101212|NCT00092534|38240462|FG002|Base Study Vaccination Period|Physician Decision|0|||
17101213|NCT00092534|38240463|FG003|Base Study Vaccination Period|Physician Decision|0|||
17101214|NCT00092534|38240464|FG004|Base Study Vaccination Period|Physician Decision|0|||
17101215|NCT00092534|38240460|FG000|Base Study Vaccination Period|Pregnancy|9|||
17101216|NCT00092534|38240461|FG001|Base Study Vaccination Period|Pregnancy|7|||
17101217|NCT00092534|38240462|FG002|Base Study Vaccination Period|Pregnancy|0|||
17101218|NCT00092534|38240463|FG003|Base Study Vaccination Period|Pregnancy|0|||
17101219|NCT00092534|38240464|FG004|Base Study Vaccination Period|Pregnancy|0|||
17101220|NCT00092534|38240460|FG000|Base Study Vaccination Period|Protocol Violation|2|||
17197462|NCT01369355|38351037|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
17197463|NCT01369355|38351029|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
17197464|NCT01369355|38351030|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
17197465|NCT01369355|38351031|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
17197466|NCT01369355|38351032|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
17197467|NCT01369355|38351033|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
17197468|NCT01369355|38351034|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
17197469|NCT01369355|38351035|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
17197470|NCT01369355|38351036|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
17197471|NCT01369355|38351037|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
17197472|NCT01369355|38351029|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
17197473|NCT01369355|38351030|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
17197474|NCT01369355|38351031|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
17197475|NCT01369355|38351032|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
17197476|NCT01369355|38351033|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
17197477|NCT01369355|38351034|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
17197478|NCT01369355|38351035|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
17197479|NCT01369355|38351036|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
17197480|NCT01369355|38351037|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
17197481|NCT01369355|38351029|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
17197482|NCT01369355|38351030|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
17015733|NCT00692770|38160409|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
17015734|NCT00692770|38160408|FG000|Overall Study|Protocol driven decision point|3|||
17015735|NCT00692770|38160409|FG001|Overall Study|Protocol driven decision point|7|||
17015736|NCT00692770|38160408|FG000|Overall Study|Completed all planned assessments|79|||
17197483|NCT01369355|38351031|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
16786789|NCT01998958|37727254|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786790|NCT01998958|37727255|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786791|NCT01998958|37727256|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786792|NCT01998958|37727257|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786793|NCT01998958|37727258|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786794|NCT01998958|37727259|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786795|NCT01998958|37727260|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786796|NCT01998958|37727261|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786797|NCT01998958|37727262|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786798|NCT01998958|37727263|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786799|NCT01998958|37727264|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786800|NCT01998958|37727265|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786801|NCT01998958|37727266|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786802|NCT01998958|37727267|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
16786803|NCT01998958|37727268|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786804|NCT01998958|37727269|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786805|NCT01998958|37727270|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786806|NCT01998958|37727271|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
16786807|NCT01998958|37727272|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786808|NCT01998958|37727273|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786809|NCT01998958|37727274|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786810|NCT01998958|37727275|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786811|NCT01998958|37727276|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786812|NCT01998958|37727277|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786813|NCT01998958|37727278|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786814|NCT01998958|37727279|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786815|NCT01998958|37727280|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786816|NCT01998958|37727281|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786817|NCT01998958|37727282|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786818|NCT01998958|37727283|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786819|NCT01998958|37727284|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16786820|NCT01998958|37727253|FG000|Open Label Phase (Optional)|Adverse Event|0|||
16786821|NCT01998958|37727254|FG001|Open Label Phase (Optional)|Adverse Event|0|||
16786822|NCT01998958|37727255|FG002|Open Label Phase (Optional)|Adverse Event|0|||
16786823|NCT01998958|37727256|FG003|Open Label Phase (Optional)|Adverse Event|0|||
16786824|NCT01998958|37727257|FG004|Open Label Phase (Optional)|Adverse Event|0|||
16786825|NCT01998958|37727258|FG005|Open Label Phase (Optional)|Adverse Event|0|||
16786826|NCT01998958|37727259|FG006|Open Label Phase (Optional)|Adverse Event|0|||
16786827|NCT01998958|37727260|FG007|Open Label Phase (Optional)|Adverse Event|0|||
16786828|NCT01998958|37727261|FG008|Open Label Phase (Optional)|Adverse Event|0|||
16786829|NCT01998958|37727262|FG009|Open Label Phase (Optional)|Adverse Event|0|||
16786830|NCT01998958|37727263|FG010|Open Label Phase (Optional)|Adverse Event|0|||
16786831|NCT01998958|37727264|FG011|Open Label Phase (Optional)|Adverse Event|0|||
16786832|NCT01998958|37727265|FG012|Open Label Phase (Optional)|Adverse Event|0|||
16786833|NCT01998958|37727266|FG013|Open Label Phase (Optional)|Adverse Event|0|||
17197484|NCT01369355|38351032|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
17197485|NCT01369355|38351033|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
17197486|NCT01369355|38351034|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
17197487|NCT01369355|38351035|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
17197488|NCT01369355|38351036|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
17197489|NCT01369355|38351037|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
17197490|NCT01369355|38351029|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
17197491|NCT01369355|38351030|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
17197492|NCT01369355|38351031|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
17197493|NCT01369355|38351032|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
17197494|NCT01369355|38351033|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
17197495|NCT01369355|38351034|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
17101221|NCT00092534|38240461|FG001|Base Study Vaccination Period|Protocol Violation|1|||
17101222|NCT00092534|38240462|FG002|Base Study Vaccination Period|Protocol Violation|0|||
17101223|NCT00092534|38240463|FG003|Base Study Vaccination Period|Protocol Violation|0|||
17101224|NCT00092534|38240464|FG004|Base Study Vaccination Period|Protocol Violation|0|||
17101225|NCT00092534|38240460|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
17101226|NCT00092534|38240461|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
17101227|NCT00092534|38240462|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
17101228|NCT00092534|38240463|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
17197496|NCT01369355|38351035|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
17197497|NCT01369355|38351036|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
17197498|NCT01369355|38351037|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
17197499|NCT01369355|38351029|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
17197500|NCT01369355|38351030|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
17197501|NCT01369355|38351031|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
17197502|NCT01369355|38351032|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
17197503|NCT01369355|38351033|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
17197504|NCT01369355|38351034|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
17197505|NCT01369355|38351035|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
17197506|NCT01369355|38351036|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
17197507|NCT01369355|38351037|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
17197508|NCT01369355|38351029|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
17197509|NCT01369355|38351030|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
17197510|NCT01369355|38351031|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
17197511|NCT01369355|38351032|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
17197512|NCT01369355|38351033|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
17197513|NCT01369355|38351034|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
17197514|NCT01369355|38351035|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
17101229|NCT00092534|38240464|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
17101230|NCT00092534|38240460|FG000|Base Study Vaccination Period|Moved|14|||
17101231|NCT00092534|38240461|FG001|Base Study Vaccination Period|Moved|12|||
17101232|NCT00092534|38240462|FG002|Base Study Vaccination Period|Moved|0|||
17101233|NCT00092534|38240463|FG003|Base Study Vaccination Period|Moved|0|||
17101234|NCT00092534|38240464|FG004|Base Study Vaccination Period|Moved|0|||
17101235|NCT00092534|38240460|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
17101236|NCT00092534|38240461|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
17101237|NCT00092534|38240462|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
17101238|NCT00092534|38240463|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
17101239|NCT00092534|38240464|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
17101240|NCT00092534|38240460|FG000|Base Study Vaccination Period|Travel|1|||
17101241|NCT00092534|38240461|FG001|Base Study Vaccination Period|Travel|0|||
17101242|NCT00092534|38240462|FG002|Base Study Vaccination Period|Travel|0|||
17101243|NCT00092534|38240463|FG003|Base Study Vaccination Period|Travel|0|||
17101244|NCT00092534|38240464|FG004|Base Study Vaccination Period|Travel|0|||
17101245|NCT00092534|38240460|FG000|Base Study Vaccination Period|Site Closed|0|||
17101246|NCT00092534|38240461|FG001|Base Study Vaccination Period|Site Closed|1|||
17101247|NCT00092534|38240462|FG002|Base Study Vaccination Period|Site Closed|0|||
17101248|NCT00092534|38240463|FG003|Base Study Vaccination Period|Site Closed|0|||
17101249|NCT00092534|38240464|FG004|Base Study Vaccination Period|Site Closed|0|||
17101250|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Adverse Event|2|||
17101251|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Adverse Event|4|||
17101252|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Adverse Event|0|||
17101253|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Adverse Event|0|||
17101254|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Adverse Event|0|||
17101255|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Death|2|||
17101256|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Death|1|||
17101257|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Death|0|||
17101258|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Death|0|||
17101259|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Death|0|||
17101260|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
17101261|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
17101262|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
17101263|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
17101264|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
17101265|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Pregnancy|6|||
17101266|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Pregnancy|10|||
17101267|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Pregnancy|0|||
17101268|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Pregnancy|0|||
17101269|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Pregnancy|0|||
17101270|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
17101271|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
17197515|NCT01369355|38351036|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
17197516|NCT01369355|38351037|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
17101272|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
17101273|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
17101274|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
17101275|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
17101276|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
17101277|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
17101278|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
17101279|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
17101280|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Moved|62|||
17101281|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Moved|58|||
17101282|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Moved|0|||
17101283|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Moved|0|||
17101284|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Moved|0|||
17101285|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Travel|10|||
17101286|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Travel|7|||
17101287|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Travel|0|||
17101288|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Travel|0|||
17197517|NCT01369355|38351029|FG000|Long-term Extension (Week 44-272)|Death|0|||
17197518|NCT01369355|38351030|FG001|Long-term Extension (Week 44-272)|Death|0|||
17197519|NCT01369355|38351031|FG002|Long-term Extension (Week 44-272)|Death|0|||
17197520|NCT01369355|38351032|FG003|Long-term Extension (Week 44-272)|Death|0|||
17197521|NCT01369355|38351033|FG004|Long-term Extension (Week 44-272)|Death|0|||
17197522|NCT01369355|38351034|FG005|Long-term Extension (Week 44-272)|Death|0|||
17197523|NCT01369355|38351035|FG006|Long-term Extension (Week 44-272)|Death|0|||
17197524|NCT01369355|38351036|FG007|Long-term Extension (Week 44-272)|Death|1|||
17197525|NCT01369355|38351037|FG008|Long-term Extension (Week 44-272)|Death|3|||
17197526|NCT01369355|38351029|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
17197527|NCT01369355|38351030|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
17197528|NCT01369355|38351031|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
17197529|NCT01369355|38351032|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
17197530|NCT01369355|38351033|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
17197531|NCT01369355|38351034|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
17197532|NCT01369355|38351035|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
17197533|NCT01369355|38351036|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
17197534|NCT01369355|38351037|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
17197535|NCT01369355|38351029|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
17197536|NCT01369355|38351030|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
17197537|NCT01369355|38351031|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
17197538|NCT01369355|38351032|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
17197539|NCT01369355|38351033|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
17197540|NCT01369355|38351034|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
17197541|NCT01369355|38351035|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
17197542|NCT01369355|38351036|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
17197543|NCT01369355|38351037|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
17197544|NCT01369355|38351029|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
17197545|NCT01369355|38351030|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
17197546|NCT01369355|38351031|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
17197547|NCT01369355|38351032|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
17197548|NCT01369355|38351033|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
17197549|NCT01369355|38351034|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
17197550|NCT01369355|38351035|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
17197551|NCT01369355|38351036|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
17197552|NCT01369355|38351037|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
17197553|NCT01369355|38351029|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
17197554|NCT01369355|38351030|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
17197555|NCT01369355|38351031|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
17197556|NCT01369355|38351032|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
17197557|NCT01369355|38351033|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
16786834|NCT01998958|37727267|FG014|Open Label Phase (Optional)|Adverse Event|0|||
17101289|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Travel|0|||
17101290|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Site Closed|0|||
17101291|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Site Closed|2|||
17101292|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Site Closed|0|||
17101293|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Site Closed|0|||
17101294|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Site Closed|0|||
17101295|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
17101296|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
17101297|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
17101298|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
17101299|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
17101300|NCT00092534|38240460|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
17101301|NCT00092534|38240461|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
17101302|NCT00092534|38240462|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
17101303|NCT00092534|38240463|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
17101304|NCT00092534|38240464|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
17101305|NCT00092534|38240460|FG000|Base Study EXT|Lost to Follow-up|0|||
17101306|NCT00092534|38240461|FG001|Base Study EXT|Lost to Follow-up|0|||
17101307|NCT00092534|38240462|FG002|Base Study EXT|Lost to Follow-up|41|||
17101308|NCT00092534|38240463|FG003|Base Study EXT|Lost to Follow-up|0|||
17101309|NCT00092534|38240464|FG004|Base Study EXT|Lost to Follow-up|0|||
17101310|NCT00092534|38240460|FG000|Base Study EXT|Physician Decision|0|||
17101311|NCT00092534|38240461|FG001|Base Study EXT|Physician Decision|0|||
17101312|NCT00092534|38240462|FG002|Base Study EXT|Physician Decision|1|||
17101313|NCT00092534|38240463|FG003|Base Study EXT|Physician Decision|0|||
16786835|NCT01998958|37727268|FG015|Open Label Phase (Optional)|Adverse Event|0|||
17197558|NCT01369355|38351034|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
17197559|NCT01369355|38351035|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
17197560|NCT01369355|38351036|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
17197561|NCT01369355|38351037|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
17197562|NCT01369355|38351029|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
16786836|NCT01998958|37727269|FG016|Open Label Phase (Optional)|Adverse Event|0|||
16786837|NCT01998958|37727270|FG017|Open Label Phase (Optional)|Adverse Event|0|||
16786838|NCT01998958|37727271|FG018|Open Label Phase (Optional)|Adverse Event|0|||
16786839|NCT01998958|37727272|FG019|Open Label Phase (Optional)|Adverse Event|0|||
16786840|NCT01998958|37727273|FG020|Open Label Phase (Optional)|Adverse Event|0|||
16786841|NCT01998958|37727274|FG021|Open Label Phase (Optional)|Adverse Event|0|||
16786842|NCT01998958|37727275|FG022|Open Label Phase (Optional)|Adverse Event|0|||
16786843|NCT01998958|37727276|FG023|Open Label Phase (Optional)|Adverse Event|1|||
16786844|NCT01998958|37727277|FG024|Open Label Phase (Optional)|Adverse Event|0|||
16786845|NCT01998958|37727278|FG025|Open Label Phase (Optional)|Adverse Event|0|||
16786846|NCT01998958|37727279|FG026|Open Label Phase (Optional)|Adverse Event|0|||
16786847|NCT01998958|37727280|FG027|Open Label Phase (Optional)|Adverse Event|0|||
17101314|NCT00092534|38240464|FG004|Base Study EXT|Physician Decision|0|||
17197563|NCT01369355|38351030|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
17197564|NCT01369355|38351031|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
17197565|NCT01369355|38351032|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
17197566|NCT01369355|38351033|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
17197567|NCT01369355|38351034|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
17197568|NCT01369355|38351035|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
17197569|NCT01369355|38351036|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
17197570|NCT01369355|38351037|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
17197571|NCT01369355|38351029|FG000|Long-term Extension (Week 44-272)|Other|0|||
17197572|NCT01369355|38351030|FG001|Long-term Extension (Week 44-272)|Other|0|||
17197573|NCT01369355|38351031|FG002|Long-term Extension (Week 44-272)|Other|0|||
17197574|NCT01369355|38351032|FG003|Long-term Extension (Week 44-272)|Other|0|||
17197575|NCT01369355|38351033|FG004|Long-term Extension (Week 44-272)|Other|0|||
17197576|NCT01369355|38351034|FG005|Long-term Extension (Week 44-272)|Other|0|||
17197577|NCT01369355|38351035|FG006|Long-term Extension (Week 44-272)|Other|110|||
17197578|NCT01369355|38351036|FG007|Long-term Extension (Week 44-272)|Other|9|||
17197579|NCT01369355|38351037|FG008|Long-term Extension (Week 44-272)|Other|17|||
17197580|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Adverse Event|8|||
17197581|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Adverse Event|5|||
17197582|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Adverse Event|9|||
17197583|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Adverse Event|0|||
17197584|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Adverse Event|0|||
17197585|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Adverse Event|0|||
17197586|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
17197587|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
17197588|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
17197589|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
17197590|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
17197591|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
17197592|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
17197593|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
17197594|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
17197595|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
17197596|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
17101315|NCT00092534|38240460|FG000|Base Study EXT|Pregnancy|0|||
17101316|NCT00092534|38240461|FG001|Base Study EXT|Pregnancy|0|||
17101317|NCT00092534|38240462|FG002|Base Study EXT|Pregnancy|12|||
17101318|NCT00092534|38240463|FG003|Base Study EXT|Pregnancy|0|||
17101319|NCT00092534|38240464|FG004|Base Study EXT|Pregnancy|0|||
17101320|NCT00092534|38240460|FG000|Base Study EXT|Withdrawal by Subject|0|||
17197597|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
17197598|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Physician Decision|4|||
17197599|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Physician Decision|0|||
17197600|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Physician Decision|2|||
17197601|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Physician Decision|0|||
17197602|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Physician Decision|0|||
17197603|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Physician Decision|0|||
17197604|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Pregnancy|1|||
17197605|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Pregnancy|2|||
17197606|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Pregnancy|0|||
17197607|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Pregnancy|0|||
17197608|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Pregnancy|0|||
16786848|NCT01998958|37727281|FG028|Open Label Phase (Optional)|Adverse Event|0|||
17101321|NCT00092534|38240461|FG001|Base Study EXT|Withdrawal by Subject|0|||
17197609|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Pregnancy|0|||
17197610|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
17197611|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
17197612|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
17197613|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
17197614|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
17197615|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
17197616|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
17197617|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
17197618|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
17197619|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
17197620|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
17197621|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
17197622|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
17197623|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
17197624|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
17197625|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
17197626|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
17197627|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
17197628|NCT02614196|38351060|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
17197629|NCT02614196|38351061|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
17197630|NCT02614196|38351062|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
17197631|NCT02614196|38351063|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
17197632|NCT02614196|38351064|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
17197633|NCT02614196|38351065|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
17197634|NCT02614196|38351060|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
17197635|NCT02614196|38351061|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
17197636|NCT02614196|38351062|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
17197637|NCT02614196|38351063|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
17197638|NCT02614196|38351064|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
17197639|NCT02614196|38351065|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
17197640|NCT02614196|38351060|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
17197641|NCT02614196|38351061|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
17197642|NCT02614196|38351062|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
17197643|NCT02614196|38351063|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
17197644|NCT02614196|38351064|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
17197645|NCT02614196|38351065|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
17197646|NCT02614196|38351060|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
17197647|NCT02614196|38351061|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
17197648|NCT02614196|38351062|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
16786849|NCT01998958|37727282|FG029|Open Label Phase (Optional)|Adverse Event|0|||
16786850|NCT01998958|37727283|FG030|Open Label Phase (Optional)|Adverse Event|0|||
16786851|NCT01998958|37727284|FG031|Open Label Phase (Optional)|Adverse Event|0|||
16786852|NCT01998958|37727253|FG000|Open Label Phase (Optional)|Other|0|||
16786853|NCT01998958|37727254|FG001|Open Label Phase (Optional)|Other|0|||
16786854|NCT01998958|37727255|FG002|Open Label Phase (Optional)|Other|0|||
16786855|NCT01998958|37727256|FG003|Open Label Phase (Optional)|Other|0|||
16786856|NCT01998958|37727257|FG004|Open Label Phase (Optional)|Other|0|||
16786857|NCT01998958|37727258|FG005|Open Label Phase (Optional)|Other|0|||
16786858|NCT01998958|37727259|FG006|Open Label Phase (Optional)|Other|0|||
16786859|NCT01998958|37727260|FG007|Open Label Phase (Optional)|Other|0|||
16786860|NCT01998958|37727261|FG008|Open Label Phase (Optional)|Other|0|||
16786861|NCT01998958|37727262|FG009|Open Label Phase (Optional)|Other|0|||
16786862|NCT01998958|37727263|FG010|Open Label Phase (Optional)|Other|0|||
16786863|NCT01998958|37727264|FG011|Open Label Phase (Optional)|Other|0|||
16786864|NCT01998958|37727265|FG012|Open Label Phase (Optional)|Other|0|||
16786865|NCT01998958|37727266|FG013|Open Label Phase (Optional)|Other|0|||
16786866|NCT01998958|37727267|FG014|Open Label Phase (Optional)|Other|0|||
16786867|NCT01998958|37727268|FG015|Open Label Phase (Optional)|Other|0|||
16786868|NCT01998958|37727269|FG016|Open Label Phase (Optional)|Other|0|||
16786869|NCT01998958|37727270|FG017|Open Label Phase (Optional)|Other|0|||
16786870|NCT01998958|37727271|FG018|Open Label Phase (Optional)|Other|0|||
16786871|NCT01998958|37727272|FG019|Open Label Phase (Optional)|Other|0|||
16786872|NCT01998958|37727273|FG020|Open Label Phase (Optional)|Other|0|||
16786873|NCT01998958|37727274|FG021|Open Label Phase (Optional)|Other|0|||
16786874|NCT01998958|37727275|FG022|Open Label Phase (Optional)|Other|5|||
16786875|NCT01998958|37727276|FG023|Open Label Phase (Optional)|Other|1|||
16786876|NCT01998958|37727277|FG024|Open Label Phase (Optional)|Other|0|||
17197649|NCT02614196|38351063|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
16786877|NCT01998958|37727278|FG025|Open Label Phase (Optional)|Other|0|||
16786878|NCT01998958|37727279|FG026|Open Label Phase (Optional)|Other|0|||
16786879|NCT01998958|37727280|FG027|Open Label Phase (Optional)|Other|0|||
16786880|NCT01998958|37727281|FG028|Open Label Phase (Optional)|Other|0|||
17197650|NCT02614196|38351064|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
17101322|NCT00092534|38240462|FG002|Base Study EXT|Withdrawal by Subject|18|||
17197651|NCT02614196|38351065|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
17197652|NCT02614196|38351060|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
17197653|NCT02614196|38351061|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
17197654|NCT02614196|38351062|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
16786881|NCT01998958|37727282|FG029|Open Label Phase (Optional)|Other|0|||
16786882|NCT01998958|37727283|FG030|Open Label Phase (Optional)|Other|0|||
16786883|NCT01998958|37727284|FG031|Open Label Phase (Optional)|Other|0|||
16786884|NCT01998958|37727253|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786885|NCT01998958|37727254|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786886|NCT01998958|37727255|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786887|NCT01998958|37727256|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786888|NCT01998958|37727257|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786889|NCT01998958|37727258|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786890|NCT01998958|37727259|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786891|NCT01998958|37727260|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786892|NCT01998958|37727261|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786893|NCT01998958|37727262|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786894|NCT01998958|37727263|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786895|NCT01998958|37727264|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786896|NCT01998958|37727265|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786897|NCT01998958|37727266|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786898|NCT01998958|37727267|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786899|NCT01998958|37727268|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786900|NCT01998958|37727269|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786901|NCT01998958|37727270|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786902|NCT01998958|37727271|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786903|NCT01998958|37727272|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786904|NCT01998958|37727273|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786905|NCT01998958|37727274|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786906|NCT01998958|37727275|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
16786907|NCT01998958|37727276|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786908|NCT01998958|37727277|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786909|NCT01998958|37727278|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786910|NCT01998958|37727279|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786911|NCT01998958|37727280|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786912|NCT01998958|37727281|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786913|NCT01998958|37727282|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786914|NCT01998958|37727283|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786915|NCT01998958|37727284|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
16786916|NCT01998958|37727253|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786917|NCT01998958|37727254|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786918|NCT01998958|37727255|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786919|NCT01998958|37727256|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786920|NCT01998958|37727257|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786921|NCT01998958|37727258|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786922|NCT01998958|37727259|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786923|NCT01998958|37727260|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786924|NCT01998958|37727261|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786925|NCT01998958|37727262|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786926|NCT01998958|37727263|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786927|NCT01998958|37727264|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786928|NCT01998958|37727265|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786929|NCT01998958|37727266|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786930|NCT01998958|37727267|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786931|NCT01998958|37727268|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786932|NCT01998958|37727269|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786933|NCT01998958|37727270|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786934|NCT01998958|37727271|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786935|NCT01998958|37727272|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
17015737|NCT00692770|38160409|FG001|Overall Study|Completed all planned assessments|101|||
17015738|NCT00692770|38160408|FG000|Overall Study|Radiological and clinical progression|8|||
17015739|NCT00692770|38160409|FG001|Overall Study|Radiological and clinical progression|8|||
17015740|NCT00692770|38160408|FG000|Overall Study|Clinical endpoint reached|16|||
17015741|NCT00692770|38160409|FG001|Overall Study|Clinical endpoint reached|43|||
17015742|NCT00692770|38160408|FG000|Overall Study|Study terminated by sponsor|2|||
17015743|NCT00692770|38160409|FG001|Overall Study|Study terminated by sponsor|2|||
17197655|NCT02614196|38351063|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
17015744|NCT00692770|38160408|FG000|Overall Study|Randomized but not treated|3|||
17197656|NCT02614196|38351064|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
17197657|NCT02614196|38351065|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
17197658|NCT02765035|38351095|FG000|First Intervention (90 Days)|Adverse Event|1|||
17197659|NCT02765035|38351096|FG001|First Intervention (90 Days)|Adverse Event|1|||
17197660|NCT02765035|38351095|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
17197661|NCT02765035|38351096|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
16786936|NCT01998958|37727273|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
17197662|NCT02307682|38351106|FG000|Overall Study|Adverse Event|9|||
17197663|NCT02307682|38351107|FG001|Overall Study|Adverse Event|8|||
17197664|NCT02307682|38351108|FG002|Overall Study|Adverse Event|12|||
17101323|NCT00092534|38240463|FG003|Base Study EXT|Withdrawal by Subject|0|||
17101324|NCT00092534|38240464|FG004|Base Study EXT|Withdrawal by Subject|0|||
17101325|NCT00092534|38240460|FG000|Base Study EXT|Participant moved|0|||
17101326|NCT00092534|38240461|FG001|Base Study EXT|Participant moved|0|||
17101327|NCT00092534|38240462|FG002|Base Study EXT|Participant moved|6|||
17101328|NCT00092534|38240463|FG003|Base Study EXT|Participant moved|0|||
17101329|NCT00092534|38240464|FG004|Base Study EXT|Participant moved|0|||
17101330|NCT00092534|38240460|FG000|Base Study EXT|Travel|0|||
17101331|NCT00092534|38240461|FG001|Base Study EXT|Travel|0|||
17101332|NCT00092534|38240462|FG002|Base Study EXT|Travel|2|||
17101333|NCT00092534|38240463|FG003|Base Study EXT|Travel|0|||
17101334|NCT00092534|38240464|FG004|Base Study EXT|Travel|0|||
17101335|NCT00092534|38240460|FG000|Base Study EXT|Site closed|0|||
17101336|NCT00092534|38240461|FG001|Base Study EXT|Site closed|0|||
17197665|NCT02307682|38351106|FG000|Overall Study|Lack of Efficacy|1|||
17197666|NCT02307682|38351107|FG001|Overall Study|Lack of Efficacy|0|||
17197667|NCT02307682|38351108|FG002|Overall Study|Lack of Efficacy|1|||
17197668|NCT02307682|38351106|FG000|Overall Study|Physician Decision|2|||
17197669|NCT02307682|38351107|FG001|Overall Study|Physician Decision|2|||
17197670|NCT02307682|38351108|FG002|Overall Study|Physician Decision|8|||
17197671|NCT02307682|38351106|FG000|Overall Study|Progressive Disease|1|||
17197672|NCT02307682|38351107|FG001|Overall Study|Progressive Disease|0|||
17197673|NCT02307682|38351108|FG002|Overall Study|Progressive Disease|0|||
17197674|NCT02307682|38351106|FG000|Overall Study|Withdrawal by Subject|26|||
17197675|NCT02307682|38351107|FG001|Overall Study|Withdrawal by Subject|34|||
17197676|NCT02307682|38351108|FG002|Overall Study|Withdrawal by Subject|23|||
17197677|NCT02307682|38351106|FG000|Overall Study|Death|9|||
17197678|NCT02307682|38351107|FG001|Overall Study|Death|7|||
17197679|NCT02307682|38351108|FG002|Overall Study|Death|12|||
17197680|NCT02307682|38351106|FG000|Overall Study|Lost to Follow-up|1|||
17197681|NCT02307682|38351107|FG001|Overall Study|Lost to Follow-up|5|||
17197682|NCT02307682|38351108|FG002|Overall Study|Lost to Follow-up|6|||
17197683|NCT02307682|38351106|FG000|Overall Study|Protocol Deviation|0|||
17197684|NCT02307682|38351107|FG001|Overall Study|Protocol Deviation|0|||
17197685|NCT02307682|38351108|FG002|Overall Study|Protocol Deviation|2|||
17197686|NCT02307682|38351106|FG000|Overall Study|Other|1|||
17197687|NCT02307682|38351107|FG001|Overall Study|Other|1|||
17197688|NCT02307682|38351108|FG002|Overall Study|Other|0|||
17197689|NCT02615990|38351118|FG000|Overall Study|study terminated|1|||
17197690|NCT02615990|38351119|FG001|Overall Study|study terminated|1|||
17197691|NCT02613884|38351125|FG000|Overall Study|Death|1|||
17197692|NCT02613884|38351125|FG000|Overall Study|Lost to Follow-up|1|||
17197693|NCT02791763|38351133|FG000|Overall Study|Protocol Violation|0|||
17197694|NCT02791763|38351134|FG001|Overall Study|Protocol Violation|0|||
17197695|NCT02791763|38351135|FG002|Overall Study|Protocol Violation|1|||
17197696|NCT02791763|38351133|FG000|Overall Study|Withdrawal by Subject|5|||
17197697|NCT02791763|38351134|FG001|Overall Study|Withdrawal by Subject|1|||
17197698|NCT02791763|38351135|FG002|Overall Study|Withdrawal by Subject|0|||
17197699|NCT02791763|38351133|FG000|Overall Study|Physician Decision|0|||
17197700|NCT02791763|38351134|FG001|Overall Study|Physician Decision|1|||
17197701|NCT02791763|38351135|FG002|Overall Study|Physician Decision|0|||
17197702|NCT02791763|38351133|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
17197703|NCT02791763|38351134|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
17197704|NCT02791763|38351135|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
17197705|NCT02791763|38351133|FG000|Overall Study|Cancer event|1|||
17197706|NCT02791763|38351134|FG001|Overall Study|Cancer event|3|||
17197707|NCT02791763|38351135|FG002|Overall Study|Cancer event|0|||
17197708|NCT02791763|38351133|FG000|Overall Study|Participant had renal transplant|3|||
17197709|NCT02791763|38351134|FG001|Overall Study|Participant had renal transplant|0|||
17197710|NCT02791763|38351135|FG002|Overall Study|Participant had renal transplant|0|||
17197711|NCT02791763|38351133|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
16786937|NCT01998958|37727274|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
17197712|NCT02791763|38351134|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
17197713|NCT02791763|38351135|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
17197714|NCT02791763|38351133|FG000|Overall Study|Adverse Event|12|||
17197715|NCT02791763|38351134|FG001|Overall Study|Adverse Event|13|||
17101337|NCT00092534|38240462|FG002|Base Study EXT|Site closed|21|||
17101338|NCT00092534|38240463|FG003|Base Study EXT|Site closed|0|||
17197716|NCT02791763|38351135|FG002|Overall Study|Adverse Event|7|||
17197717|NCT02613572|38351155|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
17197718|NCT02613572|38351156|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
17197719|NCT02613572|38351157|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
17197720|NCT02613572|38351155|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
17197721|NCT02613572|38351156|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
17197722|NCT02613572|38351157|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
17197723|NCT02087189|38351169|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
17197724|NCT02341456|38351176|FG000|Overall Study|Disease progression|2|||
17197725|NCT02341456|38351177|FG001|Overall Study|Disease progression|3|||
17197726|NCT02341456|38351178|FG002|Overall Study|Disease progression|1|||
17197727|NCT02341456|38351176|FG000|Overall Study|Death|1|||
17197728|NCT02341456|38351177|FG001|Overall Study|Death|1|||
17197729|NCT02341456|38351178|FG002|Overall Study|Death|1|||
17197730|NCT02341456|38351176|FG000|Overall Study|Withdrawal by Subject|0|||
17197731|NCT02341456|38351177|FG001|Overall Study|Withdrawal by Subject|1|||
17197732|NCT02341456|38351178|FG002|Overall Study|Withdrawal by Subject|1|||
17197733|NCT02341456|38351176|FG000|Overall Study|Moved to local access programme.|0|||
17197734|NCT02341456|38351177|FG001|Overall Study|Moved to local access programme.|1|||
17197735|NCT02341456|38351178|FG002|Overall Study|Moved to local access programme.|1|||
17197736|NCT02341456|38351176|FG000|Overall Study|Physician Decision|1|||
17197737|NCT02341456|38351177|FG001|Overall Study|Physician Decision|0|||
17197738|NCT02341456|38351178|FG002|Overall Study|Physician Decision|0|||
17197739|NCT02370784|38351188|FG000|Overall Study|Patient started prohibited medication|0|||
17197740|NCT02370784|38351189|FG001|Overall Study|Patient started prohibited medication|1|||
17197741|NCT02307370|38351197|FG000|Overall Study|Death|5|||
17197742|NCT02307370|38351197|FG000|Overall Study|Lost to Follow-up|1|||
17197743|NCT02307370|38351197|FG000|Overall Study|Withdrawal by Subject|1|||
16786938|NCT01998958|37727275|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
16786939|NCT01998958|37727276|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786940|NCT01998958|37727277|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786941|NCT01998958|37727278|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786942|NCT01998958|37727279|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786943|NCT01998958|37727280|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786944|NCT01998958|37727281|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786945|NCT01998958|37727282|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786946|NCT01998958|37727283|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786947|NCT01998958|37727284|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
16786948|NCT01998958|37727253|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786949|NCT01998958|37727254|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786950|NCT01998958|37727255|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786951|NCT01998958|37727256|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786952|NCT01998958|37727257|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786953|NCT01998958|37727258|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786954|NCT01998958|37727259|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786955|NCT01998958|37727260|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786956|NCT01998958|37727261|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786957|NCT01998958|37727262|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786958|NCT01998958|37727263|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
17197744|NCT02307370|38351197|FG000|Overall Study|Declined Addendum ICF|6|||
17197745|NCT02307370|38351197|FG000|Overall Study|No response during telephone contact|5|||
17197746|NCT02307370|38351197|FG000|Overall Study|Protocol Violation|1|||
17197747|NCT02370394|38351205|FG000|Overall Study|Lost to Follow-up|2|||
17197748|NCT02370394|38351206|FG001|Overall Study|Lost to Follow-up|1|||
17197749|NCT02370394|38351205|FG000|Overall Study|Withdrawal by Subject|0|||
17197750|NCT02370394|38351206|FG001|Overall Study|Withdrawal by Subject|1|||
17197751|NCT01595438|38351215|FG000|Overall Study|Lost to Follow-up|20|||
16786959|NCT01998958|37727264|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786960|NCT01998958|37727265|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786961|NCT01998958|37727266|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786962|NCT01998958|37727267|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786963|NCT01998958|37727268|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786964|NCT01998958|37727269|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786965|NCT01998958|37727270|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786966|NCT01998958|37727271|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786967|NCT01998958|37727272|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786968|NCT01998958|37727273|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786969|NCT01998958|37727274|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
16786970|NCT01998958|37727275|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
16786971|NCT01998958|37727276|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
16786972|NCT01998958|37727277|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786973|NCT01998958|37727278|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786974|NCT01998958|37727279|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786975|NCT01998958|37727280|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786976|NCT01998958|37727281|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786977|NCT01998958|37727282|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786978|NCT01998958|37727283|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786979|NCT01998958|37727284|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16786980|NCT01958164|37727336|FG000|Overall Study|Adverse Event|0|||
16786981|NCT01958164|37727337|FG001|Overall Study|Adverse Event|2|||
16786982|NCT01958164|37727336|FG000|Overall Study|Lost to Follow-up|2|||
16786983|NCT01958164|37727337|FG001|Overall Study|Lost to Follow-up|3|||
16786984|NCT01976104|37727347|FG000|Overall Study|Adverse Event|0|||
16786985|NCT01976104|37727348|FG001|Overall Study|Adverse Event|0|||
16786986|NCT01976104|37727349|FG002|Overall Study|Adverse Event|1|||
16786987|NCT01976104|37727350|FG003|Overall Study|Adverse Event|0|||
16786988|NCT01976104|37727347|FG000|Overall Study|Lost to Follow-up|3|||
16786989|NCT01976104|37727348|FG001|Overall Study|Lost to Follow-up|0|||
16786990|NCT01976104|37727349|FG002|Overall Study|Lost to Follow-up|1|||
16786991|NCT01976104|37727350|FG003|Overall Study|Lost to Follow-up|1|||
16786992|NCT01976104|37727347|FG000|Overall Study|Subject Choice|0|||
16786993|NCT01976104|37727348|FG001|Overall Study|Subject Choice|1|||
16786994|NCT01976104|37727349|FG002|Overall Study|Subject Choice|0|||
16786995|NCT01976104|37727350|FG003|Overall Study|Subject Choice|1|||
16786996|NCT01976104|37727347|FG000|Overall Study|Withdrawal by Subject|3|||
16786997|NCT01976104|37727348|FG001|Overall Study|Withdrawal by Subject|0|||
17015745|NCT00692770|38160409|FG001|Overall Study|Randomized but not treated|4|||
17015746|NCT00849108|38160424|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
17015747|NCT00849108|38160425|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
17015748|NCT00849108|38160424|FG000|Cohort 2 Efficacy|Adverse Event|0|||
17197752|NCT01595438|38351216|FG001|Overall Study|Lost to Follow-up|20|||
17197753|NCT01595438|38351215|FG000|Overall Study|Withdrawal by Subject|12|||
17197754|NCT01595438|38351216|FG001|Overall Study|Withdrawal by Subject|12|||
17197755|NCT01595438|38351215|FG000|Overall Study|Other Eligibility criteria|11|||
17197756|NCT01595438|38351216|FG001|Overall Study|Other Eligibility criteria|9|||
17197757|NCT02340520|38351222|FG000|Overall Study|Lost to Follow-up|1|||
17197758|NCT02340520|38351222|FG000|Overall Study|Patient did not take drug as specified|1|||
17197759|NCT02340520|38351222|FG000|Overall Study|Withdrawal by Subject|1|||
17197760|NCT02339584|38351228|FG000|Overall Study|Adverse Event|11|||
17197761|NCT02339584|38351229|FG001|Overall Study|Adverse Event|7|||
17197762|NCT02339584|38351228|FG000|Overall Study|Lack of Efficacy|0|||
17197763|NCT02339584|38351229|FG001|Overall Study|Lack of Efficacy|1|||
17197764|NCT02339584|38351228|FG000|Overall Study|Physician Decision|1|||
17197765|NCT02339584|38351229|FG001|Overall Study|Physician Decision|2|||
17197766|NCT02339584|38351228|FG000|Overall Study|Protocol Violation|1|||
17197767|NCT02339584|38351229|FG001|Overall Study|Protocol Violation|1|||
17197768|NCT02339584|38351228|FG000|Overall Study|Withdrawal by Subject|2|||
17197769|NCT02339584|38351229|FG001|Overall Study|Withdrawal by Subject|4|||
17197770|NCT02339506|38351235|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
17197771|NCT02339506|38351236|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
17197772|NCT02339506|38351235|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
17197773|NCT02339506|38351236|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
17197774|NCT02305888|38351245|FG000|Overall Study|Lost to Follow-up|0|||
17197775|NCT02305888|38351246|FG001|Overall Study|Lost to Follow-up|0|||
17197776|NCT02305888|38351247|FG002|Overall Study|Lost to Follow-up|1|||
17197777|NCT02305888|38351245|FG000|Overall Study|Adverse Event|0|||
17197778|NCT02305888|38351246|FG001|Overall Study|Adverse Event|1|||
17197779|NCT02305888|38351247|FG002|Overall Study|Adverse Event|0|||
17197780|NCT02338882|38351257|FG000|Overall Study|Death|1|||
17197781|NCT02338882|38351258|FG001|Overall Study|Death|0|||
17197782|NCT02338882|38351257|FG000|Overall Study|Lost to Follow-up|6|||
17197783|NCT02338882|38351258|FG001|Overall Study|Lost to Follow-up|3|||
17197784|NCT01594970|38351270|FG000|Overall Study|Non-Adverse Event Related|4|||
17197785|NCT01594970|38351271|FG001|Overall Study|Non-Adverse Event Related|5|||
17197786|NCT01594970|38351272|FG002|Overall Study|Non-Adverse Event Related|6|||
17197787|NCT01594970|38351270|FG000|Overall Study|Adverse Event|17|||
17197788|NCT01594970|38351271|FG001|Overall Study|Adverse Event|23|||
17197789|NCT01594970|38351272|FG002|Overall Study|Adverse Event|23|||
17197790|NCT01594970|38351270|FG000|Overall Study|Lost to Follow-up|54|||
17197791|NCT01594970|38351271|FG001|Overall Study|Lost to Follow-up|54|||
17197792|NCT01594970|38351272|FG002|Overall Study|Lost to Follow-up|37|||
17197793|NCT02338492|38351280|FG000|Overall Study|Death|32|||
17197794|NCT02338492|38351280|FG000|Overall Study|Adverse Event|3|||
17197795|NCT02338492|38351280|FG000|Overall Study|Lost to Follow-up|4|||
17197796|NCT02338492|38351280|FG000|Overall Study|Reason not captured above|6|||
17197797|NCT02337946|38351284|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
17197798|NCT02337946|38351285|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
17197799|NCT02337946|38351286|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
17197800|NCT02337946|38351284|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
17197801|NCT02337946|38351285|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
17197802|NCT02337946|38351286|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
17101339|NCT00092534|38240464|FG004|Base Study EXT|Site closed|0|||
17101340|NCT00092534|38240460|FG000|Base Study EXT|Study ended|0|||
17101341|NCT00092534|38240461|FG001|Base Study EXT|Study ended|0|||
17101342|NCT00092534|38240462|FG002|Base Study EXT|Study ended|29|||
17101343|NCT00092534|38240463|FG003|Base Study EXT|Study ended|0|||
17101344|NCT00092534|38240464|FG004|Base Study EXT|Study ended|0|||
17101345|NCT00092534|38240460|FG000|Base Study EXT|Protocol Violation|0|||
17101346|NCT00092534|38240461|FG001|Base Study EXT|Protocol Violation|0|||
17101347|NCT00092534|38240462|FG002|Base Study EXT|Protocol Violation|15|||
17101348|NCT00092534|38240463|FG003|Base Study EXT|Protocol Violation|0|||
17101349|NCT00092534|38240464|FG004|Base Study EXT|Protocol Violation|0|||
17101350|NCT00092534|38240460|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
17101351|NCT00092534|38240461|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
17101352|NCT00092534|38240462|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
17101353|NCT00092534|38240463|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
17101354|NCT00092534|38240464|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
17101355|NCT00068250|38240477|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
17101356|NCT00068250|38240478|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
17101357|NCT00068250|38240479|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
17101358|NCT00068250|38240480|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
17101359|NCT00393887|38240490|FG000|Overall Study|Physician Decision|5|||
17101360|NCT00393887|38240491|FG001|Overall Study|Physician Decision|0|||
17101361|NCT00393887|38240490|FG000|Overall Study|Lost to Follow-up|11|||
17101362|NCT00393887|38240491|FG001|Overall Study|Lost to Follow-up|9|||
17101363|NCT00393029|38240499|FG000|Overall Study|Not treated|0|||
17101364|NCT00393029|38240500|FG001|Overall Study|Not treated|1|||
17101365|NCT00402233|38240511|FG000|Overall Study|Adverse Event|1|||
17101366|NCT00402233|38240512|FG001|Overall Study|Adverse Event|7|||
17101367|NCT00402233|38240513|FG002|Overall Study|Adverse Event|9|||
17101368|NCT00402233|38240514|FG003|Overall Study|Adverse Event|9|||
17101369|NCT00402233|38240511|FG000|Overall Study|Protocol Violation|0|||
17101370|NCT00402233|38240512|FG001|Overall Study|Protocol Violation|1|||
17101371|NCT00402233|38240513|FG002|Overall Study|Protocol Violation|0|||
17101372|NCT00402233|38240514|FG003|Overall Study|Protocol Violation|0|||
17101373|NCT00402233|38240511|FG000|Overall Study|Withdrawal by Subject|2|||
17101374|NCT00402233|38240512|FG001|Overall Study|Withdrawal by Subject|1|||
17101375|NCT00402233|38240513|FG002|Overall Study|Withdrawal by Subject|2|||
17101376|NCT00402233|38240514|FG003|Overall Study|Withdrawal by Subject|2|||
17101377|NCT00402233|38240511|FG000|Overall Study|Worsening of disease under study|2|||
17197803|NCT02337946|38351284|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
17197804|NCT02337946|38351285|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
17101378|NCT00402233|38240512|FG001|Overall Study|Worsening of disease under study|0|||
17197805|NCT02337946|38351286|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
17197806|NCT02337946|38351284|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
17197807|NCT02337946|38351285|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
17101379|NCT00402233|38240513|FG002|Overall Study|Worsening of disease under study|0|||
17101380|NCT00402233|38240514|FG003|Overall Study|Worsening of disease under study|0|||
17101381|NCT00402233|38240511|FG000|Overall Study|Worsening of other pre-existing disease|0|||
17101382|NCT00402233|38240512|FG001|Overall Study|Worsening of other pre-existing disease|1|||
17101383|NCT00402233|38240513|FG002|Overall Study|Worsening of other pre-existing disease|0|||
17101384|NCT00402233|38240514|FG003|Overall Study|Worsening of other pre-existing disease|0|||
17101385|NCT00092456|38240528|FG000|Overall Study|Adverse Event|0|||
17101386|NCT00092456|38240529|FG001|Overall Study|Adverse Event|0|||
17101387|NCT00092456|38240530|FG002|Overall Study|Adverse Event|1|||
17101388|NCT00092456|38240531|FG003|Overall Study|Adverse Event|1|||
17101389|NCT00092456|38240528|FG000|Overall Study|Lost to Follow-up|2|||
17101390|NCT00092456|38240529|FG001|Overall Study|Lost to Follow-up|2|||
17101391|NCT00092456|38240530|FG002|Overall Study|Lost to Follow-up|1|||
17101392|NCT00092456|38240531|FG003|Overall Study|Lost to Follow-up|2|||
17101393|NCT00092456|38240528|FG000|Overall Study|Protocol Violation|5|||
17101394|NCT00092456|38240529|FG001|Overall Study|Protocol Violation|7|||
17101395|NCT00092456|38240530|FG002|Overall Study|Protocol Violation|8|||
17101396|NCT00092456|38240531|FG003|Overall Study|Protocol Violation|6|||
17101397|NCT00092456|38240528|FG000|Overall Study|Withdrawal by Subject|13|||
17101398|NCT00092456|38240529|FG001|Overall Study|Withdrawal by Subject|5|||
17101399|NCT00092456|38240530|FG002|Overall Study|Withdrawal by Subject|16|||
17101400|NCT00092456|38240531|FG003|Overall Study|Withdrawal by Subject|6|||
17101401|NCT00092456|38240528|FG000|Overall Study|Moved|1|||
17101402|NCT00092456|38240529|FG001|Overall Study|Moved|1|||
17101403|NCT00092456|38240530|FG002|Overall Study|Moved|0|||
17015749|NCT00849108|38160425|FG001|Cohort 2 Efficacy|Adverse Event|1|||
17015750|NCT00849108|38160424|FG000|Cohort 2 Efficacy|Other|0|||
17015751|NCT00849108|38160425|FG001|Cohort 2 Efficacy|Other|9|||
17015752|NCT00867308|38160435|FG000|Overall Study|Death|1|||
17015753|NCT00867308|38160436|FG001|Overall Study|Death|0|||
17015754|NCT00867308|38160435|FG000|Overall Study|Adverse Event|1|||
17015755|NCT00867308|38160436|FG001|Overall Study|Adverse Event|4|||
17015756|NCT00867308|38160435|FG000|Overall Study|Lack of Efficacy|6|||
17015757|NCT00867308|38160436|FG001|Overall Study|Lack of Efficacy|12|||
17015758|NCT00867308|38160435|FG000|Overall Study|Withdrawal by Subject|1|||
17015759|NCT00867308|38160436|FG001|Overall Study|Withdrawal by Subject|2|||
17015760|NCT00866918|38160444|FG000|Overall Study|Death|1|||
17015761|NCT00866918|38160445|FG001|Overall Study|Death|5|||
17015762|NCT00866918|38160444|FG000|Overall Study|Lack of Efficacy|1|||
17015763|NCT00866918|38160445|FG001|Overall Study|Lack of Efficacy|1|||
17015764|NCT00866918|38160444|FG000|Overall Study|Physician Decision|10|||
17015765|NCT00866918|38160445|FG001|Overall Study|Physician Decision|2|||
17015766|NCT00866918|38160444|FG000|Overall Study|Ineligible|2|||
17015767|NCT00866918|38160445|FG001|Overall Study|Ineligible|4|||
17015768|NCT00866918|38160444|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
17015769|NCT00866918|38160445|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
17015770|NCT00866918|38160444|FG000|Overall Study|Secondary malignancy|1|||
17015771|NCT00866918|38160445|FG001|Overall Study|Secondary malignancy|0|||
17015772|NCT03158285|38160454|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
17015773|NCT03158285|38160455|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
17015774|NCT03158285|38160456|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
17015775|NCT03158285|38160454|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
17015776|NCT03158285|38160455|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
17015777|NCT03158285|38160456|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
17015778|NCT03158285|38160454|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
17015779|NCT03158285|38160455|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
17015780|NCT03158285|38160456|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
17015781|NCT03158285|38160454|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
17015782|NCT03158285|38160455|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
17015783|NCT03158285|38160456|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
17015784|NCT03158285|38160454|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
17015785|NCT03158285|38160455|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
17015786|NCT03158285|38160456|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
17015787|NCT03158285|38160454|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
17015788|NCT03158285|38160455|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
17015789|NCT03158285|38160456|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
17015790|NCT03158285|38160454|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
17015791|NCT03158285|38160455|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
17015792|NCT03158285|38160456|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
17101404|NCT00092456|38240531|FG003|Overall Study|Moved|1|||
17101405|NCT00092456|38240528|FG000|Overall Study|Other|4|||
17101406|NCT00092456|38240529|FG001|Overall Study|Other|2|||
17101407|NCT00092456|38240530|FG002|Overall Study|Other|3|||
17101408|NCT00092456|38240531|FG003|Overall Study|Other|0|||
17101409|NCT00067470|38240543|FG000|Overall Study|Withdrawal by Subject|0|||
17101410|NCT00067470|38240544|FG001|Overall Study|Withdrawal by Subject|1|||
17101411|NCT00401843|38240553|FG000|Overall Study|Achieved Complete Response|1|||
17101412|NCT00401843|38240554|FG001|Overall Study|Achieved Complete Response|5|||
17101413|NCT00401843|38240555|FG002|Overall Study|Achieved Complete Response|11|||
17101414|NCT00401843|38240553|FG000|Overall Study|Adverse Event|7|||
17101415|NCT00401843|38240554|FG001|Overall Study|Adverse Event|26|||
17101416|NCT00401843|38240555|FG002|Overall Study|Adverse Event|27|||
17101417|NCT00401843|38240553|FG000|Overall Study|Death|0|||
17197808|NCT02337946|38351286|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
17197809|NCT02337946|38351284|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
17197810|NCT02337946|38351285|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
17101418|NCT00401843|38240554|FG001|Overall Study|Death|8|||
17197811|NCT02337946|38351286|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
17197812|NCT02337946|38351284|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
17101419|NCT00401843|38240555|FG002|Overall Study|Death|10|||
17101420|NCT00401843|38240553|FG000|Overall Study|Disease progression|10|||
17197813|NCT02337946|38351285|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
17197814|NCT02337946|38351286|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
17197815|NCT02337946|38351284|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
17197816|NCT02337946|38351285|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
17197817|NCT02337946|38351286|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
17197818|NCT02337946|38351284|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
17197819|NCT02337946|38351285|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
17197820|NCT02337946|38351286|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
17197821|NCT02337946|38351284|FG000|In-between Period|Without Informed Consent|1|||
17197822|NCT02337946|38351285|FG001|In-between Period|Without Informed Consent|0|||
17197823|NCT02337946|38351286|FG002|In-between Period|Without Informed Consent|0|||
17197824|NCT02337946|38351284|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
17197825|NCT02337946|38351285|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
17197826|NCT02337946|38351286|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
17197827|NCT02337946|38351284|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
17197828|NCT02337946|38351285|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
17197829|NCT02337946|38351286|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
17197830|NCT02337946|38351284|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
17197831|NCT02337946|38351285|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
17197832|NCT02337946|38351286|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
17197833|NCT02337946|38351284|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
17197834|NCT02337946|38351285|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
17197835|NCT02337946|38351286|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
17197836|NCT02337946|38351284|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
17197837|NCT02337946|38351285|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
17197838|NCT02337946|38351286|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
17197839|NCT02337946|38351284|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
17101421|NCT00401843|38240554|FG001|Overall Study|Disease progression|60|||
17101422|NCT00401843|38240555|FG002|Overall Study|Disease progression|49|||
17101423|NCT00401843|38240553|FG000|Overall Study|End of Study|1|||
17101424|NCT00401843|38240554|FG001|Overall Study|End of Study|1|||
17101425|NCT00401843|38240555|FG002|Overall Study|End of Study|2|||
17101426|NCT00401843|38240553|FG000|Overall Study|Lost to Follow-up|0|||
17101427|NCT00401843|38240554|FG001|Overall Study|Lost to Follow-up|0|||
17101428|NCT00401843|38240555|FG002|Overall Study|Lost to Follow-up|2|||
17101429|NCT00401843|38240553|FG000|Overall Study|Other Unspecified|0|||
17101430|NCT00401843|38240554|FG001|Overall Study|Other Unspecified|3|||
17101431|NCT00401843|38240555|FG002|Overall Study|Other Unspecified|5|||
17101432|NCT00401843|38240553|FG000|Overall Study|Physician Decision|0|||
17101433|NCT00401843|38240554|FG001|Overall Study|Physician Decision|16|||
17101434|NCT00401843|38240555|FG002|Overall Study|Physician Decision|10|||
17101435|NCT00401843|38240553|FG000|Overall Study|Protocol Violation|0|||
17101436|NCT00401843|38240554|FG001|Overall Study|Protocol Violation|0|||
17101437|NCT00401843|38240555|FG002|Overall Study|Protocol Violation|1|||
17101438|NCT00401843|38240553|FG000|Overall Study|Withdrawal by Subject|1|||
17101439|NCT00401843|38240554|FG001|Overall Study|Withdrawal by Subject|5|||
17101440|NCT00401843|38240555|FG002|Overall Study|Withdrawal by Subject|5|||
17101441|NCT00401843|38240553|FG000|Overall Study|Withdrawal of consent to study agent|1|||
17101442|NCT00401843|38240554|FG001|Overall Study|Withdrawal of consent to study agent|15|||
17101443|NCT00401843|38240555|FG002|Overall Study|Withdrawal of consent to study agent|17|||
17101444|NCT00401843|38240553|FG000|Overall Study|Randomized but not Treated|0|||
17101445|NCT00401843|38240554|FG001|Overall Study|Randomized but not Treated|2|||
17101446|NCT00401843|38240555|FG002|Overall Study|Randomized but not Treated|3|||
17101447|NCT00401843|38240553|FG000|Overall Study|Received incorrect treatment|0|||
17101448|NCT00401843|38240554|FG001|Overall Study|Received incorrect treatment|3|||
17101449|NCT00401843|38240555|FG002|Overall Study|Received incorrect treatment|0|||
17101450|NCT00401531|38240567|FG000|Overall Study|Adverse Event|2|||
17101451|NCT00401531|38240568|FG001|Overall Study|Adverse Event|0|||
17101452|NCT00401531|38240567|FG000|Overall Study|Protocol Violation|3|||
17101453|NCT00401531|38240568|FG001|Overall Study|Protocol Violation|7|||
17101454|NCT00401531|38240567|FG000|Overall Study|Lost to Follow-up|1|||
17101455|NCT00401531|38240568|FG001|Overall Study|Lost to Follow-up|1|||
17101456|NCT00401531|38240567|FG000|Overall Study|Withdrawal by Subject|3|||
17015793|NCT03158285|38160454|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
17015794|NCT03158285|38160455|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
17015795|NCT03158285|38160456|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
17015796|NCT03158285|38160454|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
17015797|NCT03158285|38160455|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
17015798|NCT03158285|38160456|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
17015799|NCT03158285|38160454|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
17015800|NCT03158285|38160455|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
17015801|NCT03158285|38160456|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
17015802|NCT03158285|38160454|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
17015803|NCT03158285|38160455|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
17101457|NCT00401531|38240568|FG001|Overall Study|Withdrawal by Subject|2|||
17101458|NCT00401375|38240577|FG000|Overall Study|Protocol Violation|2|||
17101459|NCT00401375|38240578|FG001|Overall Study|Protocol Violation|2|||
17101460|NCT00401375|38240579|FG002|Overall Study|Protocol Violation|1|||
17101461|NCT00401375|38240577|FG000|Overall Study|Adverse Event|6|||
17101462|NCT00401375|38240578|FG001|Overall Study|Adverse Event|11|||
17101463|NCT00401375|38240579|FG002|Overall Study|Adverse Event|10|||
17101464|NCT00401375|38240577|FG000|Overall Study|Withdrawal by Subject|9|||
17101465|NCT00401375|38240578|FG001|Overall Study|Withdrawal by Subject|7|||
17101466|NCT00401375|38240579|FG002|Overall Study|Withdrawal by Subject|7|||
17101467|NCT00401375|38240577|FG000|Overall Study|Lost to Follow-up|0|||
17101468|NCT00401375|38240578|FG001|Overall Study|Lost to Follow-up|1|||
17101469|NCT00401375|38240579|FG002|Overall Study|Lost to Follow-up|1|||
17101470|NCT00401375|38240577|FG000|Overall Study|Other than specified|2|||
17101471|NCT00401375|38240578|FG001|Overall Study|Other than specified|1|||
17101472|NCT00401375|38240579|FG002|Overall Study|Other than specified|3|||
17101473|NCT00401375|38240577|FG000|Overall Study|Randomized but not treated|3|||
17101474|NCT00401375|38240578|FG001|Overall Study|Randomized but not treated|3|||
17101475|NCT00401375|38240579|FG002|Overall Study|Randomized but not treated|3|||
17101476|NCT00400985|38240587|FG000|Overall Study|Withdrawal by Subject|5|||
17101477|NCT00400985|38240587|FG000|Overall Study|system modification|8|||
17101478|NCT00400985|38240587|FG000|Overall Study|Death|30|||
17101479|NCT00400985|38240587|FG000|Overall Study|Lost to Follow-up|9|||
17101480|NCT00400517|38240591|FG000|Overall Study|Withdrawal by Subject|1|||
17101481|NCT00400517|38240591|FG000|Overall Study|Physician Decision|1|||
17101482|NCT00392171|38240595|FG000|Overall Study|Did not meet inclusion criteria|4|||
17101483|NCT00392171|38240595|FG000|Overall Study|Disease progression|101|||
17101484|NCT00392015|38240605|FG000|Overall Study|Lost to Follow-up|2|||
17101485|NCT00392015|38240606|FG001|Overall Study|Lost to Follow-up|0|||
17101486|NCT00392015|38240607|FG002|Overall Study|Lost to Follow-up|2|||
17101487|NCT00392015|38240608|FG003|Overall Study|Lost to Follow-up|1|||
17015804|NCT03158285|38160456|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
17015805|NCT03158285|38160454|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
17015806|NCT03158285|38160455|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
17015807|NCT03158285|38160456|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
17015808|NCT03158285|38160454|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
17015809|NCT03158285|38160455|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
17015810|NCT03158285|38160456|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
17015811|NCT03158285|38160454|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
17015812|NCT03158285|38160455|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
17015813|NCT03158285|38160456|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
17015814|NCT03158285|38160454|FG000|Active Treatment Period: Week 52-100|Death|1|||
17015815|NCT03158285|38160455|FG001|Active Treatment Period: Week 52-100|Death|0|||
17101488|NCT00392015|38240609|FG004|Overall Study|Lost to Follow-up|1|||
16786998|NCT01976104|37727349|FG002|Overall Study|Withdrawal by Subject|0|||
16786999|NCT01976104|37727350|FG003|Overall Study|Withdrawal by Subject|1|||
16787000|NCT01976104|37727347|FG000|Overall Study|Other|0|||
17101489|NCT00392015|38240610|FG005|Overall Study|Lost to Follow-up|0|||
17101490|NCT00392015|38240605|FG000|Overall Study|Withdrawal by Subject|0|||
17101491|NCT00392015|38240606|FG001|Overall Study|Withdrawal by Subject|0|||
17101492|NCT00392015|38240607|FG002|Overall Study|Withdrawal by Subject|2|||
17101493|NCT00392015|38240608|FG003|Overall Study|Withdrawal by Subject|0|||
17101494|NCT00392015|38240609|FG004|Overall Study|Withdrawal by Subject|0|||
17101495|NCT00392015|38240610|FG005|Overall Study|Withdrawal by Subject|0|||
17101496|NCT00392015|38240605|FG000|Overall Study|Adverse Event|0|||
17101497|NCT00392015|38240606|FG001|Overall Study|Adverse Event|0|||
17101498|NCT00392015|38240607|FG002|Overall Study|Adverse Event|0|||
17101499|NCT00392015|38240608|FG003|Overall Study|Adverse Event|0|||
17101500|NCT00392015|38240609|FG004|Overall Study|Adverse Event|1|||
17101501|NCT00392015|38240610|FG005|Overall Study|Adverse Event|0|||
17101502|NCT00392015|38240605|FG000|Overall Study|Previous trial recipient|0|||
17101503|NCT00392015|38240606|FG001|Overall Study|Previous trial recipient|0|||
17101504|NCT00392015|38240607|FG002|Overall Study|Previous trial recipient|0|||
17101505|NCT00392015|38240608|FG003|Overall Study|Previous trial recipient|0|||
17101506|NCT00392015|38240609|FG004|Overall Study|Previous trial recipient|1|||
17101507|NCT00392015|38240610|FG005|Overall Study|Previous trial recipient|0|||
17101508|NCT00391625|38240629|FG000|Month 14|Withdrawal by Subject|1|||
17101509|NCT00391625|38240629|FG000|Month 50|Physician Decision|1|||
17101510|NCT00091832|38240662|FG000|Overall Study|Physician Decision|1|||
17101511|NCT00091832|38240663|FG001|Overall Study|Physician Decision|0|||
17101512|NCT00091832|38240664|FG002|Overall Study|Physician Decision|0|||
17101513|NCT00091832|38240665|FG003|Overall Study|Physician Decision|0|||
17101514|NCT00091832|38240666|FG004|Overall Study|Physician Decision|0|||
17101515|NCT00091832|38240667|FG005|Overall Study|Physician Decision|0|||
17101516|NCT00091832|38240662|FG000|Overall Study|Adverse Event|0|||
17101517|NCT00091832|38240663|FG001|Overall Study|Adverse Event|0|||
17101518|NCT00091832|38240664|FG002|Overall Study|Adverse Event|0|||
17101519|NCT00091832|38240665|FG003|Overall Study|Adverse Event|1|||
17101520|NCT00091832|38240666|FG004|Overall Study|Adverse Event|3|||
17101521|NCT00091832|38240667|FG005|Overall Study|Adverse Event|0|||
17101522|NCT00091832|38240662|FG000|Overall Study|Withdrawal by Subject|4|||
17101523|NCT00091832|38240663|FG001|Overall Study|Withdrawal by Subject|5|||
17101524|NCT00091832|38240664|FG002|Overall Study|Withdrawal by Subject|0|||
17101525|NCT00091832|38240665|FG003|Overall Study|Withdrawal by Subject|1|||
17101526|NCT00091832|38240666|FG004|Overall Study|Withdrawal by Subject|3|||
17101527|NCT00091832|38240667|FG005|Overall Study|Withdrawal by Subject|1|||
17101528|NCT00091832|38240662|FG000|Overall Study|Death|6|||
17101529|NCT00091832|38240663|FG001|Overall Study|Death|4|||
17101530|NCT00091832|38240664|FG002|Overall Study|Death|5|||
17101531|NCT00091832|38240665|FG003|Overall Study|Death|8|||
17101532|NCT00091832|38240666|FG004|Overall Study|Death|5|||
17101533|NCT00091832|38240667|FG005|Overall Study|Death|6|||
17101534|NCT00091832|38240662|FG000|Overall Study|Disease Progression|2|||
16787001|NCT01976104|37727348|FG001|Overall Study|Other|1|||
16787002|NCT01976104|37727349|FG002|Overall Study|Other|0|||
16787003|NCT01976104|37727350|FG003|Overall Study|Other|0|||
16787004|NCT01372501|37727361|FG000|Overall Study|Adverse Event|4|||
16787005|NCT01372501|37727361|FG000|Overall Study|Device migration|1|||
16787006|NCT01958008|37727370|FG000|Overall Study|Worsening of disease under study|0|||
16787007|NCT01958008|37727371|FG001|Overall Study|Worsening of disease under study|0|||
16787008|NCT01958008|37727372|FG002|Overall Study|Worsening of disease under study|1|||
16787009|NCT01958008|37727373|FG003|Overall Study|Worsening of disease under study|0|||
16787010|NCT01958008|37727370|FG000|Overall Study|Other adverse event|1|||
16787011|NCT01958008|37727371|FG001|Overall Study|Other adverse event|0|||
16787012|NCT01958008|37727372|FG002|Overall Study|Other adverse event|0|||
16787013|NCT01958008|37727373|FG003|Overall Study|Other adverse event|0|||
16787014|NCT01998880|37727401|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
16787015|NCT01998880|37727402|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
16787016|NCT01998880|37727401|FG000|Overall Study|Disease Progression|1|||
17015816|NCT03158285|38160456|FG002|Active Treatment Period: Week 52-100|Death|0|||
17015817|NCT03158285|38160454|FG000|Active Treatment Period: Week 52-100|Other|4|||
17015818|NCT03158285|38160455|FG001|Active Treatment Period: Week 52-100|Other|1|||
17015819|NCT03158285|38160456|FG002|Active Treatment Period: Week 52-100|Other|0|||
17015820|NCT00861692|38160469|FG000|Overall Study|Death|6|||
17015821|NCT00602927|38160475|FG000|Period 1: 13 Days|Protocol Violation|2|||
17015822|NCT00602927|38160476|FG001|Period 1: 13 Days|Protocol Violation|4|||
17015823|NCT00602927|38160475|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
17015824|NCT00602927|38160476|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
17015825|NCT00602927|38160475|FG000|Period 1: 13 Days|Time|1|||
17015826|NCT00602927|38160476|FG001|Period 1: 13 Days|Time|0|||
16787017|NCT01998880|37727402|FG001|Overall Study|Disease Progression|8|||
16787018|NCT01998880|37727401|FG000|Overall Study|Withdrew Consent|2|||
16787019|NCT01998880|37727402|FG001|Overall Study|Withdrew Consent|1|||
16787020|NCT01998880|37727401|FG000|Overall Study|Death|3|||
17101535|NCT00091832|38240663|FG001|Overall Study|Disease Progression|0|||
17101536|NCT00091832|38240664|FG002|Overall Study|Disease Progression|0|||
17101537|NCT00091832|38240665|FG003|Overall Study|Disease Progression|1|||
17101538|NCT00091832|38240666|FG004|Overall Study|Disease Progression|1|||
17101539|NCT00091832|38240667|FG005|Overall Study|Disease Progression|2|||
17101540|NCT00091832|38240662|FG000|Overall Study|Ineligibility Determined|0|||
17101541|NCT00091832|38240663|FG001|Overall Study|Ineligibility Determined|0|||
17101542|NCT00091832|38240664|FG002|Overall Study|Ineligibility Determined|1|||
17101543|NCT00091832|38240665|FG003|Overall Study|Ineligibility Determined|0|||
17101544|NCT00091832|38240666|FG004|Overall Study|Ineligibility Determined|1|||
17101545|NCT00091832|38240667|FG005|Overall Study|Ineligibility Determined|0|||
17101546|NCT00091832|38240662|FG000|Overall Study|Lost to Follow-up|1|||
17101547|NCT00091832|38240663|FG001|Overall Study|Lost to Follow-up|0|||
17101548|NCT00091832|38240664|FG002|Overall Study|Lost to Follow-up|3|||
17101549|NCT00091832|38240665|FG003|Overall Study|Lost to Follow-up|3|||
17101550|NCT00091832|38240666|FG004|Overall Study|Lost to Follow-up|2|||
17101551|NCT00091832|38240667|FG005|Overall Study|Lost to Follow-up|1|||
17101552|NCT00091832|38240662|FG000|Overall Study|Noncompliance|0|||
17101553|NCT00091832|38240663|FG001|Overall Study|Noncompliance|1|||
17101554|NCT00091832|38240664|FG002|Overall Study|Noncompliance|0|||
17101555|NCT00091832|38240665|FG003|Overall Study|Noncompliance|0|||
17015827|NCT00602927|38160475|FG000|Period 1: 13 Days|Claustrophobia|0|||
17015828|NCT00602927|38160476|FG001|Period 1: 13 Days|Claustrophobia|1|||
17015829|NCT00602927|38160475|FG000|Period 2: 14 Days|Protocol Violation|0|||
17101556|NCT00091832|38240666|FG004|Overall Study|Noncompliance|0|||
17101557|NCT00091832|38240667|FG005|Overall Study|Noncompliance|0|||
17101558|NCT00091832|38240662|FG000|Overall Study|Other|0|||
17101559|NCT00091832|38240663|FG001|Overall Study|Other|1|||
17101560|NCT00091832|38240664|FG002|Overall Study|Other|2|||
17101561|NCT00091832|38240665|FG003|Overall Study|Other|0|||
17101562|NCT00091832|38240666|FG004|Overall Study|Other|0|||
17101563|NCT00091832|38240667|FG005|Overall Study|Other|0|||
17101564|NCT00091832|38240662|FG000|Overall Study|Protocol Violation|0|||
17101565|NCT00091832|38240663|FG001|Overall Study|Protocol Violation|0|||
17015830|NCT00602927|38160476|FG001|Period 2: 14 Days|Protocol Violation|2|||
17015831|NCT00602927|38160475|FG000|Period 3: 13 Days|Protocol Violation|0|||
17015832|NCT00602927|38160476|FG001|Period 3: 13 Days|Protocol Violation|1|||
17015833|NCT00602927|38160475|FG000|Period 3: 13 Days|MRI data quality|2|||
17015834|NCT00602927|38160476|FG001|Period 3: 13 Days|MRI data quality|2|||
17015835|NCT00602537|38160484|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
17015836|NCT00602537|38160485|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
17015837|NCT00602537|38160484|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
17015838|NCT00602537|38160485|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
17015839|NCT00602537|38160484|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
17015840|NCT00602537|38160485|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
17015841|NCT00602537|38160484|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
17015842|NCT00602537|38160485|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
17015843|NCT00602537|38160484|FG000|Follow Up Study Comparison|Adverse Event|1|||
17015844|NCT00602537|38160485|FG001|Follow Up Study Comparison|Adverse Event|0|||
17015845|NCT00602537|38160484|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
17015846|NCT00602537|38160485|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
17015847|NCT00602537|38160484|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
17015848|NCT00602537|38160485|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
17015849|NCT00861614|38160493|FG000|Overall Study|Disease Progression|182|||
17015850|NCT00861614|38160494|FG001|Overall Study|Disease Progression|263|||
17015851|NCT00861614|38160493|FG000|Overall Study|Study Drug Toxicity|79|||
17015852|NCT00861614|38160494|FG001|Overall Study|Study Drug Toxicity|6|||
17015853|NCT00861614|38160493|FG000|Overall Study|Death|32|||
17101566|NCT00091832|38240664|FG002|Overall Study|Protocol Violation|1|||
17101567|NCT00091832|38240665|FG003|Overall Study|Protocol Violation|0|||
17015854|NCT00861614|38160494|FG001|Overall Study|Death|19|||
17015855|NCT00861614|38160493|FG000|Overall Study|Adverse Event|27|||
17015856|NCT00861614|38160494|FG001|Overall Study|Adverse Event|23|||
17015857|NCT00861614|38160493|FG000|Overall Study|Withdrawal by Subject|34|||
17015858|NCT00861614|38160494|FG001|Overall Study|Withdrawal by Subject|35|||
17101568|NCT00091832|38240666|FG004|Overall Study|Protocol Violation|0|||
17101569|NCT00091832|38240667|FG005|Overall Study|Protocol Violation|1|||
17101570|NCT00391391|38240685|FG000|Overall Study|Adverse Event|0|||
17101571|NCT00391391|38240686|FG001|Overall Study|Adverse Event|0|||
17101572|NCT00391391|38240687|FG002|Overall Study|Adverse Event|0|||
17101573|NCT00391391|38240688|FG003|Overall Study|Adverse Event|1|||
17101574|NCT00391391|38240685|FG000|Overall Study|Lost to Follow-up|1|||
17101575|NCT00391391|38240686|FG001|Overall Study|Lost to Follow-up|3|||
17101576|NCT00391391|38240687|FG002|Overall Study|Lost to Follow-up|7|||
17101577|NCT00391391|38240688|FG003|Overall Study|Lost to Follow-up|4|||
17101578|NCT00391391|38240685|FG000|Overall Study|Protocol Violation|2|||
17101579|NCT00391391|38240686|FG001|Overall Study|Protocol Violation|3|||
17101580|NCT00391391|38240687|FG002|Overall Study|Protocol Violation|6|||
17101581|NCT00391391|38240688|FG003|Overall Study|Protocol Violation|7|||
17101582|NCT00391391|38240685|FG000|Overall Study|Withdrawal by Subject|6|||
17101583|NCT00391391|38240686|FG001|Overall Study|Withdrawal by Subject|4|||
16787021|NCT01998880|37727402|FG001|Overall Study|Death|6|||
17015859|NCT00861614|38160493|FG000|Overall Study|Other|17|||
17015860|NCT00861614|38160494|FG001|Overall Study|Other|22|||
17015861|NCT00485173|38160502|FG000|Overall Study|Death|4|||
17015862|NCT00485173|38160503|FG001|Overall Study|Death|3|||
17015863|NCT00485173|38160502|FG000|Overall Study|Lost to Follow-up|32|||
17101584|NCT00391391|38240687|FG002|Overall Study|Withdrawal by Subject|10|||
17101585|NCT00391391|38240688|FG003|Overall Study|Withdrawal by Subject|7|||
17101586|NCT00091442|38240700|FG000|Overall Study|Progressive Disease|220|||
17101587|NCT00091442|38240701|FG001|Overall Study|Progressive Disease|189|||
17101588|NCT00091442|38240700|FG000|Overall Study|Physician Decision|61|||
17101589|NCT00091442|38240701|FG001|Overall Study|Physician Decision|58|||
17101590|NCT00091442|38240700|FG000|Overall Study|Withdrawal by Subject|38|||
17101591|NCT00091442|38240701|FG001|Overall Study|Withdrawal by Subject|46|||
17101592|NCT00091442|38240700|FG000|Overall Study|Adverse Event|29|||
17101593|NCT00091442|38240701|FG001|Overall Study|Adverse Event|48|||
17101594|NCT00091442|38240700|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
17101595|NCT00091442|38240701|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
17101596|NCT00091442|38240700|FG000|Overall Study|Death|9|||
17101597|NCT00091442|38240701|FG001|Overall Study|Death|7|||
17101598|NCT00091442|38240700|FG000|Overall Study|Lost to Follow-up|1|||
17101599|NCT00091442|38240701|FG001|Overall Study|Lost to Follow-up|3|||
17101600|NCT00091442|38240700|FG000|Overall Study|Other|2|||
17101601|NCT00091442|38240701|FG001|Overall Study|Other|6|||
17101602|NCT00390689|38240710|FG000|Overall Study|Adverse Event|2|||
17101603|NCT00390689|38240711|FG001|Overall Study|Adverse Event|5|||
17101604|NCT00390689|38240712|FG002|Overall Study|Adverse Event|2|||
17101605|NCT00390689|38240710|FG000|Overall Study|Lack of Efficacy|0|||
17101606|NCT00390689|38240711|FG001|Overall Study|Lack of Efficacy|0|||
17101607|NCT00390689|38240712|FG002|Overall Study|Lack of Efficacy|1|||
17101608|NCT00390689|38240710|FG000|Overall Study|Protocol Violation|1|||
17101609|NCT00390689|38240711|FG001|Overall Study|Protocol Violation|0|||
17101610|NCT00390689|38240712|FG002|Overall Study|Protocol Violation|0|||
17101611|NCT00390689|38240710|FG000|Overall Study|Investigator's judgement|2|||
17101612|NCT00390689|38240711|FG001|Overall Study|Investigator's judgement|0|||
17101613|NCT00390689|38240712|FG002|Overall Study|Investigator's judgement|0|||
17101614|NCT00121238|38240729|FG000|Overall Study|disease progression before intervention|1|||
17101615|NCT00121238|38240729|FG000|Overall Study|Protocol Violation|2|||
17101616|NCT00390455|38240735|FG000|Overall Study|Adverse Event|17|||
17101617|NCT00390455|38240736|FG001|Overall Study|Adverse Event|3|||
17101618|NCT00390455|38240735|FG000|Overall Study|Withdrawal by Subject|8|||
17101619|NCT00390455|38240736|FG001|Overall Study|Withdrawal by Subject|8|||
17015864|NCT00485173|38160503|FG001|Overall Study|Lost to Follow-up|61|||
17015865|NCT00495469|38160516|FG000|Overall Study|Adverse Event|0|||
17101620|NCT00390455|38240735|FG000|Overall Study|Alternate Treatment|0|||
17101621|NCT00390455|38240736|FG001|Overall Study|Alternate Treatment|1|||
17101622|NCT00390455|38240735|FG000|Overall Study|Other Medical Reasons|7|||
17101623|NCT00390455|38240736|FG001|Overall Study|Other Medical Reasons|11|||
17101624|NCT03812510|38240742|FG000|Overall Study|Lost to Follow-up|39|||
17015866|NCT00495469|38160517|FG001|Overall Study|Adverse Event|1|||
17015867|NCT00495469|38160518|FG002|Overall Study|Adverse Event|3|||
17015868|NCT00495469|38160519|FG003|Overall Study|Adverse Event|0|||
17015869|NCT00495469|38160520|FG004|Overall Study|Adverse Event|1|||
17015870|NCT00495469|38160521|FG005|Overall Study|Adverse Event|1|||
17015871|NCT00495469|38160522|FG006|Overall Study|Adverse Event|1|||
17015872|NCT00495469|38160516|FG000|Overall Study|Lost to Follow-up|1|||
17015873|NCT00495469|38160517|FG001|Overall Study|Lost to Follow-up|1|||
17015874|NCT00495469|38160518|FG002|Overall Study|Lost to Follow-up|3|||
17015875|NCT00495469|38160519|FG003|Overall Study|Lost to Follow-up|1|||
17015876|NCT00495469|38160520|FG004|Overall Study|Lost to Follow-up|0|||
17015877|NCT00495469|38160521|FG005|Overall Study|Lost to Follow-up|0|||
17015878|NCT00495469|38160522|FG006|Overall Study|Lost to Follow-up|0|||
17015879|NCT00495469|38160516|FG000|Overall Study|Protocol Violation|0|||
17015880|NCT00495469|38160517|FG001|Overall Study|Protocol Violation|0|||
17015881|NCT00495469|38160518|FG002|Overall Study|Protocol Violation|0|||
17015882|NCT00495469|38160519|FG003|Overall Study|Protocol Violation|0|||
17015883|NCT00495469|38160520|FG004|Overall Study|Protocol Violation|1|||
17015884|NCT00495469|38160521|FG005|Overall Study|Protocol Violation|2|||
17015885|NCT00495469|38160522|FG006|Overall Study|Protocol Violation|0|||
17015886|NCT00495469|38160516|FG000|Overall Study|Withdrawal by Subject|5|||
17015887|NCT00495469|38160517|FG001|Overall Study|Withdrawal by Subject|3|||
17015888|NCT00495469|38160518|FG002|Overall Study|Withdrawal by Subject|1|||
17015889|NCT00495469|38160519|FG003|Overall Study|Withdrawal by Subject|3|||
17015890|NCT00495469|38160520|FG004|Overall Study|Withdrawal by Subject|3|||
17015891|NCT00495469|38160521|FG005|Overall Study|Withdrawal by Subject|2|||
17015892|NCT00495469|38160522|FG006|Overall Study|Withdrawal by Subject|3|||
17101625|NCT03812510|38240742|FG000|Overall Study|Withdrawal by Subject|42|||
17101626|NCT03812510|38240742|FG000|Overall Study|Physician Decision|2|||
17101627|NCT03812510|38240742|FG000|Overall Study|Study Terminated by Sponsor|9|||
17101628|NCT03812510|38240742|FG000|Overall Study|Did Not Start Study Medication|55|||
17101629|NCT03812510|38240742|FG000|Overall Study|Adverse Event|5|||
17015893|NCT00495469|38160516|FG000|Overall Study|Lack of Efficacy|0|||
17015894|NCT00495469|38160517|FG001|Overall Study|Lack of Efficacy|0|||
17015895|NCT00495469|38160518|FG002|Overall Study|Lack of Efficacy|0|||
17015896|NCT00495469|38160519|FG003|Overall Study|Lack of Efficacy|0|||
17015897|NCT00495469|38160520|FG004|Overall Study|Lack of Efficacy|0|||
17015898|NCT00495469|38160521|FG005|Overall Study|Lack of Efficacy|0|||
17015899|NCT00495469|38160522|FG006|Overall Study|Lack of Efficacy|1|||
17101630|NCT00390299|38240752|FG000|Overall Study|Cancellation|1|||
17197840|NCT02337946|38351285|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
17197841|NCT02337946|38351286|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
17197842|NCT01369199|38351292|FG000|Overall Study|Withdrawal by Subject|1|||
17197843|NCT01369199|38351292|FG000|Overall Study|Lost to Follow-up|2|||
17197844|NCT01368965|38351296|FG000|Overall Study|Lost to Follow-up|12|||
16787022|NCT01998880|37727401|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16787023|NCT01998880|37727402|FG001|Overall Study|Insufficient Therapeutic Response|5|||
17015900|NCT00495469|38160516|FG000|Overall Study|Liver function test abnormality|0|||
17015901|NCT00495469|38160517|FG001|Overall Study|Liver function test abnormality|1|||
17015902|NCT00495469|38160518|FG002|Overall Study|Liver function test abnormality|0|||
17015903|NCT00495469|38160519|FG003|Overall Study|Liver function test abnormality|0|||
17015904|NCT00495469|38160520|FG004|Overall Study|Liver function test abnormality|0|||
17015905|NCT00495469|38160521|FG005|Overall Study|Liver function test abnormality|0|||
17015906|NCT00495469|38160522|FG006|Overall Study|Liver function test abnormality|0|||
17015907|NCT00495469|38160516|FG000|Overall Study|ST depression at randomisation in ECG|0|||
17015908|NCT00495469|38160517|FG001|Overall Study|ST depression at randomisation in ECG|1|||
17015909|NCT00495469|38160518|FG002|Overall Study|ST depression at randomisation in ECG|0|||
17015910|NCT00495469|38160519|FG003|Overall Study|ST depression at randomisation in ECG|0|||
17015911|NCT00495469|38160520|FG004|Overall Study|ST depression at randomisation in ECG|0|||
17015912|NCT00495469|38160521|FG005|Overall Study|ST depression at randomisation in ECG|0|||
17015913|NCT00495469|38160522|FG006|Overall Study|ST depression at randomisation in ECG|0|||
17015914|NCT00861380|38160552|FG000|Overall Study|Withdrawal Information not recorded|8427|||
17015915|NCT00861380|38160553|FG001|Overall Study|Withdrawal Information not recorded|9112|||
17015916|NCT00861380|38160554|FG002|Overall Study|Withdrawal Information not recorded|8872|||
17015917|NCT00861380|38160555|FG003|Overall Study|Withdrawal Information not recorded|3689|||
17015918|NCT00861380|38160556|FG004|Overall Study|Withdrawal Information not recorded|1812|||
17015919|NCT00861380|38160557|FG005|Overall Study|Withdrawal Information not recorded|6249|||
17015920|NCT00861380|38160558|FG006|Overall Study|Withdrawal Information not recorded|3020|||
17015921|NCT00495391|38160593|FG000|Overall Study|Lack of Efficacy|34|||
17015922|NCT00495391|38160594|FG001|Overall Study|Lack of Efficacy|18|||
17015923|NCT00495391|38160593|FG000|Overall Study|Withdrawal by Subject|2|||
17015924|NCT00495391|38160594|FG001|Overall Study|Withdrawal by Subject|3|||
17015925|NCT00869960|38160600|FG000|Overall Study|Lost to Follow-up|2|||
17015926|NCT00494299|38160606|FG000|Overall Study|Adverse Event|93|||
17015927|NCT00494299|38160607|FG001|Overall Study|Adverse Event|13|||
17015928|NCT00494299|38160606|FG000|Overall Study|Lost to Follow-up|1|||
17015929|NCT00494299|38160607|FG001|Overall Study|Lost to Follow-up|0|||
17015930|NCT00494299|38160606|FG000|Overall Study|Physician Decision|0|||
17015931|NCT00494299|38160607|FG001|Overall Study|Physician Decision|2|||
17015932|NCT00494299|38160606|FG000|Overall Study|Protocol Violation|1|||
17015933|NCT00494299|38160607|FG001|Overall Study|Protocol Violation|2|||
17015934|NCT00494299|38160606|FG000|Overall Study|Withdrawal by Subject|8|||
17015935|NCT00494299|38160607|FG001|Overall Study|Withdrawal by Subject|3|||
17015936|NCT00494299|38160606|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
17015937|NCT00494299|38160607|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
17015938|NCT00494299|38160606|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
17015939|NCT00494299|38160607|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
17015940|NCT00494299|38160606|FG000|Overall Study|Site Closed by Sponsor|6|||
17015941|NCT00494299|38160607|FG001|Overall Study|Site Closed by Sponsor|0|||
17015942|NCT00494299|38160606|FG000|Overall Study|Protocol Driven Decision Point|11|||
17015943|NCT00494299|38160607|FG001|Overall Study|Protocol Driven Decision Point|22|||
17015944|NCT00593684|38160615|FG000|Overall Study|Death|2|||
17015945|NCT00593684|38160616|FG001|Overall Study|Death|1|||
17015946|NCT02963831|38160626|FG000|Overall Study|Progressive Disease|3|||
17015947|NCT02963831|38160627|FG001|Overall Study|Progressive Disease|3|||
17015948|NCT02963831|38160628|FG002|Overall Study|Progressive Disease|16|||
17015949|NCT02963831|38160629|FG003|Overall Study|Progressive Disease|27|||
17101631|NCT00390299|38240753|FG001|Overall Study|Cancellation|0|||
17101632|NCT00390299|38240754|FG002|Overall Study|Cancellation|0|||
17101633|NCT00390299|38240755|FG003|Overall Study|Cancellation|0|||
17101634|NCT00390299|38240756|FG004|Overall Study|Cancellation|0|||
17101635|NCT00119678|38240772|FG000|Double-blind Treatment Period|Death|1|||
17101636|NCT00119678|38240773|FG001|Double-blind Treatment Period|Death|0|||
17101637|NCT00119678|38240772|FG000|Double-blind Treatment Period|Adverse Event|7|||
17101638|NCT00119678|38240773|FG001|Double-blind Treatment Period|Adverse Event|1|||
17101639|NCT00119678|38240772|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
17101640|NCT00119678|38240773|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
17101641|NCT00119678|38240772|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
17101642|NCT00119678|38240773|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
17101643|NCT00119678|38240772|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
17015950|NCT02963831|38160626|FG000|Overall Study|Withdrawal by Subject|1|||
17015951|NCT02963831|38160627|FG001|Overall Study|Withdrawal by Subject|0|||
17197845|NCT02610140|38351304|FG000|Randomization and Treatment Period|Radiological progression|23|||
17197846|NCT02610140|38351305|FG001|Randomization and Treatment Period|Radiological progression|15|||
17197847|NCT02610140|38351304|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
17101644|NCT00119678|38240773|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
17101645|NCT00119678|38240772|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
17101646|NCT00119678|38240773|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
17101647|NCT00119678|38240772|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
17197848|NCT02610140|38351305|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
17197849|NCT02610140|38351304|FG000|Randomization and Treatment Period|Protocol Violation|1|||
17197850|NCT02610140|38351305|FG001|Randomization and Treatment Period|Protocol Violation|0|||
17197851|NCT02610140|38351304|FG000|Randomization and Treatment Period|Physician Decision|0|||
17197852|NCT02610140|38351305|FG001|Randomization and Treatment Period|Physician Decision|1|||
17197853|NCT02610140|38351304|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
17197854|NCT02610140|38351305|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
17197855|NCT02610140|38351304|FG000|Randomization and Treatment Period|Death|7|||
17197856|NCT02610140|38351305|FG001|Randomization and Treatment Period|Death|1|||
17101648|NCT00119678|38240773|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
17101649|NCT00119678|38240772|FG000|Double-blind Treatment Period|Pregnancy|0|||
17101650|NCT00119678|38240773|FG001|Double-blind Treatment Period|Pregnancy|2|||
17101651|NCT00119678|38240772|FG000|Double-blind Treatment Period|Not treated|1|||
17101652|NCT00119678|38240773|FG001|Double-blind Treatment Period|Not treated|2|||
17101653|NCT00119678|38240772|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
17197857|NCT02610140|38351304|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
17197858|NCT02610140|38351305|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
17197859|NCT02610140|38351304|FG000|Randomization and Treatment Period|Adverse Event|44|||
17101654|NCT00119678|38240773|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
17101655|NCT00119678|38240772|FG000|Open-label Treatment Period|Death|1|||
17101656|NCT00119678|38240773|FG001|Open-label Treatment Period|Death|0|||
17101657|NCT00119678|38240772|FG000|Open-label Treatment Period|Adverse Event|3|||
17101658|NCT00119678|38240773|FG001|Open-label Treatment Period|Adverse Event|0|||
17101659|NCT00119678|38240772|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
17101660|NCT00119678|38240773|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
17101661|NCT00119678|38240772|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
17101662|NCT00119678|38240773|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
17101663|NCT00119678|38240772|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
17101664|NCT00119678|38240773|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
17101665|NCT00119678|38240772|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
17197860|NCT02610140|38351305|FG001|Randomization and Treatment Period|Adverse Event|13|||
17197861|NCT02610140|38351304|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
17197862|NCT02610140|38351305|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
17197863|NCT02610140|38351304|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
17197864|NCT02610140|38351305|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
17197865|NCT02610140|38351304|FG000|Randomization and Treatment Period|Not treated|3|||
17197866|NCT02610140|38351305|FG001|Randomization and Treatment Period|Not treated|10|||
17197867|NCT02610140|38351304|FG000|Safety Follow-up|Other|0|||
17197868|NCT02610140|38351305|FG001|Safety Follow-up|Other|2|||
17197869|NCT02610140|38351304|FG000|Safety Follow-up|Lost to Follow-up|1|||
17197870|NCT02610140|38351305|FG001|Safety Follow-up|Lost to Follow-up|0|||
17197871|NCT02610140|38351304|FG000|Safety Follow-up|No follow-up|5|||
17197872|NCT02610140|38351305|FG001|Safety Follow-up|No follow-up|3|||
17197873|NCT02610140|38351304|FG000|Safety Follow-up|Death|12|||
17197874|NCT02610140|38351305|FG001|Safety Follow-up|Death|2|||
17197875|NCT02610140|38351304|FG000|Safety Follow-up|Deterioration of general conditions|15|||
17197876|NCT02610140|38351305|FG001|Safety Follow-up|Deterioration of general conditions|5|||
17197877|NCT02610140|38351304|FG000|Safety Follow-up|Withdrawal by Subject|12|||
17197878|NCT02610140|38351305|FG001|Safety Follow-up|Withdrawal by Subject|12|||
17197879|NCT02610140|38351304|FG000|Active Follow-up|Progressive disease - radiological|30|||
17197880|NCT02610140|38351305|FG001|Active Follow-up|Progressive disease - radiological|22|||
17197881|NCT02610140|38351304|FG000|Active Follow-up|Death|8|||
17197882|NCT02610140|38351305|FG001|Active Follow-up|Death|1|||
17015952|NCT02963831|38160628|FG002|Overall Study|Withdrawal by Subject|2|||
17015953|NCT02963831|38160629|FG003|Overall Study|Withdrawal by Subject|4|||
17015954|NCT02963831|38160626|FG000|Overall Study|Adverse Event|0|||
17015955|NCT02963831|38160627|FG001|Overall Study|Adverse Event|1|||
17015956|NCT02963831|38160628|FG002|Overall Study|Adverse Event|1|||
17015957|NCT02963831|38160629|FG003|Overall Study|Adverse Event|2|||
17015958|NCT02963831|38160626|FG000|Overall Study|Death|0|||
17015959|NCT02963831|38160627|FG001|Overall Study|Death|0|||
17015960|NCT02963831|38160628|FG002|Overall Study|Death|0|||
17015961|NCT02963831|38160629|FG003|Overall Study|Death|2|||
17015962|NCT00859898|38160644|FG000|Overall Study|Lack of Efficacy|0|||
17101666|NCT00119678|38240773|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
17197883|NCT02610140|38351304|FG000|Active Follow-up|Withdrawal by Subject|4|||
17197884|NCT02610140|38351305|FG001|Active Follow-up|Withdrawal by Subject|0|||
17197885|NCT02610140|38351304|FG000|Active Follow-up|Progressive disease - clinical|1|||
17197886|NCT02610140|38351305|FG001|Active Follow-up|Progressive disease - clinical|2|||
17197887|NCT02610140|38351304|FG000|Active Follow-up|Deterioration of general conditions|1|||
17197888|NCT02610140|38351305|FG001|Active Follow-up|Deterioration of general conditions|0|||
17197889|NCT02610140|38351304|FG000|Active Follow-up|Ongoing but not completed|4|||
17197890|NCT02610140|38351305|FG001|Active Follow-up|Ongoing but not completed|1|||
17197891|NCT02610140|38351304|FG000|Long-term Follow-up|Death|86|||
17197892|NCT02610140|38351305|FG001|Long-term Follow-up|Death|44|||
17197893|NCT02610140|38351304|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
17197894|NCT02610140|38351305|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
17197895|NCT02610140|38351304|FG000|Long-term Follow-up|Lost to Follow-up|1|||
17015963|NCT00859898|38160645|FG001|Overall Study|Lack of Efficacy|1|||
17015964|NCT00859898|38160646|FG002|Overall Study|Lack of Efficacy|1|||
17015965|NCT00859898|38160644|FG000|Overall Study|Adverse Event|4|||
17015966|NCT00859898|38160645|FG001|Overall Study|Adverse Event|9|||
17015967|NCT00859898|38160646|FG002|Overall Study|Adverse Event|8|||
17015968|NCT00859898|38160644|FG000|Overall Study|Withdrawal by Subject|11|||
17015969|NCT00859898|38160645|FG001|Overall Study|Withdrawal by Subject|8|||
17015970|NCT00859898|38160646|FG002|Overall Study|Withdrawal by Subject|11|||
17015971|NCT00859898|38160644|FG000|Overall Study|Death|0|||
17015972|NCT00859898|38160645|FG001|Overall Study|Death|0|||
17015973|NCT00859898|38160646|FG002|Overall Study|Death|1|||
17015974|NCT00859898|38160644|FG000|Overall Study|Lost to Follow-up|10|||
17015975|NCT00859898|38160645|FG001|Overall Study|Lost to Follow-up|11|||
17015976|NCT00859898|38160646|FG002|Overall Study|Lost to Follow-up|5|||
17015977|NCT00859898|38160644|FG000|Overall Study|poor/non-compliance|2|||
17015978|NCT00859898|38160645|FG001|Overall Study|poor/non-compliance|0|||
17015979|NCT00859898|38160646|FG002|Overall Study|poor/non-compliance|0|||
17015980|NCT00859898|38160644|FG000|Overall Study|No longer meets criteria|0|||
17015981|NCT00859898|38160645|FG001|Overall Study|No longer meets criteria|1|||
17015982|NCT00859898|38160646|FG002|Overall Study|No longer meets criteria|0|||
17015983|NCT00859898|38160644|FG000|Overall Study|non-specified|1|||
17101667|NCT00119678|38240772|FG000|Open-label Treatment Period|Pregnancy|1|||
17101668|NCT00119678|38240773|FG001|Open-label Treatment Period|Pregnancy|0|||
17101669|NCT00119678|38240772|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
17101670|NCT00119678|38240773|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
17101671|NCT00110084|38240781|FG000|Overall Study|Adverse Event|9|||
17101672|NCT00110084|38240781|FG000|Overall Study|Death|1|||
17101673|NCT00110084|38240781|FG000|Overall Study|Patient Refusal|10|||
17101674|NCT00110084|38240781|FG000|Overall Study|Alternate Therapy|5|||
17101675|NCT00110084|38240781|FG000|Overall Study|Intercurrent Illness|1|||
17101676|NCT00110084|38240781|FG000|Overall Study|Other|2|||
17101677|NCT00390221|38240788|FG000|Overall Study|Lost to Follow-up|0|||
17101678|NCT00390221|38240789|FG001|Overall Study|Lost to Follow-up|3|||
17101679|NCT00390221|38240790|FG002|Overall Study|Lost to Follow-up|0|||
17101680|NCT00390221|38240788|FG000|Overall Study|Adverse Event|1|||
17101681|NCT00390221|38240789|FG001|Overall Study|Adverse Event|4|||
17101682|NCT00390221|38240790|FG002|Overall Study|Adverse Event|3|||
17101683|NCT00390221|38240788|FG000|Overall Study|Investigator Decision|0|||
17101684|NCT00390221|38240789|FG001|Overall Study|Investigator Decision|0|||
17101685|NCT00390221|38240790|FG002|Overall Study|Investigator Decision|1|||
17101686|NCT00390221|38240788|FG000|Overall Study|Withdrawal by Subject|13|||
17015984|NCT00859898|38160645|FG001|Overall Study|non-specified|1|||
17015985|NCT00859898|38160646|FG002|Overall Study|non-specified|1|||
17015986|NCT00859586|38160655|FG000|Overall Study|Donors|4|||
17015987|NCT00494221|38160662|FG000|Overall Study|Death|15|||
17015988|NCT00494221|38160663|FG001|Overall Study|Death|9|||
17015989|NCT00494221|38160664|FG002|Overall Study|Death|14|||
17015990|NCT00494221|38160662|FG000|Overall Study|Withdrawal by Subject|1|||
17015991|NCT00494221|38160663|FG001|Overall Study|Withdrawal by Subject|2|||
17015992|NCT00494221|38160664|FG002|Overall Study|Withdrawal by Subject|0|||
17015993|NCT00857948|38160676|FG000|Overall Study|Withdrawal by Subject|2|||
17015994|NCT00857948|38160677|FG001|Overall Study|Withdrawal by Subject|0|||
17015995|NCT00857948|38160678|FG002|Overall Study|Withdrawal by Subject|0|||
17015996|NCT00857948|38160679|FG003|Overall Study|Withdrawal by Subject|0|||
17015997|NCT00857948|38160676|FG000|Overall Study|Protocol Violation|1|||
17101687|NCT00390221|38240789|FG001|Overall Study|Withdrawal by Subject|9|||
17101688|NCT00390221|38240790|FG002|Overall Study|Withdrawal by Subject|7|||
17101689|NCT00390221|38240788|FG000|Overall Study|Subject Non-compliance|1|||
17101690|NCT00390221|38240789|FG001|Overall Study|Subject Non-compliance|0|||
17015998|NCT00857948|38160677|FG001|Overall Study|Protocol Violation|0|||
17015999|NCT00857948|38160678|FG002|Overall Study|Protocol Violation|1|||
17016000|NCT00857948|38160679|FG003|Overall Study|Protocol Violation|0|||
17016001|NCT00866606|38160689|FG000|Overall Study|Lost to Follow-up|3|||
17016002|NCT00866606|38160689|FG000|Overall Study|Adverse Event|1|||
17101691|NCT00390221|38240790|FG002|Overall Study|Subject Non-compliance|2|||
17101692|NCT00390221|38240788|FG000|Overall Study|Other|3|||
17101693|NCT00390221|38240789|FG001|Overall Study|Other|4|||
17101694|NCT00390221|38240790|FG002|Overall Study|Other|2|||
17101695|NCT00389831|38240801|FG000|Overall Study|Lack of Efficacy|0|||
17101696|NCT00389831|38240802|FG001|Overall Study|Lack of Efficacy|2|||
17101697|NCT00389831|38240801|FG000|Overall Study|Did not receive treatment.|0|||
17101698|NCT00389831|38240802|FG001|Overall Study|Did not receive treatment.|2|||
17101699|NCT00389831|38240801|FG000|Overall Study|Other reasons|0|||
17101700|NCT00389831|38240802|FG001|Overall Study|Other reasons|2|||
17101701|NCT00389831|38240801|FG000|Overall Study|Lost to Follow-up|0|||
17101702|NCT00389831|38240802|FG001|Overall Study|Lost to Follow-up|1|||
17101703|NCT00389597|38240824|FG000|Overall Study|Lost to Follow-up|8|||
17101704|NCT00389597|38240825|FG001|Overall Study|Lost to Follow-up|6|||
17101705|NCT00389597|38240826|FG002|Overall Study|Lost to Follow-up|4|||
17101706|NCT00389597|38240827|FG003|Overall Study|Lost to Follow-up|6|||
17101707|NCT00389519|38240841|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
17101708|NCT00389519|38240842|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
17101709|NCT00389519|38240843|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
17101710|NCT00389519|38240844|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
17197896|NCT02610140|38351305|FG001|Long-term Follow-up|Lost to Follow-up|2|||
17197897|NCT02610140|38351304|FG000|Long-term Follow-up|Ongoing but not completed|30|||
17197898|NCT02610140|38351305|FG001|Long-term Follow-up|Ongoing but not completed|17|||
17197899|NCT02789657|38351315|FG000|Overall Study|Withdrawal by Subject|2|||
17197900|NCT02789657|38351316|FG001|Overall Study|Withdrawal by Subject|0|||
17197901|NCT02789657|38351317|FG002|Overall Study|Withdrawal by Subject|0|||
17101711|NCT00389519|38240841|FG000|Placebo Run-In|Withdrawal by Subject|19|||
17101712|NCT00389519|38240842|FG001|Placebo Run-In|Withdrawal by Subject|0|||
17101713|NCT00389519|38240843|FG002|Placebo Run-In|Withdrawal by Subject|0|||
17101714|NCT00389519|38240844|FG003|Placebo Run-In|Withdrawal by Subject|0|||
17101715|NCT00389519|38240841|FG000|Placebo Run-In|Reason not specified|40|||
17101716|NCT00389519|38240842|FG001|Placebo Run-In|Reason not specified|0|||
17101717|NCT00389519|38240843|FG002|Placebo Run-In|Reason not specified|0|||
17101718|NCT00389519|38240844|FG003|Placebo Run-In|Reason not specified|0|||
17101719|NCT00389519|38240841|FG000|Randomized|Did not receive study drug|2|||
17197902|NCT02789657|38351318|FG003|Overall Study|Withdrawal by Subject|0|||
17197903|NCT02609984|38351329|FG000|Overall Study|Death|29|||
17197904|NCT02609984|38351330|FG001|Overall Study|Death|26|||
17197905|NCT02609984|38351329|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
17197906|NCT02609984|38351330|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
17197907|NCT02609984|38351329|FG000|Overall Study|Lost to Follow-up|1|||
17197908|NCT02609984|38351330|FG001|Overall Study|Lost to Follow-up|2|||
17197909|NCT02609984|38351329|FG000|Overall Study|Withdrawal by Subject|0|||
17197910|NCT02609984|38351330|FG001|Overall Study|Withdrawal by Subject|1|||
17197911|NCT02609984|38351329|FG000|Overall Study|Disease Progression|2|||
17197912|NCT02609984|38351330|FG001|Overall Study|Disease Progression|0|||
17197913|NCT02609672|38351338|FG000|Overall Study|Lost to Follow-up|3|||
17197914|NCT02609672|38351339|FG001|Overall Study|Lost to Follow-up|1|||
17197915|NCT02611778|38351347|FG000|Overall Study|Withdrawal by Subject|2|||
17197916|NCT02611778|38351348|FG001|Overall Study|Withdrawal by Subject|8|||
17197917|NCT02611778|38351347|FG000|Overall Study|Adverse Event|1|||
17197918|NCT02611778|38351348|FG001|Overall Study|Adverse Event|2|||
17197919|NCT02611778|38351347|FG000|Overall Study|Death|2|||
17197920|NCT02611778|38351348|FG001|Overall Study|Death|1|||
17197921|NCT02611778|38351347|FG000|Overall Study|Protocol Violation|1|||
17197922|NCT02611778|38351348|FG001|Overall Study|Protocol Violation|0|||
17197923|NCT02611778|38351347|FG000|Overall Study|Lost to Follow-up|3|||
17197924|NCT02611778|38351348|FG001|Overall Study|Lost to Follow-up|1|||
17197925|NCT02611778|38351347|FG000|Overall Study|Need for alternative treatment|1|||
17197926|NCT02611778|38351348|FG001|Overall Study|Need for alternative treatment|0|||
17197927|NCT02611778|38351347|FG000|Overall Study|Other Reason|2|||
17197928|NCT02611778|38351348|FG001|Overall Study|Other Reason|1|||
17197929|NCT02711553|38351359|FG000|Overall Study|Withdrawal by Subject|2|||
17197930|NCT02711553|38351360|FG001|Overall Study|Withdrawal by Subject|1|||
17197931|NCT02711553|38351361|FG002|Overall Study|Withdrawal by Subject|1|||
17197932|NCT02711553|38351362|FG003|Overall Study|Withdrawal by Subject|0|||
17197933|NCT02711553|38351359|FG000|Overall Study|Lost to Follow-up|3|||
17197934|NCT02711553|38351360|FG001|Overall Study|Lost to Follow-up|3|||
17197935|NCT02711553|38351361|FG002|Overall Study|Lost to Follow-up|6|||
17197936|NCT02711553|38351362|FG003|Overall Study|Lost to Follow-up|3|||
17197937|NCT02711553|38351359|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
17101720|NCT00389519|38240842|FG001|Randomized|Did not receive study drug|0|||
17101721|NCT00389519|38240843|FG002|Randomized|Did not receive study drug|0|||
17197938|NCT02711553|38351360|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
17197939|NCT02711553|38351361|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
17197940|NCT02711553|38351362|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
17197941|NCT02709369|38351374|FG000|Overall Study|Lost to Follow-up|15|||
17197942|NCT02709369|38351374|FG000|Overall Study|Withdrawal by Subject|10|||
17197943|NCT02709369|38351374|FG000|Overall Study|Did not received intervention|2|||
17197944|NCT02613182|38351378|FG000|Overall Study|Death|6|||
17197945|NCT02613182|38351378|FG000|Overall Study|Physician Decision|1|||
17197946|NCT02613182|38351378|FG000|Overall Study|Study Terminated by Sponsor|21|||
17197947|NCT02613182|38351378|FG000|Overall Study|Withdrawal by Subject|6|||
17197948|NCT02610842|38351382|FG000|Overall Study|Lost to Follow-up|5|||
17197949|NCT01648582|38351391|FG000|Overall Study|Adverse Event|6|||
17197950|NCT01648582|38351392|FG001|Overall Study|Adverse Event|11|||
17197951|NCT01648582|38351393|FG002|Overall Study|Adverse Event|2|||
17197952|NCT01648582|38351391|FG000|Overall Study|Lost to Follow-up|9|||
17197953|NCT01648582|38351392|FG001|Overall Study|Lost to Follow-up|6|||
17197954|NCT01648582|38351393|FG002|Overall Study|Lost to Follow-up|8|||
17197955|NCT01648582|38351391|FG000|Overall Study|Protocol Violation|1|||
17197956|NCT01648582|38351392|FG001|Overall Study|Protocol Violation|2|||
17197957|NCT01648582|38351393|FG002|Overall Study|Protocol Violation|1|||
17197958|NCT01648582|38351391|FG000|Overall Study|Withdrawal by Subject|15|||
17016003|NCT00857792|38160693|FG000|Overall Study|inadequate image quality for analysis|12|||
17016004|NCT00601835|38160699|FG000|Overall Study|Withdrawal by Subject|9|||
17016005|NCT00601835|38160700|FG001|Overall Study|Withdrawal by Subject|6|||
17016006|NCT00601835|38160699|FG000|Overall Study|Physician Decision|1|||
17016007|NCT00601835|38160700|FG001|Overall Study|Physician Decision|0|||
17016008|NCT00601835|38160699|FG000|Overall Study|Lost to Follow-up|37|||
17016009|NCT00601835|38160700|FG001|Overall Study|Lost to Follow-up|5|||
17016010|NCT00601835|38160699|FG000|Overall Study|Adverse Event|1|||
17016011|NCT00601835|38160700|FG001|Overall Study|Adverse Event|1|||
17016012|NCT00601835|38160699|FG000|Overall Study|Relocate|12|||
17016013|NCT00601835|38160700|FG001|Overall Study|Relocate|2|||
17016014|NCT00857246|38160706|FG000|Induction Regimen|Adverse Event|1|||
17016015|NCT00857246|38160706|FG000|Induction Regimen|disease-related complications|1|||
17101722|NCT00389519|38240844|FG003|Randomized|Did not receive study drug|0|||
17101723|NCT00389519|38240841|FG000|Treated|Adverse Event|1|||
17101724|NCT00389519|38240842|FG001|Treated|Adverse Event|0|||
17101725|NCT00389519|38240843|FG002|Treated|Adverse Event|0|||
17101726|NCT00389519|38240844|FG003|Treated|Adverse Event|2|||
17101727|NCT00389519|38240841|FG000|Treated|Reason not specified|1|||
17101728|NCT00389519|38240842|FG001|Treated|Reason not specified|1|||
17101729|NCT00389519|38240843|FG002|Treated|Reason not specified|0|||
17101730|NCT00389519|38240844|FG003|Treated|Reason not specified|2|||
17101731|NCT00389441|38240854|FG000|Overall Study|Adverse Event|7|||
17101732|NCT00389441|38240854|FG000|Overall Study|Death|4|||
17101733|NCT00389441|38240854|FG000|Overall Study|Lost to Follow-up|2|||
17101734|NCT00389441|38240854|FG000|Overall Study|Withdrawal by Subject|4|||
17101735|NCT00389441|38240854|FG000|Overall Study|Physician Decision|1|||
17101736|NCT00389441|38240854|FG000|Overall Study|Protocol Violation|1|||
17101737|NCT00389441|38240854|FG000|Overall Study|Global deterioration of health status|4|||
17101738|NCT00389441|38240854|FG000|Overall Study|Objective progression or relapse|26|||
17101739|NCT00389441|38240854|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
17101740|NCT00389441|38240854|FG000|Overall Study|Clinical progression|1|||
17101741|NCT00118898|38240862|FG000|Overall Study|Death|6|||
17101742|NCT00118898|38240863|FG001|Overall Study|Death|11|||
17197959|NCT01648582|38351392|FG001|Overall Study|Withdrawal by Subject|17|||
16787024|NCT01998880|37727401|FG000|Overall Study|Administrative/Other|1|||
16787025|NCT01998880|37727402|FG001|Overall Study|Administrative/Other|1|||
16787026|NCT01998880|37727401|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
16787027|NCT01998880|37727402|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
16787028|NCT01998880|37727401|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
16787029|NCT01998880|37727402|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
16787030|NCT01998880|37727401|FG000|Overall Study|Did Not Receive Treatment|3|||
16787031|NCT01998880|37727402|FG001|Overall Study|Did Not Receive Treatment|2|||
17016016|NCT00857246|38160706|FG000|Induction Regimen|Withdrawal by Subject|1|||
17016017|NCT00857246|38160706|FG000|Surgery (Curative)|disease progression|6|||
17016018|NCT00857246|38160706|FG000|ChemoRT|Withdrawal by Subject|1|||
17016019|NCT00857246|38160706|FG000|ChemoRT|Adverse Event|2|||
17016020|NCT00856856|38160713|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
17016021|NCT00856856|38160713|FG000|4-year Clinical Follow-up|Missed visit|1|||
17016022|NCT00493285|38160728|FG000|Overall Study|Lost to Follow-up|0|||
17016023|NCT00493285|38160729|FG001|Overall Study|Lost to Follow-up|0|||
17016024|NCT00493285|38160730|FG002|Overall Study|Lost to Follow-up|0|||
17016025|NCT00493285|38160731|FG003|Overall Study|Lost to Follow-up|0|||
17197960|NCT01648582|38351393|FG002|Overall Study|Withdrawal by Subject|17|||
16787032|NCT01975948|37727412|FG000|Overall Study|Withdrawal by Subject|17|||
17016026|NCT00493285|38160732|FG004|Overall Study|Lost to Follow-up|1|||
17101743|NCT00118898|38240864|FG002|Overall Study|Death|6|||
17101744|NCT00118898|38240865|FG003|Overall Study|Death|8|||
17101745|NCT00118898|38240862|FG000|Overall Study|Lost to Follow-up|26|||
17197961|NCT01648582|38351391|FG000|Overall Study|Physician Decision|0|||
17197962|NCT01648582|38351392|FG001|Overall Study|Physician Decision|1|||
17197963|NCT01648582|38351393|FG002|Overall Study|Physician Decision|3|||
17197964|NCT01648582|38351391|FG000|Overall Study|Death|1|||
17197965|NCT01648582|38351392|FG001|Overall Study|Death|0|||
17197966|NCT01648582|38351393|FG002|Overall Study|Death|0|||
17197967|NCT01648582|38351391|FG000|Overall Study|Sponsor Decision|0|||
17197968|NCT01648582|38351392|FG001|Overall Study|Sponsor Decision|1|||
16787033|NCT01975948|37727413|FG001|Overall Study|Withdrawal by Subject|21|||
16787034|NCT01975948|37727414|FG002|Overall Study|Withdrawal by Subject|7|||
16787035|NCT01975948|37727415|FG003|Overall Study|Withdrawal by Subject|6|||
16787036|NCT01975246|37727427|FG000|Overall Study|Adverse Event|2|||
16787037|NCT01975246|37727428|FG001|Overall Study|Adverse Event|1|||
16787038|NCT01975246|37727427|FG000|Overall Study|Lack of Efficacy|1|||
16787039|NCT01975246|37727428|FG001|Overall Study|Lack of Efficacy|0|||
16787040|NCT01975246|37727427|FG000|Overall Study|Protocol Violation|1|||
16787041|NCT01975246|37727428|FG001|Overall Study|Protocol Violation|0|||
16787042|NCT01975246|37727427|FG000|Overall Study|Other than stated|0|||
16787043|NCT01975246|37727428|FG001|Overall Study|Other than stated|1|||
16787044|NCT01621126|37727434|FG000|Overall Study|Physician Decision|6|||
16787045|NCT01973998|37727440|FG000|Overall Study|Death|2|||
16787046|NCT01973998|37727441|FG001|Overall Study|Death|2|||
16787047|NCT02664415|37727449|FG000|Overall Study|Adverse Event|1|||
16787048|NCT02664415|37727450|FG001|Overall Study|Adverse Event|0|||
16787049|NCT02661061|37727458|FG000|Overall Study|Lack of Efficacy|1|||
16787050|NCT02661061|37727459|FG001|Overall Study|Lack of Efficacy|1|||
16787051|NCT02661061|37727458|FG000|Overall Study|Withdrawal by Subject|1|||
16787052|NCT02661061|37727459|FG001|Overall Study|Withdrawal by Subject|1|||
16787053|NCT04148287|37727465|FG000|Overall Study|Death|2|||
16787054|NCT01995838|37727476|FG000|Overall Study|Lost to Follow-up|0|||
16787055|NCT01995838|37727477|FG001|Overall Study|Lost to Follow-up|1|||
16787056|NCT01995838|37727478|FG002|Overall Study|Lost to Follow-up|0|||
16787057|NCT01995838|37727479|FG003|Overall Study|Lost to Follow-up|0|||
16787058|NCT01995838|37727480|FG004|Overall Study|Lost to Follow-up|0|||
16787059|NCT01995838|37727481|FG005|Overall Study|Lost to Follow-up|0|||
16787060|NCT01995838|37727482|FG006|Overall Study|Lost to Follow-up|1|||
16787061|NCT01995838|37727476|FG000|Overall Study|Participant choice|2|||
16787062|NCT01995838|37727477|FG001|Overall Study|Participant choice|0|||
16787063|NCT01995838|37727478|FG002|Overall Study|Participant choice|0|||
16787064|NCT01995838|37727479|FG003|Overall Study|Participant choice|0|||
16787065|NCT01995838|37727480|FG004|Overall Study|Participant choice|0|||
16787066|NCT01995838|37727481|FG005|Overall Study|Participant choice|1|||
16787067|NCT01995838|37727482|FG006|Overall Study|Participant choice|1|||
16787068|NCT01995838|37727476|FG000|Overall Study|Adverse Event|0|||
16787069|NCT01995838|37727477|FG001|Overall Study|Adverse Event|0|||
16787070|NCT01995838|37727478|FG002|Overall Study|Adverse Event|0|||
16787071|NCT01995838|37727479|FG003|Overall Study|Adverse Event|0|||
16787072|NCT01995838|37727480|FG004|Overall Study|Adverse Event|0|||
16787073|NCT01995838|37727481|FG005|Overall Study|Adverse Event|0|||
16787074|NCT01995838|37727482|FG006|Overall Study|Adverse Event|1|||
16787075|NCT01995838|37727476|FG000|Overall Study|Withdrawal by Subject|0|||
16787076|NCT01995838|37727477|FG001|Overall Study|Withdrawal by Subject|0|||
16787077|NCT01995838|37727478|FG002|Overall Study|Withdrawal by Subject|0|||
16787078|NCT01995838|37727479|FG003|Overall Study|Withdrawal by Subject|0|||
16787079|NCT01995838|37727480|FG004|Overall Study|Withdrawal by Subject|1|||
16787080|NCT01995838|37727481|FG005|Overall Study|Withdrawal by Subject|0|||
16787081|NCT01995838|37727482|FG006|Overall Study|Withdrawal by Subject|0|||
16787082|NCT01995838|37727476|FG000|Overall Study|Other|3|||
16787083|NCT01995838|37727477|FG001|Overall Study|Other|1|||
16787084|NCT01995838|37727478|FG002|Overall Study|Other|0|||
16787085|NCT01995838|37727479|FG003|Overall Study|Other|2|||
16787086|NCT01995838|37727480|FG004|Overall Study|Other|1|||
16787087|NCT01995838|37727481|FG005|Overall Study|Other|1|||
17197969|NCT01648582|38351393|FG002|Overall Study|Sponsor Decision|1|||
16787088|NCT01995838|37727482|FG006|Overall Study|Other|2|||
16787089|NCT01957462|37727499|FG000|Test Period 1|Withdrawal by Subject|1|||
16787090|NCT01957462|37727500|FG001|Test Period 1|Withdrawal by Subject|0|||
16787091|NCT01957462|37727499|FG000|Test Period 1|Adverse Event|1|||
16787092|NCT01957462|37727500|FG001|Test Period 1|Adverse Event|0|||
16787093|NCT01957150|37727508|FG000|Overall Study|Adverse Event|23|||
16787094|NCT01957150|37727509|FG001|Overall Study|Adverse Event|20|||
16787095|NCT01957150|37727508|FG000|Overall Study|Withdrawal by Subject|13|||
16787096|NCT01957150|37727509|FG001|Overall Study|Withdrawal by Subject|17|||
16787097|NCT01957150|37727508|FG000|Overall Study|Physician Decision|3|||
16787098|NCT01957150|37727509|FG001|Overall Study|Physician Decision|6|||
16787099|NCT01957150|37727508|FG000|Overall Study|Lost to Follow-up|4|||
16787100|NCT01957150|37727509|FG001|Overall Study|Lost to Follow-up|4|||
16787101|NCT01957150|37727508|FG000|Overall Study|Protocol Violation|1|||
16787102|NCT01957150|37727509|FG001|Overall Study|Protocol Violation|0|||
16787103|NCT01957150|37727508|FG000|Overall Study|Lack of Efficacy|11|||
16787104|NCT01957150|37727509|FG001|Overall Study|Lack of Efficacy|11|||
16787105|NCT01955122|37727517|FG000|Overall Study|Physician Decision|5|||
17197970|NCT02607800|38351406|FG000|Overall Study|Lost to Follow-up|7|||
17197971|NCT02607800|38351407|FG001|Overall Study|Lost to Follow-up|10|||
17197972|NCT02607800|38351406|FG000|Overall Study|Withdrew Consent|2|||
17197973|NCT02607800|38351407|FG001|Overall Study|Withdrew Consent|0|||
17197974|NCT02607800|38351406|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
17197975|NCT02607800|38351407|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
17197976|NCT02304484|38351414|FG000|Overall Study|Death|9|||
17197977|NCT02304484|38351414|FG000|Overall Study|Withdrawal by Subject|14|||
17197978|NCT02304484|38351414|FG000|Overall Study|Lost to Follow-up|2|||
17197979|NCT02708355|38351421|FG000|Overall Study|Adverse Event|1|||
17197980|NCT02708355|38351422|FG001|Overall Study|Adverse Event|0|||
17197981|NCT02708355|38351423|FG002|Overall Study|Adverse Event|0|||
17197982|NCT02708277|38351433|FG000|Overall Study|Lost to Follow-up|7|||
17197983|NCT02708277|38351434|FG001|Overall Study|Lost to Follow-up|4|||
17197984|NCT02337478|38351440|FG000|Overall Study|Lack of Efficacy|5|||
17197985|NCT02303704|38351446|FG000|Overall Study|Protocol Violation|5|||
16787106|NCT01955122|37727518|FG001|Overall Study|Physician Decision|5|||
16787107|NCT01995526|37727530|FG000|Overall Study|Physician Decision|1|||
16787108|NCT01955044|37727537|FG000|Overall Study|Death|1|||
16787109|NCT01955044|37727538|FG001|Overall Study|Death|1|||
16787110|NCT01955044|37727539|FG002|Overall Study|Death|0|||
16787111|NCT01973218|37727549|FG000|Overall Study|Adverse Event|1|||
16787112|NCT01973218|37727550|FG001|Overall Study|Adverse Event|0|||
16787113|NCT01973218|37727549|FG000|Overall Study|Withdrawal by Subject|1|||
16787114|NCT01973218|37727550|FG001|Overall Study|Withdrawal by Subject|0|||
17197986|NCT02303704|38351447|FG001|Overall Study|Protocol Violation|9|||
17197987|NCT02608892|38351455|FG000|Overall Study|Lost to Follow-up|1|||
17197988|NCT02608892|38351456|FG001|Overall Study|Lost to Follow-up|0|||
17197989|NCT02706951|38351466|FG000|Overall Study|Adverse Event|1|||
17197990|NCT02706951|38351467|FG001|Overall Study|Adverse Event|5|||
17197991|NCT02706951|38351468|FG002|Overall Study|Adverse Event|3|||
17197992|NCT02706951|38351466|FG000|Overall Study|Withdrawal by Subject|11|||
17197993|NCT02706951|38351467|FG001|Overall Study|Withdrawal by Subject|6|||
17197994|NCT02706951|38351468|FG002|Overall Study|Withdrawal by Subject|6|||
17197995|NCT02706951|38351466|FG000|Overall Study|Lost to Follow-up|0|||
17197996|NCT02706951|38351467|FG001|Overall Study|Lost to Follow-up|4|||
17197997|NCT02706951|38351468|FG002|Overall Study|Lost to Follow-up|1|||
17197998|NCT02706951|38351466|FG000|Overall Study|Other|2|||
17197999|NCT02706951|38351467|FG001|Overall Study|Other|1|||
17198000|NCT02706951|38351468|FG002|Overall Study|Other|0|||
17198001|NCT02708121|38351478|FG000|Overall Study|Withdrawn by Study Team|1|||
17198002|NCT02708121|38351479|FG001|Overall Study|Withdrawn by Study Team|1|||
17198003|NCT02708121|38351478|FG000|Overall Study|Withdrawal by Subject|0|||
17198004|NCT02708121|38351479|FG001|Overall Study|Withdrawal by Subject|4|||
17198005|NCT02707965|38351494|FG000|Overall Study|Withdrawal by Subject|0|||
17198006|NCT02707965|38351495|FG001|Overall Study|Withdrawal by Subject|0|||
17198007|NCT02707965|38351496|FG002|Overall Study|Withdrawal by Subject|1|||
17198008|NCT02707965|38351497|FG003|Overall Study|Withdrawal by Subject|0|||
17198009|NCT02707965|38351498|FG004|Overall Study|Withdrawal by Subject|0|||
17198010|NCT02707965|38351499|FG005|Overall Study|Withdrawal by Subject|0|||
17198011|NCT02707965|38351500|FG006|Overall Study|Withdrawal by Subject|0|||
17198012|NCT02707965|38351501|FG007|Overall Study|Withdrawal by Subject|2|||
17198013|NCT02707965|38351502|FG008|Overall Study|Withdrawal by Subject|0|||
17198014|NCT02707965|38351503|FG009|Overall Study|Withdrawal by Subject|0|||
17198015|NCT02707965|38351504|FG010|Overall Study|Withdrawal by Subject|0|||
17198016|NCT02707965|38351505|FG011|Overall Study|Withdrawal by Subject|0|||
17198017|NCT02707965|38351506|FG012|Overall Study|Withdrawal by Subject|0|||
17198018|NCT02707965|38351507|FG013|Overall Study|Withdrawal by Subject|0|||
17198019|NCT02707965|38351508|FG014|Overall Study|Withdrawal by Subject|0|||
17198020|NCT02707965|38351509|FG015|Overall Study|Withdrawal by Subject|0|||
17198021|NCT02707965|38351494|FG000|Overall Study|PI decisions|0|||
17198022|NCT02707965|38351495|FG001|Overall Study|PI decisions|0|||
17198023|NCT02707965|38351496|FG002|Overall Study|PI decisions|0|||
17198024|NCT02707965|38351497|FG003|Overall Study|PI decisions|0|||
16787115|NCT01954342|37727562|FG000|Overall Study|Missing data from 13-16week study visit|0|||
16787116|NCT01954342|37727563|FG001|Overall Study|Missing data from 13-16week study visit|0|||
17101746|NCT00118898|38240863|FG001|Overall Study|Lost to Follow-up|34|||
17101747|NCT00118898|38240864|FG002|Overall Study|Lost to Follow-up|33|||
17101748|NCT00118898|38240865|FG003|Overall Study|Lost to Follow-up|33|||
17101749|NCT00118898|38240862|FG000|Overall Study|Withdrawal by Subject|10|||
17101750|NCT00118898|38240863|FG001|Overall Study|Withdrawal by Subject|5|||
17101751|NCT00118898|38240864|FG002|Overall Study|Withdrawal by Subject|8|||
17101752|NCT00118898|38240865|FG003|Overall Study|Withdrawal by Subject|8|||
17101753|NCT00118898|38240862|FG000|Overall Study|Site Closure|33|||
17101754|NCT00118898|38240863|FG001|Overall Study|Site Closure|31|||
17101755|NCT00118898|38240864|FG002|Overall Study|Site Closure|28|||
16787117|NCT01954342|37727564|FG002|Overall Study|Missing data from 13-16week study visit|0|||
17198025|NCT02707965|38351498|FG004|Overall Study|PI decisions|0|||
17198026|NCT02707965|38351499|FG005|Overall Study|PI decisions|0|||
17198027|NCT02707965|38351500|FG006|Overall Study|PI decisions|0|||
17101756|NCT00118898|38240865|FG003|Overall Study|Site Closure|37|||
17101757|NCT00118898|38240862|FG000|Overall Study|Severe debilitation|1|||
17101758|NCT00118898|38240863|FG001|Overall Study|Severe debilitation|4|||
17101759|NCT00118898|38240864|FG002|Overall Study|Severe debilitation|6|||
17101760|NCT00118898|38240865|FG003|Overall Study|Severe debilitation|4|||
17101761|NCT00118898|38240862|FG000|Overall Study|Not compliant with requirements|11|||
17101762|NCT00118898|38240863|FG001|Overall Study|Not compliant with requirements|13|||
17101763|NCT00118898|38240864|FG002|Overall Study|Not compliant with requirements|11|||
17198028|NCT02707965|38351501|FG007|Overall Study|PI decisions|0|||
16787118|NCT01954342|37727565|FG003|Overall Study|Missing data from 13-16week study visit|1|||
16787119|NCT01954342|37727562|FG000|Overall Study|Miscarriage|0|||
16787120|NCT01954342|37727563|FG001|Overall Study|Miscarriage|0|||
16787121|NCT01954342|37727564|FG002|Overall Study|Miscarriage|0|||
16787122|NCT01954342|37727565|FG003|Overall Study|Miscarriage|3|||
16787123|NCT01954342|37727562|FG000|Overall Study|Lost to Follow-up|0|||
16787124|NCT01954342|37727563|FG001|Overall Study|Lost to Follow-up|0|||
16787125|NCT01954342|37727564|FG002|Overall Study|Lost to Follow-up|0|||
16787126|NCT01954342|37727565|FG003|Overall Study|Lost to Follow-up|5|||
16787127|NCT01954342|37727562|FG000|Overall Study|Preterm delivery|0|||
16787128|NCT01954342|37727563|FG001|Overall Study|Preterm delivery|0|||
16787129|NCT01954342|37727564|FG002|Overall Study|Preterm delivery|0|||
16787130|NCT01954342|37727565|FG003|Overall Study|Preterm delivery|3|||
16787131|NCT01954342|37727562|FG000|Overall Study|Pre-eclampsia|0|||
16787132|NCT01954342|37727563|FG001|Overall Study|Pre-eclampsia|0|||
16787133|NCT01954342|37727564|FG002|Overall Study|Pre-eclampsia|0|||
16787134|NCT01954342|37727565|FG003|Overall Study|Pre-eclampsia|4|||
16787135|NCT01954342|37727562|FG000|Overall Study|Unreliable Data|0|||
16787136|NCT01954342|37727563|FG001|Overall Study|Unreliable Data|0|||
16787137|NCT01954342|37727564|FG002|Overall Study|Unreliable Data|0|||
16787138|NCT01954342|37727565|FG003|Overall Study|Unreliable Data|2|||
16787139|NCT01972438|37727577|FG000|Baseline-Month 3 Crossover Period|Death|1|||
16787140|NCT01972438|37727578|FG001|Baseline-Month 3 Crossover Period|Death|0|||
16787141|NCT01972438|37727577|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
16787142|NCT01972438|37727578|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
16787143|NCT01972438|37727577|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
16787144|NCT01972438|37727578|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
16787145|NCT01972438|37727577|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
16787146|NCT01972438|37727578|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
16787147|NCT01972438|37727577|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
16787148|NCT01972438|37727578|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
16787149|NCT01972438|37727577|FG000|Months 6-12 Study Period|Death|1|||
16787150|NCT01972438|37727578|FG001|Months 6-12 Study Period|Death|0|||
16787151|NCT01972438|37727577|FG000|Months 6-12 Study Period|Early Study Closure|2|||
16787152|NCT01972438|37727578|FG001|Months 6-12 Study Period|Early Study Closure|2|||
16787153|NCT01972438|37727577|FG000|Post Month 12 Study Period|Early Study Closure|3|||
16787154|NCT01972438|37727578|FG001|Post Month 12 Study Period|Early Study Closure|4|||
16787155|NCT01946152|37727590|FG000|Overall Study|Adverse Event|1|||
16787156|NCT01946152|37727591|FG001|Overall Study|Adverse Event|0|||
16787157|NCT01946152|37727592|FG002|Overall Study|Adverse Event|0|||
16787158|NCT01946152|37727593|FG003|Overall Study|Adverse Event|0|||
16787159|NCT01946152|37727590|FG000|Overall Study|Withdrawal by Subject|0|||
16787160|NCT01946152|37727591|FG001|Overall Study|Withdrawal by Subject|2|||
16787161|NCT01946152|37727592|FG002|Overall Study|Withdrawal by Subject|0|||
16787162|NCT01946152|37727593|FG003|Overall Study|Withdrawal by Subject|0|||
16787163|NCT01946152|37727590|FG000|Overall Study|Progression|0|||
16787164|NCT01946152|37727591|FG001|Overall Study|Progression|1|||
16787165|NCT01946152|37727592|FG002|Overall Study|Progression|4|||
16787166|NCT01946152|37727593|FG003|Overall Study|Progression|7|||
16787167|NCT01946152|37727590|FG000|Overall Study|Physician Decision|0|||
16787168|NCT01946152|37727591|FG001|Overall Study|Physician Decision|0|||
16787169|NCT01946152|37727592|FG002|Overall Study|Physician Decision|1|||
16787170|NCT01946152|37727593|FG003|Overall Study|Physician Decision|0|||
16787171|NCT01946152|37727590|FG000|Overall Study|Second malignancy|0|||
16787172|NCT01946152|37727591|FG001|Overall Study|Second malignancy|0|||
16787173|NCT01946152|37727592|FG002|Overall Study|Second malignancy|1|||
16787174|NCT01946152|37727593|FG003|Overall Study|Second malignancy|0|||
16787175|NCT01946152|37727590|FG000|Overall Study|Adverse Event|0|||
16787176|NCT01946152|37727591|FG001|Overall Study|Adverse Event|0|||
17101764|NCT00118898|38240865|FG003|Overall Study|Not compliant with requirements|11|||
17101765|NCT00118898|38240862|FG000|Overall Study|Not able to get to clinic|34|||
17101766|NCT00118898|38240863|FG001|Overall Study|Not able to get to clinic|43|||
17101767|NCT00118898|38240864|FG002|Overall Study|Not able to get to clinic|31|||
17101768|NCT00118898|38240865|FG003|Overall Study|Not able to get to clinic|40|||
17101769|NCT00118430|38240878|FG000|Overall Study|Withdrawal by Subject|6|||
16787177|NCT01946152|37727592|FG002|Overall Study|Adverse Event|0|||
16787178|NCT01946152|37727593|FG003|Overall Study|Adverse Event|1|||
16787179|NCT01945996|37727607|FG000|Overall Study|Lost to Follow-up|3|||
17198029|NCT02707965|38351502|FG008|Overall Study|PI decisions|0|||
17198030|NCT02707965|38351503|FG009|Overall Study|PI decisions|0|||
17198031|NCT02707965|38351504|FG010|Overall Study|PI decisions|0|||
17198032|NCT02707965|38351505|FG011|Overall Study|PI decisions|0|||
17198033|NCT02707965|38351506|FG012|Overall Study|PI decisions|0|||
17198034|NCT02707965|38351507|FG013|Overall Study|PI decisions|0|||
17198035|NCT02707965|38351508|FG014|Overall Study|PI decisions|2|||
17198036|NCT02707965|38351509|FG015|Overall Study|PI decisions|0|||
17198037|NCT02707965|38351494|FG000|Overall Study|Protocol deviation|1|||
17198038|NCT02707965|38351495|FG001|Overall Study|Protocol deviation|1|||
17198039|NCT02707965|38351496|FG002|Overall Study|Protocol deviation|0|||
17198040|NCT02707965|38351497|FG003|Overall Study|Protocol deviation|0|||
17198041|NCT02707965|38351498|FG004|Overall Study|Protocol deviation|0|||
17198042|NCT02707965|38351499|FG005|Overall Study|Protocol deviation|0|||
17198043|NCT02707965|38351500|FG006|Overall Study|Protocol deviation|0|||
17198044|NCT02707965|38351501|FG007|Overall Study|Protocol deviation|1|||
17198045|NCT02707965|38351502|FG008|Overall Study|Protocol deviation|0|||
17198046|NCT02707965|38351503|FG009|Overall Study|Protocol deviation|0|||
17198047|NCT02707965|38351504|FG010|Overall Study|Protocol deviation|0|||
17198048|NCT02707965|38351505|FG011|Overall Study|Protocol deviation|0|||
17198049|NCT02707965|38351506|FG012|Overall Study|Protocol deviation|0|||
17198050|NCT02707965|38351507|FG013|Overall Study|Protocol deviation|0|||
17198051|NCT02707965|38351508|FG014|Overall Study|Protocol deviation|0|||
17198052|NCT02707965|38351509|FG015|Overall Study|Protocol deviation|0|||
17101770|NCT00118430|38240879|FG001|Overall Study|Withdrawal by Subject|2|||
17101771|NCT00118430|38240880|FG002|Overall Study|Withdrawal by Subject|0|||
17198053|NCT01667900|38351547|FG000|Part B|Death|0|||
17198054|NCT01667900|38351548|FG001|Part B|Death|0|||
17198055|NCT01667900|38351549|FG002|Part B|Death|0|||
17198056|NCT01667900|38351550|FG003|Part B|Death|0|||
17198057|NCT01667900|38351551|FG004|Part B|Death|0|||
17198058|NCT01667900|38351552|FG005|Part B|Death|0|||
17198059|NCT01667900|38351553|FG006|Part B|Death|0|||
17198060|NCT01667900|38351554|FG007|Part B|Death|0|||
17198061|NCT01667900|38351555|FG008|Part B|Death|0|||
17198062|NCT01667900|38351556|FG009|Part B|Death|0|||
17198063|NCT01667900|38351557|FG010|Part B|Death|0|||
17198064|NCT01667900|38351558|FG011|Part B|Death|0|||
17198065|NCT01667900|38351559|FG012|Part B|Death|0|||
17198066|NCT01667900|38351560|FG013|Part B|Death|0|||
17198067|NCT01667900|38351561|FG014|Part B|Death|0|||
17198068|NCT01667900|38351562|FG015|Part B|Death|0|||
17198069|NCT01667900|38351563|FG016|Part B|Death|1|||
17198070|NCT01667900|38351564|FG017|Part B|Death|0|||
17198071|NCT01667900|38351565|FG018|Part B|Death|0|||
17198072|NCT01667900|38351566|FG019|Part B|Death|0|||
17198073|NCT02605928|38351595|FG000|Overall Study|Model tuning phase|28|||
17101772|NCT00118430|38240878|FG000|Overall Study|Lost to Follow-up|15|||
17101773|NCT00118430|38240879|FG001|Overall Study|Lost to Follow-up|22|||
17198074|NCT02605928|38351595|FG000|Overall Study|Lack of Efficacy|5|||
17198075|NCT02706717|38351601|FG000|Overall Study|Withdrawal by Subject|1|||
17198076|NCT02706717|38351602|FG001|Overall Study|Withdrawal by Subject|8|||
17101774|NCT00118430|38240880|FG002|Overall Study|Lost to Follow-up|28|||
17101775|NCT00090584|38240889|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
17101776|NCT00090584|38240890|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
17101777|NCT00090584|38240889|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
17101778|NCT00090584|38240890|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
17101779|NCT03670810|38240910|FG000|Main Study|Adverse Event|37|||
17101780|NCT03670810|38240911|FG001|Main Study|Adverse Event|38|||
17101781|NCT03670810|38240912|FG002|Main Study|Adverse Event|3|||
17101782|NCT03670810|38240913|FG003|Main Study|Adverse Event|4|||
17101783|NCT03670810|38240914|FG004|Main Study|Adverse Event|4|||
17101784|NCT03670810|38240915|FG005|Main Study|Adverse Event|5|||
17101785|NCT03670810|38240916|FG006|Main Study|Adverse Event|0|||
17101786|NCT03670810|38240917|FG007|Main Study|Adverse Event|0|||
17101787|NCT03670810|38240918|FG008|Main Study|Adverse Event|0|||
17101788|NCT03670810|38240910|FG000|Main Study|Lack of Efficacy|8|||
17101789|NCT03670810|38240911|FG001|Main Study|Lack of Efficacy|9|||
17101790|NCT03670810|38240912|FG002|Main Study|Lack of Efficacy|3|||
17198077|NCT02706717|38351601|FG000|Overall Study|Lost to Follow-up|0|||
17198078|NCT02706717|38351602|FG001|Overall Study|Lost to Follow-up|1|||
17198079|NCT02706717|38351601|FG000|Overall Study|Physician Decision|0|||
17198080|NCT02706717|38351602|FG001|Overall Study|Physician Decision|1|||
17198081|NCT02706717|38351601|FG000|Overall Study|Death|0|||
17198082|NCT02706717|38351602|FG001|Overall Study|Death|1|||
17198083|NCT01331837|38351610|FG000|Overall Study|Death|30|||
17198084|NCT01331837|38351611|FG001|Overall Study|Death|34|||
17101791|NCT03670810|38240913|FG003|Main Study|Lack of Efficacy|4|||
17198085|NCT01331837|38351610|FG000|Overall Study|Lost to Follow-up|3|||
17198086|NCT01331837|38351611|FG001|Overall Study|Lost to Follow-up|1|||
17198087|NCT01331837|38351610|FG000|Overall Study|Info not recorded|10|||
17198088|NCT01331837|38351611|FG001|Overall Study|Info not recorded|16|||
17198089|NCT01331837|38351610|FG000|Overall Study|Withdrawal by Subject|13|||
17198090|NCT01331837|38351611|FG001|Overall Study|Withdrawal by Subject|16|||
17198091|NCT02706483|38351617|FG000|Overall Study|Adverse Event|97|||
17101792|NCT03670810|38240914|FG004|Main Study|Lack of Efficacy|0|||
17101793|NCT03670810|38240915|FG005|Main Study|Lack of Efficacy|0|||
17101794|NCT03670810|38240916|FG006|Main Study|Lack of Efficacy|0|||
17101795|NCT03670810|38240917|FG007|Main Study|Lack of Efficacy|0|||
17101796|NCT03670810|38240918|FG008|Main Study|Lack of Efficacy|0|||
17198092|NCT02706483|38351617|FG000|Overall Study|Death|1|||
17198093|NCT02706483|38351617|FG000|Overall Study|Lack of Efficacy|39|||
17198094|NCT02706483|38351617|FG000|Overall Study|Lost to Follow-up|101|||
16787180|NCT01945996|37727608|FG001|Overall Study|Lost to Follow-up|5|||
16787181|NCT01971346|37727616|FG000|Overall Study|Protocol Violation|3|||
16787182|NCT01971346|37727616|FG000|Overall Study|Lost to Follow-up|2|||
16787183|NCT01971346|37727616|FG000|Overall Study|Withdrawal by Subject|2|||
16787184|NCT01971346|37727616|FG000|Overall Study|Physician Decision|1|||
16787185|NCT01945216|37727631|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
16787186|NCT01945216|37727631|FG000|Overall Study|Protocol Violation|42|||
16787187|NCT01945216|37727631|FG000|Overall Study|CRF not assured by investigators|5|||
16787188|NCT02641379|37727650|FG000|Overall Study|Exclusion criterion during screening|1|||
16787189|NCT02641379|37727651|FG001|Overall Study|Exclusion criterion during screening|0|||
16787190|NCT02641379|37727652|FG002|Overall Study|Exclusion criterion during screening|0|||
16787191|NCT02641379|37727653|FG003|Overall Study|Exclusion criterion during screening|1|||
16787192|NCT02641379|37727654|FG004|Overall Study|Exclusion criterion during screening|2|||
16787193|NCT02641379|37727655|FG005|Overall Study|Exclusion criterion during screening|0|||
16787194|NCT02641379|37727656|FG006|Overall Study|Exclusion criterion during screening|0|||
16787195|NCT02641379|37727657|FG007|Overall Study|Exclusion criterion during screening|0|||
16787196|NCT02641379|37727658|FG008|Overall Study|Exclusion criterion during screening|0|||
16787197|NCT02641379|37727659|FG009|Overall Study|Exclusion criterion during screening|0|||
16787198|NCT02641379|37727660|FG010|Overall Study|Exclusion criterion during screening|0|||
16787199|NCT02641379|37727650|FG000|Overall Study|Withdrawal of informed consent|0|||
16787200|NCT02641379|37727651|FG001|Overall Study|Withdrawal of informed consent|1|||
16787201|NCT02641379|37727652|FG002|Overall Study|Withdrawal of informed consent|0|||
16787202|NCT02641379|37727653|FG003|Overall Study|Withdrawal of informed consent|0|||
16787203|NCT02641379|37727654|FG004|Overall Study|Withdrawal of informed consent|0|||
16787204|NCT02641379|37727655|FG005|Overall Study|Withdrawal of informed consent|0|||
16787205|NCT02641379|37727656|FG006|Overall Study|Withdrawal of informed consent|0|||
16787206|NCT02641379|37727657|FG007|Overall Study|Withdrawal of informed consent|1|||
16787207|NCT02641379|37727658|FG008|Overall Study|Withdrawal of informed consent|0|||
16787208|NCT02641379|37727659|FG009|Overall Study|Withdrawal of informed consent|0|||
16787209|NCT02641379|37727660|FG010|Overall Study|Withdrawal of informed consent|0|||
16787210|NCT02641379|37727650|FG000|Overall Study|Adverse Event|7|||
16787211|NCT02641379|37727651|FG001|Overall Study|Adverse Event|8|||
16787212|NCT02641379|37727652|FG002|Overall Study|Adverse Event|2|||
16787213|NCT02641379|37727653|FG003|Overall Study|Adverse Event|2|||
16787214|NCT02641379|37727654|FG004|Overall Study|Adverse Event|5|||
16787215|NCT02641379|37727655|FG005|Overall Study|Adverse Event|1|||
16787216|NCT02641379|37727656|FG006|Overall Study|Adverse Event|5|||
16787217|NCT02641379|37727657|FG007|Overall Study|Adverse Event|0|||
16787218|NCT02641379|37727658|FG008|Overall Study|Adverse Event|1|||
16787219|NCT02641379|37727659|FG009|Overall Study|Adverse Event|1|||
16787220|NCT02641379|37727660|FG010|Overall Study|Adverse Event|5|||
16787221|NCT02641379|37727650|FG000|Overall Study|Lack of Efficacy|0|||
16787222|NCT02641379|37727651|FG001|Overall Study|Lack of Efficacy|0|||
17101797|NCT03670810|38240910|FG000|Main Study|Lost to Follow-up|9|||
17101798|NCT03670810|38240911|FG001|Main Study|Lost to Follow-up|7|||
17101799|NCT03670810|38240912|FG002|Main Study|Lost to Follow-up|4|||
17101800|NCT03670810|38240913|FG003|Main Study|Lost to Follow-up|6|||
17198095|NCT02706483|38351617|FG000|Overall Study|Non-compliance with study drug|15|||
17198096|NCT02706483|38351617|FG000|Overall Study|Physician Decision|6|||
17198097|NCT02706483|38351617|FG000|Overall Study|Pregnancy|6|||
17198098|NCT02706483|38351617|FG000|Overall Study|Protocol Violation|18|||
17016027|NCT00493285|38160733|FG005|Overall Study|Lost to Follow-up|0|||
17016028|NCT00856778|38160747|FG000|Overall Study|Adverse Event|7|||
17016029|NCT00856778|38160747|FG000|Overall Study|Withdrawal by Subject|10|||
17016030|NCT00856778|38160747|FG000|Overall Study|Study deviation|2|||
17016031|NCT00856778|38160747|FG000|Overall Study|Lost to Follow-up|5|||
17016032|NCT00603473|38160751|FG000|Overall Study|Adverse Event|4|||
17016033|NCT00603473|38160751|FG000|Overall Study|Lack of Efficacy|4|||
17016034|NCT00603473|38160751|FG000|Overall Study|Protocol Violation|1|||
17016035|NCT00486889|38160755|FG000|Overall Study|Death|3|||
17198099|NCT02706483|38351617|FG000|Overall Study|Withdrawal by Subject|136|||
17198100|NCT02706483|38351617|FG000|Overall Study|Non-compliance with visits|6|||
17198101|NCT02706483|38351617|FG000|Overall Study|Site closure|4|||
17198102|NCT02706483|38351617|FG000|Overall Study|Subject moved|1|||
17198103|NCT01648348|38351624|FG000|Overall Study|Cancel|1|||
17198104|NCT01648348|38351625|FG001|Overall Study|Cancel|0|||
17198105|NCT01648348|38351626|FG002|Overall Study|Cancel|0|||
17198106|NCT01648348|38351627|FG003|Overall Study|Cancel|0|||
17198107|NCT01648348|38351628|FG004|Overall Study|Cancel|3|||
17198108|NCT01648348|38351629|FG005|Overall Study|Cancel|6|||
17198109|NCT01648348|38351624|FG000|Overall Study|Replaced for MTD analysis|1|||
17198110|NCT01648348|38351625|FG001|Overall Study|Replaced for MTD analysis|0|||
17198111|NCT01648348|38351626|FG002|Overall Study|Replaced for MTD analysis|1|||
17198112|NCT01648348|38351627|FG003|Overall Study|Replaced for MTD analysis|0|||
17198113|NCT01648348|38351628|FG004|Overall Study|Replaced for MTD analysis|0|||
17198114|NCT01648348|38351629|FG005|Overall Study|Replaced for MTD analysis|0|||
17198115|NCT01648270|38351642|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
17198116|NCT02302846|38351652|FG000|Overall Study|Withdrawal by Subject|1|||
17198117|NCT02336230|38351656|FG000|Overall Study|Adverse Event|1|||
17198118|NCT02336230|38351656|FG000|Overall Study|Withdrawal of consent|1|||
17198119|NCT02336230|38351656|FG000|Overall Study|Death|9|||
17198120|NCT02336230|38351656|FG000|Overall Study|Dose not received due to shipping delay|1|||
17198121|NCT02336230|38351656|FG000|Overall Study|Discontinuation of MSC infusion|1|||
17198122|NCT02302222|38351662|FG000|Overall Study|Physician Decision|0|||
17198123|NCT02302222|38351663|FG001|Overall Study|Physician Decision|4|||
17198124|NCT02302222|38351662|FG000|Overall Study|Lost to Follow-up|1|||
17198125|NCT02302222|38351663|FG001|Overall Study|Lost to Follow-up|0|||
17198126|NCT02302222|38351662|FG000|Overall Study|Treatment discontinued before day 5|0|||
17198127|NCT02302222|38351663|FG001|Overall Study|Treatment discontinued before day 5|1|||
17198128|NCT02302222|38351662|FG000|Overall Study|Withdrawn prior to any treatment|0|||
17198129|NCT02302222|38351663|FG001|Overall Study|Withdrawn prior to any treatment|1|||
17198130|NCT02336074|38351671|FG000|Overall Study|Adverse Event|0|||
17198131|NCT02336074|38351672|FG001|Overall Study|Adverse Event|2|||
17198132|NCT02335450|38351683|FG000|Overall Study|Pregnancy|1|||
17198133|NCT02603432|38351695|FG000|Overall Study|Ongoing|184|||
17198134|NCT02603432|38351696|FG001|Overall Study|Ongoing|144|||
17016036|NCT00486889|38160755|FG000|Overall Study|Non-compliant|2|||
17101801|NCT03670810|38240914|FG004|Main Study|Lost to Follow-up|1|||
17101802|NCT03670810|38240915|FG005|Main Study|Lost to Follow-up|0|||
17101803|NCT03670810|38240916|FG006|Main Study|Lost to Follow-up|0|||
17101804|NCT03670810|38240917|FG007|Main Study|Lost to Follow-up|0|||
17101805|NCT03670810|38240918|FG008|Main Study|Lost to Follow-up|0|||
17101806|NCT03670810|38240910|FG000|Main Study|Non-compliance with Study Drug|0|||
17101807|NCT03670810|38240911|FG001|Main Study|Non-compliance with Study Drug|2|||
17101808|NCT03670810|38240912|FG002|Main Study|Non-compliance with Study Drug|3|||
17101809|NCT03670810|38240913|FG003|Main Study|Non-compliance with Study Drug|0|||
17016037|NCT00486889|38160755|FG000|Overall Study|Withdrawal by Subject|6|||
17016038|NCT02577406|38160761|FG000|Randomized Period|Death|1|||
17016039|NCT02577406|38160762|FG001|Randomized Period|Death|0|||
17016040|NCT02577406|38160761|FG000|Randomized Period|Other reasons|0|||
17016041|NCT02577406|38160762|FG001|Randomized Period|Other reasons|20|||
17016042|NCT02577406|38160761|FG000|Treatment Period|Transition to commercially available treatment|1|||
17016043|NCT02577406|38160762|FG001|Treatment Period|Transition to commercially available treatment|0|||
17016044|NCT02577406|38160761|FG000|Treatment Period|Progressive disease|47|||
17016045|NCT02577406|38160762|FG001|Treatment Period|Progressive disease|36|||
17016046|NCT02577406|38160761|FG000|Treatment Period|Death|36|||
17016047|NCT02577406|38160762|FG001|Treatment Period|Death|23|||
17016048|NCT02577406|38160761|FG000|Treatment Period|Other reasons|3|||
17101810|NCT03670810|38240914|FG004|Main Study|Non-compliance with Study Drug|0|||
17101811|NCT03670810|38240915|FG005|Main Study|Non-compliance with Study Drug|0|||
17101812|NCT03670810|38240916|FG006|Main Study|Non-compliance with Study Drug|0|||
17016049|NCT02577406|38160762|FG001|Treatment Period|Other reasons|37|||
17016050|NCT02577406|38160761|FG000|Treatment Period|Withdrawal by Subject|10|||
17016051|NCT02577406|38160762|FG001|Treatment Period|Withdrawal by Subject|24|||
17016052|NCT02577406|38160761|FG000|Treatment Period|Adverse Event|17|||
17101813|NCT03670810|38240917|FG007|Main Study|Non-compliance with Study Drug|1|||
17198135|NCT02603432|38351695|FG000|Overall Study|Adverse Event|1|||
17198136|NCT02603432|38351696|FG001|Overall Study|Adverse Event|0|||
17198137|NCT02603432|38351695|FG000|Overall Study|Death|144|||
17016053|NCT02577406|38160762|FG001|Treatment Period|Adverse Event|12|||
17198138|NCT02603432|38351696|FG001|Overall Study|Death|177|||
17198139|NCT02603432|38351695|FG000|Overall Study|Lost to Follow-up|4|||
17198140|NCT02603432|38351696|FG001|Overall Study|Lost to Follow-up|6|||
17198141|NCT02603432|38351695|FG000|Overall Study|Progressive Disease|5|||
17198142|NCT02603432|38351696|FG001|Overall Study|Progressive Disease|5|||
17198143|NCT02603432|38351695|FG000|Overall Study|Withdrawal by Subject|9|||
17198144|NCT02603432|38351696|FG001|Overall Study|Withdrawal by Subject|17|||
17198145|NCT02603432|38351695|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
17198146|NCT02603432|38351696|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
17198147|NCT02603432|38351695|FG000|Overall Study|Other|0|||
17198148|NCT02603432|38351696|FG001|Overall Study|Other|1|||
17198149|NCT02302066|38351706|FG000|Overall Study|Adverse Event|1|||
17198150|NCT02302066|38351707|FG001|Overall Study|Adverse Event|1|||
17198151|NCT02302066|38351708|FG002|Overall Study|Adverse Event|3|||
17198152|NCT02302066|38351709|FG003|Overall Study|Adverse Event|0|||
17198153|NCT02302066|38351706|FG000|Overall Study|Lost to Follow-up|4|||
17198154|NCT02302066|38351707|FG001|Overall Study|Lost to Follow-up|5|||
17198155|NCT02302066|38351708|FG002|Overall Study|Lost to Follow-up|24|||
17198156|NCT02302066|38351709|FG003|Overall Study|Lost to Follow-up|7|||
17198157|NCT02302066|38351706|FG000|Overall Study|Withdrawal by Subject|25|||
17198158|NCT02302066|38351707|FG001|Overall Study|Withdrawal by Subject|58|||
16787223|NCT02641379|37727652|FG002|Overall Study|Lack of Efficacy|2|||
16787224|NCT02641379|37727653|FG003|Overall Study|Lack of Efficacy|0|||
16787225|NCT02641379|37727654|FG004|Overall Study|Lack of Efficacy|0|||
16787226|NCT02641379|37727655|FG005|Overall Study|Lack of Efficacy|2|||
16787227|NCT02641379|37727656|FG006|Overall Study|Lack of Efficacy|0|||
16787228|NCT02641379|37727657|FG007|Overall Study|Lack of Efficacy|5|||
16787229|NCT02641379|37727658|FG008|Overall Study|Lack of Efficacy|0|||
16787230|NCT02641379|37727659|FG009|Overall Study|Lack of Efficacy|0|||
16787231|NCT02641379|37727660|FG010|Overall Study|Lack of Efficacy|0|||
16787232|NCT02641379|37727650|FG000|Overall Study|Participant unable to attend study visit|4|||
16787233|NCT02641379|37727651|FG001|Overall Study|Participant unable to attend study visit|10|||
16787234|NCT02641379|37727652|FG002|Overall Study|Participant unable to attend study visit|1|||
17198159|NCT02302066|38351708|FG002|Overall Study|Withdrawal by Subject|124|||
16787235|NCT02641379|37727653|FG003|Overall Study|Participant unable to attend study visit|2|||
16787236|NCT02641379|37727654|FG004|Overall Study|Participant unable to attend study visit|5|||
16787237|NCT02641379|37727655|FG005|Overall Study|Participant unable to attend study visit|1|||
16787238|NCT02641379|37727656|FG006|Overall Study|Participant unable to attend study visit|1|||
16787239|NCT02641379|37727657|FG007|Overall Study|Participant unable to attend study visit|1|||
16787240|NCT02641379|37727658|FG008|Overall Study|Participant unable to attend study visit|0|||
16787241|NCT02641379|37727659|FG009|Overall Study|Participant unable to attend study visit|2|||
16787242|NCT02641379|37727660|FG010|Overall Study|Participant unable to attend study visit|0|||
16787243|NCT02641379|37727650|FG000|Overall Study|Participant's compliance|0|||
17198160|NCT02302066|38351709|FG003|Overall Study|Withdrawal by Subject|33|||
17198161|NCT02302066|38351706|FG000|Overall Study|Pregnancy|2|||
16787244|NCT02641379|37727651|FG001|Overall Study|Participant's compliance|1|||
16787245|NCT02641379|37727652|FG002|Overall Study|Participant's compliance|0|||
16787246|NCT02641379|37727653|FG003|Overall Study|Participant's compliance|1|||
17101814|NCT03670810|38240918|FG008|Main Study|Non-compliance with Study Drug|0|||
17101815|NCT03670810|38240910|FG000|Main Study|Physician Decision|3|||
17101816|NCT03670810|38240911|FG001|Main Study|Physician Decision|0|||
17101817|NCT03670810|38240912|FG002|Main Study|Physician Decision|1|||
17101818|NCT03670810|38240913|FG003|Main Study|Physician Decision|0|||
17101819|NCT03670810|38240914|FG004|Main Study|Physician Decision|0|||
17101820|NCT03670810|38240915|FG005|Main Study|Physician Decision|0|||
17101821|NCT03670810|38240916|FG006|Main Study|Physician Decision|1|||
17101822|NCT03670810|38240917|FG007|Main Study|Physician Decision|1|||
17101823|NCT03670810|38240918|FG008|Main Study|Physician Decision|0|||
17101824|NCT03670810|38240910|FG000|Main Study|Pregnancy|1|||
17101825|NCT03670810|38240911|FG001|Main Study|Pregnancy|2|||
17101826|NCT03670810|38240912|FG002|Main Study|Pregnancy|0|||
17101827|NCT03670810|38240913|FG003|Main Study|Pregnancy|0|||
17101828|NCT03670810|38240914|FG004|Main Study|Pregnancy|0|||
17101829|NCT03670810|38240915|FG005|Main Study|Pregnancy|0|||
17101830|NCT03670810|38240916|FG006|Main Study|Pregnancy|0|||
17101831|NCT03670810|38240917|FG007|Main Study|Pregnancy|0|||
17101832|NCT03670810|38240918|FG008|Main Study|Pregnancy|0|||
17101833|NCT03670810|38240910|FG000|Main Study|Protocol Deviation|2|||
17101834|NCT03670810|38240911|FG001|Main Study|Protocol Deviation|12|||
17101835|NCT03670810|38240912|FG002|Main Study|Protocol Deviation|8|||
17101836|NCT03670810|38240913|FG003|Main Study|Protocol Deviation|4|||
17101837|NCT03670810|38240914|FG004|Main Study|Protocol Deviation|0|||
17101838|NCT03670810|38240915|FG005|Main Study|Protocol Deviation|0|||
17101839|NCT03670810|38240916|FG006|Main Study|Protocol Deviation|0|||
17101840|NCT03670810|38240917|FG007|Main Study|Protocol Deviation|0|||
17198162|NCT02302066|38351707|FG001|Overall Study|Pregnancy|10|||
17198163|NCT02302066|38351708|FG002|Overall Study|Pregnancy|12|||
17198164|NCT02302066|38351709|FG003|Overall Study|Pregnancy|0|||
16787247|NCT02641379|37727654|FG004|Overall Study|Participant's compliance|0|||
16787248|NCT02641379|37727655|FG005|Overall Study|Participant's compliance|2|||
16787249|NCT02641379|37727656|FG006|Overall Study|Participant's compliance|0|||
16787250|NCT02641379|37727657|FG007|Overall Study|Participant's compliance|0|||
16787251|NCT02641379|37727658|FG008|Overall Study|Participant's compliance|1|||
16787252|NCT02641379|37727659|FG009|Overall Study|Participant's compliance|1|||
16787253|NCT02641379|37727660|FG010|Overall Study|Participant's compliance|1|||
16787254|NCT02641379|37727650|FG000|Overall Study|Participant cannot be reached|4|||
16787255|NCT02641379|37727651|FG001|Overall Study|Participant cannot be reached|4|||
16787256|NCT02641379|37727652|FG002|Overall Study|Participant cannot be reached|0|||
16908614|NCT01774968|38017345|FG001|Overall Study|Sponsor Decision|2|||
17101841|NCT03670810|38240918|FG008|Main Study|Protocol Deviation|0|||
17101842|NCT03670810|38240910|FG000|Main Study|Withdrawal by Subject|21|||
17101843|NCT03670810|38240911|FG001|Main Study|Withdrawal by Subject|21|||
17101844|NCT03670810|38240912|FG002|Main Study|Withdrawal by Subject|8|||
17101845|NCT03670810|38240913|FG003|Main Study|Withdrawal by Subject|9|||
17101846|NCT03670810|38240914|FG004|Main Study|Withdrawal by Subject|5|||
17101847|NCT03670810|38240915|FG005|Main Study|Withdrawal by Subject|2|||
17101848|NCT03670810|38240916|FG006|Main Study|Withdrawal by Subject|1|||
17101849|NCT03670810|38240917|FG007|Main Study|Withdrawal by Subject|1|||
17198165|NCT02302066|38351706|FG000|Overall Study|Reason Not Specified|1|||
17198166|NCT02302066|38351707|FG001|Overall Study|Reason Not Specified|1|||
17198167|NCT02302066|38351708|FG002|Overall Study|Reason Not Specified|9|||
17198168|NCT02302066|38351709|FG003|Overall Study|Reason Not Specified|1|||
17198169|NCT02790437|38351731|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
17198170|NCT02790437|38351732|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
17198171|NCT02790437|38351731|FG000|Overall Study|Adverse Event|1|||
17198172|NCT02790437|38351732|FG001|Overall Study|Adverse Event|0|||
17198173|NCT02790437|38351731|FG000|Overall Study|Withdrawal by Subject|1|||
17198174|NCT02790437|38351732|FG001|Overall Study|Withdrawal by Subject|0|||
17198175|NCT02301988|38351747|FG000|Overall Study|Withdrawal by Subject|2|||
17198176|NCT02301988|38351748|FG001|Overall Study|Withdrawal by Subject|1|||
17198177|NCT02301988|38351747|FG000|Overall Study|Physician Decision|2|||
17198178|NCT02301988|38351748|FG001|Overall Study|Physician Decision|2|||
17198179|NCT02301988|38351747|FG000|Overall Study|Unknown Reason|1|||
17198180|NCT02301988|38351748|FG001|Overall Study|Unknown Reason|3|||
17198181|NCT02301988|38351747|FG000|Overall Study|Lack of Efficacy|3|||
17198182|NCT02301988|38351748|FG001|Overall Study|Lack of Efficacy|2|||
17198183|NCT02301988|38351747|FG000|Overall Study|Death|1|||
17198184|NCT02301988|38351748|FG001|Overall Study|Death|0|||
17198185|NCT02301988|38351747|FG000|Overall Study|Adverse Event|1|||
17198186|NCT02301988|38351748|FG001|Overall Study|Adverse Event|1|||
17198187|NCT02334748|38351763|FG000|Overall Study|Adverse Event|1|||
17198188|NCT02334748|38351763|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
17198189|NCT02334748|38351763|FG000|Overall Study|Patient no longer required study drug|2|||
17198190|NCT02334748|38351763|FG000|Overall Study|Lack of Efficacy|4|||
17198191|NCT02332876|38351769|FG000|Overall Study|Lost to Follow-up|1|||
17198192|NCT02332876|38351770|FG001|Overall Study|Lost to Follow-up|1|||
17198193|NCT02332798|38351779|FG000|Overall Study|Unwilling to Participate in Study|0|||
17198194|NCT02332798|38351780|FG001|Overall Study|Unwilling to Participate in Study|1|||
17198195|NCT02332798|38351781|FG002|Overall Study|Unwilling to Participate in Study|1|||
17198196|NCT02332798|38351779|FG000|Overall Study|Positive Urine Drug Test|0|||
17198197|NCT02332798|38351780|FG001|Overall Study|Positive Urine Drug Test|1|||
17198198|NCT02332798|38351781|FG002|Overall Study|Positive Urine Drug Test|0|||
17198199|NCT02332798|38351779|FG000|Overall Study|Abnormal Laboratory Findings|1|||
17198200|NCT02332798|38351780|FG001|Overall Study|Abnormal Laboratory Findings|0|||
17198201|NCT02332798|38351781|FG002|Overall Study|Abnormal Laboratory Findings|0|||
17198202|NCT02604212|38351793|FG000|Overall Study|Study Terminated by Sponsor|2|||
17198203|NCT02604212|38351794|FG001|Overall Study|Study Terminated by Sponsor|1|||
17198204|NCT02604212|38351795|FG002|Overall Study|Study Terminated by Sponsor|3|||
17198205|NCT02604212|38351796|FG003|Overall Study|Study Terminated by Sponsor|3|||
17101850|NCT03670810|38240918|FG008|Main Study|Withdrawal by Subject|0|||
17101851|NCT03670810|38240910|FG000|Main Study|Participant did not want to take the three other treatments|1|||
17101852|NCT03670810|38240911|FG001|Main Study|Participant did not want to take the three other treatments|0|||
17101853|NCT03670810|38240912|FG002|Main Study|Participant did not want to take the three other treatments|0|||
17101854|NCT03670810|38240913|FG003|Main Study|Participant did not want to take the three other treatments|0|||
17101855|NCT03670810|38240914|FG004|Main Study|Participant did not want to take the three other treatments|0|||
17101856|NCT03670810|38240915|FG005|Main Study|Participant did not want to take the three other treatments|0|||
17101857|NCT03670810|38240916|FG006|Main Study|Participant did not want to take the three other treatments|0|||
17101858|NCT03670810|38240917|FG007|Main Study|Participant did not want to take the three other treatments|0|||
17101859|NCT03670810|38240918|FG008|Main Study|Participant did not want to take the three other treatments|0|||
17101860|NCT03670810|38240910|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
17198206|NCT02604212|38351793|FG000|Overall Study|Withdrawal by Subject|0|||
17101861|NCT03670810|38240911|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
17101862|NCT03670810|38240912|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
17101863|NCT03670810|38240913|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
17101864|NCT03670810|38240914|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
17101865|NCT03670810|38240915|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
17101866|NCT03670810|38240916|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
17101867|NCT03670810|38240917|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
17101868|NCT03670810|38240918|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
17101869|NCT03670810|38240910|FG000|Main Study|Travel and Coronavirus issues|0|||
17101870|NCT03670810|38240911|FG001|Main Study|Travel and Coronavirus issues|0|||
17101871|NCT03670810|38240912|FG002|Main Study|Travel and Coronavirus issues|0|||
17101872|NCT03670810|38240913|FG003|Main Study|Travel and Coronavirus issues|1|||
17101873|NCT03670810|38240914|FG004|Main Study|Travel and Coronavirus issues|0|||
17101874|NCT03670810|38240915|FG005|Main Study|Travel and Coronavirus issues|0|||
17101875|NCT03670810|38240916|FG006|Main Study|Travel and Coronavirus issues|0|||
17101876|NCT03670810|38240917|FG007|Main Study|Travel and Coronavirus issues|0|||
17101877|NCT03670810|38240918|FG008|Main Study|Travel and Coronavirus issues|0|||
17101878|NCT03670810|38240910|FG000|Open Label Extension|Protocol Deviation|0|||
17101879|NCT03670810|38240911|FG001|Open Label Extension|Protocol Deviation|0|||
17101880|NCT03670810|38240912|FG002|Open Label Extension|Protocol Deviation|0|||
17101881|NCT03670810|38240913|FG003|Open Label Extension|Protocol Deviation|0|||
17101882|NCT03670810|38240914|FG004|Open Label Extension|Protocol Deviation|0|||
17101883|NCT03670810|38240915|FG005|Open Label Extension|Protocol Deviation|0|||
17101884|NCT03670810|38240916|FG006|Open Label Extension|Protocol Deviation|0|||
17101885|NCT03670810|38240917|FG007|Open Label Extension|Protocol Deviation|0|||
17101886|NCT03670810|38240918|FG008|Open Label Extension|Protocol Deviation|5|||
17101887|NCT03670810|38240910|FG000|Open Label Extension|Death|0|||
17101888|NCT03670810|38240911|FG001|Open Label Extension|Death|0|||
17101889|NCT03670810|38240912|FG002|Open Label Extension|Death|0|||
17101890|NCT03670810|38240913|FG003|Open Label Extension|Death|0|||
17101891|NCT03670810|38240914|FG004|Open Label Extension|Death|0|||
17101892|NCT03670810|38240915|FG005|Open Label Extension|Death|0|||
17101893|NCT03670810|38240916|FG006|Open Label Extension|Death|0|||
17101894|NCT03670810|38240917|FG007|Open Label Extension|Death|0|||
17101895|NCT03670810|38240918|FG008|Open Label Extension|Death|1|||
17101896|NCT03670810|38240910|FG000|Open Label Extension|COVID-19|0|||
17101897|NCT03670810|38240911|FG001|Open Label Extension|COVID-19|0|||
17101898|NCT03670810|38240912|FG002|Open Label Extension|COVID-19|0|||
17101899|NCT03670810|38240913|FG003|Open Label Extension|COVID-19|0|||
17101900|NCT03670810|38240914|FG004|Open Label Extension|COVID-19|0|||
17101901|NCT03670810|38240915|FG005|Open Label Extension|COVID-19|0|||
17101902|NCT03670810|38240916|FG006|Open Label Extension|COVID-19|0|||
17101903|NCT03670810|38240917|FG007|Open Label Extension|COVID-19|0|||
17101904|NCT03670810|38240918|FG008|Open Label Extension|COVID-19|1|||
17101905|NCT03670810|38240910|FG000|Open Label Extension|Lack of Efficacy|0|||
17101906|NCT03670810|38240911|FG001|Open Label Extension|Lack of Efficacy|0|||
17016054|NCT02577406|38160761|FG000|Treatment Period|Disease relapse|27|||
17016055|NCT02577406|38160762|FG001|Treatment Period|Disease relapse|1|||
17016056|NCT02577406|38160761|FG000|Treatment Period|HSCT|6|||
17016057|NCT02577406|38160762|FG001|Treatment Period|HSCT|2|||
17016058|NCT02577406|38160761|FG000|Treatment Period|Lost to Follow-up|0|||
17016059|NCT02577406|38160762|FG001|Treatment Period|Lost to Follow-up|1|||
17016060|NCT02577406|38160761|FG000|Treatment Period|Protocol Violation|0|||
17016061|NCT02577406|38160762|FG001|Treatment Period|Protocol Violation|1|||
17016062|NCT00486811|38160775|FG000|Overall Study|Adverse Event|28|||
17101907|NCT03670810|38240912|FG002|Open Label Extension|Lack of Efficacy|0|||
17101908|NCT03670810|38240913|FG003|Open Label Extension|Lack of Efficacy|0|||
17101909|NCT03670810|38240914|FG004|Open Label Extension|Lack of Efficacy|0|||
17101910|NCT03670810|38240915|FG005|Open Label Extension|Lack of Efficacy|0|||
17101911|NCT03670810|38240916|FG006|Open Label Extension|Lack of Efficacy|0|||
17101912|NCT03670810|38240917|FG007|Open Label Extension|Lack of Efficacy|0|||
17101913|NCT03670810|38240918|FG008|Open Label Extension|Lack of Efficacy|39|||
17101914|NCT03670810|38240910|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
17101915|NCT03670810|38240911|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
17101916|NCT03670810|38240912|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
17101917|NCT03670810|38240913|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
17101918|NCT03670810|38240914|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
17101919|NCT03670810|38240915|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
17101920|NCT03670810|38240916|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
17101921|NCT03670810|38240917|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
17101922|NCT03670810|38240918|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
17101923|NCT03670810|38240910|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
17101924|NCT03670810|38240911|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
17101925|NCT03670810|38240912|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
17101926|NCT03670810|38240913|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
17101927|NCT03670810|38240914|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
17101928|NCT03670810|38240915|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
17101929|NCT03670810|38240916|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
17101930|NCT03670810|38240917|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
17101931|NCT03670810|38240918|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
17101932|NCT03670810|38240910|FG000|Open Label Extension|Withdrawal by Subject|0|||
17101933|NCT03670810|38240911|FG001|Open Label Extension|Withdrawal by Subject|0|||
17101934|NCT03670810|38240912|FG002|Open Label Extension|Withdrawal by Subject|0|||
17101935|NCT03670810|38240913|FG003|Open Label Extension|Withdrawal by Subject|0|||
17101936|NCT03670810|38240914|FG004|Open Label Extension|Withdrawal by Subject|0|||
17101937|NCT03670810|38240915|FG005|Open Label Extension|Withdrawal by Subject|0|||
17101938|NCT03670810|38240916|FG006|Open Label Extension|Withdrawal by Subject|0|||
17101939|NCT03670810|38240917|FG007|Open Label Extension|Withdrawal by Subject|0|||
17101940|NCT03670810|38240918|FG008|Open Label Extension|Withdrawal by Subject|46|||
17101941|NCT03670810|38240910|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
17101942|NCT03670810|38240911|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
17101943|NCT03670810|38240912|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
17101944|NCT03670810|38240913|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
17101945|NCT03670810|38240914|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
17101946|NCT03670810|38240915|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
17101947|NCT03670810|38240916|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
17101948|NCT03670810|38240917|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
17101949|NCT03670810|38240918|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
17101950|NCT03670810|38240910|FG000|Open Label Extension|Physician Decision|0|||
17101951|NCT03670810|38240911|FG001|Open Label Extension|Physician Decision|0|||
17101952|NCT03670810|38240912|FG002|Open Label Extension|Physician Decision|0|||
17101953|NCT03670810|38240913|FG003|Open Label Extension|Physician Decision|0|||
17101954|NCT03670810|38240914|FG004|Open Label Extension|Physician Decision|0|||
17101955|NCT03670810|38240915|FG005|Open Label Extension|Physician Decision|0|||
17101956|NCT03670810|38240916|FG006|Open Label Extension|Physician Decision|0|||
17101957|NCT03670810|38240917|FG007|Open Label Extension|Physician Decision|0|||
17101958|NCT03670810|38240918|FG008|Open Label Extension|Physician Decision|2|||
17101959|NCT03670810|38240910|FG000|Open Label Extension|Non-compliance with study drug|0|||
17101960|NCT03670810|38240911|FG001|Open Label Extension|Non-compliance with study drug|0|||
17101961|NCT03670810|38240912|FG002|Open Label Extension|Non-compliance with study drug|0|||
16787257|NCT02641379|37727653|FG003|Overall Study|Participant cannot be reached|8|||
17016063|NCT00486811|38160776|FG001|Overall Study|Adverse Event|60|||
17016064|NCT00486811|38160777|FG002|Overall Study|Adverse Event|135|||
17016065|NCT00486811|38160775|FG000|Overall Study|Lack of Efficacy|34|||
17016066|NCT00486811|38160776|FG001|Overall Study|Lack of Efficacy|14|||
17016067|NCT00486811|38160777|FG002|Overall Study|Lack of Efficacy|7|||
17016068|NCT00486811|38160775|FG000|Overall Study|Lost to Follow-up|4|||
17016069|NCT00486811|38160776|FG001|Overall Study|Lost to Follow-up|6|||
17016070|NCT00486811|38160777|FG002|Overall Study|Lost to Follow-up|4|||
16787258|NCT02641379|37727654|FG004|Overall Study|Participant cannot be reached|2|||
16787259|NCT02641379|37727655|FG005|Overall Study|Participant cannot be reached|1|||
16787260|NCT02641379|37727656|FG006|Overall Study|Participant cannot be reached|0|||
16787261|NCT02641379|37727657|FG007|Overall Study|Participant cannot be reached|1|||
16787262|NCT02641379|37727658|FG008|Overall Study|Participant cannot be reached|0|||
16787263|NCT02641379|37727659|FG009|Overall Study|Participant cannot be reached|2|||
16787264|NCT02641379|37727660|FG010|Overall Study|Participant cannot be reached|1|||
16787265|NCT02641379|37727650|FG000|Overall Study|PCR positive at Week 24|15|||
16787266|NCT02641379|37727651|FG001|Overall Study|PCR positive at Week 24|21|||
16787267|NCT02641379|37727652|FG002|Overall Study|PCR positive at Week 24|62|||
16787268|NCT02641379|37727653|FG003|Overall Study|PCR positive at Week 24|0|||
16787269|NCT02641379|37727654|FG004|Overall Study|PCR positive at Week 24|0|||
16787270|NCT02641379|37727655|FG005|Overall Study|PCR positive at Week 24|6|||
16787271|NCT02641379|37727656|FG006|Overall Study|PCR positive at Week 24|3|||
16787272|NCT02641379|37727657|FG007|Overall Study|PCR positive at Week 24|8|||
16787273|NCT02641379|37727658|FG008|Overall Study|PCR positive at Week 24|0|||
16787274|NCT02641379|37727659|FG009|Overall Study|PCR positive at Week 24|1|||
16787275|NCT02641379|37727660|FG010|Overall Study|PCR positive at Week 24|0|||
17016071|NCT00486811|38160775|FG000|Overall Study|Withdrawal by Subject|33|||
17016072|NCT00486811|38160776|FG001|Overall Study|Withdrawal by Subject|44|||
17016073|NCT00486811|38160777|FG002|Overall Study|Withdrawal by Subject|58|||
17101962|NCT03670810|38240913|FG003|Open Label Extension|Non-compliance with study drug|0|||
17101963|NCT03670810|38240914|FG004|Open Label Extension|Non-compliance with study drug|0|||
17101964|NCT03670810|38240915|FG005|Open Label Extension|Non-compliance with study drug|0|||
17101965|NCT03670810|38240916|FG006|Open Label Extension|Non-compliance with study drug|0|||
16787276|NCT02641379|37727650|FG000|Overall Study|PCR positive at follow up 2|1|||
16787277|NCT02641379|37727651|FG001|Overall Study|PCR positive at follow up 2|0|||
16787278|NCT02641379|37727652|FG002|Overall Study|PCR positive at follow up 2|0|||
16787279|NCT02641379|37727653|FG003|Overall Study|PCR positive at follow up 2|0|||
16787280|NCT02641379|37727654|FG004|Overall Study|PCR positive at follow up 2|0|||
16787281|NCT02641379|37727655|FG005|Overall Study|PCR positive at follow up 2|0|||
16787282|NCT02641379|37727656|FG006|Overall Study|PCR positive at follow up 2|0|||
16787283|NCT02641379|37727657|FG007|Overall Study|PCR positive at follow up 2|0|||
16787284|NCT02641379|37727658|FG008|Overall Study|PCR positive at follow up 2|0|||
16787285|NCT02641379|37727659|FG009|Overall Study|PCR positive at follow up 2|0|||
16787286|NCT02641379|37727660|FG010|Overall Study|PCR positive at follow up 2|0|||
16787287|NCT02641379|37727650|FG000|Overall Study|Participant showed relapse|1|||
16787288|NCT02641379|37727651|FG001|Overall Study|Participant showed relapse|0|||
16787289|NCT02641379|37727652|FG002|Overall Study|Participant showed relapse|0|||
16787290|NCT02641379|37727653|FG003|Overall Study|Participant showed relapse|0|||
16787291|NCT02641379|37727654|FG004|Overall Study|Participant showed relapse|0|||
16787292|NCT02641379|37727655|FG005|Overall Study|Participant showed relapse|0|||
16787293|NCT02641379|37727656|FG006|Overall Study|Participant showed relapse|1|||
16787294|NCT02641379|37727657|FG007|Overall Study|Participant showed relapse|0|||
16787295|NCT02641379|37727658|FG008|Overall Study|Participant showed relapse|0|||
16787296|NCT02641379|37727659|FG009|Overall Study|Participant showed relapse|0|||
16787297|NCT02641379|37727660|FG010|Overall Study|Participant showed relapse|0|||
16787298|NCT02641379|37727650|FG000|Overall Study|Participant stopped study/treatment|1|||
16787299|NCT02641379|37727651|FG001|Overall Study|Participant stopped study/treatment|3|||
16787300|NCT02641379|37727652|FG002|Overall Study|Participant stopped study/treatment|1|||
16787301|NCT02641379|37727653|FG003|Overall Study|Participant stopped study/treatment|0|||
16787302|NCT02641379|37727654|FG004|Overall Study|Participant stopped study/treatment|0|||
16787303|NCT02641379|37727655|FG005|Overall Study|Participant stopped study/treatment|1|||
16787304|NCT02641379|37727656|FG006|Overall Study|Participant stopped study/treatment|2|||
16787305|NCT02641379|37727657|FG007|Overall Study|Participant stopped study/treatment|0|||
16787306|NCT02641379|37727658|FG008|Overall Study|Participant stopped study/treatment|1|||
16787307|NCT02641379|37727659|FG009|Overall Study|Participant stopped study/treatment|0|||
16787308|NCT02641379|37727660|FG010|Overall Study|Participant stopped study/treatment|0|||
16787309|NCT02641379|37727650|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
16787310|NCT02641379|37727651|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
16787311|NCT02641379|37727652|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
16787312|NCT02641379|37727653|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
16787313|NCT02641379|37727654|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
16787314|NCT02641379|37727655|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
16787315|NCT02641379|37727656|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
16787316|NCT02641379|37727657|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
16787317|NCT02641379|37727658|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
16787318|NCT02641379|37727659|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
16787319|NCT02641379|37727660|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
16787320|NCT02641379|37727650|FG000|Overall Study|Financial problems|0|||
16787321|NCT02641379|37727651|FG001|Overall Study|Financial problems|1|||
16787322|NCT02641379|37727652|FG002|Overall Study|Financial problems|0|||
16787323|NCT02641379|37727653|FG003|Overall Study|Financial problems|0|||
16787324|NCT02641379|37727654|FG004|Overall Study|Financial problems|0|||
16787325|NCT02641379|37727655|FG005|Overall Study|Financial problems|0|||
16787326|NCT02641379|37727656|FG006|Overall Study|Financial problems|0|||
16787327|NCT02641379|37727657|FG007|Overall Study|Financial problems|0|||
16787328|NCT02641379|37727658|FG008|Overall Study|Financial problems|0|||
16787329|NCT02641379|37727659|FG009|Overall Study|Financial problems|0|||
16787330|NCT02641379|37727660|FG010|Overall Study|Financial problems|0|||
16787331|NCT02641379|37727650|FG000|Overall Study|PCR positive at Week 68|0|||
16787332|NCT02641379|37727651|FG001|Overall Study|PCR positive at Week 68|1|||
16787333|NCT02641379|37727652|FG002|Overall Study|PCR positive at Week 68|0|||
16787334|NCT02641379|37727653|FG003|Overall Study|PCR positive at Week 68|0|||
16787335|NCT02641379|37727654|FG004|Overall Study|PCR positive at Week 68|0|||
17016074|NCT00486811|38160775|FG000|Overall Study|Study drug non-compliant|5|||
16787336|NCT02641379|37727655|FG005|Overall Study|PCR positive at Week 68|0|||
16787337|NCT02641379|37727656|FG006|Overall Study|PCR positive at Week 68|0|||
16787338|NCT02641379|37727657|FG007|Overall Study|PCR positive at Week 68|0|||
17016075|NCT00486811|38160776|FG001|Overall Study|Study drug non-compliant|6|||
17016076|NCT00486811|38160777|FG002|Overall Study|Study drug non-compliant|3|||
17016077|NCT00486811|38160775|FG000|Overall Study|All other|18|||
17016078|NCT00486811|38160776|FG001|Overall Study|All other|11|||
17016079|NCT00486811|38160777|FG002|Overall Study|All other|7|||
17101966|NCT03670810|38240917|FG007|Open Label Extension|Non-compliance with study drug|0|||
17101967|NCT03670810|38240918|FG008|Open Label Extension|Non-compliance with study drug|5|||
17101968|NCT03670810|38240910|FG000|Open Label Extension|Pregnancy|0|||
17101969|NCT03670810|38240911|FG001|Open Label Extension|Pregnancy|0|||
17101970|NCT03670810|38240912|FG002|Open Label Extension|Pregnancy|0|||
17101971|NCT03670810|38240913|FG003|Open Label Extension|Pregnancy|0|||
17101972|NCT03670810|38240914|FG004|Open Label Extension|Pregnancy|0|||
17101973|NCT03670810|38240915|FG005|Open Label Extension|Pregnancy|0|||
17101974|NCT03670810|38240916|FG006|Open Label Extension|Pregnancy|0|||
17101975|NCT03670810|38240917|FG007|Open Label Extension|Pregnancy|0|||
17101976|NCT03670810|38240918|FG008|Open Label Extension|Pregnancy|3|||
17101977|NCT03670810|38240910|FG000|Open Label Extension|Adverse Event|0|||
17101978|NCT03670810|38240911|FG001|Open Label Extension|Adverse Event|0|||
17101979|NCT03670810|38240912|FG002|Open Label Extension|Adverse Event|0|||
17101980|NCT03670810|38240913|FG003|Open Label Extension|Adverse Event|0|||
17101981|NCT03670810|38240914|FG004|Open Label Extension|Adverse Event|0|||
17101982|NCT03670810|38240915|FG005|Open Label Extension|Adverse Event|0|||
17101983|NCT03670810|38240916|FG006|Open Label Extension|Adverse Event|0|||
17101984|NCT03670810|38240917|FG007|Open Label Extension|Adverse Event|0|||
17101985|NCT03670810|38240918|FG008|Open Label Extension|Adverse Event|24|||
17101986|NCT03670810|38240910|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
17101987|NCT03670810|38240911|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
17101988|NCT03670810|38240912|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
17101989|NCT03670810|38240913|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
17101990|NCT03670810|38240914|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
17101991|NCT03670810|38240915|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
17101992|NCT03670810|38240916|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
17101993|NCT03670810|38240917|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
17101994|NCT03670810|38240918|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
17101995|NCT03670810|38240910|FG000|Open Label Extension|Lost to Follow-up|0|||
17101996|NCT03670810|38240911|FG001|Open Label Extension|Lost to Follow-up|0|||
17101997|NCT03670810|38240912|FG002|Open Label Extension|Lost to Follow-up|0|||
17101998|NCT03670810|38240913|FG003|Open Label Extension|Lost to Follow-up|0|||
17101999|NCT03670810|38240914|FG004|Open Label Extension|Lost to Follow-up|0|||
17102000|NCT03670810|38240915|FG005|Open Label Extension|Lost to Follow-up|0|||
17102001|NCT03670810|38240916|FG006|Open Label Extension|Lost to Follow-up|0|||
17102002|NCT03670810|38240917|FG007|Open Label Extension|Lost to Follow-up|0|||
17102003|NCT03670810|38240918|FG008|Open Label Extension|Lost to Follow-up|23|||
17102004|NCT00089648|38240932|FG000|Overall Study|Adverse Event|7|||
17102005|NCT00089648|38240932|FG000|Overall Study|Withdrawal by Subject|1|||
17102006|NCT00089648|38240932|FG000|Overall Study|Lack of Efficacy|33|||
17102007|NCT00118040|38240939|FG000|Overall Study|Adverse Event|0|||
17102008|NCT00118040|38240940|FG001|Overall Study|Adverse Event|1|||
17102009|NCT00118040|38240941|FG002|Overall Study|Adverse Event|0|||
17102010|NCT00118040|38240939|FG000|Overall Study|Withdrawal by Subject|0|||
17102011|NCT00118040|38240940|FG001|Overall Study|Withdrawal by Subject|0|||
17102012|NCT00118040|38240941|FG002|Overall Study|Withdrawal by Subject|2|||
17102013|NCT00118040|38240939|FG000|Overall Study|Medical Contraindication|0|||
17198207|NCT02604212|38351794|FG001|Overall Study|Withdrawal by Subject|0|||
17198208|NCT02604212|38351795|FG002|Overall Study|Withdrawal by Subject|1|||
17198209|NCT02604212|38351796|FG003|Overall Study|Withdrawal by Subject|0|||
17198210|NCT02789111|38351813|FG000|Overall Study|Withdrawal by Subject|1|||
17198211|NCT02789111|38351814|FG001|Overall Study|Withdrawal by Subject|4|||
17198212|NCT01359644|38351832|FG000|Treatment Period|Lack of Efficacy|0|||
17198213|NCT01359644|38351833|FG001|Treatment Period|Lack of Efficacy|1|||
17198214|NCT01359644|38351834|FG002|Treatment Period|Lack of Efficacy|0|||
17102014|NCT00118040|38240940|FG001|Overall Study|Medical Contraindication|0|||
17102015|NCT00118040|38240941|FG002|Overall Study|Medical Contraindication|1|||
17102016|NCT00118040|38240939|FG000|Overall Study|Non-Compliant Participant|1|||
17102017|NCT00118040|38240940|FG001|Overall Study|Non-Compliant Participant|1|||
17102018|NCT00118040|38240941|FG002|Overall Study|Non-Compliant Participant|2|||
17102019|NCT00118040|38240939|FG000|Overall Study|Other|0|||
17102020|NCT00118040|38240940|FG001|Overall Study|Other|0|||
17102021|NCT00118040|38240941|FG002|Overall Study|Other|1|||
17102022|NCT00389207|38240957|FG000|Overall Study|Adverse Event|26|||
17102023|NCT00389207|38240958|FG001|Overall Study|Adverse Event|32|||
17102024|NCT00389207|38240959|FG002|Overall Study|Adverse Event|10|||
17102025|NCT00389207|38240957|FG000|Overall Study|Protocol Violation|3|||
17102026|NCT00389207|38240958|FG001|Overall Study|Protocol Violation|1|||
17102027|NCT00389207|38240959|FG002|Overall Study|Protocol Violation|4|||
17102028|NCT00389207|38240957|FG000|Overall Study|Lost to Follow-up|12|||
17102029|NCT00389207|38240958|FG001|Overall Study|Lost to Follow-up|9|||
17102030|NCT00389207|38240959|FG002|Overall Study|Lost to Follow-up|7|||
17102031|NCT00389207|38240957|FG000|Overall Study|Withdrawal by Subject|5|||
17198215|NCT01359644|38351835|FG003|Treatment Period|Lack of Efficacy|0|||
17102032|NCT00389207|38240958|FG001|Overall Study|Withdrawal by Subject|7|||
17102033|NCT00389207|38240959|FG002|Overall Study|Withdrawal by Subject|11|||
17102034|NCT00389207|38240957|FG000|Overall Study|Other|17|||
17102035|NCT00389207|38240958|FG001|Overall Study|Other|23|||
17102036|NCT00389207|38240959|FG002|Overall Study|Other|9|||
17102037|NCT00388973|38240974|FG000|Overall Study|Adverse Event|16|||
17102038|NCT00388973|38240975|FG001|Overall Study|Adverse Event|6|||
16787339|NCT02641379|37727658|FG008|Overall Study|PCR positive at Week 68|0|||
16787340|NCT02641379|37727659|FG009|Overall Study|PCR positive at Week 68|0|||
16787341|NCT02641379|37727660|FG010|Overall Study|PCR positive at Week 68|0|||
16787342|NCT02641379|37727650|FG000|Overall Study|PCR positive at Week 48|0|||
16787343|NCT02641379|37727651|FG001|Overall Study|PCR positive at Week 48|1|||
16787344|NCT02641379|37727652|FG002|Overall Study|PCR positive at Week 48|0|||
16787345|NCT02641379|37727653|FG003|Overall Study|PCR positive at Week 48|0|||
16787346|NCT02641379|37727654|FG004|Overall Study|PCR positive at Week 48|0|||
16787347|NCT02641379|37727655|FG005|Overall Study|PCR positive at Week 48|0|||
16787348|NCT02641379|37727656|FG006|Overall Study|PCR positive at Week 48|0|||
16787349|NCT02641379|37727657|FG007|Overall Study|PCR positive at Week 48|0|||
16787350|NCT02641379|37727658|FG008|Overall Study|PCR positive at Week 48|0|||
16787351|NCT02641379|37727659|FG009|Overall Study|PCR positive at Week 48|0|||
16787352|NCT02641379|37727660|FG010|Overall Study|PCR positive at Week 48|0|||
16787353|NCT02641379|37727650|FG000|Overall Study|PCR not performed at Week 12|0|||
16787354|NCT02641379|37727651|FG001|Overall Study|PCR not performed at Week 12|0|||
16787355|NCT02641379|37727652|FG002|Overall Study|PCR not performed at Week 12|1|||
16787356|NCT02641379|37727653|FG003|Overall Study|PCR not performed at Week 12|0|||
16787357|NCT02641379|37727654|FG004|Overall Study|PCR not performed at Week 12|0|||
16787358|NCT02641379|37727655|FG005|Overall Study|PCR not performed at Week 12|0|||
16787359|NCT02641379|37727656|FG006|Overall Study|PCR not performed at Week 12|0|||
16787360|NCT02641379|37727657|FG007|Overall Study|PCR not performed at Week 12|0|||
16787361|NCT02641379|37727658|FG008|Overall Study|PCR not performed at Week 12|0|||
16787362|NCT02641379|37727659|FG009|Overall Study|PCR not performed at Week 12|0|||
16787363|NCT02641379|37727660|FG010|Overall Study|PCR not performed at Week 12|0|||
16787364|NCT02641379|37727650|FG000|Overall Study|No PCR at baseline|0|||
16787365|NCT02641379|37727651|FG001|Overall Study|No PCR at baseline|0|||
16787366|NCT02641379|37727652|FG002|Overall Study|No PCR at baseline|1|||
16787367|NCT02641379|37727653|FG003|Overall Study|No PCR at baseline|0|||
16787368|NCT02641379|37727654|FG004|Overall Study|No PCR at baseline|0|||
16787369|NCT02641379|37727655|FG005|Overall Study|No PCR at baseline|0|||
16787370|NCT02641379|37727656|FG006|Overall Study|No PCR at baseline|0|||
16787371|NCT02641379|37727657|FG007|Overall Study|No PCR at baseline|0|||
16787372|NCT02641379|37727658|FG008|Overall Study|No PCR at baseline|0|||
16787373|NCT02641379|37727659|FG009|Overall Study|No PCR at baseline|0|||
16787374|NCT02641379|37727660|FG010|Overall Study|No PCR at baseline|0|||
16787375|NCT02641379|37727650|FG000|Overall Study|PCR positive at Week 28|0|||
16787376|NCT02641379|37727651|FG001|Overall Study|PCR positive at Week 28|0|||
16787377|NCT02641379|37727652|FG002|Overall Study|PCR positive at Week 28|1|||
16787378|NCT02641379|37727653|FG003|Overall Study|PCR positive at Week 28|0|||
16787379|NCT02641379|37727654|FG004|Overall Study|PCR positive at Week 28|0|||
16787380|NCT02641379|37727655|FG005|Overall Study|PCR positive at Week 28|0|||
16787381|NCT02641379|37727656|FG006|Overall Study|PCR positive at Week 28|0|||
16787382|NCT02641379|37727657|FG007|Overall Study|PCR positive at Week 28|0|||
16787383|NCT02641379|37727658|FG008|Overall Study|PCR positive at Week 28|0|||
16787384|NCT02641379|37727659|FG009|Overall Study|PCR positive at Week 28|0|||
16787385|NCT02641379|37727660|FG010|Overall Study|PCR positive at Week 28|0|||
16787386|NCT02641379|37727650|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
16787387|NCT02641379|37727651|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
16787388|NCT02641379|37727652|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
16787389|NCT02641379|37727653|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
16787390|NCT02641379|37727654|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
16787391|NCT02641379|37727655|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
16787392|NCT02641379|37727656|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
16787393|NCT02641379|37727657|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
16787394|NCT02641379|37727658|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
16787395|NCT02641379|37727659|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
17016080|NCT00486265|38160785|FG000|Overall Study|Adverse Event|1|||
16787396|NCT02641379|37727660|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
16787397|NCT02641379|37727650|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
16787398|NCT02641379|37727651|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
16787399|NCT02641379|37727652|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
16787400|NCT02641379|37727653|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
16787401|NCT02641379|37727654|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
17016081|NCT00486265|38160785|FG000|Overall Study|Lack of Efficacy|8|||
17102039|NCT00388973|38240974|FG000|Overall Study|Lack of Efficacy|1|||
17102040|NCT00388973|38240975|FG001|Overall Study|Lack of Efficacy|12|||
17198216|NCT01359644|38351836|FG004|Treatment Period|Lack of Efficacy|0|||
17198217|NCT01359644|38351837|FG005|Treatment Period|Lack of Efficacy|0|||
17198218|NCT01359644|38351838|FG006|Treatment Period|Lack of Efficacy|0|||
17198219|NCT01359644|38351839|FG007|Treatment Period|Lack of Efficacy|0|||
17198220|NCT01359644|38351840|FG008|Treatment Period|Lack of Efficacy|0|||
17198221|NCT01359644|38351841|FG009|Treatment Period|Lack of Efficacy|0|||
17198222|NCT01359644|38351832|FG000|Treatment Period|Adverse Event|0|||
17198223|NCT01359644|38351833|FG001|Treatment Period|Adverse Event|0|||
17198224|NCT01359644|38351834|FG002|Treatment Period|Adverse Event|1|||
17198225|NCT01359644|38351835|FG003|Treatment Period|Adverse Event|0|||
17198226|NCT01359644|38351836|FG004|Treatment Period|Adverse Event|0|||
17198227|NCT01359644|38351837|FG005|Treatment Period|Adverse Event|1|||
17198228|NCT01359644|38351838|FG006|Treatment Period|Adverse Event|0|||
17198229|NCT01359644|38351839|FG007|Treatment Period|Adverse Event|0|||
17198230|NCT01359644|38351840|FG008|Treatment Period|Adverse Event|0|||
17198231|NCT01359644|38351841|FG009|Treatment Period|Adverse Event|0|||
17198232|NCT01359644|38351832|FG000|Treatment Period|Lost to Follow-up|0|||
17198233|NCT01359644|38351833|FG001|Treatment Period|Lost to Follow-up|0|||
17198234|NCT01359644|38351834|FG002|Treatment Period|Lost to Follow-up|0|||
17198235|NCT01359644|38351835|FG003|Treatment Period|Lost to Follow-up|0|||
17198236|NCT01359644|38351836|FG004|Treatment Period|Lost to Follow-up|0|||
17198237|NCT01359644|38351837|FG005|Treatment Period|Lost to Follow-up|1|||
17198238|NCT01359644|38351838|FG006|Treatment Period|Lost to Follow-up|0|||
17198239|NCT01359644|38351839|FG007|Treatment Period|Lost to Follow-up|0|||
17198240|NCT01359644|38351840|FG008|Treatment Period|Lost to Follow-up|0|||
17198241|NCT01359644|38351841|FG009|Treatment Period|Lost to Follow-up|0|||
17198242|NCT01359644|38351832|FG000|Follow-up Period|Withdrawal by Subject|0|||
17198243|NCT01359644|38351833|FG001|Follow-up Period|Withdrawal by Subject|0|||
17198244|NCT01359644|38351834|FG002|Follow-up Period|Withdrawal by Subject|0|||
16787402|NCT02641379|37727655|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
16787403|NCT02641379|37727656|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
16787404|NCT02641379|37727657|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
16787405|NCT02641379|37727658|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
16787406|NCT02641379|37727659|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
16787407|NCT02641379|37727660|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
16787408|NCT02641379|37727650|FG000|Overall Study|Baseline viral load unavailable|0|||
16787409|NCT02641379|37727651|FG001|Overall Study|Baseline viral load unavailable|0|||
16787410|NCT02641379|37727652|FG002|Overall Study|Baseline viral load unavailable|0|||
16908615|NCT01774968|38017344|FG000|Overall Study|Withdrawal by Subject|6|||
16908616|NCT01774968|38017345|FG001|Overall Study|Withdrawal by Subject|11|||
17016082|NCT02151604|38160789|FG000|Overall Study|Lost to Follow-up|3|||
16787411|NCT02641379|37727653|FG003|Overall Study|Baseline viral load unavailable|1|||
16787412|NCT02641379|37727654|FG004|Overall Study|Baseline viral load unavailable|0|||
16787413|NCT02641379|37727655|FG005|Overall Study|Baseline viral load unavailable|0|||
16787414|NCT02641379|37727656|FG006|Overall Study|Baseline viral load unavailable|0|||
16787415|NCT02641379|37727657|FG007|Overall Study|Baseline viral load unavailable|0|||
16787416|NCT02641379|37727658|FG008|Overall Study|Baseline viral load unavailable|0|||
16787417|NCT02641379|37727659|FG009|Overall Study|Baseline viral load unavailable|0|||
16787418|NCT02641379|37727660|FG010|Overall Study|Baseline viral load unavailable|0|||
16787419|NCT02641379|37727650|FG000|Overall Study|Blood could not be drawn|0|||
16787420|NCT02641379|37727651|FG001|Overall Study|Blood could not be drawn|0|||
16787421|NCT02641379|37727652|FG002|Overall Study|Blood could not be drawn|0|||
16787422|NCT02641379|37727653|FG003|Overall Study|Blood could not be drawn|0|||
16787423|NCT02641379|37727654|FG004|Overall Study|Blood could not be drawn|1|||
16787424|NCT02641379|37727655|FG005|Overall Study|Blood could not be drawn|0|||
16787425|NCT02641379|37727656|FG006|Overall Study|Blood could not be drawn|0|||
16787426|NCT02641379|37727657|FG007|Overall Study|Blood could not be drawn|0|||
16787427|NCT02641379|37727658|FG008|Overall Study|Blood could not be drawn|0|||
16787428|NCT02641379|37727659|FG009|Overall Study|Blood could not be drawn|0|||
16787429|NCT02641379|37727660|FG010|Overall Study|Blood could not be drawn|0|||
16787430|NCT02641379|37727650|FG000|Overall Study|Protocol Violation|0|||
16787431|NCT02641379|37727651|FG001|Overall Study|Protocol Violation|0|||
16787432|NCT02641379|37727652|FG002|Overall Study|Protocol Violation|0|||
16787433|NCT02641379|37727653|FG003|Overall Study|Protocol Violation|0|||
16787434|NCT02641379|37727654|FG004|Overall Study|Protocol Violation|2|||
16787435|NCT02641379|37727655|FG005|Overall Study|Protocol Violation|0|||
17016083|NCT02151604|38160789|FG000|Overall Study|Withdrawal by Subject|2|||
17198245|NCT01359644|38351835|FG003|Follow-up Period|Withdrawal by Subject|0|||
17016084|NCT02151604|38160789|FG000|Overall Study|Physician Decision|3|||
17016085|NCT02151604|38160789|FG000|Overall Study|Death|1|||
17016086|NCT00466921|38160794|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
17016087|NCT00466921|38160794|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
17016088|NCT00466921|38160794|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
17016089|NCT00466921|38160794|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
17016090|NCT00466921|38160794|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
17016091|NCT00466921|38160794|FG000|Follow up for a Minimum of 1 Year|Death|6|||
17102041|NCT00388973|38240974|FG000|Overall Study|Protocol Violation|3|||
17102042|NCT00388973|38240975|FG001|Overall Study|Protocol Violation|0|||
17102043|NCT00388973|38240974|FG000|Overall Study|Withdrawal by Subject|14|||
17102044|NCT00388973|38240975|FG001|Overall Study|Withdrawal by Subject|17|||
17102045|NCT00388973|38240974|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
17102046|NCT00388973|38240975|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
17102047|NCT00388973|38240974|FG000|Overall Study|Did not complete 61 days of treatment|5|||
17102048|NCT00388973|38240975|FG001|Overall Study|Did not complete 61 days of treatment|4|||
16787436|NCT02641379|37727656|FG006|Overall Study|Protocol Violation|0|||
16787437|NCT02641379|37727657|FG007|Overall Study|Protocol Violation|0|||
16787438|NCT02641379|37727658|FG008|Overall Study|Protocol Violation|1|||
16787439|NCT02641379|37727659|FG009|Overall Study|Protocol Violation|0|||
16787440|NCT02641379|37727660|FG010|Overall Study|Protocol Violation|0|||
16787441|NCT02641379|37727650|FG000|Overall Study|Participation in sili rescue study|0|||
16787442|NCT02641379|37727651|FG001|Overall Study|Participation in sili rescue study|0|||
16787443|NCT02641379|37727652|FG002|Overall Study|Participation in sili rescue study|0|||
16787444|NCT02641379|37727653|FG003|Overall Study|Participation in sili rescue study|0|||
16787445|NCT02641379|37727654|FG004|Overall Study|Participation in sili rescue study|0|||
16787446|NCT02641379|37727655|FG005|Overall Study|Participation in sili rescue study|1|||
16787447|NCT02641379|37727656|FG006|Overall Study|Participation in sili rescue study|0|||
16787448|NCT02641379|37727657|FG007|Overall Study|Participation in sili rescue study|0|||
16787449|NCT02641379|37727658|FG008|Overall Study|Participation in sili rescue study|0|||
16787450|NCT02641379|37727659|FG009|Overall Study|Participation in sili rescue study|0|||
16787451|NCT02641379|37727660|FG010|Overall Study|Participation in sili rescue study|0|||
16787452|NCT02641379|37727650|FG000|Overall Study|Lost to Follow-up|0|||
16787453|NCT02641379|37727651|FG001|Overall Study|Lost to Follow-up|0|||
16787454|NCT02641379|37727652|FG002|Overall Study|Lost to Follow-up|0|||
16787455|NCT02641379|37727653|FG003|Overall Study|Lost to Follow-up|0|||
16787456|NCT02641379|37727654|FG004|Overall Study|Lost to Follow-up|0|||
16787457|NCT02641379|37727655|FG005|Overall Study|Lost to Follow-up|0|||
16787458|NCT02641379|37727656|FG006|Overall Study|Lost to Follow-up|0|||
16787459|NCT02641379|37727657|FG007|Overall Study|Lost to Follow-up|0|||
16787460|NCT02641379|37727658|FG008|Overall Study|Lost to Follow-up|1|||
16787461|NCT02641379|37727659|FG009|Overall Study|Lost to Follow-up|0|||
16787462|NCT02641379|37727660|FG010|Overall Study|Lost to Follow-up|0|||
16787463|NCT02641379|37727650|FG000|Overall Study|Source data not found|0|||
16787464|NCT02641379|37727651|FG001|Overall Study|Source data not found|0|||
16787465|NCT02641379|37727652|FG002|Overall Study|Source data not found|0|||
16787466|NCT02641379|37727653|FG003|Overall Study|Source data not found|0|||
16787467|NCT02641379|37727654|FG004|Overall Study|Source data not found|0|||
16787468|NCT02641379|37727655|FG005|Overall Study|Source data not found|1|||
16787469|NCT02641379|37727656|FG006|Overall Study|Source data not found|0|||
16787470|NCT02641379|37727657|FG007|Overall Study|Source data not found|0|||
16787471|NCT02641379|37727658|FG008|Overall Study|Source data not found|0|||
16787472|NCT02641379|37727659|FG009|Overall Study|Source data not found|0|||
16787473|NCT02641379|37727660|FG010|Overall Study|Source data not found|0|||
16787474|NCT02641379|37727650|FG000|Overall Study|Participant showed weight reduction|0|||
16787475|NCT02641379|37727651|FG001|Overall Study|Participant showed weight reduction|0|||
16787476|NCT02641379|37727652|FG002|Overall Study|Participant showed weight reduction|0|||
16787477|NCT02641379|37727653|FG003|Overall Study|Participant showed weight reduction|0|||
16787478|NCT02641379|37727654|FG004|Overall Study|Participant showed weight reduction|0|||
16787479|NCT02641379|37727655|FG005|Overall Study|Participant showed weight reduction|0|||
16787480|NCT02641379|37727656|FG006|Overall Study|Participant showed weight reduction|0|||
16787481|NCT02641379|37727657|FG007|Overall Study|Participant showed weight reduction|1|||
16787482|NCT02641379|37727658|FG008|Overall Study|Participant showed weight reduction|0|||
16787483|NCT02641379|37727659|FG009|Overall Study|Participant showed weight reduction|0|||
16787484|NCT02641379|37727660|FG010|Overall Study|Participant showed weight reduction|0|||
16787485|NCT02641379|37727650|FG000|Overall Study|Non-response Week 12|0|||
16787486|NCT02641379|37727651|FG001|Overall Study|Non-response Week 12|0|||
16787487|NCT02641379|37727652|FG002|Overall Study|Non-response Week 12|0|||
16787488|NCT02641379|37727653|FG003|Overall Study|Non-response Week 12|0|||
16787489|NCT02641379|37727654|FG004|Overall Study|Non-response Week 12|0|||
16787490|NCT02641379|37727655|FG005|Overall Study|Non-response Week 12|0|||
16787491|NCT02641379|37727656|FG006|Overall Study|Non-response Week 12|0|||
16787492|NCT02641379|37727657|FG007|Overall Study|Non-response Week 12|1|||
16787493|NCT02641379|37727658|FG008|Overall Study|Non-response Week 12|0|||
16787494|NCT02641379|37727659|FG009|Overall Study|Non-response Week 12|0|||
16787495|NCT02641379|37727660|FG010|Overall Study|Non-response Week 12|0|||
16787496|NCT02641379|37727650|FG000|Overall Study|No 2 Log drop at Week 12|0|||
16787497|NCT02641379|37727651|FG001|Overall Study|No 2 Log drop at Week 12|0|||
16787498|NCT02641379|37727652|FG002|Overall Study|No 2 Log drop at Week 12|0|||
17102049|NCT00388973|38240974|FG000|Overall Study|Left region|0|||
17102050|NCT00388973|38240975|FG001|Overall Study|Left region|1|||
17102051|NCT00388973|38240974|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
17102052|NCT00388973|38240975|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
17102053|NCT00085202|38240983|FG000|Overall Study|Still on therapy|2|||
17102054|NCT00085202|38240984|FG001|Overall Study|Still on therapy|0|||
17102055|NCT00085202|38240983|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
17102056|NCT00085202|38240984|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
17016092|NCT00601523|38160800|FG000|Overall Study|Adverse Event|42|||
17016093|NCT00601523|38160801|FG001|Overall Study|Adverse Event|14|||
17016094|NCT00601523|38160800|FG000|Overall Study|Lack of Efficacy|3|||
17016095|NCT00601523|38160801|FG001|Overall Study|Lack of Efficacy|0|||
17102057|NCT00085202|38240983|FG000|Overall Study|Excessive toxicity|6|||
17102058|NCT00085202|38240984|FG001|Overall Study|Excessive toxicity|5|||
17102059|NCT00085202|38240983|FG000|Overall Study|Non-specified|3|||
17102060|NCT00085202|38240984|FG001|Overall Study|Non-specified|5|||
17102061|NCT00085202|38240983|FG000|Overall Study|Withdrawal by Subject|2|||
17102062|NCT00085202|38240984|FG001|Overall Study|Withdrawal by Subject|1|||
17102063|NCT00085202|38240983|FG000|Overall Study|Physician Decision|4|||
17102064|NCT00085202|38240984|FG001|Overall Study|Physician Decision|1|||
17102065|NCT00085202|38240983|FG000|Overall Study|Progressive disease|1|||
17102066|NCT00085202|38240984|FG001|Overall Study|Progressive disease|11|||
17102067|NCT00388583|38241010|FG000|Overall Study|Protocol Violation|1|||
17102068|NCT00388583|38241011|FG001|Overall Study|Protocol Violation|0|||
17102069|NCT00388583|38241010|FG000|Overall Study|Withdrawal by Subject|3|||
17102070|NCT00388583|38241011|FG001|Overall Study|Withdrawal by Subject|3|||
17102071|NCT00388583|38241010|FG000|Overall Study|Serious Adverse Event|2|||
17102072|NCT00388583|38241011|FG001|Overall Study|Serious Adverse Event|0|||
17102073|NCT00388583|38241010|FG000|Overall Study|Did not receive vaccine|0|||
17102074|NCT00388583|38241011|FG001|Overall Study|Did not receive vaccine|1|||
17102075|NCT00117572|38241019|FG000|Overall Study|Site withdrew before starting treatment|2|||
17102076|NCT00117572|38241020|FG001|Overall Study|Site withdrew before starting treatment|3|||
17102077|NCT00117572|38241019|FG000|Overall Study|Withdrawal by Subject|3|||
17102078|NCT00117572|38241020|FG001|Overall Study|Withdrawal by Subject|3|||
17102079|NCT00117572|38241019|FG000|Overall Study|Protocol Violation|1|||
17102080|NCT00117572|38241020|FG001|Overall Study|Protocol Violation|0|||
17198246|NCT01359644|38351836|FG004|Follow-up Period|Withdrawal by Subject|0|||
17198247|NCT01359644|38351837|FG005|Follow-up Period|Withdrawal by Subject|1|||
17198248|NCT01359644|38351838|FG006|Follow-up Period|Withdrawal by Subject|0|||
17198249|NCT01359644|38351839|FG007|Follow-up Period|Withdrawal by Subject|0|||
17198250|NCT01359644|38351840|FG008|Follow-up Period|Withdrawal by Subject|0|||
17198251|NCT01359644|38351841|FG009|Follow-up Period|Withdrawal by Subject|0|||
17198252|NCT01359644|38351832|FG000|Follow-up Period|Lost to Follow-up|0|||
17198253|NCT01359644|38351833|FG001|Follow-up Period|Lost to Follow-up|0|||
17198254|NCT01359644|38351834|FG002|Follow-up Period|Lost to Follow-up|0|||
17198255|NCT01359644|38351835|FG003|Follow-up Period|Lost to Follow-up|0|||
17198256|NCT01359644|38351836|FG004|Follow-up Period|Lost to Follow-up|0|||
17198257|NCT01359644|38351837|FG005|Follow-up Period|Lost to Follow-up|0|||
17198258|NCT01359644|38351838|FG006|Follow-up Period|Lost to Follow-up|1|||
17198259|NCT01359644|38351839|FG007|Follow-up Period|Lost to Follow-up|2|||
17198260|NCT01359644|38351840|FG008|Follow-up Period|Lost to Follow-up|0|||
17198261|NCT01359644|38351841|FG009|Follow-up Period|Lost to Follow-up|0|||
17198262|NCT02603120|38351876|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
17102081|NCT00388505|38241028|FG000|Overall Study|Adverse Event or Death|43|||
17102082|NCT00388505|38241029|FG001|Overall Study|Adverse Event or Death|17|||
17102083|NCT00388505|38241028|FG000|Overall Study|Withdrawal by Subject|24|||
17102084|NCT00388505|38241029|FG001|Overall Study|Withdrawal by Subject|9|||
17198263|NCT02603120|38351877|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
17016096|NCT00601523|38160800|FG000|Overall Study|Protocol Violation|5|||
17016097|NCT00601523|38160801|FG001|Overall Study|Protocol Violation|1|||
17016098|NCT00601523|38160800|FG000|Overall Study|Lost to Follow-up|0|||
17016099|NCT00601523|38160801|FG001|Overall Study|Lost to Follow-up|1|||
17016100|NCT00601523|38160800|FG000|Overall Study|Withdrawal by Subject|18|||
17016101|NCT00601523|38160801|FG001|Overall Study|Withdrawal by Subject|9|||
17016102|NCT00601523|38160800|FG000|Overall Study|Other|9|||
17016103|NCT00601523|38160801|FG001|Overall Study|Other|1|||
17102085|NCT00388505|38241028|FG000|Overall Study|Lost to Follow-up|5|||
17102086|NCT00388505|38241029|FG001|Overall Study|Lost to Follow-up|3|||
17198264|NCT02603120|38351876|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
17102087|NCT00388505|38241028|FG000|Overall Study|Inappropriate Enrollment|0|||
17102088|NCT00388505|38241029|FG001|Overall Study|Inappropriate Enrollment|1|||
17102089|NCT00388505|38241028|FG000|Overall Study|Administrative Reason|1|||
16787499|NCT02641379|37727653|FG003|Overall Study|No 2 Log drop at Week 12|0|||
16787500|NCT02641379|37727654|FG004|Overall Study|No 2 Log drop at Week 12|0|||
16787501|NCT02641379|37727655|FG005|Overall Study|No 2 Log drop at Week 12|0|||
16787502|NCT02641379|37727656|FG006|Overall Study|No 2 Log drop at Week 12|0|||
16787503|NCT02641379|37727657|FG007|Overall Study|No 2 Log drop at Week 12|0|||
16787504|NCT02641379|37727658|FG008|Overall Study|No 2 Log drop at Week 12|0|||
16787505|NCT02641379|37727659|FG009|Overall Study|No 2 Log drop at Week 12|0|||
16787506|NCT02641379|37727660|FG010|Overall Study|No 2 Log drop at Week 12|1|||
16787507|NCT02641379|37727650|FG000|Overall Study|Negative PCR result|0|||
16787508|NCT02641379|37727651|FG001|Overall Study|Negative PCR result|0|||
16787509|NCT02641379|37727652|FG002|Overall Study|Negative PCR result|0|||
16787510|NCT02641379|37727653|FG003|Overall Study|Negative PCR result|0|||
16787511|NCT02641379|37727654|FG004|Overall Study|Negative PCR result|0|||
16787512|NCT02641379|37727655|FG005|Overall Study|Negative PCR result|0|||
16787513|NCT02641379|37727656|FG006|Overall Study|Negative PCR result|0|||
16787514|NCT02641379|37727657|FG007|Overall Study|Negative PCR result|0|||
16787515|NCT02641379|37727658|FG008|Overall Study|Negative PCR result|0|||
16787516|NCT02641379|37727659|FG009|Overall Study|Negative PCR result|1|||
16787517|NCT02641379|37727660|FG010|Overall Study|Negative PCR result|0|||
16787518|NCT02641379|37727650|FG000|Overall Study|Participant's PCR high|0|||
16787519|NCT02641379|37727651|FG001|Overall Study|Participant's PCR high|0|||
16787520|NCT02641379|37727652|FG002|Overall Study|Participant's PCR high|0|||
16787521|NCT02641379|37727653|FG003|Overall Study|Participant's PCR high|0|||
16787522|NCT02641379|37727654|FG004|Overall Study|Participant's PCR high|0|||
16787523|NCT02641379|37727655|FG005|Overall Study|Participant's PCR high|0|||
16787524|NCT02641379|37727656|FG006|Overall Study|Participant's PCR high|0|||
16787525|NCT02641379|37727657|FG007|Overall Study|Participant's PCR high|1|||
16787526|NCT02641379|37727658|FG008|Overall Study|Participant's PCR high|0|||
16787527|NCT02641379|37727659|FG009|Overall Study|Participant's PCR high|0|||
16787528|NCT02641379|37727660|FG010|Overall Study|Participant's PCR high|0|||
17016104|NCT00466687|38160807|FG000|Overall Study|Adverse Event|1|||
17016105|NCT00466687|38160807|FG000|Overall Study|Other complicating illness|3|||
16787529|NCT02641379|37727650|FG000|Overall Study|Participant treated after Week 24|0|||
16787530|NCT02641379|37727651|FG001|Overall Study|Participant treated after Week 24|0|||
16787531|NCT02641379|37727652|FG002|Overall Study|Participant treated after Week 24|0|||
16787532|NCT02641379|37727653|FG003|Overall Study|Participant treated after Week 24|0|||
17016106|NCT00466687|38160807|FG000|Overall Study|Withdrawal by Subject|1|||
16787533|NCT02641379|37727654|FG004|Overall Study|Participant treated after Week 24|0|||
16787534|NCT02641379|37727655|FG005|Overall Study|Participant treated after Week 24|0|||
16787535|NCT02641379|37727656|FG006|Overall Study|Participant treated after Week 24|0|||
16787536|NCT02641379|37727657|FG007|Overall Study|Participant treated after Week 24|0|||
16787537|NCT02641379|37727658|FG008|Overall Study|Participant treated after Week 24|1|||
16787538|NCT02641379|37727659|FG009|Overall Study|Participant treated after Week 24|0|||
16787539|NCT02641379|37727660|FG010|Overall Study|Participant treated after Week 24|0|||
16787540|NCT02641379|37727650|FG000|Overall Study|Missing PCR result at Week 8|0|||
16787541|NCT02641379|37727651|FG001|Overall Study|Missing PCR result at Week 8|0|||
16787542|NCT02641379|37727652|FG002|Overall Study|Missing PCR result at Week 8|0|||
16787543|NCT02641379|37727653|FG003|Overall Study|Missing PCR result at Week 8|0|||
16787544|NCT02641379|37727654|FG004|Overall Study|Missing PCR result at Week 8|0|||
16787545|NCT02641379|37727655|FG005|Overall Study|Missing PCR result at Week 8|0|||
16787546|NCT02641379|37727656|FG006|Overall Study|Missing PCR result at Week 8|0|||
16787547|NCT02641379|37727657|FG007|Overall Study|Missing PCR result at Week 8|0|||
16787548|NCT02641379|37727658|FG008|Overall Study|Missing PCR result at Week 8|0|||
16787549|NCT02641379|37727659|FG009|Overall Study|Missing PCR result at Week 8|1|||
16787550|NCT02641379|37727660|FG010|Overall Study|Missing PCR result at Week 8|0|||
16787551|NCT02641379|37727650|FG000|Overall Study|PCR positive|0|||
16787552|NCT02641379|37727651|FG001|Overall Study|PCR positive|0|||
16787553|NCT02641379|37727652|FG002|Overall Study|PCR positive|0|||
16787554|NCT02641379|37727653|FG003|Overall Study|PCR positive|0|||
17016107|NCT00466687|38160807|FG000|Overall Study|Disease progression|29|||
17016108|NCT00465985|38160829|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
17016109|NCT00465985|38160830|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
17016110|NCT00465985|38160829|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
17016111|NCT00465985|38160830|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
17016112|NCT00465985|38160829|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
17016113|NCT00465985|38160830|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
17016114|NCT00465985|38160829|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
17016115|NCT00465985|38160830|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
17016116|NCT00454051|38160841|FG000|Overall Study|Adverse Event|1|||
17016117|NCT00454051|38160842|FG001|Overall Study|Adverse Event|2|||
17016118|NCT00454051|38160841|FG000|Overall Study|Withdrawal by Subject|1|||
17016119|NCT00454051|38160842|FG001|Overall Study|Withdrawal by Subject|0|||
17016120|NCT00454051|38160841|FG000|Overall Study|Protocol Violation|1|||
17016121|NCT00454051|38160842|FG001|Overall Study|Protocol Violation|1|||
17016122|NCT00484939|38160850|FG000|Overall Study|Death|9|||
17016123|NCT00484939|38160851|FG001|Overall Study|Death|13|||
17016124|NCT00484939|38160850|FG000|Overall Study|Adverse Event|22|||
17016125|NCT00484939|38160851|FG001|Overall Study|Adverse Event|12|||
17016126|NCT00484939|38160850|FG000|Overall Study|Patient Withdrew Consent|19|||
17016127|NCT00484939|38160851|FG001|Overall Study|Patient Withdrew Consent|10|||
17016128|NCT00484939|38160850|FG000|Overall Study|Protocol Violation|3|||
17016129|NCT00484939|38160851|FG001|Overall Study|Protocol Violation|3|||
17016130|NCT00484939|38160850|FG000|Overall Study|Lost to Follow-up|0|||
17016131|NCT00484939|38160851|FG001|Overall Study|Lost to Follow-up|3|||
17016132|NCT00484939|38160850|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
17016133|NCT00484939|38160851|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
17016134|NCT00484939|38160850|FG000|Overall Study|Disease progression|67|||
17016135|NCT00484939|38160851|FG001|Overall Study|Disease progression|88|||
17016136|NCT00484939|38160850|FG000|Overall Study|Screen Failure|2|||
16787555|NCT02641379|37727654|FG004|Overall Study|PCR positive|0|||
16787556|NCT02641379|37727655|FG005|Overall Study|PCR positive|0|||
16787557|NCT02641379|37727656|FG006|Overall Study|PCR positive|1|||
16787558|NCT02641379|37727657|FG007|Overall Study|PCR positive|0|||
17016137|NCT00484939|38160851|FG001|Overall Study|Screen Failure|2|||
17016138|NCT00484939|38160850|FG000|Overall Study|Reason Not Specified|11|||
17016139|NCT00484939|38160851|FG001|Overall Study|Reason Not Specified|6|||
17016140|NCT00453973|38160859|FG000|Overall Study|Adverse Event|4|||
17016141|NCT00453973|38160860|FG001|Overall Study|Adverse Event|9|||
17016142|NCT00453973|38160859|FG000|Overall Study|Withdrawal by Subject|7|||
17016143|NCT00453973|38160860|FG001|Overall Study|Withdrawal by Subject|6|||
17016144|NCT00453973|38160859|FG000|Overall Study|PI Decision|0|||
17016145|NCT00453973|38160860|FG001|Overall Study|PI Decision|2|||
17016146|NCT00453973|38160859|FG000|Overall Study|Relocation|1|||
17016147|NCT00453973|38160860|FG001|Overall Study|Relocation|0|||
17016148|NCT00453973|38160859|FG000|Overall Study|Renal transplant|1|||
17016149|NCT00453973|38160860|FG001|Overall Study|Renal transplant|1|||
17016150|NCT00453973|38160859|FG000|Overall Study|Site closed by sponsor|3|||
17016151|NCT00453973|38160860|FG001|Overall Study|Site closed by sponsor|0|||
17016152|NCT00453973|38160859|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
17016153|NCT00453973|38160860|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
17016154|NCT00465361|38160866|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
17016155|NCT00464815|38160872|FG000|Overall Study|Withdrawal by Subject|6|||
17016156|NCT00464815|38160873|FG001|Overall Study|Withdrawal by Subject|3|||
17016157|NCT00464737|38160882|FG000|Overall Study|Adverse Event|12|||
17016158|NCT00464737|38160883|FG001|Overall Study|Adverse Event|17|||
17016159|NCT00464737|38160884|FG002|Overall Study|Adverse Event|33|||
17016160|NCT00464737|38160882|FG000|Overall Study|Lack of Efficacy|7|||
17016161|NCT00464737|38160883|FG001|Overall Study|Lack of Efficacy|7|||
17016162|NCT00464737|38160884|FG002|Overall Study|Lack of Efficacy|4|||
17016163|NCT00464737|38160882|FG000|Overall Study|Withdrawal by Subject|5|||
17016164|NCT00464737|38160883|FG001|Overall Study|Withdrawal by Subject|3|||
17016165|NCT00464737|38160884|FG002|Overall Study|Withdrawal by Subject|5|||
17016166|NCT00464737|38160882|FG000|Overall Study|Protocol Violation|1|||
17016167|NCT00464737|38160883|FG001|Overall Study|Protocol Violation|1|||
17016168|NCT00464737|38160884|FG002|Overall Study|Protocol Violation|5|||
17016169|NCT00464737|38160882|FG000|Overall Study|Non-compliance|0|||
17016170|NCT00464737|38160883|FG001|Overall Study|Non-compliance|1|||
17016171|NCT00464737|38160884|FG002|Overall Study|Non-compliance|1|||
17016172|NCT00464737|38160882|FG000|Overall Study|Lost to Follow-up|5|||
17016173|NCT00464737|38160883|FG001|Overall Study|Lost to Follow-up|2|||
17016174|NCT00464737|38160884|FG002|Overall Study|Lost to Follow-up|5|||
17016175|NCT00464737|38160882|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
17016176|NCT00464737|38160883|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
17016177|NCT00464737|38160884|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
17016178|NCT00464737|38160882|FG000|Overall Study|Other: Subject left town; family illness|1|||
17016179|NCT00464737|38160883|FG001|Overall Study|Other: Subject left town; family illness|0|||
17016180|NCT00464737|38160884|FG002|Overall Study|Other: Subject left town; family illness|0|||
17016181|NCT00464737|38160882|FG000|Overall Study|Other: Study demands too great|0|||
17016182|NCT00464737|38160883|FG001|Overall Study|Other: Study demands too great|1|||
17016183|NCT00464737|38160884|FG002|Overall Study|Other: Study demands too great|0|||
17016184|NCT00464737|38160882|FG000|Overall Study|Other: Personal family reasons|0|||
17016185|NCT00464737|38160883|FG001|Overall Study|Other: Personal family reasons|0|||
17016186|NCT00464737|38160884|FG002|Overall Study|Other: Personal family reasons|1|||
17016187|NCT00464737|38160882|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
17016188|NCT00464737|38160883|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
17016189|NCT00464737|38160884|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
17102090|NCT00388505|38241029|FG001|Overall Study|Administrative Reason|0|||
17102091|NCT00388505|38241028|FG000|Overall Study|Protocol Violation|6|||
17016190|NCT00453349|38160894|FG000|Randomized|Adverse Event|12|||
17016191|NCT00453349|38160895|FG001|Randomized|Adverse Event|11|||
17016192|NCT00453349|38160894|FG000|Randomized|Lack of Efficacy|2|||
17102092|NCT00388505|38241029|FG001|Overall Study|Protocol Violation|5|||
17102093|NCT00388505|38241028|FG000|Overall Study|Unable to classify|4|||
17102094|NCT00388505|38241029|FG001|Overall Study|Unable to classify|3|||
17102095|NCT00388349|38241035|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
17102096|NCT00388349|38241036|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
17102097|NCT00117338|38241046|FG000|Overall Study|Adverse Event|0|||
17102098|NCT00117338|38241047|FG001|Overall Study|Adverse Event|1|||
17102099|NCT00117338|38241046|FG000|Overall Study|Protocol Violation|3|||
17102100|NCT00117338|38241047|FG001|Overall Study|Protocol Violation|2|||
17102101|NCT00117338|38241046|FG000|Overall Study|Withdrawal by Subject|1|||
17102102|NCT00117338|38241047|FG001|Overall Study|Withdrawal by Subject|0|||
17102103|NCT00117338|38241046|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
17102104|NCT00117338|38241047|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
17102105|NCT00117338|38241046|FG000|Overall Study|Lack of Efficacy|0|||
17102106|NCT00117338|38241047|FG001|Overall Study|Lack of Efficacy|1|||
17102107|NCT00388037|38241053|FG000|Overall Study|Protocol Violation|1|||
17016193|NCT00453349|38160895|FG001|Randomized|Lack of Efficacy|1|||
17016194|NCT00453349|38160894|FG000|Randomized|Lost to Follow-up|7|||
17016195|NCT00453349|38160895|FG001|Randomized|Lost to Follow-up|5|||
17016196|NCT00453349|38160894|FG000|Randomized|Protocol Violation|1|||
17016197|NCT00453349|38160895|FG001|Randomized|Protocol Violation|1|||
17102108|NCT00387881|38241059|FG000|Overall Study|Lost to Follow-up|23|||
17102109|NCT00387881|38241060|FG001|Overall Study|Lost to Follow-up|23|||
17102110|NCT00387881|38241059|FG000|Overall Study|Protocol Violation|2|||
17102111|NCT00387881|38241060|FG001|Overall Study|Protocol Violation|12|||
17102112|NCT00387881|38241059|FG000|Overall Study|Withdrawal by Subject|15|||
17102113|NCT00387881|38241060|FG001|Overall Study|Withdrawal by Subject|18|||
17102114|NCT00387881|38241059|FG000|Overall Study|Sponsor terminated Study|0|||
17102115|NCT00387881|38241060|FG001|Overall Study|Sponsor terminated Study|1|||
17102116|NCT00387881|38241059|FG000|Overall Study|Not eligible|6|||
17102117|NCT00387881|38241060|FG001|Overall Study|Not eligible|7|||
17102118|NCT00387881|38241059|FG000|Overall Study|No opportunity to treat headache|32|||
17102119|NCT00387881|38241060|FG001|Overall Study|No opportunity to treat headache|34|||
17102120|NCT00387881|38241059|FG000|Overall Study|Not otherwise specified|11|||
17102121|NCT00387881|38241060|FG001|Overall Study|Not otherwise specified|7|||
17102122|NCT00084656|38241069|FG000|Overall Study|Other reasons|0|||
17102123|NCT00084656|38241070|FG001|Overall Study|Other reasons|12|||
17016198|NCT00453349|38160894|FG000|Randomized|Withdrawal by Subject|3|||
17016199|NCT00453349|38160895|FG001|Randomized|Withdrawal by Subject|5|||
17016200|NCT00453349|38160894|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
17016201|NCT00453349|38160895|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
17016202|NCT00453349|38160894|FG000|Completed Study|Adverse Event|12|||
17016203|NCT00453349|38160895|FG001|Completed Study|Adverse Event|11|||
17102124|NCT00084656|38241071|FG002|Overall Study|Other reasons|11|||
17198265|NCT02603120|38351877|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
17016204|NCT00453349|38160894|FG000|Completed Study|Lack of Efficacy|2|||
17016205|NCT00453349|38160895|FG001|Completed Study|Lack of Efficacy|1|||
17016206|NCT00453349|38160894|FG000|Completed Study|Lost to Follow-up|7|||
17016207|NCT00453349|38160895|FG001|Completed Study|Lost to Follow-up|5|||
17198266|NCT02603120|38351876|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
17198267|NCT02603120|38351877|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
17016208|NCT00453349|38160894|FG000|Completed Study|Protocol Violation|1|||
17016209|NCT00453349|38160895|FG001|Completed Study|Protocol Violation|1|||
17016210|NCT00453349|38160894|FG000|Completed Study|Withdrawal by Subject|3|||
17016211|NCT00453349|38160895|FG001|Completed Study|Withdrawal by Subject|5|||
17016212|NCT00453349|38160894|FG000|Completed Study|Lost to follow up after study treatment|2|||
17016213|NCT00453349|38160895|FG001|Completed Study|Lost to follow up after study treatment|11|||
17016214|NCT00464269|38160905|FG000|Overall Study|Lack of Efficacy|1|||
17016215|NCT00464269|38160906|FG001|Overall Study|Lack of Efficacy|0|||
17016216|NCT00464269|38160907|FG002|Overall Study|Lack of Efficacy|0|||
17016217|NCT00464269|38160908|FG003|Overall Study|Lack of Efficacy|0|||
17016218|NCT00464269|38160905|FG000|Overall Study|Lost to Follow-up|0|||
17016219|NCT00464269|38160906|FG001|Overall Study|Lost to Follow-up|4|||
17016220|NCT00464269|38160907|FG002|Overall Study|Lost to Follow-up|0|||
17016221|NCT00464269|38160908|FG003|Overall Study|Lost to Follow-up|1|||
17016222|NCT00464269|38160905|FG000|Overall Study|Withdrawal by Subject|0|||
17016223|NCT00464269|38160906|FG001|Overall Study|Withdrawal by Subject|2|||
17016224|NCT00464269|38160907|FG002|Overall Study|Withdrawal by Subject|1|||
17016225|NCT00464269|38160908|FG003|Overall Study|Withdrawal by Subject|1|||
17016226|NCT00464269|38160905|FG000|Overall Study|Other reason|3|||
17016227|NCT00464269|38160906|FG001|Overall Study|Other reason|3|||
17016228|NCT00464269|38160907|FG002|Overall Study|Other reason|1|||
17016229|NCT00464269|38160908|FG003|Overall Study|Other reason|1|||
17016230|NCT00464269|38160905|FG000|Overall Study|AE, serious fatal|0|||
17016231|NCT00464269|38160906|FG001|Overall Study|AE, serious fatal|0|||
17016232|NCT00464269|38160907|FG002|Overall Study|AE, serious fatal|1|||
17016233|NCT00464269|38160908|FG003|Overall Study|AE, serious fatal|1|||
17016234|NCT00464269|38160905|FG000|Overall Study|SAE, non-fatal|0|||
17016235|NCT00464269|38160906|FG001|Overall Study|SAE, non-fatal|0|||
17016236|NCT00464269|38160907|FG002|Overall Study|SAE, non-fatal|0|||
17016237|NCT00464269|38160908|FG003|Overall Study|SAE, non-fatal|1|||
17016238|NCT00464269|38160905|FG000|Overall Study|AE, non-serious non-fatal|2|||
17016239|NCT00464269|38160906|FG001|Overall Study|AE, non-serious non-fatal|8|||
17016240|NCT00464269|38160907|FG002|Overall Study|AE, non-serious non-fatal|3|||
17016241|NCT00464269|38160908|FG003|Overall Study|AE, non-serious non-fatal|4|||
17016242|NCT00464269|38160905|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
17016243|NCT00464269|38160906|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
17016244|NCT00464269|38160907|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
17016245|NCT00464269|38160908|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
17016246|NCT00484315|38160922|FG000|12-Month Clinical Follow-up|Death|6|||
17016247|NCT00484315|38160923|FG001|12-Month Clinical Follow-up|Death|2|||
17016248|NCT00484315|38160922|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
17016249|NCT00484315|38160923|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
17016250|NCT00484315|38160922|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
17102125|NCT00084656|38241069|FG000|Overall Study|Withdrawal by Subject|15|||
17016251|NCT00484315|38160923|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
17016252|NCT00484315|38160922|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
17016253|NCT00484315|38160923|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
17016254|NCT00484315|38160922|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
17016255|NCT00484315|38160923|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
17016256|NCT00484315|38160922|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
17016257|NCT00484315|38160923|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
17016258|NCT00484315|38160922|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
17016259|NCT00484315|38160923|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
17016260|NCT00463801|38160929|FG000|Overall Study|Protocol Violation|1|||
17016261|NCT00463801|38160929|FG000|Overall Study|Lack of Efficacy|2|||
17016262|NCT00463801|38160929|FG000|Overall Study|Adverse Event|4|||
17016263|NCT00463801|38160929|FG000|Overall Study|Lost to Follow-up|5|||
17016264|NCT00463801|38160929|FG000|Overall Study|No longer require therapy|1|||
17016265|NCT00463567|38160940|FG000|Overall Study|Adverse Event|29|||
17016266|NCT00463567|38160941|FG001|Overall Study|Adverse Event|26|||
17016267|NCT00463567|38160942|FG002|Overall Study|Adverse Event|17|||
17016268|NCT00463567|38160943|FG003|Overall Study|Adverse Event|46|||
17016269|NCT00463567|38160944|FG004|Overall Study|Adverse Event|10|||
17016270|NCT00463567|38160945|FG005|Overall Study|Adverse Event|10|||
17016271|NCT00463567|38160946|FG006|Overall Study|Adverse Event|4|||
17016272|NCT00463567|38160940|FG000|Overall Study|Withdrawal by Subject|29|||
17016273|NCT00463567|38160941|FG001|Overall Study|Withdrawal by Subject|22|||
17016274|NCT00463567|38160942|FG002|Overall Study|Withdrawal by Subject|20|||
17016275|NCT00463567|38160943|FG003|Overall Study|Withdrawal by Subject|37|||
17016276|NCT00463567|38160944|FG004|Overall Study|Withdrawal by Subject|6|||
17016277|NCT00463567|38160945|FG005|Overall Study|Withdrawal by Subject|5|||
17016278|NCT00463567|38160946|FG006|Overall Study|Withdrawal by Subject|1|||
17016279|NCT00463567|38160940|FG000|Overall Study|Protocol Deviation|13|||
17016280|NCT00463567|38160941|FG001|Overall Study|Protocol Deviation|9|||
17016281|NCT00463567|38160942|FG002|Overall Study|Protocol Deviation|14|||
17016282|NCT00463567|38160943|FG003|Overall Study|Protocol Deviation|11|||
17016283|NCT00463567|38160944|FG004|Overall Study|Protocol Deviation|1|||
17016284|NCT00463567|38160945|FG005|Overall Study|Protocol Deviation|1|||
17016285|NCT00463567|38160946|FG006|Overall Study|Protocol Deviation|2|||
17016286|NCT00463567|38160940|FG000|Overall Study|Lost to Follow-up|12|||
17016287|NCT00463567|38160941|FG001|Overall Study|Lost to Follow-up|6|||
17016288|NCT00463567|38160942|FG002|Overall Study|Lost to Follow-up|13|||
17016289|NCT00463567|38160943|FG003|Overall Study|Lost to Follow-up|8|||
17016290|NCT00463567|38160944|FG004|Overall Study|Lost to Follow-up|1|||
17016291|NCT00463567|38160945|FG005|Overall Study|Lost to Follow-up|1|||
17016292|NCT00463567|38160946|FG006|Overall Study|Lost to Follow-up|1|||
17016293|NCT00463567|38160940|FG000|Overall Study|Administrative problems|5|||
17016294|NCT00463567|38160941|FG001|Overall Study|Administrative problems|3|||
17016295|NCT00463567|38160942|FG002|Overall Study|Administrative problems|6|||
17016296|NCT00463567|38160943|FG003|Overall Study|Administrative problems|9|||
17016297|NCT00463567|38160944|FG004|Overall Study|Administrative problems|3|||
17016298|NCT00463567|38160945|FG005|Overall Study|Administrative problems|2|||
17016299|NCT00463567|38160946|FG006|Overall Study|Administrative problems|2|||
17016300|NCT00463567|38160940|FG000|Overall Study|Lack of Efficacy|4|||
17016301|NCT00463567|38160941|FG001|Overall Study|Lack of Efficacy|9|||
17102126|NCT00084656|38241070|FG001|Overall Study|Withdrawal by Subject|4|||
17102127|NCT00084656|38241071|FG002|Overall Study|Withdrawal by Subject|4|||
17102128|NCT00084656|38241069|FG000|Overall Study|Disease relapse|0|||
17102129|NCT00084656|38241070|FG001|Overall Study|Disease relapse|9|||
17102130|NCT00084656|38241071|FG002|Overall Study|Disease relapse|10|||
17102131|NCT00084656|38241069|FG000|Overall Study|Disease progression|9|||
17102132|NCT00084656|38241070|FG001|Overall Study|Disease progression|0|||
17102133|NCT00084656|38241071|FG002|Overall Study|Disease progression|0|||
17102134|NCT00084656|38241069|FG000|Overall Study|Lost to Follow-up|1|||
17102135|NCT00084656|38241070|FG001|Overall Study|Lost to Follow-up|0|||
17102136|NCT00084656|38241071|FG002|Overall Study|Lost to Follow-up|1|||
17102137|NCT00387725|38241085|FG000|Overall Study|Adverse Event|0|||
17016302|NCT00463567|38160942|FG002|Overall Study|Lack of Efficacy|9|||
17016303|NCT00463567|38160943|FG003|Overall Study|Lack of Efficacy|17|||
17016304|NCT00463567|38160944|FG004|Overall Study|Lack of Efficacy|1|||
17102138|NCT00387725|38241086|FG001|Overall Study|Adverse Event|0|||
17102139|NCT00387725|38241087|FG002|Overall Study|Adverse Event|0|||
17102140|NCT00387725|38241088|FG003|Overall Study|Adverse Event|1|||
17102141|NCT00387725|38241085|FG000|Overall Study|Protocol Violation|0|||
17102142|NCT00387725|38241086|FG001|Overall Study|Protocol Violation|1|||
17102143|NCT00387725|38241087|FG002|Overall Study|Protocol Violation|0|||
17102144|NCT00387725|38241088|FG003|Overall Study|Protocol Violation|0|||
17102145|NCT00387725|38241085|FG000|Overall Study|Withdrawal by Subject|1|||
17016305|NCT00463567|38160945|FG005|Overall Study|Lack of Efficacy|0|||
17016306|NCT00463567|38160946|FG006|Overall Study|Lack of Efficacy|1|||
17016307|NCT00463567|38160940|FG000|Overall Study|Abnormal lab value(s)|1|||
17016308|NCT00463567|38160941|FG001|Overall Study|Abnormal lab value(s)|1|||
17102146|NCT00387725|38241086|FG001|Overall Study|Withdrawal by Subject|0|||
17102147|NCT00387725|38241087|FG002|Overall Study|Withdrawal by Subject|1|||
17102148|NCT00387725|38241088|FG003|Overall Study|Withdrawal by Subject|0|||
17102149|NCT00387725|38241085|FG000|Overall Study|Parent/legal guardian request|0|||
17102150|NCT00387725|38241086|FG001|Overall Study|Parent/legal guardian request|0|||
17102151|NCT00387725|38241087|FG002|Overall Study|Parent/legal guardian request|1|||
17102152|NCT00387725|38241088|FG003|Overall Study|Parent/legal guardian request|1|||
17102153|NCT00102596|38241098|FG000|Part A|Screen failures|6|||
17102154|NCT00102596|38241099|FG001|Part A|Screen failures|0|||
17102155|NCT00102596|38241098|FG000|Part A|Adverse Event|1|||
17102156|NCT00102596|38241099|FG001|Part A|Adverse Event|0|||
17102157|NCT00387647|38241106|FG000|Overall Study|Death|18|||
17102158|NCT00386009|38241112|FG000|Overall Study|Adverse Event|0|||
17102159|NCT00386009|38241113|FG001|Overall Study|Adverse Event|2|||
17102160|NCT00386009|38241112|FG000|Overall Study|Death|1|||
17102161|NCT00386009|38241113|FG001|Overall Study|Death|0|||
17102162|NCT00386009|38241112|FG000|Overall Study|Entry Criteria Not Met|0|||
17102163|NCT00386009|38241113|FG001|Overall Study|Entry Criteria Not Met|2|||
17102164|NCT00386009|38241112|FG000|Overall Study|Lost to Follow-up|1|||
17102165|NCT00386009|38241113|FG001|Overall Study|Lost to Follow-up|1|||
17102166|NCT00386009|38241112|FG000|Overall Study|Protocol Violation|1|||
17102167|NCT00386009|38241113|FG001|Overall Study|Protocol Violation|0|||
17102168|NCT00386009|38241112|FG000|Overall Study|Sponsor Decision|1|||
17102169|NCT00386009|38241113|FG001|Overall Study|Sponsor Decision|1|||
17102170|NCT00386009|38241112|FG000|Overall Study|Withdrawal by Subject|5|||
17102171|NCT00386009|38241113|FG001|Overall Study|Withdrawal by Subject|4|||
17102172|NCT00373685|38241121|FG000|Overall Study|Death|2|||
17102173|NCT00373685|38241122|FG001|Overall Study|Death|1|||
17102174|NCT00373685|38241121|FG000|Overall Study|Adverse Event|278|||
17102175|NCT00373685|38241122|FG001|Overall Study|Adverse Event|253|||
17102176|NCT00373685|38241121|FG000|Overall Study|Insufficient clinical response|169|||
17102177|NCT00373685|38241122|FG001|Overall Study|Insufficient clinical response|119|||
17102178|NCT00373685|38241121|FG000|Overall Study|Did not meet entrance criteria|167|||
17102179|NCT00373685|38241122|FG001|Overall Study|Did not meet entrance criteria|184|||
17102180|NCT00373685|38241121|FG000|Overall Study|Lost to follow up|83|||
17102181|NCT00373685|38241122|FG001|Overall Study|Lost to follow up|103|||
17102182|NCT00373685|38241121|FG000|Overall Study|No longer willing to participate|337|||
17102183|NCT00373685|38241122|FG001|Overall Study|No longer willing to participate|352|||
17102184|NCT00373685|38241121|FG000|Overall Study|Other|149|||
16787559|NCT02641379|37727658|FG008|Overall Study|PCR positive|0|||
16787560|NCT02641379|37727659|FG009|Overall Study|PCR positive|0|||
16787561|NCT02641379|37727660|FG010|Overall Study|PCR positive|0|||
16787562|NCT02660983|37727691|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
17016309|NCT00463567|38160942|FG002|Overall Study|Abnormal lab value(s)|2|||
17016310|NCT00463567|38160943|FG003|Overall Study|Abnormal lab value(s)|1|||
17016311|NCT00463567|38160944|FG004|Overall Study|Abnormal lab value(s)|1|||
17016312|NCT00463567|38160945|FG005|Overall Study|Abnormal lab value(s)|0|||
16787563|NCT02660983|37727692|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
16787564|NCT02660983|37727691|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
16787565|NCT02660983|37727692|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
16787566|NCT02660983|37727691|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
16787567|NCT02660983|37727692|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
16787568|NCT02660983|37727691|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
16787569|NCT02660983|37727692|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
16787570|NCT02660983|37727691|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
16787571|NCT02660983|37727692|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
16787572|NCT02660983|37727691|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
16787573|NCT02660983|37727692|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
16787574|NCT02660983|37727691|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
16787575|NCT02660983|37727692|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
16787576|NCT01953328|37727707|FG000|Overall Study|Withdrawal by Subject|0|||
16787577|NCT01953328|37727708|FG001|Overall Study|Withdrawal by Subject|0|||
16787578|NCT01953328|37727709|FG002|Overall Study|Withdrawal by Subject|0|||
16787579|NCT01953328|37727710|FG003|Overall Study|Withdrawal by Subject|0|||
16787580|NCT01953328|37727711|FG004|Overall Study|Withdrawal by Subject|1|||
16787581|NCT01953328|37727712|FG005|Overall Study|Withdrawal by Subject|0|||
16787582|NCT01953328|37727713|FG006|Overall Study|Withdrawal by Subject|0|||
16787583|NCT01953328|37727714|FG007|Overall Study|Withdrawal by Subject|0|||
16787584|NCT01953328|37727707|FG000|Overall Study|Lost to Follow-up|0|||
17016313|NCT00463567|38160946|FG006|Overall Study|Abnormal lab value(s)|0|||
17016314|NCT00463567|38160940|FG000|Overall Study|Abnormal test procedure result(s)|1|||
17016315|NCT00463567|38160941|FG001|Overall Study|Abnormal test procedure result(s)|1|||
17016316|NCT00463567|38160942|FG002|Overall Study|Abnormal test procedure result(s)|6|||
17016317|NCT00463567|38160943|FG003|Overall Study|Abnormal test procedure result(s)|2|||
17102185|NCT00373685|38241122|FG001|Overall Study|Other|146|||
17102186|NCT00373685|38241121|FG000|Overall Study|Protocol Violation|191|||
17016318|NCT00463567|38160944|FG004|Overall Study|Abnormal test procedure result(s)|0|||
17016319|NCT00463567|38160945|FG005|Overall Study|Abnormal test procedure result(s)|2|||
16787585|NCT01953328|37727708|FG001|Overall Study|Lost to Follow-up|0|||
16787586|NCT01953328|37727709|FG002|Overall Study|Lost to Follow-up|0|||
16787587|NCT01953328|37727710|FG003|Overall Study|Lost to Follow-up|0|||
16787588|NCT01953328|37727711|FG004|Overall Study|Lost to Follow-up|1|||
16787589|NCT01953328|37727712|FG005|Overall Study|Lost to Follow-up|0|||
16787590|NCT01953328|37727713|FG006|Overall Study|Lost to Follow-up|0|||
16787591|NCT01953328|37727714|FG007|Overall Study|Lost to Follow-up|0|||
16787592|NCT02640755|37727734|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
16787593|NCT02640755|37727735|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
16787594|NCT02640755|37727734|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
16787595|NCT02640755|37727735|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
16787596|NCT02640755|37727734|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
16787597|NCT02640755|37727735|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
16787598|NCT02640677|37727742|FG000|Overall Study|Lost to Follow-up|1|||
16787599|NCT02640677|37727742|FG000|Overall Study|Withdrawal by Subject|1|||
16787600|NCT02643251|37727759|FG000|Overall Study|Adverse Event|3|||
16787601|NCT02643251|37727760|FG001|Overall Study|Adverse Event|1|||
16787602|NCT02643251|37727759|FG000|Overall Study|Withdrawal by Subject|2|||
16787603|NCT02643251|37727760|FG001|Overall Study|Withdrawal by Subject|0|||
16787604|NCT02643251|37727759|FG000|Overall Study|Lost to Follow-up|4|||
16787605|NCT02643251|37727760|FG001|Overall Study|Lost to Follow-up|1|||
16787606|NCT02643251|37727759|FG000|Overall Study|Protocol Violation|1|||
16787607|NCT02643251|37727760|FG001|Overall Study|Protocol Violation|0|||
16787608|NCT02643251|37727759|FG000|Overall Study|PI Decision to terminate patient|1|||
16787609|NCT02643251|37727760|FG001|Overall Study|PI Decision to terminate patient|0|||
16787610|NCT01970878|37727770|FG000|Overall Study|Withdrawal by Subject|11|||
16787611|NCT01970878|37727771|FG001|Overall Study|Withdrawal by Subject|10|||
16787612|NCT01970878|37727772|FG002|Overall Study|Withdrawal by Subject|14|||
16787613|NCT01970878|37727773|FG003|Overall Study|Withdrawal by Subject|7|||
16787614|NCT01970878|37727770|FG000|Overall Study|Lost to Follow-up|1|||
16787615|NCT01970878|37727771|FG001|Overall Study|Lost to Follow-up|3|||
16787616|NCT01970878|37727772|FG002|Overall Study|Lost to Follow-up|2|||
16787617|NCT01970878|37727773|FG003|Overall Study|Lost to Follow-up|4|||
16787618|NCT01970878|37727770|FG000|Overall Study|Administrative Reasons|1|||
16787619|NCT01970878|37727771|FG001|Overall Study|Administrative Reasons|0|||
16787620|NCT01970878|37727772|FG002|Overall Study|Administrative Reasons|0|||
16787621|NCT01970878|37727773|FG003|Overall Study|Administrative Reasons|4|||
16787622|NCT01970878|37727770|FG000|Overall Study|Lack of Efficacy|2|||
16787623|NCT01970878|37727771|FG001|Overall Study|Lack of Efficacy|1|||
16787624|NCT01970878|37727772|FG002|Overall Study|Lack of Efficacy|2|||
16787625|NCT01970878|37727773|FG003|Overall Study|Lack of Efficacy|0|||
16787626|NCT01970878|37727770|FG000|Overall Study|Adverse Event|12|||
16787627|NCT01970878|37727771|FG001|Overall Study|Adverse Event|7|||
16787628|NCT01970878|37727772|FG002|Overall Study|Adverse Event|4|||
16787629|NCT01970878|37727773|FG003|Overall Study|Adverse Event|3|||
16787630|NCT01970878|37727770|FG000|Overall Study|Protocol Specified Criteria|10|||
16787631|NCT01970878|37727771|FG001|Overall Study|Protocol Specified Criteria|4|||
16787632|NCT01970878|37727772|FG002|Overall Study|Protocol Specified Criteria|3|||
16787633|NCT01970878|37727773|FG003|Overall Study|Protocol Specified Criteria|6|||
16787634|NCT01970878|37727770|FG000|Overall Study|Physician Decision|0|||
16787635|NCT01970878|37727771|FG001|Overall Study|Physician Decision|1|||
16787636|NCT01970878|37727772|FG002|Overall Study|Physician Decision|1|||
16787637|NCT01970878|37727773|FG003|Overall Study|Physician Decision|0|||
16787638|NCT01970878|37727770|FG000|Overall Study|No Completion Status|0|||
16787639|NCT01970878|37727771|FG001|Overall Study|No Completion Status|1|||
16787640|NCT01970878|37727772|FG002|Overall Study|No Completion Status|0|||
16787641|NCT01970878|37727773|FG003|Overall Study|No Completion Status|0|||
16787642|NCT01970488|37727794|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
16787643|NCT01970488|37727795|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
16787644|NCT01970488|37727796|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
16787645|NCT01970488|37727797|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
16787646|NCT01970488|37727798|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
16787647|NCT01970488|37727794|FG000|Part 1: Through Week 16|Protocol Violation|1|||
16787648|NCT01970488|37727795|FG001|Part 1: Through Week 16|Protocol Violation|2|||
16787649|NCT01970488|37727796|FG002|Part 1: Through Week 16|Protocol Violation|0|||
17102187|NCT00373685|38241122|FG001|Overall Study|Protocol Violation|182|||
16787650|NCT01970488|37727797|FG003|Part 1: Through Week 16|Protocol Violation|0|||
16787651|NCT01970488|37727798|FG004|Part 1: Through Week 16|Protocol Violation|0|||
16787652|NCT01970488|37727794|FG000|Part 1: Through Week 16|Adverse Event|6|||
16787653|NCT01970488|37727795|FG001|Part 1: Through Week 16|Adverse Event|5|||
16787654|NCT01970488|37727796|FG002|Part 1: Through Week 16|Adverse Event|0|||
16787655|NCT01970488|37727797|FG003|Part 1: Through Week 16|Adverse Event|0|||
16787656|NCT01970488|37727798|FG004|Part 1: Through Week 16|Adverse Event|0|||
17102188|NCT00373685|38241121|FG000|Overall Study|Final Status Unknown|12|||
17102189|NCT00373685|38241122|FG001|Overall Study|Final Status Unknown|4|||
17102190|NCT00373685|38241121|FG000|Overall Study|Randomized, not treated|51|||
17102191|NCT00373685|38241122|FG001|Overall Study|Randomized, not treated|77|||
17102192|NCT00373529|38241128|FG000|Overall Study|Physician Decision|19|||
17102193|NCT00373529|38241128|FG000|Overall Study|Withdrawal by Subject|7|||
17016320|NCT00463567|38160946|FG006|Overall Study|Abnormal test procedure result(s)|0|||
17016321|NCT00463567|38160940|FG000|Overall Study|Death|1|||
17016322|NCT00463567|38160941|FG001|Overall Study|Death|0|||
17016323|NCT00463567|38160942|FG002|Overall Study|Death|2|||
17016324|NCT00463567|38160943|FG003|Overall Study|Death|0|||
17016325|NCT00463567|38160944|FG004|Overall Study|Death|0|||
17016326|NCT00463567|38160945|FG005|Overall Study|Death|0|||
17016327|NCT00463567|38160946|FG006|Overall Study|Death|0|||
17016328|NCT00484159|38160971|FG000|Overall Study|Lost to Follow-up|1|||
17016329|NCT00484159|38160972|FG001|Overall Study|Lost to Follow-up|1|||
17016330|NCT00484159|38160973|FG002|Overall Study|Lost to Follow-up|0|||
17016331|NCT00462865|38160981|FG000|Overall Study|Adverse Event|1|||
17016332|NCT03839641|38160987|FG000|Overall Study|Withdrawal by Subject|1|||
17016333|NCT03839641|38160988|FG001|Overall Study|Withdrawal by Subject|1|||
17016334|NCT00462709|38160996|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
17016335|NCT00462709|38160996|FG000|Overall Study|Lost to Follow-up|10|||
17016336|NCT00462709|38160996|FG000|Overall Study|Withdrawal by Subject|8|||
17102194|NCT00373529|38241128|FG000|Overall Study|Adverse Event|7|||
17102195|NCT00373529|38241128|FG000|Overall Study|Treatment failure|36|||
17102196|NCT00373529|38241128|FG000|Overall Study|Disease recurrence|10|||
17102197|NCT00373529|38241128|FG000|Overall Study|Death|16|||
17102198|NCT00373529|38241128|FG000|Overall Study|Need for treatment prohibited by study|1|||
17102199|NCT00373529|38241128|FG000|Overall Study|Other|8|||
17102200|NCT00373529|38241128|FG000|Overall Study|Failed independent confirmation of AML|3|||
17102201|NCT00373529|38241128|FG000|Overall Study|Consent violation|1|||
17102202|NCT00373295|38241132|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
17102203|NCT00373295|38241133|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
17102204|NCT00373295|38241134|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
17016337|NCT00462709|38160996|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
17016338|NCT00462709|38160996|FG000|Overall Study|Death|2|||
17016339|NCT00462709|38160996|FG000|Overall Study|Logistical reasons|2|||
17102205|NCT00373295|38241135|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
17102206|NCT00373295|38241136|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
17102207|NCT00373295|38241137|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
16787657|NCT01970488|37727794|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
16787658|NCT01970488|37727795|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
16787659|NCT01970488|37727796|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
16787660|NCT01970488|37727797|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
16787661|NCT01970488|37727798|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
16787662|NCT01970488|37727794|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
16787663|NCT01970488|37727795|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
16787664|NCT01970488|37727796|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
16787665|NCT01970488|37727797|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
16787666|NCT01970488|37727798|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
16787667|NCT01970488|37727794|FG000|Part 2: Post Week 16|Physician Decision|0|||
16787668|NCT01970488|37727795|FG001|Part 2: Post Week 16|Physician Decision|0|||
16787669|NCT01970488|37727796|FG002|Part 2: Post Week 16|Physician Decision|0|||
16787670|NCT01970488|37727797|FG003|Part 2: Post Week 16|Physician Decision|0|||
16787671|NCT01970488|37727798|FG004|Part 2: Post Week 16|Physician Decision|1|||
16787672|NCT01970488|37727794|FG000|Part 2: Post Week 16|Non-compliance|0|||
16787673|NCT01970488|37727795|FG001|Part 2: Post Week 16|Non-compliance|0|||
16787674|NCT01970488|37727796|FG002|Part 2: Post Week 16|Non-compliance|1|||
16787675|NCT01970488|37727797|FG003|Part 2: Post Week 16|Non-compliance|0|||
16787676|NCT01970488|37727798|FG004|Part 2: Post Week 16|Non-compliance|0|||
16787677|NCT01970488|37727794|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
16787678|NCT01970488|37727795|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
16787679|NCT01970488|37727796|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
16787680|NCT01970488|37727797|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
16787681|NCT01970488|37727798|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
16787682|NCT01970488|37727794|FG000|Part 2: Post Week 16|Adverse Event|0|||
16787683|NCT01970488|37727795|FG001|Part 2: Post Week 16|Adverse Event|0|||
16787684|NCT01970488|37727796|FG002|Part 2: Post Week 16|Adverse Event|5|||
16787685|NCT01970488|37727797|FG003|Part 2: Post Week 16|Adverse Event|1|||
16787686|NCT01970488|37727798|FG004|Part 2: Post Week 16|Adverse Event|1|||
16787687|NCT01970488|37727794|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
16787688|NCT01970488|37727795|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
16787689|NCT01970488|37727796|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
16787690|NCT01970488|37727797|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
17016340|NCT00462709|38160996|FG000|Overall Study|Physician Decision|1|||
16787691|NCT01970488|37727798|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
16787692|NCT01970488|37727794|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
16787693|NCT01970488|37727795|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
16787694|NCT01970488|37727796|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
16787695|NCT01970488|37727797|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
16787696|NCT01970488|37727798|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
16787697|NCT02661217|37727815|FG000|Overall Study|Physician Decision|12|||
16787698|NCT02661217|37727816|FG001|Overall Study|Physician Decision|15|||
16787699|NCT02661217|37727815|FG000|Overall Study|Lost to Follow-up|1|||
16787700|NCT02661217|37727816|FG001|Overall Study|Lost to Follow-up|4|||
16787701|NCT02661217|37727815|FG000|Overall Study|Protocol Deviation|0|||
16787702|NCT02661217|37727816|FG001|Overall Study|Protocol Deviation|4|||
16787703|NCT02661217|37727815|FG000|Overall Study|Non-compliance with study treatment|5|||
16787704|NCT02661217|37727816|FG001|Overall Study|Non-compliance with study treatment|5|||
16787705|NCT02661217|37727815|FG000|Overall Study|Death|21|||
16787706|NCT02661217|37727816|FG001|Overall Study|Death|15|||
16787707|NCT02661217|37727815|FG000|Overall Study|Adverse Event|10|||
16787708|NCT02661217|37727816|FG001|Overall Study|Adverse Event|8|||
16787709|NCT02661217|37727815|FG000|Overall Study|Withdrawal by Subject|15|||
16787710|NCT02661217|37727816|FG001|Overall Study|Withdrawal by Subject|19|||
16787711|NCT02661217|37727815|FG000|Overall Study|Did not enter follow-up epoch|7|||
16787712|NCT02661217|37727816|FG001|Overall Study|Did not enter follow-up epoch|10|||
16787713|NCT02661217|37727815|FG000|Overall Study|Death - no study drug received|1|||
16787714|NCT02661217|37727816|FG001|Overall Study|Death - no study drug received|2|||
16787715|NCT02661217|37727815|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
16787716|NCT02661217|37727816|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
16787717|NCT01952080|37727827|FG000|Overall Study|Withdrawal by Subject|0|||
16787718|NCT01952080|37727828|FG001|Overall Study|Withdrawal by Subject|0|||
16787719|NCT01952080|37727829|FG002|Overall Study|Withdrawal by Subject|0|||
16787720|NCT01952080|37727830|FG003|Overall Study|Withdrawal by Subject|1|||
16787721|NCT01952080|37727827|FG000|Overall Study|Protocol Non-compliance|0|||
16787722|NCT01952080|37727828|FG001|Overall Study|Protocol Non-compliance|1|||
16787723|NCT01952080|37727829|FG002|Overall Study|Protocol Non-compliance|0|||
16787724|NCT01952080|37727830|FG003|Overall Study|Protocol Non-compliance|0|||
16787725|NCT01951378|37727842|FG000|Overall Study|Study Terminated-Not completed|23|||
16787726|NCT01951378|37727843|FG001|Overall Study|Study Terminated-Not completed|17|||
16787727|NCT01944670|37727849|FG000|Overall Study|Lost to Follow-up|2|||
16787728|NCT01361009|37727857|FG000|Overall Study|Protocol Violation|116|||
16787729|NCT01944046|37727863|FG000|Randomized to DB|Adverse Event|5|||
16787730|NCT01944046|37727864|FG001|Randomized to DB|Adverse Event|2|||
16787731|NCT01944046|37727863|FG000|Randomized to DB|Clinical Worsening|3|||
16787732|NCT01944046|37727864|FG001|Randomized to DB|Clinical Worsening|2|||
16787733|NCT01944046|37727863|FG000|Randomized to DB|Lost to Follow-up|3|||
16787734|NCT01944046|37727864|FG001|Randomized to DB|Lost to Follow-up|3|||
16787735|NCT01944046|37727863|FG000|Randomized to DB|Withdrawal by Subject|2|||
16787736|NCT01944046|37727864|FG001|Randomized to DB|Withdrawal by Subject|4|||
16787737|NCT01944046|37727863|FG000|Randomized to DB|Physician Decision|1|||
16787738|NCT01944046|37727864|FG001|Randomized to DB|Physician Decision|2|||
16787739|NCT01944046|37727863|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
16787740|NCT01944046|37727864|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
16787741|NCT01944046|37727863|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
16787742|NCT01944046|37727864|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
16787743|NCT01944046|37727863|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
16787744|NCT01944046|37727864|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
16787745|NCT01944046|37727863|FG000|Open Label Eligible and Consented|Adverse Event|6|||
16787746|NCT01944046|37727864|FG001|Open Label Eligible and Consented|Adverse Event|1|||
16787747|NCT01944046|37727863|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
16787748|NCT01944046|37727864|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
16787749|NCT01944046|37727863|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
16787750|NCT01944046|37727864|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
16787751|NCT01969084|37727876|FG000|Overall Study|Adverse Event|0|||
16787752|NCT01969084|37727877|FG001|Overall Study|Adverse Event|1|||
16787753|NCT01942486|37727887|FG000|Overall Study|Lost to Follow-up|27|||
16787754|NCT01941940|37727891|FG000|Overall Study|Adverse Event|11|||
16787755|NCT01941940|37727891|FG000|Overall Study|Lost to Follow-up|2|||
16787756|NCT01941940|37727891|FG000|Overall Study|Physician Decision|2|||
16787757|NCT01941940|37727891|FG000|Overall Study|Withdrawal by Subject|15|||
16787758|NCT01941940|37727891|FG000|Overall Study|Death|1|||
16787759|NCT01941940|37727891|FG000|Overall Study|Other|1|||
16787760|NCT01941940|37727891|FG000|Overall Study|Other|1|||
16787761|NCT01968694|37727897|FG000|Washout (1 Month)|Lost to Follow-up|0|||
16787762|NCT01968694|37727898|FG001|Washout (1 Month)|Lost to Follow-up|1|||
16787763|NCT01968226|37727906|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
16787764|NCT02640053|37727912|FG000|Overall Study|Withdrawal by Subject|2|||
16787765|NCT02640053|37727913|FG001|Overall Study|Withdrawal by Subject|1|||
16787766|NCT02640053|37727912|FG000|Overall Study|Adverse Event|1|||
16787767|NCT02640053|37727913|FG001|Overall Study|Adverse Event|1|||
16787768|NCT02640053|37727912|FG000|Overall Study|Alternative Therapy|1|||
16787769|NCT02640053|37727913|FG001|Overall Study|Alternative Therapy|1|||
16787770|NCT02640053|37727912|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
16787771|NCT02640053|37727913|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
16787772|NCT01950364|37727921|FG000|Overall Study|Adverse Event|3|||
16787773|NCT01950364|37727922|FG001|Overall Study|Adverse Event|0|||
16787774|NCT01950364|37727921|FG000|Overall Study|Stem Cell Transplant|2|||
16787775|NCT01950364|37727922|FG001|Overall Study|Stem Cell Transplant|6|||
16787776|NCT01950364|37727921|FG000|Overall Study|Disease Progression|5|||
16787777|NCT01950364|37727922|FG001|Overall Study|Disease Progression|2|||
16787778|NCT01950364|37727921|FG000|Overall Study|Withdrawal by Subject|0|||
16787779|NCT01950364|37727922|FG001|Overall Study|Withdrawal by Subject|1|||
16787780|NCT01950364|37727921|FG000|Overall Study|Protocol Violation|0|||
16787781|NCT01950364|37727922|FG001|Overall Study|Protocol Violation|1|||
16787782|NCT01968070|37727946|FG000|Period 1|Withdrawal by Subject|0|||
16787783|NCT01968070|37727947|FG001|Period 1|Withdrawal by Subject|1|||
16787784|NCT01968070|37727948|FG002|Period 1|Withdrawal by Subject|0|||
16787785|NCT01968070|37727949|FG003|Period 1|Withdrawal by Subject|0|||
16787786|NCT01968070|37727950|FG004|Period 1|Withdrawal by Subject|0|||
16787787|NCT01968070|37727951|FG005|Period 1|Withdrawal by Subject|0|||
16787788|NCT01968070|37727952|FG006|Period 1|Withdrawal by Subject|1|||
16787789|NCT01968070|37727953|FG007|Period 1|Withdrawal by Subject|0|||
16787790|NCT01968070|37727954|FG008|Period 1|Withdrawal by Subject|0|||
16787791|NCT01968070|37727955|FG009|Period 1|Withdrawal by Subject|0|||
16787792|NCT01968070|37727956|FG010|Period 1|Withdrawal by Subject|0|||
16787793|NCT01968070|37727957|FG011|Period 1|Withdrawal by Subject|0|||
16787794|NCT01968070|37727958|FG012|Period 1|Withdrawal by Subject|0|||
16787795|NCT01968070|37727959|FG013|Period 1|Withdrawal by Subject|0|||
16787796|NCT01968070|37727960|FG014|Period 1|Withdrawal by Subject|0|||
16787797|NCT01968070|37727961|FG015|Period 1|Withdrawal by Subject|1|||
16787798|NCT01968070|37727962|FG016|Period 1|Withdrawal by Subject|0|||
16787799|NCT01968070|37727963|FG017|Period 1|Withdrawal by Subject|0|||
16787800|NCT01968070|37727946|FG000|Period 1|Protocol Violation|0|||
16787801|NCT01968070|37727947|FG001|Period 1|Protocol Violation|0|||
16787802|NCT01968070|37727948|FG002|Period 1|Protocol Violation|0|||
16787803|NCT01968070|37727949|FG003|Period 1|Protocol Violation|1|||
16787804|NCT01968070|37727950|FG004|Period 1|Protocol Violation|1|||
16787805|NCT01968070|37727951|FG005|Period 1|Protocol Violation|0|||
16787806|NCT01968070|37727952|FG006|Period 1|Protocol Violation|0|||
16787807|NCT01968070|37727953|FG007|Period 1|Protocol Violation|0|||
16787808|NCT01968070|37727954|FG008|Period 1|Protocol Violation|0|||
16787809|NCT01968070|37727955|FG009|Period 1|Protocol Violation|0|||
16787810|NCT01968070|37727956|FG010|Period 1|Protocol Violation|0|||
16787811|NCT01968070|37727957|FG011|Period 1|Protocol Violation|0|||
16787812|NCT01968070|37727958|FG012|Period 1|Protocol Violation|0|||
16787813|NCT01968070|37727959|FG013|Period 1|Protocol Violation|0|||
16787814|NCT01968070|37727960|FG014|Period 1|Protocol Violation|0|||
16787815|NCT01968070|37727961|FG015|Period 1|Protocol Violation|0|||
16787816|NCT01968070|37727962|FG016|Period 1|Protocol Violation|0|||
16787817|NCT01968070|37727963|FG017|Period 1|Protocol Violation|0|||
16787818|NCT01968070|37727946|FG000|Period 1|Lost to Follow-up|0|||
16787819|NCT01968070|37727947|FG001|Period 1|Lost to Follow-up|0|||
16787820|NCT01968070|37727948|FG002|Period 1|Lost to Follow-up|0|||
16787821|NCT01968070|37727949|FG003|Period 1|Lost to Follow-up|1|||
16787822|NCT01968070|37727950|FG004|Period 1|Lost to Follow-up|0|||
16787823|NCT01968070|37727951|FG005|Period 1|Lost to Follow-up|0|||
16787824|NCT01968070|37727952|FG006|Period 1|Lost to Follow-up|0|||
16787825|NCT01968070|37727953|FG007|Period 1|Lost to Follow-up|0|||
16787826|NCT01968070|37727954|FG008|Period 1|Lost to Follow-up|0|||
16787827|NCT01968070|37727955|FG009|Period 1|Lost to Follow-up|0|||
16787828|NCT01968070|37727956|FG010|Period 1|Lost to Follow-up|0|||
16787829|NCT01968070|37727957|FG011|Period 1|Lost to Follow-up|0|||
16787830|NCT01968070|37727958|FG012|Period 1|Lost to Follow-up|0|||
16787831|NCT01968070|37727959|FG013|Period 1|Lost to Follow-up|0|||
16787832|NCT01968070|37727960|FG014|Period 1|Lost to Follow-up|0|||
16787833|NCT01968070|37727961|FG015|Period 1|Lost to Follow-up|0|||
16787834|NCT01968070|37727962|FG016|Period 1|Lost to Follow-up|0|||
17102208|NCT00385541|38241147|FG000|Overall Study|severe pain, clinician requested unblind|0|||
17102209|NCT00385541|38241148|FG001|Overall Study|severe pain, clinician requested unblind|1|||
16787835|NCT01968070|37727963|FG017|Period 1|Lost to Follow-up|0|||
16787836|NCT01968070|37727946|FG000|Period 1|Adverse Event|0|||
16787837|NCT01968070|37727947|FG001|Period 1|Adverse Event|0|||
16787838|NCT01968070|37727948|FG002|Period 1|Adverse Event|0|||
16787839|NCT01968070|37727949|FG003|Period 1|Adverse Event|0|||
16787840|NCT01968070|37727950|FG004|Period 1|Adverse Event|0|||
16787841|NCT01968070|37727951|FG005|Period 1|Adverse Event|0|||
16787842|NCT01968070|37727952|FG006|Period 1|Adverse Event|1|||
16787843|NCT01968070|37727953|FG007|Period 1|Adverse Event|0|||
16787844|NCT01968070|37727954|FG008|Period 1|Adverse Event|0|||
16787845|NCT01968070|37727955|FG009|Period 1|Adverse Event|0|||
16787846|NCT01968070|37727956|FG010|Period 1|Adverse Event|0|||
16787847|NCT01968070|37727957|FG011|Period 1|Adverse Event|0|||
16787848|NCT01968070|37727958|FG012|Period 1|Adverse Event|0|||
16787849|NCT01968070|37727959|FG013|Period 1|Adverse Event|0|||
16787850|NCT01968070|37727960|FG014|Period 1|Adverse Event|0|||
16787851|NCT01968070|37727961|FG015|Period 1|Adverse Event|0|||
16787852|NCT01968070|37727962|FG016|Period 1|Adverse Event|0|||
16787853|NCT01968070|37727963|FG017|Period 1|Adverse Event|0|||
16787854|NCT01968070|37727946|FG000|Period 1|Physician Decision|0|||
16787855|NCT01968070|37727947|FG001|Period 1|Physician Decision|0|||
16787856|NCT01968070|37727948|FG002|Period 1|Physician Decision|0|||
16787857|NCT01968070|37727949|FG003|Period 1|Physician Decision|0|||
16787858|NCT01968070|37727950|FG004|Period 1|Physician Decision|0|||
16787859|NCT01968070|37727951|FG005|Period 1|Physician Decision|0|||
16787860|NCT01968070|37727952|FG006|Period 1|Physician Decision|0|||
16787861|NCT01968070|37727953|FG007|Period 1|Physician Decision|0|||
16787862|NCT01968070|37727954|FG008|Period 1|Physician Decision|0|||
16787863|NCT01968070|37727955|FG009|Period 1|Physician Decision|0|||
16787864|NCT01968070|37727956|FG010|Period 1|Physician Decision|0|||
16787865|NCT01968070|37727957|FG011|Period 1|Physician Decision|1|||
16787866|NCT01968070|37727958|FG012|Period 1|Physician Decision|0|||
16787867|NCT01968070|37727959|FG013|Period 1|Physician Decision|0|||
16787868|NCT01968070|37727960|FG014|Period 1|Physician Decision|0|||
16787869|NCT01968070|37727961|FG015|Period 1|Physician Decision|0|||
16787870|NCT01968070|37727962|FG016|Period 1|Physician Decision|0|||
16787871|NCT01968070|37727963|FG017|Period 1|Physician Decision|0|||
16787872|NCT01968070|37727946|FG000|Period 2|Withdrawal by Subject|0|||
16787873|NCT01968070|37727947|FG001|Period 2|Withdrawal by Subject|0|||
16787874|NCT01968070|37727948|FG002|Period 2|Withdrawal by Subject|0|||
16787875|NCT01968070|37727949|FG003|Period 2|Withdrawal by Subject|0|||
16787876|NCT01968070|37727950|FG004|Period 2|Withdrawal by Subject|1|||
16787877|NCT01968070|37727951|FG005|Period 2|Withdrawal by Subject|0|||
16787878|NCT01968070|37727952|FG006|Period 2|Withdrawal by Subject|0|||
16787879|NCT01968070|37727953|FG007|Period 2|Withdrawal by Subject|0|||
16787880|NCT01968070|37727954|FG008|Period 2|Withdrawal by Subject|0|||
16787881|NCT01968070|37727955|FG009|Period 2|Withdrawal by Subject|0|||
16787882|NCT01968070|37727956|FG010|Period 2|Withdrawal by Subject|0|||
16787883|NCT01968070|37727957|FG011|Period 2|Withdrawal by Subject|0|||
16787884|NCT01968070|37727958|FG012|Period 2|Withdrawal by Subject|0|||
16787885|NCT01968070|37727959|FG013|Period 2|Withdrawal by Subject|0|||
16787886|NCT01968070|37727960|FG014|Period 2|Withdrawal by Subject|0|||
16787887|NCT01968070|37727961|FG015|Period 2|Withdrawal by Subject|0|||
16787888|NCT01968070|37727962|FG016|Period 2|Withdrawal by Subject|0|||
16787889|NCT01968070|37727963|FG017|Period 2|Withdrawal by Subject|0|||
16787890|NCT01949662|37728003|FG000|Overall Study|Death|9|||
16787891|NCT01949662|37728004|FG001|Overall Study|Death|7|||
16787892|NCT01949662|37728003|FG000|Overall Study|Discharged before an agitation event|8|||
16787893|NCT01949662|37728004|FG001|Overall Study|Discharged before an agitation event|3|||
16787894|NCT01949662|37728003|FG000|Overall Study|Dropped out|1|||
16787895|NCT01949662|37728004|FG001|Overall Study|Dropped out|3|||
16787896|NCT01949662|37728003|FG000|Overall Study|Ineligible|0|||
16787897|NCT01949662|37728004|FG001|Overall Study|Ineligible|1|||
16787898|NCT01918774|37728010|FG000|Overall Study|Lost prior to first CBTw session|4|||
16787899|NCT01918774|37728010|FG000|Overall Study|Lost to Follow-up|1|||
16787900|NCT01949116|37728016|FG000|Overall Study|Death|2|||
16787901|NCT01949116|37728017|FG001|Overall Study|Death|0|||
16787902|NCT01949116|37728016|FG000|Overall Study|Lost to Follow-up|1|||
16787903|NCT01949116|37728017|FG001|Overall Study|Lost to Follow-up|3|||
16787904|NCT01949116|37728016|FG000|Overall Study|Withdrawal by Subject|5|||
16787905|NCT01949116|37728017|FG001|Overall Study|Withdrawal by Subject|3|||
16787906|NCT01673009|37728027|FG000|Overall Study|Physician Decision|5|||
16787907|NCT01673009|37728027|FG000|Overall Study|Withdrawal by Subject|8|||
16787908|NCT01939366|37728036|FG000|Overall Study|Adverse Event|8|||
16787909|NCT01939366|37728037|FG001|Overall Study|Adverse Event|17|||
16787910|NCT01939366|37728038|FG002|Overall Study|Adverse Event|30|||
16787911|NCT01939366|37728039|FG003|Overall Study|Adverse Event|8|||
16787912|NCT01939366|37728040|FG004|Overall Study|Adverse Event|5|||
16787913|NCT01939366|37728036|FG000|Overall Study|Lack of Efficacy|2|||
16787914|NCT01939366|37728037|FG001|Overall Study|Lack of Efficacy|1|||
16787915|NCT01939366|37728038|FG002|Overall Study|Lack of Efficacy|1|||
16787916|NCT01939366|37728039|FG003|Overall Study|Lack of Efficacy|1|||
16787917|NCT01939366|37728040|FG004|Overall Study|Lack of Efficacy|3|||
16787918|NCT01939366|37728036|FG000|Overall Study|Lost to Follow-up|1|||
16787919|NCT01939366|37728037|FG001|Overall Study|Lost to Follow-up|1|||
16787920|NCT01939366|37728038|FG002|Overall Study|Lost to Follow-up|0|||
16787921|NCT01939366|37728039|FG003|Overall Study|Lost to Follow-up|0|||
16787922|NCT01939366|37728040|FG004|Overall Study|Lost to Follow-up|0|||
16787923|NCT01939366|37728036|FG000|Overall Study|Withdrawal by Subject|1|||
16787924|NCT01939366|37728037|FG001|Overall Study|Withdrawal by Subject|0|||
16787925|NCT01939366|37728038|FG002|Overall Study|Withdrawal by Subject|2|||
16787926|NCT01939366|37728039|FG003|Overall Study|Withdrawal by Subject|2|||
16787927|NCT01939366|37728040|FG004|Overall Study|Withdrawal by Subject|3|||
16787928|NCT01939366|37728036|FG000|Overall Study|Inclusion criteria not met|0|||
16787929|NCT01939366|37728037|FG001|Overall Study|Inclusion criteria not met|1|||
16787930|NCT01939366|37728038|FG002|Overall Study|Inclusion criteria not met|1|||
16787931|NCT01939366|37728039|FG003|Overall Study|Inclusion criteria not met|0|||
16787932|NCT01939366|37728040|FG004|Overall Study|Inclusion criteria not met|1|||
16787933|NCT01939366|37728036|FG000|Overall Study|Other|0|||
16787934|NCT01939366|37728037|FG001|Overall Study|Other|0|||
16787935|NCT01939366|37728038|FG002|Overall Study|Other|2|||
16787936|NCT01939366|37728039|FG003|Overall Study|Other|2|||
16787937|NCT01939366|37728040|FG004|Overall Study|Other|1|||
16787938|NCT01939366|37728036|FG000|Overall Study|Protocol Violation|0|||
16787939|NCT01939366|37728037|FG001|Overall Study|Protocol Violation|0|||
16787940|NCT01939366|37728038|FG002|Overall Study|Protocol Violation|0|||
16787941|NCT01939366|37728039|FG003|Overall Study|Protocol Violation|1|||
16787942|NCT01939366|37728040|FG004|Overall Study|Protocol Violation|0|||
16787943|NCT01939366|37728036|FG000|Overall Study|Sponsor decision|0|||
16787944|NCT01939366|37728037|FG001|Overall Study|Sponsor decision|0|||
16787945|NCT01939366|37728038|FG002|Overall Study|Sponsor decision|0|||
16787946|NCT01939366|37728039|FG003|Overall Study|Sponsor decision|0|||
16787947|NCT01939366|37728040|FG004|Overall Study|Sponsor decision|2|||
16787948|NCT01939366|37728036|FG000|Overall Study|GCP non-compliance at site|2|||
16787949|NCT01939366|37728037|FG001|Overall Study|GCP non-compliance at site|3|||
16787950|NCT01939366|37728038|FG002|Overall Study|GCP non-compliance at site|2|||
16787951|NCT01939366|37728039|FG003|Overall Study|GCP non-compliance at site|3|||
16787952|NCT01939366|37728040|FG004|Overall Study|GCP non-compliance at site|3|||
16787953|NCT01918306|37728054|FG000|Overall Study|progresive disease|4|||
16787954|NCT01918306|37728055|FG001|Overall Study|progresive disease|0|||
16787955|NCT01918306|37728056|FG002|Overall Study|progresive disease|1|||
16787956|NCT01918306|37728057|FG003|Overall Study|progresive disease|1|||
16787957|NCT01918306|37728054|FG000|Overall Study|Withdrawal by Subject|0|||
16787958|NCT01918306|37728055|FG001|Overall Study|Withdrawal by Subject|0|||
16787959|NCT01918306|37728056|FG002|Overall Study|Withdrawal by Subject|0|||
16787960|NCT01918306|37728057|FG003|Overall Study|Withdrawal by Subject|2|||
16787961|NCT01918306|37728054|FG000|Overall Study|neutropenia|1|||
16787962|NCT01918306|37728055|FG001|Overall Study|neutropenia|0|||
16787963|NCT01918306|37728056|FG002|Overall Study|neutropenia|0|||
16787964|NCT01918306|37728057|FG003|Overall Study|neutropenia|0|||
16787965|NCT01918306|37728054|FG000|Overall Study|Lack of Efficacy|1|||
16787966|NCT01918306|37728055|FG001|Overall Study|Lack of Efficacy|0|||
16787967|NCT01918306|37728056|FG002|Overall Study|Lack of Efficacy|0|||
16787968|NCT01918306|37728057|FG003|Overall Study|Lack of Efficacy|0|||
16787969|NCT01918306|37728054|FG000|Overall Study|progress disease, crossover|0|||
16787970|NCT01918306|37728055|FG001|Overall Study|progress disease, crossover|0|||
16787971|NCT01918306|37728056|FG002|Overall Study|progress disease, crossover|1|||
16787972|NCT01918306|37728057|FG003|Overall Study|progress disease, crossover|0|||
16787973|NCT01917526|37728079|FG000|Overall Study|Protocol Violation|1|||
16787974|NCT01917526|37728080|FG001|Overall Study|Protocol Violation|1|||
16787975|NCT01948258|37728086|FG000|Overall Study|Pregnancy|41|||
16787976|NCT01948258|37728086|FG000|Overall Study|Did not complete by cut-off date|35|||
16787977|NCT01948258|37728086|FG000|Overall Study|Lost to Follow-up|27|||
16787978|NCT01948258|37728086|FG000|Overall Study|Withdrawal by SPD|8|||
16787979|NCT01948258|37728086|FG000|Overall Study|Withdrawal by Subject|6|||
16787980|NCT01948258|37728086|FG000|Overall Study|Health Care Professional|43|||
16787981|NCT01948258|37728086|FG000|Overall Study|Removed from statistical analysis|2|||
16787982|NCT01916980|37728092|FG000|Overall Study|Adverse Event|4|||
16787983|NCT01916980|37728093|FG001|Overall Study|Adverse Event|2|||
16787984|NCT01916980|37728092|FG000|Overall Study|Lack of Efficacy|2|||
16787985|NCT01916980|37728093|FG001|Overall Study|Lack of Efficacy|2|||
16787986|NCT01916980|37728092|FG000|Overall Study|Withdrawal by Subject|1|||
16787987|NCT01916980|37728093|FG001|Overall Study|Withdrawal by Subject|0|||
16787988|NCT02637557|37728109|FG000|Overall Study|Adverse Event|3|||
17198268|NCT02603120|38351876|FG000|Double-Blind Treatment Phase|Death|2|||
17198269|NCT02603120|38351877|FG001|Double-Blind Treatment Phase|Death|0|||
17198270|NCT02603120|38351876|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
17198271|NCT02603120|38351877|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
17198272|NCT02603120|38351876|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
17198273|NCT02603120|38351877|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
17198274|NCT02603120|38351876|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
16787989|NCT02637557|37728110|FG001|Overall Study|Adverse Event|1|||
16787990|NCT02637557|37728111|FG002|Overall Study|Adverse Event|3|||
16787991|NCT02637557|37728112|FG003|Overall Study|Adverse Event|3|||
16787992|NCT02637557|37728109|FG000|Overall Study|Lost to Follow-up|1|||
16787993|NCT02637557|37728110|FG001|Overall Study|Lost to Follow-up|1|||
16787994|NCT02637557|37728111|FG002|Overall Study|Lost to Follow-up|0|||
16787995|NCT02637557|37728112|FG003|Overall Study|Lost to Follow-up|1|||
16787996|NCT02637557|37728109|FG000|Overall Study|Physician Decision|1|||
16787997|NCT02637557|37728110|FG001|Overall Study|Physician Decision|0|||
16787998|NCT02637557|37728111|FG002|Overall Study|Physician Decision|0|||
16787999|NCT02637557|37728112|FG003|Overall Study|Physician Decision|0|||
16788000|NCT02637557|37728109|FG000|Overall Study|Protocol Violation|2|||
16788001|NCT02637557|37728110|FG001|Overall Study|Protocol Violation|0|||
16788002|NCT02637557|37728111|FG002|Overall Study|Protocol Violation|2|||
16788003|NCT02637557|37728112|FG003|Overall Study|Protocol Violation|1|||
16788004|NCT02637557|37728109|FG000|Overall Study|Withdrawal by Subject|1|||
16788005|NCT02637557|37728110|FG001|Overall Study|Withdrawal by Subject|3|||
16788006|NCT02637557|37728111|FG002|Overall Study|Withdrawal by Subject|4|||
16788007|NCT02637557|37728112|FG003|Overall Study|Withdrawal by Subject|2|||
16788008|NCT02638493|37728125|FG000|Overall Study|Inability to provide semen samples|2|||
16788009|NCT02638493|37728126|FG001|Overall Study|Inability to provide semen samples|0|||
16788010|NCT02638493|37728127|FG002|Overall Study|Inability to provide semen samples|0|||
16788011|NCT02638337|37728137|FG000|Overall Study|Adverse Event|6|||
16788012|NCT02638337|37728138|FG001|Overall Study|Adverse Event|10|||
16788013|NCT02638337|37728137|FG000|Overall Study|Protocol Violation|3|||
16788014|NCT02638337|37728138|FG001|Overall Study|Protocol Violation|0|||
16788015|NCT02638337|37728137|FG000|Overall Study|Withdrawal by Subject|13|||
16788016|NCT02638337|37728138|FG001|Overall Study|Withdrawal by Subject|16|||
16788017|NCT02638337|37728137|FG000|Overall Study|Lost to Follow-up|7|||
16788018|NCT02638337|37728138|FG001|Overall Study|Lost to Follow-up|7|||
16788019|NCT02638337|37728137|FG000|Overall Study|Other - Miscellaneous|4|||
16788020|NCT02638337|37728138|FG001|Overall Study|Other - Miscellaneous|3|||
16788021|NCT02638259|37728146|FG000|Treatment Period 1|Adverse Event|1|||
16788022|NCT02638259|37728147|FG001|Treatment Period 1|Adverse Event|5|||
16788023|NCT02638259|37728146|FG000|Treatment Period 1|Death|0|||
16788024|NCT02638259|37728147|FG001|Treatment Period 1|Death|1|||
16788025|NCT02638259|37728146|FG000|Treatment Period 1|Lack of Efficacy|0|||
16788026|NCT02638259|37728147|FG001|Treatment Period 1|Lack of Efficacy|1|||
16788027|NCT02638259|37728146|FG000|Treatment Period 1|Protocol Violation|0|||
16788028|NCT02638259|37728147|FG001|Treatment Period 1|Protocol Violation|3|||
16788029|NCT02638259|37728146|FG000|Treatment Period 1|Withdrawal by Subject|4|||
16788030|NCT02638259|37728147|FG001|Treatment Period 1|Withdrawal by Subject|6|||
16788031|NCT02638259|37728146|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
16788032|NCT02638259|37728147|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
16788033|NCT02638259|37728146|FG000|Treatment Period 2|Adverse Event|5|||
16788034|NCT02638259|37728147|FG001|Treatment Period 2|Adverse Event|4|||
16788035|NCT02638259|37728146|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16788036|NCT02638259|37728147|FG001|Treatment Period 2|Withdrawal by Subject|7|||
16788037|NCT02637323|37728159|FG000|Overall Study|Lost to Follow-up|2|||
16788038|NCT02637323|37728160|FG001|Overall Study|Lost to Follow-up|0|||
16788039|NCT02637323|37728159|FG000|Overall Study|Protocol Violation|0|||
16788040|NCT02637323|37728160|FG001|Overall Study|Protocol Violation|1|||
16788041|NCT03573817|37728169|FG000|Overall Study|Adverse Event|0|||
16788042|NCT03573817|37728170|FG001|Overall Study|Adverse Event|2|||
16788043|NCT03573817|37728169|FG000|Overall Study|Protocol Violation|0|||
16788044|NCT03573817|37728170|FG001|Overall Study|Protocol Violation|1|||
16788045|NCT03573817|37728169|FG000|Overall Study|Withdrawal by Subject|1|||
16788046|NCT03573817|37728170|FG001|Overall Study|Withdrawal by Subject|1|||
16788047|NCT02638103|37728185|FG000|Overall Study|Adverse Event|13|||
16788048|NCT02638103|37728186|FG001|Overall Study|Adverse Event|12|||
16788049|NCT02638103|37728187|FG002|Overall Study|Adverse Event|19|||
16788050|NCT02638103|37728188|FG003|Overall Study|Adverse Event|12|||
16788051|NCT02638103|37728185|FG000|Overall Study|Withdrawal by Subject|43|||
16788052|NCT02638103|37728186|FG001|Overall Study|Withdrawal by Subject|53|||
16788053|NCT02638103|37728187|FG002|Overall Study|Withdrawal by Subject|30|||
16788054|NCT02638103|37728188|FG003|Overall Study|Withdrawal by Subject|61|||
16788055|NCT02638103|37728185|FG000|Overall Study|Protocol Violation|1|||
16788056|NCT02638103|37728186|FG001|Overall Study|Protocol Violation|2|||
16788057|NCT02638103|37728187|FG002|Overall Study|Protocol Violation|1|||
16788058|NCT02638103|37728188|FG003|Overall Study|Protocol Violation|4|||
16788059|NCT02638103|37728185|FG000|Overall Study|Pregnancy|2|||
16788060|NCT02638103|37728186|FG001|Overall Study|Pregnancy|3|||
16788061|NCT02638103|37728187|FG002|Overall Study|Pregnancy|0|||
16788062|NCT02638103|37728188|FG003|Overall Study|Pregnancy|1|||
16788063|NCT02638103|37728185|FG000|Overall Study|Non-compliance to Study Procedures|2|||
16788064|NCT02638103|37728186|FG001|Overall Study|Non-compliance to Study Procedures|1|||
16788065|NCT02638103|37728187|FG002|Overall Study|Non-compliance to Study Procedures|1|||
16788066|NCT02638103|37728188|FG003|Overall Study|Non-compliance to Study Procedures|1|||
16788067|NCT02638103|37728185|FG000|Overall Study|Lost to Follow-up|26|||
16788068|NCT02638103|37728186|FG001|Overall Study|Lost to Follow-up|33|||
16788069|NCT02638103|37728187|FG002|Overall Study|Lost to Follow-up|20|||
16788070|NCT02638103|37728188|FG003|Overall Study|Lost to Follow-up|37|||
16788071|NCT02638103|37728185|FG000|Overall Study|Lack of Efficacy|14|||
16788072|NCT02638103|37728186|FG001|Overall Study|Lack of Efficacy|10|||
16788073|NCT02638103|37728187|FG002|Overall Study|Lack of Efficacy|12|||
16788074|NCT02638103|37728188|FG003|Overall Study|Lack of Efficacy|22|||
16788075|NCT02638103|37728185|FG000|Overall Study|Other than specified|5|||
16788076|NCT02638103|37728186|FG001|Overall Study|Other than specified|4|||
16788077|NCT02638103|37728187|FG002|Overall Study|Other than specified|2|||
16788078|NCT02638103|37728188|FG003|Overall Study|Other than specified|4|||
16788079|NCT03551743|37728210|FG000|Overall Study|Adverse Event|1|||
16788080|NCT03551743|37728211|FG001|Overall Study|Adverse Event|0|||
16788081|NCT03551743|37728212|FG002|Overall Study|Adverse Event|0|||
16788082|NCT03551743|37728213|FG003|Overall Study|Adverse Event|0|||
16788083|NCT03551743|37728210|FG000|Overall Study|Withdrawal by Subject|1|||
16788084|NCT03551743|37728211|FG001|Overall Study|Withdrawal by Subject|0|||
16788085|NCT03551743|37728212|FG002|Overall Study|Withdrawal by Subject|0|||
16788086|NCT03551743|37728213|FG003|Overall Study|Withdrawal by Subject|0|||
16788087|NCT02636699|37728225|FG000|Overall Study|Adverse Event|4|||
16788088|NCT02636699|37728226|FG001|Overall Study|Adverse Event|0|||
16788089|NCT02636699|37728225|FG000|Overall Study|Lost to Follow-up|3|||
16788090|NCT02636699|37728226|FG001|Overall Study|Lost to Follow-up|3|||
16788091|NCT02636699|37728225|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
16788092|NCT02636699|37728226|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
16788093|NCT02636699|37728225|FG000|Overall Study|Physician Decision|0|||
16788094|NCT02636699|37728226|FG001|Overall Study|Physician Decision|1|||
16788095|NCT02636699|37728225|FG000|Overall Study|Withdrawal by Subject|13|||
16788096|NCT02636699|37728226|FG001|Overall Study|Withdrawal by Subject|6|||
16788097|NCT02636699|37728225|FG000|Overall Study|Other|3|||
16788098|NCT02636699|37728226|FG001|Overall Study|Other|1|||
16788099|NCT02634983|37728232|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
16788100|NCT02634983|37728233|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
16788101|NCT02633501|37728245|FG000|Overall Study|Adverse Event|0|||
16788102|NCT02633501|37728246|FG001|Overall Study|Adverse Event|0|||
16788103|NCT02633501|37728247|FG002|Overall Study|Adverse Event|1|||
16788104|NCT02633501|37728248|FG003|Overall Study|Adverse Event|0|||
16788105|NCT02633501|37728249|FG004|Overall Study|Adverse Event|1|||
16788106|NCT02633501|37728250|FG005|Overall Study|Adverse Event|1|||
16788107|NCT02633501|37728245|FG000|Overall Study|Withdrawal by Subject|2|||
16788108|NCT02633501|37728246|FG001|Overall Study|Withdrawal by Subject|1|||
16788109|NCT02633501|37728247|FG002|Overall Study|Withdrawal by Subject|2|||
16788110|NCT02633501|37728248|FG003|Overall Study|Withdrawal by Subject|2|||
16788111|NCT02633501|37728249|FG004|Overall Study|Withdrawal by Subject|1|||
16788112|NCT02633501|37728250|FG005|Overall Study|Withdrawal by Subject|3|||
16788113|NCT02633501|37728245|FG000|Overall Study|Various other reasons|0|||
16788114|NCT02633501|37728246|FG001|Overall Study|Various other reasons|2|||
16788115|NCT02633501|37728247|FG002|Overall Study|Various other reasons|4|||
16788116|NCT02633501|37728248|FG003|Overall Study|Various other reasons|1|||
16788117|NCT02633501|37728249|FG004|Overall Study|Various other reasons|7|||
16788118|NCT02633501|37728250|FG005|Overall Study|Various other reasons|11|||
16788119|NCT02633501|37728245|FG000|Overall Study|Lost to Follow-up|0|||
16788120|NCT02633501|37728246|FG001|Overall Study|Lost to Follow-up|0|||
16788121|NCT02633501|37728247|FG002|Overall Study|Lost to Follow-up|0|||
16788122|NCT02633501|37728248|FG003|Overall Study|Lost to Follow-up|1|||
16788123|NCT02633501|37728249|FG004|Overall Study|Lost to Follow-up|2|||
16788124|NCT02633501|37728250|FG005|Overall Study|Lost to Follow-up|0|||
16788125|NCT03138499|37728271|FG000|Overall Study|Lost to Follow-up|1|||
16788126|NCT03138499|37728272|FG001|Overall Study|Lost to Follow-up|0|||
16788127|NCT03138499|37728271|FG000|Overall Study|Participants withdrew consent|1|||
16788128|NCT03138499|37728272|FG001|Overall Study|Participants withdrew consent|0|||
16788129|NCT03138499|37728271|FG000|Overall Study|Participant discontinued study before treatment|0|||
16788130|NCT03138499|37728272|FG001|Overall Study|Participant discontinued study before treatment|1|||
16788131|NCT03138499|37728271|FG000|Overall Study|Disease Progression|2|||
16788132|NCT03138499|37728272|FG001|Overall Study|Disease Progression|6|||
16788133|NCT03138499|37728271|FG000|Overall Study|Study drug toxicity|2|||
16788134|NCT03138499|37728272|FG001|Overall Study|Study drug toxicity|2|||
16788135|NCT03138499|37728271|FG000|Overall Study|Participant request to discontinue study treatment|1|||
16788136|NCT03138499|37728272|FG001|Overall Study|Participant request to discontinue study treatment|1|||
16788137|NCT03138499|37728271|FG000|Overall Study|Other reasons|2|||
16788138|NCT03138499|37728272|FG001|Overall Study|Other reasons|0|||
16788139|NCT04508621|37728281|FG000|Overall Study|Adverse Event|39|||
16788140|NCT04508621|37728282|FG001|Overall Study|Adverse Event|16|||
16788141|NCT04508621|37728281|FG000|Overall Study|Lack of Efficacy|2|||
16788142|NCT04508621|37728282|FG001|Overall Study|Lack of Efficacy|8|||
16788143|NCT04508621|37728281|FG000|Overall Study|Physician Decision|0|||
16788144|NCT04508621|37728282|FG001|Overall Study|Physician Decision|1|||
16788145|NCT04508621|37728281|FG000|Overall Study|Withdrawal by Subject|10|||
16788146|NCT04508621|37728282|FG001|Overall Study|Withdrawal by Subject|14|||
16788147|NCT04508621|37728281|FG000|Overall Study|Lost to Follow-up|12|||
16788148|NCT04508621|37728282|FG001|Overall Study|Lost to Follow-up|9|||
16788149|NCT04508621|37728281|FG000|Overall Study|COVID-19 related crisis|3|||
16788150|NCT04508621|37728282|FG001|Overall Study|COVID-19 related crisis|0|||
16788151|NCT04508621|37728281|FG000|Overall Study|Subject non-compliance|1|||
16788152|NCT04508621|37728282|FG001|Overall Study|Subject non-compliance|0|||
16788153|NCT03591107|37728290|FG000|Overall Study|Same patient in both arms|1|||
16788154|NCT03591107|37728291|FG001|Overall Study|Same patient in both arms|1|||
16788155|NCT03591107|37728290|FG000|Overall Study|Sought care at other clinics|0|||
16788156|NCT03591107|37728291|FG001|Overall Study|Sought care at other clinics|2|||
16788157|NCT03591107|37728290|FG000|Overall Study|Discharged from clinic|0|||
16788158|NCT03591107|37728291|FG001|Overall Study|Discharged from clinic|1|||
16788159|NCT03591107|37728290|FG000|Overall Study|Withdrawal by Subject|0|||
16788160|NCT03591107|37728291|FG001|Overall Study|Withdrawal by Subject|1|||
16788161|NCT02922023|37728304|FG000|Overall Study|Lost to Follow-up|2|||
16788162|NCT02922023|37728305|FG001|Overall Study|Lost to Follow-up|0|||
16788163|NCT01672853|37728314|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
16788164|NCT01672853|37728315|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
16788165|NCT01672853|37728316|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
16788166|NCT01672853|37728314|FG000|Overall Study|Pregnancy|0|||
16788167|NCT01672853|37728315|FG001|Overall Study|Pregnancy|1|||
16788168|NCT01672853|37728316|FG002|Overall Study|Pregnancy|0|||
16788169|NCT01672853|37728314|FG000|Overall Study|Investigator's Discretion|1|||
16788170|NCT01672853|37728315|FG001|Overall Study|Investigator's Discretion|0|||
16788171|NCT01672853|37728316|FG002|Overall Study|Investigator's Discretion|0|||
16788172|NCT01672853|37728314|FG000|Overall Study|Withdrew Consent|5|||
16788173|NCT01672853|37728315|FG001|Overall Study|Withdrew Consent|5|||
16788174|NCT01672853|37728316|FG002|Overall Study|Withdrew Consent|5|||
16788175|NCT01672853|37728314|FG000|Overall Study|Adverse Event|4|||
16788176|NCT01672853|37728315|FG001|Overall Study|Adverse Event|6|||
16788177|NCT01672853|37728316|FG002|Overall Study|Adverse Event|8|||
16788178|NCT01672853|37728314|FG000|Overall Study|Lost to Follow-up|0|||
16788179|NCT01672853|37728315|FG001|Overall Study|Lost to Follow-up|1|||
16788180|NCT01672853|37728316|FG002|Overall Study|Lost to Follow-up|0|||
16788181|NCT01672853|37728314|FG000|Overall Study|Randomized but Never Treated|0|||
16788182|NCT01672853|37728315|FG001|Overall Study|Randomized but Never Treated|0|||
16788183|NCT01672853|37728316|FG002|Overall Study|Randomized but Never Treated|1|||
16788184|NCT01603459|37728324|FG000|Overall Study|Adverse Event|5|||
16788185|NCT01603459|37728324|FG000|Overall Study|Withdrawal by Subject|5|||
16788186|NCT01603459|37728324|FG000|Overall Study|Lost to Follow-up|3|||
16788187|NCT01603459|37728324|FG000|Overall Study|Predefined discontinuation criteria|3|||
16788188|NCT01603459|37728324|FG000|Overall Study|Non-compliance|1|||
16788189|NCT01603459|37728324|FG000|Overall Study|Administrative reason|1|||
16788190|NCT01678807|37728363|FG000|Overall Study|Adverse Event|4|||
16788191|NCT01678807|37728364|FG001|Overall Study|Adverse Event|4|||
16788192|NCT01678807|37728365|FG002|Overall Study|Adverse Event|0|||
16788193|NCT01678807|37728363|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
16788194|NCT01678807|37728364|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
16788195|NCT01678807|37728365|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
16788196|NCT02631551|37728377|FG000|Overall Study|Adverse Event|1|||
16788197|NCT02631551|37728378|FG001|Overall Study|Adverse Event|2|||
16788198|NCT02631551|37728379|FG002|Overall Study|Adverse Event|4|||
16788199|NCT02631551|37728380|FG003|Overall Study|Adverse Event|0|||
16788200|NCT02631551|37728377|FG000|Overall Study|Lack of Efficacy|0|||
16788201|NCT02631551|37728378|FG001|Overall Study|Lack of Efficacy|0|||
16788202|NCT02631551|37728379|FG002|Overall Study|Lack of Efficacy|1|||
16788203|NCT02631551|37728380|FG003|Overall Study|Lack of Efficacy|0|||
16788204|NCT02631551|37728377|FG000|Overall Study|Lost to Follow-up|1|||
16788205|NCT02631551|37728378|FG001|Overall Study|Lost to Follow-up|2|||
16788206|NCT02631551|37728379|FG002|Overall Study|Lost to Follow-up|0|||
16788207|NCT02631551|37728380|FG003|Overall Study|Lost to Follow-up|3|||
16788208|NCT02631551|37728377|FG000|Overall Study|Withdrawal by Subject|2|||
16788209|NCT02631551|37728378|FG001|Overall Study|Withdrawal by Subject|2|||
16788210|NCT02631551|37728379|FG002|Overall Study|Withdrawal by Subject|0|||
16788211|NCT02631551|37728380|FG003|Overall Study|Withdrawal by Subject|5|||
16788212|NCT02631551|37728377|FG000|Overall Study|Protocol deviation|3|||
16788213|NCT02631551|37728378|FG001|Overall Study|Protocol deviation|6|||
16788214|NCT02631551|37728379|FG002|Overall Study|Protocol deviation|3|||
16788215|NCT02631551|37728380|FG003|Overall Study|Protocol deviation|0|||
16788216|NCT02631551|37728377|FG000|Overall Study|Non-compliance with study procedures|0|||
16788217|NCT02631551|37728378|FG001|Overall Study|Non-compliance with study procedures|0|||
16788218|NCT02631551|37728379|FG002|Overall Study|Non-compliance with study procedures|1|||
16788219|NCT02631551|37728380|FG003|Overall Study|Non-compliance with study procedures|1|||
16788220|NCT02631551|37728377|FG000|Overall Study|Non-compliance with study drug|1|||
16788221|NCT02631551|37728378|FG001|Overall Study|Non-compliance with study drug|0|||
16788222|NCT02631551|37728379|FG002|Overall Study|Non-compliance with study drug|0|||
16788223|NCT02631551|37728380|FG003|Overall Study|Non-compliance with study drug|0|||
16788224|NCT02631551|37728377|FG000|Overall Study|Other, specific reasons not collected|5|||
16788225|NCT02631551|37728378|FG001|Overall Study|Other, specific reasons not collected|7|||
16788226|NCT02631551|37728379|FG002|Overall Study|Other, specific reasons not collected|2|||
16788227|NCT02631551|37728380|FG003|Overall Study|Other, specific reasons not collected|2|||
16788228|NCT01680991|37728393|FG000|Overall Study|Adverse Event|1|||
16788229|NCT01680991|37728394|FG001|Overall Study|Adverse Event|0|||
16788230|NCT01680991|37728395|FG002|Overall Study|Adverse Event|0|||
16788231|NCT01680991|37728393|FG000|Overall Study|Death|1|||
16788232|NCT01680991|37728394|FG001|Overall Study|Death|0|||
16788233|NCT01680991|37728395|FG002|Overall Study|Death|1|||
16788234|NCT01680991|37728393|FG000|Overall Study|Protocol Violation|0|||
16788235|NCT01680991|37728394|FG001|Overall Study|Protocol Violation|1|||
16788236|NCT01680991|37728395|FG002|Overall Study|Protocol Violation|0|||
16788237|NCT01680991|37728393|FG000|Overall Study|Withdrawal by Subject|5|||
16788238|NCT01680991|37728394|FG001|Overall Study|Withdrawal by Subject|1|||
16788239|NCT01680991|37728395|FG002|Overall Study|Withdrawal by Subject|0|||
16788240|NCT01680991|37728393|FG000|Overall Study|Progressive disease (PD)|0|||
16788241|NCT01680991|37728394|FG001|Overall Study|Progressive disease (PD)|10|||
16788242|NCT01680991|37728395|FG002|Overall Study|Progressive disease (PD)|0|||
16788243|NCT01680991|37728393|FG000|Overall Study|Physician Decision|0|||
16788244|NCT01680991|37728394|FG001|Overall Study|Physician Decision|7|||
16788245|NCT01680991|37728395|FG002|Overall Study|Physician Decision|2|||
16788246|NCT01680991|37728393|FG000|Overall Study|Bad physical condition|0|||
16788247|NCT01680991|37728394|FG001|Overall Study|Bad physical condition|0|||
16788248|NCT01680991|37728395|FG002|Overall Study|Bad physical condition|1|||
16788249|NCT01680991|37728393|FG000|Overall Study|PD confirmed in other hospital|1|||
16788250|NCT01680991|37728394|FG001|Overall Study|PD confirmed in other hospital|0|||
16788251|NCT01680991|37728395|FG002|Overall Study|PD confirmed in other hospital|0|||
16788252|NCT02819479|37728405|FG000|Overall Study|Adverse Event|2|||
16788253|NCT04064411|37728412|FG000|Overall Study|Adverse Event|29|||
16788254|NCT04064411|37728413|FG001|Overall Study|Adverse Event|19|||
16788255|NCT04064411|37728412|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
16788256|NCT04064411|37728413|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
16788257|NCT04064411|37728412|FG000|Overall Study|Protocol Deviation|0|||
16788258|NCT04064411|37728413|FG001|Overall Study|Protocol Deviation|2|||
16788259|NCT04064411|37728412|FG000|Overall Study|Withdrawal by Subject|25|||
16788260|NCT04064411|37728413|FG001|Overall Study|Withdrawal by Subject|29|||
16788261|NCT04064411|37728412|FG000|Overall Study|Lost to Follow-up|5|||
16788262|NCT04064411|37728413|FG001|Overall Study|Lost to Follow-up|2|||
16788263|NCT04064411|37728412|FG000|Overall Study|Other than Specified|4|||
16788264|NCT04064411|37728413|FG001|Overall Study|Other than Specified|1|||
16788265|NCT04064411|37728412|FG000|Overall Study|Death|1|||
16788266|NCT04064411|37728413|FG001|Overall Study|Death|0|||
16788267|NCT02004691|37728421|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
16788268|NCT02004691|37728422|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
16788269|NCT02004691|37728421|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
16788270|NCT02004691|37728422|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
16788271|NCT02004691|37728421|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
16788272|NCT02004691|37728422|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
16788273|NCT02004691|37728421|FG000|ETP: Ongoing From Week 52|Other|0|||
16788274|NCT02004691|37728422|FG001|ETP: Ongoing From Week 52|Other|1|||
16788275|NCT02004691|37728421|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
16788276|NCT02004691|37728422|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
16788277|NCT02629133|37728430|FG000|Overall Study|Lost to Follow-up|3|||
16788278|NCT02629133|37728431|FG001|Overall Study|Lost to Follow-up|1|||
16788279|NCT02629133|37728430|FG000|Overall Study|Withdrawal by Subject|1|||
16788280|NCT02629133|37728431|FG001|Overall Study|Withdrawal by Subject|1|||
16788281|NCT02660359|37728440|FG000|Overall Study|Protocol Deviation|0|||
16788282|NCT02660359|37728441|FG001|Overall Study|Protocol Deviation|0|||
16788283|NCT02660359|37728442|FG002|Overall Study|Protocol Deviation|1|||
16788284|NCT02660359|37728440|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
16788285|NCT02660359|37728441|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
16788286|NCT02660359|37728442|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
16788287|NCT02660359|37728440|FG000|Overall Study|Lack of Efficacy|1|||
16788288|NCT02660359|37728441|FG001|Overall Study|Lack of Efficacy|1|||
16788289|NCT02660359|37728442|FG002|Overall Study|Lack of Efficacy|1|||
16788290|NCT02660359|37728440|FG000|Overall Study|Adverse Event|0|||
16788291|NCT02660359|37728441|FG001|Overall Study|Adverse Event|1|||
16788292|NCT02660359|37728442|FG002|Overall Study|Adverse Event|0|||
16788293|NCT02660359|37728440|FG000|Overall Study|Other|2|||
16788294|NCT02660359|37728441|FG001|Overall Study|Other|1|||
16788295|NCT02660359|37728442|FG002|Overall Study|Other|3|||
16788296|NCT02660359|37728440|FG000|Overall Study|Withdrawal by Subject|7|||
16788297|NCT02660359|37728441|FG001|Overall Study|Withdrawal by Subject|5|||
16788298|NCT02660359|37728442|FG002|Overall Study|Withdrawal by Subject|8|||
16788299|NCT02660359|37728440|FG000|Overall Study|Lost to Follow-up|3|||
16788300|NCT02660359|37728441|FG001|Overall Study|Lost to Follow-up|3|||
16788301|NCT02660359|37728442|FG002|Overall Study|Lost to Follow-up|0|||
16788302|NCT02628743|37728450|FG000|Overall Study|Other|3|||
16788303|NCT02628743|37728450|FG000|Overall Study|Withdrawal by Subject|50|||
16788304|NCT02628743|37728450|FG000|Overall Study|Study Terminated by Sponsor|76|||
16788305|NCT02628743|37728450|FG000|Overall Study|Physician Decision|2|||
16788306|NCT03839459|37728454|FG000|Overall Study|Withdrawal by Subject|2|||
16788307|NCT03839459|37728454|FG000|Overall Study|progression of disease|3|||
16788308|NCT02630693|37728460|FG000|Overall Study|No receive treatment|0|||
16788309|NCT02630693|37728461|FG001|Overall Study|No receive treatment|1|||
16788310|NCT05059301|37728470|FG000|Overall Study|Adverse Event|0|||
16788311|NCT05059301|37728471|FG001|Overall Study|Adverse Event|2|||
16788312|NCT05059301|37728472|FG002|Overall Study|Adverse Event|2|||
16788313|NCT05059301|37728470|FG000|Overall Study|Lost to Follow-up|2|||
16788314|NCT05059301|37728471|FG001|Overall Study|Lost to Follow-up|3|||
16788315|NCT05059301|37728472|FG002|Overall Study|Lost to Follow-up|3|||
16788316|NCT01938430|37728498|FG000|Overall Study|Randomized but Not Treated|0|||
16788317|NCT01938430|37728499|FG001|Overall Study|Randomized but Not Treated|0|||
16788318|NCT01938430|37728500|FG002|Overall Study|Randomized but Not Treated|0|||
16788319|NCT01938430|37728501|FG003|Overall Study|Randomized but Not Treated|0|||
16788320|NCT01938430|37728502|FG004|Overall Study|Randomized but Not Treated|0|||
16788321|NCT01938430|37728503|FG005|Overall Study|Randomized but Not Treated|0|||
16788322|NCT01938430|37728504|FG006|Overall Study|Randomized but Not Treated|0|||
16788323|NCT01938430|37728505|FG007|Overall Study|Randomized but Not Treated|0|||
16788324|NCT01938430|37728506|FG008|Overall Study|Randomized but Not Treated|0|||
16788325|NCT01938430|37728507|FG009|Overall Study|Randomized but Not Treated|0|||
16788326|NCT01938430|37728508|FG010|Overall Study|Randomized but Not Treated|1|||
16788327|NCT01938430|37728509|FG011|Overall Study|Randomized but Not Treated|0|||
16788328|NCT01938430|37728510|FG012|Overall Study|Randomized but Not Treated|0|||
16788329|NCT01938430|37728511|FG013|Overall Study|Randomized but Not Treated|1|||
16788330|NCT01938430|37728498|FG000|Overall Study|Adverse Event|0|||
16788331|NCT01938430|37728499|FG001|Overall Study|Adverse Event|0|||
16788332|NCT01938430|37728500|FG002|Overall Study|Adverse Event|0|||
16788333|NCT01938430|37728501|FG003|Overall Study|Adverse Event|0|||
16788334|NCT01938430|37728502|FG004|Overall Study|Adverse Event|0|||
16788335|NCT01938430|37728503|FG005|Overall Study|Adverse Event|0|||
16788336|NCT01938430|37728504|FG006|Overall Study|Adverse Event|1|||
16788337|NCT01938430|37728505|FG007|Overall Study|Adverse Event|0|||
16788338|NCT01938430|37728506|FG008|Overall Study|Adverse Event|0|||
16788339|NCT01938430|37728507|FG009|Overall Study|Adverse Event|0|||
16788340|NCT01938430|37728508|FG010|Overall Study|Adverse Event|0|||
16788341|NCT01938430|37728509|FG011|Overall Study|Adverse Event|0|||
16788342|NCT01938430|37728510|FG012|Overall Study|Adverse Event|0|||
16788343|NCT01938430|37728511|FG013|Overall Study|Adverse Event|0|||
16788344|NCT01938430|37728498|FG000|Overall Study|Death|1|||
16788345|NCT01938430|37728499|FG001|Overall Study|Death|2|||
16788346|NCT01938430|37728500|FG002|Overall Study|Death|2|||
16788347|NCT01938430|37728501|FG003|Overall Study|Death|1|||
16788348|NCT01938430|37728502|FG004|Overall Study|Death|0|||
16788349|NCT01938430|37728503|FG005|Overall Study|Death|0|||
16788350|NCT01938430|37728504|FG006|Overall Study|Death|1|||
16788351|NCT01938430|37728505|FG007|Overall Study|Death|1|||
16788352|NCT01938430|37728506|FG008|Overall Study|Death|2|||
16788353|NCT01938430|37728507|FG009|Overall Study|Death|3|||
16788354|NCT01938430|37728508|FG010|Overall Study|Death|0|||
16788355|NCT01938430|37728509|FG011|Overall Study|Death|0|||
16788356|NCT01938430|37728510|FG012|Overall Study|Death|0|||
16788357|NCT01938430|37728511|FG013|Overall Study|Death|0|||
16788358|NCT01938430|37728498|FG000|Overall Study|Investigator's Discretion|0|||
16788359|NCT01938430|37728499|FG001|Overall Study|Investigator's Discretion|0|||
16788360|NCT01938430|37728500|FG002|Overall Study|Investigator's Discretion|1|||
16788361|NCT01938430|37728501|FG003|Overall Study|Investigator's Discretion|0|||
16788362|NCT01938430|37728502|FG004|Overall Study|Investigator's Discretion|0|||
16788363|NCT01938430|37728503|FG005|Overall Study|Investigator's Discretion|0|||
16788364|NCT01938430|37728504|FG006|Overall Study|Investigator's Discretion|0|||
16788365|NCT01938430|37728505|FG007|Overall Study|Investigator's Discretion|0|||
16788366|NCT01938430|37728506|FG008|Overall Study|Investigator's Discretion|0|||
16788367|NCT01938430|37728507|FG009|Overall Study|Investigator's Discretion|0|||
16788368|NCT01938430|37728508|FG010|Overall Study|Investigator's Discretion|0|||
16788369|NCT01938430|37728509|FG011|Overall Study|Investigator's Discretion|0|||
16788370|NCT01938430|37728510|FG012|Overall Study|Investigator's Discretion|0|||
16788371|NCT01938430|37728511|FG013|Overall Study|Investigator's Discretion|0|||
16788372|NCT01938430|37728498|FG000|Overall Study|Lack of Efficacy|3|||
16788373|NCT01938430|37728499|FG001|Overall Study|Lack of Efficacy|1|||
16788374|NCT01938430|37728500|FG002|Overall Study|Lack of Efficacy|1|||
16788375|NCT01938430|37728501|FG003|Overall Study|Lack of Efficacy|1|||
16788376|NCT01938430|37728502|FG004|Overall Study|Lack of Efficacy|0|||
16788377|NCT01938430|37728503|FG005|Overall Study|Lack of Efficacy|0|||
16788378|NCT01938430|37728504|FG006|Overall Study|Lack of Efficacy|0|||
16788379|NCT01938430|37728505|FG007|Overall Study|Lack of Efficacy|0|||
16788380|NCT01938430|37728506|FG008|Overall Study|Lack of Efficacy|1|||
16788381|NCT01938430|37728507|FG009|Overall Study|Lack of Efficacy|0|||
16788382|NCT01938430|37728508|FG010|Overall Study|Lack of Efficacy|2|||
16788383|NCT01938430|37728509|FG011|Overall Study|Lack of Efficacy|1|||
16788384|NCT01938430|37728510|FG012|Overall Study|Lack of Efficacy|0|||
16788385|NCT01938430|37728511|FG013|Overall Study|Lack of Efficacy|0|||
16788386|NCT01938430|37728498|FG000|Overall Study|Lost to Follow-up|0|||
16788387|NCT01938430|37728499|FG001|Overall Study|Lost to Follow-up|0|||
16788388|NCT01938430|37728500|FG002|Overall Study|Lost to Follow-up|1|||
16788389|NCT01938430|37728501|FG003|Overall Study|Lost to Follow-up|0|||
16788390|NCT01938430|37728502|FG004|Overall Study|Lost to Follow-up|0|||
16788391|NCT01938430|37728503|FG005|Overall Study|Lost to Follow-up|1|||
16788392|NCT01938430|37728504|FG006|Overall Study|Lost to Follow-up|0|||
16788393|NCT01938430|37728505|FG007|Overall Study|Lost to Follow-up|0|||
16788394|NCT01938430|37728506|FG008|Overall Study|Lost to Follow-up|0|||
16788395|NCT01938430|37728507|FG009|Overall Study|Lost to Follow-up|0|||
16788396|NCT01938430|37728508|FG010|Overall Study|Lost to Follow-up|0|||
16788397|NCT01938430|37728509|FG011|Overall Study|Lost to Follow-up|0|||
16788398|NCT01938430|37728510|FG012|Overall Study|Lost to Follow-up|0|||
16788399|NCT01938430|37728511|FG013|Overall Study|Lost to Follow-up|0|||
16788400|NCT01938430|37728498|FG000|Overall Study|Withdrew Consent|0|||
16788401|NCT01938430|37728499|FG001|Overall Study|Withdrew Consent|0|||
16788402|NCT01938430|37728500|FG002|Overall Study|Withdrew Consent|0|||
16788403|NCT01938430|37728501|FG003|Overall Study|Withdrew Consent|0|||
16788404|NCT01938430|37728502|FG004|Overall Study|Withdrew Consent|0|||
16788405|NCT01938430|37728503|FG005|Overall Study|Withdrew Consent|0|||
16788406|NCT01938430|37728504|FG006|Overall Study|Withdrew Consent|0|||
16788407|NCT01938430|37728505|FG007|Overall Study|Withdrew Consent|0|||
16788408|NCT01938430|37728506|FG008|Overall Study|Withdrew Consent|1|||
16788409|NCT01938430|37728507|FG009|Overall Study|Withdrew Consent|0|||
16788410|NCT01938430|37728508|FG010|Overall Study|Withdrew Consent|0|||
16788411|NCT01938430|37728509|FG011|Overall Study|Withdrew Consent|0|||
16788412|NCT01938430|37728510|FG012|Overall Study|Withdrew Consent|0|||
16788413|NCT01938430|37728511|FG013|Overall Study|Withdrew Consent|0|||
16788414|NCT01937884|37728568|FG000|Overall Study|Withdrawal by Subject|1|||
16788415|NCT01937884|37728569|FG001|Overall Study|Withdrawal by Subject|0|||
16788416|NCT01916824|37728579|FG000|Overall Study|Lost to Follow-up|3|||
16788417|NCT01916824|37728580|FG001|Overall Study|Lost to Follow-up|6|||
16788418|NCT01916824|37728579|FG000|Overall Study|Physician Decision|2|||
16788419|NCT01916824|37728580|FG001|Overall Study|Physician Decision|0|||
16788420|NCT01916824|37728579|FG000|Overall Study|Withdrawal by Subject|2|||
16788421|NCT01916824|37728580|FG001|Overall Study|Withdrawal by Subject|3|||
16788422|NCT01915732|37728588|FG000|Overall Study|Withdrawal by Subject|18|||
16788423|NCT01915732|37728589|FG001|Overall Study|Withdrawal by Subject|18|||
16788424|NCT01915732|37728588|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
16788425|NCT01915732|37728589|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
16788426|NCT01915732|37728588|FG000|Overall Study|Adverse Event|12|||
16788427|NCT01915732|37728589|FG001|Overall Study|Adverse Event|4|||
16788428|NCT01915732|37728588|FG000|Overall Study|Protocol Violation|5|||
16788429|NCT01915732|37728589|FG001|Overall Study|Protocol Violation|5|||
16788430|NCT01915732|37728588|FG000|Overall Study|Lack of Efficacy|6|||
16788431|NCT01915732|37728589|FG001|Overall Study|Lack of Efficacy|11|||
16788432|NCT01915732|37728588|FG000|Overall Study|Lost to Follow-up|22|||
16788433|NCT01915732|37728589|FG001|Overall Study|Lost to Follow-up|26|||
16788434|NCT01915732|37728588|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
16788435|NCT01915732|37728589|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
16788436|NCT01915732|37728588|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
16788437|NCT01915732|37728589|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
16788438|NCT01915732|37728588|FG000|Overall Study|Drug Release Error|1|||
16788439|NCT01915732|37728589|FG001|Overall Study|Drug Release Error|0|||
16788440|NCT01915732|37728588|FG000|Overall Study|Recovered|1|||
16788441|NCT01915732|37728589|FG001|Overall Study|Recovered|0|||
16788442|NCT01915732|37728588|FG000|Overall Study|Pregnancy|1|||
16788443|NCT01915732|37728589|FG001|Overall Study|Pregnancy|0|||
16788444|NCT01915732|37728588|FG000|Overall Study|Poor Perceived Efficacy|1|||
16788445|NCT01915732|37728589|FG001|Overall Study|Poor Perceived Efficacy|0|||
16788446|NCT01915732|37728588|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
16788447|NCT01915732|37728589|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
16788448|NCT01915732|37728588|FG000|Overall Study|Got Well|0|||
16788449|NCT01915732|37728589|FG001|Overall Study|Got Well|1|||
17198275|NCT02603120|38351877|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
16788450|NCT01915732|37728588|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
16788451|NCT01915732|37728589|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
16788452|NCT01915732|37728588|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
16788453|NCT01915732|37728589|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
16788454|NCT01915732|37728588|FG000|Overall Study|Job Transfer|0|||
16788455|NCT01915732|37728589|FG001|Overall Study|Job Transfer|1|||
16788456|NCT01915732|37728588|FG000|Overall Study|Improper Facial Procedure|0|||
16788457|NCT01915732|37728589|FG001|Overall Study|Improper Facial Procedure|1|||
16788458|NCT01915732|37728588|FG000|Overall Study|Poor Conscious Effect|0|||
16788459|NCT01915732|37728589|FG001|Overall Study|Poor Conscious Effect|1|||
16788460|NCT01936948|37728599|FG000|Overall Study|no 30-day follow-up data|0|||
16788461|NCT01936948|37728600|FG001|Overall Study|no 30-day follow-up data|3|||
16788462|NCT01936948|37728601|FG002|Overall Study|no 30-day follow-up data|3|||
16788463|NCT01936948|37728602|FG003|Overall Study|no 30-day follow-up data|3|||
16788464|NCT01936870|37728610|FG000|Overall Study|No Visit After Treatment|176|||
16788465|NCT01936870|37728610|FG000|Overall Study|Protocol Violation|12|||
16788466|NCT01936870|37728610|FG000|Overall Study|No Drug Administration|1|||
16788467|NCT01618864|37728614|FG000|Overall Study|Withdrawal by Subject|2|||
16788468|NCT01618864|37728614|FG000|Overall Study|Lost to Follow-up|2|||
16788469|NCT01618708|37728625|FG000|Overall Study|Adverse Event|10|||
16788470|NCT01618708|37728626|FG001|Overall Study|Adverse Event|10|||
16788471|NCT01618708|37728625|FG000|Overall Study|Lost to Follow-up|3|||
16788472|NCT01618708|37728626|FG001|Overall Study|Lost to Follow-up|3|||
16788473|NCT01618708|37728625|FG000|Overall Study|Withdrawal by Subject|17|||
16788474|NCT01618708|37728626|FG001|Overall Study|Withdrawal by Subject|22|||
16788475|NCT01618708|37728625|FG000|Overall Study|Lack of Efficacy|8|||
16788476|NCT01618708|37728626|FG001|Overall Study|Lack of Efficacy|8|||
16788477|NCT01618708|37728625|FG000|Overall Study|Technical problems|2|||
16788478|NCT01618708|37728626|FG001|Overall Study|Technical problems|0|||
16788479|NCT01618708|37728625|FG000|Overall Study|Other than specified above|1|||
16788480|NCT01618708|37728626|FG001|Overall Study|Other than specified above|1|||
16788481|NCT01618708|37728625|FG000|Overall Study|Randomized but not treated|3|||
16788482|NCT01618708|37728626|FG001|Overall Study|Randomized but not treated|2|||
16788483|NCT00790933|37728642|FG000|Overall Study|Adverse Event|94|||
16788484|NCT00790933|37728643|FG001|Overall Study|Adverse Event|119|||
16788485|NCT00790933|37728644|FG002|Overall Study|Adverse Event|65|||
16788486|NCT00790933|37728645|FG003|Overall Study|Adverse Event|5|||
16788487|NCT00790933|37728646|FG004|Overall Study|Adverse Event|69|||
16788488|NCT00790933|37728642|FG000|Overall Study|Protocol Violation(s)|8|||
16788489|NCT00790933|37728643|FG001|Overall Study|Protocol Violation(s)|18|||
16788490|NCT00790933|37728644|FG002|Overall Study|Protocol Violation(s)|7|||
16788491|NCT00790933|37728645|FG003|Overall Study|Protocol Violation(s)|0|||
16788492|NCT00790933|37728646|FG004|Overall Study|Protocol Violation(s)|12|||
16788493|NCT00790933|37728642|FG000|Overall Study|Lack of Efficacy|192|||
16788494|NCT00790933|37728643|FG001|Overall Study|Lack of Efficacy|176|||
16788495|NCT00790933|37728644|FG002|Overall Study|Lack of Efficacy|130|||
16788496|NCT00790933|37728645|FG003|Overall Study|Lack of Efficacy|1|||
16788497|NCT00790933|37728646|FG004|Overall Study|Lack of Efficacy|121|||
16788498|NCT00790933|37728642|FG000|Overall Study|Study Terminated by Sponsor|0|||
16788499|NCT00790933|37728643|FG001|Overall Study|Study Terminated by Sponsor|0|||
16788500|NCT00790933|37728644|FG002|Overall Study|Study Terminated by Sponsor|1|||
16788501|NCT00790933|37728645|FG003|Overall Study|Study Terminated by Sponsor|0|||
16788502|NCT00790933|37728646|FG004|Overall Study|Study Terminated by Sponsor|0|||
16788503|NCT00790933|37728642|FG000|Overall Study|Withdrawal by Subject|123|||
16788504|NCT00790933|37728643|FG001|Overall Study|Withdrawal by Subject|120|||
16788505|NCT00790933|37728644|FG002|Overall Study|Withdrawal by Subject|52|||
16788506|NCT00790933|37728645|FG003|Overall Study|Withdrawal by Subject|6|||
16788507|NCT00790933|37728646|FG004|Overall Study|Withdrawal by Subject|50|||
16788508|NCT00790933|37728642|FG000|Overall Study|Lost to Follow-up|13|||
16788509|NCT00790933|37728643|FG001|Overall Study|Lost to Follow-up|31|||
16788510|NCT00790933|37728644|FG002|Overall Study|Lost to Follow-up|10|||
16788511|NCT00790933|37728645|FG003|Overall Study|Lost to Follow-up|1|||
16788512|NCT00790933|37728646|FG004|Overall Study|Lost to Follow-up|15|||
16788513|NCT00790933|37728642|FG000|Overall Study|Reason Not Specified|8|||
16788514|NCT00790933|37728643|FG001|Overall Study|Reason Not Specified|16|||
16788515|NCT00790933|37728644|FG002|Overall Study|Reason Not Specified|4|||
16788516|NCT00790933|37728645|FG003|Overall Study|Reason Not Specified|1|||
16788517|NCT00790933|37728646|FG004|Overall Study|Reason Not Specified|9|||
16788518|NCT02161211|37728665|FG000|Overall Study|Lost to Follow-up|21|||
16788519|NCT02161211|37728666|FG001|Overall Study|Lost to Follow-up|27|||
16788520|NCT02161211|37728667|FG002|Overall Study|Lost to Follow-up|21|||
16788521|NCT02161211|37728665|FG000|Overall Study|Dropped|12|||
16788522|NCT02161211|37728666|FG001|Overall Study|Dropped|5|||
16788523|NCT02161211|37728667|FG002|Overall Study|Dropped|9|||
16788524|NCT01676701|37728677|FG000|Overall Study|Protocol Violation|1|||
16788525|NCT01676701|37728678|FG001|Overall Study|Protocol Violation|0|||
16788526|NCT01676701|37728677|FG000|Overall Study|Sponsor Decision|3|||
16788527|NCT01676701|37728678|FG001|Overall Study|Sponsor Decision|4|||
16788528|NCT01670279|37728689|FG000|Overall Study|Adverse Event|0|||
16788529|NCT01670279|37728690|FG001|Overall Study|Adverse Event|1|||
16788530|NCT01670279|37728691|FG002|Overall Study|Adverse Event|0|||
16788531|NCT01670279|37728692|FG003|Overall Study|Adverse Event|0|||
17016341|NCT00462709|38160996|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
16788532|NCT01670279|37728689|FG000|Overall Study|Physician Decision|0|||
16788533|NCT01670279|37728690|FG001|Overall Study|Physician Decision|1|||
16788534|NCT01670279|37728691|FG002|Overall Study|Physician Decision|0|||
16788535|NCT01670279|37728692|FG003|Overall Study|Physician Decision|0|||
17016342|NCT00461305|38161002|FG000|Treatment|Adverse Event|26|||
17016343|NCT00461305|38161003|FG001|Treatment|Adverse Event|3|||
16788536|NCT01670279|37728689|FG000|Overall Study|Participant met withdrawal criteria|0|||
16788537|NCT01670279|37728690|FG001|Overall Study|Participant met withdrawal criteria|0|||
16788538|NCT01670279|37728691|FG002|Overall Study|Participant met withdrawal criteria|0|||
16788539|NCT01670279|37728692|FG003|Overall Study|Participant met withdrawal criteria|1|||
16788540|NCT02627495|37728700|FG000|Overall Study|Withdrawal by Subject|4|||
16788541|NCT01670045|37728704|FG000|Overall Study|Withdrawal by Subject|3|||
16788542|NCT01670045|37728704|FG000|Overall Study|Adverse Event|1|||
16788543|NCT01670045|37728704|FG000|Overall Study|Death|1|||
16788544|NCT01670045|37728704|FG000|Overall Study|Lost to Follow-up|11|||
16788545|NCT01669421|37728708|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
16788546|NCT01669421|37728708|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
16788547|NCT01671059|37728722|FG000|Overall Study|Adverse Event|4|||
16788548|NCT01671059|37728722|FG000|Overall Study|Lack of Efficacy|1|||
16788549|NCT01669811|37728738|FG000|Overall Study|Investigator decision|0|||
16788550|NCT01669811|37728739|FG001|Overall Study|Investigator decision|1|||
16788551|NCT01669811|37728738|FG000|Overall Study|Withdrawal by Subject|1|||
16788552|NCT01669811|37728739|FG001|Overall Study|Withdrawal by Subject|2|||
16788553|NCT01669811|37728738|FG000|Overall Study|Adverse Event|2|||
16788554|NCT01669811|37728739|FG001|Overall Study|Adverse Event|6|||
16788555|NCT01669811|37728738|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16788556|NCT01669811|37728739|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
16788557|NCT01669577|37728745|FG000|Overall Study|Death|22|||
16788558|NCT01669577|37728745|FG000|Overall Study|Lost to Follow-up|78|||
16788559|NCT01669577|37728745|FG000|Overall Study|Physician Decision|34|||
16788560|NCT02658175|37728752|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
16788561|NCT02658175|37728753|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
16788562|NCT02658175|37728754|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
16788563|NCT02658175|37728752|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
16788564|NCT02658175|37728753|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
16788565|NCT02658175|37728754|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
16788566|NCT02658175|37728752|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
16788567|NCT02658175|37728753|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
16788568|NCT02658175|37728754|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
16788569|NCT02658175|37728752|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
16788570|NCT02658175|37728753|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
16788571|NCT02658175|37728754|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
16788572|NCT02658175|37728752|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
16788573|NCT02658175|37728753|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
16788574|NCT02658175|37728754|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
16788575|NCT02658175|37728752|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
16788576|NCT02658175|37728753|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
16788577|NCT02658175|37728754|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
16788578|NCT02658175|37728752|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
16788579|NCT02658175|37728753|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
16788580|NCT02658175|37728754|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
16788581|NCT02658175|37728752|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
16788582|NCT02658175|37728753|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
16788583|NCT02658175|37728754|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
16788584|NCT02658175|37728752|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
16788585|NCT02658175|37728753|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
16788586|NCT02658175|37728754|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
16788587|NCT02658175|37728752|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
16788588|NCT02658175|37728753|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
16788589|NCT02658175|37728754|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
16788590|NCT02625623|37728764|FG000|Overall Study|Participants randomized but not treated|9|||
16788591|NCT02625623|37728765|FG001|Overall Study|Participants randomized but not treated|1|||
16788592|NCT02658019|37728773|FG000|Overall Study|Adverse Event|1|||
16788593|NCT02624687|37728779|FG000|Overall Study|Withdrawal by Subject|1|||
16788594|NCT02624687|37728780|FG001|Overall Study|Withdrawal by Subject|1|||
16788595|NCT02624687|37728779|FG000|Overall Study|medical leave from work|0|||
16788596|NCT02624687|37728780|FG001|Overall Study|medical leave from work|1|||
16788597|NCT01675765|37728788|FG000|Overall Study|Progressive disease|4|||
16788598|NCT01675765|37728789|FG001|Overall Study|Progressive disease|4|||
16788599|NCT01675765|37728788|FG000|Overall Study|Adverse Event|1|||
16788600|NCT01675765|37728789|FG001|Overall Study|Adverse Event|2|||
16788601|NCT01675765|37728788|FG000|Overall Study|Withdrawal by Subject|2|||
16788602|NCT01675765|37728789|FG001|Overall Study|Withdrawal by Subject|0|||
16788603|NCT01675765|37728788|FG000|Overall Study|Death|1|||
16788604|NCT01675765|37728789|FG001|Overall Study|Death|0|||
16788605|NCT01675765|37728788|FG000|Overall Study|Clinical progression|3|||
16788606|NCT01675765|37728789|FG001|Overall Study|Clinical progression|2|||
16788607|NCT02625233|37728797|FG000|Overall Study|Adverse Event|2|||
16788608|NCT02625233|37728798|FG001|Overall Study|Adverse Event|0|||
16788609|NCT02656693|37728807|FG000|Overall Study|Pregnancy|1|||
16788610|NCT02656693|37728808|FG001|Overall Study|Pregnancy|1|||
16788611|NCT02656693|37728809|FG002|Overall Study|Pregnancy|1|||
16788612|NCT02656693|37728807|FG000|Overall Study|Bariatric surgery|0|||
16788613|NCT02656693|37728808|FG001|Overall Study|Bariatric surgery|1|||
16788614|NCT02656693|37728809|FG002|Overall Study|Bariatric surgery|2|||
16788615|NCT02633293|37728817|FG000|Overall Study|Death|56|||
16788616|NCT02633293|37728817|FG000|Overall Study|Progressive Disease|12|||
16788617|NCT02633293|37728817|FG000|Overall Study|Adverse Event|29|||
16788618|NCT02633293|37728817|FG000|Overall Study|Withdrawal by Subject|41|||
16788619|NCT02633293|37728817|FG000|Overall Study|Protocol Violation|1|||
16788620|NCT02633293|37728817|FG000|Overall Study|Lost to Follow-up|1|||
16788621|NCT02633293|37728817|FG000|Overall Study|Study Terminated by Sponsor|24|||
16788622|NCT02633293|37728817|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
16788623|NCT02633293|37728817|FG000|Overall Study|Lung Transplant|5|||
16788624|NCT02633293|37728817|FG000|Overall Study|Lack of Efficacy|2|||
16788625|NCT02633293|37728817|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
16788626|NCT02623829|37728823|FG000|Overall Study|Lost to Follow-up|1|||
16788627|NCT02623829|37728824|FG001|Overall Study|Lost to Follow-up|1|||
16788628|NCT02655679|37728835|FG000|Overall Study|Adverse Event|0|||
16788629|NCT02655679|37728836|FG001|Overall Study|Adverse Event|1|||
16788630|NCT02655679|37728837|FG002|Overall Study|Adverse Event|0|||
16788631|NCT02655679|37728838|FG003|Overall Study|Adverse Event|0|||
16788632|NCT02655679|37728839|FG004|Overall Study|Adverse Event|0|||
16788633|NCT02655679|37728835|FG000|Overall Study|Withdrawal by Subject|1|||
16788634|NCT02655679|37728836|FG001|Overall Study|Withdrawal by Subject|1|||
16788635|NCT02655679|37728837|FG002|Overall Study|Withdrawal by Subject|0|||
16788636|NCT02655679|37728838|FG003|Overall Study|Withdrawal by Subject|3|||
16788637|NCT02655679|37728839|FG004|Overall Study|Withdrawal by Subject|1|||
16788638|NCT02655679|37728835|FG000|Overall Study|Inability to Comply with the Protocol|1|||
16788639|NCT02655679|37728836|FG001|Overall Study|Inability to Comply with the Protocol|0|||
16788640|NCT02655679|37728837|FG002|Overall Study|Inability to Comply with the Protocol|0|||
16788641|NCT02655679|37728838|FG003|Overall Study|Inability to Comply with the Protocol|0|||
16788642|NCT02655679|37728839|FG004|Overall Study|Inability to Comply with the Protocol|0|||
16788643|NCT02655679|37728835|FG000|Overall Study|Lost to Follow-up|0|||
16788644|NCT02655679|37728836|FG001|Overall Study|Lost to Follow-up|1|||
16788645|NCT02655679|37728837|FG002|Overall Study|Lost to Follow-up|1|||
16788646|NCT02655679|37728838|FG003|Overall Study|Lost to Follow-up|1|||
16788647|NCT02655679|37728839|FG004|Overall Study|Lost to Follow-up|0|||
16788648|NCT02655679|37728835|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16788649|NCT02655679|37728836|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16788650|NCT02655679|37728837|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16788651|NCT02655679|37728838|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16788652|NCT02655679|37728839|FG004|Overall Study|Other Miscellaneous Reasons|0|||
16788653|NCT02623361|37728854|FG000|Overall Study|Protocol Violation|0|||
16788654|NCT02623361|37728855|FG001|Overall Study|Protocol Violation|1|||
16788655|NCT02623361|37728854|FG000|Overall Study|Withdrawal by Subject|0|||
16788656|NCT02623361|37728855|FG001|Overall Study|Withdrawal by Subject|1|||
16788657|NCT01675531|37728883|FG000|Overall Study|Adverse Event|9|||
16788658|NCT01675531|37728883|FG000|Overall Study|Withdrawal by Subject|7|||
16788659|NCT01675531|37728883|FG000|Overall Study|Lack of Efficacy|1|||
16788660|NCT01675531|37728883|FG000|Overall Study|Protocol Violation|8|||
16788661|NCT02532543|37728892|FG000|Overall Study|Lost to Follow-up|0|||
16788662|NCT02532543|37728893|FG001|Overall Study|Lost to Follow-up|0|||
16788663|NCT02532543|37728894|FG002|Overall Study|Lost to Follow-up|1|||
16788664|NCT02532543|37728895|FG003|Overall Study|Lost to Follow-up|0|||
16788665|NCT02532465|37728907|FG000|Overall Study|Protocol Violation|1|||
16788666|NCT02532465|37728908|FG001|Overall Study|Protocol Violation|0|||
16788667|NCT02532465|37728907|FG000|Overall Study|Lack of Efficacy|0|||
16788668|NCT02532465|37728908|FG001|Overall Study|Lack of Efficacy|1|||
16788669|NCT02528331|37728914|FG000|Overall Study|Withdrawal by Subject|2|||
16788670|NCT02654977|37728918|FG000|Overall Study|Death|1|||
16788671|NCT02654977|37728918|FG000|Overall Study|Lost to Follow-up|1|||
16788672|NCT02654977|37728918|FG000|Overall Study|Adverse Event|1|||
16788673|NCT02654977|37728918|FG000|Overall Study|Withdrawal by Subject|1|||
16788674|NCT02654977|37728918|FG000|Overall Study|Lack of Efficacy|3|||
16788675|NCT01362517|37728922|FG000|Overall Study|Protocol Violation|1|||
16788676|NCT01362517|37728922|FG000|Overall Study|Lost to Follow-up|1|||
16788677|NCT01362439|37728929|FG000|Overall Study|Adverse Event|1|||
16788678|NCT01362439|37728929|FG000|Overall Study|Lack of Efficacy|3|||
16788679|NCT01362439|37728929|FG000|Overall Study|Lost to Follow-up|2|||
16788680|NCT01362439|37728929|FG000|Overall Study|Study medication non-compliant|1|||
16788681|NCT01362439|37728929|FG000|Overall Study|Participant who withdrew consent|8|||
16788682|NCT02653495|37728949|FG000|Overall Study|Lost to Follow-up|2|||
16788683|NCT02653495|37728950|FG001|Overall Study|Lost to Follow-up|0|||
16788684|NCT02653495|37728949|FG000|Overall Study|Screening Failure|10|||
16788685|NCT02653495|37728950|FG001|Overall Study|Screening Failure|0|||
16788686|NCT01675141|37728956|FG000|Overall Study|Lenalidomide outside NIH|3|||
16788687|NCT01675141|37728956|FG000|Overall Study|Withdrawal by Subject|3|||
16788688|NCT01675141|37728956|FG000|Overall Study|Physician Decision|4|||
16788689|NCT01675141|37728956|FG000|Overall Study|No treatment, per protocol|1|||
16788690|NCT03367819|37728991|FG000|Overall Study|Adverse Event|4|||
16788691|NCT03367819|37728992|FG001|Overall Study|Adverse Event|4|||
16788692|NCT03367819|37728991|FG000|Overall Study|Progressive Disease|15|||
16788693|NCT03367819|37728992|FG001|Overall Study|Progressive Disease|13|||
16788694|NCT03367819|37728991|FG000|Overall Study|Withdrawal by Subject|1|||
16788695|NCT03367819|37728992|FG001|Overall Study|Withdrawal by Subject|0|||
16788696|NCT03367819|37728991|FG000|Overall Study|Other|4|||
16788697|NCT03367819|37728992|FG001|Overall Study|Other|2|||
16788698|NCT01597193|37729035|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
16788699|NCT01597193|37729036|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
16788700|NCT01597193|37729037|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16788701|NCT01597193|37729038|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16788702|NCT01597193|37729039|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16788703|NCT01597193|37729040|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16788704|NCT01597193|37729041|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16788705|NCT01597193|37729035|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
16788706|NCT01597193|37729036|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
16788707|NCT01597193|37729037|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
16788708|NCT01597193|37729038|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
16788709|NCT01597193|37729039|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
16788710|NCT01597193|37729040|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
16788711|NCT01597193|37729041|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
16788712|NCT01597193|37729035|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
16788713|NCT01597193|37729036|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
16788714|NCT01597193|37729037|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
16788715|NCT01597193|37729038|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
16788716|NCT01597193|37729039|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
16788717|NCT01597193|37729040|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
16788718|NCT01597193|37729041|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
16788719|NCT01597193|37729035|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16788720|NCT01597193|37729036|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16788721|NCT01597193|37729037|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16788722|NCT01597193|37729038|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16788723|NCT01597193|37729039|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16788724|NCT01597193|37729040|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
16788725|NCT01597193|37729041|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16788726|NCT01597193|37729035|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16788727|NCT01597193|37729036|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16788728|NCT01597193|37729037|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16788729|NCT01597193|37729038|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
16788730|NCT01597193|37729039|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16788731|NCT01597193|37729040|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
16788732|NCT01597193|37729041|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16788733|NCT02649439|37729064|FG000|Overall Study|Switched to alternative treatment|6|||
16788734|NCT02649439|37729065|FG001|Overall Study|Switched to alternative treatment|4|||
16788735|NCT02649439|37729064|FG000|Overall Study|Patient decision|1|||
16788736|NCT02649439|37729065|FG001|Overall Study|Patient decision|0|||
16788737|NCT02649439|37729064|FG000|Overall Study|Patient going out of country|1|||
16788738|NCT02649439|37729065|FG001|Overall Study|Patient going out of country|0|||
16788739|NCT02649439|37729064|FG000|Overall Study|To start finasteride|1|||
16788740|NCT02649439|37729065|FG001|Overall Study|To start finasteride|0|||
16788741|NCT02649439|37729064|FG000|Overall Study|Physician Decision|1|||
16788742|NCT02649439|37729065|FG001|Overall Study|Physician Decision|0|||
16788743|NCT02649439|37729064|FG000|Overall Study|Disease progression on study|12|||
16788744|NCT02649439|37729065|FG001|Overall Study|Disease progression on study|13|||
17016344|NCT00461305|38161002|FG000|Treatment|Lost to Follow-up|4|||
17198276|NCT02603120|38351876|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
16788745|NCT02649439|37729064|FG000|Overall Study|Refused further treatment|1|||
16788746|NCT02649439|37729065|FG001|Overall Study|Refused further treatment|0|||
16788747|NCT02649439|37729064|FG000|Overall Study|Refused further follow up|2|||
16788748|NCT02649439|37729065|FG001|Overall Study|Refused further follow up|7|||
16788749|NCT02649439|37729064|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
16788750|NCT02649439|37729065|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
16788751|NCT02649439|37729064|FG000|Overall Study|No treatment, per protocol|1|||
16788752|NCT02649439|37729065|FG001|Overall Study|No treatment, per protocol|0|||
16788753|NCT02649439|37729064|FG000|Overall Study|PSA DT makes ineligible|0|||
16788754|NCT02649439|37729065|FG001|Overall Study|PSA DT makes ineligible|1|||
16788755|NCT02649439|37729064|FG000|Overall Study|Rising PSA No Mets|0|||
16788756|NCT02649439|37729065|FG001|Overall Study|Rising PSA No Mets|1|||
16788757|NCT02649439|37729064|FG000|Overall Study|Rising PSA|0|||
16788758|NCT02649439|37729065|FG001|Overall Study|Rising PSA|1|||
16788759|NCT02649439|37729064|FG000|Overall Study|Signed follow up protocol|0|||
16788760|NCT02649439|37729065|FG001|Overall Study|Signed follow up protocol|1|||
16788761|NCT02622113|37729080|FG000|Overall Study|Adverse Event|4|||
16788762|NCT02622113|37729081|FG001|Overall Study|Adverse Event|4|||
16788763|NCT02622113|37729080|FG000|Overall Study|Physician Decision|0|||
16788764|NCT02622113|37729081|FG001|Overall Study|Physician Decision|1|||
16788765|NCT02622113|37729080|FG000|Overall Study|Withdrawal by Subject|0|||
16788766|NCT02622113|37729081|FG001|Overall Study|Withdrawal by Subject|2|||
16788767|NCT02622113|37729080|FG000|Overall Study|Stopping Criteria|1|||
16788768|NCT02622113|37729081|FG001|Overall Study|Stopping Criteria|3|||
16788769|NCT02651467|37729090|FG000|Overall Study|Withdrawal by Subject|0|||
16788770|NCT02651467|37729091|FG001|Overall Study|Withdrawal by Subject|0|||
16788771|NCT02651467|37729092|FG002|Overall Study|Withdrawal by Subject|2|||
16788772|NCT02651467|37729090|FG000|Overall Study|Other (Not specified)|1|||
16788773|NCT02651467|37729091|FG001|Overall Study|Other (Not specified)|0|||
16788774|NCT02651467|37729092|FG002|Overall Study|Other (Not specified)|2|||
16788775|NCT02620787|37729121|FG000|Overall Study|Adverse Event|1|||
16788776|NCT02620787|37729122|FG001|Overall Study|Adverse Event|0|||
16788777|NCT02620787|37729121|FG000|Overall Study|Eligibility Criteria Not Met|1|||
16788778|NCT02620787|37729122|FG001|Overall Study|Eligibility Criteria Not Met|0|||
16788779|NCT02651155|37729130|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16788780|NCT02651155|37729131|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
16788781|NCT02651155|37729130|FG000|Overall Study|Voluntary Withdrawal|5|||
16788782|NCT02651155|37729131|FG001|Overall Study|Voluntary Withdrawal|0|||
16788783|NCT02619617|37729137|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
16788784|NCT02619617|37729138|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
16788785|NCT02619617|37729137|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
16788786|NCT02619617|37729138|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
17102210|NCT00094302|38241156|FG000|Overall Study|Lost to Follow-up|43|||
17102211|NCT00094302|38241157|FG001|Overall Study|Lost to Follow-up|41|||
17102212|NCT00094302|38241156|FG000|Overall Study|Physician Decision|5|||
17102213|NCT00094302|38241157|FG001|Overall Study|Physician Decision|8|||
17102214|NCT00094302|38241156|FG000|Overall Study|Withdrawal by Subject|103|||
17102215|NCT00094302|38241157|FG001|Overall Study|Withdrawal by Subject|111|||
17102216|NCT00094302|38241156|FG000|Overall Study|Death|266|||
17102217|NCT00094302|38241157|FG001|Overall Study|Death|246|||
17102218|NCT00372905|38241163|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
17102219|NCT00372905|38241164|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
17102220|NCT00372905|38241165|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
17102221|NCT00372905|38241166|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
17102222|NCT00372905|38241163|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
17102223|NCT00372905|38241164|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
17102224|NCT00372905|38241165|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
17102225|NCT00372905|38241166|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
17102226|NCT00372905|38241163|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
17102227|NCT00372905|38241164|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
17102228|NCT00372905|38241165|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
17102229|NCT00372905|38241166|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
17102230|NCT00372905|38241163|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
17102231|NCT00372905|38241164|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
17102232|NCT00372905|38241165|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
17102233|NCT00372905|38241166|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
17102234|NCT00372905|38241163|FG000|Follow up Until Relapse or Progression|Study closed|0|||
17102235|NCT00372905|38241164|FG001|Follow up Until Relapse or Progression|Study closed|0|||
16788813|NCT02650921|37729168|FG000|Overall Study|Withdrawal by Subject|4|||
16788814|NCT02650921|37729168|FG000|Overall Study|Lost to Follow-up|2|||
16788815|NCT02650921|37729168|FG000|Overall Study|Adverse Event|1|||
16788816|NCT02650921|37729168|FG000|Overall Study|Due to Medical Condition|1|||
16788817|NCT01596335|37729176|FG000|Overall Study|exacerbation of primary disease|5|||
16788818|NCT01596335|37729177|FG001|Overall Study|exacerbation of primary disease|9|||
16788819|NCT02618759|37729185|FG000|Overall Study|Lost to Follow-up|0|||
16788820|NCT02618759|37729186|FG001|Overall Study|Lost to Follow-up|1|||
16788821|NCT02618759|37729185|FG000|Overall Study|Withdrawal by Subject|1|||
16788822|NCT02618759|37729186|FG001|Overall Study|Withdrawal by Subject|0|||
16788823|NCT02618759|37729185|FG000|Overall Study|Other Reasons|1|||
16788824|NCT02618759|37729186|FG001|Overall Study|Other Reasons|4|||
16788825|NCT02614079|37729201|FG000|Overall Study|Withdrawal by Subject|1|||
16788826|NCT02616029|37729207|FG000|Overall Study|Adverse Event|1|||
16788827|NCT02616029|37729208|FG001|Overall Study|Adverse Event|0|||
16788828|NCT02616029|37729207|FG000|Overall Study|Death|0|||
16788829|NCT02616029|37729208|FG001|Overall Study|Death|1|||
16788830|NCT02616029|37729207|FG000|Overall Study|Protocol Violation|1|||
16788831|NCT02616029|37729208|FG001|Overall Study|Protocol Violation|0|||
16788832|NCT02616029|37729207|FG000|Overall Study|Withdrew Consent|1|||
16788833|NCT02616029|37729208|FG001|Overall Study|Withdrew Consent|0|||
16788834|NCT02616029|37729207|FG000|Overall Study|Enrolled and Never Treated|1|||
16788835|NCT02616029|37729208|FG001|Overall Study|Enrolled and Never Treated|1|||
16788836|NCT02614859|37729216|FG000|Overall Study|Physician Decision|0|||
16788837|NCT02614859|37729217|FG001|Overall Study|Physician Decision|1|||
16788838|NCT02615249|37729225|FG000|Overall Study|Withdrawal by Subject|1|||
16788839|NCT02615171|37729232|FG000|Overall Study|Lost to Follow-up|2|||
16788840|NCT02615171|37729233|FG001|Overall Study|Lost to Follow-up|1|||
16788841|NCT02648347|37729241|FG000|Overall Study|Death|174|||
16788842|NCT02648347|37729242|FG001|Overall Study|Death|167|||
16788843|NCT02648347|37729241|FG000|Overall Study|Withdrawal by Subject|16|||
16788844|NCT02648347|37729242|FG001|Overall Study|Withdrawal by Subject|9|||
16788845|NCT02648347|37729241|FG000|Overall Study|Lost to Follow-up|18|||
16788846|NCT02648347|37729242|FG001|Overall Study|Lost to Follow-up|21|||
16788847|NCT02648347|37729241|FG000|Overall Study|Missing|1|||
16788848|NCT02648347|37729242|FG001|Overall Study|Missing|0|||
16788849|NCT02614703|37729250|FG000|Overall Study|Withdrawal by Subject|7|||
16788850|NCT02614703|37729251|FG001|Overall Study|Withdrawal by Subject|1|||
16788851|NCT01669343|37729257|FG000|Part A: All Patients|Withdrawal by Subject|7|||
16788852|NCT01669343|37729257|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
16788853|NCT01669343|37729257|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
16788854|NCT01669343|37729257|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
16788855|NCT01669343|37729257|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
16788856|NCT01594931|37729267|FG000|Overall Study|Adverse Event|3|||
16788857|NCT01594931|37729268|FG001|Overall Study|Adverse Event|1|||
16788858|NCT01594931|37729269|FG002|Overall Study|Adverse Event|1|||
16788859|NCT01594931|37729267|FG000|Overall Study|Withdrawal by Subject|2|||
16788860|NCT01594931|37729268|FG001|Overall Study|Withdrawal by Subject|1|||
16788861|NCT01594931|37729269|FG002|Overall Study|Withdrawal by Subject|1|||
16788862|NCT01594931|37729267|FG000|Overall Study|Lack of Efficacy|7|||
16788863|NCT01594931|37729268|FG001|Overall Study|Lack of Efficacy|2|||
16788864|NCT01594931|37729269|FG002|Overall Study|Lack of Efficacy|2|||
16788865|NCT01594931|37729267|FG000|Overall Study|Lost to Follow-up|4|||
16788866|NCT01594931|37729268|FG001|Overall Study|Lost to Follow-up|3|||
16788867|NCT01594931|37729269|FG002|Overall Study|Lost to Follow-up|3|||
16788868|NCT01594931|37729267|FG000|Overall Study|Protocol Violation|2|||
16788869|NCT01594931|37729268|FG001|Overall Study|Protocol Violation|1|||
16788870|NCT01594931|37729269|FG002|Overall Study|Protocol Violation|0|||
16788871|NCT01594931|37729267|FG000|Overall Study|No defiined|11|||
16788872|NCT01594931|37729268|FG001|Overall Study|No defiined|4|||
16788873|NCT01594931|37729269|FG002|Overall Study|No defiined|7|||
16788874|NCT01594853|37729279|FG000|Overall Study|Withdrawal by Subject|1|||
16788875|NCT01594853|37729280|FG001|Overall Study|Withdrawal by Subject|1|||
16788876|NCT01594853|37729279|FG000|Overall Study|Lost to Follow-up|1|||
16788877|NCT01594853|37729280|FG001|Overall Study|Lost to Follow-up|1|||
16788878|NCT01594853|37729279|FG000|Overall Study|noncompliance with exercise|0|||
16788879|NCT01594853|37729280|FG001|Overall Study|noncompliance with exercise|1|||
16788880|NCT01668797|37729297|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
16788881|NCT01668797|37729298|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
16788882|NCT01668797|37729299|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
16788883|NCT01668797|37729300|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
16788884|NCT01668797|37729297|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
16788885|NCT01668797|37729298|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
16788886|NCT01668797|37729299|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
16788887|NCT01668797|37729300|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
16788888|NCT01668797|37729297|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
16788889|NCT01668797|37729298|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
16788890|NCT01668797|37729299|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
16788891|NCT01668797|37729300|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
16788892|NCT01668797|37729297|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
16788893|NCT01668797|37729298|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
16788894|NCT01668797|37729299|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
16788895|NCT01668797|37729300|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
16788896|NCT01668797|37729297|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
16788897|NCT01668797|37729298|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
16788898|NCT01668797|37729299|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
16788899|NCT01668797|37729300|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
16788900|NCT01668797|37729297|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
16788901|NCT01668797|37729298|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
17016345|NCT00461305|38161003|FG001|Treatment|Lost to Follow-up|2|||
16788902|NCT01668797|37729299|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
16788903|NCT01668797|37729300|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
16788904|NCT01668797|37729297|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
16788905|NCT01668797|37729298|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
16788906|NCT01668797|37729299|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
16788907|NCT01668797|37729300|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
16788908|NCT01668797|37729297|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
16788909|NCT01668797|37729298|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
16788910|NCT01668797|37729299|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
16788911|NCT01668797|37729300|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
16788912|NCT01668797|37729297|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
16788913|NCT01668797|37729298|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
16788914|NCT01668797|37729299|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
16788915|NCT01668797|37729300|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
16788916|NCT01668797|37729297|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
16788917|NCT01668797|37729298|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
16788918|NCT01668797|37729299|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
16788919|NCT01668797|37729300|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
16788920|NCT01668797|37729297|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
16788921|NCT01668797|37729298|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
16788922|NCT01668797|37729299|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
16788923|NCT01668797|37729300|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
16788924|NCT01668797|37729297|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
16788925|NCT01668797|37729298|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
16788926|NCT01668797|37729299|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
16788927|NCT01668797|37729300|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
16788928|NCT01668797|37729297|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
16788929|NCT01668797|37729298|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
16788930|NCT01668797|37729299|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
16788931|NCT01668797|37729300|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
16788932|NCT01668797|37729297|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
16788933|NCT01668797|37729298|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
16788934|NCT01668797|37729299|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
16788935|NCT01668797|37729300|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
16788936|NCT01668797|37729297|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
16788937|NCT01668797|37729298|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
16788938|NCT01668797|37729299|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
16788939|NCT01668797|37729300|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
16788940|NCT01668797|37729297|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
16788941|NCT01668797|37729298|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
16788942|NCT01668797|37729299|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
16788943|NCT01668797|37729300|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
16788944|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
16788945|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
16788946|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
16788947|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
16788948|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
16788949|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
16788950|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
16788951|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
16788952|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
16788953|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
16788954|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
16788955|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
16788956|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
16788957|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
16788958|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
16788959|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
16788960|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
16788961|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
16788962|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
16788963|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
16788964|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
17016346|NCT00461305|38161002|FG000|Treatment|Protocol Violation|13|||
16788965|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
16788966|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
16788967|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
16788968|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
16788969|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
16788970|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
16788971|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
16788972|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
16788973|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
16788974|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
16788975|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
16788976|NCT01668797|37729297|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
16788977|NCT01668797|37729298|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
16788978|NCT01668797|37729299|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
16788979|NCT01668797|37729300|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
16788980|NCT02613221|37729307|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
16788981|NCT02613221|37729307|FG000|Overall Study|Adverse Event|2|||
16788982|NCT02613221|37729307|FG000|Overall Study|Voluntary Discontinuation|1|||
16788983|NCT02613221|37729307|FG000|Overall Study|Delayed Treatment|1|||
16788984|NCT02613221|37729307|FG000|Overall Study|Enrolled but Not Treated|1|||
16788985|NCT01362049|37729315|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
16788986|NCT01362049|37729316|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
16788987|NCT01362049|37729317|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
16788988|NCT01362049|37729318|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
16788989|NCT01362049|37729315|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
16788990|NCT01362049|37729316|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
16788991|NCT01362049|37729317|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
16788992|NCT01362049|37729318|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
16788993|NCT02612909|37729350|FG000|Phase 2|Withdrawal by Subject|2|||
16788994|NCT02612909|37729351|FG001|Phase 2|Withdrawal by Subject|5|||
16788995|NCT02612909|37729352|FG002|Phase 2|Withdrawal by Subject|0|||
16788996|NCT02612909|37729353|FG003|Phase 2|Withdrawal by Subject|0|||
16788997|NCT02612909|37729354|FG004|Phase 2|Withdrawal by Subject|0|||
16788998|NCT02612909|37729350|FG000|Phase 2|Pregnancy|0|||
16788999|NCT02612909|37729351|FG001|Phase 2|Pregnancy|0|||
16789000|NCT02612909|37729352|FG002|Phase 2|Pregnancy|1|||
16789001|NCT02612909|37729353|FG003|Phase 2|Pregnancy|0|||
16789002|NCT02612909|37729354|FG004|Phase 2|Pregnancy|0|||
16789003|NCT02612909|37729350|FG000|Phase 3|Withdrawal by Subject|0|||
16789004|NCT02612909|37729351|FG001|Phase 3|Withdrawal by Subject|0|||
16789005|NCT02612909|37729352|FG002|Phase 3|Withdrawal by Subject|0|||
16789006|NCT02612909|37729353|FG003|Phase 3|Withdrawal by Subject|1|||
16789007|NCT02612909|37729354|FG004|Phase 3|Withdrawal by Subject|0|||
16789008|NCT02612285|37729368|FG000|Overall Study|Withdrawal by Subject|1|||
16789009|NCT02609633|37729374|FG000|Overall Study|Consent Withdrawn|0|||
16789010|NCT02609633|37729375|FG001|Overall Study|Consent Withdrawn|1|||
16789011|NCT02609633|37729374|FG000|Overall Study|Protocol Deviation|1|||
16789012|NCT02609633|37729375|FG001|Overall Study|Protocol Deviation|0|||
16789013|NCT02609633|37729374|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
16789014|NCT02609633|37729375|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
16789015|NCT02609633|37729374|FG000|Overall Study|Reason not Specified|2|||
16789016|NCT02609633|37729375|FG001|Overall Study|Reason not Specified|1|||
16789017|NCT01371981|37729394|FG000|Overall Study|Adverse Event|12|||
16789018|NCT01371981|37729395|FG001|Overall Study|Adverse Event|17|||
16789019|NCT01371981|37729396|FG002|Overall Study|Adverse Event|0|||
16789020|NCT01371981|37729397|FG003|Overall Study|Adverse Event|4|||
16789021|NCT01371981|37729398|FG004|Overall Study|Adverse Event|1|||
16789022|NCT01371981|37729399|FG005|Overall Study|Adverse Event|0|||
16789023|NCT01371981|37729394|FG000|Overall Study|Death|22|||
16789024|NCT01371981|37729395|FG001|Overall Study|Death|16|||
16789025|NCT01371981|37729396|FG002|Overall Study|Death|0|||
16789026|NCT01371981|37729397|FG003|Overall Study|Death|0|||
16789027|NCT01371981|37729398|FG004|Overall Study|Death|2|||
16789028|NCT01371981|37729399|FG005|Overall Study|Death|2|||
16789029|NCT01371981|37729394|FG000|Overall Study|Lack of Efficacy|69|||
16789030|NCT01371981|37729395|FG001|Overall Study|Lack of Efficacy|61|||
16789031|NCT01371981|37729396|FG002|Overall Study|Lack of Efficacy|4|||
16789032|NCT01371981|37729397|FG003|Overall Study|Lack of Efficacy|8|||
16789033|NCT01371981|37729398|FG004|Overall Study|Lack of Efficacy|5|||
16789034|NCT01371981|37729399|FG005|Overall Study|Lack of Efficacy|0|||
16789035|NCT01371981|37729394|FG000|Overall Study|Physician Decision|48|||
16789036|NCT01371981|37729395|FG001|Overall Study|Physician Decision|63|||
16789037|NCT01371981|37729396|FG002|Overall Study|Physician Decision|1|||
16789038|NCT01371981|37729397|FG003|Overall Study|Physician Decision|7|||
16789039|NCT01371981|37729398|FG004|Overall Study|Physician Decision|14|||
16789040|NCT01371981|37729399|FG005|Overall Study|Physician Decision|3|||
16789041|NCT01371981|37729394|FG000|Overall Study|Withdrawal by Subject|12|||
16789042|NCT01371981|37729395|FG001|Overall Study|Withdrawal by Subject|19|||
16789043|NCT01371981|37729396|FG002|Overall Study|Withdrawal by Subject|1|||
16789044|NCT01371981|37729397|FG003|Overall Study|Withdrawal by Subject|2|||
16789045|NCT01371981|37729398|FG004|Overall Study|Withdrawal by Subject|10|||
16789046|NCT01371981|37729399|FG005|Overall Study|Withdrawal by Subject|3|||
16789047|NCT01371981|37729394|FG000|Overall Study|Ineligible|19|||
16789048|NCT01371981|37729395|FG001|Overall Study|Ineligible|13|||
16789049|NCT01371981|37729396|FG002|Overall Study|Ineligible|0|||
16789050|NCT01371981|37729397|FG003|Overall Study|Ineligible|0|||
16789051|NCT01371981|37729398|FG004|Overall Study|Ineligible|0|||
16789052|NCT01371981|37729399|FG005|Overall Study|Ineligible|4|||
16789053|NCT01371981|37729394|FG000|Overall Study|Did not start treatment|2|||
16789054|NCT01371981|37729395|FG001|Overall Study|Did not start treatment|3|||
16789055|NCT01371981|37729396|FG002|Overall Study|Did not start treatment|0|||
16789056|NCT01371981|37729397|FG003|Overall Study|Did not start treatment|0|||
16789057|NCT01371981|37729398|FG004|Overall Study|Did not start treatment|0|||
16789058|NCT01371981|37729399|FG005|Overall Study|Did not start treatment|2|||
16789059|NCT01597375|37729427|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
16789060|NCT01597375|37729428|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
16789061|NCT01597375|37729427|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
16789062|NCT01597375|37729428|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
16789063|NCT01597375|37729427|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
16789064|NCT01597375|37729428|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
16789065|NCT01597375|37729427|FG000|Washout (2 Weeks)|Adverse Event|1|||
16789066|NCT01597375|37729428|FG001|Washout (2 Weeks)|Adverse Event|0|||
16789067|NCT01597375|37729427|FG000|Second Intervention|Failed to react at both Aspirin|1|||
16789068|NCT01597375|37729428|FG001|Second Intervention|Failed to react at both Aspirin|1|||
16789069|NCT02527161|37729435|FG000|Overall Study|Failed MRI|52|||
16789070|NCT02527161|37729435|FG000|Overall Study|Withdrawal by Subject|19|||
16789071|NCT02527161|37729435|FG000|Overall Study|Delay in or unfit for surgery|16|||
16789072|NCT02527161|37729435|FG000|Overall Study|MRI contraindication|6|||
16789073|NCT02527161|37729435|FG000|Overall Study|Consent violation|4|||
16789074|NCT02527161|37729435|FG000|Overall Study|Only Recruited to Part A|27|||
16789075|NCT02527161|37729435|FG000|Overall Study|Physician Decision|1|||
16789076|NCT02527161|37729435|FG000|Overall Study|Adverse Event|1|||
16789077|NCT02527161|37729435|FG000|Overall Study|Lost to Follow-up|6|||
16789078|NCT02609399|37729442|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
16789079|NCT02609399|37729443|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
16789080|NCT02609399|37729442|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
16789081|NCT02609399|37729443|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
16789082|NCT02609399|37729442|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
16789083|NCT02609399|37729443|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
16789084|NCT02720185|37729451|FG000|Overall Study|Lost to Follow-up|1|||
16789085|NCT02526693|37729474|FG000|Overall Study|Physician Decision|3|||
16789086|NCT02526693|37729475|FG001|Overall Study|Physician Decision|1|||
16789087|NCT02710669|37729493|FG000|Overall Study|Physician Decision|2|||
16789088|NCT02710669|37729494|FG001|Overall Study|Physician Decision|1|||
16789089|NCT02710669|37729495|FG002|Overall Study|Physician Decision|0|||
16789090|NCT02710669|37729493|FG000|Overall Study|Institutional delays (including COVID)|2|||
16789091|NCT02710669|37729494|FG001|Overall Study|Institutional delays (including COVID)|2|||
16789092|NCT02710669|37729495|FG002|Overall Study|Institutional delays (including COVID)|0|||
16789093|NCT02710669|37729493|FG000|Overall Study|arrived in afib/aflutter|10|||
16789094|NCT02710669|37729494|FG001|Overall Study|arrived in afib/aflutter|8|||
16789095|NCT02710669|37729495|FG002|Overall Study|arrived in afib/aflutter|2|||
16789096|NCT02610725|37729503|FG000|Overall Study|Lost to Follow-up|197|||
16789097|NCT02610725|37729503|FG000|Overall Study|self-reported contraindication|9|||
16789098|NCT02684461|37729510|FG000|Overall Study|Adverse Event|1|||
16789099|NCT02684461|37729511|FG001|Overall Study|Adverse Event|0|||
16789100|NCT02684461|37729512|FG002|Overall Study|Adverse Event|0|||
16789101|NCT02684461|37729510|FG000|Overall Study|Lack of Efficacy|1|||
16789102|NCT02684461|37729511|FG001|Overall Study|Lack of Efficacy|2|||
16789103|NCT02684461|37729512|FG002|Overall Study|Lack of Efficacy|0|||
16789104|NCT02647645|37729537|FG000|Overall Study|Lost to Follow-up|2|||
16789105|NCT02647645|37729538|FG001|Overall Study|Lost to Follow-up|1|||
16789106|NCT02531373|37729553|FG000|Overall Study|Lack of Efficacy|0|||
16789107|NCT02531373|37729554|FG001|Overall Study|Lack of Efficacy|0|||
16789108|NCT02531373|37729555|FG002|Overall Study|Lack of Efficacy|0|||
16789109|NCT02531373|37729556|FG003|Overall Study|Lack of Efficacy|0|||
16789110|NCT02531373|37729557|FG004|Overall Study|Lack of Efficacy|3|||
16789111|NCT02531373|37729558|FG005|Overall Study|Lack of Efficacy|2|||
16789112|NCT02531373|37729559|FG006|Overall Study|Lack of Efficacy|4|||
16789113|NCT02531373|37729560|FG007|Overall Study|Lack of Efficacy|8|||
16789114|NCT02531373|37729561|FG008|Overall Study|Lack of Efficacy|5|||
16789115|NCT02531373|37729553|FG000|Overall Study|Lost to Follow-up|0|||
16789116|NCT02531373|37729554|FG001|Overall Study|Lost to Follow-up|0|||
16789117|NCT02531373|37729555|FG002|Overall Study|Lost to Follow-up|0|||
16789118|NCT02531373|37729556|FG003|Overall Study|Lost to Follow-up|0|||
16789119|NCT02531373|37729557|FG004|Overall Study|Lost to Follow-up|0|||
16789120|NCT02531373|37729558|FG005|Overall Study|Lost to Follow-up|2|||
16789121|NCT02531373|37729559|FG006|Overall Study|Lost to Follow-up|2|||
16789122|NCT02531373|37729560|FG007|Overall Study|Lost to Follow-up|0|||
16789123|NCT02531373|37729561|FG008|Overall Study|Lost to Follow-up|0|||
16789124|NCT02531373|37729553|FG000|Overall Study|Physician Decision|0|||
16789125|NCT02531373|37729554|FG001|Overall Study|Physician Decision|0|||
16789126|NCT02531373|37729555|FG002|Overall Study|Physician Decision|0|||
16789127|NCT02531373|37729556|FG003|Overall Study|Physician Decision|0|||
16789128|NCT02531373|37729557|FG004|Overall Study|Physician Decision|2|||
16789129|NCT02531373|37729558|FG005|Overall Study|Physician Decision|1|||
16789130|NCT02531373|37729559|FG006|Overall Study|Physician Decision|0|||
16789131|NCT02531373|37729560|FG007|Overall Study|Physician Decision|0|||
16789132|NCT02531373|37729561|FG008|Overall Study|Physician Decision|0|||
16789133|NCT02531373|37729553|FG000|Overall Study|Protocol Violation|0|||
16789134|NCT02531373|37729554|FG001|Overall Study|Protocol Violation|0|||
16789135|NCT02531373|37729555|FG002|Overall Study|Protocol Violation|0|||
16789136|NCT02531373|37729556|FG003|Overall Study|Protocol Violation|0|||
16789137|NCT02531373|37729557|FG004|Overall Study|Protocol Violation|0|||
16789138|NCT02531373|37729558|FG005|Overall Study|Protocol Violation|1|||
16789139|NCT02531373|37729559|FG006|Overall Study|Protocol Violation|1|||
16789140|NCT02531373|37729560|FG007|Overall Study|Protocol Violation|0|||
16789141|NCT02531373|37729561|FG008|Overall Study|Protocol Violation|1|||
16789142|NCT02531373|37729553|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16789143|NCT02531373|37729554|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16789144|NCT02531373|37729555|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16789145|NCT02531373|37729556|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16789146|NCT02531373|37729557|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
16789147|NCT02531373|37729558|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
16789148|NCT02531373|37729559|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
16789149|NCT02531373|37729560|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
16789150|NCT02531373|37729561|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
16789151|NCT02531373|37729553|FG000|Overall Study|Withdrawal by Subject|0|||
16789152|NCT02531373|37729554|FG001|Overall Study|Withdrawal by Subject|0|||
16789153|NCT02531373|37729555|FG002|Overall Study|Withdrawal by Subject|0|||
16789154|NCT02531373|37729556|FG003|Overall Study|Withdrawal by Subject|0|||
16789155|NCT02531373|37729557|FG004|Overall Study|Withdrawal by Subject|3|||
16789156|NCT02531373|37729558|FG005|Overall Study|Withdrawal by Subject|0|||
16789157|NCT02531373|37729559|FG006|Overall Study|Withdrawal by Subject|0|||
16908617|NCT01774344|38017353|FG000|Overall Study|Withdrawal by Subject|3|||
16908618|NCT01774344|38017354|FG001|Overall Study|Withdrawal by Subject|10|||
16908619|NCT01774344|38017353|FG000|Overall Study|Protocol Violation|0|||
16908620|NCT01774344|38017354|FG001|Overall Study|Protocol Violation|1|||
16908621|NCT01774344|38017353|FG000|Overall Study|Lost to Follow-up|4|||
16908622|NCT01774344|38017354|FG001|Overall Study|Lost to Follow-up|10|||
16908623|NCT01774344|38017353|FG000|Overall Study|End of survival follow-up not available|2|||
16908624|NCT01774344|38017354|FG001|Overall Study|End of survival follow-up not available|2|||
16908625|NCT01774344|38017353|FG000|Overall Study|Data collection finished|4|||
16908626|NCT01774344|38017354|FG001|Overall Study|Data collection finished|14|||
16908627|NCT01774344|38017353|FG000|Overall Study|Other|0|||
16908628|NCT01774344|38017354|FG001|Overall Study|Other|1|||
16908629|NCT01774344|38017353|FG000|Overall Study|Did not enter Survival Follow up|49|||
16908630|NCT01774344|38017354|FG001|Overall Study|Did not enter Survival Follow up|83|||
16908631|NCT01732536|38017362|FG000|Overall Study|Withdrawal by Subject|1|||
16908632|NCT01732536|38017363|FG001|Overall Study|Withdrawal by Subject|1|||
16908633|NCT01755702|38017372|FG000|Wash Out Period I|Other Reason|3|||
16908634|NCT01755702|38017372|FG000|Washout Period II|Other Reason|5|||
16908635|NCT01732458|38017386|FG000|Overall Study|Lost to Follow-up|0|||
16908636|NCT01732458|38017387|FG001|Overall Study|Lost to Follow-up|2|||
16908637|NCT01732458|38017388|FG002|Overall Study|Lost to Follow-up|0|||
16908638|NCT01732458|38017389|FG003|Overall Study|Lost to Follow-up|0|||
16908639|NCT01732458|38017386|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16908640|NCT01732458|38017387|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16908641|NCT01732458|38017388|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16908642|NCT01732458|38017389|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16908643|NCT01732458|38017386|FG000|Overall Study|Physician Decision|1|||
16908644|NCT01732458|38017387|FG001|Overall Study|Physician Decision|2|||
16908645|NCT01732458|38017388|FG002|Overall Study|Physician Decision|2|||
16908646|NCT01732458|38017389|FG003|Overall Study|Physician Decision|0|||
16908647|NCT01732458|38017386|FG000|Overall Study|Protocol Violation|2|||
16908648|NCT01732458|38017387|FG001|Overall Study|Protocol Violation|0|||
16908649|NCT01732458|38017388|FG002|Overall Study|Protocol Violation|0|||
16908650|NCT01732458|38017389|FG003|Overall Study|Protocol Violation|2|||
16908651|NCT01732458|38017386|FG000|Overall Study|Screen Failure|0|||
16789158|NCT02531373|37729560|FG007|Overall Study|Withdrawal by Subject|0|||
16789159|NCT02531373|37729561|FG008|Overall Study|Withdrawal by Subject|0|||
16789160|NCT02606279|37729584|FG000|Overall Study|Lost to Follow-up|0|||
16789161|NCT02606279|37729585|FG001|Overall Study|Lost to Follow-up|1|||
16789162|NCT02643355|37729599|FG000|Overall Study|Withdrawal by Subject|1|||
16789163|NCT02643355|37729600|FG001|Overall Study|Withdrawal by Subject|3|||
16789164|NCT02643355|37729599|FG000|Overall Study|Protocol Violation|0|||
16789165|NCT02643355|37729600|FG001|Overall Study|Protocol Violation|2|||
16789166|NCT02604017|37729608|FG000|Overall Study|Withdrew Consent|0|||
16789167|NCT02604017|37729609|FG001|Overall Study|Withdrew Consent|2|||
16789168|NCT02604017|37729608|FG000|Overall Study|Lost to Follow-up|5|||
16789169|NCT02604017|37729609|FG001|Overall Study|Lost to Follow-up|6|||
16789170|NCT02604017|37729608|FG000|Overall Study|Other|1|||
16789171|NCT02604017|37729609|FG001|Overall Study|Other|0|||
16789172|NCT02640547|37729615|FG000|Overall Study|Failure to Return|1|||
16789173|NCT02640547|37729615|FG000|Overall Study|Withdrawal by Subject|1|||
16789174|NCT02640547|37729615|FG000|Overall Study|Death|6|||
16789175|NCT02640547|37729615|FG000|Overall Study|Miscellaneous|3|||
16789176|NCT02530905|37729629|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
16789177|NCT02530905|37729630|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
16789178|NCT02530905|37729631|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
16789179|NCT02530671|37729655|FG000|Overall Study|Lost to Follow-up|2|||
16789180|NCT02530671|37729656|FG001|Overall Study|Lost to Follow-up|0|||
16789181|NCT02530671|37729655|FG000|Overall Study|Withdrawal by Subject|1|||
16789182|NCT02530671|37729656|FG001|Overall Study|Withdrawal by Subject|0|||
16789183|NCT02603393|37729664|FG000|Overall Study|Patient/guardian decision|32|||
16789184|NCT02603393|37729665|FG001|Overall Study|Patient/guardian decision|18|||
16789185|NCT02603393|37729664|FG000|Overall Study|Adverse Event|17|||
16789186|NCT02603393|37729665|FG001|Overall Study|Adverse Event|15|||
16789187|NCT02603393|37729664|FG000|Overall Study|Technical problems|4|||
16789188|NCT02603393|37729665|FG001|Overall Study|Technical problems|7|||
16789189|NCT02603393|37729664|FG000|Overall Study|Lack of Efficacy|7|||
16789190|NCT02603393|37729665|FG001|Overall Study|Lack of Efficacy|2|||
16789191|NCT02603393|37729664|FG000|Overall Study|Death|3|||
16789192|NCT02603393|37729665|FG001|Overall Study|Death|4|||
16789193|NCT02603393|37729664|FG000|Overall Study|Physician Decision|3|||
16789194|NCT02603393|37729665|FG001|Overall Study|Physician Decision|3|||
16789195|NCT02603393|37729664|FG000|Overall Study|Protocol deviation|2|||
16789196|NCT02603393|37729665|FG001|Overall Study|Protocol deviation|3|||
16789197|NCT02603393|37729664|FG000|Overall Study|Lost to Follow-up|1|||
16789198|NCT02603393|37729665|FG001|Overall Study|Lost to Follow-up|2|||
16789199|NCT02603393|37729664|FG000|Overall Study|Non-compliance with study treatment|1|||
16789200|NCT02603393|37729665|FG001|Overall Study|Non-compliance with study treatment|0|||
16789201|NCT02603393|37729664|FG000|Overall Study|Sponsor decision|1|||
16789202|NCT02603393|37729665|FG001|Overall Study|Sponsor decision|0|||
16789203|NCT02642653|37729673|FG000|Overall Study|Adverse Event|2|||
16789204|NCT02642653|37729674|FG001|Overall Study|Adverse Event|0|||
16789205|NCT01659567|37729680|FG000|Overall Study|Lack of Efficacy|22|||
16789206|NCT01659567|37729680|FG000|Overall Study|Switched to Pegferon|6|||
16789207|NCT01659567|37729680|FG000|Overall Study|Adverse Event|12|||
16789208|NCT01659567|37729680|FG000|Overall Study|Good result at early stage of treatment|5|||
16789209|NCT01659567|37729680|FG000|Overall Study|Withdrawal by Subject|64|||
16789210|NCT01659567|37729680|FG000|Overall Study|Progression of the main disease|1|||
16789211|NCT01659567|37729680|FG000|Overall Study|Other|13|||
16789212|NCT02605967|37729686|FG000|Overall Study|subject / guardian decision|1|||
16789213|NCT02605967|37729687|FG001|Overall Study|subject / guardian decision|2|||
16789214|NCT02605967|37729686|FG000|Overall Study|Physician Decision|10|||
16789215|NCT02605967|37729687|FG001|Overall Study|Physician Decision|1|||
16789216|NCT02605967|37729686|FG000|Overall Study|Death|4|||
16789217|NCT02605967|37729687|FG001|Overall Study|Death|2|||
16789218|NCT02605967|37729686|FG000|Overall Study|Adverse Event|1|||
16789219|NCT02605967|37729687|FG001|Overall Study|Adverse Event|0|||
16789220|NCT02605967|37729686|FG000|Overall Study|progressive disease|66|||
16789221|NCT02605967|37729687|FG001|Overall Study|progressive disease|35|||
16789222|NCT01668173|37729697|FG000|Overall Study|Adverse Event|3|||
16789223|NCT01668173|37729697|FG000|Overall Study|Trial suspension|4|||
16789224|NCT02600351|37729714|FG000|Overall Study|Lack of Efficacy|3|||
16789225|NCT02600351|37729715|FG001|Overall Study|Lack of Efficacy|0|||
16789226|NCT02600351|37729716|FG002|Overall Study|Lack of Efficacy|5|||
16789227|NCT02600351|37729717|FG003|Overall Study|Lack of Efficacy|2|||
16789228|NCT02600351|37729714|FG000|Overall Study|Lost to Follow-up|1|||
16789229|NCT02600351|37729715|FG001|Overall Study|Lost to Follow-up|0|||
16789230|NCT02600351|37729716|FG002|Overall Study|Lost to Follow-up|0|||
16789231|NCT02600351|37729717|FG003|Overall Study|Lost to Follow-up|0|||
16789232|NCT02600351|37729714|FG000|Overall Study|Randomized but Not Treated|1|||
16789233|NCT02600351|37729715|FG001|Overall Study|Randomized but Not Treated|0|||
16789234|NCT02600351|37729716|FG002|Overall Study|Randomized but Not Treated|1|||
16789235|NCT02600351|37729717|FG003|Overall Study|Randomized but Not Treated|3|||
16789236|NCT02640235|37729731|FG000|Overall Study|Withdrawal by Subject|7|||
16789237|NCT02640235|37729732|FG001|Overall Study|Withdrawal by Subject|6|||
16789238|NCT02640235|37729731|FG000|Overall Study|Lost to Follow-up|4|||
16789239|NCT02640235|37729732|FG001|Overall Study|Lost to Follow-up|3|||
16789240|NCT02640235|37729731|FG000|Overall Study|Death|2|||
16789241|NCT02640235|37729732|FG001|Overall Study|Death|3|||
16789242|NCT02640235|37729731|FG000|Overall Study|Other|1|||
16789243|NCT02640235|37729732|FG001|Overall Study|Other|2|||
16789244|NCT02599961|37729738|FG000|Overall Study|Withdrawal by Subject|1|||
16789245|NCT02599961|37729738|FG000|Overall Study|Subject Non-Compliance|2|||
16789246|NCT02599961|37729738|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
16789247|NCT02599961|37729738|FG000|Overall Study|Other, Not Specified|3|||
16789248|NCT02640157|37729763|FG000|Overall Study|Adverse Event|2|||
16789249|NCT02640157|37729764|FG001|Overall Study|Adverse Event|2|||
16789250|NCT02640157|37729765|FG002|Overall Study|Adverse Event|1|||
16789251|NCT02640157|37729763|FG000|Overall Study|Withdrew consent|2|||
16789252|NCT02640157|37729764|FG001|Overall Study|Withdrew consent|0|||
16789253|NCT02640157|37729765|FG002|Overall Study|Withdrew consent|2|||
16789254|NCT02640157|37729763|FG000|Overall Study|Lost to Follow-up|9|||
16789255|NCT02640157|37729764|FG001|Overall Study|Lost to Follow-up|2|||
16789256|NCT02640157|37729765|FG002|Overall Study|Lost to Follow-up|7|||
16789257|NCT02640157|37729763|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
16789258|NCT02640157|37729764|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
16789259|NCT02640157|37729765|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
16789260|NCT01673347|37729774|FG000|Overall Study|failure of allograft|7|||
16789261|NCT02528253|37729783|FG000|Overall Study|Adverse Event|3|||
16789262|NCT02528253|37729784|FG001|Overall Study|Adverse Event|4|||
16789263|NCT02528253|37729785|FG002|Overall Study|Adverse Event|4|||
16789264|NCT02528253|37729786|FG003|Overall Study|Adverse Event|8|||
16789265|NCT02528253|37729787|FG004|Overall Study|Adverse Event|18|||
16789266|NCT02528253|37729783|FG000|Overall Study|Death|2|||
16789267|NCT02528253|37729784|FG001|Overall Study|Death|2|||
16789268|NCT02528253|37729785|FG002|Overall Study|Death|1|||
16789269|NCT02528253|37729786|FG003|Overall Study|Death|0|||
16789270|NCT02528253|37729787|FG004|Overall Study|Death|1|||
16789271|NCT02528253|37729783|FG000|Overall Study|Insufficient clinical response|7|||
16789272|NCT02528253|37729784|FG001|Overall Study|Insufficient clinical response|10|||
16789273|NCT02528253|37729785|FG002|Overall Study|Insufficient clinical response|13|||
16789274|NCT02528253|37729786|FG003|Overall Study|Insufficient clinical response|12|||
16789275|NCT02528253|37729787|FG004|Overall Study|Insufficient clinical response|16|||
16789276|NCT02528253|37729783|FG000|Overall Study|Lost to Follow-up|16|||
16789277|NCT02528253|37729784|FG001|Overall Study|Lost to Follow-up|9|||
16789278|NCT02528253|37729785|FG002|Overall Study|Lost to Follow-up|31|||
16789279|NCT02528253|37729786|FG003|Overall Study|Lost to Follow-up|16|||
16789280|NCT02528253|37729787|FG004|Overall Study|Lost to Follow-up|34|||
16789281|NCT02528253|37729783|FG000|Overall Study|Other|21|||
16789282|NCT02528253|37729784|FG001|Overall Study|Other|22|||
16789283|NCT02528253|37729785|FG002|Overall Study|Other|58|||
16789284|NCT02528253|37729786|FG003|Overall Study|Other|52|||
16789285|NCT02528253|37729787|FG004|Overall Study|Other|76|||
16789286|NCT02528253|37729783|FG000|Overall Study|Withdrawal by Subject|25|||
16789287|NCT02528253|37729784|FG001|Overall Study|Withdrawal by Subject|20|||
16789288|NCT02528253|37729785|FG002|Overall Study|Withdrawal by Subject|29|||
16789289|NCT02528253|37729786|FG003|Overall Study|Withdrawal by Subject|48|||
16789290|NCT02528253|37729787|FG004|Overall Study|Withdrawal by Subject|73|||
16789291|NCT02528253|37729783|FG000|Overall Study|Protocol Violation|1|||
16789292|NCT02528253|37729784|FG001|Overall Study|Protocol Violation|2|||
16789293|NCT02528253|37729785|FG002|Overall Study|Protocol Violation|4|||
16789294|NCT02528253|37729786|FG003|Overall Study|Protocol Violation|0|||
16789295|NCT02528253|37729787|FG004|Overall Study|Protocol Violation|4|||
16789296|NCT02528253|37729783|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
16789297|NCT02528253|37729784|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
16789298|NCT02528253|37729785|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
16789299|NCT02528253|37729786|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
16789300|NCT02528253|37729787|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
16789301|NCT01672957|37729818|FG000|Overall Study|Protocol Violation|48|||
16789302|NCT01672957|37729818|FG000|Overall Study|Death|2|||
16789303|NCT01672957|37729818|FG000|Overall Study|ICF Signed After Transplantation|5|||
16789304|NCT02525133|37729824|FG000|Overall Study|Adverse Event|0|||
16789305|NCT02525133|37729825|FG001|Overall Study|Adverse Event|1|||
16789306|NCT02525133|37729824|FG000|Overall Study|Death|0|||
16789307|NCT02525133|37729825|FG001|Overall Study|Death|1|||
16789308|NCT02525133|37729824|FG000|Overall Study|did not meet randomization criteria|1|||
16789309|NCT02525133|37729825|FG001|Overall Study|did not meet randomization criteria|0|||
16789310|NCT02525133|37729824|FG000|Overall Study|Lost to Follow-up|5|||
16789311|NCT02525133|37729825|FG001|Overall Study|Lost to Follow-up|1|||
16789312|NCT02525133|37729824|FG000|Overall Study|randomized not enrolled|3|||
16789313|NCT02525133|37729825|FG001|Overall Study|randomized not enrolled|0|||
16789314|NCT02525133|37729824|FG000|Overall Study|Withdrawal by Subject|1|||
16789315|NCT02525133|37729825|FG001|Overall Study|Withdrawal by Subject|0|||
16789316|NCT01659255|37729848|FG000|Overall Study|Adverse Event|0|||
16789317|NCT01659255|37729849|FG001|Overall Study|Adverse Event|0|||
16789318|NCT01659255|37729850|FG002|Overall Study|Adverse Event|0|||
16789319|NCT01659255|37729851|FG003|Overall Study|Adverse Event|0|||
16789320|NCT01659255|37729852|FG004|Overall Study|Adverse Event|0|||
16789321|NCT01659255|37729853|FG005|Overall Study|Adverse Event|1|||
16789322|NCT01659255|37729854|FG006|Overall Study|Adverse Event|1|||
16789323|NCT01659255|37729855|FG007|Overall Study|Adverse Event|0|||
16789324|NCT01659255|37729856|FG008|Overall Study|Adverse Event|0|||
16789325|NCT01659255|37729857|FG009|Overall Study|Adverse Event|1|||
16789326|NCT01659255|37729858|FG010|Overall Study|Adverse Event|0|||
16789327|NCT01659255|37729859|FG011|Overall Study|Adverse Event|1|||
16789328|NCT01659255|37729860|FG012|Overall Study|Adverse Event|0|||
16789329|NCT01659255|37729861|FG013|Overall Study|Adverse Event|2|||
16789330|NCT01659255|37729862|FG014|Overall Study|Adverse Event|0|||
16789331|NCT01659255|37729863|FG015|Overall Study|Adverse Event|1|||
16789332|NCT01659255|37729864|FG016|Overall Study|Adverse Event|0|||
16789333|NCT01659255|37729848|FG000|Overall Study|Death|0|||
16789334|NCT01659255|37729849|FG001|Overall Study|Death|1|||
16789335|NCT01659255|37729850|FG002|Overall Study|Death|0|||
16789336|NCT01659255|37729851|FG003|Overall Study|Death|0|||
16789337|NCT01659255|37729852|FG004|Overall Study|Death|0|||
16789338|NCT01659255|37729853|FG005|Overall Study|Death|0|||
16789339|NCT01659255|37729854|FG006|Overall Study|Death|0|||
16789340|NCT01659255|37729855|FG007|Overall Study|Death|1|||
16789341|NCT01659255|37729856|FG008|Overall Study|Death|1|||
16789342|NCT01659255|37729857|FG009|Overall Study|Death|0|||
16789343|NCT01659255|37729858|FG010|Overall Study|Death|0|||
16789344|NCT01659255|37729859|FG011|Overall Study|Death|0|||
16789345|NCT01659255|37729860|FG012|Overall Study|Death|1|||
16789346|NCT01659255|37729861|FG013|Overall Study|Death|1|||
16789347|NCT01659255|37729862|FG014|Overall Study|Death|2|||
16789348|NCT01659255|37729863|FG015|Overall Study|Death|1|||
16789349|NCT01659255|37729864|FG016|Overall Study|Death|0|||
16789350|NCT01659255|37729848|FG000|Overall Study|Progressive Disease|2|||
16789351|NCT01659255|37729849|FG001|Overall Study|Progressive Disease|0|||
16789352|NCT01659255|37729850|FG002|Overall Study|Progressive Disease|0|||
16789353|NCT01659255|37729851|FG003|Overall Study|Progressive Disease|0|||
16789354|NCT01659255|37729852|FG004|Overall Study|Progressive Disease|0|||
16789355|NCT01659255|37729853|FG005|Overall Study|Progressive Disease|0|||
16789356|NCT01659255|37729854|FG006|Overall Study|Progressive Disease|0|||
16789357|NCT01659255|37729855|FG007|Overall Study|Progressive Disease|1|||
16789358|NCT01659255|37729856|FG008|Overall Study|Progressive Disease|0|||
16789359|NCT01659255|37729857|FG009|Overall Study|Progressive Disease|2|||
16789360|NCT01659255|37729858|FG010|Overall Study|Progressive Disease|2|||
16789361|NCT01659255|37729859|FG011|Overall Study|Progressive Disease|3|||
16789362|NCT01659255|37729860|FG012|Overall Study|Progressive Disease|5|||
16789363|NCT01659255|37729861|FG013|Overall Study|Progressive Disease|13|||
16789364|NCT01659255|37729862|FG014|Overall Study|Progressive Disease|6|||
16789365|NCT01659255|37729863|FG015|Overall Study|Progressive Disease|2|||
16789366|NCT01659255|37729864|FG016|Overall Study|Progressive Disease|3|||
16789367|NCT01659255|37729848|FG000|Overall Study|Withdrew Consent|0|||
16789368|NCT01659255|37729849|FG001|Overall Study|Withdrew Consent|0|||
16789369|NCT01659255|37729850|FG002|Overall Study|Withdrew Consent|0|||
16789370|NCT01659255|37729851|FG003|Overall Study|Withdrew Consent|0|||
16789371|NCT01659255|37729852|FG004|Overall Study|Withdrew Consent|0|||
16789372|NCT01659255|37729853|FG005|Overall Study|Withdrew Consent|0|||
16789373|NCT01659255|37729854|FG006|Overall Study|Withdrew Consent|0|||
16789374|NCT01659255|37729855|FG007|Overall Study|Withdrew Consent|0|||
16789375|NCT01659255|37729856|FG008|Overall Study|Withdrew Consent|0|||
16789376|NCT01659255|37729857|FG009|Overall Study|Withdrew Consent|0|||
16789377|NCT01659255|37729858|FG010|Overall Study|Withdrew Consent|1|||
16789378|NCT01659255|37729859|FG011|Overall Study|Withdrew Consent|0|||
16789379|NCT01659255|37729860|FG012|Overall Study|Withdrew Consent|0|||
16789380|NCT01659255|37729861|FG013|Overall Study|Withdrew Consent|1|||
16789381|NCT01659255|37729862|FG014|Overall Study|Withdrew Consent|0|||
16789382|NCT01659255|37729863|FG015|Overall Study|Withdrew Consent|0|||
16789383|NCT01659255|37729864|FG016|Overall Study|Withdrew Consent|0|||
16789384|NCT01659255|37729848|FG000|Overall Study|Investigator Decision|0|||
16789385|NCT01659255|37729849|FG001|Overall Study|Investigator Decision|0|||
16789386|NCT01659255|37729850|FG002|Overall Study|Investigator Decision|0|||
16789387|NCT01659255|37729851|FG003|Overall Study|Investigator Decision|0|||
16789388|NCT01659255|37729852|FG004|Overall Study|Investigator Decision|0|||
16789389|NCT01659255|37729853|FG005|Overall Study|Investigator Decision|0|||
16789390|NCT01659255|37729854|FG006|Overall Study|Investigator Decision|0|||
16789391|NCT01659255|37729855|FG007|Overall Study|Investigator Decision|0|||
16789392|NCT01659255|37729856|FG008|Overall Study|Investigator Decision|0|||
16789393|NCT01659255|37729857|FG009|Overall Study|Investigator Decision|0|||
16789394|NCT01659255|37729858|FG010|Overall Study|Investigator Decision|0|||
16789395|NCT01659255|37729859|FG011|Overall Study|Investigator Decision|0|||
16789396|NCT01659255|37729860|FG012|Overall Study|Investigator Decision|1|||
16908652|NCT01732458|38017387|FG001|Overall Study|Screen Failure|1|||
16789397|NCT01659255|37729861|FG013|Overall Study|Investigator Decision|1|||
16789398|NCT01659255|37729862|FG014|Overall Study|Investigator Decision|0|||
16789399|NCT01659255|37729863|FG015|Overall Study|Investigator Decision|0|||
16789400|NCT01659255|37729864|FG016|Overall Study|Investigator Decision|0|||
16789401|NCT01659255|37729848|FG000|Overall Study|Sponsor's Decision|0|||
16789402|NCT01659255|37729849|FG001|Overall Study|Sponsor's Decision|0|||
16789403|NCT01659255|37729850|FG002|Overall Study|Sponsor's Decision|0|||
16789404|NCT01659255|37729851|FG003|Overall Study|Sponsor's Decision|0|||
16789405|NCT01659255|37729852|FG004|Overall Study|Sponsor's Decision|0|||
16789406|NCT01659255|37729853|FG005|Overall Study|Sponsor's Decision|0|||
16789407|NCT01659255|37729854|FG006|Overall Study|Sponsor's Decision|1|||
16789408|NCT01659255|37729855|FG007|Overall Study|Sponsor's Decision|0|||
16789409|NCT01659255|37729856|FG008|Overall Study|Sponsor's Decision|0|||
16789410|NCT01659255|37729857|FG009|Overall Study|Sponsor's Decision|0|||
16789411|NCT01659255|37729858|FG010|Overall Study|Sponsor's Decision|0|||
16789412|NCT01659255|37729859|FG011|Overall Study|Sponsor's Decision|0|||
16789413|NCT01659255|37729860|FG012|Overall Study|Sponsor's Decision|0|||
16789414|NCT01659255|37729861|FG013|Overall Study|Sponsor's Decision|0|||
16789415|NCT01659255|37729862|FG014|Overall Study|Sponsor's Decision|0|||
16789416|NCT01659255|37729863|FG015|Overall Study|Sponsor's Decision|0|||
16789417|NCT01659255|37729864|FG016|Overall Study|Sponsor's Decision|0|||
16789418|NCT01659255|37729848|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789419|NCT01659255|37729849|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789420|NCT01659255|37729850|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789421|NCT01659255|37729851|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789422|NCT01659255|37729852|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789423|NCT01659255|37729853|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789424|NCT01659255|37729854|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789425|NCT01659255|37729855|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789426|NCT01659255|37729856|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789427|NCT01659255|37729857|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789428|NCT01659255|37729858|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789429|NCT01659255|37729859|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789430|NCT01659255|37729860|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789431|NCT01659255|37729861|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789432|NCT01659255|37729862|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789433|NCT01659255|37729863|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
16789434|NCT01659255|37729864|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16789435|NCT01659255|37729848|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
16789436|NCT01659255|37729849|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
16789437|NCT01659255|37729850|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
16789438|NCT01659255|37729851|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
16789439|NCT01659255|37729852|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
16789440|NCT01659255|37729853|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
16789441|NCT01659255|37729854|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
16789442|NCT01659255|37729855|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
16789443|NCT01659255|37729856|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
16789444|NCT01659255|37729857|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
16789445|NCT01659255|37729858|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
16789446|NCT01659255|37729859|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
16789447|NCT01659255|37729860|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
16789448|NCT01659255|37729861|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
16789449|NCT01659255|37729862|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
16789450|NCT01659255|37729863|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
16789451|NCT01659255|37729864|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
16789452|NCT02637037|37729904|FG000|Overall Study|Positive drug screen at admission|1|||
16789453|NCT02637037|37729905|FG001|Overall Study|Positive drug screen at admission|0|||
16789454|NCT02637037|37729904|FG000|Overall Study|Withdrawal by Subject|2|||
16789455|NCT02637037|37729905|FG001|Overall Study|Withdrawal by Subject|1|||
16789456|NCT02637037|37729904|FG000|Overall Study|Adverse Event|1|||
16789457|NCT02637037|37729905|FG001|Overall Study|Adverse Event|0|||
16789458|NCT02637895|37729925|FG000|Overall Study|Lost to Follow-up|4|||
16789459|NCT02637895|37729926|FG001|Overall Study|Lost to Follow-up|0|||
16789460|NCT02637895|37729925|FG000|Overall Study|Protocol Violation|0|||
16789461|NCT02637895|37729926|FG001|Overall Study|Protocol Violation|1|||
16789462|NCT02637895|37729925|FG000|Overall Study|Lack of Efficacy|1|||
16789463|NCT02637895|37729926|FG001|Overall Study|Lack of Efficacy|0|||
16789464|NCT02637895|37729925|FG000|Overall Study|Withdrawal by Subject|1|||
16789465|NCT02637895|37729926|FG001|Overall Study|Withdrawal by Subject|1|||
16789466|NCT02637895|37729925|FG000|Overall Study|Abnormal baseline lab|0|||
16789467|NCT02637895|37729926|FG001|Overall Study|Abnormal baseline lab|1|||
16789468|NCT02522481|37729933|FG000|Overall Study|discontinued|1|||
16789469|NCT02522481|37729933|FG000|Overall Study|Not dosed|2|||
16789470|NCT02522403|37729946|FG000|Overall Study|Lost to Follow-up|2|||
16789471|NCT02522403|37729947|FG001|Overall Study|Lost to Follow-up|2|||
16789472|NCT02522403|37729946|FG000|Overall Study|Withdrawal by Subject|2|||
16789473|NCT02522403|37729947|FG001|Overall Study|Withdrawal by Subject|4|||
16789474|NCT02522325|37729953|FG000|Overall Study|Adverse Event|0|||
16789475|NCT02522325|37729954|FG001|Overall Study|Adverse Event|1|||
16789476|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
16789477|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
16789478|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
16789479|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
16789480|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
16789481|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
16789482|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
16789483|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
16789484|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
16789485|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
16789486|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
16789487|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
16789488|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
16789489|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
16789490|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
16789491|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
16789492|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
16789493|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
16789494|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
16789495|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
16789496|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
16789497|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
16789498|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
16789499|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
16789500|NCT01672879|37729963|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
16789501|NCT01672879|37729964|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
16789502|NCT01672879|37729965|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
16789503|NCT01672879|37729963|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
16789504|NCT01672879|37729964|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
16789505|NCT01672879|37729965|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
16789506|NCT01672879|37729963|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
16789507|NCT01672879|37729964|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
16789508|NCT01672879|37729965|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
16789509|NCT01672879|37729963|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
16789510|NCT01672879|37729964|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
16789511|NCT01672879|37729965|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
16789512|NCT01672879|37729963|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
16789513|NCT01672879|37729964|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
16789514|NCT01672879|37729965|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
16789515|NCT02601209|37729981|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
16789516|NCT02601209|37729982|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
16789517|NCT02601209|37729983|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
16789518|NCT02601209|37729984|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16789519|NCT02601209|37729985|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16789520|NCT02601209|37729986|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16789521|NCT02601209|37729987|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16789522|NCT02601209|37729988|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16789523|NCT02601209|37729989|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16789524|NCT02601209|37729981|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16789525|NCT02601209|37729982|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16789526|NCT02601209|37729983|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16789527|NCT02601209|37729984|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16789528|NCT02601209|37729985|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
16789529|NCT02601209|37729986|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
16789530|NCT02601209|37729987|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
16789531|NCT02601209|37729988|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16789532|NCT02601209|37729989|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16789533|NCT01659021|37730005|FG000|Main Study|Adverse Event|2|||
16789534|NCT01659021|37730006|FG001|Main Study|Adverse Event|3|||
16789535|NCT01659021|37730005|FG000|Main Study|Lost to Follow-up|1|||
16789536|NCT01659021|37730006|FG001|Main Study|Lost to Follow-up|0|||
16789537|NCT01659021|37730005|FG000|Main Study|Unknown Reasons|2|||
16789538|NCT01659021|37730006|FG001|Main Study|Unknown Reasons|1|||
16789539|NCT01659021|37730005|FG000|Main Study|Physician Decision|34|||
16789540|NCT01659021|37730006|FG001|Main Study|Physician Decision|16|||
16789541|NCT01659021|37730005|FG000|Main Study|Withdrawal by Subject|19|||
16789542|NCT01659021|37730006|FG001|Main Study|Withdrawal by Subject|16|||
16789543|NCT01659021|37730005|FG000|Main Study|Study Terminated by Sponsor|16|||
16789544|NCT01659021|37730006|FG001|Main Study|Study Terminated by Sponsor|1|||
16789545|NCT01659021|37730005|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
16789546|NCT01659021|37730006|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
16789547|NCT01659021|37730005|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
16789548|NCT01659021|37730006|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
16789549|NCT02524665|37730016|FG000|Overall Study|Lost to Follow-up|1|||
16789550|NCT02638129|37730023|FG000|Overall Study|Study terminated|28|||
16789551|NCT02638129|37730024|FG001|Overall Study|Study terminated|30|||
16789552|NCT02524275|37730030|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
16789553|NCT01658943|37730036|FG000|Overall Study|Adverse Event|6|||
16789554|NCT01658943|37730037|FG001|Overall Study|Adverse Event|13|||
16789555|NCT01658943|37730036|FG000|Overall Study|Withdrawal by Subject|9|||
16789556|NCT01658943|37730037|FG001|Overall Study|Withdrawal by Subject|2|||
16789557|NCT01658943|37730036|FG000|Overall Study|Progression/Relapse|39|||
16789558|NCT01658943|37730037|FG001|Overall Study|Progression/Relapse|40|||
16789559|NCT01658943|37730036|FG000|Overall Study|Death|4|||
16789560|NCT01658943|37730037|FG001|Overall Study|Death|2|||
16789561|NCT01658943|37730036|FG000|Overall Study|not protocol specified|4|||
16789562|NCT01658943|37730037|FG001|Overall Study|not protocol specified|1|||
16789563|NCT01658943|37730036|FG000|Overall Study|Not eligible|7|||
16789564|NCT01658943|37730037|FG001|Overall Study|Not eligible|9|||
16789565|NCT01658943|37730036|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
16789566|NCT01658943|37730037|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
16789567|NCT02600819|37730043|FG000|GEN Phase|Adverse Event|2|||
16789568|NCT02600819|37730044|FG001|GEN Phase|Adverse Event|0|||
16789569|NCT02600819|37730043|FG000|GEN Phase|Death|2|||
16789570|NCT02600819|37730044|FG001|GEN Phase|Death|0|||
16789571|NCT02600819|37730043|FG000|GEN Phase|Investigator's Discretion|4|||
16789572|NCT02600819|37730044|FG001|GEN Phase|Investigator's Discretion|0|||
16789573|NCT02600819|37730043|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
16789574|NCT02600819|37730044|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
16789575|NCT02600819|37730043|FG000|GEN Phase|Withdrew Consent|5|||
16789576|NCT02600819|37730044|FG001|GEN Phase|Withdrew Consent|0|||
16789577|NCT02600819|37730043|FG000|GEN Phase|Lost to Follow-up|2|||
16789578|NCT02600819|37730044|FG001|GEN Phase|Lost to Follow-up|0|||
16789579|NCT02597933|37730052|FG000|Overall Study|Withdrawal by Subject|7|||
16789580|NCT02597933|37730053|FG001|Overall Study|Withdrawal by Subject|5|||
16789581|NCT02597933|37730052|FG000|Overall Study|Protocol Violation|2|||
16789582|NCT02597933|37730053|FG001|Overall Study|Protocol Violation|2|||
16789583|NCT02597933|37730052|FG000|Overall Study|Adverse Event|20|||
16789584|NCT02597933|37730053|FG001|Overall Study|Adverse Event|28|||
16789585|NCT02597933|37730052|FG000|Overall Study|Not treated|2|||
16789586|NCT02597933|37730053|FG001|Overall Study|Not treated|2|||
16789587|NCT02597933|37730052|FG000|Overall Study|Other than stated above|7|||
16789588|NCT02597933|37730053|FG001|Overall Study|Other than stated above|14|||
16789589|NCT02597855|37730061|FG000|Overall Study|Lost to Follow-up|2|||
16789590|NCT02597855|37730062|FG001|Overall Study|Lost to Follow-up|1|||
16789591|NCT02604407|37730071|FG000|Overall Study|Adverse Event|0|||
16789592|NCT02604407|37730072|FG001|Overall Study|Adverse Event|7|||
16789593|NCT02604407|37730073|FG002|Overall Study|Adverse Event|5|||
16789594|NCT02604407|37730071|FG000|Overall Study|Protocol Violation|2|||
16789595|NCT02604407|37730072|FG001|Overall Study|Protocol Violation|0|||
16789596|NCT02604407|37730073|FG002|Overall Study|Protocol Violation|0|||
16789597|NCT02604407|37730071|FG000|Overall Study|Withdrawal by Subject|3|||
16789598|NCT02604407|37730072|FG001|Overall Study|Withdrawal by Subject|3|||
16789599|NCT02604407|37730073|FG002|Overall Study|Withdrawal by Subject|5|||
16789600|NCT02604407|37730071|FG000|Overall Study|Lost to Follow-up|2|||
16789601|NCT02604407|37730072|FG001|Overall Study|Lost to Follow-up|1|||
16789602|NCT02604407|37730073|FG002|Overall Study|Lost to Follow-up|2|||
16789603|NCT02604407|37730071|FG000|Overall Study|Lack of Efficacy|1|||
16789604|NCT02604407|37730072|FG001|Overall Study|Lack of Efficacy|0|||
16789605|NCT02604407|37730073|FG002|Overall Study|Lack of Efficacy|0|||
16789606|NCT02604407|37730071|FG000|Overall Study|Other|3|||
16789607|NCT02604407|37730072|FG001|Overall Study|Other|1|||
16789608|NCT02604407|37730073|FG002|Overall Study|Other|4|||
16789609|NCT02593097|37730083|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
16789610|NCT02593097|37730084|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
16789611|NCT02593097|37730083|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16789612|NCT02593097|37730084|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
16789613|NCT02593097|37730083|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
16789614|NCT02593097|37730084|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
16789615|NCT02593097|37730083|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
16789616|NCT02593097|37730084|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
16789617|NCT02593097|37730083|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
16789618|NCT02593097|37730084|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
16789619|NCT01657461|37730092|FG000|Overall Study|Death|9|||
16789620|NCT01657461|37730093|FG001|Overall Study|Death|12|||
16789621|NCT01657461|37730092|FG000|Overall Study|Lost to Follow-up|0|||
16789622|NCT01657461|37730093|FG001|Overall Study|Lost to Follow-up|3|||
16789623|NCT01657461|37730092|FG000|Overall Study|Physician Decision|0|||
16789624|NCT01657461|37730093|FG001|Overall Study|Physician Decision|2|||
16789625|NCT01657461|37730092|FG000|Overall Study|Withdrawal by Subject|1|||
16789626|NCT01657461|37730093|FG001|Overall Study|Withdrawal by Subject|3|||
16789627|NCT02592551|37730102|FG000|Overall Study|Not evaluable|1|||
16789628|NCT02592551|37730103|FG001|Overall Study|Not evaluable|3|||
16789629|NCT02592551|37730104|FG002|Overall Study|Not evaluable|0|||
16789630|NCT02595749|37730115|FG000|Overall Study|Withdrawal by Subject|12|||
16789631|NCT02595749|37730116|FG001|Overall Study|Withdrawal by Subject|7|||
16789632|NCT01657305|37730122|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
16789633|NCT01657305|37730122|FG000|Overall Study|Withdrawal by Subject|4|||
16789634|NCT01657305|37730122|FG000|Overall Study|Adverse Event|1|||
16789635|NCT01657305|37730122|FG000|Overall Study|Lost to Follow-up|1|||
16789636|NCT01657305|37730122|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
16789637|NCT02634307|37730165|FG000|Overall Study|Adverse Event|50|||
16789638|NCT02634307|37730166|FG001|Overall Study|Adverse Event|24|||
16789639|NCT02634307|37730167|FG002|Overall Study|Adverse Event|14|||
16789640|NCT02634307|37730165|FG000|Overall Study|Lost to Follow-up|21|||
16789641|NCT02634307|37730166|FG001|Overall Study|Lost to Follow-up|5|||
16789642|NCT02634307|37730167|FG002|Overall Study|Lost to Follow-up|6|||
16789643|NCT02634307|37730165|FG000|Overall Study|Pregnancy|5|||
16789644|NCT02634307|37730166|FG001|Overall Study|Pregnancy|1|||
16789645|NCT02634307|37730167|FG002|Overall Study|Pregnancy|3|||
16789646|NCT02634307|37730165|FG000|Overall Study|Withdrawal by Subject|38|||
16789647|NCT02634307|37730166|FG001|Overall Study|Withdrawal by Subject|24|||
16789648|NCT02634307|37730167|FG002|Overall Study|Withdrawal by Subject|18|||
16789649|NCT02634307|37730165|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16789650|NCT02634307|37730166|FG001|Overall Study|Non-Compliance with Study Drug|2|||
16789651|NCT02634307|37730167|FG002|Overall Study|Non-Compliance with Study Drug|2|||
16789652|NCT02634307|37730165|FG000|Overall Study|Lack of Efficacy|1|||
16789653|NCT02634307|37730166|FG001|Overall Study|Lack of Efficacy|5|||
16789654|NCT02634307|37730167|FG002|Overall Study|Lack of Efficacy|3|||
16789655|NCT02634307|37730165|FG000|Overall Study|Physician Decision|7|||
16789656|NCT02634307|37730166|FG001|Overall Study|Physician Decision|5|||
16789657|NCT02634307|37730167|FG002|Overall Study|Physician Decision|5|||
16789658|NCT02634307|37730165|FG000|Overall Study|Reason not Specified|3|||
16789659|NCT02634307|37730166|FG001|Overall Study|Reason not Specified|5|||
16789660|NCT02634307|37730167|FG002|Overall Study|Reason not Specified|10|||
16789661|NCT01365273|37730177|FG000|Overall Study|Lost to Follow-up|1|||
16789662|NCT01365273|37730178|FG001|Overall Study|Lost to Follow-up|0|||
16789663|NCT01365273|37730177|FG000|Overall Study|Protocol Violation|0|||
16789664|NCT01365273|37730178|FG001|Overall Study|Protocol Violation|1|||
16789665|NCT01365273|37730177|FG000|Overall Study|Physician Decision|1|||
16789666|NCT01365273|37730178|FG001|Overall Study|Physician Decision|0|||
16789667|NCT02595437|37730184|FG000|Triferic Via IV|Withdrawal by Subject|1|||
16789668|NCT02594735|37730205|FG000|Overall Study|Adverse Event|1|||
16789669|NCT02634151|37730213|FG000|Overall Study|Withdrawal by Subject|1|||
16789670|NCT02634151|37730214|FG001|Overall Study|Withdrawal by Subject|0|||
16789671|NCT02634151|37730213|FG000|Overall Study|Non-Compliance|0|||
16789672|NCT02634151|37730214|FG001|Overall Study|Non-Compliance|1|||
16789673|NCT02634151|37730213|FG000|Overall Study|Other|0|||
16789674|NCT02634151|37730214|FG001|Overall Study|Other|1|||
16789675|NCT01655823|37730225|FG000|Overall Study|Lost to Follow-up|0|||
16789676|NCT01655823|37730226|FG001|Overall Study|Lost to Follow-up|1|||
16789677|NCT01655823|37730227|FG002|Overall Study|Lost to Follow-up|0|||
16789678|NCT01655823|37730228|FG003|Overall Study|Lost to Follow-up|0|||
16789679|NCT01655823|37730229|FG004|Overall Study|Lost to Follow-up|1|||
16789680|NCT01655823|37730225|FG000|Overall Study|Withdrawal by Subject|0|||
16789681|NCT01655823|37730226|FG001|Overall Study|Withdrawal by Subject|1|||
16789682|NCT01655823|37730227|FG002|Overall Study|Withdrawal by Subject|0|||
16789683|NCT01655823|37730228|FG003|Overall Study|Withdrawal by Subject|1|||
16789684|NCT01655823|37730229|FG004|Overall Study|Withdrawal by Subject|0|||
16789685|NCT01360645|37730243|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
16789686|NCT01360645|37730244|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
16789687|NCT01360645|37730245|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
16789688|NCT01360645|37730246|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
16789689|NCT01360645|37730243|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
16789690|NCT01360645|37730244|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
16789691|NCT01360645|37730245|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
16789692|NCT01360645|37730246|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
16789693|NCT01360645|37730243|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
16789694|NCT01360645|37730244|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
16789695|NCT01360645|37730245|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
16789696|NCT01360645|37730246|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
16789697|NCT01360645|37730243|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
16789698|NCT01360645|37730244|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
16789699|NCT01360645|37730245|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
16789700|NCT01360645|37730246|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
16789701|NCT01360645|37730243|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
16789702|NCT01360645|37730244|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
16789703|NCT01360645|37730245|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
16789704|NCT01360645|37730246|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
16789705|NCT01360645|37730243|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
16789706|NCT01360645|37730244|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
16789707|NCT01360645|37730245|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
16789708|NCT01360645|37730246|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
16789709|NCT01360645|37730243|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
16789710|NCT01360645|37730244|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
16789711|NCT01360645|37730245|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
16789712|NCT01360645|37730246|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
16789713|NCT01360645|37730243|FG000|Phase B (6 Weeks)|Adverse Event|0|||
16789714|NCT01360645|37730244|FG001|Phase B (6 Weeks)|Adverse Event|6|||
16789715|NCT01360645|37730245|FG002|Phase B (6 Weeks)|Adverse Event|0|||
16789716|NCT01360645|37730246|FG003|Phase B (6 Weeks)|Adverse Event|0|||
16789717|NCT01360645|37730243|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16789718|NCT01360645|37730244|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
16789719|NCT01360645|37730245|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
16789720|NCT01360645|37730246|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16789721|NCT01360645|37730243|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
16789722|NCT01360645|37730244|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
16789723|NCT01360645|37730245|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
16789724|NCT01360645|37730246|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
16789725|NCT01360645|37730243|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
16789726|NCT01360645|37730244|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
16789727|NCT01360645|37730245|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
16789728|NCT01360645|37730246|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
16789729|NCT01360645|37730243|FG000|Phase A+|Lost to Follow-up|0|||
16789730|NCT01360645|37730244|FG001|Phase A+|Lost to Follow-up|0|||
16789731|NCT01360645|37730245|FG002|Phase A+|Lost to Follow-up|0|||
16789732|NCT01360645|37730246|FG003|Phase A+|Lost to Follow-up|7|||
16789733|NCT01360645|37730243|FG000|Phase A+|Adverse Event|0|||
16789734|NCT01360645|37730244|FG001|Phase A+|Adverse Event|0|||
16789735|NCT01360645|37730245|FG002|Phase A+|Adverse Event|0|||
16789736|NCT01360645|37730246|FG003|Phase A+|Adverse Event|2|||
16789737|NCT01360645|37730243|FG000|Phase A+|Met Withdrawal Criteria|0|||
16789738|NCT01360645|37730244|FG001|Phase A+|Met Withdrawal Criteria|0|||
16789739|NCT01360645|37730245|FG002|Phase A+|Met Withdrawal Criteria|0|||
16789740|NCT01360645|37730246|FG003|Phase A+|Met Withdrawal Criteria|4|||
16789741|NCT01360645|37730243|FG000|Phase A+|Physician Decision|0|||
16789742|NCT01360645|37730244|FG001|Phase A+|Physician Decision|0|||
16789743|NCT01360645|37730245|FG002|Phase A+|Physician Decision|0|||
16789744|NCT01360645|37730246|FG003|Phase A+|Physician Decision|2|||
16789745|NCT01360645|37730243|FG000|Phase A+|Withdrawal by Subject|0|||
16789746|NCT01360645|37730244|FG001|Phase A+|Withdrawal by Subject|0|||
16789747|NCT01360645|37730245|FG002|Phase A+|Withdrawal by Subject|0|||
16789748|NCT01360645|37730246|FG003|Phase A+|Withdrawal by Subject|5|||
16789749|NCT01360645|37730243|FG000|Phase A+|Protocol Deviation|0|||
16789750|NCT01360645|37730244|FG001|Phase A+|Protocol Deviation|0|||
16789751|NCT01360645|37730245|FG002|Phase A+|Protocol Deviation|0|||
16789752|NCT01360645|37730246|FG003|Phase A+|Protocol Deviation|4|||
16789753|NCT02633527|37730261|FG000|Overall Study|Failed to meet eligibility|0|||
16789754|NCT02633527|37730262|FG001|Overall Study|Failed to meet eligibility|1|||
16789755|NCT02633527|37730263|FG002|Overall Study|Failed to meet eligibility|1|||
16789756|NCT02633527|37730264|FG003|Overall Study|Failed to meet eligibility|0|||
16789757|NCT02633527|37730265|FG004|Overall Study|Failed to meet eligibility|1|||
16789758|NCT02633527|37730261|FG000|Overall Study|Adverse Event|0|||
16789759|NCT02633527|37730262|FG001|Overall Study|Adverse Event|4|||
16789760|NCT02633527|37730263|FG002|Overall Study|Adverse Event|3|||
16789761|NCT02633527|37730264|FG003|Overall Study|Adverse Event|1|||
16789762|NCT02633527|37730265|FG004|Overall Study|Adverse Event|5|||
16789763|NCT02633527|37730261|FG000|Overall Study|Lost to Follow-up|1|||
16789764|NCT02633527|37730262|FG001|Overall Study|Lost to Follow-up|2|||
16789765|NCT02633527|37730263|FG002|Overall Study|Lost to Follow-up|5|||
16789766|NCT02633527|37730264|FG003|Overall Study|Lost to Follow-up|5|||
16789767|NCT02633527|37730265|FG004|Overall Study|Lost to Follow-up|4|||
16789768|NCT02633527|37730261|FG000|Overall Study|Withdrawal by Subject|0|||
16789769|NCT02633527|37730262|FG001|Overall Study|Withdrawal by Subject|3|||
16789770|NCT02633527|37730263|FG002|Overall Study|Withdrawal by Subject|5|||
16789771|NCT02633527|37730264|FG003|Overall Study|Withdrawal by Subject|4|||
16789772|NCT02633527|37730265|FG004|Overall Study|Withdrawal by Subject|4|||
16789773|NCT02633527|37730261|FG000|Overall Study|Protocol Violation|0|||
16789774|NCT02633527|37730262|FG001|Overall Study|Protocol Violation|1|||
16789775|NCT02633527|37730263|FG002|Overall Study|Protocol Violation|1|||
16789776|NCT02633527|37730264|FG003|Overall Study|Protocol Violation|1|||
16789777|NCT02633527|37730265|FG004|Overall Study|Protocol Violation|1|||
16789778|NCT02633527|37730261|FG000|Overall Study|Physician Decision|0|||
16789779|NCT02633527|37730262|FG001|Overall Study|Physician Decision|0|||
16789780|NCT02633527|37730263|FG002|Overall Study|Physician Decision|0|||
16789781|NCT02633527|37730264|FG003|Overall Study|Physician Decision|0|||
16789782|NCT02633527|37730265|FG004|Overall Study|Physician Decision|1|||
16789783|NCT02633527|37730261|FG000|Overall Study|Administrative reason|1|||
16789784|NCT02633527|37730262|FG001|Overall Study|Administrative reason|0|||
16789785|NCT02633527|37730263|FG002|Overall Study|Administrative reason|0|||
16789786|NCT02633527|37730264|FG003|Overall Study|Administrative reason|1|||
16789787|NCT02633527|37730265|FG004|Overall Study|Administrative reason|0|||
16789788|NCT02633527|37730261|FG000|Overall Study|Multiple reasons|1|||
16789789|NCT02633527|37730262|FG001|Overall Study|Multiple reasons|0|||
16789790|NCT02633527|37730263|FG002|Overall Study|Multiple reasons|2|||
16789791|NCT02633527|37730264|FG003|Overall Study|Multiple reasons|2|||
16789792|NCT02633527|37730265|FG004|Overall Study|Multiple reasons|1|||
16789793|NCT01667549|37730282|FG000|Overall Study|Withdrawal by Subject|3|||
16789794|NCT01667549|37730283|FG001|Overall Study|Withdrawal by Subject|5|||
16789795|NCT01667549|37730284|FG002|Overall Study|Withdrawal by Subject|7|||
16789796|NCT01667549|37730285|FG003|Overall Study|Withdrawal by Subject|6|||
16789797|NCT01667549|37730286|FG004|Overall Study|Withdrawal by Subject|1|||
16789798|NCT01672801|37730344|FG000|Overall Study|Screen Failure|0|||
16789799|NCT01672801|37730345|FG001|Overall Study|Screen Failure|1|||
16789800|NCT01655901|37730351|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
16789801|NCT01655901|37730352|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
16789802|NCT01655901|37730353|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
16789803|NCT01655901|37730354|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
16789804|NCT01655901|37730355|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
16789805|NCT01655901|37730356|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
16789806|NCT01656759|37730367|FG000|Overall Study|Protocol Violation|2|||
16789807|NCT01656759|37730368|FG001|Overall Study|Protocol Violation|3|||
16789808|NCT02631577|37730376|FG000|Overall Study|Death|1|||
16789809|NCT02631577|37730377|FG001|Overall Study|Death|7|||
16789810|NCT02631577|37730376|FG000|Overall Study|Withdrawal by Subject|0|||
16789811|NCT02631577|37730377|FG001|Overall Study|Withdrawal by Subject|3|||
16789812|NCT01667081|37730385|FG000|Overall Study|Death|43|||
16789813|NCT01667081|37730386|FG001|Overall Study|Death|3|||
16789814|NCT01667081|37730385|FG000|Overall Study|Lost to Follow-up|99|||
16789815|NCT01667081|37730386|FG001|Overall Study|Lost to Follow-up|48|||
16789816|NCT01667081|37730385|FG000|Overall Study|Physician Decision|16|||
16789817|NCT01667081|37730386|FG001|Overall Study|Physician Decision|2|||
16789818|NCT01667081|37730385|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
16789819|NCT01667081|37730386|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
16789820|NCT01667081|37730385|FG000|Overall Study|Withdrawal by Subject|90|||
16789821|NCT01667081|37730386|FG001|Overall Study|Withdrawal by Subject|35|||
16789822|NCT04545619|37730403|FG000|Overall Study|due to equipment challenges|1|||
16789823|NCT02518971|37730409|FG000|Overall Study|Lost to Follow-up|0|||
16789824|NCT02518971|37730410|FG001|Overall Study|Lost to Follow-up|1|||
16789825|NCT02518971|37730409|FG000|Overall Study|Physician Decision|6|||
16789826|NCT02518971|37730410|FG001|Overall Study|Physician Decision|6|||
16789827|NCT02518971|37730409|FG000|Overall Study|Protocol Violation|6|||
16789828|NCT02518971|37730410|FG001|Overall Study|Protocol Violation|4|||
16789829|NCT02518971|37730409|FG000|Overall Study|Withdrawal by Subject|4|||
16789830|NCT02518971|37730410|FG001|Overall Study|Withdrawal by Subject|5|||
16789831|NCT02518971|37730409|FG000|Overall Study|Side effects|1|||
16789832|NCT02518971|37730410|FG001|Overall Study|Side effects|0|||
16789833|NCT02518971|37730409|FG000|Overall Study|medication lost in mail|0|||
16789834|NCT02518971|37730410|FG001|Overall Study|medication lost in mail|1|||
16789835|NCT02518971|37730409|FG000|Overall Study|eligibility criteria no longer met|6|||
16789836|NCT02518971|37730410|FG001|Overall Study|eligibility criteria no longer met|3|||
16789837|NCT01365039|37730419|FG000|Overall Study|Study related symptoms and complaints|1|||
16789838|NCT01365039|37730420|FG001|Overall Study|Study related symptoms and complaints|0|||
16789839|NCT01364727|37730427|FG000|Overall Study|Not Eligible|2|||
16789840|NCT02633215|37730435|FG000|Overall Study|Lost to Follow-up|2|||
16789841|NCT02633215|37730436|FG001|Overall Study|Lost to Follow-up|3|||
16789842|NCT01364649|37730444|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
16789843|NCT01364649|37730445|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
16789844|NCT01364649|37730444|FG000|Overall Study|Lack of Efficacy|6|||
16789845|NCT01364649|37730445|FG001|Overall Study|Lack of Efficacy|0|||
16789846|NCT01364649|37730444|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
16789847|NCT01364649|37730445|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
16789848|NCT01364649|37730444|FG000|Overall Study|Protocol Deviations|4|||
16789849|NCT01364649|37730445|FG001|Overall Study|Protocol Deviations|8|||
16789850|NCT01364649|37730444|FG000|Overall Study|Withdrawal of Consent|9|||
16789851|NCT01364649|37730445|FG001|Overall Study|Withdrawal of Consent|7|||
16789852|NCT01364649|37730444|FG000|Overall Study|Lost to Follow-up|12|||
16789853|NCT01364649|37730445|FG001|Overall Study|Lost to Follow-up|13|||
16789854|NCT01364649|37730444|FG000|Overall Study|Other|4|||
16789855|NCT01364649|37730445|FG001|Overall Study|Other|1|||
16789856|NCT02588261|37730453|FG000|Overall Study|Study Terminated by Sponsor|157|||
16789857|NCT02588261|37730454|FG001|Overall Study|Study Terminated by Sponsor|142|||
16789858|NCT02588261|37730453|FG000|Overall Study|Protocol Deviation|1|||
16789859|NCT02588261|37730454|FG001|Overall Study|Protocol Deviation|0|||
16789860|NCT02588261|37730453|FG000|Overall Study|Death|1|||
16789861|NCT02588261|37730454|FG001|Overall Study|Death|2|||
16789862|NCT02588261|37730453|FG000|Overall Study|Withdrawal by Subject|12|||
16789863|NCT02588261|37730454|FG001|Overall Study|Withdrawal by Subject|8|||
16789864|NCT02588261|37730453|FG000|Overall Study|Noncompliance with Study Drug|0|||
16789865|NCT02588261|37730454|FG001|Overall Study|Noncompliance with Study Drug|1|||
16789866|NCT02588261|37730453|FG000|Overall Study|Miscellaneous|5|||
16789867|NCT02588261|37730454|FG001|Overall Study|Miscellaneous|4|||
16789868|NCT02588261|37730453|FG000|Overall Study|Progressive Disease|61|||
16789869|NCT02588261|37730454|FG001|Overall Study|Progressive Disease|82|||
16789870|NCT02588261|37730453|FG000|Overall Study|Adverse Event|29|||
16789871|NCT02588261|37730454|FG001|Overall Study|Adverse Event|24|||
16789872|NCT02588261|37730453|FG000|Overall Study|Lost to Follow-up|1|||
16789873|NCT02588261|37730454|FG001|Overall Study|Lost to Follow-up|0|||
16789874|NCT01359449|37730462|FG000|Overall Study|Lost to Follow-up|1|||
16789875|NCT01359449|37730463|FG001|Overall Study|Lost to Follow-up|0|||
16789876|NCT01359449|37730462|FG000|Overall Study|Protocol Violation|0|||
16789877|NCT01359449|37730463|FG001|Overall Study|Protocol Violation|2|||
16789878|NCT01359449|37730462|FG000|Overall Study|Withdrawal by Subject|3|||
16789879|NCT01359449|37730463|FG001|Overall Study|Withdrawal by Subject|2|||
16789880|NCT01672723|37730469|FG000|First Intervention|Adverse Event|3|||
16789881|NCT01672723|37730470|FG001|First Intervention|Adverse Event|0|||
16789882|NCT02632747|37730478|FG000|Wash-out Period|Adverse Event|1|||
16789883|NCT02632747|37730479|FG001|Wash-out Period|Adverse Event|0|||
16789884|NCT02520531|37730498|FG000|Overall Study|Revision of study device components|2|||
16789885|NCT02520531|37730499|FG001|Overall Study|Revision of study device components|2|||
16789886|NCT02520531|37730498|FG000|Overall Study|Death|1|||
16789887|NCT02520531|37730499|FG001|Overall Study|Death|2|||
16789888|NCT02520531|37730498|FG000|Overall Study|Lost to Follow-up|1|||
16789889|NCT02520531|37730499|FG001|Overall Study|Lost to Follow-up|1|||
16789890|NCT02520531|37730498|FG000|Overall Study|Meet exclusion criterion|0|||
16789891|NCT02520531|37730499|FG001|Overall Study|Meet exclusion criterion|1|||
16789892|NCT02520531|37730498|FG000|Overall Study|Withdrawal by Subject|1|||
16789893|NCT02520531|37730499|FG001|Overall Study|Withdrawal by Subject|0|||
16789894|NCT02520531|37730498|FG000|Overall Study|Not study device|1|||
16789895|NCT02520531|37730499|FG001|Overall Study|Not study device|0|||
16789896|NCT01671319|37730505|FG000|Overall Study|Withdrawal by Subject|1|||
16789897|NCT01670539|37730509|FG000|Overall Study|Death|3|||
16789898|NCT01670539|37730510|FG001|Overall Study|Death|5|||
16789899|NCT01670539|37730509|FG000|Overall Study|Withdrawal by Subject|3|||
16789900|NCT01670539|37730510|FG001|Overall Study|Withdrawal by Subject|0|||
16789901|NCT02516163|37730517|FG000|Overall Study|Withdrawal by Subject|1|||
16789902|NCT02516163|37730517|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
16789903|NCT02516163|37730517|FG000|Overall Study|Unfit/delay in surgery|3|||
16789904|NCT02516163|37730517|FG000|Overall Study|Use of incorrect measurement technique|5|||
16789905|NCT02516163|37730517|FG000|Overall Study|Data not recorded|2|||
16789906|NCT02516163|37730517|FG000|Overall Study|MRI contraindication exclusion|6|||
16789907|NCT02589665|37730525|FG000|Induction Period|Did not receive drug|0|||
16789908|NCT02589665|37730526|FG001|Induction Period|Did not receive drug|0|||
16789909|NCT02589665|37730527|FG002|Induction Period|Did not receive drug|0|||
16789910|NCT02589665|37730528|FG003|Induction Period|Did not receive drug|1|||
16789911|NCT02589665|37730529|FG004|Induction Period|Did not receive drug|0|||
16789912|NCT02589665|37730530|FG005|Induction Period|Did not receive drug|0|||
16789913|NCT02589665|37730531|FG006|Induction Period|Did not receive drug|0|||
16789914|NCT02589665|37730532|FG007|Induction Period|Did not receive drug|0|||
16789915|NCT02589665|37730533|FG008|Induction Period|Did not receive drug|0|||
16789916|NCT02589665|37730534|FG009|Induction Period|Did not receive drug|0|||
16789917|NCT02589665|37730525|FG000|Induction Period|Adverse Event|3|||
16789918|NCT02589665|37730526|FG001|Induction Period|Adverse Event|0|||
16789919|NCT02589665|37730527|FG002|Induction Period|Adverse Event|2|||
16789920|NCT02589665|37730528|FG003|Induction Period|Adverse Event|2|||
16789921|NCT02589665|37730529|FG004|Induction Period|Adverse Event|0|||
16789922|NCT02589665|37730530|FG005|Induction Period|Adverse Event|0|||
16789923|NCT02589665|37730531|FG006|Induction Period|Adverse Event|0|||
16789924|NCT02589665|37730532|FG007|Induction Period|Adverse Event|0|||
16789925|NCT02589665|37730533|FG008|Induction Period|Adverse Event|0|||
16789926|NCT02589665|37730534|FG009|Induction Period|Adverse Event|0|||
16789927|NCT02589665|37730525|FG000|Induction Period|Withdrawal by Subject|0|||
16789928|NCT02589665|37730526|FG001|Induction Period|Withdrawal by Subject|1|||
16789929|NCT02589665|37730527|FG002|Induction Period|Withdrawal by Subject|0|||
16789930|NCT02589665|37730528|FG003|Induction Period|Withdrawal by Subject|1|||
16789931|NCT02589665|37730529|FG004|Induction Period|Withdrawal by Subject|0|||
16789932|NCT02589665|37730530|FG005|Induction Period|Withdrawal by Subject|0|||
16789933|NCT02589665|37730531|FG006|Induction Period|Withdrawal by Subject|0|||
16789934|NCT02589665|37730532|FG007|Induction Period|Withdrawal by Subject|0|||
16789935|NCT02589665|37730533|FG008|Induction Period|Withdrawal by Subject|0|||
16789936|NCT02589665|37730534|FG009|Induction Period|Withdrawal by Subject|0|||
16789937|NCT02589665|37730525|FG000|Induction Period|Protocol Violation|0|||
16789938|NCT02589665|37730526|FG001|Induction Period|Protocol Violation|1|||
16789939|NCT02589665|37730527|FG002|Induction Period|Protocol Violation|0|||
16789940|NCT02589665|37730528|FG003|Induction Period|Protocol Violation|0|||
16789941|NCT02589665|37730529|FG004|Induction Period|Protocol Violation|0|||
16789942|NCT02589665|37730530|FG005|Induction Period|Protocol Violation|0|||
16789943|NCT02589665|37730531|FG006|Induction Period|Protocol Violation|0|||
16789944|NCT02589665|37730532|FG007|Induction Period|Protocol Violation|0|||
16789945|NCT02589665|37730533|FG008|Induction Period|Protocol Violation|0|||
16789946|NCT02589665|37730534|FG009|Induction Period|Protocol Violation|0|||
16789947|NCT02589665|37730525|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16789948|NCT02589665|37730526|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16789949|NCT02589665|37730527|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16789950|NCT02589665|37730528|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16789951|NCT02589665|37730529|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
16789952|NCT02589665|37730530|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
16789953|NCT02589665|37730531|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
16789954|NCT02589665|37730532|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16789955|NCT02589665|37730533|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16789956|NCT02589665|37730534|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16789957|NCT02589665|37730525|FG000|Maintenance Period|Withdrawal by Subject|0|||
16789958|NCT02589665|37730526|FG001|Maintenance Period|Withdrawal by Subject|0|||
16789959|NCT02589665|37730527|FG002|Maintenance Period|Withdrawal by Subject|0|||
16789960|NCT02589665|37730528|FG003|Maintenance Period|Withdrawal by Subject|0|||
16789961|NCT02589665|37730529|FG004|Maintenance Period|Withdrawal by Subject|4|||
16789962|NCT02589665|37730530|FG005|Maintenance Period|Withdrawal by Subject|2|||
16789963|NCT02589665|37730531|FG006|Maintenance Period|Withdrawal by Subject|4|||
16789964|NCT02589665|37730532|FG007|Maintenance Period|Withdrawal by Subject|0|||
16789965|NCT02589665|37730533|FG008|Maintenance Period|Withdrawal by Subject|0|||
16789966|NCT02589665|37730534|FG009|Maintenance Period|Withdrawal by Subject|0|||
16789967|NCT02589665|37730525|FG000|Maintenance Period|Lack of Efficacy|0|||
16789968|NCT02589665|37730526|FG001|Maintenance Period|Lack of Efficacy|0|||
16789969|NCT02589665|37730527|FG002|Maintenance Period|Lack of Efficacy|0|||
16789970|NCT02589665|37730528|FG003|Maintenance Period|Lack of Efficacy|0|||
16789971|NCT02589665|37730529|FG004|Maintenance Period|Lack of Efficacy|2|||
16789972|NCT02589665|37730530|FG005|Maintenance Period|Lack of Efficacy|1|||
16789973|NCT02589665|37730531|FG006|Maintenance Period|Lack of Efficacy|0|||
16789974|NCT02589665|37730532|FG007|Maintenance Period|Lack of Efficacy|0|||
16789975|NCT02589665|37730533|FG008|Maintenance Period|Lack of Efficacy|0|||
16789976|NCT02589665|37730534|FG009|Maintenance Period|Lack of Efficacy|0|||
16789977|NCT02589665|37730525|FG000|Maintenance Period|Adverse Event|0|||
16789978|NCT02589665|37730526|FG001|Maintenance Period|Adverse Event|0|||
16789979|NCT02589665|37730527|FG002|Maintenance Period|Adverse Event|0|||
16789980|NCT02589665|37730528|FG003|Maintenance Period|Adverse Event|0|||
16789981|NCT02589665|37730529|FG004|Maintenance Period|Adverse Event|0|||
16789982|NCT02589665|37730530|FG005|Maintenance Period|Adverse Event|0|||
16789983|NCT02589665|37730531|FG006|Maintenance Period|Adverse Event|2|||
16789984|NCT02589665|37730532|FG007|Maintenance Period|Adverse Event|0|||
16789985|NCT02589665|37730533|FG008|Maintenance Period|Adverse Event|0|||
16789986|NCT02589665|37730534|FG009|Maintenance Period|Adverse Event|0|||
16789987|NCT02589665|37730525|FG000|Maintenance Period|Lost to Follow-up|0|||
16789988|NCT02589665|37730526|FG001|Maintenance Period|Lost to Follow-up|0|||
16789989|NCT02589665|37730527|FG002|Maintenance Period|Lost to Follow-up|0|||
16789990|NCT02589665|37730528|FG003|Maintenance Period|Lost to Follow-up|0|||
16789991|NCT02589665|37730529|FG004|Maintenance Period|Lost to Follow-up|0|||
16789992|NCT02589665|37730530|FG005|Maintenance Period|Lost to Follow-up|1|||
16789993|NCT02589665|37730531|FG006|Maintenance Period|Lost to Follow-up|0|||
16789994|NCT02589665|37730532|FG007|Maintenance Period|Lost to Follow-up|0|||
16789995|NCT02589665|37730533|FG008|Maintenance Period|Lost to Follow-up|0|||
16789996|NCT02589665|37730534|FG009|Maintenance Period|Lost to Follow-up|0|||
16789997|NCT02589665|37730525|FG000|Maintenance Period|Physician Decision|0|||
16789998|NCT02589665|37730526|FG001|Maintenance Period|Physician Decision|0|||
16789999|NCT02589665|37730527|FG002|Maintenance Period|Physician Decision|0|||
16790000|NCT02589665|37730528|FG003|Maintenance Period|Physician Decision|0|||
16790001|NCT02589665|37730529|FG004|Maintenance Period|Physician Decision|0|||
16790002|NCT02589665|37730530|FG005|Maintenance Period|Physician Decision|1|||
16790003|NCT02589665|37730531|FG006|Maintenance Period|Physician Decision|0|||
16790004|NCT02589665|37730532|FG007|Maintenance Period|Physician Decision|0|||
16790005|NCT02589665|37730533|FG008|Maintenance Period|Physician Decision|0|||
16790006|NCT02589665|37730534|FG009|Maintenance Period|Physician Decision|0|||
16790007|NCT02589665|37730525|FG000|Maintenance Period|Reason Not Collected|0|||
16790008|NCT02589665|37730526|FG001|Maintenance Period|Reason Not Collected|0|||
16790009|NCT02589665|37730527|FG002|Maintenance Period|Reason Not Collected|0|||
16790010|NCT02589665|37730528|FG003|Maintenance Period|Reason Not Collected|0|||
16790011|NCT02589665|37730529|FG004|Maintenance Period|Reason Not Collected|0|||
16790012|NCT02589665|37730530|FG005|Maintenance Period|Reason Not Collected|1|||
16790013|NCT02589665|37730531|FG006|Maintenance Period|Reason Not Collected|1|||
16790014|NCT02589665|37730532|FG007|Maintenance Period|Reason Not Collected|0|||
16790015|NCT02589665|37730533|FG008|Maintenance Period|Reason Not Collected|0|||
16790016|NCT02589665|37730534|FG009|Maintenance Period|Reason Not Collected|0|||
16790017|NCT02589665|37730525|FG000|Induction Extension Period|Adverse Event|0|||
16790018|NCT02589665|37730526|FG001|Induction Extension Period|Adverse Event|0|||
16790019|NCT02589665|37730527|FG002|Induction Extension Period|Adverse Event|0|||
16790020|NCT02589665|37730528|FG003|Induction Extension Period|Adverse Event|0|||
16790021|NCT02589665|37730529|FG004|Induction Extension Period|Adverse Event|0|||
16790022|NCT02589665|37730530|FG005|Induction Extension Period|Adverse Event|0|||
16790023|NCT02589665|37730531|FG006|Induction Extension Period|Adverse Event|0|||
16790024|NCT02589665|37730532|FG007|Induction Extension Period|Adverse Event|0|||
16790025|NCT02589665|37730533|FG008|Induction Extension Period|Adverse Event|4|||
16790026|NCT02589665|37730534|FG009|Induction Extension Period|Adverse Event|0|||
16790027|NCT02589665|37730525|FG000|Induction Extension Period|Lack of Efficacy|0|||
16790028|NCT02589665|37730526|FG001|Induction Extension Period|Lack of Efficacy|0|||
16790029|NCT02589665|37730527|FG002|Induction Extension Period|Lack of Efficacy|0|||
16790030|NCT02589665|37730528|FG003|Induction Extension Period|Lack of Efficacy|0|||
16790031|NCT02589665|37730529|FG004|Induction Extension Period|Lack of Efficacy|0|||
16790032|NCT02589665|37730530|FG005|Induction Extension Period|Lack of Efficacy|0|||
16790033|NCT02589665|37730531|FG006|Induction Extension Period|Lack of Efficacy|0|||
16790034|NCT02589665|37730532|FG007|Induction Extension Period|Lack of Efficacy|0|||
16790035|NCT02589665|37730533|FG008|Induction Extension Period|Lack of Efficacy|3|||
16790036|NCT02589665|37730534|FG009|Induction Extension Period|Lack of Efficacy|0|||
16908653|NCT01732458|38017388|FG002|Overall Study|Screen Failure|0|||
16908654|NCT01732458|38017389|FG003|Overall Study|Screen Failure|0|||
16908655|NCT01731990|38017413|FG000|Overall Study|Adverse Event|1|||
16908656|NCT01731990|38017414|FG001|Overall Study|Adverse Event|5|||
16908657|NCT01731990|38017413|FG000|Overall Study|Withdrawal by Subject|1|||
16908658|NCT01731990|38017414|FG001|Overall Study|Withdrawal by Subject|1|||
16908659|NCT01731990|38017413|FG000|Overall Study|Protocol deviation|1|||
16908660|NCT01731990|38017414|FG001|Overall Study|Protocol deviation|2|||
16908661|NCT01731990|38017413|FG000|Overall Study|Death|1|||
16908662|NCT01731990|38017414|FG001|Overall Study|Death|0|||
16908663|NCT01708902|38017427|FG000|Overall Study|Adverse Event|3|||
16908664|NCT01708902|38017428|FG001|Overall Study|Adverse Event|4|||
16908665|NCT01708902|38017429|FG002|Overall Study|Adverse Event|9|||
16908666|NCT01708902|38017430|FG003|Overall Study|Adverse Event|2|||
16908667|NCT01708902|38017431|FG004|Overall Study|Adverse Event|7|||
16908668|NCT01708902|38017432|FG005|Overall Study|Adverse Event|3|||
16908669|NCT01708902|38017433|FG006|Overall Study|Adverse Event|5|||
16908670|NCT01708902|38017427|FG000|Overall Study|Lack of Efficacy|3|||
16908671|NCT01708902|38017428|FG001|Overall Study|Lack of Efficacy|1|||
16908672|NCT01708902|38017429|FG002|Overall Study|Lack of Efficacy|0|||
16908673|NCT01708902|38017430|FG003|Overall Study|Lack of Efficacy|0|||
16908674|NCT01708902|38017431|FG004|Overall Study|Lack of Efficacy|0|||
16908675|NCT01708902|38017432|FG005|Overall Study|Lack of Efficacy|1|||
17102236|NCT00372905|38241165|FG002|Follow up Until Relapse or Progression|Study closed|0|||
16908676|NCT01708902|38017433|FG006|Overall Study|Lack of Efficacy|0|||
16908677|NCT01708902|38017427|FG000|Overall Study|Non compliance with protocol|0|||
16908678|NCT01708902|38017428|FG001|Overall Study|Non compliance with protocol|2|||
16908679|NCT01708902|38017429|FG002|Overall Study|Non compliance with protocol|1|||
16908680|NCT01708902|38017430|FG003|Overall Study|Non compliance with protocol|3|||
16790037|NCT02589665|37730525|FG000|Induction Extension Period|Withdrawal by Subject|0|||
16790038|NCT02589665|37730526|FG001|Induction Extension Period|Withdrawal by Subject|0|||
16790039|NCT02589665|37730527|FG002|Induction Extension Period|Withdrawal by Subject|0|||
16790040|NCT02589665|37730528|FG003|Induction Extension Period|Withdrawal by Subject|0|||
16790041|NCT02589665|37730529|FG004|Induction Extension Period|Withdrawal by Subject|0|||
16790042|NCT02589665|37730530|FG005|Induction Extension Period|Withdrawal by Subject|0|||
16790043|NCT02589665|37730531|FG006|Induction Extension Period|Withdrawal by Subject|0|||
16790044|NCT02589665|37730532|FG007|Induction Extension Period|Withdrawal by Subject|2|||
16790045|NCT02589665|37730533|FG008|Induction Extension Period|Withdrawal by Subject|3|||
16790046|NCT02589665|37730534|FG009|Induction Extension Period|Withdrawal by Subject|0|||
16790047|NCT02589665|37730525|FG000|Induction Extension Period|Physician Decision|0|||
16790048|NCT02589665|37730526|FG001|Induction Extension Period|Physician Decision|0|||
16790049|NCT02589665|37730527|FG002|Induction Extension Period|Physician Decision|0|||
16790050|NCT02589665|37730528|FG003|Induction Extension Period|Physician Decision|0|||
16790051|NCT02589665|37730529|FG004|Induction Extension Period|Physician Decision|0|||
16790052|NCT02589665|37730530|FG005|Induction Extension Period|Physician Decision|0|||
16790053|NCT02589665|37730531|FG006|Induction Extension Period|Physician Decision|0|||
16790054|NCT02589665|37730532|FG007|Induction Extension Period|Physician Decision|0|||
16790055|NCT02589665|37730533|FG008|Induction Extension Period|Physician Decision|1|||
16790056|NCT02589665|37730534|FG009|Induction Extension Period|Physician Decision|0|||
16790057|NCT02589665|37730525|FG000|Induction Extension Period|Reason Not Collected|0|||
16790058|NCT02589665|37730526|FG001|Induction Extension Period|Reason Not Collected|0|||
16790059|NCT02589665|37730527|FG002|Induction Extension Period|Reason Not Collected|0|||
16790060|NCT02589665|37730528|FG003|Induction Extension Period|Reason Not Collected|0|||
16790061|NCT02589665|37730529|FG004|Induction Extension Period|Reason Not Collected|0|||
16790062|NCT02589665|37730530|FG005|Induction Extension Period|Reason Not Collected|0|||
16790063|NCT02589665|37730531|FG006|Induction Extension Period|Reason Not Collected|0|||
16790064|NCT02589665|37730532|FG007|Induction Extension Period|Reason Not Collected|0|||
16790065|NCT02589665|37730533|FG008|Induction Extension Period|Reason Not Collected|1|||
16790066|NCT02589665|37730534|FG009|Induction Extension Period|Reason Not Collected|0|||
16790067|NCT02589665|37730525|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790068|NCT02589665|37730526|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790069|NCT02589665|37730527|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790070|NCT02589665|37730528|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790071|NCT02589665|37730529|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790072|NCT02589665|37730530|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790073|NCT02589665|37730531|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790074|NCT02589665|37730532|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790075|NCT02589665|37730533|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16790076|NCT02589665|37730534|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
16790077|NCT02589665|37730525|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
16790078|NCT02589665|37730526|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
16790079|NCT02589665|37730527|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
16790080|NCT02589665|37730528|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
16790081|NCT02589665|37730529|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
16790082|NCT02589665|37730530|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
16790083|NCT02589665|37730531|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
16790084|NCT02589665|37730532|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
16790085|NCT02589665|37730533|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
16790086|NCT02589665|37730534|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
16790087|NCT02589665|37730525|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
16790088|NCT02589665|37730526|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
16790089|NCT02589665|37730527|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
16790090|NCT02589665|37730528|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
16790091|NCT02589665|37730529|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
16790092|NCT02589665|37730530|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
16790093|NCT02589665|37730531|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
16790094|NCT02589665|37730532|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
16790095|NCT02589665|37730533|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
16790096|NCT02589665|37730534|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
16790097|NCT02589665|37730525|FG000|Maintenance Extension Period|Adverse Event|0|||
16790098|NCT02589665|37730526|FG001|Maintenance Extension Period|Adverse Event|0|||
16790099|NCT02589665|37730527|FG002|Maintenance Extension Period|Adverse Event|0|||
16790100|NCT02589665|37730528|FG003|Maintenance Extension Period|Adverse Event|0|||
16790101|NCT02589665|37730529|FG004|Maintenance Extension Period|Adverse Event|0|||
16790102|NCT02589665|37730530|FG005|Maintenance Extension Period|Adverse Event|0|||
16790103|NCT02589665|37730531|FG006|Maintenance Extension Period|Adverse Event|0|||
16790104|NCT02589665|37730532|FG007|Maintenance Extension Period|Adverse Event|0|||
16790105|NCT02589665|37730533|FG008|Maintenance Extension Period|Adverse Event|0|||
16790106|NCT02589665|37730534|FG009|Maintenance Extension Period|Adverse Event|2|||
16790107|NCT02589665|37730525|FG000|Maintenance Extension Period|Non-responder|0|||
16790108|NCT02589665|37730526|FG001|Maintenance Extension Period|Non-responder|0|||
16790109|NCT02589665|37730527|FG002|Maintenance Extension Period|Non-responder|0|||
16790110|NCT02589665|37730528|FG003|Maintenance Extension Period|Non-responder|0|||
16790111|NCT02589665|37730529|FG004|Maintenance Extension Period|Non-responder|0|||
16790112|NCT02589665|37730530|FG005|Maintenance Extension Period|Non-responder|0|||
16790113|NCT02589665|37730531|FG006|Maintenance Extension Period|Non-responder|0|||
16790114|NCT02589665|37730532|FG007|Maintenance Extension Period|Non-responder|0|||
16790115|NCT02589665|37730533|FG008|Maintenance Extension Period|Non-responder|0|||
16790116|NCT02589665|37730534|FG009|Maintenance Extension Period|Non-responder|1|||
16790117|NCT01905397|37730560|FG000|Overall Study|Death|0|||
16790118|NCT01905397|37730561|FG001|Overall Study|Death|1|||
16790119|NCT01905397|37730560|FG000|Overall Study|Withdrawal by Subject|2|||
16790120|NCT01905397|37730561|FG001|Overall Study|Withdrawal by Subject|0|||
16790121|NCT01905397|37730560|FG000|Overall Study|Surgery canceled/aborted|9|||
16790122|NCT01905397|37730561|FG001|Overall Study|Surgery canceled/aborted|5|||
16790123|NCT01905397|37730560|FG000|Overall Study|Incision < 7 cm|2|||
16790124|NCT01905397|37730561|FG001|Overall Study|Incision < 7 cm|0|||
16790125|NCT01905397|37730560|FG000|Overall Study|Wrong treatment|1|||
16790126|NCT01905397|37730561|FG001|Overall Study|Wrong treatment|1|||
16790127|NCT01905397|37730560|FG000|Overall Study|Device not applied|3|||
16790128|NCT01905397|37730561|FG001|Overall Study|Device not applied|0|||
16790129|NCT01905397|37730560|FG000|Overall Study|Dressing not applied in operating room|1|||
16790130|NCT01905397|37730561|FG001|Overall Study|Dressing not applied in operating room|0|||
16790131|NCT01905397|37730560|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
16790132|NCT01905397|37730561|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
16790133|NCT01362595|37730567|FG000|Overall Study|Screen failure|10|||
16790134|NCT01362595|37730567|FG000|Overall Study|Withdrawal by Subject|2|||
16790135|NCT02519595|37730574|FG000|Overall Study|Protocol Violation|8|||
16790136|NCT02519595|37730575|FG001|Overall Study|Protocol Violation|22|||
16790137|NCT02519595|37730576|FG002|Overall Study|Protocol Violation|16|||
16790138|NCT00660673|37730588|FG000|Overall Study|Adverse Event|84|||
16790139|NCT00660673|37730588|FG000|Overall Study|Lack of Efficacy|7|||
16790140|NCT00660673|37730588|FG000|Overall Study|Withdrawal by Subject|22|||
16790141|NCT00660673|37730588|FG000|Overall Study|Administrative|2|||
16790142|NCT00660673|37730588|FG000|Overall Study|Protocol Violation|2|||
16790143|NCT02630563|37730603|FG000|Overall Study|Administrative|1|||
16790144|NCT02588339|37730617|FG000|Overall Study|Withdrawal by Subject|1|||
16790145|NCT02588339|37730617|FG000|Overall Study|GVHD Progression prior to treatment|2|||
16908681|NCT01708902|38017431|FG004|Overall Study|Non compliance with protocol|0|||
16908682|NCT01708902|38017432|FG005|Overall Study|Non compliance with protocol|0|||
16908683|NCT01708902|38017433|FG006|Overall Study|Non compliance with protocol|0|||
16908684|NCT01708902|38017427|FG000|Overall Study|Lost to Follow-up|2|||
16908685|NCT01708902|38017428|FG001|Overall Study|Lost to Follow-up|1|||
16908686|NCT01708902|38017429|FG002|Overall Study|Lost to Follow-up|2|||
16908687|NCT01708902|38017430|FG003|Overall Study|Lost to Follow-up|2|||
16908688|NCT01708902|38017431|FG004|Overall Study|Lost to Follow-up|0|||
16908689|NCT01708902|38017432|FG005|Overall Study|Lost to Follow-up|0|||
16908690|NCT01708902|38017433|FG006|Overall Study|Lost to Follow-up|1|||
16908691|NCT01708902|38017427|FG000|Overall Study|Refused to continue trial medication|8|||
16908692|NCT01708902|38017428|FG001|Overall Study|Refused to continue trial medication|0|||
16908693|NCT01708902|38017429|FG002|Overall Study|Refused to continue trial medication|4|||
16908694|NCT01708902|38017430|FG003|Overall Study|Refused to continue trial medication|2|||
16908695|NCT01708902|38017431|FG004|Overall Study|Refused to continue trial medication|8|||
16908696|NCT01708902|38017432|FG005|Overall Study|Refused to continue trial medication|1|||
16908697|NCT01708902|38017433|FG006|Overall Study|Refused to continue trial medication|1|||
16908698|NCT01708902|38017427|FG000|Overall Study|Other Reason|1|||
16908699|NCT01708902|38017428|FG001|Overall Study|Other Reason|0|||
16908700|NCT01708902|38017429|FG002|Overall Study|Other Reason|1|||
16908701|NCT01708902|38017430|FG003|Overall Study|Other Reason|1|||
16908702|NCT01708902|38017431|FG004|Overall Study|Other Reason|1|||
16908703|NCT01708902|38017432|FG005|Overall Study|Other Reason|2|||
16908704|NCT01708902|38017433|FG006|Overall Study|Other Reason|0|||
16908705|NCT01755546|38017452|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
16908706|NCT01755546|38017452|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
16908707|NCT01755546|38017452|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
16908708|NCT01755546|38017452|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
16908709|NCT01755546|38017452|FG000|Titration Phase|Adverse Event|11|||
16908710|NCT01755546|38017452|FG000|Titration Phase|Lack of Efficacy|18|||
16908711|NCT01755546|38017452|FG000|Titration Phase|Protocol Violation|9|||
17198277|NCT02603120|38351877|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
16790146|NCT02629159|37730624|FG000|Overall Study|Adverse Event|17|||
16790147|NCT02629159|37730625|FG001|Overall Study|Adverse Event|20|||
16790148|NCT02629159|37730626|FG002|Overall Study|Adverse Event|22|||
16790149|NCT02629159|37730624|FG000|Overall Study|Withdrawal by Subject|22|||
16790150|NCT02629159|37730625|FG001|Overall Study|Withdrawal by Subject|11|||
16790151|NCT02629159|37730626|FG002|Overall Study|Withdrawal by Subject|15|||
16790152|NCT02629159|37730624|FG000|Overall Study|Lost to Follow-up|7|||
16790153|NCT02629159|37730625|FG001|Overall Study|Lost to Follow-up|4|||
16790154|NCT02629159|37730626|FG002|Overall Study|Lost to Follow-up|5|||
16790155|NCT02629159|37730624|FG000|Overall Study|Lack of Efficacy|4|||
16790156|NCT02629159|37730625|FG001|Overall Study|Lack of Efficacy|0|||
16790157|NCT02629159|37730626|FG002|Overall Study|Lack of Efficacy|1|||
16790158|NCT02629159|37730624|FG000|Overall Study|Other|6|||
16790159|NCT02629159|37730625|FG001|Overall Study|Other|4|||
16790160|NCT02629159|37730626|FG002|Overall Study|Other|8|||
16790161|NCT02628769|37730637|FG000|First Intervention|Adverse Event|1|||
16790162|NCT02628769|37730638|FG001|First Intervention|Adverse Event|0|||
16790163|NCT02628769|37730637|FG000|First Intervention|Withdrawal by Subject|0|||
16790164|NCT02628769|37730638|FG001|First Intervention|Withdrawal by Subject|1|||
16790165|NCT02628769|37730637|FG000|Second Intervention|Adverse Event|2|||
16790166|NCT02628769|37730638|FG001|Second Intervention|Adverse Event|0|||
16790167|NCT02628769|37730637|FG000|Second Intervention|Physician Decision|0|||
16790168|NCT02628769|37730638|FG001|Second Intervention|Physician Decision|1|||
16790169|NCT02626819|37730646|FG000|Overall Study|Lost to Follow-up|3|||
16790170|NCT02626819|37730647|FG001|Overall Study|Lost to Follow-up|2|||
16790171|NCT02626819|37730646|FG000|Overall Study|Withdrawal by Subject|1|||
16790172|NCT02626819|37730647|FG001|Overall Study|Withdrawal by Subject|0|||
16790173|NCT02626819|37730646|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
16790174|NCT02626819|37730647|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
16790175|NCT02630251|37730657|FG000|Overall Study|Physician Decision|0|||
16790176|NCT02630251|37730658|FG001|Overall Study|Physician Decision|0|||
16790177|NCT02630251|37730659|FG002|Overall Study|Physician Decision|1|||
16790178|NCT02630251|37730660|FG003|Overall Study|Physician Decision|0|||
16790179|NCT02518113|37730674|FG000|Overall Study|Adverse Event|1|||
16790180|NCT02518113|37730675|FG001|Overall Study|Adverse Event|0|||
16790181|NCT02518113|37730676|FG002|Overall Study|Adverse Event|1|||
16790182|NCT02518113|37730677|FG003|Overall Study|Adverse Event|0|||
16790183|NCT02518113|37730674|FG000|Overall Study|Death|1|||
16790184|NCT02518113|37730675|FG001|Overall Study|Death|2|||
16790185|NCT02518113|37730676|FG002|Overall Study|Death|0|||
16790186|NCT02518113|37730677|FG003|Overall Study|Death|0|||
16790187|NCT02518113|37730674|FG000|Overall Study|Physician Decision|0|||
16790188|NCT02518113|37730675|FG001|Overall Study|Physician Decision|1|||
16790189|NCT02518113|37730676|FG002|Overall Study|Physician Decision|0|||
16790190|NCT02518113|37730677|FG003|Overall Study|Physician Decision|0|||
16790191|NCT02518113|37730674|FG000|Overall Study|Progressive Disease|1|||
16790192|NCT02518113|37730675|FG001|Overall Study|Progressive Disease|2|||
16790193|NCT02518113|37730676|FG002|Overall Study|Progressive Disease|3|||
16790194|NCT02518113|37730677|FG003|Overall Study|Progressive Disease|0|||
16790195|NCT02629861|37730693|FG000|Overall Study|Adverse Event|7|||
16790196|NCT02629861|37730694|FG001|Overall Study|Adverse Event|5|||
16790197|NCT02629861|37730695|FG002|Overall Study|Adverse Event|4|||
16790198|NCT02629861|37730693|FG000|Overall Study|Withdrawal by Subject|5|||
16790199|NCT02629861|37730694|FG001|Overall Study|Withdrawal by Subject|8|||
16790200|NCT02629861|37730695|FG002|Overall Study|Withdrawal by Subject|13|||
16790201|NCT02629861|37730693|FG000|Overall Study|Protocol Violation|2|||
16790202|NCT02629861|37730694|FG001|Overall Study|Protocol Violation|3|||
16790203|NCT02629861|37730695|FG002|Overall Study|Protocol Violation|7|||
16790204|NCT02629861|37730693|FG000|Overall Study|Lost to Follow-up|12|||
16790205|NCT02629861|37730694|FG001|Overall Study|Lost to Follow-up|9|||
16790206|NCT02629861|37730695|FG002|Overall Study|Lost to Follow-up|4|||
16790207|NCT02629861|37730693|FG000|Overall Study|Other|1|||
16790208|NCT02629861|37730694|FG001|Overall Study|Other|1|||
16790209|NCT02629861|37730695|FG002|Overall Study|Other|0|||
16790210|NCT02629861|37730693|FG000|Overall Study|Pregnancy|2|||
16790211|NCT02629861|37730694|FG001|Overall Study|Pregnancy|1|||
16790212|NCT02629861|37730695|FG002|Overall Study|Pregnancy|0|||
16790213|NCT02482935|37730703|FG000|Period 1|Withdrawal by Subject|1|||
16790214|NCT02482935|37730704|FG001|Period 1|Withdrawal by Subject|0|||
16790215|NCT02513823|37730710|FG000|Overall Study|Lost to Follow-up|4|||
16790216|NCT02513823|37730710|FG000|Overall Study|Physician Decision|1|||
16790217|NCT02513745|37730716|FG000|Overall Study|Criteria at time of surgery not met.|3|||
16790218|NCT02513745|37730717|FG001|Overall Study|Criteria at time of surgery not met.|3|||
16790219|NCT02512965|37730725|FG000|Overall Study|Withdrawal by Subject|0|||
16790220|NCT02512965|37730726|FG001|Overall Study|Withdrawal by Subject|4|||
16790221|NCT02477553|37730734|FG000|Overall Study|Screening up-to-date|12|||
16790222|NCT02477553|37730735|FG001|Overall Study|Screening up-to-date|13|||
16790223|NCT02477553|37730734|FG000|Overall Study|No MD visit|1|||
16790224|NCT02477553|37730735|FG001|Overall Study|No MD visit|1|||
16790225|NCT02477553|37730734|FG000|Overall Study|Workup consistent w/CRC|1|||
16790226|NCT02477553|37730735|FG001|Overall Study|Workup consistent w/CRC|1|||
16790227|NCT02477553|37730734|FG000|Overall Study|Technical issues with intervention|2|||
16790228|NCT02477553|37730735|FG001|Overall Study|Technical issues with intervention|0|||
16790229|NCT02477553|37730734|FG000|Overall Study|Elevated risk for CRC|2|||
16790230|NCT02477553|37730735|FG001|Overall Study|Elevated risk for CRC|2|||
16790231|NCT02477553|37730734|FG000|Overall Study|MD advised against screening|1|||
16790232|NCT02477553|37730735|FG001|Overall Study|MD advised against screening|3|||
16790233|NCT02477553|37730734|FG000|Overall Study|patient deceased|1|||
16790234|NCT02477553|37730735|FG001|Overall Study|patient deceased|0|||
16790235|NCT01665911|37730741|FG000|Overall Study|Protocol Violation|4|||
16790236|NCT01665911|37730741|FG000|Overall Study|Withdrawal by Subject|1|||
16790237|NCT01665911|37730741|FG000|Overall Study|Adverse Event|1|||
16790238|NCT02452359|37730746|FG000|Overall Study|Adverse Event|1|||
16790239|NCT02452359|37730746|FG000|Overall Study|Lost to Follow-up|15|||
16790240|NCT02452359|37730746|FG000|Overall Study|Pregnancy|1|||
16790241|NCT02452359|37730746|FG000|Overall Study|Withdrawal by Subject|4|||
16790242|NCT02476617|37730750|FG000|Overall Study|Adverse Event|1|||
16790243|NCT02476617|37730750|FG000|Overall Study|Lost to Follow-up|1|||
16790244|NCT01665599|37730767|FG000|Overall Study|Adverse Event|1|||
16790245|NCT01665599|37730767|FG000|Overall Study|Consent Withdrawn|1|||
16790246|NCT01665599|37730767|FG000|Overall Study|Investigator/Sponsor decision|1|||
16790247|NCT01665599|37730767|FG000|Overall Study|Death|1|||
16790248|NCT01665599|37730767|FG000|Overall Study|Lost to Follow-up|2|||
16790249|NCT01665599|37730767|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
16790250|NCT01665599|37730767|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
16790251|NCT01671085|37730773|FG000|Overall Study|Withdrawal by Subject|1|||
16790252|NCT01671085|37730774|FG001|Overall Study|Withdrawal by Subject|0|||
16790253|NCT02510001|37730789|FG000|Overall Study|Early disease progression|0|||
16790254|NCT02510001|37730790|FG001|Overall Study|Early disease progression|0|||
16790255|NCT02510001|37730791|FG002|Overall Study|Early disease progression|0|||
16790256|NCT02510001|37730792|FG003|Overall Study|Early disease progression|1|||
16790257|NCT02510001|37730793|FG004|Overall Study|Early disease progression|1|||
16790258|NCT02510001|37730794|FG005|Overall Study|Early disease progression|1|||
16790259|NCT02510001|37730795|FG006|Overall Study|Early disease progression|0|||
16790260|NCT02510001|37730796|FG007|Overall Study|Early disease progression|0|||
16790261|NCT02510001|37730789|FG000|Overall Study|Adverse Event|0|||
16790262|NCT02510001|37730790|FG001|Overall Study|Adverse Event|0|||
16790263|NCT02510001|37730791|FG002|Overall Study|Adverse Event|0|||
16790264|NCT02510001|37730792|FG003|Overall Study|Adverse Event|1|||
16790265|NCT02510001|37730793|FG004|Overall Study|Adverse Event|2|||
16790266|NCT02510001|37730794|FG005|Overall Study|Adverse Event|1|||
16790267|NCT02510001|37730795|FG006|Overall Study|Adverse Event|2|||
16790268|NCT02510001|37730796|FG007|Overall Study|Adverse Event|5|||
16790269|NCT02510001|37730789|FG000|Overall Study|Physician Decision|0|||
16790270|NCT02510001|37730790|FG001|Overall Study|Physician Decision|0|||
16790271|NCT02510001|37730791|FG002|Overall Study|Physician Decision|0|||
16790272|NCT02510001|37730792|FG003|Overall Study|Physician Decision|0|||
16790273|NCT02510001|37730793|FG004|Overall Study|Physician Decision|1|||
16790274|NCT02510001|37730794|FG005|Overall Study|Physician Decision|0|||
16790275|NCT02510001|37730795|FG006|Overall Study|Physician Decision|0|||
16790276|NCT02510001|37730796|FG007|Overall Study|Physician Decision|0|||
16790277|NCT02510001|37730789|FG000|Overall Study|Withdrawal by Subject|0|||
16790278|NCT02510001|37730790|FG001|Overall Study|Withdrawal by Subject|0|||
16790279|NCT02510001|37730791|FG002|Overall Study|Withdrawal by Subject|0|||
16790280|NCT02510001|37730792|FG003|Overall Study|Withdrawal by Subject|0|||
16790281|NCT02510001|37730793|FG004|Overall Study|Withdrawal by Subject|0|||
16790282|NCT02510001|37730794|FG005|Overall Study|Withdrawal by Subject|0|||
16790283|NCT02510001|37730795|FG006|Overall Study|Withdrawal by Subject|0|||
16790284|NCT02510001|37730796|FG007|Overall Study|Withdrawal by Subject|2|||
16790285|NCT02452047|37730835|FG000|Overall Study|Adverse Event|0|||
16790286|NCT02452047|37730836|FG001|Overall Study|Adverse Event|1|||
16790287|NCT02452047|37730837|FG002|Overall Study|Adverse Event|1|||
16790288|NCT02452047|37730835|FG000|Overall Study|Death|1|||
16790289|NCT02452047|37730836|FG001|Overall Study|Death|3|||
16790290|NCT02452047|37730837|FG002|Overall Study|Death|1|||
16790291|NCT02452047|37730835|FG000|Overall Study|Physician Decision|1|||
16790292|NCT02452047|37730836|FG001|Overall Study|Physician Decision|0|||
16790293|NCT02452047|37730837|FG002|Overall Study|Physician Decision|0|||
16790294|NCT02452047|37730835|FG000|Overall Study|Lost to Follow-up|1|||
16790295|NCT02452047|37730836|FG001|Overall Study|Lost to Follow-up|1|||
16790296|NCT02452047|37730837|FG002|Overall Study|Lost to Follow-up|0|||
16790297|NCT02452047|37730835|FG000|Overall Study|Withdrawal by Subject|1|||
16790298|NCT02452047|37730836|FG001|Overall Study|Withdrawal by Subject|0|||
16790299|NCT02452047|37730837|FG002|Overall Study|Withdrawal by Subject|0|||
16790300|NCT02475369|37730845|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
16790301|NCT02475369|37730846|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
16790302|NCT02474589|37730859|FG000|Overall Study|Adverse Event|6|||
16790303|NCT02474589|37730860|FG001|Overall Study|Adverse Event|2|||
16790304|NCT02474589|37730859|FG000|Overall Study|Lost to Follow-up|6|||
16790305|NCT02474589|37730860|FG001|Overall Study|Lost to Follow-up|1|||
16790306|NCT02474589|37730859|FG000|Overall Study|Protocol Violation|4|||
16790307|NCT02474589|37730860|FG001|Overall Study|Protocol Violation|1|||
16790308|NCT02474589|37730859|FG000|Overall Study|Withdrawal by Subject|4|||
16790309|NCT02474589|37730860|FG001|Overall Study|Withdrawal by Subject|0|||
16790310|NCT02474589|37730859|FG000|Overall Study|Inability to complete study procedures|5|||
16790311|NCT02474589|37730860|FG001|Overall Study|Inability to complete study procedures|1|||
16790312|NCT02586233|37730873|FG000|Overall Study|Randomized but did not receive treatment|0|||
16790313|NCT02586233|37730874|FG001|Overall Study|Randomized but did not receive treatment|1|||
16790314|NCT02586233|37730875|FG002|Overall Study|Randomized but did not receive treatment|0|||
16790315|NCT02586233|37730876|FG003|Overall Study|Randomized but did not receive treatment|0|||
16790316|NCT02586233|37730877|FG004|Overall Study|Randomized but did not receive treatment|0|||
16790317|NCT02586233|37730878|FG005|Overall Study|Randomized but did not receive treatment|2|||
16790318|NCT02586233|37730879|FG006|Overall Study|Randomized but did not receive treatment|2|||
16790319|NCT02586233|37730873|FG000|Overall Study|Death|0|||
16790320|NCT02586233|37730874|FG001|Overall Study|Death|1|||
16790321|NCT02586233|37730875|FG002|Overall Study|Death|0|||
16790322|NCT02586233|37730876|FG003|Overall Study|Death|0|||
16790323|NCT02586233|37730877|FG004|Overall Study|Death|2|||
16790324|NCT02586233|37730878|FG005|Overall Study|Death|0|||
16790325|NCT02586233|37730879|FG006|Overall Study|Death|0|||
16790326|NCT02474355|37730899|FG000|Overall Study|Other|43|||
16790327|NCT02474355|37730899|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
16790328|NCT02474355|37730899|FG000|Overall Study|Lost to Follow-up|98|||
16790329|NCT02474355|37730899|FG000|Overall Study|Withdrawal by Subject|124|||
16790330|NCT02474355|37730899|FG000|Overall Study|Death|1361|||
16790331|NCT02474199|37730905|FG000|Overall Study|Lost to Follow-up|1|||
16790332|NCT02474199|37730906|FG001|Overall Study|Lost to Follow-up|0|||
16790333|NCT02474199|37730907|FG002|Overall Study|Lost to Follow-up|0|||
16790334|NCT02474199|37730908|FG003|Overall Study|Lost to Follow-up|0|||
16790335|NCT02474199|37730905|FG000|Overall Study|Withdrawal by Subject|1|||
16790336|NCT02474199|37730906|FG001|Overall Study|Withdrawal by Subject|2|||
16790337|NCT02474199|37730907|FG002|Overall Study|Withdrawal by Subject|0|||
16790338|NCT02474199|37730908|FG003|Overall Study|Withdrawal by Subject|1|||
16790339|NCT02474199|37730905|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
16790340|NCT02474199|37730906|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
16790341|NCT02474199|37730907|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
16790342|NCT02474199|37730908|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
16790343|NCT02474199|37730905|FG000|Overall Study|Did not meet eligibility criteria|0|||
16790344|NCT02474199|37730906|FG001|Overall Study|Did not meet eligibility criteria|0|||
16790345|NCT02474199|37730907|FG002|Overall Study|Did not meet eligibility criteria|2|||
16790346|NCT02474199|37730908|FG003|Overall Study|Did not meet eligibility criteria|2|||
16790347|NCT02450487|37730915|FG000|Overall Study|Lost to Follow-up|3|||
16790348|NCT02473965|37730922|FG000|Overall Study|Adverse Event|6|||
16790349|NCT02473965|37730923|FG001|Overall Study|Adverse Event|4|||
16790350|NCT02473965|37730922|FG000|Overall Study|MG worsening|4|||
16790351|NCT02473965|37730923|FG001|Overall Study|MG worsening|1|||
16790352|NCT02473965|37730922|FG000|Overall Study|Withdrawal by Subject|2|||
16790353|NCT02473965|37730923|FG001|Overall Study|Withdrawal by Subject|3|||
16790354|NCT02473965|37730922|FG000|Overall Study|Physician Decision|0|||
16790355|NCT02473965|37730923|FG001|Overall Study|Physician Decision|2|||
16790356|NCT02472795|37730934|FG000|Overall Study|Adverse Event|0|||
16790357|NCT02472795|37730935|FG001|Overall Study|Adverse Event|1|||
16790358|NCT02472795|37730936|FG002|Overall Study|Adverse Event|0|||
16790359|NCT02472795|37730937|FG003|Overall Study|Adverse Event|0|||
16790360|NCT02472795|37730938|FG004|Overall Study|Adverse Event|2|||
16790361|NCT02472795|37730934|FG000|Overall Study|Withdrawal by Subject|0|||
16790362|NCT02472795|37730935|FG001|Overall Study|Withdrawal by Subject|0|||
16790363|NCT02472795|37730936|FG002|Overall Study|Withdrawal by Subject|0|||
16790364|NCT02472795|37730937|FG003|Overall Study|Withdrawal by Subject|0|||
16790365|NCT02472795|37730938|FG004|Overall Study|Withdrawal by Subject|1|||
16790366|NCT02507349|37730952|FG000|Overall Study|Death|12|||
16790367|NCT02507349|37730953|FG001|Overall Study|Death|16|||
16790368|NCT02507349|37730952|FG000|Overall Study|Withdrawal by Subject|1|||
16790369|NCT02507349|37730953|FG001|Overall Study|Withdrawal by Subject|1|||
16790370|NCT02507349|37730952|FG000|Overall Study|Lost to Follow-up|174|||
16790371|NCT02507349|37730953|FG001|Overall Study|Lost to Follow-up|144|||
16790372|NCT02506881|37730963|FG000|First Intervention (Day 1)|Protocol Violation|0|||
16790373|NCT02506881|37730964|FG001|First Intervention (Day 1)|Protocol Violation|0|||
16790374|NCT02506881|37730965|FG002|First Intervention (Day 1)|Protocol Violation|1|||
16790375|NCT02506881|37730966|FG003|First Intervention (Day 1)|Protocol Violation|0|||
16790376|NCT02506881|37730963|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
16790377|NCT02506881|37730964|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
16790378|NCT02506881|37730965|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16790379|NCT02506881|37730966|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
16790380|NCT02506881|37730963|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
16790381|NCT02506881|37730964|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
16790382|NCT02506881|37730965|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
16790383|NCT02506881|37730966|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
16790384|NCT02506257|37730990|FG000|Overall Study|Adverse Event|0|||
16790385|NCT02506257|37730991|FG001|Overall Study|Adverse Event|2|||
16790386|NCT02506257|37730992|FG002|Overall Study|Adverse Event|3|||
16790387|NCT02506257|37730993|FG003|Overall Study|Adverse Event|0|||
16790388|NCT02506257|37730990|FG000|Overall Study|Protocol Violation|0|||
16790389|NCT02506257|37730991|FG001|Overall Study|Protocol Violation|0|||
16790390|NCT02506257|37730992|FG002|Overall Study|Protocol Violation|1|||
16790391|NCT02506257|37730993|FG003|Overall Study|Protocol Violation|0|||
17016347|NCT00461305|38161003|FG001|Treatment|Protocol Violation|2|||
16790392|NCT02506101|37731005|FG000|Overall Study|Transportation issues|1|||
16790393|NCT02506101|37731006|FG001|Overall Study|Transportation issues|0|||
16790394|NCT02506101|37731005|FG000|Overall Study|No enrollment and staff unavailability|1|||
16790395|NCT02506101|37731006|FG001|Overall Study|No enrollment and staff unavailability|0|||
16790396|NCT01671007|37731021|FG000|Overall Study|Other reasons than listed|166|||
16790397|NCT01671007|37731022|FG001|Overall Study|Other reasons than listed|373|||
16790398|NCT01671007|37731023|FG002|Overall Study|Other reasons than listed|197|||
16790399|NCT01671007|37731024|FG003|Overall Study|Other reasons than listed|228|||
16790400|NCT01671007|37731025|FG004|Overall Study|Other reasons than listed|14|||
16790401|NCT01671007|37731026|FG005|Overall Study|Other reasons than listed|71|||
16790402|NCT01671007|37731027|FG006|Overall Study|Other reasons than listed|17|||
16790403|NCT01671007|37731028|FG007|Overall Study|Other reasons than listed|66|||
16790404|NCT01671007|37731029|FG008|Overall Study|Other reasons than listed|0|||
16790405|NCT01671007|37731021|FG000|Overall Study|Withdrawal by Subject|36|||
16790406|NCT01671007|37731022|FG001|Overall Study|Withdrawal by Subject|59|||
16790407|NCT01671007|37731023|FG002|Overall Study|Withdrawal by Subject|53|||
16790408|NCT01671007|37731024|FG003|Overall Study|Withdrawal by Subject|58|||
16790409|NCT01671007|37731025|FG004|Overall Study|Withdrawal by Subject|4|||
16790410|NCT01671007|37731026|FG005|Overall Study|Withdrawal by Subject|15|||
16790411|NCT01671007|37731027|FG006|Overall Study|Withdrawal by Subject|1|||
16790412|NCT01671007|37731028|FG007|Overall Study|Withdrawal by Subject|19|||
16790413|NCT01671007|37731029|FG008|Overall Study|Withdrawal by Subject|0|||
16790414|NCT01671007|37731021|FG000|Overall Study|Lost to Follow-up|93|||
16790415|NCT01671007|37731022|FG001|Overall Study|Lost to Follow-up|142|||
16790416|NCT01671007|37731023|FG002|Overall Study|Lost to Follow-up|91|||
16790417|NCT01671007|37731024|FG003|Overall Study|Lost to Follow-up|63|||
16790418|NCT01671007|37731025|FG004|Overall Study|Lost to Follow-up|7|||
16790419|NCT01671007|37731026|FG005|Overall Study|Lost to Follow-up|20|||
16790420|NCT01671007|37731027|FG006|Overall Study|Lost to Follow-up|2|||
16790421|NCT01671007|37731028|FG007|Overall Study|Lost to Follow-up|28|||
16790422|NCT01671007|37731029|FG008|Overall Study|Lost to Follow-up|0|||
16790423|NCT01671007|37731021|FG000|Overall Study|No end of study case report form|3|||
16790424|NCT01671007|37731022|FG001|Overall Study|No end of study case report form|1|||
16790425|NCT01671007|37731023|FG002|Overall Study|No end of study case report form|0|||
16790426|NCT01671007|37731024|FG003|Overall Study|No end of study case report form|2|||
16790427|NCT01671007|37731025|FG004|Overall Study|No end of study case report form|0|||
16790428|NCT01671007|37731026|FG005|Overall Study|No end of study case report form|0|||
16790429|NCT01671007|37731027|FG006|Overall Study|No end of study case report form|0|||
16790430|NCT01671007|37731028|FG007|Overall Study|No end of study case report form|0|||
16790431|NCT01671007|37731029|FG008|Overall Study|No end of study case report form|0|||
16790432|NCT01671007|37731021|FG000|Overall Study|Not eligible|23|||
16790433|NCT01671007|37731022|FG001|Overall Study|Not eligible|76|||
16790434|NCT01671007|37731023|FG002|Overall Study|Not eligible|25|||
16790435|NCT01671007|37731024|FG003|Overall Study|Not eligible|17|||
16790436|NCT01671007|37731025|FG004|Overall Study|Not eligible|0|||
16790437|NCT01671007|37731026|FG005|Overall Study|Not eligible|6|||
16790438|NCT01671007|37731027|FG006|Overall Study|Not eligible|1|||
17016348|NCT00461305|38161002|FG000|Treatment|Withdrawal by Subject|48|||
17016349|NCT00461305|38161003|FG001|Treatment|Withdrawal by Subject|2|||
16790439|NCT01671007|37731028|FG007|Overall Study|Not eligible|19|||
16790440|NCT01671007|37731029|FG008|Overall Study|Not eligible|0|||
16790441|NCT02505945|37731042|FG000|Overall Study|Withdrawal by Subject|13|||
16790442|NCT02505945|37731043|FG001|Overall Study|Withdrawal by Subject|2|||
16790443|NCT02505945|37731042|FG000|Overall Study|Adverse Event|1|||
16790444|NCT02505945|37731043|FG001|Overall Study|Adverse Event|0|||
16790445|NCT02505945|37731042|FG000|Overall Study|Physician Decision|2|||
16790446|NCT02505945|37731043|FG001|Overall Study|Physician Decision|1|||
16790447|NCT02505945|37731042|FG000|Overall Study|Lost to Follow-up|6|||
16790448|NCT02505945|37731043|FG001|Overall Study|Lost to Follow-up|1|||
16790449|NCT02505867|37731051|FG000|Overall Study|Lack of Efficacy|6|||
16790450|NCT02505867|37731052|FG001|Overall Study|Lack of Efficacy|6|||
16790451|NCT02472639|37731060|FG000|Overall Study|Physician Decision|4|||
16790452|NCT02472639|37731061|FG001|Overall Study|Physician Decision|3|||
16790453|NCT02472405|37731067|FG000|Overall Study|Lost to Follow-up|9|||
16790454|NCT02472405|37731067|FG000|Overall Study|Adverse Event|1|||
16790455|NCT02448771|37731073|FG000|Overall Study|Disease Progression|30|||
16790456|NCT02448771|37731073|FG000|Overall Study|Unacceptable Toxicity|1|||
16790457|NCT02448771|37731073|FG000|Overall Study|Physician Decision|3|||
16790458|NCT02448771|37731073|FG000|Overall Study|Started new therapy|2|||
16790459|NCT02504541|37731078|FG000|Overall Study|Adverse Event|4|||
16790460|NCT02504541|37731078|FG000|Overall Study|Withdrawal by Subject|4|||
16790461|NCT02504541|37731078|FG000|Overall Study|Lost to Follow-up|1|||
16790462|NCT02504541|37731078|FG000|Overall Study|Met Stopping Criteria|1|||
16790463|NCT02504541|37731078|FG000|Overall Study|Protocol Violation|2|||
16790464|NCT02504541|37731078|FG000|Overall Study|Termination by Sponsor|1|||
17016350|NCT00461305|38161002|FG000|Treatment|Never dispensed|5|||
16790465|NCT02504541|37731078|FG000|Overall Study|Other|2|||
16790466|NCT02504541|37731078|FG000|Overall Study|Multiple|5|||
16790467|NCT02725177|37731082|FG000|Overall Study|Physician Decision|4|||
16790468|NCT02725177|37731082|FG000|Overall Study|Adverse Event|1|||
16790469|NCT02448537|37731089|FG000|Overall Study|Withdrawal by Subject|1|||
16790470|NCT02448537|37731090|FG001|Overall Study|Withdrawal by Subject|1|||
16790471|NCT02448537|37731091|FG002|Overall Study|Withdrawal by Subject|1|||
16790472|NCT02504151|37731101|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
16790473|NCT02504151|37731102|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
16790474|NCT02504151|37731101|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
16790475|NCT02504151|37731102|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
16790476|NCT02504151|37731101|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16790477|NCT02504151|37731102|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16790478|NCT02504151|37731101|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
16790479|NCT02504151|37731102|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
16790480|NCT02448381|37731110|FG000|Overall Study|Adverse Event|2|||
16790481|NCT02448381|37731111|FG001|Overall Study|Adverse Event|0|||
16790482|NCT02448381|37731110|FG000|Overall Study|Lost to Follow-up|16|||
16790483|NCT02448381|37731111|FG001|Overall Study|Lost to Follow-up|9|||
16790484|NCT02448381|37731110|FG000|Overall Study|Physician Decision|1|||
16790485|NCT02448381|37731111|FG001|Overall Study|Physician Decision|1|||
16790486|NCT02448381|37731110|FG000|Overall Study|Pregnancy|1|||
16790487|NCT02448381|37731111|FG001|Overall Study|Pregnancy|0|||
16790488|NCT02448381|37731110|FG000|Overall Study|Withdrawal by Subject|13|||
16790489|NCT02448381|37731111|FG001|Overall Study|Withdrawal by Subject|9|||
16790490|NCT02448381|37731110|FG000|Overall Study|Noncompliance with Study Procedures|2|||
16790491|NCT02448381|37731111|FG001|Overall Study|Noncompliance with Study Procedures|0|||
16790492|NCT02448225|37731123|FG000|Overall Study|Withdrawal by Subject|1|||
16790493|NCT02448225|37731123|FG000|Overall Study|Did not get FSPG scan|18|||
16790494|NCT02448225|37731123|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
16790495|NCT02503215|37731130|FG000|Overall Study|Unable to wear compression stockings|1|||
16790496|NCT02503215|37731130|FG000|Overall Study|Unable to use positive airway pressure|2|||
16790497|NCT02447991|37731136|FG000|Overall Study|Withdrawn by subject - no data|0|||
16790498|NCT02447991|37731137|FG001|Overall Study|Withdrawn by subject - no data|2|||
16790499|NCT02447991|37731136|FG000|Overall Study|Withdrawn by Subject - with data|4|||
16790500|NCT02447991|37731137|FG001|Overall Study|Withdrawn by Subject - with data|4|||
16790501|NCT02447991|37731136|FG000|Overall Study|Lost to Follow-up - no data|3|||
16790502|NCT02447991|37731137|FG001|Overall Study|Lost to Follow-up - no data|6|||
16790503|NCT02447991|37731136|FG000|Overall Study|Lost to follow-up - with data|0|||
16790504|NCT02447991|37731137|FG001|Overall Study|Lost to follow-up - with data|3|||
16790505|NCT02447991|37731136|FG000|Overall Study|End of study - no treatment results|3|||
16790506|NCT02447991|37731137|FG001|Overall Study|End of study - no treatment results|6|||
16790507|NCT02447991|37731136|FG000|Overall Study|End of study - partial treatment results|0|||
16790508|NCT02447991|37731137|FG001|Overall Study|End of study - partial treatment results|9|||
16790509|NCT02586155|37731149|FG000|Overall Study|Adverse Event|2|||
16790510|NCT02586155|37731150|FG001|Overall Study|Adverse Event|3|||
16790511|NCT02586155|37731149|FG000|Overall Study|Withdrawal by Subject|31|||
16790512|NCT02586155|37731150|FG001|Overall Study|Withdrawal by Subject|24|||
16790513|NCT02586155|37731149|FG000|Overall Study|Lost to Follow-up|7|||
16790514|NCT02586155|37731150|FG001|Overall Study|Lost to Follow-up|13|||
16790515|NCT02586155|37731149|FG000|Overall Study|Death|61|||
16790516|NCT02586155|37731150|FG001|Overall Study|Death|72|||
16790517|NCT02586155|37731149|FG000|Overall Study|Other reasons|26|||
16790518|NCT02586155|37731150|FG001|Overall Study|Other reasons|15|||
16790519|NCT02446743|37731158|FG000|Overall Study|Withdrawal by Subject|1|||
16790520|NCT02446743|37731159|FG001|Overall Study|Withdrawal by Subject|1|||
16790521|NCT02446743|37731158|FG000|Overall Study|Lost to Follow-up|1|||
16790522|NCT02446743|37731159|FG001|Overall Study|Lost to Follow-up|0|||
16790523|NCT02446743|37731158|FG000|Overall Study|Adverse Event|1|||
16790524|NCT02446743|37731159|FG001|Overall Study|Adverse Event|1|||
16790525|NCT02446743|37731158|FG000|Overall Study|Other|2|||
16790526|NCT02446743|37731159|FG001|Overall Study|Other|3|||
16790527|NCT02586077|37731174|FG000|Overall Study|Withdrawal by Subject|1|||
16790528|NCT02586077|37731174|FG000|Overall Study|Physician Decision|4|||
16790529|NCT02586077|37731174|FG000|Overall Study|Lost to Follow-up|3|||
16790530|NCT02583425|37731179|FG000|Screening|Did not meet entry criteria|12|||
16790531|NCT02583425|37731179|FG000|Baseline|Did not meet continued criteria|5|||
16790532|NCT02583425|37731179|FG000|Treatment Period|Adverse Event|1|||
16790533|NCT02581163|37731184|FG000|Overall Study|Failure to return|15|||
16790534|NCT02581163|37731184|FG000|Overall Study|Insufficient virological response|3|||
16790535|NCT02581163|37731184|FG000|Overall Study|Withdrew consent|1|||
16790536|NCT02581163|37731184|FG000|Overall Study|Death|1|||
16790537|NCT02581163|37731184|FG000|Overall Study|Other, not specified|9|||
16790538|NCT02627677|37731194|FG000|Overall Study|Adverse event (not progressive disease)|1|||
16790539|NCT02627677|37731195|FG001|Overall Study|Adverse event (not progressive disease)|4|||
16790540|NCT02627677|37731196|FG002|Overall Study|Adverse event (not progressive disease)|1|||
16790541|NCT02627677|37731194|FG000|Overall Study|Progressive disease|1|||
16790542|NCT02627677|37731195|FG001|Overall Study|Progressive disease|3|||
16790543|NCT02627677|37731196|FG002|Overall Study|Progressive disease|0|||
16790544|NCT02627677|37731194|FG000|Overall Study|Lack of Efficacy|1|||
16790545|NCT02627677|37731195|FG001|Overall Study|Lack of Efficacy|2|||
16790546|NCT02627677|37731196|FG002|Overall Study|Lack of Efficacy|0|||
16790547|NCT02627677|37731194|FG000|Overall Study|Lost to Follow-up|0|||
16790548|NCT02627677|37731195|FG001|Overall Study|Lost to Follow-up|0|||
16790549|NCT02627677|37731196|FG002|Overall Study|Lost to Follow-up|1|||
16790550|NCT02627677|37731194|FG000|Overall Study|Pregnancy|0|||
16790551|NCT02627677|37731195|FG001|Overall Study|Pregnancy|1|||
16790552|NCT02627677|37731196|FG002|Overall Study|Pregnancy|0|||
16790553|NCT02627677|37731194|FG000|Overall Study|Study Terminated by Sponsor|5|||
16790554|NCT02627677|37731195|FG001|Overall Study|Study Terminated by Sponsor|10|||
16790555|NCT02627677|37731196|FG002|Overall Study|Study Terminated by Sponsor|6|||
16790556|NCT02627677|37731194|FG000|Overall Study|Physician Decision|0|||
16790557|NCT02627677|37731195|FG001|Overall Study|Physician Decision|0|||
16790558|NCT02627677|37731196|FG002|Overall Study|Physician Decision|2|||
16908712|NCT01755546|38017452|FG000|Titration Phase|Lost to Follow-up|2|||
16908713|NCT01755546|38017452|FG000|Titration Phase|Other and Continuing|22|||
16908714|NCT01755546|38017452|FG000|Titration Phase|Withdrawal by Subject|8|||
16908715|NCT01755546|38017452|FG000|Long Term Treatment|Adverse Event|12|||
16908716|NCT01755546|38017452|FG000|Long Term Treatment|Lack of Efficacy|6|||
16908717|NCT01755546|38017452|FG000|Long Term Treatment|Protocol Violation|10|||
16908718|NCT01755546|38017452|FG000|Long Term Treatment|Withdrawal by Subject|35|||
16908719|NCT01755546|38017452|FG000|Long Term Treatment|Lost to Follow-up|17|||
16908720|NCT01755546|38017452|FG000|Long Term Treatment|other and ongoing|41|||
16908721|NCT01755234|38017458|FG000|Overall Study|Lost to Follow-up|11|||
16908722|NCT01755234|38017459|FG001|Overall Study|Lost to Follow-up|6|||
16908723|NCT01755234|38017458|FG000|Overall Study|Change in surgical case|2|||
16908724|NCT01755234|38017459|FG001|Overall Study|Change in surgical case|1|||
16908725|NCT01755234|38017458|FG000|Overall Study|case cancelled|1|||
16908726|NCT01755234|38017459|FG001|Overall Study|case cancelled|0|||
16908727|NCT01755234|38017458|FG000|Overall Study|Withdrawal by Subject|0|||
16908728|NCT01755234|38017459|FG001|Overall Study|Withdrawal by Subject|1|||
16908729|NCT01755234|38017458|FG000|Overall Study|unblinded|1|||
16908730|NCT01755234|38017459|FG001|Overall Study|unblinded|0|||
16908731|NCT01731912|38017465|FG000|Overall Study|noncompliance|2|||
16908732|NCT01731678|38017469|FG000|Overall Study|Withdrawal by Subject|3|||
16908733|NCT01731678|38017469|FG000|Overall Study|Did not meet inclusion criteria|1|||
16908734|NCT01731678|38017469|FG000|Overall Study|RMT too high, making TMS difficult|3|||
16908735|NCT01731600|38017475|FG000|Overall Study|Adverse Event|2|||
17016351|NCT00461305|38161003|FG001|Treatment|Never dispensed|0|||
17016352|NCT00461305|38161002|FG000|Treatment|Study drug not taken|1|||
16908736|NCT01731600|38017476|FG001|Overall Study|Adverse Event|0|||
16908737|NCT01731600|38017475|FG000|Overall Study|Withdrawal criteria|1|||
17016353|NCT00461305|38161003|FG001|Treatment|Study drug not taken|0|||
17016354|NCT00461305|38161002|FG000|Treatment|Partially missing diary|2|||
17016355|NCT00461305|38161003|FG001|Treatment|Partially missing diary|0|||
17016356|NCT00461305|38161002|FG000|Treatment|Other (missing drug etc)|2|||
17016357|NCT00461305|38161003|FG001|Treatment|Other (missing drug etc)|0|||
17016358|NCT00461305|38161002|FG000|Continued Treatment|Adverse Event|26|||
17016359|NCT00461305|38161003|FG001|Continued Treatment|Adverse Event|0|||
17016360|NCT00461305|38161002|FG000|Continued Treatment|Lost to Follow-up|4|||
17016361|NCT00461305|38161003|FG001|Continued Treatment|Lost to Follow-up|0|||
17016362|NCT00461305|38161002|FG000|Continued Treatment|Protocol Violation|13|||
17016363|NCT00461305|38161003|FG001|Continued Treatment|Protocol Violation|0|||
17016364|NCT00461305|38161002|FG000|Continued Treatment|Withdrawal by Subject|48|||
17016365|NCT00461305|38161003|FG001|Continued Treatment|Withdrawal by Subject|0|||
17016366|NCT00461305|38161002|FG000|Continued Treatment|Partially missing diary|2|||
17016367|NCT00461305|38161003|FG001|Continued Treatment|Partially missing diary|0|||
17016368|NCT00461305|38161002|FG000|Continued Treatment|Other (missing drug etc)|2|||
17016369|NCT00461305|38161003|FG001|Continued Treatment|Other (missing drug etc)|0|||
17016370|NCT00856544|38161014|FG000|Overall Study|Randomized but not treated|3|||
17016371|NCT00856544|38161015|FG001|Overall Study|Randomized but not treated|0|||
17016372|NCT00856544|38161016|FG002|Overall Study|Randomized but not treated|0|||
17016373|NCT00856544|38161017|FG003|Overall Study|Randomized but not treated|0|||
17016374|NCT00856544|38161014|FG000|Overall Study|Death|0|||
17016375|NCT00856544|38161015|FG001|Overall Study|Death|2|||
17016376|NCT00856544|38161016|FG002|Overall Study|Death|0|||
17016377|NCT00856544|38161017|FG003|Overall Study|Death|0|||
17016378|NCT00856544|38161014|FG000|Overall Study|Adverse Event|20|||
17016379|NCT00856544|38161015|FG001|Overall Study|Adverse Event|29|||
16790559|NCT02627677|37731194|FG000|Overall Study|Withdrawal by Subject|2|||
16908738|NCT01731600|38017476|FG001|Overall Study|Withdrawal criteria|0|||
17016380|NCT00856544|38161016|FG002|Overall Study|Adverse Event|2|||
17016381|NCT00856544|38161017|FG003|Overall Study|Adverse Event|3|||
17016382|NCT00856544|38161014|FG000|Overall Study|Lack of Efficacy|16|||
17016383|NCT00856544|38161015|FG001|Overall Study|Lack of Efficacy|12|||
17016384|NCT00856544|38161016|FG002|Overall Study|Lack of Efficacy|3|||
17016385|NCT00856544|38161017|FG003|Overall Study|Lack of Efficacy|3|||
16790560|NCT02627677|37731195|FG001|Overall Study|Withdrawal by Subject|1|||
16790561|NCT02627677|37731196|FG002|Overall Study|Withdrawal by Subject|1|||
16790562|NCT02627677|37731194|FG000|Overall Study|Reason not Specified|0|||
16790563|NCT02627677|37731195|FG001|Overall Study|Reason not Specified|0|||
16790564|NCT02627677|37731196|FG002|Overall Study|Reason not Specified|1|||
16790565|NCT02627677|37731194|FG000|Overall Study|Randomized but not Treated|1|||
16790566|NCT02627677|37731195|FG001|Overall Study|Randomized but not Treated|0|||
16790567|NCT02627677|37731196|FG002|Overall Study|Randomized but not Treated|0|||
16790568|NCT02501811|37731209|FG000|Overall Study|Death|1|||
16790569|NCT02501811|37731210|FG001|Overall Study|Death|3|||
16790570|NCT02501811|37731211|FG002|Overall Study|Death|2|||
16790571|NCT02501811|37731212|FG003|Overall Study|Death|3|||
16790572|NCT02501811|37731209|FG000|Overall Study|Withdrawal by Subject|3|||
16790573|NCT02501811|37731210|FG001|Overall Study|Withdrawal by Subject|3|||
16790574|NCT02501811|37731211|FG002|Overall Study|Withdrawal by Subject|2|||
16790575|NCT02501811|37731212|FG003|Overall Study|Withdrawal by Subject|3|||
16790576|NCT02501811|37731209|FG000|Overall Study|Lost to Follow-up|0|||
16790577|NCT02501811|37731210|FG001|Overall Study|Lost to Follow-up|0|||
16790578|NCT02501811|37731211|FG002|Overall Study|Lost to Follow-up|2|||
16790579|NCT02501811|37731212|FG003|Overall Study|Lost to Follow-up|1|||
16790580|NCT02585999|37731222|FG000|Overall Study|Lost to Follow-up|1|||
16790581|NCT02585999|37731222|FG000|Overall Study|Protocol Violation|1|||
16790582|NCT02582255|37731229|FG000|Overall Study|Protocol Violation|0|||
16790583|NCT02582255|37731230|FG001|Overall Study|Protocol Violation|3|||
16790584|NCT02500719|37731239|FG000|Overall Study|Lost to Follow-up|2|||
16790585|NCT02500719|37731240|FG001|Overall Study|Lost to Follow-up|3|||
16790586|NCT02500719|37731239|FG000|Overall Study|Trauma history|1|||
16790587|NCT02500719|37731240|FG001|Overall Study|Trauma history|0|||
16790588|NCT02500719|37731239|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
16790589|NCT02500719|37731240|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
16790590|NCT02500719|37731239|FG000|Overall Study|Did not meet criteria for PTSD|0|||
16790591|NCT02500719|37731240|FG001|Overall Study|Did not meet criteria for PTSD|1|||
16790592|NCT02500719|37731239|FG000|Overall Study|Claustrophobia|0|||
16790593|NCT02500719|37731240|FG001|Overall Study|Claustrophobia|1|||
16790594|NCT02500719|37731239|FG000|Overall Study|History of head trauma|0|||
16790595|NCT02500719|37731240|FG001|Overall Study|History of head trauma|1|||
16790596|NCT02500641|37731248|FG000|Overall Study|Adverse Event|0|||
16790597|NCT02500641|37731249|FG001|Overall Study|Adverse Event|2|||
16790598|NCT02500641|37731248|FG000|Overall Study|Withdrawal by Subject|4|||
16790599|NCT02500641|37731249|FG001|Overall Study|Withdrawal by Subject|5|||
16790600|NCT02500641|37731248|FG000|Overall Study|Unable to follow study procedures|3|||
16790601|NCT02500641|37731249|FG001|Overall Study|Unable to follow study procedures|2|||
16790602|NCT02500641|37731248|FG000|Overall Study|Protocol Violation|1|||
16790603|NCT02500641|37731249|FG001|Overall Study|Protocol Violation|2|||
16790604|NCT02500641|37731248|FG000|Overall Study|Lost to Follow-up|1|||
16790605|NCT02500641|37731249|FG001|Overall Study|Lost to Follow-up|0|||
16790606|NCT02500641|37731248|FG000|Overall Study|Sponsor decision|1|||
16790607|NCT02500641|37731249|FG001|Overall Study|Sponsor decision|0|||
16790608|NCT02500641|37731248|FG000|Overall Study|Non compliance to study drug|0|||
16790609|NCT02500641|37731249|FG001|Overall Study|Non compliance to study drug|1|||
16790610|NCT02499783|37731257|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
16790611|NCT02499783|37731258|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
16790612|NCT02499783|37731259|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
16790613|NCT02499783|37731257|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
16790614|NCT02499783|37731258|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
16790615|NCT02499783|37731259|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
16790616|NCT02499783|37731257|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
16790617|NCT02499783|37731258|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
16790618|NCT02499783|37731259|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
16790619|NCT02499783|37731257|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
16790620|NCT02499783|37731258|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
16790621|NCT02499783|37731259|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
16790622|NCT02499783|37731257|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
16790623|NCT02499783|37731258|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
16790624|NCT02499783|37731259|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
16790625|NCT02499783|37731257|FG000|DB Period: Weeks 0-8|Other|1|||
16790626|NCT02499783|37731258|FG001|DB Period: Weeks 0-8|Other|1|||
16790627|NCT02499783|37731259|FG002|DB Period: Weeks 0-8|Other|0|||
16790628|NCT02499783|37731257|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
16790629|NCT02499783|37731258|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
16790630|NCT02499783|37731259|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
16790631|NCT02499783|37731257|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
16790632|NCT02499783|37731258|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
16790633|NCT02499783|37731259|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
16790634|NCT02499783|37731257|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
16790635|NCT02499783|37731258|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
16790636|NCT02499783|37731259|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
16790637|NCT02499783|37731257|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
16790638|NCT02499783|37731258|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
16790639|NCT02499783|37731259|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
16790640|NCT02468193|37731269|FG000|Overall Study|Adverse Event|4|||
16790641|NCT02468193|37731269|FG000|Overall Study|Subject/ Guardian decision|2|||
16790642|NCT02466555|37731289|FG000|Overall Study|Lost to Follow-up|2|||
16790643|NCT02466399|37731296|FG000|Overall Study|Adverse Event|1|||
16790644|NCT02466399|37731297|FG001|Overall Study|Adverse Event|0|||
16790645|NCT02466399|37731296|FG000|Overall Study|Early exit due to family emergency|1|||
16790646|NCT02466399|37731297|FG001|Overall Study|Early exit due to family emergency|0|||
16790647|NCT02465931|37731305|FG000|Overall Study|Lost to Follow-up|9|||
16790648|NCT02465931|37731306|FG001|Overall Study|Lost to Follow-up|11|||
17016386|NCT00856544|38161014|FG000|Overall Study|Other|9|||
17016387|NCT00856544|38161015|FG001|Overall Study|Other|16|||
17016388|NCT00856544|38161016|FG002|Overall Study|Other|1|||
17016389|NCT00856544|38161017|FG003|Overall Study|Other|6|||
17016390|NCT00856544|38161014|FG000|Overall Study|Lost to Follow-up|1|||
17016391|NCT00856544|38161015|FG001|Overall Study|Lost to Follow-up|2|||
17016392|NCT00856544|38161016|FG002|Overall Study|Lost to Follow-up|2|||
17016393|NCT00856544|38161017|FG003|Overall Study|Lost to Follow-up|0|||
16790649|NCT02465931|37731305|FG000|Overall Study|Protocol Violation|1|||
16790650|NCT02465931|37731306|FG001|Overall Study|Protocol Violation|0|||
16790651|NCT02465931|37731305|FG000|Overall Study|Withdrawal by Subject|1|||
16790652|NCT02465931|37731306|FG001|Overall Study|Withdrawal by Subject|0|||
16790653|NCT02465463|37731314|FG000|Overall Study|Lost to Follow-up|2|||
16790654|NCT02465463|37731315|FG001|Overall Study|Lost to Follow-up|1|||
16790655|NCT02465463|37731314|FG000|Overall Study|Death|1|||
16790656|NCT02465463|37731315|FG001|Overall Study|Death|0|||
16790657|NCT02465463|37731314|FG000|Overall Study|Protocol Violation|1|||
16790658|NCT02465463|37731315|FG001|Overall Study|Protocol Violation|0|||
16790659|NCT02464059|37731322|FG000|Overall Study|Lost to Follow-up|6|||
16790660|NCT02463357|37731331|FG000|Overall Study|Withdrawal by Subject|1|||
16790661|NCT02463357|37731332|FG001|Overall Study|Withdrawal by Subject|0|||
16790662|NCT02463357|37731333|FG002|Overall Study|Withdrawal by Subject|0|||
16790663|NCT02463357|37731334|FG003|Overall Study|Withdrawal by Subject|0|||
16790664|NCT02463357|37731335|FG004|Overall Study|Withdrawal by Subject|0|||
16790665|NCT02463357|37731331|FG000|Overall Study|Withdrawal by Subject|0|||
16790666|NCT02463357|37731332|FG001|Overall Study|Withdrawal by Subject|0|||
16790667|NCT02463357|37731333|FG002|Overall Study|Withdrawal by Subject|0|||
16790668|NCT02463357|37731334|FG003|Overall Study|Withdrawal by Subject|0|||
16790669|NCT02463357|37731335|FG004|Overall Study|Withdrawal by Subject|1|||
16790670|NCT02579759|37731350|FG000|Overall Study|Protocol Violation|2|||
16790671|NCT02579759|37731351|FG001|Overall Study|Protocol Violation|0|||
16790672|NCT02579759|37731352|FG002|Overall Study|Protocol Violation|0|||
16790673|NCT02579759|37731350|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
16790674|NCT02579759|37731351|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
16790675|NCT02579759|37731352|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
16790676|NCT02579759|37731350|FG000|Overall Study|BfArM hold|13|||
16790677|NCT02579759|37731351|FG001|Overall Study|BfArM hold|12|||
16790678|NCT02579759|37731352|FG002|Overall Study|BfArM hold|12|||
16790679|NCT02579759|37731350|FG000|Overall Study|Sponsor stopped Dose 2|0|||
16790680|NCT02579759|37731351|FG001|Overall Study|Sponsor stopped Dose 2|41|||
16790681|NCT02579759|37731352|FG002|Overall Study|Sponsor stopped Dose 2|0|||
16790682|NCT02579759|37731350|FG000|Overall Study|Non compliance|0|||
16790683|NCT02579759|37731351|FG001|Overall Study|Non compliance|1|||
16790684|NCT02579759|37731352|FG002|Overall Study|Non compliance|0|||
16790685|NCT02579759|37731350|FG000|Overall Study|Pregnancy|0|||
16790686|NCT02579759|37731351|FG001|Overall Study|Pregnancy|1|||
16790687|NCT02579759|37731352|FG002|Overall Study|Pregnancy|0|||
16790688|NCT02579759|37731350|FG000|Overall Study|Inclusion/exclusion criteria|0|||
16790689|NCT02579759|37731351|FG001|Overall Study|Inclusion/exclusion criteria|0|||
16790690|NCT02579759|37731352|FG002|Overall Study|Inclusion/exclusion criteria|1|||
16790691|NCT02579759|37731350|FG000|Overall Study|Adverse Event|4|||
16790692|NCT02579759|37731351|FG001|Overall Study|Adverse Event|3|||
16790693|NCT02579759|37731352|FG002|Overall Study|Adverse Event|1|||
16790694|NCT02579759|37731350|FG000|Overall Study|Withdrawal by Subject|3|||
17016394|NCT00856544|38161014|FG000|Overall Study|Withdrawal by Subject|8|||
16790695|NCT02579759|37731351|FG001|Overall Study|Withdrawal by Subject|3|||
16790696|NCT02579759|37731352|FG002|Overall Study|Withdrawal by Subject|5|||
16790697|NCT02579759|37731350|FG000|Overall Study|Lost to Follow-up|2|||
16790698|NCT02579759|37731351|FG001|Overall Study|Lost to Follow-up|2|||
16790699|NCT02579759|37731352|FG002|Overall Study|Lost to Follow-up|2|||
16790700|NCT02445963|37731366|FG000|Overall Study|Lost to Follow-up|1|||
16790701|NCT02445963|37731367|FG001|Overall Study|Lost to Follow-up|0|||
16790702|NCT02445963|37731368|FG002|Overall Study|Lost to Follow-up|0|||
16790703|NCT02445963|37731369|FG003|Overall Study|Lost to Follow-up|0|||
16790704|NCT02445963|37731366|FG000|Overall Study|Change in employment|1|||
16790705|NCT02445963|37731367|FG001|Overall Study|Change in employment|0|||
16790706|NCT02445963|37731368|FG002|Overall Study|Change in employment|0|||
16790707|NCT02445963|37731369|FG003|Overall Study|Change in employment|0|||
16790708|NCT02445963|37731366|FG000|Overall Study|Symptoms post-vaccination|0|||
16790709|NCT02445963|37731367|FG001|Overall Study|Symptoms post-vaccination|0|||
16790710|NCT02445963|37731368|FG002|Overall Study|Symptoms post-vaccination|1|||
16790711|NCT02445963|37731369|FG003|Overall Study|Symptoms post-vaccination|0|||
16790712|NCT02499159|37731383|FG000|Randomization|Protocol Violation|1|||
16790713|NCT02499159|37731384|FG001|Randomization|Protocol Violation|1|||
16790714|NCT02499159|37731383|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
16790715|NCT02499159|37731384|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
16790716|NCT02499159|37731383|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
16790717|NCT02499159|37731384|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
16790718|NCT02499159|37731383|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
16790719|NCT02499159|37731384|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
16790720|NCT02499159|37731383|FG000|30-Day Follow-Up Phone Call|Other|1|||
16790721|NCT02499159|37731384|FG001|30-Day Follow-Up Phone Call|Other|0|||
16790722|NCT01664039|37731392|FG000|Overall Study|Adverse Event|3|||
16790723|NCT01664039|37731393|FG001|Overall Study|Adverse Event|4|||
16790724|NCT01664039|37731392|FG000|Overall Study|Lost to Follow-up|1|||
16790725|NCT01664039|37731393|FG001|Overall Study|Lost to Follow-up|1|||
16790726|NCT01664039|37731392|FG000|Overall Study|Withdrawal by Subject|1|||
16790727|NCT01664039|37731393|FG001|Overall Study|Withdrawal by Subject|3|||
16790728|NCT01664039|37731392|FG000|Overall Study|Noncompliance|1|||
16790729|NCT01664039|37731393|FG001|Overall Study|Noncompliance|1|||
16790730|NCT02445573|37731401|FG000|Overall Study|Withdrawal by Subject|1|||
16790731|NCT02445573|37731402|FG001|Overall Study|Withdrawal by Subject|1|||
16790732|NCT02445573|37731401|FG000|Overall Study|Lost to Follow-up|0|||
16790733|NCT02445573|37731402|FG001|Overall Study|Lost to Follow-up|1|||
16790734|NCT02445339|37731410|FG000|Overall Study|Physician Decision|1|||
16790735|NCT02445339|37731411|FG001|Overall Study|Physician Decision|0|||
16790736|NCT02445339|37731410|FG000|Overall Study|Lost to Follow-up|11|||
16790737|NCT02445339|37731411|FG001|Overall Study|Lost to Follow-up|15|||
16790738|NCT02579603|37731419|FG000|Overall Study|Not treated|1|||
16790739|NCT02579603|37731420|FG001|Overall Study|Not treated|0|||
16790740|NCT02579603|37731419|FG000|Overall Study|Adverse Event|2|||
16790741|NCT02579603|37731420|FG001|Overall Study|Adverse Event|2|||
16790742|NCT02579603|37731419|FG000|Overall Study|Other than stated|1|||
16790743|NCT02579603|37731420|FG001|Overall Study|Other than stated|0|||
16790744|NCT02625259|37731432|FG000|First Intervention (Day 1)|Other|0|||
16790745|NCT02625259|37731433|FG001|First Intervention (Day 1)|Other|0|||
16790746|NCT02625259|37731434|FG002|First Intervention (Day 1)|Other|1|||
16790747|NCT02625259|37731435|FG003|First Intervention (Day 1)|Other|0|||
16790748|NCT02625259|37731436|FG004|First Intervention (Day 1)|Other|0|||
16790749|NCT02625259|37731432|FG000|First Intervention (Day 1)|Adverse Event|2|||
16790750|NCT02625259|37731433|FG001|First Intervention (Day 1)|Adverse Event|1|||
16790751|NCT02625259|37731434|FG002|First Intervention (Day 1)|Adverse Event|0|||
16790752|NCT02625259|37731435|FG003|First Intervention (Day 1)|Adverse Event|0|||
16790753|NCT02625259|37731436|FG004|First Intervention (Day 1)|Adverse Event|0|||
16790754|NCT02625259|37731432|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
16790755|NCT02625259|37731433|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
16790756|NCT02625259|37731434|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16790757|NCT02625259|37731435|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
16790758|NCT02625259|37731436|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
16790759|NCT02577107|37731453|FG000|Overall Study|Protocol deviation|0|||
16790760|NCT02577107|37731454|FG001|Overall Study|Protocol deviation|1|||
16790761|NCT02444793|37731464|FG000|Overall Study|Lost to Follow-up|2|||
16790762|NCT02444793|37731465|FG001|Overall Study|Lost to Follow-up|2|||
16790763|NCT02444793|37731466|FG002|Overall Study|Lost to Follow-up|0|||
16790764|NCT02444793|37731467|FG003|Overall Study|Lost to Follow-up|0|||
16790765|NCT02444793|37731464|FG000|Overall Study|Death|0|||
16790766|NCT02444793|37731465|FG001|Overall Study|Death|3|||
16790767|NCT02444793|37731466|FG002|Overall Study|Death|0|||
16790768|NCT02444793|37731467|FG003|Overall Study|Death|0|||
16790769|NCT02444793|37731464|FG000|Overall Study|Other|0|||
16790770|NCT02444793|37731465|FG001|Overall Study|Other|0|||
16790771|NCT02444793|37731466|FG002|Overall Study|Other|2|||
16790772|NCT02444793|37731467|FG003|Overall Study|Other|0|||
16790773|NCT02444793|37731464|FG000|Overall Study|Objective progression or relapse|9|||
16790774|NCT02444793|37731465|FG001|Overall Study|Objective progression or relapse|1|||
16790775|NCT02444793|37731466|FG002|Overall Study|Objective progression or relapse|2|||
16790776|NCT02444793|37731467|FG003|Overall Study|Objective progression or relapse|3|||
16790777|NCT02624713|37731480|FG000|Overall Study|Lost to Follow-up|14|||
16790778|NCT02624713|37731481|FG001|Overall Study|Lost to Follow-up|0|||
16790779|NCT02624791|37731488|FG000|Overall Study|Withdrawal by Subject|2|||
16790780|NCT02624791|37731489|FG001|Overall Study|Withdrawal by Subject|0|||
16790781|NCT02624791|37731490|FG002|Overall Study|Withdrawal by Subject|0|||
16790782|NCT02624791|37731491|FG003|Overall Study|Withdrawal by Subject|0|||
16790783|NCT02624791|37731492|FG004|Overall Study|Withdrawal by Subject|0|||
16790784|NCT02624791|37731493|FG005|Overall Study|Withdrawal by Subject|0|||
16790785|NCT02577029|37731505|FG000|Overall Study|Adverse Event|1|||
16790786|NCT02577029|37731506|FG001|Overall Study|Adverse Event|0|||
16790787|NCT02577029|37731507|FG002|Overall Study|Adverse Event|2|||
16790788|NCT02577029|37731508|FG003|Overall Study|Adverse Event|0|||
16790789|NCT02577029|37731509|FG004|Overall Study|Adverse Event|1|||
16790790|NCT02577029|37731510|FG005|Overall Study|Adverse Event|0|||
16790791|NCT02577029|37731511|FG006|Overall Study|Adverse Event|0|||
16790792|NCT02577029|37731512|FG007|Overall Study|Adverse Event|0|||
16790793|NCT02577029|37731505|FG000|Overall Study|Withdrawal by Subject|0|||
16790794|NCT02577029|37731506|FG001|Overall Study|Withdrawal by Subject|0|||
16790795|NCT02577029|37731507|FG002|Overall Study|Withdrawal by Subject|0|||
16790796|NCT02577029|37731508|FG003|Overall Study|Withdrawal by Subject|0|||
16790797|NCT02577029|37731509|FG004|Overall Study|Withdrawal by Subject|0|||
16790798|NCT02577029|37731510|FG005|Overall Study|Withdrawal by Subject|1|||
16790799|NCT02577029|37731511|FG006|Overall Study|Withdrawal by Subject|0|||
16790800|NCT02577029|37731512|FG007|Overall Study|Withdrawal by Subject|0|||
16790801|NCT02577029|37731505|FG000|Overall Study|Sponsor Termination of the Study|9|||
16790802|NCT02577029|37731506|FG001|Overall Study|Sponsor Termination of the Study|2|||
16790803|NCT02577029|37731507|FG002|Overall Study|Sponsor Termination of the Study|5|||
16790804|NCT02577029|37731508|FG003|Overall Study|Sponsor Termination of the Study|12|||
16790805|NCT02577029|37731509|FG004|Overall Study|Sponsor Termination of the Study|10|||
16790806|NCT02577029|37731510|FG005|Overall Study|Sponsor Termination of the Study|12|||
16790807|NCT02577029|37731511|FG006|Overall Study|Sponsor Termination of the Study|12|||
16790808|NCT02577029|37731512|FG007|Overall Study|Sponsor Termination of the Study|12|||
16790809|NCT02577887|37731530|FG000|Overall Study|Death|93|||
16790810|NCT02577887|37731530|FG000|Overall Study|Protocol Violation|125|||
16790811|NCT02577887|37731530|FG000|Overall Study|Withdrawal by Subject|80|||
16790812|NCT03597347|37731537|FG000|Overall Study|Withdrawal by Subject|1|||
16790813|NCT03597347|37731538|FG001|Overall Study|Withdrawal by Subject|1|||
16790814|NCT03597347|37731539|FG002|Overall Study|Withdrawal by Subject|0|||
16790815|NCT03597347|37731537|FG000|Overall Study|Withdrawal due to Covid-19|3|||
16790816|NCT03597347|37731538|FG001|Overall Study|Withdrawal due to Covid-19|0|||
16790817|NCT03597347|37731539|FG002|Overall Study|Withdrawal due to Covid-19|0|||
16790818|NCT03597347|37731537|FG000|Overall Study|Sponsor decision to terminate study|3|||
16790819|NCT03597347|37731538|FG001|Overall Study|Sponsor decision to terminate study|2|||
16790820|NCT03597347|37731539|FG002|Overall Study|Sponsor decision to terminate study|4|||
16790821|NCT02576951|37731551|FG000|Overall Study|Lost to Follow-up|0|||
16790822|NCT02576951|37731552|FG001|Overall Study|Lost to Follow-up|0|||
16790823|NCT02576951|37731553|FG002|Overall Study|Lost to Follow-up|2|||
16790824|NCT02576951|37731554|FG003|Overall Study|Lost to Follow-up|2|||
16790825|NCT02576951|37731551|FG000|Overall Study|Withdrawal by Subject|1|||
16790826|NCT02576951|37731552|FG001|Overall Study|Withdrawal by Subject|0|||
16790827|NCT02576951|37731553|FG002|Overall Study|Withdrawal by Subject|0|||
16790828|NCT02576951|37731554|FG003|Overall Study|Withdrawal by Subject|2|||
16790829|NCT02576951|37731551|FG000|Overall Study|Protocol Violation|0|||
16790830|NCT02576951|37731552|FG001|Overall Study|Protocol Violation|0|||
16790831|NCT02576951|37731553|FG002|Overall Study|Protocol Violation|0|||
16790832|NCT02576951|37731554|FG003|Overall Study|Protocol Violation|1|||
16790833|NCT02621047|37731569|FG000|Overall Study|Adverse Event|0|||
16790834|NCT02621047|37731570|FG001|Overall Study|Adverse Event|0|||
16790835|NCT02621047|37731571|FG002|Overall Study|Adverse Event|1|||
16790836|NCT02443155|37731584|FG000|Overall Study|Adverse Event|3|||
16790837|NCT02443155|37731585|FG001|Overall Study|Adverse Event|4|||
16790838|NCT02443155|37731586|FG002|Overall Study|Adverse Event|1|||
16790839|NCT02443155|37731587|FG003|Overall Study|Adverse Event|2|||
16790840|NCT02443155|37731584|FG000|Overall Study|Unclassified|0|||
16790841|NCT02443155|37731585|FG001|Overall Study|Unclassified|0|||
16790842|NCT02443155|37731586|FG002|Overall Study|Unclassified|2|||
16790843|NCT02443155|37731587|FG003|Overall Study|Unclassified|1|||
16790844|NCT02443155|37731584|FG000|Overall Study|Withdrawal by Subject|4|||
16790845|NCT02443155|37731585|FG001|Overall Study|Withdrawal by Subject|7|||
16790846|NCT02443155|37731586|FG002|Overall Study|Withdrawal by Subject|3|||
16790847|NCT02443155|37731587|FG003|Overall Study|Withdrawal by Subject|9|||
16790848|NCT02443155|37731584|FG000|Overall Study|Pregnancy|3|||
16790849|NCT02443155|37731585|FG001|Overall Study|Pregnancy|1|||
16790850|NCT02443155|37731586|FG002|Overall Study|Pregnancy|1|||
16790851|NCT02443155|37731587|FG003|Overall Study|Pregnancy|2|||
16790852|NCT02443155|37731584|FG000|Overall Study|Lost to Follow-up|1|||
16790853|NCT02443155|37731585|FG001|Overall Study|Lost to Follow-up|2|||
17016395|NCT00856544|38161015|FG001|Overall Study|Withdrawal by Subject|5|||
17016396|NCT00856544|38161016|FG002|Overall Study|Withdrawal by Subject|0|||
16790854|NCT02443155|37731586|FG002|Overall Study|Lost to Follow-up|0|||
16790855|NCT02443155|37731587|FG003|Overall Study|Lost to Follow-up|1|||
16790856|NCT02443155|37731584|FG000|Overall Study|Protocol Violation|1|||
16790857|NCT02443155|37731585|FG001|Overall Study|Protocol Violation|0|||
16790858|NCT02443155|37731586|FG002|Overall Study|Protocol Violation|1|||
16790859|NCT02443155|37731587|FG003|Overall Study|Protocol Violation|1|||
16790860|NCT02443155|37731584|FG000|Overall Study|Death|0|||
16790861|NCT02443155|37731585|FG001|Overall Study|Death|0|||
16790862|NCT02443155|37731586|FG002|Overall Study|Death|1|||
16790863|NCT02443155|37731587|FG003|Overall Study|Death|0|||
16790864|NCT02460159|37731600|FG000|Overall Study|Adverse Event|4|||
16790865|NCT02460159|37731601|FG001|Overall Study|Adverse Event|1|||
16790866|NCT02460159|37731600|FG000|Overall Study|Withdrawal by Subject|2|||
16790867|NCT02460159|37731601|FG001|Overall Study|Withdrawal by Subject|0|||
16790868|NCT02498067|37731607|FG000|Overall Study|Lost to Follow-up|22|||
16790869|NCT02498067|37731607|FG000|Overall Study|Did not meet inclusion criteria|11|||
16790870|NCT02497755|37731615|FG000|Overall Study|Protocol Violation|1|||
16790871|NCT02497755|37731616|FG001|Overall Study|Protocol Violation|0|||
16790872|NCT02619175|37731625|FG000|Overall Study|Withdrawal by Subject|1|||
16790873|NCT02619175|37731626|FG001|Overall Study|Withdrawal by Subject|0|||
16790874|NCT02619175|37731625|FG000|Overall Study|foot pain|1|||
16790875|NCT02619175|37731626|FG001|Overall Study|foot pain|0|||
16790876|NCT01360021|37731643|FG000|Overall Study|Eligibility criteria + other|2|||
16790877|NCT01360021|37731644|FG001|Overall Study|Eligibility criteria + other|1|||
16790878|NCT01360021|37731645|FG002|Overall Study|Eligibility criteria + other|1|||
16790879|NCT01360021|37731643|FG000|Overall Study|Protocol Violation|0|||
16790880|NCT01360021|37731644|FG001|Overall Study|Protocol Violation|0|||
16790881|NCT01360021|37731645|FG002|Overall Study|Protocol Violation|1|||
16790882|NCT01360021|37731643|FG000|Overall Study|Withdrawal by Subject|4|||
16790883|NCT01360021|37731644|FG001|Overall Study|Withdrawal by Subject|0|||
16790884|NCT01360021|37731645|FG002|Overall Study|Withdrawal by Subject|2|||
16790885|NCT01360021|37731643|FG000|Overall Study|Adverse Event|2|||
16790886|NCT01360021|37731644|FG001|Overall Study|Adverse Event|3|||
16790887|NCT01360021|37731645|FG002|Overall Study|Adverse Event|3|||
16790888|NCT02497287|37731662|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
16790889|NCT02497287|37731662|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
16790890|NCT02497287|37731662|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
16790891|NCT02497287|37731662|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
16790892|NCT02497287|37731662|FG000|Induction Phase (4 Weeks)|Other|13|||
16790893|NCT02497287|37731662|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
16790894|NCT02497287|37731662|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
16790895|NCT02497287|37731662|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
16790896|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
16790897|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
16790898|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
16790899|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
16790900|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
16790901|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
16790902|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
16790903|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
16790904|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
16790905|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
16790906|NCT02497287|37731662|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
16790907|NCT02497287|37731662|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
16790908|NCT02497287|37731662|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
16790909|NCT02497287|37731662|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
16790910|NCT02497287|37731662|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
16790911|NCT02497287|37731662|FG000|Follow-up Phase (4 Week)|Other|1|||
16790912|NCT02458287|37731672|FG000|Overall Study|Adverse Event|0|||
16790913|NCT02458287|37731673|FG001|Overall Study|Adverse Event|0|||
16790914|NCT02458287|37731674|FG002|Overall Study|Adverse Event|0|||
16790915|NCT02458287|37731675|FG003|Overall Study|Adverse Event|1|||
16790916|NCT02458287|37731672|FG000|Overall Study|Lost to Follow-up|0|||
16790917|NCT02458287|37731673|FG001|Overall Study|Lost to Follow-up|1|||
16790918|NCT02458287|37731674|FG002|Overall Study|Lost to Follow-up|1|||
16790919|NCT02458287|37731675|FG003|Overall Study|Lost to Follow-up|0|||
16790920|NCT02458287|37731672|FG000|Overall Study|Protocol Violation|0|||
16790921|NCT02458287|37731673|FG001|Overall Study|Protocol Violation|1|||
16790922|NCT02458287|37731674|FG002|Overall Study|Protocol Violation|0|||
16790923|NCT02458287|37731675|FG003|Overall Study|Protocol Violation|0|||
16790924|NCT02458287|37731672|FG000|Overall Study|Withdrawal by Subject|0|||
16790925|NCT02458287|37731673|FG001|Overall Study|Withdrawal by Subject|2|||
16790926|NCT02458287|37731674|FG002|Overall Study|Withdrawal by Subject|2|||
16790927|NCT02458287|37731675|FG003|Overall Study|Withdrawal by Subject|1|||
16790928|NCT02458287|37731672|FG000|Overall Study|Relocated Out of State|0|||
16790929|NCT02458287|37731673|FG001|Overall Study|Relocated Out of State|0|||
16790930|NCT02458287|37731674|FG002|Overall Study|Relocated Out of State|0|||
16790931|NCT02458287|37731675|FG003|Overall Study|Relocated Out of State|1|||
16908739|NCT01731600|38017475|FG000|Overall Study|Other reasons|3|||
16790932|NCT02441517|37731691|FG000|Overall Study|Lost to Follow-up|1|||
16790933|NCT02441517|37731691|FG000|Overall Study|Withdrawal by Subject|2|||
16790934|NCT02441517|37731691|FG000|Overall Study|Study Terminated by Sponsor|1|||
16790935|NCT02457819|37731695|FG000|Overall Study|reason not given|8|||
16790936|NCT02457819|37731695|FG000|Overall Study|Withdrawal by Subject|24|||
16790937|NCT02457819|37731695|FG000|Overall Study|Protocol Violation|1|||
16790938|NCT02457819|37731695|FG000|Overall Study|non compliance with study drug|4|||
16790939|NCT02457819|37731695|FG000|Overall Study|Lost to Follow-up|10|||
16790940|NCT02457819|37731695|FG000|Overall Study|Lack of Efficacy|19|||
16790941|NCT02457819|37731695|FG000|Overall Study|Adverse Event|33|||
16790942|NCT02496039|37731699|FG000|Overall Study|Adverse Event|3|||
16790943|NCT02496039|37731699|FG000|Overall Study|Protocol Violation|1|||
16790944|NCT02441283|37731703|FG000|Overall Study|Withdrew consent|15|||
16790945|NCT02441283|37731703|FG000|Overall Study|Lost to Follow-up|42|||
16790946|NCT02441283|37731703|FG000|Overall Study|Death|1|||
16790947|NCT02441283|37731703|FG000|Overall Study|Other, not specified|32|||
16790948|NCT02495883|37731709|FG000|Overall Study|Excessive head motion|1|||
16790949|NCT02495883|37731710|FG001|Overall Study|Excessive head motion|0|||
16790950|NCT02495025|37731717|FG000|Overall Study|Lost to Follow-up|21|||
16790951|NCT02495025|37731718|FG001|Overall Study|Lost to Follow-up|14|||
16790952|NCT02495025|37731717|FG000|Overall Study|Withdrawal by Subject|5|||
16790953|NCT02495025|37731718|FG001|Overall Study|Withdrawal by Subject|0|||
16790954|NCT02439957|37731726|FG000|Overall Study|Study Terminated|3|||
16790955|NCT02439957|37731727|FG001|Overall Study|Study Terminated|3|||
16790956|NCT02494401|37731735|FG000|Overall Study|Lost to Follow-up|22|||
16790957|NCT02494401|37731736|FG001|Overall Study|Lost to Follow-up|25|||
16790958|NCT02494401|37731735|FG000|Overall Study|Withdrawal by Subject|3|||
16790959|NCT02494401|37731736|FG001|Overall Study|Withdrawal by Subject|2|||
16790960|NCT02457195|37731742|FG000|Overall Study|Adverse Event|3|||
16790961|NCT02457195|37731742|FG000|Overall Study|Protocol Violation|2|||
16790962|NCT02457195|37731742|FG000|Overall Study|Withdrawal by Subject|4|||
16790963|NCT02456727|37731748|FG000|Overall Study|Lost to Follow-up|63|||
16790964|NCT02456727|37731749|FG001|Overall Study|Lost to Follow-up|65|||
16790965|NCT02456727|37731748|FG000|Overall Study|Death|2|||
16790966|NCT02456727|37731749|FG001|Overall Study|Death|1|||
16790967|NCT02456727|37731748|FG000|Overall Study|Withdrawal by Subject|1|||
16790968|NCT02456727|37731749|FG001|Overall Study|Withdrawal by Subject|10|||
16790969|NCT02456727|37731748|FG000|Overall Study|Never Initiated Treatment|43|||
16790970|NCT02456727|37731749|FG001|Overall Study|Never Initiated Treatment|30|||
16790971|NCT02456103|37731771|FG000|Overall Study|Study Closure|207|||
16790972|NCT02456103|37731771|FG000|Overall Study|Physician Decision|1|||
16790973|NCT02456103|37731771|FG000|Overall Study|Required prohibited medications|5|||
16790974|NCT02456103|37731771|FG000|Overall Study|Protocol Violation|1|||
16790975|NCT02456103|37731771|FG000|Overall Study|Adverse Event|5|||
16790976|NCT02456103|37731771|FG000|Overall Study|Abnormal Laboratory Value|2|||
16790977|NCT02456103|37731771|FG000|Overall Study|Lost to Follow-up|1|||
16790978|NCT02456103|37731771|FG000|Overall Study|Withdrawal by Subject|24|||
16790979|NCT01653327|37731775|FG000|Overall Study|Withdrawal by Subject|1|||
16790980|NCT02493855|37731784|FG000|Overall Study|Non-compliance|1|||
16790981|NCT02493855|37731785|FG001|Overall Study|Non-compliance|0|||
16790982|NCT02493855|37731786|FG002|Overall Study|Non-compliance|0|||
16790983|NCT02493855|37731784|FG000|Overall Study|Adverse Event|0|||
16790984|NCT02493855|37731785|FG001|Overall Study|Adverse Event|1|||
16790985|NCT02493855|37731786|FG002|Overall Study|Adverse Event|0|||
16790986|NCT02493855|37731784|FG000|Overall Study|Withdrawal by Subject|1|||
16790987|NCT02493855|37731785|FG001|Overall Study|Withdrawal by Subject|0|||
16790988|NCT02493855|37731786|FG002|Overall Study|Withdrawal by Subject|0|||
16790989|NCT02438787|37731797|FG000|Overall Study|Adverse Event|1|||
16790990|NCT02438787|37731798|FG001|Overall Study|Adverse Event|0|||
16790991|NCT02438787|37731799|FG002|Overall Study|Adverse Event|2|||
16790992|NCT02438787|37731797|FG000|Overall Study|Lack of Efficacy|1|||
17016397|NCT00856544|38161017|FG003|Overall Study|Withdrawal by Subject|1|||
17016398|NCT00856388|38161039|FG000|Overall Study|Other|1|||
16790993|NCT02438787|37731798|FG001|Overall Study|Lack of Efficacy|2|||
16790994|NCT02438787|37731799|FG002|Overall Study|Lack of Efficacy|0|||
16790995|NCT02438787|37731797|FG000|Overall Study|Lost to Follow-up|0|||
16790996|NCT02438787|37731798|FG001|Overall Study|Lost to Follow-up|1|||
16790997|NCT02438787|37731799|FG002|Overall Study|Lost to Follow-up|0|||
16790998|NCT02438787|37731797|FG000|Overall Study|Protocol Violation|0|||
16790999|NCT02438787|37731798|FG001|Overall Study|Protocol Violation|0|||
16791000|NCT02438787|37731799|FG002|Overall Study|Protocol Violation|1|||
16791001|NCT02438787|37731797|FG000|Overall Study|Withdrawal by Subject|15|||
16791002|NCT02438787|37731798|FG001|Overall Study|Withdrawal by Subject|7|||
17016399|NCT00848354|38161046|FG000|Phase 1|Adverse Event|5|||
16791003|NCT02438787|37731799|FG002|Overall Study|Withdrawal by Subject|10|||
16791004|NCT02438787|37731797|FG000|Overall Study|Study discontinued by sponsor|64|||
16791005|NCT02438787|37731798|FG001|Overall Study|Study discontinued by sponsor|72|||
16791006|NCT02438787|37731799|FG002|Overall Study|Study discontinued by sponsor|69|||
16791007|NCT02438787|37731797|FG000|Overall Study|Other|0|||
16791008|NCT02438787|37731798|FG001|Overall Study|Other|1|||
16791009|NCT02438787|37731799|FG002|Overall Study|Other|0|||
16791010|NCT02438787|37731797|FG000|Overall Study|Site terminated by sponsor|0|||
16791011|NCT02438787|37731798|FG001|Overall Study|Site terminated by sponsor|0|||
16791012|NCT02438787|37731799|FG002|Overall Study|Site terminated by sponsor|1|||
16791013|NCT02493777|37731814|FG000|Overall Study|Lost to Follow-up|0|||
16791014|NCT02493777|37731815|FG001|Overall Study|Lost to Follow-up|1|||
16791016|NCT02616601|37731828|FG000|Overall Study|Withdrawal by Subject|4|||
16791017|NCT02616601|37731829|FG001|Overall Study|Withdrawal by Subject|4|||
16791018|NCT02616601|37731830|FG002|Overall Study|Withdrawal by Subject|3|||
16791019|NCT02616601|37731828|FG000|Overall Study|Adverse Event|2|||
16791020|NCT02616601|37731829|FG001|Overall Study|Adverse Event|0|||
16791021|NCT02616601|37731830|FG002|Overall Study|Adverse Event|2|||
16791022|NCT02616601|37731828|FG000|Overall Study|Death|1|||
16791023|NCT02616601|37731829|FG001|Overall Study|Death|0|||
16791024|NCT02616601|37731830|FG002|Overall Study|Death|0|||
16791025|NCT02616601|37731828|FG000|Overall Study|Lost to Follow-up|1|||
16791026|NCT02616601|37731829|FG001|Overall Study|Lost to Follow-up|0|||
16791027|NCT02616601|37731830|FG002|Overall Study|Lost to Follow-up|1|||
16791028|NCT02616601|37731828|FG000|Overall Study|Non-Compliance with Test Article|1|||
16791029|NCT02616601|37731829|FG001|Overall Study|Non-Compliance with Test Article|0|||
16791030|NCT02616601|37731830|FG002|Overall Study|Non-Compliance with Test Article|1|||
16791031|NCT02492997|37731840|FG000|Overall Study|Withdrawal by Subject|1|||
16791032|NCT02492997|37731841|FG001|Overall Study|Withdrawal by Subject|0|||
16791033|NCT02492997|37731840|FG000|Overall Study|Gained Weight|1|||
16791034|NCT02492997|37731841|FG001|Overall Study|Gained Weight|0|||
16791035|NCT02492997|37731840|FG000|Overall Study|Lost to Follow-up|0|||
16791036|NCT02492997|37731841|FG001|Overall Study|Lost to Follow-up|1|||
16791037|NCT02437305|37731849|FG000|Overall Study|Lost to Follow-up|18|||
16791038|NCT02437305|37731850|FG001|Overall Study|Lost to Follow-up|12|||
16791039|NCT02492841|37731859|FG000|Overall Study|Lost to Follow-up|34|||
16791040|NCT02492841|37731860|FG001|Overall Study|Lost to Follow-up|31|||
16791041|NCT02492841|37731861|FG002|Overall Study|Lost to Follow-up|35|||
16791042|NCT02436915|37731874|FG000|Overall Study|Withdrawal by Subject|0|||
16791043|NCT02436915|37731875|FG001|Overall Study|Withdrawal by Subject|1|||
16791044|NCT02492763|37731887|FG000|Overall Study|Withdrawal by Subject|0|||
16791045|NCT02492763|37731888|FG001|Overall Study|Withdrawal by Subject|2|||
16791046|NCT02492763|37731889|FG002|Overall Study|Withdrawal by Subject|1|||
16791047|NCT02492763|37731890|FG003|Overall Study|Withdrawal by Subject|0|||
16791048|NCT02492763|37731887|FG000|Overall Study|Adverse Event|3|||
16791049|NCT02492763|37731888|FG001|Overall Study|Adverse Event|1|||
16791050|NCT02492763|37731889|FG002|Overall Study|Adverse Event|1|||
16791051|NCT02492763|37731890|FG003|Overall Study|Adverse Event|2|||
16791052|NCT02492763|37731887|FG000|Overall Study|Death|0|||
16791053|NCT02492763|37731888|FG001|Overall Study|Death|0|||
16791054|NCT02492763|37731889|FG002|Overall Study|Death|1|||
16791055|NCT02492763|37731890|FG003|Overall Study|Death|0|||
16791056|NCT02492763|37731887|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
16791057|NCT02492763|37731888|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
16791058|NCT02492763|37731889|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
16791059|NCT02492763|37731890|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
16791060|NCT02492763|37731887|FG000|Overall Study|Lost to Follow-up|0|||
16791061|NCT02492763|37731888|FG001|Overall Study|Lost to Follow-up|0|||
16791062|NCT02492763|37731889|FG002|Overall Study|Lost to Follow-up|1|||
16791063|NCT02492763|37731890|FG003|Overall Study|Lost to Follow-up|0|||
16791064|NCT02492763|37731887|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16791065|NCT02492763|37731888|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16791066|NCT02492763|37731889|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16791067|NCT02492763|37731890|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16791068|NCT02492763|37731887|FG000|Overall Study|Screen Failure|0|||
16791069|NCT02492763|37731888|FG001|Overall Study|Screen Failure|0|||
16791070|NCT02492763|37731889|FG002|Overall Study|Screen Failure|0|||
16791071|NCT02492763|37731890|FG003|Overall Study|Screen Failure|1|||
16791072|NCT02492763|37731887|FG000|Overall Study|Study Terminated by Sponsor|13|||
16791073|NCT02492763|37731888|FG001|Overall Study|Study Terminated by Sponsor|10|||
16791074|NCT02492763|37731889|FG002|Overall Study|Study Terminated by Sponsor|6|||
16791075|NCT02492763|37731890|FG003|Overall Study|Study Terminated by Sponsor|10|||
16791076|NCT02491671|37731911|FG000|Overall Study|Adverse Event|6|||
16791077|NCT02491671|37731912|FG001|Overall Study|Adverse Event|8|||
16791078|NCT02491671|37731911|FG000|Overall Study|Death|0|||
16791079|NCT02491671|37731912|FG001|Overall Study|Death|2|||
16791080|NCT02491671|37731911|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
16791081|NCT02491671|37731912|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
16791082|NCT02453841|37731918|FG000|Overall Study|Protocol Violation|1|||
16791083|NCT02453841|37731918|FG000|Overall Study|Unable to obtain blood samples|2|||
16791084|NCT02453685|37731924|FG000|Overall Study|Adverse Event|0|||
16791085|NCT02453685|37731925|FG001|Overall Study|Adverse Event|1|||
16791086|NCT02453685|37731924|FG000|Overall Study|Protocol Violation|7|||
16791087|NCT02453685|37731925|FG001|Overall Study|Protocol Violation|4|||
16791088|NCT02453685|37731924|FG000|Overall Study|Lost to Follow-up|0|||
16791089|NCT02453685|37731925|FG001|Overall Study|Lost to Follow-up|1|||
16791090|NCT02453685|37731924|FG000|Overall Study|Withdrawal by Subject|8|||
16791091|NCT02453685|37731925|FG001|Overall Study|Withdrawal by Subject|4|||
16791092|NCT02453685|37731924|FG000|Overall Study|Unclassified|4|||
16791093|NCT02453685|37731925|FG001|Overall Study|Unclassified|2|||
16791094|NCT02436759|37731933|FG000|Overall Study|Adverse Event|3|||
16791095|NCT02436759|37731934|FG001|Overall Study|Adverse Event|0|||
16791096|NCT02436759|37731933|FG000|Overall Study|Protocol Violation|1|||
16791097|NCT02436759|37731934|FG001|Overall Study|Protocol Violation|0|||
16791098|NCT02436759|37731933|FG000|Overall Study|Withdrawal by Subject|0|||
16791099|NCT02436759|37731934|FG001|Overall Study|Withdrawal by Subject|1|||
16791100|NCT02436681|37731940|FG000|Overall Study|Lost to Follow-up|10|||
16791101|NCT02436681|37731940|FG000|Overall Study|Withdrawal by Subject|2|||
16791102|NCT02436681|37731940|FG000|Overall Study|Death|2|||
16791103|NCT02436135|37731946|FG000|Overall Study|Progressive Disease|3|||
16791104|NCT02436135|37731947|FG001|Overall Study|Progressive Disease|1|||
16791105|NCT02436135|37731946|FG000|Overall Study|Investigator Discretion|1|||
16791106|NCT02436135|37731947|FG001|Overall Study|Investigator Discretion|2|||
16791107|NCT02436135|37731946|FG000|Overall Study|Adverse Event|1|||
16791108|NCT02436135|37731947|FG001|Overall Study|Adverse Event|0|||
16791109|NCT02436135|37731946|FG000|Overall Study|Withdrawal by Participant|1|||
16791110|NCT02436135|37731947|FG001|Overall Study|Withdrawal by Participant|0|||
16791111|NCT02436135|37731946|FG000|Overall Study|Study Terminated By Sponsor|0|||
16791112|NCT02436135|37731947|FG001|Overall Study|Study Terminated By Sponsor|1|||
16791113|NCT02489799|37731955|FG000|Overall Study|Lost to Follow-up|4|||
16791114|NCT02489799|37731956|FG001|Overall Study|Lost to Follow-up|1|||
16791115|NCT02489799|37731955|FG000|Overall Study|Failure to Maintain Eligibility|4|||
16791116|NCT02489799|37731956|FG001|Overall Study|Failure to Maintain Eligibility|6|||
16791117|NCT02489799|37731955|FG000|Overall Study|Withdrawal by Subject|1|||
16791118|NCT02489799|37731956|FG001|Overall Study|Withdrawal by Subject|1|||
16791119|NCT02489799|37731955|FG000|Overall Study|Death|0|||
16791120|NCT02489799|37731956|FG001|Overall Study|Death|1|||
16791121|NCT02435277|37731966|FG000|Overall Study|Adverse Event|1|||
16791122|NCT02435277|37731967|FG001|Overall Study|Adverse Event|1|||
16791123|NCT02435277|37731968|FG002|Overall Study|Adverse Event|0|||
16791124|NCT02435277|37731969|FG003|Overall Study|Adverse Event|0|||
16791125|NCT02435277|37731966|FG000|Overall Study|Withdrawal by Subject|1|||
16791126|NCT02435277|37731967|FG001|Overall Study|Withdrawal by Subject|0|||
16791127|NCT02435277|37731968|FG002|Overall Study|Withdrawal by Subject|0|||
16791128|NCT02435277|37731969|FG003|Overall Study|Withdrawal by Subject|0|||
16791129|NCT02420223|37731981|FG000|Overall Study|Adverse Event|1|||
16791130|NCT02420223|37731982|FG001|Overall Study|Adverse Event|0|||
16791131|NCT02420223|37731981|FG000|Overall Study|Physician Decision|0|||
16791132|NCT02420223|37731982|FG001|Overall Study|Physician Decision|2|||
16791133|NCT02433483|37731988|FG000|Overall Study|Unacceptable toxicity|1|||
16791134|NCT02433483|37731988|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
16791135|NCT02419755|37731994|FG000|Overall Study|Death|1|||
16791136|NCT02419755|37731995|FG001|Overall Study|Death|3|||
16791137|NCT02419755|37731994|FG000|Overall Study|Relapse|0|||
16791138|NCT02419755|37731995|FG001|Overall Study|Relapse|1|||
16791139|NCT02419755|37731994|FG000|Overall Study|Ineligible|1|||
16791140|NCT02419755|37731995|FG001|Overall Study|Ineligible|0|||
16791141|NCT02419755|37731994|FG000|Overall Study|Withdrawal by Subject|1|||
16791142|NCT02419755|37731995|FG001|Overall Study|Withdrawal by Subject|0|||
16791143|NCT02488551|37732005|FG000|Overall Study|Lost to Follow-up|4|||
16791144|NCT02488551|37732006|FG001|Overall Study|Lost to Follow-up|7|||
16791145|NCT02488551|37732007|FG002|Overall Study|Lost to Follow-up|0|||
16791146|NCT02488551|37732008|FG003|Overall Study|Lost to Follow-up|0|||
16791147|NCT02488551|37732005|FG000|Overall Study|Military Deployment|1|||
16791148|NCT02488551|37732006|FG001|Overall Study|Military Deployment|1|||
16791149|NCT02488551|37732007|FG002|Overall Study|Military Deployment|0|||
16791150|NCT02488551|37732008|FG003|Overall Study|Military Deployment|0|||
16791151|NCT02488239|37732018|FG000|Overall Study|Death|3|||
16791152|NCT02488239|37732018|FG000|Overall Study|Withdrawal by Subject|3|||
16791153|NCT02488239|37732018|FG000|Overall Study|Physician Decision|2|||
16791154|NCT02488239|37732018|FG000|Overall Study|Consent ineligible|1|||
16791155|NCT02488239|37732018|FG000|Overall Study|Did not undergo implant procedure|1|||
16791156|NCT02488005|37732023|FG000|Overall Study|Lost to Follow-up|2|||
16791157|NCT02487771|37732029|FG000|Overall Study|Lost to Follow-up|2|||
16908740|NCT01731600|38017476|FG001|Overall Study|Other reasons|0|||
16908741|NCT01730586|38017486|FG000|Overall Study|Progressive Disease|2|||
16791158|NCT02487771|37732030|FG001|Overall Study|Lost to Follow-up|3|||
16791159|NCT02487771|37732029|FG000|Overall Study|Moved out of area|5|||
16791160|NCT02487771|37732030|FG001|Overall Study|Moved out of area|6|||
16791161|NCT02487771|37732029|FG000|Overall Study|Withdrawal by Subject|3|||
16791162|NCT02487771|37732030|FG001|Overall Study|Withdrawal by Subject|5|||
16908742|NCT01730586|38017486|FG000|Overall Study|Inadequate Trial|8|||
16791163|NCT01359943|37732039|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
16791164|NCT01359943|37732040|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
16791165|NCT01359943|37732041|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
16791166|NCT01359943|37732039|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
16791167|NCT01359943|37732040|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
16791168|NCT01359943|37732041|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
16791169|NCT01359943|37732039|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
16791170|NCT01359943|37732040|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
16791171|NCT01359943|37732041|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
16791172|NCT01359943|37732039|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
16791173|NCT01359943|37732040|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
16791174|NCT01359943|37732041|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
16791175|NCT01359943|37732039|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
16791176|NCT01359943|37732040|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
16791177|NCT01359943|37732041|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
16791178|NCT01359943|37732039|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
16791179|NCT01359943|37732040|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
16791180|NCT01359943|37732041|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
16791181|NCT01359943|37732039|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
16791182|NCT01359943|37732040|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
16791183|NCT01359943|37732041|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
16791184|NCT01359943|37732039|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
16791185|NCT01359943|37732040|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
16791186|NCT01359943|37732041|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
16791187|NCT01359943|37732039|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
16791188|NCT01359943|37732040|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
16791189|NCT01359943|37732041|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
16791190|NCT01359943|37732039|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
16791191|NCT01359943|37732040|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
16791192|NCT01359943|37732041|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
16791193|NCT01359943|37732039|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
16791194|NCT01359943|37732040|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
16791195|NCT01359943|37732041|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
16791196|NCT01359943|37732039|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
16791197|NCT01359943|37732040|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
16791198|NCT01359943|37732041|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
16791199|NCT01359943|37732039|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
16791200|NCT01359943|37732040|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
16791201|NCT01359943|37732041|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
16791202|NCT01359943|37732039|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
16791203|NCT01359943|37732040|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
16791204|NCT01359943|37732041|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
16791205|NCT01359943|37732039|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
16791206|NCT01359943|37732040|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
16791207|NCT01359943|37732041|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
16791208|NCT02432703|37732053|FG000|Overall Study|Adverse Event|1|||
16791209|NCT02432703|37732054|FG001|Overall Study|Adverse Event|4|||
16791210|NCT02432703|37732053|FG000|Overall Study|Lack of Efficacy|1|||
16791211|NCT02432703|37732054|FG001|Overall Study|Lack of Efficacy|0|||
16791212|NCT02432703|37732053|FG000|Overall Study|Lost to Follow-up|5|||
16791213|NCT02432703|37732054|FG001|Overall Study|Lost to Follow-up|3|||
16791214|NCT02432703|37732053|FG000|Overall Study|Withdrawal by Subject|9|||
16791215|NCT02432703|37732054|FG001|Overall Study|Withdrawal by Subject|6|||
16791216|NCT02432703|37732053|FG000|Overall Study|Other|6|||
16791217|NCT02432703|37732054|FG001|Overall Study|Other|5|||
16791218|NCT02486757|37732060|FG000|Overall Study|Lost to Follow-up|1|||
16791219|NCT02418819|37732068|FG000|Overall Study|Adverse Event|0|||
16791220|NCT02418819|37732069|FG001|Overall Study|Adverse Event|0|||
16791221|NCT02418819|37732070|FG002|Overall Study|Adverse Event|1|||
16791222|NCT02418819|37732071|FG003|Overall Study|Adverse Event|0|||
16791223|NCT02418819|37732068|FG000|Overall Study|Lost to Follow-up|1|||
16791224|NCT02418819|37732069|FG001|Overall Study|Lost to Follow-up|0|||
16791225|NCT02418819|37732070|FG002|Overall Study|Lost to Follow-up|0|||
16791226|NCT02418819|37732071|FG003|Overall Study|Lost to Follow-up|0|||
17016400|NCT00848354|38161047|FG001|Phase 1|Adverse Event|4|||
17016401|NCT00848354|38161046|FG000|Phase 1|Discontinuation of study by sponsor|2|||
17016402|NCT00848354|38161047|FG001|Phase 1|Discontinuation of study by sponsor|1|||
17016403|NCT00848354|38161046|FG000|Phase 1|Failed to return|0|||
17016404|NCT00848354|38161047|FG001|Phase 1|Failed to return|1|||
17016405|NCT00848354|38161046|FG000|Phase 1|Lost to Follow-up|1|||
16908743|NCT01730586|38017486|FG000|Overall Study|Adverse Event|2|||
17016406|NCT00848354|38161047|FG001|Phase 1|Lost to Follow-up|1|||
17016407|NCT00848354|38161046|FG000|Phase 1|Unspecified Reason|1|||
17016408|NCT00848354|38161047|FG001|Phase 1|Unspecified Reason|1|||
17016409|NCT00848354|38161046|FG000|Phase 1|Protocol Violation|1|||
17016410|NCT00848354|38161047|FG001|Phase 1|Protocol Violation|1|||
17016411|NCT00848354|38161046|FG000|Phase 1|Withdrawal by Subject|2|||
17016412|NCT00848354|38161047|FG001|Phase 1|Withdrawal by Subject|4|||
17016413|NCT00848354|38161046|FG000|Phase 1|Lack of Efficacy|0|||
17016414|NCT00848354|38161047|FG001|Phase 1|Lack of Efficacy|1|||
17016415|NCT00848354|38161046|FG000|Phase 2 Year 1|Adverse Event|7|||
17016416|NCT00848354|38161047|FG001|Phase 2 Year 1|Adverse Event|2|||
17016417|NCT00848354|38161046|FG000|Phase 2 Year 1|Death|1|||
16791227|NCT02418819|37732068|FG000|Overall Study|No longer meets eligibility criteria|0|||
16791228|NCT02418819|37732069|FG001|Overall Study|No longer meets eligibility criteria|0|||
16908744|NCT01730586|38017486|FG000|Overall Study|Hospice|1|||
16908745|NCT01707030|38017494|FG000|Overall Study|Death|1|||
16908746|NCT01707030|38017495|FG001|Overall Study|Death|1|||
16908747|NCT01707030|38017494|FG000|Overall Study|Withdrawal by Subject|2|||
16908748|NCT01707030|38017495|FG001|Overall Study|Withdrawal by Subject|3|||
16908749|NCT01707030|38017494|FG000|Overall Study|Lost to Follow-up|8|||
16908750|NCT01707030|38017495|FG001|Overall Study|Lost to Follow-up|13|||
16908751|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
16908752|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
16908753|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
16908754|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
16791229|NCT02418819|37732070|FG002|Overall Study|No longer meets eligibility criteria|1|||
16791230|NCT02418819|37732071|FG003|Overall Study|No longer meets eligibility criteria|0|||
16791231|NCT02418819|37732068|FG000|Overall Study|No longer willing to participate|0|||
16791232|NCT02418819|37732069|FG001|Overall Study|No longer willing to participate|0|||
16791233|NCT02418819|37732070|FG002|Overall Study|No longer willing to participate|2|||
16791234|NCT02418819|37732071|FG003|Overall Study|No longer willing to participate|1|||
16791235|NCT02576639|37732086|FG000|Overall Study|Withdrawal by Subject|1|||
16791236|NCT02576639|37732087|FG001|Overall Study|Withdrawal by Subject|2|||
16791237|NCT02576639|37732088|FG002|Overall Study|Withdrawal by Subject|1|||
16791238|NCT02576639|37732089|FG003|Overall Study|Withdrawal by Subject|0|||
16791239|NCT02576639|37732090|FG004|Overall Study|Withdrawal by Subject|1|||
16791240|NCT02576639|37732086|FG000|Overall Study|Adverse Event|1|||
16791241|NCT02576639|37732087|FG001|Overall Study|Adverse Event|0|||
16791242|NCT02576639|37732088|FG002|Overall Study|Adverse Event|1|||
16791243|NCT02576639|37732089|FG003|Overall Study|Adverse Event|1|||
16791244|NCT02576639|37732090|FG004|Overall Study|Adverse Event|2|||
16791245|NCT02576639|37732086|FG000|Overall Study|Physician Decision|0|||
16791246|NCT02576639|37732087|FG001|Overall Study|Physician Decision|0|||
16791247|NCT02576639|37732088|FG002|Overall Study|Physician Decision|0|||
16791248|NCT02576639|37732089|FG003|Overall Study|Physician Decision|0|||
16791249|NCT02576639|37732090|FG004|Overall Study|Physician Decision|1|||
16791250|NCT02418585|37732108|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
16791251|NCT02418585|37732109|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
16791252|NCT02418585|37732108|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
16791253|NCT02418585|37732109|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
16791254|NCT02418585|37732108|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
16791255|NCT02418585|37732109|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
16791256|NCT02418585|37732108|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
16791257|NCT02418585|37732109|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
16791258|NCT02418585|37732108|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
16791259|NCT02418585|37732109|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
16791260|NCT02418585|37732108|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
16791261|NCT02418585|37732109|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
16791262|NCT02418585|37732108|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
16791263|NCT02418585|37732109|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
16791264|NCT02418585|37732108|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
16791265|NCT02418585|37732109|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
16791266|NCT02418585|37732108|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
16791267|NCT02418585|37732109|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
16791268|NCT02418585|37732108|FG000|Follow-up Phase (24 Weeks)|Other|3|||
16791269|NCT02418585|37732109|FG001|Follow-up Phase (24 Weeks)|Other|2|||
16791270|NCT02417961|37732117|FG000|Overall Study|Adverse Event|1|||
16791271|NCT02417961|37732117|FG000|Overall Study|Lost to Follow-up|1|||
16791272|NCT02417961|37732117|FG000|Overall Study|Withdrawal by Subject|2|||
16791273|NCT01596127|37732121|FG000|Overall Study|Patient Ineligible|1|||
16791274|NCT01595581|37732136|FG000|Overall Study|Withdrawal by Subject|1|||
16908755|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
16908756|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
16908757|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
17016418|NCT00848354|38161047|FG001|Phase 2 Year 1|Death|0|||
17016419|NCT00848354|38161046|FG000|Phase 2 Year 1|Failed to Return|1|||
16791275|NCT01595581|37732137|FG001|Overall Study|Withdrawal by Subject|0|||
16791276|NCT01610687|37732145|FG000|Overall Study|Lack of Efficacy|26|||
16791277|NCT01610687|37732145|FG000|Overall Study|Adverse Event|18|||
16791278|NCT01610687|37732145|FG000|Overall Study|Moved out of area|6|||
16791279|NCT01610687|37732145|FG000|Overall Study|Withdrawal by Subject|7|||
16791280|NCT01610687|37732145|FG000|Overall Study|Lost to Follow-up|4|||
16791281|NCT01610687|37732145|FG000|Overall Study|Symptom control without study medication|2|||
16791282|NCT01610687|37732145|FG000|Overall Study|Unable to make journey|1|||
16791283|NCT01610687|37732145|FG000|Overall Study|Death|1|||
16791284|NCT01610687|37732145|FG000|Overall Study|Cannabis affecting job|1|||
16791285|NCT01610687|37732145|FG000|Overall Study|Felt more alter without study medication|1|||
16791286|NCT02615509|37732149|FG000|Overall Study|Lost to Follow-up|134|||
16791287|NCT02615509|37732149|FG000|Overall Study|Death|4|||
16791288|NCT02615509|37732149|FG000|Overall Study|Withdrawal by Subject|8|||
16791289|NCT02575079|37732155|FG000|Overall Study|Death|3|||
16791290|NCT02575079|37732156|FG001|Overall Study|Death|0|||
16791291|NCT02575079|37732155|FG000|Overall Study|Withdrawal by Subject|3|||
16791292|NCT02575079|37732156|FG001|Overall Study|Withdrawal by Subject|0|||
16791293|NCT02574845|37732167|FG000|Overall Study|Consent withdrawn further participation|0|||
16791294|NCT02574845|37732168|FG001|Overall Study|Consent withdrawn further participation|0|||
16791295|NCT02574845|37732169|FG002|Overall Study|Consent withdrawn further participation|0|||
16791296|NCT02574845|37732170|FG003|Overall Study|Consent withdrawn further participation|0|||
16791297|NCT02574845|37732171|FG004|Overall Study|Consent withdrawn further participation|1|||
16791298|NCT02574845|37732172|FG005|Overall Study|Consent withdrawn further participation|0|||
16791299|NCT02574845|37732167|FG000|Overall Study|Adverse Event|0|||
16791300|NCT02574845|37732168|FG001|Overall Study|Adverse Event|1|||
16791301|NCT02574845|37732169|FG002|Overall Study|Adverse Event|0|||
16791302|NCT02574845|37732170|FG003|Overall Study|Adverse Event|0|||
16791303|NCT02574845|37732171|FG004|Overall Study|Adverse Event|0|||
16791304|NCT02574845|37732172|FG005|Overall Study|Adverse Event|1|||
16791305|NCT02614183|37732189|FG000|Double Blind Treatment Phase|Adverse Event|10|||
16791306|NCT02614183|37732190|FG001|Double Blind Treatment Phase|Adverse Event|9|||
16791307|NCT02614183|37732191|FG002|Double Blind Treatment Phase|Adverse Event|7|||
16791308|NCT02614183|37732189|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
16791309|NCT02614183|37732190|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
16791310|NCT02614183|37732191|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
16791311|NCT02614183|37732189|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
16791312|NCT02614183|37732190|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
16791313|NCT02614183|37732191|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
16791314|NCT02614183|37732189|FG000|Double Blind Treatment Phase|Physician Decision|7|||
16791315|NCT02614183|37732190|FG001|Double Blind Treatment Phase|Physician Decision|3|||
16791316|NCT02614183|37732191|FG002|Double Blind Treatment Phase|Physician Decision|2|||
16791317|NCT02614183|37732189|FG000|Double Blind Treatment Phase|Pregnancy|2|||
16791318|NCT02614183|37732190|FG001|Double Blind Treatment Phase|Pregnancy|1|||
16791319|NCT02614183|37732191|FG002|Double Blind Treatment Phase|Pregnancy|3|||
16791320|NCT02614183|37732189|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
16791321|NCT02614183|37732190|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
16791322|NCT02614183|37732191|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
16791323|NCT02614183|37732189|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
16791324|NCT02614183|37732190|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
16791325|NCT02614183|37732191|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
16791326|NCT02614183|37732189|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
16791327|NCT02614183|37732190|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
16791328|NCT02614183|37732191|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
16791329|NCT02614183|37732189|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
16791330|NCT02614183|37732190|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
16791331|NCT02614183|37732191|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
16791332|NCT02614183|37732189|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
16791333|NCT02614183|37732190|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
16791334|NCT02614183|37732191|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
16791335|NCT02614183|37732189|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
16791336|NCT02614183|37732190|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
16791337|NCT02614183|37732191|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
17198278|NCT02603120|38351876|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
17198279|NCT02603120|38351877|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
17198280|NCT02603120|38351876|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
17198281|NCT02603120|38351877|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
17198282|NCT02603120|38351876|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
17198283|NCT02603120|38351877|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
17198284|NCT02603120|38351876|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
17198285|NCT02603120|38351877|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
16791338|NCT02614183|37732189|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
16791339|NCT02614183|37732190|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
16791340|NCT02614183|37732191|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
16791341|NCT02612155|37732216|FG000|Overall Study|Death|1|||
16791342|NCT02612155|37732217|FG001|Overall Study|Death|1|||
16791343|NCT02612155|37732216|FG000|Overall Study|Lost to Follow-up|2|||
16791344|NCT02612155|37732217|FG001|Overall Study|Lost to Follow-up|2|||
16791345|NCT02614729|37732225|FG000|Overall Study|Withdrawal by Subject|1|||
16791346|NCT02614729|37732226|FG001|Overall Study|Withdrawal by Subject|0|||
16791347|NCT02613871|37732234|FG000|Overall Study|Death|2|||
16791348|NCT02613871|37732234|FG000|Overall Study|Withdrew Consent|1|||
16791349|NCT05021081|37732240|FG000|Phase 2|Subject enrolled in error|1|||
16791350|NCT05021081|37732241|FG001|Phase 2|Subject enrolled in error|1|||
16791351|NCT05021081|37732242|FG002|Phase 2|Subject enrolled in error|0|||
16791352|NCT02612077|37732258|FG000|Overall Study|Adverse Event|3|||
16791353|NCT02612077|37732258|FG000|Overall Study|Withdrawal by Subject|9|||
16791354|NCT02612077|37732258|FG000|Overall Study|Protocol Violation|28|||
16791355|NCT02612077|37732258|FG000|Overall Study|Lost to Follow-up|20|||
16791356|NCT02612077|37732258|FG000|Overall Study|Death|377|||
16791357|NCT02612077|37732258|FG000|Overall Study|Moved or Changed Medical Team|23|||
16791358|NCT02612077|37732258|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
16791359|NCT02612077|37732258|FG000|Overall Study|Disease Progression|3|||
16791360|NCT02612077|37732258|FG000|Overall Study|Unknown reason|2|||
16791361|NCT02613481|37732265|FG000|Overall Study|Lost to Follow-up|7|||
16791362|NCT02613481|37732265|FG000|Overall Study|Withdrawal by Subject|2|||
16791363|NCT02613403|37732273|FG000|Overall Study|Lost to Follow-up|0|||
16791364|NCT02613403|37732274|FG001|Overall Study|Lost to Follow-up|1|||
16791365|NCT02613403|37732275|FG002|Overall Study|Lost to Follow-up|0|||
16791366|NCT02613403|37732276|FG003|Overall Study|Lost to Follow-up|0|||
16791367|NCT02613403|37732277|FG004|Overall Study|Lost to Follow-up|0|||
16791368|NCT02613403|37732273|FG000|Overall Study|Withdrawal by Subject|2|||
16791369|NCT02613403|37732274|FG001|Overall Study|Withdrawal by Subject|0|||
16791370|NCT02613403|37732275|FG002|Overall Study|Withdrawal by Subject|0|||
16791371|NCT02613403|37732276|FG003|Overall Study|Withdrawal by Subject|0|||
16791372|NCT02613403|37732277|FG004|Overall Study|Withdrawal by Subject|0|||
16791373|NCT02572817|37732289|FG000|Overall Study|Death|6|||
16791374|NCT02572817|37732290|FG001|Overall Study|Death|3|||
16791375|NCT02572817|37732289|FG000|Overall Study|Lost to Follow-up|3|||
16791376|NCT02572817|37732290|FG001|Overall Study|Lost to Follow-up|3|||
16791377|NCT02566109|37732296|FG000|Overall Study|Withdrawal by Subject|1|||
16791378|NCT02566031|37732302|FG000|Overall Study|Patient/guardian decision|14|||
16791379|NCT02566031|37732303|FG001|Overall Study|Patient/guardian decision|7|||
16791380|NCT02566031|37732302|FG000|Overall Study|Protocol deviation|2|||
16791381|NCT02566031|37732303|FG001|Overall Study|Protocol deviation|3|||
16791382|NCT02566031|37732302|FG000|Overall Study|Adverse Event|3|||
16791383|NCT02566031|37732303|FG001|Overall Study|Adverse Event|1|||
16791384|NCT02566031|37732302|FG000|Overall Study|Lost to Follow-up|1|||
16791385|NCT02566031|37732303|FG001|Overall Study|Lost to Follow-up|1|||
16791386|NCT02569853|37732312|FG000|Overall Study|Adverse Event|2|||
16791387|NCT02569853|37732313|FG001|Overall Study|Adverse Event|0|||
16791388|NCT02569853|37732312|FG000|Overall Study|Withdrawal by Subject|3|||
16791389|NCT02569853|37732313|FG001|Overall Study|Withdrawal by Subject|2|||
16791390|NCT02569853|37732312|FG000|Overall Study|Lost to Follow-up|3|||
16791391|NCT02569853|37732313|FG001|Overall Study|Lost to Follow-up|3|||
16791392|NCT02569853|37732312|FG000|Overall Study|Protocol Violation|1|||
16791393|NCT02569853|37732313|FG001|Overall Study|Protocol Violation|1|||
16791394|NCT02569853|37732312|FG000|Overall Study|Did not experience migraine attack|10|||
16791395|NCT02569853|37732313|FG001|Overall Study|Did not experience migraine attack|7|||
16791396|NCT02569853|37732312|FG000|Overall Study|Physician Decision|1|||
16791397|NCT02569853|37732313|FG001|Overall Study|Physician Decision|1|||
16791398|NCT02570711|37732323|FG000|Overall Study|Death|1|||
16791399|NCT02570711|37732324|FG001|Overall Study|Death|0|||
16791400|NCT02570711|37732323|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
16791401|NCT02570711|37732324|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
16791402|NCT02570165|37732337|FG000|Overall Study|Adverse Event|1|||
16791403|NCT02570165|37732338|FG001|Overall Study|Adverse Event|0|||
16791404|NCT02570165|37732339|FG002|Overall Study|Adverse Event|2|||
16791405|NCT02570165|37732340|FG003|Overall Study|Adverse Event|0|||
16791406|NCT02570165|37732341|FG004|Overall Study|Adverse Event|0|||
16791407|NCT02570165|37732342|FG005|Overall Study|Adverse Event|0|||
16791408|NCT02570165|37732343|FG006|Overall Study|Adverse Event|0|||
16791409|NCT02570165|37732337|FG000|Overall Study|Lack of Efficacy|0|||
16791410|NCT02570165|37732338|FG001|Overall Study|Lack of Efficacy|1|||
16791411|NCT02570165|37732339|FG002|Overall Study|Lack of Efficacy|0|||
16791412|NCT02570165|37732340|FG003|Overall Study|Lack of Efficacy|0|||
16791413|NCT02570165|37732341|FG004|Overall Study|Lack of Efficacy|4|||
16791414|NCT02570165|37732342|FG005|Overall Study|Lack of Efficacy|0|||
16791415|NCT02570165|37732343|FG006|Overall Study|Lack of Efficacy|0|||
16791416|NCT02570165|37732337|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
16791417|NCT02570165|37732338|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
16791418|NCT02570165|37732339|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
16791419|NCT02570165|37732340|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
16791420|NCT02570165|37732341|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
16791421|NCT02570165|37732342|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
16791422|NCT02570165|37732343|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
16791423|NCT02570165|37732337|FG000|Overall Study|Lost to Follow-up|0|||
16791424|NCT02570165|37732338|FG001|Overall Study|Lost to Follow-up|0|||
16791425|NCT02570165|37732339|FG002|Overall Study|Lost to Follow-up|1|||
16791426|NCT02570165|37732340|FG003|Overall Study|Lost to Follow-up|1|||
16791427|NCT02570165|37732341|FG004|Overall Study|Lost to Follow-up|0|||
16791428|NCT02570165|37732342|FG005|Overall Study|Lost to Follow-up|0|||
16791429|NCT02570165|37732343|FG006|Overall Study|Lost to Follow-up|0|||
16791430|NCT02570165|37732337|FG000|Overall Study|Physician Decision|0|||
16791431|NCT02570165|37732338|FG001|Overall Study|Physician Decision|1|||
16791432|NCT02570165|37732339|FG002|Overall Study|Physician Decision|0|||
16791433|NCT02570165|37732340|FG003|Overall Study|Physician Decision|0|||
16791434|NCT02570165|37732341|FG004|Overall Study|Physician Decision|0|||
16791435|NCT02570165|37732342|FG005|Overall Study|Physician Decision|0|||
16791436|NCT02570165|37732343|FG006|Overall Study|Physician Decision|0|||
16791437|NCT02570165|37732337|FG000|Overall Study|Withdrawal by Subject|0|||
16791438|NCT02570165|37732338|FG001|Overall Study|Withdrawal by Subject|0|||
16791439|NCT02570165|37732339|FG002|Overall Study|Withdrawal by Subject|0|||
16791440|NCT02570165|37732340|FG003|Overall Study|Withdrawal by Subject|2|||
16791441|NCT02570165|37732341|FG004|Overall Study|Withdrawal by Subject|1|||
16791442|NCT02570165|37732342|FG005|Overall Study|Withdrawal by Subject|0|||
16791443|NCT02570165|37732343|FG006|Overall Study|Withdrawal by Subject|0|||
16791444|NCT02570165|37732337|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
16791445|NCT02570165|37732338|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
16791446|NCT02570165|37732339|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
16791447|NCT02570165|37732340|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
16791448|NCT02570165|37732341|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
16791449|NCT02570165|37732342|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
16791450|NCT02570165|37732343|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
16791451|NCT02570165|37732337|FG000|Overall Study|Withdrawal Request by GSK|0|||
16791452|NCT02570165|37732338|FG001|Overall Study|Withdrawal Request by GSK|0|||
16791453|NCT02570165|37732339|FG002|Overall Study|Withdrawal Request by GSK|2|||
16791454|NCT02570165|37732340|FG003|Overall Study|Withdrawal Request by GSK|0|||
16791455|NCT02570165|37732341|FG004|Overall Study|Withdrawal Request by GSK|0|||
16791456|NCT02570165|37732342|FG005|Overall Study|Withdrawal Request by GSK|0|||
16791457|NCT02570165|37732343|FG006|Overall Study|Withdrawal Request by GSK|0|||
16791458|NCT02564471|37732363|FG000|Overall Study|Adverse Event|1|||
16791459|NCT02564471|37732364|FG001|Overall Study|Adverse Event|0|||
16791460|NCT02564471|37732365|FG002|Overall Study|Adverse Event|0|||
16791461|NCT02564471|37732366|FG003|Overall Study|Adverse Event|0|||
16791462|NCT02564471|37732363|FG000|Overall Study|Withdrawal by Subject|2|||
16791463|NCT02564471|37732364|FG001|Overall Study|Withdrawal by Subject|1|||
16791464|NCT02564471|37732365|FG002|Overall Study|Withdrawal by Subject|3|||
16791465|NCT02564471|37732366|FG003|Overall Study|Withdrawal by Subject|0|||
16791466|NCT02564471|37732363|FG000|Overall Study|Lost to Follow-up|0|||
16791467|NCT02564471|37732364|FG001|Overall Study|Lost to Follow-up|2|||
16791468|NCT02564471|37732365|FG002|Overall Study|Lost to Follow-up|0|||
16791469|NCT02564471|37732366|FG003|Overall Study|Lost to Follow-up|0|||
16791470|NCT02563067|37732379|FG000|Overall Study|Subject/guardian decision|14|||
16791471|NCT02563067|37732380|FG001|Overall Study|Subject/guardian decision|20|||
16791472|NCT02563067|37732381|FG002|Overall Study|Subject/guardian decision|16|||
16791473|NCT02563067|37732379|FG000|Overall Study|Physician Decision|0|||
16791474|NCT02563067|37732380|FG001|Overall Study|Physician Decision|1|||
16791475|NCT02563067|37732381|FG002|Overall Study|Physician Decision|3|||
16791476|NCT02563067|37732379|FG000|Overall Study|Lost to Follow-up|1|||
16791477|NCT02563067|37732380|FG001|Overall Study|Lost to Follow-up|2|||
16791478|NCT02563067|37732381|FG002|Overall Study|Lost to Follow-up|0|||
16791479|NCT02563067|37732379|FG000|Overall Study|Technical problems|0|||
16791480|NCT02563067|37732380|FG001|Overall Study|Technical problems|1|||
16791481|NCT02563067|37732381|FG002|Overall Study|Technical problems|0|||
16791482|NCT02563067|37732379|FG000|Overall Study|Lack of Efficacy|1|||
16791483|NCT02563067|37732380|FG001|Overall Study|Lack of Efficacy|0|||
16791484|NCT02563067|37732381|FG002|Overall Study|Lack of Efficacy|0|||
16791485|NCT02563067|37732379|FG000|Overall Study|Death|0|||
16791486|NCT02563067|37732380|FG001|Overall Study|Death|1|||
16791487|NCT02563067|37732381|FG002|Overall Study|Death|1|||
16791488|NCT02563067|37732379|FG000|Overall Study|Adverse Event|2|||
16791489|NCT02563067|37732380|FG001|Overall Study|Adverse Event|1|||
16791490|NCT02563067|37732381|FG002|Overall Study|Adverse Event|0|||
16791491|NCT02563067|37732379|FG000|Overall Study|Death post Treatment/safety period|1|||
16791492|NCT02563067|37732380|FG001|Overall Study|Death post Treatment/safety period|0|||
16791493|NCT02563067|37732381|FG002|Overall Study|Death post Treatment/safety period|0|||
16791494|NCT02568683|37732391|FG000|Overall Study|Death|0|||
16791495|NCT02568683|37732392|FG001|Overall Study|Death|2|||
16791496|NCT02568683|37732391|FG000|Overall Study|Withdrew Consent|1|||
16791497|NCT02568683|37732392|FG001|Overall Study|Withdrew Consent|0|||
16791498|NCT02568683|37732391|FG000|Overall Study|Study Terminated By Sponsor|5|||
16791499|NCT02568683|37732392|FG001|Overall Study|Study Terminated By Sponsor|2|||
16791500|NCT02563925|37732398|FG000|Overall Study|Withdrawal by Subject|2|||
16791501|NCT01663727|37732405|FG000|Overall Study|Death|161|||
16791502|NCT01663727|37732406|FG001|Overall Study|Death|155|||
16791503|NCT01663727|37732405|FG000|Overall Study|Lost to Follow-up|10|||
16791504|NCT01663727|37732406|FG001|Overall Study|Lost to Follow-up|8|||
16791505|NCT01663727|37732405|FG000|Overall Study|Withdrawal by Subject|18|||
16791506|NCT01663727|37732406|FG001|Overall Study|Withdrawal by Subject|25|||
16791507|NCT01663727|37732405|FG000|Overall Study|Study Terminated|51|||
16791508|NCT01663727|37732406|FG001|Overall Study|Study Terminated|50|||
16791509|NCT01663727|37732405|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
16791510|NCT01663727|37732406|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
16791511|NCT01663727|37732405|FG000|Overall Study|Withdrawal prior to dosing.|1|||
16908758|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
16908759|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
16908760|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
16908761|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
16908762|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
16908763|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
17016420|NCT00848354|38161047|FG001|Phase 2 Year 1|Failed to Return|1|||
17016421|NCT00848354|38161046|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
17016422|NCT00848354|38161047|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
17016423|NCT00848354|38161046|FG000|Phase 2 Year 1|Unspecified Reason|3|||
17016424|NCT00848354|38161047|FG001|Phase 2 Year 1|Unspecified Reason|0|||
17016425|NCT00848354|38161046|FG000|Phase 2 Year 1|Protocol Violation|4|||
17016426|NCT00848354|38161047|FG001|Phase 2 Year 1|Protocol Violation|1|||
17016427|NCT00848354|38161046|FG000|Phase 2 Year 1|Subject Request|1|||
17016428|NCT00848354|38161047|FG001|Phase 2 Year 1|Subject Request|2|||
17016429|NCT00848354|38161046|FG000|Phase 2 Year 2|Adverse Event|12|||
17016430|NCT00848354|38161047|FG001|Phase 2 Year 2|Adverse Event|2|||
17016431|NCT00848354|38161046|FG000|Phase 2 Year 2|Death|2|||
17016432|NCT00848354|38161047|FG001|Phase 2 Year 2|Death|0|||
17016433|NCT00848354|38161046|FG000|Phase 2 Year 2|Failed to return|3|||
17016434|NCT00848354|38161047|FG001|Phase 2 Year 2|Failed to return|0|||
17016435|NCT00848354|38161046|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
17016436|NCT00848354|38161047|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
17016437|NCT00848354|38161046|FG000|Phase 2 Year 2|Unspecified Reason|1|||
17016438|NCT00848354|38161047|FG001|Phase 2 Year 2|Unspecified Reason|0|||
17016439|NCT00848354|38161046|FG000|Phase 2 Year 2|Protocol Violation|1|||
16791512|NCT01663727|37732406|FG001|Overall Study|Withdrawal prior to dosing.|0|||
16791513|NCT02614261|37732415|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
16791514|NCT02614261|37732416|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
16791515|NCT02614261|37732417|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
16908764|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
16908765|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
16791516|NCT02614261|37732418|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
16791517|NCT02614261|37732415|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
16791518|NCT02614261|37732416|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16791519|NCT02614261|37732417|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16791520|NCT02614261|37732418|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16791521|NCT02614261|37732415|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
16791522|NCT02614261|37732416|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
16791523|NCT02614261|37732417|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16791524|NCT02614261|37732418|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16791525|NCT02614261|37732415|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
16791526|NCT02614261|37732416|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
16791527|NCT02614261|37732417|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
16791528|NCT02614261|37732418|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
16908766|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
16908767|NCT01755156|38017507|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
16908768|NCT01755156|38017508|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
16908769|NCT01755156|38017507|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
17016440|NCT00848354|38161047|FG001|Phase 2 Year 2|Protocol Violation|1|||
17016441|NCT00848354|38161046|FG000|Phase 2 Year 2|Subject Request|1|||
17016442|NCT00848354|38161047|FG001|Phase 2 Year 2|Subject Request|1|||
17016443|NCT00848354|38161046|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
17016444|NCT00848354|38161047|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
17016445|NCT00848198|38161057|FG000|Overall Study|Incomplete Case Report Forms|15|||
16791529|NCT02614261|37732415|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
16791530|NCT02614261|37732416|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
16791531|NCT02614261|37732417|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
16791532|NCT02614261|37732418|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
16791533|NCT02614261|37732415|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
16791534|NCT02614261|37732416|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
16791535|NCT02614261|37732417|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
16791536|NCT02614261|37732418|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
16791537|NCT02614261|37732415|FG000|Double-Blind Treatment Phase|Screen failure|0|||
16791538|NCT02614261|37732416|FG001|Double-Blind Treatment Phase|Screen failure|1|||
16791539|NCT02614261|37732417|FG002|Double-Blind Treatment Phase|Screen failure|2|||
16791540|NCT02614261|37732418|FG003|Double-Blind Treatment Phase|Screen failure|0|||
16791541|NCT02614261|37732415|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
16791542|NCT02614261|37732416|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
16791543|NCT02614261|37732417|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
16791544|NCT02614261|37732418|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16791545|NCT02614261|37732415|FG000|Open-Label Extension Phase|Adverse Event|23|||
16791546|NCT02614261|37732416|FG001|Open-Label Extension Phase|Adverse Event|12|||
16791547|NCT02614261|37732417|FG002|Open-Label Extension Phase|Adverse Event|11|||
16791548|NCT02614261|37732418|FG003|Open-Label Extension Phase|Adverse Event|0|||
16791549|NCT02614261|37732415|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
16791550|NCT02614261|37732416|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
16791551|NCT02614261|37732417|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
16791552|NCT02614261|37732418|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
16791553|NCT02614261|37732415|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
16791554|NCT02614261|37732416|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
16791555|NCT02614261|37732417|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
16791556|NCT02614261|37732418|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
16791557|NCT02614261|37732415|FG000|Open-Label Extension Phase|Physician Decision|2|||
16791558|NCT02614261|37732416|FG001|Open-Label Extension Phase|Physician Decision|0|||
16791559|NCT02614261|37732417|FG002|Open-Label Extension Phase|Physician Decision|0|||
16791560|NCT02614261|37732418|FG003|Open-Label Extension Phase|Physician Decision|0|||
16791561|NCT02614261|37732415|FG000|Open-Label Extension Phase|Pregnancy|1|||
16791562|NCT02614261|37732416|FG001|Open-Label Extension Phase|Pregnancy|2|||
16791563|NCT02614261|37732417|FG002|Open-Label Extension Phase|Pregnancy|1|||
16791564|NCT02614261|37732418|FG003|Open-Label Extension Phase|Pregnancy|0|||
16791565|NCT02614261|37732415|FG000|Open-Label Extension Phase|Protocol Violation|3|||
16791566|NCT02614261|37732416|FG001|Open-Label Extension Phase|Protocol Violation|4|||
16791567|NCT02614261|37732417|FG002|Open-Label Extension Phase|Protocol Violation|1|||
16791568|NCT02614261|37732418|FG003|Open-Label Extension Phase|Protocol Violation|0|||
16791569|NCT02614261|37732415|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
16791570|NCT02614261|37732416|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
16791571|NCT02614261|37732417|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
16791572|NCT02614261|37732418|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
16791573|NCT02614261|37732415|FG000|Follow-up Phase|Adverse Event|2|||
16791574|NCT02614261|37732416|FG001|Follow-up Phase|Adverse Event|0|||
16791575|NCT02614261|37732417|FG002|Follow-up Phase|Adverse Event|1|||
16791576|NCT02614261|37732418|FG003|Follow-up Phase|Adverse Event|0|||
16791577|NCT02614261|37732415|FG000|Follow-up Phase|Lost to Follow-up|12|||
16791578|NCT02614261|37732416|FG001|Follow-up Phase|Lost to Follow-up|5|||
16791579|NCT02614261|37732417|FG002|Follow-up Phase|Lost to Follow-up|2|||
16791580|NCT02614261|37732418|FG003|Follow-up Phase|Lost to Follow-up|0|||
16791581|NCT02614261|37732415|FG000|Follow-up Phase|Physician Decision|5|||
16791582|NCT02614261|37732416|FG001|Follow-up Phase|Physician Decision|1|||
16791583|NCT02614261|37732417|FG002|Follow-up Phase|Physician Decision|0|||
16791584|NCT02614261|37732418|FG003|Follow-up Phase|Physician Decision|0|||
16791585|NCT02614261|37732415|FG000|Follow-up Phase|Pregnancy|0|||
16791586|NCT02614261|37732416|FG001|Follow-up Phase|Pregnancy|1|||
16791587|NCT02614261|37732417|FG002|Follow-up Phase|Pregnancy|0|||
16791588|NCT02614261|37732418|FG003|Follow-up Phase|Pregnancy|0|||
16791589|NCT02614261|37732415|FG000|Follow-up Phase|Protocol Violation|1|||
16791590|NCT02614261|37732416|FG001|Follow-up Phase|Protocol Violation|0|||
16791591|NCT02614261|37732417|FG002|Follow-up Phase|Protocol Violation|0|||
16791592|NCT02614261|37732418|FG003|Follow-up Phase|Protocol Violation|0|||
16791593|NCT02614261|37732415|FG000|Follow-up Phase|Withdrawal by Subject|12|||
16791594|NCT02614261|37732416|FG001|Follow-up Phase|Withdrawal by Subject|4|||
16791595|NCT02614261|37732417|FG002|Follow-up Phase|Withdrawal by Subject|11|||
16791596|NCT02614261|37732418|FG003|Follow-up Phase|Withdrawal by Subject|0|||
16791597|NCT02614261|37732415|FG000|Israel Addendum|Withdrawal by Subject|0|||
16791598|NCT02614261|37732416|FG001|Israel Addendum|Withdrawal by Subject|0|||
16791599|NCT02614261|37732417|FG002|Israel Addendum|Withdrawal by Subject|0|||
16791600|NCT02614261|37732418|FG003|Israel Addendum|Withdrawal by Subject|4|||
16791601|NCT01594411|37732444|FG000|Overall Study|Lost to Follow-up|2|||
16791602|NCT01594333|37732453|FG000|Overall Study|Death|96|||
16791603|NCT01594333|37732454|FG001|Overall Study|Death|83|||
16791604|NCT01594333|37732453|FG000|Overall Study|Lost to Follow-up|5|||
16791605|NCT01594333|37732454|FG001|Overall Study|Lost to Follow-up|5|||
16791606|NCT01594333|37732453|FG000|Overall Study|Withdrawal by Subject|60|||
16791607|NCT01594333|37732454|FG001|Overall Study|Withdrawal by Subject|63|||
16791608|NCT02609659|37732460|FG000|Overall Study|Adverse Event|1|||
16791609|NCT02609659|37732460|FG000|Overall Study|Lost to Follow-up|6|||
16791610|NCT02609659|37732460|FG000|Overall Study|Other|1|||
16791611|NCT02613169|37732466|FG000|Overall Study|Withdrawal by Subject|4|||
16791612|NCT02613169|37732467|FG001|Overall Study|Withdrawal by Subject|1|||
16791613|NCT02613169|37732466|FG000|Overall Study|Lost to Follow-up|0|||
16791614|NCT02613169|37732467|FG001|Overall Study|Lost to Follow-up|5|||
16791615|NCT02613169|37732466|FG000|Overall Study|HIV|0|||
16791616|NCT02613169|37732467|FG001|Overall Study|HIV|2|||
16791617|NCT02613169|37732466|FG000|Overall Study|No TB infection endpoint|14|||
16791618|NCT02613169|37732467|FG001|Overall Study|No TB infection endpoint|9|||
16791619|NCT02612779|37732475|FG000|Overall Study|Administrative reason by sponsor|4|||
16791620|NCT02612779|37732476|FG001|Overall Study|Administrative reason by sponsor|1|||
16791621|NCT02612779|37732475|FG000|Overall Study|No longer meet study criteria|0|||
16791622|NCT02612779|37732476|FG001|Overall Study|No longer meet study criteria|1|||
16791623|NCT02612779|37732475|FG000|Overall Study|Disease progression|29|||
16791624|NCT02612779|37732476|FG001|Overall Study|Disease progression|2|||
16791625|NCT02612779|37732475|FG000|Overall Study|Study drug toxicity|10|||
16791626|NCT02612779|37732476|FG001|Overall Study|Study drug toxicity|1|||
16791627|NCT02612779|37732475|FG000|Overall Study|Death|1|||
16791628|NCT02612779|37732476|FG001|Overall Study|Death|0|||
16791629|NCT02612779|37732475|FG000|Overall Study|Adverse event unrelated to study drug|5|||
16791630|NCT02612779|37732476|FG001|Overall Study|Adverse event unrelated to study drug|0|||
16791631|NCT02612779|37732475|FG000|Overall Study|Participant withdrew consent|4|||
16791632|NCT02612779|37732476|FG001|Overall Study|Participant withdrew consent|0|||
16791633|NCT02612779|37732475|FG000|Overall Study|Lost to Follow-up|1|||
16791634|NCT02612779|37732476|FG001|Overall Study|Lost to Follow-up|0|||
16791635|NCT02612779|37732475|FG000|Overall Study|Maximum clinical benefit|10|||
16791636|NCT02612779|37732476|FG001|Overall Study|Maximum clinical benefit|1|||
16791637|NCT02612779|37732475|FG000|Overall Study|Other reasons|4|||
16791638|NCT02612779|37732476|FG001|Overall Study|Other reasons|0|||
16791639|NCT02612623|37732487|FG000|Overall Study|Withdrawal by Subject|0|||
16791640|NCT02612623|37732488|FG001|Overall Study|Withdrawal by Subject|1|||
16791641|NCT02612623|37732489|FG002|Overall Study|Withdrawal by Subject|0|||
16791642|NCT02612623|37732490|FG003|Overall Study|Withdrawal by Subject|0|||
16791643|NCT02612623|37732487|FG000|Overall Study|Adverse Event|1|||
16791644|NCT02612623|37732488|FG001|Overall Study|Adverse Event|0|||
16791645|NCT02612623|37732489|FG002|Overall Study|Adverse Event|1|||
16791646|NCT02612623|37732490|FG003|Overall Study|Adverse Event|0|||
16791647|NCT02607865|37732504|FG000|Overall Study|Lost to Follow-up|9|||
16791648|NCT02607865|37732505|FG001|Overall Study|Lost to Follow-up|7|||
16791649|NCT02607865|37732506|FG002|Overall Study|Lost to Follow-up|7|||
16791650|NCT02607865|37732507|FG003|Overall Study|Lost to Follow-up|5|||
16791651|NCT02607865|37732504|FG000|Overall Study|Withdrawal by Subject|18|||
16791652|NCT02607865|37732505|FG001|Overall Study|Withdrawal by Subject|18|||
16791653|NCT02607865|37732506|FG002|Overall Study|Withdrawal by Subject|17|||
16791654|NCT02607865|37732507|FG003|Overall Study|Withdrawal by Subject|8|||
16791655|NCT02607865|37732504|FG000|Overall Study|Death|5|||
16791656|NCT02607865|37732505|FG001|Overall Study|Death|4|||
16791657|NCT02607865|37732506|FG002|Overall Study|Death|1|||
16791658|NCT02607865|37732507|FG003|Overall Study|Death|3|||
16791659|NCT02607865|37732504|FG000|Overall Study|Unclassified|1|||
16791660|NCT02607865|37732505|FG001|Overall Study|Unclassified|1|||
16791661|NCT02607865|37732506|FG002|Overall Study|Unclassified|2|||
16791662|NCT02607865|37732507|FG003|Overall Study|Unclassified|0|||
16791663|NCT01668667|37732521|FG000|Overall Study|Adverse Event|3|||
16791664|NCT01668667|37732522|FG001|Overall Study|Adverse Event|6|||
16791665|NCT01668667|37732523|FG002|Overall Study|Adverse Event|4|||
16791666|NCT01668667|37732524|FG003|Overall Study|Adverse Event|4|||
16791667|NCT01668667|37732521|FG000|Overall Study|Lack of Efficacy|3|||
16791668|NCT01668667|37732522|FG001|Overall Study|Lack of Efficacy|2|||
17102237|NCT00372905|38241166|FG003|Follow up Until Relapse or Progression|Study closed|3|||
17102238|NCT00372905|38241163|FG000|Follow up Until Relapse or Progression|Other|0|||
17102239|NCT00372905|38241164|FG001|Follow up Until Relapse or Progression|Other|1|||
17102240|NCT00372905|38241165|FG002|Follow up Until Relapse or Progression|Other|0|||
17102241|NCT00372905|38241166|FG003|Follow up Until Relapse or Progression|Other|0|||
17102242|NCT00384839|38241176|FG000|Overall Study|Adverse Event|4|||
17102243|NCT00384839|38241176|FG000|Overall Study|Investigator Request|1|||
17102244|NCT00384839|38241176|FG000|Overall Study|Patient Request|1|||
16791669|NCT01668667|37732523|FG002|Overall Study|Lack of Efficacy|2|||
16791670|NCT01668667|37732524|FG003|Overall Study|Lack of Efficacy|3|||
16791671|NCT01668667|37732521|FG000|Overall Study|Protocol Violation|6|||
16791672|NCT01668667|37732522|FG001|Overall Study|Protocol Violation|10|||
16791673|NCT01668667|37732523|FG002|Overall Study|Protocol Violation|12|||
16791674|NCT01668667|37732524|FG003|Overall Study|Protocol Violation|5|||
16791675|NCT01668667|37732521|FG000|Overall Study|Lost to Follow-up|9|||
16791676|NCT01668667|37732522|FG001|Overall Study|Lost to Follow-up|4|||
16791677|NCT01668667|37732523|FG002|Overall Study|Lost to Follow-up|7|||
16791678|NCT01668667|37732524|FG003|Overall Study|Lost to Follow-up|6|||
16791679|NCT01668667|37732521|FG000|Overall Study|Physician Decision|3|||
16791680|NCT01668667|37732522|FG001|Overall Study|Physician Decision|0|||
16791681|NCT01668667|37732523|FG002|Overall Study|Physician Decision|1|||
16791682|NCT01668667|37732524|FG003|Overall Study|Physician Decision|0|||
16791683|NCT01668667|37732521|FG000|Overall Study|Withdrawal by Subject|7|||
16791684|NCT01668667|37732522|FG001|Overall Study|Withdrawal by Subject|4|||
16791685|NCT01668667|37732523|FG002|Overall Study|Withdrawal by Subject|5|||
16791686|NCT01668667|37732524|FG003|Overall Study|Withdrawal by Subject|5|||
16791687|NCT02608879|37732537|FG000|Overall Study|Lost to Follow-up|1|||
16791688|NCT02608879|37732538|FG001|Overall Study|Lost to Follow-up|0|||
16791689|NCT02608879|37732539|FG002|Overall Study|Lost to Follow-up|0|||
16791690|NCT02608879|37732537|FG000|Overall Study|Did not meet continuation criteria|0|||
16791691|NCT02608879|37732538|FG001|Overall Study|Did not meet continuation criteria|0|||
16791692|NCT02608879|37732539|FG002|Overall Study|Did not meet continuation criteria|3|||
16791693|NCT02608099|37732549|FG000|Overall Study|Ablation procedure not initiated|3|||
16791694|NCT02608099|37732550|FG001|Overall Study|Ablation procedure not initiated|2|||
16791695|NCT01668589|37732560|FG000|Overall Study|Lost to Follow-up|29|||
16791696|NCT01668589|37732561|FG001|Overall Study|Lost to Follow-up|37|||
16791697|NCT01668589|37732562|FG002|Overall Study|Lost to Follow-up|15|||
16791698|NCT01668589|37732563|FG003|Overall Study|Lost to Follow-up|5|||
16791699|NCT01668589|37732560|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
16791700|NCT01668589|37732561|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
16791701|NCT01668589|37732562|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
16791702|NCT01668589|37732563|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
16791703|NCT01668589|37732560|FG000|Overall Study|Death|12|||
16791704|NCT01668589|37732561|FG001|Overall Study|Death|3|||
16791705|NCT01668589|37732562|FG002|Overall Study|Death|2|||
16791706|NCT01668589|37732563|FG003|Overall Study|Death|11|||
16791707|NCT01668589|37732560|FG000|Overall Study|Other|44|||
16791708|NCT01668589|37732561|FG001|Overall Study|Other|10|||
16791709|NCT01668589|37732562|FG002|Overall Study|Other|7|||
16791710|NCT01668589|37732563|FG003|Overall Study|Other|15|||
16791711|NCT02432235|37732585|FG000|Overall Study|Death|1|||
16791712|NCT02432235|37732586|FG001|Overall Study|Death|1|||
16791713|NCT02432235|37732587|FG002|Overall Study|Death|2|||
16791714|NCT02432235|37732588|FG003|Overall Study|Death|2|||
16791715|NCT02432235|37732589|FG004|Overall Study|Death|1|||
16791716|NCT02432235|37732590|FG005|Overall Study|Death|3|||
16791717|NCT02432235|37732591|FG006|Overall Study|Death|11|||
16791718|NCT02432235|37732592|FG007|Overall Study|Death|15|||
16791719|NCT02432235|37732593|FG008|Overall Study|Death|15|||
16791720|NCT02432235|37732594|FG009|Overall Study|Death|3|||
16791721|NCT02432235|37732595|FG010|Overall Study|Death|1|||
16791722|NCT02432235|37732596|FG011|Overall Study|Death|0|||
16791723|NCT02432235|37732585|FG000|Overall Study|Withdrawal by Subject|0|||
16791724|NCT02432235|37732586|FG001|Overall Study|Withdrawal by Subject|1|||
16791725|NCT02432235|37732587|FG002|Overall Study|Withdrawal by Subject|0|||
16791726|NCT02432235|37732588|FG003|Overall Study|Withdrawal by Subject|0|||
16791727|NCT02432235|37732589|FG004|Overall Study|Withdrawal by Subject|0|||
16791728|NCT02432235|37732590|FG005|Overall Study|Withdrawal by Subject|2|||
16791729|NCT02432235|37732591|FG006|Overall Study|Withdrawal by Subject|5|||
16791730|NCT02432235|37732592|FG007|Overall Study|Withdrawal by Subject|3|||
16791731|NCT02432235|37732593|FG008|Overall Study|Withdrawal by Subject|1|||
16791732|NCT02432235|37732594|FG009|Overall Study|Withdrawal by Subject|0|||
16791733|NCT02432235|37732595|FG010|Overall Study|Withdrawal by Subject|0|||
16791734|NCT02432235|37732596|FG011|Overall Study|Withdrawal by Subject|0|||
16791735|NCT02432235|37732585|FG000|Overall Study|Lost to Follow-up|0|||
16791736|NCT02432235|37732586|FG001|Overall Study|Lost to Follow-up|0|||
16791737|NCT02432235|37732587|FG002|Overall Study|Lost to Follow-up|0|||
16791738|NCT02432235|37732588|FG003|Overall Study|Lost to Follow-up|0|||
16791739|NCT02432235|37732589|FG004|Overall Study|Lost to Follow-up|0|||
16791740|NCT02432235|37732590|FG005|Overall Study|Lost to Follow-up|1|||
16791741|NCT02432235|37732591|FG006|Overall Study|Lost to Follow-up|0|||
16791742|NCT02432235|37732592|FG007|Overall Study|Lost to Follow-up|0|||
16791743|NCT02432235|37732593|FG008|Overall Study|Lost to Follow-up|1|||
16791744|NCT02432235|37732594|FG009|Overall Study|Lost to Follow-up|0|||
16791745|NCT02432235|37732595|FG010|Overall Study|Lost to Follow-up|0|||
16791746|NCT02432235|37732596|FG011|Overall Study|Lost to Follow-up|0|||
16791747|NCT02432235|37732585|FG000|Overall Study|Miscellaneous|0|||
16791748|NCT02432235|37732586|FG001|Overall Study|Miscellaneous|0|||
16791749|NCT02432235|37732587|FG002|Overall Study|Miscellaneous|0|||
16791750|NCT02432235|37732588|FG003|Overall Study|Miscellaneous|0|||
16791751|NCT02432235|37732589|FG004|Overall Study|Miscellaneous|1|||
16791752|NCT02432235|37732590|FG005|Overall Study|Miscellaneous|6|||
16791753|NCT02432235|37732591|FG006|Overall Study|Miscellaneous|2|||
16791754|NCT02432235|37732592|FG007|Overall Study|Miscellaneous|2|||
16791755|NCT02432235|37732593|FG008|Overall Study|Miscellaneous|4|||
16791756|NCT02432235|37732594|FG009|Overall Study|Miscellaneous|0|||
16791757|NCT02432235|37732595|FG010|Overall Study|Miscellaneous|0|||
16791758|NCT02432235|37732596|FG011|Overall Study|Miscellaneous|1|||
16791759|NCT02431533|37732626|FG000|Overall Study|Withdrawal by Subject|1|||
16791760|NCT02431533|37732627|FG001|Overall Study|Withdrawal by Subject|3|||
16791761|NCT02431533|37732626|FG000|Overall Study|Developed Exclusionary criteria|1|||
17016446|NCT00848120|38161065|FG000|Overall Study|Adverse Event|1|||
17016447|NCT00600821|38161071|FG000|Overall Study|Death|45|||
17016448|NCT00600821|38161072|FG001|Overall Study|Death|46|||
17016449|NCT00600821|38161071|FG000|Overall Study|Lost to Follow-up|2|||
17016450|NCT00600821|38161072|FG001|Overall Study|Lost to Follow-up|2|||
17016451|NCT00600821|38161071|FG000|Overall Study|Withdrawal by Subject|1|||
17016452|NCT00600821|38161072|FG001|Overall Study|Withdrawal by Subject|1|||
17016453|NCT00600821|38161071|FG000|Overall Study|Terminated by sponsor|8|||
17016454|NCT00600821|38161072|FG001|Overall Study|Terminated by sponsor|6|||
17016455|NCT00600821|38161071|FG000|Overall Study|Objective progression or relapse|0|||
17016456|NCT00600821|38161072|FG001|Overall Study|Objective progression or relapse|1|||
17016457|NCT00600821|38161071|FG000|Overall Study|Randomized but not treated|0|||
17016458|NCT00600821|38161072|FG001|Overall Study|Randomized but not treated|1|||
17016459|NCT00600821|38161071|FG000|Overall Study|Other|2|||
16791762|NCT02431533|37732627|FG001|Overall Study|Developed Exclusionary criteria|0|||
16791763|NCT02416791|37732636|FG000|6 Months|Lost to Follow-up|0|||
16791764|NCT02416791|37732637|FG001|6 Months|Lost to Follow-up|0|||
16791765|NCT02416791|37732638|FG002|6 Months|Lost to Follow-up|1|||
16791766|NCT02414841|37732648|FG000|Overall Study|Withdrawal by Subject|7|||
16791767|NCT02414841|37732649|FG001|Overall Study|Withdrawal by Subject|5|||
16791768|NCT02414841|37732648|FG000|Overall Study|Lost to Follow-up|13|||
16791769|NCT02414841|37732649|FG001|Overall Study|Lost to Follow-up|6|||
16791770|NCT02414841|37732648|FG000|Overall Study|Death|17|||
16791771|NCT02414841|37732649|FG001|Overall Study|Death|14|||
16791772|NCT02414841|37732648|FG000|Overall Study|Received a Kidney Transplant|13|||
16791773|NCT02414841|37732649|FG001|Overall Study|Received a Kidney Transplant|4|||
16791774|NCT02414841|37732648|FG000|Overall Study|Randomized But Not Treated|6|||
16791775|NCT02414841|37732649|FG001|Overall Study|Randomized But Not Treated|4|||
16791776|NCT02413593|37732657|FG000|Overall Study|Lost to Follow-up|3|||
16791777|NCT02413593|37732657|FG000|Overall Study|Adverse Event|1|||
16791778|NCT01652703|37732667|FG000|Overall Study|Withdrawal by Subject|0|||
16791779|NCT01652703|37732668|FG001|Overall Study|Withdrawal by Subject|1|||
16791780|NCT01652703|37732669|FG002|Overall Study|Withdrawal by Subject|3|||
16791781|NCT01652703|37732670|FG003|Overall Study|Withdrawal by Subject|1|||
16791782|NCT01652703|37732671|FG004|Overall Study|Withdrawal by Subject|0|||
16791783|NCT01652703|37732672|FG005|Overall Study|Withdrawal by Subject|1|||
16791784|NCT01652703|37732667|FG000|Overall Study|Other|0|||
16791785|NCT01652703|37732668|FG001|Overall Study|Other|0|||
16791786|NCT01652703|37732669|FG002|Overall Study|Other|0|||
16791787|NCT01652703|37732670|FG003|Overall Study|Other|1|||
16791788|NCT01652703|37732671|FG004|Overall Study|Other|1|||
16791789|NCT01652703|37732672|FG005|Overall Study|Other|1|||
16791790|NCT01652469|37732688|FG000|Overall Study|Withdrawal by Subject|1|||
16791791|NCT01652469|37732689|FG001|Overall Study|Withdrawal by Subject|4|||
16791792|NCT01652469|37732688|FG000|Overall Study|Lost to Follow-up|0|||
16791793|NCT01652469|37732689|FG001|Overall Study|Lost to Follow-up|2|||
16791794|NCT02429427|37732697|FG000|Overall Study|Adverse Event|220|||
17102245|NCT00384839|38241176|FG000|Overall Study|Ineligible|2|||
17102246|NCT00384293|38241182|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
16791795|NCT02429427|37732698|FG001|Overall Study|Adverse Event|92|||
16791796|NCT02429427|37732697|FG000|Overall Study|Protocol Violation|10|||
16791797|NCT02429427|37732698|FG001|Overall Study|Protocol Violation|6|||
16791798|NCT02429427|37732697|FG000|Overall Study|Lost to Follow-up|15|||
16791799|NCT02429427|37732698|FG001|Overall Study|Lost to Follow-up|6|||
16791800|NCT02429427|37732697|FG000|Overall Study|Withdrawal by Subject|64|||
16791801|NCT02429427|37732698|FG001|Overall Study|Withdrawal by Subject|34|||
16791802|NCT02429427|37732697|FG000|Overall Study|Other|62|||
16791803|NCT02429427|37732698|FG001|Overall Study|Other|41|||
16791804|NCT02412735|37732707|FG000|Overall Study|Adverse Event|0|||
16791805|NCT02412735|37732708|FG001|Overall Study|Adverse Event|1|||
16791806|NCT02412735|37732709|FG002|Overall Study|Adverse Event|2|||
16791807|NCT02412735|37732707|FG000|Overall Study|Withdrawal by Subject|23|||
16791808|NCT02412735|37732708|FG001|Overall Study|Withdrawal by Subject|27|||
17016460|NCT00600821|38161072|FG001|Overall Study|Other|3|||
17016461|NCT00592904|38161084|FG000|Overall Study|Adverse Event|15|||
17016462|NCT00592904|38161085|FG001|Overall Study|Adverse Event|25|||
17016463|NCT00592904|38161086|FG002|Overall Study|Adverse Event|13|||
17016464|NCT00592904|38161087|FG003|Overall Study|Adverse Event|5|||
16791809|NCT02412735|37732709|FG002|Overall Study|Withdrawal by Subject|22|||
16791810|NCT02412735|37732707|FG000|Overall Study|Investigator Decision|3|||
16791811|NCT02412735|37732708|FG001|Overall Study|Investigator Decision|3|||
16791812|NCT02412735|37732709|FG002|Overall Study|Investigator Decision|2|||
16791813|NCT02412735|37732707|FG000|Overall Study|Lost to Follow-up|17|||
16791814|NCT02412735|37732708|FG001|Overall Study|Lost to Follow-up|11|||
16791815|NCT02412735|37732709|FG002|Overall Study|Lost to Follow-up|18|||
16791816|NCT02412735|37732707|FG000|Overall Study|Reason not Specified|3|||
16791817|NCT02412735|37732708|FG001|Overall Study|Reason not Specified|2|||
16791818|NCT02412735|37732709|FG002|Overall Study|Reason not Specified|2|||
16791819|NCT02412657|37732720|FG000|Overall Study|Lost to Follow-up|1|||
16791820|NCT02412657|37732721|FG001|Overall Study|Lost to Follow-up|0|||
16791821|NCT02412657|37732722|FG002|Overall Study|Lost to Follow-up|0|||
16791822|NCT02412657|37732720|FG000|Overall Study|Protocol Violation|0|||
16791823|NCT02412657|37732721|FG001|Overall Study|Protocol Violation|2|||
16791824|NCT02412657|37732722|FG002|Overall Study|Protocol Violation|3|||
16791825|NCT02428413|37732732|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
16791826|NCT02428413|37732733|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
16791827|NCT02428413|37732732|FG000|Overall Study|Protocol Violation|1|||
16791828|NCT02428413|37732733|FG001|Overall Study|Protocol Violation|2|||
16791829|NCT02428413|37732732|FG000|Overall Study|Case Cancelled|2|||
16791830|NCT02428413|37732733|FG001|Overall Study|Case Cancelled|0|||
16791831|NCT02428413|37732732|FG000|Overall Study|Missed Cases|1|||
16791832|NCT02428413|37732733|FG001|Overall Study|Missed Cases|2|||
16791833|NCT02428413|37732732|FG000|Overall Study|Nurse Refusal|1|||
16791834|NCT02428413|37732733|FG001|Overall Study|Nurse Refusal|0|||
16791835|NCT02412111|37732741|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
16791836|NCT02412111|37732742|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
16791837|NCT02412111|37732743|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
16791838|NCT02412111|37732741|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
16791839|NCT02412111|37732742|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
16791840|NCT02412111|37732743|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
16791841|NCT02412111|37732741|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
16791842|NCT02412111|37732742|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
16791843|NCT02412111|37732743|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
16791844|NCT02412111|37732741|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
16791845|NCT02412111|37732742|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
16791846|NCT02412111|37732743|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
16791847|NCT02412111|37732741|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
16791848|NCT02412111|37732742|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
16791849|NCT02412111|37732743|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
16791850|NCT02412111|37732741|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
16791851|NCT02412111|37732742|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
16791852|NCT02412111|37732743|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
16791853|NCT02412111|37732741|FG000|Active Comparator Period (8 Weeks)|Other|0|||
16791854|NCT02412111|37732742|FG001|Active Comparator Period (8 Weeks)|Other|0|||
16791855|NCT02412111|37732743|FG002|Active Comparator Period (8 Weeks)|Other|2|||
16791856|NCT02427477|37732755|FG000|Period 1|Adverse Event|1|||
16791857|NCT02427477|37732756|FG001|Period 1|Adverse Event|0|||
16791858|NCT02427399|37732767|FG000|Overall Study|Protocol Violation|14|||
16791859|NCT02427399|37732768|FG001|Overall Study|Protocol Violation|16|||
16791860|NCT02427399|37732769|FG002|Overall Study|Protocol Violation|12|||
16791861|NCT02427399|37732770|FG003|Overall Study|Protocol Violation|18|||
16791862|NCT02427399|37732771|FG004|Overall Study|Protocol Violation|15|||
16791863|NCT02426541|37732785|FG000|Overall Study|Protocol Violation|1|||
16791864|NCT02426541|37732786|FG001|Overall Study|Protocol Violation|0|||
16791865|NCT02484651|37732794|FG000|Overall Study|Patients' data files were corrupted.|1|||
16791866|NCT02484651|37732795|FG001|Overall Study|Patients' data files were corrupted.|1|||
16791867|NCT02484651|37732794|FG000|Overall Study|BIS monitoring failed.|1|||
16791868|NCT02484651|37732795|FG001|Overall Study|BIS monitoring failed.|1|||
16791869|NCT02484651|37732794|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
17102247|NCT00384293|38241183|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
17102248|NCT00384293|38241184|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
17102249|NCT00384293|38241182|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
17102250|NCT00384293|38241183|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
17102251|NCT00384293|38241184|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
17198286|NCT02603120|38351876|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
17198287|NCT02603120|38351877|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
17102252|NCT00384293|38241182|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
17102253|NCT00384293|38241183|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
17198288|NCT02603120|38351876|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
17198289|NCT02603120|38351877|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
17198290|NCT02599688|38351885|FG000|Overall Study|Lack of Efficacy|1|||
17198291|NCT02599688|38351885|FG000|Overall Study|Withdrawal by Subject|1|||
17198292|NCT02599688|38351885|FG000|Overall Study|Termination by Sponsor|2|||
16791870|NCT02484651|37732795|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
16791871|NCT02410551|37732802|FG000|Overall Study|Adverse Event|1|||
16791872|NCT02410551|37732802|FG000|Overall Study|Withdrawal by Subject|1|||
16791873|NCT02410551|37732802|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
16791874|NCT02424591|37732809|FG000|Overall Study|Protocol Violation|2|||
16791875|NCT02424591|37732810|FG001|Overall Study|Protocol Violation|3|||
16791876|NCT02603419|37732822|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16791877|NCT02603419|37732823|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
16791878|NCT02603419|37732824|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16791879|NCT02603419|37732825|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16791880|NCT02603419|37732826|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16791881|NCT02603419|37732827|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16791882|NCT02603419|37732822|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
16791883|NCT02603419|37732823|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
16791884|NCT02603419|37732824|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
16791885|NCT02603419|37732825|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
16791886|NCT02603419|37732826|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
16791887|NCT02603419|37732827|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
16791888|NCT02603419|37732822|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
16791889|NCT02603419|37732823|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
16791890|NCT02603419|37732824|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
16791891|NCT02603419|37732825|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
16791892|NCT02603419|37732826|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
16791893|NCT02603419|37732827|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
16791894|NCT02603419|37732822|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16791895|NCT02603419|37732823|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16791896|NCT02603419|37732824|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16791897|NCT02603419|37732825|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16791898|NCT02603419|37732826|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
16791899|NCT02603419|37732827|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16791900|NCT02603419|37732822|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16791901|NCT02603419|37732823|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
16791902|NCT02603419|37732824|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16791903|NCT02603419|37732825|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16791904|NCT02603419|37732826|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16791905|NCT02603419|37732827|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16791906|NCT02603419|37732822|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
16791907|NCT02603419|37732823|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
16791908|NCT02603419|37732824|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
16791909|NCT02603419|37732825|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
16791910|NCT02603419|37732826|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
16791911|NCT02603419|37732827|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
16791912|NCT02603419|37732822|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16791913|NCT02603419|37732823|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16791914|NCT02603419|37732824|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16791915|NCT02603419|37732825|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
16791916|NCT02603419|37732826|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16791917|NCT02603419|37732827|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16791918|NCT02603419|37732822|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16791919|NCT02603419|37732823|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16791920|NCT02603419|37732824|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16791921|NCT02603419|37732825|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16791922|NCT02603419|37732826|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16791923|NCT02603419|37732827|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
16791924|NCT02603419|37732822|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16791925|NCT02603419|37732823|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16791926|NCT02603419|37732824|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16791927|NCT02603419|37732825|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16791928|NCT02603419|37732826|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16791929|NCT02603419|37732827|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
16791930|NCT02603419|37732822|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16791931|NCT02603419|37732823|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16908770|NCT01755156|38017508|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
16908771|NCT01755156|38017507|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
16908772|NCT01755156|38017508|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
16791932|NCT02603419|37732824|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16791933|NCT02603419|37732825|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16791934|NCT02603419|37732826|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16791935|NCT02603419|37732827|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
16791936|NCT02408523|37732844|FG000|Overall Study|Adverse Event|4|||
16791937|NCT02408523|37732845|FG001|Overall Study|Adverse Event|10|||
16791938|NCT02408523|37732844|FG000|Overall Study|Lack of Efficacy|0|||
16791939|NCT02408523|37732845|FG001|Overall Study|Lack of Efficacy|1|||
16791940|NCT02408523|37732844|FG000|Overall Study|Protocol Violation|1|||
16791941|NCT02408523|37732845|FG001|Overall Study|Protocol Violation|2|||
16791942|NCT02408523|37732844|FG000|Overall Study|Lost to Follow-up|2|||
16791943|NCT02408523|37732845|FG001|Overall Study|Lost to Follow-up|3|||
16791944|NCT02408523|37732844|FG000|Overall Study|Withdrawal by Subject|3|||
16791945|NCT02408523|37732845|FG001|Overall Study|Withdrawal by Subject|1|||
16791946|NCT02408523|37732844|FG000|Overall Study|Sponsor request|1|||
16791947|NCT02408523|37732845|FG001|Overall Study|Sponsor request|0|||
16791948|NCT02408523|37732844|FG000|Overall Study|Did not satisfy extension conditions|0|||
16791949|NCT02408523|37732845|FG001|Overall Study|Did not satisfy extension conditions|1|||
16791950|NCT01668355|37732861|FG000|Overall Study|Death|3|||
16791951|NCT01668355|37732862|FG001|Overall Study|Death|1|||
16791952|NCT01668355|37732861|FG000|Overall Study|Withdrawal by Subject|6|||
16791953|NCT01668355|37732862|FG001|Overall Study|Withdrawal by Subject|1|||
16791954|NCT01667731|37732874|FG000|Overall Study|Enrolled but not treated|0|||
16791955|NCT01667731|37732875|FG001|Overall Study|Enrolled but not treated|0|||
16791956|NCT01667731|37732876|FG002|Overall Study|Enrolled but not treated|0|||
16791957|NCT01667731|37732877|FG003|Overall Study|Enrolled but not treated|0|||
16791958|NCT01667731|37732878|FG004|Overall Study|Enrolled but not treated|1|||
16791959|NCT01667731|37732874|FG000|Overall Study|Efficacy Failure|1|||
16791960|NCT01667731|37732875|FG001|Overall Study|Efficacy Failure|12|||
16791961|NCT01667731|37732876|FG002|Overall Study|Efficacy Failure|0|||
16791962|NCT01667731|37732877|FG003|Overall Study|Efficacy Failure|1|||
16791963|NCT01667731|37732878|FG004|Overall Study|Efficacy Failure|24|||
16791964|NCT01667731|37732874|FG000|Overall Study|Lost to Follow-up|2|||
16791965|NCT01667731|37732875|FG001|Overall Study|Lost to Follow-up|3|||
16791966|NCT01667731|37732876|FG002|Overall Study|Lost to Follow-up|1|||
16791967|NCT01667731|37732877|FG003|Overall Study|Lost to Follow-up|1|||
16791968|NCT01667731|37732878|FG004|Overall Study|Lost to Follow-up|2|||
16791969|NCT01667731|37732874|FG000|Overall Study|Subject Withdrew Consent|2|||
16791970|NCT01667731|37732875|FG001|Overall Study|Subject Withdrew Consent|0|||
16791971|NCT01667731|37732876|FG002|Overall Study|Subject Withdrew Consent|1|||
16791972|NCT01667731|37732877|FG003|Overall Study|Subject Withdrew Consent|0|||
16791973|NCT01667731|37732878|FG004|Overall Study|Subject Withdrew Consent|1|||
16791974|NCT01667731|37732874|FG000|Overall Study|Death|0|||
16791975|NCT01667731|37732875|FG001|Overall Study|Death|1|||
16791976|NCT01667731|37732876|FG002|Overall Study|Death|0|||
16791977|NCT01667731|37732877|FG003|Overall Study|Death|0|||
16791978|NCT01667731|37732878|FG004|Overall Study|Death|0|||
16791979|NCT02605837|37732893|FG000|Overall Study|Adverse Event|3|||
16791980|NCT02605837|37732894|FG001|Overall Study|Adverse Event|1|||
16791981|NCT02605837|37732893|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16791982|NCT02605837|37732894|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16791983|NCT02605837|37732893|FG000|Overall Study|Withdrawal by Subject|8|||
16791984|NCT02605837|37732894|FG001|Overall Study|Withdrawal by Subject|8|||
16791985|NCT02605837|37732893|FG000|Overall Study|Physician Decision|0|||
16791986|NCT02605837|37732894|FG001|Overall Study|Physician Decision|1|||
16791987|NCT02423343|37732907|FG000|Overall Study|Withdrawal by Subject|0|||
16791988|NCT02423343|37732908|FG001|Overall Study|Withdrawal by Subject|1|||
16791989|NCT02423343|37732909|FG002|Overall Study|Withdrawal by Subject|0|||
16791990|NCT02423343|37732910|FG003|Overall Study|Withdrawal by Subject|0|||
16791991|NCT02423343|37732911|FG004|Overall Study|Withdrawal by Subject|0|||
16791992|NCT02423343|37732912|FG005|Overall Study|Withdrawal by Subject|0|||
16791993|NCT02423343|37732907|FG000|Overall Study|Progressive Disease|0|||
16791994|NCT02423343|37732908|FG001|Overall Study|Progressive Disease|0|||
16791995|NCT02423343|37732909|FG002|Overall Study|Progressive Disease|0|||
16791996|NCT02423343|37732910|FG003|Overall Study|Progressive Disease|0|||
16791997|NCT02423343|37732911|FG004|Overall Study|Progressive Disease|2|||
16791998|NCT02423343|37732912|FG005|Overall Study|Progressive Disease|0|||
16791999|NCT02423343|37732907|FG000|Overall Study|Adverse Event|0|||
16792000|NCT02423343|37732908|FG001|Overall Study|Adverse Event|0|||
16792001|NCT02423343|37732909|FG002|Overall Study|Adverse Event|0|||
16792002|NCT02423343|37732910|FG003|Overall Study|Adverse Event|0|||
16792003|NCT02423343|37732911|FG004|Overall Study|Adverse Event|2|||
16792004|NCT02423343|37732912|FG005|Overall Study|Adverse Event|0|||
16792005|NCT02423343|37732907|FG000|Overall Study|Death|0|||
16792006|NCT02423343|37732908|FG001|Overall Study|Death|0|||
16792007|NCT02423343|37732909|FG002|Overall Study|Death|0|||
16792008|NCT02423343|37732910|FG003|Overall Study|Death|0|||
16792009|NCT02423343|37732911|FG004|Overall Study|Death|1|||
16792010|NCT02423343|37732912|FG005|Overall Study|Death|0|||
16792011|NCT02605447|37732940|FG000|Overall Study|Death|66|||
16792012|NCT02605447|37732940|FG000|Overall Study|Physician Decision|1|||
16792013|NCT02605447|37732940|FG000|Overall Study|Lost to Follow-up|24|||
16792014|NCT02605447|37732940|FG000|Overall Study|Withdrawal by Subject|10|||
16792015|NCT02605447|37732940|FG000|Overall Study|Not disclosed|1|||
16792016|NCT02485899|37732947|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
16792017|NCT02485899|37732948|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
16792018|NCT02485899|37732947|FG000|Overall Study|Withdrawal by Subject|1|||
16792019|NCT02485899|37732948|FG001|Overall Study|Withdrawal by Subject|0|||
16792020|NCT02485899|37732947|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
16792021|NCT02485899|37732948|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
16792022|NCT02423109|37732954|FG000|Lens 1|Adverse Event|1|||
16792023|NCT02423109|37732955|FG001|Lens 1|Adverse Event|0|||
16792024|NCT02420691|37732963|FG000|Overall Study|Adverse Event|3|||
16792025|NCT02420691|37732963|FG000|Overall Study|Withdrawal by Subject|3|||
16792026|NCT02406651|37732967|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
16792027|NCT02406261|37732974|FG000|Period 1|Lost to Follow-up|2|||
16792028|NCT02406261|37732975|FG001|Period 1|Lost to Follow-up|0|||
16792029|NCT02406261|37732974|FG000|Period 1|Adverse Event|1|||
16792030|NCT02406261|37732975|FG001|Period 1|Adverse Event|0|||
16792031|NCT02406261|37732974|FG000|Period 2|Physician Decision|0|||
16792032|NCT02406261|37732975|FG001|Period 2|Physician Decision|1|||
16792033|NCT02406261|37732974|FG000|Period 2|Protocol Violation|0|||
16792034|NCT02406261|37732975|FG001|Period 2|Protocol Violation|1|||
16792035|NCT02406261|37732974|FG000|Period 2|Withdrawal by Subject|0|||
16792036|NCT02406261|37732975|FG001|Period 2|Withdrawal by Subject|1|||
16792037|NCT02405091|37732985|FG000|Overall Study|Adverse Event|16|||
16792038|NCT02405091|37732986|FG001|Overall Study|Adverse Event|10|||
16792039|NCT02405091|37732987|FG002|Overall Study|Adverse Event|0|||
16792040|NCT02405091|37732985|FG000|Overall Study|Protocol Violation|1|||
16792041|NCT02405091|37732986|FG001|Overall Study|Protocol Violation|0|||
16792042|NCT02405091|37732987|FG002|Overall Study|Protocol Violation|0|||
16792043|NCT02405091|37732985|FG000|Overall Study|Noncompliance|1|||
16792044|NCT02405091|37732986|FG001|Overall Study|Noncompliance|6|||
16792045|NCT02405091|37732987|FG002|Overall Study|Noncompliance|2|||
16792046|NCT02405091|37732985|FG000|Overall Study|Withdrawal by Subject|4|||
16792047|NCT02405091|37732986|FG001|Overall Study|Withdrawal by Subject|8|||
16792048|NCT02405091|37732987|FG002|Overall Study|Withdrawal by Subject|0|||
16792049|NCT02405091|37732985|FG000|Overall Study|Death|0|||
16792050|NCT02405091|37732986|FG001|Overall Study|Death|1|||
16792051|NCT02405091|37732987|FG002|Overall Study|Death|0|||
16792052|NCT02405091|37732985|FG000|Overall Study|Lost to Follow-up|5|||
16792053|NCT02405091|37732986|FG001|Overall Study|Lost to Follow-up|6|||
16792054|NCT02405091|37732987|FG002|Overall Study|Lost to Follow-up|0|||
16792055|NCT02405091|37732985|FG000|Overall Study|Physician Decision|2|||
16792056|NCT02405091|37732986|FG001|Overall Study|Physician Decision|2|||
16792057|NCT02405091|37732987|FG002|Overall Study|Physician Decision|0|||
16792058|NCT02485353|37732998|FG000|Overall Study|Death|1|||
16792059|NCT02485353|37732998|FG000|Overall Study|Disease Progression|1|||
16792060|NCT02603107|37733004|FG000|Randomized Phase|Withdrew consent|8|||
16792061|NCT02603107|37733005|FG001|Randomized Phase|Withdrew consent|15|||
16792062|NCT02603107|37733004|FG000|Randomized Phase|Lost to Follow-up|1|||
16792063|NCT02603107|37733005|FG001|Randomized Phase|Lost to Follow-up|3|||
16792064|NCT02603107|37733004|FG000|Randomized Phase|Adverse Event|2|||
16792065|NCT02603107|37733005|FG001|Randomized Phase|Adverse Event|0|||
16792066|NCT02603107|37733004|FG000|Randomized Phase|Death|1|||
16792067|NCT02603107|37733005|FG001|Randomized Phase|Death|1|||
16792068|NCT02603107|37733004|FG000|Randomized Phase|Non-compliance with study drug|1|||
16792069|NCT02603107|37733005|FG001|Randomized Phase|Non-compliance with study drug|1|||
16792070|NCT02603107|37733004|FG000|Randomized Phase|Investigator's discretion|0|||
16792071|NCT02603107|37733005|FG001|Randomized Phase|Investigator's discretion|1|||
16792072|NCT02603107|37733004|FG000|Randomized Phase|Lack of Efficacy|1|||
16792073|NCT02603107|37733005|FG001|Randomized Phase|Lack of Efficacy|0|||
16792074|NCT02603107|37733004|FG000|Randomized Phase|Protocol Violation|1|||
16792075|NCT02603107|37733005|FG001|Randomized Phase|Protocol Violation|0|||
16792076|NCT02603107|37733004|FG000|Optional Extension Phase|Lost to Follow-up|3|||
16792077|NCT02603107|37733005|FG001|Optional Extension Phase|Lost to Follow-up|3|||
16792078|NCT02603107|37733004|FG000|Optional Extension Phase|Withdrew consent|3|||
16792079|NCT02603107|37733005|FG001|Optional Extension Phase|Withdrew consent|2|||
16792080|NCT02603107|37733004|FG000|Optional Extension Phase|Investigator's discretion|2|||
16792081|NCT02603107|37733005|FG001|Optional Extension Phase|Investigator's discretion|2|||
16792082|NCT02603107|37733004|FG000|Optional Extension Phase|Pregnancy|0|||
16792083|NCT02603107|37733005|FG001|Optional Extension Phase|Pregnancy|3|||
16792084|NCT02603107|37733004|FG000|Optional Extension Phase|Adverse Event|0|||
16792085|NCT02603107|37733005|FG001|Optional Extension Phase|Adverse Event|2|||
16792086|NCT02603107|37733004|FG000|Optional Extension Phase|Not treated in extension phase|0|||
16908773|NCT01754922|38017520|FG000|Overall Study|Adverse Event|0|||
16792087|NCT02603107|37733005|FG001|Optional Extension Phase|Not treated in extension phase|1|||
16792088|NCT02603107|37733004|FG000|Optional Extension Phase|Protocol Violation|1|||
16792089|NCT02603107|37733005|FG001|Optional Extension Phase|Protocol Violation|0|||
16792090|NCT02484729|37733023|FG000|Overall Study|Failure of IntelliCap Error|0|||
16792091|NCT02484729|37733024|FG001|Overall Study|Failure of IntelliCap Error|0|||
16792092|NCT02484729|37733025|FG002|Overall Study|Failure of IntelliCap Error|0|||
16792093|NCT02484729|37733026|FG003|Overall Study|Failure of IntelliCap Error|0|||
16792094|NCT02484729|37733027|FG004|Overall Study|Failure of IntelliCap Error|0|||
16792095|NCT02484729|37733028|FG005|Overall Study|Failure of IntelliCap Error|0|||
16792096|NCT02484729|37733029|FG006|Overall Study|Failure of IntelliCap Error|0|||
16792097|NCT02484729|37733030|FG007|Overall Study|Failure of IntelliCap Error|0|||
16792098|NCT02484729|37733031|FG008|Overall Study|Failure of IntelliCap Error|0|||
16792099|NCT02484729|37733032|FG009|Overall Study|Failure of IntelliCap Error|1|||
16792100|NCT02601625|37733070|FG000|Overall Study|Lost to Follow-up|0|||
16792101|NCT02601625|37733071|FG001|Overall Study|Lost to Follow-up|0|||
16792102|NCT02601625|37733072|FG002|Overall Study|Lost to Follow-up|1|||
16792103|NCT02601625|37733073|FG003|Overall Study|Lost to Follow-up|1|||
16792104|NCT02601469|37733099|FG000|Overall Study|Enrolled in Error|1|||
16792105|NCT02601469|37733100|FG001|Overall Study|Enrolled in Error|0|||
16792106|NCT02604589|37733109|FG000|Overall Study|catheter dislodgement|0|||
16792107|NCT02604589|37733110|FG001|Overall Study|catheter dislodgement|0|||
16792108|NCT02604589|37733111|FG002|Overall Study|catheter dislodgement|1|||
16792109|NCT02601001|37733122|FG000|Dosing Period 2|Adverse Event|0|||
16792110|NCT02601001|37733123|FG001|Dosing Period 2|Adverse Event|0|||
16792111|NCT02601001|37733124|FG002|Dosing Period 2|Adverse Event|0|||
16792112|NCT02601001|37733125|FG003|Dosing Period 2|Adverse Event|0|||
16792113|NCT02601001|37733126|FG004|Dosing Period 2|Adverse Event|0|||
16792114|NCT02601001|37733127|FG005|Dosing Period 2|Adverse Event|0|||
16792115|NCT02601001|37733128|FG006|Dosing Period 2|Adverse Event|1|||
16792116|NCT02604199|37733153|FG000|Overall Study|Pregnancy|0|||
16792117|NCT02604199|37733154|FG001|Overall Study|Pregnancy|0|||
16792118|NCT02604199|37733155|FG002|Overall Study|Pregnancy|0|||
16792119|NCT02604199|37733156|FG003|Overall Study|Pregnancy|1|||
16792120|NCT02604199|37733153|FG000|Overall Study|Study terminated by sponsor|0|||
16792121|NCT02604199|37733154|FG001|Overall Study|Study terminated by sponsor|2|||
16792122|NCT02604199|37733155|FG002|Overall Study|Study terminated by sponsor|0|||
16792123|NCT02604199|37733156|FG003|Overall Study|Study terminated by sponsor|2|||
16792124|NCT02604199|37733153|FG000|Overall Study|Withdrawal by Subject|0|||
16792125|NCT02604199|37733154|FG001|Overall Study|Withdrawal by Subject|1|||
16792126|NCT02604199|37733155|FG002|Overall Study|Withdrawal by Subject|0|||
16792127|NCT02604199|37733156|FG003|Overall Study|Withdrawal by Subject|0|||
16792128|NCT02600845|37733169|FG000|Overall Study|Reason Not Specified|3|||
16792129|NCT02600845|37733169|FG000|Overall Study|Non-compliance with Study Procedures|10|||
16792130|NCT02600845|37733169|FG000|Overall Study|Consent Withdrawal|5|||
16792131|NCT02599129|37733175|FG000|Overall Study|Lack of Efficacy|2|||
16792132|NCT02599129|37733176|FG001|Overall Study|Lack of Efficacy|2|||
16792133|NCT02599129|37733175|FG000|Overall Study|Lost to Follow-up|1|||
16792134|NCT02599129|37733176|FG001|Overall Study|Lost to Follow-up|0|||
16792135|NCT02599129|37733175|FG000|Overall Study|Withdrawal by Subject|2|||
16792136|NCT02599129|37733176|FG001|Overall Study|Withdrawal by Subject|1|||
16792137|NCT02596711|37733185|FG000|Overall Study|Lost to Follow-up|1|||
16792138|NCT02596711|37733186|FG001|Overall Study|Lost to Follow-up|2|||
16792139|NCT02596711|37733187|FG002|Overall Study|Lost to Follow-up|3|||
16792140|NCT02596009|37733195|FG000|Overall Study|Administrative problems|0|||
16792141|NCT02596009|37733196|FG001|Overall Study|Administrative problems|1|||
16792142|NCT02596009|37733197|FG002|Overall Study|Administrative problems|0|||
16792143|NCT02596009|37733198|FG003|Overall Study|Administrative problems|0|||
16792144|NCT02596009|37733199|FG004|Overall Study|Administrative problems|0|||
16792145|NCT02596009|37733200|FG005|Overall Study|Administrative problems|0|||
16792146|NCT02590939|37733208|FG000|Overall Study|Withdrawal by Subject|3|||
16792147|NCT02590939|37733209|FG001|Overall Study|Withdrawal by Subject|1|||
16792148|NCT02590939|37733208|FG000|Overall Study|Failed the nociceptive test|2|||
16792149|NCT02590939|37733209|FG001|Overall Study|Failed the nociceptive test|1|||
16792150|NCT02598193|37733215|FG000|Overall Study|Adverse Event|13|||
16792151|NCT02598193|37733215|FG000|Overall Study|Withdrawal by Subject|1|||
16792152|NCT02598193|37733215|FG000|Overall Study|Listed in active lung transplant list|1|||
16792153|NCT02598193|37733215|FG000|Overall Study|Does not want to take Nintedanib|1|||
16792154|NCT02595073|37733221|FG000|Overall Study|Progressive Disease|0|||
16792155|NCT02595073|37733222|FG001|Overall Study|Progressive Disease|1|||
16792156|NCT02595073|37733221|FG000|Overall Study|Protocol Violation|2|||
16792157|NCT02595073|37733222|FG001|Overall Study|Protocol Violation|0|||
16792158|NCT02593825|37733230|FG000|Intervention|Lost to Follow-up|10|||
16792159|NCT02593825|37733231|FG001|Intervention|Lost to Follow-up|12|||
16792160|NCT02388165|37733241|FG000|Overall Study|Study terminated by sponsor|5|||
16792161|NCT02388165|37733242|FG001|Overall Study|Study terminated by sponsor|5|||
16792162|NCT02388165|37733241|FG000|Overall Study|Other|11|||
16792163|NCT02388165|37733242|FG001|Overall Study|Other|13|||
16908774|NCT01754922|38017521|FG001|Overall Study|Adverse Event|1|||
16792164|NCT02388165|37733241|FG000|Overall Study|No longer meet eligibility criteria|40|||
16792165|NCT02388165|37733242|FG001|Overall Study|No longer meet eligibility criteria|43|||
16792166|NCT02388165|37733241|FG000|Overall Study|Withdrawal of consent|31|||
16792167|NCT02388165|37733242|FG001|Overall Study|Withdrawal of consent|32|||
16792168|NCT02388165|37733241|FG000|Overall Study|Lost to Follow-up|19|||
16792169|NCT02388165|37733242|FG001|Overall Study|Lost to Follow-up|20|||
16792170|NCT02388165|37733241|FG000|Overall Study|Death|13|||
16792171|NCT02388165|37733242|FG001|Overall Study|Death|10|||
16792172|NCT02388165|37733241|FG000|Overall Study|Adverse Event|3|||
16792173|NCT02388165|37733242|FG001|Overall Study|Adverse Event|5|||
16792174|NCT02388165|37733241|FG000|Overall Study|Did not meet entrance criteria|5|||
16792175|NCT02388165|37733242|FG001|Overall Study|Did not meet entrance criteria|2|||
16792176|NCT02404545|37733250|FG000|Overall Study|Sponsor Termination|6|||
16792177|NCT02404545|37733251|FG001|Overall Study|Sponsor Termination|6|||
16792178|NCT02420379|37733260|FG000|Overall Study|Withdrawal by Subject|0|||
16792179|NCT02420379|37733261|FG001|Overall Study|Withdrawal by Subject|3|||
16792180|NCT02420379|37733260|FG000|Overall Study|Unable to complete due to schooling|0|||
16792181|NCT02420379|37733261|FG001|Overall Study|Unable to complete due to schooling|1|||
16792182|NCT02420379|37733260|FG000|Overall Study|Transitioned to commercial drug|1|||
16792183|NCT02420379|37733261|FG001|Overall Study|Transitioned to commercial drug|0|||
16792184|NCT02347761|37733270|FG000|All Collected|Death|1|||
16792185|NCT02347761|37733271|FG001|All Collected|Death|0|||
16792186|NCT02347761|37733272|FG002|All Collected|Death|0|||
16792187|NCT02347761|37733270|FG000|All Collected|Lost to Follow-up|3|||
16792188|NCT02347761|37733271|FG001|All Collected|Lost to Follow-up|2|||
16792189|NCT02347761|37733272|FG002|All Collected|Lost to Follow-up|3|||
16792190|NCT02347761|37733270|FG000|All Collected|Withdrawal by Subject|11|||
16792191|NCT02347761|37733271|FG001|All Collected|Withdrawal by Subject|11|||
16792192|NCT02347761|37733272|FG002|All Collected|Withdrawal by Subject|22|||
16792193|NCT02347761|37733270|FG000|All Collected|invetigator disretion|2|||
16792194|NCT02347761|37733271|FG001|All Collected|invetigator disretion|0|||
16792195|NCT02347761|37733272|FG002|All Collected|invetigator disretion|0|||
16792196|NCT02347761|37733270|FG000|All Collected|instillation site pain|0|||
16792197|NCT02347761|37733271|FG001|All Collected|instillation site pain|0|||
16792198|NCT02347761|37733272|FG002|All Collected|instillation site pain|1|||
16792199|NCT02347761|37733270|FG000|All Collected|exacerbation of COPD|0|||
16792200|NCT02347761|37733271|FG001|All Collected|exacerbation of COPD|0|||
16792201|NCT02347761|37733272|FG002|All Collected|exacerbation of COPD|1|||
16792202|NCT02347761|37733270|FG000|All Collected|moved/travel|0|||
16792203|NCT02347761|37733271|FG001|All Collected|moved/travel|1|||
16792204|NCT02347761|37733272|FG002|All Collected|moved/travel|0|||
16792205|NCT02347761|37733270|FG000|On Study Treatment|Lack of Efficacy|2|||
16792206|NCT02347761|37733271|FG001|On Study Treatment|Lack of Efficacy|3|||
16792207|NCT02347761|37733272|FG002|On Study Treatment|Lack of Efficacy|4|||
16792208|NCT02347761|37733270|FG000|On Study Treatment|non-compliance with study medication|0|||
16792209|NCT02347761|37733271|FG001|On Study Treatment|non-compliance with study medication|0|||
16792210|NCT02347761|37733272|FG002|On Study Treatment|non-compliance with study medication|2|||
16792211|NCT02347761|37733270|FG000|On Study Treatment|Withdrawal by Subject|7|||
16792212|NCT02347761|37733271|FG001|On Study Treatment|Withdrawal by Subject|3|||
16792213|NCT02347761|37733272|FG002|On Study Treatment|Withdrawal by Subject|5|||
16792214|NCT02347761|37733270|FG000|On Study Treatment|move/travel|2|||
16792215|NCT02347761|37733271|FG001|On Study Treatment|move/travel|6|||
16792216|NCT02347761|37733272|FG002|On Study Treatment|move/travel|5|||
16792217|NCT02347761|37733270|FG000|On Study Treatment|dissastisfaction with device|2|||
16792218|NCT02347761|37733271|FG001|On Study Treatment|dissastisfaction with device|1|||
16908775|NCT01754766|38017531|FG000|Overall Study|Personal reasons|1|||
16908776|NCT01754766|38017532|FG001|Overall Study|Personal reasons|1|||
16908777|NCT01754766|38017533|FG002|Overall Study|Personal reasons|0|||
16908778|NCT01754376|38017541|FG000|Overall Study|Adverse Event|1|||
16908779|NCT01754376|38017541|FG000|Overall Study|Lack of Efficacy|2|||
16908780|NCT01605396|38017548|FG000|Overall Study|Adverse Event|5|||
16908781|NCT01605396|38017549|FG001|Overall Study|Adverse Event|3|||
17016465|NCT00592904|38161084|FG000|Overall Study|Protocol Violation|1|||
16792219|NCT02347761|37733272|FG002|On Study Treatment|dissastisfaction with device|4|||
16792220|NCT02347761|37733270|FG000|On Study Treatment|Lost to Follow-up|2|||
16792221|NCT02347761|37733271|FG001|On Study Treatment|Lost to Follow-up|1|||
16792222|NCT02347761|37733272|FG002|On Study Treatment|Lost to Follow-up|1|||
16792223|NCT02347761|37733270|FG000|On Study Treatment|investigator discretion|2|||
16792224|NCT02347761|37733271|FG001|On Study Treatment|investigator discretion|0|||
16792225|NCT02347761|37733272|FG002|On Study Treatment|investigator discretion|0|||
16792226|NCT02347761|37733270|FG000|On Study Treatment|durg not working|0|||
16792227|NCT02347761|37733271|FG001|On Study Treatment|durg not working|1|||
16792228|NCT02347761|37733272|FG002|On Study Treatment|durg not working|1|||
16792229|NCT02347761|37733270|FG000|On Study Treatment|Adverse Event|10|||
16792230|NCT02347761|37733271|FG001|On Study Treatment|Adverse Event|8|||
16792231|NCT02347761|37733272|FG002|On Study Treatment|Adverse Event|20|||
16792232|NCT02596945|37733280|FG000|Overall Study|No documentation of study drug dosing|3|||
16792233|NCT02596945|37733280|FG000|Overall Study|Other|32|||
16792234|NCT02596945|37733280|FG000|Overall Study|Change to hemodialysis|15|||
16792235|NCT02596945|37733280|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
16792236|NCT02596945|37733280|FG000|Overall Study|Withdrawal by Subject|1|||
16792237|NCT02596945|37733280|FG000|Overall Study|Missing|1|||
16792238|NCT02404389|37733298|FG000|Overall Study|Adverse Event|1|||
16792239|NCT02404389|37733299|FG001|Overall Study|Adverse Event|0|||
16792240|NCT02404389|37733300|FG002|Overall Study|Adverse Event|1|||
16792241|NCT02404389|37733301|FG003|Overall Study|Adverse Event|0|||
16792242|NCT02404389|37733302|FG004|Overall Study|Adverse Event|2|||
16792243|NCT02404389|37733298|FG000|Overall Study|Subject/guardian decision|1|||
16792244|NCT02404389|37733299|FG001|Overall Study|Subject/guardian decision|0|||
16792245|NCT02404389|37733300|FG002|Overall Study|Subject/guardian decision|0|||
16792246|NCT02404389|37733301|FG003|Overall Study|Subject/guardian decision|1|||
16792247|NCT02404389|37733302|FG004|Overall Study|Subject/guardian decision|1|||
16792248|NCT01667419|37733320|FG000|Overall Study|Reason Not Specified|1|||
16792249|NCT01667419|37733321|FG001|Overall Study|Reason Not Specified|0|||
16792250|NCT01667419|37733322|FG002|Overall Study|Reason Not Specified|0|||
16792251|NCT01667419|37733323|FG003|Overall Study|Reason Not Specified|0|||
16792252|NCT01667419|37733320|FG000|Overall Study|Withdrawal by Subject|16|||
16792253|NCT01667419|37733321|FG001|Overall Study|Withdrawal by Subject|8|||
16792254|NCT01667419|37733322|FG002|Overall Study|Withdrawal by Subject|9|||
16792255|NCT01667419|37733323|FG003|Overall Study|Withdrawal by Subject|8|||
16792256|NCT01667419|37733320|FG000|Overall Study|Non-compliance|0|||
16792257|NCT01667419|37733321|FG001|Overall Study|Non-compliance|0|||
16792258|NCT01667419|37733322|FG002|Overall Study|Non-compliance|0|||
16792259|NCT01667419|37733323|FG003|Overall Study|Non-compliance|1|||
16792260|NCT01667419|37733320|FG000|Overall Study|Protocol Violation|1|||
16792261|NCT01667419|37733321|FG001|Overall Study|Protocol Violation|0|||
16792262|NCT01667419|37733322|FG002|Overall Study|Protocol Violation|0|||
16792263|NCT01667419|37733323|FG003|Overall Study|Protocol Violation|0|||
16792264|NCT01667419|37733320|FG000|Overall Study|Lost to Follow-up|7|||
16792265|NCT01667419|37733321|FG001|Overall Study|Lost to Follow-up|6|||
16792266|NCT01667419|37733322|FG002|Overall Study|Lost to Follow-up|2|||
16792267|NCT01667419|37733323|FG003|Overall Study|Lost to Follow-up|4|||
16792268|NCT01667419|37733320|FG000|Overall Study|Death|18|||
16792269|NCT01667419|37733321|FG001|Overall Study|Death|33|||
16792270|NCT01667419|37733322|FG002|Overall Study|Death|25|||
16792271|NCT01667419|37733323|FG003|Overall Study|Death|26|||
16792272|NCT02588833|37733340|FG000|Part 1|Withdrawal by Subject|1|||
16792273|NCT02588833|37733341|FG001|Part 1|Withdrawal by Subject|0|||
16792274|NCT02588833|37733340|FG000|Part 2A|Physician Decision|0|||
16792275|NCT02588833|37733341|FG001|Part 2A|Physician Decision|1|||
16792276|NCT02588833|37733340|FG000|Part 2A|Withdrawal by Subject|0|||
16792277|NCT02588833|37733341|FG001|Part 2A|Withdrawal by Subject|1|||
16792278|NCT02588833|37733340|FG000|Part 2B|Adverse Event|0|||
16792279|NCT02588833|37733341|FG001|Part 2B|Adverse Event|1|||
16792280|NCT02588833|37733340|FG000|Part 2C|Adverse Event|0|||
16792281|NCT02588833|37733341|FG001|Part 2C|Adverse Event|1|||
16792282|NCT02588833|37733340|FG000|Part 2C|Withdrawal by Subject|0|||
16792283|NCT02588833|37733341|FG001|Part 2C|Withdrawal by Subject|1|||
16792284|NCT02588833|37733340|FG000|Part 3 (Safety Follow-up)|Other|0|||
16792285|NCT02588833|37733341|FG001|Part 3 (Safety Follow-up)|Other|2|||
16792286|NCT01667107|37733350|FG000|Overall Study|Adverse Event|4|||
16792287|NCT01667107|37733351|FG001|Overall Study|Adverse Event|3|||
16792288|NCT01667107|37733350|FG000|Overall Study|Tolerability issues|0|||
16792289|NCT01667107|37733351|FG001|Overall Study|Tolerability issues|2|||
16792290|NCT01667107|37733350|FG000|Overall Study|Protocol Violation|0|||
16792291|NCT01667107|37733351|FG001|Overall Study|Protocol Violation|1|||
16792292|NCT01667107|37733350|FG000|Overall Study|Lack of Efficacy|0|||
16792293|NCT01667107|37733351|FG001|Overall Study|Lack of Efficacy|1|||
16792294|NCT02590003|37733375|FG000|Overall Study|Death|1|||
16792295|NCT02590003|37733376|FG001|Overall Study|Death|2|||
16792296|NCT02404311|37733405|FG000|Part A: Month 0-18|Death|2|||
17016466|NCT00592904|38161085|FG001|Overall Study|Protocol Violation|1|||
16792297|NCT02404311|37733406|FG001|Part A: Month 0-18|Death|0|||
16792298|NCT02404311|37733407|FG002|Part A: Month 0-18|Death|0|||
16792299|NCT02404311|37733408|FG003|Part A: Month 0-18|Death|0|||
16792300|NCT02404311|37733409|FG004|Part A: Month 0-18|Death|0|||
16792301|NCT02404311|37733405|FG000|Part A: Month 0-18|Physician Decision|1|||
17016467|NCT00592904|38161086|FG002|Overall Study|Protocol Violation|0|||
16792302|NCT02404311|37733406|FG001|Part A: Month 0-18|Physician Decision|0|||
16792303|NCT02404311|37733407|FG002|Part A: Month 0-18|Physician Decision|0|||
16792304|NCT02404311|37733408|FG003|Part A: Month 0-18|Physician Decision|0|||
16792305|NCT02404311|37733409|FG004|Part A: Month 0-18|Physician Decision|0|||
16792306|NCT02404311|37733405|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
16792307|NCT02404311|37733406|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
16792308|NCT02404311|37733407|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
16792309|NCT02404311|37733408|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
16792310|NCT02404311|37733409|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
16792311|NCT02404311|37733405|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
16792312|NCT02404311|37733406|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
16792313|NCT02404311|37733407|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
16792314|NCT02404311|37733408|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
16792315|NCT02404311|37733409|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
16792316|NCT02404311|37733405|FG000|Part A: Month 0-18|HIV Infection|6|||
16792317|NCT02404311|37733406|FG001|Part A: Month 0-18|HIV Infection|2|||
16792318|NCT02404311|37733407|FG002|Part A: Month 0-18|HIV Infection|0|||
16792319|NCT02404311|37733408|FG003|Part A: Month 0-18|HIV Infection|0|||
16792320|NCT02404311|37733409|FG004|Part A: Month 0-18|HIV Infection|0|||
16792321|NCT02404311|37733405|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
16792322|NCT02404311|37733406|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
16792323|NCT02404311|37733407|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
16792324|NCT02404311|37733408|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
16792325|NCT02404311|37733409|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
16792326|NCT01650519|37733423|FG000|Overall Study|Withdrawal by Subject|1|||
16792327|NCT01650519|37733424|FG001|Overall Study|Withdrawal by Subject|0|||
16792328|NCT01650285|37733430|FG000|Overall Study|Adverse Event|1|||
16792329|NCT02347527|37733438|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
16792330|NCT02347527|37733439|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
16792331|NCT02347527|37733440|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
16792332|NCT02347527|37733441|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
16792333|NCT02347527|37733438|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
16792334|NCT02347527|37733439|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
16792335|NCT02347527|37733440|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
16792336|NCT02347527|37733441|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
16792337|NCT02347527|37733438|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
16792338|NCT02347527|37733439|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
16792339|NCT02347527|37733440|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
16792340|NCT02347527|37733441|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
16792341|NCT02347527|37733438|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
16792342|NCT02347527|37733439|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
16792343|NCT02347527|37733440|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
16792344|NCT02347527|37733441|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
16792345|NCT02347527|37733438|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
16792346|NCT02347527|37733439|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
16792347|NCT02347527|37733440|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
16792348|NCT02347527|37733441|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
16792349|NCT02386839|37733455|FG000|Overall Study|Death|1|||
16792350|NCT02386839|37733456|FG001|Overall Study|Death|0|||
16792351|NCT02386839|37733455|FG000|Overall Study|Withdrawal by Subject|9|||
16792352|NCT02386839|37733456|FG001|Overall Study|Withdrawal by Subject|10|||
16792353|NCT02386839|37733455|FG000|Overall Study|Lost to Follow-up|4|||
16792354|NCT02386839|37733456|FG001|Overall Study|Lost to Follow-up|4|||
16792355|NCT02386839|37733455|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
16792356|NCT02386839|37733456|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
16792357|NCT02386839|37733455|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
16792358|NCT02386839|37733456|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
16792359|NCT02386839|37733455|FG000|Overall Study|Other (unspecified)|1|||
16792360|NCT02386839|37733456|FG001|Overall Study|Other (unspecified)|0|||
16792361|NCT01649271|37733468|FG000|Overall Study|Progressive disease|4|||
16792362|NCT01649271|37733469|FG001|Overall Study|Progressive disease|5|||
16792363|NCT01649271|37733468|FG000|Overall Study|Other Adverse Event|0|||
16792364|NCT01649271|37733469|FG001|Overall Study|Other Adverse Event|2|||
16792365|NCT01649271|37733468|FG000|Overall Study|Withdrawal by Subject|1|||
16792366|NCT01649271|37733469|FG001|Overall Study|Withdrawal by Subject|0|||
16792367|NCT01649271|37733468|FG000|Overall Study|Other than stated above|1|||
16792368|NCT01649271|37733469|FG001|Overall Study|Other than stated above|0|||
16792369|NCT02385669|37733476|FG000|Overall Study|Adverse Event|2|||
16792370|NCT02402907|37733482|FG000|Overall Study|Delivered vaginally|9|||
16792371|NCT02402907|37733483|FG001|Overall Study|Delivered vaginally|3|||
16792372|NCT02402907|37733482|FG000|Overall Study|Delivered outside of Sinai|1|||
16792373|NCT02402907|37733483|FG001|Overall Study|Delivered outside of Sinai|1|||
16792374|NCT02402907|37733482|FG000|Overall Study|Lost to follow up after C-Section|10|||
16792375|NCT02402907|37733483|FG001|Overall Study|Lost to follow up after C-Section|23|||
16792376|NCT02345889|37733493|FG000|Overall Study|Inadequate Bowel Prep|17|||
16792377|NCT02345889|37733494|FG001|Overall Study|Inadequate Bowel Prep|16|||
16792378|NCT02345889|37733495|FG002|Overall Study|Inadequate Bowel Prep|18|||
16792379|NCT02345889|37733496|FG003|Overall Study|Inadequate Bowel Prep|14|||
16792380|NCT02345889|37733493|FG000|Overall Study|Polyposis identified during procedure|1|||
16792381|NCT02345889|37733494|FG001|Overall Study|Polyposis identified during procedure|1|||
16792382|NCT02345889|37733495|FG002|Overall Study|Polyposis identified during procedure|0|||
16792383|NCT02345889|37733496|FG003|Overall Study|Polyposis identified during procedure|1|||
16792384|NCT02345889|37733493|FG000|Overall Study|Recognized ineligible post-randomization|1|||
16792385|NCT02345889|37733494|FG001|Overall Study|Recognized ineligible post-randomization|0|||
16792386|NCT02345889|37733495|FG002|Overall Study|Recognized ineligible post-randomization|2|||
16792387|NCT02345889|37733496|FG003|Overall Study|Recognized ineligible post-randomization|1|||
16792388|NCT02345889|37733493|FG000|Overall Study|Ulcerative Colitis identified|1|||
16792389|NCT02345889|37733494|FG001|Overall Study|Ulcerative Colitis identified|0|||
16792390|NCT02345889|37733495|FG002|Overall Study|Ulcerative Colitis identified|0|||
16792391|NCT02345889|37733496|FG003|Overall Study|Ulcerative Colitis identified|0|||
16792392|NCT02345889|37733493|FG000|Overall Study|Cecum not intubated|1|||
16792393|NCT02345889|37733494|FG001|Overall Study|Cecum not intubated|0|||
16792394|NCT02345889|37733495|FG002|Overall Study|Cecum not intubated|0|||
16792395|NCT02345889|37733496|FG003|Overall Study|Cecum not intubated|0|||
16792396|NCT02345811|37733506|FG000|First Intervention|Withdrawal by Subject|1|||
16792397|NCT02345811|37733507|FG001|First Intervention|Withdrawal by Subject|1|||
16792398|NCT02344173|37733515|FG000|Procedure|Ablation Procedure Not Performed|7|||
16792399|NCT02344173|37733515|FG000|12-month Visit|Death|8|||
16792400|NCT02344173|37733515|FG000|12-month Visit|Withdrawal by Subject|30|||
16792401|NCT02344173|37733515|FG000|12-month Visit|Lost to Follow-up|58|||
16792402|NCT02586493|37733521|FG000|Overall Study|Adverse Event|4|||
16792403|NCT02586493|37733521|FG000|Overall Study|Protocol Violation|6|||
16792404|NCT02586493|37733521|FG000|Overall Study|Lost to Follow-up|1|||
16792405|NCT02586493|37733521|FG000|Overall Study|Withdrawal by Subject|1|||
16792406|NCT02400333|37733529|FG000|Overall Study|Withdrawal by Subject|0|||
16792407|NCT02400333|37733530|FG001|Overall Study|Withdrawal by Subject|1|||
16792408|NCT02400333|37733531|FG002|Overall Study|Withdrawal by Subject|0|||
16792409|NCT02400333|37733532|FG003|Overall Study|Withdrawal by Subject|1|||
16792410|NCT02400333|37733529|FG000|Overall Study|Protocol Violation|1|||
16792411|NCT02400333|37733530|FG001|Overall Study|Protocol Violation|0|||
16792412|NCT02400333|37733531|FG002|Overall Study|Protocol Violation|2|||
16792413|NCT02400333|37733532|FG003|Overall Study|Protocol Violation|1|||
16792414|NCT02399475|37733545|FG000|Overall Study|Physician Decision|1|||
16792415|NCT02399475|37733546|FG001|Overall Study|Physician Decision|0|||
16792416|NCT02399163|37733552|FG000|Overall Study|Adverse Event|2|||
16792417|NCT02399163|37733552|FG000|Overall Study|Protocol Deviation|2|||
16792418|NCT02399163|37733552|FG000|Overall Study|Withdrawal by Participant|5|||
16792419|NCT02398227|37733566|FG000|Overall Study|Lost to Follow-up|21|||
16792420|NCT02398227|37733567|FG001|Overall Study|Lost to Follow-up|12|||
16792421|NCT02398227|37733566|FG000|Overall Study|Withdrawal by Subject|5|||
16792422|NCT02398227|37733567|FG001|Overall Study|Withdrawal by Subject|6|||
16792423|NCT02398227|37733566|FG000|Overall Study|Removed from treatment and dropped out|1|||
16792424|NCT02398227|37733567|FG001|Overall Study|Removed from treatment and dropped out|0|||
16792425|NCT02397915|37733573|FG000|Period 1|Protocol Violation|0|||
16792426|NCT02397915|37733574|FG001|Period 1|Protocol Violation|1|||
16792427|NCT02397915|37733575|FG002|Period 1|Protocol Violation|0|||
16792428|NCT02397915|37733576|FG003|Period 1|Protocol Violation|0|||
16792429|NCT02397915|37733573|FG000|Period 1|Physician Decision|1|||
16792430|NCT02397915|37733574|FG001|Period 1|Physician Decision|0|||
16792431|NCT02397915|37733575|FG002|Period 1|Physician Decision|0|||
16792432|NCT02397915|37733576|FG003|Period 1|Physician Decision|0|||
16792433|NCT02397837|37733586|FG000|Overall Study|Withdrawal by Subject|6|||
16792434|NCT02397837|37733587|FG001|Overall Study|Withdrawal by Subject|5|||
16792435|NCT02397837|37733586|FG000|Overall Study|Physician Decision|1|||
16792436|NCT02397837|37733587|FG001|Overall Study|Physician Decision|1|||
16792437|NCT02586415|37733595|FG000|Overall Study|Death|13|||
16792438|NCT02586415|37733596|FG001|Overall Study|Death|23|||
16792439|NCT02586415|37733595|FG000|Overall Study|Lost to Follow-up|1|||
16792440|NCT02586415|37733596|FG001|Overall Study|Lost to Follow-up|2|||
16792441|NCT02383173|37733605|FG000|Overall Study|Palliative Care Team withdrew|0|||
16792442|NCT02383173|37733606|FG001|Overall Study|Palliative Care Team withdrew|2|||
16792443|NCT02383017|37733614|FG000|Overall Study|Injury Sustained Outside Study|1|||
16792444|NCT02383017|37733615|FG001|Overall Study|Injury Sustained Outside Study|0|||
16792445|NCT02383017|37733614|FG000|Overall Study|Compliance|3|||
16792446|NCT02383017|37733615|FG001|Overall Study|Compliance|2|||
16792447|NCT02383017|37733614|FG000|Overall Study|Found to be Hypogonadal|1|||
16792448|NCT02383017|37733615|FG001|Overall Study|Found to be Hypogonadal|0|||
16792449|NCT02382939|37733623|FG000|Overall Study|Adverse Event|1|||
16792450|NCT02382939|37733624|FG001|Overall Study|Adverse Event|1|||
16792451|NCT02382939|37733623|FG000|Overall Study|Withdrawal by Subject|2|||
16792452|NCT02382939|37733624|FG001|Overall Study|Withdrawal by Subject|2|||
16792453|NCT02587819|37733631|FG000|Overall Study|Adverse Event|1|||
16792454|NCT02587819|37733631|FG000|Overall Study|Lost to Follow-up|1|||
16792455|NCT01666951|37733638|FG000|Overall Study|Not dosed|1|||
16792456|NCT01666951|37733639|FG001|Overall Study|Not dosed|1|||
16792457|NCT02586805|37733649|FG000|Overall Study|Withdrawal by Subject|3|||
16792458|NCT02586805|37733650|FG001|Overall Study|Withdrawal by Subject|1|||
16792459|NCT02586805|37733651|FG002|Overall Study|Withdrawal by Subject|1|||
16792460|NCT02586805|37733652|FG003|Overall Study|Withdrawal by Subject|2|||
16792461|NCT02586805|37733649|FG000|Overall Study|Adverse Event|2|||
16792462|NCT02586805|37733650|FG001|Overall Study|Adverse Event|0|||
16792463|NCT02586805|37733651|FG002|Overall Study|Adverse Event|1|||
16792464|NCT02586805|37733652|FG003|Overall Study|Adverse Event|0|||
16792465|NCT02586805|37733649|FG000|Overall Study|Lost to Follow-up|0|||
16792466|NCT02586805|37733650|FG001|Overall Study|Lost to Follow-up|0|||
16792467|NCT02586805|37733651|FG002|Overall Study|Lost to Follow-up|1|||
16792468|NCT02586805|37733652|FG003|Overall Study|Lost to Follow-up|0|||
16792469|NCT02586805|37733649|FG000|Overall Study|Physician Decision|1|||
16792470|NCT02586805|37733650|FG001|Overall Study|Physician Decision|0|||
16792471|NCT02586805|37733651|FG002|Overall Study|Physician Decision|0|||
16792472|NCT02586805|37733652|FG003|Overall Study|Physician Decision|0|||
16792473|NCT02586727|37733664|FG000|Overall Study|Lost to Follow-up|1|||
16792474|NCT02586727|37733665|FG001|Overall Study|Lost to Follow-up|0|||
16792475|NCT02580877|37733673|FG000|Overall Study|Withdrawal by Subject|1|||
16792476|NCT02580877|37733674|FG001|Overall Study|Withdrawal by Subject|3|||
16792477|NCT02580877|37733673|FG000|Overall Study|Adverse Event|0|||
16792478|NCT02580877|37733674|FG001|Overall Study|Adverse Event|1|||
16792479|NCT02582983|37733690|FG000|Overall Study|Death|3|||
16792480|NCT02582983|37733690|FG000|Overall Study|Withdrawal by Subject|2|||
16792481|NCT02582983|37733690|FG000|Overall Study|Adverse Event|1|||
16792482|NCT02582749|37733696|FG000|Overall Study|Study terminated by funder|5|||
16792483|NCT02582749|37733697|FG001|Overall Study|Study terminated by funder|10|||
16792484|NCT02582749|37733696|FG000|Overall Study|Withdrawal by Subject|0|||
16792485|NCT02582749|37733697|FG001|Overall Study|Withdrawal by Subject|1|||
16792486|NCT02586025|37733705|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
16792487|NCT02586025|37733706|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
16792488|NCT02586025|37733705|FG000|Neoadjuvant Treatment|Death|1|||
16792489|NCT02586025|37733706|FG001|Neoadjuvant Treatment|Death|0|||
16792490|NCT02586025|37733705|FG000|Neoadjuvant Treatment|Adverse Event|1|||
16792491|NCT02586025|37733706|FG001|Neoadjuvant Treatment|Adverse Event|0|||
16792492|NCT02586025|37733705|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
16792493|NCT02586025|37733706|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
16792494|NCT02586025|37733705|FG000|Neoadjuvant Treatment|Physician Decision|2|||
16792495|NCT02586025|37733706|FG001|Neoadjuvant Treatment|Physician Decision|1|||
16792496|NCT02586025|37733705|FG000|Neoadjuvant Treatment|Progressive Disease|2|||
16792497|NCT02586025|37733706|FG001|Neoadjuvant Treatment|Progressive Disease|3|||
16792498|NCT02586025|37733705|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133|||
16792499|NCT02586025|37733706|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61|||
16792500|NCT02586025|37733705|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
16792501|NCT02586025|37733706|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
16792502|NCT02586025|37733705|FG000|Adjuvant Treatment|Physician Decision|0|||
16792503|NCT02586025|37733706|FG001|Adjuvant Treatment|Physician Decision|1|||
16792504|NCT02586025|37733705|FG000|Adjuvant Treatment|Recurrent Disease|1|||
16792505|NCT02586025|37733706|FG001|Adjuvant Treatment|Recurrent Disease|4|||
16792506|NCT02586025|37733705|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56|||
16792507|NCT02586025|37733706|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35|||
16792508|NCT02582671|37733712|FG000|Overall Study|Failure to return|1|||
16792509|NCT02582671|37733712|FG000|Overall Study|Other, not specified|1|||
16792510|NCT02585713|37733719|FG000|Overall Study|Withdrew prior to treatment|2|||
16792511|NCT02585713|37733720|FG001|Overall Study|Withdrew prior to treatment|7|||
16792512|NCT02585713|37733719|FG000|Overall Study|Other|3|||
16792513|NCT02585713|37733720|FG001|Overall Study|Other|1|||
16792514|NCT02579863|37733728|FG000|Overall Study|Final Disposition Unknown|2|||
16792515|NCT02579863|37733729|FG001|Overall Study|Final Disposition Unknown|1|||
16792516|NCT02579863|37733728|FG000|Overall Study|Adverse Event|18|||
16792517|NCT02579863|37733729|FG001|Overall Study|Adverse Event|11|||
16792518|NCT02579863|37733728|FG000|Overall Study|Death|31|||
16792519|NCT02579863|37733729|FG001|Overall Study|Death|29|||
16792520|NCT02579863|37733728|FG000|Overall Study|Lost to Follow-up|2|||
16792521|NCT02579863|37733729|FG001|Overall Study|Lost to Follow-up|1|||
16792522|NCT02579863|37733728|FG000|Overall Study|Physician Decision|1|||
16792523|NCT02579863|37733729|FG001|Overall Study|Physician Decision|2|||
16792524|NCT02579863|37733728|FG000|Overall Study|Screen Failure|0|||
16792525|NCT02579863|37733729|FG001|Overall Study|Screen Failure|2|||
16792526|NCT02579863|37733728|FG000|Overall Study|Study Terminated at Selected Sites|82|||
16792527|NCT02579863|37733729|FG001|Overall Study|Study Terminated at Selected Sites|88|||
16792528|NCT02579863|37733728|FG000|Overall Study|Withdrawal by Subject|20|||
16792529|NCT02579863|37733729|FG001|Overall Study|Withdrawal by Subject|20|||
16792530|NCT02582515|37733737|FG000|Overall Study|Withdrawal by Subject|0|||
16792531|NCT02582515|37733738|FG001|Overall Study|Withdrawal by Subject|1|||
16792532|NCT02579629|37733747|FG000|Overall Study|Withdrawal by Subject|0|||
16792533|NCT02579629|37733748|FG001|Overall Study|Withdrawal by Subject|1|||
16792534|NCT02579629|37733749|FG002|Overall Study|Withdrawal by Subject|0|||
16792535|NCT02579629|37733747|FG000|Overall Study|Screen Failure|2|||
16792536|NCT02579629|37733748|FG001|Overall Study|Screen Failure|0|||
16792537|NCT02579629|37733749|FG002|Overall Study|Screen Failure|2|||
16792538|NCT02343939|37733766|FG000|Overall Study|Death|0|||
16792539|NCT02343939|37733767|FG001|Overall Study|Death|15|||
16792540|NCT02343939|37733768|FG002|Overall Study|Death|4|||
16792541|NCT02343939|37733769|FG003|Overall Study|Death|2|||
16792542|NCT02343939|37733770|FG004|Overall Study|Death|5|||
16792543|NCT02343939|37733771|FG005|Overall Study|Death|11|||
16792544|NCT02343939|37733772|FG006|Overall Study|Death|8|||
16792545|NCT02343939|37733773|FG007|Overall Study|Death|22|||
16792546|NCT02343939|37733774|FG008|Overall Study|Death|1|||
16792547|NCT02343939|37733766|FG000|Overall Study|Study terminated by sponsor|0|||
16792548|NCT02343939|37733767|FG001|Overall Study|Study terminated by sponsor|27|||
16792549|NCT02343939|37733768|FG002|Overall Study|Study terminated by sponsor|0|||
16792550|NCT02343939|37733769|FG003|Overall Study|Study terminated by sponsor|1|||
16792551|NCT02343939|37733770|FG004|Overall Study|Study terminated by sponsor|1|||
16792552|NCT02343939|37733771|FG005|Overall Study|Study terminated by sponsor|5|||
16792553|NCT02343939|37733772|FG006|Overall Study|Study terminated by sponsor|3|||
16792554|NCT02343939|37733773|FG007|Overall Study|Study terminated by sponsor|4|||
16792555|NCT02343939|37733774|FG008|Overall Study|Study terminated by sponsor|0|||
16792556|NCT02343939|37733766|FG000|Overall Study|Withdrew consent|3|||
16792557|NCT02343939|37733767|FG001|Overall Study|Withdrew consent|6|||
16792558|NCT02343939|37733768|FG002|Overall Study|Withdrew consent|1|||
16792559|NCT02343939|37733769|FG003|Overall Study|Withdrew consent|2|||
16792560|NCT02343939|37733770|FG004|Overall Study|Withdrew consent|2|||
16792561|NCT02343939|37733771|FG005|Overall Study|Withdrew consent|0|||
16792562|NCT02343939|37733772|FG006|Overall Study|Withdrew consent|0|||
16792563|NCT02343939|37733773|FG007|Overall Study|Withdrew consent|8|||
16792564|NCT02343939|37733774|FG008|Overall Study|Withdrew consent|6|||
16792565|NCT02343939|37733766|FG000|Overall Study|Treatment failure|0|||
16792566|NCT02343939|37733767|FG001|Overall Study|Treatment failure|0|||
16792567|NCT02343939|37733768|FG002|Overall Study|Treatment failure|0|||
16792568|NCT02343939|37733769|FG003|Overall Study|Treatment failure|0|||
16792569|NCT02343939|37733770|FG004|Overall Study|Treatment failure|0|||
16792570|NCT02343939|37733771|FG005|Overall Study|Treatment failure|0|||
16792571|NCT02343939|37733772|FG006|Overall Study|Treatment failure|2|||
16792572|NCT02343939|37733773|FG007|Overall Study|Treatment failure|1|||
16792573|NCT02343939|37733774|FG008|Overall Study|Treatment failure|0|||
16792574|NCT02343939|37733766|FG000|Overall Study|Investigator's discretion|0|||
16792575|NCT02343939|37733767|FG001|Overall Study|Investigator's discretion|0|||
16792576|NCT02343939|37733768|FG002|Overall Study|Investigator's discretion|0|||
16792577|NCT02343939|37733769|FG003|Overall Study|Investigator's discretion|1|||
16792578|NCT02343939|37733770|FG004|Overall Study|Investigator's discretion|0|||
16792579|NCT02343939|37733771|FG005|Overall Study|Investigator's discretion|0|||
16792580|NCT02343939|37733772|FG006|Overall Study|Investigator's discretion|1|||
16792581|NCT02343939|37733773|FG007|Overall Study|Investigator's discretion|0|||
16792582|NCT02343939|37733774|FG008|Overall Study|Investigator's discretion|0|||
16792583|NCT02343939|37733766|FG000|Overall Study|Adverse Event|0|||
16792584|NCT02343939|37733767|FG001|Overall Study|Adverse Event|0|||
16792585|NCT02343939|37733768|FG002|Overall Study|Adverse Event|0|||
16792586|NCT02343939|37733769|FG003|Overall Study|Adverse Event|0|||
16792587|NCT02343939|37733770|FG004|Overall Study|Adverse Event|0|||
16792588|NCT02343939|37733771|FG005|Overall Study|Adverse Event|1|||
16792589|NCT02343939|37733772|FG006|Overall Study|Adverse Event|0|||
16792590|NCT02343939|37733773|FG007|Overall Study|Adverse Event|0|||
16792591|NCT02343939|37733774|FG008|Overall Study|Adverse Event|0|||
16792592|NCT02343939|37733766|FG000|Overall Study|Never Treated With ENTO|0|||
16792593|NCT02343939|37733767|FG001|Overall Study|Never Treated With ENTO|0|||
16792594|NCT02343939|37733768|FG002|Overall Study|Never Treated With ENTO|0|||
16792595|NCT02343939|37733769|FG003|Overall Study|Never Treated With ENTO|0|||
16792596|NCT02343939|37733770|FG004|Overall Study|Never Treated With ENTO|0|||
16792597|NCT02343939|37733771|FG005|Overall Study|Never Treated With ENTO|0|||
16792598|NCT02343939|37733772|FG006|Overall Study|Never Treated With ENTO|1|||
16792599|NCT02343939|37733773|FG007|Overall Study|Never Treated With ENTO|2|||
16792600|NCT02343939|37733774|FG008|Overall Study|Never Treated With ENTO|0|||
16792601|NCT02397447|37733810|FG000|Overall Study|Lost to Follow-up|2|||
16792602|NCT02397447|37733811|FG001|Overall Study|Lost to Follow-up|2|||
16792603|NCT02397057|37733819|FG000|Overall Study|Withdrawal by Subject|6|||
16792604|NCT02397057|37733820|FG001|Overall Study|Withdrawal by Subject|7|||
17198293|NCT01331681|38351892|FG000|Overall Study|Adverse Event|10|||
16792605|NCT02397057|37733819|FG000|Overall Study|Lost to Follow-up|4|||
16792606|NCT02397057|37733820|FG001|Overall Study|Lost to Follow-up|3|||
16792607|NCT02397057|37733819|FG000|Overall Study|Death|1|||
16792608|NCT02397057|37733820|FG001|Overall Study|Death|0|||
16792609|NCT02397057|37733819|FG000|Overall Study|Adverse Event|0|||
16792610|NCT02397057|37733820|FG001|Overall Study|Adverse Event|1|||
16792611|NCT02397057|37733819|FG000|Overall Study|Physician Decision|0|||
16792612|NCT02397057|37733820|FG001|Overall Study|Physician Decision|1|||
16792613|NCT02397057|37733819|FG000|Overall Study|Subject did not receive study drug|0|||
16792614|NCT02397057|37733820|FG001|Overall Study|Subject did not receive study drug|1|||
16792615|NCT02343549|37733826|FG000|Overall Study|Death|11|||
16792616|NCT02343549|37733826|FG000|Overall Study|Withdrawal by Subject|2|||
16792617|NCT02343159|37733833|FG000|Overall Study|Early Study Termination|16|||
16792618|NCT02343159|37733834|FG001|Overall Study|Early Study Termination|19|||
16792619|NCT02343159|37733835|FG002|Overall Study|Early Study Termination|23|||
16792620|NCT02343159|37733833|FG000|Overall Study|Physician Decision|2|||
16792621|NCT02343159|37733834|FG001|Overall Study|Physician Decision|0|||
16792622|NCT02343159|37733835|FG002|Overall Study|Physician Decision|1|||
16792623|NCT02343159|37733833|FG000|Overall Study|Withdrawal by Subject|3|||
16792624|NCT02343159|37733834|FG001|Overall Study|Withdrawal by Subject|0|||
16792625|NCT02343159|37733835|FG002|Overall Study|Withdrawal by Subject|2|||
16792626|NCT02343159|37733833|FG000|Overall Study|Lost to Follow-up|0|||
16792627|NCT02343159|37733834|FG001|Overall Study|Lost to Follow-up|2|||
16792628|NCT02343159|37733835|FG002|Overall Study|Lost to Follow-up|2|||
16792629|NCT02343159|37733833|FG000|Overall Study|Adverse Event|4|||
16792630|NCT02343159|37733834|FG001|Overall Study|Adverse Event|4|||
16792631|NCT02343159|37733835|FG002|Overall Study|Adverse Event|2|||
16792632|NCT02343159|37733833|FG000|Overall Study|Sponsor Decision|0|||
16792633|NCT02343159|37733834|FG001|Overall Study|Sponsor Decision|1|||
16792634|NCT02343159|37733835|FG002|Overall Study|Sponsor Decision|0|||
16792635|NCT02343159|37733833|FG000|Overall Study|Enrollment Error|1|||
16792636|NCT02343159|37733834|FG001|Overall Study|Enrollment Error|0|||
16792637|NCT02343159|37733835|FG002|Overall Study|Enrollment Error|0|||
16792638|NCT02395653|37733844|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
16792639|NCT02395653|37733844|FG000|Overall Study|Consent Withdrawn at Screening|1|||
16792640|NCT02395653|37733844|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
16792641|NCT02395653|37733844|FG000|Overall Study|Investigator Decision at Screening|1|||
16792642|NCT02395653|37733844|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
16792643|NCT02395653|37733844|FG000|Overall Study|Withdrawal by Subject|1|||
16792644|NCT02395653|37733844|FG000|Overall Study|Lost to Follow-up|1|||
16792645|NCT01664923|37733850|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
16792646|NCT01664923|37733851|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
16792647|NCT01664923|37733850|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
16792648|NCT01664923|37733851|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
16792649|NCT01664923|37733850|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
16792650|NCT01664923|37733851|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
16792651|NCT01664923|37733850|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
16792652|NCT01664923|37733851|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
16792653|NCT01664923|37733850|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
16792654|NCT01664923|37733851|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
16792655|NCT01664923|37733850|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
16792656|NCT01664923|37733851|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
16792657|NCT01664923|37733850|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
16792658|NCT01664923|37733851|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
16792659|NCT01664923|37733850|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
16792660|NCT01664923|37733851|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
16792661|NCT01664923|37733850|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
16792662|NCT01664923|37733851|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
16792663|NCT01664923|37733850|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
16792664|NCT01664923|37733851|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
16792665|NCT01664923|37733850|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
16792666|NCT01664923|37733851|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
16792667|NCT01664923|37733850|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
16792668|NCT01664923|37733851|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
16792669|NCT01664923|37733850|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
16792670|NCT01664923|37733851|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
16792671|NCT01664923|37733850|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
16792672|NCT01664923|37733851|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
16908782|NCT01605396|38017548|FG000|Overall Study|Lost to Follow-up|1|||
16908783|NCT01605396|38017549|FG001|Overall Study|Lost to Follow-up|0|||
17198294|NCT01331681|38351893|FG001|Overall Study|Adverse Event|13|||
17198295|NCT01331681|38351894|FG002|Overall Study|Adverse Event|10|||
17198296|NCT01331681|38351892|FG000|Overall Study|Death|6|||
17198297|NCT01331681|38351893|FG001|Overall Study|Death|6|||
17198298|NCT01331681|38351894|FG002|Overall Study|Death|2|||
17198299|NCT01331681|38351892|FG000|Overall Study|Lack of Efficacy|0|||
17198300|NCT01331681|38351893|FG001|Overall Study|Lack of Efficacy|1|||
17198301|NCT01331681|38351894|FG002|Overall Study|Lack of Efficacy|0|||
17198302|NCT01331681|38351892|FG000|Overall Study|Withdrawal by Subject|12|||
17198303|NCT01331681|38351893|FG001|Overall Study|Withdrawal by Subject|8|||
17198304|NCT01331681|38351894|FG002|Overall Study|Withdrawal by Subject|15|||
16792673|NCT01664533|37733861|FG000|Overall Study|Death|42|||
16792674|NCT01664533|37733861|FG000|Overall Study|Lost to Follow-up|3|||
16792675|NCT01664533|37733861|FG000|Overall Study|Study termination|9|||
16792676|NCT01664533|37733861|FG000|Overall Study|Protocol Violation|3|||
16792677|NCT02584855|37733866|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
16792678|NCT02584855|37733867|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
16792679|NCT02584855|37733868|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
16792680|NCT02584855|37733869|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
16792681|NCT02584855|37733870|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
16792682|NCT02584855|37733871|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
16792683|NCT02584855|37733866|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
16792684|NCT02584855|37733867|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
16792685|NCT02584855|37733868|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
16792686|NCT02584855|37733869|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
16792687|NCT02584855|37733870|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
16792688|NCT02584855|37733871|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
16792689|NCT02584855|37733866|FG000|Open-Label Treatment Period|Adverse Event|14|||
16792690|NCT02584855|37733867|FG001|Open-Label Treatment Period|Adverse Event|0|||
16792691|NCT02584855|37733868|FG002|Open-Label Treatment Period|Adverse Event|0|||
16792692|NCT02584855|37733869|FG003|Open-Label Treatment Period|Adverse Event|0|||
16792693|NCT02584855|37733870|FG004|Open-Label Treatment Period|Adverse Event|0|||
16792694|NCT02584855|37733871|FG005|Open-Label Treatment Period|Adverse Event|0|||
16792695|NCT02584855|37733866|FG000|Open-Label Treatment Period|Death|2|||
16792696|NCT02584855|37733867|FG001|Open-Label Treatment Period|Death|0|||
16792697|NCT02584855|37733868|FG002|Open-Label Treatment Period|Death|0|||
16792698|NCT02584855|37733869|FG003|Open-Label Treatment Period|Death|0|||
16792699|NCT02584855|37733870|FG004|Open-Label Treatment Period|Death|0|||
16792700|NCT02584855|37733871|FG005|Open-Label Treatment Period|Death|0|||
16792701|NCT02584855|37733866|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
16792702|NCT02584855|37733867|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
16792703|NCT02584855|37733868|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
16792704|NCT02584855|37733869|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
16792705|NCT02584855|37733870|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
16792706|NCT02584855|37733871|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
16792707|NCT02584855|37733866|FG000|Open-Label Treatment Period|Protocol Violation|1|||
16792708|NCT02584855|37733867|FG001|Open-Label Treatment Period|Protocol Violation|0|||
16792709|NCT02584855|37733868|FG002|Open-Label Treatment Period|Protocol Violation|0|||
16792710|NCT02584855|37733869|FG003|Open-Label Treatment Period|Protocol Violation|0|||
16792711|NCT02584855|37733870|FG004|Open-Label Treatment Period|Protocol Violation|0|||
16792712|NCT02584855|37733871|FG005|Open-Label Treatment Period|Protocol Violation|0|||
16792713|NCT02584855|37733866|FG000|Open-Label Treatment Period|No PI Available|2|||
16792714|NCT02584855|37733867|FG001|Open-Label Treatment Period|No PI Available|0|||
16792715|NCT02584855|37733868|FG002|Open-Label Treatment Period|No PI Available|0|||
16792716|NCT02584855|37733869|FG003|Open-Label Treatment Period|No PI Available|0|||
16792717|NCT02584855|37733870|FG004|Open-Label Treatment Period|No PI Available|0|||
16792718|NCT02584855|37733871|FG005|Open-Label Treatment Period|No PI Available|0|||
16792719|NCT02584855|37733866|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
16792720|NCT02584855|37733867|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
16792721|NCT02584855|37733868|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
16792722|NCT02584855|37733869|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
16792723|NCT02584855|37733870|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
16792724|NCT02584855|37733871|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
16792725|NCT02584855|37733866|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16792726|NCT02584855|37733867|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16792727|NCT02584855|37733868|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
16792728|NCT02584855|37733869|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16792729|NCT02584855|37733870|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16792730|NCT02584855|37733871|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16792731|NCT02584855|37733866|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
16792732|NCT02584855|37733867|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
16792733|NCT02584855|37733868|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
16792734|NCT02584855|37733869|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
16792735|NCT02584855|37733870|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
16792736|NCT02584855|37733871|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
16792737|NCT02584855|37733866|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16792738|NCT02584855|37733867|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
16792739|NCT02584855|37733868|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16792740|NCT02584855|37733869|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16792741|NCT02584855|37733870|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16792742|NCT02584855|37733871|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16792743|NCT02584855|37733866|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16792744|NCT02584855|37733867|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
16792745|NCT02584855|37733868|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16792746|NCT02584855|37733869|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16792747|NCT02584855|37733870|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16792748|NCT02584855|37733871|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16792749|NCT02584855|37733866|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16792750|NCT02584855|37733867|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16792751|NCT02584855|37733868|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16792752|NCT02584855|37733869|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16792753|NCT02584855|37733870|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
16792754|NCT02584855|37733871|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16792755|NCT02584855|37733866|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
16792756|NCT02584855|37733867|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
16792757|NCT02584855|37733868|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
16792758|NCT02584855|37733869|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
16792759|NCT02584855|37733870|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
16792760|NCT02584855|37733871|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
16792761|NCT02581891|37733886|FG000|Overall Study|Adverse Event|4|||
16792762|NCT02581891|37733887|FG001|Overall Study|Adverse Event|6|||
16792763|NCT02581891|37733886|FG000|Overall Study|Death|3|||
16792764|NCT02581891|37733887|FG001|Overall Study|Death|4|||
16792765|NCT02581891|37733886|FG000|Overall Study|Lost to Follow-up|1|||
16792766|NCT02581891|37733887|FG001|Overall Study|Lost to Follow-up|2|||
16792767|NCT02581891|37733886|FG000|Overall Study|Physician Decision|0|||
16792768|NCT02581891|37733887|FG001|Overall Study|Physician Decision|1|||
16792769|NCT02581891|37733886|FG000|Overall Study|Withdrawal by Subject|4|||
16792770|NCT02581891|37733887|FG001|Overall Study|Withdrawal by Subject|5|||
16792771|NCT02581891|37733886|FG000|Overall Study|Other Reasons|3|||
16792772|NCT02581891|37733887|FG001|Overall Study|Other Reasons|1|||
16792773|NCT02581891|37733886|FG000|Overall Study|Discontinued during followup|1|||
16792774|NCT02581891|37733887|FG001|Overall Study|Discontinued during followup|0|||
16792775|NCT02581345|37733896|FG000|Part 1: up to Week 16|Adverse Event|3|||
16792776|NCT02581345|37733897|FG001|Part 1: up to Week 16|Adverse Event|8|||
16792777|NCT02581345|37733898|FG002|Part 1: up to Week 16|Adverse Event|0|||
16792778|NCT02581345|37733899|FG003|Part 1: up to Week 16|Adverse Event|0|||
16792779|NCT02581345|37733896|FG000|Part 1: up to Week 16|Physician Decision|2|||
16792780|NCT02581345|37733897|FG001|Part 1: up to Week 16|Physician Decision|4|||
16792781|NCT02581345|37733898|FG002|Part 1: up to Week 16|Physician Decision|0|||
16792782|NCT02581345|37733899|FG003|Part 1: up to Week 16|Physician Decision|0|||
16792783|NCT02581345|37733896|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
16792784|NCT02581345|37733897|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
16792785|NCT02581345|37733898|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
16792786|NCT02581345|37733899|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
16792787|NCT02581345|37733896|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
16792788|NCT02581345|37733897|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
16792789|NCT02581345|37733898|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
16792790|NCT02581345|37733899|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
16792791|NCT02581345|37733896|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
16792792|NCT02581345|37733897|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
16792793|NCT02581345|37733898|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
16792794|NCT02581345|37733899|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
16792795|NCT02581345|37733896|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
16792796|NCT02581345|37733897|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
16792797|NCT02581345|37733898|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
16792798|NCT02581345|37733899|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
16792799|NCT02581345|37733896|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
16792800|NCT02581345|37733897|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
16792801|NCT02581345|37733898|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
16792802|NCT02581345|37733899|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
16792803|NCT02581345|37733896|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
16792804|NCT02581345|37733897|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
16792805|NCT02581345|37733898|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
16792806|NCT02581345|37733899|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
16792807|NCT02581345|37733896|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
16792808|NCT02581345|37733897|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
16792809|NCT02581345|37733898|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
16792810|NCT02581345|37733899|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
16792811|NCT02581345|37733896|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
16792812|NCT02581345|37733897|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
16908784|NCT01605396|38017548|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16908785|NCT01605396|38017549|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16792813|NCT02581345|37733898|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
16792814|NCT02581345|37733899|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
16792815|NCT02581345|37733896|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
16792816|NCT02581345|37733897|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
16792817|NCT02581345|37733898|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
16792818|NCT02581345|37733899|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
16792819|NCT02581345|37733896|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
16792820|NCT02581345|37733897|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
16792821|NCT02581345|37733898|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
16792822|NCT02581345|37733899|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
16792823|NCT02581189|37733917|FG000|Overall Study|Failure to return|36|||
16792824|NCT02581189|37733917|FG000|Overall Study|Withdrew consent|5|||
16792825|NCT02581189|37733917|FG000|Overall Study|Death|3|||
16792826|NCT02581189|37733917|FG000|Overall Study|Insufficient virological response|2|||
16792827|NCT02581189|37733917|FG000|Overall Study|Other, not specified|7|||
16792828|NCT00352027|37733924|FG000|Overall Study|Progressive disease|3|||
16792829|NCT02577523|37733952|FG000|Overall Study|Adverse Event|1|||
16792830|NCT02577523|37733953|FG001|Overall Study|Adverse Event|1|||
16792831|NCT02577523|37733952|FG000|Overall Study|Lack of Efficacy|1|||
16792832|NCT02577523|37733953|FG001|Overall Study|Lack of Efficacy|1|||
16792833|NCT02577523|37733952|FG000|Overall Study|Withdrawal by Subject|1|||
16792834|NCT02577523|37733953|FG001|Overall Study|Withdrawal by Subject|0|||
16792835|NCT02576977|37733961|FG000|Overall Study|Adverse Event|13|||
16792836|NCT02576977|37733962|FG001|Overall Study|Adverse Event|2|||
16792837|NCT02576977|37733961|FG000|Overall Study|Death|73|||
16792838|NCT02576977|37733962|FG001|Overall Study|Death|60|||
16792839|NCT02576977|37733961|FG000|Overall Study|Screen failure|1|||
16792840|NCT02576977|37733962|FG001|Overall Study|Screen failure|0|||
16792841|NCT02576977|37733961|FG000|Overall Study|Study Terminated at Selected Sites|27|||
16792842|NCT02576977|37733962|FG001|Overall Study|Study Terminated at Selected Sites|50|||
16792843|NCT02576977|37733961|FG000|Overall Study|Withdrawal by Subject|11|||
16792844|NCT02576977|37733962|FG001|Overall Study|Withdrawal by Subject|11|||
16792845|NCT02576977|37733961|FG000|Overall Study|Final Disposition Unknown|0|||
16792846|NCT02576977|37733962|FG001|Overall Study|Final Disposition Unknown|1|||
16792847|NCT02576977|37733961|FG000|Overall Study|Lost to Follow-up|1|||
16792848|NCT02576977|37733962|FG001|Overall Study|Lost to Follow-up|0|||
16792849|NCT02576977|37733961|FG000|Overall Study|Progressive Disease|0|||
16792850|NCT02576977|37733962|FG001|Overall Study|Progressive Disease|1|||
16792851|NCT02576587|37733979|FG000|Baseline|Equipment failure|0|||
16792852|NCT02576587|37733980|FG001|Baseline|Equipment failure|1|||
16792853|NCT02576587|37733979|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
16792854|NCT02576587|37733980|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
16792855|NCT02576587|37733979|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
16792856|NCT02576587|37733980|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
16792857|NCT02576587|37733979|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
16792858|NCT02576587|37733980|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
16792859|NCT03016975|37734004|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
16792860|NCT03016975|37734005|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
16792861|NCT03016975|37734006|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
16792862|NCT03016975|37734004|FG000|At 6 Months Follow-up|Death|2|||
16792863|NCT03016975|37734005|FG001|At 6 Months Follow-up|Death|0|||
16792864|NCT03016975|37734006|FG002|At 6 Months Follow-up|Death|0|||
16792865|NCT03016975|37734004|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
16792866|NCT03016975|37734005|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
16792867|NCT03016975|37734006|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
16792868|NCT03016975|37734004|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
16792869|NCT03016975|37734005|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
16792870|NCT03016975|37734006|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
16792871|NCT03016975|37734004|FG000|At 6 Months Follow-up|Aborted implant|1|||
16792872|NCT03016975|37734005|FG001|At 6 Months Follow-up|Aborted implant|0|||
16792873|NCT03016975|37734006|FG002|At 6 Months Follow-up|Aborted implant|0|||
16792874|NCT03016975|37734004|FG000|At 2 Year Follow-up|Death|1|||
16792875|NCT03016975|37734005|FG001|At 2 Year Follow-up|Death|0|||
16792876|NCT03016975|37734006|FG002|At 2 Year Follow-up|Death|0|||
16792877|NCT03016975|37734004|FG000|At 3 Year Follow-up|Death|1|||
16792878|NCT03016975|37734005|FG001|At 3 Year Follow-up|Death|0|||
16792879|NCT03016975|37734006|FG002|At 3 Year Follow-up|Death|0|||
16792880|NCT03016975|37734004|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
16792881|NCT03016975|37734005|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
16792882|NCT03016975|37734006|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
16792883|NCT05340751|37734060|FG000|Overall Study|Physician Decision|3|||
16792884|NCT02575807|37734069|FG000|Overall Study|Death|8|||
16792885|NCT02575807|37734070|FG001|Overall Study|Death|3|||
16792886|NCT02575807|37734071|FG002|Overall Study|Death|7|||
16792887|NCT02575807|37734072|FG003|Overall Study|Death|0|||
16792888|NCT02575807|37734073|FG004|Overall Study|Death|1|||
16792889|NCT02575807|37734069|FG000|Overall Study|Study terminated by Sponsor|0|||
16792890|NCT02575807|37734070|FG001|Overall Study|Study terminated by Sponsor|1|||
16792891|NCT02575807|37734071|FG002|Overall Study|Study terminated by Sponsor|7|||
16792892|NCT02575807|37734072|FG003|Overall Study|Study terminated by Sponsor|0|||
16792893|NCT02575807|37734073|FG004|Overall Study|Study terminated by Sponsor|1|||
16792894|NCT02575807|37734069|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
16792895|NCT02575807|37734070|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
16792896|NCT02575807|37734071|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
16792897|NCT02575807|37734072|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
16792898|NCT02575807|37734073|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
16792899|NCT02575807|37734069|FG000|Overall Study|Terminated due to physician decision|0|||
16792900|NCT02575807|37734070|FG001|Overall Study|Terminated due to physician decision|0|||
16792901|NCT02575807|37734071|FG002|Overall Study|Terminated due to physician decision|1|||
16792902|NCT02575807|37734072|FG003|Overall Study|Terminated due to physician decision|0|||
16792903|NCT02575807|37734073|FG004|Overall Study|Terminated due to physician decision|0|||
16792904|NCT02575807|37734069|FG000|Overall Study|Subject ineligible - medical implant|0|||
16792905|NCT02575807|37734070|FG001|Overall Study|Subject ineligible - medical implant|0|||
16792906|NCT02575807|37734071|FG002|Overall Study|Subject ineligible - medical implant|0|||
16792907|NCT02575807|37734072|FG003|Overall Study|Subject ineligible - medical implant|1|||
16792908|NCT02575807|37734073|FG004|Overall Study|Subject ineligible - medical implant|0|||
16792909|NCT02575807|37734069|FG000|Overall Study|Withdrawal by Subject|0|||
16792910|NCT02575807|37734070|FG001|Overall Study|Withdrawal by Subject|0|||
16792911|NCT02575807|37734071|FG002|Overall Study|Withdrawal by Subject|1|||
16792912|NCT02575807|37734072|FG003|Overall Study|Withdrawal by Subject|1|||
16792913|NCT02575807|37734073|FG004|Overall Study|Withdrawal by Subject|2|||
16792914|NCT02575339|37734108|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
16792915|NCT02575339|37734109|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
16792916|NCT02575339|37734110|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
16792917|NCT02575339|37734108|FG000|Study Treatment|Disease Progression|5|||
16792918|NCT02575339|37734109|FG001|Study Treatment|Disease Progression|2|||
16792919|NCT02575339|37734110|FG002|Study Treatment|Disease Progression|0|||
16792920|NCT02575339|37734108|FG000|Study Treatment|Adverse Event|1|||
16792921|NCT02575339|37734109|FG001|Study Treatment|Adverse Event|2|||
16792922|NCT02575339|37734110|FG002|Study Treatment|Adverse Event|0|||
16792923|NCT02575339|37734108|FG000|Follow up|Death|6|||
16792924|NCT02575339|37734109|FG001|Follow up|Death|2|||
16792925|NCT02575339|37734110|FG002|Follow up|Death|0|||
16792926|NCT02575339|37734108|FG000|Follow up|Study Terminated|0|||
16792927|NCT02575339|37734109|FG001|Follow up|Study Terminated|2|||
16792928|NCT02575339|37734110|FG002|Follow up|Study Terminated|0|||
16792929|NCT02575339|37734108|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
16792930|NCT02575339|37734109|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
16792931|NCT02575339|37734110|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
16792932|NCT01712659|37734123|FG000|Dose Escalation|Physician Decision|0|||
16792933|NCT01712659|37734124|FG001|Dose Escalation|Physician Decision|1|||
16792934|NCT01712659|37734125|FG002|Dose Escalation|Physician Decision|0|||
16792935|NCT01712659|37734126|FG003|Dose Escalation|Physician Decision|0|||
16792936|NCT01712659|37734127|FG004|Dose Escalation|Physician Decision|0|||
16792937|NCT01712659|37734123|FG000|Dose Escalation|Unable to take study drug|0|||
16792938|NCT01712659|37734124|FG001|Dose Escalation|Unable to take study drug|1|||
16792939|NCT01712659|37734125|FG002|Dose Escalation|Unable to take study drug|0|||
16792940|NCT01712659|37734126|FG003|Dose Escalation|Unable to take study drug|0|||
16792941|NCT01712659|37734127|FG004|Dose Escalation|Unable to take study drug|0|||
16792942|NCT01712659|37734123|FG000|Dose Expansion|Early disease progression|1|||
16792943|NCT01712659|37734124|FG001|Dose Expansion|Early disease progression|0|||
16792944|NCT01712659|37734125|FG002|Dose Expansion|Early disease progression|0|||
16792945|NCT01712659|37734126|FG003|Dose Expansion|Early disease progression|0|||
16792946|NCT01712659|37734127|FG004|Dose Expansion|Early disease progression|0|||
16792947|NCT01712659|37734123|FG000|Dose Expansion|Physician Decision|1|||
16792948|NCT01712659|37734124|FG001|Dose Expansion|Physician Decision|0|||
16792949|NCT01712659|37734125|FG002|Dose Expansion|Physician Decision|0|||
16792950|NCT01712659|37734126|FG003|Dose Expansion|Physician Decision|0|||
16792951|NCT01712659|37734127|FG004|Dose Expansion|Physician Decision|0|||
16792952|NCT01610713|37734153|FG000|Overall Study|Adverse Event|3|||
16792953|NCT01610713|37734154|FG001|Overall Study|Adverse Event|0|||
16792954|NCT01610713|37734153|FG000|Overall Study|Lack of Efficacy|1|||
16792955|NCT01610713|37734154|FG001|Overall Study|Lack of Efficacy|0|||
16792956|NCT01610713|37734153|FG000|Overall Study|low mood and poor motivation|1|||
16792957|NCT01610713|37734154|FG001|Overall Study|low mood and poor motivation|0|||
16792958|NCT01610713|37734153|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
16792959|NCT01610713|37734154|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
16792960|NCT01610713|37734153|FG000|Overall Study|Lost to Follow-up|0|||
16792961|NCT01610713|37734154|FG001|Overall Study|Lost to Follow-up|1|||
16792962|NCT01606189|37734160|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
16792963|NCT01606189|37734161|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
16792964|NCT01606189|37734162|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
16792965|NCT01606189|37734163|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
16792966|NCT01606189|37734164|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
16792967|NCT01606189|37734165|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
16792968|NCT01606189|37734160|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16792969|NCT01606189|37734161|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16792970|NCT01606189|37734162|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16792971|NCT01606189|37734163|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16792972|NCT01606189|37734164|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16792973|NCT01606189|37734165|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
16792974|NCT01663987|37734175|FG000|Overall Study|Adverse Event|7|||
16792975|NCT01663987|37734176|FG001|Overall Study|Adverse Event|2|||
16792976|NCT01663987|37734175|FG000|Overall Study|Lost to Follow-up|1|||
16792977|NCT01663987|37734176|FG001|Overall Study|Lost to Follow-up|1|||
16792978|NCT01663987|37734175|FG000|Overall Study|Withdrawal by Subject|2|||
16792979|NCT01663987|37734176|FG001|Overall Study|Withdrawal by Subject|3|||
16792980|NCT01663987|37734175|FG000|Overall Study|Other reason not defined above|3|||
16792981|NCT01663987|37734176|FG001|Overall Study|Other reason not defined above|0|||
16792982|NCT02380677|37734194|FG000|Overall Study|Adverse Event|0|||
16792983|NCT02380677|37734195|FG001|Overall Study|Adverse Event|0|||
16792984|NCT02380677|37734196|FG002|Overall Study|Adverse Event|0|||
16792985|NCT02380677|37734197|FG003|Overall Study|Adverse Event|1|||
16792986|NCT02380677|37734198|FG004|Overall Study|Adverse Event|1|||
16792987|NCT02380677|37734199|FG005|Overall Study|Adverse Event|4|||
16792988|NCT02380677|37734200|FG006|Overall Study|Adverse Event|2|||
16792989|NCT02380677|37734201|FG007|Overall Study|Adverse Event|2|||
16792990|NCT02380677|37734202|FG008|Overall Study|Adverse Event|2|||
16792991|NCT02380677|37734203|FG009|Overall Study|Adverse Event|1|||
16792992|NCT02380677|37734204|FG010|Overall Study|Adverse Event|2|||
16792993|NCT02380677|37734205|FG011|Overall Study|Adverse Event|1|||
16792994|NCT02380677|37734194|FG000|Overall Study|Physician Decision|1|||
16792995|NCT02380677|37734195|FG001|Overall Study|Physician Decision|0|||
16792996|NCT02380677|37734196|FG002|Overall Study|Physician Decision|1|||
16908786|NCT01605396|38017548|FG000|Overall Study|Physician Decision|2|||
16908787|NCT01605396|38017549|FG001|Overall Study|Physician Decision|2|||
16908788|NCT01605396|38017548|FG000|Overall Study|Progressive Disease|23|||
16908789|NCT01605396|38017549|FG001|Overall Study|Progressive Disease|27|||
16908790|NCT01605396|38017548|FG000|Overall Study|Withdrawal by Subject|4|||
16908791|NCT01605396|38017549|FG001|Overall Study|Withdrawal by Subject|2|||
16908792|NCT01605396|38017548|FG000|Overall Study|Transfer Off Study|4|||
16908793|NCT01605396|38017549|FG001|Overall Study|Transfer Off Study|5|||
16908794|NCT01730118|38017562|FG000|Dose Escalation|Death on study|5|||
16908795|NCT01730118|38017563|FG001|Dose Escalation|Death on study|7|||
16908796|NCT01730118|38017564|FG002|Dose Escalation|Death on study|2|||
16908797|NCT01730118|38017565|FG003|Dose Escalation|Death on study|6|||
16908798|NCT01730118|38017566|FG004|Dose Escalation|Death on study|0|||
16908799|NCT01730118|38017567|FG005|Dose Escalation|Death on study|0|||
16908800|NCT01730118|38017568|FG006|Dose Escalation|Death on study|0|||
16908801|NCT01730118|38017562|FG000|Dose Escalation|Died before treatment|0|||
16908802|NCT01730118|38017563|FG001|Dose Escalation|Died before treatment|0|||
16908803|NCT01730118|38017564|FG002|Dose Escalation|Died before treatment|0|||
16908804|NCT01730118|38017565|FG003|Dose Escalation|Died before treatment|0|||
16908805|NCT01730118|38017566|FG004|Dose Escalation|Died before treatment|0|||
16908806|NCT01730118|38017567|FG005|Dose Escalation|Died before treatment|0|||
16908807|NCT01730118|38017568|FG006|Dose Escalation|Died before treatment|1|||
16908808|NCT01730118|38017562|FG000|Dose Escalation|Chose to start a different treatment|1|||
16908809|NCT01730118|38017563|FG001|Dose Escalation|Chose to start a different treatment|0|||
16908810|NCT01730118|38017564|FG002|Dose Escalation|Chose to start a different treatment|0|||
16908811|NCT01730118|38017565|FG003|Dose Escalation|Chose to start a different treatment|0|||
16792997|NCT02380677|37734197|FG003|Overall Study|Physician Decision|1|||
16792998|NCT02380677|37734198|FG004|Overall Study|Physician Decision|0|||
16792999|NCT02380677|37734199|FG005|Overall Study|Physician Decision|0|||
16793000|NCT02380677|37734200|FG006|Overall Study|Physician Decision|0|||
16908812|NCT01730118|38017566|FG004|Dose Escalation|Chose to start a different treatment|0|||
16908813|NCT01730118|38017567|FG005|Dose Escalation|Chose to start a different treatment|0|||
16908814|NCT01730118|38017568|FG006|Dose Escalation|Chose to start a different treatment|0|||
16908815|NCT01730118|38017562|FG000|Dose Escalation|Withdrawal by Subject|0|||
16908816|NCT01730118|38017563|FG001|Dose Escalation|Withdrawal by Subject|0|||
16908817|NCT01730118|38017564|FG002|Dose Escalation|Withdrawal by Subject|1|||
16908818|NCT01730118|38017565|FG003|Dose Escalation|Withdrawal by Subject|0|||
16908819|NCT01730118|38017566|FG004|Dose Escalation|Withdrawal by Subject|0|||
16908820|NCT01730118|38017567|FG005|Dose Escalation|Withdrawal by Subject|0|||
16793001|NCT02380677|37734201|FG007|Overall Study|Physician Decision|0|||
16793002|NCT02380677|37734202|FG008|Overall Study|Physician Decision|0|||
16793003|NCT02380677|37734203|FG009|Overall Study|Physician Decision|0|||
16793004|NCT02380677|37734204|FG010|Overall Study|Physician Decision|0|||
16793005|NCT02380677|37734205|FG011|Overall Study|Physician Decision|0|||
16793006|NCT02380677|37734194|FG000|Overall Study|Lack of Efficacy|0|||
16793007|NCT02380677|37734195|FG001|Overall Study|Lack of Efficacy|1|||
16793008|NCT02380677|37734196|FG002|Overall Study|Lack of Efficacy|2|||
16793009|NCT02380677|37734197|FG003|Overall Study|Lack of Efficacy|0|||
16793010|NCT02380677|37734198|FG004|Overall Study|Lack of Efficacy|4|||
16793011|NCT02380677|37734199|FG005|Overall Study|Lack of Efficacy|1|||
16793012|NCT02380677|37734200|FG006|Overall Study|Lack of Efficacy|1|||
16793013|NCT02380677|37734201|FG007|Overall Study|Lack of Efficacy|2|||
16793014|NCT02380677|37734202|FG008|Overall Study|Lack of Efficacy|2|||
16793015|NCT02380677|37734203|FG009|Overall Study|Lack of Efficacy|0|||
16793016|NCT02380677|37734204|FG010|Overall Study|Lack of Efficacy|2|||
16793017|NCT02380677|37734205|FG011|Overall Study|Lack of Efficacy|1|||
16793018|NCT02380677|37734194|FG000|Overall Study|Withdrawal by Subject|0|||
16793019|NCT02380677|37734195|FG001|Overall Study|Withdrawal by Subject|0|||
16793020|NCT02380677|37734196|FG002|Overall Study|Withdrawal by Subject|0|||
16793021|NCT02380677|37734197|FG003|Overall Study|Withdrawal by Subject|0|||
16793022|NCT02380677|37734198|FG004|Overall Study|Withdrawal by Subject|0|||
16793023|NCT02380677|37734199|FG005|Overall Study|Withdrawal by Subject|0|||
16793024|NCT02380677|37734200|FG006|Overall Study|Withdrawal by Subject|0|||
16793025|NCT02380677|37734201|FG007|Overall Study|Withdrawal by Subject|0|||
16793026|NCT02380677|37734202|FG008|Overall Study|Withdrawal by Subject|0|||
16908821|NCT01730118|38017568|FG006|Dose Escalation|Withdrawal by Subject|0|||
16908822|NCT01730118|38017562|FG000|Dose Escalation|Disease progression prior to treatment|0|||
16908823|NCT01730118|38017563|FG001|Dose Escalation|Disease progression prior to treatment|0|||
16908824|NCT01730118|38017564|FG002|Dose Escalation|Disease progression prior to treatment|0|||
16908825|NCT01730118|38017565|FG003|Dose Escalation|Disease progression prior to treatment|0|||
16908826|NCT01730118|38017566|FG004|Dose Escalation|Disease progression prior to treatment|0|||
16908827|NCT01730118|38017567|FG005|Dose Escalation|Disease progression prior to treatment|0|||
16908828|NCT01730118|38017568|FG006|Dose Escalation|Disease progression prior to treatment|1|||
16908829|NCT01730118|38017562|FG000|Dose Expansion|Death|0|||
16908830|NCT01730118|38017563|FG001|Dose Expansion|Death|0|||
16908831|NCT01730118|38017564|FG002|Dose Expansion|Death|0|||
16908832|NCT01730118|38017565|FG003|Dose Expansion|Death|0|||
16908833|NCT01730118|38017566|FG004|Dose Expansion|Death|1|||
16908834|NCT01730118|38017567|FG005|Dose Expansion|Death|0|||
16908835|NCT01730118|38017568|FG006|Dose Expansion|Death|0|||
16908836|NCT01730118|38017562|FG000|Dose Expansion|Other medical condition|0|||
16908837|NCT01730118|38017563|FG001|Dose Expansion|Other medical condition|0|||
16908838|NCT01730118|38017564|FG002|Dose Expansion|Other medical condition|0|||
16908839|NCT01730118|38017565|FG003|Dose Expansion|Other medical condition|0|||
16908840|NCT01730118|38017566|FG004|Dose Expansion|Other medical condition|1|||
16908841|NCT01730118|38017567|FG005|Dose Expansion|Other medical condition|0|||
16908842|NCT01730118|38017568|FG006|Dose Expansion|Other medical condition|0|||
16908843|NCT01730118|38017562|FG000|Dose Expansion|Withdrawal by Subject|0|||
16908844|NCT01730118|38017563|FG001|Dose Expansion|Withdrawal by Subject|0|||
16908845|NCT01730118|38017564|FG002|Dose Expansion|Withdrawal by Subject|0|||
16908846|NCT01730118|38017565|FG003|Dose Expansion|Withdrawal by Subject|0|||
16908847|NCT01730118|38017566|FG004|Dose Expansion|Withdrawal by Subject|1|||
16908848|NCT01730118|38017567|FG005|Dose Expansion|Withdrawal by Subject|0|||
16908849|NCT01730118|38017568|FG006|Dose Expansion|Withdrawal by Subject|0|||
16908850|NCT01730118|38017562|FG000|Dose Expansion|Disease progression|0|||
16908851|NCT01730118|38017563|FG001|Dose Expansion|Disease progression|0|||
16908852|NCT01730118|38017564|FG002|Dose Expansion|Disease progression|0|||
16908853|NCT01730118|38017565|FG003|Dose Expansion|Disease progression|0|||
16908854|NCT01730118|38017566|FG004|Dose Expansion|Disease progression|0|||
16908855|NCT01730118|38017567|FG005|Dose Expansion|Disease progression|1|||
16908856|NCT01730118|38017568|FG006|Dose Expansion|Disease progression|0|||
16908857|NCT01730118|38017562|FG000|Dose Expansion|Inability to return|0|||
16908858|NCT01730118|38017563|FG001|Dose Expansion|Inability to return|0|||
16908859|NCT01730118|38017564|FG002|Dose Expansion|Inability to return|0|||
16908860|NCT01730118|38017565|FG003|Dose Expansion|Inability to return|0|||
16908861|NCT01730118|38017566|FG004|Dose Expansion|Inability to return|0|||
16908862|NCT01730118|38017567|FG005|Dose Expansion|Inability to return|1|||
16908863|NCT01730118|38017568|FG006|Dose Expansion|Inability to return|0|||
16908864|NCT01730118|38017562|FG000|Dose Expansion|Physician Decision|0|||
16908865|NCT01730118|38017563|FG001|Dose Expansion|Physician Decision|0|||
16908866|NCT01730118|38017564|FG002|Dose Expansion|Physician Decision|0|||
16908867|NCT01730118|38017565|FG003|Dose Expansion|Physician Decision|0|||
16908868|NCT01730118|38017566|FG004|Dose Expansion|Physician Decision|0|||
16908869|NCT01730118|38017567|FG005|Dose Expansion|Physician Decision|1|||
16908870|NCT01730118|38017568|FG006|Dose Expansion|Physician Decision|0|||
16793027|NCT02380677|37734203|FG009|Overall Study|Withdrawal by Subject|1|||
16793028|NCT02380677|37734204|FG010|Overall Study|Withdrawal by Subject|0|||
16793029|NCT02380677|37734205|FG011|Overall Study|Withdrawal by Subject|3|||
16793030|NCT02380677|37734194|FG000|Overall Study|Other|0|||
16793031|NCT02380677|37734195|FG001|Overall Study|Other|0|||
16793032|NCT02380677|37734196|FG002|Overall Study|Other|0|||
16793033|NCT02380677|37734197|FG003|Overall Study|Other|1|||
16793034|NCT02380677|37734198|FG004|Overall Study|Other|1|||
16793035|NCT02380677|37734199|FG005|Overall Study|Other|1|||
16793036|NCT02380677|37734200|FG006|Overall Study|Other|0|||
16793037|NCT02380677|37734201|FG007|Overall Study|Other|0|||
16793038|NCT02380677|37734202|FG008|Overall Study|Other|0|||
16793039|NCT02380677|37734203|FG009|Overall Study|Other|0|||
16793040|NCT02380677|37734204|FG010|Overall Study|Other|0|||
16793041|NCT02380677|37734205|FG011|Overall Study|Other|0|||
16793042|NCT02380287|37734241|FG000|Overall Study|Adverse Event|0|||
16793043|NCT02380287|37734242|FG001|Overall Study|Adverse Event|0|||
16793044|NCT02380287|37734243|FG002|Overall Study|Adverse Event|1|||
16793045|NCT02380287|37734244|FG003|Overall Study|Adverse Event|0|||
16793046|NCT02380287|37734245|FG004|Overall Study|Adverse Event|0|||
16793047|NCT02380287|37734246|FG005|Overall Study|Adverse Event|0|||
16793048|NCT02380287|37734247|FG006|Overall Study|Adverse Event|0|||
16793049|NCT02380287|37734248|FG007|Overall Study|Adverse Event|0|||
16793050|NCT02343003|37734275|FG000|Overall Study|Withdrawal by Subject|9|||
16793051|NCT02343003|37734276|FG001|Overall Study|Withdrawal by Subject|4|||
16793052|NCT02343003|37734275|FG000|Overall Study|Lost to Follow-up|5|||
16793053|NCT02343003|37734276|FG001|Overall Study|Lost to Follow-up|1|||
16793054|NCT02343003|37734275|FG000|Overall Study|Protocol Violation|1|||
16793055|NCT02343003|37734276|FG001|Overall Study|Protocol Violation|0|||
16793056|NCT02343003|37734275|FG000|Overall Study|Death|0|||
16793057|NCT02343003|37734276|FG001|Overall Study|Death|1|||
16793058|NCT02343003|37734275|FG000|Overall Study|exclusion criteria met|1|||
16793059|NCT02343003|37734276|FG001|Overall Study|exclusion criteria met|1|||
16793060|NCT02343003|37734275|FG000|Overall Study|terminated by sponsor|2|||
16793061|NCT02343003|37734276|FG001|Overall Study|terminated by sponsor|0|||
16793062|NCT02394561|37734284|FG000|CORE Phase|Adverse Event|7|||
16793063|NCT02394561|37734285|FG001|CORE Phase|Adverse Event|9|||
16793064|NCT02394561|37734284|FG000|CORE Phase|Death|0|||
16793065|NCT02394561|37734285|FG001|CORE Phase|Death|1|||
16793066|NCT02394561|37734284|FG000|CORE Phase|Pregnancy|1|||
16793067|NCT02394561|37734285|FG001|CORE Phase|Pregnancy|0|||
16793068|NCT02394561|37734284|FG000|CORE Phase|Lost to Follow-up|1|||
16793069|NCT02394561|37734285|FG001|CORE Phase|Lost to Follow-up|0|||
16793070|NCT02394561|37734284|FG000|CORE Phase|Physician Decision|1|||
16793071|NCT02394561|37734285|FG001|CORE Phase|Physician Decision|1|||
16793072|NCT02394561|37734284|FG000|CORE Phase|Withdrawal by Subject|2|||
16793073|NCT02394561|37734285|FG001|CORE Phase|Withdrawal by Subject|2|||
16793074|NCT02394561|37734284|FG000|CORE Phase|Lack of Efficacy|1|||
16793075|NCT02394561|37734285|FG001|CORE Phase|Lack of Efficacy|6|||
16793076|NCT02394561|37734284|FG000|Extension Phase|Adverse Event|6|||
16793077|NCT02394561|37734285|FG001|Extension Phase|Adverse Event|1|||
16793078|NCT02394561|37734284|FG000|Extension Phase|Death|0|||
16793079|NCT02394561|37734285|FG001|Extension Phase|Death|1|||
16793080|NCT02394561|37734284|FG000|Extension Phase|Protocol Violation|1|||
16793081|NCT02394561|37734285|FG001|Extension Phase|Protocol Violation|0|||
16793082|NCT02394561|37734284|FG000|Extension Phase|Lost to Follow-up|1|||
16793083|NCT02394561|37734285|FG001|Extension Phase|Lost to Follow-up|0|||
16793084|NCT02394561|37734284|FG000|Extension Phase|Physician Decision|0|||
16793085|NCT02394561|37734285|FG001|Extension Phase|Physician Decision|2|||
16793086|NCT02394561|37734284|FG000|Extension Phase|Withdrawal by Subject|0|||
16793087|NCT02394561|37734285|FG001|Extension Phase|Withdrawal by Subject|5|||
16793088|NCT02394561|37734284|FG000|Extension Phase|Lack of Efficacy|3|||
16793089|NCT02394561|37734285|FG001|Extension Phase|Lack of Efficacy|3|||
16793090|NCT02342223|37734294|FG000|Overall Study|Lost to Follow-up|1|||
16793091|NCT02393547|37734298|FG000|Overall Study|Adverse Event|2|||
16793092|NCT02393547|37734298|FG000|Overall Study|Withdrawal by Subject|3|||
16793093|NCT02393547|37734298|FG000|Overall Study|Lost to Follow-up|1|||
16793094|NCT02574637|37734307|FG000|Double-blind Period|Adverse Event|1|||
16793095|NCT02574637|37734308|FG001|Double-blind Period|Adverse Event|0|||
16793096|NCT02574637|37734309|FG002|Double-blind Period|Adverse Event|0|||
16793097|NCT02574637|37734310|FG003|Double-blind Period|Adverse Event|0|||
16793098|NCT02574637|37734311|FG004|Double-blind Period|Adverse Event|0|||
16793099|NCT02574637|37734312|FG005|Double-blind Period|Adverse Event|0|||
16793100|NCT02574637|37734313|FG006|Double-blind Period|Adverse Event|0|||
16793101|NCT02574637|37734314|FG007|Double-blind Period|Adverse Event|0|||
16793102|NCT02574637|37734315|FG008|Double-blind Period|Adverse Event|0|||
16793103|NCT02574637|37734316|FG009|Double-blind Period|Adverse Event|0|||
16793104|NCT02574637|37734307|FG000|Double-blind Period|Lack of Efficacy|0|||
16793105|NCT02574637|37734308|FG001|Double-blind Period|Lack of Efficacy|0|||
16793106|NCT02574637|37734309|FG002|Double-blind Period|Lack of Efficacy|2|||
16793107|NCT02574637|37734310|FG003|Double-blind Period|Lack of Efficacy|0|||
16793108|NCT02574637|37734311|FG004|Double-blind Period|Lack of Efficacy|0|||
17016468|NCT00592904|38161087|FG003|Overall Study|Protocol Violation|1|||
16793109|NCT02574637|37734312|FG005|Double-blind Period|Lack of Efficacy|0|||
16793110|NCT02574637|37734313|FG006|Double-blind Period|Lack of Efficacy|0|||
16793111|NCT02574637|37734314|FG007|Double-blind Period|Lack of Efficacy|0|||
16793112|NCT02574637|37734315|FG008|Double-blind Period|Lack of Efficacy|0|||
16793113|NCT02574637|37734316|FG009|Double-blind Period|Lack of Efficacy|0|||
16793114|NCT02574637|37734307|FG000|Double-blind Period|Protocol Deviation|1|||
16793115|NCT02574637|37734308|FG001|Double-blind Period|Protocol Deviation|0|||
16793116|NCT02574637|37734309|FG002|Double-blind Period|Protocol Deviation|0|||
16793117|NCT02574637|37734310|FG003|Double-blind Period|Protocol Deviation|0|||
16793118|NCT02574637|37734311|FG004|Double-blind Period|Protocol Deviation|0|||
16793119|NCT02574637|37734312|FG005|Double-blind Period|Protocol Deviation|0|||
16793120|NCT02574637|37734313|FG006|Double-blind Period|Protocol Deviation|0|||
16793121|NCT02574637|37734314|FG007|Double-blind Period|Protocol Deviation|0|||
16793122|NCT02574637|37734315|FG008|Double-blind Period|Protocol Deviation|0|||
16793123|NCT02574637|37734316|FG009|Double-blind Period|Protocol Deviation|0|||
16793124|NCT02574637|37734307|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
16793125|NCT02574637|37734308|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
16793126|NCT02574637|37734309|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
16793127|NCT02574637|37734310|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
16793128|NCT02574637|37734311|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
16793129|NCT02574637|37734312|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
16793130|NCT02574637|37734313|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
16793131|NCT02574637|37734314|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
16793132|NCT02574637|37734315|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
16793133|NCT02574637|37734316|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
16793134|NCT02574637|37734307|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
16793135|NCT02574637|37734308|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
16793136|NCT02574637|37734309|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
16793137|NCT02574637|37734310|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
16793138|NCT02574637|37734311|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
16793139|NCT02574637|37734312|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
16793140|NCT02574637|37734313|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
16793141|NCT02574637|37734314|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
16793142|NCT02574637|37734315|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
16793143|NCT02574637|37734316|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
16793144|NCT02574637|37734307|FG000|Double-blind Period|Reason Not Specified|0|||
16793145|NCT02574637|37734308|FG001|Double-blind Period|Reason Not Specified|0|||
16793146|NCT02574637|37734309|FG002|Double-blind Period|Reason Not Specified|0|||
16793147|NCT02574637|37734310|FG003|Double-blind Period|Reason Not Specified|1|||
16793148|NCT02574637|37734311|FG004|Double-blind Period|Reason Not Specified|0|||
16793149|NCT02574637|37734312|FG005|Double-blind Period|Reason Not Specified|0|||
16793150|NCT02574637|37734313|FG006|Double-blind Period|Reason Not Specified|0|||
16793151|NCT02574637|37734314|FG007|Double-blind Period|Reason Not Specified|0|||
16793152|NCT02574637|37734315|FG008|Double-blind Period|Reason Not Specified|0|||
16793153|NCT02574637|37734316|FG009|Double-blind Period|Reason Not Specified|0|||
16793154|NCT02574637|37734307|FG000|Open-label (OL) Period|Adverse Event|0|||
16793155|NCT02574637|37734308|FG001|Open-label (OL) Period|Adverse Event|0|||
16793156|NCT02574637|37734309|FG002|Open-label (OL) Period|Adverse Event|0|||
16793157|NCT02574637|37734310|FG003|Open-label (OL) Period|Adverse Event|0|||
16793158|NCT02574637|37734311|FG004|Open-label (OL) Period|Adverse Event|0|||
16793159|NCT02574637|37734312|FG005|Open-label (OL) Period|Adverse Event|0|||
16793160|NCT02574637|37734313|FG006|Open-label (OL) Period|Adverse Event|0|||
16793161|NCT02574637|37734314|FG007|Open-label (OL) Period|Adverse Event|0|||
16793162|NCT02574637|37734315|FG008|Open-label (OL) Period|Adverse Event|1|||
16793163|NCT02574637|37734316|FG009|Open-label (OL) Period|Adverse Event|0|||
16793164|NCT02574637|37734307|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
16793165|NCT02574637|37734308|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
16793166|NCT02574637|37734309|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
16793167|NCT02574637|37734310|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
16793168|NCT02574637|37734311|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
16793169|NCT02574637|37734312|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
16793170|NCT02574637|37734313|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
16793171|NCT02574637|37734314|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
16793172|NCT02574637|37734315|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
16793173|NCT02574637|37734316|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
16793174|NCT02574637|37734307|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16793175|NCT02574637|37734308|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16793176|NCT02574637|37734309|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16793177|NCT02574637|37734310|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16793178|NCT02574637|37734311|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16793179|NCT02574637|37734312|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
16793180|NCT02574637|37734313|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
16793181|NCT02574637|37734314|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
16793182|NCT02574637|37734315|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
16793183|NCT02574637|37734316|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16793184|NCT02392611|37734346|FG000|Overall Study|Adverse Event|0|||
16793185|NCT02392611|37734347|FG001|Overall Study|Adverse Event|0|||
16793186|NCT02392611|37734348|FG002|Overall Study|Adverse Event|0|||
16793187|NCT02392611|37734349|FG003|Overall Study|Adverse Event|1|||
16793188|NCT02392611|37734350|FG004|Overall Study|Adverse Event|0|||
16793189|NCT02392611|37734351|FG005|Overall Study|Adverse Event|0|||
16793190|NCT02392611|37734352|FG006|Overall Study|Adverse Event|0|||
16793191|NCT02392611|37734353|FG007|Overall Study|Adverse Event|0|||
16793192|NCT02392611|37734354|FG008|Overall Study|Adverse Event|0|||
16793193|NCT02392611|37734346|FG000|Overall Study|Progressive disease|0|||
16793194|NCT02392611|37734347|FG001|Overall Study|Progressive disease|0|||
16793195|NCT02392611|37734348|FG002|Overall Study|Progressive disease|0|||
16793196|NCT02392611|37734349|FG003|Overall Study|Progressive disease|2|||
16793197|NCT02392611|37734350|FG004|Overall Study|Progressive disease|1|||
16793198|NCT02392611|37734351|FG005|Overall Study|Progressive disease|0|||
16793199|NCT02392611|37734352|FG006|Overall Study|Progressive disease|0|||
16793200|NCT02392611|37734353|FG007|Overall Study|Progressive disease|0|||
16793201|NCT02392611|37734354|FG008|Overall Study|Progressive disease|0|||
16793202|NCT02392611|37734346|FG000|Overall Study|Death|1|||
16793203|NCT02392611|37734347|FG001|Overall Study|Death|0|||
16793204|NCT02392611|37734348|FG002|Overall Study|Death|0|||
16793205|NCT02392611|37734349|FG003|Overall Study|Death|0|||
16793206|NCT02392611|37734350|FG004|Overall Study|Death|0|||
16793207|NCT02392611|37734351|FG005|Overall Study|Death|1|||
16793208|NCT02392611|37734352|FG006|Overall Study|Death|0|||
16793209|NCT02392611|37734353|FG007|Overall Study|Death|0|||
16793210|NCT02392611|37734354|FG008|Overall Study|Death|0|||
16793211|NCT02392611|37734346|FG000|Overall Study|Withdrawal by Subject|0|||
16793212|NCT02392611|37734347|FG001|Overall Study|Withdrawal by Subject|0|||
16793213|NCT02392611|37734348|FG002|Overall Study|Withdrawal by Subject|0|||
16908871|NCT01730040|38017592|FG000|Overall Study|Randomized but not treated|0|||
16908872|NCT01730040|38017593|FG001|Overall Study|Randomized but not treated|0|||
16908873|NCT01730040|38017594|FG002|Overall Study|Randomized but not treated|0|||
16908874|NCT01730040|38017595|FG003|Overall Study|Randomized but not treated|0|||
16908875|NCT01730040|38017596|FG004|Overall Study|Randomized but not treated|0|||
16908876|NCT01730040|38017597|FG005|Overall Study|Randomized but not treated|1|||
16908877|NCT01730040|38017598|FG006|Overall Study|Randomized but not treated|0|||
16908878|NCT01730040|38017592|FG000|Overall Study|Subject moved|0|||
16908879|NCT01730040|38017593|FG001|Overall Study|Subject moved|0|||
16908880|NCT01730040|38017594|FG002|Overall Study|Subject moved|1|||
16908881|NCT01730040|38017595|FG003|Overall Study|Subject moved|0|||
16908882|NCT01730040|38017596|FG004|Overall Study|Subject moved|0|||
16908883|NCT01730040|38017597|FG005|Overall Study|Subject moved|0|||
16908884|NCT01730040|38017598|FG006|Overall Study|Subject moved|1|||
16908885|NCT01730040|38017592|FG000|Overall Study|Physician Decision|0|||
16908886|NCT01730040|38017593|FG001|Overall Study|Physician Decision|0|||
16908887|NCT01730040|38017594|FG002|Overall Study|Physician Decision|0|||
16908888|NCT01730040|38017595|FG003|Overall Study|Physician Decision|0|||
16908889|NCT01730040|38017596|FG004|Overall Study|Physician Decision|0|||
16908890|NCT01730040|38017597|FG005|Overall Study|Physician Decision|1|||
16908891|NCT01730040|38017598|FG006|Overall Study|Physician Decision|1|||
16908892|NCT01730040|38017592|FG000|Overall Study|Other than specified|7|||
16908893|NCT01730040|38017593|FG001|Overall Study|Other than specified|8|||
16908894|NCT01730040|38017594|FG002|Overall Study|Other than specified|5|||
16908895|NCT01730040|38017595|FG003|Overall Study|Other than specified|5|||
16908896|NCT01730040|38017596|FG004|Overall Study|Other than specified|5|||
16908897|NCT01730040|38017597|FG005|Overall Study|Other than specified|4|||
16908898|NCT01730040|38017598|FG006|Overall Study|Other than specified|4|||
16908899|NCT01730040|38017592|FG000|Overall Study|Adverse Event|4|||
16908900|NCT01730040|38017593|FG001|Overall Study|Adverse Event|3|||
16908901|NCT01730040|38017594|FG002|Overall Study|Adverse Event|5|||
16908902|NCT01730040|38017595|FG003|Overall Study|Adverse Event|3|||
16908903|NCT01730040|38017596|FG004|Overall Study|Adverse Event|1|||
16908904|NCT01730040|38017597|FG005|Overall Study|Adverse Event|1|||
16908905|NCT01730040|38017598|FG006|Overall Study|Adverse Event|2|||
16908906|NCT01730040|38017592|FG000|Overall Study|Poor compliance to protocol|2|||
16908907|NCT01730040|38017593|FG001|Overall Study|Poor compliance to protocol|4|||
16908908|NCT01730040|38017594|FG002|Overall Study|Poor compliance to protocol|0|||
16908909|NCT01730040|38017595|FG003|Overall Study|Poor compliance to protocol|0|||
16908910|NCT01730040|38017596|FG004|Overall Study|Poor compliance to protocol|0|||
16793214|NCT02392611|37734349|FG003|Overall Study|Withdrawal by Subject|1|||
16793215|NCT02392611|37734350|FG004|Overall Study|Withdrawal by Subject|0|||
16793216|NCT02392611|37734351|FG005|Overall Study|Withdrawal by Subject|0|||
16793217|NCT02392611|37734352|FG006|Overall Study|Withdrawal by Subject|0|||
16793218|NCT02392611|37734353|FG007|Overall Study|Withdrawal by Subject|0|||
16793219|NCT02392611|37734354|FG008|Overall Study|Withdrawal by Subject|0|||
16793220|NCT02392611|37734346|FG000|Overall Study|Lost to Follow-up|0|||
16793221|NCT02392611|37734347|FG001|Overall Study|Lost to Follow-up|0|||
16793222|NCT02392611|37734348|FG002|Overall Study|Lost to Follow-up|0|||
16793223|NCT02392611|37734349|FG003|Overall Study|Lost to Follow-up|0|||
16793224|NCT02392611|37734350|FG004|Overall Study|Lost to Follow-up|0|||
16793225|NCT02392611|37734351|FG005|Overall Study|Lost to Follow-up|0|||
16793226|NCT02392611|37734352|FG006|Overall Study|Lost to Follow-up|1|||
16793227|NCT02392611|37734353|FG007|Overall Study|Lost to Follow-up|0|||
16793228|NCT02392611|37734354|FG008|Overall Study|Lost to Follow-up|0|||
16793229|NCT02392611|37734346|FG000|Overall Study|Enrolled, not treated|0|||
16793230|NCT02392611|37734347|FG001|Overall Study|Enrolled, not treated|0|||
16793231|NCT02392611|37734348|FG002|Overall Study|Enrolled, not treated|0|||
16793232|NCT02392611|37734349|FG003|Overall Study|Enrolled, not treated|2|||
16793233|NCT02392611|37734350|FG004|Overall Study|Enrolled, not treated|0|||
16793234|NCT02392611|37734351|FG005|Overall Study|Enrolled, not treated|0|||
16793235|NCT02392611|37734352|FG006|Overall Study|Enrolled, not treated|0|||
16793236|NCT02392611|37734353|FG007|Overall Study|Enrolled, not treated|0|||
16793237|NCT02392611|37734354|FG008|Overall Study|Enrolled, not treated|0|||
16793238|NCT02378961|37734378|FG000|Overall Study|Lack of Efficacy|4|||
16793239|NCT02378961|37734379|FG001|Overall Study|Lack of Efficacy|2|||
16793240|NCT02378961|37734380|FG002|Overall Study|Lack of Efficacy|0|||
16793241|NCT02378961|37734381|FG003|Overall Study|Lack of Efficacy|1|||
16793242|NCT02378961|37734378|FG000|Overall Study|Death|0|||
16793243|NCT02378961|37734379|FG001|Overall Study|Death|0|||
16793244|NCT02378961|37734380|FG002|Overall Study|Death|1|||
16793245|NCT02378961|37734381|FG003|Overall Study|Death|0|||
16793246|NCT02378883|37734391|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
16793247|NCT02378883|37734391|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
16793248|NCT02378883|37734391|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
16908911|NCT01730040|38017597|FG005|Overall Study|Poor compliance to protocol|0|||
16908912|NCT01730040|38017598|FG006|Overall Study|Poor compliance to protocol|1|||
16908913|NCT01706328|38017616|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
16908914|NCT01706328|38017617|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16908915|NCT01706328|38017618|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16908916|NCT01706328|38017616|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
16908917|NCT01706328|38017617|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16908918|NCT01706328|38017618|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16908919|NCT01706328|38017616|FG000|2-week Run-in Period|Physician Decision|4|||
16908920|NCT01706328|38017617|FG001|2-week Run-in Period|Physician Decision|0|||
16908921|NCT01706328|38017618|FG002|2-week Run-in Period|Physician Decision|0|||
16908922|NCT01706328|38017616|FG000|2-week Run-in Period|Adverse Event|4|||
16908923|NCT01706328|38017617|FG001|2-week Run-in Period|Adverse Event|0|||
16908924|NCT01706328|38017618|FG002|2-week Run-in Period|Adverse Event|0|||
16908925|NCT01706328|38017616|FG000|2-week Run-in Period|Lost to Follow-up|2|||
16908926|NCT01706328|38017617|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16908927|NCT01706328|38017618|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16908928|NCT01706328|38017616|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
16908929|NCT01706328|38017617|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
16908930|NCT01706328|38017618|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
16908931|NCT01706328|38017616|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
16908932|NCT01706328|38017617|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
16908933|NCT01706328|38017618|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
16908934|NCT01706328|38017616|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
16908935|NCT01706328|38017617|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
16908936|NCT01706328|38017618|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
16908937|NCT01706328|38017616|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
16908938|NCT01706328|38017617|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
16908939|NCT01706328|38017618|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
16908940|NCT01706328|38017616|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
16908941|NCT01706328|38017617|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
16908942|NCT01706328|38017618|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
16908943|NCT01706328|38017616|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
16908944|NCT01706328|38017617|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
16908945|NCT01706328|38017618|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
16908946|NCT01706328|38017616|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16908947|NCT01706328|38017617|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
17016469|NCT00592904|38161084|FG000|Overall Study|Withdrawal by Subject|4|||
16793249|NCT02378883|37734391|FG000|30 Day Follow-Up|Physician Decision|2|||
16793250|NCT02378883|37734391|FG000|30 Day Follow-Up|Missed Visit|2|||
16793251|NCT02378883|37734391|FG000|30 Day Follow-Up|Death|1|||
16793252|NCT02378883|37734391|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
16793253|NCT02378883|37734391|FG000|12 Months Follow-Up|Death|2|||
16793254|NCT02574481|37734400|FG000|Overall Study|Withdrawal by Subject|6|||
16793255|NCT02574481|37734401|FG001|Overall Study|Withdrawal by Subject|4|||
16793256|NCT02574481|37734402|FG002|Overall Study|Withdrawal by Subject|1|||
16793257|NCT02574481|37734403|FG003|Overall Study|Withdrawal by Subject|0|||
16793258|NCT02574481|37734400|FG000|Overall Study|Adverse Event|2|||
16793259|NCT02574481|37734401|FG001|Overall Study|Adverse Event|0|||
16793260|NCT02574481|37734402|FG002|Overall Study|Adverse Event|0|||
16793261|NCT02574481|37734403|FG003|Overall Study|Adverse Event|0|||
16793262|NCT02574481|37734400|FG000|Overall Study|Visit Missed|12|||
16793263|NCT02574481|37734401|FG001|Overall Study|Visit Missed|4|||
16793264|NCT02574481|37734402|FG002|Overall Study|Visit Missed|2|||
16793265|NCT02574481|37734403|FG003|Overall Study|Visit Missed|0|||
16793266|NCT02574481|37734400|FG000|Overall Study|Other|1|||
16793267|NCT02574481|37734401|FG001|Overall Study|Other|0|||
16793268|NCT02574481|37734402|FG002|Overall Study|Other|0|||
16793269|NCT02574481|37734403|FG003|Overall Study|Other|0|||
16793270|NCT02574481|37734400|FG000|Overall Study|Death|6|||
16793271|NCT02574481|37734401|FG001|Overall Study|Death|6|||
16793272|NCT02574481|37734402|FG002|Overall Study|Death|0|||
16793273|NCT02574481|37734403|FG003|Overall Study|Death|0|||
16793274|NCT02340975|37734422|FG000|Overall Study|Death|6|||
16793275|NCT02340975|37734423|FG001|Overall Study|Death|23|||
16793276|NCT02340975|37734424|FG002|Overall Study|Death|21|||
16793277|NCT02340975|37734425|FG003|Overall Study|Death|7|||
16793278|NCT02340975|37734426|FG004|Overall Study|Death|21|||
16793279|NCT02340975|37734427|FG005|Overall Study|Death|13|||
16793280|NCT02340975|37734422|FG000|Overall Study|Lost to Follow-up|0|||
16793281|NCT02340975|37734423|FG001|Overall Study|Lost to Follow-up|0|||
16793282|NCT02340975|37734424|FG002|Overall Study|Lost to Follow-up|0|||
16793283|NCT02340975|37734425|FG003|Overall Study|Lost to Follow-up|0|||
16793284|NCT02340975|37734426|FG004|Overall Study|Lost to Follow-up|2|||
16793285|NCT02340975|37734427|FG005|Overall Study|Lost to Follow-up|0|||
16793286|NCT02340975|37734422|FG000|Overall Study|Withdrawal by Subject|0|||
16793287|NCT02340975|37734423|FG001|Overall Study|Withdrawal by Subject|0|||
16793288|NCT02340975|37734424|FG002|Overall Study|Withdrawal by Subject|3|||
16793289|NCT02340975|37734425|FG003|Overall Study|Withdrawal by Subject|3|||
16793290|NCT02340975|37734426|FG004|Overall Study|Withdrawal by Subject|2|||
16793291|NCT02340975|37734427|FG005|Overall Study|Withdrawal by Subject|0|||
16793292|NCT02340975|37734422|FG000|Overall Study|Other|0|||
16793293|NCT02340975|37734423|FG001|Overall Study|Other|4|||
16793294|NCT02340975|37734424|FG002|Overall Study|Other|0|||
16793295|NCT02340975|37734425|FG003|Overall Study|Other|2|||
16793296|NCT02340975|37734426|FG004|Overall Study|Other|0|||
16793297|NCT02340975|37734427|FG005|Overall Study|Other|6|||
16793298|NCT02392377|37734444|FG000|Overall Study|Withdrawal by Subject|0|||
16793299|NCT02392377|37734445|FG001|Overall Study|Withdrawal by Subject|1|||
16793300|NCT02340819|37734453|FG000|Overall Study|Adverse Event|1|||
16793301|NCT02340819|37734453|FG000|Overall Study|Withdrawal by Subject|2|||
16793302|NCT02340819|37734453|FG000|Overall Study|Discontinued with other reason|1|||
16793303|NCT02340663|37734459|FG000|Overall Study|Lost to Follow-up|1|||
16793304|NCT02340663|37734460|FG001|Overall Study|Lost to Follow-up|0|||
16793305|NCT02340663|37734459|FG000|Overall Study|Protocol Violation|1|||
16793306|NCT02340663|37734460|FG001|Overall Study|Protocol Violation|0|||
16793307|NCT02340663|37734459|FG000|Overall Study|Withdrawal by Subject|3|||
16793308|NCT02340663|37734460|FG001|Overall Study|Withdrawal by Subject|1|||
16793309|NCT02573467|37734470|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
16793310|NCT02573467|37734471|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
16793311|NCT02573467|37734472|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
16793312|NCT02573467|37734473|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
16793313|NCT02573467|37734470|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
16793314|NCT02573467|37734471|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
16793315|NCT02573467|37734472|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
16793316|NCT02573467|37734473|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
17198305|NCT01331681|38351892|FG000|Overall Study|Protocol Violation|1|||
16793317|NCT02573467|37734470|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
16793318|NCT02573467|37734471|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
16793319|NCT02573467|37734472|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
16793320|NCT02573467|37734473|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
16793321|NCT02573467|37734470|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
16793322|NCT02573467|37734471|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
16793323|NCT02573467|37734472|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
16793324|NCT02573467|37734473|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
16793325|NCT02573467|37734470|FG000|Post-treatment Follow up Epoch|Death|1|||
16793326|NCT02573467|37734471|FG001|Post-treatment Follow up Epoch|Death|1|||
16793327|NCT02573467|37734472|FG002|Post-treatment Follow up Epoch|Death|0|||
16793328|NCT02573467|37734473|FG003|Post-treatment Follow up Epoch|Death|1|||
16793329|NCT02573467|37734470|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
16793330|NCT02573467|37734471|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
16793331|NCT02573467|37734472|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
16908948|NCT01706328|38017618|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
16908949|NCT01753518|38017626|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
16908950|NCT01753518|38017627|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
16908951|NCT01753518|38017626|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
16908952|NCT01753518|38017627|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
16908953|NCT01753518|38017626|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
16908954|NCT01753518|38017627|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
16908955|NCT01753518|38017626|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
16908956|NCT01753518|38017627|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
16908957|NCT01706250|38017633|FG000|Overall Study|Lost to Follow-up|2|||
16908958|NCT01729728|38017645|FG000|Overall Study|Adverse Event|0|||
16908959|NCT01729728|38017646|FG001|Overall Study|Adverse Event|6|||
16793332|NCT02573467|37734473|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
16793333|NCT02573467|37734470|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
16793334|NCT02573467|37734471|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
16793335|NCT02573467|37734472|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
16793336|NCT02573467|37734473|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
16793337|NCT02337387|37734488|FG000|Overall Study|Adverse Event|0|||
16793338|NCT02337387|37734489|FG001|Overall Study|Adverse Event|1|||
16793339|NCT02337387|37734490|FG002|Overall Study|Adverse Event|0|||
16793340|NCT02337387|37734491|FG003|Overall Study|Adverse Event|0|||
16793341|NCT02337387|37734488|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
16793342|NCT02337387|37734489|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
16793343|NCT02337387|37734490|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
16793344|NCT02337387|37734491|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
16793345|NCT02574247|37734504|FG000|Overall Study|Withdrawal by Subject|1|||
16793346|NCT02574247|37734505|FG001|Overall Study|Withdrawal by Subject|0|||
16793347|NCT02574247|37734506|FG002|Overall Study|Withdrawal by Subject|0|||
16793348|NCT02574247|37734504|FG000|Overall Study|Did not meet inclusion criteria|4|||
16793349|NCT02574247|37734505|FG001|Overall Study|Did not meet inclusion criteria|3|||
16793350|NCT02574247|37734506|FG002|Overall Study|Did not meet inclusion criteria|5|||
16793351|NCT02391363|37734518|FG000|Overall Study|Lost to Follow-up|5|||
16793352|NCT02391363|37734519|FG001|Overall Study|Lost to Follow-up|5|||
16793353|NCT02391363|37734518|FG000|Overall Study|Withdrawal by Subject|6|||
16793354|NCT02391363|37734519|FG001|Overall Study|Withdrawal by Subject|3|||
16793355|NCT02569957|37734527|FG000|Overall Study|Withdrawal by Subject|0|||
16793356|NCT02569957|37734528|FG001|Overall Study|Withdrawal by Subject|1|||
16793357|NCT01649427|37734536|FG000|Overall Study|Adverse Event|1|||
16793358|NCT01649427|37734537|FG001|Overall Study|Adverse Event|1|||
16793359|NCT01649427|37734536|FG000|Overall Study|Withdrawal by Subject|8|||
16793360|NCT01649427|37734537|FG001|Overall Study|Withdrawal by Subject|7|||
16793361|NCT01649427|37734536|FG000|Overall Study|Lost to Follow-up|0|||
16793362|NCT01649427|37734537|FG001|Overall Study|Lost to Follow-up|1|||
16793363|NCT01649427|37734536|FG000|Overall Study|Graft loss|0|||
16793364|NCT01649427|37734537|FG001|Overall Study|Graft loss|1|||
16793365|NCT01649427|37734536|FG000|Overall Study|Surgical problems during nephrectomy|2|||
16793366|NCT01649427|37734537|FG001|Overall Study|Surgical problems during nephrectomy|2|||
16793367|NCT02375373|37734543|FG000|Overall Study|Withdrawal by Subject|11|||
16793368|NCT02336607|37734551|FG000|Overall Study|Physician Decision|1|||
16793369|NCT02336607|37734552|FG001|Overall Study|Physician Decision|4|||
16793370|NCT02336607|37734553|FG002|Overall Study|Physician Decision|3|||
16793371|NCT02336607|37734554|FG003|Overall Study|Physician Decision|15|||
16793372|NCT02336607|37734551|FG000|Overall Study|Lack of Efficacy|1|||
16793373|NCT02336607|37734552|FG001|Overall Study|Lack of Efficacy|0|||
16793374|NCT02336607|37734553|FG002|Overall Study|Lack of Efficacy|0|||
16793375|NCT02336607|37734554|FG003|Overall Study|Lack of Efficacy|2|||
16793376|NCT02336607|37734551|FG000|Overall Study|Lost to Follow-up|2|||
16793377|NCT02336607|37734552|FG001|Overall Study|Lost to Follow-up|1|||
16793378|NCT02336607|37734553|FG002|Overall Study|Lost to Follow-up|0|||
16793379|NCT02336607|37734554|FG003|Overall Study|Lost to Follow-up|21|||
16793380|NCT02336607|37734551|FG000|Overall Study|Protocol Violation|0|||
16793381|NCT02336607|37734552|FG001|Overall Study|Protocol Violation|1|||
16793382|NCT02336607|37734553|FG002|Overall Study|Protocol Violation|1|||
16793383|NCT02336607|37734554|FG003|Overall Study|Protocol Violation|3|||
16793384|NCT02336607|37734551|FG000|Overall Study|Adverse Event|0|||
16793385|NCT02336607|37734552|FG001|Overall Study|Adverse Event|2|||
16793386|NCT02336607|37734553|FG002|Overall Study|Adverse Event|2|||
16793387|NCT02336607|37734554|FG003|Overall Study|Adverse Event|26|||
16793388|NCT02336607|37734551|FG000|Overall Study|Withdrawal by Subject|0|||
16793389|NCT02336607|37734552|FG001|Overall Study|Withdrawal by Subject|2|||
16793390|NCT02336607|37734553|FG002|Overall Study|Withdrawal by Subject|0|||
16793391|NCT02336607|37734554|FG003|Overall Study|Withdrawal by Subject|20|||
16908960|NCT01729728|38017647|FG002|Overall Study|Adverse Event|0|||
16908961|NCT01729728|38017645|FG000|Overall Study|Protocol Violation|1|||
16793392|NCT02374671|37734567|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
16793393|NCT02374671|37734568|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
16793394|NCT02374671|37734569|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
16793395|NCT02374671|37734567|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
16793396|NCT02374671|37734568|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
16793397|NCT02374671|37734569|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
16793398|NCT02374671|37734567|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
16793399|NCT02374671|37734568|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
16793400|NCT02374671|37734569|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
16793401|NCT02374671|37734567|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
16793402|NCT02374671|37734568|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
16793403|NCT02374671|37734569|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
16793404|NCT02374671|37734567|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
16793405|NCT02374671|37734568|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
16793406|NCT02374671|37734569|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
16793407|NCT02569801|37734577|FG000|Overall Study|Withdrawal by Subject|9|||
16793408|NCT02569801|37734578|FG001|Overall Study|Withdrawal by Subject|9|||
16793409|NCT02569801|37734577|FG000|Overall Study|Sponsor Decision|13|||
16793410|NCT02569801|37734578|FG001|Overall Study|Sponsor Decision|14|||
16793411|NCT02569801|37734577|FG000|Overall Study|Progressive Disease|2|||
16793412|NCT02569801|37734578|FG001|Overall Study|Progressive Disease|7|||
16793413|NCT02569801|37734577|FG000|Overall Study|Lost to Follow-up|0|||
16793414|NCT02569801|37734578|FG001|Overall Study|Lost to Follow-up|1|||
16793415|NCT02569801|37734577|FG000|Overall Study|Death|12|||
16793416|NCT02569801|37734578|FG001|Overall Study|Death|4|||
16793417|NCT02573311|37734586|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
16793418|NCT02573311|37734587|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
16793419|NCT02573311|37734586|FG000|Disposition for Part 2|Physician Decision|25|||
16793420|NCT02573311|37734587|FG001|Disposition for Part 2|Physician Decision|7|||
16793421|NCT02573311|37734586|FG000|Disposition for Part 2|Adverse Event|36|||
16793422|NCT02573311|37734587|FG001|Disposition for Part 2|Adverse Event|5|||
16793423|NCT02573311|37734586|FG000|Disposition for Part 2|Lost to Follow-up|76|||
16793424|NCT02573311|37734587|FG001|Disposition for Part 2|Lost to Follow-up|7|||
16793425|NCT02573311|37734586|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
16793426|NCT02573311|37734587|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
16793427|NCT02573311|37734586|FG000|Disposition for Part 2|Investigator decision|0|||
16793428|NCT02573311|37734587|FG001|Disposition for Part 2|Investigator decision|1|||
16793429|NCT02573311|37734586|FG000|Disposition for Part 2|Other than specified above|13|||
16793430|NCT02573311|37734587|FG001|Disposition for Part 2|Other than specified above|3|||
16793431|NCT02571049|37734593|FG000|Screening|Did not meet entry criteria|2|||
16793432|NCT02571049|37734594|FG001|Screening|Did not meet entry criteria|2|||
16793433|NCT02571049|37734593|FG000|Randomization|No migraine attack|0|||
16793434|NCT02571049|37734594|FG001|Randomization|No migraine attack|1|||
16793435|NCT02571049|37734593|FG000|Randomization|Adverse Event|0|||
16793436|NCT02571049|37734594|FG001|Randomization|Adverse Event|1|||
16793437|NCT02573155|37734602|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
16793438|NCT02573155|37734603|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
16793439|NCT02573155|37734602|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
16793440|NCT02573155|37734603|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
16793441|NCT02573155|37734602|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
16793442|NCT02573155|37734603|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
16793443|NCT02573155|37734602|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
16793444|NCT02573155|37734603|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
16793445|NCT02573155|37734602|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
16793446|NCT02573155|37734603|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
16793447|NCT02573155|37734602|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
16793448|NCT02573155|37734603|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
16793449|NCT02573155|37734602|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
16793450|NCT02573155|37734603|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
16793451|NCT02573155|37734602|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
16793452|NCT02573155|37734603|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
16793453|NCT02568475|37734631|FG000|Overall Study|Lost to Follow-up|40|||
16793454|NCT02568475|37734632|FG001|Overall Study|Lost to Follow-up|39|||
16793455|NCT02568475|37734631|FG000|Overall Study|Withdrawal by Subject|2|||
16793456|NCT02568475|37734632|FG001|Overall Study|Withdrawal by Subject|0|||
16793457|NCT02568475|37734631|FG000|Overall Study|Discharged home|4|||
16793458|NCT02568475|37734632|FG001|Overall Study|Discharged home|4|||
16793459|NCT02568475|37734631|FG000|Overall Study|Short-term: Discharge location unknown|4|||
16793460|NCT02568475|37734632|FG001|Overall Study|Short-term: Discharge location unknown|0|||
16793461|NCT02568475|37734631|FG000|Overall Study|Transferred to another facility|1|||
16793462|NCT02568475|37734632|FG001|Overall Study|Transferred to another facility|0|||
16793463|NCT02568397|37734638|FG000|Period 2|Withdrawal by Subject|0|||
16793464|NCT02568397|37734639|FG001|Period 2|Withdrawal by Subject|1|||
16793465|NCT02568397|37734638|FG000|Period 2|Physician Decision|0|||
16793466|NCT02568397|37734639|FG001|Period 2|Physician Decision|1|||
16793467|NCT02566525|37734656|FG000|Overall Study|Protocol Violation|3|||
16793468|NCT02566525|37734657|FG001|Overall Study|Protocol Violation|5|||
16793469|NCT02567227|37734667|FG000|9 Weeks|Adverse Event|5|||
16793470|NCT02567227|37734668|FG001|9 Weeks|Adverse Event|5|||
16793471|NCT02567227|37734667|FG000|9 Weeks|Withdrawal by Subject|18|||
16793472|NCT02567227|37734668|FG001|9 Weeks|Withdrawal by Subject|8|||
16793473|NCT02567227|37734667|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
16793474|NCT02567227|37734668|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
16793475|NCT02567227|37734667|FG000|6 Month|Death|2|||
16793476|NCT02567227|37734668|FG001|6 Month|Death|0|||
16793477|NCT02567227|37734667|FG000|6 Month|Lost to Follow-up|43|||
16793478|NCT02567227|37734668|FG001|6 Month|Lost to Follow-up|40|||
16793479|NCT02567227|37734667|FG000|12 Months|Lost to Follow-up|31|||
16793480|NCT02567227|37734668|FG001|12 Months|Lost to Follow-up|32|||
16793481|NCT02567227|37734667|FG000|12 Months|Death|0|||
16793482|NCT02567227|37734668|FG001|12 Months|Death|2|||
16793483|NCT02336451|37734679|FG000|Overall Study|Adverse Event|1|||
16793484|NCT02336451|37734680|FG001|Overall Study|Adverse Event|2|||
16793485|NCT02336451|37734681|FG002|Overall Study|Adverse Event|0|||
16793486|NCT02336451|37734682|FG003|Overall Study|Adverse Event|6|||
16793487|NCT02336451|37734683|FG004|Overall Study|Adverse Event|4|||
16793488|NCT02336451|37734679|FG000|Overall Study|Death|6|||
16793489|NCT02336451|37734680|FG001|Overall Study|Death|2|||
16793490|NCT02336451|37734681|FG002|Overall Study|Death|3|||
16793491|NCT02336451|37734682|FG003|Overall Study|Death|6|||
16793492|NCT02336451|37734683|FG004|Overall Study|Death|6|||
16793493|NCT02336451|37734679|FG000|Overall Study|Physician Decision|9|||
16793494|NCT02336451|37734680|FG001|Overall Study|Physician Decision|6|||
16793495|NCT02336451|37734681|FG002|Overall Study|Physician Decision|7|||
16793496|NCT02336451|37734682|FG003|Overall Study|Physician Decision|16|||
16793497|NCT02336451|37734683|FG004|Overall Study|Physician Decision|3|||
16793498|NCT02336451|37734679|FG000|Overall Study|Progressive disease|23|||
16793499|NCT02336451|37734680|FG001|Overall Study|Progressive disease|26|||
16793500|NCT02336451|37734681|FG002|Overall Study|Progressive disease|2|||
16793501|NCT02336451|37734682|FG003|Overall Study|Progressive disease|14|||
16793502|NCT02336451|37734683|FG004|Overall Study|Progressive disease|4|||
16793503|NCT02336451|37734679|FG000|Overall Study|Protocol Violation|1|||
16793504|NCT02336451|37734680|FG001|Overall Study|Protocol Violation|0|||
16793505|NCT02336451|37734681|FG002|Overall Study|Protocol Violation|0|||
16793506|NCT02336451|37734682|FG003|Overall Study|Protocol Violation|0|||
16793507|NCT02336451|37734683|FG004|Overall Study|Protocol Violation|0|||
16793508|NCT02336451|37734679|FG000|Overall Study|Patient/guardian decision|2|||
16793509|NCT02336451|37734680|FG001|Overall Study|Patient/guardian decision|4|||
16793510|NCT02336451|37734681|FG002|Overall Study|Patient/guardian decision|0|||
16793511|NCT02336451|37734682|FG003|Overall Study|Patient/guardian decision|2|||
16793512|NCT02336451|37734683|FG004|Overall Study|Patient/guardian decision|1|||
16793513|NCT02374593|37734699|FG000|Overall Study|non-compliant|2|||
16793514|NCT02374593|37734700|FG001|Overall Study|non-compliant|0|||
16793515|NCT01648101|37734713|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
16793516|NCT01648101|37734714|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
16793517|NCT01648101|37734715|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
16793518|NCT01648101|37734713|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
16793519|NCT01648101|37734714|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
16793520|NCT01648101|37734715|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
16793521|NCT01648101|37734713|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
16793522|NCT01648101|37734714|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
16793523|NCT01648101|37734715|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
16793524|NCT01648101|37734713|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
16793525|NCT01648101|37734714|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
16793526|NCT01648101|37734715|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
16793527|NCT01648101|37734713|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
16793528|NCT01648101|37734714|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
16793529|NCT01648101|37734715|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
16793530|NCT01648101|37734713|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
16793531|NCT01648101|37734714|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
16793532|NCT01648101|37734715|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
16793533|NCT01648101|37734713|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
16793534|NCT01648101|37734714|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
16793535|NCT01648101|37734715|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
16793536|NCT01648101|37734713|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
16793537|NCT01648101|37734714|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
16793538|NCT01648101|37734715|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
16793539|NCT01648101|37734713|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
16793540|NCT01648101|37734714|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
16793541|NCT01648101|37734715|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
16793542|NCT01648101|37734713|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
16793543|NCT01648101|37734714|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
16793544|NCT01648101|37734715|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
16793545|NCT01648101|37734713|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
16793546|NCT01648101|37734714|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
16793547|NCT01648101|37734715|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
16793548|NCT02336373|37734727|FG000|Overall Study|Protocol closed early|4|||
16793549|NCT02336373|37734727|FG000|Overall Study|Physician Decision|14|||
16793550|NCT02372799|37734736|FG000|Treatment Period|Adverse Event|3|||
16793551|NCT02372799|37734737|FG001|Treatment Period|Adverse Event|10|||
16793552|NCT02372799|37734738|FG002|Treatment Period|Adverse Event|6|||
16793553|NCT02372799|37734736|FG000|Treatment Period|Insufficient therapeutic response|2|||
16793554|NCT02372799|37734737|FG001|Treatment Period|Insufficient therapeutic response|2|||
16793555|NCT02372799|37734738|FG002|Treatment Period|Insufficient therapeutic response|0|||
16793556|NCT02372799|37734736|FG000|Treatment Period|Withdrawal by Subject|10|||
16793557|NCT02372799|37734737|FG001|Treatment Period|Withdrawal by Subject|10|||
16793558|NCT02372799|37734738|FG002|Treatment Period|Withdrawal by Subject|2|||
16793559|NCT02372799|37734736|FG000|Treatment Period|Lost to Follow-up|11|||
16793560|NCT02372799|37734737|FG001|Treatment Period|Lost to Follow-up|5|||
16793561|NCT02372799|37734738|FG002|Treatment Period|Lost to Follow-up|3|||
16793562|NCT02372799|37734736|FG000|Treatment Period|Protocol Violation|3|||
16793563|NCT02372799|37734737|FG001|Treatment Period|Protocol Violation|0|||
16793564|NCT02372799|37734738|FG002|Treatment Period|Protocol Violation|0|||
16793565|NCT02372799|37734736|FG000|Treatment Period|Non-compliance with study drug|4|||
16793566|NCT02372799|37734737|FG001|Treatment Period|Non-compliance with study drug|4|||
16793567|NCT02372799|37734738|FG002|Treatment Period|Non-compliance with study drug|4|||
16793568|NCT02372799|37734736|FG000|Treatment Period|Miscellaneous Reasons|1|||
16793569|NCT02372799|37734737|FG001|Treatment Period|Miscellaneous Reasons|1|||
16793570|NCT02372799|37734738|FG002|Treatment Period|Miscellaneous Reasons|0|||
16793571|NCT02372799|37734736|FG000|Down-taper Period|Lost to Follow-up|1|||
16793572|NCT02372799|37734737|FG001|Down-taper Period|Lost to Follow-up|2|||
16793573|NCT02372799|37734738|FG002|Down-taper Period|Lost to Follow-up|2|||
16793574|NCT02566993|37734748|FG000|Overall Study|Randomized but not treated|5|||
16793575|NCT02566993|37734749|FG001|Overall Study|Randomized but not treated|16|||
16793576|NCT02566993|37734748|FG000|Overall Study|Progressive disease|213|||
16793577|NCT02566993|37734749|FG001|Overall Study|Progressive disease|152|||
16793578|NCT02566993|37734748|FG000|Overall Study|Withdrawal by Subject|12|||
16793579|NCT02566993|37734749|FG001|Overall Study|Withdrawal by Subject|28|||
16793580|NCT02566993|37734748|FG000|Overall Study|Death|17|||
16793581|NCT02566993|37734749|FG001|Overall Study|Death|23|||
16793582|NCT02566993|37734748|FG000|Overall Study|Physician Decision|10|||
16793583|NCT02566993|37734749|FG001|Overall Study|Physician Decision|17|||
16793584|NCT02566993|37734748|FG000|Overall Study|Study drug-related adverse event|20|||
16793585|NCT02566993|37734749|FG001|Overall Study|Study drug-related adverse event|41|||
16793586|NCT02566993|37734748|FG000|Overall Study|Non study drug-related adverse event|9|||
16793587|NCT02566993|37734749|FG001|Overall Study|Non study drug-related adverse event|9|||
16793588|NCT02566993|37734748|FG000|Overall Study|Symptomatic deterioration|9|||
16793589|NCT02566993|37734749|FG001|Overall Study|Symptomatic deterioration|16|||
16793590|NCT02566993|37734748|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
16793591|NCT02566993|37734749|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
16793592|NCT02566993|37734748|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
16793593|NCT02566993|37734749|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
16793594|NCT02566993|37734748|FG000|Overall Study|Screening failure|2|||
16793595|NCT02566993|37734749|FG001|Overall Study|Screening failure|0|||
16793596|NCT02566993|37734748|FG000|Overall Study|Lost to Follow-up|0|||
16793597|NCT02566993|37734749|FG001|Overall Study|Lost to Follow-up|1|||
16793598|NCT02566993|37734748|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
16793599|NCT02566993|37734749|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
16793600|NCT02311881|37734760|FG000|Overall Study|Did not meet the study criteria|2|||
16793601|NCT02311881|37734761|FG001|Overall Study|Did not meet the study criteria|2|||
16793602|NCT02311881|37734762|FG002|Overall Study|Did not meet the study criteria|0|||
16793603|NCT02311881|37734760|FG000|Overall Study|Adverse Event|7|||
16793604|NCT02311881|37734761|FG001|Overall Study|Adverse Event|15|||
16793605|NCT02311881|37734762|FG002|Overall Study|Adverse Event|8|||
16793606|NCT02311881|37734760|FG000|Overall Study|Lost to Follow-up|3|||
16793607|NCT02311881|37734761|FG001|Overall Study|Lost to Follow-up|3|||
16793608|NCT02311881|37734762|FG002|Overall Study|Lost to Follow-up|2|||
16793609|NCT02311881|37734760|FG000|Overall Study|Protocol Violation|1|||
16793610|NCT02311881|37734761|FG001|Overall Study|Protocol Violation|2|||
17102254|NCT00384293|38241184|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
16793611|NCT02311881|37734762|FG002|Overall Study|Protocol Violation|3|||
16793612|NCT02311881|37734760|FG000|Overall Study|Withdrawal of consent|14|||
16793613|NCT02311881|37734761|FG001|Overall Study|Withdrawal of consent|16|||
16793614|NCT02311881|37734762|FG002|Overall Study|Withdrawal of consent|17|||
16793615|NCT02311881|37734760|FG000|Overall Study|Other|0|||
16793616|NCT02311881|37734761|FG001|Overall Study|Other|0|||
16793617|NCT02311881|37734762|FG002|Overall Study|Other|1|||
16793618|NCT02311881|37734760|FG000|Overall Study|Lack of Efficacy|1|||
16793619|NCT02311881|37734761|FG001|Overall Study|Lack of Efficacy|2|||
16793620|NCT02311881|37734762|FG002|Overall Study|Lack of Efficacy|0|||
16793621|NCT02311881|37734760|FG000|Overall Study|Subject has border line pregnancy test|1|||
16793622|NCT02311881|37734761|FG001|Overall Study|Subject has border line pregnancy test|0|||
16793623|NCT02311881|37734762|FG002|Overall Study|Subject has border line pregnancy test|0|||
16793624|NCT02311881|37734760|FG000|Overall Study|Withdrawal by Subject|3|||
16793625|NCT02311881|37734761|FG001|Overall Study|Withdrawal by Subject|1|||
16793626|NCT02311881|37734762|FG002|Overall Study|Withdrawal by Subject|4|||
16793627|NCT02311881|37734760|FG000|Overall Study|Sponsor Decision|1|||
16793628|NCT02311881|37734761|FG001|Overall Study|Sponsor Decision|1|||
16793629|NCT02311881|37734762|FG002|Overall Study|Sponsor Decision|1|||
16793630|NCT02311881|37734760|FG000|Overall Study|Protocol Deviation|1|||
16793631|NCT02311881|37734761|FG001|Overall Study|Protocol Deviation|0|||
16793632|NCT02311881|37734762|FG002|Overall Study|Protocol Deviation|0|||
16793633|NCT02311881|37734760|FG000|Overall Study|Non-Compliance|1|||
16793634|NCT02311881|37734761|FG001|Overall Study|Non-Compliance|0|||
16793635|NCT02311881|37734762|FG002|Overall Study|Non-Compliance|2|||
16793636|NCT02311881|37734760|FG000|Overall Study|Physician Decision|0|||
16793637|NCT02311881|37734761|FG001|Overall Study|Physician Decision|0|||
16793638|NCT02311881|37734762|FG002|Overall Study|Physician Decision|1|||
16793639|NCT02311881|37734760|FG000|Overall Study|Medical Monitor Discretion|0|||
16793640|NCT02311881|37734761|FG001|Overall Study|Medical Monitor Discretion|0|||
16793641|NCT02311881|37734762|FG002|Overall Study|Medical Monitor Discretion|1|||
16793642|NCT02311881|37734760|FG000|Overall Study|Participant taking another medication|0|||
16793643|NCT02311881|37734761|FG001|Overall Study|Participant taking another medication|0|||
16793644|NCT02311881|37734762|FG002|Overall Study|Participant taking another medication|1|||
16793645|NCT02311881|37734760|FG000|Overall Study|Serious Adverse Event|0|||
16793646|NCT02311881|37734761|FG001|Overall Study|Serious Adverse Event|1|||
16793647|NCT02311881|37734762|FG002|Overall Study|Serious Adverse Event|0|||
16793648|NCT02565511|37734777|FG000|Overall Study|Study terminated by Sponsor|35|||
16793649|NCT02565511|37734778|FG001|Overall Study|Study terminated by Sponsor|22|||
16793650|NCT02565511|37734779|FG002|Overall Study|Study terminated by Sponsor|235|||
16793651|NCT02565511|37734780|FG003|Overall Study|Study terminated by Sponsor|156|||
16793652|NCT02565511|37734777|FG000|Overall Study|Withdrawal by Subject|3|||
16793653|NCT02565511|37734778|FG001|Overall Study|Withdrawal by Subject|0|||
16793654|NCT02565511|37734779|FG002|Overall Study|Withdrawal by Subject|12|||
16793655|NCT02565511|37734780|FG003|Overall Study|Withdrawal by Subject|5|||
16793656|NCT02565511|37734777|FG000|Overall Study|Adverse Event|0|||
16793657|NCT02565511|37734778|FG001|Overall Study|Adverse Event|0|||
16793658|NCT02565511|37734779|FG002|Overall Study|Adverse Event|1|||
16793659|NCT02565511|37734780|FG003|Overall Study|Adverse Event|1|||
16793660|NCT02565511|37734777|FG000|Overall Study|Lost to Follow-up|4|||
16793661|NCT02565511|37734778|FG001|Overall Study|Lost to Follow-up|1|||
16793662|NCT02565511|37734779|FG002|Overall Study|Lost to Follow-up|0|||
16793663|NCT02565511|37734780|FG003|Overall Study|Lost to Follow-up|1|||
16793664|NCT02565511|37734777|FG000|Overall Study|Physician Decision|0|||
16793665|NCT02565511|37734778|FG001|Overall Study|Physician Decision|0|||
16793666|NCT02565511|37734779|FG002|Overall Study|Physician Decision|0|||
16793667|NCT02565511|37734780|FG003|Overall Study|Physician Decision|1|||
16793668|NCT02565511|37734777|FG000|Overall Study|Protocol deviation|0|||
16793669|NCT02565511|37734778|FG001|Overall Study|Protocol deviation|0|||
16793670|NCT02565511|37734779|FG002|Overall Study|Protocol deviation|3|||
16793671|NCT02565511|37734780|FG003|Overall Study|Protocol deviation|0|||
16793672|NCT02561455|37734794|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
16793673|NCT02561455|37734795|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
17198306|NCT01331681|38351893|FG001|Overall Study|Protocol Violation|1|||
17198307|NCT01331681|38351894|FG002|Overall Study|Protocol Violation|0|||
17198308|NCT01331681|38351892|FG000|Overall Study|Lost to Follow-up|2|||
17198309|NCT01331681|38351893|FG001|Overall Study|Lost to Follow-up|4|||
17198310|NCT01331681|38351894|FG002|Overall Study|Lost to Follow-up|1|||
17198311|NCT01331681|38351892|FG000|Overall Study|Physician Decision|2|||
17198312|NCT01331681|38351893|FG001|Overall Study|Physician Decision|0|||
17198313|NCT01331681|38351894|FG002|Overall Study|Physician Decision|4|||
16793674|NCT02561455|37734796|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
16793675|NCT02561455|37734797|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
17198314|NCT01331681|38351892|FG000|Overall Study|Therapeutic procedure required|1|||
16793676|NCT02561455|37734794|FG000|Overall Study|Withdrawal by Subject|1|||
16793677|NCT02561455|37734795|FG001|Overall Study|Withdrawal by Subject|0|||
16793678|NCT02561455|37734796|FG002|Overall Study|Withdrawal by Subject|1|||
16793679|NCT02561455|37734797|FG003|Overall Study|Withdrawal by Subject|0|||
16793680|NCT02561455|37734794|FG000|Overall Study|Disease Progression|0|||
16793681|NCT02561455|37734795|FG001|Overall Study|Disease Progression|1|||
16793682|NCT02561455|37734796|FG002|Overall Study|Disease Progression|0|||
16793683|NCT02561455|37734797|FG003|Overall Study|Disease Progression|0|||
16793684|NCT02561299|37734809|FG000|Overall Study|Death|2|||
16793685|NCT02561299|37734810|FG001|Overall Study|Death|4|||
16793686|NCT02561299|37734809|FG000|Overall Study|Lost to Follow-up|1|||
16793687|NCT02561299|37734810|FG001|Overall Study|Lost to Follow-up|0|||
16793688|NCT02561299|37734809|FG000|Overall Study|Withdrawal by Subject|2|||
16793689|NCT02561299|37734810|FG001|Overall Study|Withdrawal by Subject|2|||
16793690|NCT02566759|37734833|FG000|All Parts|Withdrawal by Subject|0|||
16793691|NCT02566759|37734834|FG001|All Parts|Withdrawal by Subject|1|||
16793692|NCT02566759|37734835|FG002|All Parts|Withdrawal by Subject|0|||
16793693|NCT02566759|37734836|FG003|All Parts|Withdrawal by Subject|0|||
16793694|NCT02566759|37734837|FG004|All Parts|Withdrawal by Subject|0|||
16793695|NCT02566759|37734838|FG005|All Parts|Withdrawal by Subject|0|||
16793696|NCT02566759|37734839|FG006|All Parts|Withdrawal by Subject|0|||
16793697|NCT02566759|37734840|FG007|All Parts|Withdrawal by Subject|0|||
16793698|NCT02566759|37734841|FG008|All Parts|Withdrawal by Subject|0|||
16793699|NCT02566759|37734842|FG009|All Parts|Withdrawal by Subject|0|||
16793700|NCT02566759|37734843|FG010|All Parts|Withdrawal by Subject|0|||
16793701|NCT02566759|37734844|FG011|All Parts|Withdrawal by Subject|0|||
16793702|NCT02566759|37734845|FG012|All Parts|Withdrawal by Subject|0|||
16793703|NCT02566759|37734846|FG013|All Parts|Withdrawal by Subject|0|||
16793704|NCT02566759|37734847|FG014|All Parts|Withdrawal by Subject|0|||
16793705|NCT02566759|37734848|FG015|All Parts|Withdrawal by Subject|0|||
16793706|NCT02566759|37734849|FG016|All Parts|Withdrawal by Subject|0|||
16793707|NCT02566759|37734833|FG000|All Parts|Adverse Event|0|||
16793708|NCT02566759|37734834|FG001|All Parts|Adverse Event|0|||
16793709|NCT02566759|37734835|FG002|All Parts|Adverse Event|0|||
16793710|NCT02566759|37734836|FG003|All Parts|Adverse Event|0|||
16793711|NCT02566759|37734837|FG004|All Parts|Adverse Event|0|||
16793712|NCT02566759|37734838|FG005|All Parts|Adverse Event|0|||
16793713|NCT02566759|37734839|FG006|All Parts|Adverse Event|0|||
16793714|NCT02566759|37734840|FG007|All Parts|Adverse Event|0|||
16793715|NCT02566759|37734841|FG008|All Parts|Adverse Event|0|||
16793716|NCT02566759|37734842|FG009|All Parts|Adverse Event|0|||
16793717|NCT02566759|37734843|FG010|All Parts|Adverse Event|0|||
16793718|NCT02566759|37734844|FG011|All Parts|Adverse Event|0|||
16793719|NCT02566759|37734845|FG012|All Parts|Adverse Event|1|||
16793720|NCT02566759|37734846|FG013|All Parts|Adverse Event|3|||
16793721|NCT02566759|37734847|FG014|All Parts|Adverse Event|0|||
16793722|NCT02566759|37734848|FG015|All Parts|Adverse Event|0|||
16793723|NCT02566759|37734849|FG016|All Parts|Adverse Event|0|||
16793724|NCT02566759|37734833|FG000|All Parts|Other|0|||
16793725|NCT02566759|37734834|FG001|All Parts|Other|0|||
16793726|NCT02566759|37734835|FG002|All Parts|Other|0|||
16793727|NCT02566759|37734836|FG003|All Parts|Other|0|||
16793728|NCT02566759|37734837|FG004|All Parts|Other|0|||
16793729|NCT02566759|37734838|FG005|All Parts|Other|0|||
16793730|NCT02566759|37734839|FG006|All Parts|Other|0|||
16793731|NCT02566759|37734840|FG007|All Parts|Other|0|||
16793732|NCT02566759|37734841|FG008|All Parts|Other|0|||
16793733|NCT02566759|37734842|FG009|All Parts|Other|0|||
16793734|NCT02566759|37734843|FG010|All Parts|Other|0|||
16793735|NCT02566759|37734844|FG011|All Parts|Other|0|||
16793736|NCT02566759|37734845|FG012|All Parts|Other|0|||
16793737|NCT02566759|37734846|FG013|All Parts|Other|2|||
16793738|NCT02566759|37734847|FG014|All Parts|Other|0|||
16793739|NCT02566759|37734848|FG015|All Parts|Other|0|||
16793740|NCT02566759|37734849|FG016|All Parts|Other|0|||
16793741|NCT02566759|37734833|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793742|NCT02566759|37734834|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793743|NCT02566759|37734835|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793744|NCT02566759|37734836|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793745|NCT02566759|37734837|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793746|NCT02566759|37734838|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793747|NCT02566759|37734839|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793748|NCT02566759|37734840|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793749|NCT02566759|37734841|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793750|NCT02566759|37734842|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793751|NCT02566759|37734843|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793752|NCT02566759|37734844|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793753|NCT02566759|37734845|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793754|NCT02566759|37734846|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793755|NCT02566759|37734847|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793756|NCT02566759|37734848|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16793757|NCT02566759|37734849|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
16793758|NCT02335983|37734914|FG000|Overall Study|Sponsor Decision|0|||
16793759|NCT02335983|37734915|FG001|Overall Study|Sponsor Decision|0|||
16793760|NCT02335983|37734916|FG002|Overall Study|Sponsor Decision|1|||
16793761|NCT02335983|37734917|FG003|Overall Study|Sponsor Decision|1|||
16793762|NCT02335983|37734918|FG004|Overall Study|Sponsor Decision|0|||
16793763|NCT02335983|37734919|FG005|Overall Study|Sponsor Decision|1|||
16793764|NCT02335983|37734914|FG000|Overall Study|Withdrawal by Subject|3|||
16793765|NCT02335983|37734915|FG001|Overall Study|Withdrawal by Subject|2|||
16793766|NCT02335983|37734916|FG002|Overall Study|Withdrawal by Subject|2|||
16793767|NCT02335983|37734917|FG003|Overall Study|Withdrawal by Subject|1|||
16793768|NCT02335983|37734918|FG004|Overall Study|Withdrawal by Subject|3|||
16793769|NCT02335983|37734919|FG005|Overall Study|Withdrawal by Subject|9|||
16793770|NCT02335983|37734914|FG000|Overall Study|Death|0|||
16793771|NCT02335983|37734915|FG001|Overall Study|Death|0|||
16793772|NCT02335983|37734916|FG002|Overall Study|Death|2|||
16793773|NCT02335983|37734917|FG003|Overall Study|Death|0|||
16793774|NCT02335983|37734918|FG004|Overall Study|Death|0|||
16793775|NCT02335983|37734919|FG005|Overall Study|Death|0|||
16793776|NCT02335983|37734914|FG000|Overall Study|Lost to Follow-up|0|||
16793777|NCT02335983|37734915|FG001|Overall Study|Lost to Follow-up|0|||
16793778|NCT02335983|37734916|FG002|Overall Study|Lost to Follow-up|0|||
16793779|NCT02335983|37734917|FG003|Overall Study|Lost to Follow-up|0|||
16793780|NCT02335983|37734918|FG004|Overall Study|Lost to Follow-up|0|||
16793781|NCT02335983|37734919|FG005|Overall Study|Lost to Follow-up|1|||
16793782|NCT02335983|37734914|FG000|Overall Study|Protocol Specified Criteria|5|||
16793783|NCT02335983|37734915|FG001|Overall Study|Protocol Specified Criteria|7|||
16793784|NCT02335983|37734916|FG002|Overall Study|Protocol Specified Criteria|27|||
16793785|NCT02335983|37734917|FG003|Overall Study|Protocol Specified Criteria|7|||
16793786|NCT02335983|37734918|FG004|Overall Study|Protocol Specified Criteria|5|||
16793787|NCT02335983|37734919|FG005|Overall Study|Protocol Specified Criteria|21|||
16793788|NCT04640311|37734955|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
16793789|NCT04640311|37734956|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793790|NCT04640311|37734957|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793791|NCT04640311|37734958|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793792|NCT04640311|37734959|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793793|NCT04640311|37734960|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793794|NCT04640311|37734961|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793795|NCT04640311|37734962|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793796|NCT04640311|37734963|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793797|NCT04640311|37734964|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793798|NCT04640311|37734965|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793799|NCT04640311|37734966|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793800|NCT04640311|37734967|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793801|NCT04640311|37734955|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793802|NCT04640311|37734956|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
16793803|NCT04640311|37734957|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793804|NCT04640311|37734958|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793805|NCT04640311|37734959|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793806|NCT04640311|37734960|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793807|NCT04640311|37734961|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793808|NCT04640311|37734962|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793809|NCT04640311|37734963|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793810|NCT04640311|37734964|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793811|NCT04640311|37734965|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793812|NCT04640311|37734966|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793813|NCT04640311|37734967|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16793814|NCT04640311|37734955|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793815|NCT04640311|37734956|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
16793816|NCT04640311|37734957|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793817|NCT04640311|37734958|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793818|NCT04640311|37734959|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793819|NCT04640311|37734960|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793820|NCT04640311|37734961|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793821|NCT04640311|37734962|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793822|NCT04640311|37734963|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793823|NCT04640311|37734964|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16908962|NCT01729728|38017646|FG001|Overall Study|Protocol Violation|0|||
16793824|NCT04640311|37734965|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793825|NCT04640311|37734966|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793826|NCT04640311|37734967|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793827|NCT04640311|37734955|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
16793828|NCT04640311|37734956|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
16793829|NCT04640311|37734957|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
16793830|NCT04640311|37734958|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793831|NCT04640311|37734959|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793832|NCT04640311|37734960|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793833|NCT04640311|37734961|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793834|NCT04640311|37734962|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793835|NCT04640311|37734963|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793836|NCT04640311|37734964|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793837|NCT04640311|37734965|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793838|NCT04640311|37734966|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793839|NCT04640311|37734967|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16793840|NCT04640311|37734955|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793841|NCT04640311|37734956|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793842|NCT04640311|37734957|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
16793843|NCT04640311|37734958|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793844|NCT04640311|37734959|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793845|NCT04640311|37734960|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793846|NCT04640311|37734961|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793847|NCT04640311|37734962|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793848|NCT04640311|37734963|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793849|NCT04640311|37734964|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793850|NCT04640311|37734965|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793851|NCT04640311|37734966|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793852|NCT04640311|37734967|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16793853|NCT04640311|37734955|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793854|NCT04640311|37734956|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793855|NCT04640311|37734957|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793856|NCT04640311|37734958|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
16793857|NCT04640311|37734959|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793858|NCT04640311|37734960|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793859|NCT04640311|37734961|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
16793860|NCT04640311|37734962|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793861|NCT04640311|37734963|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793862|NCT04640311|37734964|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793863|NCT04640311|37734965|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793864|NCT04640311|37734966|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793865|NCT04640311|37734967|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16793866|NCT04640311|37734955|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793867|NCT04640311|37734956|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793868|NCT04640311|37734957|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793869|NCT04640311|37734958|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793870|NCT04640311|37734959|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793871|NCT04640311|37734960|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
16793872|NCT04640311|37734961|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793873|NCT04640311|37734962|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793874|NCT04640311|37734963|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
16793875|NCT04640311|37734964|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793876|NCT04640311|37734965|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793877|NCT04640311|37734966|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793878|NCT04640311|37734967|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16793879|NCT04640311|37734955|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
17102255|NCT00384293|38241182|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
16793880|NCT04640311|37734956|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793881|NCT04640311|37734957|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793882|NCT04640311|37734958|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793883|NCT04640311|37734959|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793884|NCT04640311|37734960|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793885|NCT04640311|37734961|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
16793886|NCT04640311|37734962|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793887|NCT04640311|37734963|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793888|NCT04640311|37734964|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793889|NCT04640311|37734965|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
16793890|NCT04640311|37734966|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793891|NCT04640311|37734967|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16793892|NCT04640311|37734955|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793893|NCT04640311|37734956|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793894|NCT04640311|37734957|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793895|NCT04640311|37734958|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793896|NCT04640311|37734959|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793897|NCT04640311|37734960|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793898|NCT04640311|37734961|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793899|NCT04640311|37734962|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793900|NCT04640311|37734963|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793901|NCT04640311|37734964|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793902|NCT04640311|37734965|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793903|NCT04640311|37734966|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
16793904|NCT04640311|37734967|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16793905|NCT02334423|37734998|FG000|Overall Study|Protocol Violation|10|||
16793906|NCT02334423|37734999|FG001|Overall Study|Protocol Violation|3|||
16793907|NCT02310789|37735005|FG000|Overall Study|Adverse Event|1|||
16793908|NCT02372253|37735011|FG000|Overall Study|Non Compliance|2|||
16793909|NCT02372253|37735012|FG001|Overall Study|Non Compliance|0|||
16793910|NCT02559895|37735024|FG000|Overall Study|Adverse Event|3|||
16793911|NCT02559895|37735025|FG001|Overall Study|Adverse Event|3|||
16793912|NCT02559895|37735026|FG002|Overall Study|Adverse Event|2|||
16793913|NCT02559895|37735027|FG003|Overall Study|Adverse Event|1|||
16793914|NCT02559895|37735024|FG000|Overall Study|Lack of Efficacy|2|||
16793915|NCT02559895|37735025|FG001|Overall Study|Lack of Efficacy|3|||
16793916|NCT02559895|37735026|FG002|Overall Study|Lack of Efficacy|2|||
16793917|NCT02559895|37735027|FG003|Overall Study|Lack of Efficacy|8|||
16793918|NCT02559895|37735024|FG000|Overall Study|Lost to Follow-up|22|||
16793919|NCT02559895|37735025|FG001|Overall Study|Lost to Follow-up|16|||
16793920|NCT02559895|37735026|FG002|Overall Study|Lost to Follow-up|12|||
16793921|NCT02559895|37735027|FG003|Overall Study|Lost to Follow-up|17|||
16793922|NCT02559895|37735024|FG000|Overall Study|Physician Decision|1|||
16793923|NCT02559895|37735025|FG001|Overall Study|Physician Decision|1|||
16793924|NCT02559895|37735026|FG002|Overall Study|Physician Decision|3|||
16793925|NCT02559895|37735027|FG003|Overall Study|Physician Decision|0|||
16793926|NCT02559895|37735024|FG000|Overall Study|Withdrawal by Subject|16|||
16793927|NCT02559895|37735025|FG001|Overall Study|Withdrawal by Subject|9|||
16793928|NCT02559895|37735026|FG002|Overall Study|Withdrawal by Subject|20|||
16793929|NCT02559895|37735027|FG003|Overall Study|Withdrawal by Subject|9|||
16793930|NCT02559895|37735024|FG000|Overall Study|Study Burden|10|||
16793931|NCT02559895|37735025|FG001|Overall Study|Study Burden|16|||
16793932|NCT02559895|37735026|FG002|Overall Study|Study Burden|12|||
16793933|NCT02559895|37735027|FG003|Overall Study|Study Burden|22|||
16793934|NCT02559895|37735024|FG000|Overall Study|Other|1|||
16793935|NCT02559895|37735025|FG001|Overall Study|Other|5|||
16793936|NCT02559895|37735026|FG002|Overall Study|Other|3|||
16793937|NCT02559895|37735027|FG003|Overall Study|Other|3|||
16793938|NCT02371629|37735039|FG000|Overall Study|Patient decision|14|||
16793939|NCT02371629|37735040|FG001|Overall Study|Patient decision|10|||
16793940|NCT02371629|37735039|FG000|Overall Study|Adverse Event|8|||
16793941|NCT02371629|37735040|FG001|Overall Study|Adverse Event|8|||
16793942|NCT02371629|37735039|FG000|Overall Study|Physician Decision|2|||
16793943|NCT02371629|37735040|FG001|Overall Study|Physician Decision|3|||
16793944|NCT02371629|37735039|FG000|Overall Study|Death|1|||
16793945|NCT02371629|37735040|FG001|Overall Study|Death|1|||
16793946|NCT02371629|37735039|FG000|Overall Study|Noncompliance with study treatment|1|||
16793947|NCT02371629|37735040|FG001|Overall Study|Noncompliance with study treatment|0|||
16793948|NCT02371629|37735039|FG000|Overall Study|Lack of Efficacy|0|||
16793949|NCT02371629|37735040|FG001|Overall Study|Lack of Efficacy|2|||
16793950|NCT02371629|37735039|FG000|Overall Study|Protocol deviation|0|||
16793951|NCT02371629|37735040|FG001|Overall Study|Protocol deviation|1|||
16793952|NCT02559817|37735051|FG000|Treatment Period|Adverse Event|1|||
16793953|NCT02559817|37735052|FG001|Treatment Period|Adverse Event|0|||
16793954|NCT02559817|37735053|FG002|Treatment Period|Adverse Event|1|||
16793955|NCT02559817|37735054|FG003|Treatment Period|Adverse Event|0|||
16793956|NCT02559817|37735055|FG004|Treatment Period|Adverse Event|0|||
16793957|NCT02559817|37735051|FG000|Treatment Period|Lack of Efficacy|0|||
16793958|NCT02559817|37735052|FG001|Treatment Period|Lack of Efficacy|1|||
16793959|NCT02559817|37735053|FG002|Treatment Period|Lack of Efficacy|0|||
16793960|NCT02559817|37735054|FG003|Treatment Period|Lack of Efficacy|0|||
16793961|NCT02559817|37735055|FG004|Treatment Period|Lack of Efficacy|0|||
16793962|NCT02559817|37735051|FG000|Treatment Period|Lost to Follow-up|0|||
16793963|NCT02559817|37735052|FG001|Treatment Period|Lost to Follow-up|1|||
16793964|NCT02559817|37735053|FG002|Treatment Period|Lost to Follow-up|0|||
16793965|NCT02559817|37735054|FG003|Treatment Period|Lost to Follow-up|1|||
16793966|NCT02559817|37735055|FG004|Treatment Period|Lost to Follow-up|0|||
16793967|NCT02559817|37735051|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
16793968|NCT02559817|37735052|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
16793969|NCT02559817|37735053|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
16793970|NCT02559817|37735054|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
16793971|NCT02559817|37735055|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
16793972|NCT02559817|37735051|FG000|Treatment Period|Protocol Violation|0|||
16793973|NCT02559817|37735052|FG001|Treatment Period|Protocol Violation|0|||
16793974|NCT02559817|37735053|FG002|Treatment Period|Protocol Violation|0|||
16793975|NCT02559817|37735054|FG003|Treatment Period|Protocol Violation|1|||
16793976|NCT02559817|37735055|FG004|Treatment Period|Protocol Violation|0|||
16793977|NCT02564887|37735069|FG000|Overall Study|Lost to Follow-up|6|||
16793978|NCT02564887|37735070|FG001|Overall Study|Lost to Follow-up|0|||
16793979|NCT02333487|37735081|FG000|Overall Study|Adverse Event|0|||
16793980|NCT02333487|37735082|FG001|Overall Study|Adverse Event|2|||
16793981|NCT02333487|37735083|FG002|Overall Study|Adverse Event|0|||
16793982|NCT02333331|37735096|FG000|Overall Study|Adverse Event|1|||
16793983|NCT02333331|37735097|FG001|Overall Study|Adverse Event|0|||
16793984|NCT02333331|37735098|FG002|Overall Study|Adverse Event|4|||
16793985|NCT02333331|37735099|FG003|Overall Study|Adverse Event|1|||
16793986|NCT02333331|37735096|FG000|Overall Study|Death|0|||
16793987|NCT02333331|37735097|FG001|Overall Study|Death|0|||
16793988|NCT02333331|37735098|FG002|Overall Study|Death|2|||
16793989|NCT02333331|37735099|FG003|Overall Study|Death|0|||
16793990|NCT02333331|37735096|FG000|Overall Study|Lost to Follow-up|0|||
16793991|NCT02333331|37735097|FG001|Overall Study|Lost to Follow-up|0|||
16793992|NCT02333331|37735098|FG002|Overall Study|Lost to Follow-up|1|||
16793993|NCT02333331|37735099|FG003|Overall Study|Lost to Follow-up|0|||
16793994|NCT02333331|37735096|FG000|Overall Study|Physician Decision|0|||
16793995|NCT02333331|37735097|FG001|Overall Study|Physician Decision|1|||
16793996|NCT02333331|37735098|FG002|Overall Study|Physician Decision|0|||
16793997|NCT02333331|37735099|FG003|Overall Study|Physician Decision|0|||
16793998|NCT02333331|37735096|FG000|Overall Study|Protocol Deviation|0|||
16793999|NCT02333331|37735097|FG001|Overall Study|Protocol Deviation|3|||
16794000|NCT02333331|37735098|FG002|Overall Study|Protocol Deviation|2|||
16794001|NCT02333331|37735099|FG003|Overall Study|Protocol Deviation|1|||
16794002|NCT02333331|37735096|FG000|Overall Study|Patient/Guardian Decision|1|||
16794003|NCT02333331|37735097|FG001|Overall Study|Patient/Guardian Decision|2|||
16794004|NCT02333331|37735098|FG002|Overall Study|Patient/Guardian Decision|9|||
16794005|NCT02333331|37735099|FG003|Overall Study|Patient/Guardian Decision|1|||
16794006|NCT02563561|37735112|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
16794007|NCT02563561|37735113|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
16794008|NCT02563561|37735114|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
16794009|NCT02563561|37735112|FG000|Overall Study|Withdrew of Consent|1|||
16794010|NCT02563561|37735113|FG001|Overall Study|Withdrew of Consent|1|||
16794011|NCT02563561|37735114|FG002|Overall Study|Withdrew of Consent|2|||
16794012|NCT02563561|37735112|FG000|Overall Study|Lost to Follow-up|1|||
16794013|NCT02563561|37735113|FG001|Overall Study|Lost to Follow-up|1|||
16794014|NCT02563561|37735114|FG002|Overall Study|Lost to Follow-up|0|||
16794015|NCT02563561|37735112|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
16794016|NCT02563561|37735113|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
16794017|NCT02563561|37735114|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
16794018|NCT02563561|37735112|FG000|Overall Study|Investigator Decision|3|||
16794019|NCT02563561|37735113|FG001|Overall Study|Investigator Decision|4|||
16794020|NCT02563561|37735114|FG002|Overall Study|Investigator Decision|2|||
16794021|NCT02563561|37735112|FG000|Overall Study|Sponsor Decision|5|||
16794022|NCT02563561|37735113|FG001|Overall Study|Sponsor Decision|2|||
16794023|NCT02563561|37735114|FG002|Overall Study|Sponsor Decision|4|||
16794024|NCT02563561|37735112|FG000|Overall Study|Other|1|||
16794025|NCT02563561|37735113|FG001|Overall Study|Other|5|||
16794026|NCT02563561|37735114|FG002|Overall Study|Other|2|||
16794027|NCT02559505|37735130|FG000|Overall Study|Lost to Follow-up|23|||
16794028|NCT02559505|37735131|FG001|Overall Study|Lost to Follow-up|20|||
16794029|NCT02559505|37735130|FG000|Overall Study|Withdrawal by Subject|4|||
16794030|NCT02559505|37735131|FG001|Overall Study|Withdrawal by Subject|2|||
16794031|NCT04476043|37735153|FG000|Overall Study|Withdrawal by Subject|1|||
16794032|NCT04476043|37735154|FG001|Overall Study|Withdrawal by Subject|3|||
16794033|NCT04476043|37735155|FG002|Overall Study|Withdrawal by Subject|4|||
16794034|NCT04476043|37735156|FG003|Overall Study|Withdrawal by Subject|1|||
16794035|NCT04476043|37735153|FG000|Overall Study|Lost to Follow-up|1|||
16794036|NCT04476043|37735154|FG001|Overall Study|Lost to Follow-up|1|||
16794037|NCT04476043|37735155|FG002|Overall Study|Lost to Follow-up|2|||
16794038|NCT04476043|37735156|FG003|Overall Study|Lost to Follow-up|1|||
16794039|NCT04476043|37735153|FG000|Overall Study|Adverse Event|2|||
16794040|NCT04476043|37735154|FG001|Overall Study|Adverse Event|0|||
16794041|NCT04476043|37735155|FG002|Overall Study|Adverse Event|1|||
16794042|NCT04476043|37735156|FG003|Overall Study|Adverse Event|0|||
16794043|NCT04476043|37735153|FG000|Overall Study|Protocol Violation|0|||
16794044|NCT04476043|37735154|FG001|Overall Study|Protocol Violation|1|||
16794045|NCT04476043|37735155|FG002|Overall Study|Protocol Violation|0|||
16794046|NCT04476043|37735156|FG003|Overall Study|Protocol Violation|0|||
16794047|NCT04191967|37735170|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
16794048|NCT04191967|37735170|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
16794049|NCT02556307|37735176|FG000|Overall Study|Premature treatment interruption|11|||
16794050|NCT02556307|37735176|FG000|Overall Study|Lost to Follow-up|36|||
16794051|NCT02556307|37735176|FG000|Overall Study|Change to triple therapy|4|||
16908963|NCT01729728|38017647|FG002|Overall Study|Protocol Violation|1|||
16908964|NCT01729026|38017780|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
16908965|NCT01729026|38017781|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
16908966|NCT01729026|38017780|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
16908967|NCT01729026|38017781|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
16908968|NCT01728792|38017795|FG000|Overall Study|Withdrawal of Consent|1|||
16908969|NCT01728792|38017796|FG001|Overall Study|Withdrawal of Consent|1|||
16908970|NCT01728792|38017797|FG002|Overall Study|Withdrawal of Consent|0|||
16908971|NCT01728792|38017798|FG003|Overall Study|Withdrawal of Consent|1|||
16908972|NCT01728792|38017799|FG004|Overall Study|Withdrawal of Consent|0|||
16908973|NCT01728792|38017795|FG000|Overall Study|Lost to Follow-up|2|||
16908974|NCT01728792|38017796|FG001|Overall Study|Lost to Follow-up|1|||
16908975|NCT01728792|38017797|FG002|Overall Study|Lost to Follow-up|4|||
16908976|NCT01728792|38017798|FG003|Overall Study|Lost to Follow-up|2|||
16908977|NCT01728792|38017799|FG004|Overall Study|Lost to Follow-up|0|||
16908978|NCT01752036|38017811|FG000|Overall Study|Death|2|||
16908979|NCT01728324|38017819|FG000|Termination of DBV|Adverse Event|14|||
16908980|NCT01728324|38017820|FG001|Termination of DBV|Adverse Event|13|||
16908981|NCT01728324|38017821|FG002|Termination of DBV|Adverse Event|4|||
16908982|NCT01728324|38017819|FG000|Termination of DBV|Lack of Efficacy|14|||
16908983|NCT01728324|38017820|FG001|Termination of DBV|Lack of Efficacy|12|||
16908984|NCT01728324|38017821|FG002|Termination of DBV|Lack of Efficacy|8|||
16908985|NCT01728324|38017819|FG000|Termination of DBV|Withdrawal by Subject|9|||
16908986|NCT01728324|38017820|FG001|Termination of DBV|Withdrawal by Subject|6|||
16908987|NCT01728324|38017821|FG002|Termination of DBV|Withdrawal by Subject|2|||
16908988|NCT01728324|38017819|FG000|Termination of DBV|Other than stated|1|||
16908989|NCT01728324|38017820|FG001|Termination of DBV|Other than stated|3|||
16908990|NCT01728324|38017821|FG002|Termination of DBV|Other than stated|0|||
16908991|NCT01728324|38017819|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
16908992|NCT01728324|38017820|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
16908993|NCT01728324|38017821|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
16908994|NCT01728324|38017819|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
16908995|NCT01728324|38017820|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
16908996|NCT01728324|38017821|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
16908997|NCT01728324|38017819|FG000|Termination of FDV|Adverse Event|14|||
16908998|NCT01728324|38017820|FG001|Termination of FDV|Adverse Event|13|||
16908999|NCT01728324|38017821|FG002|Termination of FDV|Adverse Event|4|||
16909000|NCT01728324|38017819|FG000|Termination of FDV|Lack of Efficacy|14|||
16909001|NCT01728324|38017820|FG001|Termination of FDV|Lack of Efficacy|12|||
16909002|NCT01728324|38017821|FG002|Termination of FDV|Lack of Efficacy|8|||
16909003|NCT01728324|38017819|FG000|Termination of FDV|Withdrawal by Subject|9|||
16909004|NCT01728324|38017820|FG001|Termination of FDV|Withdrawal by Subject|6|||
16794052|NCT02556307|37735176|FG000|Overall Study|Enrolled but not treated|2|||
16794053|NCT04364737|37735182|FG000|Overall Study|Withdrawal by Subject|4|||
16909005|NCT01728324|38017821|FG002|Termination of FDV|Withdrawal by Subject|2|||
16909006|NCT01728324|38017819|FG000|Termination of FDV|Other than stated|1|||
16909007|NCT01728324|38017820|FG001|Termination of FDV|Other than stated|3|||
16909008|NCT01728324|38017821|FG002|Termination of FDV|Other than stated|0|||
16909009|NCT01728324|38017819|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
16909010|NCT01728324|38017820|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
16909011|NCT01728324|38017821|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
16909012|NCT01728324|38017819|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
16909013|NCT01728324|38017820|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
16909014|NCT01728324|38017821|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
16909015|NCT01728324|38017819|FG000|Termination of RBV|Adverse Event|15|||
16909016|NCT01728324|38017820|FG001|Termination of RBV|Adverse Event|16|||
16909017|NCT01728324|38017821|FG002|Termination of RBV|Adverse Event|5|||
16909018|NCT01728324|38017819|FG000|Termination of RBV|Lack of Efficacy|14|||
16909019|NCT01728324|38017820|FG001|Termination of RBV|Lack of Efficacy|11|||
16909020|NCT01728324|38017821|FG002|Termination of RBV|Lack of Efficacy|7|||
16909021|NCT01728324|38017819|FG000|Termination of RBV|Withdrawal by Subject|9|||
16909022|NCT01728324|38017820|FG001|Termination of RBV|Withdrawal by Subject|5|||
16909023|NCT01728324|38017821|FG002|Termination of RBV|Withdrawal by Subject|2|||
16909024|NCT01728324|38017819|FG000|Termination of RBV|Other than stated|1|||
16909025|NCT01728324|38017820|FG001|Termination of RBV|Other than stated|3|||
16909026|NCT01728324|38017821|FG002|Termination of RBV|Other than stated|1|||
16909027|NCT01728324|38017819|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
16909028|NCT01728324|38017820|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
16909029|NCT01728324|38017821|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
16909030|NCT01728324|38017819|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
16909031|NCT01728324|38017820|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
16909032|NCT01728324|38017821|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
16909033|NCT01728246|38017833|FG000|Overall Study|Participant needed rescue medication|1|||
16909034|NCT01728246|38017834|FG001|Overall Study|Participant needed rescue medication|5|||
17016470|NCT00592904|38161085|FG001|Overall Study|Withdrawal by Subject|16|||
17016471|NCT00592904|38161086|FG002|Overall Study|Withdrawal by Subject|1|||
17016472|NCT00592904|38161087|FG003|Overall Study|Withdrawal by Subject|2|||
17016473|NCT00592904|38161084|FG000|Overall Study|Lack of Efficacy|2|||
17016474|NCT00592904|38161085|FG001|Overall Study|Lack of Efficacy|7|||
17016475|NCT00592904|38161086|FG002|Overall Study|Lack of Efficacy|2|||
17102256|NCT00384293|38241183|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
17102257|NCT00384293|38241184|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
17016476|NCT00592904|38161087|FG003|Overall Study|Lack of Efficacy|3|||
17016477|NCT00592904|38161084|FG000|Overall Study|Physician Decision|0|||
17016478|NCT00592904|38161085|FG001|Overall Study|Physician Decision|3|||
17016479|NCT00592904|38161086|FG002|Overall Study|Physician Decision|1|||
17016480|NCT00592904|38161087|FG003|Overall Study|Physician Decision|0|||
17102258|NCT00384293|38241182|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
17198315|NCT01331681|38351893|FG001|Overall Study|Therapeutic procedure required|0|||
17198316|NCT01331681|38351894|FG002|Overall Study|Therapeutic procedure required|0|||
17198317|NCT01331681|38351892|FG000|Overall Study|Sponsor decision|1|||
17198318|NCT01331681|38351893|FG001|Overall Study|Sponsor decision|1|||
17198319|NCT01331681|38351894|FG002|Overall Study|Sponsor decision|0|||
17198320|NCT01331681|38351892|FG000|Overall Study|Switching to other therapy|0|||
17198321|NCT01331681|38351893|FG001|Overall Study|Switching to other therapy|0|||
17198322|NCT01331681|38351894|FG002|Overall Study|Switching to other therapy|1|||
17198323|NCT01331681|38351892|FG000|Overall Study|Not Received Study Treatment|0|||
17198324|NCT01331681|38351893|FG001|Overall Study|Not Received Study Treatment|0|||
17198325|NCT01331681|38351894|FG002|Overall Study|Not Received Study Treatment|2|||
17198326|NCT01331291|38351904|FG000|Overall Study|Lack of Efficacy|2|||
17198327|NCT01331291|38351905|FG001|Overall Study|Lack of Efficacy|8|||
17198328|NCT01331291|38351904|FG000|Overall Study|Death|0|||
17198329|NCT01331291|38351905|FG001|Overall Study|Death|1|||
17198330|NCT02601560|38351918|FG000|Overall Study|Other|0|||
17198331|NCT02601560|38351919|FG001|Overall Study|Other|0|||
17198332|NCT02601560|38351920|FG002|Overall Study|Other|0|||
17198333|NCT02601560|38351921|FG003|Overall Study|Other|0|||
17198334|NCT02601560|38351922|FG004|Overall Study|Other|0|||
17198335|NCT02601560|38351923|FG005|Overall Study|Other|0|||
17198336|NCT02601560|38351924|FG006|Overall Study|Other|1|||
17198337|NCT02601560|38351925|FG007|Overall Study|Other|0|||
17198338|NCT02595398|38351956|FG000|Overall Study|Non-compliance|1|||
16909035|NCT01728246|38017833|FG000|Overall Study|Protocol Violation|1|||
16909036|NCT01728246|38017834|FG001|Overall Study|Protocol Violation|0|||
16909037|NCT01728246|38017833|FG000|Overall Study|Withdrawal by Subject|2|||
16909038|NCT01728246|38017834|FG001|Overall Study|Withdrawal by Subject|3|||
16909039|NCT01728246|38017833|FG000|Overall Study|Lost to Follow-up|23|||
16909040|NCT01728246|38017834|FG001|Overall Study|Lost to Follow-up|22|||
17016481|NCT00592904|38161084|FG000|Overall Study|Other|3|||
17016482|NCT00592904|38161085|FG001|Overall Study|Other|3|||
17102259|NCT00384293|38241183|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
17102260|NCT00384293|38241184|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
17102261|NCT00384293|38241182|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
17102262|NCT00384293|38241183|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
17102263|NCT00384293|38241184|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
17102264|NCT00384293|38241182|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
17102265|NCT00384293|38241183|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
17198339|NCT02595398|38351957|FG001|Overall Study|Non-compliance|0|||
16909041|NCT01728246|38017833|FG000|Overall Study|Lack of Efficacy|1|||
16909042|NCT01728246|38017834|FG001|Overall Study|Lack of Efficacy|1|||
16909043|NCT01728246|38017833|FG000|Overall Study|Adverse Event|8|||
16909044|NCT01728246|38017834|FG001|Overall Study|Adverse Event|5|||
16909045|NCT01705236|38017840|FG000|Overall Study|Lost to Follow-up|1|||
16909046|NCT01705236|38017840|FG000|Overall Study|Administrative problems|2|||
16909047|NCT01705236|38017840|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16909048|NCT01705236|38017840|FG000|Overall Study|Protocol Violation|3|||
16909049|NCT01705236|38017840|FG000|Overall Study|Abnormal test procedure result(s)|4|||
16909050|NCT01705236|38017840|FG000|Overall Study|Abnormal laboratory value(s)|4|||
16909051|NCT01705236|38017840|FG000|Overall Study|Withdrawal by Subject|5|||
16909052|NCT01705236|38017840|FG000|Overall Study|Adverse Event|5|||
16909053|NCT01705080|38017847|FG000|Overall Study|Missed visit|10|||
16909054|NCT01705080|38017848|FG001|Overall Study|Missed visit|4|||
16909055|NCT01705080|38017849|FG002|Overall Study|Missed visit|1|||
16909056|NCT01705080|38017847|FG000|Overall Study|Death|4|||
16909057|NCT01705080|38017848|FG001|Overall Study|Death|4|||
16909058|NCT01705080|38017849|FG002|Overall Study|Death|6|||
16909059|NCT01705080|38017847|FG000|Overall Study|Withdrawal by Subject|61|||
16909060|NCT01705080|38017848|FG001|Overall Study|Withdrawal by Subject|44|||
16909061|NCT01705080|38017849|FG002|Overall Study|Withdrawal by Subject|9|||
16909062|NCT01704846|38017859|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16909063|NCT01704846|38017860|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16909064|NCT01751802|38017868|FG000|Overall Study|Adverse Event|4|||
16909065|NCT01751802|38017869|FG001|Overall Study|Adverse Event|2|||
16909066|NCT01704456|38017883|FG000|Overall Study|Lost to Follow-up|8|||
16909067|NCT01704456|38017884|FG001|Overall Study|Lost to Follow-up|14|||
16909068|NCT01703988|38017894|FG000|Overall Study|Investigator Judgment|0|||
16909069|NCT01703988|38017895|FG001|Overall Study|Investigator Judgment|0|||
16909070|NCT01703988|38017896|FG002|Overall Study|Investigator Judgment|0|||
16909071|NCT01703988|38017897|FG003|Overall Study|Investigator Judgment|1|||
16909072|NCT01703832|38017910|FG000|Overall Study|Withdrawal by Subject|1|||
16909073|NCT01703832|38017911|FG001|Overall Study|Withdrawal by Subject|0|||
16909074|NCT01703286|38017917|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
16909075|NCT01703286|38017918|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
16909076|NCT01703286|38017919|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
16909077|NCT01703286|38017920|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
16909078|NCT01703286|38017921|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
16909079|NCT01703286|38017922|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
16909080|NCT01703286|38017917|FG000|Period 2 Including Washout|Adverse Event|0|||
16909081|NCT01703286|38017918|FG001|Period 2 Including Washout|Adverse Event|0|||
16909082|NCT01703286|38017919|FG002|Period 2 Including Washout|Adverse Event|0|||
16909083|NCT01703286|38017920|FG003|Period 2 Including Washout|Adverse Event|1|||
16909084|NCT01703286|38017921|FG004|Period 2 Including Washout|Adverse Event|0|||
16909085|NCT01703286|38017922|FG005|Period 2 Including Washout|Adverse Event|0|||
16909086|NCT01703208|38017935|FG000|Overall Study|Death|61|||
16909087|NCT01703208|38017936|FG001|Overall Study|Death|48|||
16909088|NCT01703208|38017935|FG000|Overall Study|Lack of Efficacy|1|||
16909089|NCT01703208|38017936|FG001|Overall Study|Lack of Efficacy|2|||
16909090|NCT01703208|38017935|FG000|Overall Study|Lost to Follow-up|68|||
16909091|NCT01703208|38017936|FG001|Overall Study|Lost to Follow-up|62|||
16909092|NCT01703208|38017935|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16909093|NCT01703208|38017936|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16909094|NCT01703208|38017935|FG000|Overall Study|Excluded Medication|1|||
16909095|NCT01703208|38017936|FG001|Overall Study|Excluded Medication|2|||
16909096|NCT01703208|38017935|FG000|Overall Study|Site Discontinued Study Participation|23|||
16909097|NCT01703208|38017936|FG001|Overall Study|Site Discontinued Study Participation|27|||
16909098|NCT01703208|38017935|FG000|Overall Study|Physician Decision|11|||
16794054|NCT04364737|37735183|FG001|Overall Study|Withdrawal by Subject|9|||
16794055|NCT04364737|37735182|FG000|Overall Study|Lost to Follow-up|1|||
16794056|NCT04364737|37735183|FG001|Overall Study|Lost to Follow-up|1|||
16794057|NCT02559115|37735189|FG000|Overall Study|Withdrawal by Subject|3|||
16794058|NCT01662895|37735207|FG000|Overall Study|Lost to Follow-up|0|||
16794059|NCT01662895|37735208|FG001|Overall Study|Lost to Follow-up|1|||
16794060|NCT04147195|37735216|FG000|Overall Study|Adverse Event|0|||
16794061|NCT04147195|37735217|FG001|Overall Study|Adverse Event|3|||
16909099|NCT01703208|38017936|FG001|Overall Study|Physician Decision|13|||
17016483|NCT00592904|38161086|FG002|Overall Study|Other|0|||
16794062|NCT04147195|37735216|FG000|Overall Study|Study Terminated by Sponsor|4|||
16794063|NCT04147195|37735217|FG001|Overall Study|Study Terminated by Sponsor|2|||
16909100|NCT01703208|38017935|FG000|Overall Study|Progressive disease|2|||
16909101|NCT01703208|38017936|FG001|Overall Study|Progressive disease|2|||
16909102|NCT01703208|38017935|FG000|Overall Study|Protocol Violation|1|||
16909103|NCT01703208|38017936|FG001|Overall Study|Protocol Violation|1|||
16909104|NCT01703208|38017935|FG000|Overall Study|Study Terminated by Sponsor|1710|||
16909105|NCT01703208|38017936|FG001|Overall Study|Study Terminated by Sponsor|1716|||
16909106|NCT01703208|38017935|FG000|Overall Study|Withdrawal by Subject|205|||
16794064|NCT04147195|37735216|FG000|Overall Study|Withdrawal by Subject|0|||
16794065|NCT04147195|37735217|FG001|Overall Study|Withdrawal by Subject|1|||
16794066|NCT02557399|37735226|FG000|Overall Study|Adverse Event|6|||
16794067|NCT02557399|37735227|FG001|Overall Study|Adverse Event|5|||
16794068|NCT02557399|37735226|FG000|Overall Study|Protocol Violation|0|||
16794069|NCT02557399|37735227|FG001|Overall Study|Protocol Violation|1|||
16794070|NCT02557399|37735226|FG000|Overall Study|Protocol-defined stopping criteria|0|||
16794071|NCT02557399|37735227|FG001|Overall Study|Protocol-defined stopping criteria|1|||
16794072|NCT02557399|37735226|FG000|Overall Study|Withdrawal by Subject|1|||
16794073|NCT02557399|37735227|FG001|Overall Study|Withdrawal by Subject|1|||
16794074|NCT02555371|37735236|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
16794075|NCT02555371|37735237|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
16794076|NCT02555371|37735238|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
16794077|NCT02555371|37735239|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
16794078|NCT02555371|37735240|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
16794079|NCT02555371|37735236|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
16794080|NCT02555371|37735237|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
16794081|NCT02555371|37735238|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
16794082|NCT02555371|37735239|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
16794083|NCT02555371|37735240|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
16794084|NCT02555371|37735236|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
16794085|NCT02555371|37735237|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
16794086|NCT02555371|37735238|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
16794087|NCT02555371|37735239|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
16794088|NCT02555371|37735240|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
16794089|NCT02555371|37735236|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
16794090|NCT02555371|37735237|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
16794091|NCT02555371|37735238|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
16794092|NCT02555371|37735239|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
16794093|NCT02555371|37735240|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
16794094|NCT02555371|37735236|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
16794095|NCT02555371|37735237|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
16794096|NCT02555371|37735238|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
16794097|NCT02555371|37735239|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
16794098|NCT02555371|37735240|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
16794099|NCT02555371|37735236|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
16794100|NCT02555371|37735237|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
16794101|NCT02555371|37735238|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
16794102|NCT02555371|37735239|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
16794103|NCT02555371|37735240|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
16794104|NCT02555371|37735236|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
16794105|NCT02555371|37735237|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
16794106|NCT02555371|37735238|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
16794107|NCT02555371|37735239|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
16794108|NCT02555371|37735240|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
16794109|NCT02555371|37735236|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
16794110|NCT02555371|37735237|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
16794111|NCT02555371|37735238|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
16794112|NCT02555371|37735239|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
16794113|NCT02555371|37735240|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
16794114|NCT02555371|37735236|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
16794115|NCT02555371|37735237|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
16794116|NCT02555371|37735238|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
16794117|NCT02555371|37735239|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
16794118|NCT02555371|37735240|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
16794119|NCT02555371|37735236|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
16794120|NCT02555371|37735237|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
16794121|NCT02555371|37735238|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
16794122|NCT02555371|37735239|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
16794123|NCT02555371|37735240|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
16794124|NCT02555371|37735236|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
16794125|NCT02555371|37735237|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
16794126|NCT02555371|37735238|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
16794127|NCT02555371|37735239|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
16794128|NCT02555371|37735240|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
16794129|NCT02555371|37735236|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
17016484|NCT00592904|38161087|FG003|Overall Study|Other|0|||
16794130|NCT02555371|37735237|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
16794131|NCT02555371|37735238|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
16794132|NCT02555371|37735239|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
16794133|NCT02555371|37735240|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
16794134|NCT02555371|37735236|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
16794135|NCT02555371|37735237|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
16794136|NCT02555371|37735238|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
16794137|NCT02555371|37735239|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
16794138|NCT02555371|37735240|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
16794139|NCT02555371|37735236|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
16794140|NCT02555371|37735237|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
16794141|NCT02555371|37735238|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
16794142|NCT02555371|37735239|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
16794143|NCT02555371|37735240|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
16794144|NCT02555215|37735249|FG000|Overall Study|Other|1|||
16794145|NCT02555215|37735249|FG000|Overall Study|Investigator Decision|2|||
16794146|NCT02555683|37735256|FG000|Overall Study|Physician Decision|1|||
16794147|NCT02555683|37735257|FG001|Overall Study|Physician Decision|0|||
16794148|NCT02555683|37735258|FG002|Overall Study|Physician Decision|2|||
16794149|NCT02555683|37735256|FG000|Overall Study|Lost to Follow-up|2|||
16794150|NCT02555683|37735257|FG001|Overall Study|Lost to Follow-up|1|||
16794151|NCT02555683|37735258|FG002|Overall Study|Lost to Follow-up|2|||
16794152|NCT02555683|37735256|FG000|Overall Study|Technical Problems|1|||
16794153|NCT02555683|37735257|FG001|Overall Study|Technical Problems|1|||
16794154|NCT02555683|37735258|FG002|Overall Study|Technical Problems|0|||
16794155|NCT02555683|37735256|FG000|Overall Study|Protocol deviation|0|||
16794156|NCT02555683|37735257|FG001|Overall Study|Protocol deviation|1|||
16794157|NCT02555683|37735258|FG002|Overall Study|Protocol deviation|0|||
16794158|NCT02555683|37735256|FG000|Overall Study|Lack of Efficacy|2|||
16794159|NCT02555683|37735257|FG001|Overall Study|Lack of Efficacy|0|||
16794160|NCT02555683|37735258|FG002|Overall Study|Lack of Efficacy|0|||
16794161|NCT02555683|37735256|FG000|Overall Study|Death|0|||
16794162|NCT02555683|37735257|FG001|Overall Study|Death|1|||
16794163|NCT02555683|37735258|FG002|Overall Study|Death|2|||
16794164|NCT02555683|37735256|FG000|Overall Study|Adverse Event|1|||
16794165|NCT02555683|37735257|FG001|Overall Study|Adverse Event|0|||
16794166|NCT02555683|37735258|FG002|Overall Study|Adverse Event|1|||
16794167|NCT02555683|37735256|FG000|Overall Study|Subject/guardian decision|12|||
16794168|NCT02555683|37735257|FG001|Overall Study|Subject/guardian decision|12|||
16794169|NCT02555683|37735258|FG002|Overall Study|Subject/guardian decision|22|||
16794170|NCT02555683|37735256|FG000|Overall Study|Death post Treatment/safety period|0|||
16794171|NCT02555683|37735257|FG001|Overall Study|Death post Treatment/safety period|1|||
16794172|NCT02555683|37735258|FG002|Overall Study|Death post Treatment/safety period|0|||
16794173|NCT02554981|37735266|FG000|Overall Study|Adverse Event|1|||
16794174|NCT02554981|37735266|FG000|Overall Study|Administrative Reasons|1|||
16794175|NCT02554981|37735266|FG000|Overall Study|Other Miscellaneous Reasons|3|||
16794176|NCT02556775|37735274|FG000|Overall Study|Withdrawal by Subject|1|||
16794177|NCT02556775|37735275|FG001|Overall Study|Withdrawal by Subject|0|||
16794178|NCT02556775|37735276|FG002|Overall Study|Withdrawal by Subject|1|||
16794179|NCT02556775|37735277|FG003|Overall Study|Withdrawal by Subject|0|||
16794180|NCT02556775|37735274|FG000|Overall Study|Lost to Follow-up|1|||
16794181|NCT02556775|37735275|FG001|Overall Study|Lost to Follow-up|0|||
16794182|NCT02556775|37735276|FG002|Overall Study|Lost to Follow-up|0|||
16794183|NCT02556775|37735277|FG003|Overall Study|Lost to Follow-up|0|||
16794184|NCT01662505|37735292|FG000|Overall Study|Progressive disease|6|||
16794185|NCT01662505|37735293|FG001|Overall Study|Progressive disease|1|||
16794186|NCT01662505|37735294|FG002|Overall Study|Progressive disease|5|||
16794187|NCT01662505|37735292|FG000|Overall Study|Refused cont. medication|0|||
16794188|NCT01662505|37735293|FG001|Overall Study|Refused cont. medication|0|||
16794189|NCT01662505|37735294|FG002|Overall Study|Refused cont. medication|1|||
16794190|NCT01662505|37735292|FG000|Overall Study|Not specified above|1|||
16794191|NCT01662505|37735293|FG001|Overall Study|Not specified above|3|||
16794192|NCT01662505|37735294|FG002|Overall Study|Not specified above|2|||
16794193|NCT03796195|37735303|FG000|Overall Study|Study closed early|1|||
16794194|NCT02554513|37735337|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
16794195|NCT02554513|37735338|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
16794196|NCT02554279|37735352|FG000|Overall Study|Adverse Event|2|||
16794197|NCT02554279|37735353|FG001|Overall Study|Adverse Event|5|||
16794198|NCT02554279|37735352|FG000|Overall Study|Lost to Follow-up|3|||
16794199|NCT02554279|37735353|FG001|Overall Study|Lost to Follow-up|2|||
16794200|NCT02554279|37735352|FG000|Overall Study|Withdrawal by Subject|6|||
16794201|NCT02554279|37735353|FG001|Overall Study|Withdrawal by Subject|4|||
16794202|NCT02554279|37735352|FG000|Overall Study|Protocol Violation|2|||
16794203|NCT02554279|37735353|FG001|Overall Study|Protocol Violation|1|||
16794204|NCT02554279|37735352|FG000|Overall Study|Other reason|19|||
16794205|NCT02554279|37735353|FG001|Overall Study|Other reason|6|||
16794206|NCT02554903|37735368|FG000|Overall Study|Death|1|||
16794207|NCT02554903|37735369|FG001|Overall Study|Death|1|||
16794208|NCT02554903|37735368|FG000|Overall Study|Physician Decision|2|||
16794209|NCT02554903|37735369|FG001|Overall Study|Physician Decision|2|||
16794210|NCT02554903|37735368|FG000|Overall Study|Heart Transplant|1|||
16794211|NCT02554903|37735369|FG001|Overall Study|Heart Transplant|2|||
16794212|NCT02332707|37735394|FG000|Overall Study|Adverse Event|0|||
16794213|NCT02332707|37735395|FG001|Overall Study|Adverse Event|0|||
16794214|NCT02332707|37735396|FG002|Overall Study|Adverse Event|0|||
16794215|NCT02332707|37735397|FG003|Overall Study|Adverse Event|0|||
16794216|NCT02332707|37735398|FG004|Overall Study|Adverse Event|0|||
16794217|NCT02332707|37735399|FG005|Overall Study|Adverse Event|0|||
16794218|NCT02332707|37735400|FG006|Overall Study|Adverse Event|0|||
16794219|NCT02332707|37735401|FG007|Overall Study|Adverse Event|0|||
16794220|NCT02332707|37735402|FG008|Overall Study|Adverse Event|0|||
16794221|NCT02332707|37735403|FG009|Overall Study|Adverse Event|0|||
16794222|NCT02332707|37735404|FG010|Overall Study|Adverse Event|0|||
16794223|NCT02332707|37735405|FG011|Overall Study|Adverse Event|0|||
16794224|NCT02332707|37735406|FG012|Overall Study|Adverse Event|1|||
16794225|NCT02332707|37735407|FG013|Overall Study|Adverse Event|0|||
16794226|NCT02332707|37735408|FG014|Overall Study|Adverse Event|0|||
16794227|NCT02332707|37735409|FG015|Overall Study|Adverse Event|0|||
16794228|NCT02332707|37735410|FG016|Overall Study|Adverse Event|0|||
16794229|NCT02332707|37735411|FG017|Overall Study|Adverse Event|0|||
16794230|NCT02332707|37735394|FG000|Overall Study|Lost to Follow-up|0|||
16794231|NCT02332707|37735395|FG001|Overall Study|Lost to Follow-up|0|||
16794232|NCT02332707|37735396|FG002|Overall Study|Lost to Follow-up|0|||
16794233|NCT02332707|37735397|FG003|Overall Study|Lost to Follow-up|0|||
16794234|NCT02332707|37735398|FG004|Overall Study|Lost to Follow-up|0|||
16794235|NCT02332707|37735399|FG005|Overall Study|Lost to Follow-up|1|||
16794236|NCT02332707|37735400|FG006|Overall Study|Lost to Follow-up|0|||
16794237|NCT02332707|37735401|FG007|Overall Study|Lost to Follow-up|0|||
16794238|NCT02332707|37735402|FG008|Overall Study|Lost to Follow-up|0|||
16794239|NCT02332707|37735403|FG009|Overall Study|Lost to Follow-up|0|||
16794240|NCT02332707|37735404|FG010|Overall Study|Lost to Follow-up|2|||
16794241|NCT02332707|37735405|FG011|Overall Study|Lost to Follow-up|0|||
16794242|NCT02332707|37735406|FG012|Overall Study|Lost to Follow-up|3|||
16794243|NCT02332707|37735407|FG013|Overall Study|Lost to Follow-up|0|||
16794244|NCT02332707|37735408|FG014|Overall Study|Lost to Follow-up|0|||
16794245|NCT02332707|37735409|FG015|Overall Study|Lost to Follow-up|0|||
16794246|NCT02332707|37735410|FG016|Overall Study|Lost to Follow-up|0|||
16794247|NCT02332707|37735411|FG017|Overall Study|Lost to Follow-up|0|||
16794248|NCT02332707|37735394|FG000|Overall Study|Physician Decision|0|||
16794249|NCT02332707|37735395|FG001|Overall Study|Physician Decision|0|||
16794250|NCT02332707|37735396|FG002|Overall Study|Physician Decision|0|||
16794251|NCT02332707|37735397|FG003|Overall Study|Physician Decision|1|||
16794252|NCT02332707|37735398|FG004|Overall Study|Physician Decision|0|||
16794253|NCT02332707|37735399|FG005|Overall Study|Physician Decision|0|||
16794254|NCT02332707|37735400|FG006|Overall Study|Physician Decision|0|||
16794255|NCT02332707|37735401|FG007|Overall Study|Physician Decision|0|||
16794256|NCT02332707|37735402|FG008|Overall Study|Physician Decision|0|||
16794257|NCT02332707|37735403|FG009|Overall Study|Physician Decision|0|||
16794258|NCT02332707|37735404|FG010|Overall Study|Physician Decision|0|||
16794259|NCT02332707|37735405|FG011|Overall Study|Physician Decision|0|||
16794260|NCT02332707|37735406|FG012|Overall Study|Physician Decision|1|||
16794261|NCT02332707|37735407|FG013|Overall Study|Physician Decision|0|||
16794262|NCT02332707|37735408|FG014|Overall Study|Physician Decision|0|||
16794263|NCT02332707|37735409|FG015|Overall Study|Physician Decision|0|||
16794264|NCT02332707|37735410|FG016|Overall Study|Physician Decision|0|||
16794265|NCT02332707|37735411|FG017|Overall Study|Physician Decision|0|||
16794266|NCT02332707|37735394|FG000|Overall Study|Withdrawal by Subject|0|||
16794267|NCT02332707|37735395|FG001|Overall Study|Withdrawal by Subject|0|||
16794268|NCT02332707|37735396|FG002|Overall Study|Withdrawal by Subject|1|||
16794269|NCT02332707|37735397|FG003|Overall Study|Withdrawal by Subject|0|||
16794270|NCT02332707|37735398|FG004|Overall Study|Withdrawal by Subject|0|||
16794271|NCT02332707|37735399|FG005|Overall Study|Withdrawal by Subject|0|||
16794272|NCT02332707|37735400|FG006|Overall Study|Withdrawal by Subject|0|||
16794273|NCT02332707|37735401|FG007|Overall Study|Withdrawal by Subject|0|||
16909107|NCT01703208|38017936|FG001|Overall Study|Withdrawal by Subject|209|||
16794274|NCT02332707|37735402|FG008|Overall Study|Withdrawal by Subject|0|||
16794275|NCT02332707|37735403|FG009|Overall Study|Withdrawal by Subject|3|||
16794276|NCT02332707|37735404|FG010|Overall Study|Withdrawal by Subject|0|||
16794277|NCT02332707|37735405|FG011|Overall Study|Withdrawal by Subject|0|||
16794278|NCT02332707|37735406|FG012|Overall Study|Withdrawal by Subject|0|||
16794279|NCT02332707|37735407|FG013|Overall Study|Withdrawal by Subject|0|||
16794280|NCT02332707|37735408|FG014|Overall Study|Withdrawal by Subject|0|||
16794281|NCT02332707|37735409|FG015|Overall Study|Withdrawal by Subject|0|||
16794282|NCT02332707|37735410|FG016|Overall Study|Withdrawal by Subject|0|||
16794283|NCT02332707|37735411|FG017|Overall Study|Withdrawal by Subject|0|||
16794284|NCT02370615|37735451|FG000|Overall Study|Adverse Event|1|||
16794285|NCT02370615|37735452|FG001|Overall Study|Adverse Event|0|||
16794286|NCT02307513|37735467|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
16794287|NCT02307513|37735468|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
16794288|NCT02307513|37735467|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
16794289|NCT02307513|37735468|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
16794290|NCT02307513|37735467|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
16794291|NCT02307513|37735468|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
16794292|NCT02307513|37735467|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
16794293|NCT02307513|37735468|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
16794294|NCT02307513|37735467|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
16794295|NCT02307513|37735468|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
16794296|NCT02307513|37735467|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
16794297|NCT02307513|37735468|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
16794298|NCT02307513|37735467|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
16794299|NCT02307513|37735468|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
16794300|NCT02307513|37735467|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
16794301|NCT02307513|37735468|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
16794302|NCT02307513|37735467|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
16794303|NCT02307513|37735468|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
16794304|NCT02307513|37735467|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
16794305|NCT02307513|37735468|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
16794306|NCT02307513|37735467|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
16794307|NCT02307513|37735468|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
16794308|NCT02307513|37735467|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
16794309|NCT02307513|37735468|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
16794310|NCT02307513|37735467|FG000|Long-term Extension|Physician Decision|1|||
16794311|NCT02307513|37735468|FG001|Long-term Extension|Physician Decision|0|||
16794312|NCT02332239|37735480|FG000|Overall Study|Lost to Follow-up|4|||
16794313|NCT02332239|37735481|FG001|Overall Study|Lost to Follow-up|6|||
16794314|NCT02370537|37735492|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
16794315|NCT02370537|37735493|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
16794316|NCT02370537|37735494|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
16794317|NCT02370537|37735492|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
16794318|NCT02370537|37735493|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
16794319|NCT02370537|37735494|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
16794320|NCT02370537|37735492|FG000|Part B|Not randomised to receive treatment|1|||
16794321|NCT02370537|37735493|FG001|Part B|Not randomised to receive treatment|2|||
16794322|NCT02370537|37735494|FG002|Part B|Not randomised to receive treatment|259|||
16794323|NCT02370537|37735492|FG000|Part B|Withdrawal by Subject|0|||
16794324|NCT02370537|37735493|FG001|Part B|Withdrawal by Subject|1|||
16794325|NCT02370537|37735494|FG002|Part B|Withdrawal by Subject|0|||
16794326|NCT02330055|37735513|FG000|Overall Study|technical issues|2|||
16794327|NCT02330055|37735514|FG001|Overall Study|technical issues|0|||
16794328|NCT02330055|37735513|FG000|Overall Study|participant forgot to wear device|5|||
16794329|NCT02330055|37735514|FG001|Overall Study|participant forgot to wear device|5|||
16794330|NCT02330055|37735513|FG000|Overall Study|data for less than 60 minutes|3|||
16794331|NCT02330055|37735514|FG001|Overall Study|data for less than 60 minutes|3|||
16794332|NCT02330055|37735513|FG000|Overall Study|participant did not sleep|0|||
16794333|NCT02330055|37735514|FG001|Overall Study|participant did not sleep|1|||
16794334|NCT02306265|37735520|FG000|Overall Study|Withdrawal by Subject|1|||
16794335|NCT02329743|37735528|FG000|Overall Study|Adverse Event|1|||
16794336|NCT02329743|37735529|FG001|Overall Study|Adverse Event|1|||
16794337|NCT02329743|37735530|FG002|Overall Study|Adverse Event|3|||
16794338|NCT02329743|37735528|FG000|Overall Study|Lost to Follow-up|1|||
16794339|NCT02329743|37735529|FG001|Overall Study|Lost to Follow-up|0|||
16794340|NCT02329743|37735530|FG002|Overall Study|Lost to Follow-up|1|||
16794341|NCT02329743|37735528|FG000|Overall Study|Withdrawal by Subject|4|||
16794342|NCT02329743|37735529|FG001|Overall Study|Withdrawal by Subject|4|||
16794343|NCT02329743|37735530|FG002|Overall Study|Withdrawal by Subject|1|||
16794344|NCT02329743|37735528|FG000|Overall Study|Other|0|||
16794345|NCT02329743|37735529|FG001|Overall Study|Other|2|||
16794346|NCT02329743|37735530|FG002|Overall Study|Other|3|||
16794347|NCT02329431|37735540|FG000|Overall Study|Lost to Follow-up|20|||
16794348|NCT02329431|37735541|FG001|Overall Study|Lost to Follow-up|13|||
16794349|NCT02328105|37735547|FG000|Overall Study|Death|6|||
17016485|NCT00855920|38161100|FG000|Overall Study|Protocol Violation|0|||
16794350|NCT02328105|37735547|FG000|Overall Study|Withdrawal by Subject|1|||
16794351|NCT02328105|37735547|FG000|Overall Study|Still On Study in Follow-Up|4|||
16794352|NCT02305797|37735553|FG000|Overall Study|Adverse Event|11|||
16794353|NCT02305797|37735554|FG001|Overall Study|Adverse Event|2|||
16794354|NCT02305797|37735553|FG000|Overall Study|Withdrawal by Subject|9|||
16794355|NCT02305797|37735554|FG001|Overall Study|Withdrawal by Subject|10|||
16794356|NCT02305797|37735553|FG000|Overall Study|Lack of Efficacy|6|||
16794357|NCT02305797|37735554|FG001|Overall Study|Lack of Efficacy|0|||
16794358|NCT02305797|37735553|FG000|Overall Study|Lost to Follow-up|5|||
16794359|NCT02305797|37735554|FG001|Overall Study|Lost to Follow-up|11|||
16794360|NCT02305797|37735553|FG000|Overall Study|Pregnancy|0|||
16794361|NCT02305797|37735554|FG001|Overall Study|Pregnancy|2|||
16794362|NCT02305797|37735553|FG000|Overall Study|Noncompliance|14|||
16794363|NCT02305797|37735554|FG001|Overall Study|Noncompliance|12|||
16794364|NCT02305797|37735553|FG000|Overall Study|Reason not collected|0|||
16794365|NCT02305797|37735554|FG001|Overall Study|Reason not collected|1|||
16794366|NCT01646073|37735562|FG000|Period A (12 Weeks)|Adverse Event|0|||
16794367|NCT01646073|37735563|FG001|Period A (12 Weeks)|Adverse Event|2|||
16794368|NCT01646073|37735562|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
16794369|NCT01646073|37735563|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
16794370|NCT01646073|37735562|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
16794371|NCT01646073|37735563|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
16794372|NCT01646073|37735562|FG000|Period A (12 Weeks)|Protocol Violation|0|||
16794373|NCT01646073|37735563|FG001|Period A (12 Weeks)|Protocol Violation|1|||
16794374|NCT01646073|37735562|FG000|Period A (12 Weeks)|Other|0|||
16794375|NCT01646073|37735563|FG001|Period A (12 Weeks)|Other|1|||
16794376|NCT01646073|37735562|FG000|Period B (12 Weeks)|Adverse Event|0|||
16794377|NCT01646073|37735563|FG001|Period B (12 Weeks)|Adverse Event|7|||
16794378|NCT01646073|37735562|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
16794379|NCT01646073|37735563|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
16794380|NCT01646073|37735562|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
16794381|NCT01646073|37735563|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
16794382|NCT02328027|37735574|FG000|Overall Study|Withdrawal by Subject|0|||
16794383|NCT02328027|37735575|FG001|Overall Study|Withdrawal by Subject|1|||
16794384|NCT02551159|37735585|FG000|Overall Study|Death|352|||
16794385|NCT02551159|37735586|FG001|Overall Study|Death|174|||
16794386|NCT02551159|37735587|FG002|Overall Study|Death|161|||
16794387|NCT02551159|37735585|FG000|Overall Study|Withdrawal by Subject|8|||
16794388|NCT02551159|37735586|FG001|Overall Study|Withdrawal by Subject|5|||
16794389|NCT02551159|37735587|FG002|Overall Study|Withdrawal by Subject|16|||
16794390|NCT02551159|37735585|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
16794391|NCT02551159|37735586|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
16794392|NCT02551159|37735587|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
16794393|NCT02305563|37735600|FG000|Treatment Period|Disease progression|0|||
16794394|NCT02305563|37735601|FG001|Treatment Period|Disease progression|0|||
16794395|NCT02305563|37735602|FG002|Treatment Period|Disease progression|15|||
16794396|NCT02305563|37735603|FG003|Treatment Period|Disease progression|6|||
16794397|NCT02305563|37735604|FG004|Treatment Period|Disease progression|6|||
16794398|NCT02305563|37735600|FG000|Treatment Period|Study drug toxicity|0|||
16794399|NCT02305563|37735601|FG001|Treatment Period|Study drug toxicity|0|||
16794400|NCT02305563|37735602|FG002|Treatment Period|Study drug toxicity|0|||
16794401|NCT02305563|37735603|FG003|Treatment Period|Study drug toxicity|1|||
16794402|NCT02305563|37735604|FG004|Treatment Period|Study drug toxicity|2|||
16794403|NCT02305563|37735600|FG000|Treatment Period|Death|0|||
16794404|NCT02305563|37735601|FG001|Treatment Period|Death|0|||
16794405|NCT02305563|37735602|FG002|Treatment Period|Death|1|||
16794406|NCT02305563|37735603|FG003|Treatment Period|Death|2|||
16794407|NCT02305563|37735604|FG004|Treatment Period|Death|1|||
16794408|NCT02305563|37735600|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
16794409|NCT02305563|37735601|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
16794410|NCT02305563|37735602|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
16794411|NCT02305563|37735603|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
16794412|NCT02305563|37735604|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
16794413|NCT02305563|37735600|FG000|Treatment Period|Participant request to stop therapy|0|||
16794414|NCT02305563|37735601|FG001|Treatment Period|Participant request to stop therapy|2|||
16794415|NCT02305563|37735602|FG002|Treatment Period|Participant request to stop therapy|0|||
16794416|NCT02305563|37735603|FG003|Treatment Period|Participant request to stop therapy|1|||
16794417|NCT02305563|37735604|FG004|Treatment Period|Participant request to stop therapy|0|||
16794418|NCT02305563|37735600|FG000|Treatment Period|Participant withdrew consent|0|||
16794419|NCT02305563|37735601|FG001|Treatment Period|Participant withdrew consent|0|||
16794420|NCT02305563|37735602|FG002|Treatment Period|Participant withdrew consent|1|||
16794421|NCT02305563|37735603|FG003|Treatment Period|Participant withdrew consent|1|||
16794422|NCT02305563|37735604|FG004|Treatment Period|Participant withdrew consent|1|||
16794423|NCT02305563|37735600|FG000|Treatment Period|Maximum clinical benefit|0|||
16909108|NCT01703208|38017935|FG000|Overall Study|Adverse Event|14|||
16794424|NCT02305563|37735601|FG001|Treatment Period|Maximum clinical benefit|0|||
16794425|NCT02305563|37735602|FG002|Treatment Period|Maximum clinical benefit|0|||
16794426|NCT02305563|37735603|FG003|Treatment Period|Maximum clinical benefit|0|||
16794427|NCT02305563|37735604|FG004|Treatment Period|Maximum clinical benefit|1|||
16794428|NCT02305563|37735600|FG000|Treatment Period|Poor/non-compliance|0|||
16794429|NCT02305563|37735601|FG001|Treatment Period|Poor/non-compliance|0|||
16909109|NCT01703208|38017936|FG001|Overall Study|Adverse Event|19|||
16794430|NCT02305563|37735602|FG002|Treatment Period|Poor/non-compliance|0|||
16794431|NCT02305563|37735603|FG003|Treatment Period|Poor/non-compliance|0|||
16794432|NCT02305563|37735604|FG004|Treatment Period|Poor/non-compliance|1|||
16794433|NCT02305563|37735600|FG000|Treatment Period|Administrative reason by Sponsor|0|||
16794434|NCT02305563|37735601|FG001|Treatment Period|Administrative reason by Sponsor|0|||
16794435|NCT02305563|37735602|FG002|Treatment Period|Administrative reason by Sponsor|0|||
16794436|NCT02305563|37735603|FG003|Treatment Period|Administrative reason by Sponsor|0|||
16794437|NCT02305563|37735604|FG004|Treatment Period|Administrative reason by Sponsor|1|||
16794438|NCT02305563|37735600|FG000|Treatment Period|other reason|2|||
16794439|NCT02305563|37735601|FG001|Treatment Period|other reason|0|||
16794440|NCT02305563|37735602|FG002|Treatment Period|other reason|2|||
16794441|NCT02305563|37735603|FG003|Treatment Period|other reason|2|||
16794442|NCT02305563|37735604|FG004|Treatment Period|other reason|1|||
16794443|NCT02305563|37735600|FG000|Treatment Period|Randomized but not treated|0|||
16794444|NCT02305563|37735601|FG001|Treatment Period|Randomized but not treated|0|||
16794445|NCT02305563|37735602|FG002|Treatment Period|Randomized but not treated|0|||
16794446|NCT02305563|37735603|FG003|Treatment Period|Randomized but not treated|0|||
16794447|NCT02305563|37735604|FG004|Treatment Period|Randomized but not treated|2|||
17016486|NCT00855920|38161101|FG001|Overall Study|Protocol Violation|0|||
17016487|NCT00855920|38161102|FG002|Overall Study|Protocol Violation|2|||
17016488|NCT00855920|38161100|FG000|Overall Study|Adverse Event|2|||
17016489|NCT00855920|38161101|FG001|Overall Study|Adverse Event|1|||
17102266|NCT00384293|38241184|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
16794448|NCT02305563|37735600|FG000|Treatment Period|added ULO, then disease progression|0|||
16794449|NCT02305563|37735601|FG001|Treatment Period|added ULO, then disease progression|0|||
16794450|NCT02305563|37735602|FG002|Treatment Period|added ULO, then disease progression|0|||
16794451|NCT02305563|37735603|FG003|Treatment Period|added ULO, then disease progression|0|||
16794452|NCT02305563|37735604|FG004|Treatment Period|added ULO, then disease progression|4|||
16794453|NCT02305563|37735600|FG000|Treatment Period|added ULO; then other reason|0|||
16794454|NCT02305563|37735601|FG001|Treatment Period|added ULO; then other reason|0|||
16794455|NCT02305563|37735602|FG002|Treatment Period|added ULO; then other reason|0|||
16794456|NCT02305563|37735603|FG003|Treatment Period|added ULO; then other reason|0|||
16794457|NCT02305563|37735604|FG004|Treatment Period|added ULO; then other reason|1|||
16794458|NCT02305563|37735600|FG000|Treatment Period|added ULO, then request to stop|0|||
16794459|NCT02305563|37735601|FG001|Treatment Period|added ULO, then request to stop|0|||
16794460|NCT02305563|37735602|FG002|Treatment Period|added ULO, then request to stop|0|||
16794461|NCT02305563|37735603|FG003|Treatment Period|added ULO, then request to stop|0|||
16794462|NCT02305563|37735604|FG004|Treatment Period|added ULO, then request to stop|1|||
16794463|NCT02305563|37735600|FG000|Follow-up Period|Death|0|||
17102267|NCT00384293|38241182|FG000|Post-randomization Period|Adverse Event|0|||
17102268|NCT00384293|38241183|FG001|Post-randomization Period|Adverse Event|23|||
17102269|NCT00384293|38241184|FG002|Post-randomization Period|Adverse Event|7|||
17102270|NCT00384293|38241182|FG000|Post-randomization Period|Lost to Follow-up|0|||
17102271|NCT00384293|38241183|FG001|Post-randomization Period|Lost to Follow-up|2|||
16794464|NCT02305563|37735601|FG001|Follow-up Period|Death|0|||
16794465|NCT02305563|37735602|FG002|Follow-up Period|Death|5|||
16794466|NCT02305563|37735603|FG003|Follow-up Period|Death|4|||
16794467|NCT02305563|37735604|FG004|Follow-up Period|Death|7|||
16794468|NCT02305563|37735600|FG000|Follow-up Period|Participant withdrew consent|0|||
16794469|NCT02305563|37735601|FG001|Follow-up Period|Participant withdrew consent|0|||
16794470|NCT02305563|37735602|FG002|Follow-up Period|Participant withdrew consent|2|||
16794471|NCT02305563|37735603|FG003|Follow-up Period|Participant withdrew consent|1|||
16794472|NCT02305563|37735604|FG004|Follow-up Period|Participant withdrew consent|0|||
16794473|NCT02305563|37735600|FG000|Follow-up Period|other reason|0|||
16794474|NCT02305563|37735601|FG001|Follow-up Period|other reason|0|||
16909110|NCT01703208|38017935|FG000|Overall Study|Technical Problems|0|||
16909111|NCT01703208|38017936|FG001|Overall Study|Technical Problems|1|||
17016490|NCT00855920|38161102|FG002|Overall Study|Adverse Event|1|||
17016491|NCT00855920|38161100|FG000|Overall Study|Lack of Efficacy|2|||
17016492|NCT00855920|38161101|FG001|Overall Study|Lack of Efficacy|2|||
17016493|NCT00855920|38161102|FG002|Overall Study|Lack of Efficacy|2|||
17016494|NCT00855920|38161100|FG000|Overall Study|Withdrawal by Subject|2|||
17016495|NCT00855920|38161101|FG001|Overall Study|Withdrawal by Subject|3|||
17016496|NCT00855920|38161102|FG002|Overall Study|Withdrawal by Subject|2|||
17016497|NCT00855920|38161100|FG000|Overall Study|Lost to Follow-up|1|||
17016498|NCT00855920|38161101|FG001|Overall Study|Lost to Follow-up|0|||
17016499|NCT00855920|38161102|FG002|Overall Study|Lost to Follow-up|2|||
17016500|NCT00855920|38161100|FG000|Overall Study|Death|0|||
17016501|NCT00855920|38161101|FG001|Overall Study|Death|1|||
17016502|NCT00855920|38161102|FG002|Overall Study|Death|0|||
17016503|NCT00855920|38161100|FG000|Overall Study|Decision by the sponsor|0|||
17016504|NCT00855920|38161101|FG001|Overall Study|Decision by the sponsor|1|||
17016505|NCT00855920|38161102|FG002|Overall Study|Decision by the sponsor|1|||
17016506|NCT00855920|38161100|FG000|Overall Study|Other than specified above|1|||
16794475|NCT02305563|37735602|FG002|Follow-up Period|other reason|0|||
16794476|NCT02305563|37735603|FG003|Follow-up Period|other reason|0|||
16794477|NCT02305563|37735604|FG004|Follow-up Period|other reason|1|||
16794478|NCT02305563|37735600|FG000|Follow-up Period|Followup no longer required per protocol|3|||
16794479|NCT02305563|37735601|FG001|Follow-up Period|Followup no longer required per protocol|3|||
16794480|NCT02305563|37735602|FG002|Follow-up Period|Followup no longer required per protocol|4|||
16794481|NCT02305563|37735603|FG003|Follow-up Period|Followup no longer required per protocol|1|||
16794482|NCT02305563|37735604|FG004|Follow-up Period|Followup no longer required per protocol|4|||
16794483|NCT02327325|37735623|FG000|Overall Study|Withdrawal by Subject|1|||
16794484|NCT02327325|37735624|FG001|Overall Study|Withdrawal by Subject|4|||
16794485|NCT02327325|37735625|FG002|Overall Study|Withdrawal by Subject|4|||
16794486|NCT02327325|37735623|FG000|Overall Study|Excluded by Study Team|0|||
16794487|NCT02327325|37735624|FG001|Overall Study|Excluded by Study Team|0|||
16794488|NCT02327325|37735625|FG002|Overall Study|Excluded by Study Team|1|||
16794489|NCT02304705|37735635|FG000|Overall Study|Withdrawal by Subject|2|||
16794490|NCT02304705|37735636|FG001|Overall Study|Withdrawal by Subject|0|||
16794491|NCT02304705|37735635|FG000|Overall Study|Physician Decision|2|||
16794492|NCT02304705|37735636|FG001|Overall Study|Physician Decision|4|||
16794493|NCT02304705|37735635|FG000|Overall Study|Death|0|||
16794494|NCT02304705|37735636|FG001|Overall Study|Death|1|||
16794495|NCT02304705|37735635|FG000|Overall Study|Lost to Follow-up|0|||
16794496|NCT02304705|37735636|FG001|Overall Study|Lost to Follow-up|2|||
16794497|NCT02553499|37735656|FG000|Overall Study|Adverse Event|0|||
16794498|NCT02553499|37735657|FG001|Overall Study|Adverse Event|0|||
16794499|NCT02553499|37735658|FG002|Overall Study|Adverse Event|0|||
16794500|NCT02553499|37735659|FG003|Overall Study|Adverse Event|0|||
16794501|NCT02553499|37735660|FG004|Overall Study|Adverse Event|0|||
16794502|NCT02553499|37735661|FG005|Overall Study|Adverse Event|0|||
16794503|NCT02553499|37735662|FG006|Overall Study|Adverse Event|1|||
16794504|NCT02553499|37735663|FG007|Overall Study|Adverse Event|1|||
16794505|NCT02553499|37735664|FG008|Overall Study|Adverse Event|0|||
16794506|NCT02553499|37735665|FG009|Overall Study|Adverse Event|0|||
16794507|NCT02553499|37735666|FG010|Overall Study|Adverse Event|0|||
16794508|NCT02553499|37735667|FG011|Overall Study|Adverse Event|0|||
16794509|NCT02553499|37735668|FG012|Overall Study|Adverse Event|0|||
16794510|NCT02553499|37735669|FG013|Overall Study|Adverse Event|1|||
16794511|NCT02553499|37735656|FG000|Overall Study|Death|0|||
16794512|NCT02553499|37735657|FG001|Overall Study|Death|1|||
16794513|NCT02553499|37735658|FG002|Overall Study|Death|1|||
16794514|NCT02553499|37735659|FG003|Overall Study|Death|0|||
16794515|NCT02553499|37735660|FG004|Overall Study|Death|1|||
16794516|NCT02553499|37735661|FG005|Overall Study|Death|2|||
16794517|NCT02553499|37735662|FG006|Overall Study|Death|0|||
16794518|NCT02553499|37735663|FG007|Overall Study|Death|0|||
16794519|NCT02553499|37735664|FG008|Overall Study|Death|0|||
16794520|NCT02553499|37735665|FG009|Overall Study|Death|0|||
16794521|NCT02553499|37735666|FG010|Overall Study|Death|1|||
16794522|NCT02553499|37735667|FG011|Overall Study|Death|0|||
16794523|NCT02553499|37735668|FG012|Overall Study|Death|0|||
16794524|NCT02553499|37735669|FG013|Overall Study|Death|0|||
16794525|NCT02553499|37735656|FG000|Overall Study|Lost to Follow-up|0|||
16794526|NCT02553499|37735657|FG001|Overall Study|Lost to Follow-up|0|||
16794527|NCT02553499|37735658|FG002|Overall Study|Lost to Follow-up|0|||
16794528|NCT02553499|37735659|FG003|Overall Study|Lost to Follow-up|0|||
16794529|NCT02553499|37735660|FG004|Overall Study|Lost to Follow-up|0|||
16794530|NCT02553499|37735661|FG005|Overall Study|Lost to Follow-up|0|||
16794531|NCT02553499|37735662|FG006|Overall Study|Lost to Follow-up|1|||
16794532|NCT02553499|37735663|FG007|Overall Study|Lost to Follow-up|0|||
16794533|NCT02553499|37735664|FG008|Overall Study|Lost to Follow-up|0|||
16794534|NCT02553499|37735665|FG009|Overall Study|Lost to Follow-up|0|||
16794535|NCT02553499|37735666|FG010|Overall Study|Lost to Follow-up|0|||
16794536|NCT02553499|37735667|FG011|Overall Study|Lost to Follow-up|0|||
16794537|NCT02553499|37735668|FG012|Overall Study|Lost to Follow-up|0|||
16794538|NCT02553499|37735669|FG013|Overall Study|Lost to Follow-up|0|||
16794539|NCT02553499|37735656|FG000|Overall Study|Physician Decision|0|||
16794540|NCT02553499|37735657|FG001|Overall Study|Physician Decision|1|||
16794541|NCT02553499|37735658|FG002|Overall Study|Physician Decision|1|||
16794542|NCT02553499|37735659|FG003|Overall Study|Physician Decision|0|||
16794543|NCT02553499|37735660|FG004|Overall Study|Physician Decision|1|||
16794544|NCT02553499|37735661|FG005|Overall Study|Physician Decision|0|||
16794545|NCT02553499|37735662|FG006|Overall Study|Physician Decision|0|||
16794546|NCT02553499|37735663|FG007|Overall Study|Physician Decision|1|||
16794547|NCT02553499|37735664|FG008|Overall Study|Physician Decision|1|||
16794548|NCT02553499|37735665|FG009|Overall Study|Physician Decision|2|||
16794549|NCT02553499|37735666|FG010|Overall Study|Physician Decision|1|||
16794550|NCT02553499|37735667|FG011|Overall Study|Physician Decision|3|||
16794551|NCT02553499|37735668|FG012|Overall Study|Physician Decision|1|||
16794552|NCT02553499|37735669|FG013|Overall Study|Physician Decision|0|||
16794553|NCT02553499|37735656|FG000|Overall Study|Progressive Disease|0|||
16794554|NCT02553499|37735657|FG001|Overall Study|Progressive Disease|0|||
16794555|NCT02553499|37735658|FG002|Overall Study|Progressive Disease|0|||
16794556|NCT02553499|37735659|FG003|Overall Study|Progressive Disease|2|||
16794557|NCT02553499|37735660|FG004|Overall Study|Progressive Disease|1|||
16794558|NCT02553499|37735661|FG005|Overall Study|Progressive Disease|1|||
16794559|NCT02553499|37735662|FG006|Overall Study|Progressive Disease|1|||
16794560|NCT02553499|37735663|FG007|Overall Study|Progressive Disease|0|||
16794561|NCT02553499|37735664|FG008|Overall Study|Progressive Disease|0|||
16794562|NCT02553499|37735665|FG009|Overall Study|Progressive Disease|1|||
16794563|NCT02553499|37735666|FG010|Overall Study|Progressive Disease|0|||
16794564|NCT02553499|37735667|FG011|Overall Study|Progressive Disease|0|||
16794565|NCT02553499|37735668|FG012|Overall Study|Progressive Disease|2|||
16794566|NCT02553499|37735669|FG013|Overall Study|Progressive Disease|1|||
16794567|NCT02553499|37735656|FG000|Overall Study|Study Terminated by Sponsor|0|||
16794568|NCT02553499|37735657|FG001|Overall Study|Study Terminated by Sponsor|0|||
16794569|NCT02553499|37735658|FG002|Overall Study|Study Terminated by Sponsor|0|||
16794570|NCT02553499|37735659|FG003|Overall Study|Study Terminated by Sponsor|0|||
16794571|NCT02553499|37735660|FG004|Overall Study|Study Terminated by Sponsor|0|||
16794572|NCT02553499|37735661|FG005|Overall Study|Study Terminated by Sponsor|0|||
16794573|NCT02553499|37735662|FG006|Overall Study|Study Terminated by Sponsor|0|||
16794574|NCT02553499|37735663|FG007|Overall Study|Study Terminated by Sponsor|0|||
16794575|NCT02553499|37735664|FG008|Overall Study|Study Terminated by Sponsor|1|||
16794576|NCT02553499|37735665|FG009|Overall Study|Study Terminated by Sponsor|0|||
16794577|NCT02553499|37735666|FG010|Overall Study|Study Terminated by Sponsor|0|||
16794578|NCT02553499|37735667|FG011|Overall Study|Study Terminated by Sponsor|0|||
16794579|NCT02553499|37735668|FG012|Overall Study|Study Terminated by Sponsor|0|||
16794580|NCT02553499|37735669|FG013|Overall Study|Study Terminated by Sponsor|0|||
16794581|NCT02553499|37735656|FG000|Overall Study|Withdrawal by Subject|2|||
16794582|NCT02553499|37735657|FG001|Overall Study|Withdrawal by Subject|0|||
16794583|NCT02553499|37735658|FG002|Overall Study|Withdrawal by Subject|0|||
16794584|NCT02553499|37735659|FG003|Overall Study|Withdrawal by Subject|0|||
16794585|NCT02553499|37735660|FG004|Overall Study|Withdrawal by Subject|0|||
16794586|NCT02553499|37735661|FG005|Overall Study|Withdrawal by Subject|0|||
16794587|NCT02553499|37735662|FG006|Overall Study|Withdrawal by Subject|0|||
16794588|NCT02553499|37735663|FG007|Overall Study|Withdrawal by Subject|1|||
16794589|NCT02553499|37735664|FG008|Overall Study|Withdrawal by Subject|1|||
16794590|NCT02553499|37735665|FG009|Overall Study|Withdrawal by Subject|0|||
16794591|NCT02553499|37735666|FG010|Overall Study|Withdrawal by Subject|1|||
16794592|NCT02553499|37735667|FG011|Overall Study|Withdrawal by Subject|0|||
16794593|NCT02553499|37735668|FG012|Overall Study|Withdrawal by Subject|0|||
16794594|NCT02553499|37735669|FG013|Overall Study|Withdrawal by Subject|0|||
16794595|NCT02553421|37735702|FG000|Overall Study|Lost to Follow-up|21|||
16794596|NCT02553421|37735703|FG001|Overall Study|Lost to Follow-up|1|||
16794597|NCT02553421|37735702|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
16794598|NCT02553421|37735703|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
16794599|NCT02553421|37735702|FG000|Overall Study|Improper Device Placement|3|||
16794600|NCT02553421|37735703|FG001|Overall Study|Improper Device Placement|0|||
16794601|NCT02549287|37735712|FG000|Overall Study|Lost to Follow-up|65|||
16794602|NCT02549287|37735713|FG001|Overall Study|Lost to Follow-up|26|||
16794603|NCT02549287|37735712|FG000|Overall Study|Withdrawal by Subject|15|||
16794604|NCT02549287|37735713|FG001|Overall Study|Withdrawal by Subject|6|||
16794605|NCT02553265|37735719|FG000|Enrollment|Death|0|||
16794606|NCT02553265|37735720|FG001|Enrollment|Death|0|||
16794607|NCT02553265|37735721|FG002|Enrollment|Death|1|||
16794608|NCT02553265|37735719|FG000|First Intervention (28 Days)|Adverse Event|1|||
16794609|NCT02553265|37735720|FG001|First Intervention (28 Days)|Adverse Event|0|||
16794610|NCT02553265|37735721|FG002|First Intervention (28 Days)|Adverse Event|0|||
16794611|NCT02553265|37735719|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
16794612|NCT02553265|37735720|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
16794613|NCT02553265|37735721|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
16794614|NCT02553265|37735719|FG000|Second Intervention (28 Days)|Adverse Event|1|||
16794615|NCT02553265|37735720|FG001|Second Intervention (28 Days)|Adverse Event|0|||
16794616|NCT02553265|37735721|FG002|Second Intervention (28 Days)|Adverse Event|0|||
16794617|NCT02553265|37735719|FG000|Third Intervention (28 Days)|Adverse Event|1|||
16794618|NCT02553265|37735720|FG001|Third Intervention (28 Days)|Adverse Event|0|||
16794619|NCT02553265|37735721|FG002|Third Intervention (28 Days)|Adverse Event|0|||
16794620|NCT02553265|37735719|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
16794621|NCT02553265|37735720|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
16794622|NCT02553265|37735721|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
16794623|NCT02561195|37735738|FG000|Vaccination 1 to 3|Adverse Event|4|||
16794624|NCT02561195|37735739|FG001|Vaccination 1 to 3|Adverse Event|5|||
16794625|NCT02561195|37735740|FG002|Vaccination 1 to 3|Adverse Event|0|||
16794626|NCT02561195|37735741|FG003|Vaccination 1 to 3|Adverse Event|3|||
16794627|NCT02561195|37735742|FG004|Vaccination 1 to 3|Adverse Event|4|||
16794628|NCT02561195|37735743|FG005|Vaccination 1 to 3|Adverse Event|0|||
16794629|NCT02561195|37735744|FG006|Vaccination 1 to 3|Adverse Event|0|||
16794630|NCT02561195|37735745|FG007|Vaccination 1 to 3|Adverse Event|0|||
16794631|NCT02561195|37735746|FG008|Vaccination 1 to 3|Adverse Event|0|||
16794632|NCT02561195|37735747|FG009|Vaccination 1 to 3|Adverse Event|0|||
16794633|NCT02561195|37735748|FG010|Vaccination 1 to 3|Adverse Event|0|||
16794634|NCT02561195|37735749|FG011|Vaccination 1 to 3|Adverse Event|0|||
16794635|NCT02561195|37735750|FG012|Vaccination 1 to 3|Adverse Event|0|||
16794636|NCT02561195|37735751|FG013|Vaccination 1 to 3|Adverse Event|0|||
16794637|NCT02561195|37735738|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
16794638|NCT02561195|37735739|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
16794639|NCT02561195|37735740|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
16794640|NCT02561195|37735741|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
16794641|NCT02561195|37735742|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
16794642|NCT02561195|37735743|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
16794643|NCT02561195|37735744|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
16794644|NCT02561195|37735745|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
16794645|NCT02561195|37735746|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
16794646|NCT02561195|37735747|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
16794647|NCT02561195|37735748|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
16794648|NCT02561195|37735749|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
16794649|NCT02561195|37735750|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
16794650|NCT02561195|37735751|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
16794651|NCT02561195|37735738|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794652|NCT02561195|37735739|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
16794653|NCT02561195|37735740|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794654|NCT02561195|37735741|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
16794655|NCT02561195|37735742|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
16794656|NCT02561195|37735743|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
16794657|NCT02561195|37735744|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794658|NCT02561195|37735745|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794659|NCT02561195|37735746|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794660|NCT02561195|37735747|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794661|NCT02561195|37735748|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794662|NCT02561195|37735749|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794663|NCT02561195|37735750|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794664|NCT02561195|37735751|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16794665|NCT02561195|37735738|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
16794666|NCT02561195|37735739|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
17198340|NCT02595398|38351956|FG000|Overall Study|Withdrawal by Subject|2|||
16794667|NCT02561195|37735740|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
16794668|NCT02561195|37735741|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
16794669|NCT02561195|37735742|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
16794670|NCT02561195|37735743|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
16794671|NCT02561195|37735744|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
16794672|NCT02561195|37735745|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
16794673|NCT02561195|37735746|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
16794674|NCT02561195|37735747|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
16794675|NCT02561195|37735748|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
16794676|NCT02561195|37735749|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
16794677|NCT02561195|37735750|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
16794678|NCT02561195|37735751|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
16794679|NCT02561195|37735738|FG000|Vaccination 1 to 3|Other|7|||
16794680|NCT02561195|37735739|FG001|Vaccination 1 to 3|Other|3|||
16794681|NCT02561195|37735740|FG002|Vaccination 1 to 3|Other|1|||
16794682|NCT02561195|37735741|FG003|Vaccination 1 to 3|Other|7|||
16909112|NCT01703208|38017935|FG000|Overall Study|Protocol Deviation|2|||
16909113|NCT01703208|38017936|FG001|Overall Study|Protocol Deviation|0|||
16794683|NCT02561195|37735742|FG004|Vaccination 1 to 3|Other|5|||
16794684|NCT02561195|37735743|FG005|Vaccination 1 to 3|Other|1|||
16794685|NCT02561195|37735744|FG006|Vaccination 1 to 3|Other|0|||
16794686|NCT02561195|37735745|FG007|Vaccination 1 to 3|Other|0|||
16909114|NCT01727700|38017945|FG000|Overall Study|Adverse Event|0|||
16909115|NCT01727700|38017946|FG001|Overall Study|Adverse Event|7|||
16909116|NCT01727700|38017947|FG002|Overall Study|Adverse Event|1|||
16909117|NCT01727700|38017945|FG000|Overall Study|Particpant withdrew consent|0|||
16909118|NCT01727700|38017946|FG001|Overall Study|Particpant withdrew consent|3|||
16909119|NCT01727700|38017947|FG002|Overall Study|Particpant withdrew consent|1|||
16909120|NCT01727700|38017945|FG000|Overall Study|Protocol Violation|2|||
16909121|NCT01727700|38017946|FG001|Overall Study|Protocol Violation|0|||
16909122|NCT01727700|38017947|FG002|Overall Study|Protocol Violation|0|||
16909123|NCT01727154|38017955|FG000|Overall Study|Death|17|||
16909124|NCT01727154|38017955|FG000|Overall Study|Withdrawal by Subject|14|||
16909125|NCT01727154|38017955|FG000|Overall Study|Subject Withdrew Consent|18|||
16909126|NCT01727154|38017955|FG000|Overall Study|Study Terminated|6|||
16909127|NCT01727154|38017955|FG000|Overall Study|No Discontinuation Documentation|4|||
16909128|NCT01725750|38017961|FG000|Overall Study|Adverse Event|1|||
16794687|NCT02561195|37735746|FG008|Vaccination 1 to 3|Other|0|||
16794688|NCT02561195|37735747|FG009|Vaccination 1 to 3|Other|0|||
16794689|NCT02561195|37735748|FG010|Vaccination 1 to 3|Other|0|||
16794690|NCT02561195|37735749|FG011|Vaccination 1 to 3|Other|0|||
16794691|NCT02561195|37735750|FG012|Vaccination 1 to 3|Other|0|||
16794692|NCT02561195|37735751|FG013|Vaccination 1 to 3|Other|0|||
16794693|NCT02561195|37735738|FG000|Vaccination 1 to 3|Protocol Violation|1|||
16794694|NCT02561195|37735739|FG001|Vaccination 1 to 3|Protocol Violation|0|||
16794695|NCT02561195|37735740|FG002|Vaccination 1 to 3|Protocol Violation|1|||
16794696|NCT02561195|37735741|FG003|Vaccination 1 to 3|Protocol Violation|2|||
16794697|NCT02561195|37735742|FG004|Vaccination 1 to 3|Protocol Violation|5|||
16794698|NCT02561195|37735743|FG005|Vaccination 1 to 3|Protocol Violation|2|||
16794699|NCT02561195|37735744|FG006|Vaccination 1 to 3|Protocol Violation|0|||
16794700|NCT02561195|37735745|FG007|Vaccination 1 to 3|Protocol Violation|0|||
16794701|NCT02561195|37735746|FG008|Vaccination 1 to 3|Protocol Violation|0|||
16794702|NCT02561195|37735747|FG009|Vaccination 1 to 3|Protocol Violation|0|||
16794703|NCT02561195|37735748|FG010|Vaccination 1 to 3|Protocol Violation|0|||
16794704|NCT02561195|37735749|FG011|Vaccination 1 to 3|Protocol Violation|0|||
16794705|NCT02561195|37735750|FG012|Vaccination 1 to 3|Protocol Violation|0|||
16794706|NCT02561195|37735751|FG013|Vaccination 1 to 3|Protocol Violation|0|||
16794707|NCT02561195|37735738|FG000|Vaccination 1 to 3|Death|2|||
16794708|NCT02561195|37735739|FG001|Vaccination 1 to 3|Death|1|||
16794709|NCT02561195|37735740|FG002|Vaccination 1 to 3|Death|0|||
16794710|NCT02561195|37735741|FG003|Vaccination 1 to 3|Death|2|||
16794711|NCT02561195|37735742|FG004|Vaccination 1 to 3|Death|0|||
16794712|NCT02561195|37735743|FG005|Vaccination 1 to 3|Death|0|||
16794713|NCT02561195|37735744|FG006|Vaccination 1 to 3|Death|0|||
16794714|NCT02561195|37735745|FG007|Vaccination 1 to 3|Death|0|||
16794715|NCT02561195|37735746|FG008|Vaccination 1 to 3|Death|0|||
16794716|NCT02561195|37735747|FG009|Vaccination 1 to 3|Death|0|||
16794717|NCT02561195|37735748|FG010|Vaccination 1 to 3|Death|0|||
16794718|NCT02561195|37735749|FG011|Vaccination 1 to 3|Death|0|||
16794719|NCT02561195|37735750|FG012|Vaccination 1 to 3|Death|0|||
16794720|NCT02561195|37735751|FG013|Vaccination 1 to 3|Death|0|||
16794721|NCT02561195|37735738|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
16794722|NCT02561195|37735739|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
16794723|NCT02561195|37735740|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
16794724|NCT02561195|37735741|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
16794725|NCT02561195|37735742|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
16794726|NCT02561195|37735743|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794727|NCT02561195|37735744|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794728|NCT02561195|37735745|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794729|NCT02561195|37735746|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794730|NCT02561195|37735747|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794731|NCT02561195|37735748|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794732|NCT02561195|37735749|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794733|NCT02561195|37735750|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794734|NCT02561195|37735751|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
16794735|NCT02561195|37735738|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
16794736|NCT02561195|37735739|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
16794737|NCT02561195|37735740|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
16794738|NCT02561195|37735741|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
16794739|NCT02561195|37735742|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
16794740|NCT02561195|37735743|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
16794741|NCT02561195|37735744|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
16794742|NCT02561195|37735745|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
16794743|NCT02561195|37735746|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
16794744|NCT02561195|37735747|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
16794745|NCT02561195|37735748|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
16794746|NCT02561195|37735749|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
16794747|NCT02561195|37735750|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
16794748|NCT02561195|37735751|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
16794749|NCT02561195|37735738|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794750|NCT02561195|37735739|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794751|NCT02561195|37735740|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794752|NCT02561195|37735741|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794753|NCT02561195|37735742|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794754|NCT02561195|37735743|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794755|NCT02561195|37735744|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794756|NCT02561195|37735745|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794757|NCT02561195|37735746|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
16794758|NCT02561195|37735747|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
16794759|NCT02561195|37735748|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
16794760|NCT02561195|37735749|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
16794761|NCT02561195|37735750|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
16794762|NCT02561195|37735751|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16794763|NCT02561195|37735738|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794764|NCT02561195|37735739|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794765|NCT02561195|37735740|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794766|NCT02561195|37735741|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794767|NCT02561195|37735742|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794768|NCT02561195|37735743|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794769|NCT02561195|37735744|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794770|NCT02561195|37735745|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794771|NCT02561195|37735746|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794772|NCT02561195|37735747|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794773|NCT02561195|37735748|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794774|NCT02561195|37735749|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794775|NCT02561195|37735750|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
16794776|NCT02561195|37735751|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
16794777|NCT02561195|37735738|FG000|Extension Stage (Vaccination 4)|Death|0|||
16794778|NCT02561195|37735739|FG001|Extension Stage (Vaccination 4)|Death|0|||
16794779|NCT02561195|37735740|FG002|Extension Stage (Vaccination 4)|Death|0|||
16794780|NCT02561195|37735741|FG003|Extension Stage (Vaccination 4)|Death|0|||
16794781|NCT02561195|37735742|FG004|Extension Stage (Vaccination 4)|Death|0|||
16794782|NCT02561195|37735743|FG005|Extension Stage (Vaccination 4)|Death|0|||
16794783|NCT02561195|37735744|FG006|Extension Stage (Vaccination 4)|Death|0|||
16794784|NCT02561195|37735745|FG007|Extension Stage (Vaccination 4)|Death|0|||
16794785|NCT02561195|37735746|FG008|Extension Stage (Vaccination 4)|Death|0|||
16794786|NCT02561195|37735747|FG009|Extension Stage (Vaccination 4)|Death|1|||
16794787|NCT02561195|37735748|FG010|Extension Stage (Vaccination 4)|Death|0|||
16794788|NCT02561195|37735749|FG011|Extension Stage (Vaccination 4)|Death|0|||
16794789|NCT02561195|37735750|FG012|Extension Stage (Vaccination 4)|Death|0|||
16794790|NCT02561195|37735751|FG013|Extension Stage (Vaccination 4)|Death|0|||
16794791|NCT02561195|37735738|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16794792|NCT02561195|37735739|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16794793|NCT02561195|37735740|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16794794|NCT02561195|37735741|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16794795|NCT02561195|37735742|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16794796|NCT02561195|37735743|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16794797|NCT02561195|37735744|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
16794798|NCT02561195|37735745|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
16794799|NCT02561195|37735746|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16794800|NCT02561195|37735747|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16794801|NCT02561195|37735748|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
16794802|NCT02561195|37735749|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
16794803|NCT02561195|37735750|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
16794804|NCT02561195|37735751|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
16794805|NCT02561195|37735738|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794806|NCT02561195|37735739|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794807|NCT02561195|37735740|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794808|NCT02561195|37735741|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794809|NCT02561195|37735742|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794810|NCT02561195|37735743|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794811|NCT02561195|37735744|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794812|NCT02561195|37735745|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794813|NCT02561195|37735746|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794814|NCT02561195|37735747|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794815|NCT02561195|37735748|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16794816|NCT02561195|37735749|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
16794817|NCT02561195|37735750|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
16794818|NCT02561195|37735751|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
16794819|NCT02561195|37735738|FG000|Extension Stage (Vaccination 4)|Other|0|||
16794820|NCT02561195|37735739|FG001|Extension Stage (Vaccination 4)|Other|0|||
16794821|NCT02561195|37735740|FG002|Extension Stage (Vaccination 4)|Other|0|||
16794822|NCT02561195|37735741|FG003|Extension Stage (Vaccination 4)|Other|0|||
16794823|NCT02561195|37735742|FG004|Extension Stage (Vaccination 4)|Other|0|||
16794824|NCT02561195|37735743|FG005|Extension Stage (Vaccination 4)|Other|0|||
16794825|NCT02561195|37735744|FG006|Extension Stage (Vaccination 4)|Other|0|||
16794826|NCT02561195|37735745|FG007|Extension Stage (Vaccination 4)|Other|0|||
16794827|NCT02561195|37735746|FG008|Extension Stage (Vaccination 4)|Other|0|||
16794828|NCT02561195|37735747|FG009|Extension Stage (Vaccination 4)|Other|0|||
16794829|NCT02561195|37735748|FG010|Extension Stage (Vaccination 4)|Other|2|||
16794830|NCT02561195|37735749|FG011|Extension Stage (Vaccination 4)|Other|2|||
16794831|NCT02561195|37735750|FG012|Extension Stage (Vaccination 4)|Other|1|||
16794832|NCT02561195|37735751|FG013|Extension Stage (Vaccination 4)|Other|0|||
16794833|NCT02561195|37735738|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794834|NCT02561195|37735739|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794835|NCT02561195|37735740|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794836|NCT02561195|37735741|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794837|NCT02561195|37735742|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794838|NCT02561195|37735743|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794839|NCT02561195|37735744|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
16794840|NCT02561195|37735745|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794841|NCT02561195|37735746|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794842|NCT02561195|37735747|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794843|NCT02561195|37735748|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
16794844|NCT02561195|37735749|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
16794845|NCT02561195|37735750|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16794846|NCT02561195|37735751|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
16794847|NCT01663103|37735785|FG000|Overall Study|Withdrawal by Subject|1|||
16794848|NCT01663103|37735786|FG001|Overall Study|Withdrawal by Subject|2|||
16794849|NCT01663103|37735785|FG000|Overall Study|Adverse Event|1|||
16794850|NCT01663103|37735786|FG001|Overall Study|Adverse Event|0|||
16794851|NCT01663103|37735785|FG000|Overall Study|dog bite|1|||
16794852|NCT01663103|37735786|FG001|Overall Study|dog bite|0|||
16794853|NCT02560025|37735805|FG000|Overall Study|Ineligible after consent/ registration|3|||
16794854|NCT02566889|37735829|FG000|Overall Study|Withdrawal by Subject|3|||
16794855|NCT02566889|37735830|FG001|Overall Study|Withdrawal by Subject|1|||
16794856|NCT02566889|37735829|FG000|Overall Study|Adverse Event|4|||
16794857|NCT02566889|37735830|FG001|Overall Study|Adverse Event|2|||
16794858|NCT02566889|37735829|FG000|Overall Study|Other|6|||
16794859|NCT02566889|37735830|FG001|Overall Study|Other|2|||
16794860|NCT02566577|37735837|FG000|Overall Study|Withdrawal by Subject|1|||
16794861|NCT02566577|37735838|FG001|Overall Study|Withdrawal by Subject|1|||
16794862|NCT02566577|37735837|FG000|Overall Study|Equipment failure|1|||
16794863|NCT02566577|37735838|FG001|Overall Study|Equipment failure|1|||
16794864|NCT02566577|37735837|FG000|Overall Study|Physical limitation|1|||
16794865|NCT02566577|37735838|FG001|Overall Study|Physical limitation|0|||
16794866|NCT02559713|37735846|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
16794867|NCT01358981|37735857|FG000|Period 1|Withdrawal by Subject|0|||
16794868|NCT01358981|37735858|FG001|Period 1|Withdrawal by Subject|0|||
16794869|NCT01358981|37735859|FG002|Period 1|Withdrawal by Subject|0|||
16794870|NCT01358981|37735860|FG003|Period 1|Withdrawal by Subject|1|||
16794871|NCT01358981|37735861|FG004|Period 1|Withdrawal by Subject|0|||
16794872|NCT01358981|37735862|FG005|Period 1|Withdrawal by Subject|0|||
16794873|NCT01358981|37735863|FG006|Period 1|Withdrawal by Subject|0|||
16794874|NCT02548585|37735895|FG000|Overall Study|Withdrawal by Subject|0|||
16794875|NCT02548585|37735896|FG001|Overall Study|Withdrawal by Subject|0|||
16794876|NCT02548585|37735897|FG002|Overall Study|Withdrawal by Subject|0|||
16794877|NCT02548585|37735898|FG003|Overall Study|Withdrawal by Subject|0|||
16794878|NCT02548585|37735899|FG004|Overall Study|Withdrawal by Subject|0|||
16794879|NCT02548585|37735900|FG005|Overall Study|Withdrawal by Subject|1|||
16794880|NCT02548585|37735901|FG006|Overall Study|Withdrawal by Subject|0|||
16794881|NCT02548585|37735895|FG000|Overall Study|Lost to Follow-up|1|||
16794882|NCT02548585|37735896|FG001|Overall Study|Lost to Follow-up|0|||
16794883|NCT02548585|37735897|FG002|Overall Study|Lost to Follow-up|0|||
16794884|NCT02548585|37735898|FG003|Overall Study|Lost to Follow-up|0|||
16794885|NCT02548585|37735899|FG004|Overall Study|Lost to Follow-up|0|||
16794886|NCT02548585|37735900|FG005|Overall Study|Lost to Follow-up|0|||
16794887|NCT02548585|37735901|FG006|Overall Study|Lost to Follow-up|0|||
16794888|NCT02548585|37735895|FG000|Overall Study|Other|1|||
16794889|NCT02548585|37735896|FG001|Overall Study|Other|0|||
16794890|NCT02548585|37735897|FG002|Overall Study|Other|0|||
16794891|NCT02548585|37735898|FG003|Overall Study|Other|2|||
16794892|NCT02548585|37735899|FG004|Overall Study|Other|3|||
16794893|NCT02548585|37735900|FG005|Overall Study|Other|0|||
16909129|NCT01725750|38017962|FG001|Overall Study|Adverse Event|0|||
16909130|NCT01725750|38017961|FG000|Overall Study|Lost to Follow-up|1|||
16909131|NCT01725750|38017962|FG001|Overall Study|Lost to Follow-up|1|||
16909132|NCT01725750|38017961|FG000|Overall Study|Withdrawal by Subject|0|||
16794894|NCT02548585|37735901|FG006|Overall Study|Other|1|||
16794895|NCT02548585|37735895|FG000|Overall Study|Randomized but not treated|0|||
16794896|NCT02548585|37735896|FG001|Overall Study|Randomized but not treated|0|||
16794897|NCT02548585|37735897|FG002|Overall Study|Randomized but not treated|0|||
16794898|NCT02548585|37735898|FG003|Overall Study|Randomized but not treated|0|||
16794899|NCT02548585|37735899|FG004|Overall Study|Randomized but not treated|0|||
16794900|NCT02548585|37735900|FG005|Overall Study|Randomized but not treated|1|||
16794901|NCT02548585|37735901|FG006|Overall Study|Randomized but not treated|0|||
16794902|NCT02547649|37735945|FG000|Overall Study|Lost to Follow-up|3|||
16794903|NCT02547649|37735946|FG001|Overall Study|Lost to Follow-up|1|||
16794904|NCT02547649|37735947|FG002|Overall Study|Lost to Follow-up|1|||
16794905|NCT02547649|37735945|FG000|Overall Study|Not vaccinated|0|||
16794906|NCT02547649|37735946|FG001|Overall Study|Not vaccinated|0|||
16794907|NCT02547649|37735947|FG002|Overall Study|Not vaccinated|1|||
16794908|NCT02547649|37735945|FG000|Overall Study|Withdrawal by Subject|0|||
16794909|NCT02547649|37735946|FG001|Overall Study|Withdrawal by Subject|4|||
16794910|NCT02547649|37735947|FG002|Overall Study|Withdrawal by Subject|2|||
16794911|NCT02535715|37735967|FG000|Overall Study|Withdrawal by Subject|0|||
16794912|NCT02535715|37735968|FG001|Overall Study|Withdrawal by Subject|0|||
16794913|NCT02535715|37735969|FG002|Overall Study|Withdrawal by Subject|1|||
16794914|NCT02336815|37735982|FG000|Overall Study|Disease Progression|45|||
16794915|NCT02336815|37735983|FG001|Overall Study|Disease Progression|70|||
16794916|NCT02336815|37735982|FG000|Overall Study|Adverse Event|18|||
16794917|NCT02336815|37735983|FG001|Overall Study|Adverse Event|39|||
16794918|NCT02336815|37735982|FG000|Overall Study|Physician Decision|11|||
16794919|NCT02336815|37735983|FG001|Overall Study|Physician Decision|4|||
16794920|NCT02336815|37735982|FG000|Overall Study|Withdrawal by Subject|3|||
16794921|NCT02336815|37735983|FG001|Overall Study|Withdrawal by Subject|2|||
16794922|NCT02336815|37735982|FG000|Overall Study|Lost to Follow-up|1|||
16794923|NCT02336815|37735983|FG001|Overall Study|Lost to Follow-up|3|||
16794924|NCT02336815|37735982|FG000|Overall Study|Other|1|||
16794925|NCT02336815|37735983|FG001|Overall Study|Other|5|||
16794926|NCT02543203|37735993|FG000|Overall Study|Unpalatable Fragrance|2|||
16794927|NCT02543203|37735994|FG001|Overall Study|Unpalatable Fragrance|2|||
16794928|NCT02543203|37735993|FG000|Overall Study|Lost to Follow-up|1|||
16794929|NCT02543203|37735994|FG001|Overall Study|Lost to Follow-up|0|||
16794930|NCT02543203|37735993|FG000|Overall Study|Increased Irritability|1|||
16794931|NCT02543203|37735994|FG001|Overall Study|Increased Irritability|0|||
16794932|NCT02543203|37735993|FG000|Overall Study|Family|1|||
16794933|NCT02543203|37735994|FG001|Overall Study|Family|2|||
16794934|NCT02543203|37735993|FG000|Overall Study|Negative Behavior|1|||
16794935|NCT02543203|37735994|FG001|Overall Study|Negative Behavior|0|||
16794936|NCT02543203|37735993|FG000|Overall Study|Withdrawal by Subject|0|||
16794937|NCT02543203|37735994|FG001|Overall Study|Withdrawal by Subject|1|||
16794938|NCT02546323|37736010|FG000|Overall Study|Withdrawal by Subject|36|||
16794939|NCT02546323|37736011|FG001|Overall Study|Withdrawal by Subject|33|||
16794940|NCT02546323|37736010|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
16794941|NCT02546323|37736011|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
16794942|NCT02546323|37736010|FG000|Overall Study|Adverse Event|17|||
16794943|NCT02546323|37736011|FG001|Overall Study|Adverse Event|11|||
16794944|NCT02546323|37736010|FG000|Overall Study|Patient Specific Reasons|1|||
16794945|NCT02546323|37736011|FG001|Overall Study|Patient Specific Reasons|2|||
16794946|NCT02546323|37736010|FG000|Overall Study|Lost to Follow-up|2|||
16794947|NCT02546323|37736011|FG001|Overall Study|Lost to Follow-up|3|||
16794948|NCT02546323|37736010|FG000|Overall Study|Non-compliance with Study Drug|2|||
16794949|NCT02546323|37736011|FG001|Overall Study|Non-compliance with Study Drug|2|||
16794950|NCT02546323|37736010|FG000|Overall Study|Met Withdrawal Criteria|2|||
16794951|NCT02546323|37736011|FG001|Overall Study|Met Withdrawal Criteria|14|||
16794952|NCT02545933|37736020|FG000|Overall Study|Adverse Event|3|||
16794953|NCT02545933|37736021|FG001|Overall Study|Adverse Event|0|||
16794954|NCT02545933|37736022|FG002|Overall Study|Adverse Event|0|||
16794955|NCT02545933|37736020|FG000|Overall Study|Withdrawal by Subject|2|||
16794956|NCT02545933|37736021|FG001|Overall Study|Withdrawal by Subject|3|||
16794957|NCT02545933|37736022|FG002|Overall Study|Withdrawal by Subject|3|||
16794958|NCT02545933|37736020|FG000|Overall Study|Protocol Violation|1|||
16794959|NCT02545933|37736021|FG001|Overall Study|Protocol Violation|0|||
16794960|NCT02545933|37736022|FG002|Overall Study|Protocol Violation|1|||
16794961|NCT01661179|37736030|FG000|Overall Study|Death|1|||
16794962|NCT01661179|37736030|FG000|Overall Study|Withdrawal by Subject|1|||
16794963|NCT01661179|37736030|FG000|Overall Study|Other Eligibility criteria|4|||
16794964|NCT02545543|37736036|FG000|Overall Study|Lost to Follow-up|67|||
16794965|NCT02545543|37736037|FG001|Overall Study|Lost to Follow-up|25|||
16794966|NCT02545543|37736036|FG000|Overall Study|Physician Decision|3|||
16794967|NCT02545543|37736037|FG001|Overall Study|Physician Decision|0|||
16794968|NCT02545543|37736036|FG000|Overall Study|Withdrawal by Subject|9|||
16794969|NCT02545543|37736037|FG001|Overall Study|Withdrawal by Subject|8|||
16794970|NCT02545543|37736036|FG000|Overall Study|Noncomplaince|1|||
16794971|NCT02545543|37736037|FG001|Overall Study|Noncomplaince|0|||
16794972|NCT02545543|37736036|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
16794973|NCT02545543|37736037|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
16794974|NCT02542267|37736045|FG000|Overall Study|Withdrawal by Subject|10|||
16794975|NCT02542267|37736045|FG000|Overall Study|Physician Decision|6|||
17102272|NCT00384293|38241184|FG002|Post-randomization Period|Lost to Follow-up|1|||
17102273|NCT00384293|38241182|FG000|Post-randomization Period|Protocol Violation|0|||
16794976|NCT02542267|37736045|FG000|Overall Study|Lost to Follow-up|4|||
16794977|NCT02542267|37736045|FG000|Overall Study|Death|13|||
16794978|NCT02542267|37736045|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
16794979|NCT02542267|37736045|FG000|Overall Study|Other|9|||
16794980|NCT02545075|37736051|FG000|Randomization|Lost to Follow-up|0|||
16794981|NCT02545075|37736052|FG001|Randomization|Lost to Follow-up|1|||
16794982|NCT02545075|37736051|FG000|Randomization|Withdrawal by Subject|0|||
16794983|NCT02545075|37736052|FG001|Randomization|Withdrawal by Subject|6|||
16794984|NCT02545075|37736051|FG000|Treatment|Disease progression|71|||
16794985|NCT02545075|37736052|FG001|Treatment|Disease progression|32|||
16794986|NCT02545075|37736051|FG000|Treatment|Participant dicontinued study treatment|7|||
16794987|NCT02545075|37736052|FG001|Treatment|Participant dicontinued study treatment|9|||
16794988|NCT02545075|37736051|FG000|Treatment|Withdrawal by Subject|1|||
16794989|NCT02545075|37736052|FG001|Treatment|Withdrawal by Subject|0|||
16794990|NCT02545075|37736051|FG000|Treatment|Adverse event not related to study drug|1|||
16794991|NCT02545075|37736052|FG001|Treatment|Adverse event not related to study drug|0|||
16794992|NCT02545075|37736051|FG000|Treatment|Death|1|||
16794993|NCT02545075|37736052|FG001|Treatment|Death|0|||
16794994|NCT02545075|37736051|FG000|Treatment|Participant drug toxicity|1|||
16794995|NCT02545075|37736052|FG001|Treatment|Participant drug toxicity|0|||
16794996|NCT02545075|37736051|FG000|Treatment|Completed treatment|40|||
16794997|NCT02545075|37736052|FG001|Treatment|Completed treatment|12|||
16794998|NCT03004183|37736067|FG000|Overall Study|Adverse Event|7|||
16794999|NCT03004183|37736067|FG000|Overall Study|Lost to Follow-up|1|||
16795000|NCT03004183|37736067|FG000|Overall Study|Physician Decision|40|||
16795001|NCT03004183|37736067|FG000|Overall Study|Withdrawal by Subject|1|||
16795002|NCT03004183|37736067|FG000|Overall Study|COVID-19|1|||
16795003|NCT02544763|37736074|FG000|Overall Study|Adverse Event|8|||
16795004|NCT02544763|37736075|FG001|Overall Study|Adverse Event|8|||
16795005|NCT02544763|37736076|FG002|Overall Study|Adverse Event|0|||
16795006|NCT02544763|37736074|FG000|Overall Study|Withdrawn by parent/guardian|1|||
16795007|NCT02544763|37736075|FG001|Overall Study|Withdrawn by parent/guardian|1|||
16795008|NCT02544763|37736076|FG002|Overall Study|Withdrawn by parent/guardian|1|||
16795009|NCT02544763|37736074|FG000|Overall Study|Met withdrawal criteria|0|||
16795010|NCT02544763|37736075|FG001|Overall Study|Met withdrawal criteria|2|||
16795011|NCT02544763|37736076|FG002|Overall Study|Met withdrawal criteria|0|||
16795012|NCT02544763|37736074|FG000|Overall Study|Physician Decision|0|||
16795013|NCT02544763|37736075|FG001|Overall Study|Physician Decision|1|||
16795014|NCT02544763|37736076|FG002|Overall Study|Physician Decision|0|||
16795015|NCT02544763|37736074|FG000|Overall Study|Difficulties taking IMP|1|||
16795016|NCT02544763|37736075|FG001|Overall Study|Difficulties taking IMP|0|||
16795017|NCT02544763|37736076|FG002|Overall Study|Difficulties taking IMP|0|||
16795018|NCT02556203|37736086|FG000|Overall Study|Withdrawal by Subject|21|||
16795019|NCT02556203|37736087|FG001|Overall Study|Withdrawal by Subject|21|||
16795020|NCT02556203|37736086|FG000|Overall Study|Lost to Follow-up|5|||
16795021|NCT02556203|37736087|FG001|Overall Study|Lost to Follow-up|5|||
16795022|NCT02556203|37736086|FG000|Overall Study|Adverse Event|1|||
16795023|NCT02556203|37736087|FG001|Overall Study|Adverse Event|0|||
16795024|NCT02558231|37736104|FG000|Overall Study|Death|4|||
16795025|NCT02558231|37736105|FG001|Overall Study|Death|12|||
16795026|NCT02558231|37736104|FG000|Overall Study|Lost to Follow-up|7|||
16795027|NCT02558231|37736105|FG001|Overall Study|Lost to Follow-up|4|||
16795028|NCT02558231|37736104|FG000|Overall Study|Withdrawal by Subject|7|||
16795029|NCT02558231|37736105|FG001|Overall Study|Withdrawal by Subject|4|||
16795030|NCT02558231|37736104|FG000|Overall Study|Physician Decision|7|||
16795031|NCT02558231|37736105|FG001|Overall Study|Physician Decision|5|||
16795032|NCT02558231|37736104|FG000|Overall Study|Sponsor Decision|0|||
16795033|NCT02558231|37736105|FG001|Overall Study|Sponsor Decision|1|||
16795034|NCT02554877|37736115|FG000|Overall Study|Adverse Event|2|||
16795035|NCT02554877|37736116|FG001|Overall Study|Adverse Event|0|||
16795036|NCT02554877|37736117|FG002|Overall Study|Adverse Event|0|||
16795037|NCT02554877|37736118|FG003|Overall Study|Adverse Event|1|||
16795038|NCT02554877|37736115|FG000|Overall Study|Lost to Follow-up|1|||
16795039|NCT02554877|37736116|FG001|Overall Study|Lost to Follow-up|1|||
16795040|NCT02554877|37736117|FG002|Overall Study|Lost to Follow-up|1|||
16795041|NCT02554877|37736118|FG003|Overall Study|Lost to Follow-up|2|||
16795042|NCT02554877|37736115|FG000|Overall Study|Did not meet entrance criteria|0|||
16795043|NCT02554877|37736116|FG001|Overall Study|Did not meet entrance criteria|0|||
16795044|NCT02554877|37736117|FG002|Overall Study|Did not meet entrance criteria|1|||
16795045|NCT02554877|37736118|FG003|Overall Study|Did not meet entrance criteria|0|||
16795046|NCT02554877|37736115|FG000|Overall Study|No longer met eligibility criteria|1|||
16795047|NCT02554877|37736116|FG001|Overall Study|No longer met eligibility criteria|0|||
16795048|NCT02554877|37736117|FG002|Overall Study|No longer met eligibility criteria|1|||
16795049|NCT02554877|37736118|FG003|Overall Study|No longer met eligibility criteria|1|||
16795050|NCT02554877|37736115|FG000|Overall Study|Protocol Violation|3|||
16795051|NCT02554877|37736116|FG001|Overall Study|Protocol Violation|1|||
16795052|NCT02554877|37736117|FG002|Overall Study|Protocol Violation|1|||
16795053|NCT02554877|37736118|FG003|Overall Study|Protocol Violation|0|||
16795054|NCT02554877|37736115|FG000|Overall Study|Other|1|||
16795055|NCT02554877|37736116|FG001|Overall Study|Other|3|||
16795056|NCT02554877|37736117|FG002|Overall Study|Other|0|||
16795057|NCT02554877|37736118|FG003|Overall Study|Other|3|||
16795058|NCT02554877|37736115|FG000|Overall Study|Insufficient clinical response|4|||
16795059|NCT02554877|37736116|FG001|Overall Study|Insufficient clinical response|0|||
16795060|NCT02554877|37736117|FG002|Overall Study|Insufficient clinical response|0|||
16795061|NCT02554877|37736118|FG003|Overall Study|Insufficient clinical response|0|||
16795062|NCT02554877|37736115|FG000|Overall Study|No longer willing to participate|0|||
16795063|NCT02554877|37736116|FG001|Overall Study|No longer willing to participate|2|||
16795064|NCT02554877|37736117|FG002|Overall Study|No longer willing to participate|2|||
16795065|NCT02554877|37736118|FG003|Overall Study|No longer willing to participate|0|||
16795066|NCT02554721|37736133|FG000|Overall Study|Adverse Event|1|||
16795067|NCT02554721|37736134|FG001|Overall Study|Adverse Event|0|||
16795068|NCT02554721|37736135|FG002|Overall Study|Adverse Event|0|||
16795069|NCT02554721|37736136|FG003|Overall Study|Adverse Event|0|||
16795070|NCT02554721|37736137|FG004|Overall Study|Adverse Event|1|||
16795071|NCT02554721|37736133|FG000|Overall Study|Noncompliance|0|||
16795072|NCT02554721|37736134|FG001|Overall Study|Noncompliance|0|||
16795073|NCT02554721|37736135|FG002|Overall Study|Noncompliance|0|||
16795074|NCT02554721|37736136|FG003|Overall Study|Noncompliance|0|||
16795075|NCT02554721|37736137|FG004|Overall Study|Noncompliance|1|||
16795076|NCT02552225|37736148|FG000|Overall Study|Withdrawal by Subject|1|||
16795077|NCT02552225|37736149|FG001|Overall Study|Withdrawal by Subject|0|||
16795078|NCT02552147|37736155|FG000|First Intervention (7 Days)|Protocol Violation|1|||
16795079|NCT02552147|37736156|FG001|First Intervention (7 Days)|Protocol Violation|0|||
16795080|NCT02552147|37736155|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
16795081|NCT02552147|37736156|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
16795082|NCT01662635|37736162|FG000|Overall Study|scarce samples for evaluation|30|||
16795083|NCT02534935|37736171|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
16795084|NCT02534935|37736172|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
16795085|NCT02534935|37736173|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
16795086|NCT02534935|37736171|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
16795087|NCT02534935|37736172|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
16795088|NCT02534935|37736173|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
16795089|NCT02534935|37736171|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
16795090|NCT02534935|37736172|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
16795091|NCT02534935|37736173|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
16795092|NCT02534935|37736171|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
16795093|NCT02534935|37736172|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
16795094|NCT02534935|37736173|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
16795095|NCT02534935|37736171|FG000|Stage 1: 24 Months|Adverse Event|0|||
16795096|NCT02534935|37736172|FG001|Stage 1: 24 Months|Adverse Event|2|||
16795097|NCT02534935|37736173|FG002|Stage 1: 24 Months|Adverse Event|0|||
16795098|NCT02534935|37736171|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
16795099|NCT02534935|37736172|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
16795100|NCT02534935|37736173|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
16795101|NCT02534935|37736171|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
16795102|NCT02534935|37736172|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
16795103|NCT02534935|37736173|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
16795104|NCT02544451|37736202|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
16795105|NCT02544451|37736203|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
16795106|NCT02544451|37736204|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
16795107|NCT02544451|37736205|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
16795108|NCT02544451|37736202|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
16795109|NCT02544451|37736203|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
16795110|NCT02544451|37736204|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
16795111|NCT02544451|37736205|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
16795112|NCT02544451|37736202|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
16795113|NCT02544451|37736203|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
16795114|NCT02544451|37736204|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
16795115|NCT02544451|37736205|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
16795116|NCT02544451|37736202|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
16795117|NCT02544451|37736203|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
16795118|NCT02544451|37736204|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
16795119|NCT02544451|37736205|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
16795120|NCT02544451|37736202|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
16795121|NCT02544451|37736203|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
16795122|NCT02544451|37736204|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
16795123|NCT02544451|37736205|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
17102274|NCT00384293|38241183|FG001|Post-randomization Period|Protocol Violation|1|||
17102275|NCT00384293|38241184|FG002|Post-randomization Period|Protocol Violation|0|||
17102276|NCT00384293|38241182|FG000|Post-randomization Period|Withdrawal by Subject|0|||
16795124|NCT02544451|37736202|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
16795125|NCT02544451|37736203|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
16795126|NCT02544451|37736204|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
16795127|NCT02544451|37736205|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
16795128|NCT02544373|37736225|FG000|Overall Study|Lost to Follow-up|5|||
16795129|NCT02544373|37736226|FG001|Overall Study|Lost to Follow-up|3|||
16795130|NCT02544373|37736225|FG000|Overall Study|Withdrawal by Subject|8|||
16795131|NCT02544373|37736226|FG001|Overall Study|Withdrawal by Subject|2|||
16795132|NCT02551991|37736238|FG000|Overall Study|Death|5|||
16795133|NCT02551991|37736239|FG001|Overall Study|Death|7|||
16795134|NCT02551991|37736240|FG002|Overall Study|Death|8|||
16795135|NCT02551991|37736241|FG003|Overall Study|Death|7|||
16795136|NCT02551991|37736242|FG004|Overall Study|Death|17|||
16795137|NCT02551991|37736238|FG000|Overall Study|Withdrawal by Subject|1|||
16795138|NCT02551991|37736239|FG001|Overall Study|Withdrawal by Subject|0|||
16795139|NCT02551991|37736240|FG002|Overall Study|Withdrawal by Subject|0|||
16795140|NCT02551991|37736241|FG003|Overall Study|Withdrawal by Subject|0|||
16795141|NCT02551991|37736242|FG004|Overall Study|Withdrawal by Subject|2|||
16795142|NCT02551991|37736238|FG000|Overall Study|Lost to Follow-up|0|||
16795143|NCT02551991|37736239|FG001|Overall Study|Lost to Follow-up|0|||
16795144|NCT02551991|37736240|FG002|Overall Study|Lost to Follow-up|1|||
16795145|NCT02551991|37736241|FG003|Overall Study|Lost to Follow-up|0|||
16795146|NCT02551991|37736242|FG004|Overall Study|Lost to Follow-up|0|||
16795147|NCT02551991|37736238|FG000|Overall Study|Sponsor Decision|1|||
16795148|NCT02551991|37736239|FG001|Overall Study|Sponsor Decision|0|||
16795149|NCT02551991|37736240|FG002|Overall Study|Sponsor Decision|1|||
16795150|NCT02551991|37736241|FG003|Overall Study|Sponsor Decision|0|||
16795151|NCT02551991|37736242|FG004|Overall Study|Sponsor Decision|5|||
16795152|NCT02551991|37736238|FG000|Overall Study|Other|0|||
16795153|NCT02551991|37736239|FG001|Overall Study|Other|0|||
16795154|NCT02551991|37736240|FG002|Overall Study|Other|0|||
16795155|NCT02551991|37736241|FG003|Overall Study|Other|0|||
16795156|NCT02551991|37736242|FG004|Overall Study|Other|1|||
16795157|NCT01661933|37736255|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
16795158|NCT01661933|37736255|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
16795159|NCT02544217|37736267|FG000|Overall Study|Withdrawal by Subject|1|||
16795160|NCT02544217|37736268|FG001|Overall Study|Withdrawal by Subject|1|||
16795161|NCT02544217|37736269|FG002|Overall Study|Withdrawal by Subject|0|||
16795162|NCT02544217|37736270|FG003|Overall Study|Withdrawal by Subject|0|||
16795163|NCT02544217|37736271|FG004|Overall Study|Withdrawal by Subject|0|||
16795164|NCT02544217|37736272|FG005|Overall Study|Withdrawal by Subject|0|||
16795165|NCT02533999|37736341|FG000|Overall Study|Lost to Follow-up|3|||
16795166|NCT02533999|37736342|FG001|Overall Study|Lost to Follow-up|5|||
16795167|NCT02533999|37736341|FG000|Overall Study|Protocol Violation|3|||
16795168|NCT02533999|37736342|FG001|Overall Study|Protocol Violation|0|||
16795169|NCT02533999|37736341|FG000|Overall Study|Adverse Event|0|||
16795170|NCT02533999|37736342|FG001|Overall Study|Adverse Event|1|||
16795171|NCT02533999|37736341|FG000|Overall Study|Randomized but intervention not received|0|||
16795172|NCT02533999|37736342|FG001|Overall Study|Randomized but intervention not received|1|||
16795173|NCT02533531|37736348|FG000|Overall Study|Device did not turn on|1|||
16795174|NCT02533453|37736352|FG000|Overall Study|Adverse Event|6|||
16795175|NCT02533453|37736352|FG000|Overall Study|Protocol Violation|1|||
16795176|NCT02533453|37736352|FG000|Overall Study|Withdrawal by Subject|2|||
16795177|NCT02533375|37736356|FG000|Overall Study|Lack of Efficacy|3|||
16795178|NCT02533375|37736356|FG000|Overall Study|Adverse Event|2|||
16795179|NCT01553149|37736362|FG000|Overall Study|Adverse Event|0|||
16795180|NCT01553149|37736363|FG001|Overall Study|Adverse Event|9|||
16795181|NCT01553149|37736362|FG000|Overall Study|Physician Decision|5|||
16795182|NCT01553149|37736363|FG001|Overall Study|Physician Decision|10|||
16795183|NCT01553149|37736362|FG000|Overall Study|Ineligible|0|||
16795184|NCT01553149|37736363|FG001|Overall Study|Ineligible|1|||
16795185|NCT02551055|37736376|FG000|Overall Study|Death|2|||
16795186|NCT02551055|37736377|FG001|Overall Study|Death|4|||
16795187|NCT02551055|37736378|FG002|Overall Study|Death|2|||
16795188|NCT02551055|37736379|FG003|Overall Study|Death|2|||
16795189|NCT02551055|37736380|FG004|Overall Study|Death|2|||
16795190|NCT02551055|37736381|FG005|Overall Study|Death|1|||
16795191|NCT02551055|37736382|FG006|Overall Study|Death|2|||
16795192|NCT02551055|37736383|FG007|Overall Study|Death|0|||
16795193|NCT02551055|37736376|FG000|Overall Study|Study Terminated by Sponsor|1|||
16795194|NCT02551055|37736377|FG001|Overall Study|Study Terminated by Sponsor|1|||
16795195|NCT02551055|37736378|FG002|Overall Study|Study Terminated by Sponsor|0|||
16795196|NCT02551055|37736379|FG003|Overall Study|Study Terminated by Sponsor|2|||
16795197|NCT02551055|37736380|FG004|Overall Study|Study Terminated by Sponsor|2|||
16795198|NCT02551055|37736381|FG005|Overall Study|Study Terminated by Sponsor|0|||
16795199|NCT02551055|37736382|FG006|Overall Study|Study Terminated by Sponsor|0|||
16795200|NCT02551055|37736383|FG007|Overall Study|Study Terminated by Sponsor|0|||
16795201|NCT02551055|37736376|FG000|Overall Study|Withdrawal by Subject|1|||
16795202|NCT02551055|37736377|FG001|Overall Study|Withdrawal by Subject|1|||
16795203|NCT02551055|37736378|FG002|Overall Study|Withdrawal by Subject|0|||
16795204|NCT02551055|37736379|FG003|Overall Study|Withdrawal by Subject|1|||
16795205|NCT02551055|37736380|FG004|Overall Study|Withdrawal by Subject|2|||
16795206|NCT02551055|37736381|FG005|Overall Study|Withdrawal by Subject|0|||
16795207|NCT02551055|37736382|FG006|Overall Study|Withdrawal by Subject|0|||
16795208|NCT02551055|37736383|FG007|Overall Study|Withdrawal by Subject|0|||
16795209|NCT02551055|37736376|FG000|Overall Study|Reason not specified|0|||
16795210|NCT02551055|37736377|FG001|Overall Study|Reason not specified|0|||
16795211|NCT02551055|37736378|FG002|Overall Study|Reason not specified|0|||
16795212|NCT02551055|37736379|FG003|Overall Study|Reason not specified|0|||
16795213|NCT02551055|37736380|FG004|Overall Study|Reason not specified|1|||
16795214|NCT02551055|37736381|FG005|Overall Study|Reason not specified|0|||
16795215|NCT02551055|37736382|FG006|Overall Study|Reason not specified|1|||
16795216|NCT02551055|37736383|FG007|Overall Study|Reason not specified|0|||
16795217|NCT02542943|37736404|FG000|Overall Study|Lost to Follow-up|1|||
16795218|NCT02542943|37736405|FG001|Overall Study|Lost to Follow-up|0|||
16795219|NCT02542943|37736406|FG002|Overall Study|Lost to Follow-up|0|||
16795220|NCT02542943|37736404|FG000|Overall Study|Withdrawal by Subject|0|||
16795221|NCT02542943|37736405|FG001|Overall Study|Withdrawal by Subject|1|||
16795222|NCT02542943|37736406|FG002|Overall Study|Withdrawal by Subject|0|||
16795223|NCT02542865|37736417|FG000|Overall Study|Identified as screen failure|1|||
16795224|NCT02542865|37736418|FG001|Overall Study|Identified as screen failure|0|||
16795225|NCT02542865|37736417|FG000|Overall Study|Withdrawal by Subject|16|||
16795226|NCT02542865|37736418|FG001|Overall Study|Withdrawal by Subject|0|||
16795227|NCT03644927|37736424|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
16795228|NCT03644927|37736425|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
16795229|NCT02542631|37736432|FG000|Overall Study|Adverse Event|1|||
16795230|NCT02542631|37736433|FG001|Overall Study|Adverse Event|1|||
16795231|NCT02542631|37736432|FG000|Overall Study|Sponsor Termination|1|||
16795232|NCT02542631|37736433|FG001|Overall Study|Sponsor Termination|0|||
16795233|NCT02542631|37736432|FG000|Overall Study|Withdrawal by Subject|11|||
16795234|NCT02542631|37736433|FG001|Overall Study|Withdrawal by Subject|16|||
16795235|NCT02542631|37736432|FG000|Overall Study|Protocol Violation|1|||
16795236|NCT02542631|37736433|FG001|Overall Study|Protocol Violation|1|||
16795237|NCT02542631|37736432|FG000|Overall Study|Physician Decision|6|||
16795238|NCT02542631|37736433|FG001|Overall Study|Physician Decision|4|||
16795239|NCT02542631|37736432|FG000|Overall Study|Lost to Follow-up|6|||
16795240|NCT02542631|37736433|FG001|Overall Study|Lost to Follow-up|5|||
16795241|NCT02542631|37736432|FG000|Overall Study|Death|1|||
16795242|NCT02542631|37736433|FG001|Overall Study|Death|2|||
16795243|NCT02542631|37736432|FG000|Overall Study|Other|2|||
16795244|NCT02542631|37736433|FG001|Overall Study|Other|1|||
16795245|NCT02542631|37736432|FG000|Overall Study|Used Prohibited Medication|2|||
16795246|NCT02542631|37736433|FG001|Overall Study|Used Prohibited Medication|1|||
16795247|NCT02549573|37736441|FG000|Overall Study|Withdrawal by Subject|0|||
16795248|NCT02549573|37736442|FG001|Overall Study|Withdrawal by Subject|2|||
16795249|NCT02549573|37736441|FG000|Overall Study|Protocol Violation|0|||
16795250|NCT02549573|37736442|FG001|Overall Study|Protocol Violation|1|||
16795251|NCT02542397|37736448|FG000|Overall Study|Death|2|||
16795252|NCT02542397|37736448|FG000|Overall Study|Physician Decision|6|||
16795253|NCT02542397|37736448|FG000|Overall Study|Withdrawal by Subject|6|||
16795254|NCT02542397|37736448|FG000|Overall Study|Lost to Follow-up|2|||
16795255|NCT02549339|37736455|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
16795256|NCT02549339|37736456|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
16795257|NCT02549339|37736455|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
16795258|NCT02549339|37736456|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
16795259|NCT02549339|37736455|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
16795260|NCT02549339|37736456|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
16795261|NCT02549339|37736455|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
16795262|NCT02549339|37736456|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
16795263|NCT02549339|37736455|FG000|12-month Follow-up|Lack of Efficacy|0|||
16795264|NCT02549339|37736456|FG001|12-month Follow-up|Lack of Efficacy|2|||
16795265|NCT02549339|37736455|FG000|12-month Follow-up|Withdrawal by Subject|8|||
16795266|NCT02549339|37736456|FG001|12-month Follow-up|Withdrawal by Subject|3|||
16795267|NCT02549339|37736455|FG000|12-month Follow-up|Lost to Follow-up|1|||
16795268|NCT02549339|37736456|FG001|12-month Follow-up|Lost to Follow-up|3|||
16795269|NCT02549339|37736455|FG000|12-month Follow-up|Other|0|||
16795270|NCT02549339|37736456|FG001|12-month Follow-up|Other|3|||
16795271|NCT02549027|37736464|FG000|Washout After Period 4|Withdrawal by Subject|0|||
16795272|NCT02549027|37736465|FG001|Washout After Period 4|Withdrawal by Subject|1|||
16795273|NCT02549027|37736466|FG002|Washout After Period 4|Withdrawal by Subject|1|||
16795274|NCT02549027|37736467|FG003|Washout After Period 4|Withdrawal by Subject|1|||
16795275|NCT02549027|37736468|FG004|Washout After Period 4|Withdrawal by Subject|0|||
16795276|NCT02549027|37736469|FG005|Washout After Period 4|Withdrawal by Subject|0|||
16795277|NCT02549027|37736464|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16795278|NCT02549027|37736465|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16795279|NCT02549027|37736466|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16795280|NCT02549027|37736467|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16795281|NCT02549027|37736468|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
16795282|NCT02549027|37736469|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16795283|NCT02529553|37736497|FG000|Overall Study|Progressive Disease|1|||
16795284|NCT02529553|37736498|FG001|Overall Study|Progressive Disease|0|||
16795285|NCT02529553|37736499|FG002|Overall Study|Progressive Disease|1|||
16795286|NCT02529553|37736500|FG003|Overall Study|Progressive Disease|3|||
16795287|NCT02529553|37736501|FG004|Overall Study|Progressive Disease|2|||
16795288|NCT02529553|37736502|FG005|Overall Study|Progressive Disease|3|||
16795289|NCT02529553|37736503|FG006|Overall Study|Progressive Disease|3|||
16795290|NCT02529553|37736504|FG007|Overall Study|Progressive Disease|5|||
16795291|NCT02529553|37736505|FG008|Overall Study|Progressive Disease|3|||
16795292|NCT02529553|37736497|FG000|Overall Study|Physician Decision|0|||
16795293|NCT02529553|37736498|FG001|Overall Study|Physician Decision|1|||
16795294|NCT02529553|37736499|FG002|Overall Study|Physician Decision|0|||
16795295|NCT02529553|37736500|FG003|Overall Study|Physician Decision|0|||
16795296|NCT02529553|37736501|FG004|Overall Study|Physician Decision|1|||
16795297|NCT02529553|37736502|FG005|Overall Study|Physician Decision|0|||
16795298|NCT02529553|37736503|FG006|Overall Study|Physician Decision|0|||
16795299|NCT02529553|37736504|FG007|Overall Study|Physician Decision|0|||
16795300|NCT02529553|37736505|FG008|Overall Study|Physician Decision|0|||
16795301|NCT02529553|37736497|FG000|Overall Study|Withdrawal by Subject|0|||
16795302|NCT02529553|37736498|FG001|Overall Study|Withdrawal by Subject|0|||
16795303|NCT02529553|37736499|FG002|Overall Study|Withdrawal by Subject|0|||
16795304|NCT02529553|37736500|FG003|Overall Study|Withdrawal by Subject|0|||
16795305|NCT02529553|37736501|FG004|Overall Study|Withdrawal by Subject|0|||
16795306|NCT02529553|37736502|FG005|Overall Study|Withdrawal by Subject|1|||
16795307|NCT02529553|37736503|FG006|Overall Study|Withdrawal by Subject|0|||
16795308|NCT02529553|37736504|FG007|Overall Study|Withdrawal by Subject|1|||
16795309|NCT02529553|37736505|FG008|Overall Study|Withdrawal by Subject|0|||
16795310|NCT02547935|37736529|FG000|Overall Study|Other|0|||
16795311|NCT02547935|37736530|FG001|Overall Study|Other|1|||
16795312|NCT02547935|37736531|FG002|Overall Study|Other|0|||
16795313|NCT02547935|37736529|FG000|Overall Study|Withdrawal by Subject|2|||
16795314|NCT02547935|37736530|FG001|Overall Study|Withdrawal by Subject|3|||
16795315|NCT02547935|37736531|FG002|Overall Study|Withdrawal by Subject|4|||
16795316|NCT02547935|37736529|FG000|Overall Study|Screen Failure|2|||
16795317|NCT02547935|37736530|FG001|Overall Study|Screen Failure|0|||
16795318|NCT02547935|37736531|FG002|Overall Study|Screen Failure|0|||
16795319|NCT02547935|37736529|FG000|Overall Study|Physician Decision|0|||
16795320|NCT02547935|37736530|FG001|Overall Study|Physician Decision|1|||
16795321|NCT02547935|37736531|FG002|Overall Study|Physician Decision|0|||
16795322|NCT02547935|37736529|FG000|Overall Study|Lost to Follow-up|0|||
16795323|NCT02547935|37736530|FG001|Overall Study|Lost to Follow-up|2|||
16795324|NCT02547935|37736531|FG002|Overall Study|Lost to Follow-up|1|||
16795325|NCT02547935|37736529|FG000|Overall Study|Death|1|||
16795326|NCT02547935|37736530|FG001|Overall Study|Death|1|||
16795327|NCT02547935|37736531|FG002|Overall Study|Death|0|||
16795328|NCT02554019|37736544|FG000|Overall Study|Withdrawal by Subject|1|||
16795329|NCT02554019|37736545|FG001|Overall Study|Withdrawal by Subject|0|||
16795330|NCT02554019|37736546|FG002|Overall Study|Withdrawal by Subject|2|||
16795331|NCT02554019|37736544|FG000|Overall Study|Adverse Event|1|||
16795332|NCT02554019|37736545|FG001|Overall Study|Adverse Event|0|||
16795333|NCT02554019|37736546|FG002|Overall Study|Adverse Event|0|||
16795334|NCT02327169|37736569|FG000|Overall Study|Progressive Disease|1|||
16795335|NCT02327169|37736570|FG001|Overall Study|Progressive Disease|3|||
16795336|NCT02327169|37736571|FG002|Overall Study|Progressive Disease|4|||
16795337|NCT02327169|37736572|FG003|Overall Study|Progressive Disease|3|||
16795338|NCT02327169|37736573|FG004|Overall Study|Progressive Disease|4|||
16795339|NCT02327169|37736574|FG005|Overall Study|Progressive Disease|3|||
16795340|NCT02327169|37736575|FG006|Overall Study|Progressive Disease|3|||
16795341|NCT02327169|37736576|FG007|Overall Study|Progressive Disease|3|||
16795342|NCT02327169|37736577|FG008|Overall Study|Progressive Disease|4|||
16795343|NCT02327169|37736578|FG009|Overall Study|Progressive Disease|4|||
16795344|NCT02327169|37736579|FG010|Overall Study|Progressive Disease|4|||
16795345|NCT02327169|37736580|FG011|Overall Study|Progressive Disease|3|||
16795346|NCT02327169|37736581|FG012|Overall Study|Progressive Disease|1|||
16795347|NCT02327169|37736582|FG013|Overall Study|Progressive Disease|3|||
16795348|NCT02327169|37736583|FG014|Overall Study|Progressive Disease|3|||
16795349|NCT02327169|37736569|FG000|Overall Study|Adverse Event|2|||
16795350|NCT02327169|37736570|FG001|Overall Study|Adverse Event|0|||
16795351|NCT02327169|37736571|FG002|Overall Study|Adverse Event|1|||
16795352|NCT02327169|37736572|FG003|Overall Study|Adverse Event|0|||
16795353|NCT02327169|37736573|FG004|Overall Study|Adverse Event|1|||
16795354|NCT02327169|37736574|FG005|Overall Study|Adverse Event|0|||
16795355|NCT02327169|37736575|FG006|Overall Study|Adverse Event|0|||
16795356|NCT02327169|37736576|FG007|Overall Study|Adverse Event|0|||
16795357|NCT02327169|37736577|FG008|Overall Study|Adverse Event|0|||
16795358|NCT02327169|37736578|FG009|Overall Study|Adverse Event|2|||
16795359|NCT02327169|37736579|FG010|Overall Study|Adverse Event|0|||
16795360|NCT02327169|37736580|FG011|Overall Study|Adverse Event|3|||
16795361|NCT02327169|37736581|FG012|Overall Study|Adverse Event|0|||
16795362|NCT02327169|37736582|FG013|Overall Study|Adverse Event|2|||
16795363|NCT02327169|37736583|FG014|Overall Study|Adverse Event|1|||
16795364|NCT02327169|37736569|FG000|Overall Study|Symptomatic Deterioration|0|||
16795365|NCT02327169|37736570|FG001|Overall Study|Symptomatic Deterioration|0|||
16795366|NCT02327169|37736571|FG002|Overall Study|Symptomatic Deterioration|1|||
16795367|NCT02327169|37736572|FG003|Overall Study|Symptomatic Deterioration|0|||
16795368|NCT02327169|37736573|FG004|Overall Study|Symptomatic Deterioration|1|||
16795369|NCT02327169|37736574|FG005|Overall Study|Symptomatic Deterioration|1|||
16795370|NCT02327169|37736575|FG006|Overall Study|Symptomatic Deterioration|0|||
16795371|NCT02327169|37736576|FG007|Overall Study|Symptomatic Deterioration|0|||
16795372|NCT02327169|37736577|FG008|Overall Study|Symptomatic Deterioration|2|||
16795373|NCT02327169|37736578|FG009|Overall Study|Symptomatic Deterioration|1|||
16795374|NCT02327169|37736579|FG010|Overall Study|Symptomatic Deterioration|0|||
16795375|NCT02327169|37736580|FG011|Overall Study|Symptomatic Deterioration|0|||
16795376|NCT02327169|37736581|FG012|Overall Study|Symptomatic Deterioration|0|||
16795377|NCT02327169|37736582|FG013|Overall Study|Symptomatic Deterioration|2|||
16795378|NCT02327169|37736583|FG014|Overall Study|Symptomatic Deterioration|1|||
16795379|NCT02327169|37736569|FG000|Overall Study|Reason Not Specified|0|||
16795380|NCT02327169|37736570|FG001|Overall Study|Reason Not Specified|0|||
16795381|NCT02327169|37736571|FG002|Overall Study|Reason Not Specified|1|||
16795382|NCT02327169|37736572|FG003|Overall Study|Reason Not Specified|0|||
16795383|NCT02327169|37736573|FG004|Overall Study|Reason Not Specified|0|||
16795384|NCT02327169|37736574|FG005|Overall Study|Reason Not Specified|0|||
16795385|NCT02327169|37736575|FG006|Overall Study|Reason Not Specified|0|||
16795386|NCT02327169|37736576|FG007|Overall Study|Reason Not Specified|0|||
16795387|NCT02327169|37736577|FG008|Overall Study|Reason Not Specified|0|||
16795388|NCT02327169|37736578|FG009|Overall Study|Reason Not Specified|1|||
16795389|NCT02327169|37736579|FG010|Overall Study|Reason Not Specified|2|||
16795390|NCT02327169|37736580|FG011|Overall Study|Reason Not Specified|1|||
16795391|NCT02327169|37736581|FG012|Overall Study|Reason Not Specified|0|||
16795392|NCT02327169|37736582|FG013|Overall Study|Reason Not Specified|0|||
16795393|NCT02327169|37736583|FG014|Overall Study|Reason Not Specified|2|||
16795394|NCT02327169|37736569|FG000|Overall Study|Withdrawal by Subject|1|||
16795395|NCT02327169|37736570|FG001|Overall Study|Withdrawal by Subject|0|||
16795396|NCT02327169|37736571|FG002|Overall Study|Withdrawal by Subject|0|||
16795397|NCT02327169|37736572|FG003|Overall Study|Withdrawal by Subject|0|||
16795398|NCT02327169|37736573|FG004|Overall Study|Withdrawal by Subject|1|||
16795399|NCT02327169|37736574|FG005|Overall Study|Withdrawal by Subject|0|||
16795400|NCT02327169|37736575|FG006|Overall Study|Withdrawal by Subject|0|||
16795401|NCT02327169|37736576|FG007|Overall Study|Withdrawal by Subject|1|||
16795402|NCT02327169|37736577|FG008|Overall Study|Withdrawal by Subject|0|||
16795403|NCT02327169|37736578|FG009|Overall Study|Withdrawal by Subject|0|||
16795404|NCT02327169|37736579|FG010|Overall Study|Withdrawal by Subject|0|||
16795405|NCT02327169|37736580|FG011|Overall Study|Withdrawal by Subject|0|||
16795406|NCT02327169|37736581|FG012|Overall Study|Withdrawal by Subject|0|||
16795407|NCT02327169|37736582|FG013|Overall Study|Withdrawal by Subject|0|||
16795408|NCT02327169|37736583|FG014|Overall Study|Withdrawal by Subject|3|||
16795409|NCT02327169|37736569|FG000|Overall Study|Lost to Follow-up|0|||
16795410|NCT02327169|37736570|FG001|Overall Study|Lost to Follow-up|0|||
16795411|NCT02327169|37736571|FG002|Overall Study|Lost to Follow-up|0|||
16795412|NCT02327169|37736572|FG003|Overall Study|Lost to Follow-up|0|||
16795413|NCT02327169|37736573|FG004|Overall Study|Lost to Follow-up|1|||
16795414|NCT02327169|37736574|FG005|Overall Study|Lost to Follow-up|0|||
16795415|NCT02327169|37736575|FG006|Overall Study|Lost to Follow-up|0|||
16795416|NCT02327169|37736576|FG007|Overall Study|Lost to Follow-up|0|||
16795417|NCT02327169|37736577|FG008|Overall Study|Lost to Follow-up|0|||
16795418|NCT02327169|37736578|FG009|Overall Study|Lost to Follow-up|0|||
16795419|NCT02327169|37736579|FG010|Overall Study|Lost to Follow-up|0|||
16795420|NCT02327169|37736580|FG011|Overall Study|Lost to Follow-up|0|||
16795421|NCT02327169|37736581|FG012|Overall Study|Lost to Follow-up|0|||
16795422|NCT02327169|37736582|FG013|Overall Study|Lost to Follow-up|0|||
16795423|NCT02327169|37736583|FG014|Overall Study|Lost to Follow-up|0|||
16795424|NCT02327013|37736628|FG000|Overall Study|Adverse Event|4|||
16795425|NCT02327013|37736629|FG001|Overall Study|Adverse Event|4|||
16795426|NCT02327013|37736630|FG002|Overall Study|Adverse Event|3|||
16795427|NCT02327013|37736631|FG003|Overall Study|Adverse Event|0|||
16795428|NCT02327013|37736632|FG004|Overall Study|Adverse Event|1|||
16795429|NCT02327013|37736628|FG000|Overall Study|Lack of Efficacy|2|||
16795430|NCT02327013|37736629|FG001|Overall Study|Lack of Efficacy|0|||
16795431|NCT02327013|37736630|FG002|Overall Study|Lack of Efficacy|5|||
16795432|NCT02327013|37736631|FG003|Overall Study|Lack of Efficacy|0|||
16795433|NCT02327013|37736632|FG004|Overall Study|Lack of Efficacy|1|||
16795434|NCT02327013|37736628|FG000|Overall Study|Non-compliance with IMP|1|||
16795435|NCT02327013|37736629|FG001|Overall Study|Non-compliance with IMP|2|||
16795436|NCT02327013|37736630|FG002|Overall Study|Non-compliance with IMP|7|||
16795437|NCT02327013|37736631|FG003|Overall Study|Non-compliance with IMP|0|||
16795438|NCT02327013|37736632|FG004|Overall Study|Non-compliance with IMP|0|||
16795439|NCT02327013|37736628|FG000|Overall Study|Withdrawal of Consent|1|||
16795440|NCT02327013|37736629|FG001|Overall Study|Withdrawal of Consent|0|||
16795441|NCT02327013|37736630|FG002|Overall Study|Withdrawal of Consent|3|||
16795442|NCT02327013|37736631|FG003|Overall Study|Withdrawal of Consent|0|||
16795443|NCT02327013|37736632|FG004|Overall Study|Withdrawal of Consent|0|||
16795444|NCT02327013|37736628|FG000|Overall Study|Lost to Follow-up|2|||
16795445|NCT02327013|37736629|FG001|Overall Study|Lost to Follow-up|4|||
16795446|NCT02327013|37736630|FG002|Overall Study|Lost to Follow-up|5|||
16795447|NCT02327013|37736631|FG003|Overall Study|Lost to Follow-up|0|||
16795448|NCT02327013|37736632|FG004|Overall Study|Lost to Follow-up|0|||
16795449|NCT02327013|37736628|FG000|Overall Study|Administrative or other reason(s)|1|||
16795450|NCT02327013|37736629|FG001|Overall Study|Administrative or other reason(s)|5|||
16795451|NCT02327013|37736630|FG002|Overall Study|Administrative or other reason(s)|11|||
16795452|NCT02327013|37736631|FG003|Overall Study|Administrative or other reason(s)|1|||
16795453|NCT02327013|37736632|FG004|Overall Study|Administrative or other reason(s)|1|||
16795454|NCT02327013|37736628|FG000|Overall Study|Protocol Violation|0|||
16795455|NCT02327013|37736629|FG001|Overall Study|Protocol Violation|0|||
16795456|NCT02327013|37736630|FG002|Overall Study|Protocol Violation|3|||
16795457|NCT02327013|37736631|FG003|Overall Study|Protocol Violation|0|||
16795458|NCT02327013|37736632|FG004|Overall Study|Protocol Violation|1|||
16795459|NCT02327013|37736628|FG000|Overall Study|Withdrawal before treatment|2|||
16795460|NCT02327013|37736629|FG001|Overall Study|Withdrawal before treatment|1|||
16795461|NCT02327013|37736630|FG002|Overall Study|Withdrawal before treatment|5|||
16795462|NCT02327013|37736631|FG003|Overall Study|Withdrawal before treatment|0|||
16795463|NCT02327013|37736632|FG004|Overall Study|Withdrawal before treatment|0|||
16795464|NCT02301975|37736655|FG000|Overall Study|Adverse Event|8|||
16795465|NCT02301975|37736656|FG001|Overall Study|Adverse Event|3|||
16795466|NCT02301975|37736657|FG002|Overall Study|Adverse Event|2|||
16795467|NCT02301975|37736655|FG000|Overall Study|Lack of Efficacy|1|||
16795468|NCT02301975|37736656|FG001|Overall Study|Lack of Efficacy|1|||
16795469|NCT02301975|37736657|FG002|Overall Study|Lack of Efficacy|1|||
16795470|NCT02301975|37736655|FG000|Overall Study|Protocol Violation|3|||
16795471|NCT02301975|37736656|FG001|Overall Study|Protocol Violation|5|||
16795472|NCT02301975|37736657|FG002|Overall Study|Protocol Violation|3|||
16795473|NCT02301975|37736655|FG000|Overall Study|Lost to Follow-up|0|||
16795474|NCT02301975|37736656|FG001|Overall Study|Lost to Follow-up|2|||
16795475|NCT02301975|37736657|FG002|Overall Study|Lost to Follow-up|2|||
16795476|NCT02301975|37736655|FG000|Overall Study|Physician Decision|4|||
16795477|NCT02301975|37736656|FG001|Overall Study|Physician Decision|2|||
16795478|NCT02301975|37736657|FG002|Overall Study|Physician Decision|3|||
16795479|NCT02301975|37736655|FG000|Overall Study|Withdrawal by Subject|15|||
16795480|NCT02301975|37736656|FG001|Overall Study|Withdrawal by Subject|12|||
16795481|NCT02301975|37736657|FG002|Overall Study|Withdrawal by Subject|11|||
16795482|NCT02301897|37736668|FG000|Treatment Course 1|Non-Compliance|0|||
16795483|NCT02301897|37736669|FG001|Treatment Course 1|Non-Compliance|0|||
16795484|NCT02301897|37736670|FG002|Treatment Course 1|Non-Compliance|1|||
16795485|NCT02301897|37736668|FG000|Treatment Course 1|Adverse Event|1|||
16795486|NCT02301897|37736669|FG001|Treatment Course 1|Adverse Event|1|||
16795487|NCT02301897|37736670|FG002|Treatment Course 1|Adverse Event|0|||
16795488|NCT02301897|37736668|FG000|Treatment Course 1|Lost to Follow-up|1|||
16795489|NCT02301897|37736669|FG001|Treatment Course 1|Lost to Follow-up|2|||
16795490|NCT02301897|37736670|FG002|Treatment Course 1|Lost to Follow-up|1|||
16795491|NCT02301897|37736668|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
16795492|NCT02301897|37736669|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
16795493|NCT02301897|37736670|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
16795494|NCT02301897|37736668|FG000|Treatment Course 1|Withdrawal by Subject|0|||
16795495|NCT02301897|37736669|FG001|Treatment Course 1|Withdrawal by Subject|0|||
16795496|NCT02301897|37736670|FG002|Treatment Course 1|Withdrawal by Subject|2|||
16795497|NCT02301897|37736668|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
16795498|NCT02301897|37736669|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
16795499|NCT02301897|37736670|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
16795500|NCT02301897|37736668|FG000|Treatment Course 2|Lost to Follow-up|0|||
16795501|NCT02301897|37736669|FG001|Treatment Course 2|Lost to Follow-up|2|||
16795502|NCT02301897|37736670|FG002|Treatment Course 2|Lost to Follow-up|0|||
16795503|NCT02301897|37736668|FG000|Treatment Course 2|Pregnancy|0|||
16795504|NCT02301897|37736669|FG001|Treatment Course 2|Pregnancy|1|||
16795505|NCT02301897|37736670|FG002|Treatment Course 2|Pregnancy|1|||
16795506|NCT02301897|37736668|FG000|Treatment Course 2|Withdrawal by Subject|0|||
16795507|NCT02301897|37736669|FG001|Treatment Course 2|Withdrawal by Subject|2|||
16795508|NCT02301897|37736670|FG002|Treatment Course 2|Withdrawal by Subject|0|||
16795509|NCT02301897|37736668|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
16795510|NCT02301897|37736669|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
16795511|NCT02301897|37736670|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
16795512|NCT02301429|37736678|FG000|Overall Study|not acceptable vascular anatomy|3|||
16795513|NCT02300259|37736685|FG000|Period 1|Adverse Event|0|||
16795514|NCT02300259|37736686|FG001|Period 1|Adverse Event|0|||
16795515|NCT02300259|37736687|FG002|Period 1|Adverse Event|1|||
16795516|NCT02300259|37736685|FG000|Period 1|Withdrawal by Subject|0|||
16795517|NCT02300259|37736686|FG001|Period 1|Withdrawal by Subject|0|||
16795518|NCT02300259|37736687|FG002|Period 1|Withdrawal by Subject|1|||
16795519|NCT02300259|37736685|FG000|Period 2|Adverse Event|1|||
16795520|NCT02300259|37736686|FG001|Period 2|Adverse Event|0|||
16795521|NCT02300259|37736687|FG002|Period 2|Adverse Event|0|||
16795522|NCT02300259|37736685|FG000|Period 2|Withdrawal by Subject|0|||
16795523|NCT02300259|37736686|FG001|Period 2|Withdrawal by Subject|0|||
16795524|NCT02300259|37736687|FG002|Period 2|Withdrawal by Subject|1|||
16795525|NCT02367885|37736709|FG000|Overall Study|Lost to Follow-up|1|||
16795526|NCT02367885|37736710|FG001|Overall Study|Lost to Follow-up|0|||
16795527|NCT02367885|37736711|FG002|Overall Study|Lost to Follow-up|0|||
16795528|NCT02367885|37736709|FG000|Overall Study|Withdrawal by Subject|1|||
16795529|NCT02367885|37736710|FG001|Overall Study|Withdrawal by Subject|0|||
16795530|NCT02367885|37736711|FG002|Overall Study|Withdrawal by Subject|0|||
16795531|NCT02367729|37736724|FG000|Overall Study|Organic disorder diagnosed|2|||
16795532|NCT02367729|37736725|FG001|Overall Study|Organic disorder diagnosed|1|||
16795533|NCT02367729|37736724|FG000|Overall Study|Adverse Event|1|||
16795534|NCT02367729|37736725|FG001|Overall Study|Adverse Event|2|||
16795535|NCT02367729|37736724|FG000|Overall Study|Withdrawal by Subject|0|||
16795536|NCT02367729|37736725|FG001|Overall Study|Withdrawal by Subject|5|||
16795537|NCT02366637|37736732|FG000|First Intervention Period|Adverse Event|0|||
16795538|NCT02366637|37736733|FG001|First Intervention Period|Adverse Event|1|||
16795539|NCT02366637|37736732|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
16795540|NCT02366637|37736733|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
16795541|NCT02366637|37736732|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
16795542|NCT02366637|37736733|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
16795543|NCT02300103|37736739|FG000|Overall Study|Lack of Efficacy|3|||
16795544|NCT02300103|37736739|FG000|Overall Study|Protocol Violation|1|||
16795545|NCT02300103|37736739|FG000|Overall Study|Withdrew Consent|2|||
16795546|NCT02326467|37736743|FG000|Overall Study|Withdrawal by Subject|1|||
16795547|NCT02299635|37736748|FG000|Overall Study|Adverse Event|2|||
16795548|NCT02299635|37736748|FG000|Overall Study|Death|1|||
16795549|NCT02299635|37736748|FG000|Overall Study|Global deterioration of health status|1|||
16795550|NCT02299635|37736748|FG000|Overall Study|Objective progression or relapse|10|||
16795551|NCT02299635|37736748|FG000|Overall Study|Withdrawal by Subject|2|||
16795552|NCT02299635|37736748|FG000|Overall Study|Other|3|||
16795553|NCT02366091|37736756|FG000|Overall Study|Withdrawal by Subject|3|||
16795554|NCT02366091|37736757|FG001|Overall Study|Withdrawal by Subject|7|||
16795555|NCT02366091|37736758|FG002|Overall Study|Withdrawal by Subject|3|||
16795556|NCT02366091|37736759|FG003|Overall Study|Withdrawal by Subject|1|||
16795557|NCT02326155|37736771|FG000|Overall Study|Adverse Event|21|||
16795558|NCT02326155|37736772|FG001|Overall Study|Adverse Event|5|||
16795559|NCT02326155|37736771|FG000|Overall Study|Death|3|||
16795560|NCT02326155|37736772|FG001|Overall Study|Death|0|||
16795561|NCT02326155|37736771|FG000|Overall Study|Lack of Efficacy|49|||
16795562|NCT02326155|37736772|FG001|Overall Study|Lack of Efficacy|5|||
16795563|NCT02326155|37736771|FG000|Overall Study|Lost to Follow-up|14|||
16795564|NCT02326155|37736772|FG001|Overall Study|Lost to Follow-up|3|||
16795565|NCT02326155|37736771|FG000|Overall Study|Protocol Violation|2|||
16795566|NCT02326155|37736772|FG001|Overall Study|Protocol Violation|0|||
16795567|NCT02326155|37736771|FG000|Overall Study|Withdrawal by Subject|34|||
16795568|NCT02326155|37736772|FG001|Overall Study|Withdrawal by Subject|11|||
16795569|NCT02326155|37736771|FG000|Overall Study|Disease progression|37|||
16795570|NCT02326155|37736772|FG001|Overall Study|Disease progression|4|||
16795571|NCT02326155|37736771|FG000|Overall Study|Study close|188|||
16795572|NCT02326155|37736772|FG001|Overall Study|Study close|21|||
16795573|NCT02326155|37736771|FG000|Overall Study|except for study close|46|||
16795574|NCT02326155|37736772|FG001|Overall Study|except for study close|13|||
16795575|NCT02299167|37736778|FG000|Overall Study|patients were excluded from the study|11|||
16795576|NCT01647711|37736787|FG000|Overall Study|Progressive disease|6|||
16795577|NCT01647711|37736788|FG001|Overall Study|Progressive disease|2|||
16795578|NCT01647711|37736789|FG002|Overall Study|Progressive disease|6|||
16795579|NCT01647711|37736790|FG003|Overall Study|Progressive disease|8|||
16795580|NCT01647711|37736791|FG004|Overall Study|Progressive disease|2|||
16795581|NCT01647711|37736787|FG000|Overall Study|Other adverse event|0|||
16795582|NCT01647711|37736788|FG001|Overall Study|Other adverse event|0|||
16795583|NCT01647711|37736789|FG002|Overall Study|Other adverse event|2|||
16795584|NCT01647711|37736790|FG003|Overall Study|Other adverse event|0|||
17102277|NCT00384293|38241183|FG001|Post-randomization Period|Withdrawal by Subject|8|||
16795585|NCT01647711|37736791|FG004|Overall Study|Other adverse event|2|||
16795586|NCT01647711|37736787|FG000|Overall Study|Protocol Violation|0|||
16795587|NCT01647711|37736788|FG001|Overall Study|Protocol Violation|0|||
16795588|NCT01647711|37736789|FG002|Overall Study|Protocol Violation|0|||
16795589|NCT01647711|37736790|FG003|Overall Study|Protocol Violation|0|||
16795590|NCT01647711|37736791|FG004|Overall Study|Protocol Violation|1|||
16795591|NCT01647711|37736787|FG000|Overall Study|Refused to continue taking medication|0|||
16795592|NCT01647711|37736788|FG001|Overall Study|Refused to continue taking medication|0|||
16795593|NCT01647711|37736789|FG002|Overall Study|Refused to continue taking medication|0|||
16795594|NCT01647711|37736790|FG003|Overall Study|Refused to continue taking medication|2|||
16795595|NCT01647711|37736791|FG004|Overall Study|Refused to continue taking medication|1|||
16795596|NCT01647711|37736787|FG000|Overall Study|Other reason not defined|0|||
16795597|NCT01647711|37736788|FG001|Overall Study|Other reason not defined|1|||
16795598|NCT01647711|37736789|FG002|Overall Study|Other reason not defined|1|||
16795599|NCT01647711|37736790|FG003|Overall Study|Other reason not defined|1|||
16795600|NCT01647711|37736791|FG004|Overall Study|Other reason not defined|0|||
16795601|NCT02540993|37736807|FG000|Overall Study|Lost to Follow-up|5|||
16795602|NCT02540993|37736808|FG001|Overall Study|Lost to Follow-up|3|||
16795603|NCT02540993|37736807|FG000|Overall Study|Withdrawal by Subject|4|||
16795604|NCT02540993|37736808|FG001|Overall Study|Withdrawal by Subject|6|||
16795605|NCT02540993|37736807|FG000|Overall Study|GCP violations|33|||
16795606|NCT02540993|37736808|FG001|Overall Study|GCP violations|27|||
16795607|NCT02547233|37736816|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
16795608|NCT02547233|37736817|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
16795609|NCT02547233|37736816|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
16795610|NCT02547233|37736817|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
16795611|NCT02547233|37736816|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
16795612|NCT02547233|37736817|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
16795613|NCT02547233|37736816|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
16795614|NCT02547233|37736817|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
16795615|NCT02547233|37736816|FG000|12-month Follow-up|Withdrawal by Subject|10|||
16795616|NCT02547233|37736817|FG001|12-month Follow-up|Withdrawal by Subject|10|||
16795617|NCT02547233|37736816|FG000|12-month Follow-up|Lost to Follow-up|3|||
16795618|NCT02547233|37736817|FG001|12-month Follow-up|Lost to Follow-up|3|||
16795619|NCT02547233|37736816|FG000|12-month Follow-up|Lack of Efficacy|1|||
16795620|NCT02547233|37736817|FG001|12-month Follow-up|Lack of Efficacy|2|||
16795621|NCT02547233|37736816|FG000|12-month Follow-up|Protocol Violation|0|||
16795622|NCT02547233|37736817|FG001|12-month Follow-up|Protocol Violation|1|||
16795623|NCT02547233|37736816|FG000|12-month Follow-up|Other|0|||
16795624|NCT02547233|37736817|FG001|12-month Follow-up|Other|1|||
16795625|NCT02546765|37736829|FG000|Overall Study|Withdrawal by Subject|0|||
16795626|NCT02546765|37736830|FG001|Overall Study|Withdrawal by Subject|1|||
16795627|NCT02546765|37736831|FG002|Overall Study|Withdrawal by Subject|0|||
16795628|NCT02546765|37736832|FG003|Overall Study|Withdrawal by Subject|0|||
16795629|NCT02553629|37736855|FG000|Overall Study|Logistic reasons|3|||
16795630|NCT02553629|37736856|FG001|Overall Study|Logistic reasons|6|||
16795631|NCT02546609|37736865|FG000|Overall Study|Withdrawal by Subject|0|||
16795632|NCT02546609|37736866|FG001|Overall Study|Withdrawal by Subject|1|||
16795633|NCT02546609|37736867|FG002|Overall Study|Withdrawal by Subject|2|||
16795634|NCT02546609|37736865|FG000|Overall Study|Adverse Event|0|||
16795635|NCT02546609|37736866|FG001|Overall Study|Adverse Event|6|||
16795636|NCT02546609|37736867|FG002|Overall Study|Adverse Event|1|||
16795637|NCT02546609|37736865|FG000|Overall Study|Protocol Violation|0|||
16795638|NCT02546609|37736866|FG001|Overall Study|Protocol Violation|1|||
16795639|NCT02546609|37736867|FG002|Overall Study|Protocol Violation|1|||
16795640|NCT02546609|37736865|FG000|Overall Study|Lost to Follow-up|2|||
16795641|NCT02546609|37736866|FG001|Overall Study|Lost to Follow-up|3|||
16795642|NCT02546609|37736867|FG002|Overall Study|Lost to Follow-up|1|||
16795643|NCT02546609|37736865|FG000|Overall Study|travel or work schedule restriction|0|||
16795644|NCT02546609|37736866|FG001|Overall Study|travel or work schedule restriction|0|||
16795645|NCT02546609|37736867|FG002|Overall Study|travel or work schedule restriction|2|||
16795646|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
16795647|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
16795648|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
16795649|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
16795650|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
16795651|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
16795652|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Death|1|||
16795653|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Death|3|||
16795654|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
16795655|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
16795656|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
16795657|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
16795658|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
16795659|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
16795660|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
16795661|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
16795662|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
16795663|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
16795664|NCT02553317|37736877|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
16795665|NCT02553317|37736878|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
16795666|NCT02325219|37736888|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
16795667|NCT02325219|37736889|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
16795668|NCT02325219|37736890|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
16795669|NCT02325219|37736891|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
16795670|NCT02325219|37736892|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
16795671|NCT02325219|37736888|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
16795672|NCT02325219|37736889|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
16795673|NCT02325219|37736890|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16795674|NCT02325219|37736891|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16795675|NCT02325219|37736892|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16795676|NCT02325219|37736888|FG000|Controlled Period (Week 0 - 16)|Other|0|||
16795677|NCT02325219|37736889|FG001|Controlled Period (Week 0 - 16)|Other|0|||
16795678|NCT02325219|37736890|FG002|Controlled Period (Week 0 - 16)|Other|1|||
16795679|NCT02325219|37736891|FG003|Controlled Period (Week 0 - 16)|Other|0|||
16795680|NCT02325219|37736892|FG004|Controlled Period (Week 0 - 16)|Other|0|||
16795681|NCT02325219|37736888|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16795682|NCT02325219|37736889|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16795683|NCT02325219|37736890|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16795684|NCT02325219|37736891|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16795685|NCT02325219|37736892|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
16795686|NCT02325219|37736888|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
16795687|NCT02325219|37736889|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
16795688|NCT02325219|37736890|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
16795689|NCT02325219|37736891|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
16795690|NCT02325219|37736892|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
16795691|NCT02325219|37736888|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16795692|NCT02325219|37736889|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
16795693|NCT02325219|37736890|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16795694|NCT02325219|37736891|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16795695|NCT02325219|37736892|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16795696|NCT02297841|37736908|FG000|Overall Study|Withdrawal by Subject|1|||
16795697|NCT02297841|37736908|FG000|Overall Study|Protocol Violation|7|||
16795698|NCT02365467|37736912|FG000|Overall Study|Death|3|||
16795699|NCT02324361|37736918|FG000|Overall Study|Lost to Follow-up|5|||
16795700|NCT02324361|37736919|FG001|Overall Study|Lost to Follow-up|2|||
16795701|NCT02365233|37736928|FG000|Overall Study|IRB withheld the data|1|||
16795702|NCT02365233|37736929|FG001|Overall Study|IRB withheld the data|2|||
16795703|NCT02365233|37736930|FG002|Overall Study|IRB withheld the data|2|||
16795704|NCT02324205|37736938|FG000|Overall Study|Withdrawal by Subject|37|||
16795705|NCT02324049|37736942|FG000|Part C|Study terminated|11|||
16795706|NCT02364999|37736948|FG000|Overall Study|Death|136|||
16795707|NCT02364999|37736949|FG001|Overall Study|Death|138|||
16795708|NCT02364999|37736948|FG000|Overall Study|Lost to Follow-up|10|||
16795709|NCT02364999|37736949|FG001|Overall Study|Lost to Follow-up|15|||
16795710|NCT02364999|37736948|FG000|Overall Study|Protocol Violation|3|||
16795711|NCT02364999|37736949|FG001|Overall Study|Protocol Violation|2|||
16795712|NCT02364999|37736948|FG000|Overall Study|Withdrawal by Subject|14|||
16795713|NCT02364999|37736949|FG001|Overall Study|Withdrawal by Subject|14|||
16795714|NCT02364999|37736948|FG000|Overall Study|Other|0|||
16795715|NCT02364999|37736949|FG001|Overall Study|Other|1|||
16795716|NCT02364999|37736948|FG000|Overall Study|Randomized but did not receive treatment|2|||
16795717|NCT02364999|37736949|FG001|Overall Study|Randomized but did not receive treatment|3|||
16795718|NCT02322879|37736958|FG000|First Intervention|Physician Decision|1|||
16795719|NCT02322879|37736959|FG001|First Intervention|Physician Decision|0|||
16795720|NCT02322411|37736967|FG000|Overall Study|Lost to Follow-up|4|||
16795721|NCT02322411|37736968|FG001|Overall Study|Lost to Follow-up|7|||
16795722|NCT02322411|37736967|FG000|Overall Study|Withdrawal by Subject|1|||
16795723|NCT02322411|37736968|FG001|Overall Study|Withdrawal by Subject|0|||
16795724|NCT02322021|37736978|FG000|Core Phase|Adverse Event|1|||
16795725|NCT02322021|37736979|FG001|Core Phase|Adverse Event|3|||
16795726|NCT02322021|37736980|FG002|Core Phase|Adverse Event|4|||
16795727|NCT02322021|37736981|FG003|Core Phase|Adverse Event|2|||
16795728|NCT02322021|37736982|FG004|Core Phase|Adverse Event|0|||
16795729|NCT02322021|37736978|FG000|Core Phase|Participant Choice|4|||
16795730|NCT02322021|37736979|FG001|Core Phase|Participant Choice|5|||
16795731|NCT02322021|37736980|FG002|Core Phase|Participant Choice|4|||
16795732|NCT02322021|37736981|FG003|Core Phase|Participant Choice|2|||
16795733|NCT02322021|37736982|FG004|Core Phase|Participant Choice|0|||
16795734|NCT02322021|37736978|FG000|Core Phase|Lost to Follow-up|0|||
16795735|NCT02322021|37736979|FG001|Core Phase|Lost to Follow-up|0|||
16795736|NCT02322021|37736980|FG002|Core Phase|Lost to Follow-up|0|||
16795737|NCT02322021|37736981|FG003|Core Phase|Lost to Follow-up|1|||
16795738|NCT02322021|37736982|FG004|Core Phase|Lost to Follow-up|0|||
16795739|NCT02322021|37736978|FG000|Core Phase|Other|0|||
16795740|NCT02322021|37736979|FG001|Core Phase|Other|0|||
16795741|NCT02322021|37736980|FG002|Core Phase|Other|1|||
16795742|NCT02322021|37736981|FG003|Core Phase|Other|0|||
16795743|NCT02322021|37736982|FG004|Core Phase|Other|0|||
16795744|NCT02322021|37736978|FG000|Extension Phase|Adverse Event|0|||
16795745|NCT02322021|37736979|FG001|Extension Phase|Adverse Event|0|||
16795746|NCT02322021|37736980|FG002|Extension Phase|Adverse Event|0|||
16795747|NCT02322021|37736981|FG003|Extension Phase|Adverse Event|0|||
16795748|NCT02322021|37736982|FG004|Extension Phase|Adverse Event|3|||
16795749|NCT02322021|37736978|FG000|Extension Phase|Participant Choice|0|||
16795750|NCT02322021|37736979|FG001|Extension Phase|Participant Choice|0|||
16795751|NCT02322021|37736980|FG002|Extension Phase|Participant Choice|0|||
16795752|NCT02322021|37736981|FG003|Extension Phase|Participant Choice|0|||
16795753|NCT02322021|37736982|FG004|Extension Phase|Participant Choice|6|||
16795754|NCT02322021|37736978|FG000|Extension Phase|Other|0|||
16795755|NCT02322021|37736979|FG001|Extension Phase|Other|0|||
16795756|NCT02322021|37736980|FG002|Extension Phase|Other|0|||
16795757|NCT02322021|37736981|FG003|Extension Phase|Other|0|||
16795758|NCT02322021|37736982|FG004|Extension Phase|Other|3|||
16795759|NCT02322021|37736978|FG000|Extension Phase|Lost to Follow-up|0|||
16795760|NCT02322021|37736979|FG001|Extension Phase|Lost to Follow-up|0|||
16795761|NCT02322021|37736980|FG002|Extension Phase|Lost to Follow-up|0|||
16795762|NCT02322021|37736981|FG003|Extension Phase|Lost to Follow-up|0|||
16795763|NCT02322021|37736982|FG004|Extension Phase|Lost to Follow-up|1|||
16795764|NCT02322021|37736978|FG000|Extension Phase|Study terminated by sponsor|0|||
16795765|NCT02322021|37736979|FG001|Extension Phase|Study terminated by sponsor|0|||
16795766|NCT02322021|37736980|FG002|Extension Phase|Study terminated by sponsor|0|||
16795767|NCT02322021|37736981|FG003|Extension Phase|Study terminated by sponsor|0|||
16795768|NCT02322021|37736982|FG004|Extension Phase|Study terminated by sponsor|28|||
16795769|NCT02363439|37736997|FG000|Overall Study|Lack of Efficacy|4|||
16795770|NCT02363283|37737001|FG000|Overall Study|Withdrawal by Subject|1|||
16795771|NCT02363283|37737001|FG000|Overall Study|Not eligible due to transaminitis|1|||
16795772|NCT02321319|37737005|FG000|Overall Study|Product discontinued|5|||
16795773|NCT02294175|37737011|FG000|Overall Study|Withdrawal by Subject|1|||
16795774|NCT02294175|37737012|FG001|Overall Study|Withdrawal by Subject|2|||
16795775|NCT02294175|37737011|FG000|Overall Study|pt taking excluded medication|3|||
16795776|NCT02294175|37737012|FG001|Overall Study|pt taking excluded medication|1|||
16795777|NCT02294175|37737011|FG000|Overall Study|Protocol Violation|1|||
16795778|NCT02294175|37737012|FG001|Overall Study|Protocol Violation|0|||
16795779|NCT02294175|37737011|FG000|Overall Study|Lost to Follow-up|0|||
16795780|NCT02294175|37737012|FG001|Overall Study|Lost to Follow-up|1|||
16795781|NCT02294175|37737011|FG000|Overall Study|wound healed|0|||
16795782|NCT02294175|37737012|FG001|Overall Study|wound healed|2|||
16795783|NCT02088541|37737023|FG000|Overall Study|Adverse Event|3|||
16795784|NCT02088541|37737024|FG001|Overall Study|Adverse Event|0|||
16795785|NCT02088541|37737025|FG002|Overall Study|Adverse Event|3|||
16795786|NCT02088541|37737026|FG003|Overall Study|Adverse Event|3|||
16795787|NCT02088541|37737027|FG004|Overall Study|Adverse Event|0|||
16795788|NCT02088541|37737023|FG000|Overall Study|Death|51|||
16795789|NCT02088541|37737024|FG001|Overall Study|Death|21|||
16795790|NCT02088541|37737025|FG002|Overall Study|Death|85|||
16795791|NCT02088541|37737026|FG003|Overall Study|Death|28|||
16795792|NCT02088541|37737027|FG004|Overall Study|Death|38|||
16795793|NCT02088541|37737023|FG000|Overall Study|Lost to Follow-up|2|||
16795794|NCT02088541|37737024|FG001|Overall Study|Lost to Follow-up|0|||
16795795|NCT02088541|37737025|FG002|Overall Study|Lost to Follow-up|1|||
16795796|NCT02088541|37737026|FG003|Overall Study|Lost to Follow-up|0|||
16795797|NCT02088541|37737027|FG004|Overall Study|Lost to Follow-up|0|||
16795798|NCT02088541|37737023|FG000|Overall Study|Physician Decision|2|||
16795799|NCT02088541|37737024|FG001|Overall Study|Physician Decision|1|||
16795800|NCT02088541|37737025|FG002|Overall Study|Physician Decision|2|||
16795801|NCT02088541|37737026|FG003|Overall Study|Physician Decision|0|||
16795802|NCT02088541|37737027|FG004|Overall Study|Physician Decision|2|||
16795803|NCT02088541|37737023|FG000|Overall Study|Disease progression|7|||
16795804|NCT02088541|37737024|FG001|Overall Study|Disease progression|1|||
16795805|NCT02088541|37737025|FG002|Overall Study|Disease progression|2|||
16795806|NCT02088541|37737026|FG003|Overall Study|Disease progression|3|||
16795807|NCT02088541|37737027|FG004|Overall Study|Disease progression|1|||
16795808|NCT02088541|37737023|FG000|Overall Study|Study terminated by sponsor|1|||
16795809|NCT02088541|37737024|FG001|Overall Study|Study terminated by sponsor|1|||
16795810|NCT02088541|37737025|FG002|Overall Study|Study terminated by sponsor|12|||
16795811|NCT02088541|37737026|FG003|Overall Study|Study terminated by sponsor|2|||
16795812|NCT02088541|37737027|FG004|Overall Study|Study terminated by sponsor|6|||
16795813|NCT02088541|37737023|FG000|Overall Study|Withdrawal by Subject|3|||
16795814|NCT02088541|37737024|FG001|Overall Study|Withdrawal by Subject|2|||
16795815|NCT02088541|37737025|FG002|Overall Study|Withdrawal by Subject|9|||
16795816|NCT02088541|37737026|FG003|Overall Study|Withdrawal by Subject|7|||
16795817|NCT02088541|37737027|FG004|Overall Study|Withdrawal by Subject|10|||
16795818|NCT02088541|37737023|FG000|Overall Study|Other|2|||
16795819|NCT02088541|37737024|FG001|Overall Study|Other|1|||
16795820|NCT02088541|37737025|FG002|Overall Study|Other|3|||
16795821|NCT02088541|37737026|FG003|Overall Study|Other|1|||
16795822|NCT02088541|37737027|FG004|Overall Study|Other|1|||
16795823|NCT02294019|37737037|FG000|Overall Study|Adverse Event|2|||
16795824|NCT02294019|37737037|FG000|Overall Study|Protocol Violation|68|||
16795825|NCT02294019|37737037|FG000|Overall Study|Lost to Follow-up|31|||
16795826|NCT02294019|37737037|FG000|Overall Study|Other|1|||
16795827|NCT02294019|37737037|FG000|Overall Study|Withdrawal by Subject|1|||
16795828|NCT02320149|37737043|FG000|Overall Study|Adverse Event|3|||
16795829|NCT02320149|37737044|FG001|Overall Study|Adverse Event|7|||
16795830|NCT02320149|37737043|FG000|Overall Study|Withdrawal of Consent|28|||
16795831|NCT02320149|37737044|FG001|Overall Study|Withdrawal of Consent|32|||
16795832|NCT02320149|37737043|FG000|Overall Study|Lost to Follow-up|21|||
16795833|NCT02320149|37737044|FG001|Overall Study|Lost to Follow-up|34|||
16795834|NCT02320149|37737043|FG000|Overall Study|Protocol Violation|2|||
16795835|NCT02320149|37737044|FG001|Overall Study|Protocol Violation|1|||
16795836|NCT02320149|37737043|FG000|Overall Study|Noncompliance with Study Treatment|7|||
16795837|NCT02320149|37737044|FG001|Overall Study|Noncompliance with Study Treatment|2|||
16795838|NCT02320149|37737043|FG000|Overall Study|Lack of Efficacy|0|||
16795839|NCT02320149|37737044|FG001|Overall Study|Lack of Efficacy|1|||
16795840|NCT02320149|37737043|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16795841|NCT02320149|37737044|FG001|Overall Study|Other Miscellaneous Reasons|3|||
16795842|NCT02540083|37737050|FG000|Overall Study|Withdrawal by Subject|16|||
16795843|NCT02293863|37737057|FG000|Overall Study|Death|4|||
16795844|NCT02293863|37737058|FG001|Overall Study|Death|6|||
16795845|NCT02293863|37737059|FG002|Overall Study|Death|4|||
16795846|NCT02293863|37737057|FG000|Overall Study|Lost to Follow-up|2|||
16795847|NCT02293863|37737058|FG001|Overall Study|Lost to Follow-up|2|||
16795848|NCT02293863|37737059|FG002|Overall Study|Lost to Follow-up|2|||
16795849|NCT02293863|37737057|FG000|Overall Study|Withdrawal by Subject|3|||
16795850|NCT02293863|37737058|FG001|Overall Study|Withdrawal by Subject|3|||
16795851|NCT02293863|37737059|FG002|Overall Study|Withdrawal by Subject|1|||
16795852|NCT02293863|37737057|FG000|Overall Study|Reason Not Specified|0|||
16795853|NCT02293863|37737058|FG001|Overall Study|Reason Not Specified|2|||
16795854|NCT02293863|37737059|FG002|Overall Study|Reason Not Specified|2|||
16795855|NCT02293395|37737071|FG000|Overall Study|Lost to Follow-up|1|||
16795856|NCT02293395|37737072|FG001|Overall Study|Lost to Follow-up|0|||
16795857|NCT02293395|37737071|FG000|Overall Study|Withdrawal by Subject|8|||
16795858|NCT02293395|37737072|FG001|Overall Study|Withdrawal by Subject|7|||
16795859|NCT02025985|37737083|FG000|Overall Study|Consent withdrawn|0|||
16795860|NCT02025985|37737084|FG001|Overall Study|Consent withdrawn|0|||
16795861|NCT02025985|37737085|FG002|Overall Study|Consent withdrawn|1|||
16795862|NCT02025985|37737086|FG003|Overall Study|Consent withdrawn|0|||
16795863|NCT02025985|37737087|FG004|Overall Study|Consent withdrawn|0|||
16795864|NCT02025985|37737083|FG000|Overall Study|Termination of study by Sponsor|4|||
16795865|NCT02025985|37737084|FG001|Overall Study|Termination of study by Sponsor|3|||
16795866|NCT02025985|37737085|FG002|Overall Study|Termination of study by Sponsor|1|||
16795867|NCT02025985|37737086|FG003|Overall Study|Termination of study by Sponsor|1|||
16795868|NCT02025985|37737087|FG004|Overall Study|Termination of study by Sponsor|3|||
16795869|NCT02025985|37737083|FG000|Overall Study|Death|21|||
16795870|NCT02025985|37737084|FG001|Overall Study|Death|20|||
16795871|NCT02025985|37737085|FG002|Overall Study|Death|23|||
16795872|NCT02025985|37737086|FG003|Overall Study|Death|20|||
16795873|NCT02025985|37737087|FG004|Overall Study|Death|17|||
16795874|NCT02528305|37737101|FG000|Overall Study|Withdrawal by Subject|1|||
16795875|NCT02528305|37737101|FG000|Overall Study|Adverse Event|1|||
16795876|NCT02528305|37737101|FG000|Overall Study|Physician Decision|1|||
16795877|NCT02532517|37737107|FG000|Overall Study|Did not complete 24-Month visit|4|||
16795878|NCT02532517|37737107|FG000|Overall Study|Failed Angiographic eligibility|1|||
16795879|NCT02532517|37737107|FG000|Overall Study|Lost to Follow-up|4|||
16795880|NCT02532517|37737107|FG000|Overall Study|Withdrawal by Subject|4|||
16795881|NCT02532517|37737107|FG000|Overall Study|Death|4|||
16795882|NCT02545049|37737113|FG000|Overall Study|Withdrawal by Subject|1|||
16795883|NCT02545049|37737114|FG001|Overall Study|Withdrawal by Subject|7|||
16795884|NCT02545049|37737113|FG000|Overall Study|Lost to Follow-up|4|||
16795885|NCT02545049|37737114|FG001|Overall Study|Lost to Follow-up|6|||
16795886|NCT02545049|37737113|FG000|Overall Study|GCP violations|37|||
16795887|NCT02545049|37737114|FG001|Overall Study|GCP violations|48|||
16795888|NCT02532283|37737122|FG000|Overall Study|Adverse Event|0|||
16795889|NCT02532283|37737123|FG001|Overall Study|Adverse Event|1|||
16795890|NCT02532283|37737122|FG000|Overall Study|Death|1|||
16795891|NCT02532283|37737123|FG001|Overall Study|Death|0|||
16795892|NCT02532283|37737122|FG000|Overall Study|Lost to Follow-up|0|||
16795893|NCT02532283|37737123|FG001|Overall Study|Lost to Follow-up|1|||
16795894|NCT02532283|37737122|FG000|Overall Study|Withdrawal by Subject|8|||
16795895|NCT02532283|37737123|FG001|Overall Study|Withdrawal by Subject|3|||
16795896|NCT01349959|37737144|FG000|Overall Study|Adverse Event|7|||
16795897|NCT01295125|37737164|FG000|Overall Study|Study stopped prematurely|9|||
16795898|NCT02540291|37737172|FG000|Overall Study|Death|7|||
16795899|NCT02540291|37737173|FG001|Overall Study|Death|7|||
16795900|NCT02540291|37737174|FG002|Overall Study|Death|5|||
16795901|NCT02540291|37737175|FG003|Overall Study|Death|7|||
16795902|NCT02540291|37737172|FG000|Overall Study|Lost to Follow-up|0|||
16795903|NCT02540291|37737173|FG001|Overall Study|Lost to Follow-up|0|||
16795904|NCT02540291|37737174|FG002|Overall Study|Lost to Follow-up|1|||
16795905|NCT02540291|37737175|FG003|Overall Study|Lost to Follow-up|0|||
16795906|NCT02540291|37737172|FG000|Overall Study|Withdrawal Of Consent|0|||
16795907|NCT02540291|37737173|FG001|Overall Study|Withdrawal Of Consent|1|||
16795908|NCT02540291|37737174|FG002|Overall Study|Withdrawal Of Consent|0|||
16795909|NCT02540291|37737175|FG003|Overall Study|Withdrawal Of Consent|0|||
16795910|NCT02540291|37737172|FG000|Overall Study|Study Terminated By Sponsor|1|||
16795911|NCT02540291|37737173|FG001|Overall Study|Study Terminated By Sponsor|0|||
16795912|NCT02540291|37737174|FG002|Overall Study|Study Terminated By Sponsor|0|||
16795913|NCT02540291|37737175|FG003|Overall Study|Study Terminated By Sponsor|0|||
16795914|NCT02540291|37737172|FG000|Overall Study|Other|0|||
16795915|NCT02540291|37737173|FG001|Overall Study|Other|0|||
16795916|NCT02540291|37737174|FG002|Overall Study|Other|1|||
16795917|NCT02540291|37737175|FG003|Overall Study|Other|0|||
16795918|NCT02540213|37737187|FG000|Overall Study|Death/adverse event|18|||
16795919|NCT02540213|37737187|FG000|Overall Study|Administrative reasons|3|||
16795920|NCT02540213|37737187|FG000|Overall Study|Kidney transplant|3|||
16795921|NCT02540213|37737187|FG000|Overall Study|Lack of Efficacy|6|||
16795922|NCT02540213|37737187|FG000|Overall Study|Consent withdrawn|7|||
16795923|NCT02540213|37737187|FG000|Overall Study|Enrolled but not treated|2|||
16795924|NCT02544503|37737193|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
16795925|NCT02544503|37737194|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
16795926|NCT02544503|37737193|FG000|Overall Study|Lost to Follow-up|9|||
16795927|NCT02544503|37737194|FG001|Overall Study|Lost to Follow-up|0|||
16795928|NCT02544503|37737193|FG000|Overall Study|Withdrawal by Subject|1|||
16795929|NCT02544503|37737194|FG001|Overall Study|Withdrawal by Subject|0|||
16795930|NCT02552303|37737204|FG000|Allocation|Withdrawal by Subject|2|||
16795931|NCT02552303|37737205|FG001|Allocation|Withdrawal by Subject|1|||
16795932|NCT02552303|37737206|FG002|Allocation|Withdrawal by Subject|1|||
16795933|NCT02552303|37737207|FG003|Allocation|Withdrawal by Subject|1|||
16795934|NCT02552303|37737204|FG000|Allocation|ineligible|1|||
16795935|NCT02552303|37737205|FG001|Allocation|ineligible|1|||
16795936|NCT02552303|37737206|FG002|Allocation|ineligible|0|||
16795937|NCT02552303|37737207|FG003|Allocation|ineligible|0|||
16795938|NCT02552303|37737204|FG000|Follow-Up|Lost to Follow-up|0|||
16795939|NCT02552303|37737205|FG001|Follow-Up|Lost to Follow-up|0|||
16795940|NCT02552303|37737206|FG002|Follow-Up|Lost to Follow-up|1|||
16795941|NCT02552303|37737207|FG003|Follow-Up|Lost to Follow-up|0|||
16795942|NCT02552303|37737204|FG000|Follow-Up|ineligible|0|||
16795943|NCT02552303|37737205|FG001|Follow-Up|ineligible|2|||
16795944|NCT02552303|37737206|FG002|Follow-Up|ineligible|0|||
16795945|NCT02552303|37737207|FG003|Follow-Up|ineligible|0|||
16795946|NCT01660711|37737217|FG000|Overall Study|Adverse Event|7|||
16795947|NCT01660711|37737217|FG000|Overall Study|Withdrawal by Subject|1|||
16795948|NCT02544113|37737223|FG000|Overall Study|Death|3|||
16795949|NCT02544113|37737224|FG001|Overall Study|Death|4|||
16795950|NCT02538965|37737230|FG000|Treatment Period|Other = Death due to disease progression|1|||
16795951|NCT02538965|37737230|FG000|Treatment Period|Adverse Event|2|||
16795952|NCT02538965|37737230|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
16795953|NCT02538965|37737230|FG000|Treatment Period|Treatment Failure|9|||
16795954|NCT02538965|37737230|FG000|Treatment Period|Disease Progression|1|||
16795955|NCT02538965|37737230|FG000|Treatment Period|Physician Decision|2|||
16795956|NCT02538965|37737230|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
16795957|NCT02538965|37737230|FG000|Follow-Up Period|Withdrawal by Parent|4|||
16795958|NCT02543801|37737238|FG000|Overall Study|Protocol Violation|1|||
16795959|NCT02543801|37737239|FG001|Overall Study|Protocol Violation|2|||
16795960|NCT02543801|37737240|FG002|Overall Study|Protocol Violation|0|||
16795961|NCT02543801|37737241|FG003|Overall Study|Protocol Violation|0|||
16795962|NCT02537431|37737251|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
16795963|NCT02470091|37737257|FG000|Overall Study|Withdrawal by Subject|1|||
16795964|NCT02470091|37737258|FG001|Overall Study|Withdrawal by Subject|0|||
16795965|NCT02470091|37737257|FG000|Overall Study|Ineligible|0|||
16795966|NCT02470091|37737258|FG001|Overall Study|Ineligible|2|||
16795967|NCT02362503|37737269|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
16795968|NCT02362503|37737270|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
16795969|NCT02362503|37737271|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
16795970|NCT02362503|37737269|FG000|Double-blind Period-Up to 8 Days|Death|1|||
16795971|NCT02362503|37737270|FG001|Double-blind Period-Up to 8 Days|Death|0|||
16795972|NCT02362503|37737271|FG002|Double-blind Period-Up to 8 Days|Death|0|||
16795973|NCT02362503|37737269|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
16795974|NCT02362503|37737270|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
16795975|NCT02362503|37737271|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
16795976|NCT02362503|37737269|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
16795977|NCT02362503|37737270|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
16795978|NCT02362503|37737271|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
16795979|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
16795980|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
16795981|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
16795982|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
16795983|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
16795984|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
16795985|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
17102278|NCT00384293|38241184|FG002|Post-randomization Period|Withdrawal by Subject|6|||
17016507|NCT00855920|38161101|FG001|Overall Study|Other than specified above|1|||
17016508|NCT00855920|38161102|FG002|Overall Study|Other than specified above|1|||
17102279|NCT00384293|38241182|FG000|Post-randomization Period|Trial Termination|0|||
16795986|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
16795987|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
16795988|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
16795989|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
16795990|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
16795991|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
16795992|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
16795993|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
16795994|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
16795995|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
16795996|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
16795997|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
16795998|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
16795999|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
16796000|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
16796001|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
16796002|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
16796003|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
16796004|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
16796005|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
16796006|NCT02362503|37737269|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
16796007|NCT02362503|37737270|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
16796008|NCT02362503|37737271|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
16796009|NCT02535065|37737282|FG000|Overall Study|Death|13|||
16796010|NCT02535065|37737282|FG000|Overall Study|Lost to Follow-up|1|||
16796011|NCT02535065|37737282|FG000|Overall Study|Withdrawal by Subject|6|||
16796012|NCT02530619|37737286|FG000|Registered for Study|Withdrawal by Subject|2|||
16796013|NCT02530619|37737286|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
16796014|NCT02530619|37737286|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
16796015|NCT02530619|37737286|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
16796016|NCT02530619|37737286|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
16796017|NCT02530619|37737286|FG000|Follow-up Period (6 Months)|Death|4|||
16796018|NCT02530619|37737286|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
16796019|NCT02530619|37737286|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
16796020|NCT02530385|37737292|FG000|Overall Study|Withdrawal by Subject|0|||
16796021|NCT02530385|37737293|FG001|Overall Study|Withdrawal by Subject|1|||
16796022|NCT02362425|37737303|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
16796023|NCT02362425|37737304|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
16796024|NCT02362425|37737305|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
16796025|NCT02362425|37737306|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
16796026|NCT02362425|37737303|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
16796027|NCT02362425|37737304|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
16796028|NCT02362425|37737305|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
16909133|NCT01725750|38017962|FG001|Overall Study|Withdrawal by Subject|9|||
17016509|NCT00848042|38161113|FG000|Overall Study|Death|1|||
17102280|NCT00384293|38241183|FG001|Post-randomization Period|Trial Termination|180|||
17102281|NCT00384293|38241184|FG002|Post-randomization Period|Trial Termination|204|||
17102282|NCT00384293|38241182|FG000|Post-randomization Period|Patient Randomized in Error|0|||
17102283|NCT00384293|38241183|FG001|Post-randomization Period|Patient Randomized in Error|0|||
17102284|NCT00384293|38241184|FG002|Post-randomization Period|Patient Randomized in Error|1|||
17102285|NCT00067002|38241194|FG000|Overall Study|Early Death|1|||
16796029|NCT02362425|37737306|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
16796030|NCT02362425|37737303|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
16796031|NCT02362425|37737304|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
16796032|NCT02362425|37737305|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
16796033|NCT02362425|37737306|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
16796034|NCT02362425|37737303|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
16796035|NCT02362425|37737304|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
16796036|NCT02362425|37737305|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
16796037|NCT02362425|37737306|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
16796038|NCT02362425|37737303|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
16796039|NCT02362425|37737304|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
16796040|NCT02362425|37737305|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
16796041|NCT02362425|37737306|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
16796042|NCT02362425|37737303|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
16796043|NCT02362425|37737304|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
16796044|NCT02362425|37737305|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
16796045|NCT02362425|37737306|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
16796046|NCT02362425|37737303|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
16796047|NCT02362425|37737304|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
16796048|NCT02362425|37737305|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
16796049|NCT02362425|37737306|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
16796050|NCT02362425|37737303|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
16796051|NCT02362425|37737304|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
16796052|NCT02362425|37737305|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
16796053|NCT02362425|37737306|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
16796054|NCT02362269|37737319|FG000|Overall Study|Moved|1|||
16796055|NCT02362269|37737320|FG001|Overall Study|Moved|0|||
16796056|NCT02362269|37737319|FG000|Overall Study|Lost to Follow-up|0|||
16796057|NCT02362269|37737320|FG001|Overall Study|Lost to Follow-up|6|||
16796058|NCT02529995|37737328|FG000|Part A|Ongoing Study at Data Cut-off|14|||
16796059|NCT02529995|37737329|FG001|Part A|Ongoing Study at Data Cut-off|16|||
16796060|NCT02529995|37737328|FG000|Part A|Discontinued Study|1|||
16796061|NCT02529995|37737329|FG001|Part A|Discontinued Study|0|||
16796062|NCT02529995|37737328|FG000|Part B|Ongoing Study at Data Cut-off|0|||
16796063|NCT02529995|37737329|FG001|Part B|Ongoing Study at Data Cut-off|7|||
16796064|NCT02529995|37737328|FG000|Part B|Discontinued Study|6|||
16796065|NCT02529995|37737329|FG001|Part B|Discontinued Study|5|||
16796066|NCT02529137|37737335|FG000|Overall Study|Discontinuation for different reasons|8|||
16796067|NCT02319759|37737342|FG000|Week 0 - 16|Lack of Efficacy|1|||
16796068|NCT02319759|37737343|FG001|Week 0 - 16|Lack of Efficacy|0|||
16796069|NCT02319759|37737344|FG002|Week 0 - 16|Lack of Efficacy|0|||
16796070|NCT02319759|37737345|FG003|Week 0 - 16|Lack of Efficacy|0|||
16796071|NCT02319759|37737346|FG004|Week 0 - 16|Lack of Efficacy|0|||
16796072|NCT02319759|37737342|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
16796073|NCT02319759|37737343|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
16796074|NCT02319759|37737344|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
16796075|NCT02319759|37737345|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
16796076|NCT02319759|37737346|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
16796077|NCT02319759|37737342|FG000|Week 16 - 24|Lack of Efficacy|1|||
16796078|NCT02319759|37737343|FG001|Week 16 - 24|Lack of Efficacy|0|||
16796079|NCT02319759|37737344|FG002|Week 16 - 24|Lack of Efficacy|1|||
16796080|NCT02319759|37737345|FG003|Week 16 - 24|Lack of Efficacy|0|||
16796081|NCT02319759|37737346|FG004|Week 16 - 24|Lack of Efficacy|0|||
16796082|NCT02319759|37737342|FG000|Week 16 - 24|Lost to Follow-up|1|||
16796083|NCT02319759|37737343|FG001|Week 16 - 24|Lost to Follow-up|0|||
16796084|NCT02319759|37737344|FG002|Week 16 - 24|Lost to Follow-up|0|||
16796085|NCT02319759|37737345|FG003|Week 16 - 24|Lost to Follow-up|0|||
16796086|NCT02319759|37737346|FG004|Week 16 - 24|Lost to Follow-up|0|||
16796087|NCT02319759|37737342|FG000|Week 16 - 24|Withdrawal by Subject|0|||
16796088|NCT02319759|37737343|FG001|Week 16 - 24|Withdrawal by Subject|0|||
16796089|NCT02319759|37737344|FG002|Week 16 - 24|Withdrawal by Subject|2|||
16796090|NCT02319759|37737345|FG003|Week 16 - 24|Withdrawal by Subject|0|||
16796091|NCT02319759|37737346|FG004|Week 16 - 24|Withdrawal by Subject|0|||
16796092|NCT02319759|37737342|FG000|Week 24 - 56|Adverse Event|0|||
16796093|NCT02319759|37737343|FG001|Week 24 - 56|Adverse Event|0|||
16796094|NCT02319759|37737344|FG002|Week 24 - 56|Adverse Event|2|||
16796095|NCT02319759|37737345|FG003|Week 24 - 56|Adverse Event|0|||
16796096|NCT02319759|37737346|FG004|Week 24 - 56|Adverse Event|0|||
16796097|NCT02319759|37737342|FG000|Week 24 - 56|Lack of Efficacy|0|||
16796098|NCT02319759|37737343|FG001|Week 24 - 56|Lack of Efficacy|0|||
16796099|NCT02319759|37737344|FG002|Week 24 - 56|Lack of Efficacy|0|||
16796100|NCT02319759|37737345|FG003|Week 24 - 56|Lack of Efficacy|2|||
16796101|NCT02319759|37737346|FG004|Week 24 - 56|Lack of Efficacy|1|||
16796102|NCT02319759|37737342|FG000|Week 24 - 56|Withdrawal by Subject|0|||
16796103|NCT02319759|37737343|FG001|Week 24 - 56|Withdrawal by Subject|1|||
16796104|NCT02319759|37737344|FG002|Week 24 - 56|Withdrawal by Subject|0|||
16796105|NCT02319759|37737345|FG003|Week 24 - 56|Withdrawal by Subject|0|||
16796106|NCT02319759|37737346|FG004|Week 24 - 56|Withdrawal by Subject|0|||
16796107|NCT02319759|37737342|FG000|Week 24 - 56|Lost to Follow-up|0|||
16796108|NCT02319759|37737343|FG001|Week 24 - 56|Lost to Follow-up|0|||
16796109|NCT02319759|37737344|FG002|Week 24 - 56|Lost to Follow-up|0|||
16796110|NCT02319759|37737345|FG003|Week 24 - 56|Lost to Follow-up|0|||
16796111|NCT02319759|37737346|FG004|Week 24 - 56|Lost to Follow-up|1|||
16796112|NCT02293005|37737359|FG000|Overall Study|Adverse Event|2|||
16796113|NCT02293005|37737359|FG000|Overall Study|Death|4|||
16796114|NCT02293005|37737359|FG000|Overall Study|Lost to Follow-up|1|||
16796115|NCT02293005|37737359|FG000|Overall Study|Withdrawal by Subject|2|||
16796116|NCT02293005|37737359|FG000|Overall Study|Progression|17|||
16796117|NCT02319525|37737365|FG000|Overall Study|Withdrawal by Subject|2|||
16796118|NCT02319525|37737366|FG001|Overall Study|Withdrawal by Subject|1|||
16796119|NCT02292927|37737374|FG000|Overall Study|Protocol Violation|13|||
16796120|NCT02292927|37737375|FG001|Overall Study|Protocol Violation|7|||
16796121|NCT02292849|37737387|FG000|Overall Study|Lost to Follow-up|0|||
16796122|NCT02292849|37737388|FG001|Overall Study|Lost to Follow-up|2|||
16796123|NCT02292849|37737389|FG002|Overall Study|Lost to Follow-up|2|||
16796124|NCT02292849|37737387|FG000|Overall Study|Physician Decision|4|||
16796125|NCT02292849|37737388|FG001|Overall Study|Physician Decision|0|||
16796126|NCT02292849|37737389|FG002|Overall Study|Physician Decision|0|||
16796127|NCT02318667|37737397|FG000|Overall Study|Adverse Event|1|||
16796128|NCT02318667|37737397|FG000|Overall Study|Lack of Efficacy|6|||
16796129|NCT02318667|37737397|FG000|Overall Study|Protocol Violation|2|||
16796130|NCT02292771|37737407|FG000|Overall Study|Withdrawal by Subject|2|||
16796131|NCT02292771|37737408|FG001|Overall Study|Withdrawal by Subject|1|||
16796132|NCT02292771|37737407|FG000|Overall Study|Lost to Follow-up|2|||
16796133|NCT02292771|37737408|FG001|Overall Study|Lost to Follow-up|1|||
16796134|NCT02291913|37737418|FG000|Overall Study|Progressive Disease|32|||
16796135|NCT02291913|37737418|FG000|Overall Study|Adverse Event|11|||
16796136|NCT02291913|37737418|FG000|Overall Study|Death|2|||
16796137|NCT02291913|37737418|FG000|Overall Study|Physician Decision|1|||
16796138|NCT02291913|37737418|FG000|Overall Study|Withdrawal by Subject|1|||
16796139|NCT02291913|37737418|FG000|Overall Study|Protocol Violation|1|||
16796140|NCT02291679|37737425|FG000|Overall Study|Adverse Event|2|||
16796141|NCT02291679|37737426|FG001|Overall Study|Adverse Event|12|||
16796142|NCT02291679|37737427|FG002|Overall Study|Adverse Event|19|||
16796143|NCT02291679|37737425|FG000|Overall Study|Protocol Violation|5|||
16796144|NCT02291679|37737426|FG001|Overall Study|Protocol Violation|1|||
16796145|NCT02291679|37737427|FG002|Overall Study|Protocol Violation|7|||
16796146|NCT02291679|37737425|FG000|Overall Study|Withdrew Consent|18|||
16796147|NCT02291679|37737426|FG001|Overall Study|Withdrew Consent|10|||
16796148|NCT02291679|37737427|FG002|Overall Study|Withdrew Consent|15|||
16796149|NCT02291679|37737425|FG000|Overall Study|Lost to Follow-up|12|||
16796150|NCT02291679|37737426|FG001|Overall Study|Lost to Follow-up|10|||
16796151|NCT02291679|37737427|FG002|Overall Study|Lost to Follow-up|9|||
16796152|NCT02291679|37737425|FG000|Overall Study|Insufficient Therapeutic Response|5|||
16796153|NCT02291679|37737426|FG001|Overall Study|Insufficient Therapeutic Response|5|||
16796154|NCT02291679|37737427|FG002|Overall Study|Insufficient Therapeutic Response|7|||
16796155|NCT02291679|37737425|FG000|Overall Study|Other|2|||
16796156|NCT02291679|37737426|FG001|Overall Study|Other|4|||
16796157|NCT02291679|37737427|FG002|Overall Study|Other|2|||
16796158|NCT02291601|37737434|FG000|Abdomen|Did not qualify|333|||
16796159|NCT02291601|37737435|FG001|Abdomen|Did not qualify|54|||
16796160|NCT02291601|37737436|FG002|Abdomen|Did not qualify|339|||
16796161|NCT02291601|37737434|FG000|Groin|Did not qualify|183|||
16909134|NCT01725282|38017974|FG000|Overall Study|Adverse Event|1|||
16909135|NCT01725282|38017975|FG001|Overall Study|Adverse Event|3|||
16909136|NCT01725282|38017976|FG002|Overall Study|Adverse Event|6|||
16909137|NCT01725282|38017977|FG003|Overall Study|Adverse Event|4|||
16909138|NCT01725282|38017974|FG000|Overall Study|Exacerbation of Target Disease|1|||
16909139|NCT01725282|38017975|FG001|Overall Study|Exacerbation of Target Disease|0|||
16909140|NCT01725282|38017976|FG002|Overall Study|Exacerbation of Target Disease|0|||
17016510|NCT00848042|38161114|FG001|Overall Study|Death|2|||
16796162|NCT02291601|37737435|FG001|Groin|Did not qualify|30|||
16796163|NCT02291601|37737436|FG002|Groin|Did not qualify|177|||
16796164|NCT02360475|37737451|FG000|Overall Study|Lost to Follow-up|4|||
16796165|NCT02360475|37737452|FG001|Overall Study|Lost to Follow-up|12|||
16796166|NCT02360475|37737453|FG002|Overall Study|Lost to Follow-up|6|||
16796167|NCT02360475|37737454|FG003|Overall Study|Lost to Follow-up|4|||
16796168|NCT02360475|37737451|FG000|Overall Study|Withdrawal by Subject|0|||
16796169|NCT02360475|37737452|FG001|Overall Study|Withdrawal by Subject|1|||
16796170|NCT02360475|37737453|FG002|Overall Study|Withdrawal by Subject|2|||
16796171|NCT02360475|37737454|FG003|Overall Study|Withdrawal by Subject|0|||
16796172|NCT02360475|37737451|FG000|Overall Study|Migrated/moved from study area|0|||
16796173|NCT02360475|37737452|FG001|Overall Study|Migrated/moved from study area|0|||
16796174|NCT02360475|37737453|FG002|Overall Study|Migrated/moved from study area|0|||
16796175|NCT02360475|37737454|FG003|Overall Study|Migrated/moved from study area|1|||
16796176|NCT02360397|37737464|FG000|Overall Study|Incomplete screening|3|||
16796177|NCT02360397|37737464|FG000|Overall Study|Adverse Event|1|||
16796178|NCT02317809|37737469|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
16796179|NCT02317809|37737470|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
16796180|NCT02317809|37737469|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
16796181|NCT02317809|37737470|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
16796182|NCT02359851|37737479|FG000|Overall Study|Death|1|||
16796183|NCT02359851|37737479|FG000|Overall Study|Disease progression|1|||
16796184|NCT01607905|37737490|FG000|Overall Study|Withdrawal by participant|7|||
16796185|NCT01607905|37737491|FG001|Overall Study|Withdrawal by participant|2|||
16796186|NCT01607905|37737492|FG002|Overall Study|Withdrawal by participant|4|||
16796187|NCT01607905|37737493|FG003|Overall Study|Withdrawal by participant|6|||
16796188|NCT01607905|37737494|FG004|Overall Study|Withdrawal by participant|0|||
16796189|NCT01607905|37737495|FG005|Overall Study|Withdrawal by participant|4|||
16796190|NCT01607905|37737496|FG006|Overall Study|Withdrawal by participant|12|||
16796191|NCT01607905|37737490|FG000|Overall Study|Incidence or severity of AEs|5|||
16796192|NCT01607905|37737491|FG001|Overall Study|Incidence or severity of AEs|1|||
16796193|NCT01607905|37737492|FG002|Overall Study|Incidence or severity of AEs|1|||
16796194|NCT01607905|37737493|FG003|Overall Study|Incidence or severity of AEs|3|||
16796195|NCT01607905|37737494|FG004|Overall Study|Incidence or severity of AEs|0|||
16796196|NCT01607905|37737495|FG005|Overall Study|Incidence or severity of AEs|2|||
16796197|NCT01607905|37737496|FG006|Overall Study|Incidence or severity of AEs|8|||
16796198|NCT01607905|37737490|FG000|Overall Study|Disease progression|44|||
16796199|NCT01607905|37737491|FG001|Overall Study|Disease progression|16|||
16796200|NCT01607905|37737492|FG002|Overall Study|Disease progression|15|||
16796201|NCT01607905|37737493|FG003|Overall Study|Disease progression|11|||
16796202|NCT01607905|37737494|FG004|Overall Study|Disease progression|6|||
16796203|NCT01607905|37737495|FG005|Overall Study|Disease progression|7|||
16796204|NCT01607905|37737496|FG006|Overall Study|Disease progression|21|||
16796205|NCT01607905|37737490|FG000|Overall Study|Non-compliance with study procedures|0|||
16796206|NCT01607905|37737491|FG001|Overall Study|Non-compliance with study procedures|0|||
16796207|NCT01607905|37737492|FG002|Overall Study|Non-compliance with study procedures|0|||
16796208|NCT01607905|37737493|FG003|Overall Study|Non-compliance with study procedures|0|||
16796209|NCT01607905|37737494|FG004|Overall Study|Non-compliance with study procedures|0|||
16796210|NCT01607905|37737495|FG005|Overall Study|Non-compliance with study procedures|0|||
16796211|NCT01607905|37737496|FG006|Overall Study|Non-compliance with study procedures|1|||
16796212|NCT01607905|37737490|FG000|Overall Study|Death|1|||
16796213|NCT01607905|37737491|FG001|Overall Study|Death|1|||
16796214|NCT01607905|37737492|FG002|Overall Study|Death|1|||
16796215|NCT01607905|37737493|FG003|Overall Study|Death|1|||
16796216|NCT01607905|37737494|FG004|Overall Study|Death|0|||
16796217|NCT01607905|37737495|FG005|Overall Study|Death|0|||
16796218|NCT01607905|37737496|FG006|Overall Study|Death|3|||
16796219|NCT01607905|37737490|FG000|Overall Study|Other treatments become available|1|||
16796220|NCT01607905|37737491|FG001|Overall Study|Other treatments become available|0|||
16796221|NCT01607905|37737492|FG002|Overall Study|Other treatments become available|0|||
16796222|NCT01607905|37737493|FG003|Overall Study|Other treatments become available|0|||
16796223|NCT01607905|37737494|FG004|Overall Study|Other treatments become available|0|||
16796224|NCT01607905|37737495|FG005|Overall Study|Other treatments become available|0|||
16796225|NCT01607905|37737496|FG006|Overall Study|Other treatments become available|1|||
16796226|NCT01607905|37737490|FG000|Overall Study|Investigator discretion|0|||
16796227|NCT01607905|37737491|FG001|Overall Study|Investigator discretion|0|||
16796228|NCT01607905|37737492|FG002|Overall Study|Investigator discretion|0|||
16796229|NCT01607905|37737493|FG003|Overall Study|Investigator discretion|0|||
16796230|NCT01607905|37737494|FG004|Overall Study|Investigator discretion|0|||
16796231|NCT01607905|37737495|FG005|Overall Study|Investigator discretion|1|||
16796232|NCT01607905|37737496|FG006|Overall Study|Investigator discretion|0|||
16796233|NCT01607905|37737490|FG000|Overall Study|Other|1|||
16796234|NCT01607905|37737491|FG001|Overall Study|Other|0|||
16796235|NCT01607905|37737492|FG002|Overall Study|Other|0|||
16796236|NCT01607905|37737493|FG003|Overall Study|Other|0|||
16796237|NCT01607905|37737494|FG004|Overall Study|Other|0|||
16796238|NCT01607905|37737495|FG005|Overall Study|Other|0|||
16796239|NCT01607905|37737496|FG006|Overall Study|Other|1|||
16796240|NCT01607905|37737490|FG000|Overall Study|Randomized but not treated|1|||
16796241|NCT01607905|37737491|FG001|Overall Study|Randomized but not treated|0|||
16796242|NCT01607905|37737492|FG002|Overall Study|Randomized but not treated|0|||
16796243|NCT01607905|37737493|FG003|Overall Study|Randomized but not treated|0|||
16796244|NCT01607905|37737494|FG004|Overall Study|Randomized but not treated|1|||
16796245|NCT01607905|37737495|FG005|Overall Study|Randomized but not treated|1|||
16796246|NCT01607905|37737496|FG006|Overall Study|Randomized but not treated|0|||
16796247|NCT02536963|37737554|FG000|Overall Study|Withdrawal by Subject|18|||
16796248|NCT00602641|37737560|FG000|Overall Study|Never started protocol therapy|6|||
16796249|NCT00602641|37737561|FG001|Overall Study|Never started protocol therapy|2|||
16796250|NCT00602641|37737560|FG000|Overall Study|Still on treatment at time of analysis|8|||
16796251|NCT00602641|37737561|FG001|Overall Study|Still on treatment at time of analysis|15|||
16796252|NCT00602641|37737560|FG000|Overall Study|Adverse Event|62|||
16796253|NCT00602641|37737561|FG001|Overall Study|Adverse Event|53|||
16796254|NCT00602641|37737560|FG000|Overall Study|Disease progression|38|||
16796255|NCT00602641|37737561|FG001|Overall Study|Disease progression|55|||
16796256|NCT00602641|37737560|FG000|Overall Study|Death|6|||
16796257|NCT00602641|37737561|FG001|Overall Study|Death|5|||
16796258|NCT00602641|37737560|FG000|Overall Study|Withdrawal by Subject|15|||
16796259|NCT00602641|37737561|FG001|Overall Study|Withdrawal by Subject|12|||
16796260|NCT00602641|37737560|FG000|Overall Study|Alternative therapy|5|||
16796261|NCT00602641|37737561|FG001|Overall Study|Alternative therapy|2|||
16796262|NCT00602641|37737560|FG000|Overall Study|Other Complicating Disease|5|||
16796263|NCT00602641|37737561|FG001|Overall Study|Other Complicating Disease|2|||
16796264|NCT00602641|37737560|FG000|Overall Study|Physician Decision|5|||
16796265|NCT00602641|37737561|FG001|Overall Study|Physician Decision|4|||
16796266|NCT00602641|37737560|FG000|Overall Study|Administrative Closure|1|||
16796267|NCT00602641|37737561|FG001|Overall Study|Administrative Closure|1|||
16796268|NCT00602641|37737560|FG000|Overall Study|Other|3|||
16796269|NCT00602641|37737561|FG001|Overall Study|Other|1|||
16796270|NCT02531113|37737567|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
16796271|NCT02531113|37737567|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
16796272|NCT02531113|37737567|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
16796273|NCT02531113|37737567|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
16796274|NCT02531113|37737567|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
16796275|NCT02531113|37737567|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
16796276|NCT02531113|37737567|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
16796277|NCT02531113|37737567|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
16796278|NCT02531035|37737573|FG000|Overall Study|Death|0|||
16796279|NCT02531035|37737574|FG001|Overall Study|Death|1|||
16796280|NCT02531035|37737573|FG000|Overall Study|Protocol Violation|1|||
16796281|NCT02531035|37737574|FG001|Overall Study|Protocol Violation|1|||
16796282|NCT02531035|37737573|FG000|Overall Study|Noncompliance with study drug|8|||
16796283|NCT02531035|37737574|FG001|Overall Study|Noncompliance with study drug|3|||
16796284|NCT02531035|37737573|FG000|Overall Study|Physician Decision|1|||
16796285|NCT02531035|37737574|FG001|Overall Study|Physician Decision|0|||
16796286|NCT02531035|37737573|FG000|Overall Study|Adverse Event|16|||
16796287|NCT02531035|37737574|FG001|Overall Study|Adverse Event|45|||
16796288|NCT02531035|37737573|FG000|Overall Study|Other|3|||
16796289|NCT02531035|37737574|FG001|Overall Study|Other|2|||
16796290|NCT02531035|37737573|FG000|Overall Study|Withdrawal by Subject|42|||
16796291|NCT02531035|37737574|FG001|Overall Study|Withdrawal by Subject|32|||
16796292|NCT02531035|37737573|FG000|Overall Study|Lost to Follow-up|8|||
16796293|NCT02531035|37737574|FG001|Overall Study|Lost to Follow-up|10|||
16796294|NCT02531035|37737573|FG000|Overall Study|Randomized, not treated|2|||
16796295|NCT02531035|37737574|FG001|Overall Study|Randomized, not treated|1|||
16796296|NCT01659853|37737590|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
16796297|NCT01659853|37737591|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
16796298|NCT01659853|37737590|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
16796299|NCT01659853|37737591|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
16796300|NCT01660243|37737603|FG000|Overall Study|Adverse Event|1|||
16796301|NCT01660243|37737604|FG001|Overall Study|Adverse Event|0|||
16796302|NCT01660243|37737605|FG002|Overall Study|Adverse Event|1|||
16796303|NCT01660243|37737606|FG003|Overall Study|Adverse Event|0|||
16796304|NCT01660243|37737603|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
16796305|NCT01660243|37737604|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
16796306|NCT01660243|37737605|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
16796307|NCT01660243|37737606|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
16796308|NCT01660243|37737603|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
16796309|NCT01660243|37737604|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
16796310|NCT01660243|37737605|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
16796311|NCT01660243|37737606|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
16796312|NCT01660243|37737603|FG000|Overall Study|Randomization error|0|||
16796313|NCT01660243|37737604|FG001|Overall Study|Randomization error|0|||
16796314|NCT01660243|37737605|FG002|Overall Study|Randomization error|0|||
16796315|NCT01660243|37737606|FG003|Overall Study|Randomization error|1|||
16796316|NCT01659151|37737620|FG000|Overall Study|Inadequate TIL growth|1|||
16796317|NCT02522767|37737626|FG000|Double-blind|Withdrawal by Subject|8|||
16796318|NCT02522767|37737627|FG001|Double-blind|Withdrawal by Subject|11|||
16796319|NCT02522767|37737626|FG000|Double-blind|Lost to Follow-up|1|||
16796320|NCT02522767|37737627|FG001|Double-blind|Lost to Follow-up|0|||
16796321|NCT02522767|37737626|FG000|Double-blind|Adverse Event|1|||
16796322|NCT02522767|37737627|FG001|Double-blind|Adverse Event|10|||
16796323|NCT02522767|37737626|FG000|Double-blind|Protocol Violation|0|||
16796324|NCT02522767|37737627|FG001|Double-blind|Protocol Violation|1|||
16796325|NCT02522767|37737626|FG000|Double-blind|Lack of Efficacy|0|||
16796326|NCT02522767|37737627|FG001|Double-blind|Lack of Efficacy|2|||
16796327|NCT02522767|37737626|FG000|Double-blind|Protocol Deviation|1|||
16796328|NCT02522767|37737627|FG001|Double-blind|Protocol Deviation|0|||
16796329|NCT02522767|37737626|FG000|Open-label|Withdrawal by Subject|2|||
16796330|NCT02522767|37737627|FG001|Open-label|Withdrawal by Subject|3|||
16796331|NCT02522767|37737626|FG000|Open-label|Lost to Follow-up|0|||
16796332|NCT02522767|37737627|FG001|Open-label|Lost to Follow-up|1|||
16796333|NCT02522767|37737626|FG000|Open-label|Adverse Event|2|||
16796334|NCT02522767|37737627|FG001|Open-label|Adverse Event|1|||
16796335|NCT02522767|37737626|FG000|Open-label|Lack of Efficacy|1|||
16796336|NCT02522767|37737627|FG001|Open-label|Lack of Efficacy|1|||
16796337|NCT02522767|37737626|FG000|Open-label|Protocol Violation|0|||
16796338|NCT02522767|37737627|FG001|Open-label|Protocol Violation|1|||
16796339|NCT02522377|37737637|FG000|Overall Study|Withdrawal by Subject|1|||
16796340|NCT02522377|37737638|FG001|Overall Study|Withdrawal by Subject|0|||
16796341|NCT02522377|37737637|FG000|Overall Study|Remission Achieved|3|||
16796342|NCT02522377|37737638|FG001|Overall Study|Remission Achieved|0|||
16796343|NCT01657903|37737644|FG000|Overall Study|Lost to Follow-up|1|||
16796344|NCT01657903|37737644|FG000|Overall Study|Withdrawal by Subject|1|||
16796345|NCT01656733|37737657|FG000|Overall Study|No permission to collect birth outcomes|0|||
16796346|NCT01656733|37737658|FG001|Overall Study|No permission to collect birth outcomes|1|||
16796347|NCT01656733|37737657|FG000|Overall Study|Delivery at another hospital|0|||
16796348|NCT01656733|37737658|FG001|Overall Study|Delivery at another hospital|2|||
16796349|NCT01656733|37737657|FG000|Overall Study|Spontaneous abortion|0|||
16796350|NCT01656733|37737658|FG001|Overall Study|Spontaneous abortion|1|||
16796351|NCT01656967|37737666|FG000|Overall Study|faulty monitor|1|||
16796352|NCT01656967|37737667|FG001|Overall Study|faulty monitor|0|||
16796353|NCT01656967|37737666|FG000|Overall Study|unsuccessful ETT insertion|3|||
16796354|NCT01656967|37737667|FG001|Overall Study|unsuccessful ETT insertion|2|||
16796355|NCT01656889|37737679|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
16796356|NCT01656889|37737680|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
16796357|NCT01656889|37737679|FG000|Treatment Period, 12 Weeks|Death|0|||
16796358|NCT01656889|37737680|FG001|Treatment Period, 12 Weeks|Death|1|||
16796359|NCT01656889|37737679|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
16796360|NCT01656889|37737680|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
16796361|NCT01656889|37737679|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
16796362|NCT01656889|37737680|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
16796363|NCT01656889|37737679|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
16796364|NCT01656889|37737680|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
16796365|NCT01656889|37737679|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
16796366|NCT01656889|37737680|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
16796367|NCT01656889|37737679|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
16796368|NCT01656889|37737680|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
16796369|NCT01656889|37737679|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
16796370|NCT01656889|37737680|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
16796371|NCT01656889|37737679|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
16796372|NCT01656889|37737680|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
16796373|NCT01656889|37737679|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
16796374|NCT01656889|37737680|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
16796375|NCT02522299|37737688|FG000|Overall Study|Adverse Event|2|||
16796376|NCT02522299|37737689|FG001|Overall Study|Adverse Event|0|||
16796377|NCT02522299|37737688|FG000|Overall Study|Physician Decision|0|||
16796378|NCT02522299|37737689|FG001|Overall Study|Physician Decision|1|||
16796379|NCT02522299|37737688|FG000|Overall Study|Withdrawal by Subject|2|||
16796380|NCT02522299|37737689|FG001|Overall Study|Withdrawal by Subject|0|||
16796381|NCT01365091|37737713|FG000|Period 1|Adverse Event|1|||
16796382|NCT01365091|37737714|FG001|Period 1|Adverse Event|0|||
16796383|NCT01365091|37737715|FG002|Period 1|Adverse Event|2|||
16796384|NCT01365091|37737716|FG003|Period 1|Adverse Event|3|||
16796385|NCT01365091|37737713|FG000|Period 1|Positive test result for drugs of abuse|1|||
16796386|NCT01365091|37737714|FG001|Period 1|Positive test result for drugs of abuse|0|||
16796387|NCT01365091|37737715|FG002|Period 1|Positive test result for drugs of abuse|0|||
16796388|NCT01365091|37737716|FG003|Period 1|Positive test result for drugs of abuse|0|||
16796389|NCT01365091|37737713|FG000|Period 1|No longer met study criteria|0|||
16796390|NCT01365091|37737714|FG001|Period 1|No longer met study criteria|1|||
16796391|NCT01365091|37737715|FG002|Period 1|No longer met study criteria|0|||
16796392|NCT01365091|37737716|FG003|Period 1|No longer met study criteria|0|||
16796393|NCT01365091|37737713|FG000|Period 1|Withdrawal by Subject|0|||
16796394|NCT01365091|37737714|FG001|Period 1|Withdrawal by Subject|1|||
16796395|NCT01365091|37737715|FG002|Period 1|Withdrawal by Subject|0|||
16796396|NCT01365091|37737716|FG003|Period 1|Withdrawal by Subject|0|||
16796397|NCT01365091|37737713|FG000|Period 1|Personal reasons|0|||
16796398|NCT01365091|37737714|FG001|Period 1|Personal reasons|0|||
16796399|NCT01365091|37737715|FG002|Period 1|Personal reasons|1|||
16796400|NCT01365091|37737716|FG003|Period 1|Personal reasons|0|||
16796401|NCT01365091|37737713|FG000|Period 2|Withdrawal by Subject|1|||
16796402|NCT01365091|37737714|FG001|Period 2|Withdrawal by Subject|0|||
16796403|NCT01365091|37737715|FG002|Period 2|Withdrawal by Subject|0|||
16796404|NCT01365091|37737716|FG003|Period 2|Withdrawal by Subject|0|||
16796405|NCT01365091|37737713|FG000|Period 2|Adverse Event|0|||
16796406|NCT01365091|37737714|FG001|Period 2|Adverse Event|0|||
16796407|NCT01365091|37737715|FG002|Period 2|Adverse Event|1|||
16796408|NCT01365091|37737716|FG003|Period 2|Adverse Event|0|||
16796409|NCT01364467|37737742|FG000|Overall Study|Lost to Follow-up|1|||
16796410|NCT01364467|37737743|FG001|Overall Study|Lost to Follow-up|2|||
16796411|NCT02520661|37737751|FG000|Overall Study|Lost to Follow-up|7|||
16796412|NCT02520661|37737752|FG001|Overall Study|Lost to Follow-up|3|||
16796413|NCT02520661|37737751|FG000|Overall Study|Admitted from ED|49|||
16796414|NCT02520661|37737752|FG001|Overall Study|Admitted from ED|48|||
16796415|NCT02520661|37737751|FG000|Overall Study|ED greater than 24 hours|29|||
16796416|NCT02520661|37737752|FG001|Overall Study|ED greater than 24 hours|38|||
16796417|NCT02520661|37737751|FG000|Overall Study|other ineligibility|14|||
16796418|NCT02520661|37737752|FG001|Overall Study|other ineligibility|22|||
16796419|NCT02520661|37737751|FG000|Overall Study|Withdrawal by Subject|7|||
16796420|NCT02520661|37737752|FG001|Overall Study|Withdrawal by Subject|16|||
16796421|NCT01364389|37737765|FG000|Overall Study|Withdrawal by Subject|0|||
16796422|NCT01364389|37737766|FG001|Overall Study|Withdrawal by Subject|1|||
16796423|NCT01364389|37737767|FG002|Overall Study|Withdrawal by Subject|0|||
16796424|NCT01364389|37737765|FG000|Overall Study|Protocol deviation|0|||
16796425|NCT01364389|37737766|FG001|Overall Study|Protocol deviation|0|||
16796426|NCT01364389|37737767|FG002|Overall Study|Protocol deviation|1|||
16796427|NCT01364389|37737765|FG000|Overall Study|Administrative problems|1|||
16796428|NCT01364389|37737766|FG001|Overall Study|Administrative problems|0|||
16796429|NCT01364389|37737767|FG002|Overall Study|Administrative problems|0|||
16796430|NCT01364389|37737765|FG000|Overall Study|Adverse Event|1|||
16796431|NCT01364389|37737766|FG001|Overall Study|Adverse Event|0|||
16796432|NCT01364389|37737767|FG002|Overall Study|Adverse Event|0|||
16796433|NCT01364233|37737775|FG000|Overall Study|Lost to Follow-up|1|||
16796434|NCT02291289|37737783|FG000|Induction Treatment|Not Dosed|2|||
16796435|NCT02291289|37737784|FG001|Induction Treatment|Not Dosed|0|||
16796436|NCT02291289|37737785|FG002|Induction Treatment|Not Dosed|0|||
16796437|NCT02291289|37737786|FG003|Induction Treatment|Not Dosed|9|||
16796438|NCT02291289|37737787|FG004|Induction Treatment|Not Dosed|0|||
16796439|NCT02291289|37737788|FG005|Induction Treatment|Not Dosed|0|||
16796440|NCT02291289|37737789|FG006|Induction Treatment|Not Dosed|0|||
16796441|NCT02291289|37737790|FG007|Induction Treatment|Not Dosed|0|||
16796442|NCT02291289|37737791|FG008|Induction Treatment|Not Dosed|0|||
16796443|NCT02291289|37737792|FG009|Induction Treatment|Not Dosed|1|||
16796444|NCT02291289|37737793|FG010|Induction Treatment|Not Dosed|0|||
16796445|NCT02291289|37737794|FG011|Induction Treatment|Not Dosed|0|||
16796446|NCT02291289|37737783|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16796447|NCT02291289|37737784|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16796448|NCT02291289|37737785|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16796449|NCT02291289|37737786|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16796450|NCT02291289|37737787|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
16796451|NCT02291289|37737788|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
16796452|NCT02291289|37737789|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16796453|NCT02291289|37737790|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16796454|NCT02291289|37737791|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16796455|NCT02291289|37737792|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16796456|NCT02291289|37737793|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
16796457|NCT02291289|37737794|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
16796458|NCT02291289|37737783|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
16796459|NCT02291289|37737784|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
16796460|NCT02291289|37737785|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
16796461|NCT02291289|37737786|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
16796462|NCT02291289|37737787|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
16796463|NCT02291289|37737788|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
16796464|NCT02291289|37737789|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
16796465|NCT02291289|37737790|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
16796466|NCT02291289|37737791|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
16796467|NCT02291289|37737792|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
17016511|NCT00848042|38161115|FG002|Overall Study|Death|0|||
16796468|NCT02291289|37737793|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
16796469|NCT02291289|37737794|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
17016512|NCT00848042|38161113|FG000|Overall Study|Other Therapy|3|||
16796470|NCT02291289|37737783|FG000|Maintenance Treatment Phase|Death|0|||
16796471|NCT02291289|37737784|FG001|Maintenance Treatment Phase|Death|23|||
16796472|NCT02291289|37737785|FG002|Maintenance Treatment Phase|Death|13|||
16796473|NCT02291289|37737786|FG003|Maintenance Treatment Phase|Death|0|||
16796474|NCT02291289|37737787|FG004|Maintenance Treatment Phase|Death|185|||
16796475|NCT02291289|37737788|FG005|Maintenance Treatment Phase|Death|100|||
16796476|NCT02291289|37737789|FG006|Maintenance Treatment Phase|Death|0|||
16796477|NCT02291289|37737790|FG007|Maintenance Treatment Phase|Death|1|||
16796478|NCT02291289|37737791|FG008|Maintenance Treatment Phase|Death|1|||
16796479|NCT02291289|37737792|FG009|Maintenance Treatment Phase|Death|0|||
16796480|NCT02291289|37737793|FG010|Maintenance Treatment Phase|Death|26|||
16796481|NCT02291289|37737794|FG011|Maintenance Treatment Phase|Death|11|||
16796482|NCT02291289|37737783|FG000|Maintenance Treatment Phase|Adverse Event|0|||
16796483|NCT02291289|37737784|FG001|Maintenance Treatment Phase|Adverse Event|0|||
16796484|NCT02291289|37737785|FG002|Maintenance Treatment Phase|Adverse Event|0|||
16796485|NCT02291289|37737786|FG003|Maintenance Treatment Phase|Adverse Event|0|||
16796486|NCT02291289|37737787|FG004|Maintenance Treatment Phase|Adverse Event|1|||
16796487|NCT02291289|37737788|FG005|Maintenance Treatment Phase|Adverse Event|0|||
16796488|NCT02291289|37737789|FG006|Maintenance Treatment Phase|Adverse Event|0|||
16796489|NCT02291289|37737790|FG007|Maintenance Treatment Phase|Adverse Event|0|||
16796490|NCT02291289|37737791|FG008|Maintenance Treatment Phase|Adverse Event|0|||
16796491|NCT02291289|37737792|FG009|Maintenance Treatment Phase|Adverse Event|0|||
16796492|NCT02291289|37737793|FG010|Maintenance Treatment Phase|Adverse Event|0|||
16796493|NCT02291289|37737794|FG011|Maintenance Treatment Phase|Adverse Event|0|||
16796494|NCT02291289|37737783|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
16796495|NCT02291289|37737784|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
16796496|NCT02291289|37737785|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
16796497|NCT02291289|37737786|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
16796498|NCT02291289|37737787|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
16796499|NCT02291289|37737788|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
16796500|NCT02291289|37737789|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
16796501|NCT02291289|37737790|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
16796502|NCT02291289|37737791|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
16796503|NCT02291289|37737792|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
16796504|NCT02291289|37737793|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
16796505|NCT02291289|37737794|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
16796506|NCT02291289|37737783|FG000|Maintenance Treatment Phase|Other|0|||
16796507|NCT02291289|37737784|FG001|Maintenance Treatment Phase|Other|0|||
16796508|NCT02291289|37737785|FG002|Maintenance Treatment Phase|Other|1|||
16796509|NCT02291289|37737786|FG003|Maintenance Treatment Phase|Other|0|||
16796510|NCT02291289|37737787|FG004|Maintenance Treatment Phase|Other|29|||
16796511|NCT02291289|37737788|FG005|Maintenance Treatment Phase|Other|8|||
16796512|NCT02291289|37737789|FG006|Maintenance Treatment Phase|Other|0|||
16796513|NCT02291289|37737790|FG007|Maintenance Treatment Phase|Other|0|||
16796514|NCT02291289|37737791|FG008|Maintenance Treatment Phase|Other|1|||
16796515|NCT02291289|37737792|FG009|Maintenance Treatment Phase|Other|0|||
16796516|NCT02291289|37737793|FG010|Maintenance Treatment Phase|Other|0|||
16796517|NCT02291289|37737794|FG011|Maintenance Treatment Phase|Other|0|||
16796518|NCT02291289|37737783|FG000|Maintenance Treatment Phase|Physician Decision|0|||
16796519|NCT02291289|37737784|FG001|Maintenance Treatment Phase|Physician Decision|0|||
16796520|NCT02291289|37737785|FG002|Maintenance Treatment Phase|Physician Decision|0|||
16796521|NCT02291289|37737786|FG003|Maintenance Treatment Phase|Physician Decision|0|||
16796522|NCT02291289|37737787|FG004|Maintenance Treatment Phase|Physician Decision|2|||
16796523|NCT02291289|37737788|FG005|Maintenance Treatment Phase|Physician Decision|0|||
16796524|NCT02291289|37737789|FG006|Maintenance Treatment Phase|Physician Decision|0|||
16796525|NCT02291289|37737790|FG007|Maintenance Treatment Phase|Physician Decision|0|||
16796526|NCT02291289|37737791|FG008|Maintenance Treatment Phase|Physician Decision|0|||
16796527|NCT02291289|37737792|FG009|Maintenance Treatment Phase|Physician Decision|0|||
16796528|NCT02291289|37737793|FG010|Maintenance Treatment Phase|Physician Decision|0|||
16796529|NCT02291289|37737794|FG011|Maintenance Treatment Phase|Physician Decision|1|||
16796530|NCT02291289|37737783|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
16796531|NCT02291289|37737784|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
16796532|NCT02291289|37737785|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
16796533|NCT02291289|37737786|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
16796534|NCT02291289|37737787|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
16796535|NCT02291289|37737788|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
16796536|NCT02291289|37737789|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
16796537|NCT02291289|37737790|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
16796538|NCT02291289|37737791|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
16796539|NCT02291289|37737792|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
16796540|NCT02291289|37737793|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
16796541|NCT02291289|37737794|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
16796542|NCT02291289|37737783|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
16796543|NCT02291289|37737784|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
16796544|NCT02291289|37737785|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
16796545|NCT02291289|37737786|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
16796546|NCT02291289|37737787|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
16796547|NCT02291289|37737788|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
16796548|NCT02291289|37737789|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
16796549|NCT02291289|37737790|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
16796550|NCT02291289|37737791|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
16796551|NCT02291289|37737792|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
16796552|NCT02291289|37737793|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
16796553|NCT02291289|37737794|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
16796554|NCT02317575|37737819|FG000|Period 1|Difficulty with venous cannulation|0|||
16796555|NCT02317575|37737820|FG001|Period 1|Difficulty with venous cannulation|1|||
16796556|NCT02317575|37737821|FG002|Period 1|Difficulty with venous cannulation|0|||
16796557|NCT02317575|37737822|FG003|Period 1|Difficulty with venous cannulation|0|||
16796558|NCT02317575|37737823|FG004|Period 1|Difficulty with venous cannulation|0|||
16796559|NCT02317575|37737819|FG000|Period 1|Withdrawal by Subject|1|||
16796560|NCT02317575|37737820|FG001|Period 1|Withdrawal by Subject|0|||
16796561|NCT02317575|37737821|FG002|Period 1|Withdrawal by Subject|0|||
16796562|NCT02317575|37737822|FG003|Period 1|Withdrawal by Subject|0|||
16796563|NCT02317575|37737823|FG004|Period 1|Withdrawal by Subject|0|||
16796564|NCT02316717|37737844|FG000|Overall Study|Adverse Event|2|||
16796565|NCT02316717|37737845|FG001|Overall Study|Adverse Event|2|||
16796566|NCT02316717|37737846|FG002|Overall Study|Adverse Event|0|||
16796567|NCT02316717|37737844|FG000|Overall Study|Lost to Follow-up|1|||
16796568|NCT02316717|37737845|FG001|Overall Study|Lost to Follow-up|2|||
16796569|NCT02316717|37737846|FG002|Overall Study|Lost to Follow-up|1|||
16796570|NCT02316717|37737844|FG000|Overall Study|Non compliance|3|||
16796571|NCT02316717|37737845|FG001|Overall Study|Non compliance|1|||
16796572|NCT02316717|37737846|FG002|Overall Study|Non compliance|0|||
16796573|NCT02316717|37737844|FG000|Overall Study|Protocol Violation|2|||
16796574|NCT02316717|37737845|FG001|Overall Study|Protocol Violation|0|||
16796575|NCT02316717|37737846|FG002|Overall Study|Protocol Violation|0|||
16796576|NCT02316717|37737844|FG000|Overall Study|Withdrawal by Subject|2|||
16796577|NCT02316717|37737845|FG001|Overall Study|Withdrawal by Subject|1|||
16796578|NCT02316717|37737846|FG002|Overall Study|Withdrawal by Subject|1|||
16796579|NCT02316717|37737844|FG000|Overall Study|Death|0|||
16796580|NCT02316717|37737845|FG001|Overall Study|Death|0|||
16796581|NCT02316717|37737846|FG002|Overall Study|Death|1|||
16796582|NCT02316717|37737844|FG000|Overall Study|Physician Decision|0|||
16796583|NCT02316717|37737845|FG001|Overall Study|Physician Decision|1|||
16796584|NCT02316717|37737846|FG002|Overall Study|Physician Decision|0|||
16796585|NCT02316717|37737844|FG000|Overall Study|TBC|1|||
16796586|NCT02316717|37737845|FG001|Overall Study|TBC|0|||
16796587|NCT02316717|37737846|FG002|Overall Study|TBC|0|||
16796588|NCT02290821|37737859|FG000|Overall Study|Withdrawal by Subject|1|||
16796589|NCT02290821|37737860|FG001|Overall Study|Withdrawal by Subject|1|||
16796590|NCT02290821|37737859|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
16796591|NCT02290821|37737860|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
16796592|NCT02290821|37737859|FG000|Overall Study|Lost to Follow-up|3|||
16796593|NCT02290821|37737860|FG001|Overall Study|Lost to Follow-up|2|||
16796594|NCT02289963|37737868|FG000|Overall Study|Adverse Event|1|||
16796595|NCT02289963|37737869|FG001|Overall Study|Adverse Event|2|||
16796596|NCT02289963|37737868|FG000|Overall Study|Poor compliance to protocol|1|||
16796597|NCT02289963|37737869|FG001|Overall Study|Poor compliance to protocol|0|||
16796598|NCT02289963|37737868|FG000|Overall Study|Withdrawal by Subject|1|||
16796599|NCT02289963|37737869|FG001|Overall Study|Withdrawal by Subject|0|||
16796600|NCT02289963|37737868|FG000|Overall Study|Last injection missed|2|||
16796601|NCT02289963|37737869|FG001|Overall Study|Last injection missed|2|||
16796602|NCT02289963|37737868|FG000|Overall Study|End treatment visit outside visit window|0|||
16796603|NCT02289963|37737869|FG001|Overall Study|End treatment visit outside visit window|4|||
16796604|NCT02289963|37737868|FG000|Overall Study|Other than specified above|0|||
16796605|NCT02289963|37737869|FG001|Overall Study|Other than specified above|2|||
16796606|NCT02358369|37737878|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
16796607|NCT02358369|37737879|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
16796608|NCT02358369|37737880|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
16796609|NCT02358369|37737881|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
16796610|NCT02358369|37737882|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
16796611|NCT02358369|37737878|FG000|Treatment Period A/B|Adverse Event|0|||
16796612|NCT02358369|37737879|FG001|Treatment Period A/B|Adverse Event|0|||
16796613|NCT02358369|37737880|FG002|Treatment Period A/B|Adverse Event|1|||
16796614|NCT02358369|37737881|FG003|Treatment Period A/B|Adverse Event|2|||
16796615|NCT02358369|37737882|FG004|Treatment Period A/B|Adverse Event|0|||
16796616|NCT02358369|37737878|FG000|Treatment Period A/B|Death|0|||
16796617|NCT02358369|37737879|FG001|Treatment Period A/B|Death|0|||
16796618|NCT02358369|37737880|FG002|Treatment Period A/B|Death|1|||
16796619|NCT02358369|37737881|FG003|Treatment Period A/B|Death|0|||
16796620|NCT02358369|37737882|FG004|Treatment Period A/B|Death|0|||
16796621|NCT02358369|37737878|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
16796622|NCT02358369|37737879|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
16796623|NCT02358369|37737880|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
16909141|NCT01725282|38017977|FG003|Overall Study|Exacerbation of Target Disease|1|||
16909142|NCT01725282|38017974|FG000|Overall Study|Met Exclusion Criteria|0|||
16909143|NCT01725282|38017975|FG001|Overall Study|Met Exclusion Criteria|0|||
16909144|NCT01725282|38017976|FG002|Overall Study|Met Exclusion Criteria|1|||
16909145|NCT01725282|38017977|FG003|Overall Study|Met Exclusion Criteria|0|||
16909146|NCT01725282|38017974|FG000|Overall Study|Study Site Withdrawal|0|||
16909147|NCT01725282|38017975|FG001|Overall Study|Study Site Withdrawal|1|||
16909148|NCT01725282|38017976|FG002|Overall Study|Study Site Withdrawal|0|||
16909149|NCT01725282|38017977|FG003|Overall Study|Study Site Withdrawal|0|||
16909150|NCT01725282|38017974|FG000|Overall Study|Withdrawal by Subject|0|||
16909151|NCT01725282|38017975|FG001|Overall Study|Withdrawal by Subject|0|||
16909152|NCT01725282|38017976|FG002|Overall Study|Withdrawal by Subject|1|||
16909153|NCT01725282|38017977|FG003|Overall Study|Withdrawal by Subject|1|||
16909154|NCT01725282|38017974|FG000|Overall Study|Lack of Efficacy|0|||
16909155|NCT01725282|38017975|FG001|Overall Study|Lack of Efficacy|1|||
16909156|NCT01725282|38017976|FG002|Overall Study|Lack of Efficacy|0|||
16909157|NCT01725282|38017977|FG003|Overall Study|Lack of Efficacy|1|||
16909158|NCT01725126|38017993|FG000|Overall Study|Protocol Violation|0|||
16909159|NCT01725126|38017994|FG001|Overall Study|Protocol Violation|1|||
16909160|NCT01725126|38017995|FG002|Overall Study|Protocol Violation|0|||
16909161|NCT01725126|38017996|FG003|Overall Study|Protocol Violation|0|||
16909162|NCT01725126|38017997|FG004|Overall Study|Protocol Violation|0|||
16909163|NCT01725126|38017998|FG005|Overall Study|Protocol Violation|0|||
16909164|NCT01725126|38017993|FG000|Overall Study|Withdrawal by Subject|0|||
16909165|NCT01725126|38017994|FG001|Overall Study|Withdrawal by Subject|0|||
16909166|NCT01725126|38017995|FG002|Overall Study|Withdrawal by Subject|0|||
16909167|NCT01725126|38017996|FG003|Overall Study|Withdrawal by Subject|1|||
16909168|NCT01725126|38017997|FG004|Overall Study|Withdrawal by Subject|0|||
16909169|NCT01725126|38017998|FG005|Overall Study|Withdrawal by Subject|0|||
16909170|NCT01751724|38018035|FG000|Overall Study|extubated bef.start assigned treatment|1|||
16909171|NCT01751724|38018036|FG001|Overall Study|extubated bef.start assigned treatment|0|||
16909172|NCT01751724|38018035|FG000|Overall Study|withdrawn by parent|0|||
16909173|NCT01751724|38018036|FG001|Overall Study|withdrawn by parent|2|||
16909174|NCT01751646|38018044|FG000|Overall Study|Lost to Follow-up|5|||
16909175|NCT01751646|38018045|FG001|Overall Study|Lost to Follow-up|1|||
16909176|NCT01751646|38018044|FG000|Overall Study|Withdrawal by Subject|0|||
16796624|NCT02358369|37737881|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
16796625|NCT02358369|37737882|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
16796626|NCT02358369|37737878|FG000|Treatment Period C|Adverse Event|0|||
16796627|NCT02358369|37737879|FG001|Treatment Period C|Adverse Event|0|||
16796628|NCT02358369|37737880|FG002|Treatment Period C|Adverse Event|0|||
16796629|NCT02358369|37737881|FG003|Treatment Period C|Adverse Event|0|||
16796630|NCT02358369|37737882|FG004|Treatment Period C|Adverse Event|7|||
16796631|NCT02316171|37737894|FG000|Overall Study|difficulties with urinary catheter|1|||
16796632|NCT02316171|37737895|FG001|Overall Study|difficulties with urinary catheter|0|||
16796633|NCT02316171|37737896|FG002|Overall Study|difficulties with urinary catheter|0|||
16796634|NCT02316171|37737897|FG003|Overall Study|difficulties with urinary catheter|0|||
16796635|NCT02289729|37737903|FG000|Overall Study|Lack of Efficacy|3|||
16796636|NCT02289729|37737903|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
16796637|NCT02289729|37737903|FG000|Overall Study|Withdrawal by Subject|1|||
16796638|NCT02289729|37737903|FG000|Overall Study|Death|1|||
16796639|NCT02315625|37737909|FG000|First Intervention|Disease Progression|1|||
16796640|NCT02315625|37737910|FG001|First Intervention|Disease Progression|0|||
16796641|NCT02315625|37737909|FG000|Second Intervention|Physician Decision|2|||
16796642|NCT02315625|37737910|FG001|Second Intervention|Physician Decision|1|||
16796643|NCT02315625|37737909|FG000|Second Intervention|Study closure|1|||
16796644|NCT02315625|37737910|FG001|Second Intervention|Study closure|0|||
16796645|NCT02315625|37737909|FG000|Second Intervention|Disease Progression|1|||
16796646|NCT02315625|37737910|FG001|Second Intervention|Disease Progression|0|||
16796647|NCT02357979|37737920|FG000|Overall Study|Lost to Follow-up|5|||
16796648|NCT02357979|37737921|FG001|Overall Study|Lost to Follow-up|5|||
16796649|NCT02357901|37737930|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
16796650|NCT02357901|37737931|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
16796651|NCT02357901|37737932|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
16796652|NCT02357901|37737933|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
16796653|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
16796654|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
16796655|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
16796656|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
16796657|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
16796658|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
16909177|NCT01751646|38018045|FG001|Overall Study|Withdrawal by Subject|4|||
16909178|NCT01751646|38018044|FG000|Overall Study|Starting hormone therapy|1|||
16796659|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
16796660|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
16796661|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
16796662|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
16796663|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
16796664|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
16796665|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
16796666|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
16796667|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
16796668|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
16796669|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
16796670|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
16796671|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
16796672|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
16796673|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
16796674|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
16796675|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
16796676|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
16796677|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
16796678|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
16796679|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
16796680|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
16796681|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
16796682|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
16796683|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
16796684|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
16796685|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
16796686|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
16796687|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
16796688|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
16796689|NCT02357901|37737930|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
16796690|NCT02357901|37737931|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
16796691|NCT02357901|37737932|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
16796692|NCT02357901|37737933|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
16796693|NCT01601847|37737943|FG000|Overall Study|Death|1|||
16796694|NCT01601847|37737944|FG001|Overall Study|Death|0|||
16796695|NCT01601847|37737943|FG000|Overall Study|Withdrawal by Subject|11|||
16796696|NCT01601847|37737944|FG001|Overall Study|Withdrawal by Subject|7|||
16796697|NCT01601847|37737943|FG000|Overall Study|Lost to Follow-up|1|||
16796698|NCT01601847|37737944|FG001|Overall Study|Lost to Follow-up|3|||
16796699|NCT02515669|37737954|FG000|228 Week Open-Label Phase|Other|0|||
16796700|NCT02515669|37737955|FG001|228 Week Open-Label Phase|Other|0|||
16796701|NCT02515669|37737956|FG002|228 Week Open-Label Phase|Other|1|||
16796702|NCT02515669|37737957|FG003|228 Week Open-Label Phase|Other|4|||
16796703|NCT02515669|37737954|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
16796704|NCT02515669|37737955|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
16796705|NCT02515669|37737956|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
16796706|NCT02515669|37737957|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
16796707|NCT02515669|37737954|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
16796708|NCT02515669|37737955|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
16796709|NCT02515669|37737956|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
16796710|NCT02515669|37737957|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
16796711|NCT02515669|37737954|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
16796712|NCT02515669|37737955|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
16796713|NCT02515669|37737956|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
16796714|NCT02515669|37737957|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
16796715|NCT02515669|37737954|FG000|228 Week Open-Label Phase|Missing|0|||
16796716|NCT02515669|37737955|FG001|228 Week Open-Label Phase|Missing|2|||
16796717|NCT02515669|37737956|FG002|228 Week Open-Label Phase|Missing|2|||
16796718|NCT02515669|37737957|FG003|228 Week Open-Label Phase|Missing|2|||
16796719|NCT02515279|37737987|FG000|Overall Study|Adverse Event|7|||
16796720|NCT02515279|37737987|FG000|Overall Study|Lack of Efficacy|31|||
16796721|NCT02515279|37737987|FG000|Overall Study|Lost to Follow-up|9|||
16796722|NCT02515279|37737987|FG000|Overall Study|Withdrawal by Subject|18|||
16796723|NCT02515279|37737987|FG000|Overall Study|End-of-treatment visit not attended|17|||
16796724|NCT02515279|37737987|FG000|Overall Study|Other|22|||
17102286|NCT00067002|38241195|FG001|Overall Study|Early Death|2|||
17102287|NCT00067002|38241194|FG000|Overall Study|Delayed|1|||
16796725|NCT02515045|37737993|FG000|Overall Study|Adverse Event|0|||
16796726|NCT02515045|37737994|FG001|Overall Study|Adverse Event|3|||
16796727|NCT02515045|37737995|FG002|Overall Study|Adverse Event|3|||
16796728|NCT02515045|37737993|FG000|Overall Study|Lost to Follow-up|0|||
16796729|NCT02515045|37737994|FG001|Overall Study|Lost to Follow-up|1|||
16796730|NCT02515045|37737995|FG002|Overall Study|Lost to Follow-up|1|||
16796731|NCT02514577|37738005|FG000|Overall Study|Lost to Follow-up|6|||
16796732|NCT02514577|37738006|FG001|Overall Study|Lost to Follow-up|6|||
16796733|NCT02514577|37738005|FG000|Overall Study|Protocol Violation|1|||
16796734|NCT02514577|37738006|FG001|Overall Study|Protocol Violation|0|||
16796735|NCT02514577|37738005|FG000|Overall Study|Withdrawal by Subject|6|||
16796736|NCT02514577|37738006|FG001|Overall Study|Withdrawal by Subject|6|||
16796737|NCT02514577|37738005|FG000|Overall Study|Adverse Event|1|||
16796738|NCT02514577|37738006|FG001|Overall Study|Adverse Event|1|||
16796739|NCT02513485|37738014|FG000|Overall Study|Adverse Event|1|||
16796740|NCT02513485|37738015|FG001|Overall Study|Adverse Event|0|||
16796741|NCT02289417|37738024|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
16796742|NCT02289417|37738025|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16796743|NCT02289417|37738026|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
16796744|NCT02289417|37738027|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16796745|NCT02289417|37738028|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16796746|NCT02289417|37738029|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16796747|NCT02289417|37738030|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16796748|NCT02289417|37738031|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16796749|NCT02289417|37738032|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16796750|NCT02289417|37738024|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
16796751|NCT02289417|37738025|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
16796752|NCT02289417|37738026|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
16796753|NCT02289417|37738027|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16796754|NCT02289417|37738028|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16796755|NCT02289417|37738029|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16796756|NCT02289417|37738030|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16796757|NCT02289417|37738031|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16796758|NCT02289417|37738032|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16796759|NCT02289417|37738024|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16796760|NCT02289417|37738025|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
16796761|NCT02289417|37738026|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16796762|NCT02289417|37738027|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16796763|NCT02289417|37738028|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16796764|NCT02289417|37738029|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16796765|NCT02289417|37738030|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16796766|NCT02289417|37738031|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16796767|NCT02289417|37738032|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16796768|NCT02289417|37738024|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
16796769|NCT02289417|37738025|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16796770|NCT02289417|37738026|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16796771|NCT02289417|37738027|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16796772|NCT02289417|37738028|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16796773|NCT02289417|37738029|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16796774|NCT02289417|37738030|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16796775|NCT02289417|37738031|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16796776|NCT02289417|37738032|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16796777|NCT02289417|37738024|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
16796778|NCT02289417|37738025|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
16796779|NCT02289417|37738026|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
16796780|NCT02289417|37738027|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
16796781|NCT02289417|37738028|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
16796782|NCT02289417|37738029|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
16796783|NCT02289417|37738030|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
16796784|NCT02289417|37738031|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
16796785|NCT02289417|37738032|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
16796786|NCT02289417|37738024|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16796787|NCT02289417|37738025|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16796788|NCT02289417|37738026|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
16796789|NCT02289417|37738027|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16796790|NCT02289417|37738028|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16796791|NCT02289417|37738029|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16796792|NCT02289417|37738030|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16909179|NCT01751646|38018045|FG001|Overall Study|Starting hormone therapy|0|||
16796793|NCT02289417|37738031|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16796794|NCT02289417|37738032|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16796795|NCT02289417|37738024|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
16796796|NCT02289417|37738025|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
16796797|NCT02289417|37738026|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
16796798|NCT02289417|37738027|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
16796799|NCT02289417|37738028|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
16796800|NCT02289417|37738029|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
16796801|NCT02289417|37738030|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
16796802|NCT02289417|37738031|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
16796803|NCT02289417|37738032|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
16796804|NCT02289417|37738024|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16796805|NCT02289417|37738025|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16796806|NCT02289417|37738026|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
16796807|NCT02289417|37738027|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16796808|NCT02289417|37738028|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
16796809|NCT02289417|37738029|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
16796810|NCT02289417|37738030|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16796811|NCT02289417|37738031|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16796812|NCT02289417|37738032|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16909180|NCT01751646|38018044|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
16909181|NCT01751646|38018045|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
16909182|NCT01751646|38018044|FG000|Overall Study|Inadvertent enrollment|1|||
16909183|NCT01751646|38018045|FG001|Overall Study|Inadvertent enrollment|1|||
16909184|NCT01751646|38018044|FG000|Overall Study|Moved out of the area|1|||
16909185|NCT01751646|38018045|FG001|Overall Study|Moved out of the area|5|||
16909186|NCT01751646|38018044|FG000|Overall Study|Inability to attend required visits|0|||
16909187|NCT01751646|38018045|FG001|Overall Study|Inability to attend required visits|1|||
16909188|NCT01751646|38018044|FG000|Overall Study|Off study due to multiple obligations|0|||
16909189|NCT01751646|38018045|FG001|Overall Study|Off study due to multiple obligations|1|||
16909190|NCT01751646|38018044|FG000|Overall Study|Fails to comply with study requirements|0|||
16909191|NCT01751646|38018045|FG001|Overall Study|Fails to comply with study requirements|1|||
16909192|NCT01751646|38018044|FG000|Overall Study|Childcare issues|1|||
16909193|NCT01751646|38018045|FG001|Overall Study|Childcare issues|1|||
16909194|NCT01751568|38018058|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
16909195|NCT01751568|38018059|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
16909196|NCT01751568|38018060|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
16909197|NCT01751412|38018068|FG000|Overall Study|Disease Progression Before Treatment|1|||
16909198|NCT01751178|38018075|FG000|Overall Study|Adverse Event|2|||
16909199|NCT01751178|38018076|FG001|Overall Study|Adverse Event|0|||
16909200|NCT01751178|38018077|FG002|Overall Study|Adverse Event|0|||
16909201|NCT01751178|38018075|FG000|Overall Study|Other Reason (unknown)|1|||
16909202|NCT01751178|38018076|FG001|Overall Study|Other Reason (unknown)|0|||
16909203|NCT01751178|38018077|FG002|Overall Study|Other Reason (unknown)|2|||
16909204|NCT01606254|38018093|FG000|Overall Study|Withdrawal by Subject|1|||
16909205|NCT01606254|38018094|FG001|Overall Study|Withdrawal by Subject|3|||
16909206|NCT01606254|38018095|FG002|Overall Study|Withdrawal by Subject|0|||
16909207|NCT01606254|38018096|FG003|Overall Study|Withdrawal by Subject|2|||
16909208|NCT01606254|38018093|FG000|Overall Study|Adverse Event|1|||
16909209|NCT01606254|38018094|FG001|Overall Study|Adverse Event|1|||
16909210|NCT01606254|38018095|FG002|Overall Study|Adverse Event|0|||
16909211|NCT01606254|38018096|FG003|Overall Study|Adverse Event|1|||
16909212|NCT01750242|38018106|FG000|Overall Study|Unreadable Images|3|||
16909213|NCT01723254|38018119|FG000|Overall Study|Conflict with work schedule|0|||
16909214|NCT01723254|38018120|FG001|Overall Study|Conflict with work schedule|0|||
16909215|NCT01723254|38018121|FG002|Overall Study|Conflict with work schedule|0|||
16909216|NCT01723254|38018122|FG003|Overall Study|Conflict with work schedule|0|||
16909217|NCT01723254|38018123|FG004|Overall Study|Conflict with work schedule|0|||
16909218|NCT01723254|38018124|FG005|Overall Study|Conflict with work schedule|0|||
16909219|NCT01723254|38018125|FG006|Overall Study|Conflict with work schedule|0|||
16909220|NCT01723254|38018126|FG007|Overall Study|Conflict with work schedule|1|||
16909221|NCT01723254|38018119|FG000|Overall Study|Personal issues|0|||
16909222|NCT01723254|38018120|FG001|Overall Study|Personal issues|0|||
16909223|NCT01723254|38018121|FG002|Overall Study|Personal issues|0|||
16909224|NCT01723254|38018122|FG003|Overall Study|Personal issues|0|||
16909225|NCT01723254|38018123|FG004|Overall Study|Personal issues|0|||
16909226|NCT01723254|38018124|FG005|Overall Study|Personal issues|1|||
16909227|NCT01723254|38018125|FG006|Overall Study|Personal issues|0|||
16909228|NCT01723254|38018126|FG007|Overall Study|Personal issues|0|||
16909229|NCT01723254|38018119|FG000|Overall Study|No longer have time to participate|0|||
16909230|NCT01723254|38018120|FG001|Overall Study|No longer have time to participate|0|||
16909231|NCT01723254|38018121|FG002|Overall Study|No longer have time to participate|0|||
16909232|NCT01723254|38018122|FG003|Overall Study|No longer have time to participate|1|||
16909233|NCT01723254|38018123|FG004|Overall Study|No longer have time to participate|0|||
16909234|NCT01723254|38018124|FG005|Overall Study|No longer have time to participate|0|||
16909235|NCT01723254|38018125|FG006|Overall Study|No longer have time to participate|0|||
16909236|NCT01723254|38018126|FG007|Overall Study|No longer have time to participate|0|||
16909237|NCT01723254|38018119|FG000|Overall Study|Move/Left to another country/city|0|||
16909238|NCT01723254|38018120|FG001|Overall Study|Move/Left to another country/city|0|||
16909239|NCT01723254|38018121|FG002|Overall Study|Move/Left to another country/city|2|||
16909240|NCT01723254|38018122|FG003|Overall Study|Move/Left to another country/city|1|||
16909241|NCT01723254|38018123|FG004|Overall Study|Move/Left to another country/city|1|||
16909242|NCT01723254|38018124|FG005|Overall Study|Move/Left to another country/city|0|||
16909243|NCT01723254|38018125|FG006|Overall Study|Move/Left to another country/city|0|||
16909244|NCT01723254|38018126|FG007|Overall Study|Move/Left to another country/city|0|||
16909245|NCT01723254|38018119|FG000|Overall Study|Protocol Violation|0|||
16909246|NCT01723254|38018120|FG001|Overall Study|Protocol Violation|1|||
16909247|NCT01723254|38018121|FG002|Overall Study|Protocol Violation|0|||
16909248|NCT01723254|38018122|FG003|Overall Study|Protocol Violation|0|||
16909249|NCT01723254|38018123|FG004|Overall Study|Protocol Violation|0|||
16909250|NCT01723254|38018124|FG005|Overall Study|Protocol Violation|0|||
16909251|NCT01723254|38018125|FG006|Overall Study|Protocol Violation|0|||
16909252|NCT01723254|38018126|FG007|Overall Study|Protocol Violation|0|||
16909253|NCT01723254|38018119|FG000|Overall Study|Withdrawal by Subject|1|||
16909254|NCT01723254|38018120|FG001|Overall Study|Withdrawal by Subject|2|||
16909255|NCT01723254|38018121|FG002|Overall Study|Withdrawal by Subject|1|||
16909256|NCT01723254|38018122|FG003|Overall Study|Withdrawal by Subject|0|||
16909257|NCT01723254|38018123|FG004|Overall Study|Withdrawal by Subject|1|||
16909258|NCT01723254|38018124|FG005|Overall Study|Withdrawal by Subject|1|||
16909259|NCT01723254|38018125|FG006|Overall Study|Withdrawal by Subject|1|||
16909260|NCT01723254|38018126|FG007|Overall Study|Withdrawal by Subject|2|||
16909261|NCT01722162|38018146|FG000|Overall Study|Withdrawal by Subject|1|||
16909262|NCT01722162|38018147|FG001|Overall Study|Withdrawal by Subject|1|||
16909263|NCT01722162|38018146|FG000|Overall Study|Found ineligible|1|||
16909264|NCT01722162|38018147|FG001|Overall Study|Found ineligible|0|||
16909265|NCT01722162|38018146|FG000|Overall Study|Unrelated to study adverse event|2|||
17016513|NCT00848042|38161114|FG001|Overall Study|Other Therapy|0|||
17016514|NCT00848042|38161115|FG002|Overall Study|Other Therapy|0|||
17016515|NCT00847886|38161125|FG000|Overall Study|Adverse Event|0|||
17016516|NCT00847886|38161126|FG001|Overall Study|Adverse Event|1|||
17016517|NCT00847808|38161132|FG000|Overall Study|Adverse Event|7|||
17102288|NCT00067002|38241195|FG001|Overall Study|Delayed|1|||
16909266|NCT01722162|38018147|FG001|Overall Study|Unrelated to study adverse event|2|||
16909267|NCT01722162|38018146|FG000|Overall Study|Adverse Event|1|||
16909268|NCT01722162|38018147|FG001|Overall Study|Adverse Event|1|||
16909269|NCT01722162|38018146|FG000|Overall Study|Insurance denial post enrollment|0|||
16909270|NCT01722162|38018147|FG001|Overall Study|Insurance denial post enrollment|1|||
16909271|NCT01722162|38018146|FG000|Overall Study|Noncompliance|0|||
16909272|NCT01722162|38018147|FG001|Overall Study|Noncompliance|1|||
16909273|NCT01721772|38018155|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
16909274|NCT01721772|38018156|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
16909275|NCT01721772|38018155|FG000|Pre-Treatment|Poor/non-compliance|0|||
16909276|NCT01721772|38018156|FG001|Pre-Treatment|Poor/non-compliance|1|||
16909277|NCT01721772|38018155|FG000|Pre-Treatment|Participant withdrew consent|0|||
16909278|NCT01721772|38018156|FG001|Pre-Treatment|Participant withdrew consent|1|||
16909279|NCT01721772|38018155|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
16909280|NCT01721772|38018156|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
16909281|NCT01721772|38018155|FG000|Treatment|Disease progression|119|||
16909282|NCT01721772|38018156|FG001|Treatment|Disease progression|168|||
16909283|NCT01721772|38018155|FG000|Treatment|Study drug toxicity|19|||
16909284|NCT01721772|38018156|FG001|Treatment|Study drug toxicity|10|||
16909285|NCT01721772|38018155|FG000|Treatment|Adverse event unrelated to study drug|7|||
16909286|NCT01721772|38018156|FG001|Treatment|Adverse event unrelated to study drug|7|||
16909287|NCT01721772|38018155|FG000|Treatment|Maximum clinical benefit|16|||
16909288|NCT01721772|38018156|FG001|Treatment|Maximum clinical benefit|4|||
16909289|NCT01721772|38018155|FG000|Treatment|Other|19|||
16909290|NCT01721772|38018156|FG001|Treatment|Other|2|||
16909291|NCT01721772|38018155|FG000|Treatment|Participant withdrew consent|2|||
16909292|NCT01721772|38018156|FG001|Treatment|Participant withdrew consent|5|||
16909293|NCT01721772|38018155|FG000|Treatment|Participant request to discontinue study treatment|21|||
16909294|NCT01721772|38018156|FG001|Treatment|Participant request to discontinue study treatment|8|||
16909295|NCT01721772|38018155|FG000|Treatment|Death|1|||
16909296|NCT01721772|38018156|FG001|Treatment|Death|0|||
16909297|NCT01721772|38018155|FG000|Treatment|Not reported|1|||
16909298|NCT01721772|38018156|FG001|Treatment|Not reported|0|||
16909299|NCT01721772|38018155|FG000|Treatment|Poor/non-compliance|1|||
16909300|NCT01721772|38018156|FG001|Treatment|Poor/non-compliance|0|||
17016518|NCT00847808|38161132|FG000|Overall Study|Protocol Violation|1|||
16796813|NCT02289417|37738024|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16796814|NCT02289417|37738025|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16796815|NCT02289417|37738026|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16796816|NCT02289417|37738027|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16796817|NCT02289417|37738028|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16796818|NCT02289417|37738029|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16796819|NCT02289417|37738030|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
16796820|NCT02289417|37738031|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16796821|NCT02289417|37738032|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16796822|NCT02289417|37738024|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16796823|NCT02289417|37738025|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16796824|NCT02289417|37738026|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16796825|NCT02289417|37738027|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
16796826|NCT02289417|37738028|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16796827|NCT02289417|37738029|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16796828|NCT02289417|37738030|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
16796829|NCT02289417|37738031|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16796830|NCT02289417|37738032|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16796831|NCT02289417|37738024|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
16796832|NCT02289417|37738025|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
16796833|NCT02289417|37738026|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
16796834|NCT02289417|37738027|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
16796835|NCT02289417|37738028|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
16796836|NCT02289417|37738029|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
16796837|NCT02289417|37738030|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
16796838|NCT02289417|37738031|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
16796839|NCT02289417|37738032|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
16796840|NCT02289417|37738024|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16796841|NCT02289417|37738025|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16796842|NCT02289417|37738026|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16796843|NCT02289417|37738027|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16796844|NCT02289417|37738028|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16796845|NCT02289417|37738029|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16796846|NCT02289417|37738030|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16796847|NCT02289417|37738031|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
16796848|NCT02289417|37738032|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
16796849|NCT02289417|37738024|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16796850|NCT02289417|37738025|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16796851|NCT02289417|37738026|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16796852|NCT02289417|37738027|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16796853|NCT02289417|37738028|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16796854|NCT02289417|37738029|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16796855|NCT02289417|37738030|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16796856|NCT02289417|37738031|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
16796857|NCT02289417|37738032|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
16796858|NCT02289417|37738024|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
16796859|NCT02289417|37738025|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
16796860|NCT02289417|37738026|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
16796861|NCT02289417|37738027|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
16796862|NCT02289417|37738028|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
16796863|NCT02289417|37738029|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
16796864|NCT02289417|37738030|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
16796865|NCT02289417|37738031|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
16796866|NCT02289417|37738032|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
16796867|NCT02512861|37738050|FG000|Overall Study|Protocol Violation|3|||
16796868|NCT02512861|37738051|FG001|Overall Study|Protocol Violation|7|||
16796869|NCT02512861|37738050|FG000|Overall Study|Physician Decision|3|||
16796870|NCT02512861|37738051|FG001|Overall Study|Physician Decision|1|||
16796871|NCT02512861|37738050|FG000|Overall Study|Withdrawal by Subject|0|||
16796872|NCT02512861|37738051|FG001|Overall Study|Withdrawal by Subject|1|||
16796873|NCT02288559|37738061|FG000|Overall Study|Adverse Event|1|||
16796874|NCT02288559|37738062|FG001|Overall Study|Adverse Event|1|||
16796875|NCT02288559|37738063|FG002|Overall Study|Adverse Event|5|||
16796876|NCT02288559|37738064|FG003|Overall Study|Adverse Event|0|||
16796877|NCT02288559|37738061|FG000|Overall Study|Death|0|||
16796878|NCT02288559|37738062|FG001|Overall Study|Death|0|||
16796879|NCT02288559|37738063|FG002|Overall Study|Death|1|||
16796880|NCT02288559|37738064|FG003|Overall Study|Death|0|||
16796881|NCT02288559|37738061|FG000|Overall Study|Lost to Follow-up|0|||
16796882|NCT02288559|37738062|FG001|Overall Study|Lost to Follow-up|0|||
16796883|NCT02288559|37738063|FG002|Overall Study|Lost to Follow-up|0|||
16796884|NCT02288559|37738064|FG003|Overall Study|Lost to Follow-up|1|||
16796885|NCT02288559|37738061|FG000|Overall Study|Withdrawal by Subject|0|||
16796886|NCT02288559|37738062|FG001|Overall Study|Withdrawal by Subject|0|||
16796887|NCT02288559|37738063|FG002|Overall Study|Withdrawal by Subject|2|||
16796888|NCT02288559|37738064|FG003|Overall Study|Withdrawal by Subject|1|||
16796889|NCT02288559|37738061|FG000|Overall Study|Reason Not Specified|0|||
16796890|NCT02288559|37738062|FG001|Overall Study|Reason Not Specified|0|||
16796891|NCT02288559|37738063|FG002|Overall Study|Reason Not Specified|3|||
16796892|NCT02288559|37738064|FG003|Overall Study|Reason Not Specified|0|||
16796893|NCT02288325|37738076|FG000|Run-in Period|Adverse Event|48|||
16796894|NCT02288325|37738077|FG001|Run-in Period|Adverse Event|0|||
16796895|NCT02288325|37738078|FG002|Run-in Period|Adverse Event|0|||
16796896|NCT02288325|37738076|FG000|Run-in Period|Lack of Efficacy|16|||
16796897|NCT02288325|37738077|FG001|Run-in Period|Lack of Efficacy|0|||
16796898|NCT02288325|37738078|FG002|Run-in Period|Lack of Efficacy|0|||
16796899|NCT02288325|37738076|FG000|Run-in Period|Withdrawal of Consent|28|||
16796900|NCT02288325|37738077|FG001|Run-in Period|Withdrawal of Consent|0|||
16796901|NCT02288325|37738078|FG002|Run-in Period|Withdrawal of Consent|0|||
16796902|NCT02288325|37738076|FG000|Run-in Period|Lost to Follow-up|25|||
16796903|NCT02288325|37738077|FG001|Run-in Period|Lost to Follow-up|0|||
16796904|NCT02288325|37738078|FG002|Run-in Period|Lost to Follow-up|0|||
16796905|NCT02288325|37738076|FG000|Run-in Period|Protocol Violation|17|||
16796906|NCT02288325|37738077|FG001|Run-in Period|Protocol Violation|0|||
16796907|NCT02288325|37738078|FG002|Run-in Period|Protocol Violation|0|||
16796908|NCT02288325|37738076|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
16796909|NCT02288325|37738077|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
16796910|NCT02288325|37738078|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
16796911|NCT02288325|37738076|FG000|Run-in Period|Reason not Specified|8|||
16796912|NCT02288325|37738077|FG001|Run-in Period|Reason not Specified|0|||
16796913|NCT02288325|37738078|FG002|Run-in Period|Reason not Specified|0|||
16796914|NCT02288325|37738076|FG000|Stabilization Period|Adverse Event|13|||
16796915|NCT02288325|37738077|FG001|Stabilization Period|Adverse Event|0|||
16796916|NCT02288325|37738078|FG002|Stabilization Period|Adverse Event|0|||
16796917|NCT02288325|37738076|FG000|Stabilization Period|Lack of Efficacy|22|||
16796918|NCT02288325|37738077|FG001|Stabilization Period|Lack of Efficacy|0|||
16796919|NCT02288325|37738078|FG002|Stabilization Period|Lack of Efficacy|0|||
16796920|NCT02288325|37738076|FG000|Stabilization Period|Withdrawal of Consent|23|||
16796921|NCT02288325|37738077|FG001|Stabilization Period|Withdrawal of Consent|0|||
16796922|NCT02288325|37738078|FG002|Stabilization Period|Withdrawal of Consent|0|||
16796923|NCT02288325|37738076|FG000|Stabilization Period|Lost to Follow-up|12|||
16796924|NCT02288325|37738077|FG001|Stabilization Period|Lost to Follow-up|0|||
16796925|NCT02288325|37738078|FG002|Stabilization Period|Lost to Follow-up|0|||
16796926|NCT02288325|37738076|FG000|Stabilization Period|Protocol Violation|8|||
16796927|NCT02288325|37738077|FG001|Stabilization Period|Protocol Violation|0|||
16796928|NCT02288325|37738078|FG002|Stabilization Period|Protocol Violation|0|||
16796929|NCT02288325|37738076|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
16796930|NCT02288325|37738077|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
16796931|NCT02288325|37738078|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
16796932|NCT02288325|37738076|FG000|Stabilization Period|Reason not Specified|15|||
16796933|NCT02288325|37738077|FG001|Stabilization Period|Reason not Specified|0|||
16796934|NCT02288325|37738078|FG002|Stabilization Period|Reason not Specified|0|||
16796935|NCT02288325|37738076|FG000|Double-blind Treatment Period|Adverse Event|0|||
16796936|NCT02288325|37738077|FG001|Double-blind Treatment Period|Adverse Event|2|||
16796937|NCT02288325|37738078|FG002|Double-blind Treatment Period|Adverse Event|5|||
16796938|NCT02288325|37738076|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
16796939|NCT02288325|37738077|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
16796940|NCT02288325|37738078|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
16796941|NCT02288325|37738076|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16796942|NCT02288325|37738077|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
16796943|NCT02288325|37738078|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
16796944|NCT02288325|37738076|FG000|Double-blind Treatment Period|Protocol Violation|0|||
16796945|NCT02288325|37738077|FG001|Double-blind Treatment Period|Protocol Violation|1|||
16796946|NCT02288325|37738078|FG002|Double-blind Treatment Period|Protocol Violation|2|||
16796947|NCT02288325|37738076|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
16796948|NCT02288325|37738077|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
16796949|NCT02288325|37738078|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
16796950|NCT02288325|37738076|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
16796951|NCT02288325|37738077|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
16796952|NCT02288325|37738078|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
16796953|NCT02509117|37738095|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16796954|NCT02509117|37738096|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
16796955|NCT02509117|37738097|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16909301|NCT01721772|38018155|FG000|Treatment|Lost to Follow-up|0|||
16796956|NCT02509117|37738098|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16796957|NCT02509117|37738099|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16796958|NCT02509117|37738100|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16796959|NCT02509117|37738101|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16796960|NCT02509117|37738102|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16796961|NCT02509117|37738103|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16796962|NCT02509117|37738104|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16796963|NCT02509117|37738095|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796964|NCT02509117|37738096|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796965|NCT02509117|37738097|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796966|NCT02509117|37738098|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796967|NCT02509117|37738099|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796968|NCT02509117|37738100|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796969|NCT02509117|37738101|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796970|NCT02509117|37738102|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796971|NCT02509117|37738103|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16796972|NCT02509117|37738104|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
16796973|NCT02509117|37738095|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796974|NCT02509117|37738096|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796975|NCT02509117|37738097|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796976|NCT02509117|37738098|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796977|NCT02509117|37738099|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796978|NCT02509117|37738100|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796979|NCT02509117|37738101|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796980|NCT02509117|37738102|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796981|NCT02509117|37738103|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16796982|NCT02509117|37738104|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
16796983|NCT01654549|37738144|FG000|Overall Study|H.pylori eradication not successful|0|||
16796984|NCT01654549|37738145|FG001|Overall Study|H.pylori eradication not successful|1|||
16796985|NCT02508649|37738159|FG000|Overall Study|Withdrawal by Subject|4|||
16796986|NCT02508649|37738160|FG001|Overall Study|Withdrawal by Subject|6|||
16796987|NCT02508649|37738161|FG002|Overall Study|Withdrawal by Subject|5|||
16796988|NCT02508649|37738162|FG003|Overall Study|Withdrawal by Subject|6|||
16796989|NCT02508649|37738159|FG000|Overall Study|Investigator withdrew the subject|1|||
16796990|NCT02508649|37738160|FG001|Overall Study|Investigator withdrew the subject|2|||
16796991|NCT02508649|37738161|FG002|Overall Study|Investigator withdrew the subject|1|||
16796992|NCT02508649|37738162|FG003|Overall Study|Investigator withdrew the subject|0|||
16796993|NCT02508649|37738159|FG000|Overall Study|Post randomization screening failure|12|||
16796994|NCT02508649|37738160|FG001|Overall Study|Post randomization screening failure|4|||
16796995|NCT02508649|37738161|FG002|Overall Study|Post randomization screening failure|9|||
16796996|NCT02508649|37738162|FG003|Overall Study|Post randomization screening failure|3|||
16796997|NCT02508649|37738159|FG000|Overall Study|Lost to Follow-up|1|||
16796998|NCT02508649|37738160|FG001|Overall Study|Lost to Follow-up|1|||
16796999|NCT02508649|37738161|FG002|Overall Study|Lost to Follow-up|0|||
16797000|NCT02508649|37738162|FG003|Overall Study|Lost to Follow-up|1|||
16797001|NCT02505217|37738177|FG000|Overall Study|Withdrawal by Subject|1|||
16797002|NCT02505217|37738178|FG001|Overall Study|Withdrawal by Subject|2|||
16797003|NCT02504827|37738184|FG000|Overall Study|Could not produce sputum|1|||
16797004|NCT02504671|37738194|FG000|Overall Study|Withdrawal by Subject|1|||
16797005|NCT02504671|37738195|FG001|Overall Study|Withdrawal by Subject|5|||
16797006|NCT02504671|37738196|FG002|Overall Study|Withdrawal by Subject|4|||
16797007|NCT02504671|37738197|FG003|Overall Study|Withdrawal by Subject|4|||
16797008|NCT02504671|37738198|FG004|Overall Study|Withdrawal by Subject|5|||
16797009|NCT02504671|37738199|FG005|Overall Study|Withdrawal by Subject|3|||
16797010|NCT02504671|37738194|FG000|Overall Study|Lack of Efficacy|1|||
16797011|NCT02504671|37738195|FG001|Overall Study|Lack of Efficacy|3|||
16797012|NCT02504671|37738196|FG002|Overall Study|Lack of Efficacy|1|||
16797013|NCT02504671|37738197|FG003|Overall Study|Lack of Efficacy|0|||
16797014|NCT02504671|37738198|FG004|Overall Study|Lack of Efficacy|4|||
16797015|NCT02504671|37738199|FG005|Overall Study|Lack of Efficacy|4|||
16797016|NCT02504671|37738194|FG000|Overall Study|Adverse Event|1|||
16797017|NCT02504671|37738195|FG001|Overall Study|Adverse Event|1|||
16797018|NCT02504671|37738196|FG002|Overall Study|Adverse Event|0|||
16797019|NCT02504671|37738197|FG003|Overall Study|Adverse Event|1|||
16797020|NCT02504671|37738198|FG004|Overall Study|Adverse Event|0|||
16797021|NCT02504671|37738199|FG005|Overall Study|Adverse Event|2|||
16797022|NCT02504671|37738194|FG000|Overall Study|Protocol Violation|2|||
16797023|NCT02504671|37738195|FG001|Overall Study|Protocol Violation|1|||
17102289|NCT00067002|38241194|FG000|Overall Study|Graft Failure|5|||
16797024|NCT02504671|37738196|FG002|Overall Study|Protocol Violation|0|||
16797025|NCT02504671|37738197|FG003|Overall Study|Protocol Violation|0|||
16797026|NCT02504671|37738198|FG004|Overall Study|Protocol Violation|0|||
16797027|NCT02504671|37738199|FG005|Overall Study|Protocol Violation|1|||
16797028|NCT02504671|37738194|FG000|Overall Study|Lost to Follow-up|0|||
16797029|NCT02504671|37738195|FG001|Overall Study|Lost to Follow-up|0|||
16797030|NCT02504671|37738196|FG002|Overall Study|Lost to Follow-up|2|||
16797031|NCT02504671|37738197|FG003|Overall Study|Lost to Follow-up|0|||
16797032|NCT02504671|37738198|FG004|Overall Study|Lost to Follow-up|0|||
16797033|NCT02504671|37738199|FG005|Overall Study|Lost to Follow-up|1|||
16797034|NCT02504671|37738194|FG000|Overall Study|Protocol defined stopping criteria|7|||
16797035|NCT02504671|37738195|FG001|Overall Study|Protocol defined stopping criteria|4|||
16797036|NCT02504671|37738196|FG002|Overall Study|Protocol defined stopping criteria|3|||
16797037|NCT02504671|37738197|FG003|Overall Study|Protocol defined stopping criteria|5|||
16797038|NCT02504671|37738198|FG004|Overall Study|Protocol defined stopping criteria|3|||
16797039|NCT02504671|37738199|FG005|Overall Study|Protocol defined stopping criteria|3|||
16797040|NCT02314143|37738216|FG000|Overall Study|Adverse Event|0|||
16797041|NCT02314143|37738217|FG001|Overall Study|Adverse Event|6|||
16797042|NCT02314143|37738218|FG002|Overall Study|Adverse Event|4|||
16797043|NCT02314143|37738216|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
16797044|NCT02314143|37738217|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
16797045|NCT02314143|37738218|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
16797046|NCT02314143|37738216|FG000|Overall Study|Physician Decision|2|||
16797047|NCT02314143|37738217|FG001|Overall Study|Physician Decision|1|||
16797048|NCT02314143|37738218|FG002|Overall Study|Physician Decision|0|||
16797049|NCT02314143|37738216|FG000|Overall Study|Withdrawal by Subject|1|||
16797050|NCT02314143|37738217|FG001|Overall Study|Withdrawal by Subject|0|||
16797051|NCT02314143|37738218|FG002|Overall Study|Withdrawal by Subject|1|||
16797052|NCT02288091|37738227|FG000|Overall Study|Lost to Follow-up|1|||
16797053|NCT02288091|37738227|FG000|Overall Study|Screen fail|7|||
16797054|NCT02503501|37738233|FG000|Overall Study|Physician Decision|1|||
16797055|NCT02503501|37738234|FG001|Overall Study|Physician Decision|0|||
16797056|NCT02503501|37738233|FG000|Overall Study|Protocol Violation|0|||
16797057|NCT02503501|37738234|FG001|Overall Study|Protocol Violation|1|||
16797058|NCT02503501|37738233|FG000|Overall Study|Withdrawal by Subject|0|||
16797059|NCT02503501|37738234|FG001|Overall Study|Withdrawal by Subject|2|||
16797060|NCT02502097|37738244|FG000|Period 1|Adverse Event|0|||
16797061|NCT02502097|37738245|FG001|Period 1|Adverse Event|0|||
16797062|NCT02502097|37738246|FG002|Period 1|Adverse Event|1|||
16797063|NCT02502097|37738247|FG003|Period 1|Adverse Event|0|||
16797064|NCT02502097|37738244|FG000|Wash Out Period|Adverse Event|0|||
16797065|NCT02502097|37738245|FG001|Wash Out Period|Adverse Event|1|||
16797066|NCT02502097|37738246|FG002|Wash Out Period|Adverse Event|1|||
16797067|NCT02502097|37738247|FG003|Wash Out Period|Adverse Event|1|||
16797068|NCT02502097|37738244|FG000|Period 2|Adverse Event|0|||
16797069|NCT02502097|37738245|FG001|Period 2|Adverse Event|0|||
16797070|NCT02502097|37738246|FG002|Period 2|Adverse Event|1|||
16797071|NCT02502097|37738247|FG003|Period 2|Adverse Event|0|||
16797072|NCT02501629|37738256|FG000|Overall Study|Death|0|||
16797073|NCT02501629|37738257|FG001|Overall Study|Death|1|||
16797074|NCT02501629|37738256|FG000|Overall Study|Withdrawn from study by sponsor|1|||
16797075|NCT02501629|37738257|FG001|Overall Study|Withdrawn from study by sponsor|0|||
16797076|NCT02501629|37738256|FG000|Overall Study|Early termination by sponsor|1|||
16797077|NCT02501629|37738257|FG001|Overall Study|Early termination by sponsor|0|||
16797078|NCT02501629|37738256|FG000|Overall Study|Withdrawal by Subject|3|||
16797079|NCT02501629|37738257|FG001|Overall Study|Withdrawal by Subject|5|||
16797080|NCT02501629|37738256|FG000|Overall Study|Subject did not return to site|0|||
16797081|NCT02501629|37738257|FG001|Overall Study|Subject did not return to site|1|||
16797082|NCT02501473|37738270|FG000|Overall Study|Study Terminated|2|||
16797083|NCT02501473|37738271|FG001|Overall Study|Study Terminated|3|||
16797084|NCT02501473|37738272|FG002|Overall Study|Study Terminated|7|||
16797085|NCT02501473|37738273|FG003|Overall Study|Study Terminated|9|||
16797086|NCT02501473|37738274|FG004|Overall Study|Study Terminated|2|||
16797087|NCT02501473|37738275|FG005|Overall Study|Study Terminated|10|||
16797088|NCT02501473|37738276|FG006|Overall Study|Study Terminated|1|||
16797089|NCT02501473|37738277|FG007|Overall Study|Study Terminated|0|||
16797090|NCT02501473|37738270|FG000|Overall Study|Withdrawal by Subject|0|||
16797091|NCT02501473|37738271|FG001|Overall Study|Withdrawal by Subject|0|||
16797092|NCT02501473|37738272|FG002|Overall Study|Withdrawal by Subject|3|||
16797093|NCT02501473|37738273|FG003|Overall Study|Withdrawal by Subject|3|||
16797094|NCT02501473|37738274|FG004|Overall Study|Withdrawal by Subject|2|||
16797095|NCT02501473|37738275|FG005|Overall Study|Withdrawal by Subject|2|||
16797096|NCT02501473|37738276|FG006|Overall Study|Withdrawal by Subject|0|||
16797097|NCT02501473|37738277|FG007|Overall Study|Withdrawal by Subject|0|||
16797098|NCT02501473|37738270|FG000|Overall Study|Death|0|||
16797099|NCT02501473|37738271|FG001|Overall Study|Death|0|||
16797100|NCT02501473|37738272|FG002|Overall Study|Death|1|||
16797101|NCT02501473|37738273|FG003|Overall Study|Death|1|||
16797102|NCT02501473|37738274|FG004|Overall Study|Death|0|||
16797103|NCT02501473|37738275|FG005|Overall Study|Death|1|||
16797104|NCT02501473|37738276|FG006|Overall Study|Death|0|||
16797105|NCT02501473|37738277|FG007|Overall Study|Death|0|||
16797106|NCT02501473|37738270|FG000|Overall Study|Lost to Follow-up|1|||
16797107|NCT02501473|37738271|FG001|Overall Study|Lost to Follow-up|0|||
16797108|NCT02501473|37738272|FG002|Overall Study|Lost to Follow-up|1|||
16797109|NCT02501473|37738273|FG003|Overall Study|Lost to Follow-up|0|||
16797110|NCT02501473|37738274|FG004|Overall Study|Lost to Follow-up|0|||
16797111|NCT02501473|37738275|FG005|Overall Study|Lost to Follow-up|1|||
16797112|NCT02501473|37738276|FG006|Overall Study|Lost to Follow-up|0|||
16797113|NCT02501473|37738277|FG007|Overall Study|Lost to Follow-up|0|||
16797114|NCT02501473|37738270|FG000|Overall Study|Reason not specified|0|||
16797115|NCT02501473|37738271|FG001|Overall Study|Reason not specified|0|||
16797116|NCT02501473|37738272|FG002|Overall Study|Reason not specified|1|||
16797117|NCT02501473|37738273|FG003|Overall Study|Reason not specified|1|||
16797118|NCT02501473|37738274|FG004|Overall Study|Reason not specified|0|||
16797119|NCT02501473|37738275|FG005|Overall Study|Reason not specified|0|||
16797120|NCT02501473|37738276|FG006|Overall Study|Reason not specified|0|||
16797121|NCT02501473|37738277|FG007|Overall Study|Reason not specified|0|||
16797122|NCT02501161|37738295|FG000|Overall Study|Adverse Event|2|||
16797123|NCT02501161|37738296|FG001|Overall Study|Adverse Event|6|||
16797124|NCT02501161|37738295|FG000|Overall Study|Lost to Follow-up|7|||
16797125|NCT02501161|37738296|FG001|Overall Study|Lost to Follow-up|4|||
16797126|NCT02501161|37738295|FG000|Overall Study|Withdrawal by Subject|10|||
16797127|NCT02501161|37738296|FG001|Overall Study|Withdrawal by Subject|15|||
16797128|NCT02501161|37738295|FG000|Overall Study|Other|3|||
16797129|NCT02501161|37738296|FG001|Overall Study|Other|0|||
16797130|NCT02500537|37738304|FG000|Overall Study|Death|2|||
16797131|NCT02500537|37738305|FG001|Overall Study|Death|0|||
16797132|NCT02500537|37738304|FG000|Overall Study|Lost to Follow-up|0|||
16797133|NCT02500537|37738305|FG001|Overall Study|Lost to Follow-up|1|||
16797134|NCT02500537|37738304|FG000|Overall Study|Withdrawal by Subject|1|||
16797135|NCT02500537|37738305|FG001|Overall Study|Withdrawal by Subject|0|||
16797136|NCT02498821|37738314|FG000|Overall Study|Screen failure|3|||
16797137|NCT02498821|37738315|FG001|Overall Study|Screen failure|5|||
16797138|NCT02313909|37738323|FG000|Overall Study|Consent withdrawn by participant|33|||
16797139|NCT02313909|37738324|FG001|Overall Study|Consent withdrawn by participant|33|||
16797140|NCT02313909|37738323|FG000|Overall Study|Lost to Follow-up|24|||
16797141|NCT02313909|37738324|FG001|Overall Study|Lost to Follow-up|17|||
16797142|NCT02287623|37738332|FG000|Overall Study|Protocol Violation|0|||
16797143|NCT02287623|37738333|FG001|Overall Study|Protocol Violation|1|||
16797144|NCT02287467|37738341|FG000|Overall Study|Protocol Violation|12|||
16797145|NCT02287467|37738342|FG001|Overall Study|Protocol Violation|9|||
16797146|NCT02287233|37738354|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
16797147|NCT02287233|37738355|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
16797148|NCT02287233|37738356|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
16797149|NCT02287233|37738354|FG000|Overall Study|Adverse Event Related to Progression|0|||
16797150|NCT02287233|37738355|FG001|Overall Study|Adverse Event Related to Progression|2|||
16797151|NCT02287233|37738356|FG002|Overall Study|Adverse Event Related to Progression|8|||
16797152|NCT02287233|37738354|FG000|Overall Study|Physician Decision|1|||
16797153|NCT02287233|37738355|FG001|Overall Study|Physician Decision|2|||
16797154|NCT02287233|37738356|FG002|Overall Study|Physician Decision|4|||
16797155|NCT02287233|37738354|FG000|Overall Study|Progressive Disease with Death|0|||
16797156|NCT02287233|37738355|FG001|Overall Study|Progressive Disease with Death|0|||
16797157|NCT02287233|37738356|FG002|Overall Study|Progressive Disease with Death|10|||
16797158|NCT02287233|37738354|FG000|Overall Study|Progressive Disease Without Death|2|||
16797159|NCT02287233|37738355|FG001|Overall Study|Progressive Disease Without Death|3|||
16797160|NCT02287233|37738356|FG002|Overall Study|Progressive Disease Without Death|20|||
16797161|NCT02287233|37738354|FG000|Overall Study|Withdrawal by Subject|1|||
16797162|NCT02287233|37738355|FG001|Overall Study|Withdrawal by Subject|1|||
16797163|NCT02287233|37738356|FG002|Overall Study|Withdrawal by Subject|7|||
16797164|NCT02287233|37738354|FG000|Overall Study|Other|3|||
16797165|NCT02287233|37738355|FG001|Overall Study|Other|0|||
16797166|NCT02287233|37738356|FG002|Overall Study|Other|15|||
16797167|NCT02287233|37738354|FG000|Overall Study|Did Not Receive Treatment|0|||
16797168|NCT02287233|37738355|FG001|Overall Study|Did Not Receive Treatment|0|||
16797169|NCT02287233|37738356|FG002|Overall Study|Did Not Receive Treatment|2|||
16797170|NCT01646385|37738369|FG000|Overall Study|Death|202|||
16797171|NCT01646385|37738370|FG001|Overall Study|Death|222|||
16797172|NCT01646385|37738369|FG000|Overall Study|Switched to alternate biologic|636|||
16797173|NCT01646385|37738370|FG001|Overall Study|Switched to alternate biologic|649|||
16797174|NCT02286843|37738376|FG000|Overall Study|Not Treated|4|||
16797175|NCT02286843|37738376|FG000|Overall Study|Protocol Violation|1|||
16797176|NCT02286843|37738376|FG000|Overall Study|Withdrawal by Subject|1|||
16797177|NCT02282163|37738380|FG000|Overall Study|Protocol Violation|1|||
16797178|NCT02281773|37738398|FG000|Overall Study|Adverse Event|6|||
16797179|NCT02281773|37738399|FG001|Overall Study|Adverse Event|1|||
16797180|NCT02281773|37738400|FG002|Overall Study|Adverse Event|4|||
16797181|NCT02281773|37738401|FG003|Overall Study|Adverse Event|8|||
16797182|NCT02281773|37738402|FG004|Overall Study|Adverse Event|9|||
16797183|NCT02281773|37738398|FG000|Overall Study|Protocol Violation|1|||
16797184|NCT02281773|37738399|FG001|Overall Study|Protocol Violation|0|||
16797185|NCT02281773|37738400|FG002|Overall Study|Protocol Violation|0|||
16797186|NCT02281773|37738401|FG003|Overall Study|Protocol Violation|2|||
16797187|NCT02281773|37738402|FG004|Overall Study|Protocol Violation|2|||
16797188|NCT02281773|37738398|FG000|Overall Study|Lost to Follow-up|2|||
16797189|NCT02281773|37738399|FG001|Overall Study|Lost to Follow-up|2|||
16797190|NCT02281773|37738400|FG002|Overall Study|Lost to Follow-up|6|||
16797191|NCT02281773|37738401|FG003|Overall Study|Lost to Follow-up|2|||
16797192|NCT02281773|37738402|FG004|Overall Study|Lost to Follow-up|10|||
16797193|NCT02281773|37738398|FG000|Overall Study|Withdrawal by Subject|2|||
16797194|NCT02281773|37738399|FG001|Overall Study|Withdrawal by Subject|8|||
16797195|NCT02281773|37738400|FG002|Overall Study|Withdrawal by Subject|6|||
16797196|NCT02281773|37738401|FG003|Overall Study|Withdrawal by Subject|6|||
16797197|NCT02281773|37738402|FG004|Overall Study|Withdrawal by Subject|8|||
16797198|NCT02281773|37738398|FG000|Overall Study|Other Reason|0|||
16797199|NCT02281773|37738399|FG001|Overall Study|Other Reason|4|||
16797200|NCT02281773|37738400|FG002|Overall Study|Other Reason|2|||
16797201|NCT02281773|37738401|FG003|Overall Study|Other Reason|3|||
16797202|NCT02281773|37738402|FG004|Overall Study|Other Reason|1|||
16797203|NCT02285361|37738414|FG000|Overall Study|Protocol Violation|43|||
16797204|NCT02285361|37738414|FG000|Overall Study|Lost to Follow-up|5|||
16797205|NCT02285361|37738414|FG000|Overall Study|Not taken GIOTRIF|2|||
16797206|NCT02285361|37738414|FG000|Overall Study|Consented prior to the contract date|1|||
16797207|NCT02354235|37738420|FG000|Overall Study|Adverse Event|2|||
16797208|NCT02354235|37738421|FG001|Overall Study|Adverse Event|2|||
16797209|NCT02354235|37738420|FG000|Overall Study|Physician Decision|0|||
16797210|NCT02354235|37738421|FG001|Overall Study|Physician Decision|1|||
16797211|NCT02354235|37738420|FG000|Overall Study|Withdrawal by Subject|1|||
16797212|NCT02354235|37738421|FG001|Overall Study|Withdrawal by Subject|3|||
16797213|NCT02354235|37738420|FG000|Overall Study|Conflict with the stopping criteria|0|||
16797214|NCT02354235|37738421|FG001|Overall Study|Conflict with the stopping criteria|1|||
16797215|NCT02280291|37738431|FG000|Overall Study|Lost to Follow-up|2|||
16797216|NCT02280291|37738432|FG001|Overall Study|Lost to Follow-up|1|||
16797217|NCT02280291|37738433|FG002|Overall Study|Lost to Follow-up|3|||
16797218|NCT02280291|37738434|FG003|Overall Study|Lost to Follow-up|8|||
16797219|NCT02280291|37738431|FG000|Overall Study|Protocol Violation|1|||
16797220|NCT02280291|37738432|FG001|Overall Study|Protocol Violation|0|||
16797221|NCT02280291|37738433|FG002|Overall Study|Protocol Violation|0|||
16797222|NCT02280291|37738434|FG003|Overall Study|Protocol Violation|0|||
16797223|NCT02280291|37738431|FG000|Overall Study|Other|1|||
16797224|NCT02280291|37738432|FG001|Overall Study|Other|1|||
16797225|NCT02280291|37738433|FG002|Overall Study|Other|0|||
16797226|NCT02280291|37738434|FG003|Overall Study|Other|0|||
16797227|NCT02284893|37738448|FG000|26 Week (Short Term)|Adverse Event|1|||
16797228|NCT02284893|37738449|FG001|26 Week (Short Term)|Adverse Event|9|||
16797229|NCT02284893|37738448|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
16797230|NCT02284893|37738449|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
16797231|NCT02284893|37738448|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
16797232|NCT02284893|37738449|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
16797233|NCT02284893|37738448|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
16797234|NCT02284893|37738449|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
16797235|NCT02284893|37738448|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
16797236|NCT02284893|37738449|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
16797237|NCT02284893|37738448|FG000|26 Week (Short Term)|Other|1|||
16797238|NCT02284893|37738449|FG001|26 Week (Short Term)|Other|1|||
16797239|NCT02284893|37738448|FG000|52 Week (Long Term)|Adverse Event|3|||
16797240|NCT02284893|37738449|FG001|52 Week (Long Term)|Adverse Event|1|||
16797241|NCT02284893|37738448|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
16797242|NCT02284893|37738449|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
16797243|NCT02284893|37738448|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
16797244|NCT02284893|37738449|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
16797245|NCT02284893|37738448|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
16797246|NCT02284893|37738449|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
16797247|NCT02284893|37738448|FG000|52 Week (Long Term)|Non-Compliance|2|||
16797248|NCT02284893|37738449|FG001|52 Week (Long Term)|Non-Compliance|3|||
16797249|NCT02284347|37738455|FG000|Overall Study|Lost to Follow-up|2|||
16797250|NCT02284347|37738455|FG000|Overall Study|Withdrawn prior to treatment|1|||
16797251|NCT02279043|37738462|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
16797252|NCT02279043|37738463|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
16797253|NCT02279043|37738464|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
16797254|NCT02279043|37738462|FG000|Overall Study|Lost to Follow-up|46|||
16797255|NCT02279043|37738463|FG001|Overall Study|Lost to Follow-up|88|||
16797256|NCT02279043|37738464|FG002|Overall Study|Lost to Follow-up|0|||
16797257|NCT02283411|37738470|FG000|Overall Study|Withdrawal by Subject|3|||
16797258|NCT02283411|37738470|FG000|Overall Study|Screen Failed|28|||
16797259|NCT02351817|37738474|FG000|Period 1|Adverse Event|1|||
16797260|NCT02351817|37738475|FG001|Period 1|Adverse Event|2|||
16797261|NCT02351817|37738474|FG000|Period 1|Lack of Efficacy|0|||
16797262|NCT02351817|37738475|FG001|Period 1|Lack of Efficacy|1|||
16797263|NCT02351817|37738474|FG000|Period 2|Adverse Event|0|||
16797264|NCT02351817|37738475|FG001|Period 2|Adverse Event|2|||
16797265|NCT02351817|37738474|FG000|Period 2|Protocol Violation|1|||
16797266|NCT02351817|37738475|FG001|Period 2|Protocol Violation|0|||
16797267|NCT02351349|37738484|FG000|Overall Study|Withdrawal by Subject|2|||
16797268|NCT02351349|37738485|FG001|Overall Study|Withdrawal by Subject|3|||
16797269|NCT02484547|37738499|FG000|Placebo-Controlled Period|Adverse Event|10|||
16797270|NCT02484547|37738500|FG001|Placebo-Controlled Period|Adverse Event|13|||
16797271|NCT02484547|37738501|FG002|Placebo-Controlled Period|Adverse Event|20|||
16797272|NCT02484547|37738502|FG003|Placebo-Controlled Period|Adverse Event|0|||
16797273|NCT02484547|37738503|FG004|Placebo-Controlled Period|Adverse Event|0|||
16797274|NCT02484547|37738504|FG005|Placebo-Controlled Period|Adverse Event|0|||
16797275|NCT02484547|37738505|FG006|Placebo-Controlled Period|Adverse Event|0|||
16797276|NCT02484547|37738499|FG000|Placebo-Controlled Period|Change of Treatment|0|||
16797277|NCT02484547|37738500|FG001|Placebo-Controlled Period|Change of Treatment|0|||
16797278|NCT02484547|37738501|FG002|Placebo-Controlled Period|Change of Treatment|1|||
16797279|NCT02484547|37738502|FG003|Placebo-Controlled Period|Change of Treatment|0|||
16797280|NCT02484547|37738503|FG004|Placebo-Controlled Period|Change of Treatment|0|||
16797281|NCT02484547|37738504|FG005|Placebo-Controlled Period|Change of Treatment|0|||
16797282|NCT02484547|37738505|FG006|Placebo-Controlled Period|Change of Treatment|0|||
16797283|NCT02484547|37738499|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
16797284|NCT02484547|37738500|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
16797285|NCT02484547|37738501|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
16797286|NCT02484547|37738502|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
16797287|NCT02484547|37738503|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
16797288|NCT02484547|37738504|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
16797289|NCT02484547|37738505|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
16797290|NCT02484547|37738499|FG000|Placebo-Controlled Period|Death|5|||
16797291|NCT02484547|37738500|FG001|Placebo-Controlled Period|Death|0|||
16797292|NCT02484547|37738501|FG002|Placebo-Controlled Period|Death|6|||
16797293|NCT02484547|37738502|FG003|Placebo-Controlled Period|Death|0|||
16797294|NCT02484547|37738503|FG004|Placebo-Controlled Period|Death|0|||
16797295|NCT02484547|37738504|FG005|Placebo-Controlled Period|Death|0|||
16797296|NCT02484547|37738505|FG006|Placebo-Controlled Period|Death|0|||
16797297|NCT02484547|37738499|FG000|Placebo-Controlled Period|Disease Progression|2|||
16797298|NCT02484547|37738500|FG001|Placebo-Controlled Period|Disease Progression|0|||
16797299|NCT02484547|37738501|FG002|Placebo-Controlled Period|Disease Progression|1|||
16797300|NCT02484547|37738502|FG003|Placebo-Controlled Period|Disease Progression|0|||
16797301|NCT02484547|37738503|FG004|Placebo-Controlled Period|Disease Progression|0|||
16797302|NCT02484547|37738504|FG005|Placebo-Controlled Period|Disease Progression|0|||
16797303|NCT02484547|37738505|FG006|Placebo-Controlled Period|Disease Progression|0|||
16797304|NCT02484547|37738499|FG000|Placebo-Controlled Period|Investigator Decision|2|||
16797305|NCT02484547|37738500|FG001|Placebo-Controlled Period|Investigator Decision|2|||
16797306|NCT02484547|37738501|FG002|Placebo-Controlled Period|Investigator Decision|5|||
16797307|NCT02484547|37738502|FG003|Placebo-Controlled Period|Investigator Decision|0|||
16797308|NCT02484547|37738503|FG004|Placebo-Controlled Period|Investigator Decision|0|||
16797309|NCT02484547|37738504|FG005|Placebo-Controlled Period|Investigator Decision|0|||
16797310|NCT02484547|37738505|FG006|Placebo-Controlled Period|Investigator Decision|0|||
16797311|NCT02484547|37738499|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
16797312|NCT02484547|37738500|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
16797313|NCT02484547|37738501|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
16797314|NCT02484547|37738502|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
16797315|NCT02484547|37738503|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
16797316|NCT02484547|37738504|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
16797317|NCT02484547|37738505|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
16797318|NCT02484547|37738499|FG000|Placebo-Controlled Period|Relocation|1|||
16797319|NCT02484547|37738500|FG001|Placebo-Controlled Period|Relocation|1|||
16797320|NCT02484547|37738501|FG002|Placebo-Controlled Period|Relocation|1|||
16797321|NCT02484547|37738502|FG003|Placebo-Controlled Period|Relocation|0|||
16797322|NCT02484547|37738503|FG004|Placebo-Controlled Period|Relocation|0|||
16797323|NCT02484547|37738504|FG005|Placebo-Controlled Period|Relocation|0|||
16909302|NCT01721772|38018156|FG001|Treatment|Lost to Follow-up|1|||
16797324|NCT02484547|37738505|FG006|Placebo-Controlled Period|Relocation|0|||
16797325|NCT02484547|37738499|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
17102290|NCT00067002|38241195|FG001|Overall Study|Graft Failure|6|||
16797326|NCT02484547|37738500|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
16797327|NCT02484547|37738501|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
16797328|NCT02484547|37738502|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
16797329|NCT02484547|37738503|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
16797330|NCT02484547|37738504|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
16797331|NCT02484547|37738505|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
16797332|NCT02484547|37738499|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
16797333|NCT02484547|37738500|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
16797334|NCT02484547|37738501|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
16797335|NCT02484547|37738502|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16797336|NCT02484547|37738503|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16797337|NCT02484547|37738504|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16797338|NCT02484547|37738505|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16797339|NCT02484547|37738499|FG000|Placebo-Controlled Period|Reason not Specified|216|||
16797340|NCT02484547|37738500|FG001|Placebo-Controlled Period|Reason not Specified|194|||
16797341|NCT02484547|37738501|FG002|Placebo-Controlled Period|Reason not Specified|183|||
16797342|NCT02484547|37738502|FG003|Placebo-Controlled Period|Reason not Specified|0|||
16797343|NCT02484547|37738503|FG004|Placebo-Controlled Period|Reason not Specified|0|||
16797344|NCT02484547|37738504|FG005|Placebo-Controlled Period|Reason not Specified|0|||
16797345|NCT02484547|37738505|FG006|Placebo-Controlled Period|Reason not Specified|0|||
16797346|NCT02484547|37738499|FG000|Long-Term Extension Period|Adverse Event|0|||
16797347|NCT02484547|37738500|FG001|Long-Term Extension Period|Adverse Event|0|||
16797348|NCT02484547|37738501|FG002|Long-Term Extension Period|Adverse Event|0|||
16797349|NCT02484547|37738502|FG003|Long-Term Extension Period|Adverse Event|0|||
16797350|NCT02484547|37738503|FG004|Long-Term Extension Period|Adverse Event|1|||
16797351|NCT02484547|37738504|FG005|Long-Term Extension Period|Adverse Event|3|||
16797352|NCT02484547|37738505|FG006|Long-Term Extension Period|Adverse Event|2|||
16797353|NCT02484547|37738499|FG000|Long-Term Extension Period|Death|0|||
16797354|NCT02484547|37738500|FG001|Long-Term Extension Period|Death|0|||
16797355|NCT02484547|37738501|FG002|Long-Term Extension Period|Death|0|||
16797356|NCT02484547|37738502|FG003|Long-Term Extension Period|Death|0|||
16797357|NCT02484547|37738503|FG004|Long-Term Extension Period|Death|0|||
16797358|NCT02484547|37738504|FG005|Long-Term Extension Period|Death|3|||
16797359|NCT02484547|37738505|FG006|Long-Term Extension Period|Death|0|||
16797360|NCT02484547|37738499|FG000|Long-Term Extension Period|Disease Progression|0|||
16797361|NCT02484547|37738500|FG001|Long-Term Extension Period|Disease Progression|0|||
16797362|NCT02484547|37738501|FG002|Long-Term Extension Period|Disease Progression|0|||
16797363|NCT02484547|37738502|FG003|Long-Term Extension Period|Disease Progression|0|||
16797364|NCT02484547|37738503|FG004|Long-Term Extension Period|Disease Progression|2|||
16797365|NCT02484547|37738504|FG005|Long-Term Extension Period|Disease Progression|4|||
16797366|NCT02484547|37738505|FG006|Long-Term Extension Period|Disease Progression|0|||
16797367|NCT02484547|37738499|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
16797368|NCT02484547|37738500|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
16797369|NCT02484547|37738501|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
16797370|NCT02484547|37738502|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
16797371|NCT02484547|37738503|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
16797372|NCT02484547|37738504|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
16797373|NCT02484547|37738505|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
16797374|NCT02484547|37738499|FG000|Long-Term Extension Period|Loss of Capacity|0|||
16797375|NCT02484547|37738500|FG001|Long-Term Extension Period|Loss of Capacity|0|||
16797376|NCT02484547|37738501|FG002|Long-Term Extension Period|Loss of Capacity|0|||
16797377|NCT02484547|37738502|FG003|Long-Term Extension Period|Loss of Capacity|0|||
16797378|NCT02484547|37738503|FG004|Long-Term Extension Period|Loss of Capacity|1|||
16797379|NCT02484547|37738504|FG005|Long-Term Extension Period|Loss of Capacity|0|||
16797380|NCT02484547|37738505|FG006|Long-Term Extension Period|Loss of Capacity|0|||
16797381|NCT02484547|37738499|FG000|Long-Term Extension Period|Change of Treatment|0|||
16797382|NCT02484547|37738500|FG001|Long-Term Extension Period|Change of Treatment|0|||
16797383|NCT02484547|37738501|FG002|Long-Term Extension Period|Change of Treatment|0|||
16797384|NCT02484547|37738502|FG003|Long-Term Extension Period|Change of Treatment|0|||
16797385|NCT02484547|37738503|FG004|Long-Term Extension Period|Change of Treatment|0|||
16797386|NCT02484547|37738504|FG005|Long-Term Extension Period|Change of Treatment|0|||
16797387|NCT02484547|37738505|FG006|Long-Term Extension Period|Change of Treatment|1|||
16797388|NCT02484547|37738499|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
16797389|NCT02484547|37738500|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
16797390|NCT02484547|37738501|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
16797391|NCT02484547|37738502|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
16797392|NCT02484547|37738503|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
16797393|NCT02484547|37738504|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
16797394|NCT02484547|37738505|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
16797395|NCT02484547|37738499|FG000|Long-Term Extension Period|Investigator Decision|0|||
16797396|NCT02484547|37738500|FG001|Long-Term Extension Period|Investigator Decision|0|||
16797397|NCT02484547|37738501|FG002|Long-Term Extension Period|Investigator Decision|0|||
16797398|NCT02484547|37738502|FG003|Long-Term Extension Period|Investigator Decision|2|||
16797399|NCT02484547|37738503|FG004|Long-Term Extension Period|Investigator Decision|1|||
16797400|NCT02484547|37738504|FG005|Long-Term Extension Period|Investigator Decision|0|||
16797401|NCT02484547|37738505|FG006|Long-Term Extension Period|Investigator Decision|1|||
16797402|NCT02484547|37738499|FG000|Long-Term Extension Period|Relocation|0|||
16797403|NCT02484547|37738500|FG001|Long-Term Extension Period|Relocation|0|||
16797404|NCT02484547|37738501|FG002|Long-Term Extension Period|Relocation|0|||
16797405|NCT02484547|37738502|FG003|Long-Term Extension Period|Relocation|1|||
16797406|NCT02484547|37738503|FG004|Long-Term Extension Period|Relocation|1|||
16797407|NCT02484547|37738504|FG005|Long-Term Extension Period|Relocation|0|||
16797408|NCT02484547|37738505|FG006|Long-Term Extension Period|Relocation|0|||
16797409|NCT02484547|37738499|FG000|Long-Term Extension Period|Study Visit Burden|0|||
16797410|NCT02484547|37738500|FG001|Long-Term Extension Period|Study Visit Burden|0|||
16797411|NCT02484547|37738501|FG002|Long-Term Extension Period|Study Visit Burden|0|||
16797412|NCT02484547|37738502|FG003|Long-Term Extension Period|Study Visit Burden|2|||
16797413|NCT02484547|37738503|FG004|Long-Term Extension Period|Study Visit Burden|0|||
16797414|NCT02484547|37738504|FG005|Long-Term Extension Period|Study Visit Burden|0|||
16797415|NCT02484547|37738505|FG006|Long-Term Extension Period|Study Visit Burden|3|||
16797416|NCT02484547|37738499|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
16797417|NCT02484547|37738500|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
16797418|NCT02484547|37738501|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
16797419|NCT02484547|37738502|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
16797420|NCT02484547|37738503|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
16797421|NCT02484547|37738504|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
16797422|NCT02484547|37738505|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
16797423|NCT02484547|37738499|FG000|Long-Term Extension Period|Reason not Specified|0|||
16797424|NCT02484547|37738500|FG001|Long-Term Extension Period|Reason not Specified|0|||
16797425|NCT02484547|37738501|FG002|Long-Term Extension Period|Reason not Specified|0|||
16797426|NCT02484547|37738502|FG003|Long-Term Extension Period|Reason not Specified|119|||
16797427|NCT02484547|37738503|FG004|Long-Term Extension Period|Reason not Specified|117|||
16797428|NCT02484547|37738504|FG005|Long-Term Extension Period|Reason not Specified|223|||
16797429|NCT02484547|37738505|FG006|Long-Term Extension Period|Reason not Specified|231|||
16797430|NCT02517541|37738517|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
16797431|NCT02517541|37738517|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
16797432|NCT02517541|37738517|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
16797433|NCT02517541|37738517|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
16797434|NCT02517541|37738517|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
16797435|NCT02517541|37738517|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
16797436|NCT02496091|37738523|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16797437|NCT02483611|37738531|FG000|Overall Study|Protocol Violation|0|||
16797438|NCT02483611|37738532|FG001|Overall Study|Protocol Violation|0|||
16797439|NCT02483611|37738533|FG002|Overall Study|Protocol Violation|1|||
16797440|NCT02483533|37738543|FG000|Overall Study|Lack of Efficacy|50|||
16797441|NCT02483533|37738544|FG001|Overall Study|Lack of Efficacy|50|||
16797442|NCT02482129|37738552|FG000|Overall Study|Adverse Event-prior to treatment|0|||
16797443|NCT02482129|37738553|FG001|Overall Study|Adverse Event-prior to treatment|1|||
16797444|NCT02482129|37738552|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
16797445|NCT02482129|37738553|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
16797446|NCT02482129|37738552|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
16797447|NCT02482129|37738553|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
16797448|NCT02482129|37738552|FG000|Overall Study|Criteria not met-prior to treatment|1|||
16797449|NCT02482129|37738553|FG001|Overall Study|Criteria not met-prior to treatment|0|||
16797450|NCT02482129|37738552|FG000|Overall Study|Adverse Event|1|||
16797451|NCT02482129|37738553|FG001|Overall Study|Adverse Event|0|||
16797452|NCT02482129|37738552|FG000|Overall Study|Withdrawal by Subject|2|||
16797453|NCT02482129|37738553|FG001|Overall Study|Withdrawal by Subject|0|||
16797454|NCT02482129|37738552|FG000|Overall Study|Criteria not met|1|||
16797455|NCT02482129|37738553|FG001|Overall Study|Criteria not met|0|||
16797456|NCT02495857|37738564|FG000|Overall Study|Adverse Event|5|||
16797457|NCT02495857|37738565|FG001|Overall Study|Adverse Event|0|||
16797458|NCT02495857|37738566|FG002|Overall Study|Adverse Event|1|||
16797459|NCT02495857|37738564|FG000|Overall Study|Withdrawal by Subject|9|||
16797460|NCT02495857|37738565|FG001|Overall Study|Withdrawal by Subject|6|||
16797461|NCT02495857|37738566|FG002|Overall Study|Withdrawal by Subject|10|||
16797462|NCT02495857|37738564|FG000|Overall Study|Physician Decision|0|||
16797463|NCT02495857|37738565|FG001|Overall Study|Physician Decision|1|||
16797464|NCT02495857|37738566|FG002|Overall Study|Physician Decision|0|||
16797465|NCT02495857|37738564|FG000|Overall Study|Protocol Violation|1|||
16797466|NCT02495857|37738565|FG001|Overall Study|Protocol Violation|1|||
16797467|NCT02495857|37738566|FG002|Overall Study|Protocol Violation|2|||
16797468|NCT02495857|37738564|FG000|Overall Study|Lost to Follow-up|4|||
16797469|NCT02495857|37738565|FG001|Overall Study|Lost to Follow-up|5|||
16797470|NCT02495857|37738566|FG002|Overall Study|Lost to Follow-up|3|||
16797471|NCT02495857|37738564|FG000|Overall Study|Other|3|||
16797472|NCT02495857|37738565|FG001|Overall Study|Other|3|||
16797473|NCT02495857|37738566|FG002|Overall Study|Other|2|||
16797474|NCT02495389|37738574|FG000|Overall Study|Withdrawal by Subject|40|||
16797475|NCT02495233|37738580|FG000|Overall Study|Miscellaneous|0|||
16797476|NCT02495233|37738581|FG001|Overall Study|Miscellaneous|1|||
16797477|NCT02495077|37738589|FG000|Overall Study|Adverse Event|0|||
16797478|NCT02495077|37738590|FG001|Overall Study|Adverse Event|1|||
16797479|NCT02495077|37738591|FG002|Overall Study|Adverse Event|1|||
16797480|NCT02495077|37738592|FG003|Overall Study|Adverse Event|0|||
16797481|NCT02495077|37738589|FG000|Overall Study|Death|3|||
16797482|NCT02495077|37738590|FG001|Overall Study|Death|5|||
16797483|NCT02495077|37738591|FG002|Overall Study|Death|0|||
16797484|NCT02495077|37738592|FG003|Overall Study|Death|0|||
16797485|NCT02495077|37738589|FG000|Overall Study|Lost to Follow-up|6|||
16797486|NCT02495077|37738590|FG001|Overall Study|Lost to Follow-up|4|||
16797487|NCT02495077|37738591|FG002|Overall Study|Lost to Follow-up|0|||
16797488|NCT02495077|37738592|FG003|Overall Study|Lost to Follow-up|0|||
16797489|NCT02495077|37738589|FG000|Overall Study|Physician Decision|2|||
16797490|NCT02495077|37738590|FG001|Overall Study|Physician Decision|1|||
16797491|NCT02495077|37738591|FG002|Overall Study|Physician Decision|4|||
16797492|NCT02495077|37738592|FG003|Overall Study|Physician Decision|0|||
16797493|NCT02495077|37738589|FG000|Overall Study|Protocol Violation|0|||
16797494|NCT02495077|37738590|FG001|Overall Study|Protocol Violation|1|||
16797495|NCT02495077|37738591|FG002|Overall Study|Protocol Violation|0|||
16797496|NCT02495077|37738592|FG003|Overall Study|Protocol Violation|0|||
16797497|NCT02495077|37738589|FG000|Overall Study|Screen Failure|0|||
16797498|NCT02495077|37738590|FG001|Overall Study|Screen Failure|0|||
16797499|NCT02495077|37738591|FG002|Overall Study|Screen Failure|0|||
16797500|NCT02495077|37738592|FG003|Overall Study|Screen Failure|48|||
16797501|NCT02495077|37738589|FG000|Overall Study|Withdrawal by Subject|7|||
16797502|NCT02495077|37738590|FG001|Overall Study|Withdrawal by Subject|7|||
16797503|NCT02495077|37738591|FG002|Overall Study|Withdrawal by Subject|7|||
16797504|NCT02495077|37738592|FG003|Overall Study|Withdrawal by Subject|0|||
16797505|NCT02495077|37738589|FG000|Overall Study|Covid-19 research restrictions|1|||
16797506|NCT02495077|37738590|FG001|Overall Study|Covid-19 research restrictions|0|||
16797507|NCT02495077|37738591|FG002|Overall Study|Covid-19 research restrictions|0|||
16797508|NCT02495077|37738592|FG003|Overall Study|Covid-19 research restrictions|0|||
16797509|NCT02495077|37738589|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
16797510|NCT02495077|37738590|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
16797511|NCT02495077|37738591|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
16797512|NCT02495077|37738592|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
16797513|NCT02495077|37738589|FG000|Overall Study|Incarcerated|0|||
16797514|NCT02495077|37738590|FG001|Overall Study|Incarcerated|1|||
16797515|NCT02495077|37738591|FG002|Overall Study|Incarcerated|0|||
16797516|NCT02495077|37738592|FG003|Overall Study|Incarcerated|0|||
16797517|NCT02495077|37738589|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
16797518|NCT02495077|37738590|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
16797519|NCT02495077|37738591|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
16797520|NCT02495077|37738592|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
16797521|NCT02495077|37738589|FG000|Overall Study|Timing of transplant and randomization|0|||
16797522|NCT02495077|37738590|FG001|Overall Study|Timing of transplant and randomization|0|||
16797523|NCT02495077|37738591|FG002|Overall Study|Timing of transplant and randomization|5|||
16797524|NCT02495077|37738592|FG003|Overall Study|Timing of transplant and randomization|0|||
16797525|NCT02278341|37738600|FG000|Overall Study|Randomized but never received study drug|1|||
16797526|NCT02278341|37738601|FG001|Overall Study|Randomized but never received study drug|1|||
16797527|NCT02278341|37738600|FG000|Overall Study|Adverse Event|3|||
16797528|NCT02278341|37738601|FG001|Overall Study|Adverse Event|0|||
16797529|NCT02278341|37738600|FG000|Overall Study|Death|68|||
16797530|NCT02278341|37738601|FG001|Overall Study|Death|56|||
16797531|NCT02278341|37738600|FG000|Overall Study|Withdrawal by Subject|30|||
16797532|NCT02278341|37738601|FG001|Overall Study|Withdrawal by Subject|19|||
16797533|NCT02278341|37738600|FG000|Overall Study|Lost to Follow-up|0|||
16797534|NCT02278341|37738601|FG001|Overall Study|Lost to Follow-up|1|||
16797535|NCT02278341|37738600|FG000|Overall Study|Physician Decision|1|||
16797536|NCT02278341|37738601|FG001|Overall Study|Physician Decision|1|||
16797537|NCT02278341|37738600|FG000|Overall Study|Miscellaneous|15|||
16797538|NCT02278341|37738601|FG001|Overall Study|Miscellaneous|14|||
16797539|NCT02282631|37738610|FG000|Overall Study|Lost to Follow-up|2|||
16797540|NCT02282631|37738611|FG001|Overall Study|Lost to Follow-up|0|||
16797541|NCT02278263|37738626|FG000|Overall Study|Protocol Violation|7|||
16797542|NCT02278263|37738627|FG001|Overall Study|Protocol Violation|0|||
16797543|NCT02278263|37738628|FG002|Overall Study|Protocol Violation|9|||
16797544|NCT02349789|37738639|FG000|Overall Study|Withdrawal by Subject|2|||
16797545|NCT02349711|37738645|FG000|Overall Study|Withdrawal by Subject|2|||
16797546|NCT02349711|37738646|FG001|Overall Study|Withdrawal by Subject|1|||
16797547|NCT02349711|37738645|FG000|Overall Study|Lost to Follow-up|1|||
16797548|NCT02349711|37738646|FG001|Overall Study|Lost to Follow-up|1|||
16797549|NCT02494921|37738657|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
16797550|NCT02494921|37738658|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
16797551|NCT02494921|37738659|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
16797552|NCT02494921|37738660|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
16797553|NCT02494921|37738661|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
16797554|NCT02494921|37738657|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
16797555|NCT02494921|37738658|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
16797556|NCT02494921|37738659|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
16797557|NCT02494921|37738660|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
16797558|NCT02494921|37738661|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
16797559|NCT02494921|37738657|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
16797560|NCT02494921|37738658|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
16797561|NCT02494921|37738659|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
16797562|NCT02494921|37738660|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
16797563|NCT02494921|37738661|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
16797564|NCT01653847|37738681|FG000|Overall Study|Withdrawal by Subject|1|||
16797565|NCT01653847|37738682|FG001|Overall Study|Withdrawal by Subject|0|||
16797566|NCT02493751|37738690|FG000|Overall Study|Withdrawal by Subject|2|||
16797567|NCT02493751|37738691|FG001|Overall Study|Withdrawal by Subject|8|||
16797568|NCT02493751|37738690|FG000|Overall Study|Death|6|||
16797569|NCT02493751|37738691|FG001|Overall Study|Death|13|||
16797570|NCT02493751|37738690|FG000|Overall Study|Lost to Follow-up|2|||
16797571|NCT02493751|37738691|FG001|Overall Study|Lost to Follow-up|3|||
16797572|NCT02493751|37738690|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
16797573|NCT02493751|37738691|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
16797574|NCT02493517|37738700|FG000|Overall Study|Protocol Violation|1|||
16797575|NCT02493517|37738701|FG001|Overall Study|Protocol Violation|2|||
16797576|NCT02493517|37738700|FG000|Overall Study|Withdrawal by Subject|1|||
16797577|NCT02493517|37738701|FG001|Overall Study|Withdrawal by Subject|2|||
16797578|NCT02493517|37738700|FG000|Overall Study|Adverse Event|0|||
16797579|NCT02493517|37738701|FG001|Overall Study|Adverse Event|2|||
16797580|NCT02493517|37738700|FG000|Overall Study|Missed study visit|0|||
16909303|NCT01702428|38018166|FG000|Overall Study|Adverse Event|2|||
16909304|NCT01702428|38018167|FG001|Overall Study|Adverse Event|0|||
16909305|NCT01702428|38018168|FG002|Overall Study|Adverse Event|0|||
16909306|NCT01702428|38018169|FG003|Overall Study|Adverse Event|0|||
16909307|NCT01702428|38018166|FG000|Overall Study|Lost to Follow-up|33|||
16909308|NCT01702428|38018167|FG001|Overall Study|Lost to Follow-up|41|||
16909309|NCT01702428|38018168|FG002|Overall Study|Lost to Follow-up|37|||
16909310|NCT01702428|38018169|FG003|Overall Study|Lost to Follow-up|44|||
16909311|NCT01702428|38018166|FG000|Overall Study|Parents cannot assist to site|1|||
16909312|NCT01702428|38018167|FG001|Overall Study|Parents cannot assist to site|0|||
16909313|NCT01702428|38018168|FG002|Overall Study|Parents cannot assist to site|1|||
16909314|NCT01702428|38018169|FG003|Overall Study|Parents cannot assist to site|0|||
16909315|NCT01702428|38018166|FG000|Overall Study|Lost Coverage|0|||
16909316|NCT01702428|38018167|FG001|Overall Study|Lost Coverage|0|||
16909317|NCT01702428|38018168|FG002|Overall Study|Lost Coverage|0|||
16909318|NCT01702428|38018169|FG003|Overall Study|Lost Coverage|1|||
16909319|NCT01702428|38018166|FG000|Overall Study|Lost Health Plan|3|||
16909320|NCT01702428|38018167|FG001|Overall Study|Lost Health Plan|5|||
16909321|NCT01702428|38018168|FG002|Overall Study|Lost Health Plan|0|||
16909322|NCT01702428|38018169|FG003|Overall Study|Lost Health Plan|2|||
16909323|NCT01702428|38018166|FG000|Overall Study|Mother transferred care|0|||
16909324|NCT01702428|38018167|FG001|Overall Study|Mother transferred care|1|||
16909325|NCT01702428|38018168|FG002|Overall Study|Mother transferred care|0|||
16909326|NCT01702428|38018169|FG003|Overall Study|Mother transferred care|0|||
16909327|NCT01702428|38018166|FG000|Overall Study|Parents too busy|1|||
16909328|NCT01702428|38018167|FG001|Overall Study|Parents too busy|0|||
16909329|NCT01702428|38018168|FG002|Overall Study|Parents too busy|0|||
16909330|NCT01702428|38018169|FG003|Overall Study|Parents too busy|0|||
16909331|NCT01702428|38018166|FG000|Overall Study|Protocol Violation|3|||
16909332|NCT01702428|38018167|FG001|Overall Study|Protocol Violation|0|||
16909333|NCT01702428|38018168|FG002|Overall Study|Protocol Violation|1|||
16909334|NCT01702428|38018169|FG003|Overall Study|Protocol Violation|0|||
16909335|NCT01702428|38018166|FG000|Overall Study|Withdrawal by Subject|21|||
16909336|NCT01702428|38018167|FG001|Overall Study|Withdrawal by Subject|23|||
16909337|NCT01702428|38018168|FG002|Overall Study|Withdrawal by Subject|14|||
16909338|NCT01702428|38018169|FG003|Overall Study|Withdrawal by Subject|10|||
16909339|NCT01701258|38018190|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
17016519|NCT00847808|38161132|FG000|Overall Study|Lost to Follow-up|1|||
17016520|NCT00847808|38161132|FG000|Overall Study|Withdrawal by Subject|4|||
17102291|NCT00091572|38241203|FG000|Overall Study|Lost to Follow-up|1|||
16797581|NCT02493517|37738701|FG001|Overall Study|Missed study visit|1|||
16909340|NCT01701258|38018191|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
16909341|NCT01701258|38018192|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
16909342|NCT01701258|38018193|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
16909343|NCT01701258|38018194|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
16797582|NCT02493361|37738709|FG000|Overall Study|Withdrawal by Subject|3|||
16797583|NCT02493127|37738715|FG000|Overall Study|Lost to Follow-up|1|||
16797584|NCT02493127|37738716|FG001|Overall Study|Lost to Follow-up|1|||
16797585|NCT02478463|37738724|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
16797586|NCT02478463|37738724|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
16797587|NCT02478463|37738724|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
16797588|NCT02491411|37738730|FG000|Overall Study|Physician Decision|4|||
16797589|NCT02517463|37738736|FG000|Overall Study|Lost to Follow-up|5|||
16797590|NCT02517463|37738737|FG001|Overall Study|Lost to Follow-up|2|||
16797591|NCT02516605|37738748|FG000|Overall Study|Protocol Violation|0|||
16797592|NCT02516605|37738749|FG001|Overall Study|Protocol Violation|0|||
16797593|NCT02516605|37738750|FG002|Overall Study|Protocol Violation|0|||
16797594|NCT02516605|37738751|FG003|Overall Study|Protocol Violation|0|||
16797595|NCT02516605|37738752|FG004|Overall Study|Protocol Violation|1|||
16797596|NCT02516605|37738748|FG000|Overall Study|Withdrawal by Subject|0|||
16797597|NCT02516605|37738749|FG001|Overall Study|Withdrawal by Subject|0|||
16797598|NCT02516605|37738750|FG002|Overall Study|Withdrawal by Subject|0|||
16797599|NCT02516605|37738751|FG003|Overall Study|Withdrawal by Subject|1|||
16797600|NCT02516605|37738752|FG004|Overall Study|Withdrawal by Subject|0|||
16797601|NCT02490475|37738772|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
16797602|NCT02490475|37738773|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
16797603|NCT02490475|37738774|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
16797604|NCT02490475|37738775|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
16797605|NCT02490475|37738772|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
16797606|NCT02490475|37738773|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
16797607|NCT02490475|37738774|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
16797608|NCT02490475|37738775|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
16797609|NCT02490475|37738772|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
16797610|NCT02490475|37738773|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
16797611|NCT02490475|37738774|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
16797612|NCT02490475|37738775|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
16797613|NCT02490475|37738772|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
16797614|NCT02490475|37738773|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
16797615|NCT02490475|37738774|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
16797616|NCT02490475|37738775|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
16797617|NCT02490475|37738772|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
16797618|NCT02490475|37738773|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
16797619|NCT02490475|37738774|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
16797620|NCT02490475|37738775|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
16797621|NCT02490475|37738772|FG000|Period 2: Extension Phase|Refused Treatment|0|||
16797622|NCT02490475|37738773|FG001|Period 2: Extension Phase|Refused Treatment|0|||
16797623|NCT02490475|37738774|FG002|Period 2: Extension Phase|Refused Treatment|0|||
16797624|NCT02490475|37738775|FG003|Period 2: Extension Phase|Refused Treatment|1|||
16797625|NCT02490475|37738772|FG000|Period 2: Extension Phase|Adverse Event|0|||
16797626|NCT02490475|37738773|FG001|Period 2: Extension Phase|Adverse Event|0|||
16797627|NCT02490475|37738774|FG002|Period 2: Extension Phase|Adverse Event|1|||
16797628|NCT02490475|37738775|FG003|Period 2: Extension Phase|Adverse Event|0|||
16797629|NCT02477839|37738798|FG000|Overall Study|Adverse Event|0|||
16797630|NCT02477839|37738799|FG001|Overall Study|Adverse Event|1|||
16797631|NCT02477839|37738798|FG000|Overall Study|Protocol Violation|0|||
16797632|NCT02477839|37738799|FG001|Overall Study|Protocol Violation|2|||
16797633|NCT02477839|37738798|FG000|Overall Study|Withdrawal by Subject|3|||
16797634|NCT02477839|37738799|FG001|Overall Study|Withdrawal by Subject|3|||
16797635|NCT02477839|37738798|FG000|Overall Study|Participant had PGS during V6|0|||
16797636|NCT02477839|37738799|FG001|Overall Study|Participant had PGS during V6|1|||
16797637|NCT02477839|37738798|FG000|Overall Study|Parents decided to stop medication|0|||
16797638|NCT02477839|37738799|FG001|Overall Study|Parents decided to stop medication|1|||
16797639|NCT02477839|37738798|FG000|Overall Study|Lack of tolerability|0|||
16797640|NCT02477839|37738799|FG001|Overall Study|Lack of tolerability|1|||
16797641|NCT02477839|37738798|FG000|Overall Study|Exclusion criterion|0|||
16797642|NCT02477839|37738799|FG001|Overall Study|Exclusion criterion|1|||
16797643|NCT02489773|37738809|FG000|Overall Study|Lost to Follow-up|4|||
16797644|NCT02489773|37738810|FG001|Overall Study|Lost to Follow-up|1|||
16797645|NCT02489773|37738809|FG000|Overall Study|Physician Decision|1|||
16797646|NCT02489773|37738810|FG001|Overall Study|Physician Decision|0|||
16797647|NCT02489773|37738809|FG000|Overall Study|Withdrawal by Subject|1|||
16797648|NCT02489773|37738810|FG001|Overall Study|Withdrawal by Subject|0|||
16797649|NCT02489773|37738809|FG000|Overall Study|Leave the country or the state|1|||
17016521|NCT00847808|38161132|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
16797650|NCT02489773|37738810|FG001|Overall Study|Leave the country or the state|1|||
16797651|NCT02488915|37738816|FG000|Overall Study|Death|21|||
17016522|NCT00847808|38161132|FG000|Overall Study|Participant Took Excluded Medication|1|||
16797652|NCT02488915|37738816|FG000|Overall Study|Lost to Follow-up|4|||
16797653|NCT02488915|37738816|FG000|Overall Study|Withdrawal by Subject|1|||
16797654|NCT02488681|37738820|FG000|Overall Study|Implant unsuccessful|7|||
16797655|NCT02477605|37738826|FG000|Overall Study|Discontinued prior to treatment|1|||
16797656|NCT02477605|37738827|FG001|Overall Study|Discontinued prior to treatment|0|||
16797657|NCT02477605|37738826|FG000|Overall Study|Lost to Follow-up|0|||
16797658|NCT02477605|37738827|FG001|Overall Study|Lost to Follow-up|2|||
16797659|NCT02477605|37738826|FG000|Overall Study|Withdrawal by Subject|0|||
16797660|NCT02477605|37738827|FG001|Overall Study|Withdrawal by Subject|1|||
16797661|NCT02477605|37738826|FG000|Overall Study|Administered gas during surgery|0|||
16797662|NCT02477605|37738827|FG001|Overall Study|Administered gas during surgery|1|||
16797663|NCT02477527|37738837|FG000|Overall Study|Lost to Follow-up|2|||
16797664|NCT02477527|37738837|FG000|Overall Study|Withdrawal by Subject|1|||
16797665|NCT02477527|37738837|FG000|Overall Study|Screen Failure|3|||
16797666|NCT02477215|37738845|FG000|Dose Escalation Phase|Physician Decision|1|||
16797667|NCT02477215|37738846|FG001|Dose Escalation Phase|Physician Decision|2|||
16797668|NCT02477215|37738847|FG002|Dose Escalation Phase|Physician Decision|0|||
16797669|NCT02477215|37738845|FG000|Fixed Dose Phase|Physician Decision|0|||
16797670|NCT02477215|37738846|FG001|Fixed Dose Phase|Physician Decision|7|||
16797671|NCT02477215|37738847|FG002|Fixed Dose Phase|Physician Decision|0|||
16797672|NCT02487199|37738860|FG000|Overall Study|Withdrew Consent|0|||
16797673|NCT02487199|37738861|FG001|Overall Study|Withdrew Consent|1|||
16797674|NCT02475733|37738869|FG000|Overall Study|Withdrawal by Subject|1|||
16797675|NCT02475733|37738870|FG001|Overall Study|Withdrawal by Subject|0|||
16797676|NCT02475733|37738869|FG000|Overall Study|Physician Decision|1|||
16797677|NCT02475733|37738870|FG001|Overall Study|Physician Decision|0|||
16797678|NCT02486653|37738878|FG000|Overall Study|Withdrawal by Subject|1|||
16797679|NCT02486653|37738879|FG001|Overall Study|Withdrawal by Subject|3|||
16797680|NCT02486653|37738878|FG000|Overall Study|Protocol Violation|1|||
16797681|NCT02486653|37738879|FG001|Overall Study|Protocol Violation|0|||
16797682|NCT02486653|37738878|FG000|Overall Study|surgery cancelled|4|||
16797683|NCT02486653|37738879|FG001|Overall Study|surgery cancelled|1|||
16797684|NCT02475655|37738887|FG000|Overall Study|Lost to Follow-up|0|||
16797685|NCT02475655|37738888|FG001|Overall Study|Lost to Follow-up|1|||
16797686|NCT02475265|37738894|FG000|Overall Study|Physician Decision|1|||
16797687|NCT02475265|37738894|FG000|Overall Study|Withdrawal by Subject|2|||
16797688|NCT02485717|37738901|FG000|Overall Study|Lost to Follow-up|6|||
16797689|NCT02485717|37738902|FG001|Overall Study|Lost to Follow-up|0|||
16797690|NCT02485717|37738903|FG002|Overall Study|Lost to Follow-up|0|||
16797691|NCT02485717|37738901|FG000|Overall Study|Withdrawal by Subject|0|||
16797692|NCT02485717|37738902|FG001|Overall Study|Withdrawal by Subject|0|||
16797693|NCT02485717|37738903|FG002|Overall Study|Withdrawal by Subject|1|||
16797694|NCT02485717|37738901|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
16797695|NCT02485717|37738902|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
16797696|NCT02485717|37738903|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
16797697|NCT02485717|37738901|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
16797698|NCT02485717|37738902|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
16797699|NCT02485717|37738903|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
16797700|NCT02451007|37738911|FG000|Overall Study|Withdrawal by Subject|4|||
16797701|NCT02451007|37738911|FG000|Overall Study|Adverse Event|1|||
16797702|NCT02451007|37738911|FG000|Overall Study|Disease Progression|2|||
16797703|NCT02485483|37738917|FG000|Overall Study|Depression at baseline|15|||
16797704|NCT02485483|37738918|FG001|Overall Study|Depression at baseline|0|||
16797705|NCT02485483|37738917|FG000|Overall Study|Discontinued after baseline|39|||
16797706|NCT02485483|37738918|FG001|Overall Study|Discontinued after baseline|0|||
16797707|NCT02473471|37738924|FG000|Overall Study|poor oral hygiene|2|||
16797708|NCT02473471|37738924|FG000|Overall Study|Lost to Follow-up|1|||
16797709|NCT02450539|37738936|FG000|Overall Study|Withdrawal by Subject|12|||
16797710|NCT02450539|37738937|FG001|Overall Study|Withdrawal by Subject|6|||
16797711|NCT02450539|37738936|FG000|Overall Study|Lost to Follow-up|4|||
16797712|NCT02450539|37738937|FG001|Overall Study|Lost to Follow-up|1|||
16797713|NCT02449915|37738948|FG000|Overall Study|Exclusion criteria - drug use|1|||
16797714|NCT02449915|37738949|FG001|Overall Study|Exclusion criteria - drug use|0|||
16797715|NCT02449915|37738948|FG000|Overall Study|Withdrawal by Subject|0|||
16797716|NCT02449915|37738949|FG001|Overall Study|Withdrawal by Subject|2|||
16797717|NCT02449915|37738948|FG000|Overall Study|Intraoperative surgical findings|1|||
16797718|NCT02449915|37738949|FG001|Overall Study|Intraoperative surgical findings|1|||
16797719|NCT02449915|37738948|FG000|Overall Study|Abnormal preop lab|0|||
16797720|NCT02449915|37738949|FG001|Overall Study|Abnormal preop lab|1|||
16797721|NCT02420119|37738955|FG000|Overall Study|insufficient laboratory data|5|||
16797722|NCT02473393|37738963|FG000|Overall Study|Adverse Event|0|||
16797723|NCT02473393|37738964|FG001|Overall Study|Adverse Event|0|||
16797724|NCT02473393|37738965|FG002|Overall Study|Adverse Event|1|||
16797725|NCT02473393|37738966|FG003|Overall Study|Adverse Event|0|||
16797726|NCT02473393|37738963|FG000|Overall Study|Withdrawal by Subject|0|||
17102292|NCT00091572|38241204|FG001|Overall Study|Lost to Follow-up|1|||
16797727|NCT02473393|37738964|FG001|Overall Study|Withdrawal by Subject|0|||
16797728|NCT02473393|37738965|FG002|Overall Study|Withdrawal by Subject|1|||
16797729|NCT02473393|37738966|FG003|Overall Study|Withdrawal by Subject|1|||
16797730|NCT02419573|37738978|FG000|Overall Study|Lost to Follow-up|3|||
16797731|NCT02419573|37738979|FG001|Overall Study|Lost to Follow-up|0|||
16797732|NCT02419573|37738978|FG000|Overall Study|Withdrawal by Subject|1|||
16797733|NCT02419573|37738979|FG001|Overall Study|Withdrawal by Subject|0|||
16797734|NCT02472847|37738987|FG000|Overall Study|Withdrawal by Subject|1|||
16797735|NCT02472847|37738988|FG001|Overall Study|Withdrawal by Subject|5|||
16797736|NCT02472145|37738997|FG000|Overall Study|Death|10|||
16797737|NCT02472145|37738998|FG001|Overall Study|Death|101|||
16797738|NCT02472145|37738999|FG002|Overall Study|Death|99|||
16797739|NCT02472145|37738997|FG000|Overall Study|Lost to Follow-up|0|||
16797740|NCT02472145|37738998|FG001|Overall Study|Lost to Follow-up|1|||
16797741|NCT02472145|37738999|FG002|Overall Study|Lost to Follow-up|0|||
16797742|NCT02472145|37738997|FG000|Overall Study|Withdrawal by Subject|0|||
16797743|NCT02472145|37738998|FG001|Overall Study|Withdrawal by Subject|9|||
16797744|NCT02472145|37738999|FG002|Overall Study|Withdrawal by Subject|13|||
16797745|NCT02472145|37738997|FG000|Overall Study|Sponsor decision|0|||
16797746|NCT02472145|37738998|FG001|Overall Study|Sponsor decision|3|||
16797747|NCT02472145|37738999|FG002|Overall Study|Sponsor decision|2|||
16797748|NCT02472145|37738997|FG000|Overall Study|Other|0|||
16797749|NCT02472145|37738998|FG001|Overall Study|Other|45|||
16797750|NCT02472145|37738999|FG002|Overall Study|Other|43|||
16797751|NCT02418949|37739010|FG000|Overall Study|Withdrawal by Subject|1|||
16797752|NCT02418949|37739011|FG001|Overall Study|Withdrawal by Subject|0|||
16797753|NCT02418949|37739012|FG002|Overall Study|Withdrawal by Subject|1|||
16797754|NCT02418949|37739013|FG003|Overall Study|Withdrawal by Subject|1|||
16797755|NCT02418949|37739010|FG000|Overall Study|Lost to Follow-up|1|||
16797756|NCT02418949|37739011|FG001|Overall Study|Lost to Follow-up|0|||
16797757|NCT02418949|37739012|FG002|Overall Study|Lost to Follow-up|1|||
16797758|NCT02418949|37739013|FG003|Overall Study|Lost to Follow-up|0|||
16797759|NCT02418949|37739010|FG000|Overall Study|Physician Decision|1|||
16797760|NCT02418949|37739011|FG001|Overall Study|Physician Decision|1|||
16797761|NCT02418949|37739012|FG002|Overall Study|Physician Decision|1|||
16797762|NCT02418949|37739013|FG003|Overall Study|Physician Decision|0|||
16797763|NCT02448043|37739025|FG000|Overall Study|Withdrawal by Subject|2|||
16797764|NCT02448043|37739026|FG001|Overall Study|Withdrawal by Subject|2|||
16797765|NCT02448043|37739025|FG000|Overall Study|Protocol Violation|1|||
16797766|NCT02448043|37739026|FG001|Overall Study|Protocol Violation|2|||
16797767|NCT02447887|37739035|FG000|Overall Study|Study was terminated|3|||
16797768|NCT02471755|37739041|FG000|Overall Study|Withdrawal by Subject|1|||
16797769|NCT02471755|37739042|FG001|Overall Study|Withdrawal by Subject|0|||
16797770|NCT02471755|37739041|FG000|Overall Study|Lost to Follow-up|0|||
16797771|NCT02471755|37739042|FG001|Overall Study|Lost to Follow-up|1|||
16797772|NCT02470429|37739050|FG000|Overall Study|Adverse Event|1|||
16797773|NCT02470429|37739051|FG001|Overall Study|Adverse Event|0|||
16797774|NCT02470429|37739050|FG000|Overall Study|Withdrawal by Subject|1|||
16797775|NCT02470429|37739051|FG001|Overall Study|Withdrawal by Subject|0|||
16797776|NCT02447497|37739062|FG000|Overall Study|Did not meet treatment day baseline.|6|||
16797777|NCT02447497|37739063|FG001|Overall Study|Did not meet treatment day baseline.|5|||
16797778|NCT02447497|37739064|FG002|Overall Study|Did not meet treatment day baseline.|2|||
16797779|NCT02447497|37739065|FG003|Overall Study|Did not meet treatment day baseline.|2|||
16797780|NCT02447497|37739062|FG000|Overall Study|Dressing was compromised|0|||
16797781|NCT02447497|37739063|FG001|Overall Study|Dressing was compromised|1|||
16797782|NCT02447497|37739064|FG002|Overall Study|Dressing was compromised|0|||
16797783|NCT02447497|37739065|FG003|Overall Study|Dressing was compromised|0|||
16797784|NCT02417935|37739085|FG000|Treatment Period|Adverse Event|12|||
16797785|NCT02417935|37739086|FG001|Treatment Period|Adverse Event|10|||
16797786|NCT02417935|37739085|FG000|Treatment Period|Lost to Follow-up|1|||
16797787|NCT02417935|37739086|FG001|Treatment Period|Lost to Follow-up|0|||
16797788|NCT02417935|37739085|FG000|Treatment Period|Entry Criteria not met|0|||
16797789|NCT02417935|37739086|FG001|Treatment Period|Entry Criteria not met|1|||
16797790|NCT02417935|37739085|FG000|Treatment Period|Protocol Violation|2|||
16797791|NCT02417935|37739086|FG001|Treatment Period|Protocol Violation|1|||
16797792|NCT02417935|37739085|FG000|Treatment Period|Withdrawal by Subject|3|||
16797793|NCT02417935|37739086|FG001|Treatment Period|Withdrawal by Subject|3|||
16797794|NCT02417935|37739085|FG000|Treatment Period|Physician Decision|3|||
16797795|NCT02417935|37739086|FG001|Treatment Period|Physician Decision|1|||
16797796|NCT02417233|37739095|FG000|Overall Study|Death|4|||
16797797|NCT02417233|37739096|FG001|Overall Study|Death|10|||
16797798|NCT02417233|37739097|FG002|Overall Study|Death|14|||
16797799|NCT02417233|37739095|FG000|Overall Study|Lost to Follow-up|27|||
16797800|NCT02417233|37739096|FG001|Overall Study|Lost to Follow-up|39|||
17016523|NCT00600353|38161138|FG000|Overall Study|history of malignancy within 5 years|1|||
16797801|NCT02417233|37739097|FG002|Overall Study|Lost to Follow-up|34|||
16797802|NCT02417233|37739095|FG000|Overall Study|Protocol Violation|2|||
16797803|NCT02417233|37739096|FG001|Overall Study|Protocol Violation|0|||
16797804|NCT02417233|37739097|FG002|Overall Study|Protocol Violation|2|||
16797805|NCT02417233|37739095|FG000|Overall Study|Withdrawal by Subject|2|||
16797806|NCT02417233|37739096|FG001|Overall Study|Withdrawal by Subject|1|||
16797807|NCT02417233|37739097|FG002|Overall Study|Withdrawal by Subject|8|||
16797808|NCT02417233|37739095|FG000|Overall Study|Relocation out of study area|1|||
16797809|NCT02417233|37739096|FG001|Overall Study|Relocation out of study area|0|||
16797810|NCT02417233|37739097|FG002|Overall Study|Relocation out of study area|1|||
16797811|NCT02417233|37739095|FG000|Overall Study|Mentally unstable|0|||
16797812|NCT02417233|37739096|FG001|Overall Study|Mentally unstable|1|||
16797813|NCT02417233|37739097|FG002|Overall Study|Mentally unstable|0|||
16797814|NCT02447029|37739108|FG000|Overall Study|Withdrawal by Subject|3|||
16797815|NCT02447029|37739109|FG001|Overall Study|Withdrawal by Subject|2|||
16797816|NCT02416453|37739126|FG000|Overall Study|Adverse Event|0|||
16797817|NCT02416453|37739127|FG001|Overall Study|Adverse Event|0|||
16797818|NCT02416453|37739128|FG002|Overall Study|Adverse Event|0|||
16797819|NCT02416453|37739129|FG003|Overall Study|Adverse Event|2|||
16797820|NCT02416453|37739130|FG004|Overall Study|Adverse Event|0|||
16797821|NCT02416453|37739131|FG005|Overall Study|Adverse Event|1|||
16797822|NCT02416453|37739132|FG006|Overall Study|Adverse Event|0|||
16797823|NCT02416453|37739133|FG007|Overall Study|Adverse Event|0|||
16797824|NCT02416453|37739134|FG008|Overall Study|Adverse Event|0|||
16797825|NCT02416453|37739135|FG009|Overall Study|Adverse Event|0|||
16797826|NCT02416453|37739136|FG010|Overall Study|Adverse Event|0|||
16797827|NCT02416453|37739126|FG000|Overall Study|Lost to Follow-up|1|||
16797828|NCT02416453|37739127|FG001|Overall Study|Lost to Follow-up|3|||
16797829|NCT02416453|37739128|FG002|Overall Study|Lost to Follow-up|0|||
16797830|NCT02416453|37739129|FG003|Overall Study|Lost to Follow-up|8|||
16797831|NCT02416453|37739130|FG004|Overall Study|Lost to Follow-up|0|||
16797832|NCT02416453|37739131|FG005|Overall Study|Lost to Follow-up|5|||
16797833|NCT02416453|37739132|FG006|Overall Study|Lost to Follow-up|1|||
16797834|NCT02416453|37739133|FG007|Overall Study|Lost to Follow-up|3|||
16797835|NCT02416453|37739134|FG008|Overall Study|Lost to Follow-up|1|||
16797836|NCT02416453|37739135|FG009|Overall Study|Lost to Follow-up|0|||
16797837|NCT02416453|37739136|FG010|Overall Study|Lost to Follow-up|0|||
16797838|NCT02416453|37739126|FG000|Overall Study|Physician Decision|0|||
16797839|NCT02416453|37739127|FG001|Overall Study|Physician Decision|0|||
16797840|NCT02416453|37739128|FG002|Overall Study|Physician Decision|0|||
16797841|NCT02416453|37739129|FG003|Overall Study|Physician Decision|0|||
16797842|NCT02416453|37739130|FG004|Overall Study|Physician Decision|0|||
16797843|NCT02416453|37739131|FG005|Overall Study|Physician Decision|1|||
16797844|NCT02416453|37739132|FG006|Overall Study|Physician Decision|1|||
16797845|NCT02416453|37739133|FG007|Overall Study|Physician Decision|1|||
16797846|NCT02416453|37739134|FG008|Overall Study|Physician Decision|0|||
16797847|NCT02416453|37739135|FG009|Overall Study|Physician Decision|0|||
16797848|NCT02416453|37739136|FG010|Overall Study|Physician Decision|0|||
16797849|NCT02416453|37739126|FG000|Overall Study|Withdrawal by Subject|2|||
16797850|NCT02416453|37739127|FG001|Overall Study|Withdrawal by Subject|0|||
16797851|NCT02416453|37739128|FG002|Overall Study|Withdrawal by Subject|0|||
16797852|NCT02416453|37739129|FG003|Overall Study|Withdrawal by Subject|5|||
16797853|NCT02416453|37739130|FG004|Overall Study|Withdrawal by Subject|1|||
16797854|NCT02416453|37739131|FG005|Overall Study|Withdrawal by Subject|8|||
16797855|NCT02416453|37739132|FG006|Overall Study|Withdrawal by Subject|0|||
16797856|NCT02416453|37739133|FG007|Overall Study|Withdrawal by Subject|8|||
16797857|NCT02416453|37739134|FG008|Overall Study|Withdrawal by Subject|4|||
16797858|NCT02416453|37739135|FG009|Overall Study|Withdrawal by Subject|0|||
16797859|NCT02416453|37739136|FG010|Overall Study|Withdrawal by Subject|0|||
16797860|NCT02416453|37739126|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797861|NCT02416453|37739127|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797862|NCT02416453|37739128|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
16797863|NCT02416453|37739129|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797864|NCT02416453|37739130|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797865|NCT02416453|37739131|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797866|NCT02416453|37739132|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797867|NCT02416453|37739133|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797868|NCT02416453|37739134|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797869|NCT02416453|37739135|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797870|NCT02416453|37739136|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16797871|NCT02416453|37739126|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797872|NCT02416453|37739127|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797873|NCT02416453|37739128|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797874|NCT02416453|37739129|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797875|NCT02416453|37739130|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797876|NCT02416453|37739131|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
16797877|NCT02416453|37739132|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797878|NCT02416453|37739133|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797879|NCT02416453|37739134|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797880|NCT02416453|37739135|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797881|NCT02416453|37739136|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16797882|NCT02469961|37739168|FG000|Overall Study|Physician Decision|4|||
16797883|NCT02469961|37739169|FG001|Overall Study|Physician Decision|1|||
16797884|NCT02415595|37739184|FG000|Overall Study|Administrative reason by sponsor|39|||
16797885|NCT02415595|37739185|FG001|Overall Study|Administrative reason by sponsor|40|||
16797886|NCT02415595|37739186|FG002|Overall Study|Administrative reason by sponsor|41|||
16797887|NCT02415595|37739187|FG003|Overall Study|Administrative reason by sponsor|39|||
16797888|NCT02415595|37739184|FG000|Overall Study|Adverse Event|1|||
16797889|NCT02415595|37739185|FG001|Overall Study|Adverse Event|3|||
16797890|NCT02415595|37739186|FG002|Overall Study|Adverse Event|5|||
16797891|NCT02415595|37739187|FG003|Overall Study|Adverse Event|10|||
16797892|NCT02415595|37739184|FG000|Overall Study|Lack of Efficacy|4|||
16797893|NCT02415595|37739185|FG001|Overall Study|Lack of Efficacy|4|||
16797894|NCT02415595|37739186|FG002|Overall Study|Lack of Efficacy|0|||
16797895|NCT02415595|37739187|FG003|Overall Study|Lack of Efficacy|0|||
16797896|NCT02415595|37739184|FG000|Overall Study|Lost to Follow-up|1|||
16797897|NCT02415595|37739185|FG001|Overall Study|Lost to Follow-up|3|||
16797898|NCT02415595|37739186|FG002|Overall Study|Lost to Follow-up|1|||
16797899|NCT02415595|37739187|FG003|Overall Study|Lost to Follow-up|1|||
16797900|NCT02415595|37739184|FG000|Overall Study|Poor/Non-compliance|1|||
16797901|NCT02415595|37739185|FG001|Overall Study|Poor/Non-compliance|0|||
16797902|NCT02415595|37739186|FG002|Overall Study|Poor/Non-compliance|1|||
16797903|NCT02415595|37739187|FG003|Overall Study|Poor/Non-compliance|0|||
16797904|NCT02415595|37739184|FG000|Overall Study|Reached stopping criteria|0|||
16797905|NCT02415595|37739185|FG001|Overall Study|Reached stopping criteria|1|||
16797906|NCT02415595|37739186|FG002|Overall Study|Reached stopping criteria|1|||
16797907|NCT02415595|37739187|FG003|Overall Study|Reached stopping criteria|0|||
16797908|NCT02415595|37739184|FG000|Overall Study|Withdrawal by Subject|4|||
16797909|NCT02415595|37739185|FG001|Overall Study|Withdrawal by Subject|0|||
16797910|NCT02415595|37739186|FG002|Overall Study|Withdrawal by Subject|1|||
16797911|NCT02415595|37739187|FG003|Overall Study|Withdrawal by Subject|3|||
16797912|NCT02415595|37739184|FG000|Overall Study|Other|0|||
16797913|NCT02415595|37739185|FG001|Overall Study|Other|1|||
16797914|NCT02415595|37739186|FG002|Overall Study|Other|1|||
16797915|NCT02415595|37739187|FG003|Overall Study|Other|0|||
16797916|NCT02446717|37739203|FG000|Overall Study|Adverse Event|0|||
16797917|NCT02446717|37739204|FG001|Overall Study|Adverse Event|0|||
16797918|NCT02446717|37739205|FG002|Overall Study|Adverse Event|1|||
16797919|NCT02446717|37739206|FG003|Overall Study|Adverse Event|0|||
16797920|NCT02446717|37739207|FG004|Overall Study|Adverse Event|0|||
16797921|NCT02446717|37739203|FG000|Overall Study|Lost to Follow-up|0|||
16797922|NCT02446717|37739204|FG001|Overall Study|Lost to Follow-up|1|||
16797923|NCT02446717|37739205|FG002|Overall Study|Lost to Follow-up|1|||
16797924|NCT02446717|37739206|FG003|Overall Study|Lost to Follow-up|0|||
16797925|NCT02446717|37739207|FG004|Overall Study|Lost to Follow-up|1|||
16797926|NCT02446717|37739203|FG000|Overall Study|Withdrew consent|0|||
16797927|NCT02446717|37739204|FG001|Overall Study|Withdrew consent|0|||
16797928|NCT02446717|37739205|FG002|Overall Study|Withdrew consent|0|||
16797929|NCT02446717|37739206|FG003|Overall Study|Withdrew consent|1|||
16797930|NCT02446717|37739207|FG004|Overall Study|Withdrew consent|0|||
16797931|NCT02469415|37739219|FG000|Overall Study|Withdrawal by Subject|1|||
16797932|NCT02469415|37739219|FG000|Overall Study|Investigational agent placed on hold|2|||
16797933|NCT02446171|37739227|FG000|Overall Study|Withdrawal by Subject|0|||
16797934|NCT02446171|37739228|FG001|Overall Study|Withdrawal by Subject|0|||
16797935|NCT02446171|37739229|FG002|Overall Study|Withdrawal by Subject|2|||
16797936|NCT02446171|37739230|FG003|Overall Study|Withdrawal by Subject|0|||
16797937|NCT02446015|37739244|FG000|Overall Study|Adverse Event|0|||
16797938|NCT02446015|37739245|FG001|Overall Study|Adverse Event|1|||
16797939|NCT02446015|37739244|FG000|Overall Study|Withdrawal by Subject|1|||
16797940|NCT02446015|37739245|FG001|Overall Study|Withdrawal by Subject|0|||
16797941|NCT02415127|37739254|FG000|Overall Study|Adverse Event|1|||
16797942|NCT02415127|37739255|FG001|Overall Study|Adverse Event|0|||
16797943|NCT02468557|37739261|FG000|Overall Study|Adverse Event|1|||
16797944|NCT02468557|37739261|FG000|Overall Study|Death|1|||
16797945|NCT02468557|37739261|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
16797946|NCT02468557|37739261|FG000|Overall Study|All Enrolled but Never Dosed|4|||
16797947|NCT02413489|37739272|FG000|Overall Study|Death|11|||
16797948|NCT02413489|37739273|FG001|Overall Study|Death|3|||
16797949|NCT02413489|37739274|FG002|Overall Study|Death|4|||
16797950|NCT02413489|37739272|FG000|Overall Study|Withdrawal by Subject|2|||
16797951|NCT02413489|37739273|FG001|Overall Study|Withdrawal by Subject|0|||
16797952|NCT02413489|37739274|FG002|Overall Study|Withdrawal by Subject|0|||
16797953|NCT02413489|37739272|FG000|Overall Study|Study Terminated By Sponsor|2|||
16797954|NCT02413489|37739273|FG001|Overall Study|Study Terminated By Sponsor|13|||
16797955|NCT02413489|37739274|FG002|Overall Study|Study Terminated By Sponsor|1|||
16797956|NCT02413333|37739286|FG000|Period 1|Adverse Event|1|||
16797957|NCT02413333|37739287|FG001|Period 1|Adverse Event|0|||
16797958|NCT02413333|37739286|FG000|Period 1|Reason Not Specified|0|||
16797959|NCT02413333|37739287|FG001|Period 1|Reason Not Specified|1|||
16797960|NCT02413333|37739286|FG000|Period 2|Protocol Deviation|1|||
16797961|NCT02413333|37739287|FG001|Period 2|Protocol Deviation|0|||
16797962|NCT02413255|37739310|FG000|Overall Study|Voluntary Withdrawal|0|||
16797963|NCT02413255|37739311|FG001|Overall Study|Voluntary Withdrawal|0|||
16797964|NCT02413255|37739312|FG002|Overall Study|Voluntary Withdrawal|0|||
16797965|NCT02413255|37739313|FG003|Overall Study|Voluntary Withdrawal|0|||
16797966|NCT02413255|37739314|FG004|Overall Study|Voluntary Withdrawal|0|||
16797967|NCT02413255|37739315|FG005|Overall Study|Voluntary Withdrawal|0|||
16797968|NCT02413255|37739316|FG006|Overall Study|Voluntary Withdrawal|0|||
16797969|NCT02413255|37739317|FG007|Overall Study|Voluntary Withdrawal|0|||
16797970|NCT02413255|37739318|FG008|Overall Study|Voluntary Withdrawal|0|||
16797971|NCT02413255|37739319|FG009|Overall Study|Voluntary Withdrawal|0|||
16797972|NCT02413255|37739320|FG010|Overall Study|Voluntary Withdrawal|0|||
16797973|NCT02413255|37739321|FG011|Overall Study|Voluntary Withdrawal|0|||
16797974|NCT02413255|37739322|FG012|Overall Study|Voluntary Withdrawal|0|||
16797975|NCT02413255|37739323|FG013|Overall Study|Voluntary Withdrawal|0|||
16797976|NCT02413255|37739324|FG014|Overall Study|Voluntary Withdrawal|1|||
16797977|NCT02413255|37739325|FG015|Overall Study|Voluntary Withdrawal|0|||
16797978|NCT02413255|37739326|FG016|Overall Study|Voluntary Withdrawal|0|||
16797979|NCT02444533|37739379|FG000|Overall Study|Not able to complete forms|0|||
16797980|NCT02444533|37739380|FG001|Overall Study|Not able to complete forms|2|||
16797981|NCT02444533|37739379|FG000|Overall Study|Only gave post-procedure complications|2|||
16797982|NCT02444533|37739380|FG001|Overall Study|Only gave post-procedure complications|2|||
16797983|NCT01651039|37739386|FG000|Overall Study|Non-evaluables|5|||
16797984|NCT01651039|37739386|FG000|Overall Study|Physician Decision|2|||
16797985|NCT01651039|37739386|FG000|Overall Study|Withdrawal by Subject|1|||
16797986|NCT01651039|37739386|FG000|Overall Study|Progressive Disease|22|||
16797987|NCT02349633|37739404|FG000|Overall Study|Death|0|||
16797988|NCT02349633|37739405|FG001|Overall Study|Death|1|||
16797989|NCT02349633|37739406|FG002|Overall Study|Death|0|||
16797990|NCT02349633|37739407|FG003|Overall Study|Death|0|||
16797991|NCT02349633|37739408|FG004|Overall Study|Death|0|||
16797992|NCT02349633|37739409|FG005|Overall Study|Death|1|||
16797993|NCT02349633|37739410|FG006|Overall Study|Death|1|||
16797994|NCT02349633|37739411|FG007|Overall Study|Death|1|||
16797995|NCT02349633|37739412|FG008|Overall Study|Death|0|||
16797996|NCT02349633|37739413|FG009|Overall Study|Death|1|||
16797997|NCT02349633|37739414|FG010|Overall Study|Death|0|||
16797998|NCT02349633|37739415|FG011|Overall Study|Death|0|||
16797999|NCT02349633|37739416|FG012|Overall Study|Death|0|||
16798000|NCT02349633|37739417|FG013|Overall Study|Death|0|||
16798001|NCT02349633|37739404|FG000|Overall Study|Withdrawal by Subject|0|||
16798002|NCT02349633|37739405|FG001|Overall Study|Withdrawal by Subject|0|||
16798003|NCT02349633|37739406|FG002|Overall Study|Withdrawal by Subject|0|||
16798004|NCT02349633|37739407|FG003|Overall Study|Withdrawal by Subject|1|||
16798005|NCT02349633|37739408|FG004|Overall Study|Withdrawal by Subject|0|||
16798006|NCT02349633|37739409|FG005|Overall Study|Withdrawal by Subject|0|||
16798007|NCT02349633|37739410|FG006|Overall Study|Withdrawal by Subject|0|||
16798008|NCT02349633|37739411|FG007|Overall Study|Withdrawal by Subject|2|||
16798009|NCT02349633|37739412|FG008|Overall Study|Withdrawal by Subject|2|||
16798010|NCT02349633|37739413|FG009|Overall Study|Withdrawal by Subject|1|||
16798011|NCT02349633|37739414|FG010|Overall Study|Withdrawal by Subject|0|||
16798012|NCT02349633|37739415|FG011|Overall Study|Withdrawal by Subject|0|||
16798013|NCT02349633|37739416|FG012|Overall Study|Withdrawal by Subject|0|||
16798014|NCT02349633|37739417|FG013|Overall Study|Withdrawal by Subject|0|||
16798015|NCT02349633|37739404|FG000|Overall Study|Withdrawal of informed consent|0|||
16798016|NCT02349633|37739405|FG001|Overall Study|Withdrawal of informed consent|0|||
16798017|NCT02349633|37739406|FG002|Overall Study|Withdrawal of informed consent|0|||
16798018|NCT02349633|37739407|FG003|Overall Study|Withdrawal of informed consent|1|||
16798019|NCT02349633|37739408|FG004|Overall Study|Withdrawal of informed consent|1|||
16798020|NCT02349633|37739409|FG005|Overall Study|Withdrawal of informed consent|0|||
16798021|NCT02349633|37739410|FG006|Overall Study|Withdrawal of informed consent|0|||
16798022|NCT02349633|37739411|FG007|Overall Study|Withdrawal of informed consent|3|||
16798023|NCT02349633|37739412|FG008|Overall Study|Withdrawal of informed consent|0|||
16798024|NCT02349633|37739413|FG009|Overall Study|Withdrawal of informed consent|0|||
16798025|NCT02349633|37739414|FG010|Overall Study|Withdrawal of informed consent|0|||
16798026|NCT02349633|37739415|FG011|Overall Study|Withdrawal of informed consent|0|||
16798027|NCT02349633|37739416|FG012|Overall Study|Withdrawal of informed consent|0|||
16798028|NCT02349633|37739417|FG013|Overall Study|Withdrawal of informed consent|0|||
16798029|NCT02349633|37739404|FG000|Overall Study|Transition to compassionate use|0|||
16798030|NCT02349633|37739405|FG001|Overall Study|Transition to compassionate use|0|||
16798031|NCT02349633|37739406|FG002|Overall Study|Transition to compassionate use|0|||
16798032|NCT02349633|37739407|FG003|Overall Study|Transition to compassionate use|0|||
16798033|NCT02349633|37739408|FG004|Overall Study|Transition to compassionate use|1|||
16798034|NCT02349633|37739409|FG005|Overall Study|Transition to compassionate use|0|||
16798035|NCT02349633|37739410|FG006|Overall Study|Transition to compassionate use|0|||
16798036|NCT02349633|37739411|FG007|Overall Study|Transition to compassionate use|3|||
16798037|NCT02349633|37739412|FG008|Overall Study|Transition to compassionate use|0|||
16798038|NCT02349633|37739413|FG009|Overall Study|Transition to compassionate use|1|||
16798039|NCT02349633|37739414|FG010|Overall Study|Transition to compassionate use|0|||
16798040|NCT02349633|37739415|FG011|Overall Study|Transition to compassionate use|0|||
16798041|NCT02349633|37739416|FG012|Overall Study|Transition to compassionate use|0|||
16798042|NCT02349633|37739417|FG013|Overall Study|Transition to compassionate use|0|||
16798043|NCT02349633|37739404|FG000|Overall Study|Early termination of survival follow-up|0|||
16798044|NCT02349633|37739405|FG001|Overall Study|Early termination of survival follow-up|0|||
16798045|NCT02349633|37739406|FG002|Overall Study|Early termination of survival follow-up|0|||
16798046|NCT02349633|37739407|FG003|Overall Study|Early termination of survival follow-up|0|||
16798047|NCT02349633|37739408|FG004|Overall Study|Early termination of survival follow-up|0|||
16798048|NCT02349633|37739409|FG005|Overall Study|Early termination of survival follow-up|0|||
16798049|NCT02349633|37739410|FG006|Overall Study|Early termination of survival follow-up|0|||
16798050|NCT02349633|37739411|FG007|Overall Study|Early termination of survival follow-up|4|||
16798051|NCT02349633|37739412|FG008|Overall Study|Early termination of survival follow-up|0|||
16798052|NCT02349633|37739413|FG009|Overall Study|Early termination of survival follow-up|0|||
16798053|NCT02349633|37739414|FG010|Overall Study|Early termination of survival follow-up|0|||
16798054|NCT02349633|37739415|FG011|Overall Study|Early termination of survival follow-up|0|||
16798055|NCT02349633|37739416|FG012|Overall Study|Early termination of survival follow-up|0|||
16798056|NCT02349633|37739417|FG013|Overall Study|Early termination of survival follow-up|0|||
16798057|NCT02349633|37739404|FG000|Overall Study|Termination by sponsor|0|||
16798058|NCT02349633|37739405|FG001|Overall Study|Termination by sponsor|0|||
16798059|NCT02349633|37739406|FG002|Overall Study|Termination by sponsor|0|||
16798060|NCT02349633|37739407|FG003|Overall Study|Termination by sponsor|0|||
16798061|NCT02349633|37739408|FG004|Overall Study|Termination by sponsor|0|||
16798062|NCT02349633|37739409|FG005|Overall Study|Termination by sponsor|0|||
16798063|NCT02349633|37739410|FG006|Overall Study|Termination by sponsor|0|||
16798064|NCT02349633|37739411|FG007|Overall Study|Termination by sponsor|1|||
16798065|NCT02349633|37739412|FG008|Overall Study|Termination by sponsor|0|||
16798066|NCT02349633|37739413|FG009|Overall Study|Termination by sponsor|2|||
16798067|NCT02349633|37739414|FG010|Overall Study|Termination by sponsor|0|||
16798068|NCT02349633|37739415|FG011|Overall Study|Termination by sponsor|0|||
16798069|NCT02349633|37739416|FG012|Overall Study|Termination by sponsor|0|||
16798070|NCT02349633|37739417|FG013|Overall Study|Termination by sponsor|0|||
16798071|NCT02349633|37739404|FG000|Overall Study|Other|0|||
16798072|NCT02349633|37739405|FG001|Overall Study|Other|0|||
16798073|NCT02349633|37739406|FG002|Overall Study|Other|0|||
16798074|NCT02349633|37739407|FG003|Overall Study|Other|0|||
16798075|NCT02349633|37739408|FG004|Overall Study|Other|0|||
16798076|NCT02349633|37739409|FG005|Overall Study|Other|0|||
16798077|NCT02349633|37739410|FG006|Overall Study|Other|0|||
16798078|NCT02349633|37739411|FG007|Overall Study|Other|2|||
16798079|NCT02349633|37739412|FG008|Overall Study|Other|0|||
16798080|NCT02349633|37739413|FG009|Overall Study|Other|0|||
16798081|NCT02349633|37739414|FG010|Overall Study|Other|0|||
16798082|NCT02349633|37739415|FG011|Overall Study|Other|0|||
16798083|NCT02349633|37739416|FG012|Overall Study|Other|0|||
16798084|NCT02349633|37739417|FG013|Overall Study|Other|0|||
16798085|NCT02275611|37739482|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
16798086|NCT02275611|37739483|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
16798087|NCT02275611|37739484|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
16798088|NCT02275611|37739485|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
16798089|NCT01642251|37739500|FG000|Overall Study|Progressive disease|0|||
16798090|NCT01642251|37739501|FG001|Overall Study|Progressive disease|0|||
16798091|NCT01642251|37739502|FG002|Overall Study|Progressive disease|3|||
16798092|NCT01642251|37739503|FG003|Overall Study|Progressive disease|3|||
16798093|NCT01642251|37739500|FG000|Overall Study|Adverse Event|0|||
16798094|NCT01642251|37739501|FG001|Overall Study|Adverse Event|0|||
16798095|NCT01642251|37739502|FG002|Overall Study|Adverse Event|5|||
16798096|NCT01642251|37739503|FG003|Overall Study|Adverse Event|4|||
16798097|NCT01642251|37739500|FG000|Overall Study|Death|0|||
16798098|NCT01642251|37739501|FG001|Overall Study|Death|0|||
16798099|NCT01642251|37739502|FG002|Overall Study|Death|1|||
16798100|NCT01642251|37739503|FG003|Overall Study|Death|3|||
16798101|NCT01642251|37739500|FG000|Overall Study|Withdrawal by Subject|0|||
16798102|NCT01642251|37739501|FG001|Overall Study|Withdrawal by Subject|0|||
16798103|NCT01642251|37739502|FG002|Overall Study|Withdrawal by Subject|1|||
16798104|NCT01642251|37739503|FG003|Overall Study|Withdrawal by Subject|3|||
16798105|NCT01642251|37739500|FG000|Overall Study|Alternative therapy|0|||
16798106|NCT01642251|37739501|FG001|Overall Study|Alternative therapy|0|||
16798107|NCT01642251|37739502|FG002|Overall Study|Alternative therapy|0|||
16798108|NCT01642251|37739503|FG003|Overall Study|Alternative therapy|2|||
16798109|NCT01642251|37739500|FG000|Overall Study|Other complicating disease|0|||
16798110|NCT01642251|37739501|FG001|Overall Study|Other complicating disease|0|||
16798111|NCT01642251|37739502|FG002|Overall Study|Other complicating disease|1|||
16798112|NCT01642251|37739503|FG003|Overall Study|Other complicating disease|0|||
16798113|NCT01642251|37739500|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
16798114|NCT01642251|37739501|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
16798115|NCT01642251|37739502|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
16798116|NCT01642251|37739503|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
16798117|NCT02275065|37739517|FG000|Overall Study|Randomized but not treated|1|||
16798118|NCT02275065|37739518|FG001|Overall Study|Randomized but not treated|0|||
16798119|NCT02275065|37739519|FG002|Overall Study|Randomized but not treated|1|||
16798120|NCT02275065|37739520|FG003|Overall Study|Randomized but not treated|1|||
16798121|NCT02275065|37739521|FG004|Overall Study|Randomized but not treated|0|||
16798122|NCT02273973|37739535|FG000|Overall Study|Adverse Event|4|||
16798123|NCT02273973|37739536|FG001|Overall Study|Adverse Event|0|||
16798124|NCT02273973|37739535|FG000|Overall Study|Withdrawal by Subject|2|||
16798125|NCT02273973|37739536|FG001|Overall Study|Withdrawal by Subject|3|||
16798126|NCT02273973|37739535|FG000|Overall Study|Death|1|||
16798127|NCT02273973|37739536|FG001|Overall Study|Death|0|||
16798128|NCT02273973|37739535|FG000|Overall Study|Non-compliance|1|||
16798129|NCT02273973|37739536|FG001|Overall Study|Non-compliance|0|||
16798130|NCT02273973|37739535|FG000|Overall Study|Protocol Violation|1|||
16798131|NCT02273973|37739536|FG001|Overall Study|Protocol Violation|0|||
16798132|NCT02273973|37739535|FG000|Overall Study|Progression of disease|0|||
16798133|NCT02273973|37739536|FG001|Overall Study|Progression of disease|2|||
16798134|NCT02273973|37739535|FG000|Overall Study|Lost to Follow-up|0|||
16798135|NCT02273973|37739536|FG001|Overall Study|Lost to Follow-up|1|||
16798136|NCT02273973|37739535|FG000|Overall Study|Physician Decision|0|||
16798137|NCT02273973|37739536|FG001|Overall Study|Physician Decision|1|||
16798138|NCT02273973|37739535|FG000|Overall Study|Reason not specified|0|||
16798139|NCT02273973|37739536|FG001|Overall Study|Reason not specified|1|||
16798140|NCT02273739|37739546|FG000|Overall Study|Progression of Disease|3|||
16798141|NCT02273739|37739547|FG001|Overall Study|Progression of Disease|4|||
16798142|NCT02273739|37739548|FG002|Overall Study|Progression of Disease|5|||
16798143|NCT02273739|37739549|FG003|Overall Study|Progression of Disease|2|||
16798144|NCT02273739|37739546|FG000|Overall Study|Death|0|||
16798145|NCT02273739|37739547|FG001|Overall Study|Death|0|||
16798146|NCT02273739|37739548|FG002|Overall Study|Death|0|||
16798147|NCT02273739|37739549|FG003|Overall Study|Death|2|||
16798148|NCT02273739|37739546|FG000|Overall Study|Adverse Event|0|||
16798149|NCT02273739|37739547|FG001|Overall Study|Adverse Event|0|||
16798150|NCT02273739|37739548|FG002|Overall Study|Adverse Event|0|||
16798151|NCT02273739|37739549|FG003|Overall Study|Adverse Event|1|||
16798152|NCT02273739|37739546|FG000|Overall Study|Withdrawal by Subject|0|||
16798153|NCT02273739|37739547|FG001|Overall Study|Withdrawal by Subject|0|||
16798154|NCT02273739|37739548|FG002|Overall Study|Withdrawal by Subject|2|||
16798155|NCT02273739|37739549|FG003|Overall Study|Withdrawal by Subject|1|||
16798156|NCT02273739|37739546|FG000|Overall Study|Physician Decision|0|||
16798157|NCT02273739|37739547|FG001|Overall Study|Physician Decision|0|||
16798158|NCT02273739|37739548|FG002|Overall Study|Physician Decision|0|||
16798159|NCT02273739|37739549|FG003|Overall Study|Physician Decision|1|||
16798160|NCT02273037|37739566|FG000|Overall Study|Lost to Follow-up|1|||
16798161|NCT02273037|37739567|FG001|Overall Study|Lost to Follow-up|0|||
16798162|NCT02273037|37739566|FG000|Overall Study|Delivered before monitoring initiated|1|||
16798163|NCT02273037|37739567|FG001|Overall Study|Delivered before monitoring initiated|3|||
16798164|NCT02273037|37739566|FG000|Overall Study|Breech delivery|2|||
16798165|NCT02273037|37739567|FG001|Overall Study|Breech delivery|3|||
16798166|NCT02273037|37739566|FG000|Overall Study|Multiple delivery|2|||
16798167|NCT02273037|37739567|FG001|Overall Study|Multiple delivery|2|||
16798168|NCT02273037|37739566|FG000|Overall Study|Other complication|2|||
16798169|NCT02273037|37739567|FG001|Overall Study|Other complication|0|||
16798170|NCT02465515|37739577|FG000|Overall Study|Investigator site closed|4|||
16798171|NCT02465515|37739578|FG001|Overall Study|Investigator site closed|5|||
16798172|NCT02465515|37739577|FG000|Overall Study|Withdrawal by Subject|74|||
16798173|NCT02465515|37739578|FG001|Overall Study|Withdrawal by Subject|43|||
16798174|NCT02465515|37739577|FG000|Overall Study|Physician Decision|8|||
16798175|NCT02465515|37739578|FG001|Overall Study|Physician Decision|12|||
16798176|NCT02465515|37739577|FG000|Overall Study|Lost to Follow-up|68|||
16798177|NCT02465515|37739578|FG001|Overall Study|Lost to Follow-up|51|||
16798178|NCT02412631|37739586|FG000|Overall Study|Adverse Event|1|||
16798179|NCT02412631|37739587|FG001|Overall Study|Adverse Event|2|||
16798180|NCT02412631|37739586|FG000|Overall Study|Lost to Follow-up|5|||
16798181|NCT02412631|37739587|FG001|Overall Study|Lost to Follow-up|9|||
16798182|NCT02412631|37739586|FG000|Overall Study|Withdrawal by Subject|9|||
16798183|NCT02412631|37739587|FG001|Overall Study|Withdrawal by Subject|3|||
16798184|NCT02412631|37739586|FG000|Overall Study|Early stop by FDA|5|||
16798185|NCT02412631|37739587|FG001|Overall Study|Early stop by FDA|2|||
16798186|NCT02412631|37739586|FG000|Overall Study|Unspecified reason|6|||
16798187|NCT02412631|37739587|FG001|Overall Study|Unspecified reason|8|||
16798188|NCT02272803|37739595|FG000|Overall Study|Disease progression|16|||
16798189|NCT02272803|37739596|FG001|Overall Study|Disease progression|8|||
16798190|NCT02272803|37739595|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
16798191|NCT02272803|37739596|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
16798192|NCT02272803|37739595|FG000|Overall Study|Study drug toxicity|4|||
16798193|NCT02272803|37739596|FG001|Overall Study|Study drug toxicity|9|||
16798194|NCT02272803|37739595|FG000|Overall Study|Participant request to discontinue study treatment|3|||
16798195|NCT02272803|37739596|FG001|Overall Study|Participant request to discontinue study treatment|7|||
16798196|NCT02272803|37739595|FG000|Overall Study|Maximum clinical benefit|4|||
16798197|NCT02272803|37739596|FG001|Overall Study|Maximum clinical benefit|2|||
16798198|NCT02272803|37739595|FG000|Overall Study|Poor/non-compliance|2|||
16798199|NCT02272803|37739596|FG001|Overall Study|Poor/non-compliance|2|||
16798200|NCT02272803|37739595|FG000|Overall Study|Withdrawal by Subject|2|||
16798201|NCT02272803|37739596|FG001|Overall Study|Withdrawal by Subject|1|||
16798202|NCT02272803|37739595|FG000|Overall Study|Death|0|||
16798203|NCT02272803|37739596|FG001|Overall Study|Death|1|||
16798204|NCT02272803|37739595|FG000|Overall Study|Other reasons|1|||
16798205|NCT02272803|37739596|FG001|Overall Study|Other reasons|3|||
16798206|NCT02272803|37739595|FG000|Overall Study|Administrative reason by sponsor|5|||
16798207|NCT02272803|37739596|FG001|Overall Study|Administrative reason by sponsor|4|||
16798208|NCT02272725|37739604|FG000|Overall Study|equipment malfunction|2|||
16798209|NCT02272725|37739605|FG001|Overall Study|equipment malfunction|0|||
16798210|NCT01650805|37739613|FG000|Overall Study|Withdrawal by Subject|1|||
16798211|NCT01650805|37739614|FG001|Overall Study|Withdrawal by Subject|0|||
16798212|NCT02442349|37739620|FG000|Overall Study|Death|14|||
16798213|NCT02442349|37739620|FG000|Overall Study|Withdrawal by Subject|8|||
16798214|NCT02442349|37739620|FG000|Overall Study|On-going Study at Data Cut-off|149|||
16798215|NCT02411539|37739626|FG000|Overall Study|Lost to Follow-up|2|||
16798216|NCT02411539|37739627|FG001|Overall Study|Lost to Follow-up|0|||
16798217|NCT02411539|37739626|FG000|Overall Study|Confounding medical condition|0|||
16798218|NCT02411539|37739627|FG001|Overall Study|Confounding medical condition|1|||
16798219|NCT02465437|37739640|FG000|Overall Study|Physician Decision|0|||
16798220|NCT02465437|37739641|FG001|Overall Study|Physician Decision|0|||
16798221|NCT02465437|37739642|FG002|Overall Study|Physician Decision|1|||
16798222|NCT02465437|37739643|FG003|Overall Study|Physician Decision|0|||
16798223|NCT02465437|37739640|FG000|Overall Study|Withdrawal by Subject|1|||
16798224|NCT02465437|37739641|FG001|Overall Study|Withdrawal by Subject|0|||
16798225|NCT02465437|37739642|FG002|Overall Study|Withdrawal by Subject|0|||
16798226|NCT02465437|37739643|FG003|Overall Study|Withdrawal by Subject|1|||
16798227|NCT02465437|37739640|FG000|Overall Study|Adverse Event|0|||
16798228|NCT02465437|37739641|FG001|Overall Study|Adverse Event|1|||
16798229|NCT02465437|37739642|FG002|Overall Study|Adverse Event|0|||
16798230|NCT02465437|37739643|FG003|Overall Study|Adverse Event|0|||
16798231|NCT02442271|37739651|FG000|Overall Study|Adverse Event|1|||
16798232|NCT02442271|37739651|FG000|Overall Study|Withdrew Consent|1|||
16798233|NCT02442271|37739651|FG000|Overall Study|Lost to Follow-up|1|||
16798234|NCT02442271|37739651|FG000|Overall Study|Other|1|||
16798235|NCT02465203|37739672|FG000|Overall Study|Protocol Violation|1|||
16798236|NCT02465203|37739673|FG001|Overall Study|Protocol Violation|1|||
16798237|NCT02465203|37739674|FG002|Overall Study|Protocol Violation|1|||
16798238|NCT02465203|37739672|FG000|Overall Study|Study terminated by sponsor|50|||
16798239|NCT02465203|37739673|FG001|Overall Study|Study terminated by sponsor|34|||
16798240|NCT02465203|37739674|FG002|Overall Study|Study terminated by sponsor|11|||
16798241|NCT02465203|37739672|FG000|Overall Study|New therapy for study indication|4|||
16798242|NCT02465203|37739673|FG001|Overall Study|New therapy for study indication|0|||
16798243|NCT02465203|37739674|FG002|Overall Study|New therapy for study indication|0|||
16798244|NCT02465203|37739672|FG000|Overall Study|Patient/guardian decision|1|||
16798245|NCT02465203|37739673|FG001|Overall Study|Patient/guardian decision|1|||
16798246|NCT02465203|37739674|FG002|Overall Study|Patient/guardian decision|1|||
16798247|NCT02463409|37739681|FG000|Overall Study|Withdrawal by Subject|1|||
16798248|NCT02463409|37739681|FG000|Overall Study|Screen failure|1|||
16798249|NCT02528357|37739704|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798250|NCT02528357|37739705|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
16798251|NCT02528357|37739706|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798252|NCT02528357|37739707|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798253|NCT02528357|37739708|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798254|NCT02528357|37739709|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798255|NCT02528357|37739710|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798256|NCT02528357|37739711|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798257|NCT02528357|37739712|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798258|NCT02528357|37739713|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798259|NCT02528357|37739714|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798260|NCT02528357|37739715|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798261|NCT02528357|37739716|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798262|NCT02528357|37739717|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798263|NCT02528357|37739718|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798264|NCT02528357|37739719|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798265|NCT02528357|37739720|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798266|NCT02528357|37739721|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798267|NCT02528357|37739722|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16798268|NCT02528357|37739704|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798269|NCT02528357|37739705|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798270|NCT02528357|37739706|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798271|NCT02528357|37739707|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
16798272|NCT02528357|37739708|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798273|NCT02528357|37739709|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
16798274|NCT02528357|37739710|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798275|NCT02528357|37739711|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
16798276|NCT02528357|37739712|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798277|NCT02528357|37739713|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798278|NCT02528357|37739714|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798279|NCT02528357|37739715|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798280|NCT02528357|37739716|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798281|NCT02528357|37739717|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798282|NCT02528357|37739718|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798283|NCT02528357|37739719|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798284|NCT02528357|37739720|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798285|NCT02528357|37739721|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798286|NCT02528357|37739722|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16798287|NCT02528357|37739704|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798288|NCT02528357|37739705|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798289|NCT02528357|37739706|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
16798290|NCT02528357|37739707|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798291|NCT02528357|37739708|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
16798292|NCT02528357|37739709|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798293|NCT02528357|37739710|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
16798294|NCT02528357|37739711|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
16798295|NCT02528357|37739712|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798296|NCT02528357|37739713|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798297|NCT02528357|37739714|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798298|NCT02528357|37739715|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798299|NCT02528357|37739716|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798300|NCT02528357|37739717|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798301|NCT02528357|37739718|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798302|NCT02528357|37739719|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798303|NCT02528357|37739720|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798304|NCT02528357|37739721|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798305|NCT02528357|37739722|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16798306|NCT02528357|37739704|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798307|NCT02528357|37739705|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798308|NCT02528357|37739706|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798309|NCT02528357|37739707|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798310|NCT02528357|37739708|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16798311|NCT02528357|37739709|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798312|NCT02528357|37739710|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798313|NCT02528357|37739711|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798314|NCT02528357|37739712|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798315|NCT02528357|37739713|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16909344|NCT01701258|38018195|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
16909345|NCT01701258|38018196|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
16909346|NCT01701258|38018197|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
17016524|NCT00600353|38161139|FG001|Overall Study|history of malignancy within 5 years|0|||
17016525|NCT00600353|38161138|FG000|Overall Study|History of prepartive regimen|0|||
16798316|NCT02528357|37739714|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798317|NCT02528357|37739715|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798318|NCT02528357|37739716|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798319|NCT02528357|37739717|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798320|NCT02528357|37739718|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798321|NCT02528357|37739719|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798322|NCT02528357|37739720|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798323|NCT02528357|37739721|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798324|NCT02528357|37739722|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798325|NCT02528357|37739704|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798326|NCT02528357|37739705|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798327|NCT02528357|37739706|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798328|NCT02528357|37739707|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798329|NCT02528357|37739708|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798330|NCT02528357|37739709|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798331|NCT02528357|37739710|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798332|NCT02528357|37739711|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798333|NCT02528357|37739712|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798334|NCT02528357|37739713|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798335|NCT02528357|37739714|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798336|NCT02528357|37739715|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798337|NCT02528357|37739716|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798338|NCT02528357|37739717|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
16798339|NCT02528357|37739718|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
16798340|NCT02528357|37739719|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798341|NCT02528357|37739720|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798342|NCT02528357|37739721|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798343|NCT02528357|37739722|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16798344|NCT02528357|37739704|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798345|NCT02528357|37739705|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798346|NCT02528357|37739706|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798347|NCT02528357|37739707|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798348|NCT02528357|37739708|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798349|NCT02528357|37739709|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798350|NCT02528357|37739710|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798351|NCT02528357|37739711|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798352|NCT02528357|37739712|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798353|NCT02528357|37739713|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798354|NCT02528357|37739714|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798355|NCT02528357|37739715|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798356|NCT02528357|37739716|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798357|NCT02528357|37739717|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
16798358|NCT02528357|37739718|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798359|NCT02528357|37739719|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798360|NCT02528357|37739720|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798361|NCT02528357|37739721|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798362|NCT02528357|37739722|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16798363|NCT02528357|37739704|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798364|NCT02528357|37739705|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798365|NCT02528357|37739706|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798366|NCT02528357|37739707|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798367|NCT02528357|37739708|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798368|NCT02528357|37739709|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798369|NCT02528357|37739710|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798370|NCT02528357|37739711|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798371|NCT02528357|37739712|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798372|NCT02528357|37739713|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798373|NCT02528357|37739714|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
16798374|NCT02528357|37739715|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798375|NCT02528357|37739716|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
16798376|NCT02528357|37739717|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
16798377|NCT02528357|37739718|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
16798378|NCT02528357|37739719|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798379|NCT02528357|37739720|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798380|NCT02528357|37739721|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798381|NCT02528357|37739722|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16798382|NCT02528357|37739704|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798383|NCT02528357|37739705|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798384|NCT02528357|37739706|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798385|NCT02528357|37739707|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798386|NCT02528357|37739708|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798387|NCT02528357|37739709|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798388|NCT02528357|37739710|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798389|NCT02528357|37739711|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798390|NCT02528357|37739712|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16798391|NCT02528357|37739713|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16798392|NCT02528357|37739714|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798393|NCT02528357|37739715|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
16798394|NCT02528357|37739716|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
16798395|NCT02528357|37739717|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16798396|NCT02528357|37739718|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16798397|NCT02528357|37739719|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798398|NCT02528357|37739720|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798399|NCT02528357|37739721|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798400|NCT02528357|37739722|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798401|NCT02528357|37739704|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798402|NCT02528357|37739705|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798403|NCT02528357|37739706|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798404|NCT02528357|37739707|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798405|NCT02528357|37739708|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798406|NCT02528357|37739709|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798407|NCT02528357|37739710|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798408|NCT02528357|37739711|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798409|NCT02528357|37739712|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798410|NCT02528357|37739713|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798411|NCT02528357|37739714|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798412|NCT02528357|37739715|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798413|NCT02528357|37739716|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798414|NCT02528357|37739717|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798415|NCT02528357|37739718|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798416|NCT02528357|37739719|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798417|NCT02528357|37739720|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
16798418|NCT02528357|37739721|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798419|NCT02528357|37739722|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16798420|NCT02528357|37739704|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798421|NCT02528357|37739705|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798422|NCT02528357|37739706|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798423|NCT02528357|37739707|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798424|NCT02528357|37739708|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798425|NCT02528357|37739709|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798426|NCT02528357|37739710|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798427|NCT02528357|37739711|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798428|NCT02528357|37739712|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16909347|NCT01701258|38018198|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
16798429|NCT02528357|37739713|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798430|NCT02528357|37739714|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798431|NCT02528357|37739715|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798432|NCT02528357|37739716|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798433|NCT02528357|37739717|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798434|NCT02528357|37739718|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798435|NCT02528357|37739719|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16798436|NCT02528357|37739720|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16798437|NCT02528357|37739721|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
16798438|NCT02528357|37739722|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
16798439|NCT02463331|37739764|FG000|Overall Study|Adverse Event|4|||
16798440|NCT02463331|37739765|FG001|Overall Study|Adverse Event|2|||
16798441|NCT02463331|37739764|FG000|Overall Study|Lost to Follow-up|1|||
16798442|NCT02463331|37739765|FG001|Overall Study|Lost to Follow-up|1|||
16798443|NCT02463331|37739764|FG000|Overall Study|Pregnancy|2|||
16798444|NCT02463331|37739765|FG001|Overall Study|Pregnancy|3|||
16798445|NCT02463331|37739764|FG000|Overall Study|Lack of Efficacy|6|||
16798446|NCT02463331|37739765|FG001|Overall Study|Lack of Efficacy|0|||
16798447|NCT02463331|37739764|FG000|Overall Study|Physician Decision|3|||
16798448|NCT02463331|37739765|FG001|Overall Study|Physician Decision|0|||
16798449|NCT02410837|37739771|FG000|Overall Study|Death|387|||
16798450|NCT02410837|37739771|FG000|Overall Study|Lost to Follow-up|50|||
16798451|NCT02410837|37739771|FG000|Overall Study|Withdrawal by Subject|44|||
16798452|NCT02410837|37739771|FG000|Overall Study|Physician Decision|6|||
16798453|NCT02410837|37739771|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
16798454|NCT02314247|37739777|FG000|Overall Study|Adverse Event|2|||
16798455|NCT02314247|37739778|FG001|Overall Study|Adverse Event|1|||
16798456|NCT02314247|37739779|FG002|Overall Study|Adverse Event|0|||
16798457|NCT02314247|37739777|FG000|Overall Study|Withdrawal by Subject|1|||
16798458|NCT02314247|37739778|FG001|Overall Study|Withdrawal by Subject|3|||
16798459|NCT02314247|37739779|FG002|Overall Study|Withdrawal by Subject|1|||
16798460|NCT02314247|37739777|FG000|Overall Study|Progression of Disease|6|||
16798461|NCT02314247|37739778|FG001|Overall Study|Progression of Disease|2|||
16798462|NCT02314247|37739779|FG002|Overall Study|Progression of Disease|0|||
16798463|NCT02463097|37739789|FG000|Overall Study|Withdrawal by Subject|1|||
16798464|NCT02441179|37739795|FG000|Overall Study|Withdrawal by Subject|1|||
16798465|NCT02441179|37739796|FG001|Overall Study|Withdrawal by Subject|1|||
16798466|NCT02462473|37739803|FG000|Overall Study|Death|1|||
16798467|NCT02462473|37739803|FG000|Overall Study|Other|3|||
16798468|NCT02440789|37739816|FG000|Overall Study|Withdrawal by Subject|3|||
16798469|NCT02440789|37739816|FG000|Overall Study|Not willing to adhere to reqs|1|||
16798470|NCT02462083|37739820|FG000|Overall Study|Sponsor request|39|||
16798471|NCT02462083|37739820|FG000|Overall Study|Withdrawal by Subject|87|||
16798472|NCT02462083|37739820|FG000|Overall Study|Lost to Follow-up|41|||
16798473|NCT02462083|37739820|FG000|Overall Study|Lack of Efficacy|151|||
16798474|NCT02462083|37739820|FG000|Overall Study|Pregnancy|1|||
16798475|NCT02462083|37739820|FG000|Overall Study|Protocol Violation|6|||
16798476|NCT02462083|37739820|FG000|Overall Study|Adverse Event|33|||
16798477|NCT02462083|37739820|FG000|Overall Study|Worsening condition|16|||
16798478|NCT02462083|37739820|FG000|Overall Study|Other than specified|45|||
16798479|NCT02538341|37739826|FG000|Overall Study|Lost to Follow-up|51|||
16798480|NCT02538341|37739827|FG001|Overall Study|Lost to Follow-up|46|||
16798481|NCT02538341|37739826|FG000|Overall Study|Withdrawal by Subject|3|||
16798482|NCT02538341|37739827|FG001|Overall Study|Withdrawal by Subject|1|||
16798483|NCT02538341|37739826|FG000|Overall Study|Death|2|||
16798484|NCT02538341|37739827|FG001|Overall Study|Death|0|||
16798485|NCT02538107|37739833|FG000|Overall Study|Did not receive any Mircera dose|11|||
16798486|NCT02538107|37739833|FG000|Overall Study|Missing|5|||
16798487|NCT02538107|37739833|FG000|Overall Study|Necessity of dialysis|20|||
16798488|NCT02538107|37739833|FG000|Overall Study|Administration of other ESA|11|||
16798489|NCT02538107|37739833|FG000|Overall Study|No further treatment necessary|18|||
16798490|NCT02538107|37739833|FG000|Overall Study|Withdrawal by Subject|17|||
16798491|NCT02538107|37739833|FG000|Overall Study|Death|4|||
16798492|NCT02538107|37739833|FG000|Overall Study|Administrative reason|5|||
16798493|NCT02538107|37739833|FG000|Overall Study|Adverse Event|4|||
16798494|NCT02538107|37739833|FG000|Overall Study|Surgery|1|||
16798495|NCT02538107|37739833|FG000|Overall Study|Other|7|||
16798496|NCT02538107|37739833|FG000|Overall Study|Not recorded|7|||
16798497|NCT02538029|37739850|FG000|Overall Study|unable to complete cognitive assessments|1|||
16798498|NCT02538029|37739851|FG001|Overall Study|unable to complete cognitive assessments|0|||
16798499|NCT02538029|37739852|FG002|Overall Study|unable to complete cognitive assessments|1|||
16798500|NCT02272413|37739864|FG000|Randomized Through Treatment Start|Not treated|3|||
16798501|NCT02272413|37739865|FG001|Randomized Through Treatment Start|Not treated|5|||
16798502|NCT02272413|37739864|FG000|Pre-switch Period|Adverse Event|38|||
16798503|NCT02272413|37739865|FG001|Pre-switch Period|Adverse Event|37|||
16798504|NCT02272413|37739864|FG000|Pre-switch Period|Death|26|||
16798505|NCT02272413|37739865|FG001|Pre-switch Period|Death|26|||
16798506|NCT02272413|37739864|FG000|Pre-switch Period|Withdrawal by Subject|27|||
16798507|NCT02272413|37739865|FG001|Pre-switch Period|Withdrawal by Subject|15|||
16798508|NCT02272413|37739864|FG000|Pre-switch Period|Physician Decision|6|||
16798509|NCT02272413|37739865|FG001|Pre-switch Period|Physician Decision|18|||
16798510|NCT02272413|37739864|FG000|Pre-switch Period|Progressive disease|185|||
16798511|NCT02272413|37739865|FG001|Pre-switch Period|Progressive disease|173|||
16798512|NCT02272413|37739864|FG000|Pre-switch Period|Lost to Follow-up|0|||
16798513|NCT02272413|37739865|FG001|Pre-switch Period|Lost to Follow-up|2|||
16798514|NCT02272413|37739864|FG000|Pre-switch Period|Protocol Violation|1|||
16798515|NCT02272413|37739865|FG001|Pre-switch Period|Protocol Violation|0|||
16798516|NCT02272413|37739864|FG000|Pre-switch Period|Other than listed|10|||
16798517|NCT02272413|37739865|FG001|Pre-switch Period|Other than listed|11|||
16798518|NCT02272413|37739864|FG000|Post-switch Period|Adverse Event|4|||
16798519|NCT02272413|37739865|FG001|Post-switch Period|Adverse Event|4|||
16798520|NCT02272413|37739864|FG000|Post-switch Period|Death|3|||
16798521|NCT02272413|37739865|FG001|Post-switch Period|Death|2|||
16798522|NCT02272413|37739864|FG000|Post-switch Period|Withdrawal by Subject|1|||
16798523|NCT02272413|37739865|FG001|Post-switch Period|Withdrawal by Subject|2|||
16798524|NCT02272413|37739864|FG000|Post-switch Period|Physician Decision|1|||
16798525|NCT02272413|37739865|FG001|Post-switch Period|Physician Decision|1|||
16798526|NCT02272413|37739864|FG000|Post-switch Period|Progressive disease|21|||
16798527|NCT02272413|37739865|FG001|Post-switch Period|Progressive disease|21|||
16798528|NCT02272413|37739864|FG000|Post-switch Period|Study terminated by sponsor|8|||
16798529|NCT02272413|37739865|FG001|Post-switch Period|Study terminated by sponsor|11|||
16798530|NCT02272413|37739864|FG000|Post-switch Period|Other than listed|4|||
16798531|NCT02272413|37739865|FG001|Post-switch Period|Other than listed|5|||
16798532|NCT02396381|37739877|FG000|Overall Study|Adverse Event|3|||
16798533|NCT02396381|37739878|FG001|Overall Study|Adverse Event|2|||
16798534|NCT02396381|37739877|FG000|Overall Study|Withdrawal by Subject|33|||
16798535|NCT02396381|37739878|FG001|Overall Study|Withdrawal by Subject|24|||
16798536|NCT02396381|37739877|FG000|Overall Study|Lost to Follow-up|49|||
16798537|NCT02396381|37739878|FG001|Overall Study|Lost to Follow-up|31|||
16798538|NCT02396381|37739877|FG000|Overall Study|Protocol Violation|1|||
16798539|NCT02396381|37739878|FG001|Overall Study|Protocol Violation|0|||
16798540|NCT02396381|37739877|FG000|Overall Study|Site terminated by sponsor|7|||
16798541|NCT02396381|37739878|FG001|Overall Study|Site terminated by sponsor|8|||
16798542|NCT02396381|37739877|FG000|Overall Study|Physician Decision|5|||
16798543|NCT02396381|37739878|FG001|Overall Study|Physician Decision|5|||
16798544|NCT02396381|37739877|FG000|Overall Study|Pregnancy|2|||
16798545|NCT02396381|37739878|FG001|Overall Study|Pregnancy|0|||
16798546|NCT02396381|37739877|FG000|Overall Study|Non-compliance with study procedures|1|||
16798547|NCT02396381|37739878|FG001|Overall Study|Non-compliance with study procedures|0|||
16798548|NCT02396381|37739877|FG000|Overall Study|Moved out of town/state|1|||
16798549|NCT02396381|37739878|FG001|Overall Study|Moved out of town/state|3|||
16798550|NCT02396381|37739877|FG000|Overall Study|Could not complete visit|1|||
16798551|NCT02396381|37739878|FG001|Overall Study|Could not complete visit|0|||
16798552|NCT02396381|37739877|FG000|Overall Study|Possible conflict of interest|1|||
16798553|NCT02396381|37739878|FG001|Overall Study|Possible conflict of interest|0|||
16798554|NCT02396381|37739877|FG000|Overall Study|Randomization/Screening Error|3|||
16798555|NCT02396381|37739878|FG001|Overall Study|Randomization/Screening Error|1|||
16798556|NCT02532647|37739890|FG000|Overall Study|Did not receive trial medication|1|||
16798557|NCT02532647|37739891|FG001|Overall Study|Did not receive trial medication|0|||
16798558|NCT02532647|37739892|FG002|Overall Study|Did not receive trial medication|1|||
16798559|NCT02537015|37739900|FG000|Overall Study|Adverse Event|3|||
16798560|NCT02537015|37739900|FG000|Overall Study|Withdrawal by Subject|2|||
16798561|NCT02537015|37739900|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16798562|NCT02271945|37739906|FG000|Overall Study|Death|3|||
16798563|NCT02271945|37739907|FG001|Overall Study|Death|3|||
16798564|NCT02271945|37739906|FG000|Overall Study|Withdrawal by Subject|1|||
16798565|NCT02271945|37739907|FG001|Overall Study|Withdrawal by Subject|1|||
16798566|NCT02271945|37739906|FG000|Overall Study|Other|1|||
16798567|NCT02271945|37739907|FG001|Overall Study|Other|1|||
16798568|NCT01660763|37739915|FG000|Overall Study|Lack of Efficacy|45|||
16798569|NCT01660763|37739916|FG001|Overall Study|Lack of Efficacy|50|||
16798570|NCT01660763|37739915|FG000|Overall Study|Adverse Event|22|||
16798571|NCT01660763|37739916|FG001|Overall Study|Adverse Event|7|||
16798572|NCT01660763|37739915|FG000|Overall Study|Protocol Violation|1|||
16798573|NCT01660763|37739916|FG001|Overall Study|Protocol Violation|0|||
16798574|NCT01660763|37739915|FG000|Overall Study|Withdrawal by Subject|4|||
16798575|NCT01660763|37739916|FG001|Overall Study|Withdrawal by Subject|0|||
16798576|NCT01660763|37739915|FG000|Overall Study|Patient ready for early discharge|28|||
16798577|NCT01660763|37739916|FG001|Overall Study|Patient ready for early discharge|4|||
16798578|NCT01937117|37739922|FG000|Overall Study|Disease Progression|7|||
16798579|NCT01937117|37739922|FG000|Overall Study|Physician Decision|4|||
16798580|NCT01937117|37739922|FG000|Overall Study|Adverse Event|2|||
16798581|NCT02268045|37739928|FG000|Overall Study|Death|4|||
16798582|NCT02268045|37739929|FG001|Overall Study|Death|4|||
16798583|NCT02268045|37739928|FG000|Overall Study|Disease Progression|2|||
16798584|NCT02268045|37739929|FG001|Overall Study|Disease Progression|1|||
16798585|NCT02268045|37739928|FG000|Overall Study|Adverse Event|7|||
16798586|NCT02268045|37739929|FG001|Overall Study|Adverse Event|7|||
16798587|NCT02268045|37739928|FG000|Overall Study|Withdrawal by Subject|2|||
16798588|NCT02268045|37739929|FG001|Overall Study|Withdrawal by Subject|6|||
16798589|NCT02268045|37739928|FG000|Overall Study|Physician Decision|0|||
16798590|NCT02268045|37739929|FG001|Overall Study|Physician Decision|1|||
16798591|NCT02268045|37739928|FG000|Overall Study|Protocol Violation|1|||
16798592|NCT02268045|37739929|FG001|Overall Study|Protocol Violation|1|||
16798593|NCT02536781|37739939|FG000|Overall Study|Lost to Follow-up|2|||
16798594|NCT02536781|37739940|FG001|Overall Study|Lost to Follow-up|0|||
16798595|NCT02267187|37739946|FG000|Overall Study|Physician Decision|2|||
16798596|NCT02267187|37739946|FG000|Overall Study|Screen fail|3|||
16798597|NCT02532179|37739950|FG000|Overall Study|Lost to Follow-up|1|||
16798598|NCT02532179|37739950|FG000|Overall Study|Pregnancy|1|||
16798599|NCT02532179|37739950|FG000|Overall Study|Subject received depot steroid injection|1|||
16798600|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
16798601|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
16798602|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
16798603|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
16798604|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
16798605|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
16798606|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
16798607|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
16798608|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
16798609|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
16798610|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
16798611|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
16798612|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
16798613|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
16798614|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
16798615|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
16798616|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
16798617|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
16798618|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
16798619|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
16798620|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
16798621|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
16798622|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
16798623|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
16798624|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
16798625|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
16798626|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
16798627|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
16798628|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
16798629|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
16798630|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
16798631|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
16798632|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
16798633|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
16798634|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
16798635|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
16798636|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
16798637|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
16798638|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
16798639|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
16798640|NCT02409667|37739954|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
16798641|NCT02409667|37739955|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
16798642|NCT02409667|37739956|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
16798643|NCT02409667|37739957|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
16798644|NCT02409667|37739958|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
16798645|NCT02409667|37739954|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
16798646|NCT02409667|37739955|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
16798647|NCT02409667|37739956|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
16798648|NCT02409667|37739957|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
16798649|NCT02409667|37739958|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
16798650|NCT02409667|37739954|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
16798651|NCT02409667|37739955|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
16798652|NCT02409667|37739956|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
16798653|NCT02409667|37739957|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
17016526|NCT00600353|38161139|FG001|Overall Study|History of prepartive regimen|1|||
16798654|NCT02409667|37739958|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
16798655|NCT02409667|37739954|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
16798656|NCT02409667|37739955|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
16798657|NCT02409667|37739956|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
16798658|NCT02409667|37739957|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
16798659|NCT02409667|37739958|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
16798660|NCT02409667|37739954|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
16798661|NCT02409667|37739955|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
16798662|NCT02409667|37739956|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
16798663|NCT02409667|37739957|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
16798664|NCT02409667|37739958|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
16798665|NCT02409667|37739954|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
16798666|NCT02409667|37739955|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
16798667|NCT02409667|37739956|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
16798668|NCT02409667|37739957|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
16798669|NCT02409667|37739958|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
16798670|NCT02409667|37739954|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
16798671|NCT02409667|37739955|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
16798672|NCT02409667|37739956|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
16798673|NCT02409667|37739957|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
16798674|NCT02409667|37739958|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
16798675|NCT02409667|37739954|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
16798676|NCT02409667|37739955|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
16798677|NCT02409667|37739956|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
16798678|NCT02409667|37739957|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
16798679|NCT02409667|37739958|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
16798680|NCT01641939|37739972|FG000|Overall Study|Death|90|||
16798681|NCT01641939|37739973|FG001|Overall Study|Death|187|||
16798682|NCT01641939|37739974|FG002|Overall Study|Death|61|||
16798683|NCT01641939|37739972|FG000|Overall Study|Lost to Follow-up|3|||
16798684|NCT01641939|37739973|FG001|Overall Study|Lost to Follow-up|2|||
16798685|NCT01641939|37739974|FG002|Overall Study|Lost to Follow-up|1|||
16798686|NCT01641939|37739972|FG000|Overall Study|Withdrawal by Subject|14|||
16798687|NCT01641939|37739973|FG001|Overall Study|Withdrawal by Subject|11|||
16798688|NCT01641939|37739974|FG002|Overall Study|Withdrawal by Subject|5|||
16798689|NCT01641939|37739972|FG000|Overall Study|Study Terminated by Sponsor|10|||
16798690|NCT01641939|37739973|FG001|Overall Study|Study Terminated by Sponsor|28|||
16798691|NCT01641939|37739974|FG002|Overall Study|Study Terminated by Sponsor|3|||
16798692|NCT01641861|37739986|FG000|Overall Study|Lost to Follow-up|21|||
16798693|NCT01641861|37739987|FG001|Overall Study|Lost to Follow-up|16|||
16798694|NCT01641861|37739986|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
16798695|NCT01641861|37739987|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
16798696|NCT01641861|37739986|FG000|Overall Study|Died due to drowning|0|||
16798697|NCT01641861|37739987|FG001|Overall Study|Died due to drowning|1|||
16798698|NCT02409355|37739995|FG000|Overall Study|Withdrawal by Subject|1|||
16798699|NCT02409355|37739996|FG001|Overall Study|Withdrawal by Subject|0|||
16798700|NCT02409355|37739995|FG000|Overall Study|Death|1|||
16798701|NCT02409355|37739996|FG001|Overall Study|Death|1|||
16798702|NCT02409355|37739995|FG000|Overall Study|Study terminated by Sponsor|2|||
16798703|NCT02409355|37739996|FG001|Overall Study|Study terminated by Sponsor|3|||
16798704|NCT02408887|37740004|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
16798705|NCT02408887|37740005|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
16798706|NCT02408887|37740004|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
16798707|NCT02408887|37740005|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
16798708|NCT02266875|37740013|FG000|Overall Study|Withdrawal by Subject|9|||
16798709|NCT02266875|37740014|FG001|Overall Study|Withdrawal by Subject|0|||
16798710|NCT02266875|37740013|FG000|Overall Study|Lost to Follow-up|2|||
16798711|NCT02266875|37740014|FG001|Overall Study|Lost to Follow-up|0|||
16798712|NCT02438371|37740022|FG000|Overall Study|Lost to Follow-up|3|||
16798713|NCT02438371|37740023|FG001|Overall Study|Lost to Follow-up|2|||
16798714|NCT02438371|37740022|FG000|Overall Study|Withdrawal by Subject|1|||
16798715|NCT02438371|37740023|FG001|Overall Study|Withdrawal by Subject|1|||
16798716|NCT02438137|37740031|FG000|Overall Study|Lost to Follow-up|3|||
16798717|NCT02438137|37740032|FG001|Overall Study|Lost to Follow-up|2|||
16798718|NCT02438137|37740031|FG000|Overall Study|Adverse Event|1|||
16798719|NCT02438137|37740032|FG001|Overall Study|Adverse Event|0|||
16798720|NCT02438137|37740031|FG000|Overall Study|Withdrawal by Subject|4|||
16798721|NCT02438137|37740032|FG001|Overall Study|Withdrawal by Subject|3|||
16798722|NCT02438137|37740031|FG000|Overall Study|Physician Decision|0|||
16798723|NCT02438137|37740032|FG001|Overall Study|Physician Decision|1|||
16798724|NCT02437903|37740040|FG000|Overall Study|Adverse Event|1|||
16798725|NCT02437903|37740040|FG000|Overall Study|Withdrawal by Subject|1|||
16798726|NCT02437903|37740040|FG000|Overall Study|Lost to Follow-up|3|||
16798727|NCT02437513|37740045|FG000|Overall Study|Withdrawal by Subject|2|||
16798728|NCT02460991|37740051|FG000|Overall Study|Withdrawal by Subject|0|||
16798729|NCT02460991|37740052|FG001|Overall Study|Withdrawal by Subject|2|||
16798730|NCT02407249|37740063|FG000|Overall Study|Did not complete 12-month follow-up|13|||
16798731|NCT02407249|37740063|FG000|Overall Study|Not treated|13|||
16798732|NCT02460679|37740067|FG000|Overall Study|Investigator Decision|1|||
16798733|NCT02460679|37740067|FG000|Overall Study|Withdrawal by Subject|4|||
16798734|NCT02459899|37740075|FG000|Overall Study|Adverse Event|1|||
16798735|NCT02459899|37740076|FG001|Overall Study|Adverse Event|1|||
16798736|NCT02459899|37740077|FG002|Overall Study|Adverse Event|0|||
16798737|NCT02459899|37740078|FG003|Overall Study|Adverse Event|0|||
16798738|NCT02459899|37740075|FG000|Overall Study|Lost to Follow-up|1|||
16798739|NCT02459899|37740076|FG001|Overall Study|Lost to Follow-up|2|||
16798740|NCT02459899|37740077|FG002|Overall Study|Lost to Follow-up|0|||
16798741|NCT02459899|37740078|FG003|Overall Study|Lost to Follow-up|1|||
16798742|NCT02459899|37740075|FG000|Overall Study|Non-compliance with the treatment|0|||
16798743|NCT02459899|37740076|FG001|Overall Study|Non-compliance with the treatment|0|||
16798744|NCT02459899|37740077|FG002|Overall Study|Non-compliance with the treatment|0|||
16798745|NCT02459899|37740078|FG003|Overall Study|Non-compliance with the treatment|1|||
16798746|NCT02459899|37740075|FG000|Overall Study|Withdrawal by Subject|1|||
16798747|NCT02459899|37740076|FG001|Overall Study|Withdrawal by Subject|3|||
16798748|NCT02459899|37740077|FG002|Overall Study|Withdrawal by Subject|0|||
16798749|NCT02459899|37740078|FG003|Overall Study|Withdrawal by Subject|0|||
16798750|NCT02436889|37740090|FG000|Overall Study|No improvement in symptoms|1|||
16798751|NCT02436889|37740091|FG001|Overall Study|No improvement in symptoms|0|||
16798752|NCT02436889|37740090|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
16798753|NCT02436889|37740091|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
16798754|NCT02436811|37740100|FG000|Overall Study|Lost to Follow-up|2|||
16798755|NCT02436811|37740101|FG001|Overall Study|Lost to Follow-up|9|||
16798756|NCT02436811|37740102|FG002|Overall Study|Lost to Follow-up|7|||
16798757|NCT02436577|37740116|FG000|Overall Study|Protocol Deviation|0|||
16798758|NCT02436577|37740117|FG001|Overall Study|Protocol Deviation|1|||
16798759|NCT02436577|37740118|FG002|Overall Study|Protocol Deviation|0|||
16798760|NCT02436577|37740119|FG003|Overall Study|Protocol Deviation|0|||
16798761|NCT02436577|37740120|FG004|Overall Study|Protocol Deviation|0|||
16798762|NCT02436577|37740121|FG005|Overall Study|Protocol Deviation|0|||
16798763|NCT02265705|37740131|FG000|Treatment Period Week 0-24|Adverse Event|3|||
16798764|NCT02265705|37740132|FG001|Treatment Period Week 0-24|Adverse Event|2|||
16798765|NCT02265705|37740133|FG002|Treatment Period Week 0-24|Adverse Event|0|||
16798766|NCT02265705|37740134|FG003|Treatment Period Week 0-24|Adverse Event|0|||
16798767|NCT02265705|37740135|FG004|Treatment Period Week 0-24|Adverse Event|0|||
16798768|NCT02265705|37740136|FG005|Treatment Period Week 0-24|Adverse Event|0|||
16798769|NCT02265705|37740137|FG006|Treatment Period Week 0-24|Adverse Event|0|||
16798770|NCT02265705|37740131|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
16798771|NCT02265705|37740132|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
16798772|NCT02265705|37740133|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16798773|NCT02265705|37740134|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16798774|NCT02265705|37740135|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16798775|NCT02265705|37740136|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16798776|NCT02265705|37740137|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16798777|NCT02265705|37740131|FG000|Treatment Period Week 0-24|Physician Decision|1|||
16798778|NCT02265705|37740132|FG001|Treatment Period Week 0-24|Physician Decision|0|||
16798779|NCT02265705|37740133|FG002|Treatment Period Week 0-24|Physician Decision|0|||
16798780|NCT02265705|37740134|FG003|Treatment Period Week 0-24|Physician Decision|0|||
16798781|NCT02265705|37740135|FG004|Treatment Period Week 0-24|Physician Decision|0|||
16798782|NCT02265705|37740136|FG005|Treatment Period Week 0-24|Physician Decision|0|||
16798783|NCT02265705|37740137|FG006|Treatment Period Week 0-24|Physician Decision|0|||
16798784|NCT02265705|37740131|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
16798785|NCT02265705|37740132|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
16798786|NCT02265705|37740133|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16798787|NCT02265705|37740134|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16798788|NCT02265705|37740135|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16798789|NCT02265705|37740136|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16798790|NCT02265705|37740137|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16798791|NCT02265705|37740131|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
16798792|NCT02265705|37740132|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
16798793|NCT02265705|37740133|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
16798794|NCT02265705|37740134|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
16798795|NCT02265705|37740135|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
16798796|NCT02265705|37740136|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
16798797|NCT02265705|37740137|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
16798798|NCT02265705|37740131|FG000|Rescue Period|Withdrawal by Subject|0|||
16798799|NCT02265705|37740132|FG001|Rescue Period|Withdrawal by Subject|0|||
16798800|NCT02265705|37740133|FG002|Rescue Period|Withdrawal by Subject|1|||
16798801|NCT02265705|37740134|FG003|Rescue Period|Withdrawal by Subject|0|||
16798802|NCT02265705|37740135|FG004|Rescue Period|Withdrawal by Subject|0|||
16798803|NCT02265705|37740136|FG005|Rescue Period|Withdrawal by Subject|0|||
16798804|NCT02265705|37740137|FG006|Rescue Period|Withdrawal by Subject|0|||
16798805|NCT02265705|37740131|FG000|Rescue Period|Death|0|||
16798806|NCT02265705|37740132|FG001|Rescue Period|Death|0|||
16798807|NCT02265705|37740133|FG002|Rescue Period|Death|1|||
16798808|NCT02265705|37740134|FG003|Rescue Period|Death|0|||
16798809|NCT02265705|37740135|FG004|Rescue Period|Death|0|||
16798810|NCT02265705|37740136|FG005|Rescue Period|Death|0|||
16798811|NCT02265705|37740137|FG006|Rescue Period|Death|0|||
16798812|NCT02265705|37740131|FG000|Rescue Period|Lack of Efficacy|0|||
16798813|NCT02265705|37740132|FG001|Rescue Period|Lack of Efficacy|0|||
16798814|NCT02265705|37740133|FG002|Rescue Period|Lack of Efficacy|1|||
16798815|NCT02265705|37740134|FG003|Rescue Period|Lack of Efficacy|0|||
16798816|NCT02265705|37740135|FG004|Rescue Period|Lack of Efficacy|0|||
16798817|NCT02265705|37740136|FG005|Rescue Period|Lack of Efficacy|0|||
16798818|NCT02265705|37740137|FG006|Rescue Period|Lack of Efficacy|0|||
16798819|NCT02265705|37740131|FG000|Open Label Period|Adverse Event|0|||
16798820|NCT02265705|37740132|FG001|Open Label Period|Adverse Event|0|||
16798821|NCT02265705|37740133|FG002|Open Label Period|Adverse Event|0|||
16798822|NCT02265705|37740134|FG003|Open Label Period|Adverse Event|2|||
16798823|NCT02265705|37740135|FG004|Open Label Period|Adverse Event|2|||
16798824|NCT02265705|37740136|FG005|Open Label Period|Adverse Event|0|||
16798825|NCT02265705|37740137|FG006|Open Label Period|Adverse Event|0|||
16798826|NCT02265705|37740131|FG000|Open Label Period|Physician Decision|0|||
16798827|NCT02265705|37740132|FG001|Open Label Period|Physician Decision|0|||
16798828|NCT02265705|37740133|FG002|Open Label Period|Physician Decision|0|||
16798829|NCT02265705|37740134|FG003|Open Label Period|Physician Decision|0|||
16798830|NCT02265705|37740135|FG004|Open Label Period|Physician Decision|1|||
16798831|NCT02265705|37740136|FG005|Open Label Period|Physician Decision|0|||
16798832|NCT02265705|37740137|FG006|Open Label Period|Physician Decision|0|||
16798833|NCT02265705|37740131|FG000|Open Label Period|Withdrawal by Subject|0|||
16798834|NCT02265705|37740132|FG001|Open Label Period|Withdrawal by Subject|0|||
16798835|NCT02265705|37740133|FG002|Open Label Period|Withdrawal by Subject|0|||
16798836|NCT02265705|37740134|FG003|Open Label Period|Withdrawal by Subject|0|||
16798837|NCT02265705|37740135|FG004|Open Label Period|Withdrawal by Subject|2|||
16798838|NCT02265705|37740136|FG005|Open Label Period|Withdrawal by Subject|0|||
16798839|NCT02265705|37740137|FG006|Open Label Period|Withdrawal by Subject|0|||
16798840|NCT02265705|37740131|FG000|Follow-up Period|Sponsor Decision|0|||
16798841|NCT02265705|37740132|FG001|Follow-up Period|Sponsor Decision|0|||
16798842|NCT02265705|37740133|FG002|Follow-up Period|Sponsor Decision|0|||
16798843|NCT02265705|37740134|FG003|Follow-up Period|Sponsor Decision|0|||
16798844|NCT02265705|37740135|FG004|Follow-up Period|Sponsor Decision|0|||
16798845|NCT02265705|37740136|FG005|Follow-up Period|Sponsor Decision|1|||
16798846|NCT02265705|37740137|FG006|Follow-up Period|Sponsor Decision|6|||
16798847|NCT02265705|37740131|FG000|Follow-up Period|Adverse Event|0|||
16798848|NCT02265705|37740132|FG001|Follow-up Period|Adverse Event|0|||
16798849|NCT02265705|37740133|FG002|Follow-up Period|Adverse Event|0|||
16798850|NCT02265705|37740134|FG003|Follow-up Period|Adverse Event|0|||
16798851|NCT02265705|37740135|FG004|Follow-up Period|Adverse Event|0|||
16798852|NCT02265705|37740136|FG005|Follow-up Period|Adverse Event|0|||
16798853|NCT02265705|37740137|FG006|Follow-up Period|Adverse Event|3|||
16798854|NCT02265705|37740131|FG000|Follow-up Period|Physician Decision|0|||
16798855|NCT02265705|37740132|FG001|Follow-up Period|Physician Decision|0|||
16798856|NCT02265705|37740133|FG002|Follow-up Period|Physician Decision|0|||
16798857|NCT02265705|37740134|FG003|Follow-up Period|Physician Decision|0|||
16798858|NCT02265705|37740135|FG004|Follow-up Period|Physician Decision|0|||
16798859|NCT02265705|37740136|FG005|Follow-up Period|Physician Decision|0|||
16798860|NCT02265705|37740137|FG006|Follow-up Period|Physician Decision|1|||
16798861|NCT02265705|37740131|FG000|Follow-up Period|Withdrawal by Subject|0|||
16798862|NCT02265705|37740132|FG001|Follow-up Period|Withdrawal by Subject|0|||
16798863|NCT02265705|37740133|FG002|Follow-up Period|Withdrawal by Subject|0|||
16798864|NCT02265705|37740134|FG003|Follow-up Period|Withdrawal by Subject|0|||
16798865|NCT02265705|37740135|FG004|Follow-up Period|Withdrawal by Subject|0|||
16798866|NCT02265705|37740136|FG005|Follow-up Period|Withdrawal by Subject|0|||
16798867|NCT02265705|37740137|FG006|Follow-up Period|Withdrawal by Subject|1|||
16798868|NCT02459665|37740152|FG000|Overall Study|Withdrawal by Subject|0|||
16798869|NCT02459665|37740153|FG001|Overall Study|Withdrawal by Subject|1|||
16798870|NCT02459665|37740154|FG002|Overall Study|Withdrawal by Subject|1|||
16798871|NCT02459665|37740155|FG003|Overall Study|Withdrawal by Subject|2|||
16798872|NCT02459587|37740174|FG000|3-Month Follow-up Assessment|Death|0|||
16798873|NCT02459587|37740175|FG001|3-Month Follow-up Assessment|Death|2|||
16798874|NCT02459587|37740174|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
16798875|NCT02459587|37740175|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
16798876|NCT02459587|37740174|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
16798877|NCT02459587|37740175|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
16798878|NCT02459587|37740174|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
16798879|NCT02459587|37740175|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
16798880|NCT02459587|37740174|FG000|6-month Follow-up Assessment|Death|2|||
16798881|NCT02459587|37740175|FG001|6-month Follow-up Assessment|Death|1|||
16798882|NCT02459587|37740174|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
16798883|NCT02459587|37740175|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
16798884|NCT02459587|37740174|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
16798885|NCT02459587|37740175|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
16798886|NCT02459587|37740174|FG000|12-month Follow-up Assessment|Death|2|||
16798887|NCT02459587|37740175|FG001|12-month Follow-up Assessment|Death|0|||
16798888|NCT02459587|37740174|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
16798889|NCT02459587|37740175|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
16798890|NCT02459587|37740174|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
16798891|NCT02459587|37740175|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
16798892|NCT02459587|37740174|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
16798893|NCT02459587|37740175|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
16798894|NCT02265237|37740186|FG000|As Treated (Overall Study)|Adverse Event|1|||
16798895|NCT02265237|37740187|FG001|As Treated (Overall Study)|Adverse Event|1|||
16798896|NCT02265237|37740188|FG002|As Treated (Overall Study)|Adverse Event|0|||
16798897|NCT02265237|37740189|FG003|As Treated (Overall Study)|Adverse Event|0|||
16798898|NCT02265237|37740186|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
16798899|NCT02265237|37740187|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
16798900|NCT02265237|37740188|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
16798901|NCT02265237|37740189|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
16798902|NCT02265237|37740186|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
16798903|NCT02265237|37740187|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
16798904|NCT02265237|37740188|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
16798905|NCT02265237|37740189|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
16798906|NCT02265237|37740186|FG000|As Treated (Overall Study)|Other|2|||
16798907|NCT02265237|37740187|FG001|As Treated (Overall Study)|Other|0|||
16798908|NCT02265237|37740188|FG002|As Treated (Overall Study)|Other|3|||
16798909|NCT02265237|37740189|FG003|As Treated (Overall Study)|Other|1|||
16798910|NCT02263365|37740202|FG000|Overall Study|Physician Decision|22|||
16798911|NCT02263365|37740203|FG001|Overall Study|Physician Decision|18|||
16798912|NCT02261493|37740213|FG000|Overall Study|Noncompliance|0|||
16798913|NCT02261493|37740214|FG001|Overall Study|Noncompliance|0|||
16798914|NCT02261493|37740215|FG002|Overall Study|Noncompliance|2|||
16798915|NCT02261493|37740213|FG000|Overall Study|Physician Decision|0|||
16798916|NCT02261493|37740214|FG001|Overall Study|Physician Decision|1|||
16798917|NCT02261493|37740215|FG002|Overall Study|Physician Decision|0|||
16798918|NCT02261493|37740213|FG000|Overall Study|Undisclosed alcohol abuse|0|||
16798919|NCT02261493|37740214|FG001|Overall Study|Undisclosed alcohol abuse|1|||
16798920|NCT02261493|37740215|FG002|Overall Study|Undisclosed alcohol abuse|0|||
16798921|NCT02261493|37740213|FG000|Overall Study|Protocol Violation|1|||
16798922|NCT02261493|37740214|FG001|Overall Study|Protocol Violation|0|||
16798923|NCT02261493|37740215|FG002|Overall Study|Protocol Violation|0|||
16798924|NCT02261493|37740213|FG000|Overall Study|Personal Reasons|14|||
16798925|NCT02261493|37740214|FG001|Overall Study|Personal Reasons|14|||
16798926|NCT02261493|37740215|FG002|Overall Study|Personal Reasons|16|||
16798927|NCT02261493|37740213|FG000|Overall Study|Lost to Follow-up|14|||
16798928|NCT02261493|37740214|FG001|Overall Study|Lost to Follow-up|27|||
16798929|NCT02261493|37740215|FG002|Overall Study|Lost to Follow-up|8|||
16798930|NCT02261493|37740213|FG000|Overall Study|Pregnancy|1|||
16798931|NCT02261493|37740214|FG001|Overall Study|Pregnancy|2|||
16798932|NCT02261493|37740215|FG002|Overall Study|Pregnancy|0|||
16798933|NCT02261493|37740213|FG000|Overall Study|Lack of Efficacy|0|||
16798934|NCT02261493|37740214|FG001|Overall Study|Lack of Efficacy|1|||
16798935|NCT02261493|37740215|FG002|Overall Study|Lack of Efficacy|0|||
16798936|NCT02261493|37740213|FG000|Overall Study|Adverse Event|0|||
16798937|NCT02261493|37740214|FG001|Overall Study|Adverse Event|1|||
16798938|NCT02261493|37740215|FG002|Overall Study|Adverse Event|0|||
16798939|NCT02260791|37740225|FG000|Overall Study|Lost to Follow-up|4|||
16798940|NCT02260791|37740226|FG001|Overall Study|Lost to Follow-up|4|||
16798941|NCT02260791|37740225|FG000|Overall Study|Lack of Efficacy|2|||
16798942|NCT02260791|37740226|FG001|Overall Study|Lack of Efficacy|1|||
16798943|NCT02260791|37740225|FG000|Overall Study|Adverse Event|13|||
16798944|NCT02260791|37740226|FG001|Overall Study|Adverse Event|9|||
16798945|NCT02260791|37740225|FG000|Overall Study|Death|1|||
16798946|NCT02260791|37740226|FG001|Overall Study|Death|0|||
16798947|NCT02260791|37740225|FG000|Overall Study|Withdrawal by Subject|11|||
16798948|NCT02260791|37740226|FG001|Overall Study|Withdrawal by Subject|16|||
16798949|NCT02260791|37740225|FG000|Overall Study|Screen failure|0|||
16798950|NCT02260791|37740226|FG001|Overall Study|Screen failure|1|||
16798951|NCT02260791|37740225|FG000|Overall Study|Protocol deviation|2|||
16798952|NCT02260791|37740226|FG001|Overall Study|Protocol deviation|3|||
16798953|NCT02260635|37740234|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
16798954|NCT02260635|37740235|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
16798955|NCT02260635|37740234|FG000|Open-Label Extension|Study Termination|25|||
16798956|NCT02260635|37740235|FG001|Open-Label Extension|Study Termination|25|||
16798957|NCT02260635|37740234|FG000|Open-Label Extension|Withdrawal by Subject|1|||
16798958|NCT02260635|37740235|FG001|Open-Label Extension|Withdrawal by Subject|0|||
16798959|NCT02259231|37740250|FG000|Overall Study|Adverse Event|1|||
16798960|NCT02259231|37740251|FG001|Overall Study|Adverse Event|1|||
16798961|NCT02259231|37740252|FG002|Overall Study|Adverse Event|2|||
16798962|NCT02259231|37740253|FG003|Overall Study|Adverse Event|0|||
16798963|NCT02259231|37740254|FG004|Overall Study|Adverse Event|0|||
16798964|NCT02259231|37740255|FG005|Overall Study|Adverse Event|0|||
16798965|NCT02259231|37740256|FG006|Overall Study|Adverse Event|0|||
16798966|NCT02259231|37740250|FG000|Overall Study|Progressive Disease|4|||
16798967|NCT02259231|37740251|FG001|Overall Study|Progressive Disease|5|||
16798968|NCT02259231|37740252|FG002|Overall Study|Progressive Disease|4|||
16798969|NCT02259231|37740253|FG003|Overall Study|Progressive Disease|5|||
16798970|NCT02259231|37740254|FG004|Overall Study|Progressive Disease|4|||
16798971|NCT02259231|37740255|FG005|Overall Study|Progressive Disease|5|||
16798972|NCT02259231|37740256|FG006|Overall Study|Progressive Disease|4|||
16798973|NCT02259231|37740250|FG000|Overall Study|Sponsor termination of study|1|||
16798974|NCT02259231|37740251|FG001|Overall Study|Sponsor termination of study|0|||
16798975|NCT02259231|37740252|FG002|Overall Study|Sponsor termination of study|0|||
16798976|NCT02259231|37740253|FG003|Overall Study|Sponsor termination of study|1|||
16798977|NCT02259231|37740254|FG004|Overall Study|Sponsor termination of study|2|||
16798978|NCT02259231|37740255|FG005|Overall Study|Sponsor termination of study|1|||
16798979|NCT02259231|37740256|FG006|Overall Study|Sponsor termination of study|1|||
16798980|NCT02258529|37740272|FG000|Overall Study|Study Terminated by Sponsor|9|||
16798981|NCT02258529|37740272|FG000|Overall Study|Adverse Event|1|||
16798982|NCT02256969|37740279|FG000|Overall Study|Screenfailed or withdrew|2|||
16798983|NCT02256969|37740280|FG001|Overall Study|Screenfailed or withdrew|1|||
16798984|NCT02256969|37740281|FG002|Overall Study|Screenfailed or withdrew|1|||
16798985|NCT02256891|37740291|FG000|Overall Study|Death|0|||
16798986|NCT02256891|37740292|FG001|Overall Study|Death|2|||
16798987|NCT02256891|37740291|FG000|Overall Study|Lost to Follow-up|0|||
16798988|NCT02256891|37740292|FG001|Overall Study|Lost to Follow-up|3|||
16798989|NCT02256891|37740291|FG000|Overall Study|Physician Decision|7|||
16798990|NCT02256891|37740292|FG001|Overall Study|Physician Decision|3|||
16798991|NCT02256891|37740291|FG000|Overall Study|Screen Fail|5|||
16798992|NCT02256891|37740292|FG001|Overall Study|Screen Fail|4|||
16798993|NCT02256891|37740291|FG000|Overall Study|Equipment Malfunction|0|||
16798994|NCT02256891|37740292|FG001|Overall Study|Equipment Malfunction|1|||
16798995|NCT02256267|37740300|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
16798996|NCT02256267|37740300|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
16798997|NCT01641471|37740309|FG000|Overall Study|Withdrawal by Subject|19|||
16798998|NCT01641471|37740310|FG001|Overall Study|Withdrawal by Subject|19|||
16798999|NCT01641471|37740309|FG000|Overall Study|Lost to Follow-up|2|||
16799000|NCT01641471|37740310|FG001|Overall Study|Lost to Follow-up|4|||
16799001|NCT01641471|37740309|FG000|Overall Study|Protocol Violation|2|||
16799002|NCT01641471|37740310|FG001|Overall Study|Protocol Violation|4|||
16799003|NCT02255565|37740319|FG000|Overall Study|Withdrawal by Subject|0|||
16799004|NCT02255565|37740320|FG001|Overall Study|Withdrawal by Subject|1|||
16799005|NCT02255565|37740321|FG002|Overall Study|Withdrawal by Subject|0|||
17016527|NCT00691210|38161153|FG000|Overall Study|Progression of Disease|0|||
17016528|NCT00691210|38161154|FG001|Overall Study|Progression of Disease|0|||
16799006|NCT01640301|37740364|FG000|Overall Study|Death|0|||
16799007|NCT01640301|37740365|FG001|Overall Study|Death|8|||
16799008|NCT01642407|37740373|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
16799009|NCT01642407|37740373|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
16799010|NCT01642407|37740373|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
16799011|NCT02255097|37740377|FG000|Overall Study|Death|151|||
16799012|NCT02255097|37740377|FG000|Overall Study|Lost to Follow-up|5|||
16799013|NCT02255097|37740377|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
16799014|NCT02255097|37740377|FG000|Overall Study|Withdrawal by Subject|7|||
16799015|NCT02255097|37740377|FG000|Overall Study|Allocated but not treated|1|||
16799016|NCT02254551|37740382|FG000|Dose Escalation|Physician Decision|1|||
16799017|NCT02254551|37740382|FG000|Dose Escalation|Dose-limiting toxicity|2|||
16799018|NCT01641237|37740389|FG000|Period II|Withdrawal by Subject|1|||
16799019|NCT01641237|37740390|FG001|Period II|Withdrawal by Subject|0|||
16799020|NCT01641237|37740391|FG002|Period II|Withdrawal by Subject|0|||
16799021|NCT01641237|37740392|FG003|Period II|Withdrawal by Subject|0|||
16799022|NCT01641237|37740389|FG000|Period III|Lost to Follow-up|1|||
16799023|NCT01641237|37740390|FG001|Period III|Lost to Follow-up|0|||
16799024|NCT01641237|37740391|FG002|Period III|Lost to Follow-up|0|||
16799025|NCT01641237|37740392|FG003|Period III|Lost to Follow-up|0|||
16799026|NCT01639833|37740404|FG000|Overall Study|Death|4|||
16799027|NCT01639833|37740405|FG001|Overall Study|Death|2|||
16799028|NCT01639833|37740404|FG000|Overall Study|Withdrawal by Subject|2|||
16799029|NCT01639833|37740405|FG001|Overall Study|Withdrawal by Subject|2|||
16799030|NCT01639131|37740411|FG000|Overall Study|Disease Progression|6|||
16799031|NCT01641159|37740417|FG000|Overall Study|Lost to Follow-up|2|||
16799032|NCT01641159|37740418|FG001|Overall Study|Lost to Follow-up|1|||
16799033|NCT01641159|37740417|FG000|Overall Study|Withdrawal by Subject|0|||
16799034|NCT01641159|37740418|FG001|Overall Study|Withdrawal by Subject|1|||
16799035|NCT01641081|37740424|FG000|Period 1|Sponsor request (potential unblinding)|0|||
16799036|NCT01641081|37740425|FG001|Period 1|Sponsor request (potential unblinding)|0|||
16799037|NCT01641081|37740426|FG002|Period 1|Sponsor request (potential unblinding)|0|||
16799038|NCT01641081|37740427|FG003|Period 1|Sponsor request (potential unblinding)|0|||
16799039|NCT01641081|37740428|FG004|Period 1|Sponsor request (potential unblinding)|0|||
16799040|NCT01641081|37740429|FG005|Period 1|Sponsor request (potential unblinding)|0|||
16799041|NCT01641081|37740430|FG006|Period 1|Sponsor request (potential unblinding)|1|||
16799042|NCT01641081|37740431|FG007|Period 1|Sponsor request (potential unblinding)|0|||
16799043|NCT01641081|37740432|FG008|Period 1|Sponsor request (potential unblinding)|0|||
16799044|NCT01641081|37740433|FG009|Period 1|Sponsor request (potential unblinding)|0|||
16799045|NCT01641081|37740424|FG000|Period 1|Protocol Violation|0|||
16799046|NCT01641081|37740425|FG001|Period 1|Protocol Violation|0|||
16799047|NCT01641081|37740426|FG002|Period 1|Protocol Violation|0|||
16799048|NCT01641081|37740427|FG003|Period 1|Protocol Violation|0|||
16799049|NCT01641081|37740428|FG004|Period 1|Protocol Violation|1|||
16799050|NCT01641081|37740429|FG005|Period 1|Protocol Violation|0|||
16799051|NCT01641081|37740430|FG006|Period 1|Protocol Violation|0|||
16799052|NCT01641081|37740431|FG007|Period 1|Protocol Violation|1|||
16799053|NCT01641081|37740432|FG008|Period 1|Protocol Violation|0|||
16799054|NCT01641081|37740433|FG009|Period 1|Protocol Violation|0|||
16799055|NCT01641081|37740424|FG000|Period 1|Adverse Event|1|||
16799056|NCT01641081|37740425|FG001|Period 1|Adverse Event|0|||
16799057|NCT01641081|37740426|FG002|Period 1|Adverse Event|0|||
16799058|NCT01641081|37740427|FG003|Period 1|Adverse Event|0|||
16799059|NCT01641081|37740428|FG004|Period 1|Adverse Event|0|||
16799060|NCT01641081|37740429|FG005|Period 1|Adverse Event|0|||
16799061|NCT01641081|37740430|FG006|Period 1|Adverse Event|0|||
16799062|NCT01641081|37740431|FG007|Period 1|Adverse Event|2|||
16799063|NCT01641081|37740432|FG008|Period 1|Adverse Event|0|||
16799064|NCT01641081|37740433|FG009|Period 1|Adverse Event|0|||
16799065|NCT01641081|37740424|FG000|Period 2|Adverse Event|0|||
16799066|NCT01641081|37740425|FG001|Period 2|Adverse Event|0|||
16799067|NCT01641081|37740426|FG002|Period 2|Adverse Event|0|||
16799068|NCT01641081|37740427|FG003|Period 2|Adverse Event|0|||
16799069|NCT01641081|37740428|FG004|Period 2|Adverse Event|0|||
16799070|NCT01641081|37740429|FG005|Period 2|Adverse Event|1|||
16799071|NCT01641081|37740430|FG006|Period 2|Adverse Event|0|||
16799072|NCT01641081|37740431|FG007|Period 2|Adverse Event|0|||
16799073|NCT01641081|37740432|FG008|Period 2|Adverse Event|0|||
16799074|NCT01641081|37740433|FG009|Period 2|Adverse Event|0|||
16799075|NCT01641081|37740424|FG000|Period 2|Withdrawal by Subject|0|||
16799076|NCT01641081|37740425|FG001|Period 2|Withdrawal by Subject|0|||
16799077|NCT01641081|37740426|FG002|Period 2|Withdrawal by Subject|0|||
16799078|NCT01641081|37740427|FG003|Period 2|Withdrawal by Subject|1|||
16799079|NCT01641081|37740428|FG004|Period 2|Withdrawal by Subject|0|||
16799080|NCT01641081|37740429|FG005|Period 2|Withdrawal by Subject|0|||
16799081|NCT01641081|37740430|FG006|Period 2|Withdrawal by Subject|2|||
16799082|NCT01641081|37740431|FG007|Period 2|Withdrawal by Subject|0|||
16799083|NCT01641081|37740432|FG008|Period 2|Withdrawal by Subject|0|||
16799084|NCT01641081|37740433|FG009|Period 2|Withdrawal by Subject|0|||
16799085|NCT01641081|37740424|FG000|Period 2|Protocol Violation|1|||
17102293|NCT00091572|38241203|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
17102294|NCT00091572|38241204|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
16799086|NCT01641081|37740425|FG001|Period 2|Protocol Violation|0|||
16799087|NCT01641081|37740426|FG002|Period 2|Protocol Violation|0|||
16799088|NCT01641081|37740427|FG003|Period 2|Protocol Violation|0|||
16799089|NCT01641081|37740428|FG004|Period 2|Protocol Violation|0|||
16799090|NCT01641081|37740429|FG005|Period 2|Protocol Violation|0|||
16799091|NCT01641081|37740430|FG006|Period 2|Protocol Violation|0|||
16799092|NCT01641081|37740431|FG007|Period 2|Protocol Violation|0|||
16799093|NCT01641081|37740432|FG008|Period 2|Protocol Violation|0|||
16799094|NCT01641081|37740433|FG009|Period 2|Protocol Violation|0|||
16799095|NCT01641081|37740424|FG000|Period 3|Adverse Event|0|||
16799096|NCT01641081|37740425|FG001|Period 3|Adverse Event|0|||
16799097|NCT01641081|37740426|FG002|Period 3|Adverse Event|1|||
16799098|NCT01641081|37740427|FG003|Period 3|Adverse Event|0|||
16799099|NCT01641081|37740428|FG004|Period 3|Adverse Event|0|||
16799100|NCT01641081|37740429|FG005|Period 3|Adverse Event|0|||
16799101|NCT01641081|37740430|FG006|Period 3|Adverse Event|0|||
16799102|NCT01641081|37740431|FG007|Period 3|Adverse Event|0|||
16799103|NCT01641081|37740432|FG008|Period 3|Adverse Event|0|||
16799104|NCT01641081|37740433|FG009|Period 3|Adverse Event|0|||
16799105|NCT01641081|37740424|FG000|Period 3|Withdrawal by Subject|0|||
16799106|NCT01641081|37740425|FG001|Period 3|Withdrawal by Subject|0|||
16799107|NCT01641081|37740426|FG002|Period 3|Withdrawal by Subject|0|||
16799108|NCT01641081|37740427|FG003|Period 3|Withdrawal by Subject|0|||
16909348|NCT01701258|38018199|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
16909349|NCT01701258|38018200|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
16909350|NCT01701258|38018201|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
16909351|NCT01701258|38018202|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
16909352|NCT01701258|38018190|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
16909353|NCT01701258|38018191|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
16909354|NCT01701258|38018192|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
16909355|NCT01701258|38018193|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
16909356|NCT01701258|38018194|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
16909357|NCT01701258|38018195|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
16909358|NCT01701258|38018196|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
16909359|NCT01701258|38018197|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
16909360|NCT01701258|38018198|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
16909361|NCT01701258|38018199|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
16909362|NCT01701258|38018200|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
16909363|NCT01701258|38018201|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
16909364|NCT01701258|38018202|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
16909365|NCT01701258|38018190|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
16909366|NCT01701258|38018191|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
16909367|NCT01701258|38018192|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
16909368|NCT01701258|38018193|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
16909369|NCT01701258|38018194|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
16909370|NCT01701258|38018195|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
16909371|NCT01701258|38018196|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
16909372|NCT01701258|38018197|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
16909373|NCT01701258|38018198|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
16909374|NCT01701258|38018199|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
16909375|NCT01701258|38018200|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
16909376|NCT01701258|38018201|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
16909377|NCT01701258|38018202|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
16909378|NCT01701258|38018190|FG000|Assessment and Scheduling|Investigator Terminated|2|||
16909379|NCT01701258|38018191|FG001|Assessment and Scheduling|Investigator Terminated|0|||
16909380|NCT01701258|38018192|FG002|Assessment and Scheduling|Investigator Terminated|0|||
16909381|NCT01701258|38018193|FG003|Assessment and Scheduling|Investigator Terminated|0|||
16909382|NCT01701258|38018194|FG004|Assessment and Scheduling|Investigator Terminated|0|||
16909383|NCT01701258|38018195|FG005|Assessment and Scheduling|Investigator Terminated|0|||
16909384|NCT01701258|38018196|FG006|Assessment and Scheduling|Investigator Terminated|0|||
16909385|NCT01701258|38018197|FG007|Assessment and Scheduling|Investigator Terminated|0|||
16909386|NCT01701258|38018198|FG008|Assessment and Scheduling|Investigator Terminated|0|||
16909387|NCT01701258|38018199|FG009|Assessment and Scheduling|Investigator Terminated|0|||
16909388|NCT01701258|38018200|FG010|Assessment and Scheduling|Investigator Terminated|0|||
16909389|NCT01701258|38018201|FG011|Assessment and Scheduling|Investigator Terminated|0|||
16909390|NCT01701258|38018202|FG012|Assessment and Scheduling|Investigator Terminated|0|||
16909391|NCT01700946|38018232|FG000|Overall Study|Lost to Follow-up|1|||
16909392|NCT01700946|38018233|FG001|Overall Study|Lost to Follow-up|0|||
16909393|NCT01700946|38018232|FG000|Overall Study|Physician Decision|7|||
16909394|NCT01700946|38018233|FG001|Overall Study|Physician Decision|12|||
16909395|NCT01700946|38018232|FG000|Overall Study|Withdrawal by Subject|0|||
16909396|NCT01700946|38018233|FG001|Overall Study|Withdrawal by Subject|2|||
16909397|NCT01700946|38018232|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
16909398|NCT01700946|38018233|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
16909399|NCT01700946|38018232|FG000|Overall Study|Relapse|2|||
16909400|NCT01700946|38018233|FG001|Overall Study|Relapse|1|||
16909401|NCT01700946|38018232|FG000|Overall Study|Unacceptable toxicity|1|||
16799109|NCT01641081|37740428|FG004|Period 3|Withdrawal by Subject|0|||
16909402|NCT01700946|38018233|FG001|Overall Study|Unacceptable toxicity|0|||
16909403|NCT01748994|38018245|FG000|Overall Study|Lost to Follow-up|8|||
16909404|NCT01748994|38018246|FG001|Overall Study|Lost to Follow-up|6|||
16909405|NCT01721070|38018252|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
16799110|NCT01641081|37740429|FG005|Period 3|Withdrawal by Subject|0|||
16799111|NCT01641081|37740430|FG006|Period 3|Withdrawal by Subject|0|||
16799112|NCT01641081|37740431|FG007|Period 3|Withdrawal by Subject|0|||
16799113|NCT01641081|37740432|FG008|Period 3|Withdrawal by Subject|1|||
16799114|NCT01641081|37740433|FG009|Period 3|Withdrawal by Subject|0|||
16799115|NCT01641081|37740424|FG000|Period 4|Adverse Event|0|||
16799116|NCT01641081|37740425|FG001|Period 4|Adverse Event|1|||
16799117|NCT01641081|37740426|FG002|Period 4|Adverse Event|0|||
16799118|NCT01641081|37740427|FG003|Period 4|Adverse Event|1|||
16799119|NCT01641081|37740428|FG004|Period 4|Adverse Event|0|||
16799120|NCT01641081|37740429|FG005|Period 4|Adverse Event|0|||
16799121|NCT01641081|37740430|FG006|Period 4|Adverse Event|0|||
16799122|NCT01641081|37740431|FG007|Period 4|Adverse Event|0|||
16799123|NCT01641081|37740432|FG008|Period 4|Adverse Event|0|||
16799124|NCT01641081|37740433|FG009|Period 4|Adverse Event|0|||
16799125|NCT01641081|37740424|FG000|Period 5|Adverse Event|0|||
16799126|NCT01641081|37740425|FG001|Period 5|Adverse Event|0|||
16799127|NCT01641081|37740426|FG002|Period 5|Adverse Event|2|||
16799128|NCT01641081|37740427|FG003|Period 5|Adverse Event|0|||
16799129|NCT01641081|37740428|FG004|Period 5|Adverse Event|0|||
16799130|NCT01641081|37740429|FG005|Period 5|Adverse Event|0|||
16799131|NCT01641081|37740430|FG006|Period 5|Adverse Event|0|||
16799132|NCT01641081|37740431|FG007|Period 5|Adverse Event|0|||
16799133|NCT01641081|37740432|FG008|Period 5|Adverse Event|0|||
16799134|NCT01641081|37740433|FG009|Period 5|Adverse Event|0|||
16799135|NCT01640925|37740447|FG000|Overall Study|Withdrawal by Subject|1|||
16799136|NCT01640925|37740448|FG001|Overall Study|Withdrawal by Subject|0|||
16799137|NCT01640925|37740447|FG000|Overall Study|Previously enrolled in this trial|13|||
16799138|NCT01640925|37740448|FG001|Overall Study|Previously enrolled in this trial|11|||
16799139|NCT01638429|37740454|FG000|Overall Study|Withdrawal by Subject|1|||
16799140|NCT01639755|37740462|FG000|Overall Study|Study Ongoing|15|||
16799141|NCT01639755|37740462|FG000|Overall Study|Patient had device explantation|4|||
16799142|NCT01601535|37740472|FG000|Phase 1|Adverse Event|1|||
16799143|NCT01601535|37740473|FG001|Phase 1|Adverse Event|0|||
16799144|NCT01601535|37740474|FG002|Phase 1|Adverse Event|2|||
16799145|NCT01601535|37740475|FG003|Phase 1|Adverse Event|1|||
16799146|NCT01601535|37740476|FG004|Phase 1|Adverse Event|0|||
16799147|NCT01601535|37740477|FG005|Phase 1|Adverse Event|0|||
16799148|NCT01601535|37740472|FG000|Phase 1|Withdrawal by Subject|2|||
16799149|NCT01601535|37740473|FG001|Phase 1|Withdrawal by Subject|1|||
16799150|NCT01601535|37740474|FG002|Phase 1|Withdrawal by Subject|1|||
16799151|NCT01601535|37740475|FG003|Phase 1|Withdrawal by Subject|2|||
16799152|NCT01601535|37740476|FG004|Phase 1|Withdrawal by Subject|0|||
16799153|NCT01601535|37740477|FG005|Phase 1|Withdrawal by Subject|0|||
16799154|NCT01601535|37740472|FG000|Phase 1|Progressive Disease|2|||
16799155|NCT01601535|37740473|FG001|Phase 1|Progressive Disease|3|||
16799156|NCT01601535|37740474|FG002|Phase 1|Progressive Disease|2|||
16799157|NCT01601535|37740475|FG003|Phase 1|Progressive Disease|1|||
16799158|NCT01601535|37740476|FG004|Phase 1|Progressive Disease|0|||
16799159|NCT01601535|37740477|FG005|Phase 1|Progressive Disease|0|||
16799160|NCT01601535|37740472|FG000|Phase 1|Started Another Treatment|1|||
16799161|NCT01601535|37740473|FG001|Phase 1|Started Another Treatment|2|||
16799162|NCT01601535|37740474|FG002|Phase 1|Started Another Treatment|0|||
16799163|NCT01601535|37740475|FG003|Phase 1|Started Another Treatment|0|||
16799164|NCT01601535|37740476|FG004|Phase 1|Started Another Treatment|0|||
16799165|NCT01601535|37740477|FG005|Phase 1|Started Another Treatment|0|||
16799166|NCT01601535|37740472|FG000|Phase 2|Adverse Event|0|||
16799167|NCT01601535|37740473|FG001|Phase 2|Adverse Event|0|||
16799168|NCT01601535|37740474|FG002|Phase 2|Adverse Event|0|||
16799169|NCT01601535|37740475|FG003|Phase 2|Adverse Event|0|||
16799170|NCT01601535|37740476|FG004|Phase 2|Adverse Event|5|||
16799171|NCT01601535|37740477|FG005|Phase 2|Adverse Event|1|||
16799172|NCT01601535|37740472|FG000|Phase 2|Withdrawal by Subject|0|||
16799173|NCT01601535|37740473|FG001|Phase 2|Withdrawal by Subject|0|||
16799174|NCT01601535|37740474|FG002|Phase 2|Withdrawal by Subject|0|||
16909406|NCT01748760|38018261|FG000|Overall Study|Withdrawal by Subject|1|||
16799175|NCT01601535|37740475|FG003|Phase 2|Withdrawal by Subject|0|||
16799176|NCT01601535|37740476|FG004|Phase 2|Withdrawal by Subject|8|||
17016529|NCT00691210|38161155|FG002|Overall Study|Progression of Disease|0|||
16799177|NCT01601535|37740477|FG005|Phase 2|Withdrawal by Subject|2|||
16799178|NCT01601535|37740472|FG000|Phase 2|Progressive Disease|0|||
16799179|NCT01601535|37740473|FG001|Phase 2|Progressive Disease|0|||
16799180|NCT01601535|37740474|FG002|Phase 2|Progressive Disease|0|||
16799181|NCT01601535|37740475|FG003|Phase 2|Progressive Disease|0|||
16799182|NCT01601535|37740476|FG004|Phase 2|Progressive Disease|5|||
16799183|NCT01601535|37740477|FG005|Phase 2|Progressive Disease|7|||
16799184|NCT01601535|37740472|FG000|Phase 2|Started Another Treatment|0|||
16799185|NCT01601535|37740473|FG001|Phase 2|Started Another Treatment|0|||
16799186|NCT01601535|37740474|FG002|Phase 2|Started Another Treatment|0|||
16799187|NCT01601535|37740475|FG003|Phase 2|Started Another Treatment|0|||
16799188|NCT01601535|37740476|FG004|Phase 2|Started Another Treatment|1|||
16799189|NCT01601535|37740477|FG005|Phase 2|Started Another Treatment|2|||
16799190|NCT01638819|37740502|FG000|Overall Study|Lost to Follow-up|1|||
16799191|NCT01638819|37740503|FG001|Overall Study|Lost to Follow-up|0|||
16799192|NCT01363713|37740508|FG000|Overall Study|Adverse Event|1|||
16799193|NCT01363713|37740508|FG000|Overall Study|Protocol Violation|3|||
16799194|NCT01363713|37740508|FG000|Overall Study|Withdrawal by Subject|2|||
16799195|NCT01637961|37740512|FG000|Overall Study|Ineligible: wrong primary|1|||
16799196|NCT01637961|37740512|FG000|Overall Study|Ineligible: inadequate pathology|1|||
16799197|NCT04183335|37740524|FG000|Overall Study|Adverse Event|1|||
16799198|NCT04183335|37740525|FG001|Overall Study|Adverse Event|0|||
16799199|NCT04183335|37740524|FG000|Overall Study|Withdrawal by Subject|12|||
16799200|NCT04183335|37740525|FG001|Overall Study|Withdrawal by Subject|3|||
16799201|NCT04199793|37740533|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
16799202|NCT04199793|37740534|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
16799203|NCT04199793|37740533|FG000|Overall Study|Withdrawal by Subject|1|||
16799204|NCT04199793|37740534|FG001|Overall Study|Withdrawal by Subject|1|||
16799205|NCT01636947|37740542|FG000|Overall Study|Not Treated|2|||
16799206|NCT01636947|37740543|FG001|Overall Study|Not Treated|2|||
16799207|NCT01636947|37740542|FG000|Overall Study|Lost to Follow-up|4|||
16799208|NCT01636947|37740543|FG001|Overall Study|Lost to Follow-up|0|||
16799209|NCT01636947|37740542|FG000|Overall Study|Protocol Violation|1|||
16799210|NCT01636947|37740543|FG001|Overall Study|Protocol Violation|1|||
16799211|NCT01636947|37740542|FG000|Overall Study|Withdrawal by Subject|3|||
16799212|NCT01636947|37740543|FG001|Overall Study|Withdrawal by Subject|3|||
16799213|NCT01636947|37740542|FG000|Overall Study|Adverse Event|1|||
16799214|NCT01636947|37740543|FG001|Overall Study|Adverse Event|1|||
16799215|NCT01636947|37740542|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
16799216|NCT01636947|37740543|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
16799217|NCT01635933|37740551|FG000|Overall Study|Adverse Event|1|||
16799218|NCT01635933|37740552|FG001|Overall Study|Adverse Event|0|||
16799219|NCT01635933|37740551|FG000|Overall Study|Lost to Follow-up|0|||
16799220|NCT01635933|37740552|FG001|Overall Study|Lost to Follow-up|5|||
16799221|NCT01635933|37740551|FG000|Overall Study|Subject decision|1|||
16799222|NCT01635933|37740552|FG001|Overall Study|Subject decision|1|||
16799223|NCT01635933|37740551|FG000|Overall Study|Noncompliance|0|||
16799224|NCT01635933|37740552|FG001|Overall Study|Noncompliance|1|||
16799225|NCT01635933|37740551|FG000|Overall Study|No longer had transportation|0|||
16799226|NCT01635933|37740552|FG001|Overall Study|No longer had transportation|1|||
16799227|NCT01635855|37740558|FG000|Overall Study|Withdrawal by Subject|4|||
16799228|NCT03052725|37740564|FG000|Overall Study|Adverse Event|2|||
16799229|NCT03052725|37740565|FG001|Overall Study|Adverse Event|0|||
16799230|NCT03052725|37740564|FG000|Overall Study|Withdrawal by Subject|3|||
16799231|NCT03052725|37740565|FG001|Overall Study|Withdrawal by Subject|4|||
16799232|NCT03052725|37740564|FG000|Overall Study|Pregnancy|0|||
16799233|NCT03052725|37740565|FG001|Overall Study|Pregnancy|1|||
16799234|NCT03052725|37740564|FG000|Overall Study|Site closure|0|||
16799235|NCT03052725|37740565|FG001|Overall Study|Site closure|1|||
16799236|NCT03052725|37740564|FG000|Overall Study|Study terminated by sponsor|143|||
16799237|NCT03052725|37740565|FG001|Overall Study|Study terminated by sponsor|144|||
16799238|NCT02775435|37740572|FG000|Overall Study|Adverse Event|48|||
16799239|NCT02775435|37740573|FG001|Overall Study|Adverse Event|25|||
16799240|NCT02775435|37740572|FG000|Overall Study|Lost to Follow-up|0|||
16799241|NCT02775435|37740573|FG001|Overall Study|Lost to Follow-up|2|||
16799242|NCT02775435|37740572|FG000|Overall Study|Physician Decision|5|||
16799243|NCT02775435|37740573|FG001|Overall Study|Physician Decision|6|||
16799244|NCT02775435|37740572|FG000|Overall Study|Withdrawal by Subject|5|||
16799245|NCT02775435|37740573|FG001|Overall Study|Withdrawal by Subject|9|||
16799246|NCT02775435|37740572|FG000|Overall Study|Progressive Disease|86|||
16799247|NCT02775435|37740573|FG001|Overall Study|Progressive Disease|140|||
16799248|NCT02775435|37740572|FG000|Overall Study|Clinical Progression|13|||
16799249|NCT02775435|37740573|FG001|Overall Study|Clinical Progression|26|||
16799250|NCT02775435|37740572|FG000|Overall Study|Ongoing in Study|121|||
16799251|NCT02775435|37740573|FG001|Overall Study|Ongoing in Study|72|||
16799252|NCT02775435|37740572|FG000|Overall Study|Not Treated|0|||
16799253|NCT02775435|37740573|FG001|Overall Study|Not Treated|1|||
16799254|NCT01635153|37740598|FG000|Overall Study|Lost to Follow-up|40|||
16799255|NCT01635153|37740599|FG001|Overall Study|Lost to Follow-up|43|||
16799256|NCT01636713|37740608|FG000|Overall Study|Adverse Event|16|||
16799257|NCT01636713|37740609|FG001|Overall Study|Adverse Event|16|||
16799258|NCT01636713|37740610|FG002|Overall Study|Adverse Event|7|||
16799259|NCT01636713|37740608|FG000|Overall Study|Lack of Efficacy|6|||
16799260|NCT01636713|37740609|FG001|Overall Study|Lack of Efficacy|6|||
16799261|NCT01636713|37740610|FG002|Overall Study|Lack of Efficacy|2|||
16799262|NCT01636713|37740608|FG000|Overall Study|Protocol Violation|3|||
16799263|NCT01636713|37740609|FG001|Overall Study|Protocol Violation|0|||
16799264|NCT01636713|37740610|FG002|Overall Study|Protocol Violation|1|||
16799265|NCT01636713|37740608|FG000|Overall Study|Lost to Follow-up|0|||
16799266|NCT01636713|37740609|FG001|Overall Study|Lost to Follow-up|0|||
16799267|NCT01636713|37740610|FG002|Overall Study|Lost to Follow-up|1|||
16799268|NCT01636713|37740608|FG000|Overall Study|Withdrawal by Subject|5|||
16799269|NCT01636713|37740609|FG001|Overall Study|Withdrawal by Subject|4|||
16799270|NCT01636713|37740610|FG002|Overall Study|Withdrawal by Subject|8|||
16799271|NCT01636713|37740608|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
16799272|NCT01636713|37740609|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
16799273|NCT01636713|37740610|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
16799274|NCT01600053|37740618|FG000|Overall Study|Adverse Event|2|||
16799275|NCT01600053|37740618|FG000|Overall Study|trial will not meet the interim endpoint|9|||
16799276|NCT01068249|37740622|FG000|Overall Study|Death|1|||
16799277|NCT01068249|37740622|FG000|Overall Study|Withdrawal by Subject|3|||
16799278|NCT00098475|37740638|FG000|Step 1|Progressive disease|33|||
16799279|NCT00098475|37740639|FG001|Step 1|Progressive disease|35|||
16799280|NCT00098475|37740640|FG002|Step 1|Progressive disease|2|||
16799281|NCT00098475|37740641|FG003|Step 1|Progressive disease|1|||
16799282|NCT00098475|37740638|FG000|Step 1|Adverse Event|56|||
16799283|NCT00098475|37740639|FG001|Step 1|Adverse Event|37|||
16799284|NCT00098475|37740640|FG002|Step 1|Adverse Event|0|||
16799285|NCT00098475|37740641|FG003|Step 1|Adverse Event|1|||
16799286|NCT00098475|37740638|FG000|Step 1|Death|8|||
16799287|NCT00098475|37740639|FG001|Step 1|Death|5|||
16799288|NCT00098475|37740640|FG002|Step 1|Death|0|||
16799289|NCT00098475|37740641|FG003|Step 1|Death|1|||
16799290|NCT00098475|37740638|FG000|Step 1|Withdrawal by Subject|14|||
16799291|NCT00098475|37740639|FG001|Step 1|Withdrawal by Subject|11|||
16799292|NCT00098475|37740640|FG002|Step 1|Withdrawal by Subject|0|||
16799293|NCT00098475|37740641|FG003|Step 1|Withdrawal by Subject|0|||
16799294|NCT00098475|37740638|FG000|Step 1|Physician Decision|5|||
16799295|NCT00098475|37740639|FG001|Step 1|Physician Decision|2|||
16799296|NCT00098475|37740640|FG002|Step 1|Physician Decision|0|||
16799297|NCT00098475|37740641|FG003|Step 1|Physician Decision|0|||
16799298|NCT00098475|37740638|FG000|Step 1|Alternative therapy|31|||
16799299|NCT00098475|37740639|FG001|Step 1|Alternative therapy|43|||
16799300|NCT00098475|37740640|FG002|Step 1|Alternative therapy|1|||
16799301|NCT00098475|37740641|FG003|Step 1|Alternative therapy|0|||
16799302|NCT00098475|37740638|FG000|Step 1|Other disease|2|||
16799303|NCT00098475|37740639|FG001|Step 1|Other disease|1|||
16799304|NCT00098475|37740640|FG002|Step 1|Other disease|1|||
16799305|NCT00098475|37740641|FG003|Step 1|Other disease|0|||
16799306|NCT00098475|37740638|FG000|Step 1|Never started treatment|0|||
16799307|NCT00098475|37740639|FG001|Step 1|Never started treatment|2|||
16799308|NCT00098475|37740640|FG002|Step 1|Never started treatment|0|||
16799309|NCT00098475|37740641|FG003|Step 1|Never started treatment|0|||
16799310|NCT00098475|37740638|FG000|Step 1|Still on treatment as of this analysis|14|||
16799311|NCT00098475|37740639|FG001|Step 1|Still on treatment as of this analysis|27|||
16799312|NCT00098475|37740640|FG002|Step 1|Still on treatment as of this analysis|0|||
16799313|NCT00098475|37740641|FG003|Step 1|Still on treatment as of this analysis|0|||
16799314|NCT00098475|37740638|FG000|Step 1|Knee surgery|1|||
16799315|NCT00098475|37740639|FG001|Step 1|Knee surgery|0|||
16799316|NCT00098475|37740640|FG002|Step 1|Knee surgery|0|||
16799317|NCT00098475|37740641|FG003|Step 1|Knee surgery|0|||
16799318|NCT00098475|37740638|FG000|Step 1|Complications|1|||
16799319|NCT00098475|37740639|FG001|Step 1|Complications|0|||
16799320|NCT00098475|37740640|FG002|Step 1|Complications|0|||
16799321|NCT00098475|37740641|FG003|Step 1|Complications|0|||
16799322|NCT00098475|37740638|FG000|Step 1|Cannot comply due to other tx|0|||
16799323|NCT00098475|37740639|FG001|Step 1|Cannot comply due to other tx|1|||
16799324|NCT00098475|37740640|FG002|Step 1|Cannot comply due to other tx|0|||
16799325|NCT00098475|37740641|FG003|Step 1|Cannot comply due to other tx|0|||
16799326|NCT00098475|37740638|FG000|Step 1|Both patient and physician's decision|2|||
16799327|NCT00098475|37740639|FG001|Step 1|Both patient and physician's decision|1|||
16799328|NCT00098475|37740640|FG002|Step 1|Both patient and physician's decision|0|||
16799329|NCT00098475|37740641|FG003|Step 1|Both patient and physician's decision|0|||
16799330|NCT00098475|37740638|FG000|Step 1|Incorrect disease assessment|2|||
16799331|NCT00098475|37740639|FG001|Step 1|Incorrect disease assessment|0|||
16799332|NCT00098475|37740640|FG002|Step 1|Incorrect disease assessment|0|||
16799333|NCT00098475|37740641|FG003|Step 1|Incorrect disease assessment|0|||
16799334|NCT00098475|37740638|FG000|Step 1|Off treatment for > specified timeframe|1|||
16799335|NCT00098475|37740639|FG001|Step 1|Off treatment for > specified timeframe|1|||
16799336|NCT00098475|37740640|FG002|Step 1|Off treatment for > specified timeframe|0|||
16799337|NCT00098475|37740641|FG003|Step 1|Off treatment for > specified timeframe|0|||
16799338|NCT00098475|37740638|FG000|Step 1|Declining performance status|0|||
16799339|NCT00098475|37740639|FG001|Step 1|Declining performance status|1|||
16799340|NCT00098475|37740640|FG002|Step 1|Declining performance status|0|||
16799341|NCT00098475|37740641|FG003|Step 1|Declining performance status|0|||
16799342|NCT00098475|37740638|FG000|Step 1|Insurance issue|0|||
16799343|NCT00098475|37740639|FG001|Step 1|Insurance issue|1|||
16799344|NCT00098475|37740640|FG002|Step 1|Insurance issue|0|||
16799345|NCT00098475|37740641|FG003|Step 1|Insurance issue|0|||
16799346|NCT00098475|37740638|FG000|Step 1|Rising paraprotein|0|||
16799347|NCT00098475|37740639|FG001|Step 1|Rising paraprotein|1|||
16799348|NCT00098475|37740640|FG002|Step 1|Rising paraprotein|0|||
16799349|NCT00098475|37740641|FG003|Step 1|Rising paraprotein|0|||
16799350|NCT00098475|37740638|FG000|Step 1|Referred to other physicians|0|||
16799351|NCT00098475|37740639|FG001|Step 1|Referred to other physicians|1|||
16799352|NCT00098475|37740640|FG002|Step 1|Referred to other physicians|0|||
16799353|NCT00098475|37740641|FG003|Step 1|Referred to other physicians|0|||
16799354|NCT00098475|37740638|FG000|Step 1|Criteria to continue treatment not met|0|||
16799355|NCT00098475|37740639|FG001|Step 1|Criteria to continue treatment not met|1|||
16799356|NCT00098475|37740640|FG002|Step 1|Criteria to continue treatment not met|0|||
16799357|NCT00098475|37740641|FG003|Step 1|Criteria to continue treatment not met|0|||
16799358|NCT00098475|37740638|FG000|Step 1|Misinterpretation of lab data|0|||
16799359|NCT00098475|37740639|FG001|Step 1|Misinterpretation of lab data|1|||
16799360|NCT00098475|37740640|FG002|Step 1|Misinterpretation of lab data|0|||
16799361|NCT00098475|37740641|FG003|Step 1|Misinterpretation of lab data|0|||
16799362|NCT00098475|37740638|FG000|Step 1|Patient fell with fracture|1|||
16799363|NCT00098475|37740639|FG001|Step 1|Patient fell with fracture|0|||
16799364|NCT00098475|37740640|FG002|Step 1|Patient fell with fracture|0|||
16799365|NCT00098475|37740641|FG003|Step 1|Patient fell with fracture|0|||
16799366|NCT00098475|37740638|FG000|Step 1|Not documented|0|||
16799367|NCT00098475|37740639|FG001|Step 1|Not documented|1|||
16799368|NCT00098475|37740640|FG002|Step 1|Not documented|0|||
16799369|NCT00098475|37740641|FG003|Step 1|Not documented|0|||
16799370|NCT00098475|37740638|FG000|Step 2|Disease progression|1|||
16799371|NCT00098475|37740639|FG001|Step 2|Disease progression|4|||
16799372|NCT00098475|37740640|FG002|Step 2|Disease progression|0|||
16799373|NCT00098475|37740641|FG003|Step 2|Disease progression|0|||
16799374|NCT00098475|37740638|FG000|Step 2|Adverse Event|2|||
16799375|NCT00098475|37740639|FG001|Step 2|Adverse Event|0|||
16799376|NCT00098475|37740640|FG002|Step 2|Adverse Event|0|||
16799377|NCT00098475|37740641|FG003|Step 2|Adverse Event|0|||
16799378|NCT00098475|37740638|FG000|Step 2|Withdrawal by Subject|0|||
16799379|NCT00098475|37740639|FG001|Step 2|Withdrawal by Subject|2|||
16799380|NCT00098475|37740640|FG002|Step 2|Withdrawal by Subject|0|||
16799381|NCT00098475|37740641|FG003|Step 2|Withdrawal by Subject|0|||
16799382|NCT00098475|37740638|FG000|Step 2|Physician Decision|0|||
16799383|NCT00098475|37740639|FG001|Step 2|Physician Decision|1|||
16799384|NCT00098475|37740640|FG002|Step 2|Physician Decision|0|||
16799385|NCT00098475|37740641|FG003|Step 2|Physician Decision|0|||
16799386|NCT00098475|37740638|FG000|Step 2|Alternative therapy|1|||
16799387|NCT00098475|37740639|FG001|Step 2|Alternative therapy|2|||
16799388|NCT00098475|37740640|FG002|Step 2|Alternative therapy|0|||
16799389|NCT00098475|37740641|FG003|Step 2|Alternative therapy|0|||
16799390|NCT00098475|37740638|FG000|Step 2|Never started treatment|1|||
16799391|NCT00098475|37740639|FG001|Step 2|Never started treatment|1|||
16799392|NCT00098475|37740640|FG002|Step 2|Never started treatment|0|||
16799393|NCT00098475|37740641|FG003|Step 2|Never started treatment|0|||
16799394|NCT02246673|37740656|FG000|Overall Study|Sponsor Decision|1|||
16799395|NCT02246673|37740657|FG001|Overall Study|Sponsor Decision|0|||
16799396|NCT02246673|37740658|FG002|Overall Study|Sponsor Decision|0|||
16799397|NCT02246673|37740659|FG003|Overall Study|Sponsor Decision|0|||
16799398|NCT02246673|37740660|FG004|Overall Study|Sponsor Decision|0|||
16799399|NCT02246673|37740656|FG000|Overall Study|Withdrawal by Subject|0|||
16799400|NCT02246673|37740657|FG001|Overall Study|Withdrawal by Subject|0|||
16799401|NCT02246673|37740658|FG002|Overall Study|Withdrawal by Subject|0|||
16799402|NCT02246673|37740659|FG003|Overall Study|Withdrawal by Subject|0|||
16799403|NCT02246673|37740660|FG004|Overall Study|Withdrawal by Subject|1|||
16799404|NCT02246673|37740656|FG000|Overall Study|Lost to Follow-up|0|||
16799405|NCT02246673|37740657|FG001|Overall Study|Lost to Follow-up|0|||
16799406|NCT02246673|37740658|FG002|Overall Study|Lost to Follow-up|0|||
16799407|NCT02246673|37740659|FG003|Overall Study|Lost to Follow-up|1|||
16799408|NCT02246673|37740660|FG004|Overall Study|Lost to Follow-up|0|||
16799409|NCT02246673|37740656|FG000|Overall Study|Protocol Violation|0|||
16799410|NCT02246673|37740657|FG001|Overall Study|Protocol Violation|0|||
16799411|NCT02246673|37740658|FG002|Overall Study|Protocol Violation|0|||
16799412|NCT02246673|37740659|FG003|Overall Study|Protocol Violation|1|||
16799413|NCT02246673|37740660|FG004|Overall Study|Protocol Violation|0|||
16799414|NCT02246439|37740722|FG000|Overall Study|Adverse Event|3|||
16799415|NCT02246439|37740723|FG001|Overall Study|Adverse Event|0|||
16799416|NCT02246439|37740722|FG000|Overall Study|Lost to Follow-up|7|||
16799417|NCT02246439|37740723|FG001|Overall Study|Lost to Follow-up|5|||
16799418|NCT02246439|37740722|FG000|Overall Study|Protocol Violation|0|||
16799419|NCT02246439|37740723|FG001|Overall Study|Protocol Violation|2|||
16799420|NCT02246439|37740722|FG000|Overall Study|Physician Decision|0|||
16799421|NCT02246439|37740723|FG001|Overall Study|Physician Decision|1|||
16799422|NCT02246439|37740722|FG000|Overall Study|Unkonwn|1|||
17016530|NCT00691210|38161156|FG003|Overall Study|Progression of Disease|2|||
16799423|NCT02246439|37740723|FG001|Overall Study|Unkonwn|3|||
16799424|NCT02246439|37740722|FG000|Overall Study|Withdrawal by Subject|1|||
16799425|NCT02246439|37740723|FG001|Overall Study|Withdrawal by Subject|0|||
16799426|NCT02245737|37740732|FG000|Overall Study|Adverse Event|23|||
16799427|NCT02245737|37740733|FG001|Overall Study|Adverse Event|26|||
16799428|NCT02245737|37740734|FG002|Overall Study|Adverse Event|33|||
16799429|NCT02245737|37740732|FG000|Overall Study|Condition Worsened|9|||
16799430|NCT02245737|37740733|FG001|Overall Study|Condition Worsened|10|||
16799431|NCT02245737|37740734|FG002|Overall Study|Condition Worsened|9|||
16799432|NCT02245737|37740732|FG000|Overall Study|Death|2|||
16799433|NCT02245737|37740733|FG001|Overall Study|Death|4|||
16799434|NCT02245737|37740734|FG002|Overall Study|Death|4|||
16799435|NCT02245737|37740732|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
16799436|NCT02245737|37740733|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
16799437|NCT02245737|37740734|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
16799438|NCT02245737|37740732|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
16799439|NCT02245737|37740733|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
16799440|NCT02245737|37740734|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
16799441|NCT02245737|37740732|FG000|Overall Study|Lost to Follow-up|2|||
16799442|NCT02245737|37740733|FG001|Overall Study|Lost to Follow-up|5|||
16799443|NCT02245737|37740734|FG002|Overall Study|Lost to Follow-up|4|||
16799444|NCT02245737|37740732|FG000|Overall Study|Other-determined by Investigator|9|||
16799445|NCT02245737|37740733|FG001|Overall Study|Other-determined by Investigator|10|||
16799446|NCT02245737|37740734|FG002|Overall Study|Other-determined by Investigator|10|||
16799447|NCT02245737|37740732|FG000|Overall Study|Physician Decision|6|||
16799448|NCT02245737|37740733|FG001|Overall Study|Physician Decision|3|||
16799449|NCT02245737|37740734|FG002|Overall Study|Physician Decision|6|||
16799450|NCT02245737|37740732|FG000|Overall Study|Protocol Violation|3|||
16799451|NCT02245737|37740733|FG001|Overall Study|Protocol Violation|2|||
16799452|NCT02245737|37740734|FG002|Overall Study|Protocol Violation|3|||
16799453|NCT02245737|37740732|FG000|Overall Study|Withdrawal by Subject|40|||
16799454|NCT02245737|37740733|FG001|Overall Study|Withdrawal by Subject|41|||
16799455|NCT02245737|37740734|FG002|Overall Study|Withdrawal by Subject|44|||
16799456|NCT02245737|37740732|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
16799457|NCT02245737|37740733|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
16799458|NCT02245737|37740734|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
16799459|NCT02245737|37740732|FG000|Overall Study|Sponsor Decision|445|||
16799460|NCT02245737|37740733|FG001|Overall Study|Sponsor Decision|430|||
16799461|NCT02245737|37740734|FG002|Overall Study|Sponsor Decision|432|||
16799462|NCT02244957|37740746|FG000|Overall Study|Lack of Efficacy|1|||
16799463|NCT02244957|37740747|FG001|Overall Study|Lack of Efficacy|0|||
16799464|NCT02243865|37740757|FG000|Overall Study|Protocol Violation|1|||
16799465|NCT02243865|37740758|FG001|Overall Study|Protocol Violation|3|||
16799466|NCT02243865|37740757|FG000|Overall Study|Lost to Follow-up|1|||
16799467|NCT02243865|37740758|FG001|Overall Study|Lost to Follow-up|1|||
16799468|NCT02243865|37740757|FG000|Overall Study|Withdrawal by Subject|1|||
16799469|NCT02243865|37740758|FG001|Overall Study|Withdrawal by Subject|0|||
16799470|NCT02243865|37740757|FG000|Overall Study|Adverse Event|1|||
16799471|NCT02243865|37740758|FG001|Overall Study|Adverse Event|1|||
16799472|NCT02243631|37740768|FG000|Overall Study|no synovial fluid on second aspirate|0|||
16799473|NCT02243631|37740769|FG001|Overall Study|no synovial fluid on second aspirate|1|||
16799474|NCT02242305|37740777|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
16799475|NCT02242305|37740778|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
16799476|NCT02242305|37740777|FG000|Overall Study|Adverse Event|1|||
16799477|NCT02242305|37740778|FG001|Overall Study|Adverse Event|0|||
16799478|NCT02242305|37740777|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
16799479|NCT02242305|37740778|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
16799480|NCT02242305|37740777|FG000|Overall Study|Subject withdraws inform consent|0|||
16799481|NCT02242305|37740778|FG001|Overall Study|Subject withdraws inform consent|4|||
16799482|NCT02242305|37740777|FG000|Overall Study|Lost to Follow-up|2|||
16799483|NCT02242305|37740778|FG001|Overall Study|Lost to Follow-up|0|||
16799484|NCT02240121|37740786|FG000|Overall Study|Protocol Violation|1|||
16799485|NCT02240121|37740787|FG001|Overall Study|Protocol Violation|2|||
16799486|NCT02240121|37740786|FG000|Overall Study|Physician Decision|0|||
16799487|NCT02240121|37740787|FG001|Overall Study|Physician Decision|1|||
16799488|NCT02240121|37740786|FG000|Overall Study|Change in protocol interpretation|1|||
16799489|NCT02240121|37740787|FG001|Overall Study|Change in protocol interpretation|0|||
16799490|NCT02240121|37740786|FG000|Overall Study|Lack of Efficacy|2|||
16799491|NCT02240121|37740787|FG001|Overall Study|Lack of Efficacy|3|||
16799492|NCT02240121|37740786|FG000|Overall Study|Site closed|1|||
16799493|NCT02240121|37740787|FG001|Overall Study|Site closed|1|||
16799494|NCT02240121|37740786|FG000|Overall Study|Pregnancy|1|||
16799495|NCT02240121|37740787|FG001|Overall Study|Pregnancy|0|||
16799496|NCT02240121|37740786|FG000|Overall Study|Adverse Event|2|||
16799497|NCT02240121|37740787|FG001|Overall Study|Adverse Event|4|||
16799498|NCT02240121|37740786|FG000|Overall Study|Withdrawal by Subject|6|||
16799499|NCT02240121|37740787|FG001|Overall Study|Withdrawal by Subject|2|||
16799500|NCT02240121|37740786|FG000|Overall Study|Lost to Follow-up|3|||
16799501|NCT02240121|37740787|FG001|Overall Study|Lost to Follow-up|4|||
16799502|NCT02240121|37740786|FG000|Overall Study|Other than specified|1|||
16799503|NCT02240121|37740787|FG001|Overall Study|Other than specified|3|||
16799504|NCT02239263|37740793|FG000|Overall Study|Protocol Violation|6|||
16799505|NCT02238483|37740801|FG000|Overall Study|Withdrawal by Subject|2|||
16799506|NCT02238483|37740802|FG001|Overall Study|Withdrawal by Subject|7|||
16799507|NCT02238483|37740801|FG000|Overall Study|Lost to Follow-up|1|||
16799508|NCT02238483|37740802|FG001|Overall Study|Lost to Follow-up|1|||
16799509|NCT02238483|37740801|FG000|Overall Study|Protocol Violation|1|||
16799510|NCT02238483|37740802|FG001|Overall Study|Protocol Violation|2|||
16799511|NCT02238483|37740801|FG000|Overall Study|Death|1|||
16799512|NCT02238483|37740802|FG001|Overall Study|Death|0|||
16799513|NCT02238483|37740801|FG000|Overall Study|Adverse Event|7|||
16799514|NCT02238483|37740802|FG001|Overall Study|Adverse Event|3|||
16799515|NCT02238483|37740801|FG000|Overall Study|Withdrawn due to physician decision|1|||
16799516|NCT02238483|37740802|FG001|Overall Study|Withdrawn due to physician decision|0|||
16799517|NCT02238483|37740801|FG000|Overall Study|Completion status not recorded|1|||
16799518|NCT02238483|37740802|FG001|Overall Study|Completion status not recorded|1|||
16799519|NCT02238483|37740801|FG000|Overall Study|Illness in family member|1|||
16799520|NCT02238483|37740802|FG001|Overall Study|Illness in family member|0|||
16799521|NCT01632891|37740810|FG000|Overall Study|Lost to Follow-up|0|||
16799522|NCT01632891|37740811|FG001|Overall Study|Lost to Follow-up|1|||
16799523|NCT01632891|37740810|FG000|Overall Study|Withdrawal by Subject|1|||
16799524|NCT01632891|37740811|FG001|Overall Study|Withdrawal by Subject|0|||
16799525|NCT02208999|37740823|FG000|Overall Study|Lost to Follow-up|1|||
16799526|NCT02208843|37740842|FG000|Overall Study|Clinical symptoms of progression|2|||
16799527|NCT02208843|37740842|FG000|Overall Study|Progression disease according to RECIST|24|||
16799528|NCT02208843|37740842|FG000|Overall Study|Adverse Event|12|||
16799529|NCT02208843|37740842|FG000|Overall Study|Protocol Violation|1|||
16799530|NCT02208843|37740842|FG000|Overall Study|Withdrawal by Subject|1|||
16799531|NCT02208843|37740842|FG000|Overall Study|Switched to commercial afatinib|20|||
16799532|NCT02208063|37740848|FG000|Overall Study|Death|3|||
16799533|NCT02208063|37740849|FG001|Overall Study|Death|5|||
16799534|NCT02208063|37740848|FG000|Overall Study|Not Specified in report|3|||
16799535|NCT02208063|37740849|FG001|Overall Study|Not Specified in report|4|||
16799536|NCT02208063|37740848|FG000|Overall Study|Withdrawal by Subject|5|||
16799537|NCT02208063|37740849|FG001|Overall Study|Withdrawal by Subject|2|||
16799538|NCT02208063|37740848|FG000|Overall Study|Lost to Follow-up|1|||
16799539|NCT02208063|37740849|FG001|Overall Study|Lost to Follow-up|0|||
16799540|NCT02207907|37740857|FG000|Overall Study|Lost to Follow-up|3|||
16799541|NCT02207907|37740858|FG001|Overall Study|Lost to Follow-up|1|||
16799542|NCT02207907|37740857|FG000|Overall Study|Withdrawal by Subject|5|||
16799543|NCT02207907|37740858|FG001|Overall Study|Withdrawal by Subject|6|||
16799544|NCT02207907|37740857|FG000|Overall Study|Did not meet study criteria|3|||
16799545|NCT02207907|37740858|FG001|Overall Study|Did not meet study criteria|0|||
16799546|NCT02207907|37740857|FG000|Overall Study|Pregnancy|0|||
16799547|NCT02207907|37740858|FG001|Overall Study|Pregnancy|1|||
16799548|NCT02207829|37740867|FG000|Overall Study|Adverse Event|10|||
16799549|NCT02207829|37740868|FG001|Overall Study|Adverse Event|9|||
16799550|NCT02207829|37740867|FG000|Overall Study|Lack of Efficacy|7|||
16799551|NCT02207829|37740868|FG001|Overall Study|Lack of Efficacy|5|||
16799552|NCT02207829|37740867|FG000|Overall Study|Lost to Follow-up|2|||
16799553|NCT02207829|37740868|FG001|Overall Study|Lost to Follow-up|2|||
16799554|NCT02207829|37740867|FG000|Overall Study|Protocol deviation|5|||
16799555|NCT02207829|37740868|FG001|Overall Study|Protocol deviation|4|||
16799556|NCT02207829|37740867|FG000|Overall Study|Withdrew consent|18|||
16799557|NCT02207829|37740868|FG001|Overall Study|Withdrew consent|14|||
16799558|NCT02237157|37740874|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
16799559|NCT02237157|37740875|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
16799560|NCT02237157|37740876|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
16799561|NCT02237157|37740877|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
16799562|NCT02237157|37740874|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
16799563|NCT02237157|37740875|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
16799564|NCT02237157|37740876|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
16799565|NCT02237157|37740877|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
16799566|NCT02237001|37740884|FG000|Overall Study|Lost to Follow-up|2|||
16799567|NCT02237001|37740884|FG000|Overall Study|Withdrawal by Subject|1|||
16799568|NCT02237001|37740884|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
16799569|NCT02237001|37740884|FG000|Overall Study|Re-operation|4|||
16799570|NCT02237001|37740884|FG000|Overall Study|Incarceration|1|||
16799571|NCT02236611|37740890|FG000|Overall Study|Adverse Event|10|||
16799572|NCT02236611|37740891|FG001|Overall Study|Adverse Event|16|||
16799573|NCT02236611|37740890|FG000|Overall Study|Lack of Efficacy|4|||
16799574|NCT02236611|37740891|FG001|Overall Study|Lack of Efficacy|7|||
17102295|NCT00091572|38241203|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
16799575|NCT02236611|37740890|FG000|Overall Study|Lost to Follow-up|0|||
16799576|NCT02236611|37740891|FG001|Overall Study|Lost to Follow-up|2|||
16799577|NCT02236611|37740890|FG000|Overall Study|Protocol deviation|3|||
16799578|NCT02236611|37740891|FG001|Overall Study|Protocol deviation|5|||
16799579|NCT02236611|37740890|FG000|Overall Study|Withdrew consent|9|||
16799580|NCT02236611|37740891|FG001|Overall Study|Withdrew consent|4|||
16799581|NCT02234583|37740899|FG000|Overall Study|Adverse Event|172|||
16799582|NCT02234583|37740900|FG001|Overall Study|Adverse Event|156|||
16799583|NCT02234583|37740899|FG000|Overall Study|Withdrawal by Subject|109|||
16799584|NCT02234583|37740900|FG001|Overall Study|Withdrawal by Subject|157|||
16799585|NCT02234583|37740899|FG000|Overall Study|Lost to Follow-up|0|||
16799586|NCT02234583|37740900|FG001|Overall Study|Lost to Follow-up|1|||
16799587|NCT02234583|37740899|FG000|Overall Study|Lack of Efficacy|58|||
16799588|NCT02234583|37740900|FG001|Overall Study|Lack of Efficacy|103|||
16799589|NCT02234583|37740899|FG000|Overall Study|Protocol Violation|35|||
16799590|NCT02234583|37740900|FG001|Overall Study|Protocol Violation|42|||
16799591|NCT02234583|37740899|FG000|Overall Study|Other|39|||
16799592|NCT02234583|37740900|FG001|Overall Study|Other|97|||
16799593|NCT03686397|37740914|FG000|Overall Study|Lack of Efficacy|3|||
16799594|NCT03686397|37740915|FG001|Overall Study|Lack of Efficacy|5|||
16799595|NCT03686397|37740914|FG000|Overall Study|Adverse Event|0|||
16799596|NCT03686397|37740915|FG001|Overall Study|Adverse Event|1|||
16799597|NCT03686397|37740914|FG000|Overall Study|Protocol Violation|0|||
16799598|NCT03686397|37740915|FG001|Overall Study|Protocol Violation|1|||
16799599|NCT03686397|37740914|FG000|Overall Study|Withdrawal by Subject|0|||
16799600|NCT03686397|37740915|FG001|Overall Study|Withdrawal by Subject|1|||
16799601|NCT03686397|37740914|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
16799602|NCT03686397|37740915|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
16799603|NCT02233803|37740921|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
16799604|NCT02233803|37740922|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
16799605|NCT02233803|37740921|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
16799606|NCT02233803|37740922|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
16799607|NCT02233803|37740921|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
16799608|NCT02233803|37740922|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
16799609|NCT02233803|37740921|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
16799610|NCT02233803|37740922|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
16799611|NCT02233803|37740921|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
16799612|NCT02233803|37740922|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
16799613|NCT02233803|37740921|FG000|Washout Period (4-Wks)|Physician Decision|1|||
16799614|NCT02233803|37740922|FG001|Washout Period (4-Wks)|Physician Decision|0|||
16799615|NCT02233803|37740921|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
16799616|NCT02233803|37740922|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
16799617|NCT02233803|37740921|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
16799618|NCT02233803|37740922|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
16799619|NCT02233803|37740921|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
16799620|NCT02233803|37740922|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
16799621|NCT02233647|37740930|FG000|Overall Study|Adverse Event|1|||
16799622|NCT02233413|37740936|FG000|Overall Study|Lost to Follow-up|7|||
16799623|NCT02233413|37740937|FG001|Overall Study|Lost to Follow-up|9|||
16799624|NCT02233413|37740936|FG000|Overall Study|Withdrawal by Subject|4|||
16799625|NCT02233413|37740937|FG001|Overall Study|Withdrawal by Subject|5|||
16799626|NCT01632579|37740943|FG000|Washout Period|Adverse Event|1|||
16799627|NCT01632579|37740944|FG001|Washout Period|Adverse Event|0|||
16799628|NCT01632579|37740945|FG002|Washout Period|Adverse Event|0|||
16799629|NCT01632579|37740946|FG003|Washout Period|Adverse Event|0|||
16799630|NCT01632579|37740947|FG004|Washout Period|Adverse Event|0|||
16799631|NCT01632579|37740948|FG005|Washout Period|Adverse Event|0|||
16799632|NCT01632579|37740949|FG006|Washout Period|Adverse Event|0|||
16799633|NCT01632579|37740950|FG007|Washout Period|Adverse Event|0|||
16799634|NCT01632579|37740951|FG008|Washout Period|Adverse Event|0|||
16799635|NCT01632579|37740943|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
16799636|NCT01632579|37740944|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
16799637|NCT01632579|37740945|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
16799638|NCT01632579|37740946|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
16799639|NCT01632579|37740947|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
16799640|NCT01632579|37740948|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
16799641|NCT01632579|37740949|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
16799642|NCT01632579|37740950|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
16799643|NCT01632579|37740951|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
16799644|NCT01632345|37740980|FG000|Treatment: Part I|Adverse Event|1|||
16799645|NCT01632345|37740981|FG001|Treatment: Part I|Adverse Event|4|||
16799646|NCT01632345|37740982|FG002|Treatment: Part I|Adverse Event|2|||
16799647|NCT01632345|37740983|FG003|Treatment: Part I|Adverse Event|1|||
16799648|NCT01632345|37740984|FG004|Treatment: Part I|Adverse Event|3|||
16799649|NCT01632345|37740985|FG005|Treatment: Part I|Adverse Event|0|||
16799650|NCT01632345|37740986|FG006|Treatment: Part I|Adverse Event|0|||
16799651|NCT01632345|37740980|FG000|Treatment: Part I|Lack of Efficacy|0|||
16799652|NCT01632345|37740981|FG001|Treatment: Part I|Lack of Efficacy|1|||
16799653|NCT01632345|37740982|FG002|Treatment: Part I|Lack of Efficacy|0|||
16799654|NCT01632345|37740983|FG003|Treatment: Part I|Lack of Efficacy|1|||
16799655|NCT01632345|37740984|FG004|Treatment: Part I|Lack of Efficacy|1|||
16799656|NCT01632345|37740985|FG005|Treatment: Part I|Lack of Efficacy|0|||
16799657|NCT01632345|37740986|FG006|Treatment: Part I|Lack of Efficacy|0|||
16799658|NCT01632345|37740980|FG000|Treatment: Part I|Lost to Follow-up|3|||
16799659|NCT01632345|37740981|FG001|Treatment: Part I|Lost to Follow-up|2|||
16799660|NCT01632345|37740982|FG002|Treatment: Part I|Lost to Follow-up|1|||
16799661|NCT01632345|37740983|FG003|Treatment: Part I|Lost to Follow-up|3|||
16799662|NCT01632345|37740984|FG004|Treatment: Part I|Lost to Follow-up|4|||
16799663|NCT01632345|37740985|FG005|Treatment: Part I|Lost to Follow-up|0|||
16799664|NCT01632345|37740986|FG006|Treatment: Part I|Lost to Follow-up|0|||
16799665|NCT01632345|37740980|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
16799666|NCT01632345|37740981|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
16799667|NCT01632345|37740982|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
16799668|NCT01632345|37740983|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
16799669|NCT01632345|37740984|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
16799670|NCT01632345|37740985|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
16799671|NCT01632345|37740986|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
16799672|NCT01632345|37740980|FG000|Treatment: Part I|Physician Decision|2|||
16799673|NCT01632345|37740981|FG001|Treatment: Part I|Physician Decision|1|||
16799674|NCT01632345|37740982|FG002|Treatment: Part I|Physician Decision|0|||
16799675|NCT01632345|37740983|FG003|Treatment: Part I|Physician Decision|0|||
16799676|NCT01632345|37740984|FG004|Treatment: Part I|Physician Decision|1|||
16799677|NCT01632345|37740985|FG005|Treatment: Part I|Physician Decision|0|||
16799678|NCT01632345|37740986|FG006|Treatment: Part I|Physician Decision|0|||
16799679|NCT01632345|37740980|FG000|Treatment: Part I|Pregnancy|0|||
16799680|NCT01632345|37740981|FG001|Treatment: Part I|Pregnancy|1|||
16799681|NCT01632345|37740982|FG002|Treatment: Part I|Pregnancy|0|||
16799682|NCT01632345|37740983|FG003|Treatment: Part I|Pregnancy|0|||
16799683|NCT01632345|37740984|FG004|Treatment: Part I|Pregnancy|0|||
16799684|NCT01632345|37740985|FG005|Treatment: Part I|Pregnancy|0|||
16799685|NCT01632345|37740986|FG006|Treatment: Part I|Pregnancy|0|||
16799686|NCT01632345|37740980|FG000|Treatment: Part I|Protocol Deviation|0|||
16799687|NCT01632345|37740981|FG001|Treatment: Part I|Protocol Deviation|0|||
16799688|NCT01632345|37740982|FG002|Treatment: Part I|Protocol Deviation|1|||
16799689|NCT01632345|37740983|FG003|Treatment: Part I|Protocol Deviation|1|||
16799690|NCT01632345|37740984|FG004|Treatment: Part I|Protocol Deviation|0|||
16799691|NCT01632345|37740985|FG005|Treatment: Part I|Protocol Deviation|0|||
16799692|NCT01632345|37740986|FG006|Treatment: Part I|Protocol Deviation|0|||
16799693|NCT01632345|37740980|FG000|Treatment: Part I|Withdrawal by Subject|3|||
16799694|NCT01632345|37740981|FG001|Treatment: Part I|Withdrawal by Subject|4|||
16799695|NCT01632345|37740982|FG002|Treatment: Part I|Withdrawal by Subject|4|||
16799696|NCT01632345|37740983|FG003|Treatment: Part I|Withdrawal by Subject|1|||
16799697|NCT01632345|37740984|FG004|Treatment: Part I|Withdrawal by Subject|4|||
16799698|NCT01632345|37740985|FG005|Treatment: Part I|Withdrawal by Subject|0|||
16799699|NCT01632345|37740986|FG006|Treatment: Part I|Withdrawal by Subject|0|||
16799700|NCT01632345|37740980|FG000|Treatment: Part II|Adverse Event|0|||
16799701|NCT01632345|37740981|FG001|Treatment: Part II|Adverse Event|0|||
16799702|NCT01632345|37740982|FG002|Treatment: Part II|Adverse Event|0|||
16799703|NCT01632345|37740983|FG003|Treatment: Part II|Adverse Event|0|||
16799704|NCT01632345|37740984|FG004|Treatment: Part II|Adverse Event|0|||
16799705|NCT01632345|37740985|FG005|Treatment: Part II|Adverse Event|3|||
16799706|NCT01632345|37740986|FG006|Treatment: Part II|Adverse Event|8|||
16799707|NCT01632345|37740980|FG000|Treatment: Part II|Lost to Follow-up|0|||
16799708|NCT01632345|37740981|FG001|Treatment: Part II|Lost to Follow-up|0|||
16799709|NCT01632345|37740982|FG002|Treatment: Part II|Lost to Follow-up|0|||
16799710|NCT01632345|37740983|FG003|Treatment: Part II|Lost to Follow-up|0|||
16799711|NCT01632345|37740984|FG004|Treatment: Part II|Lost to Follow-up|0|||
16799712|NCT01632345|37740985|FG005|Treatment: Part II|Lost to Follow-up|3|||
16799713|NCT01632345|37740986|FG006|Treatment: Part II|Lost to Follow-up|1|||
16799714|NCT01632345|37740980|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
16799715|NCT01632345|37740981|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
16799716|NCT01632345|37740982|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
16799717|NCT01632345|37740983|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
16799718|NCT01632345|37740984|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
16799719|NCT01632345|37740985|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
16799720|NCT01632345|37740986|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
16799721|NCT01632345|37740980|FG000|Treatment: Part II|Withdrawal by Subject|0|||
16799722|NCT01632345|37740981|FG001|Treatment: Part II|Withdrawal by Subject|0|||
16799723|NCT01632345|37740982|FG002|Treatment: Part II|Withdrawal by Subject|0|||
16799724|NCT01632345|37740983|FG003|Treatment: Part II|Withdrawal by Subject|0|||
16799725|NCT01632345|37740984|FG004|Treatment: Part II|Withdrawal by Subject|0|||
16799726|NCT01632345|37740985|FG005|Treatment: Part II|Withdrawal by Subject|2|||
16799727|NCT01632345|37740986|FG006|Treatment: Part II|Withdrawal by Subject|2|||
16799728|NCT02232243|37741004|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
16799729|NCT02232243|37741005|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
16799730|NCT02232243|37741006|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
16799731|NCT02205333|37741024|FG000|Overall Study|Death|5|||
16799732|NCT02205333|37741025|FG001|Overall Study|Death|6|||
16799733|NCT02205333|37741026|FG002|Overall Study|Death|2|||
16799734|NCT02205333|37741027|FG003|Overall Study|Death|6|||
16799735|NCT02205333|37741028|FG004|Overall Study|Death|5|||
16799736|NCT02205333|37741029|FG005|Overall Study|Death|3|||
16799737|NCT02205333|37741030|FG006|Overall Study|Death|3|||
16799738|NCT02205333|37741031|FG007|Overall Study|Death|2|||
16799739|NCT02205333|37741032|FG008|Overall Study|Death|0|||
16799740|NCT02205333|37741024|FG000|Overall Study|Withdrawal by Subject|1|||
16799741|NCT02205333|37741025|FG001|Overall Study|Withdrawal by Subject|0|||
16799742|NCT02205333|37741026|FG002|Overall Study|Withdrawal by Subject|0|||
16799743|NCT02205333|37741027|FG003|Overall Study|Withdrawal by Subject|1|||
16799744|NCT02205333|37741028|FG004|Overall Study|Withdrawal by Subject|0|||
16799745|NCT02205333|37741029|FG005|Overall Study|Withdrawal by Subject|0|||
16799746|NCT02205333|37741030|FG006|Overall Study|Withdrawal by Subject|2|||
16799747|NCT02205333|37741031|FG007|Overall Study|Withdrawal by Subject|0|||
16799748|NCT02205333|37741032|FG008|Overall Study|Withdrawal by Subject|0|||
16799749|NCT02230683|37741052|FG000|Overall Study|Adverse Event|1|||
16799750|NCT02230527|37741064|FG000|Overall Study|Withdrawal by Subject|1|||
16799751|NCT02230527|37741065|FG001|Overall Study|Withdrawal by Subject|1|||
16799752|NCT02230527|37741064|FG000|Overall Study|Death|1|||
16799753|NCT02230527|37741065|FG001|Overall Study|Death|0|||
17102296|NCT00091572|38241204|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
17102297|NCT00091572|38241203|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
17102298|NCT00091572|38241204|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
17102299|NCT00091572|38241203|FG000|Overall Study|Other Reason|6|||
17102300|NCT00091572|38241204|FG001|Overall Study|Other Reason|13|||
17102301|NCT00091572|38241203|FG000|Overall Study|Ongoing (still on treatment)|8|||
16799754|NCT02230527|37741064|FG000|Overall Study|Lost to Follow-up|2|||
16799755|NCT02230527|37741065|FG001|Overall Study|Lost to Follow-up|1|||
16799756|NCT02230527|37741064|FG000|Overall Study|Other|1|||
16799757|NCT02230527|37741065|FG001|Overall Study|Other|0|||
16799758|NCT02204319|37741071|FG000|Overall Study|Pregnancy|1|||
16799759|NCT02204319|37741071|FG000|Overall Study|Withdrawal by Subject|2|||
16799760|NCT02204007|37741078|FG000|Overall Study|Surgery Canceled|1|||
16799761|NCT02204007|37741079|FG001|Overall Study|Surgery Canceled|1|||
16799762|NCT02203851|37741085|FG000|Overall Study|Lost to Follow-up|4|||
16799763|NCT02203851|37741085|FG000|Overall Study|Withdrawal by Subject|6|||
16799764|NCT02203851|37741085|FG000|Overall Study|Other|1|||
16799765|NCT02228967|37741098|FG000|Overall Study|Lost to Follow-up|146|||
16799766|NCT02228967|37741099|FG001|Overall Study|Lost to Follow-up|142|||
16799767|NCT02228967|37741098|FG000|Overall Study|Withdrawal by Subject|13|||
16799768|NCT02228967|37741099|FG001|Overall Study|Withdrawal by Subject|18|||
16799769|NCT02227875|37741107|FG000|Overall Study|Protocol Violation|10|||
16799770|NCT02227875|37741108|FG001|Overall Study|Protocol Violation|7|||
16799771|NCT02227875|37741107|FG000|Overall Study|Other|1|||
16799772|NCT02227875|37741108|FG001|Overall Study|Other|3|||
16799773|NCT02227875|37741107|FG000|Overall Study|Physician Decision|1|||
16799774|NCT02227875|37741108|FG001|Overall Study|Physician Decision|0|||
16799775|NCT02227875|37741107|FG000|Overall Study|Adverse Event|3|||
16799776|NCT02227875|37741108|FG001|Overall Study|Adverse Event|0|||
16799777|NCT02227875|37741107|FG000|Overall Study|Withdrawal by Subject|12|||
16799778|NCT02227875|37741108|FG001|Overall Study|Withdrawal by Subject|13|||
16799779|NCT02227875|37741107|FG000|Overall Study|Lost to Follow-up|10|||
16799780|NCT02227875|37741108|FG001|Overall Study|Lost to Follow-up|10|||
16799781|NCT02203149|37741119|FG000|Part 1|Adverse Event|0|||
16799782|NCT02203149|37741120|FG001|Part 1|Adverse Event|1|||
16799783|NCT02203149|37741121|FG002|Part 1|Adverse Event|0|||
16799784|NCT02203149|37741122|FG003|Part 1|Adverse Event|0|||
16799785|NCT02203149|37741123|FG004|Part 1|Adverse Event|0|||
16799786|NCT02203149|37741119|FG000|Part 2|Death|0|||
16799787|NCT02203149|37741120|FG001|Part 2|Death|0|||
16799788|NCT02203149|37741121|FG002|Part 2|Death|1|||
16799789|NCT02203149|37741122|FG003|Part 2|Death|1|||
16799790|NCT02203149|37741123|FG004|Part 2|Death|0|||
16799791|NCT02203149|37741119|FG000|Part 2|Withdrawal by Subject|0|||
16799792|NCT02203149|37741120|FG001|Part 2|Withdrawal by Subject|0|||
16799793|NCT02203149|37741121|FG002|Part 2|Withdrawal by Subject|0|||
16799794|NCT02203149|37741122|FG003|Part 2|Withdrawal by Subject|1|||
16799795|NCT02203149|37741123|FG004|Part 2|Withdrawal by Subject|0|||
16799796|NCT02203149|37741119|FG000|Part 2|Adverse Event|0|||
16799797|NCT02203149|37741120|FG001|Part 2|Adverse Event|0|||
16799798|NCT02203149|37741121|FG002|Part 2|Adverse Event|0|||
16799799|NCT02203149|37741122|FG003|Part 2|Adverse Event|1|||
16799800|NCT02203149|37741123|FG004|Part 2|Adverse Event|1|||
16799801|NCT02203071|37741147|FG000|Overall Study|Lost to Follow-up|3|||
16799802|NCT02203071|37741148|FG001|Overall Study|Lost to Follow-up|1|||
16799803|NCT02202837|37741156|FG000|Overall Study|Enbrel treatment discontinued|36|||
16799804|NCT02202837|37741157|FG001|Overall Study|Enbrel treatment discontinued|4|||
16799805|NCT02202837|37741156|FG000|Overall Study|Other|10|||
16799806|NCT02202837|37741157|FG001|Overall Study|Other|0|||
16799807|NCT02202837|37741156|FG000|Overall Study|Lost to Follow-up|7|||
16799808|NCT02202837|37741157|FG001|Overall Study|Lost to Follow-up|1|||
16799809|NCT02202759|37741166|FG000|Overall Study|Study Terminated by Sponsor|3|||
16799810|NCT02202759|37741167|FG001|Overall Study|Study Terminated by Sponsor|3|||
16799811|NCT02202759|37741168|FG002|Overall Study|Study Terminated by Sponsor|3|||
16799812|NCT02202759|37741166|FG000|Overall Study|Withdrawal by Subject|2|||
16799813|NCT02202759|37741167|FG001|Overall Study|Withdrawal by Subject|1|||
16799814|NCT02202759|37741168|FG002|Overall Study|Withdrawal by Subject|1|||
16799815|NCT02202759|37741166|FG000|Overall Study|Reason not Specified|4|||
16799816|NCT02202759|37741167|FG001|Overall Study|Reason not Specified|11|||
16799817|NCT02202759|37741168|FG002|Overall Study|Reason not Specified|10|||
16799818|NCT02226549|37741177|FG000|Overall Study|Randomized but Never Treated|1|||
16799819|NCT02226549|37741178|FG001|Overall Study|Randomized but Never Treated|0|||
16799820|NCT02226549|37741177|FG000|Overall Study|Lost to Follow-up|0|||
16799821|NCT02226549|37741178|FG001|Overall Study|Lost to Follow-up|1|||
16799822|NCT02226003|37741187|FG000|Overall Study|Lost to Follow-up|2|||
16799823|NCT02226003|37741188|FG001|Overall Study|Lost to Follow-up|1|||
16799824|NCT02226003|37741189|FG002|Overall Study|Lost to Follow-up|3|||
16799825|NCT02226003|37741187|FG000|Overall Study|Withdrawal by Subject|0|||
16799826|NCT02226003|37741188|FG001|Overall Study|Withdrawal by Subject|0|||
16799827|NCT02226003|37741189|FG002|Overall Study|Withdrawal by Subject|3|||
16799828|NCT02225223|37741199|FG000|Overall Study|Death|10|||
16799829|NCT02225223|37741200|FG001|Overall Study|Death|1|||
16799830|NCT02225223|37741199|FG000|Overall Study|Lost to Follow-up|5|||
16799831|NCT02225223|37741200|FG001|Overall Study|Lost to Follow-up|0|||
16799832|NCT02225223|37741199|FG000|Overall Study|Other|1|||
16799833|NCT02225223|37741200|FG001|Overall Study|Other|2|||
16799834|NCT02225223|37741199|FG000|Overall Study|Physician Decision|1|||
16799835|NCT02225223|37741200|FG001|Overall Study|Physician Decision|0|||
16799836|NCT02225223|37741199|FG000|Overall Study|Withdrawal by Subject|2|||
16799837|NCT02225223|37741200|FG001|Overall Study|Withdrawal by Subject|2|||
16799838|NCT01634139|37741209|FG000|Overall Study|Non compliant with protocol|1|||
16799839|NCT01634139|37741210|FG001|Overall Study|Non compliant with protocol|0|||
16799840|NCT01634139|37741211|FG002|Overall Study|Non compliant with protocol|0|||
16799841|NCT01634139|37741209|FG000|Overall Study|Consent withdrawn not due to AE|4|||
16799842|NCT01634139|37741210|FG001|Overall Study|Consent withdrawn not due to AE|3|||
16799843|NCT01634139|37741211|FG002|Overall Study|Consent withdrawn not due to AE|2|||
16799844|NCT01634139|37741209|FG000|Overall Study|Other|4|||
16799845|NCT01634139|37741210|FG001|Overall Study|Other|0|||
16799846|NCT01634139|37741211|FG002|Overall Study|Other|3|||
16799847|NCT01634139|37741209|FG000|Overall Study|Lost to Follow-up|0|||
16799848|NCT01634139|37741210|FG001|Overall Study|Lost to Follow-up|2|||
16799849|NCT01634139|37741211|FG002|Overall Study|Lost to Follow-up|0|||
16799850|NCT01634139|37741209|FG000|Overall Study|Not treated|1|||
16799851|NCT01634139|37741210|FG001|Overall Study|Not treated|1|||
16799852|NCT01634139|37741211|FG002|Overall Study|Not treated|0|||
16799853|NCT02224755|37741221|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
16799854|NCT02224755|37741222|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
16799855|NCT02224755|37741221|FG000|Two Year Follow up Post-implant|Death|103|||
16799856|NCT02224755|37741222|FG001|Two Year Follow up Post-implant|Death|98|||
16799857|NCT02224755|37741221|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
16799858|NCT02224755|37741222|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
16799859|NCT02224755|37741221|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
16799860|NCT02224755|37741222|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
16799861|NCT02224755|37741221|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
16799862|NCT02224755|37741222|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
16799863|NCT02404441|37741242|FG000|Phase 1 Part|Adverse Event|1|||
16799864|NCT02404441|37741243|FG001|Phase 1 Part|Adverse Event|0|||
16799865|NCT02404441|37741244|FG002|Phase 1 Part|Adverse Event|0|||
16799866|NCT02404441|37741245|FG003|Phase 1 Part|Adverse Event|0|||
16799867|NCT02404441|37741246|FG004|Phase 1 Part|Adverse Event|0|||
16799868|NCT02404441|37741247|FG005|Phase 1 Part|Adverse Event|0|||
16799869|NCT02404441|37741248|FG006|Phase 1 Part|Adverse Event|0|||
16799870|NCT02404441|37741249|FG007|Phase 1 Part|Adverse Event|0|||
16799871|NCT02404441|37741250|FG008|Phase 1 Part|Adverse Event|0|||
16799872|NCT02404441|37741251|FG009|Phase 1 Part|Adverse Event|0|||
16799873|NCT02404441|37741242|FG000|Phase 1 Part|Physician Decision|0|||
16799874|NCT02404441|37741243|FG001|Phase 1 Part|Physician Decision|1|||
16799875|NCT02404441|37741244|FG002|Phase 1 Part|Physician Decision|0|||
16799876|NCT02404441|37741245|FG003|Phase 1 Part|Physician Decision|0|||
16799877|NCT02404441|37741246|FG004|Phase 1 Part|Physician Decision|0|||
16799878|NCT02404441|37741247|FG005|Phase 1 Part|Physician Decision|0|||
16799879|NCT02404441|37741248|FG006|Phase 1 Part|Physician Decision|0|||
16799880|NCT02404441|37741249|FG007|Phase 1 Part|Physician Decision|0|||
16799881|NCT02404441|37741250|FG008|Phase 1 Part|Physician Decision|0|||
16799882|NCT02404441|37741251|FG009|Phase 1 Part|Physician Decision|0|||
16799883|NCT02404441|37741242|FG000|Phase 1 Part|Progressive Disease|14|||
16799884|NCT02404441|37741243|FG001|Phase 1 Part|Progressive Disease|11|||
16799885|NCT02404441|37741244|FG002|Phase 1 Part|Progressive Disease|7|||
16799886|NCT02404441|37741245|FG003|Phase 1 Part|Progressive Disease|6|||
16799887|NCT02404441|37741246|FG004|Phase 1 Part|Progressive Disease|9|||
16799888|NCT02404441|37741247|FG005|Phase 1 Part|Progressive Disease|0|||
16799889|NCT02404441|37741248|FG006|Phase 1 Part|Progressive Disease|0|||
16799890|NCT02404441|37741249|FG007|Phase 1 Part|Progressive Disease|0|||
16799891|NCT02404441|37741250|FG008|Phase 1 Part|Progressive Disease|0|||
16799892|NCT02404441|37741251|FG009|Phase 1 Part|Progressive Disease|0|||
16799893|NCT02404441|37741242|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
16799894|NCT02404441|37741243|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
16799895|NCT02404441|37741244|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
16799896|NCT02404441|37741245|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
16799897|NCT02404441|37741246|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
16799898|NCT02404441|37741247|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
16799899|NCT02404441|37741248|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
16799900|NCT02404441|37741249|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
16799901|NCT02404441|37741250|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
16799902|NCT02404441|37741251|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
16799903|NCT02404441|37741242|FG000|Phase 1 Part|Death|1|||
16799904|NCT02404441|37741243|FG001|Phase 1 Part|Death|1|||
16799905|NCT02404441|37741244|FG002|Phase 1 Part|Death|1|||
16799906|NCT02404441|37741245|FG003|Phase 1 Part|Death|0|||
16799907|NCT02404441|37741246|FG004|Phase 1 Part|Death|1|||
16799908|NCT02404441|37741247|FG005|Phase 1 Part|Death|0|||
16799909|NCT02404441|37741248|FG006|Phase 1 Part|Death|0|||
16799910|NCT02404441|37741249|FG007|Phase 1 Part|Death|0|||
16799911|NCT02404441|37741250|FG008|Phase 1 Part|Death|0|||
16799912|NCT02404441|37741251|FG009|Phase 1 Part|Death|0|||
16799913|NCT02404441|37741242|FG000|Phase 2 Part|Adverse Event|0|||
16799914|NCT02404441|37741243|FG001|Phase 2 Part|Adverse Event|0|||
16799915|NCT02404441|37741244|FG002|Phase 2 Part|Adverse Event|0|||
16799916|NCT02404441|37741245|FG003|Phase 2 Part|Adverse Event|0|||
16799917|NCT02404441|37741246|FG004|Phase 2 Part|Adverse Event|0|||
16799918|NCT02404441|37741247|FG005|Phase 2 Part|Adverse Event|2|||
16799919|NCT02404441|37741248|FG006|Phase 2 Part|Adverse Event|3|||
16799920|NCT02404441|37741249|FG007|Phase 2 Part|Adverse Event|3|||
16799921|NCT02404441|37741250|FG008|Phase 2 Part|Adverse Event|6|||
16799922|NCT02404441|37741251|FG009|Phase 2 Part|Adverse Event|1|||
16799923|NCT02404441|37741242|FG000|Phase 2 Part|Physician Decision|0|||
16799924|NCT02404441|37741243|FG001|Phase 2 Part|Physician Decision|0|||
16799925|NCT02404441|37741244|FG002|Phase 2 Part|Physician Decision|0|||
16799926|NCT02404441|37741245|FG003|Phase 2 Part|Physician Decision|0|||
16799927|NCT02404441|37741246|FG004|Phase 2 Part|Physician Decision|0|||
16799928|NCT02404441|37741247|FG005|Phase 2 Part|Physician Decision|7|||
16799929|NCT02404441|37741248|FG006|Phase 2 Part|Physician Decision|9|||
16799930|NCT02404441|37741249|FG007|Phase 2 Part|Physician Decision|2|||
16799931|NCT02404441|37741250|FG008|Phase 2 Part|Physician Decision|1|||
16799932|NCT02404441|37741251|FG009|Phase 2 Part|Physician Decision|3|||
16799933|NCT02404441|37741242|FG000|Phase 2 Part|Progressive disease|0|||
16799934|NCT02404441|37741243|FG001|Phase 2 Part|Progressive disease|0|||
16799935|NCT02404441|37741244|FG002|Phase 2 Part|Progressive disease|0|||
16799936|NCT02404441|37741245|FG003|Phase 2 Part|Progressive disease|0|||
16799937|NCT02404441|37741246|FG004|Phase 2 Part|Progressive disease|0|||
16799938|NCT02404441|37741247|FG005|Phase 2 Part|Progressive disease|43|||
16799939|NCT02404441|37741248|FG006|Phase 2 Part|Progressive disease|32|||
16799940|NCT02404441|37741249|FG007|Phase 2 Part|Progressive disease|31|||
16799941|NCT02404441|37741250|FG008|Phase 2 Part|Progressive disease|39|||
16799942|NCT02404441|37741251|FG009|Phase 2 Part|Progressive disease|27|||
16799943|NCT02404441|37741242|FG000|Phase 2 Part|Subject/guardian decision|0|||
16799944|NCT02404441|37741243|FG001|Phase 2 Part|Subject/guardian decision|0|||
16799945|NCT02404441|37741244|FG002|Phase 2 Part|Subject/guardian decision|0|||
16799946|NCT02404441|37741245|FG003|Phase 2 Part|Subject/guardian decision|0|||
16799947|NCT02404441|37741246|FG004|Phase 2 Part|Subject/guardian decision|0|||
16799948|NCT02404441|37741247|FG005|Phase 2 Part|Subject/guardian decision|3|||
16799949|NCT02404441|37741248|FG006|Phase 2 Part|Subject/guardian decision|9|||
16799950|NCT02404441|37741249|FG007|Phase 2 Part|Subject/guardian decision|0|||
16799951|NCT02404441|37741250|FG008|Phase 2 Part|Subject/guardian decision|3|||
16799952|NCT02404441|37741251|FG009|Phase 2 Part|Subject/guardian decision|2|||
16799953|NCT02404441|37741242|FG000|Phase 2 Part|Death|0|||
16799954|NCT02404441|37741243|FG001|Phase 2 Part|Death|0|||
16799955|NCT02404441|37741244|FG002|Phase 2 Part|Death|0|||
16799956|NCT02404441|37741245|FG003|Phase 2 Part|Death|0|||
16799957|NCT02404441|37741246|FG004|Phase 2 Part|Death|0|||
16799958|NCT02404441|37741247|FG005|Phase 2 Part|Death|4|||
16799959|NCT02404441|37741248|FG006|Phase 2 Part|Death|8|||
16799960|NCT02404441|37741249|FG007|Phase 2 Part|Death|4|||
16799961|NCT02404441|37741250|FG008|Phase 2 Part|Death|10|||
16799962|NCT02404441|37741251|FG009|Phase 2 Part|Death|9|||
16799963|NCT02101281|37741297|FG000|Overall Study|Adverse Event|0|||
16799964|NCT02101281|37741298|FG001|Overall Study|Adverse Event|1|||
16799965|NCT02224599|37741310|FG000|Overall Study|Physician Decision|1|||
16799966|NCT02224599|37741310|FG000|Overall Study|Progression of Disease|1|||
16799967|NCT02201901|37741317|FG000|Overall Study|Randomized but never treated|0|||
16799968|NCT02201901|37741318|FG001|Overall Study|Randomized but never treated|1|||
16799969|NCT02201901|37741319|FG002|Overall Study|Randomized but never treated|0|||
16799970|NCT02201901|37741317|FG000|Overall Study|Lack of Efficacy|7|||
16799971|NCT02201901|37741318|FG001|Overall Study|Lack of Efficacy|1|||
16799972|NCT02201901|37741319|FG002|Overall Study|Lack of Efficacy|6|||
16799973|NCT02201901|37741317|FG000|Overall Study|Death|3|||
16799974|NCT02201901|37741318|FG001|Overall Study|Death|3|||
16799975|NCT02201901|37741319|FG002|Overall Study|Death|3|||
16799976|NCT02201901|37741317|FG000|Overall Study|Lost to Follow-up|2|||
16799977|NCT02201901|37741318|FG001|Overall Study|Lost to Follow-up|3|||
16799978|NCT02201901|37741319|FG002|Overall Study|Lost to Follow-up|2|||
16799979|NCT02201901|37741317|FG000|Overall Study|Withdrew Consent|2|||
16799980|NCT02201901|37741318|FG001|Overall Study|Withdrew Consent|0|||
16799981|NCT02201901|37741319|FG002|Overall Study|Withdrew Consent|2|||
16799982|NCT02201901|37741317|FG000|Overall Study|Adverse Event|1|||
16799983|NCT02201901|37741318|FG001|Overall Study|Adverse Event|1|||
16799984|NCT02201901|37741319|FG002|Overall Study|Adverse Event|0|||
16799985|NCT02201277|37741330|FG000|Overall Study|Death|3|||
16799986|NCT02201277|37741331|FG001|Overall Study|Death|4|||
16799987|NCT02201277|37741330|FG000|Overall Study|Lost to Follow-up|2|||
16799988|NCT02201277|37741331|FG001|Overall Study|Lost to Follow-up|1|||
16799989|NCT02201277|37741330|FG000|Overall Study|Failed retrieval|1|||
16799990|NCT02201277|37741331|FG001|Overall Study|Failed retrieval|0|||
16799991|NCT02201277|37741330|FG000|Overall Study|Physician Decision|1|||
16799992|NCT02201277|37741331|FG001|Overall Study|Physician Decision|0|||
16799993|NCT02224053|37741341|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
16799994|NCT02224053|37741341|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
16799995|NCT02224053|37741341|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
16799996|NCT02224053|37741341|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
16799997|NCT02224053|37741341|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
16799998|NCT02457793|37741353|FG000|Overall Study|Reason not specified|0|||
16799999|NCT02457793|37741354|FG001|Overall Study|Reason not specified|0|||
16800000|NCT02457793|37741355|FG002|Overall Study|Reason not specified|0|||
16800001|NCT02457793|37741356|FG003|Overall Study|Reason not specified|1|||
16800002|NCT02457793|37741357|FG004|Overall Study|Reason not specified|1|||
16800003|NCT02457793|37741358|FG005|Overall Study|Reason not specified|1|||
16800004|NCT02457793|37741353|FG000|Overall Study|Withdrawal by Subject|0|||
16800005|NCT02457793|37741354|FG001|Overall Study|Withdrawal by Subject|4|||
16800006|NCT02457793|37741355|FG002|Overall Study|Withdrawal by Subject|2|||
16800007|NCT02457793|37741356|FG003|Overall Study|Withdrawal by Subject|2|||
16800008|NCT02457793|37741357|FG004|Overall Study|Withdrawal by Subject|2|||
16800009|NCT02457793|37741358|FG005|Overall Study|Withdrawal by Subject|2|||
16800010|NCT02457793|37741353|FG000|Overall Study|Adverse Event|0|||
16800011|NCT02457793|37741354|FG001|Overall Study|Adverse Event|0|||
16800012|NCT02457793|37741355|FG002|Overall Study|Adverse Event|0|||
16800013|NCT02457793|37741356|FG003|Overall Study|Adverse Event|1|||
16800014|NCT02457793|37741357|FG004|Overall Study|Adverse Event|0|||
16800015|NCT02457793|37741358|FG005|Overall Study|Adverse Event|0|||
16800016|NCT02457793|37741353|FG000|Overall Study|Physician Decision|1|||
16800017|NCT02457793|37741354|FG001|Overall Study|Physician Decision|0|||
16800018|NCT02457793|37741355|FG002|Overall Study|Physician Decision|1|||
16800019|NCT02457793|37741356|FG003|Overall Study|Physician Decision|1|||
16800020|NCT02457793|37741357|FG004|Overall Study|Physician Decision|1|||
16800021|NCT02457793|37741358|FG005|Overall Study|Physician Decision|3|||
16800022|NCT01650259|37741375|FG000|Overall Study|Improvement|105|||
16800023|NCT01650259|37741376|FG001|Overall Study|Improvement|0|||
16800024|NCT01650259|37741375|FG000|Overall Study|Adverse Event|127|||
16800025|NCT01650259|37741376|FG001|Overall Study|Adverse Event|0|||
16800026|NCT01650259|37741375|FG000|Overall Study|Lack of Efficacy|143|||
16800027|NCT01650259|37741376|FG001|Overall Study|Lack of Efficacy|0|||
16800028|NCT01650259|37741375|FG000|Overall Study|Lost to Follow-up|435|||
16800029|NCT01650259|37741376|FG001|Overall Study|Lost to Follow-up|0|||
16800030|NCT01650259|37741375|FG000|Overall Study|Patients had no visit after entry|70|||
16800031|NCT01650259|37741376|FG001|Overall Study|Patients had no visit after entry|0|||
16800032|NCT01650259|37741375|FG000|Overall Study|CRF not collected|98|||
16800033|NCT01650259|37741376|FG001|Overall Study|CRF not collected|82|||
16800034|NCT01650259|37741375|FG000|Overall Study|Not treated|1|||
16800035|NCT01650259|37741376|FG001|Overall Study|Not treated|7|||
16800036|NCT01650259|37741375|FG000|Overall Study|Other than listed|64|||
16800037|NCT01650259|37741376|FG001|Overall Study|Other than listed|146|||
16800038|NCT02434939|37741382|FG000|Overall Study|Lack of Efficacy|34|||
16800039|NCT02434939|37741383|FG001|Overall Study|Lack of Efficacy|48|||
16800040|NCT02434939|37741382|FG000|Overall Study|Withdrawal by Subject|3|||
16800041|NCT02434939|37741383|FG001|Overall Study|Withdrawal by Subject|0|||
16800042|NCT02434939|37741382|FG000|Overall Study|Adverse Event|0|||
16800043|NCT02434939|37741383|FG001|Overall Study|Adverse Event|1|||
16800044|NCT02434471|37741390|FG000|Overall Study|Physician Decision|9|||
16800045|NCT02457637|37741395|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
16800046|NCT02457325|37741402|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
16800047|NCT02457325|37741403|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
16800048|NCT02434081|37741409|FG000|Overall Study|Death (never started treatment)|2|||
16800049|NCT02434081|37741409|FG000|Overall Study|Death|2|||
16800050|NCT02434081|37741409|FG000|Overall Study|Progression|20|||
16800051|NCT02434081|37741409|FG000|Overall Study|Adverse Event|20|||
16800052|NCT02434081|37741409|FG000|Overall Study|Physician Decision|2|||
16800053|NCT02434081|37741409|FG000|Overall Study|Withdrawal by Subject|1|||
16800054|NCT02434081|37741409|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
16800055|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
16800056|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
16800057|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
16800058|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
16800059|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
16800060|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
16800061|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
16800062|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
16800063|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
16800064|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
16800065|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
16800066|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
16800067|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
16800068|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
16800069|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
16800070|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
16800071|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
16800072|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
16800073|NCT02222493|37741415|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
16800074|NCT02222493|37741416|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
16800075|NCT02222493|37741415|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
16800076|NCT02222493|37741416|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
16800077|NCT02222493|37741415|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
16800078|NCT02222493|37741416|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
16800079|NCT02222493|37741415|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
16800080|NCT02222493|37741416|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
16800081|NCT02222493|37741415|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
16800082|NCT02222493|37741416|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
16800083|NCT02222493|37741415|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
16800084|NCT02222493|37741416|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
16800085|NCT02222493|37741415|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
16800086|NCT02222493|37741416|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
16800087|NCT02222493|37741415|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
16800088|NCT02222493|37741416|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
16800089|NCT02222493|37741415|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
16800090|NCT02222493|37741416|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
16800091|NCT02222493|37741415|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
16800092|NCT02222493|37741416|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
16800093|NCT02222493|37741415|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
16800094|NCT02222493|37741416|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
16800095|NCT02222493|37741415|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
16800096|NCT02222493|37741416|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
16800097|NCT02222493|37741415|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
16800098|NCT02222493|37741416|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
16800099|NCT02433379|37741435|FG000|Overall Study|Screen Failures|55|||
16800100|NCT02433379|37741435|FG000|Overall Study|Death|57|||
16800101|NCT02433379|37741435|FG000|Overall Study|Total Withdrawals|209|||
16800102|NCT02199795|37741443|FG000|Overall Study|no longer met inclusion criteria|1|||
16800103|NCT02199795|37741444|FG001|Overall Study|no longer met inclusion criteria|0|||
16800104|NCT02199795|37741443|FG000|Overall Study|withdrew due to shoulder pain|1|||
16800105|NCT02199795|37741444|FG001|Overall Study|withdrew due to shoulder pain|0|||
16800106|NCT02403817|37741452|FG000|Overall Study|Withdrawal by Subject|5|||
16800107|NCT02403817|37741453|FG001|Overall Study|Withdrawal by Subject|0|||
16800108|NCT02403271|37741459|FG000|Period 1|Other varied reasons|1|||
16800109|NCT02403271|37741460|FG001|Period 1|Other varied reasons|0|||
16800110|NCT02403271|37741459|FG000|Period 2|Withdrawal by Subject|0|||
16800111|NCT02403271|37741460|FG001|Period 2|Withdrawal by Subject|14|||
16800112|NCT02403271|37741459|FG000|Period 2|Death|0|||
16800113|NCT02403271|37741460|FG001|Period 2|Death|84|||
16800114|NCT02403271|37741459|FG000|Period 2|Lost to Follow-up|0|||
16800115|NCT02403271|37741460|FG001|Period 2|Lost to Follow-up|2|||
16800116|NCT02403271|37741459|FG000|Period 2|Study Terminated by Sponsor|0|||
16800117|NCT02403271|37741460|FG001|Period 2|Study Terminated by Sponsor|14|||
16800118|NCT02403271|37741459|FG000|Period 2|Other varied reasons|0|||
16800119|NCT02403271|37741460|FG001|Period 2|Other varied reasons|10|||
16800120|NCT02219685|37741468|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
16800121|NCT02219685|37741469|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
16800122|NCT02219685|37741468|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
16800123|NCT02219685|37741469|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
16800124|NCT02457247|37741481|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
16800125|NCT02457247|37741482|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
16800126|NCT02457247|37741483|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
16800127|NCT02457247|37741484|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
16800128|NCT02457247|37741481|FG000|Period 1|Significant Protocol Deviation|1|||
16800129|NCT02457247|37741482|FG001|Period 1|Significant Protocol Deviation|1|||
16800130|NCT02457247|37741483|FG002|Period 1|Significant Protocol Deviation|0|||
16800131|NCT02457247|37741484|FG003|Period 1|Significant Protocol Deviation|0|||
16800132|NCT02457247|37741481|FG000|Period 1|Voluntary Withdrawal|1|||
16800133|NCT02457247|37741482|FG001|Period 1|Voluntary Withdrawal|0|||
16800134|NCT02457247|37741483|FG002|Period 1|Voluntary Withdrawal|0|||
16800135|NCT02457247|37741484|FG003|Period 1|Voluntary Withdrawal|0|||
16800136|NCT02457247|37741481|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
16800137|NCT02457247|37741482|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
16800138|NCT02457247|37741483|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
16800139|NCT02457247|37741484|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
16800140|NCT02457247|37741481|FG000|Period 2|Significant Protocol Deviation|1|||
16800141|NCT02457247|37741482|FG001|Period 2|Significant Protocol Deviation|0|||
16800142|NCT02457247|37741483|FG002|Period 2|Significant Protocol Deviation|0|||
16800143|NCT02457247|37741484|FG003|Period 2|Significant Protocol Deviation|0|||
16800144|NCT02457247|37741481|FG000|Period 2|Lost to Follow-up|0|||
16800145|NCT02457247|37741482|FG001|Period 2|Lost to Follow-up|1|||
16800146|NCT02457247|37741483|FG002|Period 2|Lost to Follow-up|0|||
16800147|NCT02457247|37741484|FG003|Period 2|Lost to Follow-up|0|||
16800148|NCT02457247|37741481|FG000|Period 2|Voluntary Withdrawal|1|||
16800149|NCT02457247|37741482|FG001|Period 2|Voluntary Withdrawal|1|||
16800150|NCT02457247|37741483|FG002|Period 2|Voluntary Withdrawal|0|||
16800151|NCT02457247|37741484|FG003|Period 2|Voluntary Withdrawal|0|||
16800152|NCT02401867|37741500|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
16800153|NCT02401867|37741500|FG000|Analysis|Cervical assay could not be conducted|9|||
16800154|NCT02198235|37741508|FG000|Overall Study|Lost to Follow-up|3|||
16800155|NCT02198235|37741509|FG001|Overall Study|Lost to Follow-up|2|||
16800156|NCT02198235|37741510|FG002|Overall Study|Lost to Follow-up|2|||
16800157|NCT02253147|37741518|FG000|Overall Study|Protocol Violation|30|||
16800158|NCT02253147|37741518|FG000|Overall Study|Did not consent to study extension|9|||
16800159|NCT02253147|37741518|FG000|Overall Study|Conditional re-treatment at W52|5|||
16800160|NCT02253147|37741518|FG000|Overall Study|Lost to Follow-up|2|||
16800161|NCT02253147|37741518|FG000|Overall Study|Withdrawal by Subject|1|||
16800162|NCT02217501|37741526|FG000|Overall Study|Death|3|||
16800163|NCT02217501|37741527|FG001|Overall Study|Death|4|||
16800164|NCT01649869|37741535|FG000|Overall Study|Family member illness|1|||
16800165|NCT01649869|37741536|FG001|Overall Study|Family member illness|0|||
16800166|NCT01649869|37741535|FG000|Overall Study|Required treatment outside protocol|1|||
16800167|NCT01649869|37741536|FG001|Overall Study|Required treatment outside protocol|0|||
16800168|NCT01649869|37741535|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
16800169|NCT01649869|37741536|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
16800170|NCT02197377|37741546|FG000|Overall Study|Insertion Failure|0|||
16800171|NCT02197377|37741547|FG001|Overall Study|Insertion Failure|3|||
16800172|NCT02400307|37741555|FG000|Overall Study|Enrolled and Never Dosed|1|||
16800173|NCT02400307|37741556|FG001|Overall Study|Enrolled and Never Dosed|0|||
16800174|NCT02196675|37741565|FG000|Overall Study|Withdrawal by Subject|1|||
16800175|NCT02196675|37741566|FG001|Overall Study|Withdrawal by Subject|0|||
16800176|NCT02196675|37741567|FG002|Overall Study|Withdrawal by Subject|0|||
16800177|NCT02196675|37741565|FG000|Overall Study|Intra-operative surgical exclusion|1|||
16800178|NCT02196675|37741566|FG001|Overall Study|Intra-operative surgical exclusion|1|||
16800179|NCT02196675|37741567|FG002|Overall Study|Intra-operative surgical exclusion|0|||
16800180|NCT02196675|37741565|FG000|Overall Study|Protocol Violation|0|||
16800181|NCT02196675|37741566|FG001|Overall Study|Protocol Violation|1|||
16800182|NCT02196675|37741567|FG002|Overall Study|Protocol Violation|0|||
16800183|NCT02196675|37741565|FG000|Overall Study|Death|0|||
16800184|NCT02196675|37741566|FG001|Overall Study|Death|0|||
16800185|NCT02196675|37741567|FG002|Overall Study|Death|1|||
16800186|NCT02399449|37741577|FG000|Overall Study|Withdrawal by Subject|3|||
16800187|NCT02399449|37741578|FG001|Overall Study|Withdrawal by Subject|9|||
16800188|NCT02399449|37741577|FG000|Overall Study|Physician Decision|0|||
16800189|NCT02399449|37741578|FG001|Overall Study|Physician Decision|1|||
16800190|NCT02217345|37741586|FG000|Overall Study|Lost to Follow-up|2|||
16800191|NCT02217345|37741587|FG001|Overall Study|Lost to Follow-up|1|||
16800192|NCT02217345|37741586|FG000|Overall Study|Withdrawal by Subject|3|||
16800193|NCT02217345|37741587|FG001|Overall Study|Withdrawal by Subject|2|||
16800194|NCT02217345|37741586|FG000|Overall Study|Adverse Event|2|||
16800195|NCT02217345|37741587|FG001|Overall Study|Adverse Event|1|||
16800196|NCT02217345|37741586|FG000|Overall Study|Physician Decision|0|||
16800197|NCT02217345|37741587|FG001|Overall Study|Physician Decision|1|||
16800198|NCT01652287|37741595|FG000|Overall Study|Withdrawal by Subject|2|||
16800199|NCT01652287|37741596|FG001|Overall Study|Withdrawal by Subject|0|||
16800200|NCT02251743|37741604|FG000|Overall Study|Withdrawal by Subject|1|||
16800201|NCT02251743|37741605|FG001|Overall Study|Withdrawal by Subject|1|||
16800202|NCT02453191|37741611|FG000|Overall Study|Withdrawal by Subject|1|||
16800203|NCT02428855|37741615|FG000|Overall Study|Withdrawal by Subject|2|||
16800204|NCT02428699|37741619|FG000|Washout Period 1|Screen Failure|1|||
16800205|NCT02428699|37741620|FG001|Washout Period 1|Screen Failure|2|||
16800206|NCT02428231|37741633|FG000|Overall Study|Other|10|||
16800207|NCT02428231|37741634|FG001|Overall Study|Other|16|||
16800208|NCT02428231|37741633|FG000|Overall Study|Required Symptomatic Therapy|0|||
16800209|NCT02428231|37741634|FG001|Overall Study|Required Symptomatic Therapy|1|||
16800210|NCT02428231|37741633|FG000|Overall Study|Adverse Event|3|||
16800211|NCT02428231|37741634|FG001|Overall Study|Adverse Event|0|||
16800212|NCT02427841|37741640|FG000|Overall Study|Physician Decision|8|||
16800213|NCT02397889|37741646|FG000|Overall Study|Physician Decision|1|||
16800214|NCT02397889|37741647|FG001|Overall Study|Physician Decision|0|||
16800215|NCT02397655|37741653|FG000|Overall Study|data not completed|1301|||
16800216|NCT02396953|37741660|FG000|Overall Study|Withdrawal by Subject|0|||
16800217|NCT02396953|37741661|FG001|Overall Study|Withdrawal by Subject|0|||
16800218|NCT02396953|37741662|FG002|Overall Study|Withdrawal by Subject|1|||
16800219|NCT02396953|37741660|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
16800220|NCT02396953|37741661|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
16800221|NCT02396953|37741662|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
16800222|NCT02396953|37741660|FG000|Overall Study|Personal Reasons|1|||
16800223|NCT02396953|37741661|FG001|Overall Study|Personal Reasons|1|||
16800224|NCT02396953|37741662|FG002|Overall Study|Personal Reasons|0|||
16800225|NCT02387983|37741677|FG000|Overall Study|Adverse Event|4|||
16800226|NCT02387983|37741677|FG000|Overall Study|Protocol Violation|1|||
16800227|NCT02387983|37741677|FG000|Overall Study|Withdrawal by Subject|2|||
16800228|NCT02395627|37741684|FG000|Overall Study|Withdrawal by Subject|0|||
16800229|NCT02395627|37741685|FG001|Overall Study|Withdrawal by Subject|2|||
16800230|NCT02395627|37741686|FG002|Overall Study|Withdrawal by Subject|0|||
16800231|NCT02395627|37741684|FG000|Overall Study|Did not receive pembrolizumab|3|||
16800232|NCT02395627|37741685|FG001|Overall Study|Did not receive pembrolizumab|1|||
16800233|NCT02395627|37741686|FG002|Overall Study|Did not receive pembrolizumab|0|||
16800234|NCT02395471|37741698|FG000|Overall Study|Lost to Follow-up|2|||
16800235|NCT02395471|37741699|FG001|Overall Study|Lost to Follow-up|0|||
16800236|NCT02395471|37741698|FG000|Overall Study|Withdrawal by Subject|2|||
16800237|NCT02395471|37741699|FG001|Overall Study|Withdrawal by Subject|1|||
16800238|NCT02395471|37741698|FG000|Overall Study|Physician Decision|1|||
16800239|NCT02395471|37741699|FG001|Overall Study|Physician Decision|0|||
16800240|NCT02395471|37741698|FG000|Overall Study|Protocol Violation|0|||
16800241|NCT02395471|37741699|FG001|Overall Study|Protocol Violation|1|||
16800242|NCT02395471|37741698|FG000|Overall Study|Failure to swollow sponge twice|1|||
16800243|NCT02395471|37741699|FG001|Overall Study|Failure to swollow sponge twice|0|||
16800244|NCT02395471|37741698|FG000|Overall Study|Patient did not return for procedure|0|||
16800245|NCT02395471|37741699|FG001|Overall Study|Patient did not return for procedure|1|||
16800246|NCT02395471|37741698|FG000|Overall Study|Subject not eligible|1|||
16800247|NCT02395471|37741699|FG001|Overall Study|Subject not eligible|0|||
16800248|NCT02395081|37741717|FG000|Overall Study|Withdrawal by Subject|1|||
16800249|NCT02395081|37741718|FG001|Overall Study|Withdrawal by Subject|1|||
16800250|NCT02395081|37741719|FG002|Overall Study|Withdrawal by Subject|0|||
16800251|NCT02395081|37741717|FG000|Overall Study|Moved where blood couldn't be collected|4|||
16800252|NCT02395081|37741718|FG001|Overall Study|Moved where blood couldn't be collected|1|||
16800253|NCT02395081|37741719|FG002|Overall Study|Moved where blood couldn't be collected|3|||
16800254|NCT02395081|37741717|FG000|Overall Study|Fetal Loss|2|||
16800255|NCT02395081|37741718|FG001|Overall Study|Fetal Loss|3|||
16800256|NCT02395081|37741719|FG002|Overall Study|Fetal Loss|1|||
16800257|NCT02394925|37741730|FG000|Overall Study|Adverse Event|1|||
16800258|NCT02394925|37741730|FG000|Overall Study|Lens Discomfort|3|||
16800259|NCT02394925|37741730|FG000|Overall Study|Lens handling difficulities|5|||
16800260|NCT02394925|37741730|FG000|Overall Study|Lost to Follow-up|9|||
16800261|NCT02394925|37741730|FG000|Overall Study|Protocol Violation|5|||
16800262|NCT02394925|37741730|FG000|Overall Study|No longer meet eligibility criteria|1|||
16800263|NCT02394925|37741730|FG000|Overall Study|Unsatisfactory Visual Response|5|||
16800264|NCT02427607|37741734|FG000|Overall Study|Withdrawal by Subject|1|||
16800265|NCT02426125|37741740|FG000|Overall Study|Lost to Follow-up|12|||
16800266|NCT02426125|37741741|FG001|Overall Study|Lost to Follow-up|10|||
16800267|NCT02426125|37741740|FG000|Overall Study|Protocol Violation|1|||
16800268|NCT02426125|37741741|FG001|Overall Study|Protocol Violation|0|||
16800269|NCT02426125|37741740|FG000|Overall Study|Withdrawal by Subject|16|||
16800270|NCT02426125|37741741|FG001|Overall Study|Withdrawal by Subject|16|||
16800271|NCT02425111|37741749|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
16800272|NCT02425111|37741749|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
16800273|NCT02425111|37741749|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
16800274|NCT02425111|37741749|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
16800275|NCT02425111|37741749|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
16800276|NCT02425111|37741749|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
16800277|NCT02424565|37741754|FG000|Period 1 (D0)|Protocol Violation|0|||
16800278|NCT02424565|37741755|FG001|Period 1 (D0)|Protocol Violation|1|||
16800279|NCT02424253|37741763|FG000|Overall Study|Other, unspecified|1|||
16800280|NCT02424253|37741764|FG001|Overall Study|Other, unspecified|0|||
16800281|NCT02424253|37741763|FG000|Overall Study|Compliance problems|1|||
16800282|NCT02424253|37741764|FG001|Overall Study|Compliance problems|0|||
16800283|NCT02424253|37741763|FG000|Overall Study|Physician Decision|2|||
16800284|NCT02424253|37741764|FG001|Overall Study|Physician Decision|0|||
16800285|NCT02424253|37741763|FG000|Overall Study|Lack of Efficacy|0|||
16800286|NCT02424253|37741764|FG001|Overall Study|Lack of Efficacy|7|||
16800287|NCT02424253|37741763|FG000|Overall Study|Adverse Event|2|||
16800288|NCT02424253|37741764|FG001|Overall Study|Adverse Event|0|||
16800289|NCT02424253|37741763|FG000|Overall Study|Consent withdrawn by subject|4|||
16800290|NCT02424253|37741764|FG001|Overall Study|Consent withdrawn by subject|1|||
16800291|NCT02424253|37741763|FG000|Overall Study|Lost to Follow-up|1|||
16800292|NCT02424253|37741764|FG001|Overall Study|Lost to Follow-up|1|||
16800293|NCT02393755|37741772|FG000|Overall Study|Withdrawal by Subject|0|||
16800294|NCT02393755|37741773|FG001|Overall Study|Withdrawal by Subject|3|||
16800295|NCT02393755|37741772|FG000|Overall Study|Adverse Event|0|||
16800296|NCT02393755|37741773|FG001|Overall Study|Adverse Event|2|||
16800297|NCT02393755|37741772|FG000|Overall Study|Physician Decision|0|||
16800298|NCT02393755|37741773|FG001|Overall Study|Physician Decision|2|||
16800299|NCT02393209|37741780|FG000|Overall Study|Study Terminated by Sponsor|1|||
16800300|NCT02393209|37741781|FG001|Overall Study|Study Terminated by Sponsor|1|||
16800301|NCT02393209|37741782|FG002|Overall Study|Study Terminated by Sponsor|0|||
16800302|NCT02393209|37741783|FG003|Overall Study|Study Terminated by Sponsor|0|||
16800303|NCT02393209|37741780|FG000|Overall Study|Withdrawal by Patient|1|||
16800304|NCT02393209|37741781|FG001|Overall Study|Withdrawal by Patient|0|||
16800305|NCT02393209|37741782|FG002|Overall Study|Withdrawal by Patient|0|||
16800306|NCT02393209|37741783|FG003|Overall Study|Withdrawal by Patient|0|||
16800307|NCT02393209|37741780|FG000|Overall Study|Death|2|||
16800308|NCT02393209|37741781|FG001|Overall Study|Death|2|||
16800309|NCT02393209|37741782|FG002|Overall Study|Death|0|||
16800310|NCT02393209|37741783|FG003|Overall Study|Death|0|||
16800311|NCT02393209|37741780|FG000|Overall Study|Death due to Disease Progression|2|||
16800312|NCT02393209|37741781|FG001|Overall Study|Death due to Disease Progression|2|||
16800313|NCT02393209|37741782|FG002|Overall Study|Death due to Disease Progression|0|||
16800314|NCT02393209|37741783|FG003|Overall Study|Death due to Disease Progression|0|||
16800315|NCT02393209|37741780|FG000|Overall Study|Death from Legionella Infection|0|||
16800316|NCT02393209|37741781|FG001|Overall Study|Death from Legionella Infection|1|||
16800317|NCT02393209|37741782|FG002|Overall Study|Death from Legionella Infection|0|||
16800318|NCT02393209|37741783|FG003|Overall Study|Death from Legionella Infection|0|||
16800319|NCT02393209|37741780|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
16800320|NCT02393209|37741781|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
16800321|NCT02393209|37741782|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
16800322|NCT02393209|37741783|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
16800323|NCT02393209|37741780|FG000|Overall Study|Lost to Follow-up|0|||
16800324|NCT02393209|37741781|FG001|Overall Study|Lost to Follow-up|1|||
16800325|NCT02393209|37741782|FG002|Overall Study|Lost to Follow-up|0|||
16800326|NCT02393209|37741783|FG003|Overall Study|Lost to Follow-up|0|||
16800327|NCT02424097|37741794|FG000|Overall Study|Lost to Follow-up|1|||
16800328|NCT02424097|37741795|FG001|Overall Study|Lost to Follow-up|2|||
16800329|NCT02392507|37741801|FG000|Induction Regimen|Death|3|||
17016531|NCT00691210|38161157|FG004|Overall Study|Progression of Disease|0|||
17102302|NCT00091572|38241204|FG001|Overall Study|Ongoing (still on treatment)|12|||
16800330|NCT02392507|37741801|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
16800331|NCT02392507|37741801|FG000|Induction Regimen|Physician Decision|1|||
16800332|NCT02392507|37741801|FG000|Induction Regimen|Withdrawal by Subject|2|||
16800333|NCT02392507|37741801|FG000|Maintenance Regimen|Death|1|||
16800334|NCT02392507|37741801|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
16800335|NCT02386345|37741810|FG000|Overall Study|Not treated|14|||
16800336|NCT02386345|37741810|FG000|Overall Study|Lost to Follow-up|1|||
16800337|NCT02386345|37741810|FG000|Overall Study|Adverse Event|5|||
16800338|NCT02386345|37741810|FG000|Overall Study|Repeat Procedure|10|||
16800339|NCT02386345|37741810|FG000|Overall Study|Did not complete 12-month follow-up|72|||
16800340|NCT01651117|37741818|FG000|Overall Study|Death|2|||
16800341|NCT01651117|37741819|FG001|Overall Study|Death|3|||
16800342|NCT01651117|37741820|FG002|Overall Study|Death|2|||
16800343|NCT01651117|37741821|FG003|Overall Study|Death|2|||
16800344|NCT02386189|37741836|FG000|Overall Study|Lost to Follow-up|2|||
16800345|NCT02386189|37741837|FG001|Overall Study|Lost to Follow-up|3|||
16800346|NCT02386189|37741836|FG000|Overall Study|Withdrawal by Subject|1|||
16800347|NCT02386189|37741837|FG001|Overall Study|Withdrawal by Subject|0|||
16800348|NCT02386189|37741836|FG000|Overall Study|Death|1|||
16800349|NCT02386189|37741837|FG001|Overall Study|Death|0|||
16800350|NCT02385799|37741845|FG000|Overall Study|Lost to Follow-up|1|||
16800351|NCT02385799|37741846|FG001|Overall Study|Lost to Follow-up|2|||
16800352|NCT02385799|37741845|FG000|Overall Study|Adverse Event|4|||
16800353|NCT02385799|37741846|FG001|Overall Study|Adverse Event|2|||
16800354|NCT02385799|37741845|FG000|Overall Study|Withdrawal by Subject|0|||
16800355|NCT02385799|37741846|FG001|Overall Study|Withdrawal by Subject|4|||
16800356|NCT02422303|37741854|FG000|Overall Study|Lost to Follow-up|1|||
16800357|NCT02422303|37741855|FG001|Overall Study|Lost to Follow-up|1|||
16800358|NCT02392195|37741861|FG000|Overall Study|Lost to Follow-up|4|||
16800359|NCT02392195|37741861|FG000|Overall Study|Withdrawal by Subject|4|||
16800360|NCT02391961|37741867|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
16800361|NCT02391961|37741868|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
16800362|NCT02391961|37741867|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
16800363|NCT02391961|37741868|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
16800364|NCT02391961|37741867|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16800365|NCT02391961|37741868|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16800366|NCT02384941|37741877|FG000|Overall Study|Adverse Event|11|||
16800367|NCT02384941|37741878|FG001|Overall Study|Adverse Event|13|||
16800368|NCT02384941|37741879|FG002|Overall Study|Adverse Event|17|||
16800369|NCT02384941|37741877|FG000|Overall Study|Lost to Follow-up|3|||
16800370|NCT02384941|37741878|FG001|Overall Study|Lost to Follow-up|2|||
16800371|NCT02384941|37741879|FG002|Overall Study|Lost to Follow-up|1|||
16800372|NCT02384941|37741877|FG000|Overall Study|Non-Compliance With Study Drug|2|||
16800373|NCT02384941|37741878|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16800374|NCT02384941|37741879|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16800375|NCT02384941|37741877|FG000|Overall Study|Physician Decision|1|||
16800376|NCT02384941|37741878|FG001|Overall Study|Physician Decision|1|||
16800377|NCT02384941|37741879|FG002|Overall Study|Physician Decision|0|||
16800378|NCT02384941|37741877|FG000|Overall Study|Protocol Violation|3|||
16800379|NCT02384941|37741878|FG001|Overall Study|Protocol Violation|0|||
16800380|NCT02384941|37741879|FG002|Overall Study|Protocol Violation|0|||
16800381|NCT02384941|37741877|FG000|Overall Study|Withdrawal by Subject|26|||
16800382|NCT02384941|37741878|FG001|Overall Study|Withdrawal by Subject|19|||
16800383|NCT02384941|37741879|FG002|Overall Study|Withdrawal by Subject|20|||
16800384|NCT02384941|37741877|FG000|Overall Study|Pregnancy|0|||
16800385|NCT02384941|37741878|FG001|Overall Study|Pregnancy|0|||
16800386|NCT02384941|37741879|FG002|Overall Study|Pregnancy|1|||
16800387|NCT02384941|37741877|FG000|Overall Study|Other than specified above|4|||
16800388|NCT02384941|37741878|FG001|Overall Study|Other than specified above|0|||
16800389|NCT02384941|37741879|FG002|Overall Study|Other than specified above|1|||
16800390|NCT02384395|37741888|FG000|Overall Study|Physician Decision|4|||
16800391|NCT02384395|37741888|FG000|Overall Study|Withdrawal by Subject|3|||
16800392|NCT02384395|37741888|FG000|Overall Study|Lost to Follow-up|3|||
16800393|NCT02420353|37741894|FG000|Overall Study|Withdrawal by Subject|0|||
16800394|NCT02420353|37741895|FG001|Overall Study|Withdrawal by Subject|1|||
16800395|NCT02391337|37741903|FG000|6 Months Follow-up|Death|5|||
16800396|NCT02391337|37741904|FG001|6 Months Follow-up|Death|4|||
16800397|NCT02391337|37741903|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
16800398|NCT02391337|37741904|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
16800399|NCT02391337|37741903|FG000|12 Months Follow-up|Death|2|||
16800400|NCT02391337|37741904|FG001|12 Months Follow-up|Death|0|||
16800401|NCT02391337|37741903|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
16800402|NCT02391337|37741904|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
16800403|NCT02391337|37741903|FG000|12 Months Follow-up|Lost to Follow-up|0|||
16800404|NCT02391337|37741904|FG001|12 Months Follow-up|Lost to Follow-up|2|||
16800405|NCT02382991|37741912|FG000|Overall Study|Adverse Event|1|||
16800406|NCT02382991|37741913|FG001|Overall Study|Adverse Event|2|||
16800407|NCT02382991|37741912|FG000|Overall Study|Lost to Follow-up|1|||
16800408|NCT02382991|37741913|FG001|Overall Study|Lost to Follow-up|0|||
16800409|NCT02382991|37741912|FG000|Overall Study|Withdrawal by Subject|0|||
16800410|NCT02382991|37741913|FG001|Overall Study|Withdrawal by Subject|1|||
16800411|NCT02390557|37741921|FG000|Wave 2|Survey non-respondent|72|||
16800412|NCT02390557|37741922|FG001|Wave 2|Survey non-respondent|41|||
16800413|NCT02390557|37741923|FG002|Wave 2|Survey non-respondent|23|||
16800414|NCT01649791|37741931|FG000|Overall Study|Disease Progression|2|||
16800415|NCT01649791|37741931|FG000|Overall Study|Adverse Event|1|||
16800416|NCT01649557|37741938|FG000|Overall Study|Lost to Follow-up|5|||
16800417|NCT01649557|37741939|FG001|Overall Study|Lost to Follow-up|0|||
16800418|NCT01649557|37741940|FG002|Overall Study|Lost to Follow-up|3|||
16800419|NCT01649557|37741938|FG000|Overall Study|Adverse Event|7|||
16800420|NCT01649557|37741939|FG001|Overall Study|Adverse Event|5|||
16800421|NCT01649557|37741940|FG002|Overall Study|Adverse Event|1|||
16800422|NCT01649557|37741938|FG000|Overall Study|Met withdrawal criteria|4|||
16800423|NCT01649557|37741939|FG001|Overall Study|Met withdrawal criteria|0|||
16800424|NCT01649557|37741940|FG002|Overall Study|Met withdrawal criteria|0|||
16800425|NCT01649557|37741938|FG000|Overall Study|Physician Decision|8|||
16800426|NCT01649557|37741939|FG001|Overall Study|Physician Decision|2|||
16800427|NCT01649557|37741940|FG002|Overall Study|Physician Decision|1|||
16800428|NCT01649557|37741938|FG000|Overall Study|Withdrawal by Subject|15|||
16800429|NCT01649557|37741939|FG001|Overall Study|Withdrawal by Subject|5|||
16800430|NCT01649557|37741940|FG002|Overall Study|Withdrawal by Subject|4|||
16800431|NCT01649557|37741938|FG000|Overall Study|Protocol deviation|0|||
16800432|NCT01649557|37741939|FG001|Overall Study|Protocol deviation|2|||
16800433|NCT01649557|37741940|FG002|Overall Study|Protocol deviation|0|||
16800434|NCT01649557|37741938|FG000|Overall Study|Lack of Efficacy|5|||
16800435|NCT01649557|37741939|FG001|Overall Study|Lack of Efficacy|0|||
16800436|NCT01649557|37741940|FG002|Overall Study|Lack of Efficacy|0|||
16800437|NCT02390245|37741948|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
16800438|NCT02390245|37741949|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
16800439|NCT02390245|37741950|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
16909407|NCT01748760|38018262|FG001|Overall Study|Withdrawal by Subject|1|||
16909408|NCT01748760|38018261|FG000|Overall Study|Lost to Follow-up|5|||
16909409|NCT01748760|38018262|FG001|Overall Study|Lost to Follow-up|1|||
16909410|NCT01748292|38018270|FG000|Overall Study|Adverse Event|2|||
16909411|NCT01748292|38018271|FG001|Overall Study|Adverse Event|4|||
16909412|NCT01748292|38018270|FG000|Overall Study|Lost to Follow-up|0|||
16909413|NCT01748292|38018271|FG001|Overall Study|Lost to Follow-up|3|||
16909414|NCT01748292|38018270|FG000|Overall Study|Death|0|||
16909415|NCT01748292|38018271|FG001|Overall Study|Death|3|||
16909416|NCT01748292|38018270|FG000|Overall Study|Withdrawal by Subject|0|||
16909417|NCT01748292|38018271|FG001|Overall Study|Withdrawal by Subject|2|||
16909418|NCT01720602|38018277|FG000|Overall Study|Adverse Event|3|||
16909419|NCT01720602|38018277|FG000|Overall Study|Progressive disease on therapy|2|||
16909420|NCT01746732|38018281|FG000|Lead-In Period|Withdrawal by Subject|1|||
16909421|NCT01746732|38018282|FG001|Lead-In Period|Withdrawal by Subject|0|||
16909422|NCT01746732|38018283|FG002|Lead-In Period|Withdrawal by Subject|0|||
16909423|NCT01746732|38018281|FG000|Period 1|Physician Decision|0|||
16909424|NCT01746732|38018282|FG001|Period 1|Physician Decision|1|||
16909425|NCT01746732|38018283|FG002|Period 1|Physician Decision|0|||
16909426|NCT01746732|38018281|FG000|Period 2|Withdrawal by Subject|0|||
16909427|NCT01746732|38018282|FG001|Period 2|Withdrawal by Subject|0|||
16909428|NCT01746732|38018283|FG002|Period 2|Withdrawal by Subject|2|||
16909429|NCT01746732|38018281|FG000|Period 2|Adverse Event|0|||
16909430|NCT01746732|38018282|FG001|Period 2|Adverse Event|0|||
16909431|NCT01746732|38018283|FG002|Period 2|Adverse Event|1|||
16909432|NCT01746732|38018281|FG000|Period 2|Lost to Follow-up|0|||
16909433|NCT01746732|38018282|FG001|Period 2|Lost to Follow-up|0|||
16909434|NCT01746732|38018283|FG002|Period 2|Lost to Follow-up|1|||
16909435|NCT01720524|38018293|FG000|Part A|Insufficient Clinical Response|2|||
16909436|NCT01720524|38018294|FG001|Part A|Insufficient Clinical Response|4|||
16909437|NCT01720524|38018293|FG000|Part A|Adverse Event|2|||
16909438|NCT01720524|38018294|FG001|Part A|Adverse Event|2|||
16909439|NCT01720524|38018293|FG000|Part A|Death|2|||
16909440|NCT01720524|38018294|FG001|Part A|Death|1|||
16909441|NCT01720524|38018293|FG000|Part A|Lost to Follow-up|0|||
16909442|NCT01720524|38018294|FG001|Part A|Lost to Follow-up|1|||
16909443|NCT01720524|38018293|FG000|Part A|Missed 28 day follow-up visit|1|||
16909444|NCT01720524|38018294|FG001|Part A|Missed 28 day follow-up visit|1|||
16909445|NCT01720524|38018293|FG000|Part A|Withdrawal by Subject|0|||
16909446|NCT01720524|38018294|FG001|Part A|Withdrawal by Subject|1|||
16909447|NCT01720524|38018293|FG000|Part A|Other|0|||
16909448|NCT01720524|38018294|FG001|Part A|Other|1|||
16909449|NCT01720524|38018293|FG000|Part A|Lost to Follow-up|0|||
16909450|NCT01720524|38018294|FG001|Part A|Lost to Follow-up|1|||
16909451|NCT01720524|38018293|FG000|Part B|No longer willing to participate in study|1|||
16909452|NCT01720524|38018294|FG001|Part B|No longer willing to participate in study|4|||
16909453|NCT01720524|38018293|FG000|Part B|Other|2|||
16909454|NCT01720524|38018294|FG001|Part B|Other|0|||
16800440|NCT02390245|37741948|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
16800441|NCT02390245|37741949|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
16800442|NCT02390245|37741950|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
16800443|NCT02390167|37741959|FG000|Overall Study|Lost to Follow-up|1|||
16909455|NCT01720524|38018293|FG000|Part B|Lost to Follow-up|2|||
16909456|NCT01720524|38018294|FG001|Part B|Lost to Follow-up|3|||
16909457|NCT01720524|38018293|FG000|Part B|Death|0|||
16800444|NCT02347657|37741969|FG000|Overall Study|Physician Decision|0|||
16800445|NCT02347657|37741970|FG001|Overall Study|Physician Decision|1|||
16800446|NCT02347657|37741969|FG000|Overall Study|Adverse Event|8|||
16800447|NCT02347657|37741970|FG001|Overall Study|Adverse Event|4|||
16800448|NCT02347657|37741969|FG000|Overall Study|Withdrawal by Subject|6|||
16800449|NCT02347657|37741970|FG001|Overall Study|Withdrawal by Subject|7|||
16800450|NCT02347657|37741969|FG000|Overall Study|Randomized but not treated|1|||
16800451|NCT02347657|37741970|FG001|Overall Study|Randomized but not treated|0|||
16800452|NCT02347657|37741969|FG000|Overall Study|Other|3|||
16800453|NCT02347657|37741970|FG001|Overall Study|Other|3|||
16800454|NCT02347189|37741977|FG000|Overall Study|No implant attempted of study device|9|||
16800455|NCT02347189|37741977|FG000|Overall Study|No primary outcome data available|2|||
16800456|NCT02382133|37741992|FG000|Overall Study|Death|22|||
16800457|NCT02382133|37741992|FG000|Overall Study|transfer out of ICU|4|||
16800458|NCT02382133|37741992|FG000|Overall Study|Physician Decision|2|||
16800459|NCT02382133|37741992|FG000|Overall Study|arterial catheter loss|4|||
16800460|NCT02382133|37741992|FG000|Overall Study|pressure injury both sites|1|||
16800461|NCT02346877|37741998|FG000|Overall Study|Adverse Event|1|||
16800462|NCT02346877|37741999|FG001|Overall Study|Adverse Event|0|||
16800463|NCT02346877|37741998|FG000|Overall Study|Administrative Decision|1|||
16800464|NCT02346877|37741999|FG001|Overall Study|Administrative Decision|0|||
16800465|NCT02346877|37741998|FG000|Overall Study|Sponsor Decision|12|||
16800466|NCT02346877|37741999|FG001|Overall Study|Sponsor Decision|0|||
16800467|NCT02346877|37741998|FG000|Overall Study|Missing|5|||
16800468|NCT02346877|37741999|FG001|Overall Study|Missing|0|||
16800469|NCT02346721|37742005|FG000|Overall Study|Withdrew Consent|3|||
16800470|NCT02346721|37742005|FG000|Overall Study|Lack of Efficacy|1|||
16800471|NCT02389621|37742013|FG000|Treatment Period|Withdrawal by Subject|1|||
16800472|NCT02389621|37742014|FG001|Treatment Period|Withdrawal by Subject|1|||
16800473|NCT02389621|37742013|FG000|Posttreatment Period|Adverse Event|3|||
16800474|NCT02389621|37742014|FG001|Posttreatment Period|Adverse Event|1|||
16800475|NCT02389621|37742013|FG000|Posttreatment Period|Withdrawal by Subject|3|||
16800476|NCT02389621|37742014|FG001|Posttreatment Period|Withdrawal by Subject|2|||
16800477|NCT02389621|37742013|FG000|Posttreatment Period|Lost to Follow-up|1|||
16800478|NCT02389621|37742014|FG001|Posttreatment Period|Lost to Follow-up|1|||
16800479|NCT02389621|37742013|FG000|Posttreatment Period|Other - Miscellaneous|2|||
16800480|NCT02389621|37742014|FG001|Posttreatment Period|Other - Miscellaneous|0|||
16800481|NCT02388997|37742026|FG000|Overall Study|Adverse Event|1|||
16800482|NCT02388997|37742027|FG001|Overall Study|Adverse Event|2|||
16800483|NCT02388997|37742026|FG000|Overall Study|Withdrawal by Subject|2|||
16800484|NCT02388997|37742027|FG001|Overall Study|Withdrawal by Subject|1|||
16800485|NCT02388997|37742026|FG000|Overall Study|Lung function exclusion criteria|0|||
16800486|NCT02388997|37742027|FG001|Overall Study|Lung function exclusion criteria|2|||
16800487|NCT02388997|37742026|FG000|Overall Study|Tested positive for virus during run-in|0|||
16800488|NCT02388997|37742027|FG001|Overall Study|Tested positive for virus during run-in|1|||
16800489|NCT02388763|37742033|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
16800490|NCT02388763|37742034|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
16800491|NCT02388763|37742033|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
16800492|NCT02388763|37742034|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
16800493|NCT02388295|37742046|FG000|Dose Escalation Week 1|Adverse Event|1|||
16800494|NCT02388295|37742047|FG001|Dose Escalation Week 1|Adverse Event|2|||
16800495|NCT02388295|37742048|FG002|Dose Escalation Week 1|Adverse Event|1|||
16800496|NCT02388295|37742046|FG000|Dose Escalation Week 1|Determined not eligible|1|||
16800497|NCT02388295|37742047|FG001|Dose Escalation Week 1|Determined not eligible|1|||
16800498|NCT02388295|37742048|FG002|Dose Escalation Week 1|Determined not eligible|1|||
16800499|NCT02388295|37742046|FG000|Dose Escalation Week 2|Protocol Violation|0|||
16800500|NCT02388295|37742047|FG001|Dose Escalation Week 2|Protocol Violation|1|||
16800501|NCT02388295|37742048|FG002|Dose Escalation Week 2|Protocol Violation|0|||
16800502|NCT02388295|37742046|FG000|Dose Escalation Week 2|Determined not eligible|1|||
16800503|NCT02388295|37742047|FG001|Dose Escalation Week 2|Determined not eligible|1|||
16800504|NCT02388295|37742048|FG002|Dose Escalation Week 2|Determined not eligible|1|||
16800505|NCT02388295|37742046|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
16800506|NCT02388295|37742047|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
16800507|NCT02388295|37742048|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
16800508|NCT02345161|37742058|FG000|Overall Study|Withdrawal by Subject|25|||
16800509|NCT02345161|37742059|FG001|Overall Study|Withdrawal by Subject|33|||
16800510|NCT02345161|37742058|FG000|Overall Study|Adverse Event|16|||
16800511|NCT02345161|37742059|FG001|Overall Study|Adverse Event|19|||
16800512|NCT02345161|37742058|FG000|Overall Study|Physician Decision|4|||
16800513|NCT02345161|37742059|FG001|Overall Study|Physician Decision|4|||
16800514|NCT02345161|37742058|FG000|Overall Study|Lost to Follow-up|0|||
16800515|NCT02345161|37742059|FG001|Overall Study|Lost to Follow-up|1|||
16800516|NCT02251275|37742075|FG000|Overall Study|Adverse Event|23|||
16800517|NCT02251275|37742076|FG001|Overall Study|Adverse Event|60|||
16800518|NCT02251275|37742077|FG002|Overall Study|Adverse Event|28|||
16800519|NCT02251275|37742078|FG003|Overall Study|Adverse Event|0|||
16800520|NCT02251275|37742079|FG004|Overall Study|Adverse Event|0|||
16800521|NCT02251275|37742075|FG000|Overall Study|Lost to Follow-up|5|||
16800522|NCT02251275|37742076|FG001|Overall Study|Lost to Follow-up|6|||
16800523|NCT02251275|37742077|FG002|Overall Study|Lost to Follow-up|4|||
16800524|NCT02251275|37742078|FG003|Overall Study|Lost to Follow-up|0|||
16800525|NCT02251275|37742079|FG004|Overall Study|Lost to Follow-up|0|||
16800526|NCT02251275|37742075|FG000|Overall Study|Physician Decision|19|||
16800527|NCT02251275|37742076|FG001|Overall Study|Physician Decision|30|||
16800528|NCT02251275|37742077|FG002|Overall Study|Physician Decision|26|||
16800529|NCT02251275|37742078|FG003|Overall Study|Physician Decision|0|||
16800530|NCT02251275|37742079|FG004|Overall Study|Physician Decision|1|||
16800531|NCT02251275|37742075|FG000|Overall Study|Protocol Deviation|0|||
16800532|NCT02251275|37742076|FG001|Overall Study|Protocol Deviation|0|||
16800533|NCT02251275|37742077|FG002|Overall Study|Protocol Deviation|1|||
16800534|NCT02251275|37742078|FG003|Overall Study|Protocol Deviation|0|||
16800535|NCT02251275|37742079|FG004|Overall Study|Protocol Deviation|0|||
16800536|NCT02251275|37742075|FG000|Overall Study|Withdrawal by Subject|25|||
16800537|NCT02251275|37742076|FG001|Overall Study|Withdrawal by Subject|51|||
16800538|NCT02251275|37742077|FG002|Overall Study|Withdrawal by Subject|35|||
16800539|NCT02251275|37742078|FG003|Overall Study|Withdrawal by Subject|1|||
16800540|NCT02251275|37742079|FG004|Overall Study|Withdrawal by Subject|0|||
16800541|NCT02379637|37742093|FG000|Overall Study|Protocol Violation|0|||
16800542|NCT02379637|37742094|FG001|Overall Study|Protocol Violation|1|||
16800543|NCT02379637|37742093|FG000|Overall Study|Adverse Event|1|||
16800544|NCT02379637|37742094|FG001|Overall Study|Adverse Event|0|||
16800545|NCT02379637|37742093|FG000|Overall Study|Withdrawal by Subject|1|||
16800546|NCT02379637|37742094|FG001|Overall Study|Withdrawal by Subject|0|||
16800547|NCT02195583|37742100|FG000|Overall Study|Lost to Follow-up|1|||
16800548|NCT02195583|37742100|FG000|Overall Study|Withdrawal by Subject|4|||
16800549|NCT02195583|37742100|FG000|Overall Study|Adverse Event|2|||
16800550|NCT02195583|37742100|FG000|Overall Study|Other Reason|2|||
16800551|NCT02379091|37742119|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16800552|NCT02379091|37742120|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
16800553|NCT02379091|37742121|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16800554|NCT02379091|37742122|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
16800555|NCT02379091|37742119|FG000|Overall Study|Principal Investigator Discretion|0|||
16800556|NCT02379091|37742120|FG001|Overall Study|Principal Investigator Discretion|1|||
16800557|NCT02379091|37742121|FG002|Overall Study|Principal Investigator Discretion|0|||
16800558|NCT02379091|37742122|FG003|Overall Study|Principal Investigator Discretion|0|||
16800559|NCT02379091|37742119|FG000|Overall Study|Lost to Follow-up|0|||
16800560|NCT02379091|37742120|FG001|Overall Study|Lost to Follow-up|0|||
16800561|NCT02379091|37742121|FG002|Overall Study|Lost to Follow-up|0|||
16800562|NCT02379091|37742122|FG003|Overall Study|Lost to Follow-up|1|||
16800563|NCT02379091|37742119|FG000|Overall Study|Voluntary Withdrawal|2|||
16800564|NCT02379091|37742120|FG001|Overall Study|Voluntary Withdrawal|5|||
16800565|NCT02379091|37742121|FG002|Overall Study|Voluntary Withdrawal|2|||
16800566|NCT02379091|37742122|FG003|Overall Study|Voluntary Withdrawal|4|||
16800567|NCT02379091|37742119|FG000|Overall Study|Study Termination|7|||
16800568|NCT02379091|37742120|FG001|Overall Study|Study Termination|2|||
16800569|NCT02379091|37742121|FG002|Overall Study|Study Termination|5|||
16800570|NCT02379091|37742122|FG003|Overall Study|Study Termination|8|||
16800571|NCT02379091|37742119|FG000|Overall Study|Lack of Efficacy|3|||
16800572|NCT02379091|37742120|FG001|Overall Study|Lack of Efficacy|0|||
16800573|NCT02379091|37742121|FG002|Overall Study|Lack of Efficacy|0|||
16800574|NCT02379091|37742122|FG003|Overall Study|Lack of Efficacy|0|||
16800575|NCT02378935|37742141|FG000|Overall Study|Lack of Efficacy|10|||
16800576|NCT02378935|37742142|FG001|Overall Study|Lack of Efficacy|0|||
16800577|NCT02378935|37742143|FG002|Overall Study|Lack of Efficacy|2|||
16800578|NCT02378935|37742144|FG003|Overall Study|Lack of Efficacy|6|||
16800579|NCT02378935|37742145|FG004|Overall Study|Lack of Efficacy|0|||
16800580|NCT02378935|37742146|FG005|Overall Study|Lack of Efficacy|0|||
16800581|NCT02378935|37742147|FG006|Overall Study|Lack of Efficacy|0|||
16800582|NCT02378935|37742141|FG000|Overall Study|Death|0|||
16800583|NCT02378935|37742142|FG001|Overall Study|Death|0|||
16800584|NCT02378935|37742143|FG002|Overall Study|Death|1|||
16800585|NCT02378935|37742144|FG003|Overall Study|Death|0|||
16800586|NCT02378935|37742145|FG004|Overall Study|Death|0|||
16800587|NCT02378935|37742146|FG005|Overall Study|Death|0|||
16800588|NCT02378935|37742147|FG006|Overall Study|Death|0|||
16800589|NCT02250651|37742166|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
16800590|NCT02250651|37742167|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
16800591|NCT02250651|37742168|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
16800592|NCT02250651|37742166|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
16800593|NCT02250651|37742167|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
16800594|NCT02250651|37742168|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
16800595|NCT02250651|37742166|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
16800596|NCT02250651|37742167|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
16909458|NCT01720524|38018294|FG001|Part B|Death|2|||
16800597|NCT02250651|37742168|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
16800598|NCT02250651|37742166|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
16800599|NCT02250651|37742167|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
16800600|NCT02250651|37742168|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
16800601|NCT02250651|37742166|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
16800602|NCT02250651|37742167|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
16800603|NCT02250651|37742168|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
16800604|NCT02250651|37742166|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
16800605|NCT02250651|37742167|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
16800606|NCT02250651|37742168|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
16800607|NCT02250651|37742166|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
16800608|NCT02250651|37742167|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
16800609|NCT02250651|37742168|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
16800610|NCT02250651|37742166|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
16800611|NCT02250651|37742167|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
16800612|NCT02250651|37742168|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
16800613|NCT02250651|37742166|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
16800614|NCT02250651|37742167|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
16800615|NCT02250651|37742168|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
16800616|NCT02250651|37742166|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
16800617|NCT02250651|37742167|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
16800618|NCT02250651|37742168|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
16800619|NCT02250651|37742166|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
16800620|NCT02250651|37742167|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
16800621|NCT02250651|37742168|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
16800622|NCT02250651|37742166|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
16800623|NCT02250651|37742167|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
16800624|NCT02250651|37742168|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
16800625|NCT02250651|37742166|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
16800626|NCT02250651|37742167|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
16800627|NCT02250651|37742168|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
16800628|NCT02250651|37742166|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
16800629|NCT02250651|37742167|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
16800630|NCT02250651|37742168|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
16800631|NCT02250651|37742166|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
16800632|NCT02250651|37742167|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
16800633|NCT02250651|37742168|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
16800634|NCT02377921|37742178|FG000|Overall Study|Subject non-compliance|1|||
16800635|NCT02377921|37742179|FG001|Overall Study|Subject non-compliance|1|||
16800636|NCT02311153|37742187|FG000|Overall Study|Lost to Follow-up|5|||
16800637|NCT02311153|37742188|FG001|Overall Study|Lost to Follow-up|7|||
16800638|NCT02195427|37742196|FG000|Overall Study|Did not consent to study extension|13|||
16800639|NCT02195427|37742197|FG001|Overall Study|Did not consent to study extension|9|||
16800640|NCT02195427|37742196|FG000|Overall Study|Withdrawal by Subject|4|||
16800641|NCT02195427|37742197|FG001|Overall Study|Withdrawal by Subject|2|||
16800642|NCT02195427|37742196|FG000|Overall Study|Lost to Follow-up|0|||
16800643|NCT02195427|37742197|FG001|Overall Study|Lost to Follow-up|1|||
16800644|NCT02195427|37742196|FG000|Overall Study|Protocol Violation|7|||
16800645|NCT02195427|37742197|FG001|Overall Study|Protocol Violation|14|||
16800646|NCT02195427|37742196|FG000|Overall Study|Conditional re-treatment at W52|2|||
16800647|NCT02195427|37742197|FG001|Overall Study|Conditional re-treatment at W52|1|||
16800648|NCT02214225|37742210|FG000|Overall Study|Lost to Follow-up|46|||
16800649|NCT02214225|37742211|FG001|Overall Study|Lost to Follow-up|18|||
16800650|NCT02214225|37742212|FG002|Overall Study|Lost to Follow-up|18|||
16800651|NCT02214225|37742210|FG000|Overall Study|Withdrawal by Subject|2|||
16800652|NCT02214225|37742211|FG001|Overall Study|Withdrawal by Subject|0|||
16800653|NCT02214225|37742212|FG002|Overall Study|Withdrawal by Subject|2|||
16800654|NCT02214225|37742210|FG000|Overall Study|Death|5|||
16800655|NCT02214225|37742211|FG001|Overall Study|Death|0|||
16800656|NCT02214225|37742212|FG002|Overall Study|Death|1|||
16800657|NCT02214225|37742210|FG000|Overall Study|randomized in error, not vaccinated|2|||
16800658|NCT02214225|37742211|FG001|Overall Study|randomized in error, not vaccinated|1|||
16800659|NCT02214225|37742212|FG002|Overall Study|randomized in error, not vaccinated|1|||
16800660|NCT02250183|37742243|FG000|Overall Study|Withdrawal by Subject|2|||
16800661|NCT02250183|37742243|FG000|Overall Study|Adverse Event|5|||
16800662|NCT02250183|37742243|FG000|Overall Study|Lost to Follow-up|1|||
16800663|NCT02249949|37742250|FG000|Overall Study|Cancelled prior to treatment|2|||
16800664|NCT02249091|37742256|FG000|Overall Study|Lack of Efficacy|8|||
16800665|NCT02249091|37742257|FG001|Overall Study|Lack of Efficacy|3|||
16800666|NCT02249091|37742256|FG000|Overall Study|Physician Decision|4|||
16800667|NCT02249091|37742257|FG001|Overall Study|Physician Decision|1|||
16800668|NCT02249091|37742256|FG000|Overall Study|Withdrawal by Subject|2|||
16800669|NCT02249091|37742257|FG001|Overall Study|Withdrawal by Subject|2|||
16800670|NCT02249091|37742256|FG000|Overall Study|Death|3|||
16800671|NCT02249091|37742257|FG001|Overall Study|Death|4|||
16800672|NCT02249091|37742256|FG000|Overall Study|Adverse Event|1|||
16800673|NCT02249091|37742257|FG001|Overall Study|Adverse Event|0|||
16800674|NCT02249091|37742256|FG000|Overall Study|Stable disease with following SCT|0|||
16800675|NCT02249091|37742257|FG001|Overall Study|Stable disease with following SCT|1|||
16800676|NCT02249091|37742256|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
16800677|NCT02249091|37742257|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
16800678|NCT02249091|37742256|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
16800679|NCT02249091|37742257|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
16800680|NCT02249091|37742256|FG000|Overall Study|Refractory AML|1|||
16800681|NCT02249091|37742257|FG001|Overall Study|Refractory AML|1|||
16800682|NCT02248857|37742266|FG000|3 Month|Withdrawal by Subject|9|||
16800683|NCT02248857|37742267|FG001|3 Month|Withdrawal by Subject|3|||
16800684|NCT02248857|37742268|FG002|3 Month|Withdrawal by Subject|4|||
16800685|NCT02248857|37742266|FG000|3 Month|Unable to reach for 3 month|35|||
16800686|NCT02248857|37742267|FG001|3 Month|Unable to reach for 3 month|29|||
16800687|NCT02248857|37742268|FG002|3 Month|Unable to reach for 3 month|26|||
16800688|NCT02248857|37742266|FG000|3 Month|Partially completed, unable to finish|2|||
16800689|NCT02248857|37742267|FG001|3 Month|Partially completed, unable to finish|2|||
16800690|NCT02248857|37742268|FG002|3 Month|Partially completed, unable to finish|1|||
16800691|NCT02248857|37742266|FG000|6 Month|Lost to Follow-up|27|||
16800692|NCT02248857|37742267|FG001|6 Month|Lost to Follow-up|26|||
16800693|NCT02248857|37742268|FG002|6 Month|Lost to Follow-up|15|||
16800694|NCT02248857|37742266|FG000|6 Month|Partially completed, unable to finish|0|||
16800695|NCT02248857|37742267|FG001|6 Month|Partially completed, unable to finish|1|||
16800696|NCT02248857|37742268|FG002|6 Month|Partially completed, unable to finish|0|||
16800697|NCT02248857|37742266|FG000|6 Month|Withdrawal by Subject|0|||
16800698|NCT02248857|37742267|FG001|6 Month|Withdrawal by Subject|2|||
16800699|NCT02248857|37742268|FG002|6 Month|Withdrawal by Subject|2|||
16800700|NCT02248857|37742266|FG000|6 Month|Death|1|||
16800701|NCT02248857|37742267|FG001|6 Month|Death|0|||
16800702|NCT02248857|37742268|FG002|6 Month|Death|0|||
16800703|NCT02213055|37742278|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
16800704|NCT02213055|37742279|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
16800705|NCT02213055|37742278|FG000|Overall Study|Protocol was not Followed during Study|1|||
16800706|NCT02213055|37742279|FG001|Overall Study|Protocol was not Followed during Study|0|||
16800707|NCT02213055|37742278|FG000|Overall Study|Documentation Issue at Enrollment|1|||
16800708|NCT02213055|37742279|FG001|Overall Study|Documentation Issue at Enrollment|0|||
16800709|NCT02213055|37742278|FG000|Overall Study|Documentation Issue during Study|10|||
16800710|NCT02213055|37742279|FG001|Overall Study|Documentation Issue during Study|0|||
16800711|NCT02213055|37742278|FG000|Overall Study|Did not have Live Lice|8|||
16800712|NCT02213055|37742279|FG001|Overall Study|Did not have Live Lice|0|||
16800713|NCT02213055|37742278|FG000|Overall Study|Had another Treatment during the Study|3|||
16800714|NCT02213055|37742279|FG001|Overall Study|Had another Treatment during the Study|0|||
16800715|NCT02213055|37742278|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
16800716|NCT02213055|37742279|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
16800717|NCT02213055|37742278|FG000|Overall Study|Did not Return to School|5|||
16800718|NCT02213055|37742279|FG001|Overall Study|Did not Return to School|0|||
16800719|NCT02310763|37742288|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
16800720|NCT02310763|37742289|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
16800721|NCT02310763|37742290|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
16800722|NCT02310763|37742288|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
16800723|NCT02310763|37742289|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
16800724|NCT02310763|37742290|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
16800725|NCT02310763|37742288|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
16800726|NCT02310763|37742289|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
16800727|NCT02310763|37742290|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
16800728|NCT02310763|37742288|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
16800729|NCT02310763|37742289|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
16800730|NCT02310763|37742290|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
16800731|NCT02310763|37742288|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
16800732|NCT02310763|37742289|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
16800733|NCT02310763|37742290|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
16800734|NCT02342743|37742316|FG000|Baseline Period|Withdrawal by Subject|3|||
16800735|NCT02342743|37742316|FG000|Baseline Period|Lost to Follow-up|2|||
16800736|NCT02342743|37742316|FG000|Baseline Period|Change in prophylactic medication|3|||
16800737|NCT02342743|37742316|FG000|Baseline Period|Screening failure regarding baseline|7|||
16800738|NCT02342743|37742316|FG000|Treatment Period|Withdrawal by Subject|2|||
16800739|NCT02342743|37742316|FG000|Treatment Period|Lost to Follow-up|8|||
16800740|NCT02342743|37742316|FG000|Treatment Period|Change in prophylactic medication|1|||
16800741|NCT02377063|37742320|FG000|Overall Study|Non-compliance|5|||
16800742|NCT02309515|37742326|FG000|Overall Study|Withdrawal by Subject|0|||
16800743|NCT02309515|37742327|FG001|Overall Study|Withdrawal by Subject|1|||
16800744|NCT02309359|37742338|FG000|Overall Study|Adverse Event|4|||
16800745|NCT02309359|37742339|FG001|Overall Study|Adverse Event|5|||
16800746|NCT02309359|37742340|FG002|Overall Study|Adverse Event|5|||
16800747|NCT02309359|37742341|FG003|Overall Study|Adverse Event|4|||
16800748|NCT02309359|37742342|FG004|Overall Study|Adverse Event|4|||
16800749|NCT02309359|37742338|FG000|Overall Study|Death|1|||
16800750|NCT02309359|37742339|FG001|Overall Study|Death|0|||
16800751|NCT02309359|37742340|FG002|Overall Study|Death|0|||
16800752|NCT02309359|37742341|FG003|Overall Study|Death|0|||
16800753|NCT02309359|37742342|FG004|Overall Study|Death|0|||
16800754|NCT02309359|37742338|FG000|Overall Study|Withdrawal by Subject|2|||
16800755|NCT02309359|37742339|FG001|Overall Study|Withdrawal by Subject|2|||
16800756|NCT02309359|37742340|FG002|Overall Study|Withdrawal by Subject|4|||
16800757|NCT02309359|37742341|FG003|Overall Study|Withdrawal by Subject|4|||
16800758|NCT02309359|37742342|FG004|Overall Study|Withdrawal by Subject|0|||
16800759|NCT02309359|37742338|FG000|Overall Study|Lack of Efficacy|3|||
16800760|NCT02309359|37742339|FG001|Overall Study|Lack of Efficacy|1|||
16800761|NCT02309359|37742340|FG002|Overall Study|Lack of Efficacy|0|||
16800762|NCT02309359|37742341|FG003|Overall Study|Lack of Efficacy|0|||
16800763|NCT02309359|37742342|FG004|Overall Study|Lack of Efficacy|3|||
16800764|NCT02309359|37742338|FG000|Overall Study|Lost to Follow-up|0|||
16800765|NCT02309359|37742339|FG001|Overall Study|Lost to Follow-up|0|||
16800766|NCT02309359|37742340|FG002|Overall Study|Lost to Follow-up|0|||
16800767|NCT02309359|37742341|FG003|Overall Study|Lost to Follow-up|1|||
16800768|NCT02309359|37742342|FG004|Overall Study|Lost to Follow-up|0|||
16800769|NCT02309359|37742338|FG000|Overall Study|Other|2|||
16800770|NCT02309359|37742339|FG001|Overall Study|Other|0|||
16800771|NCT02309359|37742340|FG002|Overall Study|Other|2|||
16800772|NCT02309359|37742341|FG003|Overall Study|Other|3|||
16800773|NCT02309359|37742342|FG004|Overall Study|Other|2|||
16800774|NCT02247531|37742358|FG000|Overall Study|Adverse Event|3|||
16800775|NCT02247531|37742359|FG001|Overall Study|Adverse Event|4|||
16800776|NCT02247531|37742360|FG002|Overall Study|Adverse Event|9|||
16800777|NCT02247531|37742358|FG000|Overall Study|Death|8|||
16800778|NCT02247531|37742359|FG001|Overall Study|Death|9|||
16800779|NCT02247531|37742360|FG002|Overall Study|Death|5|||
16800780|NCT02247531|37742358|FG000|Overall Study|Lost to Follow-up|1|||
16800781|NCT02247531|37742359|FG001|Overall Study|Lost to Follow-up|8|||
16800782|NCT02247531|37742360|FG002|Overall Study|Lost to Follow-up|3|||
16800783|NCT02247531|37742358|FG000|Overall Study|Non-compliance|2|||
16800784|NCT02247531|37742359|FG001|Overall Study|Non-compliance|2|||
16800785|NCT02247531|37742360|FG002|Overall Study|Non-compliance|0|||
16800786|NCT02247531|37742358|FG000|Overall Study|Withdrawal by Subject|26|||
16800787|NCT02247531|37742359|FG001|Overall Study|Withdrawal by Subject|31|||
16800788|NCT02247531|37742360|FG002|Overall Study|Withdrawal by Subject|25|||
16800789|NCT02247531|37742358|FG000|Overall Study|Study Terminated by Sponsor|64|||
16800790|NCT02247531|37742359|FG001|Overall Study|Study Terminated by Sponsor|66|||
16800791|NCT02247531|37742360|FG002|Overall Study|Study Terminated by Sponsor|62|||
16800792|NCT02247531|37742358|FG000|Overall Study|Physician Decision|0|||
16800793|NCT02247531|37742359|FG001|Overall Study|Physician Decision|2|||
16800794|NCT02247531|37742360|FG002|Overall Study|Physician Decision|2|||
16800795|NCT02247531|37742358|FG000|Overall Study|Unspecified Reason|2|||
16800796|NCT02247531|37742359|FG001|Overall Study|Unspecified Reason|3|||
16800797|NCT02247531|37742360|FG002|Overall Study|Unspecified Reason|4|||
16800798|NCT02375971|37742371|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
16800799|NCT02375971|37742372|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
16800800|NCT02375971|37742373|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
16800801|NCT02375971|37742371|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
16800802|NCT02375971|37742372|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
16800803|NCT02375971|37742373|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
16800804|NCT02375971|37742371|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
16800805|NCT02375971|37742372|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
16800806|NCT02375971|37742373|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
16800807|NCT02375971|37742371|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
16800808|NCT02375971|37742372|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
16800809|NCT02375971|37742373|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
16800810|NCT02375971|37742371|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
16800811|NCT02375971|37742372|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
16800812|NCT02375971|37742373|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
17016532|NCT00691210|38161158|FG005|Overall Study|Progression of Disease|0|||
17016533|NCT00691210|38161159|FG006|Overall Study|Progression of Disease|0|||
17016534|NCT00691210|38161160|FG007|Overall Study|Progression of Disease|0|||
16800813|NCT02375971|37742371|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
16800814|NCT02375971|37742372|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
16800815|NCT02375971|37742373|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
16800816|NCT02375971|37742371|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
16800817|NCT02375971|37742372|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
16800818|NCT02375971|37742373|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
16800819|NCT02375971|37742371|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
16800820|NCT02375971|37742372|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
16800821|NCT02375971|37742373|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
16800822|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800823|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800824|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800825|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16800826|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16800827|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800828|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800829|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800830|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800831|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16800832|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800833|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800834|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16800835|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
16800836|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16800837|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
16800838|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
16800839|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
16800840|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16800841|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
16800842|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
16800843|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16800844|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16800845|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
16800846|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
16800847|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16800848|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
16800849|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16800850|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
16800851|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16800852|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16800853|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
16800854|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
16800855|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16800856|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
16800857|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
16800858|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
16800859|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
16800860|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
16800861|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
16800862|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
16800863|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
16800864|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
16800865|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
16800866|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
16800867|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
16800868|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
16800869|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
16800870|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
16800871|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
16800872|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
16800873|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
16800874|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
16800875|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
16800876|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
16800877|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
16800878|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
16800879|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800880|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800881|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800882|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800883|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800884|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800885|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800886|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800887|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800888|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800889|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
16800890|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800891|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800892|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800893|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800894|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800895|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800896|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800897|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16800898|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
16800899|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16800900|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16800901|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16800902|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16800903|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
16800904|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16800905|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16800906|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16800907|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16800908|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
16800909|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16800910|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16800911|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
16800912|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16800913|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
16800914|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
16800915|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
16800916|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16800917|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800918|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800919|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800920|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800921|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
16800922|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800923|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800924|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800925|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800926|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
16800927|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800928|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800929|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800930|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800931|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800932|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800933|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800934|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800935|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16800936|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800937|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16800938|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
16800939|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800940|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800941|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800942|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800943|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
17016535|NCT00691210|38161153|FG000|Overall Study|Lack of Efficacy|0|||
17016536|NCT00691210|38161154|FG001|Overall Study|Lack of Efficacy|0|||
16800944|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16800945|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16800946|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800947|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16800948|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800949|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16800950|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800951|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16800952|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
16800953|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
16800954|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16800955|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16800956|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
16800957|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16800958|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16800959|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16800960|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16800961|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16800962|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16800963|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16800964|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16800965|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16800966|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16800967|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16800968|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
16800969|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
16800970|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
16800971|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
16800972|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
16800973|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16800974|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800975|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800976|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800977|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800978|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800979|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800980|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800981|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800982|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800983|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800984|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
16800985|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800986|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800987|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
16800988|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800989|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800990|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
16800991|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
16800992|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16800993|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
16800994|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16800995|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16800996|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16800997|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16800998|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
16800999|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801000|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801001|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801002|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801003|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801004|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801005|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801006|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801007|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
16801008|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801009|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801010|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
16801011|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16801012|NCT01915498|37742399|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801013|NCT01915498|37742400|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801014|NCT01915498|37742401|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801015|NCT01915498|37742402|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801016|NCT01915498|37742403|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801017|NCT01915498|37742404|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
16801018|NCT01915498|37742405|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801019|NCT01915498|37742406|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801020|NCT01915498|37742407|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801021|NCT01915498|37742408|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
16801022|NCT01915498|37742409|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801023|NCT01915498|37742410|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801024|NCT01915498|37742411|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801025|NCT01915498|37742412|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
16801026|NCT01915498|37742413|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
16801027|NCT01915498|37742414|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
16801028|NCT01915498|37742415|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
16801029|NCT01915498|37742416|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
16801030|NCT01915498|37742417|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16801031|NCT01915498|37742399|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801032|NCT01915498|37742400|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801033|NCT01915498|37742401|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801034|NCT01915498|37742402|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801035|NCT01915498|37742403|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801036|NCT01915498|37742404|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801037|NCT01915498|37742405|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801038|NCT01915498|37742406|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801039|NCT01915498|37742407|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801040|NCT01915498|37742408|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801041|NCT01915498|37742409|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801042|NCT01915498|37742410|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801043|NCT01915498|37742411|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801044|NCT01915498|37742412|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801045|NCT01915498|37742413|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801046|NCT01915498|37742414|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801047|NCT01915498|37742415|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801048|NCT01915498|37742416|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16801049|NCT01915498|37742417|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
16801050|NCT02308735|37742509|FG000|Overall Study|Physician Decision|2|||
16801051|NCT02308735|37742510|FG001|Overall Study|Physician Decision|0|||
16801052|NCT02308735|37742511|FG002|Overall Study|Physician Decision|0|||
16801053|NCT02308735|37742512|FG003|Overall Study|Physician Decision|2|||
16801054|NCT02212197|37742525|FG000|Overall Study|Need for radiotherapy|1|||
16801055|NCT02212197|37742526|FG001|Overall Study|Need for radiotherapy|0|||
16801056|NCT02212197|37742527|FG002|Overall Study|Need for radiotherapy|0|||
16801057|NCT02193165|37742538|FG000|4 Week Product Use|Lost to Follow-up|1|||
16801058|NCT02193165|37742539|FG001|4 Week Product Use|Lost to Follow-up|1|||
16801059|NCT02193165|37742540|FG002|4 Week Product Use|Lost to Follow-up|1|||
16801060|NCT02193165|37742538|FG000|6 Week Product Use|Lost to Follow-up|0|||
16801061|NCT02193165|37742539|FG001|6 Week Product Use|Lost to Follow-up|1|||
16801062|NCT02193165|37742540|FG002|6 Week Product Use|Lost to Follow-up|0|||
16801063|NCT01617460|37742548|FG000|Overall Study|Adverse Event|10|||
16801064|NCT01617460|37742548|FG000|Overall Study|Physician Decision|16|||
16801065|NCT01617460|37742548|FG000|Overall Study|Protocol Violation|5|||
16801066|NCT01617460|37742548|FG000|Overall Study|Withdrawal by Subject|9|||
16801067|NCT01890148|37742552|FG000|Overall Study|Adverse Event|1|||
16801068|NCT01889602|37742559|FG000|First Intervention|Adverse Event|1|||
16801069|NCT01889602|37742560|FG001|First Intervention|Adverse Event|1|||
16801070|NCT01889602|37742561|FG002|First Intervention|Adverse Event|1|||
16801071|NCT01889602|37742559|FG000|First Intervention|Protocol Violation|0|||
16801072|NCT01889602|37742560|FG001|First Intervention|Protocol Violation|1|||
16801073|NCT01889602|37742561|FG002|First Intervention|Protocol Violation|1|||
16801074|NCT01889602|37742559|FG000|First Intervention|Study ending|0|||
16801075|NCT01889602|37742560|FG001|First Intervention|Study ending|1|||
16801076|NCT01889602|37742561|FG002|First Intervention|Study ending|0|||
16801077|NCT01889602|37742559|FG000|Second Intervention|Adverse Event|0|||
16801078|NCT01889602|37742560|FG001|Second Intervention|Adverse Event|0|||
16801079|NCT01889602|37742561|FG002|Second Intervention|Adverse Event|1|||
16801080|NCT01889602|37742559|FG000|Second Intervention|Study ending|1|||
16801081|NCT01889602|37742560|FG001|Second Intervention|Study ending|0|||
16801082|NCT01889602|37742561|FG002|Second Intervention|Study ending|0|||
16801083|NCT01889602|37742559|FG000|Second Intervention|Withdrawal by Subject|0|||
16801084|NCT01889602|37742560|FG001|Second Intervention|Withdrawal by Subject|0|||
16801085|NCT01889602|37742561|FG002|Second Intervention|Withdrawal by Subject|1|||
16801086|NCT01889602|37742559|FG000|Third Intervention|Protocol Violation|1|||
16801087|NCT01889602|37742560|FG001|Third Intervention|Protocol Violation|0|||
16801088|NCT01889602|37742561|FG002|Third Intervention|Protocol Violation|0|||
16801089|NCT01889602|37742559|FG000|Third Intervention|Withdrawal by Subject|2|||
16801090|NCT01889602|37742560|FG001|Third Intervention|Withdrawal by Subject|2|||
16801091|NCT01889602|37742561|FG002|Third Intervention|Withdrawal by Subject|0|||
16801092|NCT01935700|37742579|FG000|Overall Study|Withdrawal by Subject|1|||
16801093|NCT01935700|37742580|FG001|Overall Study|Withdrawal by Subject|0|||
16801094|NCT01935700|37742579|FG000|Overall Study|Physician Decision|4|||
16801095|NCT01935700|37742580|FG001|Overall Study|Physician Decision|0|||
16801096|NCT01618162|37742590|FG000|Overall Study|Protocol Violation|13|||
16801097|NCT01618162|37742591|FG001|Overall Study|Protocol Violation|10|||
16801098|NCT01618162|37742590|FG000|Overall Study|Adverse Event|9|||
16801099|NCT01618162|37742591|FG001|Overall Study|Adverse Event|2|||
16801100|NCT01618162|37742590|FG000|Overall Study|Withdrawal Criteria|2|||
16801101|NCT01618162|37742591|FG001|Overall Study|Withdrawal Criteria|10|||
16801102|NCT01618162|37742590|FG000|Overall Study|Unclassified|14|||
16801103|NCT01618162|37742591|FG001|Overall Study|Unclassified|13|||
16801104|NCT02193087|37742601|FG000|Overall Study|Adverse Event|2|||
16801105|NCT02193087|37742602|FG001|Overall Study|Adverse Event|0|||
16801106|NCT02193087|37742603|FG002|Overall Study|Adverse Event|0|||
16801107|NCT02193087|37742604|FG003|Overall Study|Adverse Event|11|||
16801108|NCT02193087|37742601|FG000|Overall Study|Lost to Follow-up|14|||
16801109|NCT02193087|37742602|FG001|Overall Study|Lost to Follow-up|6|||
16801110|NCT02193087|37742603|FG002|Overall Study|Lost to Follow-up|4|||
16801111|NCT02193087|37742604|FG003|Overall Study|Lost to Follow-up|37|||
16801112|NCT02193087|37742601|FG000|Overall Study|Protocol Violation|2|||
16801113|NCT02193087|37742602|FG001|Overall Study|Protocol Violation|0|||
16801114|NCT02193087|37742603|FG002|Overall Study|Protocol Violation|1|||
16801115|NCT02193087|37742604|FG003|Overall Study|Protocol Violation|2|||
16801116|NCT02193087|37742601|FG000|Overall Study|Withdrawal by Subject|10|||
16801117|NCT02193087|37742602|FG001|Overall Study|Withdrawal by Subject|3|||
16801118|NCT02193087|37742603|FG002|Overall Study|Withdrawal by Subject|1|||
16801119|NCT02193087|37742604|FG003|Overall Study|Withdrawal by Subject|19|||
16801120|NCT02193087|37742601|FG000|Overall Study|Other Reason Not Specified|7|||
16801121|NCT02193087|37742602|FG001|Overall Study|Other Reason Not Specified|2|||
16801122|NCT02193087|37742603|FG002|Overall Study|Other Reason Not Specified|1|||
16801123|NCT02193087|37742604|FG003|Overall Study|Other Reason Not Specified|9|||
16801124|NCT02193087|37742601|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
16801125|NCT02193087|37742602|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
16801126|NCT02193087|37742603|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
16801127|NCT02193087|37742604|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
16801128|NCT01617070|37742621|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
16801129|NCT02341417|37742634|FG000|Overall Study|Withdrawal by Subject|0|||
16801130|NCT02341417|37742635|FG001|Overall Study|Withdrawal by Subject|2|||
16801131|NCT02341417|37742636|FG002|Overall Study|Withdrawal by Subject|0|||
16801132|NCT02341417|37742634|FG000|Overall Study|Decision by sponsor|2|||
16801133|NCT02341417|37742635|FG001|Overall Study|Decision by sponsor|0|||
16801134|NCT02341417|37742636|FG002|Overall Study|Decision by sponsor|0|||
16801135|NCT02341417|37742634|FG000|Overall Study|Death|0|||
16801136|NCT02341417|37742635|FG001|Overall Study|Death|0|||
16801137|NCT02341417|37742636|FG002|Overall Study|Death|1|||
16801138|NCT01888900|37742647|FG000|Overall Study|failed treatment|0|||
16801139|NCT01888900|37742648|FG001|Overall Study|failed treatment|2|||
16801140|NCT02340949|37742658|FG000|Overall Study|Adverse Event|4|||
16801141|NCT02340949|37742659|FG001|Overall Study|Adverse Event|2|||
16801142|NCT02340949|37742658|FG000|Overall Study|Withdrawal by Subject|2|||
16801143|NCT02340949|37742659|FG001|Overall Study|Withdrawal by Subject|0|||
16801144|NCT02340949|37742658|FG000|Overall Study|Progression disease|6|||
16801145|NCT02340949|37742659|FG001|Overall Study|Progression disease|2|||
16801146|NCT02340949|37742658|FG000|Overall Study|Death|3|||
16801147|NCT02340949|37742659|FG001|Overall Study|Death|0|||
16801148|NCT02340949|37742658|FG000|Overall Study|Physician Decision|1|||
16801149|NCT02340949|37742659|FG001|Overall Study|Physician Decision|0|||
16801150|NCT01646203|37742668|FG000|Overall Study|Adverse Event|2|||
16801151|NCT01646203|37742669|FG001|Overall Study|Adverse Event|0|||
16801152|NCT01646203|37742670|FG002|Overall Study|Adverse Event|1|||
16801153|NCT01646203|37742668|FG000|Overall Study|Withdrawal by Subject|0|||
16801154|NCT01646203|37742669|FG001|Overall Study|Withdrawal by Subject|1|||
16801155|NCT01646203|37742670|FG002|Overall Study|Withdrawal by Subject|0|||
16801156|NCT01646203|37742668|FG000|Overall Study|Physician's Decision|0|||
16801157|NCT01646203|37742669|FG001|Overall Study|Physician's Decision|1|||
16801158|NCT01646203|37742670|FG002|Overall Study|Physician's Decision|0|||
16801159|NCT02375347|37742683|FG000|Overall Study|Protocol Violation|1|||
16801160|NCT02374957|37742689|FG000|Overall Study|Patient did not complete forms correctly|1|||
16801161|NCT02374957|37742690|FG001|Overall Study|Patient did not complete forms correctly|0|||
16801162|NCT02374255|37742700|FG000|Overall Study|Withdrawal by Subject|2|||
16801163|NCT02374255|37742701|FG001|Overall Study|Withdrawal by Subject|0|||
16801164|NCT02374255|37742702|FG002|Overall Study|Withdrawal by Subject|0|||
16801165|NCT02374255|37742703|FG003|Overall Study|Withdrawal by Subject|0|||
16801166|NCT02308033|37742721|FG000|Overall Study|Normal Gram stain at Baseline|13|||
16801167|NCT02308033|37742722|FG001|Overall Study|Normal Gram stain at Baseline|10|||
16801168|NCT02308033|37742721|FG000|Overall Study|Positive for STD at Baseline|7|||
16801169|NCT02308033|37742722|FG001|Overall Study|Positive for STD at Baseline|4|||
16801170|NCT02308033|37742721|FG000|Overall Study|Lost to Follow-up|6|||
16801171|NCT02308033|37742722|FG001|Overall Study|Lost to Follow-up|5|||
16801172|NCT02339155|37742730|FG000|Overall Study|Adverse Event|0|||
16801173|NCT02339155|37742731|FG001|Overall Study|Adverse Event|6|||
16801174|NCT02339155|37742730|FG000|Overall Study|Death|1|||
16801175|NCT02339155|37742731|FG001|Overall Study|Death|1|||
16801176|NCT02339155|37742730|FG000|Overall Study|Lost to Follow-up|8|||
16801177|NCT02339155|37742731|FG001|Overall Study|Lost to Follow-up|9|||
16801178|NCT02339155|37742730|FG000|Overall Study|Physician Decision|2|||
16801179|NCT02339155|37742731|FG001|Overall Study|Physician Decision|1|||
16801180|NCT02339155|37742730|FG000|Overall Study|Withdrawal by Subject|4|||
16801181|NCT02339155|37742731|FG001|Overall Study|Withdrawal by Subject|4|||
16801182|NCT02211261|37742750|FG000|Overall Study|Withdrawal by Subject|0|||
16801183|NCT02211261|37742751|FG001|Overall Study|Withdrawal by Subject|0|||
16801184|NCT02211261|37742752|FG002|Overall Study|Withdrawal by Subject|1|||
16801185|NCT02211261|37742753|FG003|Overall Study|Withdrawal by Subject|0|||
16801186|NCT02211261|37742754|FG004|Overall Study|Withdrawal by Subject|2|||
16801187|NCT02211261|37742755|FG005|Overall Study|Withdrawal by Subject|0|||
16801188|NCT02211261|37742756|FG006|Overall Study|Withdrawal by Subject|0|||
16801189|NCT02211261|37742757|FG007|Overall Study|Withdrawal by Subject|0|||
16801190|NCT02211261|37742758|FG008|Overall Study|Withdrawal by Subject|0|||
16801191|NCT02211261|37742759|FG009|Overall Study|Withdrawal by Subject|0|||
16801192|NCT02211261|37742760|FG010|Overall Study|Withdrawal by Subject|0|||
16801193|NCT02211261|37742750|FG000|Overall Study|Other|0|||
16801194|NCT02211261|37742751|FG001|Overall Study|Other|0|||
16801195|NCT02211261|37742752|FG002|Overall Study|Other|0|||
16801196|NCT02211261|37742753|FG003|Overall Study|Other|0|||
16801197|NCT02211261|37742754|FG004|Overall Study|Other|0|||
16801198|NCT02211261|37742755|FG005|Overall Study|Other|1|||
16801199|NCT02211261|37742756|FG006|Overall Study|Other|0|||
16801200|NCT02211261|37742757|FG007|Overall Study|Other|0|||
16801201|NCT02211261|37742758|FG008|Overall Study|Other|0|||
16801202|NCT02211261|37742759|FG009|Overall Study|Other|2|||
16801203|NCT02211261|37742760|FG010|Overall Study|Other|0|||
16801204|NCT02211261|37742750|FG000|Overall Study|Lost to Follow-up|0|||
16801205|NCT02211261|37742751|FG001|Overall Study|Lost to Follow-up|0|||
16801206|NCT02211261|37742752|FG002|Overall Study|Lost to Follow-up|0|||
16801207|NCT02211261|37742753|FG003|Overall Study|Lost to Follow-up|0|||
16801208|NCT02211261|37742754|FG004|Overall Study|Lost to Follow-up|0|||
16801209|NCT02211261|37742755|FG005|Overall Study|Lost to Follow-up|0|||
16801210|NCT02211261|37742756|FG006|Overall Study|Lost to Follow-up|0|||
16801211|NCT02211261|37742757|FG007|Overall Study|Lost to Follow-up|1|||
16801212|NCT02211261|37742758|FG008|Overall Study|Lost to Follow-up|0|||
16801213|NCT02211261|37742759|FG009|Overall Study|Lost to Follow-up|0|||
16801214|NCT02211261|37742760|FG010|Overall Study|Lost to Follow-up|0|||
16801215|NCT02170077|37742796|FG000|Overall Study|Withdrawal by Subject|3|||
16801216|NCT02170077|37742797|FG001|Overall Study|Withdrawal by Subject|4|||
16801217|NCT02170077|37742798|FG002|Overall Study|Withdrawal by Subject|2|||
16801218|NCT02170077|37742796|FG000|Overall Study|Adverse Event|4|||
16801219|NCT02170077|37742797|FG001|Overall Study|Adverse Event|4|||
16801220|NCT02170077|37742798|FG002|Overall Study|Adverse Event|4|||
16801221|NCT02170077|37742796|FG000|Overall Study|Lost to Follow-up|0|||
16801222|NCT02170077|37742797|FG001|Overall Study|Lost to Follow-up|1|||
16801223|NCT02170077|37742798|FG002|Overall Study|Lost to Follow-up|0|||
16801224|NCT02170077|37742796|FG000|Overall Study|Exclusion criteria|2|||
16801225|NCT02170077|37742797|FG001|Overall Study|Exclusion criteria|2|||
16801226|NCT02170077|37742798|FG002|Overall Study|Exclusion criteria|5|||
16801227|NCT02170077|37742796|FG000|Overall Study|Exacerbation of seizures|0|||
16801228|NCT02170077|37742797|FG001|Overall Study|Exacerbation of seizures|2|||
16801229|NCT02170077|37742798|FG002|Overall Study|Exacerbation of seizures|1|||
16801230|NCT02210091|37742808|FG000|Overall Study|Physician Decision|0|||
16801231|NCT02210091|37742809|FG001|Overall Study|Physician Decision|1|||
16801232|NCT02210091|37742808|FG000|Overall Study|Withdrawal by Sponsor|0|||
16801233|NCT02210091|37742809|FG001|Overall Study|Withdrawal by Sponsor|1|||
16801234|NCT02338999|37742833|FG000|First Intervention|Withdrawal by Subject|3|||
16801235|NCT02338999|37742834|FG001|First Intervention|Withdrawal by Subject|1|||
16801236|NCT02338999|37742833|FG000|Washout Period|Withdrawal by Subject|0|||
16801237|NCT02338999|37742834|FG001|Washout Period|Withdrawal by Subject|2|||
16801238|NCT02338999|37742833|FG000|Second Intervention|Withdrawal by Subject|0|||
16801239|NCT02338999|37742834|FG001|Second Intervention|Withdrawal by Subject|2|||
16801240|NCT02169219|37742840|FG000|Overall Study|Lack of Efficacy|6|||
16801241|NCT02191605|37742854|FG000|Overall Study|Lost to Follow-up|9|||
16801242|NCT02191605|37742855|FG001|Overall Study|Lost to Follow-up|4|||
16801243|NCT02191605|37742856|FG002|Overall Study|Lost to Follow-up|7|||
16801244|NCT02191605|37742857|FG003|Overall Study|Lost to Follow-up|3|||
16801245|NCT02191605|37742858|FG004|Overall Study|Lost to Follow-up|4|||
16801246|NCT02191137|37742870|FG000|Treatment|Death|4|||
16801247|NCT02191137|37742870|FG000|Treatment|Withdrawal by Subject|3|||
16801248|NCT02191137|37742870|FG000|Treatment|Adverse Event|2|||
16801249|NCT02191137|37742870|FG000|Treatment|Other|1|||
16801250|NCT02191137|37742870|FG000|Follow-up|Lost to Follow-up|2|||
16801251|NCT02191137|37742870|FG000|Follow-up|Ongoing/unknown|2|||
16801252|NCT02191137|37742870|FG000|Follow-up|Adverse Event|1|||
16801253|NCT02168439|37742876|FG000|Overall Study|Protocol Violation|0|||
16801254|NCT02168439|37742877|FG001|Overall Study|Protocol Violation|2|||
16801255|NCT02190591|37742885|FG000|Overall Study|Withdrawal by Subject|1|||
16801256|NCT02190591|37742886|FG001|Overall Study|Withdrawal by Subject|8|||
16801257|NCT02190591|37742885|FG000|Overall Study|Protocol Violation|1|||
16801258|NCT02190591|37742886|FG001|Overall Study|Protocol Violation|0|||
16801259|NCT02190591|37742885|FG000|Overall Study|did not use peanut ball as instructed|0|||
16801260|NCT02190591|37742886|FG001|Overall Study|did not use peanut ball as instructed|2|||
16801261|NCT02190591|37742885|FG000|Overall Study|face presentation so she was ineligible|0|||
16801262|NCT02190591|37742886|FG001|Overall Study|face presentation so she was ineligible|1|||
16801263|NCT02190435|37742894|FG000|Overall Study|First 12 patients were lead-ins|12|||
16801264|NCT02190435|37742895|FG001|Overall Study|First 12 patients were lead-ins|0|||
16801265|NCT02190435|37742894|FG000|Overall Study|3 consented screen fails|3|||
16801266|NCT02190435|37742895|FG001|Overall Study|3 consented screen fails|0|||
16801267|NCT02338843|37742903|FG000|Overall Study|Adverse Event|2|||
16801268|NCT02338843|37742904|FG001|Overall Study|Adverse Event|1|||
16801269|NCT02338843|37742903|FG000|Overall Study|Death|40|||
16801270|NCT02338843|37742904|FG001|Overall Study|Death|53|||
16801271|NCT02338843|37742903|FG000|Overall Study|Physician Decision|1|||
16801272|NCT02338843|37742904|FG001|Overall Study|Physician Decision|0|||
16801273|NCT02338843|37742903|FG000|Overall Study|Withdrawal by Subject|0|||
16801274|NCT02338843|37742904|FG001|Overall Study|Withdrawal by Subject|2|||
16801275|NCT02338843|37742903|FG000|Overall Study|Subject Recovered|0|||
16801276|NCT02338843|37742904|FG001|Overall Study|Subject Recovered|2|||
16801277|NCT02338843|37742903|FG000|Overall Study|Discontinued prior to randomizat|1|||
16801278|NCT02338843|37742904|FG001|Overall Study|Discontinued prior to randomizat|0|||
16801279|NCT02190279|37742913|FG000|Overall Study|Withdrawal consent|1|||
16801280|NCT02190279|37742914|FG001|Overall Study|Withdrawal consent|0|||
16801281|NCT02190279|37742915|FG002|Overall Study|Withdrawal consent|1|||
16801282|NCT02190279|37742913|FG000|Overall Study|Lost to Follow-up|2|||
16801283|NCT02190279|37742914|FG001|Overall Study|Lost to Follow-up|0|||
16801284|NCT02190279|37742915|FG002|Overall Study|Lost to Follow-up|0|||
16801285|NCT02190279|37742913|FG000|Overall Study|Refused further treatment|0|||
16801286|NCT02190279|37742914|FG001|Overall Study|Refused further treatment|0|||
16801287|NCT02190279|37742915|FG002|Overall Study|Refused further treatment|1|||
16801288|NCT02190279|37742913|FG000|Overall Study|Screening failure|0|||
16801289|NCT02190279|37742914|FG001|Overall Study|Screening failure|0|||
16801290|NCT02190279|37742915|FG002|Overall Study|Screening failure|1|||
16801291|NCT02135445|37742927|FG000|Overall Study|Lost to Follow-up|1|||
16801292|NCT02135445|37742928|FG001|Overall Study|Lost to Follow-up|0|||
16801293|NCT02135445|37742927|FG000|Overall Study|Withdrawal by Subject|1|||
16801294|NCT02135445|37742928|FG001|Overall Study|Withdrawal by Subject|0|||
16801295|NCT02374099|37742936|FG000|Overall Study|Adverse Event|1|||
16801296|NCT02374099|37742937|FG001|Overall Study|Adverse Event|0|||
16801297|NCT02374099|37742936|FG000|Overall Study|Progressive Disease|35|||
16801298|NCT02374099|37742937|FG001|Overall Study|Progressive Disease|40|||
16801299|NCT02374099|37742936|FG000|Overall Study|Withdrawal by Subject|5|||
16801300|NCT02374099|37742937|FG001|Overall Study|Withdrawal by Subject|1|||
17102303|NCT00091572|38241203|FG000|Overall Study|Major Protocol Violation|2|||
16801301|NCT02374099|37742936|FG000|Overall Study|Miscellaneous|2|||
16801302|NCT02374099|37742937|FG001|Overall Study|Miscellaneous|3|||
16801303|NCT02374099|37742936|FG000|Overall Study|Randomized, but not treated|2|||
16801304|NCT02374099|37742937|FG001|Overall Study|Randomized, but not treated|1|||
16801305|NCT02374099|37742936|FG000|Overall Study|Study Terminated by Sponsor|3|||
16801306|NCT02374099|37742937|FG001|Overall Study|Study Terminated by Sponsor|4|||
16801307|NCT02134977|37742943|FG000|Overall Study|Protocol Deviation|102|||
16801308|NCT02374021|37742949|FG000|Overall Study|Adverse Event|1|||
16801309|NCT02374021|37742950|FG001|Overall Study|Adverse Event|0|||
16801310|NCT02374021|37742949|FG000|Overall Study|Lost to Follow-up|3|||
16801311|NCT02374021|37742950|FG001|Overall Study|Lost to Follow-up|2|||
16801312|NCT02374021|37742949|FG000|Overall Study|Physician Decision|0|||
16801313|NCT02374021|37742950|FG001|Overall Study|Physician Decision|3|||
16801314|NCT02374021|37742949|FG000|Overall Study|Withdrawal by Subject|6|||
16801315|NCT02374021|37742950|FG001|Overall Study|Withdrawal by Subject|5|||
16801316|NCT02374021|37742949|FG000|Overall Study|Poor Adherence|0|||
16801317|NCT02374021|37742950|FG001|Overall Study|Poor Adherence|1|||
16801318|NCT02374021|37742949|FG000|Overall Study|Scan protocol not followed|0|||
16801319|NCT02374021|37742950|FG001|Overall Study|Scan protocol not followed|1|||
16801320|NCT02374021|37742949|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
16801321|NCT02374021|37742950|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
16801322|NCT02134587|37742956|FG000|Overall Study|Did not completed all meetings|30|||
16801323|NCT02372383|37742967|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
16801324|NCT02372383|37742968|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
16801325|NCT02372383|37742969|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
16801326|NCT01648699|37742979|FG000|Overall Study|Death|1|||
16801327|NCT01648699|37742979|FG000|Overall Study|Lost to Follow-up|2|||
16801328|NCT01648699|37742979|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
16801329|NCT02134353|37742994|FG000|Overall Study|Adverse Event|10|||
16801330|NCT02134353|37742995|FG001|Overall Study|Adverse Event|6|||
16801331|NCT02134353|37742994|FG000|Overall Study|Lost to Follow-up|1|||
16801332|NCT02134353|37742995|FG001|Overall Study|Lost to Follow-up|1|||
16801333|NCT02134353|37742994|FG000|Overall Study|Lack of Efficacy|2|||
16801334|NCT02134353|37742995|FG001|Overall Study|Lack of Efficacy|1|||
16801335|NCT02134353|37742994|FG000|Overall Study|Withdrawal by Subject|12|||
16801336|NCT02134353|37742995|FG001|Overall Study|Withdrawal by Subject|13|||
16801337|NCT02134353|37742994|FG000|Overall Study|Death|0|||
16801338|NCT02134353|37742995|FG001|Overall Study|Death|1|||
16801339|NCT02134353|37742994|FG000|Overall Study|Pregnancy|0|||
16801340|NCT02134353|37742995|FG001|Overall Study|Pregnancy|1|||
16801341|NCT02134353|37742994|FG000|Overall Study|Relocation|1|||
16801342|NCT02134353|37742995|FG001|Overall Study|Relocation|0|||
16801343|NCT02134353|37742994|FG000|Overall Study|Other - Patient's Choice|0|||
16801344|NCT02134353|37742995|FG001|Overall Study|Other - Patient's Choice|1|||
16801345|NCT01646125|37743003|FG000|Overall Study|Untreated|2|||
16801346|NCT01646125|37743004|FG001|Overall Study|Untreated|5|||
16801347|NCT01646125|37743003|FG000|Overall Study|Adverse Event|2|||
16801348|NCT01646125|37743004|FG001|Overall Study|Adverse Event|1|||
16801349|NCT01646125|37743003|FG000|Overall Study|Death|1|||
16801350|NCT01646125|37743004|FG001|Overall Study|Death|1|||
16801351|NCT01646125|37743003|FG000|Overall Study|Physician Decision|1|||
16801352|NCT01646125|37743004|FG001|Overall Study|Physician Decision|3|||
16801353|NCT01646125|37743003|FG000|Overall Study|Progressive disease|22|||
16801354|NCT01646125|37743004|FG001|Overall Study|Progressive disease|16|||
16801355|NCT01646125|37743003|FG000|Overall Study|Study terminated by sponsor|2|||
16801356|NCT01646125|37743004|FG001|Overall Study|Study terminated by sponsor|1|||
16801357|NCT01646125|37743003|FG000|Overall Study|Subject/Guardian decision|1|||
16801358|NCT01646125|37743004|FG001|Overall Study|Subject/Guardian decision|1|||
16801359|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
16801360|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16801361|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16801362|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16801363|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16801364|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16801365|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16801366|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
16801367|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
16801368|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
16801369|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
16801370|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
16801371|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
16801372|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
16801373|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
16801374|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
17102304|NCT00091572|38241204|FG001|Overall Study|Major Protocol Violation|0|||
17102305|NCT00091572|38241203|FG000|Overall Study|Toxicity (Related AE)|53|||
16801375|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
16801376|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
16801377|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
16801378|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
16801379|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
16801380|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
16801381|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
16801382|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
16801383|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
16801384|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
16801385|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
16801386|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
16801387|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
16801388|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
16801389|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
16801390|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
16801391|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
16801392|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
16801393|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
16801394|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
16801395|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
16801396|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
16801397|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
16801398|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
16801399|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
16801400|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
16801401|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
16801402|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16801403|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16801404|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16801405|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16801406|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16801407|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16801408|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16801409|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
16801410|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16801411|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16801412|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16801413|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16801414|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16801415|NCT01362790|37743017|FG000|Pilot Phase & Phase 2|Death on study|0|||
16801416|NCT01362790|37743018|FG001|Pilot Phase & Phase 2|Death on study|0|||
16801417|NCT01362790|37743019|FG002|Pilot Phase & Phase 2|Death on study|0|||
16801418|NCT01362790|37743020|FG003|Pilot Phase & Phase 2|Death on study|1|||
16801419|NCT01362790|37743021|FG004|Pilot Phase & Phase 2|Death on study|0|||
16801420|NCT01362790|37743022|FG005|Pilot Phase & Phase 2|Death on study|0|||
16801421|NCT01362790|37743023|FG006|Pilot Phase & Phase 2|Death on study|0|||
16801422|NCT01362790|37743017|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
16801423|NCT01362790|37743018|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
16801424|NCT01362790|37743019|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
16801425|NCT01362790|37743020|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
16801426|NCT01362790|37743021|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
16801427|NCT01362790|37743022|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
16801428|NCT01362790|37743023|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
16801429|NCT01362790|37743017|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16801430|NCT01362790|37743018|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16801431|NCT01362790|37743019|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16801432|NCT01362790|37743020|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16801433|NCT01362790|37743021|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
16801434|NCT01362790|37743022|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16801435|NCT01362790|37743023|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16801436|NCT01362790|37743017|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
16801437|NCT01362790|37743018|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
16801438|NCT01362790|37743019|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
16801439|NCT01362790|37743020|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
16801440|NCT01362790|37743021|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
16801441|NCT01362790|37743022|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
16801442|NCT01362790|37743023|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
16801443|NCT02167893|37743043|FG000|Overall Study|Investigator transferred|85|||
16801444|NCT02167893|37743043|FG000|Overall Study|Investigator health reasons|10|||
16801445|NCT02167893|37743043|FG000|Overall Study|Case report forms not collected|68|||
16801446|NCT02167035|37743049|FG000|Overall Study|Adverse Event|2|||
16801447|NCT02167035|37743050|FG001|Overall Study|Adverse Event|2|||
16801448|NCT02167035|37743049|FG000|Overall Study|Lost to Follow-up|3|||
16801449|NCT02167035|37743050|FG001|Overall Study|Lost to Follow-up|3|||
16801450|NCT02167035|37743049|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
16801451|NCT02167035|37743050|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
16801452|NCT01615198|37743060|FG000|Overall Study|Withdrawal by Subject|5|||
16801453|NCT01615198|37743061|FG001|Overall Study|Withdrawal by Subject|5|||
16801454|NCT01615198|37743060|FG000|Overall Study|Protocol deviation|1|||
16801455|NCT01615198|37743061|FG001|Overall Study|Protocol deviation|1|||
16801456|NCT01615198|37743060|FG000|Overall Study|Physician Decision|5|||
16801457|NCT01615198|37743061|FG001|Overall Study|Physician Decision|1|||
16801458|NCT01615198|37743060|FG000|Overall Study|Lost to Follow-up|1|||
16801459|NCT01615198|37743061|FG001|Overall Study|Lost to Follow-up|1|||
16801460|NCT01615198|37743060|FG000|Overall Study|Lack of Efficacy|1|||
16801461|NCT01615198|37743061|FG001|Overall Study|Lack of Efficacy|6|||
16801462|NCT01615198|37743060|FG000|Overall Study|Adverse Event|11|||
16801463|NCT01615198|37743061|FG001|Overall Study|Adverse Event|5|||
16801464|NCT02337907|37743073|FG000|Overall Study|Other than listed|1|||
16801465|NCT02337907|37743074|FG001|Overall Study|Other than listed|0|||
16801466|NCT02337907|37743075|FG002|Overall Study|Other than listed|0|||
16801467|NCT02337907|37743076|FG003|Overall Study|Other than listed|1|||
16801468|NCT02337907|37743077|FG004|Overall Study|Other than listed|1|||
16801469|NCT02337907|37743078|FG005|Overall Study|Other than listed|0|||
16801470|NCT02337907|37743073|FG000|Overall Study|Withdrawal by Subject|2|||
16801471|NCT02337907|37743074|FG001|Overall Study|Withdrawal by Subject|3|||
16801472|NCT02337907|37743075|FG002|Overall Study|Withdrawal by Subject|0|||
16801473|NCT02337907|37743076|FG003|Overall Study|Withdrawal by Subject|2|||
16801474|NCT02337907|37743077|FG004|Overall Study|Withdrawal by Subject|5|||
16801475|NCT02337907|37743078|FG005|Overall Study|Withdrawal by Subject|0|||
16801476|NCT02337907|37743073|FG000|Overall Study|Lost to Follow-up|0|||
16801477|NCT02337907|37743074|FG001|Overall Study|Lost to Follow-up|0|||
16801478|NCT02337907|37743075|FG002|Overall Study|Lost to Follow-up|0|||
16801479|NCT02337907|37743076|FG003|Overall Study|Lost to Follow-up|0|||
16801480|NCT02337907|37743077|FG004|Overall Study|Lost to Follow-up|0|||
16801481|NCT02337907|37743078|FG005|Overall Study|Lost to Follow-up|1|||
16801482|NCT02337907|37743073|FG000|Overall Study|Adverse Event|1|||
16801483|NCT02337907|37743074|FG001|Overall Study|Adverse Event|1|||
16801484|NCT02337907|37743075|FG002|Overall Study|Adverse Event|1|||
16801485|NCT02337907|37743076|FG003|Overall Study|Adverse Event|1|||
16801486|NCT02337907|37743077|FG004|Overall Study|Adverse Event|4|||
16801487|NCT02337907|37743078|FG005|Overall Study|Adverse Event|0|||
16801488|NCT01913470|37743095|FG000|Overall Study|Lost to Follow-up|0|||
16801489|NCT01913470|37743096|FG001|Overall Study|Lost to Follow-up|1|||
16801490|NCT01913470|37743095|FG000|Overall Study|Physician Decision|0|||
16801491|NCT01913470|37743096|FG001|Overall Study|Physician Decision|1|||
16801492|NCT01913470|37743095|FG000|Overall Study|Withdrawal by Subject|0|||
16801493|NCT01913470|37743096|FG001|Overall Study|Withdrawal by Subject|1|||
16801494|NCT02372071|37743103|FG000|Overall Study|Protocol Violation|18|||
16801495|NCT02337751|37743110|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
16801496|NCT02337751|37743111|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
16801497|NCT02337751|37743110|FG000|Overall Study|Voluntary Withdrawal|6|||
16801498|NCT02337751|37743111|FG001|Overall Study|Voluntary Withdrawal|8|||
16801499|NCT02337751|37743110|FG000|Overall Study|Lack of Efficacy|2|||
16801500|NCT02337751|37743111|FG001|Overall Study|Lack of Efficacy|5|||
16801501|NCT02337751|37743110|FG000|Overall Study|Investigator's Judgement|1|||
16801502|NCT02337751|37743111|FG001|Overall Study|Investigator's Judgement|0|||
16801503|NCT02166333|37743122|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
16801504|NCT02166333|37743123|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
16801505|NCT02166333|37743124|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
16801506|NCT02166333|37743125|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
16801507|NCT02166333|37743126|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
16801508|NCT02166333|37743127|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
16909459|NCT01720446|38018306|FG000|Overall Study|Lost to Follow-up|12|||
16909460|NCT01720446|38018307|FG001|Overall Study|Lost to Follow-up|6|||
16909461|NCT01720446|38018308|FG002|Overall Study|Lost to Follow-up|16|||
16909462|NCT01720446|38018309|FG003|Overall Study|Lost to Follow-up|16|||
17102306|NCT00091572|38241204|FG001|Overall Study|Toxicity (Related AE)|9|||
16801509|NCT02166333|37743122|FG000|Stage 1|Death|4|||
16801510|NCT02166333|37743123|FG001|Stage 1|Death|0|||
16801511|NCT02166333|37743124|FG002|Stage 1|Death|2|||
16801512|NCT02166333|37743125|FG003|Stage 1|Death|0|||
16801513|NCT02166333|37743126|FG004|Stage 1|Death|3|||
16801514|NCT02166333|37743127|FG005|Stage 1|Death|2|||
16801515|NCT02166333|37743122|FG000|Stage 1|Lost to Follow-up|12|||
16801516|NCT02166333|37743123|FG001|Stage 1|Lost to Follow-up|0|||
16801517|NCT02166333|37743124|FG002|Stage 1|Lost to Follow-up|6|||
16909463|NCT01720446|38018306|FG000|Overall Study|Withdrawal by Subject|2|||
17102307|NCT00084266|38241212|FG000|Overall Study|Death|42|||
16801518|NCT02166333|37743125|FG003|Stage 1|Lost to Follow-up|0|||
16801519|NCT02166333|37743126|FG004|Stage 1|Lost to Follow-up|3|||
16801520|NCT02166333|37743127|FG005|Stage 1|Lost to Follow-up|3|||
16801521|NCT02166333|37743122|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
16801522|NCT02166333|37743123|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
16801523|NCT02166333|37743124|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
16801524|NCT02166333|37743125|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
16801525|NCT02166333|37743126|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
16801526|NCT02166333|37743127|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
16801527|NCT02166333|37743122|FG000|Stage 2|Death|4|||
16801528|NCT02166333|37743123|FG001|Stage 2|Death|2|||
16801529|NCT02166333|37743124|FG002|Stage 2|Death|1|||
16801530|NCT02166333|37743125|FG003|Stage 2|Death|0|||
16801531|NCT02166333|37743126|FG004|Stage 2|Death|0|||
16801532|NCT02166333|37743127|FG005|Stage 2|Death|1|||
16801533|NCT02166333|37743122|FG000|Stage 2|Lost to Follow-up|23|||
16801534|NCT02166333|37743123|FG001|Stage 2|Lost to Follow-up|4|||
16801535|NCT02166333|37743124|FG002|Stage 2|Lost to Follow-up|11|||
16801536|NCT02166333|37743125|FG003|Stage 2|Lost to Follow-up|9|||
16801537|NCT02166333|37743126|FG004|Stage 2|Lost to Follow-up|3|||
16801538|NCT02166333|37743127|FG005|Stage 2|Lost to Follow-up|6|||
16801539|NCT02132949|37743141|FG000|Overall Study|Death|7|||
16801540|NCT02132949|37743142|FG001|Overall Study|Death|13|||
16801541|NCT02132949|37743141|FG000|Overall Study|Lost to Follow-up|14|||
16801542|NCT02132949|37743142|FG001|Overall Study|Lost to Follow-up|4|||
16801543|NCT02132949|37743141|FG000|Overall Study|Withdrawal by Subject|6|||
16801544|NCT02132949|37743142|FG001|Overall Study|Withdrawal by Subject|5|||
16801545|NCT02132949|37743141|FG000|Overall Study|Noncompliance|5|||
16801546|NCT02132949|37743142|FG001|Overall Study|Noncompliance|1|||
16801547|NCT02132949|37743141|FG000|Overall Study|Physician Decision|3|||
16801548|NCT02132949|37743142|FG001|Overall Study|Physician Decision|1|||
16801549|NCT02132949|37743141|FG000|Overall Study|Disease Progression|3|||
16801550|NCT02132949|37743142|FG001|Overall Study|Disease Progression|0|||
16801551|NCT02132949|37743141|FG000|Overall Study|Adverse Event|2|||
16801552|NCT02132949|37743142|FG001|Overall Study|Adverse Event|1|||
16801553|NCT02132949|37743141|FG000|Overall Study|Withdrew Prior to Treatment|1|||
16801554|NCT02132949|37743142|FG001|Overall Study|Withdrew Prior to Treatment|2|||
16801555|NCT02132949|37743141|FG000|Overall Study|Reason Unspecified|0|||
16801556|NCT02132949|37743142|FG001|Overall Study|Reason Unspecified|1|||
16801557|NCT02165397|37743151|FG000|Overall Study|Death|7|||
16801558|NCT02165397|37743152|FG001|Overall Study|Death|10|||
16801559|NCT02165397|37743153|FG002|Overall Study|Death|8|||
16801560|NCT02165397|37743151|FG000|Overall Study|Lost to Follow-up|1|||
16801561|NCT02165397|37743152|FG001|Overall Study|Lost to Follow-up|3|||
16801562|NCT02165397|37743153|FG002|Overall Study|Lost to Follow-up|0|||
16801563|NCT02165397|37743151|FG000|Overall Study|Withdrawal by Subject|6|||
16801564|NCT02165397|37743152|FG001|Overall Study|Withdrawal by Subject|6|||
16801565|NCT02165397|37743153|FG002|Overall Study|Withdrawal by Subject|1|||
16801566|NCT02165397|37743151|FG000|Overall Study|Other, Not Specified|0|||
16801567|NCT02165397|37743152|FG001|Overall Study|Other, Not Specified|0|||
16801568|NCT02165397|37743153|FG002|Overall Study|Other, Not Specified|1|||
16801569|NCT02132637|37743165|FG000|Study Period 1|Withdrawal by Subject|0|||
16909464|NCT01720446|38018307|FG001|Overall Study|Withdrawal by Subject|5|||
16909465|NCT01720446|38018308|FG002|Overall Study|Withdrawal by Subject|4|||
16909466|NCT01720446|38018309|FG003|Overall Study|Withdrawal by Subject|4|||
16909467|NCT01698918|38018322|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
16909468|NCT01698918|38018322|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
16909469|NCT01698918|38018322|FG000|First Line Treatment (Core+Extension)|Death|2|||
16909470|NCT01698918|38018322|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
17102308|NCT00084266|38241213|FG001|Overall Study|Death|39|||
16801570|NCT02132637|37743166|FG001|Study Period 1|Withdrawal by Subject|4|||
16801571|NCT02132637|37743165|FG000|Study Period 1|Physician Decision|1|||
16801572|NCT02132637|37743166|FG001|Study Period 1|Physician Decision|0|||
16801573|NCT02132637|37743165|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
16801574|NCT02132637|37743166|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
16801575|NCT02132637|37743165|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
16801576|NCT02132637|37743166|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
16801577|NCT02164929|37743176|FG000|Overall Study|Converted to open procedure|1|||
16801578|NCT02164929|37743177|FG001|Overall Study|Converted to open procedure|0|||
16801579|NCT02164929|37743178|FG002|Overall Study|Converted to open procedure|0|||
16801580|NCT02164929|37743179|FG003|Overall Study|Converted to open procedure|2|||
16801581|NCT02164929|37743176|FG000|Overall Study|Failed regional block|0|||
16801582|NCT02164929|37743177|FG001|Overall Study|Failed regional block|0|||
16801583|NCT02164929|37743178|FG002|Overall Study|Failed regional block|1|||
16801584|NCT02164929|37743179|FG003|Overall Study|Failed regional block|0|||
16909471|NCT01698918|38018322|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
16801585|NCT01888432|37743191|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
16801586|NCT01888432|37743192|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
16801587|NCT01888432|37743191|FG000|12-month Analysis (FAS)|Physician Decision|1|||
16801588|NCT01888432|37743192|FG001|12-month Analysis (FAS)|Physician Decision|1|||
16801589|NCT01888432|37743191|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
16801590|NCT01888432|37743192|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
16801591|NCT01888432|37743191|FG000|12-month Analysis (FAS)|Death|4|||
16801592|NCT01888432|37743192|FG001|12-month Analysis (FAS)|Death|3|||
16801593|NCT01888432|37743191|FG000|24-month Analysis (FAS)|Graft loss|0|||
16801594|NCT01888432|37743192|FG001|24-month Analysis (FAS)|Graft loss|1|||
16801595|NCT01888432|37743191|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
16801596|NCT01888432|37743192|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
16801597|NCT01888432|37743191|FG000|24-month Analysis (FAS)|Physician Decision|2|||
16801598|NCT01888432|37743192|FG001|24-month Analysis (FAS)|Physician Decision|4|||
16801599|NCT01888432|37743191|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
16801600|NCT01888432|37743192|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
16801601|NCT01888432|37743191|FG000|24-month Analysis (FAS)|Death|8|||
16801602|NCT01888432|37743192|FG001|24-month Analysis (FAS)|Death|4|||
16801603|NCT01888432|37743191|FG000|36-month Analysis (Extension)|Death|1|||
16801604|NCT01888432|37743192|FG001|36-month Analysis (Extension)|Death|0|||
16801605|NCT02188719|37743204|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
16801606|NCT02188719|37743205|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
16801607|NCT02188719|37743206|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
16801608|NCT02188719|37743207|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
16801609|NCT01934140|37743217|FG000|Persistence Phase (Year 6-10)|Other|24|||
16801610|NCT01934140|37743218|FG001|Persistence Phase (Year 6-10)|Other|6|||
16801611|NCT01934140|37743217|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
16801612|NCT01934140|37743218|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
16801613|NCT01934140|37743217|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
16801614|NCT01934140|37743218|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
16801615|NCT01934140|37743217|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
16801616|NCT01934140|37743218|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
16801617|NCT01934140|37743217|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
16801618|NCT01934140|37743218|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
16801619|NCT01934140|37743217|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
16801620|NCT01934140|37743218|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
16801621|NCT01934140|37743217|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
16801622|NCT01934140|37743218|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
16801623|NCT01934140|37743217|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
16801624|NCT01934140|37743218|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
16801625|NCT01933672|37743226|FG000|Metformin Run-in Period|Adverse Event|1|||
16801626|NCT01933672|37743227|FG001|Metformin Run-in Period|Adverse Event|0|||
16801627|NCT01933672|37743228|FG002|Metformin Run-in Period|Adverse Event|0|||
16801628|NCT01933672|37743229|FG003|Metformin Run-in Period|Adverse Event|0|||
16801629|NCT01933672|37743230|FG004|Metformin Run-in Period|Adverse Event|0|||
16801630|NCT01933672|37743231|FG005|Metformin Run-in Period|Adverse Event|0|||
16801631|NCT01933672|37743232|FG006|Metformin Run-in Period|Adverse Event|0|||
16801632|NCT01933672|37743226|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
16801633|NCT01933672|37743227|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16801634|NCT01933672|37743228|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16801635|NCT01933672|37743229|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16801636|NCT01933672|37743230|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16801637|NCT01933672|37743231|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16801638|NCT01933672|37743232|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16801639|NCT01933672|37743226|FG000|Metformin Run-in Period|Other|5|||
16801640|NCT01933672|37743227|FG001|Metformin Run-in Period|Other|0|||
16801641|NCT01933672|37743228|FG002|Metformin Run-in Period|Other|0|||
16801642|NCT01933672|37743229|FG003|Metformin Run-in Period|Other|0|||
16801643|NCT01933672|37743230|FG004|Metformin Run-in Period|Other|0|||
16801644|NCT01933672|37743231|FG005|Metformin Run-in Period|Other|0|||
16801645|NCT01933672|37743232|FG006|Metformin Run-in Period|Other|0|||
16801646|NCT01933672|37743226|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801647|NCT01933672|37743227|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801648|NCT01933672|37743228|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801649|NCT01933672|37743229|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801650|NCT01933672|37743230|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
16801651|NCT01933672|37743231|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801652|NCT01933672|37743232|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801653|NCT01933672|37743226|FG000|First Intervention Period (12-16 Days)|Other|0|||
16801654|NCT01933672|37743227|FG001|First Intervention Period (12-16 Days)|Other|0|||
16801655|NCT01933672|37743228|FG002|First Intervention Period (12-16 Days)|Other|1|||
16801656|NCT01933672|37743229|FG003|First Intervention Period (12-16 Days)|Other|0|||
16801657|NCT01933672|37743230|FG004|First Intervention Period (12-16 Days)|Other|0|||
16801658|NCT01933672|37743231|FG005|First Intervention Period (12-16 Days)|Other|1|||
16801659|NCT01933672|37743232|FG006|First Intervention Period (12-16 Days)|Other|0|||
16801660|NCT01933672|37743226|FG000|Second Intervention Period (12-16 Days)|Other|0|||
16801661|NCT01933672|37743227|FG001|Second Intervention Period (12-16 Days)|Other|1|||
16801662|NCT01933672|37743228|FG002|Second Intervention Period (12-16 Days)|Other|1|||
16801663|NCT01933672|37743229|FG003|Second Intervention Period (12-16 Days)|Other|0|||
16801664|NCT01933672|37743230|FG004|Second Intervention Period (12-16 Days)|Other|0|||
16801665|NCT01933672|37743231|FG005|Second Intervention Period (12-16 Days)|Other|0|||
16801666|NCT01933672|37743232|FG006|Second Intervention Period (12-16 Days)|Other|0|||
16801667|NCT01933672|37743226|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801668|NCT01933672|37743227|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801669|NCT01933672|37743228|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801670|NCT01933672|37743229|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
16801671|NCT01933672|37743230|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801672|NCT01933672|37743231|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801673|NCT01933672|37743232|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16801674|NCT01933672|37743226|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16801675|NCT01933672|37743227|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
16801676|NCT01933672|37743228|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16801677|NCT01933672|37743229|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16801678|NCT01933672|37743230|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16801679|NCT01933672|37743231|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16801680|NCT01933672|37743232|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16801681|NCT02164539|37743251|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
16801682|NCT02164539|37743252|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
16801683|NCT02164539|37743253|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
16801684|NCT02164539|37743254|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
16801685|NCT02164539|37743255|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
16801686|NCT02164539|37743256|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
16801687|NCT02164539|37743257|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
16801688|NCT02164539|37743251|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
16801689|NCT02164539|37743252|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
16801690|NCT02164539|37743253|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
16801691|NCT02164539|37743254|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
16801692|NCT02164539|37743255|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
16801693|NCT02164539|37743256|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
16801694|NCT02164539|37743257|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
16801695|NCT02164539|37743251|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
16801696|NCT02164539|37743252|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
16801697|NCT02164539|37743253|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
16801698|NCT02164539|37743254|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
16801699|NCT02164539|37743255|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
16801700|NCT02164539|37743256|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
16801701|NCT02164539|37743257|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
16801702|NCT02164539|37743251|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
16801703|NCT02164539|37743252|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16801704|NCT02164539|37743253|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16801705|NCT02164539|37743254|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16801706|NCT02164539|37743255|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16801707|NCT02164539|37743256|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16801708|NCT02164539|37743257|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16801709|NCT02164539|37743251|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
16801710|NCT02164539|37743252|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
16801711|NCT02164539|37743253|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
16801712|NCT02164539|37743254|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
16801713|NCT02164539|37743255|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
16801714|NCT02164539|37743256|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
16801715|NCT02164539|37743257|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
16909472|NCT01698918|38018322|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
16909473|NCT01698918|38018322|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
16909474|NCT01698918|38018322|FG000|Second Line Treatment (Core+Extension)|Death|1|||
16909475|NCT01698918|38018322|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
17016537|NCT00691210|38161155|FG002|Overall Study|Lack of Efficacy|0|||
16801716|NCT02164539|37743251|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
16801717|NCT02164539|37743252|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
16801718|NCT02164539|37743253|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
16801719|NCT02164539|37743254|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
16801720|NCT02164539|37743255|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
16801721|NCT02164539|37743256|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
16801722|NCT02164539|37743257|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
16801723|NCT02188485|37743274|FG000|Overall Study|Withdrawal by Subject|2|||
16801724|NCT02188485|37743275|FG001|Overall Study|Withdrawal by Subject|1|||
16801725|NCT02188485|37743274|FG000|Overall Study|PI withdrew, lack of capacity|0|||
16801726|NCT02188485|37743275|FG001|Overall Study|PI withdrew, lack of capacity|2|||
16801727|NCT02132247|37743283|FG000|Overall Study|Protocol Violation|1|||
16801728|NCT02132247|37743284|FG001|Overall Study|Protocol Violation|0|||
16801729|NCT01629381|37743292|FG000|Overall Study|Withdrawal by Subject|2|||
16801730|NCT01629381|37743293|FG001|Overall Study|Withdrawal by Subject|5|||
16801731|NCT02131311|37743303|FG000|Overall Study|Adverse Event|2|||
16801732|NCT02131311|37743303|FG000|Overall Study|Protocol Violation|1|||
16801733|NCT02131311|37743303|FG000|Overall Study|Lost to Follow-up|1|||
16801734|NCT01628913|37743310|FG000|Overall Study|Adverse Event|12|||
16801735|NCT01628913|37743311|FG001|Overall Study|Adverse Event|5|||
16801736|NCT01628913|37743310|FG000|Overall Study|Disease Progression|11|||
16801737|NCT01628913|37743311|FG001|Overall Study|Disease Progression|14|||
16801738|NCT01628913|37743310|FG000|Overall Study|Protocol Violation|1|||
16801739|NCT01628913|37743311|FG001|Overall Study|Protocol Violation|0|||
16801740|NCT01628913|37743310|FG000|Overall Study|Death|1|||
16801741|NCT01628913|37743311|FG001|Overall Study|Death|0|||
16801742|NCT01628913|37743310|FG000|Overall Study|study terminated by Sponsor|4|||
16801743|NCT01628913|37743311|FG001|Overall Study|study terminated by Sponsor|9|||
16801744|NCT01628913|37743310|FG000|Overall Study|Withdrawal by Subject|1|||
16801745|NCT01628913|37743311|FG001|Overall Study|Withdrawal by Subject|0|||
16801746|NCT01628913|37743310|FG000|Overall Study|Physician Decision|1|||
16801747|NCT01628913|37743311|FG001|Overall Study|Physician Decision|3|||
16801748|NCT02164383|37743319|FG000|Overall Study|Lost to Follow-up|1|||
16801749|NCT02164383|37743320|FG001|Overall Study|Lost to Follow-up|0|||
16801750|NCT02131233|37743328|FG000|Overall Study|Not Treated|2|||
16801751|NCT02131233|37743329|FG001|Overall Study|Not Treated|3|||
16801752|NCT02131233|37743328|FG000|Overall Study|Adverse Event|7|||
16801753|NCT02131233|37743329|FG001|Overall Study|Adverse Event|6|||
16801754|NCT02131233|37743328|FG000|Overall Study|Death|0|||
16801755|NCT02131233|37743329|FG001|Overall Study|Death|1|||
16801756|NCT02131233|37743328|FG000|Overall Study|Lack of Efficacy|6|||
16801757|NCT02131233|37743329|FG001|Overall Study|Lack of Efficacy|3|||
16801758|NCT02131233|37743328|FG000|Overall Study|Lost to Follow-up|14|||
16801759|NCT02131233|37743329|FG001|Overall Study|Lost to Follow-up|13|||
16801760|NCT02131233|37743328|FG000|Overall Study|Non-Compliance With Study Drug|8|||
16801761|NCT02131233|37743329|FG001|Overall Study|Non-Compliance With Study Drug|5|||
16801762|NCT02131233|37743328|FG000|Overall Study|Physician Decision|7|||
16801763|NCT02131233|37743329|FG001|Overall Study|Physician Decision|0|||
16801764|NCT02131233|37743328|FG000|Overall Study|Pregnancy|4|||
16801765|NCT02131233|37743329|FG001|Overall Study|Pregnancy|0|||
16801766|NCT02131233|37743328|FG000|Overall Study|Withdrawal by Subject|18|||
16801767|NCT02131233|37743329|FG001|Overall Study|Withdrawal by Subject|11|||
16801768|NCT02131155|37743337|FG000|Overall Study|Adverse Event|1|||
16801769|NCT02131155|37743338|FG001|Overall Study|Adverse Event|0|||
16801770|NCT02131155|37743337|FG000|Overall Study|Treatment completed|1|||
16801771|NCT02131155|37743338|FG001|Overall Study|Treatment completed|0|||
16801772|NCT02131155|37743337|FG000|Overall Study|Primary tumour recurrence|2|||
16801773|NCT02131155|37743338|FG001|Overall Study|Primary tumour recurrence|1|||
16801774|NCT02131155|37743337|FG000|Overall Study|Refused to continue study medication|1|||
16801775|NCT02131155|37743338|FG001|Overall Study|Refused to continue study medication|0|||
16801776|NCT02131155|37743337|FG000|Overall Study|Study early termination|20|||
16801777|NCT02131155|37743338|FG001|Overall Study|Study early termination|10|||
16801778|NCT01933594|37743350|FG000|Overall Study|Lost to Follow-up|1|||
16801779|NCT01933594|37743351|FG001|Overall Study|Lost to Follow-up|0|||
16801780|NCT01933594|37743352|FG002|Overall Study|Lost to Follow-up|0|||
16801781|NCT01933594|37743353|FG003|Overall Study|Lost to Follow-up|0|||
16801782|NCT01933594|37743354|FG004|Overall Study|Lost to Follow-up|1|||
16801783|NCT01933594|37743355|FG005|Overall Study|Lost to Follow-up|0|||
16801784|NCT01933594|37743350|FG000|Overall Study|Ineligible for subsequent study step|0|||
16801785|NCT01933594|37743351|FG001|Overall Study|Ineligible for subsequent study step|0|||
16801786|NCT01933594|37743352|FG002|Overall Study|Ineligible for subsequent study step|0|||
16801787|NCT01933594|37743353|FG003|Overall Study|Ineligible for subsequent study step|0|||
16801788|NCT01933594|37743354|FG004|Overall Study|Ineligible for subsequent study step|1|||
16801789|NCT01933594|37743355|FG005|Overall Study|Ineligible for subsequent study step|0|||
16801790|NCT01932970|37743373|FG000|Overall Study|Withdrawal by Subject|5|||
16801791|NCT01932970|37743373|FG000|Overall Study|Death|1|||
16909476|NCT01698918|38018322|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
16801792|NCT01932970|37743373|FG000|Overall Study|Lost to Follow-up|2|||
16801793|NCT01932970|37743373|FG000|Overall Study|Protocol Specified Criteria|10|||
16801794|NCT01912768|37743379|FG000|Overall Study|Adverse Event|2|||
16801795|NCT01912768|37743380|FG001|Overall Study|Adverse Event|0|||
16801796|NCT01912768|37743379|FG000|Overall Study|Lost to Follow-up|2|||
16801797|NCT01912768|37743380|FG001|Overall Study|Lost to Follow-up|1|||
16801798|NCT01912768|37743379|FG000|Overall Study|Withdrawal by Subject|5|||
16801799|NCT01912768|37743380|FG001|Overall Study|Withdrawal by Subject|3|||
16801800|NCT01912768|37743379|FG000|Overall Study|Randomized in error|1|||
16801801|NCT01912768|37743380|FG001|Overall Study|Randomized in error|0|||
16801802|NCT02305849|37743390|FG000|Overall Study|Adverse Event|10|||
16801803|NCT02305849|37743391|FG001|Overall Study|Adverse Event|12|||
16801804|NCT02305849|37743392|FG002|Overall Study|Adverse Event|7|||
16801805|NCT02305849|37743393|FG003|Overall Study|Adverse Event|3|||
16801806|NCT02305849|37743390|FG000|Overall Study|Lack of Efficacy|10|||
16801807|NCT02305849|37743391|FG001|Overall Study|Lack of Efficacy|6|||
16801808|NCT02305849|37743392|FG002|Overall Study|Lack of Efficacy|3|||
16801809|NCT02305849|37743393|FG003|Overall Study|Lack of Efficacy|9|||
16801810|NCT02305849|37743390|FG000|Overall Study|Withdrawal by Subject|2|||
16801811|NCT02305849|37743391|FG001|Overall Study|Withdrawal by Subject|2|||
16801812|NCT02305849|37743392|FG002|Overall Study|Withdrawal by Subject|1|||
16801813|NCT02305849|37743393|FG003|Overall Study|Withdrawal by Subject|4|||
16801814|NCT02305849|37743390|FG000|Overall Study|Lost to Follow-up|0|||
16801815|NCT02305849|37743391|FG001|Overall Study|Lost to Follow-up|2|||
16801816|NCT02305849|37743392|FG002|Overall Study|Lost to Follow-up|0|||
16801817|NCT02305849|37743393|FG003|Overall Study|Lost to Follow-up|0|||
16801818|NCT02305849|37743390|FG000|Overall Study|Protocol Violation|3|||
16801819|NCT02305849|37743391|FG001|Overall Study|Protocol Violation|2|||
16801820|NCT02305849|37743392|FG002|Overall Study|Protocol Violation|1|||
16801821|NCT02305849|37743393|FG003|Overall Study|Protocol Violation|1|||
16801822|NCT02305849|37743390|FG000|Overall Study|Lab data met discontinuation criteria|0|||
16801823|NCT02305849|37743391|FG001|Overall Study|Lab data met discontinuation criteria|1|||
16801824|NCT02305849|37743392|FG002|Overall Study|Lab data met discontinuation criteria|2|||
16801825|NCT02305849|37743393|FG003|Overall Study|Lab data met discontinuation criteria|1|||
16801826|NCT02305849|37743390|FG000|Overall Study|Miscellaneous|1|||
16801827|NCT02305849|37743391|FG001|Overall Study|Miscellaneous|2|||
16801828|NCT02305849|37743392|FG002|Overall Study|Miscellaneous|4|||
16801829|NCT02305849|37743393|FG003|Overall Study|Miscellaneous|1|||
16801830|NCT02305849|37743390|FG000|Overall Study|Not fulfill eligibility criteria|1|||
16801831|NCT02305849|37743391|FG001|Overall Study|Not fulfill eligibility criteria|1|||
16801832|NCT02305849|37743392|FG002|Overall Study|Not fulfill eligibility criteria|0|||
16801833|NCT02305849|37743393|FG003|Overall Study|Not fulfill eligibility criteria|0|||
16801834|NCT02371759|37743432|FG000|Overall Study|Protocol Violation|3|||
16801835|NCT02371759|37743433|FG001|Overall Study|Protocol Violation|1|||
16801836|NCT02371759|37743434|FG002|Overall Study|Protocol Violation|1|||
16801837|NCT02371759|37743435|FG003|Overall Study|Protocol Violation|0|||
16801838|NCT02371759|37743436|FG004|Overall Study|Protocol Violation|3|||
16801839|NCT02371759|37743437|FG005|Overall Study|Protocol Violation|1|||
16801840|NCT02371759|37743438|FG006|Overall Study|Protocol Violation|0|||
16801841|NCT02371759|37743439|FG007|Overall Study|Protocol Violation|3|||
16801842|NCT02371759|37743432|FG000|Overall Study|Withdrawal by Subject|0|||
16801843|NCT02371759|37743433|FG001|Overall Study|Withdrawal by Subject|0|||
16801844|NCT02371759|37743434|FG002|Overall Study|Withdrawal by Subject|0|||
16801845|NCT02371759|37743435|FG003|Overall Study|Withdrawal by Subject|0|||
16801846|NCT02371759|37743436|FG004|Overall Study|Withdrawal by Subject|0|||
16801847|NCT02371759|37743437|FG005|Overall Study|Withdrawal by Subject|0|||
16801848|NCT02371759|37743438|FG006|Overall Study|Withdrawal by Subject|0|||
16801849|NCT02371759|37743439|FG007|Overall Study|Withdrawal by Subject|1|||
16801850|NCT02531633|37743462|FG000|Part A (52 Weeks)|Sponsor request|24|||
16801851|NCT02531633|37743463|FG001|Part A (52 Weeks)|Sponsor request|24|||
16801852|NCT02531633|37743464|FG002|Part A (52 Weeks)|Sponsor request|18|||
16801853|NCT02531633|37743465|FG003|Part A (52 Weeks)|Sponsor request|18|||
16801854|NCT02531633|37743466|FG004|Part A (52 Weeks)|Sponsor request|19|||
16801855|NCT02531633|37743467|FG005|Part A (52 Weeks)|Sponsor request|0|||
16801856|NCT02531633|37743468|FG006|Part A (52 Weeks)|Sponsor request|0|||
16801857|NCT02531633|37743469|FG007|Part A (52 Weeks)|Sponsor request|0|||
16801858|NCT02531633|37743470|FG008|Part A (52 Weeks)|Sponsor request|0|||
16801859|NCT02531633|37743471|FG009|Part A (52 Weeks)|Sponsor request|0|||
16801860|NCT02531633|37743462|FG000|Part A (52 Weeks)|Protocol Violation|1|||
16801861|NCT02531633|37743463|FG001|Part A (52 Weeks)|Protocol Violation|0|||
16801862|NCT02531633|37743464|FG002|Part A (52 Weeks)|Protocol Violation|0|||
17016538|NCT00691210|38161156|FG003|Overall Study|Lack of Efficacy|1|||
17016539|NCT00691210|38161157|FG004|Overall Study|Lack of Efficacy|0|||
16801863|NCT02531633|37743465|FG003|Part A (52 Weeks)|Protocol Violation|0|||
16801864|NCT02531633|37743466|FG004|Part A (52 Weeks)|Protocol Violation|0|||
16801865|NCT02531633|37743467|FG005|Part A (52 Weeks)|Protocol Violation|0|||
16801866|NCT02531633|37743468|FG006|Part A (52 Weeks)|Protocol Violation|0|||
16801867|NCT02531633|37743469|FG007|Part A (52 Weeks)|Protocol Violation|0|||
16801868|NCT02531633|37743470|FG008|Part A (52 Weeks)|Protocol Violation|0|||
16801869|NCT02531633|37743471|FG009|Part A (52 Weeks)|Protocol Violation|0|||
16801870|NCT02531633|37743462|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
16801871|NCT02531633|37743463|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
16801872|NCT02531633|37743464|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
16801873|NCT02531633|37743465|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
16801874|NCT02531633|37743466|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
16801875|NCT02531633|37743467|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
16801876|NCT02531633|37743468|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
16801877|NCT02531633|37743469|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
16801878|NCT02531633|37743470|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
16801879|NCT02531633|37743471|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
16801880|NCT02531633|37743462|FG000|Part A (52 Weeks)|Physician Decision|1|||
16801881|NCT02531633|37743463|FG001|Part A (52 Weeks)|Physician Decision|4|||
16801882|NCT02531633|37743464|FG002|Part A (52 Weeks)|Physician Decision|3|||
16801883|NCT02531633|37743465|FG003|Part A (52 Weeks)|Physician Decision|1|||
16801884|NCT02531633|37743466|FG004|Part A (52 Weeks)|Physician Decision|0|||
16801885|NCT02531633|37743467|FG005|Part A (52 Weeks)|Physician Decision|0|||
16801886|NCT02531633|37743468|FG006|Part A (52 Weeks)|Physician Decision|0|||
16801887|NCT02531633|37743469|FG007|Part A (52 Weeks)|Physician Decision|0|||
16801888|NCT02531633|37743470|FG008|Part A (52 Weeks)|Physician Decision|0|||
16801889|NCT02531633|37743471|FG009|Part A (52 Weeks)|Physician Decision|0|||
16801890|NCT02531633|37743462|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
16801891|NCT02531633|37743463|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
16801892|NCT02531633|37743464|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
16801893|NCT02531633|37743465|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
16801894|NCT02531633|37743466|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
16801895|NCT02531633|37743467|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
16801896|NCT02531633|37743468|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
16801897|NCT02531633|37743469|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
16801898|NCT02531633|37743470|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
16801899|NCT02531633|37743471|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
16801900|NCT02531633|37743462|FG000|Part A (52 Weeks)|Other|2|||
16801901|NCT02531633|37743463|FG001|Part A (52 Weeks)|Other|0|||
16801902|NCT02531633|37743464|FG002|Part A (52 Weeks)|Other|0|||
16801903|NCT02531633|37743465|FG003|Part A (52 Weeks)|Other|0|||
16801904|NCT02531633|37743466|FG004|Part A (52 Weeks)|Other|0|||
16801905|NCT02531633|37743467|FG005|Part A (52 Weeks)|Other|0|||
16801906|NCT02531633|37743468|FG006|Part A (52 Weeks)|Other|0|||
16801907|NCT02531633|37743469|FG007|Part A (52 Weeks)|Other|0|||
16801908|NCT02531633|37743470|FG008|Part A (52 Weeks)|Other|0|||
16801909|NCT02531633|37743471|FG009|Part A (52 Weeks)|Other|0|||
16801910|NCT02531633|37743462|FG000|Part B (104 Weeks)|Sponsor request|0|||
16801911|NCT02531633|37743463|FG001|Part B (104 Weeks)|Sponsor request|0|||
16801912|NCT02531633|37743464|FG002|Part B (104 Weeks)|Sponsor request|0|||
16801913|NCT02531633|37743465|FG003|Part B (104 Weeks)|Sponsor request|0|||
16801914|NCT02531633|37743466|FG004|Part B (104 Weeks)|Sponsor request|0|||
16801915|NCT02531633|37743467|FG005|Part B (104 Weeks)|Sponsor request|8|||
16801916|NCT02531633|37743468|FG006|Part B (104 Weeks)|Sponsor request|5|||
16801917|NCT02531633|37743469|FG007|Part B (104 Weeks)|Sponsor request|3|||
16801918|NCT02531633|37743470|FG008|Part B (104 Weeks)|Sponsor request|5|||
16801919|NCT02531633|37743471|FG009|Part B (104 Weeks)|Sponsor request|4|||
16801920|NCT02531633|37743462|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
16801921|NCT02531633|37743463|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
16801922|NCT02531633|37743464|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
16801923|NCT02531633|37743465|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
16801924|NCT02531633|37743466|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
16801925|NCT02531633|37743467|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
16801926|NCT02531633|37743468|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
16801927|NCT02531633|37743469|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
16801928|NCT02531633|37743470|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
16801929|NCT02531633|37743471|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
16801930|NCT02536313|37743513|FG000|Overall Study|Lack of Efficacy|0|||
16801931|NCT02536313|37743514|FG001|Overall Study|Lack of Efficacy|1|||
16801932|NCT02187861|37743526|FG000|Overall Study|Adverse Event|2|||
16801933|NCT02187861|37743527|FG001|Overall Study|Adverse Event|1|||
16801934|NCT02187861|37743528|FG002|Overall Study|Adverse Event|2|||
16801935|NCT02187861|37743529|FG003|Overall Study|Adverse Event|1|||
16801936|NCT02187861|37743526|FG000|Overall Study|Death|0|||
17016540|NCT00691210|38161158|FG005|Overall Study|Lack of Efficacy|1|||
16801937|NCT02187861|37743527|FG001|Overall Study|Death|3|||
16801938|NCT02187861|37743528|FG002|Overall Study|Death|1|||
16801939|NCT02187861|37743529|FG003|Overall Study|Death|2|||
16801940|NCT02187861|37743526|FG000|Overall Study|Physician Decision|0|||
16801941|NCT02187861|37743527|FG001|Overall Study|Physician Decision|1|||
16801942|NCT02187861|37743528|FG002|Overall Study|Physician Decision|0|||
16801943|NCT02187861|37743529|FG003|Overall Study|Physician Decision|3|||
16801944|NCT02187861|37743526|FG000|Overall Study|Progressive Disease|4|||
16801945|NCT02187861|37743527|FG001|Overall Study|Progressive Disease|42|||
16801946|NCT02187861|37743528|FG002|Overall Study|Progressive Disease|19|||
16801947|NCT02187861|37743529|FG003|Overall Study|Progressive Disease|22|||
16801948|NCT02187861|37743526|FG000|Overall Study|Withdrawal by Subject|0|||
16801949|NCT02187861|37743527|FG001|Overall Study|Withdrawal by Subject|0|||
16801950|NCT02187861|37743528|FG002|Overall Study|Withdrawal by Subject|3|||
16801951|NCT02187861|37743529|FG003|Overall Study|Withdrawal by Subject|3|||
16801952|NCT02187861|37743526|FG000|Overall Study|Other|0|||
16801953|NCT02187861|37743527|FG001|Overall Study|Other|1|||
16801954|NCT02187861|37743528|FG002|Overall Study|Other|7|||
16801955|NCT02187861|37743529|FG003|Overall Study|Other|1|||
16801956|NCT02163993|37743544|FG000|Treatment Period|Adverse Event|0|||
16801957|NCT02163993|37743545|FG001|Treatment Period|Adverse Event|1|||
16801958|NCT02163993|37743546|FG002|Treatment Period|Adverse Event|0|||
16801959|NCT02163993|37743547|FG003|Treatment Period|Adverse Event|0|||
16801960|NCT02163993|37743548|FG004|Treatment Period|Adverse Event|1|||
16801961|NCT02163993|37743544|FG000|Treatment Period|Lost to Follow-up|2|||
16801962|NCT02163993|37743545|FG001|Treatment Period|Lost to Follow-up|3|||
16801963|NCT02163993|37743546|FG002|Treatment Period|Lost to Follow-up|1|||
16801964|NCT02163993|37743547|FG003|Treatment Period|Lost to Follow-up|3|||
16801965|NCT02163993|37743548|FG004|Treatment Period|Lost to Follow-up|1|||
16801966|NCT02163993|37743544|FG000|Treatment Period|Physician Decision|1|||
16801967|NCT02163993|37743545|FG001|Treatment Period|Physician Decision|0|||
16801968|NCT02163993|37743546|FG002|Treatment Period|Physician Decision|0|||
16801969|NCT02163993|37743547|FG003|Treatment Period|Physician Decision|0|||
16801970|NCT02163993|37743548|FG004|Treatment Period|Physician Decision|0|||
16801971|NCT02163993|37743544|FG000|Treatment Period|Protocol Violation|2|||
16801972|NCT02163993|37743545|FG001|Treatment Period|Protocol Violation|1|||
16801973|NCT02163993|37743546|FG002|Treatment Period|Protocol Violation|0|||
16801974|NCT02163993|37743547|FG003|Treatment Period|Protocol Violation|1|||
16801975|NCT02163993|37743548|FG004|Treatment Period|Protocol Violation|2|||
16801976|NCT02163993|37743544|FG000|Treatment Period|Withdrawal by Subject|6|||
16801977|NCT02163993|37743545|FG001|Treatment Period|Withdrawal by Subject|4|||
16801978|NCT02163993|37743546|FG002|Treatment Period|Withdrawal by Subject|1|||
16801979|NCT02163993|37743547|FG003|Treatment Period|Withdrawal by Subject|4|||
16801980|NCT02163993|37743548|FG004|Treatment Period|Withdrawal by Subject|1|||
16801981|NCT02163993|37743544|FG000|Treatment Period|Not treated|1|||
16801982|NCT02163993|37743545|FG001|Treatment Period|Not treated|0|||
16801983|NCT02163993|37743546|FG002|Treatment Period|Not treated|0|||
16801984|NCT02163993|37743547|FG003|Treatment Period|Not treated|1|||
16801985|NCT02163993|37743548|FG004|Treatment Period|Not treated|2|||
16801986|NCT02163993|37743544|FG000|Post-treatment Period|Adverse Event|0|||
16801987|NCT02163993|37743545|FG001|Post-treatment Period|Adverse Event|0|||
16801988|NCT02163993|37743546|FG002|Post-treatment Period|Adverse Event|1|||
16801989|NCT02163993|37743547|FG003|Post-treatment Period|Adverse Event|0|||
16801990|NCT02163993|37743548|FG004|Post-treatment Period|Adverse Event|0|||
16801991|NCT02163993|37743544|FG000|Post-treatment Period|Lost to Follow-up|2|||
16801992|NCT02163993|37743545|FG001|Post-treatment Period|Lost to Follow-up|2|||
16801993|NCT02163993|37743546|FG002|Post-treatment Period|Lost to Follow-up|3|||
16801994|NCT02163993|37743547|FG003|Post-treatment Period|Lost to Follow-up|1|||
16801995|NCT02163993|37743548|FG004|Post-treatment Period|Lost to Follow-up|0|||
16801996|NCT02163993|37743544|FG000|Post-treatment Period|Protocol Violation|0|||
16801997|NCT02163993|37743545|FG001|Post-treatment Period|Protocol Violation|0|||
16801998|NCT02163993|37743546|FG002|Post-treatment Period|Protocol Violation|0|||
16801999|NCT02163993|37743547|FG003|Post-treatment Period|Protocol Violation|0|||
16802000|NCT02163993|37743548|FG004|Post-treatment Period|Protocol Violation|1|||
16802001|NCT02163993|37743544|FG000|Post-treatment Period|Withdrawal by Subject|2|||
16802002|NCT02163993|37743545|FG001|Post-treatment Period|Withdrawal by Subject|4|||
16802003|NCT02163993|37743546|FG002|Post-treatment Period|Withdrawal by Subject|0|||
16802004|NCT02163993|37743547|FG003|Post-treatment Period|Withdrawal by Subject|1|||
16802005|NCT02163993|37743548|FG004|Post-treatment Period|Withdrawal by Subject|2|||
16802006|NCT02527421|37743571|FG000|Overall Study|Withdrawal by Subject|1|||
16802007|NCT02527421|37743572|FG001|Overall Study|Withdrawal by Subject|0|||
16802008|NCT02163915|37743583|FG000|Overall Study|Withdrawal by Subject|2|||
16802009|NCT02163915|37743584|FG001|Overall Study|Withdrawal by Subject|0|||
16802010|NCT02163915|37743585|FG002|Overall Study|Withdrawal by Subject|2|||
16802011|NCT02163915|37743586|FG003|Overall Study|Withdrawal by Subject|2|||
16802012|NCT02163915|37743587|FG004|Overall Study|Withdrawal by Subject|2|||
16802013|NCT02163915|37743583|FG000|Overall Study|Study termination|1|||
16802014|NCT02163915|37743584|FG001|Overall Study|Study termination|0|||
16802015|NCT02163915|37743585|FG002|Overall Study|Study termination|0|||
16802016|NCT02163915|37743586|FG003|Overall Study|Study termination|0|||
16802017|NCT02163915|37743587|FG004|Overall Study|Study termination|2|||
16802018|NCT02163915|37743583|FG000|Overall Study|Physician Decision|0|||
16802019|NCT02163915|37743584|FG001|Overall Study|Physician Decision|0|||
16802020|NCT02163915|37743585|FG002|Overall Study|Physician Decision|0|||
16802021|NCT02163915|37743586|FG003|Overall Study|Physician Decision|1|||
16802022|NCT02163915|37743587|FG004|Overall Study|Physician Decision|0|||
16802023|NCT02163759|37743606|FG000|Overall Study|Withdrawal by Subject|1|||
16802024|NCT02163759|37743607|FG001|Overall Study|Withdrawal by Subject|5|||
16802025|NCT02163759|37743608|FG002|Overall Study|Withdrawal by Subject|1|||
16802026|NCT02163759|37743606|FG000|Overall Study|Adverse Event|0|||
16802027|NCT02163759|37743607|FG001|Overall Study|Adverse Event|0|||
16802028|NCT02163759|37743608|FG002|Overall Study|Adverse Event|1|||
16802029|NCT02163759|37743606|FG000|Overall Study|Death|0|||
16802030|NCT02163759|37743607|FG001|Overall Study|Death|0|||
16802031|NCT02163759|37743608|FG002|Overall Study|Death|1|||
16802032|NCT02371369|37743621|FG000|Part 1|Physician Decision|0|||
16802033|NCT02371369|37743622|FG001|Part 1|Physician Decision|3|||
16802034|NCT02371369|37743621|FG000|Part 1|Adverse Event|8|||
16802035|NCT02371369|37743622|FG001|Part 1|Adverse Event|0|||
16802036|NCT02371369|37743621|FG000|Part 1|Withdrawal by Subject|1|||
16802037|NCT02371369|37743622|FG001|Part 1|Withdrawal by Subject|6|||
16802038|NCT02371369|37743621|FG000|Part 1|Disease progression|0|||
16802039|NCT02371369|37743622|FG001|Part 1|Disease progression|1|||
16802040|NCT02371369|37743621|FG000|Part 1|Protocol Violation|0|||
16802041|NCT02371369|37743622|FG001|Part 1|Protocol Violation|1|||
16802042|NCT02371369|37743621|FG000|Part 2|Adverse Event|6|||
16802043|NCT02371369|37743622|FG001|Part 2|Adverse Event|5|||
16802044|NCT02371369|37743621|FG000|Part 2|Withdrawal by Subject|16|||
16802045|NCT02371369|37743622|FG001|Part 2|Withdrawal by Subject|6|||
16802046|NCT02371369|37743621|FG000|Part 2|Investigator decision|1|||
16802047|NCT02371369|37743622|FG001|Part 2|Investigator decision|2|||
16802048|NCT02371369|37743621|FG000|Part 2|Death|0|||
16802049|NCT02371369|37743622|FG001|Part 2|Death|1|||
16802050|NCT02371369|37743621|FG000|Part 2|Disease progression|1|||
16802051|NCT02371369|37743622|FG001|Part 2|Disease progression|0|||
16802052|NCT02371369|37743621|FG000|Part 2|Subject Noncompliance|1|||
16802053|NCT02371369|37743622|FG001|Part 2|Subject Noncompliance|0|||
16802054|NCT02371369|37743621|FG000|Part 2|Lost to Follow-up|1|||
16802055|NCT02371369|37743622|FG001|Part 2|Lost to Follow-up|1|||
16802056|NCT02371369|37743621|FG000|Part 2|Subject transitioned to commercial supply|6|||
16802057|NCT02371369|37743622|FG001|Part 2|Subject transitioned to commercial supply|4|||
16802058|NCT02371369|37743621|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
16802059|NCT02371369|37743622|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
16802060|NCT02371369|37743621|FG000|Part 2|Surgical resection of tumor|1|||
16802061|NCT02371369|37743622|FG001|Part 2|Surgical resection of tumor|1|||
16802062|NCT02371369|37743621|FG000|Part 2|Other|0|||
16802063|NCT02371369|37743622|FG001|Part 2|Other|1|||
16802064|NCT02187783|37743644|FG000|Overall Study|Adverse Event|8|||
16802065|NCT02187783|37743644|FG000|Overall Study|Death|3|||
16802066|NCT02187783|37743644|FG000|Overall Study|Progressive disease|80|||
16802067|NCT02187783|37743644|FG000|Overall Study|Protocol Violation|3|||
16802068|NCT02187783|37743644|FG000|Overall Study|Physician Decision|2|||
16802069|NCT02187783|37743644|FG000|Overall Study|Withdrawal by Subject|9|||
16802070|NCT02187783|37743644|FG000|Overall Study|Study terminated by sponsor|1|||
16802071|NCT02337361|37743650|FG000|3-month Follow-up|Lost to Follow-up|19|||
16802072|NCT02337361|37743651|FG001|3-month Follow-up|Lost to Follow-up|14|||
16802073|NCT02337361|37743650|FG000|6-month Follow-up|Lost to Follow-up|2|||
16802074|NCT02337361|37743651|FG001|6-month Follow-up|Lost to Follow-up|4|||
16802075|NCT02336737|37743658|FG000|Overall Study|Withdrawal by Subject|5|||
16802076|NCT02336737|37743658|FG000|Overall Study|Physician Decision|8|||
16802077|NCT02130765|37743667|FG000|Overall Study|Did not receive treatment|4|||
16802078|NCT02130765|37743668|FG001|Overall Study|Did not receive treatment|0|||
16802079|NCT02130765|37743669|FG002|Overall Study|Did not receive treatment|0|||
16802080|NCT02130765|37743670|FG003|Overall Study|Did not receive treatment|0|||
16802081|NCT02305381|37743685|FG000|Overall Study|Unclassified|5|||
16802082|NCT02305381|37743686|FG001|Overall Study|Unclassified|5|||
16802083|NCT02305381|37743687|FG002|Overall Study|Unclassified|7|||
16802084|NCT02336425|37743699|FG000|Overall Study|Study terminated.|2|||
16802085|NCT02336425|37743700|FG001|Overall Study|Study terminated.|2|||
16802086|NCT02336425|37743701|FG002|Overall Study|Study terminated.|3|||
16802087|NCT02336425|37743702|FG003|Overall Study|Study terminated.|3|||
16802088|NCT02163447|37743715|FG000|Overall Study|Withdrawal by Subject|2|||
16802089|NCT02163447|37743716|FG001|Overall Study|Withdrawal by Subject|0|||
16802090|NCT02163447|37743717|FG002|Overall Study|Withdrawal by Subject|1|||
16802091|NCT02163447|37743715|FG000|Overall Study|Lost to Follow-up|1|||
16802092|NCT02163447|37743716|FG001|Overall Study|Lost to Follow-up|3|||
16802093|NCT02163447|37743717|FG002|Overall Study|Lost to Follow-up|0|||
16802094|NCT02163447|37743715|FG000|Overall Study|Moved out of study area|2|||
16802095|NCT02163447|37743716|FG001|Overall Study|Moved out of study area|3|||
17016541|NCT00691210|38161159|FG006|Overall Study|Lack of Efficacy|0|||
17016542|NCT00691210|38161160|FG007|Overall Study|Lack of Efficacy|0|||
16802096|NCT02163447|37743717|FG002|Overall Study|Moved out of study area|2|||
16802097|NCT02163447|37743715|FG000|Overall Study|Became HIV infected at time of delivery|1|||
16802098|NCT02163447|37743716|FG001|Overall Study|Became HIV infected at time of delivery|0|||
16802099|NCT02163447|37743717|FG002|Overall Study|Became HIV infected at time of delivery|0|||
16802100|NCT02370667|37743738|FG000|Overall Study|Lost to Follow-up|0|||
16802101|NCT02370667|37743739|FG001|Overall Study|Lost to Follow-up|1|||
16802102|NCT02370667|37743740|FG002|Overall Study|Lost to Follow-up|0|||
16802103|NCT02130297|37743748|FG000|Overall Study|Lost to Follow-up|4|||
16802104|NCT01931956|37743756|FG000|Overall Study|Death|42|||
16802105|NCT01931956|37743757|FG001|Overall Study|Death|7|||
16802106|NCT01931956|37743758|FG002|Overall Study|Death|379|||
16802107|NCT01931956|37743759|FG003|Overall Study|Death|96|||
16802108|NCT01931956|37743756|FG000|Overall Study|Withdrawal by Subject|5|||
16802109|NCT01931956|37743757|FG001|Overall Study|Withdrawal by Subject|0|||
16802110|NCT01931956|37743758|FG002|Overall Study|Withdrawal by Subject|70|||
16802111|NCT01931956|37743759|FG003|Overall Study|Withdrawal by Subject|30|||
16802112|NCT01931956|37743756|FG000|Overall Study|Lost to Follow-up|2|||
16802113|NCT01931956|37743757|FG001|Overall Study|Lost to Follow-up|0|||
16802114|NCT01931956|37743758|FG002|Overall Study|Lost to Follow-up|11|||
16802115|NCT01931956|37743759|FG003|Overall Study|Lost to Follow-up|7|||
16802116|NCT01931956|37743756|FG000|Overall Study|Expected|2|||
16802117|NCT01931956|37743757|FG001|Overall Study|Expected|0|||
16802118|NCT01931956|37743758|FG002|Overall Study|Expected|6|||
16802119|NCT01931956|37743759|FG003|Overall Study|Expected|0|||
16802120|NCT01931956|37743756|FG000|Overall Study|Not due|0|||
16802121|NCT01931956|37743757|FG001|Overall Study|Not due|0|||
16802122|NCT01931956|37743758|FG002|Overall Study|Not due|21|||
16802123|NCT01931956|37743759|FG003|Overall Study|Not due|0|||
16802124|NCT01887418|37743785|FG000|Overall Study|Travelling difficulties|0|||
16802125|NCT01887418|37743786|FG001|Overall Study|Travelling difficulties|0|||
16802126|NCT01887418|37743787|FG002|Overall Study|Travelling difficulties|1|||
16802127|NCT01886716|37743799|FG000|Week 1|Lost to Follow-up|0|||
16802128|NCT01886716|37743800|FG001|Week 1|Lost to Follow-up|0|||
16802129|NCT01886716|37743801|FG002|Week 1|Lost to Follow-up|2|||
16802130|NCT01886716|37743802|FG003|Week 1|Lost to Follow-up|2|||
16802131|NCT01886716|37743799|FG000|Week 2|Lost to Follow-up|3|||
16802132|NCT01886716|37743800|FG001|Week 2|Lost to Follow-up|2|||
16802133|NCT01886716|37743801|FG002|Week 2|Lost to Follow-up|1|||
16802134|NCT01886716|37743802|FG003|Week 2|Lost to Follow-up|3|||
16802135|NCT01886716|37743799|FG000|Week 3|Lost to Follow-up|1|||
16802136|NCT01886716|37743800|FG001|Week 3|Lost to Follow-up|1|||
16802137|NCT01886716|37743801|FG002|Week 3|Lost to Follow-up|0|||
16802138|NCT01886716|37743802|FG003|Week 3|Lost to Follow-up|1|||
16802139|NCT01912612|37743814|FG000|Overall Study|Adverse Event|4|||
16802140|NCT01912612|37743815|FG001|Overall Study|Adverse Event|0|||
16802141|NCT01912612|37743816|FG002|Overall Study|Adverse Event|0|||
16802142|NCT01912612|37743814|FG000|Overall Study|Withdrew consent|1|||
16802143|NCT01912612|37743815|FG001|Overall Study|Withdrew consent|0|||
16802144|NCT01912612|37743816|FG002|Overall Study|Withdrew consent|0|||
16802145|NCT01912612|37743814|FG000|Overall Study|Study design change|0|||
16802146|NCT01912612|37743815|FG001|Overall Study|Study design change|0|||
16802147|NCT01912612|37743816|FG002|Overall Study|Study design change|3|||
16802148|NCT02304367|37743822|FG000|Overall Study|Lack of Response to Bruosumab|1|||
16802149|NCT02304367|37743822|FG000|Overall Study|Sponsor Decision|3|||
16802150|NCT02304367|37743822|FG000|Overall Study|Death|2|||
16802151|NCT02304367|37743822|FG000|Overall Study|Physician Decision|1|||
16802152|NCT02304367|37743822|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
16802153|NCT02370511|37743836|FG000|Overall Study|Death|10|||
16802154|NCT02370511|37743837|FG001|Overall Study|Death|7|||
17016543|NCT00691132|38161180|FG000|Overall Study|Adverse Event|2|||
17016544|NCT00691132|38161181|FG001|Overall Study|Adverse Event|3|||
16802155|NCT02370511|37743838|FG002|Overall Study|Death|1|||
16802156|NCT02370511|37743836|FG000|Overall Study|Withdrawal by Subject|2|||
16802157|NCT02370511|37743837|FG001|Overall Study|Withdrawal by Subject|0|||
16802158|NCT02370511|37743838|FG002|Overall Study|Withdrawal by Subject|0|||
16802159|NCT02370511|37743836|FG000|Overall Study|Lost to Follow-up|0|||
16802160|NCT02370511|37743837|FG001|Overall Study|Lost to Follow-up|4|||
16802161|NCT02370511|37743838|FG002|Overall Study|Lost to Follow-up|0|||
16802162|NCT02303041|37743848|FG000|Overall Study|Adverse Event|1|||
16802163|NCT02303041|37743849|FG001|Overall Study|Adverse Event|2|||
16802164|NCT02302807|37743857|FG000|Overall Study|Withdrawal by Subject|28|||
16802165|NCT02302807|37743858|FG001|Overall Study|Withdrawal by Subject|11|||
16802166|NCT02302807|37743857|FG000|Overall Study|Lost to Follow-up|4|||
16802167|NCT02302807|37743858|FG001|Overall Study|Lost to Follow-up|6|||
16802168|NCT02302807|37743857|FG000|Overall Study|Death|397|||
16802169|NCT02302807|37743858|FG001|Overall Study|Death|385|||
16802170|NCT02302807|37743857|FG000|Overall Study|Study Terminated By Sponsor|35|||
16802171|NCT02302807|37743858|FG001|Overall Study|Study Terminated By Sponsor|64|||
16802172|NCT02302807|37743857|FG000|Overall Study|Physician Decision|0|||
16802173|NCT02302807|37743858|FG001|Overall Study|Physician Decision|1|||
16802174|NCT02335489|37743877|FG000|Overall Study|Sponsor terminated study|4|||
16802175|NCT02335489|37743877|FG000|Overall Study|Lost to Follow-up|1|||
16802176|NCT02335489|37743877|FG000|Overall Study|Withdrawal by Subject|2|||
16802177|NCT02335489|37743877|FG000|Overall Study|Physician Decision|2|||
16802178|NCT02335489|37743877|FG000|Overall Study|Lack of Efficacy|1|||
16802179|NCT02527343|37743883|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
16802180|NCT02527343|37743884|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16802181|NCT02527343|37743885|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16802182|NCT02527343|37743886|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16802183|NCT02527343|37743887|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16802184|NCT02527343|37743888|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16802185|NCT02527343|37743883|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
16802186|NCT02527343|37743884|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16802187|NCT02527343|37743885|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16802188|NCT02527343|37743886|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16802189|NCT02527343|37743887|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16802190|NCT02527343|37743888|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16802191|NCT02527343|37743883|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16802192|NCT02527343|37743884|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
16802193|NCT02527343|37743885|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16802194|NCT02527343|37743886|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16802195|NCT02527343|37743887|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16802196|NCT02527343|37743888|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16802197|NCT02527343|37743883|FG000|RT Period: Weeks 1 to 52|Other|4|||
16802198|NCT02527343|37743884|FG001|RT Period: Weeks 1 to 52|Other|3|||
16802199|NCT02527343|37743885|FG002|RT Period: Weeks 1 to 52|Other|0|||
16802200|NCT02527343|37743886|FG003|RT Period: Weeks 1 to 52|Other|0|||
16802201|NCT02527343|37743887|FG004|RT Period: Weeks 1 to 52|Other|0|||
16802202|NCT02527343|37743888|FG005|RT Period: Weeks 1 to 52|Other|0|||
16802203|NCT02527343|37743883|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16802204|NCT02527343|37743884|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16802205|NCT02527343|37743885|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
16802206|NCT02527343|37743886|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16802207|NCT02527343|37743887|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16802208|NCT02527343|37743888|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16802209|NCT02527343|37743883|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16802210|NCT02527343|37743884|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16802211|NCT02527343|37743885|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16802212|NCT02527343|37743886|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
16802213|NCT02527343|37743887|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16802214|NCT02527343|37743888|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16802215|NCT02527343|37743883|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16802216|NCT02527343|37743884|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16802217|NCT02527343|37743885|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16802218|NCT02527343|37743886|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16802219|NCT02527343|37743887|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
16802220|NCT02527343|37743888|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16802221|NCT02527343|37743883|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
16802222|NCT02527343|37743884|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
16802223|NCT02527343|37743885|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
16802224|NCT02527343|37743886|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
16802225|NCT02527343|37743887|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
16802226|NCT02527343|37743888|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
16802227|NCT02527343|37743883|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
16802228|NCT02527343|37743884|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
16802229|NCT02527343|37743885|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
16802230|NCT02527343|37743886|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
16802231|NCT02527343|37743887|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
16802232|NCT02527343|37743888|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
16802233|NCT02527343|37743883|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
16802234|NCT02527343|37743884|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
16802235|NCT02527343|37743885|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
16802236|NCT02527343|37743886|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
16802237|NCT02527343|37743887|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
17016545|NCT00691132|38161180|FG000|Overall Study|Withdrawal by Subject|10|||
17016546|NCT00691132|38161181|FG001|Overall Study|Withdrawal by Subject|10|||
17016547|NCT00855218|38161203|FG000|Overall Study|Adverse Event|43|||
16802238|NCT02527343|37743888|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
16802239|NCT02527343|37743883|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
16802240|NCT02527343|37743884|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
16802241|NCT02527343|37743885|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
16802242|NCT02527343|37743886|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
16802243|NCT02527343|37743887|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
16802244|NCT02527343|37743888|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
16802245|NCT02527343|37743883|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16802246|NCT02527343|37743884|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16802247|NCT02527343|37743885|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16802248|NCT02527343|37743886|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16802249|NCT02527343|37743887|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
16802250|NCT02527343|37743888|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16802251|NCT02527343|37743883|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
16802252|NCT02527343|37743884|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
16802253|NCT02527343|37743885|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
16802254|NCT02527343|37743886|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
16802255|NCT02527343|37743887|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
16802256|NCT02527343|37743888|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
16802257|NCT01931566|37743906|FG000|Overall Study|Randomized But Not Treated|6|||
16802258|NCT01931566|37743907|FG001|Overall Study|Randomized But Not Treated|9|||
16802259|NCT01931566|37743908|FG002|Overall Study|Randomized But Not Treated|14|||
16802260|NCT01931566|37743906|FG000|Overall Study|Adverse Event|37|||
16802261|NCT01931566|37743907|FG001|Overall Study|Adverse Event|167|||
16802262|NCT01931566|37743908|FG002|Overall Study|Adverse Event|132|||
16802263|NCT01931566|37743906|FG000|Overall Study|Major Protocol Deviation|5|||
16802264|NCT01931566|37743907|FG001|Overall Study|Major Protocol Deviation|14|||
16802265|NCT01931566|37743908|FG002|Overall Study|Major Protocol Deviation|21|||
16802266|NCT01931566|37743906|FG000|Overall Study|Lost to Follow-up|3|||
16802267|NCT01931566|37743907|FG001|Overall Study|Lost to Follow-up|26|||
16802268|NCT01931566|37743908|FG002|Overall Study|Lost to Follow-up|23|||
16802269|NCT01931566|37743906|FG000|Overall Study|Voluntary Withdrawal|78|||
16802270|NCT01931566|37743907|FG001|Overall Study|Voluntary Withdrawal|245|||
16802271|NCT01931566|37743908|FG002|Overall Study|Voluntary Withdrawal|225|||
16802272|NCT01931566|37743906|FG000|Overall Study|Study Termination|289|||
16802273|NCT01931566|37743907|FG001|Overall Study|Study Termination|968|||
16802274|NCT01931566|37743908|FG002|Overall Study|Study Termination|1037|||
16802275|NCT01931566|37743906|FG000|Overall Study|Reason Not Specified|11|||
16802276|NCT01931566|37743907|FG001|Overall Study|Reason Not Specified|47|||
16802277|NCT01931566|37743908|FG002|Overall Study|Reason Not Specified|53|||
16802278|NCT01931566|37743906|FG000|Overall Study|Missing|0|||
16802279|NCT01931566|37743907|FG001|Overall Study|Missing|0|||
16802280|NCT01931566|37743908|FG002|Overall Study|Missing|1|||
16802281|NCT01912456|37743919|FG000|Period 1|Physician Decision|0|||
16802282|NCT01912456|37743920|FG001|Period 1|Physician Decision|0|||
16802283|NCT01912456|37743921|FG002|Period 1|Physician Decision|1|||
16802284|NCT01912456|37743922|FG003|Period 1|Physician Decision|0|||
16802285|NCT01912456|37743919|FG000|Period 1|non-compliance|1|||
16802286|NCT01912456|37743920|FG001|Period 1|non-compliance|0|||
16802287|NCT01912456|37743921|FG002|Period 1|non-compliance|0|||
16802288|NCT01912456|37743922|FG003|Period 1|non-compliance|1|||
16802289|NCT01912456|37743919|FG000|Period 1|Adverse Event|1|||
16802290|NCT01912456|37743920|FG001|Period 1|Adverse Event|0|||
16802291|NCT01912456|37743921|FG002|Period 1|Adverse Event|0|||
16802292|NCT01912456|37743922|FG003|Period 1|Adverse Event|1|||
16802293|NCT01912456|37743919|FG000|Period 1|Withdrawal by Subject|0|||
16802294|NCT01912456|37743920|FG001|Period 1|Withdrawal by Subject|1|||
16802295|NCT01912456|37743921|FG002|Period 1|Withdrawal by Subject|1|||
16802296|NCT01912456|37743922|FG003|Period 1|Withdrawal by Subject|1|||
16802297|NCT01912456|37743919|FG000|Period 2|Lack of Efficacy|0|||
16802298|NCT01912456|37743920|FG001|Period 2|Lack of Efficacy|2|||
16802299|NCT01912456|37743921|FG002|Period 2|Lack of Efficacy|0|||
16802300|NCT01912456|37743922|FG003|Period 2|Lack of Efficacy|0|||
16802301|NCT01912456|37743919|FG000|Period 2|Adverse Event|0|||
16802302|NCT01912456|37743920|FG001|Period 2|Adverse Event|0|||
16802303|NCT01912456|37743921|FG002|Period 2|Adverse Event|0|||
16802304|NCT01912456|37743922|FG003|Period 2|Adverse Event|1|||
16802305|NCT01885936|37743934|FG000|Overall Study|Withdrawal by Subject|1|||
16802306|NCT01885936|37743935|FG001|Overall Study|Withdrawal by Subject|0|||
16802307|NCT01912222|37743944|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
16802308|NCT01912222|37743945|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
16802309|NCT01912222|37743946|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
16802310|NCT01912222|37743944|FG000|Part B: Treatment Period|Progressive disease|10|||
16802311|NCT01912222|37743945|FG001|Part B: Treatment Period|Progressive disease|12|||
16802312|NCT01912222|37743946|FG002|Part B: Treatment Period|Progressive disease|15|||
17016548|NCT00855218|38161204|FG001|Overall Study|Adverse Event|27|||
16802313|NCT01912222|37743944|FG000|Part B: Treatment Period|Adverse Event|1|||
16802314|NCT01912222|37743945|FG001|Part B: Treatment Period|Adverse Event|2|||
16802315|NCT01912222|37743946|FG002|Part B: Treatment Period|Adverse Event|3|||
16802316|NCT01912222|37743944|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
16802317|NCT01912222|37743945|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
16802318|NCT01912222|37743946|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
16802319|NCT02525861|37743957|FG000|Overall Study|Adverse Event|1|||
16802320|NCT02525861|37743958|FG001|Overall Study|Adverse Event|0|||
16802321|NCT02525861|37743957|FG000|Overall Study|Withdrawal by Subject|0|||
16802322|NCT02525861|37743958|FG001|Overall Study|Withdrawal by Subject|1|||
16802323|NCT02525861|37743957|FG000|Overall Study|Physician Decision|0|||
16802324|NCT02525861|37743958|FG001|Overall Study|Physician Decision|1|||
16802325|NCT02524847|37743966|FG000|Overall Study|Adverse Event|4|||
16802326|NCT02524847|37743966|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
16802327|NCT02524847|37743966|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
17102309|NCT00084266|38241212|FG000|Overall Study|Adverse Event|8|||
16802328|NCT02524847|37743966|FG000|Overall Study|Death|1|||
16802329|NCT02524847|37743966|FG000|Overall Study|Reason not Specified|1|||
16802330|NCT02525627|37743973|FG000|Overall Study|Revision|1|||
16802331|NCT02525627|37743974|FG001|Overall Study|Revision|1|||
16802332|NCT02525627|37743973|FG000|Overall Study|Withdrawal by Subject|1|||
16802333|NCT02525627|37743974|FG001|Overall Study|Withdrawal by Subject|2|||
16802334|NCT02525627|37743973|FG000|Overall Study|Death|1|||
16802335|NCT02525627|37743974|FG001|Overall Study|Death|0|||
16802336|NCT02525627|37743973|FG000|Overall Study|Site terminated|11|||
16802337|NCT02525627|37743974|FG001|Overall Study|Site terminated|10|||
16802338|NCT02129205|37743990|FG000|Overall Study|Withdrawal by Subject|0|||
16802339|NCT02129205|37743991|FG001|Overall Study|Withdrawal by Subject|0|||
16802340|NCT02129205|37743992|FG002|Overall Study|Withdrawal by Subject|0|||
16802341|NCT02129205|37743993|FG003|Overall Study|Withdrawal by Subject|0|||
16802342|NCT02129205|37743994|FG004|Overall Study|Withdrawal by Subject|1|||
16802343|NCT02129205|37743995|FG005|Overall Study|Withdrawal by Subject|1|||
16802344|NCT02129205|37743996|FG006|Overall Study|Withdrawal by Subject|1|||
16802345|NCT02129205|37743997|FG007|Overall Study|Withdrawal by Subject|0|||
16802346|NCT02129205|37743998|FG008|Overall Study|Withdrawal by Subject|1|||
16802347|NCT02129205|37743999|FG009|Overall Study|Withdrawal by Subject|0|||
16802348|NCT02129205|37743990|FG000|Overall Study|Other|1|||
16802349|NCT02129205|37743991|FG001|Overall Study|Other|0|||
16802350|NCT02129205|37743992|FG002|Overall Study|Other|0|||
16802351|NCT02129205|37743993|FG003|Overall Study|Other|0|||
16802352|NCT02129205|37743994|FG004|Overall Study|Other|2|||
16802353|NCT02129205|37743995|FG005|Overall Study|Other|3|||
16802354|NCT02129205|37743996|FG006|Overall Study|Other|3|||
16802355|NCT02129205|37743997|FG007|Overall Study|Other|2|||
16802356|NCT02129205|37743998|FG008|Overall Study|Other|1|||
16802357|NCT02129205|37743999|FG009|Overall Study|Other|0|||
16802358|NCT02128269|37744023|FG000|Treatment Period|Adverse Event|1|||
16802359|NCT02128269|37744023|FG000|Treatment Period|Physician Decision|1|||
16802360|NCT01626885|37744027|FG000|Overall Study|Adverse Event|8|||
16802361|NCT01626885|37744027|FG000|Overall Study|Withdrawal by Subject|4|||
16802362|NCT02524379|37744031|FG000|Overall Study|Death|1|||
16802363|NCT02524145|37744038|FG000|Overall Study|Withdrawal by Subject|2|||
16802364|NCT02524145|37744039|FG001|Overall Study|Withdrawal by Subject|2|||
16802365|NCT02524145|37744040|FG002|Overall Study|Withdrawal by Subject|3|||
16802366|NCT01658813|37744048|FG000|Overall Study|Disease progression|3|||
16802367|NCT02187471|37744060|FG000|Overall Study|Protocol Violation|4|||
16802368|NCT02187471|37744061|FG001|Overall Study|Protocol Violation|5|||
16802369|NCT02187471|37744062|FG002|Overall Study|Protocol Violation|4|||
16802370|NCT02187471|37744063|FG003|Overall Study|Protocol Violation|4|||
16802371|NCT02187471|37744060|FG000|Overall Study|Missing|0|||
16802372|NCT02187471|37744061|FG001|Overall Study|Missing|0|||
16802373|NCT02187471|37744062|FG002|Overall Study|Missing|0|||
16802374|NCT02187471|37744063|FG003|Overall Study|Missing|1|||
16802375|NCT02187471|37744060|FG000|Overall Study|Lack of Efficacy|18|||
16802376|NCT02187471|37744061|FG001|Overall Study|Lack of Efficacy|9|||
16802377|NCT02187471|37744062|FG002|Overall Study|Lack of Efficacy|13|||
16802378|NCT02187471|37744063|FG003|Overall Study|Lack of Efficacy|11|||
16802379|NCT02187471|37744060|FG000|Overall Study|Adverse Event|24|||
16802380|NCT02187471|37744061|FG001|Overall Study|Adverse Event|34|||
16802381|NCT02187471|37744062|FG002|Overall Study|Adverse Event|44|||
16802382|NCT02187471|37744063|FG003|Overall Study|Adverse Event|36|||
16802383|NCT02187471|37744060|FG000|Overall Study|Withdrawal by Subject|23|||
16802384|NCT02187471|37744061|FG001|Overall Study|Withdrawal by Subject|29|||
16802385|NCT02187471|37744062|FG002|Overall Study|Withdrawal by Subject|22|||
16802386|NCT02187471|37744063|FG003|Overall Study|Withdrawal by Subject|24|||
16802387|NCT02187471|37744060|FG000|Overall Study|Other|7|||
16802388|NCT02187471|37744061|FG001|Overall Study|Other|5|||
16802389|NCT02187471|37744062|FG002|Overall Study|Other|3|||
16802390|NCT02187471|37744063|FG003|Overall Study|Other|4|||
16802391|NCT02525471|37744074|FG000|Overall Study|Screen Failure|6|||
16802392|NCT02525471|37744074|FG000|Overall Study|Withdrawal by Subject|4|||
16802393|NCT02525471|37744074|FG000|Overall Study|Death|1|||
16802394|NCT01658735|37744082|FG000|Overall Study|Lack of Efficacy|1|||
16802395|NCT01658735|37744083|FG001|Overall Study|Lack of Efficacy|0|||
16802396|NCT01658735|37744084|FG002|Overall Study|Lack of Efficacy|1|||
16802397|NCT01658735|37744082|FG000|Overall Study|Lost to Follow-up|1|||
16802398|NCT01658735|37744083|FG001|Overall Study|Lost to Follow-up|1|||
16802399|NCT01658735|37744084|FG002|Overall Study|Lost to Follow-up|0|||
16802400|NCT01658735|37744082|FG000|Overall Study|Protocol Violation|0|||
16802401|NCT01658735|37744083|FG001|Overall Study|Protocol Violation|1|||
16802402|NCT01658735|37744084|FG002|Overall Study|Protocol Violation|0|||
16802403|NCT01658735|37744082|FG000|Overall Study|Withdrawal by Subject|3|||
16802404|NCT01658735|37744083|FG001|Overall Study|Withdrawal by Subject|5|||
16802405|NCT01658735|37744084|FG002|Overall Study|Withdrawal by Subject|3|||
16802406|NCT02523599|37744094|FG000|Overall Study|Adverse Event|1|||
16802407|NCT02523599|37744095|FG001|Overall Study|Adverse Event|0|||
16802408|NCT02523599|37744094|FG000|Overall Study|Physician Decision|1|||
16802409|NCT02523599|37744095|FG001|Overall Study|Physician Decision|0|||
16802410|NCT02523599|37744094|FG000|Overall Study|Lost to Follow-up|4|||
16802411|NCT02523599|37744095|FG001|Overall Study|Lost to Follow-up|1|||
16802412|NCT02523599|37744094|FG000|Overall Study|Did not return for Day 30 visit|2|||
16802413|NCT02523599|37744095|FG001|Overall Study|Did not return for Day 30 visit|0|||
16802414|NCT02187159|37744105|FG000|Overall Study|Protocol Violation|4|||
16802415|NCT02187159|37744106|FG001|Overall Study|Protocol Violation|6|||
16802416|NCT02187159|37744107|FG002|Overall Study|Protocol Violation|3|||
16802417|NCT02187159|37744108|FG003|Overall Study|Protocol Violation|4|||
16802418|NCT02187159|37744105|FG000|Overall Study|Lack of Efficacy|10|||
16802419|NCT02187159|37744106|FG001|Overall Study|Lack of Efficacy|5|||
16802420|NCT02187159|37744107|FG002|Overall Study|Lack of Efficacy|4|||
16802421|NCT02187159|37744108|FG003|Overall Study|Lack of Efficacy|7|||
16802422|NCT02187159|37744105|FG000|Overall Study|Adverse Event|28|||
16802423|NCT02187159|37744106|FG001|Overall Study|Adverse Event|33|||
16802424|NCT02187159|37744107|FG002|Overall Study|Adverse Event|42|||
16802425|NCT02187159|37744108|FG003|Overall Study|Adverse Event|50|||
16802426|NCT02187159|37744105|FG000|Overall Study|Withdrawal by Subject|24|||
16802427|NCT02187159|37744106|FG001|Overall Study|Withdrawal by Subject|28|||
16802428|NCT02187159|37744107|FG002|Overall Study|Withdrawal by Subject|25|||
16802429|NCT02187159|37744108|FG003|Overall Study|Withdrawal by Subject|26|||
16802430|NCT02187159|37744105|FG000|Overall Study|Other|3|||
16802431|NCT02187159|37744106|FG001|Overall Study|Other|7|||
16802432|NCT02187159|37744107|FG002|Overall Study|Other|3|||
16802433|NCT02187159|37744108|FG003|Overall Study|Other|9|||
16802434|NCT02335411|37744121|FG000|Overall Study|Death|223|||
16802435|NCT02335411|37744122|FG001|Overall Study|Death|22|||
16802436|NCT02335411|37744123|FG002|Overall Study|Death|26|||
16802437|NCT02335411|37744121|FG000|Overall Study|Physician Decision|3|||
16802438|NCT02335411|37744122|FG001|Overall Study|Physician Decision|0|||
16802439|NCT02335411|37744123|FG002|Overall Study|Physician Decision|0|||
16802440|NCT02335411|37744121|FG000|Overall Study|Protocol Violation|1|||
16802441|NCT02335411|37744122|FG001|Overall Study|Protocol Violation|0|||
16802442|NCT02335411|37744123|FG002|Overall Study|Protocol Violation|0|||
16802443|NCT02335411|37744121|FG000|Overall Study|Withdrawal by Subject|11|||
16802444|NCT02335411|37744122|FG001|Overall Study|Withdrawal by Subject|0|||
16802445|NCT02335411|37744123|FG002|Overall Study|Withdrawal by Subject|3|||
16802446|NCT02335411|37744121|FG000|Overall Study|Sponsor Decision|12|||
16802447|NCT02335411|37744122|FG001|Overall Study|Sponsor Decision|3|||
16802448|NCT02335411|37744123|FG002|Overall Study|Sponsor Decision|2|||
16802449|NCT02335411|37744121|FG000|Overall Study|Adverse Event|9|||
16802450|NCT02335411|37744122|FG001|Overall Study|Adverse Event|0|||
16802451|NCT02335411|37744123|FG002|Overall Study|Adverse Event|0|||
16802452|NCT02186301|37744137|FG000|Overall Study|Progressive Disease|7|||
16802453|NCT02186301|37744138|FG001|Overall Study|Progressive Disease|22|||
16802454|NCT02186301|37744139|FG002|Overall Study|Progressive Disease|27|||
16802455|NCT02186301|37744137|FG000|Overall Study|Adverse Event|5|||
16802456|NCT02186301|37744138|FG001|Overall Study|Adverse Event|5|||
16802457|NCT02186301|37744139|FG002|Overall Study|Adverse Event|5|||
17016549|NCT00855218|38161203|FG000|Overall Study|Withdrawal by Subject|10|||
16802458|NCT02186301|37744137|FG000|Overall Study|Death|1|||
16802459|NCT02186301|37744138|FG001|Overall Study|Death|0|||
16802460|NCT02186301|37744139|FG002|Overall Study|Death|0|||
16802461|NCT02186301|37744137|FG000|Overall Study|Withdrawal by Subject|5|||
16802462|NCT02186301|37744138|FG001|Overall Study|Withdrawal by Subject|1|||
16802463|NCT02186301|37744139|FG002|Overall Study|Withdrawal by Subject|3|||
16802464|NCT02186301|37744137|FG000|Overall Study|Physician Decision|1|||
16802465|NCT02186301|37744138|FG001|Overall Study|Physician Decision|0|||
16802466|NCT02186301|37744139|FG002|Overall Study|Physician Decision|1|||
16802467|NCT02186301|37744137|FG000|Overall Study|Study Terminated by Sponsor|1|||
16802468|NCT02186301|37744138|FG001|Overall Study|Study Terminated by Sponsor|0|||
16802469|NCT02186301|37744139|FG002|Overall Study|Study Terminated by Sponsor|11|||
16802470|NCT02186301|37744137|FG000|Overall Study|Protocol Deviation|0|||
16802471|NCT02186301|37744138|FG001|Overall Study|Protocol Deviation|2|||
16802472|NCT02186301|37744139|FG002|Overall Study|Protocol Deviation|0|||
16802473|NCT02186301|37744137|FG000|Overall Study|Missing|0|||
16802474|NCT02186301|37744138|FG001|Overall Study|Missing|0|||
17016550|NCT00855218|38161204|FG001|Overall Study|Withdrawal by Subject|6|||
16802475|NCT02186301|37744139|FG002|Overall Study|Missing|2|||
16802476|NCT02186301|37744137|FG000|Overall Study|Other|0|||
16802477|NCT02186301|37744138|FG001|Overall Study|Other|0|||
17016551|NCT00855218|38161203|FG000|Overall Study|Physician Decision|18|||
16802478|NCT02186301|37744139|FG002|Overall Study|Other|1|||
16802479|NCT02186223|37744149|FG000|Overall Study|Not eligible for device placement|6|||
16802480|NCT02186223|37744149|FG000|Overall Study|Unable to obtain femoral access|3|||
16802481|NCT02186223|37744149|FG000|Overall Study|Death|3|||
17016552|NCT00855218|38161204|FG001|Overall Study|Physician Decision|11|||
16802482|NCT02186223|37744149|FG000|Overall Study|Device in place less than 48 hours|9|||
16802483|NCT02163057|37744156|FG000|Overall Study|Participant Refusal to Continue|2|||
16802484|NCT02163057|37744157|FG001|Overall Study|Participant Refusal to Continue|2|||
16802485|NCT02163057|37744156|FG000|Overall Study|Participant Significant Noncompliance|0|||
16802486|NCT02163057|37744157|FG001|Overall Study|Participant Significant Noncompliance|1|||
16802487|NCT02163057|37744156|FG000|Overall Study|Progression of Disease|1|||
16802488|NCT02163057|37744157|FG001|Overall Study|Progression of Disease|2|||
16802489|NCT02185521|37744165|FG000|Overall Study|Withdrawal by Subject|1|||
16802490|NCT02185521|37744165|FG000|Overall Study|Protocol Violation|1|||
16802491|NCT01599585|37744172|FG000|Overall Study|Withdrawal by Subject|16|||
16802492|NCT01599585|37744173|FG001|Overall Study|Withdrawal by Subject|9|||
16802493|NCT01599585|37744172|FG000|Overall Study|Lost to Follow-up|3|||
16802494|NCT01599585|37744173|FG001|Overall Study|Lost to Follow-up|5|||
16802495|NCT01599585|37744172|FG000|Overall Study|randomized did not start treatment|3|||
16802496|NCT01599585|37744173|FG001|Overall Study|randomized did not start treatment|3|||
16802497|NCT02185053|37744179|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
16802498|NCT02185053|37744180|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
16802499|NCT02185053|37744181|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
16802500|NCT02185053|37744179|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
16802501|NCT02185053|37744180|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
16802502|NCT02185053|37744181|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
16802503|NCT02185053|37744179|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
16802504|NCT02185053|37744180|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
16802505|NCT02185053|37744181|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
16802506|NCT02185053|37744179|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
16802507|NCT02185053|37744180|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
16802508|NCT02185053|37744181|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
16802509|NCT02185053|37744179|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
16802510|NCT02185053|37744180|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
16802511|NCT02185053|37744181|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
16802512|NCT02185053|37744179|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
16802513|NCT02185053|37744180|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
16802514|NCT02185053|37744181|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
16802515|NCT02185053|37744179|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
16802516|NCT02185053|37744180|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
16802517|NCT02185053|37744181|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
16802518|NCT02185053|37744179|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
16802519|NCT02185053|37744180|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
16802520|NCT02185053|37744181|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
16802521|NCT02161731|37744190|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
16802522|NCT02161731|37744191|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
16802523|NCT02161731|37744190|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
16802524|NCT02161731|37744191|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
16802525|NCT02124759|37744201|FG000|Overall Study|Withdrawal by Subject|3|||
16802526|NCT02124759|37744202|FG001|Overall Study|Withdrawal by Subject|1|||
16802527|NCT02124759|37744203|FG002|Overall Study|Withdrawal by Subject|1|||
16802528|NCT02124759|37744201|FG000|Overall Study|Screen Fail|2|||
16802529|NCT02124759|37744202|FG001|Overall Study|Screen Fail|2|||
16802530|NCT02124759|37744203|FG002|Overall Study|Screen Fail|3|||
16802531|NCT02302339|37744220|FG000|Overall Study|Lost to Follow-up|1|||
16802532|NCT02302339|37744221|FG001|Overall Study|Lost to Follow-up|0|||
16802533|NCT02302339|37744222|FG002|Overall Study|Lost to Follow-up|0|||
16802534|NCT02302339|37744223|FG003|Overall Study|Lost to Follow-up|0|||
16802535|NCT02302339|37744220|FG000|Overall Study|Withdrawal by Subject|0|||
16802536|NCT02302339|37744221|FG001|Overall Study|Withdrawal by Subject|2|||
16802537|NCT02302339|37744222|FG002|Overall Study|Withdrawal by Subject|1|||
16802538|NCT02302339|37744223|FG003|Overall Study|Withdrawal by Subject|0|||
16802539|NCT02161575|37744234|FG000|Overall Study|Protocol Violation|8|||
16802540|NCT02161575|37744234|FG000|Overall Study|Lack of Efficacy|1|||
16802541|NCT02161575|37744234|FG000|Overall Study|Adverse Event|2|||
16802542|NCT02370121|37744240|FG000|Overall Study|Lost to Follow-up|1|||
16802543|NCT02370121|37744241|FG001|Overall Study|Lost to Follow-up|1|||
16802544|NCT02161185|37744247|FG000|Treatment Phase|Administrative/Other|7|||
16802545|NCT02159469|37744251|FG000|Overall Study|Missing Completion status|1|||
16802546|NCT02159469|37744251|FG000|Overall Study|Adverse Event|5|||
16802547|NCT02159469|37744251|FG000|Overall Study|Non-compliance|2|||
16802548|NCT02159469|37744251|FG000|Overall Study|Withdrawal by Subject|9|||
16802549|NCT02159469|37744251|FG000|Overall Study|Lost to Follow-up|1|||
16802550|NCT02159469|37744251|FG000|Overall Study|Sponsor's request|2|||
16802551|NCT02159469|37744251|FG000|Overall Study|Met Stopping Criteria|3|||
16909477|NCT01746108|38018337|FG000|Overall Study|Migrated /moved from study area|0|||
16802552|NCT02159469|37744251|FG000|Overall Study|Other|1|||
16802553|NCT02159469|37744251|FG000|Overall Study|Multiple|29|||
16802554|NCT02123511|37744258|FG000|Overall Study|Cancelled treatment|1|||
16802555|NCT02123511|37744259|FG001|Overall Study|Cancelled treatment|0|||
16802556|NCT02123511|37744258|FG000|Overall Study|Incomplete data|1|||
16802557|NCT02123511|37744259|FG001|Overall Study|Incomplete data|3|||
16802558|NCT02123511|37744258|FG000|Overall Study|Ineligible|0|||
16802559|NCT02123511|37744259|FG001|Overall Study|Ineligible|1|||
16802560|NCT02122887|37744267|FG000|Overall Study|Withdrawal by Subject|20|||
16802561|NCT02122887|37744268|FG001|Overall Study|Withdrawal by Subject|2|||
16802562|NCT02182947|37744274|FG000|Overall Study|Withdrawal by Subject|7|||
16802563|NCT02182947|37744274|FG000|Overall Study|Lost to Follow-up|3|||
16802564|NCT02182947|37744274|FG000|Overall Study|Failed screening activities|8|||
16802565|NCT02370043|37744278|FG000|Overall Study|Withdrawal by Subject|0|||
16802566|NCT02370043|37744279|FG001|Overall Study|Withdrawal by Subject|0|||
16802567|NCT02370043|37744280|FG002|Overall Study|Withdrawal by Subject|0|||
16802568|NCT02370043|37744281|FG003|Overall Study|Withdrawal by Subject|0|||
16802569|NCT02370043|37744282|FG004|Overall Study|Withdrawal by Subject|1|||
16802570|NCT02370043|37744283|FG005|Overall Study|Withdrawal by Subject|1|||
16802571|NCT02301403|37744313|FG000|Overall Study|Withdrawal by Subject|28|||
16802572|NCT02301403|37744314|FG001|Overall Study|Withdrawal by Subject|41|||
16802573|NCT02301169|37744322|FG000|Overall Study|Adverse Event|1|||
16802574|NCT02301169|37744323|FG001|Overall Study|Adverse Event|0|||
16802575|NCT02333383|37744329|FG000|Overall Study|Adalimumab discontinuation|21|||
16802576|NCT02333383|37744329|FG000|Overall Study|Lost to Follow-up|15|||
16802577|NCT02333383|37744329|FG000|Overall Study|Withdrawal by Subject|3|||
16802578|NCT02333383|37744329|FG000|Overall Study|Transfer to another hospital|2|||
16802579|NCT02332915|37744335|FG000|Overall Study|Moved out of region|3|||
16802580|NCT02332915|37744336|FG001|Overall Study|Moved out of region|0|||
16802581|NCT02332915|37744335|FG000|Overall Study|Unrelated illness|1|||
16802582|NCT02332915|37744336|FG001|Overall Study|Unrelated illness|1|||
16802583|NCT02332915|37744335|FG000|Overall Study|Travel distance prohibitive|0|||
16802584|NCT02332915|37744336|FG001|Overall Study|Travel distance prohibitive|1|||
16802585|NCT02332915|37744335|FG000|Overall Study|did not meet inclusion criteria|2|||
16802586|NCT02332915|37744336|FG001|Overall Study|did not meet inclusion criteria|4|||
16802587|NCT02369341|37744349|FG000|Overall Study|Migrated/moved from study area|1|||
16802588|NCT02369341|37744350|FG001|Overall Study|Migrated/moved from study area|0|||
16802589|NCT02121795|37744362|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
16802590|NCT02121795|37744363|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
16802591|NCT02121795|37744362|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
16802592|NCT02121795|37744363|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
16802593|NCT02121795|37744362|FG000|Double-Blind Phase|Lost to Follow-up|7|||
16802594|NCT02121795|37744363|FG001|Double-Blind Phase|Lost to Follow-up|4|||
16802595|NCT02121795|37744362|FG000|Double-Blind Phase|Physician Decision|2|||
16802596|NCT02121795|37744363|FG001|Double-Blind Phase|Physician Decision|5|||
16802597|NCT02121795|37744362|FG000|Double-Blind Phase|Adverse Event|5|||
16802598|NCT02121795|37744363|FG001|Double-Blind Phase|Adverse Event|0|||
16802599|NCT02121795|37744362|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
16802600|NCT02121795|37744363|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16802601|NCT02121795|37744362|FG000|Double-Blind Phase|Protocol Violation|0|||
16802602|NCT02121795|37744363|FG001|Double-Blind Phase|Protocol Violation|3|||
16802603|NCT02121795|37744362|FG000|Double-Blind Phase|Death|1|||
16802604|NCT02121795|37744363|FG001|Double-Blind Phase|Death|1|||
16802605|NCT02121795|37744362|FG000|Open-Label Phase|Physician Decision|8|||
16802606|NCT02121795|37744363|FG001|Open-Label Phase|Physician Decision|8|||
16802607|NCT02121795|37744362|FG000|Open-Label Phase|Withdrawal by Subject|3|||
16802608|NCT02121795|37744363|FG001|Open-Label Phase|Withdrawal by Subject|2|||
16802609|NCT02121795|37744362|FG000|Open-Label Phase|Lost to Follow-up|1|||
16802610|NCT02121795|37744363|FG001|Open-Label Phase|Lost to Follow-up|0|||
16802611|NCT02158533|37744374|FG000|Stage 1|Adverse Event|6|||
16802612|NCT02158533|37744375|FG001|Stage 1|Adverse Event|4|||
16802613|NCT02158533|37744376|FG002|Stage 1|Adverse Event|7|||
16802614|NCT02158533|37744377|FG003|Stage 1|Adverse Event|0|||
16802615|NCT02158533|37744378|FG004|Stage 1|Adverse Event|0|||
16802616|NCT02158533|37744379|FG005|Stage 1|Adverse Event|0|||
16802617|NCT02158533|37744374|FG000|Stage 1|Withdrawal by Subject|3|||
16802618|NCT02158533|37744375|FG001|Stage 1|Withdrawal by Subject|2|||
16802619|NCT02158533|37744376|FG002|Stage 1|Withdrawal by Subject|1|||
16802620|NCT02158533|37744377|FG003|Stage 1|Withdrawal by Subject|0|||
16802621|NCT02158533|37744378|FG004|Stage 1|Withdrawal by Subject|0|||
16802622|NCT02158533|37744379|FG005|Stage 1|Withdrawal by Subject|0|||
16802623|NCT02158533|37744374|FG000|Stage 1|Lack of Efficacy|1|||
16802624|NCT02158533|37744375|FG001|Stage 1|Lack of Efficacy|0|||
16802625|NCT02158533|37744376|FG002|Stage 1|Lack of Efficacy|0|||
16802626|NCT02158533|37744377|FG003|Stage 1|Lack of Efficacy|0|||
16802627|NCT02158533|37744378|FG004|Stage 1|Lack of Efficacy|0|||
16802628|NCT02158533|37744379|FG005|Stage 1|Lack of Efficacy|0|||
16802629|NCT02158533|37744374|FG000|Stage 1|Lost to Follow-up|3|||
16802630|NCT02158533|37744375|FG001|Stage 1|Lost to Follow-up|1|||
16802631|NCT02158533|37744376|FG002|Stage 1|Lost to Follow-up|0|||
16802632|NCT02158533|37744377|FG003|Stage 1|Lost to Follow-up|0|||
16802633|NCT02158533|37744378|FG004|Stage 1|Lost to Follow-up|0|||
16802634|NCT02158533|37744379|FG005|Stage 1|Lost to Follow-up|0|||
16802635|NCT02158533|37744374|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
16802636|NCT02158533|37744375|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
16802637|NCT02158533|37744376|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
16802638|NCT02158533|37744377|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
16802639|NCT02158533|37744378|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
16802640|NCT02158533|37744379|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
16802641|NCT02158533|37744374|FG000|Stage 1|Non-compliance with study visits|1|||
16802642|NCT02158533|37744375|FG001|Stage 1|Non-compliance with study visits|0|||
16802643|NCT02158533|37744376|FG002|Stage 1|Non-compliance with study visits|0|||
16802644|NCT02158533|37744377|FG003|Stage 1|Non-compliance with study visits|0|||
16802645|NCT02158533|37744378|FG004|Stage 1|Non-compliance with study visits|0|||
16802646|NCT02158533|37744379|FG005|Stage 1|Non-compliance with study visits|0|||
16802647|NCT02158533|37744374|FG000|Stage 2|Adverse Event|0|||
16802648|NCT02158533|37744375|FG001|Stage 2|Adverse Event|0|||
16802649|NCT02158533|37744376|FG002|Stage 2|Adverse Event|0|||
16802650|NCT02158533|37744377|FG003|Stage 2|Adverse Event|0|||
16802651|NCT02158533|37744378|FG004|Stage 2|Adverse Event|0|||
16802652|NCT02158533|37744379|FG005|Stage 2|Adverse Event|1|||
16802653|NCT02158533|37744374|FG000|Stage 2|Lack of Efficacy|0|||
16909478|NCT01746108|38018338|FG001|Overall Study|Migrated /moved from study area|1|||
16909479|NCT01746108|38018339|FG002|Overall Study|Migrated /moved from study area|0|||
16909480|NCT01746108|38018337|FG000|Overall Study|Adverse event, non-fatal|0|||
16909481|NCT01746108|38018338|FG001|Overall Study|Adverse event, non-fatal|1|||
16909482|NCT01746108|38018339|FG002|Overall Study|Adverse event, non-fatal|0|||
16909483|NCT01746108|38018337|FG000|Overall Study|Withdrawal by Subject|0|||
16909484|NCT01746108|38018338|FG001|Overall Study|Withdrawal by Subject|1|||
16909485|NCT01746108|38018339|FG002|Overall Study|Withdrawal by Subject|0|||
16909486|NCT01746108|38018337|FG000|Overall Study|Lost to Follow-up|0|||
16909487|NCT01746108|38018338|FG001|Overall Study|Lost to Follow-up|1|||
16909488|NCT01746108|38018339|FG002|Overall Study|Lost to Follow-up|0|||
16909489|NCT01717638|38018368|FG000|Overall Study|Lost to Follow-up|0|||
16909490|NCT01717638|38018369|FG001|Overall Study|Lost to Follow-up|0|||
16909491|NCT01717638|38018370|FG002|Overall Study|Lost to Follow-up|0|||
16909492|NCT01717638|38018371|FG003|Overall Study|Lost to Follow-up|0|||
16909493|NCT01717638|38018372|FG004|Overall Study|Lost to Follow-up|0|||
16909494|NCT01717638|38018373|FG005|Overall Study|Lost to Follow-up|1|||
16909495|NCT01717638|38018374|FG006|Overall Study|Lost to Follow-up|0|||
16909496|NCT01717638|38018375|FG007|Overall Study|Lost to Follow-up|0|||
16909497|NCT01717638|38018376|FG008|Overall Study|Lost to Follow-up|0|||
16909498|NCT01717638|38018377|FG009|Overall Study|Lost to Follow-up|0|||
16909499|NCT01717638|38018378|FG010|Overall Study|Lost to Follow-up|0|||
16909500|NCT01717638|38018379|FG011|Overall Study|Lost to Follow-up|0|||
16909501|NCT01717638|38018380|FG012|Overall Study|Lost to Follow-up|0|||
16909502|NCT01717638|38018368|FG000|Overall Study|Father in hospital|0|||
16909503|NCT01717638|38018369|FG001|Overall Study|Father in hospital|0|||
16909504|NCT01717638|38018370|FG002|Overall Study|Father in hospital|0|||
16909505|NCT01717638|38018371|FG003|Overall Study|Father in hospital|0|||
16909506|NCT01717638|38018372|FG004|Overall Study|Father in hospital|0|||
16909507|NCT01717638|38018373|FG005|Overall Study|Father in hospital|0|||
16909508|NCT01717638|38018374|FG006|Overall Study|Father in hospital|0|||
16909509|NCT01717638|38018375|FG007|Overall Study|Father in hospital|0|||
16909510|NCT01717638|38018376|FG008|Overall Study|Father in hospital|0|||
16909511|NCT01717638|38018377|FG009|Overall Study|Father in hospital|0|||
16909512|NCT01717638|38018378|FG010|Overall Study|Father in hospital|0|||
16909513|NCT01717638|38018379|FG011|Overall Study|Father in hospital|0|||
16909514|NCT01717638|38018380|FG012|Overall Study|Father in hospital|1|||
16909515|NCT01717638|38018368|FG000|Overall Study|Withdrawal by Subject|0|||
16909516|NCT01717638|38018369|FG001|Overall Study|Withdrawal by Subject|1|||
16909517|NCT01717638|38018370|FG002|Overall Study|Withdrawal by Subject|1|||
16909518|NCT01717638|38018371|FG003|Overall Study|Withdrawal by Subject|0|||
16909519|NCT01717638|38018372|FG004|Overall Study|Withdrawal by Subject|1|||
16909520|NCT01717638|38018373|FG005|Overall Study|Withdrawal by Subject|0|||
16909521|NCT01717638|38018374|FG006|Overall Study|Withdrawal by Subject|2|||
16802654|NCT02158533|37744375|FG001|Stage 2|Lack of Efficacy|0|||
16802655|NCT02158533|37744376|FG002|Stage 2|Lack of Efficacy|0|||
16909522|NCT01717638|38018375|FG007|Overall Study|Withdrawal by Subject|1|||
16909523|NCT01717638|38018376|FG008|Overall Study|Withdrawal by Subject|2|||
16909524|NCT01717638|38018377|FG009|Overall Study|Withdrawal by Subject|1|||
16909525|NCT01717638|38018378|FG010|Overall Study|Withdrawal by Subject|0|||
16909526|NCT01717638|38018379|FG011|Overall Study|Withdrawal by Subject|0|||
16909527|NCT01717638|38018380|FG012|Overall Study|Withdrawal by Subject|18|||
16909528|NCT01745094|38018418|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
16909529|NCT01745094|38018419|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
16909530|NCT01745094|38018420|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
16909531|NCT01745094|38018421|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
16802656|NCT02158533|37744377|FG003|Stage 2|Lack of Efficacy|0|||
16802657|NCT02158533|37744378|FG004|Stage 2|Lack of Efficacy|1|||
16802658|NCT02158533|37744379|FG005|Stage 2|Lack of Efficacy|0|||
16802659|NCT02158533|37744374|FG000|Stage 2|Lost to Follow-up|0|||
16802660|NCT02158533|37744375|FG001|Stage 2|Lost to Follow-up|0|||
16802661|NCT02158533|37744376|FG002|Stage 2|Lost to Follow-up|0|||
16802662|NCT02158533|37744377|FG003|Stage 2|Lost to Follow-up|1|||
16802663|NCT02158533|37744378|FG004|Stage 2|Lost to Follow-up|1|||
16802664|NCT02158533|37744379|FG005|Stage 2|Lost to Follow-up|2|||
16802665|NCT02158533|37744374|FG000|Stage 2|Withdrawal by Subject|0|||
16802666|NCT02158533|37744375|FG001|Stage 2|Withdrawal by Subject|0|||
16802667|NCT02158533|37744376|FG002|Stage 2|Withdrawal by Subject|0|||
16802668|NCT02158533|37744377|FG003|Stage 2|Withdrawal by Subject|0|||
16802669|NCT02158533|37744378|FG004|Stage 2|Withdrawal by Subject|1|||
16802670|NCT02158533|37744379|FG005|Stage 2|Withdrawal by Subject|2|||
16802671|NCT02158533|37744374|FG000|Stage 2|Physician Decision|0|||
16802672|NCT02158533|37744375|FG001|Stage 2|Physician Decision|0|||
16802673|NCT02158533|37744376|FG002|Stage 2|Physician Decision|0|||
16802674|NCT02158533|37744377|FG003|Stage 2|Physician Decision|0|||
16802675|NCT02158533|37744378|FG004|Stage 2|Physician Decision|1|||
16802676|NCT02158533|37744379|FG005|Stage 2|Physician Decision|0|||
16802677|NCT02158533|37744374|FG000|Stage 2|Pregnancy|0|||
16802678|NCT02158533|37744375|FG001|Stage 2|Pregnancy|0|||
16802679|NCT02158533|37744376|FG002|Stage 2|Pregnancy|0|||
16802680|NCT02158533|37744377|FG003|Stage 2|Pregnancy|1|||
16802681|NCT02158533|37744378|FG004|Stage 2|Pregnancy|0|||
16802682|NCT02158533|37744379|FG005|Stage 2|Pregnancy|0|||
16802683|NCT02158533|37744374|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
16802684|NCT02158533|37744375|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
16802685|NCT02158533|37744376|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
16802686|NCT02158533|37744377|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
16802687|NCT02158533|37744378|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
16802688|NCT02158533|37744379|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
16802689|NCT02158533|37744374|FG000|Stage 2|Non-adherence with study visits|0|||
16802690|NCT02158533|37744375|FG001|Stage 2|Non-adherence with study visits|0|||
16802691|NCT02158533|37744376|FG002|Stage 2|Non-adherence with study visits|0|||
16802692|NCT02158533|37744377|FG003|Stage 2|Non-adherence with study visits|0|||
16802693|NCT02158533|37744378|FG004|Stage 2|Non-adherence with study visits|0|||
16802694|NCT02158533|37744379|FG005|Stage 2|Non-adherence with study visits|1|||
16802695|NCT02120781|37744395|FG000|Overall Study|Physician Decision|2|||
16802696|NCT02120781|37744396|FG001|Overall Study|Physician Decision|0|||
16802697|NCT02120781|37744395|FG000|Overall Study|Completion not documented|2|||
16802698|NCT02120781|37744396|FG001|Overall Study|Completion not documented|1|||
16802699|NCT02120625|37744402|FG000|Overall Study|Physician Decision|2|||
16802700|NCT02120469|37744409|FG000|Overall Study|HER-2/neu-amplified|1|||
16802701|NCT02120469|37744410|FG001|Overall Study|HER-2/neu-amplified|0|||
16802702|NCT02120469|37744411|FG002|Overall Study|HER-2/neu-amplified|1|||
16802703|NCT02157519|37744424|FG000|Overall Study|Death|3|||
16802704|NCT02157519|37744425|FG001|Overall Study|Death|1|||
16802705|NCT02157519|37744424|FG000|Overall Study|Withdrawal by Subject|7|||
16802706|NCT02157519|37744425|FG001|Overall Study|Withdrawal by Subject|0|||
16802707|NCT02157519|37744424|FG000|Overall Study|Lost to Follow-up|1|||
16802708|NCT02157519|37744425|FG001|Overall Study|Lost to Follow-up|0|||
16802709|NCT02180061|37744433|FG000|Overall Study|Adverse Event|4|||
16802710|NCT02180061|37744434|FG001|Overall Study|Adverse Event|2|||
16802711|NCT02180061|37744433|FG000|Overall Study|Clinical Progression|5|||
16802712|NCT02180061|37744434|FG001|Overall Study|Clinical Progression|1|||
16802713|NCT02180061|37744433|FG000|Overall Study|Progressive Disease|15|||
16802714|NCT02180061|37744434|FG001|Overall Study|Progressive Disease|5|||
16802715|NCT02180061|37744433|FG000|Overall Study|Physician Decision|1|||
16802716|NCT02180061|37744434|FG001|Overall Study|Physician Decision|0|||
16802717|NCT02179515|37744443|FG000|Overall Study|switched to alternative treatment|0|||
16802718|NCT02179515|37744444|FG001|Overall Study|switched to alternative treatment|1|||
16802719|NCT02179515|37744445|FG002|Overall Study|switched to alternative treatment|1|||
16802720|NCT02179515|37744443|FG000|Overall Study|Death|0|||
16802721|NCT02179515|37744444|FG001|Overall Study|Death|1|||
16909532|NCT01745094|38018418|FG000|Overall Study|Adverse Event|0|||
16802722|NCT02179515|37744445|FG002|Overall Study|Death|1|||
16802723|NCT02179515|37744443|FG000|Overall Study|refused further treatment|0|||
16802724|NCT02179515|37744444|FG001|Overall Study|refused further treatment|3|||
16802725|NCT02179515|37744445|FG002|Overall Study|refused further treatment|4|||
16802726|NCT02179515|37744443|FG000|Overall Study|Disease progression on study|2|||
16802727|NCT02179515|37744444|FG001|Overall Study|Disease progression on study|11|||
16909533|NCT01745094|38018419|FG001|Overall Study|Adverse Event|0|||
16802728|NCT02179515|37744445|FG002|Overall Study|Disease progression on study|8|||
16802729|NCT02120157|37744457|FG000|Overall Study|Death|8|||
16802730|NCT02119299|37744463|FG000|Overall Study|Withdrawal by Subject|7|||
16802731|NCT02119299|37744463|FG000|Overall Study|Lack of Efficacy|1|||
16802732|NCT02119299|37744463|FG000|Overall Study|Pregnancy|1|||
16802733|NCT02156271|37744469|FG000|Overall Study|Physician Decision|4|||
16802734|NCT02156271|37744470|FG001|Overall Study|Physician Decision|3|||
16802735|NCT01365455|37744479|FG000|Induction Period|Adverse Event|5|||
16802736|NCT01365455|37744480|FG001|Induction Period|Adverse Event|3|||
16802737|NCT01365455|37744481|FG002|Induction Period|Adverse Event|4|||
16802738|NCT01365455|37744482|FG003|Induction Period|Adverse Event|0|||
16802739|NCT01365455|37744483|FG004|Induction Period|Adverse Event|0|||
16802740|NCT01365455|37744479|FG000|Induction Period|Lack of Efficacy|1|||
16802741|NCT01365455|37744480|FG001|Induction Period|Lack of Efficacy|1|||
16802742|NCT01365455|37744481|FG002|Induction Period|Lack of Efficacy|0|||
16802743|NCT01365455|37744482|FG003|Induction Period|Lack of Efficacy|0|||
16802744|NCT01365455|37744483|FG004|Induction Period|Lack of Efficacy|0|||
16802745|NCT01365455|37744479|FG000|Induction Period|Pregnancy|0|||
16802746|NCT01365455|37744480|FG001|Induction Period|Pregnancy|1|||
16802747|NCT01365455|37744481|FG002|Induction Period|Pregnancy|0|||
16802748|NCT01365455|37744482|FG003|Induction Period|Pregnancy|0|||
16802749|NCT01365455|37744483|FG004|Induction Period|Pregnancy|0|||
16802750|NCT01365455|37744479|FG000|Induction Period|Protocol deviation|0|||
16802751|NCT01365455|37744480|FG001|Induction Period|Protocol deviation|1|||
16802752|NCT01365455|37744481|FG002|Induction Period|Protocol deviation|1|||
16802753|NCT01365455|37744482|FG003|Induction Period|Protocol deviation|0|||
16802754|NCT01365455|37744483|FG004|Induction Period|Protocol deviation|0|||
16802755|NCT01365455|37744479|FG000|Induction Period|Subject/guardian decision|9|||
16802756|NCT01365455|37744480|FG001|Induction Period|Subject/guardian decision|1|||
16802757|NCT01365455|37744481|FG002|Induction Period|Subject/guardian decision|8|||
16802758|NCT01365455|37744482|FG003|Induction Period|Subject/guardian decision|0|||
16802759|NCT01365455|37744483|FG004|Induction Period|Subject/guardian decision|0|||
16802760|NCT01365455|37744479|FG000|Induction Period|Lost to Follow-up|0|||
16802761|NCT01365455|37744480|FG001|Induction Period|Lost to Follow-up|0|||
16802762|NCT01365455|37744481|FG002|Induction Period|Lost to Follow-up|3|||
16802763|NCT01365455|37744482|FG003|Induction Period|Lost to Follow-up|0|||
16802764|NCT01365455|37744483|FG004|Induction Period|Lost to Follow-up|0|||
16802765|NCT01365455|37744479|FG000|Maintenance Period|Adverse Event|12|||
16802766|NCT01365455|37744480|FG001|Maintenance Period|Adverse Event|5|||
16802767|NCT01365455|37744481|FG002|Maintenance Period|Adverse Event|1|||
16802768|NCT01365455|37744482|FG003|Maintenance Period|Adverse Event|2|||
16802769|NCT01365455|37744483|FG004|Maintenance Period|Adverse Event|4|||
16802770|NCT01365455|37744479|FG000|Maintenance Period|Lack of Efficacy|10|||
16802771|NCT01365455|37744480|FG001|Maintenance Period|Lack of Efficacy|2|||
16802772|NCT01365455|37744481|FG002|Maintenance Period|Lack of Efficacy|0|||
16802773|NCT01365455|37744482|FG003|Maintenance Period|Lack of Efficacy|2|||
16802774|NCT01365455|37744483|FG004|Maintenance Period|Lack of Efficacy|2|||
16802775|NCT01365455|37744479|FG000|Maintenance Period|Lost to Follow-up|2|||
16802776|NCT01365455|37744480|FG001|Maintenance Period|Lost to Follow-up|4|||
16802777|NCT01365455|37744481|FG002|Maintenance Period|Lost to Follow-up|0|||
16802778|NCT01365455|37744482|FG003|Maintenance Period|Lost to Follow-up|0|||
16802779|NCT01365455|37744483|FG004|Maintenance Period|Lost to Follow-up|3|||
16802780|NCT01365455|37744479|FG000|Maintenance Period|Non-compliance with study treatment|0|||
16802781|NCT01365455|37744480|FG001|Maintenance Period|Non-compliance with study treatment|0|||
16802782|NCT01365455|37744481|FG002|Maintenance Period|Non-compliance with study treatment|0|||
16802783|NCT01365455|37744482|FG003|Maintenance Period|Non-compliance with study treatment|1|||
16802784|NCT01365455|37744483|FG004|Maintenance Period|Non-compliance with study treatment|0|||
16802785|NCT01365455|37744479|FG000|Maintenance Period|Physician Decision|0|||
16802786|NCT01365455|37744480|FG001|Maintenance Period|Physician Decision|1|||
16802787|NCT01365455|37744481|FG002|Maintenance Period|Physician Decision|0|||
16802788|NCT01365455|37744482|FG003|Maintenance Period|Physician Decision|0|||
16802789|NCT01365455|37744483|FG004|Maintenance Period|Physician Decision|1|||
16802790|NCT01365455|37744479|FG000|Maintenance Period|Pregnancy|0|||
16802791|NCT01365455|37744480|FG001|Maintenance Period|Pregnancy|4|||
16802792|NCT01365455|37744481|FG002|Maintenance Period|Pregnancy|0|||
16802793|NCT01365455|37744482|FG003|Maintenance Period|Pregnancy|0|||
16802794|NCT01365455|37744483|FG004|Maintenance Period|Pregnancy|2|||
16802795|NCT01365455|37744479|FG000|Maintenance Period|Protocol deviation|1|||
16802796|NCT01365455|37744480|FG001|Maintenance Period|Protocol deviation|1|||
16802797|NCT01365455|37744481|FG002|Maintenance Period|Protocol deviation|0|||
16802798|NCT01365455|37744482|FG003|Maintenance Period|Protocol deviation|0|||
16802799|NCT01365455|37744483|FG004|Maintenance Period|Protocol deviation|0|||
16802800|NCT01365455|37744479|FG000|Maintenance Period|Subject/guardian decision|4|||
16802801|NCT01365455|37744480|FG001|Maintenance Period|Subject/guardian decision|6|||
16802802|NCT01365455|37744481|FG002|Maintenance Period|Subject/guardian decision|2|||
16802803|NCT01365455|37744482|FG003|Maintenance Period|Subject/guardian decision|4|||
16802804|NCT01365455|37744483|FG004|Maintenance Period|Subject/guardian decision|1|||
16802805|NCT02155881|37744503|FG000|Overall Study|Withdrawal by Subject|0|||
16802806|NCT02155881|37744504|FG001|Overall Study|Withdrawal by Subject|2|||
16802807|NCT02155881|37744503|FG000|Overall Study|Inappropriately randomized|2|||
16802808|NCT02155881|37744504|FG001|Overall Study|Inappropriately randomized|2|||
16802809|NCT01658579|37744514|FG000|Treatment Period A|Other|0|||
16802810|NCT01658579|37744515|FG001|Treatment Period A|Other|0|||
16802811|NCT01658579|37744516|FG002|Treatment Period A|Other|1|||
16802812|NCT01658579|37744517|FG003|Treatment Period A|Other|1|||
16802813|NCT01658579|37744514|FG000|Treatment Period A|Adverse Event|1|||
16802814|NCT01658579|37744515|FG001|Treatment Period A|Adverse Event|0|||
16802815|NCT01658579|37744516|FG002|Treatment Period A|Adverse Event|0|||
16802816|NCT01658579|37744517|FG003|Treatment Period A|Adverse Event|0|||
16802817|NCT01658579|37744514|FG000|Treatment Period B|Other|0|||
16802818|NCT01658579|37744515|FG001|Treatment Period B|Other|0|||
16802819|NCT01658579|37744516|FG002|Treatment Period B|Other|0|||
16802820|NCT01658579|37744517|FG003|Treatment Period B|Other|1|||
17102310|NCT00084266|38241213|FG001|Overall Study|Adverse Event|5|||
17102311|NCT00084266|38241212|FG000|Overall Study|Lack of Efficacy|2|||
16802821|NCT02155647|37744525|FG000|Overall Study|Still on Treatment|26|||
16802822|NCT02155647|37744526|FG001|Overall Study|Still on Treatment|26|||
16802823|NCT02155647|37744525|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
16802824|NCT02155647|37744526|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
16802825|NCT02154087|37744532|FG000|Overall Study|Study Termination|1|||
16802826|NCT02118597|37744536|FG000|Overall Study|Sponsor terminated the study|14|||
16802827|NCT02118597|37744536|FG000|Overall Study|Serious Adverse Event|1|||
16802828|NCT02118597|37744536|FG000|Overall Study|Investigator's decision|1|||
16802829|NCT01659125|37744540|FG000|Overall Study|Withdrawal by Subject|2|||
16802830|NCT01659125|37744540|FG000|Overall Study|Lost to Follow-up|7|||
16802831|NCT01659125|37744540|FG000|Overall Study|Technical Problem|1|||
16802832|NCT01659125|37744540|FG000|Overall Study|Time Constraints|2|||
16802833|NCT01659125|37744540|FG000|Overall Study|Failed to Start Treatment|2|||
16802834|NCT01657253|37744546|FG000|Overall Study|Lost to Follow-up|6|||
16802835|NCT01657253|37744547|FG001|Overall Study|Lost to Follow-up|5|||
16802836|NCT01657253|37744546|FG000|Overall Study|Withdrawal by Subject|11|||
16802837|NCT01657253|37744547|FG001|Overall Study|Withdrawal by Subject|12|||
16802838|NCT01657253|37744546|FG000|Overall Study|Adverse Event|0|||
16802839|NCT01657253|37744547|FG001|Overall Study|Adverse Event|1|||
16802840|NCT02117427|37744556|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
16802841|NCT02117427|37744557|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
16802842|NCT02117427|37744558|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
16802843|NCT02117427|37744556|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
16802844|NCT02117427|37744557|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
16802845|NCT02117427|37744558|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
16802846|NCT02117427|37744556|FG000|Overall Study|Physician Decision|0|||
16802847|NCT02117427|37744557|FG001|Overall Study|Physician Decision|2|||
16802848|NCT02117427|37744558|FG002|Overall Study|Physician Decision|0|||
16802849|NCT02117427|37744556|FG000|Overall Study|No longer meets inclusion criteria|0|||
16802850|NCT02117427|37744557|FG001|Overall Study|No longer meets inclusion criteria|1|||
16802851|NCT02117427|37744558|FG002|Overall Study|No longer meets inclusion criteria|0|||
16802852|NCT02117427|37744556|FG000|Overall Study|Death|0|||
16802853|NCT02117427|37744557|FG001|Overall Study|Death|1|||
16802854|NCT02117427|37744558|FG002|Overall Study|Death|0|||
16802855|NCT02117349|37744566|FG000|Overall Study|Withdrawal by Subject|1|||
16802856|NCT02117349|37744567|FG001|Overall Study|Withdrawal by Subject|0|||
16802857|NCT02117349|37744566|FG000|Overall Study|Lost to Follow-up|1|||
16802858|NCT02117349|37744567|FG001|Overall Study|Lost to Follow-up|1|||
16802859|NCT02117349|37744566|FG000|Overall Study|Death|1|||
16802860|NCT02117349|37744567|FG001|Overall Study|Death|0|||
16802861|NCT01626495|37744573|FG000|Overall Study|Adverse Event|3|||
16802862|NCT01626495|37744573|FG000|Overall Study|Disease progression|27|||
16802863|NCT01626495|37744573|FG000|Overall Study|Withdrawal by Subject|1|||
16802864|NCT01626495|37744573|FG000|Overall Study|Administrative problem|1|||
16802865|NCT01626495|37744573|FG000|Overall Study|Death|2|||
16802866|NCT01626495|37744573|FG000|Overall Study|Physician Decision|1|||
16802867|NCT01626495|37744573|FG000|Overall Study|New cancer therapy|16|||
16802868|NCT01626495|37744573|FG000|Overall Study|Manufacturing failure|1|||
16802869|NCT02177175|37744579|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
16802870|NCT02177175|37744580|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
16802871|NCT02153073|37744586|FG000|Overall Study|Case Report Forms Uncollected|230|||
16802872|NCT02153073|37744586|FG000|Overall Study|Protocol Deviation|68|||
16802873|NCT01657877|37744590|FG000|Overall Study|Withdrawal by Subject|4|||
16802874|NCT01657877|37744590|FG000|Overall Study|Protocol Violation|6|||
16802875|NCT01657877|37744590|FG000|Overall Study|Adverse Event|2|||
16802876|NCT01657877|37744590|FG000|Overall Study|Other Reason|2|||
16802877|NCT02175771|37744615|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
16802878|NCT02175771|37744616|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16802879|NCT02175771|37744617|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16802880|NCT02175771|37744618|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16802881|NCT02175771|37744619|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16802882|NCT02175771|37744620|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16802883|NCT02175771|37744621|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16802884|NCT02175771|37744622|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16802885|NCT02175771|37744623|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16802886|NCT02175771|37744615|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
16802887|NCT02175771|37744616|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16802888|NCT02175771|37744617|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16802889|NCT02175771|37744618|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16802890|NCT02175771|37744619|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16802891|NCT02175771|37744620|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16802892|NCT02175771|37744621|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16802893|NCT02175771|37744622|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16802894|NCT02175771|37744623|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16802895|NCT02175771|37744615|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
16802896|NCT02175771|37744616|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16802897|NCT02175771|37744617|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16802898|NCT02175771|37744618|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16802899|NCT02175771|37744619|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16802900|NCT02175771|37744620|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16802901|NCT02175771|37744621|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16802902|NCT02175771|37744622|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16802903|NCT02175771|37744623|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16802904|NCT02175771|37744615|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
16802905|NCT02175771|37744616|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
16802906|NCT02175771|37744617|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
16802907|NCT02175771|37744618|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
16802908|NCT02175771|37744619|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
16802909|NCT02175771|37744620|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
16802910|NCT02175771|37744621|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
16802911|NCT02175771|37744622|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
16802912|NCT02175771|37744623|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
16802913|NCT02175771|37744615|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
16802914|NCT02175771|37744616|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16802915|NCT02175771|37744617|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16802916|NCT02175771|37744618|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16802917|NCT02175771|37744619|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16802918|NCT02175771|37744620|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16802919|NCT02175771|37744621|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16802920|NCT02175771|37744622|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16802921|NCT02175771|37744623|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16802922|NCT02175771|37744615|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
16802923|NCT02175771|37744616|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16802924|NCT02175771|37744617|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16802925|NCT02175771|37744618|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16802926|NCT02175771|37744619|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16802927|NCT02175771|37744620|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16802928|NCT02175771|37744621|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16802929|NCT02175771|37744622|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16802930|NCT02175771|37744623|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16802931|NCT02175771|37744615|FG000|Run-In Period (Pre-assignment)|Other|8|||
16802932|NCT02175771|37744616|FG001|Run-In Period (Pre-assignment)|Other|0|||
16802933|NCT02175771|37744617|FG002|Run-In Period (Pre-assignment)|Other|0|||
16802934|NCT02175771|37744618|FG003|Run-In Period (Pre-assignment)|Other|0|||
16802935|NCT02175771|37744619|FG004|Run-In Period (Pre-assignment)|Other|0|||
16802936|NCT02175771|37744620|FG005|Run-In Period (Pre-assignment)|Other|0|||
16802937|NCT02175771|37744621|FG006|Run-In Period (Pre-assignment)|Other|0|||
16802938|NCT02175771|37744622|FG007|Run-In Period (Pre-assignment)|Other|0|||
16802939|NCT02175771|37744623|FG008|Run-In Period (Pre-assignment)|Other|0|||
16802940|NCT02175771|37744615|FG000|Treatment Period|Adverse Event|0|||
16802941|NCT02175771|37744616|FG001|Treatment Period|Adverse Event|2|||
16802942|NCT02175771|37744617|FG002|Treatment Period|Adverse Event|1|||
16802943|NCT02175771|37744618|FG003|Treatment Period|Adverse Event|1|||
16802944|NCT02175771|37744619|FG004|Treatment Period|Adverse Event|1|||
16802945|NCT02175771|37744620|FG005|Treatment Period|Adverse Event|3|||
16802946|NCT02175771|37744621|FG006|Treatment Period|Adverse Event|2|||
16802947|NCT02175771|37744622|FG007|Treatment Period|Adverse Event|0|||
16802948|NCT02175771|37744623|FG008|Treatment Period|Adverse Event|1|||
16802949|NCT02175771|37744615|FG000|Treatment Period|Withdrawal by Subject|0|||
16802950|NCT02175771|37744616|FG001|Treatment Period|Withdrawal by Subject|9|||
16802951|NCT02175771|37744617|FG002|Treatment Period|Withdrawal by Subject|3|||
16802952|NCT02175771|37744618|FG003|Treatment Period|Withdrawal by Subject|6|||
16802953|NCT02175771|37744619|FG004|Treatment Period|Withdrawal by Subject|2|||
16802954|NCT02175771|37744620|FG005|Treatment Period|Withdrawal by Subject|4|||
16802955|NCT02175771|37744621|FG006|Treatment Period|Withdrawal by Subject|2|||
16802956|NCT02175771|37744622|FG007|Treatment Period|Withdrawal by Subject|9|||
16802957|NCT02175771|37744623|FG008|Treatment Period|Withdrawal by Subject|2|||
16802958|NCT02175771|37744615|FG000|Treatment Period|Noncompliance|0|||
16802959|NCT02175771|37744616|FG001|Treatment Period|Noncompliance|1|||
16802960|NCT02175771|37744617|FG002|Treatment Period|Noncompliance|2|||
16802961|NCT02175771|37744618|FG003|Treatment Period|Noncompliance|0|||
16802962|NCT02175771|37744619|FG004|Treatment Period|Noncompliance|0|||
16802963|NCT02175771|37744620|FG005|Treatment Period|Noncompliance|0|||
16802964|NCT02175771|37744621|FG006|Treatment Period|Noncompliance|0|||
16802965|NCT02175771|37744622|FG007|Treatment Period|Noncompliance|0|||
16802966|NCT02175771|37744623|FG008|Treatment Period|Noncompliance|1|||
16802967|NCT02175771|37744615|FG000|Treatment Period|Protocol Violation|0|||
16802968|NCT02175771|37744616|FG001|Treatment Period|Protocol Violation|0|||
16802969|NCT02175771|37744617|FG002|Treatment Period|Protocol Violation|0|||
16802970|NCT02175771|37744618|FG003|Treatment Period|Protocol Violation|0|||
16802971|NCT02175771|37744619|FG004|Treatment Period|Protocol Violation|0|||
16802972|NCT02175771|37744620|FG005|Treatment Period|Protocol Violation|0|||
16802973|NCT02175771|37744621|FG006|Treatment Period|Protocol Violation|0|||
16802974|NCT02175771|37744622|FG007|Treatment Period|Protocol Violation|1|||
16802975|NCT02175771|37744623|FG008|Treatment Period|Protocol Violation|0|||
16802976|NCT02175771|37744615|FG000|Treatment Period|Disease progression|0|||
16802977|NCT02175771|37744616|FG001|Treatment Period|Disease progression|0|||
16802978|NCT02175771|37744617|FG002|Treatment Period|Disease progression|0|||
16802979|NCT02175771|37744618|FG003|Treatment Period|Disease progression|0|||
16802980|NCT02175771|37744619|FG004|Treatment Period|Disease progression|0|||
16802981|NCT02175771|37744620|FG005|Treatment Period|Disease progression|0|||
16802982|NCT02175771|37744621|FG006|Treatment Period|Disease progression|0|||
16802983|NCT02175771|37744622|FG007|Treatment Period|Disease progression|2|||
16802984|NCT02175771|37744623|FG008|Treatment Period|Disease progression|0|||
16802985|NCT02175771|37744615|FG000|Treatment Period|Lost to Follow-up|0|||
16802986|NCT02175771|37744616|FG001|Treatment Period|Lost to Follow-up|3|||
16802987|NCT02175771|37744617|FG002|Treatment Period|Lost to Follow-up|1|||
16802988|NCT02175771|37744618|FG003|Treatment Period|Lost to Follow-up|3|||
16802989|NCT02175771|37744619|FG004|Treatment Period|Lost to Follow-up|1|||
16802990|NCT02175771|37744620|FG005|Treatment Period|Lost to Follow-up|2|||
16802991|NCT02175771|37744621|FG006|Treatment Period|Lost to Follow-up|1|||
16802992|NCT02175771|37744622|FG007|Treatment Period|Lost to Follow-up|2|||
16802993|NCT02175771|37744623|FG008|Treatment Period|Lost to Follow-up|2|||
16802994|NCT02175771|37744615|FG000|Treatment Period|Lack of Efficacy|0|||
16802995|NCT02175771|37744616|FG001|Treatment Period|Lack of Efficacy|0|||
16802996|NCT02175771|37744617|FG002|Treatment Period|Lack of Efficacy|0|||
16802997|NCT02175771|37744618|FG003|Treatment Period|Lack of Efficacy|0|||
16802998|NCT02175771|37744619|FG004|Treatment Period|Lack of Efficacy|0|||
16802999|NCT02175771|37744620|FG005|Treatment Period|Lack of Efficacy|1|||
16803000|NCT02175771|37744621|FG006|Treatment Period|Lack of Efficacy|0|||
16803001|NCT02175771|37744622|FG007|Treatment Period|Lack of Efficacy|1|||
16803002|NCT02175771|37744623|FG008|Treatment Period|Lack of Efficacy|0|||
16803003|NCT02175771|37744615|FG000|Treatment Period|Other|0|||
16803004|NCT02175771|37744616|FG001|Treatment Period|Other|1|||
16803005|NCT02175771|37744617|FG002|Treatment Period|Other|0|||
16803006|NCT02175771|37744618|FG003|Treatment Period|Other|3|||
16803007|NCT02175771|37744619|FG004|Treatment Period|Other|1|||
16803008|NCT02175771|37744620|FG005|Treatment Period|Other|0|||
16803009|NCT02175771|37744621|FG006|Treatment Period|Other|0|||
16803010|NCT02175771|37744622|FG007|Treatment Period|Other|2|||
16803011|NCT02175771|37744623|FG008|Treatment Period|Other|0|||
16803012|NCT01657799|37744644|FG000|Overall Study|Adverse Event Related to progression|6|||
16803013|NCT01657799|37744645|FG001|Overall Study|Adverse Event Related to progression|8|||
16803014|NCT01657799|37744646|FG002|Overall Study|Adverse Event Related to progression|12|||
16803015|NCT01657799|37744644|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
16803016|NCT01657799|37744645|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
16803017|NCT01657799|37744646|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
16803018|NCT01657799|37744644|FG000|Overall Study|Withdrawal by Subject|13|||
16803019|NCT01657799|37744645|FG001|Overall Study|Withdrawal by Subject|10|||
16803020|NCT01657799|37744646|FG002|Overall Study|Withdrawal by Subject|10|||
16803021|NCT01657799|37744644|FG000|Overall Study|Lost to Follow-up|1|||
16803022|NCT01657799|37744645|FG001|Overall Study|Lost to Follow-up|0|||
16803023|NCT01657799|37744646|FG002|Overall Study|Lost to Follow-up|1|||
16803024|NCT01657799|37744644|FG000|Overall Study|Disease Progression|2|||
16803025|NCT01657799|37744645|FG001|Overall Study|Disease Progression|4|||
16803026|NCT01657799|37744646|FG002|Overall Study|Disease Progression|4|||
16803027|NCT01657799|37744644|FG000|Overall Study|Progressive Disease Clinical|7|||
16803028|NCT01657799|37744645|FG001|Overall Study|Progressive Disease Clinical|4|||
16803029|NCT01657799|37744646|FG002|Overall Study|Progressive Disease Clinical|7|||
16803030|NCT01657799|37744644|FG000|Overall Study|Radiographic & Clinical Progression|16|||
16803031|NCT01657799|37744645|FG001|Overall Study|Radiographic & Clinical Progression|11|||
16803032|NCT01657799|37744646|FG002|Overall Study|Radiographic & Clinical Progression|15|||
16803033|NCT01657799|37744644|FG000|Overall Study|Other|52|||
16803034|NCT01657799|37744645|FG001|Overall Study|Other|62|||
16803035|NCT01657799|37744646|FG002|Overall Study|Other|49|||
16803036|NCT02116803|37744656|FG000|Overall Study|Adverse Event|2|||
16803037|NCT02116803|37744657|FG001|Overall Study|Adverse Event|1|||
16803038|NCT02116803|37744656|FG000|Overall Study|Physician Decision|1|||
16803039|NCT02116803|37744657|FG001|Overall Study|Physician Decision|0|||
16803040|NCT02116803|37744656|FG000|Overall Study|Progressive disease|4|||
16803041|NCT02116803|37744657|FG001|Overall Study|Progressive disease|0|||
16803042|NCT02116803|37744656|FG000|Overall Study|Study terminated by sponsor|2|||
16803043|NCT02116803|37744657|FG001|Overall Study|Study terminated by sponsor|1|||
16803044|NCT02116803|37744656|FG000|Overall Study|Death|1|||
16803045|NCT02116803|37744657|FG001|Overall Study|Death|0|||
16803046|NCT02115321|37744665|FG000|Overall Study|Death|1|||
16803047|NCT02115321|37744666|FG001|Overall Study|Death|0|||
16803048|NCT02367781|37744674|FG000|Overall Study|Withdrawal by Subject|20|||
16803049|NCT02367781|37744675|FG001|Overall Study|Withdrawal by Subject|13|||
16803050|NCT02367781|37744674|FG000|Overall Study|Protocol Violation|0|||
16803051|NCT02367781|37744675|FG001|Overall Study|Protocol Violation|1|||
16803052|NCT02367781|37744674|FG000|Overall Study|Physician Decision|7|||
16803053|NCT02367781|37744675|FG001|Overall Study|Physician Decision|0|||
16803054|NCT02367781|37744674|FG000|Overall Study|Randomized in Error|5|||
16803055|NCT02367781|37744675|FG001|Overall Study|Randomized in Error|4|||
16803056|NCT02367781|37744674|FG000|Overall Study|Non-Compliance|1|||
16803057|NCT02367781|37744675|FG001|Overall Study|Non-Compliance|0|||
16803058|NCT02367781|37744674|FG000|Overall Study|Lost to Follow-up|1|||
16803059|NCT02367781|37744675|FG001|Overall Study|Lost to Follow-up|2|||
16803060|NCT02367781|37744674|FG000|Overall Study|Death|330|||
16803061|NCT02367781|37744675|FG001|Overall Study|Death|176|||
16803062|NCT02367781|37744674|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
16803063|NCT02367781|37744675|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
16803064|NCT02367781|37744674|FG000|Overall Study|Prolonged Hospitalization|1|||
16803065|NCT02367781|37744675|FG001|Overall Study|Prolonged Hospitalization|0|||
16803066|NCT02367781|37744674|FG000|Overall Study|Death Prior First Dose|1|||
16803067|NCT02367781|37744675|FG001|Overall Study|Death Prior First Dose|0|||
16803068|NCT02367781|37744674|FG000|Overall Study|Administrative-Change Facility|1|||
16803069|NCT02367781|37744675|FG001|Overall Study|Administrative-Change Facility|0|||
16803070|NCT02367781|37744674|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
16803071|NCT02367781|37744675|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
16803072|NCT02367781|37744674|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
16803073|NCT02367781|37744675|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
16803074|NCT02367781|37744674|FG000|Overall Study|Study Terminated by Sponsor|3|||
16803075|NCT02367781|37744675|FG001|Overall Study|Study Terminated by Sponsor|1|||
16803076|NCT02367781|37744674|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
16803077|NCT02367781|37744675|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
16803078|NCT02367781|37744674|FG000|Overall Study|Sponsor Decision|2|||
16803079|NCT02367781|37744675|FG001|Overall Study|Sponsor Decision|0|||
16803080|NCT02367781|37744674|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
16803081|NCT02367781|37744675|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
16803082|NCT02152761|37744687|FG000|Epoch: Treatment Epoch|Technical problems|0|||
16803083|NCT02152761|37744688|FG001|Epoch: Treatment Epoch|Technical problems|0|||
16803084|NCT02152761|37744689|FG002|Epoch: Treatment Epoch|Technical problems|0|||
16803085|NCT02152761|37744690|FG003|Epoch: Treatment Epoch|Technical problems|1|||
16803086|NCT02152761|37744687|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
16803087|NCT02152761|37744688|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
16803088|NCT02152761|37744689|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
16803089|NCT02152761|37744690|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
16803090|NCT02152761|37744687|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
16803091|NCT02152761|37744688|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
16803092|NCT02152761|37744689|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
16803093|NCT02152761|37744690|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
16803094|NCT02152761|37744687|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
16803095|NCT02152761|37744688|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
16803096|NCT02152761|37744689|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
16803097|NCT02152761|37744690|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
16803098|NCT02152761|37744687|FG000|Epoch: Treatment Epoch|Death|0|||
16803099|NCT02152761|37744688|FG001|Epoch: Treatment Epoch|Death|3|||
16803100|NCT02152761|37744689|FG002|Epoch: Treatment Epoch|Death|1|||
16803101|NCT02152761|37744690|FG003|Epoch: Treatment Epoch|Death|0|||
16803102|NCT02152761|37744687|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
16803103|NCT02152761|37744688|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
16803104|NCT02152761|37744689|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
16803105|NCT02152761|37744690|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
16803106|NCT02152761|37744687|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
16803107|NCT02152761|37744688|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
16803108|NCT02152761|37744689|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
16803109|NCT02152761|37744690|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
16803110|NCT02152761|37744687|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
16803111|NCT02152761|37744688|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
16803112|NCT02152761|37744689|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
16803113|NCT02152761|37744690|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
16803114|NCT02152761|37744687|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
16803115|NCT02152761|37744688|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
16803116|NCT02152761|37744689|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
16803117|NCT02152761|37744690|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
16803118|NCT02152761|37744687|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
16803119|NCT02152761|37744688|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
16803120|NCT02152761|37744689|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
16803121|NCT02152761|37744690|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
16803122|NCT02152605|37744712|FG000|Overall Study|Adverse Event|6|||
16803123|NCT02152605|37744713|FG001|Overall Study|Adverse Event|8|||
16803124|NCT02152605|37744712|FG000|Overall Study|Lack of Efficacy|7|||
16803125|NCT02152605|37744713|FG001|Overall Study|Lack of Efficacy|4|||
16803126|NCT02152605|37744712|FG000|Overall Study|Protocol deviation|1|||
16803127|NCT02152605|37744713|FG001|Overall Study|Protocol deviation|4|||
16803128|NCT02152605|37744712|FG000|Overall Study|Lost to Follow-up|1|||
16803129|NCT02152605|37744713|FG001|Overall Study|Lost to Follow-up|0|||
16803130|NCT02152605|37744712|FG000|Overall Study|Withdrew consent|4|||
16803131|NCT02152605|37744713|FG001|Overall Study|Withdrew consent|2|||
16803132|NCT02152371|37744722|FG000|Overall Study|Adverse Event|6|||
16803133|NCT02152371|37744723|FG001|Overall Study|Adverse Event|2|||
16803134|NCT02152371|37744722|FG000|Overall Study|Withdrawal by Subject|3|||
16803135|NCT02152371|37744723|FG001|Overall Study|Withdrawal by Subject|7|||
16803136|NCT02152371|37744722|FG000|Overall Study|Protocol Violation|2|||
16803137|NCT02152371|37744723|FG001|Overall Study|Protocol Violation|3|||
16803138|NCT02152371|37744722|FG000|Overall Study|Lost to Follow-up|1|||
16803139|NCT02152371|37744723|FG001|Overall Study|Lost to Follow-up|0|||
16803140|NCT02152371|37744722|FG000|Overall Study|Lack of Efficacy|0|||
16803141|NCT02152371|37744723|FG001|Overall Study|Lack of Efficacy|1|||
16803142|NCT02152371|37744722|FG000|Overall Study|Physician Decision|0|||
16803143|NCT02152371|37744723|FG001|Overall Study|Physician Decision|2|||
16803144|NCT02152371|37744722|FG000|Overall Study|Reason Not Given|0|||
16803145|NCT02152371|37744723|FG001|Overall Study|Reason Not Given|1|||
16803146|NCT02332291|37744731|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
16803147|NCT02332291|37744732|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
16803148|NCT02332291|37744731|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
16803149|NCT02332291|37744732|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
16803150|NCT02332291|37744731|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
16803151|NCT02332291|37744732|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
16803152|NCT02332291|37744731|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
16803153|NCT02332291|37744732|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
16803154|NCT02332291|37744731|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
16803155|NCT02332291|37744732|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
16803156|NCT02332291|37744731|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
16803157|NCT02332291|37744732|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
16803158|NCT01656395|37744748|FG000|Overall Study|Adverse Event|1|||
16803159|NCT01656395|37744749|FG001|Overall Study|Adverse Event|14|||
16803160|NCT01656395|37744750|FG002|Overall Study|Adverse Event|5|||
16803161|NCT01656395|37744751|FG003|Overall Study|Adverse Event|4|||
16803162|NCT01656395|37744752|FG004|Overall Study|Adverse Event|5|||
16803163|NCT01656395|37744753|FG005|Overall Study|Adverse Event|7|||
16803164|NCT01656395|37744754|FG006|Overall Study|Adverse Event|0|||
16803165|NCT01656395|37744755|FG007|Overall Study|Adverse Event|0|||
16803166|NCT01656395|37744748|FG000|Overall Study|Lack of Efficacy|1|||
16803167|NCT01656395|37744749|FG001|Overall Study|Lack of Efficacy|8|||
16803168|NCT01656395|37744750|FG002|Overall Study|Lack of Efficacy|6|||
16803169|NCT01656395|37744751|FG003|Overall Study|Lack of Efficacy|1|||
16803170|NCT01656395|37744752|FG004|Overall Study|Lack of Efficacy|1|||
16803171|NCT01656395|37744753|FG005|Overall Study|Lack of Efficacy|6|||
16803172|NCT01656395|37744754|FG006|Overall Study|Lack of Efficacy|0|||
16803173|NCT01656395|37744755|FG007|Overall Study|Lack of Efficacy|0|||
16803174|NCT01656395|37744748|FG000|Overall Study|Lost to Follow-up|1|||
16803175|NCT01656395|37744749|FG001|Overall Study|Lost to Follow-up|0|||
16803176|NCT01656395|37744750|FG002|Overall Study|Lost to Follow-up|0|||
16803177|NCT01656395|37744751|FG003|Overall Study|Lost to Follow-up|0|||
16803178|NCT01656395|37744752|FG004|Overall Study|Lost to Follow-up|0|||
16803179|NCT01656395|37744753|FG005|Overall Study|Lost to Follow-up|0|||
16803180|NCT01656395|37744754|FG006|Overall Study|Lost to Follow-up|0|||
16803181|NCT01656395|37744755|FG007|Overall Study|Lost to Follow-up|0|||
16803182|NCT01656395|37744748|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16803183|NCT01656395|37744749|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16803184|NCT01656395|37744750|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16803185|NCT01656395|37744751|FG003|Overall Study|Non-Compliance with Study Drug|0|||
16803186|NCT01656395|37744752|FG004|Overall Study|Non-Compliance with Study Drug|1|||
16803187|NCT01656395|37744753|FG005|Overall Study|Non-Compliance with Study Drug|1|||
16803188|NCT01656395|37744754|FG006|Overall Study|Non-Compliance with Study Drug|0|||
16803189|NCT01656395|37744755|FG007|Overall Study|Non-Compliance with Study Drug|0|||
16803190|NCT01656395|37744748|FG000|Overall Study|Other|0|||
16803191|NCT01656395|37744749|FG001|Overall Study|Other|0|||
16803192|NCT01656395|37744750|FG002|Overall Study|Other|1|||
16803193|NCT01656395|37744751|FG003|Overall Study|Other|0|||
16803194|NCT01656395|37744752|FG004|Overall Study|Other|0|||
16803195|NCT01656395|37744753|FG005|Overall Study|Other|1|||
16803196|NCT01656395|37744754|FG006|Overall Study|Other|0|||
16803197|NCT01656395|37744755|FG007|Overall Study|Other|0|||
16803198|NCT01656395|37744748|FG000|Overall Study|Physician Decision|2|||
16803199|NCT01656395|37744749|FG001|Overall Study|Physician Decision|3|||
16803200|NCT01656395|37744750|FG002|Overall Study|Physician Decision|3|||
16803201|NCT01656395|37744751|FG003|Overall Study|Physician Decision|2|||
16803202|NCT01656395|37744752|FG004|Overall Study|Physician Decision|3|||
16803203|NCT01656395|37744753|FG005|Overall Study|Physician Decision|3|||
16803204|NCT01656395|37744754|FG006|Overall Study|Physician Decision|0|||
16803205|NCT01656395|37744755|FG007|Overall Study|Physician Decision|0|||
16803206|NCT01656395|37744748|FG000|Overall Study|Pregnancy|0|||
16803207|NCT01656395|37744749|FG001|Overall Study|Pregnancy|0|||
16803208|NCT01656395|37744750|FG002|Overall Study|Pregnancy|1|||
16803209|NCT01656395|37744751|FG003|Overall Study|Pregnancy|0|||
16803210|NCT01656395|37744752|FG004|Overall Study|Pregnancy|0|||
16803211|NCT01656395|37744753|FG005|Overall Study|Pregnancy|0|||
16803212|NCT01656395|37744754|FG006|Overall Study|Pregnancy|0|||
16803213|NCT01656395|37744755|FG007|Overall Study|Pregnancy|0|||
16803214|NCT01656395|37744748|FG000|Overall Study|Progressive Disease|0|||
16803215|NCT01656395|37744749|FG001|Overall Study|Progressive Disease|0|||
16803216|NCT01656395|37744750|FG002|Overall Study|Progressive Disease|0|||
16803217|NCT01656395|37744751|FG003|Overall Study|Progressive Disease|0|||
16803218|NCT01656395|37744752|FG004|Overall Study|Progressive Disease|0|||
16803219|NCT01656395|37744753|FG005|Overall Study|Progressive Disease|1|||
16803220|NCT01656395|37744754|FG006|Overall Study|Progressive Disease|0|||
16803221|NCT01656395|37744755|FG007|Overall Study|Progressive Disease|0|||
16803222|NCT01656395|37744748|FG000|Overall Study|Protocol Violation|6|||
16803223|NCT01656395|37744749|FG001|Overall Study|Protocol Violation|6|||
16803224|NCT01656395|37744750|FG002|Overall Study|Protocol Violation|9|||
16803225|NCT01656395|37744751|FG003|Overall Study|Protocol Violation|2|||
16803226|NCT01656395|37744752|FG004|Overall Study|Protocol Violation|4|||
16803227|NCT01656395|37744753|FG005|Overall Study|Protocol Violation|10|||
16803228|NCT01656395|37744754|FG006|Overall Study|Protocol Violation|0|||
16803229|NCT01656395|37744755|FG007|Overall Study|Protocol Violation|0|||
16803230|NCT01656395|37744748|FG000|Overall Study|Screen Failure|2|||
16803231|NCT01656395|37744749|FG001|Overall Study|Screen Failure|1|||
16803232|NCT01656395|37744750|FG002|Overall Study|Screen Failure|7|||
16803233|NCT01656395|37744751|FG003|Overall Study|Screen Failure|1|||
16803234|NCT01656395|37744752|FG004|Overall Study|Screen Failure|0|||
16803235|NCT01656395|37744753|FG005|Overall Study|Screen Failure|8|||
16803236|NCT01656395|37744754|FG006|Overall Study|Screen Failure|0|||
16803237|NCT01656395|37744755|FG007|Overall Study|Screen Failure|0|||
16803238|NCT01656395|37744748|FG000|Overall Study|Withdrawal by Subject|3|||
16803239|NCT01656395|37744749|FG001|Overall Study|Withdrawal by Subject|1|||
16803240|NCT01656395|37744750|FG002|Overall Study|Withdrawal by Subject|4|||
16803241|NCT01656395|37744751|FG003|Overall Study|Withdrawal by Subject|2|||
16803242|NCT01656395|37744752|FG004|Overall Study|Withdrawal by Subject|0|||
16803243|NCT01656395|37744753|FG005|Overall Study|Withdrawal by Subject|3|||
16803244|NCT01656395|37744754|FG006|Overall Study|Withdrawal by Subject|0|||
16803245|NCT01656395|37744755|FG007|Overall Study|Withdrawal by Subject|0|||
16803246|NCT02114931|37744771|FG000|Overall Study|Withdrawal by Subject|15|||
16909534|NCT01745094|38018420|FG002|Overall Study|Adverse Event|3|||
16909535|NCT01745094|38018421|FG003|Overall Study|Adverse Event|0|||
16803247|NCT02114931|37744772|FG001|Overall Study|Withdrawal by Subject|18|||
16803248|NCT02114931|37744771|FG000|Overall Study|Adverse Event|4|||
16803249|NCT02114931|37744772|FG001|Overall Study|Adverse Event|6|||
16803250|NCT02114931|37744771|FG000|Overall Study|Lost to Follow-up|3|||
16803251|NCT02114931|37744772|FG001|Overall Study|Lost to Follow-up|3|||
16803252|NCT02114931|37744771|FG000|Overall Study|Physician Decision|1|||
16803253|NCT02114931|37744772|FG001|Overall Study|Physician Decision|2|||
16803254|NCT02114931|37744771|FG000|Overall Study|Other|2|||
16803255|NCT02114931|37744772|FG001|Overall Study|Other|1|||
16803256|NCT01657019|37744778|FG000|Overall Study|Withdrawal by Subject|65|||
16803257|NCT01657019|37744778|FG000|Overall Study|Adverse Event|55|||
16803258|NCT01657019|37744778|FG000|Overall Study|Lost to Follow-up|48|||
16803259|NCT01657019|37744778|FG000|Overall Study|Protocol Violation|6|||
16803260|NCT01657019|37744778|FG000|Overall Study|Lack of Efficacy|3|||
16803261|NCT01657019|37744778|FG000|Overall Study|Other|58|||
16803262|NCT02329327|37744784|FG000|Overall Study|Death|78|||
16803263|NCT02329327|37744785|FG001|Overall Study|Death|0|||
16803264|NCT02329327|37744784|FG000|Overall Study|Withdrawal by Subject|3|||
16803265|NCT02329327|37744785|FG001|Overall Study|Withdrawal by Subject|0|||
16803266|NCT02329327|37744784|FG000|Overall Study|Lost to Follow-up|4|||
16803267|NCT02329327|37744785|FG001|Overall Study|Lost to Follow-up|0|||
16803268|NCT02328937|37744804|FG000|Period 1|Lost to Follow-up|0|||
16803269|NCT02328937|37744805|FG001|Period 1|Lost to Follow-up|0|||
16803270|NCT02328937|37744806|FG002|Period 1|Lost to Follow-up|0|||
16803271|NCT02328937|37744807|FG003|Period 1|Lost to Follow-up|1|||
16803272|NCT02328937|37744808|FG004|Period 1|Lost to Follow-up|0|||
16803273|NCT02328937|37744809|FG005|Period 1|Lost to Follow-up|0|||
16803274|NCT02328937|37744804|FG000|Period 2|Adverse Event|0|||
16803275|NCT02328937|37744805|FG001|Period 2|Adverse Event|0|||
16803276|NCT02328937|37744806|FG002|Period 2|Adverse Event|1|||
16803277|NCT02328937|37744807|FG003|Period 2|Adverse Event|0|||
16803278|NCT02328937|37744808|FG004|Period 2|Adverse Event|0|||
16803279|NCT02328937|37744809|FG005|Period 2|Adverse Event|0|||
16803280|NCT02328547|37744819|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
16803281|NCT02328547|37744820|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
16803282|NCT02328547|37744819|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
16803283|NCT02328547|37744820|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
16803284|NCT02300311|37744834|FG000|Overall Study|Other than the reason specified|1|||
16803285|NCT02300311|37744835|FG001|Overall Study|Other than the reason specified|0|||
16803286|NCT02300311|37744834|FG000|Overall Study|Refused to continue taking medication|18|||
16803287|NCT02300311|37744835|FG001|Overall Study|Refused to continue taking medication|0|||
16803288|NCT02300233|37744844|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
16803289|NCT02300233|37744845|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
16803290|NCT02300233|37744846|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
16803291|NCT02300233|37744844|FG000|Overall Study|Withdrawal by Subject|1|||
16803292|NCT02300233|37744845|FG001|Overall Study|Withdrawal by Subject|0|||
16803293|NCT02300233|37744846|FG002|Overall Study|Withdrawal by Subject|3|||
16803294|NCT02300233|37744844|FG000|Overall Study|Investigator Judgement|0|||
16803295|NCT02300233|37744845|FG001|Overall Study|Investigator Judgement|0|||
16803296|NCT02300233|37744846|FG002|Overall Study|Investigator Judgement|1|||
16803297|NCT02300233|37744844|FG000|Overall Study|Reason Not Specified|0|||
16803298|NCT02300233|37744845|FG001|Overall Study|Reason Not Specified|0|||
16803299|NCT02300233|37744846|FG002|Overall Study|Reason Not Specified|5|||
16803300|NCT02175225|37744857|FG000|Overall Study|Withdrawal by Subject|1|||
16803301|NCT02175225|37744858|FG001|Overall Study|Withdrawal by Subject|2|||
16803302|NCT02175225|37744857|FG000|Overall Study|Lost to Follow-up|6|||
16803303|NCT02175225|37744858|FG001|Overall Study|Lost to Follow-up|7|||
16803304|NCT02175225|37744857|FG000|Overall Study|Study drug not administered|1|||
16803305|NCT02175225|37744858|FG001|Overall Study|Study drug not administered|2|||
16803306|NCT02152137|37744864|FG000|Overall Study|Withdrawal by Subject|1|||
16803307|NCT02152137|37744864|FG000|Overall Study|Originally assigned to Arm B|3|||
16803308|NCT02299375|37744870|FG000|Overall Study|Adverse Event, serious fatal|1|||
16803309|NCT02299375|37744871|FG001|Overall Study|Adverse Event, serious fatal|3|||
16803310|NCT02299375|37744870|FG000|Overall Study|Adverse Event, non-fatal|8|||
16803311|NCT02299375|37744871|FG001|Overall Study|Adverse Event, non-fatal|9|||
16803312|NCT02299375|37744870|FG000|Overall Study|Lack of Efficacy|1|||
16803313|NCT02299375|37744871|FG001|Overall Study|Lack of Efficacy|3|||
16803314|NCT02299375|37744870|FG000|Overall Study|Protocol Violation|1|||
16803315|NCT02299375|37744871|FG001|Overall Study|Protocol Violation|3|||
16803316|NCT02299375|37744870|FG000|Overall Study|Other: Met stopping criteria|1|||
16803317|NCT02299375|37744871|FG001|Overall Study|Other: Met stopping criteria|0|||
16803318|NCT02299375|37744870|FG000|Overall Study|Other: Study closed/terminated|66|||
16803319|NCT02299375|37744871|FG001|Overall Study|Other: Study closed/terminated|55|||
16803320|NCT02299375|37744870|FG000|Overall Study|Lost to Follow-up|0|||
17102312|NCT00084266|38241213|FG001|Overall Study|Lack of Efficacy|4|||
16803321|NCT02299375|37744871|FG001|Overall Study|Lost to Follow-up|2|||
16803322|NCT02299375|37744870|FG000|Overall Study|Physician Decision|1|||
16803323|NCT02299375|37744871|FG001|Overall Study|Physician Decision|1|||
16803324|NCT02299375|37744870|FG000|Overall Study|Withdrawal by Subject|1|||
16803325|NCT02299375|37744871|FG001|Overall Study|Withdrawal by Subject|4|||
16803326|NCT02151903|37744880|FG000|Overall Study|Withdrawal by Subject|1|||
16803327|NCT02151903|37744881|FG001|Overall Study|Withdrawal by Subject|0|||
16803328|NCT02151903|37744880|FG000|Overall Study|Progressive disease|2|||
16803329|NCT02151903|37744881|FG001|Overall Study|Progressive disease|1|||
16803330|NCT02151591|37744889|FG000|Overall Study|Lost to Follow-up|6|||
16803331|NCT02151591|37744890|FG001|Overall Study|Lost to Follow-up|3|||
17102313|NCT00084266|38241212|FG000|Overall Study|Lost to Follow-up|5|||
16803332|NCT02174523|37744898|FG000|Overall Study|Withdrawal by Subject|1|||
16803333|NCT02174523|37744899|FG001|Overall Study|Withdrawal by Subject|0|||
16803334|NCT02297815|37744906|FG000|Overall Study|Lost to Follow-up|236|||
16803335|NCT02297815|37744907|FG001|Overall Study|Lost to Follow-up|140|||
16803336|NCT02114385|37744917|FG000|Overall Study|Withdrawal by Subject|3|||
16803337|NCT02114385|37744918|FG001|Overall Study|Withdrawal by Subject|2|||
16803338|NCT02114385|37744917|FG000|Overall Study|Lost to Follow-up|0|||
16803339|NCT02114385|37744918|FG001|Overall Study|Lost to Follow-up|6|||
16803340|NCT02114151|37744924|FG000|Overall Study|Death|1|||
16803341|NCT02114151|37744924|FG000|Overall Study|Lost to Follow-up|1|||
16803342|NCT02114151|37744924|FG000|Overall Study|Withdrawal by Subject|5|||
16803343|NCT02297503|37744930|FG000|Overall Study|Withdrawal by Subject|1|||
16803344|NCT02297503|37744931|FG001|Overall Study|Withdrawal by Subject|1|||
16803345|NCT02297503|37744930|FG000|Overall Study|Protocol Violation|1|||
16803346|NCT02297503|37744931|FG001|Overall Study|Protocol Violation|0|||
16803347|NCT02297503|37744930|FG000|Overall Study|Pregnancy|0|||
16803348|NCT02297503|37744931|FG001|Overall Study|Pregnancy|1|||
16803349|NCT02297503|37744930|FG000|Overall Study|Lost to Follow-up|0|||
16803350|NCT02297503|37744931|FG001|Overall Study|Lost to Follow-up|1|||
16803351|NCT02297503|37744930|FG000|Overall Study|Medical reason|0|||
16803352|NCT02297503|37744931|FG001|Overall Study|Medical reason|1|||
16803353|NCT02113449|37744946|FG000|Overall Study|Adverse Event|4|||
16803354|NCT02366923|37744954|FG000|Overall Study|Withdrawal by Subject|1|||
16803355|NCT02366923|37744954|FG000|Overall Study|Positive Slit Lamp Findings|2|||
16803356|NCT02366923|37744954|FG000|Overall Study|High Astigmatism|3|||
16803357|NCT02326597|37744961|FG000|Overall Study|Lost to Follow-up|42|||
16803358|NCT02326597|37744962|FG001|Overall Study|Lost to Follow-up|32|||
16803359|NCT02366767|37744972|FG000|Overall Study|left for home after 1 day at camp|1|||
16803360|NCT02366767|37744973|FG001|Overall Study|left for home after 1 day at camp|0|||
16803361|NCT02150343|37744983|FG000|Overall Study|Adverse Event|2|||
16803362|NCT02150343|37744984|FG001|Overall Study|Adverse Event|0|||
16803363|NCT02150343|37744985|FG002|Overall Study|Adverse Event|1|||
16803364|NCT02150343|37744986|FG003|Overall Study|Adverse Event|1|||
16803365|NCT02150343|37744983|FG000|Overall Study|Withdrawal by Subject|13|||
16803366|NCT02150343|37744984|FG001|Overall Study|Withdrawal by Subject|10|||
16803367|NCT02150343|37744985|FG002|Overall Study|Withdrawal by Subject|9|||
16803368|NCT02150343|37744986|FG003|Overall Study|Withdrawal by Subject|4|||
16803369|NCT02150343|37744983|FG000|Overall Study|Lost to Follow-up|4|||
16803370|NCT02150343|37744984|FG001|Overall Study|Lost to Follow-up|4|||
16803371|NCT02150343|37744985|FG002|Overall Study|Lost to Follow-up|2|||
16803372|NCT02150343|37744986|FG003|Overall Study|Lost to Follow-up|3|||
16803373|NCT02150343|37744983|FG000|Overall Study|Other|2|||
16803374|NCT02150343|37744984|FG001|Overall Study|Other|6|||
16803375|NCT02150343|37744985|FG002|Overall Study|Other|0|||
16803376|NCT02150343|37744986|FG003|Overall Study|Other|2|||
16803377|NCT02149875|37744999|FG000|Overall Study|Lost to Follow-up|3|||
16803378|NCT02149875|37745000|FG001|Overall Study|Lost to Follow-up|4|||
16803379|NCT02149875|37745001|FG002|Overall Study|Lost to Follow-up|5|||
16803380|NCT02149875|37744999|FG000|Overall Study|Withdrawal by Subject|3|||
16803381|NCT02149875|37745000|FG001|Overall Study|Withdrawal by Subject|2|||
16803382|NCT02149875|37745001|FG002|Overall Study|Withdrawal by Subject|2|||
16803383|NCT02149875|37744999|FG000|Overall Study|Physician Decision|1|||
16803384|NCT02149875|37745000|FG001|Overall Study|Physician Decision|2|||
16803385|NCT02149875|37745001|FG002|Overall Study|Physician Decision|2|||
16803386|NCT02112045|37745011|FG000|Overall Study|Withdrawal by Subject|1|||
16803387|NCT02112045|37745012|FG001|Overall Study|Withdrawal by Subject|0|||
16803388|NCT01629693|37745020|FG000|Overall Study|Lost to Follow-up|2|||
16803389|NCT01629693|37745021|FG001|Overall Study|Lost to Follow-up|4|||
16803390|NCT01629693|37745020|FG000|Overall Study|Withdrawal by Subject|2|||
16803391|NCT01629693|37745021|FG001|Overall Study|Withdrawal by Subject|2|||
16803392|NCT01629693|37745020|FG000|Overall Study|Adverse Event|1|||
16803393|NCT01629693|37745021|FG001|Overall Study|Adverse Event|0|||
16803394|NCT01629693|37745020|FG000|Overall Study|Investigator decision|0|||
16803395|NCT01629693|37745021|FG001|Overall Study|Investigator decision|1|||
16803396|NCT01629693|37745020|FG000|Overall Study|Poor comfort of study lenses|0|||
16803397|NCT01629693|37745021|FG001|Overall Study|Poor comfort of study lenses|2|||
16803398|NCT01629693|37745020|FG000|Overall Study|Subject decision unrelated to AE|0|||
16803399|NCT01629693|37745021|FG001|Overall Study|Subject decision unrelated to AE|1|||
16803400|NCT02147691|37745029|FG000|Overall Study|Withdrawal by Subject|2|||
16803401|NCT02147691|37745030|FG001|Overall Study|Withdrawal by Subject|0|||
16803402|NCT02147691|37745029|FG000|Overall Study|Adverse Event|2|||
16803403|NCT02147691|37745030|FG001|Overall Study|Adverse Event|0|||
16803404|NCT02147691|37745029|FG000|Overall Study|Lost to Follow-up|0|||
16803405|NCT02147691|37745030|FG001|Overall Study|Lost to Follow-up|1|||
16803406|NCT02111811|37745038|FG000|Treatment Phase|Lost to Follow-up|22|||
16803407|NCT02111811|37745039|FG001|Treatment Phase|Lost to Follow-up|18|||
16803408|NCT02111811|37745038|FG000|Treatment Phase|Death|2|||
16803409|NCT02111811|37745039|FG001|Treatment Phase|Death|0|||
16803410|NCT02111811|37745038|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
16803411|NCT02111811|37745039|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
16803412|NCT02111811|37745038|FG000|Follow up Period (Aim 2)|Death|2|||
16803413|NCT02111811|37745039|FG001|Follow up Period (Aim 2)|Death|0|||
16803414|NCT01655693|37745048|FG000|Overall Study|Progression of Disease|92|||
16803415|NCT01655693|37745049|FG001|Overall Study|Progression of Disease|76|||
16803416|NCT01655693|37745050|FG002|Overall Study|Progression of Disease|58|||
16803417|NCT01655693|37745048|FG000|Overall Study|Death|8|||
16803418|NCT01655693|37745049|FG001|Overall Study|Death|9|||
16803419|NCT01655693|37745050|FG002|Overall Study|Death|12|||
16803420|NCT01655693|37745048|FG000|Overall Study|Serious Adverse Event|3|||
16803421|NCT01655693|37745049|FG001|Overall Study|Serious Adverse Event|15|||
16803422|NCT01655693|37745050|FG002|Overall Study|Serious Adverse Event|11|||
16803423|NCT01655693|37745048|FG000|Overall Study|Withdrawal by Subject|3|||
16803424|NCT01655693|37745049|FG001|Overall Study|Withdrawal by Subject|2|||
16803425|NCT01655693|37745050|FG002|Overall Study|Withdrawal by Subject|20|||
16803426|NCT01655693|37745048|FG000|Overall Study|Adverse Event|3|||
16803427|NCT01655693|37745049|FG001|Overall Study|Adverse Event|11|||
16803428|NCT01655693|37745050|FG002|Overall Study|Adverse Event|3|||
16803429|NCT01655693|37745048|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
16803430|NCT01655693|37745049|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
16803431|NCT01655693|37745050|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
16803432|NCT01655693|37745048|FG000|Overall Study|Non-Compliance|0|||
16803433|NCT01655693|37745049|FG001|Overall Study|Non-Compliance|0|||
16803434|NCT01655693|37745050|FG002|Overall Study|Non-Compliance|7|||
16803435|NCT01655693|37745048|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
16803436|NCT01655693|37745049|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
16803437|NCT01655693|37745050|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
16803438|NCT01655693|37745048|FG000|Overall Study|Protocol Violation|1|||
16803439|NCT01655693|37745049|FG001|Overall Study|Protocol Violation|0|||
16803440|NCT01655693|37745050|FG002|Overall Study|Protocol Violation|3|||
16803441|NCT01655693|37745048|FG000|Overall Study|Lost to Follow-up|1|||
16803442|NCT01655693|37745049|FG001|Overall Study|Lost to Follow-up|0|||
16803443|NCT01655693|37745050|FG002|Overall Study|Lost to Follow-up|1|||
16803444|NCT01655693|37745048|FG000|Overall Study|Screening Failure|1|||
16803445|NCT01655693|37745049|FG001|Overall Study|Screening Failure|0|||
16803446|NCT01655693|37745050|FG002|Overall Study|Screening Failure|0|||
16803447|NCT01655693|37745048|FG000|Overall Study|Other|8|||
16803448|NCT01655693|37745049|FG001|Overall Study|Other|6|||
16803449|NCT01655693|37745050|FG002|Overall Study|Other|15|||
16803450|NCT01655381|37745068|FG000|Overall Study|Investigator Decision|1|||
16803451|NCT01655381|37745068|FG000|Overall Study|Moved to Another City|1|||
16803452|NCT01655381|37745068|FG000|Overall Study|Insufficient Treatment Response|1|||
16803453|NCT01656161|37745073|FG000|Overall Study|Death|3|||
16803454|NCT01656161|37745073|FG000|Overall Study|Adverse Event|2|||
16803455|NCT01656161|37745073|FG000|Overall Study|Protocol Violation|1|||
16803456|NCT01656161|37745073|FG000|Overall Study|Withdrawal by Subject|1|||
16803457|NCT02111577|37745082|FG000|Overall Study|Protocol Violation|2|||
16803458|NCT02111577|37745083|FG001|Overall Study|Protocol Violation|0|||
16803459|NCT02111577|37745082|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
16803460|NCT02111577|37745083|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
16803461|NCT02111577|37745082|FG000|Overall Study|Failure to produce study treatment|6|||
16803462|NCT02111577|37745083|FG001|Overall Study|Failure to produce study treatment|0|||
16803463|NCT02111577|37745082|FG000|Overall Study|Death|518|||
16803464|NCT02111577|37745083|FG001|Overall Study|Death|254|||
16803465|NCT02111577|37745082|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
16803466|NCT02111577|37745083|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
16803467|NCT02111577|37745082|FG000|Overall Study|Adverse Event|1|||
16803468|NCT02111577|37745083|FG001|Overall Study|Adverse Event|1|||
16803469|NCT02111577|37745082|FG000|Overall Study|Withdrawal by Subject|51|||
16803470|NCT02111577|37745083|FG001|Overall Study|Withdrawal by Subject|23|||
16803471|NCT02111577|37745082|FG000|Overall Study|Disease progression|0|||
16803472|NCT02111577|37745083|FG001|Overall Study|Disease progression|1|||
16803473|NCT02111577|37745082|FG000|Overall Study|Lost to Follow-up|19|||
16803474|NCT02111577|37745083|FG001|Overall Study|Lost to Follow-up|10|||
16803475|NCT02170779|37745093|FG000|Overall Study|Withdrawal by Subject|1|||
16803476|NCT02170779|37745094|FG001|Overall Study|Withdrawal by Subject|0|||
16803477|NCT02170779|37745093|FG000|Overall Study|Lost to Follow-up|0|||
16803478|NCT02170779|37745094|FG001|Overall Study|Lost to Follow-up|1|||
16803479|NCT02147067|37745102|FG000|Overall Study|Withdrawal by Subject|2|||
16803480|NCT02147067|37745103|FG001|Overall Study|Withdrawal by Subject|2|||
16803481|NCT02170389|37745109|FG000|Overall Study|Study terminated prior to start of treat|1|||
16803482|NCT02146599|37745113|FG000|Overall Study|Failed to meet inclusion criteria|5|||
16803483|NCT02146365|37745123|FG000|Overall Study|Lost to Follow-up|2|||
16803484|NCT02146365|37745124|FG001|Overall Study|Lost to Follow-up|1|||
16803485|NCT02146365|37745125|FG002|Overall Study|Lost to Follow-up|3|||
16803486|NCT02146365|37745126|FG003|Overall Study|Lost to Follow-up|3|||
16803487|NCT02146365|37745127|FG004|Overall Study|Lost to Follow-up|1|||
16803488|NCT02146365|37745128|FG005|Overall Study|Lost to Follow-up|1|||
16803489|NCT02146365|37745129|FG006|Overall Study|Lost to Follow-up|0|||
16803490|NCT02146365|37745130|FG007|Overall Study|Lost to Follow-up|1|||
16803491|NCT02146365|37745123|FG000|Overall Study|Withdrawal by Subject|1|||
16803492|NCT02146365|37745124|FG001|Overall Study|Withdrawal by Subject|2|||
16803493|NCT02146365|37745125|FG002|Overall Study|Withdrawal by Subject|1|||
16803494|NCT02146365|37745126|FG003|Overall Study|Withdrawal by Subject|5|||
16803495|NCT02146365|37745127|FG004|Overall Study|Withdrawal by Subject|1|||
16803496|NCT02146365|37745128|FG005|Overall Study|Withdrawal by Subject|0|||
16803497|NCT02146365|37745129|FG006|Overall Study|Withdrawal by Subject|0|||
16803498|NCT02146365|37745130|FG007|Overall Study|Withdrawal by Subject|0|||
16803499|NCT02146365|37745123|FG000|Overall Study|Unable to Comply with Protocol|0|||
16803500|NCT02146365|37745124|FG001|Overall Study|Unable to Comply with Protocol|1|||
16803501|NCT02146365|37745125|FG002|Overall Study|Unable to Comply with Protocol|1|||
16803502|NCT02146365|37745126|FG003|Overall Study|Unable to Comply with Protocol|0|||
16803503|NCT02146365|37745127|FG004|Overall Study|Unable to Comply with Protocol|0|||
16803504|NCT02146365|37745128|FG005|Overall Study|Unable to Comply with Protocol|0|||
16803505|NCT02146365|37745129|FG006|Overall Study|Unable to Comply with Protocol|0|||
16803506|NCT02146365|37745130|FG007|Overall Study|Unable to Comply with Protocol|0|||
16803507|NCT02146365|37745123|FG000|Overall Study|Other|1|||
16803508|NCT02146365|37745124|FG001|Overall Study|Other|0|||
16803509|NCT02146365|37745125|FG002|Overall Study|Other|2|||
16803510|NCT02146365|37745126|FG003|Overall Study|Other|1|||
16803511|NCT02146365|37745127|FG004|Overall Study|Other|0|||
16803512|NCT02146365|37745128|FG005|Overall Study|Other|0|||
16803513|NCT02146365|37745129|FG006|Overall Study|Other|0|||
16803514|NCT02146365|37745130|FG007|Overall Study|Other|0|||
16803515|NCT02146131|37745150|FG000|Overall Study|Physician Decision|61|||
16803516|NCT02146131|37745151|FG001|Overall Study|Physician Decision|56|||
16803517|NCT02107131|37745159|FG000|Overall Study|Lost to Follow-up|4|||
16803518|NCT02107131|37745160|FG001|Overall Study|Lost to Follow-up|4|||
16803519|NCT02107131|37745159|FG000|Overall Study|Physician Decision|1|||
16803520|NCT02107131|37745160|FG001|Overall Study|Physician Decision|0|||
16803521|NCT02107131|37745159|FG000|Overall Study|Withdrawal by Subject|2|||
16803522|NCT02107131|37745160|FG001|Overall Study|Withdrawal by Subject|0|||
16803523|NCT02107131|37745159|FG000|Overall Study|mental instability|1|||
16803524|NCT02107131|37745160|FG001|Overall Study|mental instability|0|||
16803525|NCT02107131|37745159|FG000|Overall Study|Death|0|||
16803526|NCT02107131|37745160|FG001|Overall Study|Death|1|||
16803527|NCT02107131|37745159|FG000|Overall Study|Protocol Violation|0|||
16803528|NCT02107131|37745160|FG001|Overall Study|Protocol Violation|4|||
16803529|NCT02106975|37745170|FG000|Overall Study|Death|25|||
16803530|NCT02106975|37745171|FG001|Overall Study|Death|39|||
16803531|NCT02145429|37745179|FG000|Overall Study|Death|4|||
16803532|NCT02145429|37745180|FG001|Overall Study|Death|5|||
16803533|NCT02145429|37745179|FG000|Overall Study|Lost to Follow-up|4|||
16803534|NCT02145429|37745180|FG001|Overall Study|Lost to Follow-up|3|||
16803535|NCT02145429|37745179|FG000|Overall Study|Withdrawal by Subject|8|||
16803536|NCT02145429|37745180|FG001|Overall Study|Withdrawal by Subject|3|||
16803537|NCT02144337|37745188|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
16803538|NCT02144337|37745189|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
16803539|NCT02144337|37745188|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
16803540|NCT02144337|37745189|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
16803541|NCT02144337|37745188|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
16803542|NCT02144337|37745189|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
16803543|NCT02144337|37745188|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
16803544|NCT02144337|37745189|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
16803545|NCT02144337|37745188|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
16803546|NCT02144337|37745189|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
16803547|NCT02520011|37745199|FG000|Overall Study|Adverse Event|0|||
16803548|NCT02520011|37745200|FG001|Overall Study|Adverse Event|1|||
16803549|NCT02520011|37745201|FG002|Overall Study|Adverse Event|2|||
16803550|NCT02520011|37745199|FG000|Overall Study|Death|0|||
16803551|NCT02520011|37745200|FG001|Overall Study|Death|8|||
16803552|NCT02520011|37745201|FG002|Overall Study|Death|1|||
16803553|NCT02520011|37745199|FG000|Overall Study|Lack of Efficacy|4|||
16803554|NCT02520011|37745200|FG001|Overall Study|Lack of Efficacy|26|||
16803555|NCT02520011|37745201|FG002|Overall Study|Lack of Efficacy|4|||
16803556|NCT02520011|37745199|FG000|Overall Study|Physician Decision|0|||
16803557|NCT02520011|37745200|FG001|Overall Study|Physician Decision|2|||
16803558|NCT02520011|37745201|FG002|Overall Study|Physician Decision|0|||
16803559|NCT02520011|37745199|FG000|Overall Study|Withdrawal by Subject|1|||
16803560|NCT02520011|37745200|FG001|Overall Study|Withdrawal by Subject|3|||
16803561|NCT02520011|37745201|FG002|Overall Study|Withdrawal by Subject|0|||
16803562|NCT02520011|37745199|FG000|Overall Study|Protocol Deviation|0|||
16803563|NCT02520011|37745200|FG001|Overall Study|Protocol Deviation|1|||
16803564|NCT02520011|37745201|FG002|Overall Study|Protocol Deviation|0|||
17016553|NCT00855218|38161203|FG000|Overall Study|Lost to Follow-up|0|||
16803565|NCT02520011|37745199|FG000|Overall Study|Patient went to hospice|0|||
16803566|NCT02520011|37745200|FG001|Overall Study|Patient went to hospice|1|||
16803567|NCT02520011|37745201|FG002|Overall Study|Patient went to hospice|0|||
16803568|NCT02520011|37745199|FG000|Overall Study|Progressive disease following response|0|||
16803569|NCT02520011|37745200|FG001|Overall Study|Progressive disease following response|4|||
16803570|NCT02520011|37745201|FG002|Overall Study|Progressive disease following response|2|||
16803571|NCT02519231|37745216|FG000|Overall Study|Lost to Follow-up|2|||
16803572|NCT02519231|37745217|FG001|Overall Study|Lost to Follow-up|5|||
16803573|NCT02519231|37745216|FG000|Overall Study|Withdrawal by Subject|0|||
16803574|NCT02519231|37745217|FG001|Overall Study|Withdrawal by Subject|1|||
16803575|NCT02106351|37745228|FG000|Treatment Cycle 1|Adverse Event|2|||
16803576|NCT02106351|37745229|FG001|Treatment Cycle 1|Adverse Event|0|||
16803577|NCT02106351|37745230|FG002|Treatment Cycle 1|Adverse Event|0|||
16803578|NCT02106351|37745228|FG000|Treatment Cycle 1|Consent withdrawn|1|||
16803579|NCT02106351|37745229|FG001|Treatment Cycle 1|Consent withdrawn|0|||
16803580|NCT02106351|37745230|FG002|Treatment Cycle 1|Consent withdrawn|2|||
16803581|NCT02106351|37745228|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
16803582|NCT02106351|37745229|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
16803583|NCT02106351|37745230|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
16803584|NCT02106351|37745228|FG000|Treatment Cycle 1|Other|0|||
16803585|NCT02106351|37745229|FG001|Treatment Cycle 1|Other|3|||
16803586|NCT02106351|37745230|FG002|Treatment Cycle 1|Other|1|||
16803587|NCT02106351|37745228|FG000|Treatment Cycle 1|Randomised but not treated|1|||
16803588|NCT02106351|37745229|FG001|Treatment Cycle 1|Randomised but not treated|0|||
16803589|NCT02106351|37745230|FG002|Treatment Cycle 1|Randomised but not treated|1|||
16803590|NCT02106351|37745228|FG000|Treatment Cycle 2|Adverse Event|0|||
16803591|NCT02106351|37745229|FG001|Treatment Cycle 2|Adverse Event|2|||
16803592|NCT02106351|37745230|FG002|Treatment Cycle 2|Adverse Event|0|||
16803593|NCT02106351|37745228|FG000|Treatment Cycle 2|Consent withdrawn|0|||
16803594|NCT02106351|37745229|FG001|Treatment Cycle 2|Consent withdrawn|1|||
16803595|NCT02106351|37745230|FG002|Treatment Cycle 2|Consent withdrawn|1|||
16803596|NCT02106351|37745228|FG000|Treatment Cycle 2|Other|0|||
16803597|NCT02106351|37745229|FG001|Treatment Cycle 2|Other|2|||
16803598|NCT02106351|37745230|FG002|Treatment Cycle 2|Other|2|||
16803599|NCT02106351|37745228|FG000|Treatment Cycle 3|Adverse Event|0|||
16803600|NCT02106351|37745229|FG001|Treatment Cycle 3|Adverse Event|1|||
16803601|NCT02106351|37745230|FG002|Treatment Cycle 3|Adverse Event|0|||
16803602|NCT02106351|37745228|FG000|Treatment Cycle 3|Consent withdrawn|0|||
16803603|NCT02106351|37745229|FG001|Treatment Cycle 3|Consent withdrawn|0|||
16803604|NCT02106351|37745230|FG002|Treatment Cycle 3|Consent withdrawn|2|||
16803605|NCT02106351|37745228|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
16803606|NCT02106351|37745229|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
16803607|NCT02106351|37745230|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
16803608|NCT02106351|37745228|FG000|Treatment Cycle 3|Other|0|||
16803609|NCT02106351|37745229|FG001|Treatment Cycle 3|Other|2|||
16803610|NCT02106351|37745230|FG002|Treatment Cycle 3|Other|3|||
16803611|NCT02106351|37745228|FG000|Treatment Cycle 4|Consent withdrawn|0|||
16803612|NCT02106351|37745229|FG001|Treatment Cycle 4|Consent withdrawn|0|||
16803613|NCT02106351|37745230|FG002|Treatment Cycle 4|Consent withdrawn|2|||
16803614|NCT02106351|37745228|FG000|Treatment Cycle 4|Other|0|||
16803615|NCT02106351|37745229|FG001|Treatment Cycle 4|Other|1|||
16803616|NCT02106351|37745230|FG002|Treatment Cycle 4|Other|0|||
16803617|NCT02143947|37745246|FG000|Overall Study|Lost to Follow-up|4|||
16803618|NCT02143947|37745247|FG001|Overall Study|Lost to Follow-up|2|||
16803619|NCT02075073|37745258|FG000|Overall Study|Withdrawal by Subject|0|||
16803620|NCT02075073|37745259|FG001|Overall Study|Withdrawal by Subject|1|||
16803621|NCT02075073|37745260|FG002|Overall Study|Withdrawal by Subject|0|||
16803622|NCT02074059|37745274|FG000|Overall Study|Death|0|||
16803623|NCT02074059|37745275|FG001|Overall Study|Death|0|||
16803624|NCT02074059|37745276|FG002|Overall Study|Death|0|||
16803625|NCT02074059|37745277|FG003|Overall Study|Death|0|||
16803626|NCT02074059|37745278|FG004|Overall Study|Death|1|||
16803627|NCT02074059|37745279|FG005|Overall Study|Death|1|||
16803628|NCT01364597|37745298|FG000|Overall Study|Adverse Event|4|||
17102314|NCT00084266|38241213|FG001|Overall Study|Lost to Follow-up|3|||
16803629|NCT01364597|37745299|FG001|Overall Study|Adverse Event|5|||
16803630|NCT01364597|37745300|FG002|Overall Study|Adverse Event|16|||
16803631|NCT01364597|37745301|FG003|Overall Study|Adverse Event|7|||
16803632|NCT01364597|37745298|FG000|Overall Study|Lack of Efficacy|4|||
16803633|NCT01364597|37745299|FG001|Overall Study|Lack of Efficacy|4|||
16803634|NCT01364597|37745300|FG002|Overall Study|Lack of Efficacy|23|||
16803635|NCT01364597|37745301|FG003|Overall Study|Lack of Efficacy|8|||
16803636|NCT01364597|37745298|FG000|Overall Study|Protocol Violation|0|||
16803637|NCT01364597|37745299|FG001|Overall Study|Protocol Violation|0|||
16803638|NCT01364597|37745300|FG002|Overall Study|Protocol Violation|2|||
16803639|NCT01364597|37745301|FG003|Overall Study|Protocol Violation|0|||
16803640|NCT01364597|37745298|FG000|Overall Study|Lost to Follow-up|0|||
16803641|NCT01364597|37745299|FG001|Overall Study|Lost to Follow-up|0|||
16803642|NCT01364597|37745300|FG002|Overall Study|Lost to Follow-up|5|||
16803643|NCT01364597|37745301|FG003|Overall Study|Lost to Follow-up|3|||
16803644|NCT01364597|37745298|FG000|Overall Study|Withdrawal by Subject|4|||
16803645|NCT01364597|37745299|FG001|Overall Study|Withdrawal by Subject|1|||
16803646|NCT01364597|37745300|FG002|Overall Study|Withdrawal by Subject|18|||
16803647|NCT01364597|37745301|FG003|Overall Study|Withdrawal by Subject|6|||
16803648|NCT01364597|37745298|FG000|Overall Study|Non compliance|1|||
16803649|NCT01364597|37745299|FG001|Overall Study|Non compliance|0|||
16803650|NCT01364597|37745300|FG002|Overall Study|Non compliance|1|||
16803651|NCT01364597|37745301|FG003|Overall Study|Non compliance|0|||
16803652|NCT01364597|37745298|FG000|Overall Study|Lack of compliance|1|||
16803653|NCT01364597|37745299|FG001|Overall Study|Lack of compliance|0|||
16803654|NCT01364597|37745300|FG002|Overall Study|Lack of compliance|0|||
16803655|NCT01364597|37745301|FG003|Overall Study|Lack of compliance|0|||
16803656|NCT01364597|37745298|FG000|Overall Study|End of treatment epilepsy|1|||
16803657|NCT01364597|37745299|FG001|Overall Study|End of treatment epilepsy|0|||
16803658|NCT01364597|37745300|FG002|Overall Study|End of treatment epilepsy|0|||
16803659|NCT01364597|37745301|FG003|Overall Study|End of treatment epilepsy|0|||
16803660|NCT01364597|37745298|FG000|Overall Study|No Seizures|1|||
16803661|NCT01364597|37745299|FG001|Overall Study|No Seizures|0|||
16803662|NCT01364597|37745300|FG002|Overall Study|No Seizures|0|||
16803663|NCT01364597|37745301|FG003|Overall Study|No Seizures|0|||
16803664|NCT01364597|37745298|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
16803665|NCT01364597|37745299|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
16803666|NCT01364597|37745300|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
16803667|NCT01364597|37745301|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
16803668|NCT01364597|37745298|FG000|Overall Study|Cure|1|||
16803669|NCT01364597|37745299|FG001|Overall Study|Cure|0|||
16803670|NCT01364597|37745300|FG002|Overall Study|Cure|0|||
16803671|NCT01364597|37745301|FG003|Overall Study|Cure|0|||
16803672|NCT01364597|37745298|FG000|Overall Study|Patient was moving|0|||
16803673|NCT01364597|37745299|FG001|Overall Study|Patient was moving|1|||
16803674|NCT01364597|37745300|FG002|Overall Study|Patient was moving|0|||
16803675|NCT01364597|37745301|FG003|Overall Study|Patient was moving|0|||
16803676|NCT01364597|37745298|FG000|Overall Study|Seizures resolved|0|||
16803677|NCT01364597|37745299|FG001|Overall Study|Seizures resolved|0|||
16803678|NCT01364597|37745300|FG002|Overall Study|Seizures resolved|1|||
16803679|NCT01364597|37745301|FG003|Overall Study|Seizures resolved|0|||
16803680|NCT01364597|37745298|FG000|Overall Study|Patient became seizure-free after surgery|0|||
16803681|NCT01364597|37745299|FG001|Overall Study|Patient became seizure-free after surgery|0|||
16803682|NCT01364597|37745300|FG002|Overall Study|Patient became seizure-free after surgery|1|||
16803683|NCT01364597|37745301|FG003|Overall Study|Patient became seizure-free after surgery|0|||
16803684|NCT01364597|37745298|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
16803685|NCT01364597|37745299|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
16803686|NCT01364597|37745300|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
16803687|NCT01364597|37745301|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
16803688|NCT01364597|37745298|FG000|Overall Study|Patient cured from Epilepsy|0|||
16803689|NCT01364597|37745299|FG001|Overall Study|Patient cured from Epilepsy|0|||
16803690|NCT01364597|37745300|FG002|Overall Study|Patient cured from Epilepsy|1|||
16803691|NCT01364597|37745301|FG003|Overall Study|Patient cured from Epilepsy|0|||
16803692|NCT01364597|37745298|FG000|Overall Study|Investigator decision|0|||
16803693|NCT01364597|37745299|FG001|Overall Study|Investigator decision|0|||
16803694|NCT01364597|37745300|FG002|Overall Study|Investigator decision|1|||
16803695|NCT01364597|37745301|FG003|Overall Study|Investigator decision|0|||
16803696|NCT01364597|37745298|FG000|Overall Study|Sponsor recommended discontinuation|0|||
16803697|NCT01364597|37745299|FG001|Overall Study|Sponsor recommended discontinuation|0|||
16803698|NCT01364597|37745300|FG002|Overall Study|Sponsor recommended discontinuation|0|||
16803699|NCT01364597|37745301|FG003|Overall Study|Sponsor recommended discontinuation|1|||
16803700|NCT01364597|37745298|FG000|Overall Study|Parents went abroad with the patient|0|||
16803701|NCT01364597|37745299|FG001|Overall Study|Parents went abroad with the patient|0|||
16803702|NCT01364597|37745300|FG002|Overall Study|Parents went abroad with the patient|1|||
16803703|NCT01364597|37745301|FG003|Overall Study|Parents went abroad with the patient|0|||
16803704|NCT01364597|37745298|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
16803705|NCT01364597|37745299|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
16803706|NCT01364597|37745300|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
16803707|NCT01364597|37745301|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
16803708|NCT01364597|37745298|FG000|Overall Study|BRV administration dropout|0|||
16803709|NCT01364597|37745299|FG001|Overall Study|BRV administration dropout|0|||
16803710|NCT01364597|37745300|FG002|Overall Study|BRV administration dropout|1|||
16803711|NCT01364597|37745301|FG003|Overall Study|BRV administration dropout|0|||
16803712|NCT01364597|37745298|FG000|Overall Study|Dropout|0|||
16803713|NCT01364597|37745299|FG001|Overall Study|Dropout|0|||
16803714|NCT01364597|37745300|FG002|Overall Study|Dropout|3|||
16803715|NCT01364597|37745301|FG003|Overall Study|Dropout|1|||
16803716|NCT01364597|37745298|FG000|Overall Study|Unreliable subject|0|||
16803717|NCT01364597|37745299|FG001|Overall Study|Unreliable subject|0|||
16803718|NCT01364597|37745300|FG002|Overall Study|Unreliable subject|0|||
16803719|NCT01364597|37745301|FG003|Overall Study|Unreliable subject|1|||
16803720|NCT01364597|37745298|FG000|Overall Study|Other|0|||
16803721|NCT01364597|37745299|FG001|Overall Study|Other|0|||
16803722|NCT01364597|37745300|FG002|Overall Study|Other|0|||
16803723|NCT01364597|37745301|FG003|Overall Study|Other|1|||
16803724|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
16803725|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
16803726|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
16803727|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
16803728|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Adverse Event|7|||
16803729|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Adverse Event|8|||
16803730|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Adverse Event|8|||
16803731|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Adverse Event|9|||
16803732|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
16803733|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
16803734|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
16803735|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
16803736|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
16803737|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
16803738|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
16803739|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
16803740|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Pregnancy|0|||
16803741|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Pregnancy|2|||
16803742|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Pregnancy|2|||
16803743|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Pregnancy|0|||
16803744|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Non-compliance|1|||
16803745|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Non-compliance|0|||
16803746|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Non-compliance|0|||
16803747|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Non-compliance|3|||
16803748|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Other|3|||
16803749|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Other|0|||
16803750|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Other|3|||
16803751|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Other|2|||
16803752|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
16803753|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
16803754|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
16803755|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
16803756|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
16803757|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
16803758|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
16803759|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
16803760|NCT02143713|37745318|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
16803761|NCT02143713|37745319|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
16803762|NCT02143713|37745320|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
16803763|NCT02143713|37745321|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
16803764|NCT02143713|37745318|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
16803765|NCT02143713|37745319|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
16803766|NCT02143713|37745320|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
16803767|NCT02143713|37745321|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
16803768|NCT02143713|37745318|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
16803769|NCT02143713|37745319|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
16803770|NCT02143713|37745320|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
16803771|NCT02143713|37745321|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
16803772|NCT02143713|37745318|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
16803773|NCT02143713|37745319|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
16803774|NCT02143713|37745320|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
16803775|NCT02143713|37745321|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
16803776|NCT02143713|37745318|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
16803777|NCT02143713|37745319|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
16803778|NCT02143713|37745320|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
16909536|NCT01745094|38018418|FG000|Overall Study|Withdrawal by Subject|2|||
16909537|NCT01745094|38018419|FG001|Overall Study|Withdrawal by Subject|0|||
16909538|NCT01745094|38018420|FG002|Overall Study|Withdrawal by Subject|1|||
16909539|NCT01745094|38018421|FG003|Overall Study|Withdrawal by Subject|2|||
16803779|NCT02143713|37745321|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
16803780|NCT02143713|37745318|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
16803781|NCT02143713|37745319|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
16803782|NCT02143713|37745320|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
16803783|NCT02143713|37745321|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
16803784|NCT02143713|37745318|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
16803785|NCT02143713|37745319|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
16803786|NCT02143713|37745320|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
16803787|NCT02143713|37745321|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
16803788|NCT02519855|37745334|FG000|Overall Study|Adverse Event|0|||
16803789|NCT02519855|37745335|FG001|Overall Study|Adverse Event|1|||
16803790|NCT02519855|37745334|FG000|Overall Study|Lost to Follow-up|3|||
16803791|NCT02519855|37745335|FG001|Overall Study|Lost to Follow-up|3|||
16803792|NCT02142387|37745343|FG000|Overall Study|<19 years old|49|||
16803793|NCT02142387|37745344|FG001|Overall Study|<19 years old|326|||
16803794|NCT02142387|37745343|FG000|Overall Study|non-cardiac etiology|504|||
16803795|NCT02142387|37745344|FG001|Overall Study|non-cardiac etiology|3431|||
16803796|NCT02142387|37745343|FG000|Overall Study|CPR not performed|74|||
16803797|NCT02142387|37745344|FG001|Overall Study|CPR not performed|473|||
16803798|NCT02142387|37745343|FG000|Overall Study|witnessed by paramedic|139|||
16803799|NCT02142387|37745344|FG001|Overall Study|witnessed by paramedic|917|||
16803800|NCT02142387|37745343|FG000|Overall Study|incomplete data|1|||
16803801|NCT02142387|37745344|FG001|Overall Study|incomplete data|9|||
16803802|NCT02142387|37745343|FG000|Overall Study|occurred not at home|298|||
16803803|NCT02142387|37745344|FG001|Overall Study|occurred not at home|2474|||
16803804|NCT02518919|37745353|FG000|Overall Study|Protocol Violation|1|||
16803805|NCT02518919|37745354|FG001|Overall Study|Protocol Violation|1|||
16803806|NCT02518919|37745355|FG002|Overall Study|Protocol Violation|2|||
16803807|NCT02518685|37745365|FG000|Overall Study|Adverse Event|29|||
16803808|NCT02518685|37745366|FG001|Overall Study|Adverse Event|1|||
16803809|NCT02518685|37745365|FG000|Overall Study|Withdrawal by Subject|10|||
16803810|NCT02518685|37745366|FG001|Overall Study|Withdrawal by Subject|3|||
16803811|NCT02518685|37745365|FG000|Overall Study|relocation, study fatigue|7|||
16803812|NCT02518685|37745366|FG001|Overall Study|relocation, study fatigue|2|||
16803813|NCT02518685|37745365|FG000|Overall Study|Pregnancy|1|||
16803814|NCT02518685|37745366|FG001|Overall Study|Pregnancy|0|||
16803815|NCT02518685|37745365|FG000|Overall Study|Physician Decision|1|||
16803816|NCT02518685|37745366|FG001|Overall Study|Physician Decision|0|||
16803817|NCT02518685|37745365|FG000|Overall Study|Lost to Follow-up|1|||
16803818|NCT02518685|37745366|FG001|Overall Study|Lost to Follow-up|4|||
16803819|NCT02520089|37745375|FG000|Overall Study|Lost to Follow-up|3|||
16803820|NCT02520089|37745376|FG001|Overall Study|Lost to Follow-up|4|||
16803821|NCT02105961|37745385|FG000|Overall Study|Adverse Event|18|||
16803822|NCT02105961|37745386|FG001|Overall Study|Adverse Event|7|||
16803823|NCT02105961|37745387|FG002|Overall Study|Adverse Event|13|||
16803824|NCT02105961|37745385|FG000|Overall Study|Lack of Efficacy|3|||
16803825|NCT02105961|37745386|FG001|Overall Study|Lack of Efficacy|0|||
16803826|NCT02105961|37745387|FG002|Overall Study|Lack of Efficacy|3|||
16803827|NCT02105961|37745385|FG000|Overall Study|Lost to Follow-up|2|||
16803828|NCT02105961|37745386|FG001|Overall Study|Lost to Follow-up|0|||
16803829|NCT02105961|37745387|FG002|Overall Study|Lost to Follow-up|1|||
16803830|NCT02105961|37745385|FG000|Overall Study|Physician Decision|3|||
16803831|NCT02105961|37745386|FG001|Overall Study|Physician Decision|3|||
16803832|NCT02105961|37745387|FG002|Overall Study|Physician Decision|2|||
16803833|NCT02105961|37745385|FG000|Overall Study|Withdrawal by Subject|15|||
16803834|NCT02105961|37745386|FG001|Overall Study|Withdrawal by Subject|7|||
16803835|NCT02105961|37745387|FG002|Overall Study|Withdrawal by Subject|11|||
16803836|NCT02141997|37745400|FG000|Overall Study|Adverse Event|0|||
16803837|NCT02141997|37745401|FG001|Overall Study|Adverse Event|2|||
16803838|NCT02141997|37745402|FG002|Overall Study|Adverse Event|0|||
16803839|NCT02141997|37745403|FG003|Overall Study|Adverse Event|1|||
16803840|NCT02141997|37745400|FG000|Overall Study|Participant noncompliance|1|||
16803841|NCT02141997|37745401|FG001|Overall Study|Participant noncompliance|0|||
17198341|NCT02595398|38351957|FG001|Overall Study|Withdrawal by Subject|1|||
16803842|NCT02141997|37745402|FG002|Overall Study|Participant noncompliance|0|||
16803843|NCT02141997|37745403|FG003|Overall Study|Participant noncompliance|0|||
16803844|NCT02141997|37745400|FG000|Overall Study|Withdrew consent|1|||
16803845|NCT02141997|37745401|FG001|Overall Study|Withdrew consent|0|||
16803846|NCT02141997|37745402|FG002|Overall Study|Withdrew consent|3|||
16803847|NCT02141997|37745403|FG003|Overall Study|Withdrew consent|0|||
16803848|NCT02141997|37745400|FG000|Overall Study|Other|1|||
16803849|NCT02141997|37745401|FG001|Overall Study|Other|4|||
16803850|NCT02141997|37745402|FG002|Overall Study|Other|0|||
16803851|NCT02141997|37745403|FG003|Overall Study|Other|0|||
16803852|NCT01628367|37745415|FG000|Overall Study|Adverse Event|1|||
16803853|NCT01628367|37745416|FG001|Overall Study|Adverse Event|0|||
16803854|NCT01627899|37745422|FG000|Overall Study|Study terminated early by sponsor.|5|||
16803855|NCT02519777|37745429|FG000|Overall Study|Death|1|||
16803856|NCT02519777|37745430|FG001|Overall Study|Death|0|||
16803857|NCT02519777|37745431|FG002|Overall Study|Death|0|||
16803858|NCT02519777|37745429|FG000|Overall Study|Lost to Follow-up|0|||
16803859|NCT02519777|37745430|FG001|Overall Study|Lost to Follow-up|4|||
16803860|NCT02519777|37745431|FG002|Overall Study|Lost to Follow-up|2|||
16803861|NCT02519777|37745429|FG000|Overall Study|Withdrawal by Subject|3|||
16803862|NCT02519777|37745430|FG001|Overall Study|Withdrawal by Subject|1|||
16803863|NCT02519777|37745431|FG002|Overall Study|Withdrawal by Subject|0|||
16803864|NCT02519777|37745429|FG000|Overall Study|Severe Debilitation|1|||
16803865|NCT02519777|37745430|FG001|Overall Study|Severe Debilitation|1|||
16803866|NCT02519777|37745431|FG002|Overall Study|Severe Debilitation|1|||
16803867|NCT02519777|37745429|FG000|Overall Study|Not able to get to clinic|1|||
16803868|NCT02519777|37745430|FG001|Overall Study|Not able to get to clinic|2|||
16803869|NCT02519777|37745431|FG002|Overall Study|Not able to get to clinic|1|||
16803870|NCT02515331|37745442|FG000|Overall Study|Withdrawal by Subject|0|||
16803871|NCT02515331|37745443|FG001|Overall Study|Withdrawal by Subject|0|||
16803872|NCT02515331|37745444|FG002|Overall Study|Withdrawal by Subject|1|||
16803873|NCT02515331|37745442|FG000|Overall Study|Protocol deviation|0|||
16803874|NCT02515331|37745443|FG001|Overall Study|Protocol deviation|0|||
16803875|NCT02515331|37745444|FG002|Overall Study|Protocol deviation|3|||
16803876|NCT02515331|37745442|FG000|Overall Study|Adverse Event|2|||
16803877|NCT02515331|37745443|FG001|Overall Study|Adverse Event|0|||
16803878|NCT02515331|37745444|FG002|Overall Study|Adverse Event|0|||
16803879|NCT02515097|37745454|FG000|Overall Study|Lost to Follow-up|4|||
16803880|NCT02515097|37745455|FG001|Overall Study|Lost to Follow-up|2|||
16803881|NCT02515097|37745454|FG000|Overall Study|Withdrawal by Subject|1|||
16803882|NCT02515097|37745455|FG001|Overall Study|Withdrawal by Subject|3|||
16803883|NCT02515097|37745454|FG000|Overall Study|Adverse Event|2|||
16803884|NCT02515097|37745455|FG001|Overall Study|Adverse Event|1|||
16803885|NCT02141295|37745464|FG000|Overall Study|Adverse Event|1|||
16803886|NCT02141295|37745465|FG001|Overall Study|Adverse Event|18|||
16803887|NCT02141295|37745466|FG002|Overall Study|Adverse Event|11|||
16803888|NCT02141295|37745464|FG000|Overall Study|Physician Decision|2|||
16803889|NCT02141295|37745465|FG001|Overall Study|Physician Decision|19|||
16803890|NCT02141295|37745466|FG002|Overall Study|Physician Decision|14|||
16803891|NCT02141295|37745464|FG000|Overall Study|Study terminated by sponsor|0|||
16803892|NCT02141295|37745465|FG001|Overall Study|Study terminated by sponsor|6|||
16803893|NCT02141295|37745466|FG002|Overall Study|Study terminated by sponsor|6|||
16803894|NCT02141295|37745464|FG000|Overall Study|Non-compliance|0|||
16803895|NCT02141295|37745465|FG001|Overall Study|Non-compliance|1|||
16803896|NCT02141295|37745466|FG002|Overall Study|Non-compliance|0|||
16803897|NCT02141295|37745464|FG000|Overall Study|Progressive disease|3|||
16803898|NCT02141295|37745465|FG001|Overall Study|Progressive disease|32|||
16803899|NCT02141295|37745466|FG002|Overall Study|Progressive disease|50|||
16803900|NCT02141295|37745464|FG000|Overall Study|Reason not specified|0|||
16803901|NCT02141295|37745465|FG001|Overall Study|Reason not specified|9|||
16803902|NCT02141295|37745466|FG002|Overall Study|Reason not specified|10|||
16803903|NCT02141295|37745464|FG000|Overall Study|Withdrawal by Subject|0|||
16803904|NCT02141295|37745465|FG001|Overall Study|Withdrawal by Subject|9|||
16803905|NCT02141295|37745466|FG002|Overall Study|Withdrawal by Subject|4|||
16803906|NCT02514551|37745478|FG000|Overall Study|Lost to Follow-up|0|||
16803907|NCT02514551|37745479|FG001|Overall Study|Lost to Follow-up|1|||
16803908|NCT02514551|37745478|FG000|Overall Study|Participant Never Treated|0|||
16803909|NCT02514551|37745479|FG001|Overall Study|Participant Never Treated|2|||
16803910|NCT02141217|37745488|FG000|Overall Study|Adverse Event|1|||
16803911|NCT02141217|37745489|FG001|Overall Study|Adverse Event|2|||
16803912|NCT02141217|37745488|FG000|Overall Study|Protocol Violation|1|||
16803913|NCT02141217|37745489|FG001|Overall Study|Protocol Violation|4|||
16803914|NCT02141217|37745488|FG000|Overall Study|Withdrawal by Subject|6|||
16803915|NCT02141217|37745489|FG001|Overall Study|Withdrawal by Subject|0|||
16803916|NCT02141217|37745488|FG000|Overall Study|Lost to Follow-up|1|||
16803917|NCT02141217|37745489|FG001|Overall Study|Lost to Follow-up|1|||
16803918|NCT02141217|37745488|FG000|Overall Study|Physician Decision|1|||
16803919|NCT02141217|37745489|FG001|Overall Study|Physician Decision|0|||
16803920|NCT02141217|37745488|FG000|Overall Study|Surgical Intervention|1|||
16803921|NCT02141217|37745489|FG001|Overall Study|Surgical Intervention|1|||
16803922|NCT02138253|37745500|FG000|Overall Study|Adverse Event|3|||
16803923|NCT02138253|37745501|FG001|Overall Study|Adverse Event|3|||
16803924|NCT02138253|37745500|FG000|Overall Study|Lost to Follow-up|2|||
16803925|NCT02138253|37745501|FG001|Overall Study|Lost to Follow-up|1|||
16803926|NCT02138253|37745500|FG000|Overall Study|Physician Decision|2|||
16803927|NCT02138253|37745501|FG001|Overall Study|Physician Decision|0|||
16803928|NCT02138253|37745500|FG000|Overall Study|Non compliance|1|||
16803929|NCT02138253|37745501|FG001|Overall Study|Non compliance|0|||
16803930|NCT02138253|37745500|FG000|Overall Study|Withdrawal by Subject|1|||
16803931|NCT02138253|37745501|FG001|Overall Study|Withdrawal by Subject|0|||
16803932|NCT02514473|37745509|FG000|Overall Study|Adverse Event|0|||
16803933|NCT02514473|37745510|FG001|Overall Study|Adverse Event|2|||
16803934|NCT02514473|37745509|FG000|Overall Study|Withdrawal by Subject|2|||
16803935|NCT02514473|37745510|FG001|Overall Study|Withdrawal by Subject|1|||
16803936|NCT02514473|37745509|FG000|Overall Study|Lost to Follow-up|0|||
16803937|NCT02514473|37745510|FG001|Overall Study|Lost to Follow-up|1|||
16803938|NCT02514473|37745509|FG000|Overall Study|Other|1|||
16803939|NCT02514473|37745510|FG001|Overall Study|Other|1|||
16803940|NCT02513771|37745519|FG000|Overall Study|Lost to Follow-up|1|||
16803941|NCT02513771|37745520|FG001|Overall Study|Lost to Follow-up|1|||
16803942|NCT02513771|37745519|FG000|Overall Study|Not being able to get to clinic|1|||
16803943|NCT02513771|37745520|FG001|Overall Study|Not being able to get to clinic|0|||
16803944|NCT02104947|37745528|FG000|Overall Study|Withdrawal by Subject|10|||
16803945|NCT02104947|37745529|FG001|Overall Study|Withdrawal by Subject|3|||
16803946|NCT02104947|37745528|FG000|Overall Study|Lost to Follow-up|4|||
16803947|NCT02104947|37745529|FG001|Overall Study|Lost to Follow-up|4|||
16803948|NCT02104947|37745528|FG000|Overall Study|Protocol Violation|6|||
16803949|NCT02104947|37745529|FG001|Overall Study|Protocol Violation|8|||
16803950|NCT02104947|37745528|FG000|Overall Study|Adverse Event|57|||
16803951|NCT02104947|37745529|FG001|Overall Study|Adverse Event|38|||
16803952|NCT02104947|37745528|FG000|Overall Study|Other than stated above|2|||
16803953|NCT02104947|37745529|FG001|Overall Study|Other than stated above|3|||
16803954|NCT02513459|37745539|FG000|Overall Study|Adverse Event|7|||
16803955|NCT02513459|37745539|FG000|Overall Study|Withdrew consent|5|||
16803956|NCT02513459|37745539|FG000|Overall Study|Loss of efficacy|2|||
16803957|NCT02513459|37745539|FG000|Overall Study|Pregnancy|2|||
16803958|NCT02513459|37745539|FG000|Overall Study|Subject decision|2|||
16803959|NCT02513459|37745539|FG000|Overall Study|Lack of response|1|||
16803960|NCT02513459|37745539|FG000|Overall Study|Reproductive plans|1|||
16803961|NCT02513459|37745539|FG000|Overall Study|Surgery planned-- not done|1|||
16803962|NCT02104557|37745548|FG000|Overall Study|Adverse Event|24|||
16803963|NCT02104557|37745548|FG000|Overall Study|Lost to Follow-up|34|||
16803964|NCT02104557|37745548|FG000|Overall Study|Violated the usage and dosage|14|||
16803965|NCT02104557|37745548|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
16803966|NCT02104557|37745548|FG000|Overall Study|Administered Sayana prior to the contract|1|||
16803967|NCT02104557|37745548|FG000|Overall Study|Other|17|||
16803968|NCT02104557|37745548|FG000|Overall Study|Change to other contraception methods|5|||
16803969|NCT02104557|37745548|FG000|Overall Study|Discontinuation due to no pain|1|||
16803970|NCT02104557|37745548|FG000|Overall Study|Withdrawal consent|2|||
16803971|NCT02104557|37745548|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
16803972|NCT02104557|37745548|FG000|Overall Study|Discontinuation of contraception|9|||
16803973|NCT02069379|37745554|FG000|Baseline Measurements|Lost to Follow-up|1|||
16803974|NCT02069379|37745555|FG001|Baseline Measurements|Lost to Follow-up|0|||
16803975|NCT02069379|37745556|FG002|Baseline Measurements|Lost to Follow-up|0|||
16803976|NCT02069379|37745557|FG003|Baseline Measurements|Lost to Follow-up|0|||
16803977|NCT02069379|37745554|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
16803978|NCT02069379|37745555|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
16803979|NCT02069379|37745556|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
16803980|NCT02069379|37745557|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
16803981|NCT02069379|37745554|FG000|First Treatment Arm|Lost to Follow-up|0|||
16803982|NCT02069379|37745555|FG001|First Treatment Arm|Lost to Follow-up|1|||
16803983|NCT02069379|37745556|FG002|First Treatment Arm|Lost to Follow-up|1|||
16803984|NCT02069379|37745557|FG003|First Treatment Arm|Lost to Follow-up|0|||
16803985|NCT02069379|37745554|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
16803986|NCT02069379|37745555|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
16803987|NCT02069379|37745556|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
16803988|NCT02069379|37745557|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
16803989|NCT02069379|37745554|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
16803990|NCT02069379|37745555|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
16803991|NCT02069379|37745556|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
16803992|NCT02069379|37745557|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
16803993|NCT02069379|37745554|FG000|Second Treatment Arm|Lost to Follow-up|0|||
16803994|NCT02069379|37745555|FG001|Second Treatment Arm|Lost to Follow-up|0|||
16803995|NCT02069379|37745556|FG002|Second Treatment Arm|Lost to Follow-up|1|||
16803996|NCT02069379|37745557|FG003|Second Treatment Arm|Lost to Follow-up|0|||
16803997|NCT02511431|37745573|FG000|Treatment|Lost to Follow-up|0|||
16803998|NCT02511431|37745574|FG001|Treatment|Lost to Follow-up|0|||
16803999|NCT02511431|37745575|FG002|Treatment|Lost to Follow-up|1|||
16804000|NCT02511431|37745576|FG003|Treatment|Lost to Follow-up|0|||
16804001|NCT02511431|37745577|FG004|Treatment|Lost to Follow-up|0|||
16804002|NCT02511431|37745578|FG005|Treatment|Lost to Follow-up|1|||
16804003|NCT02137785|37745595|FG000|Overall Study|Lost to Follow-up|1|||
16804004|NCT02137785|37745596|FG001|Overall Study|Lost to Follow-up|0|||
16804005|NCT02137785|37745595|FG000|Overall Study|Withdrawal by Subject|1|||
16804006|NCT02137785|37745596|FG001|Overall Study|Withdrawal by Subject|4|||
16804007|NCT02137785|37745595|FG000|Overall Study|subject moved out of state|1|||
16804008|NCT02137785|37745596|FG001|Overall Study|subject moved out of state|0|||
16804009|NCT01655069|37745606|FG000|Overall Study|Physician Decision|0|||
16804010|NCT01655069|37745607|FG001|Overall Study|Physician Decision|0|||
17016554|NCT00855218|38161204|FG001|Overall Study|Lost to Follow-up|1|||
16804011|NCT01655069|37745608|FG002|Overall Study|Physician Decision|0|||
16804012|NCT01655069|37745609|FG003|Overall Study|Physician Decision|1|||
17016555|NCT00855218|38161203|FG000|Overall Study|Protocol Violation|5|||
16804013|NCT01655069|37745606|FG000|Overall Study|Adverse Event|6|||
16804014|NCT01655069|37745607|FG001|Overall Study|Adverse Event|7|||
16804015|NCT01655069|37745608|FG002|Overall Study|Adverse Event|2|||
16804016|NCT01655069|37745609|FG003|Overall Study|Adverse Event|3|||
16804017|NCT01655069|37745606|FG000|Overall Study|Lack of Efficacy|0|||
16804018|NCT01655069|37745607|FG001|Overall Study|Lack of Efficacy|1|||
16804019|NCT01655069|37745608|FG002|Overall Study|Lack of Efficacy|0|||
16804020|NCT01655069|37745609|FG003|Overall Study|Lack of Efficacy|0|||
16804021|NCT01655069|37745606|FG000|Overall Study|No Treatment Needed|0|||
16804022|NCT01655069|37745607|FG001|Overall Study|No Treatment Needed|1|||
16804023|NCT01655069|37745608|FG002|Overall Study|No Treatment Needed|0|||
16804024|NCT01655069|37745609|FG003|Overall Study|No Treatment Needed|0|||
16804025|NCT01655069|37745606|FG000|Overall Study|Withdrawal by Subject|2|||
16804026|NCT01655069|37745607|FG001|Overall Study|Withdrawal by Subject|3|||
16804027|NCT01655069|37745608|FG002|Overall Study|Withdrawal by Subject|0|||
16804028|NCT01655069|37745609|FG003|Overall Study|Withdrawal by Subject|0|||
16804029|NCT02068599|37745620|FG000|Overall Study|Adverse Event|4|||
16804030|NCT02068599|37745621|FG001|Overall Study|Adverse Event|1|||
16804031|NCT02068599|37745622|FG002|Overall Study|Adverse Event|1|||
16804032|NCT02068599|37745620|FG000|Overall Study|Withdrawal by Subject|2|||
16804033|NCT02068599|37745621|FG001|Overall Study|Withdrawal by Subject|7|||
16804034|NCT02068599|37745622|FG002|Overall Study|Withdrawal by Subject|5|||
16804035|NCT02068599|37745620|FG000|Overall Study|Protocol Violation|4|||
16804036|NCT02068599|37745621|FG001|Overall Study|Protocol Violation|2|||
16804037|NCT02068599|37745622|FG002|Overall Study|Protocol Violation|3|||
16804038|NCT02068599|37745620|FG000|Overall Study|Lost to Follow-up|1|||
16804039|NCT02068599|37745621|FG001|Overall Study|Lost to Follow-up|0|||
16804040|NCT02068599|37745622|FG002|Overall Study|Lost to Follow-up|0|||
16804041|NCT02068599|37745620|FG000|Overall Study|Lack of Efficacy|0|||
16804042|NCT02068599|37745621|FG001|Overall Study|Lack of Efficacy|0|||
16804043|NCT02068599|37745622|FG002|Overall Study|Lack of Efficacy|3|||
16804044|NCT02068599|37745620|FG000|Overall Study|Noncompliance|0|||
16804045|NCT02068599|37745621|FG001|Overall Study|Noncompliance|0|||
16804046|NCT02068599|37745622|FG002|Overall Study|Noncompliance|1|||
16804047|NCT01654601|37745632|FG000|1st Administration|Withdrawal by Subject|2|||
16804048|NCT01654601|37745633|FG001|1st Administration|Withdrawal by Subject|0|||
16804049|NCT01654601|37745632|FG000|1st Administration|Protocol Violation|0|||
16804050|NCT01654601|37745633|FG001|1st Administration|Protocol Violation|2|||
16804051|NCT01654601|37745632|FG000|2nd Administration|Adverse Event|1|||
16804052|NCT01654601|37745633|FG001|2nd Administration|Adverse Event|0|||
16804053|NCT01654601|37745632|FG000|2nd Administration|Protocol Violation|0|||
16804054|NCT01654601|37745633|FG001|2nd Administration|Protocol Violation|1|||
16804055|NCT01654523|37745639|FG000|Overall Study|Withdrawal by Subject|1|||
16804056|NCT02068443|37745646|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16804057|NCT02068443|37745647|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
16804058|NCT02068443|37745648|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
16804059|NCT02068443|37745646|FG000|Overall Study|Voluntary Withdrawal|4|||
16804060|NCT02068443|37745647|FG001|Overall Study|Voluntary Withdrawal|0|||
16804061|NCT02068443|37745648|FG002|Overall Study|Voluntary Withdrawal|1|||
16804062|NCT02068443|37745646|FG000|Overall Study|Lack of Efficacy|2|||
16804063|NCT02068443|37745647|FG001|Overall Study|Lack of Efficacy|1|||
16804064|NCT02068443|37745648|FG002|Overall Study|Lack of Efficacy|0|||
16804065|NCT02068443|37745646|FG000|Overall Study|Other Reason Not Specified|1|||
16804066|NCT02068443|37745647|FG001|Overall Study|Other Reason Not Specified|0|||
16804067|NCT02068443|37745648|FG002|Overall Study|Other Reason Not Specified|0|||
16804068|NCT02508935|37745656|FG000|Overall Study|Withdrawal by Subject|1|||
16804069|NCT02508935|37745656|FG000|Overall Study|Withdrawal by Caregiver|8|||
16804070|NCT02508935|37745656|FG000|Overall Study|Pain Score <4|1|||
16804071|NCT02508935|37745656|FG000|Overall Study|Emesis|3|||
16804072|NCT02508935|37745656|FG000|Overall Study|Adverse Event|3|||
16804073|NCT02508935|37745656|FG000|Overall Study|Protocol Violation|1|||
16804074|NCT02508935|37745656|FG000|Overall Study|Physician Decision|1|||
16804075|NCT02508935|37745656|FG000|Overall Study|Trial terminated by sponsor|5|||
16804076|NCT02508701|37745666|FG000|Overall Study|Lost to Follow-up|9|||
16804077|NCT02508701|37745667|FG001|Overall Study|Lost to Follow-up|5|||
16804078|NCT02508701|37745668|FG002|Overall Study|Lost to Follow-up|5|||
16804079|NCT02508701|37745669|FG003|Overall Study|Lost to Follow-up|3|||
16804080|NCT02507375|37745685|FG000|Overall Study|Progressive Disease|4|||
16804081|NCT02507375|37745686|FG001|Overall Study|Progressive Disease|5|||
16804082|NCT02507375|37745685|FG000|Overall Study|Death|0|||
16804083|NCT02507375|37745686|FG001|Overall Study|Death|1|||
16804084|NCT02507375|37745685|FG000|Overall Study|Refused treatment|0|||
16804085|NCT02507375|37745686|FG001|Overall Study|Refused treatment|1|||
16804086|NCT02507375|37745685|FG000|Overall Study|Adverse Event|0|||
16804087|NCT02507375|37745686|FG001|Overall Study|Adverse Event|1|||
16804088|NCT02507297|37745698|FG000|Overall Study|Withdrawal by Subject|1|||
16804089|NCT02507297|37745699|FG001|Overall Study|Withdrawal by Subject|0|||
16804090|NCT02507297|37745698|FG000|Overall Study|Lost to Follow-up|0|||
16804091|NCT02507297|37745699|FG001|Overall Study|Lost to Follow-up|1|||
16804092|NCT02507219|37745705|FG000|Overall Study|Physician Decision|1|||
16804093|NCT02507219|37745706|FG001|Overall Study|Physician Decision|0|||
16804094|NCT02507219|37745707|FG002|Overall Study|Physician Decision|0|||
16804095|NCT02507219|37745708|FG003|Overall Study|Physician Decision|0|||
16804096|NCT02507219|37745709|FG004|Overall Study|Physician Decision|0|||
16804097|NCT02507219|37745710|FG005|Overall Study|Physician Decision|0|||
16804098|NCT02507219|37745705|FG000|Overall Study|Withdrawal by Subject|0|||
16804099|NCT02507219|37745706|FG001|Overall Study|Withdrawal by Subject|0|||
16804100|NCT02507219|37745707|FG002|Overall Study|Withdrawal by Subject|0|||
16804101|NCT02507219|37745708|FG003|Overall Study|Withdrawal by Subject|0|||
16804102|NCT02507219|37745709|FG004|Overall Study|Withdrawal by Subject|1|||
16804103|NCT02507219|37745710|FG005|Overall Study|Withdrawal by Subject|0|||
16804104|NCT02483975|37745720|FG000|Overall Study|Adverse Event|0|||
16804105|NCT02483975|37745721|FG001|Overall Study|Adverse Event|1|||
16804106|NCT02483975|37745720|FG000|Overall Study|Lost to Follow-up|0|||
16909540|NCT01745094|38018418|FG000|Overall Study|Protocol Violation|1|||
16909541|NCT01745094|38018419|FG001|Overall Study|Protocol Violation|0|||
16909542|NCT01745094|38018420|FG002|Overall Study|Protocol Violation|3|||
16909543|NCT01745094|38018421|FG003|Overall Study|Protocol Violation|1|||
16909544|NCT01745094|38018418|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
16909545|NCT01745094|38018419|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
16909546|NCT01745094|38018420|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
16909547|NCT01745094|38018421|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
16909548|NCT01745094|38018418|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
16909549|NCT01745094|38018419|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
16909550|NCT01745094|38018420|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
16909551|NCT01745094|38018421|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
16909552|NCT01745094|38018418|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
16909553|NCT01745094|38018419|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
16909554|NCT01745094|38018420|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
16909555|NCT01745094|38018421|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
17198342|NCT02595398|38351956|FG000|Overall Study|Lost to Follow-up|1|||
16909556|NCT01697748|38018436|FG000|Overall Study|ineligible skin incision|1|||
16909557|NCT01697748|38018437|FG001|Overall Study|ineligible skin incision|2|||
16909558|NCT01697748|38018436|FG000|Overall Study|ineligible uterine incision|4|||
16909559|NCT01697748|38018437|FG001|Overall Study|ineligible uterine incision|1|||
16909560|NCT01697748|38018436|FG000|Overall Study|Lost to Follow-up|53|||
16909561|NCT01697748|38018437|FG001|Overall Study|Lost to Follow-up|65|||
16909562|NCT01717326|38018463|FG000|Overall Study|Death|0|||
16909563|NCT01717326|38018464|FG001|Overall Study|Death|0|||
16909564|NCT01717326|38018465|FG002|Overall Study|Death|0|||
16909565|NCT01717326|38018466|FG003|Overall Study|Death|0|||
16909566|NCT01717326|38018467|FG004|Overall Study|Death|0|||
16909567|NCT01717326|38018468|FG005|Overall Study|Death|0|||
16909568|NCT01717326|38018469|FG006|Overall Study|Death|0|||
16909569|NCT01717326|38018470|FG007|Overall Study|Death|0|||
16909570|NCT01717326|38018471|FG008|Overall Study|Death|0|||
16909571|NCT01717326|38018472|FG009|Overall Study|Death|0|||
16804107|NCT02483975|37745721|FG001|Overall Study|Lost to Follow-up|1|||
16804108|NCT02483975|37745720|FG000|Overall Study|Physician Decision|2|||
16804109|NCT02483975|37745721|FG001|Overall Study|Physician Decision|0|||
16804110|NCT02047227|37745732|FG000|Overall Study|Adverse Event|2|||
16804111|NCT02047227|37745733|FG001|Overall Study|Adverse Event|4|||
16804112|NCT02047227|37745732|FG000|Overall Study|Lost to Follow-up|0|||
16804113|NCT02047227|37745733|FG001|Overall Study|Lost to Follow-up|3|||
16804114|NCT02047227|37745732|FG000|Overall Study|Protocol Violation|1|||
16804115|NCT02047227|37745733|FG001|Overall Study|Protocol Violation|0|||
16804116|NCT02047227|37745732|FG000|Overall Study|Spontaneous pregnancy|1|||
16804117|NCT02047227|37745733|FG001|Overall Study|Spontaneous pregnancy|0|||
16804118|NCT02047227|37745732|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
16804119|NCT02047227|37745733|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
16804120|NCT02047227|37745732|FG000|Overall Study|No oocytes retrieved|21|||
16804121|NCT02047227|37745733|FG001|Overall Study|No oocytes retrieved|20|||
16804122|NCT02047227|37745732|FG000|Overall Study|No fertilization|61|||
16804123|NCT02047227|37745733|FG001|Overall Study|No fertilization|51|||
16804124|NCT02047227|37745732|FG000|Overall Study|Intention to freeze all embryos|1|||
16804125|NCT02047227|37745733|FG001|Overall Study|Intention to freeze all embryos|0|||
16804126|NCT02047227|37745732|FG000|Overall Study|All embryos discarded|12|||
16909572|NCT01717326|38018473|FG010|Overall Study|Death|1|||
16909573|NCT01717326|38018474|FG011|Overall Study|Death|0|||
16909574|NCT01717326|38018475|FG012|Overall Study|Death|0|||
16909575|NCT01717326|38018476|FG013|Overall Study|Death|0|||
16909576|NCT01717326|38018477|FG014|Overall Study|Death|0|||
16804127|NCT02047227|37745733|FG001|Overall Study|All embryos discarded|11|||
16804128|NCT02047227|37745732|FG000|Overall Study|Other|10|||
16804129|NCT02047227|37745733|FG001|Overall Study|Other|9|||
16804130|NCT02483585|37745741|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
16909577|NCT01717326|38018478|FG015|Overall Study|Death|0|||
16804131|NCT02483585|37745742|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
16804132|NCT02483585|37745741|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
16804133|NCT02483585|37745742|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
16804134|NCT02483585|37745741|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
16804135|NCT02483585|37745742|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
16804136|NCT02483585|37745741|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
16804137|NCT02483585|37745742|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
16804138|NCT02483585|37745741|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
16804139|NCT02483585|37745742|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
16804140|NCT02483585|37745741|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
16804141|NCT02483585|37745742|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
16804142|NCT02483585|37745741|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
16804143|NCT02483585|37745742|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
16804144|NCT02046993|37745754|FG000|Overall Study|Withdrawal by Subject|2|||
16804145|NCT02046993|37745755|FG001|Overall Study|Withdrawal by Subject|10|||
16804146|NCT02046993|37745754|FG000|Overall Study|Lost to Follow-up|1|||
16804147|NCT02046993|37745755|FG001|Overall Study|Lost to Follow-up|1|||
16804148|NCT02101983|37745765|FG000|Overall Study|Physician Decision|1|||
16804149|NCT02101983|37745766|FG001|Overall Study|Physician Decision|0|||
16804150|NCT02482805|37745775|FG000|Overall Study|Lost to Follow-up|4|||
16804151|NCT02482805|37745776|FG001|Overall Study|Lost to Follow-up|4|||
16804152|NCT02482805|37745777|FG002|Overall Study|Lost to Follow-up|0|||
16804153|NCT02503865|37745788|FG000|Overall Study|Moved out of area|1|||
16804154|NCT02503865|37745789|FG001|Overall Study|Moved out of area|8|||
16804155|NCT02503865|37745790|FG002|Overall Study|Moved out of area|0|||
16804156|NCT02503865|37745788|FG000|Overall Study|Refused treatment|4|||
16804157|NCT02503865|37745789|FG001|Overall Study|Refused treatment|39|||
16804158|NCT02503865|37745790|FG002|Overall Study|Refused treatment|2|||
16804159|NCT01623531|37745801|FG000|Overall Study|Death|1|||
16804160|NCT01623531|37745802|FG001|Overall Study|Death|0|||
16804161|NCT01623531|37745801|FG000|Overall Study|Protocol Violation|2|||
16804162|NCT01623531|37745802|FG001|Overall Study|Protocol Violation|1|||
16804163|NCT01623531|37745801|FG000|Overall Study|Missing data at primary outcome time poi|1|||
16804164|NCT01623531|37745802|FG001|Overall Study|Missing data at primary outcome time poi|1|||
16804165|NCT02503787|37745811|FG000|Enrollment|Withdrawal by Subject|6|||
16804166|NCT02503787|37745811|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
16804167|NCT02503787|37745811|FG000|Enrollment|Physician Decision|2|||
16804168|NCT02503787|37745811|FG000|Enrollment|Insurance issue|2|||
16804169|NCT02503787|37745811|FG000|Enrollment|Lost to Follow-up|1|||
16804170|NCT02503787|37745811|FG000|Enrollment|Study closure|1|||
16804171|NCT02503787|37745811|FG000|Enrollment|Adverse Event|1|||
16804172|NCT02503787|37745811|FG000|Enrollment|Protocol Violation|1|||
16804173|NCT02503787|37745811|FG000|Enrollment|Inability to implant system|1|||
16804174|NCT02503787|37745811|FG000|Enrollment|Unable to be programmed|1|||
16804175|NCT02503787|37745811|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
16804176|NCT02503787|37745811|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
16804177|NCT02503787|37745811|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
16804178|NCT02503787|37745811|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
16804179|NCT02503787|37745811|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
16804180|NCT02503787|37745811|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
16804181|NCT02482571|37745815|FG000|Overall Study|Adverse Event|1|||
16804182|NCT02482571|37745815|FG000|Overall Study|Scanner or Respiract failure|3|||
16804183|NCT02482571|37745815|FG000|Overall Study|Withdrawal by Subject|4|||
16804184|NCT02481947|37745822|FG000|Overall Study|Withdrawal by Subject|24|||
16804185|NCT02481947|37745823|FG001|Overall Study|Withdrawal by Subject|10|||
16804186|NCT02481947|37745822|FG000|Overall Study|Lost to Follow-up|11|||
16804187|NCT02481947|37745823|FG001|Overall Study|Lost to Follow-up|5|||
16804188|NCT02481947|37745822|FG000|Overall Study|Adverse Event|6|||
16804189|NCT02481947|37745823|FG001|Overall Study|Adverse Event|11|||
16804190|NCT02481947|37745822|FG000|Overall Study|Physician Decision|4|||
16804191|NCT02481947|37745823|FG001|Overall Study|Physician Decision|5|||
16804192|NCT02481947|37745822|FG000|Overall Study|Protocol Violation|1|||
16804193|NCT02481947|37745823|FG001|Overall Study|Protocol Violation|5|||
16804194|NCT02503085|37745829|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
16804195|NCT02503085|37745830|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
16804196|NCT02503085|37745831|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
16804197|NCT02503085|37745832|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
16804198|NCT02481869|37745841|FG000|Overall Study|Lost to Follow-up|3|||
16804199|NCT02481869|37745842|FG001|Overall Study|Lost to Follow-up|4|||
16804200|NCT02481869|37745841|FG000|Overall Study|Withdrawal by Subject|2|||
16804201|NCT02481869|37745842|FG001|Overall Study|Withdrawal by Subject|0|||
16804202|NCT02502149|37745849|FG000|Intermediate|Discontinued prematurely|1|||
16804203|NCT02502149|37745850|FG001|Intermediate|Discontinued prematurely|0|||
16804204|NCT02502149|37745851|FG002|Intermediate|Discontinued prematurely|0|||
16804205|NCT02502149|37745852|FG003|Intermediate|Discontinued prematurely|0|||
16804206|NCT02502149|37745853|FG004|Intermediate|Discontinued prematurely|0|||
16804207|NCT02480621|37745872|FG000|Randomization|Withdrawal by Subject|1|||
16804208|NCT02480621|37745873|FG001|Randomization|Withdrawal by Subject|0|||
16804209|NCT02480621|37745872|FG000|Randomization|Surgeon did not give intervention|0|||
16804210|NCT02480621|37745873|FG001|Randomization|Surgeon did not give intervention|1|||
16804211|NCT02480621|37745872|FG000|Follow Up|Lost to Follow-up|4|||
16804212|NCT02480621|37745873|FG001|Follow Up|Lost to Follow-up|2|||
16804213|NCT02046603|37745881|FG000|Overall Study|Other|11|||
16804214|NCT02046603|37745882|FG001|Overall Study|Other|66|||
16804215|NCT02046603|37745881|FG000|Overall Study|Protocol Violation|0|||
16804216|NCT02046603|37745882|FG001|Overall Study|Protocol Violation|1|||
16804217|NCT02046603|37745881|FG000|Overall Study|Participant/legal guardian decision|1|||
16804218|NCT02046603|37745882|FG001|Overall Study|Participant/legal guardian decision|3|||
16804219|NCT02046603|37745881|FG000|Overall Study|Physician Decision|2|||
16804220|NCT02046603|37745882|FG001|Overall Study|Physician Decision|1|||
16804221|NCT02046603|37745881|FG000|Overall Study|Lost to Follow-up|1|||
16804222|NCT02046603|37745882|FG001|Overall Study|Lost to Follow-up|2|||
16804223|NCT02046603|37745881|FG000|Overall Study|Death|0|||
16804224|NCT02046603|37745882|FG001|Overall Study|Death|1|||
16804225|NCT02046603|37745881|FG000|Overall Study|Adverse Event|0|||
16804226|NCT02046603|37745882|FG001|Overall Study|Adverse Event|1|||
16804227|NCT01885078|37745897|FG000|Treatment Period|Adverse Event|52|||
16804228|NCT01885078|37745898|FG001|Treatment Period|Adverse Event|136|||
16804229|NCT01885078|37745899|FG002|Treatment Period|Adverse Event|30|||
16804230|NCT01885078|37745900|FG003|Treatment Period|Adverse Event|73|||
16804231|NCT01885078|37745901|FG004|Treatment Period|Adverse Event|17|||
16804232|NCT01885078|37745902|FG005|Treatment Period|Adverse Event|72|||
16804233|NCT01885078|37745903|FG006|Treatment Period|Adverse Event|24|||
16804234|NCT01885078|37745904|FG007|Treatment Period|Adverse Event|5|||
16804235|NCT01885078|37745905|FG008|Treatment Period|Adverse Event|0|||
16804236|NCT01885078|37745906|FG009|Treatment Period|Adverse Event|0|||
16804237|NCT01885078|37745897|FG000|Treatment Period|Death|13|||
16804238|NCT01885078|37745898|FG001|Treatment Period|Death|33|||
16804239|NCT01885078|37745899|FG002|Treatment Period|Death|5|||
16804240|NCT01885078|37745900|FG003|Treatment Period|Death|9|||
16804241|NCT01885078|37745901|FG004|Treatment Period|Death|2|||
16804242|NCT01885078|37745902|FG005|Treatment Period|Death|10|||
16804243|NCT01885078|37745903|FG006|Treatment Period|Death|3|||
16804244|NCT01885078|37745904|FG007|Treatment Period|Death|2|||
16804245|NCT01885078|37745905|FG008|Treatment Period|Death|0|||
16804246|NCT01885078|37745906|FG009|Treatment Period|Death|0|||
16804247|NCT01885078|37745897|FG000|Treatment Period|Lack of Efficacy|12|||
16804248|NCT01885078|37745898|FG001|Treatment Period|Lack of Efficacy|33|||
16804249|NCT01885078|37745899|FG002|Treatment Period|Lack of Efficacy|10|||
16804250|NCT01885078|37745900|FG003|Treatment Period|Lack of Efficacy|23|||
16804251|NCT01885078|37745901|FG004|Treatment Period|Lack of Efficacy|24|||
16804252|NCT01885078|37745902|FG005|Treatment Period|Lack of Efficacy|58|||
16804253|NCT01885078|37745903|FG006|Treatment Period|Lack of Efficacy|9|||
16804254|NCT01885078|37745904|FG007|Treatment Period|Lack of Efficacy|5|||
16804255|NCT01885078|37745905|FG008|Treatment Period|Lack of Efficacy|0|||
16804256|NCT01885078|37745906|FG009|Treatment Period|Lack of Efficacy|0|||
16804257|NCT01885078|37745897|FG000|Treatment Period|Lost to Follow-up|16|||
16804258|NCT01885078|37745898|FG001|Treatment Period|Lost to Follow-up|19|||
16804259|NCT01885078|37745899|FG002|Treatment Period|Lost to Follow-up|7|||
16804260|NCT01885078|37745900|FG003|Treatment Period|Lost to Follow-up|9|||
16804261|NCT01885078|37745901|FG004|Treatment Period|Lost to Follow-up|2|||
16804262|NCT01885078|37745902|FG005|Treatment Period|Lost to Follow-up|8|||
16804263|NCT01885078|37745903|FG006|Treatment Period|Lost to Follow-up|2|||
16804264|NCT01885078|37745904|FG007|Treatment Period|Lost to Follow-up|0|||
16804265|NCT01885078|37745905|FG008|Treatment Period|Lost to Follow-up|0|||
16804266|NCT01885078|37745906|FG009|Treatment Period|Lost to Follow-up|0|||
16804267|NCT01885078|37745897|FG000|Treatment Period|Physician Decision|19|||
16804268|NCT01885078|37745898|FG001|Treatment Period|Physician Decision|21|||
16804269|NCT01885078|37745899|FG002|Treatment Period|Physician Decision|5|||
16804270|NCT01885078|37745900|FG003|Treatment Period|Physician Decision|12|||
16804271|NCT01885078|37745901|FG004|Treatment Period|Physician Decision|9|||
16804272|NCT01885078|37745902|FG005|Treatment Period|Physician Decision|24|||
16804273|NCT01885078|37745903|FG006|Treatment Period|Physician Decision|4|||
16804274|NCT01885078|37745904|FG007|Treatment Period|Physician Decision|3|||
16804275|NCT01885078|37745905|FG008|Treatment Period|Physician Decision|0|||
16804276|NCT01885078|37745906|FG009|Treatment Period|Physician Decision|0|||
16804277|NCT01885078|37745897|FG000|Treatment Period|Protocol Violation|3|||
16804278|NCT01885078|37745898|FG001|Treatment Period|Protocol Violation|5|||
16804279|NCT01885078|37745899|FG002|Treatment Period|Protocol Violation|0|||
16804280|NCT01885078|37745900|FG003|Treatment Period|Protocol Violation|3|||
16804281|NCT01885078|37745901|FG004|Treatment Period|Protocol Violation|1|||
16804282|NCT01885078|37745902|FG005|Treatment Period|Protocol Violation|6|||
16804283|NCT01885078|37745903|FG006|Treatment Period|Protocol Violation|0|||
16804284|NCT01885078|37745904|FG007|Treatment Period|Protocol Violation|0|||
16804285|NCT01885078|37745905|FG008|Treatment Period|Protocol Violation|0|||
16804286|NCT01885078|37745906|FG009|Treatment Period|Protocol Violation|0|||
16804287|NCT01885078|37745897|FG000|Treatment Period|Sponsor Decision|245|||
16804288|NCT01885078|37745898|FG001|Treatment Period|Sponsor Decision|648|||
16804289|NCT01885078|37745899|FG002|Treatment Period|Sponsor Decision|49|||
16804290|NCT01885078|37745900|FG003|Treatment Period|Sponsor Decision|90|||
16804291|NCT01885078|37745901|FG004|Treatment Period|Sponsor Decision|20|||
16804292|NCT01885078|37745902|FG005|Treatment Period|Sponsor Decision|38|||
16804293|NCT01885078|37745903|FG006|Treatment Period|Sponsor Decision|162|||
16804294|NCT01885078|37745904|FG007|Treatment Period|Sponsor Decision|3|||
16804295|NCT01885078|37745905|FG008|Treatment Period|Sponsor Decision|0|||
16804296|NCT01885078|37745906|FG009|Treatment Period|Sponsor Decision|0|||
16804297|NCT01885078|37745897|FG000|Treatment Period|Withdrawal by Subject|72|||
16804298|NCT01885078|37745898|FG001|Treatment Period|Withdrawal by Subject|132|||
16804299|NCT01885078|37745899|FG002|Treatment Period|Withdrawal by Subject|25|||
16804300|NCT01885078|37745900|FG003|Treatment Period|Withdrawal by Subject|63|||
16804301|NCT01885078|37745901|FG004|Treatment Period|Withdrawal by Subject|15|||
16804302|NCT01885078|37745902|FG005|Treatment Period|Withdrawal by Subject|34|||
16804303|NCT01885078|37745903|FG006|Treatment Period|Withdrawal by Subject|17|||
16804304|NCT01885078|37745904|FG007|Treatment Period|Withdrawal by Subject|10|||
16804305|NCT01885078|37745905|FG008|Treatment Period|Withdrawal by Subject|0|||
16804306|NCT01885078|37745906|FG009|Treatment Period|Withdrawal by Subject|0|||
16804307|NCT01885078|37745897|FG000|Treatment Period|Other|0|||
16804308|NCT01885078|37745898|FG001|Treatment Period|Other|0|||
16804309|NCT01885078|37745899|FG002|Treatment Period|Other|0|||
16804310|NCT01885078|37745900|FG003|Treatment Period|Other|1|||
16804311|NCT01885078|37745901|FG004|Treatment Period|Other|0|||
16804312|NCT01885078|37745902|FG005|Treatment Period|Other|0|||
16804313|NCT01885078|37745903|FG006|Treatment Period|Other|0|||
16804314|NCT01885078|37745904|FG007|Treatment Period|Other|0|||
16804315|NCT01885078|37745905|FG008|Treatment Period|Other|0|||
16804316|NCT01885078|37745906|FG009|Treatment Period|Other|0|||
16804317|NCT01885078|37745897|FG000|Step-down Period|Sponsor Decision|0|||
16804318|NCT01885078|37745898|FG001|Step-down Period|Sponsor Decision|0|||
16804319|NCT01885078|37745899|FG002|Step-down Period|Sponsor Decision|0|||
16804320|NCT01885078|37745900|FG003|Step-down Period|Sponsor Decision|0|||
16804321|NCT01885078|37745901|FG004|Step-down Period|Sponsor Decision|0|||
16804322|NCT01885078|37745902|FG005|Step-down Period|Sponsor Decision|0|||
16804323|NCT01885078|37745903|FG006|Step-down Period|Sponsor Decision|0|||
16804324|NCT01885078|37745904|FG007|Step-down Period|Sponsor Decision|0|||
16804325|NCT01885078|37745905|FG008|Step-down Period|Sponsor Decision|1|||
16804326|NCT01885078|37745906|FG009|Step-down Period|Sponsor Decision|1|||
16804327|NCT01885078|37745897|FG000|Step-down Period|Adverse Event|0|||
16804328|NCT01885078|37745898|FG001|Step-down Period|Adverse Event|0|||
16804329|NCT01885078|37745899|FG002|Step-down Period|Adverse Event|0|||
16804330|NCT01885078|37745900|FG003|Step-down Period|Adverse Event|0|||
16804331|NCT01885078|37745901|FG004|Step-down Period|Adverse Event|0|||
16804332|NCT01885078|37745902|FG005|Step-down Period|Adverse Event|0|||
16804333|NCT01885078|37745903|FG006|Step-down Period|Adverse Event|0|||
16804334|NCT01885078|37745904|FG007|Step-down Period|Adverse Event|0|||
16804335|NCT01885078|37745905|FG008|Step-down Period|Adverse Event|29|||
16804336|NCT01885078|37745906|FG009|Step-down Period|Adverse Event|38|||
16804337|NCT01885078|37745897|FG000|Step-down Period|Withdrawal by Subject|0|||
16804338|NCT01885078|37745898|FG001|Step-down Period|Withdrawal by Subject|0|||
16804339|NCT01885078|37745899|FG002|Step-down Period|Withdrawal by Subject|0|||
16804340|NCT01885078|37745900|FG003|Step-down Period|Withdrawal by Subject|0|||
16804341|NCT01885078|37745901|FG004|Step-down Period|Withdrawal by Subject|0|||
16804342|NCT01885078|37745902|FG005|Step-down Period|Withdrawal by Subject|0|||
16804343|NCT01885078|37745903|FG006|Step-down Period|Withdrawal by Subject|0|||
16804344|NCT01885078|37745904|FG007|Step-down Period|Withdrawal by Subject|0|||
16804345|NCT01885078|37745905|FG008|Step-down Period|Withdrawal by Subject|25|||
16804346|NCT01885078|37745906|FG009|Step-down Period|Withdrawal by Subject|15|||
16804347|NCT01885078|37745897|FG000|Step-down Period|Physician Decision|0|||
16804348|NCT01885078|37745898|FG001|Step-down Period|Physician Decision|0|||
16804349|NCT01885078|37745899|FG002|Step-down Period|Physician Decision|0|||
16804350|NCT01885078|37745900|FG003|Step-down Period|Physician Decision|0|||
16804351|NCT01885078|37745901|FG004|Step-down Period|Physician Decision|0|||
16804352|NCT01885078|37745902|FG005|Step-down Period|Physician Decision|0|||
16804353|NCT01885078|37745903|FG006|Step-down Period|Physician Decision|0|||
16804354|NCT01885078|37745904|FG007|Step-down Period|Physician Decision|0|||
16804355|NCT01885078|37745905|FG008|Step-down Period|Physician Decision|7|||
16804356|NCT01885078|37745906|FG009|Step-down Period|Physician Decision|2|||
16804357|NCT01885078|37745897|FG000|Step-down Period|Death|0|||
16804358|NCT01885078|37745898|FG001|Step-down Period|Death|0|||
16804359|NCT01885078|37745899|FG002|Step-down Period|Death|0|||
16804360|NCT01885078|37745900|FG003|Step-down Period|Death|0|||
16804361|NCT01885078|37745901|FG004|Step-down Period|Death|0|||
16804362|NCT01885078|37745902|FG005|Step-down Period|Death|0|||
16804363|NCT01885078|37745903|FG006|Step-down Period|Death|0|||
16804364|NCT01885078|37745904|FG007|Step-down Period|Death|0|||
16804365|NCT01885078|37745905|FG008|Step-down Period|Death|4|||
16804366|NCT01885078|37745906|FG009|Step-down Period|Death|3|||
16804367|NCT01885078|37745897|FG000|Step-down Period|Lost to Follow-up|0|||
16804368|NCT01885078|37745898|FG001|Step-down Period|Lost to Follow-up|0|||
16804369|NCT01885078|37745899|FG002|Step-down Period|Lost to Follow-up|0|||
16804370|NCT01885078|37745900|FG003|Step-down Period|Lost to Follow-up|0|||
16804371|NCT01885078|37745901|FG004|Step-down Period|Lost to Follow-up|0|||
16804372|NCT01885078|37745902|FG005|Step-down Period|Lost to Follow-up|0|||
16804373|NCT01885078|37745903|FG006|Step-down Period|Lost to Follow-up|0|||
16804374|NCT01885078|37745904|FG007|Step-down Period|Lost to Follow-up|0|||
16804375|NCT01885078|37745905|FG008|Step-down Period|Lost to Follow-up|1|||
16804376|NCT01885078|37745906|FG009|Step-down Period|Lost to Follow-up|1|||
16804377|NCT01885078|37745897|FG000|Step-down Period|Lack of Efficacy|0|||
16804378|NCT01885078|37745898|FG001|Step-down Period|Lack of Efficacy|0|||
16804379|NCT01885078|37745899|FG002|Step-down Period|Lack of Efficacy|0|||
16804380|NCT01885078|37745900|FG003|Step-down Period|Lack of Efficacy|0|||
16804381|NCT01885078|37745901|FG004|Step-down Period|Lack of Efficacy|0|||
16804382|NCT01885078|37745902|FG005|Step-down Period|Lack of Efficacy|0|||
16804383|NCT01885078|37745903|FG006|Step-down Period|Lack of Efficacy|0|||
16804384|NCT01885078|37745904|FG007|Step-down Period|Lack of Efficacy|0|||
16804385|NCT01885078|37745905|FG008|Step-down Period|Lack of Efficacy|1|||
16804386|NCT01885078|37745906|FG009|Step-down Period|Lack of Efficacy|0|||
16804387|NCT01885078|37745897|FG000|Step-down Period|Protocol Violation|0|||
16804388|NCT01885078|37745898|FG001|Step-down Period|Protocol Violation|0|||
16804389|NCT01885078|37745899|FG002|Step-down Period|Protocol Violation|0|||
16804390|NCT01885078|37745900|FG003|Step-down Period|Protocol Violation|0|||
16804391|NCT01885078|37745901|FG004|Step-down Period|Protocol Violation|0|||
16804392|NCT01885078|37745902|FG005|Step-down Period|Protocol Violation|0|||
16804393|NCT01885078|37745903|FG006|Step-down Period|Protocol Violation|0|||
16804394|NCT01885078|37745904|FG007|Step-down Period|Protocol Violation|0|||
16804395|NCT01885078|37745905|FG008|Step-down Period|Protocol Violation|1|||
16804396|NCT01885078|37745906|FG009|Step-down Period|Protocol Violation|1|||
16804397|NCT02046369|37745929|FG000|Overall Study|Adverse Event|3|||
16804398|NCT02046369|37745930|FG001|Overall Study|Adverse Event|3|||
16804399|NCT02046369|37745929|FG000|Overall Study|Lack of Efficacy|3|||
16804400|NCT02046369|37745930|FG001|Overall Study|Lack of Efficacy|3|||
16804401|NCT02046369|37745929|FG000|Overall Study|Lost to Follow-up|3|||
16804402|NCT02046369|37745930|FG001|Overall Study|Lost to Follow-up|3|||
16804403|NCT02046369|37745929|FG000|Overall Study|Protocol Violation|1|||
16804404|NCT02046369|37745930|FG001|Overall Study|Protocol Violation|2|||
16804405|NCT02046369|37745929|FG000|Overall Study|Withdrawal by Subject|3|||
16804406|NCT02046369|37745930|FG001|Overall Study|Withdrawal by Subject|6|||
16804407|NCT02046369|37745929|FG000|Overall Study|never received study drug|0|||
16804408|NCT02046369|37745930|FG001|Overall Study|never received study drug|1|||
16804409|NCT02046369|37745929|FG000|Overall Study|non compliance|1|||
16804410|NCT02046369|37745930|FG001|Overall Study|non compliance|0|||
16804411|NCT02101359|37745938|FG000|Overall Study|Not included|23|||
16804412|NCT02101359|37745939|FG001|Overall Study|Not included|13|||
16804413|NCT02101359|37745938|FG000|Overall Study|Withdrawal by Subject|5|||
16804414|NCT02101359|37745939|FG001|Overall Study|Withdrawal by Subject|4|||
16804415|NCT02101359|37745938|FG000|Overall Study|Lost to Follow-up|1|||
16804416|NCT02101359|37745939|FG001|Overall Study|Lost to Follow-up|0|||
16804417|NCT02101359|37745938|FG000|Overall Study|Protocol Violation|0|||
16804418|NCT02101359|37745939|FG001|Overall Study|Protocol Violation|2|||
16804419|NCT02100969|37745945|FG000|Overall Study|Did not pass screening phase|1|||
16804420|NCT01885000|37745952|FG000|Overall Study|Adverse Event|1|||
16804421|NCT01885000|37745953|FG001|Overall Study|Adverse Event|0|||
16804422|NCT01885000|37745952|FG000|Overall Study|Withdrawal by Subject|1|||
16804423|NCT01885000|37745953|FG001|Overall Study|Withdrawal by Subject|1|||
16804424|NCT01885000|37745952|FG000|Overall Study|Protocol Violation|0|||
16804425|NCT01885000|37745953|FG001|Overall Study|Protocol Violation|1|||
16804426|NCT01884688|37745959|FG000|Overall Study|Screen Failure|2|||
16909578|NCT01717326|38018479|FG016|Overall Study|Death|0|||
16804427|NCT01883362|37745965|FG000|Treatment|Adverse Event|1|||
16804428|NCT01883362|37745966|FG001|Treatment|Adverse Event|8|||
16804429|NCT01883362|37745965|FG000|Treatment|Withdrawal by Subject|6|||
16804430|NCT01883362|37745966|FG001|Treatment|Withdrawal by Subject|2|||
16804431|NCT01883362|37745965|FG000|Treatment|Administrative problems|4|||
16804432|NCT01883362|37745966|FG001|Treatment|Administrative problems|1|||
16804433|NCT01883362|37745965|FG000|Treatment|Relapse|4|||
16804434|NCT01883362|37745966|FG001|Treatment|Relapse|2|||
16804435|NCT01883362|37745965|FG000|Treatment|Randomized, not treated|1|||
16804436|NCT01883362|37745966|FG001|Treatment|Randomized, not treated|1|||
16804437|NCT01883362|37745965|FG000|Post Treatment Follow-up|Protocol Violation|0|||
16804438|NCT01883362|37745966|FG001|Post Treatment Follow-up|Protocol Violation|1|||
16804439|NCT01883362|37745965|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
16804440|NCT01883362|37745966|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
16804441|NCT01883362|37745965|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
16909579|NCT01717326|38018480|FG017|Overall Study|Death|0|||
16804442|NCT01883362|37745966|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
16804443|NCT01883362|37745965|FG000|Post Treatment Follow-up|Administrative problems|2|||
16804444|NCT01883362|37745966|FG001|Post Treatment Follow-up|Administrative problems|0|||
16804445|NCT01883362|37745965|FG000|Post Treatment Follow-up|Death|8|||
16804446|NCT01883362|37745966|FG001|Post Treatment Follow-up|Death|4|||
16804447|NCT01883362|37745965|FG000|Post Treatment Follow-up|Relapse|1|||
16804448|NCT01883362|37745966|FG001|Post Treatment Follow-up|Relapse|2|||
16804449|NCT02100813|37745984|FG000|Overall Study|Adverse Event|0|||
16804450|NCT02100813|37745985|FG001|Overall Study|Adverse Event|0|||
16804451|NCT02100813|37745986|FG002|Overall Study|Adverse Event|0|||
16804452|NCT02100813|37745987|FG003|Overall Study|Adverse Event|0|||
16804453|NCT02100813|37745988|FG004|Overall Study|Adverse Event|0|||
16804454|NCT02100813|37745989|FG005|Overall Study|Adverse Event|0|||
16804455|NCT02100813|37745990|FG006|Overall Study|Adverse Event|0|||
16804456|NCT02100813|37745991|FG007|Overall Study|Adverse Event|1|||
16804457|NCT01930162|37746013|FG000|Overall Study|Abnormal test procedure result(s)|4|||
16804458|NCT01930162|37746013|FG000|Overall Study|Death|1|||
16804459|NCT02045979|37746021|FG000|Overall Study|Informed Consent Withdrawn|2|||
16804460|NCT02045979|37746022|FG001|Overall Study|Informed Consent Withdrawn|0|||
16804461|NCT02045979|37746023|FG002|Overall Study|Informed Consent Withdrawn|1|||
16804462|NCT02045979|37746021|FG000|Overall Study|not specified above|0|||
16804463|NCT02045979|37746022|FG001|Overall Study|not specified above|1|||
16804464|NCT02045979|37746023|FG002|Overall Study|not specified above|0|||
16804465|NCT01929226|37746033|FG000|Overall Study|Lost to Follow-up|4|||
16804466|NCT01929226|37746034|FG001|Overall Study|Lost to Follow-up|0|||
16804467|NCT01929226|37746033|FG000|Overall Study|Withdrawal by Subject|1|||
16804468|NCT01929226|37746034|FG001|Overall Study|Withdrawal by Subject|1|||
16804469|NCT02045433|37746041|FG000|Overall Study|Withdrawal by Subject|1|||
16804470|NCT01911442|37746048|FG000|Overall Study|Adverse Event|2|||
16804471|NCT01911442|37746049|FG001|Overall Study|Adverse Event|2|||
16804472|NCT01911442|37746050|FG002|Overall Study|Adverse Event|4|||
16804473|NCT01911442|37746048|FG000|Overall Study|Lack of Efficacy|1|||
16804474|NCT01911442|37746049|FG001|Overall Study|Lack of Efficacy|1|||
16804475|NCT01911442|37746050|FG002|Overall Study|Lack of Efficacy|1|||
16804476|NCT01911442|37746048|FG000|Overall Study|Lost to Follow-up|2|||
16804477|NCT01911442|37746049|FG001|Overall Study|Lost to Follow-up|0|||
16804478|NCT01911442|37746050|FG002|Overall Study|Lost to Follow-up|1|||
16804479|NCT01911442|37746048|FG000|Overall Study|Withdrawal by Subject|1|||
16804480|NCT01911442|37746049|FG001|Overall Study|Withdrawal by Subject|0|||
16804481|NCT01911442|37746050|FG002|Overall Study|Withdrawal by Subject|6|||
16804482|NCT01911442|37746048|FG000|Overall Study|Mother's Work Schedule|0|||
16804483|NCT01911442|37746049|FG001|Overall Study|Mother's Work Schedule|1|||
16804484|NCT01911442|37746050|FG002|Overall Study|Mother's Work Schedule|0|||
16804485|NCT01928758|37746064|FG000|Overall Study|Lost to Follow-up|14|||
16804486|NCT01928758|37746065|FG001|Overall Study|Lost to Follow-up|9|||
16804487|NCT01928758|37746064|FG000|Overall Study|Withdrawal by Subject|5|||
16804488|NCT01928758|37746065|FG001|Overall Study|Withdrawal by Subject|2|||
16804489|NCT01928758|37746064|FG000|Overall Study|Adverse Event|3|||
16804490|NCT01928758|37746065|FG001|Overall Study|Adverse Event|5|||
16804491|NCT01928758|37746064|FG000|Overall Study|Protocol Violation|3|||
16804492|NCT01928758|37746065|FG001|Overall Study|Protocol Violation|4|||
16804493|NCT01910116|37746074|FG000|Overall Study|Adverse Event|0|||
16804494|NCT01910116|37746075|FG001|Overall Study|Adverse Event|3|||
16804495|NCT01910116|37746074|FG000|Overall Study|Lack of Efficacy|3|||
16804496|NCT01910116|37746075|FG001|Overall Study|Lack of Efficacy|4|||
16804497|NCT01910116|37746074|FG000|Overall Study|Lost to Follow-up|1|||
16804498|NCT01910116|37746075|FG001|Overall Study|Lost to Follow-up|0|||
16804499|NCT01910116|37746074|FG000|Overall Study|Protocol Violation|1|||
16804500|NCT01910116|37746075|FG001|Overall Study|Protocol Violation|2|||
16804501|NCT01910116|37746074|FG000|Overall Study|Withdrawal by Subject|8|||
16804502|NCT01910116|37746075|FG001|Overall Study|Withdrawal by Subject|3|||
16804503|NCT01910116|37746074|FG000|Overall Study|uncertain allocation|1|||
16804504|NCT01910116|37746075|FG001|Overall Study|uncertain allocation|3|||
16804505|NCT01910116|37746074|FG000|Overall Study|incomplete data|0|||
16804506|NCT01910116|37746075|FG001|Overall Study|incomplete data|1|||
16804507|NCT01614886|37746083|FG000|Overall Study|Adverse Event|15|||
16804508|NCT01614886|37746084|FG001|Overall Study|Adverse Event|20|||
16804509|NCT01614886|37746083|FG000|Overall Study|Withdrawal by Subject|4|||
16804510|NCT01614886|37746084|FG001|Overall Study|Withdrawal by Subject|4|||
16804511|NCT01614886|37746083|FG000|Overall Study|Death|1|||
16804512|NCT01614886|37746084|FG001|Overall Study|Death|0|||
16804513|NCT01614886|37746083|FG000|Overall Study|Protocol deviation|0|||
16804514|NCT01614886|37746084|FG001|Overall Study|Protocol deviation|2|||
16804515|NCT01880554|37746090|FG000|Overall Study|Protocol Violation|14|||
16804516|NCT01880554|37746090|FG000|Overall Study|Simon's design requirements|2|||
16804517|NCT02100657|37746098|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
16804518|NCT02100657|37746099|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
16804519|NCT02100657|37746100|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
16909580|NCT01717326|38018481|FG018|Overall Study|Death|0|||
16804520|NCT02100657|37746098|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
16804521|NCT02100657|37746099|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
16804522|NCT02100657|37746100|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
16804523|NCT02100657|37746098|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
16804524|NCT02100657|37746099|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
16804525|NCT02100657|37746100|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
16804526|NCT02100657|37746098|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
16804527|NCT02100657|37746099|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
16804528|NCT02100657|37746100|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
16804529|NCT02100657|37746098|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
16804530|NCT02100657|37746099|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
16804531|NCT02100657|37746100|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
16804532|NCT02100657|37746098|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
16804533|NCT02100657|37746099|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
16804534|NCT02100657|37746100|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
16804535|NCT02100657|37746098|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
16804536|NCT02100657|37746099|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
16804537|NCT02100657|37746100|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
16804538|NCT02100657|37746098|FG000|Cohort 3: Dose Level 3|Death|0|||
16804539|NCT02100657|37746099|FG001|Cohort 3: Dose Level 3|Death|0|||
16804540|NCT02100657|37746100|FG002|Cohort 3: Dose Level 3|Death|1|||
16804541|NCT02100657|37746098|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
16804542|NCT02100657|37746099|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
16804543|NCT02100657|37746100|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
16804544|NCT02100657|37746098|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
16804545|NCT02100657|37746099|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
16804546|NCT02100657|37746100|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
16804547|NCT02100657|37746098|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
16804548|NCT02100657|37746099|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
16804549|NCT02100657|37746100|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
16804550|NCT02100657|37746098|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
16804551|NCT02100657|37746099|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
16804552|NCT02100657|37746100|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
16804553|NCT02100657|37746098|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
16804554|NCT02100657|37746099|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
16804555|NCT02100657|37746100|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
16804556|NCT02067663|37746111|FG000|Overall Study|Lost to Follow-up|13|||
16804557|NCT02067663|37746112|FG001|Overall Study|Lost to Follow-up|14|||
16804558|NCT01909804|37746130|FG000|Overall Study|Randomized but Never Treated|0|||
16804559|NCT01909804|37746131|FG001|Overall Study|Randomized but Never Treated|0|||
16804560|NCT01909804|37746132|FG002|Overall Study|Randomized but Never Treated|0|||
16804561|NCT01909804|37746133|FG003|Overall Study|Randomized but Never Treated|0|||
16804562|NCT01909804|37746134|FG004|Overall Study|Randomized but Never Treated|0|||
16804563|NCT01909804|37746135|FG005|Overall Study|Randomized but Never Treated|0|||
16804564|NCT01909804|37746136|FG006|Overall Study|Randomized but Never Treated|1|||
16804565|NCT01909804|37746137|FG007|Overall Study|Randomized but Never Treated|0|||
16804566|NCT01909804|37746138|FG008|Overall Study|Randomized but Never Treated|0|||
16804567|NCT01909804|37746139|FG009|Overall Study|Randomized but Never Treated|0|||
16804568|NCT01909804|37746140|FG010|Overall Study|Randomized but Never Treated|0|||
16804569|NCT01909804|37746141|FG011|Overall Study|Randomized but Never Treated|1|||
16804570|NCT01909804|37746130|FG000|Overall Study|Death|0|||
16804571|NCT01909804|37746131|FG001|Overall Study|Death|0|||
16804572|NCT01909804|37746132|FG002|Overall Study|Death|0|||
16804573|NCT01909804|37746133|FG003|Overall Study|Death|0|||
16804574|NCT01909804|37746134|FG004|Overall Study|Death|0|||
16804575|NCT01909804|37746135|FG005|Overall Study|Death|0|||
16804576|NCT01909804|37746136|FG006|Overall Study|Death|0|||
16804577|NCT01909804|37746137|FG007|Overall Study|Death|0|||
16804578|NCT01909804|37746138|FG008|Overall Study|Death|0|||
16804579|NCT01909804|37746139|FG009|Overall Study|Death|0|||
16804580|NCT01909804|37746140|FG010|Overall Study|Death|1|||
16804581|NCT01909804|37746141|FG011|Overall Study|Death|0|||
16804582|NCT01909804|37746130|FG000|Overall Study|Lack of Efficacy|4|||
16804583|NCT01909804|37746131|FG001|Overall Study|Lack of Efficacy|1|||
16804584|NCT01909804|37746132|FG002|Overall Study|Lack of Efficacy|0|||
16804585|NCT01909804|37746133|FG003|Overall Study|Lack of Efficacy|0|||
16804586|NCT01909804|37746134|FG004|Overall Study|Lack of Efficacy|7|||
16804587|NCT01909804|37746135|FG005|Overall Study|Lack of Efficacy|3|||
16804588|NCT01909804|37746136|FG006|Overall Study|Lack of Efficacy|1|||
16804589|NCT01909804|37746137|FG007|Overall Study|Lack of Efficacy|1|||
16804590|NCT01909804|37746138|FG008|Overall Study|Lack of Efficacy|0|||
16804591|NCT01909804|37746139|FG009|Overall Study|Lack of Efficacy|1|||
16804592|NCT01909804|37746140|FG010|Overall Study|Lack of Efficacy|0|||
16804593|NCT01909804|37746141|FG011|Overall Study|Lack of Efficacy|1|||
16804594|NCT01909804|37746130|FG000|Overall Study|Withdrew Consent|0|||
16804595|NCT01909804|37746131|FG001|Overall Study|Withdrew Consent|0|||
16804596|NCT01909804|37746132|FG002|Overall Study|Withdrew Consent|0|||
16804597|NCT01909804|37746133|FG003|Overall Study|Withdrew Consent|0|||
16804598|NCT01909804|37746134|FG004|Overall Study|Withdrew Consent|1|||
16804599|NCT01909804|37746135|FG005|Overall Study|Withdrew Consent|1|||
16804600|NCT01909804|37746136|FG006|Overall Study|Withdrew Consent|0|||
16804601|NCT01909804|37746137|FG007|Overall Study|Withdrew Consent|0|||
16804602|NCT01909804|37746138|FG008|Overall Study|Withdrew Consent|0|||
16804603|NCT01909804|37746139|FG009|Overall Study|Withdrew Consent|0|||
16804604|NCT01909804|37746140|FG010|Overall Study|Withdrew Consent|0|||
16804605|NCT01909804|37746141|FG011|Overall Study|Withdrew Consent|0|||
16804606|NCT01909804|37746130|FG000|Overall Study|Protocol Violation|0|||
16804607|NCT01909804|37746131|FG001|Overall Study|Protocol Violation|0|||
16804608|NCT01909804|37746132|FG002|Overall Study|Protocol Violation|0|||
16804609|NCT01909804|37746133|FG003|Overall Study|Protocol Violation|0|||
16804610|NCT01909804|37746134|FG004|Overall Study|Protocol Violation|0|||
16804611|NCT01909804|37746135|FG005|Overall Study|Protocol Violation|0|||
16804612|NCT01909804|37746136|FG006|Overall Study|Protocol Violation|0|||
16804613|NCT01909804|37746137|FG007|Overall Study|Protocol Violation|0|||
16804614|NCT01909804|37746138|FG008|Overall Study|Protocol Violation|0|||
16804615|NCT01909804|37746139|FG009|Overall Study|Protocol Violation|0|||
16804616|NCT01909804|37746140|FG010|Overall Study|Protocol Violation|0|||
16804617|NCT01909804|37746141|FG011|Overall Study|Protocol Violation|1|||
16804618|NCT01880086|37746165|FG000|Overall Study|Lost to Follow-up|1|||
16804619|NCT01880086|37746166|FG001|Overall Study|Lost to Follow-up|1|||
16804620|NCT01879852|37746174|FG000|Overall Study|Withdrawal by Subject|2|||
16804621|NCT01879852|37746175|FG001|Overall Study|Withdrawal by Subject|0|||
16804622|NCT01879618|37746181|FG000|Overall Study|Does not meet entrance criteria|1|||
16804623|NCT01879618|37746181|FG000|Overall Study|Withdrawal by Subject|1|||
16804624|NCT01879618|37746181|FG000|Overall Study|Surgery;changed schedule; not available|8|||
16804625|NCT01879618|37746181|FG000|Overall Study|Protocol Violation|6|||
16804626|NCT01879618|37746181|FG000|Overall Study|Adverse Event|5|||
16804627|NCT01926886|37746185|FG000|Overall Study|Administrative/other|1|||
16804628|NCT01926886|37746186|FG001|Overall Study|Administrative/other|0|||
16804629|NCT01926886|37746185|FG000|Overall Study|Adverse event/intercurrent illness|4|||
16804630|NCT01926886|37746186|FG001|Overall Study|Adverse event/intercurrent illness|0|||
16804631|NCT01926886|37746185|FG000|Overall Study|Disease progression/recurrence|4|||
16804632|NCT01926886|37746186|FG001|Overall Study|Disease progression/recurrence|0|||
16804633|NCT01926886|37746185|FG000|Overall Study|Withdrawal by Subject|15|||
16804634|NCT01926886|37746186|FG001|Overall Study|Withdrawal by Subject|0|||
16804635|NCT01926886|37746185|FG000|Overall Study|Failure to return|3|||
16804636|NCT01926886|37746186|FG001|Overall Study|Failure to return|0|||
16804637|NCT01926886|37746185|FG000|Overall Study|Recurrence of disease|1|||
16804638|NCT01926886|37746186|FG001|Overall Study|Recurrence of disease|0|||
16804639|NCT01926886|37746185|FG000|Overall Study|Progression of disease|2|||
16804640|NCT01926886|37746186|FG001|Overall Study|Progression of disease|0|||
16804641|NCT01926886|37746185|FG000|Overall Study|Death|1|||
16804642|NCT01926886|37746186|FG001|Overall Study|Death|0|||
16804643|NCT01926886|37746185|FG000|Overall Study|Did not cooperate|1|||
16804644|NCT01926886|37746186|FG001|Overall Study|Did not cooperate|0|||
16804645|NCT01909336|37746195|FG000|Overall Study|Lost to Follow-up|4|||
16804646|NCT01909336|37746196|FG001|Overall Study|Lost to Follow-up|2|||
16804647|NCT01909336|37746197|FG002|Overall Study|Lost to Follow-up|2|||
16804648|NCT01909336|37746195|FG000|Overall Study|Physician Decision|0|||
16804649|NCT01909336|37746196|FG001|Overall Study|Physician Decision|1|||
16804650|NCT01909336|37746197|FG002|Overall Study|Physician Decision|1|||
16804651|NCT01926028|37746208|FG000|Overall Study|Lost to Follow-up|7|||
16804652|NCT01926028|37746209|FG001|Overall Study|Lost to Follow-up|6|||
16804653|NCT01926028|37746210|FG002|Overall Study|Lost to Follow-up|0|||
16804654|NCT01926028|37746208|FG000|Overall Study|Physician Decision|1|||
16804655|NCT01926028|37746209|FG001|Overall Study|Physician Decision|5|||
16804656|NCT01926028|37746210|FG002|Overall Study|Physician Decision|0|||
16804657|NCT01926028|37746208|FG000|Overall Study|Withdrawal by Subject|9|||
16804658|NCT01926028|37746209|FG001|Overall Study|Withdrawal by Subject|9|||
16804659|NCT01926028|37746210|FG002|Overall Study|Withdrawal by Subject|2|||
16804660|NCT01926028|37746208|FG000|Overall Study|Non compliance or other reasons|4|||
16804661|NCT01926028|37746209|FG001|Overall Study|Non compliance or other reasons|2|||
16804662|NCT01926028|37746210|FG002|Overall Study|Non compliance or other reasons|0|||
16804663|NCT01925950|37746221|FG000|Part 2|Withdrawal by Subject|1|||
16804664|NCT01925950|37746222|FG001|Part 2|Withdrawal by Subject|0|||
16804665|NCT01878292|37746231|FG000|Randomized|Protocol Violation|1|||
16804666|NCT01878292|37746232|FG001|Randomized|Protocol Violation|0|||
16804667|NCT01878292|37746233|FG002|Randomized|Protocol Violation|0|||
16804668|NCT01878292|37746231|FG000|Randomized|Lost to Follow-up|1|||
16804669|NCT01878292|37746232|FG001|Randomized|Lost to Follow-up|0|||
16804670|NCT01878292|37746233|FG002|Randomized|Lost to Follow-up|0|||
16804671|NCT01878292|37746231|FG000|Randomized|Adverse Event|1|||
16804672|NCT01878292|37746232|FG001|Randomized|Adverse Event|0|||
16804673|NCT01878292|37746233|FG002|Randomized|Adverse Event|0|||
16804674|NCT01878292|37746231|FG000|Double-blind Treatment Period|Other Reasons|2|||
16804675|NCT01878292|37746232|FG001|Double-blind Treatment Period|Other Reasons|0|||
16804676|NCT01878292|37746233|FG002|Double-blind Treatment Period|Other Reasons|0|||
16804677|NCT01878292|37746231|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
16804678|NCT01878292|37746232|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
16804679|NCT01878292|37746233|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
16804680|NCT01878292|37746231|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
16804681|NCT01878292|37746232|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
16804682|NCT01878292|37746233|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
16804683|NCT01878292|37746231|FG000|Double-blind Treatment Period|Protocol Violation|3|||
16804684|NCT01878292|37746232|FG001|Double-blind Treatment Period|Protocol Violation|4|||
16804685|NCT01878292|37746233|FG002|Double-blind Treatment Period|Protocol Violation|2|||
16804686|NCT01878292|37746231|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
16804687|NCT01878292|37746232|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
16804688|NCT01878292|37746233|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
16804689|NCT01878292|37746231|FG000|Double-blind Treatment Period|Adverse Event|4|||
16804690|NCT01878292|37746232|FG001|Double-blind Treatment Period|Adverse Event|9|||
16804691|NCT01878292|37746233|FG002|Double-blind Treatment Period|Adverse Event|8|||
16804692|NCT01878292|37746231|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
16804693|NCT01878292|37746232|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
16804694|NCT01878292|37746233|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
16804695|NCT01908634|37746241|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
16804696|NCT01908634|37746241|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
16804697|NCT01878214|37746251|FG000|Overall Study|Withdrawal by Subject|18|||
16804698|NCT01878214|37746252|FG001|Overall Study|Withdrawal by Subject|7|||
16804699|NCT01878214|37746251|FG000|Overall Study|Death|0|||
16804700|NCT01878214|37746252|FG001|Overall Study|Death|1|||
16804701|NCT01878214|37746251|FG000|Overall Study|Lost to Follow-up|35|||
16804702|NCT01878214|37746252|FG001|Overall Study|Lost to Follow-up|36|||
16804703|NCT01907854|37746260|FG000|Overall Study|Protocol Violation|1|||
16804704|NCT01907854|37746261|FG001|Overall Study|Protocol Violation|1|||
16804705|NCT01907854|37746260|FG000|Overall Study|Withdrawal by Subject|9|||
16804706|NCT01907854|37746261|FG001|Overall Study|Withdrawal by Subject|7|||
16804707|NCT01907854|37746260|FG000|Overall Study|Lost to Follow-up|2|||
16804708|NCT01907854|37746261|FG001|Overall Study|Lost to Follow-up|2|||
16804709|NCT01907854|37746260|FG000|Overall Study|Unclassified|4|||
16804710|NCT01907854|37746261|FG001|Overall Study|Unclassified|3|||
16804711|NCT02480153|37746269|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
16804712|NCT02480153|37746270|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
16804713|NCT02480153|37746271|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
16804714|NCT02480153|37746269|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
16804715|NCT02480153|37746270|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
16804716|NCT02480153|37746271|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
16804717|NCT02480153|37746269|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
16804718|NCT02480153|37746270|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
16804719|NCT02480153|37746271|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
16804720|NCT02480153|37746269|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
16804721|NCT02480153|37746270|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
16804722|NCT02480153|37746271|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
16804723|NCT02480153|37746269|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
16804724|NCT02480153|37746270|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
16804725|NCT02480153|37746271|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
16804726|NCT02480153|37746269|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
16804727|NCT02480153|37746270|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
16804728|NCT02480153|37746271|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
16804729|NCT02480153|37746269|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
16804730|NCT02480153|37746270|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
16804731|NCT02480153|37746271|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
16804732|NCT02480153|37746269|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
16804733|NCT02480153|37746270|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
16804734|NCT02480153|37746271|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
16804735|NCT02480153|37746269|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
16804736|NCT02480153|37746270|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
16804737|NCT02480153|37746271|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
16804738|NCT02480153|37746269|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
16804739|NCT02480153|37746270|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
16804740|NCT02480153|37746271|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
16804741|NCT02480153|37746269|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
16804742|NCT02480153|37746270|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
16804743|NCT02480153|37746271|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
16804744|NCT02480153|37746269|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
16804745|NCT02480153|37746270|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
16804746|NCT02480153|37746271|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
16804747|NCT02480153|37746269|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
16804748|NCT02480153|37746270|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
16804749|NCT02480153|37746271|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
16804750|NCT02480153|37746269|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
16804751|NCT02480153|37746270|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
16804752|NCT02480153|37746271|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
16804753|NCT02480153|37746269|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
16804754|NCT02480153|37746270|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
16804755|NCT02480153|37746271|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
16804756|NCT02480153|37746269|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
16804757|NCT02480153|37746270|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
16804758|NCT02480153|37746271|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
16804759|NCT02480153|37746269|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
16804760|NCT02480153|37746270|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
16804761|NCT02480153|37746271|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
16804762|NCT02480153|37746269|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
16804763|NCT02480153|37746270|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
16804764|NCT02480153|37746271|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
16804765|NCT02500979|37746296|FG000|Period 1|Hyperglycemia|1|||
16804766|NCT02500979|37746297|FG001|Period 1|Hyperglycemia|0|||
16804767|NCT02500979|37746296|FG000|Period 1|Severe non-compliance to protocol|0|||
16804768|NCT02500979|37746297|FG001|Period 1|Severe non-compliance to protocol|1|||
16804769|NCT02500979|37746296|FG000|Period 1|Adverse Event|1|||
16804770|NCT02500979|37746297|FG001|Period 1|Adverse Event|0|||
16804771|NCT02500979|37746296|FG000|Period 1|Subject decision|2|||
16804772|NCT02500979|37746297|FG001|Period 1|Subject decision|0|||
16804773|NCT02500979|37746296|FG000|Period 2|Change in risk|1|||
16804774|NCT02500979|37746297|FG001|Period 2|Change in risk|0|||
16804775|NCT02500901|37746303|FG000|Overall Study|Disease ProgressionDD|2|||
16804776|NCT02479139|37746313|FG000|Overall Study|Lost to Follow-up|2|||
16804777|NCT02479139|37746314|FG001|Overall Study|Lost to Follow-up|4|||
16804778|NCT02479139|37746315|FG002|Overall Study|Lost to Follow-up|4|||
16804779|NCT02479139|37746316|FG003|Overall Study|Lost to Follow-up|2|||
16804780|NCT02479139|37746317|FG004|Overall Study|Lost to Follow-up|3|||
16804781|NCT02479139|37746318|FG005|Overall Study|Lost to Follow-up|5|||
16804782|NCT02479139|37746313|FG000|Overall Study|Withdrew Consent|5|||
16804783|NCT02479139|37746314|FG001|Overall Study|Withdrew Consent|6|||
16804784|NCT02479139|37746315|FG002|Overall Study|Withdrew Consent|1|||
16804785|NCT02479139|37746316|FG003|Overall Study|Withdrew Consent|4|||
16804786|NCT02479139|37746317|FG004|Overall Study|Withdrew Consent|1|||
16804787|NCT02479139|37746318|FG005|Overall Study|Withdrew Consent|1|||
16804788|NCT02479139|37746313|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16804789|NCT02479139|37746314|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16804790|NCT02479139|37746315|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
16804791|NCT02479139|37746316|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16804792|NCT02479139|37746317|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16804793|NCT02479139|37746318|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16804794|NCT02479139|37746313|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16804795|NCT02479139|37746314|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16804796|NCT02479139|37746315|FG002|Overall Study|Other Miscellaneous Reasons|1|||
16804797|NCT02479139|37746316|FG003|Overall Study|Other Miscellaneous Reasons|1|||
16804798|NCT02479139|37746317|FG004|Overall Study|Other Miscellaneous Reasons|1|||
16804799|NCT02479139|37746318|FG005|Overall Study|Other Miscellaneous Reasons|0|||
16804800|NCT02478359|37746334|FG000|Overall Study|Disenrolled from health plan|106|||
16804801|NCT02478359|37746335|FG001|Overall Study|Disenrolled from health plan|65|||
16804802|NCT01877668|37746348|FG000|Overall Study|Death|0|||
16804803|NCT01877668|37746349|FG001|Overall Study|Death|0|||
16804804|NCT01877668|37746350|FG002|Overall Study|Death|0|||
16804805|NCT01877668|37746351|FG003|Overall Study|Death|1|||
16804806|NCT01877668|37746352|FG004|Overall Study|Death|0|||
16804807|NCT01877668|37746348|FG000|Overall Study|No longer met study criteria|1|||
16804808|NCT01877668|37746349|FG001|Overall Study|No longer met study criteria|0|||
16804809|NCT01877668|37746350|FG002|Overall Study|No longer met study criteria|1|||
16804810|NCT01877668|37746351|FG003|Overall Study|No longer met study criteria|0|||
16804811|NCT01877668|37746352|FG004|Overall Study|No longer met study criteria|0|||
16804812|NCT01877668|37746348|FG000|Overall Study|Insufficient clinical response|0|||
16804813|NCT01877668|37746349|FG001|Overall Study|Insufficient clinical response|1|||
16804814|NCT01877668|37746350|FG002|Overall Study|Insufficient clinical response|2|||
16804815|NCT01877668|37746351|FG003|Overall Study|Insufficient clinical response|2|||
16804816|NCT01877668|37746352|FG004|Overall Study|Insufficient clinical response|0|||
16804817|NCT01877668|37746348|FG000|Overall Study|Lost to Follow-up|0|||
16804818|NCT01877668|37746349|FG001|Overall Study|Lost to Follow-up|2|||
16804819|NCT01877668|37746350|FG002|Overall Study|Lost to Follow-up|1|||
16804820|NCT01877668|37746351|FG003|Overall Study|Lost to Follow-up|0|||
16804821|NCT01877668|37746352|FG004|Overall Study|Lost to Follow-up|0|||
16804822|NCT01877668|37746348|FG000|Overall Study|Withdrawal by Subject|2|||
16804823|NCT01877668|37746349|FG001|Overall Study|Withdrawal by Subject|0|||
16804824|NCT01877668|37746350|FG002|Overall Study|Withdrawal by Subject|3|||
16804825|NCT01877668|37746351|FG003|Overall Study|Withdrawal by Subject|2|||
16804826|NCT01877668|37746352|FG004|Overall Study|Withdrawal by Subject|2|||
16804827|NCT01877668|37746348|FG000|Overall Study|Other|1|||
16804828|NCT01877668|37746349|FG001|Overall Study|Other|1|||
16804829|NCT01877668|37746350|FG002|Overall Study|Other|1|||
16804830|NCT01877668|37746351|FG003|Overall Study|Other|1|||
16804831|NCT01877668|37746352|FG004|Overall Study|Other|3|||
16804832|NCT01877668|37746348|FG000|Overall Study|Protocol Violation|1|||
16804833|NCT01877668|37746349|FG001|Overall Study|Protocol Violation|1|||
16804834|NCT01877668|37746350|FG002|Overall Study|Protocol Violation|0|||
16804835|NCT01877668|37746351|FG003|Overall Study|Protocol Violation|0|||
16804836|NCT01877668|37746352|FG004|Overall Study|Protocol Violation|3|||
16804837|NCT01877668|37746348|FG000|Overall Study|Adverse event related to study drug|2|||
16804838|NCT01877668|37746349|FG001|Overall Study|Adverse event related to study drug|2|||
16804839|NCT01877668|37746350|FG002|Overall Study|Adverse event related to study drug|2|||
16804840|NCT01877668|37746351|FG003|Overall Study|Adverse event related to study drug|2|||
16909581|NCT01717326|38018482|FG019|Overall Study|Death|0|||
16909582|NCT01717326|38018463|FG000|Overall Study|Lost to Follow-up|3|||
17198343|NCT02595398|38351957|FG001|Overall Study|Lost to Follow-up|0|||
17198344|NCT01368497|38351963|FG000|Overall Study|Lost to Follow-up|2|||
17198345|NCT02595008|38351969|FG000|Overall Study|Enrolled In Error|1|||
17198346|NCT02595008|38351970|FG001|Overall Study|Enrolled In Error|0|||
17198347|NCT02598128|38351976|FG000|Period A: Days -7 to -1|Adverse Event|1|||
16909583|NCT01717326|38018464|FG001|Overall Study|Lost to Follow-up|0|||
16909584|NCT01717326|38018465|FG002|Overall Study|Lost to Follow-up|0|||
16909585|NCT01717326|38018466|FG003|Overall Study|Lost to Follow-up|2|||
16909586|NCT01717326|38018467|FG004|Overall Study|Lost to Follow-up|1|||
16909587|NCT01717326|38018468|FG005|Overall Study|Lost to Follow-up|0|||
16909588|NCT01717326|38018469|FG006|Overall Study|Lost to Follow-up|1|||
16909589|NCT01717326|38018470|FG007|Overall Study|Lost to Follow-up|0|||
16909590|NCT01717326|38018471|FG008|Overall Study|Lost to Follow-up|0|||
16909591|NCT01717326|38018472|FG009|Overall Study|Lost to Follow-up|0|||
16909592|NCT01717326|38018473|FG010|Overall Study|Lost to Follow-up|1|||
16909593|NCT01717326|38018474|FG011|Overall Study|Lost to Follow-up|0|||
16909594|NCT01717326|38018475|FG012|Overall Study|Lost to Follow-up|0|||
16909595|NCT01717326|38018476|FG013|Overall Study|Lost to Follow-up|0|||
16909596|NCT01717326|38018477|FG014|Overall Study|Lost to Follow-up|0|||
16909597|NCT01717326|38018478|FG015|Overall Study|Lost to Follow-up|2|||
16909598|NCT01717326|38018479|FG016|Overall Study|Lost to Follow-up|1|||
16909599|NCT01717326|38018480|FG017|Overall Study|Lost to Follow-up|0|||
16909600|NCT01717326|38018481|FG018|Overall Study|Lost to Follow-up|2|||
16909601|NCT01717326|38018482|FG019|Overall Study|Lost to Follow-up|3|||
16909602|NCT01717326|38018463|FG000|Overall Study|Physician Decision|0|||
16909603|NCT01717326|38018464|FG001|Overall Study|Physician Decision|0|||
16909604|NCT01717326|38018465|FG002|Overall Study|Physician Decision|0|||
16909605|NCT01717326|38018466|FG003|Overall Study|Physician Decision|0|||
16909606|NCT01717326|38018467|FG004|Overall Study|Physician Decision|0|||
16909607|NCT01717326|38018468|FG005|Overall Study|Physician Decision|0|||
16909608|NCT01717326|38018469|FG006|Overall Study|Physician Decision|0|||
16909609|NCT01717326|38018470|FG007|Overall Study|Physician Decision|0|||
16909610|NCT01717326|38018471|FG008|Overall Study|Physician Decision|0|||
16909611|NCT01717326|38018472|FG009|Overall Study|Physician Decision|1|||
16909612|NCT01717326|38018473|FG010|Overall Study|Physician Decision|0|||
16909613|NCT01717326|38018474|FG011|Overall Study|Physician Decision|0|||
16909614|NCT01717326|38018475|FG012|Overall Study|Physician Decision|0|||
16909615|NCT01717326|38018476|FG013|Overall Study|Physician Decision|0|||
16909616|NCT01717326|38018477|FG014|Overall Study|Physician Decision|0|||
16909617|NCT01717326|38018478|FG015|Overall Study|Physician Decision|0|||
16909618|NCT01717326|38018479|FG016|Overall Study|Physician Decision|0|||
16909619|NCT01717326|38018480|FG017|Overall Study|Physician Decision|0|||
16909620|NCT01717326|38018481|FG018|Overall Study|Physician Decision|0|||
16909621|NCT01717326|38018482|FG019|Overall Study|Physician Decision|0|||
16909622|NCT01717326|38018463|FG000|Overall Study|Protocol Violation|0|||
16909623|NCT01717326|38018464|FG001|Overall Study|Protocol Violation|0|||
17198348|NCT02598128|38351977|FG001|Period A: Days -7 to -1|Adverse Event|0|||
17198349|NCT02598128|38351978|FG002|Period A: Days -7 to -1|Adverse Event|0|||
16804841|NCT01877668|37746352|FG004|Overall Study|Adverse event related to study drug|1|||
16909624|NCT01717326|38018465|FG002|Overall Study|Protocol Violation|0|||
17198350|NCT02598128|38351979|FG003|Period A: Days -7 to -1|Adverse Event|0|||
16909625|NCT01717326|38018466|FG003|Overall Study|Protocol Violation|0|||
16909626|NCT01717326|38018467|FG004|Overall Study|Protocol Violation|1|||
16909627|NCT01717326|38018468|FG005|Overall Study|Protocol Violation|0|||
16909628|NCT01717326|38018469|FG006|Overall Study|Protocol Violation|0|||
16909629|NCT01717326|38018470|FG007|Overall Study|Protocol Violation|0|||
16909630|NCT01717326|38018471|FG008|Overall Study|Protocol Violation|0|||
16909631|NCT01717326|38018472|FG009|Overall Study|Protocol Violation|0|||
16909632|NCT01717326|38018473|FG010|Overall Study|Protocol Violation|0|||
16909633|NCT01717326|38018474|FG011|Overall Study|Protocol Violation|0|||
16909634|NCT01717326|38018475|FG012|Overall Study|Protocol Violation|0|||
16909635|NCT01717326|38018476|FG013|Overall Study|Protocol Violation|0|||
16909636|NCT01717326|38018477|FG014|Overall Study|Protocol Violation|0|||
16909637|NCT01717326|38018478|FG015|Overall Study|Protocol Violation|0|||
16909638|NCT01717326|38018479|FG016|Overall Study|Protocol Violation|0|||
16909639|NCT01717326|38018480|FG017|Overall Study|Protocol Violation|0|||
16909640|NCT01717326|38018481|FG018|Overall Study|Protocol Violation|0|||
16909641|NCT01717326|38018482|FG019|Overall Study|Protocol Violation|0|||
16909642|NCT01717326|38018463|FG000|Overall Study|Withdrawal by Subject|0|||
16909643|NCT01717326|38018464|FG001|Overall Study|Withdrawal by Subject|1|||
16909644|NCT01717326|38018465|FG002|Overall Study|Withdrawal by Subject|0|||
16909645|NCT01717326|38018466|FG003|Overall Study|Withdrawal by Subject|0|||
16909646|NCT01717326|38018467|FG004|Overall Study|Withdrawal by Subject|0|||
16909647|NCT01717326|38018468|FG005|Overall Study|Withdrawal by Subject|0|||
16909648|NCT01717326|38018469|FG006|Overall Study|Withdrawal by Subject|0|||
16909649|NCT01717326|38018470|FG007|Overall Study|Withdrawal by Subject|0|||
16909650|NCT01717326|38018471|FG008|Overall Study|Withdrawal by Subject|0|||
16909651|NCT01717326|38018472|FG009|Overall Study|Withdrawal by Subject|1|||
16909652|NCT01717326|38018473|FG010|Overall Study|Withdrawal by Subject|0|||
16909653|NCT01717326|38018474|FG011|Overall Study|Withdrawal by Subject|0|||
16909654|NCT01717326|38018475|FG012|Overall Study|Withdrawal by Subject|1|||
16909655|NCT01717326|38018476|FG013|Overall Study|Withdrawal by Subject|0|||
16909656|NCT01717326|38018477|FG014|Overall Study|Withdrawal by Subject|0|||
16909657|NCT01717326|38018478|FG015|Overall Study|Withdrawal by Subject|1|||
16909658|NCT01717326|38018479|FG016|Overall Study|Withdrawal by Subject|0|||
16909659|NCT01717326|38018480|FG017|Overall Study|Withdrawal by Subject|0|||
16909660|NCT01717326|38018481|FG018|Overall Study|Withdrawal by Subject|2|||
16909661|NCT01717326|38018482|FG019|Overall Study|Withdrawal by Subject|3|||
16909662|NCT01697592|38018534|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
16909663|NCT01697592|38018535|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909664|NCT01697592|38018536|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909665|NCT01697592|38018537|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909666|NCT01697592|38018538|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909667|NCT01697592|38018539|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909668|NCT01697592|38018540|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909669|NCT01697592|38018541|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909670|NCT01697592|38018542|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909671|NCT01697592|38018543|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16909672|NCT01697592|38018534|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909673|NCT01697592|38018535|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909674|NCT01697592|38018536|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909675|NCT01697592|38018537|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909676|NCT01697592|38018538|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909677|NCT01697592|38018539|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
16909678|NCT01697592|38018540|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909679|NCT01697592|38018541|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909680|NCT01697592|38018542|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909681|NCT01697592|38018543|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16909682|NCT01697592|38018534|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
16909683|NCT01697592|38018535|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16909684|NCT01697592|38018536|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16909685|NCT01697592|38018537|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16804842|NCT01877668|37746348|FG000|Overall Study|Adverse event unrelated to study drug|4|||
16804843|NCT01877668|37746349|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16804844|NCT01877668|37746350|FG002|Overall Study|Adverse event unrelated to study drug|2|||
16804845|NCT01877668|37746351|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16804846|NCT01877668|37746352|FG004|Overall Study|Adverse event unrelated to study drug|1|||
16804847|NCT01877278|37746370|FG000|Overall Study|Lost to Follow-up|3|||
16804848|NCT01877278|37746371|FG001|Overall Study|Lost to Follow-up|3|||
16804849|NCT01906372|37746377|FG000|Overall Study|Withdrawal by Subject|2|||
16804850|NCT01925170|37746382|FG000|Overall Study|Unverified cancer status|53|||
16804851|NCT01925014|37746390|FG000|Overall Study|Inappropriate enrollment|4|||
16804852|NCT01925014|37746391|FG001|Overall Study|Inappropriate enrollment|6|||
16909686|NCT01697592|38018538|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16804853|NCT01925014|37746390|FG000|Overall Study|Withdrawal by Subject|5|||
16804854|NCT01925014|37746391|FG001|Overall Study|Withdrawal by Subject|13|||
16804855|NCT01876810|37746397|FG000|Overall Study|Physician Decision|0|||
16804856|NCT01876810|37746398|FG001|Overall Study|Physician Decision|1|||
16804857|NCT01876732|37746407|FG000|Overall Study|MMA was not over 800mg/dL|75|||
16804858|NCT01905592|37746414|FG000|Overall Study|Disease Progression|51|||
16804859|NCT01905592|37746415|FG001|Overall Study|Disease Progression|110|||
16804860|NCT01905592|37746414|FG000|Overall Study|Toxicity|1|||
16804861|NCT01905592|37746415|FG001|Overall Study|Toxicity|16|||
16804862|NCT01905592|37746414|FG000|Overall Study|Physician Decision|0|||
16804863|NCT01905592|37746415|FG001|Overall Study|Physician Decision|2|||
16804864|NCT01905592|37746414|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
16804865|NCT01905592|37746415|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
16804866|NCT01905592|37746414|FG000|Overall Study|Protocol Violation|0|||
16804867|NCT01905592|37746415|FG001|Overall Study|Protocol Violation|1|||
16804868|NCT01905592|37746414|FG000|Overall Study|Sponsor's decision|1|||
16804869|NCT01905592|37746415|FG001|Overall Study|Sponsor's decision|1|||
16804870|NCT01905592|37746414|FG000|Overall Study|Not treated|7|||
16804871|NCT01905592|37746415|FG001|Overall Study|Not treated|3|||
16804872|NCT01905592|37746414|FG000|Overall Study|Withdrawal by Subject|10|||
16804873|NCT01905592|37746415|FG001|Overall Study|Withdrawal by Subject|2|||
16804874|NCT01876420|37746421|FG000|Overall Study|Missed 30 day visit|1|||
16804875|NCT01875874|37746425|FG000|Overall Study|Death|3|||
16804876|NCT02500121|37746432|FG000|Overall Study|Lost to Follow-up|0|||
16804877|NCT02500121|37746433|FG001|Overall Study|Lost to Follow-up|1|||
16804878|NCT02500121|37746432|FG000|Overall Study|Withdrawal by Subject|1|||
16804879|NCT02500121|37746433|FG001|Overall Study|Withdrawal by Subject|1|||
16804880|NCT02500121|37746432|FG000|Overall Study|Death|26|||
16804881|NCT02500121|37746433|FG001|Overall Study|Death|24|||
16804882|NCT01875250|37746443|FG000|Overall Study|Adverse Event|2|||
16804883|NCT01875250|37746444|FG001|Overall Study|Adverse Event|0|||
16804884|NCT01904032|37746454|FG000|Overall Study|Adverse Event|3|||
16804885|NCT01904032|37746455|FG001|Overall Study|Adverse Event|1|||
16804886|NCT01904032|37746454|FG000|Overall Study|Lost to Follow-up|4|||
16804887|NCT01904032|37746455|FG001|Overall Study|Lost to Follow-up|2|||
16804888|NCT01903876|37746463|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
16804889|NCT01903876|37746464|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
16804890|NCT01903876|37746463|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
16804891|NCT01903876|37746464|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
16804892|NCT01921348|37746472|FG000|Overall Study|Withdrawal by Subject|1|||
16804893|NCT01921348|37746473|FG001|Overall Study|Withdrawal by Subject|0|||
16804894|NCT01921348|37746472|FG000|Overall Study|Lost to Follow-up|0|||
16804895|NCT01921348|37746473|FG001|Overall Study|Lost to Follow-up|2|||
16804896|NCT01921270|37746479|FG000|Overall Study|Withdrawal by Subject|1|||
16804897|NCT02325739|37746494|FG000|Phase I Part|Adverse Event|1|||
16804898|NCT02325739|37746495|FG001|Phase I Part|Adverse Event|0|||
16804899|NCT02325739|37746496|FG002|Phase I Part|Adverse Event|1|||
16804900|NCT02325739|37746497|FG003|Phase I Part|Adverse Event|2|||
16804901|NCT02325739|37746498|FG004|Phase I Part|Adverse Event|3|||
16804902|NCT02325739|37746499|FG005|Phase I Part|Adverse Event|1|||
16804903|NCT02325739|37746500|FG006|Phase I Part|Adverse Event|0|||
16804904|NCT02325739|37746501|FG007|Phase I Part|Adverse Event|2|||
16804905|NCT02325739|37746502|FG008|Phase I Part|Adverse Event|0|||
16804906|NCT02325739|37746503|FG009|Phase I Part|Adverse Event|0|||
16804907|NCT02325739|37746504|FG010|Phase I Part|Adverse Event|0|||
16804908|NCT02325739|37746494|FG000|Phase I Part|Progressive disease|9|||
16804909|NCT02325739|37746495|FG001|Phase I Part|Progressive disease|6|||
16804910|NCT02325739|37746496|FG002|Phase I Part|Progressive disease|3|||
16804911|NCT02325739|37746497|FG003|Phase I Part|Progressive disease|23|||
16804912|NCT02325739|37746498|FG004|Phase I Part|Progressive disease|14|||
16804913|NCT02325739|37746499|FG005|Phase I Part|Progressive disease|6|||
16804914|NCT02325739|37746500|FG006|Phase I Part|Progressive disease|6|||
16804915|NCT02325739|37746501|FG007|Phase I Part|Progressive disease|3|||
16804916|NCT02325739|37746502|FG008|Phase I Part|Progressive disease|0|||
16804917|NCT02325739|37746503|FG009|Phase I Part|Progressive disease|0|||
16804918|NCT02325739|37746504|FG010|Phase I Part|Progressive disease|0|||
16804919|NCT02325739|37746494|FG000|Phase I Part|Subject/guardian decision|1|||
16804920|NCT02325739|37746495|FG001|Phase I Part|Subject/guardian decision|0|||
16804921|NCT02325739|37746496|FG002|Phase I Part|Subject/guardian decision|1|||
16804922|NCT02325739|37746497|FG003|Phase I Part|Subject/guardian decision|1|||
16804923|NCT02325739|37746498|FG004|Phase I Part|Subject/guardian decision|0|||
16804924|NCT02325739|37746499|FG005|Phase I Part|Subject/guardian decision|0|||
16804925|NCT02325739|37746500|FG006|Phase I Part|Subject/guardian decision|0|||
16804926|NCT02325739|37746501|FG007|Phase I Part|Subject/guardian decision|1|||
16804927|NCT02325739|37746502|FG008|Phase I Part|Subject/guardian decision|0|||
16804928|NCT02325739|37746503|FG009|Phase I Part|Subject/guardian decision|0|||
17016556|NCT00855218|38161204|FG001|Overall Study|Protocol Violation|9|||
16804929|NCT02325739|37746504|FG010|Phase I Part|Subject/guardian decision|0|||
16804930|NCT02325739|37746494|FG000|Phase I Part|Death|0|||
16804931|NCT02325739|37746495|FG001|Phase I Part|Death|0|||
16804932|NCT02325739|37746496|FG002|Phase I Part|Death|0|||
16804933|NCT02325739|37746497|FG003|Phase I Part|Death|0|||
16804934|NCT02325739|37746498|FG004|Phase I Part|Death|2|||
16804935|NCT02325739|37746499|FG005|Phase I Part|Death|0|||
16804936|NCT02325739|37746500|FG006|Phase I Part|Death|0|||
16804937|NCT02325739|37746501|FG007|Phase I Part|Death|0|||
16804938|NCT02325739|37746502|FG008|Phase I Part|Death|0|||
16804939|NCT02325739|37746503|FG009|Phase I Part|Death|0|||
16804940|NCT02325739|37746504|FG010|Phase I Part|Death|0|||
16804941|NCT02325739|37746494|FG000|Phase II Part|Adverse Event|0|||
16804942|NCT02325739|37746495|FG001|Phase II Part|Adverse Event|0|||
16804943|NCT02325739|37746496|FG002|Phase II Part|Adverse Event|0|||
16804944|NCT02325739|37746497|FG003|Phase II Part|Adverse Event|0|||
16804945|NCT02325739|37746498|FG004|Phase II Part|Adverse Event|0|||
16804946|NCT02325739|37746499|FG005|Phase II Part|Adverse Event|0|||
16804947|NCT02325739|37746500|FG006|Phase II Part|Adverse Event|0|||
16804948|NCT02325739|37746501|FG007|Phase II Part|Adverse Event|0|||
16804949|NCT02325739|37746502|FG008|Phase II Part|Adverse Event|4|||
16804950|NCT02325739|37746503|FG009|Phase II Part|Adverse Event|5|||
16804951|NCT02325739|37746504|FG010|Phase II Part|Adverse Event|1|||
16804952|NCT02325739|37746494|FG000|Phase II Part|Physician Decision|0|||
16804953|NCT02325739|37746495|FG001|Phase II Part|Physician Decision|0|||
16804954|NCT02325739|37746496|FG002|Phase II Part|Physician Decision|0|||
16804955|NCT02325739|37746497|FG003|Phase II Part|Physician Decision|0|||
16804956|NCT02325739|37746498|FG004|Phase II Part|Physician Decision|0|||
16804957|NCT02325739|37746499|FG005|Phase II Part|Physician Decision|0|||
16804958|NCT02325739|37746500|FG006|Phase II Part|Physician Decision|0|||
16804959|NCT02325739|37746501|FG007|Phase II Part|Physician Decision|0|||
16804960|NCT02325739|37746502|FG008|Phase II Part|Physician Decision|0|||
16804961|NCT02325739|37746503|FG009|Phase II Part|Physician Decision|1|||
16804962|NCT02325739|37746504|FG010|Phase II Part|Physician Decision|0|||
16804963|NCT02325739|37746494|FG000|Phase II Part|Progressive disease|0|||
16804964|NCT02325739|37746495|FG001|Phase II Part|Progressive disease|0|||
16804965|NCT02325739|37746496|FG002|Phase II Part|Progressive disease|0|||
16804966|NCT02325739|37746497|FG003|Phase II Part|Progressive disease|0|||
16804967|NCT02325739|37746498|FG004|Phase II Part|Progressive disease|0|||
16804968|NCT02325739|37746499|FG005|Phase II Part|Progressive disease|0|||
16804969|NCT02325739|37746500|FG006|Phase II Part|Progressive disease|0|||
16804970|NCT02325739|37746501|FG007|Phase II Part|Progressive disease|0|||
16804971|NCT02325739|37746502|FG008|Phase II Part|Progressive disease|22|||
16804972|NCT02325739|37746503|FG009|Phase II Part|Progressive disease|29|||
16804973|NCT02325739|37746504|FG010|Phase II Part|Progressive disease|18|||
16804974|NCT02325739|37746494|FG000|Phase II Part|Subject/guardian decision|0|||
16804975|NCT02325739|37746495|FG001|Phase II Part|Subject/guardian decision|0|||
16804976|NCT02325739|37746496|FG002|Phase II Part|Subject/guardian decision|0|||
16804977|NCT02325739|37746497|FG003|Phase II Part|Subject/guardian decision|0|||
16804978|NCT02325739|37746498|FG004|Phase II Part|Subject/guardian decision|0|||
16804979|NCT02325739|37746499|FG005|Phase II Part|Subject/guardian decision|0|||
16804980|NCT02325739|37746500|FG006|Phase II Part|Subject/guardian decision|0|||
16804981|NCT02325739|37746501|FG007|Phase II Part|Subject/guardian decision|0|||
16804982|NCT02325739|37746502|FG008|Phase II Part|Subject/guardian decision|4|||
16804983|NCT02325739|37746503|FG009|Phase II Part|Subject/guardian decision|1|||
16804984|NCT02325739|37746504|FG010|Phase II Part|Subject/guardian decision|1|||
16804985|NCT01903720|37746549|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
16804986|NCT01903720|37746549|FG000|Overall Study|Adverse Event|1|||
16804987|NCT01903720|37746549|FG000|Overall Study|Rescinding of informed consent|2|||
16804988|NCT01903720|37746549|FG000|Overall Study|Lost to Follow-up|2|||
16804989|NCT01903720|37746549|FG000|Overall Study|Treatment with alternative drug|1|||
16804990|NCT02366689|37746556|FG000|Overall Study|Withdrawal by Subject|1|||
16804991|NCT02366689|37746557|FG001|Overall Study|Withdrawal by Subject|0|||
16804992|NCT02366689|37746558|FG002|Overall Study|Withdrawal by Subject|1|||
16804993|NCT02366689|37746556|FG000|Overall Study|Lost to Follow-up|3|||
16804994|NCT02366689|37746557|FG001|Overall Study|Lost to Follow-up|2|||
16804995|NCT02366689|37746558|FG002|Overall Study|Lost to Follow-up|0|||
16804996|NCT02366689|37746556|FG000|Overall Study|Pregnancy|0|||
16804997|NCT02366689|37746557|FG001|Overall Study|Pregnancy|1|||
16804998|NCT02366689|37746558|FG002|Overall Study|Pregnancy|1|||
16804999|NCT01903252|37746568|FG000|Double-Blind Induction|Adverse Event|20|||
16805000|NCT01903252|37746569|FG001|Double-Blind Induction|Adverse Event|18|||
16805001|NCT01903252|37746570|FG002|Double-Blind Induction|Adverse Event|0|||
16805002|NCT01903252|37746571|FG003|Double-Blind Induction|Adverse Event|0|||
16805003|NCT01903252|37746572|FG004|Double-Blind Induction|Adverse Event|0|||
16805004|NCT01903252|37746573|FG005|Double-Blind Induction|Adverse Event|0|||
16805005|NCT01903252|37746568|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
16805006|NCT01903252|37746569|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
16805007|NCT01903252|37746570|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
16805008|NCT01903252|37746571|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
16805009|NCT01903252|37746572|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
16805010|NCT01903252|37746573|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
16805011|NCT01903252|37746568|FG000|Double-Blind Induction|Physician Decision|2|||
16805012|NCT01903252|37746569|FG001|Double-Blind Induction|Physician Decision|3|||
16805013|NCT01903252|37746570|FG002|Double-Blind Induction|Physician Decision|0|||
16805014|NCT01903252|37746571|FG003|Double-Blind Induction|Physician Decision|0|||
16805015|NCT01903252|37746572|FG004|Double-Blind Induction|Physician Decision|0|||
16805016|NCT01903252|37746573|FG005|Double-Blind Induction|Physician Decision|0|||
16805017|NCT01903252|37746568|FG000|Double-Blind Induction|non-compliance,|7|||
16805018|NCT01903252|37746569|FG001|Double-Blind Induction|non-compliance,|7|||
16805019|NCT01903252|37746570|FG002|Double-Blind Induction|non-compliance,|0|||
16805020|NCT01903252|37746571|FG003|Double-Blind Induction|non-compliance,|0|||
16805021|NCT01903252|37746572|FG004|Double-Blind Induction|non-compliance,|0|||
16805022|NCT01903252|37746573|FG005|Double-Blind Induction|non-compliance,|0|||
16805023|NCT01903252|37746568|FG000|Extended Induction, Open-Label|Adverse Event|0|||
16805024|NCT01903252|37746569|FG001|Extended Induction, Open-Label|Adverse Event|0|||
16805025|NCT01903252|37746570|FG002|Extended Induction, Open-Label|Adverse Event|17|||
16805026|NCT01903252|37746571|FG003|Extended Induction, Open-Label|Adverse Event|0|||
16805027|NCT01903252|37746572|FG004|Extended Induction, Open-Label|Adverse Event|0|||
16805028|NCT01903252|37746573|FG005|Extended Induction, Open-Label|Adverse Event|0|||
16805029|NCT01903252|37746568|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16805030|NCT01903252|37746569|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16805031|NCT01903252|37746570|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
16805032|NCT01903252|37746571|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16805033|NCT01903252|37746572|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16805034|NCT01903252|37746573|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16805035|NCT01903252|37746568|FG000|Extended Induction, Open-Label|Physician Decision|0|||
16805036|NCT01903252|37746569|FG001|Extended Induction, Open-Label|Physician Decision|0|||
16805037|NCT01903252|37746570|FG002|Extended Induction, Open-Label|Physician Decision|1|||
16805038|NCT01903252|37746571|FG003|Extended Induction, Open-Label|Physician Decision|0|||
16805039|NCT01903252|37746572|FG004|Extended Induction, Open-Label|Physician Decision|0|||
16805040|NCT01903252|37746573|FG005|Extended Induction, Open-Label|Physician Decision|0|||
16805041|NCT01903252|37746568|FG000|Maintenance, Open-Label|Adverse Event|0|||
16805042|NCT01903252|37746569|FG001|Maintenance, Open-Label|Adverse Event|0|||
16805043|NCT01903252|37746570|FG002|Maintenance, Open-Label|Adverse Event|0|||
16805044|NCT01903252|37746571|FG003|Maintenance, Open-Label|Adverse Event|3|||
16805045|NCT01903252|37746572|FG004|Maintenance, Open-Label|Adverse Event|9|||
16805046|NCT01903252|37746573|FG005|Maintenance, Open-Label|Adverse Event|14|||
16805047|NCT01903252|37746568|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
16805048|NCT01903252|37746569|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
16805049|NCT01903252|37746570|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
16805050|NCT01903252|37746571|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
16805051|NCT01903252|37746572|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
16805052|NCT01903252|37746573|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
16805053|NCT01903252|37746568|FG000|Maintenance, Open-Label|Other|0|||
16805054|NCT01903252|37746569|FG001|Maintenance, Open-Label|Other|0|||
16805055|NCT01903252|37746570|FG002|Maintenance, Open-Label|Other|0|||
16805056|NCT01903252|37746571|FG003|Maintenance, Open-Label|Other|2|||
16805057|NCT01903252|37746572|FG004|Maintenance, Open-Label|Other|6|||
16805058|NCT01903252|37746573|FG005|Maintenance, Open-Label|Other|2|||
16805059|NCT01920958|37746591|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
16805060|NCT01613716|37746595|FG000|Overall Study|screen failures|3|||
16805061|NCT01613716|37746595|FG000|Overall Study|Lost to Follow-up|4|||
16805062|NCT01872910|37746605|FG000|Overall Study|Lost to Follow-up|2|||
16805063|NCT01872910|37746606|FG001|Overall Study|Lost to Follow-up|0|||
16805064|NCT01872910|37746607|FG002|Overall Study|Lost to Follow-up|2|||
16805065|NCT01872910|37746608|FG003|Overall Study|Lost to Follow-up|0|||
16805066|NCT01872910|37746609|FG004|Overall Study|Lost to Follow-up|0|||
16805067|NCT01872910|37746610|FG005|Overall Study|Lost to Follow-up|0|||
16805068|NCT01920568|37746625|FG000|Overall Study|Adverse Event|27|||
16805069|NCT01920568|37746626|FG001|Overall Study|Adverse Event|8|||
16805070|NCT01920568|37746625|FG000|Overall Study|Protocol Violation|5|||
16805071|NCT01920568|37746626|FG001|Overall Study|Protocol Violation|3|||
16805072|NCT01920568|37746625|FG000|Overall Study|Lost to Follow-up|2|||
16805073|NCT01920568|37746626|FG001|Overall Study|Lost to Follow-up|2|||
16805074|NCT01920568|37746625|FG000|Overall Study|Physician Decision|13|||
16805075|NCT01920568|37746626|FG001|Overall Study|Physician Decision|4|||
16909687|NCT01697592|38018539|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16909688|NCT01697592|38018540|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16909689|NCT01697592|38018541|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16909690|NCT01697592|38018542|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16909691|NCT01697592|38018543|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16909692|NCT01697592|38018534|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16909693|NCT01697592|38018535|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16909694|NCT01697592|38018536|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16909695|NCT01697592|38018537|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16805076|NCT01920568|37746625|FG000|Overall Study|Withdrawal by Subject|79|||
16805077|NCT01920568|37746626|FG001|Overall Study|Withdrawal by Subject|55|||
16805078|NCT01920568|37746625|FG000|Overall Study|Death due to disease progression|25|||
16805079|NCT01920568|37746626|FG001|Overall Study|Death due to disease progression|12|||
16805080|NCT01902628|37746633|FG000|Overall Study|Withdrawal of participant's consent|7|||
16805081|NCT01902628|37746633|FG000|Overall Study|Adverse Event|41|||
16805082|NCT01902628|37746633|FG000|Overall Study|Lost to Follow-up|35|||
16805083|NCT01920178|37746639|FG000|Overall Study|Lost to Follow-up|2|||
16805084|NCT01920178|37746640|FG001|Overall Study|Lost to Follow-up|1|||
16805085|NCT01901848|37746648|FG000|Randomized and Treated|Lost to Follow-up|3|||
16805086|NCT01901848|37746649|FG001|Randomized and Treated|Lost to Follow-up|6|||
16805087|NCT01901848|37746648|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
16805088|NCT01901848|37746649|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
16805089|NCT01901614|37746657|FG000|Overall Study|Adverse Event|0|||
16805090|NCT01901614|37746658|FG001|Overall Study|Adverse Event|1|||
16805091|NCT01901614|37746657|FG000|Overall Study|Lost to Follow-up|1|||
16805092|NCT01901614|37746658|FG001|Overall Study|Lost to Follow-up|0|||
16805093|NCT01901614|37746657|FG000|Overall Study|Screen Fail|1|||
16805094|NCT01901614|37746658|FG001|Overall Study|Screen Fail|0|||
16805095|NCT01901302|37746666|FG000|Overall Study|Adverse Event|2|||
16805096|NCT01901302|37746667|FG001|Overall Study|Adverse Event|1|||
16805097|NCT01901302|37746666|FG000|Overall Study|Lack of Efficacy|0|||
16805098|NCT01901302|37746667|FG001|Overall Study|Lack of Efficacy|2|||
16805099|NCT01901302|37746666|FG000|Overall Study|Study Terminated by Sponsor|23|||
16805100|NCT01901302|37746667|FG001|Overall Study|Study Terminated by Sponsor|20|||
16805101|NCT01901302|37746666|FG000|Overall Study|Withdrawal by Subject|2|||
16805102|NCT01901302|37746667|FG001|Overall Study|Withdrawal by Subject|0|||
16805103|NCT01919398|37746676|FG000|Overall Study|Progressive Disease|0|||
16805104|NCT01919398|37746677|FG001|Overall Study|Progressive Disease|0|||
16805105|NCT01919398|37746678|FG002|Overall Study|Progressive Disease|4|||
16805106|NCT02500043|37746688|FG000|Overall Study|Randomized, but not Treated|2|||
16805107|NCT02500043|37746689|FG001|Overall Study|Randomized, but not Treated|2|||
16805108|NCT02500043|37746688|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
16805109|NCT02500043|37746689|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
16805110|NCT02500043|37746688|FG000|Overall Study|Adverse Event|33|||
16805111|NCT02500043|37746689|FG001|Overall Study|Adverse Event|11|||
16805112|NCT02500043|37746688|FG000|Overall Study|Clinical Progression|54|||
16805113|NCT02500043|37746689|FG001|Overall Study|Clinical Progression|35|||
16805114|NCT02500043|37746688|FG000|Overall Study|Radiological Progression|192|||
16805115|NCT02500043|37746689|FG001|Overall Study|Radiological Progression|110|||
16805116|NCT02500043|37746688|FG000|Overall Study|Physician's Decision|11|||
16805117|NCT02500043|37746689|FG001|Overall Study|Physician's Decision|3|||
16805118|NCT02500043|37746688|FG000|Overall Study|Withdrawal by Subject|14|||
16805119|NCT02500043|37746689|FG001|Overall Study|Withdrawal by Subject|4|||
16805120|NCT02500043|37746688|FG000|Overall Study|Death|11|||
16805121|NCT02500043|37746689|FG001|Overall Study|Death|2|||
16805122|NCT02500043|37746688|FG000|Overall Study|Protocol Deviation|1|||
16805123|NCT02500043|37746689|FG001|Overall Study|Protocol Deviation|0|||
16805124|NCT02499575|37746697|FG000|Overall Study|Protocol Violation|0|||
16805125|NCT02499575|37746698|FG001|Overall Study|Protocol Violation|1|||
16805126|NCT02065791|37746706|FG000|Overall Study|Closed Site|1|||
16805127|NCT02065791|37746707|FG001|Overall Study|Closed Site|1|||
16805128|NCT02065791|37746706|FG000|Overall Study|Withdrawal by Subject|11|||
16805129|NCT02065791|37746707|FG001|Overall Study|Withdrawal by Subject|5|||
16805130|NCT02065791|37746706|FG000|Overall Study|Lost to Follow-up|13|||
16805131|NCT02065791|37746707|FG001|Overall Study|Lost to Follow-up|9|||
16805132|NCT02499263|37746713|FG000|Overall Study|Lost to Follow-up|9|||
16805133|NCT02499263|37746713|FG000|Overall Study|Participant's withdrawal of consent|4|||
16805134|NCT02499263|37746713|FG000|Overall Study|Lack of Efficacy|22|||
16805135|NCT02499263|37746713|FG000|Overall Study|investigator's judgment|12|||
16805136|NCT02499263|37746713|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
16805137|NCT02499263|37746713|FG000|Overall Study|Participant's decision|3|||
16805138|NCT02499263|37746713|FG000|Overall Study|Pregnancy|1|||
16805139|NCT01654289|37746720|FG000|Overall Study|Withdrawal by Subject|10|||
16805140|NCT01654289|37746721|FG001|Overall Study|Withdrawal by Subject|8|||
16805141|NCT01654289|37746722|FG002|Overall Study|Withdrawal by Subject|5|||
16805142|NCT01654289|37746720|FG000|Overall Study|Withdrew from intervention only|17|||
16805143|NCT01654289|37746721|FG001|Overall Study|Withdrew from intervention only|20|||
16805144|NCT01654289|37746722|FG002|Overall Study|Withdrew from intervention only|0|||
16805145|NCT02499029|37746732|FG000|Overall Study|Lost to Follow-up|2|||
17198351|NCT02788175|38351991|FG000|Overall Study|Protocol Violation|3|||
16805146|NCT02499029|37746733|FG001|Overall Study|Lost to Follow-up|2|||
16805147|NCT02499029|37746732|FG000|Overall Study|Physician Decision|2|||
16805148|NCT02499029|37746733|FG001|Overall Study|Physician Decision|1|||
16805149|NCT02499029|37746732|FG000|Overall Study|Death|1|||
16805150|NCT02499029|37746733|FG001|Overall Study|Death|0|||
16805151|NCT02477111|37746739|FG000|Overall Study|Death|5|||
16805152|NCT02477111|37746739|FG000|Overall Study|Withdrawal by Subject|2|||
17198352|NCT02788175|38351991|FG000|Overall Study|Withdrawal by Subject|4|||
17198353|NCT02788175|38351991|FG000|Overall Study|Ineligible prior to study agent|6|||
17198354|NCT02787083|38351997|FG000|Overall Study|Adverse Event|1|||
17198355|NCT02787083|38351998|FG001|Overall Study|Adverse Event|0|||
17198356|NCT02787083|38351997|FG000|Overall Study|Withdrawal by Subject|2|||
17198357|NCT02787083|38351998|FG001|Overall Study|Withdrawal by Subject|2|||
17198358|NCT02787863|38352012|FG000|Overall Study|Death|1|||
17198359|NCT02787863|38352013|FG001|Overall Study|Death|0|||
17198360|NCT02787863|38352014|FG002|Overall Study|Death|1|||
17198361|NCT02787863|38352015|FG003|Overall Study|Death|0|||
17198362|NCT02787863|38352016|FG004|Overall Study|Death|0|||
17198363|NCT02787863|38352017|FG005|Overall Study|Death|0|||
17198364|NCT02787863|38352018|FG006|Overall Study|Death|0|||
17198365|NCT02787863|38352019|FG007|Overall Study|Death|0|||
17198366|NCT02787863|38352012|FG000|Overall Study|Withdrawal by Subject|0|||
17198367|NCT02787863|38352013|FG001|Overall Study|Withdrawal by Subject|1|||
17198368|NCT02787863|38352014|FG002|Overall Study|Withdrawal by Subject|1|||
17198369|NCT02787863|38352015|FG003|Overall Study|Withdrawal by Subject|0|||
17198370|NCT02787863|38352016|FG004|Overall Study|Withdrawal by Subject|0|||
17198371|NCT02787863|38352017|FG005|Overall Study|Withdrawal by Subject|0|||
17198372|NCT02787863|38352018|FG006|Overall Study|Withdrawal by Subject|0|||
16805153|NCT02477111|37746739|FG000|Overall Study|missed visit|4|||
16805154|NCT02065713|37746747|FG000|Overall Study|Adverse Event|0|||
16805155|NCT02065713|37746748|FG001|Overall Study|Adverse Event|1|||
16805156|NCT02065713|37746747|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16805157|NCT02065713|37746748|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16805158|NCT02497781|37746756|FG000|Overall Study|Withdrawal by Subject|2|||
16805159|NCT02497781|37746757|FG001|Overall Study|Withdrawal by Subject|0|||
16805160|NCT02497781|37746756|FG000|Overall Study|Lack of Efficacy|0|||
16805161|NCT02497781|37746757|FG001|Overall Study|Lack of Efficacy|1|||
16805162|NCT02497781|37746756|FG000|Overall Study|Randomised but not treated|1|||
16805163|NCT02497781|37746757|FG001|Overall Study|Randomised but not treated|1|||
16805164|NCT02497781|37746756|FG000|Overall Study|Lost to Follow-up|1|||
16805165|NCT02497781|37746757|FG001|Overall Study|Lost to Follow-up|1|||
16805166|NCT02497469|37746765|FG000|Overall Study|Randomized but not Treated|0|||
16805167|NCT02497469|37746766|FG001|Overall Study|Randomized but not Treated|2|||
16805168|NCT02497469|37746765|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
16805169|NCT02497469|37746766|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
16805170|NCT02497469|37746765|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
16805171|NCT02497469|37746766|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
16805172|NCT02497469|37746765|FG000|Overall Study|Significant Protocol Deviation|4|||
16805173|NCT02497469|37746766|FG001|Overall Study|Significant Protocol Deviation|5|||
16805174|NCT02497469|37746765|FG000|Overall Study|Lost to Follow-up|14|||
16805175|NCT02497469|37746766|FG001|Overall Study|Lost to Follow-up|4|||
16805176|NCT02497469|37746765|FG000|Overall Study|Voluntary Withdrawal|39|||
16805177|NCT02497469|37746766|FG001|Overall Study|Voluntary Withdrawal|41|||
16805178|NCT02497469|37746765|FG000|Overall Study|Pregnancy|1|||
16805179|NCT02497469|37746766|FG001|Overall Study|Pregnancy|1|||
16805180|NCT02497469|37746765|FG000|Overall Study|Lack of Efficacy|86|||
16805181|NCT02497469|37746766|FG001|Overall Study|Lack of Efficacy|40|||
16805182|NCT02497469|37746765|FG000|Overall Study|Reason not Specified|6|||
16805183|NCT02497469|37746766|FG001|Overall Study|Reason not Specified|6|||
16805184|NCT02497391|37746772|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
16805185|NCT02497391|37746773|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
16805186|NCT02497391|37746774|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
16805187|NCT02497391|37746775|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
16805188|NCT02497391|37746776|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
16805189|NCT02497391|37746777|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
16805190|NCT02497391|37746772|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
16805191|NCT02497391|37746773|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
16805192|NCT02497391|37746774|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
16805193|NCT02497391|37746775|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
16805194|NCT02497391|37746776|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
16805195|NCT02497391|37746777|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
16805196|NCT02497391|37746772|FG000|Period 3 (14 Days)|Adverse Event|0|||
16805197|NCT02497391|37746773|FG001|Period 3 (14 Days)|Adverse Event|1|||
16805198|NCT02497391|37746774|FG002|Period 3 (14 Days)|Adverse Event|0|||
16805199|NCT02497391|37746775|FG003|Period 3 (14 Days)|Adverse Event|0|||
16805200|NCT02497391|37746776|FG004|Period 3 (14 Days)|Adverse Event|0|||
16805201|NCT02497391|37746777|FG005|Period 3 (14 Days)|Adverse Event|0|||
16805202|NCT02497391|37746772|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
16805203|NCT02497391|37746773|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
17198373|NCT02787863|38352019|FG007|Overall Study|Withdrawal by Subject|0|||
17198374|NCT02596958|38352060|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
17198375|NCT02596958|38352060|FG000|Overall Study|Cancer Progression|441|||
17198376|NCT02596958|38352060|FG000|Overall Study|Death From Cancer|112|||
17198377|NCT02596958|38352060|FG000|Overall Study|Death From Other Cause|33|||
16805204|NCT02497391|37746774|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
16805205|NCT02497391|37746775|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
16805206|NCT02497391|37746776|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
16805207|NCT02497391|37746777|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
16805208|NCT02497391|37746772|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
16805209|NCT02497391|37746773|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
16805210|NCT02497391|37746774|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
16805211|NCT02497391|37746775|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
16805212|NCT02497391|37746776|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
16805213|NCT02497391|37746777|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
16805214|NCT02476175|37746785|FG000|Overall Study|Adverse Event|2|||
16805215|NCT02065557|37746792|FG000|Induction Period|Withdrawal by Subject|2|||
16805216|NCT02065557|37746793|FG001|Induction Period|Withdrawal by Subject|1|||
16805217|NCT02065557|37746794|FG002|Induction Period|Withdrawal by Subject|0|||
16805218|NCT02065557|37746795|FG003|Induction Period|Withdrawal by Subject|0|||
16805219|NCT02065557|37746796|FG004|Induction Period|Withdrawal by Subject|0|||
16805220|NCT02065557|37746797|FG005|Induction Period|Withdrawal by Subject|0|||
16805221|NCT02065557|37746792|FG000|Induction Period|Lack of Efficacy|2|||
16805222|NCT02065557|37746793|FG001|Induction Period|Lack of Efficacy|1|||
16805223|NCT02065557|37746794|FG002|Induction Period|Lack of Efficacy|1|||
16805224|NCT02065557|37746795|FG003|Induction Period|Lack of Efficacy|0|||
16805225|NCT02065557|37746796|FG004|Induction Period|Lack of Efficacy|0|||
16805226|NCT02065557|37746797|FG005|Induction Period|Lack of Efficacy|0|||
16805227|NCT02065557|37746792|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
16805228|NCT02065557|37746793|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
16805229|NCT02065557|37746794|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
16805230|NCT02065557|37746795|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
16805231|NCT02065557|37746796|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
16805232|NCT02065557|37746797|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
16805233|NCT02065557|37746792|FG000|Induction Period|Non-Responder at Week 8|4|||
16805234|NCT02065557|37746793|FG001|Induction Period|Non-Responder at Week 8|4|||
16805235|NCT02065557|37746794|FG002|Induction Period|Non-Responder at Week 8|0|||
16805236|NCT02065557|37746795|FG003|Induction Period|Non-Responder at Week 8|0|||
16805237|NCT02065557|37746796|FG004|Induction Period|Non-Responder at Week 8|0|||
16805238|NCT02065557|37746797|FG005|Induction Period|Non-Responder at Week 8|0|||
16805239|NCT02065557|37746792|FG000|Induction Period|Adverse Event|1|||
16805240|NCT02065557|37746793|FG001|Induction Period|Adverse Event|1|||
16805241|NCT02065557|37746794|FG002|Induction Period|Adverse Event|0|||
16805242|NCT02065557|37746795|FG003|Induction Period|Adverse Event|0|||
16805243|NCT02065557|37746796|FG004|Induction Period|Adverse Event|0|||
16805244|NCT02065557|37746797|FG005|Induction Period|Adverse Event|0|||
16805245|NCT02065557|37746792|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
16805246|NCT02065557|37746793|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
16805247|NCT02065557|37746794|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
16805248|NCT02065557|37746795|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
16805249|NCT02065557|37746796|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
16805250|NCT02065557|37746797|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
16805251|NCT02065557|37746792|FG000|Maintenance Period|Withdrawal by Subject|0|||
16805252|NCT02065557|37746793|FG001|Maintenance Period|Withdrawal by Subject|0|||
16805253|NCT02065557|37746794|FG002|Maintenance Period|Withdrawal by Subject|0|||
16805254|NCT02065557|37746795|FG003|Maintenance Period|Withdrawal by Subject|0|||
16805255|NCT02065557|37746796|FG004|Maintenance Period|Withdrawal by Subject|2|||
16805256|NCT02065557|37746797|FG005|Maintenance Period|Withdrawal by Subject|1|||
16805257|NCT02065557|37746792|FG000|Maintenance Period|Lack of Efficacy|0|||
16805258|NCT02065557|37746793|FG001|Maintenance Period|Lack of Efficacy|0|||
16805259|NCT02065557|37746794|FG002|Maintenance Period|Lack of Efficacy|0|||
16805260|NCT02065557|37746795|FG003|Maintenance Period|Lack of Efficacy|0|||
16805261|NCT02065557|37746796|FG004|Maintenance Period|Lack of Efficacy|5|||
16805262|NCT02065557|37746797|FG005|Maintenance Period|Lack of Efficacy|2|||
16805263|NCT02065557|37746792|FG000|Maintenance Period|Subject Non-Compliance|0|||
16805264|NCT02065557|37746793|FG001|Maintenance Period|Subject Non-Compliance|0|||
16805265|NCT02065557|37746794|FG002|Maintenance Period|Subject Non-Compliance|0|||
16805266|NCT02065557|37746795|FG003|Maintenance Period|Subject Non-Compliance|0|||
16805267|NCT02065557|37746796|FG004|Maintenance Period|Subject Non-Compliance|0|||
16805268|NCT02065557|37746797|FG005|Maintenance Period|Subject Non-Compliance|1|||
16805269|NCT02065245|37746829|FG000|Infusion 1|Lost to Follow-up|0|||
16805270|NCT02065245|37746830|FG001|Infusion 1|Lost to Follow-up|0|||
16805271|NCT02065245|37746831|FG002|Infusion 1|Lost to Follow-up|0|||
16805272|NCT02065245|37746832|FG003|Infusion 1|Lost to Follow-up|0|||
16805273|NCT02065245|37746833|FG004|Infusion 1|Lost to Follow-up|0|||
16805274|NCT02065245|37746834|FG005|Infusion 1|Lost to Follow-up|0|||
16805275|NCT02065245|37746835|FG006|Infusion 1|Lost to Follow-up|1|||
16805276|NCT02065245|37746829|FG000|Infusion 1|Death|0|||
16805277|NCT02065245|37746830|FG001|Infusion 1|Death|0|||
16805278|NCT02065245|37746831|FG002|Infusion 1|Death|1|||
16805279|NCT02065245|37746832|FG003|Infusion 1|Death|0|||
16805280|NCT02065245|37746833|FG004|Infusion 1|Death|1|||
16805281|NCT02065245|37746834|FG005|Infusion 1|Death|0|||
16805282|NCT02065245|37746835|FG006|Infusion 1|Death|0|||
16805283|NCT02065245|37746829|FG000|Infusion 2|Death|0|||
16805284|NCT02065245|37746830|FG001|Infusion 2|Death|0|||
16805285|NCT02065245|37746831|FG002|Infusion 2|Death|0|||
16805286|NCT02065245|37746832|FG003|Infusion 2|Death|0|||
16805287|NCT02065245|37746833|FG004|Infusion 2|Death|0|||
16805288|NCT02065245|37746834|FG005|Infusion 2|Death|0|||
16805289|NCT02065245|37746835|FG006|Infusion 2|Death|1|||
16805290|NCT02065245|37746829|FG000|Infusion 3|Lost to Follow-up|1|||
16805291|NCT02065245|37746830|FG001|Infusion 3|Lost to Follow-up|1|||
16805292|NCT02065245|37746831|FG002|Infusion 3|Lost to Follow-up|0|||
16805293|NCT02065245|37746832|FG003|Infusion 3|Lost to Follow-up|0|||
16805294|NCT02065245|37746833|FG004|Infusion 3|Lost to Follow-up|0|||
16805295|NCT02065245|37746834|FG005|Infusion 3|Lost to Follow-up|0|||
16805296|NCT02065245|37746835|FG006|Infusion 3|Lost to Follow-up|0|||
16805297|NCT02043015|37746851|FG000|Overall Study|Lost to Follow-up|4|||
16805298|NCT02043015|37746851|FG000|Overall Study|Withdrawal by Subject|4|||
16805299|NCT02043015|37746851|FG000|Overall Study|Removed once target enrollment reached|15|||
16805300|NCT02043015|37746851|FG000|Overall Study|Participant moved away from study city|4|||
16805301|NCT02043015|37746851|FG000|Overall Study|Incarceration|1|||
16805302|NCT02064231|37746857|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
16805303|NCT02064231|37746858|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
16805304|NCT02064231|37746859|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
16805305|NCT02064231|37746860|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
16805306|NCT02064231|37746857|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
16805307|NCT02064231|37746858|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
16805308|NCT02064231|37746859|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
16805309|NCT02064231|37746860|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
16805310|NCT02064231|37746857|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
16805311|NCT02064231|37746858|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
16805312|NCT02064231|37746859|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
16805313|NCT02064231|37746860|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
16805314|NCT02064231|37746857|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
16805315|NCT02064231|37746858|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
16805316|NCT02064231|37746859|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
16805317|NCT02064231|37746860|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
16805318|NCT02063217|37746875|FG000|Overall Study|Withdrawal by Subject|1|||
16805319|NCT02063217|37746876|FG001|Overall Study|Withdrawal by Subject|0|||
16805320|NCT02063217|37746877|FG002|Overall Study|Withdrawal by Subject|0|||
16805321|NCT02497001|37746889|FG000|Overall Study|Lost to Follow-up|10|||
16805322|NCT02497001|37746890|FG001|Overall Study|Lost to Follow-up|2|||
16805323|NCT02497001|37746891|FG002|Overall Study|Lost to Follow-up|0|||
16805324|NCT02497001|37746892|FG003|Overall Study|Lost to Follow-up|2|||
16805325|NCT02497001|37746889|FG000|Overall Study|Adverse Event|28|||
16805326|NCT02497001|37746890|FG001|Overall Study|Adverse Event|30|||
16805327|NCT02497001|37746891|FG002|Overall Study|Adverse Event|11|||
16805328|NCT02497001|37746892|FG003|Overall Study|Adverse Event|11|||
16805329|NCT02497001|37746889|FG000|Overall Study|Withdrawal by Subject|14|||
16805330|NCT02497001|37746890|FG001|Overall Study|Withdrawal by Subject|37|||
16805331|NCT02497001|37746891|FG002|Overall Study|Withdrawal by Subject|19|||
16805332|NCT02497001|37746892|FG003|Overall Study|Withdrawal by Subject|15|||
16805333|NCT02497001|37746889|FG000|Overall Study|Physician Decision|5|||
16805334|NCT02497001|37746890|FG001|Overall Study|Physician Decision|11|||
16805335|NCT02497001|37746891|FG002|Overall Study|Physician Decision|5|||
16805336|NCT02497001|37746892|FG003|Overall Study|Physician Decision|1|||
16805337|NCT02497001|37746889|FG000|Overall Study|subjects that were not treated|1|||
16805338|NCT02497001|37746890|FG001|Overall Study|subjects that were not treated|2|||
16805339|NCT02497001|37746891|FG002|Overall Study|subjects that were not treated|2|||
16805340|NCT02497001|37746892|FG003|Overall Study|subjects that were not treated|1|||
16805341|NCT02497001|37746889|FG000|Overall Study|Major Protocol Deviation|3|||
16805342|NCT02497001|37746890|FG001|Overall Study|Major Protocol Deviation|4|||
16805343|NCT02497001|37746891|FG002|Overall Study|Major Protocol Deviation|4|||
16805344|NCT02497001|37746892|FG003|Overall Study|Major Protocol Deviation|4|||
16805345|NCT02497001|37746889|FG000|Overall Study|Lack of Efficacy|10|||
16805346|NCT02497001|37746890|FG001|Overall Study|Lack of Efficacy|16|||
16805347|NCT02497001|37746891|FG002|Overall Study|Lack of Efficacy|6|||
16805348|NCT02497001|37746892|FG003|Overall Study|Lack of Efficacy|6|||
16805349|NCT02497001|37746889|FG000|Overall Study|Protocol Violation|3|||
16805350|NCT02497001|37746890|FG001|Overall Study|Protocol Violation|1|||
16805351|NCT02497001|37746891|FG002|Overall Study|Protocol Violation|3|||
16805352|NCT02497001|37746892|FG003|Overall Study|Protocol Violation|1|||
16805353|NCT02366143|37746908|FG000|Overall Study|Death|307|||
16805354|NCT02366143|37746909|FG001|Overall Study|Death|278|||
16805355|NCT02366143|37746910|FG002|Overall Study|Death|280|||
16805356|NCT02366143|37746908|FG000|Overall Study|Lost to Follow-up|2|||
16805357|NCT02366143|37746909|FG001|Overall Study|Lost to Follow-up|4|||
16805358|NCT02366143|37746910|FG002|Overall Study|Lost to Follow-up|2|||
16805359|NCT02366143|37746908|FG000|Overall Study|Physician Decision|1|||
16805360|NCT02366143|37746909|FG001|Overall Study|Physician Decision|2|||
16805361|NCT02366143|37746910|FG002|Overall Study|Physician Decision|1|||
16805362|NCT02366143|37746908|FG000|Overall Study|Protocol Violation|0|||
16805363|NCT02366143|37746909|FG001|Overall Study|Protocol Violation|0|||
16805364|NCT02366143|37746910|FG002|Overall Study|Protocol Violation|2|||
16805365|NCT02366143|37746908|FG000|Overall Study|Withdrawal by Subject|16|||
16805366|NCT02366143|37746909|FG001|Overall Study|Withdrawal by Subject|17|||
16805367|NCT02366143|37746910|FG002|Overall Study|Withdrawal by Subject|22|||
16805368|NCT02366143|37746908|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
16805369|NCT02366143|37746909|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
16805370|NCT02366143|37746910|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
16805371|NCT02366143|37746908|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
16805372|NCT02366143|37746909|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
16805373|NCT02366143|37746910|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
16805374|NCT02366143|37746908|FG000|Overall Study|Randomization Error|1|||
16805375|NCT02366143|37746909|FG001|Overall Study|Randomization Error|0|||
16805376|NCT02366143|37746910|FG002|Overall Study|Randomization Error|0|||
16805377|NCT02366143|37746908|FG000|Overall Study|PI Move and Site Closure|1|||
16805378|NCT02366143|37746909|FG001|Overall Study|PI Move and Site Closure|0|||
16805379|NCT02366143|37746910|FG002|Overall Study|PI Move and Site Closure|1|||
16805380|NCT02366143|37746908|FG000|Overall Study|Study Terminated By Sponsor|0|||
16805381|NCT02366143|37746909|FG001|Overall Study|Study Terminated By Sponsor|0|||
16805382|NCT02366143|37746910|FG002|Overall Study|Study Terminated By Sponsor|2|||
16805383|NCT02366143|37746908|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
16805384|NCT02366143|37746909|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
16805385|NCT02366143|37746910|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
16805386|NCT02366143|37746908|FG000|Overall Study|Patient moved to roll-over study|1|||
16805387|NCT02366143|37746909|FG001|Overall Study|Patient moved to roll-over study|19|||
16805388|NCT02366143|37746910|FG002|Overall Study|Patient moved to roll-over study|28|||
16805389|NCT02366143|37746908|FG000|Overall Study|Patient moved to commercial stock|0|||
16805390|NCT02366143|37746909|FG001|Overall Study|Patient moved to commercial stock|0|||
16805391|NCT02366143|37746910|FG002|Overall Study|Patient moved to commercial stock|1|||
16805392|NCT02366143|37746908|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
16805393|NCT02366143|37746909|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
16805394|NCT02366143|37746910|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
16805395|NCT02366143|37746908|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
16805396|NCT02366143|37746909|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
16805397|NCT02366143|37746910|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
16805398|NCT02366143|37746908|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
16805399|NCT02366143|37746909|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
16805400|NCT02366143|37746910|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
16805401|NCT02366143|37746908|FG000|Overall Study|Requester's instructions|1|||
16805402|NCT02366143|37746909|FG001|Overall Study|Requester's instructions|1|||
16805403|NCT02366143|37746910|FG002|Overall Study|Requester's instructions|1|||
16805404|NCT02366143|37746908|FG000|Overall Study|Uneligible|0|||
16805405|NCT02366143|37746909|FG001|Overall Study|Uneligible|1|||
16805406|NCT02366143|37746910|FG002|Overall Study|Uneligible|0|||
16805407|NCT02366143|37746908|FG000|Overall Study|Post Trial Migration|0|||
16805408|NCT02366143|37746909|FG001|Overall Study|Post Trial Migration|1|||
16805409|NCT02366143|37746910|FG002|Overall Study|Post Trial Migration|0|||
16805410|NCT02366143|37746908|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
16805411|NCT02366143|37746909|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
16805412|NCT02366143|37746910|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
16805413|NCT02366143|37746908|FG000|Overall Study|Patient switched to PTAP|0|||
16805414|NCT02366143|37746909|FG001|Overall Study|Patient switched to PTAP|1|||
16805415|NCT02366143|37746910|FG002|Overall Study|Patient switched to PTAP|0|||
16805416|NCT02366143|37746908|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
16805417|NCT02366143|37746909|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
16805418|NCT02366143|37746910|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
16805419|NCT02098395|37746926|FG000|Overall Study|Protocol Violation|2|||
16805420|NCT02098395|37746927|FG001|Overall Study|Protocol Violation|2|||
16805421|NCT02098395|37746928|FG002|Overall Study|Protocol Violation|0|||
16805422|NCT02098395|37746929|FG003|Overall Study|Protocol Violation|7|||
16805423|NCT02098395|37746926|FG000|Overall Study|Withdrawal by Subject|10|||
16805424|NCT02098395|37746927|FG001|Overall Study|Withdrawal by Subject|10|||
16805425|NCT02098395|37746928|FG002|Overall Study|Withdrawal by Subject|5|||
16805426|NCT02098395|37746929|FG003|Overall Study|Withdrawal by Subject|13|||
16805427|NCT02098395|37746926|FG000|Overall Study|Adverse Event|12|||
16805428|NCT02098395|37746927|FG001|Overall Study|Adverse Event|19|||
16805429|NCT02098395|37746928|FG002|Overall Study|Adverse Event|34|||
16805430|NCT02098395|37746929|FG003|Overall Study|Adverse Event|2|||
16805431|NCT02098395|37746926|FG000|Overall Study|Lost to Follow-up|2|||
16805432|NCT02098395|37746927|FG001|Overall Study|Lost to Follow-up|1|||
16805433|NCT02098395|37746928|FG002|Overall Study|Lost to Follow-up|0|||
16805434|NCT02098395|37746929|FG003|Overall Study|Lost to Follow-up|3|||
16805435|NCT02098395|37746926|FG000|Overall Study|Unclassified|0|||
16805436|NCT02098395|37746927|FG001|Overall Study|Unclassified|0|||
16805437|NCT02098395|37746928|FG002|Overall Study|Unclassified|3|||
16805438|NCT02098395|37746929|FG003|Overall Study|Unclassified|2|||
16805439|NCT02041923|37746941|FG000|Overall Study|Lost to Follow-up|26|||
16805440|NCT02041923|37746942|FG001|Overall Study|Lost to Follow-up|30|||
16805441|NCT02062437|37746950|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
16805442|NCT02062437|37746950|FG000|Overall Study|Patient not available for the 2y visit|18|||
16805443|NCT02062437|37746950|FG000|Overall Study|Death|2|||
16805444|NCT02062437|37746950|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
16805445|NCT02365519|37746956|FG000|Randomized and Treated|Adverse Event|0|||
16805446|NCT02365519|37746957|FG001|Randomized and Treated|Adverse Event|1|||
16805447|NCT02365519|37746958|FG002|Randomized and Treated|Adverse Event|0|||
16805448|NCT02365519|37746956|FG000|Randomized and Treated|Withdrawal by Subject|0|||
16805449|NCT02365519|37746957|FG001|Randomized and Treated|Withdrawal by Subject|1|||
16805450|NCT02365519|37746958|FG002|Randomized and Treated|Withdrawal by Subject|1|||
16805451|NCT02061813|37746967|FG000|Overall Study|Withdrawal by Subject|1|||
16805452|NCT02061813|37746967|FG000|Overall Study|Protocol Violation|2|||
16805453|NCT02096835|37746977|FG000|Overall Study|Withdrawal by Subject|1|||
16805454|NCT02096835|37746978|FG001|Overall Study|Withdrawal by Subject|0|||
16805455|NCT02096835|37746979|FG002|Overall Study|Withdrawal by Subject|0|||
16805456|NCT02096835|37746977|FG000|Overall Study|converted to open procedures|1|||
16805457|NCT02096835|37746978|FG001|Overall Study|converted to open procedures|0|||
16805458|NCT02096835|37746979|FG002|Overall Study|converted to open procedures|0|||
16805459|NCT02096835|37746977|FG000|Overall Study|Lost to Follow-up|1|||
16805460|NCT02096835|37746978|FG001|Overall Study|Lost to Follow-up|0|||
16805461|NCT02096835|37746979|FG002|Overall Study|Lost to Follow-up|1|||
16805462|NCT02324569|37746989|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16805463|NCT02324569|37746990|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
16805464|NCT02324569|37746989|FG000|Overall Study|Voluntary Withdrawal|3|||
16805465|NCT02324569|37746990|FG001|Overall Study|Voluntary Withdrawal|6|||
16805466|NCT02324569|37746989|FG000|Overall Study|Lack of Efficacy|2|||
16805467|NCT02324569|37746990|FG001|Overall Study|Lack of Efficacy|3|||
16805468|NCT02324569|37746989|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
16805469|NCT02324569|37746990|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
16805470|NCT02324569|37746989|FG000|Overall Study|Inconvenient Schedule|2|||
16805471|NCT02324569|37746990|FG001|Overall Study|Inconvenient Schedule|0|||
16805472|NCT02294773|37746998|FG000|Overall Study|Withdrawal by Subject|0|||
16805473|NCT02294773|37746999|FG001|Overall Study|Withdrawal by Subject|2|||
16805474|NCT02365285|37747009|FG000|Overall Study|Physician Decision|0|||
16805475|NCT02365285|37747010|FG001|Overall Study|Physician Decision|1|||
16805476|NCT02365285|37747011|FG002|Overall Study|Physician Decision|1|||
16805477|NCT02365285|37747012|FG003|Overall Study|Physician Decision|0|||
16805478|NCT02365285|37747009|FG000|Overall Study|Adverse Event|0|||
16805479|NCT02365285|37747010|FG001|Overall Study|Adverse Event|0|||
16805480|NCT02365285|37747011|FG002|Overall Study|Adverse Event|0|||
16805481|NCT02365285|37747012|FG003|Overall Study|Adverse Event|2|||
16805482|NCT02041299|37747026|FG000|Overall Study|Adverse Event|9|||
16805483|NCT02041299|37747027|FG001|Overall Study|Adverse Event|3|||
16805484|NCT02041299|37747026|FG000|Overall Study|Lost to Follow-up|4|||
16805485|NCT02041299|37747027|FG001|Overall Study|Lost to Follow-up|1|||
16805486|NCT02041299|37747026|FG000|Overall Study|Physician Decision|1|||
16805487|NCT02041299|37747027|FG001|Overall Study|Physician Decision|1|||
16805488|NCT02041299|37747026|FG000|Overall Study|Withdrawal by Subject|13|||
16805489|NCT02041299|37747027|FG001|Overall Study|Withdrawal by Subject|7|||
16805490|NCT02041299|37747026|FG000|Overall Study|Protocol Violation|11|||
16909696|NCT01697592|38018538|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16805491|NCT02041299|37747027|FG001|Overall Study|Protocol Violation|4|||
16805492|NCT02041299|37747026|FG000|Overall Study|Termination of the study|7|||
16805493|NCT02041299|37747027|FG001|Overall Study|Termination of the study|3|||
16805494|NCT02041299|37747026|FG000|Overall Study|Required bone marrow transplant|0|||
16805495|NCT02041299|37747027|FG001|Overall Study|Required bone marrow transplant|1|||
16805496|NCT02041299|37747026|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
16805497|NCT02041299|37747027|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
16805498|NCT01645735|37747039|FG000|Overall Study|Physician Decision|2|||
16805499|NCT01645735|37747040|FG001|Overall Study|Physician Decision|0|||
16805500|NCT01645735|37747039|FG000|Overall Study|Withdrawal by Subject|1|||
16805501|NCT01645735|37747040|FG001|Overall Study|Withdrawal by Subject|0|||
16805502|NCT01645735|37747039|FG000|Overall Study|Protocol Violation|1|||
16805503|NCT01645735|37747040|FG001|Overall Study|Protocol Violation|0|||
16805504|NCT01645735|37747039|FG000|Overall Study|Adverse Event|0|||
16805505|NCT01645735|37747040|FG001|Overall Study|Adverse Event|1|||
16805506|NCT02365207|37747047|FG000|Overall Study|Withdrawal by Subject|1|||
16805507|NCT02365207|37747047|FG000|Overall Study|Physician Decision|1|||
16805508|NCT01645111|37747051|FG000|Overall Study|Did not require Clevidipine|15|||
16805509|NCT02364037|37747057|FG000|Overall Study|Withdrawal by Subject|7|||
16805510|NCT02364037|37747058|FG001|Overall Study|Withdrawal by Subject|4|||
16805511|NCT02364037|37747057|FG000|Overall Study|Lost to Follow-up|37|||
16805512|NCT02364037|37747058|FG001|Overall Study|Lost to Follow-up|49|||
16805513|NCT01919164|37747069|FG000|Overall Study|Adverse Event|6|||
16805514|NCT01919164|37747070|FG001|Overall Study|Adverse Event|4|||
16805515|NCT01919164|37747071|FG002|Overall Study|Adverse Event|9|||
16805516|NCT01919164|37747072|FG003|Overall Study|Adverse Event|3|||
16805517|NCT01919164|37747073|FG004|Overall Study|Adverse Event|2|||
16805518|NCT01919164|37747069|FG000|Overall Study|Lost to Follow-up|2|||
16805519|NCT01919164|37747070|FG001|Overall Study|Lost to Follow-up|2|||
16805520|NCT01919164|37747071|FG002|Overall Study|Lost to Follow-up|2|||
16805521|NCT01919164|37747072|FG003|Overall Study|Lost to Follow-up|0|||
16805522|NCT01919164|37747073|FG004|Overall Study|Lost to Follow-up|4|||
16805523|NCT01919164|37747069|FG000|Overall Study|Death|1|||
16805524|NCT01919164|37747070|FG001|Overall Study|Death|0|||
16805525|NCT01919164|37747071|FG002|Overall Study|Death|0|||
16805526|NCT01919164|37747072|FG003|Overall Study|Death|0|||
16805527|NCT01919164|37747073|FG004|Overall Study|Death|0|||
16805528|NCT01919164|37747069|FG000|Overall Study|Protocol Violation|6|||
16805529|NCT01919164|37747070|FG001|Overall Study|Protocol Violation|0|||
16805530|NCT01919164|37747071|FG002|Overall Study|Protocol Violation|3|||
16805531|NCT01919164|37747072|FG003|Overall Study|Protocol Violation|2|||
16805532|NCT01919164|37747073|FG004|Overall Study|Protocol Violation|2|||
16805533|NCT01919164|37747069|FG000|Overall Study|Disease progression|2|||
16805534|NCT01919164|37747070|FG001|Overall Study|Disease progression|2|||
16805535|NCT01919164|37747071|FG002|Overall Study|Disease progression|1|||
16805536|NCT01919164|37747072|FG003|Overall Study|Disease progression|2|||
16805537|NCT01919164|37747073|FG004|Overall Study|Disease progression|1|||
16805538|NCT01919164|37747069|FG000|Overall Study|Withdrew consent|13|||
16805539|NCT01919164|37747070|FG001|Overall Study|Withdrew consent|13|||
16805540|NCT01919164|37747071|FG002|Overall Study|Withdrew consent|14|||
16805541|NCT01919164|37747072|FG003|Overall Study|Withdrew consent|14|||
16805542|NCT01919164|37747073|FG004|Overall Study|Withdrew consent|9|||
16805543|NCT01919164|37747069|FG000|Overall Study|Other Un-specified|13|||
16805544|NCT01919164|37747070|FG001|Overall Study|Other Un-specified|9|||
16805545|NCT01919164|37747071|FG002|Overall Study|Other Un-specified|8|||
16805546|NCT01919164|37747072|FG003|Overall Study|Other Un-specified|7|||
16805547|NCT01919164|37747073|FG004|Overall Study|Other Un-specified|15|||
16805548|NCT01901224|37747085|FG000|Overall Study|study was not funded and terminated|2|||
16805549|NCT01901146|37747091|FG000|Neoadjuvant Phase|Death|1|||
16805550|NCT01901146|37747092|FG001|Neoadjuvant Phase|Death|2|||
16805551|NCT01901146|37747093|FG002|Neoadjuvant Phase|Death|0|||
16805552|NCT01901146|37747094|FG003|Neoadjuvant Phase|Death|0|||
16805553|NCT01901146|37747095|FG004|Neoadjuvant Phase|Death|0|||
16805554|NCT01901146|37747091|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
16805555|NCT01901146|37747092|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
16805556|NCT01901146|37747093|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
16805557|NCT01901146|37747094|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
16805558|NCT01901146|37747095|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
16805559|NCT01901146|37747091|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
16805560|NCT01901146|37747092|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
16805561|NCT01901146|37747093|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
16805562|NCT01901146|37747094|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
16805563|NCT01901146|37747095|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
16805564|NCT01901146|37747091|FG000|Neoadjuvant Phase|Physician Decision|1|||
16805565|NCT01901146|37747092|FG001|Neoadjuvant Phase|Physician Decision|2|||
16805566|NCT01901146|37747093|FG002|Neoadjuvant Phase|Physician Decision|0|||
16805567|NCT01901146|37747094|FG003|Neoadjuvant Phase|Physician Decision|0|||
16805568|NCT01901146|37747095|FG004|Neoadjuvant Phase|Physician Decision|0|||
16805569|NCT01901146|37747091|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
16805570|NCT01901146|37747092|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
16805571|NCT01901146|37747093|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
16805572|NCT01901146|37747094|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
16805573|NCT01901146|37747095|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
16805574|NCT01901146|37747091|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
16805575|NCT01901146|37747092|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
16805576|NCT01901146|37747093|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
16805577|NCT01901146|37747094|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
16805578|NCT01901146|37747095|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
16805579|NCT01901146|37747091|FG000|Adjuvant Phase|Other|0|||
16805580|NCT01901146|37747092|FG001|Adjuvant Phase|Other|0|||
16805581|NCT01901146|37747093|FG002|Adjuvant Phase|Other|1|||
16805582|NCT01901146|37747094|FG003|Adjuvant Phase|Other|0|||
16805583|NCT01901146|37747095|FG004|Adjuvant Phase|Other|0|||
16805584|NCT01901146|37747091|FG000|Adjuvant Phase|Death|0|||
16805585|NCT01901146|37747092|FG001|Adjuvant Phase|Death|0|||
16805586|NCT01901146|37747093|FG002|Adjuvant Phase|Death|0|||
16805587|NCT01901146|37747094|FG003|Adjuvant Phase|Death|0|||
16805588|NCT01901146|37747095|FG004|Adjuvant Phase|Death|3|||
16805589|NCT01901146|37747091|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
16805590|NCT01901146|37747092|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
16805591|NCT01901146|37747093|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
16805592|NCT01901146|37747094|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
16805593|NCT01901146|37747095|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
16805594|NCT01901146|37747091|FG000|Adjuvant Phase|Physician Decision|0|||
16805595|NCT01901146|37747092|FG001|Adjuvant Phase|Physician Decision|0|||
16805596|NCT01901146|37747093|FG002|Adjuvant Phase|Physician Decision|9|||
16805597|NCT01901146|37747094|FG003|Adjuvant Phase|Physician Decision|2|||
16805598|NCT01901146|37747095|FG004|Adjuvant Phase|Physician Decision|4|||
16805599|NCT01901146|37747091|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
16805600|NCT01901146|37747092|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
16805601|NCT01901146|37747093|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
16805602|NCT01901146|37747094|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
16805603|NCT01901146|37747095|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
16805604|NCT01644643|37747108|FG000|Overall Study|Death|1|||
16805605|NCT01644643|37747109|FG001|Overall Study|Death|0|||
16805606|NCT01644643|37747110|FG002|Overall Study|Death|3|||
16805607|NCT01644643|37747111|FG003|Overall Study|Death|3|||
16805608|NCT01644643|37747108|FG000|Overall Study|Lost to Follow-up|0|||
16805609|NCT01644643|37747109|FG001|Overall Study|Lost to Follow-up|0|||
16805610|NCT01644643|37747110|FG002|Overall Study|Lost to Follow-up|0|||
16805611|NCT01644643|37747111|FG003|Overall Study|Lost to Follow-up|4|||
16805612|NCT01644643|37747108|FG000|Overall Study|Withdrawal by Subject|1|||
16805613|NCT01644643|37747109|FG001|Overall Study|Withdrawal by Subject|0|||
16805614|NCT01644643|37747110|FG002|Overall Study|Withdrawal by Subject|2|||
16805615|NCT01644643|37747111|FG003|Overall Study|Withdrawal by Subject|1|||
16805616|NCT01644643|37747108|FG000|Overall Study|Other Eligibility criteria|0|||
16805617|NCT01644643|37747109|FG001|Overall Study|Other Eligibility criteria|0|||
16805618|NCT01644643|37747110|FG002|Overall Study|Other Eligibility criteria|0|||
16805619|NCT01644643|37747111|FG003|Overall Study|Other Eligibility criteria|2|||
16805620|NCT01864564|37747129|FG000|Overall Study|Lost to Follow-up|17|||
16805621|NCT01864564|37747130|FG001|Overall Study|Lost to Follow-up|23|||
16805622|NCT01864564|37747129|FG000|Overall Study|Withdrawal by Subject|20|||
16805623|NCT01864564|37747130|FG001|Overall Study|Withdrawal by Subject|11|||
16805624|NCT01864564|37747129|FG000|Overall Study|Protocol Violation|0|||
16805625|NCT01864564|37747130|FG001|Overall Study|Protocol Violation|27|||
16805626|NCT01864564|37747129|FG000|Overall Study|not reported|0|||
16805627|NCT01864564|37747130|FG001|Overall Study|not reported|34|||
16805628|NCT01864174|37747138|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
16805629|NCT01864174|37747139|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
16805630|NCT01864174|37747138|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
16805631|NCT01864174|37747139|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
16805632|NCT01864174|37747138|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
16805633|NCT01864174|37747139|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
16805634|NCT01864174|37747138|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
16805635|NCT01864174|37747139|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
16805636|NCT01864174|37747138|FG000|Double Blind - Compliant Randomized|Death|1|||
16805637|NCT01864174|37747139|FG001|Double Blind - Compliant Randomized|Death|0|||
16805638|NCT01864174|37747138|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
16805639|NCT01864174|37747139|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
16805640|NCT01864174|37747138|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
16805641|NCT01864174|37747139|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
16805642|NCT01864174|37747138|FG000|Double Blind - Compliant Randomized|Other|6|||
16805643|NCT01864174|37747139|FG001|Double Blind - Compliant Randomized|Other|10|||
16805644|NCT01864174|37747138|FG000|Off Treatment Follow-Up|Other|2|||
16805645|NCT01864174|37747139|FG001|Off Treatment Follow-Up|Other|0|||
16805646|NCT01864174|37747138|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
16805647|NCT01864174|37747139|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
16805648|NCT01864018|37747147|FG000|Overall Study|Ineligible|3|||
16805649|NCT01864018|37747148|FG001|Overall Study|Ineligible|1|||
16805650|NCT01900444|37747159|FG000|Overall Study|Protocol Violation|2|||
16805651|NCT01900444|37747159|FG000|Overall Study|Lost to Follow-up|1|||
16805652|NCT02294227|37747166|FG000|Overall Study|Death|0|||
16805653|NCT02294227|37747167|FG001|Overall Study|Death|0|||
16805654|NCT02294227|37747168|FG002|Overall Study|Death|1|||
16805655|NCT02294227|37747166|FG000|Overall Study|Subject/Guardian Decision|6|||
16805656|NCT02294227|37747167|FG001|Overall Study|Subject/Guardian Decision|3|||
16805657|NCT02294227|37747168|FG002|Overall Study|Subject/Guardian Decision|7|||
16805658|NCT02294227|37747166|FG000|Overall Study|Physician Decision|1|||
16805659|NCT02294227|37747167|FG001|Overall Study|Physician Decision|2|||
16805660|NCT02294227|37747168|FG002|Overall Study|Physician Decision|1|||
16805661|NCT02294227|37747166|FG000|Overall Study|Lost to Follow-up|1|||
16805662|NCT02294227|37747167|FG001|Overall Study|Lost to Follow-up|0|||
16805663|NCT02294227|37747168|FG002|Overall Study|Lost to Follow-up|0|||
16805664|NCT02294227|37747166|FG000|Overall Study|Lack of Efficacy|11|||
16805665|NCT02294227|37747167|FG001|Overall Study|Lack of Efficacy|12|||
16805666|NCT02294227|37747168|FG002|Overall Study|Lack of Efficacy|8|||
16805667|NCT02294227|37747166|FG000|Overall Study|Adverse Event|6|||
16805668|NCT02294227|37747167|FG001|Overall Study|Adverse Event|8|||
16805669|NCT02294227|37747168|FG002|Overall Study|Adverse Event|2|||
16805670|NCT02496767|37747182|FG000|Open-label Lead-in Phase|Adverse Event|176|||
16805671|NCT02496767|37747183|FG001|Open-label Lead-in Phase|Adverse Event|0|||
16805672|NCT02496767|37747184|FG002|Open-label Lead-in Phase|Adverse Event|0|||
16805673|NCT02496767|37747185|FG003|Open-label Lead-in Phase|Adverse Event|0|||
16805674|NCT02496767|37747186|FG004|Open-label Lead-in Phase|Adverse Event|0|||
16805675|NCT02496767|37747187|FG005|Open-label Lead-in Phase|Adverse Event|0|||
16805676|NCT02496767|37747188|FG006|Open-label Lead-in Phase|Adverse Event|0|||
16805677|NCT02496767|37747189|FG007|Open-label Lead-in Phase|Adverse Event|0|||
16805678|NCT02496767|37747182|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
16805679|NCT02496767|37747183|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
16805680|NCT02496767|37747184|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
16805681|NCT02496767|37747185|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
16805682|NCT02496767|37747186|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
16805683|NCT02496767|37747187|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
16805684|NCT02496767|37747188|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
16805685|NCT02496767|37747189|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
16805686|NCT02496767|37747182|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
16805687|NCT02496767|37747183|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
16805688|NCT02496767|37747184|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
16805689|NCT02496767|37747185|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
16805690|NCT02496767|37747186|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
16805691|NCT02496767|37747187|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
16805692|NCT02496767|37747188|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
16805693|NCT02496767|37747189|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
16805694|NCT02496767|37747182|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16805695|NCT02496767|37747183|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
16805696|NCT02496767|37747184|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
16805697|NCT02496767|37747185|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
16805698|NCT02496767|37747186|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
16805699|NCT02496767|37747187|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16805700|NCT02496767|37747188|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16805701|NCT02496767|37747189|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16805702|NCT02496767|37747182|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
16805703|NCT02496767|37747183|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
16805704|NCT02496767|37747184|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
16805705|NCT02496767|37747185|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
16805706|NCT02496767|37747186|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
16805707|NCT02496767|37747187|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
16805708|NCT02496767|37747188|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
16805709|NCT02496767|37747189|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
16805710|NCT02496767|37747182|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
16805711|NCT02496767|37747183|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
16805712|NCT02496767|37747184|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
16805713|NCT02496767|37747185|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
16805714|NCT02496767|37747186|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
16805715|NCT02496767|37747187|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
16805716|NCT02496767|37747188|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
16805717|NCT02496767|37747189|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
16805718|NCT02496767|37747182|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
16805719|NCT02496767|37747183|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
16805720|NCT02496767|37747184|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
16805721|NCT02496767|37747185|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
16805722|NCT02496767|37747186|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
16805723|NCT02496767|37747187|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
16805724|NCT02496767|37747188|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
16805725|NCT02496767|37747189|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
16805726|NCT02496767|37747182|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16805727|NCT02496767|37747183|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
16805728|NCT02496767|37747184|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
16805729|NCT02496767|37747185|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
16805730|NCT02496767|37747186|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
16805731|NCT02496767|37747187|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16805732|NCT02496767|37747188|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16805733|NCT02496767|37747189|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16805734|NCT02496767|37747182|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16805735|NCT02496767|37747183|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
16805736|NCT02496767|37747184|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
16805737|NCT02496767|37747185|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16805738|NCT02496767|37747186|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16805739|NCT02496767|37747187|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16805740|NCT02496767|37747188|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16805741|NCT02496767|37747189|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16805742|NCT02496767|37747182|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16805743|NCT02496767|37747183|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
16805744|NCT02496767|37747184|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16805745|NCT02496767|37747185|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
16805746|NCT02496767|37747186|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
16805747|NCT02496767|37747187|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16805748|NCT02496767|37747188|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16805749|NCT02496767|37747189|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16805750|NCT02496767|37747182|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16805751|NCT02496767|37747183|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
16805752|NCT02496767|37747184|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16805753|NCT02496767|37747185|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16805754|NCT02496767|37747186|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16805755|NCT02496767|37747187|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16805756|NCT02496767|37747188|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16805757|NCT02496767|37747189|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16805758|NCT02496767|37747182|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
16805759|NCT02496767|37747183|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
16805760|NCT02496767|37747184|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
16805761|NCT02496767|37747185|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
16805762|NCT02496767|37747186|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
16805763|NCT02496767|37747187|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
16805764|NCT02496767|37747188|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
16805765|NCT02496767|37747189|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
16805766|NCT02496767|37747182|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
16805767|NCT02496767|37747183|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
16805768|NCT02496767|37747184|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
16805769|NCT02496767|37747185|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
16805770|NCT02496767|37747186|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
16805771|NCT02496767|37747187|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
16805772|NCT02496767|37747188|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
16805773|NCT02496767|37747189|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
16805774|NCT02496767|37747182|FG000|Double-blind, Withdrawal Phase|Death|0|||
16805775|NCT02496767|37747183|FG001|Double-blind, Withdrawal Phase|Death|0|||
16805776|NCT02496767|37747184|FG002|Double-blind, Withdrawal Phase|Death|0|||
16805777|NCT02496767|37747185|FG003|Double-blind, Withdrawal Phase|Death|0|||
16805778|NCT02496767|37747186|FG004|Double-blind, Withdrawal Phase|Death|0|||
16805779|NCT02496767|37747187|FG005|Double-blind, Withdrawal Phase|Death|0|||
16805780|NCT02496767|37747188|FG006|Double-blind, Withdrawal Phase|Death|1|||
16805781|NCT02496767|37747189|FG007|Double-blind, Withdrawal Phase|Death|2|||
16805782|NCT02496767|37747182|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16805783|NCT02496767|37747183|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16805784|NCT02496767|37747184|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16805785|NCT02496767|37747185|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16805786|NCT02496767|37747186|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16805787|NCT02496767|37747187|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
16805788|NCT02496767|37747188|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
16805789|NCT02496767|37747189|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
16805790|NCT02496533|37747205|FG000|Overall Study|Lack of data on outcome|3|||
16805791|NCT02496533|37747206|FG001|Overall Study|Lack of data on outcome|0|||
16805792|NCT02496533|37747205|FG000|Overall Study|Patient did not complete all measures|0|||
16805793|NCT02496533|37747206|FG001|Overall Study|Patient did not complete all measures|4|||
16805794|NCT02496533|37747205|FG000|Overall Study|Late for radiologic testing|0|||
16805795|NCT02496533|37747206|FG001|Overall Study|Late for radiologic testing|2|||
16805796|NCT02496221|37747212|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
16805797|NCT02496221|37747213|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
16805798|NCT02496221|37747212|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
16805799|NCT02496221|37747213|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
16805800|NCT02496221|37747212|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
16805801|NCT02496221|37747213|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
16805802|NCT02475629|37747221|FG000|Overall Study|Adverse Event|1|||
16805803|NCT02475629|37747221|FG000|Overall Study|Death|4|||
16805804|NCT02475629|37747221|FG000|Overall Study|Physician Decision|1|||
16805805|NCT02475629|37747221|FG000|Overall Study|Withdrawal by Subject|1|||
16805806|NCT02475629|37747221|FG000|Overall Study|Lost to Follow-up|1|||
16805807|NCT02475629|37747221|FG000|Overall Study|Subject non-compliance|1|||
16805808|NCT02475395|37747227|FG000|Overall Study|Protocol Violation|30|||
16805809|NCT02475395|37747228|FG001|Overall Study|Protocol Violation|3|||
16805810|NCT01653743|37747236|FG000|Overall Study|Withdrawal by Subject|1|||
16805811|NCT01653743|37747237|FG001|Overall Study|Withdrawal by Subject|0|||
16805812|NCT01653743|37747236|FG000|Overall Study|Investigator discretion|3|||
16805813|NCT01653743|37747237|FG001|Overall Study|Investigator discretion|0|||
16805814|NCT02293993|37747247|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
16805815|NCT02293993|37747248|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
16805816|NCT02293993|37747249|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
16805817|NCT02293993|37747250|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
16805818|NCT02293993|37747247|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
16805819|NCT02293993|37747248|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
16805820|NCT02293993|37747249|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
16805821|NCT02293993|37747250|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
16805822|NCT02293993|37747247|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
16805823|NCT02293993|37747248|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
16805824|NCT02293993|37747249|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
16805825|NCT02293993|37747250|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
16805826|NCT02293993|37747247|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
16805827|NCT02293993|37747248|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
16805828|NCT02293993|37747249|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
16805829|NCT02293993|37747250|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
16805830|NCT02293993|37747247|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
16805831|NCT02293993|37747248|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
16805832|NCT02293993|37747249|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
16805833|NCT02293993|37747250|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
16805834|NCT02322775|37747270|FG000|Overall Study|Adverse Event|1|||
16805835|NCT02322775|37747271|FG001|Overall Study|Adverse Event|0|||
16805836|NCT02322775|37747270|FG000|Overall Study|Lost to Follow-up|0|||
16805837|NCT02322775|37747271|FG001|Overall Study|Lost to Follow-up|1|||
16805838|NCT02322775|37747270|FG000|Overall Study|Protocol Violation|1|||
16805839|NCT02322775|37747271|FG001|Overall Study|Protocol Violation|0|||
16805840|NCT02322775|37747270|FG000|Overall Study|Withdrawal by Subject|3|||
16805841|NCT02322775|37747271|FG001|Overall Study|Withdrawal by Subject|4|||
16805842|NCT02322775|37747270|FG000|Overall Study|Not willing to perform all FU visits|0|||
16805843|NCT02322775|37747271|FG001|Overall Study|Not willing to perform all FU visits|1|||
16805844|NCT02322229|37747277|FG000|Overall Study|Physician Decision|2|||
16805845|NCT02363959|37747284|FG000|Overall Study|Medical instability|1|||
16805846|NCT02363959|37747285|FG001|Overall Study|Medical instability|0|||
16805847|NCT02362789|37747293|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
16805848|NCT02362789|37747294|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
16805849|NCT02362789|37747295|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
16805850|NCT02362789|37747293|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
16805851|NCT02362789|37747294|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
16805852|NCT02362789|37747295|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
16805853|NCT02362789|37747293|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
16805854|NCT02362789|37747294|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
16805855|NCT02362789|37747295|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
16805856|NCT02362789|37747293|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
16805857|NCT02362789|37747294|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
16805858|NCT02362789|37747295|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
16805859|NCT02362789|37747293|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
16805860|NCT02362789|37747294|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
16805861|NCT02362789|37747295|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
16805862|NCT01646827|37747304|FG000|Overall Study|Lost to Follow-up|0|||
16805863|NCT01646827|37747305|FG001|Overall Study|Lost to Follow-up|3|||
16805864|NCT01646827|37747304|FG000|Overall Study|Physician Decision|1|||
16805865|NCT01646827|37747305|FG001|Overall Study|Physician Decision|2|||
16805866|NCT01646827|37747304|FG000|Overall Study|Withdrawal by Subject|1|||
16805867|NCT01646827|37747305|FG001|Overall Study|Withdrawal by Subject|0|||
16805868|NCT02494583|37747314|FG000|Overall Study|Death|195|||
16805869|NCT02494583|37747315|FG001|Overall Study|Death|189|||
16805870|NCT02494583|37747316|FG002|Overall Study|Death|201|||
16805871|NCT02494583|37747314|FG000|Overall Study|Lost to Follow-up|1|||
16805872|NCT02494583|37747315|FG001|Overall Study|Lost to Follow-up|0|||
16805873|NCT02494583|37747316|FG002|Overall Study|Lost to Follow-up|0|||
16805874|NCT02494583|37747314|FG000|Overall Study|Protocol Violation|1|||
16805875|NCT02494583|37747315|FG001|Overall Study|Protocol Violation|2|||
16805876|NCT02494583|37747316|FG002|Overall Study|Protocol Violation|0|||
16805877|NCT02494583|37747314|FG000|Overall Study|Withdrawal by Subject|3|||
16805878|NCT02494583|37747315|FG001|Overall Study|Withdrawal by Subject|15|||
16805879|NCT02494583|37747316|FG002|Overall Study|Withdrawal by Subject|15|||
16805880|NCT02494583|37747314|FG000|Overall Study|Ongoing in Study|56|||
16805881|NCT02494583|37747315|FG001|Overall Study|Ongoing in Study|51|||
16805882|NCT02494583|37747316|FG002|Overall Study|Ongoing in Study|34|||
16805883|NCT02293837|37747328|FG000|Overall Study|Lost to Follow-up|0|||
16805884|NCT02293837|37747329|FG001|Overall Study|Lost to Follow-up|2|||
16805885|NCT02293837|37747330|FG002|Overall Study|Lost to Follow-up|1|||
16805886|NCT02293837|37747331|FG003|Overall Study|Lost to Follow-up|0|||
16805887|NCT02293837|37747328|FG000|Overall Study|Withdrawal by Subject|2|||
16805888|NCT02293837|37747329|FG001|Overall Study|Withdrawal by Subject|1|||
16805889|NCT02293837|37747330|FG002|Overall Study|Withdrawal by Subject|2|||
16805890|NCT02293837|37747331|FG003|Overall Study|Withdrawal by Subject|1|||
16805891|NCT02293837|37747328|FG000|Overall Study|COVID-19 Related|1|||
16805892|NCT02293837|37747329|FG001|Overall Study|COVID-19 Related|1|||
16805893|NCT02293837|37747330|FG002|Overall Study|COVID-19 Related|0|||
16805894|NCT02293837|37747331|FG003|Overall Study|COVID-19 Related|0|||
16805895|NCT02293837|37747328|FG000|Overall Study|Participant ill and could not be infused|0|||
16805896|NCT02293837|37747329|FG001|Overall Study|Participant ill and could not be infused|0|||
16805897|NCT02293837|37747330|FG002|Overall Study|Participant ill and could not be infused|1|||
16805898|NCT02293837|37747331|FG003|Overall Study|Participant ill and could not be infused|0|||
16805899|NCT02361307|37747347|FG000|Overall Study|Unstable medical condition.|0|||
16805900|NCT02361307|37747348|FG001|Overall Study|Unstable medical condition.|1|||
16805901|NCT02320903|37747357|FG000|Overall Study|Withdrawal by Subject|0|||
16805902|NCT02320903|37747358|FG001|Overall Study|Withdrawal by Subject|9|||
16805903|NCT02320903|37747359|FG002|Overall Study|Withdrawal by Subject|9|||
16805904|NCT02320903|37747357|FG000|Overall Study|Exited therapy; no longer eligible|8|||
16805905|NCT02320903|37747358|FG001|Overall Study|Exited therapy; no longer eligible|2|||
16805906|NCT02320903|37747359|FG002|Overall Study|Exited therapy; no longer eligible|2|||
16805907|NCT02320903|37747357|FG000|Overall Study|Lost to Follow-up|0|||
16805908|NCT02320903|37747358|FG001|Overall Study|Lost to Follow-up|5|||
16805909|NCT02320903|37747359|FG002|Overall Study|Lost to Follow-up|5|||
16805910|NCT02320123|37747370|FG000|Overall Study|Lost to Follow-up|4|||
16805911|NCT02320123|37747371|FG001|Overall Study|Lost to Follow-up|6|||
16805912|NCT02320123|37747370|FG000|Overall Study|Death|6|||
16805913|NCT02320123|37747371|FG001|Overall Study|Death|5|||
16805914|NCT02360995|37747384|FG000|Overall Study|Lost to Follow-up|2|||
16805915|NCT02360995|37747385|FG001|Overall Study|Lost to Follow-up|0|||
16805916|NCT02360995|37747386|FG002|Overall Study|Lost to Follow-up|2|||
16805917|NCT02360995|37747384|FG000|Overall Study|Withdrawal by Subject|0|||
16805918|NCT02360995|37747385|FG001|Overall Study|Withdrawal by Subject|1|||
16805919|NCT02360995|37747386|FG002|Overall Study|Withdrawal by Subject|0|||
16805920|NCT02360605|37747396|FG000|Overall Study|Withdrawal by Subject|4|||
16805921|NCT02360605|37747397|FG001|Overall Study|Withdrawal by Subject|9|||
16805922|NCT02360605|37747396|FG000|Overall Study|Lost to Follow-up|7|||
16805923|NCT02360605|37747397|FG001|Overall Study|Lost to Follow-up|8|||
16805924|NCT02360605|37747396|FG000|Overall Study|Death|0|||
16805925|NCT02360605|37747397|FG001|Overall Study|Death|1|||
16805926|NCT02360293|37747407|FG000|Overall Study|Lost to Follow-up|73|||
16805927|NCT02360293|37747408|FG001|Overall Study|Lost to Follow-up|95|||
16805928|NCT02360293|37747407|FG000|Overall Study|Withdrawal by Subject|2|||
16805929|NCT02360293|37747408|FG001|Overall Study|Withdrawal by Subject|1|||
16805930|NCT02360293|37747407|FG000|Overall Study|Excluded|1|||
16805931|NCT02360293|37747408|FG001|Overall Study|Excluded|0|||
16805932|NCT02359903|37747416|FG000|Overall Study|Adverse Event|0|||
16805933|NCT02359903|37747417|FG001|Overall Study|Adverse Event|2|||
16805934|NCT02291419|37747425|FG000|Overall Study|Early study termination|1|||
16805935|NCT02291419|37747426|FG001|Overall Study|Early study termination|5|||
16805936|NCT02319031|37747434|FG000|Treatment Period|Death|1|||
16805937|NCT02319031|37747435|FG001|Treatment Period|Death|0|||
16805938|NCT02318797|37747443|FG000|Overall Study|Death|3|||
16805939|NCT02318797|37747444|FG001|Overall Study|Death|6|||
16805940|NCT02318797|37747443|FG000|Overall Study|Lost to Follow-up|85|||
16805941|NCT02318797|37747444|FG001|Overall Study|Lost to Follow-up|96|||
16805942|NCT02359435|37747452|FG000|Overall Study|Lost to Follow-up|4|||
16805943|NCT02359435|37747453|FG001|Overall Study|Lost to Follow-up|4|||
16805944|NCT02318719|37747463|FG000|Double-blind Phase|Adverse Event|7|||
16805945|NCT02318719|37747464|FG001|Double-blind Phase|Adverse Event|6|||
16805946|NCT02318719|37747465|FG002|Double-blind Phase|Adverse Event|12|||
16805947|NCT02318719|37747466|FG003|Double-blind Phase|Adverse Event|4|||
16805948|NCT02318719|37747467|FG004|Double-blind Phase|Adverse Event|0|||
16805949|NCT02318719|37747463|FG000|Double-blind Phase|Lack of Efficacy|5|||
16805950|NCT02318719|37747464|FG001|Double-blind Phase|Lack of Efficacy|0|||
16805951|NCT02318719|37747465|FG002|Double-blind Phase|Lack of Efficacy|1|||
16805952|NCT02318719|37747466|FG003|Double-blind Phase|Lack of Efficacy|1|||
16805953|NCT02318719|37747467|FG004|Double-blind Phase|Lack of Efficacy|0|||
16805954|NCT02318719|37747463|FG000|Double-blind Phase|Protocol Violation|0|||
16805955|NCT02318719|37747464|FG001|Double-blind Phase|Protocol Violation|1|||
16805956|NCT02318719|37747465|FG002|Double-blind Phase|Protocol Violation|3|||
16805957|NCT02318719|37747466|FG003|Double-blind Phase|Protocol Violation|0|||
16805958|NCT02318719|37747467|FG004|Double-blind Phase|Protocol Violation|0|||
16805959|NCT02318719|37747463|FG000|Double-blind Phase|Withdrawal by Subject|25|||
16805960|NCT02318719|37747464|FG001|Double-blind Phase|Withdrawal by Subject|7|||
16805961|NCT02318719|37747465|FG002|Double-blind Phase|Withdrawal by Subject|9|||
16805962|NCT02318719|37747466|FG003|Double-blind Phase|Withdrawal by Subject|10|||
16805963|NCT02318719|37747467|FG004|Double-blind Phase|Withdrawal by Subject|0|||
16805964|NCT02318719|37747463|FG000|Double-blind Phase|Other|1|||
16805965|NCT02318719|37747464|FG001|Double-blind Phase|Other|2|||
16805966|NCT02318719|37747465|FG002|Double-blind Phase|Other|0|||
16805967|NCT02318719|37747466|FG003|Double-blind Phase|Other|0|||
16805968|NCT02318719|37747467|FG004|Double-blind Phase|Other|0|||
16805969|NCT02318719|37747463|FG000|Open-label Extension Phase|Adverse Event|0|||
16805970|NCT02318719|37747464|FG001|Open-label Extension Phase|Adverse Event|0|||
16805971|NCT02318719|37747465|FG002|Open-label Extension Phase|Adverse Event|0|||
16805972|NCT02318719|37747466|FG003|Open-label Extension Phase|Adverse Event|0|||
16805973|NCT02318719|37747467|FG004|Open-label Extension Phase|Adverse Event|15|||
16805974|NCT02318719|37747463|FG000|Open-label Extension Phase|Death|0|||
16805975|NCT02318719|37747464|FG001|Open-label Extension Phase|Death|0|||
16805976|NCT02318719|37747465|FG002|Open-label Extension Phase|Death|0|||
16805977|NCT02318719|37747466|FG003|Open-label Extension Phase|Death|0|||
16805978|NCT02318719|37747467|FG004|Open-label Extension Phase|Death|1|||
16805979|NCT02318719|37747463|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
16805980|NCT02318719|37747464|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
16805981|NCT02318719|37747465|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
16805982|NCT02318719|37747466|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
16805983|NCT02318719|37747467|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
16805984|NCT02318719|37747463|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
16805985|NCT02318719|37747464|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
16805986|NCT02318719|37747465|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
16805987|NCT02318719|37747466|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
16805988|NCT02318719|37747467|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
16805989|NCT02318719|37747463|FG000|Open-label Extension Phase|Other|0|||
16805990|NCT02318719|37747464|FG001|Open-label Extension Phase|Other|0|||
16805991|NCT02318719|37747465|FG002|Open-label Extension Phase|Other|0|||
16805992|NCT02318719|37747466|FG003|Open-label Extension Phase|Other|0|||
16805993|NCT02318719|37747467|FG004|Open-label Extension Phase|Other|7|||
16805994|NCT01870726|37747486|FG000|Overall Study|Withdrawal of informed consent|0|||
16805995|NCT01870726|37747487|FG001|Overall Study|Withdrawal of informed consent|0|||
16805996|NCT01870726|37747488|FG002|Overall Study|Withdrawal of informed consent|0|||
16805997|NCT01870726|37747489|FG003|Overall Study|Withdrawal of informed consent|1|||
16805998|NCT01870726|37747490|FG004|Overall Study|Withdrawal of informed consent|0|||
16805999|NCT01870726|37747491|FG005|Overall Study|Withdrawal of informed consent|0|||
16806000|NCT01870726|37747492|FG006|Overall Study|Withdrawal of informed consent|0|||
16806001|NCT01870726|37747486|FG000|Overall Study|Withdrawal by Subject|0|||
16806002|NCT01870726|37747487|FG001|Overall Study|Withdrawal by Subject|1|||
16806003|NCT01870726|37747488|FG002|Overall Study|Withdrawal by Subject|0|||
16806004|NCT01870726|37747489|FG003|Overall Study|Withdrawal by Subject|0|||
16806005|NCT01870726|37747490|FG004|Overall Study|Withdrawal by Subject|0|||
16806006|NCT01870726|37747491|FG005|Overall Study|Withdrawal by Subject|0|||
16806007|NCT01870726|37747492|FG006|Overall Study|Withdrawal by Subject|0|||
16806008|NCT01870726|37747486|FG000|Overall Study|Adverse Event|0|||
16806009|NCT01870726|37747487|FG001|Overall Study|Adverse Event|0|||
16806010|NCT01870726|37747488|FG002|Overall Study|Adverse Event|0|||
16806011|NCT01870726|37747489|FG003|Overall Study|Adverse Event|0|||
16806012|NCT01870726|37747490|FG004|Overall Study|Adverse Event|1|||
16806013|NCT01870726|37747491|FG005|Overall Study|Adverse Event|1|||
16806014|NCT01870726|37747492|FG006|Overall Study|Adverse Event|0|||
16806015|NCT01870726|37747486|FG000|Overall Study|Progressive disease|5|||
16806016|NCT01870726|37747487|FG001|Overall Study|Progressive disease|5|||
16806017|NCT01870726|37747488|FG002|Overall Study|Progressive disease|4|||
16806018|NCT01870726|37747489|FG003|Overall Study|Progressive disease|5|||
16806019|NCT01870726|37747490|FG004|Overall Study|Progressive disease|6|||
16909697|NCT01697592|38018539|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16909698|NCT01697592|38018540|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16909699|NCT01697592|38018541|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16909700|NCT01697592|38018542|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16909701|NCT01697592|38018543|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16909702|NCT01697592|38018534|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16909703|NCT01697592|38018535|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
16909704|NCT01697592|38018536|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
16909705|NCT01697592|38018537|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
16909706|NCT01697592|38018538|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16909707|NCT01697592|38018539|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16909708|NCT01697592|38018540|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
16909709|NCT01697592|38018541|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16909710|NCT01697592|38018542|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16909711|NCT01697592|38018543|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
16909712|NCT01697592|38018534|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
16909713|NCT01697592|38018535|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16909714|NCT01697592|38018536|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16909715|NCT01697592|38018537|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
16909716|NCT01697592|38018538|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16909717|NCT01697592|38018539|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16909718|NCT01697592|38018540|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16806020|NCT01870726|37747491|FG005|Overall Study|Progressive disease|4|||
16806021|NCT01870726|37747492|FG006|Overall Study|Progressive disease|10|||
16909719|NCT01697592|38018541|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16909720|NCT01697592|38018542|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16806022|NCT01900054|37747517|FG000|Overall Study|Physician Decision|1|||
16806023|NCT01900054|37747517|FG000|Overall Study|Withdrawal by Subject|1|||
16909721|NCT01697592|38018543|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16909722|NCT01697592|38018534|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
16909723|NCT01697592|38018535|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16909724|NCT01697592|38018536|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16909725|NCT01697592|38018537|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16909726|NCT01697592|38018538|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16909727|NCT01697592|38018539|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
16909728|NCT01697592|38018540|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16909729|NCT01697592|38018541|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
16909730|NCT01697592|38018542|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16909731|NCT01697592|38018543|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16909732|NCT01697592|38018534|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
16806024|NCT01612156|37747523|FG000|Overall Study|Protocol Violation|2|||
16806025|NCT01612156|37747524|FG001|Overall Study|Protocol Violation|0|||
16806026|NCT01899742|37747532|FG000|Overall Study|Adverse Event|5|||
16909733|NCT01697592|38018535|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
16909734|NCT01697592|38018536|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
16909735|NCT01697592|38018537|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
16909736|NCT01697592|38018538|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
16909737|NCT01697592|38018539|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
16909738|NCT01697592|38018540|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
16909739|NCT01697592|38018541|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
16909740|NCT01697592|38018542|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
16909741|NCT01697592|38018543|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
16909742|NCT01744782|38018579|FG000|Overall Study|Death|1|||
16909743|NCT01744392|38018583|FG000|Overall Study|Physician Decision|1|||
16909744|NCT01604850|38018590|FG000|Overall Study|Enrolled but never treated|0|||
16909745|NCT01604850|38018591|FG001|Overall Study|Enrolled but never treated|1|||
16909746|NCT01604850|38018590|FG000|Overall Study|Efficacy Failure|50|||
16909747|NCT01604850|38018591|FG001|Overall Study|Efficacy Failure|29|||
16909748|NCT01604850|38018590|FG000|Overall Study|Lost to Follow-up|1|||
16909749|NCT01604850|38018591|FG001|Overall Study|Lost to Follow-up|0|||
16909750|NCT01604850|38018590|FG000|Overall Study|Subject withdrew consent|1|||
16909751|NCT01604850|38018591|FG001|Overall Study|Subject withdrew consent|0|||
16909752|NCT01742286|38018604|FG000|Escalation Phase|Administrative problems|1|||
16909753|NCT01742286|38018605|FG001|Escalation Phase|Administrative problems|1|||
16806027|NCT01899742|37747533|FG001|Overall Study|Adverse Event|4|||
16806028|NCT01899742|37747532|FG000|Overall Study|Lack of Efficacy|1|||
16806029|NCT01899742|37747533|FG001|Overall Study|Lack of Efficacy|5|||
16806030|NCT01899742|37747532|FG000|Overall Study|Protocol Violation|2|||
16806031|NCT01899742|37747533|FG001|Overall Study|Protocol Violation|2|||
16806032|NCT01899742|37747532|FG000|Overall Study|Withdrawal by Subject|9|||
16806033|NCT01899742|37747533|FG001|Overall Study|Withdrawal by Subject|5|||
16806034|NCT01615822|37747542|FG000|Period 1|Withdrawal by Subject|0|||
16806035|NCT01615822|37747543|FG001|Period 1|Withdrawal by Subject|1|||
16806036|NCT01615822|37747544|FG002|Period 1|Withdrawal by Subject|0|||
16806037|NCT01615822|37747542|FG000|Period 1|Adverse Event|1|||
16806038|NCT01615822|37747543|FG001|Period 1|Adverse Event|1|||
16806039|NCT01615822|37747544|FG002|Period 1|Adverse Event|0|||
16806040|NCT01615822|37747542|FG000|Period 2|Lost to Follow-up|0|||
16806041|NCT01615822|37747543|FG001|Period 2|Lost to Follow-up|1|||
16806042|NCT01615822|37747544|FG002|Period 2|Lost to Follow-up|2|||
16806043|NCT01898884|37747560|FG000|Multiple Dose Period|Adverse Event|0|||
16806044|NCT01898884|37747561|FG001|Multiple Dose Period|Adverse Event|0|||
16806045|NCT01898884|37747562|FG002|Multiple Dose Period|Adverse Event|0|||
16806046|NCT01898884|37747563|FG003|Multiple Dose Period|Adverse Event|0|||
16806047|NCT01898884|37747564|FG004|Multiple Dose Period|Adverse Event|0|||
16806048|NCT01898884|37747565|FG005|Multiple Dose Period|Adverse Event|0|||
16806049|NCT01898884|37747566|FG006|Multiple Dose Period|Adverse Event|1|||
16806050|NCT01898884|37747567|FG007|Multiple Dose Period|Adverse Event|0|||
16806051|NCT01898884|37747568|FG008|Multiple Dose Period|Adverse Event|0|||
16806052|NCT01898884|37747560|FG000|Multiple Dose Period|Randomized Not Treated|0|||
16806053|NCT01898884|37747561|FG001|Multiple Dose Period|Randomized Not Treated|0|||
16806054|NCT01898884|37747562|FG002|Multiple Dose Period|Randomized Not Treated|0|||
16806055|NCT01898884|37747563|FG003|Multiple Dose Period|Randomized Not Treated|0|||
16806056|NCT01898884|37747564|FG004|Multiple Dose Period|Randomized Not Treated|0|||
16806057|NCT01898884|37747565|FG005|Multiple Dose Period|Randomized Not Treated|0|||
16806058|NCT01898884|37747566|FG006|Multiple Dose Period|Randomized Not Treated|0|||
16806059|NCT01898884|37747567|FG007|Multiple Dose Period|Randomized Not Treated|0|||
16806060|NCT01898884|37747568|FG008|Multiple Dose Period|Randomized Not Treated|1|||
16806061|NCT01613326|37747606|FG000|Overall Study|Adverse Event|7|||
16806062|NCT01613326|37747607|FG001|Overall Study|Adverse Event|5|||
16806063|NCT01613326|37747606|FG000|Overall Study|Withdrawal by Subject|3|||
16806064|NCT01613326|37747607|FG001|Overall Study|Withdrawal by Subject|4|||
16806065|NCT01613326|37747606|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16806066|NCT01613326|37747607|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16806067|NCT01613326|37747606|FG000|Overall Study|inability to use device|1|||
16806068|NCT01613326|37747607|FG001|Overall Study|inability to use device|0|||
16806069|NCT01613326|37747606|FG000|Overall Study|Lack of Efficacy|0|||
16806070|NCT01613326|37747607|FG001|Overall Study|Lack of Efficacy|1|||
16806071|NCT01613326|37747606|FG000|Overall Study|Lost to Follow-up|0|||
16806072|NCT01613326|37747607|FG001|Overall Study|Lost to Follow-up|1|||
16806073|NCT01613326|37747606|FG000|Overall Study|Administrative|0|||
16806074|NCT01613326|37747607|FG001|Overall Study|Administrative|2|||
16806075|NCT01613326|37747606|FG000|Overall Study|Protocol Violation|0|||
16806076|NCT01613326|37747607|FG001|Overall Study|Protocol Violation|1|||
16806077|NCT01613248|37747619|FG000|Overall Study|Adverse Event|0|||
16806078|NCT01613248|37747620|FG001|Overall Study|Adverse Event|0|||
16806079|NCT01613248|37747621|FG002|Overall Study|Adverse Event|0|||
16806080|NCT01613248|37747622|FG003|Overall Study|Adverse Event|1|||
16806081|NCT01613248|37747623|FG004|Overall Study|Adverse Event|0|||
16806082|NCT01613248|37747624|FG005|Overall Study|Adverse Event|0|||
16806083|NCT01613248|37747619|FG000|Overall Study|Withdrawal by Subject|3|||
16806084|NCT01613248|37747620|FG001|Overall Study|Withdrawal by Subject|2|||
16806085|NCT01613248|37747621|FG002|Overall Study|Withdrawal by Subject|2|||
16806086|NCT01613248|37747622|FG003|Overall Study|Withdrawal by Subject|5|||
16806087|NCT01613248|37747623|FG004|Overall Study|Withdrawal by Subject|0|||
16806088|NCT01613248|37747624|FG005|Overall Study|Withdrawal by Subject|1|||
16806089|NCT01613248|37747619|FG000|Overall Study|Lost to Follow-up|5|||
16806090|NCT01613248|37747620|FG001|Overall Study|Lost to Follow-up|7|||
16806091|NCT01613248|37747621|FG002|Overall Study|Lost to Follow-up|4|||
16806092|NCT01613248|37747622|FG003|Overall Study|Lost to Follow-up|8|||
16806093|NCT01613248|37747623|FG004|Overall Study|Lost to Follow-up|4|||
16806094|NCT01613248|37747624|FG005|Overall Study|Lost to Follow-up|2|||
16806095|NCT01613248|37747619|FG000|Overall Study|Study Terminated by Sponsor|4|||
16806096|NCT01613248|37747620|FG001|Overall Study|Study Terminated by Sponsor|6|||
16806097|NCT01613248|37747621|FG002|Overall Study|Study Terminated by Sponsor|8|||
17102315|NCT00084266|38241212|FG000|Overall Study|Participant not willing to participate|3|||
16806098|NCT01613248|37747622|FG003|Overall Study|Study Terminated by Sponsor|8|||
16806099|NCT01613248|37747623|FG004|Overall Study|Study Terminated by Sponsor|9|||
16806100|NCT01613248|37747624|FG005|Overall Study|Study Terminated by Sponsor|11|||
16806101|NCT01613248|37747619|FG000|Overall Study|Physician Decision|8|||
16806102|NCT01613248|37747620|FG001|Overall Study|Physician Decision|8|||
16806103|NCT01613248|37747621|FG002|Overall Study|Physician Decision|9|||
16806104|NCT01613248|37747622|FG003|Overall Study|Physician Decision|4|||
16806105|NCT01613248|37747623|FG004|Overall Study|Physician Decision|7|||
16806106|NCT01613248|37747624|FG005|Overall Study|Physician Decision|6|||
16806107|NCT01613248|37747619|FG000|Overall Study|Lack of Qualifying Event|9|||
16806108|NCT01613248|37747620|FG001|Overall Study|Lack of Qualifying Event|11|||
16806109|NCT01613248|37747621|FG002|Overall Study|Lack of Qualifying Event|10|||
16806110|NCT01613248|37747622|FG003|Overall Study|Lack of Qualifying Event|11|||
16806111|NCT01613248|37747623|FG004|Overall Study|Lack of Qualifying Event|15|||
16806112|NCT01613248|37747624|FG005|Overall Study|Lack of Qualifying Event|18|||
16806113|NCT01613248|37747619|FG000|Overall Study|Pregnancy|0|||
16806114|NCT01613248|37747620|FG001|Overall Study|Pregnancy|0|||
16806115|NCT01613248|37747621|FG002|Overall Study|Pregnancy|0|||
16806116|NCT01613248|37747622|FG003|Overall Study|Pregnancy|1|||
16806117|NCT01613248|37747623|FG004|Overall Study|Pregnancy|0|||
16806118|NCT01613248|37747624|FG005|Overall Study|Pregnancy|0|||
16806119|NCT01898806|37747638|FG000|Overall Study|Withdrawal by Subject|2|||
16806120|NCT01898806|37747638|FG000|Overall Study|Physician Decision|1|||
16806121|NCT02291029|37747648|FG000|Overall Study|Withdrawal by Subject|0|||
16806122|NCT02291029|37747649|FG001|Overall Study|Withdrawal by Subject|0|||
16806123|NCT02291029|37747650|FG002|Overall Study|Withdrawal by Subject|1|||
16806124|NCT02291029|37747651|FG003|Overall Study|Withdrawal by Subject|0|||
16806125|NCT02291029|37747652|FG004|Overall Study|Withdrawal by Subject|0|||
16806126|NCT02291029|37747653|FG005|Overall Study|Withdrawal by Subject|0|||
16806127|NCT02291029|37747648|FG000|Overall Study|Adverse Event|0|||
16806128|NCT02291029|37747649|FG001|Overall Study|Adverse Event|1|||
16806129|NCT02291029|37747650|FG002|Overall Study|Adverse Event|0|||
16806130|NCT02291029|37747651|FG003|Overall Study|Adverse Event|0|||
16806131|NCT02291029|37747652|FG004|Overall Study|Adverse Event|0|||
16806132|NCT02291029|37747653|FG005|Overall Study|Adverse Event|0|||
16806133|NCT02290873|37747670|FG000|Overall Study|Withdrawal by Subject|0|||
16806134|NCT02290873|37747671|FG001|Overall Study|Withdrawal by Subject|1|||
16806135|NCT02290873|37747672|FG002|Overall Study|Withdrawal by Subject|1|||
16806136|NCT02290873|37747670|FG000|Overall Study|Nellcor device error|1|||
16806137|NCT02290873|37747671|FG001|Overall Study|Nellcor device error|0|||
16806138|NCT02290873|37747672|FG002|Overall Study|Nellcor device error|0|||
16806139|NCT02290873|37747670|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
16806140|NCT02290873|37747671|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
16806141|NCT02290873|37747672|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
16806142|NCT02290873|37747670|FG000|Overall Study|Protocol Violation|0|||
16806143|NCT02290873|37747671|FG001|Overall Study|Protocol Violation|0|||
16806144|NCT02290873|37747672|FG002|Overall Study|Protocol Violation|1|||
16806145|NCT02290405|37747683|FG000|Overall Study|Withdrawal by Subject|1|||
16806146|NCT02290405|37747684|FG001|Overall Study|Withdrawal by Subject|0|||
16806147|NCT02359045|37747692|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
16806148|NCT02359045|37747693|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16806149|NCT02359045|37747692|FG000|Overall Study|Lost to Follow-up|1|||
16806150|NCT02359045|37747693|FG001|Overall Study|Lost to Follow-up|1|||
16806151|NCT02359045|37747692|FG000|Overall Study|Adverse Event|0|||
16806152|NCT02359045|37747693|FG001|Overall Study|Adverse Event|1|||
16806153|NCT02358343|37747714|FG000|Screening Intervention|Death|0|||
16806154|NCT02358343|37747715|FG001|Screening Intervention|Death|2|||
16806155|NCT02358343|37747716|FG002|Screening Intervention|Death|0|||
16806156|NCT02358343|37747717|FG003|Screening Intervention|Death|0|||
16806157|NCT02358343|37747718|FG004|Screening Intervention|Death|0|||
16806158|NCT02358343|37747714|FG000|Screening Intervention|Withdrawal by Subject|1|||
16806159|NCT02358343|37747715|FG001|Screening Intervention|Withdrawal by Subject|0|||
16806160|NCT02358343|37747716|FG002|Screening Intervention|Withdrawal by Subject|0|||
16806161|NCT02358343|37747717|FG003|Screening Intervention|Withdrawal by Subject|0|||
16806162|NCT02358343|37747718|FG004|Screening Intervention|Withdrawal by Subject|0|||
16806163|NCT02358343|37747714|FG000|Screening Intervention|Determined Ineligible|5|||
16806164|NCT02358343|37747715|FG001|Screening Intervention|Determined Ineligible|6|||
16806165|NCT02358343|37747716|FG002|Screening Intervention|Determined Ineligible|0|||
16806166|NCT02358343|37747717|FG003|Screening Intervention|Determined Ineligible|0|||
16806167|NCT02358343|37747718|FG004|Screening Intervention|Determined Ineligible|0|||
16806168|NCT02358343|37747714|FG000|Comparative Efficacy Trial / Observation|Death|0|||
16806169|NCT02358343|37747715|FG001|Comparative Efficacy Trial / Observation|Death|0|||
16806170|NCT02358343|37747716|FG002|Comparative Efficacy Trial / Observation|Death|2|||
16806171|NCT02358343|37747717|FG003|Comparative Efficacy Trial / Observation|Death|0|||
16806172|NCT02358343|37747718|FG004|Comparative Efficacy Trial / Observation|Death|0|||
16806173|NCT02358343|37747714|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
16909754|NCT01742286|38018606|FG002|Escalation Phase|Administrative problems|0|||
16909755|NCT01742286|38018607|FG003|Escalation Phase|Administrative problems|0|||
16806174|NCT02358343|37747715|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
16806175|NCT02358343|37747716|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
16806176|NCT02358343|37747717|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
16806177|NCT02358343|37747718|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
16806178|NCT02358343|37747714|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
16806179|NCT02358343|37747715|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
16806180|NCT02358343|37747716|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
16806181|NCT02358343|37747717|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
16806182|NCT02358343|37747718|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
16806183|NCT02356783|37747731|FG000|Overall Study|Lost to Follow-up|1|||
16806184|NCT02356783|37747732|FG001|Overall Study|Lost to Follow-up|3|||
16806185|NCT02289469|37747740|FG000|Overall Study|Unable to match a control|6|||
16806186|NCT02289469|37747741|FG001|Overall Study|Unable to match a control|0|||
16806187|NCT02289079|37747749|FG000|Overall Study|Physician Decision|2|||
16806188|NCT02289079|37747750|FG001|Overall Study|Physician Decision|0|||
16806189|NCT02289079|37747749|FG000|Overall Study|Lost to Follow-up|0|||
16806190|NCT02289079|37747750|FG001|Overall Study|Lost to Follow-up|1|||
16806191|NCT02318095|37747756|FG000|Overall Study|Adverse Event|1|||
16806192|NCT02317705|37747761|FG000|Overall Study|Withdrawal by Subject|3|||
16806193|NCT02317705|37747761|FG000|Overall Study|Physician Decision|1|||
16806194|NCT02317705|37747761|FG000|Overall Study|Drug not usable|1|||
16806195|NCT02474069|37747765|FG000|Selection Phase (SP)|Adverse Event|8|||
16806196|NCT02474069|37747766|FG001|Selection Phase (SP)|Adverse Event|0|||
16806197|NCT02474069|37747767|FG002|Selection Phase (SP)|Adverse Event|0|||
16806198|NCT02474069|37747765|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
16806199|NCT02474069|37747766|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
16806200|NCT02474069|37747767|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
16806201|NCT02474069|37747765|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
16806202|NCT02474069|37747766|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
16806203|NCT02474069|37747767|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
16806204|NCT02474069|37747765|FG000|Selection Phase (SP)|Physician Decision|1|||
16806205|NCT02474069|37747766|FG001|Selection Phase (SP)|Physician Decision|0|||
16806206|NCT02474069|37747767|FG002|Selection Phase (SP)|Physician Decision|0|||
16806207|NCT02474069|37747765|FG000|Selection Phase (SP)|Protocol Violation|1|||
16806208|NCT02474069|37747766|FG001|Selection Phase (SP)|Protocol Violation|0|||
16806209|NCT02474069|37747767|FG002|Selection Phase (SP)|Protocol Violation|0|||
16806210|NCT02474069|37747765|FG000|Selection Phase (SP)|No longer requires treatment|1|||
16806211|NCT02474069|37747766|FG001|Selection Phase (SP)|No longer requires treatment|0|||
16806212|NCT02474069|37747767|FG002|Selection Phase (SP)|No longer requires treatment|0|||
16806213|NCT02474069|37747765|FG000|Selection Phase (SP)|Technical Problem|1|||
16806214|NCT02474069|37747766|FG001|Selection Phase (SP)|Technical Problem|0|||
16806215|NCT02474069|37747767|FG002|Selection Phase (SP)|Technical Problem|0|||
16806216|NCT02474069|37747765|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
16806217|NCT02474069|37747766|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
16806218|NCT02474069|37747767|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
16806219|NCT02474069|37747765|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
16806220|NCT02474069|37747766|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
16806221|NCT02474069|37747767|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
16806222|NCT02474069|37747765|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
16806223|NCT02474069|37747766|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
16806224|NCT02474069|37747767|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
16806225|NCT02474069|37747765|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
16806226|NCT02474069|37747766|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
16806227|NCT02474069|37747767|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
16806228|NCT02474069|37747765|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
16806229|NCT02474069|37747766|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
16806230|NCT02474069|37747767|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
16806231|NCT02474069|37747765|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
16806232|NCT02474069|37747766|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
16806233|NCT02474069|37747767|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
16806234|NCT02317627|37747780|FG000|Overall Study|Withdrawal by Subject|0|||
16806235|NCT02317627|37747781|FG001|Overall Study|Withdrawal by Subject|1|||
16806236|NCT02317627|37747782|FG002|Overall Study|Withdrawal by Subject|1|||
16806237|NCT02317627|37747780|FG000|Overall Study|Lost to Follow-up|2|||
16806238|NCT02317627|37747781|FG001|Overall Study|Lost to Follow-up|0|||
16806239|NCT02317627|37747782|FG002|Overall Study|Lost to Follow-up|0|||
16806240|NCT02317627|37747780|FG000|Overall Study|Stopped by Investigator|0|||
16806241|NCT02317627|37747781|FG001|Overall Study|Stopped by Investigator|1|||
16806242|NCT02317627|37747782|FG002|Overall Study|Stopped by Investigator|0|||
16806243|NCT02317627|37747780|FG000|Overall Study|Adverse Event|0|||
16806244|NCT02317627|37747781|FG001|Overall Study|Adverse Event|2|||
16806245|NCT02317627|37747782|FG002|Overall Study|Adverse Event|3|||
16806246|NCT02317627|37747780|FG000|Overall Study|Non-compliance with study drug|0|||
16806247|NCT02317627|37747781|FG001|Overall Study|Non-compliance with study drug|1|||
16806248|NCT02317627|37747782|FG002|Overall Study|Non-compliance with study drug|0|||
16806249|NCT02517905|37747798|FG000|Overall Study|Lost to Follow-up|4|||
16806250|NCT02517905|37747799|FG001|Overall Study|Lost to Follow-up|0|||
16806251|NCT02517905|37747798|FG000|Overall Study|Withdrawal by Subject|4|||
16806252|NCT02517905|37747799|FG001|Overall Study|Withdrawal by Subject|0|||
16806253|NCT02517905|37747798|FG000|Overall Study|Screen failure|2|||
16806254|NCT02517905|37747799|FG001|Overall Study|Screen failure|2|||
16806255|NCT02473913|37747807|FG000|Overall Study|Lost to Follow-up|3|||
16806256|NCT02473913|37747808|FG001|Overall Study|Lost to Follow-up|3|||
16806257|NCT02316847|37747816|FG000|Overall Study|Adverse Event|0|||
16806258|NCT02316847|37747817|FG001|Overall Study|Adverse Event|3|||
16806259|NCT02316847|37747816|FG000|Overall Study|Lost to Follow-up|0|||
16806260|NCT02316847|37747817|FG001|Overall Study|Lost to Follow-up|2|||
16806261|NCT02316847|37747816|FG000|Overall Study|Physician Decision|0|||
16806262|NCT02316847|37747817|FG001|Overall Study|Physician Decision|1|||
16806263|NCT02316847|37747816|FG000|Overall Study|Pregnancy|0|||
16806264|NCT02316847|37747817|FG001|Overall Study|Pregnancy|1|||
16806265|NCT02316847|37747816|FG000|Overall Study|Withdrawal by Subject|2|||
16806266|NCT02316847|37747817|FG001|Overall Study|Withdrawal by Subject|9|||
16806267|NCT02316847|37747816|FG000|Overall Study|Noncompliance with study drug|0|||
16806268|NCT02316847|37747817|FG001|Overall Study|Noncompliance with study drug|3|||
16806269|NCT02316847|37747816|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
16806270|NCT02316847|37747817|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
16806271|NCT02473523|37747825|FG000|Overall Study|Death|1|||
16806272|NCT02473523|37747825|FG000|Overall Study|Lost to Follow-up|1|||
16806273|NCT02316769|37747831|FG000|Overall Study|Physician Decision|1|||
16806274|NCT02316769|37747832|FG001|Overall Study|Physician Decision|0|||
16806275|NCT02316769|37747831|FG000|Overall Study|Withdrawal by Subject|1|||
16806276|NCT02316769|37747832|FG001|Overall Study|Withdrawal by Subject|0|||
16806277|NCT02473445|37747838|FG000|Overall Study|Withdrawal by Subject|2|||
16806278|NCT02473445|37747838|FG000|Overall Study|Sponsor Decision|20|||
16806279|NCT02473367|37747842|FG000|Wait 1|Withdrawal by Subject|1|||
16806280|NCT02473367|37747842|FG000|Period 4|Lost to Follow-up|1|||
16806281|NCT02316613|37747852|FG000|Overall Study|Death|63|||
16806282|NCT02316613|37747852|FG000|Overall Study|Lost to Follow-up|9|||
16806283|NCT02316613|37747852|FG000|Overall Study|Lymphoma transformation|2|||
16806284|NCT02316613|37747852|FG000|Overall Study|Participant moved/changed medical team|11|||
16806285|NCT02316613|37747852|FG000|Overall Study|No data and duplicate cases|5|||
16806286|NCT02316613|37747852|FG000|Overall Study|Did not met selection criteria|14|||
16806287|NCT02492165|37747871|FG000|Overall Study|Withdrawal by Subject|0|||
16806288|NCT02492165|37747872|FG001|Overall Study|Withdrawal by Subject|1|||
16806289|NCT02492165|37747873|FG002|Overall Study|Withdrawal by Subject|0|||
16806290|NCT02492165|37747874|FG003|Overall Study|Withdrawal by Subject|0|||
16806291|NCT02355691|37747886|FG000|Overall Study|Loss of Research Personnel|7|||
16806292|NCT02355691|37747887|FG001|Overall Study|Loss of Research Personnel|9|||
16806293|NCT02473289|37747895|FG000|Overall Study|Adverse Event|2|||
16806294|NCT02473289|37747896|FG001|Overall Study|Adverse Event|3|||
16806295|NCT02473289|37747895|FG000|Overall Study|Lost to Follow-up|1|||
16806296|NCT02473289|37747896|FG001|Overall Study|Lost to Follow-up|1|||
16806297|NCT02473289|37747895|FG000|Overall Study|Protocol Violation|0|||
16806298|NCT02473289|37747896|FG001|Overall Study|Protocol Violation|1|||
16806299|NCT02473289|37747895|FG000|Overall Study|Withdrawal of consent|6|||
16806300|NCT02473289|37747896|FG001|Overall Study|Withdrawal of consent|7|||
16806301|NCT02473289|37747895|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
16806302|NCT02473289|37747896|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
16806303|NCT02473289|37747895|FG000|Overall Study|Other|2|||
16806304|NCT02473289|37747896|FG001|Overall Study|Other|0|||
16806305|NCT02354599|37747908|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16806306|NCT02354599|37747909|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16806307|NCT02354599|37747910|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16806308|NCT02354599|37747911|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
16806309|NCT02354599|37747912|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
16806310|NCT02354599|37747913|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
16806311|NCT02354599|37747908|FG000|Overall Study|Withdrawal by Subject|1|||
16806312|NCT02354599|37747909|FG001|Overall Study|Withdrawal by Subject|1|||
16806313|NCT02354599|37747910|FG002|Overall Study|Withdrawal by Subject|0|||
16806314|NCT02354599|37747911|FG003|Overall Study|Withdrawal by Subject|0|||
16806315|NCT02354599|37747912|FG004|Overall Study|Withdrawal by Subject|0|||
16806316|NCT02354599|37747913|FG005|Overall Study|Withdrawal by Subject|0|||
16806317|NCT02316223|37747936|FG000|Overall Study|Lack of Efficacy|0|||
16806318|NCT02316223|37747937|FG001|Overall Study|Lack of Efficacy|1|||
16806319|NCT02316223|37747938|FG002|Overall Study|Lack of Efficacy|1|||
16806320|NCT02316223|37747936|FG000|Overall Study|Lost to Follow-up|27|||
16806321|NCT02316223|37747937|FG001|Overall Study|Lost to Follow-up|34|||
16806322|NCT02316223|37747938|FG002|Overall Study|Lost to Follow-up|36|||
16806323|NCT02316223|37747936|FG000|Overall Study|COPD Diagnosis|3|||
16806324|NCT02316223|37747937|FG001|Overall Study|COPD Diagnosis|2|||
16806325|NCT02316223|37747938|FG002|Overall Study|COPD Diagnosis|3|||
16806326|NCT02316223|37747936|FG000|Overall Study|Reside outside study area|1|||
16806327|NCT02316223|37747937|FG001|Overall Study|Reside outside study area|1|||
16806328|NCT02316223|37747938|FG002|Overall Study|Reside outside study area|1|||
16806329|NCT02316223|37747936|FG000|Overall Study|No asthma|2|||
16806330|NCT02316223|37747937|FG001|Overall Study|No asthma|0|||
16806331|NCT02316223|37747938|FG002|Overall Study|No asthma|0|||
16806332|NCT02316223|37747936|FG000|Overall Study|Discontinued by PI|11|||
16806333|NCT02316223|37747937|FG001|Overall Study|Discontinued by PI|19|||
16806334|NCT02316223|37747938|FG002|Overall Study|Discontinued by PI|3|||
16806335|NCT02286895|37747948|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
16806336|NCT02286895|37747949|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
16806337|NCT02286895|37747948|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
16806338|NCT02286895|37747949|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
16806339|NCT02286895|37747948|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
16806340|NCT02286895|37747949|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
16806341|NCT02472977|37747958|FG000|Overall Study|Disease progression|4|||
16806342|NCT02472977|37747959|FG001|Overall Study|Disease progression|25|||
16806343|NCT02472977|37747960|FG002|Overall Study|Disease progression|6|||
16806344|NCT02472977|37747958|FG000|Overall Study|Withdrawal by Subject|0|||
16806345|NCT02472977|37747959|FG001|Overall Study|Withdrawal by Subject|1|||
16806346|NCT02472977|37747960|FG002|Overall Study|Withdrawal by Subject|0|||
16806347|NCT02472977|37747958|FG000|Overall Study|Study drug toxicity|2|||
16806348|NCT02472977|37747959|FG001|Overall Study|Study drug toxicity|0|||
16806349|NCT02472977|37747960|FG002|Overall Study|Study drug toxicity|2|||
16806350|NCT02472977|37747958|FG000|Overall Study|Subject request to discontinue treatment|0|||
16806351|NCT02472977|37747959|FG001|Overall Study|Subject request to discontinue treatment|1|||
16806352|NCT02472977|37747960|FG002|Overall Study|Subject request to discontinue treatment|0|||
16806353|NCT02060487|37747971|FG000|Overall Study|Other|1|||
16806354|NCT02060487|37747972|FG001|Overall Study|Other|2|||
16806355|NCT02060487|37747973|FG002|Overall Study|Other|1|||
16806356|NCT02060487|37747971|FG000|Overall Study|Lack of Efficacy|0|||
16806357|NCT02060487|37747972|FG001|Overall Study|Lack of Efficacy|1|||
16806358|NCT02060487|37747973|FG002|Overall Study|Lack of Efficacy|0|||
16806359|NCT02060487|37747971|FG000|Overall Study|Withdrawal by Subject|3|||
16806360|NCT02060487|37747972|FG001|Overall Study|Withdrawal by Subject|10|||
16806361|NCT02060487|37747973|FG002|Overall Study|Withdrawal by Subject|4|||
16806362|NCT02060487|37747971|FG000|Overall Study|Study Terminated By Sponsor|87|||
16806363|NCT02060487|37747972|FG001|Overall Study|Study Terminated By Sponsor|89|||
16806364|NCT02060487|37747973|FG002|Overall Study|Study Terminated By Sponsor|100|||
16806365|NCT02060487|37747971|FG000|Overall Study|Randomized in error|1|||
16806366|NCT02060487|37747972|FG001|Overall Study|Randomized in error|0|||
16806367|NCT02060487|37747973|FG002|Overall Study|Randomized in error|0|||
16806368|NCT02060487|37747971|FG000|Overall Study|Protocol Violation|0|||
16806369|NCT02060487|37747972|FG001|Overall Study|Protocol Violation|1|||
16806370|NCT02060487|37747973|FG002|Overall Study|Protocol Violation|1|||
16806371|NCT02060487|37747971|FG000|Overall Study|Lost to Follow-up|3|||
16806372|NCT02060487|37747972|FG001|Overall Study|Lost to Follow-up|0|||
16806373|NCT02060487|37747973|FG002|Overall Study|Lost to Follow-up|2|||
16806374|NCT02060487|37747971|FG000|Overall Study|Death|34|||
16806375|NCT02060487|37747972|FG001|Overall Study|Death|25|||
16806376|NCT02060487|37747973|FG002|Overall Study|Death|19|||
16806377|NCT02060487|37747971|FG000|Overall Study|Adverse Event|0|||
16806378|NCT02060487|37747972|FG001|Overall Study|Adverse Event|0|||
16806379|NCT02060487|37747973|FG002|Overall Study|Adverse Event|1|||
16806380|NCT02059395|37747983|FG000|Overall Study|Lost to Follow-up|2|||
16806381|NCT02059395|37747984|FG001|Overall Study|Lost to Follow-up|4|||
16806382|NCT02059239|37747992|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
16806383|NCT02059239|37747993|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
16806384|NCT02059239|37747992|FG000|Overall Study|Physician Decision|1|||
16806385|NCT02059239|37747993|FG001|Overall Study|Physician Decision|0|||
16806386|NCT02059161|37748002|FG000|Overall Study|Pregnancy|0|||
16806387|NCT02059161|37748003|FG001|Overall Study|Pregnancy|2|||
16806388|NCT02059161|37748002|FG000|Overall Study|Adverse Event|2|||
16806389|NCT02059161|37748003|FG001|Overall Study|Adverse Event|6|||
16806390|NCT02059161|37748002|FG000|Overall Study|Lost to Follow-up|20|||
16806391|NCT02059161|37748003|FG001|Overall Study|Lost to Follow-up|12|||
16806392|NCT02059161|37748002|FG000|Overall Study|Physician Decision|4|||
16806393|NCT02059161|37748003|FG001|Overall Study|Physician Decision|4|||
16806394|NCT02059161|37748002|FG000|Overall Study|Protocol Violation|1|||
16806395|NCT02059161|37748003|FG001|Overall Study|Protocol Violation|1|||
16806396|NCT02059161|37748002|FG000|Overall Study|Withdrawal by Subject|16|||
16806397|NCT02059161|37748003|FG001|Overall Study|Withdrawal by Subject|13|||
16806398|NCT02059161|37748002|FG000|Overall Study|Randomized in error, no study drug|0|||
16806399|NCT02059161|37748003|FG001|Overall Study|Randomized in error, no study drug|1|||
16806400|NCT02059161|37748002|FG000|Overall Study|Non-compliance with study drug|6|||
16806401|NCT02059161|37748003|FG001|Overall Study|Non-compliance with study drug|2|||
16806410|NCT01897714|37748026|FG000|Phase I (Dose Escalation)|Disease progression|3|||
16806411|NCT01897714|37748027|FG001|Phase I (Dose Escalation)|Disease progression|5|||
16806412|NCT01897714|37748028|FG002|Phase I (Dose Escalation)|Disease progression|1|||
16806413|NCT01897714|37748029|FG003|Phase I (Dose Escalation)|Disease progression|3|||
16806414|NCT01897714|37748030|FG004|Phase I (Dose Escalation)|Disease progression|0|||
16806415|NCT01897714|37748031|FG005|Phase I (Dose Escalation)|Disease progression|0|||
16806416|NCT01897714|37748026|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
16806417|NCT01897714|37748027|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
16806418|NCT01897714|37748028|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
16806419|NCT01897714|37748029|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
16806420|NCT01897714|37748030|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
16806421|NCT01897714|37748031|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
16806422|NCT01897714|37748026|FG000|Phase I (Dose Escalation)|Other|0|||
16806423|NCT01897714|37748027|FG001|Phase I (Dose Escalation)|Other|1|||
16806424|NCT01897714|37748028|FG002|Phase I (Dose Escalation)|Other|0|||
16806425|NCT01897714|37748029|FG003|Phase I (Dose Escalation)|Other|0|||
16806426|NCT01897714|37748030|FG004|Phase I (Dose Escalation)|Other|0|||
16806427|NCT01897714|37748031|FG005|Phase I (Dose Escalation)|Other|0|||
16806428|NCT01897714|37748026|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
16806429|NCT01897714|37748027|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
16806430|NCT01897714|37748028|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
16806431|NCT01897714|37748029|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
16806432|NCT01897714|37748030|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
16806433|NCT01897714|37748031|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
16806434|NCT01897714|37748026|FG000|Phase II (MTD)|Lost to Follow-up|0|||
16806435|NCT01897714|37748027|FG001|Phase II (MTD)|Lost to Follow-up|0|||
16806436|NCT01897714|37748028|FG002|Phase II (MTD)|Lost to Follow-up|0|||
16806437|NCT01897714|37748029|FG003|Phase II (MTD)|Lost to Follow-up|0|||
16806438|NCT01897714|37748030|FG004|Phase II (MTD)|Lost to Follow-up|1|||
16806439|NCT01897714|37748031|FG005|Phase II (MTD)|Lost to Follow-up|0|||
16806440|NCT01897714|37748026|FG000|Phase II (MTD)|Death|0|||
16806441|NCT01897714|37748027|FG001|Phase II (MTD)|Death|0|||
16806442|NCT01897714|37748028|FG002|Phase II (MTD)|Death|0|||
16806443|NCT01897714|37748029|FG003|Phase II (MTD)|Death|0|||
16806444|NCT01897714|37748030|FG004|Phase II (MTD)|Death|25|||
16806445|NCT01897714|37748031|FG005|Phase II (MTD)|Death|10|||
16806446|NCT01897714|37748026|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
16806447|NCT01897714|37748027|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
16806448|NCT01897714|37748028|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
16806449|NCT01897714|37748029|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
16806450|NCT01897714|37748030|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
16806451|NCT01897714|37748031|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
16806452|NCT01897714|37748026|FG000|Phase II (MTD)|Other|0|||
16806453|NCT01897714|37748027|FG001|Phase II (MTD)|Other|0|||
16806454|NCT01897714|37748028|FG002|Phase II (MTD)|Other|0|||
16806455|NCT01897714|37748029|FG003|Phase II (MTD)|Other|0|||
16806456|NCT01897714|37748030|FG004|Phase II (MTD)|Other|3|||
16806457|NCT01897714|37748031|FG005|Phase II (MTD)|Other|0|||
16806458|NCT01861522|37748049|FG000|Overall Study|Adverse Event|1|||
16806459|NCT01861522|37748050|FG001|Overall Study|Adverse Event|0|||
16806460|NCT01861522|37748049|FG000|Overall Study|Withdrawal by Subject|2|||
16806461|NCT01861522|37748050|FG001|Overall Study|Withdrawal by Subject|0|||
16806462|NCT01860976|37748058|FG000|Blinded Treatment|Adverse Event|1|||
16806463|NCT01860976|37748059|FG001|Blinded Treatment|Adverse Event|3|||
16806464|NCT01860976|37748058|FG000|Blinded Treatment|Lack of Efficacy|5|||
16806465|NCT01860976|37748059|FG001|Blinded Treatment|Lack of Efficacy|12|||
16806466|NCT01860976|37748058|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
16806467|NCT01860976|37748059|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
16806468|NCT01860976|37748058|FG000|Blinded Treatment|Withdrawal by Subject|3|||
16806469|NCT01860976|37748059|FG001|Blinded Treatment|Withdrawal by Subject|5|||
16806470|NCT01860976|37748058|FG000|Blinded Treatment|Subject no longer met criteria|1|||
16806471|NCT01860976|37748059|FG001|Blinded Treatment|Subject no longer met criteria|0|||
16806472|NCT01860976|37748058|FG000|Blinded Treatment|Entered Open-Label in error|0|||
16806473|NCT01860976|37748059|FG001|Blinded Treatment|Entered Open-Label in error|1|||
16806474|NCT01860976|37748058|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
16806475|NCT01860976|37748059|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
16806476|NCT01860976|37748058|FG000|Open-Label|Adverse Event|2|||
16806477|NCT01860976|37748059|FG001|Open-Label|Adverse Event|4|||
16806478|NCT01860976|37748058|FG000|Open-Label|Lack of Efficacy|16|||
16806479|NCT01860976|37748059|FG001|Open-Label|Lack of Efficacy|8|||
16806480|NCT01860976|37748058|FG000|Open-Label|Lost to Follow-up|1|||
16806481|NCT01860976|37748059|FG001|Open-Label|Lost to Follow-up|2|||
16806482|NCT01860976|37748058|FG000|Open-Label|Subject request discontinue treatment|4|||
16806483|NCT01860976|37748059|FG001|Open-Label|Subject request discontinue treatment|3|||
16806484|NCT01860976|37748058|FG000|Open-Label|Withdrawal by Subject|4|||
16806485|NCT01860976|37748059|FG001|Open-Label|Withdrawal by Subject|1|||
16806486|NCT01860976|37748058|FG000|Open-Label|Other Reasons|1|||
16806487|NCT01860976|37748059|FG001|Open-Label|Other Reasons|1|||
16806488|NCT01860976|37748058|FG000|Long Term Extension|Adverse Event|4|||
16806489|NCT01860976|37748059|FG001|Long Term Extension|Adverse Event|0|||
16806490|NCT01860976|37748058|FG000|Long Term Extension|Lack of Efficacy|2|||
16806491|NCT01860976|37748059|FG001|Long Term Extension|Lack of Efficacy|0|||
16806492|NCT01860976|37748058|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
16806493|NCT01860976|37748059|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
16806494|NCT01860976|37748058|FG000|Long Term Extension|Lost to Follow-up|2|||
16806495|NCT01860976|37748059|FG001|Long Term Extension|Lost to Follow-up|0|||
16806496|NCT01860976|37748058|FG000|Long Term Extension|subject withdrew consent|7|||
16806497|NCT01860976|37748059|FG001|Long Term Extension|subject withdrew consent|0|||
16806498|NCT01860040|37748070|FG000|Overall Study|Withdrawal by Subject|1|||
16806499|NCT01860040|37748071|FG001|Overall Study|Withdrawal by Subject|0|||
16806500|NCT01896934|37748076|FG000|Overall Study|Adverse Event|1|||
16806501|NCT01896934|37748076|FG000|Overall Study|Withdrawal by Subject|1|||
16806502|NCT02039505|37748083|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
16806503|NCT02039505|37748084|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
16806504|NCT02039505|37748085|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
16806505|NCT02039505|37748086|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
16806506|NCT02039505|37748087|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
16806507|NCT02039505|37748088|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
16806508|NCT02039505|37748089|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
16806509|NCT02039505|37748083|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
16806510|NCT02039505|37748084|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
16806511|NCT02039505|37748085|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
16806512|NCT02039505|37748086|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
16806513|NCT02039505|37748087|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
16806514|NCT02039505|37748088|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
16806515|NCT02039505|37748089|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
16806516|NCT02039505|37748083|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
16806517|NCT02039505|37748084|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16806518|NCT02039505|37748085|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16806519|NCT02039505|37748086|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16806520|NCT02039505|37748087|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16806521|NCT02039505|37748088|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16806522|NCT02039505|37748089|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16806523|NCT02039505|37748083|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
16806524|NCT02039505|37748084|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
16806525|NCT02039505|37748085|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
16806526|NCT02039505|37748086|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
16806527|NCT02039505|37748087|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
16806528|NCT02039505|37748088|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
16806529|NCT02039505|37748089|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
16806530|NCT02039505|37748083|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
16806531|NCT02039505|37748084|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
16806532|NCT02039505|37748085|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
16806533|NCT02039505|37748086|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
16806534|NCT02039505|37748087|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
16806535|NCT02039505|37748088|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
16806536|NCT02039505|37748089|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
16806537|NCT02039505|37748083|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
16806538|NCT02039505|37748084|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
16806539|NCT02039505|37748085|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
16806540|NCT02039505|37748086|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
16806541|NCT02039505|37748087|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
16806542|NCT02039505|37748088|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
16806543|NCT02039505|37748089|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
16806544|NCT02039505|37748083|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16806545|NCT02039505|37748084|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16806546|NCT02039505|37748085|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16806547|NCT02039505|37748086|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
16806548|NCT02039505|37748087|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16806549|NCT02039505|37748088|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16806550|NCT02039505|37748089|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16806551|NCT02039505|37748083|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16806552|NCT02039505|37748084|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16806553|NCT02039505|37748085|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16806554|NCT02039505|37748086|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16806555|NCT02039505|37748087|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16806556|NCT02039505|37748088|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16806557|NCT02039505|37748089|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
16806558|NCT02039505|37748083|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16806559|NCT02039505|37748084|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16806560|NCT02039505|37748085|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16806561|NCT02039505|37748086|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16806562|NCT02039505|37748087|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16806563|NCT02039505|37748088|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16806564|NCT02039505|37748089|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
16806565|NCT02039505|37748083|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16806566|NCT02039505|37748084|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16806567|NCT02039505|37748085|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16806568|NCT02039505|37748086|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16806569|NCT02039505|37748087|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16806570|NCT02039505|37748088|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16806571|NCT02039505|37748089|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
16806572|NCT02039505|37748083|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16806573|NCT02039505|37748084|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16806574|NCT02039505|37748085|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16806575|NCT02039505|37748086|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16806576|NCT02039505|37748087|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16806577|NCT02039505|37748088|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16806578|NCT02039505|37748089|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
16806579|NCT02095197|37748111|FG000|Overall Study|Lost to Follow-up|0|||
16806580|NCT02095197|37748112|FG001|Overall Study|Lost to Follow-up|3|||
16806581|NCT02039427|37748122|FG000|Overall Study|Duration of surgery > 3h|1|||
16806582|NCT02039427|37748123|FG001|Overall Study|Duration of surgery > 3h|1|||
16806583|NCT02039427|37748124|FG002|Overall Study|Duration of surgery > 3h|0|||
16806584|NCT02039427|37748125|FG003|Overall Study|Duration of surgery > 3h|0|||
16806585|NCT02039427|37748122|FG000|Overall Study|Withdrawal on concent|0|||
16806586|NCT02039427|37748123|FG001|Overall Study|Withdrawal on concent|0|||
16806587|NCT02039427|37748124|FG002|Overall Study|Withdrawal on concent|0|||
16806588|NCT02039427|37748125|FG003|Overall Study|Withdrawal on concent|1|||
16806589|NCT02039427|37748122|FG000|Overall Study|Cancellation of surgery|0|||
16806590|NCT02039427|37748123|FG001|Overall Study|Cancellation of surgery|0|||
16806591|NCT02039427|37748124|FG002|Overall Study|Cancellation of surgery|1|||
16806592|NCT02039427|37748125|FG003|Overall Study|Cancellation of surgery|0|||
16806593|NCT02039427|37748122|FG000|Overall Study|Loss of follow - up|1|||
16806594|NCT02039427|37748123|FG001|Overall Study|Loss of follow - up|0|||
16806595|NCT02039427|37748124|FG002|Overall Study|Loss of follow - up|2|||
16806596|NCT02039427|37748125|FG003|Overall Study|Loss of follow - up|4|||
16806597|NCT02039427|37748122|FG000|Overall Study|Steroid Use|1|||
16806598|NCT02039427|37748123|FG001|Overall Study|Steroid Use|0|||
16806599|NCT02039427|37748124|FG002|Overall Study|Steroid Use|0|||
16806600|NCT02039427|37748125|FG003|Overall Study|Steroid Use|0|||
16806601|NCT02094885|37748141|FG000|Overall Study|Death|1|||
16806602|NCT02094885|37748142|FG001|Overall Study|Death|5|||
16806603|NCT02094885|37748141|FG000|Overall Study|Withdrawn due to age|1|||
16806604|NCT02094885|37748142|FG001|Overall Study|Withdrawn due to age|0|||
16806605|NCT01896856|37748154|FG000|Overall Study|Transportation issues / Non-compliance|0|||
16806606|NCT01896856|37748155|FG001|Overall Study|Transportation issues / Non-compliance|0|||
16806607|NCT01896856|37748156|FG002|Overall Study|Transportation issues / Non-compliance|1|||
16806608|NCT01896856|37748157|FG003|Overall Study|Transportation issues / Non-compliance|0|||
16806609|NCT01896856|37748158|FG004|Overall Study|Transportation issues / Non-compliance|0|||
16806610|NCT01896856|37748159|FG005|Overall Study|Transportation issues / Non-compliance|0|||
16806611|NCT02038959|37748176|FG000|Overall Study|Withdrawal by Subject|6|||
16806612|NCT02038959|37748177|FG001|Overall Study|Withdrawal by Subject|8|||
16806613|NCT01896700|37748185|FG000|Overall Study|Adverse Event|4|||
16806614|NCT01896700|37748186|FG001|Overall Study|Adverse Event|5|||
16806615|NCT01896700|37748185|FG000|Overall Study|Withdrawal by Subject|0|||
16806616|NCT01896700|37748186|FG001|Overall Study|Withdrawal by Subject|1|||
16806617|NCT02352493|37748210|FG000|Overall Study|Pregnancy|0|||
16806618|NCT02352493|37748211|FG001|Overall Study|Pregnancy|0|||
16806619|NCT02352493|37748212|FG002|Overall Study|Pregnancy|0|||
16806620|NCT02352493|37748213|FG003|Overall Study|Pregnancy|0|||
16806621|NCT02352493|37748214|FG004|Overall Study|Pregnancy|0|||
16806622|NCT02352493|37748215|FG005|Overall Study|Pregnancy|0|||
16806623|NCT02352493|37748216|FG006|Overall Study|Pregnancy|1|||
16806624|NCT02352493|37748217|FG007|Overall Study|Pregnancy|0|||
16806625|NCT02352493|37748218|FG008|Overall Study|Pregnancy|1|||
16806626|NCT02352493|37748219|FG009|Overall Study|Pregnancy|0|||
16806627|NCT02352493|37748220|FG010|Overall Study|Pregnancy|0|||
16806628|NCT02352493|37748221|FG011|Overall Study|Pregnancy|0|||
16806629|NCT02352493|37748222|FG012|Overall Study|Pregnancy|0|||
16806630|NCT02352493|37748223|FG013|Overall Study|Pregnancy|0|||
16806631|NCT02352493|37748224|FG014|Overall Study|Pregnancy|0|||
16806632|NCT02352493|37748225|FG015|Overall Study|Pregnancy|0|||
16806633|NCT02352493|37748226|FG016|Overall Study|Pregnancy|0|||
16806634|NCT02352493|37748227|FG017|Overall Study|Pregnancy|0|||
16806635|NCT02352493|37748210|FG000|Overall Study|Withdrawal by Subject|0|||
16806636|NCT02352493|37748211|FG001|Overall Study|Withdrawal by Subject|0|||
16806637|NCT02352493|37748212|FG002|Overall Study|Withdrawal by Subject|0|||
16806638|NCT02352493|37748213|FG003|Overall Study|Withdrawal by Subject|0|||
16806639|NCT02352493|37748214|FG004|Overall Study|Withdrawal by Subject|0|||
16806640|NCT02352493|37748215|FG005|Overall Study|Withdrawal by Subject|0|||
16806641|NCT02352493|37748216|FG006|Overall Study|Withdrawal by Subject|0|||
16806642|NCT02352493|37748217|FG007|Overall Study|Withdrawal by Subject|0|||
16806643|NCT02352493|37748218|FG008|Overall Study|Withdrawal by Subject|1|||
16806644|NCT02352493|37748219|FG009|Overall Study|Withdrawal by Subject|0|||
16806645|NCT02352493|37748220|FG010|Overall Study|Withdrawal by Subject|0|||
16806646|NCT02352493|37748221|FG011|Overall Study|Withdrawal by Subject|0|||
16806647|NCT02352493|37748222|FG012|Overall Study|Withdrawal by Subject|0|||
16806648|NCT02352493|37748223|FG013|Overall Study|Withdrawal by Subject|0|||
16806649|NCT02352493|37748224|FG014|Overall Study|Withdrawal by Subject|1|||
16806650|NCT02352493|37748225|FG015|Overall Study|Withdrawal by Subject|0|||
16806651|NCT02352493|37748226|FG016|Overall Study|Withdrawal by Subject|0|||
16806652|NCT02352493|37748227|FG017|Overall Study|Withdrawal by Subject|0|||
16806653|NCT02352493|37748210|FG000|Overall Study|Lost to Follow-up|0|||
16806654|NCT02352493|37748211|FG001|Overall Study|Lost to Follow-up|0|||
16806655|NCT02352493|37748212|FG002|Overall Study|Lost to Follow-up|0|||
16806656|NCT02352493|37748213|FG003|Overall Study|Lost to Follow-up|0|||
16806657|NCT02352493|37748214|FG004|Overall Study|Lost to Follow-up|0|||
16806658|NCT02352493|37748215|FG005|Overall Study|Lost to Follow-up|0|||
16806659|NCT02352493|37748216|FG006|Overall Study|Lost to Follow-up|0|||
16806660|NCT02352493|37748217|FG007|Overall Study|Lost to Follow-up|0|||
16806661|NCT02352493|37748218|FG008|Overall Study|Lost to Follow-up|0|||
16806662|NCT02352493|37748219|FG009|Overall Study|Lost to Follow-up|1|||
16806663|NCT02352493|37748220|FG010|Overall Study|Lost to Follow-up|0|||
16806664|NCT02352493|37748221|FG011|Overall Study|Lost to Follow-up|0|||
16806665|NCT02352493|37748222|FG012|Overall Study|Lost to Follow-up|1|||
16806666|NCT02352493|37748223|FG013|Overall Study|Lost to Follow-up|2|||
16806667|NCT02352493|37748224|FG014|Overall Study|Lost to Follow-up|0|||
16806668|NCT02352493|37748225|FG015|Overall Study|Lost to Follow-up|0|||
16806669|NCT02352493|37748226|FG016|Overall Study|Lost to Follow-up|0|||
16806670|NCT02352493|37748227|FG017|Overall Study|Lost to Follow-up|0|||
16806671|NCT02286193|37748282|FG000|Overall Study|Referred: CRS unable to make contact|62|||
16806672|NCT02286193|37748282|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
16806673|NCT02286193|37748282|FG000|Overall Study|Referred: Declined service|38|||
16806674|NCT01896232|37748289|FG000|Overall Study|Death|6|||
16806675|NCT01896232|37748290|FG001|Overall Study|Death|10|||
16806676|NCT01896232|37748289|FG000|Overall Study|Withdrawal by Subject|32|||
16806677|NCT01896232|37748290|FG001|Overall Study|Withdrawal by Subject|31|||
16806678|NCT01896232|37748289|FG000|Overall Study|Sponsor Decision|2|||
16806679|NCT01896232|37748290|FG001|Overall Study|Sponsor Decision|0|||
16806680|NCT01896232|37748289|FG000|Overall Study|Lost to Follow-up|9|||
16806681|NCT01896232|37748290|FG001|Overall Study|Lost to Follow-up|12|||
16806682|NCT02460224|37748325|FG000|Overall Study|Adverse Event|0|||
16806683|NCT02460224|37748326|FG001|Overall Study|Adverse Event|0|||
16806684|NCT02460224|37748327|FG002|Overall Study|Adverse Event|0|||
16806685|NCT02460224|37748328|FG003|Overall Study|Adverse Event|0|||
16806686|NCT02460224|37748329|FG004|Overall Study|Adverse Event|0|||
16806687|NCT02460224|37748330|FG005|Overall Study|Adverse Event|0|||
16806688|NCT02460224|37748331|FG006|Overall Study|Adverse Event|1|||
16806689|NCT02460224|37748332|FG007|Overall Study|Adverse Event|0|||
16806690|NCT02460224|37748333|FG008|Overall Study|Adverse Event|0|||
16806691|NCT02460224|37748334|FG009|Overall Study|Adverse Event|0|||
16806692|NCT02460224|37748335|FG010|Overall Study|Adverse Event|0|||
16806693|NCT02460224|37748336|FG011|Overall Study|Adverse Event|0|||
16806694|NCT02460224|37748337|FG012|Overall Study|Adverse Event|1|||
16806695|NCT02460224|37748338|FG013|Overall Study|Adverse Event|0|||
16806696|NCT02460224|37748339|FG014|Overall Study|Adverse Event|0|||
16806697|NCT02460224|37748340|FG015|Overall Study|Adverse Event|0|||
16806698|NCT02460224|37748341|FG016|Overall Study|Adverse Event|1|||
16806699|NCT02460224|37748342|FG017|Overall Study|Adverse Event|0|||
16806700|NCT02460224|37748343|FG018|Overall Study|Adverse Event|1|||
16806701|NCT02460224|37748344|FG019|Overall Study|Adverse Event|0|||
16806702|NCT02460224|37748345|FG020|Overall Study|Adverse Event|1|||
16806703|NCT02460224|37748346|FG021|Overall Study|Adverse Event|1|||
16806704|NCT02460224|37748347|FG022|Overall Study|Adverse Event|1|||
16806705|NCT02460224|37748348|FG023|Overall Study|Adverse Event|0|||
16806706|NCT02460224|37748349|FG024|Overall Study|Adverse Event|0|||
16806707|NCT02460224|37748350|FG025|Overall Study|Adverse Event|0|||
16806708|NCT02460224|37748351|FG026|Overall Study|Adverse Event|11|||
16806709|NCT02460224|37748352|FG027|Overall Study|Adverse Event|1|||
16806710|NCT02460224|37748353|FG028|Overall Study|Adverse Event|6|||
16806711|NCT02460224|37748325|FG000|Overall Study|Death|0|||
16806712|NCT02460224|37748326|FG001|Overall Study|Death|0|||
16806713|NCT02460224|37748327|FG002|Overall Study|Death|0|||
16806714|NCT02460224|37748328|FG003|Overall Study|Death|0|||
16806715|NCT02460224|37748329|FG004|Overall Study|Death|0|||
16806716|NCT02460224|37748330|FG005|Overall Study|Death|2|||
16806717|NCT02460224|37748331|FG006|Overall Study|Death|1|||
16806718|NCT02460224|37748332|FG007|Overall Study|Death|0|||
16806719|NCT02460224|37748333|FG008|Overall Study|Death|0|||
16806720|NCT02460224|37748334|FG009|Overall Study|Death|1|||
16806721|NCT02460224|37748335|FG010|Overall Study|Death|0|||
16806722|NCT02460224|37748336|FG011|Overall Study|Death|0|||
16806723|NCT02460224|37748337|FG012|Overall Study|Death|0|||
16806724|NCT02460224|37748338|FG013|Overall Study|Death|1|||
16806725|NCT02460224|37748339|FG014|Overall Study|Death|0|||
16806726|NCT02460224|37748340|FG015|Overall Study|Death|0|||
16806727|NCT02460224|37748341|FG016|Overall Study|Death|2|||
16806728|NCT02460224|37748342|FG017|Overall Study|Death|1|||
16806729|NCT02460224|37748343|FG018|Overall Study|Death|0|||
16806730|NCT02460224|37748344|FG019|Overall Study|Death|2|||
16806731|NCT02460224|37748345|FG020|Overall Study|Death|0|||
16806732|NCT02460224|37748346|FG021|Overall Study|Death|0|||
16806733|NCT02460224|37748347|FG022|Overall Study|Death|0|||
16806734|NCT02460224|37748348|FG023|Overall Study|Death|0|||
16806735|NCT02460224|37748349|FG024|Overall Study|Death|1|||
16806736|NCT02460224|37748350|FG025|Overall Study|Death|1|||
16806737|NCT02460224|37748351|FG026|Overall Study|Death|5|||
16806738|NCT02460224|37748352|FG027|Overall Study|Death|0|||
16806739|NCT02460224|37748353|FG028|Overall Study|Death|1|||
16806740|NCT02460224|37748325|FG000|Overall Study|Lost to Follow-up|0|||
16806741|NCT02460224|37748326|FG001|Overall Study|Lost to Follow-up|0|||
16806742|NCT02460224|37748327|FG002|Overall Study|Lost to Follow-up|0|||
16806743|NCT02460224|37748328|FG003|Overall Study|Lost to Follow-up|0|||
16806744|NCT02460224|37748329|FG004|Overall Study|Lost to Follow-up|0|||
16806745|NCT02460224|37748330|FG005|Overall Study|Lost to Follow-up|0|||
16806746|NCT02460224|37748331|FG006|Overall Study|Lost to Follow-up|0|||
16806747|NCT02460224|37748332|FG007|Overall Study|Lost to Follow-up|0|||
16806748|NCT02460224|37748333|FG008|Overall Study|Lost to Follow-up|0|||
16806749|NCT02460224|37748334|FG009|Overall Study|Lost to Follow-up|0|||
16806750|NCT02460224|37748335|FG010|Overall Study|Lost to Follow-up|0|||
16806751|NCT02460224|37748336|FG011|Overall Study|Lost to Follow-up|0|||
16806752|NCT02460224|37748337|FG012|Overall Study|Lost to Follow-up|0|||
16806753|NCT02460224|37748338|FG013|Overall Study|Lost to Follow-up|0|||
16806754|NCT02460224|37748339|FG014|Overall Study|Lost to Follow-up|0|||
16806755|NCT02460224|37748340|FG015|Overall Study|Lost to Follow-up|0|||
16806756|NCT02460224|37748341|FG016|Overall Study|Lost to Follow-up|0|||
16806757|NCT02460224|37748342|FG017|Overall Study|Lost to Follow-up|0|||
16806758|NCT02460224|37748343|FG018|Overall Study|Lost to Follow-up|0|||
16806759|NCT02460224|37748344|FG019|Overall Study|Lost to Follow-up|0|||
16806760|NCT02460224|37748345|FG020|Overall Study|Lost to Follow-up|0|||
16806761|NCT02460224|37748346|FG021|Overall Study|Lost to Follow-up|0|||
16806762|NCT02460224|37748347|FG022|Overall Study|Lost to Follow-up|1|||
16806763|NCT02460224|37748348|FG023|Overall Study|Lost to Follow-up|0|||
16806764|NCT02460224|37748349|FG024|Overall Study|Lost to Follow-up|0|||
16806765|NCT02460224|37748350|FG025|Overall Study|Lost to Follow-up|0|||
16806766|NCT02460224|37748351|FG026|Overall Study|Lost to Follow-up|0|||
16806767|NCT02460224|37748352|FG027|Overall Study|Lost to Follow-up|0|||
16806768|NCT02460224|37748353|FG028|Overall Study|Lost to Follow-up|0|||
16806769|NCT02460224|37748325|FG000|Overall Study|Physician Decision|0|||
16806770|NCT02460224|37748326|FG001|Overall Study|Physician Decision|1|||
16806771|NCT02460224|37748327|FG002|Overall Study|Physician Decision|0|||
16806772|NCT02460224|37748328|FG003|Overall Study|Physician Decision|0|||
16806773|NCT02460224|37748329|FG004|Overall Study|Physician Decision|1|||
16806774|NCT02460224|37748330|FG005|Overall Study|Physician Decision|0|||
16806775|NCT02460224|37748331|FG006|Overall Study|Physician Decision|0|||
16806776|NCT02460224|37748332|FG007|Overall Study|Physician Decision|1|||
16806777|NCT02460224|37748333|FG008|Overall Study|Physician Decision|0|||
16806778|NCT02460224|37748334|FG009|Overall Study|Physician Decision|0|||
16806779|NCT02460224|37748335|FG010|Overall Study|Physician Decision|0|||
16806780|NCT02460224|37748336|FG011|Overall Study|Physician Decision|1|||
16806781|NCT02460224|37748337|FG012|Overall Study|Physician Decision|0|||
16806782|NCT02460224|37748338|FG013|Overall Study|Physician Decision|1|||
16806783|NCT02460224|37748339|FG014|Overall Study|Physician Decision|0|||
16806784|NCT02460224|37748340|FG015|Overall Study|Physician Decision|0|||
16806785|NCT02460224|37748341|FG016|Overall Study|Physician Decision|2|||
16806786|NCT02460224|37748342|FG017|Overall Study|Physician Decision|1|||
16806787|NCT02460224|37748343|FG018|Overall Study|Physician Decision|1|||
16806788|NCT02460224|37748344|FG019|Overall Study|Physician Decision|2|||
16806789|NCT02460224|37748345|FG020|Overall Study|Physician Decision|1|||
16806790|NCT02460224|37748346|FG021|Overall Study|Physician Decision|1|||
16806791|NCT02460224|37748347|FG022|Overall Study|Physician Decision|0|||
16806792|NCT02460224|37748348|FG023|Overall Study|Physician Decision|0|||
16806793|NCT02460224|37748349|FG024|Overall Study|Physician Decision|1|||
16806794|NCT02460224|37748350|FG025|Overall Study|Physician Decision|0|||
16806795|NCT02460224|37748351|FG026|Overall Study|Physician Decision|14|||
16806796|NCT02460224|37748352|FG027|Overall Study|Physician Decision|1|||
16806797|NCT02460224|37748353|FG028|Overall Study|Physician Decision|6|||
16806798|NCT02460224|37748325|FG000|Overall Study|Progressive disease|15|||
16806799|NCT02460224|37748326|FG001|Overall Study|Progressive disease|11|||
16806800|NCT02460224|37748327|FG002|Overall Study|Progressive disease|5|||
16806801|NCT02460224|37748328|FG003|Overall Study|Progressive disease|6|||
16806802|NCT02460224|37748329|FG004|Overall Study|Progressive disease|3|||
16806803|NCT02460224|37748330|FG005|Overall Study|Progressive disease|26|||
16806804|NCT02460224|37748331|FG006|Overall Study|Progressive disease|28|||
16806805|NCT02460224|37748332|FG007|Overall Study|Progressive disease|4|||
16806806|NCT02460224|37748333|FG008|Overall Study|Progressive disease|5|||
16806807|NCT02460224|37748334|FG009|Overall Study|Progressive disease|9|||
16806808|NCT02460224|37748335|FG010|Overall Study|Progressive disease|5|||
16806809|NCT02460224|37748336|FG011|Overall Study|Progressive disease|4|||
16806810|NCT02460224|37748337|FG012|Overall Study|Progressive disease|5|||
16806811|NCT02460224|37748338|FG013|Overall Study|Progressive disease|4|||
16806812|NCT02460224|37748339|FG014|Overall Study|Progressive disease|5|||
16806813|NCT02460224|37748340|FG015|Overall Study|Progressive disease|5|||
16806814|NCT02460224|37748341|FG016|Overall Study|Progressive disease|15|||
16806815|NCT02460224|37748342|FG017|Overall Study|Progressive disease|3|||
16806816|NCT02460224|37748343|FG018|Overall Study|Progressive disease|8|||
16806817|NCT02460224|37748344|FG019|Overall Study|Progressive disease|3|||
16806818|NCT02460224|37748345|FG020|Overall Study|Progressive disease|4|||
16806819|NCT02460224|37748346|FG021|Overall Study|Progressive disease|9|||
16806820|NCT02460224|37748347|FG022|Overall Study|Progressive disease|4|||
16806821|NCT02460224|37748348|FG023|Overall Study|Progressive disease|11|||
16806822|NCT02460224|37748349|FG024|Overall Study|Progressive disease|4|||
16806823|NCT02460224|37748350|FG025|Overall Study|Progressive disease|5|||
16806824|NCT02460224|37748351|FG026|Overall Study|Progressive disease|85|||
16806825|NCT02460224|37748352|FG027|Overall Study|Progressive disease|17|||
16806826|NCT02460224|37748353|FG028|Overall Study|Progressive disease|77|||
16806827|NCT02460224|37748325|FG000|Overall Study|Subject/guardian decision|2|||
16806828|NCT02460224|37748326|FG001|Overall Study|Subject/guardian decision|0|||
16806829|NCT02460224|37748327|FG002|Overall Study|Subject/guardian decision|1|||
16806830|NCT02460224|37748328|FG003|Overall Study|Subject/guardian decision|0|||
16806831|NCT02460224|37748329|FG004|Overall Study|Subject/guardian decision|2|||
16806832|NCT02460224|37748330|FG005|Overall Study|Subject/guardian decision|2|||
16806833|NCT02460224|37748331|FG006|Overall Study|Subject/guardian decision|0|||
16806834|NCT02460224|37748332|FG007|Overall Study|Subject/guardian decision|0|||
16806835|NCT02460224|37748333|FG008|Overall Study|Subject/guardian decision|1|||
16806836|NCT02460224|37748334|FG009|Overall Study|Subject/guardian decision|1|||
16806837|NCT02460224|37748335|FG010|Overall Study|Subject/guardian decision|0|||
16806838|NCT02460224|37748336|FG011|Overall Study|Subject/guardian decision|1|||
16806839|NCT02460224|37748337|FG012|Overall Study|Subject/guardian decision|0|||
16806840|NCT02460224|37748338|FG013|Overall Study|Subject/guardian decision|0|||
16806841|NCT02460224|37748339|FG014|Overall Study|Subject/guardian decision|0|||
16806842|NCT02460224|37748340|FG015|Overall Study|Subject/guardian decision|1|||
16806843|NCT02460224|37748341|FG016|Overall Study|Subject/guardian decision|0|||
16806844|NCT02460224|37748342|FG017|Overall Study|Subject/guardian decision|1|||
16806845|NCT02460224|37748343|FG018|Overall Study|Subject/guardian decision|2|||
16806846|NCT02460224|37748344|FG019|Overall Study|Subject/guardian decision|0|||
16806847|NCT02460224|37748345|FG020|Overall Study|Subject/guardian decision|0|||
16806848|NCT02460224|37748346|FG021|Overall Study|Subject/guardian decision|1|||
16806849|NCT02460224|37748347|FG022|Overall Study|Subject/guardian decision|0|||
16806850|NCT02460224|37748348|FG023|Overall Study|Subject/guardian decision|0|||
16806851|NCT02460224|37748349|FG024|Overall Study|Subject/guardian decision|0|||
16806852|NCT02460224|37748350|FG025|Overall Study|Subject/guardian decision|0|||
16806853|NCT02460224|37748351|FG026|Overall Study|Subject/guardian decision|6|||
16806854|NCT02460224|37748352|FG027|Overall Study|Subject/guardian decision|2|||
16806855|NCT02460224|37748353|FG028|Overall Study|Subject/guardian decision|3|||
16806856|NCT02094573|37748427|FG000|Overall Study|Adverse Event|4|||
16806857|NCT02094573|37748428|FG001|Overall Study|Adverse Event|14|||
16806858|NCT02094573|37748427|FG000|Overall Study|Clinical Progressive Disease|9|||
16806859|NCT02094573|37748428|FG001|Overall Study|Clinical Progressive Disease|13|||
16806860|NCT02094573|37748427|FG000|Overall Study|Death|11|||
16806861|NCT02094573|37748428|FG001|Overall Study|Death|3|||
16806862|NCT02094573|37748427|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
16806863|NCT02094573|37748428|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
16806864|NCT02094573|37748427|FG000|Overall Study|Non-compliance with Study Drug|1|||
16806865|NCT02094573|37748428|FG001|Overall Study|Non-compliance with Study Drug|1|||
16806866|NCT02094573|37748427|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
16806867|NCT02094573|37748428|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
16806868|NCT02094573|37748427|FG000|Overall Study|Physician Decision|4|||
16806869|NCT02094573|37748428|FG001|Overall Study|Physician Decision|4|||
16806870|NCT02094573|37748427|FG000|Overall Study|Site Terminated by Sponsor|10|||
16806871|NCT02094573|37748428|FG001|Overall Study|Site Terminated by Sponsor|17|||
16806872|NCT02094573|37748427|FG000|Overall Study|Withdrawal by Subject|6|||
16806873|NCT02094573|37748428|FG001|Overall Study|Withdrawal by Subject|8|||
16806874|NCT02094573|37748427|FG000|Overall Study|Randomized but not Treated|3|||
16806875|NCT02094573|37748428|FG001|Overall Study|Randomized but not Treated|0|||
16806876|NCT01859494|37748434|FG000|Overall Study|Adverse Event|1|||
16806877|NCT01858636|37748438|FG000|Overall Study|No Device Deployment Attempted|24|||
16806878|NCT01858636|37748438|FG000|Overall Study|Physician Decision|1|||
16806879|NCT01858636|37748438|FG000|Overall Study|Death|1|||
16806880|NCT01858636|37748438|FG000|Overall Study|Lost to Follow-up|1|||
16806881|NCT01858636|37748438|FG000|Overall Study|Withdrawal by Subject|1|||
16806882|NCT02058849|37748445|FG000|Overall Study|Hospitalization|1|||
16806883|NCT02058849|37748446|FG001|Overall Study|Hospitalization|1|||
16806884|NCT02058849|37748445|FG000|Overall Study|Death|1|||
16806885|NCT02058849|37748446|FG001|Overall Study|Death|0|||
16806886|NCT02058849|37748445|FG000|Overall Study|Lost to Follow-up|1|||
16806887|NCT02058849|37748446|FG001|Overall Study|Lost to Follow-up|0|||
16806888|NCT02058849|37748445|FG000|Overall Study|Withdrawal by Subject|4|||
16806889|NCT02058849|37748446|FG001|Overall Study|Withdrawal by Subject|0|||
16806890|NCT01858558|37748454|FG000|Overall Study|Death|1|||
16806891|NCT01858558|37748455|FG001|Overall Study|Death|1|||
16806892|NCT01858558|37748454|FG000|Overall Study|Lost to Follow-up|1|||
16806893|NCT01858558|37748455|FG001|Overall Study|Lost to Follow-up|0|||
16806894|NCT01858558|37748454|FG000|Overall Study|Disease progression|3|||
16806895|NCT01858558|37748455|FG001|Overall Study|Disease progression|1|||
16806896|NCT01858558|37748454|FG000|Overall Study|Product contamination|2|||
16806897|NCT01858558|37748455|FG001|Overall Study|Product contamination|0|||
16806898|NCT01858558|37748454|FG000|Overall Study|Failed expansion of cell product|2|||
16806899|NCT01858558|37748455|FG001|Overall Study|Failed expansion of cell product|0|||
16806900|NCT02058537|37748461|FG000|Overall Study|Withdrawal by Subject|1|||
16806901|NCT01612000|37748469|FG000|Overall Study|Lost to Follow-up|6|||
16806902|NCT01612000|37748470|FG001|Overall Study|Lost to Follow-up|4|||
16806903|NCT01612000|37748471|FG002|Overall Study|Lost to Follow-up|4|||
16806904|NCT01612000|37748472|FG003|Overall Study|Lost to Follow-up|8|||
16806905|NCT01612000|37748469|FG000|Overall Study|Physician Decision|0|||
16806906|NCT01612000|37748470|FG001|Overall Study|Physician Decision|0|||
16806907|NCT01612000|37748471|FG002|Overall Study|Physician Decision|1|||
16806908|NCT01612000|37748472|FG003|Overall Study|Physician Decision|0|||
16806909|NCT01612000|37748469|FG000|Overall Study|Withdrawal by Subject|3|||
16806910|NCT01612000|37748470|FG001|Overall Study|Withdrawal by Subject|1|||
16806911|NCT01612000|37748471|FG002|Overall Study|Withdrawal by Subject|2|||
16806912|NCT01612000|37748472|FG003|Overall Study|Withdrawal by Subject|2|||
16806913|NCT01895608|37748486|FG000|Overall Study|change in health status|0|||
16806914|NCT01895608|37748487|FG001|Overall Study|change in health status|1|||
16806915|NCT01895608|37748488|FG002|Overall Study|change in health status|1|||
16806916|NCT01895608|37748489|FG003|Overall Study|change in health status|0|||
16806917|NCT01895608|37748486|FG000|Overall Study|Withdrawal by Subject|0|||
16806918|NCT01895608|37748487|FG001|Overall Study|Withdrawal by Subject|0|||
16806919|NCT01895608|37748488|FG002|Overall Study|Withdrawal by Subject|2|||
16806920|NCT01895608|37748489|FG003|Overall Study|Withdrawal by Subject|0|||
16806921|NCT02409680|37748501|FG000|Overall Study|Lost to Follow-up|15|||
16806922|NCT02409680|37748502|FG001|Overall Study|Lost to Follow-up|30|||
16806923|NCT01895452|37748510|FG000|Overall Study|Adverse Event|1|||
16806924|NCT01895452|37748511|FG001|Overall Study|Adverse Event|4|||
16806925|NCT01895452|37748510|FG000|Overall Study|Lost to Follow-up|1|||
16806926|NCT01895452|37748511|FG001|Overall Study|Lost to Follow-up|5|||
16806927|NCT01895452|37748510|FG000|Overall Study|Pregnancy|0|||
16806928|NCT01895452|37748511|FG001|Overall Study|Pregnancy|1|||
16806929|NCT01895452|37748510|FG000|Overall Study|Withdrawal by Subject|2|||
16806930|NCT01895452|37748511|FG001|Overall Study|Withdrawal by Subject|14|||
16806931|NCT01895452|37748510|FG000|Overall Study|Underlying disease|0|||
16806932|NCT01895452|37748511|FG001|Overall Study|Underlying disease|3|||
16806933|NCT01895452|37748510|FG000|Overall Study|Noncompliance with study drug|0|||
16806934|NCT01895452|37748511|FG001|Overall Study|Noncompliance with study drug|1|||
16806935|NCT02094417|37748521|FG000|Overall Study|Adverse Event|0|||
16806936|NCT02094417|37748522|FG001|Overall Study|Adverse Event|0|||
16806937|NCT02094417|37748523|FG002|Overall Study|Adverse Event|0|||
16806938|NCT02094417|37748524|FG003|Overall Study|Adverse Event|1|||
16806939|NCT02094417|37748521|FG000|Overall Study|Eligibility criteria|0|||
16806940|NCT02094417|37748522|FG001|Overall Study|Eligibility criteria|1|||
16806941|NCT02094417|37748523|FG002|Overall Study|Eligibility criteria|0|||
16806942|NCT02094417|37748524|FG003|Overall Study|Eligibility criteria|0|||
16909756|NCT01742286|38018608|FG004|Escalation Phase|Administrative problems|0|||
16909757|NCT01742286|38018609|FG005|Escalation Phase|Administrative problems|0|||
16909758|NCT01742286|38018610|FG006|Escalation Phase|Administrative problems|2|||
16909759|NCT01742286|38018604|FG000|Escalation Phase|Adverse Event|0|||
16909760|NCT01742286|38018605|FG001|Escalation Phase|Adverse Event|1|||
16909761|NCT01742286|38018606|FG002|Escalation Phase|Adverse Event|2|||
16806943|NCT02094417|37748521|FG000|Overall Study|No responder|4|||
16806944|NCT02094417|37748522|FG001|Overall Study|No responder|4|||
16806945|NCT02094417|37748523|FG002|Overall Study|No responder|4|||
16806946|NCT02094417|37748524|FG003|Overall Study|No responder|3|||
16909762|NCT01742286|38018607|FG003|Escalation Phase|Adverse Event|0|||
16909763|NCT01742286|38018608|FG004|Escalation Phase|Adverse Event|0|||
16909764|NCT01742286|38018609|FG005|Escalation Phase|Adverse Event|1|||
16909765|NCT01742286|38018610|FG006|Escalation Phase|Adverse Event|0|||
16909766|NCT01742286|38018604|FG000|Escalation Phase|Disease progression|3|||
16909767|NCT01742286|38018605|FG001|Escalation Phase|Disease progression|7|||
16909768|NCT01742286|38018606|FG002|Escalation Phase|Disease progression|4|||
16909769|NCT01742286|38018607|FG003|Escalation Phase|Disease progression|1|||
16909770|NCT01742286|38018608|FG004|Escalation Phase|Disease progression|4|||
16909771|NCT01742286|38018609|FG005|Escalation Phase|Disease progression|3|||
16909772|NCT01742286|38018610|FG006|Escalation Phase|Disease progression|2|||
16909773|NCT01742286|38018604|FG000|Escalation Phase|Death|0|||
16909774|NCT01742286|38018605|FG001|Escalation Phase|Death|0|||
16909775|NCT01742286|38018606|FG002|Escalation Phase|Death|0|||
16909776|NCT01742286|38018607|FG003|Escalation Phase|Death|0|||
16909777|NCT01742286|38018608|FG004|Escalation Phase|Death|0|||
16909778|NCT01742286|38018609|FG005|Escalation Phase|Death|1|||
16909779|NCT01742286|38018610|FG006|Escalation Phase|Death|0|||
16909780|NCT01742286|38018604|FG000|Escalation Phase|Physician Decision|0|||
16909781|NCT01742286|38018605|FG001|Escalation Phase|Physician Decision|3|||
16909782|NCT01742286|38018606|FG002|Escalation Phase|Physician Decision|0|||
16909783|NCT01742286|38018607|FG003|Escalation Phase|Physician Decision|1|||
16909784|NCT01742286|38018608|FG004|Escalation Phase|Physician Decision|0|||
16909785|NCT01742286|38018609|FG005|Escalation Phase|Physician Decision|0|||
16909786|NCT01742286|38018610|FG006|Escalation Phase|Physician Decision|2|||
16909787|NCT01742286|38018604|FG000|Escalation Phase|Subject/guardian decision|1|||
16909788|NCT01742286|38018605|FG001|Escalation Phase|Subject/guardian decision|0|||
16909789|NCT01742286|38018606|FG002|Escalation Phase|Subject/guardian decision|0|||
16909790|NCT01742286|38018607|FG003|Escalation Phase|Subject/guardian decision|0|||
16909791|NCT01742286|38018608|FG004|Escalation Phase|Subject/guardian decision|0|||
16909792|NCT01742286|38018609|FG005|Escalation Phase|Subject/guardian decision|0|||
16909793|NCT01742286|38018610|FG006|Escalation Phase|Subject/guardian decision|0|||
16909794|NCT01742286|38018604|FG000|Expansion Phase|Administrative problems|0|||
16909795|NCT01742286|38018605|FG001|Expansion Phase|Administrative problems|0|||
16909796|NCT01742286|38018606|FG002|Expansion Phase|Administrative problems|0|||
16909797|NCT01742286|38018607|FG003|Expansion Phase|Administrative problems|0|||
16909798|NCT01742286|38018608|FG004|Expansion Phase|Administrative problems|0|||
16909799|NCT01742286|38018609|FG005|Expansion Phase|Administrative problems|0|||
16909800|NCT01742286|38018610|FG006|Expansion Phase|Administrative problems|5|||
16909801|NCT01742286|38018604|FG000|Expansion Phase|Physician Decision|0|||
16909802|NCT01742286|38018605|FG001|Expansion Phase|Physician Decision|0|||
16909803|NCT01742286|38018606|FG002|Expansion Phase|Physician Decision|4|||
16909804|NCT01742286|38018607|FG003|Expansion Phase|Physician Decision|0|||
16909805|NCT01742286|38018608|FG004|Expansion Phase|Physician Decision|0|||
16909806|NCT01742286|38018609|FG005|Expansion Phase|Physician Decision|0|||
16909807|NCT01742286|38018610|FG006|Expansion Phase|Physician Decision|9|||
16909808|NCT01742286|38018604|FG000|Expansion Phase|Adverse Event|0|||
16909809|NCT01742286|38018605|FG001|Expansion Phase|Adverse Event|0|||
16909810|NCT01742286|38018606|FG002|Expansion Phase|Adverse Event|0|||
16909811|NCT01742286|38018607|FG003|Expansion Phase|Adverse Event|0|||
16909812|NCT01742286|38018608|FG004|Expansion Phase|Adverse Event|0|||
16909813|NCT01742286|38018609|FG005|Expansion Phase|Adverse Event|0|||
16909814|NCT01742286|38018610|FG006|Expansion Phase|Adverse Event|6|||
16909815|NCT01742286|38018604|FG000|Expansion Phase|Disease progression|0|||
16909816|NCT01742286|38018605|FG001|Expansion Phase|Disease progression|0|||
16909817|NCT01742286|38018606|FG002|Expansion Phase|Disease progression|3|||
16909818|NCT01742286|38018607|FG003|Expansion Phase|Disease progression|0|||
16909819|NCT01742286|38018608|FG004|Expansion Phase|Disease progression|0|||
16909820|NCT01742286|38018609|FG005|Expansion Phase|Disease progression|0|||
16806947|NCT02094417|37748521|FG000|Overall Study|Unable to conduct observations or assess|0|||
16806948|NCT02094417|37748522|FG001|Overall Study|Unable to conduct observations or assess|1|||
16806949|NCT02094417|37748523|FG002|Overall Study|Unable to conduct observations or assess|0|||
16806950|NCT02094417|37748524|FG003|Overall Study|Unable to conduct observations or assess|0|||
16806951|NCT02094417|37748521|FG000|Overall Study|Withdrawal by Subject|1|||
16806952|NCT02094417|37748522|FG001|Overall Study|Withdrawal by Subject|2|||
16806953|NCT02094417|37748523|FG002|Overall Study|Withdrawal by Subject|1|||
16806954|NCT02094417|37748524|FG003|Overall Study|Withdrawal by Subject|3|||
16806955|NCT01894984|37748536|FG000|Overall Study|Other|314|||
16806956|NCT01894984|37748537|FG001|Overall Study|Other|175|||
16806957|NCT02375672|37748543|FG000|Overall Study|remain on follow up|20|||
16806958|NCT01894516|37748551|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
16806959|NCT01894516|37748552|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
16806960|NCT01894516|37748553|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
16806961|NCT01894516|37748554|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
16806962|NCT01894516|37748551|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
16806963|NCT01894516|37748552|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16806964|NCT01894516|37748553|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16806965|NCT01894516|37748554|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16806966|NCT01894516|37748551|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
16806967|NCT01894516|37748552|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
16806968|NCT01894516|37748553|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
16806969|NCT01894516|37748554|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
16806970|NCT01894516|37748551|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
16806971|NCT01894516|37748552|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
16806972|NCT01894516|37748553|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
16806973|NCT01894516|37748554|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
16806974|NCT01894516|37748551|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
16806975|NCT01894516|37748552|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
16806976|NCT01894516|37748553|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
16806977|NCT01894516|37748554|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
16806978|NCT01894516|37748551|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
16806979|NCT01894516|37748552|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
16806980|NCT01894516|37748553|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
16806981|NCT01894516|37748554|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
16806982|NCT01894516|37748551|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
16806983|NCT01894516|37748552|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
16806984|NCT01894516|37748553|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
16806985|NCT01894516|37748554|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
16806986|NCT01894516|37748551|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16806987|NCT01894516|37748552|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16806988|NCT01894516|37748553|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
16806989|NCT01894516|37748554|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16806990|NCT02491463|37748572|FG000|Overall Study|Withdrawal by Subject|1|||
16806991|NCT02491463|37748573|FG001|Overall Study|Withdrawal by Subject|2|||
16806992|NCT02491463|37748574|FG002|Overall Study|Withdrawal by Subject|0|||
16806993|NCT02491463|37748575|FG003|Overall Study|Withdrawal by Subject|0|||
16806994|NCT02491463|37748572|FG000|Overall Study|Migrated/moved from study area|1|||
16806995|NCT02491463|37748573|FG001|Overall Study|Migrated/moved from study area|5|||
16806996|NCT02491463|37748574|FG002|Overall Study|Migrated/moved from study area|1|||
16806997|NCT02491463|37748575|FG003|Overall Study|Migrated/moved from study area|1|||
16806998|NCT02491463|37748572|FG000|Overall Study|Lost to Follow-up|0|||
16806999|NCT02491463|37748573|FG001|Overall Study|Lost to Follow-up|3|||
16807000|NCT02491463|37748574|FG002|Overall Study|Lost to Follow-up|3|||
16807001|NCT02491463|37748575|FG003|Overall Study|Lost to Follow-up|0|||
16807002|NCT02038881|37748588|FG000|Overall Study|Withdrawal by Subject|0|||
16807003|NCT02038881|37748589|FG001|Overall Study|Withdrawal by Subject|0|||
16807004|NCT02038881|37748590|FG002|Overall Study|Withdrawal by Subject|1|||
16807005|NCT02038881|37748588|FG000|Overall Study|Lost to Follow-up|2|||
16807006|NCT02038881|37748589|FG001|Overall Study|Lost to Follow-up|0|||
16807007|NCT02038881|37748590|FG002|Overall Study|Lost to Follow-up|0|||
16807008|NCT02038881|37748588|FG000|Overall Study|incarcerated|1|||
16807009|NCT02038881|37748589|FG001|Overall Study|incarcerated|0|||
16807010|NCT02038881|37748590|FG002|Overall Study|incarcerated|0|||
16807011|NCT01857622|37748603|FG000|Overall Study|Adverse Event|5|||
16807012|NCT01857622|37748604|FG001|Overall Study|Adverse Event|0|||
16807013|NCT01857622|37748605|FG002|Overall Study|Adverse Event|2|||
16807014|NCT01857622|37748603|FG000|Overall Study|Physician Decision|1|||
16807015|NCT01857622|37748604|FG001|Overall Study|Physician Decision|0|||
16807016|NCT01857622|37748605|FG002|Overall Study|Physician Decision|0|||
16807017|NCT01857622|37748603|FG000|Overall Study|Protocol Violation|4|||
16807018|NCT01857622|37748604|FG001|Overall Study|Protocol Violation|1|||
16807019|NCT01857622|37748605|FG002|Overall Study|Protocol Violation|0|||
16807020|NCT01857622|37748603|FG000|Overall Study|Withdrawal by Subject|1|||
16807021|NCT01857622|37748604|FG001|Overall Study|Withdrawal by Subject|0|||
16807022|NCT01857622|37748605|FG002|Overall Study|Withdrawal by Subject|0|||
16807023|NCT01857310|37748615|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
16807024|NCT01857310|37748616|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
16807025|NCT02472353|37748624|FG000|Overall Study|Lost to Follow-up|1|||
16807026|NCT02472353|37748625|FG001|Overall Study|Lost to Follow-up|1|||
16807027|NCT02472353|37748624|FG000|Overall Study|Withdrawal by Subject|2|||
16807028|NCT02472353|37748625|FG001|Overall Study|Withdrawal by Subject|1|||
16807029|NCT02472353|37748624|FG000|Overall Study|Study Termination|1|||
16807030|NCT02472353|37748625|FG001|Overall Study|Study Termination|4|||
16807031|NCT02491073|37748633|FG000|Overall Study|screen failure|1|||
16807032|NCT02491073|37748634|FG001|Overall Study|screen failure|0|||
16807033|NCT02314117|37748658|FG000|Overall Study|Lost to Follow-up|9|||
16807034|NCT02314117|37748659|FG001|Overall Study|Lost to Follow-up|14|||
16807035|NCT02314117|37748658|FG000|Overall Study|Withdrawal by Subject|3|||
16807036|NCT02314117|37748659|FG001|Overall Study|Withdrawal by Subject|2|||
16807037|NCT01893346|37748670|FG000|Overall Study|Lost to Follow-up|0|||
16807038|NCT01893346|37748671|FG001|Overall Study|Lost to Follow-up|1|||
16807039|NCT01893346|37748672|FG002|Overall Study|Lost to Follow-up|0|||
16807040|NCT01893346|37748673|FG003|Overall Study|Lost to Follow-up|0|||
16807041|NCT01893346|37748670|FG000|Overall Study|Protocol Violation|1|||
16807042|NCT01893346|37748671|FG001|Overall Study|Protocol Violation|0|||
16807043|NCT01893346|37748672|FG002|Overall Study|Protocol Violation|0|||
16807044|NCT01893346|37748673|FG003|Overall Study|Protocol Violation|0|||
16807045|NCT01893346|37748670|FG000|Overall Study|Withdrawal by Subject|2|||
16807046|NCT01893346|37748671|FG001|Overall Study|Withdrawal by Subject|0|||
16807047|NCT01893346|37748672|FG002|Overall Study|Withdrawal by Subject|0|||
16807048|NCT01893346|37748673|FG003|Overall Study|Withdrawal by Subject|0|||
16807049|NCT02490371|37748685|FG000|Overall Study|Lost to Follow-up|1|||
16807050|NCT02490371|37748686|FG001|Overall Study|Lost to Follow-up|1|||
16807051|NCT01856686|37748694|FG000|Overall Study|Lost to Follow-up|5|||
16807052|NCT01856686|37748695|FG001|Overall Study|Lost to Follow-up|11|||
16807053|NCT02058147|37748704|FG000|Overall Study|Randomized but not treated|0|||
16807054|NCT02058147|37748705|FG001|Overall Study|Randomized but not treated|0|||
16807055|NCT02058147|37748706|FG002|Overall Study|Randomized but not treated|1|||
16807056|NCT02058147|37748704|FG000|Overall Study|Adverse Event|12|||
16807057|NCT02058147|37748705|FG001|Overall Study|Adverse Event|9|||
16807058|NCT02058147|37748706|FG002|Overall Study|Adverse Event|21|||
16807059|NCT02058147|37748704|FG000|Overall Study|Lack of Efficacy|1|||
16807060|NCT02058147|37748705|FG001|Overall Study|Lack of Efficacy|0|||
16807061|NCT02058147|37748706|FG002|Overall Study|Lack of Efficacy|3|||
16807062|NCT02058147|37748704|FG000|Overall Study|Poor compliance to protocol|8|||
16807063|NCT02058147|37748705|FG001|Overall Study|Poor compliance to protocol|9|||
16807064|NCT02058147|37748706|FG002|Overall Study|Poor compliance to protocol|4|||
16807065|NCT02058147|37748704|FG000|Overall Study|Other than specified|8|||
16807066|NCT02058147|37748705|FG001|Overall Study|Other than specified|9|||
16807067|NCT02058147|37748706|FG002|Overall Study|Other than specified|0|||
16807068|NCT02489981|37748714|FG000|Overall Study|Adverse Event|21|||
16807069|NCT02489981|37748714|FG000|Overall Study|Insufficient effectiveness|16|||
16807070|NCT02489981|37748714|FG000|Overall Study|Improved|31|||
16807071|NCT02489981|37748714|FG000|Overall Study|Lost to Follow-up|31|||
16807072|NCT02489981|37748714|FG000|Overall Study|Other than listed|28|||
16807073|NCT02471183|37748718|FG000|Main Treatment Period|Adverse Event|1|||
16807074|NCT02471183|37748718|FG000|Main Treatment Period|Withdrawal by Subject|1|||
16807075|NCT02471183|37748718|FG000|Extended Treatment Period|Lack of Efficacy|1|||
16807076|NCT01855828|37748722|FG000|Overall Study|Adverse Event|1|||
16807077|NCT01855828|37748722|FG000|Overall Study|Withdrawal by Subject|1|||
16807078|NCT02489279|37748733|FG000|Overall Study|Lost to Follow-up|12|||
16807079|NCT02489279|37748734|FG001|Overall Study|Lost to Follow-up|10|||
16807080|NCT02489045|37748740|FG000|Overall Study|unable to collect usable data|53|||
16807081|NCT02489045|37748740|FG000|Follow-up|Lost to Follow-up|10|||
16807082|NCT02488109|37748746|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
16807083|NCT02488109|37748747|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
16807084|NCT02488109|37748746|FG000|12-month Follow-Up|Lost to Follow-up|4|||
16807085|NCT02488109|37748747|FG001|12-month Follow-Up|Lost to Follow-up|7|||
16807086|NCT02351167|37748758|FG000|Overall Study|Withdrawal by Subject|19|||
16807087|NCT02351167|37748759|FG001|Overall Study|Withdrawal by Subject|18|||
16807088|NCT02351167|37748760|FG002|Overall Study|Withdrawal by Subject|21|||
16807089|NCT02350309|37748775|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
16807090|NCT02350309|37748776|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
16807091|NCT02350309|37748777|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
16807092|NCT02350309|37748778|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
16807093|NCT02350309|37748779|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
16807094|NCT02350309|37748780|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
16807095|NCT02350309|37748775|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
16807096|NCT02350309|37748776|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
16807097|NCT02350309|37748777|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
16807098|NCT02350309|37748778|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
16807099|NCT02350309|37748779|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
16807100|NCT02350309|37748780|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
16807101|NCT02038647|37748797|FG000|Overall Study|Progressive Disease|50|||
16807102|NCT02038647|37748798|FG001|Overall Study|Progressive Disease|59|||
16807103|NCT02038647|37748797|FG000|Overall Study|Adverse Event|18|||
16807104|NCT02038647|37748798|FG001|Overall Study|Adverse Event|10|||
16807105|NCT02038647|37748797|FG000|Overall Study|Symptomatic Deterioration|7|||
16807106|NCT02038647|37748798|FG001|Overall Study|Symptomatic Deterioration|7|||
16807107|NCT02038647|37748797|FG000|Overall Study|Withdrawal by Subject|5|||
16807108|NCT02038647|37748798|FG001|Overall Study|Withdrawal by Subject|2|||
16807109|NCT02038647|37748797|FG000|Overall Study|Not Reported|0|||
16807110|NCT02038647|37748798|FG001|Overall Study|Not Reported|1|||
16807111|NCT02038647|37748797|FG000|Overall Study|Ongoing at Datacut|9|||
16807112|NCT02038647|37748798|FG001|Overall Study|Ongoing at Datacut|10|||
16807113|NCT02058069|37748804|FG000|Overall Study|Exclusion due to implant size|5|||
16807114|NCT02058069|37748804|FG000|Overall Study|Withdrawal by Subject|6|||
16807115|NCT02057835|37748818|FG000|Overall Study|Withdrawal by Subject|0|||
16807116|NCT02057835|37748819|FG001|Overall Study|Withdrawal by Subject|2|||
16807117|NCT02057835|37748820|FG002|Overall Study|Withdrawal by Subject|0|||
16807118|NCT02057835|37748821|FG003|Overall Study|Withdrawal by Subject|0|||
16807119|NCT02057835|37748822|FG004|Overall Study|Withdrawal by Subject|0|||
16807120|NCT02057835|37748823|FG005|Overall Study|Withdrawal by Subject|0|||
16807121|NCT02057835|37748824|FG006|Overall Study|Withdrawal by Subject|0|||
16807122|NCT02057835|37748825|FG007|Overall Study|Withdrawal by Subject|0|||
16807123|NCT02057835|37748826|FG008|Overall Study|Withdrawal by Subject|0|||
16807124|NCT02057835|37748827|FG009|Overall Study|Withdrawal by Subject|0|||
16807125|NCT02057757|37748858|FG000|Overall Study|Withdrawal by Subject|3|||
16807126|NCT02057757|37748859|FG001|Overall Study|Withdrawal by Subject|5|||
16807127|NCT02057757|37748858|FG000|Overall Study|Death|2|||
16807128|NCT02057757|37748859|FG001|Overall Study|Death|0|||
16807129|NCT02057757|37748858|FG000|Overall Study|Lost to Follow-up|8|||
16807130|NCT02057757|37748859|FG001|Overall Study|Lost to Follow-up|3|||
16807131|NCT02057757|37748858|FG000|Overall Study|Non-compliance|1|||
16807132|NCT02057757|37748859|FG001|Overall Study|Non-compliance|0|||
16807133|NCT02037477|37748873|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
16807134|NCT02037477|37748874|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
16807135|NCT02037477|37748875|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
16807136|NCT02037477|37748876|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
16807137|NCT02057523|37748886|FG000|Overall Study|Withdrawal by Subject|1|||
16807138|NCT02057523|37748886|FG000|Overall Study|Lack of Efficacy|1|||
16807139|NCT02037165|37748895|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
16807140|NCT02037165|37748896|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
16807141|NCT02037165|37748897|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
16807142|NCT02037165|37748898|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
16807143|NCT02037165|37748899|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
16807144|NCT02470403|37748920|FG000|Overall Study|Adverse Event|1|||
16807145|NCT02470403|37748921|FG001|Overall Study|Adverse Event|0|||
16807146|NCT02470403|37748922|FG002|Overall Study|Adverse Event|0|||
16807147|NCT02470403|37748923|FG003|Overall Study|Adverse Event|0|||
16807148|NCT02470403|37748924|FG004|Overall Study|Adverse Event|0|||
16807149|NCT02470403|37748920|FG000|Overall Study|Lost to Follow-up|0|||
16807150|NCT02470403|37748921|FG001|Overall Study|Lost to Follow-up|1|||
16807151|NCT02470403|37748922|FG002|Overall Study|Lost to Follow-up|0|||
16807152|NCT02470403|37748923|FG003|Overall Study|Lost to Follow-up|0|||
16807153|NCT02470403|37748924|FG004|Overall Study|Lost to Follow-up|0|||
16807154|NCT02470403|37748920|FG000|Overall Study|Subject/guardian decision|1|||
16807155|NCT02470403|37748921|FG001|Overall Study|Subject/guardian decision|0|||
16807156|NCT02470403|37748922|FG002|Overall Study|Subject/guardian decision|0|||
16807157|NCT02470403|37748923|FG003|Overall Study|Subject/guardian decision|4|||
16807158|NCT02470403|37748924|FG004|Overall Study|Subject/guardian decision|0|||
16807159|NCT01855750|37748941|FG000|Overall Study|Death|78|||
16807160|NCT01855750|37748942|FG001|Overall Study|Death|78|||
16807161|NCT01855750|37748941|FG000|Overall Study|Lost to Follow-up|9|||
16807162|NCT01855750|37748942|FG001|Overall Study|Lost to Follow-up|23|||
16807163|NCT01855750|37748941|FG000|Overall Study|Withdrawal by Subject|35|||
16807164|NCT01855750|37748942|FG001|Overall Study|Withdrawal by Subject|28|||
16807165|NCT01855750|37748941|FG000|Overall Study|Sponsor ends the study|297|||
16807166|NCT01855750|37748942|FG001|Overall Study|Sponsor ends the study|290|||
16807167|NCT01855126|37748950|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
16807168|NCT01855126|37748951|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
16807169|NCT01855126|37748950|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
16807170|NCT01855126|37748951|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
16807171|NCT01622673|37748967|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16807172|NCT01622673|37748968|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16807173|NCT01622673|37748969|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16807174|NCT01622673|37748970|FG003|Treatment Period 1|Withdrawal by Subject|1|||
16807175|NCT01622673|37748971|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16807176|NCT01622673|37748972|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16807177|NCT01622673|37748967|FG000|Treatment Period 1|Protocol Violation|0|||
16807178|NCT01622673|37748968|FG001|Treatment Period 1|Protocol Violation|1|||
16807179|NCT01622673|37748969|FG002|Treatment Period 1|Protocol Violation|0|||
16807180|NCT01622673|37748970|FG003|Treatment Period 1|Protocol Violation|0|||
16807181|NCT01622673|37748971|FG004|Treatment Period 1|Protocol Violation|0|||
16807182|NCT01622673|37748972|FG005|Treatment Period 1|Protocol Violation|0|||
16807183|NCT01622673|37748967|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16807184|NCT01622673|37748968|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16807185|NCT01622673|37748969|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16807186|NCT01622673|37748970|FG003|Treatment Period 2|Withdrawal by Subject|1|||
16807187|NCT01622673|37748971|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16807188|NCT01622673|37748972|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16807189|NCT01622673|37748967|FG000|Treatment Period 3|Protocol Violation|0|||
16807190|NCT01622673|37748968|FG001|Treatment Period 3|Protocol Violation|1|||
16807191|NCT01622673|37748969|FG002|Treatment Period 3|Protocol Violation|0|||
16807192|NCT01622673|37748970|FG003|Treatment Period 3|Protocol Violation|0|||
16807193|NCT01622673|37748971|FG004|Treatment Period 3|Protocol Violation|0|||
16807194|NCT01622673|37748972|FG005|Treatment Period 3|Protocol Violation|0|||
16807195|NCT01855048|37748997|FG000|Overall Study|Withdrawal by Subject|0|||
16807196|NCT01855048|37748998|FG001|Overall Study|Withdrawal by Subject|1|||
16807197|NCT01855048|37748999|FG002|Overall Study|Withdrawal by Subject|0|||
16807198|NCT01855048|37749000|FG003|Overall Study|Withdrawal by Subject|0|||
16807199|NCT01855048|37749001|FG004|Overall Study|Withdrawal by Subject|1|||
16807200|NCT01855048|37749002|FG005|Overall Study|Withdrawal by Subject|0|||
16807201|NCT02469857|37749028|FG000|Overall Study|Death|24|||
16807202|NCT02469857|37749029|FG001|Overall Study|Death|29|||
16807203|NCT02469857|37749028|FG000|Overall Study|Discontinuation|1|||
16807204|NCT02469857|37749029|FG001|Overall Study|Discontinuation|3|||
16807205|NCT02036853|37749039|FG000|Overall Study|Adverse Event|0|||
16807206|NCT02036853|37749040|FG001|Overall Study|Adverse Event|2|||
16807207|NCT02036853|37749039|FG000|Overall Study|Lack of Efficacy|0|||
16807208|NCT02036853|37749040|FG001|Overall Study|Lack of Efficacy|2|||
16807209|NCT02036853|37749039|FG000|Overall Study|Physician Decision|0|||
16807210|NCT02036853|37749040|FG001|Overall Study|Physician Decision|1|||
16807211|NCT02036853|37749039|FG000|Overall Study|Withdrawal by Subject|0|||
16807212|NCT02036853|37749040|FG001|Overall Study|Withdrawal by Subject|1|||
16807213|NCT02469623|37749046|FG000|Overall Study|Not consented for long-term follow-up|4|||
16807214|NCT02469623|37749046|FG000|Overall Study|Lost to Follow-up|4|||
16807215|NCT02469623|37749046|FG000|Overall Study|Withdrawal by Subject|2|||
16807216|NCT02469623|37749046|FG000|Overall Study|Death|3|||
16807217|NCT02469077|37749053|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
16807218|NCT02469077|37749054|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
16807219|NCT02469077|37749053|FG000|Post Randomization/Intervention Period|Relocated|1|||
16807220|NCT02469077|37749054|FG001|Post Randomization/Intervention Period|Relocated|1|||
16807221|NCT02469077|37749053|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
16807222|NCT02469077|37749054|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
16807223|NCT02469077|37749053|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
16807224|NCT02469077|37749054|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
16807225|NCT02486627|37749066|FG000|Overall Study|Death|1|||
16807226|NCT02486627|37749067|FG001|Overall Study|Death|0|||
16807227|NCT02486627|37749066|FG000|Overall Study|Other Unspecified|0|||
16807228|NCT02486627|37749067|FG001|Overall Study|Other Unspecified|2|||
16807229|NCT02486627|37749066|FG000|Overall Study|Consent Withdrawn by Participant|4|||
16807230|NCT02486627|37749067|FG001|Overall Study|Consent Withdrawn by Participant|3|||
16807231|NCT02486627|37749066|FG000|Overall Study|Significant Participant Noncompliance|1|||
16909821|NCT01742286|38018610|FG006|Expansion Phase|Disease progression|15|||
16909822|NCT01742286|38018604|FG000|Expansion Phase|Withdrawal by Subject|0|||
16909823|NCT01742286|38018605|FG001|Expansion Phase|Withdrawal by Subject|0|||
16909824|NCT01742286|38018606|FG002|Expansion Phase|Withdrawal by Subject|0|||
16807232|NCT02486627|37749067|FG001|Overall Study|Significant Participant Noncompliance|1|||
16807233|NCT02486627|37749066|FG000|Overall Study|Lost to Follow-up|1|||
16807234|NCT02486627|37749067|FG001|Overall Study|Lost to Follow-up|3|||
16807235|NCT01644565|37749073|FG000|Overall Study|Undisclosed Medical History|1|||
16807236|NCT01644565|37749074|FG001|Overall Study|Undisclosed Medical History|0|||
16807237|NCT01644565|37749075|FG002|Overall Study|Undisclosed Medical History|0|||
16807238|NCT01644565|37749076|FG003|Overall Study|Undisclosed Medical History|0|||
16807239|NCT01644565|37749077|FG004|Overall Study|Undisclosed Medical History|0|||
16807240|NCT01644565|37749078|FG005|Overall Study|Undisclosed Medical History|0|||
16807241|NCT01644565|37749079|FG006|Overall Study|Undisclosed Medical History|0|||
16807242|NCT01644565|37749080|FG007|Overall Study|Undisclosed Medical History|0|||
16807243|NCT01644565|37749081|FG008|Overall Study|Undisclosed Medical History|0|||
16807244|NCT01644565|37749073|FG000|Overall Study|Lost to Follow-up|0|||
16807245|NCT01644565|37749074|FG001|Overall Study|Lost to Follow-up|0|||
16807246|NCT01644565|37749075|FG002|Overall Study|Lost to Follow-up|0|||
16807247|NCT01644565|37749076|FG003|Overall Study|Lost to Follow-up|1|||
16807248|NCT01644565|37749077|FG004|Overall Study|Lost to Follow-up|0|||
16807249|NCT01644565|37749078|FG005|Overall Study|Lost to Follow-up|0|||
16807250|NCT01644565|37749079|FG006|Overall Study|Lost to Follow-up|0|||
16807251|NCT01644565|37749080|FG007|Overall Study|Lost to Follow-up|2|||
16807252|NCT01644565|37749081|FG008|Overall Study|Lost to Follow-up|0|||
16807253|NCT01644565|37749073|FG000|Overall Study|Family emergency|0|||
16807254|NCT01644565|37749074|FG001|Overall Study|Family emergency|0|||
16807255|NCT01644565|37749075|FG002|Overall Study|Family emergency|0|||
16807256|NCT01644565|37749076|FG003|Overall Study|Family emergency|0|||
16807257|NCT01644565|37749077|FG004|Overall Study|Family emergency|1|||
16807258|NCT01644565|37749078|FG005|Overall Study|Family emergency|0|||
16807259|NCT01644565|37749079|FG006|Overall Study|Family emergency|0|||
16909825|NCT01742286|38018607|FG003|Expansion Phase|Withdrawal by Subject|0|||
16909826|NCT01742286|38018608|FG004|Expansion Phase|Withdrawal by Subject|0|||
16909827|NCT01742286|38018609|FG005|Expansion Phase|Withdrawal by Subject|0|||
16909828|NCT01742286|38018610|FG006|Expansion Phase|Withdrawal by Subject|1|||
16909829|NCT01697358|38018635|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
16909830|NCT01697358|38018636|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
16909831|NCT01697358|38018635|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
16909832|NCT01697358|38018636|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
16909833|NCT01697358|38018635|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
16909834|NCT01697358|38018636|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
16807260|NCT01644565|37749080|FG007|Overall Study|Family emergency|0|||
16807261|NCT01644565|37749081|FG008|Overall Study|Family emergency|0|||
16807262|NCT01644565|37749073|FG000|Overall Study|Relocation|0|||
16807263|NCT01644565|37749074|FG001|Overall Study|Relocation|0|||
16807264|NCT01644565|37749075|FG002|Overall Study|Relocation|0|||
16807265|NCT01644565|37749076|FG003|Overall Study|Relocation|0|||
16807266|NCT01644565|37749077|FG004|Overall Study|Relocation|0|||
16807267|NCT01644565|37749078|FG005|Overall Study|Relocation|0|||
16807268|NCT01644565|37749079|FG006|Overall Study|Relocation|0|||
16807269|NCT01644565|37749080|FG007|Overall Study|Relocation|0|||
16807270|NCT01644565|37749081|FG008|Overall Study|Relocation|1|||
16807271|NCT02485925|37749101|FG000|Overall Study|Withdrawal by Subject|3|||
16807272|NCT02485925|37749101|FG000|Overall Study|Death|1|||
16807273|NCT02485925|37749101|FG000|Overall Study|Lost to Follow-up|11|||
16807274|NCT02282293|37749107|FG000|Overall Study|Lost to Follow-up|2|||
16807275|NCT02282293|37749108|FG001|Overall Study|Lost to Follow-up|2|||
16807276|NCT02282293|37749107|FG000|Overall Study|Unable to comply with study procedures|1|||
16807277|NCT02282293|37749108|FG001|Overall Study|Unable to comply with study procedures|0|||
16807278|NCT02282293|37749107|FG000|Overall Study|Moved out of study area|0|||
16807279|NCT02282293|37749108|FG001|Overall Study|Moved out of study area|1|||
16807280|NCT01854658|37749118|FG000|Overall Study|Protocol Violation|6|||
16807281|NCT01854658|37749119|FG001|Overall Study|Protocol Violation|2|||
16807282|NCT01854658|37749120|FG002|Overall Study|Protocol Violation|2|||
16807283|NCT01854658|37749121|FG003|Overall Study|Protocol Violation|1|||
16807284|NCT01854658|37749118|FG000|Overall Study|Physician Decision|7|||
16807285|NCT01854658|37749119|FG001|Overall Study|Physician Decision|5|||
16807286|NCT01854658|37749120|FG002|Overall Study|Physician Decision|2|||
16807287|NCT01854658|37749121|FG003|Overall Study|Physician Decision|4|||
16807288|NCT01854658|37749118|FG000|Overall Study|Lost to Follow-up|8|||
16807289|NCT01854658|37749119|FG001|Overall Study|Lost to Follow-up|9|||
16807290|NCT01854658|37749120|FG002|Overall Study|Lost to Follow-up|8|||
16807291|NCT01854658|37749121|FG003|Overall Study|Lost to Follow-up|4|||
16807292|NCT01854658|37749118|FG000|Overall Study|Withdrawal by Subject|28|||
16909835|NCT01697358|38018635|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
16909836|NCT01697358|38018636|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
16909837|NCT01697358|38018635|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
16807293|NCT01854658|37749119|FG001|Overall Study|Withdrawal by Subject|21|||
16807294|NCT01854658|37749120|FG002|Overall Study|Withdrawal by Subject|29|||
16807295|NCT01854658|37749121|FG003|Overall Study|Withdrawal by Subject|15|||
16807296|NCT01854658|37749118|FG000|Overall Study|Protocol-specified criteria|15|||
16807297|NCT01854658|37749119|FG001|Overall Study|Protocol-specified criteria|15|||
16807298|NCT01854658|37749120|FG002|Overall Study|Protocol-specified criteria|10|||
16807299|NCT01854658|37749121|FG003|Overall Study|Protocol-specified criteria|7|||
16807300|NCT01854658|37749118|FG000|Overall Study|Lack of Efficacy|3|||
16807301|NCT01854658|37749119|FG001|Overall Study|Lack of Efficacy|8|||
16807302|NCT01854658|37749120|FG002|Overall Study|Lack of Efficacy|4|||
16807303|NCT01854658|37749121|FG003|Overall Study|Lack of Efficacy|7|||
16807304|NCT01854658|37749118|FG000|Overall Study|Adverse Event|21|||
16807305|NCT01854658|37749119|FG001|Overall Study|Adverse Event|14|||
16807306|NCT01854658|37749120|FG002|Overall Study|Adverse Event|23|||
16807307|NCT01854658|37749121|FG003|Overall Study|Adverse Event|19|||
16807308|NCT01854658|37749118|FG000|Overall Study|Administrative reasons|5|||
16807309|NCT01854658|37749119|FG001|Overall Study|Administrative reasons|1|||
16807310|NCT01854658|37749120|FG002|Overall Study|Administrative reasons|2|||
16807311|NCT01854658|37749121|FG003|Overall Study|Administrative reasons|2|||
16807312|NCT01892020|37749131|FG000|Period 1|Adverse Event|1|||
16807313|NCT01892020|37749132|FG001|Period 1|Adverse Event|1|||
16807314|NCT01892020|37749131|FG000|Period 1|Protocol Violation|2|||
16807315|NCT01892020|37749132|FG001|Period 1|Protocol Violation|4|||
16807316|NCT01892020|37749131|FG000|Period 1|Unclassified|0|||
16807317|NCT01892020|37749132|FG001|Period 1|Unclassified|1|||
16807318|NCT01892020|37749131|FG000|Period 2|Protocol Violation|1|||
16807319|NCT01892020|37749132|FG001|Period 2|Protocol Violation|0|||
16807320|NCT02485691|37749140|FG000|Overall Study|Adverse Event|25|||
16807321|NCT02485691|37749141|FG001|Overall Study|Adverse Event|11|||
16807322|NCT02485691|37749140|FG000|Overall Study|Poor compliance to protocol|0|||
16807323|NCT02485691|37749141|FG001|Overall Study|Poor compliance to protocol|1|||
16807324|NCT02485691|37749140|FG000|Overall Study|Disease progression|57|||
16807325|NCT02485691|37749141|FG001|Overall Study|Disease progression|92|||
16807326|NCT02485691|37749140|FG000|Overall Study|Investigator's decision|23|||
16807327|NCT02485691|37749141|FG001|Overall Study|Investigator's decision|5|||
16807328|NCT02485691|37749140|FG000|Overall Study|Participant's request|13|||
16807329|NCT02485691|37749141|FG001|Overall Study|Participant's request|6|||
16807330|NCT02485691|37749140|FG000|Overall Study|Other reason|8|||
16807331|NCT02485691|37749141|FG001|Overall Study|Other reason|9|||
16807332|NCT02485691|37749140|FG000|Overall Study|Randomized and not treated|3|||
16807333|NCT02485691|37749141|FG001|Overall Study|Randomized and not treated|2|||
16807334|NCT02517515|37749150|FG000|Overall Study|Adverse Event|0|||
16807335|NCT02517515|37749151|FG001|Overall Study|Adverse Event|1|||
16807336|NCT02517515|37749150|FG000|Overall Study|Withdrew Consent|0|||
16807337|NCT02517515|37749151|FG001|Overall Study|Withdrew Consent|1|||
16807338|NCT02517515|37749150|FG000|Overall Study|Lost to Follow-up|1|||
16807339|NCT02517515|37749151|FG001|Overall Study|Lost to Follow-up|0|||
16807340|NCT02517515|37749150|FG000|Overall Study|Other|1|||
16807341|NCT02517515|37749151|FG001|Overall Study|Other|0|||
16807342|NCT02466659|37749160|FG000|Overall Study|Lost to Follow-up|5|||
16807343|NCT02466659|37749161|FG001|Overall Study|Lost to Follow-up|2|||
16807344|NCT01891864|37749169|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
16807345|NCT01891864|37749170|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
16807346|NCT01891864|37749171|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
16807347|NCT01891864|37749172|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
16807348|NCT01891864|37749173|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
16807349|NCT01891864|37749174|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
16807350|NCT01891864|37749169|FG000|Treatment Period 1|Physician Decision|0|||
16807351|NCT01891864|37749170|FG001|Treatment Period 1|Physician Decision|1|||
16807352|NCT01891864|37749171|FG002|Treatment Period 1|Physician Decision|0|||
16807353|NCT01891864|37749172|FG003|Treatment Period 1|Physician Decision|0|||
16807354|NCT01891864|37749173|FG004|Treatment Period 1|Physician Decision|0|||
16807355|NCT01891864|37749174|FG005|Treatment Period 1|Physician Decision|0|||
16807356|NCT01891864|37749169|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16807357|NCT01891864|37749170|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
16807358|NCT01891864|37749171|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16807359|NCT01891864|37749172|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16807360|NCT01891864|37749173|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16807361|NCT01891864|37749174|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16807362|NCT01891864|37749169|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
16807363|NCT01891864|37749170|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
16807364|NCT01891864|37749171|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
16807365|NCT01891864|37749172|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
16807366|NCT01891864|37749173|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
16807367|NCT01891864|37749174|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
16807368|NCT01891864|37749169|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16807369|NCT01891864|37749170|FG001|Treatment Period 1|Withdrawal by Subject|5|||
16807370|NCT01891864|37749171|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16807371|NCT01891864|37749172|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16807372|NCT01891864|37749173|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16807373|NCT01891864|37749174|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16807374|NCT01891864|37749169|FG000|Treatment Period 1|Lost to Follow-up|1|||
16807375|NCT01891864|37749170|FG001|Treatment Period 1|Lost to Follow-up|0|||
16807376|NCT01891864|37749171|FG002|Treatment Period 1|Lost to Follow-up|0|||
16807377|NCT01891864|37749172|FG003|Treatment Period 1|Lost to Follow-up|0|||
16807378|NCT01891864|37749173|FG004|Treatment Period 1|Lost to Follow-up|0|||
16807379|NCT01891864|37749174|FG005|Treatment Period 1|Lost to Follow-up|0|||
16807380|NCT01891864|37749169|FG000|Treatment Period 2|Protocol Violation|0|||
16807381|NCT01891864|37749170|FG001|Treatment Period 2|Protocol Violation|0|||
16807382|NCT01891864|37749171|FG002|Treatment Period 2|Protocol Violation|0|||
16807383|NCT01891864|37749172|FG003|Treatment Period 2|Protocol Violation|1|||
16807384|NCT01891864|37749173|FG004|Treatment Period 2|Protocol Violation|0|||
16807385|NCT01891864|37749174|FG005|Treatment Period 2|Protocol Violation|0|||
16807386|NCT01891864|37749169|FG000|Treatment Period 2|Physician Decision|0|||
16807387|NCT01891864|37749170|FG001|Treatment Period 2|Physician Decision|0|||
16807388|NCT01891864|37749171|FG002|Treatment Period 2|Physician Decision|1|||
16807389|NCT01891864|37749172|FG003|Treatment Period 2|Physician Decision|0|||
16807390|NCT01891864|37749173|FG004|Treatment Period 2|Physician Decision|0|||
16807391|NCT01891864|37749174|FG005|Treatment Period 2|Physician Decision|0|||
16807392|NCT01891864|37749169|FG000|Treatment Period 2|Site Termination|0|||
16807393|NCT01891864|37749170|FG001|Treatment Period 2|Site Termination|0|||
16807394|NCT01891864|37749171|FG002|Treatment Period 2|Site Termination|1|||
16807395|NCT01891864|37749172|FG003|Treatment Period 2|Site Termination|2|||
16807396|NCT01891864|37749173|FG004|Treatment Period 2|Site Termination|0|||
16807397|NCT01891864|37749174|FG005|Treatment Period 2|Site Termination|0|||
16807398|NCT01891864|37749169|FG000|Treatment Period 2|Lack of Efficacy|0|||
16807399|NCT01891864|37749170|FG001|Treatment Period 2|Lack of Efficacy|0|||
16807400|NCT01891864|37749171|FG002|Treatment Period 2|Lack of Efficacy|1|||
16807401|NCT01891864|37749172|FG003|Treatment Period 2|Lack of Efficacy|0|||
16807402|NCT01891864|37749173|FG004|Treatment Period 2|Lack of Efficacy|1|||
16807403|NCT01891864|37749174|FG005|Treatment Period 2|Lack of Efficacy|0|||
16807404|NCT01891864|37749169|FG000|Treatment Period 2|Adverse Event|0|||
16807405|NCT01891864|37749170|FG001|Treatment Period 2|Adverse Event|0|||
16807406|NCT01891864|37749171|FG002|Treatment Period 2|Adverse Event|1|||
16807407|NCT01891864|37749172|FG003|Treatment Period 2|Adverse Event|2|||
16807408|NCT01891864|37749173|FG004|Treatment Period 2|Adverse Event|0|||
16807409|NCT01891864|37749174|FG005|Treatment Period 2|Adverse Event|4|||
16807410|NCT01891864|37749169|FG000|Treatment Period 2|Termination of Site|0|||
16807411|NCT01891864|37749170|FG001|Treatment Period 2|Termination of Site|0|||
16807412|NCT01891864|37749171|FG002|Treatment Period 2|Termination of Site|0|||
16807413|NCT01891864|37749172|FG003|Treatment Period 2|Termination of Site|0|||
16807414|NCT01891864|37749173|FG004|Treatment Period 2|Termination of Site|2|||
16807415|NCT01891864|37749174|FG005|Treatment Period 2|Termination of Site|0|||
16807416|NCT01891864|37749169|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16807417|NCT01891864|37749170|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16807418|NCT01891864|37749171|FG002|Treatment Period 2|Withdrawal by Subject|3|||
16807419|NCT01891864|37749172|FG003|Treatment Period 2|Withdrawal by Subject|4|||
16807420|NCT01891864|37749173|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16807421|NCT01891864|37749174|FG005|Treatment Period 2|Withdrawal by Subject|1|||
16807422|NCT01891864|37749169|FG000|Extension Period|Lack of Efficacy|0|||
16807423|NCT01891864|37749170|FG001|Extension Period|Lack of Efficacy|0|||
16807424|NCT01891864|37749171|FG002|Extension Period|Lack of Efficacy|0|||
16807425|NCT01891864|37749172|FG003|Extension Period|Lack of Efficacy|1|||
16807426|NCT01891864|37749173|FG004|Extension Period|Lack of Efficacy|1|||
16807427|NCT01891864|37749174|FG005|Extension Period|Lack of Efficacy|0|||
16807428|NCT01891864|37749169|FG000|Extension Period|Pregnancy|0|||
16807429|NCT01891864|37749170|FG001|Extension Period|Pregnancy|0|||
16807430|NCT01891864|37749171|FG002|Extension Period|Pregnancy|1|||
16807431|NCT01891864|37749172|FG003|Extension Period|Pregnancy|0|||
16807432|NCT01891864|37749173|FG004|Extension Period|Pregnancy|0|||
16807433|NCT01891864|37749174|FG005|Extension Period|Pregnancy|0|||
16807434|NCT01891864|37749169|FG000|Extension Period|Adverse Event|0|||
16807435|NCT01891864|37749170|FG001|Extension Period|Adverse Event|0|||
16807436|NCT01891864|37749171|FG002|Extension Period|Adverse Event|4|||
16807437|NCT01891864|37749172|FG003|Extension Period|Adverse Event|2|||
16807438|NCT01891864|37749173|FG004|Extension Period|Adverse Event|2|||
16807439|NCT01891864|37749174|FG005|Extension Period|Adverse Event|0|||
16807440|NCT01891864|37749169|FG000|Extension Period|Withdrawal by Subject|0|||
16807441|NCT01891864|37749170|FG001|Extension Period|Withdrawal by Subject|0|||
16807442|NCT01891864|37749171|FG002|Extension Period|Withdrawal by Subject|1|||
16807443|NCT01891864|37749172|FG003|Extension Period|Withdrawal by Subject|2|||
16807444|NCT01891864|37749173|FG004|Extension Period|Withdrawal by Subject|4|||
16807445|NCT01891864|37749174|FG005|Extension Period|Withdrawal by Subject|0|||
16807446|NCT01891864|37749169|FG000|Extension Period|Lost to Follow-up|0|||
16807447|NCT01891864|37749170|FG001|Extension Period|Lost to Follow-up|0|||
16807448|NCT01891864|37749171|FG002|Extension Period|Lost to Follow-up|2|||
16807449|NCT01891864|37749172|FG003|Extension Period|Lost to Follow-up|0|||
16807450|NCT01891864|37749173|FG004|Extension Period|Lost to Follow-up|0|||
16807451|NCT01891864|37749174|FG005|Extension Period|Lost to Follow-up|0|||
16807452|NCT02485301|37749188|FG000|Overall Study|Serious Adverse Events|2|||
16807453|NCT02485301|37749189|FG001|Overall Study|Serious Adverse Events|1|||
16807454|NCT02485301|37749188|FG000|Overall Study|Protocol Violation|0|||
16807455|NCT02485301|37749189|FG001|Overall Study|Protocol Violation|1|||
16807456|NCT02485301|37749188|FG000|Overall Study|Withdrawal by Subject|6|||
16807457|NCT02485301|37749189|FG001|Overall Study|Withdrawal by Subject|7|||
16807458|NCT02485301|37749188|FG000|Overall Study|Migrated/moved from study area|10|||
16807459|NCT02485301|37749189|FG001|Overall Study|Migrated/moved from study area|19|||
16807460|NCT02485301|37749188|FG000|Overall Study|Lost to Follow-up|17|||
16807461|NCT02485301|37749189|FG001|Overall Study|Lost to Follow-up|17|||
16807462|NCT02485301|37749188|FG000|Overall Study|Other|3|||
16807463|NCT02485301|37749189|FG001|Overall Study|Other|4|||
16807464|NCT02484911|37749197|FG000|Overall Study|Withdrawal by Subject|2|||
16807465|NCT02484911|37749198|FG001|Overall Study|Withdrawal by Subject|1|||
16807466|NCT02484911|37749197|FG000|Overall Study|Protocol Violation|2|||
16807467|NCT02484911|37749198|FG001|Overall Study|Protocol Violation|1|||
16807468|NCT01891396|37749208|FG000|Overall Study|Withdrawal by Subject|4|||
16807469|NCT01891396|37749209|FG001|Overall Study|Withdrawal by Subject|4|||
16807470|NCT01891396|37749210|FG002|Overall Study|Withdrawal by Subject|3|||
16807471|NCT01891396|37749208|FG000|Overall Study|Lost to Follow-up|0|||
16807472|NCT01891396|37749209|FG001|Overall Study|Lost to Follow-up|1|||
16807473|NCT01891396|37749210|FG002|Overall Study|Lost to Follow-up|0|||
16807474|NCT02466425|37749224|FG000|Overall Study|Adverse Event|3|||
16807475|NCT02466425|37749225|FG001|Overall Study|Adverse Event|11|||
16807476|NCT02466425|37749224|FG000|Overall Study|Lack of Efficacy|4|||
16807477|NCT02466425|37749225|FG001|Overall Study|Lack of Efficacy|1|||
16807478|NCT02466425|37749224|FG000|Overall Study|Lost to Follow-up|3|||
16807479|NCT02466425|37749225|FG001|Overall Study|Lost to Follow-up|0|||
16807480|NCT02466425|37749224|FG000|Overall Study|Protocol Violation|1|||
16807481|NCT02466425|37749225|FG001|Overall Study|Protocol Violation|0|||
16807482|NCT02466425|37749224|FG000|Overall Study|Withdrawal by Subject|0|||
16909838|NCT01697358|38018636|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
16909839|NCT01697358|38018635|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
16909840|NCT01697358|38018636|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
16909841|NCT01697358|38018635|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
16909842|NCT01697358|38018636|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
16909843|NCT01697358|38018635|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
16909844|NCT01697358|38018636|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
16909845|NCT01697358|38018635|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
16909846|NCT01697358|38018636|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
16909847|NCT01697358|38018635|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
16909848|NCT01697358|38018636|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
16909849|NCT01716234|38018649|FG000|Overall Study|Protocol Violation|0|||
17102316|NCT00084266|38241213|FG001|Overall Study|Participant not willing to participate|8|||
16807483|NCT02466425|37749225|FG001|Overall Study|Withdrawal by Subject|1|||
16807484|NCT02466425|37749224|FG000|Overall Study|Other|1|||
16807485|NCT02466425|37749225|FG001|Overall Study|Other|3|||
16807486|NCT02466425|37749224|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16807487|NCT02466425|37749225|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16807488|NCT02451917|37749233|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
16807489|NCT02451917|37749234|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
16807490|NCT02451917|37749233|FG000|First Intervention (24 Weeks)|Death|0|||
16807491|NCT02451917|37749234|FG001|First Intervention (24 Weeks)|Death|1|||
16807492|NCT02451917|37749233|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
16807493|NCT02451917|37749234|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
16807494|NCT02349451|37749247|FG000|Overall Study|Withdrawal by Subject|0|||
16807495|NCT02349451|37749248|FG001|Overall Study|Withdrawal by Subject|1|||
16807496|NCT02349451|37749249|FG002|Overall Study|Withdrawal by Subject|2|||
16807497|NCT02349451|37749250|FG003|Overall Study|Withdrawal by Subject|1|||
16807498|NCT02409368|37749267|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
16807499|NCT02409368|37749268|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
16807500|NCT02409368|37749269|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
16807501|NCT02409368|37749270|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
16807502|NCT02409368|37749267|FG000|ECOG Reclassification|Death|1|||
16807503|NCT02409368|37749268|FG001|ECOG Reclassification|Death|5|||
16807504|NCT02409368|37749269|FG002|ECOG Reclassification|Death|0|||
16807505|NCT02409368|37749270|FG003|ECOG Reclassification|Death|0|||
16807506|NCT02409368|37749267|FG000|ECOG Reclassification|Disease Progression|113|||
16807507|NCT02409368|37749268|FG001|ECOG Reclassification|Disease Progression|382|||
16807508|NCT02409368|37749269|FG002|ECOG Reclassification|Disease Progression|70|||
16807509|NCT02409368|37749270|FG003|ECOG Reclassification|Disease Progression|1|||
16807510|NCT02409368|37749267|FG000|ECOG Reclassification|Lost to Follow-up|1|||
16807511|NCT02409368|37749268|FG001|ECOG Reclassification|Lost to Follow-up|5|||
16807512|NCT02409368|37749269|FG002|ECOG Reclassification|Lost to Follow-up|0|||
16807513|NCT02409368|37749270|FG003|ECOG Reclassification|Lost to Follow-up|0|||
16807514|NCT02409368|37749267|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
16807515|NCT02409368|37749268|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
16807516|NCT02409368|37749269|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
16807517|NCT02409368|37749270|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
16807518|NCT02409368|37749267|FG000|ECOG Reclassification|Poor/non-compliance|0|||
16807519|NCT02409368|37749268|FG001|ECOG Reclassification|Poor/non-compliance|3|||
16807520|NCT02409368|37749269|FG002|ECOG Reclassification|Poor/non-compliance|2|||
16807521|NCT02409368|37749270|FG003|ECOG Reclassification|Poor/non-compliance|0|||
16807522|NCT02409368|37749267|FG000|ECOG Reclassification|Study drug toxicity|17|||
16807523|NCT02409368|37749268|FG001|ECOG Reclassification|Study drug toxicity|42|||
16807524|NCT02409368|37749269|FG002|ECOG Reclassification|Study drug toxicity|7|||
16807525|NCT02409368|37749270|FG003|ECOG Reclassification|Study drug toxicity|0|||
16807526|NCT02409368|37749267|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
16807527|NCT02409368|37749268|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
16807528|NCT02409368|37749269|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
16807529|NCT02409368|37749270|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
16807530|NCT02409368|37749267|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
16807531|NCT02409368|37749268|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
16807532|NCT02409368|37749269|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
16807533|NCT02409368|37749270|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
16807534|NCT02409368|37749267|FG000|ECOG Reclassification|Participant withdrew consent|2|||
16807535|NCT02409368|37749268|FG001|ECOG Reclassification|Participant withdrew consent|3|||
16807536|NCT02409368|37749269|FG002|ECOG Reclassification|Participant withdrew consent|4|||
16807537|NCT02409368|37749270|FG003|ECOG Reclassification|Participant withdrew consent|0|||
16807538|NCT02409368|37749267|FG000|ECOG Reclassification|Other Reasons|5|||
16807539|NCT02409368|37749268|FG001|ECOG Reclassification|Other Reasons|26|||
16807540|NCT02409368|37749269|FG002|ECOG Reclassification|Other Reasons|2|||
16807541|NCT02409368|37749270|FG003|ECOG Reclassification|Other Reasons|0|||
16807542|NCT02409368|37749267|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
16807543|NCT02409368|37749268|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
16807544|NCT02409368|37749269|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
16807545|NCT02409368|37749270|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
16807546|NCT01853878|37749283|FG000|Overall Study|Recurrence|2|||
16807547|NCT01853878|37749284|FG001|Overall Study|Recurrence|0|||
16807548|NCT01853878|37749283|FG000|Overall Study|Adverse Event|2|||
16807549|NCT01853878|37749284|FG001|Overall Study|Adverse Event|0|||
16807550|NCT01853878|37749283|FG000|Overall Study|Withdrawal by Subject|3|||
16807551|NCT01853878|37749284|FG001|Overall Study|Withdrawal by Subject|1|||
16807552|NCT01853878|37749283|FG000|Overall Study|Migrated/moved from the study area|1|||
16807553|NCT01853878|37749284|FG001|Overall Study|Migrated/moved from the study area|0|||
16807554|NCT01853878|37749283|FG000|Overall Study|Other|55|||
16807555|NCT01853878|37749284|FG001|Overall Study|Other|43|||
16807556|NCT02342678|37749292|FG000|Overall Study|Lost to Follow-up|0|||
16807557|NCT02342678|37749293|FG001|Overall Study|Lost to Follow-up|1|||
16807558|NCT02342678|37749292|FG000|Overall Study|Too busy to complete study|0|||
16807559|NCT02342678|37749293|FG001|Overall Study|Too busy to complete study|2|||
16807560|NCT02342678|37749292|FG000|Overall Study|Family illness/emergency|0|||
16807561|NCT02342678|37749293|FG001|Overall Study|Family illness/emergency|1|||
16807562|NCT02342678|37749292|FG000|Overall Study|Illness/medical reason|1|||
16807563|NCT02342678|37749293|FG001|Overall Study|Illness/medical reason|1|||
16807564|NCT02408120|37749301|FG000|Overall Study|Withdrawal by Subject|0|||
16807565|NCT02408120|37749302|FG001|Overall Study|Withdrawal by Subject|1|||
16807566|NCT02408120|37749301|FG000|Overall Study|Treatment Refusal|1|||
16807567|NCT02408120|37749302|FG001|Overall Study|Treatment Refusal|0|||
16807568|NCT02408120|37749301|FG000|Overall Study|Received Steroids|1|||
16807569|NCT02408120|37749302|FG001|Overall Study|Received Steroids|1|||
16807570|NCT02408120|37749301|FG000|Overall Study|Discharged same day|1|||
16807571|NCT02408120|37749302|FG001|Overall Study|Discharged same day|1|||
16807572|NCT02408120|37749301|FG000|Overall Study|Did not receive insulin|1|||
16807573|NCT02408120|37749302|FG001|Overall Study|Did not receive insulin|2|||
16807574|NCT02342288|37749310|FG000|Overall Study|no protocol anesthesiologist available|3|||
16807575|NCT02342288|37749311|FG001|Overall Study|no protocol anesthesiologist available|2|||
16807576|NCT02342288|37749310|FG000|Overall Study|anesthesia leak in system|1|||
16807577|NCT02342288|37749311|FG001|Overall Study|anesthesia leak in system|0|||
16807578|NCT02342288|37749310|FG000|Overall Study|Withdrawal by Subject|1|||
16807579|NCT02342288|37749311|FG001|Overall Study|Withdrawal by Subject|0|||
16807580|NCT02342288|37749310|FG000|Overall Study|coordinator contaminated with blood|0|||
16807581|NCT02342288|37749311|FG001|Overall Study|coordinator contaminated with blood|1|||
16807582|NCT02342288|37749310|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
16807583|NCT02342288|37749311|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
16807584|NCT02342288|37749310|FG000|Overall Study|coordinator not available|0|||
16807585|NCT02342288|37749311|FG001|Overall Study|coordinator not available|2|||
16807586|NCT01853644|37749317|FG000|Registration and Treatment Start|Did not start treatment|1|||
16807587|NCT01853644|37749317|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
16807588|NCT01853644|37749317|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
16807589|NCT01853644|37749317|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
16807590|NCT01853644|37749317|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
16807591|NCT01853644|37749317|FG000|Continued Treatment After First Response|Adverse Event|2|||
16807592|NCT01853644|37749317|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
16807593|NCT02374346|37749321|FG000|Overall Study|operated or discharged during weekend|48|||
16807594|NCT01853254|37749327|FG000|Overall Study|Abnormal Laboratory Test|1|||
16807595|NCT01853254|37749327|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
16807596|NCT01853254|37749327|FG000|Overall Study|Death|1|||
16807597|NCT01853254|37749327|FG000|Overall Study|Failure to Return|43|||
16807598|NCT01853254|37749327|FG000|Overall Study|Insufficient Therapeutic Response|22|||
16807599|NCT01853254|37749327|FG000|Overall Study|Refusal of Treatment|1|||
16807600|NCT01853254|37749327|FG000|Overall Study|Other Protocol Violation|1|||
16807601|NCT01853254|37749327|FG000|Overall Study|Withdrawal of Consent|16|||
16807602|NCT01853254|37749327|FG000|Overall Study|Administrative/Other|16|||
16807603|NCT02373098|37749333|FG000|Overall Study|Lost to Follow-up|1|||
16807604|NCT02373098|37749334|FG001|Overall Study|Lost to Follow-up|0|||
16807605|NCT02373098|37749333|FG000|Overall Study|Protocol Violation|3|||
16807606|NCT02373098|37749334|FG001|Overall Study|Protocol Violation|0|||
16807607|NCT02373098|37749333|FG000|Overall Study|Withdrawal by Subject|5|||
16807608|NCT02373098|37749334|FG001|Overall Study|Withdrawal by Subject|0|||
16807609|NCT02373098|37749333|FG000|Overall Study|Adverse Event|3|||
16807610|NCT02373098|37749334|FG001|Overall Study|Adverse Event|0|||
16807611|NCT01853176|37749348|FG000|Overall Study|Study terminated|4|||
16807612|NCT01853176|37749349|FG001|Overall Study|Study terminated|0|||
16807613|NCT02372396|37749357|FG000|Overall Study|Lost to Follow-up|7|||
16807614|NCT02372396|37749358|FG001|Overall Study|Lost to Follow-up|9|||
16807615|NCT01835548|37749366|FG000|Dose Optimization Period|Adverse Event|0|||
16807616|NCT01835548|37749367|FG001|Dose Optimization Period|Adverse Event|0|||
16807617|NCT01835548|37749368|FG002|Dose Optimization Period|Adverse Event|1|||
16807618|NCT01835548|37749366|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
16807619|NCT01835548|37749367|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
16807620|NCT01835548|37749368|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
16807621|NCT01835548|37749366|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16807622|NCT01835548|37749367|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16807623|NCT01835548|37749368|FG002|Double-Blind Treatment Period|Adverse Event|0|||
16807624|NCT01835548|37749366|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16807625|NCT01835548|37749367|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16807626|NCT01835548|37749368|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16807627|NCT02340962|37749382|FG000|Overall Study|Lost to Follow-up|1|||
16807628|NCT02340962|37749383|FG001|Overall Study|Lost to Follow-up|0|||
16807629|NCT01852942|37749391|FG000|Overall Study|Physician Decision|1|||
16807630|NCT01852942|37749392|FG001|Overall Study|Physician Decision|0|||
16807631|NCT01852942|37749391|FG000|Overall Study|Death|1|||
16807632|NCT01852942|37749392|FG001|Overall Study|Death|1|||
16807633|NCT01852942|37749391|FG000|Overall Study|Withdrawal by Subject|2|||
16807634|NCT01852942|37749392|FG001|Overall Study|Withdrawal by Subject|3|||
16807635|NCT01852942|37749391|FG000|Overall Study|Lost to Follow-up|1|||
16807636|NCT01852942|37749392|FG001|Overall Study|Lost to Follow-up|2|||
16807637|NCT01852162|37749401|FG000|Overall Study|Adverse Event|1|||
16807638|NCT01852162|37749402|FG001|Overall Study|Adverse Event|0|||
16807639|NCT01852162|37749401|FG000|Overall Study|Withdrawal by Subject|3|||
16807640|NCT01852162|37749402|FG001|Overall Study|Withdrawal by Subject|1|||
16807641|NCT01835470|37749408|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
16807642|NCT01835470|37749408|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
16807643|NCT02451137|37749415|FG000|Overall Study|Randomized but not treated|19|||
16807644|NCT02451137|37749416|FG001|Overall Study|Randomized but not treated|27|||
16807645|NCT02451137|37749415|FG000|Overall Study|Adverse Event|43|||
16807646|NCT02451137|37749416|FG001|Overall Study|Adverse Event|42|||
16807647|NCT02451137|37749415|FG000|Overall Study|Lack of Efficacy|4|||
16807648|NCT02451137|37749416|FG001|Overall Study|Lack of Efficacy|9|||
16807649|NCT02451137|37749415|FG000|Overall Study|Participant decision:discontinue insulin|41|||
16807650|NCT02451137|37749416|FG001|Overall Study|Participant decision:discontinue insulin|43|||
16807651|NCT02451137|37749415|FG000|Overall Study|Hypoglycemia|2|||
16807652|NCT02451137|37749416|FG001|Overall Study|Hypoglycemia|1|||
16807653|NCT02451137|37749415|FG000|Overall Study|Investigator's decision|23|||
16807654|NCT02451137|37749416|FG001|Overall Study|Investigator's decision|19|||
16807655|NCT02451137|37749415|FG000|Overall Study|Lost to Follow-up|53|||
16807656|NCT02451137|37749416|FG001|Overall Study|Lost to Follow-up|61|||
16807657|NCT02451137|37749415|FG000|Overall Study|Physician Decision|6|||
16807658|NCT02451137|37749416|FG001|Overall Study|Physician Decision|5|||
16807659|NCT02451137|37749415|FG000|Overall Study|Sponsor decision|13|||
16807660|NCT02451137|37749416|FG001|Overall Study|Sponsor decision|25|||
16807661|NCT02451137|37749415|FG000|Overall Study|Withdrawal by Subject|40|||
16807662|NCT02451137|37749416|FG001|Overall Study|Withdrawal by Subject|63|||
16807663|NCT02451137|37749415|FG000|Overall Study|Other than specified above|2|||
16807664|NCT02451137|37749416|FG001|Overall Study|Other than specified above|3|||
16807665|NCT02372006|37749425|FG000|Overall Study|Progressive disease|8|||
16807666|NCT02372006|37749426|FG001|Overall Study|Progressive disease|7|||
16807667|NCT02372006|37749427|FG002|Overall Study|Progressive disease|34|||
16807668|NCT02372006|37749425|FG000|Overall Study|Dose limiting toxicity|0|||
16807669|NCT02372006|37749426|FG001|Overall Study|Dose limiting toxicity|1|||
16807670|NCT02372006|37749427|FG002|Overall Study|Dose limiting toxicity|0|||
16807671|NCT02372006|37749425|FG000|Overall Study|Adverse Event|0|||
16807672|NCT02372006|37749426|FG001|Overall Study|Adverse Event|0|||
16807673|NCT02372006|37749427|FG002|Overall Study|Adverse Event|3|||
16807674|NCT02372006|37749425|FG000|Overall Study|Withdrawal by Subject|0|||
16807675|NCT02372006|37749426|FG001|Overall Study|Withdrawal by Subject|1|||
16807676|NCT02372006|37749427|FG002|Overall Study|Withdrawal by Subject|1|||
16807677|NCT02372006|37749425|FG000|Overall Study|Other reason for not completing|0|||
16807678|NCT02372006|37749426|FG001|Overall Study|Other reason for not completing|0|||
16807679|NCT02372006|37749427|FG002|Overall Study|Other reason for not completing|1|||
16807680|NCT02406248|37749436|FG000|Overall Study|Death|7|||
16807681|NCT02406248|37749436|FG000|Overall Study|Withdrawal by Subject|2|||
16807682|NCT02450903|37749440|FG000|Overall Study|Adverse Event|3|||
16807683|NCT02450903|37749440|FG000|Overall Study|Progressive disease|15|||
16807684|NCT02450903|37749440|FG000|Overall Study|Switched to commercial drug|1|||
16909850|NCT01716234|38018650|FG001|Overall Study|Protocol Violation|0|||
16909851|NCT01716234|38018651|FG002|Overall Study|Protocol Violation|0|||
17016557|NCT00855218|38161203|FG000|Overall Study|non-compliant with study drug|3|||
17102317|NCT00084266|38241212|FG000|Overall Study|Other|360|||
16807685|NCT02450903|37749440|FG000|Overall Study|Subject/guardian decision|1|||
16807686|NCT02371616|37749446|FG000|Overall Study|Protocol Violation|2|||
16807687|NCT02371616|37749447|FG001|Overall Study|Protocol Violation|1|||
16807688|NCT02371616|37749446|FG000|Overall Study|Adverse Event|0|||
16807689|NCT02371616|37749447|FG001|Overall Study|Adverse Event|1|||
16807690|NCT02371616|37749446|FG000|Overall Study|Withdrawal of Consent|1|||
16807691|NCT02371616|37749447|FG001|Overall Study|Withdrawal of Consent|0|||
16807692|NCT02371616|37749446|FG000|Overall Study|Other (Not specified)|1|||
16807693|NCT02371616|37749447|FG001|Overall Study|Other (Not specified)|5|||
16807694|NCT02370914|37749453|FG000|Overall Study|Protocol Violation|2|||
16807695|NCT02370602|37749463|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16807696|NCT02370602|37749464|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16807697|NCT02370602|37749465|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16807698|NCT02370602|37749466|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
16807699|NCT02370602|37749467|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
16807700|NCT02370602|37749468|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
16807701|NCT02370368|37749487|FG000|Overall Study|Adverse Event|1|||
16807702|NCT02370368|37749488|FG001|Overall Study|Adverse Event|2|||
16807703|NCT02370368|37749487|FG000|Overall Study|Withdrawal by Subject|5|||
16807704|NCT02370368|37749488|FG001|Overall Study|Withdrawal by Subject|4|||
16807705|NCT02340806|37749496|FG000|Overall Study|Protocol Violation|2|||
16807706|NCT02340806|37749497|FG001|Overall Study|Protocol Violation|0|||
16807707|NCT02340806|37749496|FG000|Overall Study|epidural catheter replaced|2|||
16807708|NCT02340806|37749497|FG001|Overall Study|epidural catheter replaced|1|||
16807709|NCT02340806|37749496|FG000|Overall Study|history of chronic pain medication|1|||
16807710|NCT02340806|37749497|FG001|Overall Study|history of chronic pain medication|0|||
16807711|NCT02340806|37749496|FG000|Overall Study|re-dose < 90 min of CSE|1|||
16807712|NCT02340806|37749497|FG001|Overall Study|re-dose < 90 min of CSE|3|||
16807713|NCT02338154|37749503|FG000|Overall Study|Death|46|||
16807714|NCT02338154|37749503|FG000|Overall Study|Valve Implant Failure|17|||
16807715|NCT02338154|37749503|FG000|Overall Study|Valve Explant|11|||
16807716|NCT02338154|37749503|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
16807717|NCT02338154|37749503|FG000|Overall Study|Lost to Follow-up|8|||
16807718|NCT02338154|37749503|FG000|Overall Study|Other Reason|3|||
16807719|NCT02338154|37749503|FG000|Overall Study|Patients Without Exit Form|47|||
16807720|NCT02338154|37749503|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
16807721|NCT01835158|37749517|FG000|Overall Study|Withdrawal by Subject|1|||
16807722|NCT01835158|37749518|FG001|Overall Study|Withdrawal by Subject|6|||
16807723|NCT02337764|37749524|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
16807724|NCT02337764|37749524|FG000|Overall Study|Voluntary Withdrawal|12|||
16807725|NCT02337764|37749524|FG000|Overall Study|Lack of Efficacy|2|||
16807726|NCT01834222|37749528|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
16807727|NCT01833832|37749532|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
16807728|NCT01833520|37749538|FG000|Overall Study|Lack of Efficacy|3|||
16909852|NCT01716234|38018652|FG003|Overall Study|Protocol Violation|1|||
16909853|NCT01716234|38018653|FG004|Overall Study|Protocol Violation|1|||
16807729|NCT01833520|37749539|FG001|Overall Study|Lack of Efficacy|3|||
16807730|NCT01833520|37749540|FG002|Overall Study|Lack of Efficacy|8|||
16807731|NCT01833520|37749541|FG003|Overall Study|Lack of Efficacy|3|||
16807732|NCT01850602|37749555|FG000|Overall Study|Adverse Event|7|||
16807733|NCT01850602|37749556|FG001|Overall Study|Adverse Event|10|||
16807734|NCT01850602|37749555|FG000|Overall Study|Physician Decision|2|||
17102318|NCT00084266|38241213|FG001|Overall Study|Other|344|||
16807735|NCT01850602|37749556|FG001|Overall Study|Physician Decision|1|||
16807736|NCT01850602|37749555|FG000|Overall Study|Withdrawal by Subject|2|||
16807737|NCT01850602|37749556|FG001|Overall Study|Withdrawal by Subject|4|||
16807738|NCT01850602|37749555|FG000|Overall Study|Decrease in serum calcium|2|||
16807739|NCT01850602|37749556|FG001|Overall Study|Decrease in serum calcium|3|||
16807740|NCT01850602|37749555|FG000|Overall Study|Increase in serum ferritin|1|||
16807741|NCT01850602|37749556|FG001|Overall Study|Increase in serum ferritin|0|||
16807742|NCT01832818|37749562|FG000|Overall Study|Lost to Follow-up|6|||
16807743|NCT02405780|37749570|FG000|Period I|Adverse Event|8|||
16807744|NCT02405780|37749571|FG001|Period I|Adverse Event|0|||
16807745|NCT02405780|37749572|FG002|Period I|Adverse Event|3|||
16807746|NCT02405780|37749573|FG003|Period I|Adverse Event|7|||
16807747|NCT02405780|37749570|FG000|Period I|Medical reasons|1|||
16807748|NCT02405780|37749571|FG001|Period I|Medical reasons|1|||
16807749|NCT02405780|37749572|FG002|Period I|Medical reasons|0|||
16807750|NCT02405780|37749573|FG003|Period I|Medical reasons|1|||
16807751|NCT02405780|37749570|FG000|Period I|Screening Failure|1|||
16807752|NCT02405780|37749571|FG001|Period I|Screening Failure|0|||
16807753|NCT02405780|37749572|FG002|Period I|Screening Failure|1|||
16807754|NCT02405780|37749573|FG003|Period I|Screening Failure|0|||
16807755|NCT02405780|37749570|FG000|Period I|Withdrawal by Subject|9|||
16807756|NCT02405780|37749571|FG001|Period I|Withdrawal by Subject|1|||
16807757|NCT02405780|37749572|FG002|Period I|Withdrawal by Subject|3|||
16807758|NCT02405780|37749573|FG003|Period I|Withdrawal by Subject|4|||
16807759|NCT02405780|37749570|FG000|Period I|Non-compliance with study procedures|8|||
16807760|NCT02405780|37749571|FG001|Period I|Non-compliance with study procedures|6|||
16807761|NCT02405780|37749572|FG002|Period I|Non-compliance with study procedures|8|||
16807762|NCT02405780|37749573|FG003|Period I|Non-compliance with study procedures|11|||
16807763|NCT02405780|37749570|FG000|Period II|Adverse Event|3|||
16807764|NCT02405780|37749571|FG001|Period II|Adverse Event|5|||
16807765|NCT02405780|37749572|FG002|Period II|Adverse Event|4|||
16807766|NCT02405780|37749573|FG003|Period II|Adverse Event|11|||
16807767|NCT02405780|37749570|FG000|Period II|Medical reason|0|||
16807768|NCT02405780|37749571|FG001|Period II|Medical reason|1|||
16807769|NCT02405780|37749572|FG002|Period II|Medical reason|0|||
16807770|NCT02405780|37749573|FG003|Period II|Medical reason|0|||
16807771|NCT02405780|37749570|FG000|Period II|Pregnancy|0|||
16807772|NCT02405780|37749571|FG001|Period II|Pregnancy|0|||
16807773|NCT02405780|37749572|FG002|Period II|Pregnancy|1|||
16807774|NCT02405780|37749573|FG003|Period II|Pregnancy|0|||
16807775|NCT02405780|37749570|FG000|Period II|Withdrawal by Subject|7|||
16807776|NCT02405780|37749571|FG001|Period II|Withdrawal by Subject|4|||
16807777|NCT02405780|37749572|FG002|Period II|Withdrawal by Subject|0|||
16807778|NCT02405780|37749573|FG003|Period II|Withdrawal by Subject|3|||
16807779|NCT02405780|37749570|FG000|Period II|Non-compliance with study procedures|5|||
16807780|NCT02405780|37749571|FG001|Period II|Non-compliance with study procedures|2|||
16807781|NCT02405780|37749572|FG002|Period II|Non-compliance with study procedures|7|||
16807782|NCT02405780|37749573|FG003|Period II|Non-compliance with study procedures|4|||
16807783|NCT02369510|37749601|FG000|Overall Study|Spilled Medication|1|||
16807784|NCT02369510|37749602|FG001|Overall Study|Spilled Medication|2|||
16807785|NCT02369510|37749603|FG002|Overall Study|Spilled Medication|1|||
16807786|NCT02369510|37749601|FG000|Overall Study|Epidural Activation|1|||
16807787|NCT02369510|37749602|FG001|Overall Study|Epidural Activation|1|||
16807788|NCT02369510|37749603|FG002|Overall Study|Epidural Activation|5|||
16807789|NCT01650194|37749611|FG000|Overall Study|Progressive Disease (PD)|35|||
16807790|NCT01650194|37749611|FG000|Overall Study|Withdrawal by Subject|2|||
16807791|NCT01650194|37749611|FG000|Overall Study|Miscellaneous|10|||
16807792|NCT02367716|37749616|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
16807793|NCT02366936|37749621|FG000|Overall Study|Withdrawal by Subject|2|||
16807794|NCT02366936|37749621|FG000|Overall Study|Lost to Follow-up|4|||
16807795|NCT02366936|37749621|FG000|Overall Study|Physician Decision|2|||
16807796|NCT01648166|37749627|FG000|Overall Study|inadequate toenail samples|53|||
16807797|NCT01648166|37749628|FG001|Overall Study|inadequate toenail samples|100|||
16807798|NCT02336282|37749634|FG000|Overall Study|Unrelated illness|1|||
16807799|NCT02336282|37749634|FG000|Overall Study|Uncomfortable with technology|1|||
16807800|NCT02336282|37749634|FG000|Overall Study|Lost to Follow-up|1|||
16807801|NCT02336282|37749634|FG000|Overall Study|Not enough time to complete sessions|2|||
16807802|NCT02404220|37749650|FG000|Overall Study|Adverse Event|0|||
16807803|NCT02404220|37749651|FG001|Overall Study|Adverse Event|0|||
16807804|NCT02404220|37749652|FG002|Overall Study|Adverse Event|1|||
16807805|NCT02404220|37749653|FG003|Overall Study|Adverse Event|0|||
16807806|NCT02404220|37749650|FG000|Overall Study|Death|5|||
16807807|NCT02404220|37749651|FG001|Overall Study|Death|5|||
16807808|NCT02404220|37749652|FG002|Overall Study|Death|3|||
16807809|NCT02404220|37749653|FG003|Overall Study|Death|8|||
16807810|NCT02404220|37749650|FG000|Overall Study|Progressive Disease|0|||
16807811|NCT02404220|37749651|FG001|Overall Study|Progressive Disease|0|||
16807812|NCT02404220|37749652|FG002|Overall Study|Progressive Disease|1|||
16807813|NCT02404220|37749653|FG003|Overall Study|Progressive Disease|1|||
16807814|NCT02404220|37749650|FG000|Overall Study|Study Terminated by Sponsor|0|||
16807815|NCT02404220|37749651|FG001|Overall Study|Study Terminated by Sponsor|0|||
16807816|NCT02404220|37749652|FG002|Overall Study|Study Terminated by Sponsor|2|||
16807817|NCT02404220|37749653|FG003|Overall Study|Study Terminated by Sponsor|1|||
16807818|NCT02404220|37749650|FG000|Overall Study|Withdrawal by Subject|0|||
16807819|NCT02404220|37749651|FG001|Overall Study|Withdrawal by Subject|1|||
16807820|NCT02404220|37749652|FG002|Overall Study|Withdrawal by Subject|0|||
16807821|NCT02404220|37749653|FG003|Overall Study|Withdrawal by Subject|0|||
16807822|NCT02404220|37749650|FG000|Overall Study|Enrolled but Never Treated|0|||
16807823|NCT02404220|37749651|FG001|Overall Study|Enrolled but Never Treated|2|||
16807824|NCT02404220|37749652|FG002|Overall Study|Enrolled but Never Treated|0|||
16807825|NCT02404220|37749653|FG003|Overall Study|Enrolled but Never Treated|0|||
16807826|NCT02335658|37749665|FG000|Overall Study|Adverse Event|18|||
16807827|NCT02335658|37749666|FG001|Overall Study|Adverse Event|12|||
16807828|NCT02335658|37749665|FG000|Overall Study|Lack of Efficacy|4|||
16807829|NCT02335658|37749666|FG001|Overall Study|Lack of Efficacy|5|||
16807830|NCT02335658|37749665|FG000|Overall Study|Pregnancy|1|||
16807831|NCT02335658|37749666|FG001|Overall Study|Pregnancy|0|||
16807832|NCT02335658|37749665|FG000|Overall Study|Withdrawal by Subject|13|||
16807833|NCT02335658|37749666|FG001|Overall Study|Withdrawal by Subject|21|||
16807834|NCT02335658|37749665|FG000|Overall Study|non-compliance|2|||
16807835|NCT02335658|37749666|FG001|Overall Study|non-compliance|3|||
16807836|NCT02335658|37749665|FG000|Overall Study|other reason|2|||
16807837|NCT02335658|37749666|FG001|Overall Study|other reason|3|||
16807838|NCT02366468|37749676|FG000|Overall Study|Adverse Event|2|||
16807839|NCT02366468|37749677|FG001|Overall Study|Adverse Event|0|||
16807840|NCT02366468|37749676|FG000|Overall Study|Withdrawal by Subject|1|||
16807841|NCT02366468|37749677|FG001|Overall Study|Withdrawal by Subject|5|||
16807842|NCT02366468|37749676|FG000|Overall Study|Lost to Follow-up|2|||
16807843|NCT02366468|37749677|FG001|Overall Study|Lost to Follow-up|0|||
16807844|NCT02366468|37749676|FG000|Overall Study|Death|1|||
16807845|NCT02366468|37749677|FG001|Overall Study|Death|2|||
16807846|NCT02366468|37749676|FG000|Overall Study|Other|0|||
16807847|NCT02366468|37749677|FG001|Overall Study|Other|2|||
16807848|NCT02366312|37749685|FG000|Overall Study|Lost to Follow-up|0|||
16807849|NCT02366312|37749686|FG001|Overall Study|Lost to Follow-up|1|||
16807850|NCT02335346|37749692|FG000|Overall Study|Adverse Event|11|||
16807851|NCT02335346|37749692|FG000|Overall Study|Withdrawal by Subject|1|||
16807852|NCT02403674|37749698|FG000|Overall Study|Adverse Event|10|||
16807853|NCT02403674|37749699|FG001|Overall Study|Adverse Event|23|||
16807854|NCT02403674|37749698|FG000|Overall Study|Death|1|||
16807855|NCT02403674|37749699|FG001|Overall Study|Death|3|||
16807856|NCT02403674|37749698|FG000|Overall Study|Lack of Efficacy|18|||
16807857|NCT02403674|37749699|FG001|Overall Study|Lack of Efficacy|10|||
16807858|NCT02403674|37749698|FG000|Overall Study|Lost to Follow-up|6|||
16807859|NCT02403674|37749699|FG001|Overall Study|Lost to Follow-up|7|||
16807860|NCT02403674|37749698|FG000|Overall Study|Noncompliance with study drug|1|||
16807861|NCT02403674|37749699|FG001|Overall Study|Noncompliance with study drug|2|||
16807862|NCT02403674|37749698|FG000|Overall Study|Withdrawal by Subject|8|||
16807863|NCT02403674|37749699|FG001|Overall Study|Withdrawal by Subject|11|||
16807864|NCT02403674|37749698|FG000|Overall Study|Physician Decision|2|||
16807865|NCT02403674|37749699|FG001|Overall Study|Physician Decision|2|||
16807866|NCT02403674|37749698|FG000|Overall Study|Not treated with study drug|4|||
16807867|NCT02403674|37749699|FG001|Overall Study|Not treated with study drug|2|||
16807868|NCT02403674|37749698|FG000|Overall Study|Pregnancy|1|||
16807869|NCT02403674|37749699|FG001|Overall Study|Pregnancy|1|||
16807870|NCT02403674|37749698|FG000|Overall Study|Protocol Violation|4|||
16807871|NCT02403674|37749699|FG001|Overall Study|Protocol Violation|2|||
16807872|NCT02403206|37749707|FG000|Overall Study|Lost to Follow-up|4|||
16807873|NCT02403206|37749708|FG001|Overall Study|Lost to Follow-up|3|||
16807874|NCT02403206|37749707|FG000|Overall Study|Physician Decision|2|||
16807875|NCT02403206|37749708|FG001|Overall Study|Physician Decision|0|||
16807876|NCT02403206|37749707|FG000|Overall Study|Withdrawal by Subject|3|||
16807877|NCT02403206|37749708|FG001|Overall Study|Withdrawal by Subject|3|||
16807878|NCT02403206|37749707|FG000|Overall Study|Reason not given|2|||
16807879|NCT02403206|37749708|FG001|Overall Study|Reason not given|4|||
16807880|NCT02333630|37749717|FG000|Overall Study|Lost to Follow-up|5|||
16807881|NCT02333630|37749718|FG001|Overall Study|Lost to Follow-up|2|||
16807882|NCT02401412|37749730|FG000|Overall Study|Lost to Follow-up|1|||
16807883|NCT02401412|37749731|FG001|Overall Study|Lost to Follow-up|0|||
16807884|NCT02401412|37749730|FG000|Overall Study|Discontinued Intervention|15|||
16807885|NCT02401412|37749731|FG001|Overall Study|Discontinued Intervention|21|||
16807886|NCT02401412|37749730|FG000|Overall Study|Withdrawal by Subject|4|||
16807887|NCT02401412|37749731|FG001|Overall Study|Withdrawal by Subject|4|||
16807888|NCT02401412|37749730|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
16807889|NCT02401412|37749731|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
16807890|NCT02401412|37749730|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
16807891|NCT02401412|37749731|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
16807892|NCT02365298|37749737|FG000|Period 2|incorrect Rx dispensed|1|||
16807893|NCT02365298|37749738|FG001|Period 2|incorrect Rx dispensed|0|||
16807894|NCT02365298|37749737|FG000|Period 2|Discontinued at request of Sponsor|1|||
16807895|NCT02365298|37749738|FG001|Period 2|Discontinued at request of Sponsor|0|||
16807896|NCT02365298|37749737|FG000|Period 2|Test Article longer available|0|||
16807897|NCT02365298|37749738|FG001|Period 2|Test Article longer available|1|||
16807898|NCT02365298|37749737|FG000|Period 2|Protocol Violation|0|||
16807899|NCT02365298|37749738|FG001|Period 2|Protocol Violation|1|||
16807900|NCT02365064|37749746|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
16807901|NCT02365064|37749747|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
16807902|NCT02365064|37749746|FG000|Overall Study|Withdrawal by Subject|6|||
16807903|NCT02365064|37749747|FG001|Overall Study|Withdrawal by Subject|9|||
16807904|NCT02365064|37749746|FG000|Overall Study|Treatment intolerance|2|||
16807905|NCT02365064|37749747|FG001|Overall Study|Treatment intolerance|4|||
16807906|NCT02401256|37749753|FG000|Overall Study|Adverse Event|5|||
16807907|NCT02401256|37749753|FG000|Overall Study|Withdrawal by Subject|12|||
16807908|NCT02349295|37749762|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
16807909|NCT02349295|37749763|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
16807910|NCT02349295|37749764|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
16807911|NCT02349295|37749765|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807912|NCT02349295|37749766|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807913|NCT02349295|37749767|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807914|NCT02349295|37749768|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807915|NCT02349295|37749769|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807916|NCT02349295|37749770|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807917|NCT02349295|37749771|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807918|NCT02349295|37749772|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807919|NCT02349295|37749773|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807920|NCT02349295|37749774|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807921|NCT02349295|37749775|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16807922|NCT02349295|37749762|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
16807923|NCT02349295|37749763|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
16807924|NCT02349295|37749764|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
16807925|NCT02349295|37749765|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807926|NCT02349295|37749766|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807927|NCT02349295|37749767|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807928|NCT02349295|37749768|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807929|NCT02349295|37749769|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807930|NCT02349295|37749770|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807931|NCT02349295|37749771|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807932|NCT02349295|37749772|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807933|NCT02349295|37749773|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807934|NCT02349295|37749774|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807935|NCT02349295|37749775|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16807936|NCT02349295|37749762|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
16807937|NCT02349295|37749763|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
16807938|NCT02349295|37749764|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
16807939|NCT02349295|37749765|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807940|NCT02349295|37749766|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807941|NCT02349295|37749767|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807942|NCT02349295|37749768|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807943|NCT02349295|37749769|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807944|NCT02349295|37749770|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807945|NCT02349295|37749771|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807946|NCT02349295|37749772|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807947|NCT02349295|37749773|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807948|NCT02349295|37749774|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807949|NCT02349295|37749775|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16807950|NCT02349295|37749762|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
16807951|NCT02349295|37749763|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
16807952|NCT02349295|37749764|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
16807953|NCT02349295|37749765|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807954|NCT02349295|37749766|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807955|NCT02349295|37749767|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807956|NCT02349295|37749768|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807957|NCT02349295|37749769|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807958|NCT02349295|37749770|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807959|NCT02349295|37749771|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807960|NCT02349295|37749772|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807961|NCT02349295|37749773|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807962|NCT02349295|37749774|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807963|NCT02349295|37749775|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16807964|NCT02349295|37749762|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807965|NCT02349295|37749763|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
16807966|NCT02349295|37749764|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
16807967|NCT02349295|37749765|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807968|NCT02349295|37749766|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807969|NCT02349295|37749767|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807970|NCT02349295|37749768|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807971|NCT02349295|37749769|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807972|NCT02349295|37749770|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807973|NCT02349295|37749771|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807974|NCT02349295|37749772|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807975|NCT02349295|37749773|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807976|NCT02349295|37749774|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807977|NCT02349295|37749775|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16807978|NCT02349295|37749762|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
16807979|NCT02349295|37749763|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
16807980|NCT02349295|37749764|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
16807981|NCT02349295|37749765|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
16807982|NCT02349295|37749766|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
16807983|NCT02349295|37749767|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
16807984|NCT02349295|37749768|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
16807985|NCT02349295|37749769|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
16807986|NCT02349295|37749770|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
16807987|NCT02349295|37749771|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
16807988|NCT02349295|37749772|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
16807989|NCT02349295|37749773|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
16807990|NCT02349295|37749774|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
16807991|NCT02349295|37749775|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
16807992|NCT02349295|37749762|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16807993|NCT02349295|37749763|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16807994|NCT02349295|37749764|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16807995|NCT02349295|37749765|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16807996|NCT02349295|37749766|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16807997|NCT02349295|37749767|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16807998|NCT02349295|37749768|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16807999|NCT02349295|37749769|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
16808000|NCT02349295|37749770|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
16808001|NCT02349295|37749771|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
16808002|NCT02349295|37749772|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
16808003|NCT02349295|37749773|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16808004|NCT02349295|37749774|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16808005|NCT02349295|37749775|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16808006|NCT02349295|37749762|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808007|NCT02349295|37749763|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808008|NCT02349295|37749764|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808009|NCT02349295|37749765|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808010|NCT02349295|37749766|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808011|NCT02349295|37749767|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808012|NCT02349295|37749768|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808013|NCT02349295|37749769|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
16808014|NCT02349295|37749770|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
16808015|NCT02349295|37749771|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
16808016|NCT02349295|37749772|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
16808017|NCT02349295|37749773|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808018|NCT02349295|37749774|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808019|NCT02349295|37749775|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16808020|NCT02349295|37749762|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808021|NCT02349295|37749763|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808022|NCT02349295|37749764|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808023|NCT02349295|37749765|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808024|NCT02349295|37749766|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808025|NCT02349295|37749767|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808026|NCT02349295|37749768|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808027|NCT02349295|37749769|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
17016558|NCT00855218|38161204|FG001|Overall Study|non-compliant with study drug|1|||
16808028|NCT02349295|37749770|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808029|NCT02349295|37749771|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
16808030|NCT02349295|37749772|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808031|NCT02349295|37749773|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808032|NCT02349295|37749774|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808033|NCT02349295|37749775|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16808034|NCT02349295|37749762|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
16808035|NCT02349295|37749763|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
16808036|NCT02349295|37749764|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
16808037|NCT02349295|37749765|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
16808038|NCT02349295|37749766|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
16808039|NCT02349295|37749767|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
16808040|NCT02349295|37749768|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
16808041|NCT02349295|37749769|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
16808042|NCT02349295|37749770|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
16808043|NCT02349295|37749771|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
16808044|NCT02349295|37749772|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
16808045|NCT02349295|37749773|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
16808046|NCT02349295|37749774|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
16808047|NCT02349295|37749775|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
16808048|NCT02349295|37749762|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808049|NCT02349295|37749763|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808050|NCT02349295|37749764|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808051|NCT02349295|37749765|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808052|NCT02349295|37749766|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808053|NCT02349295|37749767|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808054|NCT02349295|37749768|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808055|NCT02349295|37749769|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
16808056|NCT02349295|37749770|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
16808057|NCT02349295|37749771|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
16808058|NCT02349295|37749772|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
16808059|NCT02349295|37749773|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808060|NCT02349295|37749774|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808061|NCT02349295|37749775|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16808062|NCT02349295|37749762|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808063|NCT02349295|37749763|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808064|NCT02349295|37749764|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808065|NCT02349295|37749765|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808066|NCT02349295|37749766|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808067|NCT02349295|37749767|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808068|NCT02349295|37749768|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808069|NCT02349295|37749769|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
16808070|NCT02349295|37749770|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
16808071|NCT02349295|37749771|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808072|NCT02349295|37749772|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808073|NCT02349295|37749773|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808074|NCT02349295|37749774|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808075|NCT02349295|37749775|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16808076|NCT02349295|37749762|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808077|NCT02349295|37749763|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808078|NCT02349295|37749764|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808079|NCT02349295|37749765|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808080|NCT02349295|37749766|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808081|NCT02349295|37749767|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808082|NCT02349295|37749768|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808083|NCT02349295|37749769|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
16808084|NCT02349295|37749770|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
16808085|NCT02349295|37749771|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808086|NCT02349295|37749772|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808087|NCT02349295|37749773|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808088|NCT02349295|37749774|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16808089|NCT02349295|37749775|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16909854|NCT01716234|38018654|FG005|Overall Study|Protocol Violation|1|||
17102319|NCT00084266|38241212|FG000|Overall Study|Randomized not treated|21|||
16808090|NCT02349295|37749762|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808091|NCT02349295|37749763|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808092|NCT02349295|37749764|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808093|NCT02349295|37749765|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808094|NCT02349295|37749766|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808095|NCT02349295|37749767|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808096|NCT02349295|37749768|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808097|NCT02349295|37749769|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808098|NCT02349295|37749770|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808099|NCT02349295|37749771|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808100|NCT02349295|37749772|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16808101|NCT02349295|37749773|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
16808102|NCT02349295|37749774|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
16808103|NCT02349295|37749775|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
16808104|NCT02349295|37749762|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808105|NCT02349295|37749763|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808106|NCT02349295|37749764|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808107|NCT02349295|37749765|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808108|NCT02349295|37749766|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808109|NCT02349295|37749767|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808110|NCT02349295|37749768|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808111|NCT02349295|37749769|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808112|NCT02349295|37749770|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808113|NCT02349295|37749771|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808114|NCT02349295|37749772|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808115|NCT02349295|37749773|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
16808116|NCT02349295|37749774|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
16808117|NCT02349295|37749775|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16808118|NCT02349295|37749762|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808119|NCT02349295|37749763|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808120|NCT02349295|37749764|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808121|NCT02349295|37749765|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808122|NCT02349295|37749766|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808123|NCT02349295|37749767|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808124|NCT02349295|37749768|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808125|NCT02349295|37749769|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808126|NCT02349295|37749770|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808127|NCT02349295|37749771|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808128|NCT02349295|37749772|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808129|NCT02349295|37749773|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
16808130|NCT02349295|37749774|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
16808131|NCT02349295|37749775|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16808132|NCT02349295|37749762|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808133|NCT02349295|37749763|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808134|NCT02349295|37749764|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808135|NCT02349295|37749765|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808136|NCT02349295|37749766|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808137|NCT02349295|37749767|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808138|NCT02349295|37749768|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808139|NCT02349295|37749769|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808140|NCT02349295|37749770|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808141|NCT02349295|37749771|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808142|NCT02349295|37749772|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808143|NCT02349295|37749773|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
16808144|NCT02349295|37749774|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808145|NCT02349295|37749775|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16808146|NCT02349295|37749762|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808147|NCT02349295|37749763|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808148|NCT02349295|37749764|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808149|NCT02349295|37749765|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808150|NCT02349295|37749766|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808151|NCT02349295|37749767|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808152|NCT02349295|37749768|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16909855|NCT01716234|38018655|FG006|Overall Study|Protocol Violation|0|||
17102320|NCT00084266|38241213|FG001|Overall Study|Randomized not treated|20|||
16808153|NCT02349295|37749769|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808154|NCT02349295|37749770|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808155|NCT02349295|37749771|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808156|NCT02349295|37749772|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808157|NCT02349295|37749773|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
16808158|NCT02349295|37749774|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808159|NCT02349295|37749775|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16808160|NCT02281357|37749802|FG000|Overall Study|Adverse Event|2|||
16808161|NCT02281357|37749803|FG001|Overall Study|Adverse Event|1|||
16808162|NCT02281357|37749802|FG000|Overall Study|Lost to Follow-up|1|||
16808163|NCT02281357|37749803|FG001|Overall Study|Lost to Follow-up|0|||
16808164|NCT02281357|37749802|FG000|Overall Study|Withdrawal by Subject|4|||
16808165|NCT02281357|37749803|FG001|Overall Study|Withdrawal by Subject|3|||
16808166|NCT02284243|37749811|FG000|Overall Study|Lack of Efficacy|3|||
16808167|NCT02284243|37749812|FG001|Overall Study|Lack of Efficacy|3|||
16808168|NCT02284243|37749811|FG000|Overall Study|Adverse Event|1|||
16808169|NCT02284243|37749812|FG001|Overall Study|Adverse Event|0|||
16808170|NCT02284009|37749820|FG000|Overall Study|Adverse Event|3|||
16808171|NCT02284009|37749821|FG001|Overall Study|Adverse Event|0|||
16808172|NCT02284009|37749820|FG000|Overall Study|Lost to Follow-up|1|||
16808173|NCT02284009|37749821|FG001|Overall Study|Lost to Follow-up|3|||
16808174|NCT02284009|37749820|FG000|Overall Study|Physician Decision|0|||
16808175|NCT02284009|37749821|FG001|Overall Study|Physician Decision|2|||
16808176|NCT02284009|37749820|FG000|Overall Study|Withdrawal by Subject|2|||
16808177|NCT02284009|37749821|FG001|Overall Study|Withdrawal by Subject|5|||
16808178|NCT02280499|37749829|FG000|Overall Study|Death|14|||
16808179|NCT02280499|37749829|FG000|Overall Study|Lost to Follow-up|42|||
16808180|NCT02280499|37749829|FG000|Overall Study|Adverse Event|5|||
16808181|NCT02400476|37749839|FG000|Overall Study|Adverse Event|57|||
16808182|NCT02400476|37749840|FG001|Overall Study|Adverse Event|10|||
16808183|NCT02400476|37749841|FG002|Overall Study|Adverse Event|22|||
16808184|NCT02400476|37749842|FG003|Overall Study|Adverse Event|19|||
16808185|NCT02400476|37749843|FG004|Overall Study|Adverse Event|5|||
16808186|NCT02400476|37749844|FG005|Overall Study|Adverse Event|8|||
16808187|NCT02400476|37749839|FG000|Overall Study|Withdrawal by Subject|4|||
16808188|NCT02400476|37749840|FG001|Overall Study|Withdrawal by Subject|1|||
16808189|NCT02400476|37749841|FG002|Overall Study|Withdrawal by Subject|12|||
16808190|NCT02400476|37749842|FG003|Overall Study|Withdrawal by Subject|7|||
16808191|NCT02400476|37749843|FG004|Overall Study|Withdrawal by Subject|5|||
16808192|NCT02400476|37749844|FG005|Overall Study|Withdrawal by Subject|5|||
16808193|NCT02400476|37749839|FG000|Overall Study|Lost to Follow-up|0|||
16808194|NCT02400476|37749840|FG001|Overall Study|Lost to Follow-up|0|||
16808195|NCT02400476|37749841|FG002|Overall Study|Lost to Follow-up|0|||
16808196|NCT02400476|37749842|FG003|Overall Study|Lost to Follow-up|1|||
16808197|NCT02400476|37749843|FG004|Overall Study|Lost to Follow-up|3|||
16808198|NCT02400476|37749844|FG005|Overall Study|Lost to Follow-up|1|||
16808199|NCT02400476|37749839|FG000|Overall Study|Physician Decision|0|||
16808200|NCT02400476|37749840|FG001|Overall Study|Physician Decision|0|||
16808201|NCT02400476|37749841|FG002|Overall Study|Physician Decision|1|||
16808202|NCT02400476|37749842|FG003|Overall Study|Physician Decision|1|||
16808203|NCT02400476|37749843|FG004|Overall Study|Physician Decision|0|||
16808204|NCT02400476|37749844|FG005|Overall Study|Physician Decision|1|||
16808205|NCT02400476|37749839|FG000|Overall Study|Other, Disease Progression|0|||
16808206|NCT02400476|37749840|FG001|Overall Study|Other, Disease Progression|1|||
16808207|NCT02400476|37749841|FG002|Overall Study|Other, Disease Progression|2|||
16808208|NCT02400476|37749842|FG003|Overall Study|Other, Disease Progression|1|||
16808209|NCT02400476|37749843|FG004|Overall Study|Other, Disease Progression|2|||
16808210|NCT02400476|37749844|FG005|Overall Study|Other, Disease Progression|1|||
16808211|NCT02400476|37749839|FG000|Overall Study|Other, Decreased Quality of Life|0|||
16808212|NCT02400476|37749840|FG001|Overall Study|Other, Decreased Quality of Life|0|||
16808213|NCT02400476|37749841|FG002|Overall Study|Other, Decreased Quality of Life|2|||
16808214|NCT02400476|37749842|FG003|Overall Study|Other, Decreased Quality of Life|0|||
16808215|NCT02400476|37749843|FG004|Overall Study|Other, Decreased Quality of Life|0|||
16808216|NCT02400476|37749844|FG005|Overall Study|Other, Decreased Quality of Life|0|||
16808217|NCT02400476|37749839|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
16808218|NCT02400476|37749840|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
16808219|NCT02400476|37749841|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
16808220|NCT02400476|37749842|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
16808221|NCT02400476|37749843|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
16808222|NCT02400476|37749844|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
16808223|NCT02363738|37749860|FG000|Overall Study|Adverse Event|5|||
16808224|NCT02363738|37749861|FG001|Overall Study|Adverse Event|2|||
16808225|NCT02363738|37749860|FG000|Overall Study|Lack of Efficacy|1|||
16808226|NCT02363738|37749861|FG001|Overall Study|Lack of Efficacy|2|||
16808227|NCT02363738|37749860|FG000|Overall Study|Lost to Follow-up|2|||
16808228|NCT02363738|37749861|FG001|Overall Study|Lost to Follow-up|1|||
16808229|NCT02331680|37749870|FG000|Overall Study|Adverse Event|3|||
16808230|NCT02331680|37749871|FG001|Overall Study|Adverse Event|0|||
16808231|NCT02331680|37749872|FG002|Overall Study|Adverse Event|2|||
16808232|NCT02331680|37749870|FG000|Overall Study|Physician Decision|1|||
16808233|NCT02331680|37749871|FG001|Overall Study|Physician Decision|1|||
16808234|NCT02331680|37749872|FG002|Overall Study|Physician Decision|2|||
16808235|NCT02331680|37749870|FG000|Overall Study|Withdrawal by Subject|0|||
16808236|NCT02331680|37749871|FG001|Overall Study|Withdrawal by Subject|1|||
16808237|NCT02331680|37749872|FG002|Overall Study|Withdrawal by Subject|2|||
16808238|NCT02331680|37749870|FG000|Overall Study|Met withdrawal criteria|2|||
16808239|NCT02331680|37749871|FG001|Overall Study|Met withdrawal criteria|2|||
16808240|NCT02331680|37749872|FG002|Overall Study|Met withdrawal criteria|5|||
16808241|NCT02331680|37749870|FG000|Overall Study|Non-compliance with study drug|0|||
16808242|NCT02331680|37749871|FG001|Overall Study|Non-compliance with study drug|0|||
16808243|NCT02331680|37749872|FG002|Overall Study|Non-compliance with study drug|1|||
16808244|NCT02331680|37749870|FG000|Overall Study|Protocol Violation|0|||
16808245|NCT02331680|37749871|FG001|Overall Study|Protocol Violation|0|||
16808246|NCT02331680|37749872|FG002|Overall Study|Protocol Violation|3|||
16808247|NCT02331446|37749884|FG000|Overall Study|Lost to Follow-up|2|||
16808248|NCT02331446|37749885|FG001|Overall Study|Lost to Follow-up|1|||
16808249|NCT02331446|37749886|FG002|Overall Study|Lost to Follow-up|0|||
16808250|NCT02331446|37749887|FG003|Overall Study|Lost to Follow-up|1|||
16808251|NCT02331446|37749884|FG000|Overall Study|Personal Problem|2|||
16808252|NCT02331446|37749885|FG001|Overall Study|Personal Problem|0|||
16808253|NCT02331446|37749886|FG002|Overall Study|Personal Problem|0|||
16808254|NCT02331446|37749887|FG003|Overall Study|Personal Problem|0|||
16808255|NCT02331446|37749884|FG000|Overall Study|Disease|0|||
16808256|NCT02331446|37749885|FG001|Overall Study|Disease|2|||
16808257|NCT02331446|37749886|FG002|Overall Study|Disease|2|||
16808258|NCT02331446|37749887|FG003|Overall Study|Disease|1|||
16808259|NCT02331446|37749884|FG000|Overall Study|Physician Decision|0|||
16808260|NCT02331446|37749885|FG001|Overall Study|Physician Decision|1|||
16808261|NCT02331446|37749886|FG002|Overall Study|Physician Decision|0|||
16808262|NCT02331446|37749887|FG003|Overall Study|Physician Decision|1|||
16808263|NCT02331446|37749884|FG000|Overall Study|Lost before baseline analysis|0|||
16808264|NCT02331446|37749885|FG001|Overall Study|Lost before baseline analysis|1|||
16808265|NCT02331446|37749886|FG002|Overall Study|Lost before baseline analysis|1|||
16808266|NCT02331446|37749887|FG003|Overall Study|Lost before baseline analysis|0|||
16808267|NCT02349061|37749899|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
16808268|NCT02349061|37749900|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
16808269|NCT02349061|37749901|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
16808270|NCT02349061|37749899|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
16808271|NCT02349061|37749900|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
16808272|NCT02349061|37749901|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
16808273|NCT02349061|37749899|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
16808274|NCT02349061|37749900|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
16808275|NCT02349061|37749901|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
16808276|NCT02349061|37749899|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
16808277|NCT02349061|37749900|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
16808278|NCT02349061|37749901|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
16808279|NCT02349061|37749899|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
16808280|NCT02349061|37749900|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
16808281|NCT02349061|37749901|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
16808282|NCT02349061|37749899|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
16808283|NCT02349061|37749900|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
16808284|NCT02349061|37749901|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
16808285|NCT02349061|37749899|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
16808286|NCT02349061|37749900|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
16808287|NCT02349061|37749901|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
16808288|NCT02349061|37749899|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
16808289|NCT02349061|37749900|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
16808290|NCT02349061|37749901|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
16808291|NCT02349061|37749899|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
16808292|NCT02349061|37749900|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
16808293|NCT02349061|37749901|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
16808294|NCT02349061|37749899|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
16808295|NCT02349061|37749900|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
16808296|NCT02349061|37749901|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
16808297|NCT02349061|37749899|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
16808298|NCT02349061|37749900|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
16808299|NCT02349061|37749901|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
16808300|NCT02349061|37749899|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
16808301|NCT02349061|37749900|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
16808302|NCT02349061|37749901|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
16808303|NCT02349061|37749899|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
16808304|NCT02349061|37749900|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
16808305|NCT02349061|37749901|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
16808306|NCT02331368|37749911|FG000|Overall Study|Withdrawal by Subject|3|||
16808307|NCT02362724|37749917|FG000|Overall Study|Withdrawal by Subject|3|||
16808308|NCT02362724|37749918|FG001|Overall Study|Withdrawal by Subject|1|||
16808309|NCT02362724|37749917|FG000|Overall Study|Adverse Event|3|||
16808310|NCT02362724|37749918|FG001|Overall Study|Adverse Event|0|||
16808311|NCT02362646|37749926|FG000|Overall Study|Death|15|||
16808312|NCT02362646|37749927|FG001|Overall Study|Death|8|||
16808313|NCT02362646|37749926|FG000|Overall Study|Withdrawal by Subject|2|||
16808314|NCT02362646|37749927|FG001|Overall Study|Withdrawal by Subject|2|||
16808315|NCT02362646|37749926|FG000|Overall Study|received transplant|21|||
16808316|NCT02362646|37749927|FG001|Overall Study|received transplant|14|||
16808317|NCT02280421|37749937|FG000|Washout (2 Weeks)|Adverse Event|0|||
16808318|NCT02280421|37749938|FG001|Washout (2 Weeks)|Adverse Event|1|||
16808319|NCT02280421|37749937|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
16808320|NCT02280421|37749938|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
16808321|NCT02362412|37749956|FG000|Treatment Period III|Lost to Follow-up|0|||
16808322|NCT02362412|37749957|FG001|Treatment Period III|Lost to Follow-up|1|||
16808323|NCT02280187|37749969|FG000|Overall Study|Lost to Follow-up|218|||
16808324|NCT02347813|37749975|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
16808325|NCT02347813|37749976|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
16808326|NCT02347813|37749975|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
16808327|NCT02347813|37749976|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
16808328|NCT02329730|37749986|FG000|Overall Study|Protocol Violation|0|||
16808329|NCT02329730|37749987|FG001|Overall Study|Protocol Violation|0|||
16808330|NCT02329730|37749988|FG002|Overall Study|Protocol Violation|0|||
16808331|NCT02329730|37749989|FG003|Overall Study|Protocol Violation|0|||
16808332|NCT02329730|37749990|FG004|Overall Study|Protocol Violation|2|||
16808333|NCT02329730|37749991|FG005|Overall Study|Protocol Violation|2|||
16808334|NCT02329730|37749992|FG006|Overall Study|Protocol Violation|0|||
16808335|NCT02329730|37749993|FG007|Overall Study|Protocol Violation|0|||
16808336|NCT02329730|37749994|FG008|Overall Study|Protocol Violation|0|||
16808337|NCT02329730|37749995|FG009|Overall Study|Protocol Violation|0|||
16808338|NCT02329730|37749996|FG010|Overall Study|Protocol Violation|0|||
16808339|NCT02329730|37749997|FG011|Overall Study|Protocol Violation|0|||
16808340|NCT02329730|37749986|FG000|Overall Study|Withdrawal by Subject|0|||
16808341|NCT02329730|37749987|FG001|Overall Study|Withdrawal by Subject|0|||
16808342|NCT02329730|37749988|FG002|Overall Study|Withdrawal by Subject|0|||
16808343|NCT02329730|37749989|FG003|Overall Study|Withdrawal by Subject|0|||
16808344|NCT02329730|37749990|FG004|Overall Study|Withdrawal by Subject|1|||
16808345|NCT02329730|37749991|FG005|Overall Study|Withdrawal by Subject|0|||
16808346|NCT02329730|37749992|FG006|Overall Study|Withdrawal by Subject|1|||
16808347|NCT02329730|37749993|FG007|Overall Study|Withdrawal by Subject|1|||
16909856|NCT01716234|38018649|FG000|Overall Study|Lack of Efficacy|0|||
16909857|NCT01716234|38018650|FG001|Overall Study|Lack of Efficacy|0|||
16909858|NCT01716234|38018651|FG002|Overall Study|Lack of Efficacy|0|||
16909859|NCT01716234|38018652|FG003|Overall Study|Lack of Efficacy|1|||
16909860|NCT01716234|38018653|FG004|Overall Study|Lack of Efficacy|0|||
16909861|NCT01716234|38018654|FG005|Overall Study|Lack of Efficacy|0|||
16909862|NCT01716234|38018655|FG006|Overall Study|Lack of Efficacy|0|||
16909863|NCT01716234|38018649|FG000|Overall Study|Did not meet protocol eligibility|0|||
16909864|NCT01716234|38018650|FG001|Overall Study|Did not meet protocol eligibility|0|||
16909865|NCT01716234|38018651|FG002|Overall Study|Did not meet protocol eligibility|1|||
16909866|NCT01716234|38018652|FG003|Overall Study|Did not meet protocol eligibility|0|||
16909867|NCT01716234|38018653|FG004|Overall Study|Did not meet protocol eligibility|0|||
16909868|NCT01716234|38018654|FG005|Overall Study|Did not meet protocol eligibility|4|||
16909869|NCT01716234|38018655|FG006|Overall Study|Did not meet protocol eligibility|0|||
16909870|NCT01716234|38018649|FG000|Overall Study|Adverse Event|7|||
16909871|NCT01716234|38018650|FG001|Overall Study|Adverse Event|10|||
16909872|NCT01716234|38018651|FG002|Overall Study|Adverse Event|2|||
16909873|NCT01716234|38018652|FG003|Overall Study|Adverse Event|8|||
16909874|NCT01716234|38018653|FG004|Overall Study|Adverse Event|3|||
16909875|NCT01716234|38018654|FG005|Overall Study|Adverse Event|6|||
16909876|NCT01716234|38018655|FG006|Overall Study|Adverse Event|0|||
16909877|NCT01716234|38018649|FG000|Overall Study|Withdrawal by Subject|3|||
16909878|NCT01716234|38018650|FG001|Overall Study|Withdrawal by Subject|0|||
16909879|NCT01716234|38018651|FG002|Overall Study|Withdrawal by Subject|2|||
16808348|NCT02329730|37749994|FG008|Overall Study|Withdrawal by Subject|1|||
16808349|NCT02329730|37749995|FG009|Overall Study|Withdrawal by Subject|1|||
16808350|NCT02329730|37749996|FG010|Overall Study|Withdrawal by Subject|0|||
16909880|NCT01716234|38018652|FG003|Overall Study|Withdrawal by Subject|2|||
16808351|NCT02329730|37749997|FG011|Overall Study|Withdrawal by Subject|0|||
16808352|NCT02328326|37750017|FG000|Overall Study|Withdrawal by Subject|10|||
16808353|NCT02328326|37750018|FG001|Overall Study|Withdrawal by Subject|3|||
16808354|NCT02328326|37750017|FG000|Overall Study|Death|2|||
16808355|NCT02328326|37750018|FG001|Overall Study|Death|1|||
16808356|NCT02328326|37750017|FG000|Overall Study|Lost to Follow-up|10|||
16808357|NCT02328326|37750018|FG001|Overall Study|Lost to Follow-up|4|||
16808358|NCT01649804|37750026|FG000|Overall Study|Administrative/Other|8|||
16808359|NCT02397278|37750032|FG000|Overall Study|Withdrawal by Subject|0|||
16808360|NCT02397278|37750033|FG001|Overall Study|Withdrawal by Subject|2|||
16808361|NCT02397278|37750032|FG000|Overall Study|Deemed ineligible following surgery|1|||
16808362|NCT02397278|37750033|FG001|Overall Study|Deemed ineligible following surgery|1|||
16808363|NCT02360228|37750042|FG000|Overall Study|Withdrawal by Subject|1|||
16808364|NCT02360228|37750043|FG001|Overall Study|Withdrawal by Subject|0|||
16808365|NCT02360228|37750044|FG002|Overall Study|Withdrawal by Subject|0|||
16808366|NCT02360228|37750042|FG000|Overall Study|Self-discontinued medication|0|||
16808367|NCT02360228|37750043|FG001|Overall Study|Self-discontinued medication|1|||
16808368|NCT02360228|37750044|FG002|Overall Study|Self-discontinued medication|0|||
16808369|NCT02360228|37750042|FG000|Overall Study|Unstable symptoms during screening|0|||
16808370|NCT02360228|37750043|FG001|Overall Study|Unstable symptoms during screening|0|||
16808371|NCT02360228|37750044|FG002|Overall Study|Unstable symptoms during screening|1|||
16808372|NCT02359994|37750054|FG000|Overall Population Study|Adverse Event|1|||
16808373|NCT02359994|37750055|FG001|Overall Population Study|Adverse Event|1|||
16808374|NCT02359994|37750054|FG000|Overall Population Study|Death|1|||
16808375|NCT02359994|37750055|FG001|Overall Population Study|Death|5|||
16808376|NCT02359994|37750054|FG000|Overall Population Study|Lost to Follow-up|1|||
16808377|NCT02359994|37750055|FG001|Overall Population Study|Lost to Follow-up|1|||
16808378|NCT02359994|37750054|FG000|Overall Population Study|Withdrawal by Subject|1|||
16808379|NCT02359994|37750055|FG001|Overall Population Study|Withdrawal by Subject|0|||
16808380|NCT02359994|37750054|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
16808381|NCT02359994|37750055|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
16808382|NCT02359994|37750054|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
16808383|NCT02359994|37750055|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
16808384|NCT02359994|37750054|FG000|Extended Oncology 24-Month Survival|Death|19|||
16808385|NCT02359994|37750055|FG001|Extended Oncology 24-Month Survival|Death|21|||
16808386|NCT02359994|37750054|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
16808387|NCT02359994|37750055|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
16808388|NCT02326298|37750064|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808389|NCT02326298|37750065|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808390|NCT02326298|37750066|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
16808391|NCT02326298|37750067|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808392|NCT02326298|37750068|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808393|NCT02326298|37750069|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808394|NCT02326298|37750070|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808395|NCT02326298|37750071|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808396|NCT02326298|37750072|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808397|NCT02326298|37750073|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808398|NCT02326298|37750074|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808399|NCT02326298|37750075|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808400|NCT02326298|37750076|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808401|NCT02326298|37750077|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16808402|NCT02326298|37750064|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
16808403|NCT02326298|37750065|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808404|NCT02326298|37750066|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808405|NCT02326298|37750067|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808406|NCT02326298|37750068|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808407|NCT02326298|37750069|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808408|NCT02326298|37750070|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808409|NCT02326298|37750071|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808410|NCT02326298|37750072|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808411|NCT02326298|37750073|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808412|NCT02326298|37750074|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808413|NCT02326298|37750075|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808414|NCT02326298|37750076|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808415|NCT02326298|37750077|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16808416|NCT02326298|37750064|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
16808417|NCT02326298|37750065|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
16808418|NCT02326298|37750066|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808419|NCT02326298|37750067|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808420|NCT02326298|37750068|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808421|NCT02326298|37750069|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808422|NCT02326298|37750070|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808423|NCT02326298|37750071|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808424|NCT02326298|37750072|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808425|NCT02326298|37750073|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808426|NCT02326298|37750074|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808427|NCT02326298|37750075|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808428|NCT02326298|37750076|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808429|NCT02326298|37750077|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16808430|NCT02326298|37750064|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
16808431|NCT02326298|37750065|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
16808432|NCT02326298|37750066|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808433|NCT02326298|37750067|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808434|NCT02326298|37750068|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808435|NCT02326298|37750069|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808436|NCT02326298|37750070|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808437|NCT02326298|37750071|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808438|NCT02326298|37750072|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808439|NCT02326298|37750073|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808440|NCT02326298|37750074|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808441|NCT02326298|37750075|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808442|NCT02326298|37750076|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808443|NCT02326298|37750077|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16808444|NCT02326298|37750064|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808445|NCT02326298|37750065|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808446|NCT02326298|37750066|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
16808447|NCT02326298|37750067|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808448|NCT02326298|37750068|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808449|NCT02326298|37750069|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808450|NCT02326298|37750070|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808451|NCT02326298|37750071|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808452|NCT02326298|37750072|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808453|NCT02326298|37750073|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808454|NCT02326298|37750074|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808455|NCT02326298|37750075|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808456|NCT02326298|37750076|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808457|NCT02326298|37750077|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16808458|NCT02326298|37750064|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808459|NCT02326298|37750065|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808460|NCT02326298|37750066|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808461|NCT02326298|37750067|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808462|NCT02326298|37750068|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808463|NCT02326298|37750069|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16808464|NCT02326298|37750070|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
16808465|NCT02326298|37750071|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16808466|NCT02326298|37750072|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16808467|NCT02326298|37750073|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16808468|NCT02326298|37750074|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808469|NCT02326298|37750075|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808470|NCT02326298|37750076|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808471|NCT02326298|37750077|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16808472|NCT02326298|37750064|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808473|NCT02326298|37750065|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808474|NCT02326298|37750066|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808475|NCT02326298|37750067|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808476|NCT02326298|37750068|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808477|NCT02326298|37750069|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
16808478|NCT02326298|37750070|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
16808479|NCT02326298|37750071|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808480|NCT02326298|37750072|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
16808481|NCT02326298|37750073|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808482|NCT02326298|37750074|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808483|NCT02326298|37750075|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808484|NCT02326298|37750076|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808485|NCT02326298|37750077|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16808486|NCT02326298|37750064|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808487|NCT02326298|37750065|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808488|NCT02326298|37750066|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808489|NCT02326298|37750067|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808490|NCT02326298|37750068|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808491|NCT02326298|37750069|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
16808492|NCT02326298|37750070|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808493|NCT02326298|37750071|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808494|NCT02326298|37750072|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808495|NCT02326298|37750073|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808496|NCT02326298|37750074|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808497|NCT02326298|37750075|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808498|NCT02326298|37750076|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808499|NCT02326298|37750077|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16808500|NCT02326298|37750064|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808501|NCT02326298|37750065|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808502|NCT02326298|37750066|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808503|NCT02326298|37750067|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808504|NCT02326298|37750068|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808505|NCT02326298|37750069|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808506|NCT02326298|37750070|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
16808507|NCT02326298|37750071|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808508|NCT02326298|37750072|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808509|NCT02326298|37750073|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808510|NCT02326298|37750074|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808511|NCT02326298|37750075|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808512|NCT02326298|37750076|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808513|NCT02326298|37750077|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16808514|NCT02326298|37750064|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808515|NCT02326298|37750065|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808516|NCT02326298|37750066|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808517|NCT02326298|37750067|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808518|NCT02326298|37750068|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808519|NCT02326298|37750069|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808520|NCT02326298|37750070|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808521|NCT02326298|37750071|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
16808522|NCT02326298|37750072|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808523|NCT02326298|37750073|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808524|NCT02326298|37750074|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808525|NCT02326298|37750075|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808526|NCT02326298|37750076|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808527|NCT02326298|37750077|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16808528|NCT02326298|37750064|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808529|NCT02326298|37750065|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808530|NCT02326298|37750066|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808531|NCT02326298|37750067|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808532|NCT02326298|37750068|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808533|NCT02326298|37750069|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808534|NCT02326298|37750070|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
16808535|NCT02326298|37750071|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
16808536|NCT02326298|37750072|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808537|NCT02326298|37750073|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808538|NCT02326298|37750074|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808539|NCT02326298|37750075|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808540|NCT02326298|37750076|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808541|NCT02326298|37750077|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16808542|NCT02326298|37750064|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808543|NCT02326298|37750065|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808544|NCT02326298|37750066|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808545|NCT02326298|37750067|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808546|NCT02326298|37750068|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808547|NCT02326298|37750069|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808548|NCT02326298|37750070|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808549|NCT02326298|37750071|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16808550|NCT02326298|37750072|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808551|NCT02326298|37750073|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808552|NCT02326298|37750074|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808553|NCT02326298|37750075|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808554|NCT02326298|37750076|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808555|NCT02326298|37750077|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16808556|NCT02326298|37750064|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808557|NCT02326298|37750065|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808558|NCT02326298|37750066|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808559|NCT02326298|37750067|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808560|NCT02326298|37750068|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808561|NCT02326298|37750069|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
16808562|NCT02326298|37750070|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808563|NCT02326298|37750071|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808564|NCT02326298|37750072|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808565|NCT02326298|37750073|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808566|NCT02326298|37750074|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808567|NCT02326298|37750075|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808568|NCT02326298|37750076|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808569|NCT02326298|37750077|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16808570|NCT02326298|37750064|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
16808571|NCT02326298|37750065|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
16808572|NCT02326298|37750066|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
16808573|NCT02326298|37750067|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
16808574|NCT02326298|37750068|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
16808575|NCT02326298|37750069|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
16808576|NCT02326298|37750070|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
16808577|NCT02326298|37750071|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
16808578|NCT02326298|37750072|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
16808579|NCT02326298|37750073|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
16808580|NCT02326298|37750074|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
16808581|NCT02326298|37750075|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
16808582|NCT02326298|37750076|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
16808583|NCT02326298|37750077|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
16808584|NCT02326298|37750064|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808585|NCT02326298|37750065|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808586|NCT02326298|37750066|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808587|NCT02326298|37750067|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808588|NCT02326298|37750068|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808589|NCT02326298|37750069|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808590|NCT02326298|37750070|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808591|NCT02326298|37750071|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808592|NCT02326298|37750072|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808593|NCT02326298|37750073|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808594|NCT02326298|37750074|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808595|NCT02326298|37750075|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
16808596|NCT02326298|37750076|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
16808597|NCT02326298|37750077|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16808598|NCT02326298|37750064|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808599|NCT02326298|37750065|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808600|NCT02326298|37750066|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808601|NCT02326298|37750067|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808602|NCT02326298|37750068|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808603|NCT02326298|37750069|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808604|NCT02326298|37750070|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808605|NCT02326298|37750071|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808606|NCT02326298|37750072|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808607|NCT02326298|37750073|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808608|NCT02326298|37750074|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808609|NCT02326298|37750075|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16808610|NCT02326298|37750076|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16808611|NCT02326298|37750077|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16808612|NCT02326298|37750064|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808613|NCT02326298|37750065|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808614|NCT02326298|37750066|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808615|NCT02326298|37750067|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808616|NCT02326298|37750068|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808617|NCT02326298|37750069|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808618|NCT02326298|37750070|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808619|NCT02326298|37750071|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808620|NCT02326298|37750072|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808621|NCT02326298|37750073|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808622|NCT02326298|37750074|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808623|NCT02326298|37750075|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808624|NCT02326298|37750076|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16808625|NCT02326298|37750077|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
16808626|NCT02326298|37750064|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808627|NCT02326298|37750065|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808628|NCT02326298|37750066|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808629|NCT02326298|37750067|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808630|NCT02326298|37750068|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808631|NCT02326298|37750069|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808632|NCT02326298|37750070|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808633|NCT02326298|37750071|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808634|NCT02326298|37750072|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808635|NCT02326298|37750073|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808636|NCT02326298|37750074|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16808637|NCT02326298|37750075|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
16808638|NCT02326298|37750076|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
16808639|NCT02326298|37750077|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
16808640|NCT02326298|37750064|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808641|NCT02326298|37750065|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808642|NCT02326298|37750066|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808643|NCT02326298|37750067|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808644|NCT02326298|37750068|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808645|NCT02326298|37750069|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808646|NCT02326298|37750070|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808647|NCT02326298|37750071|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808648|NCT02326298|37750072|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808649|NCT02326298|37750073|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808650|NCT02326298|37750074|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16808651|NCT02326298|37750075|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
16808652|NCT02326298|37750076|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
16808653|NCT02326298|37750077|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
16808654|NCT02326298|37750064|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808655|NCT02326298|37750065|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808656|NCT02326298|37750066|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808657|NCT02326298|37750067|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808658|NCT02326298|37750068|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808659|NCT02326298|37750069|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808660|NCT02326298|37750070|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808661|NCT02326298|37750071|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808662|NCT02326298|37750072|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808663|NCT02326298|37750073|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808664|NCT02326298|37750074|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16808665|NCT02326298|37750075|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
16808666|NCT02326298|37750076|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
16808667|NCT02326298|37750077|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
16808668|NCT02396420|37750086|FG000|Overall Study|Death|1|||
16808669|NCT02279719|37750098|FG000|Overall Study|Patients randomized but never treated|0|||
16808670|NCT02279719|37750099|FG001|Overall Study|Patients randomized but never treated|0|||
16808671|NCT02279719|37750100|FG002|Overall Study|Patients randomized but never treated|0|||
16808672|NCT02279719|37750101|FG003|Overall Study|Patients randomized but never treated|0|||
16808673|NCT02279719|37750102|FG004|Overall Study|Patients randomized but never treated|3|||
16808674|NCT02279719|37750103|FG005|Overall Study|Patients randomized but never treated|0|||
16808675|NCT02279719|37750104|FG006|Overall Study|Patients randomized but never treated|3|||
16808676|NCT02279407|37750141|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
16808677|NCT02279407|37750142|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
16808678|NCT02279407|37750143|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
16808679|NCT02279407|37750144|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
16808680|NCT02279407|37750141|FG000|Overall Study|Withdrawal by Subject|1|||
16808681|NCT02279407|37750142|FG001|Overall Study|Withdrawal by Subject|0|||
16808682|NCT02279407|37750143|FG002|Overall Study|Withdrawal by Subject|1|||
16808683|NCT02279407|37750144|FG003|Overall Study|Withdrawal by Subject|1|||
16808684|NCT02279407|37750141|FG000|Overall Study|Adverse Event|1|||
16808685|NCT02279407|37750142|FG001|Overall Study|Adverse Event|1|||
16808686|NCT02279407|37750143|FG002|Overall Study|Adverse Event|2|||
16808687|NCT02279407|37750144|FG003|Overall Study|Adverse Event|0|||
16808688|NCT02326220|37750156|FG000|Double-blind Treatment Period|Adverse Event|1|||
16808689|NCT02326220|37750157|FG001|Double-blind Treatment Period|Adverse Event|2|||
16808690|NCT02326220|37750158|FG002|Double-blind Treatment Period|Adverse Event|0|||
16808691|NCT02326220|37750156|FG000|Double-blind Treatment Period|Protocol Violation|0|||
16808692|NCT02326220|37750157|FG001|Double-blind Treatment Period|Protocol Violation|1|||
16808693|NCT02326220|37750158|FG002|Double-blind Treatment Period|Protocol Violation|0|||
16808694|NCT02326220|37750156|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
16808695|NCT02326220|37750157|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
16808696|NCT02326220|37750158|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16808697|NCT02326220|37750156|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
16808698|NCT02326220|37750157|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16808699|NCT02326220|37750158|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
16808700|NCT02326220|37750156|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
16808701|NCT02326220|37750157|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
16808702|NCT02326220|37750158|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
16808703|NCT02279173|37750168|FG000|Overall Study|Protocol-specified Criteria|67|||
16808704|NCT02279173|37750168|FG000|Overall Study|Withdrawal by Subject|20|||
16808705|NCT02279173|37750168|FG000|Overall Study|Decision by Sponsor|4|||
16808706|NCT02279173|37750168|FG000|Overall Study|Lost to Follow-up|3|||
16808707|NCT02282917|37750174|FG000|Overall Study|Withdrawal by Subject|1|||
16808708|NCT02282917|37750174|FG000|Overall Study|Screen Failure/Not Eligible|1|||
16808709|NCT02358668|37750181|FG000|Overall Study|Adverse Event|2|||
16808710|NCT02358668|37750182|FG001|Overall Study|Adverse Event|0|||
16808711|NCT02358668|37750183|FG002|Overall Study|Adverse Event|0|||
16808712|NCT02358668|37750181|FG000|Overall Study|Withdrawal by Subject|0|||
16808713|NCT02358668|37750182|FG001|Overall Study|Withdrawal by Subject|1|||
16808714|NCT02358668|37750183|FG002|Overall Study|Withdrawal by Subject|0|||
16808715|NCT02282605|37750194|FG000|Overall Study|negative SA result on Day -1|3|||
16808716|NCT02282605|37750195|FG001|Overall Study|negative SA result on Day -1|0|||
16808717|NCT02282605|37750196|FG002|Overall Study|negative SA result on Day -1|0|||
16808718|NCT02282527|37750206|FG000|Overall Study|Lost to Follow-up|0|||
16808719|NCT02282527|37750207|FG001|Overall Study|Lost to Follow-up|1|||
16808720|NCT02282527|37750206|FG000|Overall Study|Lack of home health aid|1|||
16808721|NCT02282527|37750207|FG001|Overall Study|Lack of home health aid|0|||
16808722|NCT02278939|37750218|FG000|Overall Study|lack of time|1|||
16808723|NCT02278939|37750219|FG001|Overall Study|lack of time|0|||
16808724|NCT02278939|37750218|FG000|Overall Study|Lost to Follow-up|1|||
16808725|NCT02278939|37750219|FG001|Overall Study|Lost to Follow-up|1|||
16808726|NCT02278939|37750218|FG000|Overall Study|death in family|1|||
16808727|NCT02278939|37750219|FG001|Overall Study|death in family|0|||
16808728|NCT02278939|37750218|FG000|Overall Study|family emergency unable to commit|2|||
16808729|NCT02278939|37750219|FG001|Overall Study|family emergency unable to commit|0|||
16808730|NCT02278471|37750227|FG000|Overall Study|Lost to Follow-up|6|||
16808731|NCT02278471|37750228|FG001|Overall Study|Lost to Follow-up|15|||
16808732|NCT02278471|37750227|FG000|Overall Study|Death|2|||
16808733|NCT02278471|37750228|FG001|Overall Study|Death|2|||
16808734|NCT02278471|37750227|FG000|Overall Study|Withdrawal by Subject|0|||
16808735|NCT02278471|37750228|FG001|Overall Study|Withdrawal by Subject|3|||
16808736|NCT02278003|37750237|FG000|Overall Study|Withdrawal by Subject|11|||
16808737|NCT02278003|37750238|FG001|Overall Study|Withdrawal by Subject|0|||
16808738|NCT02278003|37750237|FG000|Overall Study|Not Treated|1|||
16808739|NCT02278003|37750238|FG001|Overall Study|Not Treated|0|||
16808740|NCT02278003|37750237|FG000|Overall Study|Recognition task improperly completed|7|||
16808741|NCT02278003|37750238|FG001|Overall Study|Recognition task improperly completed|0|||
16808742|NCT02277769|37750247|FG000|Overall Study|Protocol Violation|3|||
16909881|NCT01716234|38018653|FG004|Overall Study|Withdrawal by Subject|1|||
16909882|NCT01716234|38018654|FG005|Overall Study|Withdrawal by Subject|3|||
16808743|NCT02277769|37750248|FG001|Overall Study|Protocol Violation|3|||
16808744|NCT02277769|37750249|FG002|Overall Study|Protocol Violation|5|||
16808745|NCT02277769|37750247|FG000|Overall Study|Lack of Efficacy|17|||
16808746|NCT02277769|37750248|FG001|Overall Study|Lack of Efficacy|0|||
16808747|NCT02277769|37750249|FG002|Overall Study|Lack of Efficacy|4|||
16808748|NCT02277769|37750247|FG000|Overall Study|Adverse Event|14|||
16808749|NCT02277769|37750248|FG001|Overall Study|Adverse Event|2|||
16808750|NCT02277769|37750249|FG002|Overall Study|Adverse Event|4|||
16808751|NCT02277769|37750247|FG000|Overall Study|Other than specified above|12|||
16808752|NCT02277769|37750248|FG001|Overall Study|Other than specified above|8|||
16808753|NCT02277769|37750249|FG002|Overall Study|Other than specified above|5|||
16808754|NCT01641991|37750261|FG000|Overall Study|Physician Decision|0|||
16808755|NCT01641991|37750262|FG001|Overall Study|Physician Decision|1|||
16808756|NCT01641991|37750263|FG002|Overall Study|Physician Decision|7|||
16808757|NCT01641991|37750264|FG003|Overall Study|Physician Decision|5|||
16808758|NCT01641991|37750261|FG000|Overall Study|Withdrawal by Subject|4|||
16808759|NCT01641991|37750262|FG001|Overall Study|Withdrawal by Subject|2|||
16808760|NCT01641991|37750263|FG002|Overall Study|Withdrawal by Subject|1|||
16808761|NCT01641991|37750264|FG003|Overall Study|Withdrawal by Subject|5|||
16808762|NCT01641991|37750261|FG000|Overall Study|Adverse Event|2|||
16808763|NCT01641991|37750262|FG001|Overall Study|Adverse Event|1|||
16808764|NCT01641991|37750263|FG002|Overall Study|Adverse Event|2|||
16808765|NCT01641991|37750264|FG003|Overall Study|Adverse Event|1|||
16808766|NCT01641991|37750261|FG000|Overall Study|Lost to Follow-up|0|||
16808767|NCT01641991|37750262|FG001|Overall Study|Lost to Follow-up|2|||
16808768|NCT01641991|37750263|FG002|Overall Study|Lost to Follow-up|3|||
16808769|NCT01641991|37750264|FG003|Overall Study|Lost to Follow-up|1|||
16808770|NCT01641991|37750261|FG000|Overall Study|Protocol Violation|1|||
16808771|NCT01641991|37750262|FG001|Overall Study|Protocol Violation|1|||
16808772|NCT01641991|37750263|FG002|Overall Study|Protocol Violation|3|||
16808773|NCT01641991|37750264|FG003|Overall Study|Protocol Violation|0|||
16808774|NCT01641991|37750261|FG000|Overall Study|Pregnancy|0|||
16808775|NCT01641991|37750262|FG001|Overall Study|Pregnancy|0|||
16808776|NCT01641991|37750263|FG002|Overall Study|Pregnancy|1|||
16808777|NCT01641991|37750264|FG003|Overall Study|Pregnancy|0|||
16808778|NCT01641991|37750261|FG000|Overall Study|no longer eligible|2|||
16808779|NCT01641991|37750262|FG001|Overall Study|no longer eligible|1|||
16808780|NCT01641991|37750263|FG002|Overall Study|no longer eligible|0|||
16808781|NCT01641991|37750264|FG003|Overall Study|no longer eligible|4|||
16808782|NCT02277691|37750277|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
16808783|NCT02277691|37750277|FG000|Overall Study|Voluntary Withdrawal|7|||
16808784|NCT02277691|37750277|FG000|Overall Study|Lack of Efficacy|5|||
16808785|NCT02277691|37750277|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
16808786|NCT02395172|37750283|FG000|Overall Study|Participants randomized but not treated|3|||
16808787|NCT02395172|37750284|FG001|Overall Study|Participants randomized but not treated|31|||
16808788|NCT02276053|37750290|FG000|Overall Study|Death|2|||
16808789|NCT02276053|37750290|FG000|Overall Study|Adverse Event|5|||
16808790|NCT02276053|37750290|FG000|Overall Study|Lack of Efficacy|2|||
16808791|NCT02276053|37750290|FG000|Overall Study|Withdrawal by Subject|1|||
16808792|NCT02276053|37750290|FG000|Overall Study|Patient does not meet selection criteria|3|||
16808793|NCT02276053|37750290|FG000|Overall Study|Patient needs to increase baseline AED|1|||
16808794|NCT02275819|37750297|FG000|Overall Study|Adverse Event|0|||
16808795|NCT02275819|37750298|FG001|Overall Study|Adverse Event|1|||
16808796|NCT02358044|37750306|FG000|Overall Study|Adverse Event|0|||
16808797|NCT02358044|37750307|FG001|Overall Study|Adverse Event|1|||
16808798|NCT02358044|37750306|FG000|Overall Study|Lost to Follow-up|2|||
16808799|NCT02358044|37750307|FG001|Overall Study|Lost to Follow-up|1|||
16808800|NCT02358044|37750306|FG000|Overall Study|Physician Decision|0|||
16808801|NCT02358044|37750307|FG001|Overall Study|Physician Decision|1|||
16808802|NCT02358044|37750306|FG000|Overall Study|Withdrawal by Subject|0|||
16808803|NCT02358044|37750307|FG001|Overall Study|Withdrawal by Subject|4|||
16808804|NCT02275117|37750318|FG000|Overall Study|Adverse Event|0|||
16808805|NCT02275117|37750319|FG001|Overall Study|Adverse Event|0|||
16808806|NCT02275117|37750320|FG002|Overall Study|Adverse Event|0|||
16808807|NCT02275117|37750321|FG003|Overall Study|Adverse Event|0|||
16808808|NCT02275117|37750322|FG004|Overall Study|Adverse Event|1|||
16909883|NCT01716234|38018655|FG006|Overall Study|Withdrawal by Subject|0|||
16808809|NCT02275117|37750318|FG000|Overall Study|Lack of Efficacy|6|||
16808810|NCT02275117|37750319|FG001|Overall Study|Lack of Efficacy|7|||
16808811|NCT02275117|37750320|FG002|Overall Study|Lack of Efficacy|5|||
16808812|NCT02275117|37750321|FG003|Overall Study|Lack of Efficacy|2|||
16808813|NCT02275117|37750322|FG004|Overall Study|Lack of Efficacy|10|||
16808814|NCT02275117|37750318|FG000|Overall Study|Lost to Follow-up|11|||
16808815|NCT02275117|37750319|FG001|Overall Study|Lost to Follow-up|16|||
16808816|NCT02275117|37750320|FG002|Overall Study|Lost to Follow-up|15|||
16808817|NCT02275117|37750321|FG003|Overall Study|Lost to Follow-up|16|||
16808818|NCT02275117|37750322|FG004|Overall Study|Lost to Follow-up|8|||
16808819|NCT02275117|37750318|FG000|Overall Study|Physician Decision|0|||
16808820|NCT02275117|37750319|FG001|Overall Study|Physician Decision|1|||
16808821|NCT02275117|37750320|FG002|Overall Study|Physician Decision|1|||
16808822|NCT02275117|37750321|FG003|Overall Study|Physician Decision|0|||
16808823|NCT02275117|37750322|FG004|Overall Study|Physician Decision|1|||
16808824|NCT02275117|37750318|FG000|Overall Study|Protocol Violation|1|||
16808825|NCT02275117|37750319|FG001|Overall Study|Protocol Violation|0|||
16808826|NCT02275117|37750320|FG002|Overall Study|Protocol Violation|1|||
16808827|NCT02275117|37750321|FG003|Overall Study|Protocol Violation|1|||
16808828|NCT02275117|37750322|FG004|Overall Study|Protocol Violation|0|||
16808829|NCT02275117|37750318|FG000|Overall Study|Withdrawal by Subject|6|||
16808830|NCT02275117|37750319|FG001|Overall Study|Withdrawal by Subject|4|||
16808831|NCT02275117|37750320|FG002|Overall Study|Withdrawal by Subject|7|||
16808832|NCT02275117|37750321|FG003|Overall Study|Withdrawal by Subject|3|||
16808833|NCT02275117|37750322|FG004|Overall Study|Withdrawal by Subject|3|||
16808834|NCT02275117|37750318|FG000|Overall Study|Terminated by Sponsor|4|||
16808835|NCT02275117|37750319|FG001|Overall Study|Terminated by Sponsor|4|||
16808836|NCT02275117|37750320|FG002|Overall Study|Terminated by Sponsor|4|||
16808837|NCT02275117|37750321|FG003|Overall Study|Terminated by Sponsor|6|||
16808838|NCT02275117|37750322|FG004|Overall Study|Terminated by Sponsor|4|||
16808839|NCT02275117|37750318|FG000|Overall Study|Worsening of Study Indication|0|||
16808840|NCT02275117|37750319|FG001|Overall Study|Worsening of Study Indication|1|||
16808841|NCT02275117|37750320|FG002|Overall Study|Worsening of Study Indication|2|||
16808842|NCT02275117|37750321|FG003|Overall Study|Worsening of Study Indication|0|||
16808843|NCT02275117|37750322|FG004|Overall Study|Worsening of Study Indication|0|||
16808844|NCT02275117|37750318|FG000|Overall Study|Study Burden|5|||
16808845|NCT02275117|37750319|FG001|Overall Study|Study Burden|4|||
16808846|NCT02275117|37750320|FG002|Overall Study|Study Burden|7|||
16808847|NCT02275117|37750321|FG003|Overall Study|Study Burden|5|||
16808848|NCT02275117|37750322|FG004|Overall Study|Study Burden|7|||
16808849|NCT02275117|37750318|FG000|Overall Study|Other|1|||
16808850|NCT02275117|37750319|FG001|Overall Study|Other|0|||
16808851|NCT02275117|37750320|FG002|Overall Study|Other|0|||
16808852|NCT02275117|37750321|FG003|Overall Study|Other|0|||
16808853|NCT02275117|37750322|FG004|Overall Study|Other|2|||
16808854|NCT02274493|37750334|FG000|Overall Study|Withdrawal by Subject|1|||
16808855|NCT02273167|37750341|FG000|Overall Study|Adverse Event|1|||
16808856|NCT02273167|37750342|FG001|Overall Study|Adverse Event|0|||
16808857|NCT02273167|37750343|FG002|Overall Study|Adverse Event|0|||
16808858|NCT02273167|37750341|FG000|Overall Study|Protocol Violation|3|||
16808859|NCT02273167|37750342|FG001|Overall Study|Protocol Violation|1|||
16808860|NCT02273167|37750343|FG002|Overall Study|Protocol Violation|1|||
16808861|NCT02273167|37750341|FG000|Overall Study|Lost to Follow-up|0|||
16808862|NCT02273167|37750342|FG001|Overall Study|Lost to Follow-up|1|||
16808863|NCT02273167|37750343|FG002|Overall Study|Lost to Follow-up|1|||
16808864|NCT02273167|37750341|FG000|Overall Study|Withdrawal by Subject|10|||
16808865|NCT02273167|37750342|FG001|Overall Study|Withdrawal by Subject|12|||
16808866|NCT02273167|37750343|FG002|Overall Study|Withdrawal by Subject|11|||
16808867|NCT02273167|37750341|FG000|Overall Study|Various|10|||
16808868|NCT02273167|37750342|FG001|Overall Study|Various|9|||
16808869|NCT02273167|37750343|FG002|Overall Study|Various|8|||
16808870|NCT01850524|37750354|FG000|Overall Study|Ongoing on Treatment|57|||
16808871|NCT01850524|37750355|FG001|Overall Study|Ongoing on Treatment|54|||
16808872|NCT01850524|37750354|FG000|Overall Study|Adverse Event|96|||
16808873|NCT01850524|37750355|FG001|Overall Study|Adverse Event|122|||
16808874|NCT01850524|37750354|FG000|Overall Study|Lost to Follow-up|2|||
16808875|NCT01850524|37750355|FG001|Overall Study|Lost to Follow-up|0|||
16808876|NCT01850524|37750354|FG000|Overall Study|Progressive Disease|166|||
16808877|NCT01850524|37750355|FG001|Overall Study|Progressive Disease|123|||
16808878|NCT01850524|37750354|FG000|Overall Study|Protocol Violation|1|||
16808879|NCT01850524|37750355|FG001|Overall Study|Protocol Violation|2|||
16808880|NCT01850524|37750354|FG000|Overall Study|Withdrawal by Subject|8|||
16808881|NCT01850524|37750355|FG001|Overall Study|Withdrawal by Subject|19|||
16808882|NCT01850524|37750354|FG000|Overall Study|Participant Wished to Discontinue Treatment|15|||
16808883|NCT01850524|37750355|FG001|Overall Study|Participant Wished to Discontinue Treatment|22|||
16808884|NCT01850524|37750354|FG000|Overall Study|Investigator Decision|4|||
16808885|NCT01850524|37750355|FG001|Overall Study|Investigator Decision|4|||
16808886|NCT01850524|37750354|FG000|Overall Study|Participants Removed From Study|0|||
16808887|NCT01850524|37750355|FG001|Overall Study|Participants Removed From Study|1|||
16808888|NCT01850524|37750354|FG000|Overall Study|Medical Monitor Decision|0|||
16808889|NCT01850524|37750355|FG001|Overall Study|Medical Monitor Decision|1|||
16808890|NCT01850524|37750354|FG000|Overall Study|Participants Decision|2|||
16808891|NCT01850524|37750355|FG001|Overall Study|Participants Decision|2|||
16808892|NCT01850524|37750354|FG000|Overall Study|Progressive Disease Per Local Lab|1|||
16808893|NCT01850524|37750355|FG001|Overall Study|Progressive Disease Per Local Lab|0|||
16808894|NCT01850524|37750354|FG000|Overall Study|Lack of Improvement|0|||
16808895|NCT01850524|37750355|FG001|Overall Study|Lack of Improvement|1|||
16808896|NCT01850524|37750354|FG000|Overall Study|Minimal Response|1|||
16808897|NCT01850524|37750355|FG001|Overall Study|Minimal Response|0|||
16808898|NCT01850524|37750354|FG000|Overall Study|Comorbidities|1|||
16808899|NCT01850524|37750355|FG001|Overall Study|Comorbidities|0|||
16808900|NCT02272777|37750365|FG000|Overall Study|Adverse Event|0|||
16808901|NCT02272777|37750366|FG001|Overall Study|Adverse Event|1|||
16808902|NCT02272777|37750365|FG000|Overall Study|Withdrawal by Subject|0|||
16808903|NCT02272777|37750366|FG001|Overall Study|Withdrawal by Subject|3|||
16808904|NCT02272777|37750365|FG000|Overall Study|Lost to Follow-up|2|||
16808905|NCT02272777|37750366|FG001|Overall Study|Lost to Follow-up|0|||
16808906|NCT02272777|37750365|FG000|Overall Study|Other|2|||
16808907|NCT02272777|37750366|FG001|Overall Study|Other|0|||
16808908|NCT02357810|37750372|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
16808909|NCT02357810|37750372|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
16808910|NCT02357810|37750372|FG000|Reached 12 Weeks Response|Adverse Event|5|||
16808911|NCT02357810|37750372|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
16808912|NCT02357810|37750372|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
16808913|NCT02357810|37750372|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
16808914|NCT02357810|37750372|FG000|Reached 12 Weeks Response|Death|1|||
16808915|NCT02357810|37750372|FG000|Reached 12 Weeks Response|Physician Decision|1|||
16808916|NCT02357810|37750372|FG000|Reached 12 Weeks Response|Other|1|||
16808917|NCT02357810|37750372|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
16808918|NCT02357810|37750372|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
16808919|NCT02357810|37750372|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
16808920|NCT02357810|37750372|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
16808921|NCT02357810|37750372|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
16808922|NCT02357810|37750372|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
16808923|NCT02357576|37750378|FG000|Treatment Period|Withdrawal by Subject|0|||
16808924|NCT02357576|37750379|FG001|Treatment Period|Withdrawal by Subject|1|||
16808925|NCT02357576|37750378|FG000|Treatment Period|Physician Decision|0|||
16808926|NCT02357576|37750379|FG001|Treatment Period|Physician Decision|1|||
16808927|NCT02357576|37750378|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
16808928|NCT02357576|37750379|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
16808929|NCT02357576|37750378|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
16808930|NCT02357576|37750379|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
16808931|NCT02357576|37750378|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
16808932|NCT02357576|37750379|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
16808933|NCT02357576|37750378|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
16808934|NCT02357576|37750379|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
16808935|NCT01850446|37750387|FG000|Overall Study|Lack of Efficacy|1|||
16808936|NCT01850446|37750388|FG001|Overall Study|Lack of Efficacy|0|||
16808937|NCT01850446|37750387|FG000|Overall Study|Withdrawal by Subject|4|||
16808938|NCT01850446|37750388|FG001|Overall Study|Withdrawal by Subject|0|||
16808939|NCT01850446|37750387|FG000|Overall Study|Protocol Violation|0|||
16808940|NCT01850446|37750388|FG001|Overall Study|Protocol Violation|2|||
16808941|NCT02465567|37750398|FG000|Overall Study|Adverse Event|118|||
16808942|NCT02465567|37750399|FG001|Overall Study|Adverse Event|113|||
16808943|NCT02465567|37750400|FG002|Overall Study|Adverse Event|147|||
16808944|NCT02465567|37750401|FG003|Overall Study|Adverse Event|138|||
16808945|NCT02465567|37750398|FG000|Overall Study|Lack of Efficacy|103|||
16808946|NCT02465567|37750399|FG001|Overall Study|Lack of Efficacy|102|||
16808947|NCT02465567|37750400|FG002|Overall Study|Lack of Efficacy|171|||
16808948|NCT02465567|37750401|FG003|Overall Study|Lack of Efficacy|135|||
16808949|NCT02465567|37750398|FG000|Overall Study|Withdrawal by Subject|104|||
16808950|NCT02465567|37750399|FG001|Overall Study|Withdrawal by Subject|94|||
16808951|NCT02465567|37750400|FG002|Overall Study|Withdrawal by Subject|123|||
16808952|NCT02465567|37750401|FG003|Overall Study|Withdrawal by Subject|130|||
16808953|NCT02465567|37750398|FG000|Overall Study|Physician Decision|23|||
16808954|NCT02465567|37750399|FG001|Overall Study|Physician Decision|33|||
16808955|NCT02465567|37750400|FG002|Overall Study|Physician Decision|38|||
16808956|NCT02465567|37750401|FG003|Overall Study|Physician Decision|28|||
16808957|NCT02465567|37750398|FG000|Overall Study|Major Protocol Deviation|24|||
16808958|NCT02465567|37750399|FG001|Overall Study|Major Protocol Deviation|26|||
16808959|NCT02465567|37750400|FG002|Overall Study|Major Protocol Deviation|22|||
16808960|NCT02465567|37750401|FG003|Overall Study|Major Protocol Deviation|25|||
16808961|NCT02465567|37750398|FG000|Overall Study|Lost to Follow-up|25|||
16808962|NCT02465567|37750399|FG001|Overall Study|Lost to Follow-up|21|||
16808963|NCT02465567|37750400|FG002|Overall Study|Lost to Follow-up|19|||
16808964|NCT02465567|37750401|FG003|Overall Study|Lost to Follow-up|15|||
16808965|NCT02465567|37750398|FG000|Overall Study|Protocol Specified Criteria|20|||
16808966|NCT02465567|37750399|FG001|Overall Study|Protocol Specified Criteria|10|||
16808967|NCT02465567|37750400|FG002|Overall Study|Protocol Specified Criteria|9|||
16808968|NCT02465567|37750401|FG003|Overall Study|Protocol Specified Criteria|12|||
16808969|NCT02465567|37750398|FG000|Overall Study|Administrative Reasons|12|||
17102321|NCT00091026|38241221|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
16808970|NCT02465567|37750399|FG001|Overall Study|Administrative Reasons|9|||
16808971|NCT02465567|37750400|FG002|Overall Study|Administrative Reasons|11|||
16808972|NCT02465567|37750401|FG003|Overall Study|Administrative Reasons|5|||
16808973|NCT02465567|37750398|FG000|Overall Study|Randomized but not treated|1|||
16808974|NCT02465567|37750399|FG001|Overall Study|Randomized but not treated|5|||
16808975|NCT02465567|37750400|FG002|Overall Study|Randomized but not treated|4|||
16808976|NCT02465567|37750401|FG003|Overall Study|Randomized but not treated|5|||
16808977|NCT02465567|37750398|FG000|Overall Study|enrolled in >1 studies|18|||
16808978|NCT02465567|37750399|FG001|Overall Study|enrolled in >1 studies|11|||
16808979|NCT02465567|37750400|FG002|Overall Study|enrolled in >1 studies|19|||
16808980|NCT02465567|37750401|FG003|Overall Study|enrolled in >1 studies|15|||
16808981|NCT02465567|37750398|FG000|Overall Study|missing PI Signature|1|||
16808982|NCT02465567|37750399|FG001|Overall Study|missing PI Signature|0|||
16808983|NCT02465567|37750400|FG002|Overall Study|missing PI Signature|0|||
16808984|NCT02465567|37750401|FG003|Overall Study|missing PI Signature|0|||
16808985|NCT01644175|37750413|FG000|Overall Study|Randomized But Not Treated|0|||
16808986|NCT01644175|37750414|FG001|Overall Study|Randomized But Not Treated|2|||
16808987|NCT01644175|37750413|FG000|Overall Study|Adverse Event|8|||
16808988|NCT01644175|37750414|FG001|Overall Study|Adverse Event|13|||
16808989|NCT01644175|37750413|FG000|Overall Study|Death|1|||
16808990|NCT01644175|37750414|FG001|Overall Study|Death|2|||
16808991|NCT01644175|37750413|FG000|Overall Study|Poor compliance to protocol|9|||
16808992|NCT01644175|37750414|FG001|Overall Study|Poor compliance to protocol|10|||
16808993|NCT01644175|37750413|FG000|Overall Study|Physician Decision|1|||
16808994|NCT01644175|37750414|FG001|Overall Study|Physician Decision|2|||
16808995|NCT01644175|37750413|FG000|Overall Study|Participant Moved|1|||
16808996|NCT01644175|37750414|FG001|Overall Study|Participant Moved|2|||
16808997|NCT01644175|37750413|FG000|Overall Study|Consent withdrawn by participant|3|||
16808998|NCT01644175|37750414|FG001|Overall Study|Consent withdrawn by participant|4|||
16808999|NCT01644175|37750413|FG000|Overall Study|Related to Autoinjector Administration|2|||
16809000|NCT01644175|37750414|FG001|Overall Study|Related to Autoinjector Administration|1|||
16809001|NCT01644175|37750413|FG000|Overall Study|Last visit outside protocol visit window|4|||
16809002|NCT01644175|37750414|FG001|Overall Study|Last visit outside protocol visit window|11|||
16809003|NCT01644175|37750413|FG000|Overall Study|Selection criteria finally not met|0|||
16809004|NCT01644175|37750414|FG001|Overall Study|Selection criteria finally not met|1|||
16809005|NCT01644175|37750413|FG000|Overall Study|Site closure|2|||
16809006|NCT01644175|37750414|FG001|Overall Study|Site closure|2|||
16809007|NCT01644175|37750413|FG000|Overall Study|Lost to Follow-up|1|||
16809008|NCT01644175|37750414|FG001|Overall Study|Lost to Follow-up|0|||
16809009|NCT01644175|37750413|FG000|Overall Study|Other than specified above|0|||
16809010|NCT01644175|37750414|FG001|Overall Study|Other than specified above|3|||
16809011|NCT02357420|37750424|FG000|Overall Study|Adverse Event|3|||
16809012|NCT02357420|37750425|FG001|Overall Study|Adverse Event|3|||
16809013|NCT02357420|37750426|FG002|Overall Study|Adverse Event|8|||
16809014|NCT02357420|37750427|FG003|Overall Study|Adverse Event|9|||
16809015|NCT02357420|37750424|FG000|Overall Study|Investigator Decision|1|||
16809016|NCT02357420|37750425|FG001|Overall Study|Investigator Decision|0|||
16809017|NCT02357420|37750426|FG002|Overall Study|Investigator Decision|0|||
16809018|NCT02357420|37750427|FG003|Overall Study|Investigator Decision|0|||
16809019|NCT02357420|37750424|FG000|Overall Study|Prohibited Medication|1|||
16809020|NCT02357420|37750425|FG001|Overall Study|Prohibited Medication|1|||
16809021|NCT02357420|37750426|FG002|Overall Study|Prohibited Medication|0|||
16809022|NCT02357420|37750427|FG003|Overall Study|Prohibited Medication|0|||
16809023|NCT02357420|37750424|FG000|Overall Study|Protocol Non-compliance|0|||
16809024|NCT02357420|37750425|FG001|Overall Study|Protocol Non-compliance|0|||
16809025|NCT02357420|37750426|FG002|Overall Study|Protocol Non-compliance|0|||
16809026|NCT02357420|37750427|FG003|Overall Study|Protocol Non-compliance|1|||
16809027|NCT02357420|37750424|FG000|Overall Study|Withdrawn Consent|4|||
16809028|NCT02357420|37750425|FG001|Overall Study|Withdrawn Consent|8|||
16809029|NCT02357420|37750426|FG002|Overall Study|Withdrawn Consent|6|||
16809030|NCT02357420|37750427|FG003|Overall Study|Withdrawn Consent|6|||
16809031|NCT02357420|37750424|FG000|Overall Study|Lost to Follow-up|3|||
16809032|NCT02357420|37750425|FG001|Overall Study|Lost to Follow-up|0|||
16809033|NCT02357420|37750426|FG002|Overall Study|Lost to Follow-up|2|||
16809034|NCT02357420|37750427|FG003|Overall Study|Lost to Follow-up|3|||
16809035|NCT01832038|37750437|FG000|Overall Study|Death|5|||
16809036|NCT01832038|37750437|FG000|Overall Study|Adverse Event|50|||
16809037|NCT01832038|37750437|FG000|Overall Study|Lack of Efficacy|81|||
16809038|NCT01832038|37750437|FG000|Overall Study|Protocol Violation|7|||
16809039|NCT01832038|37750437|FG000|Overall Study|Lost to Follow-up|10|||
16809040|NCT01832038|37750437|FG000|Overall Study|Withdrawal by Subject|49|||
16809041|NCT01832038|37750437|FG000|Overall Study|Visit non-compliance|2|||
16809042|NCT01832038|37750437|FG000|Overall Study|Subject refused to return visit|2|||
16809043|NCT01832038|37750437|FG000|Overall Study|Not convenient to come back to site|2|||
16809044|NCT01832038|37750437|FG000|Overall Study|Participant was asked to quit|5|||
16809045|NCT01832038|37750437|FG000|Overall Study|Back home|1|||
16809046|NCT01832038|37750437|FG000|Overall Study|Pregnancy|1|||
16809047|NCT01832038|37750437|FG000|Overall Study|Low compliance|3|||
16809048|NCT01832038|37750437|FG000|Overall Study|Prohibit procedure|2|||
16809049|NCT01832038|37750437|FG000|Overall Study|Not possible to visit the hospital|1|||
16909884|NCT01716156|38018674|FG000|Overall Study|Protocol Violation|1|||
16909885|NCT01716156|38018675|FG001|Overall Study|Protocol Violation|0|||
16909886|NCT01716156|38018676|FG002|Overall Study|Protocol Violation|0|||
16909887|NCT01716156|38018674|FG000|Overall Study|Withdrawal by Subject|0|||
16909888|NCT01716156|38018675|FG001|Overall Study|Withdrawal by Subject|1|||
16809050|NCT01832038|37750437|FG000|Overall Study|Changes of implementation system|3|||
16809051|NCT01832038|37750437|FG000|Overall Study|Plan to pregnancy|7|||
16809052|NCT01832038|37750437|FG000|Overall Study|Bad mood and has suicidal thought|1|||
16809053|NCT01832038|37750437|FG000|Overall Study|Prohibited concomitant medication|1|||
16809054|NCT01832038|37750437|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
16809055|NCT01832038|37750437|FG000|Overall Study|Subject considered the efficacy was poor|1|||
16809056|NCT01849588|37750442|FG000|Overall Study|Lack of Efficacy|3|||
16809057|NCT02357342|37750448|FG000|First 6 Months|Death|2|||
16809058|NCT02357342|37750449|FG001|First 6 Months|Death|0|||
16809059|NCT02271529|37750455|FG000|Overall Study|Withdrawal by Subject|1|||
16809060|NCT02325518|37750461|FG000|Overall Study|Adverse Event|4|||
16809061|NCT02325518|37750462|FG001|Overall Study|Adverse Event|1|||
16809062|NCT02325518|37750461|FG000|Overall Study|Physician Decision|0|||
16809063|NCT02325518|37750462|FG001|Overall Study|Physician Decision|1|||
16809064|NCT02325518|37750461|FG000|Overall Study|Withdrawal by Subject|0|||
16809065|NCT02325518|37750462|FG001|Overall Study|Withdrawal by Subject|1|||
16809066|NCT02270983|37750472|FG000|Overall Study|Adverse Event|3|||
16809067|NCT02270983|37750473|FG001|Overall Study|Adverse Event|2|||
16809068|NCT02270983|37750474|FG002|Overall Study|Adverse Event|6|||
16809069|NCT02270983|37750472|FG000|Overall Study|Lack of Efficacy|2|||
16809070|NCT02270983|37750473|FG001|Overall Study|Lack of Efficacy|1|||
16809071|NCT02270983|37750474|FG002|Overall Study|Lack of Efficacy|1|||
16809072|NCT02270983|37750472|FG000|Overall Study|Withdrawal by Subject|1|||
16809073|NCT02270983|37750473|FG001|Overall Study|Withdrawal by Subject|0|||
16809074|NCT02270983|37750474|FG002|Overall Study|Withdrawal by Subject|2|||
16809075|NCT02270983|37750472|FG000|Overall Study|Lost to Follow-up|1|||
16809076|NCT02270983|37750473|FG001|Overall Study|Lost to Follow-up|1|||
16809077|NCT02270983|37750474|FG002|Overall Study|Lost to Follow-up|2|||
16809078|NCT02270983|37750472|FG000|Overall Study|Protocol Violation|1|||
16809079|NCT02270983|37750473|FG001|Overall Study|Protocol Violation|1|||
16809080|NCT02270983|37750474|FG002|Overall Study|Protocol Violation|1|||
16809081|NCT02270983|37750472|FG000|Overall Study|family emergency|0|||
16809082|NCT02270983|37750473|FG001|Overall Study|family emergency|1|||
16809083|NCT02270983|37750474|FG002|Overall Study|family emergency|0|||
16809084|NCT02270983|37750472|FG000|Overall Study|study procedure non-compliance|1|||
16809085|NCT02270983|37750473|FG001|Overall Study|study procedure non-compliance|0|||
16809086|NCT02270983|37750474|FG002|Overall Study|study procedure non-compliance|0|||
16809087|NCT02270983|37750472|FG000|Overall Study|moved away from study site|0|||
16809088|NCT02270983|37750473|FG001|Overall Study|moved away from study site|1|||
16809089|NCT02270983|37750474|FG002|Overall Study|moved away from study site|0|||
16809090|NCT02449889|37750485|FG000|Overall Study|Adverse Event|1|||
16809091|NCT02449889|37750486|FG001|Overall Study|Adverse Event|2|||
16809092|NCT02449889|37750487|FG002|Overall Study|Adverse Event|0|||
16809093|NCT02449889|37750485|FG000|Overall Study|Protocol Violation|0|||
16809094|NCT02449889|37750486|FG001|Overall Study|Protocol Violation|4|||
16809095|NCT02449889|37750487|FG002|Overall Study|Protocol Violation|1|||
16809096|NCT01831804|37750504|FG000|Overall Study|Adverse Event|0|||
16809097|NCT01831804|37750505|FG001|Overall Study|Adverse Event|0|||
16809098|NCT01831804|37750506|FG002|Overall Study|Adverse Event|0|||
16809099|NCT01831804|37750507|FG003|Overall Study|Adverse Event|0|||
16809100|NCT01831804|37750508|FG004|Overall Study|Adverse Event|0|||
16809101|NCT01831804|37750509|FG005|Overall Study|Adverse Event|0|||
16809102|NCT01831804|37750510|FG006|Overall Study|Adverse Event|1|||
16809103|NCT01831804|37750511|FG007|Overall Study|Adverse Event|0|||
16809104|NCT01831804|37750512|FG008|Overall Study|Adverse Event|1|||
16809105|NCT01831804|37750504|FG000|Overall Study|Protocol Violation|0|||
16809106|NCT01831804|37750505|FG001|Overall Study|Protocol Violation|0|||
16809107|NCT01831804|37750506|FG002|Overall Study|Protocol Violation|2|||
16809108|NCT01831804|37750507|FG003|Overall Study|Protocol Violation|0|||
16809109|NCT01831804|37750508|FG004|Overall Study|Protocol Violation|0|||
16809110|NCT01831804|37750509|FG005|Overall Study|Protocol Violation|0|||
16809111|NCT01831804|37750510|FG006|Overall Study|Protocol Violation|0|||
16809112|NCT01831804|37750511|FG007|Overall Study|Protocol Violation|0|||
16809113|NCT01831804|37750512|FG008|Overall Study|Protocol Violation|0|||
16809114|NCT01831804|37750504|FG000|Overall Study|Protocol defined stopping criteria|1|||
16809115|NCT01831804|37750505|FG001|Overall Study|Protocol defined stopping criteria|1|||
16809116|NCT01831804|37750506|FG002|Overall Study|Protocol defined stopping criteria|3|||
16809117|NCT01831804|37750507|FG003|Overall Study|Protocol defined stopping criteria|0|||
16809118|NCT01831804|37750508|FG004|Overall Study|Protocol defined stopping criteria|1|||
16809119|NCT01831804|37750509|FG005|Overall Study|Protocol defined stopping criteria|0|||
16809120|NCT01831804|37750510|FG006|Overall Study|Protocol defined stopping criteria|0|||
16909889|NCT01716156|38018676|FG002|Overall Study|Withdrawal by Subject|2|||
16809121|NCT01831804|37750511|FG007|Overall Study|Protocol defined stopping criteria|0|||
16809122|NCT01831804|37750512|FG008|Overall Study|Protocol defined stopping criteria|0|||
16809123|NCT01831804|37750504|FG000|Overall Study|Lost to Follow-up|0|||
16809124|NCT01831804|37750505|FG001|Overall Study|Lost to Follow-up|0|||
16809125|NCT01831804|37750506|FG002|Overall Study|Lost to Follow-up|1|||
16809126|NCT01831804|37750507|FG003|Overall Study|Lost to Follow-up|0|||
16809127|NCT01831804|37750508|FG004|Overall Study|Lost to Follow-up|0|||
16809128|NCT01831804|37750509|FG005|Overall Study|Lost to Follow-up|0|||
16809129|NCT01831804|37750510|FG006|Overall Study|Lost to Follow-up|0|||
16809130|NCT01831804|37750511|FG007|Overall Study|Lost to Follow-up|0|||
16809131|NCT01831804|37750512|FG008|Overall Study|Lost to Follow-up|1|||
16809132|NCT01831804|37750504|FG000|Overall Study|Investigator discretion|0|||
16809133|NCT01831804|37750505|FG001|Overall Study|Investigator discretion|0|||
16809134|NCT01831804|37750506|FG002|Overall Study|Investigator discretion|0|||
16809135|NCT01831804|37750507|FG003|Overall Study|Investigator discretion|0|||
16809136|NCT01831804|37750508|FG004|Overall Study|Investigator discretion|1|||
16809137|NCT01831804|37750509|FG005|Overall Study|Investigator discretion|0|||
16809138|NCT01831804|37750510|FG006|Overall Study|Investigator discretion|0|||
16809139|NCT01831804|37750511|FG007|Overall Study|Investigator discretion|1|||
16809140|NCT01831804|37750512|FG008|Overall Study|Investigator discretion|0|||
16809141|NCT01831804|37750504|FG000|Overall Study|Withdrew Consent|0|||
16809142|NCT01831804|37750505|FG001|Overall Study|Withdrew Consent|1|||
16809143|NCT01831804|37750506|FG002|Overall Study|Withdrew Consent|0|||
16809144|NCT01831804|37750507|FG003|Overall Study|Withdrew Consent|0|||
16809145|NCT01831804|37750508|FG004|Overall Study|Withdrew Consent|0|||
16809146|NCT01831804|37750509|FG005|Overall Study|Withdrew Consent|0|||
16809147|NCT01831804|37750510|FG006|Overall Study|Withdrew Consent|0|||
16809148|NCT01831804|37750511|FG007|Overall Study|Withdrew Consent|2|||
16809149|NCT01831804|37750512|FG008|Overall Study|Withdrew Consent|0|||
16809150|NCT02270671|37750543|FG000|Overall Study|Withdrawal by Subject|1|||
16809151|NCT02270671|37750544|FG001|Overall Study|Withdrawal by Subject|1|||
16809152|NCT02270671|37750543|FG000|Overall Study|Protocol Violation|0|||
16809153|NCT02270671|37750544|FG001|Overall Study|Protocol Violation|1|||
16809154|NCT02270671|37750543|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
17102322|NCT00091026|38241222|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
17102323|NCT00091026|38241221|FG000|Overall Study|Patient withdrew and never received trea|0|||
17102324|NCT00091026|38241222|FG001|Overall Study|Patient withdrew and never received trea|2|||
17102325|NCT00091026|38241221|FG000|Overall Study|Unknown-never received treatment|0|||
17102326|NCT00091026|38241222|FG001|Overall Study|Unknown-never received treatment|1|||
17102327|NCT00116558|38241231|FG000|Overall Study|Death|11|||
16809155|NCT02270671|37750544|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
16809156|NCT02270671|37750543|FG000|Overall Study|Lost to Follow-up|2|||
16809157|NCT02270671|37750544|FG001|Overall Study|Lost to Follow-up|1|||
16809158|NCT02324270|37750553|FG000|Overall Study|Withdrawal by Subject|0|||
16809159|NCT02324270|37750554|FG001|Overall Study|Withdrawal by Subject|1|||
16809160|NCT02324270|37750555|FG002|Overall Study|Withdrawal by Subject|0|||
16809161|NCT02324270|37750553|FG000|Overall Study|Lost to Follow-up|4|||
16809162|NCT02324270|37750554|FG001|Overall Study|Lost to Follow-up|3|||
16809163|NCT02324270|37750555|FG002|Overall Study|Lost to Follow-up|4|||
16809164|NCT02324270|37750553|FG000|Overall Study|Protocol Violation|0|||
16809165|NCT02324270|37750554|FG001|Overall Study|Protocol Violation|1|||
16809166|NCT02324270|37750555|FG002|Overall Study|Protocol Violation|1|||
16809167|NCT02324270|37750553|FG000|Overall Study|Non Compliance with Study Drug|1|||
16809168|NCT02324270|37750554|FG001|Overall Study|Non Compliance with Study Drug|2|||
16809169|NCT02324270|37750555|FG002|Overall Study|Non Compliance with Study Drug|0|||
16809170|NCT02270515|37750563|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
16809171|NCT02270515|37750563|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
16809172|NCT02270515|37750563|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
16809173|NCT02270515|37750563|FG000|Intervention Period 1: 0-6 Months|Death|7|||
16809174|NCT02270515|37750563|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
16809175|NCT02270515|37750563|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
16809176|NCT02270515|37750563|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
16809177|NCT02270515|37750563|FG000|Intervention Period 2: 6-12 Months|Death|5|||
16809178|NCT02270515|37750563|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
16809179|NCT02270515|37750563|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
16809180|NCT02270515|37750563|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
16809181|NCT02270515|37750563|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
16809182|NCT02270515|37750563|FG000|Intervention Period 3: 12-18 Months|Death|3|||
16809183|NCT02270515|37750563|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
16809184|NCT02448875|37750577|FG000|Overall Study|Adverse Event|2|||
16809185|NCT02448875|37750578|FG001|Overall Study|Adverse Event|1|||
16809186|NCT02448875|37750579|FG002|Overall Study|Adverse Event|0|||
16809187|NCT02448875|37750577|FG000|Overall Study|Lost to Follow-up|1|||
16809188|NCT02448875|37750578|FG001|Overall Study|Lost to Follow-up|0|||
16809189|NCT02448875|37750579|FG002|Overall Study|Lost to Follow-up|0|||
16809190|NCT02448875|37750577|FG000|Overall Study|Investigator Decision|3|||
16809191|NCT02448875|37750578|FG001|Overall Study|Investigator Decision|0|||
16809192|NCT02448875|37750579|FG002|Overall Study|Investigator Decision|1|||
16809193|NCT02448875|37750577|FG000|Overall Study|Withdrawal by Subject|1|||
16809194|NCT02448875|37750578|FG001|Overall Study|Withdrawal by Subject|0|||
16809195|NCT02448875|37750579|FG002|Overall Study|Withdrawal by Subject|0|||
16809196|NCT01831726|37750590|FG000|Overall Study|Adverse Event|16|||
16809197|NCT01831726|37750590|FG000|Overall Study|Death|7|||
16809198|NCT01831726|37750590|FG000|Overall Study|Disease Progression|49|||
16809199|NCT01831726|37750590|FG000|Overall Study|Physician Decision|1|||
16809200|NCT01831726|37750590|FG000|Overall Study|Subject/guardian decision|7|||
16809201|NCT01831258|37750594|FG000|Overall Study|Withdrawal by Subject|2|||
16809202|NCT01831258|37750595|FG001|Overall Study|Withdrawal by Subject|1|||
16809203|NCT01831258|37750594|FG000|Overall Study|Lost to Follow-up|3|||
16809204|NCT01831258|37750595|FG001|Overall Study|Lost to Follow-up|2|||
16809205|NCT01849276|37750603|FG000|Followed for Survival for 5 Years|Death|1|||
16809206|NCT01849276|37750603|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
16809207|NCT02465489|37750607|FG000|Overall Study|Adverse Event|5|||
16809208|NCT01829464|37750622|FG000|Overall Study|Adverse Event|1|||
16809209|NCT01829464|37750623|FG001|Overall Study|Adverse Event|0|||
16809210|NCT01829464|37750624|FG002|Overall Study|Adverse Event|0|||
16809211|NCT01829464|37750622|FG000|Overall Study|Lost to Follow-up|0|||
16809212|NCT01829464|37750623|FG001|Overall Study|Lost to Follow-up|0|||
16809213|NCT01829464|37750624|FG002|Overall Study|Lost to Follow-up|1|||
16809214|NCT01829464|37750622|FG000|Overall Study|Withdrawal by Subject|2|||
16809215|NCT01829464|37750623|FG001|Overall Study|Withdrawal by Subject|0|||
16809216|NCT01829464|37750624|FG002|Overall Study|Withdrawal by Subject|0|||
16809217|NCT01829464|37750622|FG000|Overall Study|Study terminated by sponsor|25|||
16809218|NCT01829464|37750623|FG001|Overall Study|Study terminated by sponsor|28|||
16809219|NCT01829464|37750624|FG002|Overall Study|Study terminated by sponsor|25|||
16809220|NCT01829464|37750622|FG000|Overall Study|Lack of Efficacy|0|||
16809221|NCT01829464|37750623|FG001|Overall Study|Lack of Efficacy|1|||
16809222|NCT01829464|37750624|FG002|Overall Study|Lack of Efficacy|0|||
16809223|NCT01847092|37750634|FG000|Overall Study|Adverse Event|12|||
16809224|NCT01847092|37750635|FG001|Overall Study|Adverse Event|3|||
16809225|NCT01847092|37750634|FG000|Overall Study|Withdrawal by Subject|5|||
16809226|NCT01847092|37750635|FG001|Overall Study|Withdrawal by Subject|5|||
16809227|NCT01847092|37750634|FG000|Overall Study|Protocol Specified|8|||
16809228|NCT01847092|37750635|FG001|Overall Study|Protocol Specified|0|||
16809229|NCT01847092|37750634|FG000|Overall Study|Physician Decision|1|||
16809230|NCT01847092|37750635|FG001|Overall Study|Physician Decision|1|||
16809231|NCT01847092|37750634|FG000|Overall Study|Protocol Violation|0|||
16809232|NCT01847092|37750635|FG001|Overall Study|Protocol Violation|2|||
16809233|NCT01601821|37750643|FG000|Overall Study|Death|2|||
16809234|NCT01601821|37750644|FG001|Overall Study|Death|5|||
16809235|NCT01601821|37750643|FG000|Overall Study|Protocol Violation|2|||
16809236|NCT01601821|37750644|FG001|Overall Study|Protocol Violation|2|||
16809237|NCT01601821|37750643|FG000|Overall Study|Lost to Follow-up|6|||
16809238|NCT01601821|37750644|FG001|Overall Study|Lost to Follow-up|14|||
16809239|NCT01601821|37750643|FG000|Overall Study|Withdrawal by Subject|1|||
16809240|NCT01601821|37750644|FG001|Overall Study|Withdrawal by Subject|0|||
16809241|NCT01601821|37750643|FG000|Overall Study|Graft Loss|6|||
16809242|NCT01601821|37750644|FG001|Overall Study|Graft Loss|6|||
16809243|NCT01601821|37750643|FG000|Overall Study|Study Events|7|||
16809244|NCT01601821|37750644|FG001|Overall Study|Study Events|1|||
16809245|NCT01601821|37750643|FG000|Overall Study|Other|5|||
16809246|NCT01601821|37750644|FG001|Overall Study|Other|1|||
16809247|NCT02323646|37750653|FG000|Treatment Course 1|Adverse Event|1|||
16809248|NCT02323646|37750654|FG001|Treatment Course 1|Adverse Event|0|||
16809249|NCT02323646|37750655|FG002|Treatment Course 1|Adverse Event|1|||
16809250|NCT02323646|37750653|FG000|Treatment Course 1|Heavy Bleeding|1|||
16809251|NCT02323646|37750654|FG001|Treatment Course 1|Heavy Bleeding|1|||
16809252|NCT02323646|37750655|FG002|Treatment Course 1|Heavy Bleeding|0|||
16809253|NCT02323646|37750653|FG000|Treatment Course 1|Lost to Follow-up|1|||
16809254|NCT02323646|37750654|FG001|Treatment Course 1|Lost to Follow-up|0|||
16809255|NCT02323646|37750655|FG002|Treatment Course 1|Lost to Follow-up|2|||
16809256|NCT02323646|37750653|FG000|Treatment Course 1|Withdrawal by Subject|0|||
16809257|NCT02323646|37750654|FG001|Treatment Course 1|Withdrawal by Subject|2|||
16809258|NCT02323646|37750655|FG002|Treatment Course 1|Withdrawal by Subject|0|||
16809259|NCT02323646|37750653|FG000|Treatment Course 2|Adverse Event|1|||
16809260|NCT02323646|37750654|FG001|Treatment Course 2|Adverse Event|0|||
16809261|NCT02323646|37750655|FG002|Treatment Course 2|Adverse Event|1|||
16809262|NCT02323646|37750653|FG000|Treatment Course 2|Lost to Follow-up|0|||
16809263|NCT02323646|37750654|FG001|Treatment Course 2|Lost to Follow-up|0|||
16809264|NCT02323646|37750655|FG002|Treatment Course 2|Lost to Follow-up|1|||
16809265|NCT02323646|37750653|FG000|Treatment Course 2|Non-compliance|0|||
16809266|NCT02323646|37750654|FG001|Treatment Course 2|Non-compliance|1|||
16809267|NCT02323646|37750655|FG002|Treatment Course 2|Non-compliance|1|||
16809268|NCT01846624|37750663|FG000|Overall Study|Died during induction, no midostaurin|1|||
16809269|NCT01829230|37750669|FG000|Overall Study|Protocol Violation|0|||
16809270|NCT01829230|37750670|FG001|Overall Study|Protocol Violation|2|||
16809271|NCT01829230|37750669|FG000|Overall Study|Withdrawal by Subject|0|||
16809272|NCT01829230|37750670|FG001|Overall Study|Withdrawal by Subject|1|||
16809273|NCT01829230|37750669|FG000|Overall Study|Lost to Follow-up|1|||
16809274|NCT01829230|37750670|FG001|Overall Study|Lost to Follow-up|1|||
16809275|NCT02269657|37750676|FG000|Overall Study|Protocol Violation|3|||
16809276|NCT02269423|37750686|FG000|Overall Study|Discontinued due to change in residence|0|||
16809277|NCT02269423|37750687|FG001|Overall Study|Discontinued due to change in residence|1|||
16809278|NCT02269423|37750688|FG002|Overall Study|Discontinued due to change in residence|0|||
16809279|NCT02269423|37750689|FG003|Overall Study|Discontinued due to change in residence|1|||
16809280|NCT01844986|37750701|FG000|Overall Study|Severe non-compliance to protocol|1|||
16809281|NCT01844986|37750702|FG001|Overall Study|Severe non-compliance to protocol|0|||
16809282|NCT01844986|37750701|FG000|Overall Study|Withdrawal by Subject|21|||
16809283|NCT01844986|37750702|FG001|Overall Study|Withdrawal by Subject|14|||
16809284|NCT01844986|37750701|FG000|Overall Study|Death|55|||
16809285|NCT01844986|37750702|FG001|Overall Study|Death|26|||
16809286|NCT01827670|37750710|FG000|Overall Study|Withdrawal of Consent|3|||
16809287|NCT01827670|37750711|FG001|Overall Study|Withdrawal of Consent|2|||
16809288|NCT01827670|37750710|FG000|Overall Study|Lost to Follow-up|0|||
16809289|NCT01827670|37750711|FG001|Overall Study|Lost to Follow-up|1|||
16809290|NCT02267317|37750725|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
16809291|NCT02267317|37750726|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16809292|NCT02267317|37750727|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16809293|NCT02267317|37750728|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16809294|NCT02267317|37750729|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16809295|NCT02267317|37750730|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16809296|NCT02267317|37750725|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
16809297|NCT02267317|37750726|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16809298|NCT02267317|37750727|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16809299|NCT02267317|37750728|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16809300|NCT02267317|37750729|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16809301|NCT02267317|37750730|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16809302|NCT01844830|37750746|FG000|Overall Study|Withdrawal by Subject|1|||
16809303|NCT01844830|37750747|FG001|Overall Study|Withdrawal by Subject|0|||
16809304|NCT01827592|37750756|FG000|Overall Study|Adverse Event|11|||
16809305|NCT01827592|37750757|FG001|Overall Study|Adverse Event|9|||
16809306|NCT01827592|37750758|FG002|Overall Study|Adverse Event|2|||
16809307|NCT01827592|37750756|FG000|Overall Study|Physician Decision|0|||
16809308|NCT01827592|37750757|FG001|Overall Study|Physician Decision|2|||
16809309|NCT01827592|37750758|FG002|Overall Study|Physician Decision|1|||
16809310|NCT01827592|37750756|FG000|Overall Study|Protocol Violation|2|||
16809311|NCT01827592|37750757|FG001|Overall Study|Protocol Violation|1|||
16809312|NCT01827592|37750758|FG002|Overall Study|Protocol Violation|0|||
16809313|NCT01827592|37750756|FG000|Overall Study|Lost to Follow-up|1|||
16809314|NCT01827592|37750757|FG001|Overall Study|Lost to Follow-up|2|||
16809315|NCT01827592|37750758|FG002|Overall Study|Lost to Follow-up|2|||
16809316|NCT01827592|37750756|FG000|Overall Study|Withdrawal by Subject|12|||
16809317|NCT01827592|37750757|FG001|Overall Study|Withdrawal by Subject|11|||
16809318|NCT01827592|37750758|FG002|Overall Study|Withdrawal by Subject|11|||
16809319|NCT01827592|37750756|FG000|Overall Study|Patient's substantial non-compliance|1|||
16809320|NCT01827592|37750757|FG001|Overall Study|Patient's substantial non-compliance|1|||
16809321|NCT01827592|37750758|FG002|Overall Study|Patient's substantial non-compliance|6|||
16809322|NCT01827592|37750756|FG000|Overall Study|Trial terminated by Sponsor|47|||
16809323|NCT01827592|37750757|FG001|Overall Study|Trial terminated by Sponsor|53|||
16809324|NCT01827592|37750758|FG002|Overall Study|Trial terminated by Sponsor|51|||
16809325|NCT01827592|37750756|FG000|Overall Study|Others|0|||
16809326|NCT01827592|37750757|FG001|Overall Study|Others|1|||
16809327|NCT01827592|37750758|FG002|Overall Study|Others|3|||
16809328|NCT02323334|37750776|FG000|Period 3|Lost to Follow-up|0|||
16809329|NCT02323334|37750777|FG001|Period 3|Lost to Follow-up|0|||
16809330|NCT02323334|37750778|FG002|Period 3|Lost to Follow-up|1|||
16809331|NCT02323334|37750779|FG003|Period 3|Lost to Follow-up|0|||
16809332|NCT02323334|37750780|FG004|Period 3|Lost to Follow-up|0|||
16809333|NCT02323334|37750781|FG005|Period 3|Lost to Follow-up|0|||
16809334|NCT02323334|37750782|FG006|Period 3|Lost to Follow-up|0|||
16809335|NCT02323334|37750783|FG007|Period 3|Lost to Follow-up|0|||
16809336|NCT02323334|37750784|FG008|Period 3|Lost to Follow-up|0|||
16809337|NCT02323334|37750785|FG009|Period 3|Lost to Follow-up|0|||
16809338|NCT02323334|37750786|FG010|Period 3|Lost to Follow-up|0|||
16909890|NCT01716156|38018674|FG000|Overall Study|Lost to Follow-up|1|||
16809339|NCT02323334|37750787|FG011|Period 3|Lost to Follow-up|0|||
16809340|NCT02323334|37750788|FG012|Period 3|Lost to Follow-up|0|||
16809341|NCT02323334|37750789|FG013|Period 3|Lost to Follow-up|0|||
16809342|NCT02323334|37750790|FG014|Period 3|Lost to Follow-up|0|||
16809343|NCT02323334|37750791|FG015|Period 3|Lost to Follow-up|0|||
16809344|NCT02323334|37750792|FG016|Period 3|Lost to Follow-up|0|||
16809345|NCT02323334|37750776|FG000|Period 3|Withdrawal by Subject|1|||
16809346|NCT02323334|37750777|FG001|Period 3|Withdrawal by Subject|0|||
16809347|NCT02323334|37750778|FG002|Period 3|Withdrawal by Subject|0|||
16809348|NCT02323334|37750779|FG003|Period 3|Withdrawal by Subject|0|||
16809349|NCT02323334|37750780|FG004|Period 3|Withdrawal by Subject|0|||
16809350|NCT02323334|37750781|FG005|Period 3|Withdrawal by Subject|0|||
16809351|NCT02323334|37750782|FG006|Period 3|Withdrawal by Subject|0|||
16809352|NCT02323334|37750783|FG007|Period 3|Withdrawal by Subject|0|||
16809353|NCT02323334|37750784|FG008|Period 3|Withdrawal by Subject|0|||
16809354|NCT02323334|37750785|FG009|Period 3|Withdrawal by Subject|0|||
16809355|NCT02323334|37750786|FG010|Period 3|Withdrawal by Subject|0|||
16809356|NCT02323334|37750787|FG011|Period 3|Withdrawal by Subject|0|||
16809357|NCT02323334|37750788|FG012|Period 3|Withdrawal by Subject|0|||
16809358|NCT02323334|37750789|FG013|Period 3|Withdrawal by Subject|0|||
16809359|NCT02323334|37750790|FG014|Period 3|Withdrawal by Subject|0|||
16809360|NCT02323334|37750791|FG015|Period 3|Withdrawal by Subject|0|||
16809361|NCT02323334|37750792|FG016|Period 3|Withdrawal by Subject|0|||
16809362|NCT02448719|37750865|FG000|Overall Study|Withdrawal by Subject|0|||
16809363|NCT02448719|37750866|FG001|Overall Study|Withdrawal by Subject|0|||
16809364|NCT02448719|37750867|FG002|Overall Study|Withdrawal by Subject|0|||
16809365|NCT02448719|37750868|FG003|Overall Study|Withdrawal by Subject|0|||
16809366|NCT02448719|37750869|FG004|Overall Study|Withdrawal by Subject|1|||
16809367|NCT02448719|37750870|FG005|Overall Study|Withdrawal by Subject|0|||
16809368|NCT02448719|37750871|FG006|Overall Study|Withdrawal by Subject|0|||
16809369|NCT02448719|37750872|FG007|Overall Study|Withdrawal by Subject|0|||
16809370|NCT02448719|37750873|FG008|Overall Study|Withdrawal by Subject|0|||
16809371|NCT02448719|37750874|FG009|Overall Study|Withdrawal by Subject|0|||
16809372|NCT02448719|37750875|FG010|Overall Study|Withdrawal by Subject|0|||
16809373|NCT02322866|37750938|FG000|Overall Study|Adverse Event|6|||
16809374|NCT02322866|37750939|FG001|Overall Study|Adverse Event|11|||
16809375|NCT02322866|37750938|FG000|Overall Study|Withdrawal of Consent|16|||
16809376|NCT02322866|37750939|FG001|Overall Study|Withdrawal of Consent|25|||
16809377|NCT02322866|37750938|FG000|Overall Study|Lost to Follow-up|36|||
16809378|NCT02322866|37750939|FG001|Overall Study|Lost to Follow-up|39|||
16809379|NCT02322866|37750938|FG000|Overall Study|Protocol Violation|1|||
16809380|NCT02322866|37750939|FG001|Overall Study|Protocol Violation|0|||
16809381|NCT02322866|37750938|FG000|Overall Study|Noncompliance with Treatment|3|||
16809382|NCT02322866|37750939|FG001|Overall Study|Noncompliance with Treatment|4|||
16809383|NCT02322866|37750938|FG000|Overall Study|Lack of Efficacy|3|||
16809384|NCT02322866|37750939|FG001|Overall Study|Lack of Efficacy|1|||
16809385|NCT02322866|37750938|FG000|Overall Study|Other Miscellaneous Reasons|6|||
16809386|NCT02322866|37750939|FG001|Overall Study|Other Miscellaneous Reasons|6|||
16809387|NCT01844518|37750947|FG000|Overall Study|Adverse Event|7|||
16809388|NCT01844518|37750948|FG001|Overall Study|Adverse Event|1|||
16809389|NCT01844518|37750947|FG000|Overall Study|Lack of Efficacy|17|||
16809390|NCT01844518|37750948|FG001|Overall Study|Lack of Efficacy|5|||
16809391|NCT01844518|37750947|FG000|Overall Study|Participant's request to discontinue|4|||
16809392|NCT01844518|37750948|FG001|Overall Study|Participant's request to discontinue|1|||
16809393|NCT01844518|37750947|FG000|Overall Study|Poor/Non-compliance|1|||
16809394|NCT01844518|37750948|FG001|Overall Study|Poor/Non-compliance|0|||
16809395|NCT01844518|37750947|FG000|Overall Study|No Longer Met Study Criteria|2|||
16809396|NCT01844518|37750948|FG001|Overall Study|No Longer Met Study Criteria|0|||
16809397|NCT01844518|37750947|FG000|Overall Study|Withdrawal by Subject|9|||
16809398|NCT01844518|37750948|FG001|Overall Study|Withdrawal by Subject|0|||
16809399|NCT01844518|37750947|FG000|Overall Study|Pregnancy|1|||
16809400|NCT01844518|37750948|FG001|Overall Study|Pregnancy|0|||
16809401|NCT01640353|37750957|FG000|Overall Study|Withdrew prior to treatment|10|||
16809402|NCT01640353|37750957|FG000|Overall Study|Withdrawn from analysis at term site|12|||
16809403|NCT01640353|37750957|FG000|Overall Study|Withdrawal by Subject|5|||
16809404|NCT01640353|37750957|FG000|Overall Study|Death|2|||
16809405|NCT01640353|37750957|FG000|Overall Study|Early site termination|3|||
16809406|NCT01640353|37750957|FG000|Overall Study|Lost to Follow-up|12|||
16809407|NCT01640353|37750957|FG000|Overall Study|Physician Decision|1|||
16809408|NCT02463071|37750964|FG000|Overall Study|Adverse Event|3|||
16809409|NCT02463071|37750965|FG001|Overall Study|Adverse Event|5|||
16809410|NCT02463071|37750966|FG002|Overall Study|Adverse Event|1|||
16809411|NCT02463071|37750964|FG000|Overall Study|Death|1|||
16809412|NCT02463071|37750965|FG001|Overall Study|Death|0|||
16809413|NCT02463071|37750966|FG002|Overall Study|Death|0|||
16809414|NCT02463071|37750964|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
16809415|NCT02463071|37750965|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16809416|NCT02463071|37750966|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
16809417|NCT02463071|37750964|FG000|Overall Study|Reason not specified|7|||
16809418|NCT02463071|37750965|FG001|Overall Study|Reason not specified|9|||
16809419|NCT02463071|37750966|FG002|Overall Study|Reason not specified|4|||
16809420|NCT02463071|37750964|FG000|Overall Study|Protocol Violation|0|||
16809421|NCT02463071|37750965|FG001|Overall Study|Protocol Violation|2|||
16809422|NCT02463071|37750966|FG002|Overall Study|Protocol Violation|0|||
16809423|NCT02463071|37750964|FG000|Overall Study|Lost to Follow-up|0|||
16809424|NCT02463071|37750965|FG001|Overall Study|Lost to Follow-up|0|||
16809425|NCT02463071|37750966|FG002|Overall Study|Lost to Follow-up|1|||
16809426|NCT02266381|37750977|FG000|Overall Study|Physician Decision|3|||
16809427|NCT02266381|37750978|FG001|Overall Study|Physician Decision|5|||
16809428|NCT02266381|37750979|FG002|Overall Study|Physician Decision|4|||
16809429|NCT01827046|37750991|FG000|Overall Study|Lost to Follow-up|1|||
16809430|NCT01827046|37750992|FG001|Overall Study|Lost to Follow-up|5|||
16809431|NCT01827046|37750991|FG000|Overall Study|Withdrawal by Subject|0|||
16809432|NCT01827046|37750992|FG001|Overall Study|Withdrawal by Subject|4|||
16809433|NCT02356562|37751000|FG000|Overall Study|Withdrawal by Subject|0|||
16809434|NCT02356562|37751001|FG001|Overall Study|Withdrawal by Subject|1|||
16809435|NCT02356562|37751000|FG000|Overall Study|Re-entered treatment in a previous study|1|||
16809436|NCT02356562|37751001|FG001|Overall Study|Re-entered treatment in a previous study|0|||
16809437|NCT02356562|37751000|FG000|Overall Study|site closure|1|||
16809438|NCT02356562|37751001|FG001|Overall Study|site closure|0|||
16809439|NCT02448563|37751012|FG000|Overall Study|Lost to Follow-up|16|||
16809440|NCT02448563|37751013|FG001|Overall Study|Lost to Follow-up|10|||
16809441|NCT02448563|37751012|FG000|Overall Study|Withdrawal by Subject|0|||
16809442|NCT02448563|37751013|FG001|Overall Study|Withdrawal by Subject|1|||
16809443|NCT02266225|37751023|FG000|Overall Study|Lost to Follow-up|2|||
16809444|NCT02266225|37751023|FG000|Overall Study|Death|1|||
16809445|NCT02266225|37751023|FG000|Overall Study|Withdrawal by Subject|13|||
16809446|NCT02354690|37751028|FG000|Overall Study|Physician Decision|1|||
16809447|NCT02354222|37751034|FG000|Overall Study|Adverse Event|0|||
16809448|NCT02354222|37751035|FG001|Overall Study|Adverse Event|3|||
16809449|NCT02354222|37751034|FG000|Overall Study|Physician Decision|1|||
16809450|NCT02354222|37751035|FG001|Overall Study|Physician Decision|1|||
16809451|NCT02354222|37751034|FG000|Overall Study|Pregnancy|1|||
16809452|NCT02354222|37751035|FG001|Overall Study|Pregnancy|0|||
16809453|NCT02354222|37751034|FG000|Overall Study|Withdrawal by Subject|2|||
16809454|NCT02354222|37751035|FG001|Overall Study|Withdrawal by Subject|3|||
16809455|NCT02354222|37751034|FG000|Overall Study|Conflict with the stopping criteria|0|||
16809456|NCT02354222|37751035|FG001|Overall Study|Conflict with the stopping criteria|4|||
16809457|NCT02353442|37751043|FG000|Overall Study|Withdrawal by Subject|3|||
16809458|NCT02353442|37751044|FG001|Overall Study|Withdrawal by Subject|4|||
16809459|NCT02351960|37751052|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
16809460|NCT02351960|37751053|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
16809461|NCT02351960|37751052|FG000|Overall Study|Voluntary Withdrawal|5|||
16809462|NCT02351960|37751053|FG001|Overall Study|Voluntary Withdrawal|4|||
16809463|NCT02351960|37751052|FG000|Overall Study|Significant Protocol Deviation|0|||
16809464|NCT02351960|37751053|FG001|Overall Study|Significant Protocol Deviation|5|||
16809465|NCT02351180|37751062|FG000|Overall Study|Withdrawal by Subject|1|||
16809466|NCT02351180|37751063|FG001|Overall Study|Withdrawal by Subject|0|||
16809467|NCT02350478|37751071|FG000|Overall Study|Lost to Follow-up|5|||
16809468|NCT02350478|37751072|FG001|Overall Study|Lost to Follow-up|1|||
16809469|NCT02349542|37751078|FG000|Overall Study|Withdrawal by Subject|5|||
16809470|NCT02321930|37751082|FG000|Overall Study|Lost to Follow-up|1|||
16809471|NCT01647542|37751089|FG000|Overall Study|Major Protocol Deviation|1|||
16809472|NCT01647542|37751090|FG001|Overall Study|Major Protocol Deviation|0|||
16909891|NCT01716156|38018675|FG001|Overall Study|Lost to Follow-up|0|||
16909892|NCT01716156|38018676|FG002|Overall Study|Lost to Follow-up|0|||
16909893|NCT01696188|38018690|FG000|Overall Study|Protocol Violation|1|||
16909894|NCT01696188|38018691|FG001|Overall Study|Protocol Violation|1|||
16909895|NCT01739790|38018699|FG000|Overall Study|Early Trial Termination|2|||
16909896|NCT01739790|38018700|FG001|Overall Study|Early Trial Termination|4|||
16909897|NCT01696032|38018710|FG000|Overall Study|Withdrawal by Subject|0|||
16909898|NCT01696032|38018711|FG001|Overall Study|Withdrawal by Subject|0|||
16909899|NCT01696032|38018712|FG002|Overall Study|Withdrawal by Subject|1|||
16909900|NCT01696032|38018713|FG003|Overall Study|Withdrawal by Subject|2|||
16909901|NCT01696032|38018710|FG000|Overall Study|Death|14|||
16909902|NCT01696032|38018711|FG001|Overall Study|Death|4|||
16909903|NCT01696032|38018712|FG002|Overall Study|Death|43|||
16909904|NCT01696032|38018713|FG003|Overall Study|Death|18|||
16909905|NCT01696032|38018710|FG000|Overall Study|Lost to Follow-up|0|||
16909906|NCT01696032|38018711|FG001|Overall Study|Lost to Follow-up|1|||
16909907|NCT01696032|38018712|FG002|Overall Study|Lost to Follow-up|0|||
16909908|NCT01696032|38018713|FG003|Overall Study|Lost to Follow-up|0|||
16909909|NCT01696032|38018710|FG000|Overall Study|Database lock|0|||
16909910|NCT01696032|38018711|FG001|Overall Study|Database lock|1|||
16909911|NCT01696032|38018712|FG002|Overall Study|Database lock|7|||
16909912|NCT01696032|38018713|FG003|Overall Study|Database lock|2|||
16909913|NCT01695954|38018729|FG000|Overall Study|Withdrawal by Subject|4|||
16809473|NCT01647542|37751091|FG002|Overall Study|Major Protocol Deviation|0|||
16909914|NCT01695954|38018730|FG001|Overall Study|Withdrawal by Subject|0|||
16809474|NCT01647542|37751089|FG000|Overall Study|Adverse Event|4|||
16809475|NCT01647542|37751090|FG001|Overall Study|Adverse Event|5|||
16809476|NCT01647542|37751091|FG002|Overall Study|Adverse Event|4|||
16809477|NCT01647542|37751089|FG000|Overall Study|Lost to Follow-up|0|||
16809478|NCT01647542|37751090|FG001|Overall Study|Lost to Follow-up|2|||
16809479|NCT01647542|37751091|FG002|Overall Study|Lost to Follow-up|2|||
16809480|NCT01647542|37751089|FG000|Overall Study|Withdrawal by Subject|6|||
16809481|NCT01647542|37751090|FG001|Overall Study|Withdrawal by Subject|4|||
16809482|NCT01647542|37751091|FG002|Overall Study|Withdrawal by Subject|0|||
16809483|NCT01647542|37751089|FG000|Overall Study|Study Termination|64|||
16809484|NCT01647542|37751090|FG001|Overall Study|Study Termination|61|||
16809485|NCT01647542|37751091|FG002|Overall Study|Study Termination|65|||
16809486|NCT01647542|37751089|FG000|Overall Study|Lack of Efficacy|1|||
16809487|NCT01647542|37751090|FG001|Overall Study|Lack of Efficacy|1|||
16809488|NCT01647542|37751091|FG002|Overall Study|Lack of Efficacy|0|||
16809489|NCT01647542|37751089|FG000|Overall Study|Death|0|||
16809490|NCT01647542|37751090|FG001|Overall Study|Death|0|||
16809491|NCT01647542|37751091|FG002|Overall Study|Death|1|||
16809492|NCT02321462|37751101|FG000|Overall Study|Withdrawal by Subject|5|||
16809493|NCT02321462|37751102|FG001|Overall Study|Withdrawal by Subject|2|||
16809494|NCT02321462|37751101|FG000|Overall Study|Subject withdrawn before any treatment|1|||
16809495|NCT02321462|37751102|FG001|Overall Study|Subject withdrawn before any treatment|1|||
16809496|NCT02391584|37751111|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
16809497|NCT02391584|37751112|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
16809498|NCT02391584|37751111|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
16809499|NCT02391584|37751112|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
16809500|NCT02391584|37751111|FG000|3 Month|Lost to Follow-up|1|||
16809501|NCT02391584|37751112|FG001|3 Month|Lost to Follow-up|0|||
16809502|NCT02391584|37751111|FG000|6 Month|Withdrawal by Subject|1|||
16809503|NCT02391584|37751112|FG001|6 Month|Withdrawal by Subject|0|||
16809504|NCT02391584|37751111|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
16809505|NCT02391584|37751112|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
16809506|NCT02266147|37751125|FG000|PART 1: Dose Escalation|Physician Decision|0|||
16809507|NCT02266147|37751126|FG001|PART 1: Dose Escalation|Physician Decision|0|||
16809508|NCT02266147|37751127|FG002|PART 1: Dose Escalation|Physician Decision|1|||
16809509|NCT02266147|37751128|FG003|PART 1: Dose Escalation|Physician Decision|0|||
16809510|NCT02266147|37751125|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
16809511|NCT02266147|37751126|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
16809512|NCT02266147|37751127|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
16809513|NCT02266147|37751128|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
16809514|NCT02266147|37751125|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
16809515|NCT02266147|37751126|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
16809516|NCT02266147|37751127|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
16809517|NCT02266147|37751128|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
16809518|NCT02266147|37751125|FG000|PART 1: Dose Escalation|Other|1|||
16809519|NCT02266147|37751126|FG001|PART 1: Dose Escalation|Other|1|||
16809520|NCT02266147|37751127|FG002|PART 1: Dose Escalation|Other|0|||
16809521|NCT02266147|37751128|FG003|PART 1: Dose Escalation|Other|0|||
16809522|NCT02266147|37751125|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
16809523|NCT02266147|37751126|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
16809524|NCT02266147|37751127|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
16809525|NCT02266147|37751128|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
16809526|NCT02266147|37751125|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
16809527|NCT02266147|37751126|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
16809528|NCT02266147|37751127|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
16809529|NCT02266147|37751128|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
16809530|NCT02264977|37751140|FG000|Overall Study|Death|3|||
16809531|NCT02264977|37751140|FG000|Overall Study|Physician Decision|1|||
16809532|NCT02264977|37751140|FG000|Overall Study|Refuse to return|1|||
16809533|NCT02264821|37751147|FG000|Overall Study|Protocol Violation|1|||
16809534|NCT02264821|37751148|FG001|Overall Study|Protocol Violation|3|||
16809535|NCT02264821|37751149|FG002|Overall Study|Protocol Violation|6|||
16809536|NCT02261467|37751159|FG000|Overall Study|Enrolled in Error|1|||
16809537|NCT02261467|37751160|FG001|Overall Study|Enrolled in Error|0|||
16809538|NCT02261467|37751159|FG000|Overall Study|Protocol Violation|0|||
16809539|NCT02261467|37751160|FG001|Overall Study|Protocol Violation|1|||
16809540|NCT02261467|37751159|FG000|Overall Study|Personal Reasons|17|||
16809541|NCT02261467|37751160|FG001|Overall Study|Personal Reasons|22|||
16809542|NCT02261467|37751159|FG000|Overall Study|Lost to Follow-up|2|||
16809543|NCT02261467|37751160|FG001|Overall Study|Lost to Follow-up|13|||
16809544|NCT02261467|37751159|FG000|Overall Study|Adverse Event|1|||
16809545|NCT02261467|37751160|FG001|Overall Study|Adverse Event|1|||
16809546|NCT02260921|37751168|FG000|Overall Study|Adverse Event|1|||
16809547|NCT02260921|37751169|FG001|Overall Study|Adverse Event|0|||
16809548|NCT02260921|37751168|FG000|Overall Study|Lost to Follow-up|4|||
16809549|NCT02260921|37751169|FG001|Overall Study|Lost to Follow-up|3|||
16809550|NCT02260921|37751168|FG000|Overall Study|Withdraw Consent|4|||
16809551|NCT02260921|37751169|FG001|Overall Study|Withdraw Consent|1|||
16809552|NCT02260921|37751168|FG000|Overall Study|Death|1|||
16809553|NCT02260921|37751169|FG001|Overall Study|Death|0|||
16809554|NCT02260921|37751168|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
16809555|NCT02260921|37751169|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
16809556|NCT01643473|37751177|FG000|Overall Study|Lost to Follow-up|1|||
16809557|NCT01643473|37751178|FG001|Overall Study|Lost to Follow-up|0|||
16809558|NCT02258659|37751184|FG000|Overall Study|Withdrawal by Subject|1|||
16809559|NCT02320058|37751190|FG000|Overall Study|Death|25|||
16809560|NCT02320058|37751191|FG001|Overall Study|Death|10|||
16809561|NCT02320058|37751190|FG000|Overall Study|Lost to Follow-up|4|||
16809562|NCT02320058|37751191|FG001|Overall Study|Lost to Follow-up|0|||
16809563|NCT02320058|37751190|FG000|Overall Study|Other reasons|4|||
16809564|NCT02320058|37751191|FG001|Overall Study|Other reasons|1|||
16809565|NCT02320058|37751190|FG000|Overall Study|Withdrawal by Subject|8|||
16809566|NCT02320058|37751191|FG001|Overall Study|Withdrawal by Subject|2|||
16809567|NCT02320058|37751190|FG000|Overall Study|Not reported|1|||
16809568|NCT02320058|37751191|FG001|Overall Study|Not reported|0|||
16809569|NCT02319668|37751199|FG000|Overall Study|Other (Not specified)|0|||
16809570|NCT02319668|37751200|FG001|Overall Study|Other (Not specified)|2|||
16809571|NCT02092467|37751212|FG000|Overall Study|Death|49|||
16809572|NCT02092467|37751213|FG001|Overall Study|Death|66|||
16809573|NCT02092467|37751214|FG002|Overall Study|Death|38|||
16809574|NCT02092467|37751212|FG000|Overall Study|Lost to Follow-up|38|||
16809575|NCT02092467|37751213|FG001|Overall Study|Lost to Follow-up|35|||
16809576|NCT02092467|37751214|FG002|Overall Study|Lost to Follow-up|40|||
16809577|NCT02092467|37751212|FG000|Overall Study|Global Deterioration of Health Status|1|||
16809578|NCT02092467|37751213|FG001|Overall Study|Global Deterioration of Health Status|0|||
16809579|NCT02092467|37751214|FG002|Overall Study|Global Deterioration of Health Status|0|||
16809580|NCT02092467|37751212|FG000|Overall Study|Other|32|||
16809581|NCT02092467|37751213|FG001|Overall Study|Other|30|||
16809582|NCT02092467|37751214|FG002|Overall Study|Other|24|||
16809583|NCT02092467|37751212|FG000|Overall Study|Withdrawal by Subject|282|||
16809584|NCT02092467|37751213|FG001|Overall Study|Withdrawal by Subject|327|||
16809585|NCT02092467|37751214|FG002|Overall Study|Withdrawal by Subject|289|||
16809586|NCT02092467|37751212|FG000|Overall Study|Randomized but not treated|2|||
16809587|NCT02092467|37751213|FG001|Overall Study|Randomized but not treated|1|||
16809588|NCT02092467|37751214|FG002|Overall Study|Randomized but not treated|7|||
16809589|NCT02462759|37751226|FG000|Part 1: Double Blind|Death|1|||
16809590|NCT02462759|37751227|FG001|Part 1: Double Blind|Death|0|||
16809591|NCT02462759|37751228|FG002|Part 1: Double Blind|Death|0|||
16809592|NCT02349386|37751243|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
16809593|NCT02349386|37751244|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
16809594|NCT02349386|37751245|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
16809595|NCT02349386|37751246|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
16809596|NCT02349386|37751243|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
16809597|NCT02349386|37751244|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
16809598|NCT02349386|37751245|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
16809599|NCT02349386|37751246|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
16809600|NCT02349386|37751243|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
16809601|NCT02349386|37751244|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
16809602|NCT02349386|37751245|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
16809603|NCT02349386|37751246|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
16809604|NCT02349386|37751243|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
16809605|NCT02349386|37751244|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
16809606|NCT02349386|37751245|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
16809607|NCT02349386|37751246|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
16809608|NCT02349386|37751243|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
16809609|NCT02349386|37751244|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
16809610|NCT02349386|37751245|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
16809611|NCT02349386|37751246|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
16809612|NCT02349386|37751243|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
16809613|NCT02349386|37751244|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
16809614|NCT02349386|37751245|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
16809615|NCT02349386|37751246|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
16809616|NCT02036775|37751256|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16809617|NCT02036775|37751257|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16809618|NCT02036775|37751258|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16809619|NCT02036775|37751259|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16809620|NCT02036775|37751260|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16809621|NCT02036775|37751261|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
16809622|NCT02092389|37751269|FG000|Overall Study|Adverse Event|1|||
16809623|NCT02092389|37751269|FG000|Overall Study|Other|5|||
16809624|NCT02034591|37751273|FG000|Overall Study|Withdrawal by Subject|0|||
16809625|NCT02034591|37751274|FG001|Overall Study|Withdrawal by Subject|0|||
16809626|NCT02034591|37751275|FG002|Overall Study|Withdrawal by Subject|0|||
16809627|NCT02034591|37751276|FG003|Overall Study|Withdrawal by Subject|0|||
16809628|NCT02034591|37751277|FG004|Overall Study|Withdrawal by Subject|1|||
16809629|NCT02034591|37751278|FG005|Overall Study|Withdrawal by Subject|0|||
16809630|NCT02391116|37751287|FG000|Treatment|Withdrawal by Subject|1|||
16809631|NCT02391116|37751287|FG000|Treatment|Protocol Violation|1|||
16809632|NCT02391116|37751287|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
16809633|NCT02391116|37751287|FG000|Treatment|AE with Clinical PD|3|||
16809634|NCT02391116|37751287|FG000|Safety Follow-up|Adverse Event|1|||
16809635|NCT02391116|37751287|FG000|Safety Follow-up|Withdrawal by Subject|4|||
16809636|NCT02391116|37751287|FG000|Safety Follow-up|Switching to Other Therapy|4|||
16809637|NCT02391116|37751287|FG000|Safety Follow-up|No Follow Up|1|||
16809638|NCT02391116|37751287|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
16809639|NCT02391116|37751287|FG000|Active Follow-up|Withdrawal by Subject|1|||
16809640|NCT02391116|37751287|FG000|Active Follow-up|Switching to Other Therapy|2|||
16809641|NCT02391116|37751287|FG000|Survival Follow-up|Withdrawal by Subject|3|||
16809642|NCT02391116|37751287|FG000|Survival Follow-up|Switching to Other Therapy|1|||
16809643|NCT02091921|37751298|FG000|Overall Study|Adverse Event|3|||
16809644|NCT02447081|37751305|FG000|Overall Study|Death|161|||
16809645|NCT02447081|37751305|FG000|Overall Study|Lost to Follow-up|36|||
16809646|NCT02447081|37751305|FG000|Overall Study|Visit not completed|17|||
16809647|NCT02447081|37751305|FG000|Overall Study|unsuccessful implant procedure|10|||
16809648|NCT02391038|37751309|FG000|Overall Study|Progressive disease|3|||
16809649|NCT02391038|37751310|FG001|Overall Study|Progressive disease|3|||
16809650|NCT02391038|37751311|FG002|Overall Study|Progressive disease|6|||
16809651|NCT02462603|37751320|FG000|Overall Study|Investigator Decision|1|||
16809652|NCT02462603|37751320|FG000|Overall Study|Non-Compliance|1|||
16809653|NCT02462603|37751320|FG000|Overall Study|Withdrawal by Subject|2|||
16809654|NCT02034513|37751326|FG000|Overall Study|Adverse Event|11|||
16809655|NCT02034513|37751327|FG001|Overall Study|Adverse Event|10|||
16809656|NCT02034513|37751326|FG000|Overall Study|Lack of Efficacy|0|||
16809657|NCT02034513|37751327|FG001|Overall Study|Lack of Efficacy|1|||
16809658|NCT02034513|37751326|FG000|Overall Study|Lost to Follow-up|6|||
16809659|NCT02034513|37751327|FG001|Overall Study|Lost to Follow-up|7|||
16809660|NCT02034513|37751326|FG000|Overall Study|Pregnancy|0|||
16809661|NCT02034513|37751327|FG001|Overall Study|Pregnancy|3|||
16809662|NCT02034513|37751326|FG000|Overall Study|Protocol Violation|7|||
16809663|NCT02034513|37751327|FG001|Overall Study|Protocol Violation|10|||
16809664|NCT02034513|37751326|FG000|Overall Study|Withdrawal by Subject|25|||
16809665|NCT02034513|37751327|FG001|Overall Study|Withdrawal by Subject|25|||
16809666|NCT02034513|37751326|FG000|Overall Study|Unclassified|0|||
16809667|NCT02034513|37751327|FG001|Overall Study|Unclassified|1|||
16809668|NCT02348840|37751339|FG000|Overall Study|Withdrawal by Subject|2|||
16809669|NCT02348840|37751340|FG001|Overall Study|Withdrawal by Subject|1|||
16809670|NCT02348840|37751341|FG002|Overall Study|Withdrawal by Subject|0|||
16809671|NCT02348840|37751342|FG003|Overall Study|Withdrawal by Subject|0|||
16809672|NCT02462057|37751357|FG000|Overall Study|Left Vitality|32|||
16809673|NCT02462057|37751358|FG001|Overall Study|Left Vitality|27|||
16809674|NCT02462057|37751359|FG002|Overall Study|Left Vitality|23|||
16809675|NCT02462057|37751360|FG003|Overall Study|Left Vitality|35|||
16809676|NCT02462057|37751361|FG004|Overall Study|Left Vitality|33|||
16809677|NCT02462057|37751357|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
16809678|NCT02462057|37751358|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
16809679|NCT02462057|37751359|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
16809680|NCT02462057|37751360|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
16809681|NCT02462057|37751361|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
16809682|NCT02461745|37751375|FG000|Overall Study|Lack of Efficacy|9|||
16809683|NCT02461745|37751376|FG001|Overall Study|Lack of Efficacy|1|||
16809684|NCT02461745|37751375|FG000|Overall Study|Lost to Follow-up|2|||
16809685|NCT02461745|37751376|FG001|Overall Study|Lost to Follow-up|2|||
16809686|NCT02461745|37751375|FG000|Overall Study|Withdrawal by Subject|3|||
16809687|NCT02461745|37751376|FG001|Overall Study|Withdrawal by Subject|1|||
16809688|NCT02034435|37751386|FG000|Overall Study|Withdrawal by Subject|1|||
16809689|NCT02034435|37751387|FG001|Overall Study|Withdrawal by Subject|0|||
16809690|NCT02034435|37751388|FG002|Overall Study|Withdrawal by Subject|0|||
16809691|NCT02034435|37751389|FG003|Overall Study|Withdrawal by Subject|0|||
16809692|NCT02034435|37751386|FG000|Overall Study|Illness|0|||
16809693|NCT02034435|37751387|FG001|Overall Study|Illness|2|||
16809694|NCT02034435|37751388|FG002|Overall Study|Illness|0|||
16809695|NCT02034435|37751389|FG003|Overall Study|Illness|0|||
16809696|NCT02034435|37751386|FG000|Overall Study|Inadequate IV access|1|||
16809697|NCT02034435|37751387|FG001|Overall Study|Inadequate IV access|0|||
16809698|NCT02034435|37751388|FG002|Overall Study|Inadequate IV access|0|||
16909915|NCT01695954|38018729|FG000|Overall Study|Adverse Event|0|||
16809699|NCT02034435|37751389|FG003|Overall Study|Inadequate IV access|1|||
16809700|NCT02033889|37751402|FG000|Overall Study|Adverse Event|3|||
16809701|NCT02033889|37751403|FG001|Overall Study|Adverse Event|1|||
16809702|NCT02033889|37751404|FG002|Overall Study|Adverse Event|3|||
16809703|NCT02033889|37751402|FG000|Overall Study|Death|3|||
16809704|NCT02033889|37751403|FG001|Overall Study|Death|1|||
16809705|NCT02033889|37751404|FG002|Overall Study|Death|2|||
16809706|NCT02033889|37751402|FG000|Overall Study|Excluded Medication|1|||
16809707|NCT02033889|37751403|FG001|Overall Study|Excluded Medication|1|||
16809708|NCT02033889|37751404|FG002|Overall Study|Excluded Medication|0|||
16809709|NCT02033889|37751402|FG000|Overall Study|Lost to Follow-up|8|||
16809710|NCT02033889|37751403|FG001|Overall Study|Lost to Follow-up|5|||
16809711|NCT02033889|37751404|FG002|Overall Study|Lost to Follow-up|6|||
16809712|NCT02033889|37751402|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16809713|NCT02033889|37751403|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16809714|NCT02033889|37751404|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16809715|NCT02033889|37751402|FG000|Overall Study|Physician Decision|0|||
16809716|NCT02033889|37751403|FG001|Overall Study|Physician Decision|1|||
16809717|NCT02033889|37751404|FG002|Overall Study|Physician Decision|1|||
16809718|NCT02033889|37751402|FG000|Overall Study|Participant moved|0|||
16809719|NCT02033889|37751403|FG001|Overall Study|Participant moved|1|||
16809720|NCT02033889|37751404|FG002|Overall Study|Participant moved|0|||
16809721|NCT02033889|37751402|FG000|Overall Study|Withdrawal by Subject|18|||
16809722|NCT02033889|37751403|FG001|Overall Study|Withdrawal by Subject|10|||
16809723|NCT02033889|37751404|FG002|Overall Study|Withdrawal by Subject|13|||
16809724|NCT02447003|37751414|FG000|Overall Study|Other|0|||
16809725|NCT02447003|37751415|FG001|Overall Study|Other|4|||
16809726|NCT02447003|37751414|FG000|Overall Study|Site discontinued|0|||
16809727|NCT02447003|37751415|FG001|Overall Study|Site discontinued|2|||
16809728|NCT02447003|37751414|FG000|Overall Study|Physician Decision|0|||
16809729|NCT02447003|37751415|FG001|Overall Study|Physician Decision|1|||
16809730|NCT02447003|37751414|FG000|Overall Study|Withdrawal by Subject|4|||
16809731|NCT02447003|37751415|FG001|Overall Study|Withdrawal by Subject|3|||
16809732|NCT02447003|37751414|FG000|Overall Study|Sponsor Decision|6|||
16809733|NCT02447003|37751415|FG001|Overall Study|Sponsor Decision|11|||
16809734|NCT02447003|37751414|FG000|Overall Study|Progressive Disease|1|||
16809735|NCT02447003|37751415|FG001|Overall Study|Progressive Disease|0|||
16809736|NCT02447003|37751414|FG000|Overall Study|Lost to Follow-up|5|||
16809737|NCT02447003|37751415|FG001|Overall Study|Lost to Follow-up|0|||
16809738|NCT02447003|37751414|FG000|Overall Study|Death|154|||
16809739|NCT02447003|37751415|FG001|Overall Study|Death|63|||
16809740|NCT01844284|37751425|FG000|Overall Study|Lost to Follow-up|12|||
16809741|NCT01844284|37751426|FG001|Overall Study|Lost to Follow-up|7|||
16809742|NCT02054715|37751434|FG000|Baseline/Follow-up 1|Refused|1|||
16809743|NCT02054715|37751435|FG001|Baseline/Follow-up 1|Refused|3|||
16809744|NCT02054715|37751434|FG000|Baseline/Follow-up 1|Medical|0|||
16809745|NCT02054715|37751435|FG001|Baseline/Follow-up 1|Medical|1|||
16809746|NCT02054715|37751434|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
16809747|NCT02054715|37751435|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
16809748|NCT02054715|37751434|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
16809749|NCT02054715|37751435|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
16809750|NCT02054715|37751434|FG000|Baseline/Follow-up 1|No Reason|0|||
16809751|NCT02054715|37751435|FG001|Baseline/Follow-up 1|No Reason|1|||
16809752|NCT02054715|37751434|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
16809753|NCT02054715|37751435|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
16809754|NCT02054715|37751434|FG000|Baseline/Follow-up 1|Ineligible|3|||
16809755|NCT02054715|37751435|FG001|Baseline/Follow-up 1|Ineligible|0|||
16809756|NCT02054715|37751434|FG000|Baseline/Follow-up 1|Hospitalization|1|||
16809757|NCT02054715|37751435|FG001|Baseline/Follow-up 1|Hospitalization|0|||
16809758|NCT02054715|37751434|FG000|Baseline/Follow-up 1|Changed Mind|1|||
16809759|NCT02054715|37751435|FG001|Baseline/Follow-up 1|Changed Mind|0|||
16809760|NCT02054715|37751434|FG000|Follow-up 2|Lost to Followup|3|||
16809761|NCT02054715|37751435|FG001|Follow-up 2|Lost to Followup|1|||
16809762|NCT02054715|37751434|FG000|Follow-up 2|Refused|3|||
16809763|NCT02054715|37751435|FG001|Follow-up 2|Refused|2|||
16809764|NCT02054715|37751434|FG000|Follow-up 2|Followup Not Completed|3|||
16909916|NCT01695954|38018730|FG001|Overall Study|Adverse Event|2|||
16809765|NCT02054715|37751435|FG001|Follow-up 2|Followup Not Completed|4|||
16809766|NCT02054715|37751434|FG000|Follow-up 2|Ineligible|4|||
16809767|NCT02054715|37751435|FG001|Follow-up 2|Ineligible|5|||
16809768|NCT02054715|37751434|FG000|Follow-up 2|Death|3|||
16809769|NCT02054715|37751435|FG001|Follow-up 2|Death|3|||
16809770|NCT02054715|37751434|FG000|Follow-up 2|Hospitalization|0|||
16809771|NCT02054715|37751435|FG001|Follow-up 2|Hospitalization|2|||
16809772|NCT02054715|37751434|FG000|Follow-up 2|Changed MD/Facility|0|||
16809773|NCT02054715|37751435|FG001|Follow-up 2|Changed MD/Facility|1|||
16809774|NCT02054715|37751434|FG000|Follow-up 2|Changed Mind|0|||
16809775|NCT02054715|37751435|FG001|Follow-up 2|Changed Mind|1|||
16809776|NCT02054715|37751434|FG000|Follow-up 2|No Reason|2|||
16809777|NCT02054715|37751435|FG001|Follow-up 2|No Reason|0|||
16809778|NCT02054715|37751434|FG000|Follow-up 2|Treatment Change or Delay|1|||
16809779|NCT02054715|37751435|FG001|Follow-up 2|Treatment Change or Delay|0|||
16809780|NCT02446769|37751441|FG000|Screening Period|Screen Failure|11|||
16809781|NCT02446769|37751442|FG001|Screening Period|Screen Failure|0|||
16809782|NCT02446769|37751443|FG002|Screening Period|Screen Failure|0|||
16809783|NCT02446769|37751441|FG000|Study Period|Randomized in Error|0|||
16809784|NCT02446769|37751442|FG001|Study Period|Randomized in Error|2|||
16809785|NCT02446769|37751443|FG002|Study Period|Randomized in Error|0|||
16809786|NCT02420093|37751452|FG000|Overall Study|Withdrawal by Subject|1|||
16809787|NCT02420093|37751453|FG001|Overall Study|Withdrawal by Subject|1|||
16809788|NCT02419937|37751461|FG000|Overall Study|Lost to Follow-up|1|||
16809789|NCT02419937|37751462|FG001|Overall Study|Lost to Follow-up|0|||
16809790|NCT02054481|37751472|FG000|Overall Study|Adverse Event|1|||
16809791|NCT02054481|37751473|FG001|Overall Study|Adverse Event|1|||
16809792|NCT02054481|37751474|FG002|Overall Study|Adverse Event|0|||
16809793|NCT02054481|37751475|FG003|Overall Study|Adverse Event|1|||
16809794|NCT02054481|37751472|FG000|Overall Study|Lost to Follow-up|1|||
16809795|NCT02054481|37751473|FG001|Overall Study|Lost to Follow-up|0|||
16809796|NCT02054481|37751474|FG002|Overall Study|Lost to Follow-up|0|||
16809797|NCT02054481|37751475|FG003|Overall Study|Lost to Follow-up|0|||
16809798|NCT02054481|37751472|FG000|Overall Study|Other reason|2|||
16809799|NCT02054481|37751473|FG001|Overall Study|Other reason|1|||
16809800|NCT02054481|37751474|FG002|Overall Study|Other reason|2|||
16809801|NCT02054481|37751475|FG003|Overall Study|Other reason|0|||
16809802|NCT01610752|37751489|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
16809803|NCT01610752|37751490|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
16809804|NCT01610752|37751491|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
16809805|NCT02054325|37751501|FG000|Overall Study|Lost to Follow-up|8|||
16809806|NCT02054325|37751502|FG001|Overall Study|Lost to Follow-up|5|||
16809807|NCT02446691|37751508|FG000|Overall Study|Withdrawal by Subject|2|||
16809808|NCT02446691|37751508|FG000|Overall Study|Lost to Follow-up|8|||
16809809|NCT02446691|37751508|FG000|Overall Study|Protocol Violation|1|||
16809810|NCT02091375|37751514|FG000|Overall Study|Adverse Event|8|||
16809811|NCT02091375|37751515|FG001|Overall Study|Adverse Event|1|||
16809812|NCT02091375|37751514|FG000|Overall Study|Lost to Follow-up|0|||
16809813|NCT02091375|37751515|FG001|Overall Study|Lost to Follow-up|1|||
16809814|NCT02091375|37751514|FG000|Overall Study|Withdrawal by Subject|0|||
16809815|NCT02091375|37751515|FG001|Overall Study|Withdrawal by Subject|1|||
16809816|NCT02091375|37751514|FG000|Overall Study|Withdrawn by the investigator|1|||
16809817|NCT02091375|37751515|FG001|Overall Study|Withdrawn by the investigator|0|||
16809818|NCT02032875|37751523|FG000|Treatment Period|Adverse Event|1|||
16809819|NCT02032875|37751524|FG001|Treatment Period|Adverse Event|0|||
16809820|NCT02032875|37751523|FG000|Treatment Period|Liver transplant, No extension needed|0|||
16809821|NCT02032875|37751524|FG001|Treatment Period|Liver transplant, No extension needed|1|||
16809822|NCT02032875|37751523|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
16809823|NCT02032875|37751524|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
16809824|NCT02032875|37751523|FG000|Follow-up Period|Death|0|||
16809825|NCT02032875|37751524|FG001|Follow-up Period|Death|1|||
16809826|NCT02032875|37751523|FG000|Follow-up Period|Virologic Relapse|3|||
16809827|NCT02032875|37751524|FG001|Follow-up Period|Virologic Relapse|10|||
16809828|NCT02032407|37751531|FG000|Overall Study|Lost to Follow-up|2|||
16809829|NCT02032407|37751531|FG000|Overall Study|Pregnancy|1|||
16809830|NCT02032407|37751531|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16809831|NCT01843972|37751545|FG000|Overall Study|Withdrawal by Subject|0|||
16809832|NCT01843972|37751546|FG001|Overall Study|Withdrawal by Subject|0|||
16809833|NCT01843972|37751547|FG002|Overall Study|Withdrawal by Subject|0|||
16809834|NCT01843972|37751548|FG003|Overall Study|Withdrawal by Subject|0|||
16809835|NCT01843972|37751549|FG004|Overall Study|Withdrawal by Subject|1|||
16809836|NCT01843972|37751550|FG005|Overall Study|Withdrawal by Subject|0|||
16809837|NCT01843972|37751551|FG006|Overall Study|Withdrawal by Subject|0|||
16809838|NCT01843972|37751552|FG007|Overall Study|Withdrawal by Subject|0|||
16809839|NCT01843972|37751553|FG008|Overall Study|Withdrawal by Subject|0|||
16809840|NCT01843972|37751554|FG009|Overall Study|Withdrawal by Subject|0|||
16809841|NCT01826422|37751592|FG000|Overall Study|Withdrawal by Subject|1|||
16809842|NCT01826422|37751593|FG001|Overall Study|Withdrawal by Subject|3|||
16809843|NCT01843660|37751599|FG000|Overall Study|Other|30|||
16809844|NCT02090283|37751606|FG000|Overall Study|Withdrawal by Subject|6|||
16809845|NCT02090283|37751607|FG001|Overall Study|Withdrawal by Subject|6|||
16809846|NCT02090283|37751608|FG002|Overall Study|Withdrawal by Subject|6|||
16809847|NCT02090283|37751606|FG000|Overall Study|Sponsor Terminated Study|6|||
16809848|NCT02090283|37751607|FG001|Overall Study|Sponsor Terminated Study|6|||
16809849|NCT02090283|37751608|FG002|Overall Study|Sponsor Terminated Study|1|||
16809850|NCT02090283|37751606|FG000|Overall Study|Lost to Follow-up|2|||
16809851|NCT02090283|37751607|FG001|Overall Study|Lost to Follow-up|2|||
16809852|NCT02090283|37751608|FG002|Overall Study|Lost to Follow-up|3|||
16809853|NCT02090283|37751606|FG000|Overall Study|Adverse Event|1|||
16809854|NCT02090283|37751607|FG001|Overall Study|Adverse Event|1|||
16809855|NCT02090283|37751608|FG002|Overall Study|Adverse Event|0|||
16809856|NCT02090283|37751606|FG000|Overall Study|Protocol Violation|2|||
16809857|NCT02090283|37751607|FG001|Overall Study|Protocol Violation|0|||
16809858|NCT02090283|37751608|FG002|Overall Study|Protocol Violation|0|||
16809859|NCT02032173|37751616|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
16809860|NCT02031471|37751620|FG000|24 Week Treatment Period|Adverse Event|6|||
16809861|NCT02031471|37751620|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
16809862|NCT02031471|37751620|FG000|24 Week Treatment Period|Protocol Violation|1|||
16809863|NCT02031471|37751620|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
16809864|NCT02031471|37751620|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
16809865|NCT02031471|37751620|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
16809866|NCT02031471|37751620|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
16809867|NCT02461589|37751634|FG000|Overall Study|Withdrawal by Subject|5|||
16809868|NCT02461589|37751635|FG001|Overall Study|Withdrawal by Subject|1|||
16809869|NCT02461589|37751636|FG002|Overall Study|Withdrawal by Subject|3|||
16809870|NCT02461589|37751637|FG003|Overall Study|Withdrawal by Subject|2|||
16809871|NCT02461589|37751638|FG004|Overall Study|Withdrawal by Subject|1|||
16809872|NCT02461589|37751639|FG005|Overall Study|Withdrawal by Subject|2|||
16809873|NCT02461589|37751640|FG006|Overall Study|Withdrawal by Subject|1|||
16809874|NCT02461589|37751641|FG007|Overall Study|Withdrawal by Subject|3|||
16809875|NCT02461589|37751642|FG008|Overall Study|Withdrawal by Subject|3|||
16809876|NCT02461589|37751643|FG009|Overall Study|Withdrawal by Subject|1|||
16809877|NCT02461589|37751634|FG000|Overall Study|Lost to Follow-up|0|||
16809878|NCT02461589|37751635|FG001|Overall Study|Lost to Follow-up|0|||
16809879|NCT02461589|37751636|FG002|Overall Study|Lost to Follow-up|2|||
16809880|NCT02461589|37751637|FG003|Overall Study|Lost to Follow-up|3|||
16809881|NCT02461589|37751638|FG004|Overall Study|Lost to Follow-up|1|||
16809882|NCT02461589|37751639|FG005|Overall Study|Lost to Follow-up|1|||
16809883|NCT02461589|37751640|FG006|Overall Study|Lost to Follow-up|3|||
16809884|NCT02461589|37751641|FG007|Overall Study|Lost to Follow-up|1|||
16809885|NCT02461589|37751642|FG008|Overall Study|Lost to Follow-up|3|||
16809886|NCT02461589|37751643|FG009|Overall Study|Lost to Follow-up|1|||
16809887|NCT02461589|37751634|FG000|Overall Study|Death|0|||
16809888|NCT02461589|37751635|FG001|Overall Study|Death|0|||
16809889|NCT02461589|37751636|FG002|Overall Study|Death|0|||
16809890|NCT02461589|37751637|FG003|Overall Study|Death|0|||
16809891|NCT02461589|37751638|FG004|Overall Study|Death|0|||
16809892|NCT02461589|37751639|FG005|Overall Study|Death|0|||
16809893|NCT02461589|37751640|FG006|Overall Study|Death|0|||
16809894|NCT02461589|37751641|FG007|Overall Study|Death|1|||
16809895|NCT02461589|37751642|FG008|Overall Study|Death|0|||
16809896|NCT02461589|37751643|FG009|Overall Study|Death|0|||
16809897|NCT02461589|37751634|FG000|Overall Study|Unclassified|0|||
16809898|NCT02461589|37751635|FG001|Overall Study|Unclassified|0|||
16809899|NCT02461589|37751636|FG002|Overall Study|Unclassified|0|||
16809900|NCT02461589|37751637|FG003|Overall Study|Unclassified|0|||
16809901|NCT02461589|37751638|FG004|Overall Study|Unclassified|0|||
16809902|NCT02461589|37751639|FG005|Overall Study|Unclassified|0|||
16809903|NCT02461589|37751640|FG006|Overall Study|Unclassified|1|||
16809904|NCT02461589|37751641|FG007|Overall Study|Unclassified|0|||
16809905|NCT02461589|37751642|FG008|Overall Study|Unclassified|0|||
16809906|NCT02461589|37751643|FG009|Overall Study|Unclassified|2|||
16809907|NCT02461589|37751634|FG000|Overall Study|Missing follow-up information|1|||
16809908|NCT02461589|37751635|FG001|Overall Study|Missing follow-up information|1|||
16809909|NCT02461589|37751636|FG002|Overall Study|Missing follow-up information|0|||
16809910|NCT02461589|37751637|FG003|Overall Study|Missing follow-up information|0|||
16809911|NCT02461589|37751638|FG004|Overall Study|Missing follow-up information|0|||
16809912|NCT02461589|37751639|FG005|Overall Study|Missing follow-up information|0|||
16809913|NCT02461589|37751640|FG006|Overall Study|Missing follow-up information|1|||
16809914|NCT02461589|37751641|FG007|Overall Study|Missing follow-up information|0|||
16809915|NCT02461589|37751642|FG008|Overall Study|Missing follow-up information|0|||
16809916|NCT02461589|37751643|FG009|Overall Study|Missing follow-up information|0|||
16809917|NCT02461589|37751634|FG000|Overall Study|Withdrawal from trial before exposure|0|||
16809918|NCT02461589|37751635|FG001|Overall Study|Withdrawal from trial before exposure|0|||
16809919|NCT02461589|37751636|FG002|Overall Study|Withdrawal from trial before exposure|0|||
16809920|NCT02461589|37751637|FG003|Overall Study|Withdrawal from trial before exposure|0|||
16809921|NCT02461589|37751638|FG004|Overall Study|Withdrawal from trial before exposure|0|||
16809922|NCT02461589|37751639|FG005|Overall Study|Withdrawal from trial before exposure|0|||
16809923|NCT02461589|37751640|FG006|Overall Study|Withdrawal from trial before exposure|0|||
16809924|NCT02461589|37751641|FG007|Overall Study|Withdrawal from trial before exposure|0|||
16809925|NCT02461589|37751642|FG008|Overall Study|Withdrawal from trial before exposure|0|||
16809926|NCT02461589|37751643|FG009|Overall Study|Withdrawal from trial before exposure|1|||
16809927|NCT02089737|37751665|FG000|Overall Study|Survey form not completed|5|||
16809928|NCT02089737|37751665|FG000|Overall Study|Not treated|1|||
16809929|NCT02460575|37751672|FG000|Overall Study|Lost to Follow-up|1|||
16809930|NCT02460575|37751673|FG001|Overall Study|Lost to Follow-up|0|||
16809931|NCT02089347|37751681|FG000|Overall Study|Protocol Violation|1|||
16809932|NCT02089347|37751682|FG001|Overall Study|Protocol Violation|0|||
16809933|NCT02445755|37751688|FG000|Overall Study|Withdrawal by Subject|2|||
16809934|NCT02445755|37751688|FG000|Overall Study|Protocol Violation|6|||
16809935|NCT02445755|37751688|FG000|Overall Study|Screen Failure|5|||
16809936|NCT02419469|37751695|FG000|Overall Study|Withdrawal by Subject|1|||
16809937|NCT02419313|37751699|FG000|First Intervention|Lost to Follow-up|2|||
16809938|NCT02419313|37751700|FG001|First Intervention|Lost to Follow-up|0|||
16809939|NCT02419313|37751699|FG000|Second Intervention|Lost to Follow-up|1|||
16809940|NCT02419313|37751700|FG001|Second Intervention|Lost to Follow-up|0|||
16809941|NCT02419001|37751708|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
16809942|NCT02419001|37751709|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
16809943|NCT02031237|37751717|FG000|Overall Study|Death|1|||
16809944|NCT02031237|37751718|FG001|Overall Study|Death|5|||
16809945|NCT02031237|37751719|FG002|Overall Study|Death|0|||
16809946|NCT02031237|37751717|FG000|Overall Study|Physician Decision|0|||
16809947|NCT02031237|37751718|FG001|Overall Study|Physician Decision|1|||
16809948|NCT02031237|37751719|FG002|Overall Study|Physician Decision|0|||
16809949|NCT02031237|37751717|FG000|Overall Study|Withdrawal by Subject|2|||
16809950|NCT02031237|37751718|FG001|Overall Study|Withdrawal by Subject|2|||
16809951|NCT02031237|37751719|FG002|Overall Study|Withdrawal by Subject|0|||
16809952|NCT02031237|37751717|FG000|Overall Study|Protocol Violation|2|||
16809953|NCT02031237|37751718|FG001|Overall Study|Protocol Violation|6|||
16809954|NCT02031237|37751719|FG002|Overall Study|Protocol Violation|0|||
16809955|NCT02031237|37751717|FG000|Overall Study|Alternate Treatment Given|0|||
16809956|NCT02031237|37751718|FG001|Overall Study|Alternate Treatment Given|0|||
16809957|NCT02031237|37751719|FG002|Overall Study|Alternate Treatment Given|3|||
16809958|NCT02088957|37751726|FG000|Overall Study|Lack of Efficacy|1|||
16809959|NCT02088957|37751727|FG001|Overall Study|Lack of Efficacy|0|||
16809960|NCT02418845|37751735|FG000|Overall Study|Lost to Follow-up|7|||
16809961|NCT02418845|37751736|FG001|Overall Study|Lost to Follow-up|2|||
16809962|NCT02418845|37751735|FG000|Overall Study|Lack of Efficacy|0|||
16809963|NCT02418845|37751736|FG001|Overall Study|Lack of Efficacy|3|||
16809964|NCT02418845|37751735|FG000|Overall Study|Physician Decision|5|||
16809965|NCT02418845|37751736|FG001|Overall Study|Physician Decision|5|||
16809966|NCT02418845|37751735|FG000|Overall Study|Protocol Violation|1|||
16809967|NCT02418845|37751736|FG001|Overall Study|Protocol Violation|0|||
16809968|NCT02418845|37751735|FG000|Overall Study|Withdrawal by Subject|3|||
16809969|NCT02418845|37751736|FG001|Overall Study|Withdrawal by Subject|2|||
16809970|NCT02030847|37751742|FG000|Overall Study|Death|10|||
16809971|NCT02030847|37751742|FG000|Overall Study|Disease Progression|15|||
16809972|NCT02030847|37751742|FG000|Overall Study|New Cancer Therapy|8|||
16809973|NCT02030847|37751742|FG000|Overall Study|Physician Decision|3|||
16809974|NCT02030847|37751742|FG000|Overall Study|Withdrawal by Subject|1|||
16809975|NCT02088177|37751747|FG000|Overall Study|Lost to Follow-up|3|||
16909917|NCT01694706|38018738|FG000|Overall Study|Adverse Event|0|||
16909918|NCT01694706|38018739|FG001|Overall Study|Adverse Event|1|||
16909919|NCT01694706|38018740|FG002|Overall Study|Adverse Event|0|||
16909920|NCT01694706|38018738|FG000|Overall Study|other reason not defined above|1|||
16909921|NCT01694706|38018739|FG001|Overall Study|other reason not defined above|0|||
16909922|NCT01694706|38018740|FG002|Overall Study|other reason not defined above|0|||
16909923|NCT01693692|38018752|FG000|Overall Study|Withdrawal by Subject|12|||
16909924|NCT01693692|38018753|FG001|Overall Study|Withdrawal by Subject|10|||
16909925|NCT01693692|38018754|FG002|Overall Study|Withdrawal by Subject|11|||
16909926|NCT01693692|38018752|FG000|Overall Study|Adverse Event|7|||
16909927|NCT01693692|38018753|FG001|Overall Study|Adverse Event|14|||
16909928|NCT01693692|38018754|FG002|Overall Study|Adverse Event|9|||
16809976|NCT02030535|37751751|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
16809977|NCT02029989|37751767|FG000|Overall Study|Withdrawal by Subject|1|||
16809978|NCT02029989|37751768|FG001|Overall Study|Withdrawal by Subject|0|||
16809979|NCT02029989|37751767|FG000|Overall Study|Withdrawal: Fear of needles|1|||
16809980|NCT02029989|37751768|FG001|Overall Study|Withdrawal: Fear of needles|0|||
16809981|NCT02029989|37751767|FG000|Overall Study|Change of location|2|||
16809982|NCT02029989|37751768|FG001|Overall Study|Change of location|3|||
16809983|NCT02029989|37751767|FG000|Overall Study|Physician Decision|2|||
16809984|NCT02029989|37751768|FG001|Overall Study|Physician Decision|0|||
16809985|NCT02029989|37751767|FG000|Overall Study|Lost to Follow-up|9|||
16809986|NCT02029989|37751768|FG001|Overall Study|Lost to Follow-up|7|||
16809987|NCT02029989|37751767|FG000|Overall Study|Death|0|||
16809988|NCT02029989|37751768|FG001|Overall Study|Death|1|||
16809989|NCT02029989|37751767|FG000|Overall Study|Protocol Violation|1|||
16809990|NCT02029989|37751768|FG001|Overall Study|Protocol Violation|0|||
16809991|NCT02048241|37751776|FG000|Overall Study|Withdrawal by Subject|0|||
16809992|NCT02048241|37751777|FG001|Overall Study|Withdrawal by Subject|1|||
16809993|NCT02087943|37751786|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
16809994|NCT02087943|37751787|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
16809995|NCT02087943|37751788|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
16909929|NCT01693692|38018752|FG000|Overall Study|Physician Decision|0|||
16909930|NCT01693692|38018753|FG001|Overall Study|Physician Decision|0|||
16809996|NCT02087943|37751789|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
16809997|NCT02087943|37751790|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
16809998|NCT02087943|37751786|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
16809999|NCT02087943|37751787|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
16810000|NCT02087943|37751788|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
16810001|NCT02087943|37751789|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
16810002|NCT02087943|37751790|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
16810003|NCT02087943|37751786|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
16810004|NCT02087943|37751787|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
16810005|NCT02087943|37751788|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
16810006|NCT02087943|37751789|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
16810007|NCT02087943|37751790|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
16810008|NCT02087943|37751786|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
16810009|NCT02087943|37751787|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
16810010|NCT02087943|37751788|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
16810011|NCT02087943|37751789|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
16810012|NCT02087943|37751790|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
16810013|NCT02087943|37751786|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
16810014|NCT02087943|37751787|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
16810015|NCT02087943|37751788|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
16810016|NCT02087943|37751789|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
16810017|NCT02087943|37751790|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
16810018|NCT02087943|37751786|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
16810019|NCT02087943|37751787|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
16810020|NCT02087943|37751788|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
16810021|NCT02087943|37751789|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
16810022|NCT02087943|37751790|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
16810023|NCT02087943|37751786|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
16810024|NCT02087943|37751787|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
16810025|NCT02087943|37751788|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
16810026|NCT02087943|37751789|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
16810027|NCT02087943|37751790|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
16810028|NCT02087943|37751786|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
16810029|NCT02087943|37751787|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
16810030|NCT02087943|37751788|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
16810031|NCT02087943|37751789|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
16810032|NCT02087943|37751790|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
16810033|NCT02087943|37751786|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
16810034|NCT02087943|37751787|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
16810035|NCT02087943|37751788|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
16810036|NCT02087943|37751789|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
16810037|NCT02087943|37751790|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
16810038|NCT02087943|37751786|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
16810039|NCT02087943|37751787|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
16810040|NCT02087943|37751788|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
16810041|NCT02087943|37751789|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
16810042|NCT02087943|37751790|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
16810043|NCT02029521|37751804|FG000|Overall Study|Protocol Violation|1|||
16810044|NCT02029521|37751805|FG001|Overall Study|Protocol Violation|0|||
16810045|NCT02029521|37751804|FG000|Overall Study|Withdrawal by Subject|1|||
16810046|NCT02029521|37751805|FG001|Overall Study|Withdrawal by Subject|1|||
16810047|NCT02443883|37751826|FG000|Overall Study|Adverse Event|0|||
16810048|NCT02443883|37751827|FG001|Overall Study|Adverse Event|1|||
16810049|NCT02443883|37751828|FG002|Overall Study|Adverse Event|0|||
16810050|NCT02443883|37751829|FG003|Overall Study|Adverse Event|0|||
16810051|NCT02443883|37751826|FG000|Overall Study|Lost to Follow-up|3|||
16810052|NCT02443883|37751827|FG001|Overall Study|Lost to Follow-up|2|||
16810053|NCT02443883|37751828|FG002|Overall Study|Lost to Follow-up|1|||
16810054|NCT02443883|37751829|FG003|Overall Study|Lost to Follow-up|0|||
16810055|NCT02443883|37751826|FG000|Overall Study|Physician Decision|1|||
16810056|NCT02443883|37751827|FG001|Overall Study|Physician Decision|1|||
16810057|NCT02443883|37751828|FG002|Overall Study|Physician Decision|0|||
16810058|NCT02443883|37751829|FG003|Overall Study|Physician Decision|3|||
16810059|NCT02443883|37751826|FG000|Overall Study|Withdrawal by Subject|1|||
16810060|NCT02443883|37751827|FG001|Overall Study|Withdrawal by Subject|0|||
16810061|NCT02443883|37751828|FG002|Overall Study|Withdrawal by Subject|0|||
16810062|NCT02443883|37751829|FG003|Overall Study|Withdrawal by Subject|2|||
16810063|NCT02443883|37751826|FG000|Overall Study|Randomized, but never treated|1|||
16810064|NCT02443883|37751827|FG001|Overall Study|Randomized, but never treated|0|||
16810065|NCT02443883|37751828|FG002|Overall Study|Randomized, but never treated|0|||
16810066|NCT02443883|37751829|FG003|Overall Study|Randomized, but never treated|0|||
16810067|NCT02460263|37751839|FG000|Transition Period|Withdrawal by Subject|1|||
16810068|NCT02460263|37751839|FG000|Transition Period|Death|1|||
16810069|NCT02443805|37751849|FG000|Overall Study|Adverse Event|100|||
16810070|NCT02443805|37751850|FG001|Overall Study|Adverse Event|18|||
16810071|NCT02443805|37751849|FG000|Overall Study|Withdrawal by Subject|73|||
16810072|NCT02443805|37751850|FG001|Overall Study|Withdrawal by Subject|74|||
16810073|NCT02443805|37751849|FG000|Overall Study|Lost to Follow-up|19|||
16810074|NCT02443805|37751850|FG001|Overall Study|Lost to Follow-up|14|||
16810075|NCT02443805|37751849|FG000|Overall Study|Pregnancy|6|||
16810076|NCT02443805|37751850|FG001|Overall Study|Pregnancy|5|||
16810077|NCT02443805|37751849|FG000|Overall Study|Protocol Violation|2|||
16810078|NCT02443805|37751850|FG001|Overall Study|Protocol Violation|4|||
16810079|NCT02443805|37751849|FG000|Overall Study|Lack of Efficacy|1|||
16810080|NCT02443805|37751850|FG001|Overall Study|Lack of Efficacy|1|||
16810081|NCT02443805|37751849|FG000|Overall Study|Non-compliance with study drug|6|||
16810082|NCT02443805|37751850|FG001|Overall Study|Non-compliance with study drug|4|||
16810083|NCT02443805|37751849|FG000|Overall Study|Withdrawal by parent/guardian|3|||
16810084|NCT02443805|37751850|FG001|Overall Study|Withdrawal by parent/guardian|5|||
16810085|NCT02443805|37751849|FG000|Overall Study|Any other reason not above-mentioned|3|||
16810086|NCT02443805|37751850|FG001|Overall Study|Any other reason not above-mentioned|2|||
16810087|NCT01652885|37751856|FG000|Overall Study|Adverse Event|1|||
16810088|NCT02459951|37751860|FG000|Overall Study|Unable to meet holding requirement|1|||
16810089|NCT02087241|37751869|FG000|Overall Study|Death|2|||
16810090|NCT02087241|37751870|FG001|Overall Study|Death|1|||
16810091|NCT02087241|37751871|FG002|Overall Study|Death|1|||
16810092|NCT02087241|37751872|FG003|Overall Study|Death|1|||
16810093|NCT02087241|37751869|FG000|Overall Study|Withdrawal by Subject|1|||
16810094|NCT02087241|37751870|FG001|Overall Study|Withdrawal by Subject|0|||
16810095|NCT02087241|37751871|FG002|Overall Study|Withdrawal by Subject|0|||
16810096|NCT02087241|37751872|FG003|Overall Study|Withdrawal by Subject|1|||
16810097|NCT02087241|37751869|FG000|Overall Study|Progressive Disease|0|||
16810098|NCT02087241|37751870|FG001|Overall Study|Progressive Disease|0|||
16810099|NCT02087241|37751871|FG002|Overall Study|Progressive Disease|0|||
16810100|NCT02087241|37751872|FG003|Overall Study|Progressive Disease|1|||
16810101|NCT02087241|37751869|FG000|Overall Study|Study Terminated by Sponsor|0|||
16810102|NCT02087241|37751870|FG001|Overall Study|Study Terminated by Sponsor|2|||
16810103|NCT02087241|37751871|FG002|Overall Study|Study Terminated by Sponsor|0|||
16810104|NCT02087241|37751872|FG003|Overall Study|Study Terminated by Sponsor|4|||
16810105|NCT02087085|37751888|FG000|Overall Study|Adverse Event|10|||
16810106|NCT02087085|37751889|FG001|Overall Study|Adverse Event|14|||
16810107|NCT02087085|37751888|FG000|Overall Study|Lack of Efficacy|4|||
16810108|NCT02087085|37751889|FG001|Overall Study|Lack of Efficacy|3|||
16810109|NCT02087085|37751888|FG000|Overall Study|Lost to Follow-up|6|||
16810110|NCT02087085|37751889|FG001|Overall Study|Lost to Follow-up|4|||
16810111|NCT02087085|37751888|FG000|Overall Study|Withdrawal by Subject|9|||
16810112|NCT02087085|37751889|FG001|Overall Study|Withdrawal by Subject|11|||
16810113|NCT02087085|37751888|FG000|Overall Study|Protocol Violation|1|||
16810114|NCT02087085|37751889|FG001|Overall Study|Protocol Violation|0|||
16810115|NCT02087085|37751888|FG000|Overall Study|Study Terminated by Sponsor|87|||
16810116|NCT02087085|37751889|FG001|Overall Study|Study Terminated by Sponsor|80|||
16810117|NCT02087085|37751888|FG000|Overall Study|Other Miscellaneous Reasons|3|||
16810118|NCT02087085|37751889|FG001|Overall Study|Other Miscellaneous Reasons|4|||
16810119|NCT02443337|37751897|FG000|Overall Study|Adverse Event|0|||
16810120|NCT02443337|37751898|FG001|Overall Study|Adverse Event|1|||
16810121|NCT02443337|37751897|FG000|Overall Study|Clinical Progressive Disease|3|||
16810122|NCT02443337|37751898|FG001|Overall Study|Clinical Progressive Disease|0|||
16810123|NCT02443337|37751897|FG000|Overall Study|Withdrawal by Subject|2|||
16810124|NCT02443337|37751898|FG001|Overall Study|Withdrawal by Subject|1|||
16810125|NCT02443103|37751909|FG000|Overall Study|Adverse Event|2|||
16810126|NCT02443103|37751909|FG000|Overall Study|Noncompliance|1|||
16810127|NCT02022657|37751913|FG000|Overall Study|Withdrawal by Subject|2|||
16810128|NCT02022657|37751914|FG001|Overall Study|Withdrawal by Subject|0|||
16810129|NCT02022657|37751915|FG002|Overall Study|Withdrawal by Subject|1|||
16810130|NCT02022657|37751916|FG003|Overall Study|Withdrawal by Subject|0|||
16810131|NCT02022657|37751917|FG004|Overall Study|Withdrawal by Subject|0|||
16810132|NCT02022657|37751918|FG005|Overall Study|Withdrawal by Subject|0|||
16810133|NCT02022657|37751913|FG000|Overall Study|Physician Decision|0|||
16810134|NCT02022657|37751914|FG001|Overall Study|Physician Decision|0|||
16810135|NCT02022657|37751915|FG002|Overall Study|Physician Decision|0|||
16810136|NCT02022657|37751916|FG003|Overall Study|Physician Decision|0|||
16810137|NCT02022657|37751917|FG004|Overall Study|Physician Decision|0|||
16810138|NCT02022657|37751918|FG005|Overall Study|Physician Decision|1|||
16810139|NCT02418455|37751924|FG000|48-Week Treatment Period|Other- Not Specified|1|||
16810140|NCT02418455|37751924|FG000|Continuation Period|Sponsor Decision|7|||
16909931|NCT01693692|38018754|FG002|Overall Study|Physician Decision|1|||
16810141|NCT02417753|37751930|FG000|Overall Study|Death|1|||
16810142|NCT02417441|37751936|FG000|Overall Study|Inconclusive due to missing data|52|||
16810143|NCT02417441|37751937|FG001|Overall Study|Inconclusive due to missing data|19|||
16810144|NCT02021643|37751950|FG000|Overall Study|Enrolled but Never Treated|1|||
16810145|NCT02021643|37751951|FG001|Overall Study|Enrolled but Never Treated|0|||
16810146|NCT02021643|37751952|FG002|Overall Study|Enrolled but Never Treated|0|||
16810147|NCT02021643|37751953|FG003|Overall Study|Enrolled but Never Treated|0|||
16810148|NCT02021643|37751950|FG000|Overall Study|Adverse Event|0|||
16810149|NCT02021643|37751951|FG001|Overall Study|Adverse Event|1|||
16810150|NCT02021643|37751952|FG002|Overall Study|Adverse Event|0|||
16810151|NCT02021643|37751953|FG003|Overall Study|Adverse Event|0|||
16810152|NCT02021643|37751950|FG000|Overall Study|Death|0|||
16810153|NCT02021643|37751951|FG001|Overall Study|Death|1|||
16810154|NCT02021643|37751952|FG002|Overall Study|Death|0|||
16810155|NCT02021643|37751953|FG003|Overall Study|Death|0|||
16810156|NCT02021643|37751950|FG000|Overall Study|Investigator's Discretion|1|||
16810157|NCT02021643|37751951|FG001|Overall Study|Investigator's Discretion|0|||
16810158|NCT02021643|37751952|FG002|Overall Study|Investigator's Discretion|0|||
16810159|NCT02021643|37751953|FG003|Overall Study|Investigator's Discretion|0|||
16810160|NCT02021643|37751950|FG000|Overall Study|Lack of Efficacy|7|||
16810161|NCT02021643|37751951|FG001|Overall Study|Lack of Efficacy|6|||
16810162|NCT02021643|37751952|FG002|Overall Study|Lack of Efficacy|0|||
16810163|NCT02021643|37751953|FG003|Overall Study|Lack of Efficacy|12|||
16810164|NCT02021643|37751950|FG000|Overall Study|Lost to Follow-up|0|||
16810165|NCT02021643|37751951|FG001|Overall Study|Lost to Follow-up|1|||
16810166|NCT02021643|37751952|FG002|Overall Study|Lost to Follow-up|0|||
16810167|NCT02021643|37751953|FG003|Overall Study|Lost to Follow-up|0|||
16909932|NCT01693692|38018752|FG000|Overall Study|Protocol Violation|5|||
16909933|NCT01693692|38018753|FG001|Overall Study|Protocol Violation|4|||
16909934|NCT01693692|38018754|FG002|Overall Study|Protocol Violation|6|||
17016559|NCT00855218|38161203|FG000|Overall Study|patient convenience|2|||
17016560|NCT00855218|38161204|FG001|Overall Study|patient convenience|0|||
17016561|NCT00855218|38161203|FG000|Overall Study|technical problems|2|||
17016562|NCT00855218|38161204|FG001|Overall Study|technical problems|1|||
17016563|NCT00855218|38161203|FG000|Overall Study|Still treated with study medication|0|||
17016564|NCT00855218|38161204|FG001|Overall Study|Still treated with study medication|1|||
17016565|NCT00855218|38161203|FG000|Overall Study|Untreatable disease progression|54|||
17016566|NCT00855218|38161204|FG001|Overall Study|Untreatable disease progression|67|||
17016567|NCT00855218|38161203|FG000|Overall Study|Second malignancy|0|||
17016568|NCT00855218|38161204|FG001|Overall Study|Second malignancy|1|||
17016569|NCT00855218|38161203|FG000|Overall Study|Progression measurement proven|7|||
17016570|NCT00855218|38161204|FG001|Overall Study|Progression measurement proven|15|||
16810168|NCT02021643|37751950|FG000|Overall Study|Withdrew Consent|0|||
16810169|NCT02021643|37751951|FG001|Overall Study|Withdrew Consent|1|||
16810170|NCT02021643|37751952|FG002|Overall Study|Withdrew Consent|0|||
16909935|NCT01693692|38018752|FG000|Overall Study|Lost to Follow-up|2|||
16909936|NCT01693692|38018753|FG001|Overall Study|Lost to Follow-up|2|||
16909937|NCT01693692|38018754|FG002|Overall Study|Lost to Follow-up|3|||
16909938|NCT01693692|38018752|FG000|Overall Study|Other|4|||
16909939|NCT01693692|38018753|FG001|Overall Study|Other|4|||
16909940|NCT01693692|38018754|FG002|Overall Study|Other|6|||
16909941|NCT01693614|38018765|FG000|Overall Study|Adverse Event|7|||
16909942|NCT01693614|38018766|FG001|Overall Study|Adverse Event|11|||
16909943|NCT01693614|38018767|FG002|Overall Study|Adverse Event|5|||
16909944|NCT01693614|38018765|FG000|Overall Study|Disease progression|11|||
16909945|NCT01693614|38018766|FG001|Overall Study|Disease progression|8|||
16909946|NCT01693614|38018767|FG002|Overall Study|Disease progression|7|||
16909947|NCT01693614|38018765|FG000|Overall Study|Protocol Violation|5|||
16909948|NCT01693614|38018766|FG001|Overall Study|Protocol Violation|2|||
16909949|NCT01693614|38018767|FG002|Overall Study|Protocol Violation|1|||
16909950|NCT01693614|38018765|FG000|Overall Study|Death|1|||
16909951|NCT01693614|38018766|FG001|Overall Study|Death|0|||
16909952|NCT01693614|38018767|FG002|Overall Study|Death|0|||
16909953|NCT01693614|38018765|FG000|Overall Study|Physician Decision|1|||
16909954|NCT01693614|38018766|FG001|Overall Study|Physician Decision|1|||
16909955|NCT01693614|38018767|FG002|Overall Study|Physician Decision|4|||
16909956|NCT01693614|38018765|FG000|Overall Study|Withdrawal by subject/guardian|0|||
16909957|NCT01693614|38018766|FG001|Overall Study|Withdrawal by subject/guardian|0|||
16909958|NCT01693614|38018767|FG002|Overall Study|Withdrawal by subject/guardian|2|||
16909959|NCT01693614|38018765|FG000|Overall Study|Withdrawal by Subject|1|||
16909960|NCT01693614|38018766|FG001|Overall Study|Withdrawal by Subject|0|||
16909961|NCT01693614|38018767|FG002|Overall Study|Withdrawal by Subject|5|||
16909962|NCT01715298|38018778|FG000|Overall Study|Lost to Follow-up|0|||
16909963|NCT01715298|38018779|FG001|Overall Study|Lost to Follow-up|2|||
16909964|NCT01715298|38018778|FG000|Overall Study|Patient/guardian decision|7|||
17016571|NCT00855218|38161203|FG000|Overall Study|Clinical endpoint reached|10|||
17016572|NCT00855218|38161204|FG001|Overall Study|Clinical endpoint reached|13|||
16810171|NCT02021643|37751953|FG003|Overall Study|Withdrew Consent|0|||
16810172|NCT02415959|37751974|FG000|Overall Study|Adverse Event|0|||
16909965|NCT01715298|38018779|FG001|Overall Study|Patient/guardian decision|9|||
16909966|NCT01713582|38018806|FG000|Overall Study|Disease progression|3|||
16909967|NCT01713582|38018807|FG001|Overall Study|Disease progression|3|||
16909968|NCT01713582|38018808|FG002|Overall Study|Disease progression|3|||
16909969|NCT01713582|38018809|FG003|Overall Study|Disease progression|2|||
16909970|NCT01713582|38018810|FG004|Overall Study|Disease progression|3|||
16909971|NCT01713582|38018811|FG005|Overall Study|Disease progression|3|||
16909972|NCT01713582|38018812|FG006|Overall Study|Disease progression|3|||
16909973|NCT01713582|38018813|FG007|Overall Study|Disease progression|3|||
16909974|NCT01713582|38018814|FG008|Overall Study|Disease progression|3|||
16909975|NCT01713582|38018815|FG009|Overall Study|Disease progression|11|||
16909976|NCT01713582|38018816|FG010|Overall Study|Disease progression|10|||
16909977|NCT01713582|38018817|FG011|Overall Study|Disease progression|5|||
16909978|NCT01713582|38018818|FG012|Overall Study|Disease progression|3|||
16909979|NCT01713582|38018819|FG013|Overall Study|Disease progression|3|||
16909980|NCT01713582|38018820|FG014|Overall Study|Disease progression|6|||
16909981|NCT01713582|38018821|FG015|Overall Study|Disease progression|6|||
16909982|NCT01713582|38018822|FG016|Overall Study|Disease progression|5|||
16909983|NCT01713582|38018823|FG017|Overall Study|Disease progression|2|||
16909984|NCT01713582|38018824|FG018|Overall Study|Disease progression|3|||
16909985|NCT01713582|38018825|FG019|Overall Study|Disease progression|5|||
16909986|NCT01713582|38018826|FG020|Overall Study|Disease progression|15|||
16909987|NCT01713582|38018806|FG000|Overall Study|Death|0|||
16909988|NCT01713582|38018807|FG001|Overall Study|Death|0|||
16909989|NCT01713582|38018808|FG002|Overall Study|Death|0|||
16909990|NCT01713582|38018809|FG003|Overall Study|Death|1|||
16810173|NCT02415959|37751975|FG001|Overall Study|Adverse Event|1|||
16810174|NCT02415959|37751976|FG002|Overall Study|Adverse Event|0|||
16810175|NCT02415959|37751977|FG003|Overall Study|Adverse Event|0|||
16810176|NCT02415959|37751978|FG004|Overall Study|Adverse Event|0|||
16810177|NCT02415959|37751974|FG000|Overall Study|Protocol Violation|0|||
16810178|NCT02415959|37751975|FG001|Overall Study|Protocol Violation|0|||
16810179|NCT02415959|37751976|FG002|Overall Study|Protocol Violation|0|||
16810180|NCT02415959|37751977|FG003|Overall Study|Protocol Violation|1|||
16810181|NCT02415959|37751978|FG004|Overall Study|Protocol Violation|0|||
16810182|NCT02021565|37751992|FG000|Baseline Through Intervention|Death|0|||
16810183|NCT02021565|37751993|FG001|Baseline Through Intervention|Death|1|||
16810184|NCT02021565|37751992|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
16810185|NCT02021565|37751993|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
16810186|NCT02021565|37751992|FG000|Baseline Through Intervention|Protocol Violation|0|||
16810187|NCT02021565|37751993|FG001|Baseline Through Intervention|Protocol Violation|7|||
16810188|NCT02021565|37751992|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
16810189|NCT02021565|37751993|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
16810190|NCT02021565|37751992|FG000|3-month Follow-up|Death|3|||
16810191|NCT02021565|37751993|FG001|3-month Follow-up|Death|0|||
16810192|NCT02021565|37751992|FG000|3-month Follow-up|Withdrawal by Subject|4|||
16810193|NCT02021565|37751993|FG001|3-month Follow-up|Withdrawal by Subject|0|||
16810194|NCT02021565|37751992|FG000|3-month Follow-up|Protocol Violation|3|||
16810195|NCT02021565|37751993|FG001|3-month Follow-up|Protocol Violation|2|||
16810196|NCT02021331|37752003|FG000|Overall Study|Adverse Event|0|||
16810197|NCT02021331|37752004|FG001|Overall Study|Adverse Event|2|||
16810198|NCT02085135|37752012|FG000|Overall Study|Adverse Event|4|||
16810199|NCT02085135|37752013|FG001|Overall Study|Adverse Event|7|||
16810200|NCT02085135|37752012|FG000|Overall Study|Lost to Follow-up|2|||
16810201|NCT02085135|37752013|FG001|Overall Study|Lost to Follow-up|2|||
16810202|NCT02085135|37752012|FG000|Overall Study|Withdrawal by Subject|3|||
16810203|NCT02085135|37752013|FG001|Overall Study|Withdrawal by Subject|0|||
16810204|NCT02085135|37752012|FG000|Overall Study|Lack of Efficacy|2|||
16810205|NCT02085135|37752013|FG001|Overall Study|Lack of Efficacy|0|||
16810206|NCT02441309|37752022|FG000|Overall Study|Disease progression|2|||
16810207|NCT02441309|37752023|FG001|Overall Study|Disease progression|1|||
16810208|NCT02441309|37752024|FG002|Overall Study|Disease progression|2|||
16810209|NCT02441309|37752022|FG000|Overall Study|Adverse Event|0|||
16810210|NCT02441309|37752023|FG001|Overall Study|Adverse Event|1|||
16810211|NCT02441309|37752024|FG002|Overall Study|Adverse Event|0|||
16810212|NCT02441309|37752022|FG000|Overall Study|Withdrawal by Subject|1|||
16810213|NCT02441309|37752023|FG001|Overall Study|Withdrawal by Subject|0|||
16810214|NCT02441309|37752024|FG002|Overall Study|Withdrawal by Subject|1|||
16810215|NCT02027025|37752038|FG000|Overall Study|Adverse Event|0|||
16909991|NCT01713582|38018810|FG004|Overall Study|Death|1|||
16909992|NCT01713582|38018811|FG005|Overall Study|Death|3|||
16810216|NCT02027025|37752039|FG001|Overall Study|Adverse Event|1|||
16810217|NCT02027025|37752040|FG002|Overall Study|Adverse Event|1|||
16810218|NCT02027025|37752038|FG000|Overall Study|Protocol Violation|1|||
16810219|NCT02027025|37752039|FG001|Overall Study|Protocol Violation|0|||
16810220|NCT02027025|37752040|FG002|Overall Study|Protocol Violation|0|||
16810221|NCT02027025|37752038|FG000|Overall Study|Lost to Follow-up|0|||
16909993|NCT01713582|38018812|FG006|Overall Study|Death|3|||
16909994|NCT01713582|38018813|FG007|Overall Study|Death|2|||
16909995|NCT01713582|38018814|FG008|Overall Study|Death|3|||
16909996|NCT01713582|38018815|FG009|Overall Study|Death|4|||
16909997|NCT01713582|38018816|FG010|Overall Study|Death|3|||
16810222|NCT02027025|37752039|FG001|Overall Study|Lost to Follow-up|2|||
16810223|NCT02027025|37752040|FG002|Overall Study|Lost to Follow-up|0|||
16810224|NCT02027025|37752038|FG000|Overall Study|Withdrawal by Subject|0|||
16810225|NCT02027025|37752039|FG001|Overall Study|Withdrawal by Subject|1|||
16810226|NCT02027025|37752040|FG002|Overall Study|Withdrawal by Subject|0|||
16810227|NCT02027025|37752038|FG000|Overall Study|Sponsor's decision|0|||
16810228|NCT02027025|37752039|FG001|Overall Study|Sponsor's decision|1|||
16810229|NCT02027025|37752040|FG002|Overall Study|Sponsor's decision|0|||
16810230|NCT01652729|37752062|FG000|Overall Study|Withdrawal by Subject|14|||
16810231|NCT01652729|37752063|FG001|Overall Study|Withdrawal by Subject|7|||
16810232|NCT01652729|37752064|FG002|Overall Study|Withdrawal by Subject|7|||
16810233|NCT01652729|37752062|FG000|Overall Study|Adverse Event|4|||
16810234|NCT01652729|37752063|FG001|Overall Study|Adverse Event|0|||
16810235|NCT01652729|37752064|FG002|Overall Study|Adverse Event|3|||
16810236|NCT01652729|37752062|FG000|Overall Study|Physician Decision|1|||
16810237|NCT01652729|37752063|FG001|Overall Study|Physician Decision|0|||
16810238|NCT01652729|37752064|FG002|Overall Study|Physician Decision|1|||
16810239|NCT01652729|37752062|FG000|Overall Study|Protocol Violation|1|||
16810240|NCT01652729|37752063|FG001|Overall Study|Protocol Violation|0|||
16810241|NCT01652729|37752064|FG002|Overall Study|Protocol Violation|0|||
16810242|NCT01652729|37752062|FG000|Overall Study|Lost to Follow-up|6|||
16810243|NCT01652729|37752063|FG001|Overall Study|Lost to Follow-up|6|||
16810244|NCT01652729|37752064|FG002|Overall Study|Lost to Follow-up|3|||
16810245|NCT01652729|37752062|FG000|Overall Study|Administrative|1|||
16810246|NCT01652729|37752063|FG001|Overall Study|Administrative|0|||
16810247|NCT01652729|37752064|FG002|Overall Study|Administrative|0|||
16810248|NCT02083965|37752074|FG000|Treatment Period|Other|1|||
16810249|NCT02083965|37752075|FG001|Treatment Period|Other|0|||
16810250|NCT02438813|37752083|FG000|Overall Study|Patient Decision|59|||
16810251|NCT02438813|37752083|FG000|Overall Study|Patient Lost to Follow-Up|137|||
16810252|NCT02438813|37752083|FG000|Overall Study|Study Ended by Sponsor|80|||
16810253|NCT02438813|37752083|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
16810254|NCT02437409|37752097|FG000|Overall Study|Withdrawal by Subject|3|||
16810255|NCT02437409|37752097|FG000|Overall Study|Screening failure|12|||
16810256|NCT02459093|37752104|FG000|Overall Study|Protocol Violation|6|||
16810257|NCT02459093|37752105|FG001|Overall Study|Protocol Violation|11|||
16810258|NCT02459093|37752104|FG000|Overall Study|Lost to Follow-up|6|||
16810259|NCT02459093|37752105|FG001|Overall Study|Lost to Follow-up|7|||
16810260|NCT02458469|37752111|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16810261|NCT02458469|37752112|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16810262|NCT02458469|37752113|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
16810263|NCT02458469|37752114|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16810264|NCT02458469|37752115|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16810265|NCT02458469|37752116|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16810266|NCT02458469|37752111|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
16810267|NCT02458469|37752112|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
16810268|NCT02458469|37752113|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
16810269|NCT02458469|37752114|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
16810270|NCT02458469|37752115|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
16810271|NCT02458469|37752116|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
16810272|NCT02458469|37752111|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16810273|NCT02458469|37752112|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16810274|NCT02458469|37752113|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16810275|NCT02458469|37752114|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16810276|NCT02458469|37752115|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16810277|NCT02458469|37752116|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
16810278|NCT01843348|37752127|FG000|Overall Study|Withdrawal by Subject|4|||
16810279|NCT01843348|37752128|FG001|Overall Study|Withdrawal by Subject|16|||
16810280|NCT01843348|37752129|FG002|Overall Study|Withdrawal by Subject|18|||
16810281|NCT01843348|37752127|FG000|Overall Study|Lost to Follow-up|5|||
16810282|NCT01843348|37752128|FG001|Overall Study|Lost to Follow-up|4|||
16810283|NCT01843348|37752129|FG002|Overall Study|Lost to Follow-up|2|||
16810284|NCT01843348|37752127|FG000|Overall Study|Death|5|||
16810285|NCT01843348|37752128|FG001|Overall Study|Death|3|||
16810286|NCT01843348|37752129|FG002|Overall Study|Death|4|||
16909998|NCT01713582|38018817|FG011|Overall Study|Death|0|||
16810287|NCT01843348|37752127|FG000|Overall Study|Graft loss/retransplantation|5|||
16810288|NCT01843348|37752128|FG001|Overall Study|Graft loss/retransplantation|8|||
16810289|NCT01843348|37752129|FG002|Overall Study|Graft loss/retransplantation|11|||
16810290|NCT01843348|37752127|FG000|Overall Study|Various reasons|4|||
16909999|NCT01713582|38018818|FG012|Overall Study|Death|0|||
17102328|NCT00116558|38241232|FG001|Overall Study|Death|5|||
16810291|NCT01843348|37752128|FG001|Overall Study|Various reasons|9|||
16810292|NCT01843348|37752129|FG002|Overall Study|Various reasons|6|||
16810293|NCT01843192|37752142|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
16810294|NCT01843192|37752143|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
16810295|NCT01843192|37752144|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
16810296|NCT01825876|37752152|FG000|Period 2|Withdrawal by Subject|0|||
16810297|NCT01825876|37752153|FG001|Period 2|Withdrawal by Subject|1|||
16810298|NCT01842958|37752164|FG000|Overall Study|Lost to Follow-up|1|||
16810299|NCT01842958|37752165|FG001|Overall Study|Lost to Follow-up|1|||
16810300|NCT02413229|37752179|FG000|Overall Study|Adverse Event|0|||
16810301|NCT02413229|37752180|FG001|Overall Study|Adverse Event|0|||
16810302|NCT02413229|37752181|FG002|Overall Study|Adverse Event|0|||
16810303|NCT02413229|37752182|FG003|Overall Study|Adverse Event|1|||
16810304|NCT02413229|37752183|FG004|Overall Study|Adverse Event|0|||
16810305|NCT02413229|37752184|FG005|Overall Study|Adverse Event|0|||
16810306|NCT02413229|37752185|FG006|Overall Study|Adverse Event|0|||
16810307|NCT02413229|37752186|FG007|Overall Study|Adverse Event|1|||
16810308|NCT02413229|37752179|FG000|Overall Study|Lost to Follow-up|0|||
16810309|NCT02413229|37752180|FG001|Overall Study|Lost to Follow-up|0|||
16810310|NCT02413229|37752181|FG002|Overall Study|Lost to Follow-up|1|||
16810311|NCT02413229|37752182|FG003|Overall Study|Lost to Follow-up|0|||
16810312|NCT02413229|37752183|FG004|Overall Study|Lost to Follow-up|2|||
16810313|NCT02413229|37752184|FG005|Overall Study|Lost to Follow-up|0|||
16810314|NCT02413229|37752185|FG006|Overall Study|Lost to Follow-up|0|||
16810315|NCT02413229|37752186|FG007|Overall Study|Lost to Follow-up|0|||
16810316|NCT02413229|37752179|FG000|Overall Study|Withdrawal by Subject|1|||
16810317|NCT02413229|37752180|FG001|Overall Study|Withdrawal by Subject|1|||
16810318|NCT02413229|37752181|FG002|Overall Study|Withdrawal by Subject|0|||
16810319|NCT02413229|37752182|FG003|Overall Study|Withdrawal by Subject|0|||
16810320|NCT02413229|37752183|FG004|Overall Study|Withdrawal by Subject|1|||
16810321|NCT02413229|37752184|FG005|Overall Study|Withdrawal by Subject|0|||
16810322|NCT02413229|37752185|FG006|Overall Study|Withdrawal by Subject|0|||
16810323|NCT02413229|37752186|FG007|Overall Study|Withdrawal by Subject|2|||
16810324|NCT02413229|37752179|FG000|Overall Study|Progressive Disease|0|||
16810325|NCT02413229|37752180|FG001|Overall Study|Progressive Disease|0|||
16810326|NCT02413229|37752181|FG002|Overall Study|Progressive Disease|0|||
16810327|NCT02413229|37752182|FG003|Overall Study|Progressive Disease|0|||
16810328|NCT02413229|37752183|FG004|Overall Study|Progressive Disease|0|||
16810329|NCT02413229|37752184|FG005|Overall Study|Progressive Disease|0|||
16810330|NCT02413229|37752185|FG006|Overall Study|Progressive Disease|0|||
16810331|NCT02413229|37752186|FG007|Overall Study|Progressive Disease|1|||
16810332|NCT01825798|37752206|FG000|Overall Study|Adverse Event|1|||
16810333|NCT01825798|37752207|FG001|Overall Study|Adverse Event|5|||
16810334|NCT01825798|37752206|FG000|Overall Study|Lost to Follow-up|1|||
16810335|NCT01825798|37752207|FG001|Overall Study|Lost to Follow-up|0|||
16810336|NCT01824472|37752216|FG000|Overall Study|Lost to Follow-up|0|||
16810337|NCT01824472|37752217|FG001|Overall Study|Lost to Follow-up|0|||
16810338|NCT01824472|37752218|FG002|Overall Study|Lost to Follow-up|1|||
16810339|NCT01824472|37752216|FG000|Overall Study|Withdrawal by Subject|1|||
16810340|NCT01824472|37752217|FG001|Overall Study|Withdrawal by Subject|5|||
16810341|NCT01824472|37752218|FG002|Overall Study|Withdrawal by Subject|3|||
16810342|NCT01824472|37752216|FG000|Overall Study|Ineligible post randomization&screening|0|||
16810343|NCT01824472|37752217|FG001|Overall Study|Ineligible post randomization&screening|2|||
16810344|NCT01824472|37752218|FG002|Overall Study|Ineligible post randomization&screening|0|||
16810345|NCT02412761|37752226|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16810346|NCT02412761|37752227|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16810347|NCT02412761|37752228|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16810348|NCT02412761|37752229|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16810349|NCT02412761|37752230|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16810350|NCT02412761|37752231|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16810351|NCT01842334|37752241|FG000|Overall Study|Withdrawal by Subject|3|||
16810352|NCT01842334|37752242|FG001|Overall Study|Withdrawal by Subject|3|||
16810353|NCT01842334|37752241|FG000|Overall Study|Moved away mid-study|0|||
16810354|NCT01842334|37752242|FG001|Overall Study|Moved away mid-study|1|||
16810355|NCT02457611|37752248|FG000|Overall Study|Lost to Follow-up|3|||
16810356|NCT02457065|37752254|FG000|Overall Study|Lost to Follow-up|9|||
16810357|NCT02457065|37752255|FG001|Overall Study|Lost to Follow-up|11|||
16810358|NCT02083653|37752264|FG000|Overall Study|Randomized but not Treated|0|||
16810359|NCT02083653|37752265|FG001|Overall Study|Randomized but not Treated|2|||
16810360|NCT02083653|37752266|FG002|Overall Study|Randomized but not Treated|7|||
16810361|NCT02083653|37752264|FG000|Overall Study|Adverse Event|12|||
16810362|NCT02083653|37752265|FG001|Overall Study|Adverse Event|5|||
16810363|NCT02083653|37752266|FG002|Overall Study|Adverse Event|4|||
16810364|NCT02083653|37752264|FG000|Overall Study|Lost to Follow-up|1|||
16810365|NCT02083653|37752265|FG001|Overall Study|Lost to Follow-up|0|||
16810366|NCT02083653|37752266|FG002|Overall Study|Lost to Follow-up|0|||
16810367|NCT02083653|37752264|FG000|Overall Study|Death|2|||
16810368|NCT02083653|37752265|FG001|Overall Study|Death|2|||
16810369|NCT02083653|37752266|FG002|Overall Study|Death|2|||
16810370|NCT02083653|37752264|FG000|Overall Study|Progressive Disease|65|||
16810371|NCT02083653|37752265|FG001|Overall Study|Progressive Disease|73|||
16810372|NCT02083653|37752266|FG002|Overall Study|Progressive Disease|63|||
16810373|NCT02083653|37752264|FG000|Overall Study|Withdrawal by Subject|2|||
16810374|NCT02083653|37752265|FG001|Overall Study|Withdrawal by Subject|1|||
16810375|NCT02083653|37752266|FG002|Overall Study|Withdrawal by Subject|2|||
16810376|NCT02083653|37752264|FG000|Overall Study|Other Events|0|||
16810377|NCT02083653|37752265|FG001|Overall Study|Other Events|2|||
16810378|NCT02083653|37752266|FG002|Overall Study|Other Events|2|||
16810379|NCT02083653|37752264|FG000|Overall Study|Reason Missing|0|||
16810380|NCT02083653|37752265|FG001|Overall Study|Reason Missing|0|||
16810381|NCT02083653|37752266|FG002|Overall Study|Reason Missing|4|||
16810382|NCT02436239|37752278|FG000|Open-Lable Treatment Period|Adverse Event|12|||
16810383|NCT02436239|37752279|FG001|Open-Lable Treatment Period|Adverse Event|3|||
16810384|NCT02436239|37752280|FG002|Open-Lable Treatment Period|Adverse Event|4|||
16810385|NCT02436239|37752281|FG003|Open-Lable Treatment Period|Adverse Event|2|||
16810386|NCT02436239|37752278|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
16810387|NCT02436239|37752279|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
16810388|NCT02436239|37752280|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
16810389|NCT02436239|37752281|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
16810390|NCT02436239|37752278|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
16810391|NCT02436239|37752279|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
16810392|NCT02436239|37752280|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
16810393|NCT02436239|37752281|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
16810394|NCT02436239|37752278|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
16810395|NCT02436239|37752279|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
16810396|NCT02436239|37752280|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
16810397|NCT02436239|37752281|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
16810398|NCT02436239|37752278|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
16810399|NCT02436239|37752279|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
16810400|NCT02436239|37752280|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
16810401|NCT02436239|37752281|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
16810402|NCT02436239|37752278|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
16810403|NCT02436239|37752279|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
16810404|NCT02436239|37752280|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
16810405|NCT02436239|37752281|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
16810406|NCT02436239|37752278|FG000|Open-Lable Treatment Period|Other Reason|1|||
16810407|NCT02436239|37752279|FG001|Open-Lable Treatment Period|Other Reason|1|||
16810408|NCT02436239|37752280|FG002|Open-Lable Treatment Period|Other Reason|0|||
16810409|NCT02436239|37752281|FG003|Open-Lable Treatment Period|Other Reason|0|||
16810410|NCT02436239|37752278|FG000|Down-Taper Period|Withdrawal by Subject|4|||
16810411|NCT02436239|37752279|FG001|Down-Taper Period|Withdrawal by Subject|4|||
16810412|NCT02436239|37752280|FG002|Down-Taper Period|Withdrawal by Subject|1|||
16810413|NCT02436239|37752281|FG003|Down-Taper Period|Withdrawal by Subject|2|||
16810414|NCT02026011|37752293|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
16810415|NCT02026011|37752294|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
16810416|NCT02026011|37752293|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
16810417|NCT02026011|37752294|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
16810418|NCT02026011|37752293|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
16810419|NCT02026011|37752294|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
16810420|NCT02026011|37752293|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
16810421|NCT02026011|37752294|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
16810422|NCT02436005|37752303|FG000|Second Intervention|Adverse Event|0|||
16810423|NCT02436005|37752304|FG001|Second Intervention|Adverse Event|1|||
16810424|NCT02456909|37752312|FG000|Overall Study|Did not receive allocated intervention|24|||
16810425|NCT02456909|37752313|FG001|Overall Study|Did not receive allocated intervention|26|||
16810426|NCT02456909|37752312|FG000|Overall Study|Did not complete the primary outcome|0|||
16810427|NCT02456909|37752313|FG001|Overall Study|Did not complete the primary outcome|1|||
16810428|NCT02025621|37752321|FG000|Overall Study|Withdrawal by Subject|1|||
16810429|NCT02025621|37752322|FG001|Overall Study|Withdrawal by Subject|0|||
16810430|NCT02025621|37752321|FG000|Overall Study|Death|0|||
16810431|NCT02025621|37752322|FG001|Overall Study|Death|1|||
16810432|NCT02025621|37752321|FG000|Overall Study|No longer eligible|10|||
16810433|NCT02025621|37752322|FG001|Overall Study|No longer eligible|15|||
16810434|NCT02025621|37752321|FG000|Overall Study|Surgery initiated before infusion|3|||
16810435|NCT02025621|37752322|FG001|Overall Study|Surgery initiated before infusion|3|||
16810436|NCT02020941|37752328|FG000|Overall Study|Adverse Event|1|||
16810437|NCT02020941|37752328|FG000|Overall Study|Physician Decision|2|||
16810438|NCT02020941|37752328|FG000|Overall Study|Withdrawal by Subject|1|||
16810439|NCT02020941|37752328|FG000|Overall Study|Disease Progression|4|||
16810440|NCT02024529|37752334|FG000|Overall Study|Withdrawal by Subject|11|||
16810441|NCT02024529|37752335|FG001|Overall Study|Withdrawal by Subject|21|||
16810442|NCT02024529|37752334|FG000|Overall Study|Lost to Follow-up|2|||
16810443|NCT02024529|37752335|FG001|Overall Study|Lost to Follow-up|4|||
16810444|NCT02020863|37752343|FG000|Overall Study|Discovery of Metastatic disease|4|||
16810445|NCT02020863|37752343|FG000|Overall Study|Team chose not to place an a line|1|||
16810446|NCT01824394|37752350|FG000|Overall Study|Early Termination|1|||
16810447|NCT01824394|37752351|FG001|Overall Study|Early Termination|1|||
16810448|NCT01824394|37752352|FG002|Overall Study|Early Termination|3|||
16810449|NCT01824394|37752350|FG000|Overall Study|Withdrawn due to Study Termination|91|||
16810450|NCT01824394|37752351|FG001|Overall Study|Withdrawn due to Study Termination|83|||
16810451|NCT01824394|37752352|FG002|Overall Study|Withdrawn due to Study Termination|41|||
16810452|NCT01824394|37752350|FG000|Overall Study|Lost to Follow-up|0|||
16810453|NCT01824394|37752351|FG001|Overall Study|Lost to Follow-up|9|||
16810454|NCT01824394|37752352|FG002|Overall Study|Lost to Follow-up|3|||
16810455|NCT01824394|37752350|FG000|Overall Study|Death|3|||
16810456|NCT01824394|37752351|FG001|Overall Study|Death|2|||
16810457|NCT01824394|37752352|FG002|Overall Study|Death|4|||
16810458|NCT01824394|37752350|FG000|Overall Study|Discontinued Subjects|1|||
16810459|NCT01824394|37752351|FG001|Overall Study|Discontinued Subjects|1|||
16810460|NCT01824394|37752352|FG002|Overall Study|Discontinued Subjects|2|||
16810461|NCT01824394|37752350|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
16810462|NCT01824394|37752351|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
16810463|NCT01824394|37752352|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
16810464|NCT01823536|37752366|FG000|Overall Study|Lost to Follow-up|1|||
16810465|NCT01823536|37752367|FG001|Overall Study|Lost to Follow-up|0|||
16810466|NCT01823536|37752368|FG002|Overall Study|Lost to Follow-up|0|||
16810467|NCT01823536|37752369|FG003|Overall Study|Lost to Follow-up|1|||
16810468|NCT01823536|37752370|FG004|Overall Study|Lost to Follow-up|1|||
16810469|NCT01823536|37752371|FG005|Overall Study|Lost to Follow-up|0|||
16810470|NCT01823536|37752366|FG000|Overall Study|Protocol Violation|0|||
16810471|NCT01823536|37752367|FG001|Overall Study|Protocol Violation|1|||
16810472|NCT01823536|37752368|FG002|Overall Study|Protocol Violation|0|||
16810473|NCT01823536|37752369|FG003|Overall Study|Protocol Violation|0|||
16810474|NCT01823536|37752370|FG004|Overall Study|Protocol Violation|0|||
16810475|NCT01823536|37752371|FG005|Overall Study|Protocol Violation|0|||
16810476|NCT01823536|37752366|FG000|Overall Study|Withdrawal by Subject|1|||
16810477|NCT01823536|37752367|FG001|Overall Study|Withdrawal by Subject|1|||
16810478|NCT01823536|37752368|FG002|Overall Study|Withdrawal by Subject|0|||
16810479|NCT01823536|37752369|FG003|Overall Study|Withdrawal by Subject|0|||
16810480|NCT01823536|37752370|FG004|Overall Study|Withdrawal by Subject|0|||
16810481|NCT01823536|37752371|FG005|Overall Study|Withdrawal by Subject|0|||
16810482|NCT01823536|37752366|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16810483|NCT01823536|37752367|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16810484|NCT01823536|37752368|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
16810485|NCT01823536|37752369|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16810486|NCT01823536|37752370|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16810487|NCT01823536|37752371|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16810488|NCT01823536|37752366|FG000|Overall Study|Met exclusion criterion No 6|0|||
16810489|NCT01823536|37752367|FG001|Overall Study|Met exclusion criterion No 6|0|||
16810490|NCT01823536|37752368|FG002|Overall Study|Met exclusion criterion No 6|0|||
16810491|NCT01823536|37752369|FG003|Overall Study|Met exclusion criterion No 6|1|||
16810492|NCT01823536|37752370|FG004|Overall Study|Met exclusion criterion No 6|0|||
16810493|NCT01823536|37752371|FG005|Overall Study|Met exclusion criterion No 6|0|||
16810494|NCT01823536|37752366|FG000|Overall Study|Subject moved out of the state|0|||
16810495|NCT01823536|37752367|FG001|Overall Study|Subject moved out of the state|0|||
16810496|NCT01823536|37752368|FG002|Overall Study|Subject moved out of the state|0|||
16810497|NCT01823536|37752369|FG003|Overall Study|Subject moved out of the state|0|||
16810498|NCT01823536|37752370|FG004|Overall Study|Subject moved out of the state|1|||
16810499|NCT01823536|37752371|FG005|Overall Study|Subject moved out of the state|0|||
16810500|NCT01841554|37752384|FG000|Overall Study|Death|7|||
16810501|NCT01841554|37752384|FG000|Overall Study|No Implantation|1|||
16810502|NCT01841554|37752384|FG000|Overall Study|Discontinued Follow Up|5|||
16810503|NCT01841554|37752384|FG000|Overall Study|Study exit due to secondary intervention|6|||
16810504|NCT01823224|37752390|FG000|Overall Study|Lost to Follow-up|5|||
16810505|NCT01823224|37752391|FG001|Overall Study|Lost to Follow-up|6|||
16810506|NCT01823224|37752390|FG000|Overall Study|didn't qualify|1|||
16810507|NCT01823224|37752391|FG001|Overall Study|didn't qualify|2|||
16810508|NCT01823224|37752390|FG000|Overall Study|pharmacy error|0|||
16810509|NCT01823224|37752391|FG001|Overall Study|pharmacy error|1|||
16810510|NCT01823224|37752390|FG000|Overall Study|missed med dose|0|||
16810511|NCT01823224|37752391|FG001|Overall Study|missed med dose|1|||
16810512|NCT01823224|37752390|FG000|Overall Study|Withdrawal by Subject|0|||
16810513|NCT01823224|37752391|FG001|Overall Study|Withdrawal by Subject|1|||
16810514|NCT01840228|37752401|FG000|Overall Study|Lost to Follow-up|1|||
16810515|NCT01840228|37752402|FG001|Overall Study|Lost to Follow-up|1|||
16810516|NCT01839916|37752412|FG000|Overall Study|Death|9|||
16810517|NCT01839916|37752412|FG000|Overall Study|Physician Decision|17|||
16810518|NCT01839916|37752412|FG000|Overall Study|Relapse|12|||
16810519|NCT01839916|37752412|FG000|Overall Study|GVHD|2|||
16810520|NCT01839916|37752412|FG000|Overall Study|Graft Failure|1|||
16810521|NCT01823146|37752418|FG000|Overall Study|Withdrawal by Subject|0|||
16810522|NCT01823146|37752419|FG001|Overall Study|Withdrawal by Subject|1|||
16810523|NCT01823146|37752418|FG000|Overall Study|Lost to Follow-up|2|||
16810524|NCT01823146|37752419|FG001|Overall Study|Lost to Follow-up|1|||
16810525|NCT02083185|37752428|FG000|Overall Study|Lost to Follow-up|0|||
16810526|NCT02083185|37752429|FG001|Overall Study|Lost to Follow-up|3|||
16810527|NCT02083185|37752430|FG002|Overall Study|Lost to Follow-up|0|||
16810528|NCT02083185|37752428|FG000|Overall Study|Withdrawal by Subject|9|||
16810529|NCT02083185|37752429|FG001|Overall Study|Withdrawal by Subject|15|||
16810530|NCT02083185|37752430|FG002|Overall Study|Withdrawal by Subject|1|||
16810531|NCT02083185|37752428|FG000|Overall Study|Death|2|||
16810532|NCT02083185|37752429|FG001|Overall Study|Death|2|||
16810533|NCT02083185|37752430|FG002|Overall Study|Death|1|||
16810534|NCT02083185|37752428|FG000|Overall Study|Reason not Specified|9|||
16810535|NCT02083185|37752429|FG001|Overall Study|Reason not Specified|6|||
16810536|NCT02083185|37752430|FG002|Overall Study|Reason not Specified|5|||
16810537|NCT02083185|37752428|FG000|Overall Study|Study Terminated by Sponsor|0|||
16810538|NCT02083185|37752429|FG001|Overall Study|Study Terminated by Sponsor|1|||
16810539|NCT02083185|37752430|FG002|Overall Study|Study Terminated by Sponsor|0|||
16810540|NCT02083185|37752428|FG000|Overall Study|Did not Receive Study Drug|0|||
16810541|NCT02083185|37752429|FG001|Overall Study|Did not Receive Study Drug|2|||
16810542|NCT02083185|37752430|FG002|Overall Study|Did not Receive Study Drug|0|||
16810543|NCT02019927|37752444|FG000|Overall Study|Lost to Follow-up|2|||
16810544|NCT02019927|37752445|FG001|Overall Study|Lost to Follow-up|4|||
16810545|NCT02019927|37752446|FG002|Overall Study|Lost to Follow-up|1|||
16810546|NCT02019927|37752447|FG003|Overall Study|Lost to Follow-up|2|||
16810547|NCT02019927|37752448|FG004|Overall Study|Lost to Follow-up|3|||
16810548|NCT02019927|37752449|FG005|Overall Study|Lost to Follow-up|1|||
16810549|NCT02412371|37752473|FG000|Overall Study|Withdrawal by Subject|0|||
16810550|NCT02412371|37752474|FG001|Overall Study|Withdrawal by Subject|2|||
16810551|NCT02412371|37752475|FG002|Overall Study|Withdrawal by Subject|0|||
16810552|NCT02412371|37752476|FG003|Overall Study|Withdrawal by Subject|1|||
16810553|NCT02412371|37752477|FG004|Overall Study|Withdrawal by Subject|1|||
16810554|NCT02412371|37752478|FG005|Overall Study|Withdrawal by Subject|0|||
16810555|NCT02412371|37752473|FG000|Overall Study|Sponsor Discontinued Study|1|||
16810556|NCT02412371|37752474|FG001|Overall Study|Sponsor Discontinued Study|4|||
16810557|NCT02412371|37752475|FG002|Overall Study|Sponsor Discontinued Study|6|||
16810558|NCT02412371|37752476|FG003|Overall Study|Sponsor Discontinued Study|4|||
16810559|NCT02412371|37752477|FG004|Overall Study|Sponsor Discontinued Study|5|||
16810560|NCT02412371|37752478|FG005|Overall Study|Sponsor Discontinued Study|0|||
16810561|NCT02412371|37752473|FG000|Overall Study|Death|4|||
16810562|NCT02412371|37752474|FG001|Overall Study|Death|2|||
16810563|NCT02412371|37752475|FG002|Overall Study|Death|1|||
16810564|NCT02412371|37752476|FG003|Overall Study|Death|3|||
16810565|NCT02412371|37752477|FG004|Overall Study|Death|5|||
16810566|NCT02412371|37752478|FG005|Overall Study|Death|2|||
16810567|NCT02412371|37752473|FG000|Overall Study|Other|2|||
16810568|NCT02412371|37752474|FG001|Overall Study|Other|1|||
16810569|NCT02412371|37752475|FG002|Overall Study|Other|0|||
16810570|NCT02412371|37752476|FG003|Overall Study|Other|0|||
16810571|NCT02412371|37752477|FG004|Overall Study|Other|1|||
16810572|NCT02412371|37752478|FG005|Overall Study|Other|3|||
16810573|NCT02411747|37752495|FG000|Overall Study|Withdrawal by Subject|1|||
16810574|NCT02411747|37752496|FG001|Overall Study|Withdrawal by Subject|0|||
16810575|NCT02411747|37752495|FG000|Overall Study|Protocol Violation|2|||
16810576|NCT02411747|37752496|FG001|Overall Study|Protocol Violation|4|||
16810577|NCT01822756|37752507|FG000|Overall Study|Adverse Event|0|||
16810578|NCT01822756|37752508|FG001|Overall Study|Adverse Event|0|||
16810579|NCT01822756|37752509|FG002|Overall Study|Adverse Event|0|||
16810580|NCT01822756|37752510|FG003|Overall Study|Adverse Event|2|||
16810581|NCT01822756|37752511|FG004|Overall Study|Adverse Event|0|||
16810582|NCT01822756|37752507|FG000|Overall Study|Disease progression|11|||
16810583|NCT01822756|37752508|FG001|Overall Study|Disease progression|1|||
16810584|NCT01822756|37752509|FG002|Overall Study|Disease progression|7|||
16810585|NCT01822756|37752510|FG003|Overall Study|Disease progression|2|||
16810586|NCT01822756|37752511|FG004|Overall Study|Disease progression|6|||
16810587|NCT01822756|37752507|FG000|Overall Study|Death|2|||
16810588|NCT01822756|37752508|FG001|Overall Study|Death|2|||
16810589|NCT01822756|37752509|FG002|Overall Study|Death|1|||
16810590|NCT01822756|37752510|FG003|Overall Study|Death|0|||
16810591|NCT01822756|37752511|FG004|Overall Study|Death|0|||
16810592|NCT01822756|37752507|FG000|Overall Study|Lost to Follow-up|1|||
16810593|NCT01822756|37752508|FG001|Overall Study|Lost to Follow-up|0|||
16910000|NCT01713582|38018819|FG013|Overall Study|Death|0|||
16810594|NCT01822756|37752509|FG002|Overall Study|Lost to Follow-up|1|||
16810595|NCT01822756|37752510|FG003|Overall Study|Lost to Follow-up|0|||
16810596|NCT01822756|37752511|FG004|Overall Study|Lost to Follow-up|1|||
16810597|NCT01822756|37752507|FG000|Overall Study|Physician Decision|0|||
16810598|NCT01822756|37752508|FG001|Overall Study|Physician Decision|1|||
16810599|NCT01822756|37752509|FG002|Overall Study|Physician Decision|0|||
16810600|NCT01822756|37752510|FG003|Overall Study|Physician Decision|0|||
16810601|NCT01822756|37752511|FG004|Overall Study|Physician Decision|0|||
16810602|NCT01822756|37752507|FG000|Overall Study|disease progression & patient preference|2|||
16810603|NCT01822756|37752508|FG001|Overall Study|disease progression & patient preference|0|||
16810604|NCT01822756|37752509|FG002|Overall Study|disease progression & patient preference|1|||
16810605|NCT01822756|37752510|FG003|Overall Study|disease progression & patient preference|0|||
16810606|NCT01822756|37752511|FG004|Overall Study|disease progression & patient preference|0|||
16810607|NCT01822678|37752526|FG000|Overall Study|Withdrawal by Subject|5|||
16810608|NCT01822678|37752527|FG001|Overall Study|Withdrawal by Subject|4|||
16810609|NCT01822678|37752528|FG002|Overall Study|Withdrawal by Subject|4|||
16810610|NCT01822678|37752526|FG000|Overall Study|Adverse Event|4|||
16810611|NCT01822678|37752527|FG001|Overall Study|Adverse Event|3|||
16810612|NCT01822678|37752528|FG002|Overall Study|Adverse Event|1|||
16810613|NCT01822678|37752526|FG000|Overall Study|Lack of Efficacy|3|||
16810614|NCT01822678|37752527|FG001|Overall Study|Lack of Efficacy|6|||
16810615|NCT01822678|37752528|FG002|Overall Study|Lack of Efficacy|5|||
16810616|NCT01822678|37752526|FG000|Overall Study|Lost to Follow-up|0|||
16810617|NCT01822678|37752527|FG001|Overall Study|Lost to Follow-up|2|||
16810618|NCT01822678|37752528|FG002|Overall Study|Lost to Follow-up|1|||
16810619|NCT01822366|37752540|FG000|Overall Study|Lost to Follow-up|5|||
16810620|NCT01822366|37752541|FG001|Overall Study|Lost to Follow-up|1|||
16810621|NCT01822366|37752542|FG002|Overall Study|Lost to Follow-up|5|||
16810622|NCT01822366|37752543|FG003|Overall Study|Lost to Follow-up|1|||
16810623|NCT01822366|37752540|FG000|Overall Study|Withdrawal by Subject|0|||
16810624|NCT01822366|37752541|FG001|Overall Study|Withdrawal by Subject|6|||
16810625|NCT01822366|37752542|FG002|Overall Study|Withdrawal by Subject|0|||
16810626|NCT01822366|37752543|FG003|Overall Study|Withdrawal by Subject|6|||
16810627|NCT01822366|37752540|FG000|Overall Study|Partial Intervention Completion|0|||
16810628|NCT01822366|37752541|FG001|Overall Study|Partial Intervention Completion|15|||
16810629|NCT01822366|37752542|FG002|Overall Study|Partial Intervention Completion|0|||
16810630|NCT01822366|37752543|FG003|Overall Study|Partial Intervention Completion|15|||
16810631|NCT01838590|37752575|FG000|Overall Study|Lack of Efficacy|12|||
16810632|NCT01838590|37752576|FG001|Overall Study|Lack of Efficacy|4|||
16810633|NCT01838590|37752575|FG000|Overall Study|Lost to Follow-up|0|||
16810634|NCT01838590|37752576|FG001|Overall Study|Lost to Follow-up|1|||
16810635|NCT01611454|37752588|FG000|Overall Study|Lack of Efficacy|18|||
16810636|NCT01611454|37752589|FG001|Overall Study|Lack of Efficacy|10|||
16810637|NCT01611298|37752599|FG000|Overall Study|Relapsed|2|||
16810638|NCT01822132|37752605|FG000|Overall Study|Lost to Follow-up|4|||
16810639|NCT01822132|37752606|FG001|Overall Study|Lost to Follow-up|2|||
16810640|NCT01821898|37752620|FG000|Overall Study|Withdrawal by Subject|2|||
16810641|NCT01821898|37752621|FG001|Overall Study|Withdrawal by Subject|1|||
16810642|NCT02411591|37752631|FG000|Overall Study|Adverse Event|0|||
16810643|NCT02411591|37752632|FG001|Overall Study|Adverse Event|4|||
16810644|NCT02411591|37752633|FG002|Overall Study|Adverse Event|2|||
16810645|NCT02411591|37752631|FG000|Overall Study|Withdrawal by Subject|0|||
16810646|NCT02411591|37752632|FG001|Overall Study|Withdrawal by Subject|3|||
16810647|NCT02411591|37752633|FG002|Overall Study|Withdrawal by Subject|0|||
16810648|NCT02411591|37752631|FG000|Overall Study|Physician Decision|0|||
16810649|NCT02411591|37752632|FG001|Overall Study|Physician Decision|3|||
16810650|NCT02411591|37752633|FG002|Overall Study|Physician Decision|1|||
16810651|NCT02454959|37752649|FG000|Overall Study|Protocol-Specified Criteria|3|||
16810652|NCT02454959|37752649|FG000|Overall Study|Physician Decision|1|||
16810653|NCT02454959|37752649|FG000|Overall Study|Withdrawal by Subject|3|||
16810654|NCT02454959|37752649|FG000|Overall Study|Adverse Event|2|||
16810655|NCT01821118|37752657|FG000|Overall Study|Death|0|||
16810656|NCT01821118|37752658|FG001|Overall Study|Death|1|||
16810657|NCT01650779|37752664|FG000|Overall Study|Withdrawal by Subject|1|||
16810658|NCT02411201|37752668|FG000|Overall Study|Adverse Event|2|||
16810659|NCT02411201|37752668|FG000|Overall Study|Withdrawal by Subject|2|||
16810660|NCT02411201|37752668|FG000|Overall Study|Age group completed|2|||
16810661|NCT01838044|37752676|FG000|Overall Study|Adverse Event|4|||
16810662|NCT01838044|37752677|FG001|Overall Study|Adverse Event|6|||
16810663|NCT01838044|37752676|FG000|Overall Study|Protocol Violation|3|||
16810664|NCT01838044|37752677|FG001|Overall Study|Protocol Violation|3|||
16810665|NCT01838044|37752676|FG000|Overall Study|Withdrawal by Subject|0|||
16810666|NCT01838044|37752677|FG001|Overall Study|Withdrawal by Subject|2|||
16810667|NCT01838044|37752676|FG000|Overall Study|Insufficient clinical response|1|||
16810668|NCT01838044|37752677|FG001|Overall Study|Insufficient clinical response|2|||
16810669|NCT01838044|37752676|FG000|Overall Study|Medication error without associated AE|0|||
16810670|NCT01838044|37752677|FG001|Overall Study|Medication error without associated AE|1|||
16810671|NCT01838044|37752676|FG000|Overall Study|Lost to Follow-up|0|||
16810672|NCT01838044|37752677|FG001|Overall Study|Lost to Follow-up|2|||
16810673|NCT02410811|37752688|FG000|Overall Study|Withdrawal by Subject|0|||
16810674|NCT02410811|37752689|FG001|Overall Study|Withdrawal by Subject|0|||
16810675|NCT02410811|37752690|FG002|Overall Study|Withdrawal by Subject|1|||
16810676|NCT02410811|37752691|FG003|Overall Study|Withdrawal by Subject|0|||
16810677|NCT02435381|37752701|FG000|Overall Study|Lost to Follow-up|2|||
16810678|NCT02435381|37752702|FG001|Overall Study|Lost to Follow-up|1|||
16810679|NCT01837966|37752718|FG000|Overall Study|Withdrawal by Subject|2|||
16810680|NCT01837966|37752719|FG001|Overall Study|Withdrawal by Subject|1|||
16810681|NCT02435147|37752725|FG000|Overall Study|non-evaluable DXA scan|11|||
16810682|NCT02435069|37752729|FG000|Dose Response - First Intervention|Adverse Event|0|||
16810683|NCT02435069|37752730|FG001|Dose Response - First Intervention|Adverse Event|1|||
16810684|NCT02435069|37752731|FG002|Dose Response - First Intervention|Adverse Event|1|||
16810685|NCT02435069|37752732|FG003|Dose Response - First Intervention|Adverse Event|0|||
16810686|NCT02435069|37752733|FG004|Dose Response - First Intervention|Adverse Event|0|||
16810687|NCT02435069|37752729|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
16810688|NCT02435069|37752730|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
16810689|NCT02435069|37752731|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
16810690|NCT02435069|37752732|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
16810691|NCT02435069|37752733|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
16810692|NCT02454101|37752755|FG000|Overall Study|Adverse Event|2|||
16810693|NCT02454101|37752756|FG001|Overall Study|Adverse Event|3|||
16810694|NCT02454101|37752755|FG000|Overall Study|Lost to Follow-up|3|||
16810695|NCT02454101|37752756|FG001|Overall Study|Lost to Follow-up|4|||
16810696|NCT02409719|37752764|FG000|Overall Study|Lost to Follow-up|3|||
16810697|NCT02409719|37752765|FG001|Overall Study|Lost to Follow-up|3|||
16810698|NCT01820572|37752773|FG000|Randomization|Not Treated|2|||
16810699|NCT01820572|37752774|FG001|Randomization|Not Treated|1|||
16810700|NCT01820572|37752773|FG000|Treatment Period|Adverse Event|12|||
16810701|NCT01820572|37752774|FG001|Treatment Period|Adverse Event|7|||
16810702|NCT01820572|37752773|FG000|Treatment Period|Death|3|||
16810703|NCT01820572|37752774|FG001|Treatment Period|Death|3|||
16810704|NCT01820572|37752773|FG000|Treatment Period|Lack of Efficacy|1|||
16810705|NCT01820572|37752774|FG001|Treatment Period|Lack of Efficacy|0|||
16810706|NCT01820572|37752773|FG000|Treatment Period|poor/non compliance|0|||
16810707|NCT01820572|37752774|FG001|Treatment Period|poor/non compliance|3|||
16810708|NCT01820572|37752773|FG000|Treatment Period|request to discontinue|6|||
16810709|NCT01820572|37752774|FG001|Treatment Period|request to discontinue|11|||
16810710|NCT01820572|37752773|FG000|Treatment Period|No longer meets study criteria|3|||
16810711|NCT01820572|37752774|FG001|Treatment Period|No longer meets study criteria|10|||
16810712|NCT01820572|37752773|FG000|Treatment Period|withdrew consent|1|||
16810713|NCT01820572|37752774|FG001|Treatment Period|withdrew consent|2|||
16810714|NCT01820260|37752794|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810715|NCT01820260|37752795|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810716|NCT01820260|37752796|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810717|NCT01820260|37752797|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810718|NCT01820260|37752798|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810719|NCT01820260|37752799|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810720|NCT01820260|37752800|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
16810721|NCT01820260|37752801|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810722|NCT01820260|37752802|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810723|NCT01820260|37752803|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810724|NCT01820260|37752804|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810725|NCT01820260|37752805|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810726|NCT01820260|37752806|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810727|NCT01820260|37752807|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16810728|NCT01820260|37752794|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810729|NCT01820260|37752795|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810730|NCT01820260|37752796|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810731|NCT01820260|37752797|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810732|NCT01820260|37752798|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810733|NCT01820260|37752799|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810734|NCT01820260|37752800|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810735|NCT01820260|37752801|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810736|NCT01820260|37752802|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810737|NCT01820260|37752803|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
16810738|NCT01820260|37752804|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16910001|NCT01713582|38018820|FG014|Overall Study|Death|0|||
16910002|NCT01713582|38018821|FG015|Overall Study|Death|0|||
16910003|NCT01713582|38018822|FG016|Overall Study|Death|0|||
16910004|NCT01713582|38018823|FG017|Overall Study|Death|0|||
16910005|NCT01713582|38018824|FG018|Overall Study|Death|0|||
16910006|NCT01713582|38018825|FG019|Overall Study|Death|0|||
16910007|NCT01713582|38018826|FG020|Overall Study|Death|0|||
16910008|NCT01713582|38018806|FG000|Overall Study|Adverse event-related|0|||
16910009|NCT01713582|38018807|FG001|Overall Study|Adverse event-related|0|||
16810739|NCT01820260|37752805|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810740|NCT01820260|37752806|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810741|NCT01820260|37752807|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16810742|NCT01610596|37752845|FG000|Overall Study|Lost to Follow-up|0|||
16810743|NCT01610596|37752846|FG001|Overall Study|Lost to Follow-up|1|||
16810744|NCT01818700|37752852|FG000|Overall Study|Adverse Event|67|||
16810745|NCT01818700|37752852|FG000|Overall Study|Lack of Efficacy|2|||
16810746|NCT01818700|37752852|FG000|Overall Study|Lost to Follow-up|5|||
16810747|NCT01818700|37752852|FG000|Overall Study|Withdrawal by Subject|27|||
16810748|NCT01818700|37752852|FG000|Overall Study|Protocol Violation|2|||
16810749|NCT01818700|37752852|FG000|Overall Study|Other|1|||
16810750|NCT01817764|37752860|FG000|Overall Study|Adverse Event|7|||
16810751|NCT01817764|37752861|FG001|Overall Study|Adverse Event|10|||
16810752|NCT01817764|37752860|FG000|Overall Study|Lack of Efficacy|9|||
16810753|NCT01817764|37752861|FG001|Overall Study|Lack of Efficacy|7|||
16810754|NCT01817764|37752860|FG000|Overall Study|Protocol Violation|7|||
16810755|NCT01817764|37752861|FG001|Overall Study|Protocol Violation|5|||
16810756|NCT01817764|37752860|FG000|Overall Study|Lost to Follow-up|1|||
16810757|NCT01817764|37752861|FG001|Overall Study|Lost to Follow-up|4|||
16810758|NCT01817764|37752860|FG000|Overall Study|Withdrawal by Subject|10|||
16810759|NCT01817764|37752861|FG001|Overall Study|Withdrawal by Subject|12|||
16810760|NCT01803880|37752870|FG000|Overall Study|Adverse Event|1|||
16810761|NCT01803880|37752871|FG001|Overall Study|Adverse Event|0|||
16810762|NCT01803880|37752872|FG002|Overall Study|Adverse Event|0|||
16810763|NCT01803880|37752870|FG000|Overall Study|Withdrawal by Subject|1|||
16810764|NCT01803880|37752871|FG001|Overall Study|Withdrawal by Subject|1|||
16810765|NCT01803880|37752872|FG002|Overall Study|Withdrawal by Subject|4|||
16810766|NCT01803880|37752870|FG000|Overall Study|Physician Decision|0|||
16810767|NCT01803880|37752871|FG001|Overall Study|Physician Decision|0|||
16810768|NCT01803880|37752872|FG002|Overall Study|Physician Decision|1|||
16810769|NCT01803880|37752870|FG000|Overall Study|Unable to return for follow-up visits|0|||
16810770|NCT01803880|37752871|FG001|Overall Study|Unable to return for follow-up visits|1|||
16810771|NCT01803880|37752872|FG002|Overall Study|Unable to return for follow-up visits|2|||
16810772|NCT01803880|37752870|FG000|Overall Study|Lost to Follow-up|1|||
16810773|NCT01803880|37752871|FG001|Overall Study|Lost to Follow-up|2|||
16810774|NCT01803880|37752872|FG002|Overall Study|Lost to Follow-up|3|||
16810775|NCT01803880|37752870|FG000|Overall Study|Protocol Violation|1|||
16810776|NCT01803880|37752871|FG001|Overall Study|Protocol Violation|0|||
16810777|NCT01803880|37752872|FG002|Overall Study|Protocol Violation|0|||
16810778|NCT01803880|37752870|FG000|Overall Study|Early study termination|0|||
16810779|NCT01803880|37752871|FG001|Overall Study|Early study termination|6|||
16810780|NCT01803880|37752872|FG002|Overall Study|Early study termination|5|||
16810781|NCT01803880|37752870|FG000|Overall Study|Incomplete data entry by sites|2|||
16810782|NCT01803880|37752871|FG001|Overall Study|Incomplete data entry by sites|0|||
16810783|NCT01803880|37752872|FG002|Overall Study|Incomplete data entry by sites|0|||
16810784|NCT01803646|37752884|FG000|Overall Study|Protocol Violation|1|||
16810785|NCT01803646|37752885|FG001|Overall Study|Protocol Violation|0|||
16810786|NCT01803646|37752884|FG000|Overall Study|Adverse Event|1|||
16810787|NCT01803646|37752885|FG001|Overall Study|Adverse Event|1|||
16810788|NCT01803646|37752884|FG000|Overall Study|Withdrawal by Subject|9|||
16810789|NCT01803646|37752885|FG001|Overall Study|Withdrawal by Subject|6|||
16810790|NCT01803646|37752884|FG000|Overall Study|Randomization error|1|||
16810791|NCT01803646|37752885|FG001|Overall Study|Randomization error|2|||
16810792|NCT01803646|37752884|FG000|Overall Study|Lost to Follow-up|5|||
16810793|NCT01803646|37752885|FG001|Overall Study|Lost to Follow-up|1|||
16810794|NCT01817530|37752899|FG000|Overall Study|Exclusionary Medication Received|0|||
16810795|NCT01817530|37752900|FG001|Overall Study|Exclusionary Medication Received|0|||
16810796|NCT01817530|37752901|FG002|Overall Study|Exclusionary Medication Received|0|||
16810797|NCT01817530|37752902|FG003|Overall Study|Exclusionary Medication Received|0|||
16810798|NCT01817530|37752903|FG004|Overall Study|Exclusionary Medication Received|1|||
16810799|NCT01817530|37752904|FG005|Overall Study|Exclusionary Medication Received|0|||
16810800|NCT01817530|37752905|FG006|Overall Study|Exclusionary Medication Received|0|||
16810801|NCT01817530|37752906|FG007|Overall Study|Exclusionary Medication Received|0|||
16810802|NCT01817530|37752899|FG000|Overall Study|Adverse Event|6|||
16810803|NCT01817530|37752900|FG001|Overall Study|Adverse Event|3|||
16810804|NCT01817530|37752901|FG002|Overall Study|Adverse Event|2|||
16810805|NCT01817530|37752902|FG003|Overall Study|Adverse Event|5|||
16810806|NCT01817530|37752903|FG004|Overall Study|Adverse Event|0|||
16810807|NCT01817530|37752904|FG005|Overall Study|Adverse Event|10|||
16810808|NCT01817530|37752905|FG006|Overall Study|Adverse Event|5|||
16810809|NCT01817530|37752906|FG007|Overall Study|Adverse Event|8|||
16810810|NCT01817530|37752899|FG000|Overall Study|Subject Noncompliant|3|||
16810811|NCT01817530|37752900|FG001|Overall Study|Subject Noncompliant|1|||
16810812|NCT01817530|37752901|FG002|Overall Study|Subject Noncompliant|0|||
16810813|NCT01817530|37752902|FG003|Overall Study|Subject Noncompliant|4|||
16810814|NCT01817530|37752903|FG004|Overall Study|Subject Noncompliant|0|||
16810815|NCT01817530|37752904|FG005|Overall Study|Subject Noncompliant|1|||
16810816|NCT01817530|37752905|FG006|Overall Study|Subject Noncompliant|1|||
16810817|NCT01817530|37752906|FG007|Overall Study|Subject Noncompliant|1|||
16810818|NCT01817530|37752899|FG000|Overall Study|Lack of Efficacy|1|||
16810819|NCT01817530|37752900|FG001|Overall Study|Lack of Efficacy|0|||
16810820|NCT01817530|37752901|FG002|Overall Study|Lack of Efficacy|0|||
16810821|NCT01817530|37752902|FG003|Overall Study|Lack of Efficacy|0|||
16810822|NCT01817530|37752903|FG004|Overall Study|Lack of Efficacy|0|||
16810823|NCT01817530|37752904|FG005|Overall Study|Lack of Efficacy|1|||
16810824|NCT01817530|37752905|FG006|Overall Study|Lack of Efficacy|0|||
16810825|NCT01817530|37752906|FG007|Overall Study|Lack of Efficacy|1|||
16810826|NCT01817530|37752899|FG000|Overall Study|Pregnancy|0|||
16810827|NCT01817530|37752900|FG001|Overall Study|Pregnancy|0|||
16810828|NCT01817530|37752901|FG002|Overall Study|Pregnancy|0|||
16810829|NCT01817530|37752902|FG003|Overall Study|Pregnancy|0|||
16810830|NCT01817530|37752903|FG004|Overall Study|Pregnancy|0|||
16810831|NCT01817530|37752904|FG005|Overall Study|Pregnancy|1|||
16810832|NCT01817530|37752905|FG006|Overall Study|Pregnancy|0|||
16810833|NCT01817530|37752906|FG007|Overall Study|Pregnancy|0|||
16810834|NCT01817530|37752899|FG000|Overall Study|Other|0|||
16810835|NCT01817530|37752900|FG001|Overall Study|Other|1|||
16810836|NCT01817530|37752901|FG002|Overall Study|Other|0|||
16810837|NCT01817530|37752902|FG003|Overall Study|Other|0|||
16810838|NCT01817530|37752903|FG004|Overall Study|Other|1|||
16810839|NCT01817530|37752904|FG005|Overall Study|Other|0|||
16810840|NCT01817530|37752905|FG006|Overall Study|Other|5|||
16810841|NCT01817530|37752906|FG007|Overall Study|Other|0|||
16810842|NCT01817530|37752899|FG000|Overall Study|Surgery or Invasive Intervention|1|||
16810843|NCT01817530|37752900|FG001|Overall Study|Surgery or Invasive Intervention|0|||
16810844|NCT01817530|37752901|FG002|Overall Study|Surgery or Invasive Intervention|0|||
16810845|NCT01817530|37752902|FG003|Overall Study|Surgery or Invasive Intervention|0|||
16810846|NCT01817530|37752903|FG004|Overall Study|Surgery or Invasive Intervention|1|||
16810847|NCT01817530|37752904|FG005|Overall Study|Surgery or Invasive Intervention|1|||
16810848|NCT01817530|37752905|FG006|Overall Study|Surgery or Invasive Intervention|1|||
16810849|NCT01817530|37752906|FG007|Overall Study|Surgery or Invasive Intervention|0|||
16810850|NCT01817530|37752899|FG000|Overall Study|Consent Withdrawn by Subject|3|||
16810851|NCT01817530|37752900|FG001|Overall Study|Consent Withdrawn by Subject|4|||
16810852|NCT01817530|37752901|FG002|Overall Study|Consent Withdrawn by Subject|7|||
16810853|NCT01817530|37752902|FG003|Overall Study|Consent Withdrawn by Subject|3|||
16810854|NCT01817530|37752903|FG004|Overall Study|Consent Withdrawn by Subject|5|||
16810855|NCT01817530|37752904|FG005|Overall Study|Consent Withdrawn by Subject|3|||
16810856|NCT01817530|37752905|FG006|Overall Study|Consent Withdrawn by Subject|3|||
16810857|NCT01817530|37752906|FG007|Overall Study|Consent Withdrawn by Subject|10|||
16810858|NCT01817530|37752899|FG000|Overall Study|Lost to Follow-up|1|||
16810859|NCT01817530|37752900|FG001|Overall Study|Lost to Follow-up|4|||
16810860|NCT01817530|37752901|FG002|Overall Study|Lost to Follow-up|2|||
16810861|NCT01817530|37752902|FG003|Overall Study|Lost to Follow-up|1|||
16810862|NCT01817530|37752903|FG004|Overall Study|Lost to Follow-up|3|||
16810863|NCT01817530|37752904|FG005|Overall Study|Lost to Follow-up|2|||
16810864|NCT01817530|37752905|FG006|Overall Study|Lost to Follow-up|8|||
16810865|NCT01817530|37752906|FG007|Overall Study|Lost to Follow-up|4|||
16810866|NCT01816984|37752924|FG000|Overall Study|declining health status|1|||
16810867|NCT01816906|37752930|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
16810868|NCT01816906|37752931|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
16810869|NCT01816906|37752930|FG000|Six Months|Lost to Follow-up|14|||
16810870|NCT01816906|37752931|FG001|Six Months|Lost to Follow-up|16|||
16810871|NCT01816906|37752930|FG000|12 Months|Adverse Event|2|||
16810872|NCT01816906|37752931|FG001|12 Months|Adverse Event|2|||
16810873|NCT01816906|37752930|FG000|12 Months|Death|0|||
16810874|NCT01816906|37752931|FG001|12 Months|Death|2|||
16810875|NCT01816906|37752930|FG000|12 Months|Lost to Follow-up|2|||
16810876|NCT01816906|37752931|FG001|12 Months|Lost to Follow-up|1|||
16810877|NCT01816594|37752940|FG000|Overall Study|Local Progress|0|||
16810878|NCT01816594|37752941|FG001|Overall Study|Local Progress|2|||
16810879|NCT01816594|37752940|FG000|Overall Study|Adverse Event|9|||
16810880|NCT01816594|37752941|FG001|Overall Study|Adverse Event|0|||
16810881|NCT01816594|37752940|FG000|Overall Study|Withdrawal by Subject|1|||
16810882|NCT01816594|37752941|FG001|Overall Study|Withdrawal by Subject|0|||
16810883|NCT01816594|37752940|FG000|Overall Study|Physician Decision|1|||
16810884|NCT01816594|37752941|FG001|Overall Study|Physician Decision|0|||
16810885|NCT01802320|37752953|FG000|Overall Study|Death|1|||
16810886|NCT01802320|37752953|FG000|Overall Study|Withdrawal by Subject|1|||
16810887|NCT02453711|37752966|FG000|Overall Study|Withdrawal by Subject|5|||
16810888|NCT02453711|37752967|FG001|Overall Study|Withdrawal by Subject|4|||
16810889|NCT02453711|37752968|FG002|Overall Study|Withdrawal by Subject|6|||
16810890|NCT02453711|37752969|FG003|Overall Study|Withdrawal by Subject|4|||
16810891|NCT02453711|37752970|FG004|Overall Study|Withdrawal by Subject|1|||
16810892|NCT02453711|37752971|FG005|Overall Study|Withdrawal by Subject|1|||
16810893|NCT02453711|37752972|FG006|Overall Study|Withdrawal by Subject|0|||
16810894|NCT02453711|37752973|FG007|Overall Study|Withdrawal by Subject|1|||
16810895|NCT02453711|37752974|FG008|Overall Study|Withdrawal by Subject|7|||
16810896|NCT02453711|37752966|FG000|Overall Study|Lost to Follow-up|5|||
16810897|NCT02453711|37752967|FG001|Overall Study|Lost to Follow-up|3|||
16810898|NCT02453711|37752968|FG002|Overall Study|Lost to Follow-up|2|||
16810899|NCT02453711|37752969|FG003|Overall Study|Lost to Follow-up|3|||
16810900|NCT02453711|37752970|FG004|Overall Study|Lost to Follow-up|1|||
16810901|NCT02453711|37752971|FG005|Overall Study|Lost to Follow-up|5|||
16810902|NCT02453711|37752972|FG006|Overall Study|Lost to Follow-up|2|||
16810903|NCT02453711|37752973|FG007|Overall Study|Lost to Follow-up|6|||
16810904|NCT02453711|37752974|FG008|Overall Study|Lost to Follow-up|6|||
16810905|NCT02453711|37752966|FG000|Overall Study|Death|0|||
16810906|NCT02453711|37752967|FG001|Overall Study|Death|0|||
16810907|NCT02453711|37752968|FG002|Overall Study|Death|0|||
16810908|NCT02453711|37752969|FG003|Overall Study|Death|0|||
16810909|NCT02453711|37752970|FG004|Overall Study|Death|0|||
16810910|NCT02453711|37752971|FG005|Overall Study|Death|0|||
16810911|NCT02453711|37752972|FG006|Overall Study|Death|1|||
16810912|NCT02453711|37752973|FG007|Overall Study|Death|0|||
16810913|NCT02453711|37752974|FG008|Overall Study|Death|0|||
16810914|NCT02453711|37752966|FG000|Overall Study|Unclassified|1|||
16810915|NCT02453711|37752967|FG001|Overall Study|Unclassified|0|||
16810916|NCT02453711|37752968|FG002|Overall Study|Unclassified|1|||
16810917|NCT02453711|37752969|FG003|Overall Study|Unclassified|0|||
16810918|NCT02453711|37752970|FG004|Overall Study|Unclassified|0|||
16810919|NCT02453711|37752971|FG005|Overall Study|Unclassified|0|||
16810920|NCT02453711|37752972|FG006|Overall Study|Unclassified|0|||
16810921|NCT02453711|37752973|FG007|Overall Study|Unclassified|0|||
16810922|NCT02453711|37752974|FG008|Overall Study|Unclassified|0|||
16810923|NCT02453555|37752996|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
16810924|NCT02453555|37752997|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
16810925|NCT02453555|37752998|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
16810926|NCT02453555|37752999|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
16810927|NCT02453555|37753000|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
16810928|NCT02453555|37753001|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
16810929|NCT02453555|37752996|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
16810930|NCT02453555|37752997|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16810931|NCT02453555|37752998|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16810932|NCT02453555|37752999|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16810933|NCT02453555|37753000|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16810934|NCT02453555|37753001|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16810935|NCT02453555|37752996|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
16810936|NCT02453555|37752997|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
16810937|NCT02453555|37752998|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16810938|NCT02453555|37752999|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16810939|NCT02453555|37753000|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16810940|NCT02453555|37753001|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16810941|NCT02453555|37752996|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
16810942|NCT02453555|37752997|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
16810943|NCT02453555|37752998|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
16810944|NCT02453555|37752999|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
16810945|NCT02453555|37753000|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
16810946|NCT02453555|37753001|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
16810947|NCT02453555|37752996|FG000|Extension Period|Adverse Event|0|||
16810948|NCT02453555|37752997|FG001|Extension Period|Adverse Event|0|||
16810949|NCT02453555|37752998|FG002|Extension Period|Adverse Event|1|||
16810950|NCT02453555|37752999|FG003|Extension Period|Adverse Event|2|||
16810951|NCT02453555|37753000|FG004|Extension Period|Adverse Event|1|||
16810952|NCT02453555|37753001|FG005|Extension Period|Adverse Event|1|||
16810953|NCT02453555|37752996|FG000|Extension Period|Protocol Violation|0|||
16810954|NCT02453555|37752997|FG001|Extension Period|Protocol Violation|0|||
16810955|NCT02453555|37752998|FG002|Extension Period|Protocol Violation|1|||
16810956|NCT02453555|37752999|FG003|Extension Period|Protocol Violation|0|||
16810957|NCT02453555|37753000|FG004|Extension Period|Protocol Violation|0|||
16810958|NCT02453555|37753001|FG005|Extension Period|Protocol Violation|0|||
16810959|NCT02453555|37752996|FG000|Extension Period|Withdrawal by Subject|0|||
16810960|NCT02453555|37752997|FG001|Extension Period|Withdrawal by Subject|0|||
16810961|NCT02453555|37752998|FG002|Extension Period|Withdrawal by Subject|1|||
16810962|NCT02453555|37752999|FG003|Extension Period|Withdrawal by Subject|0|||
16810963|NCT02453555|37753000|FG004|Extension Period|Withdrawal by Subject|0|||
16810964|NCT02453555|37753001|FG005|Extension Period|Withdrawal by Subject|0|||
16810965|NCT02453321|37753014|FG000|Overall Study|Weakness|1|||
16810966|NCT02453321|37753015|FG001|Overall Study|Weakness|1|||
16810967|NCT02453321|37753016|FG002|Overall Study|Weakness|2|||
16810968|NCT02453321|37753014|FG000|Overall Study|Deep Venous Thrombosis|0|||
16810969|NCT02453321|37753015|FG001|Overall Study|Deep Venous Thrombosis|1|||
16810970|NCT02453321|37753016|FG002|Overall Study|Deep Venous Thrombosis|0|||
16810971|NCT01610284|37753029|FG000|Randomization Phase|Adverse Event|1|||
16810972|NCT01610284|37753030|FG001|Randomization Phase|Adverse Event|0|||
16810973|NCT01610284|37753029|FG000|Randomization Phase|Physician Decision|1|||
16810974|NCT01610284|37753030|FG001|Randomization Phase|Physician Decision|1|||
16810975|NCT01610284|37753029|FG000|Randomization Phase|Death|0|||
16810976|NCT01610284|37753030|FG001|Randomization Phase|Death|1|||
16810977|NCT01610284|37753029|FG000|Treatment Phase|Adverse Event|80|||
16810978|NCT01610284|37753030|FG001|Treatment Phase|Adverse Event|12|||
16810979|NCT01610284|37753029|FG000|Treatment Phase|Lost to Follow-up|1|||
16810980|NCT01610284|37753030|FG001|Treatment Phase|Lost to Follow-up|0|||
16810981|NCT01610284|37753029|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
16810982|NCT01610284|37753030|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
16810983|NCT01610284|37753029|FG000|Treatment Phase|Physician Decision|27|||
16810984|NCT01610284|37753030|FG001|Treatment Phase|Physician Decision|24|||
16810985|NCT01610284|37753029|FG000|Treatment Phase|Progressive Disease|377|||
16810986|NCT01610284|37753030|FG001|Treatment Phase|Progressive Disease|486|||
16810987|NCT01610284|37753029|FG000|Treatment Phase|Protocol Deviation|2|||
16810988|NCT01610284|37753030|FG001|Treatment Phase|Protocol Deviation|3|||
16810989|NCT01610284|37753029|FG000|Treatment Phase|Study terminated by Sponsor|18|||
16810990|NCT01610284|37753030|FG001|Treatment Phase|Study terminated by Sponsor|15|||
16810991|NCT01610284|37753029|FG000|Treatment Phase|Subject/Guardian Decision|55|||
16810992|NCT01610284|37753030|FG001|Treatment Phase|Subject/Guardian Decision|23|||
16810993|NCT01610284|37753029|FG000|Treatment Phase|Death|6|||
16810994|NCT01610284|37753030|FG001|Treatment Phase|Death|5|||
16810995|NCT01610284|37753029|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
16810996|NCT01610284|37753030|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16810997|NCT01610284|37753029|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
16810998|NCT01610284|37753030|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
16810999|NCT01610284|37753029|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
16811000|NCT01610284|37753030|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
16811001|NCT01610284|37753029|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
16811002|NCT01610284|37753030|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
16811003|NCT01610284|37753029|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
16811004|NCT01610284|37753030|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
16811005|NCT01610284|37753029|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
16811006|NCT01610284|37753030|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
16811007|NCT02452463|37753039|FG000|Overall Study|Death|1|||
16811008|NCT02452463|37753040|FG001|Overall Study|Death|0|||
16811009|NCT02452463|37753041|FG002|Overall Study|Death|0|||
16811010|NCT02452463|37753039|FG000|Overall Study|Study Suspended|1|||
16811011|NCT02452463|37753040|FG001|Overall Study|Study Suspended|0|||
16811012|NCT02452463|37753041|FG002|Overall Study|Study Suspended|0|||
16811013|NCT02452463|37753039|FG000|Overall Study|Recommended by DSMB|0|||
16811014|NCT02452463|37753040|FG001|Overall Study|Recommended by DSMB|1|||
16811015|NCT02452463|37753041|FG002|Overall Study|Recommended by DSMB|0|||
16811016|NCT02452463|37753039|FG000|Overall Study|Withdrawal by Subject|0|||
16811017|NCT02452463|37753040|FG001|Overall Study|Withdrawal by Subject|1|||
16811018|NCT02452463|37753041|FG002|Overall Study|Withdrawal by Subject|0|||
16811019|NCT02432105|37753052|FG000|Overall Study|Lost to Follow-up|1|||
16811020|NCT02432105|37753053|FG001|Overall Study|Lost to Follow-up|1|||
16811021|NCT02432105|37753054|FG002|Overall Study|Lost to Follow-up|0|||
16811022|NCT02432105|37753052|FG000|Overall Study|Withdrawal by Subject|1|||
16811023|NCT02432105|37753053|FG001|Overall Study|Withdrawal by Subject|0|||
16811024|NCT02432105|37753054|FG002|Overall Study|Withdrawal by Subject|1|||
16811025|NCT02432105|37753052|FG000|Overall Study|Culture positive for yeast|0|||
16811026|NCT02432105|37753053|FG001|Overall Study|Culture positive for yeast|1|||
16811027|NCT02432105|37753054|FG002|Overall Study|Culture positive for yeast|0|||
16811028|NCT02432105|37753052|FG000|Overall Study|Randomized in error|0|||
16811029|NCT02432105|37753053|FG001|Overall Study|Randomized in error|0|||
16811030|NCT02432105|37753054|FG002|Overall Study|Randomized in error|2|||
16811031|NCT02431793|37753066|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
16811032|NCT02431793|37753067|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
16811033|NCT02431793|37753068|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
16811034|NCT02431793|37753066|FG000|Overall Study|Withdrawal by Subject|7|||
16811035|NCT02431793|37753067|FG001|Overall Study|Withdrawal by Subject|5|||
16811036|NCT02431793|37753068|FG002|Overall Study|Withdrawal by Subject|5|||
16811037|NCT02431793|37753066|FG000|Overall Study|Lost to Follow-up|101|||
16811038|NCT02431793|37753067|FG001|Overall Study|Lost to Follow-up|122|||
16811039|NCT02431793|37753068|FG002|Overall Study|Lost to Follow-up|104|||
16811040|NCT01801930|37753080|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
16811041|NCT01801930|37753081|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
16811042|NCT01801930|37753082|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
16811043|NCT01801930|37753083|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
16811044|NCT01801930|37753080|FG000|Overall Study|DLT occurs|0|||
16811045|NCT01801930|37753081|FG001|Overall Study|DLT occurs|1|||
16811046|NCT01801930|37753082|FG002|Overall Study|DLT occurs|0|||
16811047|NCT01801930|37753083|FG003|Overall Study|DLT occurs|0|||
16811048|NCT01610206|37753095|FG000|Overall Study|Adverse Event|10|||
16811049|NCT01610206|37753096|FG001|Overall Study|Adverse Event|30|||
16811050|NCT01816048|37753102|FG000|Overall Study|Adverse Event|1|||
16811051|NCT01816048|37753102|FG000|Overall Study|Death|1|||
16811052|NCT01816048|37753102|FG000|Overall Study|Withdrawal by Subject|1|||
16811053|NCT01816048|37753102|FG000|Overall Study|Disease Progression|3|||
16811054|NCT01612858|37753109|FG000|Overall Study|Withdrawal by Subject|5|||
16811055|NCT01612858|37753110|FG001|Overall Study|Withdrawal by Subject|1|||
16811056|NCT01612780|37753116|FG000|Overall Study|Treatment not completed|1|||
16811057|NCT01612780|37753116|FG000|Overall Study|Withdrawal by Subject|5|||
16910010|NCT01713582|38018808|FG002|Overall Study|Adverse event-related|0|||
16910011|NCT01713582|38018809|FG003|Overall Study|Adverse event-related|0|||
16910012|NCT01713582|38018810|FG004|Overall Study|Adverse event-related|0|||
16910013|NCT01713582|38018811|FG005|Overall Study|Adverse event-related|0|||
16910014|NCT01713582|38018812|FG006|Overall Study|Adverse event-related|0|||
16910015|NCT01713582|38018813|FG007|Overall Study|Adverse event-related|0|||
16910016|NCT01713582|38018814|FG008|Overall Study|Adverse event-related|0|||
16910017|NCT01713582|38018815|FG009|Overall Study|Adverse event-related|1|||
16910018|NCT01713582|38018816|FG010|Overall Study|Adverse event-related|1|||
16910019|NCT01713582|38018817|FG011|Overall Study|Adverse event-related|0|||
16910020|NCT01713582|38018818|FG012|Overall Study|Adverse event-related|0|||
16910021|NCT01713582|38018819|FG013|Overall Study|Adverse event-related|0|||
16910022|NCT01713582|38018820|FG014|Overall Study|Adverse event-related|0|||
16910023|NCT01713582|38018821|FG015|Overall Study|Adverse event-related|0|||
16910024|NCT01713582|38018822|FG016|Overall Study|Adverse event-related|0|||
16910025|NCT01713582|38018823|FG017|Overall Study|Adverse event-related|0|||
16910026|NCT01713582|38018824|FG018|Overall Study|Adverse event-related|1|||
16910027|NCT01713582|38018825|FG019|Overall Study|Adverse event-related|0|||
16910028|NCT01713582|38018826|FG020|Overall Study|Adverse event-related|0|||
16910029|NCT01713582|38018806|FG000|Overall Study|Adverse event-unrelated|0|||
16910030|NCT01713582|38018807|FG001|Overall Study|Adverse event-unrelated|0|||
16910031|NCT01713582|38018808|FG002|Overall Study|Adverse event-unrelated|0|||
16910032|NCT01713582|38018809|FG003|Overall Study|Adverse event-unrelated|0|||
16910033|NCT01713582|38018810|FG004|Overall Study|Adverse event-unrelated|0|||
16910034|NCT01713582|38018811|FG005|Overall Study|Adverse event-unrelated|1|||
16910035|NCT01713582|38018812|FG006|Overall Study|Adverse event-unrelated|1|||
16910036|NCT01713582|38018813|FG007|Overall Study|Adverse event-unrelated|1|||
16910037|NCT01713582|38018814|FG008|Overall Study|Adverse event-unrelated|0|||
16910038|NCT01713582|38018815|FG009|Overall Study|Adverse event-unrelated|0|||
16910039|NCT01713582|38018816|FG010|Overall Study|Adverse event-unrelated|0|||
16910040|NCT01713582|38018817|FG011|Overall Study|Adverse event-unrelated|0|||
16910041|NCT01713582|38018818|FG012|Overall Study|Adverse event-unrelated|0|||
16910042|NCT01713582|38018819|FG013|Overall Study|Adverse event-unrelated|1|||
16910043|NCT01713582|38018820|FG014|Overall Study|Adverse event-unrelated|1|||
16910044|NCT01713582|38018821|FG015|Overall Study|Adverse event-unrelated|0|||
16910045|NCT01713582|38018822|FG016|Overall Study|Adverse event-unrelated|0|||
16910046|NCT01713582|38018823|FG017|Overall Study|Adverse event-unrelated|0|||
16910047|NCT01713582|38018824|FG018|Overall Study|Adverse event-unrelated|0|||
16910048|NCT01713582|38018825|FG019|Overall Study|Adverse event-unrelated|0|||
16910049|NCT01713582|38018826|FG020|Overall Study|Adverse event-unrelated|0|||
16910050|NCT01713582|38018806|FG000|Overall Study|Withdrawal of consent|0|||
16910051|NCT01713582|38018807|FG001|Overall Study|Withdrawal of consent|0|||
16910052|NCT01713582|38018808|FG002|Overall Study|Withdrawal of consent|1|||
16910053|NCT01713582|38018809|FG003|Overall Study|Withdrawal of consent|0|||
16910054|NCT01713582|38018810|FG004|Overall Study|Withdrawal of consent|0|||
16910055|NCT01713582|38018811|FG005|Overall Study|Withdrawal of consent|1|||
16910056|NCT01713582|38018812|FG006|Overall Study|Withdrawal of consent|0|||
16910057|NCT01713582|38018813|FG007|Overall Study|Withdrawal of consent|0|||
16910058|NCT01713582|38018814|FG008|Overall Study|Withdrawal of consent|0|||
16910059|NCT01713582|38018815|FG009|Overall Study|Withdrawal of consent|1|||
16910060|NCT01713582|38018816|FG010|Overall Study|Withdrawal of consent|0|||
16910061|NCT01713582|38018817|FG011|Overall Study|Withdrawal of consent|0|||
16910062|NCT01713582|38018818|FG012|Overall Study|Withdrawal of consent|0|||
16910063|NCT01713582|38018819|FG013|Overall Study|Withdrawal of consent|0|||
16910064|NCT01713582|38018820|FG014|Overall Study|Withdrawal of consent|0|||
16910065|NCT01713582|38018821|FG015|Overall Study|Withdrawal of consent|0|||
16811058|NCT01612702|37753122|FG000|Overall Study|Protocol Violation|11|||
16811059|NCT01612702|37753123|FG001|Overall Study|Protocol Violation|11|||
16910066|NCT01713582|38018822|FG016|Overall Study|Withdrawal of consent|0|||
16910067|NCT01713582|38018823|FG017|Overall Study|Withdrawal of consent|0|||
16811060|NCT02431559|37753133|FG000|Overall Study|Adverse Event|0|||
16811061|NCT02431559|37753134|FG001|Overall Study|Adverse Event|1|||
17016573|NCT01063348|38161212|FG000|Overall Study|Lost to Follow-up|3|||
16811062|NCT02431559|37753135|FG002|Overall Study|Adverse Event|0|||
16811063|NCT02431559|37753136|FG003|Overall Study|Adverse Event|4|||
16811064|NCT02431559|37753133|FG000|Overall Study|Progressive disease|2|||
16811065|NCT02431559|37753134|FG001|Overall Study|Progressive disease|1|||
16811066|NCT02431559|37753135|FG002|Overall Study|Progressive disease|4|||
16811067|NCT02431559|37753136|FG003|Overall Study|Progressive disease|22|||
16811068|NCT02431559|37753133|FG000|Overall Study|Withdrawal by Subject|0|||
16811069|NCT02431559|37753134|FG001|Overall Study|Withdrawal by Subject|1|||
16811070|NCT02431559|37753135|FG002|Overall Study|Withdrawal by Subject|0|||
16811071|NCT02431559|37753136|FG003|Overall Study|Withdrawal by Subject|4|||
16811072|NCT02431559|37753133|FG000|Overall Study|Physician Decision|0|||
16811073|NCT02431559|37753134|FG001|Overall Study|Physician Decision|0|||
16811074|NCT02431559|37753135|FG002|Overall Study|Physician Decision|0|||
16811075|NCT02431559|37753136|FG003|Overall Study|Physician Decision|1|||
16811076|NCT02388269|37753150|FG000|Overall Study|Adverse Event|2|||
16811077|NCT02388269|37753151|FG001|Overall Study|Adverse Event|0|||
17016574|NCT01063348|38161213|FG001|Overall Study|Lost to Follow-up|10|||
16811078|NCT02388269|37753152|FG002|Overall Study|Adverse Event|0|||
16811079|NCT02388269|37753150|FG000|Overall Study|Withdrawal by Subject|1|||
16811080|NCT02388269|37753151|FG001|Overall Study|Withdrawal by Subject|2|||
16811081|NCT02388269|37753152|FG002|Overall Study|Withdrawal by Subject|0|||
16811082|NCT02388269|37753150|FG000|Overall Study|less than 50% stimulations|1|||
16811083|NCT02388269|37753151|FG001|Overall Study|less than 50% stimulations|0|||
16811084|NCT02388269|37753152|FG002|Overall Study|less than 50% stimulations|0|||
16811085|NCT02388269|37753150|FG000|Overall Study|no diary data|3|||
16811086|NCT02388269|37753151|FG001|Overall Study|no diary data|0|||
16811087|NCT02388269|37753152|FG002|Overall Study|no diary data|0|||
16811088|NCT02388269|37753150|FG000|Overall Study|Protocol Violation|2|||
16811089|NCT02388269|37753151|FG001|Overall Study|Protocol Violation|0|||
16811090|NCT02388269|37753152|FG002|Overall Study|Protocol Violation|0|||
16811091|NCT02388269|37753150|FG000|Overall Study|Screen Failure|0|||
16811092|NCT02388269|37753151|FG001|Overall Study|Screen Failure|0|||
16811093|NCT02388269|37753152|FG002|Overall Study|Screen Failure|10|||
16811094|NCT01652573|37753178|FG000|Overall Study|Adverse Event|0|||
16811095|NCT01652573|37753179|FG001|Overall Study|Adverse Event|1|||
16811096|NCT02388191|37753187|FG000|Overall Study|Patient did not receive IUD|1|||
16811097|NCT02388191|37753188|FG001|Overall Study|Patient did not receive IUD|0|||
16811098|NCT01815736|37753196|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
16811099|NCT01815736|37753197|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
16811100|NCT01815736|37753196|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
16811101|NCT01815736|37753197|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
16811102|NCT01815736|37753196|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
16811103|NCT01815736|37753197|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
16811104|NCT01815736|37753196|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
16811105|NCT01815736|37753197|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
16811106|NCT01815736|37753196|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
16811107|NCT01815736|37753197|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
16811108|NCT01815736|37753196|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
16811109|NCT01815736|37753197|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
16811110|NCT01815736|37753196|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
16811111|NCT01815736|37753197|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
16811112|NCT01815736|37753196|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
16811113|NCT01815736|37753197|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
16811114|NCT01815736|37753196|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
16811115|NCT01815736|37753197|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
16811116|NCT01815736|37753196|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
16811117|NCT01815736|37753197|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
16811118|NCT01815736|37753196|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
16811119|NCT01815736|37753197|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
16811120|NCT01815736|37753196|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
16811121|NCT01815736|37753197|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
16811122|NCT01815736|37753196|FG000|Extension Treatment Phase- After Week 96|Death|1|||
16811123|NCT01815736|37753197|FG001|Extension Treatment Phase- After Week 96|Death|0|||
16811124|NCT01651949|37753208|FG000|Overall Study|Unknown status|4|||
16811125|NCT01651949|37753209|FG001|Overall Study|Unknown status|4|||
16811126|NCT01651949|37753210|FG002|Overall Study|Unknown status|0|||
16811127|NCT01651949|37753208|FG000|Overall Study|Lost to Follow-up|30|||
16811128|NCT01651949|37753209|FG001|Overall Study|Lost to Follow-up|56|||
16811129|NCT01651949|37753210|FG002|Overall Study|Lost to Follow-up|20|||
16811130|NCT01651949|37753208|FG000|Overall Study|Protocol Violation|0|||
16811131|NCT01651949|37753209|FG001|Overall Study|Protocol Violation|2|||
16811132|NCT01651949|37753210|FG002|Overall Study|Protocol Violation|1|||
16811133|NCT01651949|37753208|FG000|Overall Study|Physician Decision|0|||
16811134|NCT01651949|37753209|FG001|Overall Study|Physician Decision|2|||
16811135|NCT01651949|37753210|FG002|Overall Study|Physician Decision|0|||
16811136|NCT01651949|37753208|FG000|Overall Study|Adverse Event|0|||
16811137|NCT01651949|37753209|FG001|Overall Study|Adverse Event|2|||
16811138|NCT01651949|37753210|FG002|Overall Study|Adverse Event|1|||
16811139|NCT01651949|37753208|FG000|Overall Study|Screen failure|2|||
16811140|NCT01651949|37753209|FG001|Overall Study|Screen failure|2|||
16811141|NCT01651949|37753210|FG002|Overall Study|Screen failure|0|||
16811142|NCT01651949|37753208|FG000|Overall Study|Withdrawal by Subject|17|||
16811143|NCT01651949|37753209|FG001|Overall Study|Withdrawal by Subject|18|||
16811144|NCT01651949|37753210|FG002|Overall Study|Withdrawal by Subject|9|||
16811145|NCT02387957|37753221|FG000|Overall Study|The study was discontinued|21|||
16811146|NCT02387957|37753222|FG001|Overall Study|The study was discontinued|21|||
16811147|NCT02387957|37753223|FG002|Overall Study|The study was discontinued|20|||
16811148|NCT01800916|37753231|FG000|Test Period 1 (1 Week)|Convex product user|0|||
16811149|NCT01800916|37753232|FG001|Test Period 1 (1 Week)|Convex product user|0|||
16811150|NCT01800916|37753233|FG002|Test Period 1 (1 Week)|Convex product user|0|||
16910068|NCT01713582|38018824|FG018|Overall Study|Withdrawal of consent|1|||
16910069|NCT01713582|38018825|FG019|Overall Study|Withdrawal of consent|0|||
16910070|NCT01713582|38018826|FG020|Overall Study|Withdrawal of consent|0|||
16910071|NCT01713582|38018806|FG000|Overall Study|Lack of Efficacy|0|||
16910072|NCT01713582|38018807|FG001|Overall Study|Lack of Efficacy|0|||
16910073|NCT01713582|38018808|FG002|Overall Study|Lack of Efficacy|0|||
16910074|NCT01713582|38018809|FG003|Overall Study|Lack of Efficacy|0|||
16910075|NCT01713582|38018810|FG004|Overall Study|Lack of Efficacy|0|||
16910076|NCT01713582|38018811|FG005|Overall Study|Lack of Efficacy|0|||
16910077|NCT01713582|38018812|FG006|Overall Study|Lack of Efficacy|0|||
16910078|NCT01713582|38018813|FG007|Overall Study|Lack of Efficacy|0|||
16910079|NCT01713582|38018814|FG008|Overall Study|Lack of Efficacy|0|||
16910080|NCT01713582|38018815|FG009|Overall Study|Lack of Efficacy|1|||
16910081|NCT01713582|38018816|FG010|Overall Study|Lack of Efficacy|2|||
16910082|NCT01713582|38018817|FG011|Overall Study|Lack of Efficacy|0|||
16910083|NCT01713582|38018818|FG012|Overall Study|Lack of Efficacy|0|||
16910084|NCT01713582|38018819|FG013|Overall Study|Lack of Efficacy|0|||
16910085|NCT01713582|38018820|FG014|Overall Study|Lack of Efficacy|0|||
16910086|NCT01713582|38018821|FG015|Overall Study|Lack of Efficacy|0|||
16910087|NCT01713582|38018822|FG016|Overall Study|Lack of Efficacy|0|||
16910088|NCT01713582|38018823|FG017|Overall Study|Lack of Efficacy|0|||
16910089|NCT01713582|38018824|FG018|Overall Study|Lack of Efficacy|0|||
16910090|NCT01713582|38018825|FG019|Overall Study|Lack of Efficacy|0|||
16910091|NCT01713582|38018826|FG020|Overall Study|Lack of Efficacy|0|||
16910092|NCT01713582|38018806|FG000|Overall Study|Withdrawal by Subject|0|||
16910093|NCT01713582|38018807|FG001|Overall Study|Withdrawal by Subject|0|||
16910094|NCT01713582|38018808|FG002|Overall Study|Withdrawal by Subject|0|||
16910095|NCT01713582|38018809|FG003|Overall Study|Withdrawal by Subject|0|||
16910096|NCT01713582|38018810|FG004|Overall Study|Withdrawal by Subject|0|||
16910097|NCT01713582|38018811|FG005|Overall Study|Withdrawal by Subject|0|||
16910098|NCT01713582|38018812|FG006|Overall Study|Withdrawal by Subject|0|||
16910099|NCT01713582|38018813|FG007|Overall Study|Withdrawal by Subject|0|||
16910100|NCT01713582|38018814|FG008|Overall Study|Withdrawal by Subject|0|||
16910101|NCT01713582|38018815|FG009|Overall Study|Withdrawal by Subject|0|||
16910102|NCT01713582|38018816|FG010|Overall Study|Withdrawal by Subject|0|||
16910103|NCT01713582|38018817|FG011|Overall Study|Withdrawal by Subject|0|||
16910104|NCT01713582|38018818|FG012|Overall Study|Withdrawal by Subject|0|||
16910105|NCT01713582|38018819|FG013|Overall Study|Withdrawal by Subject|0|||
16910106|NCT01713582|38018820|FG014|Overall Study|Withdrawal by Subject|0|||
16910107|NCT01713582|38018821|FG015|Overall Study|Withdrawal by Subject|0|||
16910108|NCT01713582|38018822|FG016|Overall Study|Withdrawal by Subject|0|||
16910109|NCT01713582|38018823|FG017|Overall Study|Withdrawal by Subject|1|||
16910110|NCT01713582|38018824|FG018|Overall Study|Withdrawal by Subject|0|||
16910111|NCT01713582|38018825|FG019|Overall Study|Withdrawal by Subject|0|||
16910112|NCT01713582|38018826|FG020|Overall Study|Withdrawal by Subject|0|||
16910113|NCT01713582|38018806|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
17198378|NCT02596958|38352060|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
17198379|NCT02596958|38352060|FG000|Overall Study|Administrative Reasons/Other|231|||
16811151|NCT01800916|37753234|FG003|Test Period 1 (1 Week)|Convex product user|1|||
16811152|NCT01800916|37753235|FG004|Test Period 1 (1 Week)|Convex product user|0|||
16811153|NCT01800916|37753236|FG005|Test Period 1 (1 Week)|Convex product user|0|||
16811154|NCT01800916|37753237|FG006|Test Period 1 (1 Week)|Convex product user|0|||
16811155|NCT01800916|37753238|FG007|Test Period 1 (1 Week)|Convex product user|0|||
16811156|NCT01800916|37753239|FG008|Test Period 1 (1 Week)|Convex product user|0|||
16811157|NCT01800916|37753231|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
16811158|NCT01800916|37753232|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
16811159|NCT01800916|37753233|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
16910114|NCT01713582|38018807|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
16910115|NCT01713582|38018808|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
16910116|NCT01713582|38018809|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
16910117|NCT01713582|38018810|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
16910118|NCT01713582|38018811|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
16910119|NCT01713582|38018812|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
16910120|NCT01713582|38018813|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
16910121|NCT01713582|38018814|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
16910122|NCT01713582|38018815|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
16910123|NCT01713582|38018816|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
16910124|NCT01713582|38018817|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
16910125|NCT01713582|38018818|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
16910126|NCT01713582|38018819|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
16910127|NCT01713582|38018820|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
16910128|NCT01713582|38018821|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
17198380|NCT02596958|38352060|FG000|Overall Study|Lost to Follow-up|33|||
16811160|NCT01800916|37753234|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
16811161|NCT01800916|37753235|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
16811162|NCT01800916|37753236|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
16811163|NCT01800916|37753237|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
16811164|NCT01800916|37753238|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
16811165|NCT01800916|37753239|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
16811166|NCT01800058|37753249|FG000|Overall Study|Lost to Follow-up|1|||
16811167|NCT01815580|37753256|FG000|Overall Study|Lost to Follow-up|4|||
16811168|NCT01815580|37753257|FG001|Overall Study|Lost to Follow-up|7|||
16811169|NCT01815580|37753256|FG000|Overall Study|Withdrawal by Subject|3|||
16811170|NCT01815580|37753257|FG001|Overall Study|Withdrawal by Subject|4|||
16811171|NCT01815580|37753256|FG000|Overall Study|Excluded from analysis|5|||
16811172|NCT01815580|37753257|FG001|Overall Study|Excluded from analysis|4|||
16811173|NCT01651403|37753270|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
16811174|NCT01651403|37753271|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
16811175|NCT01651403|37753270|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
16811176|NCT01651403|37753271|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
16811177|NCT01651403|37753270|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
16811178|NCT01651403|37753271|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
16811179|NCT01651403|37753270|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
16811180|NCT01651403|37753271|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
16811181|NCT01651403|37753270|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
16811182|NCT01651403|37753271|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
16811183|NCT01651403|37753270|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
16811184|NCT01651403|37753271|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
16811185|NCT01799590|37753285|FG000|Overall Study|Adverse Event|13|||
16811186|NCT01799590|37753286|FG001|Overall Study|Adverse Event|7|||
16811187|NCT01799590|37753287|FG002|Overall Study|Adverse Event|5|||
16811188|NCT01799590|37753285|FG000|Overall Study|Pregnancy|2|||
16811189|NCT01799590|37753286|FG001|Overall Study|Pregnancy|0|||
16811190|NCT01799590|37753287|FG002|Overall Study|Pregnancy|0|||
16811191|NCT01799590|37753285|FG000|Overall Study|Lack of Efficacy|3|||
16811192|NCT01799590|37753286|FG001|Overall Study|Lack of Efficacy|1|||
16811193|NCT01799590|37753287|FG002|Overall Study|Lack of Efficacy|3|||
16811194|NCT01799590|37753285|FG000|Overall Study|Participants convenience|4|||
16811195|NCT01799590|37753286|FG001|Overall Study|Participants convenience|4|||
16811196|NCT01799590|37753287|FG002|Overall Study|Participants convenience|2|||
16811197|NCT01799590|37753285|FG000|Overall Study|Aggravation of complications|0|||
16811198|NCT01799590|37753286|FG001|Overall Study|Aggravation of complications|1|||
16811199|NCT01799590|37753287|FG002|Overall Study|Aggravation of complications|1|||
16811200|NCT01799590|37753285|FG000|Overall Study|Using drugs with restricted days of use|0|||
16811201|NCT01799590|37753286|FG001|Overall Study|Using drugs with restricted days of use|3|||
16811202|NCT01799590|37753287|FG002|Overall Study|Using drugs with restricted days of use|2|||
16811203|NCT01799590|37753285|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
16811204|NCT01799590|37753286|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
16811205|NCT01799590|37753287|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
16811206|NCT01799590|37753285|FG000|Overall Study|Other|3|||
16811207|NCT01799590|37753286|FG001|Overall Study|Other|0|||
16811208|NCT01799590|37753287|FG002|Overall Study|Other|1|||
16811209|NCT01815424|37753298|FG000|Week 0 to 16|Adverse Event|1|||
16811210|NCT01815424|37753299|FG001|Week 0 to 16|Adverse Event|3|||
16811211|NCT01815424|37753300|FG002|Week 0 to 16|Adverse Event|3|||
16811212|NCT01815424|37753301|FG003|Week 0 to 16|Adverse Event|0|||
16811213|NCT01815424|37753302|FG004|Week 0 to 16|Adverse Event|0|||
16811214|NCT01815424|37753298|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
16811215|NCT01815424|37753299|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
16811216|NCT01815424|37753300|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
16811217|NCT01815424|37753301|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
16811218|NCT01815424|37753302|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
16811219|NCT01815424|37753298|FG000|Week 0 to 16|Lost to Follow-up|0|||
16811220|NCT01815424|37753299|FG001|Week 0 to 16|Lost to Follow-up|1|||
16811221|NCT01815424|37753300|FG002|Week 0 to 16|Lost to Follow-up|0|||
16811222|NCT01815424|37753301|FG003|Week 0 to 16|Lost to Follow-up|0|||
16811223|NCT01815424|37753302|FG004|Week 0 to 16|Lost to Follow-up|0|||
16811224|NCT01815424|37753298|FG000|Week 0 to 16|Withdrawal by Subject|0|||
16811225|NCT01815424|37753299|FG001|Week 0 to 16|Withdrawal by Subject|0|||
16811226|NCT01815424|37753300|FG002|Week 0 to 16|Withdrawal by Subject|1|||
16811227|NCT01815424|37753301|FG003|Week 0 to 16|Withdrawal by Subject|0|||
16811228|NCT01815424|37753302|FG004|Week 0 to 16|Withdrawal by Subject|0|||
16811229|NCT01815424|37753298|FG000|Week 0 to 16|Other|1|||
16811230|NCT01815424|37753299|FG001|Week 0 to 16|Other|0|||
16811231|NCT01815424|37753300|FG002|Week 0 to 16|Other|3|||
16811232|NCT01815424|37753301|FG003|Week 0 to 16|Other|0|||
16811233|NCT01815424|37753302|FG004|Week 0 to 16|Other|0|||
16811234|NCT01815424|37753298|FG000|Week 0 to 16|Protocol Violation|1|||
16811235|NCT01815424|37753299|FG001|Week 0 to 16|Protocol Violation|0|||
16811236|NCT01815424|37753300|FG002|Week 0 to 16|Protocol Violation|0|||
16811237|NCT01815424|37753301|FG003|Week 0 to 16|Protocol Violation|0|||
16811238|NCT01815424|37753302|FG004|Week 0 to 16|Protocol Violation|0|||
16811239|NCT01815424|37753298|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
16811240|NCT01815424|37753299|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
16811241|NCT01815424|37753300|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
16811242|NCT01815424|37753301|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
16811243|NCT01815424|37753302|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
16811244|NCT01815424|37753298|FG000|Week 16 to 52|Other|0|||
16811245|NCT01815424|37753299|FG001|Week 16 to 52|Other|1|||
16811246|NCT01815424|37753300|FG002|Week 16 to 52|Other|0|||
16811247|NCT01815424|37753301|FG003|Week 16 to 52|Other|0|||
16811248|NCT01815424|37753302|FG004|Week 16 to 52|Other|0|||
16811249|NCT01815424|37753298|FG000|Week 16 to 52|Adverse Event|0|||
16811250|NCT01815424|37753299|FG001|Week 16 to 52|Adverse Event|0|||
16811251|NCT01815424|37753300|FG002|Week 16 to 52|Adverse Event|0|||
16811252|NCT01815424|37753301|FG003|Week 16 to 52|Adverse Event|0|||
16811253|NCT01815424|37753302|FG004|Week 16 to 52|Adverse Event|1|||
16811254|NCT01815424|37753298|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
16811255|NCT01815424|37753299|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
16811256|NCT01815424|37753300|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
16811257|NCT01815424|37753301|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
16811258|NCT01815424|37753302|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
16811259|NCT01815424|37753298|FG000|Week 16 to 52|Lost to Follow-up|0|||
16811260|NCT01815424|37753299|FG001|Week 16 to 52|Lost to Follow-up|2|||
16811261|NCT01815424|37753300|FG002|Week 16 to 52|Lost to Follow-up|0|||
16811262|NCT01815424|37753301|FG003|Week 16 to 52|Lost to Follow-up|2|||
16811263|NCT01815424|37753302|FG004|Week 16 to 52|Lost to Follow-up|1|||
16811264|NCT01815424|37753298|FG000|Week 16 to 52|Withdrawal by Subject|1|||
16811265|NCT01815424|37753299|FG001|Week 16 to 52|Withdrawal by Subject|2|||
16811266|NCT01815424|37753300|FG002|Week 16 to 52|Withdrawal by Subject|0|||
16811267|NCT01815424|37753301|FG003|Week 16 to 52|Withdrawal by Subject|0|||
16811268|NCT01815424|37753302|FG004|Week 16 to 52|Withdrawal by Subject|0|||
16811269|NCT02431247|37753317|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
16811270|NCT02431247|37753318|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
16811271|NCT02431247|37753319|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
16811272|NCT02431247|37753317|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
16811273|NCT02431247|37753318|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
16811274|NCT02431247|37753319|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
16811275|NCT02431247|37753317|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
16811276|NCT02431247|37753318|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
16811277|NCT02431247|37753319|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
16811278|NCT02431247|37753317|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
16811279|NCT02431247|37753318|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
16811280|NCT02431247|37753319|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
16811281|NCT02431247|37753317|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
16811282|NCT02431247|37753318|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
16811283|NCT02431247|37753319|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
16811284|NCT02431247|37753317|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
16811285|NCT02431247|37753318|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
16811286|NCT02431247|37753319|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
16811287|NCT02431247|37753317|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
16811288|NCT02431247|37753318|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
16811289|NCT02431247|37753319|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
16811290|NCT02431247|37753317|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
16811291|NCT02431247|37753318|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
16811292|NCT02431247|37753319|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
16811293|NCT02431247|37753317|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
16811294|NCT02431247|37753318|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
16811295|NCT02431247|37753319|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
16811296|NCT02431247|37753317|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
16811297|NCT02431247|37753318|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
16910129|NCT01713582|38018822|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
16811298|NCT02431247|37753319|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
16811299|NCT02431247|37753317|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
16811300|NCT02431247|37753318|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
16811301|NCT02431247|37753319|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
16811302|NCT02431247|37753317|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
16811303|NCT02431247|37753318|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
16811304|NCT02431247|37753319|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
16811305|NCT02431247|37753317|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
16811306|NCT02431247|37753318|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
16811307|NCT02431247|37753319|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
16811308|NCT02431247|37753317|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
16811309|NCT02431247|37753318|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
16811310|NCT02431247|37753319|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
16811311|NCT01814878|37753333|FG000|Overall Study|Adverse Event|16|||
16811312|NCT01814878|37753334|FG001|Overall Study|Adverse Event|5|||
16811313|NCT01814878|37753333|FG000|Overall Study|Withdrawal by Subject|20|||
16811314|NCT01814878|37753334|FG001|Overall Study|Withdrawal by Subject|16|||
16811315|NCT01814878|37753333|FG000|Overall Study|Protocol Violation|5|||
16811316|NCT01814878|37753334|FG001|Overall Study|Protocol Violation|5|||
16811317|NCT01814878|37753333|FG000|Overall Study|Physician Decision|3|||
16811318|NCT01814878|37753334|FG001|Overall Study|Physician Decision|1|||
16811319|NCT01814878|37753333|FG000|Overall Study|Screening failure (drop-out)|0|||
16811320|NCT01814878|37753334|FG001|Overall Study|Screening failure (drop-out)|3|||
16811321|NCT01814878|37753333|FG000|Overall Study|Other|2|||
16811322|NCT01814878|37753334|FG001|Overall Study|Other|0|||
16811323|NCT02407457|37753342|FG000|1 Month|Death|3|||
16811324|NCT02407457|37753343|FG001|1 Month|Death|0|||
16811325|NCT02407457|37753342|FG000|1 Month|Lost to Follow-up|1|||
16811326|NCT02407457|37753343|FG001|1 Month|Lost to Follow-up|1|||
16811327|NCT02407457|37753342|FG000|1 Month|missed visit|2|||
16811328|NCT02407457|37753343|FG001|1 Month|missed visit|6|||
16811329|NCT02407457|37753342|FG000|6-Month|Death|2|||
16811330|NCT02407457|37753343|FG001|6-Month|Death|8|||
16811331|NCT02407457|37753342|FG000|6-Month|Lost to Follow-up|2|||
16811332|NCT02407457|37753343|FG001|6-Month|Lost to Follow-up|2|||
16811333|NCT02407457|37753342|FG000|6-Month|missed visit|15|||
16811334|NCT02407457|37753343|FG001|6-Month|missed visit|12|||
16811335|NCT02407457|37753342|FG000|6-Month|Over Due|1|||
16811336|NCT02407457|37753343|FG001|6-Month|Over Due|2|||
16811337|NCT02407457|37753342|FG000|6-Month|Open Repair|0|||
16811338|NCT02407457|37753343|FG001|6-Month|Open Repair|1|||
16811339|NCT02407457|37753342|FG000|1 Year|Death|6|||
16811340|NCT02407457|37753343|FG001|1 Year|Death|11|||
16811341|NCT02407457|37753342|FG000|1 Year|Lost to Follow-up|3|||
16811342|NCT02407457|37753343|FG001|1 Year|Lost to Follow-up|2|||
16811343|NCT02407457|37753342|FG000|1 Year|Missed Visit|18|||
16811344|NCT02407457|37753343|FG001|1 Year|Missed Visit|10|||
16811345|NCT02407457|37753342|FG000|1 Year|Over Due|6|||
16811346|NCT02407457|37753343|FG001|1 Year|Over Due|4|||
16811347|NCT02407457|37753342|FG000|1 Year|Open Repair|0|||
16811348|NCT02407457|37753343|FG001|1 Year|Open Repair|1|||
16811349|NCT02407457|37753342|FG000|2-year|Death|14|||
16811350|NCT02407457|37753343|FG001|2-year|Death|8|||
16811351|NCT02407457|37753342|FG000|2-year|Lost to Follow-up|6|||
16811352|NCT02407457|37753343|FG001|2-year|Lost to Follow-up|9|||
16811353|NCT02407457|37753342|FG000|2-year|Missed Visit|13|||
16811354|NCT02407457|37753343|FG001|2-year|Missed Visit|11|||
16811355|NCT02407457|37753342|FG000|2-year|Over Due|1|||
16811356|NCT02407457|37753343|FG001|2-year|Over Due|5|||
16811357|NCT02407457|37753342|FG000|2-year|Open Repair|0|||
16811358|NCT02407457|37753343|FG001|2-year|Open Repair|2|||
16811359|NCT02407457|37753342|FG000|3-year|Death|11|||
16811360|NCT02407457|37753343|FG001|3-year|Death|10|||
16811361|NCT02407457|37753342|FG000|3-year|Lost to Follow-up|6|||
16811362|NCT02407457|37753343|FG001|3-year|Lost to Follow-up|9|||
16811363|NCT02407457|37753342|FG000|3-year|Missed Visit|21|||
16811364|NCT02407457|37753343|FG001|3-year|Missed Visit|16|||
16811365|NCT02407457|37753342|FG000|3-year|Over Due|4|||
16811366|NCT02407457|37753343|FG001|3-year|Over Due|3|||
16811367|NCT02407457|37753342|FG000|4-year|Death|14|||
16811368|NCT02407457|37753343|FG001|4-year|Death|7|||
16811369|NCT02407457|37753342|FG000|4-year|Lost to Follow-up|9|||
16811370|NCT02407457|37753343|FG001|4-year|Lost to Follow-up|12|||
16811371|NCT02407457|37753342|FG000|4-year|Over Due|10|||
16811372|NCT02407457|37753343|FG001|4-year|Over Due|5|||
16811373|NCT02407457|37753342|FG000|4-year|Missed Visit|13|||
16811374|NCT02407457|37753343|FG001|4-year|Missed Visit|13|||
16811375|NCT02407457|37753342|FG000|4-year|Pending visit|19|||
16811376|NCT02407457|37753343|FG001|4-year|Pending visit|14|||
16811377|NCT02407457|37753342|FG000|4-year|Not Due|16|||
16811378|NCT02407457|37753343|FG001|4-year|Not Due|10|||
16811379|NCT02407457|37753342|FG000|5-year|Death|6|||
16811380|NCT02407457|37753343|FG001|5-year|Death|1|||
16811381|NCT02407457|37753342|FG000|5-year|Lost to Follow-up|4|||
16811382|NCT02407457|37753343|FG001|5-year|Lost to Follow-up|4|||
16811383|NCT02407457|37753342|FG000|5-year|Missed Visit|10|||
16811384|NCT02407457|37753343|FG001|5-year|Missed Visit|9|||
16811385|NCT02407457|37753342|FG000|5-year|Pending Visit|18|||
16811386|NCT02407457|37753343|FG001|5-year|Pending Visit|17|||
16811387|NCT02407457|37753342|FG000|5-year|Not Due|54|||
16811388|NCT02407457|37753343|FG001|5-year|Not Due|46|||
16811389|NCT01814800|37753349|FG000|Overall Study|Adverse Event|2|||
16811390|NCT01814800|37753349|FG000|Overall Study|Pregnancy|1|||
16811391|NCT01814800|37753349|FG000|Overall Study|Sponsor decision|1|||
16811392|NCT01814800|37753349|FG000|Overall Study|Subject relocation|1|||
16811393|NCT01814332|37753355|FG000|Overall Study|Adverse Event|8|||
16811394|NCT01814332|37753356|FG001|Overall Study|Adverse Event|3|||
16811395|NCT01814332|37753355|FG000|Overall Study|Withdrawal by Subject|3|||
16811396|NCT01814332|37753356|FG001|Overall Study|Withdrawal by Subject|8|||
16811397|NCT01814332|37753355|FG000|Overall Study|Protocol Violation|0|||
16811398|NCT01814332|37753356|FG001|Overall Study|Protocol Violation|4|||
16811399|NCT01814332|37753355|FG000|Overall Study|Lost to Follow-up|5|||
16811400|NCT01814332|37753356|FG001|Overall Study|Lost to Follow-up|1|||
16811401|NCT02407223|37753365|FG000|Overall Study|Adverse Event|1|||
16811402|NCT02407223|37753366|FG001|Overall Study|Adverse Event|0|||
16811403|NCT02407223|37753367|FG002|Overall Study|Adverse Event|1|||
16811404|NCT02407223|37753365|FG000|Overall Study|Lack of Efficacy|6|||
16811405|NCT02407223|37753366|FG001|Overall Study|Lack of Efficacy|6|||
16811406|NCT02407223|37753367|FG002|Overall Study|Lack of Efficacy|4|||
16811407|NCT02407223|37753365|FG000|Overall Study|Lost to Follow-up|1|||
16811408|NCT02407223|37753366|FG001|Overall Study|Lost to Follow-up|0|||
16811409|NCT02407223|37753367|FG002|Overall Study|Lost to Follow-up|2|||
16811410|NCT02407223|37753365|FG000|Overall Study|Withdrawal by Subject|2|||
16811411|NCT02407223|37753366|FG001|Overall Study|Withdrawal by Subject|4|||
16811412|NCT02407223|37753367|FG002|Overall Study|Withdrawal by Subject|4|||
16811413|NCT02407223|37753365|FG000|Overall Study|Study Terminated by Sponsor|77|||
16811414|NCT02407223|37753366|FG001|Overall Study|Study Terminated by Sponsor|80|||
16811415|NCT02407223|37753367|FG002|Overall Study|Study Terminated by Sponsor|86|||
16811416|NCT02407223|37753365|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
16811417|NCT02407223|37753366|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
16811418|NCT02407223|37753367|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
16811419|NCT02407223|37753365|FG000|Overall Study|Other|29|||
16811420|NCT02407223|37753366|FG001|Overall Study|Other|27|||
16811421|NCT02407223|37753367|FG002|Overall Study|Other|25|||
16811422|NCT01797562|37753377|FG000|Overall Study|Protocol Violation|5|||
16811423|NCT01813474|37753385|FG000|Overall Study|Withdrawal by Subject|0|||
16811424|NCT01813474|37753386|FG001|Overall Study|Withdrawal by Subject|0|||
16811425|NCT01813474|37753387|FG002|Overall Study|Withdrawal by Subject|1|||
16811426|NCT01813474|37753385|FG000|Overall Study|Adverse Event|1|||
16811427|NCT01813474|37753386|FG001|Overall Study|Adverse Event|1|||
16811428|NCT01813474|37753387|FG002|Overall Study|Adverse Event|0|||
16811429|NCT01813474|37753385|FG000|Overall Study|Lack of Efficacy|2|||
16811430|NCT01813474|37753386|FG001|Overall Study|Lack of Efficacy|6|||
16811431|NCT01813474|37753387|FG002|Overall Study|Lack of Efficacy|9|||
16811432|NCT01813474|37753385|FG000|Overall Study|Death|0|||
16811433|NCT01813474|37753386|FG001|Overall Study|Death|0|||
16811434|NCT01813474|37753387|FG002|Overall Study|Death|1|||
16811435|NCT01868542|37753398|FG000|Overall Study|Protocol Violation|0|||
16811436|NCT01868542|37753399|FG001|Overall Study|Protocol Violation|1|||
16811437|NCT01868542|37753398|FG000|Overall Study|Unclassified|0|||
16811438|NCT01868542|37753399|FG001|Overall Study|Unclassified|1|||
16811439|NCT01797094|37753407|FG000|Overall Study|Adverse Event|1|||
16811440|NCT01797094|37753408|FG001|Overall Study|Adverse Event|1|||
16811441|NCT01797094|37753407|FG000|Overall Study|Personal Reasons|4|||
16811442|NCT01797094|37753408|FG001|Overall Study|Personal Reasons|0|||
16811443|NCT01797094|37753407|FG000|Overall Study|Protocol Violation|0|||
16811444|NCT01797094|37753408|FG001|Overall Study|Protocol Violation|1|||
16811445|NCT01797094|37753407|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16811446|NCT01797094|37753408|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16811447|NCT02383589|37753416|FG000|Treatment Period|Adverse Event|1|||
16811448|NCT02383589|37753417|FG001|Treatment Period|Adverse Event|3|||
16811449|NCT02383589|37753416|FG000|Treatment Period|Lost to Follow-up|0|||
16811450|NCT02383589|37753417|FG001|Treatment Period|Lost to Follow-up|1|||
16811451|NCT02383589|37753416|FG000|Treatment Period|Withdrawal by Subject|0|||
16811452|NCT02383589|37753417|FG001|Treatment Period|Withdrawal by Subject|5|||
16811453|NCT02383589|37753416|FG000|Treatment Period|Non-compliance with study drug|0|||
16811454|NCT02383589|37753417|FG001|Treatment Period|Non-compliance with study drug|1|||
16811455|NCT02383589|37753416|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
16811456|NCT02383589|37753417|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
16811457|NCT02383589|37753416|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
16811458|NCT02383589|37753417|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
16811459|NCT02383589|37753416|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
16811460|NCT02383589|37753417|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
16811461|NCT01810432|37753425|FG000|Washout|Protocol Violation|0|||
16811462|NCT01810432|37753426|FG001|Washout|Protocol Violation|1|||
16811463|NCT01810432|37753425|FG000|Washout|Adverse Event|1|||
16811464|NCT01810432|37753426|FG001|Washout|Adverse Event|0|||
16811465|NCT01810432|37753425|FG000|Period 2|Withdrawal by Subject|2|||
16811466|NCT01810432|37753426|FG001|Period 2|Withdrawal by Subject|1|||
16811467|NCT01810432|37753425|FG000|Period 2|Physician Decision|1|||
16811468|NCT01810432|37753426|FG001|Period 2|Physician Decision|0|||
16811469|NCT01810432|37753425|FG000|Period 2|Lost to Follow-up|1|||
16811470|NCT01810432|37753426|FG001|Period 2|Lost to Follow-up|1|||
16811471|NCT01796860|37753432|FG000|Overall Study|Withdrawal by Subject|3|||
16811472|NCT01796548|37753436|FG000|Overall Study|Lost to Follow-up|1|||
16811473|NCT01796548|37753436|FG000|Overall Study|Other|2|||
16811474|NCT02406677|37753442|FG000|Overall Study|Death|16|||
16811475|NCT02406677|37753443|FG001|Overall Study|Death|8|||
16811476|NCT02406677|37753442|FG000|Overall Study|Discharged without P2Y12|1|||
16811477|NCT02406677|37753443|FG001|Overall Study|Discharged without P2Y12|3|||
16811478|NCT02406677|37753442|FG000|Overall Study|Discharged on prasugrel|283|||
16811479|NCT02406677|37753443|FG001|Overall Study|Discharged on prasugrel|587|||
16811480|NCT02406677|37753442|FG000|Overall Study|Withdrawal by Subject|1|||
16811481|NCT02406677|37753443|FG001|Overall Study|Withdrawal by Subject|0|||
16811482|NCT02404805|37753459|FG000|Overall Study|Withdrawal by Subject|1|||
16811483|NCT02404805|37753460|FG001|Overall Study|Withdrawal by Subject|0|||
16811484|NCT02404805|37753461|FG002|Overall Study|Withdrawal by Subject|0|||
16811485|NCT02404805|37753462|FG003|Overall Study|Withdrawal by Subject|0|||
16811486|NCT02404805|37753463|FG004|Overall Study|Withdrawal by Subject|0|||
16811487|NCT02404805|37753464|FG005|Overall Study|Withdrawal by Subject|0|||
16811488|NCT02430311|37753475|FG000|Part A|Adverse Event|0|||
16811489|NCT02430311|37753476|FG001|Part A|Adverse Event|1|||
16811490|NCT02430311|37753475|FG000|Part A|Withdrawal by Subject|1|||
16811491|NCT02430311|37753476|FG001|Part A|Withdrawal by Subject|0|||
16811492|NCT02430311|37753475|FG000|Part B|Meet study-specific withdrawal criteria|6|||
16811493|NCT02430311|37753476|FG001|Part B|Meet study-specific withdrawal criteria|6|||
16811494|NCT02430311|37753475|FG000|Part B|Withdrawal by Subject|2|||
16811495|NCT02430311|37753476|FG001|Part B|Withdrawal by Subject|2|||
16811496|NCT02430311|37753475|FG000|Part B|Adverse Event|1|||
16811497|NCT02430311|37753476|FG001|Part B|Adverse Event|0|||
16811498|NCT02430311|37753475|FG000|Part B|Death|1|||
16811499|NCT02430311|37753476|FG001|Part B|Death|0|||
16811500|NCT02383433|37753491|FG000|Overall Study|Disease progression|2|||
16811501|NCT02404649|37753497|FG000|Overall Study|Adverse Event|1|||
16811502|NCT02404649|37753498|FG001|Overall Study|Adverse Event|2|||
16811503|NCT02383355|37753506|FG000|Overall Study|Adverse Event|2|||
16811504|NCT02383355|37753507|FG001|Overall Study|Adverse Event|0|||
16811505|NCT02381795|37753513|FG000|Overall Study|Withdrawal by Subject|1|||
16811506|NCT02381795|37753513|FG000|Overall Study|Study Terminated|2|||
16811507|NCT02404493|37753519|FG000|Overall Study|Adverse Event|1|||
16811508|NCT02404493|37753520|FG001|Overall Study|Adverse Event|1|||
16811509|NCT02380859|37753528|FG000|Overall Study|Withdrawal by Subject|2|||
16811510|NCT02380859|37753529|FG001|Overall Study|Withdrawal by Subject|0|||
16811511|NCT02380703|37753537|FG000|Overall Study|Withdrawal by Subject|12|||
16811512|NCT02380703|37753538|FG001|Overall Study|Withdrawal by Subject|9|||
16811513|NCT02380703|37753537|FG000|Overall Study|Lost to Follow-up|12|||
16811514|NCT02380703|37753538|FG001|Overall Study|Lost to Follow-up|12|||
16811515|NCT02380703|37753537|FG000|Overall Study|Caregiver death|1|||
16811516|NCT02380703|37753538|FG001|Overall Study|Caregiver death|0|||
16811517|NCT02380703|37753537|FG000|Overall Study|Person with dementia (PWD) death|7|||
16811518|NCT02380703|37753538|FG001|Overall Study|Person with dementia (PWD) death|8|||
16811519|NCT02380703|37753537|FG000|Overall Study|Entered Long-term Care|4|||
16811520|NCT02380703|37753538|FG001|Overall Study|Entered Long-term Care|7|||
16811521|NCT02379923|37753544|FG000|Overall Study|Death|5|||
16811522|NCT02379221|37753551|FG000|Overall Study|Lost to Follow-up|1|||
16811523|NCT02404103|37753562|FG000|Overall Study|Adverse Event|1|||
16811524|NCT02404103|37753563|FG001|Overall Study|Adverse Event|0|||
16811525|NCT02404103|37753562|FG000|Overall Study|Lost to Follow-up|3|||
16811526|NCT02404103|37753563|FG001|Overall Study|Lost to Follow-up|3|||
16811527|NCT02404025|37753579|FG000|Overall Study|Adverse Event|1|||
16811528|NCT02404025|37753579|FG000|Overall Study|Lack of Efficacy|3|||
16811529|NCT02377817|37753585|FG000|Overall Study|Transportation/childcare barriers.|2|||
16811530|NCT02377817|37753586|FG001|Overall Study|Transportation/childcare barriers.|0|||
16811531|NCT02377817|37753585|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
16811532|NCT02377817|37753586|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
16811533|NCT02403635|37753594|FG000|Overall Study|Not eligible|9|||
17198381|NCT02596958|38352060|FG000|Overall Study|Missing|32|||
16811534|NCT02402933|37753614|FG000|Overall Study|Withdrawal by Subject|4|||
16811535|NCT02402933|37753614|FG000|Overall Study|Discontinued; Site Termination|10|||
16811536|NCT01796470|37753623|FG000|Overall Study|Adverse Event|4|||
16811537|NCT01796470|37753624|FG001|Overall Study|Adverse Event|2|||
16811538|NCT01796470|37753625|FG002|Overall Study|Adverse Event|2|||
16811539|NCT01796470|37753626|FG003|Overall Study|Adverse Event|1|||
16811540|NCT01796470|37753627|FG004|Overall Study|Adverse Event|3|||
16811541|NCT01796470|37753623|FG000|Overall Study|Death|2|||
16811542|NCT01796470|37753624|FG001|Overall Study|Death|0|||
16811543|NCT01796470|37753625|FG002|Overall Study|Death|0|||
16811544|NCT01796470|37753626|FG003|Overall Study|Death|0|||
16811545|NCT01796470|37753627|FG004|Overall Study|Death|1|||
16811546|NCT01796470|37753623|FG000|Overall Study|Initiated New Therapy|9|||
16811547|NCT01796470|37753624|FG001|Overall Study|Initiated New Therapy|0|||
16811548|NCT01796470|37753625|FG002|Overall Study|Initiated New Therapy|0|||
16811549|NCT01796470|37753626|FG003|Overall Study|Initiated New Therapy|0|||
16811550|NCT01796470|37753627|FG004|Overall Study|Initiated New Therapy|2|||
16811551|NCT01796470|37753623|FG000|Overall Study|Lost to Follow-up|0|||
17198382|NCT02596958|38352060|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
16811552|NCT01796470|37753624|FG001|Overall Study|Lost to Follow-up|1|||
16811553|NCT01796470|37753625|FG002|Overall Study|Lost to Follow-up|0|||
16811554|NCT01796470|37753626|FG003|Overall Study|Lost to Follow-up|0|||
16811555|NCT01796470|37753627|FG004|Overall Study|Lost to Follow-up|0|||
16811556|NCT01796470|37753623|FG000|Overall Study|Physician Decision|5|||
16811557|NCT01796470|37753624|FG001|Overall Study|Physician Decision|4|||
16811558|NCT01796470|37753625|FG002|Overall Study|Physician Decision|1|||
16811559|NCT01796470|37753626|FG003|Overall Study|Physician Decision|0|||
16811560|NCT01796470|37753627|FG004|Overall Study|Physician Decision|1|||
16811561|NCT01796470|37753623|FG000|Overall Study|Progressive Disease|7|||
16811562|NCT01796470|37753624|FG001|Overall Study|Progressive Disease|7|||
16811563|NCT01796470|37753625|FG002|Overall Study|Progressive Disease|3|||
16811564|NCT01796470|37753626|FG003|Overall Study|Progressive Disease|2|||
16811565|NCT01796470|37753627|FG004|Overall Study|Progressive Disease|0|||
16811566|NCT01796470|37753623|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
16811567|NCT01796470|37753624|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
16811568|NCT01796470|37753625|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
16811569|NCT01796470|37753626|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
16811570|NCT01796470|37753627|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
16811571|NCT01796470|37753623|FG000|Overall Study|Withdrawal by Subject|7|||
16811572|NCT01796470|37753624|FG001|Overall Study|Withdrawal by Subject|0|||
16811573|NCT01796470|37753625|FG002|Overall Study|Withdrawal by Subject|0|||
16811574|NCT01796470|37753626|FG003|Overall Study|Withdrawal by Subject|0|||
16811575|NCT01796470|37753627|FG004|Overall Study|Withdrawal by Subject|1|||
16811576|NCT01796392|37753645|FG000|Overall Study|Withdrawal by Subject|2|||
16811577|NCT01796392|37753646|FG001|Overall Study|Withdrawal by Subject|0|||
16811578|NCT01796392|37753645|FG000|Overall Study|Death|5|||
16811579|NCT01796392|37753646|FG001|Overall Study|Death|1|||
16811580|NCT01796392|37753645|FG000|Overall Study|Excluded for medical reasons|1|||
16811581|NCT01796392|37753646|FG001|Overall Study|Excluded for medical reasons|2|||
16811582|NCT01796392|37753645|FG000|Overall Study|Lost to Follow-up|1|||
16811583|NCT01796392|37753646|FG001|Overall Study|Lost to Follow-up|0|||
16811584|NCT01868074|37753654|FG000|Overall Study|Lost to Follow-up|3|||
16811585|NCT01868074|37753655|FG001|Overall Study|Lost to Follow-up|2|||
16811586|NCT01868074|37753654|FG000|Overall Study|Withdrawal by Subject|4|||
16811587|NCT01868074|37753655|FG001|Overall Study|Withdrawal by Subject|2|||
16811588|NCT01810042|37753661|FG000|Overall Study|Lost to Follow-up|10|||
16811589|NCT02424539|37753668|FG000|Overall Study|Adverse Event|0|||
16811590|NCT02424539|37753669|FG001|Overall Study|Adverse Event|0|||
16811591|NCT02424539|37753670|FG002|Overall Study|Adverse Event|1|||
16811592|NCT02424539|37753668|FG000|Overall Study|Physician Decision|0|||
16811593|NCT02424539|37753669|FG001|Overall Study|Physician Decision|0|||
16811594|NCT02424539|37753670|FG002|Overall Study|Physician Decision|1|||
16811595|NCT02424539|37753668|FG000|Overall Study|Withdrawal by Subject|3|||
16811596|NCT02424539|37753669|FG001|Overall Study|Withdrawal by Subject|1|||
16811597|NCT02424539|37753670|FG002|Overall Study|Withdrawal by Subject|0|||
16811598|NCT02424539|37753668|FG000|Overall Study|Other: Reached stopping criteria|11|||
16811599|NCT02424539|37753669|FG001|Overall Study|Other: Reached stopping criteria|7|||
16811600|NCT02424539|37753670|FG002|Overall Study|Other: Reached stopping criteria|6|||
16811601|NCT01809262|37753678|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811602|NCT01809262|37753679|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811603|NCT01809262|37753680|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811604|NCT01809262|37753681|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811605|NCT01809262|37753682|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
16811606|NCT01809262|37753683|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811607|NCT01809262|37753684|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811608|NCT01809262|37753685|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811609|NCT01809262|37753686|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811610|NCT01809262|37753687|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
16811611|NCT01809262|37753678|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811612|NCT01809262|37753679|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
16811613|NCT01809262|37753680|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811614|NCT01809262|37753681|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811615|NCT01809262|37753682|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811616|NCT01809262|37753683|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811617|NCT01809262|37753684|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811618|NCT01809262|37753685|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811619|NCT01809262|37753686|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811620|NCT01809262|37753687|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16811621|NCT01808248|37753701|FG000|Overall Study|Lack of Efficacy|3|||
16811622|NCT01808248|37753701|FG000|Overall Study|Withdrawal by Subject|1|||
16811623|NCT01808248|37753701|FG000|Overall Study|Lost to Follow-up|1|||
16811624|NCT02424383|37753707|FG000|Overall Study|Withdrawal by Subject|32|||
16811625|NCT02424383|37753707|FG000|Overall Study|Death|170|||
16811626|NCT02424383|37753707|FG000|Overall Study|Sponsor's decision|3|||
17016575|NCT00855062|38161221|FG000|Step1|Early Study Closure|5|||
16811627|NCT02424383|37753707|FG000|Overall Study|Investigator's decision|44|||
16811628|NCT02424383|37753707|FG000|Overall Study|Lost to Follow-up|81|||
16811629|NCT02424383|37753707|FG000|Overall Study|Other|7|||
16811630|NCT02424383|37753707|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
16811631|NCT01867294|37753715|FG000|Overall Study|Withdrawal by Subject|1|||
16811632|NCT01867294|37753716|FG001|Overall Study|Withdrawal by Subject|1|||
16811633|NCT01867294|37753717|FG002|Overall Study|Withdrawal by Subject|0|||
16811634|NCT01867294|37753718|FG003|Overall Study|Withdrawal by Subject|0|||
16811635|NCT02424149|37753728|FG000|Overall Study|surgery cancelled|2|||
16811636|NCT02424149|37753729|FG001|Overall Study|surgery cancelled|0|||
16811637|NCT02424149|37753728|FG000|Overall Study|Withdrawal by Subject|0|||
16811638|NCT02424149|37753729|FG001|Overall Study|Withdrawal by Subject|1|||
16811639|NCT02423291|37753735|FG000|Overall Study|Lack of Efficacy|14|||
16811640|NCT02423291|37753735|FG000|Overall Study|Adverse Event|1|||
16811641|NCT02401529|37753741|FG000|Overall Study|Lost to Follow-up|2|||
16811642|NCT02401529|37753742|FG001|Overall Study|Lost to Follow-up|1|||
16811643|NCT02401529|37753741|FG000|Overall Study|Physician Decision|2|||
16811644|NCT02401529|37753742|FG001|Overall Study|Physician Decision|6|||
16811645|NCT02401529|37753741|FG000|Overall Study|Protocol Violation|5|||
16811646|NCT02401529|37753742|FG001|Overall Study|Protocol Violation|0|||
16811647|NCT01867216|37753756|FG000|Overall Study|Withdrawal by Subject|2|||
16811648|NCT01867216|37753757|FG001|Overall Study|Withdrawal by Subject|0|||
16811649|NCT01867216|37753758|FG002|Overall Study|Withdrawal by Subject|0|||
16811650|NCT01867216|37753759|FG003|Overall Study|Withdrawal by Subject|0|||
16811651|NCT01867216|37753760|FG004|Overall Study|Withdrawal by Subject|1|||
16811652|NCT01867216|37753761|FG005|Overall Study|Withdrawal by Subject|0|||
16811653|NCT01867216|37753762|FG006|Overall Study|Withdrawal by Subject|1|||
16811654|NCT01867216|37753756|FG000|Overall Study|Physician Decision|1|||
16811655|NCT01867216|37753757|FG001|Overall Study|Physician Decision|0|||
16811656|NCT01867216|37753758|FG002|Overall Study|Physician Decision|0|||
16811657|NCT01867216|37753759|FG003|Overall Study|Physician Decision|0|||
16811658|NCT01867216|37753760|FG004|Overall Study|Physician Decision|0|||
16811659|NCT01867216|37753761|FG005|Overall Study|Physician Decision|0|||
16811660|NCT01867216|37753762|FG006|Overall Study|Physician Decision|0|||
16811661|NCT01867216|37753756|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
16811662|NCT01867216|37753757|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16811663|NCT01867216|37753758|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16811664|NCT01867216|37753759|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16811665|NCT01867216|37753760|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16811666|NCT01867216|37753761|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16811667|NCT01867216|37753762|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16811668|NCT01866826|37753784|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
16811669|NCT01866826|37753785|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
16811670|NCT01866826|37753784|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
16811671|NCT01866826|37753785|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
16811672|NCT01866826|37753784|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
16811673|NCT01866826|37753785|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
16811674|NCT01791244|37753802|FG000|Overall Study|Adverse Event|5|||
16811675|NCT01791244|37753803|FG001|Overall Study|Adverse Event|7|||
16811676|NCT01791244|37753802|FG000|Overall Study|Insufficient clinical response|10|||
16811677|NCT01791244|37753803|FG001|Overall Study|Insufficient clinical response|10|||
16811678|NCT01791244|37753802|FG000|Overall Study|Laboratory Abnormality|0|||
16811679|NCT01791244|37753803|FG001|Overall Study|Laboratory Abnormality|1|||
16811680|NCT01865812|37753811|FG000|Primary Treatment Phase|Adverse Event|2|||
16811681|NCT01865812|37753812|FG001|Primary Treatment Phase|Adverse Event|0|||
16811682|NCT01865812|37753811|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
16811683|NCT01865812|37753812|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
16811684|NCT01865812|37753811|FG000|Long-term Safety Extension Phase|Pruritus|0|||
16811685|NCT01865812|37753812|FG001|Long-term Safety Extension Phase|Pruritus|3|||
16811686|NCT01865812|37753811|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
16811687|NCT01865812|37753812|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
16811688|NCT01865812|37753811|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
16811689|NCT01865812|37753812|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
16811690|NCT01808092|37753821|FG000|Overall Study|Death|39|||
16811691|NCT01808092|37753822|FG001|Overall Study|Death|29|||
16811692|NCT01808092|37753821|FG000|Overall Study|Lost to Follow-up|3|||
16811693|NCT01808092|37753822|FG001|Overall Study|Lost to Follow-up|7|||
16811694|NCT01808092|37753821|FG000|Overall Study|Withdrawal by Subject|9|||
16811695|NCT01808092|37753822|FG001|Overall Study|Withdrawal by Subject|4|||
16811696|NCT01808092|37753821|FG000|Overall Study|Other Eligibility criteria|3|||
16811697|NCT01808092|37753822|FG001|Overall Study|Other Eligibility criteria|5|||
16811698|NCT01774084|37753830|FG000|Overall Study|Personal reasons|1|||
16811699|NCT01774084|37753831|FG001|Overall Study|Personal reasons|0|||
16811700|NCT01807234|37753843|FG000|Overall Study|Lost to Follow-up|2|||
16811701|NCT01807234|37753844|FG001|Overall Study|Lost to Follow-up|5|||
16811702|NCT01807234|37753845|FG002|Overall Study|Lost to Follow-up|1|||
16811703|NCT01807234|37753846|FG003|Overall Study|Lost to Follow-up|1|||
16811704|NCT01807234|37753847|FG004|Overall Study|Lost to Follow-up|1|||
16811705|NCT01807234|37753848|FG005|Overall Study|Lost to Follow-up|2|||
16811706|NCT01807234|37753843|FG000|Overall Study|Withdrawal by Subject|3|||
16811707|NCT01807234|37753844|FG001|Overall Study|Withdrawal by Subject|1|||
16811708|NCT01807234|37753845|FG002|Overall Study|Withdrawal by Subject|1|||
16811709|NCT01807234|37753846|FG003|Overall Study|Withdrawal by Subject|1|||
16811710|NCT01807234|37753847|FG004|Overall Study|Withdrawal by Subject|2|||
16811711|NCT01807234|37753848|FG005|Overall Study|Withdrawal by Subject|1|||
16811712|NCT01807234|37753843|FG000|Overall Study|Lack of Efficacy|0|||
16811713|NCT01807234|37753844|FG001|Overall Study|Lack of Efficacy|0|||
16811714|NCT01807234|37753845|FG002|Overall Study|Lack of Efficacy|0|||
16811715|NCT01807234|37753846|FG003|Overall Study|Lack of Efficacy|0|||
16811716|NCT01807234|37753847|FG004|Overall Study|Lack of Efficacy|1|||
16811717|NCT01807234|37753848|FG005|Overall Study|Lack of Efficacy|1|||
16811718|NCT01790932|37753858|FG000|Overall Study|Disease Progression|41|||
16811719|NCT01790932|37753858|FG000|Overall Study|Adverse Event|7|||
16811720|NCT01790932|37753858|FG000|Overall Study|Physician Decision|1|||
16811721|NCT01790932|37753858|FG000|Overall Study|Withdrawal by Subject|1|||
16811722|NCT02377427|37753864|FG000|Part A (Up to Week 20)|Physician Decision|1|||
16811723|NCT02377427|37753865|FG001|Part A (Up to Week 20)|Physician Decision|0|||
16811724|NCT02377427|37753866|FG002|Part A (Up to Week 20)|Physician Decision|0|||
16811725|NCT02377427|37753867|FG003|Part A (Up to Week 20)|Physician Decision|0|||
16811726|NCT02377427|37753868|FG004|Part A (Up to Week 20)|Physician Decision|0|||
16811727|NCT02377427|37753864|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
16811728|NCT02377427|37753865|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
16811729|NCT02377427|37753866|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
16811730|NCT02377427|37753867|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
16811731|NCT02377427|37753868|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
16811732|NCT02377427|37753864|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
16811733|NCT02377427|37753865|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
16811734|NCT02377427|37753866|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
16811735|NCT02377427|37753867|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
16811736|NCT02377427|37753868|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
16811737|NCT02377427|37753864|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
16811738|NCT02377427|37753865|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
16811739|NCT02377427|37753866|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
16811740|NCT02377427|37753867|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
16910130|NCT01713582|38018823|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
16910131|NCT01713582|38018824|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
16910132|NCT01713582|38018825|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
16910133|NCT01713582|38018826|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
16910134|NCT01713582|38018806|FG000|Overall Study|Disease progression and adverse event|0|||
16910135|NCT01713582|38018807|FG001|Overall Study|Disease progression and adverse event|0|||
16910136|NCT01713582|38018808|FG002|Overall Study|Disease progression and adverse event|0|||
16910137|NCT01713582|38018809|FG003|Overall Study|Disease progression and adverse event|0|||
16910138|NCT01713582|38018810|FG004|Overall Study|Disease progression and adverse event|0|||
16910139|NCT01713582|38018811|FG005|Overall Study|Disease progression and adverse event|0|||
16910140|NCT01713582|38018812|FG006|Overall Study|Disease progression and adverse event|0|||
16910141|NCT01713582|38018813|FG007|Overall Study|Disease progression and adverse event|0|||
16910142|NCT01713582|38018814|FG008|Overall Study|Disease progression and adverse event|0|||
16910143|NCT01713582|38018815|FG009|Overall Study|Disease progression and adverse event|0|||
16910144|NCT01713582|38018816|FG010|Overall Study|Disease progression and adverse event|0|||
16910145|NCT01713582|38018817|FG011|Overall Study|Disease progression and adverse event|0|||
16910146|NCT01713582|38018818|FG012|Overall Study|Disease progression and adverse event|0|||
16910147|NCT01713582|38018819|FG013|Overall Study|Disease progression and adverse event|0|||
16910148|NCT01713582|38018820|FG014|Overall Study|Disease progression and adverse event|0|||
16910149|NCT01713582|38018821|FG015|Overall Study|Disease progression and adverse event|0|||
16910150|NCT01713582|38018822|FG016|Overall Study|Disease progression and adverse event|1|||
16910151|NCT01713582|38018823|FG017|Overall Study|Disease progression and adverse event|0|||
16910152|NCT01713582|38018824|FG018|Overall Study|Disease progression and adverse event|0|||
16910153|NCT01713582|38018825|FG019|Overall Study|Disease progression and adverse event|0|||
16910154|NCT01713582|38018826|FG020|Overall Study|Disease progression and adverse event|0|||
16910155|NCT01739400|38018886|FG000|Overall Study|Physician Decision|3|||
16910156|NCT01739400|38018887|FG001|Overall Study|Physician Decision|0|||
16910157|NCT01739400|38018886|FG000|Overall Study|Lost to Follow-up|2|||
16910158|NCT01739400|38018887|FG001|Overall Study|Lost to Follow-up|0|||
16910159|NCT01739400|38018886|FG000|Overall Study|Death|5|||
16910160|NCT01739400|38018887|FG001|Overall Study|Death|2|||
16811741|NCT02377427|37753868|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
16811742|NCT01807156|37753881|FG000|Overall Study|Physician Decision|1|||
16811743|NCT02421887|37753887|FG000|Overall Study|Lost to Follow-up|5|||
16811744|NCT02421887|37753888|FG001|Overall Study|Lost to Follow-up|0|||
16811745|NCT02421887|37753887|FG000|Overall Study|Withdrawal by Subject|8|||
16811746|NCT02421887|37753888|FG001|Overall Study|Withdrawal by Subject|5|||
16811747|NCT02421887|37753887|FG000|Overall Study|Physician Decision|2|||
16811748|NCT02421887|37753888|FG001|Overall Study|Physician Decision|4|||
16811749|NCT02421887|37753887|FG000|Overall Study|Adverse Event|2|||
16811750|NCT02421887|37753888|FG001|Overall Study|Adverse Event|0|||
16811751|NCT01609582|37753896|FG000|Overall Study|Adverse Event|20|||
16811752|NCT01609582|37753897|FG001|Overall Study|Adverse Event|18|||
16811753|NCT01609582|37753896|FG000|Overall Study|Lost to Follow-up|10|||
16811754|NCT01609582|37753897|FG001|Overall Study|Lost to Follow-up|10|||
16811755|NCT01609582|37753896|FG000|Overall Study|Withdrawal by Subject|21|||
16811756|NCT01609582|37753897|FG001|Overall Study|Withdrawal by Subject|15|||
16811757|NCT01609582|37753896|FG000|Overall Study|Study Terminated by Sponsor|1543|||
16811758|NCT01609582|37753897|FG001|Overall Study|Study Terminated by Sponsor|1548|||
16811759|NCT01609582|37753896|FG000|Overall Study|Other|9|||
16811760|NCT01609582|37753897|FG001|Overall Study|Other|10|||
16811761|NCT01609582|37753896|FG000|Overall Study|Randomized, but not treated|0|||
16811762|NCT01609582|37753897|FG001|Overall Study|Randomized, but not treated|3|||
16811763|NCT01789606|37753905|FG000|Overall Study|Participant not Purchased the Product|0|||
16811764|NCT01789606|37753906|FG001|Overall Study|Participant not Purchased the Product|20|||
16811765|NCT01789606|37753905|FG000|Overall Study|Withdrawal by Subject|0|||
16811766|NCT01789606|37753906|FG001|Overall Study|Withdrawal by Subject|1|||
16811767|NCT01789606|37753905|FG000|Overall Study|Ineligible|6|||
16811768|NCT01789606|37753906|FG001|Overall Study|Ineligible|2|||
16811769|NCT01789606|37753905|FG000|Overall Study|Administrative Reasons|17|||
16811770|NCT01789606|37753906|FG001|Overall Study|Administrative Reasons|6|||
16811771|NCT01789606|37753905|FG000|Overall Study|No Study Medication Taken|0|||
16811772|NCT01789606|37753906|FG001|Overall Study|No Study Medication Taken|1|||
16811773|NCT01789606|37753905|FG000|Overall Study|Protocol Violation|0|||
16811774|NCT01789606|37753906|FG001|Overall Study|Protocol Violation|55|||
16811775|NCT01789606|37753905|FG000|Overall Study|Adverse Event|0|||
16811776|NCT01789606|37753906|FG001|Overall Study|Adverse Event|3|||
16811777|NCT01789606|37753905|FG000|Overall Study|Lost to Follow-up|0|||
16811778|NCT01789606|37753906|FG001|Overall Study|Lost to Follow-up|14|||
16811779|NCT01789606|37753905|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
16811780|NCT01789606|37753906|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
16811781|NCT01788358|37753911|FG000|Overall Study|Other|11|||
16811782|NCT01788358|37753911|FG000|Overall Study|Logistical difficulties|1|||
16811783|NCT01788358|37753911|FG000|Overall Study|Lost to Follow-up|5|||
16811784|NCT01788358|37753911|FG000|Overall Study|Protocol Violation|3|||
16811785|NCT01788358|37753911|FG000|Overall Study|Withdrawal by Subject|26|||
16811786|NCT01788358|37753911|FG000|Overall Study|Lack of Efficacy|1|||
16811787|NCT01788358|37753911|FG000|Overall Study|Adverse Event|51|||
16811788|NCT01773226|37753915|FG000|Overall Study|Withdrawal by Subject|1|||
16811789|NCT01773070|37753919|FG000|Overall Study|Withdrawal by Subject|24|||
16811790|NCT01773070|37753919|FG000|Overall Study|Lost to Follow-up|39|||
16811791|NCT01773070|37753919|FG000|Overall Study|Other|15|||
16811792|NCT01773070|37753919|FG000|Overall Study|Death (unrelated to study procedures)|3|||
16811793|NCT01772368|37753923|FG000|Overall Study|Adverse Event|1|||
16811794|NCT01772368|37753923|FG000|Overall Study|Withdrawal by Subject|3|||
16811795|NCT01772368|37753923|FG000|Overall Study|Protocol Violation|2|||
16811796|NCT01772368|37753923|FG000|Overall Study|Other|1|||
16811797|NCT01788046|37753941|FG000|Overall Study|Withdrawal by Subject|12|||
16811798|NCT01788046|37753942|FG001|Overall Study|Withdrawal by Subject|12|||
16811799|NCT01788046|37753941|FG000|Overall Study|Lost to Follow-up|12|||
16811800|NCT01788046|37753942|FG001|Overall Study|Lost to Follow-up|19|||
16811801|NCT01788046|37753941|FG000|Overall Study|Death|7|||
16811802|NCT01788046|37753942|FG001|Overall Study|Death|5|||
16811803|NCT01788046|37753941|FG000|Overall Study|Protocol Specified Criteria|25|||
16811804|NCT01788046|37753942|FG001|Overall Study|Protocol Specified Criteria|1|||
16811805|NCT01806298|37753948|FG000|Overall Study|Adverse Event|3|||
16811806|NCT01806298|37753948|FG000|Overall Study|Protocol Non-compliance|1|||
16811807|NCT01806298|37753948|FG000|Overall Study|Withdrawal by Subject|1|||
16811808|NCT01806298|37753948|FG000|Overall Study|Other|5|||
16811809|NCT01772134|37753955|FG000|Overall Study|Adverse Event|6|||
16811810|NCT01772134|37753956|FG001|Overall Study|Adverse Event|5|||
16811811|NCT01772134|37753957|FG002|Overall Study|Adverse Event|10|||
16811812|NCT01772134|37753955|FG000|Overall Study|Withdrew Consent|3|||
16811813|NCT01772134|37753956|FG001|Overall Study|Withdrew Consent|1|||
16811814|NCT01772134|37753957|FG002|Overall Study|Withdrew Consent|5|||
16811815|NCT01772134|37753955|FG000|Overall Study|Lost to Follow-up|2|||
16811816|NCT01772134|37753956|FG001|Overall Study|Lost to Follow-up|0|||
16811817|NCT01772134|37753957|FG002|Overall Study|Lost to Follow-up|0|||
16811818|NCT01772134|37753955|FG000|Overall Study|Protocol Deviation|4|||
16811819|NCT01772134|37753956|FG001|Overall Study|Protocol Deviation|3|||
16811820|NCT01772134|37753957|FG002|Overall Study|Protocol Deviation|3|||
16811821|NCT01772134|37753955|FG000|Overall Study|Lack of Efficacy|11|||
16811822|NCT01772134|37753956|FG001|Overall Study|Lack of Efficacy|5|||
16811823|NCT01772134|37753957|FG002|Overall Study|Lack of Efficacy|3|||
16811824|NCT01772134|37753955|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
16811825|NCT01772134|37753956|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
16811826|NCT01772134|37753957|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
16811827|NCT01772134|37753955|FG000|Overall Study|Randomized Study Medication Not Received|2|||
16811828|NCT01772134|37753956|FG001|Overall Study|Randomized Study Medication Not Received|0|||
16811829|NCT01772134|37753957|FG002|Overall Study|Randomized Study Medication Not Received|1|||
16811830|NCT01994889|37753968|FG000|Overall Study|Adverse Event|5|||
16811831|NCT01994889|37753969|FG001|Overall Study|Adverse Event|12|||
16811832|NCT01994889|37753970|FG002|Overall Study|Adverse Event|11|||
16811833|NCT01994889|37753968|FG000|Overall Study|Cardiac Device Implantation|0|||
16811834|NCT01994889|37753969|FG001|Overall Study|Cardiac Device Implantation|2|||
16811835|NCT01994889|37753970|FG002|Overall Study|Cardiac Device Implantation|0|||
16811836|NCT01994889|37753968|FG000|Overall Study|Organ Transplantation|1|||
16811837|NCT01994889|37753969|FG001|Overall Study|Organ Transplantation|5|||
16811838|NCT01994889|37753970|FG002|Overall Study|Organ Transplantation|5|||
16811839|NCT01994889|37753968|FG000|Overall Study|No longer willing to participate|8|||
16811840|NCT01994889|37753969|FG001|Overall Study|No longer willing to participate|17|||
16811841|NCT01994889|37753970|FG002|Overall Study|No longer willing to participate|37|||
16811842|NCT01994889|37753968|FG000|Overall Study|Lost to Follow-up|0|||
16811843|NCT01994889|37753969|FG001|Overall Study|Lost to Follow-up|1|||
16811844|NCT01994889|37753970|FG002|Overall Study|Lost to Follow-up|0|||
16811845|NCT01994889|37753968|FG000|Overall Study|Protocol Violation|0|||
16811846|NCT01994889|37753969|FG001|Overall Study|Protocol Violation|1|||
16811847|NCT01994889|37753970|FG002|Overall Study|Protocol Violation|1|||
16811848|NCT01994889|37753968|FG000|Overall Study|Death|14|||
16811849|NCT01994889|37753969|FG001|Overall Study|Death|25|||
16811850|NCT01994889|37753970|FG002|Overall Study|Death|38|||
16811851|NCT02082483|37753979|FG000|Overall Study|Lost to Follow-up|1|||
16811852|NCT02082483|37753980|FG001|Overall Study|Lost to Follow-up|1|||
16811853|NCT02082483|37753979|FG000|Overall Study|Withdrawal by Subject|2|||
16811854|NCT02082483|37753980|FG001|Overall Study|Withdrawal by Subject|1|||
16811855|NCT02082483|37753979|FG000|Overall Study|Physician Decision|1|||
16811856|NCT02082483|37753980|FG001|Overall Study|Physician Decision|1|||
16811857|NCT02082483|37753979|FG000|Overall Study|Death|2|||
16811858|NCT02082483|37753980|FG001|Overall Study|Death|3|||
16811859|NCT02017899|37753993|FG000|Overall Study|Withdrawal by Subject|0|||
16811860|NCT02017899|37753994|FG001|Overall Study|Withdrawal by Subject|0|||
16811861|NCT02017899|37753995|FG002|Overall Study|Withdrawal by Subject|0|||
16811862|NCT02017899|37753996|FG003|Overall Study|Withdrawal by Subject|1|||
16811863|NCT02017899|37753997|FG004|Overall Study|Withdrawal by Subject|1|||
16811864|NCT02017899|37753998|FG005|Overall Study|Withdrawal by Subject|0|||
16811865|NCT01993329|37754018|FG000|Period 2|Adverse Event|0|||
16811866|NCT01993329|37754019|FG001|Period 2|Adverse Event|0|||
16811867|NCT01993329|37754020|FG002|Period 2|Adverse Event|0|||
16811868|NCT01993329|37754021|FG003|Period 2|Adverse Event|0|||
16811869|NCT01993329|37754022|FG004|Period 2|Adverse Event|0|||
16811870|NCT01993329|37754023|FG005|Period 2|Adverse Event|1|||
16811871|NCT01993329|37754018|FG000|Wash-out|Personal reasons|0|||
16811872|NCT01993329|37754019|FG001|Wash-out|Personal reasons|1|||
16811873|NCT01993329|37754020|FG002|Wash-out|Personal reasons|0|||
16811874|NCT01993329|37754021|FG003|Wash-out|Personal reasons|0|||
16811875|NCT01993329|37754022|FG004|Wash-out|Personal reasons|0|||
16811876|NCT01993329|37754023|FG005|Wash-out|Personal reasons|0|||
16811877|NCT02016183|37754035|FG000|Overall Study|Case Report Forms Uncollected|13|||
16811878|NCT02016183|37754035|FG000|Overall Study|Protocol Violation|52|||
16811879|NCT02377349|37754041|FG000|Overall Study|Serious Adverse Event|1|||
16811880|NCT02377349|37754042|FG001|Overall Study|Serious Adverse Event|0|||
16811881|NCT02377349|37754041|FG000|Overall Study|Protocol Violation|3|||
16811882|NCT02377349|37754042|FG001|Overall Study|Protocol Violation|2|||
16811883|NCT02377349|37754041|FG000|Overall Study|Withdrawal by Subject|5|||
16811884|NCT02377349|37754042|FG001|Overall Study|Withdrawal by Subject|3|||
16811885|NCT02377349|37754041|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
16811886|NCT02377349|37754042|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
16811887|NCT02377349|37754041|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
16811888|NCT02377349|37754042|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
16811889|NCT02377349|37754041|FG000|Overall Study|Other|0|||
16811890|NCT02377349|37754042|FG001|Overall Study|Other|1|||
16910161|NCT01739400|38018886|FG000|Overall Study|Withdrawal by Subject|7|||
16910162|NCT01739400|38018887|FG001|Overall Study|Withdrawal by Subject|7|||
16910163|NCT01713348|38018896|FG000|Overall Study|Withdrawal by Subject|3|||
16910164|NCT01713348|38018897|FG001|Overall Study|Withdrawal by Subject|2|||
16910165|NCT01713348|38018898|FG002|Overall Study|Withdrawal by Subject|2|||
16910166|NCT01713348|38018899|FG003|Overall Study|Withdrawal by Subject|0|||
16811891|NCT02421419|37754060|FG000|Overall Study|Physician Decision|0|||
16811892|NCT02421419|37754061|FG001|Overall Study|Physician Decision|0|||
16811893|NCT02421419|37754062|FG002|Overall Study|Physician Decision|1|||
16811894|NCT02420717|37754073|FG000|Overall Study|Did not receive all study medication|2|||
16811895|NCT02420717|37754074|FG001|Overall Study|Did not receive all study medication|0|||
16811896|NCT02420717|37754075|FG002|Overall Study|Did not receive all study medication|0|||
16811897|NCT02016105|37754085|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
16811898|NCT02016105|37754086|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
16811899|NCT02016105|37754087|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
16811900|NCT02016105|37754088|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
16811901|NCT02016105|37754089|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
16811902|NCT02016105|37754090|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
16811903|NCT02016105|37754085|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
16811904|NCT02016105|37754086|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
17198383|NCT01367249|38352066|FG000|Overall Study|Withdrawal by Subject|6|||
16811905|NCT02016105|37754087|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
16811906|NCT02016105|37754088|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
16811907|NCT02016105|37754089|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
16811908|NCT02016105|37754090|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
16811909|NCT02016105|37754085|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
16811910|NCT02016105|37754086|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
16811911|NCT02016105|37754087|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
16811912|NCT02016105|37754088|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
16811913|NCT02016105|37754089|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
16811914|NCT02016105|37754090|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
16811915|NCT02016105|37754085|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
16811916|NCT02016105|37754086|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
16811917|NCT02016105|37754087|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
16811918|NCT02016105|37754088|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
16811919|NCT02016105|37754089|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
16811920|NCT02016105|37754090|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
16811921|NCT02016105|37754085|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
16811922|NCT02016105|37754086|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
16811923|NCT02016105|37754087|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
16811924|NCT02016105|37754088|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
16811925|NCT02016105|37754089|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
16811926|NCT02016105|37754090|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
16811927|NCT02016105|37754085|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
16811928|NCT02016105|37754086|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
16811929|NCT02016105|37754087|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
16811930|NCT02016105|37754088|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
16811931|NCT02016105|37754089|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
16811932|NCT02016105|37754090|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
16910167|NCT01713348|38018896|FG000|Overall Study|Lost to Follow-up|1|||
16910168|NCT01713348|38018897|FG001|Overall Study|Lost to Follow-up|0|||
16910169|NCT01713348|38018898|FG002|Overall Study|Lost to Follow-up|0|||
16910170|NCT01713348|38018899|FG003|Overall Study|Lost to Follow-up|0|||
16910171|NCT01737996|38018912|FG000|Overall Study|Adverse Event|0|||
16910172|NCT01737996|38018913|FG001|Overall Study|Adverse Event|1|||
16910173|NCT01737996|38018914|FG002|Overall Study|Adverse Event|1|||
16910174|NCT01737996|38018912|FG000|Overall Study|Withdrawal by Subject|0|||
16910175|NCT01737996|38018913|FG001|Overall Study|Withdrawal by Subject|0|||
16910176|NCT01737996|38018914|FG002|Overall Study|Withdrawal by Subject|1|||
16910177|NCT01713036|38018922|FG000|Overall Study|Death|1|||
16910178|NCT01712490|38018934|FG000|Overall Study|Ongoing|601|||
16910179|NCT01712490|38018935|FG001|Overall Study|Ongoing|586|||
16910180|NCT01712490|38018934|FG000|Overall Study|Other|11|||
16910181|NCT01712490|38018935|FG001|Overall Study|Other|11|||
16910182|NCT01712490|38018934|FG000|Overall Study|Withdrawal by Subject|36|||
16910183|NCT01712490|38018935|FG001|Overall Study|Withdrawal by Subject|44|||
16910184|NCT01712490|38018934|FG000|Overall Study|Lost to Follow-up|16|||
16910185|NCT01712490|38018935|FG001|Overall Study|Lost to Follow-up|29|||
16910186|NCT01712334|38018941|FG000|Treatment Period 1|Randomized in Error|0|||
16910187|NCT01712334|38018942|FG001|Treatment Period 1|Randomized in Error|2|||
16910188|NCT01712256|38018948|FG000|Overall Study|Lost to Follow-up|1|||
16910189|NCT01712178|38018954|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
16811933|NCT02016105|37754085|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
16811934|NCT02016105|37754086|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
16811935|NCT02016105|37754087|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
16811936|NCT02016105|37754088|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
16811937|NCT02016105|37754089|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
16811938|NCT02016105|37754090|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
16811939|NCT02016105|37754085|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
16910190|NCT01712178|38018955|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
16910191|NCT01712178|38018954|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
16811940|NCT02016105|37754086|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
17198384|NCT01367249|38352067|FG001|Overall Study|Withdrawal by Subject|6|||
16811941|NCT02016105|37754087|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
16811942|NCT02016105|37754088|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
16811943|NCT02016105|37754089|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
16811944|NCT02016105|37754090|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
16811945|NCT02016105|37754085|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
16811946|NCT02016105|37754086|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
16811947|NCT02016105|37754087|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
16811948|NCT02016105|37754088|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
16811949|NCT02016105|37754089|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
16811950|NCT02016105|37754090|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
16811951|NCT02016105|37754085|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
16811952|NCT02016105|37754086|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
16811953|NCT02016105|37754087|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
16811954|NCT02016105|37754088|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
16811955|NCT02016105|37754089|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
16811956|NCT02016105|37754090|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
16811957|NCT02016105|37754085|FG000|TREATMENT PERIOD 2|Death|0|||
16811958|NCT02016105|37754086|FG001|TREATMENT PERIOD 2|Death|0|||
16811959|NCT02016105|37754087|FG002|TREATMENT PERIOD 2|Death|0|||
16811960|NCT02016105|37754088|FG003|TREATMENT PERIOD 2|Death|0|||
16811961|NCT02016105|37754089|FG004|TREATMENT PERIOD 2|Death|0|||
16811962|NCT02016105|37754090|FG005|TREATMENT PERIOD 2|Death|1|||
16811963|NCT02016105|37754085|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
16811964|NCT02016105|37754086|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
16811965|NCT02016105|37754087|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
16811966|NCT02016105|37754088|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
16811967|NCT02016105|37754089|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
16811968|NCT02016105|37754090|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
16811969|NCT02016105|37754085|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
16811970|NCT02016105|37754086|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
16811971|NCT02016105|37754087|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
16811972|NCT02016105|37754088|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
16811973|NCT02016105|37754089|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
16811974|NCT02016105|37754090|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
16811975|NCT02016105|37754085|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
16811976|NCT02016105|37754086|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
16811977|NCT02016105|37754087|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
16811978|NCT02016105|37754088|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
16811979|NCT02016105|37754089|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
16811980|NCT02016105|37754090|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
16811981|NCT02016105|37754085|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
16811982|NCT02016105|37754086|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
16811983|NCT02016105|37754087|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
16811984|NCT02016105|37754088|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
16811985|NCT02016105|37754089|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
16811986|NCT02016105|37754090|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
16811987|NCT02016105|37754085|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
16811988|NCT02016105|37754086|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
16811989|NCT02016105|37754087|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
16811990|NCT02016105|37754088|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
16811991|NCT02016105|37754089|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
16811992|NCT02016105|37754090|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
16811993|NCT02016105|37754085|FG000|EXTENSION PERIOD|Adverse Event|0|||
16811994|NCT02016105|37754086|FG001|EXTENSION PERIOD|Adverse Event|0|||
16811995|NCT02016105|37754087|FG002|EXTENSION PERIOD|Adverse Event|2|||
16811996|NCT02016105|37754088|FG003|EXTENSION PERIOD|Adverse Event|0|||
16811997|NCT02016105|37754089|FG004|EXTENSION PERIOD|Adverse Event|1|||
16811998|NCT02016105|37754090|FG005|EXTENSION PERIOD|Adverse Event|0|||
16811999|NCT02016105|37754085|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
16910192|NCT01712178|38018955|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
16910193|NCT01712178|38018954|FG000|Overall Study|Lost to Follow-up|0|||
16910194|NCT01712178|38018955|FG001|Overall Study|Lost to Follow-up|1|||
16910195|NCT01693068|38018963|FG000|Randomization Period|On-study|2|||
16910196|NCT01693068|38018964|FG001|Randomization Period|On-study|5|||
16812000|NCT02016105|37754086|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
16812001|NCT02016105|37754087|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
16812002|NCT02016105|37754088|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
16812003|NCT02016105|37754089|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
16812004|NCT02016105|37754090|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
16812005|NCT02016105|37754085|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
16812006|NCT02016105|37754086|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
16812007|NCT02016105|37754087|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
16812008|NCT02016105|37754088|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
16812009|NCT02016105|37754089|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
16812010|NCT02016105|37754090|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
16910197|NCT01693068|38018965|FG002|Randomization Period|On-study|0|||
16812011|NCT02016105|37754085|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
16812012|NCT02016105|37754086|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
16812013|NCT02016105|37754087|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
16812014|NCT02016105|37754088|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
16812015|NCT02016105|37754089|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
16812016|NCT02016105|37754090|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
16812017|NCT02400905|37754104|FG000|Overall Study|Death|24|||
16812018|NCT02400905|37754104|FG000|Overall Study|Lost to Follow-up|18|||
16812019|NCT02400905|37754104|FG000|Overall Study|Withdrawal by Subject|16|||
16812020|NCT02400905|37754104|FG000|Overall Study|Physician Decision|4|||
16812021|NCT02400905|37754104|FG000|Overall Study|Other|1|||
16812022|NCT02400749|37754111|FG000|Week 0 -16|Withdrawal by Subject|5|||
16812023|NCT02400749|37754112|FG001|Week 0 -16|Withdrawal by Subject|5|||
16812024|NCT02400749|37754111|FG000|Week 0 -16|Adverse Event|3|||
16812025|NCT02400749|37754112|FG001|Week 0 -16|Adverse Event|1|||
16812026|NCT02400749|37754111|FG000|Week 0 -16|Lost to Follow-up|2|||
16812027|NCT02400749|37754112|FG001|Week 0 -16|Lost to Follow-up|0|||
16812028|NCT02400749|37754111|FG000|Week 0 -16|Protocol Violation|1|||
16812029|NCT02400749|37754112|FG001|Week 0 -16|Protocol Violation|0|||
16812030|NCT02400749|37754111|FG000|Week 17 - 32|Withdrawal by Subject|3|||
16812031|NCT02400749|37754112|FG001|Week 17 - 32|Withdrawal by Subject|2|||
16812032|NCT02400749|37754111|FG000|Week 17 - 32|Adverse Event|2|||
16812033|NCT02400749|37754112|FG001|Week 17 - 32|Adverse Event|1|||
16812034|NCT02420327|37754118|FG000|Overall Study|Adverse Event|7|||
16812035|NCT02420327|37754118|FG000|Overall Study|Pregnancy|1|||
16812036|NCT02420327|37754118|FG000|Overall Study|Withdrawal by Subject|6|||
16812037|NCT02420327|37754118|FG000|Overall Study|Lost to Follow-up|1|||
16812038|NCT02420327|37754118|FG000|Overall Study|Protocol Violation|1|||
16812039|NCT02374853|37754130|FG000|Overall Study|Surgery Cancelled|5|||
16812040|NCT02374853|37754131|FG001|Overall Study|Surgery Cancelled|11|||
16812041|NCT02015793|37754139|FG000|Overall Study|Adverse Event|3|||
16812042|NCT02015793|37754140|FG001|Overall Study|Adverse Event|3|||
16812043|NCT02015793|37754139|FG000|Overall Study|Withdrawal by Subject|1|||
16812044|NCT02015793|37754140|FG001|Overall Study|Withdrawal by Subject|1|||
16812045|NCT02347631|37754154|FG000|First Intervention (2 Months)|Adverse Event|1|||
16812046|NCT02347631|37754155|FG001|First Intervention (2 Months)|Adverse Event|1|||
16812047|NCT02347631|37754154|FG000|First Intervention (2 Months)|Pregnancy|1|||
16812048|NCT02347631|37754155|FG001|First Intervention (2 Months)|Pregnancy|0|||
16812049|NCT02347631|37754154|FG000|First Intervention (2 Months)|Moved out of area|0|||
16812050|NCT02347631|37754155|FG001|First Intervention (2 Months)|Moved out of area|2|||
16812051|NCT02347631|37754154|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
16812052|NCT02347631|37754155|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
16812053|NCT02347631|37754154|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
16812054|NCT02347631|37754155|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
16812055|NCT02347631|37754154|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
16812056|NCT02347631|37754155|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
16812057|NCT02347631|37754154|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
16812058|NCT02347631|37754155|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
16812059|NCT02347631|37754154|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
16812060|NCT02347631|37754155|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
16812061|NCT02015637|37754165|FG000|Overall Study|Lost to Follow-up|3|||
16812062|NCT02015637|37754166|FG001|Overall Study|Lost to Follow-up|5|||
16812063|NCT02015637|37754165|FG000|Overall Study|Adverse Event|3|||
16812064|NCT02015637|37754166|FG001|Overall Study|Adverse Event|0|||
16812065|NCT02015637|37754165|FG000|Overall Study|Did not take study drug|2|||
16812066|NCT02015637|37754166|FG001|Overall Study|Did not take study drug|0|||
16812067|NCT02347085|37754172|FG000|Overall Study|Adverse Event|2|||
16812068|NCT02347085|37754172|FG000|Overall Study|Lack of Efficacy|1|||
16812069|NCT02347085|37754172|FG000|Overall Study|Withdrawal by Subject|4|||
16812070|NCT02347085|37754172|FG000|Overall Study|Lost to Follow-up|1|||
16812071|NCT02347085|37754172|FG000|Overall Study|Protocol Criteria|2|||
16812072|NCT02374463|37754180|FG000|Overall Study|Withdrawal by Subject|3|||
16812073|NCT02374463|37754181|FG001|Overall Study|Withdrawal by Subject|3|||
16910198|NCT01693068|38018963|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
16910199|NCT01693068|38018964|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
16910200|NCT01693068|38018965|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
16910201|NCT01691898|38018979|FG000|Overall Study|Death|34|||
16910202|NCT01691898|38018980|FG001|Overall Study|Death|32|||
16910203|NCT01691898|38018981|FG002|Overall Study|Death|6|||
16910204|NCT01691898|38018982|FG003|Overall Study|Death|3|||
16910205|NCT01691898|38018983|FG004|Overall Study|Death|8|||
16910206|NCT01691898|38018984|FG005|Overall Study|Death|31|||
16812074|NCT02015481|37754188|FG000|Overall Study|Death|1|||
16812075|NCT02374307|37754195|FG000|3-months Follow-up|Lost to Follow-up|1|||
16812076|NCT02374307|37754196|FG001|3-months Follow-up|Lost to Follow-up|2|||
16812077|NCT02374307|37754195|FG000|3-months Follow-up|Withdrawal by Subject|1|||
16910207|NCT01691898|38018979|FG000|Overall Study|Adverse Event|0|||
16910208|NCT01691898|38018980|FG001|Overall Study|Adverse Event|1|||
16812078|NCT02374307|37754196|FG001|3-months Follow-up|Withdrawal by Subject|4|||
16812079|NCT02374307|37754195|FG000|3-months Follow-up|Death|1|||
16812080|NCT02374307|37754196|FG001|3-months Follow-up|Death|2|||
16812081|NCT02374307|37754195|FG000|3-months Follow-up|Missed first follow-up|5|||
16812082|NCT02374307|37754196|FG001|3-months Follow-up|Missed first follow-up|1|||
16812083|NCT02374307|37754195|FG000|6-months Follow-up|Lost to Follow-up|1|||
16812084|NCT02374307|37754196|FG001|6-months Follow-up|Lost to Follow-up|2|||
16812085|NCT02374307|37754195|FG000|6-months Follow-up|Death|2|||
16812086|NCT02374307|37754196|FG001|6-months Follow-up|Death|1|||
16812087|NCT02374307|37754195|FG000|6-months Follow-up|Withdrawal by Subject|0|||
16812088|NCT02374307|37754196|FG001|6-months Follow-up|Withdrawal by Subject|3|||
16812089|NCT02397473|37754204|FG000|Treatment Phase|Adverse Event|1|||
16812090|NCT02397473|37754205|FG001|Treatment Phase|Adverse Event|2|||
16812091|NCT02397473|37754204|FG000|Treatment Phase|Lack of Efficacy|8|||
16812092|NCT02397473|37754205|FG001|Treatment Phase|Lack of Efficacy|1|||
16812093|NCT02397473|37754204|FG000|Treatment Phase|Lost to Follow-up|1|||
16812094|NCT02397473|37754205|FG001|Treatment Phase|Lost to Follow-up|0|||
16812095|NCT02397473|37754204|FG000|Treatment Phase|Withdrawal by Subject|2|||
16812096|NCT02397473|37754205|FG001|Treatment Phase|Withdrawal by Subject|1|||
16812097|NCT02397473|37754204|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
16812098|NCT02397473|37754205|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
16812099|NCT02397473|37754204|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
16812100|NCT02397473|37754205|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
16812101|NCT02397473|37754204|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
16812102|NCT02397473|37754205|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
16812103|NCT02397473|37754204|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
16812104|NCT02397473|37754205|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
16812105|NCT02397473|37754204|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
16812106|NCT02397473|37754205|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
16812107|NCT02344745|37754216|FG000|Overall Study|Data collection sheets were lost|2|||
16812108|NCT02344745|37754217|FG001|Overall Study|Data collection sheets were lost|0|||
16812109|NCT02370641|37754225|FG000|Overall Study|dropped study|4|||
16812110|NCT02370641|37754226|FG001|Overall Study|dropped study|2|||
16812111|NCT01621191|37754232|FG000|Overall Study|Adverse Event|9|||
16812112|NCT01621191|37754232|FG000|Overall Study|Withdrawal by Subject|8|||
16812113|NCT01621191|37754232|FG000|Overall Study|Lack of Efficacy|6|||
16812114|NCT01621191|37754232|FG000|Overall Study|Lost to Follow-up|1|||
16812115|NCT01621191|37754232|FG000|Overall Study|Site Removed From Study|1|||
16812116|NCT02343263|37754240|FG000|Overall Study|Physician Decision|5|||
16812117|NCT02343263|37754241|FG001|Overall Study|Physician Decision|3|||
16812118|NCT02343263|37754242|FG002|Overall Study|Physician Decision|1|||
16812119|NCT02081859|37754256|FG000|Overall Study|No fertilization|2|||
16812120|NCT02081859|37754257|FG001|Overall Study|No fertilization|2|||
16812121|NCT02081859|37754256|FG000|Overall Study|No sperm|1|||
16812122|NCT02081859|37754257|FG001|Overall Study|No sperm|0|||
16812123|NCT02081859|37754256|FG000|Overall Study|Unanticipated freeze all cycle|2|||
16812124|NCT02081859|37754257|FG001|Overall Study|Unanticipated freeze all cycle|6|||
16812125|NCT02081859|37754256|FG000|Overall Study|< 4 embryos|27|||
16812126|NCT02081859|37754257|FG001|Overall Study|< 4 embryos|23|||
16812127|NCT02081859|37754256|FG000|Overall Study|Other reasons|2|||
16812128|NCT02081859|37754257|FG001|Overall Study|Other reasons|0|||
16812129|NCT02342639|37754265|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
16812130|NCT02342639|37754266|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
16812131|NCT02342639|37754265|FG000|Overall Study|Protocol Violation|0|||
16812132|NCT02342639|37754266|FG001|Overall Study|Protocol Violation|2|||
16812133|NCT01625091|37754276|FG000|Intervention|Death|1|||
16812134|NCT01625091|37754277|FG001|Intervention|Death|1|||
16812135|NCT01625091|37754276|FG000|Intervention|Withdrawal by Subject|4|||
16812136|NCT01625091|37754277|FG001|Intervention|Withdrawal by Subject|1|||
16812137|NCT01625091|37754276|FG000|Intervention|Adverse Event|0|||
16812138|NCT01625091|37754277|FG001|Intervention|Adverse Event|2|||
16812139|NCT01625091|37754276|FG000|Intervention|Lost to Follow-up|4|||
16812140|NCT01625091|37754277|FG001|Intervention|Lost to Follow-up|4|||
16812141|NCT01625091|37754276|FG000|Intervention|Study termination|2|||
16812142|NCT01625091|37754277|FG001|Intervention|Study termination|3|||
16812143|NCT01625091|37754276|FG000|Post-intervention|Death|0|||
16812144|NCT01625091|37754277|FG001|Post-intervention|Death|1|||
16812145|NCT01625091|37754276|FG000|Post-intervention|Lost to Follow-up|2|||
16812146|NCT01625091|37754277|FG001|Post-intervention|Lost to Follow-up|0|||
16812147|NCT01625091|37754276|FG000|Post-intervention|Study termination|2|||
16812148|NCT01625091|37754277|FG001|Post-intervention|Study termination|1|||
16812149|NCT02396849|37754285|FG000|Overall Study|Lost to Follow-up|1|||
16812150|NCT02396849|37754286|FG001|Overall Study|Lost to Follow-up|1|||
16812151|NCT02396849|37754285|FG000|Overall Study|Did not tolerate intervention|1|||
16812152|NCT02396849|37754286|FG001|Overall Study|Did not tolerate intervention|1|||
16812153|NCT02370251|37754294|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
17016576|NCT00855062|38161222|FG001|Step1|Early Study Closure|7|||
16812154|NCT02370251|37754294|FG000|Overall Study|Death|4|||
16812155|NCT02396537|37754300|FG000|Overall Study|Protocol Violation|0|||
16812156|NCT02396537|37754301|FG001|Overall Study|Protocol Violation|1|||
16812157|NCT02342171|37754309|FG000|Overall Study|Death|4|||
16812158|NCT02342171|37754310|FG001|Overall Study|Death|87|||
16812159|NCT02342171|37754309|FG000|Overall Study|Received favipiravir|10|||
16812160|NCT02342171|37754310|FG001|Overall Study|Received favipiravir|0|||
16812161|NCT02342171|37754309|FG000|Overall Study|Missing cycle treshold value|1|||
16812162|NCT02342171|37754310|FG001|Overall Study|Missing cycle treshold value|0|||
16812163|NCT02342171|37754309|FG000|Overall Study|Unknown outcome|0|||
16812164|NCT02342171|37754310|FG001|Overall Study|Unknown outcome|1|||
16812165|NCT02342171|37754309|FG000|Overall Study|Missing age data|0|||
16812166|NCT02342171|37754310|FG001|Overall Study|Missing age data|1|||
16812167|NCT01624467|37754315|FG000|Overall Study|Withdrawal by Subject|2|||
16812168|NCT01624467|37754315|FG000|Overall Study|Lost to Follow-up|1|||
16812169|NCT01624467|37754315|FG000|Overall Study|Adverse Event|7|||
16812170|NCT01624467|37754315|FG000|Overall Study|Progressive Disease|19|||
16812171|NCT01624467|37754315|FG000|Overall Study|Per Sponsor Requirement|1|||
16812172|NCT01624467|37754315|FG000|Overall Study|Subject Withdrew from Treatment|1|||
16812173|NCT01624233|37754321|FG000|Period 2 - Induction|Adverse Event|1|||
16812174|NCT01624233|37754321|FG000|Period 3 - Maintenance|Adverse Event|2|||
16812175|NCT01624233|37754321|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
16812176|NCT01624233|37754321|FG000|Period 3 - Maintenance|Physician Decision|2|||
16812177|NCT01624233|37754321|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
16812178|NCT01624233|37754321|FG000|Period 4 - Drug Free Period|Relapsed|61|||
16812179|NCT01624233|37754321|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
16812180|NCT01624233|37754321|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
16812181|NCT01624233|37754321|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
16812182|NCT01624233|37754321|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
16812183|NCT01624233|37754321|FG000|Period 6: Follow-up|Adverse Event|3|||
16812184|NCT01624233|37754321|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
16812185|NCT01624233|37754321|FG000|Period 6: Follow-up|Physician Decision|1|||
16812186|NCT01624233|37754321|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
16812187|NCT01993017|37754332|FG000|Overall Study|Death|23|||
16812188|NCT01993017|37754333|FG001|Overall Study|Death|26|||
16812189|NCT01993017|37754334|FG002|Overall Study|Death|18|||
16812190|NCT01993017|37754332|FG000|Overall Study|Could not be contacted|43|||
16812191|NCT01993017|37754333|FG001|Overall Study|Could not be contacted|42|||
16812192|NCT01993017|37754334|FG002|Overall Study|Could not be contacted|38|||
16812193|NCT01993017|37754332|FG000|Overall Study|Dropped out|19|||
16812194|NCT01993017|37754333|FG001|Overall Study|Dropped out|6|||
16812195|NCT01993017|37754334|FG002|Overall Study|Dropped out|11|||
16812196|NCT01993017|37754332|FG000|Overall Study|Other reasons|17|||
16812197|NCT01993017|37754333|FG001|Overall Study|Other reasons|11|||
16812198|NCT01993017|37754334|FG002|Overall Study|Other reasons|7|||
16812199|NCT01993017|37754332|FG000|Overall Study|Ineligible after randomization|4|||
16812200|NCT01993017|37754333|FG001|Overall Study|Ineligible after randomization|5|||
16812201|NCT01993017|37754334|FG002|Overall Study|Ineligible after randomization|5|||
16812202|NCT01992549|37754343|FG000|Overall Study|Lost to Follow-up|2|||
16812203|NCT01992549|37754343|FG000|Overall Study|Serious Adverse Event|1|||
16812204|NCT01992549|37754343|FG000|Overall Study|Product Switch to Extend Half Life|1|||
16812205|NCT01992159|37754357|FG000|Overall Study|Withdrawal by Subject|4|||
16812206|NCT01992159|37754358|FG001|Overall Study|Withdrawal by Subject|7|||
16812207|NCT01992159|37754359|FG002|Overall Study|Withdrawal by Subject|0|||
16812208|NCT01992159|37754360|FG003|Overall Study|Withdrawal by Subject|3|||
16812209|NCT01992159|37754357|FG000|Overall Study|Adverse Event|0|||
16812210|NCT01992159|37754358|FG001|Overall Study|Adverse Event|1|||
16812211|NCT01992159|37754359|FG002|Overall Study|Adverse Event|0|||
16812212|NCT01992159|37754360|FG003|Overall Study|Adverse Event|1|||
16812213|NCT01992159|37754357|FG000|Overall Study|Death|0|||
16812214|NCT01992159|37754358|FG001|Overall Study|Death|0|||
16812215|NCT01992159|37754359|FG002|Overall Study|Death|1|||
16812216|NCT01992159|37754360|FG003|Overall Study|Death|0|||
16812217|NCT01988493|37754375|FG000|Overall Study|Randomized but not treated|0|||
16812218|NCT01988493|37754376|FG001|Overall Study|Randomized but not treated|0|||
16812219|NCT01988493|37754377|FG002|Overall Study|Randomized but not treated|0|||
16812220|NCT01988493|37754378|FG003|Overall Study|Randomized but not treated|0|||
16812221|NCT01988493|37754379|FG004|Overall Study|Randomized but not treated|1|||
16812222|NCT02081079|37754395|FG000|Overall Study|Lack of Efficacy|3|||
16812223|NCT02081079|37754396|FG001|Overall Study|Lack of Efficacy|2|||
16812224|NCT02081079|37754395|FG000|Overall Study|Lost to Follow-up|1|||
16812225|NCT02081079|37754396|FG001|Overall Study|Lost to Follow-up|0|||
16812226|NCT02081001|37754408|FG000|Overall Study|Adverse Event|0|||
16812227|NCT02081001|37754409|FG001|Overall Study|Adverse Event|0|||
16812228|NCT02081001|37754410|FG002|Overall Study|Adverse Event|0|||
16812229|NCT02081001|37754411|FG003|Overall Study|Adverse Event|0|||
16812230|NCT02081001|37754412|FG004|Overall Study|Adverse Event|1|||
16812231|NCT02081001|37754413|FG005|Overall Study|Adverse Event|0|||
17016577|NCT00855062|38161221|FG000|Step1|Adverse Event|1|||
17016578|NCT00855062|38161222|FG001|Step1|Adverse Event|1|||
17016579|NCT00855062|38161221|FG000|Step1|Protocol Violation|1|||
17016580|NCT00855062|38161222|FG001|Step1|Protocol Violation|0|||
17016581|NCT00855062|38161221|FG000|Step1|Pregnancy|1|||
17016582|NCT00855062|38161222|FG001|Step1|Pregnancy|0|||
17016583|NCT00855062|38161221|FG000|Step1|Withdrawal by Subject|2|||
17016584|NCT00855062|38161222|FG001|Step1|Withdrawal by Subject|3|||
16812232|NCT02081001|37754414|FG006|Overall Study|Adverse Event|0|||
16812233|NCT02081001|37754415|FG007|Overall Study|Adverse Event|0|||
16812234|NCT02081001|37754416|FG008|Overall Study|Adverse Event|0|||
16812235|NCT02081001|37754417|FG009|Overall Study|Adverse Event|0|||
16812236|NCT02081001|37754418|FG010|Overall Study|Adverse Event|0|||
16812237|NCT02081001|37754419|FG011|Overall Study|Adverse Event|0|||
16812238|NCT02080221|37754430|FG000|Overall Study|Withdrawal by Subject|1|||
16812239|NCT02080221|37754430|FG000|Overall Study|Clinical Progression of Disease|1|||
16812240|NCT02079909|37754437|FG000|Overall Study|Adverse Event|23|||
16812241|NCT02079909|37754438|FG001|Overall Study|Adverse Event|23|||
16812242|NCT02079909|37754439|FG002|Overall Study|Adverse Event|7|||
16812243|NCT02079909|37754437|FG000|Overall Study|Withdrawal by Subject|9|||
16812244|NCT02079909|37754438|FG001|Overall Study|Withdrawal by Subject|17|||
16812245|NCT02079909|37754439|FG002|Overall Study|Withdrawal by Subject|4|||
16812246|NCT02079909|37754437|FG000|Overall Study|Lost to Follow-up|2|||
16812247|NCT02079909|37754438|FG001|Overall Study|Lost to Follow-up|3|||
16812248|NCT02079909|37754439|FG002|Overall Study|Lost to Follow-up|1|||
16812249|NCT02079909|37754437|FG000|Overall Study|Death|2|||
16812250|NCT02079909|37754438|FG001|Overall Study|Death|2|||
16812251|NCT02079909|37754439|FG002|Overall Study|Death|0|||
16812252|NCT02079909|37754437|FG000|Overall Study|Lack of Efficacy|0|||
16812253|NCT02079909|37754438|FG001|Overall Study|Lack of Efficacy|0|||
16812254|NCT02079909|37754439|FG002|Overall Study|Lack of Efficacy|1|||
16812255|NCT02079909|37754437|FG000|Overall Study|Protocol Violation|0|||
16812256|NCT02079909|37754438|FG001|Overall Study|Protocol Violation|1|||
16812257|NCT02079909|37754439|FG002|Overall Study|Protocol Violation|1|||
16812258|NCT02079909|37754437|FG000|Overall Study|Physician Decision|0|||
16812259|NCT02079909|37754438|FG001|Overall Study|Physician Decision|1|||
16812260|NCT02079909|37754439|FG002|Overall Study|Physician Decision|1|||
16812261|NCT02079909|37754437|FG000|Overall Study|Relocation etc.|2|||
16812262|NCT02079909|37754438|FG001|Overall Study|Relocation etc.|2|||
16812263|NCT02079909|37754439|FG002|Overall Study|Relocation etc.|3|||
16812264|NCT02014467|37754449|FG000|Overall Study|Adverse Event|4|||
16812265|NCT02014467|37754450|FG001|Overall Study|Adverse Event|0|||
16812266|NCT02014467|37754449|FG000|Overall Study|Protocol Violation|3|||
16812267|NCT02014467|37754450|FG001|Overall Study|Protocol Violation|0|||
16812268|NCT02014467|37754449|FG000|Overall Study|Physician Decision|2|||
16812269|NCT02014467|37754450|FG001|Overall Study|Physician Decision|3|||
16812270|NCT02014467|37754449|FG000|Overall Study|Withdrawal by Subject|16|||
16812271|NCT02014467|37754450|FG001|Overall Study|Withdrawal by Subject|4|||
16812272|NCT02013765|37754456|FG000|Overall Study|Trial was terminated by sponsor|1|||
16812273|NCT02013687|37754464|FG000|Overall Study|Lost to Follow-up|0|||
16812274|NCT02013687|37754465|FG001|Overall Study|Lost to Follow-up|0|||
16812275|NCT02013687|37754466|FG002|Overall Study|Lost to Follow-up|1|||
16812276|NCT02013687|37754467|FG003|Overall Study|Lost to Follow-up|0|||
16812277|NCT02013687|37754464|FG000|Overall Study|Protocol Violation|0|||
16812278|NCT02013687|37754465|FG001|Overall Study|Protocol Violation|0|||
16812279|NCT02013687|37754466|FG002|Overall Study|Protocol Violation|0|||
16812280|NCT02013687|37754467|FG003|Overall Study|Protocol Violation|1|||
16812281|NCT02013687|37754464|FG000|Overall Study|Withdrawal by Subject|0|||
16812282|NCT02013687|37754465|FG001|Overall Study|Withdrawal by Subject|0|||
16812283|NCT02013687|37754466|FG002|Overall Study|Withdrawal by Subject|0|||
16812284|NCT02013687|37754467|FG003|Overall Study|Withdrawal by Subject|1|||
16812285|NCT02013687|37754464|FG000|Overall Study|Missed visits due to patient travel|0|||
16812286|NCT02013687|37754465|FG001|Overall Study|Missed visits due to patient travel|0|||
16812287|NCT02013687|37754466|FG002|Overall Study|Missed visits due to patient travel|1|||
16812288|NCT02013687|37754467|FG003|Overall Study|Missed visits due to patient travel|0|||
16812289|NCT02013609|37754481|FG000|Overall Study|Withdrawal by Subject|9|||
16812290|NCT02013609|37754481|FG000|Overall Study|Lost to Follow-up|3|||
16812291|NCT02013609|37754481|FG000|Overall Study|Adverse Event|3|||
16812292|NCT02013609|37754481|FG000|Overall Study|Met Withdrawal Criteria|3|||
16812293|NCT01988337|37754485|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
17016585|NCT00855062|38161221|FG000|Step2|Early Study Closure|6|||
17016586|NCT00855062|38161222|FG001|Step2|Early Study Closure|2|||
16812294|NCT02013531|37754491|FG000|Overall Study|Lost to Follow-up|3|||
16812295|NCT02013531|37754491|FG000|Overall Study|Met Withdrawal Criteria|1|||
16812296|NCT02013531|37754491|FG000|Overall Study|Withdrawal by Subject|1|||
16812297|NCT01988103|37754498|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
16812298|NCT01988103|37754499|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
16812299|NCT01988103|37754500|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
17016587|NCT00855062|38161221|FG000|Step2|Adverse Event|0|||
16812300|NCT01988103|37754501|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
16812301|NCT01988103|37754502|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
16812302|NCT01988103|37754498|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
16812303|NCT01988103|37754499|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
16812304|NCT01988103|37754500|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
16812305|NCT01988103|37754501|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
16812306|NCT01988103|37754502|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
16812307|NCT01988103|37754498|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
16812308|NCT01988103|37754499|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
16812309|NCT01988103|37754500|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
16812310|NCT01988103|37754501|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
16812311|NCT01988103|37754502|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
16812312|NCT01988103|37754498|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
16812313|NCT01988103|37754499|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
16812314|NCT01988103|37754500|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
16812315|NCT01988103|37754501|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
16812316|NCT01988103|37754502|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
16812317|NCT01988103|37754498|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
16812318|NCT01988103|37754499|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
16812319|NCT01988103|37754500|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
16812320|NCT01988103|37754501|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
16812321|NCT01988103|37754502|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
16812322|NCT01988103|37754498|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
16812323|NCT01988103|37754499|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
16812324|NCT01988103|37754500|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
16812325|NCT01988103|37754501|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
16812326|NCT01988103|37754502|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
16812327|NCT01988103|37754498|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
16812328|NCT01988103|37754499|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
16812329|NCT01988103|37754500|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
16812330|NCT01988103|37754501|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
16812331|NCT01988103|37754502|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
16812332|NCT02013375|37754517|FG000|Overall Study|Did not engraft|1|||
16812333|NCT02013375|37754517|FG000|Overall Study|Did not engraft|1|||
16812334|NCT02079519|37754522|FG000|Overall Study|Disease Progression|9|||
16812335|NCT02079519|37754522|FG000|Overall Study|Adverse Event|1|||
16812336|NCT01987557|37754529|FG000|Overall Study|Protocol Violation|1|||
16812337|NCT01987557|37754530|FG001|Overall Study|Protocol Violation|0|||
16812338|NCT01987557|37754531|FG002|Overall Study|Protocol Violation|1|||
16812339|NCT01987557|37754529|FG000|Overall Study|Withdrawal by Subject|2|||
16812340|NCT01987557|37754530|FG001|Overall Study|Withdrawal by Subject|1|||
16812341|NCT01987557|37754531|FG002|Overall Study|Withdrawal by Subject|2|||
16812342|NCT01987557|37754529|FG000|Overall Study|Adverse Event|0|||
16812343|NCT01987557|37754530|FG001|Overall Study|Adverse Event|2|||
16812344|NCT01987557|37754531|FG002|Overall Study|Adverse Event|0|||
16812345|NCT02078817|37754539|FG000|Overall Study|Withdrawal by Subject|1|||
16812346|NCT02011893|37754543|FG000|Enrollment to Randomization|Adverse Event|2|||
16812347|NCT02011893|37754544|FG001|Enrollment to Randomization|Adverse Event|0|||
16812348|NCT02011893|37754545|FG002|Enrollment to Randomization|Adverse Event|0|||
16812349|NCT02011893|37754543|FG000|Enrollment to Randomization|Physician Decision|10|||
16812350|NCT02011893|37754544|FG001|Enrollment to Randomization|Physician Decision|0|||
16812351|NCT02011893|37754545|FG002|Enrollment to Randomization|Physician Decision|0|||
16812352|NCT02011893|37754543|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
16812353|NCT02011893|37754544|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
16812354|NCT02011893|37754545|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
16812355|NCT02011893|37754543|FG000|Enrollment to Randomization|Screening Failure|29|||
16812356|NCT02011893|37754544|FG001|Enrollment to Randomization|Screening Failure|0|||
16812357|NCT02011893|37754545|FG002|Enrollment to Randomization|Screening Failure|0|||
16812358|NCT02011893|37754543|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
16812359|NCT02011893|37754544|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
16812360|NCT02011893|37754545|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
16812361|NCT02011893|37754543|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
16812362|NCT02011893|37754544|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
16812363|NCT02011893|37754545|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
16812364|NCT02011893|37754543|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
16812365|NCT02011893|37754544|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
16812366|NCT02011893|37754545|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
16910209|NCT01691898|38018981|FG002|Overall Study|Adverse Event|0|||
16812367|NCT02011893|37754543|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
16812368|NCT02011893|37754544|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
16812369|NCT02011893|37754545|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
16812370|NCT02011893|37754543|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
16812371|NCT02011893|37754544|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
16812372|NCT02011893|37754545|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
16812373|NCT02011113|37754550|FG000|Overall Study|Adverse Event|4|||
16812374|NCT02011113|37754550|FG000|Overall Study|Disease Progression (DP)|16|||
16812375|NCT02011113|37754550|FG000|Overall Study|Death|1|||
16812376|NCT02011113|37754550|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
16812377|NCT02011113|37754550|FG000|Overall Study|Investigator's judgement- DP|3|||
16812378|NCT02011113|37754550|FG000|Overall Study|Study terminated by sponsor|11|||
16812379|NCT01987479|37754555|FG000|Overall Study|Protocol Violation|1|||
16812380|NCT01987479|37754555|FG000|Overall Study|Physician Decision|2|||
16812381|NCT01987479|37754555|FG000|Overall Study|Participant/legal guardian decision|1|||
16812382|NCT01987479|37754555|FG000|Overall Study|Other|5|||
16812383|NCT01987479|37754555|FG000|Overall Study|Lost to Follow-up|1|||
16812384|NCT01987479|37754555|FG000|Overall Study|Adverse Event|7|||
16812385|NCT01620489|37754561|FG000|Overall Study|Adverse Event|17|||
16812386|NCT01620489|37754562|FG001|Overall Study|Adverse Event|4|||
16812387|NCT01620489|37754561|FG000|Overall Study|Protocol Violation|0|||
16812388|NCT01620489|37754562|FG001|Overall Study|Protocol Violation|3|||
16812389|NCT01620489|37754561|FG000|Overall Study|Withdrawal Criteria|17|||
16812390|NCT01620489|37754562|FG001|Overall Study|Withdrawal Criteria|25|||
16812391|NCT01620489|37754561|FG000|Overall Study|Unclassified|1|||
16812392|NCT01620489|37754562|FG001|Overall Study|Unclassified|2|||
16812393|NCT02076165|37754570|FG000|Overall Study|Lost to Follow-up|7|||
16812394|NCT02076165|37754571|FG001|Overall Study|Lost to Follow-up|5|||
16812395|NCT02076165|37754570|FG000|Overall Study|Refused follow-up assessment|1|||
16812396|NCT02076165|37754571|FG001|Overall Study|Refused follow-up assessment|1|||
16812397|NCT01620255|37754582|FG000|Overall Study|Withdrawal by Subject|4|||
16812398|NCT01620255|37754583|FG001|Overall Study|Withdrawal by Subject|1|||
16812399|NCT01620255|37754584|FG002|Overall Study|Withdrawal by Subject|1|||
16812400|NCT01620255|37754585|FG003|Overall Study|Withdrawal by Subject|2|||
16812401|NCT01620255|37754586|FG004|Overall Study|Withdrawal by Subject|4|||
16812402|NCT01620255|37754582|FG000|Overall Study|Participant underwent fecal transplant|0|||
16812403|NCT01620255|37754583|FG001|Overall Study|Participant underwent fecal transplant|0|||
16812404|NCT01620255|37754584|FG002|Overall Study|Participant underwent fecal transplant|1|||
16812405|NCT01620255|37754585|FG003|Overall Study|Participant underwent fecal transplant|0|||
16812406|NCT01620255|37754586|FG004|Overall Study|Participant underwent fecal transplant|0|||
16812407|NCT01620255|37754582|FG000|Overall Study|Non-compliance|0|||
16812408|NCT01620255|37754583|FG001|Overall Study|Non-compliance|1|||
16812409|NCT01620255|37754584|FG002|Overall Study|Non-compliance|0|||
16812410|NCT01620255|37754585|FG003|Overall Study|Non-compliance|0|||
16812411|NCT01620255|37754586|FG004|Overall Study|Non-compliance|0|||
16812412|NCT01620255|37754582|FG000|Overall Study|Adverse Event|0|||
16812413|NCT01620255|37754583|FG001|Overall Study|Adverse Event|4|||
16812414|NCT01620255|37754584|FG002|Overall Study|Adverse Event|0|||
16812415|NCT01620255|37754585|FG003|Overall Study|Adverse Event|1|||
16812416|NCT01620255|37754586|FG004|Overall Study|Adverse Event|1|||
16812417|NCT01620255|37754582|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
16812418|NCT01620255|37754583|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
16812419|NCT01620255|37754584|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
16812420|NCT01620255|37754585|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
16812421|NCT01620255|37754586|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
16812422|NCT02010567|37754603|FG000|Overall Study|Adverse Event|0|||
16812423|NCT02010567|37754604|FG001|Overall Study|Adverse Event|0|||
16812424|NCT02010567|37754605|FG002|Overall Study|Adverse Event|1|||
16812425|NCT02010567|37754606|FG003|Overall Study|Adverse Event|0|||
16812426|NCT02010567|37754607|FG004|Overall Study|Adverse Event|1|||
16812427|NCT01806064|37754622|FG000|Overall Study|Randomized Not Enrolled|0|||
16812428|NCT01806064|37754623|FG001|Overall Study|Randomized Not Enrolled|0|||
16812429|NCT01806064|37754624|FG002|Overall Study|Randomized Not Enrolled|0|||
16812430|NCT01806064|37754625|FG003|Overall Study|Randomized Not Enrolled|1|||
16812431|NCT01806064|37754626|FG004|Overall Study|Randomized Not Enrolled|2|||
16812432|NCT01804582|37754644|FG000|Overall Study|Lost to Follow-up|47|||
16812433|NCT01804582|37754645|FG001|Overall Study|Lost to Follow-up|56|||
16812434|NCT01804582|37754644|FG000|Overall Study|Physician Decision|2|||
16812435|NCT01804582|37754645|FG001|Overall Study|Physician Decision|0|||
16812436|NCT01787188|37754655|FG000|Overall Study|Adverse Event|2|||
16812437|NCT01787188|37754656|FG001|Overall Study|Adverse Event|4|||
16812438|NCT01787188|37754657|FG002|Overall Study|Adverse Event|6|||
16812439|NCT01787188|37754655|FG000|Overall Study|Lack of Efficacy|7|||
16812440|NCT01787188|37754656|FG001|Overall Study|Lack of Efficacy|3|||
16812441|NCT01787188|37754657|FG002|Overall Study|Lack of Efficacy|5|||
16910210|NCT01691898|38018982|FG003|Overall Study|Adverse Event|1|||
16812442|NCT01787188|37754655|FG000|Overall Study|Non-compliance with Study Drug|0|||
16812443|NCT01787188|37754656|FG001|Overall Study|Non-compliance with Study Drug|1|||
16812444|NCT01787188|37754657|FG002|Overall Study|Non-compliance with Study Drug|0|||
16812445|NCT01787188|37754655|FG000|Overall Study|Withdrawal by Subject|4|||
16812446|NCT01787188|37754656|FG001|Overall Study|Withdrawal by Subject|3|||
16812447|NCT01787188|37754657|FG002|Overall Study|Withdrawal by Subject|2|||
16812448|NCT01787188|37754655|FG000|Overall Study|Protocol Violation|3|||
16812449|NCT01787188|37754656|FG001|Overall Study|Protocol Violation|2|||
16812450|NCT01787188|37754657|FG002|Overall Study|Protocol Violation|3|||
16812451|NCT01787188|37754655|FG000|Overall Study|Lost to Follow-up|1|||
16812452|NCT01787188|37754656|FG001|Overall Study|Lost to Follow-up|2|||
16812453|NCT01787188|37754657|FG002|Overall Study|Lost to Follow-up|2|||
16812454|NCT01787188|37754655|FG000|Overall Study|Other, including patient moved|0|||
16812455|NCT01787188|37754656|FG001|Overall Study|Other, including patient moved|3|||
16812456|NCT01787188|37754657|FG002|Overall Study|Other, including patient moved|0|||
16812457|NCT01787032|37754671|FG000|Overall Study|Protocol Violation|0|||
16812458|NCT01787032|37754672|FG001|Overall Study|Protocol Violation|0|||
16812459|NCT01787032|37754673|FG002|Overall Study|Protocol Violation|0|||
16812460|NCT01787032|37754674|FG003|Overall Study|Protocol Violation|0|||
16812461|NCT01787032|37754675|FG004|Overall Study|Protocol Violation|1|||
16812462|NCT01787032|37754676|FG005|Overall Study|Protocol Violation|1|||
16812463|NCT01737268|37754686|FG000|Overall Study|Adverse Event|6|||
16812464|NCT01737268|37754686|FG000|Overall Study|Worsening of Target Disease|2|||
16812465|NCT01737268|37754686|FG000|Overall Study|In consideration of the patient's safety|1|||
16812466|NCT01769404|37754691|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
16812467|NCT01769404|37754692|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
16812468|NCT01769404|37754691|FG000|Treatment Period 1|Withdrawal by Subject|3|||
16812469|NCT01769404|37754692|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16812470|NCT01769404|37754691|FG000|Treatment Period 1|Sponsor decision|1|||
16812471|NCT01769404|37754692|FG001|Treatment Period 1|Sponsor decision|0|||
16812472|NCT01769404|37754691|FG000|Treatment Period 2|Sponsor decision|7|||
16812473|NCT01769404|37754692|FG001|Treatment Period 2|Sponsor decision|0|||
16812474|NCT01769326|37754704|FG000|Overall Study|Lost to Follow-up|1|||
16812475|NCT01769326|37754705|FG001|Overall Study|Lost to Follow-up|2|||
16812476|NCT01769326|37754706|FG002|Overall Study|Lost to Follow-up|0|||
16812477|NCT01769326|37754707|FG003|Overall Study|Lost to Follow-up|0|||
16812478|NCT01769326|37754704|FG000|Overall Study|unrelated injry|1|||
16812479|NCT01769326|37754705|FG001|Overall Study|unrelated injry|1|||
16812480|NCT01769326|37754706|FG002|Overall Study|unrelated injry|0|||
16812481|NCT01769326|37754707|FG003|Overall Study|unrelated injry|0|||
16812482|NCT01769326|37754704|FG000|Overall Study|got a job|0|||
16812483|NCT01769326|37754705|FG001|Overall Study|got a job|1|||
16812484|NCT01769326|37754706|FG002|Overall Study|got a job|0|||
16812485|NCT01769326|37754707|FG003|Overall Study|got a job|0|||
16812486|NCT01769326|37754704|FG000|Overall Study|Got sick and could not complete study|0|||
16812487|NCT01769326|37754705|FG001|Overall Study|Got sick and could not complete study|0|||
16812488|NCT01769326|37754706|FG002|Overall Study|Got sick and could not complete study|1|||
16812489|NCT01769326|37754707|FG003|Overall Study|Got sick and could not complete study|0|||
16812490|NCT01786564|37754717|FG000|Overall Study|Lost to Follow-up|47|||
16812491|NCT01786564|37754717|FG000|Overall Study|Ineligible|17|||
16812492|NCT01786330|37754723|FG000|Overall Study|Withdrawal by Subject|0|||
16812493|NCT01786330|37754724|FG001|Overall Study|Withdrawal by Subject|1|||
16812494|NCT01786330|37754723|FG000|Overall Study|Lost to Follow-up|0|||
16812495|NCT01786330|37754724|FG001|Overall Study|Lost to Follow-up|1|||
16812496|NCT01786330|37754723|FG000|Overall Study|Excluded intraoperatively|0|||
16812497|NCT01786330|37754724|FG001|Overall Study|Excluded intraoperatively|1|||
16812498|NCT01786330|37754723|FG000|Overall Study|Protocol Violation|1|||
16812499|NCT01786330|37754724|FG001|Overall Study|Protocol Violation|0|||
16812500|NCT01786174|37754732|FG000|Overall Study|Discontinued Study Drug|2|||
16812501|NCT01786174|37754733|FG001|Overall Study|Discontinued Study Drug|0|||
16812502|NCT01736566|37754744|FG000|Long Term Follow-up|Still collecting data|42|||
17102329|NCT00116558|38241233|FG002|Overall Study|Death|3|||
16812503|NCT01736566|37754745|FG001|Long Term Follow-up|Still collecting data|0|||
16812504|NCT01736566|37754746|FG002|Long Term Follow-up|Still collecting data|49|||
16812505|NCT01736566|37754747|FG003|Long Term Follow-up|Still collecting data|0|||
16812506|NCT01736566|37754748|FG004|Long Term Follow-up|Still collecting data|1|||
16812507|NCT01768858|37754773|FG000|Overall Study|Lost to Follow-up|9|||
16812508|NCT01768858|37754773|FG000|Overall Study|Lack of Efficacy|8|||
16812509|NCT01768858|37754773|FG000|Overall Study|Serious Adverse Event|1|||
16812510|NCT01768858|37754773|FG000|Overall Study|Participant moved to Germany|1|||
16812511|NCT01768858|37754773|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
16812512|NCT01768858|37754773|FG000|Overall Study|Exanthema|1|||
16812513|NCT01768858|37754773|FG000|Overall Study|Withdrawal by Subject|1|||
16812514|NCT01736254|37754777|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
16812515|NCT01736254|37754777|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
16812516|NCT01767376|37754788|FG000|Overall Study|Lost to Follow-up|3|||
17102330|NCT00116558|38241231|FG000|Overall Study|Withdrawal by Subject|17|||
16812517|NCT01767376|37754789|FG001|Overall Study|Lost to Follow-up|2|||
16812518|NCT01767376|37754790|FG002|Overall Study|Lost to Follow-up|0|||
16812519|NCT01767376|37754788|FG000|Overall Study|Withdrawal by Subject|1|||
16812520|NCT01767376|37754789|FG001|Overall Study|Withdrawal by Subject|1|||
16812521|NCT01767376|37754790|FG002|Overall Study|Withdrawal by Subject|0|||
16812522|NCT01767142|37754800|FG000|Overall Study|Lost to Follow-up|3|||
16812523|NCT01785628|37754806|FG000|Overall Study|Lost to Follow-up|2|||
16812524|NCT01785628|37754807|FG001|Overall Study|Lost to Follow-up|3|||
16812525|NCT01785472|37754816|FG000|Overall Study|Adverse Event|5|||
16812526|NCT01785472|37754817|FG001|Overall Study|Adverse Event|4|||
16812527|NCT01785472|37754818|FG002|Overall Study|Adverse Event|6|||
16812528|NCT01785472|37754816|FG000|Overall Study|Lack of Efficacy|2|||
16812529|NCT01785472|37754817|FG001|Overall Study|Lack of Efficacy|0|||
16812530|NCT01785472|37754818|FG002|Overall Study|Lack of Efficacy|1|||
16812531|NCT01785472|37754816|FG000|Overall Study|Lost to Follow-up|1|||
16812532|NCT01785472|37754817|FG001|Overall Study|Lost to Follow-up|2|||
16812533|NCT01785472|37754818|FG002|Overall Study|Lost to Follow-up|0|||
16812534|NCT01785472|37754816|FG000|Overall Study|Physician Decision|1|||
16812535|NCT01785472|37754817|FG001|Overall Study|Physician Decision|1|||
16812536|NCT01785472|37754818|FG002|Overall Study|Physician Decision|1|||
16812537|NCT01785472|37754816|FG000|Overall Study|Protocol deviation|0|||
16812538|NCT01785472|37754817|FG001|Overall Study|Protocol deviation|2|||
16812539|NCT01785472|37754818|FG002|Overall Study|Protocol deviation|2|||
16812540|NCT01785472|37754816|FG000|Overall Study|Subject/guardian decision|15|||
16812541|NCT01785472|37754817|FG001|Overall Study|Subject/guardian decision|10|||
16812542|NCT01785472|37754818|FG002|Overall Study|Subject/guardian decision|11|||
16812543|NCT01785472|37754816|FG000|Overall Study|Technical problems|0|||
16812544|NCT01785472|37754817|FG001|Overall Study|Technical problems|0|||
16812545|NCT01785472|37754818|FG002|Overall Study|Technical problems|1|||
16812546|NCT01785160|37754828|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
16812547|NCT01785160|37754828|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
16812548|NCT01736176|37754834|FG000|Overall Study|Adverse Event|3|||
16812549|NCT01736176|37754834|FG000|Overall Study|Withdrawal by Subject|4|||
16812550|NCT01736176|37754834|FG000|Overall Study|Lack of Efficacy|3|||
16812551|NCT01736176|37754834|FG000|Overall Study|Unable to Complete PEG Placement|1|||
16812552|NCT01735630|37754844|FG000|Overall Study|Adverse Event|8|||
16812553|NCT01735630|37754845|FG001|Overall Study|Adverse Event|7|||
16812554|NCT01735630|37754844|FG000|Overall Study|Lost to Follow-up|1|||
16812555|NCT01735630|37754845|FG001|Overall Study|Lost to Follow-up|0|||
16812556|NCT01735630|37754844|FG000|Overall Study|Physician Decision|0|||
16812557|NCT01735630|37754845|FG001|Overall Study|Physician Decision|1|||
16812558|NCT01735630|37754844|FG000|Overall Study|Sponsor Decision|2|||
16812559|NCT01735630|37754845|FG001|Overall Study|Sponsor Decision|1|||
16812560|NCT01735630|37754844|FG000|Overall Study|Withdrawal by Subject|7|||
16812561|NCT01735630|37754845|FG001|Overall Study|Withdrawal by Subject|9|||
16812562|NCT01735396|37754851|FG000|Overall Study|not evaluable|1|||
16812563|NCT01766206|37754855|FG000|Overall Study|Withdrawal by Subject|22|||
16812564|NCT01766206|37754855|FG000|Overall Study|Lost to Follow-up|10|||
16812565|NCT01766206|37754855|FG000|Overall Study|Inappropriate enrollment|18|||
16812566|NCT01766206|37754855|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
16812567|NCT01734850|37754862|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
16812568|NCT01734850|37754863|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
16812569|NCT01734850|37754864|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
16812570|NCT01734850|37754862|FG000|Overall Study|Not infused due to manufacturing failure|0|||
16812571|NCT01734850|37754863|FG001|Overall Study|Not infused due to manufacturing failure|0|||
16812572|NCT01734850|37754864|FG002|Overall Study|Not infused due to manufacturing failure|1|||
16812573|NCT01766050|37754875|FG000|Overall Study|Adverse Event|1|||
16812574|NCT01766050|37754875|FG000|Overall Study|Lost to Follow-up|1|||
16812575|NCT01766050|37754875|FG000|Overall Study|Withdrawal by Subject|2|||
16812576|NCT02341625|37754903|FG000|Overall Study|Disease Progression|2|||
16812577|NCT02341625|37754904|FG001|Overall Study|Disease Progression|2|||
16812578|NCT02341625|37754905|FG002|Overall Study|Disease Progression|3|||
16812579|NCT02341625|37754906|FG003|Overall Study|Disease Progression|6|||
16812580|NCT02341625|37754907|FG004|Overall Study|Disease Progression|7|||
16812581|NCT02341625|37754908|FG005|Overall Study|Disease Progression|7|||
17016588|NCT00855062|38161222|FG001|Step2|Adverse Event|3|||
16812582|NCT02341625|37754909|FG006|Overall Study|Disease Progression|28|||
16812583|NCT02341625|37754910|FG007|Overall Study|Disease Progression|5|||
16812584|NCT02341625|37754911|FG008|Overall Study|Disease Progression|4|||
16910211|NCT01691898|38018983|FG004|Overall Study|Adverse Event|1|||
16812585|NCT02341625|37754912|FG009|Overall Study|Disease Progression|19|||
16812586|NCT02341625|37754903|FG000|Overall Study|Study Drug Toxicity|0|||
16812587|NCT02341625|37754904|FG001|Overall Study|Study Drug Toxicity|0|||
16812588|NCT02341625|37754905|FG002|Overall Study|Study Drug Toxicity|0|||
16812589|NCT02341625|37754906|FG003|Overall Study|Study Drug Toxicity|1|||
16812590|NCT02341625|37754907|FG004|Overall Study|Study Drug Toxicity|0|||
16812591|NCT02341625|37754908|FG005|Overall Study|Study Drug Toxicity|3|||
16812592|NCT02341625|37754909|FG006|Overall Study|Study Drug Toxicity|10|||
16812593|NCT02341625|37754910|FG007|Overall Study|Study Drug Toxicity|0|||
16812594|NCT02341625|37754911|FG008|Overall Study|Study Drug Toxicity|0|||
16812595|NCT02341625|37754912|FG009|Overall Study|Study Drug Toxicity|3|||
16812596|NCT02341625|37754903|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16812597|NCT02341625|37754904|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16812598|NCT02341625|37754905|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16812599|NCT02341625|37754906|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16812600|NCT02341625|37754907|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16812601|NCT02341625|37754908|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16812602|NCT02341625|37754909|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16812603|NCT02341625|37754910|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
16812604|NCT02341625|37754911|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16812605|NCT02341625|37754912|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16812606|NCT02341625|37754903|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16812607|NCT02341625|37754904|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16812608|NCT02341625|37754905|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16812609|NCT02341625|37754906|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16812610|NCT02341625|37754907|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16812611|NCT02341625|37754908|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16812612|NCT02341625|37754909|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
16812613|NCT02341625|37754910|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
16812614|NCT02341625|37754911|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16812615|NCT02341625|37754912|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16812616|NCT02341625|37754903|FG000|Overall Study|Participant Withdrew Consent|0|||
16812617|NCT02341625|37754904|FG001|Overall Study|Participant Withdrew Consent|0|||
16812618|NCT02341625|37754905|FG002|Overall Study|Participant Withdrew Consent|0|||
16812619|NCT02341625|37754906|FG003|Overall Study|Participant Withdrew Consent|1|||
16812620|NCT02341625|37754907|FG004|Overall Study|Participant Withdrew Consent|0|||
16812621|NCT02341625|37754908|FG005|Overall Study|Participant Withdrew Consent|0|||
16812622|NCT02341625|37754909|FG006|Overall Study|Participant Withdrew Consent|0|||
16812623|NCT02341625|37754910|FG007|Overall Study|Participant Withdrew Consent|0|||
16812624|NCT02341625|37754911|FG008|Overall Study|Participant Withdrew Consent|0|||
16812625|NCT02341625|37754912|FG009|Overall Study|Participant Withdrew Consent|0|||
16812626|NCT02341625|37754903|FG000|Overall Study|Completed Treatment as per Protocol|0|||
16812627|NCT02341625|37754904|FG001|Overall Study|Completed Treatment as per Protocol|0|||
16812628|NCT02341625|37754905|FG002|Overall Study|Completed Treatment as per Protocol|0|||
16812629|NCT02341625|37754906|FG003|Overall Study|Completed Treatment as per Protocol|0|||
16812630|NCT02341625|37754907|FG004|Overall Study|Completed Treatment as per Protocol|0|||
16812631|NCT02341625|37754908|FG005|Overall Study|Completed Treatment as per Protocol|0|||
16812632|NCT02341625|37754909|FG006|Overall Study|Completed Treatment as per Protocol|0|||
16812633|NCT02341625|37754910|FG007|Overall Study|Completed Treatment as per Protocol|0|||
16812634|NCT02341625|37754911|FG008|Overall Study|Completed Treatment as per Protocol|0|||
16812635|NCT02341625|37754912|FG009|Overall Study|Completed Treatment as per Protocol|1|||
16812636|NCT02341625|37754903|FG000|Overall Study|Other Reasons|0|||
16812637|NCT02341625|37754904|FG001|Overall Study|Other Reasons|0|||
16812638|NCT02341625|37754905|FG002|Overall Study|Other Reasons|0|||
16812639|NCT02341625|37754906|FG003|Overall Study|Other Reasons|0|||
16812640|NCT02341625|37754907|FG004|Overall Study|Other Reasons|1|||
16812641|NCT02341625|37754908|FG005|Overall Study|Other Reasons|0|||
16812642|NCT02341625|37754909|FG006|Overall Study|Other Reasons|5|||
16812643|NCT02341625|37754910|FG007|Overall Study|Other Reasons|0|||
16812644|NCT02341625|37754911|FG008|Overall Study|Other Reasons|0|||
16812645|NCT02341625|37754912|FG009|Overall Study|Other Reasons|2|||
16812646|NCT02341625|37754903|FG000|Overall Study|Not Reported|0|||
16812647|NCT02341625|37754904|FG001|Overall Study|Not Reported|0|||
16812648|NCT02341625|37754905|FG002|Overall Study|Not Reported|0|||
16812649|NCT02341625|37754906|FG003|Overall Study|Not Reported|0|||
16812650|NCT02341625|37754907|FG004|Overall Study|Not Reported|0|||
16812651|NCT02341625|37754908|FG005|Overall Study|Not Reported|0|||
16812652|NCT02341625|37754909|FG006|Overall Study|Not Reported|0|||
16812653|NCT02341625|37754910|FG007|Overall Study|Not Reported|0|||
16812654|NCT02341625|37754911|FG008|Overall Study|Not Reported|0|||
16812655|NCT02341625|37754912|FG009|Overall Study|Not Reported|3|||
16812656|NCT02370095|37754959|FG000|Overall Study|Withdrawal by Subject|0|||
16812657|NCT02370095|37754960|FG001|Overall Study|Withdrawal by Subject|1|||
16812658|NCT01784068|37754966|FG000|NTCS Phase|Adverse Event|5|||
16812659|NCT01784068|37754967|FG001|NTCS Phase|Adverse Event|0|||
16812660|NCT01784068|37754966|FG000|NTCS Phase|Physician Decision|2|||
16812661|NCT01784068|37754967|FG001|NTCS Phase|Physician Decision|0|||
16812662|NCT01784068|37754966|FG000|NTCS Phase|Patient/guardian decision|3|||
16910212|NCT01691898|38018984|FG005|Overall Study|Adverse Event|0|||
16812663|NCT01784068|37754967|FG001|NTCS Phase|Patient/guardian decision|0|||
16812664|NCT01784068|37754966|FG000|NTCS Phase|Death|2|||
16812665|NCT01784068|37754967|FG001|NTCS Phase|Death|0|||
16910213|NCT01691898|38018979|FG000|Overall Study|Progression of Disease|1|||
16910214|NCT01691898|38018980|FG001|Overall Study|Progression of Disease|2|||
16910215|NCT01691898|38018981|FG002|Overall Study|Progression of Disease|1|||
16910216|NCT01691898|38018982|FG003|Overall Study|Progression of Disease|0|||
16910217|NCT01691898|38018983|FG004|Overall Study|Progression of Disease|0|||
16910218|NCT01691898|38018984|FG005|Overall Study|Progression of Disease|1|||
16910219|NCT01691898|38018979|FG000|Overall Study|Lost to Follow-up|3|||
16910220|NCT01691898|38018980|FG001|Overall Study|Lost to Follow-up|1|||
16910221|NCT01691898|38018981|FG002|Overall Study|Lost to Follow-up|0|||
16910222|NCT01691898|38018982|FG003|Overall Study|Lost to Follow-up|0|||
16910223|NCT01691898|38018983|FG004|Overall Study|Lost to Follow-up|1|||
16910224|NCT01691898|38018984|FG005|Overall Study|Lost to Follow-up|0|||
16910225|NCT01691898|38018979|FG000|Overall Study|Withdrawal by Subject|9|||
16910226|NCT01691898|38018980|FG001|Overall Study|Withdrawal by Subject|8|||
16910227|NCT01691898|38018981|FG002|Overall Study|Withdrawal by Subject|2|||
16910228|NCT01691898|38018982|FG003|Overall Study|Withdrawal by Subject|1|||
16910229|NCT01691898|38018983|FG004|Overall Study|Withdrawal by Subject|3|||
16910230|NCT01691898|38018984|FG005|Overall Study|Withdrawal by Subject|3|||
16910231|NCT01691898|38018979|FG000|Overall Study|Non-Compliance|0|||
16910232|NCT01691898|38018980|FG001|Overall Study|Non-Compliance|0|||
16910233|NCT01691898|38018981|FG002|Overall Study|Non-Compliance|0|||
16910234|NCT01691898|38018982|FG003|Overall Study|Non-Compliance|0|||
16910235|NCT01691898|38018983|FG004|Overall Study|Non-Compliance|1|||
16910236|NCT01691898|38018984|FG005|Overall Study|Non-Compliance|0|||
16910237|NCT01737840|38019018|FG000|Overall Study|Diagnosed with an other pathology|2|||
16910238|NCT01737840|38019019|FG001|Overall Study|Diagnosed with an other pathology|2|||
16910239|NCT01691820|38019029|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
16910240|NCT01691820|38019030|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
16910241|NCT01691820|38019029|FG000|Overall Study|Migrated/moved from study area|7|||
16910242|NCT01691820|38019030|FG001|Overall Study|Migrated/moved from study area|4|||
16910243|NCT01691820|38019029|FG000|Overall Study|Lost to Follow-up|6|||
16910244|NCT01691820|38019030|FG001|Overall Study|Lost to Follow-up|17|||
16910245|NCT01691820|38019029|FG000|Overall Study|Other (unspecified)|4|||
16910246|NCT01691820|38019030|FG001|Overall Study|Other (unspecified)|1|||
16910247|NCT01711866|38019040|FG000|Overall Study|Noncompliant|3|||
16910248|NCT01711866|38019040|FG000|Overall Study|Withdrawal by Subject|3|||
16910249|NCT01711866|38019040|FG000|Overall Study|Adverse Event|2|||
16910250|NCT01737762|38019046|FG000|Overall Study|Adverse Event|2|||
16910251|NCT01737762|38019047|FG001|Overall Study|Adverse Event|2|||
16910252|NCT01737762|38019046|FG000|Overall Study|Lost to Follow-up|1|||
16910253|NCT01737762|38019047|FG001|Overall Study|Lost to Follow-up|0|||
16910254|NCT01737762|38019046|FG000|Overall Study|Withdrawal by Subject|2|||
16910255|NCT01737762|38019047|FG001|Overall Study|Withdrawal by Subject|2|||
16910256|NCT01737762|38019046|FG000|Overall Study|Progressive disease|1|||
16910257|NCT01737762|38019047|FG001|Overall Study|Progressive disease|2|||
16910258|NCT01737762|38019046|FG000|Overall Study|Physician Decision|1|||
16910259|NCT01737762|38019047|FG001|Overall Study|Physician Decision|1|||
16910260|NCT01737762|38019046|FG000|Overall Study|Moved from area|2|||
16910261|NCT01737762|38019047|FG001|Overall Study|Moved from area|1|||
16910262|NCT01737762|38019046|FG000|Overall Study|Trial termination|11|||
16910263|NCT01737762|38019047|FG001|Overall Study|Trial termination|9|||
16910264|NCT01691508|38019055|FG000|Overall Study|Adverse Event|3|||
16910265|NCT01691508|38019056|FG001|Overall Study|Adverse Event|3|||
16910266|NCT01691508|38019055|FG000|Overall Study|Withdrawal by Subject|1|||
16910267|NCT01691508|38019056|FG001|Overall Study|Withdrawal by Subject|0|||
16910268|NCT01682460|38019062|FG000|Overall Study|Withdrawal by Subject|2|||
16910269|NCT01682460|38019062|FG000|Overall Study|Did not meet inclusion criteria|2|||
16910270|NCT01691430|38019068|FG000|Overall Study|Death|17|||
16910271|NCT01691430|38019069|FG001|Overall Study|Death|16|||
17198385|NCT01367249|38352066|FG000|Overall Study|Other|3|||
16812666|NCT01784068|37754966|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
16812667|NCT01784068|37754967|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
16812668|NCT01784068|37754966|FG000|TFR Phase|Physician Decision|0|||
16812669|NCT01784068|37754967|FG001|TFR Phase|Physician Decision|1|||
16812670|NCT01784068|37754966|FG000|TFR Phase|Patient/guardian decision|0|||
16812671|NCT01784068|37754967|FG001|TFR Phase|Patient/guardian decision|3|||
16812672|NCT01784068|37754966|FG000|TFR Phase|Death|0|||
16812673|NCT01784068|37754967|FG001|TFR Phase|Death|1|||
16812674|NCT01784068|37754966|FG000|TFR Phase|Lack of Efficacy|0|||
16910272|NCT01691430|38019068|FG000|Overall Study|Withdrawal by Subject|5|||
16910273|NCT01691430|38019069|FG001|Overall Study|Withdrawal by Subject|1|||
16910274|NCT01691430|38019068|FG000|Overall Study|Lost to Follow-up|0|||
16910275|NCT01691430|38019069|FG001|Overall Study|Lost to Follow-up|3|||
16910276|NCT01709838|38019075|FG000|Overall Study|Withdrawal by Subject|21|||
16910277|NCT01709838|38019075|FG000|Overall Study|Lost to Follow-up|16|||
16910278|NCT01709838|38019075|FG000|Overall Study|Pregnancy|10|||
16812675|NCT01784068|37754967|FG001|TFR Phase|Lack of Efficacy|88|||
16812676|NCT01783678|37754984|FG000|Overall Study|Randomized but Not Treated|0|||
16812677|NCT01783678|37754985|FG001|Overall Study|Randomized but Not Treated|0|||
16812678|NCT01783678|37754986|FG002|Overall Study|Randomized but Not Treated|0|||
16812679|NCT01783678|37754987|FG003|Overall Study|Randomized but Not Treated|1|||
16812680|NCT01783678|37754988|FG004|Overall Study|Randomized but Not Treated|0|||
16812681|NCT01783678|37754989|FG005|Overall Study|Randomized but Not Treated|0|||
16812682|NCT01783678|37754984|FG000|Overall Study|Lack of Efficacy|1|||
16812683|NCT01783678|37754985|FG001|Overall Study|Lack of Efficacy|13|||
16812684|NCT01783678|37754986|FG002|Overall Study|Lack of Efficacy|1|||
16812685|NCT01783678|37754987|FG003|Overall Study|Lack of Efficacy|3|||
16812686|NCT01783678|37754988|FG004|Overall Study|Lack of Efficacy|6|||
16812687|NCT01783678|37754989|FG005|Overall Study|Lack of Efficacy|5|||
16812688|NCT01783678|37754984|FG000|Overall Study|Lost to Follow-up|0|||
16812689|NCT01783678|37754985|FG001|Overall Study|Lost to Follow-up|4|||
16812690|NCT01783678|37754986|FG002|Overall Study|Lost to Follow-up|0|||
16812691|NCT01783678|37754987|FG003|Overall Study|Lost to Follow-up|2|||
16812692|NCT01783678|37754988|FG004|Overall Study|Lost to Follow-up|1|||
16812693|NCT01783678|37754989|FG005|Overall Study|Lost to Follow-up|0|||
16812694|NCT01783678|37754984|FG000|Overall Study|Withdrew Consent|1|||
16812695|NCT01783678|37754985|FG001|Overall Study|Withdrew Consent|1|||
16812696|NCT01783678|37754986|FG002|Overall Study|Withdrew Consent|0|||
16812697|NCT01783678|37754987|FG003|Overall Study|Withdrew Consent|2|||
16812698|NCT01783678|37754988|FG004|Overall Study|Withdrew Consent|0|||
16812699|NCT01783678|37754989|FG005|Overall Study|Withdrew Consent|0|||
16812700|NCT01734772|37755006|FG000|Overall Study|Adverse Event|1|||
16812701|NCT01734772|37755007|FG001|Overall Study|Adverse Event|2|||
16812702|NCT01734772|37755006|FG000|Overall Study|Withdrawal by Subject|0|||
16812703|NCT01734772|37755007|FG001|Overall Study|Withdrawal by Subject|1|||
16812704|NCT02340221|37755021|FG000|Overall Study|Death|100|||
16812705|NCT02340221|37755022|FG001|Overall Study|Death|197|||
16812706|NCT02340221|37755021|FG000|Overall Study|Withdrawal by Participant|24|||
16812707|NCT02340221|37755022|FG001|Overall Study|Withdrawal by Participant|37|||
16812708|NCT02340221|37755021|FG000|Overall Study|Lost to Follow-up|4|||
16812709|NCT02340221|37755022|FG001|Overall Study|Lost to Follow-up|15|||
16812710|NCT02340221|37755021|FG000|Overall Study|Reason Not Specified|85|||
16812711|NCT02340221|37755022|FG001|Overall Study|Reason Not Specified|165|||
16812712|NCT02340221|37755021|FG000|Overall Study|Study Terminated by Sponsor|1|||
16812713|NCT02340221|37755022|FG001|Overall Study|Study Terminated by Sponsor|3|||
16812714|NCT02339909|37755032|FG000|Overall Study|Became ineligible after randomisation|89|||
16812715|NCT02339909|37755033|FG001|Overall Study|Became ineligible after randomisation|63|||
16812716|NCT02339909|37755034|FG002|Overall Study|Became ineligible after randomisation|71|||
16812717|NCT02395133|37755046|FG000|Overall Study|Adverse Event|4|||
16812718|NCT02395133|37755047|FG001|Overall Study|Adverse Event|1|||
16812719|NCT02395133|37755048|FG002|Overall Study|Adverse Event|3|||
16812720|NCT02395133|37755049|FG003|Overall Study|Adverse Event|0|||
16812721|NCT02395133|37755046|FG000|Overall Study|Lack of Efficacy|1|||
16812722|NCT02395133|37755047|FG001|Overall Study|Lack of Efficacy|0|||
16812723|NCT02395133|37755048|FG002|Overall Study|Lack of Efficacy|1|||
16812724|NCT02395133|37755049|FG003|Overall Study|Lack of Efficacy|1|||
16812725|NCT02395133|37755046|FG000|Overall Study|Protocol Violation|1|||
16812726|NCT02395133|37755047|FG001|Overall Study|Protocol Violation|1|||
16812727|NCT02395133|37755048|FG002|Overall Study|Protocol Violation|0|||
16812728|NCT02395133|37755049|FG003|Overall Study|Protocol Violation|3|||
16812729|NCT02395133|37755046|FG000|Overall Study|Lost to Follow-up|0|||
16812730|NCT02395133|37755047|FG001|Overall Study|Lost to Follow-up|1|||
16812731|NCT02395133|37755048|FG002|Overall Study|Lost to Follow-up|1|||
16812732|NCT02395133|37755049|FG003|Overall Study|Lost to Follow-up|0|||
16812733|NCT02395133|37755046|FG000|Overall Study|Pregnancy|0|||
16812734|NCT02395133|37755047|FG001|Overall Study|Pregnancy|0|||
16812735|NCT02395133|37755048|FG002|Overall Study|Pregnancy|3|||
16812736|NCT02395133|37755049|FG003|Overall Study|Pregnancy|0|||
16812737|NCT02395133|37755046|FG000|Overall Study|Consent withdrawn with no reason given|1|||
16812738|NCT02395133|37755047|FG001|Overall Study|Consent withdrawn with no reason given|3|||
16812739|NCT02395133|37755048|FG002|Overall Study|Consent withdrawn with no reason given|0|||
16812740|NCT02395133|37755049|FG003|Overall Study|Consent withdrawn with no reason given|2|||
16812741|NCT02395133|37755046|FG000|Overall Study|Consent withdrawn with personal reason|0|||
16812742|NCT02395133|37755047|FG001|Overall Study|Consent withdrawn with personal reason|1|||
16812743|NCT02395133|37755048|FG002|Overall Study|Consent withdrawn with personal reason|0|||
16812744|NCT02395133|37755049|FG003|Overall Study|Consent withdrawn with personal reason|3|||
16812745|NCT02395133|37755046|FG000|Overall Study|Sponsor decision|2|||
16812746|NCT02395133|37755047|FG001|Overall Study|Sponsor decision|0|||
16812747|NCT02395133|37755048|FG002|Overall Study|Sponsor decision|0|||
16812748|NCT02395133|37755049|FG003|Overall Study|Sponsor decision|1|||
16812749|NCT02395133|37755046|FG000|Overall Study|Other than specified above|5|||
16812750|NCT02395133|37755047|FG001|Overall Study|Other than specified above|2|||
16812751|NCT02395133|37755048|FG002|Overall Study|Other than specified above|2|||
16812752|NCT02395133|37755049|FG003|Overall Study|Other than specified above|4|||
16812753|NCT02395055|37755061|FG000|Overall Study|Withdrawal by Subject|7|||
16812754|NCT02395055|37755062|FG001|Overall Study|Withdrawal by Subject|3|||
16812755|NCT02369159|37755070|FG000|Overall Study|Adverse Event|0|||
16812756|NCT02369159|37755071|FG001|Overall Study|Adverse Event|1|||
16812757|NCT02369159|37755070|FG000|Overall Study|Lost to Follow-up|1|||
16812758|NCT02369159|37755071|FG001|Overall Study|Lost to Follow-up|1|||
16812759|NCT02369159|37755070|FG000|Overall Study|Withdrawal by Subject|7|||
16812760|NCT02369159|37755071|FG001|Overall Study|Withdrawal by Subject|0|||
16812761|NCT02368691|37755088|FG000|Overall Study|Death|13|||
16812762|NCT02368691|37755088|FG000|Overall Study|Lack of Efficacy|15|||
16812763|NCT02368691|37755088|FG000|Overall Study|Physician Decision|4|||
16812764|NCT02394665|37755095|FG000|Overall Study|Physician Decision|1|||
16812765|NCT02394665|37755096|FG001|Overall Study|Physician Decision|0|||
16812766|NCT02394665|37755097|FG002|Overall Study|Physician Decision|0|||
16812767|NCT02367911|37755107|FG000|Overall Study|Withdrawal by Subject|3|||
16812768|NCT02367911|37755108|FG001|Overall Study|Withdrawal by Subject|2|||
16812769|NCT02367911|37755107|FG000|Overall Study|Lost to Follow-up|2|||
16812770|NCT02367911|37755108|FG001|Overall Study|Lost to Follow-up|2|||
16812771|NCT02339285|37755117|FG000|Overall Study|Withdrawal by Subject|0|||
16812772|NCT02339285|37755118|FG001|Overall Study|Withdrawal by Subject|1|||
16812773|NCT02339285|37755119|FG002|Overall Study|Withdrawal by Subject|1|||
16812774|NCT02339285|37755117|FG000|Overall Study|Lost to Follow-up|1|||
16812775|NCT02339285|37755118|FG001|Overall Study|Lost to Follow-up|1|||
16812776|NCT02339285|37755119|FG002|Overall Study|Lost to Follow-up|1|||
16812777|NCT02339285|37755117|FG000|Overall Study|Protocol Deviation|0|||
16812778|NCT02339285|37755118|FG001|Overall Study|Protocol Deviation|1|||
16812779|NCT02339285|37755119|FG002|Overall Study|Protocol Deviation|0|||
16812780|NCT02367833|37755130|FG000|Overall Study|Withdrawal by Subject|1|||
16812781|NCT02367833|37755131|FG001|Overall Study|Withdrawal by Subject|1|||
16812782|NCT02367833|37755132|FG002|Overall Study|Withdrawal by Subject|0|||
16812783|NCT02367521|37755142|FG000|Overall Study|severe headache after intervention|2|||
16812784|NCT02367521|37755143|FG001|Overall Study|severe headache after intervention|0|||
16812785|NCT02367521|37755142|FG000|Overall Study|unable to find transportation|2|||
16812786|NCT02367521|37755143|FG001|Overall Study|unable to find transportation|0|||
16812787|NCT02338193|37755152|FG000|Overall Study|Withdrawal by Subject|0|||
16812788|NCT02338193|37755153|FG001|Overall Study|Withdrawal by Subject|0|||
16812789|NCT02338193|37755154|FG002|Overall Study|Withdrawal by Subject|2|||
16812790|NCT02338193|37755152|FG000|Overall Study|Pregnancy|0|||
16812791|NCT02338193|37755153|FG001|Overall Study|Pregnancy|1|||
16812792|NCT02338193|37755154|FG002|Overall Study|Pregnancy|1|||
16812793|NCT02338193|37755152|FG000|Overall Study|Noncompliant with visits|2|||
16812794|NCT02338193|37755153|FG001|Overall Study|Noncompliant with visits|2|||
16812795|NCT02338193|37755154|FG002|Overall Study|Noncompliant with visits|7|||
16812796|NCT02338193|37755152|FG000|Overall Study|moved out of state|0|||
16812797|NCT02338193|37755153|FG001|Overall Study|moved out of state|1|||
16812798|NCT02338193|37755154|FG002|Overall Study|moved out of state|0|||
16812799|NCT02338193|37755152|FG000|Overall Study|intolerant of side effects|1|||
16812800|NCT02338193|37755153|FG001|Overall Study|intolerant of side effects|0|||
16812801|NCT02338193|37755154|FG002|Overall Study|intolerant of side effects|0|||
16812802|NCT01783444|37755165|FG000|Treatment Phase|Adverse Event|9|||
16812803|NCT01783444|37755166|FG001|Treatment Phase|Adverse Event|20|||
16812804|NCT01783444|37755167|FG002|Treatment Phase|Adverse Event|19|||
16812805|NCT01783444|37755165|FG000|Treatment Phase|Disease Progression|76|||
16812806|NCT01783444|37755166|FG001|Treatment Phase|Disease Progression|66|||
16812807|NCT01783444|37755167|FG002|Treatment Phase|Disease Progression|64|||
16812808|NCT01783444|37755165|FG000|Treatment Phase|Death|2|||
16812809|NCT01783444|37755166|FG001|Treatment Phase|Death|2|||
16812810|NCT01783444|37755167|FG002|Treatment Phase|Death|2|||
16812811|NCT01783444|37755165|FG000|Treatment Phase|Protocol Violation|1|||
16812812|NCT01783444|37755166|FG001|Treatment Phase|Protocol Violation|1|||
16812813|NCT01783444|37755167|FG002|Treatment Phase|Protocol Violation|2|||
16812814|NCT01783444|37755165|FG000|Treatment Phase|Withdrawal by Subject|6|||
16812815|NCT01783444|37755166|FG001|Treatment Phase|Withdrawal by Subject|8|||
16812816|NCT01783444|37755167|FG002|Treatment Phase|Withdrawal by Subject|9|||
16812817|NCT01783444|37755165|FG000|Treatment Phase|Administrative problems|2|||
16812818|NCT01783444|37755166|FG001|Treatment Phase|Administrative problems|0|||
16812819|NCT01783444|37755167|FG002|Treatment Phase|Administrative problems|1|||
16812820|NCT01783444|37755165|FG000|Treatment Phase|Physician Decision|8|||
16812821|NCT01783444|37755166|FG001|Treatment Phase|Physician Decision|6|||
16812822|NCT01783444|37755167|FG002|Treatment Phase|Physician Decision|5|||
16812823|NCT01783444|37755165|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
16812824|NCT01783444|37755166|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
16812825|NCT01783444|37755167|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
16812826|NCT01783444|37755165|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
16812827|NCT01783444|37755166|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
16812828|NCT01783444|37755167|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
17198386|NCT01367249|38352067|FG001|Overall Study|Other|10|||
16812829|NCT01783444|37755165|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
16812830|NCT01783444|37755166|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
16812831|NCT01783444|37755167|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
16812832|NCT01783444|37755165|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
16812833|NCT01783444|37755166|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
16812834|NCT01783444|37755167|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
16812835|NCT01783444|37755165|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
16812836|NCT01783444|37755166|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
16812837|NCT01783444|37755167|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
16812838|NCT01783444|37755165|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
16812839|NCT01783444|37755166|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
16812840|NCT01783444|37755167|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
16812841|NCT02367131|37755176|FG000|Overall Study|Adverse Event|64|||
16812842|NCT02367131|37755176|FG000|Overall Study|No visit since the first visit|4|||
16812843|NCT02367131|37755176|FG000|Overall Study|Request by patient|54|||
16812844|NCT02367131|37755176|FG000|Overall Study|Improvement/remission|2|||
16812845|NCT02367131|37755176|FG000|Overall Study|No change/progressive disease|78|||
16812846|NCT02367131|37755176|FG000|Overall Study|Other than stated above|20|||
16812847|NCT02394275|37755180|FG000|Overall Study|Adverse Event|22|||
16812848|NCT02394275|37755180|FG000|Overall Study|Lost to Follow-up|7|||
16812849|NCT01608724|37755185|FG000|Overall Study|Withdrawal by Subject|131|||
16812850|NCT01608724|37755185|FG000|Overall Study|Lost to Follow-up|41|||
16812851|NCT01608724|37755185|FG000|Overall Study|Study-specific discontinuation criteria|32|||
16812852|NCT01608724|37755185|FG000|Overall Study|Adverse Event|29|||
16812853|NCT01608724|37755185|FG000|Overall Study|Protocol Violation|6|||
16812854|NCT01608724|37755185|FG000|Overall Study|bood sugar too high, etc.|3|||
16812855|NCT01608724|37755185|FG000|Overall Study|Safety reasons|1|||
16812856|NCT02366195|37755189|FG000|Overall Study|Protocol-specified criteria|3|||
16812857|NCT02366195|37755189|FG000|Overall Study|Withdrawal by Subject|9|||
16812858|NCT02366195|37755189|FG000|Overall Study|Lost to Follow-up|1|||
16812859|NCT02366195|37755189|FG000|Overall Study|Death|41|||
16812860|NCT02364947|37755196|FG000|Overall Study|Withdrawal by Subject|10|||
16812861|NCT02364947|37755197|FG001|Overall Study|Withdrawal by Subject|8|||
16812862|NCT02364947|37755198|FG002|Overall Study|Withdrawal by Subject|9|||
16812863|NCT02364947|37755196|FG000|Overall Study|Adverse Event|45|||
16812864|NCT02364947|37755197|FG001|Overall Study|Adverse Event|33|||
16812865|NCT02364947|37755198|FG002|Overall Study|Adverse Event|11|||
16812866|NCT02364947|37755196|FG000|Overall Study|Protocol Violation|1|||
16812867|NCT02364947|37755197|FG001|Overall Study|Protocol Violation|1|||
16812868|NCT02364947|37755198|FG002|Overall Study|Protocol Violation|1|||
16812869|NCT02364947|37755196|FG000|Overall Study|Physician Decision|3|||
16812870|NCT02364947|37755197|FG001|Overall Study|Physician Decision|2|||
16812871|NCT02364947|37755198|FG002|Overall Study|Physician Decision|5|||
16812872|NCT02364947|37755196|FG000|Overall Study|Death|0|||
16812873|NCT02364947|37755197|FG001|Overall Study|Death|1|||
16812874|NCT02364947|37755198|FG002|Overall Study|Death|0|||
16812875|NCT02392481|37755210|FG000|Overall Study|Adverse Event|0|||
16812876|NCT02392481|37755211|FG001|Overall Study|Adverse Event|0|||
16812877|NCT02392481|37755212|FG002|Overall Study|Adverse Event|1|||
16812878|NCT02392481|37755213|FG003|Overall Study|Adverse Event|2|||
16812879|NCT02392481|37755210|FG000|Overall Study|Withdrawal by Subject|0|||
16812880|NCT02392481|37755211|FG001|Overall Study|Withdrawal by Subject|0|||
16812881|NCT02392481|37755212|FG002|Overall Study|Withdrawal by Subject|1|||
16812882|NCT02392481|37755213|FG003|Overall Study|Withdrawal by Subject|0|||
16812883|NCT02392403|37755223|FG000|Overall Study|Adverse Event|1|||
16812884|NCT02392403|37755223|FG000|Overall Study|Death|1|||
16812885|NCT02392403|37755223|FG000|Overall Study|Withdrawal by Subject|1|||
16812886|NCT02392247|37755227|FG000|Overall Study|Withdrawal by Subject|1|||
16812887|NCT02392247|37755227|FG000|Overall Study|Surgery cancelled; no data|1|||
16812888|NCT02337725|37755233|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
16812889|NCT02337725|37755234|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
16812890|NCT02337725|37755233|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
16812891|NCT02337725|37755234|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
16812892|NCT02337725|37755233|FG000|Overall Study|Major Protocol Deviation|0|||
16812893|NCT02337725|37755234|FG001|Overall Study|Major Protocol Deviation|1|||
16812894|NCT02337725|37755233|FG000|Overall Study|Voluntary Withdrawal|14|||
16812895|NCT02337725|37755234|FG001|Overall Study|Voluntary Withdrawal|3|||
16812896|NCT02337725|37755233|FG000|Overall Study|Lack of Efficacy|4|||
16812897|NCT02337725|37755234|FG001|Overall Study|Lack of Efficacy|0|||
16812898|NCT02337491|37755242|FG000|Overall Study|Death|1|||
16812899|NCT02337491|37755243|FG001|Overall Study|Death|1|||
16812900|NCT02337491|37755242|FG000|Overall Study|Adverse Event|0|||
16812901|NCT02337491|37755243|FG001|Overall Study|Adverse Event|1|||
16812902|NCT02337491|37755242|FG000|Overall Study|Withdrawal by Subject|3|||
16812903|NCT02337491|37755243|FG001|Overall Study|Withdrawal by Subject|0|||
16812904|NCT02337491|37755242|FG000|Overall Study|Progressive Disease|44|||
16812905|NCT02337491|37755243|FG001|Overall Study|Progressive Disease|28|||
16812906|NCT02337491|37755242|FG000|Overall Study|On Treatment|2|||
16812907|NCT02337491|37755243|FG001|Overall Study|On Treatment|0|||
16812908|NCT01765582|37755253|FG000|Overall Study|Other|3|||
16812909|NCT01765582|37755254|FG001|Overall Study|Other|6|||
16812910|NCT01765582|37755255|FG002|Overall Study|Other|9|||
16812911|NCT01765582|37755253|FG000|Overall Study|Lost to Follow-up|2|||
16812912|NCT01765582|37755254|FG001|Overall Study|Lost to Follow-up|2|||
16812913|NCT01765582|37755255|FG002|Overall Study|Lost to Follow-up|1|||
16812914|NCT01765582|37755253|FG000|Overall Study|Death|31|||
16812915|NCT01765582|37755254|FG001|Overall Study|Death|36|||
16812916|NCT01765582|37755255|FG002|Overall Study|Death|33|||
16812917|NCT01765582|37755253|FG000|Overall Study|Sponsor Decision|46|||
16812918|NCT01765582|37755254|FG001|Overall Study|Sponsor Decision|42|||
16812919|NCT01765582|37755255|FG002|Overall Study|Sponsor Decision|42|||
16812920|NCT01765582|37755253|FG000|Overall Study|Withdrawal of Consent|11|||
16812921|NCT01765582|37755254|FG001|Overall Study|Withdrawal of Consent|6|||
16812922|NCT01765582|37755255|FG002|Overall Study|Withdrawal of Consent|10|||
16812923|NCT01649375|37755267|FG000|Up to Week 16|Adverse Event|2|||
16812924|NCT01649375|37755268|FG001|Up to Week 16|Adverse Event|5|||
16812925|NCT01649375|37755269|FG002|Up to Week 16|Adverse Event|4|||
16812926|NCT01649375|37755270|FG003|Up to Week 16|Adverse Event|0|||
16812927|NCT01649375|37755271|FG004|Up to Week 16|Adverse Event|0|||
16812928|NCT01649375|37755267|FG000|Up to Week 16|Lack of Efficacy|0|||
16812929|NCT01649375|37755268|FG001|Up to Week 16|Lack of Efficacy|0|||
16812930|NCT01649375|37755269|FG002|Up to Week 16|Lack of Efficacy|1|||
16812931|NCT01649375|37755270|FG003|Up to Week 16|Lack of Efficacy|0|||
16812932|NCT01649375|37755271|FG004|Up to Week 16|Lack of Efficacy|0|||
16812933|NCT01649375|37755267|FG000|Up to Week 16|Physician Decision|0|||
16812934|NCT01649375|37755268|FG001|Up to Week 16|Physician Decision|0|||
16812935|NCT01649375|37755269|FG002|Up to Week 16|Physician Decision|1|||
16812936|NCT01649375|37755270|FG003|Up to Week 16|Physician Decision|0|||
16812937|NCT01649375|37755271|FG004|Up to Week 16|Physician Decision|0|||
16812938|NCT01649375|37755267|FG000|Up to Week 16|Withdrawal by Subject|2|||
16812939|NCT01649375|37755268|FG001|Up to Week 16|Withdrawal by Subject|1|||
16812940|NCT01649375|37755269|FG002|Up to Week 16|Withdrawal by Subject|2|||
16812941|NCT01649375|37755270|FG003|Up to Week 16|Withdrawal by Subject|0|||
16812942|NCT01649375|37755271|FG004|Up to Week 16|Withdrawal by Subject|0|||
16812943|NCT01649375|37755267|FG000|Up to Week 16|Death|1|||
16812944|NCT01649375|37755268|FG001|Up to Week 16|Death|0|||
16812945|NCT01649375|37755269|FG002|Up to Week 16|Death|0|||
16812946|NCT01649375|37755270|FG003|Up to Week 16|Death|0|||
16812947|NCT01649375|37755271|FG004|Up to Week 16|Death|0|||
16812948|NCT01649375|37755267|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
16812949|NCT01649375|37755268|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
16812950|NCT01649375|37755269|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
16812951|NCT01649375|37755270|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
16812952|NCT01649375|37755271|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
16812953|NCT01649375|37755267|FG000|Week 16 up to Week 260|Non-compliance|0|||
16812954|NCT01649375|37755268|FG001|Week 16 up to Week 260|Non-compliance|1|||
16812955|NCT01649375|37755269|FG002|Week 16 up to Week 260|Non-compliance|0|||
16812956|NCT01649375|37755270|FG003|Week 16 up to Week 260|Non-compliance|1|||
16812957|NCT01649375|37755271|FG004|Week 16 up to Week 260|Non-compliance|0|||
16812958|NCT01649375|37755267|FG000|Week 16 up to Week 260|Physician Decision|0|||
16812959|NCT01649375|37755268|FG001|Week 16 up to Week 260|Physician Decision|2|||
16812960|NCT01649375|37755269|FG002|Week 16 up to Week 260|Physician Decision|0|||
16812961|NCT01649375|37755270|FG003|Week 16 up to Week 260|Physician Decision|0|||
16812962|NCT01649375|37755271|FG004|Week 16 up to Week 260|Physician Decision|0|||
16812963|NCT01649375|37755267|FG000|Week 16 up to Week 260|Technical issues|0|||
16812964|NCT01649375|37755268|FG001|Week 16 up to Week 260|Technical issues|1|||
16812965|NCT01649375|37755269|FG002|Week 16 up to Week 260|Technical issues|0|||
16812966|NCT01649375|37755270|FG003|Week 16 up to Week 260|Technical issues|1|||
16812967|NCT01649375|37755271|FG004|Week 16 up to Week 260|Technical issues|0|||
16812968|NCT01649375|37755267|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
16812969|NCT01649375|37755268|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
16812970|NCT01649375|37755269|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
16812971|NCT01649375|37755270|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
16812972|NCT01649375|37755271|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
16812973|NCT01649375|37755267|FG000|Week 16 up to Week 260|Death|1|||
16812974|NCT01649375|37755268|FG001|Week 16 up to Week 260|Death|1|||
16812975|NCT01649375|37755269|FG002|Week 16 up to Week 260|Death|0|||
16812976|NCT01649375|37755270|FG003|Week 16 up to Week 260|Death|0|||
16812977|NCT01649375|37755271|FG004|Week 16 up to Week 260|Death|0|||
16812978|NCT01649375|37755267|FG000|Week 16 up to Week 260|Adverse Event|5|||
16812979|NCT01649375|37755268|FG001|Week 16 up to Week 260|Adverse Event|2|||
16812980|NCT01649375|37755269|FG002|Week 16 up to Week 260|Adverse Event|0|||
16812981|NCT01649375|37755270|FG003|Week 16 up to Week 260|Adverse Event|3|||
16812982|NCT01649375|37755271|FG004|Week 16 up to Week 260|Adverse Event|2|||
16812983|NCT02336555|37755281|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16812984|NCT02336555|37755282|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16812985|NCT02336555|37755281|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
16812986|NCT02336555|37755282|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
16812987|NCT02336555|37755281|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
16812988|NCT02336555|37755282|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
16812989|NCT01648283|37755288|FG000|Overall Study|Withdrawal by Subject|14|||
16812990|NCT01649297|37755299|FG000|Overall Study|Adverse Event|5|||
16812991|NCT01649297|37755300|FG001|Overall Study|Adverse Event|5|||
16812992|NCT01649297|37755301|FG002|Overall Study|Adverse Event|4|||
16812993|NCT01649297|37755302|FG003|Overall Study|Adverse Event|13|||
16812994|NCT01649297|37755303|FG004|Overall Study|Adverse Event|1|||
16812995|NCT01649297|37755299|FG000|Overall Study|Lack of Efficacy|0|||
16812996|NCT01649297|37755300|FG001|Overall Study|Lack of Efficacy|0|||
16812997|NCT01649297|37755301|FG002|Overall Study|Lack of Efficacy|0|||
16812998|NCT01649297|37755302|FG003|Overall Study|Lack of Efficacy|0|||
16812999|NCT01649297|37755303|FG004|Overall Study|Lack of Efficacy|1|||
16813000|NCT01649297|37755299|FG000|Overall Study|Non compliant with Protocol|1|||
16813001|NCT01649297|37755300|FG001|Overall Study|Non compliant with Protocol|0|||
16813002|NCT01649297|37755301|FG002|Overall Study|Non compliant with Protocol|3|||
16813003|NCT01649297|37755302|FG003|Overall Study|Non compliant with Protocol|2|||
16813004|NCT01649297|37755303|FG004|Overall Study|Non compliant with Protocol|1|||
16813005|NCT01649297|37755299|FG000|Overall Study|Lost to Follow-up|1|||
16813006|NCT01649297|37755300|FG001|Overall Study|Lost to Follow-up|1|||
16813007|NCT01649297|37755301|FG002|Overall Study|Lost to Follow-up|4|||
16813008|NCT01649297|37755302|FG003|Overall Study|Lost to Follow-up|3|||
16813009|NCT01649297|37755303|FG004|Overall Study|Lost to Follow-up|0|||
16813010|NCT01649297|37755299|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
16813011|NCT01649297|37755300|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
16813012|NCT01649297|37755301|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
16813013|NCT01649297|37755302|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
16813014|NCT01649297|37755303|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
16813015|NCT01649297|37755299|FG000|Overall Study|For other reason|4|||
16813016|NCT01649297|37755300|FG001|Overall Study|For other reason|1|||
16813017|NCT01649297|37755301|FG002|Overall Study|For other reason|2|||
16813018|NCT01649297|37755302|FG003|Overall Study|For other reason|0|||
16813019|NCT01649297|37755303|FG004|Overall Study|For other reason|0|||
16813020|NCT01648205|37755315|FG000|Placebo|Pregnancy|1|||
16813021|NCT01648205|37755315|FG000|Placebo|Withdrawal by Subject|1|||
16813022|NCT01648205|37755315|FG000|Placebo|Protocol Violation|2|||
16813023|NCT01648205|37755315|FG000|Ranolazine|Death|1|||
16813024|NCT01648205|37755315|FG000|Ranolazine|Withdrawal by Subject|1|||
16813025|NCT01648205|37755315|FG000|Ranolazine|Protocol Violation|3|||
16813026|NCT02391545|37755325|FG000|Overall Study|Death|0|||
16813027|NCT02391545|37755326|FG001|Overall Study|Death|2|||
16813028|NCT02391545|37755325|FG000|Overall Study|Lost to Follow-up|0|||
16813029|NCT02391545|37755326|FG001|Overall Study|Lost to Follow-up|1|||
16813030|NCT02391545|37755325|FG000|Overall Study|Termination of study by sponsor|20|||
16813031|NCT02391545|37755326|FG001|Overall Study|Termination of study by sponsor|20|||
16813032|NCT02391545|37755325|FG000|Overall Study|Withdrawal by Subject|0|||
16813033|NCT02391545|37755326|FG001|Overall Study|Withdrawal by Subject|1|||
16813034|NCT02391545|37755325|FG000|Overall Study|Other Reasons|6|||
16813035|NCT02391545|37755326|FG001|Overall Study|Other Reasons|4|||
16813036|NCT02362451|37755335|FG000|Overall Study|Withdrawal by Subject|0|||
16813037|NCT02362451|37755336|FG001|Overall Study|Withdrawal by Subject|1|||
16813038|NCT02362451|37755335|FG000|Overall Study|Lack of Efficacy|2|||
16813039|NCT02362451|37755336|FG001|Overall Study|Lack of Efficacy|0|||
16813040|NCT02362451|37755335|FG000|Overall Study|Progression|1|||
16813041|NCT02362451|37755336|FG001|Overall Study|Progression|0|||
16813042|NCT02362451|37755335|FG000|Overall Study|Participant chose other therapy.|1|||
16813043|NCT02362451|37755336|FG001|Overall Study|Participant chose other therapy.|0|||
16813044|NCT01734382|37755345|FG000|Part 1|Adverse Event|2|||
16813045|NCT01734382|37755346|FG001|Part 1|Adverse Event|0|||
16813046|NCT01734382|37755347|FG002|Part 1|Adverse Event|0|||
16813047|NCT01734382|37755345|FG000|Part 2|Adverse Event|0|||
16813048|NCT01734382|37755346|FG001|Part 2|Adverse Event|0|||
16813049|NCT01734382|37755347|FG002|Part 2|Adverse Event|1|||
16813050|NCT01734382|37755345|FG000|Part 2|Lack of Efficacy|0|||
16813051|NCT01734382|37755346|FG001|Part 2|Lack of Efficacy|1|||
16813052|NCT01734382|37755347|FG002|Part 2|Lack of Efficacy|1|||
16813053|NCT01734382|37755345|FG000|Part 2|Other|0|||
16813054|NCT01734382|37755346|FG001|Part 2|Other|0|||
16813055|NCT01734382|37755347|FG002|Part 2|Other|1|||
16813056|NCT01734382|37755345|FG000|Part 2|Physician Decision|0|||
16813057|NCT01734382|37755346|FG001|Part 2|Physician Decision|0|||
16813058|NCT01734382|37755347|FG002|Part 2|Physician Decision|3|||
16813059|NCT01734382|37755345|FG000|Part 2|Protocol Violation|0|||
16813060|NCT01734382|37755346|FG001|Part 2|Protocol Violation|1|||
16813061|NCT01734382|37755347|FG002|Part 2|Protocol Violation|0|||
16813062|NCT01734382|37755345|FG000|Part 2|Withdrawal by Subject|0|||
16813063|NCT01734382|37755346|FG001|Part 2|Withdrawal by Subject|0|||
16813064|NCT01734382|37755347|FG002|Part 2|Withdrawal by Subject|1|||
16813065|NCT02391311|37755361|FG000|Overall Study|Lost to Follow-up|2|||
16813066|NCT02391311|37755362|FG001|Overall Study|Lost to Follow-up|1|||
16813067|NCT02391311|37755361|FG000|Overall Study|deemed ineligible after baseline|1|||
16813068|NCT02391311|37755362|FG001|Overall Study|deemed ineligible after baseline|1|||
16813069|NCT01765426|37755372|FG000|Overall Study|Lost to Follow-up|0|||
16813070|NCT01765426|37755373|FG001|Overall Study|Lost to Follow-up|1|||
16813071|NCT01765426|37755374|FG002|Overall Study|Lost to Follow-up|0|||
16813072|NCT01765426|37755375|FG003|Overall Study|Lost to Follow-up|0|||
16813073|NCT01765270|37755387|FG000|Overall Study|Physician Decision|1|||
16813074|NCT01765270|37755388|FG001|Overall Study|Physician Decision|0|||
16813075|NCT01765270|37755387|FG000|Overall Study|Withdrawal by Subject|0|||
16813076|NCT01765270|37755388|FG001|Overall Study|Withdrawal by Subject|1|||
16813077|NCT01733758|37755399|FG000|Overall Study|Adverse Event|5|||
16813078|NCT01733758|37755400|FG001|Overall Study|Adverse Event|7|||
16813079|NCT01733758|37755401|FG002|Overall Study|Adverse Event|8|||
16813080|NCT01733758|37755402|FG003|Overall Study|Adverse Event|1|||
16813081|NCT01733758|37755399|FG000|Overall Study|Withdrawal by Subject|1|||
16813082|NCT01733758|37755400|FG001|Overall Study|Withdrawal by Subject|1|||
16813083|NCT01733758|37755401|FG002|Overall Study|Withdrawal by Subject|5|||
16813084|NCT01733758|37755402|FG003|Overall Study|Withdrawal by Subject|3|||
16813085|NCT01733758|37755399|FG000|Overall Study|Persistent Hyperglycemia|3|||
16813086|NCT01733758|37755400|FG001|Overall Study|Persistent Hyperglycemia|2|||
16813087|NCT01733758|37755401|FG002|Overall Study|Persistent Hyperglycemia|0|||
16813088|NCT01733758|37755402|FG003|Overall Study|Persistent Hyperglycemia|0|||
16813089|NCT01733758|37755399|FG000|Overall Study|Protocol Violation|0|||
16813090|NCT01733758|37755400|FG001|Overall Study|Protocol Violation|1|||
16813091|NCT01733758|37755401|FG002|Overall Study|Protocol Violation|2|||
16813092|NCT01733758|37755402|FG003|Overall Study|Protocol Violation|2|||
16813093|NCT01733758|37755399|FG000|Overall Study|Non-compliance|1|||
16813094|NCT01733758|37755400|FG001|Overall Study|Non-compliance|0|||
16813095|NCT01733758|37755401|FG002|Overall Study|Non-compliance|0|||
16813096|NCT01733758|37755402|FG003|Overall Study|Non-compliance|0|||
16813097|NCT01733758|37755399|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
16813098|NCT01733758|37755400|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
16813099|NCT01733758|37755401|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
16813100|NCT01733758|37755402|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
16813101|NCT01733758|37755399|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
16813102|NCT01733758|37755400|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
16813103|NCT01733758|37755401|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
16813104|NCT01733758|37755402|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
16813105|NCT01607554|37755414|FG000|Overall Study|Disease progression|2|||
16813106|NCT01607476|37755421|FG000|Overall Study|Withdrawal by Subject|1|||
16813107|NCT01607476|37755422|FG001|Overall Study|Withdrawal by Subject|0|||
16813108|NCT01607476|37755423|FG002|Overall Study|Withdrawal by Subject|1|||
16813109|NCT01607476|37755421|FG000|Overall Study|Lost to Follow-up|0|||
16813110|NCT01607476|37755422|FG001|Overall Study|Lost to Follow-up|0|||
16813111|NCT01607476|37755423|FG002|Overall Study|Lost to Follow-up|2|||
16813112|NCT01765192|37755433|FG000|Treatment Period 1|Adverse Event|0|||
16813113|NCT01765192|37755434|FG001|Treatment Period 1|Adverse Event|1|||
16813114|NCT01765192|37755433|FG000|Washout Period|Voluntary Withdrawal|1|||
16813115|NCT01765192|37755434|FG001|Washout Period|Voluntary Withdrawal|1|||
16813116|NCT01765192|37755433|FG000|Washout Period|Reason not specified|1|||
16813117|NCT01765192|37755434|FG001|Washout Period|Reason not specified|0|||
16813118|NCT01765192|37755433|FG000|Treatment Period 2|Reason not specified|0|||
16813119|NCT01765192|37755434|FG001|Treatment Period 2|Reason not specified|2|||
16813120|NCT01765192|37755433|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
16813121|NCT01765192|37755434|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
16813122|NCT01733680|37755442|FG000|Overall Study|Withdrawal by Subject|0|||
16813123|NCT01733680|37755443|FG001|Overall Study|Withdrawal by Subject|1|||
16813124|NCT02348216|37755460|FG000|Overall Study|Death|4|||
16813125|NCT02348216|37755461|FG001|Overall Study|Death|27|||
16813126|NCT02348216|37755462|FG002|Overall Study|Death|3|||
16813127|NCT02348216|37755463|FG003|Overall Study|Death|18|||
16813128|NCT02348216|37755464|FG004|Overall Study|Death|9|||
16813129|NCT02348216|37755465|FG005|Overall Study|Death|23|||
16813130|NCT02348216|37755466|FG006|Overall Study|Death|6|||
16813131|NCT02348216|37755460|FG000|Overall Study|Full consent withdrawal|0|||
16813132|NCT02348216|37755461|FG001|Overall Study|Full consent withdrawal|0|||
16813133|NCT02348216|37755462|FG002|Overall Study|Full consent withdrawal|0|||
16813134|NCT02348216|37755463|FG003|Overall Study|Full consent withdrawal|1|||
16813135|NCT02348216|37755464|FG004|Overall Study|Full consent withdrawal|0|||
16813136|NCT02348216|37755465|FG005|Overall Study|Full consent withdrawal|0|||
16813137|NCT02348216|37755466|FG006|Overall Study|Full consent withdrawal|1|||
16813138|NCT02348216|37755460|FG000|Overall Study|Lost to Follow-up|0|||
16813139|NCT02348216|37755461|FG001|Overall Study|Lost to Follow-up|0|||
16813140|NCT02348216|37755462|FG002|Overall Study|Lost to Follow-up|0|||
16813141|NCT02348216|37755463|FG003|Overall Study|Lost to Follow-up|0|||
16813142|NCT02348216|37755464|FG004|Overall Study|Lost to Follow-up|0|||
16813143|NCT02348216|37755465|FG005|Overall Study|Lost to Follow-up|0|||
16813144|NCT02348216|37755466|FG006|Overall Study|Lost to Follow-up|1|||
16813145|NCT02348216|37755460|FG000|Overall Study|Still on study|3|||
16813146|NCT02348216|37755461|FG001|Overall Study|Still on study|50|||
16813147|NCT02348216|37755462|FG002|Overall Study|Still on study|21|||
16813148|NCT02348216|37755463|FG003|Overall Study|Still on study|19|||
16813149|NCT02348216|37755464|FG004|Overall Study|Still on study|32|||
16813150|NCT02348216|37755465|FG005|Overall Study|Still on study|27|||
16813151|NCT02348216|37755466|FG006|Overall Study|Still on study|32|||
16813152|NCT02348216|37755460|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
16813153|NCT02348216|37755461|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
16813154|NCT02348216|37755462|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
16813155|NCT02348216|37755463|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
16813156|NCT02348216|37755464|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
16813157|NCT02348216|37755465|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
16813158|NCT02348216|37755466|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
16813159|NCT02336165|37755509|FG000|Overall Study|Death|3|||
16813160|NCT02336165|37755510|FG001|Overall Study|Death|0|||
16813161|NCT02336165|37755511|FG002|Overall Study|Death|0|||
16813162|NCT02336165|37755512|FG003|Overall Study|Death|0|||
16813163|NCT02336165|37755513|FG004|Overall Study|Death|1|||
16813164|NCT02336165|37755509|FG000|Overall Study|Physician Decision|2|||
16813165|NCT02336165|37755510|FG001|Overall Study|Physician Decision|2|||
16813166|NCT02336165|37755511|FG002|Overall Study|Physician Decision|1|||
16813167|NCT02336165|37755512|FG003|Overall Study|Physician Decision|1|||
16813168|NCT02336165|37755513|FG004|Overall Study|Physician Decision|0|||
16813169|NCT02336165|37755509|FG000|Overall Study|Withdrawal by Subject|0|||
16813170|NCT02336165|37755510|FG001|Overall Study|Withdrawal by Subject|0|||
16813171|NCT02336165|37755511|FG002|Overall Study|Withdrawal by Subject|1|||
16813172|NCT02336165|37755512|FG003|Overall Study|Withdrawal by Subject|0|||
16813173|NCT02336165|37755513|FG004|Overall Study|Withdrawal by Subject|1|||
16813174|NCT02336165|37755509|FG000|Overall Study|Adverse Event|4|||
16813175|NCT02336165|37755510|FG001|Overall Study|Adverse Event|1|||
16813176|NCT02336165|37755511|FG002|Overall Study|Adverse Event|2|||
16813177|NCT02336165|37755512|FG003|Overall Study|Adverse Event|4|||
16813178|NCT02336165|37755513|FG004|Overall Study|Adverse Event|1|||
16813179|NCT02336165|37755509|FG000|Overall Study|Progressive disease|23|||
16813180|NCT02336165|37755510|FG001|Overall Study|Progressive disease|22|||
16813181|NCT02336165|37755511|FG002|Overall Study|Progressive disease|27|||
16813182|NCT02336165|37755512|FG003|Overall Study|Progressive disease|24|||
16813183|NCT02336165|37755513|FG004|Overall Study|Progressive disease|19|||
16813184|NCT02336165|37755509|FG000|Overall Study|Non-compliance|1|||
16813185|NCT02336165|37755510|FG001|Overall Study|Non-compliance|0|||
16813186|NCT02336165|37755511|FG002|Overall Study|Non-compliance|0|||
16813187|NCT02336165|37755512|FG003|Overall Study|Non-compliance|1|||
16813188|NCT02336165|37755513|FG004|Overall Study|Non-compliance|0|||
16813189|NCT02336165|37755509|FG000|Overall Study|Other|1|||
16813190|NCT02336165|37755510|FG001|Overall Study|Other|0|||
16813191|NCT02336165|37755511|FG002|Overall Study|Other|0|||
16813192|NCT02336165|37755512|FG003|Overall Study|Other|1|||
16813193|NCT02336165|37755513|FG004|Overall Study|Other|0|||
16813194|NCT02360111|37755529|FG000|Overall Study|Death|2|||
16813195|NCT02334683|37755535|FG000|First 12 Week Period|Lost to Follow-up|1|||
16813196|NCT02334683|37755536|FG001|First 12 Week Period|Lost to Follow-up|0|||
16813197|NCT02334683|37755535|FG000|Second 12 Week Period|Adverse Event|0|||
16813198|NCT02334683|37755536|FG001|Second 12 Week Period|Adverse Event|1|||
16813199|NCT02319044|37755545|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
16813200|NCT02319044|37755546|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
16813201|NCT02319044|37755547|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
16813202|NCT02319044|37755545|FG000|Overall Study|Withdrawal by Subject|3|||
16813203|NCT02319044|37755546|FG001|Overall Study|Withdrawal by Subject|3|||
16813204|NCT02319044|37755547|FG002|Overall Study|Withdrawal by Subject|6|||
16813205|NCT02319044|37755545|FG000|Overall Study|Condition under investigation worsened|100|||
16813206|NCT02319044|37755546|FG001|Overall Study|Condition under investigation worsened|50|||
16813207|NCT02319044|37755547|FG002|Overall Study|Condition under investigation worsened|46|||
16813208|NCT02319044|37755545|FG000|Overall Study|Adverse Event|17|||
16813209|NCT02319044|37755546|FG001|Overall Study|Adverse Event|2|||
16813210|NCT02319044|37755547|FG002|Overall Study|Adverse Event|8|||
16813211|NCT02319044|37755545|FG000|Overall Study|Study specific discontinuation criteria|2|||
16813212|NCT02319044|37755546|FG001|Overall Study|Study specific discontinuation criteria|2|||
16813213|NCT02319044|37755547|FG002|Overall Study|Study specific discontinuation criteria|1|||
16813214|NCT02319044|37755545|FG000|Overall Study|Not treated|0|||
16813215|NCT02319044|37755546|FG001|Overall Study|Not treated|2|||
16813216|NCT02319044|37755547|FG002|Overall Study|Not treated|2|||
16813217|NCT01649765|37755558|FG000|Overall Study|Adverse Event|5|||
16813218|NCT01649765|37755559|FG001|Overall Study|Adverse Event|3|||
16813219|NCT01649765|37755558|FG000|Overall Study|Lack of Efficacy|1|||
16813220|NCT01649765|37755559|FG001|Overall Study|Lack of Efficacy|1|||
16813221|NCT01649765|37755558|FG000|Overall Study|Physician Decision|0|||
16813222|NCT01649765|37755559|FG001|Overall Study|Physician Decision|3|||
16813223|NCT01649765|37755558|FG000|Overall Study|Protocol Violation|1|||
16813224|NCT01649765|37755559|FG001|Overall Study|Protocol Violation|0|||
16813225|NCT01649765|37755558|FG000|Overall Study|Withdrawal by Subject|2|||
16813226|NCT01649765|37755559|FG001|Overall Study|Withdrawal by Subject|1|||
16813227|NCT02317562|37755566|FG000|Overall Study|Physician Decision|1|||
16813228|NCT02317562|37755566|FG000|Overall Study|early termination of the study|8|||
16813229|NCT02317562|37755566|FG000|Overall Study|Lack of Efficacy|4|||
16813230|NCT02317562|37755566|FG000|Overall Study|Withdrawal by Subject|1|||
16813231|NCT02317016|37755570|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
16813232|NCT02317016|37755570|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
16813233|NCT02317016|37755570|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
16813234|NCT02317016|37755570|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
16813235|NCT02317016|37755570|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
16813236|NCT02317016|37755570|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
16813237|NCT02317016|37755570|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
16813238|NCT02311478|37755578|FG000|Overall Study|Withdrawal by Subject|1|||
16813239|NCT02311478|37755578|FG000|Overall Study|Lost to Follow-up|5|||
16813240|NCT02311478|37755578|FG000|Overall Study|Failed IUD Insertion|1|||
16813241|NCT02388932|37755583|FG000|Overall Study|Death|1|||
16813242|NCT02388776|37755588|FG000|Overall Study|Death|1|||
16813243|NCT02388776|37755588|FG000|Overall Study|Lost to Follow-up|1|||
16813244|NCT02316548|37755595|FG000|Overall Study|Protocol Violation|0|||
16813245|NCT02316548|37755596|FG001|Overall Study|Protocol Violation|1|||
16813246|NCT02281760|37755602|FG000|Overall Study|Withdrawal by Subject|1|||
16813247|NCT02390531|37755614|FG000|Overall Study|Death|0|||
16813248|NCT02390531|37755615|FG001|Overall Study|Death|2|||
16813249|NCT02390531|37755616|FG002|Overall Study|Death|0|||
16813250|NCT02390531|37755617|FG003|Overall Study|Death|1|||
16813251|NCT02390531|37755618|FG004|Overall Study|Death|0|||
16813252|NCT02390531|37755619|FG005|Overall Study|Death|0|||
16813253|NCT02390531|37755620|FG006|Overall Study|Death|0|||
16813254|NCT02390531|37755621|FG007|Overall Study|Death|1|||
16813255|NCT02390531|37755614|FG000|Overall Study|Protocol Violation|0|||
16813256|NCT02390531|37755615|FG001|Overall Study|Protocol Violation|0|||
16813257|NCT02390531|37755616|FG002|Overall Study|Protocol Violation|0|||
16813258|NCT02390531|37755617|FG003|Overall Study|Protocol Violation|0|||
16813259|NCT02390531|37755618|FG004|Overall Study|Protocol Violation|1|||
16813260|NCT02390531|37755619|FG005|Overall Study|Protocol Violation|0|||
16813261|NCT02390531|37755620|FG006|Overall Study|Protocol Violation|2|||
16813262|NCT02390531|37755621|FG007|Overall Study|Protocol Violation|0|||
16813263|NCT02390219|37755657|FG000|Overall Study|Death|1|||
16813264|NCT02390219|37755657|FG000|Overall Study|Physician Decision|1|||
16813265|NCT02390219|37755657|FG000|Overall Study|Adverse Event|6|||
16813266|NCT02390219|37755657|FG000|Overall Study|Withdrawal by Subject|1|||
16813267|NCT02390219|37755657|FG000|Overall Study|Lost to Follow-up|2|||
16813268|NCT02390219|37755657|FG000|Overall Study|Other|2|||
16813269|NCT02334215|37755664|FG000|Overall Study|Death|1|||
16813270|NCT02334215|37755665|FG001|Overall Study|Death|1|||
16813271|NCT02334215|37755666|FG002|Overall Study|Death|0|||
16813272|NCT02334215|37755664|FG000|Overall Study|Lost to Follow-up|1|||
16813273|NCT02334215|37755665|FG001|Overall Study|Lost to Follow-up|0|||
16813274|NCT02334215|37755666|FG002|Overall Study|Lost to Follow-up|4|||
16813275|NCT02334215|37755664|FG000|Overall Study|Withdrawal by Subject|2|||
16813276|NCT02334215|37755665|FG001|Overall Study|Withdrawal by Subject|2|||
16813277|NCT02334215|37755666|FG002|Overall Study|Withdrawal by Subject|1|||
16813278|NCT02334215|37755664|FG000|Overall Study|Not released from incarceration on time|3|||
16813279|NCT02334215|37755665|FG001|Overall Study|Not released from incarceration on time|3|||
16813280|NCT02334215|37755666|FG002|Overall Study|Not released from incarceration on time|3|||
16813281|NCT02334215|37755664|FG000|Overall Study|Incarcerated|0|||
16813282|NCT02334215|37755665|FG001|Overall Study|Incarcerated|0|||
16813283|NCT02334215|37755666|FG002|Overall Study|Incarcerated|7|||
16813284|NCT02359877|37755678|FG000|Overall Study|Withdrawal by Subject|1|||
16910279|NCT01709838|38019075|FG000|Overall Study|Subject/guardian decision|8|||
16813285|NCT02359877|37755679|FG001|Overall Study|Withdrawal by Subject|0|||
16813286|NCT02359877|37755680|FG002|Overall Study|Withdrawal by Subject|0|||
16813287|NCT02359877|37755681|FG003|Overall Study|Withdrawal by Subject|2|||
16813288|NCT02359877|37755678|FG000|Overall Study|Adverse Event|0|||
16813289|NCT02359877|37755679|FG001|Overall Study|Adverse Event|0|||
16813290|NCT02359877|37755680|FG002|Overall Study|Adverse Event|0|||
16813291|NCT02359877|37755681|FG003|Overall Study|Adverse Event|1|||
16813292|NCT02389829|37755711|FG000|Overall Study|Lost to Follow-up|0|||
16813293|NCT02389829|37755712|FG001|Overall Study|Lost to Follow-up|1|||
16813294|NCT02358863|37755718|FG000|Overall Study|Physician Decision|3|||
16813295|NCT02358473|37755722|FG000|Overall Study|Disease Progession|6|||
16813296|NCT02358473|37755722|FG000|Overall Study|Adverse Event|3|||
16813297|NCT02358473|37755722|FG000|Overall Study|Withdrawal by Subject|2|||
16813298|NCT02358473|37755722|FG000|Overall Study|Physician Decision|2|||
16813299|NCT02357459|37755729|FG000|Overall Study|Adverse Event|0|||
16813300|NCT02357459|37755730|FG001|Overall Study|Adverse Event|1|||
16813301|NCT02357459|37755731|FG002|Overall Study|Adverse Event|1|||
16813302|NCT02357459|37755729|FG000|Overall Study|Withdrawal by Subject|5|||
16813303|NCT02357459|37755730|FG001|Overall Study|Withdrawal by Subject|3|||
16813304|NCT02357459|37755731|FG002|Overall Study|Withdrawal by Subject|3|||
16813305|NCT02357459|37755729|FG000|Overall Study|Physician Decision|0|||
16813306|NCT02357459|37755730|FG001|Overall Study|Physician Decision|2|||
16813307|NCT02357459|37755731|FG002|Overall Study|Physician Decision|0|||
16813308|NCT02357459|37755729|FG000|Overall Study|Protocol Violation|1|||
16813309|NCT02357459|37755730|FG001|Overall Study|Protocol Violation|1|||
16813310|NCT02357459|37755731|FG002|Overall Study|Protocol Violation|0|||
16813311|NCT02357459|37755729|FG000|Overall Study|Lost to Follow-up|1|||
16813312|NCT02357459|37755730|FG001|Overall Study|Lost to Follow-up|3|||
16813313|NCT02357459|37755731|FG002|Overall Study|Lost to Follow-up|0|||
16813314|NCT02357459|37755729|FG000|Overall Study|Lack of Efficacy|7|||
16813315|NCT02357459|37755730|FG001|Overall Study|Lack of Efficacy|4|||
16813316|NCT02357459|37755731|FG002|Overall Study|Lack of Efficacy|4|||
16813317|NCT02357459|37755729|FG000|Overall Study|Patient Relocated|2|||
16813318|NCT02357459|37755730|FG001|Overall Study|Patient Relocated|0|||
16813319|NCT02357459|37755731|FG002|Overall Study|Patient Relocated|0|||
16813320|NCT02357459|37755729|FG000|Overall Study|Instruction from PCP|1|||
16813321|NCT02357459|37755730|FG001|Overall Study|Instruction from PCP|0|||
16813322|NCT02357459|37755731|FG002|Overall Study|Instruction from PCP|0|||
16813323|NCT02357459|37755729|FG000|Overall Study|Incarceration|0|||
16813324|NCT02357459|37755730|FG001|Overall Study|Incarceration|0|||
16813325|NCT02357459|37755731|FG002|Overall Study|Incarceration|1|||
16813326|NCT02357459|37755729|FG000|Overall Study|Pre-planned Knee surgery|0|||
16813327|NCT02357459|37755730|FG001|Overall Study|Pre-planned Knee surgery|0|||
16813328|NCT02357459|37755731|FG002|Overall Study|Pre-planned Knee surgery|2|||
16813329|NCT02357459|37755729|FG000|Overall Study|Job Commitments|0|||
16813330|NCT02357459|37755730|FG001|Overall Study|Job Commitments|0|||
16813331|NCT02357459|37755731|FG002|Overall Study|Job Commitments|1|||
16813332|NCT02332889|37755742|FG000|Overall Study|Physician Decision|1|||
16813333|NCT02357147|37755748|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
16813334|NCT02357147|37755749|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
16813335|NCT02357147|37755748|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
16813336|NCT02357147|37755749|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
16813337|NCT02357147|37755748|FG000|Combination Treatment Phase|Investigator Discretion|1|||
16813338|NCT02357147|37755749|FG001|Combination Treatment Phase|Investigator Discretion|1|||
16813339|NCT02357147|37755748|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
16813340|NCT02357147|37755749|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
16813341|NCT02357147|37755748|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
16813342|NCT02357147|37755749|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
16813343|NCT02357147|37755748|FG000|Combination Treatment Phase|Adverse Event|12|||
16813344|NCT02357147|37755749|FG001|Combination Treatment Phase|Adverse Event|4|||
16813345|NCT02357147|37755748|FG000|Combination Treatment Phase|Death|1|||
16813346|NCT02357147|37755749|FG001|Combination Treatment Phase|Death|1|||
16813347|NCT02357147|37755748|FG000|Combination Treatment Phase|Sponsor Decision|0|||
16813348|NCT02357147|37755749|FG001|Combination Treatment Phase|Sponsor Decision|12|||
16813349|NCT02357147|37755748|FG000|Combination Treatment Phase|Other|1|||
16813350|NCT02357147|37755749|FG001|Combination Treatment Phase|Other|0|||
16813351|NCT02357147|37755748|FG000|Combination Treatment Phase|Not treated|0|||
16813352|NCT02357147|37755749|FG001|Combination Treatment Phase|Not treated|2|||
16813353|NCT02357147|37755748|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
16813354|NCT02357147|37755749|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
16813355|NCT02357147|37755748|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16813356|NCT02357147|37755749|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
16813357|NCT02357147|37755748|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
16813358|NCT02357147|37755749|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
16813359|NCT02357147|37755748|FG000|Maintenance Treatment Phase|Adverse Event|0|||
16813360|NCT02357147|37755749|FG001|Maintenance Treatment Phase|Adverse Event|3|||
16813361|NCT02357147|37755748|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
16813362|NCT02357147|37755749|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
16813363|NCT02357147|37755748|FG000|Maintenance Treatment Phase|Not Treated|1|||
16813364|NCT02357147|37755749|FG001|Maintenance Treatment Phase|Not Treated|0|||
16813365|NCT02356211|37755761|FG000|Overall Study|Withdrawal by Subject|2|||
16813366|NCT02356211|37755762|FG001|Overall Study|Withdrawal by Subject|2|||
16813367|NCT02356211|37755761|FG000|Overall Study|ineligible|1|||
16813368|NCT02356211|37755762|FG001|Overall Study|ineligible|8|||
16813369|NCT02332655|37755768|FG000|Overall Study|Lack of Efficacy|1|||
16813370|NCT02388737|37755775|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
16813371|NCT02388737|37755776|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
16813372|NCT02388737|37755777|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
16813373|NCT02388737|37755775|FG000|Overall Study|Major Protocol Deviation|18|||
16813374|NCT02388737|37755776|FG001|Overall Study|Major Protocol Deviation|25|||
16813375|NCT02388737|37755777|FG002|Overall Study|Major Protocol Deviation|22|||
16813376|NCT02388737|37755775|FG000|Overall Study|Lost to Follow-up|5|||
16813377|NCT02388737|37755776|FG001|Overall Study|Lost to Follow-up|1|||
16813378|NCT02388737|37755777|FG002|Overall Study|Lost to Follow-up|4|||
16813379|NCT02388737|37755775|FG000|Overall Study|Voluntary Withdrawal|10|||
16813380|NCT02388737|37755776|FG001|Overall Study|Voluntary Withdrawal|18|||
16813381|NCT02388737|37755777|FG002|Overall Study|Voluntary Withdrawal|17|||
16813382|NCT02388737|37755775|FG000|Overall Study|Lack of Efficacy|3|||
16813383|NCT02388737|37755776|FG001|Overall Study|Lack of Efficacy|0|||
16813384|NCT02388737|37755777|FG002|Overall Study|Lack of Efficacy|3|||
16813385|NCT02388737|37755775|FG000|Overall Study|Reason Not Specified|5|||
16813386|NCT02388737|37755776|FG001|Overall Study|Reason Not Specified|5|||
16813387|NCT02388737|37755777|FG002|Overall Study|Reason Not Specified|4|||
16813388|NCT02355743|37755785|FG000|Overall Study|Withdrawal by Subject|1|||
16813389|NCT02355743|37755785|FG000|Overall Study|Lost to Follow-up|1|||
16813390|NCT02388347|37755794|FG000|Overall Study|Withdrawal by Subject|0|||
16813391|NCT02388347|37755795|FG001|Overall Study|Withdrawal by Subject|0|||
16813392|NCT02388347|37755796|FG002|Overall Study|Withdrawal by Subject|1|||
16813393|NCT02388347|37755797|FG003|Overall Study|Withdrawal by Subject|0|||
16813394|NCT02388347|37755798|FG004|Overall Study|Withdrawal by Subject|0|||
16813395|NCT02355665|37755816|FG000|Overall Study|Adverse Event|16|||
16813396|NCT02355665|37755817|FG001|Overall Study|Adverse Event|24|||
16813397|NCT02355665|37755816|FG000|Overall Study|Protocol Violation|2|||
16813398|NCT02355665|37755817|FG001|Overall Study|Protocol Violation|0|||
16813399|NCT02355665|37755816|FG000|Overall Study|Withdrawal by Subject|90|||
16813400|NCT02355665|37755817|FG001|Overall Study|Withdrawal by Subject|100|||
16813401|NCT02355665|37755816|FG000|Overall Study|Lost to Follow-up|131|||
16813402|NCT02355665|37755817|FG001|Overall Study|Lost to Follow-up|103|||
16813403|NCT02355665|37755816|FG000|Overall Study|Death|4|||
16813404|NCT02355665|37755817|FG001|Overall Study|Death|2|||
16813405|NCT02355665|37755816|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
16813406|NCT02355665|37755817|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
16813407|NCT02010255|37755837|FG000|Overall Study|Death|0|||
16813408|NCT02010255|37755838|FG001|Overall Study|Death|1|||
16813409|NCT02010255|37755839|FG002|Overall Study|Death|4|||
16813410|NCT02010255|37755840|FG003|Overall Study|Death|4|||
16813411|NCT02010255|37755841|FG004|Overall Study|Death|2|||
16813412|NCT02010255|37755842|FG005|Overall Study|Death|0|||
16813413|NCT02010255|37755843|FG006|Overall Study|Death|1|||
16813414|NCT02010255|37755844|FG007|Overall Study|Death|1|||
16813415|NCT02010255|37755845|FG008|Overall Study|Death|1|||
16813416|NCT02010255|37755846|FG009|Overall Study|Death|0|||
16813417|NCT02010255|37755847|FG010|Overall Study|Death|1|||
16813418|NCT02010255|37755848|FG011|Overall Study|Death|1|||
16813419|NCT02010255|37755849|FG012|Overall Study|Death|0|||
16813420|NCT02010255|37755850|FG013|Overall Study|Death|0|||
16813421|NCT02010255|37755837|FG000|Overall Study|Lack of Efficacy|4|||
16813422|NCT02010255|37755838|FG001|Overall Study|Lack of Efficacy|1|||
16813423|NCT02010255|37755839|FG002|Overall Study|Lack of Efficacy|2|||
16813424|NCT02010255|37755840|FG003|Overall Study|Lack of Efficacy|1|||
16813425|NCT02010255|37755841|FG004|Overall Study|Lack of Efficacy|1|||
16813426|NCT02010255|37755842|FG005|Overall Study|Lack of Efficacy|0|||
16813427|NCT02010255|37755843|FG006|Overall Study|Lack of Efficacy|0|||
16813428|NCT02010255|37755844|FG007|Overall Study|Lack of Efficacy|0|||
16813429|NCT02010255|37755845|FG008|Overall Study|Lack of Efficacy|0|||
16813430|NCT02010255|37755846|FG009|Overall Study|Lack of Efficacy|0|||
16813431|NCT02010255|37755847|FG010|Overall Study|Lack of Efficacy|1|||
16813432|NCT02010255|37755848|FG011|Overall Study|Lack of Efficacy|0|||
16813433|NCT02010255|37755849|FG012|Overall Study|Lack of Efficacy|0|||
16813434|NCT02010255|37755850|FG013|Overall Study|Lack of Efficacy|0|||
16813435|NCT02010255|37755837|FG000|Overall Study|Withdrew Consent|1|||
16813436|NCT02010255|37755838|FG001|Overall Study|Withdrew Consent|0|||
16813437|NCT02010255|37755839|FG002|Overall Study|Withdrew Consent|0|||
16813438|NCT02010255|37755840|FG003|Overall Study|Withdrew Consent|1|||
16813439|NCT02010255|37755841|FG004|Overall Study|Withdrew Consent|0|||
17102331|NCT00116558|38241232|FG001|Overall Study|Withdrawal by Subject|3|||
16813440|NCT02010255|37755842|FG005|Overall Study|Withdrew Consent|0|||
16813441|NCT02010255|37755843|FG006|Overall Study|Withdrew Consent|0|||
16813442|NCT02010255|37755844|FG007|Overall Study|Withdrew Consent|0|||
16813443|NCT02010255|37755845|FG008|Overall Study|Withdrew Consent|0|||
16813444|NCT02010255|37755846|FG009|Overall Study|Withdrew Consent|0|||
16813445|NCT02010255|37755847|FG010|Overall Study|Withdrew Consent|0|||
16813446|NCT02010255|37755848|FG011|Overall Study|Withdrew Consent|0|||
16813447|NCT02010255|37755849|FG012|Overall Study|Withdrew Consent|0|||
16813448|NCT02010255|37755850|FG013|Overall Study|Withdrew Consent|0|||
16813449|NCT02010255|37755837|FG000|Overall Study|Adverse Event|1|||
16813450|NCT02010255|37755838|FG001|Overall Study|Adverse Event|0|||
16813451|NCT02010255|37755839|FG002|Overall Study|Adverse Event|0|||
16813452|NCT02010255|37755840|FG003|Overall Study|Adverse Event|0|||
16813453|NCT02010255|37755841|FG004|Overall Study|Adverse Event|0|||
16813454|NCT02010255|37755842|FG005|Overall Study|Adverse Event|0|||
16813455|NCT02010255|37755843|FG006|Overall Study|Adverse Event|0|||
16813456|NCT02010255|37755844|FG007|Overall Study|Adverse Event|0|||
16813457|NCT02010255|37755845|FG008|Overall Study|Adverse Event|0|||
16813458|NCT02010255|37755846|FG009|Overall Study|Adverse Event|0|||
16813459|NCT02010255|37755847|FG010|Overall Study|Adverse Event|0|||
16813460|NCT02010255|37755848|FG011|Overall Study|Adverse Event|0|||
16813461|NCT02010255|37755849|FG012|Overall Study|Adverse Event|0|||
16813462|NCT02010255|37755850|FG013|Overall Study|Adverse Event|0|||
16813463|NCT02010255|37755837|FG000|Overall Study|Lost to Follow-up|0|||
16813464|NCT02010255|37755838|FG001|Overall Study|Lost to Follow-up|0|||
16813465|NCT02010255|37755839|FG002|Overall Study|Lost to Follow-up|1|||
16813466|NCT02010255|37755840|FG003|Overall Study|Lost to Follow-up|0|||
16813467|NCT02010255|37755841|FG004|Overall Study|Lost to Follow-up|1|||
16813468|NCT02010255|37755842|FG005|Overall Study|Lost to Follow-up|0|||
16813469|NCT02010255|37755843|FG006|Overall Study|Lost to Follow-up|0|||
16813470|NCT02010255|37755844|FG007|Overall Study|Lost to Follow-up|0|||
16813471|NCT02010255|37755845|FG008|Overall Study|Lost to Follow-up|0|||
16813472|NCT02010255|37755846|FG009|Overall Study|Lost to Follow-up|0|||
16813473|NCT02010255|37755847|FG010|Overall Study|Lost to Follow-up|0|||
16813474|NCT02010255|37755848|FG011|Overall Study|Lost to Follow-up|0|||
16813475|NCT02010255|37755849|FG012|Overall Study|Lost to Follow-up|0|||
16813476|NCT02010255|37755850|FG013|Overall Study|Lost to Follow-up|0|||
16813477|NCT02010255|37755837|FG000|Overall Study|Randomized but Not Treated|0|||
16813478|NCT02010255|37755838|FG001|Overall Study|Randomized but Not Treated|0|||
16813479|NCT02010255|37755839|FG002|Overall Study|Randomized but Not Treated|0|||
16813480|NCT02010255|37755840|FG003|Overall Study|Randomized but Not Treated|0|||
16813481|NCT02010255|37755841|FG004|Overall Study|Randomized but Not Treated|0|||
16813482|NCT02010255|37755842|FG005|Overall Study|Randomized but Not Treated|0|||
16813483|NCT02010255|37755843|FG006|Overall Study|Randomized but Not Treated|0|||
16813484|NCT02010255|37755844|FG007|Overall Study|Randomized but Not Treated|0|||
16813485|NCT02010255|37755845|FG008|Overall Study|Randomized but Not Treated|0|||
16813486|NCT02010255|37755846|FG009|Overall Study|Randomized but Not Treated|0|||
16813487|NCT02010255|37755847|FG010|Overall Study|Randomized but Not Treated|0|||
16813488|NCT02010255|37755848|FG011|Overall Study|Randomized but Not Treated|0|||
16813489|NCT02010255|37755849|FG012|Overall Study|Randomized but Not Treated|0|||
16813490|NCT02010255|37755850|FG013|Overall Study|Randomized but Not Treated|1|||
16813491|NCT02354417|37755905|FG000|Overall Study|Physician Decision|1|||
16813492|NCT02332187|37755911|FG000|Overall Study|Withdrawal by Subject|2|||
16813493|NCT02332187|37755912|FG001|Overall Study|Withdrawal by Subject|2|||
16813494|NCT02332187|37755911|FG000|Overall Study|Adverse Event|0|||
16813495|NCT02332187|37755912|FG001|Overall Study|Adverse Event|1|||
16813496|NCT02330549|37755920|FG000|Overall Study|Adverse Event|1|||
16813497|NCT02330549|37755921|FG001|Overall Study|Adverse Event|0|||
16813498|NCT02330549|37755920|FG000|Overall Study|Subject withdrew consent|2|||
16813499|NCT02330549|37755921|FG001|Overall Study|Subject withdrew consent|1|||
16813500|NCT02330549|37755920|FG000|Overall Study|Failure to meet randomization criteria|1|||
16813501|NCT02330549|37755921|FG001|Overall Study|Failure to meet randomization criteria|0|||
16813502|NCT02009865|37755929|FG000|Overall Study|Adverse Event|0|||
16813503|NCT02009865|37755930|FG001|Overall Study|Adverse Event|2|||
16813504|NCT02009865|37755929|FG000|Overall Study|Protocol Violation|0|||
16813505|NCT02009865|37755930|FG001|Overall Study|Protocol Violation|2|||
16813506|NCT02009865|37755929|FG000|Overall Study|Withdrawal by Subject|1|||
16813507|NCT02009865|37755930|FG001|Overall Study|Withdrawal by Subject|1|||
16813508|NCT01620177|37755936|FG000|Overall Study|Failure at Screening Visit|43|||
16813509|NCT01620177|37755936|FG000|Overall Study|Withdrawal by Subject|26|||
16813510|NCT01620177|37755936|FG000|Overall Study|Lost to Follow-up|7|||
16813511|NCT01620177|37755936|FG000|Overall Study|Physician Decision|2|||
16813512|NCT01620177|37755936|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
16813513|NCT02075541|37755955|FG000|Overall Study|Serious Adverse Event|1|||
16813514|NCT02075541|37755956|FG001|Overall Study|Serious Adverse Event|4|||
16813515|NCT02075541|37755955|FG000|Overall Study|Protocol Violation|1|||
16813516|NCT02075541|37755956|FG001|Overall Study|Protocol Violation|0|||
16813517|NCT02075541|37755955|FG000|Overall Study|Withdrawal by Subject|1|||
16813518|NCT02075541|37755956|FG001|Overall Study|Withdrawal by Subject|3|||
16813519|NCT02075541|37755955|FG000|Overall Study|Sponsor study termination|0|||
16813520|NCT02075541|37755956|FG001|Overall Study|Sponsor study termination|1|||
16813521|NCT02075541|37755955|FG000|Overall Study|Other- unable to perform study procedure|1|||
16813522|NCT02075541|37755956|FG001|Overall Study|Other- unable to perform study procedure|0|||
16813523|NCT02312687|37755962|FG000|Overall Study|Other, Not Specified|1|||
16813524|NCT02330081|37755966|FG000|Overall Study|Adverse Event|1|||
16813525|NCT02330081|37755966|FG000|Overall Study|Donation did not meet criteria|1|||
16813526|NCT02330081|37755966|FG000|Overall Study|Protocol Violation|6|||
16813527|NCT01986855|37755976|FG000|Overall Study|Adverse Event|1|||
16813528|NCT01986855|37755977|FG001|Overall Study|Adverse Event|0|||
16813529|NCT01986855|37755978|FG002|Overall Study|Adverse Event|0|||
16813530|NCT01986855|37755976|FG000|Overall Study|Death|3|||
16813531|NCT01986855|37755977|FG001|Overall Study|Death|4|||
16813532|NCT01986855|37755978|FG002|Overall Study|Death|4|||
16813533|NCT01986855|37755976|FG000|Overall Study|Lost to Follow-up|2|||
16813534|NCT01986855|37755977|FG001|Overall Study|Lost to Follow-up|1|||
16813535|NCT01986855|37755978|FG002|Overall Study|Lost to Follow-up|0|||
16813536|NCT01986855|37755976|FG000|Overall Study|Screen Failure|0|||
16813537|NCT01986855|37755977|FG001|Overall Study|Screen Failure|1|||
16813538|NCT01986855|37755978|FG002|Overall Study|Screen Failure|0|||
16813539|NCT01986855|37755976|FG000|Overall Study|Participant Moved|0|||
16813540|NCT01986855|37755977|FG001|Overall Study|Participant Moved|0|||
16813541|NCT01986855|37755978|FG002|Overall Study|Participant Moved|2|||
16813542|NCT01986855|37755976|FG000|Overall Study|Withdrawal by Subject|7|||
16813543|NCT01986855|37755977|FG001|Overall Study|Withdrawal by Subject|8|||
16813544|NCT01986855|37755978|FG002|Overall Study|Withdrawal by Subject|5|||
16813545|NCT02075463|37755986|FG000|Overall Study|Adverse Event|3|||
16813546|NCT02075463|37755986|FG000|Overall Study|Par. reached stopping criteria|4|||
16813547|NCT02075463|37755986|FG000|Overall Study|Withdrawal by Subject|1|||
16813548|NCT02353871|37755993|FG000|Overall Study|Protocol deviation|0|||
16813549|NCT02353871|37755994|FG001|Overall Study|Protocol deviation|1|||
16813550|NCT02353871|37755993|FG000|Overall Study|Consent withdrawn|1|||
16813551|NCT02353871|37755994|FG001|Overall Study|Consent withdrawn|8|||
16813552|NCT02353871|37755993|FG000|Overall Study|Lost to Follow-up|2|||
16813553|NCT02353871|37755994|FG001|Overall Study|Lost to Follow-up|0|||
16813554|NCT02009397|37756000|FG000|Overall Study|Protocol Violation|6|||
16813555|NCT02009397|37756000|FG000|Overall Study|Death|8|||
16813556|NCT02009397|37756000|FG000|Overall Study|Lost to Follow-up|6|||
16813557|NCT02312219|37756006|FG000|Overall Study|Withdrawal by Subject|1|||
16813558|NCT02312219|37756007|FG001|Overall Study|Withdrawal by Subject|2|||
16813559|NCT02312219|37756006|FG000|Overall Study|could not schedule imaging in time|0|||
16813560|NCT02312219|37756007|FG001|Overall Study|could not schedule imaging in time|2|||
16813561|NCT02312219|37756006|FG000|Overall Study|Other|0|||
16813562|NCT02312219|37756007|FG001|Overall Study|Other|1|||
16813563|NCT02312219|37756006|FG000|Overall Study|Not randomized. Ineligible|0|||
16813564|NCT02312219|37756007|FG001|Overall Study|Not randomized. Ineligible|1|||
16813565|NCT01986231|37756013|FG000|Overall Study|Adverse Event|1|||
16813566|NCT02312063|37756019|FG000|Overall Study|Withdrawal by Subject|0|||
16813567|NCT02312063|37756020|FG001|Overall Study|Withdrawal by Subject|1|||
16813568|NCT02353169|37756031|FG000|Overall Study|QTc > 450 msec|1|||
16813569|NCT02353169|37756032|FG001|Overall Study|QTc > 450 msec|1|||
16813570|NCT02353169|37756033|FG002|Overall Study|QTc > 450 msec|1|||
16813571|NCT02353169|37756034|FG003|Overall Study|QTc > 450 msec|1|||
16813572|NCT02353169|37756031|FG000|Overall Study|OR team declined|2|||
16813573|NCT02353169|37756032|FG001|Overall Study|OR team declined|0|||
16813574|NCT02353169|37756033|FG002|Overall Study|OR team declined|0|||
16813575|NCT02353169|37756034|FG003|Overall Study|OR team declined|0|||
16813576|NCT02353169|37756031|FG000|Overall Study|Inhalational induction|0|||
16813577|NCT02353169|37756032|FG001|Overall Study|Inhalational induction|2|||
16813578|NCT02353169|37756033|FG002|Overall Study|Inhalational induction|0|||
16813579|NCT02353169|37756034|FG003|Overall Study|Inhalational induction|0|||
16813580|NCT02353169|37756031|FG000|Overall Study|ECG data error|0|||
16813581|NCT02353169|37756032|FG001|Overall Study|ECG data error|3|||
16813582|NCT02353169|37756033|FG002|Overall Study|ECG data error|2|||
16813583|NCT02353169|37756034|FG003|Overall Study|ECG data error|2|||
16813584|NCT02353169|37756031|FG000|Overall Study|Pre-op medication|0|||
16813585|NCT02353169|37756032|FG001|Overall Study|Pre-op medication|0|||
16813586|NCT02353169|37756033|FG002|Overall Study|Pre-op medication|1|||
16813587|NCT02353169|37756034|FG003|Overall Study|Pre-op medication|0|||
16813588|NCT02009163|37756044|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
16813589|NCT02009163|37756045|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
16813590|NCT02009163|37756046|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
16813591|NCT02009163|37756044|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
16813592|NCT02009163|37756045|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
16813593|NCT02009163|37756046|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
16813594|NCT02009163|37756044|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
16813595|NCT02009163|37756045|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
16813596|NCT02009163|37756046|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
16813597|NCT02009163|37756044|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
16813598|NCT02009163|37756045|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
16813599|NCT02009163|37756046|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
16813600|NCT02009163|37756044|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
16813601|NCT02009163|37756045|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
16813602|NCT02009163|37756046|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
16813603|NCT02009163|37756044|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
16813604|NCT02009163|37756045|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
16813605|NCT02009163|37756046|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
16813606|NCT02009163|37756044|FG000|Open-label Period (Non-randomized)|Other|13|||
16813607|NCT02009163|37756045|FG001|Open-label Period (Non-randomized)|Other|0|||
16813608|NCT02009163|37756046|FG002|Open-label Period (Non-randomized)|Other|0|||
16813609|NCT02009163|37756044|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
16813610|NCT02009163|37756045|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
16813611|NCT02009163|37756046|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
16813612|NCT02009163|37756044|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
16813613|NCT02009163|37756045|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
16813614|NCT02009163|37756046|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
16813615|NCT02009163|37756044|FG000|Randomized-withdrawal Period|Adverse Event|0|||
16813616|NCT02009163|37756045|FG001|Randomized-withdrawal Period|Adverse Event|0|||
16813617|NCT02009163|37756046|FG002|Randomized-withdrawal Period|Adverse Event|6|||
16813618|NCT02009163|37756044|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
16813619|NCT02009163|37756045|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
16813620|NCT02009163|37756046|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
16813621|NCT02009163|37756044|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
16813622|NCT02009163|37756045|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
16910280|NCT01709838|38019075|FG000|Overall Study|Adverse Event|4|||
16910281|NCT01709838|38019075|FG000|Overall Study|Physician Decision|4|||
16910282|NCT01709838|38019075|FG000|Overall Study|Death|3|||
17102332|NCT00116558|38241233|FG002|Overall Study|Withdrawal by Subject|12|||
17102333|NCT00116558|38241231|FG000|Overall Study|disease progression|3|||
17102334|NCT00116558|38241232|FG001|Overall Study|disease progression|7|||
16813623|NCT02009163|37756046|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
16813624|NCT02009163|37756044|FG000|Randomized-withdrawal Period|Pregnancy|0|||
16813625|NCT02009163|37756045|FG001|Randomized-withdrawal Period|Pregnancy|0|||
16813626|NCT02009163|37756046|FG002|Randomized-withdrawal Period|Pregnancy|2|||
16813627|NCT02009163|37756044|FG000|Randomized-withdrawal Period|Other|0|||
16813628|NCT02009163|37756045|FG001|Randomized-withdrawal Period|Other|9|||
16813629|NCT02009163|37756046|FG002|Randomized-withdrawal Period|Other|5|||
16813630|NCT01983969|37756059|FG000|Overall Study|Disease Progression|0|||
16813631|NCT01983969|37756060|FG001|Overall Study|Disease Progression|1|||
16813632|NCT01983969|37756061|FG002|Overall Study|Disease Progression|0|||
16813633|NCT02008773|37756077|FG000|Overall Study|Adverse Event|3|||
16813634|NCT02008773|37756078|FG001|Overall Study|Adverse Event|3|||
16813635|NCT02008773|37756079|FG002|Overall Study|Adverse Event|1|||
16813636|NCT02008773|37756080|FG003|Overall Study|Adverse Event|2|||
16813637|NCT02008773|37756077|FG000|Overall Study|Medication Non-compliance|2|||
16813638|NCT02008773|37756078|FG001|Overall Study|Medication Non-compliance|1|||
16813639|NCT02008773|37756079|FG002|Overall Study|Medication Non-compliance|3|||
16813640|NCT02008773|37756080|FG003|Overall Study|Medication Non-compliance|2|||
16813641|NCT02008773|37756077|FG000|Overall Study|Withdrawal by Subject|8|||
16813642|NCT02008773|37756078|FG001|Overall Study|Withdrawal by Subject|4|||
16813643|NCT02008773|37756079|FG002|Overall Study|Withdrawal by Subject|7|||
16813644|NCT02008773|37756080|FG003|Overall Study|Withdrawal by Subject|6|||
16813645|NCT02008773|37756077|FG000|Overall Study|Lost to Follow-up|0|||
16813646|NCT02008773|37756078|FG001|Overall Study|Lost to Follow-up|1|||
16813647|NCT02008773|37756079|FG002|Overall Study|Lost to Follow-up|3|||
16813648|NCT02008773|37756080|FG003|Overall Study|Lost to Follow-up|2|||
16813649|NCT02257567|37756099|FG000|Overall Study|Adverse Event|0|||
16813650|NCT02257567|37756100|FG001|Overall Study|Adverse Event|0|||
16813651|NCT02257567|37756101|FG002|Overall Study|Adverse Event|0|||
16813652|NCT02257567|37756102|FG003|Overall Study|Adverse Event|1|||
16813653|NCT02257567|37756103|FG004|Overall Study|Adverse Event|1|||
16813654|NCT02257567|37756104|FG005|Overall Study|Adverse Event|0|||
16813655|NCT02257567|37756105|FG006|Overall Study|Adverse Event|0|||
16813656|NCT02257567|37756106|FG007|Overall Study|Adverse Event|0|||
16813657|NCT02257567|37756107|FG008|Overall Study|Adverse Event|1|||
16813658|NCT02257567|37756108|FG009|Overall Study|Adverse Event|0|||
16813659|NCT02257567|37756109|FG010|Overall Study|Adverse Event|0|||
16813660|NCT02257567|37756099|FG000|Overall Study|Death|2|||
16813661|NCT02257567|37756100|FG001|Overall Study|Death|2|||
16813662|NCT02257567|37756101|FG002|Overall Study|Death|2|||
16813663|NCT02257567|37756102|FG003|Overall Study|Death|4|||
16813664|NCT02257567|37756103|FG004|Overall Study|Death|15|||
16813665|NCT02257567|37756104|FG005|Overall Study|Death|11|||
16813666|NCT02257567|37756105|FG006|Overall Study|Death|26|||
16813667|NCT02257567|37756106|FG007|Overall Study|Death|30|||
16813668|NCT02257567|37756107|FG008|Overall Study|Death|2|||
16910283|NCT01709838|38019075|FG000|Overall Study|Protocol Violation|1|||
17102335|NCT00116558|38241233|FG002|Overall Study|disease progression|18|||
16813669|NCT02257567|37756108|FG009|Overall Study|Death|18|||
16813670|NCT02257567|37756109|FG010|Overall Study|Death|65|||
16813671|NCT02257567|37756099|FG000|Overall Study|Lost to Follow-up|0|||
16813672|NCT02257567|37756100|FG001|Overall Study|Lost to Follow-up|0|||
16813673|NCT02257567|37756101|FG002|Overall Study|Lost to Follow-up|0|||
16813674|NCT02257567|37756102|FG003|Overall Study|Lost to Follow-up|0|||
16813675|NCT02257567|37756103|FG004|Overall Study|Lost to Follow-up|2|||
16813676|NCT02257567|37756104|FG005|Overall Study|Lost to Follow-up|2|||
16813677|NCT02257567|37756105|FG006|Overall Study|Lost to Follow-up|0|||
16813678|NCT02257567|37756106|FG007|Overall Study|Lost to Follow-up|0|||
16813679|NCT02257567|37756107|FG008|Overall Study|Lost to Follow-up|0|||
16813680|NCT02257567|37756108|FG009|Overall Study|Lost to Follow-up|1|||
16813681|NCT02257567|37756109|FG010|Overall Study|Lost to Follow-up|1|||
16813682|NCT02257567|37756099|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813683|NCT02257567|37756100|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813684|NCT02257567|37756101|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813685|NCT02257567|37756102|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813686|NCT02257567|37756103|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
16813687|NCT02257567|37756104|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813688|NCT02257567|37756105|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
16813689|NCT02257567|37756106|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813690|NCT02257567|37756107|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813691|NCT02257567|37756108|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813692|NCT02257567|37756109|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16813693|NCT02257567|37756099|FG000|Overall Study|Physician Decision|0|||
16813694|NCT02257567|37756100|FG001|Overall Study|Physician Decision|0|||
16813695|NCT02257567|37756101|FG002|Overall Study|Physician Decision|0|||
16813696|NCT02257567|37756102|FG003|Overall Study|Physician Decision|0|||
16813697|NCT02257567|37756103|FG004|Overall Study|Physician Decision|0|||
16813698|NCT02257567|37756104|FG005|Overall Study|Physician Decision|0|||
16813699|NCT02257567|37756105|FG006|Overall Study|Physician Decision|0|||
16813700|NCT02257567|37756106|FG007|Overall Study|Physician Decision|2|||
16813701|NCT02257567|37756107|FG008|Overall Study|Physician Decision|0|||
16813702|NCT02257567|37756108|FG009|Overall Study|Physician Decision|1|||
16813703|NCT02257567|37756109|FG010|Overall Study|Physician Decision|0|||
16813704|NCT02257567|37756099|FG000|Overall Study|Withdrawal by Subject|0|||
16813705|NCT02257567|37756100|FG001|Overall Study|Withdrawal by Subject|0|||
16813706|NCT02257567|37756101|FG002|Overall Study|Withdrawal by Subject|2|||
16813707|NCT02257567|37756102|FG003|Overall Study|Withdrawal by Subject|0|||
16813708|NCT02257567|37756103|FG004|Overall Study|Withdrawal by Subject|0|||
16813709|NCT02257567|37756104|FG005|Overall Study|Withdrawal by Subject|6|||
16813710|NCT02257567|37756105|FG006|Overall Study|Withdrawal by Subject|6|||
16813711|NCT02257567|37756106|FG007|Overall Study|Withdrawal by Subject|6|||
16813712|NCT02257567|37756107|FG008|Overall Study|Withdrawal by Subject|1|||
16813713|NCT02257567|37756108|FG009|Overall Study|Withdrawal by Subject|1|||
16813714|NCT02257567|37756109|FG010|Overall Study|Withdrawal by Subject|10|||
16813715|NCT01642615|37756166|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
16813716|NCT01642615|37756167|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16813717|NCT01642615|37756168|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16813718|NCT01642615|37756166|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
16813719|NCT01642615|37756167|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
16813720|NCT01642615|37756168|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
16813721|NCT01642615|37756166|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
16813722|NCT01642615|37756167|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
16813723|NCT01642615|37756168|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
16813724|NCT01642615|37756166|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
16813725|NCT01642615|37756167|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
16813726|NCT01642615|37756168|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
16813727|NCT01642615|37756166|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
16813728|NCT01642615|37756167|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
16813729|NCT01642615|37756168|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
16813730|NCT01642615|37756166|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
16813731|NCT01642615|37756167|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
16813732|NCT01642615|37756168|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
16813733|NCT01642615|37756166|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
17102336|NCT00116168|38241244|FG000|Overall Study|Lost to Follow-up|6|||
17102337|NCT00116168|38241245|FG001|Overall Study|Lost to Follow-up|5|||
16813734|NCT01642615|37756167|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
16813735|NCT01642615|37756168|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
16813736|NCT01642615|37756166|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16813737|NCT01642615|37756167|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
16813738|NCT01642615|37756168|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16813739|NCT01642615|37756166|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
16813740|NCT01642615|37756167|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
16813741|NCT01642615|37756168|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
16813742|NCT02311361|37756180|FG000|Overall Study|Did not receive treatment|0|||
16813743|NCT02311361|37756181|FG001|Overall Study|Did not receive treatment|1|||
16813744|NCT02311361|37756182|FG002|Overall Study|Did not receive treatment|0|||
16813745|NCT02311361|37756183|FG003|Overall Study|Did not receive treatment|1|||
16813746|NCT02352779|37756200|FG000|Overall Study|Personal Issues|1|||
16813747|NCT02352779|37756201|FG001|Overall Study|Personal Issues|1|||
16813748|NCT02352779|37756202|FG002|Overall Study|Personal Issues|0|||
16813749|NCT02352779|37756200|FG000|Overall Study|Too Many Forms|2|||
16813750|NCT02352779|37756201|FG001|Overall Study|Too Many Forms|0|||
16813751|NCT02352779|37756202|FG002|Overall Study|Too Many Forms|0|||
16813752|NCT02352779|37756200|FG000|Overall Study|Feeling Overwhelmed|1|||
16813753|NCT02352779|37756201|FG001|Overall Study|Feeling Overwhelmed|0|||
16813754|NCT02352779|37756202|FG002|Overall Study|Feeling Overwhelmed|0|||
16813755|NCT02352779|37756200|FG000|Overall Study|Disliked Intervention|1|||
16813756|NCT02352779|37756201|FG001|Overall Study|Disliked Intervention|0|||
16813757|NCT02352779|37756202|FG002|Overall Study|Disliked Intervention|0|||
16813758|NCT02352779|37756200|FG000|Overall Study|Changed Mind|1|||
16813759|NCT02352779|37756201|FG001|Overall Study|Changed Mind|0|||
16813760|NCT02352779|37756202|FG002|Overall Study|Changed Mind|0|||
16813761|NCT02352779|37756200|FG000|Overall Study|Study Related Symptoms|1|||
16813762|NCT02352779|37756201|FG001|Overall Study|Study Related Symptoms|0|||
16813763|NCT02352779|37756202|FG002|Overall Study|Study Related Symptoms|0|||
16813764|NCT02352779|37756200|FG000|Overall Study|Absence of Symptoms|1|||
16813765|NCT02352779|37756201|FG001|Overall Study|Absence of Symptoms|0|||
16813766|NCT02352779|37756202|FG002|Overall Study|Absence of Symptoms|0|||
16813767|NCT02352779|37756200|FG000|Overall Study|Other Medical Reason|0|||
16813768|NCT02352779|37756201|FG001|Overall Study|Other Medical Reason|0|||
16813769|NCT02352779|37756202|FG002|Overall Study|Other Medical Reason|1|||
16813770|NCT02352779|37756200|FG000|Overall Study|No Reason|0|||
16813771|NCT02352779|37756201|FG001|Overall Study|No Reason|0|||
16813772|NCT02352779|37756202|FG002|Overall Study|No Reason|1|||
16813773|NCT02257489|37756219|FG000|Overall Study|Withdrawal by Subject|0|||
16813774|NCT02257489|37756220|FG001|Overall Study|Withdrawal by Subject|0|||
16813775|NCT02257489|37756221|FG002|Overall Study|Withdrawal by Subject|0|||
16813776|NCT02257489|37756222|FG003|Overall Study|Withdrawal by Subject|1|||
16813777|NCT02257489|37756223|FG004|Overall Study|Withdrawal by Subject|0|||
16813778|NCT02257489|37756224|FG005|Overall Study|Withdrawal by Subject|0|||
16813779|NCT02257489|37756225|FG006|Overall Study|Withdrawal by Subject|0|||
16813780|NCT02257489|37756226|FG007|Overall Study|Withdrawal by Subject|0|||
16813781|NCT02257489|37756227|FG008|Overall Study|Withdrawal by Subject|0|||
16813782|NCT02329223|37756250|FG000|Overall Study|Withdrawal by Subject|1|||
16813783|NCT02329223|37756251|FG001|Overall Study|Withdrawal by Subject|2|||
16813784|NCT02329223|37756252|FG002|Overall Study|Withdrawal by Subject|5|||
16813785|NCT02329223|37756250|FG000|Overall Study|Physician Decision|0|||
16813786|NCT02329223|37756251|FG001|Overall Study|Physician Decision|0|||
16813787|NCT02329223|37756252|FG002|Overall Study|Physician Decision|1|||
16813788|NCT02329223|37756250|FG000|Overall Study|Adverse Event|0|||
16813789|NCT02329223|37756251|FG001|Overall Study|Adverse Event|1|||
16813790|NCT02329223|37756252|FG002|Overall Study|Adverse Event|0|||
16813791|NCT01641601|37756262|FG000|Overall Study|Study discontinued.|3|||
16813792|NCT01641601|37756263|FG001|Overall Study|Study discontinued.|5|||
16813793|NCT02350127|37756271|FG000|4-Month Assessment|Withdrawal by Subject|10|||
16813794|NCT02350127|37756272|FG001|4-Month Assessment|Withdrawal by Subject|9|||
16813795|NCT02350127|37756271|FG000|4-Month Assessment|Death|1|||
16813796|NCT02350127|37756272|FG001|4-Month Assessment|Death|0|||
16813797|NCT02350127|37756271|FG000|8-Month Assessment|Death|1|||
16813798|NCT02350127|37756272|FG001|8-Month Assessment|Death|1|||
16910284|NCT01682226|38019081|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
16813799|NCT02350127|37756271|FG000|8-Month Assessment|Withdrawal by Subject|5|||
16813800|NCT02350127|37756272|FG001|8-Month Assessment|Withdrawal by Subject|8|||
16813801|NCT02256553|37756279|FG000|Period I|Adverse Event|5|||
16813802|NCT02256553|37756279|FG000|Period I|Protocol Violation|1|||
16813803|NCT02256553|37756279|FG000|Period II|Adverse Event|1|||
16813804|NCT02256553|37756279|FG000|Period II|Subject Moved|1|||
16813805|NCT02256553|37756279|FG000|Period III|Adverse Event|3|||
16813806|NCT02349425|37756289|FG000|Period 1|Adverse Event|1|||
16813807|NCT02349425|37756290|FG001|Period 1|Adverse Event|1|||
16813808|NCT02349425|37756291|FG002|Period 1|Adverse Event|0|||
16813809|NCT02349425|37756292|FG003|Period 1|Adverse Event|0|||
16813810|NCT02349425|37756289|FG000|Period 2|Adverse Event|0|||
16813811|NCT02349425|37756290|FG001|Period 2|Adverse Event|1|||
16813812|NCT02349425|37756291|FG002|Period 2|Adverse Event|1|||
16813813|NCT02349425|37756292|FG003|Period 2|Adverse Event|0|||
16813814|NCT02310581|37756334|FG000|Overall Study|Adverse Event|1|||
16813815|NCT02310581|37756335|FG001|Overall Study|Adverse Event|1|||
16813816|NCT02310581|37756336|FG002|Overall Study|Adverse Event|1|||
16813817|NCT02310581|37756337|FG003|Overall Study|Adverse Event|0|||
16813818|NCT02310581|37756334|FG000|Overall Study|Withdrawal by Subject|2|||
16813819|NCT02310581|37756335|FG001|Overall Study|Withdrawal by Subject|1|||
16813820|NCT02310581|37756336|FG002|Overall Study|Withdrawal by Subject|0|||
16813821|NCT02310581|37756337|FG003|Overall Study|Withdrawal by Subject|1|||
16813822|NCT02309723|37756350|FG000|Overall Study|Withdrawal by Subject|24|||
16813823|NCT02309723|37756351|FG001|Overall Study|Withdrawal by Subject|23|||
16813824|NCT02309723|37756352|FG002|Overall Study|Withdrawal by Subject|24|||
16813825|NCT02309411|37756363|FG000|Overall Study|Physician Decision|1|||
16813826|NCT02309411|37756364|FG001|Overall Study|Physician Decision|0|||
16813827|NCT02309411|37756365|FG002|Overall Study|Physician Decision|0|||
16813828|NCT02309411|37756363|FG000|Overall Study|Withdrawal by Subject|1|||
16813829|NCT02309411|37756364|FG001|Overall Study|Withdrawal by Subject|1|||
16813830|NCT02309411|37756365|FG002|Overall Study|Withdrawal by Subject|0|||
16813831|NCT02008227|37756374|FG000|Overall Study|Lost to Follow-up|7|||
16813832|NCT02008227|37756375|FG001|Overall Study|Lost to Follow-up|9|||
16813833|NCT02008227|37756374|FG000|Overall Study|Death|494|||
16813834|NCT02008227|37756375|FG001|Overall Study|Death|485|||
16813835|NCT02008227|37756374|FG000|Overall Study|Withdrawal by Subject|67|||
16813836|NCT02008227|37756375|FG001|Overall Study|Withdrawal by Subject|36|||
16813837|NCT02008227|37756374|FG000|Overall Study|Study Terminated By Sponsor|44|||
16813838|NCT02008227|37756375|FG001|Overall Study|Study Terminated By Sponsor|83|||
16813839|NCT02006979|37756384|FG000|Overall Study|Withdrawal by Subject|1|||
16813840|NCT02006979|37756385|FG001|Overall Study|Withdrawal by Subject|1|||
16813841|NCT02006979|37756384|FG000|Overall Study|Protocol Violation|0|||
16813842|NCT02006979|37756385|FG001|Overall Study|Protocol Violation|1|||
16813843|NCT02348723|37756393|FG000|Overall Study|No ablation|21|||
16813844|NCT02348723|37756394|FG001|Overall Study|No ablation|20|||
16813845|NCT02348723|37756393|FG000|Overall Study|Non-compliant with Protocol|1|||
16813846|NCT02348723|37756394|FG001|Overall Study|Non-compliant with Protocol|0|||
16813847|NCT02348723|37756393|FG000|Overall Study|Lost to Follow-up|1|||
16813848|NCT02348723|37756394|FG001|Overall Study|Lost to Follow-up|1|||
16813849|NCT02348723|37756393|FG000|Overall Study|Consent withdrawn|1|||
16813850|NCT02348723|37756394|FG001|Overall Study|Consent withdrawn|3|||
16813851|NCT02348723|37756393|FG000|Overall Study|Reason other than specified|1|||
16813852|NCT02348723|37756394|FG001|Overall Study|Reason other than specified|1|||
16813853|NCT02348723|37756393|FG000|Overall Study|Adverse Event|3|||
16813854|NCT02348723|37756394|FG001|Overall Study|Adverse Event|1|||
16813855|NCT01967277|37756402|FG000|Overall Study|Lost to Follow-up|1|||
16910285|NCT01682226|38019081|FG000|Overall Study|Participants did not receive treatment|2|||
16910286|NCT01682226|38019081|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
16910287|NCT01688466|38019087|FG000|Overall Study|Withdrawal by Subject|2|||
16910288|NCT01688466|38019088|FG001|Overall Study|Withdrawal by Subject|1|||
16910289|NCT01688466|38019087|FG000|Overall Study|Death|0|||
16910290|NCT01688466|38019088|FG001|Overall Study|Death|1|||
16910291|NCT01688466|38019087|FG000|Overall Study|Adverse Event|0|||
16910292|NCT01688466|38019088|FG001|Overall Study|Adverse Event|4|||
16910293|NCT01688466|38019087|FG000|Overall Study|Not evaluable|0|||
16910294|NCT01688466|38019088|FG001|Overall Study|Not evaluable|1|||
16910295|NCT01682148|38019096|FG000|Overall Study|Withdrawal by Subject|2|||
16910296|NCT01682148|38019097|FG001|Overall Study|Withdrawal by Subject|0|||
16910297|NCT01682148|38019096|FG000|Overall Study|Lost to Follow-up|1|||
16910298|NCT01682148|38019097|FG001|Overall Study|Lost to Follow-up|2|||
16910299|NCT01682148|38019096|FG000|Overall Study|Protocol Violation|1|||
16910300|NCT01682148|38019097|FG001|Overall Study|Protocol Violation|1|||
16910301|NCT01681992|38019111|FG000|Overall Study|Adverse Event|3|||
16910302|NCT01681992|38019112|FG001|Overall Study|Adverse Event|2|||
16910303|NCT01681992|38019113|FG002|Overall Study|Adverse Event|3|||
16910304|NCT01681992|38019111|FG000|Overall Study|Lost to Follow-up|36|||
16910305|NCT01681992|38019112|FG001|Overall Study|Lost to Follow-up|38|||
16910306|NCT01681992|38019113|FG002|Overall Study|Lost to Follow-up|53|||
16910307|NCT01681992|38019111|FG000|Overall Study|As Per Sponsor Decision|0|||
16910308|NCT01681992|38019112|FG001|Overall Study|As Per Sponsor Decision|0|||
16910309|NCT01681992|38019113|FG002|Overall Study|As Per Sponsor Decision|1|||
16813856|NCT01967277|37756403|FG001|Overall Study|Lost to Follow-up|2|||
16813857|NCT01967277|37756402|FG000|Overall Study|Unrelated illness|0|||
16813858|NCT01967277|37756403|FG001|Overall Study|Unrelated illness|1|||
16910310|NCT01681992|38019111|FG000|Overall Study|Protocol Violation|0|||
16910311|NCT01681992|38019112|FG001|Overall Study|Protocol Violation|0|||
16910312|NCT01681992|38019113|FG002|Overall Study|Protocol Violation|1|||
16910313|NCT01681992|38019111|FG000|Overall Study|Withdrawal by Subject|27|||
16910314|NCT01681992|38019112|FG001|Overall Study|Withdrawal by Subject|30|||
16813859|NCT02326883|37756412|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
16813860|NCT02326883|37756413|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
16813861|NCT02326883|37756414|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
16813862|NCT02006667|37756422|FG000|Overall Study|Adverse Event|3|||
16813863|NCT02006667|37756422|FG000|Overall Study|Death|2|||
16813864|NCT02006667|37756422|FG000|Overall Study|Withdrawal by Subject|1|||
16813865|NCT01983111|37756428|FG000|Overall Study|Withdrawal by Subject|8|||
16813866|NCT01983111|37756429|FG001|Overall Study|Withdrawal by Subject|6|||
16813867|NCT01983111|37756428|FG000|Overall Study|Adverse Event|4|||
16813868|NCT01983111|37756429|FG001|Overall Study|Adverse Event|0|||
16813869|NCT01983111|37756428|FG000|Overall Study|Protocol Violation|0|||
16813870|NCT01983111|37756429|FG001|Overall Study|Protocol Violation|1|||
16813871|NCT02348489|37756437|FG000|Overall Study|Death|336|||
16813872|NCT02348489|37756438|FG001|Overall Study|Death|335|||
16813873|NCT02348489|37756437|FG000|Overall Study|Withdrawal by Subject|14|||
16813874|NCT02348489|37756438|FG001|Overall Study|Withdrawal by Subject|27|||
16813875|NCT02348489|37756437|FG000|Overall Study|Lost to Follow-up|3|||
16813876|NCT02348489|37756438|FG001|Overall Study|Lost to Follow-up|5|||
16813877|NCT02309099|37756448|FG000|Overall Study|Adverse Event|2|||
16813878|NCT02309099|37756449|FG001|Overall Study|Adverse Event|0|||
16813879|NCT01966107|37756457|FG000|Overall Study|excluded from FAS|21|||
16813880|NCT01966107|37756458|FG001|Overall Study|excluded from FAS|20|||
16813881|NCT01966107|37756457|FG000|Overall Study|discontinued treatment|345|||
16813882|NCT01966107|37756458|FG001|Overall Study|discontinued treatment|372|||
16813883|NCT01966107|37756457|FG000|Overall Study|due to study closure|164|||
16813884|NCT01966107|37756458|FG001|Overall Study|due to study closure|186|||
16813885|NCT01966107|37756457|FG000|Overall Study|withdrew from the study|272|||
16813886|NCT01966107|37756458|FG001|Overall Study|withdrew from the study|303|||
16813887|NCT02347943|37756467|FG000|Overall Study|Study was cancelled|140|||
16813888|NCT02347943|37756468|FG001|Overall Study|Study was cancelled|67|||
16813889|NCT02347943|37756469|FG002|Overall Study|Study was cancelled|45|||
16813890|NCT01982331|37756479|FG000|Received Vaccination 2|Adverse Event|1|||
16813891|NCT01982331|37756480|FG001|Received Vaccination 2|Adverse Event|2|||
16813892|NCT01982331|37756479|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
16813893|NCT01982331|37756480|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
16813894|NCT01982331|37756479|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
16813895|NCT01982331|37756480|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
16813896|NCT02326025|37756488|FG000|Overall Study|Adverse Event|3|||
16813897|NCT02326025|37756489|FG001|Overall Study|Adverse Event|0|||
16813898|NCT02326025|37756488|FG000|Overall Study|Physician Decision|1|||
16813899|NCT02326025|37756489|FG001|Overall Study|Physician Decision|2|||
16813900|NCT02326025|37756488|FG000|Overall Study|Physician and Participant Decision|1|||
16813901|NCT02326025|37756489|FG001|Overall Study|Physician and Participant Decision|0|||
16813902|NCT02326025|37756488|FG000|Overall Study|Withdrawal by Subject|0|||
16813903|NCT02326025|37756489|FG001|Overall Study|Withdrawal by Subject|2|||
16813904|NCT02326025|37756488|FG000|Overall Study|Protocol Violation|0|||
16813905|NCT02326025|37756489|FG001|Overall Study|Protocol Violation|1|||
16813906|NCT01619865|37756508|FG000|Overall Study|Adverse Event|1|||
16813907|NCT01619865|37756508|FG000|Overall Study|Death|2|||
16813908|NCT01619865|37756508|FG000|Overall Study|subject not able to comply|1|||
16813909|NCT02006121|37756515|FG000|Double Blind Phase|Adverse Event|6|||
16813910|NCT02006121|37756516|FG001|Double Blind Phase|Adverse Event|0|||
16813911|NCT02006121|37756515|FG000|Double Blind Phase|Lack of Efficacy|1|||
16813912|NCT02006121|37756516|FG001|Double Blind Phase|Lack of Efficacy|16|||
16813913|NCT02006121|37756515|FG000|Double Blind Phase|Withdrawal by Subject|3|||
16813914|NCT02006121|37756516|FG001|Double Blind Phase|Withdrawal by Subject|4|||
16813915|NCT02006121|37756515|FG000|Double Blind Phase|Non-compliance with study drug|1|||
16813916|NCT02006121|37756516|FG001|Double Blind Phase|Non-compliance with study drug|3|||
16813917|NCT02006121|37756515|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
16813918|NCT02006121|37756516|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
16813919|NCT02006121|37756515|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
16813920|NCT02006121|37756516|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
16813921|NCT02006121|37756515|FG000|Open Label Phase|Adverse Event|15|||
16813922|NCT02006121|37756516|FG001|Open Label Phase|Adverse Event|0|||
16813923|NCT02006121|37756515|FG000|Open Label Phase|Lack of Efficacy|2|||
16813924|NCT02006121|37756516|FG001|Open Label Phase|Lack of Efficacy|0|||
16813925|NCT02006121|37756515|FG000|Open Label Phase|Protocol Violation|2|||
16813926|NCT02006121|37756516|FG001|Open Label Phase|Protocol Violation|0|||
16813927|NCT02006121|37756515|FG000|Open Label Phase|Withdrawal by Subject|3|||
16813928|NCT02006121|37756516|FG001|Open Label Phase|Withdrawal by Subject|0|||
16813929|NCT02006121|37756515|FG000|Open Label Phase|Non-compliance with study drug|3|||
16813930|NCT02006121|37756516|FG001|Open Label Phase|Non-compliance with study drug|0|||
16813931|NCT02005887|37756528|FG000|Overall Study|Protocol Violation|0|||
16813932|NCT02005887|37756529|FG001|Overall Study|Protocol Violation|2|||
16813933|NCT01982253|37756538|FG000|Overall Study|Withdrawal by Subject|1|||
16813934|NCT01982253|37756539|FG001|Overall Study|Withdrawal by Subject|0|||
16813935|NCT01982253|37756540|FG002|Overall Study|Withdrawal by Subject|0|||
16813936|NCT01982253|37756538|FG000|Overall Study|Study terminated by sponsor|1|||
16813937|NCT01982253|37756539|FG001|Overall Study|Study terminated by sponsor|4|||
16813938|NCT01982253|37756540|FG002|Overall Study|Study terminated by sponsor|4|||
16813939|NCT01619787|37756550|FG000|Overall Study|Lost to Follow-up|5|||
16813940|NCT01981473|37756559|FG000|Overall Study|Incorrect diagnosis of RA|0|||
16813941|NCT01981473|37756560|FG001|Overall Study|Incorrect diagnosis of RA|0|||
16813942|NCT01981473|37756561|FG002|Overall Study|Incorrect diagnosis of RA|1|||
16813943|NCT01981473|37756559|FG000|Overall Study|Received treatment for < 6 months|0|||
16813944|NCT01981473|37756560|FG001|Overall Study|Received treatment for < 6 months|0|||
16813945|NCT01981473|37756561|FG002|Overall Study|Received treatment for < 6 months|1|||
16813946|NCT01981473|37756559|FG000|Overall Study|Received treatment for >24 months|2|||
16813947|NCT01981473|37756560|FG001|Overall Study|Received treatment for >24 months|0|||
16813948|NCT01981473|37756561|FG002|Overall Study|Received treatment for >24 months|6|||
16813949|NCT02005029|37756574|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
16813950|NCT02005029|37756575|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
16813951|NCT02325791|37756603|FG000|Overall Study|Adverse Event|0|||
16813952|NCT02325791|37756604|FG001|Overall Study|Adverse Event|1|||
16813953|NCT02325791|37756605|FG002|Overall Study|Adverse Event|1|||
16813954|NCT02325791|37756606|FG003|Overall Study|Adverse Event|0|||
16813955|NCT02325791|37756603|FG000|Overall Study|Death|0|||
16813956|NCT02325791|37756604|FG001|Overall Study|Death|3|||
16813957|NCT02325791|37756605|FG002|Overall Study|Death|0|||
16813958|NCT02325791|37756606|FG003|Overall Study|Death|1|||
16813959|NCT02325791|37756603|FG000|Overall Study|Lost to Follow-up|0|||
16813960|NCT02325791|37756604|FG001|Overall Study|Lost to Follow-up|15|||
16813961|NCT02325791|37756605|FG002|Overall Study|Lost to Follow-up|14|||
16813962|NCT02325791|37756606|FG003|Overall Study|Lost to Follow-up|9|||
16813963|NCT02325791|37756603|FG000|Overall Study|Physician Decision|0|||
16813964|NCT02325791|37756604|FG001|Overall Study|Physician Decision|1|||
16813965|NCT02325791|37756605|FG002|Overall Study|Physician Decision|1|||
16813966|NCT02325791|37756606|FG003|Overall Study|Physician Decision|0|||
16813967|NCT02325791|37756603|FG000|Overall Study|Protocol Violation|0|||
16813968|NCT02325791|37756604|FG001|Overall Study|Protocol Violation|0|||
16813969|NCT02325791|37756605|FG002|Overall Study|Protocol Violation|1|||
16813970|NCT02325791|37756606|FG003|Overall Study|Protocol Violation|0|||
16813971|NCT02325791|37756603|FG000|Overall Study|Withdrawal by Subject|0|||
16813972|NCT02325791|37756604|FG001|Overall Study|Withdrawal by Subject|5|||
16813973|NCT02325791|37756605|FG002|Overall Study|Withdrawal by Subject|8|||
16813974|NCT02325791|37756606|FG003|Overall Study|Withdrawal by Subject|16|||
16813975|NCT02004873|37756619|FG000|Overall Study|Implant unsuccessful|6|||
16813976|NCT02004873|37756619|FG000|Overall Study|Awaiting 6-month visit|390|||
16813977|NCT02004873|37756619|FG000|Overall Study|Missed 6-month visit|4|||
16813978|NCT02004873|37756619|FG000|Overall Study|Death|23|||
16813979|NCT02004873|37756619|FG000|Overall Study|Withdrawal by Subject|1|||
16813980|NCT02347787|37756628|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
16813981|NCT02347787|37756629|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
16813982|NCT02347787|37756628|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
16813983|NCT02347787|37756629|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
16813984|NCT02347787|37756628|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
16813985|NCT02347787|37756629|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
16813986|NCT02347787|37756628|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
16813987|NCT02347787|37756629|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
16813988|NCT01979835|37756640|FG000|Primary Outcome SA Measurment|failed insertion|18|||
16813989|NCT01979835|37756640|FG000|Follow-up|Lost to Follow-up|32|||
16813990|NCT02282345|37756646|FG000|Overall Study|Progression|0|||
16813991|NCT02282345|37756647|FG001|Overall Study|Progression|1|||
16813992|NCT01732822|37756658|FG000|Overall Study|Withdrawal by Subject|123|||
16813993|NCT01732822|37756659|FG001|Overall Study|Withdrawal by Subject|113|||
16813994|NCT02004093|37756689|FG000|Overall Study|Death|2|||
16813995|NCT02004093|37756690|FG001|Overall Study|Death|1|||
16813996|NCT02004093|37756689|FG000|Overall Study|Lack of Efficacy|66|||
16813997|NCT02004093|37756690|FG001|Overall Study|Lack of Efficacy|62|||
16813998|NCT02004093|37756689|FG000|Overall Study|Protocol Violation|0|||
16813999|NCT02004093|37756690|FG001|Overall Study|Protocol Violation|1|||
16814000|NCT02004093|37756689|FG000|Overall Study|Lost to Follow-up|0|||
16814001|NCT02004093|37756690|FG001|Overall Study|Lost to Follow-up|1|||
16814002|NCT02004093|37756689|FG000|Overall Study|Withdrawal by Subject|3|||
16814003|NCT02004093|37756690|FG001|Overall Study|Withdrawal by Subject|7|||
16814004|NCT02004093|37756689|FG000|Overall Study|Other|3|||
16910315|NCT01681992|38019113|FG002|Overall Study|Withdrawal by Subject|25|||
16814005|NCT02004093|37756690|FG001|Overall Study|Other|1|||
16814006|NCT01641367|37756705|FG000|Cohorts|Death|18|||
16814007|NCT01641367|37756706|FG001|Cohorts|Death|1|||
16814008|NCT01641367|37756707|FG002|Cohorts|Death|2|||
16814009|NCT01641367|37756708|FG003|Cohorts|Death|0|||
16814010|NCT01641367|37756709|FG004|Cohorts|Death|1|||
16814011|NCT01641367|37756710|FG005|Cohorts|Death|1|||
16814012|NCT01641367|37756711|FG006|Cohorts|Death|0|||
16814013|NCT01641367|37756712|FG007|Cohorts|Death|0|||
16814014|NCT01641367|37756705|FG000|Cohorts|Lost to Follow-up|16|||
16814015|NCT01641367|37756706|FG001|Cohorts|Lost to Follow-up|0|||
16814016|NCT01641367|37756707|FG002|Cohorts|Lost to Follow-up|2|||
16814017|NCT01641367|37756708|FG003|Cohorts|Lost to Follow-up|0|||
16814018|NCT01641367|37756709|FG004|Cohorts|Lost to Follow-up|2|||
16814019|NCT01641367|37756710|FG005|Cohorts|Lost to Follow-up|0|||
16814020|NCT01641367|37756711|FG006|Cohorts|Lost to Follow-up|0|||
16814021|NCT01641367|37756712|FG007|Cohorts|Lost to Follow-up|0|||
16814022|NCT01641367|37756705|FG000|Randomized Adherence Intervention|Death|0|||
16814023|NCT01641367|37756706|FG001|Randomized Adherence Intervention|Death|0|||
16814024|NCT01641367|37756707|FG002|Randomized Adherence Intervention|Death|0|||
16814025|NCT01641367|37756708|FG003|Randomized Adherence Intervention|Death|0|||
16814026|NCT01641367|37756709|FG004|Randomized Adherence Intervention|Death|0|||
16814027|NCT01641367|37756710|FG005|Randomized Adherence Intervention|Death|0|||
16814028|NCT01641367|37756711|FG006|Randomized Adherence Intervention|Death|11|||
16814029|NCT01641367|37756712|FG007|Randomized Adherence Intervention|Death|12|||
16814030|NCT01641367|37756705|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
16814031|NCT01641367|37756706|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
16814032|NCT01641367|37756707|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
16814033|NCT01641367|37756708|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
16814034|NCT01641367|37756709|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
16814035|NCT01641367|37756710|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
16814036|NCT01641367|37756711|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
16814037|NCT01641367|37756712|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
16814038|NCT02325713|37756751|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814039|NCT02325713|37756752|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814040|NCT02325713|37756753|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814041|NCT02325713|37756754|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814042|NCT02325713|37756755|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814043|NCT02325713|37756756|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814044|NCT02325713|37756757|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814045|NCT02325713|37756758|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814046|NCT02325713|37756759|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814047|NCT02325713|37756760|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814048|NCT02325713|37756761|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
16814049|NCT02325713|37756762|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814050|NCT02325713|37756763|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814051|NCT02325713|37756764|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814052|NCT02325713|37756765|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814053|NCT02325713|37756766|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16814054|NCT02325713|37756751|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
16814055|NCT02325713|37756752|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814056|NCT02325713|37756753|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814057|NCT02325713|37756754|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814058|NCT02325713|37756755|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814059|NCT02325713|37756756|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814060|NCT02325713|37756757|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814061|NCT02325713|37756758|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814062|NCT02325713|37756759|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814063|NCT02325713|37756760|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814064|NCT02325713|37756761|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814065|NCT02325713|37756762|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814066|NCT02325713|37756763|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814067|NCT02325713|37756764|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814068|NCT02325713|37756765|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814069|NCT02325713|37756766|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16814070|NCT02325713|37756751|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814071|NCT02325713|37756752|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814072|NCT02325713|37756753|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814073|NCT02325713|37756754|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814074|NCT02325713|37756755|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814075|NCT02325713|37756756|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814076|NCT02325713|37756757|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814077|NCT02325713|37756758|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814078|NCT02325713|37756759|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814079|NCT02325713|37756760|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
16814080|NCT02325713|37756761|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814081|NCT02325713|37756762|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814082|NCT02325713|37756763|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814083|NCT02325713|37756764|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814084|NCT02325713|37756765|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814085|NCT02325713|37756766|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16814086|NCT02325401|37756781|FG000|Overall Study|Withdrawal by Subject|0|||
16814087|NCT02325401|37756782|FG001|Overall Study|Withdrawal by Subject|1|||
16814088|NCT02325401|37756783|FG002|Overall Study|Withdrawal by Subject|1|||
16814089|NCT02324699|37756797|FG000|Overall Study|study terminated|1|||
16814090|NCT01764256|37756805|FG000|Received All Vaccinations|Adverse Event|1|||
16814091|NCT01764256|37756806|FG001|Received All Vaccinations|Adverse Event|1|||
16814092|NCT01764256|37756807|FG002|Received All Vaccinations|Adverse Event|0|||
16814093|NCT01764256|37756808|FG003|Received All Vaccinations|Adverse Event|0|||
16814094|NCT01764256|37756805|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
16814095|NCT01764256|37756806|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
16814096|NCT01764256|37756807|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
16814097|NCT01764256|37756808|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
16814098|NCT01764256|37756805|FG000|Received All Vaccinations|Lost to Follow-up|1|||
16814099|NCT01764256|37756806|FG001|Received All Vaccinations|Lost to Follow-up|0|||
16814100|NCT01764256|37756807|FG002|Received All Vaccinations|Lost to Follow-up|0|||
16814101|NCT01764256|37756808|FG003|Received All Vaccinations|Lost to Follow-up|0|||
16814102|NCT01764256|37756805|FG000|Completed Study|Lost to Follow-up|0|||
16814103|NCT01764256|37756806|FG001|Completed Study|Lost to Follow-up|0|||
16814104|NCT01764256|37756807|FG002|Completed Study|Lost to Follow-up|0|||
16814105|NCT01764256|37756808|FG003|Completed Study|Lost to Follow-up|1|||
16814106|NCT01979523|37756824|FG000|Overall Study|Withdrawal by Subject|1|||
16814107|NCT01979523|37756825|FG001|Overall Study|Withdrawal by Subject|0|||
16814108|NCT02255461|37756837|FG000|Overall Study|Adverse Event|0|||
16814109|NCT02255461|37756838|FG001|Overall Study|Adverse Event|1|||
16814110|NCT02255461|37756839|FG002|Overall Study|Adverse Event|0|||
16814111|NCT02255461|37756840|FG003|Overall Study|Adverse Event|0|||
16814112|NCT02255461|37756841|FG004|Overall Study|Adverse Event|1|||
16814113|NCT02255461|37756837|FG000|Overall Study|Withdrawal by Subject|0|||
16814114|NCT02255461|37756838|FG001|Overall Study|Withdrawal by Subject|0|||
16814115|NCT02255461|37756839|FG002|Overall Study|Withdrawal by Subject|1|||
16814116|NCT02255461|37756840|FG003|Overall Study|Withdrawal by Subject|0|||
16814117|NCT02255461|37756841|FG004|Overall Study|Withdrawal by Subject|1|||
16814118|NCT02255461|37756837|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
16814119|NCT02255461|37756838|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
16814120|NCT02255461|37756839|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
16814121|NCT02255461|37756840|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
16814122|NCT02255461|37756841|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
16814123|NCT02255149|37756858|FG000|Overall Study|Lost to Follow-up|2|||
16814124|NCT02255149|37756858|FG000|Overall Study|Withdrawal by Subject|1|||
16814125|NCT02255149|37756858|FG000|Overall Study|Withdrawal by PI|1|||
16814126|NCT02255149|37756858|FG000|Overall Study|Implant Failure|1|||
16814127|NCT01764022|37756864|FG000|Overall Study|Death|3|||
16814128|NCT01764022|37756865|FG001|Overall Study|Death|5|||
16814129|NCT01764022|37756864|FG000|Overall Study|Withdrawal by Subject|2|||
16814130|NCT01764022|37756865|FG001|Overall Study|Withdrawal by Subject|6|||
16814131|NCT01764022|37756864|FG000|Overall Study|Lack of Efficacy|0|||
16814132|NCT01764022|37756865|FG001|Overall Study|Lack of Efficacy|1|||
16814133|NCT01764022|37756864|FG000|Overall Study|Physician Decision|0|||
16814134|NCT01764022|37756865|FG001|Overall Study|Physician Decision|2|||
16814135|NCT01764022|37756864|FG000|Overall Study|Lost to Follow-up|2|||
16814136|NCT01764022|37756865|FG001|Overall Study|Lost to Follow-up|0|||
16814137|NCT01764022|37756864|FG000|Overall Study|Protocol Violation|1|||
16814138|NCT01764022|37756865|FG001|Overall Study|Protocol Violation|0|||
16814139|NCT02003391|37756875|FG000|Overall Study|Withdrawal by Subject|2|||
16814140|NCT02003391|37756876|FG001|Overall Study|Withdrawal by Subject|1|||
16814141|NCT02003391|37756875|FG000|Overall Study|Protocol Violation|0|||
16814142|NCT02003391|37756876|FG001|Overall Study|Protocol Violation|1|||
16814143|NCT02003391|37756875|FG000|Overall Study|Adverse Event|1|||
16814144|NCT02003391|37756876|FG001|Overall Study|Adverse Event|0|||
16814145|NCT02254681|37756882|FG000|Overall Study|Lack of Efficacy|6|||
16814146|NCT01965327|37756887|FG000|Overall Study|Physician Decision|2|||
16814147|NCT02002689|37756891|FG000|Overall Study|Disease Progression|7|||
16814148|NCT02002689|37756891|FG000|Overall Study|Adverse Event|3|||
16814149|NCT01639729|37756895|FG000|Overall Study|Withdrawal by Subject|1|||
16814150|NCT01639729|37756896|FG001|Overall Study|Withdrawal by Subject|0|||
16814151|NCT01639729|37756897|FG002|Overall Study|Withdrawal by Subject|1|||
16814152|NCT01639729|37756898|FG003|Overall Study|Withdrawal by Subject|1|||
16814153|NCT01639729|37756899|FG004|Overall Study|Withdrawal by Subject|0|||
16814154|NCT01639729|37756900|FG005|Overall Study|Withdrawal by Subject|0|||
16814155|NCT02002533|37756912|FG000|Overall Study|Withdrawal by Subject|6|||
16814156|NCT02002533|37756913|FG001|Overall Study|Withdrawal by Subject|13|||
16814157|NCT02002533|37756912|FG000|Overall Study|Protocol Violation|0|||
16814158|NCT02002533|37756913|FG001|Overall Study|Protocol Violation|1|||
16814159|NCT02002533|37756912|FG000|Overall Study|Adverse Event|0|||
16814160|NCT02002533|37756913|FG001|Overall Study|Adverse Event|3|||
16814161|NCT02002533|37756912|FG000|Overall Study|Lost to Follow-up|0|||
16814162|NCT02002533|37756913|FG001|Overall Study|Lost to Follow-up|1|||
16814163|NCT02002221|37756922|FG000|Overall Study|Adverse Event|2|||
16814164|NCT02002221|37756923|FG001|Overall Study|Adverse Event|1|||
16814165|NCT02002221|37756922|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16814166|NCT02002221|37756923|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16814167|NCT02002221|37756922|FG000|Overall Study|Patient withdrew consent|0|||
16814168|NCT02002221|37756923|FG001|Overall Study|Patient withdrew consent|1|||
16814169|NCT01639495|37756929|FG000|Overall Study|Lost to Follow-up|6|||
16814170|NCT01639495|37756929|FG000|Overall Study|Consented but didn't have study catheter|4|||
16814171|NCT01639495|37756929|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
16814172|NCT01639495|37756929|FG000|Overall Study|No radiofrequency energy applied|2|||
16814173|NCT02001987|37756933|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
16814174|NCT02001987|37756933|FG000|Core Study Period (24 Weeks)|Death|1|||
16814175|NCT02001987|37756933|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
16814176|NCT02001987|37756933|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
16814177|NCT02001987|37756933|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
16814178|NCT02001987|37756933|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
16814179|NCT02001987|37756933|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
16814180|NCT02001987|37756933|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
16814181|NCT02001987|37756933|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
16814182|NCT02001987|37756933|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
16814183|NCT02001987|37756933|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
16814184|NCT02001987|37756933|FG000|LTE Period (52 Weeks)|Other|3|||
16814185|NCT01363765|37756944|FG000|Overall Study|non-diagnostic|2621|||
16814186|NCT01363765|37756945|FG001|Overall Study|non-diagnostic|1124|||
16814187|NCT01363765|37756944|FG000|Overall Study|duplicate records|736|||
16814188|NCT01363765|37756945|FG001|Overall Study|duplicate records|3177|||
16814189|NCT01363765|37756944|FG000|Overall Study|non-resident|156|||
16814190|NCT01363765|37756945|FG001|Overall Study|non-resident|76|||
16814191|NCT01363765|37756944|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
16814192|NCT01363765|37756945|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
16814193|NCT01363765|37756944|FG000|Overall Study|smear during intervention|2170|||
16814194|NCT01363765|37756945|FG001|Overall Study|smear during intervention|0|||
16814195|NCT02001051|37756955|FG000|Overall Study|Deemed not eligible following enrollment|0|||
16814196|NCT02001051|37756956|FG001|Overall Study|Deemed not eligible following enrollment|1|||
16814197|NCT01763164|37756964|FG000|Treatment Phase|Participant/Guardian decision|26|||
16814198|NCT01763164|37756965|FG001|Treatment Phase|Participant/Guardian decision|14|||
16814199|NCT01763164|37756964|FG000|Treatment Phase|Protocol Violation|1|||
16814200|NCT01763164|37756965|FG001|Treatment Phase|Protocol Violation|1|||
16814201|NCT01763164|37756964|FG000|Treatment Phase|Progressive Disease|142|||
16814202|NCT01763164|37756965|FG001|Treatment Phase|Progressive Disease|76|||
16814203|NCT01763164|37756964|FG000|Treatment Phase|Physician Decision|24|||
16814204|NCT01763164|37756965|FG001|Treatment Phase|Physician Decision|13|||
16814205|NCT01763164|37756964|FG000|Treatment Phase|Death|10|||
16814206|NCT01763164|37756965|FG001|Treatment Phase|Death|1|||
16814207|NCT01763164|37756964|FG000|Treatment Phase|Adverse Event|66|||
16814208|NCT01763164|37756965|FG001|Treatment Phase|Adverse Event|8|||
16814209|NCT01763164|37756964|FG000|Treatment Phase|Randomized but not Treated|0|||
16814210|NCT01763164|37756965|FG001|Treatment Phase|Randomized but not Treated|19|||
16814211|NCT01763164|37756964|FG000|Treatment Phase|Other|0|||
16814212|NCT01763164|37756965|FG001|Treatment Phase|Other|1|||
16814213|NCT01763164|37756964|FG000|Follow up Phase|New therapy for study indication|12|||
16814214|NCT01763164|37756965|FG001|Follow up Phase|New therapy for study indication|3|||
16814215|NCT01763164|37756964|FG000|Follow up Phase|Death|21|||
16814216|NCT01763164|37756965|FG001|Follow up Phase|Death|4|||
16814217|NCT01763164|37756964|FG000|Follow up Phase|Subject/guardian decision|9|||
16814218|NCT01763164|37756965|FG001|Follow up Phase|Subject/guardian decision|2|||
16814219|NCT01763164|37756964|FG000|Follow up Phase|Progressive disease|127|||
16814220|NCT01763164|37756965|FG001|Follow up Phase|Progressive disease|62|||
16814221|NCT01763164|37756964|FG000|Follow up Phase|Physician Decision|10|||
16814222|NCT01763164|37756965|FG001|Follow up Phase|Physician Decision|3|||
16814223|NCT01763164|37756964|FG000|Follow up Phase|Lost to Follow-up|1|||
16814224|NCT01763164|37756965|FG001|Follow up Phase|Lost to Follow-up|0|||
16814225|NCT01763164|37756964|FG000|Follow up Phase|Adverse Event|17|||
16814226|NCT01763164|37756965|FG001|Follow up Phase|Adverse Event|1|||
16814227|NCT01782742|37756973|FG000|Double-blind Treatment Phase|Adverse Event|1|||
16814228|NCT01782742|37756974|FG001|Double-blind Treatment Phase|Adverse Event|0|||
16814229|NCT01782664|37756988|FG000|Overall Study|Adverse Event|2|||
16814230|NCT01782664|37756989|FG001|Overall Study|Adverse Event|2|||
16814231|NCT01782664|37756990|FG002|Overall Study|Adverse Event|2|||
16814232|NCT01782664|37756991|FG003|Overall Study|Adverse Event|2|||
16814233|NCT01782664|37756992|FG004|Overall Study|Adverse Event|0|||
16814234|NCT01782664|37756993|FG005|Overall Study|Adverse Event|0|||
16814235|NCT01782664|37756988|FG000|Overall Study|Lack of Efficacy|2|||
16814236|NCT01782664|37756989|FG001|Overall Study|Lack of Efficacy|0|||
16814237|NCT01782664|37756990|FG002|Overall Study|Lack of Efficacy|2|||
16814238|NCT01782664|37756991|FG003|Overall Study|Lack of Efficacy|2|||
16814239|NCT01782664|37756992|FG004|Overall Study|Lack of Efficacy|0|||
16814240|NCT01782664|37756993|FG005|Overall Study|Lack of Efficacy|0|||
16814241|NCT01782664|37756988|FG000|Overall Study|Protocol Violation|0|||
16814242|NCT01782664|37756989|FG001|Overall Study|Protocol Violation|1|||
16814243|NCT01782664|37756990|FG002|Overall Study|Protocol Violation|0|||
16814244|NCT01782664|37756991|FG003|Overall Study|Protocol Violation|1|||
16814245|NCT01782664|37756992|FG004|Overall Study|Protocol Violation|0|||
16814246|NCT01782664|37756993|FG005|Overall Study|Protocol Violation|0|||
16814247|NCT01782664|37756988|FG000|Overall Study|Withdrawal by Subject|2|||
16814248|NCT01782664|37756989|FG001|Overall Study|Withdrawal by Subject|2|||
16814249|NCT01782664|37756990|FG002|Overall Study|Withdrawal by Subject|0|||
16814250|NCT01782664|37756991|FG003|Overall Study|Withdrawal by Subject|0|||
16814251|NCT01782664|37756992|FG004|Overall Study|Withdrawal by Subject|0|||
16814252|NCT01782664|37756993|FG005|Overall Study|Withdrawal by Subject|0|||
16814253|NCT01732588|37757010|FG000|First Intervention (7 Days)|Adverse Event|0|||
16814254|NCT01732588|37757011|FG001|First Intervention (7 Days)|Adverse Event|1|||
16814255|NCT01732588|37757012|FG002|First Intervention (7 Days)|Adverse Event|0|||
16814256|NCT01781962|37757020|FG000|Overall Study|Other Miscellaneous Reasons|5|||
16814257|NCT01639339|37757026|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
16814258|NCT01639339|37757027|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
16814259|NCT01639339|37757026|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
16814260|NCT01639339|37757027|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
16814261|NCT01639339|37757026|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
16814262|NCT01639339|37757027|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
16814263|NCT01639339|37757026|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
16814264|NCT01639339|37757027|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
16814265|NCT01639339|37757026|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
16814266|NCT01639339|37757027|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
16814267|NCT01639339|37757026|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
16814268|NCT01639339|37757027|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
16814269|NCT01639339|37757026|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
16814270|NCT01639339|37757027|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
16814271|NCT01639339|37757026|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
16814272|NCT01639339|37757027|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
16814273|NCT01639339|37757026|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
16814274|NCT01639339|37757027|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
16814275|NCT01639339|37757026|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
16814276|NCT01639339|37757027|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
16814277|NCT02000817|37757041|FG000|Overall Study|Withdrawal by Subject|2|||
16814278|NCT02000817|37757042|FG001|Overall Study|Withdrawal by Subject|0|||
16814279|NCT02000817|37757043|FG002|Overall Study|Withdrawal by Subject|0|||
16814280|NCT02000817|37757044|FG003|Overall Study|Withdrawal by Subject|0|||
16814281|NCT02000817|37757041|FG000|Overall Study|Adverse Event|0|||
16814282|NCT02000817|37757042|FG001|Overall Study|Adverse Event|1|||
16814283|NCT02000817|37757043|FG002|Overall Study|Adverse Event|0|||
16814284|NCT02000817|37757044|FG003|Overall Study|Adverse Event|0|||
16814285|NCT02000817|37757041|FG000|Overall Study|Lost to Follow-up|0|||
16814286|NCT02000817|37757042|FG001|Overall Study|Lost to Follow-up|0|||
16814287|NCT02000817|37757043|FG002|Overall Study|Lost to Follow-up|1|||
16814288|NCT02000817|37757044|FG003|Overall Study|Lost to Follow-up|0|||
16814289|NCT01641133|37757060|FG000|Overall Study|Protocol Violation|0|||
16814290|NCT01641133|37757061|FG001|Overall Study|Protocol Violation|1|||
16814291|NCT01641133|37757062|FG002|Overall Study|Protocol Violation|1|||
16814292|NCT01641133|37757060|FG000|Overall Study|Migrated/moved from study area|5|||
16814293|NCT01641133|37757061|FG001|Overall Study|Migrated/moved from study area|3|||
16814294|NCT01641133|37757062|FG002|Overall Study|Migrated/moved from study area|1|||
16814295|NCT01641133|37757060|FG000|Overall Study|Adverse Event|0|||
16814296|NCT01641133|37757061|FG001|Overall Study|Adverse Event|0|||
16814297|NCT01641133|37757062|FG002|Overall Study|Adverse Event|1|||
16814298|NCT01641133|37757060|FG000|Overall Study|Withdrawal by Subject|5|||
16814299|NCT01641133|37757061|FG001|Overall Study|Withdrawal by Subject|3|||
16814300|NCT01641133|37757062|FG002|Overall Study|Withdrawal by Subject|3|||
16814301|NCT01641133|37757060|FG000|Overall Study|Lost to Follow-up|0|||
16814302|NCT01641133|37757061|FG001|Overall Study|Lost to Follow-up|2|||
16814303|NCT01641133|37757062|FG002|Overall Study|Lost to Follow-up|2|||
16814304|NCT02000427|37757070|FG000|Overall Study|Death|22|||
16814305|NCT04662073|37757076|FG000|Overall Study|Withdrawal by Subject|1|||
16814306|NCT04662073|37757077|FG001|Overall Study|Withdrawal by Subject|0|||
16814307|NCT01600885|37757083|FG000|First Period|Adverse Event|1|||
16814308|NCT01600885|37757084|FG001|First Period|Adverse Event|1|||
16814309|NCT01600885|37757083|FG000|First Period|moved out of area|1|||
16814310|NCT01600885|37757084|FG001|First Period|moved out of area|0|||
16814311|NCT01732510|37757097|FG000|Overall Study|Adverse Event|0|||
16814312|NCT01732510|37757098|FG001|Overall Study|Adverse Event|1|||
16814313|NCT01732510|37757099|FG002|Overall Study|Adverse Event|1|||
16814314|NCT01732510|37757100|FG003|Overall Study|Adverse Event|0|||
16814315|NCT01732510|37757101|FG004|Overall Study|Adverse Event|0|||
16814316|NCT01732510|37757102|FG005|Overall Study|Adverse Event|0|||
16814317|NCT01732510|37757103|FG006|Overall Study|Adverse Event|1|||
16814318|NCT01732510|37757097|FG000|Overall Study|Protocol Violation|0|||
16814319|NCT01732510|37757098|FG001|Overall Study|Protocol Violation|0|||
16814320|NCT01732510|37757099|FG002|Overall Study|Protocol Violation|0|||
16814321|NCT01732510|37757100|FG003|Overall Study|Protocol Violation|1|||
16814322|NCT01732510|37757101|FG004|Overall Study|Protocol Violation|0|||
16814323|NCT01732510|37757102|FG005|Overall Study|Protocol Violation|0|||
16814324|NCT01732510|37757103|FG006|Overall Study|Protocol Violation|0|||
16814325|NCT01732510|37757097|FG000|Overall Study|Withdrawal by Subject|1|||
16814326|NCT01732510|37757098|FG001|Overall Study|Withdrawal by Subject|3|||
16814327|NCT01732510|37757099|FG002|Overall Study|Withdrawal by Subject|2|||
16814328|NCT01732510|37757100|FG003|Overall Study|Withdrawal by Subject|1|||
16814329|NCT01732510|37757101|FG004|Overall Study|Withdrawal by Subject|5|||
16814330|NCT01732510|37757102|FG005|Overall Study|Withdrawal by Subject|0|||
16814331|NCT01732510|37757103|FG006|Overall Study|Withdrawal by Subject|1|||
16814332|NCT01732510|37757097|FG000|Overall Study|Lost to Follow-up|0|||
16814333|NCT01732510|37757098|FG001|Overall Study|Lost to Follow-up|0|||
16814334|NCT01732510|37757099|FG002|Overall Study|Lost to Follow-up|1|||
16814335|NCT01732510|37757100|FG003|Overall Study|Lost to Follow-up|1|||
16814336|NCT01732510|37757101|FG004|Overall Study|Lost to Follow-up|0|||
16814337|NCT01732510|37757102|FG005|Overall Study|Lost to Follow-up|1|||
16814338|NCT01732510|37757103|FG006|Overall Study|Lost to Follow-up|0|||
16814339|NCT01732510|37757097|FG000|Overall Study|Physician Decision|0|||
16814340|NCT01732510|37757098|FG001|Overall Study|Physician Decision|1|||
16814341|NCT01732510|37757099|FG002|Overall Study|Physician Decision|0|||
16814342|NCT01732510|37757100|FG003|Overall Study|Physician Decision|0|||
16814343|NCT01732510|37757101|FG004|Overall Study|Physician Decision|0|||
16814344|NCT01732510|37757102|FG005|Overall Study|Physician Decision|0|||
16814345|NCT01732510|37757103|FG006|Overall Study|Physician Decision|0|||
16814346|NCT01732510|37757097|FG000|Overall Study|Pregnancy|0|||
16814347|NCT01732510|37757098|FG001|Overall Study|Pregnancy|0|||
16814348|NCT01732510|37757099|FG002|Overall Study|Pregnancy|0|||
16814349|NCT01732510|37757100|FG003|Overall Study|Pregnancy|1|||
16814350|NCT01732510|37757101|FG004|Overall Study|Pregnancy|0|||
16814351|NCT01732510|37757102|FG005|Overall Study|Pregnancy|0|||
16814352|NCT01732510|37757103|FG006|Overall Study|Pregnancy|0|||
16814353|NCT01732510|37757097|FG000|Overall Study|Study Terminated By Sponsor|0|||
16814354|NCT01732510|37757098|FG001|Overall Study|Study Terminated By Sponsor|0|||
16814355|NCT01732510|37757099|FG002|Overall Study|Study Terminated By Sponsor|0|||
16814356|NCT01732510|37757100|FG003|Overall Study|Study Terminated By Sponsor|1|||
16910316|NCT01687998|38019123|FG000|Overall Study|Withdrawal by Subject|49|||
16910317|NCT01687998|38019124|FG001|Overall Study|Withdrawal by Subject|51|||
16910318|NCT01687998|38019123|FG000|Overall Study|Known to be Alive at Study End|54|||
16910319|NCT01687998|38019124|FG001|Overall Study|Known to be Alive at Study End|62|||
16910320|NCT01687998|38019123|FG000|Overall Study|Lost to Follow-up|9|||
16910321|NCT01687998|38019124|FG001|Overall Study|Lost to Follow-up|7|||
16910322|NCT01681836|38019130|FG000|Second Intervention|Withdrawal by Subject|0|||
16910323|NCT01681836|38019131|FG001|Second Intervention|Withdrawal by Subject|1|||
16910324|NCT01681368|38019137|FG000|Overall Study|Refused further treatment|1|||
16910325|NCT01681368|38019137|FG000|Overall Study|Refused further follow up|1|||
16910326|NCT01681212|38019141|FG000|Overall Study|No longer met study criteria|5|||
16910327|NCT01681212|38019141|FG000|Overall Study|Administrative reason by sponsor|1|||
16910328|NCT01687296|38019147|FG000|Overall Study|Lack of Efficacy|1|||
16910329|NCT01687296|38019148|FG001|Overall Study|Lack of Efficacy|1|||
16910330|NCT01687296|38019147|FG000|Overall Study|Protocol Violation|0|||
17016589|NCT00855062|38161221|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
17016590|NCT00855062|38161222|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
16814357|NCT01732510|37757101|FG004|Overall Study|Study Terminated By Sponsor|0|||
16814358|NCT01732510|37757102|FG005|Overall Study|Study Terminated By Sponsor|12|||
16814359|NCT01732510|37757103|FG006|Overall Study|Study Terminated By Sponsor|6|||
16814360|NCT01637077|37757124|FG000|Overall Study|Cancel|1|||
16814361|NCT01637077|37757125|FG001|Overall Study|Cancel|1|||
16814362|NCT01637077|37757124|FG000|Overall Study|Withdrawal by Subject|1|||
16814363|NCT01637077|37757125|FG001|Overall Study|Withdrawal by Subject|0|||
16814364|NCT01637077|37757124|FG000|Overall Study|No cycle 1 questionnaire data|2|||
16814365|NCT01637077|37757125|FG001|Overall Study|No cycle 1 questionnaire data|0|||
16910331|NCT01687296|38019148|FG001|Overall Study|Protocol Violation|1|||
16910332|NCT01687296|38019147|FG000|Overall Study|Withdrawal by Subject|6|||
16814366|NCT02308163|37757135|FG000|Overall Study|Not fulfill eligible criteria|1|||
16814367|NCT02308163|37757136|FG001|Overall Study|Not fulfill eligible criteria|2|||
16814368|NCT02308163|37757137|FG002|Overall Study|Not fulfill eligible criteria|0|||
16814369|NCT02308163|37757138|FG003|Overall Study|Not fulfill eligible criteria|1|||
16814370|NCT02308163|37757139|FG004|Overall Study|Not fulfill eligible criteria|1|||
16814371|NCT02308163|37757135|FG000|Overall Study|Adverse Event|9|||
16814372|NCT02308163|37757136|FG001|Overall Study|Adverse Event|5|||
16814373|NCT02308163|37757137|FG002|Overall Study|Adverse Event|2|||
16814374|NCT02308163|37757138|FG003|Overall Study|Adverse Event|2|||
16814375|NCT02308163|37757139|FG004|Overall Study|Adverse Event|11|||
16814376|NCT02308163|37757135|FG000|Overall Study|Lack of Efficacy|11|||
16814377|NCT02308163|37757136|FG001|Overall Study|Lack of Efficacy|3|||
16814378|NCT02308163|37757137|FG002|Overall Study|Lack of Efficacy|8|||
16814379|NCT02308163|37757138|FG003|Overall Study|Lack of Efficacy|4|||
16814380|NCT02308163|37757139|FG004|Overall Study|Lack of Efficacy|6|||
16814381|NCT02308163|37757135|FG000|Overall Study|Withdrawal of consent|2|||
16814382|NCT02308163|37757136|FG001|Overall Study|Withdrawal of consent|3|||
16814383|NCT02308163|37757137|FG002|Overall Study|Withdrawal of consent|0|||
16814384|NCT02308163|37757138|FG003|Overall Study|Withdrawal of consent|2|||
16814385|NCT02308163|37757139|FG004|Overall Study|Withdrawal of consent|6|||
16814386|NCT02308163|37757135|FG000|Overall Study|Protocol Violation|3|||
16814387|NCT02308163|37757136|FG001|Overall Study|Protocol Violation|3|||
16814388|NCT02308163|37757137|FG002|Overall Study|Protocol Violation|3|||
16814389|NCT02308163|37757138|FG003|Overall Study|Protocol Violation|2|||
16814390|NCT02308163|37757139|FG004|Overall Study|Protocol Violation|5|||
16910333|NCT01687296|38019148|FG001|Overall Study|Withdrawal by Subject|3|||
16910334|NCT01568892|38019169|FG000|Open-label Phase|Adverse Event|2|||
16910335|NCT01568892|38019170|FG001|Open-label Phase|Adverse Event|0|||
16910336|NCT01568892|38019169|FG000|Open-label Phase|Lack of Efficacy|4|||
16910337|NCT01568892|38019170|FG001|Open-label Phase|Lack of Efficacy|2|||
16910338|NCT01568892|38019169|FG000|Open-label Phase|Lost to Follow-up|0|||
16910339|NCT01568892|38019170|FG001|Open-label Phase|Lost to Follow-up|1|||
16910340|NCT01568112|38019181|FG000|Overall Study|Randomized But Not Treated|0|||
16910341|NCT01568112|38019182|FG001|Overall Study|Randomized But Not Treated|1|||
16910342|NCT01568112|38019183|FG002|Overall Study|Randomized But Not Treated|0|||
16910343|NCT01568112|38019184|FG003|Overall Study|Randomized But Not Treated|0|||
16910344|NCT01568112|38019181|FG000|Overall Study|Withdrew due to Adverse Event|2|||
16910345|NCT01568112|38019182|FG001|Overall Study|Withdrew due to Adverse Event|4|||
16910346|NCT01568112|38019183|FG002|Overall Study|Withdrew due to Adverse Event|6|||
16910347|NCT01568112|38019184|FG003|Overall Study|Withdrew due to Adverse Event|3|||
16910348|NCT01568112|38019181|FG000|Overall Study|Lost to Follow-up|0|||
16910349|NCT01568112|38019182|FG001|Overall Study|Lost to Follow-up|0|||
16910350|NCT01568112|38019183|FG002|Overall Study|Lost to Follow-up|0|||
16910351|NCT01568112|38019184|FG003|Overall Study|Lost to Follow-up|1|||
16910352|NCT01568112|38019181|FG000|Overall Study|Withdrawal by Subject|2|||
16910353|NCT01568112|38019182|FG001|Overall Study|Withdrawal by Subject|3|||
16910354|NCT01568112|38019183|FG002|Overall Study|Withdrawal by Subject|0|||
16910355|NCT01568112|38019184|FG003|Overall Study|Withdrawal by Subject|7|||
16910356|NCT01568112|38019181|FG000|Overall Study|Withdrawal by Physician|1|||
16910357|NCT01568112|38019182|FG001|Overall Study|Withdrawal by Physician|0|||
16910358|NCT01568112|38019183|FG002|Overall Study|Withdrawal by Physician|1|||
16910359|NCT01568112|38019184|FG003|Overall Study|Withdrawal by Physician|1|||
16910360|NCT01568034|38019195|FG000|Overall Study|Withdrawal by Subject|1|||
16910361|NCT01568034|38019196|FG001|Overall Study|Withdrawal by Subject|0|||
16910362|NCT01568034|38019197|FG002|Overall Study|Withdrawal by Subject|0|||
16910363|NCT01568034|38019198|FG003|Overall Study|Withdrawal by Subject|0|||
16910364|NCT01687218|38019214|FG000|Overall Study|Withdrawal by Subject|2|||
16910365|NCT01687218|38019215|FG001|Overall Study|Withdrawal by Subject|3|||
16910366|NCT01687218|38019216|FG002|Overall Study|Withdrawal by Subject|0|||
16910367|NCT01687218|38019217|FG003|Overall Study|Withdrawal by Subject|1|||
16910368|NCT01687218|38019218|FG004|Overall Study|Withdrawal by Subject|1|||
16910369|NCT01687218|38019219|FG005|Overall Study|Withdrawal by Subject|0|||
16910370|NCT01687218|38019214|FG000|Overall Study|Relocated, no follow-up planned|1|||
16910371|NCT01687218|38019215|FG001|Overall Study|Relocated, no follow-up planned|0|||
16910372|NCT01687218|38019216|FG002|Overall Study|Relocated, no follow-up planned|1|||
16910373|NCT01687218|38019217|FG003|Overall Study|Relocated, no follow-up planned|1|||
16910374|NCT01687218|38019218|FG004|Overall Study|Relocated, no follow-up planned|0|||
16910375|NCT01687218|38019219|FG005|Overall Study|Relocated, no follow-up planned|0|||
17016591|NCT00854906|38161228|FG000|Overall Study|One person had no ocular history|1|||
16814391|NCT02308163|37757135|FG000|Overall Study|Lab data met discontinuation criteria|3|||
16910376|NCT01686828|38019231|FG000|Overall Study|Physician Decision|1|||
16910377|NCT01686828|38019232|FG001|Overall Study|Physician Decision|0|||
16910378|NCT01686828|38019233|FG002|Overall Study|Physician Decision|0|||
16910379|NCT01686828|38019234|FG003|Overall Study|Physician Decision|0|||
16910380|NCT01686828|38019231|FG000|Overall Study|New Job|0|||
16910381|NCT01686828|38019232|FG001|Overall Study|New Job|1|||
16814392|NCT02308163|37757136|FG001|Overall Study|Lab data met discontinuation criteria|0|||
16814393|NCT02308163|37757137|FG002|Overall Study|Lab data met discontinuation criteria|0|||
16814394|NCT02308163|37757138|FG003|Overall Study|Lab data met discontinuation criteria|2|||
16814395|NCT02308163|37757139|FG004|Overall Study|Lab data met discontinuation criteria|0|||
16814396|NCT02308163|37757135|FG000|Overall Study|Miscellaneous|2|||
16814397|NCT02308163|37757136|FG001|Overall Study|Miscellaneous|2|||
16814398|NCT02308163|37757137|FG002|Overall Study|Miscellaneous|1|||
16814399|NCT02308163|37757138|FG003|Overall Study|Miscellaneous|0|||
16814400|NCT02308163|37757139|FG004|Overall Study|Miscellaneous|5|||
16814401|NCT02000115|37757169|FG000|Overall Study|Death|56|||
16910382|NCT01686828|38019233|FG002|Overall Study|New Job|0|||
16910383|NCT01686828|38019234|FG003|Overall Study|New Job|0|||
16910384|NCT01686828|38019231|FG000|Overall Study|Weight Loss|0|||
16910385|NCT01686828|38019232|FG001|Overall Study|Weight Loss|0|||
16910386|NCT01686828|38019233|FG002|Overall Study|Weight Loss|1|||
16910387|NCT01686828|38019234|FG003|Overall Study|Weight Loss|0|||
16910388|NCT01686438|38019251|FG000|Overall Study|Lost to Follow-up|8|||
16910389|NCT01686438|38019252|FG001|Overall Study|Lost to Follow-up|9|||
16910390|NCT01686438|38019253|FG002|Overall Study|Lost to Follow-up|10|||
16910391|NCT01686438|38019251|FG000|Overall Study|Adverse Event|0|||
16910392|NCT01686438|38019252|FG001|Overall Study|Adverse Event|0|||
16910393|NCT01686438|38019253|FG002|Overall Study|Adverse Event|1|||
16910394|NCT01686438|38019251|FG000|Overall Study|Protocol Violation|0|||
16910395|NCT01686438|38019252|FG001|Overall Study|Protocol Violation|0|||
16910396|NCT01686438|38019253|FG002|Overall Study|Protocol Violation|1|||
16910397|NCT01686438|38019251|FG000|Overall Study|Withdrawal by Subject|0|||
16910398|NCT01686438|38019252|FG001|Overall Study|Withdrawal by Subject|0|||
16910399|NCT01686438|38019253|FG002|Overall Study|Withdrawal by Subject|1|||
16910400|NCT01593696|38019267|FG000|Dose Escalation|Progressive Disease|2|||
16910401|NCT01593696|38019268|FG001|Dose Escalation|Progressive Disease|0|||
16910402|NCT01593696|38019269|FG002|Dose Escalation|Progressive Disease|0|||
16910403|NCT01593696|38019270|FG003|Dose Escalation|Progressive Disease|0|||
16910404|NCT01593696|38019267|FG000|Dose Expansion|Fungal infection|0|||
16910405|NCT01593696|38019268|FG001|Dose Expansion|Fungal infection|0|||
16910406|NCT01593696|38019269|FG002|Dose Expansion|Fungal infection|1|||
16910407|NCT01593696|38019270|FG003|Dose Expansion|Fungal infection|0|||
16910408|NCT01592760|38019283|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
16910409|NCT01592760|38019284|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
16910410|NCT01592760|38019285|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
16910411|NCT01592370|38019303|FG000|Overall Study|Disease Progression|62|||
16910412|NCT01592370|38019304|FG001|Overall Study|Disease Progression|16|||
16910413|NCT01592370|38019305|FG002|Overall Study|Disease Progression|52|||
16910414|NCT01592370|38019306|FG003|Overall Study|Disease Progression|3|||
16910415|NCT01592370|38019307|FG004|Overall Study|Disease Progression|3|||
16910416|NCT01592370|38019308|FG005|Overall Study|Disease Progression|31|||
16910417|NCT01592370|38019309|FG006|Overall Study|Disease Progression|14|||
16910418|NCT01592370|38019303|FG000|Overall Study|Study Drug Toxicity|14|||
16910419|NCT01592370|38019304|FG001|Overall Study|Study Drug Toxicity|3|||
16910420|NCT01592370|38019305|FG002|Overall Study|Study Drug Toxicity|0|||
16910421|NCT01592370|38019306|FG003|Overall Study|Study Drug Toxicity|0|||
16910422|NCT01592370|38019307|FG004|Overall Study|Study Drug Toxicity|0|||
16910423|NCT01592370|38019308|FG005|Overall Study|Study Drug Toxicity|0|||
16910424|NCT01592370|38019309|FG006|Overall Study|Study Drug Toxicity|1|||
16910425|NCT01592370|38019303|FG000|Overall Study|AE unrelated to study drug|4|||
16910426|NCT01592370|38019304|FG001|Overall Study|AE unrelated to study drug|3|||
16910427|NCT01592370|38019305|FG002|Overall Study|AE unrelated to study drug|0|||
16910428|NCT01592370|38019306|FG003|Overall Study|AE unrelated to study drug|0|||
16910429|NCT01592370|38019307|FG004|Overall Study|AE unrelated to study drug|0|||
16910430|NCT01592370|38019308|FG005|Overall Study|AE unrelated to study drug|0|||
16910431|NCT01592370|38019309|FG006|Overall Study|AE unrelated to study drug|1|||
16910432|NCT01592370|38019303|FG000|Overall Study|Request to discontinue study treatment|5|||
16910433|NCT01592370|38019304|FG001|Overall Study|Request to discontinue study treatment|0|||
16910434|NCT01592370|38019305|FG002|Overall Study|Request to discontinue study treatment|2|||
16910435|NCT01592370|38019306|FG003|Overall Study|Request to discontinue study treatment|0|||
16910436|NCT01592370|38019307|FG004|Overall Study|Request to discontinue study treatment|1|||
17016592|NCT00854828|38161239|FG000|Overall Study|Death|1|||
17016593|NCT00854828|38161240|FG001|Overall Study|Death|0|||
16910437|NCT01592370|38019308|FG005|Overall Study|Request to discontinue study treatment|2|||
16910438|NCT01592370|38019309|FG006|Overall Study|Request to discontinue study treatment|0|||
16910439|NCT01592370|38019303|FG000|Overall Study|Withdrew consent|1|||
16910440|NCT01592370|38019304|FG001|Overall Study|Withdrew consent|2|||
16910441|NCT01592370|38019305|FG002|Overall Study|Withdrew consent|1|||
16910442|NCT01592370|38019306|FG003|Overall Study|Withdrew consent|1|||
16910443|NCT01592370|38019307|FG004|Overall Study|Withdrew consent|0|||
16910444|NCT01592370|38019308|FG005|Overall Study|Withdrew consent|0|||
16910445|NCT01592370|38019309|FG006|Overall Study|Withdrew consent|0|||
16910446|NCT01592370|38019303|FG000|Overall Study|Maximum clinical benefit|11|||
16910447|NCT01592370|38019304|FG001|Overall Study|Maximum clinical benefit|1|||
16814402|NCT02000115|37757170|FG001|Overall Study|Death|45|||
16814403|NCT02000115|37757171|FG002|Overall Study|Death|0|||
16814404|NCT02000115|37757172|FG003|Overall Study|Death|0|||
16814405|NCT02000115|37757169|FG000|Overall Study|Missed Visit|6|||
16814406|NCT02000115|37757170|FG001|Overall Study|Missed Visit|8|||
16814407|NCT02000115|37757171|FG002|Overall Study|Missed Visit|1|||
16814408|NCT02000115|37757172|FG003|Overall Study|Missed Visit|0|||
16814409|NCT02000115|37757169|FG000|Overall Study|Protocol Violation|2|||
16814410|NCT02000115|37757170|FG001|Overall Study|Protocol Violation|1|||
16814411|NCT02000115|37757171|FG002|Overall Study|Protocol Violation|0|||
16814412|NCT02000115|37757172|FG003|Overall Study|Protocol Violation|0|||
16814413|NCT02000115|37757169|FG000|Overall Study|Physician Decision|2|||
16814414|NCT02000115|37757170|FG001|Overall Study|Physician Decision|0|||
17016594|NCT00854828|38161241|FG002|Overall Study|Death|0|||
17016595|NCT00854828|38161242|FG003|Overall Study|Death|0|||
17016596|NCT00854828|38161239|FG000|Overall Study|Withdrawal by Subject|1|||
17016597|NCT00854828|38161240|FG001|Overall Study|Withdrawal by Subject|1|||
17016598|NCT00854828|38161241|FG002|Overall Study|Withdrawal by Subject|0|||
17016599|NCT00854828|38161242|FG003|Overall Study|Withdrawal by Subject|9|||
17016600|NCT00854828|38161239|FG000|Overall Study|Missed 24mo visit|1|||
17016601|NCT00854828|38161240|FG001|Overall Study|Missed 24mo visit|1|||
17016602|NCT00854828|38161241|FG002|Overall Study|Missed 24mo visit|8|||
17016603|NCT00854828|38161242|FG003|Overall Study|Missed 24mo visit|8|||
16814415|NCT02000115|37757171|FG002|Overall Study|Physician Decision|0|||
16814416|NCT02000115|37757172|FG003|Overall Study|Physician Decision|0|||
16814417|NCT02000115|37757169|FG000|Overall Study|Withdrawal by Subject|11|||
16814418|NCT02000115|37757170|FG001|Overall Study|Withdrawal by Subject|11|||
16814419|NCT02000115|37757171|FG002|Overall Study|Withdrawal by Subject|0|||
16814420|NCT02000115|37757172|FG003|Overall Study|Withdrawal by Subject|0|||
16814421|NCT02000115|37757169|FG000|Overall Study|Lost to Follow-up|0|||
16814422|NCT02000115|37757170|FG001|Overall Study|Lost to Follow-up|1|||
16814423|NCT02000115|37757171|FG002|Overall Study|Lost to Follow-up|0|||
16814424|NCT02000115|37757172|FG003|Overall Study|Lost to Follow-up|0|||
16814425|NCT02000115|37757169|FG000|Overall Study|Non-compliance|2|||
16814426|NCT02000115|37757170|FG001|Overall Study|Non-compliance|1|||
16814427|NCT02000115|37757171|FG002|Overall Study|Non-compliance|0|||
16814428|NCT02000115|37757172|FG003|Overall Study|Non-compliance|0|||
16814429|NCT02000115|37757169|FG000|Overall Study|Withdrawn on day of randomization|0|||
16910448|NCT01592370|38019305|FG002|Overall Study|Maximum clinical benefit|7|||
16910449|NCT01592370|38019306|FG003|Overall Study|Maximum clinical benefit|1|||
16910450|NCT01592370|38019307|FG004|Overall Study|Maximum clinical benefit|0|||
16910451|NCT01592370|38019308|FG005|Overall Study|Maximum clinical benefit|0|||
16910452|NCT01592370|38019309|FG006|Overall Study|Maximum clinical benefit|0|||
16910453|NCT01592370|38019303|FG000|Overall Study|No longer meets study criteria|1|||
16910454|NCT01592370|38019304|FG001|Overall Study|No longer meets study criteria|0|||
16910455|NCT01592370|38019305|FG002|Overall Study|No longer meets study criteria|0|||
16910456|NCT01592370|38019306|FG003|Overall Study|No longer meets study criteria|0|||
16910457|NCT01592370|38019307|FG004|Overall Study|No longer meets study criteria|0|||
16910458|NCT01592370|38019308|FG005|Overall Study|No longer meets study criteria|0|||
16910459|NCT01592370|38019309|FG006|Overall Study|No longer meets study criteria|0|||
16910460|NCT01592370|38019303|FG000|Overall Study|Other Reasons|6|||
16910461|NCT01592370|38019304|FG001|Overall Study|Other Reasons|0|||
16910462|NCT01592370|38019305|FG002|Overall Study|Other Reasons|10|||
16910463|NCT01592370|38019306|FG003|Overall Study|Other Reasons|0|||
16910464|NCT01592370|38019307|FG004|Overall Study|Other Reasons|0|||
16910465|NCT01592370|38019308|FG005|Overall Study|Other Reasons|1|||
16910466|NCT01592370|38019309|FG006|Overall Study|Other Reasons|0|||
16910467|NCT01603602|38019332|FG000|Overall Study|Adverse Event|1|||
16910468|NCT01603602|38019333|FG001|Overall Study|Adverse Event|0|||
16910469|NCT01603602|38019334|FG002|Overall Study|Adverse Event|0|||
16910470|NCT01603602|38019332|FG000|Overall Study|Personal Reasons|1|||
16910471|NCT01603602|38019333|FG001|Overall Study|Personal Reasons|0|||
16910472|NCT01603602|38019334|FG002|Overall Study|Personal Reasons|1|||
16910473|NCT01684878|38019346|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
16910474|NCT01684878|38019347|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
16910475|NCT01684878|38019348|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
16910476|NCT01684878|38019349|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
16910477|NCT01684878|38019346|FG000|Part 1: Safety Run in Phase|Death|15|||
16814430|NCT02000115|37757170|FG001|Overall Study|Withdrawn on day of randomization|1|||
16814431|NCT02000115|37757171|FG002|Overall Study|Withdrawn on day of randomization|0|||
16814432|NCT02000115|37757172|FG003|Overall Study|Withdrawn on day of randomization|0|||
16814433|NCT02000115|37757169|FG000|Overall Study|Still on Study|0|||
16814434|NCT02000115|37757170|FG001|Overall Study|Still on Study|0|||
16910478|NCT01684878|38019347|FG001|Part 1: Safety Run in Phase|Death|20|||
17016604|NCT00847730|38161252|FG000|Overall Study|Multiple interruptions in therapy|8|||
17016605|NCT00600119|38161262|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
16814435|NCT02000115|37757171|FG002|Overall Study|Still on Study|0|||
16814436|NCT02000115|37757172|FG003|Overall Study|Still on Study|53|||
16814437|NCT01999335|37757186|FG000|Overall Study|Discontinued before receiving treatment|0|||
16814438|NCT01999335|37757187|FG001|Overall Study|Discontinued before receiving treatment|0|||
16814439|NCT01999335|37757188|FG002|Overall Study|Discontinued before receiving treatment|0|||
16814440|NCT01999335|37757189|FG003|Overall Study|Discontinued before receiving treatment|0|||
16814441|NCT01999335|37757190|FG004|Overall Study|Discontinued before receiving treatment|2|||
16814442|NCT01978119|37757205|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
16814443|NCT01978119|37757206|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
16814444|NCT01978119|37757205|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
16814445|NCT01978119|37757206|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16814446|NCT01978119|37757205|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16814447|NCT01978119|37757206|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
16814448|NCT01999179|37757212|FG000|Overall Study|Adverse Event|1|||
16814449|NCT01999179|37757212|FG000|Overall Study|Lost to Follow-up|1|||
16814450|NCT01999179|37757212|FG000|Overall Study|Change in Therapy|3|||
16814451|NCT01999179|37757212|FG000|Overall Study|New catheter|2|||
16814452|NCT01977729|37757216|FG000|Overall Study|Study terminated|1|||
16814453|NCT01998477|37757224|FG000|Overall Study|Lost to Follow-up|4|||
16814454|NCT01998477|37757225|FG001|Overall Study|Lost to Follow-up|5|||
16814455|NCT01998477|37757224|FG000|Overall Study|Withdrawal by Subject|6|||
16814456|NCT01998477|37757225|FG001|Overall Study|Withdrawal by Subject|0|||
16814457|NCT01998399|37757258|FG000|Overall Study|Lost to Follow-up|1|||
16814458|NCT01998399|37757259|FG001|Overall Study|Lost to Follow-up|3|||
16814459|NCT01998399|37757258|FG000|Overall Study|Death|4|||
16814460|NCT01998399|37757259|FG001|Overall Study|Death|2|||
16814461|NCT01998399|37757258|FG000|Overall Study|Study stopped before dosing completed|3|||
16814462|NCT01998399|37757259|FG001|Overall Study|Study stopped before dosing completed|3|||
16814463|NCT01998399|37757258|FG000|Overall Study|Withdrawal by Subject|0|||
16814464|NCT01998399|37757259|FG001|Overall Study|Withdrawal by Subject|1|||
16814465|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
16814466|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
16814467|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
16814468|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
16814469|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
16814470|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
16814471|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
16814472|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
16814473|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
16814474|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
16814475|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
16814476|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
16814477|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
16814478|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
16814479|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
16814480|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
16814481|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
16814482|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
16814483|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
16814484|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
16814485|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
16814486|NCT01781572|37757276|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
16814487|NCT01781572|37757277|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
16814488|NCT01781572|37757278|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
16814489|NCT01781572|37757276|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
16814490|NCT01781572|37757277|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
16814491|NCT01781572|37757278|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
16814492|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
16814493|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
16814494|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
16814495|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
16814496|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
16814497|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
16814498|NCT01781572|37757276|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
16814499|NCT01781572|37757277|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
16814500|NCT01781572|37757278|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
16814501|NCT01781572|37757276|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
16814502|NCT01781572|37757277|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
16814503|NCT01781572|37757278|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
16814504|NCT01781572|37757276|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
17016606|NCT00600119|38161263|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
17016607|NCT00600119|38161264|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
16814505|NCT01781572|37757277|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
16814506|NCT01781572|37757278|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
16814507|NCT01781572|37757276|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
16814508|NCT01781572|37757277|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
16814509|NCT01781572|37757278|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
16814510|NCT01781572|37757276|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
16814511|NCT01781572|37757277|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
16814512|NCT01781572|37757278|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
16814513|NCT01781572|37757276|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
16814514|NCT01781572|37757277|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
16814515|NCT01781572|37757278|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
16814516|NCT01781572|37757276|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
16814517|NCT01781572|37757277|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
16814518|NCT01781572|37757278|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
16814519|NCT01977651|37757307|FG000|4 Month Treatment Period|Adverse Event|34|||
16814520|NCT01977651|37757307|FG000|4 Month Treatment Period|Death|3|||
16814521|NCT01977651|37757307|FG000|4 Month Treatment Period|Progressive Disease|43|||
16814522|NCT01977651|37757307|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
16814523|NCT01977651|37757307|FG000|4 Month Treatment Period|Physician Decision|4|||
16814524|NCT01977651|37757307|FG000|1 Year Extension Period|Adverse Event|14|||
16814525|NCT01977651|37757307|FG000|1 Year Extension Period|Death|10|||
16814526|NCT01977651|37757307|FG000|1 Year Extension Period|Lost to Follow-up|2|||
16814527|NCT01977651|37757307|FG000|1 Year Extension Period|Progressive Disease|86|||
16814528|NCT01977651|37757307|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
16814529|NCT01977651|37757307|FG000|1 Year Extension Period|Physician Decision|6|||
16814530|NCT01977651|37757307|FG000|1 Year Extension Period|Miscellaneous|1|||
16814531|NCT01977651|37757307|FG000|Post 1 Year Extension Period|Adverse Event|5|||
16814532|NCT01977651|37757307|FG000|Post 1 Year Extension Period|Death|13|||
16814533|NCT01977651|37757307|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
16814534|NCT01977651|37757307|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
16814535|NCT01977651|37757307|FG000|Post 1 Year Extension Period|Physician Decision|4|||
16814536|NCT01977651|37757307|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
16814537|NCT01998243|37757313|FG000|Overall Study|Pregnancy|0|||
16814538|NCT01998243|37757314|FG001|Overall Study|Pregnancy|1|||
16814539|NCT01998243|37757313|FG000|Overall Study|Protocol Violation|5|||
16814540|NCT01998243|37757314|FG001|Overall Study|Protocol Violation|2|||
16814541|NCT01998243|37757313|FG000|Overall Study|Withdrawal by Subject|3|||
16814542|NCT01998243|37757314|FG001|Overall Study|Withdrawal by Subject|4|||
16814543|NCT01977573|37757326|FG000|Overall Study|Adverse Event|7|||
16814544|NCT01977573|37757327|FG001|Overall Study|Adverse Event|0|||
16814545|NCT01977573|37757328|FG002|Overall Study|Adverse Event|2|||
16814546|NCT01977573|37757329|FG003|Overall Study|Adverse Event|1|||
16814547|NCT01977573|37757326|FG000|Overall Study|Lost to Follow-up|1|||
16814548|NCT01977573|37757327|FG001|Overall Study|Lost to Follow-up|0|||
16814549|NCT01977573|37757328|FG002|Overall Study|Lost to Follow-up|0|||
16814550|NCT01977573|37757329|FG003|Overall Study|Lost to Follow-up|1|||
16814551|NCT01977573|37757326|FG000|Overall Study|Physician Decision|1|||
16814552|NCT01977573|37757327|FG001|Overall Study|Physician Decision|0|||
16814553|NCT01977573|37757328|FG002|Overall Study|Physician Decision|0|||
16814554|NCT01977573|37757329|FG003|Overall Study|Physician Decision|0|||
16814555|NCT01977573|37757326|FG000|Overall Study|Protocol Violation|3|||
16814556|NCT01977573|37757327|FG001|Overall Study|Protocol Violation|1|||
16814557|NCT01977573|37757328|FG002|Overall Study|Protocol Violation|0|||
16814558|NCT01977573|37757329|FG003|Overall Study|Protocol Violation|0|||
16814559|NCT01977573|37757326|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
16814560|NCT01977573|37757327|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
16814561|NCT01977573|37757328|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
16814562|NCT01977573|37757329|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
16814563|NCT01977573|37757326|FG000|Overall Study|Withdrawal by Subject|6|||
16814564|NCT01977573|37757327|FG001|Overall Study|Withdrawal by Subject|1|||
16814565|NCT01977573|37757328|FG002|Overall Study|Withdrawal by Subject|1|||
16814566|NCT01977573|37757329|FG003|Overall Study|Withdrawal by Subject|1|||
16814567|NCT01963767|37757342|FG000|Overall Study|Withdrawal by Subject|4|||
16814568|NCT01963767|37757343|FG001|Overall Study|Withdrawal by Subject|2|||
16814569|NCT01963767|37757342|FG000|Overall Study|Adverse Event|2|||
16814570|NCT01963767|37757343|FG001|Overall Study|Adverse Event|0|||
16814571|NCT01761292|37757352|FG000|Part 1|Adverse Event|1|||
16814572|NCT01761292|37757352|FG000|Part 1|not receiving treatment in Part 1|1|||
16814573|NCT01761292|37757352|FG000|Extension 1|Withdrawal by Subject|1|||
16814574|NCT01731886|37757365|FG000|Overall Study|Death|1|||
16814575|NCT01731886|37757366|FG001|Overall Study|Death|0|||
16814576|NCT01731886|37757365|FG000|Overall Study|Never started treatment|0|||
16814577|NCT01731886|37757366|FG001|Overall Study|Never started treatment|1|||
16814578|NCT01731886|37757365|FG000|Overall Study|Non-compliant|1|||
16814579|NCT01731886|37757366|FG001|Overall Study|Non-compliant|0|||
16814580|NCT01759420|37757373|FG000|Overall Study|Screen failure|5|||
16814581|NCT01759420|37757373|FG000|Overall Study|Inaccurate EKG machine readings|1|||
16814582|NCT01781026|37757377|FG000|Overall Study|Lack of Efficacy|2|||
16814583|NCT01607398|37757383|FG000|Overall Study|Adverse Event|0|||
16814584|NCT01607398|37757384|FG001|Overall Study|Adverse Event|2|||
16814585|NCT01607398|37757383|FG000|Overall Study|Severe COPD|2|||
16814586|NCT01607398|37757384|FG001|Overall Study|Severe COPD|0|||
16814587|NCT01779856|37757390|FG000|Overall Study|Withdrawal by Subject|15|||
16814588|NCT01779856|37757390|FG000|Overall Study|Death|3|||
16814589|NCT01779856|37757390|FG000|Overall Study|Physician Decision|1|||
16814590|NCT01779856|37757390|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
16814591|NCT01779856|37757390|FG000|Overall Study|Delays in scheduling implant|1|||
16910479|NCT01684878|38019348|FG002|Part 1: Safety Run in Phase|Death|0|||
16910480|NCT01684878|38019349|FG003|Part 1: Safety Run in Phase|Death|0|||
16910481|NCT01684878|38019346|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
16910482|NCT01684878|38019347|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
16910483|NCT01684878|38019348|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
16910484|NCT01684878|38019349|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
16910485|NCT01684878|38019346|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
16910486|NCT01684878|38019347|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
16910487|NCT01684878|38019348|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
16910488|NCT01684878|38019349|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
16910489|NCT01684878|38019346|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
16910490|NCT01684878|38019347|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
16910491|NCT01684878|38019348|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
16910492|NCT01684878|38019349|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
16814592|NCT01779856|37757390|FG000|Overall Study|Subject ineligible for Implant|2|||
16814593|NCT01729156|37757404|FG000|Overall Study|Withdrawal by Subject|1|||
16814594|NCT01729156|37757405|FG001|Overall Study|Withdrawal by Subject|0|||
16814595|NCT01729156|37757406|FG002|Overall Study|Withdrawal by Subject|0|||
16814596|NCT01779700|37757417|FG000|Overall Study|Adverse Event|4|||
16814597|NCT01779700|37757418|FG001|Overall Study|Adverse Event|3|||
16814598|NCT01779700|37757417|FG000|Overall Study|Withdrawal by Subject|0|||
16814599|NCT01779700|37757418|FG001|Overall Study|Withdrawal by Subject|2|||
16814600|NCT01778530|37757424|FG000|Overall Study|Progression on study|1|||
16814601|NCT01778530|37757424|FG000|Overall Study|Adverse event/side effect|1|||
16814602|NCT01778062|37757430|FG000|Overall Study|Adverse Event|1|||
16814603|NCT01778062|37757431|FG001|Overall Study|Adverse Event|3|||
16814604|NCT01778062|37757430|FG000|Overall Study|Consent Withdrawal|1|||
16814605|NCT01778062|37757431|FG001|Overall Study|Consent Withdrawal|5|||
16814606|NCT01778062|37757430|FG000|Overall Study|major protocol deviation|4|||
16814607|NCT01778062|37757431|FG001|Overall Study|major protocol deviation|3|||
16814608|NCT01759264|37757437|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
16814609|NCT01759264|37757437|FG000|Overall Study|Adverse Event|1|||
16814610|NCT01759264|37757437|FG000|Overall Study|Other|2|||
16814611|NCT01759264|37757437|FG000|Overall Study|Lost to Follow-up|2|||
16814612|NCT01759264|37757437|FG000|Overall Study|Withdrawal by Subject|3|||
16814613|NCT01759264|37757437|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
16814614|NCT01757704|37757444|FG000|Overall Study|Protocol Violation|1|||
16814615|NCT01757704|37757445|FG001|Overall Study|Protocol Violation|3|||
16814616|NCT01757392|37757451|FG000|Overall Study|Withdrawal by Subject|1|||
16814617|NCT01757392|37757451|FG000|Overall Study|Screen Fail|3|||
16814618|NCT01756846|37757457|FG000|Overall Study|Lost to Follow-up|5|||
16814619|NCT01756846|37757458|FG001|Overall Study|Lost to Follow-up|10|||
16814620|NCT01756846|37757457|FG000|Overall Study|Withdrawal by Subject|1|||
16814621|NCT01756846|37757458|FG001|Overall Study|Withdrawal by Subject|2|||
16814622|NCT01963611|37757469|FG000|Overall Study|Adverse Event|1|||
16814623|NCT01963611|37757470|FG001|Overall Study|Adverse Event|1|||
16814624|NCT01963611|37757471|FG002|Overall Study|Adverse Event|3|||
16814625|NCT01963611|37757472|FG003|Overall Study|Adverse Event|4|||
16814626|NCT01963611|37757473|FG004|Overall Study|Adverse Event|3|||
16814627|NCT01963611|37757469|FG000|Overall Study|Protocol Violation|0|||
16814628|NCT01963611|37757470|FG001|Overall Study|Protocol Violation|0|||
16814629|NCT01963611|37757471|FG002|Overall Study|Protocol Violation|0|||
16814630|NCT01963611|37757472|FG003|Overall Study|Protocol Violation|1|||
16814631|NCT01963611|37757473|FG004|Overall Study|Protocol Violation|0|||
16814632|NCT01963611|37757469|FG000|Overall Study|Lack of Efficacy|0|||
16814633|NCT01963611|37757470|FG001|Overall Study|Lack of Efficacy|0|||
16814634|NCT01963611|37757471|FG002|Overall Study|Lack of Efficacy|0|||
16814635|NCT01963611|37757472|FG003|Overall Study|Lack of Efficacy|1|||
16910493|NCT01684878|38019346|FG000|Part 2: Randomized Phase|Death|0|||
16910494|NCT01684878|38019347|FG001|Part 2: Randomized Phase|Death|0|||
16814636|NCT01963611|37757473|FG004|Overall Study|Lack of Efficacy|0|||
16814637|NCT01963611|37757469|FG000|Overall Study|Withdrawal by Subject|3|||
16814638|NCT01963611|37757470|FG001|Overall Study|Withdrawal by Subject|2|||
16910495|NCT01684878|38019348|FG002|Part 2: Randomized Phase|Death|62|||
16814639|NCT01963611|37757471|FG002|Overall Study|Withdrawal by Subject|1|||
16814640|NCT01963611|37757472|FG003|Overall Study|Withdrawal by Subject|1|||
16814641|NCT01963611|37757473|FG004|Overall Study|Withdrawal by Subject|3|||
16814642|NCT01963611|37757469|FG000|Overall Study|Other|47|||
16814643|NCT01963611|37757470|FG001|Overall Study|Other|46|||
16814644|NCT01963611|37757471|FG002|Overall Study|Other|48|||
16814645|NCT01963611|37757472|FG003|Overall Study|Other|45|||
16814646|NCT01963611|37757473|FG004|Overall Study|Other|45|||
16814647|NCT01975701|37757486|FG000|Overall Study|Lost to Follow-up|1|||
16814648|NCT01975701|37757486|FG000|Overall Study|Death|23|||
16814649|NCT01975701|37757486|FG000|Overall Study|Physician Decision|1|||
16814650|NCT01962987|37757493|FG000|Overall Study|Adverse Event|4|||
16814651|NCT01962987|37757494|FG001|Overall Study|Adverse Event|4|||
16814652|NCT01962987|37757495|FG002|Overall Study|Adverse Event|0|||
16814653|NCT01962987|37757493|FG000|Overall Study|Lost to Follow-up|0|||
16814654|NCT01962987|37757494|FG001|Overall Study|Lost to Follow-up|0|||
16814655|NCT01962987|37757495|FG002|Overall Study|Lost to Follow-up|1|||
16814656|NCT01962987|37757493|FG000|Overall Study|Non compliance with dosing requirements|4|||
16814657|NCT01962987|37757494|FG001|Overall Study|Non compliance with dosing requirements|2|||
16814658|NCT01962987|37757495|FG002|Overall Study|Non compliance with dosing requirements|0|||
16814659|NCT01962987|37757493|FG000|Overall Study|Miscellaneous|1|||
16814660|NCT01962987|37757494|FG001|Overall Study|Miscellaneous|9|||
16814661|NCT01962987|37757495|FG002|Overall Study|Miscellaneous|2|||
16814662|NCT01962987|37757493|FG000|Overall Study|Restricted medication|5|||
16814663|NCT01962987|37757494|FG001|Overall Study|Restricted medication|1|||
16814664|NCT01962987|37757495|FG002|Overall Study|Restricted medication|1|||
16814665|NCT01962987|37757493|FG000|Overall Study|Serious Adverse Event|1|||
16814666|NCT01962987|37757494|FG001|Overall Study|Serious Adverse Event|0|||
16814667|NCT01962987|37757495|FG002|Overall Study|Serious Adverse Event|0|||
16814668|NCT01962987|37757493|FG000|Overall Study|Withdrawal by Subject|11|||
16814669|NCT01962987|37757494|FG001|Overall Study|Withdrawal by Subject|10|||
16814670|NCT01962987|37757495|FG002|Overall Study|Withdrawal by Subject|6|||
16814671|NCT01962987|37757493|FG000|Overall Study|Randomized in Error|4|||
16814672|NCT01962987|37757494|FG001|Overall Study|Randomized in Error|2|||
16814673|NCT01962987|37757495|FG002|Overall Study|Randomized in Error|2|||
16814674|NCT01962441|37757506|FG000|Randomized Period|Randomized but Never Treated|4|||
16814675|NCT01962441|37757507|FG001|Randomized Period|Randomized but Never Treated|2|||
16814676|NCT01962441|37757508|FG002|Randomized Period|Randomized but Never Treated|3|||
16814677|NCT01962441|37757506|FG000|Randomized Period|Lost to Follow-up|2|||
16814678|NCT01962441|37757507|FG001|Randomized Period|Lost to Follow-up|4|||
16814679|NCT01962441|37757508|FG002|Randomized Period|Lost to Follow-up|4|||
16814680|NCT01962441|37757506|FG000|Randomized Period|Withdrew Consent|3|||
16814681|NCT01962441|37757507|FG001|Randomized Period|Withdrew Consent|3|||
16814682|NCT01962441|37757508|FG002|Randomized Period|Withdrew Consent|2|||
16814683|NCT01962441|37757506|FG000|Randomized Period|Adverse Event|1|||
16814684|NCT01962441|37757507|FG001|Randomized Period|Adverse Event|1|||
16814685|NCT01962441|37757508|FG002|Randomized Period|Adverse Event|0|||
16814686|NCT01962441|37757506|FG000|Randomized Period|Death|0|||
16814687|NCT01962441|37757507|FG001|Randomized Period|Death|0|||
16814688|NCT01962441|37757508|FG002|Randomized Period|Death|2|||
16814689|NCT01962441|37757506|FG000|Randomized Period|Protocol Violation|0|||
16814690|NCT01962441|37757507|FG001|Randomized Period|Protocol Violation|1|||
16814691|NCT01962441|37757508|FG002|Randomized Period|Protocol Violation|0|||
16814692|NCT01962441|37757506|FG000|Retreatment Substudy|Lack of Efficacy|1|||
16814693|NCT01962441|37757507|FG001|Retreatment Substudy|Lack of Efficacy|0|||
16814694|NCT01962441|37757508|FG002|Retreatment Substudy|Lack of Efficacy|0|||
16814695|NCT01962441|37757506|FG000|Retreatment Substudy|Lost to Follow-up|1|||
16814696|NCT01962441|37757507|FG001|Retreatment Substudy|Lost to Follow-up|0|||
16814697|NCT01962441|37757508|FG002|Retreatment Substudy|Lost to Follow-up|0|||
16814698|NCT01638013|37757520|FG000|Overall Study|Adverse Event|36|||
16814699|NCT01638013|37757521|FG001|Overall Study|Adverse Event|29|||
16814700|NCT01638013|37757522|FG002|Overall Study|Adverse Event|48|||
16814701|NCT01638013|37757520|FG000|Overall Study|Lack of Efficacy|39|||
16814702|NCT01638013|37757521|FG001|Overall Study|Lack of Efficacy|11|||
16814703|NCT01638013|37757522|FG002|Overall Study|Lack of Efficacy|14|||
16814704|NCT01638013|37757520|FG000|Overall Study|Protocol Violation|10|||
16814705|NCT01638013|37757521|FG001|Overall Study|Protocol Violation|7|||
16814706|NCT01638013|37757522|FG002|Overall Study|Protocol Violation|11|||
16814707|NCT01638013|37757520|FG000|Overall Study|Met discontinuation criteria|4|||
16814708|NCT01638013|37757521|FG001|Overall Study|Met discontinuation criteria|0|||
16814709|NCT01638013|37757522|FG002|Overall Study|Met discontinuation criteria|7|||
16814710|NCT01638013|37757520|FG000|Overall Study|Subject Lost to Follow up|1|||
16814711|NCT01638013|37757521|FG001|Overall Study|Subject Lost to Follow up|0|||
16814712|NCT01638013|37757522|FG002|Overall Study|Subject Lost to Follow up|1|||
17102338|NCT00116168|38241246|FG002|Overall Study|Lost to Follow-up|0|||
16814713|NCT01638013|37757520|FG000|Overall Study|Miscellaneous|25|||
16814714|NCT01638013|37757521|FG001|Overall Study|Miscellaneous|19|||
16814715|NCT01638013|37757522|FG002|Overall Study|Miscellaneous|23|||
16814716|NCT01638013|37757520|FG000|Overall Study|Withdrawal of Consent|16|||
16814717|NCT01638013|37757521|FG001|Overall Study|Withdrawal of Consent|12|||
16814718|NCT01638013|37757522|FG002|Overall Study|Withdrawal of Consent|16|||
16814719|NCT01638013|37757520|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
16814720|NCT01638013|37757521|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
16814721|NCT01638013|37757522|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
16814722|NCT01637623|37757537|FG000|Overall Study|Lost to Follow-up|0|||
16814723|NCT01637623|37757538|FG001|Overall Study|Lost to Follow-up|0|||
16814724|NCT01637623|37757539|FG002|Overall Study|Lost to Follow-up|2|||
16814725|NCT01637623|37757537|FG000|Overall Study|Physician Decision|1|||
16814726|NCT01637623|37757538|FG001|Overall Study|Physician Decision|0|||
16814727|NCT01637623|37757539|FG002|Overall Study|Physician Decision|1|||
16814728|NCT01962207|37757551|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
16814729|NCT01962207|37757552|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
16814730|NCT01962207|37757553|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
16814731|NCT01962207|37757554|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
16814732|NCT01962207|37757551|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
16814733|NCT01962207|37757552|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
16814734|NCT01962207|37757553|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
16814735|NCT01962207|37757554|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
16814736|NCT01962207|37757551|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
16814737|NCT01962207|37757552|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
16814738|NCT01962207|37757553|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
16814739|NCT01962207|37757554|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
16910496|NCT01684878|38019349|FG003|Part 2: Randomized Phase|Death|68|||
16910497|NCT01684878|38019346|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
16910498|NCT01684878|38019347|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
16910499|NCT01684878|38019348|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
16910500|NCT01684878|38019349|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
16910501|NCT01684878|38019346|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
16910502|NCT01684878|38019347|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
16910503|NCT01684878|38019348|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
16910504|NCT01684878|38019349|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
16910505|NCT01684722|38019363|FG000|Overall Study|Lost to Follow-up|78|||
16910506|NCT01684722|38019364|FG001|Overall Study|Lost to Follow-up|56|||
16910507|NCT01684722|38019365|FG002|Overall Study|Lost to Follow-up|75|||
16910508|NCT01684722|38019366|FG003|Overall Study|Lost to Follow-up|89|||
16910509|NCT01684722|38019363|FG000|Overall Study|Death|19|||
16910510|NCT01684722|38019364|FG001|Overall Study|Death|21|||
16910511|NCT01684722|38019365|FG002|Overall Study|Death|19|||
16910512|NCT01684722|38019366|FG003|Overall Study|Death|21|||
16910513|NCT01592292|38019383|FG000|Overall Study|Follow-up loss|3|||
16910514|NCT01592292|38019384|FG001|Overall Study|Follow-up loss|3|||
16910515|NCT01592292|38019385|FG002|Overall Study|Follow-up loss|1|||
16910516|NCT01592292|38019386|FG003|Overall Study|Follow-up loss|0|||
16910517|NCT01592292|38019383|FG000|Overall Study|Withdrew consent|2|||
16910518|NCT01592292|38019384|FG001|Overall Study|Withdrew consent|1|||
16910519|NCT01592292|38019385|FG002|Overall Study|Withdrew consent|0|||
16910520|NCT01592292|38019386|FG003|Overall Study|Withdrew consent|0|||
16910521|NCT01592292|38019383|FG000|Overall Study|Other|1|||
16910522|NCT01592292|38019384|FG001|Overall Study|Other|1|||
16910523|NCT01592292|38019385|FG002|Overall Study|Other|2|||
16910524|NCT01592292|38019386|FG003|Overall Study|Other|1|||
16910525|NCT01590888|38019395|FG000|Overall Study|Adverse Event|3|||
16910526|NCT01590888|38019396|FG001|Overall Study|Adverse Event|0|||
16910527|NCT01590888|38019397|FG002|Overall Study|Adverse Event|1|||
16910528|NCT01590888|38019395|FG000|Overall Study|Lost to Follow-up|1|||
16910529|NCT01590888|38019396|FG001|Overall Study|Lost to Follow-up|0|||
16910530|NCT01590888|38019397|FG002|Overall Study|Lost to Follow-up|0|||
16910531|NCT01565928|38019405|FG000|Overall Study|Adverse Event|3|||
16910532|NCT01565928|38019405|FG000|Overall Study|Other|3|||
16910533|NCT01565928|38019405|FG000|Overall Study|Progressive Disease|13|||
16910534|NCT01565928|38019405|FG000|Overall Study|Withdrawal by Subject|1|||
16910535|NCT01565928|38019405|FG000|Overall Study|Death|2|||
16910536|NCT01565850|38019414|FG000|Overall Study|Adverse Event|0|||
16910537|NCT01565850|38019415|FG001|Overall Study|Adverse Event|1|||
16910538|NCT01565850|38019414|FG000|Overall Study|Lost to Follow-up|12|||
16910539|NCT01565850|38019415|FG001|Overall Study|Lost to Follow-up|4|||
16910540|NCT01565850|38019414|FG000|Overall Study|Investigator's Discretion|2|||
16910541|NCT01565850|38019415|FG001|Overall Study|Investigator's Discretion|1|||
16910542|NCT01565850|38019414|FG000|Overall Study|Participant noncompliance|2|||
16910543|NCT01565850|38019415|FG001|Overall Study|Participant noncompliance|0|||
16910544|NCT01565850|38019414|FG000|Overall Study|Withdrew Consent|4|||
16910545|NCT01565850|38019415|FG001|Overall Study|Withdrew Consent|2|||
16910546|NCT01565694|38019421|FG000|Dose-Titration Period|Adverse Event|4|||
16910547|NCT01565694|38019421|FG000|Dose-Titration Period|Protocol Violation|10|||
17016608|NCT00600119|38161265|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
16910548|NCT01565694|38019421|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
16814740|NCT01962207|37757551|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
16814741|NCT01962207|37757552|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
16814742|NCT01962207|37757553|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
16814743|NCT01962207|37757554|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
16814744|NCT01962207|37757551|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
16814745|NCT01962207|37757552|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
16814746|NCT01962207|37757553|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
16814747|NCT01962207|37757554|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
16814748|NCT01962207|37757551|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
16814749|NCT01962207|37757552|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
16814750|NCT01962207|37757553|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
16814751|NCT01962207|37757554|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
16814752|NCT01995825|37757570|FG000|Overall Study|Withdrawal by Subject|1|||
16814753|NCT01995825|37757571|FG001|Overall Study|Withdrawal by Subject|0|||
16814754|NCT01995357|37757577|FG000|Period 5|Lack of Efficacy|1|||
16814755|NCT01995357|37757578|FG001|Period 5|Lack of Efficacy|0|||
16814756|NCT01995357|37757579|FG002|Period 5|Lack of Efficacy|0|||
16814757|NCT01995357|37757580|FG003|Period 5|Lack of Efficacy|0|||
16814758|NCT01995357|37757581|FG004|Period 5|Lack of Efficacy|0|||
16814759|NCT01995357|37757582|FG005|Period 5|Lack of Efficacy|0|||
16814760|NCT01995357|37757577|FG000|Period 5|Adverse Event|1|||
16814761|NCT01995357|37757578|FG001|Period 5|Adverse Event|0|||
16814762|NCT01995357|37757579|FG002|Period 5|Adverse Event|1|||
16814763|NCT01995357|37757580|FG003|Period 5|Adverse Event|0|||
16814764|NCT01995357|37757581|FG004|Period 5|Adverse Event|0|||
16814765|NCT01995357|37757582|FG005|Period 5|Adverse Event|0|||
16814766|NCT01638559|37757598|FG000|Overall Study|Lost to Follow-up|1|||
16814767|NCT01638559|37757598|FG000|Overall Study|Withdrawal by Subject|1|||
16814768|NCT01638559|37757598|FG000|Overall Study|Subject declined to travel for biopsy|1|||
16814769|NCT01756456|37757619|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
16814770|NCT01756456|37757620|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
16814771|NCT01756456|37757621|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
16814772|NCT01756456|37757622|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
16814773|NCT01756456|37757623|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
16814774|NCT01756456|37757624|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
16814775|NCT01756456|37757619|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
16814776|NCT01756456|37757620|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
16814777|NCT01756456|37757621|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
16814778|NCT01756456|37757622|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
16814779|NCT01756456|37757623|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
16814780|NCT01756456|37757624|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
16814781|NCT01756456|37757619|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16814782|NCT01756456|37757620|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
16814783|NCT01756456|37757621|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16814784|NCT01756456|37757622|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16814785|NCT01756456|37757623|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16814786|NCT01756456|37757624|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16814787|NCT01756456|37757619|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
16814788|NCT01756456|37757620|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
16814789|NCT01756456|37757621|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
16814790|NCT01756456|37757622|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
16814791|NCT01756456|37757623|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
16814792|NCT01756456|37757624|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
16814793|NCT01756456|37757619|FG000|Treatment Period: Phase I/II|Other causes|0|||
16814794|NCT01756456|37757620|FG001|Treatment Period: Phase I/II|Other causes|0|||
16814795|NCT01756456|37757621|FG002|Treatment Period: Phase I/II|Other causes|0|||
16814796|NCT01756456|37757622|FG003|Treatment Period: Phase I/II|Other causes|1|||
16814797|NCT01756456|37757623|FG004|Treatment Period: Phase I/II|Other causes|2|||
16814798|NCT01756456|37757624|FG005|Treatment Period: Phase I/II|Other causes|2|||
16814799|NCT01756456|37757619|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
16814800|NCT01756456|37757620|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
16814801|NCT01756456|37757621|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
16814802|NCT01756456|37757622|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
16814803|NCT01756456|37757623|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
16814804|NCT01756456|37757624|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
16814805|NCT01756456|37757619|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16814806|NCT01756456|37757620|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
16814807|NCT01756456|37757621|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16814808|NCT01756456|37757622|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16910549|NCT01543152|38019430|FG000|Overall Study|Withdrawal by Subject|0|||
16814809|NCT01756456|37757623|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16814810|NCT01756456|37757624|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16814811|NCT01756456|37757619|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16814812|NCT01756456|37757620|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16814813|NCT01756456|37757621|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16814814|NCT01756456|37757622|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16814815|NCT01756456|37757623|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16814816|NCT01756456|37757624|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
16814817|NCT01756456|37757619|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
16814818|NCT01756456|37757620|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
16814819|NCT01756456|37757621|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
16814820|NCT01756456|37757622|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
16814821|NCT01756456|37757623|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
16814822|NCT01756456|37757624|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
16814823|NCT01756456|37757619|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
16814824|NCT01756456|37757620|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
16814825|NCT01756456|37757621|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
16814826|NCT01756456|37757622|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
16814827|NCT01756456|37757623|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
16814828|NCT01756456|37757624|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
16814829|NCT01756456|37757619|FG000|Follow Up Period Phase I/II|Other causes|0|||
16814830|NCT01756456|37757620|FG001|Follow Up Period Phase I/II|Other causes|0|||
16814831|NCT01756456|37757621|FG002|Follow Up Period Phase I/II|Other causes|0|||
16814832|NCT01756456|37757622|FG003|Follow Up Period Phase I/II|Other causes|1|||
16814833|NCT01756456|37757623|FG004|Follow Up Period Phase I/II|Other causes|3|||
16814834|NCT01756456|37757624|FG005|Follow Up Period Phase I/II|Other causes|5|||
16814835|NCT01756300|37757647|FG000|Overall Study|Death|1|||
16814836|NCT01756300|37757647|FG000|Overall Study|Withdrawal by Subject|1|||
16814837|NCT01995201|37757670|FG000|From Baseline Until Week 24|Adverse Event|4|||
16814838|NCT01995201|37757671|FG001|From Baseline Until Week 24|Adverse Event|15|||
16814839|NCT01995201|37757672|FG002|From Baseline Until Week 24|Adverse Event|0|||
16814840|NCT01995201|37757673|FG003|From Baseline Until Week 24|Adverse Event|0|||
16814841|NCT01995201|37757674|FG004|From Baseline Until Week 24|Adverse Event|0|||
16814842|NCT01995201|37757675|FG005|From Baseline Until Week 24|Adverse Event|0|||
16814843|NCT01995201|37757676|FG006|From Baseline Until Week 24|Adverse Event|0|||
16814844|NCT01995201|37757670|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16814845|NCT01995201|37757671|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
16814846|NCT01995201|37757672|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16814847|NCT01995201|37757673|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16814848|NCT01995201|37757674|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16814849|NCT01995201|37757675|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16814850|NCT01995201|37757676|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16814851|NCT01995201|37757670|FG000|From Baseline Until Week 24|Death|0|||
16814852|NCT01995201|37757671|FG001|From Baseline Until Week 24|Death|1|||
16814853|NCT01995201|37757672|FG002|From Baseline Until Week 24|Death|0|||
16814854|NCT01995201|37757673|FG003|From Baseline Until Week 24|Death|0|||
16814855|NCT01995201|37757674|FG004|From Baseline Until Week 24|Death|0|||
16814856|NCT01995201|37757675|FG005|From Baseline Until Week 24|Death|0|||
16814857|NCT01995201|37757676|FG006|From Baseline Until Week 24|Death|0|||
16814858|NCT01995201|37757670|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
16814859|NCT01995201|37757671|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
16814860|NCT01995201|37757672|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
16814861|NCT01995201|37757673|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
16814862|NCT01995201|37757674|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
16814863|NCT01995201|37757675|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
16814864|NCT01995201|37757676|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
16814865|NCT01995201|37757670|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
16814866|NCT01995201|37757671|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
16814867|NCT01995201|37757672|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
16814868|NCT01995201|37757673|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
16814869|NCT01995201|37757674|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
16814870|NCT01995201|37757675|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
16814871|NCT01995201|37757676|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
16814872|NCT01995201|37757670|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
16814873|NCT01995201|37757671|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
16814874|NCT01995201|37757672|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
16814875|NCT01995201|37757673|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
16814876|NCT01995201|37757674|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
16814877|NCT01995201|37757675|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
16814878|NCT01995201|37757676|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
16814879|NCT01995201|37757670|FG000|From Baseline Until Week 24|Physician Decision|0|||
16814880|NCT01995201|37757671|FG001|From Baseline Until Week 24|Physician Decision|2|||
16814881|NCT01995201|37757672|FG002|From Baseline Until Week 24|Physician Decision|0|||
16814882|NCT01995201|37757673|FG003|From Baseline Until Week 24|Physician Decision|0|||
16814883|NCT01995201|37757674|FG004|From Baseline Until Week 24|Physician Decision|0|||
16814884|NCT01995201|37757675|FG005|From Baseline Until Week 24|Physician Decision|0|||
16814885|NCT01995201|37757676|FG006|From Baseline Until Week 24|Physician Decision|0|||
16814886|NCT01995201|37757670|FG000|From Baseline Until Week 24|Protocol Violation|0|||
16814887|NCT01995201|37757671|FG001|From Baseline Until Week 24|Protocol Violation|9|||
16814888|NCT01995201|37757672|FG002|From Baseline Until Week 24|Protocol Violation|0|||
16814889|NCT01995201|37757673|FG003|From Baseline Until Week 24|Protocol Violation|0|||
16814890|NCT01995201|37757674|FG004|From Baseline Until Week 24|Protocol Violation|0|||
16814891|NCT01995201|37757675|FG005|From Baseline Until Week 24|Protocol Violation|0|||
16814892|NCT01995201|37757676|FG006|From Baseline Until Week 24|Protocol Violation|0|||
16814893|NCT01995201|37757670|FG000|From Week 24 Until Week 48|Adverse Event|0|||
16814894|NCT01995201|37757671|FG001|From Week 24 Until Week 48|Adverse Event|0|||
16814895|NCT01995201|37757672|FG002|From Week 24 Until Week 48|Adverse Event|2|||
16814896|NCT01995201|37757673|FG003|From Week 24 Until Week 48|Adverse Event|1|||
16814897|NCT01995201|37757674|FG004|From Week 24 Until Week 48|Adverse Event|1|||
16814898|NCT01995201|37757675|FG005|From Week 24 Until Week 48|Adverse Event|3|||
16814899|NCT01995201|37757676|FG006|From Week 24 Until Week 48|Adverse Event|1|||
16814900|NCT01995201|37757670|FG000|From Week 24 Until Week 48|Death|0|||
16814901|NCT01995201|37757671|FG001|From Week 24 Until Week 48|Death|0|||
16814902|NCT01995201|37757672|FG002|From Week 24 Until Week 48|Death|0|||
16814903|NCT01995201|37757673|FG003|From Week 24 Until Week 48|Death|0|||
16814904|NCT01995201|37757674|FG004|From Week 24 Until Week 48|Death|0|||
16814905|NCT01995201|37757675|FG005|From Week 24 Until Week 48|Death|2|||
16814906|NCT01995201|37757676|FG006|From Week 24 Until Week 48|Death|0|||
16814907|NCT01995201|37757670|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
16814908|NCT01995201|37757671|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
16814909|NCT01995201|37757672|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
16814910|NCT01995201|37757673|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
16814911|NCT01995201|37757674|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
16814912|NCT01995201|37757675|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
16814913|NCT01995201|37757676|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
16814914|NCT01995201|37757670|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
16814915|NCT01995201|37757671|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
16814916|NCT01995201|37757672|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
16814917|NCT01995201|37757673|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
16814918|NCT01995201|37757674|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
16814919|NCT01995201|37757675|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
16814920|NCT01995201|37757676|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
16814921|NCT01995201|37757670|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16814922|NCT01995201|37757671|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16814923|NCT01995201|37757672|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
16814924|NCT01995201|37757673|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16814925|NCT01995201|37757674|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
16814926|NCT01995201|37757675|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16814927|NCT01995201|37757676|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16814928|NCT01995201|37757670|FG000|From Week 24 Until Week 48|Physician Decision|0|||
16814929|NCT01995201|37757671|FG001|From Week 24 Until Week 48|Physician Decision|0|||
16814930|NCT01995201|37757672|FG002|From Week 24 Until Week 48|Physician Decision|0|||
16814931|NCT01995201|37757673|FG003|From Week 24 Until Week 48|Physician Decision|0|||
16814932|NCT01995201|37757674|FG004|From Week 24 Until Week 48|Physician Decision|1|||
16814933|NCT01995201|37757675|FG005|From Week 24 Until Week 48|Physician Decision|0|||
16814934|NCT01995201|37757676|FG006|From Week 24 Until Week 48|Physician Decision|0|||
16814935|NCT01995201|37757670|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
16814936|NCT01995201|37757671|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
16814937|NCT01995201|37757672|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
16814938|NCT01995201|37757673|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
16814939|NCT01995201|37757674|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
16814940|NCT01995201|37757675|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
16814941|NCT01995201|37757676|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
16814942|NCT01728454|37757700|FG000|Stage 1 and 2|Pregnancy|1|||
16814943|NCT01728454|37757701|FG001|Stage 1 and 2|Pregnancy|0|||
16814944|NCT01728454|37757702|FG002|Stage 1 and 2|Pregnancy|0|||
16814945|NCT01728454|37757700|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
16814946|NCT01728454|37757701|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
16814947|NCT01728454|37757702|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
16814948|NCT01728454|37757700|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
16814949|NCT01728454|37757701|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
16814950|NCT01728454|37757702|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
16814951|NCT01728454|37757700|FG000|Stage 1 and 2|Lost to Follow-up|1|||
16814952|NCT01728454|37757701|FG001|Stage 1 and 2|Lost to Follow-up|1|||
16814953|NCT01728454|37757702|FG002|Stage 1 and 2|Lost to Follow-up|0|||
16814954|NCT01728454|37757700|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
16814955|NCT01728454|37757701|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
16814956|NCT01728454|37757702|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
16814957|NCT01728454|37757700|FG000|Stage 3|Reason Missing|0|||
16814958|NCT01728454|37757701|FG001|Stage 3|Reason Missing|0|||
16814959|NCT01728454|37757702|FG002|Stage 3|Reason Missing|1|||
16814960|NCT01728454|37757700|FG000|Stage 3|Subject Required Other Treatment|0|||
16814961|NCT01728454|37757701|FG001|Stage 3|Subject Required Other Treatment|1|||
16814962|NCT01728454|37757702|FG002|Stage 3|Subject Required Other Treatment|0|||
16814963|NCT01728454|37757700|FG000|Stage 3|Pregnancy|1|||
16814964|NCT01728454|37757701|FG001|Stage 3|Pregnancy|0|||
16814965|NCT01728454|37757702|FG002|Stage 3|Pregnancy|0|||
16814966|NCT01728454|37757700|FG000|Stage 3|Withdrew Consent|1|||
16814967|NCT01728454|37757701|FG001|Stage 3|Withdrew Consent|0|||
16814968|NCT01728454|37757702|FG002|Stage 3|Withdrew Consent|1|||
16814969|NCT01728454|37757700|FG000|Stage 3|Non-compliance with Protocol|0|||
16814970|NCT01728454|37757701|FG001|Stage 3|Non-compliance with Protocol|0|||
16814971|NCT01728454|37757702|FG002|Stage 3|Non-compliance with Protocol|1|||
16814972|NCT01728454|37757700|FG000|Stage 3|Lost to Follow-up|0|||
16814973|NCT01728454|37757701|FG001|Stage 3|Lost to Follow-up|3|||
16814974|NCT01728454|37757702|FG002|Stage 3|Lost to Follow-up|1|||
16814975|NCT01728454|37757700|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
16814976|NCT01728454|37757701|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
16814977|NCT01728454|37757702|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
16814978|NCT01636687|37757716|FG000|Induction Period|Withdrawal by Subject|1|||
16814979|NCT01636687|37757717|FG001|Induction Period|Withdrawal by Subject|0|||
16814980|NCT01636687|37757718|FG002|Induction Period|Withdrawal by Subject|0|||
16814981|NCT01636687|37757719|FG003|Induction Period|Withdrawal by Subject|0|||
16814982|NCT01636687|37757720|FG004|Induction Period|Withdrawal by Subject|0|||
16814983|NCT01636687|37757716|FG000|Induction Period|Adverse Event|1|||
16814984|NCT01636687|37757717|FG001|Induction Period|Adverse Event|0|||
16814985|NCT01636687|37757718|FG002|Induction Period|Adverse Event|0|||
16814986|NCT01636687|37757719|FG003|Induction Period|Adverse Event|0|||
16814987|NCT01636687|37757720|FG004|Induction Period|Adverse Event|1|||
16814988|NCT01636687|37757716|FG000|Induction Period|Lack of Efficacy|0|||
16814989|NCT01636687|37757717|FG001|Induction Period|Lack of Efficacy|0|||
16814990|NCT01636687|37757718|FG002|Induction Period|Lack of Efficacy|0|||
16814991|NCT01636687|37757719|FG003|Induction Period|Lack of Efficacy|0|||
16814992|NCT01636687|37757720|FG004|Induction Period|Lack of Efficacy|1|||
16814993|NCT01636687|37757716|FG000|Induction Period|Physician Decision|1|||
16814994|NCT01636687|37757717|FG001|Induction Period|Physician Decision|0|||
16814995|NCT01636687|37757718|FG002|Induction Period|Physician Decision|0|||
16814996|NCT01636687|37757719|FG003|Induction Period|Physician Decision|0|||
16814997|NCT01636687|37757720|FG004|Induction Period|Physician Decision|0|||
16814998|NCT01636687|37757716|FG000|Maintenance Period|Withdrawal by Subject|2|||
16814999|NCT01636687|37757717|FG001|Maintenance Period|Withdrawal by Subject|0|||
16815000|NCT01636687|37757718|FG002|Maintenance Period|Withdrawal by Subject|2|||
16815001|NCT01636687|37757719|FG003|Maintenance Period|Withdrawal by Subject|0|||
16815002|NCT01636687|37757720|FG004|Maintenance Period|Withdrawal by Subject|0|||
16815003|NCT01636687|37757716|FG000|Maintenance Period|Adverse Event|1|||
16815004|NCT01636687|37757717|FG001|Maintenance Period|Adverse Event|0|||
16815005|NCT01636687|37757718|FG002|Maintenance Period|Adverse Event|0|||
16815006|NCT01636687|37757719|FG003|Maintenance Period|Adverse Event|0|||
16815007|NCT01636687|37757720|FG004|Maintenance Period|Adverse Event|0|||
16815008|NCT01636687|37757716|FG000|Maintenance Period|Lack of Efficacy|4|||
16815009|NCT01636687|37757717|FG001|Maintenance Period|Lack of Efficacy|1|||
16815010|NCT01636687|37757718|FG002|Maintenance Period|Lack of Efficacy|0|||
16815011|NCT01636687|37757719|FG003|Maintenance Period|Lack of Efficacy|0|||
16815012|NCT01636687|37757720|FG004|Maintenance Period|Lack of Efficacy|0|||
16815013|NCT01636687|37757716|FG000|Maintenance Period|Lost to Follow-up|1|||
16815014|NCT01636687|37757717|FG001|Maintenance Period|Lost to Follow-up|1|||
16815015|NCT01636687|37757718|FG002|Maintenance Period|Lost to Follow-up|0|||
16815016|NCT01636687|37757719|FG003|Maintenance Period|Lost to Follow-up|0|||
16815017|NCT01636687|37757720|FG004|Maintenance Period|Lost to Follow-up|1|||
16815018|NCT01636687|37757716|FG000|Maintenance Period|Physician Decision|0|||
16815019|NCT01636687|37757717|FG001|Maintenance Period|Physician Decision|0|||
16815020|NCT01636687|37757718|FG002|Maintenance Period|Physician Decision|0|||
16815021|NCT01636687|37757719|FG003|Maintenance Period|Physician Decision|0|||
16815022|NCT01636687|37757720|FG004|Maintenance Period|Physician Decision|1|||
16815023|NCT01636687|37757716|FG000|Extension Period|technical problems|0|||
16815024|NCT01636687|37757717|FG001|Extension Period|technical problems|1|||
16815025|NCT01636687|37757718|FG002|Extension Period|technical problems|2|||
16815026|NCT01636687|37757719|FG003|Extension Period|technical problems|1|||
16815027|NCT01636687|37757720|FG004|Extension Period|technical problems|0|||
16815028|NCT01636687|37757716|FG000|Extension Period|Adverse Event|4|||
16815029|NCT01636687|37757717|FG001|Extension Period|Adverse Event|3|||
16815030|NCT01636687|37757718|FG002|Extension Period|Adverse Event|2|||
16815031|NCT01636687|37757719|FG003|Extension Period|Adverse Event|1|||
16815032|NCT01636687|37757720|FG004|Extension Period|Adverse Event|0|||
16815033|NCT01636687|37757716|FG000|Extension Period|Lack of Efficacy|7|||
16815034|NCT01636687|37757717|FG001|Extension Period|Lack of Efficacy|0|||
16815035|NCT01636687|37757718|FG002|Extension Period|Lack of Efficacy|2|||
16815036|NCT01636687|37757719|FG003|Extension Period|Lack of Efficacy|1|||
16815037|NCT01636687|37757720|FG004|Extension Period|Lack of Efficacy|0|||
16815038|NCT01636687|37757716|FG000|Extension Period|Lost to Follow-up|1|||
16815039|NCT01636687|37757717|FG001|Extension Period|Lost to Follow-up|0|||
16815040|NCT01636687|37757718|FG002|Extension Period|Lost to Follow-up|1|||
16815041|NCT01636687|37757719|FG003|Extension Period|Lost to Follow-up|0|||
16815042|NCT01636687|37757720|FG004|Extension Period|Lost to Follow-up|0|||
16815043|NCT01636687|37757716|FG000|Extension Period|Physician Decision|1|||
16815044|NCT01636687|37757717|FG001|Extension Period|Physician Decision|0|||
16815045|NCT01636687|37757718|FG002|Extension Period|Physician Decision|0|||
16815046|NCT01636687|37757719|FG003|Extension Period|Physician Decision|1|||
16815047|NCT01636687|37757720|FG004|Extension Period|Physician Decision|0|||
16815048|NCT01636687|37757716|FG000|Extension Period|study terminated by sponsor|33|||
16815049|NCT01636687|37757717|FG001|Extension Period|study terminated by sponsor|50|||
16815050|NCT01636687|37757718|FG002|Extension Period|study terminated by sponsor|17|||
16815051|NCT01636687|37757719|FG003|Extension Period|study terminated by sponsor|23|||
16815052|NCT01636687|37757720|FG004|Extension Period|study terminated by sponsor|0|||
16815053|NCT01636687|37757716|FG000|Extension Period|Withdrawal by Subject|1|||
16815054|NCT01636687|37757717|FG001|Extension Period|Withdrawal by Subject|0|||
16815055|NCT01636687|37757718|FG002|Extension Period|Withdrawal by Subject|1|||
16815056|NCT01636687|37757719|FG003|Extension Period|Withdrawal by Subject|1|||
16815057|NCT01636687|37757720|FG004|Extension Period|Withdrawal by Subject|0|||
16815058|NCT01636687|37757716|FG000|Follow-up Period|Withdrawal by Subject|1|||
16815059|NCT01636687|37757717|FG001|Follow-up Period|Withdrawal by Subject|0|||
16815060|NCT01636687|37757718|FG002|Follow-up Period|Withdrawal by Subject|0|||
16815061|NCT01636687|37757719|FG003|Follow-up Period|Withdrawal by Subject|0|||
16815062|NCT01636687|37757720|FG004|Follow-up Period|Withdrawal by Subject|1|||
16815063|NCT01634659|37757740|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
16815064|NCT01634659|37757741|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
16815065|NCT01634659|37757740|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
16815066|NCT01634659|37757741|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
16815067|NCT01599793|37757747|FG000|Overall Study|Adverse Event|2|||
16815068|NCT01755598|37757762|FG000|Overall Study|Other|109|||
16815069|NCT01755598|37757763|FG001|Overall Study|Other|109|||
16815070|NCT01755598|37757762|FG000|Overall Study|Lost to Follow-up|32|||
16815071|NCT01755598|37757763|FG001|Overall Study|Lost to Follow-up|43|||
16815072|NCT01755598|37757762|FG000|Overall Study|Migrated/moved from study area|76|||
16815073|NCT01755598|37757763|FG001|Overall Study|Migrated/moved from study area|65|||
16815074|NCT01755598|37757762|FG000|Overall Study|Withdrawal by Subject|22|||
16815075|NCT01755598|37757763|FG001|Overall Study|Withdrawal by Subject|31|||
16815076|NCT01755598|37757762|FG000|Overall Study|Protocol Violation|7|||
16815077|NCT01755598|37757763|FG001|Overall Study|Protocol Violation|7|||
16815078|NCT01755598|37757762|FG000|Overall Study|Adverse Event|19|||
16815079|NCT01755598|37757763|FG001|Overall Study|Adverse Event|28|||
16815080|NCT01606306|37757775|FG000|Overall Study|Lack of Efficacy|2|||
16815081|NCT01606306|37757776|FG001|Overall Study|Lack of Efficacy|1|||
16815082|NCT01606306|37757777|FG002|Overall Study|Lack of Efficacy|4|||
16815083|NCT01606306|37757778|FG003|Overall Study|Lack of Efficacy|4|||
16815084|NCT01606306|37757779|FG004|Overall Study|Lack of Efficacy|1|||
16815085|NCT01606306|37757780|FG005|Overall Study|Lack of Efficacy|2|||
16815086|NCT01606306|37757775|FG000|Overall Study|Adverse Event|1|||
16815087|NCT01606306|37757776|FG001|Overall Study|Adverse Event|0|||
16815088|NCT01606306|37757777|FG002|Overall Study|Adverse Event|1|||
16815089|NCT01606306|37757778|FG003|Overall Study|Adverse Event|1|||
16815090|NCT01606306|37757779|FG004|Overall Study|Adverse Event|2|||
16815091|NCT01606306|37757780|FG005|Overall Study|Adverse Event|0|||
16815092|NCT01606306|37757775|FG000|Overall Study|Lost to Follow-up|7|||
16815093|NCT01606306|37757776|FG001|Overall Study|Lost to Follow-up|4|||
16815094|NCT01606306|37757777|FG002|Overall Study|Lost to Follow-up|5|||
16815095|NCT01606306|37757778|FG003|Overall Study|Lost to Follow-up|4|||
16815096|NCT01606306|37757779|FG004|Overall Study|Lost to Follow-up|3|||
16815097|NCT01606306|37757780|FG005|Overall Study|Lost to Follow-up|5|||
16815098|NCT01606306|37757775|FG000|Overall Study|Withdrawal by Subject|4|||
16815099|NCT01606306|37757776|FG001|Overall Study|Withdrawal by Subject|3|||
16815100|NCT01606306|37757777|FG002|Overall Study|Withdrawal by Subject|4|||
16815101|NCT01606306|37757778|FG003|Overall Study|Withdrawal by Subject|4|||
16815102|NCT01606306|37757779|FG004|Overall Study|Withdrawal by Subject|5|||
16815103|NCT01606306|37757780|FG005|Overall Study|Withdrawal by Subject|4|||
16815104|NCT01606306|37757775|FG000|Overall Study|Physician Decision|1|||
16815105|NCT01606306|37757776|FG001|Overall Study|Physician Decision|2|||
16815106|NCT01606306|37757777|FG002|Overall Study|Physician Decision|0|||
16815107|NCT01606306|37757778|FG003|Overall Study|Physician Decision|0|||
16815108|NCT01606306|37757779|FG004|Overall Study|Physician Decision|0|||
16815109|NCT01606306|37757780|FG005|Overall Study|Physician Decision|0|||
16815110|NCT01754194|37757788|FG000|Overall Study|Lost to Follow-up|39|||
16815111|NCT01754194|37757789|FG001|Overall Study|Lost to Follow-up|14|||
16815112|NCT01754194|37757788|FG000|Overall Study|Withdrawal by Subject|4|||
16815113|NCT01754194|37757789|FG001|Overall Study|Withdrawal by Subject|5|||
16815114|NCT01754194|37757788|FG000|Overall Study|Other|9|||
16815115|NCT01754194|37757789|FG001|Overall Study|Other|8|||
16815116|NCT01753570|37757800|FG000|Overall Study|Adverse Event|1|||
16815117|NCT01753570|37757801|FG001|Overall Study|Adverse Event|0|||
16815118|NCT01753570|37757802|FG002|Overall Study|Adverse Event|1|||
16815119|NCT01753570|37757800|FG000|Overall Study|Physician Decision|0|||
16815120|NCT01753570|37757801|FG001|Overall Study|Physician Decision|1|||
16815121|NCT01753570|37757802|FG002|Overall Study|Physician Decision|0|||
16815122|NCT01753570|37757800|FG000|Overall Study|Withdrawal by Subject|1|||
16815123|NCT01753570|37757801|FG001|Overall Study|Withdrawal by Subject|4|||
16815124|NCT01753570|37757802|FG002|Overall Study|Withdrawal by Subject|0|||
16815125|NCT01753336|37757811|FG000|Overall Study|Patient decision|12|||
16815126|NCT01753336|37757811|FG000|Overall Study|Lost to Follow-up|3|||
16815127|NCT01753336|37757811|FG000|Overall Study|Physician Decision|2|||
16815128|NCT01753336|37757811|FG000|Overall Study|Sponsor's decision|2|||
16815129|NCT01753336|37757811|FG000|Overall Study|Withdrawal by Subject|1|||
16815130|NCT01777282|37757820|FG000|Overall Study|Persistent Hyperglycemia|0|||
16815131|NCT01777282|37757821|FG001|Overall Study|Persistent Hyperglycemia|0|||
16815132|NCT01777282|37757822|FG002|Overall Study|Persistent Hyperglycemia|1|||
16815133|NCT01777282|37757823|FG003|Overall Study|Persistent Hyperglycemia|0|||
16815134|NCT01777282|37757824|FG004|Overall Study|Persistent Hyperglycemia|0|||
16815135|NCT01777282|37757820|FG000|Overall Study|New Antidiabetic Medication|0|||
16815136|NCT01777282|37757821|FG001|Overall Study|New Antidiabetic Medication|0|||
16815137|NCT01777282|37757822|FG002|Overall Study|New Antidiabetic Medication|1|||
16815138|NCT01777282|37757823|FG003|Overall Study|New Antidiabetic Medication|0|||
16815139|NCT01777282|37757824|FG004|Overall Study|New Antidiabetic Medication|0|||
16815140|NCT01777282|37757820|FG000|Overall Study|Adverse Event|4|||
16815141|NCT01777282|37757821|FG001|Overall Study|Adverse Event|4|||
16815142|NCT01777282|37757822|FG002|Overall Study|Adverse Event|2|||
16815143|NCT01777282|37757823|FG003|Overall Study|Adverse Event|1|||
16815144|NCT01777282|37757824|FG004|Overall Study|Adverse Event|3|||
16815145|NCT01777282|37757820|FG000|Overall Study|Withdrawal by Subject|4|||
16815146|NCT01777282|37757821|FG001|Overall Study|Withdrawal by Subject|0|||
16815147|NCT01777282|37757822|FG002|Overall Study|Withdrawal by Subject|0|||
16815148|NCT01777282|37757823|FG003|Overall Study|Withdrawal by Subject|1|||
16815149|NCT01777282|37757824|FG004|Overall Study|Withdrawal by Subject|2|||
16815150|NCT01777282|37757820|FG000|Overall Study|Protocol Violation|2|||
16815151|NCT01777282|37757821|FG001|Overall Study|Protocol Violation|0|||
16815152|NCT01777282|37757822|FG002|Overall Study|Protocol Violation|1|||
16815153|NCT01777282|37757823|FG003|Overall Study|Protocol Violation|0|||
16815154|NCT01777282|37757824|FG004|Overall Study|Protocol Violation|2|||
16815155|NCT01777282|37757820|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
16815156|NCT01777282|37757821|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
16815157|NCT01777282|37757822|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
16815158|NCT01777282|37757823|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
16815159|NCT01777282|37757824|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
16815160|NCT01975389|37757838|FG000|Overall Study|Adverse Event|10|||
16815161|NCT01975389|37757839|FG001|Overall Study|Adverse Event|6|||
16815162|NCT01975389|37757838|FG000|Overall Study|Death|61|||
16815163|NCT01975389|37757839|FG001|Overall Study|Death|54|||
16815164|NCT01975389|37757838|FG000|Overall Study|Lost to Follow-up|81|||
16815165|NCT01975389|37757839|FG001|Overall Study|Lost to Follow-up|86|||
16815166|NCT01975389|37757838|FG000|Overall Study|Withdrawal by Subject|90|||
16815167|NCT01975389|37757839|FG001|Overall Study|Withdrawal by Subject|76|||
16815168|NCT01975389|37757838|FG000|Overall Study|Other|6|||
16815169|NCT01975389|37757839|FG001|Overall Study|Other|9|||
16815170|NCT01975389|37757838|FG000|Overall Study|Randomized, not treated|4|||
16815171|NCT01975389|37757839|FG001|Overall Study|Randomized, not treated|5|||
16815172|NCT01946139|37757845|FG000|Overall Study|Withdrawal by Subject|8|||
16815173|NCT01946139|37757845|FG000|Overall Study|ineligible|8|||
16815174|NCT01946139|37757845|FG000|Overall Study|Specimens not available|4|||
16815175|NCT01974141|37757851|FG000|Overall Study|Other Reasons|28|||
16815176|NCT01974141|37757852|FG001|Overall Study|Other Reasons|18|||
16815177|NCT01974141|37757851|FG000|Overall Study|Protocol Violation|2|||
16815178|NCT01974141|37757852|FG001|Overall Study|Protocol Violation|6|||
16815179|NCT01974141|37757851|FG000|Overall Study|Personal Reasons|21|||
16815180|NCT01974141|37757852|FG001|Overall Study|Personal Reasons|20|||
16815181|NCT01974141|37757851|FG000|Overall Study|Lost to Follow-up|38|||
16815182|NCT01974141|37757852|FG001|Overall Study|Lost to Follow-up|29|||
16815183|NCT01974141|37757851|FG000|Overall Study|Pregnancy|3|||
16815184|NCT01974141|37757852|FG001|Overall Study|Pregnancy|3|||
16815185|NCT01974141|37757851|FG000|Overall Study|Lack of Efficacy|0|||
16815186|NCT01974141|37757852|FG001|Overall Study|Lack of Efficacy|1|||
16815187|NCT01974141|37757851|FG000|Overall Study|Adverse Event|4|||
16815188|NCT01974141|37757852|FG001|Overall Study|Adverse Event|5|||
16815189|NCT01945593|37757862|FG000|Overall Study|Adverse Event|0|||
16815190|NCT01945593|37757863|FG001|Overall Study|Adverse Event|0|||
16815191|NCT01945593|37757864|FG002|Overall Study|Adverse Event|0|||
16815192|NCT01945593|37757865|FG003|Overall Study|Adverse Event|5|||
16815193|NCT01945593|37757862|FG000|Overall Study|Physician Decision|0|||
16815194|NCT01945593|37757863|FG001|Overall Study|Physician Decision|0|||
16815195|NCT01945593|37757864|FG002|Overall Study|Physician Decision|1|||
16815196|NCT01945593|37757865|FG003|Overall Study|Physician Decision|1|||
16815197|NCT01945593|37757862|FG000|Overall Study|Withdrawal by Subject|0|||
16815198|NCT01945593|37757863|FG001|Overall Study|Withdrawal by Subject|2|||
16815199|NCT01945593|37757864|FG002|Overall Study|Withdrawal by Subject|0|||
16815200|NCT01945593|37757865|FG003|Overall Study|Withdrawal by Subject|4|||
16815201|NCT01945593|37757862|FG000|Overall Study|Protocol Violation|0|||
16815202|NCT01945593|37757863|FG001|Overall Study|Protocol Violation|2|||
16815203|NCT01945593|37757864|FG002|Overall Study|Protocol Violation|1|||
16815204|NCT01945593|37757865|FG003|Overall Study|Protocol Violation|3|||
16815205|NCT01945593|37757862|FG000|Overall Study|Death|0|||
16815206|NCT01945593|37757863|FG001|Overall Study|Death|0|||
16815207|NCT01945593|37757864|FG002|Overall Study|Death|1|||
16815208|NCT01945593|37757865|FG003|Overall Study|Death|0|||
16815209|NCT01945593|37757862|FG000|Overall Study|Other: Terminated|0|||
16815210|NCT01945593|37757863|FG001|Overall Study|Other: Terminated|0|||
16815211|NCT01945593|37757864|FG002|Overall Study|Other: Terminated|0|||
16815212|NCT01945593|37757865|FG003|Overall Study|Other: Terminated|1|||
16815213|NCT01945593|37757862|FG000|Overall Study|Other: Surgical Procedure|0|||
16815214|NCT01945593|37757863|FG001|Overall Study|Other: Surgical Procedure|2|||
16815215|NCT01945593|37757864|FG002|Overall Study|Other: Surgical Procedure|0|||
16815216|NCT01945593|37757865|FG003|Overall Study|Other: Surgical Procedure|6|||
16815217|NCT01945593|37757862|FG000|Overall Study|Other: Screen Failure|0|||
16815218|NCT01945593|37757863|FG001|Overall Study|Other: Screen Failure|2|||
16815219|NCT01945593|37757864|FG002|Overall Study|Other: Screen Failure|0|||
16815220|NCT01945593|37757865|FG003|Overall Study|Other: Screen Failure|0|||
16815221|NCT01945281|37757882|FG000|Overall Study|Adverse Event|1|||
16815222|NCT01945281|37757883|FG001|Overall Study|Adverse Event|0|||
16815223|NCT01945281|37757882|FG000|Overall Study|Death|3|||
16815224|NCT01945281|37757883|FG001|Overall Study|Death|3|||
16815225|NCT01945281|37757882|FG000|Overall Study|Physician Decision|1|||
16815226|NCT01945281|37757883|FG001|Overall Study|Physician Decision|1|||
16815227|NCT01945281|37757882|FG000|Overall Study|Technical Problems|1|||
16815228|NCT01945281|37757883|FG001|Overall Study|Technical Problems|0|||
16815229|NCT01961349|37757892|FG000|Overall Study|Withdrawal by Subject|1|||
16815230|NCT01961349|37757893|FG001|Overall Study|Withdrawal by Subject|4|||
16815231|NCT01961349|37757894|FG002|Overall Study|Withdrawal by Subject|0|||
16815232|NCT01961349|37757892|FG000|Overall Study|Adverse Event|0|||
16815233|NCT01961349|37757893|FG001|Overall Study|Adverse Event|0|||
16815234|NCT01961349|37757894|FG002|Overall Study|Adverse Event|1|||
16815235|NCT01961349|37757892|FG000|Overall Study|registration error, personal reason etc|2|||
16815236|NCT01961349|37757893|FG001|Overall Study|registration error, personal reason etc|2|||
16815237|NCT01961349|37757894|FG002|Overall Study|registration error, personal reason etc|1|||
16815238|NCT01973595|37757906|FG000|Washout|Withdrawal by Subject|1|||
16815239|NCT01973595|37757907|FG001|Washout|Withdrawal by Subject|0|||
16815240|NCT01973595|37757908|FG002|Washout|Withdrawal by Subject|1|||
16815241|NCT01973595|37757909|FG003|Washout|Withdrawal by Subject|0|||
16815242|NCT01944969|37757920|FG000|Overall Study|Adverse Event|1|||
16815243|NCT01944969|37757920|FG000|Overall Study|Lack of Efficacy|1|||
16815244|NCT01944969|37757920|FG000|Overall Study|Non-compliance with IMP|1|||
16815245|NCT01944969|37757920|FG000|Overall Study|Administrative or other reasons|23|||
16815246|NCT01961115|37757929|FG000|Overall Study|Disease Progression|1|||
16815247|NCT01961115|37757930|FG001|Overall Study|Disease Progression|0|||
16815248|NCT01961115|37757931|FG002|Overall Study|Disease Progression|3|||
16815249|NCT01961115|37757929|FG000|Overall Study|Adverse Event|1|||
16815250|NCT01961115|37757930|FG001|Overall Study|Adverse Event|0|||
16815251|NCT01961115|37757931|FG002|Overall Study|Adverse Event|1|||
16815252|NCT01973439|37757939|FG000|Overall Study|Lost samples from one PK Day|2|||
16815253|NCT01973439|37757939|FG000|Overall Study|Vomiting after commencing once daily|1|||
16815254|NCT01973439|37757939|FG000|Overall Study|PK curve incomplete|2|||
16815255|NCT01973283|37757943|FG000|Overall Study|Lost to Follow-up|4|||
16815256|NCT01943799|37757953|FG000|Overall Study|Lost to Follow-up|0|||
17016609|NCT00600119|38161266|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
16815257|NCT01943799|37757954|FG001|Overall Study|Lost to Follow-up|1|||
16815258|NCT01943799|37757955|FG002|Overall Study|Lost to Follow-up|1|||
16815259|NCT01943799|37757956|FG003|Overall Study|Lost to Follow-up|0|||
16815260|NCT01943799|37757953|FG000|Overall Study|Protocol Violation|1|||
16815261|NCT01943799|37757954|FG001|Overall Study|Protocol Violation|0|||
16815262|NCT01943799|37757955|FG002|Overall Study|Protocol Violation|0|||
16815263|NCT01943799|37757956|FG003|Overall Study|Protocol Violation|0|||
16815264|NCT01943799|37757953|FG000|Overall Study|Withdrawal by Subject|4|||
16815265|NCT01943799|37757954|FG001|Overall Study|Withdrawal by Subject|2|||
16815266|NCT01943799|37757955|FG002|Overall Study|Withdrawal by Subject|1|||
16815267|NCT01943799|37757956|FG003|Overall Study|Withdrawal by Subject|0|||
16815268|NCT01972659|37757968|FG000|Overall Study|Protocol Violation|2|||
16815269|NCT01972659|37757969|FG001|Overall Study|Protocol Violation|2|||
16815270|NCT01972659|37757968|FG000|Overall Study|problems realted to acceleromyograph|2|||
16815271|NCT01972659|37757969|FG001|Overall Study|problems realted to acceleromyograph|1|||
16815272|NCT01971723|37757977|FG000|Overall Study|Withdrawal by Subject|1|||
16815273|NCT01971723|37757978|FG001|Overall Study|Withdrawal by Subject|1|||
16815274|NCT01971723|37757977|FG000|Overall Study|Protocol Violation|1|||
16815275|NCT01971723|37757978|FG001|Overall Study|Protocol Violation|2|||
16815276|NCT01942785|37757984|FG000|Overall Study|Adverse Event|2|||
16815277|NCT01942785|37757984|FG000|Overall Study|Withdrawal by Subject|1|||
16815278|NCT01942785|37757984|FG000|Overall Study|Protocol Violation|1|||
16815279|NCT01774786|37757992|FG000|Overall Study|Death|300|||
16815280|NCT01774786|37757993|FG001|Overall Study|Death|319|||
16815281|NCT01774786|37757992|FG000|Overall Study|Lost to Follow-up|6|||
16815282|NCT01774786|37757993|FG001|Overall Study|Lost to Follow-up|7|||
16815283|NCT01774786|37757992|FG000|Overall Study|Withdrawal by Subject|18|||
16815284|NCT01774786|37757993|FG001|Overall Study|Withdrawal by Subject|14|||
16815285|NCT01774786|37757992|FG000|Overall Study|Physician Decision|2|||
16815286|NCT01774786|37757993|FG001|Overall Study|Physician Decision|0|||
16815287|NCT01774786|37757992|FG000|Overall Study|Non-compliance|0|||
16815288|NCT01774786|37757993|FG001|Overall Study|Non-compliance|1|||
16815289|NCT01774786|37757992|FG000|Overall Study|Reason Not Specified|2|||
16815290|NCT01774786|37757993|FG001|Overall Study|Reason Not Specified|5|||
16815291|NCT01960725|37758001|FG000|Overall Study|Lost to Follow-up|4|||
16815292|NCT01960725|37758002|FG001|Overall Study|Lost to Follow-up|3|||
16815293|NCT01960725|37758001|FG000|Overall Study|Withdrawal by Subject|1|||
16815294|NCT01960725|37758002|FG001|Overall Study|Withdrawal by Subject|0|||
16815295|NCT01960725|37758001|FG000|Overall Study|unable to obtain blood sample|1|||
16815296|NCT01960725|37758002|FG001|Overall Study|unable to obtain blood sample|2|||
16815297|NCT01942161|37758011|FG000|Overall Study|Adverse Event|1|||
16815298|NCT01942161|37758012|FG001|Overall Study|Adverse Event|2|||
16815299|NCT01942161|37758013|FG002|Overall Study|Adverse Event|5|||
16815300|NCT01942161|37758011|FG000|Overall Study|Physician Decision|3|||
16815301|NCT01942161|37758012|FG001|Overall Study|Physician Decision|1|||
16815302|NCT01942161|37758013|FG002|Overall Study|Physician Decision|0|||
16815303|NCT01942161|37758011|FG000|Overall Study|Protocol Violation|1|||
16815304|NCT01942161|37758012|FG001|Overall Study|Protocol Violation|0|||
16815305|NCT01942161|37758013|FG002|Overall Study|Protocol Violation|0|||
16815306|NCT01942161|37758011|FG000|Overall Study|Withdrawal by Subject|3|||
16815307|NCT01942161|37758012|FG001|Overall Study|Withdrawal by Subject|3|||
16815308|NCT01942161|37758013|FG002|Overall Study|Withdrawal by Subject|1|||
16815309|NCT01971645|37758024|FG000|Overall Study|Adverse Event|1|||
16815310|NCT01971645|37758025|FG001|Overall Study|Adverse Event|0|||
16815311|NCT01971645|37758026|FG002|Overall Study|Adverse Event|0|||
16815312|NCT01971645|37758024|FG000|Overall Study|Lost to Follow-up|1|||
16815313|NCT01971645|37758025|FG001|Overall Study|Lost to Follow-up|0|||
16815314|NCT01971645|37758026|FG002|Overall Study|Lost to Follow-up|1|||
16815315|NCT01971645|37758024|FG000|Overall Study|Protocol Violation|0|||
16815316|NCT01971645|37758025|FG001|Overall Study|Protocol Violation|0|||
16815317|NCT01971645|37758026|FG002|Overall Study|Protocol Violation|1|||
16815318|NCT01941537|37758036|FG000|Overall Study|Lack of Efficacy|1|||
16815319|NCT01941537|37758037|FG001|Overall Study|Lack of Efficacy|2|||
16815320|NCT01941537|37758036|FG000|Overall Study|Lost to Follow-up|1|||
16815321|NCT01941537|37758037|FG001|Overall Study|Lost to Follow-up|0|||
16815322|NCT01941537|37758036|FG000|Overall Study|Pregnancy|1|||
16815323|NCT01941537|37758037|FG001|Overall Study|Pregnancy|0|||
16815324|NCT01941537|37758036|FG000|Overall Study|Adverse Event|1|||
16815325|NCT01941537|37758037|FG001|Overall Study|Adverse Event|0|||
16815326|NCT01941537|37758036|FG000|Overall Study|Withdrawal by Subject|0|||
16815327|NCT01941537|37758037|FG001|Overall Study|Withdrawal by Subject|1|||
16815328|NCT01971567|37758046|FG000|Overall Study|Withdrawal by Subject|3|||
16815329|NCT01971567|37758047|FG001|Overall Study|Withdrawal by Subject|2|||
16815330|NCT01971567|37758046|FG000|Overall Study|Lost to Follow-up|1|||
16815331|NCT01971567|37758047|FG001|Overall Study|Lost to Follow-up|0|||
16815332|NCT01960413|37758055|FG000|Overall Study|Withdrawal by Subject|1|||
16815333|NCT01960413|37758056|FG001|Overall Study|Withdrawal by Subject|1|||
16815334|NCT01960413|37758055|FG000|Overall Study|Physician Decision|1|||
16815335|NCT01960413|37758056|FG001|Overall Study|Physician Decision|0|||
16815336|NCT01960413|37758055|FG000|Overall Study|Lost to Follow-up|2|||
16815337|NCT01960413|37758056|FG001|Overall Study|Lost to Follow-up|0|||
16815338|NCT01970475|37758064|FG000|Overall Study|Withdrawal by Subject|11|||
16815339|NCT01970475|37758065|FG001|Overall Study|Withdrawal by Subject|6|||
16815340|NCT01970475|37758064|FG000|Overall Study|Adverse Event|7|||
16815341|NCT01970475|37758065|FG001|Overall Study|Adverse Event|3|||
16815342|NCT01970475|37758064|FG000|Overall Study|Lost to Follow-up|2|||
16815343|NCT01970475|37758065|FG001|Overall Study|Lost to Follow-up|2|||
16815344|NCT01970475|37758064|FG000|Overall Study|Protocol Violation|1|||
16815345|NCT01970475|37758065|FG001|Overall Study|Protocol Violation|0|||
16815346|NCT01939977|37758073|FG000|Overall Study|Adverse Event|4|||
16815347|NCT01939977|37758074|FG001|Overall Study|Adverse Event|3|||
16815348|NCT01939977|37758073|FG000|Overall Study|Lack of Efficacy|3|||
16815349|NCT01939977|37758074|FG001|Overall Study|Lack of Efficacy|0|||
16815350|NCT01939977|37758073|FG000|Overall Study|Physician Decision|1|||
16815351|NCT01939977|37758074|FG001|Overall Study|Physician Decision|1|||
16815352|NCT01939977|37758073|FG000|Overall Study|Withdrawal by Subject|0|||
16815353|NCT01939977|37758074|FG001|Overall Study|Withdrawal by Subject|2|||
16815354|NCT01939977|37758073|FG000|Overall Study|Did not meet inclusion criteria|1|||
16815355|NCT01939977|37758074|FG001|Overall Study|Did not meet inclusion criteria|0|||
16815356|NCT01939977|37758073|FG000|Overall Study|Did not receive study medication|0|||
16815357|NCT01939977|37758074|FG001|Overall Study|Did not receive study medication|1|||
16815358|NCT01708954|37758083|FG000|Step 1|Disease progression|26|||
16815359|NCT01708954|37758084|FG001|Step 1|Disease progression|17|||
16815360|NCT01708954|37758085|FG002|Step 1|Disease progression|14|||
16815361|NCT01708954|37758083|FG000|Step 1|Adverse Event|3|||
16815362|NCT01708954|37758084|FG001|Step 1|Adverse Event|11|||
16815363|NCT01708954|37758085|FG002|Step 1|Adverse Event|13|||
16815364|NCT01708954|37758083|FG000|Step 1|Death|3|||
16815365|NCT01708954|37758084|FG001|Step 1|Death|2|||
16815366|NCT01708954|37758085|FG002|Step 1|Death|3|||
16815367|NCT01708954|37758083|FG000|Step 1|Withdrawal by Subject|2|||
16815368|NCT01708954|37758084|FG001|Step 1|Withdrawal by Subject|5|||
16815369|NCT01708954|37758085|FG002|Step 1|Withdrawal by Subject|3|||
16815370|NCT01708954|37758083|FG000|Step 1|Other complicating disease|0|||
16815371|NCT01708954|37758084|FG001|Step 1|Other complicating disease|2|||
16815372|NCT01708954|37758085|FG002|Step 1|Other complicating disease|0|||
16815373|NCT01708954|37758083|FG000|Step 1|Crossed over to Step 2|2|||
16815374|NCT01708954|37758084|FG001|Step 1|Crossed over to Step 2|0|||
16815375|NCT01708954|37758085|FG002|Step 1|Crossed over to Step 2|0|||
16815376|NCT01708954|37758083|FG000|Step 1|Symptomatic deterioration|1|||
16815377|NCT01708954|37758084|FG001|Step 1|Symptomatic deterioration|0|||
16815378|NCT01708954|37758085|FG002|Step 1|Symptomatic deterioration|1|||
16815379|NCT01708954|37758083|FG000|Step 1|Off-treatment reason not submitted|1|||
16815380|NCT01708954|37758084|FG001|Step 1|Off-treatment reason not submitted|1|||
16815381|NCT01708954|37758085|FG002|Step 1|Off-treatment reason not submitted|1|||
16815382|NCT01708954|37758083|FG000|Step 1|Ineligible or never received treatment|4|||
16815383|NCT01708954|37758084|FG001|Step 1|Ineligible or never received treatment|2|||
16815384|NCT01708954|37758085|FG002|Step 1|Ineligible or never received treatment|8|||
16815385|NCT01708954|37758083|FG000|Step 2|Disease progression|9|||
16815386|NCT01708954|37758084|FG001|Step 2|Disease progression|4|||
16815387|NCT01708954|37758085|FG002|Step 2|Disease progression|0|||
16815388|NCT01708954|37758083|FG000|Step 2|Adverse Event|3|||
16815389|NCT01708954|37758084|FG001|Step 2|Adverse Event|2|||
16815390|NCT01708954|37758085|FG002|Step 2|Adverse Event|0|||
16815391|NCT01708954|37758083|FG000|Step 2|Withdrawal by Subject|1|||
16815392|NCT01708954|37758084|FG001|Step 2|Withdrawal by Subject|1|||
16815393|NCT01708954|37758085|FG002|Step 2|Withdrawal by Subject|0|||
16815394|NCT01939899|37758099|FG000|Lead-in Dose Finding Phase|Death|0|||
16815395|NCT01939899|37758100|FG001|Lead-in Dose Finding Phase|Death|3|||
16815396|NCT01939899|37758101|FG002|Lead-in Dose Finding Phase|Death|1|||
16815397|NCT01939899|37758102|FG003|Lead-in Dose Finding Phase|Death|0|||
16815398|NCT01939899|37758103|FG004|Lead-in Dose Finding Phase|Death|0|||
16815399|NCT01939899|37758099|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
16815400|NCT01939899|37758100|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
16815401|NCT01939899|37758101|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
16815402|NCT01939899|37758102|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
16815403|NCT01939899|37758103|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
16815404|NCT01939899|37758099|FG000|Lead-in Dose Finding Phase|Other|0|||
16815405|NCT01939899|37758100|FG001|Lead-in Dose Finding Phase|Other|0|||
16815406|NCT01939899|37758101|FG002|Lead-in Dose Finding Phase|Other|1|||
16815407|NCT01939899|37758102|FG003|Lead-in Dose Finding Phase|Other|0|||
16815408|NCT01939899|37758103|FG004|Lead-in Dose Finding Phase|Other|0|||
16815409|NCT01939899|37758099|FG000|Phase 2|Withdrawal by Subject|0|||
16815410|NCT01939899|37758100|FG001|Phase 2|Withdrawal by Subject|0|||
16815411|NCT01939899|37758101|FG002|Phase 2|Withdrawal by Subject|0|||
16815412|NCT01939899|37758102|FG003|Phase 2|Withdrawal by Subject|2|||
16815413|NCT01939899|37758103|FG004|Phase 2|Withdrawal by Subject|0|||
16815414|NCT01939899|37758099|FG000|Phase 2|Disease Progression|0|||
16815415|NCT01939899|37758100|FG001|Phase 2|Disease Progression|0|||
16815416|NCT01939899|37758101|FG002|Phase 2|Disease Progression|0|||
16815417|NCT01939899|37758102|FG003|Phase 2|Disease Progression|9|||
16815418|NCT01939899|37758103|FG004|Phase 2|Disease Progression|1|||
16815419|NCT01970397|37758123|FG000|Overall Study|Adverse Event|0|||
16815420|NCT01970397|37758124|FG001|Overall Study|Adverse Event|1|||
16815421|NCT01970397|37758123|FG000|Overall Study|Lost to Follow-up|0|||
16815422|NCT01970397|37758124|FG001|Overall Study|Lost to Follow-up|1|||
16815423|NCT01970397|37758123|FG000|Overall Study|Personal Reasons|1|||
16815424|NCT01970397|37758124|FG001|Overall Study|Personal Reasons|2|||
16815425|NCT01970397|37758123|FG000|Overall Study|Protocol Violation|1|||
16815426|NCT01970397|37758124|FG001|Overall Study|Protocol Violation|1|||
16815427|NCT01970241|37758132|FG000|Overall Study|Withdrawal by Subject|2|||
16815428|NCT01970241|37758133|FG001|Overall Study|Withdrawal by Subject|0|||
16815429|NCT01970241|37758132|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
16815430|NCT01970241|37758133|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
16815431|NCT01939353|37758141|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
16815432|NCT01939353|37758141|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
16815433|NCT01939353|37758141|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
16815434|NCT01939353|37758141|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
16815435|NCT01939353|37758141|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
16815436|NCT01970007|37758145|FG000|Overall Study|Death|5|||
16815437|NCT01970007|37758145|FG000|Overall Study|Withdrawal by Subject|23|||
16815438|NCT01970007|37758145|FG000|Overall Study|Lost to Follow-up|24|||
16815439|NCT01970007|37758145|FG000|Overall Study|"Other endpoint"|3|||
16815440|NCT01728376|37758155|FG000|Overall Study|Adverse Event|1|||
16815441|NCT01728376|37758156|FG001|Overall Study|Adverse Event|1|||
16815442|NCT01728376|37758157|FG002|Overall Study|Adverse Event|1|||
16815443|NCT01728376|37758158|FG003|Overall Study|Adverse Event|1|||
16815444|NCT01728376|37758159|FG004|Overall Study|Adverse Event|1|||
16815445|NCT01728376|37758160|FG005|Overall Study|Adverse Event|0|||
16815446|NCT01728376|37758155|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
16815447|NCT01728376|37758156|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
16815448|NCT01728376|37758157|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
16815449|NCT01728376|37758158|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
16815450|NCT01728376|37758159|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
16815451|NCT01728376|37758160|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
16815452|NCT01728376|37758155|FG000|Overall Study|No relevant bacteria|2|||
16815453|NCT01728376|37758156|FG001|Overall Study|No relevant bacteria|0|||
16815454|NCT01728376|37758157|FG002|Overall Study|No relevant bacteria|0|||
16815455|NCT01728376|37758158|FG003|Overall Study|No relevant bacteria|0|||
16815456|NCT01728376|37758159|FG004|Overall Study|No relevant bacteria|1|||
16815457|NCT01728376|37758160|FG005|Overall Study|No relevant bacteria|1|||
16815458|NCT01728376|37758155|FG000|Overall Study|Did not receive treatment|0|||
16815459|NCT01728376|37758156|FG001|Overall Study|Did not receive treatment|1|||
16815460|NCT01728376|37758157|FG002|Overall Study|Did not receive treatment|0|||
16815461|NCT01728376|37758158|FG003|Overall Study|Did not receive treatment|0|||
16815462|NCT01728376|37758159|FG004|Overall Study|Did not receive treatment|0|||
16815463|NCT01728376|37758160|FG005|Overall Study|Did not receive treatment|0|||
16815464|NCT01728376|37758155|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
16815465|NCT01728376|37758156|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
16815466|NCT01728376|37758157|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
16815467|NCT01728376|37758158|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
16815468|NCT01728376|37758159|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
16815469|NCT01728376|37758160|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
16815470|NCT01708174|37758177|FG000|Treatment Period|Withdrawal by Subject|1|||
16815471|NCT01708174|37758178|FG001|Treatment Period|Withdrawal by Subject|0|||
16815472|NCT01708174|37758179|FG002|Treatment Period|Withdrawal by Subject|0|||
16815473|NCT01708174|37758177|FG000|Treatment Period|Progressive disease|0|||
16815474|NCT01708174|37758178|FG001|Treatment Period|Progressive disease|1|||
16815475|NCT01708174|37758179|FG002|Treatment Period|Progressive disease|0|||
16815476|NCT01708174|37758177|FG000|Treatment Period|Death|0|||
16815477|NCT01708174|37758178|FG001|Treatment Period|Death|0|||
16815478|NCT01708174|37758179|FG002|Treatment Period|Death|1|||
16815479|NCT01708174|37758177|FG000|Treatment Period|Adverse Event|0|||
16815480|NCT01708174|37758178|FG001|Treatment Period|Adverse Event|1|||
16815481|NCT01708174|37758179|FG002|Treatment Period|Adverse Event|0|||
16815482|NCT02488759|37758194|FG000|Overall Study|Disease progression|74|||
16815483|NCT02488759|37758195|FG001|Overall Study|Disease progression|110|||
16815484|NCT02488759|37758196|FG002|Overall Study|Disease progression|62|||
16815485|NCT02488759|37758197|FG003|Overall Study|Disease progression|7|||
16815486|NCT02488759|37758198|FG004|Overall Study|Disease progression|4|||
16815487|NCT02488759|37758199|FG005|Overall Study|Disease progression|2|||
16815488|NCT02488759|37758194|FG000|Overall Study|Study drug toxicity|11|||
16815489|NCT02488759|37758195|FG001|Overall Study|Study drug toxicity|33|||
16815490|NCT02488759|37758196|FG002|Overall Study|Study drug toxicity|31|||
16815491|NCT02488759|37758197|FG003|Overall Study|Study drug toxicity|0|||
16815492|NCT02488759|37758198|FG004|Overall Study|Study drug toxicity|0|||
16815493|NCT02488759|37758199|FG005|Overall Study|Study drug toxicity|2|||
16815494|NCT02488759|37758194|FG000|Overall Study|Adverse event unrelated to study drug|9|||
16815495|NCT02488759|37758195|FG001|Overall Study|Adverse event unrelated to study drug|11|||
16815496|NCT02488759|37758196|FG002|Overall Study|Adverse event unrelated to study drug|7|||
16815497|NCT02488759|37758197|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16815498|NCT02488759|37758198|FG004|Overall Study|Adverse event unrelated to study drug|1|||
16815499|NCT02488759|37758199|FG005|Overall Study|Adverse event unrelated to study drug|0|||
16815500|NCT02488759|37758194|FG000|Overall Study|Participant request to discontinue study treatment|7|||
16815501|NCT02488759|37758195|FG001|Overall Study|Participant request to discontinue study treatment|8|||
16815502|NCT02488759|37758196|FG002|Overall Study|Participant request to discontinue study treatment|4|||
16815503|NCT02488759|37758197|FG003|Overall Study|Participant request to discontinue study treatment|0|||
16815504|NCT02488759|37758198|FG004|Overall Study|Participant request to discontinue study treatment|0|||
16815505|NCT02488759|37758199|FG005|Overall Study|Participant request to discontinue study treatment|0|||
16815506|NCT02488759|37758194|FG000|Overall Study|Withdrawal by Subject|2|||
16815507|NCT02488759|37758195|FG001|Overall Study|Withdrawal by Subject|0|||
16815508|NCT02488759|37758196|FG002|Overall Study|Withdrawal by Subject|3|||
16815509|NCT02488759|37758197|FG003|Overall Study|Withdrawal by Subject|0|||
16815510|NCT02488759|37758198|FG004|Overall Study|Withdrawal by Subject|0|||
16815511|NCT02488759|37758199|FG005|Overall Study|Withdrawal by Subject|2|||
16815512|NCT02488759|37758194|FG000|Overall Study|Lost to Follow-up|0|||
16815513|NCT02488759|37758195|FG001|Overall Study|Lost to Follow-up|1|||
16815514|NCT02488759|37758196|FG002|Overall Study|Lost to Follow-up|2|||
16815515|NCT02488759|37758197|FG003|Overall Study|Lost to Follow-up|0|||
16815516|NCT02488759|37758198|FG004|Overall Study|Lost to Follow-up|0|||
16815517|NCT02488759|37758199|FG005|Overall Study|Lost to Follow-up|0|||
16815518|NCT02488759|37758194|FG000|Overall Study|Maximum clinical benefit|3|||
16815519|NCT02488759|37758195|FG001|Overall Study|Maximum clinical benefit|0|||
16815520|NCT02488759|37758196|FG002|Overall Study|Maximum clinical benefit|1|||
16815521|NCT02488759|37758197|FG003|Overall Study|Maximum clinical benefit|0|||
16815522|NCT02488759|37758198|FG004|Overall Study|Maximum clinical benefit|0|||
16815523|NCT02488759|37758199|FG005|Overall Study|Maximum clinical benefit|0|||
16815524|NCT02488759|37758194|FG000|Overall Study|Completed treatment|0|||
16815525|NCT02488759|37758195|FG001|Overall Study|Completed treatment|0|||
16815526|NCT02488759|37758196|FG002|Overall Study|Completed treatment|0|||
16815527|NCT02488759|37758197|FG003|Overall Study|Completed treatment|0|||
16910550|NCT01543152|38019431|FG001|Overall Study|Withdrawal by Subject|2|||
16910551|NCT01543152|38019432|FG002|Overall Study|Withdrawal by Subject|0|||
16910552|NCT01543152|38019433|FG003|Overall Study|Withdrawal by Subject|0|||
16910553|NCT01543152|38019434|FG004|Overall Study|Withdrawal by Subject|0|||
16910554|NCT01590810|38019451|FG000|Overall Study|Physician Decision|0|||
16910555|NCT01590810|38019452|FG001|Overall Study|Physician Decision|1|||
16910556|NCT01590810|38019453|FG002|Overall Study|Physician Decision|1|||
16910557|NCT01590810|38019454|FG003|Overall Study|Physician Decision|0|||
16910558|NCT01590810|38019455|FG004|Overall Study|Physician Decision|0|||
16910559|NCT01542528|38019490|FG000|Overall Study|Lost to Follow-up|2|||
16910560|NCT01542528|38019491|FG001|Overall Study|Lost to Follow-up|1|||
16910561|NCT01542528|38019490|FG000|Overall Study|Physician Decision|1|||
16910562|NCT01542528|38019491|FG001|Overall Study|Physician Decision|0|||
16910563|NCT01542528|38019490|FG000|Overall Study|Withdrawal by Subject|9|||
16910564|NCT01542528|38019491|FG001|Overall Study|Withdrawal by Subject|6|||
16910565|NCT01565148|38019501|FG000|Overall Study|Withdrawal by Subject|1|||
16910566|NCT01565148|38019502|FG001|Overall Study|Withdrawal by Subject|1|||
16910567|NCT01565148|38019503|FG002|Overall Study|Withdrawal by Subject|1|||
16910568|NCT01565148|38019504|FG003|Overall Study|Withdrawal by Subject|2|||
16910569|NCT01565148|38019501|FG000|Overall Study|Lost to Follow-up|4|||
16910570|NCT01565148|38019502|FG001|Overall Study|Lost to Follow-up|4|||
16910571|NCT01565148|38019503|FG002|Overall Study|Lost to Follow-up|0|||
16910572|NCT01565148|38019504|FG003|Overall Study|Lost to Follow-up|3|||
16910573|NCT01565148|38019501|FG000|Overall Study|Rescue Therapy|8|||
16910574|NCT01565148|38019502|FG001|Overall Study|Rescue Therapy|5|||
16910575|NCT01565148|38019503|FG002|Overall Study|Rescue Therapy|5|||
16910576|NCT01565148|38019504|FG003|Overall Study|Rescue Therapy|8|||
16910577|NCT01565148|38019501|FG000|Overall Study|Death|0|||
16910578|NCT01565148|38019502|FG001|Overall Study|Death|0|||
16910579|NCT01565148|38019503|FG002|Overall Study|Death|1|||
16910580|NCT01565148|38019504|FG003|Overall Study|Death|0|||
16910581|NCT01565148|38019501|FG000|Overall Study|Physician Decision|2|||
16910582|NCT01565148|38019502|FG001|Overall Study|Physician Decision|5|||
16910583|NCT01565148|38019503|FG002|Overall Study|Physician Decision|0|||
16910584|NCT01565148|38019504|FG003|Overall Study|Physician Decision|0|||
16910585|NCT01564758|38019518|FG000|Overall Study|Death|8|||
16910586|NCT01564758|38019518|FG000|Overall Study|Adverse Event|3|||
16910587|NCT01564758|38019518|FG000|Overall Study|Other|3|||
16910588|NCT01541826|38019525|FG000|Overall Study|Lost to Follow-up|2|||
16910589|NCT01541826|38019526|FG001|Overall Study|Lost to Follow-up|3|||
16910590|NCT01541826|38019527|FG002|Overall Study|Lost to Follow-up|0|||
16910591|NCT01541826|38019525|FG000|Overall Study|Withdrawal by Subject|2|||
16910592|NCT01541826|38019526|FG001|Overall Study|Withdrawal by Subject|0|||
16910593|NCT01541826|38019527|FG002|Overall Study|Withdrawal by Subject|0|||
16910594|NCT01541748|38019535|FG000|Overall Study|Lost to Follow-up|17|||
16910595|NCT01541748|38019535|FG000|Overall Study|Moved out of state|1|||
16910596|NCT01541748|38019535|FG000|Overall Study|Withdrawal by Subject|7|||
16815528|NCT02488759|37758198|FG004|Overall Study|Completed treatment|0|||
16815529|NCT02488759|37758199|FG005|Overall Study|Completed treatment|116|||
16815530|NCT02488759|37758194|FG000|Overall Study|Other reasons|5|||
16815531|NCT02488759|37758195|FG001|Overall Study|Other reasons|32|||
16815532|NCT02488759|37758196|FG002|Overall Study|Other reasons|21|||
16815533|NCT02488759|37758197|FG003|Overall Study|Other reasons|1|||
16815534|NCT02488759|37758198|FG004|Overall Study|Other reasons|1|||
16815535|NCT02488759|37758199|FG005|Overall Study|Other reasons|1|||
16815536|NCT01605916|37758218|FG000|Overall Study|Adverse Event|1|||
16815537|NCT01605916|37758219|FG001|Overall Study|Adverse Event|0|||
16815538|NCT01605916|37758220|FG002|Overall Study|Adverse Event|0|||
16815539|NCT01605916|37758221|FG003|Overall Study|Adverse Event|1|||
16815540|NCT01605916|37758222|FG004|Overall Study|Adverse Event|0|||
16815541|NCT01605916|37758218|FG000|Overall Study|Lack of Efficacy|2|||
16815542|NCT01605916|37758219|FG001|Overall Study|Lack of Efficacy|3|||
16815543|NCT01605916|37758220|FG002|Overall Study|Lack of Efficacy|3|||
16815544|NCT01605916|37758221|FG003|Overall Study|Lack of Efficacy|5|||
16815545|NCT01605916|37758222|FG004|Overall Study|Lack of Efficacy|4|||
16815546|NCT01605916|37758218|FG000|Overall Study|Withdrawal by Subject|1|||
16815547|NCT01605916|37758219|FG001|Overall Study|Withdrawal by Subject|1|||
16815548|NCT01605916|37758220|FG002|Overall Study|Withdrawal by Subject|0|||
16815549|NCT01605916|37758221|FG003|Overall Study|Withdrawal by Subject|0|||
16815550|NCT01605916|37758222|FG004|Overall Study|Withdrawal by Subject|2|||
16815551|NCT01635283|37758235|FG000|Overall Study|Tumor Progression|3|||
16815552|NCT01635283|37758235|FG000|Overall Study|Lost to Follow-up|1|||
16815553|NCT01707004|37758242|FG000|Overall Study|Physician Decision|3|||
16815554|NCT03759379|37758250|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
16815555|NCT03759379|37758251|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
16815556|NCT03759379|37758250|FG000|Treatment Period|Death|2|||
16815557|NCT03759379|37758251|FG001|Treatment Period|Death|3|||
16815558|NCT03759379|37758250|FG000|Treatment Period|Lost to Follow-up|1|||
16815559|NCT03759379|37758251|FG001|Treatment Period|Lost to Follow-up|0|||
16815560|NCT03759379|37758250|FG000|Treatment Period|Physician Decision|0|||
16815561|NCT03759379|37758251|FG001|Treatment Period|Physician Decision|1|||
16815562|NCT01939197|37758264|FG000|Overall Study|Withdrawal by Subject|1|||
16815563|NCT01939197|37758265|FG001|Overall Study|Withdrawal by Subject|0|||
16815564|NCT01939197|37758266|FG002|Overall Study|Withdrawal by Subject|0|||
16815565|NCT01939197|37758267|FG003|Overall Study|Withdrawal by Subject|0|||
16815566|NCT01939197|37758268|FG004|Overall Study|Withdrawal by Subject|1|||
16815567|NCT01939197|37758269|FG005|Overall Study|Withdrawal by Subject|0|||
16815568|NCT01939197|37758270|FG006|Overall Study|Withdrawal by Subject|0|||
16815569|NCT01939197|37758264|FG000|Overall Study|Lost to Follow-up|0|||
16815570|NCT01939197|37758265|FG001|Overall Study|Lost to Follow-up|1|||
16815571|NCT01939197|37758266|FG002|Overall Study|Lost to Follow-up|0|||
16815572|NCT01939197|37758267|FG003|Overall Study|Lost to Follow-up|1|||
16815573|NCT01939197|37758268|FG004|Overall Study|Lost to Follow-up|3|||
16815574|NCT01939197|37758269|FG005|Overall Study|Lost to Follow-up|1|||
16815575|NCT01939197|37758270|FG006|Overall Study|Lost to Follow-up|2|||
16815576|NCT01969851|37758303|FG000|Overall Study|Adverse Event|0|||
16815577|NCT01969851|37758304|FG001|Overall Study|Adverse Event|0|||
16815578|NCT01969851|37758305|FG002|Overall Study|Adverse Event|3|||
16815579|NCT01969851|37758303|FG000|Overall Study|Lack of Efficacy|0|||
16815580|NCT01969851|37758304|FG001|Overall Study|Lack of Efficacy|3|||
16815581|NCT01969851|37758305|FG002|Overall Study|Lack of Efficacy|1|||
16815582|NCT01969851|37758303|FG000|Overall Study|Withdrawal by Subject|1|||
16815583|NCT01969851|37758304|FG001|Overall Study|Withdrawal by Subject|0|||
16815584|NCT01969851|37758305|FG002|Overall Study|Withdrawal by Subject|1|||
16815585|NCT01969851|37758303|FG000|Overall Study|No effective dose in Titration period|0|||
16815586|NCT01969851|37758304|FG001|Overall Study|No effective dose in Titration period|0|||
16815587|NCT01969851|37758305|FG002|Overall Study|No effective dose in Titration period|1|||
16815588|NCT01969851|37758303|FG000|Overall Study|Sponsor decision|0|||
16815589|NCT01969851|37758304|FG001|Overall Study|Sponsor decision|0|||
16815590|NCT01969851|37758305|FG002|Overall Study|Sponsor decision|1|||
16815591|NCT01938573|37758313|FG000|Overall Study|Lack of Efficacy|1|||
16815592|NCT01938573|37758314|FG001|Overall Study|Lack of Efficacy|0|||
16815593|NCT01938573|37758313|FG000|Overall Study|Operation at other hospital|1|||
16815594|NCT01938573|37758314|FG001|Overall Study|Operation at other hospital|0|||
16815595|NCT01937871|37758322|FG000|Overall Study|Adverse Event|6|||
16815596|NCT01937871|37758323|FG001|Overall Study|Adverse Event|6|||
16815597|NCT01937871|37758324|FG002|Overall Study|Adverse Event|2|||
16815598|NCT01937871|37758322|FG000|Overall Study|Lost to Follow-up|8|||
16815599|NCT01937871|37758323|FG001|Overall Study|Lost to Follow-up|2|||
16815600|NCT01937871|37758324|FG002|Overall Study|Lost to Follow-up|4|||
16815601|NCT01937871|37758322|FG000|Overall Study|Withdrawal by Subject|9|||
16815602|NCT01937871|37758323|FG001|Overall Study|Withdrawal by Subject|6|||
16815603|NCT01937871|37758324|FG002|Overall Study|Withdrawal by Subject|4|||
16815604|NCT01937871|37758322|FG000|Overall Study|Physician Decision|0|||
16815605|NCT01937871|37758323|FG001|Overall Study|Physician Decision|1|||
16815606|NCT01937871|37758324|FG002|Overall Study|Physician Decision|0|||
16815607|NCT01937871|37758322|FG000|Overall Study|Entry Criteria Not Met|1|||
16815608|NCT01937871|37758323|FG001|Overall Study|Entry Criteria Not Met|2|||
16815609|NCT01937871|37758324|FG002|Overall Study|Entry Criteria Not Met|1|||
16815610|NCT01942135|37758337|FG000|Overall Study|Adverse Event|9|||
16815611|NCT01942135|37758338|FG001|Overall Study|Adverse Event|3|||
16815612|NCT01942135|37758337|FG000|Overall Study|Global deterioration of health status|8|||
16815613|NCT01942135|37758338|FG001|Overall Study|Global deterioration of health status|3|||
16815614|NCT01942135|37758337|FG000|Overall Study|Randomized Not Treated|2|||
16815615|NCT01942135|37758338|FG001|Overall Study|Randomized Not Treated|2|||
16815616|NCT01942135|37758337|FG000|Overall Study|Death|0|||
16815617|NCT01942135|37758338|FG001|Overall Study|Death|1|||
16815618|NCT01942135|37758337|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
16815619|NCT01942135|37758338|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
16815620|NCT01942135|37758337|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
16815621|NCT01942135|37758338|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
16815622|NCT01942135|37758337|FG000|Overall Study|Withdrawal by Subject|4|||
16815623|NCT01942135|37758338|FG001|Overall Study|Withdrawal by Subject|2|||
16815624|NCT01942135|37758337|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
16815625|NCT01942135|37758338|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
16815626|NCT01269463|37758365|FG000|First Intervention|Withdrawal by Subject|1|||
16815627|NCT01269463|37758366|FG001|First Intervention|Withdrawal by Subject|0|||
16815628|NCT01269463|37758365|FG000|First Intervention|Adverse Event|1|||
16815629|NCT01269463|37758366|FG001|First Intervention|Adverse Event|0|||
16815630|NCT01269463|37758365|FG000|First Intervention|Lack of Efficacy|0|||
16815631|NCT01269463|37758366|FG001|First Intervention|Lack of Efficacy|1|||
16815632|NCT01269463|37758365|FG000|First Intervention|Physician Decision|0|||
16815633|NCT01269463|37758366|FG001|First Intervention|Physician Decision|1|||
16815634|NCT01706926|37758381|FG000|Overall Study|Lost to Follow-up|0|||
16815635|NCT01706926|37758382|FG001|Overall Study|Lost to Follow-up|0|||
16815636|NCT01706926|37758383|FG002|Overall Study|Lost to Follow-up|1|||
16815637|NCT01706926|37758384|FG003|Overall Study|Lost to Follow-up|0|||
16815638|NCT01706926|37758381|FG000|Overall Study|Withdrawal by Subject|2|||
16815639|NCT01706926|37758382|FG001|Overall Study|Withdrawal by Subject|0|||
16815640|NCT01706926|37758383|FG002|Overall Study|Withdrawal by Subject|1|||
16815641|NCT01706926|37758384|FG003|Overall Study|Withdrawal by Subject|2|||
16815642|NCT01706926|37758381|FG000|Overall Study|Other|4|||
16815643|NCT01706926|37758382|FG001|Overall Study|Other|4|||
16815644|NCT01706926|37758383|FG002|Overall Study|Other|4|||
16815645|NCT01706926|37758384|FG003|Overall Study|Other|3|||
16815646|NCT01634113|37758400|FG000|Overall Study|Not treated|0|||
16815647|NCT01634113|37758401|FG001|Overall Study|Not treated|0|||
16815648|NCT01634113|37758402|FG002|Overall Study|Not treated|1|||
16815649|NCT01706770|37758412|FG000|Overall Study|Lost to Follow-up|1|||
16815650|NCT01706770|37758413|FG001|Overall Study|Lost to Follow-up|0|||
16815651|NCT01706770|37758412|FG000|Overall Study|Physician Decision|1|||
16815652|NCT01706770|37758413|FG001|Overall Study|Physician Decision|0|||
16815653|NCT01937715|37758424|FG000|Overall Study|Death|0|||
16815654|NCT01937715|37758425|FG001|Overall Study|Death|0|||
16815655|NCT01937715|37758426|FG002|Overall Study|Death|0|||
16815656|NCT01937715|37758427|FG003|Overall Study|Death|1|||
16815657|NCT01937715|37758428|FG004|Overall Study|Death|0|||
16815658|NCT01937715|37758424|FG000|Overall Study|Withdrawal by Subject|0|||
16815659|NCT01937715|37758425|FG001|Overall Study|Withdrawal by Subject|1|||
16815660|NCT01937715|37758426|FG002|Overall Study|Withdrawal by Subject|0|||
16815661|NCT01937715|37758427|FG003|Overall Study|Withdrawal by Subject|0|||
16815662|NCT01937715|37758428|FG004|Overall Study|Withdrawal by Subject|2|||
16815663|NCT01937715|37758424|FG000|Overall Study|Other|0|||
16815664|NCT01937715|37758425|FG001|Overall Study|Other|0|||
16815665|NCT01937715|37758426|FG002|Overall Study|Other|0|||
16815666|NCT01937715|37758427|FG003|Overall Study|Other|3|||
16815667|NCT01937715|37758428|FG004|Overall Study|Other|0|||
16815668|NCT01937559|37758443|FG000|Overall Study|Physician Decision|3|||
16815669|NCT01937559|37758444|FG001|Overall Study|Physician Decision|3|||
16815670|NCT01937559|37758445|FG002|Overall Study|Physician Decision|0|||
16815671|NCT01937559|37758443|FG000|Overall Study|Withdrawal by Subject|6|||
16815672|NCT01937559|37758444|FG001|Overall Study|Withdrawal by Subject|4|||
16815673|NCT01937559|37758445|FG002|Overall Study|Withdrawal by Subject|0|||
16815674|NCT01937559|37758443|FG000|Overall Study|screen fail|2|||
16815675|NCT01937559|37758444|FG001|Overall Study|screen fail|4|||
16815676|NCT01937559|37758445|FG002|Overall Study|screen fail|0|||
16815677|NCT01960257|37758457|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
16815678|NCT01960257|37758458|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
16815679|NCT01960257|37758459|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
16815680|NCT01960257|37758457|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
16815681|NCT01960257|37758458|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
16815682|NCT01960257|37758459|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
16815683|NCT01960257|37758457|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
16815684|NCT01960257|37758458|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
16815685|NCT01960257|37758459|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
16815686|NCT01918371|37758471|FG000|Overall Study|Missing Data|1|||
16815687|NCT01918371|37758472|FG001|Overall Study|Missing Data|1|||
16815688|NCT01917747|37758480|FG000|Overall Study|Withdrawal by Subject|1|||
16815689|NCT01917747|37758481|FG001|Overall Study|Withdrawal by Subject|2|||
16815690|NCT01917747|37758480|FG000|Overall Study|Lost to Follow-up|18|||
16815691|NCT01917747|37758481|FG001|Overall Study|Lost to Follow-up|9|||
16815692|NCT01597791|37758493|FG000|Overall Study|Physician Decision|2|||
16815693|NCT01597791|37758494|FG001|Overall Study|Physician Decision|1|||
16815694|NCT01597791|37758493|FG000|Overall Study|Cesarean Section|6|||
16815695|NCT01597791|37758494|FG001|Overall Study|Cesarean Section|7|||
16815696|NCT01597791|37758493|FG000|Overall Study|Subject withdrawal|0|||
16815697|NCT01597791|37758494|FG001|Overall Study|Subject withdrawal|1|||
16815698|NCT01597791|37758493|FG000|Overall Study|Protocol Violation|0|||
16815699|NCT01597791|37758494|FG001|Overall Study|Protocol Violation|1|||
16815700|NCT01916967|37758503|FG000|Overall Study|Adverse Event|0|||
16815701|NCT01916967|37758504|FG001|Overall Study|Adverse Event|0|||
16815702|NCT01916967|37758505|FG002|Overall Study|Adverse Event|2|||
16815703|NCT01916967|37758503|FG000|Overall Study|Lack of Efficacy|0|||
16815704|NCT01916967|37758504|FG001|Overall Study|Lack of Efficacy|0|||
16815705|NCT01916967|37758505|FG002|Overall Study|Lack of Efficacy|6|||
16815706|NCT01916967|37758503|FG000|Overall Study|Physician Decision|0|||
16815707|NCT01916967|37758504|FG001|Overall Study|Physician Decision|0|||
16815708|NCT01916967|37758505|FG002|Overall Study|Physician Decision|1|||
16815709|NCT01916967|37758503|FG000|Overall Study|Protocol Violation|0|||
16815710|NCT01916967|37758504|FG001|Overall Study|Protocol Violation|1|||
16815711|NCT01916967|37758505|FG002|Overall Study|Protocol Violation|0|||
16815712|NCT01936623|37758517|FG000|Overall Study|Lost to Follow-up|0|||
16815713|NCT01936623|37758518|FG001|Overall Study|Lost to Follow-up|5|||
16815714|NCT01959243|37758526|FG000|Overall Study|Investigator Decision|3|||
16815715|NCT01959243|37758527|FG001|Overall Study|Investigator Decision|0|||
16815716|NCT01959243|37758526|FG000|Overall Study|Adverse Event|5|||
16815717|NCT01959243|37758527|FG001|Overall Study|Adverse Event|2|||
16815718|NCT01959243|37758526|FG000|Overall Study|Administrative reasons|2|||
16815719|NCT01959243|37758527|FG001|Overall Study|Administrative reasons|1|||
16815720|NCT01959243|37758526|FG000|Overall Study|Lost to Follow-up|3|||
16815721|NCT01959243|37758527|FG001|Overall Study|Lost to Follow-up|1|||
16815722|NCT01959165|37758537|FG000|Overall Study|Adverse Event|0|||
16815723|NCT01959165|37758538|FG001|Overall Study|Adverse Event|0|||
16815724|NCT01959165|37758539|FG002|Overall Study|Adverse Event|0|||
16815725|NCT01959165|37758540|FG003|Overall Study|Adverse Event|1|||
16815726|NCT01959165|37758537|FG000|Overall Study|Lack of Efficacy|1|||
16815727|NCT01959165|37758538|FG001|Overall Study|Lack of Efficacy|0|||
16815728|NCT01959165|37758539|FG002|Overall Study|Lack of Efficacy|0|||
16815729|NCT01959165|37758540|FG003|Overall Study|Lack of Efficacy|0|||
16815730|NCT01959165|37758537|FG000|Overall Study|overdose|0|||
16815731|NCT01959165|37758538|FG001|Overall Study|overdose|0|||
16815732|NCT01959165|37758539|FG002|Overall Study|overdose|0|||
16815733|NCT01959165|37758540|FG003|Overall Study|overdose|1|||
16815734|NCT01959165|37758537|FG000|Overall Study|Welfare recipient|0|||
16815735|NCT01959165|37758538|FG001|Overall Study|Welfare recipient|1|||
16815736|NCT01959165|37758539|FG002|Overall Study|Welfare recipient|0|||
16815737|NCT01959165|37758540|FG003|Overall Study|Welfare recipient|0|||
16815738|NCT01916109|37758550|FG000|Overall Study|Withdrawal by Subject|1|||
16815739|NCT01915095|37758561|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
16815740|NCT01915095|37758562|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
16815741|NCT01915095|37758563|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
16815742|NCT01915095|37758564|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
16815743|NCT01915095|37758565|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
16815744|NCT01958619|37758590|FG000|Overall Study|Protocol Violation|2|||
16815745|NCT01958619|37758591|FG001|Overall Study|Protocol Violation|0|||
16815746|NCT01958619|37758592|FG002|Overall Study|Protocol Violation|1|||
16815747|NCT01958619|37758593|FG003|Overall Study|Protocol Violation|0|||
16815748|NCT01752634|37758609|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
16815749|NCT01752634|37758610|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
16815750|NCT01752634|37758611|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
16815751|NCT01752634|37758612|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
16815752|NCT01752634|37758613|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
16815753|NCT01752634|37758614|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
16815754|NCT01752634|37758609|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16815755|NCT01752634|37758610|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
16815756|NCT01752634|37758611|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16815757|NCT01752634|37758612|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16815758|NCT01752634|37758613|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16815759|NCT01752634|37758614|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16815760|NCT01752634|37758609|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
16815761|NCT01752634|37758610|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
16815762|NCT01752634|37758611|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
16815763|NCT01752634|37758612|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
16815764|NCT01752634|37758613|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
16815765|NCT01752634|37758614|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
16815766|NCT01752634|37758609|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
16815767|NCT01752634|37758610|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
16815768|NCT01752634|37758611|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
16815769|NCT01752634|37758612|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
16815770|NCT01752634|37758613|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
16815771|NCT01752634|37758614|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
16815772|NCT01752634|37758609|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
16815773|NCT01752634|37758610|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
16815774|NCT01752634|37758611|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
16815775|NCT01752634|37758612|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
16815776|NCT01752634|37758613|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
16815777|NCT01752634|37758614|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
16815778|NCT01752634|37758609|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
16815779|NCT01752634|37758610|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
16815780|NCT01752634|37758611|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
16815781|NCT01752634|37758612|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
16815782|NCT01752634|37758613|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
16815783|NCT01752634|37758614|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
16815784|NCT01752634|37758609|FG000|Week 24 to Week 260|Physician Decision|1|||
16815785|NCT01752634|37758610|FG001|Week 24 to Week 260|Physician Decision|2|||
16815786|NCT01752634|37758611|FG002|Week 24 to Week 260|Physician Decision|4|||
16815787|NCT01752634|37758612|FG003|Week 24 to Week 260|Physician Decision|2|||
16815788|NCT01752634|37758613|FG004|Week 24 to Week 260|Physician Decision|1|||
16815789|NCT01752634|37758614|FG005|Week 24 to Week 260|Physician Decision|0|||
16815790|NCT01752634|37758609|FG000|Week 24 to Week 260|Death|0|||
16815791|NCT01752634|37758610|FG001|Week 24 to Week 260|Death|1|||
16815792|NCT01752634|37758611|FG002|Week 24 to Week 260|Death|0|||
16815793|NCT01752634|37758612|FG003|Week 24 to Week 260|Death|0|||
16815794|NCT01752634|37758613|FG004|Week 24 to Week 260|Death|0|||
16815795|NCT01752634|37758614|FG005|Week 24 to Week 260|Death|0|||
16815796|NCT01752634|37758609|FG000|Week 24 to Week 260|Pregnancy|0|||
16815797|NCT01752634|37758610|FG001|Week 24 to Week 260|Pregnancy|0|||
16815798|NCT01752634|37758611|FG002|Week 24 to Week 260|Pregnancy|1|||
16815799|NCT01752634|37758612|FG003|Week 24 to Week 260|Pregnancy|0|||
16815800|NCT01752634|37758613|FG004|Week 24 to Week 260|Pregnancy|0|||
16815801|NCT01752634|37758614|FG005|Week 24 to Week 260|Pregnancy|0|||
16815802|NCT01752634|37758609|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
16815803|NCT01752634|37758610|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
16815804|NCT01752634|37758611|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
16815805|NCT01752634|37758612|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
16815806|NCT01752634|37758613|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
16815807|NCT01752634|37758614|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
16815808|NCT01752634|37758609|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
16815809|NCT01752634|37758610|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
16815810|NCT01752634|37758611|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
16815811|NCT01752634|37758612|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
16815812|NCT01752634|37758613|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
16815813|NCT01752634|37758614|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
16815814|NCT01752634|37758609|FG000|Week 24 to Week 260|Adverse Event|4|||
16815815|NCT01752634|37758610|FG001|Week 24 to Week 260|Adverse Event|8|||
16815816|NCT01752634|37758611|FG002|Week 24 to Week 260|Adverse Event|8|||
16815817|NCT01752634|37758612|FG003|Week 24 to Week 260|Adverse Event|4|||
16815818|NCT01752634|37758613|FG004|Week 24 to Week 260|Adverse Event|2|||
16815819|NCT01752634|37758614|FG005|Week 24 to Week 260|Adverse Event|0|||
16815820|NCT01933113|37758624|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
16815821|NCT01726270|37758628|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
16815822|NCT01726270|37758628|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
16815823|NCT01726270|37758628|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
16815824|NCT01726270|37758628|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
16815825|NCT01726270|37758628|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
16815826|NCT01726270|37758628|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
16815827|NCT00942331|37758636|FG000|Overall Study|Did not start treatment|15|||
16815828|NCT00942331|37758637|FG001|Overall Study|Did not start treatment|22|||
16815829|NCT01914393|37758646|FG000|Overall Study|Protocol Violation|11|||
16815830|NCT01914393|37758647|FG001|Overall Study|Protocol Violation|3|||
16815831|NCT01914393|37758648|FG002|Overall Study|Protocol Violation|19|||
16815832|NCT01914393|37758646|FG000|Overall Study|Lack of Efficacy|11|||
16910597|NCT01541748|38019535|FG000|Overall Study|Screen failure|5|||
16815833|NCT01914393|37758647|FG001|Overall Study|Lack of Efficacy|16|||
16815834|NCT01914393|37758648|FG002|Overall Study|Lack of Efficacy|5|||
16815835|NCT01914393|37758646|FG000|Overall Study|no reason given|14|||
16815836|NCT01914393|37758647|FG001|Overall Study|no reason given|8|||
16815837|NCT01914393|37758648|FG002|Overall Study|no reason given|16|||
16815838|NCT01914393|37758646|FG000|Overall Study|Adverse Event|29|||
16815839|NCT01914393|37758647|FG001|Overall Study|Adverse Event|18|||
16815840|NCT01914393|37758648|FG002|Overall Study|Adverse Event|31|||
16815841|NCT01914393|37758646|FG000|Overall Study|Withdrawal by Subject|38|||
16815842|NCT01914393|37758647|FG001|Overall Study|Withdrawal by Subject|20|||
16815843|NCT01914393|37758648|FG002|Overall Study|Withdrawal by Subject|47|||
16815844|NCT01914393|37758646|FG000|Overall Study|Lost to Follow-up|12|||
16815845|NCT01914393|37758647|FG001|Overall Study|Lost to Follow-up|6|||
16815846|NCT01914393|37758648|FG002|Overall Study|Lost to Follow-up|19|||
16815847|NCT01914393|37758646|FG000|Overall Study|subject never dosed|0|||
16815848|NCT01914393|37758647|FG001|Overall Study|subject never dosed|0|||
16815849|NCT01914393|37758648|FG002|Overall Study|subject never dosed|1|||
16815850|NCT01931865|37758660|FG000|Overall Study|Lost to Follow-up|2|||
16815851|NCT01931865|37758660|FG000|Overall Study|Withdrawal by Subject|2|||
16815852|NCT01617447|37758667|FG000|Overall Study|Adverse Event|0|||
16910598|NCT01541748|38019535|FG000|Overall Study|Did not receive study device|1|||
16910599|NCT01589094|38019548|FG000|Overall Study|Did not receive treatment|2|||
16910600|NCT01563978|38019554|FG000|Overall Study|Physician Decision|1|||
16910601|NCT01563978|38019555|FG001|Overall Study|Physician Decision|0|||
16910602|NCT01563978|38019554|FG000|Overall Study|Lost to Follow-up|1|||
16910603|NCT01563978|38019555|FG001|Overall Study|Lost to Follow-up|0|||
16910604|NCT01563978|38019554|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
16910605|NCT01563978|38019555|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
16910606|NCT01563978|38019554|FG000|Overall Study|Adverse Event|1|||
16910607|NCT01563978|38019555|FG001|Overall Study|Adverse Event|2|||
16910608|NCT01563354|38019564|FG000|Core Phase|Adverse Event|5|||
16910609|NCT01563354|38019565|FG001|Core Phase|Adverse Event|15|||
16910610|NCT01563354|38019566|FG002|Core Phase|Adverse Event|13|||
16910611|NCT01563354|38019564|FG000|Core Phase|Withdrawal by Subject|1|||
16910612|NCT01563354|38019565|FG001|Core Phase|Withdrawal by Subject|0|||
16910613|NCT01563354|38019566|FG002|Core Phase|Withdrawal by Subject|3|||
16910614|NCT01563354|38019564|FG000|Core Phase|Lost to Follow-up|1|||
16910615|NCT01563354|38019565|FG001|Core Phase|Lost to Follow-up|0|||
16910616|NCT01563354|38019566|FG002|Core Phase|Lost to Follow-up|0|||
16910617|NCT01563354|38019564|FG000|Core Phase|Death|1|||
16910618|NCT01563354|38019565|FG001|Core Phase|Death|5|||
16910619|NCT01563354|38019566|FG002|Core Phase|Death|2|||
16910620|NCT01563354|38019564|FG000|Core Phase|Diseasse progression|18|||
16910621|NCT01563354|38019565|FG001|Core Phase|Diseasse progression|7|||
16910622|NCT01563354|38019566|FG002|Core Phase|Diseasse progression|8|||
16910623|NCT01563354|38019564|FG000|Core Phase|Protocol deviation|2|||
16910624|NCT01563354|38019565|FG001|Core Phase|Protocol deviation|0|||
16910625|NCT01563354|38019566|FG002|Core Phase|Protocol deviation|0|||
16910626|NCT01563354|38019564|FG000|Core Phase|PI decision - did not enter extension|0|||
16910627|NCT01563354|38019565|FG001|Core Phase|PI decision - did not enter extension|1|||
16910628|NCT01563354|38019566|FG002|Core Phase|PI decision - did not enter extension|0|||
16910629|NCT01563354|38019564|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
16910630|NCT01563354|38019565|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
16910631|NCT01563354|38019566|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
16910632|NCT01563354|38019564|FG000|Extension Phase|Adverse Event|0|||
16910633|NCT01563354|38019565|FG001|Extension Phase|Adverse Event|3|||
16910634|NCT01563354|38019566|FG002|Extension Phase|Adverse Event|2|||
16910635|NCT01563354|38019564|FG000|Extension Phase|Withdrawal by Subject|0|||
16910636|NCT01563354|38019565|FG001|Extension Phase|Withdrawal by Subject|1|||
16910637|NCT01563354|38019566|FG002|Extension Phase|Withdrawal by Subject|0|||
16910638|NCT01563354|38019564|FG000|Extension Phase|Administration problems|3|||
16910639|NCT01563354|38019565|FG001|Extension Phase|Administration problems|2|||
16910640|NCT01563354|38019566|FG002|Extension Phase|Administration problems|3|||
16910641|NCT01563354|38019564|FG000|Extension Phase|Disease progression|9|||
16910642|NCT01563354|38019565|FG001|Extension Phase|Disease progression|8|||
16910643|NCT01563354|38019566|FG002|Extension Phase|Disease progression|10|||
16910644|NCT01588548|38019580|FG000|Overall Study|Withdrawal by Subject|0|||
16815853|NCT01617447|37758668|FG001|Overall Study|Adverse Event|1|||
16910645|NCT01588548|38019581|FG001|Overall Study|Withdrawal by Subject|1|||
16910646|NCT01588548|38019582|FG002|Overall Study|Withdrawal by Subject|1|||
16910647|NCT01588548|38019583|FG003|Overall Study|Withdrawal by Subject|1|||
16910648|NCT01588548|38019584|FG004|Overall Study|Withdrawal by Subject|2|||
16910649|NCT01588548|38019585|FG005|Overall Study|Withdrawal by Subject|3|||
16910650|NCT01588548|38019580|FG000|Overall Study|Adverse Event|0|||
16910651|NCT01588548|38019581|FG001|Overall Study|Adverse Event|0|||
16910652|NCT01588548|38019582|FG002|Overall Study|Adverse Event|1|||
16910653|NCT01588548|38019583|FG003|Overall Study|Adverse Event|2|||
16910654|NCT01588548|38019584|FG004|Overall Study|Adverse Event|1|||
16815854|NCT01617447|37758667|FG000|Overall Study|Physician Decision|0|||
16815855|NCT01617447|37758668|FG001|Overall Study|Physician Decision|2|||
16815856|NCT00432679|37758676|FG000|Overall Study|Adverse Event|2|||
16815857|NCT00432679|37758677|FG001|Overall Study|Adverse Event|1|||
16815858|NCT00432679|37758676|FG000|Overall Study|Withdrawal by Subject|3|||
16815859|NCT00432679|37758677|FG001|Overall Study|Withdrawal by Subject|2|||
16815860|NCT01600105|37758685|FG000|Total Participants|Withdrawal by Subject|1|||
16815861|NCT01600105|37758686|FG001|Total Participants|Withdrawal by Subject|0|||
16815862|NCT01600105|37758685|FG000|Total Participants|No images in PACS|10|||
16815863|NCT01600105|37758686|FG001|Total Participants|No images in PACS|0|||
16815864|NCT01600105|37758685|FG000|Total Participants|Insufficient image quality|30|||
16815865|NCT01600105|37758686|FG001|Total Participants|Insufficient image quality|10|||
16815866|NCT01600105|37758685|FG000|Sub Study I|Insufficient image quality|0|||
16815867|NCT01600105|37758686|FG001|Sub Study I|Insufficient image quality|10|||
16815868|NCT01600105|37758685|FG000|Sub Study II|Withdrawal by Subject|1|||
16815869|NCT01600105|37758686|FG001|Sub Study II|Withdrawal by Subject|0|||
16815870|NCT01600105|37758685|FG000|Sub Study II|No images in PACS|1|||
16815871|NCT01600105|37758686|FG001|Sub Study II|No images in PACS|0|||
16815872|NCT01600105|37758685|FG000|Sub Study II|Insufficient image quality|3|||
16815873|NCT01600105|37758686|FG001|Sub Study II|Insufficient image quality|0|||
16815874|NCT01600105|37758685|FG000|Sub Study III|Insufficient image quality|5|||
16815875|NCT01600105|37758686|FG001|Sub Study III|Insufficient image quality|0|||
16815876|NCT01600105|37758685|FG000|Sub Study V|Poor Image Quality|2|||
16815877|NCT01600105|37758686|FG001|Sub Study V|Poor Image Quality|0|||
16815878|NCT02246647|37758698|FG000|Overall Study|Withdrawal by Subject|1|||
16815879|NCT02246647|37758699|FG001|Overall Study|Withdrawal by Subject|1|||
16815880|NCT02244619|37758721|FG000|Overall Study|Did not receive study intervention|8|||
16815881|NCT02244619|37758722|FG001|Overall Study|Did not receive study intervention|21|||
16815882|NCT02243371|37758730|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
16815883|NCT02243371|37758731|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
16815884|NCT02243371|37758730|FG000|Overall Study|Death (unrelated)|2|||
16815885|NCT02243371|37758731|FG001|Overall Study|Death (unrelated)|4|||
16815886|NCT02243371|37758730|FG000|Overall Study|Adverse Event (unrelated)|0|||
16815887|NCT02243371|37758731|FG001|Overall Study|Adverse Event (unrelated)|1|||
16815888|NCT02243371|37758730|FG000|Overall Study|Lack of Clinical Benefit|0|||
16815889|NCT02243371|37758731|FG001|Overall Study|Lack of Clinical Benefit|1|||
16815890|NCT02243371|37758730|FG000|Overall Study|Withdrawal by Subject|0|||
16815891|NCT02243371|37758731|FG001|Overall Study|Withdrawal by Subject|2|||
16815892|NCT01931475|37758739|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
16815893|NCT01931475|37758740|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
16815894|NCT01931475|37758739|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
16815895|NCT01931475|37758740|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
16815896|NCT01931475|37758739|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
16815897|NCT01931475|37758740|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
16815898|NCT01931475|37758739|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
16815899|NCT01931475|37758740|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
16815900|NCT01931475|37758739|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
16815901|NCT01931475|37758740|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
16815902|NCT01931475|37758739|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
16815903|NCT01931475|37758740|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
16815904|NCT01931475|37758739|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
16815905|NCT01931475|37758740|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
16815906|NCT01931475|37758739|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
16815907|NCT01931475|37758740|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
16815908|NCT01931475|37758739|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
16815909|NCT01931475|37758740|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
16815910|NCT01931475|37758739|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
16815911|NCT01931475|37758740|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
16815912|NCT01931475|37758739|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
16815913|NCT01931475|37758740|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
16815914|NCT01931397|37758751|FG000|Overall Study|Physician Decision|2|||
16815915|NCT01931397|37758751|FG000|Overall Study|Withdrawal by Subject|8|||
16815916|NCT01931397|37758751|FG000|Overall Study|moved out of state|1|||
16815917|NCT01929993|37758761|FG000|Overall Study|Protocol Violation|4|||
16815918|NCT01929993|37758762|FG001|Overall Study|Protocol Violation|6|||
16815919|NCT01929993|37758761|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
16815920|NCT01929993|37758762|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
16815921|NCT01912599|37758770|FG000|Overall Study|Withdrawal by Subject|0|||
16815922|NCT01912599|37758771|FG001|Overall Study|Withdrawal by Subject|1|||
16815923|NCT01929681|37758779|FG000|Overall Study|Withdrawal by Subject|1|||
16815924|NCT01929681|37758780|FG001|Overall Study|Withdrawal by Subject|0|||
16815925|NCT01929681|37758779|FG000|Overall Study|Physician Decision|1|||
16815926|NCT01929681|37758780|FG001|Overall Study|Physician Decision|1|||
16815927|NCT01646177|37758790|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
16815928|NCT01646177|37758791|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
16815929|NCT01646177|37758792|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
16815930|NCT01646177|37758793|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
16815931|NCT01646177|37758794|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16815932|NCT01646177|37758795|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16815933|NCT01646177|37758796|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16815934|NCT01646177|37758797|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16815935|NCT01646177|37758798|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16815936|NCT01646177|37758799|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16815937|NCT01646177|37758800|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16815938|NCT01646177|37758801|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16815939|NCT01646177|37758790|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
16815940|NCT01646177|37758791|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
16815941|NCT01646177|37758792|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
16815942|NCT01646177|37758793|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
16815943|NCT01646177|37758794|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16815944|NCT01646177|37758795|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16815945|NCT01646177|37758796|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16815946|NCT01646177|37758797|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16815947|NCT01646177|37758798|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16815948|NCT01646177|37758799|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16815949|NCT01646177|37758800|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16815950|NCT01646177|37758801|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16815951|NCT01646177|37758790|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
16815952|NCT01646177|37758791|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
16815953|NCT01646177|37758792|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
16815954|NCT01646177|37758793|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
16815955|NCT01646177|37758794|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16815956|NCT01646177|37758795|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16815957|NCT01646177|37758796|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16815958|NCT01646177|37758797|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16815959|NCT01646177|37758798|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16815960|NCT01646177|37758799|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16815961|NCT01646177|37758800|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16815962|NCT01646177|37758801|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16815963|NCT01646177|37758790|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
16815964|NCT01646177|37758791|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
16815965|NCT01646177|37758792|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
16815966|NCT01646177|37758793|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
16815967|NCT01646177|37758794|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16815968|NCT01646177|37758795|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16815969|NCT01646177|37758796|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16815970|NCT01646177|37758797|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16815971|NCT01646177|37758798|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16815972|NCT01646177|37758799|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16815973|NCT01646177|37758800|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16815974|NCT01646177|37758801|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16815975|NCT01646177|37758790|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815976|NCT01646177|37758791|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815977|NCT01646177|37758792|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
16815978|NCT01646177|37758793|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
16815979|NCT01646177|37758794|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815980|NCT01646177|37758795|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815981|NCT01646177|37758796|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815982|NCT01646177|37758797|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815983|NCT01646177|37758798|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815984|NCT01646177|37758799|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815985|NCT01646177|37758800|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815986|NCT01646177|37758801|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16815987|NCT01646177|37758790|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
16815988|NCT01646177|37758791|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
16815989|NCT01646177|37758792|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
17016610|NCT00600119|38161267|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
16815990|NCT01646177|37758793|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815991|NCT01646177|37758794|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815992|NCT01646177|37758795|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815993|NCT01646177|37758796|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815994|NCT01646177|37758797|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815995|NCT01646177|37758798|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815996|NCT01646177|37758799|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815997|NCT01646177|37758800|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815998|NCT01646177|37758801|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16815999|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16816000|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16816001|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16816002|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16816003|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
16816004|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
16816005|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
16816006|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
16816007|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16816008|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16816009|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16816010|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16816011|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16816012|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16816013|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16816014|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16816015|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
16816016|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
16816017|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
16816018|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
16816019|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16816020|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16816021|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16816022|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16816023|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16816024|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16816025|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16816026|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16816027|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
16816028|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
16816029|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
16816030|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
16816031|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16816032|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16816033|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16816034|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16816035|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16816036|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16816037|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16816038|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16816039|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
16816040|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
16816041|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
16816042|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
16816043|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16816044|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16816045|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16816046|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16816047|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16816048|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16816049|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16816050|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16816051|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
16816052|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
16910655|NCT01588548|38019585|FG005|Overall Study|Adverse Event|0|||
16816053|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
16816054|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
16816055|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16816056|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16816057|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16816058|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16816059|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816060|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816061|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816062|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816063|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
16816064|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
16816065|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816066|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
16816067|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816068|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816069|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816070|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16816071|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16816072|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16816073|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16816074|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16816075|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
16816076|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
16816077|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
16816078|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
16816079|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16816080|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16816081|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16816082|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16816083|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
16816084|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
16816085|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
16816086|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
16816087|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
16816088|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
16816089|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
16816090|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
16816091|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
16816092|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
16816093|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
16816094|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
16816095|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16816096|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16816097|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16816098|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16816099|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
16816100|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
16816101|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
16816102|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
16816103|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16816104|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16816105|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16816106|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16816107|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816108|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816109|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816110|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816111|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816112|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816113|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816114|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
16816115|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816116|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816117|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816118|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16816119|NCT01646177|37758790|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816120|NCT01646177|37758791|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816121|NCT01646177|37758792|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816122|NCT01646177|37758793|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816123|NCT01646177|37758794|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816124|NCT01646177|37758795|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
16816125|NCT01646177|37758796|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
16816126|NCT01646177|37758797|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
16816127|NCT01646177|37758798|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816128|NCT01646177|37758799|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816129|NCT01646177|37758800|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816130|NCT01646177|37758801|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16816131|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16816132|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16816133|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16816134|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16816135|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16816136|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16816137|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16816138|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16816139|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
16816140|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
16816141|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
16816142|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
16816143|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16816144|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16816145|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16816146|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16816147|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16816148|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16816149|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16816150|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16816151|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
16816152|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
16816153|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
16816154|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
16816155|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16816156|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16816157|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16816158|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16816159|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16816160|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16816161|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16816162|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16816163|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
16816164|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
16816165|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
16816166|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
16816167|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16816168|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16816169|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16816170|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16816171|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16816172|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16816173|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16816174|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16816175|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
16816176|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
16816177|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
16816178|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
16816179|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16816180|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16816181|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16816182|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16816183|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16816184|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16816185|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16816186|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16816187|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
16816188|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
16816189|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
16816190|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
16816191|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16816192|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16816193|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16816194|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16816195|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16816196|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16816197|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16816198|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16816199|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
16816200|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
16816201|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
16816202|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
16816203|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816204|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816205|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816206|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816207|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816208|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816209|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816210|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816211|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16816212|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
16816213|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
16816214|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
16816215|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816216|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816217|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816218|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816219|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816220|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816221|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816222|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816223|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16816224|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
16816225|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
16816226|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
16816227|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816228|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816229|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816230|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816231|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816232|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816233|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816234|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816235|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
16816236|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16816237|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
16816238|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
16816239|NCT01646177|37758790|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816240|NCT01646177|37758791|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816241|NCT01646177|37758792|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816242|NCT01646177|37758793|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816243|NCT01646177|37758794|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816244|NCT01646177|37758795|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816245|NCT01646177|37758796|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
17102339|NCT00116168|38241247|FG003|Overall Study|Lost to Follow-up|0|||
16816246|NCT01646177|37758797|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816247|NCT01646177|37758798|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816248|NCT01646177|37758799|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16816249|NCT01646177|37758800|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
16816250|NCT01646177|37758801|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
16816251|NCT01912287|37758824|FG000|Overall Study|Ineligible|1|||
16816252|NCT01912287|37758825|FG001|Overall Study|Ineligible|0|||
16816253|NCT01912287|37758826|FG002|Overall Study|Ineligible|1|||
16816254|NCT01912287|37758824|FG000|Overall Study|No-show|0|||
16816255|NCT01912287|37758825|FG001|Overall Study|No-show|0|||
16816256|NCT01912287|37758826|FG002|Overall Study|No-show|1|||
16816257|NCT01912287|37758824|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
16816258|NCT01912287|37758825|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
16816259|NCT01912287|37758826|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
16816260|NCT01912287|37758824|FG000|Overall Study|Felt treatment no longer needed|0|||
16816261|NCT01912287|37758825|FG001|Overall Study|Felt treatment no longer needed|1|||
16816262|NCT01912287|37758826|FG002|Overall Study|Felt treatment no longer needed|0|||
16816263|NCT01912287|37758824|FG000|Overall Study|Life circumstances|4|||
16816264|NCT01912287|37758825|FG001|Overall Study|Life circumstances|2|||
16816265|NCT01912287|37758826|FG002|Overall Study|Life circumstances|0|||
16816266|NCT01912287|37758824|FG000|Overall Study|Lost Interest|1|||
16816267|NCT01912287|37758825|FG001|Overall Study|Lost Interest|0|||
16816268|NCT01912287|37758826|FG002|Overall Study|Lost Interest|0|||
16816269|NCT01912287|37758824|FG000|Overall Study|Uknown reason - subject drop out|5|||
16816270|NCT01912287|37758825|FG001|Overall Study|Uknown reason - subject drop out|7|||
16816271|NCT01912287|37758826|FG002|Overall Study|Uknown reason - subject drop out|3|||
16816272|NCT01912287|37758824|FG000|Overall Study|Missed Assesment|1|||
16816273|NCT01912287|37758825|FG001|Overall Study|Missed Assesment|1|||
16816274|NCT01912287|37758826|FG002|Overall Study|Missed Assesment|1|||
16816275|NCT01912287|37758824|FG000|Overall Study|Scheduling/change in availability|17|||
16816276|NCT01912287|37758825|FG001|Overall Study|Scheduling/change in availability|10|||
16816277|NCT01912287|37758826|FG002|Overall Study|Scheduling/change in availability|8|||
16816278|NCT01929135|37758836|FG000|Overall Study|Lost to Follow-up|1|||
16816279|NCT01929135|37758837|FG001|Overall Study|Lost to Follow-up|1|||
16816280|NCT01911819|37758848|FG000|Overall Study|Adverse Event|0|||
16816281|NCT01911819|37758849|FG001|Overall Study|Adverse Event|1|||
16816282|NCT01911819|37758850|FG002|Overall Study|Adverse Event|0|||
16816283|NCT01911819|37758848|FG000|Overall Study|Withdrawal by Subject|1|||
16816284|NCT01911819|37758849|FG001|Overall Study|Withdrawal by Subject|1|||
16816285|NCT01911819|37758850|FG002|Overall Study|Withdrawal by Subject|0|||
16816286|NCT02280863|37758860|FG000|Integrated Platform|Met stopping criteria|0|||
16816287|NCT02280863|37758861|FG001|Integrated Platform|Met stopping criteria|1|||
16816288|NCT01911429|37758874|FG000|Overall Study|Adverse Event|5|||
16816289|NCT01911429|37758875|FG001|Overall Study|Adverse Event|3|||
16816290|NCT01911429|37758876|FG002|Overall Study|Adverse Event|9|||
16816291|NCT01911429|37758874|FG000|Overall Study|Lack of Efficacy|1|||
16816292|NCT01911429|37758875|FG001|Overall Study|Lack of Efficacy|2|||
16816293|NCT01911429|37758876|FG002|Overall Study|Lack of Efficacy|4|||
16816294|NCT01911429|37758874|FG000|Overall Study|Lost to Follow-up|0|||
16816295|NCT01911429|37758875|FG001|Overall Study|Lost to Follow-up|0|||
16816296|NCT01911429|37758876|FG002|Overall Study|Lost to Follow-up|1|||
16816297|NCT01911429|37758874|FG000|Overall Study|Protocol Violation|0|||
16816298|NCT01911429|37758875|FG001|Overall Study|Protocol Violation|0|||
16816299|NCT01911429|37758876|FG002|Overall Study|Protocol Violation|1|||
16816300|NCT01911429|37758874|FG000|Overall Study|Withdrawal by Subject|5|||
16816301|NCT01911429|37758875|FG001|Overall Study|Withdrawal by Subject|5|||
16816302|NCT01911429|37758876|FG002|Overall Study|Withdrawal by Subject|4|||
16816303|NCT01911429|37758874|FG000|Overall Study|Accidental randomization|0|||
16816304|NCT01911429|37758875|FG001|Overall Study|Accidental randomization|0|||
16816305|NCT01911429|37758876|FG002|Overall Study|Accidental randomization|1|||
16816306|NCT01911429|37758874|FG000|Overall Study|subject left study|1|||
16816307|NCT01911429|37758875|FG001|Overall Study|subject left study|0|||
16816308|NCT01911429|37758876|FG002|Overall Study|subject left study|0|||
16816309|NCT02324465|37758886|FG000|Overall Study|device failure|0|||
16816310|NCT02324465|37758887|FG001|Overall Study|device failure|1|||
16816311|NCT02324153|37758895|FG000|Overall Study|Withdrawal by Subject|4|||
16816312|NCT02324153|37758896|FG001|Overall Study|Withdrawal by Subject|1|||
16816313|NCT02324153|37758895|FG000|Overall Study|Surgery postponed after randomization|3|||
16816314|NCT02324153|37758896|FG001|Overall Study|Surgery postponed after randomization|0|||
16816315|NCT02324153|37758895|FG000|Overall Study|Developed delirium preoperatively|1|||
16816316|NCT02324153|37758896|FG001|Overall Study|Developed delirium preoperatively|0|||
16816317|NCT02280473|37758904|FG000|Overall Study|Adverse Event|1|||
16816318|NCT02280473|37758905|FG001|Overall Study|Adverse Event|1|||
16816319|NCT02280473|37758904|FG000|Overall Study|Lack of Efficacy|0|||
16816320|NCT02280473|37758905|FG001|Overall Study|Lack of Efficacy|1|||
16816321|NCT02280473|37758904|FG000|Overall Study|Lost to Follow-up|0|||
16816322|NCT02280473|37758905|FG001|Overall Study|Lost to Follow-up|1|||
16816323|NCT01911273|37758913|FG000|Overall Study|Progression of Disease|1|||
16816324|NCT01911273|37758914|FG001|Overall Study|Progression of Disease|0|||
16816325|NCT01911273|37758913|FG000|Overall Study|Withdrawal by Subject|0|||
16816326|NCT01911273|37758914|FG001|Overall Study|Withdrawal by Subject|2|||
16816327|NCT02308007|37758923|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
16816328|NCT02308007|37758924|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
16816329|NCT02308007|37758925|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
16816330|NCT02308007|37758923|FG000|Overall Study|Positive for STD at Baseline|7|||
16816331|NCT02308007|37758924|FG001|Overall Study|Positive for STD at Baseline|11|||
16816332|NCT02308007|37758925|FG002|Overall Study|Positive for STD at Baseline|7|||
16816333|NCT02308007|37758923|FG000|Overall Study|Lost to Follow-up|3|||
16816334|NCT02308007|37758924|FG001|Overall Study|Lost to Follow-up|0|||
16816335|NCT02308007|37758925|FG002|Overall Study|Lost to Follow-up|1|||
16816336|NCT02278367|37758935|FG000|Overall Study|Physician Decision|5|||
16816337|NCT02278367|37758936|FG001|Overall Study|Physician Decision|0|||
16816338|NCT02278367|37758935|FG000|Overall Study|Withdrawal by Subject|5|||
16816339|NCT02278367|37758936|FG001|Overall Study|Withdrawal by Subject|0|||
16816340|NCT01910181|37758942|FG000|Overall Study|Death|37|||
16816341|NCT01910181|37758942|FG000|Overall Study|Lost to Follow-up|3|||
16816342|NCT01910181|37758942|FG000|Overall Study|Study Terminated by Sponsor|6|||
16816343|NCT01957215|37758949|FG000|Overall Study|Adverse Event|2|||
16816344|NCT01957215|37758950|FG001|Overall Study|Adverse Event|2|||
16816345|NCT01957215|37758949|FG000|Overall Study|Lost to Follow-up|3|||
16816346|NCT01957215|37758950|FG001|Overall Study|Lost to Follow-up|3|||
16816347|NCT01957215|37758949|FG000|Overall Study|Protocol Violation|1|||
16816348|NCT01957215|37758950|FG001|Overall Study|Protocol Violation|2|||
16816349|NCT01957215|37758949|FG000|Overall Study|Withdrawal by Subject|7|||
16816350|NCT01957215|37758950|FG001|Overall Study|Withdrawal by Subject|5|||
16816351|NCT02322749|37758960|FG000|Period 2|Adverse Event|0|||
16816352|NCT02322749|37758961|FG001|Period 2|Adverse Event|0|||
16816353|NCT02322749|37758962|FG002|Period 2|Adverse Event|0|||
16816354|NCT02322749|37758963|FG003|Period 2|Adverse Event|1|||
16816355|NCT02322749|37758964|FG004|Period 2|Adverse Event|0|||
16816356|NCT02322749|37758965|FG005|Period 2|Adverse Event|0|||
16816357|NCT02322749|37758960|FG000|Period 2|Withdrawal by Subject|0|||
16816358|NCT02322749|37758961|FG001|Period 2|Withdrawal by Subject|0|||
16816359|NCT02322749|37758962|FG002|Period 2|Withdrawal by Subject|0|||
16816360|NCT02322749|37758963|FG003|Period 2|Withdrawal by Subject|1|||
16816361|NCT02322749|37758964|FG004|Period 2|Withdrawal by Subject|0|||
16816362|NCT02322749|37758965|FG005|Period 2|Withdrawal by Subject|0|||
16816363|NCT02322749|37758960|FG000|Period 3|Withdrawal by Subject|0|||
16816364|NCT02322749|37758961|FG001|Period 3|Withdrawal by Subject|0|||
16816365|NCT02322749|37758962|FG002|Period 3|Withdrawal by Subject|1|||
16816366|NCT02322749|37758963|FG003|Period 3|Withdrawal by Subject|0|||
16816367|NCT02322749|37758964|FG004|Period 3|Withdrawal by Subject|0|||
16816368|NCT02322749|37758965|FG005|Period 3|Withdrawal by Subject|0|||
16816369|NCT01957137|37758974|FG000|Randomized Portion|Adverse Event|1|||
16816370|NCT01957137|37758974|FG000|Randomized Portion|Withdrawal by Subject|1|||
16816371|NCT01928433|37758989|FG000|Overall Study|Adverse Event|5|||
16816372|NCT01928433|37758990|FG001|Overall Study|Adverse Event|2|||
16816373|NCT01928433|37758991|FG002|Overall Study|Adverse Event|5|||
16816374|NCT01928433|37758989|FG000|Overall Study|Protocol Violation|0|||
16816375|NCT01928433|37758990|FG001|Overall Study|Protocol Violation|0|||
16816376|NCT01928433|37758991|FG002|Overall Study|Protocol Violation|2|||
16816377|NCT01928433|37758989|FG000|Overall Study|Lack of Efficacy|5|||
16816378|NCT01928433|37758990|FG001|Overall Study|Lack of Efficacy|4|||
16816379|NCT01928433|37758991|FG002|Overall Study|Lack of Efficacy|4|||
16816380|NCT01928433|37758989|FG000|Overall Study|Withdrawal by Subject|0|||
16816381|NCT01928433|37758990|FG001|Overall Study|Withdrawal by Subject|4|||
16816382|NCT01928433|37758991|FG002|Overall Study|Withdrawal by Subject|0|||
16816383|NCT01928433|37758989|FG000|Overall Study|Negative screening urine culture|7|||
16816384|NCT01928433|37758990|FG001|Overall Study|Negative screening urine culture|6|||
16816385|NCT01928433|37758991|FG002|Overall Study|Negative screening urine culture|10|||
16816386|NCT01928433|37758989|FG000|Overall Study|Lost to Follow-up|0|||
16816387|NCT01928433|37758990|FG001|Overall Study|Lost to Follow-up|2|||
16816388|NCT01928433|37758991|FG002|Overall Study|Lost to Follow-up|3|||
16816389|NCT01928433|37758989|FG000|Overall Study|Other reasons|3|||
16816390|NCT01928433|37758990|FG001|Overall Study|Other reasons|3|||
16816391|NCT01928433|37758991|FG002|Overall Study|Other reasons|4|||
16816392|NCT02322281|37759005|FG000|Overall Study|Progressive Disease|42|||
16816393|NCT02322281|37759006|FG001|Overall Study|Progressive Disease|14|||
16816394|NCT02322281|37759007|FG002|Overall Study|Progressive Disease|49|||
16816395|NCT02322281|37759005|FG000|Overall Study|Adverse Event|3|||
16816396|NCT02322281|37759006|FG001|Overall Study|Adverse Event|4|||
16816397|NCT02322281|37759007|FG002|Overall Study|Adverse Event|6|||
16816398|NCT02322281|37759005|FG000|Overall Study|Death|3|||
16816399|NCT02322281|37759006|FG001|Overall Study|Death|3|||
16816400|NCT02322281|37759007|FG002|Overall Study|Death|3|||
16816401|NCT02322281|37759005|FG000|Overall Study|Withdrawal by Subject|1|||
16816402|NCT02322281|37759006|FG001|Overall Study|Withdrawal by Subject|1|||
16816403|NCT02322281|37759007|FG002|Overall Study|Withdrawal by Subject|6|||
16816404|NCT02322281|37759005|FG000|Overall Study|Physician Decision|2|||
16816405|NCT02322281|37759006|FG001|Overall Study|Physician Decision|0|||
16816406|NCT02322281|37759007|FG002|Overall Study|Physician Decision|5|||
16816407|NCT02322281|37759005|FG000|Overall Study|Study Terminated by Sponsor|2|||
16816408|NCT02322281|37759006|FG001|Overall Study|Study Terminated by Sponsor|0|||
16816409|NCT02322281|37759007|FG002|Overall Study|Study Terminated by Sponsor|0|||
16816410|NCT02322281|37759005|FG000|Overall Study|Missing|0|||
16816411|NCT02322281|37759006|FG001|Overall Study|Missing|0|||
16816412|NCT02322281|37759007|FG002|Overall Study|Missing|1|||
16816413|NCT02322281|37759005|FG000|Overall Study|Miscellaneous|0|||
16816414|NCT02322281|37759006|FG001|Overall Study|Miscellaneous|0|||
16816415|NCT02322281|37759007|FG002|Overall Study|Miscellaneous|4|||
16816416|NCT02322125|37759017|FG000|Overall Study|Withdrawal by Subject|2|||
16816417|NCT02243293|37759038|FG000|Overall Study|Adverse Event|1|||
16816418|NCT02243293|37759039|FG001|Overall Study|Adverse Event|0|||
16816419|NCT02243293|37759040|FG002|Overall Study|Adverse Event|0|||
16816420|NCT02243293|37759041|FG003|Overall Study|Adverse Event|0|||
16816421|NCT02243293|37759042|FG004|Overall Study|Adverse Event|0|||
16816422|NCT02243293|37759043|FG005|Overall Study|Adverse Event|0|||
16816423|NCT02243293|37759044|FG006|Overall Study|Adverse Event|0|||
16816424|NCT02243293|37759045|FG007|Overall Study|Adverse Event|0|||
16816425|NCT02243293|37759046|FG008|Overall Study|Adverse Event|0|||
16816426|NCT02243293|37759047|FG009|Overall Study|Adverse Event|0|||
16816427|NCT02243293|37759048|FG010|Overall Study|Adverse Event|0|||
16816428|NCT02243293|37759049|FG011|Overall Study|Adverse Event|0|||
16816429|NCT02243293|37759050|FG012|Overall Study|Adverse Event|0|||
16816430|NCT02243293|37759051|FG013|Overall Study|Adverse Event|0|||
16816431|NCT02243293|37759052|FG014|Overall Study|Adverse Event|0|||
16816432|NCT02243293|37759053|FG015|Overall Study|Adverse Event|1|||
16816433|NCT02243293|37759054|FG016|Overall Study|Adverse Event|0|||
16816434|NCT02243293|37759055|FG017|Overall Study|Adverse Event|0|||
16816435|NCT02243293|37759056|FG018|Overall Study|Adverse Event|0|||
16816436|NCT02243293|37759057|FG019|Overall Study|Adverse Event|0|||
16816437|NCT02243293|37759058|FG020|Overall Study|Adverse Event|1|||
16816438|NCT02243293|37759059|FG021|Overall Study|Adverse Event|0|||
16816439|NCT02243293|37759038|FG000|Overall Study|Withdrawal by Subject|1|||
16816440|NCT02243293|37759039|FG001|Overall Study|Withdrawal by Subject|0|||
16816441|NCT02243293|37759040|FG002|Overall Study|Withdrawal by Subject|0|||
16816442|NCT02243293|37759041|FG003|Overall Study|Withdrawal by Subject|0|||
16816443|NCT02243293|37759042|FG004|Overall Study|Withdrawal by Subject|0|||
16816444|NCT02243293|37759043|FG005|Overall Study|Withdrawal by Subject|0|||
16816445|NCT02243293|37759044|FG006|Overall Study|Withdrawal by Subject|0|||
16816446|NCT02243293|37759045|FG007|Overall Study|Withdrawal by Subject|0|||
16816447|NCT02243293|37759046|FG008|Overall Study|Withdrawal by Subject|0|||
16816448|NCT02243293|37759047|FG009|Overall Study|Withdrawal by Subject|1|||
16816449|NCT02243293|37759048|FG010|Overall Study|Withdrawal by Subject|0|||
16816450|NCT02243293|37759049|FG011|Overall Study|Withdrawal by Subject|1|||
16816451|NCT02243293|37759050|FG012|Overall Study|Withdrawal by Subject|0|||
16816452|NCT02243293|37759051|FG013|Overall Study|Withdrawal by Subject|0|||
16816453|NCT02243293|37759052|FG014|Overall Study|Withdrawal by Subject|0|||
16816454|NCT02243293|37759053|FG015|Overall Study|Withdrawal by Subject|0|||
16816455|NCT02243293|37759054|FG016|Overall Study|Withdrawal by Subject|0|||
16816456|NCT02243293|37759055|FG017|Overall Study|Withdrawal by Subject|0|||
16816457|NCT02243293|37759056|FG018|Overall Study|Withdrawal by Subject|0|||
16816458|NCT02243293|37759057|FG019|Overall Study|Withdrawal by Subject|0|||
16816459|NCT02243293|37759058|FG020|Overall Study|Withdrawal by Subject|0|||
16816460|NCT02243293|37759059|FG021|Overall Study|Withdrawal by Subject|1|||
16816461|NCT02243293|37759038|FG000|Overall Study|Lost to Follow-up|0|||
16816462|NCT02243293|37759039|FG001|Overall Study|Lost to Follow-up|1|||
16816463|NCT02243293|37759040|FG002|Overall Study|Lost to Follow-up|1|||
16816464|NCT02243293|37759041|FG003|Overall Study|Lost to Follow-up|1|||
16816465|NCT02243293|37759042|FG004|Overall Study|Lost to Follow-up|0|||
16816466|NCT02243293|37759043|FG005|Overall Study|Lost to Follow-up|0|||
16816467|NCT02243293|37759044|FG006|Overall Study|Lost to Follow-up|3|||
16816468|NCT02243293|37759045|FG007|Overall Study|Lost to Follow-up|0|||
16816469|NCT02243293|37759046|FG008|Overall Study|Lost to Follow-up|0|||
16816470|NCT02243293|37759047|FG009|Overall Study|Lost to Follow-up|0|||
16816471|NCT02243293|37759048|FG010|Overall Study|Lost to Follow-up|0|||
16816472|NCT02243293|37759049|FG011|Overall Study|Lost to Follow-up|2|||
16816473|NCT02243293|37759050|FG012|Overall Study|Lost to Follow-up|0|||
16816474|NCT02243293|37759051|FG013|Overall Study|Lost to Follow-up|0|||
16816475|NCT02243293|37759052|FG014|Overall Study|Lost to Follow-up|0|||
16816476|NCT02243293|37759053|FG015|Overall Study|Lost to Follow-up|0|||
16816477|NCT02243293|37759054|FG016|Overall Study|Lost to Follow-up|3|||
16816478|NCT02243293|37759055|FG017|Overall Study|Lost to Follow-up|1|||
16816479|NCT02243293|37759056|FG018|Overall Study|Lost to Follow-up|0|||
16816480|NCT02243293|37759057|FG019|Overall Study|Lost to Follow-up|0|||
16816481|NCT02243293|37759058|FG020|Overall Study|Lost to Follow-up|1|||
16816482|NCT02243293|37759059|FG021|Overall Study|Lost to Follow-up|2|||
16816483|NCT02243293|37759038|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
16816484|NCT02243293|37759039|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
16816485|NCT02243293|37759040|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
16816486|NCT02243293|37759041|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
16816487|NCT02243293|37759042|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
16816488|NCT02243293|37759043|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
16816489|NCT02243293|37759044|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
16816490|NCT02243293|37759045|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
16816491|NCT02243293|37759046|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
16816492|NCT02243293|37759047|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
16816493|NCT02243293|37759048|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
16816494|NCT02243293|37759049|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
16816495|NCT02243293|37759050|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
16816496|NCT02243293|37759051|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
16816497|NCT02243293|37759052|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
16816498|NCT02243293|37759053|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
16816499|NCT02243293|37759054|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
16816500|NCT02243293|37759055|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
16816501|NCT02243293|37759056|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
16816502|NCT02243293|37759057|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
16816503|NCT02243293|37759058|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
16816504|NCT02243293|37759059|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
16816505|NCT02243293|37759038|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
16816506|NCT02243293|37759039|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
16816507|NCT02243293|37759040|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
16816508|NCT02243293|37759041|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
16816509|NCT02243293|37759042|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
16816510|NCT02243293|37759043|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
16816511|NCT02243293|37759044|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
16816512|NCT02243293|37759045|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
16816513|NCT02243293|37759046|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
16816514|NCT02243293|37759047|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
16816515|NCT02243293|37759048|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
16816516|NCT02243293|37759049|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
16816517|NCT02243293|37759050|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
16816518|NCT02243293|37759051|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
16816519|NCT02243293|37759052|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
16816520|NCT02243293|37759053|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
16816521|NCT02243293|37759054|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
16816522|NCT02243293|37759055|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
16816523|NCT02243293|37759056|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
16816524|NCT02243293|37759057|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
16816525|NCT02243293|37759058|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
16816526|NCT02243293|37759059|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
16816527|NCT02322047|37759100|FG000|Overall Study|Physician Decision|1|||
16816528|NCT02322047|37759101|FG001|Overall Study|Physician Decision|0|||
16816529|NCT02322047|37759102|FG002|Overall Study|Physician Decision|0|||
16816530|NCT02322047|37759103|FG003|Overall Study|Physician Decision|0|||
16816531|NCT02322047|37759100|FG000|Overall Study|Withdrawal by Subject|1|||
16816532|NCT02322047|37759101|FG001|Overall Study|Withdrawal by Subject|0|||
16816533|NCT02322047|37759102|FG002|Overall Study|Withdrawal by Subject|0|||
16816534|NCT02322047|37759103|FG003|Overall Study|Withdrawal by Subject|1|||
16816535|NCT02322047|37759100|FG000|Overall Study|Adverse Event|0|||
16816536|NCT02322047|37759101|FG001|Overall Study|Adverse Event|1|||
16816537|NCT02322047|37759102|FG002|Overall Study|Adverse Event|0|||
16816538|NCT02322047|37759103|FG003|Overall Study|Adverse Event|0|||
16816539|NCT02322047|37759100|FG000|Overall Study|Lost to Follow-up|0|||
16816540|NCT02322047|37759101|FG001|Overall Study|Lost to Follow-up|0|||
16816541|NCT02322047|37759102|FG002|Overall Study|Lost to Follow-up|1|||
16816542|NCT02322047|37759103|FG003|Overall Study|Lost to Follow-up|1|||
16816543|NCT02254291|37759116|FG000|Overall Study|Withdrawal by Subject|0|||
16816544|NCT02254291|37759117|FG001|Overall Study|Withdrawal by Subject|3|||
16816545|NCT02254291|37759118|FG002|Overall Study|Withdrawal by Subject|1|||
16816546|NCT02254291|37759116|FG000|Overall Study|Missing follow-up information|0|||
16816547|NCT02254291|37759117|FG001|Overall Study|Missing follow-up information|0|||
16816548|NCT02254291|37759118|FG002|Overall Study|Missing follow-up information|1|||
16816549|NCT02253433|37759128|FG000|Overall Study|Unable to Contact|9|||
16816550|NCT02253433|37759129|FG001|Overall Study|Unable to Contact|16|||
16816551|NCT02253433|37759128|FG000|Overall Study|Death|1|||
16816552|NCT02253433|37759129|FG001|Overall Study|Death|1|||
16816553|NCT02253433|37759128|FG000|Overall Study|No Longer Interested|3|||
16816554|NCT02253433|37759129|FG001|Overall Study|No Longer Interested|15|||
16816555|NCT02253433|37759128|FG000|Overall Study|Out of Study Area|2|||
16816556|NCT02253433|37759129|FG001|Overall Study|Out of Study Area|7|||
16816557|NCT02253433|37759128|FG000|Overall Study|Uncomfortable with home visitors|0|||
16816558|NCT02253433|37759129|FG001|Overall Study|Uncomfortable with home visitors|3|||
16816559|NCT02253433|37759128|FG000|Overall Study|Unstable Housing/Homeless|0|||
16816560|NCT02253433|37759129|FG001|Overall Study|Unstable Housing/Homeless|7|||
16816561|NCT02253433|37759128|FG000|Overall Study|Too Busy|0|||
16816562|NCT02253433|37759129|FG001|Overall Study|Too Busy|4|||
16910656|NCT01588548|38019580|FG000|Overall Study|Condition Under Investigation Worsened|3|||
16910657|NCT01588548|38019581|FG001|Overall Study|Condition Under Investigation Worsened|6|||
16910658|NCT01588548|38019582|FG002|Overall Study|Condition Under Investigation Worsened|4|||
16910659|NCT01588548|38019583|FG003|Overall Study|Condition Under Investigation Worsened|4|||
16910660|NCT01588548|38019584|FG004|Overall Study|Condition Under Investigation Worsened|3|||
16910661|NCT01588548|38019585|FG005|Overall Study|Condition Under Investigation Worsened|3|||
16910662|NCT01587924|38019603|FG000|Overall Study|Adverse Event|0|||
16910663|NCT01587924|38019604|FG001|Overall Study|Adverse Event|2|||
16816563|NCT02253433|37759128|FG000|Overall Study|Medical or Other Concerns|1|||
16816564|NCT02253433|37759129|FG001|Overall Study|Medical or Other Concerns|2|||
16816565|NCT02242981|37759136|FG000|Overall Study|Withdrawal by Subject|1|||
16816566|NCT02277743|37759143|FG000|Overall Study|Protocol Violation|1|||
16816567|NCT02277743|37759144|FG001|Overall Study|Protocol Violation|1|||
16816568|NCT02277743|37759145|FG002|Overall Study|Protocol Violation|1|||
16816569|NCT02277743|37759143|FG000|Overall Study|Adverse Event|10|||
16816570|NCT02277743|37759144|FG001|Overall Study|Adverse Event|6|||
16816571|NCT02277743|37759145|FG002|Overall Study|Adverse Event|6|||
16816572|NCT02277743|37759143|FG000|Overall Study|Lack of Efficacy|11|||
16816573|NCT02277743|37759144|FG001|Overall Study|Lack of Efficacy|4|||
16816574|NCT02277743|37759145|FG002|Overall Study|Lack of Efficacy|3|||
16816575|NCT02277743|37759143|FG000|Overall Study|Other than specified above|18|||
16816576|NCT02277743|37759144|FG001|Overall Study|Other than specified above|5|||
16816577|NCT02277743|37759145|FG002|Overall Study|Other than specified above|16|||
16816578|NCT02242903|37759160|FG000|Overall Study|Withdrawal by Subject|1|||
16816579|NCT02242903|37759161|FG001|Overall Study|Withdrawal by Subject|0|||
16816580|NCT02242903|37759162|FG002|Overall Study|Withdrawal by Subject|0|||
16816581|NCT02242903|37759163|FG003|Overall Study|Withdrawal by Subject|0|||
16816582|NCT02242903|37759164|FG004|Overall Study|Withdrawal by Subject|0|||
16816583|NCT02242903|37759165|FG005|Overall Study|Withdrawal by Subject|0|||
16816584|NCT02242903|37759166|FG006|Overall Study|Withdrawal by Subject|0|||
16816585|NCT02320721|37759190|FG000|Overall Study|Adverse Event|6|||
16816586|NCT02320721|37759191|FG001|Overall Study|Adverse Event|6|||
16816587|NCT02320721|37759190|FG000|Overall Study|Lack of Efficacy|2|||
16816588|NCT02320721|37759191|FG001|Overall Study|Lack of Efficacy|0|||
16816589|NCT02320721|37759190|FG000|Overall Study|Poor compliance to protocol|3|||
16816590|NCT02320721|37759191|FG001|Overall Study|Poor compliance to protocol|7|||
16816591|NCT02320721|37759190|FG000|Overall Study|Randomized but not treated|0|||
16816592|NCT02320721|37759191|FG001|Overall Study|Randomized but not treated|1|||
16816593|NCT02320721|37759190|FG000|Overall Study|Hypoglycemia|1|||
16816594|NCT02320721|37759191|FG001|Overall Study|Hypoglycemia|0|||
16816595|NCT02320721|37759190|FG000|Overall Study|Other than specified above|15|||
16816596|NCT02320721|37759191|FG001|Overall Study|Other than specified above|20|||
16816597|NCT02320487|37759197|FG000|Overall Study|Reason not Specified|1|||
16816598|NCT02320487|37759197|FG000|Overall Study|Physician Decision|5|||
16816599|NCT02320487|37759197|FG000|Overall Study|Withdrawal by Subject|1|||
16816600|NCT02320487|37759197|FG000|Overall Study|Death|3|||
16816601|NCT02320487|37759197|FG000|Overall Study|Adverse Event|11|||
16816602|NCT02277119|37759204|FG000|Overall Study|Lack of Efficacy|1|||
16816603|NCT02277119|37759205|FG001|Overall Study|Lack of Efficacy|1|||
16816604|NCT02277119|37759206|FG002|Overall Study|Lack of Efficacy|1|||
16816605|NCT02277119|37759204|FG000|Overall Study|Protocol Violation|2|||
16816606|NCT02277119|37759205|FG001|Overall Study|Protocol Violation|3|||
16816607|NCT02277119|37759206|FG002|Overall Study|Protocol Violation|7|||
16816608|NCT02320253|37759217|FG000|Overall Study|Withdrawal by Subject|3|||
16816609|NCT02320253|37759218|FG001|Overall Study|Withdrawal by Subject|0|||
16816610|NCT02320253|37759219|FG002|Overall Study|Withdrawal by Subject|0|||
16816611|NCT02320253|37759217|FG000|Overall Study|Lost to Follow-up|2|||
16816612|NCT02320253|37759218|FG001|Overall Study|Lost to Follow-up|2|||
16816613|NCT02320253|37759219|FG002|Overall Study|Lost to Follow-up|1|||
16816614|NCT02320253|37759217|FG000|Overall Study|Death|1|||
16816615|NCT02320253|37759218|FG001|Overall Study|Death|0|||
16816616|NCT02320253|37759219|FG002|Overall Study|Death|1|||
16816617|NCT02276807|37759229|FG000|Overall Study|Withdrawal by Subject|8|||
16816618|NCT02276807|37759230|FG001|Overall Study|Withdrawal by Subject|7|||
16816619|NCT02276807|37759229|FG000|Overall Study|Lost to Follow-up|10|||
16816620|NCT02276807|37759230|FG001|Overall Study|Lost to Follow-up|10|||
16816621|NCT02252965|37759238|FG000|Overall Study|Adverse Event|9|||
16816622|NCT02252965|37759239|FG001|Overall Study|Adverse Event|14|||
16816623|NCT02252965|37759238|FG000|Overall Study|Lost to Follow-up|16|||
16816624|NCT02252965|37759239|FG001|Overall Study|Lost to Follow-up|8|||
16816625|NCT02252965|37759238|FG000|Overall Study|Protocol Violation|4|||
16816626|NCT02252965|37759239|FG001|Overall Study|Protocol Violation|5|||
16816627|NCT02252965|37759238|FG000|Overall Study|Lack of Efficacy|0|||
16816628|NCT02252965|37759239|FG001|Overall Study|Lack of Efficacy|2|||
16816629|NCT02252965|37759238|FG000|Overall Study|Withdrawal by Subject|7|||
16816630|NCT02252965|37759239|FG001|Overall Study|Withdrawal by Subject|9|||
16816631|NCT02252965|37759238|FG000|Overall Study|Other|4|||
16816632|NCT02252965|37759239|FG001|Overall Study|Other|5|||
16816633|NCT02242435|37759249|FG000|Overall Study|Lost to Follow-up|3|||
16816634|NCT02242435|37759250|FG001|Overall Study|Lost to Follow-up|4|||
16816635|NCT02242435|37759249|FG000|Overall Study|Adverse Event|3|||
16816636|NCT02242435|37759250|FG001|Overall Study|Adverse Event|2|||
16816637|NCT02242435|37759249|FG000|Overall Study|Withdrawal by Subject|13|||
16816638|NCT02242435|37759250|FG001|Overall Study|Withdrawal by Subject|8|||
16816639|NCT02242435|37759249|FG000|Overall Study|Death|0|||
16816640|NCT02242435|37759250|FG001|Overall Study|Death|1|||
16816641|NCT02242435|37759249|FG000|Overall Study|Protocol Violation|1|||
16816642|NCT02242435|37759250|FG001|Overall Study|Protocol Violation|0|||
16816643|NCT02242435|37759249|FG000|Overall Study|Physician Decision|0|||
16816644|NCT02242435|37759250|FG001|Overall Study|Physician Decision|1|||
16816645|NCT02251717|37759258|FG000|Overall Study|Adverse Event|0|||
16816646|NCT02251717|37759259|FG001|Overall Study|Adverse Event|1|||
16816647|NCT02251717|37759258|FG000|Overall Study|Withdrew Consent|1|||
16816648|NCT02251717|37759259|FG001|Overall Study|Withdrew Consent|0|||
16816649|NCT02242201|37759268|FG000|Overall Study|preoperative identified neuropathy|2|||
16816650|NCT02242201|37759269|FG001|Overall Study|preoperative identified neuropathy|0|||
16816651|NCT02242201|37759270|FG002|Overall Study|preoperative identified neuropathy|0|||
16816652|NCT02242201|37759268|FG000|Overall Study|planned post-op anticoagulation|1|||
16816653|NCT02242201|37759269|FG001|Overall Study|planned post-op anticoagulation|0|||
16816654|NCT02242201|37759270|FG002|Overall Study|planned post-op anticoagulation|0|||
16816655|NCT02242201|37759268|FG000|Overall Study|changed surgical procedure|1|||
16816656|NCT02242201|37759269|FG001|Overall Study|changed surgical procedure|0|||
16816657|NCT02242201|37759270|FG002|Overall Study|changed surgical procedure|0|||
16816658|NCT02242201|37759268|FG000|Overall Study|postponed surgery|0|||
16816659|NCT02242201|37759269|FG001|Overall Study|postponed surgery|0|||
16816660|NCT02242201|37759270|FG002|Overall Study|postponed surgery|1|||
16816661|NCT02242201|37759268|FG000|Overall Study|preoperative opioid consumption|0|||
16816662|NCT02242201|37759269|FG001|Overall Study|preoperative opioid consumption|1|||
16816663|NCT02242201|37759270|FG002|Overall Study|preoperative opioid consumption|0|||
16816664|NCT02242045|37759278|FG000|Overall Study|Investigator's Discretion|1|||
16816665|NCT02242045|37759278|FG000|Overall Study|Progressive Disease|2|||
16816666|NCT02242045|37759278|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
16816667|NCT02242045|37759278|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
16816668|NCT02241889|37759282|FG000|Overall Study|device issues|0|||
16816669|NCT02241889|37759283|FG001|Overall Study|device issues|0|||
16816670|NCT02241889|37759284|FG002|Overall Study|device issues|1|||
16816671|NCT02241889|37759285|FG003|Overall Study|device issues|0|||
16816672|NCT02241889|37759286|FG004|Overall Study|device issues|0|||
16816673|NCT02241889|37759287|FG005|Overall Study|device issues|0|||
16816674|NCT02241889|37759282|FG000|Overall Study|Withdrawal by Subject|0|||
16816675|NCT02241889|37759283|FG001|Overall Study|Withdrawal by Subject|0|||
16816676|NCT02241889|37759284|FG002|Overall Study|Withdrawal by Subject|0|||
16816677|NCT02241889|37759285|FG003|Overall Study|Withdrawal by Subject|0|||
16816678|NCT02241889|37759286|FG004|Overall Study|Withdrawal by Subject|0|||
16816679|NCT02241889|37759287|FG005|Overall Study|Withdrawal by Subject|1|||
16816680|NCT02241733|37759297|FG000|Overall Study|Lost to Follow-up|9|||
16816681|NCT02241733|37759298|FG001|Overall Study|Lost to Follow-up|4|||
16816682|NCT02241733|37759297|FG000|Overall Study|Physician Decision|6|||
16816683|NCT02241733|37759298|FG001|Overall Study|Physician Decision|2|||
16816684|NCT02241733|37759297|FG000|Overall Study|Withdrawal by Subject|0|||
16816685|NCT02241733|37759298|FG001|Overall Study|Withdrawal by Subject|2|||
16816686|NCT02241733|37759297|FG000|Overall Study|Death|0|||
16816687|NCT02241733|37759298|FG001|Overall Study|Death|2|||
16816688|NCT02241343|37759304|FG000|Overall Study|Adverse Event|1|||
16816689|NCT02241187|37759309|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
16816690|NCT02249767|37759316|FG000|Overall Study|Did not use medication|8|||
16816691|NCT02249767|37759317|FG001|Overall Study|Did not use medication|9|||
16816692|NCT02249767|37759318|FG002|Overall Study|Did not use medication|8|||
16816693|NCT02239939|37759328|FG000|Overall Study|Adverse Event|1|||
16816694|NCT02239939|37759329|FG001|Overall Study|Adverse Event|0|||
16816695|NCT02239939|37759328|FG000|Overall Study|Withdrawal by Subject|1|||
16816696|NCT02239939|37759329|FG001|Overall Study|Withdrawal by Subject|1|||
16816697|NCT02239939|37759328|FG000|Overall Study|Lost to Follow-up|0|||
16816698|NCT02239939|37759329|FG001|Overall Study|Lost to Follow-up|1|||
16816699|NCT02248675|37759339|FG000|Overall Study|Lost to Follow-up|3|||
16816700|NCT02248675|37759340|FG001|Overall Study|Lost to Follow-up|1|||
16816701|NCT02207725|37759350|FG000|Overall Study|Did Not Receive Treatment|0|||
16816702|NCT02207725|37759351|FG001|Overall Study|Did Not Receive Treatment|1|||
16816703|NCT02207725|37759352|FG002|Overall Study|Did Not Receive Treatment|1|||
16816704|NCT02207725|37759353|FG003|Overall Study|Did Not Receive Treatment|1|||
16816705|NCT02238379|37759367|FG000|Overall Study|Lost to Follow-up|1|||
16816706|NCT02238379|37759368|FG001|Overall Study|Lost to Follow-up|0|||
16816707|NCT02238067|37759374|FG000|Overall Study|Not completed survey at Month 6|45|||
16816708|NCT02237911|37759381|FG000|Overall Study|Withdrawal by Subject|4|||
16816709|NCT02237911|37759382|FG001|Overall Study|Withdrawal by Subject|7|||
16816710|NCT02237911|37759383|FG002|Overall Study|Withdrawal by Subject|2|||
16816711|NCT02237911|37759381|FG000|Overall Study|Lost to Follow-up|3|||
16816712|NCT02237911|37759382|FG001|Overall Study|Lost to Follow-up|1|||
16816713|NCT02237911|37759383|FG002|Overall Study|Lost to Follow-up|1|||
16816714|NCT02234479|37759393|FG000|Overall Study|Withdrawal by Subject|1|||
16816715|NCT02234479|37759394|FG001|Overall Study|Withdrawal by Subject|3|||
16816716|NCT02207491|37759402|FG000|Overall Study|Adverse Event|20|||
16816717|NCT02207491|37759403|FG001|Overall Study|Adverse Event|4|||
16816718|NCT02207491|37759402|FG000|Overall Study|Withdrawal by Subject|3|||
16816719|NCT02207491|37759403|FG001|Overall Study|Withdrawal by Subject|2|||
16816720|NCT02207491|37759402|FG000|Overall Study|Non-compliant|0|||
16816721|NCT02207491|37759403|FG001|Overall Study|Non-compliant|1|||
16816722|NCT02207491|37759402|FG000|Overall Study|Lost to Follow-up|0|||
16816723|NCT02207491|37759403|FG001|Overall Study|Lost to Follow-up|1|||
16816724|NCT02207491|37759402|FG000|Overall Study|Lack of Efficacy|3|||
16816725|NCT02207491|37759403|FG001|Overall Study|Lack of Efficacy|0|||
16816726|NCT02207491|37759402|FG000|Overall Study|Physician Decision|2|||
16816727|NCT02207491|37759403|FG001|Overall Study|Physician Decision|0|||
16816728|NCT02207491|37759402|FG000|Overall Study|Protocol Violation|3|||
16816729|NCT02207491|37759403|FG001|Overall Study|Protocol Violation|5|||
16816730|NCT02315066|37759423|FG000|Overall Study|Lost to Follow-up|0|||
16816731|NCT02315066|37759424|FG001|Overall Study|Lost to Follow-up|1|||
16816732|NCT02315066|37759425|FG002|Overall Study|Lost to Follow-up|1|||
16816733|NCT02315066|37759426|FG003|Overall Study|Lost to Follow-up|0|||
16816734|NCT02315066|37759427|FG004|Overall Study|Lost to Follow-up|1|||
16816735|NCT02315066|37759428|FG005|Overall Study|Lost to Follow-up|0|||
16816736|NCT02315066|37759429|FG006|Overall Study|Lost to Follow-up|2|||
16816737|NCT02315066|37759430|FG007|Overall Study|Lost to Follow-up|1|||
16816738|NCT02315066|37759431|FG008|Overall Study|Lost to Follow-up|0|||
16816739|NCT02315066|37759432|FG009|Overall Study|Lost to Follow-up|0|||
16816740|NCT02315066|37759433|FG010|Overall Study|Lost to Follow-up|1|||
16816741|NCT02315066|37759434|FG011|Overall Study|Lost to Follow-up|2|||
16816742|NCT02315066|37759435|FG012|Overall Study|Lost to Follow-up|0|||
16816743|NCT02315066|37759436|FG013|Overall Study|Lost to Follow-up|4|||
16816744|NCT02315066|37759423|FG000|Overall Study|Death|2|||
16816745|NCT02315066|37759424|FG001|Overall Study|Death|7|||
16816746|NCT02315066|37759425|FG002|Overall Study|Death|6|||
16816747|NCT02315066|37759426|FG003|Overall Study|Death|11|||
16816748|NCT02315066|37759427|FG004|Overall Study|Death|10|||
16816749|NCT02315066|37759428|FG005|Overall Study|Death|3|||
16816750|NCT02315066|37759429|FG006|Overall Study|Death|9|||
16816751|NCT02315066|37759430|FG007|Overall Study|Death|9|||
16816752|NCT02315066|37759431|FG008|Overall Study|Death|10|||
16816753|NCT02315066|37759432|FG009|Overall Study|Death|8|||
16816754|NCT02315066|37759433|FG010|Overall Study|Death|10|||
16816755|NCT02315066|37759434|FG011|Overall Study|Death|7|||
16816756|NCT02315066|37759435|FG012|Overall Study|Death|8|||
16816757|NCT02315066|37759436|FG013|Overall Study|Death|21|||
16910664|NCT01587924|38019605|FG002|Overall Study|Adverse Event|0|||
16910665|NCT01587924|38019606|FG003|Overall Study|Adverse Event|0|||
16816758|NCT02315066|37759423|FG000|Overall Study|Other|0|||
16816759|NCT02315066|37759424|FG001|Overall Study|Other|0|||
16816760|NCT02315066|37759425|FG002|Overall Study|Other|0|||
16816761|NCT02315066|37759426|FG003|Overall Study|Other|0|||
16816762|NCT02315066|37759427|FG004|Overall Study|Other|0|||
16816763|NCT02315066|37759428|FG005|Overall Study|Other|0|||
16816764|NCT02315066|37759429|FG006|Overall Study|Other|0|||
16816765|NCT02315066|37759430|FG007|Overall Study|Other|1|||
16816766|NCT02315066|37759431|FG008|Overall Study|Other|1|||
16816767|NCT02315066|37759432|FG009|Overall Study|Other|2|||
16816768|NCT02315066|37759433|FG010|Overall Study|Other|0|||
16816769|NCT02315066|37759434|FG011|Overall Study|Other|0|||
16816770|NCT02315066|37759435|FG012|Overall Study|Other|0|||
16816771|NCT02315066|37759436|FG013|Overall Study|Other|0|||
16816772|NCT02315066|37759423|FG000|Overall Study|Subject refused further follow-up|0|||
16816773|NCT02315066|37759424|FG001|Overall Study|Subject refused further follow-up|2|||
16816774|NCT02315066|37759425|FG002|Overall Study|Subject refused further follow-up|2|||
16816775|NCT02315066|37759426|FG003|Overall Study|Subject refused further follow-up|0|||
16816776|NCT02315066|37759427|FG004|Overall Study|Subject refused further follow-up|0|||
16816777|NCT02315066|37759428|FG005|Overall Study|Subject refused further follow-up|0|||
16816778|NCT02315066|37759429|FG006|Overall Study|Subject refused further follow-up|2|||
16816779|NCT02315066|37759430|FG007|Overall Study|Subject refused further follow-up|3|||
16816780|NCT02315066|37759431|FG008|Overall Study|Subject refused further follow-up|0|||
16816781|NCT02315066|37759432|FG009|Overall Study|Subject refused further follow-up|1|||
16816782|NCT02315066|37759433|FG010|Overall Study|Subject refused further follow-up|1|||
16816783|NCT02315066|37759434|FG011|Overall Study|Subject refused further follow-up|2|||
16816784|NCT02315066|37759435|FG012|Overall Study|Subject refused further follow-up|2|||
16816785|NCT02315066|37759436|FG013|Overall Study|Subject refused further follow-up|4|||
16816786|NCT02315066|37759423|FG000|Overall Study|Study ongoing at date of cut-off|0|||
16816787|NCT02315066|37759424|FG001|Overall Study|Study ongoing at date of cut-off|0|||
16816788|NCT02315066|37759425|FG002|Overall Study|Study ongoing at date of cut-off|0|||
16816789|NCT02315066|37759426|FG003|Overall Study|Study ongoing at date of cut-off|0|||
16816790|NCT02315066|37759427|FG004|Overall Study|Study ongoing at date of cut-off|0|||
16816791|NCT02315066|37759428|FG005|Overall Study|Study ongoing at date of cut-off|0|||
16816792|NCT02315066|37759429|FG006|Overall Study|Study ongoing at date of cut-off|0|||
16816793|NCT02315066|37759430|FG007|Overall Study|Study ongoing at date of cut-off|0|||
16816794|NCT02315066|37759431|FG008|Overall Study|Study ongoing at date of cut-off|0|||
16816795|NCT02315066|37759432|FG009|Overall Study|Study ongoing at date of cut-off|0|||
16816796|NCT02315066|37759433|FG010|Overall Study|Study ongoing at date of cut-off|0|||
16816797|NCT02315066|37759434|FG011|Overall Study|Study ongoing at date of cut-off|0|||
16816798|NCT02315066|37759435|FG012|Overall Study|Study ongoing at date of cut-off|0|||
16816799|NCT02315066|37759436|FG013|Overall Study|Study ongoing at date of cut-off|1|||
16816800|NCT02207413|37759472|FG000|Overall Study|Withdrawal by Subject|1|||
16816801|NCT02207413|37759473|FG001|Overall Study|Withdrawal by Subject|0|||
16816802|NCT02207413|37759474|FG002|Overall Study|Withdrawal by Subject|0|||
16816803|NCT02207413|37759475|FG003|Overall Study|Withdrawal by Subject|0|||
16816804|NCT02207413|37759476|FG004|Overall Study|Withdrawal by Subject|3|||
16816805|NCT02207413|37759477|FG005|Overall Study|Withdrawal by Subject|7|||
16816806|NCT02207413|37759472|FG000|Overall Study|Lost to Follow-up|0|||
16816807|NCT02207413|37759473|FG001|Overall Study|Lost to Follow-up|0|||
16816808|NCT02207413|37759474|FG002|Overall Study|Lost to Follow-up|0|||
16816809|NCT02207413|37759475|FG003|Overall Study|Lost to Follow-up|1|||
16816810|NCT02207413|37759476|FG004|Overall Study|Lost to Follow-up|1|||
16816811|NCT02207413|37759477|FG005|Overall Study|Lost to Follow-up|5|||
16816812|NCT02207413|37759472|FG000|Overall Study|Adverse Event|0|||
16816813|NCT02207413|37759473|FG001|Overall Study|Adverse Event|0|||
16816814|NCT02207413|37759474|FG002|Overall Study|Adverse Event|0|||
16816815|NCT02207413|37759475|FG003|Overall Study|Adverse Event|0|||
16816816|NCT02207413|37759476|FG004|Overall Study|Adverse Event|2|||
16816817|NCT02207413|37759477|FG005|Overall Study|Adverse Event|1|||
16816818|NCT02207413|37759472|FG000|Overall Study|Migrated/moved from study area|0|||
16816819|NCT02207413|37759473|FG001|Overall Study|Migrated/moved from study area|0|||
16816820|NCT02207413|37759474|FG002|Overall Study|Migrated/moved from study area|0|||
16816821|NCT02207413|37759475|FG003|Overall Study|Migrated/moved from study area|0|||
16816822|NCT02207413|37759476|FG004|Overall Study|Migrated/moved from study area|1|||
16816823|NCT02207413|37759477|FG005|Overall Study|Migrated/moved from study area|0|||
16816824|NCT02309372|37759499|FG000|Overall Study|Lost to Follow-up|3|||
16816825|NCT02309372|37759500|FG001|Overall Study|Lost to Follow-up|2|||
16816826|NCT02276027|37759510|FG000|Overall Study|Death|1|||
16816827|NCT02276027|37759511|FG001|Overall Study|Death|0|||
16816828|NCT02276027|37759512|FG002|Overall Study|Death|0|||
16816829|NCT02276027|37759513|FG003|Overall Study|Death|2|||
16816830|NCT02276027|37759510|FG000|Overall Study|Physician Decision|0|||
16816831|NCT02276027|37759511|FG001|Overall Study|Physician Decision|0|||
16816832|NCT02276027|37759512|FG002|Overall Study|Physician Decision|0|||
16816833|NCT02276027|37759513|FG003|Overall Study|Physician Decision|1|||
16816834|NCT02276027|37759510|FG000|Overall Study|Progressive disease|1|||
16816835|NCT02276027|37759511|FG001|Overall Study|Progressive disease|13|||
16816836|NCT02276027|37759512|FG002|Overall Study|Progressive disease|12|||
16816837|NCT02276027|37759513|FG003|Overall Study|Progressive disease|14|||
16816838|NCT02276027|37759510|FG000|Overall Study|Subject/guardian decision|0|||
16816839|NCT02276027|37759511|FG001|Overall Study|Subject/guardian decision|1|||
16816840|NCT02276027|37759512|FG002|Overall Study|Subject/guardian decision|0|||
16816841|NCT02276027|37759513|FG003|Overall Study|Subject/guardian decision|3|||
16816842|NCT02276027|37759510|FG000|Overall Study|Adverse Event|0|||
16816843|NCT02276027|37759511|FG001|Overall Study|Adverse Event|2|||
16816844|NCT02276027|37759512|FG002|Overall Study|Adverse Event|8|||
16816845|NCT02276027|37759513|FG003|Overall Study|Adverse Event|2|||
16816846|NCT02309294|37759523|FG000|Overall Study|Withdrawal by Subject|2|||
16816847|NCT02233543|37759527|FG000|Period 1|Withdrawal by Subject|1|||
16816848|NCT02233543|37759528|FG001|Period 1|Withdrawal by Subject|0|||
16816849|NCT02233543|37759527|FG000|Period 1|Participants required other treatment.|2|||
16816850|NCT02233543|37759528|FG001|Period 1|Participants required other treatment.|3|||
16816851|NCT02233543|37759527|FG000|Period 2|Adverse Event|1|||
16816852|NCT02233543|37759528|FG001|Period 2|Adverse Event|0|||
16816853|NCT02233543|37759527|FG000|Period 2|Participant required other treatment.|0|||
16816854|NCT02233543|37759528|FG001|Period 2|Participant required other treatment.|1|||
16816855|NCT02233543|37759527|FG000|Period 2|COPD exacerbation|1|||
16816856|NCT02233543|37759528|FG001|Period 2|COPD exacerbation|0|||
16816857|NCT02309138|37759536|FG000|Overall Study|Withdrawal by Subject|44|||
16816858|NCT02309138|37759537|FG001|Overall Study|Withdrawal by Subject|15|||
16816859|NCT02309138|37759536|FG000|Overall Study|Protocol Violation|4|||
16816860|NCT02309138|37759537|FG001|Overall Study|Protocol Violation|2|||
16816861|NCT02309138|37759536|FG000|Overall Study|delivered before visit 2|0|||
16816862|NCT02309138|37759537|FG001|Overall Study|delivered before visit 2|1|||
16816863|NCT02233309|37759553|FG000|Overall Study|Physician Decision|5|||
16816864|NCT02204917|37759557|FG000|Overall Study|Protocol Violation|1|||
16816865|NCT02280044|37759566|FG000|Overall Study|Planned alternate|0|||
16816866|NCT02280044|37759567|FG001|Overall Study|Planned alternate|2|||
16816867|NCT02308748|37759573|FG000|Period 1|Withdrawal by Subject|0|||
16816868|NCT02308748|37759574|FG001|Period 1|Withdrawal by Subject|0|||
16816869|NCT02308748|37759575|FG002|Period 1|Withdrawal by Subject|1|||
16816870|NCT02308748|37759576|FG003|Period 1|Withdrawal by Subject|0|||
16816871|NCT02308748|37759577|FG004|Period 1|Withdrawal by Subject|0|||
16816872|NCT02308748|37759578|FG005|Period 1|Withdrawal by Subject|0|||
16816873|NCT02308748|37759579|FG006|Period 1|Withdrawal by Subject|0|||
16816874|NCT02308748|37759580|FG007|Period 1|Withdrawal by Subject|0|||
16816875|NCT02308748|37759581|FG008|Period 1|Withdrawal by Subject|0|||
16816876|NCT02308748|37759582|FG009|Period 1|Withdrawal by Subject|0|||
16816877|NCT02308748|37759573|FG000|Period 2|Adverse Event|0|||
16816878|NCT02308748|37759574|FG001|Period 2|Adverse Event|0|||
16816879|NCT02308748|37759575|FG002|Period 2|Adverse Event|0|||
16816880|NCT02308748|37759576|FG003|Period 2|Adverse Event|0|||
16816881|NCT02308748|37759577|FG004|Period 2|Adverse Event|0|||
16816882|NCT02308748|37759578|FG005|Period 2|Adverse Event|0|||
16816883|NCT02308748|37759579|FG006|Period 2|Adverse Event|0|||
16816884|NCT02308748|37759580|FG007|Period 2|Adverse Event|1|||
16816885|NCT02308748|37759581|FG008|Period 2|Adverse Event|0|||
16816886|NCT02308748|37759582|FG009|Period 2|Adverse Event|0|||
16816887|NCT02308748|37759573|FG000|Period 3|Protocol Violation|0|||
16816888|NCT02308748|37759574|FG001|Period 3|Protocol Violation|0|||
16816889|NCT02308748|37759575|FG002|Period 3|Protocol Violation|0|||
16816890|NCT02308748|37759576|FG003|Period 3|Protocol Violation|0|||
16816891|NCT02308748|37759577|FG004|Period 3|Protocol Violation|0|||
16816892|NCT02308748|37759578|FG005|Period 3|Protocol Violation|0|||
16816893|NCT02308748|37759579|FG006|Period 3|Protocol Violation|0|||
16816894|NCT02308748|37759580|FG007|Period 3|Protocol Violation|0|||
16816895|NCT02308748|37759581|FG008|Period 3|Protocol Violation|0|||
16816896|NCT02308748|37759582|FG009|Period 3|Protocol Violation|1|||
16816897|NCT02308748|37759573|FG000|Period 5|Adverse Event|1|||
16816898|NCT02308748|37759574|FG001|Period 5|Adverse Event|0|||
16816899|NCT02308748|37759575|FG002|Period 5|Adverse Event|0|||
16816900|NCT02308748|37759576|FG003|Period 5|Adverse Event|0|||
16816901|NCT02308748|37759577|FG004|Period 5|Adverse Event|0|||
16816902|NCT02308748|37759578|FG005|Period 5|Adverse Event|0|||
16816903|NCT02308748|37759579|FG006|Period 5|Adverse Event|0|||
16816904|NCT02308748|37759580|FG007|Period 5|Adverse Event|0|||
16816905|NCT02308748|37759581|FG008|Period 5|Adverse Event|1|||
16816906|NCT02308748|37759582|FG009|Period 5|Adverse Event|0|||
16816907|NCT01646216|37759596|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
16816908|NCT01646216|37759597|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
16816909|NCT01646216|37759596|FG000|Overall Study|Did not complete training|0|||
16816910|NCT01646216|37759597|FG001|Overall Study|Did not complete training|2|||
16816911|NCT01646216|37759596|FG000|Overall Study|Investigator decision|1|||
16816912|NCT01646216|37759597|FG001|Overall Study|Investigator decision|1|||
16816913|NCT02308124|37759610|FG000|Overall Study|Lost to Follow-up|6|||
16816914|NCT02308124|37759611|FG001|Overall Study|Lost to Follow-up|6|||
16816915|NCT02308124|37759612|FG002|Overall Study|Lost to Follow-up|6|||
16816916|NCT02308124|37759610|FG000|Overall Study|Adverse Event|0|||
16816917|NCT02308124|37759611|FG001|Overall Study|Adverse Event|2|||
16816918|NCT02308124|37759612|FG002|Overall Study|Adverse Event|2|||
16816919|NCT02232061|37759620|FG000|Overall Study|Administrative problems|1|||
16816920|NCT02232061|37759620|FG000|Overall Study|Withdrawal by Subject|1|||
16816921|NCT02275481|37759626|FG000|Overall Study|Death|2|||
16816922|NCT02275481|37759627|FG001|Overall Study|Death|1|||
16816923|NCT02275481|37759626|FG000|Overall Study|Lost to Follow-up|2|||
16816924|NCT02275481|37759627|FG001|Overall Study|Lost to Follow-up|0|||
16816925|NCT02275481|37759626|FG000|Overall Study|Withdrawal by Subject|3|||
16816926|NCT02275481|37759627|FG001|Overall Study|Withdrawal by Subject|0|||
16816927|NCT02275481|37759626|FG000|Overall Study|all other reasons combined|2|||
16816928|NCT02275481|37759627|FG001|Overall Study|all other reasons combined|1|||
16816929|NCT02275481|37759626|FG000|Overall Study|Physician Decision|0|||
16816930|NCT02275481|37759627|FG001|Overall Study|Physician Decision|1|||
16816931|NCT02204449|37759635|FG000|Overall Study|Lost to Follow-up|7|||
16816932|NCT02204449|37759636|FG001|Overall Study|Lost to Follow-up|9|||
16816933|NCT02204449|37759635|FG000|Overall Study|Death|0|||
16816934|NCT02204449|37759636|FG001|Overall Study|Death|1|||
16816935|NCT02204449|37759635|FG000|Overall Study|Withdrawal by Subject|0|||
16816936|NCT02204449|37759636|FG001|Overall Study|Withdrawal by Subject|1|||
16816937|NCT02308046|37759644|FG000|Overall Study|Negative yeast culture at Baseline|32|||
16816938|NCT02308046|37759645|FG001|Overall Study|Negative yeast culture at Baseline|33|||
16816939|NCT02308046|37759644|FG000|Overall Study|Positive for STD at Baseline|1|||
16816940|NCT02308046|37759645|FG001|Overall Study|Positive for STD at Baseline|2|||
16816941|NCT02308046|37759644|FG000|Overall Study|Lost to Follow-up|1|||
16816942|NCT02308046|37759645|FG001|Overall Study|Lost to Follow-up|3|||
16816943|NCT02318693|37759653|FG000|Overall Study|Protocol Violation|0|||
16816944|NCT02318693|37759654|FG001|Overall Study|Protocol Violation|1|||
16816945|NCT02230891|37759663|FG000|Baseline|Did not meet inclusion|0|||
16816946|NCT02230891|37759664|FG001|Baseline|Did not meet inclusion|1|||
16816947|NCT02230891|37759665|FG002|Baseline|Did not meet inclusion|1|||
16816948|NCT02230891|37759663|FG000|2 Week|Withdrawal by Subject|2|||
16816949|NCT02230891|37759664|FG001|2 Week|Withdrawal by Subject|2|||
16816950|NCT02230891|37759665|FG002|2 Week|Withdrawal by Subject|0|||
16816951|NCT02230891|37759663|FG000|2 Week|Consent withdrawn|1|||
16816952|NCT02230891|37759664|FG001|2 Week|Consent withdrawn|0|||
16816953|NCT02230891|37759665|FG002|2 Week|Consent withdrawn|0|||
16816954|NCT02230891|37759663|FG000|6 Month|Withdrawal by Subject|1|||
16816955|NCT02230891|37759664|FG001|6 Month|Withdrawal by Subject|1|||
16816956|NCT02230891|37759665|FG002|6 Month|Withdrawal by Subject|1|||
16816957|NCT02230891|37759663|FG000|6 Month|Physician Decision|0|||
16816958|NCT02230891|37759664|FG001|6 Month|Physician Decision|2|||
16816959|NCT02230891|37759665|FG002|6 Month|Physician Decision|0|||
16816960|NCT02230891|37759663|FG000|12 Month|Death|1|||
16816961|NCT02230891|37759664|FG001|12 Month|Death|0|||
16816962|NCT02230891|37759665|FG002|12 Month|Death|0|||
16816963|NCT02230891|37759663|FG000|12 Month|Lost to Follow-up|0|||
16816964|NCT02230891|37759664|FG001|12 Month|Lost to Follow-up|1|||
16816965|NCT02230891|37759665|FG002|12 Month|Lost to Follow-up|0|||
16816966|NCT02230891|37759663|FG000|12 Month|Withdrawal by Subject|0|||
16816967|NCT02230891|37759664|FG001|12 Month|Withdrawal by Subject|2|||
16816968|NCT02230891|37759665|FG002|12 Month|Withdrawal by Subject|0|||
16816969|NCT02230891|37759663|FG000|18 Month End of Study|Death|0|||
16816970|NCT02230891|37759664|FG001|18 Month End of Study|Death|0|||
16816971|NCT02230891|37759665|FG002|18 Month End of Study|Death|1|||
16816972|NCT02230891|37759663|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
16816973|NCT02230891|37759664|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
16816974|NCT02230891|37759665|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
16816975|NCT01646138|37759680|FG000|Overall Study|Lost to Follow-up|0|||
16816976|NCT01646138|37759681|FG001|Overall Study|Lost to Follow-up|0|||
16816977|NCT01646138|37759682|FG002|Overall Study|Lost to Follow-up|0|||
16816978|NCT01646138|37759683|FG003|Overall Study|Lost to Follow-up|0|||
16816979|NCT01646138|37759684|FG004|Overall Study|Lost to Follow-up|2|||
16816980|NCT02204371|37759696|FG000|Overall Study|Adverse Event|1|||
16816981|NCT02274857|37759702|FG000|Overall Study|Adverse Event|1|||
16816982|NCT02274857|37759703|FG001|Overall Study|Adverse Event|0|||
16816983|NCT02274857|37759702|FG000|Overall Study|Death|1|||
16816984|NCT02274857|37759703|FG001|Overall Study|Death|2|||
16816985|NCT02274857|37759702|FG000|Overall Study|Lost to Follow-up|3|||
16816986|NCT02274857|37759703|FG001|Overall Study|Lost to Follow-up|0|||
16816987|NCT02274857|37759702|FG000|Overall Study|Physician Decision|2|||
16816988|NCT02274857|37759703|FG001|Overall Study|Physician Decision|0|||
16816989|NCT02274857|37759702|FG000|Overall Study|Trial screen failure|0|||
16816990|NCT02274857|37759703|FG001|Overall Study|Trial screen failure|2|||
16910666|NCT01587924|38019603|FG000|Overall Study|Protocol Violation|2|||
16910667|NCT01587924|38019604|FG001|Overall Study|Protocol Violation|1|||
16910668|NCT01587924|38019605|FG002|Overall Study|Protocol Violation|2|||
16910669|NCT01587924|38019606|FG003|Overall Study|Protocol Violation|1|||
16910670|NCT01587924|38019603|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
16910671|NCT01587924|38019604|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
16910672|NCT01587924|38019605|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
16910673|NCT01587924|38019606|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
16910674|NCT01587924|38019603|FG000|Overall Study|Withdrawal by Subject|0|||
16910675|NCT01587924|38019604|FG001|Overall Study|Withdrawal by Subject|1|||
16910676|NCT01587924|38019605|FG002|Overall Study|Withdrawal by Subject|1|||
16910677|NCT01587924|38019606|FG003|Overall Study|Withdrawal by Subject|0|||
16910678|NCT01539642|38019618|FG000|Overall Study|Lack of Efficacy|20|||
17102340|NCT00115934|38241259|FG000|Overall Study|Lost to Follow-up|1|||
16816991|NCT02274857|37759702|FG000|Overall Study|Withdrawal by Subject|11|||
16816992|NCT02274857|37759703|FG001|Overall Study|Withdrawal by Subject|2|||
16816993|NCT02274857|37759702|FG000|Overall Study|Other|2|||
16816994|NCT02274857|37759703|FG001|Overall Study|Other|0|||
16816995|NCT02302859|37759712|FG000|Overall Study|Lost Phone|1|||
16816996|NCT02302859|37759713|FG001|Overall Study|Lost Phone|1|||
16816997|NCT02302859|37759712|FG000|Overall Study|Withdrawal by Subject|0|||
16816998|NCT02302859|37759713|FG001|Overall Study|Withdrawal by Subject|1|||
16910679|NCT01539642|38019619|FG001|Overall Study|Lack of Efficacy|18|||
16816999|NCT02274311|37759719|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
16817000|NCT02316353|37759727|FG000|Overall Study|Pregnancy|1|||
16817001|NCT02316353|37759728|FG001|Overall Study|Pregnancy|3|||
16817002|NCT02316353|37759727|FG000|Overall Study|Adverse Event|1|||
16817003|NCT02316353|37759728|FG001|Overall Study|Adverse Event|3|||
16817004|NCT02316353|37759727|FG000|Overall Study|Withdrawal by Subject|6|||
16817005|NCT02316353|37759728|FG001|Overall Study|Withdrawal by Subject|2|||
16817006|NCT02273141|37759739|FG000|Overall Study|Adverse Event|0|||
16817007|NCT02273141|37759740|FG001|Overall Study|Adverse Event|1|||
16817008|NCT02273141|37759739|FG000|Overall Study|Lost to Follow-up|1|||
16817009|NCT02273141|37759740|FG001|Overall Study|Lost to Follow-up|3|||
16817010|NCT02273141|37759739|FG000|Overall Study|Withdrawal by Subject|10|||
16817011|NCT02273141|37759740|FG001|Overall Study|Withdrawal by Subject|15|||
16817012|NCT02273141|37759739|FG000|Overall Study|Various|6|||
16817013|NCT02273141|37759740|FG001|Overall Study|Various|6|||
16817014|NCT02314052|37759746|FG000|Cycle One|Adverse Event|0|||
16817015|NCT02314052|37759747|FG001|Cycle One|Adverse Event|0|||
16817016|NCT02314052|37759748|FG002|Cycle One|Adverse Event|0|||
16817017|NCT02314052|37759749|FG003|Cycle One|Adverse Event|1|||
16817018|NCT02314052|37759750|FG004|Cycle One|Adverse Event|0|||
16817019|NCT02314052|37759751|FG005|Cycle One|Adverse Event|0|||
16817020|NCT02279732|37759767|FG000|Overall Study|Death|23|||
16817021|NCT02279732|37759768|FG001|Overall Study|Death|20|||
16817022|NCT02279732|37759767|FG000|Overall Study|Disease Progression|13|||
16817023|NCT02279732|37759768|FG001|Overall Study|Disease Progression|3|||
16817024|NCT02279732|37759767|FG000|Overall Study|Withdrawal by Subject|2|||
16817025|NCT02279732|37759768|FG001|Overall Study|Withdrawal by Subject|7|||
16817026|NCT02279732|37759767|FG000|Overall Study|Adverse Event|1|||
16817027|NCT02279732|37759768|FG001|Overall Study|Adverse Event|2|||
16817028|NCT02279732|37759767|FG000|Overall Study|Administrative Reason By Sponsor|0|||
16817029|NCT02279732|37759768|FG001|Overall Study|Administrative Reason By Sponsor|2|||
16817030|NCT02279732|37759767|FG000|Overall Study|Study Drug Toxicity|2|||
16817031|NCT02279732|37759768|FG001|Overall Study|Study Drug Toxicity|0|||
16817032|NCT02279732|37759767|FG000|Overall Study|Lost to Follow-up|0|||
16817033|NCT02279732|37759768|FG001|Overall Study|Lost to Follow-up|1|||
16817034|NCT02279732|37759767|FG000|Overall Study|Maximum Clinical Benefit|1|||
16817035|NCT02279732|37759768|FG001|Overall Study|Maximum Clinical Benefit|0|||
16817036|NCT02279732|37759767|FG000|Overall Study|Subject Requested to Discontinue|0|||
16817037|NCT02279732|37759768|FG001|Overall Study|Subject Requested to Discontinue|1|||
16817038|NCT02279732|37759767|FG000|Overall Study|Other|53|||
16817039|NCT02279732|37759768|FG001|Overall Study|Other|67|||
16817040|NCT02279732|37759767|FG000|Overall Study|Other|3|||
16817041|NCT02279732|37759768|FG001|Overall Study|Other|3|||
16817042|NCT02279498|37759776|FG000|Overall Study|Adverse Event|3|||
16817043|NCT02279498|37759777|FG001|Overall Study|Adverse Event|0|||
16817044|NCT02279498|37759776|FG000|Overall Study|Lack of Efficacy|4|||
16817045|NCT02279498|37759777|FG001|Overall Study|Lack of Efficacy|0|||
16817046|NCT02279498|37759776|FG000|Overall Study|Lost to Follow-up|0|||
16817047|NCT02279498|37759777|FG001|Overall Study|Lost to Follow-up|1|||
16817048|NCT02279498|37759776|FG000|Overall Study|Withdrawal by Subject|9|||
16817049|NCT02279498|37759777|FG001|Overall Study|Withdrawal by Subject|2|||
16817050|NCT02279498|37759776|FG000|Overall Study|Undefined|2|||
16817051|NCT02279498|37759777|FG001|Overall Study|Undefined|1|||
16817052|NCT02307266|37759787|FG000|Overall Study|Adverse Event|3|||
16817053|NCT02307266|37759788|FG001|Overall Study|Adverse Event|1|||
16817054|NCT02307266|37759789|FG002|Overall Study|Adverse Event|5|||
16817055|NCT02307266|37759787|FG000|Overall Study|Withdrawal by Subject|2|||
16817056|NCT02307266|37759788|FG001|Overall Study|Withdrawal by Subject|0|||
16817057|NCT02307266|37759789|FG002|Overall Study|Withdrawal by Subject|1|||
16817058|NCT02307266|37759787|FG000|Overall Study|Lost to Follow-up|3|||
16817059|NCT02307266|37759788|FG001|Overall Study|Lost to Follow-up|0|||
16817060|NCT02307266|37759789|FG002|Overall Study|Lost to Follow-up|0|||
16817061|NCT02279420|37759797|FG000|Overall Study|Lost to Follow-up|23|||
16817062|NCT02278952|37759801|FG000|Overall Study|Insufficient Sample|6|||
16817063|NCT02278328|37759811|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
16817064|NCT02278328|37759812|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
16817065|NCT02278328|37759813|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
16817066|NCT02278328|37759811|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
16817067|NCT02278328|37759812|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
16817068|NCT02278328|37759813|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
16817069|NCT02278328|37759811|FG000|Neuropsych Screening|incomplete consent|0|||
16817070|NCT02278328|37759812|FG001|Neuropsych Screening|incomplete consent|0|||
16817071|NCT02278328|37759813|FG002|Neuropsych Screening|incomplete consent|2|||
16817072|NCT02314637|37759821|FG000|Overall Study|Adverse Event|4|||
16817073|NCT02314637|37759822|FG001|Overall Study|Adverse Event|8|||
16817074|NCT02314637|37759821|FG000|Overall Study|Lack of Efficacy|1|||
16817075|NCT02314637|37759822|FG001|Overall Study|Lack of Efficacy|0|||
16817076|NCT02314637|37759821|FG000|Overall Study|Physician Decision|5|||
16817077|NCT02314637|37759822|FG001|Overall Study|Physician Decision|2|||
16817078|NCT02314637|37759821|FG000|Overall Study|Withdrawal by Subject|5|||
16817079|NCT02314637|37759822|FG001|Overall Study|Withdrawal by Subject|4|||
16817080|NCT02314637|37759821|FG000|Overall Study|Other Reason|1|||
16817081|NCT02314637|37759822|FG001|Overall Study|Other Reason|0|||
16817082|NCT01646645|37759828|FG000|Overall Study|No Treated|1|||
16817083|NCT01646645|37759828|FG000|Overall Study|Inevaluable Donor|29|||
16817084|NCT02272985|37759832|FG000|Overall Study|Withdrawal by Subject|1|||
16817085|NCT02272985|37759832|FG000|Overall Study|hip fracture|1|||
16817086|NCT02272985|37759832|FG000|Overall Study|kidney transplantation|1|||
16817087|NCT01644149|37759839|FG000|Overall Study|Withdrawal by Subject|1|||
16817088|NCT01644149|37759840|FG001|Overall Study|Withdrawal by Subject|0|||
16817089|NCT01644149|37759839|FG000|Overall Study|Lost to Follow-up|3|||
16817090|NCT01644149|37759840|FG001|Overall Study|Lost to Follow-up|1|||
16817091|NCT02313233|37759849|FG000|Overall Study|Withdrawal by Subject|1|||
16817092|NCT02313233|37759850|FG001|Overall Study|Withdrawal by Subject|2|||
16817093|NCT02313233|37759849|FG000|Overall Study|Administrative reason|1|||
16817094|NCT02313233|37759850|FG001|Overall Study|Administrative reason|1|||
16817095|NCT02305238|37759861|FG000|Overall Study|Death|2|||
16817096|NCT02305238|37759862|FG001|Overall Study|Death|1|||
16817097|NCT02305238|37759863|FG002|Overall Study|Death|0|||
16817098|NCT02305238|37759861|FG000|Overall Study|Progressive disease|4|||
16817099|NCT02305238|37759862|FG001|Overall Study|Progressive disease|4|||
16817100|NCT02305238|37759863|FG002|Overall Study|Progressive disease|0|||
16817101|NCT02305238|37759861|FG000|Overall Study|Logistical difficulties|1|||
16817102|NCT02305238|37759862|FG001|Overall Study|Logistical difficulties|3|||
16817103|NCT02305238|37759863|FG002|Overall Study|Logistical difficulties|0|||
16817104|NCT02305238|37759861|FG000|Overall Study|Protocol Violation|0|||
16817105|NCT02305238|37759862|FG001|Overall Study|Protocol Violation|3|||
16817106|NCT02305238|37759863|FG002|Overall Study|Protocol Violation|0|||
16817107|NCT02305238|37759861|FG000|Overall Study|Physician Decision|2|||
16817108|NCT02305238|37759862|FG001|Overall Study|Physician Decision|1|||
16817109|NCT02305238|37759863|FG002|Overall Study|Physician Decision|0|||
16817110|NCT02305238|37759861|FG000|Overall Study|Adverse Event|4|||
16817111|NCT02305238|37759862|FG001|Overall Study|Adverse Event|2|||
16817112|NCT02305238|37759863|FG002|Overall Study|Adverse Event|0|||
16817113|NCT02305238|37759861|FG000|Overall Study|Withdrawal by Subject|3|||
16817114|NCT02305238|37759862|FG001|Overall Study|Withdrawal by Subject|4|||
16817115|NCT02305238|37759863|FG002|Overall Study|Withdrawal by Subject|0|||
16817116|NCT02305238|37759861|FG000|Overall Study|Randomized failure|0|||
16817117|NCT02305238|37759862|FG001|Overall Study|Randomized failure|0|||
16817118|NCT02305238|37759863|FG002|Overall Study|Randomized failure|8|||
16817119|NCT02305238|37759861|FG000|Overall Study|Required procedure failed|0|||
16817120|NCT02305238|37759862|FG001|Overall Study|Required procedure failed|1|||
16817121|NCT02305238|37759863|FG002|Overall Study|Required procedure failed|0|||
16817122|NCT02313155|37759872|FG000|Overall Study|Lost to Follow-up|0|||
16817123|NCT02313155|37759873|FG001|Overall Study|Lost to Follow-up|1|||
16817124|NCT02204293|37759881|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
16817125|NCT02204293|37759882|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
16817126|NCT02204293|37759883|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
16817127|NCT02204293|37759884|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
16817128|NCT02204293|37759885|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
16817129|NCT02204293|37759886|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
16817130|NCT02204293|37759881|FG000|Core Study Part I|Adverse Event|1|||
16817131|NCT02204293|37759882|FG001|Core Study Part I|Adverse Event|0|||
16817132|NCT02204293|37759883|FG002|Core Study Part I|Adverse Event|0|||
16817133|NCT02204293|37759884|FG003|Core Study Part I|Adverse Event|0|||
16817134|NCT02204293|37759885|FG004|Core Study Part I|Adverse Event|0|||
16817135|NCT02204293|37759886|FG005|Core Study Part I|Adverse Event|0|||
16817136|NCT02204293|37759881|FG000|Core Study Part I|Physician Decision|0|||
16817137|NCT02204293|37759882|FG001|Core Study Part I|Physician Decision|3|||
16817138|NCT02204293|37759883|FG002|Core Study Part I|Physician Decision|0|||
16817139|NCT02204293|37759884|FG003|Core Study Part I|Physician Decision|0|||
16817140|NCT02204293|37759885|FG004|Core Study Part I|Physician Decision|0|||
16817141|NCT02204293|37759886|FG005|Core Study Part I|Physician Decision|0|||
16817142|NCT02204293|37759881|FG000|LTE Phase|Study Suspended|0|||
16817143|NCT02204293|37759882|FG001|LTE Phase|Study Suspended|0|||
16817144|NCT02204293|37759883|FG002|LTE Phase|Study Suspended|0|||
16817145|NCT02204293|37759884|FG003|LTE Phase|Study Suspended|0|||
16817146|NCT02204293|37759885|FG004|LTE Phase|Study Suspended|0|||
16817147|NCT02204293|37759886|FG005|LTE Phase|Study Suspended|7|||
16817148|NCT02304926|37759902|FG000|Overall Study|Lost to Follow-up|2|||
16817149|NCT02304926|37759903|FG001|Overall Study|Lost to Follow-up|1|||
16910680|NCT01539642|38019618|FG000|Overall Study|Patient ready for early discharge|8|||
16910681|NCT01539642|38019619|FG001|Overall Study|Patient ready for early discharge|7|||
16817150|NCT01646255|37759913|FG000|Overall Study|Adverse Event|7|||
16817151|NCT01646255|37759914|FG001|Overall Study|Adverse Event|8|||
16817152|NCT01646255|37759913|FG000|Overall Study|Lack of Efficacy|2|||
16817153|NCT01646255|37759914|FG001|Overall Study|Lack of Efficacy|0|||
16817154|NCT01646255|37759913|FG000|Overall Study|Withdrawal by Subject|10|||
16817155|NCT01646255|37759914|FG001|Overall Study|Withdrawal by Subject|6|||
16817156|NCT01646255|37759913|FG000|Overall Study|Compliance is not well|1|||
16817157|NCT01646255|37759914|FG001|Overall Study|Compliance is not well|0|||
16817158|NCT01646255|37759913|FG000|Overall Study|Inclusion Criteria Deviation|1|||
16817159|NCT01646255|37759914|FG001|Overall Study|Inclusion Criteria Deviation|0|||
16817160|NCT02304380|37759927|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16817161|NCT02304380|37759928|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16817162|NCT02304380|37759929|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16817163|NCT02304380|37759930|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
16817164|NCT02304380|37759931|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16817165|NCT02304380|37759932|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16817166|NCT02203591|37759954|FG000|Overall Study|Did not meet treatment day baseline|147|||
16817167|NCT02203591|37759955|FG001|Overall Study|Did not meet treatment day baseline|141|||
16817168|NCT02203591|37759956|FG002|Overall Study|Did not meet treatment day baseline|150|||
16817169|NCT02203591|37759957|FG003|Overall Study|Did not meet treatment day baseline|45|||
16817170|NCT02203591|37759958|FG004|Overall Study|Did not meet treatment day baseline|33|||
16817171|NCT02203591|37759959|FG005|Overall Study|Did not meet treatment day baseline|35|||
16817172|NCT02203591|37759960|FG006|Overall Study|Did not meet treatment day baseline|29|||
16817173|NCT02203591|37759961|FG007|Overall Study|Did not meet treatment day baseline|12|||
16817174|NCT02203591|37759954|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
16817175|NCT02203591|37759955|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
16817176|NCT02203591|37759956|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
16817177|NCT02203591|37759957|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
16817178|NCT02203591|37759958|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
16817179|NCT02203591|37759959|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
16817180|NCT02203591|37759960|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
16817181|NCT02203591|37759961|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
16817182|NCT01642277|37759985|FG000|Overall Study|Adverse Event|10|||
16817183|NCT01642277|37759986|FG001|Overall Study|Adverse Event|0|||
16817184|NCT01642277|37759985|FG000|Overall Study|Physician Decision|2|||
16817185|NCT01642277|37759986|FG001|Overall Study|Physician Decision|0|||
16817186|NCT01642277|37759985|FG000|Overall Study|Protocol Violation|1|||
16817187|NCT01642277|37759986|FG001|Overall Study|Protocol Violation|0|||
16817188|NCT01642277|37759985|FG000|Overall Study|Withdrawal by Subject|11|||
16817189|NCT01642277|37759986|FG001|Overall Study|Withdrawal by Subject|0|||
16817190|NCT02230189|37759996|FG000|Overall Study|Withdrawal by Subject|3|||
16817191|NCT02230189|37759997|FG001|Overall Study|Withdrawal by Subject|0|||
16817192|NCT02230189|37759998|FG002|Overall Study|Withdrawal by Subject|1|||
16817193|NCT02230189|37759996|FG000|Overall Study|Lost to Follow-up|1|||
16817194|NCT02230189|37759997|FG001|Overall Study|Lost to Follow-up|0|||
16817195|NCT02230189|37759998|FG002|Overall Study|Lost to Follow-up|0|||
16817196|NCT02230189|37759996|FG000|Overall Study|Physician Decision|1|||
16817197|NCT02230189|37759997|FG001|Overall Study|Physician Decision|0|||
16817198|NCT02230189|37759998|FG002|Overall Study|Physician Decision|0|||
16817199|NCT02304302|37760009|FG000|Overall Study|Adverse Event|2|||
16817200|NCT02304302|37760010|FG001|Overall Study|Adverse Event|3|||
16817201|NCT02304302|37760009|FG000|Overall Study|Lost to Follow-up|1|||
16817202|NCT02304302|37760010|FG001|Overall Study|Lost to Follow-up|4|||
16817203|NCT02304302|37760009|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
16817204|NCT02304302|37760010|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
16817205|NCT02276612|37760022|FG000|Overall Study|Death|1|||
16817206|NCT02276612|37760023|FG001|Overall Study|Death|0|||
16817207|NCT02276612|37760022|FG000|Overall Study|Pregnancy|1|||
16817208|NCT02276612|37760023|FG001|Overall Study|Pregnancy|0|||
16817209|NCT02276612|37760022|FG000|Overall Study|Withdrew Consent|1|||
16817210|NCT02276612|37760023|FG001|Overall Study|Withdrew Consent|0|||
16817211|NCT02276612|37760022|FG000|Overall Study|Lost to Follow-up|1|||
16817212|NCT02276612|37760023|FG001|Overall Study|Lost to Follow-up|0|||
16817213|NCT02301143|37760029|FG000|Induction Period|Enrolled But Not Treated|1|||
16817214|NCT02301143|37760030|FG001|Induction Period|Enrolled But Not Treated|0|||
16817215|NCT02301143|37760029|FG000|Induction Period|Death|1|||
16817216|NCT02301143|37760030|FG001|Induction Period|Death|0|||
16817217|NCT02301143|37760029|FG000|Induction Period|Adverse Event|22|||
16817218|NCT02301143|37760030|FG001|Induction Period|Adverse Event|0|||
16817219|NCT02301143|37760029|FG000|Induction Period|Progressive Disease|8|||
16817220|NCT02301143|37760030|FG001|Induction Period|Progressive Disease|0|||
16817221|NCT02301143|37760029|FG000|Induction Period|Withdrawal by Subject|3|||
16817222|NCT02301143|37760030|FG001|Induction Period|Withdrawal by Subject|0|||
16817223|NCT02301143|37760029|FG000|Induction Period|Noncompliance with Study Drug|1|||
16817224|NCT02301143|37760030|FG001|Induction Period|Noncompliance with Study Drug|0|||
16817225|NCT02301143|37760029|FG000|Induction Period|Physician Decision|4|||
16817226|NCT02301143|37760030|FG001|Induction Period|Physician Decision|0|||
16817227|NCT02301143|37760029|FG000|Induction Period|Symptomatic Deterioration|2|||
16817228|NCT02301143|37760030|FG001|Induction Period|Symptomatic Deterioration|0|||
16817229|NCT02301143|37760029|FG000|Induction Period|Protocol Violation|2|||
16817230|NCT02301143|37760030|FG001|Induction Period|Protocol Violation|0|||
16817231|NCT02301143|37760029|FG000|Induction Period|Other|1|||
16817232|NCT02301143|37760030|FG001|Induction Period|Other|0|||
16817233|NCT02301143|37760029|FG000|Investigator's Choice|Adverse Event|0|||
16817234|NCT02301143|37760030|FG001|Investigator's Choice|Adverse Event|3|||
16817235|NCT02301143|37760029|FG000|Investigator's Choice|Progressive Disease|0|||
16817236|NCT02301143|37760030|FG001|Investigator's Choice|Progressive Disease|3|||
16817237|NCT02301143|37760029|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
16817238|NCT02301143|37760030|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
16817239|NCT02301143|37760029|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
16817240|NCT02301143|37760030|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
16817241|NCT02301143|37760029|FG000|Investigator's Choice|Other|0|||
16817242|NCT02301143|37760030|FG001|Investigator's Choice|Other|1|||
16817243|NCT02301143|37760029|FG000|Investigator's Choice|Unresectable Surgery|0|||
16817244|NCT02301143|37760030|FG001|Investigator's Choice|Unresectable Surgery|1|||
16817245|NCT02276222|37760043|FG000|Overall Study|Adverse Event|62|||
16817246|NCT02276222|37760044|FG001|Overall Study|Adverse Event|11|||
16817247|NCT02276222|37760043|FG000|Overall Study|Death|3|||
16817248|NCT02276222|37760044|FG001|Overall Study|Death|4|||
16817249|NCT02276222|37760043|FG000|Overall Study|Lack of Efficacy|13|||
16817250|NCT02276222|37760044|FG001|Overall Study|Lack of Efficacy|3|||
16817251|NCT02276222|37760043|FG000|Overall Study|Protocol Violation|3|||
16817252|NCT02276222|37760044|FG001|Overall Study|Protocol Violation|2|||
16817253|NCT02276222|37760043|FG000|Overall Study|Withdrawal by Subject|79|||
16817254|NCT02276222|37760044|FG001|Overall Study|Withdrawal by Subject|33|||
16817255|NCT02276222|37760043|FG000|Overall Study|non compliance with study medication|6|||
16817256|NCT02276222|37760044|FG001|Overall Study|non compliance with study medication|2|||
16817257|NCT02276222|37760043|FG000|Overall Study|sponsor decision|0|||
16817258|NCT02276222|37760044|FG001|Overall Study|sponsor decision|3|||
16817259|NCT02276222|37760043|FG000|Overall Study|Lost to Follow-up|15|||
16817260|NCT02276222|37760044|FG001|Overall Study|Lost to Follow-up|5|||
16817261|NCT02276222|37760043|FG000|Overall Study|Physician Decision|2|||
16817262|NCT02276222|37760044|FG001|Overall Study|Physician Decision|1|||
16817263|NCT02276222|37760043|FG000|Overall Study|sheduling conflict|1|||
16817264|NCT02276222|37760044|FG001|Overall Study|sheduling conflict|0|||
16817265|NCT02276222|37760043|FG000|Overall Study|subject withdrew after randomization|1|||
16817266|NCT02276222|37760044|FG001|Overall Study|subject withdrew after randomization|0|||
16817267|NCT02275364|37760050|FG000|Period 1|Withdrawal by Subject|1|||
16817268|NCT02275364|37760051|FG001|Period 1|Withdrawal by Subject|0|||
16817269|NCT02275364|37760050|FG000|Period 1|Other reason|1|||
16817270|NCT02275364|37760051|FG001|Period 1|Other reason|0|||
16817271|NCT02275052|37760068|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16817272|NCT02275052|37760069|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16817273|NCT02275052|37760070|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16817274|NCT02275052|37760071|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16817275|NCT02275052|37760068|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
16817276|NCT02275052|37760069|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
16817277|NCT02275052|37760070|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
16817278|NCT02275052|37760071|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
16817279|NCT02275052|37760068|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
16817280|NCT02275052|37760069|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
16817281|NCT02275052|37760070|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16817282|NCT02275052|37760071|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16817283|NCT02275052|37760068|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
16817284|NCT02275052|37760069|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
16817285|NCT02275052|37760070|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
16817286|NCT02275052|37760071|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
16817287|NCT02275052|37760068|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
16817288|NCT02275052|37760069|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
16817289|NCT02275052|37760070|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
16817290|NCT02275052|37760071|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
16817291|NCT02275052|37760068|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
16817292|NCT02275052|37760069|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
16817293|NCT02275052|37760070|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
16817294|NCT02275052|37760071|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
16817295|NCT02275052|37760068|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
16817296|NCT02275052|37760069|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
16817297|NCT02275052|37760070|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
16817298|NCT02275052|37760071|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
16817299|NCT02275052|37760068|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16817300|NCT02275052|37760069|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16817301|NCT02275052|37760070|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
16817302|NCT02275052|37760071|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
16817303|NCT02275052|37760068|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16817304|NCT02275052|37760069|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16817305|NCT02275052|37760070|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16817306|NCT02275052|37760071|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
16817307|NCT02275052|37760068|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
16817308|NCT02275052|37760069|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
16817309|NCT02275052|37760070|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
16817310|NCT02275052|37760071|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
16817311|NCT02275052|37760068|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16817312|NCT02275052|37760069|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16817313|NCT02275052|37760070|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16817314|NCT02275052|37760071|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
16817315|NCT02274038|37760077|FG000|Overall Study|Death|1|||
16817316|NCT02300558|37760083|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
16817317|NCT02300558|37760083|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
16817318|NCT02300558|37760083|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
16817319|NCT02300558|37760083|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
16817320|NCT02273960|37760095|FG000|Short Term Period|Lost to Follow-up|1|||
16817321|NCT02273960|37760096|FG001|Short Term Period|Lost to Follow-up|0|||
16817322|NCT02273960|37760097|FG002|Short Term Period|Lost to Follow-up|0|||
16817323|NCT02273960|37760098|FG003|Short Term Period|Lost to Follow-up|0|||
16817324|NCT02273960|37760095|FG000|Short Term Period|Lack of Efficacy|0|||
16817325|NCT02273960|37760096|FG001|Short Term Period|Lack of Efficacy|0|||
16817326|NCT02273960|37760097|FG002|Short Term Period|Lack of Efficacy|0|||
16817327|NCT02273960|37760098|FG003|Short Term Period|Lack of Efficacy|1|||
16817328|NCT02273960|37760095|FG000|Short Term Period|ST complete, not entering LTE|4|||
16817329|NCT02273960|37760096|FG001|Short Term Period|ST complete, not entering LTE|6|||
16817330|NCT02273960|37760097|FG002|Short Term Period|ST complete, not entering LTE|4|||
16817331|NCT02273960|37760098|FG003|Short Term Period|ST complete, not entering LTE|5|||
16817332|NCT02273960|37760095|FG000|Long Term Extension|Death|0|||
16817333|NCT02273960|37760096|FG001|Long Term Extension|Death|0|||
16817334|NCT02273960|37760097|FG002|Long Term Extension|Death|0|||
16817335|NCT02273960|37760098|FG003|Long Term Extension|Death|1|||
16817336|NCT01646021|37760110|FG000|Overall Study|Death|77|||
16817337|NCT01646021|37760111|FG001|Overall Study|Death|83|||
16817338|NCT01646021|37760110|FG000|Overall Study|Study Terminated by Sponsor|50|||
16817339|NCT01646021|37760111|FG001|Overall Study|Study Terminated by Sponsor|41|||
16817340|NCT01646021|37760110|FG000|Overall Study|Lost to Follow-up|2|||
16817341|NCT01646021|37760111|FG001|Overall Study|Lost to Follow-up|2|||
16817342|NCT01646021|37760110|FG000|Overall Study|Withdrawal by Subject|10|||
16817343|NCT01646021|37760111|FG001|Overall Study|Withdrawal by Subject|15|||
16817344|NCT01750918|37760128|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
16817345|NCT01750918|37760129|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
16817346|NCT01750918|37760130|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
16817347|NCT01750918|37760131|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
16817348|NCT01750918|37760132|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
16817349|NCT01750918|37760133|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
16817350|NCT01750918|37760134|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
16817351|NCT01750918|37760135|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
16817352|NCT01750918|37760128|FG000|Overall Study|Lost to Follow-up|0|||
16817353|NCT01750918|37760129|FG001|Overall Study|Lost to Follow-up|0|||
16817354|NCT01750918|37760130|FG002|Overall Study|Lost to Follow-up|2|||
16817355|NCT01750918|37760131|FG003|Overall Study|Lost to Follow-up|2|||
16817356|NCT01750918|37760132|FG004|Overall Study|Lost to Follow-up|0|||
16817357|NCT01750918|37760133|FG005|Overall Study|Lost to Follow-up|0|||
16817358|NCT01750918|37760134|FG006|Overall Study|Lost to Follow-up|0|||
16817359|NCT01750918|37760135|FG007|Overall Study|Lost to Follow-up|1|||
16817360|NCT01750918|37760128|FG000|Overall Study|Withdrawal by Subject|0|||
16817361|NCT01750918|37760129|FG001|Overall Study|Withdrawal by Subject|0|||
16817362|NCT01750918|37760130|FG002|Overall Study|Withdrawal by Subject|1|||
16817363|NCT01750918|37760131|FG003|Overall Study|Withdrawal by Subject|2|||
16817364|NCT01750918|37760132|FG004|Overall Study|Withdrawal by Subject|1|||
16817365|NCT01750918|37760133|FG005|Overall Study|Withdrawal by Subject|1|||
16817366|NCT01750918|37760134|FG006|Overall Study|Withdrawal by Subject|2|||
16817367|NCT01750918|37760135|FG007|Overall Study|Withdrawal by Subject|2|||
16817368|NCT02300987|37760167|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
16817369|NCT02300987|37760168|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
16817370|NCT02300987|37760167|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
16817371|NCT02300987|37760168|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
16817372|NCT02300987|37760167|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
16817373|NCT02300987|37760168|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
16817374|NCT02300987|37760167|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
16817375|NCT02300987|37760168|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
16817376|NCT02300987|37760167|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
16817377|NCT02300987|37760168|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
16817378|NCT01750840|37760175|FG000|Overall Study|Lost to Follow-up|4|||
16817379|NCT01606228|37760180|FG000|Overall Study|Lost to Follow-up|20|||
16817380|NCT01606228|37760180|FG000|Overall Study|Withdrawal by Subject|3|||
16817381|NCT01606228|37760180|FG000|Overall Study|Non-compliant|3|||
16817382|NCT01606228|37760180|FG000|Overall Study|Lack of Efficacy|2|||
16817383|NCT01606228|37760180|FG000|Overall Study|Adverse Event|1|||
16817384|NCT01706536|37760189|FG000|Overall Study|Withdrawal by Subject|1|||
16817385|NCT01706536|37760190|FG001|Overall Study|Withdrawal by Subject|0|||
16817386|NCT01706536|37760191|FG002|Overall Study|Withdrawal by Subject|1|||
16817387|NCT01706536|37760192|FG003|Overall Study|Withdrawal by Subject|0|||
16817388|NCT01706536|37760193|FG004|Overall Study|Withdrawal by Subject|0|||
16817389|NCT01706536|37760189|FG000|Overall Study|Adverse Event|2|||
16817390|NCT01706536|37760190|FG001|Overall Study|Adverse Event|3|||
16817391|NCT01706536|37760191|FG002|Overall Study|Adverse Event|4|||
16817392|NCT01706536|37760192|FG003|Overall Study|Adverse Event|3|||
16817393|NCT01706536|37760193|FG004|Overall Study|Adverse Event|2|||
16817394|NCT01706536|37760189|FG000|Overall Study|Lack of Efficacy|1|||
16817395|NCT01706536|37760190|FG001|Overall Study|Lack of Efficacy|0|||
16817396|NCT01706536|37760191|FG002|Overall Study|Lack of Efficacy|0|||
16817397|NCT01706536|37760192|FG003|Overall Study|Lack of Efficacy|1|||
16817398|NCT01706536|37760193|FG004|Overall Study|Lack of Efficacy|0|||
16817399|NCT01706536|37760189|FG000|Overall Study|non compliance|0|||
16817400|NCT01706536|37760190|FG001|Overall Study|non compliance|1|||
16817401|NCT01706536|37760191|FG002|Overall Study|non compliance|0|||
16817402|NCT01706536|37760192|FG003|Overall Study|non compliance|0|||
16817403|NCT01706536|37760193|FG004|Overall Study|non compliance|0|||
16817404|NCT02269943|37760208|FG000|Treatment Period|Death|0|||
16817405|NCT02269943|37760209|FG001|Treatment Period|Death|1|||
16817406|NCT02269943|37760208|FG000|Treatment Period|Adverse Event|1|||
16817407|NCT02269943|37760209|FG001|Treatment Period|Adverse Event|10|||
16817408|NCT02269943|37760208|FG000|Treatment Period|Progressive Disease|5|||
16817409|NCT02269943|37760209|FG001|Treatment Period|Progressive Disease|17|||
16817410|NCT02269943|37760208|FG000|Treatment Period|Symptomatic Deterioration|0|||
16817411|NCT02269943|37760209|FG001|Treatment Period|Symptomatic Deterioration|2|||
16817412|NCT02269943|37760208|FG000|Follow-Up Survival Period|Death|3|||
16817413|NCT02269943|37760209|FG001|Follow-Up Survival Period|Death|16|||
16817414|NCT02269943|37760208|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
16817415|NCT02269943|37760209|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
16817416|NCT02269943|37760208|FG000|Follow-Up Survival Period|Alive|2|||
16817417|NCT02269943|37760209|FG001|Follow-Up Survival Period|Alive|8|||
16817418|NCT01706458|37760217|FG000|Overall Study|Physician Decision|3|||
16817419|NCT01706458|37760218|FG001|Overall Study|Physician Decision|4|||
16817420|NCT02269787|37760226|FG000|Overall Study|Lost to Follow-up|20|||
16817421|NCT02269787|37760227|FG001|Overall Study|Lost to Follow-up|6|||
16817422|NCT02269787|37760226|FG000|Overall Study|Death|2|||
16817423|NCT02269787|37760227|FG001|Overall Study|Death|3|||
16817424|NCT02269787|37760226|FG000|Overall Study|Incapacitated|0|||
16817425|NCT02269787|37760227|FG001|Overall Study|Incapacitated|1|||
16817426|NCT01605370|37760235|FG000|Overall Study|Adverse Event|1|||
16817427|NCT01605370|37760236|FG001|Overall Study|Adverse Event|0|||
16817428|NCT02269709|37760242|FG000|Time of Enrollment|Withdrawal by Subject|3|||
16817429|NCT02269709|37760242|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
16817430|NCT02269709|37760242|FG000|Six Month Follow-up|Lost to Follow-up|12|||
16817431|NCT02269475|37760249|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
16817432|NCT02269475|37760250|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
16817433|NCT02269475|37760249|FG000|Overall Study|Withdrawal by Subject|0|||
16817434|NCT02269475|37760250|FG001|Overall Study|Withdrawal by Subject|1|||
16817435|NCT01605136|37760259|FG000|Study Period|Withdrawal by Subject|2|||
16817436|NCT01605136|37760260|FG001|Study Period|Withdrawal by Subject|0|||
16817437|NCT01605136|37760259|FG000|Study Period|Physician Decision|1|||
16817438|NCT01605136|37760260|FG001|Study Period|Physician Decision|1|||
16817439|NCT01605136|37760259|FG000|Study Period|Lost to Follow-up|0|||
16817440|NCT01605136|37760260|FG001|Study Period|Lost to Follow-up|2|||
16817441|NCT01605136|37760259|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
16817442|NCT01605136|37760260|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
16817443|NCT01706146|37760266|FG000|Overall Study|Withdrawal by Subject|1|||
16817444|NCT01706146|37760266|FG000|Overall Study|Adverse Event|3|||
16910682|NCT01539642|38019618|FG000|Overall Study|Adverse Event|6|||
16817445|NCT01706146|37760266|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
16817446|NCT02269241|37760270|FG000|Overall Study|Lost to Follow-up|269|||
16817447|NCT02269241|37760270|FG000|Overall Study|Withdrawal by Subject|155|||
16817448|NCT02269241|37760270|FG000|Overall Study|Protocol Violation|1|||
16817449|NCT02269241|37760270|FG000|Overall Study|Physician Decision|7|||
16817450|NCT02269241|37760270|FG000|Overall Study|Pregnancy|15|||
16817451|NCT02269241|37760270|FG000|Overall Study|Wish for pregnancy|5|||
16817452|NCT02269241|37760270|FG000|Overall Study|Development of an exclusion criteria|16|||
16817453|NCT02269241|37760270|FG000|Overall Study|Adverse Event|113|||
16817454|NCT02269241|37760270|FG000|Overall Study|At the specific request of the sponsor|20|||
16817455|NCT02269241|37760270|FG000|Overall Study|Several reasons not classified|53|||
16817456|NCT02269241|37760270|FG000|Overall Study|Screening failures|546|||
16817457|NCT01750684|37760277|FG000|Overall Study|Death|1|||
16817458|NCT01750684|37760278|FG001|Overall Study|Death|0|||
16817459|NCT01750684|37760277|FG000|Overall Study|Non-compliance with Study Drug|0|||
16817460|NCT01750684|37760278|FG001|Overall Study|Non-compliance with Study Drug|1|||
16817461|NCT01750684|37760277|FG000|Overall Study|Withdrawn by Sponsor|0|||
16817462|NCT01750684|37760278|FG001|Overall Study|Withdrawn by Sponsor|1|||
16817463|NCT01750684|37760277|FG000|Overall Study|Protocol Violation|1|||
16817464|NCT01750684|37760278|FG001|Overall Study|Protocol Violation|0|||
16817465|NCT01750294|37760285|FG000|Overall Study|Withdrawal by Subject|1|||
16817466|NCT01750294|37760285|FG000|Overall Study|Safety Endpoint|1|||
16817467|NCT01749982|37760293|FG000|Overall Study|Physician Decision|0|||
16817468|NCT01749982|37760294|FG001|Overall Study|Physician Decision|0|||
16817469|NCT01749982|37760295|FG002|Overall Study|Physician Decision|0|||
16817470|NCT01749982|37760296|FG003|Overall Study|Physician Decision|1|||
16817471|NCT01749982|37760293|FG000|Overall Study|Lost to Follow-up|0|||
16817472|NCT01749982|37760294|FG001|Overall Study|Lost to Follow-up|0|||
16817473|NCT01749982|37760295|FG002|Overall Study|Lost to Follow-up|0|||
16817474|NCT01749982|37760296|FG003|Overall Study|Lost to Follow-up|1|||
16817475|NCT01749982|37760293|FG000|Overall Study|Withdrawal by Subject|0|||
16817476|NCT01749982|37760294|FG001|Overall Study|Withdrawal by Subject|0|||
16817477|NCT01749982|37760295|FG002|Overall Study|Withdrawal by Subject|0|||
16817478|NCT01749982|37760296|FG003|Overall Study|Withdrawal by Subject|1|||
16817479|NCT02269163|37760308|FG000|Overall Study|Lost to Follow-up|1|||
16817480|NCT02269163|37760309|FG001|Overall Study|Lost to Follow-up|0|||
16817481|NCT02269163|37760308|FG000|Overall Study|Major protocol violation|0|||
16817482|NCT02269163|37760309|FG001|Overall Study|Major protocol violation|1|||
16817483|NCT02269163|37760308|FG000|Overall Study|Other|2|||
16817484|NCT02269163|37760309|FG001|Overall Study|Other|2|||
16817485|NCT02269163|37760308|FG000|Overall Study|Withdrawal by Subject|0|||
16817486|NCT02269163|37760309|FG001|Overall Study|Withdrawal by Subject|3|||
16817487|NCT02269163|37760308|FG000|Overall Study|Physician Decision|0|||
16817488|NCT02269163|37760309|FG001|Overall Study|Physician Decision|1|||
16817489|NCT01749826|37760319|FG000|Overall Study|Study Terminated|20|||
16817490|NCT01749826|37760320|FG001|Overall Study|Study Terminated|0|||
16817491|NCT02300129|37760326|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
16817492|NCT02300129|37760327|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
16817493|NCT02300129|37760328|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
16817494|NCT02300129|37760329|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
16817495|NCT02300129|37760326|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
16817496|NCT02300129|37760327|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
16817497|NCT02300129|37760328|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
16817498|NCT02300129|37760329|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
16817499|NCT02300129|37760326|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
16817500|NCT02300129|37760327|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
16817501|NCT02300129|37760328|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
16817502|NCT02300129|37760329|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
16817503|NCT02267135|37760341|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
16817504|NCT02267135|37760342|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
16817505|NCT02267135|37760341|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
16817506|NCT02267135|37760342|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
16817507|NCT02267135|37760341|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
16817508|NCT02267135|37760342|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
16817509|NCT02267135|37760341|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
16817510|NCT02267135|37760342|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
16817511|NCT02267135|37760341|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
16817512|NCT02267135|37760342|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
16817513|NCT02299427|37760353|FG000|Overall Study|Withdrawal by Subject|1|||
16817514|NCT02299427|37760354|FG001|Overall Study|Withdrawal by Subject|0|||
16817515|NCT02299427|37760353|FG000|Overall Study|Lost to Follow-up|1|||
16817516|NCT02299427|37760354|FG001|Overall Study|Lost to Follow-up|3|||
16817517|NCT02299427|37760353|FG000|Overall Study|not adherent to dog website use|21|||
16817518|NCT02299427|37760354|FG001|Overall Study|not adherent to dog website use|0|||
16817519|NCT01724866|37760364|FG000|Overall Study|Adverse Event|0|||
16817520|NCT01724866|37760365|FG001|Overall Study|Adverse Event|0|||
16817521|NCT01724866|37760366|FG002|Overall Study|Adverse Event|1|||
16817522|NCT01724866|37760367|FG003|Overall Study|Adverse Event|1|||
16817523|NCT01724866|37760364|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
16817524|NCT01724866|37760365|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
16817525|NCT01724866|37760366|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
16817526|NCT01724866|37760367|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
16817527|NCT01724866|37760364|FG000|Overall Study|Investigator's Discretion|0|||
16817528|NCT01724866|37760365|FG001|Overall Study|Investigator's Discretion|1|||
16817529|NCT01724866|37760366|FG002|Overall Study|Investigator's Discretion|1|||
16817530|NCT01724866|37760367|FG003|Overall Study|Investigator's Discretion|0|||
16817531|NCT01724866|37760364|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
16817532|NCT01724866|37760365|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
16817533|NCT01724866|37760366|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
16817534|NCT01724866|37760367|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
16817535|NCT01724866|37760364|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
16817536|NCT01724866|37760365|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
16817537|NCT01724866|37760366|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
16817538|NCT01724866|37760367|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
16817539|NCT02266433|37760379|FG000|Overall Study|Lost to Follow-up|54|||
16817540|NCT02266433|37760380|FG001|Overall Study|Lost to Follow-up|46|||
16817541|NCT02266433|37760379|FG000|Overall Study|Withdrawal by Subject|5|||
16817542|NCT02266433|37760380|FG001|Overall Study|Withdrawal by Subject|7|||
16817543|NCT01748890|37760387|FG000|Overall Study|Insufficient recruitment for analysis|4|||
16817544|NCT01747876|37760394|FG000|Overall Study|Adverse Event|1|||
16817545|NCT01747876|37760395|FG001|Overall Study|Adverse Event|0|||
16817546|NCT01747876|37760396|FG002|Overall Study|Adverse Event|2|||
16817547|NCT01747876|37760394|FG000|Overall Study|Withdrawal by Subject|0|||
16817548|NCT01747876|37760395|FG001|Overall Study|Withdrawal by Subject|1|||
16817549|NCT01747876|37760396|FG002|Overall Study|Withdrawal by Subject|1|||
16817550|NCT01747876|37760394|FG000|Overall Study|Disease progression|4|||
16817551|NCT01747876|37760395|FG001|Overall Study|Disease progression|13|||
16817552|NCT01747876|37760396|FG002|Overall Study|Disease progression|8|||
16817553|NCT01747876|37760394|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
16817554|NCT01747876|37760395|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
16817555|NCT01747876|37760396|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
16817556|NCT02273726|37760409|FG000|Overall Study|Death|70|||
16817557|NCT02273726|37760410|FG001|Overall Study|Death|62|||
16817558|NCT02273726|37760409|FG000|Overall Study|Withdrawal by Subject|41|||
16817559|NCT02273726|37760410|FG001|Overall Study|Withdrawal by Subject|29|||
16817560|NCT02273726|37760409|FG000|Overall Study|Kidney transplant|31|||
16817561|NCT02273726|37760410|FG001|Overall Study|Kidney transplant|39|||
16817562|NCT02273726|37760409|FG000|Overall Study|Physician Decision|30|||
16817563|NCT02273726|37760410|FG001|Overall Study|Physician Decision|15|||
16817564|NCT02273726|37760409|FG000|Overall Study|Adverse Event|27|||
16817565|NCT02273726|37760410|FG001|Overall Study|Adverse Event|9|||
16817566|NCT02273726|37760409|FG000|Overall Study|Lost to Follow-up|6|||
16817567|NCT02273726|37760410|FG001|Overall Study|Lost to Follow-up|3|||
16817568|NCT02273726|37760409|FG000|Overall Study|Lack of Efficacy|6|||
16817569|NCT02273726|37760410|FG001|Overall Study|Lack of Efficacy|1|||
16817570|NCT02273726|37760409|FG000|Overall Study|Protocol Violation|4|||
16817571|NCT02273726|37760410|FG001|Overall Study|Protocol Violation|0|||
16817572|NCT02273726|37760409|FG000|Overall Study|Other than specified|28|||
16817573|NCT02273726|37760410|FG001|Overall Study|Other than specified|30|||
16817574|NCT01723228|37760418|FG000|Overall Study|Adverse Event|2|||
16817575|NCT01723228|37760419|FG001|Overall Study|Adverse Event|6|||
16817576|NCT01723228|37760418|FG000|Overall Study|Withdrawal by Subject|2|||
16817577|NCT01723228|37760419|FG001|Overall Study|Withdrawal by Subject|1|||
16817578|NCT01723228|37760418|FG000|Overall Study|Protocol Violation|0|||
16817579|NCT01723228|37760419|FG001|Overall Study|Protocol Violation|2|||
16817580|NCT01723228|37760418|FG000|Overall Study|Lost to Follow-up|2|||
16817581|NCT01723228|37760419|FG001|Overall Study|Lost to Follow-up|1|||
16817582|NCT01723228|37760418|FG000|Overall Study|Other|2|||
16817583|NCT01723228|37760419|FG001|Overall Study|Other|1|||
16817584|NCT01747486|37760427|FG000|Stage 1|Physician Decision|3|||
16817585|NCT01747486|37760428|FG001|Stage 1|Physician Decision|0|||
16817586|NCT01747486|37760427|FG000|Stage 1|Withdrawal by Subject|4|||
16817587|NCT01747486|37760428|FG001|Stage 1|Withdrawal by Subject|3|||
16817588|NCT01747486|37760427|FG000|Stage 1|Disease progression|4|||
16817589|NCT01747486|37760428|FG001|Stage 1|Disease progression|9|||
16817590|NCT01747486|37760427|FG000|Stage 1|Death|1|||
17102341|NCT00115934|38241260|FG001|Overall Study|Lost to Follow-up|0|||
16817591|NCT01747486|37760428|FG001|Stage 1|Death|1|||
16817592|NCT01747486|37760427|FG000|Stage 2|Physician Decision|2|||
16817593|NCT01747486|37760428|FG001|Stage 2|Physician Decision|0|||
16817594|NCT01747486|37760427|FG000|Stage 2|Withdrawal by Subject|1|||
16817595|NCT01747486|37760428|FG001|Stage 2|Withdrawal by Subject|0|||
16817596|NCT01747486|37760427|FG000|Stage 2|New Cancer Therapy|3|||
16817597|NCT01747486|37760428|FG001|Stage 2|New Cancer Therapy|0|||
16817598|NCT01747486|37760427|FG000|Stage 2|Disease Progression|3|||
16817599|NCT01747486|37760428|FG001|Stage 2|Disease Progression|0|||
16817600|NCT02273180|37760436|FG000|Overall Study|Adverse Event|2|||
16817601|NCT02273180|37760437|FG001|Overall Study|Adverse Event|2|||
16817602|NCT02273180|37760436|FG000|Overall Study|Lack of Efficacy|1|||
16817603|NCT02273180|37760437|FG001|Overall Study|Lack of Efficacy|0|||
16817604|NCT02273180|37760436|FG000|Overall Study|Protocol Violation|1|||
16817605|NCT02273180|37760437|FG001|Overall Study|Protocol Violation|7|||
16817606|NCT02273180|37760436|FG000|Overall Study|Randomized but not treated|1|||
16817607|NCT02273180|37760437|FG001|Overall Study|Randomized but not treated|0|||
16817608|NCT02273180|37760436|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
16817609|NCT02273180|37760437|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
16817610|NCT02273180|37760436|FG000|Overall Study|Other than specified above|21|||
16817611|NCT02273180|37760437|FG001|Overall Study|Other than specified above|10|||
16817612|NCT01746862|37760445|FG000|Overall Study|Withdrawal by Subject|1|||
16817613|NCT01746862|37760446|FG001|Overall Study|Withdrawal by Subject|1|||
16817614|NCT01746862|37760445|FG000|Overall Study|Protocol Violation|1|||
16817615|NCT01746862|37760446|FG001|Overall Study|Protocol Violation|0|||
16817616|NCT01746862|37760445|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
16817617|NCT01746862|37760446|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
16910683|NCT01539642|38019619|FG001|Overall Study|Adverse Event|4|||
16910684|NCT01539642|38019618|FG000|Overall Study|Withdrawal by Subject|2|||
16910685|NCT01539642|38019619|FG001|Overall Study|Withdrawal by Subject|2|||
16910686|NCT01586364|38019625|FG000|Overall Study|Withdrawal by Subject|40|||
16910687|NCT01586364|38019625|FG000|Overall Study|Adverse Event|37|||
16910688|NCT01586364|38019625|FG000|Overall Study|Lost to Follow-up|17|||
16910689|NCT01586364|38019625|FG000|Overall Study|Protocol Violation|16|||
16910690|NCT01586364|38019625|FG000|Overall Study|Lack of Efficacy|1|||
16910691|NCT01586364|38019625|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
16910692|NCT01586364|38019625|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
16910693|NCT01586364|38019625|FG000|Overall Study|Other-Site closure due to PI illness|1|||
16910694|NCT01586364|38019625|FG000|Overall Study|Other-PI discretion, site closing|2|||
16910695|NCT01586364|38019625|FG000|Overall Study|Other-Not specified|1|||
16910696|NCT01538628|38019631|FG000|Overall Study|Withdrawal by Subject|1|||
16910697|NCT01538628|38019632|FG001|Overall Study|Withdrawal by Subject|1|||
16910698|NCT01538628|38019631|FG000|Overall Study|Lost to Follow-up|0|||
16910699|NCT01538628|38019632|FG001|Overall Study|Lost to Follow-up|1|||
16910700|NCT01538472|38019639|FG000|Overall Study|Disease Progression|3|||
16910701|NCT01538472|38019639|FG000|Overall Study|Death|1|||
16910702|NCT01562028|38019645|FG000|Overall Study|Withdrawal by Subject|1|||
16910703|NCT01562028|38019646|FG001|Overall Study|Withdrawal by Subject|1|||
16910704|NCT01562028|38019645|FG000|Overall Study|Lost to Follow-up|2|||
16910705|NCT01562028|38019646|FG001|Overall Study|Lost to Follow-up|1|||
16910706|NCT01585584|38019652|FG000|Overall Study|Lack of Efficacy|1|||
16910707|NCT01585584|38019652|FG000|Overall Study|Withdrawal by Subject|1|||
16910708|NCT01585584|38019652|FG000|Overall Study|Physician Decision|2|||
16910709|NCT01561560|38019656|FG000|First Two Weeks of Wear|Time/job conflict|0|||
16910710|NCT01561560|38019657|FG001|First Two Weeks of Wear|Time/job conflict|1|||
16910711|NCT01561560|38019656|FG000|First Two Weeks of Wear|Adverse Event|0|||
16910712|NCT01561560|38019657|FG001|First Two Weeks of Wear|Adverse Event|1|||
16910713|NCT01561560|38019656|FG000|Second Two Weeks of Wear|Adverse Event|0|||
16910714|NCT01561560|38019657|FG001|Second Two Weeks of Wear|Adverse Event|1|||
16910715|NCT01537068|38019665|FG000|Overall Study|Lost to Follow-up|2|||
16910716|NCT01537068|38019666|FG001|Overall Study|Lost to Follow-up|1|||
16910717|NCT01537068|38019665|FG000|Overall Study|Adverse Event|0|||
16910718|NCT01537068|38019666|FG001|Overall Study|Adverse Event|1|||
16910719|NCT01537068|38019665|FG000|Overall Study|Withdrawal by Subject|1|||
16910720|NCT01537068|38019666|FG001|Overall Study|Withdrawal by Subject|1|||
16910721|NCT01537068|38019665|FG000|Overall Study|Lack of Efficacy|1|||
17016611|NCT00600119|38161262|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16817618|NCT01746862|37760445|FG000|Overall Study|Entered puberty during the study|1|||
16817619|NCT01746862|37760446|FG001|Overall Study|Entered puberty during the study|0|||
16817620|NCT01745848|37760453|FG000|Overall Study|Adverse Event|6|||
16817621|NCT01745380|37760459|FG000|Overall Study|Lost to Follow-up|1|||
16817622|NCT01745380|37760460|FG001|Overall Study|Lost to Follow-up|0|||
16910722|NCT01537068|38019666|FG001|Overall Study|Lack of Efficacy|0|||
16910723|NCT01585428|38019674|FG000|Overall Study|Death during treatment|1|||
16910724|NCT01585428|38019675|FG001|Overall Study|Death during treatment|0|||
16910725|NCT01585272|38019682|FG000|Overall Study|Adverse Event|22|||
16910726|NCT01585272|38019682|FG000|Overall Study|Protocol Violation|7|||
16910727|NCT01585272|38019682|FG000|Overall Study|Withdrawal by Subject|10|||
16910728|NCT01585194|38019686|FG000|Overall Study|Withdrawal by Subject|1|||
16910729|NCT01585194|38019686|FG000|Overall Study|Physician Decision|2|||
16910730|NCT01585194|38019686|FG000|Overall Study|Lack of insurance|1|||
16910731|NCT01560780|38019692|FG000|Overall Study|Death|2|||
16910732|NCT01560780|38019693|FG001|Overall Study|Death|1|||
16910733|NCT01560780|38019692|FG000|Overall Study|Patient Preference|11|||
16910734|NCT01560780|38019693|FG001|Overall Study|Patient Preference|11|||
16910735|NCT01585038|38019701|FG000|Overall Study|Adverse Event|2|||
16910736|NCT01585038|38019702|FG001|Overall Study|Adverse Event|2|||
16910737|NCT01560234|38019716|FG000|Overall Study|Lost to Follow-up|3|||
16910738|NCT01560234|38019717|FG001|Overall Study|Lost to Follow-up|0|||
16910739|NCT01560234|38019718|FG002|Overall Study|Lost to Follow-up|1|||
16910740|NCT01560234|38019719|FG003|Overall Study|Lost to Follow-up|0|||
16910741|NCT01560234|38019720|FG004|Overall Study|Lost to Follow-up|0|||
16910742|NCT01560234|38019721|FG005|Overall Study|Lost to Follow-up|2|||
16910743|NCT01560234|38019722|FG006|Overall Study|Lost to Follow-up|0|||
16910744|NCT01560234|38019723|FG007|Overall Study|Lost to Follow-up|2|||
17016612|NCT00600119|38161263|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
17016613|NCT00600119|38161264|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
17016614|NCT00600119|38161265|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
17016615|NCT00600119|38161266|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
17016616|NCT00600119|38161267|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
17016617|NCT00600119|38161262|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
16910745|NCT01559844|38019741|FG000|Overall Study|Consent Withdrawn|7|||
16910746|NCT01559844|38019741|FG000|Overall Study|Death|5|||
16910747|NCT01559844|38019741|FG000|Overall Study|Efficacy Failure|10|||
16910748|NCT01559844|38019741|FG000|Overall Study|No Longer A Transplant Candidate|3|||
16910749|NCT01584648|38019747|FG000|Overall Study|Death|136|||
16910750|NCT01584648|38019748|FG001|Overall Study|Death|146|||
16910751|NCT01584648|38019747|FG000|Overall Study|Lost to Follow-up|9|||
16910752|NCT01584648|38019748|FG001|Overall Study|Lost to Follow-up|9|||
16910753|NCT01584648|38019747|FG000|Overall Study|Investigator discretion|3|||
16910754|NCT01584648|38019748|FG001|Overall Study|Investigator discretion|2|||
16910755|NCT01584648|38019747|FG000|Overall Study|Withdrew consent|13|||
16910756|NCT01584648|38019748|FG001|Overall Study|Withdrew consent|4|||
16910757|NCT01584648|38019747|FG000|Overall Study|Study closed/terminated|50|||
16910758|NCT01584648|38019748|FG001|Overall Study|Study closed/terminated|23|||
16910759|NCT01584648|38019747|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
16910760|NCT01584648|38019748|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
16910761|NCT01559454|38019759|FG000|Overall Study|Lost to Follow-up|3|||
16910762|NCT01559454|38019760|FG001|Overall Study|Lost to Follow-up|2|||
16910763|NCT01559454|38019759|FG000|Overall Study|Withdrawal by Subject|0|||
16910764|NCT01559454|38019760|FG001|Overall Study|Withdrawal by Subject|1|||
16910765|NCT01559454|38019759|FG000|Overall Study|Physician Decision|0|||
16910766|NCT01559454|38019760|FG001|Overall Study|Physician Decision|1|||
16910767|NCT01559454|38019759|FG000|Overall Study|Protocol Violation|0|||
16910768|NCT01559454|38019760|FG001|Overall Study|Protocol Violation|1|||
16910769|NCT01559454|38019759|FG000|Overall Study|Lack of Efficacy|0|||
16910770|NCT01559454|38019760|FG001|Overall Study|Lack of Efficacy|1|||
16910771|NCT01584024|38019766|FG000|Overall Study|Lost to Follow-up|10|||
16910772|NCT01584024|38019766|FG000|Overall Study|Withdrawal by Subject|3|||
16910773|NCT01583166|38019773|FG000|Overall Study|Withdrawal by Subject|4|||
16910774|NCT01583166|38019774|FG001|Overall Study|Withdrawal by Subject|6|||
16910775|NCT01535274|38019782|FG000|Overall Study|Determined to be ineligible|0|||
16910776|NCT01535274|38019783|FG001|Overall Study|Determined to be ineligible|1|||
16910777|NCT01535274|38019782|FG000|Overall Study|Misallocated to propofol intervention|0|||
16910778|NCT01535274|38019783|FG001|Overall Study|Misallocated to propofol intervention|1|||
16910779|NCT01558752|38019793|FG000|Overall Study|Physician Decision|2|||
16910780|NCT01558752|38019794|FG001|Overall Study|Physician Decision|0|||
17016618|NCT00600119|38161263|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
17016619|NCT00600119|38161264|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
17016620|NCT00600119|38161265|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
17016621|NCT00600119|38161266|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
17016622|NCT00600119|38161267|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
17016623|NCT00600119|38161262|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
17198387|NCT02786927|38352073|FG000|Overall Study|Adverse Event|1|||
16910781|NCT01582854|38019802|FG000|Overall Study|Death|8|||
16910782|NCT01582854|38019803|FG001|Overall Study|Death|5|||
16910783|NCT01582854|38019802|FG000|Overall Study|Adverse Event|2|||
16910784|NCT01582854|38019803|FG001|Overall Study|Adverse Event|3|||
16910785|NCT01582854|38019802|FG000|Overall Study|Withdrawal by Participant|8|||
16910786|NCT01582854|38019803|FG001|Overall Study|Withdrawal by Participant|11|||
16910787|NCT01582854|38019802|FG000|Overall Study|Lost to Follow-up|1|||
16910788|NCT01582854|38019803|FG001|Overall Study|Lost to Follow-up|2|||
16910789|NCT01582854|38019802|FG000|Overall Study|Physician Decision|0|||
17016624|NCT00600119|38161263|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
17016625|NCT00600119|38161264|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
16910790|NCT01582854|38019803|FG001|Overall Study|Physician Decision|1|||
16910791|NCT01582854|38019802|FG000|Overall Study|Recurrent Stroke|13|||
16910792|NCT01582854|38019803|FG001|Overall Study|Recurrent Stroke|8|||
16910793|NCT01582854|38019802|FG000|Overall Study|Disallowed Concomitant Medication|3|||
16910794|NCT01582854|38019803|FG001|Overall Study|Disallowed Concomitant Medication|2|||
16910795|NCT01582854|38019802|FG000|Overall Study|Carotid or Neurosurgery|0|||
16910796|NCT01582854|38019803|FG001|Overall Study|Carotid or Neurosurgery|1|||
16910797|NCT01582854|38019802|FG000|Overall Study|General Anaesthesia|0|||
16910798|NCT01582854|38019803|FG001|Overall Study|General Anaesthesia|1|||
16910799|NCT01582854|38019802|FG000|Overall Study|Other Miscellaneous Reason|1|||
16910800|NCT01582854|38019803|FG001|Overall Study|Other Miscellaneous Reason|0|||
16910801|NCT01582308|38019809|FG000|Period 1|Withdrawal by Subject|0|||
16910802|NCT01582308|38019810|FG001|Period 1|Withdrawal by Subject|0|||
16910803|NCT01582308|38019811|FG002|Period 1|Withdrawal by Subject|0|||
16910804|NCT01582308|38019812|FG003|Period 1|Withdrawal by Subject|0|||
16910805|NCT01582308|38019813|FG004|Period 1|Withdrawal by Subject|0|||
16910806|NCT01582308|38019814|FG005|Period 1|Withdrawal by Subject|0|||
16910807|NCT01582308|38019815|FG006|Period 1|Withdrawal by Subject|1|||
16910808|NCT01582308|38019816|FG007|Period 1|Withdrawal by Subject|0|||
16910809|NCT01582308|38019817|FG008|Period 1|Withdrawal by Subject|0|||
16910810|NCT01582308|38019818|FG009|Period 1|Withdrawal by Subject|0|||
17016626|NCT00600119|38161265|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
17016627|NCT00600119|38161266|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
17016628|NCT00600119|38161267|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
17016629|NCT00600119|38161262|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
17016630|NCT00600119|38161263|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
17016631|NCT00600119|38161264|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
17016632|NCT00600119|38161265|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
17016633|NCT00600119|38161266|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
17016634|NCT00600119|38161267|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
17016635|NCT00600119|38161262|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
17016636|NCT00600119|38161263|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
17016637|NCT00600119|38161264|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
17016638|NCT00600119|38161265|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
17016639|NCT00600119|38161266|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
17102342|NCT00115934|38241259|FG000|Overall Study|Did not receive intervention|3|||
17102343|NCT00115934|38241260|FG001|Overall Study|Did not receive intervention|2|||
17102344|NCT00115778|38241266|FG000|Overall Study|Withdrawal by Subject|0|||
17102345|NCT00115778|38241267|FG001|Overall Study|Withdrawal by Subject|1|||
17102346|NCT00100178|38241276|FG000|Overall Study|Lost to Follow-up|0|||
17102347|NCT00100178|38241277|FG001|Overall Study|Lost to Follow-up|6|||
17102348|NCT00100178|38241278|FG002|Overall Study|Lost to Follow-up|5|||
17102349|NCT00100178|38241276|FG000|Overall Study|Adverse Event|2|||
17102350|NCT00100178|38241277|FG001|Overall Study|Adverse Event|2|||
17102351|NCT00100178|38241278|FG002|Overall Study|Adverse Event|1|||
17102352|NCT00100178|38241276|FG000|Overall Study|Withdrawal by Subject|1|||
17102353|NCT00100178|38241277|FG001|Overall Study|Withdrawal by Subject|1|||
17102354|NCT00100178|38241278|FG002|Overall Study|Withdrawal by Subject|1|||
17102355|NCT00100178|38241276|FG000|Overall Study|Physician Decision|6|||
17102356|NCT00100178|38241277|FG001|Overall Study|Physician Decision|1|||
17102357|NCT00100178|38241278|FG002|Overall Study|Physician Decision|3|||
16817623|NCT01745380|37760459|FG000|Overall Study|Lack of Efficacy|0|||
16817624|NCT01745380|37760460|FG001|Overall Study|Lack of Efficacy|1|||
16817625|NCT01745146|37760468|FG000|Overall Study|Withdrawal by Subject|1|||
16817626|NCT01745146|37760469|FG001|Overall Study|Withdrawal by Subject|3|||
16817627|NCT01745146|37760468|FG000|Overall Study|Lost to Follow-up|2|||
16817628|NCT01745146|37760469|FG001|Overall Study|Lost to Follow-up|0|||
16817629|NCT02272634|37760479|FG000|Overall Study|Adverse Event|1|||
16817630|NCT02272634|37760480|FG001|Overall Study|Adverse Event|0|||
16817631|NCT02272634|37760481|FG002|Overall Study|Adverse Event|0|||
16817632|NCT02272634|37760479|FG000|Overall Study|Protocol Violation|0|||
16817633|NCT02272634|37760480|FG001|Overall Study|Protocol Violation|0|||
16817634|NCT02272634|37760481|FG002|Overall Study|Protocol Violation|1|||
16817635|NCT02272634|37760479|FG000|Overall Study|Withdrawal by Subject|0|||
16817636|NCT02272634|37760480|FG001|Overall Study|Withdrawal by Subject|1|||
16817637|NCT02272634|37760481|FG002|Overall Study|Withdrawal by Subject|0|||
16817638|NCT02203513|37760497|FG000|Overall Study|Refused further treatment|2|||
16817639|NCT02203513|37760498|FG001|Overall Study|Refused further treatment|0|||
16817640|NCT02203513|37760499|FG002|Overall Study|Refused further treatment|1|||
16817641|NCT02203513|37760500|FG003|Overall Study|Refused further treatment|0|||
16817642|NCT02203513|37760501|FG004|Overall Study|Refused further treatment|0|||
16817643|NCT02203513|37760497|FG000|Overall Study|Switched to alternative treatment|3|||
16817644|NCT02203513|37760498|FG001|Overall Study|Switched to alternative treatment|4|||
16910811|NCT01582308|38019809|FG000|10-day Washout Following Period 1|Physician Decision|0|||
16910812|NCT01582308|38019810|FG001|10-day Washout Following Period 1|Physician Decision|0|||
16910813|NCT01582308|38019811|FG002|10-day Washout Following Period 1|Physician Decision|0|||
16910814|NCT01582308|38019812|FG003|10-day Washout Following Period 1|Physician Decision|0|||
16910815|NCT01582308|38019813|FG004|10-day Washout Following Period 1|Physician Decision|1|||
16910816|NCT01582308|38019814|FG005|10-day Washout Following Period 1|Physician Decision|0|||
16910817|NCT01582308|38019815|FG006|10-day Washout Following Period 1|Physician Decision|0|||
16910818|NCT01582308|38019816|FG007|10-day Washout Following Period 1|Physician Decision|0|||
16910819|NCT01582308|38019817|FG008|10-day Washout Following Period 1|Physician Decision|0|||
16910820|NCT01582308|38019818|FG009|10-day Washout Following Period 1|Physician Decision|0|||
16910821|NCT01582308|38019809|FG000|Period 4|Physician Decision|1|||
16910822|NCT01582308|38019810|FG001|Period 4|Physician Decision|0|||
16910823|NCT01582308|38019811|FG002|Period 4|Physician Decision|0|||
16910824|NCT01582308|38019812|FG003|Period 4|Physician Decision|0|||
16910825|NCT01582308|38019813|FG004|Period 4|Physician Decision|0|||
16910826|NCT01582308|38019814|FG005|Period 4|Physician Decision|1|||
16910827|NCT01582308|38019815|FG006|Period 4|Physician Decision|0|||
16910828|NCT01582308|38019816|FG007|Period 4|Physician Decision|0|||
16910829|NCT01582308|38019817|FG008|Period 4|Physician Decision|0|||
16910830|NCT01582308|38019818|FG009|Period 4|Physician Decision|1|||
16910831|NCT01558674|38019833|FG000|Part 1|Study Terminated by Sponsor|10|||
16910832|NCT01558674|38019834|FG001|Part 1|Study Terminated by Sponsor|0|||
16910833|NCT01558674|38019833|FG000|Part 1|Withdrawal by Subject|1|||
16910834|NCT01558674|38019834|FG001|Part 1|Withdrawal by Subject|0|||
16910835|NCT01558596|38019855|FG000|Overall Study|Withdrawal by Subject|1|||
16910836|NCT01558596|38019856|FG001|Overall Study|Withdrawal by Subject|0|||
16910837|NCT01558596|38019855|FG000|Overall Study|surgery elsewhere or cancelled|1|||
16910838|NCT01558596|38019856|FG001|Overall Study|surgery elsewhere or cancelled|1|||
16910839|NCT01558596|38019855|FG000|Overall Study|Protocol Violation|1|||
16910840|NCT01558596|38019856|FG001|Overall Study|Protocol Violation|0|||
16910841|NCT01535040|38019864|FG000|Overall Study|Physician Decision|0|||
16910842|NCT01535040|38019865|FG001|Overall Study|Physician Decision|1|||
16910843|NCT01535040|38019864|FG000|Overall Study|Withdrawal by Subject|13|||
16910844|NCT01535040|38019865|FG001|Overall Study|Withdrawal by Subject|10|||
16910845|NCT01535040|38019864|FG000|Overall Study|Never Started|9|||
16910846|NCT01535040|38019865|FG001|Overall Study|Never Started|4|||
16910847|NCT01535040|38019864|FG000|Overall Study|Toxicity|7|||
16910848|NCT01535040|38019865|FG001|Overall Study|Toxicity|5|||
16910849|NCT01535040|38019864|FG000|Overall Study|Multiple Reasons|1|||
16910850|NCT01535040|38019865|FG001|Overall Study|Multiple Reasons|1|||
16910851|NCT01534962|38019875|FG000|Overall Study|Randomized but did not start treatment|2|||
16910852|NCT01534962|38019876|FG001|Overall Study|Randomized but did not start treatment|0|||
16910853|NCT01534962|38019877|FG002|Overall Study|Randomized but did not start treatment|0|||
16910854|NCT01534962|38019878|FG003|Overall Study|Randomized but did not start treatment|1|||
16910855|NCT01534962|38019875|FG000|Overall Study|Discontinued at AF recurrence|35|||
16910856|NCT01534962|38019876|FG001|Overall Study|Discontinued at AF recurrence|26|||
16910857|NCT01534962|38019877|FG002|Overall Study|Discontinued at AF recurrence|24|||
16910858|NCT01534962|38019878|FG003|Overall Study|Discontinued at AF recurrence|31|||
16910859|NCT01582152|38019890|FG000|Overall Study|Disease Progression|4|||
16910860|NCT01582152|38019891|FG001|Overall Study|Disease Progression|5|||
16910861|NCT01582152|38019890|FG000|Overall Study|Adverse Event|2|||
16910862|NCT01582152|38019891|FG001|Overall Study|Adverse Event|1|||
16910863|NCT01581684|38019907|FG000|Overall Study|Other reason not defined|0|||
16910864|NCT01581684|38019908|FG001|Overall Study|Other reason not defined|0|||
16910865|NCT01581684|38019909|FG002|Overall Study|Other reason not defined|0|||
16910866|NCT01581684|38019910|FG003|Overall Study|Other reason not defined|0|||
16910867|NCT01581684|38019911|FG004|Overall Study|Other reason not defined|0|||
16910868|NCT01581684|38019912|FG005|Overall Study|Other reason not defined|0|||
16910869|NCT01581684|38019913|FG006|Overall Study|Other reason not defined|0|||
16910870|NCT01581684|38019914|FG007|Overall Study|Other reason not defined|0|||
16910871|NCT01581684|38019915|FG008|Overall Study|Other reason not defined|1|||
16910872|NCT01581684|38019916|FG009|Overall Study|Other reason not defined|0|||
16910873|NCT01557582|38019949|FG000|Overall Study|Protocol Violation|4|||
16910874|NCT01557582|38019949|FG000|Overall Study|Operator error|2|||
16910875|NCT01557504|38019955|FG000|Overall Study|Physician Decision|1|||
16910876|NCT01557504|38019956|FG001|Overall Study|Physician Decision|0|||
16910877|NCT01557348|38019970|FG000|Overall Study|Adverse Event|6|||
16910878|NCT01557348|38019971|FG001|Overall Study|Adverse Event|16|||
16910879|NCT01557348|38019970|FG000|Overall Study|Infusion reaction event|5|||
16910880|NCT01557348|38019971|FG001|Overall Study|Infusion reaction event|5|||
16910881|NCT01557348|38019970|FG000|Overall Study|Death|7|||
16910882|NCT01557348|38019971|FG001|Overall Study|Death|4|||
16910883|NCT01557348|38019970|FG000|Overall Study|Insufficient Therapeutic Response|13|||
16910884|NCT01557348|38019971|FG001|Overall Study|Insufficient Therapeutic Response|28|||
16910885|NCT01557348|38019970|FG000|Overall Study|Withdrawal by Subject|5|||
16910886|NCT01557348|38019971|FG001|Overall Study|Withdrawal by Subject|4|||
16910887|NCT01557348|38019970|FG000|Overall Study|Lost to Follow-up|26|||
16910888|NCT01557348|38019971|FG001|Overall Study|Lost to Follow-up|22|||
16910889|NCT01557348|38019970|FG000|Overall Study|Administrative|18|||
17016640|NCT00600119|38161267|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
17016641|NCT00600119|38161262|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
17016642|NCT00600119|38161263|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
17016643|NCT00600119|38161264|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
17016644|NCT00600119|38161265|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
17016645|NCT00600119|38161266|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
17016646|NCT00600119|38161267|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
17198388|NCT02786927|38352073|FG000|Overall Study|Protocol Violation|4|||
17198389|NCT02592434|38352078|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
17198390|NCT02592434|38352079|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
17198391|NCT02592434|38352080|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
17198392|NCT02592434|38352078|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
17198393|NCT02592434|38352079|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
17198394|NCT02592434|38352080|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
17198395|NCT02592434|38352078|FG000|Open-Label Phase (18 Weeks)|Other|3|||
17198396|NCT02592434|38352079|FG001|Open-Label Phase (18 Weeks)|Other|0|||
17198397|NCT02592434|38352080|FG002|Open-Label Phase (18 Weeks)|Other|0|||
17198398|NCT02592434|38352078|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
17198399|NCT02592434|38352079|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
17198400|NCT02592434|38352080|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
17198401|NCT02592434|38352078|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
17198402|NCT02592434|38352079|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
17198403|NCT02592434|38352080|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
17198404|NCT02592434|38352078|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
17198405|NCT02592434|38352079|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
17198406|NCT02592434|38352080|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
17198407|NCT02592434|38352078|FG000|Double Blind Phase (26 Weeks)|Other|0|||
17198408|NCT02592434|38352079|FG001|Double Blind Phase (26 Weeks)|Other|1|||
17198409|NCT02592434|38352080|FG002|Double Blind Phase (26 Weeks)|Other|0|||
17198410|NCT02592434|38352078|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
17198411|NCT02592434|38352079|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
17198412|NCT02592434|38352080|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
17198413|NCT02592434|38352078|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
17198414|NCT02592434|38352079|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
17198415|NCT02592434|38352080|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
17198416|NCT02592434|38352078|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
17198417|NCT02592434|38352079|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
17198418|NCT02592434|38352080|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
17198419|NCT02785913|38352088|FG000|Overall Study|Adverse Event|5|||
17198420|NCT02785913|38352088|FG000|Overall Study|Death|2|||
17198421|NCT02785913|38352088|FG000|Overall Study|Progression|18|||
17198422|NCT02785913|38352088|FG000|Overall Study|Not protocol specified|1|||
17198423|NCT02590562|38352097|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
17198424|NCT02783729|38352124|FG000|Overall Study|Lack of Efficacy|1|||
16910890|NCT01557348|38019971|FG001|Overall Study|Administrative|11|||
17016647|NCT00600119|38161262|FG000|Double-blind Treatment Period|Other|0|||
17198425|NCT02783729|38352125|FG001|Overall Study|Lack of Efficacy|0|||
17198426|NCT02783729|38352126|FG002|Overall Study|Lack of Efficacy|0|||
17198427|NCT02783729|38352127|FG003|Overall Study|Lack of Efficacy|0|||
17198428|NCT02783729|38352124|FG000|Overall Study|Adverse Event|2|||
17198429|NCT02783729|38352125|FG001|Overall Study|Adverse Event|6|||
17016648|NCT00600119|38161263|FG001|Double-blind Treatment Period|Other|0|||
17016649|NCT00600119|38161264|FG002|Double-blind Treatment Period|Other|0|||
17016650|NCT00600119|38161265|FG003|Double-blind Treatment Period|Other|0|||
17016651|NCT00600119|38161266|FG004|Double-blind Treatment Period|Other|2|||
16910891|NCT01580670|38019978|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
16910892|NCT01580670|38019978|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
16910893|NCT01534260|38019984|FG000|Overall Study|Adverse Event|1|||
16910894|NCT01534260|38019985|FG001|Overall Study|Adverse Event|8|||
16910895|NCT01534260|38019984|FG000|Overall Study|Death|2|||
16910896|NCT01534260|38019985|FG001|Overall Study|Death|0|||
16910897|NCT01534260|38019984|FG000|Overall Study|Lack of Efficacy|1|||
16910898|NCT01534260|38019985|FG001|Overall Study|Lack of Efficacy|1|||
16910899|NCT01534260|38019984|FG000|Overall Study|Withdrawal by Subject|1|||
16910900|NCT01534260|38019985|FG001|Overall Study|Withdrawal by Subject|3|||
16910901|NCT01534260|38019984|FG000|Overall Study|Disease Progression|8|||
16910902|NCT01534260|38019985|FG001|Overall Study|Disease Progression|6|||
16910903|NCT01534260|38019984|FG000|Overall Study|Physician Decision|3|||
16910904|NCT01534260|38019985|FG001|Overall Study|Physician Decision|1|||
16910905|NCT01534260|38019984|FG000|Overall Study|No treatment, per protocol|0|||
16910906|NCT01534260|38019985|FG001|Overall Study|No treatment, per protocol|1|||
16910907|NCT01534182|38019993|FG000|Overall Study|Administrative problems|1|||
16910908|NCT01534182|38019994|FG001|Overall Study|Administrative problems|0|||
16910909|NCT01534182|38019993|FG000|Overall Study|Withdrawal by Subject|4|||
16910910|NCT01534182|38019994|FG001|Overall Study|Withdrawal by Subject|7|||
16910911|NCT01534182|38019993|FG000|Overall Study|Adverse Event|7|||
16910912|NCT01534182|38019994|FG001|Overall Study|Adverse Event|3|||
16910913|NCT01579812|38020001|FG000|Overall Study|Ineligible after treatment start|40|||
16910914|NCT01579812|38020001|FG000|Overall Study|Patient choice|3|||
16910915|NCT01579812|38020001|FG000|Overall Study|Noncompliance|3|||
16910916|NCT01579812|38020001|FG000|Overall Study|Withdrawal by Subject|6|||
16910917|NCT01533714|38020014|FG000|Overall Study|Adverse Event|0|||
16910918|NCT01533714|38020015|FG001|Overall Study|Adverse Event|1|||
16910919|NCT01533714|38020016|FG002|Overall Study|Adverse Event|2|||
16910920|NCT01533714|38020017|FG003|Overall Study|Adverse Event|2|||
16910921|NCT01533714|38020018|FG004|Overall Study|Adverse Event|2|||
16910922|NCT01533714|38020019|FG005|Overall Study|Adverse Event|1|||
16910923|NCT01533714|38020014|FG000|Overall Study|Lack of Efficacy|0|||
16910924|NCT01533714|38020015|FG001|Overall Study|Lack of Efficacy|0|||
16910925|NCT01533714|38020016|FG002|Overall Study|Lack of Efficacy|0|||
16910926|NCT01533714|38020017|FG003|Overall Study|Lack of Efficacy|0|||
17016652|NCT00600119|38161267|FG005|Double-blind Treatment Period|Other|1|||
17016653|NCT00600119|38161262|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
17016654|NCT00600119|38161263|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
17016655|NCT00600119|38161264|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
16910927|NCT01533714|38020018|FG004|Overall Study|Lack of Efficacy|0|||
16910928|NCT01533714|38020019|FG005|Overall Study|Lack of Efficacy|1|||
16910929|NCT01533714|38020014|FG000|Overall Study|Withdrawal by Subject|0|||
16910930|NCT01533714|38020015|FG001|Overall Study|Withdrawal by Subject|1|||
17016656|NCT00600119|38161265|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
17102358|NCT00099632|38241292|FG000|Overall Study|Lost to Follow-up|1|||
16910931|NCT01533714|38020016|FG002|Overall Study|Withdrawal by Subject|0|||
16910932|NCT01533714|38020017|FG003|Overall Study|Withdrawal by Subject|1|||
16910933|NCT01533714|38020018|FG004|Overall Study|Withdrawal by Subject|1|||
16910934|NCT01533714|38020019|FG005|Overall Study|Withdrawal by Subject|0|||
16910935|NCT01533714|38020014|FG000|Overall Study|Exclusion criteria|0|||
16910936|NCT01533714|38020015|FG001|Overall Study|Exclusion criteria|1|||
16910937|NCT01533714|38020016|FG002|Overall Study|Exclusion criteria|0|||
16910938|NCT01533714|38020017|FG003|Overall Study|Exclusion criteria|0|||
16910939|NCT01533714|38020018|FG004|Overall Study|Exclusion criteria|0|||
16910940|NCT01533714|38020019|FG005|Overall Study|Exclusion criteria|0|||
16910941|NCT01533714|38020014|FG000|Overall Study|Positive for purified protein derivative|0|||
16910942|NCT01533714|38020015|FG001|Overall Study|Positive for purified protein derivative|0|||
16910943|NCT01533714|38020016|FG002|Overall Study|Positive for purified protein derivative|1|||
16910944|NCT01533714|38020017|FG003|Overall Study|Positive for purified protein derivative|0|||
16910945|NCT01533714|38020018|FG004|Overall Study|Positive for purified protein derivative|1|||
16910946|NCT01533714|38020019|FG005|Overall Study|Positive for purified protein derivative|0|||
16910947|NCT01533714|38020014|FG000|Overall Study|Withdrawal criteria|0|||
16910948|NCT01533714|38020015|FG001|Overall Study|Withdrawal criteria|0|||
16910949|NCT01533714|38020016|FG002|Overall Study|Withdrawal criteria|1|||
16910950|NCT01533714|38020017|FG003|Overall Study|Withdrawal criteria|0|||
16910951|NCT01533714|38020018|FG004|Overall Study|Withdrawal criteria|3|||
17016657|NCT00600119|38161266|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
16910952|NCT01533714|38020019|FG005|Overall Study|Withdrawal criteria|1|||
16910953|NCT01533714|38020014|FG000|Overall Study|Ineligibility reason|0|||
16910954|NCT01533714|38020015|FG001|Overall Study|Ineligibility reason|0|||
16910955|NCT01533714|38020016|FG002|Overall Study|Ineligibility reason|0|||
16910956|NCT01533714|38020017|FG003|Overall Study|Ineligibility reason|1|||
16910957|NCT01533714|38020018|FG004|Overall Study|Ineligibility reason|0|||
16910958|NCT01533714|38020019|FG005|Overall Study|Ineligibility reason|0|||
16910959|NCT01533246|38020033|FG000|Overall Study|Adverse Event|1|||
16910960|NCT01533246|38020033|FG000|Overall Study|Withdrawal by Subject|1|||
16910961|NCT01579578|38020039|FG000|Overall Study|Death|4|||
16910962|NCT01579578|38020040|FG001|Overall Study|Death|1|||
16910963|NCT01579578|38020039|FG000|Overall Study|Lost to Follow-up|1|||
16910964|NCT01579578|38020040|FG001|Overall Study|Lost to Follow-up|1|||
16910965|NCT01579578|38020039|FG000|Overall Study|Withdrawal by Subject|2|||
16910966|NCT01579578|38020040|FG001|Overall Study|Withdrawal by Subject|1|||
16910967|NCT01579578|38020039|FG000|Overall Study|Eligibility criteria|3|||
16910968|NCT01579578|38020040|FG001|Overall Study|Eligibility criteria|9|||
16910969|NCT01579578|38020039|FG000|Overall Study|Ongoing|3|||
16910970|NCT01579578|38020040|FG001|Overall Study|Ongoing|0|||
16910971|NCT01578486|38020046|FG000|Overall Study|Physician Decision|3|||
16910972|NCT01578486|38020046|FG000|Overall Study|Withdrawal by Subject|2|||
16910973|NCT01532934|38020052|FG000|Overall Study|Lost to Follow-up|11|||
16910974|NCT01532934|38020053|FG001|Overall Study|Lost to Follow-up|11|||
16910975|NCT01532934|38020052|FG000|Overall Study|In controlled environment|3|||
16910976|NCT01532934|38020053|FG001|Overall Study|In controlled environment|2|||
16910977|NCT01532388|38020063|FG000|3-month Follow-up|Lost to Follow-up|68|||
16910978|NCT01532388|38020064|FG001|3-month Follow-up|Lost to Follow-up|68|||
16910979|NCT01532388|38020063|FG000|6-month Follow-up|Lost to Follow-up|74|||
16910980|NCT01532388|38020064|FG001|6-month Follow-up|Lost to Follow-up|66|||
16910981|NCT01532388|38020063|FG000|12-month Follow-up|Lost to Follow-up|69|||
16910982|NCT01532388|38020064|FG001|12-month Follow-up|Lost to Follow-up|67|||
16910983|NCT01555164|38020072|FG000|Overall Study|Adverse Event|5|||
16910984|NCT01555164|38020073|FG001|Overall Study|Adverse Event|7|||
16910985|NCT01555164|38020072|FG000|Overall Study|Hyperglycemia|0|||
16910986|NCT01555164|38020073|FG001|Overall Study|Hyperglycemia|1|||
16910987|NCT01555164|38020072|FG000|Overall Study|Investigator's Discretion|2|||
16910988|NCT01555164|38020073|FG001|Overall Study|Investigator's Discretion|2|||
16910989|NCT01555164|38020072|FG000|Overall Study|Lost to Follow-up|4|||
16910990|NCT01555164|38020073|FG001|Overall Study|Lost to Follow-up|3|||
16910991|NCT01555164|38020072|FG000|Overall Study|Protocol Violation|9|||
16910992|NCT01555164|38020073|FG001|Overall Study|Protocol Violation|5|||
16910993|NCT01555164|38020072|FG000|Overall Study|Subject Non-compliance|14|||
16910994|NCT01555164|38020073|FG001|Overall Study|Subject Non-compliance|6|||
16910995|NCT01555164|38020072|FG000|Overall Study|Subject Withdrew Consent|6|||
16910996|NCT01555164|38020073|FG001|Overall Study|Subject Withdrew Consent|11|||
16910997|NCT01578330|38020079|FG000|Overall Study|Adverse Event|2|||
16910998|NCT01578330|38020079|FG000|Overall Study|Protocol Violation|5|||
16910999|NCT01577160|38020083|FG000|Overall Study|Adverse Event|9|||
16911000|NCT01577160|38020083|FG000|Overall Study|Lack of Efficacy|15|||
16911001|NCT01577160|38020083|FG000|Overall Study|Lost to Follow-up|40|||
16911002|NCT01577160|38020083|FG000|Overall Study|Withdrawal by Subject|18|||
16911003|NCT01577160|38020083|FG000|Overall Study|Subject Uncooperative|7|||
16911004|NCT01577160|38020083|FG000|Overall Study|Other|9|||
16911005|NCT01554618|38020089|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
16911006|NCT01554618|38020090|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
16911007|NCT01554618|38020089|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
16911008|NCT01554618|38020090|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
16911009|NCT01554618|38020089|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
16911010|NCT01554618|38020090|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
16911011|NCT01554618|38020089|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
16911012|NCT01554618|38020090|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
16911013|NCT01554618|38020089|FG000|Open-Label Extension Period|Physician Decision|0|||
16911014|NCT01554618|38020090|FG001|Open-Label Extension Period|Physician Decision|1|||
16911015|NCT01554618|38020089|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
16911016|NCT01554618|38020090|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
16911017|NCT01531998|38020100|FG000|Overall Study|Withdrawal by Subject|3|||
16911018|NCT01576146|38020104|FG000|Extension Period 1|Adverse Event|2|||
16911019|NCT01576146|38020104|FG000|Extension Period 1|Death|2|||
16911020|NCT01576146|38020104|FG000|Extension Period 1|Physician Decision|2|||
16911021|NCT01576146|38020104|FG000|Extension Period 1|Withdrawal by Subject|1|||
16911022|NCT01576146|38020104|FG000|Extension Period 1|Lost to Follow-up|1|||
16911023|NCT01576146|38020104|FG000|Extension Period 1|Parathyroidectomy|1|||
16911024|NCT01576146|38020104|FG000|Extension Period 1|Renal Transplant|1|||
16911025|NCT01576146|38020104|FG000|Extension Period 2|Sponsor Decision|13|||
16911026|NCT01576146|38020104|FG000|Extension Period 2|Death|1|||
16911027|NCT01576146|38020104|FG000|Extension Period 2|Adverse Event|1|||
16911028|NCT01576146|38020104|FG000|Extension Period 2|Renal Transplant|1|||
16911029|NCT01576146|38020104|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
16911030|NCT01553916|38020108|FG000|Overall Study|Withdrawal by Subject|2|||
16911031|NCT01553916|38020108|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
16911032|NCT01553136|38020114|FG000|Overall Study|Adverse Event|3|||
16911033|NCT01553136|38020115|FG001|Overall Study|Adverse Event|2|||
16911034|NCT01553136|38020114|FG000|Overall Study|Withdrawal by Subject|2|||
16911035|NCT01553136|38020115|FG001|Overall Study|Withdrawal by Subject|3|||
16911036|NCT01553136|38020114|FG000|Overall Study|Lost to Follow-up|4|||
16911037|NCT01553136|38020115|FG001|Overall Study|Lost to Follow-up|10|||
16911038|NCT01553136|38020114|FG000|Overall Study|Physician Decision|2|||
16911039|NCT01553136|38020115|FG001|Overall Study|Physician Decision|3|||
16911040|NCT01553136|38020114|FG000|Overall Study|Scheduling Difficulties|5|||
16911041|NCT01553136|38020115|FG001|Overall Study|Scheduling Difficulties|4|||
16911042|NCT01552902|38020124|FG000|Overall Study|Adverse Event|1|||
16911043|NCT01552902|38020125|FG001|Overall Study|Adverse Event|15|||
16911044|NCT01552902|38020126|FG002|Overall Study|Adverse Event|14|||
16911045|NCT01552902|38020124|FG000|Overall Study|Protocol Violation|3|||
16911046|NCT01552902|38020125|FG001|Overall Study|Protocol Violation|3|||
16911047|NCT01552902|38020126|FG002|Overall Study|Protocol Violation|3|||
16911048|NCT01552902|38020124|FG000|Overall Study|Lack of Efficacy|4|||
16911049|NCT01552902|38020125|FG001|Overall Study|Lack of Efficacy|3|||
16911050|NCT01552902|38020126|FG002|Overall Study|Lack of Efficacy|1|||
16911051|NCT01552902|38020124|FG000|Overall Study|Withdrawal by Subject|1|||
16911052|NCT01552902|38020125|FG001|Overall Study|Withdrawal by Subject|9|||
16911053|NCT01552902|38020126|FG002|Overall Study|Withdrawal by Subject|6|||
16911054|NCT01552902|38020124|FG000|Overall Study|Lost to Follow-up|1|||
16911055|NCT01552902|38020125|FG001|Overall Study|Lost to Follow-up|3|||
16911056|NCT01552902|38020126|FG002|Overall Study|Lost to Follow-up|6|||
16911057|NCT01552902|38020124|FG000|Overall Study|Other|3|||
16911058|NCT01552902|38020125|FG001|Overall Study|Other|4|||
17016658|NCT00600119|38161267|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
17016659|NCT00600119|38161262|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
16911059|NCT01552902|38020126|FG002|Overall Study|Other|3|||
16911060|NCT01529346|38020152|FG000|Overall Study|Lost to Follow-up|2|||
16911061|NCT01529346|38020153|FG001|Overall Study|Lost to Follow-up|0|||
16911062|NCT01529346|38020154|FG002|Overall Study|Lost to Follow-up|1|||
16911063|NCT01529346|38020155|FG003|Overall Study|Lost to Follow-up|0|||
16911064|NCT01529346|38020156|FG004|Overall Study|Lost to Follow-up|0|||
16911065|NCT01529346|38020152|FG000|Overall Study|Other|0|||
16911066|NCT01529346|38020153|FG001|Overall Study|Other|1|||
16911067|NCT01529346|38020154|FG002|Overall Study|Other|1|||
16911068|NCT01529346|38020155|FG003|Overall Study|Other|0|||
16911069|NCT01529346|38020156|FG004|Overall Study|Other|0|||
16911070|NCT01529268|38020180|FG000|Overall Study|Lost to Follow-up|9|||
16911071|NCT01529268|38020181|FG001|Overall Study|Lost to Follow-up|3|||
16911072|NCT01529268|38020180|FG000|Overall Study|Moved|3|||
16911073|NCT01529268|38020181|FG001|Overall Study|Moved|0|||
16911074|NCT01529112|38020189|FG000|Overall Study|Adverse Event|2|||
16911075|NCT01529112|38020190|FG001|Overall Study|Adverse Event|0|||
16911076|NCT01529112|38020189|FG000|Overall Study|Death|59|||
16911077|NCT01529112|38020190|FG001|Overall Study|Death|38|||
16911078|NCT01529112|38020189|FG000|Overall Study|Protocol Violation|1|||
16911079|NCT01529112|38020190|FG001|Overall Study|Protocol Violation|0|||
16911080|NCT01529112|38020189|FG000|Overall Study|Withdrawal by Subject|7|||
16911081|NCT01529112|38020190|FG001|Overall Study|Withdrawal by Subject|3|||
16911082|NCT01551420|38020198|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
16911083|NCT01551420|38020199|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
16911084|NCT01551420|38020198|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
16911085|NCT01551420|38020199|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
16911086|NCT01551420|38020198|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
16911087|NCT01551420|38020199|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
16911088|NCT01551420|38020198|FG000|Screened for Part B Eligibility|Declined participation|8|||
16911089|NCT01551420|38020199|FG001|Screened for Part B Eligibility|Declined participation|1|||
16911090|NCT01551420|38020198|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
16911091|NCT01551420|38020199|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
16911092|NCT01551420|38020198|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
16911093|NCT01551420|38020199|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
16911094|NCT01551420|38020198|FG000|Home Use (Part B)|Withdrawal by staff|0|||
16911095|NCT01551420|38020199|FG001|Home Use (Part B)|Withdrawal by staff|1|||
16911096|NCT01575054|38020207|FG000|Overall Study|Other Reasons|5|||
16911097|NCT01575054|38020208|FG001|Overall Study|Other Reasons|3|||
16911098|NCT01575054|38020207|FG000|Overall Study|Protocol Violation|2|||
16911099|NCT01575054|38020208|FG001|Overall Study|Protocol Violation|1|||
16911100|NCT01575054|38020207|FG000|Overall Study|Personal Reasons|10|||
16911101|NCT01575054|38020208|FG001|Overall Study|Personal Reasons|11|||
16911102|NCT01575054|38020207|FG000|Overall Study|Lost to Follow-up|3|||
16911103|NCT01575054|38020208|FG001|Overall Study|Lost to Follow-up|3|||
16911104|NCT01575054|38020207|FG000|Overall Study|Adverse Event|9|||
16911105|NCT01575054|38020208|FG001|Overall Study|Adverse Event|8|||
16911106|NCT01528254|38020216|FG000|Overall Study|Administrative problems|96|||
16911107|NCT01528254|38020217|FG001|Overall Study|Administrative problems|94|||
16911108|NCT01528254|38020216|FG000|Overall Study|Adverse Event|28|||
16911109|NCT01528254|38020217|FG001|Overall Study|Adverse Event|44|||
16911110|NCT01528254|38020216|FG000|Overall Study|Lost to Follow-up|17|||
16911111|NCT01528254|38020217|FG001|Overall Study|Lost to Follow-up|24|||
16911112|NCT01528254|38020216|FG000|Overall Study|Death|13|||
16911113|NCT01528254|38020217|FG001|Overall Study|Death|9|||
16911114|NCT01528254|38020216|FG000|Overall Study|Protocol deviation|9|||
16911115|NCT01528254|38020217|FG001|Overall Study|Protocol deviation|19|||
16911116|NCT01528254|38020216|FG000|Overall Study|New therapy for study indication|8|||
16911117|NCT01528254|38020217|FG001|Overall Study|New therapy for study indication|6|||
16911118|NCT01528254|38020216|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
16911119|NCT01528254|38020217|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
16911120|NCT01528254|38020216|FG000|Overall Study|Withdrawal by Subject|5|||
16911121|NCT01528254|38020217|FG001|Overall Study|Withdrawal by Subject|4|||
16911122|NCT01528254|38020216|FG000|Overall Study|Abnormal laboratory value(s)|3|||
16911123|NCT01528254|38020217|FG001|Overall Study|Abnormal laboratory value(s)|7|||
16911124|NCT01528254|38020216|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16911125|NCT01528254|38020217|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16911126|NCT01528254|38020216|FG000|Overall Study|No longer requires study drug|1|||
16911127|NCT01528254|38020217|FG001|Overall Study|No longer requires study drug|1|||
16911128|NCT01574352|38020226|FG000|Overall Study|Withdrawal by Subject|6|||
16911129|NCT01574352|38020227|FG001|Overall Study|Withdrawal by Subject|13|||
16911130|NCT01574352|38020226|FG000|Overall Study|Injury in non-camp related sport|1|||
16911131|NCT01574352|38020227|FG001|Overall Study|Injury in non-camp related sport|0|||
16911132|NCT01527006|38020235|FG000|Core Study|Adverse Event|0|||
16911133|NCT01527006|38020236|FG001|Core Study|Adverse Event|2|||
16911134|NCT01527006|38020235|FG000|Core Study|Lost to Follow-up|0|||
16911135|NCT01527006|38020236|FG001|Core Study|Lost to Follow-up|1|||
16911136|NCT01527006|38020235|FG000|Core Study|Subject Choice|1|||
16911137|NCT01527006|38020236|FG001|Core Study|Subject Choice|0|||
16911138|NCT01527006|38020235|FG000|Core Study|Inadequate Therapeutic Effect|1|||
16911139|NCT01527006|38020236|FG001|Core Study|Inadequate Therapeutic Effect|0|||
16911140|NCT01527006|38020235|FG000|Core Study|Withdrawal by Subject|0|||
16911141|NCT01527006|38020236|FG001|Core Study|Withdrawal by Subject|1|||
16911142|NCT01527006|38020235|FG000|Core Study|Other|0|||
16911143|NCT01527006|38020236|FG001|Core Study|Other|2|||
16911144|NCT01527006|38020235|FG000|Extension Phase|Adverse Event|4|||
16911145|NCT01527006|38020236|FG001|Extension Phase|Adverse Event|2|||
16911146|NCT01527006|38020235|FG000|Extension Phase|Lost to Follow-up|0|||
16911147|NCT01527006|38020236|FG001|Extension Phase|Lost to Follow-up|1|||
16911148|NCT01527006|38020235|FG000|Extension Phase|Subject Choice|1|||
16911149|NCT01527006|38020236|FG001|Extension Phase|Subject Choice|1|||
16911150|NCT01527006|38020235|FG000|Extension Phase|Inadequate therapeutic effect|1|||
16911151|NCT01527006|38020236|FG001|Extension Phase|Inadequate therapeutic effect|1|||
16911152|NCT01527006|38020235|FG000|Extension Phase|Other|0|||
16911153|NCT01527006|38020236|FG001|Extension Phase|Other|3|||
16911154|NCT01526928|38020254|FG000|Overall Study|Progressive Disease|35|||
16911155|NCT01526928|38020255|FG001|Overall Study|Progressive Disease|17|||
16911156|NCT01526928|38020256|FG002|Overall Study|Progressive Disease|150|||
16911157|NCT01526928|38020257|FG003|Overall Study|Progressive Disease|182|||
16911158|NCT01526928|38020258|FG004|Overall Study|Progressive Disease|76|||
16911159|NCT01526928|38020259|FG005|Overall Study|Progressive Disease|4|||
16911160|NCT01526928|38020254|FG000|Overall Study|Adverse Event|2|||
16817645|NCT02203513|37760499|FG002|Overall Study|Switched to alternative treatment|0|||
16817646|NCT02203513|37760500|FG003|Overall Study|Switched to alternative treatment|0|||
16817647|NCT02203513|37760501|FG004|Overall Study|Switched to alternative treatment|4|||
16817648|NCT02203513|37760497|FG000|Overall Study|Did not receive investigational product (IP)|0|||
16817649|NCT02203513|37760498|FG001|Overall Study|Did not receive investigational product (IP)|1|||
16817650|NCT02203513|37760499|FG002|Overall Study|Did not receive investigational product (IP)|0|||
16817651|NCT02203513|37760500|FG003|Overall Study|Did not receive investigational product (IP)|0|||
16817652|NCT02203513|37760501|FG004|Overall Study|Did not receive investigational product (IP)|0|||
16817653|NCT02203513|37760497|FG000|Overall Study|Death (unrelated to study therapy)|1|||
16817654|NCT02203513|37760498|FG001|Overall Study|Death (unrelated to study therapy)|3|||
16911161|NCT01526928|38020255|FG001|Overall Study|Adverse Event|1|||
16911162|NCT01526928|38020256|FG002|Overall Study|Adverse Event|29|||
16911163|NCT01526928|38020257|FG003|Overall Study|Adverse Event|40|||
16911164|NCT01526928|38020258|FG004|Overall Study|Adverse Event|13|||
16911165|NCT01526928|38020259|FG005|Overall Study|Adverse Event|2|||
16911166|NCT01526928|38020254|FG000|Overall Study|Death|0|||
16911167|NCT01526928|38020255|FG001|Overall Study|Death|0|||
16911168|NCT01526928|38020256|FG002|Overall Study|Death|3|||
16817655|NCT02203513|37760499|FG002|Overall Study|Death (unrelated to study therapy)|1|||
16911169|NCT01526928|38020257|FG003|Overall Study|Death|0|||
16911170|NCT01526928|38020258|FG004|Overall Study|Death|0|||
16911171|NCT01526928|38020259|FG005|Overall Study|Death|0|||
16911172|NCT01526928|38020254|FG000|Overall Study|Withdrawal by Subject|1|||
16817656|NCT02203513|37760500|FG003|Overall Study|Death (unrelated to study therapy)|0|||
16817657|NCT02203513|37760501|FG004|Overall Study|Death (unrelated to study therapy)|2|||
16817658|NCT02203513|37760497|FG000|Overall Study|Lost to Follow-up|0|||
16817659|NCT02203513|37760498|FG001|Overall Study|Lost to Follow-up|0|||
16817660|NCT02203513|37760499|FG002|Overall Study|Lost to Follow-up|1|||
16817661|NCT02203513|37760500|FG003|Overall Study|Lost to Follow-up|1|||
16817662|NCT02203513|37760501|FG004|Overall Study|Lost to Follow-up|0|||
16817663|NCT02299934|37760515|FG000|Overall Study|Termination of study|13|||
16817664|NCT01703260|37760522|FG000|Overall Study|Adverse Event|1|||
16817665|NCT01703260|37760523|FG001|Overall Study|Adverse Event|2|||
16817666|NCT01703260|37760524|FG002|Overall Study|Adverse Event|2|||
16817667|NCT01703260|37760522|FG000|Overall Study|Lost to Follow-up|1|||
16817668|NCT01703260|37760523|FG001|Overall Study|Lost to Follow-up|0|||
16817669|NCT01703260|37760524|FG002|Overall Study|Lost to Follow-up|0|||
16817670|NCT01703260|37760522|FG000|Overall Study|Withdrawal by Subject|0|||
16817671|NCT01703260|37760523|FG001|Overall Study|Withdrawal by Subject|0|||
16817672|NCT01703260|37760524|FG002|Overall Study|Withdrawal by Subject|1|||
16817673|NCT01703260|37760522|FG000|Overall Study|Study Termination|1|||
16817674|NCT01703260|37760523|FG001|Overall Study|Study Termination|2|||
16817675|NCT01703260|37760524|FG002|Overall Study|Study Termination|0|||
16817676|NCT02203357|37760535|FG000|Overall Study|Lost to Follow-up|58|||
16817677|NCT02203357|37760536|FG001|Overall Study|Lost to Follow-up|66|||
16817678|NCT02203357|37760537|FG002|Overall Study|Lost to Follow-up|70|||
16817679|NCT02299388|37760550|FG000|Overall Study|Withdrawal by Subject|0|||
16817680|NCT02299388|37760551|FG001|Overall Study|Withdrawal by Subject|1|||
16817681|NCT02202577|37760559|FG000|Overall Study|Lost to Follow-up|6|||
16817682|NCT02202577|37760560|FG001|Overall Study|Lost to Follow-up|16|||
16817683|NCT02202577|37760559|FG000|Overall Study|Protocol Violation|7|||
16817684|NCT02202577|37760560|FG001|Overall Study|Protocol Violation|3|||
16817685|NCT02299076|37760568|FG000|Overall Study|Fraudulent Entries|20|||
16817686|NCT02299076|37760569|FG001|Overall Study|Fraudulent Entries|14|||
16817687|NCT01723072|37760577|FG000|Overall Study|Withdrawal by Subject|7|||
16817688|NCT01723072|37760578|FG001|Overall Study|Withdrawal by Subject|13|||
16817689|NCT01723072|37760577|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
16817690|NCT01723072|37760578|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
16817691|NCT01723072|37760577|FG000|Overall Study|Other|4|||
16817692|NCT01723072|37760578|FG001|Overall Study|Other|3|||
16817693|NCT01722994|37760586|FG000|Overall Study|Missing data|25|||
16817694|NCT01722994|37760587|FG001|Overall Study|Missing data|17|||
16817695|NCT02228395|37760595|FG000|First Intervention Period|No longer willing to participate|1|||
16817696|NCT02228395|37760596|FG001|First Intervention Period|No longer willing to participate|0|||
16817697|NCT02228395|37760597|FG002|First Intervention Period|No longer willing to participate|0|||
16817698|NCT02228395|37760595|FG000|First Intervention Period|Unable to comply with study dates|0|||
16817699|NCT02228395|37760596|FG001|First Intervention Period|Unable to comply with study dates|1|||
16817700|NCT02228395|37760597|FG002|First Intervention Period|Unable to comply with study dates|1|||
16817701|NCT02170051|37760609|FG000|Overall Study|Withdrawal by Subject|10|||
16817702|NCT02170051|37760610|FG001|Overall Study|Withdrawal by Subject|10|||
16817703|NCT02170051|37760609|FG000|Overall Study|Lost to Follow-up|1|||
16817704|NCT02170051|37760610|FG001|Overall Study|Lost to Follow-up|3|||
16817705|NCT02169739|37760618|FG000|Overall Study|Lost to Follow-up|0|||
16817706|NCT02169739|37760619|FG001|Overall Study|Lost to Follow-up|4|||
16817707|NCT02169505|37760626|FG000|Overall Study|Withdrawal by Subject|1|||
16817708|NCT01909791|37760633|FG000|Overall Study|Death|9|||
16817709|NCT01909791|37760634|FG001|Overall Study|Death|8|||
16817710|NCT01909791|37760635|FG002|Overall Study|Death|4|||
16817711|NCT01909791|37760633|FG000|Overall Study|Withdrawal by Subject|5|||
16817712|NCT01909791|37760634|FG001|Overall Study|Withdrawal by Subject|9|||
16817713|NCT01909791|37760635|FG002|Overall Study|Withdrawal by Subject|13|||
16817714|NCT01909791|37760633|FG000|Overall Study|Lost to Follow-up|5|||
16817715|NCT01909791|37760634|FG001|Overall Study|Lost to Follow-up|11|||
16817716|NCT01909791|37760635|FG002|Overall Study|Lost to Follow-up|10|||
16817717|NCT01909791|37760633|FG000|Overall Study|Missed Visit|2|||
16817718|NCT01909791|37760634|FG001|Overall Study|Missed Visit|0|||
16817719|NCT01909791|37760635|FG002|Overall Study|Missed Visit|1|||
16817720|NCT02202499|37760651|FG000|Overall Study|Cancer diagnosis|0|||
16817721|NCT02202499|37760652|FG001|Overall Study|Cancer diagnosis|0|||
16817722|NCT02202499|37760653|FG002|Overall Study|Cancer diagnosis|1|||
16817723|NCT02202499|37760651|FG000|Overall Study|Moved from area|0|||
16817724|NCT02202499|37760652|FG001|Overall Study|Moved from area|0|||
16817725|NCT02202499|37760653|FG002|Overall Study|Moved from area|1|||
16817726|NCT02202499|37760651|FG000|Overall Study|Declined before randomization|1|||
16817727|NCT02202499|37760652|FG001|Overall Study|Declined before randomization|0|||
16817728|NCT02202499|37760653|FG002|Overall Study|Declined before randomization|0|||
16817729|NCT02202499|37760651|FG000|Overall Study|Auto accident|1|||
16817730|NCT02202499|37760652|FG001|Overall Study|Auto accident|0|||
16817731|NCT02202499|37760653|FG002|Overall Study|Auto accident|0|||
16817732|NCT02202109|37760668|FG000|Overall Study|Lost to Follow-up|88|||
16817733|NCT02202109|37760669|FG001|Overall Study|Lost to Follow-up|87|||
16817734|NCT02202109|37760668|FG000|Overall Study|Withdrawal by Subject|2|||
16817735|NCT02202109|37760669|FG001|Overall Study|Withdrawal by Subject|0|||
16817736|NCT02227849|37760675|FG000|Overall Study|Adverse Event|4|||
16817737|NCT02227849|37760675|FG000|Overall Study|Physician Decision|1|||
16817738|NCT02227849|37760675|FG000|Overall Study|Withdrawal by Subject|3|||
16817739|NCT01927497|37760681|FG000|Overall Study|Death|0|||
16817740|NCT01927497|37760682|FG001|Overall Study|Death|1|||
16817741|NCT01927497|37760681|FG000|Overall Study|Protocol Violation|2|||
16817742|NCT01927497|37760682|FG001|Overall Study|Protocol Violation|0|||
16817743|NCT02169271|37760690|FG000|Overall Study|Protocol Violation|1|||
16817744|NCT02169271|37760691|FG001|Overall Study|Protocol Violation|2|||
16817745|NCT02202031|37760699|FG000|Overall Study|Lost to Follow-up|1|||
16817746|NCT02202031|37760700|FG001|Overall Study|Lost to Follow-up|0|||
16817747|NCT02202031|37760699|FG000|Overall Study|Too Busy|1|||
16817748|NCT02202031|37760700|FG001|Overall Study|Too Busy|3|||
16817749|NCT02202031|37760699|FG000|Overall Study|Illness/Medical Reason|0|||
16817750|NCT02202031|37760700|FG001|Overall Study|Illness/Medical Reason|2|||
16817751|NCT02202031|37760699|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
16817752|NCT02202031|37760700|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
16817753|NCT01644188|37760708|FG000|Overall Study|Adverse Event|44|||
16817754|NCT01644188|37760709|FG001|Overall Study|Adverse Event|20|||
16817755|NCT01644188|37760708|FG000|Overall Study|Poor compliance to protocol|26|||
16817756|NCT01644188|37760709|FG001|Overall Study|Poor compliance to protocol|14|||
16817757|NCT01644188|37760708|FG000|Overall Study|Physician Decision|1|||
16817758|NCT01644188|37760709|FG001|Overall Study|Physician Decision|3|||
16817759|NCT01644188|37760708|FG000|Overall Study|Participant moved|7|||
16817760|NCT01644188|37760709|FG001|Overall Study|Participant moved|2|||
16817761|NCT01644188|37760708|FG000|Overall Study|Related to auto-injector administration|2|||
16817762|NCT01644188|37760709|FG001|Overall Study|Related to auto-injector administration|2|||
16817763|NCT01644188|37760708|FG000|Overall Study|Consent withdrawn by participant|14|||
16817764|NCT01644188|37760709|FG001|Overall Study|Consent withdrawn by participant|7|||
16817765|NCT01644188|37760708|FG000|Overall Study|Selection criteria finally not met|2|||
16817766|NCT01644188|37760709|FG001|Overall Study|Selection criteria finally not met|0|||
16817767|NCT01644188|37760708|FG000|Overall Study|Lost to Follow-up|1|||
16817768|NCT01644188|37760709|FG001|Overall Study|Lost to Follow-up|0|||
16817769|NCT01644188|37760708|FG000|Overall Study|Death|4|||
16817770|NCT01644188|37760709|FG001|Overall Study|Death|3|||
16817771|NCT01644188|37760708|FG000|Overall Study|Last visit outside protocol visit window|14|||
16817772|NCT01644188|37760709|FG001|Overall Study|Last visit outside protocol visit window|16|||
16817773|NCT01644188|37760708|FG000|Overall Study|Site closure|1|||
16817774|NCT01644188|37760709|FG001|Overall Study|Site closure|1|||
16817775|NCT01644188|37760708|FG000|Overall Study|Other than specified above|6|||
16817776|NCT01644188|37760709|FG001|Overall Study|Other than specified above|7|||
16817777|NCT02201953|37760717|FG000|Overall Study|Randomized but Never Treated|1|||
16817778|NCT02201953|37760718|FG001|Overall Study|Randomized but Never Treated|5|||
16817779|NCT02201953|37760717|FG000|Overall Study|Lack of Efficacy|9|||
16817780|NCT02201953|37760718|FG001|Overall Study|Lack of Efficacy|30|||
16817781|NCT02201953|37760717|FG000|Overall Study|Lost to Follow-up|8|||
16817782|NCT02201953|37760718|FG001|Overall Study|Lost to Follow-up|8|||
16817783|NCT02201953|37760717|FG000|Overall Study|Withdrew Consent|2|||
16817784|NCT02201953|37760718|FG001|Overall Study|Withdrew Consent|5|||
16817785|NCT02201953|37760717|FG000|Overall Study|Adverse Event|0|||
16817786|NCT02201953|37760718|FG001|Overall Study|Adverse Event|5|||
16817787|NCT02201953|37760717|FG000|Overall Study|Death|0|||
16817788|NCT02201953|37760718|FG001|Overall Study|Death|3|||
16817789|NCT02271854|37760724|FG000|Overall Study|Withdrawal by Subject|2|||
16817790|NCT02271854|37760724|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
16817791|NCT02271854|37760724|FG000|Overall Study|Lost to Follow-up|1|||
16817792|NCT02296892|37760732|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
16817793|NCT02296892|37760733|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
16817794|NCT02296892|37760734|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
16817795|NCT02296892|37760732|FG000|Overall Study|Lost to Follow-up|5|||
16817796|NCT02296892|37760733|FG001|Overall Study|Lost to Follow-up|0|||
16817797|NCT02296892|37760734|FG002|Overall Study|Lost to Follow-up|1|||
16911173|NCT01526928|38020255|FG001|Overall Study|Withdrawal by Subject|0|||
16817798|NCT02270684|37760744|FG000|Overall Study|Lost to Follow-up|0|||
16817799|NCT02270684|37760745|FG001|Overall Study|Lost to Follow-up|3|||
16817800|NCT02270684|37760744|FG000|Overall Study|Study terminated|1|||
16817801|NCT02270684|37760745|FG001|Overall Study|Study terminated|0|||
16817802|NCT02168803|37760754|FG000|Overall Study|Lost to Follow-up|1|||
16817803|NCT02168803|37760755|FG001|Overall Study|Lost to Follow-up|0|||
16817804|NCT02168803|37760756|FG002|Overall Study|Lost to Follow-up|1|||
16817805|NCT02168803|37760754|FG000|Overall Study|Withdrawal by Subject|1|||
16817806|NCT02168803|37760755|FG001|Overall Study|Withdrawal by Subject|1|||
16817807|NCT02168803|37760756|FG002|Overall Study|Withdrawal by Subject|2|||
16817808|NCT02168803|37760754|FG000|Overall Study|Physician Decision|0|||
17102359|NCT00099632|38241293|FG001|Overall Study|Lost to Follow-up|0|||
16817809|NCT02168803|37760755|FG001|Overall Study|Physician Decision|1|||
16817810|NCT02168803|37760756|FG002|Overall Study|Physician Decision|0|||
16817811|NCT02168803|37760754|FG000|Overall Study|Adverse Event|0|||
16817812|NCT02168803|37760755|FG001|Overall Study|Adverse Event|1|||
16817813|NCT02168803|37760756|FG002|Overall Study|Adverse Event|1|||
16817814|NCT02168803|37760754|FG000|Overall Study|Death|0|||
16817815|NCT02168803|37760755|FG001|Overall Study|Death|0|||
16817816|NCT02168803|37760756|FG002|Overall Study|Death|1|||
16817817|NCT02168803|37760754|FG000|Overall Study|Sponsor Decision|0|||
16817818|NCT02168803|37760755|FG001|Overall Study|Sponsor Decision|0|||
16817819|NCT02168803|37760756|FG002|Overall Study|Sponsor Decision|1|||
16817832|NCT02201329|37760788|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
16817833|NCT02201329|37760788|FG000|Overall Study|Withdrawal by Subject|2|||
16817834|NCT01927419|37760794|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16817835|NCT01927419|37760795|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
16817836|NCT01927419|37760794|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
16817837|NCT01927419|37760795|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
16817838|NCT01927419|37760794|FG000|Treatment Period|Disease progression|17|||
16817839|NCT01927419|37760795|FG001|Treatment Period|Disease progression|20|||
16817840|NCT01927419|37760794|FG000|Treatment Period|Study drug toxicity|48|||
16817841|NCT01927419|37760795|FG001|Treatment Period|Study drug toxicity|10|||
16817842|NCT01927419|37760794|FG000|Treatment Period|Death|0|||
16817843|NCT01927419|37760795|FG001|Treatment Period|Death|1|||
16817844|NCT01927419|37760794|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
16817845|NCT01927419|37760795|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
16817846|NCT01927419|37760794|FG000|Treatment Period|Participant request to discontinue|12|||
16817847|NCT01927419|37760795|FG001|Treatment Period|Participant request to discontinue|4|||
16817848|NCT01927419|37760794|FG000|Treatment Period|Withdrawal by Subject|1|||
16817849|NCT01927419|37760795|FG001|Treatment Period|Withdrawal by Subject|1|||
16817850|NCT01927419|37760794|FG000|Treatment Period|Maximum Clinical Benefit|6|||
16817851|NCT01927419|37760795|FG001|Treatment Period|Maximum Clinical Benefit|2|||
16817852|NCT01927419|37760794|FG000|Treatment Period|Other reasons|3|||
16817853|NCT01927419|37760795|FG001|Treatment Period|Other reasons|4|||
16817854|NCT01927419|37760794|FG000|Treatment Period|Not Reported|1|||
16817855|NCT01927419|37760795|FG001|Treatment Period|Not Reported|1|||
16817856|NCT02168491|37760801|FG000|Overall Study|Withdrawal by Subject|1|||
16817857|NCT02225743|37760805|FG000|Overall Study|Withdrawal by Subject|18|||
16817858|NCT01721746|37760811|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
16817859|NCT01721746|37760812|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
16817860|NCT01721746|37760811|FG000|Pre-Treatment|Withdrawal by Subject|1|||
16817861|NCT01721746|37760812|FG001|Pre-Treatment|Withdrawal by Subject|16|||
16817862|NCT01721746|37760811|FG000|Pre-Treatment|Poor/Non-compliance|1|||
16817863|NCT01721746|37760812|FG001|Pre-Treatment|Poor/Non-compliance|0|||
16817864|NCT01721746|37760811|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
16817865|NCT01721746|37760812|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
16817866|NCT01721746|37760811|FG000|Treatment|Disease Progression|192|||
16817867|NCT01721746|37760812|FG001|Treatment|Disease Progression|74|||
16817868|NCT01721746|37760811|FG000|Treatment|Study Drug Toxicity|19|||
16817869|NCT01721746|37760812|FG001|Treatment|Study Drug Toxicity|11|||
16817870|NCT01721746|37760811|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
16817871|NCT01721746|37760812|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
16817872|NCT01721746|37760811|FG000|Treatment|Participant request to discontinue Study treatment|26|||
16817873|NCT01721746|37760812|FG001|Treatment|Participant request to discontinue Study treatment|7|||
16817874|NCT01721746|37760811|FG000|Treatment|Participant withdrew consent|4|||
16817875|NCT01721746|37760812|FG001|Treatment|Participant withdrew consent|2|||
16817876|NCT01721746|37760811|FG000|Treatment|Maximum Clinical Benefit|9|||
16817877|NCT01721746|37760812|FG001|Treatment|Maximum Clinical Benefit|3|||
16817878|NCT01721746|37760811|FG000|Treatment|Poor/Non-compliance|2|||
16817879|NCT01721746|37760812|FG001|Treatment|Poor/Non-compliance|0|||
16817880|NCT01721746|37760811|FG000|Treatment|Participant no longer met Study criteria|4|||
16817881|NCT01721746|37760812|FG001|Treatment|Participant no longer met Study criteria|0|||
16817882|NCT01721746|37760811|FG000|Treatment|Other reasons|6|||
17102360|NCT00099632|38241294|FG002|Overall Study|Lost to Follow-up|3|||
16817883|NCT01721746|37760812|FG001|Treatment|Other reasons|2|||
16817884|NCT02225665|37760821|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
16817885|NCT02225665|37760822|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
16817886|NCT02225665|37760821|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
16817887|NCT02225665|37760822|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
16817888|NCT01721200|37760830|FG000|Overall Study|Lost to Follow-up|3|||
16817889|NCT01721200|37760831|FG001|Overall Study|Lost to Follow-up|5|||
16817890|NCT02225587|37760844|FG000|Overall Study|Adverse Event|5|||
16817891|NCT02225587|37760845|FG001|Overall Study|Adverse Event|5|||
16817892|NCT02225587|37760844|FG000|Overall Study|Lost to Follow-up|5|||
16817893|NCT02225587|37760845|FG001|Overall Study|Lost to Follow-up|5|||
16817894|NCT02225587|37760844|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16817895|NCT02225587|37760845|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16817896|NCT02225587|37760844|FG000|Overall Study|Physician Decision|2|||
16817897|NCT02225587|37760845|FG001|Overall Study|Physician Decision|0|||
16817898|NCT02225587|37760844|FG000|Overall Study|Protocol Violation|1|||
16817899|NCT02225587|37760845|FG001|Overall Study|Protocol Violation|0|||
16817900|NCT02225587|37760844|FG000|Overall Study|Participant Moved|1|||
16817901|NCT02225587|37760845|FG001|Overall Study|Participant Moved|0|||
16817902|NCT02225587|37760844|FG000|Overall Study|Withdrawal by Subject|13|||
16817903|NCT02225587|37760845|FG001|Overall Study|Withdrawal by Subject|28|||
16817904|NCT02296424|37760853|FG000|Part 1|New therapy for study indication|0|||
16817905|NCT02296424|37760854|FG001|Part 1|New therapy for study indication|1|||
16817906|NCT02296424|37760855|FG002|Part 1|New therapy for study indication|0|||
16817907|NCT02296424|37760856|FG003|Part 1|New therapy for study indication|0|||
16817908|NCT02296424|37760853|FG000|Part 1|Protocol Violation|0|||
16817909|NCT02296424|37760854|FG001|Part 1|Protocol Violation|1|||
16817910|NCT02296424|37760855|FG002|Part 1|Protocol Violation|0|||
16817911|NCT02296424|37760856|FG003|Part 1|Protocol Violation|0|||
16817912|NCT02296424|37760853|FG000|Part 1|Withdrawal by Subject|0|||
16817913|NCT02296424|37760854|FG001|Part 1|Withdrawal by Subject|2|||
16817914|NCT02296424|37760855|FG002|Part 1|Withdrawal by Subject|0|||
16817915|NCT02296424|37760856|FG003|Part 1|Withdrawal by Subject|0|||
16817916|NCT02296424|37760853|FG000|Part 1|Study terminated by sponsor|0|||
16817917|NCT02296424|37760854|FG001|Part 1|Study terminated by sponsor|1|||
16817918|NCT02296424|37760855|FG002|Part 1|Study terminated by sponsor|0|||
16817919|NCT02296424|37760856|FG003|Part 1|Study terminated by sponsor|0|||
16817920|NCT02296424|37760853|FG000|Part 1|Adverse Event|2|||
16817921|NCT02296424|37760854|FG001|Part 1|Adverse Event|11|||
16817922|NCT02296424|37760855|FG002|Part 1|Adverse Event|0|||
16817923|NCT02296424|37760856|FG003|Part 1|Adverse Event|0|||
16817924|NCT02296424|37760853|FG000|Part 1|Lack of Efficacy|5|||
16817925|NCT02296424|37760854|FG001|Part 1|Lack of Efficacy|17|||
16817926|NCT02296424|37760855|FG002|Part 1|Lack of Efficacy|0|||
16817927|NCT02296424|37760856|FG003|Part 1|Lack of Efficacy|0|||
16817928|NCT02296424|37760853|FG000|Part 1|16 directly started part II|16|||
16817929|NCT02296424|37760854|FG001|Part 1|16 directly started part II|0|||
16817930|NCT02296424|37760855|FG002|Part 1|16 directly started part II|0|||
16817931|NCT02296424|37760856|FG003|Part 1|16 directly started part II|0|||
16817932|NCT02296424|37760853|FG000|Part 2|Lack of Efficacy|0|||
16817933|NCT02296424|37760854|FG001|Part 2|Lack of Efficacy|0|||
16817934|NCT02296424|37760855|FG002|Part 2|Lack of Efficacy|1|||
16817935|NCT02296424|37760856|FG003|Part 2|Lack of Efficacy|0|||
16817936|NCT02296424|37760853|FG000|Part 2|Adverse Event|0|||
16817937|NCT02296424|37760854|FG001|Part 2|Adverse Event|0|||
16817938|NCT02296424|37760855|FG002|Part 2|Adverse Event|1|||
16817939|NCT02296424|37760856|FG003|Part 2|Adverse Event|0|||
16817940|NCT02296424|37760853|FG000|Part 2|Lost to Follow-up|0|||
16817941|NCT02296424|37760854|FG001|Part 2|Lost to Follow-up|0|||
16817942|NCT02296424|37760855|FG002|Part 2|Lost to Follow-up|1|||
16817943|NCT02296424|37760856|FG003|Part 2|Lost to Follow-up|0|||
16817944|NCT02201251|37760866|FG000|Overall Study|Adverse Event|1|||
16817945|NCT02201251|37760867|FG001|Overall Study|Adverse Event|1|||
16817946|NCT02201251|37760866|FG000|Overall Study|Protocol Violation|1|||
16817947|NCT02201251|37760867|FG001|Overall Study|Protocol Violation|0|||
16817948|NCT02201251|37760866|FG000|Overall Study|Noncompliance with Study Drug|0|||
16817949|NCT02201251|37760867|FG001|Overall Study|Noncompliance with Study Drug|1|||
16817950|NCT02201251|37760866|FG000|Overall Study|Withdrawal by Subject|2|||
16817951|NCT02201251|37760867|FG001|Overall Study|Withdrawal by Subject|1|||
16817952|NCT02296190|37760879|FG000|Overall Study|Lost to Follow-up|0|||
16817953|NCT02296190|37760880|FG001|Overall Study|Lost to Follow-up|0|||
16817954|NCT02296190|37760881|FG002|Overall Study|Lost to Follow-up|0|||
16817955|NCT02296190|37760882|FG003|Overall Study|Lost to Follow-up|0|||
16817956|NCT02296190|37760883|FG004|Overall Study|Lost to Follow-up|1|||
16817957|NCT02296190|37760884|FG005|Overall Study|Lost to Follow-up|0|||
16817958|NCT02296190|37760879|FG000|Overall Study|Failure to induce PSVT|6|||
16817959|NCT02296190|37760880|FG001|Overall Study|Failure to induce PSVT|10|||
16817960|NCT02296190|37760881|FG002|Overall Study|Failure to induce PSVT|5|||
16817961|NCT02296190|37760882|FG003|Overall Study|Failure to induce PSVT|13|||
16817962|NCT02296190|37760883|FG004|Overall Study|Failure to induce PSVT|8|||
16817963|NCT02296190|37760884|FG005|Overall Study|Failure to induce PSVT|0|||
16817964|NCT02296190|37760879|FG000|Overall Study|Physician Decision|1|||
16817965|NCT02296190|37760880|FG001|Overall Study|Physician Decision|1|||
16817966|NCT02296190|37760881|FG002|Overall Study|Physician Decision|0|||
16817967|NCT02296190|37760882|FG003|Overall Study|Physician Decision|1|||
16817968|NCT02296190|37760883|FG004|Overall Study|Physician Decision|2|||
16817969|NCT02296190|37760884|FG005|Overall Study|Physician Decision|0|||
16817970|NCT02296190|37760879|FG000|Overall Study|Withdrawal by Subject|0|||
16817971|NCT02296190|37760880|FG001|Overall Study|Withdrawal by Subject|1|||
16817972|NCT02296190|37760881|FG002|Overall Study|Withdrawal by Subject|0|||
16817973|NCT02296190|37760882|FG003|Overall Study|Withdrawal by Subject|0|||
16817974|NCT02296190|37760883|FG004|Overall Study|Withdrawal by Subject|0|||
16817975|NCT02296190|37760884|FG005|Overall Study|Withdrawal by Subject|0|||
16817976|NCT02296190|37760879|FG000|Overall Study|PSVT < 5 minutes|5|||
16817977|NCT02296190|37760880|FG001|Overall Study|PSVT < 5 minutes|6|||
16817978|NCT02296190|37760881|FG002|Overall Study|PSVT < 5 minutes|6|||
16817979|NCT02296190|37760882|FG003|Overall Study|PSVT < 5 minutes|6|||
16817980|NCT02296190|37760883|FG004|Overall Study|PSVT < 5 minutes|5|||
16817981|NCT02296190|37760884|FG005|Overall Study|PSVT < 5 minutes|0|||
16817982|NCT02296190|37760879|FG000|Overall Study|Patient was given Propofol|0|||
16817983|NCT02296190|37760880|FG001|Overall Study|Patient was given Propofol|1|||
16817984|NCT02296190|37760881|FG002|Overall Study|Patient was given Propofol|0|||
16817985|NCT02296190|37760882|FG003|Overall Study|Patient was given Propofol|1|||
16817986|NCT02296190|37760883|FG004|Overall Study|Patient was given Propofol|0|||
16817987|NCT02296190|37760884|FG005|Overall Study|Patient was given Propofol|0|||
16817988|NCT02296190|37760879|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
16817989|NCT02296190|37760880|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
16817990|NCT02296190|37760881|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
16817991|NCT02296190|37760882|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
16817992|NCT02296190|37760883|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
16817993|NCT02296190|37760884|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
16817994|NCT02296190|37760879|FG000|Overall Study|Blood pressure <100 after sedation|0|||
16817995|NCT02296190|37760880|FG001|Overall Study|Blood pressure <100 after sedation|0|||
16817996|NCT02296190|37760881|FG002|Overall Study|Blood pressure <100 after sedation|0|||
16817997|NCT02296190|37760882|FG003|Overall Study|Blood pressure <100 after sedation|1|||
16817998|NCT02296190|37760883|FG004|Overall Study|Blood pressure <100 after sedation|0|||
16817999|NCT02296190|37760884|FG005|Overall Study|Blood pressure <100 after sedation|0|||
16818000|NCT02296190|37760879|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
16818001|NCT02296190|37760880|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
16818002|NCT02296190|37760881|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
16818003|NCT02296190|37760882|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
16818004|NCT02296190|37760883|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
16818005|NCT02296190|37760884|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
16818006|NCT02296190|37760879|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
16818007|NCT02296190|37760880|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
16818008|NCT02296190|37760881|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
16818009|NCT02296190|37760882|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
16818010|NCT02296190|37760883|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
16818011|NCT02296190|37760884|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
16818012|NCT02296190|37760879|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16818013|NCT02296190|37760880|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
16818014|NCT02296190|37760881|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16818015|NCT02296190|37760882|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16818016|NCT02296190|37760883|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16818017|NCT02296190|37760884|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16818018|NCT02296190|37760879|FG000|Overall Study|Lab result not available in time|1|||
16818019|NCT02296190|37760880|FG001|Overall Study|Lab result not available in time|0|||
16818020|NCT02296190|37760881|FG002|Overall Study|Lab result not available in time|0|||
16818021|NCT02296190|37760882|FG003|Overall Study|Lab result not available in time|0|||
16818022|NCT02296190|37760883|FG004|Overall Study|Lab result not available in time|0|||
16818023|NCT02296190|37760884|FG005|Overall Study|Lab result not available in time|0|||
16818024|NCT02296112|37760897|FG000|Overall Study|Disease progression|7|||
16818025|NCT02296112|37760897|FG000|Overall Study|Toxicity|1|||
16818026|NCT02296112|37760897|FG000|Overall Study|Began an alternate therapy|1|||
16818027|NCT02295644|37760910|FG000|Overall Study|Did not meet inclusion criterion|0|||
16818028|NCT02295644|37760911|FG001|Overall Study|Did not meet inclusion criterion|0|||
16818029|NCT02295644|37760912|FG002|Overall Study|Did not meet inclusion criterion|1|||
16818030|NCT02295644|37760913|FG003|Overall Study|Did not meet inclusion criterion|2|||
16818031|NCT02269670|37760923|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
16818032|NCT02225353|37760930|FG000|Overall Study|Lost to Follow-up|0|||
16818033|NCT02225353|37760931|FG001|Overall Study|Lost to Follow-up|1|||
16818034|NCT02225353|37760932|FG002|Overall Study|Lost to Follow-up|3|||
16818035|NCT02225353|37760930|FG000|Overall Study|Protocol Violation|4|||
16818036|NCT02225353|37760931|FG001|Overall Study|Protocol Violation|5|||
16818037|NCT02225353|37760932|FG002|Overall Study|Protocol Violation|12|||
16818038|NCT01641926|37760947|FG000|Overall Study|Adverse Event|5|||
16818039|NCT01641926|37760948|FG001|Overall Study|Adverse Event|2|||
16818040|NCT01641926|37760949|FG002|Overall Study|Adverse Event|3|||
16818041|NCT01641926|37760950|FG003|Overall Study|Adverse Event|1|||
16818042|NCT01641926|37760947|FG000|Overall Study|Lost to Follow-up|2|||
16818043|NCT01641926|37760948|FG001|Overall Study|Lost to Follow-up|2|||
16818044|NCT01641926|37760949|FG002|Overall Study|Lost to Follow-up|1|||
16818045|NCT01641926|37760950|FG003|Overall Study|Lost to Follow-up|0|||
16818046|NCT01641926|37760947|FG000|Overall Study|Physician Decision|6|||
16818047|NCT01641926|37760948|FG001|Overall Study|Physician Decision|5|||
16818048|NCT01641926|37760949|FG002|Overall Study|Physician Decision|0|||
16818049|NCT01641926|37760950|FG003|Overall Study|Physician Decision|1|||
16818050|NCT01641926|37760947|FG000|Overall Study|Protocol Violation|1|||
16818051|NCT01641926|37760948|FG001|Overall Study|Protocol Violation|0|||
16818052|NCT01641926|37760949|FG002|Overall Study|Protocol Violation|0|||
16818053|NCT01641926|37760950|FG003|Overall Study|Protocol Violation|1|||
16818054|NCT01641926|37760947|FG000|Overall Study|Withdrawal by Subject|13|||
16818055|NCT01641926|37760948|FG001|Overall Study|Withdrawal by Subject|5|||
16818056|NCT01641926|37760949|FG002|Overall Study|Withdrawal by Subject|6|||
16818057|NCT01641926|37760950|FG003|Overall Study|Withdrawal by Subject|1|||
16818058|NCT01641926|37760947|FG000|Overall Study|Not Treated|1|||
16818059|NCT01641926|37760948|FG001|Overall Study|Not Treated|1|||
16818060|NCT01641926|37760949|FG002|Overall Study|Not Treated|1|||
16818061|NCT01641926|37760950|FG003|Overall Study|Not Treated|0|||
16818062|NCT02295020|37760962|FG000|Overall Study|Adverse Event|0|||
16818063|NCT02295020|37760963|FG001|Overall Study|Adverse Event|1|||
16818064|NCT02295020|37760962|FG000|Overall Study|Withdrawal by Subject|3|||
16818065|NCT02295020|37760963|FG001|Overall Study|Withdrawal by Subject|2|||
16818066|NCT02200939|37760977|FG000|Overall Study|Participant withdrew consent|0|||
16818067|NCT02200939|37760978|FG001|Overall Study|Participant withdrew consent|1|||
16818068|NCT02200939|37760977|FG000|Overall Study|Lost to Follow-up|2|||
16818069|NCT02200939|37760978|FG001|Overall Study|Lost to Follow-up|9|||
16818070|NCT02200939|37760977|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
16818071|NCT02200939|37760978|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
16818072|NCT02294786|37760990|FG000|Overall Study|Withdrawal by Subject|0|||
16818073|NCT02294786|37760991|FG001|Overall Study|Withdrawal by Subject|1|||
16818074|NCT02294786|37760990|FG000|Overall Study|Physician Decision|6|||
16818075|NCT02294786|37760991|FG001|Overall Study|Physician Decision|7|||
16818076|NCT02294786|37760990|FG000|Overall Study|Lost to Follow-up|1|||
16818077|NCT02294786|37760991|FG001|Overall Study|Lost to Follow-up|2|||
16818078|NCT02294786|37760990|FG000|Overall Study|Protocol Violation|1|||
16818079|NCT02294786|37760991|FG001|Overall Study|Protocol Violation|0|||
16818080|NCT02294786|37760990|FG000|Overall Study|Adverse Event|1|||
16818081|NCT02294786|37760991|FG001|Overall Study|Adverse Event|1|||
16818082|NCT02294786|37760990|FG000|Overall Study|Death|2|||
16818083|NCT02294786|37760991|FG001|Overall Study|Death|3|||
16818084|NCT02269124|37761000|FG000|Overall Study|Lost to Follow-up|1|||
16818085|NCT02269124|37761001|FG001|Overall Study|Lost to Follow-up|0|||
16818086|NCT02269124|37761000|FG000|Overall Study|Withdrawal by Subject|0|||
16818087|NCT02269124|37761001|FG001|Overall Study|Withdrawal by Subject|2|||
16818088|NCT01927341|37761013|FG000|Phase 1b|Lost to Follow-up|1|||
16818089|NCT01927341|37761014|FG001|Phase 1b|Lost to Follow-up|0|||
16818090|NCT01927341|37761015|FG002|Phase 1b|Lost to Follow-up|0|||
16818091|NCT01927341|37761016|FG003|Phase 1b|Lost to Follow-up|0|||
16818092|NCT01927341|37761017|FG004|Phase 1b|Lost to Follow-up|0|||
16818093|NCT01927341|37761013|FG000|Phase 1b|Death|2|||
16818094|NCT01927341|37761014|FG001|Phase 1b|Death|0|||
16818095|NCT01927341|37761015|FG002|Phase 1b|Death|0|||
16818096|NCT01927341|37761016|FG003|Phase 1b|Death|0|||
16818097|NCT01927341|37761017|FG004|Phase 1b|Death|0|||
16818098|NCT01927341|37761013|FG000|Phase 1b|Follow-up completed|7|||
16818099|NCT01927341|37761014|FG001|Phase 1b|Follow-up completed|0|||
16818100|NCT01927341|37761015|FG002|Phase 1b|Follow-up completed|0|||
16818101|NCT01927341|37761016|FG003|Phase 1b|Follow-up completed|0|||
16818102|NCT01927341|37761017|FG004|Phase 1b|Follow-up completed|0|||
16818103|NCT01927341|37761013|FG000|Phase 2|Lost to Follow-up|0|||
16818104|NCT01927341|37761014|FG001|Phase 2|Lost to Follow-up|1|||
16818105|NCT01927341|37761015|FG002|Phase 2|Lost to Follow-up|0|||
16818106|NCT01927341|37761016|FG003|Phase 2|Lost to Follow-up|0|||
16818107|NCT01927341|37761017|FG004|Phase 2|Lost to Follow-up|0|||
16818108|NCT01927341|37761013|FG000|Phase 2|Participant withdrew consent|0|||
16818109|NCT01927341|37761014|FG001|Phase 2|Participant withdrew consent|2|||
16818110|NCT01927341|37761015|FG002|Phase 2|Participant withdrew consent|1|||
16818111|NCT01927341|37761016|FG003|Phase 2|Participant withdrew consent|2|||
16818112|NCT01927341|37761017|FG004|Phase 2|Participant withdrew consent|3|||
16818113|NCT01927341|37761013|FG000|Phase 2|Death|0|||
16818114|NCT01927341|37761014|FG001|Phase 2|Death|4|||
16818115|NCT01927341|37761015|FG002|Phase 2|Death|0|||
16818116|NCT01927341|37761016|FG003|Phase 2|Death|3|||
16818117|NCT01927341|37761017|FG004|Phase 2|Death|2|||
16818118|NCT01927341|37761013|FG000|Phase 2|New cancer therapy|0|||
16818119|NCT01927341|37761014|FG001|Phase 2|New cancer therapy|1|||
16818120|NCT01927341|37761015|FG002|Phase 2|New cancer therapy|0|||
16818121|NCT01927341|37761016|FG003|Phase 2|New cancer therapy|4|||
16818122|NCT01927341|37761017|FG004|Phase 2|New cancer therapy|1|||
16818123|NCT01927341|37761013|FG000|Phase 2|Disease progression|0|||
16818124|NCT01927341|37761014|FG001|Phase 2|Disease progression|1|||
16818125|NCT01927341|37761015|FG002|Phase 2|Disease progression|1|||
16818126|NCT01927341|37761016|FG003|Phase 2|Disease progression|1|||
16818127|NCT01927341|37761017|FG004|Phase 2|Disease progression|0|||
16818128|NCT01927341|37761013|FG000|Phase 2|Follow-up completed|0|||
16818129|NCT01927341|37761014|FG001|Phase 2|Follow-up completed|6|||
16818130|NCT01927341|37761015|FG002|Phase 2|Follow-up completed|3|||
16818131|NCT01927341|37761016|FG003|Phase 2|Follow-up completed|5|||
16818132|NCT01927341|37761017|FG004|Phase 2|Follow-up completed|2|||
16818133|NCT02294474|37761035|FG000|Overall Study|Adverse Event|7|||
16818134|NCT02294474|37761036|FG001|Overall Study|Adverse Event|7|||
16818135|NCT02294474|37761035|FG000|Overall Study|Lack of Efficacy|2|||
16818136|NCT02294474|37761036|FG001|Overall Study|Lack of Efficacy|1|||
16818137|NCT02294474|37761035|FG000|Overall Study|Protocol Violation|4|||
16818138|NCT02294474|37761036|FG001|Overall Study|Protocol Violation|2|||
16818139|NCT02294474|37761035|FG000|Overall Study|Other than specified above|12|||
16818140|NCT02294474|37761036|FG001|Overall Study|Other than specified above|12|||
16818141|NCT02168101|37761046|FG000|Overall Study|Death|2|||
16818142|NCT02168101|37761047|FG001|Overall Study|Death|2|||
16818143|NCT02168101|37761048|FG002|Overall Study|Death|1|||
16818144|NCT01956123|37761059|FG000|COS Cycle 2|Protocol Violation|8|||
16818145|NCT01956123|37761060|FG001|COS Cycle 2|Protocol Violation|3|||
16818146|NCT01956123|37761061|FG002|COS Cycle 2|Protocol Violation|0|||
16818147|NCT01956123|37761062|FG003|COS Cycle 2|Protocol Violation|0|||
16818148|NCT01956123|37761059|FG000|COS Cycle 2|Adverse Event|3|||
16818149|NCT01956123|37761060|FG001|COS Cycle 2|Adverse Event|4|||
16818150|NCT01956123|37761061|FG002|COS Cycle 2|Adverse Event|0|||
16818151|NCT01956123|37761062|FG003|COS Cycle 2|Adverse Event|0|||
16818152|NCT01956123|37761059|FG000|COS Cycle 2|Personal Reasons|2|||
16818153|NCT01956123|37761060|FG001|COS Cycle 2|Personal Reasons|0|||
16818154|NCT01956123|37761061|FG002|COS Cycle 2|Personal Reasons|0|||
16911174|NCT01526928|38020256|FG002|Overall Study|Withdrawal by Subject|13|||
16911175|NCT01526928|38020257|FG003|Overall Study|Withdrawal by Subject|11|||
16911176|NCT01526928|38020258|FG004|Overall Study|Withdrawal by Subject|3|||
16911177|NCT01526928|38020259|FG005|Overall Study|Withdrawal by Subject|0|||
16911178|NCT01526928|38020254|FG000|Overall Study|Physician Decision|0|||
16911179|NCT01526928|38020255|FG001|Overall Study|Physician Decision|0|||
16911180|NCT01526928|38020256|FG002|Overall Study|Physician Decision|2|||
16911181|NCT01526928|38020257|FG003|Overall Study|Physician Decision|5|||
16911182|NCT01526928|38020258|FG004|Overall Study|Physician Decision|0|||
16911183|NCT01526928|38020259|FG005|Overall Study|Physician Decision|0|||
16911184|NCT01526928|38020254|FG000|Overall Study|Other Reason|0|||
16911185|NCT01526928|38020255|FG001|Overall Study|Other Reason|1|||
16911186|NCT01526928|38020256|FG002|Overall Study|Other Reason|11|||
16911187|NCT01526928|38020257|FG003|Overall Study|Other Reason|4|||
16911188|NCT01526928|38020258|FG004|Overall Study|Other Reason|1|||
16911189|NCT01526928|38020259|FG005|Overall Study|Other Reason|0|||
16911190|NCT01526928|38020254|FG000|Overall Study|Lost to Follow-up|0|||
16911191|NCT01526928|38020255|FG001|Overall Study|Lost to Follow-up|0|||
16911192|NCT01526928|38020256|FG002|Overall Study|Lost to Follow-up|0|||
16911193|NCT01526928|38020257|FG003|Overall Study|Lost to Follow-up|1|||
16911194|NCT01526928|38020258|FG004|Overall Study|Lost to Follow-up|0|||
16911195|NCT01526928|38020259|FG005|Overall Study|Lost to Follow-up|0|||
17102361|NCT00099632|38241295|FG003|Overall Study|Lost to Follow-up|1|||
16818155|NCT01956123|37761062|FG003|COS Cycle 2|Personal Reasons|0|||
16818156|NCT01956123|37761059|FG000|COS Cycle 2|Withdrawal by Subject|1|||
16818157|NCT01956123|37761060|FG001|COS Cycle 2|Withdrawal by Subject|0|||
16818158|NCT01956123|37761061|FG002|COS Cycle 2|Withdrawal by Subject|0|||
16818159|NCT01956123|37761062|FG003|COS Cycle 2|Withdrawal by Subject|0|||
16818160|NCT01956123|37761059|FG000|COS Cycle 3|Protocol Violation|0|||
16818161|NCT01956123|37761060|FG001|COS Cycle 3|Protocol Violation|0|||
16818162|NCT01956123|37761061|FG002|COS Cycle 3|Protocol Violation|2|||
16818163|NCT01956123|37761062|FG003|COS Cycle 3|Protocol Violation|1|||
16818164|NCT01956123|37761059|FG000|COS Cycle 3|Adverse Event|0|||
16818165|NCT01956123|37761060|FG001|COS Cycle 3|Adverse Event|0|||
16818166|NCT01956123|37761061|FG002|COS Cycle 3|Adverse Event|3|||
16911196|NCT01526928|38020254|FG000|Overall Study|Protocol Deviation|0|||
16911197|NCT01526928|38020255|FG001|Overall Study|Protocol Deviation|0|||
16911198|NCT01526928|38020256|FG002|Overall Study|Protocol Deviation|0|||
16911199|NCT01526928|38020257|FG003|Overall Study|Protocol Deviation|2|||
16911200|NCT01526928|38020258|FG004|Overall Study|Protocol Deviation|0|||
16911201|NCT01526928|38020259|FG005|Overall Study|Protocol Deviation|0|||
16911202|NCT01526928|38020254|FG000|Overall Study|Missing|0|||
16911203|NCT01526928|38020255|FG001|Overall Study|Missing|0|||
16818167|NCT01956123|37761062|FG003|COS Cycle 3|Adverse Event|0|||
16818168|NCT01956123|37761059|FG000|COS Cycle 3|Personal Reasons|0|||
16818169|NCT01956123|37761060|FG001|COS Cycle 3|Personal Reasons|0|||
16818170|NCT01956123|37761061|FG002|COS Cycle 3|Personal Reasons|1|||
16818171|NCT01956123|37761062|FG003|COS Cycle 3|Personal Reasons|0|||
16818172|NCT01956123|37761059|FG000|COS Cycle 3|Withdrawal by Subject|0|||
16818173|NCT01956123|37761060|FG001|COS Cycle 3|Withdrawal by Subject|0|||
16818174|NCT01956123|37761061|FG002|COS Cycle 3|Withdrawal by Subject|0|||
16818175|NCT01956123|37761062|FG003|COS Cycle 3|Withdrawal by Subject|1|||
16818176|NCT02298179|37761085|FG000|Overall Study|Lost to Follow-up|0|||
16818177|NCT02298179|37761086|FG001|Overall Study|Lost to Follow-up|0|||
16818178|NCT02298179|37761087|FG002|Overall Study|Lost to Follow-up|1|||
16818179|NCT02298179|37761088|FG003|Overall Study|Lost to Follow-up|0|||
16818180|NCT02298179|37761089|FG004|Overall Study|Lost to Follow-up|0|||
16818181|NCT02298179|37761090|FG005|Overall Study|Lost to Follow-up|0|||
16818182|NCT02298179|37761091|FG006|Overall Study|Lost to Follow-up|0|||
16818183|NCT02298179|37761092|FG007|Overall Study|Lost to Follow-up|1|||
16818184|NCT02298179|37761093|FG008|Overall Study|Lost to Follow-up|0|||
16818185|NCT02298179|37761094|FG009|Overall Study|Lost to Follow-up|0|||
16818186|NCT02298179|37761095|FG010|Overall Study|Lost to Follow-up|0|||
16818187|NCT02298179|37761096|FG011|Overall Study|Lost to Follow-up|0|||
16818188|NCT02298023|37761125|FG000|Overall Study|Withdrawal by Subject|1|||
16818189|NCT02298023|37761126|FG001|Overall Study|Withdrawal by Subject|0|||
16818190|NCT02298023|37761127|FG002|Overall Study|Withdrawal by Subject|0|||
16818191|NCT02296931|37761140|FG000|Overall Study|Protocol Violation|0|||
16818192|NCT02296931|37761141|FG001|Overall Study|Protocol Violation|2|||
16818193|NCT02166697|37761147|FG000|Overall Study|Protocol Violation|347|||
16818194|NCT01909479|37761153|FG000|From Baseline to Week 26|Adverse Event|3|||
16818195|NCT01909479|37761154|FG001|From Baseline to Week 26|Adverse Event|2|||
16818196|NCT01909479|37761153|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
16818197|NCT01909479|37761154|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
16818198|NCT01909479|37761153|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
16818199|NCT01909479|37761154|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
16818200|NCT01909479|37761153|FG000|26 - 52 Weeks|Adverse Event|0|||
16818201|NCT01909479|37761154|FG001|26 - 52 Weeks|Adverse Event|1|||
16818202|NCT01909479|37761153|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
16818203|NCT01909479|37761154|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
16818204|NCT01909479|37761153|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
16818205|NCT01909479|37761154|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
16818206|NCT01909479|37761153|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
16818207|NCT01909479|37761154|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
16818208|NCT01909479|37761153|FG000|52 Weeks to End of Study|Adverse Event|2|||
16818209|NCT01909479|37761154|FG001|52 Weeks to End of Study|Adverse Event|1|||
16818210|NCT01909479|37761153|FG000|52 Weeks to End of Study|Death|0|||
16818211|NCT01909479|37761154|FG001|52 Weeks to End of Study|Death|1|||
16818212|NCT01909479|37761153|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
16818213|NCT01909479|37761154|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
16818214|NCT01909479|37761153|FG000|52 Weeks to End of Study|Protocol Violation|1|||
16818215|NCT01909479|37761154|FG001|52 Weeks to End of Study|Protocol Violation|0|||
16818216|NCT01909479|37761153|FG000|52 Weeks to End of Study|Progressive disease|1|||
16818217|NCT01909479|37761154|FG001|52 Weeks to End of Study|Progressive disease|1|||
16818218|NCT01909479|37761153|FG000|52 Weeks to End of Study|Personal reasons|2|||
16818219|NCT01909479|37761154|FG001|52 Weeks to End of Study|Personal reasons|1|||
16818220|NCT01909479|37761153|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
16818221|NCT01909479|37761154|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
16818222|NCT01909479|37761153|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
16818223|NCT01909479|37761154|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
16818224|NCT01909479|37761153|FG000|52 Weeks to End of Study|Lack of contact|1|||
16818225|NCT01909479|37761154|FG001|52 Weeks to End of Study|Lack of contact|0|||
16818226|NCT01909479|37761153|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
16818227|NCT01909479|37761154|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
16818228|NCT01909479|37761153|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
16818229|NCT01909479|37761154|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
16818230|NCT01955733|37761167|FG000|Period 1|Lost to Follow-up|1|||
16818231|NCT01955733|37761168|FG001|Period 1|Lost to Follow-up|0|||
16818232|NCT01955733|37761169|FG002|Period 1|Lost to Follow-up|0|||
16818233|NCT01955733|37761167|FG000|Period 2|Adverse Event|1|||
16818234|NCT01955733|37761168|FG001|Period 2|Adverse Event|0|||
16818235|NCT01955733|37761169|FG002|Period 2|Adverse Event|0|||
16818236|NCT01955733|37761167|FG000|Period 2|Physician Decision|0|||
16818237|NCT01955733|37761168|FG001|Period 2|Physician Decision|0|||
16818238|NCT01955733|37761169|FG002|Period 2|Physician Decision|1|||
16818239|NCT01955733|37761167|FG000|Period 2|Withdrawal by Subject|1|||
16818240|NCT01955733|37761168|FG001|Period 2|Withdrawal by Subject|3|||
16818241|NCT01955733|37761169|FG002|Period 2|Withdrawal by Subject|2|||
16818242|NCT01955733|37761167|FG000|Period 2|Study terminated by sponsor|8|||
16818243|NCT01955733|37761168|FG001|Period 2|Study terminated by sponsor|14|||
16818244|NCT01955733|37761169|FG002|Period 2|Study terminated by sponsor|16|||
16818245|NCT01955733|37761167|FG000|Period 2|Lost to Follow-up|2|||
16818246|NCT01955733|37761168|FG001|Period 2|Lost to Follow-up|0|||
16818247|NCT01955733|37761169|FG002|Period 2|Lost to Follow-up|0|||
16818248|NCT01955733|37761167|FG000|Period 2|Other not defined above|0|||
16818249|NCT01955733|37761168|FG001|Period 2|Other not defined above|2|||
16818250|NCT01955733|37761169|FG002|Period 2|Other not defined above|2|||
16818251|NCT02197897|37761177|FG000|Overall Study|not eligible|1|||
16818252|NCT02223793|37761184|FG000|Overall Study|Lost to Follow-up|10|||
16818253|NCT02223793|37761185|FG001|Overall Study|Lost to Follow-up|1|||
16818254|NCT02223793|37761186|FG002|Overall Study|Lost to Follow-up|2|||
16818255|NCT02223793|37761184|FG000|Overall Study|Withdrawal by Subject|3|||
16818256|NCT02223793|37761185|FG001|Overall Study|Withdrawal by Subject|2|||
16818257|NCT02223793|37761186|FG002|Overall Study|Withdrawal by Subject|3|||
16818258|NCT02223793|37761184|FG000|Overall Study|Moved/studycenter unable to participate|4|||
16818259|NCT02223793|37761185|FG001|Overall Study|Moved/studycenter unable to participate|6|||
16818260|NCT02223793|37761186|FG002|Overall Study|Moved/studycenter unable to participate|8|||
16818261|NCT01926015|37761196|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16818262|NCT01926015|37761197|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16818263|NCT01926015|37761196|FG000|Overall Study|Randomized not treated|2|||
16818264|NCT01926015|37761197|FG001|Overall Study|Randomized not treated|0|||
16818265|NCT02223715|37761203|FG000|Overall Study|Death|31|||
16818266|NCT02223715|37761203|FG000|Overall Study|Lost to Follow-up|73|||
16818267|NCT02196259|37761213|FG000|Overall Study|Researcher choice|0|||
16818268|NCT02196259|37761214|FG001|Overall Study|Researcher choice|0|||
16818269|NCT02196259|37761215|FG002|Overall Study|Researcher choice|1|||
16818270|NCT02196259|37761213|FG000|Overall Study|Partial data analysis|0|||
16818271|NCT02196259|37761214|FG001|Overall Study|Partial data analysis|3|||
16818272|NCT02196259|37761215|FG002|Overall Study|Partial data analysis|0|||
16818273|NCT02294396|37761226|FG000|Overall Study|Adverse Event|26|||
16818274|NCT02294396|37761227|FG001|Overall Study|Adverse Event|25|||
16818275|NCT02294396|37761228|FG002|Overall Study|Adverse Event|21|||
16818276|NCT02294396|37761229|FG003|Overall Study|Adverse Event|24|||
16818277|NCT02294396|37761226|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
16818278|NCT02294396|37761227|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
16818279|NCT02294396|37761228|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
16818280|NCT02294396|37761229|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
16818281|NCT02294396|37761226|FG000|Overall Study|Withdrawal by Subject|8|||
16818282|NCT02294396|37761227|FG001|Overall Study|Withdrawal by Subject|6|||
16818283|NCT02294396|37761228|FG002|Overall Study|Withdrawal by Subject|6|||
16818284|NCT02294396|37761229|FG003|Overall Study|Withdrawal by Subject|8|||
16818285|NCT02294396|37761226|FG000|Overall Study|Lost to Follow-up|0|||
16818286|NCT02294396|37761227|FG001|Overall Study|Lost to Follow-up|0|||
16818287|NCT02294396|37761228|FG002|Overall Study|Lost to Follow-up|1|||
16818288|NCT02294396|37761229|FG003|Overall Study|Lost to Follow-up|1|||
16818289|NCT02294396|37761226|FG000|Overall Study|Protocol Deviation|3|||
16818290|NCT02294396|37761227|FG001|Overall Study|Protocol Deviation|2|||
16818291|NCT02294396|37761228|FG002|Overall Study|Protocol Deviation|2|||
16818292|NCT02294396|37761229|FG003|Overall Study|Protocol Deviation|1|||
16818293|NCT02294396|37761226|FG000|Overall Study|Miscellaneous|2|||
16818294|NCT02294396|37761227|FG001|Overall Study|Miscellaneous|0|||
16818295|NCT02294396|37761228|FG002|Overall Study|Miscellaneous|5|||
16818296|NCT02294396|37761229|FG003|Overall Study|Miscellaneous|2|||
16818297|NCT01721044|37761242|FG000|Treatment Period|Adverse Event|7|||
16818298|NCT01721044|37761243|FG001|Treatment Period|Adverse Event|7|||
16818299|NCT01721044|37761244|FG002|Treatment Period|Adverse Event|10|||
16818300|NCT01721044|37761242|FG000|Treatment Period|Death|0|||
16818301|NCT01721044|37761243|FG001|Treatment Period|Death|0|||
16818302|NCT01721044|37761244|FG002|Treatment Period|Death|1|||
16818303|NCT01721044|37761242|FG000|Treatment Period|Lack of Efficacy|16|||
16818304|NCT01721044|37761243|FG001|Treatment Period|Lack of Efficacy|4|||
16818305|NCT01721044|37761244|FG002|Treatment Period|Lack of Efficacy|4|||
16818306|NCT01721044|37761242|FG000|Treatment Period|Lost to Follow-up|0|||
16818307|NCT01721044|37761243|FG001|Treatment Period|Lost to Follow-up|0|||
16818308|NCT01721044|37761244|FG002|Treatment Period|Lost to Follow-up|1|||
16818309|NCT01721044|37761242|FG000|Treatment Period|Physician Decision|1|||
16818310|NCT01721044|37761243|FG001|Treatment Period|Physician Decision|0|||
16818311|NCT01721044|37761244|FG002|Treatment Period|Physician Decision|2|||
16818312|NCT01721044|37761242|FG000|Treatment Period|Protocol Violation|1|||
16818313|NCT01721044|37761243|FG001|Treatment Period|Protocol Violation|0|||
16818314|NCT01721044|37761244|FG002|Treatment Period|Protocol Violation|0|||
16818315|NCT01721044|37761242|FG000|Treatment Period|Withdrawal by Subject|7|||
16818316|NCT01721044|37761243|FG001|Treatment Period|Withdrawal by Subject|6|||
16818317|NCT01721044|37761244|FG002|Treatment Period|Withdrawal by Subject|1|||
16818318|NCT02164981|37761266|FG000|Started|Withdrawal by Subject|2|||
16818319|NCT02164981|37761267|FG001|Started|Withdrawal by Subject|1|||
16818320|NCT02164981|37761268|FG002|Started|Withdrawal by Subject|0|||
16818321|NCT02164981|37761266|FG000|Started|Protocol Violation|2|||
16818322|NCT02164981|37761267|FG001|Started|Protocol Violation|0|||
16818323|NCT02164981|37761268|FG002|Started|Protocol Violation|0|||
16818324|NCT02164981|37761266|FG000|Started|Adverse Event|1|||
16818325|NCT02164981|37761267|FG001|Started|Adverse Event|2|||
16818326|NCT02164981|37761268|FG002|Started|Adverse Event|0|||
16818327|NCT02164981|37761266|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
16818328|NCT02164981|37761267|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
16818329|NCT02164981|37761268|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
16818330|NCT02164981|37761266|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
16818331|NCT02164981|37761267|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
16818332|NCT02164981|37761268|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
16818333|NCT02164981|37761266|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
16818334|NCT02164981|37761267|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
16818335|NCT02164981|37761268|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
16818336|NCT02195869|37761289|FG000|Overall Study|cGVHD Progression|5|||
16818337|NCT02195869|37761289|FG000|Overall Study|Malignancy Progression/relapse|2|||
16818338|NCT02195869|37761289|FG000|Overall Study|Adverse Event|15|||
16818339|NCT02195869|37761289|FG000|Overall Study|Withdrawal by Subject|7|||
16818340|NCT02195869|37761289|FG000|Overall Study|Physician Decision|4|||
16818341|NCT02195869|37761289|FG000|Overall Study|Study Terminated by Sponsor|7|||
16818342|NCT02195869|37761289|FG000|Overall Study|Noncompliance with study drug|2|||
16818343|NCT01908699|37761298|FG000|Overall Study|Adverse Event|8|||
16818344|NCT01908699|37761299|FG001|Overall Study|Adverse Event|12|||
16818345|NCT01908699|37761298|FG000|Overall Study|Lack of Efficacy|2|||
16818346|NCT01908699|37761299|FG001|Overall Study|Lack of Efficacy|2|||
16818347|NCT01908699|37761298|FG000|Overall Study|Lost to Follow-up|2|||
16818348|NCT01908699|37761299|FG001|Overall Study|Lost to Follow-up|4|||
16818349|NCT01908699|37761298|FG000|Overall Study|Physician Decision|8|||
16818350|NCT01908699|37761299|FG001|Overall Study|Physician Decision|8|||
16818351|NCT01908699|37761298|FG000|Overall Study|Withdrawal by Subject|15|||
16818352|NCT01908699|37761299|FG001|Overall Study|Withdrawal by Subject|10|||
16818353|NCT01908699|37761298|FG000|Overall Study|Pregnancy|0|||
16818354|NCT01908699|37761299|FG001|Overall Study|Pregnancy|1|||
16818355|NCT01908699|37761298|FG000|Overall Study|Randomized in Error|1|||
16818356|NCT01908699|37761299|FG001|Overall Study|Randomized in Error|0|||
16818357|NCT01908699|37761298|FG000|Overall Study|Death|9|||
16818358|NCT01908699|37761299|FG001|Overall Study|Death|12|||
16818359|NCT01908699|37761298|FG000|Overall Study|Progressive Disease|30|||
16818360|NCT01908699|37761299|FG001|Overall Study|Progressive Disease|29|||
16818361|NCT01599637|37761308|FG000|Overall Study|administrative problems|0|||
16818362|NCT01599637|37761309|FG001|Overall Study|administrative problems|2|||
16818363|NCT01599637|37761310|FG002|Overall Study|administrative problems|0|||
16818364|NCT01599637|37761308|FG000|Overall Study|Adverse Event|1|||
16818365|NCT01599637|37761309|FG001|Overall Study|Adverse Event|0|||
16818366|NCT01599637|37761310|FG002|Overall Study|Adverse Event|0|||
16818367|NCT02264639|37761325|FG000|Overall Study|Death (after completing single-dose phase)|1|||
16818368|NCT02264639|37761326|FG001|Overall Study|Death (after completing single-dose phase)|0|||
16818369|NCT02264639|37761327|FG002|Overall Study|Death (after completing single-dose phase)|0|||
16818370|NCT02264639|37761328|FG003|Overall Study|Death (after completing single-dose phase)|0|||
16818371|NCT02264639|37761329|FG004|Overall Study|Death (after completing single-dose phase)|0|||
16818372|NCT02264639|37761325|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
16818373|NCT02264639|37761326|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
16818374|NCT02264639|37761327|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
16818375|NCT02264639|37761328|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
16818376|NCT02264639|37761329|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
16818377|NCT02264639|37761325|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
16818378|NCT02264639|37761326|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
16818379|NCT02264639|37761327|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
16818380|NCT02264639|37761328|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
16818381|NCT02264639|37761329|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
16818382|NCT02264639|37761325|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
16818383|NCT02264639|37761326|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
16911204|NCT01526928|38020256|FG002|Overall Study|Missing|1|||
16911205|NCT01526928|38020257|FG003|Overall Study|Missing|0|||
16911206|NCT01526928|38020258|FG004|Overall Study|Missing|2|||
16818384|NCT02264639|37761327|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
16818385|NCT02264639|37761328|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
16818386|NCT02264639|37761329|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
16818387|NCT01363011|37761346|FG000|Main Study|Adverse Event|2|||
16818388|NCT01363011|37761347|FG001|Main Study|Adverse Event|3|||
16818389|NCT01363011|37761346|FG000|Main Study|Investigator's Discretion|1|||
16818390|NCT01363011|37761347|FG001|Main Study|Investigator's Discretion|1|||
16911207|NCT01526928|38020259|FG005|Overall Study|Missing|0|||
16818391|NCT01363011|37761346|FG000|Main Study|Withdrew Consent|1|||
16818392|NCT01363011|37761347|FG001|Main Study|Withdrew Consent|4|||
16818393|NCT01363011|37761346|FG000|Main Study|Protocol Violation|0|||
16818394|NCT01363011|37761347|FG001|Main Study|Protocol Violation|1|||
16818395|NCT01363011|37761346|FG000|Extension Phase|Adverse Event|1|||
16818396|NCT01363011|37761347|FG001|Extension Phase|Adverse Event|1|||
16818397|NCT01363011|37761346|FG000|Extension Phase|Lack of Efficacy|0|||
16818398|NCT01363011|37761347|FG001|Extension Phase|Lack of Efficacy|1|||
16818399|NCT01363011|37761346|FG000|Extension Phase|Investigator's Discretion|2|||
16818400|NCT01363011|37761347|FG001|Extension Phase|Investigator's Discretion|2|||
16818401|NCT01363011|37761346|FG000|Extension Phase|Withdrew Consent|0|||
16818402|NCT01363011|37761347|FG001|Extension Phase|Withdrew Consent|1|||
16818403|NCT01363011|37761346|FG000|Extension Phase|Lost to Follow-up|0|||
16818404|NCT01363011|37761347|FG001|Extension Phase|Lost to Follow-up|2|||
16818405|NCT01363011|37761346|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
16818406|NCT01363011|37761347|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
16818407|NCT02263547|37761353|FG000|Overall Study|Adverse Event|1|||
16818408|NCT02263547|37761353|FG000|Overall Study|Lost to Follow-up|2|||
16818409|NCT01925703|37761357|FG000|Overall Study|Physician Decision|1|||
16818410|NCT01925703|37761357|FG000|Overall Study|Lost to Follow-up|2|||
16818411|NCT01925703|37761357|FG000|Overall Study|Discharge prior to full iron repletion|1|||
16818412|NCT02195011|37761363|FG000|Overall Study|Adverse Event|4|||
16818413|NCT02195011|37761364|FG001|Overall Study|Adverse Event|0|||
16818414|NCT02195011|37761363|FG000|Overall Study|Progressive Disease|18|||
16818415|NCT02195011|37761364|FG001|Overall Study|Progressive Disease|1|||
16818416|NCT02195011|37761363|FG000|Overall Study|Withdrawal by Subject|3|||
16818417|NCT02195011|37761364|FG001|Overall Study|Withdrawal by Subject|0|||
16818418|NCT01617681|37761374|FG000|Period 1 Double Blind|Adverse Event|2|||
16818419|NCT01617681|37761375|FG001|Period 1 Double Blind|Adverse Event|0|||
16818420|NCT01617681|37761376|FG002|Period 1 Double Blind|Adverse Event|0|||
16818421|NCT01617681|37761377|FG003|Period 1 Double Blind|Adverse Event|2|||
16818422|NCT01617681|37761378|FG004|Period 1 Double Blind|Adverse Event|0|||
16818423|NCT01617681|37761374|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
16818424|NCT01617681|37761375|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
16818425|NCT01617681|37761376|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
16818426|NCT01617681|37761377|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
16818427|NCT01617681|37761378|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
16818428|NCT01617681|37761374|FG000|Period 2 Open Label|Adverse Event|0|||
16818429|NCT01617681|37761375|FG001|Period 2 Open Label|Adverse Event|0|||
16818430|NCT01617681|37761376|FG002|Period 2 Open Label|Adverse Event|0|||
16818431|NCT01617681|37761377|FG003|Period 2 Open Label|Adverse Event|0|||
16818432|NCT01617681|37761378|FG004|Period 2 Open Label|Adverse Event|3|||
16818433|NCT01617681|37761374|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
16818434|NCT01617681|37761375|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
16818435|NCT01617681|37761376|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
16818436|NCT01617681|37761377|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
16818437|NCT01617681|37761378|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
16818438|NCT02263079|37761390|FG000|Overall Study|Physician Decision|1|||
16818439|NCT02263079|37761391|FG001|Overall Study|Physician Decision|0|||
16818440|NCT02263079|37761392|FG002|Overall Study|Physician Decision|0|||
16818441|NCT02263079|37761390|FG000|Overall Study|Withdrawal by Subject|2|||
16818442|NCT02263079|37761391|FG001|Overall Study|Withdrawal by Subject|8|||
16818443|NCT02263079|37761392|FG002|Overall Study|Withdrawal by Subject|0|||
16818444|NCT02295995|37761402|FG000|Overall Study|Lost to Follow-up|5|||
16818445|NCT02295995|37761403|FG001|Overall Study|Lost to Follow-up|1|||
16818446|NCT02294981|37761410|FG000|Overall Study|Lost to Follow-up|1|||
16818447|NCT02262377|37761416|FG000|Overall Study|Lost to Follow-up|5|||
16818448|NCT02262377|37761417|FG001|Overall Study|Lost to Follow-up|6|||
16818449|NCT02262377|37761416|FG000|Overall Study|Found ineligible after enrollment|3|||
16818450|NCT02262377|37761417|FG001|Overall Study|Found ineligible after enrollment|0|||
16818451|NCT02262377|37761416|FG000|Overall Study|Withdrawal by Subject|4|||
16818452|NCT02262377|37761417|FG001|Overall Study|Withdrawal by Subject|0|||
16818453|NCT02260817|37761426|FG000|Overall Study|Lost to Follow-up|0|||
16818454|NCT02260817|37761427|FG001|Overall Study|Lost to Follow-up|14|||
16818455|NCT02260817|37761426|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
16818456|NCT02260817|37761427|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
16818457|NCT02260817|37761426|FG000|Overall Study|Observation, no biopsy|0|||
16818458|NCT02260817|37761427|FG001|Overall Study|Observation, no biopsy|1|||
16818459|NCT02260817|37761426|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
16818460|NCT02260817|37761427|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
16818461|NCT02260817|37761426|FG000|Overall Study|Protocol Violation|0|||
16818462|NCT02260817|37761427|FG001|Overall Study|Protocol Violation|14|||
16818463|NCT01642589|37761435|FG000|Overall Study|Withdrawal by Subject|1|||
16818464|NCT01642589|37761436|FG001|Overall Study|Withdrawal by Subject|1|||
16818465|NCT02268812|37761446|FG000|Overall Study|Adverse Event|8|||
16818466|NCT02268812|37761447|FG001|Overall Study|Adverse Event|26|||
16818467|NCT02268812|37761448|FG002|Overall Study|Adverse Event|7|||
16818468|NCT02268812|37761449|FG003|Overall Study|Adverse Event|10|||
16818469|NCT02268812|37761446|FG000|Overall Study|Protocol deviation|0|||
16818470|NCT02268812|37761447|FG001|Overall Study|Protocol deviation|0|||
16818471|NCT02268812|37761448|FG002|Overall Study|Protocol deviation|1|||
16818472|NCT02268812|37761449|FG003|Overall Study|Protocol deviation|0|||
16818473|NCT02268812|37761446|FG000|Overall Study|Withdrawal by Subject|0|||
16818474|NCT02268812|37761447|FG001|Overall Study|Withdrawal by Subject|1|||
16818475|NCT02268812|37761448|FG002|Overall Study|Withdrawal by Subject|0|||
16818476|NCT02268812|37761449|FG003|Overall Study|Withdrawal by Subject|0|||
16818477|NCT02268812|37761446|FG000|Overall Study|Physician Decision|3|||
16818478|NCT02268812|37761447|FG001|Overall Study|Physician Decision|1|||
16818479|NCT02268812|37761448|FG002|Overall Study|Physician Decision|0|||
16818480|NCT02268812|37761449|FG003|Overall Study|Physician Decision|1|||
16818481|NCT02268812|37761446|FG000|Overall Study|Other|5|||
16818482|NCT02268812|37761447|FG001|Overall Study|Other|4|||
16818483|NCT02268812|37761448|FG002|Overall Study|Other|1|||
16818484|NCT02268812|37761449|FG003|Overall Study|Other|3|||
16818485|NCT01954251|37761461|FG000|Overall Study|Adverse Event|5|||
16818486|NCT01954251|37761462|FG001|Overall Study|Adverse Event|7|||
16818487|NCT01954251|37761461|FG000|Overall Study|Lost to Follow-up|6|||
16818488|NCT01954251|37761462|FG001|Overall Study|Lost to Follow-up|6|||
16818489|NCT01954251|37761461|FG000|Overall Study|Withdrawal by Subject|2|||
16818490|NCT01954251|37761462|FG001|Overall Study|Withdrawal by Subject|6|||
16818491|NCT01644617|37761472|FG000|Overall Study|Withdrawal by Subject|3|||
16818492|NCT01644617|37761473|FG001|Overall Study|Withdrawal by Subject|4|||
16818493|NCT01644617|37761474|FG002|Overall Study|Withdrawal by Subject|1|||
16818494|NCT01644617|37761472|FG000|Overall Study|Lost to Follow-up|0|||
16818495|NCT01644617|37761473|FG001|Overall Study|Lost to Follow-up|1|||
16818496|NCT01644617|37761474|FG002|Overall Study|Lost to Follow-up|0|||
16818497|NCT01644617|37761472|FG000|Overall Study|Adverse Event|3|||
16818498|NCT01644617|37761473|FG001|Overall Study|Adverse Event|0|||
16818499|NCT01644617|37761474|FG002|Overall Study|Adverse Event|6|||
16818500|NCT02294318|37761484|FG000|Overall Study|Worsening of drinking|3|||
16818501|NCT02294318|37761485|FG001|Overall Study|Worsening of drinking|0|||
16818502|NCT02294318|37761484|FG000|Overall Study|Not exposed to intervention|0|||
16818503|NCT02294318|37761485|FG001|Overall Study|Not exposed to intervention|2|||
16818504|NCT02293499|37761494|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
16818505|NCT02293499|37761495|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
16818506|NCT02293499|37761496|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
16818507|NCT02293499|37761494|FG000|Intervention - Camp|Withdrawal by Subject|3|||
16818508|NCT02293499|37761495|FG001|Intervention - Camp|Withdrawal by Subject|6|||
16818509|NCT02293499|37761496|FG002|Intervention - Camp|Withdrawal by Subject|2|||
16818510|NCT02293499|37761494|FG000|Intervention - Camp|these are those not showing up at camp|24|||
16818511|NCT02293499|37761495|FG001|Intervention - Camp|these are those not showing up at camp|28|||
16818512|NCT02293499|37761496|FG002|Intervention - Camp|these are those not showing up at camp|4|||
16818513|NCT02293499|37761494|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
16818514|NCT02293499|37761495|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
16818515|NCT02293499|37761496|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
16818516|NCT02293499|37761494|FG000|3 Month Follow Up|Lost to Follow-up|14|||
16818517|NCT02293499|37761495|FG001|3 Month Follow Up|Lost to Follow-up|15|||
16818518|NCT02293499|37761496|FG002|3 Month Follow Up|Lost to Follow-up|6|||
16818519|NCT02293499|37761494|FG000|6 Month Follow Up|Lost to Follow-up|17|||
16818520|NCT02293499|37761495|FG001|6 Month Follow Up|Lost to Follow-up|27|||
16818521|NCT02293499|37761496|FG002|6 Month Follow Up|Lost to Follow-up|6|||
16818522|NCT02293499|37761494|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
16818523|NCT02293499|37761495|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
16818524|NCT02293499|37761496|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
16818525|NCT02293499|37761494|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
16818526|NCT02293499|37761495|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
16818527|NCT02293499|37761496|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
16818528|NCT02293499|37761494|FG000|9 Month Follow Up|Lost to Follow-up|24|||
16818529|NCT02293499|37761495|FG001|9 Month Follow Up|Lost to Follow-up|28|||
16818530|NCT02293499|37761496|FG002|9 Month Follow Up|Lost to Follow-up|4|||
16818531|NCT02293499|37761494|FG000|12 Month Follow Up|Lost to Follow-up|26|||
16818532|NCT02293499|37761495|FG001|12 Month Follow Up|Lost to Follow-up|25|||
16818533|NCT02293499|37761496|FG002|12 Month Follow Up|Lost to Follow-up|6|||
16818534|NCT02293499|37761494|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
16818535|NCT02293499|37761495|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
16818536|NCT02293499|37761496|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
16818537|NCT02293499|37761494|FG000|15 Month Follow Up|Lost to Follow-up|22|||
16818538|NCT02293499|37761495|FG001|15 Month Follow Up|Lost to Follow-up|22|||
16818539|NCT02293499|37761496|FG002|15 Month Follow Up|Lost to Follow-up|7|||
16818540|NCT02257385|37761507|FG000|Overall Study|Adverse Event|12|||
16818541|NCT02257385|37761508|FG001|Overall Study|Adverse Event|8|||
16818542|NCT02257385|37761507|FG000|Overall Study|Lack of Efficacy|1|||
16818543|NCT02257385|37761508|FG001|Overall Study|Lack of Efficacy|2|||
16818544|NCT02257385|37761507|FG000|Overall Study|Protocol Violation|5|||
16818545|NCT02257385|37761508|FG001|Overall Study|Protocol Violation|7|||
16818546|NCT02257385|37761507|FG000|Overall Study|Lost to Follow-up|0|||
16818547|NCT02257385|37761508|FG001|Overall Study|Lost to Follow-up|1|||
16818548|NCT02257385|37761507|FG000|Overall Study|Withdrawal by Subject|4|||
16818549|NCT02257385|37761508|FG001|Overall Study|Withdrawal by Subject|4|||
16818550|NCT01629667|37761517|FG000|Overall Study|Lost to Follow-up|0|||
16818551|NCT01629667|37761518|FG001|Overall Study|Lost to Follow-up|1|||
16818552|NCT01629667|37761519|FG002|Overall Study|Lost to Follow-up|1|||
16818553|NCT01629667|37761517|FG000|Overall Study|Withdrawal by Subject|31|||
16818554|NCT01629667|37761518|FG001|Overall Study|Withdrawal by Subject|20|||
16818555|NCT01629667|37761519|FG002|Overall Study|Withdrawal by Subject|28|||
16818556|NCT01629667|37761517|FG000|Overall Study|Death|1|||
16818557|NCT01629667|37761518|FG001|Overall Study|Death|5|||
16818558|NCT01629667|37761519|FG002|Overall Study|Death|3|||
16818559|NCT01629667|37761517|FG000|Overall Study|Randomized, not treated|2|||
16818560|NCT01629667|37761518|FG001|Overall Study|Randomized, not treated|1|||
16818561|NCT01629667|37761519|FG002|Overall Study|Randomized, not treated|0|||
16818562|NCT01629667|37761517|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
16818563|NCT01629667|37761518|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
16818564|NCT01629667|37761519|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
16818565|NCT01629667|37761517|FG000|Overall Study|Requiring lung transplant|2|||
16818566|NCT01629667|37761518|FG001|Overall Study|Requiring lung transplant|1|||
16818567|NCT01629667|37761519|FG002|Overall Study|Requiring lung transplant|3|||
16818568|NCT01629667|37761517|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
16818569|NCT01629667|37761518|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
16818570|NCT01629667|37761519|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
16818571|NCT01629667|37761517|FG000|Overall Study|Started other medicine|1|||
16818572|NCT01629667|37761518|FG001|Overall Study|Started other medicine|0|||
16818573|NCT01629667|37761519|FG002|Overall Study|Started other medicine|1|||
16818574|NCT01629667|37761517|FG000|Overall Study|Site error in safety follow-up|0|||
16818575|NCT01629667|37761518|FG001|Overall Study|Site error in safety follow-up|0|||
16818576|NCT01629667|37761519|FG002|Overall Study|Site error in safety follow-up|1|||
16818577|NCT01629667|37761517|FG000|Overall Study|Enrolled in another clinical study|0|||
16818578|NCT01629667|37761518|FG001|Overall Study|Enrolled in another clinical study|1|||
16818579|NCT01629667|37761519|FG002|Overall Study|Enrolled in another clinical study|0|||
16818580|NCT01629667|37761517|FG000|Overall Study|Code break|1|||
16818581|NCT01629667|37761518|FG001|Overall Study|Code break|0|||
16818582|NCT01629667|37761519|FG002|Overall Study|Code break|0|||
16818583|NCT01645280|37761534|FG000|Overall Study|Death|0|||
16818584|NCT01645280|37761535|FG001|Overall Study|Death|1|||
16818585|NCT01645280|37761536|FG002|Overall Study|Death|0|||
16818586|NCT01645280|37761537|FG003|Overall Study|Death|0|||
16818587|NCT01645280|37761538|FG004|Overall Study|Death|0|||
16818588|NCT01645280|37761534|FG000|Overall Study|Withdrawal by Subject|4|||
16818589|NCT01645280|37761535|FG001|Overall Study|Withdrawal by Subject|0|||
16818590|NCT01645280|37761536|FG002|Overall Study|Withdrawal by Subject|2|||
16818591|NCT01645280|37761537|FG003|Overall Study|Withdrawal by Subject|4|||
16818592|NCT01645280|37761538|FG004|Overall Study|Withdrawal by Subject|5|||
16818593|NCT01645280|37761534|FG000|Overall Study|Lost to Follow-up|0|||
16818594|NCT01645280|37761535|FG001|Overall Study|Lost to Follow-up|0|||
16818595|NCT01645280|37761536|FG002|Overall Study|Lost to Follow-up|0|||
16818596|NCT01645280|37761537|FG003|Overall Study|Lost to Follow-up|2|||
16818597|NCT01645280|37761538|FG004|Overall Study|Lost to Follow-up|1|||
16818598|NCT01645280|37761534|FG000|Overall Study|Other|1|||
16818599|NCT01645280|37761535|FG001|Overall Study|Other|1|||
16818600|NCT01645280|37761536|FG002|Overall Study|Other|2|||
16818601|NCT01645280|37761537|FG003|Overall Study|Other|0|||
16818602|NCT01645280|37761538|FG004|Overall Study|Other|0|||
16818603|NCT01645280|37761534|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
16818604|NCT01645280|37761535|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
16818605|NCT01645280|37761536|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
16818606|NCT01645280|37761537|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
16818607|NCT01645280|37761538|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
16818608|NCT02256917|37761551|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
16818609|NCT02256917|37761551|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
16818610|NCT02256917|37761551|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
16818611|NCT02256917|37761551|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
16818612|NCT02256917|37761551|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
16818613|NCT01629589|37761564|FG000|Overall Study|Protocol Violation|4|||
16818614|NCT01629589|37761565|FG001|Overall Study|Protocol Violation|2|||
16818615|NCT01629589|37761564|FG000|Overall Study|Lost to Follow-up|2|||
16818616|NCT01629589|37761565|FG001|Overall Study|Lost to Follow-up|1|||
16818617|NCT01629589|37761564|FG000|Overall Study|Withdrawal by Subject|2|||
16818618|NCT01629589|37761565|FG001|Overall Study|Withdrawal by Subject|3|||
16818619|NCT01629589|37761564|FG000|Overall Study|Did not receive study vaccine|0|||
16818620|NCT01629589|37761565|FG001|Overall Study|Did not receive study vaccine|1|||
16818621|NCT02256839|37761573|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
16818622|NCT02256839|37761574|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
16818623|NCT02220907|37761580|FG000|Overall Study|Adverse Event|7|||
16818624|NCT02220907|37761580|FG000|Overall Study|Physician Decision|1|||
16818625|NCT02220907|37761580|FG000|Overall Study|Withdrawal by Subject|2|||
16818626|NCT02220907|37761580|FG000|Overall Study|Conflict with the stopping criteria|1|||
16818627|NCT02255981|37761584|FG000|Overall Study|Lost to Follow-up|3|||
16818628|NCT02255981|37761584|FG000|Overall Study|Withdrawal by Subject|1|||
16818629|NCT01601873|37761596|FG000|Overall Study|Lost to Follow-up|2|||
16818630|NCT01601873|37761597|FG001|Overall Study|Lost to Follow-up|3|||
16818631|NCT02194933|37761605|FG000|Overall Study|Lost to Follow-up|1|||
16818632|NCT02194933|37761606|FG001|Overall Study|Lost to Follow-up|2|||
16818633|NCT02194933|37761605|FG000|Overall Study|Participant met withdrawal criteria|1|||
16818634|NCT02194933|37761606|FG001|Overall Study|Participant met withdrawal criteria|3|||
16818635|NCT02194933|37761605|FG000|Overall Study|Withdrawal by Subject|0|||
16818636|NCT02194933|37761606|FG001|Overall Study|Withdrawal by Subject|2|||
16818637|NCT02194933|37761605|FG000|Overall Study|Lack of Efficacy|1|||
16818638|NCT02194933|37761606|FG001|Overall Study|Lack of Efficacy|2|||
16818639|NCT01644890|37761616|FG000|Overall Study|Adverse Event|7|||
16818640|NCT01644890|37761617|FG001|Overall Study|Adverse Event|20|||
16818641|NCT01644890|37761616|FG000|Overall Study|Death|1|||
16818642|NCT01644890|37761617|FG001|Overall Study|Death|3|||
16818643|NCT01644890|37761616|FG000|Overall Study|Physician Decision|3|||
16818644|NCT01644890|37761617|FG001|Overall Study|Physician Decision|9|||
16818645|NCT01644890|37761616|FG000|Overall Study|Protocol Violation|6|||
16818646|NCT01644890|37761617|FG001|Overall Study|Protocol Violation|7|||
16818647|NCT01644890|37761616|FG000|Overall Study|Withdrawal by Subject|19|||
16818648|NCT01644890|37761617|FG001|Overall Study|Withdrawal by Subject|27|||
16818649|NCT01644890|37761616|FG000|Overall Study|Progression Disease|160|||
16818650|NCT01644890|37761617|FG001|Overall Study|Progression Disease|131|||
16818651|NCT01644890|37761616|FG000|Overall Study|Clinical Progression|6|||
16818652|NCT01644890|37761617|FG001|Overall Study|Clinical Progression|6|||
16818653|NCT01644890|37761616|FG000|Overall Study|> 28 days since last dose of study drug|6|||
16818654|NCT01644890|37761617|FG001|Overall Study|> 28 days since last dose of study drug|3|||
16818655|NCT01644890|37761616|FG000|Overall Study|Other|8|||
16818656|NCT01644890|37761617|FG001|Overall Study|Other|9|||
16818657|NCT01628965|37761623|FG000|Overall Study|Adverse Event|30|||
16818658|NCT01628965|37761623|FG000|Overall Study|Lack of Efficacy|7|||
16818659|NCT01628965|37761623|FG000|Overall Study|Withdrawal by Subject|3|||
16818660|NCT01628965|37761623|FG000|Overall Study|Lost to Follow-up|1|||
16818661|NCT01628965|37761623|FG000|Overall Study|Discontinuation criteria|8|||
16818662|NCT01644734|37761627|FG000|Overall Study|Adverse Event|4|||
16818663|NCT01644734|37761627|FG000|Overall Study|Lost to Follow-up|17|||
16818664|NCT01644734|37761627|FG000|Overall Study|Reasons other than stated above|7|||
16818665|NCT01644734|37761627|FG000|Overall Study|Missing documentation|238|||
16818666|NCT02255279|37761633|FG000|Overall Study|Lost to Follow-up|2|||
16818667|NCT02255279|37761634|FG001|Overall Study|Lost to Follow-up|2|||
16818668|NCT02255279|37761633|FG000|Overall Study|Protocol Violation|0|||
16818669|NCT02255279|37761634|FG001|Overall Study|Protocol Violation|1|||
16818670|NCT02255279|37761633|FG000|Overall Study|Withdrawal by Subject|3|||
16818671|NCT02255279|37761634|FG001|Overall Study|Withdrawal by Subject|6|||
16818672|NCT01643798|37761654|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
16818673|NCT01643798|37761655|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
16818674|NCT02194699|37761668|FG000|Randomised|Did not receive treatment|1|||
16818675|NCT02194699|37761669|FG001|Randomised|Did not receive treatment|5|||
16818676|NCT02194699|37761668|FG000|Randomised|Without potential for 52 weeks of IP|5|||
16818677|NCT02194699|37761669|FG001|Randomised|Without potential for 52 weeks of IP|5|||
16818678|NCT02194699|37761668|FG000|Randomised|Duplicate patient|2|||
16818679|NCT02194699|37761669|FG001|Randomised|Duplicate patient|1|||
16818680|NCT02194699|37761668|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
16818681|NCT02194699|37761669|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
16818682|NCT02194699|37761668|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
16818683|NCT02194699|37761669|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
16818684|NCT02194699|37761668|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
16818685|NCT02194699|37761669|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
16818686|NCT02194699|37761668|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
16818687|NCT02194699|37761669|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
16818688|NCT02194699|37761668|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
16818689|NCT02194699|37761669|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
16818690|NCT02194699|37761668|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
16818691|NCT02194699|37761669|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
16818692|NCT02293538|37761685|FG000|Overall Study|Adverse Event|0|||
16818693|NCT02293538|37761686|FG001|Overall Study|Adverse Event|1|||
16818694|NCT02293538|37761685|FG000|Overall Study|Lost to Follow-up|1|||
16818695|NCT02293538|37761686|FG001|Overall Study|Lost to Follow-up|0|||
16818696|NCT02293538|37761685|FG000|Overall Study|Withdrawal by Subject|0|||
16818697|NCT02293538|37761686|FG001|Overall Study|Withdrawal by Subject|1|||
16818698|NCT02194621|37761696|FG000|Overall Study|6 withdrew prior to randomization|2|||
16818699|NCT02194621|37761697|FG001|Overall Study|6 withdrew prior to randomization|2|||
16818700|NCT02194621|37761698|FG002|Overall Study|6 withdrew prior to randomization|2|||
16818701|NCT02194621|37761696|FG000|Overall Study|Withdrawal by Subject|4|||
16818702|NCT02194621|37761697|FG001|Overall Study|Withdrawal by Subject|4|||
16818703|NCT02194621|37761698|FG002|Overall Study|Withdrawal by Subject|7|||
16818704|NCT02220205|37761708|FG000|Overall Study|Withdrawal by Subject|1|||
16818705|NCT02220205|37761709|FG001|Overall Study|Withdrawal by Subject|0|||
16818706|NCT02266706|37761724|FG000|Overall Study|Withdrawal by Subject|0|||
16818707|NCT02266706|37761725|FG001|Overall Study|Withdrawal by Subject|1|||
16818708|NCT02266706|37761726|FG002|Overall Study|Withdrawal by Subject|1|||
16818709|NCT02266706|37761727|FG003|Overall Study|Withdrawal by Subject|0|||
16818710|NCT02266706|37761728|FG004|Overall Study|Withdrawal by Subject|0|||
16818711|NCT02266706|37761729|FG005|Overall Study|Withdrawal by Subject|1|||
16818712|NCT02266706|37761730|FG006|Overall Study|Withdrawal by Subject|0|||
16818713|NCT02266706|37761731|FG007|Overall Study|Withdrawal by Subject|0|||
16818714|NCT02266706|37761732|FG008|Overall Study|Withdrawal by Subject|0|||
16818715|NCT02266706|37761724|FG000|Overall Study|Screen failure|0|||
16818716|NCT02266706|37761725|FG001|Overall Study|Screen failure|0|||
16818717|NCT02266706|37761726|FG002|Overall Study|Screen failure|0|||
16818718|NCT02266706|37761727|FG003|Overall Study|Screen failure|0|||
16818719|NCT02266706|37761728|FG004|Overall Study|Screen failure|0|||
16818720|NCT02266706|37761729|FG005|Overall Study|Screen failure|1|||
16818721|NCT02266706|37761730|FG006|Overall Study|Screen failure|1|||
16818722|NCT02266706|37761731|FG007|Overall Study|Screen failure|0|||
16818723|NCT02266706|37761732|FG008|Overall Study|Screen failure|0|||
16818724|NCT02266706|37761724|FG000|Overall Study|Enrollment in another study|0|||
16818725|NCT02266706|37761725|FG001|Overall Study|Enrollment in another study|0|||
16818726|NCT02266706|37761726|FG002|Overall Study|Enrollment in another study|0|||
16818727|NCT02266706|37761727|FG003|Overall Study|Enrollment in another study|1|||
16818728|NCT02266706|37761728|FG004|Overall Study|Enrollment in another study|0|||
16818729|NCT02266706|37761729|FG005|Overall Study|Enrollment in another study|0|||
16818730|NCT02266706|37761730|FG006|Overall Study|Enrollment in another study|0|||
16818731|NCT02266706|37761731|FG007|Overall Study|Enrollment in another study|0|||
16818732|NCT02266706|37761732|FG008|Overall Study|Enrollment in another study|0|||
16818733|NCT02293460|37761752|FG000|Overall Study|Protocol Violation|1|||
16818734|NCT02293460|37761752|FG000|Overall Study|Lack of Efficacy|2|||
16818735|NCT02293460|37761752|FG000|Overall Study|Adverse Event|2|||
16818736|NCT02293460|37761752|FG000|Overall Study|Withdrawal by Subject|1|||
16818737|NCT02266004|37761756|FG000|Overall Study|unrelated adverse event|1|||
16818738|NCT02266004|37761756|FG000|Overall Study|Physician Decision|1|||
16818739|NCT02292719|37761766|FG000|Overall Study|Withdrawal by Subject|0|||
16818740|NCT02292719|37761767|FG001|Overall Study|Withdrawal by Subject|0|||
16818741|NCT02292719|37761768|FG002|Overall Study|Withdrawal by Subject|0|||
16818742|NCT02292719|37761769|FG003|Overall Study|Withdrawal by Subject|1|||
16818743|NCT02292719|37761770|FG004|Overall Study|Withdrawal by Subject|1|||
16818744|NCT02292719|37761771|FG005|Overall Study|Withdrawal by Subject|0|||
16818745|NCT02292719|37761766|FG000|Overall Study|Subject enrolled in new study.|0|||
16818746|NCT02292719|37761767|FG001|Overall Study|Subject enrolled in new study.|0|||
16818747|NCT02292719|37761768|FG002|Overall Study|Subject enrolled in new study.|1|||
16818748|NCT02292719|37761769|FG003|Overall Study|Subject enrolled in new study.|0|||
16818749|NCT02292719|37761770|FG004|Overall Study|Subject enrolled in new study.|0|||
16818750|NCT02292719|37761771|FG005|Overall Study|Subject enrolled in new study.|0|||
16818751|NCT02291861|37761789|FG000|Overall Study|Adverse Event|2|||
16818752|NCT02291861|37761790|FG001|Overall Study|Adverse Event|4|||
16818753|NCT02291861|37761791|FG002|Overall Study|Adverse Event|1|||
16818754|NCT02291861|37761792|FG003|Overall Study|Adverse Event|2|||
16818755|NCT02291861|37761789|FG000|Overall Study|Death|0|||
16818756|NCT02291861|37761790|FG001|Overall Study|Death|0|||
16818757|NCT02291861|37761791|FG002|Overall Study|Death|1|||
16818758|NCT02291861|37761792|FG003|Overall Study|Death|1|||
16818759|NCT02291861|37761789|FG000|Overall Study|Protocol Violation|1|||
16818760|NCT02291861|37761790|FG001|Overall Study|Protocol Violation|0|||
16818761|NCT02291861|37761791|FG002|Overall Study|Protocol Violation|0|||
16818762|NCT02291861|37761792|FG003|Overall Study|Protocol Violation|1|||
16818763|NCT02291861|37761789|FG000|Overall Study|Withdrawal by Subject|1|||
16818764|NCT02291861|37761790|FG001|Overall Study|Withdrawal by Subject|2|||
16818765|NCT02291861|37761791|FG002|Overall Study|Withdrawal by Subject|1|||
16818766|NCT02291861|37761792|FG003|Overall Study|Withdrawal by Subject|4|||
16818767|NCT02291861|37761789|FG000|Overall Study|Noncompliance|1|||
16818768|NCT02291861|37761790|FG001|Overall Study|Noncompliance|1|||
16818769|NCT02291861|37761791|FG002|Overall Study|Noncompliance|2|||
16818770|NCT02291861|37761792|FG003|Overall Study|Noncompliance|1|||
16818771|NCT02291861|37761789|FG000|Overall Study|Lost to Follow-up|2|||
16818772|NCT02291861|37761790|FG001|Overall Study|Lost to Follow-up|1|||
16818773|NCT02291861|37761791|FG002|Overall Study|Lost to Follow-up|4|||
16818774|NCT02291861|37761792|FG003|Overall Study|Lost to Follow-up|0|||
16818775|NCT02291861|37761789|FG000|Overall Study|Other|0|||
16818776|NCT02291861|37761790|FG001|Overall Study|Other|0|||
16818777|NCT02291861|37761791|FG002|Overall Study|Other|0|||
16818778|NCT02291861|37761792|FG003|Overall Study|Other|1|||
16818779|NCT02291549|37761804|FG000|Overall Study|Lost to Follow-up|1|||
16818780|NCT02291549|37761805|FG001|Overall Study|Lost to Follow-up|0|||
16818781|NCT02291549|37761804|FG000|Overall Study|Withdrawal by Subject|0|||
16818782|NCT02291549|37761805|FG001|Overall Study|Withdrawal by Subject|1|||
16818783|NCT02264990|37761815|FG000|Overall Study|Death|255|||
16818784|NCT02264990|37761816|FG001|Overall Study|Death|250|||
16818785|NCT02264990|37761815|FG000|Overall Study|Withdrawal by Subject|4|||
16818786|NCT02264990|37761816|FG001|Overall Study|Withdrawal by Subject|5|||
16818787|NCT02264990|37761815|FG000|Overall Study|Lost to Follow-up|1|||
16818788|NCT02264990|37761816|FG001|Overall Study|Lost to Follow-up|3|||
16818789|NCT02264990|37761815|FG000|Overall Study|Other|0|||
16818790|NCT02264990|37761816|FG001|Overall Study|Other|1|||
16818791|NCT02291237|37761825|FG000|Overall Study|Study Terminated by Sponsor|72|||
16818792|NCT02291237|37761826|FG001|Overall Study|Study Terminated by Sponsor|67|||
16818793|NCT02291237|37761825|FG000|Overall Study|Adverse Event|1|||
16818794|NCT02291237|37761826|FG001|Overall Study|Adverse Event|3|||
16818795|NCT02291237|37761825|FG000|Overall Study|Investigator's Discretion|0|||
16818796|NCT02291237|37761826|FG001|Overall Study|Investigator's Discretion|3|||
16818797|NCT02291237|37761825|FG000|Overall Study|Withdrew Consent|11|||
16818798|NCT02291237|37761826|FG001|Overall Study|Withdrew Consent|11|||
16818799|NCT02291237|37761825|FG000|Overall Study|Lost to Follow-up|0|||
16818800|NCT02291237|37761826|FG001|Overall Study|Lost to Follow-up|2|||
16818801|NCT02291237|37761825|FG000|Overall Study|Subject Required Prohibited Medication|2|||
16818802|NCT02291237|37761826|FG001|Overall Study|Subject Required Prohibited Medication|0|||
16818803|NCT02292446|37761832|FG000|Overall Study|Adverse Event|12|||
16818804|NCT02292446|37761832|FG000|Overall Study|Death|1|||
16818805|NCT02292446|37761832|FG000|Overall Study|Disease progression|2|||
16818806|NCT02292446|37761832|FG000|Overall Study|Subject/guardian decision|2|||
16818807|NCT02292446|37761832|FG000|Overall Study|Withdrawal by Subject|3|||
16818808|NCT02290925|37761841|FG000|First Period of Three Months|Lost to Follow-up|2|||
16818809|NCT02290925|37761842|FG001|First Period of Three Months|Lost to Follow-up|1|||
16818810|NCT02290925|37761841|FG000|First Period of Three Months|Death|1|||
16818811|NCT02290925|37761842|FG001|First Period of Three Months|Death|0|||
16818812|NCT02290925|37761841|FG000|First Period of Three Months|Insulin Started|1|||
16818813|NCT02290925|37761842|FG001|First Period of Three Months|Insulin Started|1|||
16818814|NCT02290925|37761841|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
16818815|NCT02290925|37761842|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
16818816|NCT02290925|37761841|FG000|Second Period of 3 Months|insulin started|0|||
16818817|NCT02290925|37761842|FG001|Second Period of 3 Months|insulin started|1|||
16818818|NCT02290691|37761852|FG000|Overall Study|Noncompliance|0|||
16818819|NCT02290691|37761853|FG001|Overall Study|Noncompliance|1|||
16818820|NCT02290691|37761852|FG000|Overall Study|Withdrawal by Subject|1|||
16818821|NCT02290691|37761853|FG001|Overall Study|Withdrawal by Subject|1|||
16818822|NCT02290691|37761852|FG000|Overall Study|Lost to Follow-up|7|||
16818823|NCT02290691|37761853|FG001|Overall Study|Lost to Follow-up|7|||
16818824|NCT02292212|37761859|FG000|ViE Phase|Withdrawal by Subject|1|||
16818825|NCT02292212|37761859|FG000|ViE Phase|Protocol Violation|2|||
16818826|NCT02291510|37761874|FG000|Overall Study|Adverse Event|0|||
16818827|NCT02291510|37761875|FG001|Overall Study|Adverse Event|0|||
16818828|NCT02291510|37761876|FG002|Overall Study|Adverse Event|0|||
16818829|NCT02291510|37761877|FG003|Overall Study|Adverse Event|1|||
16818830|NCT02290223|37761889|FG000|6 Months|Lost to Follow-up|9|||
16818831|NCT02290223|37761890|FG001|6 Months|Lost to Follow-up|6|||
16818832|NCT02290223|37761889|FG000|6 Months|Withdrawal by Subject|5|||
16818833|NCT02290223|37761890|FG001|6 Months|Withdrawal by Subject|0|||
16818834|NCT02290223|37761889|FG000|6 Months|deceased (not related to study)|2|||
16818835|NCT02290223|37761890|FG001|6 Months|deceased (not related to study)|0|||
16818836|NCT02290223|37761889|FG000|12 Months|Lost to Follow-up|16|||
16818837|NCT02290223|37761890|FG001|12 Months|Lost to Follow-up|10|||
16818838|NCT02290223|37761889|FG000|12 Months|Refusal|0|||
16818839|NCT02290223|37761890|FG001|12 Months|Refusal|1|||
16818840|NCT02289833|37761898|FG000|Overall Study|Study discontinuation|0|||
16818841|NCT02289833|37761899|FG001|Overall Study|Study discontinuation|1|||
16818842|NCT02289833|37761898|FG000|Overall Study|Lost to Follow-up|4|||
16818843|NCT02289833|37761899|FG001|Overall Study|Lost to Follow-up|0|||
16818844|NCT02289833|37761898|FG000|Overall Study|Death|23|||
16818845|NCT02289833|37761899|FG001|Overall Study|Death|16|||
16818846|NCT01702558|37761912|FG000|Overall Study|Withdrawal by Subject|0|||
16818847|NCT01702558|37761913|FG001|Overall Study|Withdrawal by Subject|0|||
16818848|NCT01702558|37761914|FG002|Overall Study|Withdrawal by Subject|0|||
16818849|NCT01702558|37761915|FG003|Overall Study|Withdrawal by Subject|12|||
16818850|NCT01702558|37761916|FG004|Overall Study|Withdrawal by Subject|4|||
16818851|NCT01702558|37761912|FG000|Overall Study|Lost to Follow-up|0|||
16818852|NCT01702558|37761913|FG001|Overall Study|Lost to Follow-up|0|||
16818853|NCT01702558|37761914|FG002|Overall Study|Lost to Follow-up|0|||
16818854|NCT01702558|37761915|FG003|Overall Study|Lost to Follow-up|3|||
16818855|NCT01702558|37761916|FG004|Overall Study|Lost to Follow-up|0|||
16818856|NCT01702558|37761912|FG000|Overall Study|Death|4|||
16818857|NCT01702558|37761913|FG001|Overall Study|Death|3|||
16818858|NCT01702558|37761914|FG002|Overall Study|Death|3|||
16818859|NCT01702558|37761915|FG003|Overall Study|Death|16|||
16818860|NCT01702558|37761916|FG004|Overall Study|Death|20|||
16818861|NCT01702558|37761912|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
16818862|NCT01702558|37761913|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
16818863|NCT01702558|37761914|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
16818864|NCT01702558|37761915|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
16818865|NCT01702558|37761916|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
16818866|NCT01702558|37761912|FG000|Overall Study|Study Terminated by Sponsor|0|||
16818867|NCT01702558|37761913|FG001|Overall Study|Study Terminated by Sponsor|1|||
16818868|NCT01702558|37761914|FG002|Overall Study|Study Terminated by Sponsor|0|||
16818869|NCT01702558|37761915|FG003|Overall Study|Study Terminated by Sponsor|0|||
16818870|NCT01702558|37761916|FG004|Overall Study|Study Terminated by Sponsor|1|||
16818871|NCT01702558|37761912|FG000|Overall Study|Other|0|||
16818872|NCT01702558|37761913|FG001|Overall Study|Other|0|||
16818873|NCT01702558|37761914|FG002|Overall Study|Other|0|||
16818874|NCT01702558|37761915|FG003|Overall Study|Other|16|||
16818875|NCT01702558|37761916|FG004|Overall Study|Other|17|||
16818876|NCT02287883|37761931|FG000|Overall Study|Death|8|||
16818877|NCT02287883|37761932|FG001|Overall Study|Death|7|||
16818878|NCT02287883|37761931|FG000|Overall Study|No longer eligible|222|||
16818879|NCT02287883|37761932|FG001|Overall Study|No longer eligible|182|||
16818880|NCT02287883|37761931|FG000|Overall Study|Non-response to survey|229|||
16818881|NCT02287883|37761932|FG001|Overall Study|Non-response to survey|237|||
16818882|NCT01743040|37761938|FG000|Overall Study|Death|1|||
16818883|NCT01743040|37761938|FG000|Overall Study|Lost to Follow-up|66|||
16818884|NCT01743040|37761938|FG000|Overall Study|Physician Decision|40|||
16818885|NCT01743040|37761938|FG000|Overall Study|Protocol Violation|1|||
16818886|NCT01743040|37761938|FG000|Overall Study|Withdrawal by Subject|121|||
16818887|NCT02194465|37761949|FG000|Overall Study|Adverse Event|6|||
16818888|NCT02194465|37761950|FG001|Overall Study|Adverse Event|1|||
16818889|NCT02194465|37761951|FG002|Overall Study|Adverse Event|4|||
16818890|NCT02194465|37761952|FG003|Overall Study|Adverse Event|4|||
16818891|NCT02194465|37761953|FG004|Overall Study|Adverse Event|4|||
16818892|NCT02194465|37761954|FG005|Overall Study|Adverse Event|2|||
16818893|NCT02194465|37761955|FG006|Overall Study|Adverse Event|0|||
16818894|NCT02194465|37761949|FG000|Overall Study|Lost to Follow-up|0|||
16818895|NCT02194465|37761950|FG001|Overall Study|Lost to Follow-up|0|||
16818896|NCT02194465|37761951|FG002|Overall Study|Lost to Follow-up|0|||
16818897|NCT02194465|37761952|FG003|Overall Study|Lost to Follow-up|1|||
16818898|NCT02194465|37761953|FG004|Overall Study|Lost to Follow-up|0|||
16818899|NCT02194465|37761954|FG005|Overall Study|Lost to Follow-up|1|||
16818900|NCT02194465|37761955|FG006|Overall Study|Lost to Follow-up|0|||
16818901|NCT02194465|37761949|FG000|Overall Study|Physician Decision|1|||
16818902|NCT02194465|37761950|FG001|Overall Study|Physician Decision|0|||
16818903|NCT02194465|37761951|FG002|Overall Study|Physician Decision|0|||
16818904|NCT02194465|37761952|FG003|Overall Study|Physician Decision|0|||
16818905|NCT02194465|37761953|FG004|Overall Study|Physician Decision|0|||
16818906|NCT02194465|37761954|FG005|Overall Study|Physician Decision|0|||
16818907|NCT02194465|37761955|FG006|Overall Study|Physician Decision|0|||
16818908|NCT02194465|37761949|FG000|Overall Study|Protocol Violation|1|||
16818909|NCT02194465|37761950|FG001|Overall Study|Protocol Violation|1|||
16818910|NCT02194465|37761951|FG002|Overall Study|Protocol Violation|2|||
16818911|NCT02194465|37761952|FG003|Overall Study|Protocol Violation|1|||
16818912|NCT02194465|37761953|FG004|Overall Study|Protocol Violation|1|||
16818913|NCT02194465|37761954|FG005|Overall Study|Protocol Violation|0|||
16818914|NCT02194465|37761955|FG006|Overall Study|Protocol Violation|0|||
16818915|NCT02194465|37761949|FG000|Overall Study|Withdrawal by Subject|1|||
16818916|NCT02194465|37761950|FG001|Overall Study|Withdrawal by Subject|3|||
16818917|NCT02194465|37761951|FG002|Overall Study|Withdrawal by Subject|1|||
16818918|NCT02194465|37761952|FG003|Overall Study|Withdrawal by Subject|2|||
16818919|NCT02194465|37761953|FG004|Overall Study|Withdrawal by Subject|2|||
16818920|NCT02194465|37761954|FG005|Overall Study|Withdrawal by Subject|1|||
16818921|NCT02194465|37761955|FG006|Overall Study|Withdrawal by Subject|2|||
16818922|NCT02194465|37761949|FG000|Overall Study|Discontinued follow-up period|0|||
16818923|NCT02194465|37761950|FG001|Overall Study|Discontinued follow-up period|2|||
16818924|NCT02194465|37761951|FG002|Overall Study|Discontinued follow-up period|1|||
16818925|NCT02194465|37761952|FG003|Overall Study|Discontinued follow-up period|0|||
16818926|NCT02194465|37761953|FG004|Overall Study|Discontinued follow-up period|2|||
16818927|NCT02194465|37761954|FG005|Overall Study|Discontinued follow-up period|0|||
16818928|NCT02194465|37761955|FG006|Overall Study|Discontinued follow-up period|0|||
16818929|NCT02287025|37761977|FG000|Overall Study|Not treated|2|||
16818930|NCT02287025|37761978|FG001|Overall Study|Not treated|0|||
16818931|NCT02287025|37761977|FG000|Overall Study|Progression of disease|3|||
16818932|NCT02287025|37761978|FG001|Overall Study|Progression of disease|2|||
16818933|NCT02287025|37761977|FG000|Overall Study|Adverse Event|2|||
16818934|NCT02287025|37761978|FG001|Overall Study|Adverse Event|4|||
16818935|NCT02287025|37761977|FG000|Overall Study|Withdrawal by Subject|2|||
16818936|NCT02287025|37761978|FG001|Overall Study|Withdrawal by Subject|2|||
16818937|NCT02287025|37761977|FG000|Overall Study|Screening failed|1|||
16818938|NCT02287025|37761978|FG001|Overall Study|Screening failed|1|||
16818939|NCT01720264|37761982|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
16818940|NCT01720264|37761982|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
16818941|NCT01720264|37761982|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
16818942|NCT01702246|37761986|FG000|Overall Study|Lost to Follow-up|2|||
16818943|NCT01702246|37761986|FG000|Overall Study|Withdrawal by Subject|2|||
16818944|NCT01702246|37761986|FG000|Overall Study|Physician Decision|1|||
16818945|NCT01631227|37761995|FG000|Overall Study|withdrawn consent|27|||
16818946|NCT01631227|37761996|FG001|Overall Study|withdrawn consent|21|||
16818947|NCT01631227|37761995|FG000|Overall Study|Adverse Event|1|||
16818948|NCT01631227|37761996|FG001|Overall Study|Adverse Event|0|||
16818949|NCT01631227|37761995|FG000|Overall Study|administrative|2|||
16818950|NCT01631227|37761996|FG001|Overall Study|administrative|1|||
16818951|NCT01719172|37762002|FG000|Overall Study|Lost to Follow-up|1|||
16818952|NCT01719172|37762002|FG000|Overall Study|Death|1|||
16818953|NCT02286947|37762006|FG000|Overall Study|Withdrawal by Subject|2|||
16818954|NCT02286713|37762014|FG000|One Week Follow-Up|Death|1|||
16818955|NCT02286713|37762015|FG001|One Week Follow-Up|Death|0|||
16818956|NCT02286713|37762014|FG000|One Week Follow-Up|Lost to Follow-up|17|||
16818957|NCT02286713|37762015|FG001|One Week Follow-Up|Lost to Follow-up|21|||
16818958|NCT02286713|37762014|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
16818959|NCT02286713|37762015|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
16818960|NCT02286713|37762014|FG000|Three Month Follow-Up|Death|1|||
16818961|NCT02286713|37762015|FG001|Three Month Follow-Up|Death|1|||
16818962|NCT02286713|37762014|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
16818963|NCT02286713|37762015|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
16818964|NCT02286713|37762014|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
16818965|NCT02286713|37762015|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
16818966|NCT02286713|37762014|FG000|Six Month Follow-Up|Death|2|||
16818967|NCT02286713|37762015|FG001|Six Month Follow-Up|Death|0|||
16818968|NCT02286713|37762014|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
16818969|NCT02286713|37762015|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
16818970|NCT02285855|37762023|FG000|Overall Study|Withdrawal by Subject|2|||
16818971|NCT02285855|37762024|FG001|Overall Study|Withdrawal by Subject|1|||
16818972|NCT02285777|37762032|FG000|Overall Study|Withdrawal by Subject|1|||
16818973|NCT02285777|37762033|FG001|Overall Study|Withdrawal by Subject|1|||
16818974|NCT02285777|37762032|FG000|Overall Study|Lost to Follow-up|4|||
16818975|NCT02285777|37762033|FG001|Overall Study|Lost to Follow-up|2|||
16818976|NCT02285153|37762041|FG000|Overall Study|Adverse Event|1|||
16818977|NCT02285153|37762042|FG001|Overall Study|Adverse Event|0|||
16818978|NCT02284373|37762051|FG000|Overall Study|Withdrawal by Subject|0|||
16818979|NCT02284373|37762052|FG001|Overall Study|Withdrawal by Subject|1|||
16818980|NCT02284373|37762053|FG002|Overall Study|Withdrawal by Subject|0|||
16818981|NCT02284373|37762051|FG000|Overall Study|Other|0|||
16818982|NCT02284373|37762052|FG001|Overall Study|Other|1|||
16818983|NCT02284373|37762053|FG002|Overall Study|Other|0|||
16818984|NCT02284373|37762051|FG000|Overall Study|Lost to Follow-up|0|||
16818985|NCT02284373|37762052|FG001|Overall Study|Lost to Follow-up|1|||
16818986|NCT02284373|37762053|FG002|Overall Study|Lost to Follow-up|0|||
16818987|NCT01632241|37762063|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
16818988|NCT01632241|37762064|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
16818989|NCT01632241|37762063|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
16818990|NCT01632241|37762064|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
16818991|NCT01632241|37762063|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
16818992|NCT01632241|37762064|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
16818993|NCT01632241|37762063|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
16818994|NCT01632241|37762064|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
16818995|NCT01632241|37762063|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
16818996|NCT01632241|37762064|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
16818997|NCT01632241|37762063|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
16818998|NCT01632241|37762064|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
16818999|NCT01632241|37762063|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
16819000|NCT01632241|37762064|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
16819001|NCT01632241|37762063|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
16819002|NCT01632241|37762064|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
16819003|NCT01632241|37762063|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
16819004|NCT01632241|37762064|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
16819005|NCT01632241|37762063|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
16819006|NCT01632241|37762064|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
16819007|NCT01632241|37762063|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
16819008|NCT01632241|37762064|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
16819009|NCT01632241|37762063|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
16819010|NCT01632241|37762064|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
16819011|NCT01632241|37762063|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
16819012|NCT01632241|37762064|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
16819013|NCT01632241|37762063|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
16819014|NCT01632241|37762064|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
16819015|NCT02263508|37762079|FG000|Overall Study|Withdrawal by Subject|1|||
16819016|NCT02263508|37762080|FG001|Overall Study|Withdrawal by Subject|23|||
16819017|NCT02263508|37762081|FG002|Overall Study|Withdrawal by Subject|17|||
16819018|NCT02263508|37762079|FG000|Overall Study|Sponsor Decision|12|||
16819019|NCT02263508|37762080|FG001|Overall Study|Sponsor Decision|165|||
16819020|NCT02263508|37762081|FG002|Overall Study|Sponsor Decision|182|||
16819021|NCT02263508|37762079|FG000|Overall Study|Lost to Follow-up|2|||
16819022|NCT02263508|37762080|FG001|Overall Study|Lost to Follow-up|7|||
16819023|NCT02263508|37762081|FG002|Overall Study|Lost to Follow-up|7|||
16819024|NCT02263508|37762079|FG000|Overall Study|Death|6|||
16819025|NCT02263508|37762080|FG001|Overall Study|Death|151|||
16819026|NCT02263508|37762081|FG002|Overall Study|Death|140|||
16819027|NCT02291432|37762092|FG000|Overall Study|Withdrawal by Subject|2|||
16819028|NCT02290340|37762100|FG000|Overall Study|Lost to Follow-up|0|||
16819029|NCT02290340|37762101|FG001|Overall Study|Lost to Follow-up|0|||
16819030|NCT02290340|37762102|FG002|Overall Study|Lost to Follow-up|0|||
16819031|NCT02290340|37762103|FG003|Overall Study|Lost to Follow-up|1|||
16819032|NCT02290340|37762100|FG000|Overall Study|Withdrawal by Subject|1|||
16819033|NCT02290340|37762101|FG001|Overall Study|Withdrawal by Subject|0|||
16819034|NCT02290340|37762102|FG002|Overall Study|Withdrawal by Subject|0|||
16819035|NCT02290340|37762103|FG003|Overall Study|Withdrawal by Subject|0|||
16819036|NCT02290340|37762100|FG000|Overall Study|Other|1|||
16819037|NCT02290340|37762101|FG001|Overall Study|Other|0|||
16819038|NCT02290340|37762102|FG002|Overall Study|Other|0|||
16819039|NCT02290340|37762103|FG003|Overall Study|Other|1|||
16819040|NCT02290028|37762116|FG000|Overall Study|Death|217|||
16819041|NCT02290028|37762116|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
16819042|NCT02290028|37762116|FG000|Overall Study|No longer under care of study physician|76|||
16819043|NCT02290028|37762116|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
16819044|NCT02290028|37762116|FG000|Overall Study|Withdrawal by Subject|52|||
16819045|NCT02290028|37762116|FG000|Overall Study|Study site closure|44|||
16819046|NCT02290028|37762116|FG000|Overall Study|Lost to Follow-up|34|||
16819047|NCT02290028|37762116|FG000|Overall Study|Miscellaneous|10|||
16819048|NCT02290028|37762116|FG000|Overall Study|Transition to EP PASSION|1295|||
16819049|NCT02290028|37762116|FG000|Overall Study|Planned study completion at 12 months|257|||
16819050|NCT01741792|37762126|FG000|Overall Study|Death|6|||
16819051|NCT01741792|37762127|FG001|Overall Study|Death|1|||
16819052|NCT01741792|37762128|FG002|Overall Study|Death|12|||
16819053|NCT02289950|37762144|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
16819054|NCT02289950|37762145|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
16819055|NCT02289950|37762144|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
16819056|NCT02289950|37762145|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
16819057|NCT02289950|37762144|FG000|Overall Study|Lost to Follow-up|1|||
16819058|NCT02289950|37762145|FG001|Overall Study|Lost to Follow-up|0|||
16819059|NCT02289950|37762144|FG000|Overall Study|Physician Decision|9|||
16819060|NCT02289950|37762145|FG001|Overall Study|Physician Decision|3|||
16819061|NCT02289950|37762144|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
16819062|NCT02289950|37762145|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
16819063|NCT02289950|37762144|FG000|Overall Study|Withdrawal by Subject|1|||
16819064|NCT02289950|37762145|FG001|Overall Study|Withdrawal by Subject|3|||
16819065|NCT02289950|37762144|FG000|Overall Study|Test article held for greater than 28 days|0|||
16819066|NCT02289950|37762145|FG001|Overall Study|Test article held for greater than 28 days|1|||
16819067|NCT02289950|37762144|FG000|Overall Study|Adverse Event|11|||
16819068|NCT02289950|37762145|FG001|Overall Study|Adverse Event|3|||
16819069|NCT02289950|37762144|FG000|Overall Study|Death|1|||
16819070|NCT02289950|37762145|FG001|Overall Study|Death|1|||
16819071|NCT02289950|37762144|FG000|Overall Study|Other|5|||
16819072|NCT02289950|37762145|FG001|Overall Study|Other|2|||
16819073|NCT02289950|37762144|FG000|Overall Study|Not Treated|2|||
16819074|NCT02289950|37762145|FG001|Overall Study|Not Treated|1|||
16819075|NCT01741012|37762151|FG000|Overall Study|Lost to Follow-up|1|||
16819076|NCT01741012|37762151|FG000|Overall Study|Withdrawal by Subject|2|||
16819077|NCT02288312|37762159|FG000|Overall Study|Pregnancy|1|||
16819078|NCT02288312|37762160|FG001|Overall Study|Pregnancy|0|||
17102362|NCT00099632|38241296|FG004|Overall Study|Lost to Follow-up|1|||
16819079|NCT02288312|37762161|FG002|Overall Study|Pregnancy|0|||
16819080|NCT01740388|37762171|FG000|Overall Study|Withdrawal by Subject|1|||
16819081|NCT01740388|37762172|FG001|Overall Study|Withdrawal by Subject|2|||
16819082|NCT01740388|37762171|FG000|Overall Study|Lost to Follow-up|2|||
16819083|NCT01740388|37762172|FG001|Overall Study|Lost to Follow-up|0|||
16819084|NCT01740388|37762171|FG000|Overall Study|Physician Decision|2|||
16819085|NCT01740388|37762172|FG001|Overall Study|Physician Decision|6|||
16819086|NCT01740388|37762171|FG000|Overall Study|Subjects missing data, completed|41|||
16819087|NCT01740388|37762172|FG001|Overall Study|Subjects missing data, completed|36|||
16819088|NCT01740154|37762178|FG000|Overall Study|Adverse Event|1|||
16819089|NCT02287922|37762186|FG000|Overall Study|Adverse Event|1|||
16819090|NCT02287922|37762187|FG001|Overall Study|Adverse Event|1|||
16819091|NCT02287922|37762188|FG002|Overall Study|Adverse Event|3|||
16819092|NCT02287922|37762189|FG003|Overall Study|Adverse Event|4|||
16819093|NCT02287922|37762186|FG000|Overall Study|Withdrawal by Subject|1|||
16819094|NCT02287922|37762187|FG001|Overall Study|Withdrawal by Subject|1|||
16819095|NCT02287922|37762188|FG002|Overall Study|Withdrawal by Subject|1|||
16819096|NCT02287922|37762189|FG003|Overall Study|Withdrawal by Subject|2|||
16819097|NCT02287922|37762186|FG000|Overall Study|Lost to Follow-up|0|||
16819098|NCT02287922|37762187|FG001|Overall Study|Lost to Follow-up|0|||
16819099|NCT02287922|37762188|FG002|Overall Study|Lost to Follow-up|1|||
16819100|NCT02287922|37762189|FG003|Overall Study|Lost to Follow-up|0|||
16819101|NCT02287922|37762186|FG000|Overall Study|Sponsor's decision|0|||
16819102|NCT02287922|37762187|FG001|Overall Study|Sponsor's decision|0|||
16819103|NCT02287922|37762188|FG002|Overall Study|Sponsor's decision|0|||
16819104|NCT02287922|37762189|FG003|Overall Study|Sponsor's decision|1|||
16819105|NCT02287922|37762186|FG000|Overall Study|Other|1|||
16819106|NCT02287922|37762187|FG001|Overall Study|Other|0|||
16819107|NCT02287922|37762188|FG002|Overall Study|Other|2|||
16819108|NCT02287922|37762189|FG003|Overall Study|Other|0|||
16819109|NCT02287610|37762200|FG000|Overall Study|Lost to Follow-up|3|||
16819110|NCT02287610|37762200|FG000|Overall Study|Withdrawal by Subject|8|||
16819111|NCT02287610|37762200|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
16819112|NCT02262728|37762206|FG000|Follow-up Phase (3 Years)|Death|0|||
16819113|NCT02262728|37762207|FG001|Follow-up Phase (3 Years)|Death|1|||
16819114|NCT02262728|37762206|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
16819115|NCT02262728|37762207|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
16819116|NCT02262728|37762206|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
16819117|NCT02262728|37762207|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
16819118|NCT02262260|37762215|FG000|Overall Study|Adverse Event|4|||
16819119|NCT02262260|37762216|FG001|Overall Study|Adverse Event|1|||
16819120|NCT02262260|37762215|FG000|Overall Study|Withdrawal of consent|4|||
16819121|NCT02262260|37762216|FG001|Overall Study|Withdrawal of consent|2|||
16819122|NCT02262260|37762215|FG000|Overall Study|Lost to Follow-up|1|||
16819123|NCT02262260|37762216|FG001|Overall Study|Lost to Follow-up|2|||
16819124|NCT02262260|37762215|FG000|Overall Study|Protocol deviation|2|||
16819125|NCT02262260|37762216|FG001|Overall Study|Protocol deviation|5|||
16819126|NCT02285270|37762222|FG000|Overall Study|Lost to Follow-up|1|||
16819127|NCT02285270|37762222|FG000|Overall Study|Physician Decision|3|||
16819128|NCT02285270|37762222|FG000|Overall Study|Determined to be ineligible|1|||
16819129|NCT01717768|37762236|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819130|NCT01717768|37762237|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
16819131|NCT01717768|37762238|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819132|NCT01717768|37762239|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819133|NCT01717768|37762240|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819134|NCT01717768|37762241|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819135|NCT01717768|37762242|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819136|NCT01717768|37762243|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819137|NCT01717768|37762244|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819138|NCT01717768|37762245|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819139|NCT01717768|37762246|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819140|NCT01717768|37762247|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16819141|NCT01717768|37762236|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819142|NCT01717768|37762237|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819143|NCT01717768|37762238|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819144|NCT01717768|37762239|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819145|NCT01717768|37762240|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819146|NCT01717768|37762241|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819147|NCT01717768|37762242|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819148|NCT01717768|37762243|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819149|NCT01717768|37762244|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819150|NCT01717768|37762245|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16819151|NCT01717768|37762246|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
17016660|NCT00600119|38161263|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
17016661|NCT00600119|38161264|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
17016662|NCT00600119|38161265|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
16819152|NCT01717768|37762247|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
16819153|NCT01717768|37762236|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
17102363|NCT00099632|38241297|FG005|Overall Study|Lost to Follow-up|0|||
17102364|NCT00099632|38241292|FG000|Overall Study|Withdrawal by Subject|0|||
17102365|NCT00099632|38241293|FG001|Overall Study|Withdrawal by Subject|1|||
17102366|NCT00099632|38241294|FG002|Overall Study|Withdrawal by Subject|0|||
17102367|NCT00099632|38241295|FG003|Overall Study|Withdrawal by Subject|0|||
16819154|NCT01717768|37762237|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819155|NCT01717768|37762238|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819156|NCT01717768|37762239|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819157|NCT01717768|37762240|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819158|NCT01717768|37762241|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819159|NCT01717768|37762242|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819160|NCT01717768|37762243|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
16819161|NCT01717768|37762244|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819162|NCT01717768|37762245|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819163|NCT01717768|37762246|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819164|NCT01717768|37762247|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16819165|NCT01717768|37762236|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819166|NCT01717768|37762237|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819167|NCT01717768|37762238|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819168|NCT01717768|37762239|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819169|NCT01717768|37762240|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819170|NCT01717768|37762241|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819171|NCT01717768|37762242|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819172|NCT01717768|37762243|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819173|NCT01717768|37762244|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819174|NCT01717768|37762245|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
16819175|NCT01717768|37762246|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819176|NCT01717768|37762247|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16819177|NCT02260934|37762275|FG000|Overall Study|Lost to Follow-up|2|||
16819178|NCT02260934|37762276|FG001|Overall Study|Lost to Follow-up|1|||
16819179|NCT02260934|37762275|FG000|Overall Study|Withdrawal by Subject|0|||
16819180|NCT02260934|37762276|FG001|Overall Study|Withdrawal by Subject|2|||
16819181|NCT02260934|37762275|FG000|Overall Study|Participant Relocated|1|||
16819182|NCT02260934|37762276|FG001|Overall Study|Participant Relocated|0|||
16819183|NCT02260934|37762275|FG000|Overall Study|Site error|0|||
16819184|NCT02260934|37762276|FG001|Overall Study|Site error|1|||
16819185|NCT02285114|37762292|FG000|Overall Study|Investigator's Discretion|0|||
16819186|NCT02285114|37762293|FG001|Overall Study|Investigator's Discretion|2|||
16819187|NCT02285114|37762294|FG002|Overall Study|Investigator's Discretion|0|||
16819188|NCT02285114|37762292|FG000|Overall Study|Withdrew Consent|0|||
16819189|NCT02285114|37762293|FG001|Overall Study|Withdrew Consent|0|||
16819190|NCT02285114|37762294|FG002|Overall Study|Withdrew Consent|1|||
16819191|NCT02285114|37762292|FG000|Overall Study|Enrolled but not treated|1|||
16819192|NCT02285114|37762293|FG001|Overall Study|Enrolled but not treated|0|||
16819193|NCT02285114|37762294|FG002|Overall Study|Enrolled but not treated|0|||
16819194|NCT02285114|37762292|FG000|Overall Study|Still on study|21|||
16819195|NCT02285114|37762293|FG001|Overall Study|Still on study|5|||
16819196|NCT02285114|37762294|FG002|Overall Study|Still on study|2|||
16819197|NCT02260388|37762312|FG000|Overall Study|Lost to Follow-up|2|||
16819198|NCT02260388|37762313|FG001|Overall Study|Lost to Follow-up|8|||
16819199|NCT02260388|37762314|FG002|Overall Study|Lost to Follow-up|3|||
16819200|NCT02260388|37762315|FG003|Overall Study|Lost to Follow-up|4|||
16819201|NCT02260154|37762325|FG000|Overall Study|Screening failure|2|||
16819202|NCT02284178|37762332|FG000|Overall Study|Met exclusion criteria|49|||
16819203|NCT02284178|37762333|FG001|Overall Study|Met exclusion criteria|54|||
16819204|NCT01643408|37762339|FG000|Overall Study|Adverse Event|12|||
16819205|NCT01643408|37762339|FG000|Overall Study|Other|2|||
16819206|NCT02283788|37762347|FG000|Overall Study|Adverse Event|1|||
16819207|NCT02283788|37762348|FG001|Overall Study|Adverse Event|3|||
16819208|NCT02283788|37762349|FG002|Overall Study|Adverse Event|5|||
16819209|NCT02283788|37762350|FG003|Overall Study|Adverse Event|1|||
16819210|NCT02283788|37762347|FG000|Overall Study|Withdrawal by Subject|0|||
17016663|NCT00600119|38161266|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
17016664|NCT00600119|38161267|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
17016665|NCT00600119|38161262|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
17016666|NCT00600119|38161263|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
16819211|NCT02283788|37762348|FG001|Overall Study|Withdrawal by Subject|1|||
16819212|NCT02283788|37762349|FG002|Overall Study|Withdrawal by Subject|0|||
16819213|NCT02283788|37762350|FG003|Overall Study|Withdrawal by Subject|1|||
16819214|NCT01739764|37762363|FG000|Overall Study|Adverse Event|0|||
16819215|NCT01739764|37762364|FG001|Overall Study|Adverse Event|3|||
16819216|NCT01739764|37762365|FG002|Overall Study|Adverse Event|4|||
16819217|NCT01739764|37762363|FG000|Overall Study|Death|4|||
16819218|NCT01739764|37762364|FG001|Overall Study|Death|6|||
16819219|NCT01739764|37762365|FG002|Overall Study|Death|38|||
16819220|NCT01739764|37762363|FG000|Overall Study|Lost to Follow-up|0|||
16819221|NCT01739764|37762364|FG001|Overall Study|Lost to Follow-up|0|||
16819222|NCT01739764|37762365|FG002|Overall Study|Lost to Follow-up|5|||
16819223|NCT01739764|37762363|FG000|Overall Study|Non-Compliance|0|||
16819224|NCT01739764|37762364|FG001|Overall Study|Non-Compliance|0|||
16819225|NCT01739764|37762365|FG002|Overall Study|Non-Compliance|1|||
16819226|NCT01739764|37762363|FG000|Overall Study|Multiple Reasons|3|||
16819227|NCT01739764|37762364|FG001|Overall Study|Multiple Reasons|2|||
16819228|NCT01739764|37762365|FG002|Overall Study|Multiple Reasons|3|||
16819229|NCT01739764|37762363|FG000|Overall Study|Physician Decision|2|||
16819230|NCT01739764|37762364|FG001|Overall Study|Physician Decision|2|||
16819231|NCT01739764|37762365|FG002|Overall Study|Physician Decision|4|||
16819232|NCT01739764|37762363|FG000|Overall Study|Progressive Disease|3|||
16819233|NCT01739764|37762364|FG001|Overall Study|Progressive Disease|5|||
16819234|NCT01739764|37762365|FG002|Overall Study|Progressive Disease|16|||
16819235|NCT01739764|37762363|FG000|Overall Study|Protocol Violation|0|||
16819236|NCT01739764|37762364|FG001|Overall Study|Protocol Violation|0|||
16819237|NCT01739764|37762365|FG002|Overall Study|Protocol Violation|2|||
16819238|NCT01739764|37762363|FG000|Overall Study|Study Terminated by Sponsor|8|||
16819239|NCT01739764|37762364|FG001|Overall Study|Study Terminated by Sponsor|13|||
16819240|NCT01739764|37762365|FG002|Overall Study|Study Terminated by Sponsor|26|||
16819241|NCT01739764|37762363|FG000|Overall Study|Withdrawal by Subject|6|||
16819242|NCT01739764|37762364|FG001|Overall Study|Withdrawal by Subject|5|||
16819243|NCT01739764|37762365|FG002|Overall Study|Withdrawal by Subject|27|||
16819244|NCT01700530|37762376|FG000|Overall Study|Withdrawal by Subject|0|||
16819245|NCT01700530|37762377|FG001|Overall Study|Withdrawal by Subject|3|||
16819246|NCT01700530|37762378|FG002|Overall Study|Withdrawal by Subject|1|||
16819247|NCT01700140|37762389|FG000|Overall Study|Use of rescue drugs|3|||
16819248|NCT01700140|37762390|FG001|Overall Study|Use of rescue drugs|3|||
16819249|NCT01700140|37762391|FG002|Overall Study|Use of rescue drugs|1|||
16819250|NCT01700140|37762389|FG000|Overall Study|Discontinuation of radiotherapy|1|||
16819251|NCT01700140|37762390|FG001|Overall Study|Discontinuation of radiotherapy|0|||
16819252|NCT01700140|37762391|FG002|Overall Study|Discontinuation of radiotherapy|0|||
16819253|NCT01700140|37762389|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
16819254|NCT01700140|37762390|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
16819255|NCT01700140|37762391|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
16819256|NCT01700140|37762389|FG000|Overall Study|Aggravation of symptoms|1|||
16819257|NCT01700140|37762390|FG001|Overall Study|Aggravation of symptoms|0|||
16819258|NCT01700140|37762391|FG002|Overall Study|Aggravation of symptoms|0|||
16819259|NCT01700140|37762389|FG000|Overall Study|Adverse Event|0|||
16819260|NCT01700140|37762390|FG001|Overall Study|Adverse Event|1|||
16819261|NCT01700140|37762391|FG002|Overall Study|Adverse Event|0|||
16819262|NCT01700140|37762389|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
16819263|NCT01700140|37762390|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
16819264|NCT01700140|37762391|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
16819265|NCT01717456|37762404|FG000|End of Treatment|Physician Decision|0|||
16819266|NCT01717456|37762405|FG001|End of Treatment|Physician Decision|1|||
16819267|NCT01717456|37762404|FG000|End of Treatment|Lost to Follow-up|0|||
16819268|NCT01717456|37762405|FG001|End of Treatment|Lost to Follow-up|1|||
16819269|NCT01717456|37762404|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
16819270|NCT01717456|37762405|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
16819271|NCT01699750|37762414|FG000|Overall Study|Withdrew Consent|0|||
16819272|NCT01699750|37762415|FG001|Overall Study|Withdrew Consent|1|||
16819273|NCT01699750|37762414|FG000|Overall Study|Other|0|||
16819274|NCT01699750|37762415|FG001|Overall Study|Other|2|||
16819275|NCT01716754|37762429|FG000|Overall Study|Death|0|||
16819276|NCT01716754|37762430|FG001|Overall Study|Death|0|||
16819277|NCT01716754|37762431|FG002|Overall Study|Death|0|||
16819278|NCT01716754|37762432|FG003|Overall Study|Death|1|||
16819279|NCT01716754|37762429|FG000|Overall Study|Protocol deviation|0|||
16819280|NCT01716754|37762430|FG001|Overall Study|Protocol deviation|2|||
16819281|NCT01716754|37762431|FG002|Overall Study|Protocol deviation|7|||
16819282|NCT01716754|37762432|FG003|Overall Study|Protocol deviation|2|||
16819283|NCT01716754|37762429|FG000|Overall Study|Non-compliance with study treatment|0|||
16911208|NCT01549860|38020317|FG000|Overall Study|Withdrawal by Subject|1|||
16819284|NCT01716754|37762430|FG001|Overall Study|Non-compliance with study treatment|0|||
16819285|NCT01716754|37762431|FG002|Overall Study|Non-compliance with study treatment|1|||
16819286|NCT01716754|37762432|FG003|Overall Study|Non-compliance with study treatment|0|||
16819287|NCT01716754|37762429|FG000|Overall Study|Physician Decision|1|||
16819288|NCT01716754|37762430|FG001|Overall Study|Physician Decision|0|||
16819289|NCT01716754|37762431|FG002|Overall Study|Physician Decision|0|||
16819290|NCT01716754|37762432|FG003|Overall Study|Physician Decision|0|||
16819291|NCT01716754|37762429|FG000|Overall Study|Lost to Follow-up|1|||
16819292|NCT01716754|37762430|FG001|Overall Study|Lost to Follow-up|0|||
16819293|NCT01716754|37762431|FG002|Overall Study|Lost to Follow-up|0|||
16819294|NCT01716754|37762432|FG003|Overall Study|Lost to Follow-up|1|||
16819295|NCT01716754|37762429|FG000|Overall Study|Adverse Event|4|||
16819296|NCT01716754|37762430|FG001|Overall Study|Adverse Event|2|||
16819297|NCT01716754|37762431|FG002|Overall Study|Adverse Event|2|||
16819298|NCT01716754|37762432|FG003|Overall Study|Adverse Event|1|||
16819299|NCT01716754|37762429|FG000|Overall Study|Withdrawal by Subject|5|||
16819300|NCT01716754|37762430|FG001|Overall Study|Withdrawal by Subject|0|||
16911209|NCT01549860|38020318|FG001|Overall Study|Withdrawal by Subject|0|||
16911210|NCT01549860|38020317|FG000|Overall Study|Physician Decision|1|||
16911211|NCT01549860|38020318|FG001|Overall Study|Physician Decision|1|||
16911212|NCT01549392|38020326|FG000|Overall Study|Withdrawal by Subject|1|||
16911213|NCT01549392|38020327|FG001|Overall Study|Withdrawal by Subject|0|||
16911214|NCT01574274|38020335|FG000|Overall Study|Ineligible|0|||
16911215|NCT01574274|38020336|FG001|Overall Study|Ineligible|1|||
16911216|NCT01574274|38020335|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
16911217|NCT01574274|38020336|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
16911218|NCT01574274|38020335|FG000|Overall Study|Ph+ B-ALL|3|||
16911219|NCT01574274|38020336|FG001|Overall Study|Ph+ B-ALL|4|||
16911220|NCT01574274|38020335|FG000|Overall Study|Induction Death|2|||
16911221|NCT01574274|38020336|FG001|Overall Study|Induction Death|0|||
16819301|NCT01716754|37762431|FG002|Overall Study|Withdrawal by Subject|4|||
16819302|NCT01716754|37762432|FG003|Overall Study|Withdrawal by Subject|3|||
16911222|NCT01574274|38020335|FG000|Overall Study|Induction Failure|4|||
16911223|NCT01574274|38020336|FG001|Overall Study|Induction Failure|1|||
16911224|NCT01574274|38020335|FG000|Overall Study|Adverse Event|16|||
16911225|NCT01574274|38020336|FG001|Overall Study|Adverse Event|13|||
16911226|NCT01574274|38020335|FG000|Overall Study|Remission Death|1|||
16911227|NCT01574274|38020336|FG001|Overall Study|Remission Death|0|||
16911228|NCT01574274|38020335|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
16819303|NCT01698814|37762443|FG000|Overall Study|Adverse Event|0|||
16819304|NCT01698814|37762444|FG001|Overall Study|Adverse Event|2|||
16819305|NCT01698814|37762443|FG000|Overall Study|Lost to Follow-up|0|||
16819306|NCT01698814|37762444|FG001|Overall Study|Lost to Follow-up|1|||
16819307|NCT01698814|37762443|FG000|Overall Study|Pregnancy|1|||
16819308|NCT01698814|37762444|FG001|Overall Study|Pregnancy|0|||
16911229|NCT01574274|38020336|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
16911230|NCT01574274|38020335|FG000|Overall Study|Other, unknown|3|||
16911231|NCT01574274|38020336|FG001|Overall Study|Other, unknown|2|||
16911232|NCT01526148|38020344|FG000|Overall Study|Adverse Event|6|||
16911233|NCT01526148|38020345|FG001|Overall Study|Adverse Event|5|||
16911234|NCT01526148|38020344|FG000|Overall Study|Lost to Follow-up|3|||
16911235|NCT01526148|38020345|FG001|Overall Study|Lost to Follow-up|6|||
16911236|NCT01526148|38020344|FG000|Overall Study|Withdrawal by Subject|2|||
16911237|NCT01526148|38020345|FG001|Overall Study|Withdrawal by Subject|0|||
16911238|NCT01526148|38020344|FG000|Overall Study|Unstable Medical Condition|1|||
16911239|NCT01526148|38020345|FG001|Overall Study|Unstable Medical Condition|0|||
16911240|NCT01526148|38020344|FG000|Overall Study|Unable to discontinue concomitant med|1|||
16911241|NCT01526148|38020345|FG001|Overall Study|Unable to discontinue concomitant med|0|||
16911242|NCT01526148|38020344|FG000|Overall Study|Moved out of state|1|||
16911243|NCT01526148|38020345|FG001|Overall Study|Moved out of state|0|||
16911244|NCT01526148|38020344|FG000|Overall Study|Incarcerated|0|||
16911245|NCT01526148|38020345|FG001|Overall Study|Incarcerated|2|||
16911246|NCT01572948|38020353|FG000|Overall Study|Lost to Follow-up|1|||
16911247|NCT01572948|38020354|FG001|Overall Study|Lost to Follow-up|0|||
16911248|NCT01572948|38020353|FG000|Overall Study|unable to contact|0|||
16911249|NCT01572948|38020354|FG001|Overall Study|unable to contact|1|||
16911250|NCT01525602|38020372|FG000|Overall Study|Adverse Event|1|||
16911251|NCT01525602|38020373|FG001|Overall Study|Adverse Event|0|||
16911252|NCT01525602|38020374|FG002|Overall Study|Adverse Event|1|||
16819309|NCT01698814|37762443|FG000|Overall Study|Randomized in error|1|||
16911253|NCT01525602|38020375|FG003|Overall Study|Adverse Event|1|||
16911254|NCT01525602|38020376|FG004|Overall Study|Adverse Event|3|||
16911255|NCT01525602|38020377|FG005|Overall Study|Adverse Event|3|||
16911256|NCT01525602|38020378|FG006|Overall Study|Adverse Event|0|||
16911257|NCT01525602|38020379|FG007|Overall Study|Adverse Event|1|||
16911258|NCT01525602|38020372|FG000|Overall Study|Disease progression|6|||
16911259|NCT01525602|38020373|FG001|Overall Study|Disease progression|3|||
16911260|NCT01525602|38020374|FG002|Overall Study|Disease progression|2|||
16911261|NCT01525602|38020375|FG003|Overall Study|Disease progression|5|||
16911262|NCT01525602|38020376|FG004|Overall Study|Disease progression|22|||
16911263|NCT01525602|38020377|FG005|Overall Study|Disease progression|2|||
16911264|NCT01525602|38020378|FG006|Overall Study|Disease progression|3|||
16819310|NCT01698814|37762444|FG001|Overall Study|Randomized in error|0|||
16819311|NCT01738984|37762452|FG000|Overall Study|Pregnancy|4|||
16819312|NCT01738984|37762453|FG001|Overall Study|Pregnancy|0|||
16819313|NCT01738984|37762452|FG000|Overall Study|Withdrawal by Subject|1|||
16819314|NCT01738984|37762453|FG001|Overall Study|Withdrawal by Subject|0|||
16819315|NCT01738984|37762452|FG000|Overall Study|Lost to Follow-up|59|||
16819316|NCT01738984|37762453|FG001|Overall Study|Lost to Follow-up|39|||
16819317|NCT01738594|37762462|FG000|Registration and Treatment Start|Adverse Event|0|||
16819318|NCT01738594|37762463|FG001|Registration and Treatment Start|Adverse Event|1|||
16819319|NCT01738594|37762464|FG002|Registration and Treatment Start|Adverse Event|0|||
16819320|NCT01738594|37762465|FG003|Registration and Treatment Start|Adverse Event|0|||
16819321|NCT01738594|37762466|FG004|Registration and Treatment Start|Adverse Event|0|||
16819322|NCT01738594|37762467|FG005|Registration and Treatment Start|Adverse Event|0|||
16819323|NCT01738594|37762468|FG006|Registration and Treatment Start|Adverse Event|0|||
16819324|NCT01738594|37762469|FG007|Registration and Treatment Start|Adverse Event|0|||
16819325|NCT01738594|37762462|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16819326|NCT01738594|37762463|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16819327|NCT01738594|37762464|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16819328|NCT01738594|37762465|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16819329|NCT01738594|37762466|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16819330|NCT01738594|37762467|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
16819331|NCT01738594|37762468|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16819332|NCT01738594|37762469|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16819333|NCT01738594|37762462|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
16819334|NCT01738594|37762463|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
16819335|NCT01738594|37762464|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
16819336|NCT01738594|37762465|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
16819337|NCT01738594|37762466|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
16819338|NCT01738594|37762467|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
16819339|NCT01738594|37762468|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
16819340|NCT01738594|37762469|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
16819341|NCT01738594|37762462|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16819342|NCT01738594|37762463|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16819343|NCT01738594|37762464|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16819344|NCT01738594|37762465|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16819345|NCT01738594|37762466|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16819346|NCT01738594|37762467|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
16819347|NCT01738594|37762468|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16819348|NCT01738594|37762469|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16819349|NCT01738594|37762462|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16819350|NCT01738594|37762463|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16819351|NCT01738594|37762464|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16819352|NCT01738594|37762465|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16819353|NCT01738594|37762466|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16819354|NCT01738594|37762467|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
16819355|NCT01738594|37762468|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16819356|NCT01738594|37762469|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16819357|NCT01738594|37762462|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16819358|NCT01738594|37762463|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16819359|NCT01738594|37762464|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16819360|NCT01738594|37762465|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16819361|NCT01738594|37762466|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
16819362|NCT01738594|37762467|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16819363|NCT01738594|37762468|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16819364|NCT01738594|37762469|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16819365|NCT01738594|37762462|FG000|Follow up for 1 Year|Death|0|||
16819366|NCT01738594|37762463|FG001|Follow up for 1 Year|Death|0|||
16819367|NCT01738594|37762464|FG002|Follow up for 1 Year|Death|0|||
16819368|NCT01738594|37762465|FG003|Follow up for 1 Year|Death|0|||
16819369|NCT01738594|37762466|FG004|Follow up for 1 Year|Death|0|||
16819370|NCT01738594|37762467|FG005|Follow up for 1 Year|Death|1|||
16819371|NCT01738594|37762468|FG006|Follow up for 1 Year|Death|0|||
16819372|NCT01738594|37762469|FG007|Follow up for 1 Year|Death|0|||
16819373|NCT01738594|37762462|FG000|Follow up for 1 Year|Other|0|||
16819374|NCT01738594|37762463|FG001|Follow up for 1 Year|Other|0|||
16819375|NCT01738594|37762464|FG002|Follow up for 1 Year|Other|0|||
16819376|NCT01738594|37762465|FG003|Follow up for 1 Year|Other|0|||
16819377|NCT01738594|37762466|FG004|Follow up for 1 Year|Other|0|||
16819378|NCT01738594|37762467|FG005|Follow up for 1 Year|Other|2|||
16819379|NCT01738594|37762468|FG006|Follow up for 1 Year|Other|0|||
16819380|NCT01738594|37762469|FG007|Follow up for 1 Year|Other|0|||
16819381|NCT01738438|37762479|FG000|Overall Study|Disease Progression|32|||
16819382|NCT01738438|37762479|FG000|Overall Study|Adverse Event|3|||
16819383|NCT01716520|37762483|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
16819384|NCT01716520|37762484|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
16819385|NCT01716520|37762485|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
16819386|NCT01716520|37762486|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
16819387|NCT01716520|37762487|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
16819388|NCT01716520|37762488|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
16819389|NCT01716520|37762483|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
16819390|NCT01716520|37762484|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
16819391|NCT01716520|37762485|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
16819392|NCT01716520|37762486|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
16819393|NCT01716520|37762487|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
16819394|NCT01716520|37762488|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
16819395|NCT01716520|37762483|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16819396|NCT01716520|37762484|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16819397|NCT01716520|37762485|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16819398|NCT01716520|37762486|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16819399|NCT01716520|37762487|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16819400|NCT01716520|37762488|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16819401|NCT01716520|37762483|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16819402|NCT01716520|37762484|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
16819403|NCT01716520|37762485|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16819404|NCT01716520|37762486|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16819405|NCT01716520|37762487|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16819406|NCT01716520|37762488|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16819407|NCT01716520|37762483|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16819408|NCT01716520|37762484|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16819409|NCT01716520|37762485|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16819410|NCT01716520|37762486|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16819411|NCT01716520|37762487|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16819412|NCT01716520|37762488|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
16819413|NCT01716520|37762483|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
16819414|NCT01716520|37762484|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
16819415|NCT01716520|37762485|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
16819416|NCT01716520|37762486|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
16819417|NCT01716520|37762487|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
16819418|NCT01716520|37762488|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
16819419|NCT01716520|37762483|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
16819420|NCT01716520|37762484|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
16819421|NCT01716520|37762485|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
16819422|NCT01716520|37762486|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
16819423|NCT01716520|37762487|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
16819424|NCT01716520|37762488|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
16819425|NCT01716520|37762483|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16819426|NCT01716520|37762484|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16819427|NCT01716520|37762485|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16819428|NCT01716520|37762486|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16819429|NCT01716520|37762487|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16819430|NCT01716520|37762488|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16819431|NCT01716520|37762483|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16819432|NCT01716520|37762484|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16819433|NCT01716520|37762485|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16819434|NCT01716520|37762486|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
16819435|NCT01716520|37762487|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16819436|NCT01716520|37762488|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16819437|NCT01716520|37762483|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
16819438|NCT01716520|37762484|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
16911265|NCT01525602|38020379|FG007|Overall Study|Disease progression|3|||
16911266|NCT01525602|38020372|FG000|Overall Study|Clinical progression|2|||
16911267|NCT01525602|38020373|FG001|Overall Study|Clinical progression|0|||
16911268|NCT01525602|38020374|FG002|Overall Study|Clinical progression|0|||
16911269|NCT01525602|38020375|FG003|Overall Study|Clinical progression|0|||
16911270|NCT01525602|38020376|FG004|Overall Study|Clinical progression|0|||
16911271|NCT01525602|38020377|FG005|Overall Study|Clinical progression|0|||
16911272|NCT01525602|38020378|FG006|Overall Study|Clinical progression|1|||
16819439|NCT01716520|37762485|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
16819440|NCT01716520|37762486|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
16819441|NCT01716520|37762487|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
16819442|NCT01716520|37762488|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
16819443|NCT01716520|37762483|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
16819444|NCT01716520|37762484|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16819445|NCT01716520|37762485|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16819446|NCT01716520|37762486|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16819447|NCT01716520|37762487|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16819448|NCT01716520|37762488|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16819449|NCT01716520|37762483|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16819450|NCT01716520|37762484|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16819451|NCT01716520|37762485|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16911273|NCT01525602|38020379|FG007|Overall Study|Clinical progression|1|||
16911274|NCT01525602|38020372|FG000|Overall Study|Non-compliance|0|||
16911275|NCT01525602|38020373|FG001|Overall Study|Non-compliance|0|||
16911276|NCT01525602|38020374|FG002|Overall Study|Non-compliance|0|||
16911277|NCT01525602|38020375|FG003|Overall Study|Non-compliance|0|||
16911278|NCT01525602|38020376|FG004|Overall Study|Non-compliance|1|||
16911279|NCT01525602|38020377|FG005|Overall Study|Non-compliance|0|||
16911280|NCT01525602|38020378|FG006|Overall Study|Non-compliance|0|||
16911281|NCT01525602|38020379|FG007|Overall Study|Non-compliance|0|||
16819452|NCT01716520|37762486|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16819453|NCT01716520|37762487|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16819454|NCT01716520|37762488|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
16819455|NCT01716520|37762483|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16819456|NCT01716520|37762484|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
16819457|NCT01716520|37762485|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16819458|NCT01716520|37762486|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16819459|NCT01716520|37762487|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16819460|NCT01716520|37762488|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16819461|NCT01716520|37762483|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16819462|NCT01716520|37762484|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16819463|NCT01716520|37762485|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16819464|NCT01716520|37762486|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16819465|NCT01716520|37762487|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16819466|NCT01716520|37762488|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
16819467|NCT01716520|37762483|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16819468|NCT01716520|37762484|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16819469|NCT01716520|37762485|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
16819470|NCT01716520|37762486|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16819471|NCT01716520|37762487|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16819472|NCT01716520|37762488|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16819473|NCT01698268|37762498|FG000|Overall Study|Physician Decision|2|||
16819474|NCT01698268|37762499|FG001|Overall Study|Physician Decision|1|||
16819475|NCT01697956|37762507|FG000|Overall Study|Protocol Violation|1|||
16819476|NCT01697956|37762508|FG001|Overall Study|Protocol Violation|1|||
16819477|NCT01697800|37762522|FG000|Overall Study|Death|0|||
16819478|NCT01697800|37762523|FG001|Overall Study|Death|1|||
16819479|NCT01644500|37762532|FG000|Overall Study|Adverse Event|6|||
16819480|NCT01644500|37762533|FG001|Overall Study|Adverse Event|1|||
16819481|NCT01644500|37762534|FG002|Overall Study|Adverse Event|2|||
16819482|NCT01644500|37762532|FG000|Overall Study|Death|0|||
16819483|NCT01644500|37762533|FG001|Overall Study|Death|1|||
16819484|NCT01644500|37762534|FG002|Overall Study|Death|0|||
16819485|NCT01644500|37762532|FG000|Overall Study|Lost to Follow-up|3|||
16819486|NCT01644500|37762533|FG001|Overall Study|Lost to Follow-up|8|||
16819487|NCT01644500|37762534|FG002|Overall Study|Lost to Follow-up|0|||
16819488|NCT01644500|37762532|FG000|Overall Study|Protocol Violation|1|||
16819489|NCT01644500|37762533|FG001|Overall Study|Protocol Violation|1|||
16819490|NCT01644500|37762534|FG002|Overall Study|Protocol Violation|0|||
16819491|NCT01644500|37762532|FG000|Overall Study|Withdrawal by Subject|11|||
16819492|NCT01644500|37762533|FG001|Overall Study|Withdrawal by Subject|12|||
16819493|NCT01644500|37762534|FG002|Overall Study|Withdrawal by Subject|12|||
16819494|NCT01644500|37762532|FG000|Overall Study|Physician Decision|1|||
16819495|NCT01644500|37762533|FG001|Overall Study|Physician Decision|1|||
16819496|NCT01644500|37762534|FG002|Overall Study|Physician Decision|1|||
16819497|NCT01604824|37762546|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16819498|NCT01604824|37762547|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16819499|NCT01604824|37762548|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16911282|NCT01525602|38020372|FG000|Overall Study|Withdrawal by Subject|0|||
16911283|NCT01525602|38020373|FG001|Overall Study|Withdrawal by Subject|0|||
16819500|NCT01604824|37762549|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16819501|NCT01604824|37762550|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
16819502|NCT01604824|37762551|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16819503|NCT01604824|37762546|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
16819504|NCT01604824|37762547|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
16819505|NCT01604824|37762548|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
16819506|NCT01604824|37762549|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
16819507|NCT01604824|37762550|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
16819508|NCT01604824|37762551|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
16819509|NCT01716052|37762565|FG000|Overall Study|Withdrawal of funding|1|||
16819510|NCT01716052|37762566|FG001|Overall Study|Withdrawal of funding|1|||
16819511|NCT01641692|37762572|FG000|Treatment Period 1|Adverse Event|1|||
16819512|NCT01641692|37762573|FG001|Treatment Period 1|Adverse Event|0|||
16819513|NCT01641692|37762574|FG002|Treatment Period 1|Adverse Event|0|||
16819514|NCT01641692|37762575|FG003|Treatment Period 1|Adverse Event|0|||
16819515|NCT01641692|37762576|FG004|Treatment Period 1|Adverse Event|0|||
16819516|NCT01641692|37762577|FG005|Treatment Period 1|Adverse Event|0|||
16819517|NCT01641692|37762578|FG006|Treatment Period 1|Adverse Event|0|||
16819518|NCT01641692|37762579|FG007|Treatment Period 1|Adverse Event|0|||
16819519|NCT01641692|37762572|FG000|Treatment Period 1|Lack of Efficacy|0|||
16819520|NCT01641692|37762573|FG001|Treatment Period 1|Lack of Efficacy|0|||
16819521|NCT01641692|37762574|FG002|Treatment Period 1|Lack of Efficacy|0|||
16819522|NCT01641692|37762575|FG003|Treatment Period 1|Lack of Efficacy|0|||
16819523|NCT01641692|37762576|FG004|Treatment Period 1|Lack of Efficacy|0|||
16819524|NCT01641692|37762577|FG005|Treatment Period 1|Lack of Efficacy|0|||
16819525|NCT01641692|37762578|FG006|Treatment Period 1|Lack of Efficacy|0|||
16819526|NCT01641692|37762579|FG007|Treatment Period 1|Lack of Efficacy|1|||
16819527|NCT01641692|37762572|FG000|Treatment Period 1|Protocol Violation|1|||
16819528|NCT01641692|37762573|FG001|Treatment Period 1|Protocol Violation|0|||
16819529|NCT01641692|37762574|FG002|Treatment Period 1|Protocol Violation|0|||
16819530|NCT01641692|37762575|FG003|Treatment Period 1|Protocol Violation|0|||
16819531|NCT01641692|37762576|FG004|Treatment Period 1|Protocol Violation|2|||
16819532|NCT01641692|37762577|FG005|Treatment Period 1|Protocol Violation|0|||
16819533|NCT01641692|37762578|FG006|Treatment Period 1|Protocol Violation|0|||
16819534|NCT01641692|37762579|FG007|Treatment Period 1|Protocol Violation|0|||
16819535|NCT01641692|37762572|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16819536|NCT01641692|37762573|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16819537|NCT01641692|37762574|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16819538|NCT01641692|37762575|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16819539|NCT01641692|37762576|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
16819540|NCT01641692|37762577|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16819541|NCT01641692|37762578|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16819542|NCT01641692|37762579|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
16819543|NCT01641692|37762572|FG000|Treatment Period 1|Lost to Follow-up|0|||
16819544|NCT01641692|37762573|FG001|Treatment Period 1|Lost to Follow-up|0|||
16819545|NCT01641692|37762574|FG002|Treatment Period 1|Lost to Follow-up|1|||
16819546|NCT01641692|37762575|FG003|Treatment Period 1|Lost to Follow-up|0|||
16819547|NCT01641692|37762576|FG004|Treatment Period 1|Lost to Follow-up|0|||
16819548|NCT01641692|37762577|FG005|Treatment Period 1|Lost to Follow-up|0|||
16819549|NCT01641692|37762578|FG006|Treatment Period 1|Lost to Follow-up|0|||
16819550|NCT01641692|37762579|FG007|Treatment Period 1|Lost to Follow-up|0|||
16819551|NCT01641692|37762572|FG000|Treatment Period 1|Physician Decision|0|||
16819552|NCT01641692|37762573|FG001|Treatment Period 1|Physician Decision|0|||
16819553|NCT01641692|37762574|FG002|Treatment Period 1|Physician Decision|0|||
16819554|NCT01641692|37762575|FG003|Treatment Period 1|Physician Decision|0|||
16819555|NCT01641692|37762576|FG004|Treatment Period 1|Physician Decision|1|||
16819556|NCT01641692|37762577|FG005|Treatment Period 1|Physician Decision|0|||
16819557|NCT01641692|37762578|FG006|Treatment Period 1|Physician Decision|0|||
16819558|NCT01641692|37762579|FG007|Treatment Period 1|Physician Decision|0|||
16819559|NCT01641692|37762572|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16819560|NCT01641692|37762573|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16819561|NCT01641692|37762574|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16819562|NCT01641692|37762575|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16819563|NCT01641692|37762576|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16819564|NCT01641692|37762577|FG005|Treatment Period 1|Withdrawal by Subject|2|||
16819565|NCT01641692|37762578|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16819566|NCT01641692|37762579|FG007|Treatment Period 1|Withdrawal by Subject|1|||
16819567|NCT01641692|37762572|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
16819568|NCT01641692|37762573|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16819569|NCT01641692|37762574|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16819570|NCT01641692|37762575|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16819571|NCT01641692|37762576|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16819572|NCT01641692|37762577|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16819573|NCT01641692|37762578|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16819574|NCT01641692|37762579|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16819575|NCT01641692|37762572|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16819576|NCT01641692|37762573|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16819577|NCT01641692|37762574|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16819578|NCT01641692|37762575|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16819579|NCT01641692|37762576|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16819580|NCT01641692|37762577|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16819581|NCT01641692|37762578|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
16819582|NCT01641692|37762579|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16819583|NCT01641692|37762572|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
16819584|NCT01641692|37762573|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819585|NCT01641692|37762574|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
16819586|NCT01641692|37762575|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
16819587|NCT01641692|37762576|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
16819588|NCT01641692|37762577|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819589|NCT01641692|37762578|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819590|NCT01641692|37762579|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
16819591|NCT01641692|37762572|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16819592|NCT01641692|37762573|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16819593|NCT01641692|37762574|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16819594|NCT01641692|37762575|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16819595|NCT01641692|37762576|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16819596|NCT01641692|37762577|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16819597|NCT01641692|37762578|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16819598|NCT01641692|37762579|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16819599|NCT01641692|37762572|FG000|Treatment Period 2|Lack of Efficacy|1|||
16819600|NCT01641692|37762573|FG001|Treatment Period 2|Lack of Efficacy|0|||
16819601|NCT01641692|37762574|FG002|Treatment Period 2|Lack of Efficacy|0|||
16819602|NCT01641692|37762575|FG003|Treatment Period 2|Lack of Efficacy|0|||
16819603|NCT01641692|37762576|FG004|Treatment Period 2|Lack of Efficacy|0|||
16819604|NCT01641692|37762577|FG005|Treatment Period 2|Lack of Efficacy|0|||
16819605|NCT01641692|37762578|FG006|Treatment Period 2|Lack of Efficacy|0|||
16819606|NCT01641692|37762579|FG007|Treatment Period 2|Lack of Efficacy|0|||
16819607|NCT01641692|37762572|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
16819608|NCT01641692|37762573|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16819609|NCT01641692|37762574|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16819610|NCT01641692|37762575|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16819611|NCT01641692|37762576|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16819612|NCT01641692|37762577|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16819613|NCT01641692|37762578|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16819614|NCT01641692|37762579|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16819615|NCT01641692|37762572|FG000|Treatment Period 2|Lost to Follow-up|0|||
16819616|NCT01641692|37762573|FG001|Treatment Period 2|Lost to Follow-up|0|||
16819617|NCT01641692|37762574|FG002|Treatment Period 2|Lost to Follow-up|0|||
16819618|NCT01641692|37762575|FG003|Treatment Period 2|Lost to Follow-up|0|||
16819619|NCT01641692|37762576|FG004|Treatment Period 2|Lost to Follow-up|0|||
16819620|NCT01641692|37762577|FG005|Treatment Period 2|Lost to Follow-up|1|||
16819621|NCT01641692|37762578|FG006|Treatment Period 2|Lost to Follow-up|0|||
16819622|NCT01641692|37762579|FG007|Treatment Period 2|Lost to Follow-up|0|||
16819623|NCT01641692|37762572|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16819624|NCT01641692|37762573|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16819625|NCT01641692|37762574|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16819626|NCT01641692|37762575|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16819627|NCT01641692|37762576|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16819628|NCT01641692|37762577|FG005|Treatment Period 2|Withdrawal by Subject|1|||
16819629|NCT01641692|37762578|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16819630|NCT01641692|37762579|FG007|Treatment Period 2|Withdrawal by Subject|1|||
16819631|NCT01641692|37762572|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819632|NCT01641692|37762573|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819633|NCT01641692|37762574|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819634|NCT01641692|37762575|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819635|NCT01641692|37762576|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
16819636|NCT01641692|37762577|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819637|NCT01641692|37762578|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
16819638|NCT01641692|37762579|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16819639|NCT01641692|37762572|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16819640|NCT01641692|37762573|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16819641|NCT01641692|37762574|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16819642|NCT01641692|37762575|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16819643|NCT01641692|37762576|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16819644|NCT01641692|37762577|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16819645|NCT01641692|37762578|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16819646|NCT01641692|37762579|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16819647|NCT01641692|37762572|FG000|Treatment Period 3|Adverse Event|0|||
16819648|NCT01641692|37762573|FG001|Treatment Period 3|Adverse Event|0|||
16819649|NCT01641692|37762574|FG002|Treatment Period 3|Adverse Event|0|||
16819650|NCT01641692|37762575|FG003|Treatment Period 3|Adverse Event|0|||
16819651|NCT01641692|37762576|FG004|Treatment Period 3|Adverse Event|0|||
16819652|NCT01641692|37762577|FG005|Treatment Period 3|Adverse Event|0|||
16819653|NCT01641692|37762578|FG006|Treatment Period 3|Adverse Event|1|||
16819654|NCT01641692|37762579|FG007|Treatment Period 3|Adverse Event|0|||
16819655|NCT01641692|37762572|FG000|Treatment Period 3|Protocol Violation|0|||
16819656|NCT01641692|37762573|FG001|Treatment Period 3|Protocol Violation|0|||
16819657|NCT01641692|37762574|FG002|Treatment Period 3|Protocol Violation|1|||
16819658|NCT01641692|37762575|FG003|Treatment Period 3|Protocol Violation|0|||
16819659|NCT01641692|37762576|FG004|Treatment Period 3|Protocol Violation|0|||
16819660|NCT01641692|37762577|FG005|Treatment Period 3|Protocol Violation|0|||
16819661|NCT01641692|37762578|FG006|Treatment Period 3|Protocol Violation|0|||
16819662|NCT01641692|37762579|FG007|Treatment Period 3|Protocol Violation|0|||
16819663|NCT01641692|37762572|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16819664|NCT01641692|37762573|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16819665|NCT01641692|37762574|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16819666|NCT01641692|37762575|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16819667|NCT01641692|37762576|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16819668|NCT01641692|37762577|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16819669|NCT01641692|37762578|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
16819670|NCT01641692|37762579|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16819671|NCT01641692|37762572|FG000|Treatment Period 3|Lost to Follow-up|0|||
16819672|NCT01641692|37762573|FG001|Treatment Period 3|Lost to Follow-up|1|||
16819673|NCT01641692|37762574|FG002|Treatment Period 3|Lost to Follow-up|0|||
16819674|NCT01641692|37762575|FG003|Treatment Period 3|Lost to Follow-up|0|||
16819675|NCT01641692|37762576|FG004|Treatment Period 3|Lost to Follow-up|0|||
16819676|NCT01641692|37762577|FG005|Treatment Period 3|Lost to Follow-up|0|||
16819677|NCT01641692|37762578|FG006|Treatment Period 3|Lost to Follow-up|0|||
16819678|NCT01641692|37762579|FG007|Treatment Period 3|Lost to Follow-up|0|||
16819679|NCT01641692|37762572|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
16819680|NCT01641692|37762573|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
16819681|NCT01641692|37762574|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
16819682|NCT01641692|37762575|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
16819683|NCT01641692|37762576|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
16819684|NCT01641692|37762577|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
16819685|NCT01641692|37762578|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
16819686|NCT01641692|37762579|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
16819687|NCT01641692|37762572|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16819688|NCT01641692|37762573|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
16819689|NCT01641692|37762574|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16819690|NCT01641692|37762575|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16819691|NCT01641692|37762576|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
16819692|NCT01641692|37762577|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16819693|NCT01641692|37762578|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16819694|NCT01641692|37762579|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
16819695|NCT01682512|37762601|FG000|Overall Study|Adverse Event|6|||
16819696|NCT01682512|37762602|FG001|Overall Study|Adverse Event|5|||
16819697|NCT01682512|37762603|FG002|Overall Study|Adverse Event|2|||
16819698|NCT01682512|37762601|FG000|Overall Study|Withdrawal by Subject|2|||
16819699|NCT01682512|37762602|FG001|Overall Study|Withdrawal by Subject|6|||
16819700|NCT01682512|37762603|FG002|Overall Study|Withdrawal by Subject|3|||
16819701|NCT01682512|37762601|FG000|Overall Study|Physician Decision|0|||
16819702|NCT01682512|37762602|FG001|Overall Study|Physician Decision|2|||
16819703|NCT01682512|37762603|FG002|Overall Study|Physician Decision|0|||
16819704|NCT01682512|37762601|FG000|Overall Study|Study terminated by sponsor|46|||
16819705|NCT01682512|37762602|FG001|Overall Study|Study terminated by sponsor|43|||
16819706|NCT01682512|37762603|FG002|Overall Study|Study terminated by sponsor|0|||
16819707|NCT01682512|37762601|FG000|Overall Study|Lost to Follow-up|3|||
16819708|NCT01682512|37762602|FG001|Overall Study|Lost to Follow-up|0|||
16819709|NCT01682512|37762603|FG002|Overall Study|Lost to Follow-up|2|||
16819710|NCT01682512|37762601|FG000|Overall Study|Protocol Violation|2|||
16819711|NCT01682512|37762602|FG001|Overall Study|Protocol Violation|3|||
16819712|NCT01682512|37762603|FG002|Overall Study|Protocol Violation|2|||
16819713|NCT01682512|37762601|FG000|Overall Study|Primary lack of efficacy|10|||
16819714|NCT01682512|37762602|FG001|Overall Study|Primary lack of efficacy|7|||
16819715|NCT01682512|37762603|FG002|Overall Study|Primary lack of efficacy|7|||
16819716|NCT01682512|37762601|FG000|Overall Study|Secondary lack of efficacy|1|||
16819717|NCT01682512|37762602|FG001|Overall Study|Secondary lack of efficacy|1|||
16819718|NCT01682512|37762603|FG002|Overall Study|Secondary lack of efficacy|0|||
16819719|NCT01682512|37762601|FG000|Overall Study|Other than stated above|2|||
16819720|NCT01682512|37762602|FG001|Overall Study|Other than stated above|4|||
16819721|NCT01682512|37762603|FG002|Overall Study|Other than stated above|2|||
16819722|NCT02256488|37762615|FG000|Overall Study|Lost to Follow-up|6|||
16819723|NCT02256488|37762616|FG001|Overall Study|Lost to Follow-up|6|||
16819724|NCT02256488|37762617|FG002|Overall Study|Lost to Follow-up|9|||
16819725|NCT02256488|37762618|FG003|Overall Study|Lost to Follow-up|3|||
16819726|NCT02256488|37762615|FG000|Overall Study|OTHER|1|||
16819727|NCT02256488|37762616|FG001|Overall Study|OTHER|0|||
16819728|NCT02256488|37762617|FG002|Overall Study|OTHER|1|||
16819729|NCT02256488|37762618|FG003|Overall Study|OTHER|1|||
16819730|NCT02256488|37762615|FG000|Overall Study|Withdrawal by Subject|1|||
16819731|NCT02256488|37762616|FG001|Overall Study|Withdrawal by Subject|0|||
16819732|NCT02256488|37762617|FG002|Overall Study|Withdrawal by Subject|0|||
16819733|NCT02256488|37762618|FG003|Overall Study|Withdrawal by Subject|2|||
16819734|NCT01715896|37762631|FG000|Overall Study|Lost to Follow-up|0|||
16819735|NCT01715896|37762632|FG001|Overall Study|Lost to Follow-up|2|||
16819736|NCT01715896|37762631|FG000|Overall Study|Withdrawal by Subject|1|||
16819737|NCT01715896|37762632|FG001|Overall Study|Withdrawal by Subject|4|||
16819738|NCT01715896|37762631|FG000|Overall Study|Other|2|||
16819739|NCT01715896|37762632|FG001|Overall Study|Other|5|||
16819740|NCT02255552|37762641|FG000|Overall Study|Participants enrolled into another study|0|||
16819741|NCT02255552|37762642|FG001|Overall Study|Participants enrolled into another study|11|||
16819742|NCT02255552|37762641|FG000|Overall Study|Withdrawal by Subject|1|||
16819743|NCT02255552|37762642|FG001|Overall Study|Withdrawal by Subject|4|||
16819744|NCT01714726|37762650|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
16819745|NCT01714726|37762651|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
16819746|NCT01714726|37762652|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
16819747|NCT01714726|37762653|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
16819748|NCT01714726|37762650|FG000|Double-Blinded Induction Period|Adverse Event|0|||
16819749|NCT01714726|37762651|FG001|Double-Blinded Induction Period|Adverse Event|1|||
16819750|NCT01714726|37762652|FG002|Double-Blinded Induction Period|Adverse Event|0|||
16819751|NCT01714726|37762653|FG003|Double-Blinded Induction Period|Adverse Event|0|||
16819752|NCT01714726|37762650|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
16819753|NCT01714726|37762651|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
16819754|NCT01714726|37762652|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
16819755|NCT01714726|37762653|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
16819756|NCT01714726|37762650|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
16819757|NCT01714726|37762651|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
16819758|NCT01714726|37762652|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
16819759|NCT01714726|37762653|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
16819760|NCT01714726|37762650|FG000|Open-Label Period|Other|0|||
16819761|NCT01714726|37762651|FG001|Open-Label Period|Other|0|||
16819762|NCT01714726|37762652|FG002|Open-Label Period|Other|1|||
16819763|NCT01714726|37762653|FG003|Open-Label Period|Other|3|||
16819764|NCT01714726|37762650|FG000|Open-Label Period|Adverse Event|0|||
16819765|NCT01714726|37762651|FG001|Open-Label Period|Adverse Event|0|||
16819766|NCT01714726|37762652|FG002|Open-Label Period|Adverse Event|1|||
16819767|NCT01714726|37762653|FG003|Open-Label Period|Adverse Event|0|||
16819768|NCT01714726|37762650|FG000|Open-Label Period|Withdrawal by Subject|0|||
16819769|NCT01714726|37762651|FG001|Open-Label Period|Withdrawal by Subject|0|||
16819770|NCT01714726|37762652|FG002|Open-Label Period|Withdrawal by Subject|9|||
16819771|NCT01714726|37762653|FG003|Open-Label Period|Withdrawal by Subject|19|||
16819772|NCT01714726|37762650|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
16819773|NCT01714726|37762651|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
16819774|NCT01714726|37762652|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
16819775|NCT01714726|37762653|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
16819776|NCT01714726|37762650|FG000|Open-Label Period|Lost to Follow-up|0|||
16819777|NCT01714726|37762651|FG001|Open-Label Period|Lost to Follow-up|0|||
16819778|NCT01714726|37762652|FG002|Open-Label Period|Lost to Follow-up|3|||
16819779|NCT01714726|37762653|FG003|Open-Label Period|Lost to Follow-up|4|||
16819780|NCT02255474|37762666|FG000|Overall Study|Lost to Follow-up|1|||
16819781|NCT02255474|37762667|FG001|Overall Study|Lost to Follow-up|1|||
16819782|NCT02255474|37762668|FG002|Overall Study|Lost to Follow-up|3|||
16819783|NCT02255474|37762666|FG000|Overall Study|Withdrawal by Subject|1|||
16819784|NCT02255474|37762667|FG001|Overall Study|Withdrawal by Subject|1|||
16819785|NCT02255474|37762668|FG002|Overall Study|Withdrawal by Subject|0|||
16819786|NCT02254772|37762677|FG000|Overall Study|Ineligible|1|||
16819787|NCT02254772|37762677|FG000|Overall Study|Withdrawal by Subject|1|||
16819788|NCT02254460|37762681|FG000|Overall Study|Adverse Event|1|||
16819789|NCT02254460|37762682|FG001|Overall Study|Adverse Event|0|||
16819790|NCT01682044|37762688|FG000|Overall Study|Death|1|||
16819791|NCT01682044|37762688|FG000|Overall Study|Progression|3|||
16819792|NCT01696942|37762694|FG000|Overall Study|Withdrawal by Subject|1|||
16819793|NCT01696942|37762695|FG001|Overall Study|Withdrawal by Subject|0|||
16819794|NCT01696942|37762694|FG000|Overall Study|Protocol Violation|1|||
16819795|NCT01696942|37762695|FG001|Overall Study|Protocol Violation|2|||
16819796|NCT01696942|37762694|FG000|Overall Study|screen failure|0|||
16819797|NCT01696942|37762695|FG001|Overall Study|screen failure|1|||
16819798|NCT01640366|37762701|FG000|Overall Study|Withdrawal by Subject|1|||
16819799|NCT01640366|37762701|FG000|Overall Study|Protocol Violation|16|||
16819800|NCT01640366|37762701|FG000|Overall Study|Lost to Follow-up|5|||
16819801|NCT01640288|37762709|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
16819802|NCT01640288|37762710|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
16819803|NCT01640288|37762709|FG000|Overall Study|Screen Failure|20|||
16819804|NCT01640288|37762710|FG001|Overall Study|Screen Failure|18|||
16819805|NCT01640288|37762709|FG000|Overall Study|Withdrawn by PI|5|||
16819806|NCT01640288|37762710|FG001|Overall Study|Withdrawn by PI|0|||
16819807|NCT01640288|37762709|FG000|Overall Study|Withdrawal by Subject|1|||
16819808|NCT01640288|37762710|FG001|Overall Study|Withdrawal by Subject|0|||
16819809|NCT01639040|37762719|FG000|Overall Study|Adverse Event|1|||
16819810|NCT01639040|37762720|FG001|Overall Study|Adverse Event|0|||
16819811|NCT01640054|37762729|FG000|Overall Study|Study-specific disc criteria|1|||
16819812|NCT01640054|37762729|FG000|Overall Study|Lack of Efficacy|3|||
16819813|NCT01640054|37762729|FG000|Overall Study|Adverse Event|2|||
16819814|NCT01600586|37762735|FG000|Overall Study|Physician Decision|3|||
16819815|NCT01600586|37762736|FG001|Overall Study|Physician Decision|3|||
16819816|NCT01639742|37762749|FG000|Overall Study|Study Ongoing|17|||
16819817|NCT01639742|37762749|FG000|Overall Study|Lost to Follow-up|1|||
16819818|NCT02164513|37762756|FG000|Overall Study|Adverse Event|162|||
16819819|NCT02164513|37762757|FG001|Overall Study|Adverse Event|180|||
16819820|NCT02164513|37762758|FG002|Overall Study|Adverse Event|111|||
16819821|NCT02164513|37762756|FG000|Overall Study|Other: Study Closed or terminated|5|||
16819822|NCT02164513|37762757|FG001|Overall Study|Other: Study Closed or terminated|2|||
16819823|NCT02164513|37762758|FG002|Overall Study|Other: Study Closed or terminated|4|||
16819824|NCT02164513|37762756|FG000|Overall Study|Lost to Follow-up|30|||
16819825|NCT02164513|37762757|FG001|Overall Study|Lost to Follow-up|36|||
16819826|NCT02164513|37762758|FG002|Overall Study|Lost to Follow-up|22|||
16819827|NCT02164513|37762756|FG000|Overall Study|Physician Decision|47|||
16819828|NCT02164513|37762757|FG001|Overall Study|Physician Decision|57|||
16819829|NCT02164513|37762758|FG002|Overall Study|Physician Decision|28|||
16819830|NCT02164513|37762756|FG000|Overall Study|Withdrawal by Subject|192|||
16819831|NCT02164513|37762757|FG001|Overall Study|Withdrawal by Subject|261|||
16819832|NCT02164513|37762758|FG002|Overall Study|Withdrawal by Subject|130|||
16819833|NCT02164513|37762756|FG000|Overall Study|Other: Reason not provided by site|1|||
16819834|NCT02164513|37762757|FG001|Overall Study|Other: Reason not provided by site|0|||
16819835|NCT02164513|37762758|FG002|Overall Study|Other: Reason not provided by site|0|||
16819836|NCT02218489|37762769|FG000|Overall Study|Withdrawal by Subject|4|||
16819837|NCT02218489|37762770|FG001|Overall Study|Withdrawal by Subject|3|||
16819838|NCT02218489|37762769|FG000|Overall Study|Lost to Follow-up|1|||
16819839|NCT02218489|37762770|FG001|Overall Study|Lost to Follow-up|0|||
16819840|NCT02192905|37762777|FG000|Overall Study|Lost to Follow-up|1|||
16819841|NCT01713946|37762785|FG000|Overall Study|Death|0|||
16819842|NCT01713946|37762786|FG001|Overall Study|Death|2|||
16819843|NCT01713946|37762787|FG002|Overall Study|Death|2|||
16819844|NCT01713946|37762785|FG000|Overall Study|Adverse Event|19|||
16819845|NCT01713946|37762786|FG001|Overall Study|Adverse Event|14|||
16819846|NCT01713946|37762787|FG002|Overall Study|Adverse Event|13|||
16819847|NCT01713946|37762785|FG000|Overall Study|Withdrawal by Subject|12|||
16819848|NCT01713946|37762786|FG001|Overall Study|Withdrawal by Subject|12|||
16819849|NCT01713946|37762787|FG002|Overall Study|Withdrawal by Subject|8|||
16819850|NCT01713946|37762785|FG000|Overall Study|Lack of Efficacy|8|||
16819851|NCT01713946|37762786|FG001|Overall Study|Lack of Efficacy|8|||
16819852|NCT01713946|37762787|FG002|Overall Study|Lack of Efficacy|14|||
16819853|NCT01713946|37762785|FG000|Overall Study|Protocol Violation|2|||
16911284|NCT01525602|38020374|FG002|Overall Study|Withdrawal by Subject|0|||
16819854|NCT01713946|37762786|FG001|Overall Study|Protocol Violation|4|||
16819855|NCT01713946|37762787|FG002|Overall Study|Protocol Violation|1|||
16819856|NCT01713946|37762785|FG000|Overall Study|Lost to Follow-up|0|||
16819857|NCT01713946|37762786|FG001|Overall Study|Lost to Follow-up|0|||
16819858|NCT01713946|37762787|FG002|Overall Study|Lost to Follow-up|1|||
16819859|NCT01713946|37762785|FG000|Overall Study|Administrative problems|1|||
16819860|NCT01713946|37762786|FG001|Overall Study|Administrative problems|0|||
16819861|NCT01713946|37762787|FG002|Overall Study|Administrative problems|0|||
16819862|NCT01713946|37762785|FG000|Overall Study|Did not continue in Ext|0|||
16819863|NCT01713946|37762786|FG001|Overall Study|Did not continue in Ext|3|||
16819864|NCT01713946|37762787|FG002|Overall Study|Did not continue in Ext|0|||
16819865|NCT01713946|37762785|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
16819866|NCT01713946|37762786|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
16819867|NCT01713946|37762787|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
16819868|NCT01713946|37762785|FG000|Overall Study|Patients never switched to everolimus|0|||
16819869|NCT01713946|37762786|FG001|Overall Study|Patients never switched to everolimus|0|||
16819870|NCT01713946|37762787|FG002|Overall Study|Patients never switched to everolimus|5|||
16819871|NCT02163499|37762813|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
16819872|NCT02163499|37762813|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
16819873|NCT02163499|37762813|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
16819874|NCT02163499|37762813|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
16819875|NCT02163499|37762813|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
16819876|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
16819877|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
16819878|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
16819879|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
16819880|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
16819881|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
16819882|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
16819883|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
16819884|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
16819885|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Death|8|||
16819886|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
16819887|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
16819888|NCT02163499|37762813|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
16819889|NCT02163187|37762823|FG000|Overall Study|Device removed|1|||
16819890|NCT02163187|37762824|FG001|Overall Study|Device removed|0|||
16819891|NCT02163187|37762823|FG000|Overall Study|Progressive disease|1|||
16819892|NCT02163187|37762824|FG001|Overall Study|Progressive disease|0|||
16819893|NCT02191579|37762832|FG000|Treatment 1|Multiple Reasons Specified|27|||
16819894|NCT02191579|37762833|FG001|Treatment 1|Multiple Reasons Specified|58|||
16819895|NCT02191579|37762832|FG000|Treatment 2|Multiple Reasons Specified|0|||
16819896|NCT02191579|37762833|FG001|Treatment 2|Multiple Reasons Specified|25|||
16819897|NCT01363700|37762842|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
16819898|NCT01363700|37762843|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
16819899|NCT01363700|37762844|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
16819900|NCT01363700|37762845|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
16819901|NCT01363700|37762846|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
16819902|NCT01637402|37762857|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
16819903|NCT01637402|37762858|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
16819904|NCT01637402|37762857|FG000|Standard Dose Regimen|Adverse Event|1|||
16819905|NCT01637402|37762858|FG001|Standard Dose Regimen|Adverse Event|0|||
16819906|NCT01637402|37762857|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
16819907|NCT01637402|37762858|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
16819908|NCT01637402|37762857|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
16819909|NCT01637402|37762858|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
16819910|NCT01637402|37762857|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
16819911|NCT01637402|37762858|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
16819912|NCT01637402|37762857|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
16819913|NCT01637402|37762858|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
16819914|NCT02217475|37762886|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
16819915|NCT02217475|37762887|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
16819916|NCT02217475|37762888|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
16819917|NCT02217475|37762886|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
16819918|NCT02217475|37762887|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
16819919|NCT02217475|37762888|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
16819920|NCT02217475|37762886|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
16819921|NCT02217475|37762887|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
16819922|NCT02217475|37762888|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
16819923|NCT02217475|37762886|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
16819924|NCT02217475|37762887|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
16819925|NCT02217475|37762888|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
16819926|NCT02217475|37762886|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
16819927|NCT02217475|37762887|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
16819928|NCT02217475|37762888|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
16819929|NCT02217475|37762886|FG000|Discontinued After Period 1|Adverse Event|1|||
16819930|NCT02217475|37762887|FG001|Discontinued After Period 1|Adverse Event|2|||
16819931|NCT02217475|37762888|FG002|Discontinued After Period 1|Adverse Event|0|||
16819932|NCT02217475|37762886|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
16819933|NCT02217475|37762887|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
16819934|NCT02217475|37762888|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
16819935|NCT02217475|37762886|FG000|Discontinued After Period 1|Physician Decision|0|||
16819936|NCT02217475|37762887|FG001|Discontinued After Period 1|Physician Decision|0|||
16819937|NCT02217475|37762888|FG002|Discontinued After Period 1|Physician Decision|1|||
16819938|NCT02217475|37762886|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
16819939|NCT02217475|37762887|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
16819940|NCT02217475|37762888|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
16819941|NCT02217475|37762886|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
16819942|NCT02217475|37762887|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
16819943|NCT02217475|37762888|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
16819944|NCT02217475|37762886|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
16819945|NCT02217475|37762887|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
16819946|NCT02217475|37762888|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
16819947|NCT02217475|37762886|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
16819948|NCT02217475|37762887|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
16819949|NCT02217475|37762888|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
16819950|NCT02217475|37762886|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
16819951|NCT02217475|37762887|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
16819952|NCT02217475|37762888|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
16819953|NCT02191267|37762908|FG000|Overall Study|Withdrawal by Subject|1|||
16819954|NCT02191267|37762909|FG001|Overall Study|Withdrawal by Subject|0|||
16819955|NCT02191267|37762910|FG002|Overall Study|Withdrawal by Subject|0|||
16819956|NCT02189941|37762918|FG000|Overall Study|Non-compliance|0|||
16819957|NCT02189941|37762919|FG001|Overall Study|Non-compliance|0|||
16819958|NCT02189941|37762920|FG002|Overall Study|Non-compliance|1|||
16819959|NCT02216773|37762930|FG000|Overall Study|Disease progression|4|||
16819960|NCT02216773|37762931|FG001|Overall Study|Disease progression|2|||
16819961|NCT02216773|37762930|FG000|Overall Study|Insufficient FLRV|4|||
16819962|NCT02216773|37762931|FG001|Overall Study|Insufficient FLRV|0|||
16819963|NCT02216773|37762930|FG000|Overall Study|Abandoned|4|||
16819964|NCT02216773|37762931|FG001|Overall Study|Abandoned|3|||
16819965|NCT01601132|37762937|FG000|Overall Study|Patient withdrew consent|1|||
16819966|NCT01601132|37762937|FG000|Overall Study|Protocol deviation|1|||
16819967|NCT02162719|37762946|FG000|Overall Study|Death|41|||
16819968|NCT02162719|37762947|FG001|Overall Study|Death|46|||
16819969|NCT02162719|37762946|FG000|Overall Study|Lost to Follow-up|1|||
16819970|NCT02162719|37762947|FG001|Overall Study|Lost to Follow-up|3|||
16819971|NCT02162719|37762946|FG000|Overall Study|Disease Progression|2|||
16819972|NCT02162719|37762947|FG001|Overall Study|Disease Progression|1|||
16819973|NCT02162719|37762946|FG000|Overall Study|Withdrawal by Subject|8|||
16819974|NCT02162719|37762947|FG001|Overall Study|Withdrawal by Subject|2|||
16819975|NCT02162719|37762946|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
16819976|NCT02162719|37762947|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
16819977|NCT02161549|37762955|FG000|Overall Study|Physician Decision|6|||
16819978|NCT02161549|37762956|FG001|Overall Study|Physician Decision|2|||
16819979|NCT02189863|37762962|FG000|First 2 Weeks|Motion Sickness|4|||
16819980|NCT02189863|37762963|FG001|First 2 Weeks|Motion Sickness|2|||
16819981|NCT02189473|37762974|FG000|Overall Study|Death|22|||
16819982|NCT02189473|37762975|FG001|Overall Study|Death|23|||
16819983|NCT02189473|37762974|FG000|Overall Study|Lost to Follow-up|1|||
16819984|NCT02189473|37762975|FG001|Overall Study|Lost to Follow-up|2|||
16819985|NCT02188849|37762983|FG000|Overall Study|Lost to Follow-up|3|||
16819986|NCT02188849|37762984|FG001|Overall Study|Lost to Follow-up|8|||
16819987|NCT01636076|37762992|FG000|Overall Study|Terminated by sponsor|1|||
16819988|NCT01636076|37762993|FG001|Overall Study|Terminated by sponsor|1|||
16819989|NCT01636076|37762992|FG000|Overall Study|Lack of Efficacy|0|||
16819990|NCT01636076|37762993|FG001|Overall Study|Lack of Efficacy|1|||
16819991|NCT01636076|37762992|FG000|Overall Study|Lost to Follow-up|1|||
16819992|NCT01636076|37762993|FG001|Overall Study|Lost to Follow-up|0|||
16819993|NCT01636076|37762992|FG000|Overall Study|Physician Decision|1|||
16819994|NCT01636076|37762993|FG001|Overall Study|Physician Decision|1|||
16819995|NCT01636076|37762992|FG000|Overall Study|Non-compliance with study treatment|1|||
16819996|NCT01636076|37762993|FG001|Overall Study|Non-compliance with study treatment|1|||
16819997|NCT01636076|37762992|FG000|Overall Study|Adverse Event|6|||
16819998|NCT01636076|37762993|FG001|Overall Study|Adverse Event|11|||
16819999|NCT01636076|37762992|FG000|Overall Study|Withdrawal by Subject|7|||
16911285|NCT01525602|38020375|FG003|Overall Study|Withdrawal by Subject|0|||
17102368|NCT00099632|38241296|FG004|Overall Study|Withdrawal by Subject|0|||
16820000|NCT01636076|37762993|FG001|Overall Study|Withdrawal by Subject|10|||
16820001|NCT01635998|37763008|FG000|Overall Study|Death|1|||
16820002|NCT01635998|37763009|FG001|Overall Study|Death|1|||
16820003|NCT01635998|37763008|FG000|Overall Study|Lost to Follow-up|2|||
16820004|NCT01635998|37763009|FG001|Overall Study|Lost to Follow-up|1|||
16820005|NCT01635998|37763008|FG000|Overall Study|Withdrawal by Subject|1|||
16820006|NCT01635998|37763009|FG001|Overall Study|Withdrawal by Subject|5|||
16820007|NCT01635920|37763017|FG000|Overall Study|Adverse Event|1|||
16820008|NCT01635920|37763018|FG001|Overall Study|Adverse Event|0|||
16820009|NCT01635920|37763017|FG000|Overall Study|Lost to Follow-up|0|||
16820010|NCT01635920|37763018|FG001|Overall Study|Lost to Follow-up|1|||
16820011|NCT01635920|37763017|FG000|Overall Study|Subject decision|2|||
16820012|NCT01635920|37763018|FG001|Overall Study|Subject decision|0|||
16820013|NCT02160145|37763035|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
16820014|NCT02160145|37763036|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
16820015|NCT02160145|37763037|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
16820016|NCT02160145|37763035|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
16820017|NCT02160145|37763036|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
16820018|NCT02160145|37763037|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
16820019|NCT02160145|37763035|FG000|Randomized Double-blind Period|Subject decision|0|||
16820020|NCT02160145|37763036|FG001|Randomized Double-blind Period|Subject decision|21|||
16820021|NCT02160145|37763037|FG002|Randomized Double-blind Period|Subject decision|20|||
16820022|NCT02160145|37763035|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
16820023|NCT02160145|37763036|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
16820024|NCT02160145|37763037|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
16820025|NCT02160145|37763035|FG000|Randomized Double-blind Period|Physician Decision|0|||
16820026|NCT02160145|37763036|FG001|Randomized Double-blind Period|Physician Decision|7|||
16820027|NCT02160145|37763037|FG002|Randomized Double-blind Period|Physician Decision|5|||
16820028|NCT01696396|37763048|FG000|Overall Study|Withdrawal by Subject|19|||
16820029|NCT01696396|37763049|FG001|Overall Study|Withdrawal by Subject|5|||
16820030|NCT01696396|37763050|FG002|Overall Study|Withdrawal by Subject|19|||
16820031|NCT01696396|37763051|FG003|Overall Study|Withdrawal by Subject|11|||
16820032|NCT01696396|37763048|FG000|Overall Study|Decision by Sponsor|3|||
16820033|NCT01696396|37763049|FG001|Overall Study|Decision by Sponsor|1|||
16820034|NCT01696396|37763050|FG002|Overall Study|Decision by Sponsor|2|||
16820035|NCT01696396|37763051|FG003|Overall Study|Decision by Sponsor|2|||
16820036|NCT01696396|37763048|FG000|Overall Study|Lost to Follow-up|9|||
16820037|NCT01696396|37763049|FG001|Overall Study|Lost to Follow-up|1|||
16820038|NCT01696396|37763050|FG002|Overall Study|Lost to Follow-up|4|||
16820039|NCT01696396|37763051|FG003|Overall Study|Lost to Follow-up|1|||
16820040|NCT01696396|37763048|FG000|Overall Study|Death|0|||
16820041|NCT01696396|37763049|FG001|Overall Study|Death|0|||
16820042|NCT01696396|37763050|FG002|Overall Study|Death|1|||
16820043|NCT01696396|37763051|FG003|Overall Study|Death|0|||
16820044|NCT02216071|37763067|FG000|Overall Study|Withdrawal by Subject|7|||
16820045|NCT02216071|37763068|FG001|Overall Study|Withdrawal by Subject|2|||
16820046|NCT02216071|37763067|FG000|Overall Study|Lost to Follow-up|3|||
16820047|NCT02216071|37763068|FG001|Overall Study|Lost to Follow-up|3|||
16820048|NCT02216071|37763067|FG000|Overall Study|Protocol Violation|3|||
16820049|NCT02216071|37763068|FG001|Overall Study|Protocol Violation|5|||
16820050|NCT02216071|37763067|FG000|Overall Study|Other|2|||
16820051|NCT02216071|37763068|FG001|Overall Study|Other|2|||
16820052|NCT01681576|37763076|FG000|Period 1|Adverse Event|1|||
16820053|NCT01681576|37763077|FG001|Period 1|Adverse Event|0|||
16820054|NCT01681576|37763076|FG000|Period 1|Protocol Deviation|1|||
16820055|NCT01681576|37763077|FG001|Period 1|Protocol Deviation|0|||
16820056|NCT01681576|37763076|FG000|Period 2|subject/guardian decision|3|||
16820057|NCT01681576|37763077|FG001|Period 2|subject/guardian decision|1|||
16820058|NCT01681576|37763076|FG000|Period 2|Non-compliance with study treatment|1|||
16820059|NCT01681576|37763077|FG001|Period 2|Non-compliance with study treatment|0|||
16820060|NCT02188459|37763087|FG000|Overall Study|Lost to Follow-up|3|||
16820061|NCT02188459|37763088|FG001|Overall Study|Lost to Follow-up|4|||
16820062|NCT02188459|37763087|FG000|Overall Study|Early Termination|0|||
16820063|NCT02188459|37763088|FG001|Overall Study|Early Termination|3|||
16820064|NCT02214121|37763110|FG000|Part A|Patient decision|2|||
16820065|NCT02214121|37763111|FG001|Part A|Patient decision|0|||
16820066|NCT02214121|37763112|FG002|Part A|Patient decision|0|||
16820067|NCT02214121|37763110|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
16820068|NCT02214121|37763111|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
16820069|NCT02214121|37763112|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
16820070|NCT02214121|37763110|FG000|Part A|Other|1|||
16820071|NCT02214121|37763111|FG001|Part A|Other|0|||
16820072|NCT02214121|37763112|FG002|Part A|Other|0|||
16820073|NCT02214121|37763110|FG000|Part B|Patient decision|0|||
16820074|NCT02214121|37763111|FG001|Part B|Patient decision|1|||
16820075|NCT02214121|37763112|FG002|Part B|Patient decision|0|||
16820076|NCT02214121|37763110|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
16820077|NCT02214121|37763111|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
16820078|NCT02214121|37763112|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
16820079|NCT02214121|37763110|FG000|Part B|Lost to Follow-up|0|||
16820080|NCT02214121|37763111|FG001|Part B|Lost to Follow-up|0|||
16820081|NCT02214121|37763112|FG002|Part B|Lost to Follow-up|1|||
16820082|NCT01681186|37763140|FG000|Washout Period From Second Intervention|Adverse Event|0|||
16820083|NCT01681186|37763141|FG001|Washout Period From Second Intervention|Adverse Event|0|||
16820084|NCT01681186|37763142|FG002|Washout Period From Second Intervention|Adverse Event|0|||
16820085|NCT01681186|37763143|FG003|Washout Period From Second Intervention|Adverse Event|0|||
16820086|NCT01681186|37763144|FG004|Washout Period From Second Intervention|Adverse Event|0|||
16820087|NCT01681186|37763145|FG005|Washout Period From Second Intervention|Adverse Event|0|||
16820088|NCT01681186|37763146|FG006|Washout Period From Second Intervention|Adverse Event|1|||
16820089|NCT01681186|37763147|FG007|Washout Period From Second Intervention|Adverse Event|0|||
16820090|NCT01681186|37763140|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
16820091|NCT01681186|37763141|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
16820092|NCT01681186|37763142|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
16820093|NCT01681186|37763143|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
16820094|NCT01681186|37763144|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
16820095|NCT01681186|37763145|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
16820096|NCT01681186|37763146|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
16820097|NCT01681186|37763147|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
16820098|NCT01681186|37763140|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
16820099|NCT01681186|37763141|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
16820100|NCT01681186|37763142|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
16820101|NCT01681186|37763143|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
16820102|NCT01681186|37763144|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
16820103|NCT01681186|37763145|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
16820104|NCT01681186|37763146|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
16820105|NCT01681186|37763147|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
16820106|NCT01681186|37763140|FG000|Fourth Intervention|Protocol Violation|0|||
16820107|NCT01681186|37763141|FG001|Fourth Intervention|Protocol Violation|0|||
16820108|NCT01681186|37763142|FG002|Fourth Intervention|Protocol Violation|0|||
16820109|NCT01681186|37763143|FG003|Fourth Intervention|Protocol Violation|0|||
16820110|NCT01681186|37763144|FG004|Fourth Intervention|Protocol Violation|0|||
16820111|NCT01681186|37763145|FG005|Fourth Intervention|Protocol Violation|0|||
16820112|NCT01681186|37763146|FG006|Fourth Intervention|Protocol Violation|0|||
16820113|NCT01681186|37763147|FG007|Fourth Intervention|Protocol Violation|1|||
16820114|NCT03597464|37763179|FG000|Overall Study|Withdrawal by Subject|4|||
16820115|NCT03597464|37763180|FG001|Overall Study|Withdrawal by Subject|5|||
16820116|NCT03597464|37763179|FG000|Overall Study|Lost to Follow-up|3|||
16820117|NCT03597464|37763180|FG001|Overall Study|Lost to Follow-up|1|||
16820118|NCT03597464|37763179|FG000|Overall Study|Pregnancy|3|||
16820119|NCT03597464|37763180|FG001|Overall Study|Pregnancy|1|||
16820120|NCT03597464|37763179|FG000|Overall Study|Lack of Efficacy|2|||
16820121|NCT03597464|37763180|FG001|Overall Study|Lack of Efficacy|0|||
16820122|NCT03597464|37763179|FG000|Overall Study|Physician Decision|2|||
16820123|NCT03597464|37763180|FG001|Overall Study|Physician Decision|2|||
16820124|NCT03597464|37763179|FG000|Overall Study|Protocol Violation|1|||
16820125|NCT03597464|37763180|FG001|Overall Study|Protocol Violation|1|||
16820126|NCT03597464|37763179|FG000|Overall Study|Adverse Event|0|||
16820127|NCT03597464|37763180|FG001|Overall Study|Adverse Event|2|||
16820128|NCT03597464|37763179|FG000|Overall Study|Death|0|||
16820129|NCT03597464|37763180|FG001|Overall Study|Death|3|||
16820130|NCT01695772|37763188|FG000|Overall Study|Withdrawal by Subject|18|||
16820131|NCT01695772|37763188|FG000|Overall Study|Progressive Disease|8|||
16820132|NCT01695772|37763188|FG000|Overall Study|Investigator Decision|5|||
16820133|NCT01695772|37763188|FG000|Overall Study|Lost to Follow-up|4|||
16820134|NCT01695772|37763188|FG000|Overall Study|Protocol Violation|2|||
16820135|NCT01695772|37763188|FG000|Overall Study|Unspecified Reason|1|||
16820136|NCT02159521|37763192|FG000|Overall Study|Enrolled but not treated|3|||
16820137|NCT02159521|37763192|FG000|Overall Study|Withdrawal by Subject|7|||
16820138|NCT02159521|37763192|FG000|Overall Study|Lost to Follow-up|6|||
16820139|NCT02159521|37763192|FG000|Overall Study|Death|1|||
16820140|NCT02159521|37763192|FG000|Overall Study|Other than specified|1|||
16820141|NCT01636934|37763198|FG000|Overall Study|Withdrawal by Subject|3|||
16820142|NCT01636934|37763199|FG001|Overall Study|Withdrawal by Subject|2|||
16820143|NCT01636934|37763198|FG000|Overall Study|Chemo cancel|1|||
16820144|NCT01636934|37763199|FG001|Overall Study|Chemo cancel|0|||
16820145|NCT01636934|37763198|FG000|Overall Study|Too ill to continue|1|||
16820146|NCT01636934|37763199|FG001|Overall Study|Too ill to continue|0|||
16820147|NCT01636934|37763198|FG000|Overall Study|Never started study medication|1|||
16820148|NCT01636934|37763199|FG001|Overall Study|Never started study medication|1|||
16820149|NCT01712854|37763205|FG000|Overall Study|Physician Decision|1|||
16820150|NCT01693120|37763209|FG000|Enrollment|Lost to Follow-up|1|||
16820151|NCT01693120|37763209|FG000|Enrollment|Withdrawal by Subject|10|||
16820152|NCT01693120|37763209|FG000|Enrollment|Protocol Violation|46|||
16820153|NCT01693120|37763209|FG000|Enrollment|Physician Decision|3|||
16820154|NCT01693120|37763209|FG000|Enrollment|Adverse Event|1|||
16820155|NCT01693120|37763209|FG000|Enrollment|Study closed|8|||
16820156|NCT01693120|37763209|FG000|Enrollment|Other|1|||
16820157|NCT01693120|37763209|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
16820158|NCT01693120|37763209|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
16820159|NCT01693120|37763209|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
16820160|NCT01693120|37763209|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
16820161|NCT01693120|37763209|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
16820162|NCT02159365|37763213|FG000|Overall Study|Disease Progression|23|||
16820163|NCT02159365|37763213|FG000|Overall Study|Other reasons|11|||
16820164|NCT02159365|37763213|FG000|Overall Study|Administrative reason by Sponsor|9|||
16820165|NCT02159365|37763213|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
16820166|NCT02159365|37763213|FG000|Overall Study|Study drug toxicity|7|||
16820167|NCT02159365|37763213|FG000|Overall Study|Maximum clinical benefit|3|||
16820168|NCT02159365|37763213|FG000|Overall Study|Subject request to discontinue treatment|3|||
16820169|NCT02159365|37763213|FG000|Overall Study|Subject withdrew consent|3|||
16820170|NCT02159365|37763213|FG000|Overall Study|Death|1|||
16820171|NCT02159365|37763213|FG000|Overall Study|Lost to Follow-up|1|||
16820172|NCT01712074|37763220|FG000|Placebo Run-in Period|Adverse Event|2|||
16820173|NCT01712074|37763221|FG001|Placebo Run-in Period|Adverse Event|0|||
16820174|NCT01712074|37763222|FG002|Placebo Run-in Period|Adverse Event|0|||
16820175|NCT01712074|37763220|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
16820176|NCT01712074|37763221|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
16820177|NCT01712074|37763222|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
16820178|NCT01712074|37763220|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
16820179|NCT01712074|37763221|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
16820180|NCT01712074|37763222|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
16820181|NCT01712074|37763220|FG000|Placebo Run-in Period|Other|1|||
16820182|NCT01712074|37763221|FG001|Placebo Run-in Period|Other|0|||
16820183|NCT01712074|37763222|FG002|Placebo Run-in Period|Other|0|||
16820184|NCT01712074|37763220|FG000|Placebo Run-in Period|No longer willing to participate|1|||
16820185|NCT01712074|37763221|FG001|Placebo Run-in Period|No longer willing to participate|0|||
16820186|NCT01712074|37763222|FG002|Placebo Run-in Period|No longer willing to participate|0|||
16820187|NCT01712074|37763220|FG000|Double Blind Period|Adverse Event|0|||
16820188|NCT01712074|37763221|FG001|Double Blind Period|Adverse Event|2|||
16820189|NCT01712074|37763222|FG002|Double Blind Period|Adverse Event|1|||
16820190|NCT01712074|37763220|FG000|Double Blind Period|No longer willing to participate|0|||
16820191|NCT01712074|37763221|FG001|Double Blind Period|No longer willing to participate|2|||
16820192|NCT01712074|37763222|FG002|Double Blind Period|No longer willing to participate|4|||
16820193|NCT01712074|37763220|FG000|Double Blind Period|Death|0|||
16820194|NCT01712074|37763221|FG001|Double Blind Period|Death|1|||
16820195|NCT01712074|37763222|FG002|Double Blind Period|Death|0|||
16820196|NCT01712074|37763220|FG000|Double Blind Period|Lost to Follow-up|0|||
16820197|NCT01712074|37763221|FG001|Double Blind Period|Lost to Follow-up|2|||
16820198|NCT01712074|37763222|FG002|Double Blind Period|Lost to Follow-up|1|||
16820199|NCT01712074|37763220|FG000|Double Blind Period|Other|0|||
16820200|NCT01712074|37763221|FG001|Double Blind Period|Other|4|||
16820201|NCT01712074|37763222|FG002|Double Blind Period|Other|1|||
16820202|NCT01712074|37763220|FG000|Double Blind Period|Protocol Violation|0|||
16820203|NCT01712074|37763221|FG001|Double Blind Period|Protocol Violation|0|||
16820204|NCT01712074|37763222|FG002|Double Blind Period|Protocol Violation|1|||
16820205|NCT01712074|37763220|FG000|Double Blind Period|No longer met eligibility criteria|0|||
16820206|NCT01712074|37763221|FG001|Double Blind Period|No longer met eligibility criteria|3|||
16820207|NCT01712074|37763222|FG002|Double Blind Period|No longer met eligibility criteria|0|||
16820208|NCT01711216|37763237|FG000|Overall Study|Adverse Event|4|||
16820209|NCT01711216|37763237|FG000|Overall Study|Pregnancy|56|||
16820210|NCT01711216|37763237|FG000|Overall Study|Withdrawal by Subject|6|||
16820211|NCT01711216|37763237|FG000|Overall Study|Lost to Follow-up|46|||
16820212|NCT01711216|37763237|FG000|Overall Study|variety of other minor reasons|83|||
16820213|NCT01711216|37763237|FG000|Overall Study|no reason specified|22|||
16820214|NCT01692730|37763247|FG000|Overall Study|Lost to Follow-up|225|||
16820215|NCT01692730|37763248|FG001|Overall Study|Lost to Follow-up|227|||
16820216|NCT01691794|37763257|FG000|Overall Study|Poor/Non-Compliance|1|||
16820217|NCT01691794|37763258|FG001|Overall Study|Poor/Non-Compliance|4|||
16820218|NCT01691794|37763259|FG002|Overall Study|Poor/Non-Compliance|1|||
16820219|NCT01691794|37763257|FG000|Overall Study|Death|0|||
16820220|NCT01691794|37763258|FG001|Overall Study|Death|0|||
16820221|NCT01691794|37763259|FG002|Overall Study|Death|1|||
16820222|NCT01691794|37763257|FG000|Overall Study|Lack of Efficacy|0|||
16820223|NCT01691794|37763258|FG001|Overall Study|Lack of Efficacy|7|||
16820224|NCT01691794|37763259|FG002|Overall Study|Lack of Efficacy|1|||
16820225|NCT01691794|37763257|FG000|Overall Study|Participant request to discontinue|0|||
16820226|NCT01691794|37763258|FG001|Overall Study|Participant request to discontinue|1|||
16820227|NCT01691794|37763259|FG002|Overall Study|Participant request to discontinue|0|||
16820228|NCT01691794|37763257|FG000|Overall Study|Adverse Event|0|||
16820229|NCT01691794|37763258|FG001|Overall Study|Adverse Event|1|||
16820230|NCT01691794|37763259|FG002|Overall Study|Adverse Event|1|||
16820231|NCT01691794|37763257|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
16820232|NCT01691794|37763258|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
16820233|NCT01691794|37763259|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
16820234|NCT01691794|37763257|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
16820235|NCT01691794|37763258|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
16820236|NCT01691794|37763259|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
16820237|NCT01710514|37763269|FG000|Overall Study|Adverse Event|6|||
16820238|NCT01710514|37763270|FG001|Overall Study|Adverse Event|7|||
16820239|NCT01710514|37763269|FG000|Overall Study|Withdrawal by Subject|1|||
16820240|NCT01710514|37763270|FG001|Overall Study|Withdrawal by Subject|0|||
16820241|NCT01592344|37763281|FG000|Overall Study|Adverse Event|1|||
16820242|NCT01592344|37763282|FG001|Overall Study|Adverse Event|1|||
16820243|NCT01592344|37763281|FG000|Overall Study|Lack of Efficacy|1|||
16820244|NCT01592344|37763282|FG001|Overall Study|Lack of Efficacy|0|||
16820245|NCT01592344|37763281|FG000|Overall Study|not available at primary outcome visit|2|||
16820246|NCT01592344|37763282|FG001|Overall Study|not available at primary outcome visit|4|||
16820247|NCT01636778|37763288|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
16820248|NCT01636778|37763289|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
16820249|NCT01636778|37763290|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
16820250|NCT01636778|37763288|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
16820251|NCT01636778|37763289|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
16820252|NCT01636778|37763290|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
16820253|NCT01636778|37763288|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
16820254|NCT01636778|37763289|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
16820255|NCT01636778|37763290|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
16820256|NCT01636778|37763288|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
16820257|NCT01636778|37763289|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
16820258|NCT01636778|37763290|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
16820259|NCT01636778|37763288|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
16820260|NCT01636778|37763289|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
16820261|NCT01636778|37763290|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
16820262|NCT01636778|37763288|FG000|Follow-up Period After Part 2|Other|0|||
16820263|NCT01636778|37763289|FG001|Follow-up Period After Part 2|Other|0|||
16820264|NCT01636778|37763290|FG002|Follow-up Period After Part 2|Other|1|||
16820265|NCT01636778|37763288|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
16820266|NCT01636778|37763289|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
16820267|NCT01636778|37763290|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
16820268|NCT01636778|37763288|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
16820269|NCT01636778|37763289|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
16820270|NCT01636778|37763290|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
16820271|NCT02159053|37763301|FG000|Overall Study|Death|2|||
16820272|NCT02159053|37763302|FG001|Overall Study|Death|0|||
16820273|NCT02159053|37763303|FG002|Overall Study|Death|1|||
16820274|NCT02159053|37763301|FG000|Overall Study|Physician Decision|0|||
16820275|NCT02159053|37763302|FG001|Overall Study|Physician Decision|1|||
16820276|NCT02159053|37763303|FG002|Overall Study|Physician Decision|1|||
16820277|NCT02159053|37763301|FG000|Overall Study|Lack of Efficacy|3|||
16820278|NCT02159053|37763302|FG001|Overall Study|Lack of Efficacy|4|||
16820279|NCT02159053|37763303|FG002|Overall Study|Lack of Efficacy|7|||
16820280|NCT02159053|37763301|FG000|Overall Study|Adverse Event|7|||
16820281|NCT02159053|37763302|FG001|Overall Study|Adverse Event|6|||
16820282|NCT02159053|37763303|FG002|Overall Study|Adverse Event|5|||
16820283|NCT02159053|37763301|FG000|Overall Study|Participants/guardian decision|8|||
16820284|NCT02159053|37763302|FG001|Overall Study|Participants/guardian decision|10|||
16820285|NCT02159053|37763303|FG002|Overall Study|Participants/guardian decision|6|||
16820286|NCT02158975|37763313|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
16820287|NCT02158663|37763320|FG000|Overall Study|Withdrawal by Subject|5|||
16820288|NCT02158663|37763321|FG001|Overall Study|Withdrawal by Subject|4|||
16820289|NCT02158039|37763329|FG000|Overall Study|Withdrawal by Subject|1|||
16820290|NCT02158039|37763329|FG000|Overall Study|Screen Failure|9|||
16820291|NCT01635764|37763347|FG000|Overall Study|Adverse Event|46|||
16820292|NCT01635764|37763347|FG000|Overall Study|Lack of Efficacy|76|||
16820293|NCT01635764|37763347|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
16820294|NCT01635764|37763347|FG000|Overall Study|Protocol Deviation|1|||
16820295|NCT01635764|37763347|FG000|Overall Study|Withdrew Consent|67|||
16820296|NCT01635764|37763347|FG000|Overall Study|Lost to Follow-up|53|||
16820297|NCT01635764|37763347|FG000|Overall Study|Other|28|||
16820298|NCT03432260|37763363|FG000|Overall Study|Lost to Follow-up|1|||
16820299|NCT03432260|37763364|FG001|Overall Study|Lost to Follow-up|1|||
16820300|NCT03432260|37763365|FG002|Overall Study|Lost to Follow-up|0|||
16820301|NCT03432260|37763366|FG003|Overall Study|Lost to Follow-up|0|||
16820302|NCT03432260|37763367|FG004|Overall Study|Lost to Follow-up|1|||
16820303|NCT01634360|37763381|FG000|Overall Study|Adverse Event|10|||
16820304|NCT01634360|37763382|FG001|Overall Study|Adverse Event|34|||
16820305|NCT01634360|37763381|FG000|Overall Study|subject withdrew consent|13|||
16820306|NCT01634360|37763382|FG001|Overall Study|subject withdrew consent|23|||
16820307|NCT01634360|37763381|FG000|Overall Study|Protocol Violation|1|||
16820308|NCT01634360|37763382|FG001|Overall Study|Protocol Violation|1|||
16820309|NCT01634360|37763381|FG000|Overall Study|Lack of Efficacy|4|||
16820310|NCT01634360|37763382|FG001|Overall Study|Lack of Efficacy|14|||
16820311|NCT01634360|37763381|FG000|Overall Study|Other|3|||
16820312|NCT01634360|37763382|FG001|Overall Study|Other|20|||
16820313|NCT01634360|37763381|FG000|Overall Study|Study termination by sponsor|18|||
16820314|NCT01634360|37763382|FG001|Overall Study|Study termination by sponsor|44|||
16820315|NCT01635218|37763399|FG000|Overall Study|Lost to Follow-up|3|||
16820316|NCT01635218|37763400|FG001|Overall Study|Lost to Follow-up|7|||
16820317|NCT01635218|37763401|FG002|Overall Study|Lost to Follow-up|6|||
16820318|NCT02049866|37763409|FG000|Overall Study|Withdrawal by Subject|1|||
16820319|NCT04274894|37763413|FG000|Overall Study|Adverse Event|7|||
16820320|NCT04274894|37763413|FG000|Overall Study|Withdrew consent|5|||
16820321|NCT04274894|37763413|FG000|Overall Study|Lost to Follow-up|9|||
16820322|NCT04274894|37763413|FG000|Overall Study|COVID-19 infection|1|||
16820323|NCT04274894|37763413|FG000|Overall Study|Other, not specified|20|||
16820324|NCT02213263|37763419|FG000|Overall Study|Insufficient clinical response|4|||
16820325|NCT02213263|37763420|FG001|Overall Study|Insufficient clinical response|3|||
16820326|NCT02213263|37763419|FG000|Overall Study|Lost to Follow-up|0|||
16820327|NCT02213263|37763420|FG001|Overall Study|Lost to Follow-up|1|||
16820328|NCT02213263|37763419|FG000|Overall Study|No longer willing to participate|3|||
16820329|NCT02213263|37763420|FG001|Overall Study|No longer willing to participate|4|||
16820330|NCT02213263|37763419|FG000|Overall Study|Progressive disease|20|||
16820331|NCT02213263|37763420|FG001|Overall Study|Progressive disease|14|||
16820332|NCT02213263|37763419|FG000|Overall Study|Protocol Violation|0|||
16820333|NCT02213263|37763420|FG001|Overall Study|Protocol Violation|1|||
16820334|NCT02213263|37763419|FG000|Overall Study|Adverse Event|1|||
16820335|NCT02213263|37763420|FG001|Overall Study|Adverse Event|3|||
16820336|NCT02211313|37763428|FG000|Overall Study|Treatment Failure|5|||
16820337|NCT02211313|37763429|FG001|Overall Study|Treatment Failure|2|||
16820338|NCT02211313|37763428|FG000|Overall Study|No Follow up Questionnaires|1|||
16820339|NCT02211313|37763429|FG001|Overall Study|No Follow up Questionnaires|1|||
16820340|NCT02210689|37763438|FG000|Overall Study|Withdrawal by Subject|7|||
16820341|NCT02210689|37763439|FG001|Overall Study|Withdrawal by Subject|4|||
16820342|NCT02210689|37763440|FG002|Overall Study|Withdrawal by Subject|2|||
16820343|NCT02210689|37763438|FG000|Overall Study|Adverse Event|0|||
16820344|NCT02210689|37763439|FG001|Overall Study|Adverse Event|1|||
16820345|NCT02210689|37763440|FG002|Overall Study|Adverse Event|0|||
16820346|NCT02210689|37763438|FG000|Overall Study|Protocol Violation|1|||
16820347|NCT02210689|37763439|FG001|Overall Study|Protocol Violation|0|||
16820348|NCT02210689|37763440|FG002|Overall Study|Protocol Violation|0|||
16820349|NCT02210689|37763438|FG000|Overall Study|Lost to Follow-up|11|||
16820350|NCT02210689|37763439|FG001|Overall Study|Lost to Follow-up|9|||
16820351|NCT02210689|37763440|FG002|Overall Study|Lost to Follow-up|5|||
16820352|NCT02210689|37763438|FG000|Overall Study|Pregnancy|0|||
16820353|NCT02210689|37763439|FG001|Overall Study|Pregnancy|1|||
16820354|NCT02210689|37763440|FG002|Overall Study|Pregnancy|0|||
16820355|NCT02210689|37763438|FG000|Overall Study|Lack of Efficacy|0|||
16820356|NCT02210689|37763439|FG001|Overall Study|Lack of Efficacy|1|||
16820357|NCT02210689|37763440|FG002|Overall Study|Lack of Efficacy|5|||
16820358|NCT02210689|37763438|FG000|Overall Study|Prohibited medication|2|||
16820359|NCT02210689|37763439|FG001|Overall Study|Prohibited medication|8|||
16820360|NCT02210689|37763440|FG002|Overall Study|Prohibited medication|1|||
16820361|NCT02210689|37763438|FG000|Overall Study|Negative Nugent score at baseline|6|||
16820362|NCT02210689|37763439|FG001|Overall Study|Negative Nugent score at baseline|2|||
16820363|NCT02210689|37763440|FG002|Overall Study|Negative Nugent score at baseline|2|||
16820364|NCT02210689|37763438|FG000|Overall Study|Other|25|||
16820365|NCT02210689|37763439|FG001|Overall Study|Other|21|||
16820366|NCT02210689|37763440|FG002|Overall Study|Other|8|||
16820367|NCT02209597|37763448|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
16820368|NCT02209597|37763448|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
16820369|NCT02209597|37763448|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
16820370|NCT02209597|37763448|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
16820371|NCT02188303|37763477|FG000|Overall Study|Adverse Event|0|||
16820372|NCT02188303|37763478|FG001|Overall Study|Adverse Event|0|||
16820373|NCT02188303|37763479|FG002|Overall Study|Adverse Event|0|||
16820374|NCT02188303|37763480|FG003|Overall Study|Adverse Event|0|||
16820375|NCT02188303|37763481|FG004|Overall Study|Adverse Event|0|||
16820376|NCT02188303|37763482|FG005|Overall Study|Adverse Event|2|||
16820377|NCT02188303|37763483|FG006|Overall Study|Adverse Event|0|||
16820378|NCT02188303|37763484|FG007|Overall Study|Adverse Event|2|||
16820379|NCT02188303|37763477|FG000|Overall Study|Dose Termination Criteria Met|0|||
16820380|NCT02188303|37763478|FG001|Overall Study|Dose Termination Criteria Met|0|||
16820381|NCT02188303|37763479|FG002|Overall Study|Dose Termination Criteria Met|0|||
16820382|NCT02188303|37763480|FG003|Overall Study|Dose Termination Criteria Met|0|||
16820383|NCT02188303|37763481|FG004|Overall Study|Dose Termination Criteria Met|0|||
16820384|NCT02188303|37763482|FG005|Overall Study|Dose Termination Criteria Met|0|||
16820385|NCT02188303|37763483|FG006|Overall Study|Dose Termination Criteria Met|2|||
16820386|NCT02188303|37763484|FG007|Overall Study|Dose Termination Criteria Met|4|||
16820387|NCT04867382|37763520|FG000|Overall Study|Did not complete the survey|2|||
16820388|NCT04867382|37763521|FG001|Overall Study|Did not complete the survey|1|||
16820389|NCT02187055|37763530|FG000|Overall Study|Lack of Efficacy|10|||
16820390|NCT02187055|37763531|FG001|Overall Study|Lack of Efficacy|3|||
16820391|NCT02187055|37763532|FG002|Overall Study|Lack of Efficacy|7|||
16820392|NCT02187055|37763530|FG000|Overall Study|Lost to Follow-up|2|||
16820393|NCT02187055|37763531|FG001|Overall Study|Lost to Follow-up|7|||
16820394|NCT02187055|37763532|FG002|Overall Study|Lost to Follow-up|3|||
16820395|NCT02187055|37763530|FG000|Overall Study|No longer meets eligibility criteria|0|||
16820396|NCT02187055|37763531|FG001|Overall Study|No longer meets eligibility criteria|2|||
16820397|NCT02187055|37763532|FG002|Overall Study|No longer meets eligibility criteria|0|||
16820398|NCT02187055|37763530|FG000|Overall Study|No longer willing to participate|6|||
16820399|NCT02187055|37763531|FG001|Overall Study|No longer willing to participate|8|||
16820400|NCT02187055|37763532|FG002|Overall Study|No longer willing to participate|10|||
16820401|NCT02187055|37763530|FG000|Overall Study|Other|5|||
16820402|NCT02187055|37763531|FG001|Overall Study|Other|6|||
16820403|NCT02187055|37763532|FG002|Overall Study|Other|3|||
16820404|NCT02187055|37763530|FG000|Overall Study|Protocol Violation|9|||
16820405|NCT02187055|37763531|FG001|Overall Study|Protocol Violation|9|||
16820406|NCT02187055|37763532|FG002|Overall Study|Protocol Violation|4|||
16820407|NCT02187055|37763530|FG000|Overall Study|Pregnancy|3|||
16820408|NCT02187055|37763531|FG001|Overall Study|Pregnancy|1|||
16820409|NCT02187055|37763532|FG002|Overall Study|Pregnancy|0|||
16820410|NCT02187055|37763530|FG000|Overall Study|Withdrawal by Subject|11|||
16820411|NCT02187055|37763531|FG001|Overall Study|Withdrawal by Subject|11|||
16820412|NCT02187055|37763532|FG002|Overall Study|Withdrawal by Subject|11|||
16820413|NCT02187055|37763530|FG000|Overall Study|Adverse Event|21|||
16820414|NCT02187055|37763531|FG001|Overall Study|Adverse Event|26|||
16820415|NCT02187055|37763532|FG002|Overall Study|Adverse Event|36|||
16820416|NCT02187055|37763530|FG000|Overall Study|Death|2|||
16820417|NCT02187055|37763531|FG001|Overall Study|Death|0|||
16820418|NCT02187055|37763532|FG002|Overall Study|Death|0|||
16820419|NCT02246660|37763572|FG000|Overall Study|Withdrawal by Subject|0|||
16820420|NCT02246660|37763573|FG001|Overall Study|Withdrawal by Subject|1|||
16820421|NCT02246660|37763574|FG002|Overall Study|Withdrawal by Subject|0|||
16820422|NCT02246660|37763572|FG000|Overall Study|Death|0|||
16820423|NCT02246660|37763573|FG001|Overall Study|Death|0|||
16820424|NCT02246660|37763574|FG002|Overall Study|Death|1|||
16820425|NCT02246582|37763582|FG000|Overall Study|Withdrawal by Subject|3|||
16820426|NCT02246582|37763583|FG001|Overall Study|Withdrawal by Subject|4|||
16820427|NCT02137369|37763589|FG000|Overall Study|Withdrawal by Subject|3|||
16820428|NCT02137369|37763590|FG001|Overall Study|Withdrawal by Subject|2|||
16820429|NCT02137369|37763589|FG000|Overall Study|Adverse Event|2|||
16820430|NCT02137369|37763590|FG001|Overall Study|Adverse Event|0|||
16820431|NCT02137369|37763589|FG000|Overall Study|Lost to Follow-up|1|||
16820432|NCT02137369|37763590|FG001|Overall Study|Lost to Follow-up|0|||
16820433|NCT02137369|37763589|FG000|Overall Study|Moved away|2|||
16820434|NCT02137369|37763590|FG001|Overall Study|Moved away|0|||
16820435|NCT02135107|37763599|FG000|Treatment Period|Withdrawal by Subject|11|||
16820436|NCT02135107|37763600|FG001|Treatment Period|Withdrawal by Subject|0|||
16820437|NCT02135107|37763601|FG002|Treatment Period|Withdrawal by Subject|0|||
16820438|NCT02135107|37763602|FG003|Treatment Period|Withdrawal by Subject|0|||
16820439|NCT02135107|37763599|FG000|Treatment Period|Adverse Event|5|||
16820440|NCT02135107|37763600|FG001|Treatment Period|Adverse Event|2|||
16820441|NCT02135107|37763601|FG002|Treatment Period|Adverse Event|0|||
16820442|NCT02135107|37763602|FG003|Treatment Period|Adverse Event|0|||
16820443|NCT02135107|37763599|FG000|Treatment Period|Pregnancy|1|||
16820444|NCT02135107|37763600|FG001|Treatment Period|Pregnancy|0|||
16820445|NCT02135107|37763601|FG002|Treatment Period|Pregnancy|0|||
16820446|NCT02135107|37763602|FG003|Treatment Period|Pregnancy|0|||
16820447|NCT02135107|37763599|FG000|Treatment Period|Other|115|||
17102369|NCT00099632|38241297|FG005|Overall Study|Withdrawal by Subject|1|||
16820448|NCT02135107|37763600|FG001|Treatment Period|Other|24|||
16820449|NCT02135107|37763601|FG002|Treatment Period|Other|0|||
16820450|NCT02135107|37763602|FG003|Treatment Period|Other|0|||
16820451|NCT02135107|37763599|FG000|Maintenance Therapy Period|Adverse Event|0|||
16820452|NCT02135107|37763600|FG001|Maintenance Therapy Period|Adverse Event|0|||
16820453|NCT02135107|37763601|FG002|Maintenance Therapy Period|Adverse Event|3|||
16820454|NCT02135107|37763602|FG003|Maintenance Therapy Period|Adverse Event|7|||
16820455|NCT02135107|37763599|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
16820456|NCT02135107|37763600|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
16820457|NCT02135107|37763601|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
16820458|NCT02135107|37763602|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
16820459|NCT02135107|37763599|FG000|Maintenance Therapy Period|Pregnancy|0|||
16820460|NCT02135107|37763600|FG001|Maintenance Therapy Period|Pregnancy|0|||
16820461|NCT02135107|37763601|FG002|Maintenance Therapy Period|Pregnancy|0|||
16820462|NCT02135107|37763602|FG003|Maintenance Therapy Period|Pregnancy|1|||
16820463|NCT02135107|37763599|FG000|Maintenance Therapy Period|Other|0|||
16820464|NCT02135107|37763600|FG001|Maintenance Therapy Period|Other|0|||
16820465|NCT02135107|37763601|FG002|Maintenance Therapy Period|Other|7|||
16820466|NCT02135107|37763602|FG003|Maintenance Therapy Period|Other|8|||
16820467|NCT02155309|37763616|FG000|Overall Study|Protocol Violation|0|||
16820468|NCT02155309|37763617|FG001|Overall Study|Protocol Violation|0|||
16820469|NCT02155309|37763618|FG002|Overall Study|Protocol Violation|1|||
16820470|NCT02186821|37763625|FG000|Overall Study|Adverse Event|9|||
16820471|NCT02186821|37763625|FG000|Overall Study|Death|2|||
16820472|NCT02186821|37763625|FG000|Overall Study|Disease progression|32|||
16820473|NCT02186821|37763625|FG000|Overall Study|Protocol Violation|1|||
16820474|NCT02186821|37763625|FG000|Overall Study|Physician Decision|1|||
16820475|NCT02186821|37763625|FG000|Overall Study|Study terminated by sponsor|2|||
16820476|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
16820477|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
16820478|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
16820479|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
16820480|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
16820481|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
16820482|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
16820483|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
16820484|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
16820485|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
16820486|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
16820487|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
16820488|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
16820489|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
16820490|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
16820491|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
16820492|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
16820493|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
16820494|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
16820495|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
16820496|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
16820497|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
16820498|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
16820499|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
16820500|NCT01710358|37763632|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
16820501|NCT01710358|37763633|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
16820502|NCT01710358|37763634|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
16820503|NCT01710358|37763632|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
16820504|NCT01710358|37763633|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
16820505|NCT01710358|37763634|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
16820506|NCT01710358|37763632|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
16820507|NCT01710358|37763633|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
16820508|NCT01710358|37763634|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
16820509|NCT01710358|37763632|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
16820510|NCT01710358|37763633|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
16820511|NCT01710358|37763634|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
16820512|NCT01710358|37763632|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
16820513|NCT01710358|37763633|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
16820514|NCT01710358|37763634|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
16820515|NCT01710358|37763632|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
16820516|NCT01710358|37763633|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
16820517|NCT01710358|37763634|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
16820518|NCT01710358|37763632|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
16820519|NCT01710358|37763633|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
16820520|NCT01710358|37763634|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
16820521|NCT01710358|37763632|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
16820522|NCT01710358|37763633|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
16820523|NCT01710358|37763634|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
16820524|NCT01710358|37763632|FG000|Rescue Period|Adverse Event|0|||
16820525|NCT01710358|37763633|FG001|Rescue Period|Adverse Event|15|||
16820526|NCT01710358|37763634|FG002|Rescue Period|Adverse Event|0|||
16820527|NCT01710358|37763632|FG000|Rescue Period|Death|0|||
16820528|NCT01710358|37763633|FG001|Rescue Period|Death|1|||
16820529|NCT01710358|37763634|FG002|Rescue Period|Death|0|||
16820530|NCT01710358|37763632|FG000|Rescue Period|Lack of Efficacy|0|||
16820531|NCT01710358|37763633|FG001|Rescue Period|Lack of Efficacy|7|||
16820532|NCT01710358|37763634|FG002|Rescue Period|Lack of Efficacy|0|||
16820533|NCT01710358|37763632|FG000|Rescue Period|Withdrawal by Subject|0|||
16820534|NCT01710358|37763633|FG001|Rescue Period|Withdrawal by Subject|8|||
16820535|NCT01710358|37763634|FG002|Rescue Period|Withdrawal by Subject|0|||
16820536|NCT01633112|37763658|FG000|Overall Study|Lack of Efficacy|1|||
16820537|NCT01633112|37763659|FG001|Overall Study|Lack of Efficacy|6|||
16820538|NCT01633112|37763660|FG002|Overall Study|Lack of Efficacy|13|||
16820539|NCT01633112|37763658|FG000|Overall Study|Abnormal laboratory value(s)|3|||
16820540|NCT01633112|37763659|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16820541|NCT01633112|37763660|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16820542|NCT01633112|37763658|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16820543|NCT01633112|37763659|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16820544|NCT01633112|37763660|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16820545|NCT01633112|37763658|FG000|Overall Study|Administrative problems|1|||
16820546|NCT01633112|37763659|FG001|Overall Study|Administrative problems|2|||
16820547|NCT01633112|37763660|FG002|Overall Study|Administrative problems|5|||
16820548|NCT01633112|37763658|FG000|Overall Study|Adverse Event|16|||
16820549|NCT01633112|37763659|FG001|Overall Study|Adverse Event|18|||
16820550|NCT01633112|37763660|FG002|Overall Study|Adverse Event|20|||
16820551|NCT01633112|37763658|FG000|Overall Study|Lost to Follow-up|7|||
16820552|NCT01633112|37763659|FG001|Overall Study|Lost to Follow-up|19|||
16820553|NCT01633112|37763660|FG002|Overall Study|Lost to Follow-up|6|||
16820554|NCT01633112|37763658|FG000|Overall Study|Protocol Violation|4|||
16820555|NCT01633112|37763659|FG001|Overall Study|Protocol Violation|0|||
16820556|NCT01633112|37763660|FG002|Overall Study|Protocol Violation|2|||
16820557|NCT01633112|37763658|FG000|Overall Study|Subject no longer requires study drug|0|||
16820558|NCT01633112|37763659|FG001|Overall Study|Subject no longer requires study drug|0|||
16820559|NCT01633112|37763660|FG002|Overall Study|Subject no longer requires study drug|1|||
16820560|NCT01633112|37763658|FG000|Overall Study|Withdrawal by Subject|20|||
16820561|NCT01633112|37763659|FG001|Overall Study|Withdrawal by Subject|12|||
16820562|NCT01633112|37763660|FG002|Overall Study|Withdrawal by Subject|41|||
16820563|NCT01633112|37763658|FG000|Overall Study|missing Study Completion CRF|1|||
16820564|NCT01633112|37763659|FG001|Overall Study|missing Study Completion CRF|1|||
16820565|NCT01633112|37763660|FG002|Overall Study|missing Study Completion CRF|4|||
16820566|NCT01691482|37763669|FG000|Treatment Period 2|Adverse Event|0|||
16820567|NCT01691482|37763670|FG001|Treatment Period 2|Adverse Event|1|||
16820568|NCT01691482|37763669|FG000|Treatment Period 2|Protocol Violation|1|||
16820569|NCT01691482|37763670|FG001|Treatment Period 2|Protocol Violation|1|||
16820570|NCT02246114|37763679|FG000|Overall Study|miscarriage|1|||
16820571|NCT02246114|37763680|FG001|Overall Study|miscarriage|0|||
16820572|NCT01710046|37763688|FG000|Overall Study|Lost to Follow-up|1|||
16820573|NCT01710046|37763689|FG001|Overall Study|Lost to Follow-up|0|||
16820574|NCT02154529|37763699|FG000|Overall Study|Death|1|||
16820575|NCT02154529|37763700|FG001|Overall Study|Death|1|||
16820576|NCT02154529|37763701|FG002|Overall Study|Death|5|||
16820577|NCT02154529|37763702|FG003|Overall Study|Death|1|||
16820578|NCT02154529|37763699|FG000|Overall Study|Termination of study by sponsor|2|||
16820579|NCT02154529|37763700|FG001|Overall Study|Termination of study by sponsor|2|||
16820580|NCT02154529|37763701|FG002|Overall Study|Termination of study by sponsor|3|||
16820581|NCT02154529|37763702|FG003|Overall Study|Termination of study by sponsor|1|||
16911286|NCT01525602|38020376|FG004|Overall Study|Withdrawal by Subject|3|||
16911287|NCT01525602|38020377|FG005|Overall Study|Withdrawal by Subject|1|||
16820582|NCT02154529|37763699|FG000|Overall Study|Lost to Follow-up|1|||
16820583|NCT02154529|37763700|FG001|Overall Study|Lost to Follow-up|0|||
16820584|NCT02154529|37763701|FG002|Overall Study|Lost to Follow-up|0|||
16820585|NCT02154529|37763702|FG003|Overall Study|Lost to Follow-up|0|||
16820586|NCT01954017|37763717|FG000|Overall Study|Adverse Event|0|||
16820587|NCT01954017|37763718|FG001|Overall Study|Adverse Event|0|||
16820588|NCT01954017|37763719|FG002|Overall Study|Adverse Event|1|||
16820589|NCT01954017|37763717|FG000|Overall Study|Death|2|||
16820590|NCT01954017|37763718|FG001|Overall Study|Death|1|||
16820591|NCT01954017|37763719|FG002|Overall Study|Death|1|||
16820592|NCT01954017|37763717|FG000|Overall Study|Withdrawal by Subject|0|||
16911288|NCT01525602|38020378|FG006|Overall Study|Withdrawal by Subject|0|||
16820593|NCT01954017|37763718|FG001|Overall Study|Withdrawal by Subject|1|||
16820594|NCT01954017|37763719|FG002|Overall Study|Withdrawal by Subject|0|||
16820595|NCT01954017|37763717|FG000|Overall Study|Protocol Violation|0|||
16820596|NCT01954017|37763718|FG001|Overall Study|Protocol Violation|3|||
16820597|NCT01954017|37763719|FG002|Overall Study|Protocol Violation|2|||
16820598|NCT01954017|37763717|FG000|Overall Study|Necrotizing enterocolitis|1|||
16820599|NCT01954017|37763718|FG001|Overall Study|Necrotizing enterocolitis|0|||
16820600|NCT01954017|37763719|FG002|Overall Study|Necrotizing enterocolitis|1|||
16820601|NCT01954017|37763717|FG000|Overall Study|Enteral intake stopped >7 days|0|||
16820602|NCT01954017|37763718|FG001|Overall Study|Enteral intake stopped >7 days|1|||
16820603|NCT01954017|37763719|FG002|Overall Study|Enteral intake stopped >7 days|1|||
16820604|NCT01954017|37763717|FG000|Overall Study|All other reasons|2|||
16820605|NCT01954017|37763718|FG001|Overall Study|All other reasons|2|||
16820606|NCT01954017|37763719|FG002|Overall Study|All other reasons|7|||
16820607|NCT02154139|37763753|FG000|Overall Study|Injection not administered|2|||
16820608|NCT02154139|37763753|FG000|Overall Study|Other|2|||
16820609|NCT02154139|37763753|FG000|Overall Study|Investigator transferred|3|||
16820610|NCT02245568|37763757|FG000|Overall Study|Study terminated by Sponsor|346|||
16820611|NCT02245568|37763757|FG000|Overall Study|Adverse Event|144|||
16820612|NCT02245568|37763757|FG000|Overall Study|Lack of Efficacy|98|||
16820613|NCT02245568|37763757|FG000|Overall Study|Withdrawal by Caregiver|85|||
16820614|NCT02245568|37763757|FG000|Overall Study|Withdrawal by Subject|77|||
16820615|NCT02245568|37763757|FG000|Overall Study|Withdrawal by Legal Representative|31|||
16820616|NCT02245568|37763757|FG000|Overall Study|Missing (Site closure)|16|||
16820617|NCT02245568|37763757|FG000|Overall Study|Physician Decision|14|||
16820618|NCT02245568|37763757|FG000|Overall Study|Non-compliance with study drug|11|||
16820619|NCT02245568|37763757|FG000|Overall Study|Death|9|||
16820620|NCT02245568|37763757|FG000|Overall Study|Blue staining|6|||
16820621|NCT02245568|37763757|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
16820622|NCT02245568|37763757|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
16820623|NCT02245568|37763757|FG000|Overall Study|Lost to Follow-up|5|||
16911289|NCT01525602|38020379|FG007|Overall Study|Withdrawal by Subject|1|||
16911290|NCT01525602|38020372|FG000|Overall Study|Physician Decision|0|||
16911291|NCT01525602|38020373|FG001|Overall Study|Physician Decision|0|||
16911292|NCT01525602|38020374|FG002|Overall Study|Physician Decision|0|||
16911293|NCT01525602|38020375|FG003|Overall Study|Physician Decision|0|||
16911294|NCT01525602|38020376|FG004|Overall Study|Physician Decision|3|||
16911295|NCT01525602|38020377|FG005|Overall Study|Physician Decision|0|||
16911296|NCT01525602|38020378|FG006|Overall Study|Physician Decision|1|||
16911297|NCT01525602|38020379|FG007|Overall Study|Physician Decision|0|||
16911298|NCT01525602|38020372|FG000|Overall Study|Death|0|||
16911299|NCT01525602|38020373|FG001|Overall Study|Death|0|||
16911300|NCT01525602|38020374|FG002|Overall Study|Death|0|||
16911301|NCT01525602|38020375|FG003|Overall Study|Death|0|||
16911302|NCT01525602|38020376|FG004|Overall Study|Death|1|||
16911303|NCT01525602|38020377|FG005|Overall Study|Death|1|||
16911304|NCT01525602|38020378|FG006|Overall Study|Death|0|||
16911305|NCT01525602|38020379|FG007|Overall Study|Death|0|||
16911306|NCT01525602|38020372|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
16911307|NCT01525602|38020373|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
16911308|NCT01525602|38020374|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
16911309|NCT01525602|38020375|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
16911310|NCT01525602|38020376|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
16911311|NCT01525602|38020377|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
16911312|NCT01525602|38020378|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
16911313|NCT01525602|38020379|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
16911314|NCT01549002|38020406|FG000|Overall Study|Excessive pain|0|||
16911315|NCT01549002|38020407|FG001|Overall Study|Excessive pain|2|||
16911316|NCT01549002|38020406|FG000|Overall Study|Moderate sedation required|0|||
16911317|NCT01549002|38020407|FG001|Overall Study|Moderate sedation required|2|||
16911318|NCT01548768|38020417|FG000|Overall Study|Withdrawal by Subject|0|||
16911319|NCT01548768|38020418|FG001|Overall Study|Withdrawal by Subject|2|||
16911320|NCT01548768|38020419|FG002|Overall Study|Withdrawal by Subject|1|||
16911321|NCT01548768|38020420|FG003|Overall Study|Withdrawal by Subject|0|||
16911322|NCT01548768|38020417|FG000|Overall Study|Physician Decision|1|||
16911323|NCT01548768|38020418|FG001|Overall Study|Physician Decision|0|||
17102370|NCT00099632|38241292|FG000|Overall Study|Protocol Violation|0|||
16820624|NCT02154061|37763763|FG000|Overall Study|Pregnancy|1|||
16911324|NCT01548768|38020419|FG002|Overall Study|Physician Decision|0|||
16911325|NCT01548768|38020420|FG003|Overall Study|Physician Decision|0|||
16911326|NCT01548768|38020417|FG000|Overall Study|Adverse Event|0|||
16911327|NCT01548768|38020418|FG001|Overall Study|Adverse Event|0|||
16911328|NCT01548768|38020419|FG002|Overall Study|Adverse Event|0|||
16911329|NCT01548768|38020420|FG003|Overall Study|Adverse Event|1|||
16911330|NCT01548768|38020417|FG000|Overall Study|Non-Compliance|0|||
16911331|NCT01548768|38020418|FG001|Overall Study|Non-Compliance|0|||
16911332|NCT01548768|38020419|FG002|Overall Study|Non-Compliance|0|||
16820625|NCT02154061|37763764|FG001|Overall Study|Pregnancy|0|||
16820626|NCT02154061|37763763|FG000|Overall Study|enrolled but not vaccinated|1|||
16820627|NCT02154061|37763764|FG001|Overall Study|enrolled but not vaccinated|0|||
16820628|NCT01907217|37763772|FG000|Overall Study|Withdrawal by Subject|0|||
16820629|NCT01907217|37763773|FG001|Overall Study|Withdrawal by Subject|2|||
16820630|NCT01953783|37763781|FG000|Overall Study|Progressive disease|2|||
16820631|NCT02134015|37763787|FG000|Overall Study|Protocol Violation|0|||
16820632|NCT02134015|37763788|FG001|Overall Study|Protocol Violation|1|||
16820633|NCT02134015|37763787|FG000|Overall Study|Death|2|||
16820634|NCT02134015|37763788|FG001|Overall Study|Death|1|||
16820635|NCT02134015|37763787|FG000|Overall Study|Reason not provided|1|||
16820636|NCT02134015|37763788|FG001|Overall Study|Reason not provided|2|||
16820637|NCT02134015|37763787|FG000|Overall Study|Clinical progression|14|||
16820638|NCT02134015|37763788|FG001|Overall Study|Clinical progression|7|||
16820639|NCT02134015|37763787|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
16820640|NCT02134015|37763788|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
16820641|NCT02134015|37763787|FG000|Overall Study|Study terminated by sponsor|2|||
16820642|NCT02134015|37763788|FG001|Overall Study|Study terminated by sponsor|3|||
16820643|NCT02134015|37763787|FG000|Overall Study|Adverse Event|9|||
16820644|NCT02134015|37763788|FG001|Overall Study|Adverse Event|10|||
16820645|NCT02134015|37763787|FG000|Overall Study|Withdrawal by Subject|3|||
16911333|NCT01548768|38020420|FG003|Overall Study|Non-Compliance|3|||
16911334|NCT01572792|38020437|FG000|Lead-in Study|Lost to Follow-up|5|||
16911335|NCT01572792|38020438|FG001|Lead-in Study|Lost to Follow-up|9|||
16911336|NCT01572792|38020439|FG002|Lead-in Study|Lost to Follow-up|4|||
16911337|NCT01572792|38020440|FG003|Lead-in Study|Lost to Follow-up|2|||
16911338|NCT01572792|38020441|FG004|Lead-in Study|Lost to Follow-up|4|||
16911339|NCT01572792|38020437|FG000|Lead-in Study|Withdrawal by Subject|22|||
16911340|NCT01572792|38020438|FG001|Lead-in Study|Withdrawal by Subject|11|||
16911341|NCT01572792|38020439|FG002|Lead-in Study|Withdrawal by Subject|12|||
16911342|NCT01572792|38020440|FG003|Lead-in Study|Withdrawal by Subject|24|||
16911343|NCT01572792|38020441|FG004|Lead-in Study|Withdrawal by Subject|11|||
16911344|NCT01572792|38020437|FG000|Lead-in Study|Protocol Violation|19|||
16911345|NCT01572792|38020438|FG001|Lead-in Study|Protocol Violation|10|||
16911346|NCT01572792|38020439|FG002|Lead-in Study|Protocol Violation|12|||
16820646|NCT02134015|37763788|FG001|Overall Study|Withdrawal by Subject|7|||
16820647|NCT01924845|37763794|FG000|Overall Study|Adverse Event|3|||
16820648|NCT01924845|37763794|FG000|Overall Study|Withdrawal by Subject|2|||
16820649|NCT01924845|37763794|FG000|Overall Study|Protocol Violation|1|||
16820650|NCT01630135|37763800|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
16820651|NCT01630135|37763801|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
16820652|NCT01691248|37763809|FG000|Overall Study|Protocol Violation|43|||
16820653|NCT01691248|37763810|FG001|Overall Study|Protocol Violation|27|||
16820654|NCT01691248|37763809|FG000|Overall Study|Adverse Event|24|||
16820655|NCT01691248|37763810|FG001|Overall Study|Adverse Event|22|||
16820656|NCT01691248|37763809|FG000|Overall Study|Withdrawal by Subject|20|||
16820657|NCT01691248|37763810|FG001|Overall Study|Withdrawal by Subject|18|||
16820658|NCT01691248|37763809|FG000|Overall Study|Confirmed CDAD|14|||
16820659|NCT01691248|37763810|FG001|Overall Study|Confirmed CDAD|31|||
16820660|NCT01691248|37763809|FG000|Overall Study|Lost to Follow-up|2|||
16820661|NCT01691248|37763810|FG001|Overall Study|Lost to Follow-up|5|||
16820662|NCT01691248|37763809|FG000|Overall Study|Reason not provided|4|||
16820663|NCT01691248|37763810|FG001|Overall Study|Reason not provided|4|||
16820664|NCT01691248|37763809|FG000|Overall Study|Not Treated|4|||
16820665|NCT01691248|37763810|FG001|Overall Study|Not Treated|7|||
16820666|NCT01924767|37763821|FG000|Overall Study|Adverse Event|1|||
16820667|NCT01924767|37763822|FG001|Overall Study|Adverse Event|0|||
16820668|NCT01924767|37763823|FG002|Overall Study|Adverse Event|1|||
16820669|NCT01924767|37763824|FG003|Overall Study|Adverse Event|0|||
16820670|NCT01924767|37763825|FG004|Overall Study|Adverse Event|0|||
16820671|NCT01691092|37763842|FG000|Overall Study|Lost to Follow-up|10|||
16820672|NCT01691092|37763842|FG000|Overall Study|Physician Decision|4|||
16820673|NCT01691092|37763842|FG000|Overall Study|Withdrawal by Subject|3|||
16820674|NCT01691092|37763842|FG000|Overall Study|non-compliance|3|||
16820675|NCT01691092|37763842|FG000|Overall Study|used for different study|2|||
16820676|NCT01691092|37763842|FG000|Overall Study|screen fail|19|||
16820677|NCT02133001|37763848|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
16820678|NCT02133001|37763849|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
16911347|NCT01572792|38020440|FG003|Lead-in Study|Protocol Violation|13|||
16911348|NCT01572792|38020441|FG004|Lead-in Study|Protocol Violation|21|||
16911349|NCT01572792|38020437|FG000|Lead-in Study|Lack of Efficacy|20|||
16820679|NCT02133001|37763848|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
16820680|NCT02133001|37763849|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
16911350|NCT01572792|38020438|FG001|Lead-in Study|Lack of Efficacy|5|||
16911351|NCT01572792|38020439|FG002|Lead-in Study|Lack of Efficacy|4|||
16911352|NCT01572792|38020440|FG003|Lead-in Study|Lack of Efficacy|8|||
16911353|NCT01572792|38020441|FG004|Lead-in Study|Lack of Efficacy|10|||
16911354|NCT01572792|38020437|FG000|Lead-in Study|Adverse Event|21|||
16911355|NCT01572792|38020438|FG001|Lead-in Study|Adverse Event|21|||
16820681|NCT02133001|37763848|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
16820682|NCT02133001|37763849|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
16820683|NCT02133001|37763848|FG000|Double Blind (Day 1-25)|Other|2|||
16820684|NCT02133001|37763849|FG001|Double Blind (Day 1-25)|Other|2|||
16820685|NCT02133001|37763848|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
16820686|NCT02133001|37763849|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
16820687|NCT02133001|37763848|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
16820688|NCT02133001|37763849|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
16820689|NCT02133001|37763848|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
16820690|NCT02133001|37763849|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
16820691|NCT02133001|37763848|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
16820692|NCT02133001|37763849|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
16820693|NCT01709578|37763860|FG000|Overall Study|Rescued and entered in long term safety|63|||
16820694|NCT01709578|37763861|FG001|Overall Study|Rescued and entered in long term safety|25|||
16820695|NCT01709578|37763862|FG002|Overall Study|Rescued and entered in long term safety|26|||
16820696|NCT01709578|37763860|FG000|Overall Study|Adverse Event|9|||
16820697|NCT01709578|37763861|FG001|Overall Study|Adverse Event|18|||
16820698|NCT01709578|37763862|FG002|Overall Study|Adverse Event|17|||
16820699|NCT01709578|37763860|FG000|Overall Study|Lack of Efficacy|5|||
16820700|NCT01709578|37763861|FG001|Overall Study|Lack of Efficacy|4|||
16820701|NCT01709578|37763862|FG002|Overall Study|Lack of Efficacy|2|||
16820702|NCT01709578|37763860|FG000|Overall Study|Poor compliance to protocol|1|||
16820703|NCT01709578|37763861|FG001|Overall Study|Poor compliance to protocol|2|||
16820704|NCT01709578|37763862|FG002|Overall Study|Poor compliance to protocol|1|||
16820705|NCT01709578|37763860|FG000|Overall Study|Other, not related to safety or efficacy|2|||
16820706|NCT01709578|37763861|FG001|Overall Study|Other, not related to safety or efficacy|7|||
16820707|NCT01709578|37763862|FG002|Overall Study|Other, not related to safety or efficacy|5|||
16820708|NCT02132767|37763872|FG000|Overall Study|Death|3|||
16820709|NCT02132767|37763873|FG001|Overall Study|Death|2|||
16820710|NCT02132767|37763872|FG000|Overall Study|Withdrawal by Subject|10|||
16820711|NCT02132767|37763873|FG001|Overall Study|Withdrawal by Subject|9|||
16820712|NCT02132767|37763872|FG000|Overall Study|Lost to Follow-up|4|||
16820713|NCT02132767|37763873|FG001|Overall Study|Lost to Follow-up|4|||
16820714|NCT02153905|37763881|FG000|Overall Study|Death|1|||
16820715|NCT02153905|37763882|FG001|Overall Study|Death|0|||
16820716|NCT02153827|37763890|FG000|Overall Study|Lost to Follow-up|3|||
16820717|NCT02153827|37763891|FG001|Overall Study|Lost to Follow-up|9|||
16820718|NCT02153359|37763897|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
16820719|NCT02153359|37763898|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
16820720|NCT01691014|37763911|FG000|Overall Study|Premature Termination|1|||
16820721|NCT01691014|37763912|FG001|Overall Study|Premature Termination|6|||
16820722|NCT01691014|37763913|FG002|Overall Study|Premature Termination|0|||
16820723|NCT01691014|37763914|FG003|Overall Study|Premature Termination|3|||
16820724|NCT01691014|37763911|FG000|Overall Study|Other|0|||
16820725|NCT01691014|37763912|FG001|Overall Study|Other|0|||
16820726|NCT01691014|37763913|FG002|Overall Study|Other|2|||
16820727|NCT01691014|37763914|FG003|Overall Study|Other|0|||
16820728|NCT01691014|37763911|FG000|Overall Study|Withdrawal by Subject|0|||
16820729|NCT01691014|37763912|FG001|Overall Study|Withdrawal by Subject|1|||
16820730|NCT01691014|37763913|FG002|Overall Study|Withdrawal by Subject|1|||
16820731|NCT01691014|37763914|FG003|Overall Study|Withdrawal by Subject|1|||
16820732|NCT01691014|37763911|FG000|Overall Study|Adverse Event|0|||
16820733|NCT01691014|37763912|FG001|Overall Study|Adverse Event|5|||
16820734|NCT01691014|37763913|FG002|Overall Study|Adverse Event|1|||
16820735|NCT01691014|37763914|FG003|Overall Study|Adverse Event|1|||
16820736|NCT01691014|37763911|FG000|Overall Study|Lack of Efficacy|2|||
16820737|NCT01691014|37763912|FG001|Overall Study|Lack of Efficacy|3|||
16820738|NCT01691014|37763913|FG002|Overall Study|Lack of Efficacy|7|||
16820739|NCT01691014|37763914|FG003|Overall Study|Lack of Efficacy|0|||
16820740|NCT02245412|37763927|FG000|Treatment Period|Death|1|||
16820741|NCT02245412|37763928|FG001|Treatment Period|Death|1|||
16820742|NCT02245412|37763929|FG002|Treatment Period|Death|0|||
16820743|NCT02245412|37763927|FG000|Treatment Period|Physician Decision|1|||
16820744|NCT02245412|37763928|FG001|Treatment Period|Physician Decision|1|||
16820745|NCT02245412|37763929|FG002|Treatment Period|Physician Decision|0|||
16820746|NCT02245412|37763927|FG000|Treatment Period|Withdrawal by Subject|2|||
16820747|NCT02245412|37763928|FG001|Treatment Period|Withdrawal by Subject|1|||
16820748|NCT02245412|37763929|FG002|Treatment Period|Withdrawal by Subject|0|||
16820749|NCT02245412|37763927|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
16820750|NCT02245412|37763928|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
16820751|NCT02245412|37763929|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
16820752|NCT02245412|37763927|FG000|Follow-Up Period|Death|4|||
16820753|NCT02245412|37763928|FG001|Follow-Up Period|Death|2|||
16820754|NCT02245412|37763929|FG002|Follow-Up Period|Death|1|||
16820755|NCT02245412|37763927|FG000|Follow-Up Period|Physician Decision|1|||
16820756|NCT02245412|37763928|FG001|Follow-Up Period|Physician Decision|0|||
16820757|NCT02245412|37763929|FG002|Follow-Up Period|Physician Decision|0|||
16820758|NCT02245412|37763927|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
16820759|NCT02245412|37763928|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
16820760|NCT02245412|37763929|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
16820761|NCT02244944|37763937|FG000|Overall Study|Withdrawal by Subject|1|||
16820762|NCT02244944|37763937|FG000|Overall Study|Study Terminated|1|||
16820763|NCT01689532|37763943|FG000|Overall Study|Adverse Event|9|||
16820764|NCT01689532|37763944|FG001|Overall Study|Adverse Event|5|||
16820765|NCT01689532|37763943|FG000|Overall Study|Lack of Efficacy|2|||
16820766|NCT01689532|37763944|FG001|Overall Study|Lack of Efficacy|2|||
16820767|NCT01689532|37763943|FG000|Overall Study|Withdrawal by Subject|1|||
16820768|NCT01689532|37763944|FG001|Overall Study|Withdrawal by Subject|2|||
16820769|NCT01689532|37763943|FG000|Overall Study|Physician Decision|2|||
16820770|NCT01689532|37763944|FG001|Overall Study|Physician Decision|0|||
16820771|NCT01924689|37763956|FG000|Overall Study|Death|0|||
16820772|NCT01924689|37763957|FG001|Overall Study|Death|1|||
16820773|NCT01924689|37763958|FG002|Overall Study|Death|0|||
16820774|NCT01924689|37763959|FG003|Overall Study|Death|1|||
16820775|NCT01924689|37763960|FG004|Overall Study|Death|0|||
16820776|NCT01924689|37763961|FG005|Overall Study|Death|0|||
16820777|NCT01924689|37763956|FG000|Overall Study|Disease progression|0|||
16820778|NCT01924689|37763957|FG001|Overall Study|Disease progression|0|||
16820779|NCT01924689|37763958|FG002|Overall Study|Disease progression|2|||
16820780|NCT01924689|37763959|FG003|Overall Study|Disease progression|0|||
16820781|NCT01924689|37763960|FG004|Overall Study|Disease progression|3|||
16820782|NCT01924689|37763961|FG005|Overall Study|Disease progression|2|||
16820783|NCT01924689|37763956|FG000|Overall Study|New therapy or study|3|||
16820784|NCT01924689|37763957|FG001|Overall Study|New therapy or study|2|||
16820785|NCT01924689|37763958|FG002|Overall Study|New therapy or study|1|||
16820786|NCT01924689|37763959|FG003|Overall Study|New therapy or study|4|||
16820787|NCT01924689|37763960|FG004|Overall Study|New therapy or study|2|||
16820788|NCT01924689|37763961|FG005|Overall Study|New therapy or study|0|||
16820789|NCT01924689|37763956|FG000|Overall Study|Withdrawal of consent|0|||
16820790|NCT01924689|37763957|FG001|Overall Study|Withdrawal of consent|0|||
16820791|NCT01924689|37763958|FG002|Overall Study|Withdrawal of consent|1|||
16820792|NCT01924689|37763959|FG003|Overall Study|Withdrawal of consent|1|||
16820793|NCT01924689|37763960|FG004|Overall Study|Withdrawal of consent|0|||
16820794|NCT01924689|37763961|FG005|Overall Study|Withdrawal of consent|0|||
16820795|NCT01924689|37763956|FG000|Overall Study|Other|0|||
16820796|NCT01924689|37763957|FG001|Overall Study|Other|0|||
16820797|NCT01924689|37763958|FG002|Overall Study|Other|0|||
16820798|NCT01924689|37763959|FG003|Overall Study|Other|0|||
16820799|NCT01924689|37763960|FG004|Overall Study|Other|1|||
16820800|NCT01924689|37763961|FG005|Overall Study|Other|0|||
16820801|NCT01591330|37763979|FG000|Period 1|Adverse Event|1|||
16820802|NCT01591330|37763980|FG001|Period 1|Adverse Event|0|||
16820803|NCT01591330|37763981|FG002|Period 1|Adverse Event|0|||
16820804|NCT01591330|37763982|FG003|Period 1|Adverse Event|0|||
16820805|NCT01591330|37763979|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
16820806|NCT01591330|37763980|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
16820807|NCT01591330|37763981|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
16820808|NCT01591330|37763982|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
16820809|NCT01591330|37763979|FG000|Period 2|Adverse Event|1|||
16820810|NCT01591330|37763980|FG001|Period 2|Adverse Event|0|||
16820811|NCT01591330|37763981|FG002|Period 2|Adverse Event|0|||
16820812|NCT01591330|37763982|FG003|Period 2|Adverse Event|0|||
16820813|NCT01591096|37763992|FG000|Overall Study|Adverse Event|1|||
16820814|NCT01953003|37763998|FG000|Overall Study|Not treated|0|||
16820815|NCT01953003|37763999|FG001|Overall Study|Not treated|1|||
16820816|NCT01953003|37763998|FG000|Overall Study|Progressive disease|35|||
16820817|NCT01953003|37763999|FG001|Overall Study|Progressive disease|45|||
16820818|NCT01953003|37763998|FG000|Overall Study|Related Adverse events|7|||
16820819|NCT01953003|37763999|FG001|Overall Study|Related Adverse events|2|||
16820820|NCT01953003|37763998|FG000|Overall Study|Non-related adverse events|0|||
16820821|NCT01953003|37763999|FG001|Overall Study|Non-related adverse events|2|||
16820822|NCT01953003|37763998|FG000|Overall Study|Protocol Violation|0|||
16820823|NCT01953003|37763999|FG001|Overall Study|Protocol Violation|1|||
16820824|NCT01953003|37763998|FG000|Overall Study|Withdrawal by Subject|14|||
16820825|NCT01953003|37763999|FG001|Overall Study|Withdrawal by Subject|4|||
16820826|NCT01952691|37764005|FG000|Overall Study|Lost to Follow-up|2|||
16820827|NCT01709500|37764011|FG000|Overall Study|Randomized but not treated|0|||
16820828|NCT01709500|37764012|FG001|Overall Study|Randomized but not treated|1|||
16820829|NCT01709500|37764011|FG000|Overall Study|Adverse Event|5|||
16820830|NCT01709500|37764012|FG001|Overall Study|Adverse Event|1|||
16820831|NCT01709500|37764011|FG000|Overall Study|Poor compliance to protocol|2|||
16820832|NCT01709500|37764012|FG001|Overall Study|Poor compliance to protocol|1|||
16820833|NCT01709500|37764011|FG000|Overall Study|Other|3|||
16820834|NCT01709500|37764012|FG001|Overall Study|Other|1|||
16820835|NCT01709500|37764011|FG000|Overall Study|Related to IMP administration|1|||
16820836|NCT01709500|37764012|FG001|Overall Study|Related to IMP administration|0|||
16820837|NCT01709500|37764011|FG000|Overall Study|Treatment ongoing|156|||
16820838|NCT01709500|37764012|FG001|Overall Study|Treatment ongoing|78|||
16820839|NCT01599806|37764020|FG000|Overall Study|Lost to Follow-up|20|||
16820840|NCT01599806|37764021|FG001|Overall Study|Lost to Follow-up|20|||
16820841|NCT01599806|37764020|FG000|Overall Study|Withdrawal by Subject|12|||
16820842|NCT01599806|37764021|FG001|Overall Study|Withdrawal by Subject|12|||
16820843|NCT01599806|37764020|FG000|Overall Study|Other Eligibility criteria|11|||
16820844|NCT01599806|37764021|FG001|Overall Study|Other Eligibility criteria|9|||
16820845|NCT01599325|37764027|FG000|Primary Parent Phase|Adverse Event|5|||
16820846|NCT01599325|37764027|FG000|Primary Parent Phase|Disease Progression|7|||
16820847|NCT01599325|37764027|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
16820848|NCT01599325|37764027|FG000|Primary Parent Phase|Death|13|||
16820849|NCT01599325|37764027|FG000|Primary Parent Phase|Protocol Violation|1|||
16820850|NCT01599325|37764027|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
16820851|NCT01599325|37764027|FG000|Primary Parent Phase|Other|2|||
16820852|NCT01599325|37764027|FG000|Extension Phase|Study Closure|1|||
16820853|NCT01599325|37764027|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
16820854|NCT01599325|37764027|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
16820855|NCT01599325|37764027|FG000|Extension Phase|Disease Progression|1|||
16820856|NCT01599325|37764027|FG000|Extension Phase|Withdrawal by Subject|8|||
16820857|NCT01924299|37764034|FG000|Period 2|Withdrawal by Subject|1|||
16820858|NCT01924299|37764035|FG001|Period 2|Withdrawal by Subject|0|||
16820859|NCT01924299|37764034|FG000|Period 2|Adverse Event|0|||
16820860|NCT01924299|37764035|FG001|Period 2|Adverse Event|1|||
16820861|NCT02182999|37764049|FG000|Overall Study|Adverse Event|4|||
16820862|NCT02182999|37764050|FG001|Overall Study|Adverse Event|3|||
16820863|NCT02182999|37764049|FG000|Overall Study|Physician Decision|1|||
16820864|NCT02182999|37764050|FG001|Overall Study|Physician Decision|0|||
16820865|NCT02243696|37764056|FG000|Overall Study|Death|282|||
16820866|NCT02243696|37764056|FG000|Overall Study|Withdrawal by Subject|79|||
16820867|NCT02243696|37764056|FG000|Overall Study|Lost to Follow-up|57|||
16820868|NCT02243696|37764056|FG000|Overall Study|Subject No Longer has Study System|42|||
16820869|NCT02243696|37764056|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
16820870|NCT02243696|37764056|FG000|Overall Study|Study Terminated for EP PASSION|961|||
16820871|NCT01598311|37764062|FG000|Overall Study|Physician Decision|4|||
16820872|NCT01598311|37764063|FG001|Overall Study|Physician Decision|5|||
16820873|NCT01598311|37764062|FG000|Overall Study|Adverse Event|9|||
16820874|NCT01598311|37764063|FG001|Overall Study|Adverse Event|13|||
16820875|NCT01598311|37764062|FG000|Overall Study|Lost to Follow-up|7|||
16820876|NCT01598311|37764063|FG001|Overall Study|Lost to Follow-up|12|||
16820877|NCT01598311|37764062|FG000|Overall Study|Withdrawal by Subject|9|||
16820878|NCT01598311|37764063|FG001|Overall Study|Withdrawal by Subject|13|||
16820879|NCT01598311|37764062|FG000|Overall Study|No reason provided.|0|||
16820880|NCT01598311|37764063|FG001|Overall Study|No reason provided.|5|||
16820881|NCT01598311|37764062|FG000|Overall Study|Randomized but never treated|8|||
16820882|NCT01598311|37764063|FG001|Overall Study|Randomized but never treated|5|||
16820883|NCT01598311|37764062|FG000|Overall Study|Treated but no confirmed CDAD|9|||
16820884|NCT01598311|37764063|FG001|Overall Study|Treated but no confirmed CDAD|8|||
16820885|NCT01598311|37764062|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
16820886|NCT01598311|37764063|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
16820887|NCT02182843|37764069|FG000|Overall Study|Withdrawal by Subject|7|||
16820888|NCT02182843|37764069|FG000|Overall Study|Lost to Follow-up|2|||
16820889|NCT02182843|37764069|FG000|Overall Study|Adverse Event|1|||
16820890|NCT02208050|37764075|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
16820891|NCT02208050|37764076|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
16820892|NCT02978222|37764098|FG000|Overall Study|Withdrawal by Subject|2|||
16820893|NCT02978222|37764099|FG001|Overall Study|Withdrawal by Subject|2|||
16820894|NCT02978222|37764098|FG000|Overall Study|Physician Decision|2|||
16820895|NCT02978222|37764099|FG001|Overall Study|Physician Decision|0|||
16820896|NCT02978222|37764098|FG000|Overall Study|Adverse Event|0|||
16820897|NCT02978222|37764099|FG001|Overall Study|Adverse Event|1|||
16820898|NCT02978222|37764098|FG000|Overall Study|Death|1|||
16820899|NCT02978222|37764099|FG001|Overall Study|Death|0|||
16820900|NCT02978222|37764098|FG000|Overall Study|Disease Progression|32|||
16820901|NCT02978222|37764099|FG001|Overall Study|Disease Progression|32|||
16820902|NCT02978222|37764098|FG000|Overall Study|Early Study Termination|24|||
16820903|NCT02978222|37764099|FG001|Overall Study|Early Study Termination|21|||
16820904|NCT02181673|37764107|FG000|Up to Week 24|Adverse Event|2|||
16820905|NCT02181673|37764108|FG001|Up to Week 24|Adverse Event|0|||
16820906|NCT02181673|37764109|FG002|Up to Week 24|Adverse Event|3|||
16820907|NCT02181673|37764107|FG000|Up to Week 24|Death|1|||
16820908|NCT02181673|37764108|FG001|Up to Week 24|Death|0|||
16820909|NCT02181673|37764109|FG002|Up to Week 24|Death|0|||
16820910|NCT02181673|37764107|FG000|Up to Week 24|Lack of Efficacy|1|||
16820911|NCT02181673|37764108|FG001|Up to Week 24|Lack of Efficacy|0|||
16820912|NCT02181673|37764109|FG002|Up to Week 24|Lack of Efficacy|0|||
16820913|NCT02181673|37764107|FG000|Up to Week 24|Lost to Follow-up|1|||
16820914|NCT02181673|37764108|FG001|Up to Week 24|Lost to Follow-up|0|||
16820915|NCT02181673|37764109|FG002|Up to Week 24|Lost to Follow-up|0|||
16820916|NCT02181673|37764107|FG000|Up to Week 24|Physician Decision|0|||
16820917|NCT02181673|37764108|FG001|Up to Week 24|Physician Decision|0|||
16820918|NCT02181673|37764109|FG002|Up to Week 24|Physician Decision|3|||
16820919|NCT02181673|37764107|FG000|Up to Week 24|Withdrawal by Subject|10|||
16820920|NCT02181673|37764108|FG001|Up to Week 24|Withdrawal by Subject|0|||
16820921|NCT02181673|37764109|FG002|Up to Week 24|Withdrawal by Subject|1|||
16820922|NCT02181673|37764107|FG000|Up to Week 24|Other|2|||
16820923|NCT02181673|37764108|FG001|Up to Week 24|Other|0|||
16820924|NCT02181673|37764109|FG002|Up to Week 24|Other|3|||
16820925|NCT02181673|37764107|FG000|Up to Week 24|Randomized not Treated|0|||
16820926|NCT02181673|37764108|FG001|Up to Week 24|Randomized not Treated|0|||
16820927|NCT02181673|37764109|FG002|Up to Week 24|Randomized not Treated|1|||
16820928|NCT02181673|37764107|FG000|Week 24-Week 60|Adverse Event|0|||
16820929|NCT02181673|37764108|FG001|Week 24-Week 60|Adverse Event|4|||
16820930|NCT02181673|37764109|FG002|Week 24-Week 60|Adverse Event|10|||
16820931|NCT02181673|37764107|FG000|Week 24-Week 60|Other|0|||
16820932|NCT02181673|37764108|FG001|Week 24-Week 60|Other|2|||
16820933|NCT02181673|37764109|FG002|Week 24-Week 60|Other|1|||
16820934|NCT02181673|37764107|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
16820935|NCT02181673|37764108|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
16820936|NCT02181673|37764109|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
16820937|NCT02181673|37764107|FG000|Week 24-Week 60|Pregnancy|0|||
16820938|NCT02181673|37764108|FG001|Week 24-Week 60|Pregnancy|0|||
16820939|NCT02181673|37764109|FG002|Week 24-Week 60|Pregnancy|1|||
16820940|NCT02181673|37764107|FG000|Week 24-Week 60|Lack of Efficacy|0|||
16820941|NCT02181673|37764108|FG001|Week 24-Week 60|Lack of Efficacy|0|||
16820942|NCT02181673|37764109|FG002|Week 24-Week 60|Lack of Efficacy|1|||
16820943|NCT02181673|37764107|FG000|Week 24-Week 60|Lost to Follow-up|0|||
16820944|NCT02181673|37764108|FG001|Week 24-Week 60|Lost to Follow-up|0|||
16820945|NCT02181673|37764109|FG002|Week 24-Week 60|Lost to Follow-up|1|||
16820946|NCT02181673|37764107|FG000|Week 24-Week 60|Physician Decision|0|||
16820947|NCT02181673|37764108|FG001|Week 24-Week 60|Physician Decision|0|||
16820948|NCT02181673|37764109|FG002|Week 24-Week 60|Physician Decision|1|||
16820949|NCT02131129|37764118|FG000|Overall Study|Withdrawal by Subject|1|||
16820950|NCT02131129|37764119|FG001|Overall Study|Withdrawal by Subject|0|||
16820951|NCT02152345|37764127|FG000|Overall Study|Case Cancellations|2|||
16820952|NCT02152345|37764128|FG001|Overall Study|Case Cancellations|4|||
16820953|NCT02152345|37764127|FG000|Overall Study|Withdrawal by Subject|2|||
16820954|NCT02152345|37764128|FG001|Overall Study|Withdrawal by Subject|1|||
16820955|NCT02180659|37764136|FG000|Overall Study|Adverse Event|1|||
16820956|NCT02180659|37764137|FG001|Overall Study|Adverse Event|0|||
16820957|NCT02180659|37764136|FG000|Overall Study|Lost to Follow-up|4|||
16820958|NCT02180659|37764137|FG001|Overall Study|Lost to Follow-up|2|||
16820959|NCT02180659|37764136|FG000|Overall Study|Subject incarcerated during conduct|1|||
16820960|NCT02180659|37764137|FG001|Overall Study|Subject incarcerated during conduct|0|||
16820961|NCT02180659|37764136|FG000|Overall Study|Withdrawal by Subject|0|||
16820962|NCT02180659|37764137|FG001|Overall Study|Withdrawal by Subject|2|||
16820963|NCT02180659|37764136|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
16820964|NCT02180659|37764137|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
16820965|NCT02130427|37764143|FG000|Overall Study|Imaging results not interpretable|30|||
16820966|NCT02207816|37764150|FG000|Overall Study|Serious Adverse Event|0|||
16820967|NCT02207816|37764151|FG001|Overall Study|Serious Adverse Event|5|||
16820968|NCT02207816|37764152|FG002|Overall Study|Serious Adverse Event|2|||
16820969|NCT02207816|37764150|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
16820970|NCT02207816|37764151|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
16820971|NCT02207816|37764152|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
16820972|NCT02207816|37764150|FG000|Overall Study|Withdrawal by Subject|4|||
16820973|NCT02207816|37764151|FG001|Overall Study|Withdrawal by Subject|9|||
16820974|NCT02207816|37764152|FG002|Overall Study|Withdrawal by Subject|7|||
16820975|NCT02207816|37764150|FG000|Overall Study|Migrated/Moved From Study Area|41|||
16820976|NCT02207816|37764151|FG001|Overall Study|Migrated/Moved From Study Area|60|||
16820977|NCT02207816|37764152|FG002|Overall Study|Migrated/Moved From Study Area|51|||
16820978|NCT02207816|37764150|FG000|Overall Study|Lost to Follow-up|3|||
16820979|NCT02207816|37764151|FG001|Overall Study|Lost to Follow-up|9|||
16820980|NCT02207816|37764152|FG002|Overall Study|Lost to Follow-up|1|||
16820981|NCT02207816|37764150|FG000|Overall Study|Other|1|||
16820982|NCT02207816|37764151|FG001|Overall Study|Other|2|||
16820983|NCT02207816|37764152|FG002|Overall Study|Other|4|||
16820984|NCT02241512|37764165|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
16820985|NCT02241512|37764166|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
16820986|NCT02205476|37764174|FG000|Overall Study|Study termination by Sponsor|7|||
16820987|NCT02205476|37764175|FG001|Overall Study|Study termination by Sponsor|3|||
16820988|NCT01709110|37764189|FG000|Overall Study|Adverse Event|56|||
16820989|NCT01709110|37764190|FG001|Overall Study|Adverse Event|48|||
16820990|NCT01709110|37764189|FG000|Overall Study|Death|14|||
16820991|NCT01709110|37764190|FG001|Overall Study|Death|6|||
16820992|NCT01709110|37764189|FG000|Overall Study|Lost to Follow-up|7|||
16820993|NCT01709110|37764190|FG001|Overall Study|Lost to Follow-up|5|||
16820994|NCT01709110|37764189|FG000|Overall Study|Protocol Violation|4|||
16820995|NCT01709110|37764190|FG001|Overall Study|Protocol Violation|6|||
16820996|NCT01709110|37764189|FG000|Overall Study|Withdrawal by Subject|96|||
16820997|NCT01709110|37764190|FG001|Overall Study|Withdrawal by Subject|89|||
16820998|NCT01709110|37764189|FG000|Overall Study|Physician Decision|4|||
16820999|NCT01709110|37764190|FG001|Overall Study|Physician Decision|10|||
16821000|NCT01709110|37764189|FG000|Overall Study|Sponsor Decision|2|||
16821001|NCT01709110|37764190|FG001|Overall Study|Sponsor Decision|2|||
16821002|NCT01709110|37764189|FG000|Overall Study|Lack of Efficacy|1|||
16821003|NCT01709110|37764190|FG001|Overall Study|Lack of Efficacy|1|||
16821004|NCT01709110|37764189|FG000|Overall Study|Caregiver Decision|1|||
16821005|NCT01709110|37764190|FG001|Overall Study|Caregiver Decision|1|||
16821006|NCT02240108|37764198|FG000|Overall Study|Other than specified|8|||
16821007|NCT02240108|37764199|FG001|Overall Study|Other than specified|6|||
16821008|NCT02240108|37764198|FG000|Overall Study|Adverse Event|1|||
16821009|NCT02240108|37764199|FG001|Overall Study|Adverse Event|9|||
16821010|NCT02240108|37764198|FG000|Overall Study|Pregnancy|1|||
16821011|NCT02240108|37764199|FG001|Overall Study|Pregnancy|0|||
16821012|NCT02240108|37764198|FG000|Overall Study|Withdrawal by Subject|4|||
16821013|NCT02240108|37764199|FG001|Overall Study|Withdrawal by Subject|9|||
16821014|NCT02240108|37764198|FG000|Overall Study|StudyTerminated by Sponsor|0|||
16821015|NCT02240108|37764199|FG001|Overall Study|StudyTerminated by Sponsor|1|||
16821016|NCT02239640|37764205|FG000|Overall Study|Withdrawal by Subject|3|||
16821017|NCT02239640|37764205|FG000|Overall Study|Lost to Follow-up|72|||
16821018|NCT02239640|37764205|FG000|Overall Study|Death|142|||
16821019|NCT01590628|37764217|FG000|Overall Study|Death|2|||
16821020|NCT01590628|37764218|FG001|Overall Study|Death|0|||
16821021|NCT02130193|37764230|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
16821022|NCT02130193|37764231|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
16821023|NCT02130193|37764232|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
16821024|NCT02130193|37764230|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
16821025|NCT02130193|37764231|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
16821026|NCT02130193|37764232|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
16821027|NCT02130193|37764230|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
16821028|NCT02130193|37764231|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
16821029|NCT02130193|37764232|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
16821030|NCT02130193|37764230|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
16821031|NCT02130193|37764231|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
16821032|NCT02130193|37764232|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
16821033|NCT01590082|37764243|FG000|Overall Study|Withdrawal by Subject|1|||
16821034|NCT01590082|37764244|FG001|Overall Study|Withdrawal by Subject|0|||
16821035|NCT01590082|37764243|FG000|Overall Study|Ineligible|1|||
16821036|NCT01590082|37764244|FG001|Overall Study|Ineligible|0|||
16821037|NCT01631474|37764255|FG000|Overall Study|Lost to Follow-up|8|||
16821038|NCT01631474|37764256|FG001|Overall Study|Lost to Follow-up|5|||
16821039|NCT01631474|37764257|FG002|Overall Study|Lost to Follow-up|7|||
16821040|NCT01631474|37764258|FG003|Overall Study|Lost to Follow-up|5|||
16821041|NCT01631474|37764259|FG004|Overall Study|Lost to Follow-up|5|||
16821042|NCT01631474|37764255|FG000|Overall Study|Withdrawal by Subject|4|||
16821043|NCT01631474|37764256|FG001|Overall Study|Withdrawal by Subject|4|||
16821044|NCT01631474|37764257|FG002|Overall Study|Withdrawal by Subject|2|||
16821045|NCT01631474|37764258|FG003|Overall Study|Withdrawal by Subject|6|||
16821046|NCT01631474|37764259|FG004|Overall Study|Withdrawal by Subject|5|||
16821047|NCT01631474|37764255|FG000|Overall Study|Lack of Efficacy|2|||
16821048|NCT01631474|37764256|FG001|Overall Study|Lack of Efficacy|2|||
16821049|NCT01631474|37764257|FG002|Overall Study|Lack of Efficacy|0|||
16821050|NCT01631474|37764258|FG003|Overall Study|Lack of Efficacy|0|||
16821051|NCT01631474|37764259|FG004|Overall Study|Lack of Efficacy|2|||
16821052|NCT01631474|37764255|FG000|Overall Study|Noncompliance with Study Drug|0|||
16821053|NCT01631474|37764256|FG001|Overall Study|Noncompliance with Study Drug|0|||
16821054|NCT01631474|37764257|FG002|Overall Study|Noncompliance with Study Drug|0|||
16821055|NCT01631474|37764258|FG003|Overall Study|Noncompliance with Study Drug|0|||
16821056|NCT01631474|37764259|FG004|Overall Study|Noncompliance with Study Drug|1|||
16821057|NCT01631474|37764255|FG000|Overall Study|Adverse Event|0|||
16821058|NCT01631474|37764256|FG001|Overall Study|Adverse Event|1|||
16821059|NCT01631474|37764257|FG002|Overall Study|Adverse Event|0|||
16821060|NCT01631474|37764258|FG003|Overall Study|Adverse Event|0|||
16821061|NCT01631474|37764259|FG004|Overall Study|Adverse Event|0|||
16821062|NCT02203916|37764274|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16821063|NCT02203916|37764275|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
16821064|NCT02203916|37764276|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
16821065|NCT02203916|37764274|FG000|Overall Study|Major Protocol Deviation|1|||
16821066|NCT02203916|37764275|FG001|Overall Study|Major Protocol Deviation|1|||
16821067|NCT02203916|37764276|FG002|Overall Study|Major Protocol Deviation|0|||
16821068|NCT02203916|37764274|FG000|Overall Study|Lost to Follow-up|0|||
16821069|NCT02203916|37764275|FG001|Overall Study|Lost to Follow-up|1|||
16821070|NCT02203916|37764276|FG002|Overall Study|Lost to Follow-up|0|||
16821071|NCT02203916|37764274|FG000|Overall Study|Voluntary Withdrawal|3|||
16821072|NCT02203916|37764275|FG001|Overall Study|Voluntary Withdrawal|3|||
16821073|NCT02203916|37764276|FG002|Overall Study|Voluntary Withdrawal|8|||
16821074|NCT02203916|37764274|FG000|Overall Study|Lack of Efficacy|3|||
16821075|NCT02203916|37764275|FG001|Overall Study|Lack of Efficacy|0|||
16821076|NCT02203916|37764276|FG002|Overall Study|Lack of Efficacy|0|||
16821077|NCT02203916|37764274|FG000|Overall Study|Reason Not Specified|0|||
16821078|NCT02203916|37764275|FG001|Overall Study|Reason Not Specified|2|||
16821079|NCT02203916|37764276|FG002|Overall Study|Reason Not Specified|1|||
16821080|NCT02179177|37764300|FG000|Overall Study|Lost to Follow-up|1|||
16821081|NCT02179177|37764301|FG001|Overall Study|Lost to Follow-up|1|||
16821082|NCT02179177|37764300|FG000|Overall Study|Withdrawal by Subject|1|||
16821083|NCT02179177|37764301|FG001|Overall Study|Withdrawal by Subject|1|||
16821084|NCT02239328|37764307|FG000|Overall Study|Benign disease noted at time of surgery|6|||
16821085|NCT02239328|37764307|FG000|Overall Study|Equipment or website malfunction|2|||
16821086|NCT02129803|37764313|FG000|Overall Study|Protocol Violation|4|||
16821087|NCT02129803|37764314|FG001|Overall Study|Protocol Violation|0|||
16821088|NCT02129803|37764313|FG000|Overall Study|Physician Decision|0|||
16821089|NCT02129803|37764314|FG001|Overall Study|Physician Decision|1|||
16821090|NCT02129803|37764313|FG000|Overall Study|Difficulty sleeping|1|||
16821091|NCT02129803|37764314|FG001|Overall Study|Difficulty sleeping|0|||
16821092|NCT02129803|37764313|FG000|Overall Study|Morning headache|0|||
16821093|NCT02129803|37764314|FG001|Overall Study|Morning headache|1|||
16821094|NCT02129803|37764313|FG000|Overall Study|Withdrawal by Subject|1|||
16821095|NCT02129803|37764314|FG001|Overall Study|Withdrawal by Subject|1|||
16821096|NCT02239094|37764320|FG000|Overall Study|Withdrawal by Subject|1|||
16821097|NCT02239094|37764320|FG000|Overall Study|Remitted before started|1|||
16821098|NCT02129647|37764324|FG000|Overall Study|Adverse Event|2|||
16821099|NCT02129647|37764324|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
16821100|NCT02238626|37764332|FG000|Overall Study|Adverse Event|3|||
16821101|NCT02238626|37764333|FG001|Overall Study|Adverse Event|5|||
16821102|NCT02238626|37764334|FG002|Overall Study|Adverse Event|0|||
16821103|NCT02238626|37764335|FG003|Overall Study|Adverse Event|3|||
16821104|NCT02238626|37764332|FG000|Overall Study|Lost to Follow-up|2|||
16821105|NCT02238626|37764333|FG001|Overall Study|Lost to Follow-up|4|||
16821106|NCT02238626|37764334|FG002|Overall Study|Lost to Follow-up|2|||
16821107|NCT02238626|37764335|FG003|Overall Study|Lost to Follow-up|2|||
16821108|NCT02238626|37764332|FG000|Overall Study|Withdrawal by Subject|0|||
16821109|NCT02238626|37764333|FG001|Overall Study|Withdrawal by Subject|3|||
16821110|NCT02238626|37764334|FG002|Overall Study|Withdrawal by Subject|0|||
16821111|NCT02238626|37764335|FG003|Overall Study|Withdrawal by Subject|1|||
16821112|NCT02238626|37764332|FG000|Overall Study|Death|0|||
16821113|NCT02238626|37764333|FG001|Overall Study|Death|0|||
16821114|NCT02238626|37764334|FG002|Overall Study|Death|1|||
16821115|NCT02238626|37764335|FG003|Overall Study|Death|1|||
16821116|NCT02238626|37764332|FG000|Overall Study|Other|0|||
16821117|NCT02238626|37764333|FG001|Overall Study|Other|2|||
16821118|NCT02238626|37764334|FG002|Overall Study|Other|0|||
16821119|NCT02238626|37764335|FG003|Overall Study|Other|0|||
16821120|NCT02151643|37764361|FG000|Overall Study|Adverse Event|2|||
16821121|NCT02151643|37764362|FG001|Overall Study|Adverse Event|0|||
16821122|NCT02151643|37764363|FG002|Overall Study|Adverse Event|1|||
16821123|NCT02151643|37764364|FG003|Overall Study|Adverse Event|4|||
16821124|NCT02151643|37764365|FG004|Overall Study|Adverse Event|0|||
16821125|NCT02151643|37764361|FG000|Overall Study|Withdrawal by Subject|0|||
16821126|NCT02151643|37764362|FG001|Overall Study|Withdrawal by Subject|1|||
16821127|NCT02151643|37764363|FG002|Overall Study|Withdrawal by Subject|1|||
16821128|NCT02151643|37764364|FG003|Overall Study|Withdrawal by Subject|1|||
16821129|NCT02151643|37764365|FG004|Overall Study|Withdrawal by Subject|1|||
16821130|NCT02151643|37764361|FG000|Overall Study|Hyperphosphataemia|1|||
16821131|NCT02151643|37764362|FG001|Overall Study|Hyperphosphataemia|0|||
16821132|NCT02151643|37764363|FG002|Overall Study|Hyperphosphataemia|0|||
16821133|NCT02151643|37764364|FG003|Overall Study|Hyperphosphataemia|0|||
16821134|NCT02151643|37764365|FG004|Overall Study|Hyperphosphataemia|1|||
16821135|NCT02151643|37764361|FG000|Overall Study|High Ferritin levels|3|||
16821136|NCT02151643|37764362|FG001|Overall Study|High Ferritin levels|3|||
16821137|NCT02151643|37764363|FG002|Overall Study|High Ferritin levels|2|||
16821138|NCT02151643|37764364|FG003|Overall Study|High Ferritin levels|2|||
16821139|NCT02151643|37764365|FG004|Overall Study|High Ferritin levels|1|||
16821140|NCT02203838|37764381|FG000|Overall Study|Lack of Efficacy|7|||
16821141|NCT02203838|37764382|FG001|Overall Study|Lack of Efficacy|0|||
16821142|NCT02203838|37764383|FG002|Overall Study|Lack of Efficacy|1|||
16821143|NCT02203838|37764384|FG003|Overall Study|Lack of Efficacy|1|||
16821144|NCT02203838|37764381|FG000|Overall Study|Adverse Event|46|||
16821145|NCT02203838|37764382|FG001|Overall Study|Adverse Event|6|||
16821146|NCT02203838|37764383|FG002|Overall Study|Adverse Event|3|||
16821147|NCT02203838|37764384|FG003|Overall Study|Adverse Event|2|||
16821148|NCT02203838|37764381|FG000|Overall Study|Lost to Follow-up|39|||
16911356|NCT01572792|38020439|FG002|Lead-in Study|Adverse Event|22|||
16911357|NCT01572792|38020440|FG003|Lead-in Study|Adverse Event|16|||
16911358|NCT01572792|38020441|FG004|Lead-in Study|Adverse Event|14|||
16911359|NCT01572792|38020437|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
16911360|NCT01572792|38020438|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
16911361|NCT01572792|38020439|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
16911362|NCT01572792|38020440|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
16821149|NCT02203838|37764382|FG001|Overall Study|Lost to Follow-up|3|||
16821150|NCT02203838|37764383|FG002|Overall Study|Lost to Follow-up|2|||
16821151|NCT02203838|37764384|FG003|Overall Study|Lost to Follow-up|1|||
16821152|NCT02203838|37764381|FG000|Overall Study|Protocol Violation|7|||
16821153|NCT02203838|37764382|FG001|Overall Study|Protocol Violation|3|||
16821154|NCT02203838|37764383|FG002|Overall Study|Protocol Violation|0|||
16821155|NCT02203838|37764384|FG003|Overall Study|Protocol Violation|0|||
16821156|NCT02203838|37764381|FG000|Overall Study|Withdrawal by Subject|83|||
16821157|NCT02203838|37764382|FG001|Overall Study|Withdrawal by Subject|10|||
16821158|NCT02203838|37764383|FG002|Overall Study|Withdrawal by Subject|8|||
16821159|NCT02203838|37764384|FG003|Overall Study|Withdrawal by Subject|11|||
16821160|NCT02203838|37764381|FG000|Overall Study|Physician Decision|27|||
16821161|NCT02203838|37764382|FG001|Overall Study|Physician Decision|0|||
16821162|NCT02203838|37764383|FG002|Overall Study|Physician Decision|2|||
16821163|NCT02203838|37764384|FG003|Overall Study|Physician Decision|3|||
16821164|NCT02203838|37764381|FG000|Overall Study|Other|1|||
16821165|NCT02203838|37764382|FG001|Overall Study|Other|0|||
16821166|NCT02203838|37764383|FG002|Overall Study|Other|0|||
16821167|NCT02203838|37764384|FG003|Overall Study|Other|0|||
16821168|NCT02178787|37764396|FG000|Overall Study|Lost to Follow-up|1|||
16821169|NCT02178787|37764397|FG001|Overall Study|Lost to Follow-up|0|||
16821170|NCT02178787|37764396|FG000|Overall Study|Withdrawal by Subject|0|||
16821171|NCT02178787|37764397|FG001|Overall Study|Withdrawal by Subject|2|||
16821172|NCT02178787|37764396|FG000|Overall Study|No TCD window|3|||
16821173|NCT02178787|37764397|FG001|Overall Study|No TCD window|7|||
16821174|NCT02178787|37764396|FG000|Overall Study|Physician Decision|1|||
16821175|NCT02178787|37764397|FG001|Overall Study|Physician Decision|0|||
16821176|NCT02178709|37764405|FG000|Overall Study|Adverse Event|5|||
16821177|NCT02178709|37764405|FG000|Overall Study|Death|2|||
16821178|NCT02178709|37764405|FG000|Overall Study|Withdrawal by Subject|2|||
16821179|NCT02178709|37764405|FG000|Overall Study|Physician Decision|2|||
16821180|NCT02178709|37764405|FG000|Overall Study|Disease Progression|5|||
16821181|NCT02238080|37764409|FG000|Overall Study|Death|13|||
16821182|NCT02238080|37764409|FG000|Overall Study|Treatment interrupted|6|||
16821183|NCT02238080|37764409|FG000|Overall Study|Withdrawal by Subject|2|||
16821184|NCT02238080|37764409|FG000|Overall Study|Other|4|||
16821185|NCT02150863|37764416|FG000|Overall Study|Lost to Follow-up|0|||
16821186|NCT02150863|37764417|FG001|Overall Study|Lost to Follow-up|1|||
16821187|NCT02150863|37764418|FG002|Overall Study|Lost to Follow-up|0|||
16821188|NCT02178553|37764428|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
16821189|NCT02178553|37764429|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
16821190|NCT02178553|37764428|FG000|Overall Study|Physician Decision|0|||
16821191|NCT02178553|37764429|FG001|Overall Study|Physician Decision|4|||
16821192|NCT02178553|37764428|FG000|Overall Study|Technical problem with injection|1|||
16821193|NCT02178553|37764429|FG001|Overall Study|Technical problem with injection|3|||
16821194|NCT01627327|37764437|FG000|Overall Study|Adverse Event|6|||
16821195|NCT01627327|37764438|FG001|Overall Study|Adverse Event|12|||
16821196|NCT01627327|37764437|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
16821197|NCT01627327|37764438|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
16821198|NCT01627327|37764437|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
16821199|NCT01627327|37764438|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
16821200|NCT01627327|37764437|FG000|Overall Study|Protocol Violation|4|||
16821201|NCT01627327|37764438|FG001|Overall Study|Protocol Violation|10|||
16821202|NCT01627327|37764437|FG000|Overall Study|Lost to Follow-up|1|||
16821203|NCT01627327|37764438|FG001|Overall Study|Lost to Follow-up|3|||
16821204|NCT01627327|37764437|FG000|Overall Study|Physician Decision|1|||
16821205|NCT01627327|37764438|FG001|Overall Study|Physician Decision|0|||
16821206|NCT01627327|37764437|FG000|Overall Study|Withdrawal by Subject|3|||
16821207|NCT01627327|37764438|FG001|Overall Study|Withdrawal by Subject|3|||
16821208|NCT01627249|37764447|FG000|Overall Study|Death|3|||
16821209|NCT01627249|37764448|FG001|Overall Study|Death|5|||
16821210|NCT01627249|37764449|FG002|Overall Study|Death|3|||
16821211|NCT01627249|37764447|FG000|Overall Study|Withdrawal by Subject|12|||
16821212|NCT01627249|37764448|FG001|Overall Study|Withdrawal by Subject|6|||
16821213|NCT01627249|37764449|FG002|Overall Study|Withdrawal by Subject|9|||
16821214|NCT01627249|37764447|FG000|Overall Study|Missed Visit|1|||
16821215|NCT01627249|37764448|FG001|Overall Study|Missed Visit|1|||
16821216|NCT01627249|37764449|FG002|Overall Study|Missed Visit|0|||
16821217|NCT01688830|37764478|FG000|Overall Study|Lost to Follow-up|0|||
16821218|NCT01688830|37764479|FG001|Overall Study|Lost to Follow-up|0|||
16821219|NCT01688830|37764480|FG002|Overall Study|Lost to Follow-up|0|||
16821220|NCT01688830|37764481|FG003|Overall Study|Lost to Follow-up|0|||
16821221|NCT01688830|37764482|FG004|Overall Study|Lost to Follow-up|0|||
16821222|NCT01688830|37764483|FG005|Overall Study|Lost to Follow-up|0|||
16821223|NCT01688830|37764484|FG006|Overall Study|Lost to Follow-up|0|||
16821224|NCT01688830|37764485|FG007|Overall Study|Lost to Follow-up|0|||
16821225|NCT01688830|37764486|FG008|Overall Study|Lost to Follow-up|0|||
16821226|NCT01688830|37764487|FG009|Overall Study|Lost to Follow-up|0|||
16821227|NCT01688830|37764488|FG010|Overall Study|Lost to Follow-up|1|||
16821228|NCT01688830|37764489|FG011|Overall Study|Lost to Follow-up|0|||
16821229|NCT01688830|37764490|FG012|Overall Study|Lost to Follow-up|0|||
16821230|NCT01688830|37764491|FG013|Overall Study|Lost to Follow-up|0|||
16821231|NCT01688830|37764492|FG014|Overall Study|Lost to Follow-up|0|||
16821232|NCT01688830|37764493|FG015|Overall Study|Lost to Follow-up|0|||
16821233|NCT01688830|37764494|FG016|Overall Study|Lost to Follow-up|0|||
16821234|NCT01688830|37764495|FG017|Overall Study|Lost to Follow-up|0|||
16821235|NCT01688830|37764496|FG018|Overall Study|Lost to Follow-up|0|||
16821236|NCT01688830|37764497|FG019|Overall Study|Lost to Follow-up|0|||
16821237|NCT01688830|37764498|FG020|Overall Study|Lost to Follow-up|0|||
16821238|NCT02178475|37764582|FG000|Overall Study|Withdrawal by Subject|7|||
16821239|NCT02178475|37764582|FG000|Overall Study|Lost to Follow-up|10|||
16821240|NCT02178475|37764582|FG000|Overall Study|Death|13|||
16821241|NCT02178475|37764582|FG000|Overall Study|Protocol-specified Criteria|99|||
16821242|NCT01569022|37764586|FG000|First Intervention|Lost to Follow-up|2|||
16821243|NCT01569022|37764587|FG001|First Intervention|Lost to Follow-up|1|||
16821244|NCT01569022|37764586|FG000|Second Intervention|Lost to Follow-up|2|||
16821245|NCT01569022|37764587|FG001|Second Intervention|Lost to Follow-up|2|||
16821246|NCT01629823|37764598|FG000|Trial Period|Missed visit|11|||
16821247|NCT01629823|37764599|FG001|Trial Period|Missed visit|9|||
16821248|NCT01629823|37764600|FG002|Trial Period|Missed visit|8|||
16821249|NCT01629823|37764598|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
16821250|NCT01629823|37764599|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
16821251|NCT01629823|37764600|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
16821252|NCT01629823|37764598|FG000|Trial Period|Pregnancy|1|||
16821253|NCT01629823|37764599|FG001|Trial Period|Pregnancy|0|||
16821254|NCT01629823|37764600|FG002|Trial Period|Pregnancy|0|||
16821255|NCT01629823|37764598|FG000|Trial Period|Adverse Event|0|||
16821256|NCT01629823|37764599|FG001|Trial Period|Adverse Event|1|||
16821257|NCT01629823|37764600|FG002|Trial Period|Adverse Event|0|||
16821258|NCT01629823|37764598|FG000|Trial Period|Out-of-window visit|0|||
16821259|NCT01629823|37764599|FG001|Trial Period|Out-of-window visit|2|||
16821260|NCT01629823|37764600|FG002|Trial Period|Out-of-window visit|0|||
16821261|NCT01629823|37764598|FG000|Trial Period|Failed to hold medication|0|||
16821262|NCT01629823|37764599|FG001|Trial Period|Failed to hold medication|0|||
16821263|NCT01629823|37764600|FG002|Trial Period|Failed to hold medication|1|||
16821264|NCT01629823|37764598|FG000|Washout Period|Safety|2|||
16821265|NCT01629823|37764599|FG001|Washout Period|Safety|5|||
16821266|NCT01629823|37764600|FG002|Washout Period|Safety|0|||
16821267|NCT01629823|37764598|FG000|Washout Period|Pregnancy|1|||
16821268|NCT01629823|37764599|FG001|Washout Period|Pregnancy|0|||
16821269|NCT01629823|37764600|FG002|Washout Period|Pregnancy|0|||
16821270|NCT01629823|37764598|FG000|Washout Period|Protocol Violation|0|||
16821271|NCT01629823|37764599|FG001|Washout Period|Protocol Violation|1|||
16821272|NCT01629823|37764600|FG002|Washout Period|Protocol Violation|0|||
16821273|NCT01688050|37764608|FG000|Overall Study|Death|7|||
16821274|NCT01688050|37764608|FG000|Overall Study|Conversion to open repair|1|||
16821275|NCT01688050|37764608|FG000|Overall Study|Lost to Follow-up|13|||
16821276|NCT01688050|37764608|FG000|Overall Study|Withdrawal by Subject|10|||
16821277|NCT01604278|37764614|FG000|Overall Study|Lack of Efficacy|0|||
16821278|NCT01604278|37764615|FG001|Overall Study|Lack of Efficacy|1|||
16821279|NCT01604278|37764614|FG000|Overall Study|Lost to Follow-up|1|||
16821280|NCT01604278|37764615|FG001|Overall Study|Lost to Follow-up|0|||
16821281|NCT01604278|37764614|FG000|Overall Study|Administrative problems|2|||
16821282|NCT01604278|37764615|FG001|Overall Study|Administrative problems|1|||
16821283|NCT01604278|37764614|FG000|Overall Study|Withdrawal by Subject|3|||
16821284|NCT01604278|37764615|FG001|Overall Study|Withdrawal by Subject|3|||
16821285|NCT01604278|37764614|FG000|Overall Study|Adverse Event|3|||
16821286|NCT01604278|37764615|FG001|Overall Study|Adverse Event|5|||
16821287|NCT01604278|37764614|FG000|Overall Study|Protocol Deviation|5|||
16821288|NCT01604278|37764615|FG001|Overall Study|Protocol Deviation|3|||
16821289|NCT01687270|37764621|FG000|Overall Study|Lack of Efficacy|11|||
16821290|NCT01687270|37764621|FG000|Overall Study|Lost to Follow-up|1|||
16821291|NCT01589770|37764627|FG000|Overall Study|EGFR <60ml/min|6|||
16821292|NCT01589770|37764628|FG001|Overall Study|EGFR <60ml/min|4|||
16821293|NCT01589770|37764627|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
16821294|NCT01589770|37764628|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
16821295|NCT01588990|37764634|FG000|Phase A|Withdrawal by Subject|5|||
16821296|NCT01588990|37764634|FG000|Phase A|Physician Decision|11|||
16821297|NCT01588990|37764634|FG000|Phase A|Other|14|||
16821298|NCT01588990|37764634|FG000|Phase A|Lost to Follow-up|1|||
16821299|NCT01588990|37764634|FG000|Phase A|Death|5|||
16821300|NCT01588990|37764634|FG000|Phase A|Adverse Event|28|||
16821301|NCT01588990|37764634|FG000|Phase A|Still on therapy at end of study|6|||
16821302|NCT01588990|37764634|FG000|Phase B|Adverse Event|2|||
16821303|NCT01588990|37764634|FG000|Phase B|Still on therapy at end of study|5|||
16821304|NCT01588990|37764634|FG000|Phase B|Withdrawal by Subject|3|||
16821305|NCT01588990|37764634|FG000|Phase B|Physician Decision|4|||
16821306|NCT01588990|37764634|FG000|Phase B|Other|2|||
16821307|NCT02176525|37764650|FG000|Overall Study|Adverse Event|0|||
16821308|NCT02176525|37764651|FG001|Overall Study|Adverse Event|0|||
16821309|NCT02176525|37764652|FG002|Overall Study|Adverse Event|0|||
16821310|NCT02176525|37764653|FG003|Overall Study|Adverse Event|1|||
16821311|NCT02176525|37764654|FG004|Overall Study|Adverse Event|1|||
16821312|NCT02176525|37764655|FG005|Overall Study|Adverse Event|0|||
16821313|NCT02176525|37764656|FG006|Overall Study|Adverse Event|1|||
16821314|NCT02176525|37764657|FG007|Overall Study|Adverse Event|0|||
16821315|NCT02176525|37764650|FG000|Overall Study|not treated|1|||
16821316|NCT02176525|37764651|FG001|Overall Study|not treated|0|||
16821317|NCT02176525|37764652|FG002|Overall Study|not treated|0|||
16821318|NCT02176525|37764653|FG003|Overall Study|not treated|0|||
16821319|NCT02176525|37764654|FG004|Overall Study|not treated|0|||
16821320|NCT02176525|37764655|FG005|Overall Study|not treated|1|||
16821321|NCT02176525|37764656|FG006|Overall Study|not treated|0|||
16821322|NCT02176525|37764657|FG007|Overall Study|not treated|0|||
16821323|NCT02127931|37764683|FG000|Overall Study|Glitch in Game|1|||
16821324|NCT02127307|37764688|FG000|Overall Study|Protocol Violation|36|||
16821325|NCT02127307|37764688|FG000|Overall Study|Lost to Follow-up|2|||
16821326|NCT02127307|37764688|FG000|Overall Study|Death|101|||
16821327|NCT02127307|37764688|FG000|Overall Study|Other than specified above|169|||
16821328|NCT02126839|37764694|FG000|Overall Study|Adverse Event|0|||
16821329|NCT02126839|37764695|FG001|Overall Study|Adverse Event|1|||
16821330|NCT02126839|37764694|FG000|Overall Study|Withdrawal by Subject|1|||
16821331|NCT02126839|37764695|FG001|Overall Study|Withdrawal by Subject|0|||
16821332|NCT02126839|37764694|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16821333|NCT02126839|37764695|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16821334|NCT02126839|37764694|FG000|Overall Study|Protocol Violation|2|||
16821335|NCT02126839|37764695|FG001|Overall Study|Protocol Violation|3|||
16821336|NCT02126839|37764694|FG000|Overall Study|Sponsor request|0|||
16821337|NCT02126839|37764695|FG001|Overall Study|Sponsor request|1|||
16821338|NCT02126839|37764694|FG000|Overall Study|Lost to Follow-up|1|||
16821339|NCT02126839|37764695|FG001|Overall Study|Lost to Follow-up|4|||
16821340|NCT02126839|37764694|FG000|Overall Study|Other|5|||
16821341|NCT02126839|37764695|FG001|Overall Study|Other|5|||
16821342|NCT02125279|37764701|FG000|Overall Study|Lack of Efficacy|2|||
16821343|NCT02125279|37764701|FG000|Overall Study|Withdrawal by Subject|6|||
16821344|NCT02125279|37764701|FG000|Overall Study|Protocol Violation|1|||
16821345|NCT02125279|37764701|FG000|Overall Study|Lost to Follow-up|4|||
16821346|NCT02124811|37764709|FG000|Overall Study|Early termination|2|||
16821347|NCT02124811|37764710|FG001|Overall Study|Early termination|2|||
16821348|NCT02124811|37764709|FG000|Overall Study|Withdrawal by Subject|1|||
16821349|NCT02124811|37764710|FG001|Overall Study|Withdrawal by Subject|0|||
16821350|NCT02148445|37764718|FG000|Overall Study|Death|1|||
16821351|NCT02148445|37764719|FG001|Overall Study|Death|3|||
16821352|NCT02148211|37764727|FG000|Overall Study|Lost to Follow-up|352|||
16821353|NCT02147587|37764733|FG000|Overall Study|Adverse Event|9|||
16821354|NCT02147587|37764734|FG001|Overall Study|Adverse Event|4|||
16821355|NCT02147587|37764733|FG000|Overall Study|Lack of Efficacy|2|||
16821356|NCT02147587|37764734|FG001|Overall Study|Lack of Efficacy|1|||
16821357|NCT02147353|37764742|FG000|Overall Study|Lost to Follow-up|2|||
16821358|NCT02147353|37764743|FG001|Overall Study|Lost to Follow-up|0|||
16821359|NCT02147353|37764742|FG000|Overall Study|unable to make visits|4|||
16821360|NCT02147353|37764743|FG001|Overall Study|unable to make visits|0|||
16821361|NCT02147353|37764742|FG000|Overall Study|medication noncompliance|3|||
16821362|NCT02147353|37764743|FG001|Overall Study|medication noncompliance|0|||
16821363|NCT02147197|37764752|FG000|Overall Study|Adverse Event|1|||
16821364|NCT02147197|37764753|FG001|Overall Study|Adverse Event|0|||
16821365|NCT02147197|37764754|FG002|Overall Study|Adverse Event|0|||
16821366|NCT02147197|37764752|FG000|Overall Study|Withdrawal of Consent|4|||
16821367|NCT02147197|37764753|FG001|Overall Study|Withdrawal of Consent|3|||
16821368|NCT02147197|37764754|FG002|Overall Study|Withdrawal of Consent|2|||
16821369|NCT02147197|37764752|FG000|Overall Study|Lost to Follow-up|2|||
16821370|NCT02147197|37764753|FG001|Overall Study|Lost to Follow-up|3|||
16821371|NCT02147197|37764754|FG002|Overall Study|Lost to Follow-up|1|||
16821372|NCT02147197|37764752|FG000|Overall Study|Protocol Violation|1|||
16821373|NCT02147197|37764753|FG001|Overall Study|Protocol Violation|0|||
16821374|NCT02147197|37764754|FG002|Overall Study|Protocol Violation|3|||
16821375|NCT02147197|37764752|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16821376|NCT02147197|37764753|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16821377|NCT02147197|37764754|FG002|Overall Study|Other Miscellaneous Reasons|3|||
16821378|NCT02176291|37764764|FG000|Overall Study|Death|1|||
16821379|NCT02176291|37764765|FG001|Overall Study|Death|0|||
16821380|NCT02176291|37764764|FG000|Overall Study|non compliance with protocol|2|||
16821381|NCT02176291|37764765|FG001|Overall Study|non compliance with protocol|0|||
16821382|NCT02176291|37764764|FG000|Overall Study|Withdrawal by Subject|2|||
16821383|NCT02176291|37764765|FG001|Overall Study|Withdrawal by Subject|0|||
16821384|NCT02175745|37764771|FG000|Overall Study|Not Eligible|1|||
16821385|NCT02175277|37764775|FG000|Overall Study|Protocol-specified Criteria|1|||
16821386|NCT02124265|37764779|FG000|Overall Study|Adverse Event|1|||
16821387|NCT02146105|37764783|FG000|Overall Study|Adverse Event|1|||
16821388|NCT02146105|37764783|FG000|Overall Study|Withdrawal by Subject|5|||
16821389|NCT02175199|37764789|FG000|Overall Study|Withdrawal by Subject|1|||
16821390|NCT02175199|37764790|FG001|Overall Study|Withdrawal by Subject|5|||
16821391|NCT02175199|37764789|FG000|Overall Study|Randomized in Error|1|||
16821392|NCT02175199|37764790|FG001|Overall Study|Randomized in Error|0|||
16821393|NCT02175199|37764789|FG000|Overall Study|Sponsor Decision|1|||
16821394|NCT02175199|37764790|FG001|Overall Study|Sponsor Decision|0|||
16821395|NCT02123797|37764799|FG000|Baseline Intervention|Death|9|||
16821396|NCT02123797|37764800|FG001|Baseline Intervention|Death|16|||
16821397|NCT02123797|37764801|FG002|Baseline Intervention|Death|0|||
16821398|NCT02123797|37764802|FG003|Baseline Intervention|Death|0|||
16821399|NCT02123797|37764803|FG004|Baseline Intervention|Death|0|||
16821400|NCT02123797|37764799|FG000|Baseline Intervention|Withdrawal by Subject|2|||
16821401|NCT02123797|37764800|FG001|Baseline Intervention|Withdrawal by Subject|8|||
16821402|NCT02123797|37764801|FG002|Baseline Intervention|Withdrawal by Subject|0|||
16821403|NCT02123797|37764802|FG003|Baseline Intervention|Withdrawal by Subject|0|||
16821404|NCT02123797|37764803|FG004|Baseline Intervention|Withdrawal by Subject|0|||
16821405|NCT02123797|37764799|FG000|Baseline Intervention|Relocation|2|||
16821406|NCT02123797|37764800|FG001|Baseline Intervention|Relocation|0|||
16821407|NCT02123797|37764801|FG002|Baseline Intervention|Relocation|0|||
16821408|NCT02123797|37764802|FG003|Baseline Intervention|Relocation|0|||
16821409|NCT02123797|37764803|FG004|Baseline Intervention|Relocation|0|||
16821410|NCT02123797|37764799|FG000|Baseline Intervention|Out of window for initial survey|6|||
16821411|NCT02123797|37764800|FG001|Baseline Intervention|Out of window for initial survey|13|||
16821412|NCT02123797|37764801|FG002|Baseline Intervention|Out of window for initial survey|0|||
16821413|NCT02123797|37764802|FG003|Baseline Intervention|Out of window for initial survey|0|||
16821414|NCT02123797|37764803|FG004|Baseline Intervention|Out of window for initial survey|0|||
16821415|NCT02123797|37764799|FG000|Baseline Intervention|Lost to Follow-up|0|||
16821416|NCT02123797|37764800|FG001|Baseline Intervention|Lost to Follow-up|5|||
16821417|NCT02123797|37764801|FG002|Baseline Intervention|Lost to Follow-up|0|||
16821418|NCT02123797|37764802|FG003|Baseline Intervention|Lost to Follow-up|0|||
16821419|NCT02123797|37764803|FG004|Baseline Intervention|Lost to Follow-up|0|||
16821420|NCT02123797|37764799|FG000|Baseline Intervention|Other Disease|3|||
16821421|NCT02123797|37764800|FG001|Baseline Intervention|Other Disease|0|||
16821422|NCT02123797|37764801|FG002|Baseline Intervention|Other Disease|0|||
16821423|NCT02123797|37764802|FG003|Baseline Intervention|Other Disease|0|||
16821424|NCT02123797|37764803|FG004|Baseline Intervention|Other Disease|0|||
16821425|NCT02123797|37764799|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
16821426|NCT02123797|37764800|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
16821427|NCT02123797|37764801|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
16821428|NCT02123797|37764802|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
16821429|NCT02123797|37764803|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
16821430|NCT02123797|37764799|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
16821431|NCT02123797|37764800|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
16821432|NCT02123797|37764801|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
16821433|NCT02123797|37764802|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
16821434|NCT02123797|37764803|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
16821435|NCT02123797|37764799|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
16821436|NCT02123797|37764800|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
16821437|NCT02123797|37764801|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16821438|NCT02123797|37764802|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16821439|NCT02123797|37764803|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16821440|NCT02123797|37764799|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
16821441|NCT02123797|37764800|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
16821442|NCT02123797|37764801|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
16821443|NCT02123797|37764802|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
16821444|NCT02123797|37764803|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
16821445|NCT02123797|37764799|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
16821446|NCT02123797|37764800|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
16821447|NCT02123797|37764801|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
16821448|NCT02123797|37764802|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
16821449|NCT02123797|37764803|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
16821450|NCT02123797|37764799|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
16821451|NCT02123797|37764800|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
16821452|NCT02123797|37764801|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
16821453|NCT02123797|37764802|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
16821454|NCT02123797|37764803|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
16821455|NCT02123797|37764799|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
16821456|NCT02123797|37764800|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
16821457|NCT02123797|37764801|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
16821458|NCT02123797|37764802|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
16821459|NCT02123797|37764803|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
16821460|NCT02123797|37764799|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
16821461|NCT02123797|37764800|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
16821462|NCT02123797|37764801|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16821463|NCT02123797|37764802|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16821464|NCT02123797|37764803|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16821465|NCT02123797|37764799|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
16821466|NCT02123797|37764800|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
16821467|NCT02123797|37764801|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
16821468|NCT02123797|37764802|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
16821469|NCT02123797|37764803|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
16821470|NCT02175121|37764828|FG000|Overall Study|Lack of Efficacy|1|||
16821471|NCT02175121|37764829|FG001|Overall Study|Lack of Efficacy|0|||
16821472|NCT02175121|37764830|FG002|Overall Study|Lack of Efficacy|0|||
16821473|NCT02175121|37764831|FG003|Overall Study|Lack of Efficacy|0|||
16821474|NCT02175121|37764832|FG004|Overall Study|Lack of Efficacy|0|||
16821475|NCT02175121|37764828|FG000|Overall Study|Lost to Follow-up|0|||
16821476|NCT02175121|37764829|FG001|Overall Study|Lost to Follow-up|1|||
16821477|NCT02175121|37764830|FG002|Overall Study|Lost to Follow-up|0|||
16821478|NCT02175121|37764831|FG003|Overall Study|Lost to Follow-up|1|||
16821479|NCT02175121|37764832|FG004|Overall Study|Lost to Follow-up|0|||
16821480|NCT02175121|37764828|FG000|Overall Study|Personal emergency|0|||
16821481|NCT02175121|37764829|FG001|Overall Study|Personal emergency|0|||
16821482|NCT02175121|37764830|FG002|Overall Study|Personal emergency|0|||
16821483|NCT02175121|37764831|FG003|Overall Study|Personal emergency|0|||
16821484|NCT02175121|37764832|FG004|Overall Study|Personal emergency|1|||
16821485|NCT02175121|37764828|FG000|Overall Study|Schedule conflict|0|||
16821486|NCT02175121|37764829|FG001|Overall Study|Schedule conflict|0|||
16821487|NCT02175121|37764830|FG002|Overall Study|Schedule conflict|1|||
16821488|NCT02175121|37764831|FG003|Overall Study|Schedule conflict|0|||
16821489|NCT02175121|37764832|FG004|Overall Study|Schedule conflict|0|||
16821490|NCT02175121|37764828|FG000|Overall Study|Time issues|0|||
16821491|NCT02175121|37764829|FG001|Overall Study|Time issues|0|||
16821492|NCT02175121|37764830|FG002|Overall Study|Time issues|1|||
16821493|NCT02175121|37764831|FG003|Overall Study|Time issues|0|||
16821494|NCT02175121|37764832|FG004|Overall Study|Time issues|0|||
16821495|NCT01568866|37764850|FG000|Overall Study|Disease Progression|208|||
16821496|NCT01568866|37764851|FG001|Overall Study|Disease Progression|183|||
16821497|NCT01568866|37764850|FG000|Overall Study|Adverse Event|94|||
16821498|NCT01568866|37764851|FG001|Overall Study|Adverse Event|96|||
16821499|NCT01568866|37764850|FG000|Overall Study|Patient Request|55|||
16821500|NCT01568866|37764851|FG001|Overall Study|Patient Request|71|||
16821501|NCT01568866|37764850|FG000|Overall Study|Physician Decision|40|||
16821502|NCT01568866|37764851|FG001|Overall Study|Physician Decision|32|||
16821503|NCT01568866|37764850|FG000|Overall Study|Withdrawal by Subject|19|||
16821504|NCT01568866|37764851|FG001|Overall Study|Withdrawal by Subject|11|||
16821505|NCT01568866|37764850|FG000|Overall Study|Death|10|||
16821506|NCT01568866|37764851|FG001|Overall Study|Death|18|||
16821507|NCT01568866|37764850|FG000|Overall Study|Protocol Non-compliance|2|||
16821508|NCT01568866|37764851|FG001|Overall Study|Protocol Non-compliance|4|||
16821509|NCT01568866|37764850|FG000|Overall Study|Lost to Follow-up|1|||
16821510|NCT01568866|37764851|FG001|Overall Study|Lost to Follow-up|0|||
16821511|NCT01568866|37764850|FG000|Overall Study|Randomized but Not Dosed|9|||
16821512|NCT01568866|37764851|FG001|Overall Study|Randomized but Not Dosed|1|||
16821513|NCT01568320|37764857|FG000|Overall Study|Death|20|||
16821514|NCT01568320|37764857|FG000|Overall Study|Lost to Follow-up|9|||
16821515|NCT01568320|37764857|FG000|Overall Study|Withdrawal by Subject|10|||
16821516|NCT01568320|37764857|FG000|Overall Study|Conversion to open repair|1|||
16821517|NCT01568320|37764857|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
16821518|NCT01567852|37764863|FG000|Overall Study|Withdrawal by Subject|3|||
16821519|NCT01567852|37764864|FG001|Overall Study|Withdrawal by Subject|6|||
16821520|NCT01567852|37764863|FG000|Overall Study|ECT discontinued|1|||
16821521|NCT01567852|37764864|FG001|Overall Study|ECT discontinued|1|||
16821522|NCT01588366|37764875|FG000|Overall Study|Adverse Event|0|||
16821523|NCT01588366|37764876|FG001|Overall Study|Adverse Event|1|||
16821524|NCT01588366|37764877|FG002|Overall Study|Adverse Event|0|||
16821525|NCT01588366|37764878|FG003|Overall Study|Adverse Event|1|||
16821526|NCT01588366|37764879|FG004|Overall Study|Adverse Event|0|||
16821527|NCT01588366|37764880|FG005|Overall Study|Adverse Event|2|||
16821528|NCT01686958|37764896|FG000|Overall Study|Withdrawal by Subject|1|||
16821529|NCT01686568|37764903|FG000|Main Study|Withdrawal by Subject|1|||
16821530|NCT01686568|37764904|FG001|Main Study|Withdrawal by Subject|3|||
16821531|NCT01686568|37764903|FG000|Main Study|Noncompliance with protocol|0|||
16821532|NCT01686568|37764904|FG001|Main Study|Noncompliance with protocol|1|||
16821533|NCT01686568|37764903|FG000|Main Study|Liver enzymes above range of exclusion|1|||
16821534|NCT01686568|37764904|FG001|Main Study|Liver enzymes above range of exclusion|0|||
16821535|NCT01686568|37764903|FG000|Sub-Study|Not consented for sub-study|2|||
16821536|NCT01686568|37764904|FG001|Sub-Study|Not consented for sub-study|2|||
16821537|NCT01567462|37764912|FG000|Overall Study|Withdrawal by Subject|4|||
16821538|NCT01567462|37764913|FG001|Overall Study|Withdrawal by Subject|7|||
16821539|NCT01587898|37764923|FG000|Overall Study|Adverse Event|1|||
16821540|NCT01587898|37764924|FG001|Overall Study|Adverse Event|1|||
16821541|NCT01587898|37764925|FG002|Overall Study|Adverse Event|0|||
16821542|NCT01587898|37764926|FG003|Overall Study|Adverse Event|0|||
16821543|NCT01587898|37764923|FG000|Overall Study|Protocol Violation|0|||
16821544|NCT01587898|37764924|FG001|Overall Study|Protocol Violation|2|||
16821545|NCT01587898|37764925|FG002|Overall Study|Protocol Violation|1|||
16821546|NCT01587898|37764926|FG003|Overall Study|Protocol Violation|1|||
16821547|NCT01587898|37764923|FG000|Overall Study|Lost to Follow-up|0|||
16821548|NCT01587898|37764924|FG001|Overall Study|Lost to Follow-up|0|||
16821549|NCT01587898|37764925|FG002|Overall Study|Lost to Follow-up|0|||
16821550|NCT01587898|37764926|FG003|Overall Study|Lost to Follow-up|1|||
16821551|NCT01587898|37764923|FG000|Overall Study|Withdrawal by Subject|2|||
16821552|NCT01587898|37764924|FG001|Overall Study|Withdrawal by Subject|1|||
16821553|NCT01587898|37764925|FG002|Overall Study|Withdrawal by Subject|0|||
16821554|NCT01587898|37764926|FG003|Overall Study|Withdrawal by Subject|0|||
16821555|NCT01587898|37764923|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
16821556|NCT01587898|37764924|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
16821557|NCT01587898|37764925|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
16821558|NCT01587898|37764926|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
16821559|NCT01567306|37764945|FG000|Overall Study|Protocol Violation|2|||
16821560|NCT01567306|37764946|FG001|Overall Study|Protocol Violation|2|||
16821561|NCT01567306|37764947|FG002|Overall Study|Protocol Violation|0|||
16821562|NCT01567306|37764948|FG003|Overall Study|Protocol Violation|3|||
16821563|NCT01567306|37764949|FG004|Overall Study|Protocol Violation|1|||
16821564|NCT01567306|37764950|FG005|Overall Study|Protocol Violation|1|||
16821565|NCT01567306|37764945|FG000|Overall Study|Change site living|1|||
16821566|NCT01567306|37764946|FG001|Overall Study|Change site living|0|||
16821567|NCT01567306|37764947|FG002|Overall Study|Change site living|0|||
16821568|NCT01567306|37764948|FG003|Overall Study|Change site living|0|||
16821569|NCT01567306|37764949|FG004|Overall Study|Change site living|0|||
16821570|NCT01567306|37764950|FG005|Overall Study|Change site living|0|||
16821571|NCT01567306|37764945|FG000|Overall Study|Adverse Event|0|||
16821572|NCT01567306|37764946|FG001|Overall Study|Adverse Event|0|||
16821573|NCT01567306|37764947|FG002|Overall Study|Adverse Event|0|||
16821574|NCT01567306|37764948|FG003|Overall Study|Adverse Event|2|||
16821575|NCT01567306|37764949|FG004|Overall Study|Adverse Event|4|||
16821576|NCT01567306|37764950|FG005|Overall Study|Adverse Event|1|||
16821577|NCT01567306|37764945|FG000|Overall Study|Lost to Follow-up|0|||
16821578|NCT01567306|37764946|FG001|Overall Study|Lost to Follow-up|0|||
16821579|NCT01567306|37764947|FG002|Overall Study|Lost to Follow-up|0|||
16821580|NCT01567306|37764948|FG003|Overall Study|Lost to Follow-up|0|||
16821581|NCT01567306|37764949|FG004|Overall Study|Lost to Follow-up|2|||
16821582|NCT01567306|37764950|FG005|Overall Study|Lost to Follow-up|0|||
16821583|NCT01567306|37764945|FG000|Overall Study|Withdrawal by Subject|0|||
16821584|NCT01567306|37764946|FG001|Overall Study|Withdrawal by Subject|0|||
16821585|NCT01567306|37764947|FG002|Overall Study|Withdrawal by Subject|0|||
16821586|NCT01567306|37764948|FG003|Overall Study|Withdrawal by Subject|0|||
16821587|NCT01567306|37764949|FG004|Overall Study|Withdrawal by Subject|0|||
16821588|NCT01567306|37764950|FG005|Overall Study|Withdrawal by Subject|1|||
16821589|NCT01587274|37764967|FG000|Overall Study|Lost to Follow-up|4|||
16821590|NCT01587274|37764968|FG001|Overall Study|Lost to Follow-up|5|||
16821591|NCT01587274|37764969|FG002|Overall Study|Lost to Follow-up|3|||
16821592|NCT01587118|37764977|FG000|Overall Study|Adverse Event|3|||
16821593|NCT01587118|37764977|FG000|Overall Study|Lost to Follow-up|2|||
16821594|NCT01587118|37764977|FG000|Overall Study|Relocation|1|||
16821595|NCT01587118|37764977|FG000|Overall Study|nonresponse|1|||
16821596|NCT01905657|37764984|FG000|Overall Study|Adverse Event|23|||
16821597|NCT01905657|37764985|FG001|Overall Study|Adverse Event|17|||
16821598|NCT01905657|37764986|FG002|Overall Study|Adverse Event|18|||
16821599|NCT01905657|37764984|FG000|Overall Study|Clinical Progression|103|||
16821600|NCT01905657|37764985|FG001|Overall Study|Clinical Progression|78|||
16821601|NCT01905657|37764986|FG002|Overall Study|Clinical Progression|59|||
16821602|NCT01905657|37764984|FG000|Overall Study|Death|40|||
16821603|NCT01905657|37764985|FG001|Overall Study|Death|43|||
16821604|NCT01905657|37764986|FG002|Overall Study|Death|47|||
16821605|NCT01905657|37764984|FG000|Overall Study|Excluded Medication|13|||
16821606|NCT01905657|37764985|FG001|Overall Study|Excluded Medication|16|||
16821607|NCT01905657|37764986|FG002|Overall Study|Excluded Medication|9|||
16821608|NCT01905657|37764984|FG000|Overall Study|Lost to Follow-up|1|||
16821609|NCT01905657|37764985|FG001|Overall Study|Lost to Follow-up|2|||
16821610|NCT01905657|37764986|FG002|Overall Study|Lost to Follow-up|1|||
16821611|NCT01905657|37764984|FG000|Overall Study|Physician Decision|5|||
16821612|NCT01905657|37764985|FG001|Overall Study|Physician Decision|8|||
16821613|NCT01905657|37764986|FG002|Overall Study|Physician Decision|12|||
16821614|NCT01905657|37764984|FG000|Overall Study|Protocol Violation|2|||
16821615|NCT01905657|37764985|FG001|Overall Study|Protocol Violation|1|||
16821616|NCT01905657|37764986|FG002|Overall Study|Protocol Violation|1|||
16821617|NCT01905657|37764984|FG000|Overall Study|Screen Failure|0|||
16821618|NCT01905657|37764985|FG001|Overall Study|Screen Failure|1|||
16821619|NCT01905657|37764986|FG002|Overall Study|Screen Failure|0|||
16821620|NCT01905657|37764984|FG000|Overall Study|Withdrawal by Subject|15|||
16821621|NCT01905657|37764985|FG001|Overall Study|Withdrawal by Subject|21|||
16821622|NCT01905657|37764986|FG002|Overall Study|Withdrawal by Subject|53|||
16821623|NCT01905657|37764984|FG000|Overall Study|Sponsor Decision|1|||
16821624|NCT01905657|37764985|FG001|Overall Study|Sponsor Decision|0|||
16821625|NCT01905657|37764986|FG002|Overall Study|Sponsor Decision|0|||
16821626|NCT02202980|37765011|FG000|Overall Study|Lack of Efficacy|1|||
16821627|NCT02202980|37765012|FG001|Overall Study|Lack of Efficacy|0|||
16821628|NCT02202980|37765013|FG002|Overall Study|Lack of Efficacy|7|||
16821629|NCT02202980|37765014|FG003|Overall Study|Lack of Efficacy|0|||
16821630|NCT02202980|37765015|FG004|Overall Study|Lack of Efficacy|3|||
16821631|NCT02202980|37765016|FG005|Overall Study|Lack of Efficacy|1|||
16821632|NCT02202980|37765017|FG006|Overall Study|Lack of Efficacy|11|||
16821633|NCT02202980|37765018|FG007|Overall Study|Lack of Efficacy|2|||
16821634|NCT02202980|37765019|FG008|Overall Study|Lack of Efficacy|2|||
16821635|NCT02202980|37765020|FG009|Overall Study|Lack of Efficacy|0|||
16821636|NCT02202980|37765021|FG010|Overall Study|Lack of Efficacy|0|||
16821637|NCT02202980|37765022|FG011|Overall Study|Lack of Efficacy|3|||
16821638|NCT02202980|37765023|FG012|Overall Study|Lack of Efficacy|10|||
16821639|NCT02202980|37765024|FG013|Overall Study|Lack of Efficacy|0|||
16821640|NCT02202980|37765011|FG000|Overall Study|Protocol Violation|0|||
16821641|NCT02202980|37765012|FG001|Overall Study|Protocol Violation|0|||
16821642|NCT02202980|37765013|FG002|Overall Study|Protocol Violation|0|||
16821643|NCT02202980|37765014|FG003|Overall Study|Protocol Violation|3|||
16821644|NCT02202980|37765015|FG004|Overall Study|Protocol Violation|3|||
16821645|NCT02202980|37765016|FG005|Overall Study|Protocol Violation|0|||
16821646|NCT02202980|37765017|FG006|Overall Study|Protocol Violation|0|||
16821647|NCT02202980|37765018|FG007|Overall Study|Protocol Violation|0|||
16821648|NCT02202980|37765019|FG008|Overall Study|Protocol Violation|0|||
16821649|NCT02202980|37765020|FG009|Overall Study|Protocol Violation|0|||
16821650|NCT02202980|37765021|FG010|Overall Study|Protocol Violation|0|||
16821651|NCT02202980|37765022|FG011|Overall Study|Protocol Violation|0|||
16821652|NCT02202980|37765023|FG012|Overall Study|Protocol Violation|0|||
16821653|NCT02202980|37765024|FG013|Overall Study|Protocol Violation|0|||
16821654|NCT02202980|37765011|FG000|Overall Study|Lost to Follow-up|0|||
16821655|NCT02202980|37765012|FG001|Overall Study|Lost to Follow-up|1|||
16821656|NCT02202980|37765013|FG002|Overall Study|Lost to Follow-up|1|||
16821657|NCT02202980|37765014|FG003|Overall Study|Lost to Follow-up|1|||
16821658|NCT02202980|37765015|FG004|Overall Study|Lost to Follow-up|0|||
16821659|NCT02202980|37765016|FG005|Overall Study|Lost to Follow-up|0|||
16821660|NCT02202980|37765017|FG006|Overall Study|Lost to Follow-up|0|||
16821661|NCT02202980|37765018|FG007|Overall Study|Lost to Follow-up|1|||
16821662|NCT02202980|37765019|FG008|Overall Study|Lost to Follow-up|1|||
16821663|NCT02202980|37765020|FG009|Overall Study|Lost to Follow-up|0|||
16821664|NCT02202980|37765021|FG010|Overall Study|Lost to Follow-up|0|||
16821665|NCT02202980|37765022|FG011|Overall Study|Lost to Follow-up|0|||
16821666|NCT02202980|37765023|FG012|Overall Study|Lost to Follow-up|1|||
16821667|NCT02202980|37765024|FG013|Overall Study|Lost to Follow-up|0|||
16821668|NCT02202980|37765011|FG000|Overall Study|Withdrew Consent|0|||
16821669|NCT02202980|37765012|FG001|Overall Study|Withdrew Consent|1|||
16821670|NCT02202980|37765013|FG002|Overall Study|Withdrew Consent|2|||
16821671|NCT02202980|37765014|FG003|Overall Study|Withdrew Consent|0|||
16821672|NCT02202980|37765015|FG004|Overall Study|Withdrew Consent|0|||
16821673|NCT02202980|37765016|FG005|Overall Study|Withdrew Consent|0|||
16821674|NCT02202980|37765017|FG006|Overall Study|Withdrew Consent|0|||
16821675|NCT02202980|37765018|FG007|Overall Study|Withdrew Consent|0|||
16821676|NCT02202980|37765019|FG008|Overall Study|Withdrew Consent|1|||
16821677|NCT02202980|37765020|FG009|Overall Study|Withdrew Consent|0|||
16821678|NCT02202980|37765021|FG010|Overall Study|Withdrew Consent|0|||
16821679|NCT02202980|37765022|FG011|Overall Study|Withdrew Consent|0|||
16821680|NCT02202980|37765023|FG012|Overall Study|Withdrew Consent|0|||
16911363|NCT01572792|38020441|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
16821681|NCT02202980|37765024|FG013|Overall Study|Withdrew Consent|0|||
16821682|NCT01952145|37765056|FG000|Overall Study|Protocol Violation|2|||
16821683|NCT01952145|37765057|FG001|Overall Study|Protocol Violation|1|||
16821684|NCT01952145|37765056|FG000|Overall Study|Death|0|||
16821685|NCT01952145|37765057|FG001|Overall Study|Death|1|||
16821686|NCT01952145|37765056|FG000|Overall Study|Adverse Event|9|||
16821687|NCT01952145|37765057|FG001|Overall Study|Adverse Event|0|||
16821688|NCT01952145|37765056|FG000|Overall Study|Withdrawal Criteria|16|||
16821689|NCT01952145|37765057|FG001|Overall Study|Withdrawal Criteria|11|||
16821690|NCT01952145|37765056|FG000|Overall Study|Unclassified|1|||
16821691|NCT01952145|37765057|FG001|Overall Study|Unclassified|1|||
16821692|NCT01923363|37765063|FG000|Overall Study|Protocol Violation|1|||
16821693|NCT01905267|37765069|FG000|Overall Study|Physician Decision|2|||
16821694|NCT01905267|37765070|FG001|Overall Study|Physician Decision|2|||
16821695|NCT01923285|37765078|FG000|Overall Study|Withdrawal by Subject|7|||
16821696|NCT01923285|37765079|FG001|Overall Study|Withdrawal by Subject|6|||
16821697|NCT01904721|37765092|FG000|Overall Study|Other Reasons|0|||
16821698|NCT01904721|37765093|FG001|Overall Study|Other Reasons|0|||
16821699|NCT01904721|37765094|FG002|Overall Study|Other Reasons|1|||
16821700|NCT01904721|37765095|FG003|Overall Study|Other Reasons|1|||
16821701|NCT01904721|37765096|FG004|Overall Study|Other Reasons|2|||
16821702|NCT01904721|37765097|FG005|Overall Study|Other Reasons|2|||
16821703|NCT01904721|37765098|FG006|Overall Study|Other Reasons|2|||
16821704|NCT01904721|37765092|FG000|Overall Study|Personal Reasons|0|||
16821705|NCT01904721|37765093|FG001|Overall Study|Personal Reasons|0|||
16821706|NCT01904721|37765094|FG002|Overall Study|Personal Reasons|0|||
16821707|NCT01904721|37765095|FG003|Overall Study|Personal Reasons|0|||
16821708|NCT01904721|37765096|FG004|Overall Study|Personal Reasons|2|||
16821709|NCT01904721|37765097|FG005|Overall Study|Personal Reasons|3|||
16821710|NCT01904721|37765098|FG006|Overall Study|Personal Reasons|3|||
16821711|NCT01904721|37765092|FG000|Overall Study|Lost to Follow-up|0|||
16821712|NCT01904721|37765093|FG001|Overall Study|Lost to Follow-up|0|||
16821713|NCT01904721|37765094|FG002|Overall Study|Lost to Follow-up|0|||
16821714|NCT01904721|37765095|FG003|Overall Study|Lost to Follow-up|0|||
16821715|NCT01904721|37765096|FG004|Overall Study|Lost to Follow-up|1|||
16821716|NCT01904721|37765097|FG005|Overall Study|Lost to Follow-up|3|||
16821717|NCT01904721|37765098|FG006|Overall Study|Lost to Follow-up|1|||
16821718|NCT01904721|37765092|FG000|Overall Study|Lack of Efficacy|0|||
16821719|NCT01904721|37765093|FG001|Overall Study|Lack of Efficacy|0|||
16821720|NCT01904721|37765094|FG002|Overall Study|Lack of Efficacy|0|||
16821721|NCT01904721|37765095|FG003|Overall Study|Lack of Efficacy|0|||
16821722|NCT01904721|37765096|FG004|Overall Study|Lack of Efficacy|0|||
16821723|NCT01904721|37765097|FG005|Overall Study|Lack of Efficacy|0|||
16821724|NCT01904721|37765098|FG006|Overall Study|Lack of Efficacy|1|||
16821725|NCT01904721|37765092|FG000|Overall Study|Adverse Event|0|||
16821726|NCT01904721|37765093|FG001|Overall Study|Adverse Event|0|||
16821727|NCT01904721|37765094|FG002|Overall Study|Adverse Event|0|||
16821728|NCT01904721|37765095|FG003|Overall Study|Adverse Event|0|||
16821729|NCT01904721|37765096|FG004|Overall Study|Adverse Event|3|||
16821730|NCT01904721|37765097|FG005|Overall Study|Adverse Event|1|||
16821731|NCT01904721|37765098|FG006|Overall Study|Adverse Event|0|||
16821732|NCT01904019|37765110|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
16821733|NCT01904019|37765110|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
16821734|NCT01904019|37765110|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
16821735|NCT01904019|37765110|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
16821736|NCT01904019|37765110|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
16821737|NCT01904019|37765110|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
16821738|NCT01922895|37765116|FG000|Overall Study|Death|0|||
16821739|NCT01922895|37765117|FG001|Overall Study|Death|1|||
16821740|NCT01922895|37765116|FG000|Overall Study|Withdrawal by Subject|1|||
16821741|NCT01922895|37765117|FG001|Overall Study|Withdrawal by Subject|2|||
16821742|NCT01922895|37765116|FG000|Overall Study|Lost to Follow-up|5|||
16821743|NCT01922895|37765117|FG001|Overall Study|Lost to Follow-up|11|||
16821744|NCT01922739|37765125|FG000|Titration/Adjustment Period|Adverse Event|3|||
16821745|NCT01922739|37765125|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
16821746|NCT01922739|37765125|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
16821747|NCT01922739|37765125|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
16821748|NCT01922739|37765125|FG000|Open-label Treatment Period|Adverse Event|6|||
16821749|NCT01922739|37765125|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
16821750|NCT01922739|37765125|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
16821751|NCT01922739|37765125|FG000|Open-label Treatment Period|Protocol Violation|5|||
16821752|NCT01922739|37765125|FG000|Open-label Treatment Period|Pregnancy|1|||
16911364|NCT01572792|38020437|FG000|Extension Study|Lost to Follow-up|6|||
16821753|NCT01922739|37765125|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
16821754|NCT01922739|37765125|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
16821755|NCT01922739|37765125|FG000|Open-label Treatment Period|Physician Decision|1|||
16821756|NCT01922739|37765125|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
16821757|NCT02236988|37765145|FG000|Overall Study|Lost to Follow-up|0|||
16821758|NCT02236988|37765146|FG001|Overall Study|Lost to Follow-up|0|||
16821759|NCT02236988|37765147|FG002|Overall Study|Lost to Follow-up|0|||
16821760|NCT02236988|37765148|FG003|Overall Study|Lost to Follow-up|1|||
16821761|NCT02236988|37765145|FG000|Overall Study|Unable to Comply with Study Visits|0|||
16821762|NCT02236988|37765146|FG001|Overall Study|Unable to Comply with Study Visits|0|||
16821763|NCT02236988|37765147|FG002|Overall Study|Unable to Comply with Study Visits|0|||
16821764|NCT02236988|37765148|FG003|Overall Study|Unable to Comply with Study Visits|2|||
16821765|NCT02236598|37765201|FG000|Overall Study|Adverse Event|0|||
16821766|NCT02236598|37765202|FG001|Overall Study|Adverse Event|1|||
16821767|NCT02236598|37765201|FG000|Overall Study|Withdrawal by Subject|0|||
16821768|NCT02236598|37765202|FG001|Overall Study|Withdrawal by Subject|1|||
16821769|NCT01922349|37765212|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
16821770|NCT01922349|37765213|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
16821771|NCT01922349|37765214|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
16821772|NCT01922349|37765215|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
16821773|NCT02236520|37765253|FG000|Overall Study|Physician Decision|0|||
16821774|NCT02236520|37765254|FG001|Overall Study|Physician Decision|5|||
16821775|NCT02236520|37765255|FG002|Overall Study|Physician Decision|0|||
16821776|NCT02236520|37765256|FG003|Overall Study|Physician Decision|0|||
16821777|NCT02236520|37765253|FG000|Overall Study|Withdrawal by Subject|1|||
16821778|NCT02236520|37765254|FG001|Overall Study|Withdrawal by Subject|0|||
16821779|NCT02236520|37765255|FG002|Overall Study|Withdrawal by Subject|0|||
16821780|NCT02236520|37765256|FG003|Overall Study|Withdrawal by Subject|1|||
16821781|NCT02236520|37765253|FG000|Overall Study|Pregnancy|1|||
16821782|NCT02236520|37765254|FG001|Overall Study|Pregnancy|0|||
16821783|NCT02236520|37765255|FG002|Overall Study|Pregnancy|0|||
16821784|NCT02236520|37765256|FG003|Overall Study|Pregnancy|0|||
16821785|NCT01922271|37765268|FG000|WASHOUT Period|Withdrawal by Subject|1|||
16821786|NCT01922271|37765269|FG001|WASHOUT Period|Withdrawal by Subject|0|||
16821787|NCT02236130|37765277|FG000|Overall Study|Lost to Follow-up|7|||
16821788|NCT02236130|37765278|FG001|Overall Study|Lost to Follow-up|12|||
16821789|NCT02233946|37765286|FG000|Baseline|Withdrawal by Subject|2|||
16821790|NCT02233946|37765287|FG001|Baseline|Withdrawal by Subject|0|||
16821791|NCT02233946|37765286|FG000|3-months Follow-up|Lost to Follow-up|53|||
16821792|NCT02233946|37765287|FG001|3-months Follow-up|Lost to Follow-up|29|||
16821793|NCT02233946|37765286|FG000|6-months Follow-up|Lost to Follow-up|21|||
16821794|NCT02233946|37765287|FG001|6-months Follow-up|Lost to Follow-up|2|||
16821795|NCT02233946|37765286|FG000|9-month Follow-up|Lost to Follow-up|20|||
16821796|NCT02233946|37765287|FG001|9-month Follow-up|Lost to Follow-up|11|||
16821797|NCT02233946|37765286|FG000|12-month Follow-up|Lost to Follow-up|28|||
16821798|NCT02233946|37765287|FG001|12-month Follow-up|Lost to Follow-up|11|||
16821799|NCT02232698|37765295|FG000|Overall Study|Pregnancy|1|||
16821800|NCT02232698|37765296|FG001|Overall Study|Pregnancy|1|||
16821801|NCT02232698|37765295|FG000|Overall Study|Met exclusion criteria|1|||
16821802|NCT02232698|37765296|FG001|Overall Study|Met exclusion criteria|1|||
16821803|NCT02232698|37765295|FG000|Overall Study|Had device-associated symptoms|7|||
16821804|NCT02232698|37765296|FG001|Overall Study|Had device-associated symptoms|0|||
16821805|NCT02232698|37765295|FG000|Overall Study|Non-compliance with study device|1|||
16821806|NCT02232698|37765296|FG001|Overall Study|Non-compliance with study device|4|||
16821807|NCT02232698|37765295|FG000|Overall Study|Allocated to control group|0|||
16821808|NCT02232698|37765296|FG001|Overall Study|Allocated to control group|3|||
16821809|NCT02232698|37765295|FG000|Overall Study|Withdrawal by Subject|0|||
16821810|NCT02232698|37765296|FG001|Overall Study|Withdrawal by Subject|11|||
16821811|NCT01632878|37765304|FG000|Screening|Physician Decision|268|||
16821812|NCT01632878|37765304|FG000|Treatment|Lost to Follow-up|41|||
16821813|NCT01632878|37765304|FG000|Treatment|Withdrawal by Subject|36|||
16821814|NCT01632878|37765304|FG000|Treatment|Physician Decision|34|||
16821815|NCT01632878|37765304|FG000|Treatment|missing information|4|||
16821816|NCT01632878|37765304|FG000|Treatment|no information on study completion|43|||
16821817|NCT01632800|37765308|FG000|Overall Study|Subject did not fit in apparatus|1|||
16821818|NCT01641809|37765316|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
16821819|NCT01641809|37765317|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
16821820|NCT01641809|37765318|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
16821821|NCT01641809|37765319|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
16821822|NCT01641809|37765316|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
16821823|NCT01641809|37765317|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
16821824|NCT01641809|37765318|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
16821825|NCT01641809|37765319|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
16821826|NCT01641809|37765316|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
16821827|NCT01641809|37765317|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
16821828|NCT01641809|37765318|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
16821829|NCT01641809|37765319|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
16821830|NCT01641809|37765316|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
16821831|NCT01641809|37765317|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
16821832|NCT01641809|37765318|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
16821833|NCT01641809|37765319|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
16821834|NCT01641809|37765316|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
16821835|NCT01641809|37765317|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
16821836|NCT01641809|37765318|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
16911365|NCT01572792|38020438|FG001|Extension Study|Lost to Follow-up|2|||
16821837|NCT01641809|37765319|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
16821838|NCT01641809|37765316|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
16821839|NCT01641809|37765317|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
16821840|NCT01641809|37765318|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
16821841|NCT01641809|37765319|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
16821842|NCT01641809|37765316|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
16821843|NCT01641809|37765317|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
16821844|NCT01641809|37765318|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
16821845|NCT01641809|37765319|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
16821846|NCT01641809|37765316|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
16821847|NCT01641809|37765317|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
16821848|NCT01641809|37765318|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
16821849|NCT01641809|37765319|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
16821850|NCT01641809|37765316|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
16821851|NCT01641809|37765317|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
16821852|NCT01641809|37765318|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
16821853|NCT01641809|37765319|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
16821854|NCT01641809|37765316|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
16821855|NCT01641809|37765317|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
16821856|NCT01641809|37765318|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
16821857|NCT01641809|37765319|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
16821858|NCT01641809|37765316|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
16821859|NCT01641809|37765317|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
16821860|NCT01641809|37765318|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
16821861|NCT01641809|37765319|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
16821862|NCT01641809|37765316|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
16821863|NCT01641809|37765317|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
16821864|NCT01641809|37765318|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
16821865|NCT01641809|37765319|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
16821866|NCT01641809|37765316|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
16821867|NCT01641809|37765317|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
16821868|NCT01641809|37765318|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
16821869|NCT01641809|37765319|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
16821870|NCT01641809|37765316|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
16821871|NCT01641809|37765317|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
16821872|NCT01641809|37765318|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
16821873|NCT01641809|37765319|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
16821874|NCT01641809|37765316|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
16821875|NCT01641809|37765317|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
16821876|NCT01641809|37765318|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
16821877|NCT01641809|37765319|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
16821878|NCT01641809|37765316|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
16821879|NCT01641809|37765317|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
16821880|NCT01641809|37765318|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
16821881|NCT01641809|37765319|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
16821882|NCT01641809|37765316|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
16821883|NCT01641809|37765317|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
16821884|NCT01641809|37765318|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
16821885|NCT01641809|37765319|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
16821886|NCT01641809|37765316|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
16821887|NCT01641809|37765317|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
16821888|NCT01641809|37765318|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
16821889|NCT01641809|37765319|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
16821890|NCT01632566|37765342|FG000|Overall Study|Withdrawal by Subject|0|||
16821891|NCT01632566|37765343|FG001|Overall Study|Withdrawal by Subject|1|||
16821892|NCT01632566|37765344|FG002|Overall Study|Withdrawal by Subject|0|||
16821893|NCT01632566|37765345|FG003|Overall Study|Withdrawal by Subject|0|||
16821894|NCT01632566|37765346|FG004|Overall Study|Withdrawal by Subject|0|||
16821895|NCT01632566|37765342|FG000|Overall Study|Sponsor Decision|0|||
16821896|NCT01632566|37765343|FG001|Overall Study|Sponsor Decision|2|||
16821897|NCT01632566|37765344|FG002|Overall Study|Sponsor Decision|9|||
16821898|NCT01632566|37765345|FG003|Overall Study|Sponsor Decision|2|||
16821899|NCT01632566|37765346|FG004|Overall Study|Sponsor Decision|2|||
16821900|NCT02254304|37765364|FG000|Overall Study|Adverse Event|2|||
16821901|NCT02254304|37765365|FG001|Overall Study|Adverse Event|1|||
16821902|NCT02254304|37765364|FG000|Overall Study|Lost to Follow-up|2|||
16821903|NCT02254304|37765365|FG001|Overall Study|Lost to Follow-up|2|||
16821904|NCT02254304|37765364|FG000|Overall Study|Protocol Violation|1|||
16911366|NCT01572792|38020439|FG002|Extension Study|Lost to Follow-up|0|||
16821905|NCT02254304|37765365|FG001|Overall Study|Protocol Violation|0|||
16821906|NCT02254304|37765364|FG000|Overall Study|Withdrawal by Subject|3|||
16821907|NCT02254304|37765365|FG001|Overall Study|Withdrawal by Subject|0|||
16821908|NCT02254304|37765364|FG000|Overall Study|Injection site pain and Injection fear|1|||
16821909|NCT02254304|37765365|FG001|Overall Study|Injection site pain and Injection fear|0|||
16821910|NCT02254304|37765364|FG000|Overall Study|Personal causes|4|||
16821911|NCT02254304|37765365|FG001|Overall Study|Personal causes|1|||
16821912|NCT02254304|37765364|FG000|Overall Study|Personal decision|1|||
16911367|NCT01572792|38020440|FG003|Extension Study|Lost to Follow-up|3|||
16911368|NCT01572792|38020441|FG004|Extension Study|Lost to Follow-up|3|||
16911369|NCT01572792|38020437|FG000|Extension Study|Withdrawal by Subject|7|||
16911370|NCT01572792|38020438|FG001|Extension Study|Withdrawal by Subject|6|||
16911371|NCT01572792|38020439|FG002|Extension Study|Withdrawal by Subject|11|||
16911372|NCT01572792|38020440|FG003|Extension Study|Withdrawal by Subject|8|||
16911373|NCT01572792|38020441|FG004|Extension Study|Withdrawal by Subject|14|||
16911374|NCT01572792|38020437|FG000|Extension Study|Protocol Violation|0|||
16911375|NCT01572792|38020438|FG001|Extension Study|Protocol Violation|4|||
16911376|NCT01572792|38020439|FG002|Extension Study|Protocol Violation|3|||
16911377|NCT01572792|38020440|FG003|Extension Study|Protocol Violation|4|||
16911378|NCT01572792|38020441|FG004|Extension Study|Protocol Violation|3|||
16911379|NCT01572792|38020437|FG000|Extension Study|Lack of Efficacy|2|||
16911380|NCT01572792|38020438|FG001|Extension Study|Lack of Efficacy|3|||
16911381|NCT01572792|38020439|FG002|Extension Study|Lack of Efficacy|3|||
16911382|NCT01572792|38020440|FG003|Extension Study|Lack of Efficacy|2|||
16911383|NCT01572792|38020441|FG004|Extension Study|Lack of Efficacy|2|||
16911384|NCT01572792|38020437|FG000|Extension Study|Adverse Event|7|||
16911385|NCT01572792|38020438|FG001|Extension Study|Adverse Event|6|||
16911386|NCT01572792|38020439|FG002|Extension Study|Adverse Event|5|||
16911387|NCT01572792|38020440|FG003|Extension Study|Adverse Event|6|||
16911388|NCT01572792|38020441|FG004|Extension Study|Adverse Event|4|||
16911389|NCT01572792|38020437|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
16911390|NCT01572792|38020438|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
16911391|NCT01572792|38020439|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
16911392|NCT01572792|38020440|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
16911393|NCT01572792|38020441|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
16911394|NCT01547598|38020456|FG000|Overall Study|Withdrew consent|1|||
16911395|NCT01547598|38020457|FG001|Overall Study|Withdrew consent|1|||
16911396|NCT01547598|38020456|FG000|Overall Study|Lost to Follow-up|1|||
16911397|NCT01547598|38020457|FG001|Overall Study|Lost to Follow-up|1|||
16911398|NCT01547598|38020456|FG000|Overall Study|Adverse Event|1|||
16911399|NCT01547598|38020457|FG001|Overall Study|Adverse Event|1|||
16911400|NCT01547598|38020456|FG000|Overall Study|Protocol Violation|1|||
16911401|NCT01547598|38020457|FG001|Overall Study|Protocol Violation|1|||
16911402|NCT01547598|38020456|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16911403|NCT01547598|38020457|FG001|Overall Study|Other Miscellaneous Reasons|1|||
16911404|NCT01547286|38020464|FG000|Overall Study|Did not meet all eligibility criteria|1|||
16911405|NCT01547286|38020464|FG000|Overall Study|Physician Decision|1|||
16911406|NCT01547130|38020471|FG000|Overall Study|Lost to Follow-up|9|||
16911407|NCT01547130|38020472|FG001|Overall Study|Lost to Follow-up|5|||
16911408|NCT01524978|38020497|FG000|Overall Study|Other|16|||
16911409|NCT01524978|38020498|FG001|Overall Study|Other|2|||
16911410|NCT01524978|38020499|FG002|Overall Study|Other|1|||
16821913|NCT02254304|37765365|FG001|Overall Study|Personal decision|0|||
16821914|NCT02174731|37765375|FG000|Overall Study|Participant decision|67|||
16821915|NCT02174731|37765376|FG001|Overall Study|Participant decision|64|||
16821916|NCT02174731|37765375|FG000|Overall Study|Incorrect enrolment before randomization|0|||
16821917|NCT02174731|37765376|FG001|Overall Study|Incorrect enrolment before randomization|1|||
16821918|NCT02174731|37765375|FG000|Overall Study|Missing|2|||
16821919|NCT02174731|37765376|FG001|Overall Study|Missing|0|||
16821920|NCT01922037|37765384|FG000|Overall Study|Withdrawal by Subject|2|||
16821921|NCT01922037|37765385|FG001|Overall Study|Withdrawal by Subject|44|||
16821922|NCT01922037|37765384|FG000|Overall Study|Adverse Event|1|||
16821923|NCT01922037|37765385|FG001|Overall Study|Adverse Event|7|||
16821924|NCT01922037|37765384|FG000|Overall Study|Death|0|||
16821925|NCT01922037|37765385|FG001|Overall Study|Death|5|||
16821926|NCT01922037|37765384|FG000|Overall Study|Pregnancy|0|||
16911411|NCT01524978|38020500|FG003|Overall Study|Other|2|||
16911412|NCT01524978|38020501|FG004|Overall Study|Other|1|||
16911413|NCT01524978|38020502|FG005|Overall Study|Other|3|||
16911414|NCT01524978|38020503|FG006|Overall Study|Other|17|||
16911415|NCT01524978|38020504|FG007|Overall Study|Other|1|||
16911416|NCT01524978|38020505|FG008|Overall Study|Other|2|||
16911417|NCT01524978|38020506|FG009|Overall Study|Other|2|||
16911418|NCT01524978|38020507|FG010|Overall Study|Other|5|||
16911419|NCT01524978|38020497|FG000|Overall Study|Withdrawal by Subject|12|||
16911420|NCT01524978|38020498|FG001|Overall Study|Withdrawal by Subject|0|||
16911421|NCT01524978|38020499|FG002|Overall Study|Withdrawal by Subject|1|||
16911422|NCT01524978|38020500|FG003|Overall Study|Withdrawal by Subject|1|||
16911423|NCT01524978|38020501|FG004|Overall Study|Withdrawal by Subject|3|||
16911424|NCT01524978|38020502|FG005|Overall Study|Withdrawal by Subject|1|||
16911425|NCT01524978|38020503|FG006|Overall Study|Withdrawal by Subject|6|||
16911426|NCT01524978|38020504|FG007|Overall Study|Withdrawal by Subject|2|||
16821927|NCT01922037|37765385|FG001|Overall Study|Pregnancy|2|||
16821928|NCT01922037|37765384|FG000|Overall Study|Participant non-compliance|4|||
16821929|NCT01922037|37765385|FG001|Overall Study|Participant non-compliance|46|||
16821930|NCT01922037|37765384|FG000|Overall Study|Investigator/Sponsor decision|1|||
16821931|NCT01922037|37765385|FG001|Overall Study|Investigator/Sponsor decision|4|||
16821932|NCT01922037|37765384|FG000|Overall Study|Other unspecified|2|||
16821933|NCT01922037|37765385|FG001|Overall Study|Other unspecified|66|||
16821934|NCT02282813|37765396|FG000|Overall Study|Withdrawal by Subject|4|||
16821935|NCT02282813|37765397|FG001|Overall Study|Withdrawal by Subject|5|||
16821936|NCT02282813|37765398|FG002|Overall Study|Withdrawal by Subject|0|||
16821937|NCT02282813|37765396|FG000|Overall Study|Adverse Event|3|||
16821938|NCT02282813|37765397|FG001|Overall Study|Adverse Event|10|||
16821939|NCT02282813|37765398|FG002|Overall Study|Adverse Event|1|||
16911427|NCT01524978|38020505|FG008|Overall Study|Withdrawal by Subject|4|||
16911428|NCT01524978|38020506|FG009|Overall Study|Withdrawal by Subject|0|||
16911429|NCT01524978|38020507|FG010|Overall Study|Withdrawal by Subject|5|||
16911430|NCT01524978|38020497|FG000|Overall Study|Lost to Follow-up|0|||
16911431|NCT01524978|38020498|FG001|Overall Study|Lost to Follow-up|0|||
16911432|NCT01524978|38020499|FG002|Overall Study|Lost to Follow-up|3|||
16911433|NCT01524978|38020500|FG003|Overall Study|Lost to Follow-up|0|||
16911434|NCT01524978|38020501|FG004|Overall Study|Lost to Follow-up|1|||
16911435|NCT01524978|38020502|FG005|Overall Study|Lost to Follow-up|1|||
16911436|NCT01524978|38020503|FG006|Overall Study|Lost to Follow-up|2|||
16911437|NCT01524978|38020504|FG007|Overall Study|Lost to Follow-up|0|||
16911438|NCT01524978|38020505|FG008|Overall Study|Lost to Follow-up|1|||
16911439|NCT01524978|38020506|FG009|Overall Study|Lost to Follow-up|1|||
16911440|NCT01524978|38020507|FG010|Overall Study|Lost to Follow-up|1|||
16821940|NCT02282813|37765396|FG000|Overall Study|Subject non-compliance|1|||
16821941|NCT02282813|37765397|FG001|Overall Study|Subject non-compliance|4|||
16821942|NCT02282813|37765398|FG002|Overall Study|Subject non-compliance|0|||
16821943|NCT02282813|37765396|FG000|Overall Study|Physician Decision|0|||
16821944|NCT02282813|37765397|FG001|Overall Study|Physician Decision|3|||
16821945|NCT02282813|37765398|FG002|Overall Study|Physician Decision|1|||
16911441|NCT01524978|38020497|FG000|Overall Study|Death|34|||
16911442|NCT01524978|38020498|FG001|Overall Study|Death|2|||
16911443|NCT01524978|38020499|FG002|Overall Study|Death|5|||
16911444|NCT01524978|38020500|FG003|Overall Study|Death|24|||
16911445|NCT01524978|38020501|FG004|Overall Study|Death|4|||
16911446|NCT01524978|38020502|FG005|Overall Study|Death|4|||
16911447|NCT01524978|38020503|FG006|Overall Study|Death|1|||
16911448|NCT01524978|38020504|FG007|Overall Study|Death|9|||
16911449|NCT01524978|38020505|FG008|Overall Study|Death|5|||
16911450|NCT01524978|38020506|FG009|Overall Study|Death|6|||
16911451|NCT01524978|38020507|FG010|Overall Study|Death|17|||
16911452|NCT01524900|38020527|FG000|Overall Study|Lost to Follow-up|3|||
16911453|NCT01524900|38020528|FG001|Overall Study|Lost to Follow-up|12|||
16821946|NCT02282813|37765396|FG000|Overall Study|Lost to Follow-up|2|||
16821947|NCT02282813|37765397|FG001|Overall Study|Lost to Follow-up|0|||
16821948|NCT02282813|37765398|FG002|Overall Study|Lost to Follow-up|1|||
16821949|NCT02282813|37765396|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
16821950|NCT02282813|37765397|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
16821951|NCT02282813|37765398|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
16821952|NCT02282813|37765396|FG000|Overall Study|Lack of Efficacy|1|||
16821953|NCT02282813|37765397|FG001|Overall Study|Lack of Efficacy|0|||
16821954|NCT02282813|37765398|FG002|Overall Study|Lack of Efficacy|0|||
16821955|NCT02282813|37765396|FG000|Overall Study|Administrative reasons|0|||
16821956|NCT02282813|37765397|FG001|Overall Study|Administrative reasons|1|||
16821957|NCT02282813|37765398|FG002|Overall Study|Administrative reasons|0|||
16821958|NCT01903863|37765410|FG000|Overall Study|Physician Decision|2|||
16821959|NCT01903863|37765411|FG001|Overall Study|Physician Decision|0|||
16821960|NCT02123251|37765419|FG000|Overall Study|Death|1|||
16821961|NCT02123251|37765420|FG001|Overall Study|Death|1|||
16821962|NCT02123251|37765419|FG000|Overall Study|Withdrawal by Subject|0|||
16821963|NCT02123251|37765420|FG001|Overall Study|Withdrawal by Subject|3|||
16821964|NCT02123251|37765419|FG000|Overall Study|Lost Medicaid eligibility|29|||
16911454|NCT01524900|38020529|FG002|Overall Study|Lost to Follow-up|1|||
16821965|NCT02123251|37765420|FG001|Overall Study|Lost Medicaid eligibility|22|||
16821966|NCT02123251|37765419|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
16821967|NCT02123251|37765420|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
16911455|NCT01524900|38020530|FG003|Overall Study|Lost to Follow-up|0|||
16911456|NCT01524900|38020531|FG004|Overall Study|Lost to Follow-up|0|||
16911457|NCT01524900|38020527|FG000|Overall Study|Other reason than stated above|1|||
16911458|NCT01524900|38020528|FG001|Overall Study|Other reason than stated above|1|||
16911459|NCT01524900|38020529|FG002|Overall Study|Other reason than stated above|0|||
16911460|NCT01524900|38020530|FG003|Overall Study|Other reason than stated above|0|||
16821968|NCT01902303|37765429|FG000|Overall Study|Adverse Event|0|||
16821969|NCT01902303|37765430|FG001|Overall Study|Adverse Event|1|||
16821970|NCT01902303|37765429|FG000|Overall Study|Lost to Follow-up|0|||
16821971|NCT01902303|37765430|FG001|Overall Study|Lost to Follow-up|1|||
16821972|NCT01902303|37765429|FG000|Overall Study|Protocol Violation|2|||
16821973|NCT01902303|37765430|FG001|Overall Study|Protocol Violation|2|||
16821974|NCT01902303|37765429|FG000|Overall Study|subject lost investigational product|0|||
16821975|NCT01902303|37765430|FG001|Overall Study|subject lost investigational product|1|||
16821976|NCT01902303|37765429|FG000|Overall Study|Did not develop a cold sore|21|||
16821977|NCT01902303|37765430|FG001|Overall Study|Did not develop a cold sore|19|||
16821978|NCT02122783|37765440|FG000|Overall Study|Adverse Event|0|||
16821979|NCT02122783|37765441|FG001|Overall Study|Adverse Event|1|||
16821980|NCT01921257|37765450|FG000|Overall Study|Adverse Event|1|||
16821981|NCT01921257|37765450|FG000|Overall Study|Protocol Violation|1|||
16821982|NCT01921257|37765450|FG000|Overall Study|Withdrawal by Subject|1|||
16821983|NCT02121847|37765455|FG000|Overall Study|Administrative Reasons|1|||
16821984|NCT02121847|37765455|FG000|Overall Study|Adverse Event|2|||
16821985|NCT01921179|37765461|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
16821986|NCT01921179|37765462|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
16821987|NCT01921179|37765461|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
16821988|NCT01921179|37765462|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
16821989|NCT01587040|37765473|FG000|Overall Study|Protocol Violation|0|||
16821990|NCT01587040|37765474|FG001|Overall Study|Protocol Violation|0|||
16911461|NCT01524900|38020531|FG004|Overall Study|Other reason than stated above|0|||
16911462|NCT01524900|38020527|FG000|Overall Study|No reason documented|2|||
16911463|NCT01524900|38020528|FG001|Overall Study|No reason documented|1|||
16911464|NCT01524900|38020529|FG002|Overall Study|No reason documented|0|||
16821991|NCT01587040|37765475|FG002|Overall Study|Protocol Violation|1|||
16821992|NCT01587040|37765476|FG003|Overall Study|Protocol Violation|0|||
16821993|NCT01587040|37765473|FG000|Overall Study|Adverse Event|0|||
16821994|NCT01587040|37765474|FG001|Overall Study|Adverse Event|1|||
16821995|NCT01587040|37765475|FG002|Overall Study|Adverse Event|10|||
16821996|NCT01587040|37765476|FG003|Overall Study|Adverse Event|0|||
16911465|NCT01524900|38020530|FG003|Overall Study|No reason documented|1|||
16911466|NCT01524900|38020531|FG004|Overall Study|No reason documented|0|||
16911467|NCT01524198|38020546|FG000|Overall Study|Protocol Violation|8|||
16911468|NCT01524198|38020547|FG001|Overall Study|Protocol Violation|6|||
16911469|NCT01524198|38020546|FG000|Overall Study|Withdrawal by Subject|15|||
16911470|NCT01524198|38020547|FG001|Overall Study|Withdrawal by Subject|10|||
16911471|NCT01523886|38020555|FG000|Overall Study|surgery cancelled|0|||
16911472|NCT01523886|38020556|FG001|Overall Study|surgery cancelled|1|||
17102371|NCT00099632|38241293|FG001|Overall Study|Protocol Violation|0|||
17102372|NCT00099632|38241294|FG002|Overall Study|Protocol Violation|0|||
17102373|NCT00099632|38241295|FG003|Overall Study|Protocol Violation|0|||
16821997|NCT01587040|37765473|FG000|Overall Study|Disease progression|12|||
16821998|NCT01587040|37765474|FG001|Overall Study|Disease progression|1|||
16821999|NCT01587040|37765475|FG002|Overall Study|Disease progression|15|||
16822000|NCT01587040|37765476|FG003|Overall Study|Disease progression|3|||
16822001|NCT01587040|37765473|FG000|Overall Study|Other than specified|5|||
16822002|NCT01587040|37765474|FG001|Overall Study|Other than specified|1|||
16822003|NCT01587040|37765475|FG002|Overall Study|Other than specified|11|||
16822004|NCT01587040|37765476|FG003|Overall Study|Other than specified|1|||
16822005|NCT02144701|37765488|FG000|Overall Study|development of relapse, GVHD or death|9|||
16822006|NCT02144701|37765489|FG001|Overall Study|development of relapse, GVHD or death|3|||
16822007|NCT01921101|37765497|FG000|Overall Study|Death|16|||
16822008|NCT01921101|37765498|FG001|Overall Study|Death|6|||
16822009|NCT01586806|37765507|FG000|Overall Study|Protocol Violation|0|||
16822010|NCT01586806|37765508|FG001|Overall Study|Protocol Violation|1|||
16822011|NCT01586806|37765509|FG002|Overall Study|Protocol Violation|0|||
16822012|NCT01586806|37765507|FG000|Overall Study|Withdrawal by Subject|1|||
16822013|NCT01586806|37765508|FG001|Overall Study|Withdrawal by Subject|0|||
16822014|NCT01586806|37765509|FG002|Overall Study|Withdrawal by Subject|0|||
16822015|NCT01586806|37765507|FG000|Overall Study|Lost to Follow-up|2|||
16822016|NCT01586806|37765508|FG001|Overall Study|Lost to Follow-up|3|||
16822017|NCT01586806|37765509|FG002|Overall Study|Lost to Follow-up|2|||
16822018|NCT02144077|37765519|FG000|Overall Study|Withdrawal by Subject|3|||
16822019|NCT02144077|37765520|FG001|Overall Study|Withdrawal by Subject|3|||
16822020|NCT02144077|37765519|FG000|Overall Study|Adverse Event|2|||
16822021|NCT02144077|37765520|FG001|Overall Study|Adverse Event|3|||
16822022|NCT02144077|37765519|FG000|Overall Study|Lost to Follow-up|2|||
16822023|NCT02144077|37765520|FG001|Overall Study|Lost to Follow-up|2|||
16822024|NCT02144077|37765519|FG000|Overall Study|Protocol Violation|1|||
16822025|NCT02144077|37765520|FG001|Overall Study|Protocol Violation|2|||
16822026|NCT02144077|37765519|FG000|Overall Study|Death|0|||
16822027|NCT02144077|37765520|FG001|Overall Study|Death|1|||
16822028|NCT02144077|37765519|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
16822029|NCT02144077|37765520|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
17016667|NCT00600119|38161264|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
16822030|NCT02172625|37765528|FG000|Overall Study|Adverse Event|0|||
16822031|NCT02172625|37765529|FG001|Overall Study|Adverse Event|1|||
16822032|NCT02172625|37765528|FG000|Overall Study|Pregnancy|0|||
16822033|NCT02172625|37765529|FG001|Overall Study|Pregnancy|1|||
16822034|NCT02172625|37765528|FG000|Overall Study|car accident|0|||
16822035|NCT02172625|37765529|FG001|Overall Study|car accident|1|||
16822036|NCT02143843|37765539|FG000|Overall Study|Adverse Event|8|||
16822037|NCT02143843|37765539|FG000|Overall Study|Lack of Efficacy|2|||
16822038|NCT02143843|37765539|FG000|Overall Study|Withdrawal by Subject|2|||
16822039|NCT02121535|37765545|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
16822040|NCT02121535|37765546|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
16822041|NCT02121535|37765545|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
16822042|NCT02121535|37765546|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
16822043|NCT01586338|37765553|FG000|Overall Study|Adverse Event|3|||
16822044|NCT01586338|37765553|FG000|Overall Study|Lost to Follow-up|1|||
16822045|NCT01586338|37765553|FG000|Overall Study|Withdrawal by participant|3|||
16822046|NCT01586338|37765553|FG000|Overall Study|Other|1|||
16822047|NCT02143141|37765559|FG000|Overall Study|pain scores at 24 hours not collected|1|||
16822048|NCT02143141|37765560|FG001|Overall Study|pain scores at 24 hours not collected|0|||
16822049|NCT02171065|37765569|FG000|Overall Study|Withdrawal by Subject|1|||
16822050|NCT02171065|37765570|FG001|Overall Study|Withdrawal by Subject|0|||
16822051|NCT02171065|37765571|FG002|Overall Study|Withdrawal by Subject|0|||
16822052|NCT02171065|37765569|FG000|Overall Study|Lost to Follow-up|0|||
16822053|NCT02171065|37765570|FG001|Overall Study|Lost to Follow-up|0|||
16822054|NCT02171065|37765571|FG002|Overall Study|Lost to Follow-up|1|||
16822055|NCT01566604|37765583|FG000|Overall Study|Patient's inability to use the device|1|||
16822056|NCT01566604|37765584|FG001|Overall Study|Patient's inability to use the device|0|||
16822057|NCT01566604|37765583|FG000|Overall Study|Administrative problems|1|||
16822058|NCT01566604|37765584|FG001|Overall Study|Administrative problems|0|||
16822059|NCT01566604|37765583|FG000|Overall Study|Lack of Efficacy|1|||
16822060|NCT01566604|37765584|FG001|Overall Study|Lack of Efficacy|2|||
16822061|NCT01566604|37765583|FG000|Overall Study|Protocol deviation|2|||
16822062|NCT01566604|37765584|FG001|Overall Study|Protocol deviation|0|||
16822063|NCT01566604|37765583|FG000|Overall Study|Abnormal laboratory value|2|||
16822064|NCT01566604|37765584|FG001|Overall Study|Abnormal laboratory value|0|||
16822065|NCT01566604|37765583|FG000|Overall Study|Death|4|||
16822066|NCT01566604|37765584|FG001|Overall Study|Death|1|||
16822067|NCT01566604|37765583|FG000|Overall Study|Adverse Event|4|||
16822068|NCT01566604|37765584|FG001|Overall Study|Adverse Event|2|||
16822069|NCT01566604|37765583|FG000|Overall Study|Withdrawal by Subject|9|||
16822070|NCT01566604|37765584|FG001|Overall Study|Withdrawal by Subject|6|||
16822071|NCT01684930|37765592|FG000|Overall Study|Withdrawal by Subject|3|||
16822072|NCT01684930|37765593|FG001|Overall Study|Withdrawal by Subject|1|||
16822073|NCT01566214|37765601|FG000|Overall Study|Lost to Follow-up|3|||
16822074|NCT01566214|37765602|FG001|Overall Study|Lost to Follow-up|0|||
16822075|NCT02253992|37765611|FG000|Overall Study|Study drug toxicity|1|||
16822076|NCT02253992|37765612|FG001|Overall Study|Study drug toxicity|0|||
16822077|NCT02253992|37765613|FG002|Overall Study|Study drug toxicity|10|||
16822078|NCT02253992|37765611|FG000|Overall Study|Disease progression|4|||
16822079|NCT02253992|37765612|FG001|Overall Study|Disease progression|3|||
16822080|NCT02253992|37765613|FG002|Overall Study|Disease progression|98|||
16822081|NCT02253992|37765611|FG000|Overall Study|Withdrawal by Subject|0|||
16822082|NCT02253992|37765612|FG001|Overall Study|Withdrawal by Subject|0|||
16822083|NCT02253992|37765613|FG002|Overall Study|Withdrawal by Subject|3|||
16822084|NCT02253992|37765611|FG000|Overall Study|Adverse Event|0|||
16822085|NCT02253992|37765612|FG001|Overall Study|Adverse Event|0|||
16822086|NCT02253992|37765613|FG002|Overall Study|Adverse Event|8|||
16822087|NCT02253992|37765611|FG000|Overall Study|Death|0|||
16822088|NCT02253992|37765612|FG001|Overall Study|Death|0|||
16822089|NCT02253992|37765613|FG002|Overall Study|Death|1|||
16822090|NCT02253992|37765611|FG000|Overall Study|Subject discontinued study drug|1|||
16822091|NCT02253992|37765612|FG001|Overall Study|Subject discontinued study drug|0|||
16822092|NCT02253992|37765613|FG002|Overall Study|Subject discontinued study drug|1|||
16822093|NCT02253992|37765611|FG000|Overall Study|Completed treatment as per protocol|0|||
16822094|NCT02253992|37765612|FG001|Overall Study|Completed treatment as per protocol|1|||
16822095|NCT02253992|37765613|FG002|Overall Study|Completed treatment as per protocol|22|||
16822096|NCT02253992|37765611|FG000|Overall Study|Other|0|||
16822097|NCT02253992|37765612|FG001|Overall Study|Other|0|||
16822098|NCT02253992|37765613|FG002|Overall Study|Other|1|||
16822099|NCT02252588|37765637|FG000|Overall Study|Withdrawal by Subject|4|||
16822100|NCT02252588|37765638|FG001|Overall Study|Withdrawal by Subject|0|||
16822101|NCT01585558|37765647|FG000|Overall Study|Withdrawal by Subject|4|||
16822102|NCT01585558|37765648|FG001|Overall Study|Withdrawal by Subject|5|||
16822103|NCT01585558|37765649|FG002|Overall Study|Withdrawal by Subject|8|||
16822104|NCT01585558|37765647|FG000|Overall Study|Lost to Follow-up|2|||
17016668|NCT00600119|38161265|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
16822105|NCT01585558|37765648|FG001|Overall Study|Lost to Follow-up|0|||
16822106|NCT01585558|37765649|FG002|Overall Study|Lost to Follow-up|3|||
16822107|NCT01585558|37765647|FG000|Overall Study|Adverse Event|3|||
16822108|NCT01585558|37765648|FG001|Overall Study|Adverse Event|4|||
16822109|NCT01585558|37765649|FG002|Overall Study|Adverse Event|1|||
16822110|NCT01585558|37765647|FG000|Overall Study|Protocol Violation|4|||
16822111|NCT01585558|37765648|FG001|Overall Study|Protocol Violation|3|||
16822112|NCT01585558|37765649|FG002|Overall Study|Protocol Violation|2|||
16822113|NCT01585558|37765647|FG000|Overall Study|Lack of Efficacy|0|||
16822114|NCT01585558|37765648|FG001|Overall Study|Lack of Efficacy|0|||
16822115|NCT01585558|37765649|FG002|Overall Study|Lack of Efficacy|1|||
16822116|NCT01565980|37765659|FG000|Overall Study|Death|1|||
16822117|NCT01565980|37765660|FG001|Overall Study|Death|0|||
16822118|NCT01565980|37765659|FG000|Overall Study|Lost to Follow-up|1|||
16822119|NCT01565980|37765660|FG001|Overall Study|Lost to Follow-up|0|||
16822120|NCT01565980|37765659|FG000|Overall Study|health complications|1|||
16822121|NCT01565980|37765660|FG001|Overall Study|health complications|1|||
16822122|NCT01565980|37765659|FG000|Overall Study|stopped medical treatment|1|||
16822123|NCT01565980|37765660|FG001|Overall Study|stopped medical treatment|0|||
16822124|NCT01565980|37765659|FG000|Overall Study|Withdrawal by Subject|0|||
16822125|NCT01565980|37765660|FG001|Overall Study|Withdrawal by Subject|3|||
16822126|NCT01585246|37765675|FG000|Overall Study|Lost to Follow-up|0|||
16822127|NCT01585246|37765676|FG001|Overall Study|Lost to Follow-up|0|||
16822128|NCT01585246|37765677|FG002|Overall Study|Lost to Follow-up|2|||
16822129|NCT01585246|37765678|FG003|Overall Study|Lost to Follow-up|1|||
16822130|NCT01585246|37765679|FG004|Overall Study|Lost to Follow-up|0|||
16822131|NCT01585246|37765675|FG000|Overall Study|Protocol Violation|0|||
16822132|NCT01585246|37765676|FG001|Overall Study|Protocol Violation|0|||
16822133|NCT01585246|37765677|FG002|Overall Study|Protocol Violation|0|||
16822134|NCT01585246|37765678|FG003|Overall Study|Protocol Violation|0|||
16822135|NCT01585246|37765679|FG004|Overall Study|Protocol Violation|1|||
16822136|NCT01585246|37765675|FG000|Overall Study|Withdrawal by Subject|0|||
16822137|NCT01585246|37765676|FG001|Overall Study|Withdrawal by Subject|0|||
16822138|NCT01585246|37765677|FG002|Overall Study|Withdrawal by Subject|1|||
16822139|NCT01585246|37765678|FG003|Overall Study|Withdrawal by Subject|2|||
16822140|NCT01585246|37765679|FG004|Overall Study|Withdrawal by Subject|1|||
16822141|NCT01585246|37765675|FG000|Overall Study|Other|0|||
16822142|NCT01585246|37765676|FG001|Overall Study|Other|1|||
16822143|NCT01585246|37765677|FG002|Overall Study|Other|1|||
16822144|NCT01585246|37765678|FG003|Overall Study|Other|1|||
17102374|NCT00099632|38241296|FG004|Overall Study|Protocol Violation|0|||
16911477|NCT01546038|38020572|FG000|Overall Study|Death|15|||
16911478|NCT01546038|38020573|FG001|Overall Study|Death|6|||
16911479|NCT01546038|38020574|FG002|Overall Study|Death|4|||
16911480|NCT01546038|38020575|FG003|Overall Study|Death|2|||
16911481|NCT01546038|38020576|FG004|Overall Study|Death|9|||
16911482|NCT01546038|38020577|FG005|Overall Study|Death|3|||
16911483|NCT01546038|38020578|FG006|Overall Study|Death|46|||
16911484|NCT01546038|38020579|FG007|Overall Study|Death|76|||
16911485|NCT01546038|38020580|FG008|Overall Study|Death|39|||
16911486|NCT01546038|38020572|FG000|Overall Study|Lost to Follow-up|0|||
16911487|NCT01546038|38020573|FG001|Overall Study|Lost to Follow-up|0|||
16911488|NCT01546038|38020574|FG002|Overall Study|Lost to Follow-up|0|||
16911489|NCT01546038|38020575|FG003|Overall Study|Lost to Follow-up|0|||
16911490|NCT01546038|38020576|FG004|Overall Study|Lost to Follow-up|1|||
16911491|NCT01546038|38020577|FG005|Overall Study|Lost to Follow-up|0|||
16911492|NCT01546038|38020578|FG006|Overall Study|Lost to Follow-up|2|||
16911493|NCT01546038|38020579|FG007|Overall Study|Lost to Follow-up|1|||
16911494|NCT01546038|38020580|FG008|Overall Study|Lost to Follow-up|0|||
16822145|NCT01585246|37765679|FG004|Overall Study|Other|0|||
16822146|NCT01585168|37765696|FG000|Overall Study|Lost to Follow-up|3|||
16822147|NCT01585168|37765697|FG001|Overall Study|Lost to Follow-up|1|||
16822148|NCT01585168|37765698|FG002|Overall Study|Lost to Follow-up|1|||
16822149|NCT01585168|37765699|FG003|Overall Study|Lost to Follow-up|1|||
16822150|NCT02252042|37765709|FG000|Overall Study|Death|170|||
16822151|NCT02252042|37765710|FG001|Overall Study|Death|192|||
16822152|NCT02252042|37765709|FG000|Overall Study|Physician Decision|0|||
16822153|NCT02252042|37765710|FG001|Overall Study|Physician Decision|1|||
16822154|NCT02252042|37765709|FG000|Overall Study|Withdrawal by Subject|13|||
16822155|NCT02252042|37765710|FG001|Overall Study|Withdrawal by Subject|20|||
16822156|NCT02252042|37765709|FG000|Overall Study|Ongoing in study|64|||
16822157|NCT02252042|37765710|FG001|Overall Study|Ongoing in study|35|||
16822158|NCT02232074|37765718|FG000|Overall Study|Withdrawal by Subject|5|||
16822159|NCT02232074|37765719|FG001|Overall Study|Withdrawal by Subject|3|||
16822160|NCT02232074|37765718|FG000|Overall Study|No legal concerns at baseline|36|||
16822161|NCT02232074|37765719|FG001|Overall Study|No legal concerns at baseline|41|||
16822162|NCT02232074|37765718|FG000|Overall Study|deemed ineligible|0|||
16822163|NCT02232074|37765719|FG001|Overall Study|deemed ineligible|1|||
16822164|NCT02142283|37765733|FG000|Overall Study|Death|20|||
16911495|NCT01546038|38020572|FG000|Overall Study|Withdrawal by Subject|1|||
17102375|NCT00099632|38241297|FG005|Overall Study|Protocol Violation|1|||
16911496|NCT01546038|38020573|FG001|Overall Study|Withdrawal by Subject|0|||
16911497|NCT01546038|38020574|FG002|Overall Study|Withdrawal by Subject|0|||
16911498|NCT01546038|38020575|FG003|Overall Study|Withdrawal by Subject|1|||
16911499|NCT01546038|38020576|FG004|Overall Study|Withdrawal by Subject|0|||
16911500|NCT01546038|38020577|FG005|Overall Study|Withdrawal by Subject|1|||
16911501|NCT01546038|38020578|FG006|Overall Study|Withdrawal by Subject|3|||
16911502|NCT01546038|38020579|FG007|Overall Study|Withdrawal by Subject|3|||
16911503|NCT01546038|38020580|FG008|Overall Study|Withdrawal by Subject|1|||
16911504|NCT01546038|38020572|FG000|Overall Study|: Randomized, not treated|0|||
16911505|NCT01546038|38020573|FG001|Overall Study|: Randomized, not treated|0|||
16911506|NCT01546038|38020574|FG002|Overall Study|: Randomized, not treated|0|||
16911507|NCT01546038|38020575|FG003|Overall Study|: Randomized, not treated|0|||
16911508|NCT01546038|38020576|FG004|Overall Study|: Randomized, not treated|0|||
16911509|NCT01546038|38020577|FG005|Overall Study|: Randomized, not treated|0|||
16911510|NCT01546038|38020578|FG006|Overall Study|: Randomized, not treated|2|||
16911511|NCT01546038|38020579|FG007|Overall Study|: Randomized, not treated|4|||
16911512|NCT01546038|38020580|FG008|Overall Study|: Randomized, not treated|3|||
16911513|NCT01571232|38020632|FG000|Overall Study|Lost to Follow-up|0|||
16911514|NCT01571232|38020633|FG001|Overall Study|Lost to Follow-up|1|||
16911515|NCT01571232|38020632|FG000|Overall Study|Withdrawal by Subject|1|||
16911516|NCT01571232|38020633|FG001|Overall Study|Withdrawal by Subject|0|||
16911517|NCT01544478|38020640|FG000|Overall Study|Adverse Event|1|||
16911518|NCT01544478|38020640|FG000|Overall Study|Death|1|||
16911519|NCT01544478|38020640|FG000|Overall Study|Lost to Follow-up|48|||
16911520|NCT01544478|38020640|FG000|Overall Study|Physician Decision|15|||
16911521|NCT01544478|38020640|FG000|Overall Study|Pregnancy|1|||
16911522|NCT01544478|38020640|FG000|Overall Study|Withdrawal by Subject|52|||
16911523|NCT01522950|38020647|FG000|Overall Study|Withdrawal by Subject|3|||
16911524|NCT01522950|38020648|FG001|Overall Study|Withdrawal by Subject|2|||
16911525|NCT01522950|38020649|FG002|Overall Study|Withdrawal by Subject|1|||
16911526|NCT01522950|38020647|FG000|Overall Study|Adverse Event|3|||
16911527|NCT01522950|38020648|FG001|Overall Study|Adverse Event|1|||
16911528|NCT01522950|38020649|FG002|Overall Study|Adverse Event|1|||
16911529|NCT01522950|38020647|FG000|Overall Study|Protocol Violation|0|||
16911530|NCT01522950|38020648|FG001|Overall Study|Protocol Violation|0|||
16911531|NCT01522950|38020649|FG002|Overall Study|Protocol Violation|2|||
16911532|NCT01522950|38020647|FG000|Overall Study|Death|0|||
16911533|NCT01522950|38020648|FG001|Overall Study|Death|1|||
16911534|NCT01522950|38020649|FG002|Overall Study|Death|1|||
16911535|NCT01522950|38020647|FG000|Overall Study|Study Medication Sensitivity|0|||
16911536|NCT01522950|38020648|FG001|Overall Study|Study Medication Sensitivity|1|||
16911537|NCT01522950|38020649|FG002|Overall Study|Study Medication Sensitivity|0|||
16911538|NCT01522404|38020659|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
16911539|NCT01522404|38020660|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
16911540|NCT01522404|38020659|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
16911541|NCT01522404|38020660|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
16911542|NCT01522404|38020659|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
16911543|NCT01522404|38020660|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
16911544|NCT01570686|38020676|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16911545|NCT01570686|38020677|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16911546|NCT01570686|38020676|FG000|Overall Study|Administrative problems|0|||
16911547|NCT01570686|38020677|FG001|Overall Study|Administrative problems|1|||
16911548|NCT01570686|38020676|FG000|Overall Study|Adverse Event|8|||
16911549|NCT01570686|38020677|FG001|Overall Study|Adverse Event|6|||
16911550|NCT01570686|38020676|FG000|Overall Study|Lost to Follow-up|4|||
16911551|NCT01570686|38020677|FG001|Overall Study|Lost to Follow-up|3|||
16911552|NCT01570686|38020676|FG000|Overall Study|Protocol Deviation|3|||
16911553|NCT01570686|38020677|FG001|Overall Study|Protocol Deviation|0|||
16911554|NCT01570686|38020676|FG000|Overall Study|Withdrawal by Subject|4|||
16911555|NCT01570686|38020677|FG001|Overall Study|Withdrawal by Subject|4|||
16911556|NCT01570686|38020676|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
17016669|NCT00600119|38161266|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
17016670|NCT00600119|38161267|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
17016671|NCT00600119|38161262|FG000|Double-blind Treatment Period|Physician Decision|2|||
17016672|NCT00600119|38161263|FG001|Double-blind Treatment Period|Physician Decision|0|||
17016673|NCT00600119|38161264|FG002|Double-blind Treatment Period|Physician Decision|0|||
17016674|NCT00600119|38161265|FG003|Double-blind Treatment Period|Physician Decision|0|||
16911557|NCT01570686|38020677|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16911558|NCT01522248|38020685|FG000|Overall Study|Lost to Follow-up|1|||
16911559|NCT01522248|38020686|FG001|Overall Study|Lost to Follow-up|0|||
16911560|NCT01543776|38020699|FG000|Overall Study|Withdrawal by Subject|2|||
16822165|NCT02142283|37765734|FG001|Overall Study|Death|18|||
16911561|NCT01543776|38020700|FG001|Overall Study|Withdrawal by Subject|2|||
16911562|NCT01518192|38020709|FG000|Overall Study|Lost to Follow-up|29|||
16911563|NCT01518192|38020710|FG001|Overall Study|Lost to Follow-up|26|||
16911564|NCT01518192|38020711|FG002|Overall Study|Lost to Follow-up|35|||
16911565|NCT01569594|38020725|FG000|Overall Study|Physician Decision|4|||
16911566|NCT01569594|38020725|FG000|Overall Study|Death|13|||
16911567|NCT01569594|38020725|FG000|Overall Study|Lost to Follow-up|22|||
16911568|NCT01569594|38020725|FG000|Overall Study|Adverse Event|2|||
16911569|NCT01569594|38020725|FG000|Overall Study|Withdrawal by Subject|13|||
16911570|NCT01569594|38020725|FG000|Overall Study|Other|4|||
16911571|NCT01569594|38020725|FG000|Overall Study|No ECM used|9|||
16911572|NCT01517802|38020729|FG000|Overall Study|Death|1|||
16911573|NCT01520922|38020735|FG000|Treatment Phase|Physician Decision|2|||
16911574|NCT01520922|38020736|FG001|Treatment Phase|Physician Decision|1|||
16911575|NCT01520922|38020735|FG000|Treatment Phase|Progression|0|||
16911576|NCT01520922|38020736|FG001|Treatment Phase|Progression|2|||
16911577|NCT01520922|38020735|FG000|Treatment Phase|Adverse Event|3|||
16911578|NCT01520922|38020736|FG001|Treatment Phase|Adverse Event|5|||
16911579|NCT01520922|38020735|FG000|Follow up|Lost to Follow-up|0|||
16911580|NCT01520922|38020736|FG001|Follow up|Lost to Follow-up|1|||
16911581|NCT01520922|38020735|FG000|Survival Follow-up|Withdrawal by Subject|1|||
16911582|NCT01520922|38020736|FG001|Survival Follow-up|Withdrawal by Subject|0|||
16911583|NCT01569438|38020744|FG000|Overall Study|Lack of Efficacy|1|||
16911584|NCT01569438|38020745|FG001|Overall Study|Lack of Efficacy|2|||
16911585|NCT01569438|38020744|FG000|Overall Study|Withdrawal by Subject|0|||
16911586|NCT01569438|38020745|FG001|Overall Study|Withdrawal by Subject|3|||
16911587|NCT01569438|38020744|FG000|Overall Study|Adverse Event|2|||
16911588|NCT01569438|38020745|FG001|Overall Study|Adverse Event|15|||
17016675|NCT00600119|38161266|FG004|Double-blind Treatment Period|Physician Decision|0|||
17102376|NCT00098774|38241311|FG000|Overall Study|Adverse Event|2|||
16822166|NCT02142283|37765733|FG000|Overall Study|Withdrawal by Subject|1|||
16822167|NCT02142283|37765734|FG001|Overall Study|Withdrawal by Subject|3|||
16822168|NCT02231918|37765743|FG000|Overall Study|Withdrawal by Subject|0|||
16822169|NCT02231918|37765744|FG001|Overall Study|Withdrawal by Subject|1|||
16822170|NCT02231918|37765745|FG002|Overall Study|Withdrawal by Subject|0|||
16822171|NCT02231918|37765743|FG000|Overall Study|Adverse Event|0|||
16822172|NCT02231918|37765744|FG001|Overall Study|Adverse Event|0|||
16822173|NCT02231918|37765745|FG002|Overall Study|Adverse Event|1|||
16822174|NCT02199314|37765753|FG000|Overall Study|Withdrawal by Subject|6|||
16822175|NCT02199314|37765753|FG000|Overall Study|Physician Decision|10|||
16822176|NCT02199080|37765757|FG000|Overall Study|Protocol Violation|12|||
16822177|NCT02251652|37765763|FG000|Overall Study|Withdrawal by Subject|1|||
16822178|NCT02197520|37765769|FG000|Period 1|Withdrawal by Subject|1|||
16822179|NCT02197520|37765770|FG001|Period 1|Withdrawal by Subject|0|||
16822180|NCT02197520|37765769|FG000|Period 2|Adverse Event|0|||
16822181|NCT02197520|37765770|FG001|Period 2|Adverse Event|2|||
16822182|NCT02197520|37765769|FG000|Period 2|Withdrawal by Subject|1|||
16822183|NCT02197520|37765770|FG001|Period 2|Withdrawal by Subject|0|||
16822184|NCT02230904|37765780|FG000|Overall Study|Safety follow up could not take place|0|||
16822185|NCT02230904|37765781|FG001|Overall Study|Safety follow up could not take place|1|||
16822186|NCT02230670|37765791|FG000|Overall Study|Adverse Event|1|||
16822187|NCT02230670|37765792|FG001|Overall Study|Adverse Event|2|||
16822188|NCT02230670|37765791|FG000|Overall Study|Withdrawal by Subject|2|||
16822189|NCT02230670|37765792|FG001|Overall Study|Withdrawal by Subject|2|||
16822190|NCT02230670|37765791|FG000|Overall Study|Physician Decision|0|||
16822191|NCT02230670|37765792|FG001|Overall Study|Physician Decision|1|||
16822192|NCT02230670|37765791|FG000|Overall Study|Protocol Violation|0|||
16822193|NCT02230670|37765792|FG001|Overall Study|Protocol Violation|1|||
16822194|NCT02230670|37765791|FG000|Overall Study|Progression to Child-Pugh C|1|||
16822195|NCT02230670|37765792|FG001|Overall Study|Progression to Child-Pugh C|2|||
16822196|NCT02197130|37765801|FG000|Overall Study|Adverse Event|13|||
16822197|NCT02197130|37765802|FG001|Overall Study|Adverse Event|4|||
16822198|NCT02197130|37765803|FG002|Overall Study|Adverse Event|23|||
16822199|NCT02197130|37765801|FG000|Overall Study|Death|0|||
16822200|NCT02197130|37765802|FG001|Overall Study|Death|1|||
16822201|NCT02197130|37765803|FG002|Overall Study|Death|0|||
16822202|NCT02197130|37765801|FG000|Overall Study|Lost to Follow-up|2|||
16822203|NCT02197130|37765802|FG001|Overall Study|Lost to Follow-up|0|||
16822204|NCT02197130|37765803|FG002|Overall Study|Lost to Follow-up|1|||
16822205|NCT02197130|37765801|FG000|Overall Study|Does not meet entrance criteria|0|||
16822206|NCT02197130|37765802|FG001|Overall Study|Does not meet entrance criteria|0|||
16822207|NCT02197130|37765803|FG002|Overall Study|Does not meet entrance criteria|1|||
16822208|NCT02197130|37765801|FG000|Overall Study|Withdrawal by Subject|0|||
16822209|NCT02197130|37765802|FG001|Overall Study|Withdrawal by Subject|3|||
16822210|NCT02197130|37765803|FG002|Overall Study|Withdrawal by Subject|4|||
16822211|NCT02197130|37765801|FG000|Overall Study|Other|1|||
16822212|NCT02197130|37765802|FG001|Overall Study|Other|0|||
16911589|NCT01569438|38020744|FG000|Overall Study|Protocol Violation|2|||
16911590|NCT01569438|38020745|FG001|Overall Study|Protocol Violation|0|||
16911591|NCT01569438|38020744|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
16911592|NCT01569438|38020745|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
16911593|NCT01569438|38020744|FG000|Overall Study|Sponsor/Physician decision|1|||
17102377|NCT00098774|38241311|FG000|Overall Study|Disease Progression|9|||
16911594|NCT01569438|38020745|FG001|Overall Study|Sponsor/Physician decision|1|||
16911595|NCT01569438|38020744|FG000|Overall Study|Unable to adhere to study schedule|0|||
16911596|NCT01569438|38020745|FG001|Overall Study|Unable to adhere to study schedule|1|||
16911597|NCT01517412|38020753|FG000|Overall Study|Adverse Event|10|||
16911598|NCT01517412|38020754|FG001|Overall Study|Adverse Event|11|||
16911599|NCT01517412|38020753|FG000|Overall Study|Lack of Efficacy|10|||
16911600|NCT01517412|38020754|FG001|Overall Study|Lack of Efficacy|5|||
16911601|NCT01517412|38020753|FG000|Overall Study|Poor compliance to protocol|8|||
16911602|NCT01517412|38020754|FG001|Overall Study|Poor compliance to protocol|3|||
16911603|NCT01517412|38020753|FG000|Overall Study|Other than specified above|8|||
16911604|NCT01517412|38020754|FG001|Overall Study|Other than specified above|5|||
16911605|NCT01517178|38020760|FG000|Period 1|Adverse Event|1|||
16911606|NCT01517178|38020761|FG001|Period 1|Adverse Event|2|||
16911607|NCT01517178|38020760|FG000|Period 1|Lack of Efficacy|0|||
16911608|NCT01517178|38020761|FG001|Period 1|Lack of Efficacy|1|||
16911609|NCT01517178|38020760|FG000|Period 1|E.g. study termination|3|||
16911610|NCT01517178|38020761|FG001|Period 1|E.g. study termination|1|||
16911611|NCT01517178|38020760|FG000|Period 1|Withdrawal by Subject|0|||
16911612|NCT01517178|38020761|FG001|Period 1|Withdrawal by Subject|1|||
16911613|NCT01517178|38020760|FG000|Period 2|Adverse Event|1|||
16911614|NCT01517178|38020761|FG001|Period 2|Adverse Event|0|||
16911615|NCT01517178|38020760|FG000|Period 2|Withdrawal by Subject|3|||
16911616|NCT01517178|38020761|FG001|Period 2|Withdrawal by Subject|0|||
16911617|NCT01517178|38020760|FG000|Period 2|E.g. study termination|2|||
16911618|NCT01517178|38020761|FG001|Period 2|E.g. study termination|2|||
16911619|NCT01489956|38020769|FG000|Overall Study|Lost to Follow-up|1|||
16911620|NCT01489956|38020770|FG001|Overall Study|Lost to Follow-up|0|||
16911621|NCT01489956|38020771|FG002|Overall Study|Lost to Follow-up|0|||
16911622|NCT01489956|38020769|FG000|Overall Study|Withdrawal by Subject|0|||
16911623|NCT01489956|38020770|FG001|Overall Study|Withdrawal by Subject|0|||
16911624|NCT01489956|38020771|FG002|Overall Study|Withdrawal by Subject|1|||
16911625|NCT01516008|38020782|FG000|Overall Study|Adverse Event|0|||
16911626|NCT01516008|38020783|FG001|Overall Study|Adverse Event|2|||
16911627|NCT01516008|38020784|FG002|Overall Study|Adverse Event|7|||
16911628|NCT01516008|38020782|FG000|Overall Study|Lack of Efficacy|44|||
16822213|NCT02197130|37765803|FG002|Overall Study|Other|3|||
16822214|NCT02196506|37765813|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
16822215|NCT02196506|37765814|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
16822216|NCT02196506|37765815|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
16822217|NCT02196506|37765816|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
16822218|NCT02196506|37765813|FG000|Phase A|Withdrawal by Subject|34|||
16822219|NCT02196506|37765814|FG001|Phase A|Withdrawal by Subject|0|||
16822220|NCT02196506|37765815|FG002|Phase A|Withdrawal by Subject|0|||
16822221|NCT02196506|37765816|FG003|Phase A|Withdrawal by Subject|0|||
16822222|NCT02196506|37765813|FG000|Phase A|Adverse Event|22|||
16822223|NCT02196506|37765814|FG001|Phase A|Adverse Event|0|||
16822224|NCT02196506|37765815|FG002|Phase A|Adverse Event|0|||
16822225|NCT02196506|37765816|FG003|Phase A|Adverse Event|0|||
16822226|NCT02196506|37765813|FG000|Phase A|Lost to Follow-up|9|||
16822227|NCT02196506|37765814|FG001|Phase A|Lost to Follow-up|0|||
16822228|NCT02196506|37765815|FG002|Phase A|Lost to Follow-up|0|||
16822229|NCT02196506|37765816|FG003|Phase A|Lost to Follow-up|0|||
16822230|NCT02196506|37765813|FG000|Phase A|Protocol deviation|12|||
16822231|NCT02196506|37765814|FG001|Phase A|Protocol deviation|0|||
16822232|NCT02196506|37765815|FG002|Phase A|Protocol deviation|0|||
16822233|NCT02196506|37765816|FG003|Phase A|Protocol deviation|0|||
16911629|NCT01516008|38020783|FG001|Overall Study|Lack of Efficacy|14|||
16911630|NCT01516008|38020784|FG002|Overall Study|Lack of Efficacy|10|||
16911631|NCT01516008|38020782|FG000|Overall Study|Protocol Violation|1|||
16911632|NCT01516008|38020783|FG001|Overall Study|Protocol Violation|0|||
16911633|NCT01516008|38020784|FG002|Overall Study|Protocol Violation|0|||
16822234|NCT02196506|37765813|FG000|Phase A|Participant withdrawn by investigator|10|||
16822235|NCT02196506|37765814|FG001|Phase A|Participant withdrawn by investigator|0|||
16822236|NCT02196506|37765815|FG002|Phase A|Participant withdrawn by investigator|0|||
16822237|NCT02196506|37765816|FG003|Phase A|Participant withdrawn by investigator|0|||
16822238|NCT02196506|37765813|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
16822239|NCT02196506|37765814|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
16822240|NCT02196506|37765815|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
16822241|NCT02196506|37765816|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
16822242|NCT02196506|37765813|FG000|Phase B|Lack of Efficacy|0|||
16911634|NCT01516008|38020782|FG000|Overall Study|Reason not specified|0|||
16911635|NCT01516008|38020783|FG001|Overall Study|Reason not specified|0|||
16911636|NCT01516008|38020784|FG002|Overall Study|Reason not specified|1|||
16911637|NCT01489254|38020795|FG000|Double-blind Part|Adverse Event|7|||
16911638|NCT01489254|38020796|FG001|Double-blind Part|Adverse Event|2|||
16911639|NCT01489254|38020797|FG002|Double-blind Part|Adverse Event|2|||
16822243|NCT02196506|37765814|FG001|Phase B|Lack of Efficacy|1|||
16822244|NCT02196506|37765815|FG002|Phase B|Lack of Efficacy|2|||
16911640|NCT01489254|38020798|FG003|Double-blind Part|Adverse Event|0|||
16911641|NCT01489254|38020795|FG000|Double-blind Part|Pregnancy|1|||
16822245|NCT02196506|37765816|FG003|Phase B|Lack of Efficacy|0|||
16822246|NCT02196506|37765813|FG000|Phase B|Withdrawal by Participant|0|||
16822247|NCT02196506|37765814|FG001|Phase B|Withdrawal by Participant|8|||
16822248|NCT02196506|37765815|FG002|Phase B|Withdrawal by Participant|1|||
16822249|NCT02196506|37765816|FG003|Phase B|Withdrawal by Participant|0|||
16822250|NCT02196506|37765813|FG000|Phase B|Adverse Event|0|||
16822251|NCT02196506|37765814|FG001|Phase B|Adverse Event|4|||
16822252|NCT02196506|37765815|FG002|Phase B|Adverse Event|1|||
16822253|NCT02196506|37765816|FG003|Phase B|Adverse Event|0|||
16822254|NCT02196506|37765813|FG000|Phase B|Lost to Follow-up|0|||
16822255|NCT02196506|37765814|FG001|Phase B|Lost to Follow-up|2|||
16822256|NCT02196506|37765815|FG002|Phase B|Lost to Follow-up|1|||
16822257|NCT02196506|37765816|FG003|Phase B|Lost to Follow-up|0|||
16822258|NCT02196506|37765813|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
16822259|NCT02196506|37765814|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
16822260|NCT02196506|37765815|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
16822261|NCT02196506|37765816|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
16822262|NCT02196506|37765813|FG000|Phase A+|Withdrawal by Participant|0|||
16822263|NCT02196506|37765814|FG001|Phase A+|Withdrawal by Participant|0|||
16822264|NCT02196506|37765815|FG002|Phase A+|Withdrawal by Participant|0|||
16822265|NCT02196506|37765816|FG003|Phase A+|Withdrawal by Participant|5|||
16822266|NCT02196506|37765813|FG000|Phase A+|Adverse Event|0|||
16822267|NCT02196506|37765814|FG001|Phase A+|Adverse Event|0|||
16822268|NCT02196506|37765815|FG002|Phase A+|Adverse Event|0|||
16822269|NCT02196506|37765816|FG003|Phase A+|Adverse Event|1|||
16822270|NCT02196506|37765813|FG000|Phase A+|Lost to Follow-up|0|||
16822271|NCT02196506|37765814|FG001|Phase A+|Lost to Follow-up|0|||
16822272|NCT02196506|37765815|FG002|Phase A+|Lost to Follow-up|0|||
16822273|NCT02196506|37765816|FG003|Phase A+|Lost to Follow-up|6|||
16822274|NCT02196506|37765813|FG000|Phase A+|Participant withdrawn by investigator|0|||
16822275|NCT02196506|37765814|FG001|Phase A+|Participant withdrawn by investigator|0|||
16822276|NCT02196506|37765815|FG002|Phase A+|Participant withdrawn by investigator|0|||
16822277|NCT02196506|37765816|FG003|Phase A+|Participant withdrawn by investigator|1|||
16822278|NCT02228720|37765822|FG000|Open Label - Day 30|Lost to Follow-up|1|||
16822279|NCT02228564|37765826|FG000|Overall Study|Withdrawal by Subject|10|||
16822280|NCT02228564|37765826|FG000|Overall Study|Death|11|||
16822281|NCT02228564|37765826|FG000|Overall Study|Physician Decision|5|||
16822282|NCT02228564|37765826|FG000|Overall Study|Lost to Follow-up|17|||
16822283|NCT02228564|37765826|FG000|Overall Study|Other|6|||
16822284|NCT01640951|37765838|FG000|Overall Study|Adverse Event|8|||
16822285|NCT01640951|37765839|FG001|Overall Study|Adverse Event|3|||
16822286|NCT01640951|37765840|FG002|Overall Study|Adverse Event|10|||
16822287|NCT01640951|37765841|FG003|Overall Study|Adverse Event|6|||
16822288|NCT01640951|37765842|FG004|Overall Study|Adverse Event|1|||
16822289|NCT01640951|37765843|FG005|Overall Study|Adverse Event|11|||
16822290|NCT01640951|37765844|FG006|Overall Study|Adverse Event|1|||
16822291|NCT01640951|37765845|FG007|Overall Study|Adverse Event|3|||
16822292|NCT01640951|37765838|FG000|Overall Study|Lack of Efficacy|20|||
16822293|NCT01640951|37765839|FG001|Overall Study|Lack of Efficacy|1|||
16822294|NCT01640951|37765840|FG002|Overall Study|Lack of Efficacy|7|||
16822295|NCT01640951|37765841|FG003|Overall Study|Lack of Efficacy|14|||
16822296|NCT01640951|37765842|FG004|Overall Study|Lack of Efficacy|0|||
16822297|NCT01640951|37765843|FG005|Overall Study|Lack of Efficacy|6|||
16822298|NCT01640951|37765844|FG006|Overall Study|Lack of Efficacy|5|||
16822299|NCT01640951|37765845|FG007|Overall Study|Lack of Efficacy|6|||
16822300|NCT01640951|37765838|FG000|Overall Study|Lost to Follow-up|1|||
16822301|NCT01640951|37765839|FG001|Overall Study|Lost to Follow-up|0|||
16822302|NCT01640951|37765840|FG002|Overall Study|Lost to Follow-up|6|||
16822303|NCT01640951|37765841|FG003|Overall Study|Lost to Follow-up|2|||
16822304|NCT01640951|37765842|FG004|Overall Study|Lost to Follow-up|2|||
16822305|NCT01640951|37765843|FG005|Overall Study|Lost to Follow-up|3|||
16822306|NCT01640951|37765844|FG006|Overall Study|Lost to Follow-up|1|||
16822307|NCT01640951|37765845|FG007|Overall Study|Lost to Follow-up|1|||
16822308|NCT01640951|37765838|FG000|Overall Study|Non-compliance with study treatment|0|||
16822309|NCT01640951|37765839|FG001|Overall Study|Non-compliance with study treatment|0|||
16822310|NCT01640951|37765840|FG002|Overall Study|Non-compliance with study treatment|1|||
16822311|NCT01640951|37765841|FG003|Overall Study|Non-compliance with study treatment|1|||
16822312|NCT01640951|37765842|FG004|Overall Study|Non-compliance with study treatment|1|||
16822313|NCT01640951|37765843|FG005|Overall Study|Non-compliance with study treatment|4|||
16822314|NCT01640951|37765844|FG006|Overall Study|Non-compliance with study treatment|1|||
16822315|NCT01640951|37765845|FG007|Overall Study|Non-compliance with study treatment|0|||
16822316|NCT01640951|37765838|FG000|Overall Study|Physician Decision|2|||
16822317|NCT01640951|37765839|FG001|Overall Study|Physician Decision|5|||
16822318|NCT01640951|37765840|FG002|Overall Study|Physician Decision|2|||
16822319|NCT01640951|37765841|FG003|Overall Study|Physician Decision|2|||
16822320|NCT01640951|37765842|FG004|Overall Study|Physician Decision|2|||
16822321|NCT01640951|37765843|FG005|Overall Study|Physician Decision|3|||
16822322|NCT01640951|37765844|FG006|Overall Study|Physician Decision|3|||
16822323|NCT01640951|37765845|FG007|Overall Study|Physician Decision|0|||
16822324|NCT01640951|37765838|FG000|Overall Study|Pregnancy|3|||
16822325|NCT01640951|37765839|FG001|Overall Study|Pregnancy|0|||
16822326|NCT01640951|37765840|FG002|Overall Study|Pregnancy|0|||
16911642|NCT01489254|38020796|FG001|Double-blind Part|Pregnancy|3|||
16911643|NCT01489254|38020797|FG002|Double-blind Part|Pregnancy|0|||
16911644|NCT01489254|38020798|FG003|Double-blind Part|Pregnancy|0|||
16911645|NCT01489254|38020795|FG000|Double-blind Part|Withdrawal by Subject|12|||
16911646|NCT01489254|38020796|FG001|Double-blind Part|Withdrawal by Subject|20|||
16911647|NCT01489254|38020797|FG002|Double-blind Part|Withdrawal by Subject|1|||
16822327|NCT01640951|37765841|FG003|Overall Study|Pregnancy|4|||
16822328|NCT01640951|37765842|FG004|Overall Study|Pregnancy|0|||
16822329|NCT01640951|37765843|FG005|Overall Study|Pregnancy|0|||
16822330|NCT01640951|37765844|FG006|Overall Study|Pregnancy|2|||
16822331|NCT01640951|37765845|FG007|Overall Study|Pregnancy|0|||
16822332|NCT01640951|37765838|FG000|Overall Study|Protocol Deviation|0|||
16822333|NCT01640951|37765839|FG001|Overall Study|Protocol Deviation|1|||
16822334|NCT01640951|37765840|FG002|Overall Study|Protocol Deviation|2|||
16822335|NCT01640951|37765841|FG003|Overall Study|Protocol Deviation|1|||
16822336|NCT01640951|37765842|FG004|Overall Study|Protocol Deviation|0|||
16822337|NCT01640951|37765843|FG005|Overall Study|Protocol Deviation|1|||
16822338|NCT01640951|37765844|FG006|Overall Study|Protocol Deviation|0|||
16911648|NCT01489254|38020798|FG003|Double-blind Part|Withdrawal by Subject|0|||
16911649|NCT01489254|38020795|FG000|Double-blind Part|Lost to Follow-up|1|||
16911650|NCT01489254|38020796|FG001|Double-blind Part|Lost to Follow-up|2|||
16911651|NCT01489254|38020797|FG002|Double-blind Part|Lost to Follow-up|0|||
16911652|NCT01489254|38020798|FG003|Double-blind Part|Lost to Follow-up|0|||
16911653|NCT01489254|38020795|FG000|Double-blind Part|Other reasons for not completing study|4|||
16822339|NCT01640951|37765845|FG007|Overall Study|Protocol Deviation|0|||
16822340|NCT01640951|37765838|FG000|Overall Study|Subject/Guardian decision|12|||
16822341|NCT01640951|37765839|FG001|Overall Study|Subject/Guardian decision|4|||
16822342|NCT01640951|37765840|FG002|Overall Study|Subject/Guardian decision|13|||
16822343|NCT01640951|37765841|FG003|Overall Study|Subject/Guardian decision|15|||
16822344|NCT01640951|37765842|FG004|Overall Study|Subject/Guardian decision|7|||
16822345|NCT01640951|37765843|FG005|Overall Study|Subject/Guardian decision|19|||
16822346|NCT01640951|37765844|FG006|Overall Study|Subject/Guardian decision|5|||
16822347|NCT01640951|37765845|FG007|Overall Study|Subject/Guardian decision|4|||
16822348|NCT01640951|37765838|FG000|Overall Study|Death|0|||
16822349|NCT01640951|37765839|FG001|Overall Study|Death|1|||
16822350|NCT01640951|37765840|FG002|Overall Study|Death|1|||
16822351|NCT01640951|37765841|FG003|Overall Study|Death|0|||
16822352|NCT01640951|37765842|FG004|Overall Study|Death|0|||
16822353|NCT01640951|37765843|FG005|Overall Study|Death|0|||
16822354|NCT01640951|37765844|FG006|Overall Study|Death|0|||
16822355|NCT01640951|37765845|FG007|Overall Study|Death|2|||
16822356|NCT02228096|37765867|FG000|Overall Study|Study terminated by Sponsor|24|||
16822357|NCT02228096|37765867|FG000|Overall Study|Lack of Efficacy|18|||
16822358|NCT02228096|37765867|FG000|Overall Study|Death|12|||
16822359|NCT02228096|37765867|FG000|Overall Study|Physician Decision|3|||
16822360|NCT02228096|37765867|FG000|Overall Study|Subject/guardian decision|2|||
16822361|NCT02228096|37765867|FG000|Overall Study|New therapy for study indication|1|||
16822362|NCT02228096|37765867|FG000|Overall Study|Enrolled, not infused|11|||
16822363|NCT01640873|37765887|FG000|Overall Study|Protocol Violation|2|||
16822364|NCT01640873|37765888|FG001|Overall Study|Protocol Violation|1|||
16822365|NCT01683994|37765899|FG000|Overall Study|Withdrawal by Subject|1|||
16822366|NCT01683994|37765900|FG001|Overall Study|Withdrawal by Subject|0|||
16822367|NCT01683994|37765901|FG002|Overall Study|Withdrawal by Subject|0|||
16822368|NCT01683994|37765902|FG003|Overall Study|Withdrawal by Subject|1|||
16822369|NCT01683994|37765903|FG004|Overall Study|Withdrawal by Subject|0|||
16822370|NCT01683994|37765899|FG000|Overall Study|Intercurrent illness|0|||
16822371|NCT01683994|37765900|FG001|Overall Study|Intercurrent illness|0|||
16822372|NCT01683994|37765901|FG002|Overall Study|Intercurrent illness|0|||
16822373|NCT01683994|37765902|FG003|Overall Study|Intercurrent illness|2|||
16822374|NCT01683994|37765903|FG004|Overall Study|Intercurrent illness|1|||
16822375|NCT02247440|37765921|FG000|Overall Study|Withdrawal by Subject|1|||
16822376|NCT02247440|37765921|FG000|Overall Study|Lack of Efficacy|3|||
16822377|NCT01683838|37765927|FG000|Overall Study|Adverse Event|12|||
16822378|NCT01683838|37765928|FG001|Overall Study|Adverse Event|2|||
16822379|NCT01683838|37765927|FG000|Overall Study|Protocol Violation|3|||
16822380|NCT01683838|37765928|FG001|Overall Study|Protocol Violation|1|||
16822381|NCT01683838|37765927|FG000|Overall Study|Withdrawal by Subject|6|||
16822382|NCT01683838|37765928|FG001|Overall Study|Withdrawal by Subject|5|||
16822383|NCT01683838|37765927|FG000|Overall Study|Lost to Follow-up|1|||
16822384|NCT01683838|37765928|FG001|Overall Study|Lost to Follow-up|1|||
16822385|NCT01683838|37765927|FG000|Overall Study|Other|4|||
16822386|NCT01683838|37765928|FG001|Overall Study|Other|3|||
16822387|NCT01683604|37765934|FG000|Overall Study|Adverse Event|2|||
16822388|NCT01683604|37765934|FG000|Overall Study|Lack of Efficacy|1|||
16822389|NCT01683604|37765934|FG000|Overall Study|Other|2|||
16822390|NCT02196038|37765945|FG000|Overall Study|Death|16|||
16911654|NCT01489254|38020796|FG001|Double-blind Part|Other reasons for not completing study|6|||
16822391|NCT02196038|37765946|FG001|Overall Study|Death|21|||
16822392|NCT02196038|37765945|FG000|Overall Study|Withdrawal by Subject|0|||
16822393|NCT02196038|37765946|FG001|Overall Study|Withdrawal by Subject|1|||
16822394|NCT02196038|37765945|FG000|Overall Study|Lost to Follow-up|1|||
16822395|NCT02196038|37765946|FG001|Overall Study|Lost to Follow-up|0|||
16822396|NCT02141659|37765958|FG000|Overall Study|Major Protocol Deviation|0|||
16822397|NCT02141659|37765959|FG001|Overall Study|Major Protocol Deviation|1|||
16822398|NCT02141659|37765960|FG002|Overall Study|Major Protocol Deviation|0|||
16822399|NCT02141659|37765961|FG003|Overall Study|Major Protocol Deviation|0|||
16822400|NCT02141659|37765962|FG004|Overall Study|Major Protocol Deviation|0|||
16822401|NCT02141659|37765963|FG005|Overall Study|Major Protocol Deviation|0|||
16822402|NCT02141659|37765958|FG000|Overall Study|Lack of Efficacy|0|||
16822403|NCT02141659|37765959|FG001|Overall Study|Lack of Efficacy|0|||
16822404|NCT02141659|37765960|FG002|Overall Study|Lack of Efficacy|0|||
16822405|NCT02141659|37765961|FG003|Overall Study|Lack of Efficacy|0|||
16822406|NCT02141659|37765962|FG004|Overall Study|Lack of Efficacy|0|||
16822407|NCT02141659|37765963|FG005|Overall Study|Lack of Efficacy|1|||
16822408|NCT02141659|37765958|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
16822409|NCT02141659|37765959|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
16822410|NCT02141659|37765960|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
16911655|NCT01489254|38020797|FG002|Double-blind Part|Other reasons for not completing study|0|||
16911656|NCT01489254|38020798|FG003|Double-blind Part|Other reasons for not completing study|0|||
16911657|NCT01489254|38020795|FG000|Open-label Extension Part|Adverse Event|0|||
16911658|NCT01489254|38020796|FG001|Open-label Extension Part|Adverse Event|0|||
16911659|NCT01489254|38020797|FG002|Open-label Extension Part|Adverse Event|0|||
16911660|NCT01489254|38020798|FG003|Open-label Extension Part|Adverse Event|10|||
16911661|NCT01489254|38020795|FG000|Open-label Extension Part|Pregnancy|0|||
16911662|NCT01489254|38020796|FG001|Open-label Extension Part|Pregnancy|0|||
16911663|NCT01489254|38020797|FG002|Open-label Extension Part|Pregnancy|0|||
16911664|NCT01489254|38020798|FG003|Open-label Extension Part|Pregnancy|3|||
16911665|NCT01489254|38020795|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
16911666|NCT01489254|38020796|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
16911667|NCT01489254|38020797|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
16911668|NCT01489254|38020798|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
16911669|NCT01489254|38020795|FG000|Open-label Extension Part|Protocol Violation|0|||
16911670|NCT01489254|38020796|FG001|Open-label Extension Part|Protocol Violation|0|||
16911671|NCT01489254|38020797|FG002|Open-label Extension Part|Protocol Violation|0|||
16911672|NCT01489254|38020798|FG003|Open-label Extension Part|Protocol Violation|1|||
16911673|NCT01489254|38020795|FG000|Open-label Extension Part|Lost to Follow-up|0|||
16911674|NCT01489254|38020796|FG001|Open-label Extension Part|Lost to Follow-up|0|||
16911675|NCT01489254|38020797|FG002|Open-label Extension Part|Lost to Follow-up|0|||
16911676|NCT01489254|38020798|FG003|Open-label Extension Part|Lost to Follow-up|9|||
16911677|NCT01489254|38020795|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
16911678|NCT01489254|38020796|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
16911679|NCT01489254|38020797|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
16911680|NCT01489254|38020798|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
16911681|NCT01489020|38020813|FG000|Overall Study|Withdrawal by Subject|1|||
16911682|NCT01489020|38020814|FG001|Overall Study|Withdrawal by Subject|0|||
16911683|NCT01489020|38020815|FG002|Overall Study|Withdrawal by Subject|0|||
16911684|NCT01489020|38020816|FG003|Overall Study|Withdrawal by Subject|0|||
16911685|NCT01489020|38020817|FG004|Overall Study|Withdrawal by Subject|0|||
16911686|NCT01489020|38020818|FG005|Overall Study|Withdrawal by Subject|0|||
16911687|NCT01489020|38020813|FG000|Overall Study|Adverse Event|0|||
16911688|NCT01489020|38020814|FG001|Overall Study|Adverse Event|0|||
16911689|NCT01489020|38020815|FG002|Overall Study|Adverse Event|3|||
16911690|NCT01489020|38020816|FG003|Overall Study|Adverse Event|0|||
16911691|NCT01489020|38020817|FG004|Overall Study|Adverse Event|3|||
16911692|NCT01489020|38020818|FG005|Overall Study|Adverse Event|0|||
16911693|NCT01489020|38020813|FG000|Overall Study|Concomitant disease|0|||
16911694|NCT01489020|38020814|FG001|Overall Study|Concomitant disease|0|||
16911695|NCT01489020|38020815|FG002|Overall Study|Concomitant disease|0|||
16911696|NCT01489020|38020816|FG003|Overall Study|Concomitant disease|0|||
16911697|NCT01489020|38020817|FG004|Overall Study|Concomitant disease|3|||
16911698|NCT01489020|38020818|FG005|Overall Study|Concomitant disease|0|||
16911699|NCT01514760|38020838|FG000|Overall Study|Lost to Follow-up|2|||
16911700|NCT01514682|38020844|FG000|Overall Study|Withdrawal by Subject|2|||
16911701|NCT01514682|38020845|FG001|Overall Study|Withdrawal by Subject|3|||
16911702|NCT01514682|38020844|FG000|Overall Study|Physician Decision|4|||
16911703|NCT01514682|38020845|FG001|Overall Study|Physician Decision|3|||
16911704|NCT01514448|38020853|FG000|Overall Study|Death|7|||
16911705|NCT01514448|38020854|FG001|Overall Study|Death|8|||
16911706|NCT01514448|38020853|FG000|Overall Study|Withdrawal by Subject|2|||
16822411|NCT02141659|37765961|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
16822412|NCT02141659|37765962|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
16822413|NCT02141659|37765963|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
16911707|NCT01514448|38020854|FG001|Overall Study|Withdrawal by Subject|0|||
16911708|NCT01514448|38020853|FG000|Overall Study|Lost to Follow-up|2|||
16911709|NCT01514448|38020854|FG001|Overall Study|Lost to Follow-up|0|||
16911710|NCT01514448|38020853|FG000|Overall Study|New Cancer Therapy|1|||
16911711|NCT01514448|38020854|FG001|Overall Study|New Cancer Therapy|0|||
16911712|NCT01514370|38020863|FG000|Overall Study|Protocol Violation|2|||
16911713|NCT01514370|38020864|FG001|Overall Study|Protocol Violation|3|||
16911714|NCT01514370|38020863|FG000|Overall Study|Lost to Follow-up|0|||
16911715|NCT01514370|38020864|FG001|Overall Study|Lost to Follow-up|2|||
16911716|NCT01514370|38020863|FG000|Overall Study|Withdrawal by Subject|2|||
16911717|NCT01514370|38020864|FG001|Overall Study|Withdrawal by Subject|1|||
16911718|NCT01514370|38020863|FG000|Overall Study|Adverse Event|1|||
16911719|NCT01514370|38020864|FG001|Overall Study|Adverse Event|3|||
16911720|NCT01514370|38020863|FG000|Overall Study|Other|6|||
16911721|NCT01514370|38020864|FG001|Overall Study|Other|7|||
16911722|NCT01519674|38020874|FG000|Overall Study|Adverse Event|3|||
16911723|NCT01519674|38020875|FG001|Overall Study|Adverse Event|3|||
16911724|NCT01519674|38020876|FG002|Overall Study|Adverse Event|0|||
16911725|NCT01519674|38020874|FG000|Overall Study|Lack of Efficacy|1|||
16911726|NCT01519674|38020875|FG001|Overall Study|Lack of Efficacy|1|||
16911727|NCT01519674|38020876|FG002|Overall Study|Lack of Efficacy|1|||
16911728|NCT01519674|38020874|FG000|Overall Study|Protocol Violation|0|||
16911729|NCT01519674|38020875|FG001|Overall Study|Protocol Violation|3|||
16911730|NCT01519674|38020876|FG002|Overall Study|Protocol Violation|1|||
16911731|NCT01519674|38020874|FG000|Overall Study|Withdrawal Criteria|7|||
16911732|NCT01519674|38020875|FG001|Overall Study|Withdrawal Criteria|2|||
16911733|NCT01519674|38020876|FG002|Overall Study|Withdrawal Criteria|7|||
16911734|NCT01519674|38020874|FG000|Overall Study|Unsclassified|10|||
16911735|NCT01519674|38020875|FG001|Overall Study|Unsclassified|4|||
16822414|NCT01640249|37765984|FG000|Period 1|Withdrawal by Subject|1|||
16822415|NCT01640249|37765985|FG001|Period 1|Withdrawal by Subject|0|||
16822416|NCT01640249|37765986|FG002|Period 1|Withdrawal by Subject|0|||
16822417|NCT01640249|37765987|FG003|Period 1|Withdrawal by Subject|0|||
16822418|NCT01640249|37765988|FG004|Period 1|Withdrawal by Subject|0|||
16822419|NCT01640249|37765989|FG005|Period 1|Withdrawal by Subject|1|||
16822420|NCT01640249|37765990|FG006|Period 1|Withdrawal by Subject|0|||
16822421|NCT02121301|37766012|FG000|Overall Study|Protocol Violation|1|||
16822422|NCT02121301|37766013|FG001|Overall Study|Protocol Violation|4|||
16822423|NCT02121301|37766014|FG002|Overall Study|Protocol Violation|1|||
16822424|NCT02227862|37766024|FG000|Overall Study|Protocol Violation|7|||
16822425|NCT02227862|37766025|FG001|Overall Study|Protocol Violation|9|||
16822426|NCT02227862|37766024|FG000|Overall Study|Other|0|||
16822427|NCT02227862|37766025|FG001|Overall Study|Other|2|||
16822428|NCT02227862|37766024|FG000|Overall Study|Adverse Event|4|||
16822429|NCT02227862|37766025|FG001|Overall Study|Adverse Event|3|||
16822430|NCT02227862|37766024|FG000|Overall Study|Withdrawal by Subject|7|||
16822431|NCT02227862|37766025|FG001|Overall Study|Withdrawal by Subject|6|||
16822432|NCT02227862|37766024|FG000|Overall Study|Lost to Follow-up|1|||
16822433|NCT02227862|37766025|FG001|Overall Study|Lost to Follow-up|2|||
16822434|NCT02120833|37766033|FG000|Overall Study|Adverse Event|1|||
16822435|NCT02120833|37766034|FG001|Overall Study|Adverse Event|0|||
16822436|NCT02120833|37766033|FG000|Overall Study|Withdrawal by Subject|2|||
16822437|NCT02120833|37766034|FG001|Overall Study|Withdrawal by Subject|0|||
16822438|NCT02120833|37766033|FG000|Overall Study|Lost to Follow-up|1|||
16822439|NCT02120833|37766034|FG001|Overall Study|Lost to Follow-up|1|||
16822440|NCT02170207|37766040|FG000|Overall Study|Case report forms unavailable|5|||
16822441|NCT02227784|37766048|FG000|Double-Blind Phase|Adverse Event|3|||
16822442|NCT02227784|37766049|FG001|Double-Blind Phase|Adverse Event|2|||
16822443|NCT02227784|37766050|FG002|Double-Blind Phase|Adverse Event|1|||
16822444|NCT02227784|37766051|FG003|Double-Blind Phase|Adverse Event|3|||
16822445|NCT02227784|37766052|FG004|Double-Blind Phase|Adverse Event|0|||
16822446|NCT02227784|37766048|FG000|Double-Blind Phase|Physician Decision|1|||
16822447|NCT02227784|37766049|FG001|Double-Blind Phase|Physician Decision|0|||
16822448|NCT02227784|37766050|FG002|Double-Blind Phase|Physician Decision|0|||
16822449|NCT02227784|37766051|FG003|Double-Blind Phase|Physician Decision|1|||
16822450|NCT02227784|37766052|FG004|Double-Blind Phase|Physician Decision|0|||
16822451|NCT02227784|37766048|FG000|Double-Blind Phase|Protocol Violation|0|||
16822452|NCT02227784|37766049|FG001|Double-Blind Phase|Protocol Violation|0|||
16822453|NCT02227784|37766050|FG002|Double-Blind Phase|Protocol Violation|1|||
16822454|NCT02227784|37766051|FG003|Double-Blind Phase|Protocol Violation|1|||
16822455|NCT02227784|37766052|FG004|Double-Blind Phase|Protocol Violation|0|||
16822456|NCT02227784|37766048|FG000|Double-Blind Phase|Sponsor Decision|34|||
16822457|NCT02227784|37766049|FG001|Double-Blind Phase|Sponsor Decision|15|||
16822458|NCT02227784|37766050|FG002|Double-Blind Phase|Sponsor Decision|14|||
16822459|NCT02227784|37766051|FG003|Double-Blind Phase|Sponsor Decision|32|||
16822460|NCT02227784|37766052|FG004|Double-Blind Phase|Sponsor Decision|0|||
16911736|NCT01519674|38020876|FG002|Overall Study|Unsclassified|3|||
16911737|NCT01519518|38020886|FG000|Overall Study|Consent not available|7|||
16911738|NCT01519518|38020887|FG001|Overall Study|Consent not available|10|||
16822461|NCT02227784|37766048|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
16822462|NCT02227784|37766049|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
16822463|NCT02227784|37766050|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
16822464|NCT02227784|37766051|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
16822465|NCT02227784|37766052|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
16822466|NCT02227784|37766048|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
16822467|NCT02227784|37766049|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
16822468|NCT02227784|37766050|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
16822469|NCT02227784|37766051|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
16822470|NCT02227784|37766052|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
16822471|NCT02227784|37766048|FG000|Open-Label Extension Phase (OLE)|Death|0|||
16822472|NCT02227784|37766049|FG001|Open-Label Extension Phase (OLE)|Death|0|||
16822473|NCT02227784|37766050|FG002|Open-Label Extension Phase (OLE)|Death|0|||
16822474|NCT02227784|37766051|FG003|Open-Label Extension Phase (OLE)|Death|0|||
16822475|NCT02227784|37766052|FG004|Open-Label Extension Phase (OLE)|Death|1|||
16822476|NCT02227784|37766048|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16822477|NCT02227784|37766049|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16911739|NCT01519206|38020893|FG000|Overall Study|Lost to Follow-up|3|||
16911740|NCT01519206|38020893|FG000|Overall Study|Missed Visit|2|||
16911741|NCT01518972|38020906|FG000|Overall Study|Lost to Follow-up|2|||
16911742|NCT01518972|38020907|FG001|Overall Study|Lost to Follow-up|1|||
16911743|NCT01518972|38020906|FG000|Overall Study|Withdrawal by Subject|1|||
16911744|NCT01518972|38020907|FG001|Overall Study|Withdrawal by Subject|0|||
16911745|NCT01518972|38020906|FG000|Overall Study|Moved from area|1|||
16911746|NCT01518972|38020907|FG001|Overall Study|Moved from area|0|||
16911747|NCT01518972|38020906|FG000|Overall Study|Transportation problems|1|||
16911748|NCT01518972|38020907|FG001|Overall Study|Transportation problems|0|||
16911749|NCT01518972|38020906|FG000|Overall Study|Exclusionary medical condition|1|||
16911750|NCT01518972|38020907|FG001|Overall Study|Exclusionary medical condition|0|||
16911751|NCT01518972|38020906|FG000|Overall Study|Missed safety visits|0|||
16911752|NCT01518972|38020907|FG001|Overall Study|Missed safety visits|1|||
16911753|NCT01518972|38020906|FG000|Overall Study|Exclusionary medication|0|||
16911754|NCT01518972|38020907|FG001|Overall Study|Exclusionary medication|1|||
16911755|NCT01518972|38020906|FG000|Overall Study|Declined medication starting on day 12|0|||
16911756|NCT01518972|38020907|FG001|Overall Study|Declined medication starting on day 12|1|||
16911757|NCT01514136|38020915|FG000|Test Period 1; Test A|Protocol Violation|1|||
16911758|NCT01514136|38020916|FG001|Test Period 1; Test A|Protocol Violation|0|||
16911759|NCT01514136|38020917|FG002|Test Period 1; Test A|Protocol Violation|0|||
16911760|NCT01514136|38020918|FG003|Test Period 1; Test A|Protocol Violation|0|||
16911761|NCT01514136|38020919|FG004|Test Period 1; Test A|Protocol Violation|0|||
16911762|NCT01514136|38020920|FG005|Test Period 1; Test A|Protocol Violation|0|||
16911763|NCT01514136|38020921|FG006|Test Period 1; Test A|Protocol Violation|0|||
16911764|NCT01514136|38020922|FG007|Test Period 1; Test A|Protocol Violation|0|||
16911765|NCT01514136|38020915|FG000|Test Period 1; Test A|Break from study holiday|2|||
16911766|NCT01514136|38020916|FG001|Test Period 1; Test A|Break from study holiday|0|||
16911767|NCT01514136|38020917|FG002|Test Period 1; Test A|Break from study holiday|0|||
16911768|NCT01514136|38020918|FG003|Test Period 1; Test A|Break from study holiday|0|||
16822478|NCT02227784|37766050|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16822479|NCT02227784|37766051|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16822480|NCT02227784|37766052|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
16822481|NCT02227784|37766048|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
16822482|NCT02227784|37766049|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
16822483|NCT02227784|37766050|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
16822484|NCT02227784|37766051|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
16911769|NCT01514136|38020919|FG004|Test Period 1; Test A|Break from study holiday|0|||
16911770|NCT01514136|38020920|FG005|Test Period 1; Test A|Break from study holiday|0|||
16911771|NCT01514136|38020921|FG006|Test Period 1; Test A|Break from study holiday|0|||
16911772|NCT01514136|38020922|FG007|Test Period 1; Test A|Break from study holiday|0|||
16911773|NCT01514136|38020915|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
16911774|NCT01514136|38020916|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
16911775|NCT01514136|38020917|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
16911776|NCT01514136|38020918|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
16911777|NCT01514136|38020919|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
16911778|NCT01514136|38020920|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
16911779|NCT01514136|38020921|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
16911780|NCT01514136|38020922|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
16822485|NCT02227784|37766052|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
16822486|NCT01565668|37766067|FG000|Overall Study|Death|2|||
16911781|NCT01514136|38020915|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
16911782|NCT01514136|38020916|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
16911783|NCT01514136|38020917|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
16911784|NCT01514136|38020918|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
16911785|NCT01514136|38020919|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
16911786|NCT01514136|38020920|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
16911787|NCT01514136|38020921|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
16911788|NCT01514136|38020922|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
16911789|NCT01514136|38020915|FG000|Test Period 2; Test A*|Adverse Event|0|||
16911790|NCT01514136|38020916|FG001|Test Period 2; Test A*|Adverse Event|0|||
16911791|NCT01514136|38020917|FG002|Test Period 2; Test A*|Adverse Event|0|||
16911792|NCT01514136|38020918|FG003|Test Period 2; Test A*|Adverse Event|0|||
16911793|NCT01514136|38020919|FG004|Test Period 2; Test A*|Adverse Event|1|||
16822487|NCT01565668|37766068|FG001|Overall Study|Death|1|||
16822488|NCT01565668|37766067|FG000|Overall Study|Lack of Efficacy|4|||
16822489|NCT01565668|37766068|FG001|Overall Study|Lack of Efficacy|2|||
16822490|NCT01565668|37766067|FG000|Overall Study|Participant went on Hospice Care|1|||
16822491|NCT01565668|37766068|FG001|Overall Study|Participant went on Hospice Care|0|||
16822492|NCT01565668|37766067|FG000|Overall Study|Adverse Event|6|||
16822493|NCT01565668|37766068|FG001|Overall Study|Adverse Event|1|||
16822494|NCT01565668|37766067|FG000|Overall Study|Randomized, but never received drug|0|||
16822495|NCT01565668|37766068|FG001|Overall Study|Randomized, but never received drug|2|||
16822496|NCT01565668|37766067|FG000|Overall Study|Progressive disease|13|||
16822497|NCT01565668|37766068|FG001|Overall Study|Progressive disease|14|||
16822498|NCT01565668|37766067|FG000|Overall Study|Withdrawal by Subject|1|||
16822499|NCT01565668|37766068|FG001|Overall Study|Withdrawal by Subject|3|||
16822500|NCT01565668|37766067|FG000|Overall Study|HSCT Transplant|11|||
16822501|NCT01565668|37766068|FG001|Overall Study|HSCT Transplant|15|||
16822502|NCT01683058|37766074|FG000|Overall Study|Lost to Follow-up|9|||
16822503|NCT01683058|37766074|FG000|Overall Study|Adverse Event|6|||
16822504|NCT01683058|37766074|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
16822505|NCT01683058|37766074|FG000|Overall Study|Withdrawal by Subject|7|||
16822506|NCT01683058|37766074|FG000|Overall Study|Lack of Efficacy|2|||
16822507|NCT01626859|37766082|FG000|Overall Study|Adverse Event|1|||
16822508|NCT01626859|37766083|FG001|Overall Study|Adverse Event|3|||
16822509|NCT01626859|37766084|FG002|Overall Study|Adverse Event|2|||
16822510|NCT01626859|37766082|FG000|Overall Study|Physician Decision|0|||
16822511|NCT01626859|37766083|FG001|Overall Study|Physician Decision|1|||
16822512|NCT01626859|37766084|FG002|Overall Study|Physician Decision|0|||
16822513|NCT01626859|37766082|FG000|Overall Study|Withdrawal by Subject|1|||
16822514|NCT01626859|37766083|FG001|Overall Study|Withdrawal by Subject|4|||
16822515|NCT01626859|37766084|FG002|Overall Study|Withdrawal by Subject|2|||
16822516|NCT02193776|37766096|FG000|Overall Study|Consent withdrawn|1|||
16822517|NCT02193776|37766097|FG001|Overall Study|Consent withdrawn|0|||
16822518|NCT02193776|37766098|FG002|Overall Study|Consent withdrawn|0|||
16822519|NCT02193776|37766099|FG003|Overall Study|Consent withdrawn|0|||
16822520|NCT02193776|37766096|FG000|Overall Study|Failure to comply with protocol|0|||
16822521|NCT02193776|37766097|FG001|Overall Study|Failure to comply with protocol|1|||
16822522|NCT02193776|37766098|FG002|Overall Study|Failure to comply with protocol|0|||
16822523|NCT02193776|37766099|FG003|Overall Study|Failure to comply with protocol|0|||
16822524|NCT02193776|37766096|FG000|Overall Study|Investigator/Sponsor decision|1|||
16822525|NCT02193776|37766097|FG001|Overall Study|Investigator/Sponsor decision|1|||
16822526|NCT02193776|37766098|FG002|Overall Study|Investigator/Sponsor decision|0|||
16822527|NCT02193776|37766099|FG003|Overall Study|Investigator/Sponsor decision|0|||
16822528|NCT02193776|37766096|FG000|Overall Study|Death|1|||
16822529|NCT02193776|37766097|FG001|Overall Study|Death|0|||
16822530|NCT02193776|37766098|FG002|Overall Study|Death|0|||
16822531|NCT02193776|37766099|FG003|Overall Study|Death|0|||
16822532|NCT02193776|37766096|FG000|Overall Study|Adverse event/Specific toxicity|5|||
16822533|NCT02193776|37766097|FG001|Overall Study|Adverse event/Specific toxicity|5|||
16822534|NCT02193776|37766098|FG002|Overall Study|Adverse event/Specific toxicity|2|||
16822535|NCT02193776|37766099|FG003|Overall Study|Adverse event/Specific toxicity|2|||
16822536|NCT02170064|37766112|FG000|Overall Study|Withdrawal by Subject|5|||
16822537|NCT02170064|37766113|FG001|Overall Study|Withdrawal by Subject|1|||
16822538|NCT02170064|37766114|FG002|Overall Study|Withdrawal by Subject|1|||
16822539|NCT02170064|37766112|FG000|Overall Study|Physician Decision|1|||
16822540|NCT02170064|37766113|FG001|Overall Study|Physician Decision|1|||
16822541|NCT02170064|37766114|FG002|Overall Study|Physician Decision|0|||
16822542|NCT02169830|37766125|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
16822543|NCT02169830|37766126|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
16822544|NCT02169830|37766127|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
16822545|NCT02169830|37766125|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
16822546|NCT02169830|37766126|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
16822547|NCT02169830|37766127|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
16822548|NCT02169830|37766125|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
16822549|NCT02169830|37766126|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
16822550|NCT02169830|37766127|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
16822551|NCT02169830|37766125|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
16822552|NCT02169830|37766126|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
16822553|NCT02169830|37766127|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
16822554|NCT02169830|37766125|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
16822555|NCT02169830|37766126|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
16822556|NCT02169830|37766127|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
16822557|NCT02169674|37766137|FG000|Overall Study|Withdrawal by Subject|2|||
16822558|NCT02169674|37766138|FG001|Overall Study|Withdrawal by Subject|1|||
16822559|NCT02169674|37766137|FG000|Overall Study|Seroprotected|30|||
16822560|NCT02169674|37766138|FG001|Overall Study|Seroprotected|76|||
16822561|NCT02169674|37766137|FG000|Overall Study|Lost to Follow-up|0|||
16822562|NCT02169674|37766138|FG001|Overall Study|Lost to Follow-up|1|||
16822563|NCT02169284|37766146|FG000|Overall Study|Physician Decision|0|||
16822564|NCT02169284|37766147|FG001|Overall Study|Physician Decision|1|||
16822565|NCT02119819|37766161|FG000|Overall Study|Adverse Event|3|||
16822566|NCT02119819|37766162|FG001|Overall Study|Adverse Event|1|||
16822567|NCT02119819|37766163|FG002|Overall Study|Adverse Event|2|||
16822568|NCT02119819|37766164|FG003|Overall Study|Adverse Event|3|||
16822569|NCT02119819|37766165|FG004|Overall Study|Adverse Event|0|||
16822570|NCT02119819|37766166|FG005|Overall Study|Adverse Event|1|||
16822571|NCT02119819|37766161|FG000|Overall Study|Lack of Efficacy|0|||
16822572|NCT02119819|37766162|FG001|Overall Study|Lack of Efficacy|0|||
16822573|NCT02119819|37766163|FG002|Overall Study|Lack of Efficacy|0|||
16822574|NCT02119819|37766164|FG003|Overall Study|Lack of Efficacy|0|||
16822575|NCT02119819|37766165|FG004|Overall Study|Lack of Efficacy|0|||
16822576|NCT02119819|37766166|FG005|Overall Study|Lack of Efficacy|1|||
16822577|NCT02119819|37766161|FG000|Overall Study|Lost to Follow-up|0|||
16822578|NCT02119819|37766162|FG001|Overall Study|Lost to Follow-up|0|||
16822579|NCT02119819|37766163|FG002|Overall Study|Lost to Follow-up|1|||
16822580|NCT02119819|37766164|FG003|Overall Study|Lost to Follow-up|2|||
16822581|NCT02119819|37766165|FG004|Overall Study|Lost to Follow-up|1|||
16822582|NCT02119819|37766166|FG005|Overall Study|Lost to Follow-up|2|||
16822583|NCT02119819|37766161|FG000|Overall Study|Physician Decision|1|||
16822584|NCT02119819|37766162|FG001|Overall Study|Physician Decision|1|||
16822585|NCT02119819|37766163|FG002|Overall Study|Physician Decision|0|||
16822586|NCT02119819|37766164|FG003|Overall Study|Physician Decision|0|||
16822587|NCT02119819|37766165|FG004|Overall Study|Physician Decision|0|||
16822588|NCT02119819|37766166|FG005|Overall Study|Physician Decision|1|||
16822589|NCT02119819|37766161|FG000|Overall Study|Withdrawal by Subject|5|||
16822590|NCT02119819|37766162|FG001|Overall Study|Withdrawal by Subject|3|||
16822591|NCT02119819|37766163|FG002|Overall Study|Withdrawal by Subject|0|||
16822592|NCT02119819|37766164|FG003|Overall Study|Withdrawal by Subject|0|||
16822593|NCT02119819|37766165|FG004|Overall Study|Withdrawal by Subject|6|||
16822594|NCT02119819|37766166|FG005|Overall Study|Withdrawal by Subject|10|||
16822595|NCT02119819|37766161|FG000|Overall Study|Jury Duty|0|||
16822596|NCT02119819|37766162|FG001|Overall Study|Jury Duty|0|||
16822597|NCT02119819|37766163|FG002|Overall Study|Jury Duty|1|||
16822598|NCT02119819|37766164|FG003|Overall Study|Jury Duty|0|||
16822599|NCT02119819|37766165|FG004|Overall Study|Jury Duty|0|||
16822600|NCT02119819|37766166|FG005|Overall Study|Jury Duty|0|||
16822601|NCT02119819|37766161|FG000|Overall Study|Protocol Violation|0|||
16822602|NCT02119819|37766162|FG001|Overall Study|Protocol Violation|0|||
16822603|NCT02119819|37766163|FG002|Overall Study|Protocol Violation|0|||
16822604|NCT02119819|37766164|FG003|Overall Study|Protocol Violation|1|||
16822605|NCT02119819|37766165|FG004|Overall Study|Protocol Violation|0|||
16822606|NCT02119819|37766166|FG005|Overall Study|Protocol Violation|0|||
16822607|NCT02119819|37766161|FG000|Overall Study|Left the city to get a job|0|||
16822608|NCT02119819|37766162|FG001|Overall Study|Left the city to get a job|0|||
16822609|NCT02119819|37766163|FG002|Overall Study|Left the city to get a job|0|||
16822610|NCT02119819|37766164|FG003|Overall Study|Left the city to get a job|1|||
16822611|NCT02119819|37766165|FG004|Overall Study|Left the city to get a job|0|||
16822612|NCT02119819|37766166|FG005|Overall Study|Left the city to get a job|0|||
16822613|NCT02168816|37766182|FG000|Overall Study|Lost to Follow-up|2|||
16822614|NCT02168816|37766183|FG001|Overall Study|Lost to Follow-up|2|||
16822615|NCT01584232|37766191|FG000|Overall Study|Adverse Event|3|||
16822616|NCT01584232|37766192|FG001|Overall Study|Adverse Event|1|||
16822617|NCT01584232|37766191|FG000|Overall Study|Withdrawal by Subject|2|||
16822618|NCT01584232|37766192|FG001|Overall Study|Withdrawal by Subject|1|||
16822619|NCT01584232|37766191|FG000|Overall Study|Physician Decision|2|||
16822620|NCT01584232|37766192|FG001|Overall Study|Physician Decision|1|||
16822621|NCT01584232|37766191|FG000|Overall Study|Lost to Follow-up|1|||
16822622|NCT01584232|37766192|FG001|Overall Study|Lost to Follow-up|0|||
16822623|NCT01639703|37766198|FG000|Overall Study|Withdrawal by Subject|5|||
16822624|NCT01639703|37766198|FG000|Overall Study|Other reason|7|||
16822625|NCT02119663|37766216|FG000|Overall Study|Disease progression|26|||
16822626|NCT02119663|37766217|FG001|Overall Study|Disease progression|27|||
16822627|NCT02119663|37766216|FG000|Overall Study|Adverse Event|5|||
16822628|NCT02119663|37766217|FG001|Overall Study|Adverse Event|5|||
17198430|NCT02783729|38352126|FG002|Overall Study|Adverse Event|2|||
16822629|NCT02119663|37766216|FG000|Overall Study|Death|3|||
16822630|NCT02119663|37766217|FG001|Overall Study|Death|2|||
16822631|NCT02119663|37766216|FG000|Overall Study|Physician Decision|1|||
16822632|NCT02119663|37766217|FG001|Overall Study|Physician Decision|2|||
16822633|NCT02119663|37766216|FG000|Overall Study|Other unspecified|2|||
16822634|NCT02119663|37766217|FG001|Overall Study|Other unspecified|0|||
16822635|NCT02119663|37766216|FG000|Overall Study|Subject decision|0|||
16822636|NCT02119663|37766217|FG001|Overall Study|Subject decision|1|||
16822637|NCT02119663|37766216|FG000|Overall Study|Study Terminated by the Sponsor|3|||
16822638|NCT02119663|37766217|FG001|Overall Study|Study Terminated by the Sponsor|4|||
16822639|NCT01639469|37766225|FG000|Overall Study|Death|4|||
16822640|NCT01639469|37766226|FG001|Overall Study|Death|2|||
16822641|NCT01639469|37766225|FG000|Overall Study|Lost to Follow-up|1|||
16822642|NCT01639469|37766226|FG001|Overall Study|Lost to Follow-up|1|||
16822643|NCT02193074|37766234|FG000|Overall Study|Withdrawal by Subject|1|||
16822644|NCT02193074|37766235|FG001|Overall Study|Withdrawal by Subject|2|||
16822645|NCT02193074|37766234|FG000|Overall Study|Adverse Event|16|||
16822646|NCT02193074|37766235|FG001|Overall Study|Adverse Event|13|||
16822647|NCT02192606|37766243|FG000|Overall Study|surgery type was changed|1|||
16822648|NCT02192606|37766244|FG001|Overall Study|surgery type was changed|1|||
16822649|NCT02192606|37766243|FG000|Overall Study|Physician Decision|1|||
16822650|NCT02192606|37766244|FG001|Overall Study|Physician Decision|2|||
16822651|NCT02192606|37766243|FG000|Overall Study|3D equipment rep unable to join|0|||
16822652|NCT02192606|37766244|FG001|Overall Study|3D equipment rep unable to join|1|||
16822653|NCT01628107|37766250|FG000|Overall Study|Withdrawal by Subject|17|||
16822654|NCT01628107|37766250|FG000|Overall Study|Lost to Follow-up|4|||
16822655|NCT01628107|37766250|FG000|Overall Study|Adverse Event|33|||
16822656|NCT01628107|37766250|FG000|Overall Study|Physician Decision|2|||
16822657|NCT01628107|37766250|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
16822658|NCT01628107|37766250|FG000|Overall Study|Non-compliant with Study Procedures|10|||
16822659|NCT01628107|37766250|FG000|Overall Study|Not Treated|8|||
16822660|NCT01628107|37766250|FG000|Overall Study|Sponsor Decision|11|||
16822661|NCT01628107|37766250|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
16822662|NCT01628107|37766250|FG000|Overall Study|Relocated|8|||
16822663|NCT01628107|37766250|FG000|Overall Study|Kidney Transplant|9|||
16822664|NCT01628107|37766250|FG000|Overall Study|Use of Standard of Care|9|||
16822665|NCT01583530|37766260|FG000|Overall Study|Adverse Event|0|||
16822666|NCT01583530|37766261|FG001|Overall Study|Adverse Event|0|||
16822667|NCT01583530|37766262|FG002|Overall Study|Adverse Event|0|||
16822668|NCT01583530|37766263|FG003|Overall Study|Adverse Event|0|||
16822669|NCT01583530|37766264|FG004|Overall Study|Adverse Event|0|||
16822670|NCT01583530|37766265|FG005|Overall Study|Adverse Event|1|||
16822671|NCT01583530|37766260|FG000|Overall Study|Withdrawal by Subject|0|||
16822672|NCT01583530|37766261|FG001|Overall Study|Withdrawal by Subject|3|||
16822673|NCT01583530|37766262|FG002|Overall Study|Withdrawal by Subject|0|||
16822674|NCT01583530|37766263|FG003|Overall Study|Withdrawal by Subject|1|||
16822675|NCT01583530|37766264|FG004|Overall Study|Withdrawal by Subject|1|||
16822676|NCT01583530|37766265|FG005|Overall Study|Withdrawal by Subject|2|||
16822677|NCT01583530|37766260|FG000|Overall Study|Lost to Follow-up|0|||
16822678|NCT01583530|37766261|FG001|Overall Study|Lost to Follow-up|0|||
16822679|NCT01583530|37766262|FG002|Overall Study|Lost to Follow-up|0|||
16822680|NCT01583530|37766263|FG003|Overall Study|Lost to Follow-up|0|||
16822681|NCT01583530|37766264|FG004|Overall Study|Lost to Follow-up|3|||
16822682|NCT01583530|37766265|FG005|Overall Study|Lost to Follow-up|0|||
16822683|NCT01583530|37766260|FG000|Overall Study|Lack of compliance|0|||
16822684|NCT01583530|37766261|FG001|Overall Study|Lack of compliance|0|||
16822685|NCT01583530|37766262|FG002|Overall Study|Lack of compliance|0|||
16822686|NCT01583530|37766263|FG003|Overall Study|Lack of compliance|0|||
16822687|NCT01583530|37766264|FG004|Overall Study|Lack of compliance|1|||
16822688|NCT01583530|37766265|FG005|Overall Study|Lack of compliance|0|||
16822689|NCT01639001|37766284|FG000|Overall Study|Refused further follow-up|9|||
16822690|NCT01639001|37766285|FG001|Overall Study|Refused further follow-up|12|||
16911794|NCT01514136|38020920|FG005|Test Period 2; Test A*|Adverse Event|0|||
16911795|NCT01514136|38020921|FG006|Test Period 2; Test A*|Adverse Event|0|||
16911796|NCT01514136|38020922|FG007|Test Period 2; Test A*|Adverse Event|0|||
16822691|NCT01639001|37766284|FG000|Overall Study|Lost to Follow-up|3|||
16822692|NCT01639001|37766285|FG001|Overall Study|Lost to Follow-up|0|||
16822693|NCT01639001|37766284|FG000|Overall Study|Death|62|||
16822694|NCT01639001|37766285|FG001|Overall Study|Death|61|||
16822695|NCT01639001|37766284|FG000|Overall Study|Randomized but not treated|0|||
16822696|NCT01639001|37766285|FG001|Overall Study|Randomized but not treated|2|||
16822697|NCT01639001|37766284|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
16911797|NCT01514136|38020915|FG000|Test Period 2; Test A*|Holiday|0|||
16911798|NCT01514136|38020916|FG001|Test Period 2; Test A*|Holiday|0|||
16822698|NCT01639001|37766285|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
16822699|NCT02224664|37766293|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
16822700|NCT02224664|37766294|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
16822701|NCT02224664|37766295|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
16822702|NCT02224664|37766296|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
16911799|NCT01514136|38020917|FG002|Test Period 2; Test A*|Holiday|0|||
16911800|NCT01514136|38020918|FG003|Test Period 2; Test A*|Holiday|0|||
16911801|NCT01514136|38020919|FG004|Test Period 2; Test A*|Holiday|1|||
16911802|NCT01514136|38020920|FG005|Test Period 2; Test A*|Holiday|0|||
16911803|NCT01514136|38020921|FG006|Test Period 2; Test A*|Holiday|0|||
16911804|NCT01514136|38020922|FG007|Test Period 2; Test A*|Holiday|0|||
16911805|NCT01514136|38020915|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
16911806|NCT01514136|38020916|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
16822703|NCT02224664|37766297|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
16822704|NCT02224664|37766293|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
16911807|NCT01514136|38020917|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
16911808|NCT01514136|38020918|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
16911809|NCT01514136|38020919|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
16911810|NCT01514136|38020920|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
16822705|NCT02224664|37766294|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
16822706|NCT02224664|37766295|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
16822707|NCT02224664|37766296|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
16822708|NCT02224664|37766297|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
16822709|NCT02224664|37766293|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
16822710|NCT02224664|37766294|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
16822711|NCT02224664|37766295|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
16822712|NCT02224664|37766296|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
16822713|NCT02224664|37766297|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
16822714|NCT02168270|37766313|FG000|Overall Study|Lack of Efficacy|4|||
16822715|NCT02167256|37766319|FG000|Overall Study|Adverse Event|13|||
16822716|NCT02167256|37766320|FG001|Overall Study|Adverse Event|6|||
16911811|NCT01514136|38020921|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
16911812|NCT01514136|38020922|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
16911813|NCT01514136|38020915|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
16911814|NCT01514136|38020916|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
16911815|NCT01514136|38020917|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
16911816|NCT01514136|38020918|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
16911817|NCT01514136|38020919|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
16911818|NCT01514136|38020920|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
16911819|NCT01514136|38020921|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
16911820|NCT01514136|38020922|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
16911821|NCT01514136|38020915|FG000|Test Period 2; Test C*|holiday|0|||
16911822|NCT01514136|38020916|FG001|Test Period 2; Test C*|holiday|0|||
16911823|NCT01514136|38020917|FG002|Test Period 2; Test C*|holiday|0|||
16911824|NCT01514136|38020918|FG003|Test Period 2; Test C*|holiday|0|||
16911825|NCT01514136|38020919|FG004|Test Period 2; Test C*|holiday|0|||
16911826|NCT01514136|38020920|FG005|Test Period 2; Test C*|holiday|0|||
16911827|NCT01514136|38020921|FG006|Test Period 2; Test C*|holiday|1|||
16911828|NCT01514136|38020922|FG007|Test Period 2; Test C*|holiday|0|||
16911829|NCT01514136|38020915|FG000|Test Period 2; Test C*|Protocol Violation|0|||
16911830|NCT01514136|38020916|FG001|Test Period 2; Test C*|Protocol Violation|0|||
16911831|NCT01514136|38020917|FG002|Test Period 2; Test C*|Protocol Violation|0|||
16911832|NCT01514136|38020918|FG003|Test Period 2; Test C*|Protocol Violation|0|||
16911833|NCT01514136|38020919|FG004|Test Period 2; Test C*|Protocol Violation|0|||
16911834|NCT01514136|38020920|FG005|Test Period 2; Test C*|Protocol Violation|0|||
16911835|NCT01514136|38020921|FG006|Test Period 2; Test C*|Protocol Violation|1|||
16911836|NCT01514136|38020922|FG007|Test Period 2; Test C*|Protocol Violation|0|||
16911837|NCT01513590|38020950|FG000|Overall Study|Adverse Event|2|||
16911838|NCT01513590|38020951|FG001|Overall Study|Adverse Event|3|||
16911839|NCT01513590|38020950|FG000|Overall Study|Withdrawal Criteria|3|||
16911840|NCT01513590|38020951|FG001|Overall Study|Withdrawal Criteria|0|||
16911841|NCT01513590|38020950|FG000|Overall Study|Unclassified|5|||
16911842|NCT01513590|38020951|FG001|Overall Study|Unclassified|10|||
16911843|NCT01512264|38020961|FG000|Overall Study|Lost to Follow-up|0|||
16911844|NCT01512264|38020962|FG001|Overall Study|Lost to Follow-up|0|||
16911845|NCT01512264|38020963|FG002|Overall Study|Lost to Follow-up|0|||
17016676|NCT00600119|38161267|FG005|Double-blind Treatment Period|Physician Decision|0|||
17016677|NCT00600119|38161262|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
17016678|NCT00600119|38161263|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
17016679|NCT00600119|38161264|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
17016680|NCT00600119|38161265|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
17016681|NCT00600119|38161266|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
17016682|NCT00600119|38161267|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
17016683|NCT00600119|38161262|FG000|Double-blind Treatment Period|Adverse Event|1|||
17016684|NCT00600119|38161263|FG001|Double-blind Treatment Period|Adverse Event|1|||
16911846|NCT01512264|38020964|FG003|Overall Study|Lost to Follow-up|1|||
16911847|NCT01512108|38020976|FG000|Overall Study|Adverse Event|9|||
16911848|NCT01512108|38020977|FG001|Overall Study|Adverse Event|4|||
16911849|NCT01512108|38020976|FG000|Overall Study|Protocol Violation|1|||
17016685|NCT00600119|38161264|FG002|Double-blind Treatment Period|Adverse Event|0|||
16911850|NCT01512108|38020977|FG001|Overall Study|Protocol Violation|2|||
16911851|NCT01512108|38020976|FG000|Overall Study|Withdrawal Criteria|1|||
16911852|NCT01512108|38020977|FG001|Overall Study|Withdrawal Criteria|0|||
16911853|NCT01512108|38020976|FG000|Overall Study|Unclassified|11|||
16911854|NCT01512108|38020977|FG001|Overall Study|Unclassified|3|||
16911855|NCT01486758|38020985|FG000|Overall Study|Lost to Follow-up|0|||
16911856|NCT01486758|38020986|FG001|Overall Study|Lost to Follow-up|1|||
16911857|NCT01463982|38020997|FG000|Overall Study|Withdrawal by Subject|0|||
16911858|NCT01463982|38020998|FG001|Overall Study|Withdrawal by Subject|1|||
16911859|NCT01463982|38020999|FG002|Overall Study|Withdrawal by Subject|1|||
16911860|NCT01463982|38021000|FG003|Overall Study|Withdrawal by Subject|0|||
16911861|NCT01463982|38020997|FG000|Overall Study|Treatment delay over 5 week|0|||
16911862|NCT01463982|38020998|FG001|Overall Study|Treatment delay over 5 week|0|||
16911863|NCT01463982|38020999|FG002|Overall Study|Treatment delay over 5 week|1|||
16911864|NCT01463982|38021000|FG003|Overall Study|Treatment delay over 5 week|0|||
16911865|NCT01486446|38021012|FG000|Overall Study|Adverse Event|1|||
16911866|NCT01486446|38021013|FG001|Overall Study|Adverse Event|0|||
16911867|NCT01511250|38021029|FG000|Overall Study|Withdrawal of Consent|1|||
16911868|NCT01511250|38021030|FG001|Overall Study|Withdrawal of Consent|0|||
16911869|NCT01511250|38021031|FG002|Overall Study|Withdrawal of Consent|0|||
16911870|NCT01511250|38021032|FG003|Overall Study|Withdrawal of Consent|0|||
16911871|NCT01511250|38021033|FG004|Overall Study|Withdrawal of Consent|0|||
16911872|NCT01511250|38021034|FG005|Overall Study|Withdrawal of Consent|0|||
16911873|NCT01511250|38021035|FG006|Overall Study|Withdrawal of Consent|0|||
16911874|NCT01511250|38021036|FG007|Overall Study|Withdrawal of Consent|1|||
16911875|NCT01511250|38021037|FG008|Overall Study|Withdrawal of Consent|1|||
16911876|NCT01511250|38021038|FG009|Overall Study|Withdrawal of Consent|0|||
16911877|NCT01511250|38021029|FG000|Overall Study|Sponsor/Investigator Decision|1|||
16911878|NCT01511250|38021030|FG001|Overall Study|Sponsor/Investigator Decision|0|||
16911879|NCT01511250|38021031|FG002|Overall Study|Sponsor/Investigator Decision|0|||
16911880|NCT01511250|38021032|FG003|Overall Study|Sponsor/Investigator Decision|0|||
16911881|NCT01511250|38021033|FG004|Overall Study|Sponsor/Investigator Decision|0|||
16911882|NCT01511250|38021034|FG005|Overall Study|Sponsor/Investigator Decision|0|||
16822717|NCT02167256|37766319|FG000|Overall Study|Withdrawal by Subject|4|||
16822718|NCT02167256|37766320|FG001|Overall Study|Withdrawal by Subject|4|||
16822719|NCT02167256|37766319|FG000|Overall Study|non-compliance|3|||
16822720|NCT02167256|37766320|FG001|Overall Study|non-compliance|0|||
16822721|NCT02167256|37766319|FG000|Overall Study|Study partner unable to participate|1|||
16822722|NCT02167256|37766320|FG001|Overall Study|Study partner unable to participate|0|||
16911883|NCT01511250|38021035|FG006|Overall Study|Sponsor/Investigator Decision|0|||
16911884|NCT01511250|38021036|FG007|Overall Study|Sponsor/Investigator Decision|0|||
16911885|NCT01511250|38021037|FG008|Overall Study|Sponsor/Investigator Decision|0|||
16911886|NCT01511250|38021038|FG009|Overall Study|Sponsor/Investigator Decision|0|||
17016686|NCT00600119|38161265|FG003|Double-blind Treatment Period|Adverse Event|1|||
16822723|NCT02191046|37766328|FG000|Overall Study|low compliance|5|||
16822724|NCT02191046|37766329|FG001|Overall Study|low compliance|1|||
16822725|NCT02166476|37766337|FG000|Overall Study|Withdrawal by Subject|5|||
16822726|NCT02166476|37766338|FG001|Overall Study|Withdrawal by Subject|7|||
16822727|NCT02166476|37766337|FG000|Overall Study|Adverse Event|3|||
16822728|NCT02166476|37766338|FG001|Overall Study|Adverse Event|3|||
16822729|NCT02166476|37766337|FG000|Overall Study|Lost to Follow-up|5|||
16822730|NCT02166476|37766338|FG001|Overall Study|Lost to Follow-up|10|||
16822731|NCT02166476|37766337|FG000|Overall Study|Physician Decision|1|||
16822732|NCT02166476|37766338|FG001|Overall Study|Physician Decision|0|||
16822733|NCT02166476|37766337|FG000|Overall Study|Unable to Come for Visit|0|||
16822734|NCT02166476|37766338|FG001|Overall Study|Unable to Come for Visit|3|||
16822735|NCT02224274|37766349|FG000|Overall Study|Death|1|||
16822736|NCT02224274|37766350|FG001|Overall Study|Death|0|||
16822737|NCT02189252|37766360|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
16822738|NCT02189252|37766361|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
16822739|NCT02189252|37766362|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
16822740|NCT02189252|37766363|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
16822741|NCT02189252|37766360|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
16822742|NCT02189252|37766361|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
16822743|NCT02189252|37766362|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
16911887|NCT01511250|38021029|FG000|Overall Study|Lost to Follow-up|7|||
16911888|NCT01511250|38021030|FG001|Overall Study|Lost to Follow-up|3|||
16911889|NCT01511250|38021031|FG002|Overall Study|Lost to Follow-up|3|||
16911890|NCT01511250|38021032|FG003|Overall Study|Lost to Follow-up|3|||
16911891|NCT01511250|38021033|FG004|Overall Study|Lost to Follow-up|0|||
16911892|NCT01511250|38021034|FG005|Overall Study|Lost to Follow-up|0|||
16911893|NCT01511250|38021035|FG006|Overall Study|Lost to Follow-up|2|||
16911894|NCT01511250|38021036|FG007|Overall Study|Lost to Follow-up|3|||
16911895|NCT01511250|38021037|FG008|Overall Study|Lost to Follow-up|13|||
16911896|NCT01511250|38021038|FG009|Overall Study|Lost to Follow-up|5|||
16911897|NCT01511250|38021029|FG000|Overall Study|Protocol Violation|0|||
16911898|NCT01511250|38021030|FG001|Overall Study|Protocol Violation|2|||
16911899|NCT01511250|38021031|FG002|Overall Study|Protocol Violation|1|||
16911900|NCT01511250|38021032|FG003|Overall Study|Protocol Violation|0|||
16911901|NCT01511250|38021033|FG004|Overall Study|Protocol Violation|0|||
16911902|NCT01511250|38021034|FG005|Overall Study|Protocol Violation|0|||
16911903|NCT01511250|38021035|FG006|Overall Study|Protocol Violation|0|||
16911904|NCT01511250|38021036|FG007|Overall Study|Protocol Violation|0|||
16911905|NCT01511250|38021037|FG008|Overall Study|Protocol Violation|0|||
16911906|NCT01511250|38021038|FG009|Overall Study|Protocol Violation|0|||
16911907|NCT01485354|38021060|FG000|Overall Study|Withdrawal by Subject|5|||
16911908|NCT01510158|38021067|FG000|Overall Study|Adverse Event|7|||
16911909|NCT01510158|38021068|FG001|Overall Study|Adverse Event|8|||
16911910|NCT01510158|38021069|FG002|Overall Study|Adverse Event|5|||
16911911|NCT01510158|38021067|FG000|Overall Study|Gout flare|1|||
16911912|NCT01510158|38021068|FG001|Overall Study|Gout flare|0|||
16911913|NCT01510158|38021069|FG002|Overall Study|Gout flare|0|||
16911914|NCT01510158|38021067|FG000|Overall Study|Protocol Violation|17|||
16911915|NCT01510158|38021068|FG001|Overall Study|Protocol Violation|16|||
16911916|NCT01510158|38021069|FG002|Overall Study|Protocol Violation|24|||
16911917|NCT01510158|38021067|FG000|Overall Study|Sponsor terminated study.|2|||
16911918|NCT01510158|38021068|FG001|Overall Study|Sponsor terminated study.|0|||
16911919|NCT01510158|38021069|FG002|Overall Study|Sponsor terminated study.|2|||
16911920|NCT01510158|38021067|FG000|Overall Study|Lost to Follow-up|13|||
16911921|NCT01510158|38021068|FG001|Overall Study|Lost to Follow-up|16|||
16911922|NCT01510158|38021069|FG002|Overall Study|Lost to Follow-up|9|||
16911923|NCT01510158|38021067|FG000|Overall Study|Withdrawal by Subject|10|||
16911924|NCT01510158|38021068|FG001|Overall Study|Withdrawal by Subject|13|||
16911925|NCT01510158|38021069|FG002|Overall Study|Withdrawal by Subject|10|||
16911926|NCT01510158|38021067|FG000|Overall Study|Death|1|||
16911927|NCT01510158|38021068|FG001|Overall Study|Death|0|||
16911928|NCT01510158|38021069|FG002|Overall Study|Death|0|||
16911929|NCT01485120|38021086|FG000|Overall Study|Withdrawal by Subject|2|||
16911930|NCT01484496|38021093|FG000|Period 1|Protocol Violation|3|||
16911931|NCT01484496|38021094|FG001|Period 1|Protocol Violation|4|||
16911932|NCT01484496|38021095|FG002|Period 1|Protocol Violation|0|||
16911933|NCT01484496|38021096|FG003|Period 1|Protocol Violation|0|||
16911934|NCT01484496|38021093|FG000|Period 1|Physician Decision|5|||
16911935|NCT01484496|38021094|FG001|Period 1|Physician Decision|1|||
16911936|NCT01484496|38021095|FG002|Period 1|Physician Decision|0|||
16911937|NCT01484496|38021096|FG003|Period 1|Physician Decision|0|||
16911938|NCT01484496|38021093|FG000|Period 1|Lack of Efficacy|10|||
16911939|NCT01484496|38021094|FG001|Period 1|Lack of Efficacy|15|||
16911940|NCT01484496|38021095|FG002|Period 1|Lack of Efficacy|0|||
16911941|NCT01484496|38021096|FG003|Period 1|Lack of Efficacy|0|||
16911942|NCT01484496|38021093|FG000|Period 1|Adverse Event|25|||
16911943|NCT01484496|38021094|FG001|Period 1|Adverse Event|40|||
16911944|NCT01484496|38021095|FG002|Period 1|Adverse Event|0|||
16911945|NCT01484496|38021096|FG003|Period 1|Adverse Event|0|||
16911946|NCT01484496|38021093|FG000|Period 1|Withdrawal by Subject|15|||
16911947|NCT01484496|38021094|FG001|Period 1|Withdrawal by Subject|12|||
16911948|NCT01484496|38021095|FG002|Period 1|Withdrawal by Subject|0|||
16911949|NCT01484496|38021096|FG003|Period 1|Withdrawal by Subject|0|||
16911950|NCT01484496|38021093|FG000|Period 1|Lost to Follow-up|2|||
16911951|NCT01484496|38021094|FG001|Period 1|Lost to Follow-up|6|||
16911952|NCT01484496|38021095|FG002|Period 1|Lost to Follow-up|0|||
16911953|NCT01484496|38021096|FG003|Period 1|Lost to Follow-up|0|||
16911954|NCT01484496|38021093|FG000|Period 1|Positive Pregnancy|1|||
16911955|NCT01484496|38021094|FG001|Period 1|Positive Pregnancy|6|||
16911956|NCT01484496|38021095|FG002|Period 1|Positive Pregnancy|0|||
16911957|NCT01484496|38021096|FG003|Period 1|Positive Pregnancy|0|||
16911958|NCT01484496|38021093|FG000|Period 1|Treatment Failure|3|||
16911959|NCT01484496|38021094|FG001|Period 1|Treatment Failure|6|||
16911960|NCT01484496|38021095|FG002|Period 1|Treatment Failure|0|||
16911961|NCT01484496|38021096|FG003|Period 1|Treatment Failure|0|||
16911962|NCT01484496|38021093|FG000|Period 1|Lack of Compliance|2|||
16911963|NCT01484496|38021094|FG001|Period 1|Lack of Compliance|1|||
16911964|NCT01484496|38021095|FG002|Period 1|Lack of Compliance|0|||
16911965|NCT01484496|38021096|FG003|Period 1|Lack of Compliance|0|||
16911966|NCT01484496|38021093|FG000|Period 1|Unable to Visit Site|0|||
16911967|NCT01484496|38021094|FG001|Period 1|Unable to Visit Site|2|||
16911968|NCT01484496|38021095|FG002|Period 1|Unable to Visit Site|0|||
16911969|NCT01484496|38021096|FG003|Period 1|Unable to Visit Site|0|||
16911970|NCT01484496|38021093|FG000|Period 2|Lack of Efficacy|0|||
16911971|NCT01484496|38021094|FG001|Period 2|Lack of Efficacy|0|||
16911972|NCT01484496|38021095|FG002|Period 2|Lack of Efficacy|1|||
16911973|NCT01484496|38021096|FG003|Period 2|Lack of Efficacy|3|||
16911974|NCT01484496|38021093|FG000|Period 2|Adverse Event|0|||
16911975|NCT01484496|38021094|FG001|Period 2|Adverse Event|0|||
16911976|NCT01484496|38021095|FG002|Period 2|Adverse Event|5|||
16911977|NCT01484496|38021096|FG003|Period 2|Adverse Event|13|||
16911978|NCT01484496|38021093|FG000|Period 2|Other|0|||
16911979|NCT01484496|38021094|FG001|Period 2|Other|0|||
16911980|NCT01484496|38021095|FG002|Period 2|Other|9|||
16911981|NCT01484496|38021096|FG003|Period 2|Other|6|||
16911982|NCT01509846|38021109|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
16911983|NCT01509846|38021110|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
16911984|NCT01509846|38021111|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
16911985|NCT01509846|38021112|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
16911986|NCT01509846|38021113|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
16911987|NCT01509846|38021109|FG000|Received Vaccination 2|Illness|0|||
16911988|NCT01509846|38021110|FG001|Received Vaccination 2|Illness|0|||
16911989|NCT01509846|38021111|FG002|Received Vaccination 2|Illness|0|||
16911990|NCT01509846|38021112|FG003|Received Vaccination 2|Illness|0|||
16911991|NCT01509846|38021113|FG004|Received Vaccination 2|Illness|1|||
16911992|NCT01509846|38021109|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
16911993|NCT01509846|38021110|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
16911994|NCT01509846|38021111|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
16911995|NCT01509846|38021112|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
16911996|NCT01509846|38021113|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
16911997|NCT01509846|38021109|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
16911998|NCT01509846|38021110|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
16911999|NCT01509846|38021111|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
16912000|NCT01509846|38021112|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
16912001|NCT01509846|38021113|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
16912002|NCT01509846|38021109|FG000|Received Vaccination 3|Pregnancy|0|||
16912003|NCT01509846|38021110|FG001|Received Vaccination 3|Pregnancy|0|||
16912004|NCT01509846|38021111|FG002|Received Vaccination 3|Pregnancy|0|||
16912005|NCT01509846|38021112|FG003|Received Vaccination 3|Pregnancy|1|||
16912006|NCT01509846|38021113|FG004|Received Vaccination 3|Pregnancy|0|||
16912007|NCT01509846|38021109|FG000|Received Vaccination 3|Lost to Follow-up|0|||
16912008|NCT01509846|38021110|FG001|Received Vaccination 3|Lost to Follow-up|0|||
16912009|NCT01509846|38021111|FG002|Received Vaccination 3|Lost to Follow-up|1|||
16912010|NCT01509846|38021112|FG003|Received Vaccination 3|Lost to Follow-up|0|||
16912011|NCT01509846|38021113|FG004|Received Vaccination 3|Lost to Follow-up|0|||
16912012|NCT01462344|38021134|FG000|Overall Study|Withdrawal by Subject|245|||
16912013|NCT01462344|38021135|FG001|Overall Study|Withdrawal by Subject|226|||
16912014|NCT01462344|38021134|FG000|Overall Study|Adverse Event|24|||
16912015|NCT01462344|38021135|FG001|Overall Study|Adverse Event|23|||
17016687|NCT00600119|38161266|FG004|Double-blind Treatment Period|Adverse Event|2|||
17016688|NCT00600119|38161267|FG005|Double-blind Treatment Period|Adverse Event|10|||
17016689|NCT00600119|38161262|FG000|Follow-up Period|Adverse Event|0|||
17016690|NCT00600119|38161263|FG001|Follow-up Period|Adverse Event|0|||
17016691|NCT00600119|38161264|FG002|Follow-up Period|Adverse Event|0|||
17016692|NCT00600119|38161265|FG003|Follow-up Period|Adverse Event|0|||
17016693|NCT00600119|38161266|FG004|Follow-up Period|Adverse Event|0|||
17016694|NCT00600119|38161267|FG005|Follow-up Period|Adverse Event|1|||
17016695|NCT00600119|38161262|FG000|Follow-up Period|Other|1|||
16822744|NCT02189252|37766363|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
16912016|NCT01462344|38021134|FG000|Overall Study|Asthma Exacerbation|34|||
16912017|NCT01462344|38021135|FG001|Overall Study|Asthma Exacerbation|35|||
16912018|NCT01462344|38021134|FG000|Overall Study|Lack of Efficacy|5|||
16912019|NCT01462344|38021135|FG001|Overall Study|Lack of Efficacy|6|||
16912020|NCT01462344|38021134|FG000|Overall Study|Protocol Violation|68|||
16912021|NCT01462344|38021135|FG001|Overall Study|Protocol Violation|53|||
16912022|NCT01462344|38021134|FG000|Overall Study|Lost to Follow-up|7|||
16912023|NCT01462344|38021135|FG001|Overall Study|Lost to Follow-up|7|||
16912024|NCT01484028|38021141|FG000|Period 1|Lost to Follow-up|0|||
16912025|NCT01484028|38021142|FG001|Period 1|Lost to Follow-up|1|||
16912026|NCT01484028|38021143|FG002|Period 1|Lost to Follow-up|0|||
16912027|NCT01484028|38021144|FG003|Period 1|Lost to Follow-up|0|||
16912028|NCT01484028|38021141|FG000|Period 1|Non-Compliance to Protocol|0|||
16912029|NCT01484028|38021142|FG001|Period 1|Non-Compliance to Protocol|1|||
16912030|NCT01484028|38021143|FG002|Period 1|Non-Compliance to Protocol|0|||
16912031|NCT01484028|38021144|FG003|Period 1|Non-Compliance to Protocol|1|||
16912032|NCT01484028|38021141|FG000|Period 1|Lens Discomfort|0|||
16912033|NCT01484028|38021142|FG001|Period 1|Lens Discomfort|1|||
16822745|NCT01583374|37766377|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
16822746|NCT01583374|37766378|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
16822747|NCT01583374|37766379|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
16822748|NCT01583374|37766380|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16822749|NCT01583374|37766381|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16912034|NCT01484028|38021143|FG002|Period 1|Lens Discomfort|0|||
16912035|NCT01484028|38021144|FG003|Period 1|Lens Discomfort|0|||
16912036|NCT01462266|38021154|FG000|Overall Study|Adverse Event|7|||
16912037|NCT01462266|38021155|FG001|Overall Study|Adverse Event|6|||
16912038|NCT01462266|38021154|FG000|Overall Study|Death|2|||
16912039|NCT01462266|38021155|FG001|Overall Study|Death|1|||
17016696|NCT00600119|38161263|FG001|Follow-up Period|Other|0|||
17016697|NCT00600119|38161264|FG002|Follow-up Period|Other|0|||
17016698|NCT00600119|38161265|FG003|Follow-up Period|Other|0|||
16822750|NCT01583374|37766382|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16822751|NCT01583374|37766383|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16822752|NCT01583374|37766384|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16822753|NCT01583374|37766385|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16822754|NCT01583374|37766377|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
16822755|NCT01583374|37766378|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
16822756|NCT01583374|37766379|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
16822757|NCT01583374|37766380|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16822758|NCT01583374|37766381|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16822759|NCT01583374|37766382|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16822760|NCT01583374|37766383|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16822761|NCT01583374|37766384|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16822762|NCT01583374|37766385|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16822763|NCT01583374|37766377|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
16822764|NCT01583374|37766378|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
16822765|NCT01583374|37766379|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16822766|NCT01583374|37766380|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16822767|NCT01583374|37766381|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16822768|NCT01583374|37766382|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16822769|NCT01583374|37766383|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16822770|NCT01583374|37766384|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16822771|NCT01583374|37766385|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16822772|NCT01583374|37766377|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
16822773|NCT01583374|37766378|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
16822774|NCT01583374|37766379|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
16822775|NCT01583374|37766380|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16822776|NCT01583374|37766381|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16822777|NCT01583374|37766382|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16822778|NCT01583374|37766383|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16822779|NCT01583374|37766384|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16822780|NCT01583374|37766385|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16822781|NCT01583374|37766377|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
16822782|NCT01583374|37766378|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
16822783|NCT01583374|37766379|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16822784|NCT01583374|37766380|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16822785|NCT01583374|37766381|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16822786|NCT01583374|37766382|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16822787|NCT01583374|37766383|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16822788|NCT01583374|37766384|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16822789|NCT01583374|37766385|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16822790|NCT01583374|37766377|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16822791|NCT01583374|37766378|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16822792|NCT01583374|37766379|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
16822793|NCT01583374|37766380|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16822794|NCT01583374|37766381|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16822795|NCT01583374|37766382|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16822796|NCT01583374|37766383|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16822797|NCT01583374|37766384|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16822798|NCT01583374|37766385|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16822799|NCT01583374|37766377|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
16822800|NCT01583374|37766378|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
16822801|NCT01583374|37766379|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
16822802|NCT01583374|37766380|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
16822803|NCT01583374|37766381|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
16822804|NCT01583374|37766382|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
16822805|NCT01583374|37766383|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
16822806|NCT01583374|37766384|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
16822807|NCT01583374|37766385|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
16822808|NCT01583374|37766377|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16822809|NCT01583374|37766378|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16822810|NCT01583374|37766379|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16822811|NCT01583374|37766380|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16822812|NCT01583374|37766381|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16822813|NCT01583374|37766382|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16822814|NCT01583374|37766383|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16822815|NCT01583374|37766384|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
16822816|NCT01583374|37766385|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16822817|NCT01583374|37766377|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
16822818|NCT01583374|37766378|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16822819|NCT01583374|37766379|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
16822820|NCT01583374|37766380|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
16822821|NCT01583374|37766381|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16822822|NCT01583374|37766382|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16822823|NCT01583374|37766383|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
16822824|NCT01583374|37766384|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16822825|NCT01583374|37766385|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
16822826|NCT01583374|37766377|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
16822827|NCT01583374|37766378|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
16822828|NCT01583374|37766379|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
16822829|NCT01583374|37766380|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
16822830|NCT01583374|37766381|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
16822831|NCT01583374|37766382|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
16822832|NCT01583374|37766383|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
16822833|NCT01583374|37766384|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
16822834|NCT01583374|37766385|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
16822835|NCT01583374|37766377|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16822836|NCT01583374|37766378|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
16822837|NCT01583374|37766379|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
16822838|NCT01583374|37766380|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16822839|NCT01583374|37766381|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
16822840|NCT01583374|37766382|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16822841|NCT01583374|37766383|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16822842|NCT01583374|37766384|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16822843|NCT01583374|37766385|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16822844|NCT01583374|37766377|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16822845|NCT01583374|37766378|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16822846|NCT01583374|37766379|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
16822847|NCT01583374|37766380|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16822848|NCT01583374|37766381|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
16822849|NCT01583374|37766382|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
16822850|NCT01583374|37766383|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16822851|NCT01583374|37766384|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16822852|NCT01583374|37766385|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16822853|NCT01583374|37766377|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
16822854|NCT01583374|37766378|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
16822855|NCT01583374|37766379|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
16822856|NCT01583374|37766380|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
16822857|NCT01583374|37766381|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
16822858|NCT01583374|37766382|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
16822859|NCT01583374|37766383|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
16822860|NCT01583374|37766384|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
16822861|NCT01583374|37766385|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
16822862|NCT01583374|37766377|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
16822863|NCT01583374|37766378|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
16822864|NCT01583374|37766379|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
16822865|NCT01583374|37766380|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
16822866|NCT01583374|37766381|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
16822867|NCT01583374|37766382|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
16822868|NCT01583374|37766383|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
16822869|NCT01583374|37766384|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
16822870|NCT01583374|37766385|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
16822871|NCT01583374|37766377|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16822872|NCT01583374|37766378|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16822873|NCT01583374|37766379|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16822874|NCT01583374|37766380|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16822875|NCT01583374|37766381|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
16822876|NCT01583374|37766382|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16822877|NCT01583374|37766383|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
17102378|NCT00098774|38241311|FG000|Overall Study|Withdrawal by Subject|1|||
16822878|NCT01583374|37766384|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
16822879|NCT01583374|37766385|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
16822880|NCT01583374|37766377|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
16822881|NCT01583374|37766378|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
16822882|NCT01583374|37766379|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
16822883|NCT01583374|37766380|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
16822884|NCT01583374|37766381|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
16822885|NCT01583374|37766382|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
16822886|NCT01583374|37766383|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
16822887|NCT01583374|37766384|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
16822888|NCT01583374|37766385|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
16822889|NCT01583374|37766377|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
16822890|NCT01583374|37766378|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
16822891|NCT01583374|37766379|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
16822892|NCT01583374|37766380|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
16822893|NCT01583374|37766381|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
16822894|NCT01583374|37766382|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
16822895|NCT01583374|37766383|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
16822896|NCT01583374|37766384|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
16822897|NCT01583374|37766385|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
16822898|NCT01583374|37766377|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16822899|NCT01583374|37766378|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
16822900|NCT01583374|37766379|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16822901|NCT01583374|37766380|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
16822902|NCT01583374|37766381|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
16822903|NCT01583374|37766382|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16822904|NCT01583374|37766383|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
16822905|NCT01583374|37766384|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16822906|NCT01583374|37766385|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16822907|NCT01583374|37766377|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
16822908|NCT01583374|37766378|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
16822909|NCT01583374|37766379|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
16822910|NCT01583374|37766380|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
16822911|NCT01583374|37766381|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
16822912|NCT01583374|37766382|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
16822913|NCT01583374|37766383|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
16822914|NCT01583374|37766384|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
16822915|NCT01583374|37766385|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
16822916|NCT01583296|37766406|FG000|Overall Study|Withdrawal by Subject|11|||
16822917|NCT01583296|37766407|FG001|Overall Study|Withdrawal by Subject|10|||
16822918|NCT02222714|37766418|FG000|Overall Study|Death|0|||
16822919|NCT02222714|37766419|FG001|Overall Study|Death|2|||
16822920|NCT02222714|37766420|FG002|Overall Study|Death|3|||
16822921|NCT02222714|37766421|FG003|Overall Study|Death|4|||
16822922|NCT02222714|37766422|FG004|Overall Study|Death|6|||
16822923|NCT02222714|37766418|FG000|Overall Study|Withdrawal by Subject|0|||
16822924|NCT02222714|37766419|FG001|Overall Study|Withdrawal by Subject|0|||
16822925|NCT02222714|37766420|FG002|Overall Study|Withdrawal by Subject|1|||
16822926|NCT02222714|37766421|FG003|Overall Study|Withdrawal by Subject|0|||
16822927|NCT02222714|37766422|FG004|Overall Study|Withdrawal by Subject|1|||
16822928|NCT02164916|37766439|FG000|Overall Study|Adverse Event|3|||
16822929|NCT02164916|37766440|FG001|Overall Study|Adverse Event|8|||
16822930|NCT02164916|37766439|FG000|Overall Study|Death|1|||
16822931|NCT02164916|37766440|FG001|Overall Study|Death|1|||
16822932|NCT02164916|37766439|FG000|Overall Study|Refusal unrelated to adverse event|3|||
16822933|NCT02164916|37766440|FG001|Overall Study|Refusal unrelated to adverse event|7|||
16822934|NCT02164916|37766439|FG000|Overall Study|Progression|37|||
16822935|NCT02164916|37766440|FG001|Overall Study|Progression|26|||
16822936|NCT02164916|37766439|FG000|Overall Study|Not protocol specified|5|||
16822937|NCT02164916|37766440|FG001|Overall Study|Not protocol specified|1|||
16822938|NCT02164916|37766439|FG000|Overall Study|Reason under review|1|||
16822939|NCT02164916|37766440|FG001|Overall Study|Reason under review|6|||
16822940|NCT02164916|37766439|FG000|Overall Study|Not eligible|2|||
16822941|NCT02164916|37766440|FG001|Overall Study|Not eligible|5|||
16822942|NCT02222558|37766451|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
16822943|NCT02222558|37766452|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
16822944|NCT02222558|37766453|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
16822945|NCT02222558|37766454|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
16822946|NCT02222558|37766455|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
16822947|NCT02222558|37766456|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
16822948|NCT02222558|37766451|FG000|Period 3|Withdrawal by Subject|0|||
16822949|NCT02222558|37766452|FG001|Period 3|Withdrawal by Subject|0|||
16822950|NCT02222558|37766453|FG002|Period 3|Withdrawal by Subject|0|||
16822951|NCT02222558|37766454|FG003|Period 3|Withdrawal by Subject|0|||
16822952|NCT02222558|37766455|FG004|Period 3|Withdrawal by Subject|0|||
16822953|NCT02222558|37766456|FG005|Period 3|Withdrawal by Subject|1|||
16822954|NCT02188784|37766472|FG000|Overall Study|Death|3|||
16822955|NCT02188784|37766473|FG001|Overall Study|Death|1|||
16822956|NCT02188784|37766472|FG000|Overall Study|Lost to Follow-up|1|||
16822957|NCT02188784|37766473|FG001|Overall Study|Lost to Follow-up|0|||
16822958|NCT02188784|37766472|FG000|Overall Study|Withdrawal by Subject|3|||
16822959|NCT02188784|37766473|FG001|Overall Study|Withdrawal by Subject|9|||
16822960|NCT02188784|37766472|FG000|Overall Study|Physician Decision|2|||
16822961|NCT02188784|37766473|FG001|Overall Study|Physician Decision|3|||
16822962|NCT02222246|37766496|FG000|Overall Study|No Emergency Department Visits|27|||
16822963|NCT02222246|37766497|FG001|Overall Study|No Emergency Department Visits|26|||
16822964|NCT02222246|37766496|FG000|Overall Study|Physician Decision|0|||
16822965|NCT02222246|37766497|FG001|Overall Study|Physician Decision|1|||
16822966|NCT02188160|37766507|FG000|Overall Study|Adverse Event|1|||
16822967|NCT02188160|37766508|FG001|Overall Study|Adverse Event|0|||
16822968|NCT02188160|37766507|FG000|Overall Study|Use of an excluded medication|0|||
16822969|NCT02188160|37766508|FG001|Overall Study|Use of an excluded medication|1|||
16822970|NCT02220998|37766516|FG000|Overall Study|Randomized but Never Treated|1|||
16822971|NCT02220998|37766517|FG001|Overall Study|Randomized but Never Treated|2|||
16822972|NCT02220998|37766516|FG000|Overall Study|Death|2|||
16822973|NCT02220998|37766517|FG001|Overall Study|Death|0|||
16822974|NCT02220998|37766516|FG000|Overall Study|Lack of Efficacy|0|||
16822975|NCT02220998|37766517|FG001|Overall Study|Lack of Efficacy|5|||
16822976|NCT02220998|37766516|FG000|Overall Study|Lost to Follow-up|4|||
16822977|NCT02220998|37766517|FG001|Overall Study|Lost to Follow-up|4|||
16822978|NCT02220920|37766525|FG000|Overall Study|Adverse Event|1|||
16822979|NCT02220920|37766526|FG001|Overall Study|Adverse Event|0|||
16822980|NCT02220920|37766525|FG000|Overall Study|Lack of Efficacy|0|||
16822981|NCT02220920|37766526|FG001|Overall Study|Lack of Efficacy|1|||
16822982|NCT02220920|37766525|FG000|Overall Study|Withdrawal by Subject|1|||
16822983|NCT02220920|37766526|FG001|Overall Study|Withdrawal by Subject|0|||
16822984|NCT02220920|37766525|FG000|Overall Study|Conflict with the stopping criteria|1|||
16822985|NCT02220920|37766526|FG001|Overall Study|Conflict with the stopping criteria|2|||
16822986|NCT03966053|37766532|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
16822987|NCT01583218|37766547|FG000|Overall Study|Withdrawal by Subject|43|||
16822988|NCT01583218|37766548|FG001|Overall Study|Withdrawal by Subject|29|||
16822989|NCT01583218|37766547|FG000|Overall Study|Death|206|||
16822990|NCT01583218|37766548|FG001|Overall Study|Death|211|||
16822991|NCT01583218|37766547|FG000|Overall Study|Lost to Follow-up|11|||
16822992|NCT01583218|37766548|FG001|Overall Study|Lost to Follow-up|17|||
16822993|NCT01583218|37766547|FG000|Overall Study|Adverse event or serious adverse event|3|||
16822994|NCT01583218|37766548|FG001|Overall Study|Adverse event or serious adverse event|3|||
16822995|NCT01583218|37766547|FG000|Overall Study|Patient /Family decision|3|||
16822996|NCT01583218|37766548|FG001|Overall Study|Patient /Family decision|0|||
16822997|NCT01583218|37766547|FG000|Overall Study|Cannot contact patient directly|1|||
16822998|NCT01583218|37766548|FG001|Overall Study|Cannot contact patient directly|2|||
16822999|NCT01583218|37766547|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
16823000|NCT01583218|37766548|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
16823001|NCT01583218|37766547|FG000|Overall Study|Patient did not wish to attend visits|0|||
16823002|NCT01583218|37766548|FG001|Overall Study|Patient did not wish to attend visits|1|||
16823003|NCT01583218|37766547|FG000|Overall Study|Patient randomized but not dosed|17|||
16823004|NCT01583218|37766548|FG001|Overall Study|Patient randomized but not dosed|16|||
16823005|NCT01583218|37766547|FG000|Overall Study|Patient was assessed via phone in person|1|||
16823006|NCT01583218|37766548|FG001|Overall Study|Patient was assessed via phone in person|0|||
16823007|NCT01583218|37766547|FG000|Overall Study|Patient deemed ineligible after random|2|||
16823008|NCT01583218|37766548|FG001|Overall Study|Patient deemed ineligible after random|0|||
16823009|NCT01583218|37766547|FG000|Overall Study|Patient was early terminated from study|0|||
16823010|NCT01583218|37766548|FG001|Overall Study|Patient was early terminated from study|1|||
16823011|NCT01583218|37766547|FG000|Overall Study|Patient was randomized due to mistake|1|||
16823012|NCT01583218|37766548|FG001|Overall Study|Patient was randomized due to mistake|0|||
16823013|NCT01583218|37766547|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
16823014|NCT01583218|37766548|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
16823015|NCT01583218|37766547|FG000|Overall Study|Withdraw of consent on day of random|1|||
16823016|NCT01583218|37766548|FG001|Overall Study|Withdraw of consent on day of random|0|||
16823017|NCT01634555|37766554|FG000|Overall Study|Adverse Event|3|||
16823018|NCT01634555|37766554|FG000|Overall Study|Physician Decision|1|||
16823019|NCT01634243|37766561|FG000|Overall Study|Adverse Event|5|||
16823020|NCT01634243|37766562|FG001|Overall Study|Adverse Event|5|||
16823021|NCT01634243|37766561|FG000|Overall Study|Lack of Efficacy|1|||
16823022|NCT01634243|37766562|FG001|Overall Study|Lack of Efficacy|0|||
16823023|NCT01542034|37766579|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
16823024|NCT01542034|37766580|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
16823025|NCT01542034|37766579|FG000|Overall Study|Administrative decision|0|||
16823026|NCT01542034|37766580|FG001|Overall Study|Administrative decision|3|||
16823027|NCT01542034|37766579|FG000|Overall Study|Subject Noncompliance|1|||
16823028|NCT01542034|37766580|FG001|Overall Study|Subject Noncompliance|0|||
16823029|NCT01542034|37766579|FG000|Overall Study|Adverse Event|2|||
16823030|NCT01542034|37766580|FG001|Overall Study|Adverse Event|2|||
16823031|NCT01542034|37766579|FG000|Overall Study|Lost to Follow-up|7|||
16823032|NCT01542034|37766580|FG001|Overall Study|Lost to Follow-up|6|||
16823033|NCT01564732|37766588|FG000|Overall Study|Early termination by the study sponsor|6|||
16823034|NCT01564732|37766589|FG001|Overall Study|Early termination by the study sponsor|5|||
16823035|NCT01541644|37766595|FG000|Overall Study|Withdrawal by Subject|3|||
16823036|NCT01582282|37766602|FG000|Overall Study|Adverse Event|1|||
16823037|NCT01582282|37766603|FG001|Overall Study|Adverse Event|1|||
16823038|NCT01582282|37766604|FG002|Overall Study|Adverse Event|0|||
16823039|NCT01582282|37766602|FG000|Overall Study|Lost to Follow-up|1|||
16823040|NCT01582282|37766603|FG001|Overall Study|Lost to Follow-up|0|||
16823041|NCT01582282|37766604|FG002|Overall Study|Lost to Follow-up|0|||
16823042|NCT01582282|37766602|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
16823043|NCT01582282|37766603|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
16823044|NCT01582282|37766604|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
16823045|NCT01599650|37766615|FG000|Overall Study|Administrative issue|1|||
16823046|NCT01599650|37766616|FG001|Overall Study|Administrative issue|0|||
16823047|NCT01599650|37766617|FG002|Overall Study|Administrative issue|1|||
16823048|NCT01599650|37766615|FG000|Overall Study|Physician Decision|2|||
16823049|NCT01599650|37766616|FG001|Overall Study|Physician Decision|0|||
16823050|NCT01599650|37766617|FG002|Overall Study|Physician Decision|7|||
16823051|NCT01599650|37766615|FG000|Overall Study|Protocol Violation|0|||
16823052|NCT01599650|37766616|FG001|Overall Study|Protocol Violation|3|||
16823053|NCT01599650|37766617|FG002|Overall Study|Protocol Violation|0|||
16823054|NCT01599650|37766615|FG000|Overall Study|Death|2|||
16823055|NCT01599650|37766616|FG001|Overall Study|Death|1|||
16823056|NCT01599650|37766617|FG002|Overall Study|Death|2|||
16823057|NCT01599650|37766615|FG000|Overall Study|Lost to Follow-up|3|||
16823058|NCT01599650|37766616|FG001|Overall Study|Lost to Follow-up|3|||
16823059|NCT01599650|37766617|FG002|Overall Study|Lost to Follow-up|3|||
16823060|NCT01599650|37766615|FG000|Overall Study|Withdrawal by Subject|11|||
16823061|NCT01599650|37766616|FG001|Overall Study|Withdrawal by Subject|11|||
16823062|NCT01599650|37766617|FG002|Overall Study|Withdrawal by Subject|10|||
16823063|NCT01599650|37766615|FG000|Overall Study|Adverse Event|3|||
16823064|NCT01599650|37766616|FG001|Overall Study|Adverse Event|8|||
16823065|NCT01599650|37766617|FG002|Overall Study|Adverse Event|4|||
16823066|NCT01541254|37766627|FG000|Overall Study|Withdrawal by Subject|1|||
16823067|NCT01541254|37766627|FG000|Overall Study|excluded - metal allergy|1|||
16823068|NCT01541254|37766627|FG000|Overall Study|enrolled after study closed|1|||
16823069|NCT01541254|37766627|FG000|Overall Study|GI bleed prior to procedure|1|||
16823070|NCT01541254|37766627|FG000|Overall Study|stent not required|1|||
16823071|NCT01541254|37766627|FG000|Overall Study|alternate stent used|1|||
16823072|NCT02163902|37766633|FG000|Overall Study|Subject's Request|3|||
16823073|NCT02163902|37766634|FG001|Overall Study|Subject's Request|4|||
16823074|NCT02163902|37766633|FG000|Overall Study|Lost to Follow-up|6|||
16823075|NCT02163902|37766634|FG001|Overall Study|Lost to Follow-up|7|||
16823076|NCT02163902|37766633|FG000|Overall Study|Administrative Decision|2|||
16823077|NCT02163902|37766634|FG001|Overall Study|Administrative Decision|2|||
16823078|NCT01630616|37766646|FG000|Overall Study|Adverse Event|0|||
16823079|NCT01630616|37766647|FG001|Overall Study|Adverse Event|0|||
16823080|NCT01630616|37766648|FG002|Overall Study|Adverse Event|0|||
16823081|NCT01630616|37766649|FG003|Overall Study|Adverse Event|1|||
16823082|NCT01630616|37766650|FG004|Overall Study|Adverse Event|0|||
16823083|NCT01630616|37766651|FG005|Overall Study|Adverse Event|0|||
16823084|NCT01630616|37766646|FG000|Overall Study|Withdrawal by Subject|0|||
16823085|NCT01630616|37766647|FG001|Overall Study|Withdrawal by Subject|0|||
16823086|NCT01630616|37766648|FG002|Overall Study|Withdrawal by Subject|0|||
16823087|NCT01630616|37766649|FG003|Overall Study|Withdrawal by Subject|2|||
16823088|NCT01630616|37766650|FG004|Overall Study|Withdrawal by Subject|0|||
16823089|NCT01630616|37766651|FG005|Overall Study|Withdrawal by Subject|0|||
16823090|NCT03774875|37766670|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
16823091|NCT03774875|37766671|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
16823092|NCT03774875|37766670|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
16823093|NCT03774875|37766671|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
16823094|NCT03774875|37766670|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
16823095|NCT03774875|37766671|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
16823096|NCT03774875|37766670|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
16823097|NCT03774875|37766671|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
16823098|NCT03774875|37766670|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
16823099|NCT03774875|37766671|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
16823100|NCT03774875|37766670|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
16823101|NCT03774875|37766671|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
16823102|NCT03774875|37766670|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
16823103|NCT03774875|37766671|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
16823104|NCT03774875|37766670|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
16823105|NCT03774875|37766671|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
16823106|NCT03774875|37766670|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
16823107|NCT03774875|37766671|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
16823108|NCT03774875|37766670|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
16823109|NCT03774875|37766671|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
16823110|NCT03774875|37766670|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
16823111|NCT03774875|37766671|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
16823112|NCT03774875|37766670|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
16823113|NCT03774875|37766671|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
16823114|NCT03774875|37766670|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
16823115|NCT03774875|37766671|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
16823116|NCT02220764|37766684|FG000|Overall Study|Lost to Follow-up|3|||
16823117|NCT02220764|37766685|FG001|Overall Study|Lost to Follow-up|1|||
16823118|NCT02220764|37766684|FG000|Overall Study|Death|1|||
16823119|NCT02220764|37766685|FG001|Overall Study|Death|0|||
16823120|NCT01563172|37766691|FG000|Overall Study|Adverse Event|5|||
16823121|NCT01563172|37766691|FG000|Overall Study|Lost to Follow-up|2|||
16823122|NCT01563172|37766691|FG000|Overall Study|Other (Protocol deviation)|5|||
16823123|NCT01563172|37766691|FG000|Overall Study|Other (Not specified)|1|||
16823124|NCT02161718|37766708|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
16823125|NCT02161718|37766709|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
16823126|NCT02161718|37766710|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
16823127|NCT02161718|37766708|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
16823128|NCT02161718|37766709|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
16823129|NCT02161718|37766710|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
16823130|NCT02161718|37766708|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
16823131|NCT02161718|37766709|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
16823132|NCT02161718|37766710|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
16823133|NCT02161718|37766708|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
16823134|NCT02161718|37766709|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
16823135|NCT02161718|37766710|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
16823136|NCT02161718|37766708|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
16823137|NCT02161718|37766709|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
16823138|NCT02161718|37766710|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
16823139|NCT02161718|37766708|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
16823140|NCT02161718|37766709|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
16823141|NCT02161718|37766710|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
16823142|NCT02161718|37766708|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
16823143|NCT02161718|37766709|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
16823144|NCT02161718|37766710|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
16823145|NCT02161718|37766708|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
16823146|NCT02161718|37766709|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
16823147|NCT02161718|37766710|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
16823148|NCT02161718|37766708|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
16823149|NCT02161718|37766709|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
16823150|NCT02161718|37766710|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
16823151|NCT02161718|37766708|FG000|Post- Randomization Period|Lost to Follow-up|0|||
16823152|NCT02161718|37766709|FG001|Post- Randomization Period|Lost to Follow-up|9|||
16823153|NCT02161718|37766710|FG002|Post- Randomization Period|Lost to Follow-up|15|||
16823154|NCT02161718|37766708|FG000|Post- Randomization Period|Adverse Event|0|||
16823155|NCT02161718|37766709|FG001|Post- Randomization Period|Adverse Event|9|||
16823156|NCT02161718|37766710|FG002|Post- Randomization Period|Adverse Event|10|||
16823157|NCT02161718|37766708|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
16823158|NCT02161718|37766709|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
16823159|NCT02161718|37766710|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
16823160|NCT02161718|37766708|FG000|Post- Randomization Period|Physician Decision|0|||
16823161|NCT02161718|37766709|FG001|Post- Randomization Period|Physician Decision|2|||
16823162|NCT02161718|37766710|FG002|Post- Randomization Period|Physician Decision|4|||
16823163|NCT02161718|37766708|FG000|Post- Randomization Period|Protocol Violation|0|||
16823164|NCT02161718|37766709|FG001|Post- Randomization Period|Protocol Violation|2|||
16823165|NCT02161718|37766710|FG002|Post- Randomization Period|Protocol Violation|3|||
16823166|NCT02161718|37766708|FG000|Post- Randomization Period|Lack of Efficacy|0|||
16823167|NCT02161718|37766709|FG001|Post- Randomization Period|Lack of Efficacy|0|||
16823168|NCT02161718|37766710|FG002|Post- Randomization Period|Lack of Efficacy|1|||
16823169|NCT02161718|37766708|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
16823170|NCT02161718|37766709|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
16823171|NCT02161718|37766710|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
16823172|NCT02161718|37766708|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
16823173|NCT02161718|37766709|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
16823174|NCT02161718|37766710|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
16823175|NCT02161718|37766708|FG000|Post- Randomization Period|Relocation|0|||
16823176|NCT02161718|37766709|FG001|Post- Randomization Period|Relocation|3|||
16823177|NCT02161718|37766710|FG002|Post- Randomization Period|Relocation|0|||
16823178|NCT02219048|37766719|FG000|Overall Study|Adverse Event|2|||
16823179|NCT02219048|37766720|FG001|Overall Study|Adverse Event|5|||
16823180|NCT02219048|37766719|FG000|Overall Study|No longer meets eligibility criteria|1|||
16823181|NCT02219048|37766720|FG001|Overall Study|No longer meets eligibility criteria|0|||
16823182|NCT02219048|37766719|FG000|Overall Study|Study terminated by sponsor|16|||
16823183|NCT02219048|37766720|FG001|Overall Study|Study terminated by sponsor|15|||
16823184|NCT02219048|37766719|FG000|Overall Study|Withdrawal by Subject|2|||
16823185|NCT02219048|37766720|FG001|Overall Study|Withdrawal by Subject|0|||
16823186|NCT02219048|37766719|FG000|Overall Study|Other|0|||
16823187|NCT02219048|37766720|FG001|Overall Study|Other|1|||
16823188|NCT02218736|37766728|FG000|Overall Study|Withdrawal by Subject|10|||
16823189|NCT02218736|37766729|FG001|Overall Study|Withdrawal by Subject|9|||
16823190|NCT02218736|37766728|FG000|Overall Study|Protocol Violation|2|||
16823191|NCT02218736|37766729|FG001|Overall Study|Protocol Violation|0|||
16823192|NCT01540474|37766739|FG000|Vaccination Period|Lost to Follow-up|0|||
16823193|NCT01540474|37766740|FG001|Vaccination Period|Lost to Follow-up|1|||
16823194|NCT01540474|37766741|FG002|Vaccination Period|Lost to Follow-up|0|||
16823195|NCT01540474|37766742|FG003|Vaccination Period|Lost to Follow-up|0|||
16823196|NCT01580488|37766753|FG000|Overall Study|Withdrawal by Subject|1|||
16823197|NCT01580020|37766769|FG000|Overall Study|Lack of Efficacy|0|||
16823198|NCT01580020|37766770|FG001|Overall Study|Lack of Efficacy|5|||
16823199|NCT01580020|37766771|FG002|Overall Study|Lack of Efficacy|0|||
16823200|NCT01580020|37766772|FG003|Overall Study|Lack of Efficacy|1|||
16823201|NCT01580020|37766769|FG000|Overall Study|Withdrawal by Subject|0|||
16823202|NCT01580020|37766770|FG001|Overall Study|Withdrawal by Subject|1|||
16823203|NCT01580020|37766771|FG002|Overall Study|Withdrawal by Subject|1|||
16823204|NCT01580020|37766772|FG003|Overall Study|Withdrawal by Subject|0|||
16823205|NCT01580020|37766769|FG000|Overall Study|Adverse Event|1|||
16823206|NCT01580020|37766770|FG001|Overall Study|Adverse Event|1|||
16823207|NCT01580020|37766771|FG002|Overall Study|Adverse Event|1|||
16823208|NCT01580020|37766772|FG003|Overall Study|Adverse Event|1|||
16823209|NCT01580020|37766769|FG000|Overall Study|Administrative Problems|0|||
16823210|NCT01580020|37766770|FG001|Overall Study|Administrative Problems|0|||
16823211|NCT01580020|37766771|FG002|Overall Study|Administrative Problems|1|||
16823212|NCT01580020|37766772|FG003|Overall Study|Administrative Problems|0|||
16823213|NCT01580020|37766769|FG000|Overall Study|Lost to Follow-up|0|||
16823214|NCT01580020|37766770|FG001|Overall Study|Lost to Follow-up|0|||
16823215|NCT01580020|37766771|FG002|Overall Study|Lost to Follow-up|1|||
16823216|NCT01580020|37766772|FG003|Overall Study|Lost to Follow-up|0|||
16823217|NCT01579474|37766788|FG000|Overall Study|Adverse Event|1|||
16823218|NCT01579474|37766789|FG001|Overall Study|Adverse Event|13|||
16823219|NCT01579474|37766790|FG002|Overall Study|Adverse Event|2|||
16823220|NCT01579474|37766791|FG003|Overall Study|Adverse Event|0|||
16823221|NCT01579474|37766792|FG004|Overall Study|Adverse Event|0|||
16823222|NCT01579474|37766793|FG005|Overall Study|Adverse Event|1|||
16823223|NCT01579474|37766788|FG000|Overall Study|Lack of Efficacy|1|||
16823224|NCT01579474|37766789|FG001|Overall Study|Lack of Efficacy|0|||
16823225|NCT01579474|37766790|FG002|Overall Study|Lack of Efficacy|0|||
16823226|NCT01579474|37766791|FG003|Overall Study|Lack of Efficacy|0|||
16823227|NCT01579474|37766792|FG004|Overall Study|Lack of Efficacy|1|||
16823228|NCT01579474|37766793|FG005|Overall Study|Lack of Efficacy|0|||
16823229|NCT01579474|37766788|FG000|Overall Study|Withdrawal by Subject|1|||
16823230|NCT01579474|37766789|FG001|Overall Study|Withdrawal by Subject|0|||
16823231|NCT01579474|37766790|FG002|Overall Study|Withdrawal by Subject|0|||
16912040|NCT01462266|38021154|FG000|Overall Study|Lack of Efficacy|0|||
16912041|NCT01462266|38021155|FG001|Overall Study|Lack of Efficacy|2|||
16912042|NCT01462266|38021154|FG000|Overall Study|Lost to Follow-up|4|||
16912043|NCT01462266|38021155|FG001|Overall Study|Lost to Follow-up|3|||
16912044|NCT01462266|38021154|FG000|Overall Study|Non-compliance with study drug|3|||
16912045|NCT01462266|38021155|FG001|Overall Study|Non-compliance with study drug|0|||
16912046|NCT01462266|38021154|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
17102379|NCT00098774|38241311|FG000|Overall Study|Failed (to respond) during induction|4|||
16823232|NCT01579474|37766791|FG003|Overall Study|Withdrawal by Subject|0|||
16823233|NCT01579474|37766792|FG004|Overall Study|Withdrawal by Subject|0|||
16823234|NCT01579474|37766793|FG005|Overall Study|Withdrawal by Subject|0|||
16823235|NCT01579318|37766806|FG000|Overall Study|Disease Progression|1|||
16823236|NCT01562782|37766812|FG000|Overall Study|Withdrawal by Subject|3|||
16823237|NCT01562782|37766813|FG001|Overall Study|Withdrawal by Subject|3|||
16823238|NCT01562782|37766812|FG000|Overall Study|screen failure|1|||
16823239|NCT01562782|37766813|FG001|Overall Study|screen failure|2|||
16823240|NCT01579006|37766819|FG000|Overall Study|Lack of Efficacy|10|||
16823241|NCT01579006|37766819|FG000|Overall Study|Adverse Event|13|||
16823242|NCT01579006|37766819|FG000|Overall Study|Withdrawal by Subject|5|||
16823243|NCT01579006|37766819|FG000|Overall Study|Non-compliance|3|||
16823244|NCT01579006|37766819|FG000|Overall Study|Due to participant's health fund|1|||
16823245|NCT01579006|37766819|FG000|Overall Study|Scheduled surgery|1|||
16823246|NCT01578850|37766825|FG000|Period 1|Insufficient Clinical Response|1|||
16823247|NCT01578850|37766826|FG001|Period 1|Insufficient Clinical Response|0|||
16823248|NCT01578850|37766827|FG002|Period 1|Insufficient Clinical Response|0|||
16823249|NCT01578850|37766825|FG000|Period 1|Adverse Event|11|||
16823250|NCT01578850|37766826|FG001|Period 1|Adverse Event|0|||
16823251|NCT01578850|37766827|FG002|Period 1|Adverse Event|0|||
16823252|NCT01578850|37766825|FG000|Period 1|Death|1|||
16823253|NCT01578850|37766826|FG001|Period 1|Death|0|||
16823254|NCT01578850|37766827|FG002|Period 1|Death|0|||
16823255|NCT01578850|37766825|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
16823256|NCT01578850|37766826|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
16823257|NCT01578850|37766827|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
16823258|NCT01578850|37766825|FG000|Period 1|Withdrawal by Subject|9|||
16823259|NCT01578850|37766826|FG001|Period 1|Withdrawal by Subject|0|||
16823260|NCT01578850|37766827|FG002|Period 1|Withdrawal by Subject|0|||
16823261|NCT01578850|37766825|FG000|Period 1|Study Terminated by Sponsor|3|||
16823262|NCT01578850|37766826|FG001|Period 1|Study Terminated by Sponsor|0|||
16823263|NCT01578850|37766827|FG002|Period 1|Study Terminated by Sponsor|0|||
16823264|NCT01578850|37766825|FG000|Period 2|Insufficient Clinical Response|0|||
16823265|NCT01578850|37766826|FG001|Period 2|Insufficient Clinical Response|1|||
16823266|NCT01578850|37766827|FG002|Period 2|Insufficient Clinical Response|0|||
16823267|NCT01578850|37766825|FG000|Period 2|Adverse Event|0|||
16823268|NCT01578850|37766826|FG001|Period 2|Adverse Event|3|||
16823269|NCT01578850|37766827|FG002|Period 2|Adverse Event|6|||
16823270|NCT01578850|37766825|FG000|Period 2|Lost to Follow-up|0|||
16823271|NCT01578850|37766826|FG001|Period 2|Lost to Follow-up|1|||
16823272|NCT01578850|37766827|FG002|Period 2|Lost to Follow-up|2|||
16823273|NCT01578850|37766825|FG000|Period 2|Withdrawal by Subject|0|||
16823274|NCT01578850|37766826|FG001|Period 2|Withdrawal by Subject|2|||
16823275|NCT01578850|37766827|FG002|Period 2|Withdrawal by Subject|2|||
16823276|NCT01578850|37766825|FG000|Period 2|Study Terminated by Sponsor|0|||
16823277|NCT01578850|37766826|FG001|Period 2|Study Terminated by Sponsor|5|||
16823278|NCT01578850|37766827|FG002|Period 2|Study Terminated by Sponsor|4|||
16823279|NCT01578850|37766825|FG000|Period 2|Unspecified Reasons|0|||
16823280|NCT01578850|37766826|FG001|Period 2|Unspecified Reasons|1|||
16823281|NCT01578850|37766827|FG002|Period 2|Unspecified Reasons|0|||
16823282|NCT01539538|37766837|FG000|Overall Study|Adverse Event|13|||
16823283|NCT01539538|37766838|FG001|Overall Study|Adverse Event|18|||
16823284|NCT01539538|37766837|FG000|Overall Study|Lack of Efficacy|13|||
16823285|NCT01539538|37766838|FG001|Overall Study|Lack of Efficacy|16|||
16823286|NCT01539538|37766837|FG000|Overall Study|Withdrawal by Subject|2|||
16823287|NCT01539538|37766838|FG001|Overall Study|Withdrawal by Subject|3|||
16823288|NCT01539538|37766837|FG000|Overall Study|PCA no longer required or PCA problem|3|||
16823289|NCT01539538|37766838|FG001|Overall Study|PCA no longer required or PCA problem|7|||
16823290|NCT01562548|37766848|FG000|Overall Study|Lost to Follow-up|0|||
16823291|NCT01562548|37766849|FG001|Overall Study|Lost to Follow-up|0|||
16823292|NCT01562548|37766850|FG002|Overall Study|Lost to Follow-up|1|||
16823293|NCT01562548|37766851|FG003|Overall Study|Lost to Follow-up|0|||
16823294|NCT01562314|37766865|FG000|Overall Study|Adverse Event|10|||
16823295|NCT01562314|37766866|FG001|Overall Study|Adverse Event|5|||
16823296|NCT01562314|37766865|FG000|Overall Study|Met Withdrawal Criteria|3|||
16823297|NCT01562314|37766866|FG001|Overall Study|Met Withdrawal Criteria|2|||
16823298|NCT01562314|37766865|FG000|Overall Study|Withdrawal by Subject|0|||
16823299|NCT01562314|37766866|FG001|Overall Study|Withdrawal by Subject|1|||
16823300|NCT01539226|37766874|FG000|Overall Study|Withdrawal by Subject|24|||
16823301|NCT01539226|37766875|FG001|Overall Study|Withdrawal by Subject|54|||
16823302|NCT01539226|37766874|FG000|Overall Study|Lost to Follow-up|20|||
16823303|NCT01539226|37766875|FG001|Overall Study|Lost to Follow-up|54|||
16823304|NCT01539226|37766874|FG000|Overall Study|Death|1|||
16823305|NCT01539226|37766875|FG001|Overall Study|Death|2|||
16823306|NCT01539226|37766874|FG000|Overall Study|Adverse Event|2|||
16823307|NCT01539226|37766875|FG001|Overall Study|Adverse Event|0|||
16823308|NCT01539226|37766874|FG000|Overall Study|Pregnancy|13|||
16823309|NCT01539226|37766875|FG001|Overall Study|Pregnancy|29|||
16823310|NCT01539226|37766874|FG000|Overall Study|inappropriate enrollment|0|||
16823311|NCT01539226|37766875|FG001|Overall Study|inappropriate enrollment|1|||
16823312|NCT01539226|37766874|FG000|Overall Study|Multiple Reasons|3|||
16823313|NCT01539226|37766875|FG001|Overall Study|Multiple Reasons|1|||
17016699|NCT00600119|38161266|FG004|Follow-up Period|Other|0|||
16823314|NCT01539226|37766874|FG000|Overall Study|not HIV seroconversion-related|93|||
16823315|NCT01539226|37766875|FG001|Overall Study|not HIV seroconversion-related|176|||
16823316|NCT01539226|37766874|FG000|Overall Study|HIV seroconversion-related|55|||
16823317|NCT01539226|37766875|FG001|Overall Study|HIV seroconversion-related|80|||
16823318|NCT01539226|37766874|FG000|Overall Study|Non-compliance|6|||
16823319|NCT01539226|37766875|FG001|Overall Study|Non-compliance|8|||
16823320|NCT01577758|37766881|FG000|Dose Escalation Phase|Adverse Event|0|||
16823321|NCT01577758|37766882|FG001|Dose Escalation Phase|Adverse Event|0|||
16823322|NCT01577758|37766883|FG002|Dose Escalation Phase|Adverse Event|0|||
16823323|NCT01577758|37766884|FG003|Dose Escalation Phase|Adverse Event|0|||
16823324|NCT01577758|37766885|FG004|Dose Escalation Phase|Adverse Event|0|||
16823325|NCT01577758|37766886|FG005|Dose Escalation Phase|Adverse Event|2|||
16823326|NCT01577758|37766887|FG006|Dose Escalation Phase|Adverse Event|1|||
16823327|NCT01577758|37766888|FG007|Dose Escalation Phase|Adverse Event|0|||
16823328|NCT01577758|37766881|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
16823329|NCT01577758|37766882|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
16823330|NCT01577758|37766883|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
16823331|NCT01577758|37766884|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
16823332|NCT01577758|37766885|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
16823333|NCT01577758|37766886|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
16823334|NCT01577758|37766887|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
16823335|NCT01577758|37766888|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
16823336|NCT01577758|37766881|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16823337|NCT01577758|37766882|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16823338|NCT01577758|37766883|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16823339|NCT01577758|37766884|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16823340|NCT01577758|37766885|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
16823341|NCT01577758|37766886|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
16823342|NCT01577758|37766887|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
16823343|NCT01577758|37766888|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
16823344|NCT01577758|37766881|FG000|Dose Escalation Phase|Progression Disease|2|||
16823345|NCT01577758|37766882|FG001|Dose Escalation Phase|Progression Disease|2|||
16823346|NCT01577758|37766883|FG002|Dose Escalation Phase|Progression Disease|1|||
16823347|NCT01577758|37766884|FG003|Dose Escalation Phase|Progression Disease|2|||
16823348|NCT01577758|37766885|FG004|Dose Escalation Phase|Progression Disease|5|||
16823349|NCT01577758|37766886|FG005|Dose Escalation Phase|Progression Disease|0|||
16823350|NCT01577758|37766887|FG006|Dose Escalation Phase|Progression Disease|0|||
16823351|NCT01577758|37766888|FG007|Dose Escalation Phase|Progression Disease|0|||
16823352|NCT01577758|37766881|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16823353|NCT01577758|37766882|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16823354|NCT01577758|37766883|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16823355|NCT01577758|37766884|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16823356|NCT01577758|37766885|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16823357|NCT01577758|37766886|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16823358|NCT01577758|37766887|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16823359|NCT01577758|37766888|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
16823360|NCT01577758|37766881|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
16823361|NCT01577758|37766882|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
16823362|NCT01577758|37766883|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
16823363|NCT01577758|37766884|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
16823364|NCT01577758|37766885|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
16823365|NCT01577758|37766886|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
16823366|NCT01577758|37766887|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
16823367|NCT01577758|37766888|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
16823368|NCT01577758|37766881|FG000|mCRC Expansion Phase|Progression Disease|0|||
16823369|NCT01577758|37766882|FG001|mCRC Expansion Phase|Progression Disease|0|||
16823370|NCT01577758|37766883|FG002|mCRC Expansion Phase|Progression Disease|0|||
16823371|NCT01577758|37766884|FG003|mCRC Expansion Phase|Progression Disease|0|||
16823372|NCT01577758|37766885|FG004|mCRC Expansion Phase|Progression Disease|0|||
16823373|NCT01577758|37766886|FG005|mCRC Expansion Phase|Progression Disease|0|||
16823374|NCT01577758|37766887|FG006|mCRC Expansion Phase|Progression Disease|0|||
16823375|NCT01577758|37766888|FG007|mCRC Expansion Phase|Progression Disease|19|||
16823376|NCT01537432|37766910|FG000|Overall Study|Lost to Follow-up|3|||
16823377|NCT01537432|37766911|FG001|Overall Study|Lost to Follow-up|1|||
16823378|NCT01537432|37766910|FG000|Overall Study|Withdrawal by Subject|0|||
16823379|NCT01537432|37766911|FG001|Overall Study|Withdrawal by Subject|1|||
16823380|NCT01537432|37766910|FG000|Overall Study|Administrative problems|1|||
16823381|NCT01537432|37766911|FG001|Overall Study|Administrative problems|0|||
16823382|NCT01537432|37766910|FG000|Overall Study|Adverse Event|1|||
16823383|NCT01537432|37766911|FG001|Overall Study|Adverse Event|0|||
16823384|NCT01537432|37766910|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16823385|NCT01537432|37766911|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16823386|NCT01537198|37766917|FG000|Overall Study|RSV infection|2|||
16823387|NCT01537198|37766917|FG000|Overall Study|Adverse Event|4|||
16823388|NCT01537198|37766917|FG000|Overall Study|No Further Visits to the Clinic|37|||
16823389|NCT01537198|37766917|FG000|Overall Study|Other|111|||
16823390|NCT01537120|37766921|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
16823391|NCT01537120|37766921|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
16823392|NCT01537042|37766929|FG000|Overall Study|Adverse Event|0|||
16823393|NCT01537042|37766930|FG001|Overall Study|Adverse Event|2|||
16823394|NCT01537042|37766929|FG000|Overall Study|Lack of Efficacy|0|||
16823395|NCT01537042|37766930|FG001|Overall Study|Lack of Efficacy|1|||
16823396|NCT01537042|37766929|FG000|Overall Study|Protocol Violation|0|||
16823397|NCT01537042|37766930|FG001|Overall Study|Protocol Violation|1|||
16823398|NCT01537042|37766929|FG000|Overall Study|Other|0|||
16823399|NCT01537042|37766930|FG001|Overall Study|Other|1|||
16823400|NCT01536574|37766951|FG000|Overall Study|Adverse Event|4|||
16823401|NCT01536574|37766952|FG001|Overall Study|Adverse Event|5|||
16823402|NCT01536574|37766951|FG000|Overall Study|Withdrawal by Subject|1|||
16823403|NCT01536574|37766952|FG001|Overall Study|Withdrawal by Subject|2|||
16823404|NCT01536574|37766951|FG000|Overall Study|Lack of Efficacy|1|||
16823405|NCT01536574|37766952|FG001|Overall Study|Lack of Efficacy|0|||
16823406|NCT01536418|37766960|FG000|Overall Study|Protocol Violation|2|||
16823407|NCT01536418|37766961|FG001|Overall Study|Protocol Violation|3|||
16823408|NCT01536418|37766960|FG000|Overall Study|Physician Decision|1|||
16823409|NCT01536418|37766961|FG001|Overall Study|Physician Decision|3|||
16823410|NCT01536418|37766960|FG000|Overall Study|Study closed/terminated|41|||
16823411|NCT01536418|37766961|FG001|Overall Study|Study closed/terminated|37|||
16823412|NCT01536418|37766960|FG000|Overall Study|Lack of Efficacy|10|||
16823413|NCT01536418|37766961|FG001|Overall Study|Lack of Efficacy|16|||
16823414|NCT01536418|37766960|FG000|Overall Study|Adverse Event|9|||
16823415|NCT01536418|37766961|FG001|Overall Study|Adverse Event|4|||
16823416|NCT01536418|37766960|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
16823417|NCT01536418|37766961|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
16823418|NCT01536418|37766960|FG000|Overall Study|Withdrawal by Subject|5|||
16823419|NCT01536418|37766961|FG001|Overall Study|Withdrawal by Subject|3|||
16823420|NCT01576042|37766970|FG000|Overall Study|Physician Decision|2|||
16823421|NCT01576042|37766971|FG001|Overall Study|Physician Decision|0|||
16823422|NCT01561300|37766977|FG000|Run in on Placebo|Adverse Event|1|||
16823423|NCT01561300|37766978|FG001|Run in on Placebo|Adverse Event|0|||
16823424|NCT01536262|37766988|FG000|Overall Study|Adverse Event|6|||
16823425|NCT01536262|37766989|FG001|Overall Study|Adverse Event|1|||
16823426|NCT01536262|37766990|FG002|Overall Study|Adverse Event|2|||
16823427|NCT01536262|37766988|FG000|Overall Study|Withdrawal by Subject|1|||
16823428|NCT01536262|37766989|FG001|Overall Study|Withdrawal by Subject|1|||
16823429|NCT01536262|37766990|FG002|Overall Study|Withdrawal by Subject|0|||
16823430|NCT01536262|37766988|FG000|Overall Study|Other than stated above|1|||
16823431|NCT01536262|37766989|FG001|Overall Study|Other than stated above|0|||
16823432|NCT01536262|37766990|FG002|Overall Study|Other than stated above|0|||
16823433|NCT01560988|37766999|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
16823434|NCT01560988|37767000|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
16823435|NCT01560988|37766999|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
16823436|NCT01560988|37767000|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
16823437|NCT01560988|37766999|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
16823438|NCT01560988|37767000|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
16823439|NCT01535638|37767011|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
16823440|NCT01535638|37767012|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
16823441|NCT01535638|37767013|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
16823442|NCT01535638|37767014|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
16823443|NCT01535638|37767015|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
16823444|NCT01535638|37767016|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
16823445|NCT01535638|37767011|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
17016700|NCT00600119|38161267|FG005|Follow-up Period|Other|0|||
16823446|NCT01535638|37767012|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
16823447|NCT01535638|37767013|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
16823448|NCT01535638|37767014|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
16823449|NCT01535638|37767015|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
16823450|NCT01535638|37767016|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
16823451|NCT01535560|37767027|FG000|Overall Study|Adverse Event|12|||
16823452|NCT01535560|37767028|FG001|Overall Study|Adverse Event|7|||
16823453|NCT01535560|37767027|FG000|Overall Study|Lost to Follow-up|1|||
16823454|NCT01535560|37767028|FG001|Overall Study|Lost to Follow-up|3|||
16823455|NCT01535560|37767027|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
16823456|NCT01535560|37767028|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
16823457|NCT01535560|37767027|FG000|Overall Study|Treatment Failure|21|||
16823458|NCT01535560|37767028|FG001|Overall Study|Treatment Failure|83|||
17016701|NCT00866294|38161284|FG000|Overall Study|Adverse Event|12|||
16823459|NCT01535560|37767027|FG000|Overall Study|Other|0|||
16823460|NCT01535560|37767028|FG001|Overall Study|Other|1|||
16823461|NCT01535560|37767027|FG000|Overall Study|Randomized in Error|0|||
16823462|NCT01535560|37767028|FG001|Overall Study|Randomized in Error|1|||
16823463|NCT01575028|37767036|FG000|Overall Study|Physician Decision|0|||
16823464|NCT01575028|37767037|FG001|Overall Study|Physician Decision|1|||
16823465|NCT03576131|37767051|FG000|Overall Study|Investigator decision|0|||
16823466|NCT03576131|37767052|FG001|Overall Study|Investigator decision|0|||
16823467|NCT03576131|37767053|FG002|Overall Study|Investigator decision|0|||
16823468|NCT03576131|37767054|FG003|Overall Study|Investigator decision|1|||
16823469|NCT03576131|37767055|FG004|Overall Study|Investigator decision|0|||
16823470|NCT03576131|37767056|FG005|Overall Study|Investigator decision|1|||
16823471|NCT03576131|37767057|FG006|Overall Study|Investigator decision|0|||
16823472|NCT03576131|37767058|FG007|Overall Study|Investigator decision|0|||
16823473|NCT03576131|37767051|FG000|Overall Study|Withdrawal by Subject|1|||
16823474|NCT03576131|37767052|FG001|Overall Study|Withdrawal by Subject|1|||
16823475|NCT03576131|37767053|FG002|Overall Study|Withdrawal by Subject|0|||
16823476|NCT03576131|37767054|FG003|Overall Study|Withdrawal by Subject|1|||
16823477|NCT03576131|37767055|FG004|Overall Study|Withdrawal by Subject|2|||
16823478|NCT03576131|37767056|FG005|Overall Study|Withdrawal by Subject|3|||
16823479|NCT03576131|37767057|FG006|Overall Study|Withdrawal by Subject|1|||
16823480|NCT03576131|37767058|FG007|Overall Study|Withdrawal by Subject|0|||
16823481|NCT03576131|37767051|FG000|Overall Study|Death|3|||
16823482|NCT03576131|37767052|FG001|Overall Study|Death|3|||
16823483|NCT03576131|37767053|FG002|Overall Study|Death|1|||
16823484|NCT03576131|37767054|FG003|Overall Study|Death|5|||
16823485|NCT03576131|37767055|FG004|Overall Study|Death|4|||
16823486|NCT03576131|37767056|FG005|Overall Study|Death|1|||
16823487|NCT03576131|37767057|FG006|Overall Study|Death|0|||
16823488|NCT03576131|37767058|FG007|Overall Study|Death|1|||
16823489|NCT03576131|37767051|FG000|Overall Study|New anti-cancer treatment|5|||
16823490|NCT03576131|37767052|FG001|Overall Study|New anti-cancer treatment|1|||
16823491|NCT03576131|37767053|FG002|Overall Study|New anti-cancer treatment|2|||
16823492|NCT03576131|37767054|FG003|Overall Study|New anti-cancer treatment|3|||
16823493|NCT03576131|37767055|FG004|Overall Study|New anti-cancer treatment|0|||
16823494|NCT03576131|37767056|FG005|Overall Study|New anti-cancer treatment|0|||
16823495|NCT03576131|37767057|FG006|Overall Study|New anti-cancer treatment|0|||
16823496|NCT03576131|37767058|FG007|Overall Study|New anti-cancer treatment|0|||
16823497|NCT03576131|37767051|FG000|Overall Study|Unspecified reason|0|||
16823498|NCT03576131|37767052|FG001|Overall Study|Unspecified reason|0|||
16823499|NCT03576131|37767053|FG002|Overall Study|Unspecified reason|1|||
16823500|NCT03576131|37767054|FG003|Overall Study|Unspecified reason|1|||
16823501|NCT03576131|37767055|FG004|Overall Study|Unspecified reason|1|||
16823502|NCT03576131|37767056|FG005|Overall Study|Unspecified reason|1|||
16823503|NCT03576131|37767057|FG006|Overall Study|Unspecified reason|0|||
16823504|NCT03576131|37767058|FG007|Overall Study|Unspecified reason|0|||
16823505|NCT03576131|37767051|FG000|Overall Study|Subject non-compliance|0|||
16823506|NCT03576131|37767052|FG001|Overall Study|Subject non-compliance|0|||
16823507|NCT03576131|37767053|FG002|Overall Study|Subject non-compliance|0|||
16823508|NCT03576131|37767054|FG003|Overall Study|Subject non-compliance|0|||
16823509|NCT03576131|37767055|FG004|Overall Study|Subject non-compliance|0|||
16823510|NCT03576131|37767056|FG005|Overall Study|Subject non-compliance|1|||
16823511|NCT03576131|37767057|FG006|Overall Study|Subject non-compliance|0|||
16823512|NCT03576131|37767058|FG007|Overall Study|Subject non-compliance|0|||
16823513|NCT01574716|37767090|FG000|Part 1|Death|3|||
16823514|NCT01574716|37767091|FG001|Part 1|Death|1|||
16823515|NCT01574716|37767092|FG002|Part 1|Death|8|||
16823516|NCT01574716|37767093|FG003|Part 1|Death|0|||
16823517|NCT01574716|37767094|FG004|Part 1|Death|0|||
16823518|NCT01574716|37767090|FG000|Part 1|Discontinuation of study by sponsor|0|||
16823519|NCT01574716|37767091|FG001|Part 1|Discontinuation of study by sponsor|0|||
16823520|NCT01574716|37767092|FG002|Part 1|Discontinuation of study by sponsor|1|||
16823521|NCT01574716|37767093|FG003|Part 1|Discontinuation of study by sponsor|0|||
17102380|NCT00098774|38241311|FG000|Overall Study|Physician Decision|2|||
16823522|NCT01574716|37767094|FG004|Part 1|Discontinuation of study by sponsor|0|||
16823523|NCT01574716|37767090|FG000|Part 1|Withdrawal by Subject|0|||
16823524|NCT01574716|37767091|FG001|Part 1|Withdrawal by Subject|2|||
16823525|NCT01574716|37767092|FG002|Part 1|Withdrawal by Subject|0|||
16823526|NCT01574716|37767093|FG003|Part 1|Withdrawal by Subject|0|||
16823527|NCT01574716|37767094|FG004|Part 1|Withdrawal by Subject|0|||
16823528|NCT01574716|37767090|FG000|Part 1|Lost to Follow-up|0|||
16823529|NCT01574716|37767091|FG001|Part 1|Lost to Follow-up|1|||
16823530|NCT01574716|37767092|FG002|Part 1|Lost to Follow-up|0|||
16823531|NCT01574716|37767093|FG003|Part 1|Lost to Follow-up|0|||
16823532|NCT01574716|37767094|FG004|Part 1|Lost to Follow-up|0|||
16823533|NCT01574716|37767090|FG000|Part 2|Progressive disease|0|||
16823534|NCT01574716|37767091|FG001|Part 2|Progressive disease|0|||
16823535|NCT01574716|37767092|FG002|Part 2|Progressive disease|0|||
16823536|NCT01574716|37767093|FG003|Part 2|Progressive disease|1|||
16823537|NCT01574716|37767094|FG004|Part 2|Progressive disease|0|||
16823538|NCT01574716|37767090|FG000|Part 2|Death|0|||
16823539|NCT01574716|37767091|FG001|Part 2|Death|0|||
16823540|NCT01574716|37767092|FG002|Part 2|Death|0|||
16823541|NCT01574716|37767093|FG003|Part 2|Death|76|||
16823542|NCT01574716|37767094|FG004|Part 2|Death|35|||
16823543|NCT01574716|37767090|FG000|Part 2|Discontinuation of study by sponsor|0|||
16823544|NCT01574716|37767091|FG001|Part 2|Discontinuation of study by sponsor|0|||
16823545|NCT01574716|37767092|FG002|Part 2|Discontinuation of study by sponsor|0|||
16823546|NCT01574716|37767093|FG003|Part 2|Discontinuation of study by sponsor|51|||
16823547|NCT01574716|37767094|FG004|Part 2|Discontinuation of study by sponsor|31|||
16823548|NCT01574716|37767090|FG000|Part 2|Withdrawal by Subject|0|||
16823549|NCT01574716|37767091|FG001|Part 2|Withdrawal by Subject|0|||
16823550|NCT01574716|37767092|FG002|Part 2|Withdrawal by Subject|0|||
16823551|NCT01574716|37767093|FG003|Part 2|Withdrawal by Subject|5|||
16823552|NCT01574716|37767094|FG004|Part 2|Withdrawal by Subject|4|||
16823553|NCT01574716|37767090|FG000|Part 2|Brain metastases|0|||
16823554|NCT01574716|37767091|FG001|Part 2|Brain metastases|0|||
16823555|NCT01574716|37767092|FG002|Part 2|Brain metastases|0|||
16823556|NCT01574716|37767093|FG003|Part 2|Brain metastases|1|||
16823557|NCT01574716|37767094|FG004|Part 2|Brain metastases|0|||
16823558|NCT01574716|37767090|FG000|Part 2|Lost to Follow-up|0|||
16823559|NCT01574716|37767091|FG001|Part 2|Lost to Follow-up|0|||
16823560|NCT01574716|37767092|FG002|Part 2|Lost to Follow-up|0|||
16823561|NCT01574716|37767093|FG003|Part 2|Lost to Follow-up|3|||
16823562|NCT01574716|37767094|FG004|Part 2|Lost to Follow-up|0|||
16823563|NCT02161562|37767105|FG000|Overall Study|Withdrawal by Subject|5|||
16823564|NCT02161562|37767106|FG001|Overall Study|Withdrawal by Subject|8|||
16823565|NCT02161562|37767105|FG000|Overall Study|Protocol Violation|9|||
16823566|NCT02161562|37767106|FG001|Overall Study|Protocol Violation|4|||
16823567|NCT02161562|37767105|FG000|Overall Study|Pregnancy|1|||
16823568|NCT02161562|37767106|FG001|Overall Study|Pregnancy|2|||
16823569|NCT02161562|37767105|FG000|Overall Study|Lost to Follow-up|3|||
16823570|NCT02161562|37767106|FG001|Overall Study|Lost to Follow-up|1|||
16823571|NCT02161562|37767105|FG000|Overall Study|Lack of Efficacy|4|||
16823572|NCT02161562|37767106|FG001|Overall Study|Lack of Efficacy|1|||
16823573|NCT02161562|37767105|FG000|Overall Study|Adverse Event|1|||
16823574|NCT02161562|37767106|FG001|Overall Study|Adverse Event|1|||
16823575|NCT02161562|37767105|FG000|Overall Study|Participant moved back to home country|1|||
16823576|NCT02161562|37767106|FG001|Overall Study|Participant moved back to home country|0|||
16823577|NCT02161562|37767105|FG000|Overall Study|Withdrew due to being out of the country|1|||
16823578|NCT02161562|37767106|FG001|Overall Study|Withdrew due to being out of the country|0|||
16823579|NCT02161562|37767105|FG000|Overall Study|Participant moved out of province|1|||
16823580|NCT02161562|37767106|FG001|Overall Study|Participant moved out of province|0|||
16823581|NCT01559116|37767125|FG000|Overall Study|Adverse Event|10|||
16823582|NCT01559116|37767125|FG000|Overall Study|Lack of Efficacy|1|||
16823583|NCT01559116|37767125|FG000|Overall Study|Lost to Follow-up|1|||
16823584|NCT01559116|37767125|FG000|Overall Study|Protocol Violation|1|||
16823585|NCT01559116|37767125|FG000|Overall Study|Withdrawal by Subject|4|||
16823586|NCT01559116|37767125|FG000|Overall Study|other than stated above|9|||
16823587|NCT01574326|37767144|FG000|Overall Study|Randomized but not treated|0|||
16823588|NCT01574326|37767145|FG001|Overall Study|Randomized but not treated|1|||
16823589|NCT01574326|37767144|FG000|Overall Study|Withdrawal by Participant|2|||
16823590|NCT01574326|37767145|FG001|Overall Study|Withdrawal by Participant|4|||
16823591|NCT01574326|37767144|FG000|Overall Study|Physician Decision|5|||
16823592|NCT01574326|37767145|FG001|Overall Study|Physician Decision|3|||
16823593|NCT01574326|37767144|FG000|Overall Study|Adverse Event|1|||
16823594|NCT01574326|37767145|FG001|Overall Study|Adverse Event|3|||
16823595|NCT01574326|37767144|FG000|Overall Study|Other: Mainly kidney transplant|8|||
16823596|NCT01574326|37767145|FG001|Overall Study|Other: Mainly kidney transplant|8|||
16823597|NCT01574248|37767158|FG000|Overall Study|Withdrawal by Subject|2|||
16823598|NCT01574248|37767159|FG001|Overall Study|Withdrawal by Subject|0|||
16823599|NCT01574248|37767158|FG000|Overall Study|Missing primary endpoint data|1|||
16823600|NCT01574248|37767159|FG001|Overall Study|Missing primary endpoint data|0|||
16823601|NCT01573624|37767165|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16823602|NCT01573624|37767166|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16823603|NCT01573624|37767167|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
16823604|NCT01573624|37767168|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16823605|NCT01573624|37767169|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16823606|NCT01573624|37767170|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
16823607|NCT01573624|37767171|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16823608|NCT01573624|37767165|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
16823609|NCT01573624|37767166|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
16823610|NCT01573624|37767167|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
16823611|NCT01573624|37767168|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
16823612|NCT01573624|37767169|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
16823613|NCT01573624|37767170|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16823614|NCT01573624|37767171|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
17016702|NCT00866294|38161285|FG001|Overall Study|Adverse Event|13|||
16823615|NCT01573624|37767165|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
16823616|NCT01573624|37767166|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16823617|NCT01573624|37767167|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16823618|NCT01573624|37767168|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16823619|NCT01573624|37767169|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16823620|NCT01573624|37767170|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16823621|NCT01573624|37767171|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16823622|NCT01573624|37767165|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16823623|NCT01573624|37767166|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16823624|NCT01573624|37767167|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16823625|NCT01573624|37767168|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16823626|NCT01573624|37767169|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16823627|NCT01573624|37767170|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
16823628|NCT01573624|37767171|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16823629|NCT01573624|37767165|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
16823630|NCT01573624|37767166|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
16823631|NCT01573624|37767167|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
16823632|NCT01573624|37767168|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
16823633|NCT01573624|37767169|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
16823634|NCT01573624|37767170|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
16823635|NCT01573624|37767171|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
16823636|NCT01573624|37767165|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16823637|NCT01573624|37767166|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16823638|NCT01573624|37767167|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16823639|NCT01573624|37767168|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16823640|NCT01573624|37767169|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16823641|NCT01573624|37767170|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
16823642|NCT01573624|37767171|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16823643|NCT01573624|37767165|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
16823644|NCT01573624|37767166|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
16823645|NCT01573624|37767167|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
16823646|NCT01573624|37767168|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
16823647|NCT01573624|37767169|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
16823648|NCT01573624|37767170|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
16823649|NCT01573624|37767171|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
16823650|NCT01573624|37767165|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
16823651|NCT01573624|37767166|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16823652|NCT01573624|37767167|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
16823653|NCT01573624|37767168|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
16823654|NCT01573624|37767169|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16823655|NCT01573624|37767170|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16823656|NCT01573624|37767171|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16823657|NCT01573624|37767165|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16823658|NCT01573624|37767166|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16823659|NCT01573624|37767167|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16823660|NCT01573624|37767168|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16823661|NCT01573624|37767169|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16823662|NCT01573624|37767170|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
16823663|NCT01573624|37767171|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16823664|NCT01573624|37767165|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16823665|NCT01573624|37767166|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16823666|NCT01573624|37767167|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16823667|NCT01573624|37767168|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
16823668|NCT01573624|37767169|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16823669|NCT01573624|37767170|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16823670|NCT01573624|37767171|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16823671|NCT01573624|37767165|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
16823672|NCT01573624|37767166|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
16823673|NCT01573624|37767167|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
17102381|NCT00384059|38241317|FG000|Infant Series|Not consented|2|||
17102382|NCT00384059|38241318|FG001|Infant Series|Not consented|6|||
17102383|NCT00384059|38241317|FG000|Infant Series|Withdrawal by Subject|2|||
16823674|NCT01573624|37767168|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
16823675|NCT01573624|37767169|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
16823676|NCT01573624|37767170|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
16823677|NCT01573624|37767171|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
16823678|NCT01573624|37767165|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
16823679|NCT01573624|37767166|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
16823680|NCT01573624|37767167|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
16823681|NCT01573624|37767168|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
16823682|NCT01573624|37767169|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
16823683|NCT01573624|37767170|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
16823684|NCT01573624|37767171|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
16823685|NCT01573624|37767165|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16823686|NCT01573624|37767166|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
16823687|NCT01573624|37767167|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16823688|NCT01573624|37767168|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16823689|NCT01573624|37767169|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16823690|NCT01573624|37767170|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
16823691|NCT01573624|37767171|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16823692|NCT01573624|37767165|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
16823693|NCT01573624|37767166|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16823694|NCT01573624|37767167|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16823695|NCT01573624|37767168|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16823696|NCT01573624|37767169|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16823697|NCT01573624|37767170|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16823698|NCT01573624|37767171|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16823699|NCT01573624|37767165|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16823700|NCT01573624|37767166|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
16823701|NCT01573624|37767167|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
16823702|NCT01573624|37767168|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16823703|NCT01573624|37767169|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16823704|NCT01573624|37767170|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
16823705|NCT01573624|37767171|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16823706|NCT01573624|37767165|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
16823707|NCT01573624|37767166|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16823708|NCT01573624|37767167|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16823709|NCT01573624|37767168|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16823710|NCT01573624|37767169|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16823711|NCT01573624|37767170|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16823712|NCT01573624|37767171|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16823713|NCT01573624|37767165|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
16823714|NCT01573624|37767166|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16823715|NCT01573624|37767167|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16823716|NCT01573624|37767168|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16823717|NCT01573624|37767169|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16823718|NCT01573624|37767170|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16823719|NCT01573624|37767171|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
16823720|NCT01573624|37767165|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
16823721|NCT01573624|37767166|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16823722|NCT01573624|37767167|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16823723|NCT01573624|37767168|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16823724|NCT01573624|37767169|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16823725|NCT01573624|37767170|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
16823726|NCT01573624|37767171|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16823727|NCT01573624|37767165|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16823728|NCT01573624|37767166|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
17198431|NCT02783729|38352127|FG003|Overall Study|Adverse Event|3|||
17198432|NCT02783729|38352124|FG000|Overall Study|Other|1|||
17198433|NCT02783729|38352125|FG001|Overall Study|Other|6|||
17198434|NCT02783729|38352126|FG002|Overall Study|Other|2|||
17198435|NCT02783729|38352127|FG003|Overall Study|Other|3|||
17198436|NCT02783729|38352124|FG000|Overall Study|Withdrawal by Subject|2|||
17198437|NCT02783729|38352125|FG001|Overall Study|Withdrawal by Subject|3|||
17198438|NCT02783729|38352126|FG002|Overall Study|Withdrawal by Subject|1|||
17198439|NCT02783729|38352127|FG003|Overall Study|Withdrawal by Subject|2|||
16823729|NCT01573624|37767167|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16823730|NCT01573624|37767168|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16823731|NCT01573624|37767169|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16823732|NCT01573624|37767170|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16823733|NCT01573624|37767171|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16823734|NCT01573624|37767165|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16823735|NCT01573624|37767166|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
16823736|NCT01573624|37767167|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16823737|NCT01573624|37767168|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16823738|NCT01573624|37767169|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16823739|NCT01573624|37767170|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16823740|NCT01573624|37767171|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16823741|NCT01573624|37767165|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16823742|NCT01573624|37767166|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16823743|NCT01573624|37767167|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16823744|NCT01573624|37767168|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16823745|NCT01573624|37767169|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16823746|NCT01573624|37767170|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16823747|NCT01573624|37767171|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16823748|NCT01573624|37767165|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
16823749|NCT01573624|37767166|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
16823750|NCT01573624|37767167|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
16823751|NCT01573624|37767168|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
16823752|NCT01573624|37767169|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
16823753|NCT01573624|37767170|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
16823754|NCT01573624|37767171|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
16823755|NCT01573624|37767165|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
16823756|NCT01573624|37767166|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16823757|NCT01573624|37767167|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16823758|NCT01573624|37767168|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16823759|NCT01573624|37767169|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
16823760|NCT01573624|37767170|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
16823761|NCT01573624|37767171|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
16823762|NCT01573624|37767165|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16823763|NCT01573624|37767166|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
16823764|NCT01573624|37767167|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16823765|NCT01573624|37767168|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16823766|NCT01573624|37767169|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16823767|NCT01573624|37767170|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
16823768|NCT01573624|37767171|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16823769|NCT01573624|37767165|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
16823770|NCT01573624|37767166|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16823771|NCT01573624|37767167|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16823772|NCT01573624|37767168|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16823773|NCT01573624|37767169|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16823774|NCT01573624|37767170|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16823775|NCT01573624|37767171|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16823776|NCT01573624|37767165|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16823777|NCT01573624|37767166|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16823778|NCT01573624|37767167|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16823779|NCT01573624|37767168|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16823780|NCT01573624|37767169|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
16823781|NCT01573624|37767170|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
16823782|NCT01573624|37767171|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16823783|NCT01573624|37767165|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
16823784|NCT01573624|37767166|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16823785|NCT01573624|37767167|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16823786|NCT01573624|37767168|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16823787|NCT01573624|37767169|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16823788|NCT01573624|37767170|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16823789|NCT01573624|37767171|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16823790|NCT01557946|37767195|FG000|Overall Study|Adverse Event|3|||
16823791|NCT01557946|37767196|FG001|Overall Study|Adverse Event|0|||
16823792|NCT01534078|37767201|FG000|Overall Study|Death|1|||
16823793|NCT01534078|37767201|FG000|Overall Study|Withdrawal by Subject|1|||
16823794|NCT02185040|37767210|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
16823795|NCT02185040|37767211|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
16823796|NCT02185040|37767212|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
16823797|NCT02185040|37767213|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
16823798|NCT02185040|37767214|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
16823799|NCT02185040|37767215|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
16823800|NCT02185040|37767216|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
16823801|NCT02185040|37767210|FG000|Part 1 Treatment Phase|Adverse Event|1|||
16823802|NCT02185040|37767211|FG001|Part 1 Treatment Phase|Adverse Event|0|||
16823803|NCT02185040|37767212|FG002|Part 1 Treatment Phase|Adverse Event|0|||
16823804|NCT02185040|37767213|FG003|Part 1 Treatment Phase|Adverse Event|2|||
16823805|NCT02185040|37767214|FG004|Part 1 Treatment Phase|Adverse Event|3|||
16823806|NCT02185040|37767215|FG005|Part 1 Treatment Phase|Adverse Event|0|||
16823807|NCT02185040|37767216|FG006|Part 1 Treatment Phase|Adverse Event|0|||
16823808|NCT02185040|37767210|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16823809|NCT02185040|37767211|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
16823810|NCT02185040|37767212|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16823811|NCT02185040|37767213|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16823812|NCT02185040|37767214|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16823813|NCT02185040|37767215|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16823814|NCT02185040|37767216|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16823815|NCT02185040|37767210|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
16823816|NCT02185040|37767211|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
16823817|NCT02185040|37767212|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
16823818|NCT02185040|37767213|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
16823819|NCT02185040|37767214|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
16823820|NCT02185040|37767215|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
16823821|NCT02185040|37767216|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
16823822|NCT02185040|37767210|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
16823823|NCT02185040|37767211|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
16823824|NCT02185040|37767212|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
16823825|NCT02185040|37767213|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
16823826|NCT02185040|37767214|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
16823827|NCT02185040|37767215|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
16823828|NCT02185040|37767216|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
16823829|NCT02185040|37767210|FG000|Active Treatment Extension Phase|Adverse Event|0|||
16823830|NCT02185040|37767211|FG001|Active Treatment Extension Phase|Adverse Event|0|||
16823831|NCT02185040|37767212|FG002|Active Treatment Extension Phase|Adverse Event|0|||
16823832|NCT02185040|37767213|FG003|Active Treatment Extension Phase|Adverse Event|0|||
16823833|NCT02185040|37767214|FG004|Active Treatment Extension Phase|Adverse Event|0|||
16823834|NCT02185040|37767215|FG005|Active Treatment Extension Phase|Adverse Event|1|||
16823835|NCT02185040|37767216|FG006|Active Treatment Extension Phase|Adverse Event|4|||
16823836|NCT02185040|37767210|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16823837|NCT02185040|37767211|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16823838|NCT02185040|37767212|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16823839|NCT02185040|37767213|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16823840|NCT02185040|37767214|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16823841|NCT02185040|37767215|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
16823842|NCT02185040|37767216|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
16823843|NCT02185040|37767210|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
16823844|NCT02185040|37767211|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
16823845|NCT02185040|37767212|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
16823846|NCT02185040|37767213|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
16823847|NCT02185040|37767214|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
16823848|NCT02185040|37767215|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
16823849|NCT02185040|37767216|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
16823850|NCT02161406|37767238|FG000|Overall Study|Death|2|||
16823851|NCT02161406|37767239|FG001|Overall Study|Death|1|||
16823852|NCT02161406|37767238|FG000|Overall Study|Lost to Follow-up|2|||
16823853|NCT02161406|37767239|FG001|Overall Study|Lost to Follow-up|1|||
16823854|NCT02161406|37767238|FG000|Overall Study|Withdrawal by Subject|2|||
16823855|NCT02161406|37767239|FG001|Overall Study|Withdrawal by Subject|4|||
16823856|NCT02161406|37767238|FG000|Overall Study|investigator withdrew subject|3|||
16823857|NCT02161406|37767239|FG001|Overall Study|investigator withdrew subject|1|||
16823858|NCT02161406|37767238|FG000|Overall Study|Lack of Efficacy|1|||
16823859|NCT02161406|37767239|FG001|Overall Study|Lack of Efficacy|1|||
16823860|NCT02161406|37767238|FG000|Overall Study|relocation|0|||
16823861|NCT02161406|37767239|FG001|Overall Study|relocation|1|||
16823862|NCT02161016|37767245|FG000|Overall Study|withdrawn by IRB|1|||
16823863|NCT01573000|37767251|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
16823864|NCT01573000|37767252|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
16823865|NCT01573000|37767251|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
16823866|NCT01573000|37767252|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
16823867|NCT01573000|37767251|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
16823868|NCT01573000|37767252|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
16823869|NCT01573000|37767251|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
16823870|NCT01573000|37767252|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
16823871|NCT01573000|37767251|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
16823872|NCT01573000|37767252|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
16823873|NCT01573000|37767251|FG000|Crossover Phase|Lack of Efficacy|0|||
16823874|NCT01573000|37767252|FG001|Crossover Phase|Lack of Efficacy|13|||
16823875|NCT01573000|37767251|FG000|Crossover Phase|Lost to Follow-up|0|||
16823876|NCT01573000|37767252|FG001|Crossover Phase|Lost to Follow-up|2|||
16823877|NCT01573000|37767251|FG000|Crossover Phase|Death|0|||
16823878|NCT01573000|37767252|FG001|Crossover Phase|Death|3|||
16823879|NCT01573000|37767251|FG000|Long-Term Follow-Up|Death|3|||
16823880|NCT01573000|37767252|FG001|Long-Term Follow-Up|Death|0|||
16823881|NCT01573000|37767251|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
16823882|NCT01573000|37767252|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
16823883|NCT01572922|37767262|FG000|Overall Study|Adverse Event|1|||
16823884|NCT01572922|37767262|FG000|Overall Study|Protocol Violation|1|||
16823885|NCT01572922|37767262|FG000|Overall Study|Death|1|||
16823886|NCT01572844|37767271|FG000|Overall Study|Physician Decision|1|||
16823887|NCT01572844|37767272|FG001|Overall Study|Physician Decision|1|||
16823888|NCT01557400|37767281|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
16823889|NCT01557400|37767281|FG000|Overall Study|Adverse Event|3|||
16823890|NCT01557400|37767281|FG000|Overall Study|Lost to Follow-up|5|||
16823891|NCT01557400|37767281|FG000|Overall Study|Withdrawal by Subject|9|||
16823892|NCT01533922|37767285|FG000|Overall Study|Adverse Event|5|||
16823893|NCT01533922|37767286|FG001|Overall Study|Adverse Event|8|||
16823894|NCT01533922|37767287|FG002|Overall Study|Adverse Event|6|||
16823895|NCT01533922|37767288|FG003|Overall Study|Adverse Event|3|||
16823896|NCT01533922|37767289|FG004|Overall Study|Adverse Event|4|||
16823897|NCT01533922|37767285|FG000|Overall Study|Lack of Efficacy|0|||
16823898|NCT01533922|37767286|FG001|Overall Study|Lack of Efficacy|0|||
16823899|NCT01533922|37767287|FG002|Overall Study|Lack of Efficacy|1|||
16823900|NCT01533922|37767288|FG003|Overall Study|Lack of Efficacy|0|||
16823901|NCT01533922|37767289|FG004|Overall Study|Lack of Efficacy|0|||
16823902|NCT01533922|37767285|FG000|Overall Study|Protocol Violation|0|||
16823903|NCT01533922|37767286|FG001|Overall Study|Protocol Violation|3|||
16823904|NCT01533922|37767287|FG002|Overall Study|Protocol Violation|0|||
16823905|NCT01533922|37767288|FG003|Overall Study|Protocol Violation|0|||
16823906|NCT01533922|37767289|FG004|Overall Study|Protocol Violation|1|||
16823907|NCT01533922|37767285|FG000|Overall Study|Withdrawal by Subject|3|||
16823908|NCT01533922|37767286|FG001|Overall Study|Withdrawal by Subject|1|||
16823909|NCT01533922|37767287|FG002|Overall Study|Withdrawal by Subject|2|||
16823910|NCT01533922|37767288|FG003|Overall Study|Withdrawal by Subject|2|||
16823911|NCT01533922|37767289|FG004|Overall Study|Withdrawal by Subject|1|||
16823912|NCT01533922|37767285|FG000|Overall Study|Other reason not defined above|2|||
16823913|NCT01533922|37767286|FG001|Overall Study|Other reason not defined above|0|||
16823914|NCT01533922|37767287|FG002|Overall Study|Other reason not defined above|1|||
16823915|NCT01533922|37767288|FG003|Overall Study|Other reason not defined above|0|||
16823916|NCT01533922|37767289|FG004|Overall Study|Other reason not defined above|0|||
16823917|NCT01533688|37767304|FG000|Overall Study|Withdrawal by Subject|5|||
16823918|NCT01533688|37767305|FG001|Overall Study|Withdrawal by Subject|4|||
16823919|NCT01533688|37767306|FG002|Overall Study|Withdrawal by Subject|3|||
16823920|NCT01533688|37767304|FG000|Overall Study|Medically unstable|1|||
16823921|NCT01533688|37767305|FG001|Overall Study|Medically unstable|3|||
16823922|NCT01533688|37767306|FG002|Overall Study|Medically unstable|3|||
16823923|NCT01533688|37767304|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
16823924|NCT01533688|37767305|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
16823925|NCT01533688|37767306|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
16823926|NCT01532986|37767318|FG000|Overall Study|Death|9|||
16823927|NCT01532986|37767319|FG001|Overall Study|Death|9|||
16823928|NCT01532986|37767318|FG000|Overall Study|Withdrawal by Subject|7|||
16823929|NCT01532986|37767319|FG001|Overall Study|Withdrawal by Subject|10|||
16823930|NCT01532986|37767318|FG000|Overall Study|Physician Decision|7|||
16823931|NCT01532986|37767319|FG001|Overall Study|Physician Decision|5|||
16823932|NCT01532908|37767328|FG000|Overall Study|Not Transplanted|1|||
16823933|NCT01532908|37767329|FG001|Overall Study|Not Transplanted|0|||
16823934|NCT02160782|37767335|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
16823935|NCT02160782|37767336|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
16823936|NCT02160782|37767337|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
16823937|NCT02160782|37767338|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
16823938|NCT02160782|37767339|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
16823939|NCT02160782|37767335|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
16823940|NCT02160782|37767336|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
16823941|NCT02160782|37767337|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
16823942|NCT02160782|37767338|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
16823943|NCT02160782|37767339|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
16823944|NCT02160782|37767335|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
16823945|NCT02160782|37767336|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
16823946|NCT02160782|37767337|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
16823947|NCT02160782|37767338|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
16823948|NCT02160782|37767339|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
16823949|NCT02160782|37767335|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
16823950|NCT02160782|37767336|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
16823951|NCT02160782|37767337|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
16823952|NCT02160782|37767338|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
16823953|NCT02160782|37767339|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
16823954|NCT02160782|37767335|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
16823955|NCT02160782|37767336|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
16823956|NCT02160782|37767337|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
16823957|NCT02160782|37767338|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
16823958|NCT02160782|37767339|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
16823959|NCT02160782|37767335|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
16823960|NCT02160782|37767336|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
16823961|NCT02160782|37767337|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
16823962|NCT02160782|37767338|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
16823963|NCT02160782|37767339|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
16823964|NCT02160782|37767335|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
16823965|NCT02160782|37767336|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
16823966|NCT02160782|37767337|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
16823967|NCT02160782|37767338|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
16823968|NCT02160782|37767339|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
16823969|NCT02160626|37767366|FG000|Overall Study|Adverse Event|1|||
16823970|NCT02160626|37767367|FG001|Overall Study|Adverse Event|0|||
16823971|NCT02160626|37767368|FG002|Overall Study|Adverse Event|0|||
16823972|NCT02160626|37767366|FG000|Overall Study|Schedule not conducive to study visits|0|||
16823973|NCT02160626|37767367|FG001|Overall Study|Schedule not conducive to study visits|0|||
16823974|NCT02160626|37767368|FG002|Overall Study|Schedule not conducive to study visits|1|||
16823975|NCT02160626|37767366|FG000|Overall Study|Withdrawal by Subject|0|||
16823976|NCT02160626|37767367|FG001|Overall Study|Withdrawal by Subject|1|||
16823977|NCT02160626|37767368|FG002|Overall Study|Withdrawal by Subject|0|||
16823978|NCT02160314|37767380|FG000|Overall Study|Adverse Event|0|||
16823979|NCT02160314|37767381|FG001|Overall Study|Adverse Event|6|||
16823980|NCT02160314|37767380|FG000|Overall Study|Protocol Violation|0|||
16823981|NCT02160314|37767381|FG001|Overall Study|Protocol Violation|4|||
16823982|NCT02160314|37767380|FG000|Overall Study|Withdrawal by Subject|1|||
16823983|NCT02160314|37767381|FG001|Overall Study|Withdrawal by Subject|2|||
16823984|NCT02160314|37767380|FG000|Overall Study|Lost to Follow-up|0|||
16823985|NCT02160314|37767381|FG001|Overall Study|Lost to Follow-up|1|||
16823986|NCT02160002|37767389|FG000|Overall Study|Withdrawal by Subject|2|||
16823987|NCT02160002|37767390|FG001|Overall Study|Withdrawal by Subject|1|||
16823988|NCT02218268|37767396|FG000|24 Hour Washout|Physician Decision|11|||
16823989|NCT02218268|37767397|FG001|24 Hour Washout|Physician Decision|9|||
16823990|NCT02217878|37767405|FG000|Overall Study|required morphine due to chest pain|1|||
16823991|NCT02217878|37767406|FG001|Overall Study|required morphine due to chest pain|2|||
16823992|NCT02217878|37767405|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
16823993|NCT02217878|37767406|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
16823994|NCT02217566|37767412|FG000|Overall Study|Lost to Follow-up|2|||
16823995|NCT02217566|37767412|FG000|Overall Study|Death|3|||
16823996|NCT02217566|37767412|FG000|Overall Study|Early study termination|6|||
16823997|NCT02217410|37767419|FG000|Overall Study|Graft Loss|0|||
16823998|NCT02217410|37767420|FG001|Overall Study|Graft Loss|0|||
16823999|NCT02217410|37767421|FG002|Overall Study|Graft Loss|2|||
16824000|NCT02217410|37767419|FG000|Overall Study|Withdrawal by Subject|0|||
16824001|NCT02217410|37767420|FG001|Overall Study|Withdrawal by Subject|0|||
16824002|NCT02217410|37767421|FG002|Overall Study|Withdrawal by Subject|2|||
16824003|NCT02217410|37767419|FG000|Overall Study|Lost to Follow-up|0|||
16824004|NCT02217410|37767420|FG001|Overall Study|Lost to Follow-up|0|||
16824005|NCT02217410|37767421|FG002|Overall Study|Lost to Follow-up|1|||
16824006|NCT02217410|37767419|FG000|Overall Study|Lack of Efficacy|0|||
16824007|NCT02217410|37767420|FG001|Overall Study|Lack of Efficacy|1|||
16824008|NCT02217410|37767421|FG002|Overall Study|Lack of Efficacy|0|||
16824009|NCT02217410|37767419|FG000|Overall Study|Physician Decision|1|||
16824010|NCT02217410|37767420|FG001|Overall Study|Physician Decision|3|||
16824011|NCT02217410|37767421|FG002|Overall Study|Physician Decision|0|||
16824012|NCT02217332|37767434|FG000|Overall Study|Adverse Event|3|||
16824013|NCT02217332|37767434|FG000|Overall Study|Dose interruption >1 month|1|||
16824014|NCT02217332|37767434|FG000|Overall Study|Protocol Violation (eligibility)|1|||
16824015|NCT02217332|37767434|FG000|Overall Study|Withdrawal by Subject|1|||
16824016|NCT02217332|37767434|FG000|Overall Study|Lost to Follow-up|1|||
16824017|NCT02184572|37767440|FG000|Overall Study|Lost to Follow-up|29|||
16824018|NCT02184572|37767441|FG001|Overall Study|Lost to Follow-up|21|||
16824019|NCT02184572|37767440|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
16824020|NCT02184572|37767441|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
16824021|NCT02184572|37767440|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
16824022|NCT02184572|37767441|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
16824023|NCT02184572|37767440|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
16824024|NCT02184572|37767441|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
16824025|NCT02184572|37767440|FG000|Overall Study|Traveling Outside The Country|1|||
16824026|NCT02184572|37767441|FG001|Overall Study|Traveling Outside The Country|0|||
16824027|NCT02184572|37767440|FG000|Overall Study|Withdrawal by Subject|14|||
16824028|NCT02184572|37767441|FG001|Overall Study|Withdrawal by Subject|9|||
16824029|NCT02181842|37767449|FG000|Overall Study|Case Report Forms Uncollected|2|||
16824030|NCT01632020|37767455|FG000|Overall Study|Withdrawal by Subject|1|||
16824031|NCT01632020|37767456|FG001|Overall Study|Withdrawal by Subject|0|||
16824032|NCT01632020|37767455|FG000|Overall Study|Adverse Event|1|||
16824033|NCT01632020|37767456|FG001|Overall Study|Adverse Event|0|||
16824034|NCT02181296|37767464|FG000|Overall Study|Lost to Follow-up|7|||
16824035|NCT02181296|37767465|FG001|Overall Study|Lost to Follow-up|6|||
16824036|NCT02215616|37767475|FG000|Overall Study|Sponsor requested to stop study drug|0|||
16824037|NCT02215616|37767476|FG001|Overall Study|Sponsor requested to stop study drug|0|||
16824038|NCT02215616|37767477|FG002|Overall Study|Sponsor requested to stop study drug|1|||
16824039|NCT02215616|37767478|FG003|Overall Study|Sponsor requested to stop study drug|4|||
16824040|NCT02215616|37767475|FG000|Overall Study|Death|1|||
16824041|NCT02215616|37767476|FG001|Overall Study|Death|0|||
16824042|NCT02215616|37767477|FG002|Overall Study|Death|0|||
16824043|NCT02215616|37767478|FG003|Overall Study|Death|0|||
16824044|NCT02215616|37767475|FG000|Overall Study|Adverse Event|7|||
16824045|NCT02215616|37767476|FG001|Overall Study|Adverse Event|4|||
16824046|NCT02215616|37767477|FG002|Overall Study|Adverse Event|9|||
16824047|NCT02215616|37767478|FG003|Overall Study|Adverse Event|2|||
16824048|NCT02215616|37767475|FG000|Overall Study|Withdrawal by Subject|1|||
16824049|NCT02215616|37767476|FG001|Overall Study|Withdrawal by Subject|8|||
16824050|NCT02215616|37767477|FG002|Overall Study|Withdrawal by Subject|2|||
16824051|NCT02215616|37767478|FG003|Overall Study|Withdrawal by Subject|5|||
16824052|NCT02215616|37767475|FG000|Overall Study|Non-compliance|0|||
16824053|NCT02215616|37767476|FG001|Overall Study|Non-compliance|2|||
16824054|NCT02215616|37767477|FG002|Overall Study|Non-compliance|1|||
16824055|NCT02215616|37767478|FG003|Overall Study|Non-compliance|0|||
16824056|NCT02215616|37767475|FG000|Overall Study|Protocol Violation|0|||
16824057|NCT02215616|37767476|FG001|Overall Study|Protocol Violation|2|||
16824058|NCT02215616|37767477|FG002|Overall Study|Protocol Violation|0|||
16824059|NCT02215616|37767478|FG003|Overall Study|Protocol Violation|0|||
16824060|NCT02215616|37767475|FG000|Overall Study|Lost to Follow-up|1|||
16824061|NCT02215616|37767476|FG001|Overall Study|Lost to Follow-up|1|||
16824062|NCT02215616|37767477|FG002|Overall Study|Lost to Follow-up|0|||
16824063|NCT02215616|37767478|FG003|Overall Study|Lost to Follow-up|1|||
16824064|NCT02215616|37767475|FG000|Overall Study|Other than specified|1|||
16824065|NCT02215616|37767476|FG001|Overall Study|Other than specified|0|||
16824066|NCT02215616|37767477|FG002|Overall Study|Other than specified|1|||
16824067|NCT02215616|37767478|FG003|Overall Study|Other than specified|1|||
16824068|NCT02213666|37767488|FG000|Overall Study|Withdrawal by Subject|1|||
16824069|NCT02213510|37767494|FG000|Overall Study|Death|0|||
16824070|NCT02213510|37767495|FG001|Overall Study|Death|1|||
16824071|NCT02213510|37767494|FG000|Overall Study|Lost to Follow-up|1|||
16824072|NCT02213510|37767495|FG001|Overall Study|Lost to Follow-up|0|||
16824073|NCT02158442|37767503|FG000|Overall Study|Withdrawal by Subject|1|||
16824074|NCT02158442|37767504|FG001|Overall Study|Withdrawal by Subject|0|||
16824075|NCT02158442|37767503|FG000|Overall Study|Perfusion staff not available|1|||
16824076|NCT02158442|37767504|FG001|Overall Study|Perfusion staff not available|0|||
16824077|NCT02158364|37767510|FG000|Overall Study|Case report forms uncollected|10|||
16824078|NCT02158364|37767510|FG000|Overall Study|Protocol Deviation|50|||
16824079|NCT02180672|37767516|FG000|Overall Study|Lost to Follow-up|5|||
16824080|NCT02180672|37767517|FG001|Overall Study|Lost to Follow-up|7|||
16824081|NCT02213198|37767525|FG000|Baseline|No show for intake|7|||
16824082|NCT02213198|37767526|FG001|Baseline|No show for intake|9|||
16824083|NCT02213198|37767525|FG000|Baseline|Withdrawal by Subject|34|||
16824084|NCT02213198|37767526|FG001|Baseline|Withdrawal by Subject|11|||
16824085|NCT02213198|37767525|FG000|Baseline|transferred out of clinic|7|||
16824086|NCT02213198|37767526|FG001|Baseline|transferred out of clinic|9|||
16824087|NCT02213198|37767525|FG000|Baseline|Lost to Follow-up|40|||
16824088|NCT02213198|37767526|FG001|Baseline|Lost to Follow-up|21|||
16824089|NCT02213198|37767525|FG000|Baseline|incarcerated,violent|0|||
16824090|NCT02213198|37767526|FG001|Baseline|incarcerated,violent|1|||
16824091|NCT02213198|37767525|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
16824092|NCT02213198|37767526|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
16824093|NCT02213198|37767525|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
16824094|NCT02213198|37767526|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
16824095|NCT02213198|37767525|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
16824096|NCT02213198|37767526|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
16824097|NCT02213198|37767525|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
16824098|NCT02213198|37767526|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
16824099|NCT02213198|37767525|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
16824100|NCT02213198|37767526|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
16824101|NCT02213198|37767525|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
16824102|NCT02213198|37767526|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
16824103|NCT02157506|37767537|FG000|Overall Study|Adverse Event|0|||
16824104|NCT02157506|37767538|FG001|Overall Study|Adverse Event|1|||
16824105|NCT02157506|37767539|FG002|Overall Study|Adverse Event|0|||
16824106|NCT02157506|37767540|FG003|Overall Study|Adverse Event|0|||
16824107|NCT02157506|37767541|FG004|Overall Study|Adverse Event|0|||
16824108|NCT02157506|37767537|FG000|Overall Study|Lost to Follow-up|0|||
16824109|NCT02157506|37767538|FG001|Overall Study|Lost to Follow-up|0|||
16824110|NCT02157506|37767539|FG002|Overall Study|Lost to Follow-up|1|||
16824111|NCT02157506|37767540|FG003|Overall Study|Lost to Follow-up|0|||
16824112|NCT02157506|37767541|FG004|Overall Study|Lost to Follow-up|0|||
16824113|NCT01920711|37767555|FG000|Overall Study|Death|347|||
16824114|NCT01920711|37767556|FG001|Overall Study|Death|356|||
16824115|NCT01920711|37767555|FG000|Overall Study|Lost to Follow-up|13|||
16824116|NCT01920711|37767556|FG001|Overall Study|Lost to Follow-up|14|||
16824117|NCT01920711|37767555|FG000|Overall Study|Withdrawal by Subject|4|||
16824118|NCT01920711|37767556|FG001|Overall Study|Withdrawal by Subject|3|||
16824119|NCT02180438|37767563|FG000|Overall Study|Lost to Follow-up|1|||
16824120|NCT02179190|37767567|FG000|Enrollment|Exit Prior to Device Attempt|11|||
16824121|NCT02179190|37767567|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
16824122|NCT02179190|37767567|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
16824123|NCT02179190|37767567|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
16824124|NCT02179190|37767567|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
16824125|NCT02179190|37767567|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
16824126|NCT02157116|37767571|FG000|Overall Study|Withdrawal by Subject|4|||
16824127|NCT02157116|37767571|FG000|Overall Study|Physician Decision|3|||
16824128|NCT02157116|37767571|FG000|Overall Study|Failed Screening|2|||
16824129|NCT01920555|37767580|FG000|Overall Study|Physician Decision|1|||
16824130|NCT01920555|37767581|FG001|Overall Study|Physician Decision|2|||
16824131|NCT01920555|37767582|FG002|Overall Study|Physician Decision|1|||
16824132|NCT01920555|37767583|FG003|Overall Study|Physician Decision|2|||
16824133|NCT01920555|37767584|FG004|Overall Study|Physician Decision|0|||
16824134|NCT01920555|37767580|FG000|Overall Study|Lack of Efficacy|2|||
16824135|NCT01920555|37767581|FG001|Overall Study|Lack of Efficacy|0|||
16824136|NCT01920555|37767582|FG002|Overall Study|Lack of Efficacy|0|||
16824137|NCT01920555|37767583|FG003|Overall Study|Lack of Efficacy|0|||
16824138|NCT01920555|37767584|FG004|Overall Study|Lack of Efficacy|0|||
16824139|NCT01920555|37767580|FG000|Overall Study|Travel Difficulties|1|||
16824140|NCT01920555|37767581|FG001|Overall Study|Travel Difficulties|1|||
16824141|NCT01920555|37767582|FG002|Overall Study|Travel Difficulties|0|||
16824142|NCT01920555|37767583|FG003|Overall Study|Travel Difficulties|0|||
16824143|NCT01920555|37767584|FG004|Overall Study|Travel Difficulties|1|||
16824144|NCT01920555|37767580|FG000|Overall Study|Lost to Follow-up|0|||
16824145|NCT01920555|37767581|FG001|Overall Study|Lost to Follow-up|1|||
16824146|NCT01920555|37767582|FG002|Overall Study|Lost to Follow-up|0|||
16824147|NCT01920555|37767583|FG003|Overall Study|Lost to Follow-up|1|||
16824148|NCT01920555|37767584|FG004|Overall Study|Lost to Follow-up|0|||
16824149|NCT02156804|37767596|FG000|Overall Study|Withdrawal by Subject|1|||
16824150|NCT02156492|37767603|FG000|Period 1|No Reason Given|0|||
16824151|NCT02156492|37767604|FG001|Period 1|No Reason Given|1|||
16824152|NCT02156492|37767605|FG002|Period 1|No Reason Given|0|||
16824153|NCT02156492|37767603|FG000|Period 3|Adverse Event|0|||
16824154|NCT02156492|37767604|FG001|Period 3|Adverse Event|1|||
16824155|NCT02156492|37767605|FG002|Period 3|Adverse Event|0|||
16824156|NCT01920477|37767625|FG000|Overall Study|Adverse Event|0|||
16824157|NCT01920477|37767626|FG001|Overall Study|Adverse Event|1|||
16824158|NCT01920477|37767625|FG000|Overall Study|Lack of Efficacy|1|||
16824159|NCT01920477|37767626|FG001|Overall Study|Lack of Efficacy|0|||
16824160|NCT01920477|37767625|FG000|Overall Study|Study closed/terminated|14|||
16824161|NCT01920477|37767626|FG001|Overall Study|Study closed/terminated|15|||
16824162|NCT01920477|37767625|FG000|Overall Study|Withdrawal by Subject|0|||
16824163|NCT01920477|37767626|FG001|Overall Study|Withdrawal by Subject|1|||
16824164|NCT02213042|37767635|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
16824165|NCT02213042|37767636|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
16824166|NCT02213042|37767637|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
16824167|NCT02213042|37767635|FG000|Overall Study|Adverse Event|2|||
16824168|NCT02213042|37767636|FG001|Overall Study|Adverse Event|1|||
16824169|NCT02213042|37767637|FG002|Overall Study|Adverse Event|0|||
16824170|NCT02213042|37767635|FG000|Overall Study|Withdrawal by Subject|0|||
16824171|NCT02213042|37767636|FG001|Overall Study|Withdrawal by Subject|1|||
16824172|NCT02213042|37767637|FG002|Overall Study|Withdrawal by Subject|1|||
16824173|NCT02213042|37767635|FG000|Overall Study|Protocol Violation|1|||
16824174|NCT02213042|37767636|FG001|Overall Study|Protocol Violation|0|||
16824175|NCT02213042|37767637|FG002|Overall Study|Protocol Violation|0|||
16824176|NCT02213042|37767635|FG000|Overall Study|Investigator discretion|0|||
16824177|NCT02213042|37767636|FG001|Overall Study|Investigator discretion|0|||
16824178|NCT02213042|37767637|FG002|Overall Study|Investigator discretion|1|||
16824179|NCT02212730|37767649|FG000|Overall Study|Tumor not of the required cell histology|1|||
16824180|NCT02212730|37767650|FG001|Overall Study|Tumor not of the required cell histology|0|||
16824181|NCT02212730|37767649|FG000|Overall Study|Withdrawal by Subject|1|||
16824182|NCT02212730|37767650|FG001|Overall Study|Withdrawal by Subject|0|||
16824183|NCT02212730|37767649|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
16824184|NCT02212730|37767650|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
16824185|NCT02178956|37767660|FG000|Overall Study|Lost to Follow-up|4|||
16824186|NCT02178956|37767661|FG001|Overall Study|Lost to Follow-up|4|||
16824187|NCT02178956|37767660|FG000|Overall Study|Sponsor terminated study|49|||
16824188|NCT02178956|37767661|FG001|Overall Study|Sponsor terminated study|58|||
16824189|NCT02178956|37767660|FG000|Overall Study|Withdrawal by Subject|15|||
16824190|NCT02178956|37767661|FG001|Overall Study|Withdrawal by Subject|11|||
16824191|NCT02178956|37767660|FG000|Overall Study|Various Reasons|3|||
16824192|NCT02178956|37767661|FG001|Overall Study|Various Reasons|5|||
16824193|NCT02211638|37767671|FG000|Overall Study|Case Report Forms Uncollected|291|||
16824194|NCT02211638|37767671|FG000|Overall Study|Protocol Violation|692|||
16824195|NCT02178566|37767677|FG000|Overall Study|patient did not complete due to noncompliance|0|||
16824196|NCT02178566|37767678|FG001|Overall Study|patient did not complete due to noncompliance|1|||
16824197|NCT02211014|37767686|FG000|Overall Study|Adverse Event|0|||
16824198|NCT02211014|37767687|FG001|Overall Study|Adverse Event|2|||
16824199|NCT02211014|37767686|FG000|Overall Study|Physician Decision|1|||
16824200|NCT02211014|37767687|FG001|Overall Study|Physician Decision|2|||
16824201|NCT02211014|37767686|FG000|Overall Study|Started another cancer therapy|1|||
16824202|NCT02211014|37767687|FG001|Overall Study|Started another cancer therapy|0|||
16824203|NCT02211014|37767686|FG000|Overall Study|Withdrawal by Subject|0|||
16824204|NCT02211014|37767687|FG001|Overall Study|Withdrawal by Subject|1|||
16824205|NCT02211014|37767686|FG000|Overall Study|In agreement with patient, no benefit|0|||
16824206|NCT02211014|37767687|FG001|Overall Study|In agreement with patient, no benefit|1|||
16824207|NCT01631864|37767711|FG000|Overall Study|Withdrawal by Subject|0|||
16824208|NCT01631864|37767712|FG001|Overall Study|Withdrawal by Subject|1|||
16824209|NCT01631864|37767711|FG000|Overall Study|Adverse Event|2|||
16824210|NCT01631864|37767712|FG001|Overall Study|Adverse Event|3|||
16824211|NCT02210780|37767720|FG000|Overall Study|Adverse Event|0|||
16824212|NCT02210780|37767721|FG001|Overall Study|Adverse Event|5|||
16824213|NCT02210780|37767720|FG000|Overall Study|Lost to Follow-up|2|||
16824214|NCT02210780|37767721|FG001|Overall Study|Lost to Follow-up|1|||
16824215|NCT02210780|37767720|FG000|Overall Study|Withdrawal by Subject|1|||
16824216|NCT02210780|37767721|FG001|Overall Study|Withdrawal by Subject|1|||
16824217|NCT02210780|37767720|FG000|Overall Study|Physician Decision|1|||
16824218|NCT02210780|37767721|FG001|Overall Study|Physician Decision|0|||
16824219|NCT02210780|37767720|FG000|Overall Study|Protocol Violation|1|||
16824220|NCT02210780|37767721|FG001|Overall Study|Protocol Violation|0|||
16824221|NCT02210780|37767720|FG000|Overall Study|Other than specified above|0|||
16824222|NCT02210780|37767721|FG001|Overall Study|Other than specified above|1|||
16824223|NCT01557244|37767732|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
16824224|NCT01557244|37767733|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16824225|NCT01557244|37767734|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16824226|NCT01557244|37767735|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16824227|NCT01557244|37767736|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16824228|NCT01557244|37767737|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
16824229|NCT01557244|37767738|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16824230|NCT01557244|37767732|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
16824231|NCT01557244|37767733|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16824232|NCT01557244|37767734|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
17016703|NCT00866294|38161286|FG002|Overall Study|Adverse Event|9|||
16824233|NCT01557244|37767735|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16824234|NCT01557244|37767736|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16824235|NCT01557244|37767737|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16824236|NCT01557244|37767738|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16824237|NCT01557244|37767732|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
16824238|NCT01557244|37767733|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16824239|NCT01557244|37767734|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16824240|NCT01557244|37767735|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16824241|NCT01557244|37767736|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16824242|NCT01557244|37767737|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16824243|NCT01557244|37767738|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16824244|NCT01557244|37767732|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
16824245|NCT01557244|37767733|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16824246|NCT01557244|37767734|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16824247|NCT01557244|37767735|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16824248|NCT01557244|37767736|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16824249|NCT01557244|37767737|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
16824250|NCT01557244|37767738|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16824251|NCT01557244|37767732|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16824252|NCT01557244|37767733|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
16824253|NCT01557244|37767734|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16824254|NCT01557244|37767735|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16824255|NCT01557244|37767736|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16824256|NCT01557244|37767737|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16824257|NCT01557244|37767738|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16824258|NCT01557244|37767732|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16824259|NCT01557244|37767733|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16824260|NCT01557244|37767734|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16824261|NCT01557244|37767735|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16824262|NCT01557244|37767736|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16824263|NCT01557244|37767737|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
16824264|NCT01557244|37767738|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
16824265|NCT01557244|37767732|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
16824266|NCT01557244|37767733|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
16824267|NCT01557244|37767734|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
16824268|NCT01557244|37767735|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
16824269|NCT01557244|37767736|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
16824270|NCT01557244|37767737|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
16824271|NCT01557244|37767738|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
16824272|NCT01557244|37767732|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
16824273|NCT01557244|37767733|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16824274|NCT01557244|37767734|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
16824275|NCT01557244|37767735|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16824276|NCT01557244|37767736|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16824277|NCT01557244|37767737|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16824278|NCT01557244|37767738|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16824279|NCT01557244|37767732|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
16824280|NCT01557244|37767733|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
16824281|NCT01557244|37767734|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
16824282|NCT01557244|37767735|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
16824283|NCT01557244|37767736|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
16824284|NCT01557244|37767737|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
16824285|NCT01557244|37767738|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
16824286|NCT01557244|37767732|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
16824287|NCT01557244|37767733|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
16824288|NCT01557244|37767734|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16824289|NCT01557244|37767735|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16824290|NCT01557244|37767736|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16824291|NCT01557244|37767737|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16824292|NCT01557244|37767738|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
17016704|NCT00866294|38161284|FG000|Overall Study|Lack of Efficacy|7|||
16824293|NCT01557244|37767732|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16824294|NCT01557244|37767733|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16824295|NCT01557244|37767734|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16824296|NCT01557244|37767735|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
16824297|NCT01557244|37767736|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16824298|NCT01557244|37767737|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16824299|NCT01557244|37767738|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16824300|NCT01557244|37767732|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
16824301|NCT01557244|37767733|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
16824302|NCT01557244|37767734|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16824303|NCT01557244|37767735|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16824304|NCT01557244|37767736|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16824305|NCT01557244|37767737|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16824306|NCT01557244|37767738|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16824307|NCT02155712|37767768|FG000|Primary Objective|Death|3|||
16824308|NCT02155712|37767769|FG001|Primary Objective|Death|0|||
16824309|NCT02155712|37767768|FG000|Primary Objective|Lost to Follow-up|22|||
16824310|NCT02155712|37767769|FG001|Primary Objective|Lost to Follow-up|0|||
16824311|NCT02155712|37767768|FG000|Primary Objective|No 2-Year Forms but not Terminated|13|||
16824312|NCT02155712|37767769|FG001|Primary Objective|No 2-Year Forms but not Terminated|0|||
16824313|NCT02155712|37767768|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1|||
16824314|NCT02155712|37767769|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0|||
16824315|NCT02155712|37767768|FG000|Primary Objective|Withdrawal by Subject|21|||
16824316|NCT02155712|37767769|FG001|Primary Objective|Withdrawal by Subject|0|||
16824317|NCT02177942|37767777|FG000|Overall Study|Adverse Event|1|||
16824318|NCT02177942|37767778|FG001|Overall Study|Adverse Event|0|||
16824319|NCT02177942|37767777|FG000|Overall Study|Lost to Follow-up|1|||
16824320|NCT02177942|37767778|FG001|Overall Study|Lost to Follow-up|1|||
16824321|NCT02177942|37767777|FG000|Overall Study|Protocol Violation|4|||
16824322|NCT02177942|37767778|FG001|Overall Study|Protocol Violation|6|||
16824323|NCT02177942|37767777|FG000|Overall Study|Withdrawal by Subject|71|||
16824324|NCT02177942|37767778|FG001|Overall Study|Withdrawal by Subject|81|||
16824325|NCT02155322|37767788|FG000|Overall Study|Adverse Event|1|||
16824326|NCT02155322|37767788|FG000|Overall Study|Physician Decision|1|||
16824327|NCT02155322|37767788|FG000|Overall Study|Relapse/Recurrence|8|||
16824328|NCT02155322|37767788|FG000|Overall Study|Withdrawal by Subject|4|||
16824329|NCT02210000|37767794|FG000|Overall Study|Study Terminated|11|||
16824330|NCT02210000|37767795|FG001|Overall Study|Study Terminated|12|||
16824331|NCT02210000|37767794|FG000|Overall Study|Withdrawal by Subject|7|||
16824332|NCT02210000|37767795|FG001|Overall Study|Withdrawal by Subject|1|||
16824333|NCT02210000|37767794|FG000|Overall Study|Adverse Event|1|||
16824334|NCT02210000|37767795|FG001|Overall Study|Adverse Event|5|||
16824335|NCT02210000|37767794|FG000|Overall Study|Lost to Follow-up|0|||
16824336|NCT02210000|37767795|FG001|Overall Study|Lost to Follow-up|2|||
16824337|NCT02210000|37767794|FG000|Overall Study|Physician Decision|0|||
16824338|NCT02210000|37767795|FG001|Overall Study|Physician Decision|1|||
16824339|NCT01531894|37767801|FG000|Overall Study|Physician Decision|8|||
16824340|NCT01531894|37767801|FG000|Overall Study|Death|1|||
16824341|NCT02209766|37767809|FG000|Overall Study|Withdrawal by Subject|0|||
16824342|NCT02209766|37767810|FG001|Overall Study|Withdrawal by Subject|0|||
16824343|NCT02209766|37767811|FG002|Overall Study|Withdrawal by Subject|0|||
16824344|NCT02209766|37767812|FG003|Overall Study|Withdrawal by Subject|1|||
16824345|NCT02209766|37767813|FG004|Overall Study|Withdrawal by Subject|0|||
16824346|NCT02209454|37767823|FG000|Second Period|Adverse Event|1|||
16824347|NCT02209454|37767824|FG001|Second Period|Adverse Event|0|||
16824348|NCT01571596|37767833|FG000|Overall Study|Adverse Event|2|||
16824349|NCT01571596|37767834|FG001|Overall Study|Adverse Event|0|||
16824350|NCT01571596|37767835|FG002|Overall Study|Adverse Event|0|||
16824351|NCT01571596|37767833|FG000|Overall Study|Study Terminated by the Sponsor|0|||
16824352|NCT01571596|37767834|FG001|Overall Study|Study Terminated by the Sponsor|1|||
16824353|NCT01571596|37767835|FG002|Overall Study|Study Terminated by the Sponsor|1|||
16824354|NCT01557166|37767847|FG000|Overall Study|Adverse Event|20|||
16824355|NCT01557166|37767848|FG001|Overall Study|Adverse Event|6|||
16824356|NCT01557166|37767847|FG000|Overall Study|Lack of Efficacy|2|||
16824357|NCT01557166|37767848|FG001|Overall Study|Lack of Efficacy|1|||
16824358|NCT01557166|37767847|FG000|Overall Study|Protocol Violation|8|||
16824359|NCT01557166|37767848|FG001|Overall Study|Protocol Violation|5|||
16824360|NCT01557166|37767847|FG000|Overall Study|Withdrawn consent|12|||
16824361|NCT01557166|37767848|FG001|Overall Study|Withdrawn consent|20|||
16824362|NCT01557166|37767847|FG000|Overall Study|Target dose not tolerated|1|||
16824363|NCT01557166|37767848|FG001|Overall Study|Target dose not tolerated|0|||
16824364|NCT01557166|37767847|FG000|Overall Study|Psychiatric disorder|1|||
16824365|NCT01557166|37767848|FG001|Overall Study|Psychiatric disorder|0|||
16824366|NCT01557166|37767847|FG000|Overall Study|Unclassified|2|||
16824367|NCT01557166|37767848|FG001|Overall Study|Unclassified|5|||
16824368|NCT01556932|37767854|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
16824369|NCT01556932|37767855|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
16824370|NCT02177786|37767864|FG000|Overall Study|Withdrew Consent|2|||
16824371|NCT02177786|37767865|FG001|Overall Study|Withdrew Consent|6|||
16824372|NCT02177786|37767866|FG002|Overall Study|Withdrew Consent|9|||
16824373|NCT02177786|37767867|FG003|Overall Study|Withdrew Consent|5|||
16824374|NCT02177786|37767864|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
16824375|NCT02177786|37767865|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
16824376|NCT02177786|37767866|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
16824377|NCT02177786|37767867|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
16824378|NCT02177786|37767864|FG000|Overall Study|Adverse Event|1|||
16824379|NCT02177786|37767865|FG001|Overall Study|Adverse Event|1|||
16824380|NCT02177786|37767866|FG002|Overall Study|Adverse Event|2|||
16824381|NCT02177786|37767867|FG003|Overall Study|Adverse Event|3|||
16824382|NCT02177786|37767864|FG000|Overall Study|Death|1|||
16824383|NCT02177786|37767865|FG001|Overall Study|Death|1|||
16824384|NCT02177786|37767866|FG002|Overall Study|Death|1|||
16824385|NCT02177786|37767867|FG003|Overall Study|Death|1|||
16824386|NCT02177786|37767864|FG000|Overall Study|Lost to Follow-up|0|||
16824387|NCT02177786|37767865|FG001|Overall Study|Lost to Follow-up|0|||
16824388|NCT02177786|37767866|FG002|Overall Study|Lost to Follow-up|2|||
16824389|NCT02177786|37767867|FG003|Overall Study|Lost to Follow-up|2|||
16824390|NCT02177786|37767864|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16824391|NCT02177786|37767865|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16824392|NCT02177786|37767866|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16824393|NCT02177786|37767867|FG003|Overall Study|Non-Compliance with Study Drug|1|||
16824394|NCT02177786|37767864|FG000|Overall Study|Protocol Violation|0|||
16824395|NCT02177786|37767865|FG001|Overall Study|Protocol Violation|0|||
16824396|NCT02177786|37767866|FG002|Overall Study|Protocol Violation|2|||
16824397|NCT02177786|37767867|FG003|Overall Study|Protocol Violation|0|||
16824398|NCT02177786|37767864|FG000|Overall Study|Progressive Disease|0|||
16824399|NCT02177786|37767865|FG001|Overall Study|Progressive Disease|1|||
16824400|NCT02177786|37767866|FG002|Overall Study|Progressive Disease|0|||
16824401|NCT02177786|37767867|FG003|Overall Study|Progressive Disease|0|||
16824402|NCT02177786|37767864|FG000|Overall Study|Missing study completion status|0|||
16824403|NCT02177786|37767865|FG001|Overall Study|Missing study completion status|1|||
16824404|NCT02177786|37767866|FG002|Overall Study|Missing study completion status|0|||
16824405|NCT02177786|37767867|FG003|Overall Study|Missing study completion status|0|||
16824406|NCT01555762|37767877|FG000|Overall Study|No information on Bevacizumab intake|11|||
16824407|NCT01555762|37767877|FG000|Overall Study|Missing start date of infusion|8|||
16824408|NCT01555762|37767877|FG000|Overall Study|75 years old or more ticked No|1|||
16824409|NCT01555762|37767877|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
16912047|NCT01462266|38021155|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
16912048|NCT01462266|38021154|FG000|Overall Study|Physician Decision|2|||
16912049|NCT01462266|38021155|FG001|Overall Study|Physician Decision|5|||
16912050|NCT01462266|38021154|FG000|Overall Study|Protocol Violation|1|||
16912051|NCT01462266|38021155|FG001|Overall Study|Protocol Violation|3|||
16912052|NCT01462266|38021154|FG000|Overall Study|Withdrawal by Subject|7|||
16912053|NCT01462266|38021155|FG001|Overall Study|Withdrawal by Subject|2|||
16912054|NCT01462266|38021154|FG000|Overall Study|Screen failure|1|||
16912055|NCT01462266|38021155|FG001|Overall Study|Screen failure|1|||
16912056|NCT01508910|38021164|FG000|Treatment|Death|2|||
17016705|NCT00866294|38161285|FG001|Overall Study|Lack of Efficacy|1|||
17016706|NCT00866294|38161286|FG002|Overall Study|Lack of Efficacy|0|||
17016707|NCT00866294|38161284|FG000|Overall Study|Protocol Violation|2|||
17016708|NCT00866294|38161285|FG001|Overall Study|Protocol Violation|0|||
17016709|NCT00866294|38161286|FG002|Overall Study|Protocol Violation|0|||
17016710|NCT00866294|38161284|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
17016711|NCT00866294|38161285|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
17016712|NCT00866294|38161286|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
17016713|NCT00866294|38161284|FG000|Overall Study|Lost to Follow-up|1|||
17016714|NCT00866294|38161285|FG001|Overall Study|Lost to Follow-up|3|||
17016715|NCT00866294|38161286|FG002|Overall Study|Lost to Follow-up|0|||
17016716|NCT00866294|38161284|FG000|Overall Study|Physician Decision|6|||
16824410|NCT01555762|37767877|FG000|Overall Study|Death linked to progression of disease|165|||
16824411|NCT01555762|37767877|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
16824412|NCT01555762|37767877|FG000|Overall Study|Investigator's decision|10|||
16824413|NCT01555762|37767877|FG000|Overall Study|Participant not wishing to continue|5|||
16824414|NCT01555762|37767877|FG000|Overall Study|Missing data|1|||
16824415|NCT01555762|37767877|FG000|Overall Study|Death linked to an adverse event|14|||
16912057|NCT01508910|38021165|FG001|Treatment|Death|3|||
17016717|NCT00866294|38161285|FG001|Overall Study|Physician Decision|2|||
17016718|NCT00866294|38161286|FG002|Overall Study|Physician Decision|1|||
17016719|NCT00854360|38161306|FG000|Overall Study|Adverse Event|0|||
16912058|NCT01508910|38021166|FG002|Treatment|Death|2|||
17016720|NCT00854360|38161307|FG001|Overall Study|Adverse Event|1|||
16824416|NCT02153918|37767881|FG000|Overall Study|Refused further treatment|1|||
16824417|NCT02176928|37767887|FG000|Overall Study|Lost to Follow-up|2|||
16824418|NCT02176928|37767888|FG001|Overall Study|Lost to Follow-up|4|||
16824419|NCT02176226|37767894|FG000|Overall Study|Lost to Follow-up|3|||
16824420|NCT02176226|37767894|FG000|Overall Study|Withdrew prior to treatment|6|||
16824421|NCT01628510|37767900|FG000|Overall Study|Withdrawal by Subject|0|||
16824422|NCT01628510|37767901|FG001|Overall Study|Withdrawal by Subject|4|||
16824423|NCT01628510|37767900|FG000|Overall Study|Death|3|||
16824424|NCT01628510|37767901|FG001|Overall Study|Death|1|||
16824425|NCT01571362|37767909|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
16824426|NCT01571362|37767910|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
16824427|NCT01571362|37767911|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
16824428|NCT01571362|37767909|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
16824429|NCT01571362|37767910|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
16824430|NCT01571362|37767911|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
16824431|NCT01571362|37767909|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
16824432|NCT01571362|37767910|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
16824433|NCT01571362|37767911|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
16824434|NCT01571362|37767909|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
16824435|NCT01571362|37767910|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
16824436|NCT01571362|37767911|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
16824437|NCT01571362|37767909|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
16824438|NCT01571362|37767910|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
16824439|NCT01571362|37767911|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
16824440|NCT01571362|37767909|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
16824441|NCT01571362|37767910|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
16824442|NCT01571362|37767911|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
16824443|NCT01571362|37767909|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16824444|NCT01571362|37767910|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
16824445|NCT01571362|37767911|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
16824446|NCT01571362|37767909|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16824447|NCT01571362|37767910|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
16824448|NCT01571362|37767911|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
16824449|NCT01571362|37767909|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16824450|NCT01571362|37767910|FG001|Double-Blind Treatment Period|Adverse Event|9|||
16824451|NCT01571362|37767911|FG002|Double-Blind Treatment Period|Adverse Event|14|||
16824452|NCT01571362|37767909|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16824453|NCT01571362|37767910|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
16824454|NCT01571362|37767911|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
16824455|NCT01571362|37767909|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
16824456|NCT01571362|37767910|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
16824457|NCT01571362|37767911|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
16824458|NCT01571362|37767909|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
16824459|NCT01571362|37767910|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
16824460|NCT01571362|37767911|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
16824461|NCT01571284|37767919|FG000|Overall Study|Participant's decision|84|||
16824462|NCT01571284|37767919|FG000|Overall Study|Lost to Follow-up|3|||
16824463|NCT01571284|37767919|FG000|Overall Study|Enrolled but not treated|2|||
16824464|NCT01571284|37767919|FG000|Overall Study|Other than specified above|80|||
16824465|NCT02137772|37767925|FG000|Overall Study|Adverse Event|6|||
16824466|NCT02137772|37767926|FG001|Overall Study|Adverse Event|3|||
16824467|NCT02137772|37767925|FG000|Overall Study|Death|71|||
16824468|NCT02137772|37767926|FG001|Overall Study|Death|44|||
16824469|NCT02137772|37767925|FG000|Overall Study|Lost to Follow-up|8|||
16824470|NCT02137772|37767926|FG001|Overall Study|Lost to Follow-up|4|||
16824471|NCT02137772|37767925|FG000|Overall Study|Physician Decision|15|||
16824472|NCT02137772|37767926|FG001|Overall Study|Physician Decision|5|||
16824473|NCT02137772|37767925|FG000|Overall Study|Withdrawal by Subject|28|||
16824474|NCT02137772|37767926|FG001|Overall Study|Withdrawal by Subject|17|||
16824475|NCT02137772|37767925|FG000|Overall Study|Non-compliance with study drug|1|||
16824476|NCT02137772|37767926|FG001|Overall Study|Non-compliance with study drug|0|||
16824477|NCT02137772|37767925|FG000|Overall Study|Not treated|3|||
16824478|NCT02137772|37767926|FG001|Overall Study|Not treated|2|||
16824479|NCT01555138|37767934|FG000|Overall Study|Death|0|||
16824480|NCT01555138|37767935|FG001|Overall Study|Death|1|||
16824481|NCT01555138|37767934|FG000|Overall Study|Lost to Follow-up|1|||
16824482|NCT01555138|37767935|FG001|Overall Study|Lost to Follow-up|0|||
16824483|NCT01555138|37767934|FG000|Overall Study|Abnormal Lab reults|1|||
16912059|NCT01508910|38021167|FG003|Treatment|Death|0|||
16824484|NCT01555138|37767935|FG001|Overall Study|Abnormal Lab reults|3|||
16824485|NCT01555138|37767934|FG000|Overall Study|Lack of Efficacy|2|||
16912060|NCT01508910|38021164|FG000|Treatment|Lost to Follow-up|0|||
16824486|NCT01555138|37767935|FG001|Overall Study|Lack of Efficacy|2|||
16824487|NCT01555138|37767934|FG000|Overall Study|Protocol Violation|5|||
16824488|NCT01555138|37767935|FG001|Overall Study|Protocol Violation|3|||
16824489|NCT01555138|37767934|FG000|Overall Study|Administrative problems|8|||
16824490|NCT01555138|37767935|FG001|Overall Study|Administrative problems|0|||
16824491|NCT01555138|37767934|FG000|Overall Study|Withdrawal by Subject|16|||
16824492|NCT01555138|37767935|FG001|Overall Study|Withdrawal by Subject|15|||
16824493|NCT01555138|37767934|FG000|Overall Study|Adverse Event|14|||
16824494|NCT01555138|37767935|FG001|Overall Study|Adverse Event|14|||
16824495|NCT02137226|37767943|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
16824496|NCT02137226|37767944|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
16824497|NCT02137226|37767945|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
16824498|NCT02137226|37767946|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
16824499|NCT02137226|37767947|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
16824500|NCT02137226|37767943|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
16824501|NCT02137226|37767944|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
16824502|NCT02137226|37767945|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
16824503|NCT02137226|37767946|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
16824504|NCT02137226|37767947|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
16824505|NCT02137226|37767943|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
16824506|NCT02137226|37767944|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
16824507|NCT02137226|37767945|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
16824508|NCT02137226|37767946|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
16824509|NCT02137226|37767947|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
16824510|NCT02137226|37767943|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
16824511|NCT02137226|37767944|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
16824512|NCT02137226|37767945|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
16824513|NCT02137226|37767946|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
16824514|NCT02137226|37767947|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
16824515|NCT02137226|37767943|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
16824516|NCT02137226|37767944|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
16824517|NCT02137226|37767945|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
16824518|NCT02137226|37767946|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
16824519|NCT02137226|37767947|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
16824520|NCT02137226|37767943|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
16824521|NCT02137226|37767944|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
16824522|NCT02137226|37767945|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
16824523|NCT02137226|37767946|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
16824524|NCT02137226|37767947|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
16824525|NCT02137226|37767943|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
16824526|NCT02137226|37767944|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
16824527|NCT02137226|37767945|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
16824528|NCT02137226|37767946|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
16824529|NCT02137226|37767947|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
16824530|NCT02137226|37767943|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
16824531|NCT02137226|37767944|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
16824532|NCT02137226|37767945|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
16824533|NCT02137226|37767946|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
16824534|NCT02137226|37767947|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
16824535|NCT02137226|37767943|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
16824536|NCT02137226|37767944|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
16824537|NCT02137226|37767945|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
16824538|NCT02137226|37767946|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
16824539|NCT02137226|37767947|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
16824540|NCT02137226|37767943|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
16824541|NCT02137226|37767944|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
16824542|NCT02137226|37767945|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
16824543|NCT02137226|37767946|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
16824544|NCT02137226|37767947|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
16824545|NCT02137226|37767943|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
16824546|NCT02137226|37767944|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
16824547|NCT02137226|37767945|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
16824548|NCT02137226|37767946|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
16824549|NCT02137226|37767947|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
16824550|NCT02137226|37767943|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
16824551|NCT02137226|37767944|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
16824552|NCT02137226|37767945|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
16824553|NCT02137226|37767946|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
16824554|NCT02137226|37767947|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
16824555|NCT01530334|37767955|FG000|Overall Study|Adverse Event|3|||
16824556|NCT01530334|37767955|FG000|Overall Study|unknown reason|1|||
16824557|NCT01530334|37767955|FG000|Overall Study|Progressive disease|47|||
16824558|NCT01570192|37767961|FG000|Overall Study|no qualifying organism|6|||
16824559|NCT01570192|37767962|FG001|Overall Study|no qualifying organism|12|||
16824560|NCT01570192|37767961|FG000|Overall Study|changed to palliative care|1|||
16824561|NCT01570192|37767962|FG001|Overall Study|changed to palliative care|0|||
16824562|NCT01570192|37767961|FG000|Overall Study|Physician Decision|0|||
16824563|NCT01570192|37767962|FG001|Overall Study|Physician Decision|1|||
16824564|NCT02136914|37767975|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
16824565|NCT02136914|37767976|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
16824566|NCT02136914|37767975|FG000|Overall Study|Withdrawal by Subject|3|||
16824567|NCT02136914|37767976|FG001|Overall Study|Withdrawal by Subject|10|||
16824568|NCT02136914|37767975|FG000|Overall Study|Subject Unwilling to Proceed|7|||
16824569|NCT02136914|37767976|FG001|Overall Study|Subject Unwilling to Proceed|2|||
16824570|NCT02136914|37767975|FG000|Overall Study|Lost to Follow-up|1|||
16824571|NCT02136914|37767976|FG001|Overall Study|Lost to Follow-up|1|||
16824572|NCT02136914|37767975|FG000|Overall Study|Did Not Receive Study Drug|2|||
16824573|NCT02136914|37767976|FG001|Overall Study|Did Not Receive Study Drug|0|||
16824574|NCT02136914|37767975|FG000|Overall Study|Lack of Efficacy|1|||
16824575|NCT02136914|37767976|FG001|Overall Study|Lack of Efficacy|0|||
16824576|NCT02136914|37767975|FG000|Overall Study|Death|0|||
16824577|NCT02136914|37767976|FG001|Overall Study|Death|1|||
16824578|NCT01530256|37767982|FG000|Overall Study|Death|2|||
16824579|NCT01554904|37767986|FG000|Overall Study|Withdrawal by Subject|3|||
16824580|NCT01554904|37767986|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
16824581|NCT01529632|37767992|FG000|Overall Study|Administrative problem|2|||
16824582|NCT01529632|37767993|FG001|Overall Study|Administrative problem|1|||
16824583|NCT01529632|37767992|FG000|Overall Study|Protocol Violation|0|||
16824584|NCT01529632|37767993|FG001|Overall Study|Protocol Violation|1|||
16824585|NCT01529632|37767992|FG000|Overall Study|Adverse Event|1|||
16824586|NCT01529632|37767993|FG001|Overall Study|Adverse Event|1|||
16824587|NCT01554514|37767999|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
16824588|NCT01554514|37767999|FG000|Overall Study|Physician Decision|1|||
16824589|NCT01553188|37768007|FG000|Overall Study|Patient choice|1|||
16824590|NCT01553188|37768008|FG001|Overall Study|Patient choice|0|||
16824591|NCT01553188|37768009|FG002|Overall Study|Patient choice|0|||
16824592|NCT01553188|37768010|FG003|Overall Study|Patient choice|0|||
16824593|NCT01553188|37768007|FG000|Overall Study|Intercurrent illness and adverse event|0|||
16824594|NCT01553188|37768008|FG001|Overall Study|Intercurrent illness and adverse event|1|||
16824595|NCT01553188|37768009|FG002|Overall Study|Intercurrent illness and adverse event|2|||
16824596|NCT01553188|37768010|FG003|Overall Study|Intercurrent illness and adverse event|0|||
16824597|NCT02175758|37768029|FG000|Treatment Phase|Lost to Follow-up|0|||
16824598|NCT02175758|37768030|FG001|Treatment Phase|Lost to Follow-up|1|||
16824599|NCT02175758|37768031|FG002|Treatment Phase|Lost to Follow-up|0|||
16824600|NCT02175758|37768032|FG003|Treatment Phase|Lost to Follow-up|0|||
16824601|NCT02175758|37768033|FG004|Treatment Phase|Lost to Follow-up|0|||
16824602|NCT02175758|37768034|FG005|Treatment Phase|Lost to Follow-up|0|||
16824603|NCT02175758|37768029|FG000|Treatment Phase|Adverse Event|0|||
16824604|NCT02175758|37768030|FG001|Treatment Phase|Adverse Event|0|||
16824605|NCT02175758|37768031|FG002|Treatment Phase|Adverse Event|0|||
16824606|NCT02175758|37768032|FG003|Treatment Phase|Adverse Event|0|||
16824607|NCT02175758|37768033|FG004|Treatment Phase|Adverse Event|1|||
16824608|NCT02175758|37768034|FG005|Treatment Phase|Adverse Event|0|||
16824609|NCT01529008|37768076|FG000|Bone Marrow Harvesting|Physician Decision|1|||
16824610|NCT01529008|37768077|FG001|Bone Marrow Harvesting|Physician Decision|1|||
16824611|NCT01529008|37768076|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
16824612|NCT01529008|37768077|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
16824613|NCT01529008|37768076|FG000|Treatment|Adverse Event|6|||
16824614|NCT01529008|37768077|FG001|Treatment|Adverse Event|0|||
16824615|NCT01529008|37768076|FG000|Treatment|Other|3|||
16824616|NCT01529008|37768077|FG001|Treatment|Other|1|||
16824617|NCT01529008|37768076|FG000|Efficacy Analysis|Protocol Violation|2|||
16824618|NCT01529008|37768077|FG001|Efficacy Analysis|Protocol Violation|0|||
16912061|NCT01508910|38021165|FG001|Treatment|Lost to Follow-up|0|||
16824619|NCT01529008|37768076|FG000|Efficacy Analysis|Physician Decision|0|||
16824620|NCT01529008|37768077|FG001|Efficacy Analysis|Physician Decision|1|||
16824621|NCT01529008|37768076|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
16824622|NCT01529008|37768077|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
16824623|NCT01599104|37768086|FG000|Overall Study|Withdrawal by Subject|1|||
16824624|NCT01599104|37768087|FG001|Overall Study|Withdrawal by Subject|1|||
16824625|NCT01599104|37768088|FG002|Overall Study|Withdrawal by Subject|2|||
16824626|NCT01599104|37768086|FG000|Overall Study|Technical Problems|1|||
16824627|NCT01599104|37768087|FG001|Overall Study|Technical Problems|0|||
16824628|NCT01599104|37768088|FG002|Overall Study|Technical Problems|0|||
16824629|NCT01599104|37768086|FG000|Overall Study|Physician Decision|3|||
16824630|NCT01599104|37768087|FG001|Overall Study|Physician Decision|2|||
16824631|NCT01599104|37768088|FG002|Overall Study|Physician Decision|2|||
16912062|NCT01508910|38021166|FG002|Treatment|Lost to Follow-up|2|||
16824632|NCT01599104|37768086|FG000|Overall Study|Non-compliance with study treatment|0|||
16824633|NCT01599104|37768087|FG001|Overall Study|Non-compliance with study treatment|1|||
16824634|NCT01599104|37768088|FG002|Overall Study|Non-compliance with study treatment|0|||
16824635|NCT01599104|37768086|FG000|Overall Study|Lack of Efficacy|4|||
16824636|NCT01599104|37768087|FG001|Overall Study|Lack of Efficacy|4|||
16824637|NCT01599104|37768088|FG002|Overall Study|Lack of Efficacy|10|||
16824638|NCT01599104|37768086|FG000|Overall Study|Adverse Event|7|||
16824639|NCT01599104|37768087|FG001|Overall Study|Adverse Event|6|||
16824640|NCT01599104|37768088|FG002|Overall Study|Adverse Event|12|||
16824641|NCT01569568|37768098|FG000|Overall Study|Physician Decision|0|||
16824642|NCT01569568|37768099|FG001|Overall Study|Physician Decision|2|||
16824643|NCT02136680|37768107|FG000|Overall Study|No Longer Interested|1|||
16824644|NCT02136680|37768108|FG001|Overall Study|No Longer Interested|1|||
16824645|NCT02136680|37768107|FG000|Overall Study|No longer receiving care at clinic|3|||
16824646|NCT02136680|37768108|FG001|Overall Study|No longer receiving care at clinic|5|||
16824647|NCT02136680|37768107|FG000|Overall Study|Moved away|5|||
16824648|NCT02136680|37768108|FG001|Overall Study|Moved away|4|||
16824649|NCT02136680|37768107|FG000|Overall Study|Unable to schedule|17|||
16824650|NCT02136680|37768108|FG001|Overall Study|Unable to schedule|16|||
16824651|NCT02136680|37768107|FG000|Overall Study|Study ended before interview due|6|||
16824652|NCT02136680|37768108|FG001|Overall Study|Study ended before interview due|3|||
16824653|NCT01552954|37768116|FG000|Overall Study|Adverse Event|1|||
16824654|NCT01552954|37768117|FG001|Overall Study|Adverse Event|2|||
16824655|NCT01552954|37768116|FG000|Overall Study|Lost to Follow-up|1|||
16824656|NCT01552954|37768117|FG001|Overall Study|Lost to Follow-up|1|||
16824657|NCT01552954|37768116|FG000|Overall Study|Withdrawal by Subject|1|||
16824658|NCT01552954|37768117|FG001|Overall Study|Withdrawal by Subject|1|||
16824659|NCT01552954|37768116|FG000|Overall Study|Protocol Violation|1|||
16824660|NCT01552954|37768117|FG001|Overall Study|Protocol Violation|2|||
16824661|NCT01552954|37768116|FG000|Overall Study|diagnosed DM|1|||
16824662|NCT01552954|37768117|FG001|Overall Study|diagnosed DM|0|||
16824663|NCT02175368|37768123|FG000|Overall Study|Lost to Follow-up|1|||
16824664|NCT01518244|37768127|FG000|Overall Study|Adverse Event|3|||
16824665|NCT01552408|37768133|FG000|Overall Study|Lost to Follow-up|2|||
16824666|NCT01552408|37768134|FG001|Overall Study|Lost to Follow-up|0|||
16824667|NCT01552408|37768133|FG000|Overall Study|Relocation|0|||
16824668|NCT01552408|37768134|FG001|Overall Study|Relocation|1|||
16824669|NCT01552408|37768133|FG000|Overall Study|Withdrawal by Subject|2|||
16824670|NCT01552408|37768134|FG001|Overall Study|Withdrawal by Subject|1|||
16824671|NCT01528696|37768143|FG000|Overall Study|See detailed description|18|||
16824672|NCT01528696|37768144|FG001|Overall Study|See detailed description|19|||
16824673|NCT02174276|37768154|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
16824674|NCT02174276|37768155|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
16824675|NCT02174276|37768156|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
16824676|NCT02174276|37768157|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
16824677|NCT02174276|37768154|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
16824678|NCT02174276|37768155|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
16824679|NCT02174276|37768156|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
16824680|NCT02174276|37768157|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
16824681|NCT02174276|37768154|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
16824682|NCT02174276|37768155|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
16824683|NCT02174276|37768156|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
16824684|NCT02174276|37768157|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
16824685|NCT02174276|37768154|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
16824686|NCT02174276|37768155|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
16824687|NCT02174276|37768156|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
16824688|NCT02174276|37768157|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
16824689|NCT02174276|37768154|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
16824690|NCT02174276|37768155|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
16824691|NCT02174276|37768156|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
16824692|NCT02174276|37768157|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
16824693|NCT02174276|37768154|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
16824694|NCT02174276|37768155|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
16824695|NCT02174276|37768156|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
16824696|NCT02174276|37768157|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
16824697|NCT01528072|37768167|FG000|Overall Study|Withdrawal by Subject|5|||
16824698|NCT01528072|37768167|FG000|Overall Study|Physician Decision|1|||
16824699|NCT01528072|37768167|FG000|Overall Study|Determined not eligible by AEAC|1|||
16824700|NCT01528072|37768167|FG000|Overall Study|Missed Visit|2|||
16824701|NCT01528072|37768167|FG000|Overall Study|Lost to Follow-up|5|||
16824702|NCT01528072|37768167|FG000|Overall Study|Explanted|2|||
16824703|NCT01528072|37768167|FG000|Overall Study|Site Closure|4|||
16824704|NCT01528072|37768167|FG000|Overall Study|Death|2|||
16824705|NCT01528072|37768167|FG000|Overall Study|Early Termination of Study|52|||
16824706|NCT01527682|37768171|FG000|Overall Study|Protocol Violation|8|||
16824707|NCT01527370|37768175|FG000|Overall Study|Withdrawal by Subject|4|||
16824708|NCT01527370|37768175|FG000|Overall Study|Physician Decision|1|||
16824709|NCT01527370|37768175|FG000|Overall Study|Death|1|||
16824710|NCT01527292|37768181|FG000|Overall Study|Physician Decision|0|||
16824711|NCT01527292|37768182|FG001|Overall Study|Physician Decision|3|||
16824712|NCT01516216|37768190|FG000|Overall Study|Adverse Event|2|||
16824713|NCT01516216|37768191|FG001|Overall Study|Adverse Event|4|||
16824714|NCT01516216|37768190|FG000|Overall Study|Disease Progression|38|||
16824715|NCT01516216|37768191|FG001|Overall Study|Disease Progression|34|||
16824716|NCT01516216|37768190|FG000|Overall Study|Withdrawal by Subject|9|||
16824717|NCT01516216|37768191|FG001|Overall Study|Withdrawal by Subject|11|||
16824718|NCT01516216|37768190|FG000|Overall Study|Potentially Curative Resection|6|||
16824719|NCT01516216|37768191|FG001|Overall Study|Potentially Curative Resection|12|||
16824720|NCT01516216|37768190|FG000|Overall Study|Nonadherence|2|||
16824721|NCT01516216|37768191|FG001|Overall Study|Nonadherence|3|||
16824722|NCT01516216|37768190|FG000|Overall Study|Physician Decision|6|||
16824723|NCT01516216|37768191|FG001|Overall Study|Physician Decision|3|||
16824724|NCT01516216|37768190|FG000|Overall Study|Prolonged Treatment Delay|5|||
16824725|NCT01516216|37768191|FG001|Overall Study|Prolonged Treatment Delay|1|||
16824726|NCT01516216|37768190|FG000|Overall Study|Intercurrent Illness|1|||
16824727|NCT01516216|37768191|FG001|Overall Study|Intercurrent Illness|0|||
16824728|NCT01516216|37768190|FG000|Overall Study|Death|1|||
16824729|NCT01516216|37768191|FG001|Overall Study|Death|1|||
16824730|NCT01950819|37768201|FG000|Overall Study|Graft Loss|35|||
16824731|NCT01950819|37768202|FG001|Overall Study|Graft Loss|30|||
16824732|NCT01950819|37768201|FG000|Overall Study|Death|29|||
16824733|NCT01950819|37768202|FG001|Overall Study|Death|34|||
16824734|NCT01950819|37768201|FG000|Overall Study|Subject / Gardian decision|54|||
16824735|NCT01950819|37768202|FG001|Overall Study|Subject / Gardian decision|51|||
16824736|NCT01950819|37768201|FG000|Overall Study|technical problems|2|||
16824737|NCT01950819|37768202|FG001|Overall Study|technical problems|0|||
16824738|NCT01950819|37768201|FG000|Overall Study|Pregnancy|0|||
16824739|NCT01950819|37768202|FG001|Overall Study|Pregnancy|2|||
16824740|NCT01950819|37768201|FG000|Overall Study|Lost to Follow-up|9|||
16824741|NCT01950819|37768202|FG001|Overall Study|Lost to Follow-up|17|||
16824742|NCT01514422|37768208|FG000|Overall Study|Lost to Follow-up|1|||
16824743|NCT01513330|37768212|FG000|SenSura Mio First,|Adverse Event|2|||
16824744|NCT01513330|37768213|FG001|SenSura Mio First,|Adverse Event|0|||
16824745|NCT01513330|37768212|FG000|SenSura Mio First,|Lack of Efficacy|0|||
16824746|NCT01513330|37768213|FG001|SenSura Mio First,|Lack of Efficacy|1|||
16824747|NCT01513330|37768212|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
16824748|NCT01513330|37768213|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
16824749|NCT01513330|37768212|FG000|SenSura Mio First,|Other|1|||
16824750|NCT01513330|37768213|FG001|SenSura Mio First,|Other|0|||
16824751|NCT01513330|37768212|FG000|Standard Care First,|Lack of Efficacy|2|||
16824752|NCT01513330|37768213|FG001|Standard Care First,|Lack of Efficacy|2|||
16824753|NCT01513330|37768212|FG000|Standard Care First,|Withdrawal by Subject|1|||
16824754|NCT01513330|37768213|FG001|Standard Care First,|Withdrawal by Subject|2|||
16824755|NCT01513330|37768212|FG000|Standard Care First,|Other|1|||
16824756|NCT01513330|37768213|FG001|Standard Care First,|Other|0|||
16824757|NCT01524796|37768219|FG000|Overall Study|Adverse Event|13|||
16824758|NCT01524796|37768219|FG000|Overall Study|Lack of Efficacy|3|||
16824759|NCT01524796|37768219|FG000|Overall Study|Lost to Follow-up|1|||
16824760|NCT01524796|37768219|FG000|Overall Study|The price|1|||
16824761|NCT01524796|37768219|FG000|Overall Study|Withdrawal by Subject|4|||
16824762|NCT01524796|37768219|FG000|Overall Study|Move|1|||
16824763|NCT01524796|37768219|FG000|Overall Study|Deterioration of pains|1|||
16824764|NCT01524796|37768219|FG000|Overall Study|Gall stone surgery|1|||
16824765|NCT01524796|37768219|FG000|Overall Study|Nervous about confidentiality|1|||
16824766|NCT01524796|37768219|FG000|Overall Study|Switch to carbamazapine|1|||
16824767|NCT01524796|37768219|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
16824768|NCT01547728|37768223|FG000|Overall Study|Change in procedure and equipment|1|||
16824769|NCT01547728|37768223|FG000|Overall Study|Drug not ready for subject|1|||
16824770|NCT01547728|37768223|FG000|Overall Study|Screen failure|39|||
16824771|NCT01523392|37768229|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16824772|NCT01523392|37768230|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16824773|NCT01523392|37768229|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
16824774|NCT01523392|37768230|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
16824775|NCT01523392|37768229|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
16824776|NCT01523392|37768230|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
16824777|NCT01512160|37768242|FG000|Overall Study|Lost to Follow-up|1|||
16824778|NCT01512160|37768243|FG001|Overall Study|Lost to Follow-up|0|||
16824779|NCT01512160|37768244|FG002|Overall Study|Lost to Follow-up|0|||
16824780|NCT01512160|37768245|FG003|Overall Study|Lost to Follow-up|0|||
16824781|NCT01512160|37768242|FG000|Overall Study|Withdrawal by Subject|1|||
16824782|NCT01512160|37768243|FG001|Overall Study|Withdrawal by Subject|0|||
16824783|NCT01512160|37768244|FG002|Overall Study|Withdrawal by Subject|0|||
16824784|NCT01512160|37768245|FG003|Overall Study|Withdrawal by Subject|1|||
16824785|NCT01546168|37768258|FG000|Overall Study|Lost to Follow-up|1|||
16824786|NCT01546168|37768259|FG001|Overall Study|Lost to Follow-up|0|||
16824787|NCT01546168|37768258|FG000|Overall Study|Withdrawal by Subject|1|||
16824788|NCT01546168|37768259|FG001|Overall Study|Withdrawal by Subject|0|||
16824789|NCT01546168|37768258|FG000|Overall Study|ineligible after signing consent|2|||
16824790|NCT01546168|37768259|FG001|Overall Study|ineligible after signing consent|0|||
16824791|NCT01901289|37768265|FG000|Overall Study|Death|32|||
16824792|NCT01901289|37768265|FG000|Overall Study|Lost to Follow-up|16|||
16824793|NCT01901289|37768265|FG000|Overall Study|Withdrawal by Subject|35|||
16824794|NCT01901289|37768265|FG000|Overall Study|Other type of endpoint met|2|||
16824795|NCT01950741|37768269|FG000|Overall Study|Lost to Follow-up|1|||
16824796|NCT01950741|37768269|FG000|Overall Study|Death|1|||
16824797|NCT01950741|37768269|FG000|Overall Study|Withdrawal by Subject|1|||
16824798|NCT01950273|37768275|FG000|Overall Study|Protocol Violation|1|||
16824799|NCT01950273|37768276|FG001|Overall Study|Protocol Violation|0|||
16824800|NCT01950273|37768275|FG000|Overall Study|Withdrawal by Subject|2|||
16824801|NCT01950273|37768276|FG001|Overall Study|Withdrawal by Subject|0|||
16824802|NCT01950273|37768275|FG000|Overall Study|Other not defined above|1|||
16824803|NCT01950273|37768276|FG001|Overall Study|Other not defined above|0|||
16824804|NCT01919307|37768282|FG000|Overall Study|Withdrawal by Subject|9|||
16824805|NCT01919229|37768289|FG000|Overall Study|Subject/guardian decision|0|||
16824806|NCT01919229|37768290|FG001|Overall Study|Subject/guardian decision|0|||
16824807|NCT01919229|37768291|FG002|Overall Study|Subject/guardian decision|1|||
16824808|NCT01901055|37768301|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
16824809|NCT01901055|37768302|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
16824810|NCT01901055|37768301|FG000|Randomization But Not Titrated|Physician Decision|0|||
16824811|NCT01901055|37768302|FG001|Randomization But Not Titrated|Physician Decision|1|||
16824812|NCT01901055|37768301|FG000|Started Protocol to Week 6|Physician Decision|2|||
16824813|NCT01901055|37768302|FG001|Started Protocol to Week 6|Physician Decision|1|||
16824814|NCT01901055|37768301|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
16824815|NCT01901055|37768302|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
16824816|NCT01901055|37768301|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
16824817|NCT01901055|37768302|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
16824818|NCT01901055|37768301|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
16824819|NCT01901055|37768302|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
16824820|NCT01901055|37768301|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
16824821|NCT01901055|37768302|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
16824822|NCT01901055|37768301|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
16824823|NCT01901055|37768302|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
16824824|NCT01901055|37768301|FG000|Week 24|Withdrawal by Subject|13|||
16824825|NCT01901055|37768302|FG001|Week 24|Withdrawal by Subject|19|||
16824826|NCT01901055|37768301|FG000|Week 24|Physician Decision|1|||
16824827|NCT01901055|37768302|FG001|Week 24|Physician Decision|0|||
16824828|NCT01901055|37768301|FG000|Week 36|Withdrawal by Subject|0|||
16824829|NCT01901055|37768302|FG001|Week 36|Withdrawal by Subject|5|||
16824830|NCT01511536|37768314|FG000|Phase 1|Other|0|||
16824831|NCT01511536|37768315|FG001|Phase 1|Other|1|||
16824832|NCT01511536|37768316|FG002|Phase 1|Other|0|||
16824833|NCT01511536|37768314|FG000|Phase 2|Other|0|||
16824834|NCT01511536|37768315|FG001|Phase 2|Other|0|||
16824835|NCT01511536|37768316|FG002|Phase 2|Other|9|||
16824836|NCT01890759|37768326|FG000|Overall Study|Protocol Violation|0|||
16824837|NCT01890759|37768327|FG001|Overall Study|Protocol Violation|2|||
16824838|NCT01890759|37768326|FG000|Overall Study|Lost to Follow-up|0|||
16824839|NCT01890759|37768327|FG001|Overall Study|Lost to Follow-up|2|||
16824840|NCT01890759|37768326|FG000|Overall Study|Withdrawal by Subject|2|||
16824841|NCT01890759|37768327|FG001|Overall Study|Withdrawal by Subject|8|||
16824842|NCT01900899|37768335|FG000|Overall Study|Withdrawal by Subject|7|||
16824843|NCT01900899|37768336|FG001|Overall Study|Withdrawal by Subject|1|||
16824844|NCT01900899|37768335|FG000|Overall Study|Migrated from study area|2|||
16824845|NCT01900899|37768336|FG001|Overall Study|Migrated from study area|0|||
16824846|NCT01510912|37768342|FG000|Overall Study|Adverse Event|99|||
16824847|NCT01510912|37768342|FG000|Overall Study|Lack of Efficacy|12|||
16824848|NCT01510912|37768342|FG000|Overall Study|Non-compliance with trial drug|23|||
16824849|NCT01510912|37768342|FG000|Overall Study|Withdrawal by Subject|49|||
16824850|NCT01510912|37768342|FG000|Overall Study|Physician Decision|1|||
16824851|NCT01510912|37768342|FG000|Overall Study|Protocol Violation|27|||
16824852|NCT01510912|37768342|FG000|Overall Study|Lost to Follow-up|26|||
16824853|NCT01510912|37768342|FG000|Overall Study|Other, including joint replacement|5|||
16824854|NCT01510756|37768346|FG000|Overall Study|Death|1|||
16824855|NCT01510756|37768346|FG000|Overall Study|Lack of Efficacy|2|||
16824856|NCT01510756|37768346|FG000|Overall Study|Physician Decision|1|||
16824857|NCT01522456|37768350|FG000|Overall Study|Adverse Event|2|||
16824858|NCT01522456|37768350|FG000|Overall Study|Lost to Follow-up|2|||
16824859|NCT01522456|37768350|FG000|Overall Study|Withdrawal by Subject|2|||
16824860|NCT01522456|37768350|FG000|Overall Study|Pregnancy|1|||
16824861|NCT01522456|37768350|FG000|Overall Study|Tolerability Assessment|1|||
16824862|NCT01545934|37768363|FG000|Overall Study|Withdrawal by Subject|4|||
16824863|NCT01545934|37768364|FG001|Overall Study|Withdrawal by Subject|3|||
16824864|NCT01545934|37768363|FG000|Overall Study|Lost to Follow-up|1|||
16824865|NCT01545934|37768364|FG001|Overall Study|Lost to Follow-up|0|||
16824866|NCT01521364|37768371|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
16824867|NCT01521364|37768371|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
16824868|NCT01545388|37768385|FG000|Overall Study|Adverse Event|2|||
16824869|NCT01545388|37768386|FG001|Overall Study|Adverse Event|4|||
16824870|NCT01545388|37768387|FG002|Overall Study|Adverse Event|1|||
16824871|NCT01545388|37768385|FG000|Overall Study|Lack of Efficacy|3|||
16824872|NCT01545388|37768386|FG001|Overall Study|Lack of Efficacy|2|||
16824873|NCT01545388|37768387|FG002|Overall Study|Lack of Efficacy|5|||
16824874|NCT01545388|37768385|FG000|Overall Study|Participant moved or relocated|1|||
16824875|NCT01545388|37768386|FG001|Overall Study|Participant moved or relocated|0|||
16824876|NCT01545388|37768387|FG002|Overall Study|Participant moved or relocated|0|||
16824877|NCT01545388|37768385|FG000|Overall Study|Withdrawal by Subject|1|||
16824878|NCT01545388|37768386|FG001|Overall Study|Withdrawal by Subject|4|||
16824879|NCT01545388|37768387|FG002|Overall Study|Withdrawal by Subject|2|||
16824880|NCT01545388|37768385|FG000|Overall Study|Other|1|||
16824881|NCT01545388|37768386|FG001|Overall Study|Other|1|||
16824882|NCT01545388|37768387|FG002|Overall Study|Other|0|||
16824883|NCT01545076|37768395|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
16824884|NCT01545076|37768396|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
16824885|NCT01545076|37768397|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
16824886|NCT01545076|37768398|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
16824887|NCT01545076|37768399|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
16824888|NCT01545076|37768395|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
16824889|NCT01545076|37768396|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
16824890|NCT01545076|37768397|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
16824891|NCT01545076|37768398|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
16824892|NCT01545076|37768399|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
16824893|NCT01545076|37768395|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
16824894|NCT01545076|37768396|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
16824895|NCT01545076|37768397|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
16824896|NCT01545076|37768398|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
16824897|NCT01545076|37768399|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
16824898|NCT01545076|37768395|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
16824899|NCT01545076|37768396|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
16824900|NCT01545076|37768397|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
16824901|NCT01545076|37768398|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
16824902|NCT01545076|37768399|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
16824903|NCT01545076|37768395|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
16824904|NCT01545076|37768396|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
16824905|NCT01545076|37768397|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
16824906|NCT01545076|37768398|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
16824907|NCT01545076|37768399|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
16824908|NCT01545076|37768395|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
16824909|NCT01545076|37768396|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
16824910|NCT01545076|37768397|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
16824911|NCT01545076|37768398|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
16824912|NCT01545076|37768399|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
16824913|NCT01545076|37768395|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
16824914|NCT01545076|37768396|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
16824915|NCT01545076|37768397|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
16824916|NCT01545076|37768398|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
16824917|NCT01545076|37768399|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
16824918|NCT01545076|37768395|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
16824919|NCT01545076|37768396|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
16824920|NCT01545076|37768397|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
16824921|NCT01545076|37768398|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
16824922|NCT01545076|37768399|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
16824923|NCT01545076|37768395|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
16824924|NCT01545076|37768396|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
16824925|NCT01545076|37768397|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
16824926|NCT01545076|37768398|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
16824927|NCT01545076|37768399|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
16824928|NCT01544920|37768414|FG000|Overall Study|Adverse Event|0|||
16824929|NCT01544920|37768415|FG001|Overall Study|Adverse Event|3|||
16824930|NCT01544920|37768414|FG000|Overall Study|Death|0|||
16824931|NCT01544920|37768415|FG001|Overall Study|Death|1|||
16824932|NCT01544920|37768414|FG000|Overall Study|Lost to Follow-up|11|||
16824933|NCT01544920|37768415|FG001|Overall Study|Lost to Follow-up|12|||
16824934|NCT01544920|37768414|FG000|Overall Study|Protocol Violation|0|||
16824935|NCT01544920|37768415|FG001|Overall Study|Protocol Violation|2|||
16824936|NCT01544920|37768414|FG000|Overall Study|Physician Decision|4|||
16824937|NCT01544920|37768415|FG001|Overall Study|Physician Decision|1|||
16824938|NCT01544920|37768414|FG000|Overall Study|Withdrawal by Subject|4|||
16824939|NCT01544920|37768415|FG001|Overall Study|Withdrawal by Subject|4|||
16824940|NCT01509664|37768425|FG000|Overall Study|Lost to Follow-up|15|||
16824941|NCT01509664|37768426|FG001|Overall Study|Lost to Follow-up|21|||
16824942|NCT01543828|37768434|FG000|Treatment 2|Lost to Follow-up|1|||
16824943|NCT01543828|37768435|FG001|Treatment 2|Lost to Follow-up|0|||
16824944|NCT01520506|37768443|FG000|Overall Study|Missed Visit|4|||
16824945|NCT01520506|37768443|FG000|Overall Study|Lost to Follow-up|1|||
16824946|NCT01520506|37768443|FG000|Overall Study|Withdrawal by Subject|1|||
16824947|NCT01519960|37768450|FG000|Overall Study|Withdrawal from the study|26|||
16824948|NCT01519960|37768451|FG001|Overall Study|Withdrawal from the study|22|||
16824949|NCT01519960|37768452|FG002|Overall Study|Withdrawal from the study|5|||
16824950|NCT01543204|37768468|FG000|Overall Study|Non-compliance|1|||
16824951|NCT01543204|37768468|FG000|Overall Study|Adverse Event|1|||
16824952|NCT01543204|37768468|FG000|Overall Study|Withdrawal by Subject|4|||
16824953|NCT01543204|37768468|FG000|Overall Study|Requirement for Alternative Therapy|1|||
16824954|NCT01543204|37768468|FG000|Overall Study|Lost to Follow-up|1|||
16824955|NCT01488994|37768478|FG000|Overall Study|Withdrawal by Subject|0|||
16824956|NCT01488994|37768479|FG001|Overall Study|Withdrawal by Subject|1|||
16824957|NCT01508650|37768492|FG000|Overall Study|Lost to Follow-up|0|||
16824958|NCT01508650|37768493|FG001|Overall Study|Lost to Follow-up|3|||
16824959|NCT01488448|37768501|FG000|Overall Study|Withdrawal by Subject|3|||
16824960|NCT01488448|37768502|FG001|Overall Study|Withdrawal by Subject|1|||
16824961|NCT01488448|37768501|FG000|Overall Study|Adverse Event|9|||
16824962|NCT01488448|37768502|FG001|Overall Study|Adverse Event|4|||
16824963|NCT01488448|37768501|FG000|Overall Study|Physician Decision|4|||
16824964|NCT01488448|37768502|FG001|Overall Study|Physician Decision|9|||
16824965|NCT01488448|37768501|FG000|Overall Study|Protocol Violation|4|||
16824966|NCT01488448|37768502|FG001|Overall Study|Protocol Violation|3|||
16824967|NCT01518946|37768512|FG000|Open-label Phase|Other|4|||
16824968|NCT01518946|37768513|FG001|Open-label Phase|Other|0|||
16824969|NCT01518946|37768514|FG002|Open-label Phase|Other|0|||
16824970|NCT01518946|37768512|FG000|Randomized Phase (First Intervention)|Other|0|||
16824971|NCT01518946|37768513|FG001|Randomized Phase (First Intervention)|Other|1|||
16824972|NCT01518946|37768514|FG002|Randomized Phase (First Intervention)|Other|0|||
16824973|NCT01488370|37768524|FG000|Overall Study|Protocol Violation|0|||
16824974|NCT01488370|37768525|FG001|Overall Study|Protocol Violation|1|||
16824975|NCT01488370|37768526|FG002|Overall Study|Protocol Violation|1|||
16824976|NCT01518322|37768534|FG000|Overall Study|FeNO measurement was missing|13|||
16824977|NCT01507246|37768545|FG000|Overall Study|Required different surgical procedures|2|||
16824978|NCT01507246|37768546|FG001|Overall Study|Required different surgical procedures|1|||
16824979|NCT01507090|37768555|FG000|Overall Study|incomplete dataset|18|||
16824980|NCT01464346|37768569|FG000|Overall Study|Withdrawal by Subject|0|||
16824981|NCT01464346|37768570|FG001|Overall Study|Withdrawal by Subject|0|||
16824982|NCT01464346|37768571|FG002|Overall Study|Withdrawal by Subject|1|||
16824983|NCT01487200|37768598|FG000|Overall Study|Withdrawal by Subject|0|||
16824984|NCT01487200|37768599|FG001|Overall Study|Withdrawal by Subject|1|||
16824985|NCT01487200|37768600|FG002|Overall Study|Withdrawal by Subject|0|||
16824986|NCT01487200|37768601|FG003|Overall Study|Withdrawal by Subject|0|||
16824987|NCT01463878|37768614|FG000|Overall Study|no longer met criteria for tube feed|2|||
16824988|NCT01463878|37768615|FG001|Overall Study|no longer met criteria for tube feed|2|||
16824989|NCT01505608|37768623|FG000|Phase I|Lack of Efficacy|0|||
16824990|NCT01505608|37768624|FG001|Phase I|Lack of Efficacy|4|||
16824991|NCT01505608|37768623|FG000|Phase I|Adverse Event|0|||
16824992|NCT01505608|37768624|FG001|Phase I|Adverse Event|1|||
16824993|NCT01505608|37768623|FG000|Phase I|Withdrawal by Subject|0|||
16824994|NCT01505608|37768624|FG001|Phase I|Withdrawal by Subject|1|||
16824995|NCT01505608|37768623|FG000|Phase II|Lack of Efficacy|2|||
16824996|NCT01505608|37768624|FG001|Phase II|Lack of Efficacy|1|||
16824997|NCT01505608|37768623|FG000|Phase II|Protocol Violation|0|||
16824998|NCT01505608|37768624|FG001|Phase II|Protocol Violation|1|||
16824999|NCT01486966|37768635|FG000|Overall Study|Adverse Event|0|||
16825000|NCT01486966|37768636|FG001|Overall Study|Adverse Event|1|||
16825001|NCT01486966|37768635|FG000|Overall Study|Withdrawal by Subject|0|||
16825002|NCT01486966|37768636|FG001|Overall Study|Withdrawal by Subject|1|||
16825003|NCT01900665|37768644|FG000|Placebo Controlled Period|Death|9|||
16825004|NCT01900665|37768645|FG001|Placebo Controlled Period|Death|16|||
16825005|NCT01900665|37768644|FG000|Placebo Controlled Period|Adverse Event|48|||
16825006|NCT01900665|37768645|FG001|Placebo Controlled Period|Adverse Event|39|||
16825007|NCT01900665|37768644|FG000|Placebo Controlled Period|Protocol Violation|1|||
16825008|NCT01900665|37768645|FG001|Placebo Controlled Period|Protocol Violation|7|||
16825009|NCT01900665|37768644|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
16825010|NCT01900665|37768645|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
16825011|NCT01900665|37768644|FG000|Placebo Controlled Period|Physician Decision|11|||
16825012|NCT01900665|37768645|FG001|Placebo Controlled Period|Physician Decision|7|||
16825013|NCT01900665|37768644|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
16825014|NCT01900665|37768645|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
16825015|NCT01900665|37768644|FG000|Placebo Controlled Period|Caregiver Decision|33|||
16825016|NCT01900665|37768645|FG001|Placebo Controlled Period|Caregiver Decision|41|||
16825017|NCT01900665|37768644|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
16825018|NCT01900665|37768645|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
16825019|NCT01900665|37768644|FG000|Open Label Period|Adverse Event|16|||
16825020|NCT01900665|37768645|FG001|Open Label Period|Adverse Event|20|||
16825021|NCT01900665|37768644|FG000|Open Label Period|Death|5|||
16825022|NCT01900665|37768645|FG001|Open Label Period|Death|6|||
16825023|NCT01900665|37768644|FG000|Open Label Period|Lost to Follow-up|1|||
16825024|NCT01900665|37768645|FG001|Open Label Period|Lost to Follow-up|1|||
16825025|NCT01900665|37768644|FG000|Open Label Period|Parent/Caregiver Decision|33|||
16825026|NCT01900665|37768645|FG001|Open Label Period|Parent/Caregiver Decision|34|||
16825027|NCT01900665|37768644|FG000|Open Label Period|Physician Decision|4|||
16825028|NCT01900665|37768645|FG001|Open Label Period|Physician Decision|4|||
16825029|NCT01900665|37768644|FG000|Open Label Period|Protocol Violation|0|||
16825030|NCT01900665|37768645|FG001|Open Label Period|Protocol Violation|1|||
16825031|NCT01900665|37768644|FG000|Open Label Period|Sponsor Decision|802|||
16825032|NCT01900665|37768645|FG001|Open Label Period|Sponsor Decision|765|||
16825033|NCT01900665|37768644|FG000|Open Label Period|Withdrawal by Subject|20|||
16825034|NCT01900665|37768645|FG001|Open Label Period|Withdrawal by Subject|28|||
16825035|NCT01900431|37768656|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
16825036|NCT01900431|37768657|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
16825037|NCT01900431|37768658|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
16825038|NCT01900431|37768656|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
16825039|NCT01900431|37768657|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
16825040|NCT01900431|37768658|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
16825041|NCT01900431|37768656|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
16825042|NCT01900431|37768657|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
16825043|NCT01900431|37768658|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
16825044|NCT01900431|37768656|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
16825045|NCT01900431|37768657|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
16825046|NCT01900431|37768658|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
16825047|NCT01900431|37768656|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
16825048|NCT01900431|37768657|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
16825049|NCT01900431|37768658|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
16825050|NCT01900431|37768656|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
16825051|NCT01900431|37768657|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
16825052|NCT01900431|37768658|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
16825053|NCT01900431|37768656|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
16825054|NCT01900431|37768657|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
16825055|NCT01900431|37768658|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
16825056|NCT01900431|37768656|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
16825057|NCT01900431|37768657|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
16825058|NCT01900431|37768658|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
16825059|NCT01900431|37768656|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
16825060|NCT01900431|37768657|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
16825061|NCT01900431|37768658|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
16825062|NCT01948791|37768666|FG000|Overall Study|Adverse Event|12|||
16825063|NCT01948791|37768666|FG000|Overall Study|Lack of Efficacy|3|||
16825064|NCT01948791|37768666|FG000|Overall Study|Protocol Violation|2|||
16825065|NCT01948791|37768666|FG000|Overall Study|Withdrawal by Subject|5|||
16825066|NCT01948791|37768666|FG000|Overall Study|Lost to Follow-up|6|||
16825067|NCT01948791|37768666|FG000|Overall Study|Management issues|1|||
16825068|NCT01948791|37768666|FG000|Overall Study|Others|7|||
16825069|NCT01948791|37768666|FG000|Overall Study|Screening failure|35|||
16825070|NCT01899729|37768675|FG000|Overall Study|Adverse Event|1|||
16825071|NCT01899729|37768676|FG001|Overall Study|Adverse Event|0|||
16825072|NCT01899729|37768677|FG002|Overall Study|Adverse Event|0|||
16825073|NCT01899729|37768678|FG003|Overall Study|Adverse Event|0|||
16825074|NCT01899729|37768679|FG004|Overall Study|Adverse Event|1|||
16825075|NCT01899729|37768675|FG000|Overall Study|Withdrawal by Subject|1|||
16825076|NCT01899729|37768676|FG001|Overall Study|Withdrawal by Subject|2|||
16825077|NCT01899729|37768677|FG002|Overall Study|Withdrawal by Subject|0|||
16825078|NCT01899729|37768678|FG003|Overall Study|Withdrawal by Subject|0|||
16825079|NCT01899729|37768679|FG004|Overall Study|Withdrawal by Subject|0|||
16825080|NCT01899729|37768675|FG000|Overall Study|Lack of Efficacy|0|||
16825081|NCT01899729|37768676|FG001|Overall Study|Lack of Efficacy|0|||
16825082|NCT01899729|37768677|FG002|Overall Study|Lack of Efficacy|2|||
16825083|NCT01899729|37768678|FG003|Overall Study|Lack of Efficacy|0|||
16825084|NCT01899729|37768679|FG004|Overall Study|Lack of Efficacy|1|||
16825085|NCT01898091|37768693|FG000|Overall Study|Lost to Follow-up|1|||
16825086|NCT01898091|37768694|FG001|Overall Study|Lost to Follow-up|1|||
16825087|NCT01898091|37768693|FG000|Overall Study|Withdrawal by Subject|1|||
16825088|NCT01898091|37768694|FG001|Overall Study|Withdrawal by Subject|5|||
16825089|NCT01947855|37768703|FG000|Overall Study|Withdrawal by Subject|1|||
16825090|NCT01947855|37768704|FG001|Overall Study|Withdrawal by Subject|0|||
16825091|NCT01947855|37768705|FG002|Overall Study|Withdrawal by Subject|0|||
16825092|NCT01888965|37768713|FG000|Overall Study|Adverse Event|5|||
16825093|NCT01888965|37768713|FG000|Overall Study|Lack of Efficacy|4|||
16825094|NCT01888497|37768717|FG000|Washout Period 1|Withdrawal by Subject|0|||
16825095|NCT01888497|37768718|FG001|Washout Period 1|Withdrawal by Subject|0|||
16825096|NCT01888497|37768719|FG002|Washout Period 1|Withdrawal by Subject|1|||
16825097|NCT01888497|37768720|FG003|Washout Period 1|Withdrawal by Subject|1|||
16825098|NCT01888497|37768717|FG000|Washout Period 2|Adverse Event|0|||
16825099|NCT01888497|37768718|FG001|Washout Period 2|Adverse Event|0|||
16825100|NCT01888497|37768719|FG002|Washout Period 2|Adverse Event|0|||
16825101|NCT01888497|37768720|FG003|Washout Period 2|Adverse Event|1|||
16825102|NCT01888497|37768717|FG000|Washout Period 2|Withdrawal by Subject|0|||
16825103|NCT01888497|37768718|FG001|Washout Period 2|Withdrawal by Subject|0|||
16825104|NCT01888497|37768719|FG002|Washout Period 2|Withdrawal by Subject|0|||
16825105|NCT01888497|37768720|FG003|Washout Period 2|Withdrawal by Subject|1|||
16825106|NCT01505530|37768733|FG000|Overall Study|Progressive Disease|19|||
16825107|NCT01505530|37768734|FG001|Overall Study|Progressive Disease|17|||
16825108|NCT01505530|37768735|FG002|Overall Study|Progressive Disease|18|||
16825109|NCT01505530|37768733|FG000|Overall Study|Adverse Event|1|||
16825110|NCT01505530|37768734|FG001|Overall Study|Adverse Event|1|||
16825111|NCT01505530|37768735|FG002|Overall Study|Adverse Event|0|||
16825112|NCT01505530|37768733|FG000|Overall Study|Withdrawal by Subject|7|||
16825113|NCT01505530|37768734|FG001|Overall Study|Withdrawal by Subject|8|||
16825114|NCT01505530|37768735|FG002|Overall Study|Withdrawal by Subject|6|||
16825115|NCT01505530|37768733|FG000|Overall Study|Physician Decision|6|||
16825116|NCT01505530|37768734|FG001|Overall Study|Physician Decision|2|||
16825117|NCT01505530|37768735|FG002|Overall Study|Physician Decision|5|||
16825118|NCT01505530|37768733|FG000|Overall Study|Sponsor Decision|1|||
16825119|NCT01505530|37768734|FG001|Overall Study|Sponsor Decision|8|||
16825120|NCT01505530|37768735|FG002|Overall Study|Sponsor Decision|7|||
16825121|NCT01505530|37768733|FG000|Overall Study|Death|7|||
16825122|NCT01505530|37768734|FG001|Overall Study|Death|6|||
16825123|NCT01505530|37768735|FG002|Overall Study|Death|5|||
16825124|NCT01505530|37768733|FG000|Overall Study|entry criteria not met|0|||
16825125|NCT01505530|37768734|FG001|Overall Study|entry criteria not met|1|||
16825126|NCT01505530|37768735|FG002|Overall Study|entry criteria not met|0|||
16825127|NCT01485796|37768743|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
16825128|NCT01485796|37768743|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
16825129|NCT01485796|37768743|FG000|Period 2: Epoch 2|Adverse Event|3|||
16825130|NCT01485796|37768743|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
16825131|NCT01485796|37768743|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
16825132|NCT01485796|37768743|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
16825133|NCT01485796|37768743|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
16825134|NCT01485796|37768743|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
16825135|NCT01505374|37768751|FG000|Overall Study|Lost to Follow-up|1|||
16825136|NCT01505374|37768752|FG001|Overall Study|Lost to Follow-up|0|||
16825137|NCT01897233|37768759|FG000|Part B (24 Weeks)|Adverse Event|1|||
16825138|NCT01897233|37768759|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
16825139|NCT01897233|37768759|FG000|Part B (24 Weeks)|Physician Decision|1|||
16825140|NCT01887717|37768769|FG000|Overall Study|Withdrawal by Subject|1|||
16825141|NCT01887717|37768770|FG001|Overall Study|Withdrawal by Subject|7|||
16825142|NCT01887717|37768769|FG000|Overall Study|Physician Decision|0|||
16825143|NCT01887717|37768770|FG001|Overall Study|Physician Decision|2|||
16825144|NCT01887717|37768769|FG000|Overall Study|Administrative reasons|5|||
16825145|NCT01887717|37768770|FG001|Overall Study|Administrative reasons|2|||
16825146|NCT01886781|37768778|FG000|Overall Study|Protocol Violation|5|||
16825147|NCT01886781|37768779|FG001|Overall Study|Protocol Violation|0|||
16825148|NCT01886781|37768778|FG000|Overall Study|Adverse Event|1|||
16825149|NCT01886781|37768779|FG001|Overall Study|Adverse Event|0|||
16825150|NCT01886781|37768778|FG000|Overall Study|Lost to Follow-up|5|||
16825151|NCT01886781|37768779|FG001|Overall Study|Lost to Follow-up|0|||
16825152|NCT01886781|37768778|FG000|Overall Study|Withdrawal by Subject|2|||
16825153|NCT01886781|37768779|FG001|Overall Study|Withdrawal by Subject|1|||
16825154|NCT01886781|37768778|FG000|Overall Study|Worsening of symptoms|1|||
16825155|NCT01886781|37768779|FG001|Overall Study|Worsening of symptoms|1|||
16825156|NCT01946529|37768788|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
16825157|NCT01946529|37768789|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
16825158|NCT01946529|37768790|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
16825159|NCT01946529|37768788|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
16825160|NCT01946529|37768789|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
16825161|NCT01946529|37768790|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
16825162|NCT01463098|37768811|FG000|Part A (11 Days)|Participant Choice|2|||
16825163|NCT01463098|37768812|FG001|Part A (11 Days)|Participant Choice|0|||
16825164|NCT01463098|37768813|FG002|Part A (11 Days)|Participant Choice|0|||
16825165|NCT01463098|37768814|FG003|Part A (11 Days)|Participant Choice|0|||
16825166|NCT01463098|37768815|FG004|Part A (11 Days)|Participant Choice|0|||
16825167|NCT01463098|37768816|FG005|Part A (11 Days)|Participant Choice|0|||
16825168|NCT01463098|37768817|FG006|Part A (11 Days)|Participant Choice|0|||
16825169|NCT01463098|37768818|FG007|Part A (11 Days)|Participant Choice|0|||
16825170|NCT01463098|37768819|FG008|Part A (11 Days)|Participant Choice|1|||
16825171|NCT01463098|37768820|FG009|Part A (11 Days)|Participant Choice|0|||
16825172|NCT01463098|37768821|FG010|Part A (11 Days)|Participant Choice|0|||
16825173|NCT01463098|37768822|FG011|Part A (11 Days)|Participant Choice|0|||
16825174|NCT01463098|37768823|FG012|Part A (11 Days)|Participant Choice|0|||
16825175|NCT01463098|37768824|FG013|Part A (11 Days)|Participant Choice|0|||
16825176|NCT01463098|37768811|FG000|Part A (11 Days)|Lost to Follow-up|0|||
16825177|NCT01463098|37768812|FG001|Part A (11 Days)|Lost to Follow-up|0|||
16825178|NCT01463098|37768813|FG002|Part A (11 Days)|Lost to Follow-up|0|||
16825179|NCT01463098|37768814|FG003|Part A (11 Days)|Lost to Follow-up|0|||
16825180|NCT01463098|37768815|FG004|Part A (11 Days)|Lost to Follow-up|1|||
16825181|NCT01463098|37768816|FG005|Part A (11 Days)|Lost to Follow-up|0|||
16825182|NCT01463098|37768817|FG006|Part A (11 Days)|Lost to Follow-up|0|||
16825183|NCT01463098|37768818|FG007|Part A (11 Days)|Lost to Follow-up|0|||
16825184|NCT01463098|37768819|FG008|Part A (11 Days)|Lost to Follow-up|0|||
16825185|NCT01463098|37768820|FG009|Part A (11 Days)|Lost to Follow-up|0|||
16825186|NCT01463098|37768821|FG010|Part A (11 Days)|Lost to Follow-up|0|||
16825187|NCT01463098|37768822|FG011|Part A (11 Days)|Lost to Follow-up|0|||
16825188|NCT01463098|37768823|FG012|Part A (11 Days)|Lost to Follow-up|0|||
16825189|NCT01463098|37768824|FG013|Part A (11 Days)|Lost to Follow-up|0|||
16825190|NCT01463098|37768811|FG000|Part B (11 Days)|Participant Choice|0|||
16825191|NCT01463098|37768812|FG001|Part B (11 Days)|Participant Choice|0|||
16825192|NCT01463098|37768813|FG002|Part B (11 Days)|Participant Choice|0|||
16825193|NCT01463098|37768814|FG003|Part B (11 Days)|Participant Choice|0|||
16825194|NCT01463098|37768815|FG004|Part B (11 Days)|Participant Choice|0|||
16825195|NCT01463098|37768816|FG005|Part B (11 Days)|Participant Choice|0|||
16825196|NCT01463098|37768817|FG006|Part B (11 Days)|Participant Choice|0|||
16825197|NCT01463098|37768818|FG007|Part B (11 Days)|Participant Choice|0|||
16825198|NCT01463098|37768819|FG008|Part B (11 Days)|Participant Choice|0|||
16825199|NCT01463098|37768820|FG009|Part B (11 Days)|Participant Choice|0|||
16825200|NCT01463098|37768821|FG010|Part B (11 Days)|Participant Choice|0|||
16825201|NCT01463098|37768822|FG011|Part B (11 Days)|Participant Choice|1|||
16825202|NCT01463098|37768823|FG012|Part B (11 Days)|Participant Choice|0|||
16825203|NCT01463098|37768824|FG013|Part B (11 Days)|Participant Choice|0|||
16825204|NCT01626079|37768876|FG000|Overall Study|Death|117|||
16825205|NCT01626079|37768877|FG001|Overall Study|Death|153|||
16825206|NCT01626079|37768878|FG002|Overall Study|Death|39|||
16825207|NCT01626079|37768876|FG000|Overall Study|Withdrawal by Subject|15|||
16825208|NCT01626079|37768877|FG001|Overall Study|Withdrawal by Subject|39|||
16825209|NCT01626079|37768878|FG002|Overall Study|Withdrawal by Subject|5|||
16825210|NCT01626079|37768876|FG000|Overall Study|Lost to Follow-up|5|||
16825211|NCT01626079|37768877|FG001|Overall Study|Lost to Follow-up|4|||
16825212|NCT01626079|37768878|FG002|Overall Study|Lost to Follow-up|2|||
16825213|NCT01626079|37768876|FG000|Overall Study|Missed Visits|13|||
16825214|NCT01626079|37768877|FG001|Overall Study|Missed Visits|5|||
16825215|NCT01626079|37768878|FG002|Overall Study|Missed Visits|6|||
16825216|NCT01462942|37768894|FG000|Overall Study|Adverse Event|7|||
16825217|NCT01462942|37768895|FG001|Overall Study|Adverse Event|12|||
16825218|NCT01462942|37768896|FG002|Overall Study|Adverse Event|10|||
16825219|NCT01462942|37768897|FG003|Overall Study|Adverse Event|11|||
16825220|NCT01462942|37768898|FG004|Overall Study|Adverse Event|11|||
16825221|NCT01462942|37768894|FG000|Overall Study|Other, including COPD exacerbation|3|||
16825222|NCT01462942|37768895|FG001|Overall Study|Other, including COPD exacerbation|5|||
16825223|NCT01462942|37768896|FG002|Overall Study|Other, including COPD exacerbation|2|||
16825224|NCT01462942|37768897|FG003|Overall Study|Other, including COPD exacerbation|8|||
16825225|NCT01462942|37768898|FG004|Overall Study|Other, including COPD exacerbation|5|||
16825226|NCT01462942|37768894|FG000|Overall Study|Withdrawal by Subject|14|||
16825227|NCT01462942|37768895|FG001|Overall Study|Withdrawal by Subject|10|||
16825228|NCT01462942|37768896|FG002|Overall Study|Withdrawal by Subject|14|||
16825229|NCT01462942|37768897|FG003|Overall Study|Withdrawal by Subject|16|||
16825230|NCT01462942|37768898|FG004|Overall Study|Withdrawal by Subject|19|||
16825231|NCT01462942|37768894|FG000|Overall Study|Lack of Efficacy|6|||
16825232|NCT01462942|37768895|FG001|Overall Study|Lack of Efficacy|0|||
16825233|NCT01462942|37768896|FG002|Overall Study|Lack of Efficacy|4|||
16825234|NCT01462942|37768897|FG003|Overall Study|Lack of Efficacy|5|||
16825235|NCT01462942|37768898|FG004|Overall Study|Lack of Efficacy|3|||
16825236|NCT01462942|37768894|FG000|Overall Study|Lost to Follow-up|0|||
16825237|NCT01462942|37768895|FG001|Overall Study|Lost to Follow-up|1|||
16825238|NCT01462942|37768896|FG002|Overall Study|Lost to Follow-up|1|||
16825239|NCT01462942|37768897|FG003|Overall Study|Lost to Follow-up|1|||
16825240|NCT01462942|37768898|FG004|Overall Study|Lost to Follow-up|1|||
16825241|NCT01462942|37768894|FG000|Overall Study|Protocol Violation|4|||
16825242|NCT01462942|37768895|FG001|Overall Study|Protocol Violation|6|||
16825243|NCT01462942|37768896|FG002|Overall Study|Protocol Violation|9|||
16825244|NCT01462942|37768897|FG003|Overall Study|Protocol Violation|9|||
16825245|NCT01462942|37768898|FG004|Overall Study|Protocol Violation|6|||
16825246|NCT01462630|37768910|FG000|Overall Study|Did not initiate therapy|3|||
16825247|NCT01462630|37768910|FG000|Overall Study|Death|1|||
16825248|NCT01462630|37768910|FG000|Overall Study|Protocol Violation|2|||
16825249|NCT01462630|37768910|FG000|Overall Study|Adverse Event|1|||
16825250|NCT01504204|37768916|FG000|Overall Study|Lost to Follow-up|1|||
16825251|NCT01504204|37768917|FG001|Overall Study|Lost to Follow-up|1|||
16825252|NCT01485640|37768923|FG000|Overall Study|Adverse Event|10|||
16825253|NCT01485640|37768923|FG000|Overall Study|Lack of Efficacy|2|||
16825254|NCT01485640|37768923|FG000|Overall Study|Protocol Violation|1|||
16825255|NCT01485640|37768923|FG000|Overall Study|Withdrawal by Subject|14|||
16825256|NCT01485640|37768923|FG000|Overall Study|Terminated by Sponsor|95|||
16825257|NCT02118961|37768929|FG000|Overall Study|Withdrawal by Subject|1|||
16825258|NCT02118961|37768930|FG001|Overall Study|Withdrawal by Subject|0|||
16825259|NCT02140645|37768942|FG000|Overall Study|Not linked|5489|||
16825260|NCT02140645|37768943|FG001|Overall Study|Not linked|61654|||
16825261|NCT02140645|37768944|FG002|Overall Study|Not linked|4236|||
16825262|NCT02140645|37768945|FG003|Overall Study|Not linked|13833|||
16825263|NCT02140645|37768946|FG004|Overall Study|Not linked|3286|||
16825264|NCT02140645|37768947|FG005|Overall Study|Not linked|70896|||
16825265|NCT02140567|37768956|FG000|Overall Study|Problems with recording equipment|6|||
16825266|NCT02140411|37768961|FG000|Overall Study|Adverse Event|1|||
16825267|NCT02139943|37768968|FG000|Overall Study|Adverse Event|0|||
16825268|NCT02139943|37768969|FG001|Overall Study|Adverse Event|1|||
16825269|NCT02139943|37768970|FG002|Overall Study|Adverse Event|2|||
16825270|NCT02139943|37768968|FG000|Overall Study|Lost to Follow-up|3|||
16825271|NCT02139943|37768969|FG001|Overall Study|Lost to Follow-up|2|||
16825272|NCT02139943|37768970|FG002|Overall Study|Lost to Follow-up|2|||
16825273|NCT02139943|37768968|FG000|Overall Study|Withdrawal by Subject|4|||
16825274|NCT02139943|37768969|FG001|Overall Study|Withdrawal by Subject|3|||
16825275|NCT02139943|37768970|FG002|Overall Study|Withdrawal by Subject|0|||
16825276|NCT02139943|37768968|FG000|Overall Study|Other|0|||
16825277|NCT02139943|37768969|FG001|Overall Study|Other|0|||
16825278|NCT02139943|37768970|FG002|Overall Study|Other|1|||
16825279|NCT02139943|37768968|FG000|Overall Study|Participant wishes to discontinue|2|||
16825280|NCT02139943|37768969|FG001|Overall Study|Participant wishes to discontinue|0|||
16825281|NCT02139943|37768970|FG002|Overall Study|Participant wishes to discontinue|0|||
16825282|NCT02139943|37768968|FG000|Overall Study|Participant in Poor Compliance|1|||
16825283|NCT02139943|37768969|FG001|Overall Study|Participant in Poor Compliance|0|||
16825284|NCT02139943|37768970|FG002|Overall Study|Participant in Poor Compliance|1|||
16825285|NCT02139943|37768968|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
16825286|NCT02139943|37768969|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
16825287|NCT02139943|37768970|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
16825288|NCT01485172|37768984|FG000|Overall Study|Adverse Event|2|||
16825289|NCT01485172|37768985|FG001|Overall Study|Adverse Event|1|||
16825290|NCT01485172|37768986|FG002|Overall Study|Adverse Event|2|||
16825291|NCT01485172|37768987|FG003|Overall Study|Adverse Event|2|||
16825292|NCT01485172|37768988|FG004|Overall Study|Adverse Event|1|||
16825293|NCT01485172|37768989|FG005|Overall Study|Adverse Event|2|||
16825294|NCT01485172|37768984|FG000|Overall Study|Lack of Efficacy|2|||
16825295|NCT01485172|37768985|FG001|Overall Study|Lack of Efficacy|0|||
16825296|NCT01485172|37768986|FG002|Overall Study|Lack of Efficacy|0|||
16825297|NCT01485172|37768987|FG003|Overall Study|Lack of Efficacy|0|||
16825298|NCT01485172|37768988|FG004|Overall Study|Lack of Efficacy|0|||
16825299|NCT01485172|37768989|FG005|Overall Study|Lack of Efficacy|0|||
16825300|NCT01485172|37768984|FG000|Overall Study|Protocol Violation|0|||
16825301|NCT01485172|37768985|FG001|Overall Study|Protocol Violation|0|||
16825302|NCT01485172|37768986|FG002|Overall Study|Protocol Violation|4|||
16825303|NCT01485172|37768987|FG003|Overall Study|Protocol Violation|5|||
16825304|NCT01485172|37768988|FG004|Overall Study|Protocol Violation|1|||
16825305|NCT01485172|37768989|FG005|Overall Study|Protocol Violation|0|||
16825306|NCT01485172|37768984|FG000|Overall Study|Protocol defined stopping criteria|1|||
16825307|NCT01485172|37768985|FG001|Overall Study|Protocol defined stopping criteria|0|||
16825308|NCT01485172|37768986|FG002|Overall Study|Protocol defined stopping criteria|0|||
16825309|NCT01485172|37768987|FG003|Overall Study|Protocol defined stopping criteria|0|||
16825310|NCT01485172|37768988|FG004|Overall Study|Protocol defined stopping criteria|1|||
16825311|NCT01485172|37768989|FG005|Overall Study|Protocol defined stopping criteria|0|||
16825312|NCT01485172|37768984|FG000|Overall Study|Lost to Follow-up|0|||
16825313|NCT01485172|37768985|FG001|Overall Study|Lost to Follow-up|0|||
16825314|NCT01485172|37768986|FG002|Overall Study|Lost to Follow-up|1|||
16825315|NCT01485172|37768987|FG003|Overall Study|Lost to Follow-up|0|||
16825316|NCT01485172|37768988|FG004|Overall Study|Lost to Follow-up|0|||
16825317|NCT01485172|37768989|FG005|Overall Study|Lost to Follow-up|1|||
16825318|NCT01485172|37768984|FG000|Overall Study|Physician Decision|0|||
16825319|NCT01485172|37768985|FG001|Overall Study|Physician Decision|0|||
16825320|NCT01485172|37768986|FG002|Overall Study|Physician Decision|0|||
16825321|NCT01485172|37768987|FG003|Overall Study|Physician Decision|0|||
16825322|NCT01485172|37768988|FG004|Overall Study|Physician Decision|1|||
16825323|NCT01485172|37768989|FG005|Overall Study|Physician Decision|0|||
16825324|NCT01485172|37768984|FG000|Overall Study|Withdrawal by Subject|2|||
16825325|NCT01485172|37768985|FG001|Overall Study|Withdrawal by Subject|0|||
16825326|NCT01485172|37768986|FG002|Overall Study|Withdrawal by Subject|0|||
16825327|NCT01485172|37768987|FG003|Overall Study|Withdrawal by Subject|1|||
16825328|NCT01485172|37768988|FG004|Overall Study|Withdrawal by Subject|1|||
16825329|NCT01485172|37768989|FG005|Overall Study|Withdrawal by Subject|1|||
16825330|NCT02105701|37769007|FG000|Overall Study|Lost to Follow-up|1|||
16825331|NCT02105701|37769008|FG001|Overall Study|Lost to Follow-up|0|||
16825332|NCT02105701|37769009|FG002|Overall Study|Lost to Follow-up|2|||
16825333|NCT02105701|37769010|FG003|Overall Study|Lost to Follow-up|1|||
16825334|NCT02105701|37769007|FG000|Overall Study|Protocol Violation|0|||
16825335|NCT02105701|37769008|FG001|Overall Study|Protocol Violation|0|||
16825336|NCT02105701|37769009|FG002|Overall Study|Protocol Violation|1|||
16825337|NCT02105701|37769010|FG003|Overall Study|Protocol Violation|0|||
16825338|NCT02105701|37769007|FG000|Overall Study|Withdrawal by Subject|2|||
16825339|NCT02105701|37769008|FG001|Overall Study|Withdrawal by Subject|1|||
16825340|NCT02105701|37769009|FG002|Overall Study|Withdrawal by Subject|0|||
16825341|NCT02105701|37769010|FG003|Overall Study|Withdrawal by Subject|1|||
16825342|NCT02105701|37769007|FG000|Overall Study|Death|1|||
16825343|NCT02105701|37769008|FG001|Overall Study|Death|0|||
16825344|NCT02105701|37769009|FG002|Overall Study|Death|0|||
16825345|NCT02105701|37769010|FG003|Overall Study|Death|0|||
16825346|NCT01502956|37769022|FG000|Overall Study|Death|0|||
16825347|NCT01502956|37769023|FG001|Overall Study|Death|2|||
16825348|NCT01502956|37769022|FG000|Overall Study|Lost to Follow-up|14|||
16825349|NCT01502956|37769023|FG001|Overall Study|Lost to Follow-up|11|||
16825350|NCT01502956|37769022|FG000|Overall Study|Physician Decision|2|||
16825351|NCT01502956|37769023|FG001|Overall Study|Physician Decision|3|||
16825352|NCT01502956|37769022|FG000|Overall Study|Withdrawal by Subject|8|||
16825353|NCT01502956|37769023|FG001|Overall Study|Withdrawal by Subject|10|||
16825354|NCT01502644|37769032|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
16825355|NCT01502644|37769033|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
16825356|NCT01502644|37769034|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
16825357|NCT01502644|37769035|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
16825358|NCT01502644|37769032|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
16825359|NCT01502644|37769033|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
16825360|NCT01502644|37769034|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
16825361|NCT01502644|37769035|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
16825362|NCT01502644|37769032|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
16825363|NCT01502644|37769033|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
16825364|NCT01502644|37769034|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
16825365|NCT01502644|37769035|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
16825366|NCT01502644|37769032|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
16825367|NCT01502644|37769033|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
16825368|NCT01502644|37769034|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
16825369|NCT01502644|37769035|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
16825370|NCT01502644|37769032|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
16825371|NCT01502644|37769033|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
16825372|NCT01502644|37769034|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
16825373|NCT01502644|37769035|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
16825374|NCT01462318|37769045|FG000|Main Study / TP-DI Study|Other|2|||
16825375|NCT01462318|37769046|FG001|Main Study / TP-DI Study|Other|0|||
16825376|NCT01462318|37769047|FG002|Main Study / TP-DI Study|Other|0|||
16825377|NCT01462318|37769045|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
16825378|NCT01462318|37769046|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
16825379|NCT01462318|37769047|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
16825380|NCT01462318|37769045|FG000|Main Study / TP-DI Study|Adverse Event|4|||
16825381|NCT01462318|37769046|FG001|Main Study / TP-DI Study|Adverse Event|0|||
16825382|NCT01462318|37769047|FG002|Main Study / TP-DI Study|Adverse Event|0|||
16825383|NCT01462318|37769045|FG000|Extension Phase|Lost to Follow-up|0|||
16825384|NCT01462318|37769046|FG001|Extension Phase|Lost to Follow-up|0|||
16825385|NCT01462318|37769047|FG002|Extension Phase|Lost to Follow-up|1|||
16825386|NCT01462318|37769045|FG000|Extension Phase|Other|0|||
16825387|NCT01462318|37769046|FG001|Extension Phase|Other|0|||
16825388|NCT01462318|37769047|FG002|Extension Phase|Other|1|||
16825389|NCT01462318|37769045|FG000|Extension Phase|Disease Progression|0|||
16825390|NCT01462318|37769046|FG001|Extension Phase|Disease Progression|0|||
16825391|NCT01462318|37769047|FG002|Extension Phase|Disease Progression|1|||
16825392|NCT01462318|37769045|FG000|Extension Phase|Withdrawal by Subject|0|||
16825393|NCT01462318|37769046|FG001|Extension Phase|Withdrawal by Subject|0|||
16825394|NCT01462318|37769047|FG002|Extension Phase|Withdrawal by Subject|15|||
16825395|NCT01462318|37769045|FG000|Extension Phase|Investigator Decision|0|||
16825396|NCT01462318|37769046|FG001|Extension Phase|Investigator Decision|0|||
16825397|NCT01462318|37769047|FG002|Extension Phase|Investigator Decision|5|||
16825398|NCT01462318|37769045|FG000|Extension Phase|Adverse Event|0|||
16825399|NCT01462318|37769046|FG001|Extension Phase|Adverse Event|0|||
16825400|NCT01462318|37769047|FG002|Extension Phase|Adverse Event|22|||
16825401|NCT01485094|37769055|FG000|Overall Study|Adverse Event|1|||
16825402|NCT01485094|37769056|FG001|Overall Study|Adverse Event|1|||
16825403|NCT01485094|37769057|FG002|Overall Study|Adverse Event|1|||
16825404|NCT01485094|37769055|FG000|Overall Study|Lost to Follow-up|1|||
16825405|NCT01485094|37769056|FG001|Overall Study|Lost to Follow-up|0|||
16825406|NCT01485094|37769057|FG002|Overall Study|Lost to Follow-up|0|||
16825407|NCT01485094|37769055|FG000|Overall Study|Withdrawal by Subject|1|||
16825408|NCT01485094|37769056|FG001|Overall Study|Withdrawal by Subject|1|||
16825409|NCT01485094|37769057|FG002|Overall Study|Withdrawal by Subject|0|||
16825410|NCT01484938|37769065|FG000|Overall Study|Adverse Event|2|||
16825411|NCT01484938|37769065|FG000|Overall Study|Lost to Follow-up|1|||
16825412|NCT01484938|37769065|FG000|Overall Study|Noncompliance|1|||
16825413|NCT01502410|37769073|FG000|Overall Study|Adverse Event|1|||
16825414|NCT01502410|37769074|FG001|Overall Study|Adverse Event|2|||
16825415|NCT01502410|37769075|FG002|Overall Study|Adverse Event|0|||
16825416|NCT01502410|37769076|FG003|Overall Study|Adverse Event|0|||
16825417|NCT01502410|37769073|FG000|Overall Study|Lack of Efficacy|7|||
16825418|NCT01502410|37769074|FG001|Overall Study|Lack of Efficacy|7|||
16825419|NCT01502410|37769075|FG002|Overall Study|Lack of Efficacy|0|||
16825420|NCT01502410|37769076|FG003|Overall Study|Lack of Efficacy|0|||
16825421|NCT01502410|37769073|FG000|Overall Study|Physician Decision|0|||
16825422|NCT01502410|37769074|FG001|Overall Study|Physician Decision|1|||
16825423|NCT01502410|37769075|FG002|Overall Study|Physician Decision|0|||
16825424|NCT01502410|37769076|FG003|Overall Study|Physician Decision|0|||
16825425|NCT01502410|37769073|FG000|Overall Study|Withdrawal by Subject|2|||
16825426|NCT01502410|37769074|FG001|Overall Study|Withdrawal by Subject|0|||
16825427|NCT01502410|37769075|FG002|Overall Study|Withdrawal by Subject|0|||
16825428|NCT01502410|37769076|FG003|Overall Study|Withdrawal by Subject|0|||
16825429|NCT01462162|37769085|FG000|Overall Study|Adverse Event|5|||
16825430|NCT01462162|37769085|FG000|Overall Study|Lack of Efficacy|4|||
16825431|NCT01462162|37769085|FG000|Overall Study|Abnormal laboratory parameters|1|||
16825432|NCT01462162|37769085|FG000|Overall Study|Other|2|||
16825433|NCT01483924|37769095|FG000|Overall Study|Withdrawal by Subject|2|||
16825434|NCT01483924|37769096|FG001|Overall Study|Withdrawal by Subject|0|||
16825435|NCT01483924|37769097|FG002|Overall Study|Withdrawal by Subject|0|||
16825436|NCT01483924|37769098|FG003|Overall Study|Withdrawal by Subject|1|||
16825437|NCT01483924|37769099|FG004|Overall Study|Withdrawal by Subject|1|||
16825438|NCT01483924|37769095|FG000|Overall Study|Adverse Event|0|||
16825439|NCT01483924|37769096|FG001|Overall Study|Adverse Event|0|||
16825440|NCT01483924|37769097|FG002|Overall Study|Adverse Event|1|||
16825441|NCT01483924|37769098|FG003|Overall Study|Adverse Event|1|||
16825442|NCT01483924|37769099|FG004|Overall Study|Adverse Event|0|||
16825443|NCT01483924|37769095|FG000|Overall Study|Non-compliance|0|||
16825444|NCT01483924|37769096|FG001|Overall Study|Non-compliance|0|||
16825445|NCT01483924|37769097|FG002|Overall Study|Non-compliance|0|||
16825446|NCT01483924|37769098|FG003|Overall Study|Non-compliance|1|||
16825447|NCT01483924|37769099|FG004|Overall Study|Non-compliance|1|||
16825448|NCT01483924|37769095|FG000|Overall Study|Sponsor concern over ECG result|0|||
16825449|NCT01483924|37769096|FG001|Overall Study|Sponsor concern over ECG result|0|||
16825450|NCT01483924|37769097|FG002|Overall Study|Sponsor concern over ECG result|0|||
16825451|NCT01483924|37769098|FG003|Overall Study|Sponsor concern over ECG result|1|||
16825452|NCT01483924|37769099|FG004|Overall Study|Sponsor concern over ECG result|0|||
16825453|NCT01462084|37769120|FG000|Overall Study|Withdrawal by Subject|1|||
16825454|NCT01462084|37769121|FG001|Overall Study|Withdrawal by Subject|0|||
16825455|NCT01462084|37769120|FG000|Overall Study|Protocol Violation|1|||
16825456|NCT01462084|37769121|FG001|Overall Study|Protocol Violation|1|||
16825457|NCT02134028|37769136|FG000|Overall Study|Lack of Efficacy|1|||
16825458|NCT02134028|37769137|FG001|Overall Study|Lack of Efficacy|0|||
16825459|NCT02134028|37769138|FG002|Overall Study|Lack of Efficacy|3|||
16825460|NCT02134028|37769139|FG003|Overall Study|Lack of Efficacy|2|||
16825461|NCT02134028|37769140|FG004|Overall Study|Lack of Efficacy|1|||
16825462|NCT02134028|37769141|FG005|Overall Study|Lack of Efficacy|2|||
16825463|NCT02134028|37769142|FG006|Overall Study|Lack of Efficacy|1|||
16825464|NCT02134028|37769143|FG007|Overall Study|Lack of Efficacy|0|||
16825465|NCT02134028|37769136|FG000|Overall Study|Poor compliance to protocol|1|||
16825466|NCT02134028|37769137|FG001|Overall Study|Poor compliance to protocol|1|||
16825467|NCT02134028|37769138|FG002|Overall Study|Poor compliance to protocol|3|||
16825468|NCT02134028|37769139|FG003|Overall Study|Poor compliance to protocol|7|||
16825469|NCT02134028|37769140|FG004|Overall Study|Poor compliance to protocol|1|||
16825470|NCT02134028|37769141|FG005|Overall Study|Poor compliance to protocol|1|||
16825471|NCT02134028|37769142|FG006|Overall Study|Poor compliance to protocol|0|||
16825472|NCT02134028|37769143|FG007|Overall Study|Poor compliance to protocol|0|||
16825473|NCT02134028|37769136|FG000|Overall Study|Other unspecified|4|||
16825474|NCT02134028|37769137|FG001|Overall Study|Other unspecified|22|||
16825475|NCT02134028|37769138|FG002|Overall Study|Other unspecified|33|||
16825476|NCT02134028|37769139|FG003|Overall Study|Other unspecified|64|||
16825477|NCT02134028|37769140|FG004|Overall Study|Other unspecified|8|||
16825478|NCT02134028|37769141|FG005|Overall Study|Other unspecified|6|||
16825479|NCT02134028|37769142|FG006|Overall Study|Other unspecified|2|||
16825480|NCT02134028|37769143|FG007|Overall Study|Other unspecified|1|||
16825481|NCT02134028|37769136|FG000|Overall Study|Adverse Event|3|||
16825482|NCT02134028|37769137|FG001|Overall Study|Adverse Event|19|||
16825483|NCT02134028|37769138|FG002|Overall Study|Adverse Event|13|||
16825484|NCT02134028|37769139|FG003|Overall Study|Adverse Event|32|||
16825485|NCT02134028|37769140|FG004|Overall Study|Adverse Event|4|||
16825486|NCT02134028|37769141|FG005|Overall Study|Adverse Event|5|||
16825487|NCT02134028|37769142|FG006|Overall Study|Adverse Event|1|||
16825488|NCT02134028|37769143|FG007|Overall Study|Adverse Event|2|||
16825489|NCT02172950|37769165|FG000|Overall Study|Physician Decision|3|||
16825490|NCT02172950|37769166|FG001|Overall Study|Physician Decision|3|||
16825491|NCT02172950|37769165|FG000|Overall Study|Lack of Efficacy|1|||
16825492|NCT02172950|37769166|FG001|Overall Study|Lack of Efficacy|0|||
16825493|NCT02172950|37769165|FG000|Overall Study|Adverse Event|4|||
16825494|NCT02172950|37769166|FG001|Overall Study|Adverse Event|1|||
16825495|NCT02172950|37769165|FG000|Overall Study|Withdrawal by Subject|10|||
16825496|NCT02172950|37769166|FG001|Overall Study|Withdrawal by Subject|0|||
16825497|NCT02172950|37769165|FG000|Overall Study|Protocol Violation|1|||
16825498|NCT02172950|37769166|FG001|Overall Study|Protocol Violation|0|||
16825499|NCT02172950|37769165|FG000|Overall Study|Lost to Follow-up|1|||
16825500|NCT02172950|37769166|FG001|Overall Study|Lost to Follow-up|0|||
16825501|NCT02172950|37769165|FG000|Overall Study|Death|1|||
16825502|NCT02172950|37769166|FG001|Overall Study|Death|0|||
16825503|NCT02172950|37769165|FG000|Overall Study|Patient traveling|1|||
16825504|NCT02172950|37769166|FG001|Overall Study|Patient traveling|0|||
16825505|NCT02172950|37769165|FG000|Overall Study|Patient went to other country|1|||
16825506|NCT02172950|37769166|FG001|Overall Study|Patient went to other country|0|||
16825507|NCT02172950|37769165|FG000|Overall Study|Patient relocated overseas|1|||
16825508|NCT02172950|37769166|FG001|Overall Study|Patient relocated overseas|1|||
16825509|NCT02172950|37769165|FG000|Overall Study|Patient moving|1|||
16825510|NCT02172950|37769166|FG001|Overall Study|Patient moving|0|||
16825511|NCT02151266|37769176|FG000|Overall Study|Lost to Follow-up|1|||
16825512|NCT02151266|37769177|FG001|Overall Study|Lost to Follow-up|4|||
16825513|NCT02151266|37769178|FG002|Overall Study|Lost to Follow-up|1|||
16825514|NCT02151266|37769176|FG000|Overall Study|Did NOT receive intervention|3|||
16825515|NCT02151266|37769177|FG001|Overall Study|Did NOT receive intervention|6|||
16825516|NCT02151266|37769178|FG002|Overall Study|Did NOT receive intervention|2|||
16825517|NCT02151266|37769176|FG000|Overall Study|Not able to exercise|4|||
16825518|NCT02151266|37769177|FG001|Overall Study|Not able to exercise|5|||
16825519|NCT02151266|37769178|FG002|Overall Study|Not able to exercise|4|||
16825520|NCT02151110|37769194|FG000|Overall Study|Withdrawal by Subject|0|||
16825521|NCT02151110|37769195|FG001|Overall Study|Withdrawal by Subject|0|||
16825522|NCT02151110|37769196|FG002|Overall Study|Withdrawal by Subject|0|||
16825523|NCT02151110|37769197|FG003|Overall Study|Withdrawal by Subject|0|||
16825524|NCT02151110|37769198|FG004|Overall Study|Withdrawal by Subject|0|||
16825525|NCT02151110|37769199|FG005|Overall Study|Withdrawal by Subject|0|||
16825526|NCT02151110|37769200|FG006|Overall Study|Withdrawal by Subject|0|||
16825527|NCT02151110|37769201|FG007|Overall Study|Withdrawal by Subject|1|||
16825528|NCT02151110|37769194|FG000|Overall Study|Lost to Follow-up|0|||
16825529|NCT02151110|37769195|FG001|Overall Study|Lost to Follow-up|0|||
16825530|NCT02151110|37769196|FG002|Overall Study|Lost to Follow-up|0|||
16825531|NCT02151110|37769197|FG003|Overall Study|Lost to Follow-up|0|||
16825532|NCT02151110|37769198|FG004|Overall Study|Lost to Follow-up|0|||
16825533|NCT02151110|37769199|FG005|Overall Study|Lost to Follow-up|0|||
16825534|NCT02151110|37769200|FG006|Overall Study|Lost to Follow-up|0|||
16825535|NCT02151110|37769201|FG007|Overall Study|Lost to Follow-up|2|||
16825536|NCT02132312|37769228|FG000|Overall Study|Adverse Event|2|||
16825537|NCT02132312|37769229|FG001|Overall Study|Adverse Event|0|||
16825538|NCT02132312|37769228|FG000|Overall Study|Physician Decision|1|||
16825539|NCT02132312|37769229|FG001|Overall Study|Physician Decision|1|||
16825540|NCT02132312|37769228|FG000|Overall Study|Protocol Violation|0|||
16825541|NCT02132312|37769229|FG001|Overall Study|Protocol Violation|1|||
16825542|NCT02132312|37769228|FG000|Overall Study|Withdrawal by Subject|1|||
16825543|NCT02132312|37769229|FG001|Overall Study|Withdrawal by Subject|0|||
16825544|NCT02132312|37769228|FG000|Overall Study|Lost to Follow-up|2|||
16825545|NCT02132312|37769229|FG001|Overall Study|Lost to Follow-up|1|||
16825546|NCT02131766|37769235|FG000|Overall Study|Withdrawal by Subject|4|||
16825547|NCT02150954|37769244|FG000|Overall Study|Protocol Violation|1|||
16825548|NCT02150954|37769245|FG001|Overall Study|Protocol Violation|0|||
16825549|NCT02131532|37769251|FG000|Overall Study|Withdrawal by Subject|1|||
16825550|NCT02131532|37769251|FG000|Overall Study|Physician Decision|1|||
16825551|NCT02131532|37769251|FG000|Overall Study|Other health conditions|2|||
17102384|NCT00384059|38241318|FG001|Infant Series|Withdrawal by Subject|2|||
17102385|NCT00384059|38241317|FG000|Infant Series|Adverse Event|1|||
17102386|NCT00384059|38241318|FG001|Infant Series|Adverse Event|2|||
17102387|NCT00384059|38241317|FG000|Infant Series|Protocol Violation|1|||
17102388|NCT00384059|38241318|FG001|Infant Series|Protocol Violation|2|||
17102389|NCT00384059|38241317|FG000|Infant Series|Lost to Follow-up|0|||
17102390|NCT00384059|38241318|FG001|Infant Series|Lost to Follow-up|1|||
17102391|NCT00384059|38241317|FG000|After Infant Series|Protocol Violation|2|||
17102392|NCT00384059|38241318|FG001|After Infant Series|Protocol Violation|3|||
17102393|NCT00384059|38241317|FG000|After Infant Series|Withdrawal by Subject|2|||
16825552|NCT02170688|37769265|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
16825553|NCT02170688|37769266|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
16825554|NCT02170688|37769267|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
16825555|NCT02170688|37769268|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
16825556|NCT02170688|37769269|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
16825557|NCT02170688|37769265|FG000|Overall Study|Full dose not received|0|||
16825558|NCT02170688|37769266|FG001|Overall Study|Full dose not received|1|||
16825559|NCT02170688|37769267|FG002|Overall Study|Full dose not received|0|||
16825560|NCT02170688|37769268|FG003|Overall Study|Full dose not received|0|||
16825561|NCT02170688|37769269|FG004|Overall Study|Full dose not received|0|||
16825562|NCT02170688|37769265|FG000|Overall Study|Physician Decision|0|||
16825563|NCT02170688|37769266|FG001|Overall Study|Physician Decision|0|||
16825564|NCT02170688|37769267|FG002|Overall Study|Physician Decision|1|||
16825565|NCT02170688|37769268|FG003|Overall Study|Physician Decision|0|||
16825566|NCT02170688|37769269|FG004|Overall Study|Physician Decision|0|||
16825567|NCT02170298|37769283|FG000|Overall Study|Withdrawal by Subject|0|||
16825568|NCT02170298|37769284|FG001|Overall Study|Withdrawal by Subject|1|||
16825569|NCT02170298|37769283|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
16825570|NCT02170298|37769284|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
16825571|NCT02131064|37769292|FG000|Overall Study|Death|5|||
16825572|NCT02131064|37769293|FG001|Overall Study|Death|6|||
16825573|NCT02131064|37769292|FG000|Overall Study|Lost to Follow-up|4|||
16825574|NCT02131064|37769293|FG001|Overall Study|Lost to Follow-up|8|||
16825575|NCT02131064|37769292|FG000|Overall Study|Withdrawal by Subject|14|||
16825576|NCT02131064|37769293|FG001|Overall Study|Withdrawal by Subject|18|||
16825577|NCT02131064|37769292|FG000|Overall Study|Other|2|||
16825578|NCT02131064|37769293|FG001|Overall Study|Other|2|||
16825579|NCT02130986|37769302|FG000|Overall Study|Withdrawal by Subject|4|||
16825580|NCT02130986|37769303|FG001|Overall Study|Withdrawal by Subject|4|||
16825581|NCT02130986|37769302|FG000|Overall Study|Lost to Follow-up|151|||
16825582|NCT02130986|37769303|FG001|Overall Study|Lost to Follow-up|160|||
16825583|NCT02130284|37769311|FG000|Overall Study|Withdrawal by Subject|3|||
16825584|NCT02130284|37769311|FG000|Overall Study|Subject Withdrew Consent|1|||
16825585|NCT02130284|37769311|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
16825586|NCT02130284|37769311|FG000|Overall Study|Subject was screened as backup for study|3|||
16825587|NCT02130284|37769311|FG000|Overall Study|Screen Failure|1|||
16825588|NCT02147288|37769317|FG000|Overall Study|post-operative hematoma|1|||
16825589|NCT02147288|37769318|FG001|Overall Study|post-operative hematoma|1|||
16825590|NCT02147288|37769319|FG002|Overall Study|post-operative hematoma|0|||
16825591|NCT02147288|37769320|FG003|Overall Study|post-operative hematoma|0|||
16825592|NCT02147288|37769321|FG004|Overall Study|post-operative hematoma|0|||
16825593|NCT02147288|37769322|FG005|Overall Study|post-operative hematoma|0|||
16825594|NCT02147288|37769323|FG006|Overall Study|post-operative hematoma|0|||
16825595|NCT02147288|37769324|FG007|Overall Study|post-operative hematoma|0|||
16825596|NCT02147288|37769325|FG008|Overall Study|post-operative hematoma|0|||
16825597|NCT02147288|37769326|FG009|Overall Study|post-operative hematoma|0|||
16825598|NCT02147288|37769317|FG000|Overall Study|complications from concurrent hernia rep|0|||
16825599|NCT02147288|37769318|FG001|Overall Study|complications from concurrent hernia rep|1|||
16825600|NCT02147288|37769319|FG002|Overall Study|complications from concurrent hernia rep|0|||
16825601|NCT02147288|37769320|FG003|Overall Study|complications from concurrent hernia rep|0|||
16825602|NCT02147288|37769321|FG004|Overall Study|complications from concurrent hernia rep|0|||
16912063|NCT01508910|38021167|FG003|Treatment|Lost to Follow-up|1|||
17102394|NCT00384059|38241318|FG001|After Infant Series|Withdrawal by Subject|2|||
17102395|NCT00384059|38241317|FG000|After Infant Series|Failed to Return|0|||
17102396|NCT00384059|38241318|FG001|After Infant Series|Failed to Return|2|||
16825603|NCT02147288|37769322|FG005|Overall Study|complications from concurrent hernia rep|0|||
16825604|NCT02147288|37769323|FG006|Overall Study|complications from concurrent hernia rep|0|||
16825605|NCT02147288|37769324|FG007|Overall Study|complications from concurrent hernia rep|0|||
16825606|NCT02147288|37769325|FG008|Overall Study|complications from concurrent hernia rep|0|||
16825607|NCT02147288|37769326|FG009|Overall Study|complications from concurrent hernia rep|0|||
16825608|NCT02147132|37769332|FG000|Overall Study|Lost to Follow-up|1|||
16825609|NCT02147132|37769333|FG001|Overall Study|Lost to Follow-up|0|||
16825610|NCT02147132|37769334|FG002|Overall Study|Lost to Follow-up|0|||
16825611|NCT02147132|37769335|FG003|Overall Study|Lost to Follow-up|0|||
16825612|NCT02146430|37769349|FG000|Overall Study|Protocol Violation|5|||
16825613|NCT02146430|37769350|FG001|Overall Study|Protocol Violation|4|||
16825614|NCT02146430|37769351|FG002|Overall Study|Protocol Violation|8|||
16825615|NCT02146430|37769352|FG003|Overall Study|Protocol Violation|6|||
16825616|NCT02146430|37769349|FG000|Overall Study|Lack of Efficacy|13|||
16825617|NCT02146430|37769350|FG001|Overall Study|Lack of Efficacy|11|||
16825618|NCT02146430|37769351|FG002|Overall Study|Lack of Efficacy|8|||
16825619|NCT02146430|37769352|FG003|Overall Study|Lack of Efficacy|5|||
16825620|NCT02146430|37769349|FG000|Overall Study|Adverse Event|20|||
16825621|NCT02146430|37769350|FG001|Overall Study|Adverse Event|40|||
16825622|NCT02146430|37769351|FG002|Overall Study|Adverse Event|32|||
16825623|NCT02146430|37769352|FG003|Overall Study|Adverse Event|49|||
16825624|NCT02146430|37769349|FG000|Overall Study|Reason missing or not reported|2|||
16825625|NCT02146430|37769350|FG001|Overall Study|Reason missing or not reported|3|||
16825626|NCT02146430|37769351|FG002|Overall Study|Reason missing or not reported|4|||
16825627|NCT02146430|37769352|FG003|Overall Study|Reason missing or not reported|5|||
16825628|NCT02146430|37769349|FG000|Overall Study|Withdrawal by Subject|27|||
16825629|NCT02146430|37769350|FG001|Overall Study|Withdrawal by Subject|29|||
16825630|NCT02146430|37769351|FG002|Overall Study|Withdrawal by Subject|30|||
16825631|NCT02146430|37769352|FG003|Overall Study|Withdrawal by Subject|34|||
16825632|NCT02129192|37769368|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
16825633|NCT02129192|37769369|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
16825634|NCT02105948|37769382|FG000|Overall Study|Adverse Event|10|||
16825635|NCT02105948|37769383|FG001|Overall Study|Adverse Event|7|||
16825636|NCT02105948|37769384|FG002|Overall Study|Adverse Event|11|||
16825637|NCT02105948|37769385|FG003|Overall Study|Adverse Event|11|||
16825638|NCT02105948|37769382|FG000|Overall Study|Lack of Efficacy|0|||
16825639|NCT02105948|37769383|FG001|Overall Study|Lack of Efficacy|1|||
16825640|NCT02105948|37769384|FG002|Overall Study|Lack of Efficacy|3|||
16825641|NCT02105948|37769385|FG003|Overall Study|Lack of Efficacy|2|||
16825642|NCT02105948|37769382|FG000|Overall Study|Lost to Follow-up|0|||
16825643|NCT02105948|37769383|FG001|Overall Study|Lost to Follow-up|0|||
16825644|NCT02105948|37769384|FG002|Overall Study|Lost to Follow-up|2|||
16825645|NCT02105948|37769385|FG003|Overall Study|Lost to Follow-up|1|||
16825646|NCT02105948|37769382|FG000|Overall Study|Physician Decision|2|||
16825647|NCT02105948|37769383|FG001|Overall Study|Physician Decision|2|||
16825648|NCT02105948|37769384|FG002|Overall Study|Physician Decision|2|||
16825649|NCT02105948|37769385|FG003|Overall Study|Physician Decision|2|||
16825650|NCT02105948|37769382|FG000|Overall Study|Withdrawal by Subject|15|||
16825651|NCT02105948|37769383|FG001|Overall Study|Withdrawal by Subject|10|||
16825652|NCT02105948|37769384|FG002|Overall Study|Withdrawal by Subject|10|||
16825653|NCT02105948|37769385|FG003|Overall Study|Withdrawal by Subject|11|||
16825654|NCT02128724|37769400|FG000|Overall Study|Death|1|||
16825655|NCT02128724|37769401|FG001|Overall Study|Death|0|||
16825656|NCT02128724|37769402|FG002|Overall Study|Death|0|||
16825657|NCT02128724|37769403|FG003|Overall Study|Death|0|||
16825658|NCT02128724|37769400|FG000|Overall Study|Adverse Event|0|||
16825659|NCT02128724|37769401|FG001|Overall Study|Adverse Event|1|||
16825660|NCT02128724|37769402|FG002|Overall Study|Adverse Event|0|||
16825661|NCT02128724|37769403|FG003|Overall Study|Adverse Event|0|||
16825662|NCT02128724|37769400|FG000|Overall Study|Physician Decision|0|||
16825663|NCT02128724|37769401|FG001|Overall Study|Physician Decision|0|||
16825664|NCT02128724|37769402|FG002|Overall Study|Physician Decision|0|||
16825665|NCT02128724|37769403|FG003|Overall Study|Physician Decision|2|||
16825666|NCT02128724|37769400|FG000|Overall Study|Withdrawal by Subject|0|||
16825667|NCT02128724|37769401|FG001|Overall Study|Withdrawal by Subject|0|||
16825668|NCT02128724|37769402|FG002|Overall Study|Withdrawal by Subject|0|||
16825669|NCT02128724|37769403|FG003|Overall Study|Withdrawal by Subject|1|||
16825670|NCT02128490|37769417|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16825671|NCT02128490|37769418|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16825672|NCT02128490|37769419|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
16825673|NCT02128490|37769420|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
16825674|NCT02128490|37769421|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
16825675|NCT02128490|37769417|FG000|Overall Study|Major Protocol Deviation|1|||
16825676|NCT02128490|37769418|FG001|Overall Study|Major Protocol Deviation|2|||
16825677|NCT02128490|37769419|FG002|Overall Study|Major Protocol Deviation|0|||
16825678|NCT02128490|37769420|FG003|Overall Study|Major Protocol Deviation|2|||
16825679|NCT02128490|37769421|FG004|Overall Study|Major Protocol Deviation|2|||
16825680|NCT02128490|37769417|FG000|Overall Study|Lost to Follow-up|0|||
16825681|NCT02128490|37769418|FG001|Overall Study|Lost to Follow-up|0|||
16825682|NCT02128490|37769419|FG002|Overall Study|Lost to Follow-up|1|||
16825683|NCT02128490|37769420|FG003|Overall Study|Lost to Follow-up|1|||
16825684|NCT02128490|37769421|FG004|Overall Study|Lost to Follow-up|1|||
16825685|NCT02128490|37769417|FG000|Overall Study|Voluntary Withdrawal|3|||
16825686|NCT02128490|37769418|FG001|Overall Study|Voluntary Withdrawal|3|||
16825687|NCT02128490|37769419|FG002|Overall Study|Voluntary Withdrawal|1|||
16825688|NCT02128490|37769420|FG003|Overall Study|Voluntary Withdrawal|1|||
16825689|NCT02128490|37769421|FG004|Overall Study|Voluntary Withdrawal|2|||
16825690|NCT02128490|37769417|FG000|Overall Study|Lack of Efficacy|0|||
16825691|NCT02128490|37769418|FG001|Overall Study|Lack of Efficacy|1|||
16825692|NCT02128490|37769419|FG002|Overall Study|Lack of Efficacy|0|||
16825693|NCT02128490|37769420|FG003|Overall Study|Lack of Efficacy|0|||
16825694|NCT02128490|37769421|FG004|Overall Study|Lack of Efficacy|0|||
16825695|NCT02128490|37769417|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
16825696|NCT02128490|37769418|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
16825697|NCT02128490|37769419|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
16825698|NCT02128490|37769420|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
16825699|NCT02128490|37769421|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
16825700|NCT02128490|37769417|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16825701|NCT02128490|37769418|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16825702|NCT02128490|37769419|FG002|Overall Study|Other Miscellaneous Reasons|2|||
16825703|NCT02128490|37769420|FG003|Overall Study|Other Miscellaneous Reasons|1|||
16825704|NCT02128490|37769421|FG004|Overall Study|Other Miscellaneous Reasons|1|||
16825705|NCT02146352|37769433|FG000|Overall Study|Death|1|||
16825706|NCT02146352|37769433|FG000|Overall Study|Patient entered hospice care|1|||
16825707|NCT02146274|37769437|FG000|Overall Study|Protocol Violation|73|||
16825708|NCT02105636|37769446|FG000|Pre-Treatment|Disease Progression|1|||
16825709|NCT02105636|37769447|FG001|Pre-Treatment|Disease Progression|0|||
16825710|NCT02105636|37769446|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
16825711|NCT02105636|37769447|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
16825712|NCT02105636|37769446|FG000|Pre-Treatment|Participant withdrew consent|0|||
16825713|NCT02105636|37769447|FG001|Pre-Treatment|Participant withdrew consent|6|||
16825714|NCT02105636|37769446|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
16825715|NCT02105636|37769447|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
16825716|NCT02105636|37769446|FG000|Treatment|Study Drug Toxicity|14|||
16825717|NCT02105636|37769447|FG001|Treatment|Study Drug Toxicity|10|||
16825718|NCT02105636|37769446|FG000|Treatment|Adverse event unrelated to study drug|19|||
16825719|NCT02105636|37769447|FG001|Treatment|Adverse event unrelated to study drug|3|||
16825720|NCT02105636|37769446|FG000|Treatment|Participant request to discontinue study treatment|8|||
16825721|NCT02105636|37769447|FG001|Treatment|Participant request to discontinue study treatment|6|||
16825722|NCT02105636|37769446|FG000|Treatment|Participant withdrew consent|5|||
16825723|NCT02105636|37769447|FG001|Treatment|Participant withdrew consent|1|||
16825724|NCT02105636|37769446|FG000|Treatment|Lost to Follow-up|1|||
16825725|NCT02105636|37769447|FG001|Treatment|Lost to Follow-up|0|||
16825726|NCT02105636|37769446|FG000|Treatment|Maximum Clinical Benefit|1|||
16825727|NCT02105636|37769447|FG001|Treatment|Maximum Clinical Benefit|3|||
16825728|NCT02105636|37769446|FG000|Treatment|Poor/Non-compliance|0|||
16825729|NCT02105636|37769447|FG001|Treatment|Poor/Non-compliance|1|||
16825730|NCT02105636|37769446|FG000|Treatment|Participant no longer meets study criteria|1|||
16825731|NCT02105636|37769447|FG001|Treatment|Participant no longer meets study criteria|0|||
16825732|NCT02105636|37769446|FG000|Treatment|Other reasons|1|||
16825733|NCT02105636|37769447|FG001|Treatment|Other reasons|0|||
16825734|NCT02105636|37769446|FG000|Treatment|Disease Progression|185|||
16825735|NCT02105636|37769447|FG001|Treatment|Disease Progression|87|||
16825736|NCT01626872|37769456|FG000|Overall Study|Physician Decision|13|||
16825737|NCT01626872|37769457|FG001|Overall Study|Physician Decision|9|||
16825738|NCT01626872|37769458|FG002|Overall Study|Physician Decision|6|||
16825739|NCT01626872|37769456|FG000|Overall Study|Withdrawal by Subject|19|||
16825740|NCT01626872|37769457|FG001|Overall Study|Withdrawal by Subject|27|||
16825741|NCT01626872|37769458|FG002|Overall Study|Withdrawal by Subject|8|||
16825742|NCT01626872|37769456|FG000|Overall Study|Adverse Event (including Death)|20|||
16825743|NCT01626872|37769457|FG001|Overall Study|Adverse Event (including Death)|28|||
16825744|NCT01626872|37769458|FG002|Overall Study|Adverse Event (including Death)|8|||
16825745|NCT01626872|37769456|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
16825746|NCT01626872|37769457|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
16825747|NCT01626872|37769458|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
16825748|NCT01598090|37769469|FG000|Treatment Period|Poor/non-compliance|0|||
16825749|NCT01598090|37769470|FG001|Treatment Period|Poor/non-compliance|2|||
16825750|NCT01598090|37769471|FG002|Treatment Period|Poor/non-compliance|0|||
16825751|NCT01598090|37769469|FG000|Treatment Period|No longer meet study criteria|0|||
16825752|NCT01598090|37769470|FG001|Treatment Period|No longer meet study criteria|1|||
16825753|NCT01598090|37769471|FG002|Treatment Period|No longer meet study criteria|0|||
16825754|NCT01598090|37769469|FG000|Treatment Period|Lack of Efficacy|5|||
16825755|NCT01598090|37769470|FG001|Treatment Period|Lack of Efficacy|14|||
16825756|NCT01598090|37769471|FG002|Treatment Period|Lack of Efficacy|6|||
16825757|NCT01598090|37769469|FG000|Treatment Period|Adverse Event|2|||
16825758|NCT01598090|37769470|FG001|Treatment Period|Adverse Event|33|||
16825759|NCT01598090|37769471|FG002|Treatment Period|Adverse Event|17|||
16825760|NCT01598090|37769469|FG000|Treatment Period|Other reasons|0|||
16825761|NCT01598090|37769470|FG001|Treatment Period|Other reasons|4|||
16825762|NCT01598090|37769471|FG002|Treatment Period|Other reasons|1|||
16825763|NCT01598090|37769469|FG000|Treatment Period|Withdrawal by Subject|3|||
16825764|NCT01598090|37769470|FG001|Treatment Period|Withdrawal by Subject|13|||
16825765|NCT01598090|37769471|FG002|Treatment Period|Withdrawal by Subject|10|||
16825766|NCT01598090|37769469|FG000|Treatment Period|Lost to Follow-up|1|||
16825767|NCT01598090|37769470|FG001|Treatment Period|Lost to Follow-up|5|||
16825768|NCT01598090|37769471|FG002|Treatment Period|Lost to Follow-up|1|||
16825769|NCT01598090|37769469|FG000|Follow-up Period|Death|0|||
16825770|NCT01598090|37769470|FG001|Follow-up Period|Death|1|||
16825771|NCT01598090|37769471|FG002|Follow-up Period|Death|0|||
16825772|NCT01598090|37769469|FG000|Follow-up Period|No longer required per protocol|1|||
16825773|NCT01598090|37769470|FG001|Follow-up Period|No longer required per protocol|3|||
16825774|NCT01598090|37769471|FG002|Follow-up Period|No longer required per protocol|2|||
16825775|NCT01598090|37769469|FG000|Follow-up Period|Not reported|0|||
16825776|NCT01598090|37769470|FG001|Follow-up Period|Not reported|10|||
16825777|NCT01598090|37769471|FG002|Follow-up Period|Not reported|4|||
16825778|NCT01598090|37769469|FG000|Follow-up Period|Withdrawal by Subject|0|||
16825779|NCT01598090|37769470|FG001|Follow-up Period|Withdrawal by Subject|3|||
16825780|NCT01598090|37769471|FG002|Follow-up Period|Withdrawal by Subject|2|||
16825781|NCT01598090|37769469|FG000|Follow-up Period|Other reasons|2|||
16825782|NCT01598090|37769470|FG001|Follow-up Period|Other reasons|8|||
16825783|NCT01598090|37769471|FG002|Follow-up Period|Other reasons|8|||
16825784|NCT01598090|37769469|FG000|Follow-up Period|Lost to Follow-up|2|||
16825785|NCT01598090|37769470|FG001|Follow-up Period|Lost to Follow-up|10|||
16825786|NCT01598090|37769471|FG002|Follow-up Period|Lost to Follow-up|12|||
16825787|NCT02105012|37769482|FG000|Overall Study|Withdrawal by Subject|11|||
16825788|NCT02105012|37769482|FG000|Overall Study|Protocol Specified Criteria|9|||
16825789|NCT02105012|37769482|FG000|Overall Study|Lost to Follow-up|4|||
16825790|NCT02105012|37769482|FG000|Overall Study|Protocol Violation|4|||
16825791|NCT02105012|37769482|FG000|Overall Study|Physician Decision|3|||
16825792|NCT02105012|37769482|FG000|Overall Study|Adverse Event|1|||
16825793|NCT02105012|37769482|FG000|Overall Study|Lack of Efficacy|1|||
16825794|NCT02145182|37769496|FG000|Overall Study|Adverse Event|4|||
16825795|NCT02145182|37769497|FG001|Overall Study|Adverse Event|1|||
16825796|NCT02145182|37769496|FG000|Overall Study|Death|7|||
16825797|NCT02145182|37769497|FG001|Overall Study|Death|7|||
16825798|NCT02145182|37769496|FG000|Overall Study|Lost to Follow-up|2|||
16825799|NCT02145182|37769497|FG001|Overall Study|Lost to Follow-up|2|||
16825800|NCT02145182|37769496|FG000|Overall Study|Pre-transplant Withdrawal|0|||
16825801|NCT02145182|37769497|FG001|Overall Study|Pre-transplant Withdrawal|2|||
16825802|NCT02145182|37769496|FG000|Overall Study|Withdrawal by Subject|5|||
16825803|NCT02145182|37769497|FG001|Overall Study|Withdrawal by Subject|4|||
16825804|NCT02145026|37769503|FG000|Overall Study|Adverse Event|2|||
16825805|NCT02145026|37769503|FG000|Overall Study|Death|4|||
16825806|NCT02145026|37769503|FG000|Overall Study|Withdrawal by Subject|2|||
16825807|NCT02145026|37769503|FG000|Overall Study|Physician Decision|4|||
16825808|NCT02144012|37769509|FG000|Overall Study|Adverse Event|1|||
16825809|NCT02144012|37769510|FG001|Overall Study|Adverse Event|0|||
16825810|NCT02144012|37769509|FG000|Overall Study|Death|1|||
16825811|NCT02144012|37769510|FG001|Overall Study|Death|0|||
16825812|NCT02144012|37769509|FG000|Overall Study|Withdrawal by Subject|11|||
16825813|NCT02144012|37769510|FG001|Overall Study|Withdrawal by Subject|3|||
16825814|NCT02144012|37769509|FG000|Overall Study|Study Terminated by Sponsor|18|||
16825815|NCT02144012|37769510|FG001|Overall Study|Study Terminated by Sponsor|12|||
16825816|NCT02144012|37769509|FG000|Overall Study|Other|3|||
16825817|NCT02144012|37769510|FG001|Overall Study|Other|0|||
16825818|NCT02103062|37769518|FG000|Overall Study|Adverse Event|1|||
16825819|NCT02103062|37769519|FG001|Overall Study|Adverse Event|2|||
16825820|NCT02103062|37769518|FG000|Overall Study|Progressive Disease|17|||
16825821|NCT02103062|37769519|FG001|Overall Study|Progressive Disease|20|||
16825822|NCT02103062|37769518|FG000|Overall Study|Death|0|||
16825823|NCT02103062|37769519|FG001|Overall Study|Death|1|||
16825824|NCT02141984|37769527|FG000|Overall Study|Lack of Efficacy|2|||
16825825|NCT02141672|37769534|FG000|Overall Study|Adverse Event|0|||
16825826|NCT02141672|37769535|FG001|Overall Study|Adverse Event|1|||
16825827|NCT02141672|37769536|FG002|Overall Study|Adverse Event|0|||
16825828|NCT02141672|37769534|FG000|Overall Study|Death|10|||
16825829|NCT02141672|37769535|FG001|Overall Study|Death|2|||
16825830|NCT02141672|37769536|FG002|Overall Study|Death|1|||
16825831|NCT02141672|37769534|FG000|Overall Study|Lack of Efficacy|0|||
16825832|NCT02141672|37769535|FG001|Overall Study|Lack of Efficacy|0|||
16825833|NCT02141672|37769536|FG002|Overall Study|Lack of Efficacy|2|||
16825834|NCT02141672|37769534|FG000|Overall Study|Lost to Follow-up|1|||
16825835|NCT02141672|37769535|FG001|Overall Study|Lost to Follow-up|1|||
16825836|NCT02141672|37769536|FG002|Overall Study|Lost to Follow-up|3|||
16825837|NCT02141672|37769534|FG000|Overall Study|Physician Decision|1|||
16825838|NCT02141672|37769535|FG001|Overall Study|Physician Decision|2|||
16825839|NCT02141672|37769536|FG002|Overall Study|Physician Decision|5|||
16825840|NCT02141672|37769534|FG000|Overall Study|Protocol Violation|0|||
16825841|NCT02141672|37769535|FG001|Overall Study|Protocol Violation|0|||
16825842|NCT02141672|37769536|FG002|Overall Study|Protocol Violation|1|||
16825843|NCT02141672|37769534|FG000|Overall Study|Withdrawal by Subject|3|||
16825844|NCT02141672|37769535|FG001|Overall Study|Withdrawal by Subject|2|||
16825845|NCT02141672|37769536|FG002|Overall Study|Withdrawal by Subject|5|||
16825846|NCT02141672|37769534|FG000|Overall Study|refused to follow-up|1|||
16825847|NCT02141672|37769535|FG001|Overall Study|refused to follow-up|0|||
16825848|NCT02141672|37769536|FG002|Overall Study|refused to follow-up|1|||
16825849|NCT02141516|37769547|FG000|Overall Study|Adverse Event|0|||
16825850|NCT02141516|37769548|FG001|Overall Study|Adverse Event|1|||
16825851|NCT02141516|37769549|FG002|Overall Study|Adverse Event|0|||
16825852|NCT02141516|37769547|FG000|Overall Study|Lost to Follow-up|0|||
16825853|NCT02141516|37769548|FG001|Overall Study|Lost to Follow-up|1|||
16825854|NCT02141516|37769549|FG002|Overall Study|Lost to Follow-up|0|||
16825855|NCT02141516|37769547|FG000|Overall Study|Other|0|||
16825856|NCT02141516|37769548|FG001|Overall Study|Other|3|||
16825857|NCT02141516|37769549|FG002|Overall Study|Other|0|||
16825858|NCT02141360|37769563|FG000|Overall Study|Withdrawal by Subject|6|||
16825859|NCT02141360|37769564|FG001|Overall Study|Withdrawal by Subject|0|||
16825860|NCT02141360|37769565|FG002|Overall Study|Withdrawal by Subject|0|||
16825861|NCT02141360|37769563|FG000|Overall Study|Study Terminated before Visit|1|||
16825862|NCT02141360|37769564|FG001|Overall Study|Study Terminated before Visit|0|||
16825863|NCT02141360|37769565|FG002|Overall Study|Study Terminated before Visit|0|||
16825864|NCT01628198|37769573|FG000|Overall Study|Lost to Follow-up|7|||
16825865|NCT01628198|37769573|FG000|Overall Study|Withdrawal by Subject|10|||
16825866|NCT01628198|37769573|FG000|Overall Study|Screen failure|1|||
16825867|NCT01628120|37769577|FG000|Overall Study|Withdrawal by Subject|7|||
16825868|NCT01628120|37769577|FG000|Overall Study|Adverse Event|12|||
16825869|NCT01628120|37769577|FG000|Overall Study|Lost to Follow-up|1|||
16825870|NCT01628120|37769577|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
16825871|NCT01628120|37769577|FG000|Overall Study|Non-compliant with Study Procedures|1|||
16825872|NCT01628120|37769577|FG000|Overall Study|Not Treated|3|||
16825873|NCT01628120|37769577|FG000|Overall Study|Sponsor Decision|5|||
16825874|NCT01628120|37769577|FG000|Overall Study|Switched Dialysis Method|2|||
16825875|NCT01628120|37769577|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
16825876|NCT01628120|37769577|FG000|Overall Study|Moved or Relocated|5|||
16825877|NCT01628120|37769577|FG000|Overall Study|Kidney Transplant|2|||
16825878|NCT01628120|37769577|FG000|Overall Study|Use of Standard of Care|1|||
16825879|NCT01627340|37769583|FG000|Overall Study|Adverse Event|1|||
16825880|NCT01627340|37769584|FG001|Overall Study|Adverse Event|0|||
16825881|NCT01627340|37769583|FG000|Overall Study|Lost to Follow-up|8|||
16825882|NCT01627340|37769584|FG001|Overall Study|Lost to Follow-up|4|||
16825883|NCT01627340|37769583|FG000|Overall Study|Pregnancy|1|||
16825884|NCT01627340|37769584|FG001|Overall Study|Pregnancy|0|||
16825885|NCT01627340|37769583|FG000|Overall Study|Withdrawal by Subject|2|||
16825886|NCT01627340|37769584|FG001|Overall Study|Withdrawal by Subject|0|||
16825887|NCT02125838|37769594|FG000|Overall Study|Lost to Follow-up|4|||
16825888|NCT02125838|37769595|FG001|Overall Study|Lost to Follow-up|4|||
16825889|NCT02125604|37769601|FG000|Overall Study|Other|4|||
16825890|NCT02125604|37769601|FG000|Overall Study|Investigator Decision|1|||
16825891|NCT02125604|37769601|FG000|Overall Study|Lost to Follow-up|2|||
16825892|NCT02125604|37769601|FG000|Overall Study|Consent Withdrawn|4|||
16825893|NCT02125604|37769601|FG000|Overall Study|Adverse Event|20|||
16825894|NCT02124746|37769608|FG000|Overall Study|Adverse Event|2|||
16825895|NCT02124746|37769609|FG001|Overall Study|Adverse Event|1|||
16825896|NCT02124746|37769610|FG002|Overall Study|Adverse Event|2|||
16825897|NCT02124746|37769608|FG000|Overall Study|Death|2|||
16912064|NCT01508910|38021164|FG000|Treatment|Withdrawal by Subject|0|||
16912065|NCT01508910|38021165|FG001|Treatment|Withdrawal by Subject|1|||
16912066|NCT01508910|38021166|FG002|Treatment|Withdrawal by Subject|6|||
16912067|NCT01508910|38021167|FG003|Treatment|Withdrawal by Subject|1|||
16912068|NCT01508910|38021164|FG000|Treatment|Sponsor Decision|0|||
16912069|NCT01508910|38021165|FG001|Treatment|Sponsor Decision|0|||
16912070|NCT01508910|38021166|FG002|Treatment|Sponsor Decision|0|||
16912071|NCT01508910|38021167|FG003|Treatment|Sponsor Decision|1|||
16912072|NCT01462110|38021181|FG000|Overall Study|Adverse Event|1|||
16825898|NCT02124746|37769609|FG001|Overall Study|Death|1|||
16825899|NCT02124746|37769610|FG002|Overall Study|Death|3|||
16825900|NCT02124746|37769608|FG000|Overall Study|Lack of Efficacy|3|||
16912073|NCT01462110|38021182|FG001|Overall Study|Adverse Event|0|||
16825901|NCT02124746|37769609|FG001|Overall Study|Lack of Efficacy|2|||
16825902|NCT02124746|37769610|FG002|Overall Study|Lack of Efficacy|2|||
16912074|NCT01508676|38021190|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
16825903|NCT02124746|37769608|FG000|Overall Study|Physician Decision|6|||
16825904|NCT02124746|37769609|FG001|Overall Study|Physician Decision|4|||
16825905|NCT02124746|37769610|FG002|Overall Study|Physician Decision|5|||
16825906|NCT02124746|37769608|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16825907|NCT02124746|37769609|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16825908|NCT02124746|37769610|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16825909|NCT02124746|37769608|FG000|Overall Study|Withdrawal by Subject|3|||
16825910|NCT02124746|37769609|FG001|Overall Study|Withdrawal by Subject|3|||
16825911|NCT02124746|37769610|FG002|Overall Study|Withdrawal by Subject|0|||
16825912|NCT02124746|37769608|FG000|Overall Study|Study Terminated by Sponsor|0|||
16825913|NCT02124746|37769609|FG001|Overall Study|Study Terminated by Sponsor|0|||
16825914|NCT02124746|37769610|FG002|Overall Study|Study Terminated by Sponsor|6|||
16825915|NCT02124746|37769608|FG000|Overall Study|Disease Progression|3|||
16825916|NCT02124746|37769609|FG001|Overall Study|Disease Progression|6|||
16825917|NCT02124746|37769610|FG002|Overall Study|Disease Progression|4|||
16825918|NCT02123966|37769618|FG000|Overall Study|Intercurrent Illness|1|||
16825919|NCT02123576|37769624|FG000|Overall Study|Adverse Event|1|||
16825920|NCT02123576|37769625|FG001|Overall Study|Adverse Event|0|||
16825921|NCT01177397|37769643|FG000|Overall Study|Protocol Violation|0|||
16825922|NCT01177397|37769644|FG001|Overall Study|Protocol Violation|0|||
16825923|NCT01177397|37769645|FG002|Overall Study|Protocol Violation|0|||
16825924|NCT01177397|37769646|FG003|Overall Study|Protocol Violation|0|||
16825925|NCT01177397|37769647|FG004|Overall Study|Protocol Violation|0|||
16825926|NCT01177397|37769648|FG005|Overall Study|Protocol Violation|1|||
16825927|NCT01177397|37769649|FG006|Overall Study|Protocol Violation|0|||
16825928|NCT01177397|37769650|FG007|Overall Study|Protocol Violation|0|||
16825929|NCT01177397|37769651|FG008|Overall Study|Protocol Violation|0|||
16825930|NCT01177397|37769652|FG009|Overall Study|Protocol Violation|0|||
16825931|NCT01177397|37769653|FG010|Overall Study|Protocol Violation|0|||
16825932|NCT01177397|37769654|FG011|Overall Study|Protocol Violation|0|||
16825933|NCT01177397|37769643|FG000|Overall Study|Lost to Follow-up|0|||
16825934|NCT01177397|37769644|FG001|Overall Study|Lost to Follow-up|0|||
16825935|NCT01177397|37769645|FG002|Overall Study|Lost to Follow-up|0|||
16825936|NCT01177397|37769646|FG003|Overall Study|Lost to Follow-up|0|||
16825937|NCT01177397|37769647|FG004|Overall Study|Lost to Follow-up|1|||
16825938|NCT01177397|37769648|FG005|Overall Study|Lost to Follow-up|0|||
16825939|NCT01177397|37769649|FG006|Overall Study|Lost to Follow-up|0|||
16825940|NCT01177397|37769650|FG007|Overall Study|Lost to Follow-up|2|||
16825941|NCT01177397|37769651|FG008|Overall Study|Lost to Follow-up|0|||
16825942|NCT01177397|37769652|FG009|Overall Study|Lost to Follow-up|0|||
16825943|NCT01177397|37769653|FG010|Overall Study|Lost to Follow-up|0|||
16825944|NCT01177397|37769654|FG011|Overall Study|Lost to Follow-up|0|||
16825945|NCT01177397|37769643|FG000|Overall Study|Death|0|||
16825946|NCT01177397|37769644|FG001|Overall Study|Death|0|||
16825947|NCT01177397|37769645|FG002|Overall Study|Death|1|||
16825948|NCT01177397|37769646|FG003|Overall Study|Death|1|||
16825949|NCT01177397|37769647|FG004|Overall Study|Death|0|||
16825950|NCT01177397|37769648|FG005|Overall Study|Death|0|||
16825951|NCT01177397|37769649|FG006|Overall Study|Death|0|||
16825952|NCT01177397|37769650|FG007|Overall Study|Death|5|||
16825953|NCT01177397|37769651|FG008|Overall Study|Death|2|||
16825954|NCT01177397|37769652|FG009|Overall Study|Death|1|||
16825955|NCT01177397|37769653|FG010|Overall Study|Death|0|||
16825956|NCT01177397|37769654|FG011|Overall Study|Death|0|||
16825957|NCT01177397|37769643|FG000|Overall Study|Withdrawal by Subject|0|||
16825958|NCT01177397|37769644|FG001|Overall Study|Withdrawal by Subject|0|||
16825959|NCT01177397|37769645|FG002|Overall Study|Withdrawal by Subject|1|||
16825960|NCT01177397|37769646|FG003|Overall Study|Withdrawal by Subject|1|||
16825961|NCT01177397|37769647|FG004|Overall Study|Withdrawal by Subject|1|||
16825962|NCT01177397|37769648|FG005|Overall Study|Withdrawal by Subject|2|||
16825963|NCT01177397|37769649|FG006|Overall Study|Withdrawal by Subject|0|||
16825964|NCT01177397|37769650|FG007|Overall Study|Withdrawal by Subject|5|||
16825965|NCT01177397|37769651|FG008|Overall Study|Withdrawal by Subject|9|||
16825966|NCT01177397|37769652|FG009|Overall Study|Withdrawal by Subject|1|||
16825967|NCT01177397|37769653|FG010|Overall Study|Withdrawal by Subject|1|||
16825968|NCT01177397|37769654|FG011|Overall Study|Withdrawal by Subject|0|||
16825969|NCT01177397|37769643|FG000|Overall Study|Adverse Event|0|||
16825970|NCT01177397|37769644|FG001|Overall Study|Adverse Event|0|||
16825971|NCT01177397|37769645|FG002|Overall Study|Adverse Event|1|||
16825972|NCT01177397|37769646|FG003|Overall Study|Adverse Event|2|||
16825973|NCT01177397|37769647|FG004|Overall Study|Adverse Event|0|||
16825974|NCT01177397|37769648|FG005|Overall Study|Adverse Event|12|||
16825975|NCT01177397|37769649|FG006|Overall Study|Adverse Event|1|||
16825976|NCT01177397|37769650|FG007|Overall Study|Adverse Event|14|||
16825977|NCT01177397|37769651|FG008|Overall Study|Adverse Event|8|||
16825978|NCT01177397|37769652|FG009|Overall Study|Adverse Event|6|||
16825979|NCT01177397|37769653|FG010|Overall Study|Adverse Event|3|||
16825980|NCT01177397|37769654|FG011|Overall Study|Adverse Event|7|||
16825981|NCT01177397|37769643|FG000|Overall Study|Disease progression|1|||
16825982|NCT01177397|37769644|FG001|Overall Study|Disease progression|2|||
16825983|NCT01177397|37769645|FG002|Overall Study|Disease progression|5|||
16825984|NCT01177397|37769646|FG003|Overall Study|Disease progression|5|||
16825985|NCT01177397|37769647|FG004|Overall Study|Disease progression|4|||
16825986|NCT01177397|37769648|FG005|Overall Study|Disease progression|10|||
16825987|NCT01177397|37769649|FG006|Overall Study|Disease progression|10|||
16825988|NCT01177397|37769650|FG007|Overall Study|Disease progression|21|||
16825989|NCT01177397|37769651|FG008|Overall Study|Disease progression|18|||
16825990|NCT01177397|37769652|FG009|Overall Study|Disease progression|12|||
16825991|NCT01177397|37769653|FG010|Overall Study|Disease progression|10|||
16825992|NCT01177397|37769654|FG011|Overall Study|Disease progression|8|||
16825993|NCT01177397|37769643|FG000|Overall Study|Other reasons|0|||
16825994|NCT01177397|37769644|FG001|Overall Study|Other reasons|0|||
16825995|NCT01177397|37769645|FG002|Overall Study|Other reasons|1|||
16825996|NCT01177397|37769646|FG003|Overall Study|Other reasons|0|||
16825997|NCT01177397|37769647|FG004|Overall Study|Other reasons|1|||
16825998|NCT01177397|37769648|FG005|Overall Study|Other reasons|1|||
16825999|NCT01177397|37769649|FG006|Overall Study|Other reasons|2|||
16826000|NCT01177397|37769650|FG007|Overall Study|Other reasons|6|||
16826001|NCT01177397|37769651|FG008|Overall Study|Other reasons|10|||
16826002|NCT01177397|37769652|FG009|Overall Study|Other reasons|8|||
16826003|NCT01177397|37769653|FG010|Overall Study|Other reasons|0|||
16826004|NCT01177397|37769654|FG011|Overall Study|Other reasons|2|||
16826005|NCT00864227|37769695|FG000|Overall Study|Withdrawal by Subject|1|||
16826006|NCT00864227|37769695|FG000|Overall Study|Disease Relapse/Progression|3|||
16826007|NCT02102204|37769699|FG000|Overall Study|Withdrawal by Subject|137|||
16826008|NCT02102204|37769699|FG000|Overall Study|Death|92|||
16826009|NCT02102204|37769699|FG000|Overall Study|Lost to Follow-up|65|||
16826010|NCT02102204|37769699|FG000|Overall Study|Sponsor Decision|5|||
16826011|NCT02102204|37769699|FG000|Overall Study|Ongoing|5|||
16826012|NCT02141204|37769705|FG000|Overall Study|Lost to Follow-up|2|||
16826013|NCT02141204|37769706|FG001|Overall Study|Lost to Follow-up|1|||
16826014|NCT02141204|37769705|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
16826015|NCT02141204|37769706|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
16826016|NCT02141204|37769705|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
16826017|NCT02141204|37769706|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
16826018|NCT02141204|37769705|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
16826019|NCT02141204|37769706|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
16826020|NCT02140970|37769714|FG000|Overall Study|Lost to Follow-up|1|||
16826021|NCT02140970|37769715|FG001|Overall Study|Lost to Follow-up|2|||
16826022|NCT02140970|37769714|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
16826023|NCT02140970|37769715|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
16826024|NCT02140970|37769714|FG000|Overall Study|Did not meet inclusion criteria|0|||
16826025|NCT02140970|37769715|FG001|Overall Study|Did not meet inclusion criteria|1|||
16826026|NCT02101112|37769721|FG000|Overall Study|Adverse Event|0|||
16826027|NCT02101112|37769722|FG001|Overall Study|Adverse Event|0|||
16826028|NCT02101112|37769723|FG002|Overall Study|Adverse Event|1|||
16826029|NCT02101112|37769724|FG003|Overall Study|Adverse Event|0|||
16826030|NCT02101112|37769725|FG004|Overall Study|Adverse Event|0|||
16826031|NCT02101112|37769726|FG005|Overall Study|Adverse Event|0|||
16826032|NCT02101112|37769721|FG000|Overall Study|Withdrawal by Subject|0|||
16826033|NCT02101112|37769722|FG001|Overall Study|Withdrawal by Subject|0|||
16826034|NCT02101112|37769723|FG002|Overall Study|Withdrawal by Subject|0|||
16826035|NCT02101112|37769724|FG003|Overall Study|Withdrawal by Subject|0|||
16826036|NCT02101112|37769725|FG004|Overall Study|Withdrawal by Subject|1|||
16826037|NCT02101112|37769726|FG005|Overall Study|Withdrawal by Subject|0|||
16826038|NCT02139644|37769741|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
16826039|NCT02139644|37769742|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16826040|NCT02139644|37769743|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16826041|NCT02139644|37769744|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16826042|NCT02139644|37769745|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16826043|NCT02139644|37769746|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16826044|NCT02139644|37769741|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
16826045|NCT02139644|37769742|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16826046|NCT02139644|37769743|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16826047|NCT02139644|37769744|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16826048|NCT02139644|37769745|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16826049|NCT02139644|37769746|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16826050|NCT02139644|37769741|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
16826051|NCT02139644|37769742|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16826052|NCT02139644|37769743|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16826053|NCT02139644|37769744|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16826054|NCT02139644|37769745|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
17016721|NCT00854360|38161308|FG002|Overall Study|Adverse Event|2|||
16826055|NCT02139644|37769746|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16826056|NCT02139644|37769741|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
16826057|NCT02139644|37769742|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16826058|NCT02139644|37769743|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16826059|NCT02139644|37769744|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16826060|NCT02139644|37769745|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16826061|NCT02139644|37769746|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16826062|NCT02139644|37769741|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
16826063|NCT02139644|37769742|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16826064|NCT02139644|37769743|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16826065|NCT02139644|37769744|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16826066|NCT02139644|37769745|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16826067|NCT02139644|37769746|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16826068|NCT02139644|37769741|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
16826069|NCT02139644|37769742|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
16826070|NCT02139644|37769743|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
16826071|NCT02139644|37769744|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
16826072|NCT02139644|37769745|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
16826073|NCT02139644|37769746|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
16826074|NCT02139644|37769741|FG000|Run-In Period (Pre-assignment)|Other|6|||
16826075|NCT02139644|37769742|FG001|Run-In Period (Pre-assignment)|Other|0|||
16826076|NCT02139644|37769743|FG002|Run-In Period (Pre-assignment)|Other|0|||
16826077|NCT02139644|37769744|FG003|Run-In Period (Pre-assignment)|Other|0|||
16826078|NCT02139644|37769745|FG004|Run-In Period (Pre-assignment)|Other|0|||
16826079|NCT02139644|37769746|FG005|Run-In Period (Pre-assignment)|Other|0|||
16826080|NCT02139644|37769741|FG000|Treatment Period|Adverse Event|0|||
16826081|NCT02139644|37769742|FG001|Treatment Period|Adverse Event|0|||
16826082|NCT02139644|37769743|FG002|Treatment Period|Adverse Event|3|||
16826083|NCT02139644|37769744|FG003|Treatment Period|Adverse Event|2|||
16826084|NCT02139644|37769745|FG004|Treatment Period|Adverse Event|1|||
16826085|NCT02139644|37769746|FG005|Treatment Period|Adverse Event|6|||
16826086|NCT02139644|37769741|FG000|Treatment Period|Withdrawal by Subject|0|||
16826087|NCT02139644|37769742|FG001|Treatment Period|Withdrawal by Subject|0|||
16826088|NCT02139644|37769743|FG002|Treatment Period|Withdrawal by Subject|2|||
16826089|NCT02139644|37769744|FG003|Treatment Period|Withdrawal by Subject|2|||
16826090|NCT02139644|37769745|FG004|Treatment Period|Withdrawal by Subject|3|||
16826091|NCT02139644|37769746|FG005|Treatment Period|Withdrawal by Subject|2|||
16826092|NCT02139644|37769741|FG000|Treatment Period|Non-compliance|0|||
16826093|NCT02139644|37769742|FG001|Treatment Period|Non-compliance|0|||
16826094|NCT02139644|37769743|FG002|Treatment Period|Non-compliance|0|||
16826095|NCT02139644|37769744|FG003|Treatment Period|Non-compliance|1|||
16826096|NCT02139644|37769745|FG004|Treatment Period|Non-compliance|0|||
16826097|NCT02139644|37769746|FG005|Treatment Period|Non-compliance|0|||
16826098|NCT02139644|37769741|FG000|Treatment Period|Protocol Violation|0|||
16826099|NCT02139644|37769742|FG001|Treatment Period|Protocol Violation|0|||
16826100|NCT02139644|37769743|FG002|Treatment Period|Protocol Violation|0|||
16826101|NCT02139644|37769744|FG003|Treatment Period|Protocol Violation|1|||
16826102|NCT02139644|37769745|FG004|Treatment Period|Protocol Violation|1|||
16826103|NCT02139644|37769746|FG005|Treatment Period|Protocol Violation|1|||
16826104|NCT02139644|37769741|FG000|Treatment Period|Disease progression|0|||
16826105|NCT02139644|37769742|FG001|Treatment Period|Disease progression|0|||
16826106|NCT02139644|37769743|FG002|Treatment Period|Disease progression|0|||
16826107|NCT02139644|37769744|FG003|Treatment Period|Disease progression|1|||
16826108|NCT02139644|37769745|FG004|Treatment Period|Disease progression|1|||
16826109|NCT02139644|37769746|FG005|Treatment Period|Disease progression|2|||
16826110|NCT02139644|37769741|FG000|Treatment Period|Lost to Follow-up|0|||
16826111|NCT02139644|37769742|FG001|Treatment Period|Lost to Follow-up|0|||
16826112|NCT02139644|37769743|FG002|Treatment Period|Lost to Follow-up|1|||
16826113|NCT02139644|37769744|FG003|Treatment Period|Lost to Follow-up|1|||
16826114|NCT02139644|37769745|FG004|Treatment Period|Lost to Follow-up|1|||
16826115|NCT02139644|37769746|FG005|Treatment Period|Lost to Follow-up|1|||
16826116|NCT02139644|37769741|FG000|Treatment Period|Lack of Efficacy|0|||
16826117|NCT02139644|37769742|FG001|Treatment Period|Lack of Efficacy|0|||
16826118|NCT02139644|37769743|FG002|Treatment Period|Lack of Efficacy|1|||
16826119|NCT02139644|37769744|FG003|Treatment Period|Lack of Efficacy|0|||
16826120|NCT02139644|37769745|FG004|Treatment Period|Lack of Efficacy|1|||
16826121|NCT02139644|37769746|FG005|Treatment Period|Lack of Efficacy|4|||
16826122|NCT02139644|37769741|FG000|Treatment Period|Other|0|||
16826123|NCT02139644|37769742|FG001|Treatment Period|Other|3|||
16826124|NCT02139644|37769743|FG002|Treatment Period|Other|1|||
16826125|NCT02139644|37769744|FG003|Treatment Period|Other|1|||
16826126|NCT02139644|37769745|FG004|Treatment Period|Other|0|||
16826127|NCT02139644|37769746|FG005|Treatment Period|Other|1|||
16826128|NCT02100644|37769758|FG000|LTG Escalation Phase|Adverse Event|9|||
16826129|NCT02100644|37769759|FG001|LTG Escalation Phase|Adverse Event|0|||
16826130|NCT02100644|37769760|FG002|LTG Escalation Phase|Adverse Event|0|||
17016722|NCT00854360|38161309|FG003|Overall Study|Adverse Event|6|||
16826131|NCT02100644|37769758|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
16826132|NCT02100644|37769759|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
16826133|NCT02100644|37769760|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
16826134|NCT02100644|37769758|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
16826135|NCT02100644|37769759|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
16826136|NCT02100644|37769760|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
16826137|NCT02246621|37769766|FG000|Overall Study|Withdrawal by Subject|28|||
16826138|NCT02246621|37769767|FG001|Overall Study|Withdrawal by Subject|16|||
16826139|NCT02246621|37769766|FG000|Overall Study|Lost to Follow-up|1|||
16826140|NCT02246621|37769767|FG001|Overall Study|Lost to Follow-up|0|||
16826141|NCT02246621|37769766|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
16826142|NCT02246621|37769767|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
16826143|NCT02074982|37769775|FG000|Overall Study|Adverse Event|15|||
16826144|NCT02074982|37769776|FG001|Overall Study|Adverse Event|7|||
16826145|NCT02074982|37769775|FG000|Overall Study|Lack of Efficacy|6|||
16826146|NCT02074982|37769776|FG001|Overall Study|Lack of Efficacy|1|||
16826147|NCT02074982|37769775|FG000|Overall Study|Lost to Follow-up|9|||
16826148|NCT02074982|37769776|FG001|Overall Study|Lost to Follow-up|10|||
16826149|NCT02074982|37769775|FG000|Overall Study|Non-compliance with study treatment|0|||
16826150|NCT02074982|37769776|FG001|Overall Study|Non-compliance with study treatment|2|||
16826151|NCT02074982|37769775|FG000|Overall Study|Physician Decision|1|||
16826152|NCT02074982|37769776|FG001|Overall Study|Physician Decision|1|||
16826153|NCT02074982|37769775|FG000|Overall Study|Pregnancy|1|||
16826154|NCT02074982|37769776|FG001|Overall Study|Pregnancy|2|||
16826155|NCT02074982|37769775|FG000|Overall Study|Protocol deviation|4|||
16826156|NCT02074982|37769776|FG001|Overall Study|Protocol deviation|3|||
16826157|NCT02074982|37769775|FG000|Overall Study|Technical problems|0|||
16826158|NCT02074982|37769776|FG001|Overall Study|Technical problems|2|||
16826159|NCT02074982|37769775|FG000|Overall Study|Subject/guardian decision|15|||
16826160|NCT02074982|37769776|FG001|Overall Study|Subject/guardian decision|24|||
16826161|NCT02074982|37769775|FG000|Overall Study|Death|0|||
16826162|NCT02074982|37769776|FG001|Overall Study|Death|2|||
16826163|NCT02074514|37769786|FG000|Overall Study|Lack of Efficacy|3|||
16826164|NCT02074514|37769787|FG001|Overall Study|Lack of Efficacy|2|||
16826165|NCT02074514|37769786|FG000|Overall Study|Lost to Follow-up|0|||
16826166|NCT02074514|37769787|FG001|Overall Study|Lost to Follow-up|1|||
16826167|NCT02074514|37769786|FG000|Overall Study|Withdrew Consent|0|||
16826168|NCT02074514|37769787|FG001|Overall Study|Withdrew Consent|1|||
16826169|NCT02099708|37769797|FG000|Overall Study|Data Not Available|30|||
16826170|NCT02099708|37769797|FG000|Overall Study|Lost to Follow-up|141|||
16826171|NCT02099708|37769797|FG000|Overall Study|Other|29|||
16826172|NCT02073656|37769801|FG000|Primary Study|Lost to Follow-up|6|||
16826173|NCT02073656|37769801|FG000|Primary Study|Death|1|||
16826174|NCT02073656|37769801|FG000|Primary Study|Withdrew Consent|1|||
16826175|NCT02242643|37769809|FG000|Overall Study|Protocol Violation|1|||
16826176|NCT02242643|37769810|FG001|Overall Study|Protocol Violation|2|||
16826177|NCT02242643|37769809|FG000|Overall Study|Withdrawal by Subject|15|||
16826178|NCT02242643|37769810|FG001|Overall Study|Withdrawal by Subject|10|||
16826179|NCT02242643|37769809|FG000|Overall Study|Migrated/moved from study area|1|||
16826180|NCT02242643|37769810|FG001|Overall Study|Migrated/moved from study area|3|||
16826181|NCT02242643|37769809|FG000|Overall Study|Lost to Follow-up|54|||
16826182|NCT02242643|37769810|FG001|Overall Study|Lost to Follow-up|61|||
16826183|NCT02242643|37769809|FG000|Overall Study|Child placed in foster care by family|0|||
16826184|NCT02242643|37769810|FG001|Overall Study|Child placed in foster care by family|1|||
16826185|NCT02242643|37769809|FG000|Overall Study|Non-compliance|1|||
16826186|NCT02242643|37769810|FG001|Overall Study|Non-compliance|0|||
16826187|NCT02242643|37769809|FG000|Overall Study|Consent withdrawal by parent|1|||
16826188|NCT02242643|37769810|FG001|Overall Study|Consent withdrawal by parent|0|||
16826189|NCT02242643|37769809|FG000|Overall Study|Protocol requirements not followed|1|||
16826190|NCT02242643|37769810|FG001|Overall Study|Protocol requirements not followed|0|||
16826191|NCT02242643|37769809|FG000|Overall Study|Language barrier|1|||
16826192|NCT02242643|37769810|FG001|Overall Study|Language barrier|0|||
16826193|NCT02242643|37769809|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
16826194|NCT02242643|37769810|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
16826195|NCT02097290|37769818|FG000|Overall Study|Death|6|||
16826196|NCT02097290|37769818|FG000|Overall Study|Total Withdrawals|3|||
16826197|NCT02097290|37769818|FG000|Overall Study|Attempt|8|||
16826198|NCT02072174|37769824|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
16826199|NCT02072174|37769825|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
16826200|NCT02072174|37769824|FG000|Overall Study|Protocol Violation|16|||
16826201|NCT02072174|37769825|FG001|Overall Study|Protocol Violation|23|||
16826202|NCT02072174|37769824|FG000|Overall Study|Physician Decision|0|||
16826203|NCT02072174|37769825|FG001|Overall Study|Physician Decision|1|||
16826204|NCT02072174|37769824|FG000|Overall Study|Non-compliance with protocol requirement|2|||
16826205|NCT02072174|37769825|FG001|Overall Study|Non-compliance with protocol requirement|0|||
16826206|NCT02209181|37769837|FG000|Overall Study|Adverse Event|1|||
16826207|NCT02209181|37769838|FG001|Overall Study|Adverse Event|0|||
16826208|NCT02209181|37769839|FG002|Overall Study|Adverse Event|1|||
16826209|NCT02209181|37769840|FG003|Overall Study|Adverse Event|0|||
16826210|NCT02209181|37769837|FG000|Overall Study|Withdrawal by Subject|0|||
16826211|NCT02209181|37769838|FG001|Overall Study|Withdrawal by Subject|1|||
16826212|NCT02209181|37769839|FG002|Overall Study|Withdrawal by Subject|0|||
16826213|NCT02209181|37769840|FG003|Overall Study|Withdrawal by Subject|0|||
16826214|NCT02208089|37769852|FG000|Overall Study|Withdrawal by Subject|1|||
16826215|NCT02208089|37769853|FG001|Overall Study|Withdrawal by Subject|0|||
16826216|NCT02208089|37769852|FG000|Overall Study|Lost to Follow-up|6|||
16826217|NCT02208089|37769853|FG001|Overall Study|Lost to Follow-up|0|||
16826218|NCT02242487|37769862|FG000|Overall Study|Adverse Event|13|||
16826219|NCT02242487|37769863|FG001|Overall Study|Adverse Event|15|||
16826220|NCT02242487|37769862|FG000|Overall Study|Lack of Efficacy|4|||
16826221|NCT02242487|37769863|FG001|Overall Study|Lack of Efficacy|6|||
16826222|NCT02242487|37769862|FG000|Overall Study|Protocol Violation|2|||
16826223|NCT02242487|37769863|FG001|Overall Study|Protocol Violation|0|||
16826224|NCT02242487|37769862|FG000|Overall Study|Lost to Follow-up|2|||
16826225|NCT02242487|37769863|FG001|Overall Study|Lost to Follow-up|1|||
16826226|NCT02242487|37769862|FG000|Overall Study|Other - Miscellaneous|4|||
16826227|NCT02242487|37769863|FG001|Overall Study|Other - Miscellaneous|6|||
16826228|NCT02242487|37769862|FG000|Overall Study|Withdrawal by Subject|37|||
16826229|NCT02242487|37769863|FG001|Overall Study|Withdrawal by Subject|19|||
16826230|NCT02241785|37769871|FG000|Overall Study|Sponsor Termination|43|||
16826231|NCT02241785|37769871|FG000|Overall Study|Withdrawal by Subject|1|||
16826232|NCT02241785|37769871|FG000|Overall Study|Lost to Follow-up|2|||
16826233|NCT02241785|37769871|FG000|Overall Study|Adverse Event|1|||
16826234|NCT02241551|37769877|FG000|Overall Study|Adverse Event|1|||
16826235|NCT02241551|37769878|FG001|Overall Study|Adverse Event|0|||
16826236|NCT02207621|37769889|FG000|Overall Study|Adverse Event|71|||
16826237|NCT02207621|37769890|FG001|Overall Study|Adverse Event|15|||
16826238|NCT02207621|37769891|FG002|Overall Study|Adverse Event|132|||
16826239|NCT02207621|37769889|FG000|Overall Study|Withdrawal by Subject|9|||
16826240|NCT02207621|37769890|FG001|Overall Study|Withdrawal by Subject|9|||
16826241|NCT02207621|37769891|FG002|Overall Study|Withdrawal by Subject|13|||
16826242|NCT02207621|37769889|FG000|Overall Study|Non-Compliant|3|||
16826243|NCT02207621|37769890|FG001|Overall Study|Non-Compliant|3|||
16826244|NCT02207621|37769891|FG002|Overall Study|Non-Compliant|1|||
16826245|NCT02207621|37769889|FG000|Overall Study|Lost to Follow-up|1|||
16826246|NCT02207621|37769890|FG001|Overall Study|Lost to Follow-up|0|||
16826247|NCT02207621|37769891|FG002|Overall Study|Lost to Follow-up|3|||
16826248|NCT02207621|37769889|FG000|Overall Study|Lack of Efficacy|10|||
16826249|NCT02207621|37769890|FG001|Overall Study|Lack of Efficacy|2|||
16826250|NCT02207621|37769891|FG002|Overall Study|Lack of Efficacy|4|||
16826251|NCT02207621|37769889|FG000|Overall Study|Disallowed Concurrent Medication|2|||
16826252|NCT02207621|37769890|FG001|Overall Study|Disallowed Concurrent Medication|5|||
16826253|NCT02207621|37769891|FG002|Overall Study|Disallowed Concurrent Medication|2|||
16826254|NCT02207621|37769889|FG000|Overall Study|Physician Decision|1|||
16826255|NCT02207621|37769890|FG001|Overall Study|Physician Decision|2|||
16826256|NCT02207621|37769891|FG002|Overall Study|Physician Decision|2|||
16826257|NCT02207621|37769889|FG000|Overall Study|Protocol Violation|4|||
16826258|NCT02207621|37769890|FG001|Overall Study|Protocol Violation|10|||
16826259|NCT02207621|37769891|FG002|Overall Study|Protocol Violation|6|||
16826260|NCT02207621|37769889|FG000|Overall Study|Death|2|||
16826261|NCT02207621|37769890|FG001|Overall Study|Death|0|||
16826262|NCT02207621|37769891|FG002|Overall Study|Death|0|||
16826263|NCT02207621|37769889|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
16826264|NCT02207621|37769890|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
16826265|NCT02207621|37769891|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
16826266|NCT02240693|37769905|FG000|Overall Study|Adverse Event|0|||
16826267|NCT02240693|37769906|FG001|Overall Study|Adverse Event|0|||
16826268|NCT02240693|37769907|FG002|Overall Study|Adverse Event|0|||
16826269|NCT02240693|37769908|FG003|Overall Study|Adverse Event|0|||
16826270|NCT02240693|37769909|FG004|Overall Study|Adverse Event|1|||
16826271|NCT02240693|37769905|FG000|Overall Study|Withdrawal by Subject|0|||
16826272|NCT02240693|37769906|FG001|Overall Study|Withdrawal by Subject|0|||
16826273|NCT02240693|37769907|FG002|Overall Study|Withdrawal by Subject|2|||
16826274|NCT02240693|37769908|FG003|Overall Study|Withdrawal by Subject|1|||
16826275|NCT02240693|37769909|FG004|Overall Study|Withdrawal by Subject|0|||
16826276|NCT02240693|37769905|FG000|Overall Study|Other than specified|0|||
16826277|NCT02240693|37769906|FG001|Overall Study|Other than specified|0|||
16826278|NCT02240693|37769907|FG002|Overall Study|Other than specified|2|||
16826279|NCT02240693|37769908|FG003|Overall Study|Other than specified|0|||
16826280|NCT02240693|37769909|FG004|Overall Study|Other than specified|0|||
16826281|NCT02239679|37769926|FG000|Overall Study|Lost to Follow-up|1|||
16826282|NCT02239679|37769927|FG001|Overall Study|Lost to Follow-up|0|||
16826283|NCT02239679|37769928|FG002|Overall Study|Lost to Follow-up|0|||
16826284|NCT02239679|37769926|FG000|Overall Study|Withdrawal by Subject|2|||
16826285|NCT02239679|37769927|FG001|Overall Study|Withdrawal by Subject|3|||
16826286|NCT02239679|37769928|FG002|Overall Study|Withdrawal by Subject|1|||
16826287|NCT02072096|37769938|FG000|Overall Study|Lack of Efficacy|18|||
16826288|NCT02072096|37769939|FG001|Overall Study|Lack of Efficacy|29|||
16826289|NCT02072096|37769938|FG000|Overall Study|Protocol Violation|7|||
16826290|NCT02072096|37769939|FG001|Overall Study|Protocol Violation|7|||
16826291|NCT02072096|37769938|FG000|Overall Study|Withdrawal by Subject|5|||
16826292|NCT02072096|37769939|FG001|Overall Study|Withdrawal by Subject|7|||
16826293|NCT02072096|37769938|FG000|Overall Study|Adverse Event|5|||
16826294|NCT02072096|37769939|FG001|Overall Study|Adverse Event|2|||
16826295|NCT02072096|37769938|FG000|Overall Study|No Reason Provided|4|||
16826296|NCT02072096|37769939|FG001|Overall Study|No Reason Provided|2|||
16826297|NCT02072096|37769938|FG000|Overall Study|Death|2|||
16826298|NCT02072096|37769939|FG001|Overall Study|Death|0|||
16826299|NCT02072096|37769938|FG000|Overall Study|Physician Decision|0|||
16826300|NCT02072096|37769939|FG001|Overall Study|Physician Decision|1|||
16826301|NCT02072096|37769938|FG000|Overall Study|Study Terminated by Sponsor|43|||
16826302|NCT02072096|37769939|FG001|Overall Study|Study Terminated by Sponsor|30|||
16826303|NCT02072096|37769938|FG000|Overall Study|Lost to Follow-up|1|||
16826304|NCT02072096|37769939|FG001|Overall Study|Lost to Follow-up|0|||
16826305|NCT02071706|37769946|FG000|Overall Study|Adverse Event|1|||
16826306|NCT02071706|37769946|FG000|Overall Study|Withdrawal by Subject|2|||
16826307|NCT01631825|37769950|FG000|Overall Study|Adverse Event|42|||
16826308|NCT01631825|37769950|FG000|Overall Study|Lack of Efficacy|7|||
16826309|NCT01631825|37769950|FG000|Overall Study|Withdrawal by Subject|9|||
16826310|NCT01631825|37769950|FG000|Overall Study|Protocol Violation|4|||
16826311|NCT01631825|37769950|FG000|Overall Study|Discontinuation criteria|1|||
16826312|NCT01631825|37769950|FG000|Overall Study|Physician Decision|2|||
16826313|NCT02071082|37769956|FG000|Overall Study|Enrolled and Never Treated|1|||
16826314|NCT02071082|37769957|FG001|Overall Study|Enrolled and Never Treated|1|||
16826315|NCT02071082|37769956|FG000|Overall Study|Adverse Event|0|||
16826316|NCT02071082|37769957|FG001|Overall Study|Adverse Event|1|||
16826317|NCT02071082|37769956|FG000|Overall Study|Withdrew Consent|0|||
16826318|NCT02071082|37769957|FG001|Overall Study|Withdrew Consent|4|||
16826319|NCT02071082|37769956|FG000|Overall Study|Lost to Follow-up|1|||
16826320|NCT02071082|37769957|FG001|Overall Study|Lost to Follow-up|1|||
16826321|NCT02123108|37769965|FG000|Overall Study|Death|2|||
16826322|NCT02123108|37769966|FG001|Overall Study|Death|3|||
16826323|NCT02097134|37769972|FG000|Overall Study|Physician Decision|4|||
16826324|NCT02097134|37769972|FG000|Overall Study|Non-Protocol Therapy|1|||
16826325|NCT02097134|37769972|FG000|Overall Study|Progressive Disease|3|||
16826326|NCT02097134|37769972|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
16826327|NCT02121392|37769979|FG000|Prior to Intervention|Protocol Violation|40|||
16826328|NCT02121392|37769980|FG001|Prior to Intervention|Protocol Violation|35|||
16826329|NCT02121392|37769979|FG000|Prior to Intervention|Withdrawal by Subject|8|||
16826330|NCT02121392|37769980|FG001|Prior to Intervention|Withdrawal by Subject|6|||
16826331|NCT02121392|37769979|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
16826332|NCT02121392|37769980|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
16826333|NCT02121392|37769979|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
16826334|NCT02121392|37769980|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
16826335|NCT02097056|37769986|FG000|Overall Study|Protocol Violation|2|||
16826336|NCT02097056|37769986|FG000|Overall Study|Withdrawal by Subject|15|||
16826337|NCT02097056|37769986|FG000|Overall Study|Lost to Follow-up|2|||
16826338|NCT02097056|37769986|FG000|Overall Study|Adverse Event|37|||
16826339|NCT02097056|37769986|FG000|Overall Study|Other|2|||
16826340|NCT02121002|37769993|FG000|Overall Study|Physician Decision|2|||
16826341|NCT02121002|37769994|FG001|Overall Study|Physician Decision|0|||
16826342|NCT02121002|37769995|FG002|Overall Study|Physician Decision|0|||
16826343|NCT02121002|37769993|FG000|Overall Study|Withdrawal by Subject|3|||
16826344|NCT02121002|37769994|FG001|Overall Study|Withdrawal by Subject|1|||
16826345|NCT02121002|37769995|FG002|Overall Study|Withdrawal by Subject|4|||
16826346|NCT02121002|37769993|FG000|Overall Study|Protocol Violation|1|||
16826347|NCT02121002|37769994|FG001|Overall Study|Protocol Violation|2|||
16826348|NCT02121002|37769995|FG002|Overall Study|Protocol Violation|4|||
16826349|NCT02121002|37769993|FG000|Overall Study|Concomitant therapy|0|||
16826350|NCT02121002|37769994|FG001|Overall Study|Concomitant therapy|1|||
16826351|NCT02121002|37769995|FG002|Overall Study|Concomitant therapy|1|||
16826352|NCT02121002|37769993|FG000|Overall Study|Others|1|||
16826353|NCT02121002|37769994|FG001|Overall Study|Others|0|||
16826354|NCT02121002|37769995|FG002|Overall Study|Others|1|||
16826355|NCT02096900|37770005|FG000|Overall Study|Did not receive medication|3|||
16826356|NCT02096900|37770006|FG001|Overall Study|Did not receive medication|1|||
16826357|NCT02096900|37770005|FG000|Overall Study|Surgery cancelled- medication received|1|||
16826358|NCT02096900|37770006|FG001|Overall Study|Surgery cancelled- medication received|1|||
16826359|NCT02120924|37770015|FG000|Overall Study|Lack of Efficacy|1|||
16912075|NCT01508676|38021191|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
16826360|NCT02120924|37770016|FG001|Overall Study|Lack of Efficacy|2|||
16826361|NCT02120924|37770017|FG002|Overall Study|Lack of Efficacy|3|||
16826362|NCT02120924|37770015|FG000|Overall Study|Adverse Event|0|||
16826363|NCT02120924|37770016|FG001|Overall Study|Adverse Event|1|||
16826364|NCT02120924|37770017|FG002|Overall Study|Adverse Event|3|||
16826365|NCT02120924|37770015|FG000|Overall Study|Withdrawal by Subject|16|||
16826366|NCT02120924|37770016|FG001|Overall Study|Withdrawal by Subject|20|||
16826367|NCT02120924|37770017|FG002|Overall Study|Withdrawal by Subject|8|||
16826368|NCT02120924|37770015|FG000|Overall Study|Lost to Follow-up|14|||
16826369|NCT02120924|37770016|FG001|Overall Study|Lost to Follow-up|14|||
16826370|NCT02120924|37770017|FG002|Overall Study|Lost to Follow-up|11|||
16826371|NCT02120924|37770015|FG000|Overall Study|Pregnancy|2|||
16826372|NCT02120924|37770016|FG001|Overall Study|Pregnancy|0|||
16826373|NCT02120924|37770017|FG002|Overall Study|Pregnancy|0|||
16826374|NCT02120924|37770015|FG000|Overall Study|Protocol Violation|3|||
16826375|NCT02120924|37770016|FG001|Overall Study|Protocol Violation|7|||
16826376|NCT02120924|37770017|FG002|Overall Study|Protocol Violation|2|||
16826377|NCT02120924|37770015|FG000|Overall Study|Physician Decision|0|||
16826378|NCT02120924|37770016|FG001|Overall Study|Physician Decision|1|||
16826379|NCT02120924|37770017|FG002|Overall Study|Physician Decision|1|||
16826380|NCT02120924|37770015|FG000|Overall Study|Death|1|||
16826381|NCT02120924|37770016|FG001|Overall Study|Death|0|||
16826382|NCT02120924|37770017|FG002|Overall Study|Death|0|||
16826383|NCT02120924|37770015|FG000|Overall Study|Compliance with IP|5|||
16826384|NCT02120924|37770016|FG001|Overall Study|Compliance with IP|1|||
16826385|NCT02120924|37770017|FG002|Overall Study|Compliance with IP|1|||
16826386|NCT02096744|37770026|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
16826387|NCT02096744|37770027|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
16826388|NCT02096744|37770026|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
16826389|NCT02096744|37770027|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
16826390|NCT02096744|37770026|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
16826391|NCT02096744|37770027|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
16826392|NCT02096042|37770035|FG000|Overall Study|Disease Progression|1|||
16826393|NCT02096042|37770036|FG001|Overall Study|Disease Progression|0|||
16826394|NCT02096042|37770037|FG002|Overall Study|Disease Progression|0|||
16826395|NCT02120456|37770053|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16826396|NCT02120456|37770054|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16826397|NCT02120456|37770055|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16826398|NCT02120456|37770056|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16826399|NCT02120456|37770057|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16826400|NCT02120456|37770058|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16826401|NCT02120456|37770059|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
16826402|NCT02120456|37770060|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16826403|NCT02120456|37770061|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16826404|NCT02120456|37770053|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16826405|NCT02120456|37770054|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16826406|NCT02120456|37770055|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16826407|NCT02120456|37770056|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16826408|NCT02120456|37770057|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16826409|NCT02120456|37770058|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16826410|NCT02120456|37770059|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
16826411|NCT02120456|37770060|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16826412|NCT02120456|37770061|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16826413|NCT02120456|37770053|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16826414|NCT02120456|37770054|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16826415|NCT02120456|37770055|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16826416|NCT02120456|37770056|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16826417|NCT02120456|37770057|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16826418|NCT02120456|37770058|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16826419|NCT02120456|37770059|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16826420|NCT02120456|37770060|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16826421|NCT02120456|37770061|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
16826422|NCT02120300|37770085|FG000|Overall Study|Enrolled but Never Treated|2|||
16826423|NCT02120300|37770086|FG001|Overall Study|Enrolled but Never Treated|0|||
16826424|NCT02120300|37770087|FG002|Overall Study|Enrolled but Never Treated|0|||
16826425|NCT02120300|37770088|FG003|Overall Study|Enrolled but Never Treated|0|||
16826426|NCT02120300|37770085|FG000|Overall Study|Lack of Efficacy|0|||
16826427|NCT02120300|37770086|FG001|Overall Study|Lack of Efficacy|0|||
16826428|NCT02120300|37770087|FG002|Overall Study|Lack of Efficacy|0|||
16826429|NCT02120300|37770088|FG003|Overall Study|Lack of Efficacy|1|||
16826430|NCT02120300|37770085|FG000|Overall Study|Lost to Follow-up|1|||
16826431|NCT02120300|37770086|FG001|Overall Study|Lost to Follow-up|0|||
16826432|NCT02120300|37770087|FG002|Overall Study|Lost to Follow-up|0|||
16826433|NCT02120300|37770088|FG003|Overall Study|Lost to Follow-up|0|||
16826434|NCT02070380|37770104|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
16826435|NCT02070380|37770105|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
16826436|NCT02070380|37770106|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
16826437|NCT02070380|37770107|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
16826438|NCT02070380|37770104|FG000|Second Injection|Image sets missing or technically inadeq|0|||
16826439|NCT02070380|37770105|FG001|Second Injection|Image sets missing or technically inadeq|1|||
16826440|NCT02070380|37770106|FG002|Second Injection|Image sets missing or technically inadeq|0|||
16826441|NCT02070380|37770107|FG003|Second Injection|Image sets missing or technically inadeq|0|||
16826442|NCT02070380|37770104|FG000|Second Injection|Protocol Violation|0|||
16826443|NCT02070380|37770105|FG001|Second Injection|Protocol Violation|1|||
16826444|NCT02070380|37770106|FG002|Second Injection|Protocol Violation|1|||
16826445|NCT02070380|37770107|FG003|Second Injection|Protocol Violation|5|||
16826446|NCT02069366|37770125|FG000|Overall Study|Lost to Follow-up|0|||
16826447|NCT02069366|37770126|FG001|Overall Study|Lost to Follow-up|0|||
16826448|NCT02069366|37770127|FG002|Overall Study|Lost to Follow-up|1|||
16826449|NCT02069366|37770128|FG003|Overall Study|Lost to Follow-up|0|||
16826450|NCT02069366|37770129|FG004|Overall Study|Lost to Follow-up|0|||
16826451|NCT02069366|37770130|FG005|Overall Study|Lost to Follow-up|2|||
16826452|NCT02069366|37770125|FG000|Overall Study|Protocol Violation|0|||
16826453|NCT02069366|37770126|FG001|Overall Study|Protocol Violation|0|||
16826454|NCT02069366|37770127|FG002|Overall Study|Protocol Violation|1|||
16826455|NCT02069366|37770128|FG003|Overall Study|Protocol Violation|0|||
16826456|NCT02069366|37770129|FG004|Overall Study|Protocol Violation|0|||
16826457|NCT02069366|37770130|FG005|Overall Study|Protocol Violation|0|||
16826458|NCT02069366|37770125|FG000|Overall Study|Withdrawal by Subject|1|||
16826459|NCT02069366|37770126|FG001|Overall Study|Withdrawal by Subject|0|||
16826460|NCT02069366|37770127|FG002|Overall Study|Withdrawal by Subject|1|||
16826461|NCT02069366|37770128|FG003|Overall Study|Withdrawal by Subject|2|||
16826462|NCT02069366|37770129|FG004|Overall Study|Withdrawal by Subject|0|||
16826463|NCT02069366|37770130|FG005|Overall Study|Withdrawal by Subject|0|||
16826464|NCT02068508|37770145|FG000|Overall Study|Case report forms uncollected|27|||
16826465|NCT02068508|37770145|FG000|Overall Study|Patient did not visit the study site|1|||
16826466|NCT02068508|37770145|FG000|Overall Study|Protocol Violation|4|||
16826467|NCT02068352|37770152|FG000|Overall Study|Lost to Follow-up|0|||
16826468|NCT02068352|37770153|FG001|Overall Study|Lost to Follow-up|2|||
16826469|NCT02068352|37770154|FG002|Overall Study|Lost to Follow-up|0|||
16826470|NCT02068352|37770152|FG000|Overall Study|Adverse Event|4|||
16826471|NCT02068352|37770153|FG001|Overall Study|Adverse Event|2|||
16826472|NCT02068352|37770154|FG002|Overall Study|Adverse Event|7|||
16826473|NCT02068352|37770152|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
16826474|NCT02068352|37770153|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
16826475|NCT02068352|37770154|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
16826476|NCT02068352|37770152|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
16826477|NCT02068352|37770153|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
16826478|NCT02068352|37770154|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
16826479|NCT02068352|37770152|FG000|Overall Study|Protocol Deviation|0|||
16826480|NCT02068352|37770153|FG001|Overall Study|Protocol Deviation|0|||
16826481|NCT02068352|37770154|FG002|Overall Study|Protocol Deviation|1|||
16826482|NCT02207231|37770165|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
16826483|NCT02207231|37770166|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
16826484|NCT02207231|37770167|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
16826485|NCT02207231|37770168|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
16826486|NCT02207231|37770165|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
16826487|NCT02207231|37770166|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
16826488|NCT02207231|37770167|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
16826489|NCT02207231|37770168|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
16826490|NCT02207231|37770165|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
16826491|NCT02207231|37770166|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
16826492|NCT02207231|37770167|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
16826493|NCT02207231|37770168|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
16826494|NCT02207231|37770165|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
16826495|NCT02207231|37770166|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
16826496|NCT02207231|37770167|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
16826497|NCT02207231|37770168|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
16826498|NCT02207231|37770165|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
16826499|NCT02207231|37770166|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
16826500|NCT02207231|37770167|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
16826501|NCT02207231|37770168|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
16826502|NCT02207231|37770165|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
16826503|NCT02207231|37770166|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
16826504|NCT02207231|37770167|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
16826505|NCT02207231|37770168|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
16912076|NCT01508676|38021190|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
16826506|NCT02207231|37770165|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
16826507|NCT02207231|37770166|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
16826508|NCT02207231|37770167|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
16826509|NCT02207231|37770168|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
16826510|NCT02207231|37770165|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
16826511|NCT02207231|37770166|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
16826512|NCT02207231|37770167|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
16826513|NCT02207231|37770168|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
16826514|NCT02207231|37770165|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
16826515|NCT02207231|37770166|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
16826516|NCT02207231|37770167|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
16826517|NCT02207231|37770168|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
16826518|NCT02207231|37770165|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
16826519|NCT02207231|37770166|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
16826520|NCT02207231|37770167|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
16826521|NCT02207231|37770168|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
16826522|NCT02207231|37770165|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
16826523|NCT02207231|37770166|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
16826524|NCT02207231|37770167|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
16826525|NCT02207231|37770168|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
16826526|NCT02207231|37770165|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
16826527|NCT02207231|37770166|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
16826528|NCT02207231|37770167|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
16826529|NCT02207231|37770168|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
16826530|NCT02207231|37770165|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
16826531|NCT02207231|37770166|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
16826532|NCT02207231|37770167|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
16826533|NCT02207231|37770168|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
16826534|NCT02207231|37770165|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
16826535|NCT02207231|37770166|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
16826536|NCT02207231|37770167|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
16826537|NCT02207231|37770168|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
16826538|NCT02207231|37770165|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
16826539|NCT02207231|37770166|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
16826540|NCT02207231|37770167|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
16826541|NCT02207231|37770168|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
16826542|NCT02207231|37770165|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
16826543|NCT02207231|37770166|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
16826544|NCT02207231|37770167|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
16826545|NCT02207231|37770168|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
16826546|NCT02207231|37770165|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
16826547|NCT02207231|37770166|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
16826548|NCT02207231|37770167|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
16826549|NCT02207231|37770168|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
16826550|NCT02207231|37770165|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
16826551|NCT02207231|37770166|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
16826552|NCT02207231|37770167|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
16826553|NCT02207231|37770168|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
16826554|NCT02207231|37770165|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
16826555|NCT02207231|37770166|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
16826556|NCT02207231|37770167|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
16826557|NCT02207231|37770168|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
16826558|NCT02207231|37770165|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
16826559|NCT02207231|37770166|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
16826560|NCT02207231|37770167|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
16826561|NCT02207231|37770168|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
16826562|NCT02207231|37770165|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
16826563|NCT02207231|37770166|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
16826564|NCT02207231|37770167|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
16826565|NCT02207231|37770168|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
16826566|NCT02239601|37770188|FG000|Overall Study|Withdrawal by Subject|3|||
16826567|NCT02239601|37770189|FG001|Overall Study|Withdrawal by Subject|4|||
16826568|NCT02239601|37770188|FG000|Overall Study|Protocol Violation|4|||
16826569|NCT02239601|37770189|FG001|Overall Study|Protocol Violation|2|||
16826570|NCT02236559|37770202|FG000|Overall Study|Met Exclusion|3|||
16826571|NCT02236559|37770203|FG001|Overall Study|Met Exclusion|6|||
16826572|NCT02236559|37770202|FG000|Overall Study|Did not Meet Inclusion|3|||
16912077|NCT01508676|38021191|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
16826573|NCT02236559|37770203|FG001|Overall Study|Did not Meet Inclusion|3|||
16826574|NCT02236559|37770202|FG000|Overall Study|Subject Did Not Consent|4|||
16826575|NCT02236559|37770203|FG001|Overall Study|Subject Did Not Consent|2|||
16826576|NCT02236559|37770202|FG000|Overall Study|Physician Decision|1|||
16826577|NCT02236559|37770203|FG001|Overall Study|Physician Decision|1|||
16826578|NCT02236559|37770202|FG000|Overall Study|Withdrawal by Subject|1|||
16826579|NCT02236559|37770203|FG001|Overall Study|Withdrawal by Subject|0|||
16826580|NCT02206685|37770211|FG000|Overall Study|Surgery cancelled/changed|2|||
16826581|NCT02206685|37770212|FG001|Overall Study|Surgery cancelled/changed|3|||
16826582|NCT02206685|37770211|FG000|Overall Study|Withdrawal by Subject|1|||
16826583|NCT02206685|37770212|FG001|Overall Study|Withdrawal by Subject|2|||
16826584|NCT02206685|37770211|FG000|Overall Study|Protocol Violation|2|||
16826585|NCT02206685|37770212|FG001|Overall Study|Protocol Violation|2|||
16826586|NCT02206607|37770218|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
16826587|NCT02206607|37770219|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
16826588|NCT02206607|37770220|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
16826589|NCT02206607|37770221|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
16826590|NCT02206607|37770222|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
16826591|NCT02206607|37770218|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
16826592|NCT02206607|37770219|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
16826593|NCT02206607|37770220|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
16826594|NCT02206607|37770221|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
16826595|NCT02206607|37770222|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
16826596|NCT02119676|37770242|FG000|Overall Study|Adverse Event|9|||
16826597|NCT02119676|37770243|FG001|Overall Study|Adverse Event|17|||
16826598|NCT02119676|37770244|FG002|Overall Study|Adverse Event|10|||
16826599|NCT02119676|37770245|FG003|Overall Study|Adverse Event|10|||
16826600|NCT02119676|37770242|FG000|Overall Study|Disease progression|53|||
16826601|NCT02119676|37770243|FG001|Overall Study|Disease progression|55|||
16826602|NCT02119676|37770244|FG002|Overall Study|Disease progression|68|||
16826603|NCT02119676|37770245|FG003|Overall Study|Disease progression|73|||
16826604|NCT02119676|37770242|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
16826605|NCT02119676|37770243|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
16826606|NCT02119676|37770244|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
16826607|NCT02119676|37770245|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
16826608|NCT02119676|37770242|FG000|Overall Study|Physician Decision|4|||
16826609|NCT02119676|37770243|FG001|Overall Study|Physician Decision|2|||
16826610|NCT02119676|37770244|FG002|Overall Study|Physician Decision|3|||
16826611|NCT02119676|37770245|FG003|Overall Study|Physician Decision|2|||
16826612|NCT02119676|37770242|FG000|Overall Study|Death|9|||
16826613|NCT02119676|37770243|FG001|Overall Study|Death|3|||
16826614|NCT02119676|37770244|FG002|Overall Study|Death|2|||
16826615|NCT02119676|37770245|FG003|Overall Study|Death|1|||
16826616|NCT02119676|37770242|FG000|Overall Study|Noncompliance|0|||
16826617|NCT02119676|37770243|FG001|Overall Study|Noncompliance|1|||
16826618|NCT02119676|37770244|FG002|Overall Study|Noncompliance|0|||
16826619|NCT02119676|37770245|FG003|Overall Study|Noncompliance|0|||
16826620|NCT02119676|37770242|FG000|Overall Study|Lost to Follow-up|0|||
16826621|NCT02119676|37770243|FG001|Overall Study|Lost to Follow-up|0|||
16826622|NCT02119676|37770244|FG002|Overall Study|Lost to Follow-up|1|||
16826623|NCT02119676|37770245|FG003|Overall Study|Lost to Follow-up|0|||
16826624|NCT02119676|37770242|FG000|Overall Study|Protocol deviation|0|||
16826625|NCT02119676|37770243|FG001|Overall Study|Protocol deviation|0|||
16826626|NCT02119676|37770244|FG002|Overall Study|Protocol deviation|1|||
16826627|NCT02119676|37770245|FG003|Overall Study|Protocol deviation|0|||
16826628|NCT02119676|37770242|FG000|Overall Study|Other, unspecified|2|||
16826629|NCT02119676|37770243|FG001|Overall Study|Other, unspecified|1|||
16826630|NCT02119676|37770244|FG002|Overall Study|Other, unspecified|3|||
16826631|NCT02119676|37770245|FG003|Overall Study|Other, unspecified|4|||
16826632|NCT02119676|37770242|FG000|Overall Study|Did not receive study med|2|||
16826633|NCT02119676|37770243|FG001|Overall Study|Did not receive study med|2|||
16826634|NCT02119676|37770244|FG002|Overall Study|Did not receive study med|4|||
16826635|NCT02119676|37770245|FG003|Overall Study|Did not receive study med|5|||
16826636|NCT02206061|37770258|FG000|Overall Study|Withdrawal by Subject|4|||
16826637|NCT02206061|37770259|FG001|Overall Study|Withdrawal by Subject|7|||
16826638|NCT02206061|37770260|FG002|Overall Study|Withdrawal by Subject|1|||
16826639|NCT02206061|37770258|FG000|Overall Study|Lost to Follow-up|14|||
16826640|NCT02206061|37770259|FG001|Overall Study|Lost to Follow-up|7|||
16826641|NCT02206061|37770260|FG002|Overall Study|Lost to Follow-up|20|||
16826642|NCT02095106|37770270|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
16826643|NCT02095106|37770271|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
16826644|NCT01631747|37770283|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
16826645|NCT01631747|37770284|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
16826646|NCT01631747|37770283|FG000|Live Birth|Pregnancy Termination|1|||
16826647|NCT01631747|37770284|FG001|Live Birth|Pregnancy Termination|0|||
16826648|NCT01631747|37770283|FG000|Live Birth|MIscarriage|2|||
16826649|NCT01631747|37770284|FG001|Live Birth|MIscarriage|0|||
16826650|NCT01631747|37770283|FG000|Live Birth|Stillbirth|1|||
16826651|NCT01631747|37770284|FG001|Live Birth|Stillbirth|1|||
16826652|NCT01631747|37770283|FG000|One Year Infant Outcomes|Patient Refused|13|||
16826653|NCT01631747|37770284|FG001|One Year Infant Outcomes|Patient Refused|9|||
16826654|NCT02068118|37770293|FG000|18-month Comparative Study Period|Death|90|||
16826655|NCT02068118|37770294|FG001|18-month Comparative Study Period|Death|97|||
16826656|NCT02068118|37770293|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
16826657|NCT02068118|37770294|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
16826658|NCT02068118|37770293|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
16826659|NCT02068118|37770294|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
16826660|NCT02068118|37770293|FG000|18-month Comparative Study Period|Heart transplant|9|||
16826661|NCT02068118|37770294|FG001|18-month Comparative Study Period|Heart transplant|15|||
16826662|NCT02068118|37770293|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
16826663|NCT02068118|37770294|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
16826664|NCT02068118|37770293|FG000|18-month Comparative Study Period|Hemiplegia|0|||
16826665|NCT02068118|37770294|FG001|18-month Comparative Study Period|Hemiplegia|1|||
16826666|NCT02068118|37770293|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
16826667|NCT02068118|37770294|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
16826668|NCT02068118|37770293|FG000|18-month Comparative Study Period|Move|0|||
16826669|NCT02068118|37770294|FG001|18-month Comparative Study Period|Move|1|||
16826670|NCT02068118|37770293|FG000|18-month Comparative Study Period|Hearing loss|0|||
16826671|NCT02068118|37770294|FG001|18-month Comparative Study Period|Hearing loss|1|||
16826672|NCT02068118|37770293|FG000|Extension Period|Death|0|||
16826673|NCT02068118|37770294|FG001|Extension Period|Death|2|||
16826674|NCT02068118|37770293|FG000|Extension Period|Withdrawal by Subject|1|||
16826675|NCT02068118|37770294|FG001|Extension Period|Withdrawal by Subject|0|||
16826676|NCT02068118|37770293|FG000|Extension Period|Heart transplant|1|||
16826677|NCT02068118|37770294|FG001|Extension Period|Heart transplant|0|||
16826678|NCT02068118|37770293|FG000|Extension Period|Wrong device use|0|||
16826679|NCT02068118|37770294|FG001|Extension Period|Wrong device use|1|||
16826680|NCT01623830|37770304|FG000|Overall Study|Withdrawal by Subject|6|||
16826681|NCT01623830|37770305|FG001|Overall Study|Withdrawal by Subject|7|||
16826682|NCT01623830|37770304|FG000|Overall Study|Exclusion from Study|1|||
16826683|NCT01623830|37770305|FG001|Overall Study|Exclusion from Study|2|||
16826684|NCT01634165|37770311|FG000|Period 2|Adverse Event|0|||
16826685|NCT01634165|37770312|FG001|Period 2|Adverse Event|1|||
16826686|NCT01634165|37770313|FG002|Period 2|Adverse Event|0|||
16826687|NCT01634165|37770314|FG003|Period 2|Adverse Event|0|||
16826688|NCT03575897|37770326|FG000|Overall Study|Lost to Follow-up|12|||
16826689|NCT03575897|37770327|FG001|Overall Study|Lost to Follow-up|13|||
16826690|NCT02235311|37770335|FG000|Overall Study|Lost to Follow-up|0|||
16826691|NCT02235311|37770336|FG001|Overall Study|Lost to Follow-up|1|||
16826692|NCT02235311|37770335|FG000|Overall Study|Protocol Violation|0|||
16826693|NCT02235311|37770336|FG001|Overall Study|Protocol Violation|1|||
16826694|NCT02204579|37770342|FG000|Overall Study|Screen failures|2|||
16826695|NCT02235077|37770353|FG000|Overall Study|Death|5|||
16826696|NCT02235077|37770354|FG001|Overall Study|Death|7|||
16826697|NCT02235077|37770353|FG000|Overall Study|Lost to Follow-up|5|||
16826698|NCT02235077|37770354|FG001|Overall Study|Lost to Follow-up|6|||
16826699|NCT02235077|37770353|FG000|Overall Study|Withdrawal by Subject|8|||
16826700|NCT02235077|37770354|FG001|Overall Study|Withdrawal by Subject|5|||
16826701|NCT02235077|37770353|FG000|Overall Study|Physician Decision|0|||
16826702|NCT02235077|37770354|FG001|Overall Study|Physician Decision|1|||
16826703|NCT02234141|37770364|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
16826704|NCT02234141|37770365|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
16826705|NCT02234141|37770366|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
16826706|NCT02234141|37770367|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
16826707|NCT02234141|37770368|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
16826708|NCT02234141|37770369|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
16826709|NCT02234141|37770370|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
16826710|NCT02234141|37770364|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16826711|NCT02234141|37770365|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
16826712|NCT02234141|37770366|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16826713|NCT02234141|37770367|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16826714|NCT02234141|37770368|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16826715|NCT02234141|37770369|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16826716|NCT02234141|37770370|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16826717|NCT02234141|37770364|FG000|Treatment Period (24 Weeks)|Death|1|||
16826718|NCT02234141|37770365|FG001|Treatment Period (24 Weeks)|Death|2|||
16826719|NCT02234141|37770366|FG002|Treatment Period (24 Weeks)|Death|0|||
16826720|NCT02234141|37770367|FG003|Treatment Period (24 Weeks)|Death|1|||
16826721|NCT02234141|37770368|FG004|Treatment Period (24 Weeks)|Death|0|||
16826722|NCT02234141|37770369|FG005|Treatment Period (24 Weeks)|Death|0|||
16826723|NCT02234141|37770370|FG006|Treatment Period (24 Weeks)|Death|0|||
16826724|NCT02234141|37770364|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
16826725|NCT02234141|37770365|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
16826726|NCT02234141|37770366|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
16826727|NCT02234141|37770367|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
16826728|NCT02234141|37770368|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
16826729|NCT02234141|37770369|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
16826730|NCT02234141|37770370|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
16826731|NCT02234141|37770364|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16826732|NCT02234141|37770365|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
16826733|NCT02234141|37770366|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16826734|NCT02234141|37770367|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16826735|NCT02234141|37770368|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16826736|NCT02234141|37770369|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16826737|NCT02234141|37770370|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16826738|NCT02234141|37770364|FG000|Long-Term Treatment Period|Death|0|||
16826739|NCT02234141|37770365|FG001|Long-Term Treatment Period|Death|0|||
16826740|NCT02234141|37770366|FG002|Long-Term Treatment Period|Death|0|||
16826741|NCT02234141|37770367|FG003|Long-Term Treatment Period|Death|0|||
16826742|NCT02234141|37770368|FG004|Long-Term Treatment Period|Death|0|||
16826743|NCT02234141|37770369|FG005|Long-Term Treatment Period|Death|1|||
16826744|NCT02234141|37770370|FG006|Long-Term Treatment Period|Death|0|||
16826745|NCT02234141|37770364|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
16826746|NCT02234141|37770365|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
16826747|NCT02234141|37770366|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
16826748|NCT02234141|37770367|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
16826749|NCT02234141|37770368|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
16826750|NCT02234141|37770369|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
16826751|NCT02234141|37770370|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
16826752|NCT02234141|37770364|FG000|Long-Term Treatment Period|Adverse Event|4|||
16826753|NCT02234141|37770365|FG001|Long-Term Treatment Period|Adverse Event|0|||
16826754|NCT02234141|37770366|FG002|Long-Term Treatment Period|Adverse Event|5|||
16826755|NCT02234141|37770367|FG003|Long-Term Treatment Period|Adverse Event|0|||
16826756|NCT02234141|37770368|FG004|Long-Term Treatment Period|Adverse Event|1|||
16826757|NCT02234141|37770369|FG005|Long-Term Treatment Period|Adverse Event|1|||
16826758|NCT02234141|37770370|FG006|Long-Term Treatment Period|Adverse Event|1|||
16826759|NCT02234141|37770364|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
16826760|NCT02234141|37770365|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
16826761|NCT02234141|37770366|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
16826762|NCT02234141|37770367|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
16826763|NCT02234141|37770368|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
16826764|NCT02234141|37770369|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
16826765|NCT02234141|37770370|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
16826766|NCT02234141|37770364|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
16826767|NCT02234141|37770365|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
16826768|NCT02234141|37770366|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
16826769|NCT02234141|37770367|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
16826770|NCT02234141|37770368|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
16826771|NCT02234141|37770369|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
16826772|NCT02234141|37770370|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
16826773|NCT02234063|37770383|FG000|Overall Study|Lost to Follow-up|235|||
16826774|NCT02234063|37770384|FG001|Overall Study|Lost to Follow-up|42|||
16826775|NCT02234063|37770383|FG000|Overall Study|Withdrawal by Subject|20|||
16826776|NCT02234063|37770384|FG001|Overall Study|Withdrawal by Subject|1|||
16826777|NCT02232893|37770397|FG000|Overall Study|Withdrawal by Subject|4|||
16826778|NCT02232893|37770398|FG001|Overall Study|Withdrawal by Subject|1|||
16826779|NCT02232893|37770397|FG000|Overall Study|Adverse Event|0|||
16826780|NCT02232893|37770398|FG001|Overall Study|Adverse Event|1|||
16826781|NCT02232893|37770397|FG000|Overall Study|Sponsor request early termination|0|||
16826782|NCT02232893|37770398|FG001|Overall Study|Sponsor request early termination|1|||
16826783|NCT02232893|37770397|FG000|Overall Study|Developed exclusion criteria|0|||
16826784|NCT02232893|37770398|FG001|Overall Study|Developed exclusion criteria|1|||
16826785|NCT02232893|37770397|FG000|Overall Study|Other|0|||
16826786|NCT02232893|37770398|FG001|Overall Study|Other|3|||
16826787|NCT02203721|37770406|FG000|Overall Study|Lost to Follow-up|1|||
16826788|NCT02203721|37770407|FG001|Overall Study|Lost to Follow-up|0|||
16826789|NCT02203721|37770406|FG000|Overall Study|Death|0|||
16826790|NCT02203721|37770407|FG001|Overall Study|Death|2|||
16826791|NCT02203721|37770406|FG000|Overall Study|Illness|0|||
16826792|NCT02203721|37770407|FG001|Overall Study|Illness|1|||
16826793|NCT01618695|37770417|FG000|Core Phase|Adverse Event|4|||
16826794|NCT01618695|37770418|FG001|Core Phase|Adverse Event|5|||
16826795|NCT01618695|37770419|FG002|Core Phase|Adverse Event|15|||
16826796|NCT01618695|37770420|FG003|Core Phase|Adverse Event|20|||
16826797|NCT01618695|37770417|FG000|Core Phase|Lost to Follow-up|0|||
16826798|NCT01618695|37770418|FG001|Core Phase|Lost to Follow-up|0|||
16826799|NCT01618695|37770419|FG002|Core Phase|Lost to Follow-up|1|||
16826800|NCT01618695|37770420|FG003|Core Phase|Lost to Follow-up|0|||
16826801|NCT01618695|37770417|FG000|Core Phase|Withdrawal by Subject|16|||
16826802|NCT01618695|37770418|FG001|Core Phase|Withdrawal by Subject|11|||
16826803|NCT01618695|37770419|FG002|Core Phase|Withdrawal by Subject|9|||
16826804|NCT01618695|37770420|FG003|Core Phase|Withdrawal by Subject|13|||
16826805|NCT01618695|37770417|FG000|Core Phase|Pregnancy|2|||
16826806|NCT01618695|37770418|FG001|Core Phase|Pregnancy|0|||
16826807|NCT01618695|37770419|FG002|Core Phase|Pregnancy|0|||
16826808|NCT01618695|37770420|FG003|Core Phase|Pregnancy|0|||
16826809|NCT01618695|37770417|FG000|Core Phase|Lack of Efficacy|1|||
16826810|NCT01618695|37770418|FG001|Core Phase|Lack of Efficacy|2|||
16826811|NCT01618695|37770419|FG002|Core Phase|Lack of Efficacy|1|||
16826812|NCT01618695|37770420|FG003|Core Phase|Lack of Efficacy|1|||
16826813|NCT01618695|37770417|FG000|Core Phase|Other than specified|1|||
16826814|NCT01618695|37770418|FG001|Core Phase|Other than specified|2|||
16826815|NCT01618695|37770419|FG002|Core Phase|Other than specified|2|||
16826816|NCT01618695|37770420|FG003|Core Phase|Other than specified|2|||
16826817|NCT01618695|37770417|FG000|Core Phase|Not treated|1|||
16826818|NCT01618695|37770418|FG001|Core Phase|Not treated|0|||
16826819|NCT01618695|37770419|FG002|Core Phase|Not treated|2|||
16826820|NCT01618695|37770420|FG003|Core Phase|Not treated|0|||
16826821|NCT01618695|37770417|FG000|Extension Phase|Lack of Efficacy|17|||
16826822|NCT01618695|37770418|FG001|Extension Phase|Lack of Efficacy|33|||
16826823|NCT01618695|37770419|FG002|Extension Phase|Lack of Efficacy|26|||
16826824|NCT01618695|37770420|FG003|Extension Phase|Lack of Efficacy|24|||
16826825|NCT01618695|37770417|FG000|Extension Phase|Pregnancy|2|||
16826826|NCT01618695|37770418|FG001|Extension Phase|Pregnancy|0|||
16826827|NCT01618695|37770419|FG002|Extension Phase|Pregnancy|1|||
16826828|NCT01618695|37770420|FG003|Extension Phase|Pregnancy|1|||
16826829|NCT01618695|37770417|FG000|Extension Phase|Withdrawal by Subject|43|||
16826830|NCT01618695|37770418|FG001|Extension Phase|Withdrawal by Subject|48|||
16826831|NCT01618695|37770419|FG002|Extension Phase|Withdrawal by Subject|42|||
16826832|NCT01618695|37770420|FG003|Extension Phase|Withdrawal by Subject|33|||
16826833|NCT01618695|37770417|FG000|Extension Phase|Adverse Event|18|||
16826834|NCT01618695|37770418|FG001|Extension Phase|Adverse Event|16|||
16826835|NCT01618695|37770419|FG002|Extension Phase|Adverse Event|9|||
16826836|NCT01618695|37770420|FG003|Extension Phase|Adverse Event|20|||
16826837|NCT01618695|37770417|FG000|Extension Phase|Lost to Follow-up|2|||
16826838|NCT01618695|37770418|FG001|Extension Phase|Lost to Follow-up|1|||
16826839|NCT01618695|37770419|FG002|Extension Phase|Lost to Follow-up|1|||
16826840|NCT01618695|37770420|FG003|Extension Phase|Lost to Follow-up|1|||
16826841|NCT01618695|37770417|FG000|Extension Phase|Other than specified|13|||
16826842|NCT01618695|37770418|FG001|Extension Phase|Other than specified|18|||
16826843|NCT01618695|37770419|FG002|Extension Phase|Other than specified|13|||
16826844|NCT01618695|37770420|FG003|Extension Phase|Other than specified|18|||
16826845|NCT01896531|37770433|FG000|Overall Study|Death|57|||
16826846|NCT01896531|37770434|FG001|Overall Study|Death|59|||
16826847|NCT01896531|37770433|FG000|Overall Study|Lost to Follow-up|3|||
16826848|NCT01896531|37770434|FG001|Overall Study|Lost to Follow-up|0|||
16826849|NCT01896531|37770433|FG000|Overall Study|Non-compliance|0|||
16826850|NCT01896531|37770434|FG001|Overall Study|Non-compliance|1|||
16826851|NCT01896531|37770433|FG000|Overall Study|Study Ended by Sponsor|7|||
16826852|NCT01896531|37770434|FG001|Overall Study|Study Ended by Sponsor|20|||
16826853|NCT01896531|37770433|FG000|Overall Study|Withdrawal by Subject|3|||
16826854|NCT01896531|37770434|FG001|Overall Study|Withdrawal by Subject|2|||
16826855|NCT01896531|37770433|FG000|Overall Study|Death Prior to Treatment|1|||
16826856|NCT01896531|37770434|FG001|Overall Study|Death Prior to Treatment|0|||
16826857|NCT01618305|37770442|FG000|Overall Study|Death|0|||
16826858|NCT01618305|37770443|FG001|Overall Study|Death|1|||
16826859|NCT01618305|37770442|FG000|Overall Study|Lost to Follow-up|11|||
16826860|NCT01618305|37770443|FG001|Overall Study|Lost to Follow-up|7|||
16826861|NCT01618305|37770442|FG000|Overall Study|Protocol Violation|1|||
16826862|NCT01618305|37770443|FG001|Overall Study|Protocol Violation|0|||
16912078|NCT01508676|38021190|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
16826863|NCT01618305|37770442|FG000|Overall Study|Withdrawal by Subject|3|||
16826864|NCT01618305|37770443|FG001|Overall Study|Withdrawal by Subject|2|||
16826865|NCT01886313|37770455|FG000|Overall Study|Adverse Event|1|||
16826866|NCT01886313|37770456|FG001|Overall Study|Adverse Event|1|||
16826867|NCT01896297|37770462|FG000|Overall Study|Died in post treatment phase|1|||
16826868|NCT01884675|37770468|FG000|Overall Study|Study closed/terminated|3|||
16826869|NCT01884675|37770469|FG001|Overall Study|Study closed/terminated|2|||
16826870|NCT01884597|37770480|FG000|Overall Study|Adverse Event|0|||
16826871|NCT01884597|37770481|FG001|Overall Study|Adverse Event|0|||
16826872|NCT01884597|37770482|FG002|Overall Study|Adverse Event|1|||
16826873|NCT01884597|37770480|FG000|Overall Study|Lack of Efficacy|1|||
16826874|NCT01884597|37770481|FG001|Overall Study|Lack of Efficacy|0|||
16826875|NCT01884597|37770482|FG002|Overall Study|Lack of Efficacy|0|||
16826876|NCT01884597|37770480|FG000|Overall Study|Death|0|||
16826877|NCT01884597|37770481|FG001|Overall Study|Death|1|||
16826878|NCT01884597|37770482|FG002|Overall Study|Death|0|||
16826879|NCT01895361|37770499|FG000|Overall Study|Adverse Event|1|||
16826880|NCT01895361|37770500|FG001|Overall Study|Adverse Event|1|||
16826881|NCT01895361|37770501|FG002|Overall Study|Adverse Event|3|||
16826882|NCT01895361|37770499|FG000|Overall Study|Death|2|||
16826883|NCT01895361|37770500|FG001|Overall Study|Death|1|||
16826884|NCT01895361|37770501|FG002|Overall Study|Death|2|||
16826885|NCT01895361|37770499|FG000|Overall Study|Lost to Follow-up|4|||
16826886|NCT01895361|37770500|FG001|Overall Study|Lost to Follow-up|4|||
16826887|NCT01895361|37770501|FG002|Overall Study|Lost to Follow-up|6|||
16826888|NCT01895361|37770499|FG000|Overall Study|Non-compliance with study|1|||
16826889|NCT01895361|37770500|FG001|Overall Study|Non-compliance with study|3|||
16826890|NCT01895361|37770501|FG002|Overall Study|Non-compliance with study|1|||
16826891|NCT01895361|37770499|FG000|Overall Study|Physician Decision|2|||
16826892|NCT01895361|37770500|FG001|Overall Study|Physician Decision|2|||
16826893|NCT01895361|37770501|FG002|Overall Study|Physician Decision|2|||
16826894|NCT01895361|37770499|FG000|Overall Study|Withdrawal by Subject|7|||
16826895|NCT01895361|37770500|FG001|Overall Study|Withdrawal by Subject|6|||
16826896|NCT01895361|37770501|FG002|Overall Study|Withdrawal by Subject|6|||
16826897|NCT01895361|37770499|FG000|Overall Study|Lack of Efficacy|0|||
16826898|NCT01895361|37770500|FG001|Overall Study|Lack of Efficacy|1|||
16826899|NCT01895361|37770501|FG002|Overall Study|Lack of Efficacy|0|||
16826900|NCT01895361|37770499|FG000|Overall Study|Reasons different from categories above|7|||
16826901|NCT01895361|37770500|FG001|Overall Study|Reasons different from categories above|3|||
16826902|NCT01895361|37770501|FG002|Overall Study|Reasons different from categories above|4|||
16826903|NCT01883895|37770509|FG000|Overall Study|Lost to Follow-up|2|||
16826904|NCT01864005|37770515|FG000|Overall Study|Protocol Violation|0|||
16826905|NCT01864005|37770516|FG001|Overall Study|Protocol Violation|1|||
16826906|NCT01864005|37770515|FG000|Overall Study|Withdrawal by Subject|0|||
16826907|NCT01864005|37770516|FG001|Overall Study|Withdrawal by Subject|1|||
16826908|NCT01864005|37770515|FG000|Overall Study|Incorrect enrolment|1|||
16826909|NCT01864005|37770516|FG001|Overall Study|Incorrect enrolment|0|||
16826910|NCT01864005|37770515|FG000|Overall Study|Disease need|1|||
16826911|NCT01864005|37770516|FG001|Overall Study|Disease need|1|||
16826912|NCT01864005|37770515|FG000|Overall Study|Need GP IIb/IIIa|1|||
16826913|NCT01864005|37770516|FG001|Overall Study|Need GP IIb/IIIa|3|||
16826914|NCT01863849|37770524|FG000|Overall Study|Lost to Follow-up|1|||
16826915|NCT01863849|37770525|FG001|Overall Study|Lost to Follow-up|0|||
16826916|NCT01863771|37770532|FG000|Induction Phase|Adverse Event|9|||
16826917|NCT01863771|37770533|FG001|Induction Phase|Adverse Event|0|||
16826918|NCT01863771|37770534|FG002|Induction Phase|Adverse Event|0|||
16826919|NCT01863771|37770535|FG003|Induction Phase|Adverse Event|0|||
16826920|NCT01863771|37770532|FG000|Induction Phase|Lack of Efficacy|10|||
16826921|NCT01863771|37770533|FG001|Induction Phase|Lack of Efficacy|0|||
16826922|NCT01863771|37770534|FG002|Induction Phase|Lack of Efficacy|0|||
16826923|NCT01863771|37770535|FG003|Induction Phase|Lack of Efficacy|0|||
16826924|NCT01863771|37770532|FG000|Induction Phase|Withdrawal by Subject|2|||
16826925|NCT01863771|37770533|FG001|Induction Phase|Withdrawal by Subject|0|||
16826926|NCT01863771|37770534|FG002|Induction Phase|Withdrawal by Subject|0|||
16826927|NCT01863771|37770535|FG003|Induction Phase|Withdrawal by Subject|0|||
16826928|NCT01863771|37770532|FG000|Maintenance Phase|Adverse Event|0|||
16826929|NCT01863771|37770533|FG001|Maintenance Phase|Adverse Event|0|||
16826930|NCT01863771|37770534|FG002|Maintenance Phase|Adverse Event|1|||
16826931|NCT01863771|37770535|FG003|Maintenance Phase|Adverse Event|1|||
16826932|NCT01863771|37770532|FG000|Maintenance Phase|Lack of Efficacy|0|||
16826933|NCT01863771|37770533|FG001|Maintenance Phase|Lack of Efficacy|3|||
16826934|NCT01863771|37770534|FG002|Maintenance Phase|Lack of Efficacy|7|||
16826935|NCT01863771|37770535|FG003|Maintenance Phase|Lack of Efficacy|38|||
16826936|NCT01863771|37770532|FG000|Maintenance Phase|Physician Decision|0|||
16826937|NCT01863771|37770533|FG001|Maintenance Phase|Physician Decision|0|||
16826938|NCT01863771|37770534|FG002|Maintenance Phase|Physician Decision|2|||
16826939|NCT01863771|37770535|FG003|Maintenance Phase|Physician Decision|1|||
16826940|NCT01863771|37770532|FG000|Maintenance Phase|Pregnancy|0|||
16826941|NCT01863771|37770533|FG001|Maintenance Phase|Pregnancy|1|||
16826942|NCT01863771|37770534|FG002|Maintenance Phase|Pregnancy|0|||
16826943|NCT01863771|37770535|FG003|Maintenance Phase|Pregnancy|0|||
16826944|NCT01863771|37770532|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16826945|NCT01863771|37770533|FG001|Maintenance Phase|Withdrawal by Subject|1|||
16826946|NCT01863771|37770534|FG002|Maintenance Phase|Withdrawal by Subject|2|||
16826947|NCT01863771|37770535|FG003|Maintenance Phase|Withdrawal by Subject|3|||
16826948|NCT01894581|37770545|FG000|Overall Study|Withdrawal by Subject|2|||
16826949|NCT01894581|37770546|FG001|Overall Study|Withdrawal by Subject|3|||
16826950|NCT01894581|37770545|FG000|Overall Study|Screen Failure|3|||
16826951|NCT01894581|37770546|FG001|Overall Study|Screen Failure|4|||
16826952|NCT02203331|37770558|FG000|Overall Study|Pregnancy|1|||
16826953|NCT02203331|37770559|FG001|Overall Study|Pregnancy|0|||
16826954|NCT02203331|37770560|FG002|Overall Study|Pregnancy|0|||
16826955|NCT02203331|37770561|FG003|Overall Study|Pregnancy|0|||
16826956|NCT02203331|37770562|FG004|Overall Study|Pregnancy|2|||
16826957|NCT02203331|37770563|FG005|Overall Study|Pregnancy|0|||
16826958|NCT02203331|37770558|FG000|Overall Study|Withdrawal by Subject|1|||
16826959|NCT02203331|37770559|FG001|Overall Study|Withdrawal by Subject|0|||
16826960|NCT02203331|37770560|FG002|Overall Study|Withdrawal by Subject|1|||
16826961|NCT02203331|37770561|FG003|Overall Study|Withdrawal by Subject|0|||
16826962|NCT02203331|37770562|FG004|Overall Study|Withdrawal by Subject|0|||
16826963|NCT02203331|37770563|FG005|Overall Study|Withdrawal by Subject|3|||
16826964|NCT02203331|37770558|FG000|Overall Study|Adverse Event|4|||
16826965|NCT02203331|37770559|FG001|Overall Study|Adverse Event|8|||
16826966|NCT02203331|37770560|FG002|Overall Study|Adverse Event|3|||
16826967|NCT02203331|37770561|FG003|Overall Study|Adverse Event|4|||
16826968|NCT02203331|37770562|FG004|Overall Study|Adverse Event|3|||
16826969|NCT02203331|37770563|FG005|Overall Study|Adverse Event|3|||
16826970|NCT02203331|37770558|FG000|Overall Study|Other Reasons|1|||
16826971|NCT02203331|37770559|FG001|Overall Study|Other Reasons|2|||
16826972|NCT02203331|37770560|FG002|Overall Study|Other Reasons|0|||
16826973|NCT02203331|37770561|FG003|Overall Study|Other Reasons|2|||
16826974|NCT02203331|37770562|FG004|Overall Study|Other Reasons|0|||
16826975|NCT02203331|37770563|FG005|Overall Study|Other Reasons|0|||
16826976|NCT02203331|37770558|FG000|Overall Study|Lack of Efficacy|0|||
16826977|NCT02203331|37770559|FG001|Overall Study|Lack of Efficacy|2|||
16826978|NCT02203331|37770560|FG002|Overall Study|Lack of Efficacy|1|||
16826979|NCT02203331|37770561|FG003|Overall Study|Lack of Efficacy|0|||
16826980|NCT02203331|37770562|FG004|Overall Study|Lack of Efficacy|0|||
16826981|NCT02203331|37770563|FG005|Overall Study|Lack of Efficacy|1|||
16826982|NCT02203331|37770558|FG000|Overall Study|Protocol Violation|0|||
16826983|NCT02203331|37770559|FG001|Overall Study|Protocol Violation|2|||
16826984|NCT02203331|37770560|FG002|Overall Study|Protocol Violation|0|||
16826985|NCT02203331|37770561|FG003|Overall Study|Protocol Violation|1|||
16826986|NCT02203331|37770562|FG004|Overall Study|Protocol Violation|1|||
16826987|NCT02203331|37770563|FG005|Overall Study|Protocol Violation|0|||
16826988|NCT02203331|37770558|FG000|Overall Study|Lost to Follow-up|0|||
16826989|NCT02203331|37770559|FG001|Overall Study|Lost to Follow-up|0|||
16826990|NCT02203331|37770560|FG002|Overall Study|Lost to Follow-up|0|||
16826991|NCT02203331|37770561|FG003|Overall Study|Lost to Follow-up|0|||
16826992|NCT02203331|37770562|FG004|Overall Study|Lost to Follow-up|1|||
16826993|NCT02203331|37770563|FG005|Overall Study|Lost to Follow-up|0|||
16826994|NCT01893411|37770580|FG000|Overall Study|Protocol Violation|1|||
16826995|NCT01893411|37770581|FG001|Overall Study|Protocol Violation|0|||
16826996|NCT01893411|37770582|FG002|Overall Study|Protocol Violation|0|||
16826997|NCT01893411|37770580|FG000|Overall Study|Physician Decision|1|||
16826998|NCT01893411|37770581|FG001|Overall Study|Physician Decision|1|||
16826999|NCT01893411|37770582|FG002|Overall Study|Physician Decision|2|||
16827000|NCT01893411|37770580|FG000|Overall Study|Lack of Efficacy|2|||
16827001|NCT01893411|37770581|FG001|Overall Study|Lack of Efficacy|1|||
16827002|NCT01893411|37770582|FG002|Overall Study|Lack of Efficacy|0|||
16827003|NCT01893411|37770580|FG000|Overall Study|Other|3|||
16827004|NCT01893411|37770581|FG001|Overall Study|Other|1|||
16827005|NCT01893411|37770582|FG002|Overall Study|Other|3|||
16827006|NCT01893411|37770580|FG000|Overall Study|Adverse Event|1|||
16827007|NCT01893411|37770581|FG001|Overall Study|Adverse Event|0|||
16827008|NCT01893411|37770582|FG002|Overall Study|Adverse Event|0|||
16827009|NCT01893411|37770580|FG000|Overall Study|Withdrawal by Subject|7|||
16827010|NCT01893411|37770581|FG001|Overall Study|Withdrawal by Subject|4|||
16827011|NCT01893411|37770582|FG002|Overall Study|Withdrawal by Subject|3|||
16827012|NCT01893411|37770580|FG000|Overall Study|Lost to Follow-up|2|||
16827013|NCT01893411|37770581|FG001|Overall Study|Lost to Follow-up|0|||
16827014|NCT01893411|37770582|FG002|Overall Study|Lost to Follow-up|1|||
16827015|NCT02232425|37770592|FG000|Overall Study|Lost to Follow-up|6|||
16827016|NCT02232425|37770593|FG001|Overall Study|Lost to Follow-up|2|||
16827017|NCT02232425|37770592|FG000|Overall Study|Adverse Event|2|||
16827018|NCT02232425|37770593|FG001|Overall Study|Adverse Event|0|||
16827019|NCT02232425|37770592|FG000|Overall Study|Withdrawal by Subject|5|||
16827020|NCT02232425|37770593|FG001|Overall Study|Withdrawal by Subject|6|||
16827021|NCT02232425|37770592|FG000|Overall Study|Lack of Efficacy|1|||
16827022|NCT02232425|37770593|FG001|Overall Study|Lack of Efficacy|0|||
16827023|NCT01631435|37770599|FG000|Overall Study|Adverse Event|2|||
16827024|NCT01631435|37770599|FG000|Overall Study|Withdrawal by Subject|2|||
16827025|NCT01631435|37770599|FG000|Overall Study|incomplete study procedure|5|||
16827026|NCT02230085|37770604|FG000|Overall Study|Physician Decision|1|||
16827027|NCT02230085|37770604|FG000|Overall Study|Withdrawal by Subject|3|||
16827028|NCT01882803|37770608|FG000|Overall Study|Disease Progression|53|||
16827029|NCT01882803|37770608|FG000|Overall Study|Adverse Event|22|||
16827030|NCT01882803|37770608|FG000|Overall Study|Death|7|||
16827031|NCT01882803|37770608|FG000|Overall Study|Physician Decision|7|||
16827032|NCT01882803|37770608|FG000|Overall Study|Protocol Violation|1|||
16827033|NCT01882803|37770608|FG000|Overall Study|Withdrawal by Subject|4|||
16827034|NCT02202785|37770616|FG000|Overall Study|Study Terminated by Sponsor|1|||
16827035|NCT02202785|37770617|FG001|Overall Study|Study Terminated by Sponsor|6|||
16827036|NCT02202785|37770618|FG002|Overall Study|Study Terminated by Sponsor|4|||
16827037|NCT02202785|37770616|FG000|Overall Study|Withdrawal by Subject|0|||
16827038|NCT02202785|37770617|FG001|Overall Study|Withdrawal by Subject|1|||
16827039|NCT02202785|37770618|FG002|Overall Study|Withdrawal by Subject|0|||
16827040|NCT02202785|37770616|FG000|Overall Study|Lost to Follow-up|0|||
16827041|NCT02202785|37770617|FG001|Overall Study|Lost to Follow-up|1|||
16827042|NCT02202785|37770618|FG002|Overall Study|Lost to Follow-up|0|||
16827043|NCT02202785|37770616|FG000|Overall Study|Reason not Specified|10|||
16827044|NCT02202785|37770617|FG001|Overall Study|Reason not Specified|7|||
16827045|NCT02202785|37770618|FG002|Overall Study|Reason not Specified|13|||
16827046|NCT01882647|37770628|FG000|Overall Study|Lost to Follow-up|2|||
16827047|NCT01882647|37770629|FG001|Overall Study|Lost to Follow-up|2|||
16827048|NCT01882647|37770628|FG000|Overall Study|Withdrawal by Subject|0|||
16827049|NCT01882647|37770629|FG001|Overall Study|Withdrawal by Subject|4|||
16827050|NCT01882257|37770638|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
16827051|NCT01882257|37770639|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
16827052|NCT01882257|37770640|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
16827053|NCT01882257|37770638|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
16827054|NCT01882257|37770639|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
16827055|NCT01882257|37770640|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
16827056|NCT01862991|37770650|FG000|Overall Study|Lost to Follow-up|2|||
16827057|NCT01862991|37770651|FG001|Overall Study|Lost to Follow-up|1|||
16827058|NCT01862991|37770652|FG002|Overall Study|Lost to Follow-up|1|||
16827059|NCT01862991|37770650|FG000|Overall Study|Protocol Violation|1|||
16827060|NCT01862991|37770651|FG001|Overall Study|Protocol Violation|0|||
16827061|NCT01862991|37770652|FG002|Overall Study|Protocol Violation|0|||
16827062|NCT02202551|37770664|FG000|Overall Study|Adverse Event|8|||
16827063|NCT02202551|37770665|FG001|Overall Study|Adverse Event|19|||
16827064|NCT02202551|37770666|FG002|Overall Study|Adverse Event|5|||
16827065|NCT02202551|37770667|FG003|Overall Study|Adverse Event|9|||
16827066|NCT02202551|37770664|FG000|Overall Study|Death|3|||
16827067|NCT02202551|37770665|FG001|Overall Study|Death|2|||
16827068|NCT02202551|37770666|FG002|Overall Study|Death|1|||
16827069|NCT02202551|37770667|FG003|Overall Study|Death|1|||
16827070|NCT02202551|37770664|FG000|Overall Study|Lost to Follow-up|0|||
16827071|NCT02202551|37770665|FG001|Overall Study|Lost to Follow-up|1|||
16827072|NCT02202551|37770666|FG002|Overall Study|Lost to Follow-up|0|||
16827073|NCT02202551|37770667|FG003|Overall Study|Lost to Follow-up|1|||
16827074|NCT02202551|37770664|FG000|Overall Study|Needed to take excluded medication|0|||
16827075|NCT02202551|37770665|FG001|Overall Study|Needed to take excluded medication|2|||
16827076|NCT02202551|37770666|FG002|Overall Study|Needed to take excluded medication|0|||
16827077|NCT02202551|37770667|FG003|Overall Study|Needed to take excluded medication|1|||
16827078|NCT02202551|37770664|FG000|Overall Study|Subject moved away|0|||
16827079|NCT02202551|37770665|FG001|Overall Study|Subject moved away|1|||
16827080|NCT02202551|37770666|FG002|Overall Study|Subject moved away|0|||
16827081|NCT02202551|37770667|FG003|Overall Study|Subject moved away|0|||
16827082|NCT02202551|37770664|FG000|Overall Study|DBS surgery|3|||
16827083|NCT02202551|37770665|FG001|Overall Study|DBS surgery|0|||
16827084|NCT02202551|37770666|FG002|Overall Study|DBS surgery|0|||
16827085|NCT02202551|37770667|FG003|Overall Study|DBS surgery|0|||
16827086|NCT02202551|37770664|FG000|Overall Study|Dyskinesia upon taper|1|||
16827087|NCT02202551|37770665|FG001|Overall Study|Dyskinesia upon taper|0|||
16827088|NCT02202551|37770666|FG002|Overall Study|Dyskinesia upon taper|0|||
16827089|NCT02202551|37770667|FG003|Overall Study|Dyskinesia upon taper|0|||
16827090|NCT02202551|37770664|FG000|Overall Study|Lack of Efficacy|0|||
16827091|NCT02202551|37770665|FG001|Overall Study|Lack of Efficacy|1|||
16827092|NCT02202551|37770666|FG002|Overall Study|Lack of Efficacy|0|||
16827093|NCT02202551|37770667|FG003|Overall Study|Lack of Efficacy|0|||
16827094|NCT02202551|37770664|FG000|Overall Study|Physician Decision|1|||
16827095|NCT02202551|37770665|FG001|Overall Study|Physician Decision|0|||
16827096|NCT02202551|37770666|FG002|Overall Study|Physician Decision|0|||
16827097|NCT02202551|37770667|FG003|Overall Study|Physician Decision|0|||
16827098|NCT02202551|37770664|FG000|Overall Study|Site closure|3|||
16827099|NCT02202551|37770665|FG001|Overall Study|Site closure|0|||
16827100|NCT02202551|37770666|FG002|Overall Study|Site closure|0|||
16827101|NCT02202551|37770667|FG003|Overall Study|Site closure|1|||
16827102|NCT02202551|37770664|FG000|Overall Study|Unable to complete visits per protocol|1|||
16827103|NCT02202551|37770665|FG001|Overall Study|Unable to complete visits per protocol|0|||
16827104|NCT02202551|37770666|FG002|Overall Study|Unable to complete visits per protocol|0|||
16827105|NCT02202551|37770667|FG003|Overall Study|Unable to complete visits per protocol|0|||
16827106|NCT02202551|37770664|FG000|Overall Study|Worsening Dyskinesia|0|||
16827107|NCT02202551|37770665|FG001|Overall Study|Worsening Dyskinesia|0|||
17016723|NCT00854360|38161306|FG000|Overall Study|Withdrawal by Subject|0|||
17016724|NCT00854360|38161307|FG001|Overall Study|Withdrawal by Subject|0|||
16827108|NCT02202551|37770666|FG002|Overall Study|Worsening Dyskinesia|0|||
16827109|NCT02202551|37770667|FG003|Overall Study|Worsening Dyskinesia|1|||
16827110|NCT02202551|37770664|FG000|Overall Study|Protocol Violation|0|||
16827111|NCT02202551|37770665|FG001|Overall Study|Protocol Violation|1|||
16827112|NCT02202551|37770666|FG002|Overall Study|Protocol Violation|0|||
16827113|NCT02202551|37770667|FG003|Overall Study|Protocol Violation|0|||
16827114|NCT02202551|37770664|FG000|Overall Study|Sponsor's decision|2|||
16827115|NCT02202551|37770665|FG001|Overall Study|Sponsor's decision|0|||
16827116|NCT02202551|37770666|FG002|Overall Study|Sponsor's decision|0|||
16827117|NCT02202551|37770667|FG003|Overall Study|Sponsor's decision|0|||
16827118|NCT02202551|37770664|FG000|Overall Study|Subject unwilling to proceed|1|||
16827119|NCT02202551|37770665|FG001|Overall Study|Subject unwilling to proceed|5|||
16827120|NCT02202551|37770666|FG002|Overall Study|Subject unwilling to proceed|3|||
16827121|NCT02202551|37770667|FG003|Overall Study|Subject unwilling to proceed|5|||
16827122|NCT02202551|37770664|FG000|Overall Study|Subject consent withdrawn|0|||
16827123|NCT02202551|37770665|FG001|Overall Study|Subject consent withdrawn|3|||
16827124|NCT02202551|37770666|FG002|Overall Study|Subject consent withdrawn|1|||
16827125|NCT02202551|37770667|FG003|Overall Study|Subject consent withdrawn|2|||
16827126|NCT02202551|37770664|FG000|Overall Study|eGFR<50mL/min/m2|2|||
16827127|NCT02202551|37770665|FG001|Overall Study|eGFR<50mL/min/m2|2|||
16827128|NCT02202551|37770666|FG002|Overall Study|eGFR<50mL/min/m2|0|||
16827129|NCT02202551|37770667|FG003|Overall Study|eGFR<50mL/min/m2|1|||
16827130|NCT02202317|37770681|FG000|Overall Study|Lost to Follow-up|1|||
16827131|NCT02118337|37770694|FG000|Overall Study|Other|1|||
16827132|NCT02118337|37770695|FG001|Overall Study|Other|0|||
16827133|NCT02118337|37770696|FG002|Overall Study|Other|0|||
16827134|NCT02118337|37770697|FG003|Overall Study|Other|0|||
16827135|NCT02118337|37770698|FG004|Overall Study|Other|2|||
16827136|NCT02118337|37770699|FG005|Overall Study|Other|3|||
16827137|NCT02118337|37770700|FG006|Overall Study|Other|1|||
16827138|NCT02118337|37770701|FG007|Overall Study|Other|28|||
16827139|NCT02118337|37770702|FG008|Overall Study|Other|15|||
16827140|NCT02118337|37770694|FG000|Overall Study|Lost to Follow-up|0|||
16827141|NCT02118337|37770695|FG001|Overall Study|Lost to Follow-up|0|||
16827142|NCT02118337|37770696|FG002|Overall Study|Lost to Follow-up|0|||
16827143|NCT02118337|37770697|FG003|Overall Study|Lost to Follow-up|0|||
16827144|NCT02118337|37770698|FG004|Overall Study|Lost to Follow-up|0|||
16827145|NCT02118337|37770699|FG005|Overall Study|Lost to Follow-up|0|||
16827146|NCT02118337|37770700|FG006|Overall Study|Lost to Follow-up|0|||
16827147|NCT02118337|37770701|FG007|Overall Study|Lost to Follow-up|1|||
16827148|NCT02118337|37770702|FG008|Overall Study|Lost to Follow-up|0|||
16827149|NCT02118337|37770694|FG000|Overall Study|Withdrawal by Subject|1|||
16827150|NCT02118337|37770695|FG001|Overall Study|Withdrawal by Subject|3|||
16827151|NCT02118337|37770696|FG002|Overall Study|Withdrawal by Subject|2|||
16827152|NCT02118337|37770697|FG003|Overall Study|Withdrawal by Subject|1|||
16827153|NCT02118337|37770698|FG004|Overall Study|Withdrawal by Subject|2|||
16827154|NCT02118337|37770699|FG005|Overall Study|Withdrawal by Subject|2|||
16827155|NCT02118337|37770700|FG006|Overall Study|Withdrawal by Subject|1|||
16827156|NCT02118337|37770701|FG007|Overall Study|Withdrawal by Subject|4|||
16827157|NCT02118337|37770702|FG008|Overall Study|Withdrawal by Subject|2|||
16827158|NCT02118337|37770694|FG000|Overall Study|Death|2|||
16827159|NCT02118337|37770695|FG001|Overall Study|Death|2|||
16827160|NCT02118337|37770696|FG002|Overall Study|Death|1|||
16827161|NCT02118337|37770697|FG003|Overall Study|Death|2|||
16827162|NCT02118337|37770698|FG004|Overall Study|Death|5|||
16827163|NCT02118337|37770699|FG005|Overall Study|Death|1|||
16827164|NCT02118337|37770700|FG006|Overall Study|Death|2|||
16827165|NCT02118337|37770701|FG007|Overall Study|Death|9|||
16827166|NCT02118337|37770702|FG008|Overall Study|Death|4|||
16827167|NCT02117713|37770726|FG000|Week 48|Adverse Event|4|||
16827168|NCT02117713|37770726|FG000|Week 48|Withdrawal by caregiver|2|||
16827169|NCT02117713|37770726|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
16827170|NCT02117713|37770726|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
16827171|NCT02117713|37770726|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
16827172|NCT02117713|37770726|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
16827173|NCT02105467|37770740|FG000|Period 1|Lost to Follow-up|1|||
16827174|NCT02105467|37770741|FG001|Period 1|Lost to Follow-up|0|||
16827175|NCT02105467|37770740|FG000|Period 1|Death|1|||
16827176|NCT02105467|37770741|FG001|Period 1|Death|0|||
16827177|NCT02105467|37770740|FG000|Period 2|Lost to Follow-up|1|||
16827178|NCT02105467|37770741|FG001|Period 2|Lost to Follow-up|0|||
16827179|NCT02105467|37770740|FG000|Period 2|Death|1|||
16827180|NCT02105467|37770741|FG001|Period 2|Death|0|||
16827181|NCT02105467|37770740|FG000|Period 2|Withdrawal by Subject|0|||
16827182|NCT02105467|37770741|FG001|Period 2|Withdrawal by Subject|2|||
16827183|NCT02105467|37770740|FG000|Period 3|Lost to Follow-up|0|||
16827184|NCT02105467|37770741|FG001|Period 3|Lost to Follow-up|1|||
16827185|NCT02202161|37770756|FG000|Overall Study|Adverse Event|1|||
16827186|NCT02202161|37770757|FG001|Overall Study|Adverse Event|1|||
16827187|NCT02202161|37770758|FG002|Overall Study|Adverse Event|0|||
16827188|NCT02202161|37770759|FG003|Overall Study|Adverse Event|0|||
16827189|NCT02202161|37770760|FG004|Overall Study|Adverse Event|0|||
16827190|NCT02202161|37770761|FG005|Overall Study|Adverse Event|1|||
16827191|NCT02202161|37770762|FG006|Overall Study|Adverse Event|0|||
16827192|NCT02202161|37770763|FG007|Overall Study|Adverse Event|0|||
16827193|NCT02202161|37770756|FG000|Overall Study|Did not meet continuation criteria|0|||
16827194|NCT02202161|37770757|FG001|Overall Study|Did not meet continuation criteria|0|||
16827195|NCT02202161|37770758|FG002|Overall Study|Did not meet continuation criteria|0|||
16827196|NCT02202161|37770759|FG003|Overall Study|Did not meet continuation criteria|0|||
16827197|NCT02202161|37770760|FG004|Overall Study|Did not meet continuation criteria|0|||
16827198|NCT02202161|37770761|FG005|Overall Study|Did not meet continuation criteria|0|||
16827199|NCT02202161|37770762|FG006|Overall Study|Did not meet continuation criteria|0|||
16827200|NCT02202161|37770763|FG007|Overall Study|Did not meet continuation criteria|3|||
16827201|NCT02202161|37770756|FG000|Overall Study|Physician Decision|0|||
16827202|NCT02202161|37770757|FG001|Overall Study|Physician Decision|0|||
16827203|NCT02202161|37770758|FG002|Overall Study|Physician Decision|0|||
16827204|NCT02202161|37770759|FG003|Overall Study|Physician Decision|0|||
16827205|NCT02202161|37770760|FG004|Overall Study|Physician Decision|0|||
16827206|NCT02202161|37770761|FG005|Overall Study|Physician Decision|0|||
16827207|NCT02202161|37770762|FG006|Overall Study|Physician Decision|0|||
16827208|NCT02202161|37770763|FG007|Overall Study|Physician Decision|3|||
16827209|NCT02202161|37770756|FG000|Overall Study|Withdrawal by Subject|0|||
16827210|NCT02202161|37770757|FG001|Overall Study|Withdrawal by Subject|0|||
16827211|NCT02202161|37770758|FG002|Overall Study|Withdrawal by Subject|0|||
16827212|NCT02202161|37770759|FG003|Overall Study|Withdrawal by Subject|0|||
16827213|NCT02202161|37770760|FG004|Overall Study|Withdrawal by Subject|1|||
16827214|NCT02202161|37770761|FG005|Overall Study|Withdrawal by Subject|0|||
16827215|NCT02202161|37770762|FG006|Overall Study|Withdrawal by Subject|0|||
16827216|NCT02202161|37770763|FG007|Overall Study|Withdrawal by Subject|0|||
16827217|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Adverse Event|76|||
16827218|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Adverse Event|0|||
16827219|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Adverse Event|0|||
16827220|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Death|3|||
16827221|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Death|0|||
16827222|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Death|0|||
16827223|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
16827224|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
16827225|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
16827226|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Physician Decision|9|||
16827227|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Physician Decision|0|||
16827228|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Physician Decision|0|||
16827229|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
16827230|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
16827231|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
16827232|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Disease progression|45|||
16827233|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Disease progression|0|||
16827234|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Disease progression|0|||
16827235|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
16827236|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
16827237|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
16827238|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
16827239|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
16827240|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
16827241|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
16827242|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
16827243|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
16827244|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
16827245|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
16827246|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
16827247|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
16827248|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
16827249|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
16827250|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
16827251|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
16827252|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
16827253|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
16827254|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
16827255|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
16827256|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
16827257|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
16827258|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
16827259|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
16827260|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
16912079|NCT01508676|38021191|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
16912080|NCT01508676|38021190|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
17102397|NCT00384059|38241317|FG000|After Infant Series|Adverse Event|0|||
16827261|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
16827262|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Promotor request|1|||
16827263|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Promotor request|0|||
16827264|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Promotor request|0|||
16827265|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
16827266|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
16827267|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
16827268|NCT01461928|37770782|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
16827269|NCT01461928|37770783|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
16827270|NCT01461928|37770784|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
16827271|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Death|3|||
16827272|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Death|0|||
16827273|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Death|0|||
16827274|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
16827275|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
16827276|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
16827277|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
16827278|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
16827279|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
16827280|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Diseases progression|91|||
16827281|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Diseases progression|0|||
16827282|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Diseases progression|0|||
16827283|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Adverse Event|70|||
16827284|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Adverse Event|0|||
16827285|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Adverse Event|0|||
16827286|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Physician Decision|9|||
16827287|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Physician Decision|0|||
16827288|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Physician Decision|0|||
16827289|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
16827290|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
16827291|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
16827292|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
16827293|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
16827294|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
16827295|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
16827296|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
16827297|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
16827298|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Not compliant|1|||
16827299|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Not compliant|0|||
16827300|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Not compliant|0|||
16827301|NCT01461928|37770782|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
16827302|NCT01461928|37770783|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
16827303|NCT01461928|37770784|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
16827304|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Adverse Event|0|||
16827305|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Adverse Event|2|||
16827306|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Adverse Event|0|||
16827307|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Death|0|||
16827308|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Death|10|||
16827309|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Death|8|||
16827310|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Physician Decision|0|||
16827311|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Physician Decision|0|||
16827312|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Physician Decision|4|||
16827313|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
16827314|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
16827315|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
16827316|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Moved to another town|0|||
16827317|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Moved to another town|1|||
16827318|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Moved to another town|0|||
16827319|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Disease progression|0|||
16827320|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Disease progression|0|||
16827321|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Disease progression|3|||
16827322|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
16827323|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
16827324|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
16827325|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
16827326|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
16827327|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
16827328|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
16827329|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
16827330|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
16827331|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
16827332|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
16827333|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
16827334|NCT01461928|37770782|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
16827335|NCT01461928|37770783|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
16827336|NCT01461928|37770784|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
16827337|NCT03097991|37770797|FG000|Overall Study|Didn't meet study criteria|8|||
16827338|NCT03097991|37770798|FG001|Overall Study|Didn't meet study criteria|0|||
16827339|NCT03097991|37770797|FG000|Overall Study|Withdrawal by Subject|12|||
16827340|NCT03097991|37770798|FG001|Overall Study|Withdrawal by Subject|6|||
16827341|NCT03097991|37770797|FG000|Overall Study|Death of Baby|3|||
16827342|NCT03097991|37770798|FG001|Overall Study|Death of Baby|1|||
16827343|NCT03097991|37770797|FG000|Overall Study|Lost to Follow-up|24|||
16827344|NCT03097991|37770798|FG001|Overall Study|Lost to Follow-up|38|||
16827345|NCT03097991|37770797|FG000|Overall Study|Adverse Event|3|||
16827346|NCT03097991|37770798|FG001|Overall Study|Adverse Event|5|||
16827347|NCT02623205|37770810|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
16827348|NCT02623205|37770811|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
16827349|NCT01500694|37770820|FG000|Overall Study|Adverse Event|4|||
16827350|NCT01500694|37770821|FG001|Overall Study|Adverse Event|3|||
16827351|NCT01500694|37770820|FG000|Overall Study|Protocol Violation|0|||
16827352|NCT01500694|37770821|FG001|Overall Study|Protocol Violation|1|||
16827353|NCT01500694|37770820|FG000|Overall Study|Withdrawal by Subject|23|||
16827354|NCT01500694|37770821|FG001|Overall Study|Withdrawal by Subject|14|||
16827355|NCT01500694|37770820|FG000|Overall Study|Lost to Follow-up|2|||
16827356|NCT01500694|37770821|FG001|Overall Study|Lost to Follow-up|3|||
16827357|NCT01500694|37770820|FG000|Overall Study|Lack of Efficacy|14|||
16827358|NCT01500694|37770821|FG001|Overall Study|Lack of Efficacy|5|||
16827359|NCT01500694|37770820|FG000|Overall Study|Other|9|||
16827360|NCT01500694|37770821|FG001|Overall Study|Other|3|||
16827361|NCT01500382|37770831|FG000|Washout Period|Study site went out of business|0|||
16827362|NCT01500382|37770832|FG001|Washout Period|Study site went out of business|0|||
16827363|NCT01500382|37770833|FG002|Washout Period|Study site went out of business|1|||
16827364|NCT01500382|37770834|FG003|Washout Period|Study site went out of business|0|||
16827365|NCT02137837|37770847|FG000|Overall Study|Adverse Event|0|||
16827366|NCT02137837|37770848|FG001|Overall Study|Adverse Event|2|||
16827367|NCT02137837|37770849|FG002|Overall Study|Adverse Event|1|||
16827368|NCT02137837|37770847|FG000|Overall Study|Refusal unrelated to adverse event|2|||
16827369|NCT02137837|37770848|FG001|Overall Study|Refusal unrelated to adverse event|2|||
16827370|NCT02137837|37770849|FG002|Overall Study|Refusal unrelated to adverse event|1|||
16827371|NCT02137837|37770847|FG000|Overall Study|Progression/relapse|9|||
16827372|NCT02137837|37770848|FG001|Overall Study|Progression/relapse|7|||
16827373|NCT02137837|37770849|FG002|Overall Study|Progression/relapse|7|||
16827374|NCT02137837|37770847|FG000|Overall Study|Not protocol specified|2|||
16827375|NCT02137837|37770848|FG001|Overall Study|Not protocol specified|1|||
16827376|NCT02137837|37770849|FG002|Overall Study|Not protocol specified|3|||
16827377|NCT01483690|37770864|FG000|Overall Study|Adverse Event|1|||
16827378|NCT01483690|37770865|FG001|Overall Study|Adverse Event|2|||
16827379|NCT01483690|37770864|FG000|Overall Study|clinical deterioration|1|||
16827380|NCT01483690|37770865|FG001|Overall Study|clinical deterioration|0|||
16827381|NCT01483690|37770864|FG000|Overall Study|Physician Decision|0|||
16827382|NCT01483690|37770865|FG001|Overall Study|Physician Decision|2|||
16827383|NCT01483690|37770864|FG000|Overall Study|exclusionary procedure|0|||
16827384|NCT01483690|37770865|FG001|Overall Study|exclusionary procedure|1|||
16827385|NCT02104765|37770878|FG000|Overall Study|Lost to Follow-up|0|||
16827386|NCT02104765|37770879|FG001|Overall Study|Lost to Follow-up|0|||
16827387|NCT02104765|37770880|FG002|Overall Study|Lost to Follow-up|1|||
16827388|NCT02104765|37770881|FG003|Overall Study|Lost to Follow-up|0|||
16827389|NCT02104765|37770882|FG004|Overall Study|Lost to Follow-up|0|||
16827390|NCT02104765|37770883|FG005|Overall Study|Lost to Follow-up|0|||
16827391|NCT02104765|37770884|FG006|Overall Study|Lost to Follow-up|0|||
16827392|NCT02104765|37770878|FG000|Overall Study|Withdrawal by Subject|0|||
16827393|NCT02104765|37770879|FG001|Overall Study|Withdrawal by Subject|0|||
16827394|NCT02104765|37770880|FG002|Overall Study|Withdrawal by Subject|0|||
16827395|NCT02104765|37770881|FG003|Overall Study|Withdrawal by Subject|1|||
16827396|NCT02104765|37770882|FG004|Overall Study|Withdrawal by Subject|1|||
16827397|NCT02104765|37770883|FG005|Overall Study|Withdrawal by Subject|0|||
16827398|NCT02104765|37770884|FG006|Overall Study|Withdrawal by Subject|1|||
16827399|NCT01483144|37770909|FG000|Overall Study|Adverse Event|9|||
16827400|NCT01483144|37770910|FG001|Overall Study|Adverse Event|4|||
16827401|NCT01483144|37770911|FG002|Overall Study|Adverse Event|6|||
16827402|NCT01483144|37770909|FG000|Overall Study|Withdrawal by Subject|0|||
16827403|NCT01483144|37770910|FG001|Overall Study|Withdrawal by Subject|2|||
16827404|NCT01483144|37770911|FG002|Overall Study|Withdrawal by Subject|5|||
16827405|NCT01483144|37770909|FG000|Overall Study|Physician Decision|1|||
16827406|NCT01483144|37770910|FG001|Overall Study|Physician Decision|0|||
16827407|NCT01483144|37770911|FG002|Overall Study|Physician Decision|0|||
16827408|NCT01483144|37770909|FG000|Overall Study|Lost to Follow-up|2|||
16827409|NCT01483144|37770910|FG001|Overall Study|Lost to Follow-up|4|||
16827410|NCT01483144|37770911|FG002|Overall Study|Lost to Follow-up|1|||
16827411|NCT01483144|37770909|FG000|Overall Study|Protocol Violation|3|||
16827412|NCT01483144|37770910|FG001|Overall Study|Protocol Violation|3|||
16827413|NCT01483144|37770911|FG002|Overall Study|Protocol Violation|3|||
16827414|NCT01881789|37770925|FG000|Overall Study|Withdrawal by Subject|0|||
16827415|NCT01881789|37770926|FG001|Overall Study|Withdrawal by Subject|2|||
16827416|NCT01881789|37770927|FG002|Overall Study|Withdrawal by Subject|1|||
16827417|NCT01881789|37770928|FG003|Overall Study|Withdrawal by Subject|0|||
16827418|NCT01881789|37770929|FG004|Overall Study|Withdrawal by Subject|1|||
16827419|NCT01881789|37770930|FG005|Overall Study|Withdrawal by Subject|1|||
16827420|NCT01881789|37770925|FG000|Overall Study|Study Terminated by Sponsor|0|||
16827421|NCT01881789|37770926|FG001|Overall Study|Study Terminated by Sponsor|0|||
16827422|NCT01881789|37770927|FG002|Overall Study|Study Terminated by Sponsor|0|||
16827423|NCT01881789|37770928|FG003|Overall Study|Study Terminated by Sponsor|0|||
16827424|NCT01881789|37770929|FG004|Overall Study|Study Terminated by Sponsor|0|||
16827425|NCT01881789|37770930|FG005|Overall Study|Study Terminated by Sponsor|1|||
16827426|NCT01881789|37770925|FG000|Overall Study|Other|3|||
16827427|NCT01881789|37770926|FG001|Overall Study|Other|5|||
16827428|NCT01881789|37770927|FG002|Overall Study|Other|2|||
16827429|NCT01881789|37770928|FG003|Overall Study|Other|3|||
16827430|NCT01881789|37770929|FG004|Overall Study|Other|1|||
16827431|NCT01881789|37770930|FG005|Overall Study|Other|1|||
16827432|NCT02075203|37770948|FG000|Overall Study|Withdrawal by Subject|1|||
16827433|NCT02075203|37770949|FG001|Overall Study|Withdrawal by Subject|0|||
16827434|NCT02075203|37770950|FG002|Overall Study|Withdrawal by Subject|1|||
16827435|NCT02075203|37770948|FG000|Overall Study|Adverse Event|1|||
16827436|NCT02075203|37770949|FG001|Overall Study|Adverse Event|0|||
16827437|NCT02075203|37770950|FG002|Overall Study|Adverse Event|0|||
16827438|NCT02075203|37770948|FG000|Overall Study|participant refused to use contraception|1|||
16827439|NCT02075203|37770949|FG001|Overall Study|participant refused to use contraception|0|||
16827440|NCT02075203|37770950|FG002|Overall Study|participant refused to use contraception|0|||
16827441|NCT01892163|37770960|FG000|Overall Study|Death|1|||
16827442|NCT01892163|37770961|FG001|Overall Study|Death|1|||
16827443|NCT01892163|37770960|FG000|Overall Study|Lost to Follow-up|1|||
16827444|NCT01892163|37770961|FG001|Overall Study|Lost to Follow-up|0|||
16827445|NCT01881009|37770969|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
16827446|NCT01881009|37770970|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
16827447|NCT01500226|37770979|FG000|Overall Study|Adverse Event|31|||
16827448|NCT01500226|37770980|FG001|Overall Study|Adverse Event|38|||
16827449|NCT01500226|37770979|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
16827450|NCT01500226|37770980|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
16827451|NCT01500226|37770979|FG000|Overall Study|Withdrawal by Subject|93|||
16827452|NCT01500226|37770980|FG001|Overall Study|Withdrawal by Subject|96|||
16827453|NCT01500226|37770979|FG000|Overall Study|Death|12|||
16827454|NCT01500226|37770980|FG001|Overall Study|Death|4|||
16827455|NCT01500226|37770979|FG000|Overall Study|Disease Progression|16|||
16827456|NCT01500226|37770980|FG001|Overall Study|Disease Progression|14|||
16827457|NCT01500226|37770979|FG000|Overall Study|Protocol Violation|53|||
16827458|NCT01500226|37770980|FG001|Overall Study|Protocol Violation|39|||
16827459|NCT01500226|37770979|FG000|Overall Study|Physician Decision|17|||
16827460|NCT01500226|37770980|FG001|Overall Study|Physician Decision|15|||
16827461|NCT01500226|37770979|FG000|Overall Study|Lack of Efficacy|14|||
16827462|NCT01500226|37770980|FG001|Overall Study|Lack of Efficacy|30|||
16827463|NCT01500226|37770979|FG000|Overall Study|Lost to Follow-up|9|||
16827464|NCT01500226|37770980|FG001|Overall Study|Lost to Follow-up|5|||
16827465|NCT01500226|37770979|FG000|Overall Study|Other Reasons|19|||
16827466|NCT01500226|37770980|FG001|Overall Study|Other Reasons|16|||
16827467|NCT02075047|37770988|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
16827468|NCT02075047|37770989|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
16827469|NCT02075047|37770988|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
16827470|NCT02075047|37770989|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
16827471|NCT02075047|37770988|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
16827472|NCT02075047|37770989|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
16827473|NCT02075047|37770988|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
16827474|NCT02075047|37770989|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
16827475|NCT02075047|37770988|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
16827476|NCT02075047|37770989|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
16827477|NCT02075047|37770988|FG000|Treatment Phase (4 Weeks)|Other|1|||
16827478|NCT02075047|37770989|FG001|Treatment Phase (4 Weeks)|Other|1|||
16827479|NCT02075047|37770988|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
16827480|NCT02075047|37770989|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
17016725|NCT00854360|38161308|FG002|Overall Study|Withdrawal by Subject|0|||
16827481|NCT02075047|37770988|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
16827482|NCT02075047|37770989|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
16827483|NCT02075047|37770988|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
16827484|NCT02075047|37770989|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
16827485|NCT02075047|37770988|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
16827486|NCT02075047|37770989|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
16827487|NCT02075047|37770988|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
16827488|NCT02075047|37770989|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
16827489|NCT02075047|37770988|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
16827490|NCT02075047|37770989|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
16827491|NCT02075047|37770988|FG000|Follow up Phase (5 Weeks)|Other|1|||
16827492|NCT02075047|37770989|FG001|Follow up Phase (5 Weeks)|Other|2|||
16827493|NCT02075047|37770988|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
16827494|NCT02075047|37770989|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
16827495|NCT01859949|37770997|FG000|Overall Study|Family Matters|0|||
16827496|NCT01859949|37770998|FG001|Overall Study|Family Matters|1|||
16827497|NCT01859949|37770997|FG000|Overall Study|Physician Decision|2|||
16827498|NCT01859949|37770998|FG001|Overall Study|Physician Decision|4|||
16827499|NCT01859949|37770997|FG000|Overall Study|Withdrawal by Subject|11|||
16827500|NCT01859949|37770998|FG001|Overall Study|Withdrawal by Subject|10|||
16827501|NCT01859949|37770997|FG000|Overall Study|Protocol Violation|1|||
16827502|NCT01859949|37770998|FG001|Overall Study|Protocol Violation|1|||
16827503|NCT01859949|37770997|FG000|Overall Study|Adverse Event|0|||
16827504|NCT01859949|37770998|FG001|Overall Study|Adverse Event|1|||
16827505|NCT01859793|37771006|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
16827506|NCT01859793|37771007|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
16827507|NCT01859793|37771006|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
16827508|NCT01859793|37771007|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
16827509|NCT01859793|37771006|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16827510|NCT01859793|37771007|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
16827511|NCT01859793|37771006|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
16827512|NCT01859793|37771007|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
16827513|NCT01859715|37771016|FG000|Overall Study|No 2nd VAS|16|||
16827514|NCT01859715|37771017|FG001|Overall Study|No 2nd VAS|8|||
16827515|NCT01859715|37771018|FG002|Overall Study|No 2nd VAS|23|||
16827516|NCT01890915|37771030|FG000|Overall Study|Adverse Event|1|||
16827517|NCT01890915|37771031|FG001|Overall Study|Adverse Event|0|||
16827518|NCT01890915|37771030|FG000|Overall Study|Protocol Violation|2|||
16827519|NCT01890915|37771031|FG001|Overall Study|Protocol Violation|0|||
16827520|NCT01890915|37771030|FG000|Overall Study|Equipment Malfunction|0|||
16827521|NCT01890915|37771031|FG001|Overall Study|Equipment Malfunction|1|||
16827522|NCT01615263|37771039|FG000|Overall Study|Post-randomization exclusion|0|||
16827523|NCT01615263|37771040|FG001|Overall Study|Post-randomization exclusion|2|||
16827524|NCT01859403|37771057|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
16827525|NCT01859403|37771058|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
16827526|NCT01859403|37771057|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
16827527|NCT01859403|37771058|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
16827528|NCT01859403|37771057|FG000|Primary Endpoint Measure|Physician Decision|0|||
16827529|NCT01859403|37771058|FG001|Primary Endpoint Measure|Physician Decision|1|||
16827530|NCT01859403|37771057|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
16827531|NCT01859403|37771058|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
16827532|NCT01858701|37771064|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
16827533|NCT01858701|37771065|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
16827534|NCT01858701|37771064|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
16827535|NCT01858701|37771065|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
16827536|NCT01858701|37771064|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
16827537|NCT01858701|37771065|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
16827538|NCT01858701|37771064|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
16827539|NCT01858701|37771065|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
16827540|NCT01461538|37771074|FG000|Overall Study|Death|15|||
17102398|NCT00384059|38241318|FG001|After Infant Series|Adverse Event|1|||
17102399|NCT00384059|38241317|FG000|After Infant Series|Physician Decision|0|||
17102400|NCT00384059|38241318|FG001|After Infant Series|Physician Decision|1|||
17102401|NCT00384059|38241317|FG000|After Infant Series|Lost to Follow-up|0|||
17102402|NCT00384059|38241318|FG001|After Infant Series|Lost to Follow-up|1|||
16827541|NCT01461538|37771075|FG001|Overall Study|Death|6|||
16827542|NCT01461538|37771076|FG002|Overall Study|Death|2|||
16827543|NCT01461538|37771074|FG000|Overall Study|Study Stopped by Sponsor|2|||
16827544|NCT01461538|37771075|FG001|Overall Study|Study Stopped by Sponsor|1|||
16827545|NCT01461538|37771076|FG002|Overall Study|Study Stopped by Sponsor|0|||
16827546|NCT01461538|37771074|FG000|Overall Study|Withdrawal by Subject|1|||
16827547|NCT01461538|37771075|FG001|Overall Study|Withdrawal by Subject|1|||
16827548|NCT01461538|37771076|FG002|Overall Study|Withdrawal by Subject|0|||
16827549|NCT02117479|37771088|FG000|Overall Study|Death|13|||
16827550|NCT02117479|37771089|FG001|Overall Study|Death|8|||
16827551|NCT02117479|37771088|FG000|Overall Study|Adverse Event|8|||
16827552|NCT02117479|37771089|FG001|Overall Study|Adverse Event|16|||
16827553|NCT02117479|37771088|FG000|Overall Study|Subject decision|8|||
16827554|NCT02117479|37771089|FG001|Overall Study|Subject decision|9|||
16827555|NCT02117479|37771088|FG000|Overall Study|Disease progression|104|||
16827556|NCT02117479|37771089|FG001|Overall Study|Disease progression|108|||
16827557|NCT02117479|37771088|FG000|Overall Study|Noncompliance with study treatment|1|||
16827558|NCT02117479|37771089|FG001|Overall Study|Noncompliance with study treatment|0|||
16827559|NCT02117479|37771088|FG000|Overall Study|Study terminated by the sponsor|4|||
16827560|NCT02117479|37771089|FG001|Overall Study|Study terminated by the sponsor|6|||
16827561|NCT02117479|37771088|FG000|Overall Study|Physician Decision|7|||
16827562|NCT02117479|37771089|FG001|Overall Study|Physician Decision|2|||
16827563|NCT02117479|37771088|FG000|Overall Study|Other unspecified|11|||
16827564|NCT02117479|37771089|FG001|Overall Study|Other unspecified|7|||
16827565|NCT02229851|37771098|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
16827566|NCT02229851|37771099|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
16827567|NCT02229851|37771100|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
16827568|NCT02229851|37771101|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
16827569|NCT02229851|37771102|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
16827570|NCT02229851|37771103|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
16827571|NCT02229851|37771104|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
16827572|NCT02229851|37771098|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16827573|NCT02229851|37771099|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
16827574|NCT02229851|37771100|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16827575|NCT02229851|37771101|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16827576|NCT02229851|37771102|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16827577|NCT02229851|37771103|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16827578|NCT02229851|37771104|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16827579|NCT02229851|37771098|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
16827580|NCT02229851|37771099|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
16827581|NCT02229851|37771100|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
16827582|NCT02229851|37771101|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
16827583|NCT02229851|37771102|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
16827584|NCT02229851|37771103|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
16827585|NCT02229851|37771104|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
16827586|NCT02229851|37771098|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16827587|NCT02229851|37771099|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16827588|NCT02229851|37771100|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
16827589|NCT02229851|37771101|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16827590|NCT02229851|37771102|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16827591|NCT02229851|37771103|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16827592|NCT02229851|37771104|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16827593|NCT02229851|37771098|FG000|Main Phase (Double-blind Phase)|Death|1|||
16827594|NCT02229851|37771099|FG001|Main Phase (Double-blind Phase)|Death|1|||
16827595|NCT02229851|37771100|FG002|Main Phase (Double-blind Phase)|Death|0|||
16827596|NCT02229851|37771101|FG003|Main Phase (Double-blind Phase)|Death|0|||
16827597|NCT02229851|37771102|FG004|Main Phase (Double-blind Phase)|Death|0|||
16827598|NCT02229851|37771103|FG005|Main Phase (Double-blind Phase)|Death|0|||
16827599|NCT02229851|37771104|FG006|Main Phase (Double-blind Phase)|Death|0|||
16827600|NCT02229851|37771098|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
16827601|NCT02229851|37771099|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
16827602|NCT02229851|37771100|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
16827603|NCT02229851|37771101|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
16827604|NCT02229851|37771102|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
16827605|NCT02229851|37771103|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
16827606|NCT02229851|37771104|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
16827607|NCT02229851|37771098|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
16827608|NCT02229851|37771099|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
16827609|NCT02229851|37771100|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
16827610|NCT02229851|37771101|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
16827611|NCT02229851|37771102|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
16827612|NCT02229851|37771103|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
16827613|NCT02229851|37771104|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
16827614|NCT02229851|37771098|FG000|Extension Phase (Open-label Phase)|Death|0|||
16827615|NCT02229851|37771099|FG001|Extension Phase (Open-label Phase)|Death|0|||
16827616|NCT02229851|37771100|FG002|Extension Phase (Open-label Phase)|Death|0|||
16827617|NCT02229851|37771101|FG003|Extension Phase (Open-label Phase)|Death|1|||
16827618|NCT02229851|37771102|FG004|Extension Phase (Open-label Phase)|Death|0|||
16827619|NCT02229851|37771103|FG005|Extension Phase (Open-label Phase)|Death|1|||
16827620|NCT02229851|37771104|FG006|Extension Phase (Open-label Phase)|Death|1|||
16827621|NCT01482910|37771121|FG000|Overall Study|Adverse Event|6|||
16827622|NCT01482910|37771122|FG001|Overall Study|Adverse Event|5|||
16827623|NCT01482910|37771121|FG000|Overall Study|Lost to Follow-up|0|||
16827624|NCT01482910|37771122|FG001|Overall Study|Lost to Follow-up|1|||
16827625|NCT01482910|37771121|FG000|Overall Study|Protocol Violation|1|||
16827626|NCT01482910|37771122|FG001|Overall Study|Protocol Violation|1|||
16827627|NCT01482910|37771121|FG000|Overall Study|Withdrawal by Subject|7|||
16827628|NCT01482910|37771122|FG001|Overall Study|Withdrawal by Subject|2|||
16827629|NCT01482910|37771121|FG000|Overall Study|Death|1|||
16827630|NCT01482910|37771122|FG001|Overall Study|Death|0|||
16827631|NCT01626391|37771132|FG000|Overall Study|Physician Decision|1|||
16827632|NCT01626391|37771133|FG001|Overall Study|Physician Decision|0|||
16827633|NCT01626391|37771132|FG000|Overall Study|Withdrawal by Subject|1|||
16827634|NCT01626391|37771133|FG001|Overall Study|Withdrawal by Subject|0|||
16827635|NCT02103439|37771141|FG000|Overall Study|Adverse Event|0|||
16827636|NCT02103439|37771142|FG001|Overall Study|Adverse Event|2|||
16827637|NCT02103439|37771141|FG000|Overall Study|Withdrawal by Subject|3|||
16827638|NCT02103439|37771142|FG001|Overall Study|Withdrawal by Subject|1|||
16827639|NCT02229539|37771155|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
16827640|NCT02229539|37771156|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
16827641|NCT02229539|37771157|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
16827642|NCT02229539|37771155|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
16827643|NCT02229539|37771156|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
16827644|NCT02229539|37771157|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
16827645|NCT02229539|37771155|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
16827646|NCT02229539|37771156|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
16827647|NCT02229539|37771157|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
16827648|NCT02229539|37771155|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
16827649|NCT02229539|37771156|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
16827650|NCT02229539|37771157|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
16827651|NCT02229539|37771155|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
16827652|NCT02229539|37771156|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
16827653|NCT02229539|37771157|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
16827654|NCT02229539|37771155|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
16827655|NCT02229539|37771156|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
16827656|NCT02229539|37771157|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
16827657|NCT02229539|37771155|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
16827658|NCT02229539|37771156|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
16827659|NCT02229539|37771157|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
16827660|NCT02229539|37771155|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
16827661|NCT02229539|37771156|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
16827662|NCT02229539|37771157|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
16827663|NCT02229539|37771155|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
16827664|NCT02229539|37771156|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
16827665|NCT02229539|37771157|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
16827666|NCT01835223|37771167|FG000|Overall Study|Adverse Event|1|||
16827667|NCT01835223|37771168|FG001|Overall Study|Adverse Event|0|||
16827668|NCT01835223|37771167|FG000|Overall Study|Withdrawal by Subject|2|||
16827669|NCT01835223|37771168|FG001|Overall Study|Withdrawal by Subject|0|||
16827670|NCT01835223|37771167|FG000|Overall Study|Disease progression|2|||
16827671|NCT01835223|37771168|FG001|Overall Study|Disease progression|1|||
16827672|NCT01835223|37771167|FG000|Overall Study|Became Inelligible|4|||
16827673|NCT01835223|37771168|FG001|Overall Study|Became Inelligible|0|||
16827674|NCT01482598|37771178|FG000|Overall Study|Death|7|||
16827675|NCT01482598|37771179|FG001|Overall Study|Death|10|||
16827676|NCT01482598|37771178|FG000|Overall Study|Physician Decision|0|||
16827677|NCT01482598|37771179|FG001|Overall Study|Physician Decision|3|||
16827678|NCT01482598|37771178|FG000|Overall Study|Withdrawal by Subject|4|||
16827679|NCT01482598|37771179|FG001|Overall Study|Withdrawal by Subject|5|||
16827680|NCT01482598|37771178|FG000|Overall Study|Lost to Follow-up|5|||
16827681|NCT01482598|37771179|FG001|Overall Study|Lost to Follow-up|4|||
16827682|NCT01460446|37771187|FG000|Overall Study|Non-compliance|2|||
16827683|NCT01460446|37771188|FG001|Overall Study|Non-compliance|9|||
16827684|NCT01460446|37771187|FG000|Overall Study|Consent Withdrawn|0|||
17016726|NCT00854360|38161309|FG003|Overall Study|Withdrawal by Subject|1|||
16827685|NCT01460446|37771188|FG001|Overall Study|Consent Withdrawn|4|||
16827686|NCT01460446|37771187|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
16827687|NCT01460446|37771188|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
16827688|NCT01460446|37771187|FG000|Overall Study|Surgery/Illness|1|||
16827689|NCT01460446|37771188|FG001|Overall Study|Surgery/Illness|1|||
16827690|NCT01460446|37771187|FG000|Overall Study|Pregnancy|1|||
16827691|NCT01460446|37771188|FG001|Overall Study|Pregnancy|0|||
16827692|NCT01460446|37771187|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
16827693|NCT01460446|37771188|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
16827694|NCT02229383|37771197|FG000|Overall Study|Adverse Event|7|||
16827695|NCT02229383|37771198|FG001|Overall Study|Adverse Event|4|||
16827696|NCT02229383|37771197|FG000|Overall Study|Death|0|||
16827697|NCT02229383|37771198|FG001|Overall Study|Death|1|||
16827698|NCT02229383|37771197|FG000|Overall Study|Lost to Follow-up|5|||
16827699|NCT02229383|37771198|FG001|Overall Study|Lost to Follow-up|3|||
16827700|NCT02229383|37771197|FG000|Overall Study|Withdrawal by Subject|4|||
16827701|NCT02229383|37771198|FG001|Overall Study|Withdrawal by Subject|6|||
16827702|NCT02229383|37771197|FG000|Overall Study|Did not receive treatment|1|||
16827703|NCT02229383|37771198|FG001|Overall Study|Did not receive treatment|0|||
16827704|NCT02229383|37771197|FG000|Overall Study|Other|3|||
16827705|NCT02229383|37771198|FG001|Overall Study|Other|8|||
16827706|NCT01499368|37771207|FG000|Overall Study|Did not meet I/E criteria|8|||
16827707|NCT01499368|37771208|FG001|Overall Study|Did not meet I/E criteria|4|||
16827708|NCT01499368|37771209|FG002|Overall Study|Did not meet I/E criteria|4|||
16827709|NCT01499368|37771207|FG000|Overall Study|Prohibited Concomitant medication|1|||
16827710|NCT01499368|37771208|FG001|Overall Study|Prohibited Concomitant medication|1|||
16827711|NCT01499368|37771209|FG002|Overall Study|Prohibited Concomitant medication|0|||
16827712|NCT01499368|37771207|FG000|Overall Study|Withdrawal by Subject|11|||
16827713|NCT01499368|37771208|FG001|Overall Study|Withdrawal by Subject|10|||
16827714|NCT01499368|37771209|FG002|Overall Study|Withdrawal by Subject|8|||
16827715|NCT01499368|37771207|FG000|Overall Study|Lost to Follow-up|3|||
16827716|NCT01499368|37771208|FG001|Overall Study|Lost to Follow-up|2|||
16827717|NCT01499368|37771209|FG002|Overall Study|Lost to Follow-up|5|||
16827718|NCT01499368|37771207|FG000|Overall Study|Adverse Event|4|||
16827719|NCT01499368|37771208|FG001|Overall Study|Adverse Event|0|||
16827720|NCT01499368|37771209|FG002|Overall Study|Adverse Event|2|||
16827721|NCT01499368|37771207|FG000|Overall Study|Physician Decision|0|||
16827722|NCT01499368|37771208|FG001|Overall Study|Physician Decision|1|||
16827723|NCT01499368|37771209|FG002|Overall Study|Physician Decision|0|||
16827724|NCT01499368|37771207|FG000|Overall Study|Deviation from visit window|0|||
16827725|NCT01499368|37771208|FG001|Overall Study|Deviation from visit window|0|||
16827726|NCT01499368|37771209|FG002|Overall Study|Deviation from visit window|1|||
16827727|NCT01499368|37771207|FG000|Overall Study|Error of Prescriptions|0|||
16827728|NCT01499368|37771208|FG001|Overall Study|Error of Prescriptions|0|||
16827729|NCT01499368|37771209|FG002|Overall Study|Error of Prescriptions|1|||
16827730|NCT01835145|37771219|FG000|Overall Study|Ineligible prior to treatment|1|||
16827731|NCT01835145|37771220|FG001|Overall Study|Ineligible prior to treatment|0|||
16827732|NCT02229227|37771230|FG000|Overall Study|Adverse Event|14|||
16827733|NCT02229227|37771231|FG001|Overall Study|Adverse Event|9|||
16827734|NCT02229227|37771230|FG000|Overall Study|Lack of Efficacy|3|||
16827735|NCT02229227|37771231|FG001|Overall Study|Lack of Efficacy|3|||
16827736|NCT02229227|37771230|FG000|Overall Study|Protocol Violation|6|||
16827737|NCT02229227|37771231|FG001|Overall Study|Protocol Violation|8|||
16827738|NCT02229227|37771230|FG000|Overall Study|Protocol defined stopping criteria|1|||
16827739|NCT02229227|37771231|FG001|Overall Study|Protocol defined stopping criteria|3|||
16827740|NCT02229227|37771230|FG000|Overall Study|Lost to Follow-up|3|||
16827741|NCT02229227|37771231|FG001|Overall Study|Lost to Follow-up|3|||
16827742|NCT02229227|37771230|FG000|Overall Study|Study terminated by sponsor|11|||
16827743|NCT02229227|37771231|FG001|Overall Study|Study terminated by sponsor|11|||
16827744|NCT02229227|37771230|FG000|Overall Study|Withdrawal by Subject|8|||
16827745|NCT02229227|37771231|FG001|Overall Study|Withdrawal by Subject|12|||
16827746|NCT02229227|37771230|FG000|Overall Study|Other|0|||
16827747|NCT02229227|37771231|FG001|Overall Study|Other|1|||
16827748|NCT02229227|37771230|FG000|Overall Study|Physician Decision|5|||
16827749|NCT02229227|37771231|FG001|Overall Study|Physician Decision|12|||
16827750|NCT01499290|37771239|FG000|Overall Study|Withdrawal by Subject|22|||
16827751|NCT01499290|37771240|FG001|Overall Study|Withdrawal by Subject|15|||
16827752|NCT01499290|37771239|FG000|Overall Study|Not specified in study report|11|||
16827753|NCT01499290|37771240|FG001|Overall Study|Not specified in study report|5|||
16827754|NCT01499290|37771239|FG000|Overall Study|Condition improved/subject recovered|1|||
16827755|NCT01499290|37771240|FG001|Overall Study|Condition improved/subject recovered|0|||
16827756|NCT01499290|37771239|FG000|Overall Study|Lack of Efficacy|7|||
16827757|NCT01499290|37771240|FG001|Overall Study|Lack of Efficacy|8|||
16827758|NCT01499290|37771239|FG000|Overall Study|Adverse Event|14|||
16827759|NCT01499290|37771240|FG001|Overall Study|Adverse Event|7|||
16827760|NCT01833897|37771265|FG000|Overall Study|Lack of Efficacy|1|||
16827761|NCT01481896|37771269|FG000|Overall Study|Lost to Follow-up|12|||
16827762|NCT02226653|37771285|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
16827763|NCT02226653|37771286|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
16827764|NCT02226653|37771285|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
16827765|NCT02226653|37771286|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
16827766|NCT02201771|37771302|FG000|Overall Study|Death|3|||
16827767|NCT02201771|37771303|FG001|Overall Study|Death|2|||
16827768|NCT02201771|37771304|FG002|Overall Study|Death|0|||
16827769|NCT02201771|37771302|FG000|Overall Study|Protocol Violation|10|||
16827770|NCT02201771|37771303|FG001|Overall Study|Protocol Violation|8|||
16827771|NCT02201771|37771304|FG002|Overall Study|Protocol Violation|10|||
16827772|NCT02200445|37771315|FG000|Overall Study|Lack of Efficacy|1|||
16827773|NCT02200445|37771316|FG001|Overall Study|Lack of Efficacy|2|||
16827774|NCT02200445|37771317|FG002|Overall Study|Lack of Efficacy|2|||
16827775|NCT02200445|37771315|FG000|Overall Study|Adverse Event|0|||
16827776|NCT02200445|37771316|FG001|Overall Study|Adverse Event|2|||
16827777|NCT02200445|37771317|FG002|Overall Study|Adverse Event|0|||
16827778|NCT01460368|37771327|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16827779|NCT01460368|37771328|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16827780|NCT01460368|37771329|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16827781|NCT01460368|37771330|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16827782|NCT01460368|37771331|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
16827783|NCT01460368|37771332|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16827784|NCT01460368|37771333|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16827785|NCT01460368|37771327|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16827786|NCT01460368|37771328|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
16827787|NCT01460368|37771329|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16827788|NCT01460368|37771330|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16827789|NCT01460368|37771331|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16827790|NCT01460368|37771332|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16827791|NCT01460368|37771333|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
16827792|NCT01460368|37771327|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16827793|NCT01460368|37771328|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
16827794|NCT01460368|37771329|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16827795|NCT01460368|37771330|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16827796|NCT01460368|37771331|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16827797|NCT01460368|37771332|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16827798|NCT01460368|37771333|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16827799|NCT01460368|37771327|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16827800|NCT01460368|37771328|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16827801|NCT01460368|37771329|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
16827802|NCT01460368|37771330|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16827803|NCT01460368|37771331|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16827804|NCT01460368|37771332|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16827805|NCT01460368|37771333|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16827806|NCT01460368|37771327|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
16827807|NCT01460368|37771328|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
16827808|NCT01460368|37771329|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
16827809|NCT01460368|37771330|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
16827810|NCT01460368|37771331|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
16827811|NCT01460368|37771332|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
16827812|NCT01460368|37771333|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
16827813|NCT01460290|37771342|FG000|Overall Study|Adverse Event|3|||
16827814|NCT01460290|37771342|FG000|Overall Study|Elevated liver function|1|||
16827815|NCT02200211|37771351|FG000|Overall Study|Lost to Follow-up|7|||
16827816|NCT02200211|37771352|FG001|Overall Study|Lost to Follow-up|7|||
16827817|NCT02200211|37771353|FG002|Overall Study|Lost to Follow-up|1|||
16827818|NCT02200211|37771354|FG003|Overall Study|Lost to Follow-up|2|||
16827819|NCT02200211|37771351|FG000|Overall Study|Withdrawal by Subject|1|||
16827820|NCT02200211|37771352|FG001|Overall Study|Withdrawal by Subject|0|||
16827821|NCT02200211|37771353|FG002|Overall Study|Withdrawal by Subject|0|||
16827822|NCT02200211|37771354|FG003|Overall Study|Withdrawal by Subject|0|||
16827823|NCT01459666|37771374|FG000|Overall Study|PI left institution|5|||
16827824|NCT01459666|37771375|FG001|Overall Study|PI left institution|4|||
16827825|NCT01858389|37771383|FG000|Overall Study|Death|1|||
16827826|NCT01858389|37771384|FG001|Overall Study|Death|3|||
16827827|NCT01858389|37771383|FG000|Overall Study|Study terminated by sponsor|0|||
16827828|NCT01858389|37771384|FG001|Overall Study|Study terminated by sponsor|2|||
16827829|NCT01858389|37771383|FG000|Overall Study|Withdrawal by Subject|0|||
16827830|NCT01858389|37771384|FG001|Overall Study|Withdrawal by Subject|1|||
16827831|NCT01858389|37771383|FG000|Overall Study|Progressive disease|10|||
16827832|NCT01858389|37771384|FG001|Overall Study|Progressive disease|11|||
16827833|NCT01858389|37771383|FG000|Overall Study|Other|2|||
16827834|NCT01858389|37771384|FG001|Overall Study|Other|4|||
16827835|NCT01858389|37771383|FG000|Overall Study|Adverse Event|3|||
16827836|NCT01858389|37771384|FG001|Overall Study|Adverse Event|1|||
16827837|NCT01858389|37771383|FG000|Overall Study|Did not receive treatment|0|||
16827838|NCT01858389|37771384|FG001|Overall Study|Did not receive treatment|3|||
16827839|NCT02199509|37771392|FG000|Overall Study|Suicidal Ideation|0|||
16827840|NCT02199509|37771393|FG001|Overall Study|Suicidal Ideation|1|||
16827841|NCT02199509|37771392|FG000|Overall Study|Misunderstood titration schedule|1|||
16827842|NCT02199509|37771393|FG001|Overall Study|Misunderstood titration schedule|0|||
16827843|NCT01458574|37771406|FG000|Overall Study|Adverse Event|5|||
16827844|NCT01458574|37771407|FG001|Overall Study|Adverse Event|9|||
16827845|NCT01458574|37771408|FG002|Overall Study|Adverse Event|7|||
16827846|NCT01458574|37771406|FG000|Overall Study|Lack of Efficacy|70|||
16827847|NCT01458574|37771407|FG001|Overall Study|Lack of Efficacy|53|||
16827848|NCT01458574|37771408|FG002|Overall Study|Lack of Efficacy|132|||
16827849|NCT01458574|37771406|FG000|Overall Study|Lost to Follow-up|3|||
16827850|NCT01458574|37771407|FG001|Overall Study|Lost to Follow-up|2|||
16827851|NCT01458574|37771408|FG002|Overall Study|Lost to Follow-up|1|||
16827852|NCT01458574|37771406|FG000|Overall Study|Pregnancy|1|||
16827853|NCT01458574|37771407|FG001|Overall Study|Pregnancy|1|||
16827854|NCT01458574|37771408|FG002|Overall Study|Pregnancy|0|||
16827855|NCT01458574|37771406|FG000|Overall Study|Protocol Violation|0|||
16827856|NCT01458574|37771407|FG001|Overall Study|Protocol Violation|1|||
16827857|NCT01458574|37771408|FG002|Overall Study|Protocol Violation|0|||
16827858|NCT01458574|37771406|FG000|Overall Study|Withdrawal by Subject|6|||
16827859|NCT01458574|37771407|FG001|Overall Study|Withdrawal by Subject|3|||
16827860|NCT01458574|37771408|FG002|Overall Study|Withdrawal by Subject|5|||
16827861|NCT01458574|37771406|FG000|Overall Study|Other|2|||
16827862|NCT01458574|37771407|FG001|Overall Study|Other|1|||
16827863|NCT01458574|37771408|FG002|Overall Study|Other|0|||
16827864|NCT01458574|37771406|FG000|Overall Study|Randomized but not treated|0|||
16827865|NCT01458574|37771407|FG001|Overall Study|Randomized but not treated|1|||
16827866|NCT01458574|37771408|FG002|Overall Study|Randomized but not treated|0|||
16827867|NCT02224703|37771419|FG000|Overall Study|Adverse Event|0|||
16827868|NCT02224703|37771420|FG001|Overall Study|Adverse Event|5|||
16827869|NCT02224703|37771421|FG002|Overall Study|Adverse Event|0|||
16827870|NCT02224703|37771419|FG000|Overall Study|Withdrawn by investigator|1|||
16827871|NCT02224703|37771420|FG001|Overall Study|Withdrawn by investigator|0|||
16827872|NCT02224703|37771421|FG002|Overall Study|Withdrawn by investigator|0|||
16827873|NCT02224703|37771419|FG000|Overall Study|Advised by medical monitor|1|||
16827874|NCT02224703|37771420|FG001|Overall Study|Advised by medical monitor|0|||
16827875|NCT02224703|37771421|FG002|Overall Study|Advised by medical monitor|0|||
16827876|NCT02224703|37771419|FG000|Overall Study|Withdrawn by parent/guardian|0|||
16827877|NCT02224703|37771420|FG001|Overall Study|Withdrawn by parent/guardian|1|||
16827878|NCT02224703|37771421|FG002|Overall Study|Withdrawn by parent/guardian|0|||
16827879|NCT02224703|37771419|FG000|Overall Study|Lack of Efficacy|1|||
16827880|NCT02224703|37771420|FG001|Overall Study|Lack of Efficacy|0|||
16827881|NCT02224703|37771421|FG002|Overall Study|Lack of Efficacy|0|||
16827882|NCT02198963|37771430|FG000|Overall Study|Adverse Event|1|||
16827883|NCT02198963|37771430|FG000|Overall Study|Withdrawal by Subject|6|||
16827884|NCT01458106|37771454|FG000|Overall Study|Withdrawal by Subject|2|||
16827885|NCT01458106|37771455|FG001|Overall Study|Withdrawal by Subject|0|||
16827886|NCT01458106|37771454|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
16827887|NCT01458106|37771455|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
16827888|NCT01458106|37771454|FG000|Overall Study|Withdrawn Per Protocol|0|||
16827889|NCT01458106|37771455|FG001|Overall Study|Withdrawn Per Protocol|1|||
16827890|NCT01457950|37771466|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
16827891|NCT01457950|37771467|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
16827892|NCT01457950|37771468|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
16827893|NCT01457950|37771469|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
16827894|NCT01457950|37771466|FG000|Double-Blind Phase|Protocol Violation|2|||
16827895|NCT01457950|37771467|FG001|Double-Blind Phase|Protocol Violation|1|||
16827896|NCT01457950|37771468|FG002|Double-Blind Phase|Protocol Violation|0|||
16827897|NCT01457950|37771469|FG003|Double-Blind Phase|Protocol Violation|0|||
16827898|NCT01457950|37771466|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
16827899|NCT01457950|37771467|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
16827900|NCT01457950|37771468|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
16827901|NCT01457950|37771469|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
16827902|NCT01457950|37771466|FG000|Open-Label Phase|Adverse Event|0|||
16827903|NCT01457950|37771467|FG001|Open-Label Phase|Adverse Event|0|||
16827904|NCT01457950|37771468|FG002|Open-Label Phase|Adverse Event|0|||
16827905|NCT01457950|37771469|FG003|Open-Label Phase|Adverse Event|1|||
16827906|NCT01457950|37771466|FG000|Open-Label Phase|Protocol Violation|0|||
16827907|NCT01457950|37771467|FG001|Open-Label Phase|Protocol Violation|0|||
16827908|NCT01457950|37771468|FG002|Open-Label Phase|Protocol Violation|0|||
16827909|NCT01457950|37771469|FG003|Open-Label Phase|Protocol Violation|1|||
16827910|NCT01457950|37771466|FG000|Open-Label Phase|Withdrawal by Subject|0|||
16827911|NCT01457950|37771467|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16827912|NCT01457950|37771468|FG002|Open-Label Phase|Withdrawal by Subject|2|||
16827913|NCT01457950|37771469|FG003|Open-Label Phase|Withdrawal by Subject|0|||
16827914|NCT01499134|37771482|FG000|Overall Study|Withdrawal by Subject|0|||
16827915|NCT01499134|37771483|FG001|Overall Study|Withdrawal by Subject|1|||
16827916|NCT02198651|37771489|FG000|Lead-in Period|Withdrew consent|13|||
16827917|NCT02198651|37771490|FG001|Lead-in Period|Withdrew consent|0|||
16827918|NCT02198651|37771491|FG002|Lead-in Period|Withdrew consent|0|||
16827919|NCT02198651|37771492|FG003|Lead-in Period|Withdrew consent|0|||
16827920|NCT02198651|37771493|FG004|Lead-in Period|Withdrew consent|0|||
16827921|NCT02198651|37771489|FG000|Lead-in Period|Adverse Event|2|||
16827922|NCT02198651|37771490|FG001|Lead-in Period|Adverse Event|0|||
16827923|NCT02198651|37771491|FG002|Lead-in Period|Adverse Event|0|||
16827924|NCT02198651|37771492|FG003|Lead-in Period|Adverse Event|0|||
16827925|NCT02198651|37771493|FG004|Lead-in Period|Adverse Event|0|||
16827926|NCT02198651|37771489|FG000|Lead-in Period|Other, not specified|22|||
16827927|NCT02198651|37771490|FG001|Lead-in Period|Other, not specified|0|||
16827928|NCT02198651|37771491|FG002|Lead-in Period|Other, not specified|0|||
16827929|NCT02198651|37771492|FG003|Lead-in Period|Other, not specified|0|||
16827930|NCT02198651|37771493|FG004|Lead-in Period|Other, not specified|0|||
16827931|NCT02198651|37771489|FG000|Double-blind Period|Withdrew consent|0|||
16827932|NCT02198651|37771490|FG001|Double-blind Period|Withdrew consent|4|||
16827933|NCT02198651|37771491|FG002|Double-blind Period|Withdrew consent|0|||
16827934|NCT02198651|37771492|FG003|Double-blind Period|Withdrew consent|0|||
16827935|NCT02198651|37771493|FG004|Double-blind Period|Withdrew consent|0|||
16827936|NCT02198651|37771489|FG000|Double-blind Period|Adverse Event|0|||
16827937|NCT02198651|37771490|FG001|Double-blind Period|Adverse Event|1|||
16827938|NCT02198651|37771491|FG002|Double-blind Period|Adverse Event|0|||
16827939|NCT02198651|37771492|FG003|Double-blind Period|Adverse Event|0|||
16827940|NCT02198651|37771493|FG004|Double-blind Period|Adverse Event|0|||
16827941|NCT02198651|37771489|FG000|Double-blind Period|Other, not specified|0|||
16827942|NCT02198651|37771490|FG001|Double-blind Period|Other, not specified|4|||
16827943|NCT02198651|37771491|FG002|Double-blind Period|Other, not specified|1|||
16827944|NCT02198651|37771492|FG003|Double-blind Period|Other, not specified|0|||
16827945|NCT02198651|37771493|FG004|Double-blind Period|Other, not specified|0|||
16827946|NCT02198651|37771489|FG000|Open-label Rescue Period|Withdrew consent|0|||
16827947|NCT02198651|37771490|FG001|Open-label Rescue Period|Withdrew consent|0|||
16827948|NCT02198651|37771491|FG002|Open-label Rescue Period|Withdrew consent|0|||
16827949|NCT02198651|37771492|FG003|Open-label Rescue Period|Withdrew consent|2|||
16827950|NCT02198651|37771493|FG004|Open-label Rescue Period|Withdrew consent|0|||
16827951|NCT02198651|37771489|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
16827952|NCT02198651|37771490|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
16827953|NCT02198651|37771491|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
16827954|NCT02198651|37771492|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
16827955|NCT02198651|37771493|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
16827956|NCT01498822|37771508|FG000|Overall Study|Protocol Violation|8|||
16827957|NCT01498822|37771509|FG001|Overall Study|Protocol Violation|4|||
16827958|NCT01498822|37771508|FG000|Overall Study|Other Reason|5|||
16827959|NCT01498822|37771509|FG001|Overall Study|Other Reason|2|||
16827960|NCT01498822|37771508|FG000|Overall Study|Lack of Efficacy|7|||
16827961|NCT01498822|37771509|FG001|Overall Study|Lack of Efficacy|2|||
16827962|NCT01498822|37771508|FG000|Overall Study|AE, non-serious non-fatal|8|||
16827963|NCT01498822|37771509|FG001|Overall Study|AE, non-serious non-fatal|17|||
16827964|NCT01498822|37771508|FG000|Overall Study|SAE, non-fatal|2|||
16827965|NCT01498822|37771509|FG001|Overall Study|SAE, non-fatal|2|||
16827966|NCT01498822|37771508|FG000|Overall Study|Adverse Event, serious fatal|1|||
16827967|NCT01498822|37771509|FG001|Overall Study|Adverse Event, serious fatal|1|||
16827968|NCT01498822|37771508|FG000|Overall Study|Withdrawal by Subject|15|||
16827969|NCT01498822|37771509|FG001|Overall Study|Withdrawal by Subject|25|||
16827970|NCT01498822|37771508|FG000|Overall Study|Lost to Follow-up|8|||
16827971|NCT01498822|37771509|FG001|Overall Study|Lost to Follow-up|3|||
16827972|NCT01498120|37771517|FG000|Overall Study|Lost to Follow-up|1|||
16827973|NCT01498120|37771517|FG000|Overall Study|Withdrawal by Subject|5|||
16827974|NCT01498120|37771517|FG000|Overall Study|AE, non-serious non-fatal|3|||
16827975|NCT01498120|37771517|FG000|Overall Study|Other|4|||
16827976|NCT01497262|37771521|FG000|Overall Study|Abnormal Lab Values|4|||
16827977|NCT01497262|37771521|FG000|Overall Study|Abnormal Test Procedure Result|1|||
16827978|NCT01497262|37771521|FG000|Overall Study|Physician Decision|1|||
16827979|NCT01497262|37771521|FG000|Overall Study|Withdrawal by Subject|2|||
16827980|NCT01497262|37771521|FG000|Overall Study|Adverse Event|2|||
16827981|NCT01497262|37771521|FG000|Overall Study|Protocol Violation|1|||
16827982|NCT02224625|37771525|FG000|Irritation|Adverse Event|6|||
16827983|NCT02224625|37771525|FG000|Sensitization|Adverse Event|55|||
16827984|NCT02197247|37771537|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
16827985|NCT02197247|37771537|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
16827986|NCT02197247|37771537|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
16827987|NCT02197247|37771537|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
16827988|NCT02197247|37771537|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
16827989|NCT02197247|37771537|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
16827990|NCT02197247|37771537|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
16827991|NCT02197247|37771537|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
16827992|NCT02224157|37771549|FG000|Overall Study|Severe non-compliance to protocol|2|||
16827993|NCT02224157|37771550|FG001|Overall Study|Severe non-compliance to protocol|2|||
16827994|NCT02224157|37771549|FG000|Overall Study|Other|13|||
16827995|NCT02224157|37771550|FG001|Overall Study|Other|10|||
16827996|NCT02224157|37771549|FG000|Overall Study|Subject decision|58|||
16827997|NCT02224157|37771550|FG001|Overall Study|Subject decision|50|||
16827998|NCT02224157|37771549|FG000|Overall Study|Prematurely closed site|4|||
16827999|NCT02224157|37771550|FG001|Overall Study|Prematurely closed site|2|||
16828000|NCT02224157|37771549|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
16828001|NCT02224157|37771550|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
16828002|NCT02224157|37771549|FG000|Overall Study|Lost to Follow-up|27|||
16828003|NCT02224157|37771550|FG001|Overall Study|Lost to Follow-up|35|||
16828004|NCT02224157|37771549|FG000|Overall Study|Death|1|||
16828005|NCT02224157|37771550|FG001|Overall Study|Death|1|||
16828006|NCT02224157|37771549|FG000|Overall Study|Adverse Event|1|||
16828007|NCT02224157|37771550|FG001|Overall Study|Adverse Event|3|||
16828008|NCT02196701|37771558|FG000|Overall Study|Adverse Event|1|||
16828009|NCT02196701|37771558|FG000|Overall Study|Lost to Follow-up|1|||
16828010|NCT02196701|37771558|FG000|Overall Study|Non-adherence to Protocol|1|||
16828011|NCT01481116|37771568|FG000|Overall Study|Adverse Event|26|||
16828012|NCT01481116|37771569|FG001|Overall Study|Adverse Event|26|||
16828013|NCT01481116|37771570|FG002|Overall Study|Adverse Event|42|||
16828014|NCT01481116|37771568|FG000|Overall Study|Major Protocol Deviation|3|||
16828015|NCT01481116|37771569|FG001|Overall Study|Major Protocol Deviation|7|||
16828016|NCT01481116|37771570|FG002|Overall Study|Major Protocol Deviation|1|||
16828017|NCT01481116|37771568|FG000|Overall Study|Lost to Follow-up|8|||
16828018|NCT01481116|37771569|FG001|Overall Study|Lost to Follow-up|12|||
16828019|NCT01481116|37771570|FG002|Overall Study|Lost to Follow-up|11|||
16828020|NCT01481116|37771568|FG000|Overall Study|Withdrawal by Subject|37|||
16828021|NCT01481116|37771569|FG001|Overall Study|Withdrawal by Subject|33|||
16828022|NCT01481116|37771570|FG002|Overall Study|Withdrawal by Subject|37|||
16828023|NCT01481116|37771568|FG000|Overall Study|Study Termination|730|||
16828024|NCT01481116|37771569|FG001|Overall Study|Study Termination|729|||
16828025|NCT01481116|37771570|FG002|Overall Study|Study Termination|713|||
16828026|NCT01481116|37771568|FG000|Overall Study|Pregnancy|0|||
16828027|NCT01481116|37771569|FG001|Overall Study|Pregnancy|0|||
16828028|NCT01481116|37771570|FG002|Overall Study|Pregnancy|1|||
16828029|NCT01481116|37771568|FG000|Overall Study|Lack of Efficacy|3|||
16828030|NCT01481116|37771569|FG001|Overall Study|Lack of Efficacy|3|||
16828031|NCT01481116|37771570|FG002|Overall Study|Lack of Efficacy|1|||
16828032|NCT01481116|37771568|FG000|Overall Study|Contraindications|1|||
16828033|NCT01481116|37771569|FG001|Overall Study|Contraindications|1|||
16828034|NCT01481116|37771570|FG002|Overall Study|Contraindications|0|||
16828035|NCT01481116|37771568|FG000|Overall Study|Other|1|||
16828036|NCT01481116|37771569|FG001|Overall Study|Other|1|||
16828037|NCT01481116|37771570|FG002|Overall Study|Other|0|||
16828038|NCT01481116|37771568|FG000|Overall Study|Participant Started Taking Glipizide|1|||
16828039|NCT01481116|37771569|FG001|Overall Study|Participant Started Taking Glipizide|0|||
16828040|NCT01481116|37771570|FG002|Overall Study|Participant Started Taking Glipizide|0|||
16828041|NCT01481116|37771568|FG000|Overall Study|Participant Moved Out of Area|2|||
16828042|NCT01481116|37771569|FG001|Overall Study|Participant Moved Out of Area|0|||
16828043|NCT01481116|37771570|FG002|Overall Study|Participant Moved Out of Area|1|||
16828044|NCT01481116|37771568|FG000|Overall Study|Participant Moved Out of Country|1|||
16828045|NCT01481116|37771569|FG001|Overall Study|Participant Moved Out of Country|0|||
16828046|NCT01481116|37771570|FG002|Overall Study|Participant Moved Out of Country|1|||
16828047|NCT01481116|37771568|FG000|Overall Study|Investigator Decision|3|||
16828048|NCT01481116|37771569|FG001|Overall Study|Investigator Decision|2|||
16828049|NCT01481116|37771570|FG002|Overall Study|Investigator Decision|1|||
16828050|NCT01481116|37771568|FG000|Overall Study|Sponsor Decision|0|||
16828051|NCT01481116|37771569|FG001|Overall Study|Sponsor Decision|1|||
16828052|NCT01481116|37771570|FG002|Overall Study|Sponsor Decision|3|||
16828053|NCT01481116|37771568|FG000|Overall Study|Non-Compliant With Study Drug|0|||
16828054|NCT01481116|37771569|FG001|Overall Study|Non-Compliant With Study Drug|1|||
16828055|NCT01481116|37771570|FG002|Overall Study|Non-Compliant With Study Drug|1|||
16828056|NCT01481116|37771568|FG000|Overall Study|Investigator's Discretion|2|||
16828057|NCT01481116|37771569|FG001|Overall Study|Investigator's Discretion|0|||
16828058|NCT01481116|37771570|FG002|Overall Study|Investigator's Discretion|0|||
16828059|NCT01481116|37771568|FG000|Overall Study|Death|2|||
16828060|NCT01481116|37771569|FG001|Overall Study|Death|1|||
16828061|NCT01481116|37771570|FG002|Overall Study|Death|0|||
17102403|NCT00384059|38241317|FG000|Toddler Dose|Lost to Follow-up|1|||
16828062|NCT01481116|37771568|FG000|Overall Study|Hypoglycemic Event|4|||
16828063|NCT01481116|37771569|FG001|Overall Study|Hypoglycemic Event|0|||
16828064|NCT01481116|37771570|FG002|Overall Study|Hypoglycemic Event|0|||
16828065|NCT02222207|37771578|FG000|Overall Study|Death|1|||
16828066|NCT02222207|37771578|FG000|Overall Study|Other reasons|2|||
16828067|NCT02222207|37771578|FG000|Overall Study|Adverse Event|1|||
16828068|NCT01457014|37771582|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
16828069|NCT01457014|37771583|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
16828070|NCT01457014|37771584|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
16828071|NCT01457014|37771585|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
16828072|NCT01457014|37771582|FG000|First Night|Withdrawal by Subject|3|||
16828073|NCT01457014|37771583|FG001|First Night|Withdrawal by Subject|0|||
16828074|NCT01457014|37771584|FG002|First Night|Withdrawal by Subject|0|||
16828075|NCT01457014|37771585|FG003|First Night|Withdrawal by Subject|0|||
16828076|NCT02254421|37771595|FG000|Overall Study|Randomized but Not Treated|1|||
16828077|NCT02254421|37771596|FG001|Overall Study|Randomized but Not Treated|0|||
16828078|NCT02254421|37771595|FG000|Overall Study|Death|0|||
16828079|NCT02254421|37771596|FG001|Overall Study|Death|2|||
16828080|NCT02254421|37771595|FG000|Overall Study|Withdrew Consent|1|||
16828081|NCT02254421|37771596|FG001|Overall Study|Withdrew Consent|1|||
16828082|NCT02252939|37771602|FG000|Overall Study|Lost to Follow-up|3|||
16828083|NCT02196077|37771611|FG000|Overall Study|Adverse Event|4|||
16828084|NCT02196077|37771611|FG000|Overall Study|Lack of Efficacy|1|||
16828085|NCT02196077|37771611|FG000|Overall Study|Withdrawal by Subject|14|||
16828086|NCT02196077|37771611|FG000|Overall Study|Physician Decision|1|||
16828087|NCT02196077|37771611|FG000|Overall Study|Lost to Follow-up|3|||
16828088|NCT02196077|37771611|FG000|Overall Study|Protocol Violation|24|||
16828089|NCT02195687|37771625|FG000|Overall Study|Personal Reasons|1|||
16828090|NCT02195687|37771626|FG001|Overall Study|Personal Reasons|1|||
16828091|NCT02195687|37771625|FG000|Overall Study|Lost to Follow-up|4|||
16828092|NCT02195687|37771626|FG001|Overall Study|Lost to Follow-up|1|||
16828093|NCT02195531|37771635|FG000|Overall Study|Withdrawal by Subject|1|||
16828094|NCT02195531|37771636|FG001|Overall Study|Withdrawal by Subject|1|||
16828095|NCT02195531|37771637|FG002|Overall Study|Withdrawal by Subject|1|||
16828096|NCT02252081|37771647|FG000|Overall Study|Withdrawal by Subject|2|||
16828097|NCT02252081|37771648|FG001|Overall Study|Withdrawal by Subject|1|||
16828098|NCT02252081|37771647|FG000|Overall Study|Adverse Event|4|||
16828099|NCT02252081|37771648|FG001|Overall Study|Adverse Event|1|||
16828100|NCT02252081|37771647|FG000|Overall Study|non compliance & others|0|||
16828101|NCT02252081|37771648|FG001|Overall Study|non compliance & others|2|||
16828102|NCT01623752|37771662|FG000|Phase 1 (78 Weeks)|No Data|249|||
16828103|NCT01623752|37771663|FG001|Phase 1 (78 Weeks)|No Data|66|||
16828104|NCT01623752|37771664|FG002|Phase 1 (78 Weeks)|No Data|2|||
16828105|NCT01623752|37771662|FG000|Phase 1 (78 Weeks)|Other|33|||
16828106|NCT01623752|37771663|FG001|Phase 1 (78 Weeks)|Other|20|||
16828107|NCT01623752|37771664|FG002|Phase 1 (78 Weeks)|Other|0|||
16828108|NCT01623752|37771662|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
16828109|NCT01623752|37771663|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
16828110|NCT01623752|37771664|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
16828111|NCT01623752|37771662|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
16828112|NCT01623752|37771663|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
16828113|NCT01623752|37771664|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
16828114|NCT01623752|37771662|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
16828115|NCT01623752|37771663|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
16828116|NCT01623752|37771664|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
16828117|NCT01623752|37771662|FG000|Phase 2 (78 Weeks)|Other|5|||
16828118|NCT01623752|37771663|FG001|Phase 2 (78 Weeks)|Other|1|||
16828119|NCT01623752|37771664|FG002|Phase 2 (78 Weeks)|Other|0|||
16828120|NCT01623752|37771662|FG000|Phase 2 (78 Weeks)|No Data|43|||
16828121|NCT01623752|37771663|FG001|Phase 2 (78 Weeks)|No Data|11|||
16828122|NCT01623752|37771664|FG002|Phase 2 (78 Weeks)|No Data|0|||
16828123|NCT01623752|37771662|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
16828124|NCT01623752|37771663|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
16828125|NCT01623752|37771664|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
16828126|NCT01623596|37771675|FG000|Overall Study|Abnormal laboratory values|2|||
16828127|NCT01623596|37771676|FG001|Overall Study|Abnormal laboratory values|0|||
16828128|NCT01623596|37771675|FG000|Overall Study|Administrative problems|9|||
16828129|NCT01623596|37771676|FG001|Overall Study|Administrative problems|13|||
16828130|NCT01623596|37771675|FG000|Overall Study|Adverse Event|20|||
16828131|NCT01623596|37771676|FG001|Overall Study|Adverse Event|29|||
16828132|NCT01623596|37771675|FG000|Overall Study|Death|0|||
16828133|NCT01623596|37771676|FG001|Overall Study|Death|2|||
16828134|NCT01623596|37771675|FG000|Overall Study|Lost to Follow-up|12|||
16828135|NCT01623596|37771676|FG001|Overall Study|Lost to Follow-up|16|||
16828136|NCT01623596|37771675|FG000|Overall Study|Withdrawal by Subject|13|||
16828137|NCT01623596|37771676|FG001|Overall Study|Withdrawal by Subject|31|||
16828138|NCT01623596|37771675|FG000|Overall Study|Patient no longer requires study drug|1|||
16828139|NCT01623596|37771676|FG001|Overall Study|Patient no longer requires study drug|0|||
16828140|NCT01623596|37771675|FG000|Overall Study|Protocol Violation|0|||
16828141|NCT01623596|37771676|FG001|Overall Study|Protocol Violation|6|||
16828142|NCT01623596|37771675|FG000|Overall Study|Lack of Efficacy|5|||
16828143|NCT01623596|37771676|FG001|Overall Study|Lack of Efficacy|3|||
16828144|NCT02219477|37771687|FG000|Overall Study|Adverse Event|0|||
16828145|NCT02219477|37771688|FG001|Overall Study|Adverse Event|1|||
16828146|NCT02219477|37771689|FG002|Overall Study|Adverse Event|1|||
16828147|NCT02219477|37771687|FG000|Overall Study|Withdrawal by Subject|0|||
16828148|NCT02219477|37771688|FG001|Overall Study|Withdrawal by Subject|1|||
16828149|NCT02219477|37771689|FG002|Overall Study|Withdrawal by Subject|0|||
16828150|NCT02119286|37771701|FG000|Overall Study|Adverse Event|9|||
16828151|NCT02119286|37771702|FG001|Overall Study|Adverse Event|7|||
16912081|NCT01508676|38021191|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
16912082|NCT01508676|38021190|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
16912083|NCT01508676|38021191|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
16912084|NCT01508130|38021200|FG000|Overall Study|Adverse Event|81|||
16912085|NCT01508130|38021201|FG001|Overall Study|Adverse Event|28|||
16912086|NCT01508130|38021200|FG000|Overall Study|Death|3|||
16912087|NCT01508130|38021201|FG001|Overall Study|Death|1|||
16912088|NCT01508130|38021200|FG000|Overall Study|Protocol Violation|2|||
16912089|NCT01508130|38021201|FG001|Overall Study|Protocol Violation|0|||
16912090|NCT01508130|38021200|FG000|Overall Study|Lost to Follow-up|25|||
16912091|NCT01508130|38021201|FG001|Overall Study|Lost to Follow-up|2|||
16912092|NCT01508130|38021200|FG000|Overall Study|Withdrawal by Subject|3|||
16912093|NCT01508130|38021201|FG001|Overall Study|Withdrawal by Subject|3|||
16912094|NCT01508130|38021200|FG000|Overall Study|Subject's substantial non-compliance|25|||
16912095|NCT01508130|38021201|FG001|Overall Study|Subject's substantial non-compliance|9|||
17016727|NCT00854360|38161306|FG000|Overall Study|Pregnancy|0|||
17016728|NCT00854360|38161307|FG001|Overall Study|Pregnancy|1|||
17016729|NCT00854360|38161308|FG002|Overall Study|Pregnancy|0|||
17016730|NCT00854360|38161309|FG003|Overall Study|Pregnancy|0|||
17016731|NCT00854360|38161306|FG000|Overall Study|Lack of Efficacy|2|||
17016732|NCT00854360|38161307|FG001|Overall Study|Lack of Efficacy|1|||
16828152|NCT02119286|37771703|FG002|Overall Study|Adverse Event|2|||
16828153|NCT02119286|37771701|FG000|Overall Study|Lack of Efficacy|11|||
16828154|NCT02119286|37771702|FG001|Overall Study|Lack of Efficacy|3|||
16828155|NCT02119286|37771703|FG002|Overall Study|Lack of Efficacy|4|||
16828156|NCT02119286|37771701|FG000|Overall Study|Lost to Follow-up|2|||
16912096|NCT01508130|38021200|FG000|Overall Study|Insufficient therapeutic response|74|||
16912097|NCT01508130|38021201|FG001|Overall Study|Insufficient therapeutic response|23|||
16912098|NCT01508130|38021200|FG000|Overall Study|Administrative|14|||
17016733|NCT00854360|38161308|FG002|Overall Study|Lack of Efficacy|0|||
16828157|NCT02119286|37771702|FG001|Overall Study|Lost to Follow-up|0|||
16828158|NCT02119286|37771703|FG002|Overall Study|Lost to Follow-up|1|||
16828159|NCT02119286|37771701|FG000|Overall Study|Withdrawal by Subject|4|||
16828160|NCT02119286|37771702|FG001|Overall Study|Withdrawal by Subject|1|||
16828161|NCT02119286|37771703|FG002|Overall Study|Withdrawal by Subject|0|||
16828162|NCT02250443|37771711|FG000|Overall Study|Administrative problems|7|||
16828163|NCT02250443|37771711|FG000|Overall Study|Adverse Event|3|||
16828164|NCT02093390|37771717|FG000|Overall Study|Withdrawal by Subject|0|||
16828165|NCT02093390|37771718|FG001|Overall Study|Withdrawal by Subject|1|||
16828166|NCT02194985|37771725|FG000|Overall Study|Adverse Event|1|||
16828167|NCT02194985|37771725|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
16828168|NCT02194985|37771725|FG000|Overall Study|Physician Decision|4|||
16828169|NCT02194985|37771725|FG000|Overall Study|Lost to Follow-up|1|||
16828170|NCT02194985|37771725|FG000|Overall Study|Withdrawal by Subject|2|||
16828171|NCT02219087|37771731|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
16828172|NCT02219087|37771732|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
16828173|NCT02248961|37771740|FG000|Overall Study|Adverse Event|1|||
16828174|NCT02248961|37771741|FG001|Overall Study|Adverse Event|0|||
16828175|NCT02248961|37771740|FG000|Overall Study|Withdrawal by Subject|1|||
16828176|NCT02248961|37771741|FG001|Overall Study|Withdrawal by Subject|2|||
16828177|NCT02248961|37771740|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
16828178|NCT02248961|37771741|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
16828179|NCT02219009|37771749|FG000|Overall Study|Withdrawal by Subject|5|||
16828180|NCT02219009|37771750|FG001|Overall Study|Withdrawal by Subject|1|||
16828181|NCT02219009|37771749|FG000|Overall Study|Adverse Event|2|||
16828182|NCT02219009|37771750|FG001|Overall Study|Adverse Event|4|||
16828183|NCT02219009|37771749|FG000|Overall Study|Lost to Follow-up|2|||
16828184|NCT02219009|37771750|FG001|Overall Study|Lost to Follow-up|2|||
16828185|NCT02219009|37771749|FG000|Overall Study|Protocol deviation|1|||
16828186|NCT02219009|37771750|FG001|Overall Study|Protocol deviation|0|||
16828187|NCT02219009|37771749|FG000|Overall Study|Physician Decision|0|||
16828188|NCT02219009|37771750|FG001|Overall Study|Physician Decision|1|||
16828189|NCT02248649|37771758|FG000|Overall Study|Death|7|||
16828190|NCT02248649|37771759|FG001|Overall Study|Death|11|||
16828191|NCT02248649|37771758|FG000|Overall Study|Lost to Follow-up|14|||
16828192|NCT02248649|37771759|FG001|Overall Study|Lost to Follow-up|10|||
16828193|NCT02218541|37771767|FG000|Overall Study|Lost to Follow-up|2|||
16828194|NCT02218541|37771768|FG001|Overall Study|Lost to Follow-up|1|||
16828195|NCT02218541|37771767|FG000|Overall Study|Implant Failure|4|||
16828196|NCT02218541|37771768|FG001|Overall Study|Implant Failure|1|||
16828197|NCT02217527|37771777|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
16828198|NCT02217527|37771778|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
16828199|NCT02217527|37771777|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
16828200|NCT02217527|37771778|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
16828201|NCT01456936|37771788|FG000|Overall Study|Other reason|41|||
16828202|NCT01456936|37771789|FG001|Overall Study|Other reason|30|||
16828203|NCT01456936|37771790|FG002|Overall Study|Other reason|36|||
16828204|NCT01456936|37771791|FG003|Overall Study|Other reason|33|||
16828205|NCT01456936|37771788|FG000|Overall Study|No longer meets eligibility criteria|4|||
16828206|NCT01456936|37771789|FG001|Overall Study|No longer meets eligibility criteria|8|||
16828207|NCT01456936|37771790|FG002|Overall Study|No longer meets eligibility criteria|6|||
16828208|NCT01456936|37771791|FG003|Overall Study|No longer meets eligibility criteria|5|||
16828209|NCT01456936|37771788|FG000|Overall Study|Protocol Violation|4|||
16828210|NCT01456936|37771789|FG001|Overall Study|Protocol Violation|2|||
16828211|NCT01456936|37771790|FG002|Overall Study|Protocol Violation|5|||
16828212|NCT01456936|37771791|FG003|Overall Study|Protocol Violation|5|||
16828213|NCT01456936|37771788|FG000|Overall Study|Pregnancy|1|||
16828214|NCT01456936|37771789|FG001|Overall Study|Pregnancy|0|||
16828215|NCT01456936|37771790|FG002|Overall Study|Pregnancy|0|||
16828216|NCT01456936|37771791|FG003|Overall Study|Pregnancy|1|||
16828217|NCT01456936|37771788|FG000|Overall Study|Insufficient clinical response|4|||
16828218|NCT01456936|37771789|FG001|Overall Study|Insufficient clinical response|4|||
16828219|NCT01456936|37771790|FG002|Overall Study|Insufficient clinical response|14|||
16828220|NCT01456936|37771791|FG003|Overall Study|Insufficient clinical response|13|||
16828221|NCT01456936|37771788|FG000|Overall Study|No longer willing to participate|195|||
16828222|NCT01456936|37771789|FG001|Overall Study|No longer willing to participate|218|||
16828223|NCT01456936|37771790|FG002|Overall Study|No longer willing to participate|224|||
16828224|NCT01456936|37771791|FG003|Overall Study|No longer willing to participate|248|||
16828225|NCT01456936|37771788|FG000|Overall Study|Lost to Follow-up|135|||
16828226|NCT01456936|37771789|FG001|Overall Study|Lost to Follow-up|126|||
16828227|NCT01456936|37771790|FG002|Overall Study|Lost to Follow-up|144|||
16828228|NCT01456936|37771791|FG003|Overall Study|Lost to Follow-up|127|||
16828229|NCT01456936|37771788|FG000|Overall Study|Medication error|0|||
16828230|NCT01456936|37771789|FG001|Overall Study|Medication error|1|||
16828231|NCT01456936|37771790|FG002|Overall Study|Medication error|0|||
16828232|NCT01456936|37771791|FG003|Overall Study|Medication error|1|||
16828233|NCT01456936|37771788|FG000|Overall Study|Adverse event (study drug)|25|||
16828234|NCT01456936|37771789|FG001|Overall Study|Adverse event (study drug)|21|||
16828235|NCT01456936|37771790|FG002|Overall Study|Adverse event (study drug)|26|||
16828236|NCT01456936|37771791|FG003|Overall Study|Adverse event (study drug)|17|||
16828237|NCT01456936|37771788|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
16828238|NCT01456936|37771789|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
16828239|NCT01456936|37771790|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
16912099|NCT01508130|38021201|FG001|Overall Study|Administrative|3|||
16912100|NCT01482312|38021209|FG000|Period 1, 90 Minutes of Wear|Other|1|||
16912101|NCT01482312|38021210|FG001|Period 1, 90 Minutes of Wear|Other|0|||
16912102|NCT01482312|38021211|FG002|Period 1, 90 Minutes of Wear|Other|0|||
16912103|NCT01482312|38021209|FG000|Period 2, 90 Minutes of Wear|Other|1|||
16912104|NCT01482312|38021210|FG001|Period 2, 90 Minutes of Wear|Other|0|||
16912105|NCT01482312|38021211|FG002|Period 2, 90 Minutes of Wear|Other|0|||
16912106|NCT01461096|38021221|FG000|Overall Study|Death|3|||
16912107|NCT01461096|38021222|FG001|Overall Study|Death|6|||
16912108|NCT01461096|38021221|FG000|Overall Study|Severe debilitation, unable to continue|1|||
16912109|NCT01461096|38021222|FG001|Overall Study|Severe debilitation, unable to continue|1|||
16912110|NCT01461096|38021221|FG000|Overall Study|Subj not able to get to clinic|15|||
16912111|NCT01461096|38021222|FG001|Overall Study|Subj not able to get to clinic|13|||
16912112|NCT01461096|38021221|FG000|Overall Study|Site is closing|27|||
16912113|NCT01461096|38021222|FG001|Overall Study|Site is closing|30|||
16912114|NCT01461096|38021221|FG000|Overall Study|Withdrawal by Subject|5|||
16912115|NCT01461096|38021222|FG001|Overall Study|Withdrawal by Subject|3|||
16912116|NCT01461096|38021221|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
16912117|NCT01461096|38021222|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
16912118|NCT01461096|38021221|FG000|Overall Study|Lost to Follow-up|8|||
16912119|NCT01461096|38021222|FG001|Overall Study|Lost to Follow-up|4|||
16912120|NCT01507896|38021229|FG000|Overall Study|Withdrawal by Subject|1|||
16912121|NCT01507896|38021229|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
16912122|NCT01507662|38021244|FG000|Overall Study|Death|26|||
16912123|NCT01507662|38021245|FG001|Overall Study|Death|18|||
16912124|NCT01507662|38021244|FG000|Overall Study|Withdrawal by Subject|290|||
16912125|NCT01507662|38021245|FG001|Overall Study|Withdrawal by Subject|287|||
16912126|NCT01507662|38021244|FG000|Overall Study|Lost to Follow-up|498|||
16912127|NCT01507662|38021245|FG001|Overall Study|Lost to Follow-up|523|||
16912128|NCT01507662|38021244|FG000|Overall Study|Proxy interview done|2|||
16912129|NCT01507662|38021245|FG001|Overall Study|Proxy interview done|3|||
16912130|NCT01506960|38021251|FG000|Overall Study|Did not meet angiographic criteria|47|||
16912131|NCT01480674|38021257|FG000|Overall Study|Death|23|||
16912132|NCT01480674|38021257|FG000|Overall Study|Lost to Follow-up|2|||
16912133|NCT01480674|38021257|FG000|Overall Study|visit not done|10|||
16912134|NCT01506882|38021263|FG000|Overall Study|Lack of Efficacy|4|||
16912135|NCT01506882|38021264|FG001|Overall Study|Lack of Efficacy|3|||
16912136|NCT01506882|38021263|FG000|Overall Study|Lost to Follow-up|1|||
16912137|NCT01506882|38021264|FG001|Overall Study|Lost to Follow-up|0|||
16912138|NCT01506882|38021263|FG000|Overall Study|Withdrawal by Subject|9|||
16912139|NCT01506882|38021264|FG001|Overall Study|Withdrawal by Subject|3|||
16912140|NCT01506882|38021263|FG000|Overall Study|SAE, non-fatal|2|||
16912141|NCT01506882|38021264|FG001|Overall Study|SAE, non-fatal|0|||
16912142|NCT01506882|38021263|FG000|Overall Study|AE, non-serious non-fatal|3|||
16912143|NCT01506882|38021264|FG001|Overall Study|AE, non-serious non-fatal|1|||
16912144|NCT01506882|38021263|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
16912145|NCT01506882|38021264|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
16912146|NCT01506882|38021263|FG000|Overall Study|Other Reason|2|||
16912147|NCT01506882|38021264|FG001|Overall Study|Other Reason|0|||
16912148|NCT01506726|38021274|FG000|Overall Study|Adverse Event|1|||
16912149|NCT01506726|38021275|FG001|Overall Study|Adverse Event|2|||
16912150|NCT01505868|38021286|FG000|Overall Study|Withdrawal by Subject|1|||
16912151|NCT01505868|38021287|FG001|Overall Study|Withdrawal by Subject|0|||
16912152|NCT01505868|38021288|FG002|Overall Study|Withdrawal by Subject|0|||
16912153|NCT01505868|38021289|FG003|Overall Study|Withdrawal by Subject|0|||
16912154|NCT01505868|38021290|FG004|Overall Study|Withdrawal by Subject|0|||
16912155|NCT01505634|38021305|FG000|Overall Study|Withdrawal by Subject|2|||
16912156|NCT01505634|38021306|FG001|Overall Study|Withdrawal by Subject|5|||
16912157|NCT01505634|38021307|FG002|Overall Study|Withdrawal by Subject|1|||
16912158|NCT01505634|38021305|FG000|Overall Study|Physician Decision|1|||
16912159|NCT01505634|38021306|FG001|Overall Study|Physician Decision|1|||
16912160|NCT01505634|38021307|FG002|Overall Study|Physician Decision|0|||
16912161|NCT01505634|38021305|FG000|Overall Study|Adverse Event|1|||
16912162|NCT01505634|38021306|FG001|Overall Study|Adverse Event|0|||
17016734|NCT00854360|38161309|FG003|Overall Study|Lack of Efficacy|0|||
17016735|NCT00854360|38161306|FG000|Overall Study|Other|0|||
16912163|NCT01505634|38021307|FG002|Overall Study|Adverse Event|0|||
16912164|NCT01505634|38021305|FG000|Overall Study|Insufficient supply of drug at site|1|||
16912165|NCT01505634|38021306|FG001|Overall Study|Insufficient supply of drug at site|0|||
16828240|NCT01456936|37771791|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
16828241|NCT01456936|37771788|FG000|Overall Study|Death|0|||
16828242|NCT01456936|37771789|FG001|Overall Study|Death|3|||
16828243|NCT01456936|37771790|FG002|Overall Study|Death|1|||
16828244|NCT01456936|37771791|FG003|Overall Study|Death|3|||
16828245|NCT01456936|37771788|FG000|Overall Study|Randomized but not treated|21|||
16828246|NCT01456936|37771789|FG001|Overall Study|Randomized but not treated|28|||
16828247|NCT01456936|37771790|FG002|Overall Study|Randomized but not treated|16|||
16828248|NCT01456936|37771791|FG003|Overall Study|Randomized but not treated|21|||
16828249|NCT01456780|37771804|FG000|Overall Study|Lost to Follow-up|3|||
16828250|NCT01456780|37771805|FG001|Overall Study|Lost to Follow-up|3|||
16828251|NCT01456780|37771806|FG002|Overall Study|Lost to Follow-up|0|||
16828252|NCT01480258|37771816|FG000|Infant Series|Protocol Violation|2|||
16828253|NCT01480258|37771817|FG001|Infant Series|Protocol Violation|0|||
16828254|NCT01480258|37771816|FG000|Infant Series|Physician Decision|0|||
16828255|NCT01480258|37771817|FG001|Infant Series|Physician Decision|1|||
16828256|NCT01480258|37771816|FG000|Infant Series|Not Vaccinated|3|||
16828257|NCT01480258|37771817|FG001|Infant Series|Not Vaccinated|0|||
16828258|NCT01480258|37771816|FG000|Infant Series|Adverse Event|1|||
16828259|NCT01480258|37771817|FG001|Infant Series|Adverse Event|1|||
16828260|NCT01480258|37771816|FG000|Infant Series|Withdrawal by Subject|1|||
16828261|NCT01480258|37771817|FG001|Infant Series|Withdrawal by Subject|6|||
16828262|NCT01480258|37771816|FG000|Interim Period|Lost to Follow-up|0|||
16828263|NCT01480258|37771817|FG001|Interim Period|Lost to Follow-up|2|||
16828264|NCT01480258|37771816|FG000|Interim Period|Physician Decision|1|||
16828265|NCT01480258|37771817|FG001|Interim Period|Physician Decision|0|||
16828266|NCT01480258|37771816|FG000|Interim Period|Protocol Violation|0|||
16828267|NCT01480258|37771817|FG001|Interim Period|Protocol Violation|1|||
16828268|NCT01480258|37771816|FG000|Interim Period|Withdrawal by Subject|9|||
16828269|NCT01480258|37771817|FG001|Interim Period|Withdrawal by Subject|6|||
16828270|NCT01479868|37771823|FG000|Overall Study|Adverse Event|1|||
16828271|NCT01479868|37771823|FG000|Overall Study|Lost to Follow-up|4|||
16828272|NCT01479868|37771823|FG000|Overall Study|Protocol Violation|1|||
16828273|NCT01479868|37771823|FG000|Overall Study|Withdrawal by Subject|1|||
16828274|NCT01479868|37771823|FG000|Overall Study|Sponsor's Decision|1|||
16828275|NCT01479868|37771823|FG000|Overall Study|Initiation of new HCV Therapy|1|||
16828276|NCT01478620|37771827|FG000|Overall Study|Lost to Follow-up|6|||
16828277|NCT01455220|37771831|FG000|Overall Study|screen fail|30|||
16828278|NCT01454830|37771840|FG000|Overall Study|Withdrawal by Subject|4|||
16828279|NCT01454830|37771841|FG001|Overall Study|Withdrawal by Subject|4|||
16828280|NCT01454830|37771840|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
16828281|NCT01454830|37771841|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
16828282|NCT01454830|37771840|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
16828283|NCT01454830|37771841|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
16828284|NCT01454830|37771840|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
16828285|NCT01454830|37771841|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
16828286|NCT01454830|37771840|FG000|Overall Study|Withdrawal - no polysomnography|3|||
16828287|NCT01454830|37771841|FG001|Overall Study|Withdrawal - no polysomnography|2|||
16828288|NCT01454596|37771859|FG000|Overall Study|Death|0|||
16828289|NCT01454596|37771860|FG001|Overall Study|Death|0|||
16828290|NCT01454596|37771861|FG002|Overall Study|Death|0|||
16828291|NCT01454596|37771862|FG003|Overall Study|Death|0|||
16828292|NCT01454596|37771863|FG004|Overall Study|Death|0|||
16828293|NCT01454596|37771864|FG005|Overall Study|Death|0|||
16912166|NCT01505634|38021307|FG002|Overall Study|Insufficient supply of drug at site|0|||
16912167|NCT01505634|38021305|FG000|Overall Study|Protocol Violation|2|||
16912168|NCT01505634|38021306|FG001|Overall Study|Protocol Violation|0|||
16912169|NCT01505634|38021307|FG002|Overall Study|Protocol Violation|0|||
16912170|NCT01505634|38021305|FG000|Overall Study|Lost to Follow-up|1|||
16912171|NCT01505634|38021306|FG001|Overall Study|Lost to Follow-up|4|||
16912172|NCT01505634|38021307|FG002|Overall Study|Lost to Follow-up|4|||
16912173|NCT01505634|38021305|FG000|Overall Study|Death|1|||
16912174|NCT01505634|38021306|FG001|Overall Study|Death|0|||
16912175|NCT01505634|38021307|FG002|Overall Study|Death|0|||
16912176|NCT01505634|38021305|FG000|Overall Study|In a conflict zone|0|||
16912177|NCT01505634|38021306|FG001|Overall Study|In a conflict zone|0|||
16912178|NCT01505634|38021307|FG002|Overall Study|In a conflict zone|1|||
16828294|NCT01454596|37771865|FG006|Overall Study|Death|0|||
16828295|NCT01454596|37771866|FG007|Overall Study|Death|0|||
16828296|NCT01454596|37771867|FG008|Overall Study|Death|0|||
16828297|NCT01454596|37771868|FG009|Overall Study|Death|1|||
16828298|NCT01454596|37771869|FG010|Overall Study|Death|1|||
16912179|NCT01460628|38021315|FG000|Overall Study|Adverse Event|3|||
17016736|NCT00854360|38161307|FG001|Overall Study|Other|0|||
16828299|NCT01454596|37771870|FG011|Overall Study|Death|0|||
16828300|NCT02247479|37771899|FG000|Overall Study|Adverse Event|8|||
16828301|NCT02247479|37771900|FG001|Overall Study|Adverse Event|9|||
16912180|NCT01460628|38021315|FG000|Overall Study|Withdrawal by Subject|2|||
16912181|NCT01480596|38021321|FG000|Overall Study|Adverse Event|3|||
16912182|NCT01480596|38021322|FG001|Overall Study|Adverse Event|0|||
16828302|NCT02247479|37771901|FG002|Overall Study|Adverse Event|8|||
16828303|NCT02247479|37771899|FG000|Overall Study|Death|5|||
16828304|NCT02247479|37771900|FG001|Overall Study|Death|4|||
16828305|NCT02247479|37771901|FG002|Overall Study|Death|6|||
16828306|NCT02247479|37771899|FG000|Overall Study|Lost to Follow-up|3|||
16828307|NCT02247479|37771900|FG001|Overall Study|Lost to Follow-up|3|||
16828308|NCT02247479|37771901|FG002|Overall Study|Lost to Follow-up|1|||
16828309|NCT02247479|37771899|FG000|Overall Study|Non-compliance|0|||
16828310|NCT02247479|37771900|FG001|Overall Study|Non-compliance|0|||
16828311|NCT02247479|37771901|FG002|Overall Study|Non-compliance|1|||
16828312|NCT02247479|37771899|FG000|Overall Study|Withdrawal by Subject|25|||
16828313|NCT02247479|37771900|FG001|Overall Study|Withdrawal by Subject|29|||
16828314|NCT02247479|37771901|FG002|Overall Study|Withdrawal by Subject|24|||
16828315|NCT02247479|37771899|FG000|Overall Study|Study Terminated by Sponsor|98|||
16828316|NCT02247479|37771900|FG001|Overall Study|Study Terminated by Sponsor|88|||
16828317|NCT02247479|37771901|FG002|Overall Study|Study Terminated by Sponsor|94|||
16828318|NCT02247479|37771899|FG000|Overall Study|Physician Decision|1|||
16828319|NCT02247479|37771900|FG001|Overall Study|Physician Decision|0|||
16828320|NCT02247479|37771901|FG002|Overall Study|Physician Decision|2|||
16828321|NCT02247479|37771899|FG000|Overall Study|Unspecified Reason|2|||
16828322|NCT02247479|37771900|FG001|Overall Study|Unspecified Reason|5|||
16828323|NCT02247479|37771901|FG002|Overall Study|Unspecified Reason|2|||
16828324|NCT01454284|37771911|FG000|Overall Study|Adverse Event|20|||
16828325|NCT01454284|37771912|FG001|Overall Study|Adverse Event|7|||
16828326|NCT01454284|37771911|FG000|Overall Study|Death|0|||
16828327|NCT01454284|37771912|FG001|Overall Study|Death|3|||
16828328|NCT01454284|37771911|FG000|Overall Study|Lost to Follow-up|13|||
16828329|NCT01454284|37771912|FG001|Overall Study|Lost to Follow-up|8|||
16828330|NCT01454284|37771911|FG000|Overall Study|Protocol Violation|9|||
16828331|NCT01454284|37771912|FG001|Overall Study|Protocol Violation|6|||
16828332|NCT01454284|37771911|FG000|Overall Study|Withdrawal by Subject|58|||
16828333|NCT01454284|37771912|FG001|Overall Study|Withdrawal by Subject|36|||
16828334|NCT01454284|37771911|FG000|Overall Study|Physician Decision|16|||
16828335|NCT01454284|37771912|FG001|Overall Study|Physician Decision|11|||
16828336|NCT01454284|37771911|FG000|Overall Study|Sponsor Decision|0|||
16828337|NCT01454284|37771912|FG001|Overall Study|Sponsor Decision|2|||
16828338|NCT02247401|37771921|FG000|Overall Study|Adverse Event|1|||
16828339|NCT02247401|37771922|FG001|Overall Study|Adverse Event|0|||
16828340|NCT02247401|37771923|FG002|Overall Study|Adverse Event|0|||
16828341|NCT02247401|37771921|FG000|Overall Study|Withdrawal by Subject|4|||
16828342|NCT02247401|37771922|FG001|Overall Study|Withdrawal by Subject|1|||
16828343|NCT02247401|37771923|FG002|Overall Study|Withdrawal by Subject|1|||
16828344|NCT02247401|37771921|FG000|Overall Study|Lost to Follow-up|1|||
16828345|NCT02247401|37771922|FG001|Overall Study|Lost to Follow-up|1|||
16828346|NCT02247401|37771923|FG002|Overall Study|Lost to Follow-up|1|||
16828347|NCT02247011|37771934|FG000|Overall Study|Poor quality of radiological results|125|||
16828348|NCT02246777|37771941|FG000|Overall Study|Adverse Event|2|||
16828349|NCT02246777|37771941|FG000|Overall Study|Change of residence|1|||
16828350|NCT01495702|37771952|FG000|Randomized Phase|Randomized But Not Treated|1|||
16828351|NCT01495702|37771953|FG001|Randomized Phase|Randomized But Not Treated|4|||
16828352|NCT01495702|37771952|FG000|Randomized Phase|Adverse Event|2|||
16828353|NCT01495702|37771953|FG001|Randomized Phase|Adverse Event|2|||
16828354|NCT01495702|37771952|FG000|Randomized Phase|Death|1|||
16828355|NCT01495702|37771953|FG001|Randomized Phase|Death|0|||
16828356|NCT01495702|37771952|FG000|Randomized Phase|Lack of Efficacy|2|||
16828357|NCT01495702|37771953|FG001|Randomized Phase|Lack of Efficacy|0|||
16828358|NCT01495702|37771952|FG000|Randomized Phase|Investigators Discretion|2|||
16828359|NCT01495702|37771953|FG001|Randomized Phase|Investigators Discretion|0|||
16828360|NCT01495702|37771952|FG000|Randomized Phase|Withdrew Consent|10|||
16828361|NCT01495702|37771953|FG001|Randomized Phase|Withdrew Consent|18|||
16828362|NCT01495702|37771952|FG000|Randomized Phase|Lost to Follow-up|4|||
16828363|NCT01495702|37771953|FG001|Randomized Phase|Lost to Follow-up|3|||
16828364|NCT01495702|37771952|FG000|Randomized Phase|Participant Noncompliance|1|||
16828365|NCT01495702|37771953|FG001|Randomized Phase|Participant Noncompliance|0|||
16828366|NCT01495702|37771952|FG000|Randomized Phase|Protocol Violation|3|||
17102404|NCT00384059|38241318|FG001|Toddler Dose|Lost to Follow-up|1|||
16828367|NCT01495702|37771953|FG001|Randomized Phase|Protocol Violation|1|||
16828368|NCT01630889|37771960|FG000|Overall Study|Death|2|||
16828369|NCT01630889|37771960|FG000|Overall Study|Withdrawal by Subject|1|||
16828370|NCT01630889|37771960|FG000|Overall Study|Other than Specified|2|||
16828371|NCT01630889|37771960|FG000|Overall Study|Lost to Follow-up|4|||
16828372|NCT01630889|37771960|FG000|Overall Study|Other|1|||
16828373|NCT01495000|37771966|FG000|Overall Study|Lost to Follow-up|2|||
16828374|NCT01495000|37771967|FG001|Overall Study|Lost to Follow-up|2|||
16828375|NCT01495000|37771966|FG000|Overall Study|Protocol Violation|1|||
16828376|NCT01495000|37771967|FG001|Overall Study|Protocol Violation|0|||
16828377|NCT01495000|37771966|FG000|Overall Study|Withdrawal by Subject|10|||
16828378|NCT01495000|37771967|FG001|Overall Study|Withdrawal by Subject|10|||
16828379|NCT01494922|37771973|FG000|Overall Study|Adverse Event|1|||
16828380|NCT02192099|37771977|FG000|Overall Study|Adverse Event|1|||
16828381|NCT02192099|37771977|FG000|Overall Study|Lost to Follow-up|2|||
16828382|NCT02192099|37771977|FG000|Overall Study|Physician Decision|1|||
16828383|NCT02192099|37771977|FG000|Overall Study|Pregnancy|1|||
16828384|NCT02192099|37771977|FG000|Overall Study|Protocol Violation|8|||
16828385|NCT02192099|37771977|FG000|Overall Study|Study Terminated by Sponsor|32|||
16828386|NCT02192099|37771977|FG000|Overall Study|Withdrawal by Subject|11|||
16828387|NCT02192099|37771977|FG000|Overall Study|Miscellaneous Reasons|5|||
16828388|NCT01494610|37771981|FG000|Period 1|Withdrawal by Subject|1|||
16828389|NCT01494610|37771982|FG001|Period 1|Withdrawal by Subject|1|||
16828390|NCT01494610|37771981|FG000|Period 3|Adverse Event|1|||
16828391|NCT01494610|37771982|FG001|Period 3|Adverse Event|0|||
16828392|NCT01494610|37771981|FG000|Period 3|Withdrawal by Subject|1|||
16828393|NCT01494610|37771982|FG001|Period 3|Withdrawal by Subject|0|||
16828394|NCT01494610|37771981|FG000|Period 4|Protocol Violation|1|||
16828395|NCT01494610|37771982|FG001|Period 4|Protocol Violation|0|||
16828396|NCT02116777|37772001|FG000|Overall Study|Adverse Event|0|||
16828397|NCT02116777|37772002|FG001|Overall Study|Adverse Event|0|||
16828398|NCT02116777|37772003|FG002|Overall Study|Adverse Event|0|||
16828399|NCT02116777|37772004|FG003|Overall Study|Adverse Event|0|||
16828400|NCT02116777|37772005|FG004|Overall Study|Adverse Event|2|||
16828401|NCT02116777|37772006|FG005|Overall Study|Adverse Event|2|||
16828402|NCT02116777|37772007|FG006|Overall Study|Adverse Event|0|||
16828403|NCT02116777|37772001|FG000|Overall Study|Death|0|||
16828404|NCT02116777|37772002|FG001|Overall Study|Death|0|||
16828405|NCT02116777|37772003|FG002|Overall Study|Death|0|||
16828406|NCT02116777|37772004|FG003|Overall Study|Death|1|||
16828407|NCT02116777|37772005|FG004|Overall Study|Death|0|||
16828408|NCT02116777|37772006|FG005|Overall Study|Death|0|||
16828409|NCT02116777|37772007|FG006|Overall Study|Death|0|||
16828410|NCT02116777|37772001|FG000|Overall Study|Lack of Efficacy|3|||
16828411|NCT02116777|37772002|FG001|Overall Study|Lack of Efficacy|3|||
16828412|NCT02116777|37772003|FG002|Overall Study|Lack of Efficacy|3|||
16828413|NCT02116777|37772004|FG003|Overall Study|Lack of Efficacy|8|||
16828414|NCT02116777|37772005|FG004|Overall Study|Lack of Efficacy|4|||
16828415|NCT02116777|37772006|FG005|Overall Study|Lack of Efficacy|1|||
16828416|NCT02116777|37772007|FG006|Overall Study|Lack of Efficacy|9|||
16828417|NCT02116777|37772001|FG000|Overall Study|Physician Decision|0|||
16828418|NCT02116777|37772002|FG001|Overall Study|Physician Decision|0|||
16828419|NCT02116777|37772003|FG002|Overall Study|Physician Decision|0|||
16828420|NCT02116777|37772004|FG003|Overall Study|Physician Decision|2|||
16828421|NCT02116777|37772005|FG004|Overall Study|Physician Decision|0|||
16828422|NCT02116777|37772006|FG005|Overall Study|Physician Decision|0|||
16828423|NCT02116777|37772007|FG006|Overall Study|Physician Decision|0|||
16828424|NCT02116777|37772001|FG000|Overall Study|Protocol Violation|0|||
16828425|NCT02116777|37772002|FG001|Overall Study|Protocol Violation|0|||
16828426|NCT02116777|37772003|FG002|Overall Study|Protocol Violation|0|||
16828427|NCT02116777|37772004|FG003|Overall Study|Protocol Violation|1|||
16828428|NCT02116777|37772005|FG004|Overall Study|Protocol Violation|0|||
16828429|NCT02116777|37772006|FG005|Overall Study|Protocol Violation|0|||
16828430|NCT02116777|37772007|FG006|Overall Study|Protocol Violation|0|||
16828431|NCT02116777|37772001|FG000|Overall Study|Withdrawal by Subject|0|||
16828432|NCT02116777|37772002|FG001|Overall Study|Withdrawal by Subject|0|||
16828433|NCT02116777|37772003|FG002|Overall Study|Withdrawal by Subject|0|||
16828434|NCT02116777|37772004|FG003|Overall Study|Withdrawal by Subject|1|||
16828435|NCT02116777|37772005|FG004|Overall Study|Withdrawal by Subject|0|||
16828436|NCT02116777|37772006|FG005|Overall Study|Withdrawal by Subject|0|||
16828437|NCT02116777|37772007|FG006|Overall Study|Withdrawal by Subject|0|||
16828438|NCT01494532|37772032|FG000|Overall Study|Adverse Event|4|||
16828439|NCT01494532|37772033|FG001|Overall Study|Adverse Event|1|||
16828440|NCT01494532|37772034|FG002|Overall Study|Adverse Event|8|||
16828441|NCT01494532|37772035|FG003|Overall Study|Adverse Event|6|||
16828442|NCT01494532|37772036|FG004|Overall Study|Adverse Event|5|||
16828443|NCT01494532|37772037|FG005|Overall Study|Adverse Event|0|||
16828444|NCT01494532|37772032|FG000|Overall Study|Lack of Efficacy|0|||
16828445|NCT01494532|37772033|FG001|Overall Study|Lack of Efficacy|0|||
16828446|NCT01494532|37772034|FG002|Overall Study|Lack of Efficacy|0|||
16828447|NCT01494532|37772035|FG003|Overall Study|Lack of Efficacy|0|||
16828448|NCT01494532|37772036|FG004|Overall Study|Lack of Efficacy|2|||
16828449|NCT01494532|37772037|FG005|Overall Study|Lack of Efficacy|0|||
16828450|NCT01494532|37772032|FG000|Overall Study|Protocol deviation|2|||
16828451|NCT01494532|37772033|FG001|Overall Study|Protocol deviation|1|||
16828452|NCT01494532|37772034|FG002|Overall Study|Protocol deviation|3|||
16828453|NCT01494532|37772035|FG003|Overall Study|Protocol deviation|2|||
16828454|NCT01494532|37772036|FG004|Overall Study|Protocol deviation|3|||
16828455|NCT01494532|37772037|FG005|Overall Study|Protocol deviation|0|||
16828456|NCT01494532|37772032|FG000|Overall Study|Protocol-defined stopping criteria|0|||
16828457|NCT01494532|37772033|FG001|Overall Study|Protocol-defined stopping criteria|0|||
16828458|NCT01494532|37772034|FG002|Overall Study|Protocol-defined stopping criteria|1|||
16828459|NCT01494532|37772035|FG003|Overall Study|Protocol-defined stopping criteria|0|||
16828460|NCT01494532|37772036|FG004|Overall Study|Protocol-defined stopping criteria|0|||
16828461|NCT01494532|37772037|FG005|Overall Study|Protocol-defined stopping criteria|0|||
16828462|NCT01494532|37772032|FG000|Overall Study|Lost to Follow-up|1|||
16828463|NCT01494532|37772033|FG001|Overall Study|Lost to Follow-up|0|||
16828464|NCT01494532|37772034|FG002|Overall Study|Lost to Follow-up|0|||
16828465|NCT01494532|37772035|FG003|Overall Study|Lost to Follow-up|2|||
16828466|NCT01494532|37772036|FG004|Overall Study|Lost to Follow-up|0|||
16828467|NCT01494532|37772037|FG005|Overall Study|Lost to Follow-up|0|||
16828468|NCT01494532|37772032|FG000|Overall Study|Physician Decision|0|||
16828469|NCT01494532|37772033|FG001|Overall Study|Physician Decision|1|||
16828470|NCT01494532|37772034|FG002|Overall Study|Physician Decision|1|||
16828471|NCT01494532|37772035|FG003|Overall Study|Physician Decision|2|||
16828472|NCT01494532|37772036|FG004|Overall Study|Physician Decision|0|||
16828473|NCT01494532|37772037|FG005|Overall Study|Physician Decision|0|||
16828474|NCT01494532|37772032|FG000|Overall Study|Withdrawal by Subject|3|||
16828475|NCT01494532|37772033|FG001|Overall Study|Withdrawal by Subject|1|||
16828476|NCT01494532|37772034|FG002|Overall Study|Withdrawal by Subject|4|||
16828477|NCT01494532|37772035|FG003|Overall Study|Withdrawal by Subject|3|||
16828478|NCT01494532|37772036|FG004|Overall Study|Withdrawal by Subject|2|||
16828479|NCT01494532|37772037|FG005|Overall Study|Withdrawal by Subject|0|||
16828480|NCT02191397|37772054|FG000|Overall Study|Adverse Event|28|||
16828481|NCT02191397|37772055|FG001|Overall Study|Adverse Event|17|||
16828482|NCT02191397|37772054|FG000|Overall Study|Lack of Efficacy|10|||
16828483|NCT02191397|37772055|FG001|Overall Study|Lack of Efficacy|5|||
16828484|NCT02191397|37772054|FG000|Overall Study|Protocol Violation|0|||
16828485|NCT02191397|37772055|FG001|Overall Study|Protocol Violation|3|||
16828486|NCT02191397|37772054|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
16828487|NCT02191397|37772055|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
16828488|NCT02191397|37772054|FG000|Overall Study|Lost to Follow-up|10|||
16828489|NCT02191397|37772055|FG001|Overall Study|Lost to Follow-up|11|||
16828490|NCT02191397|37772054|FG000|Overall Study|Physician Decision|8|||
16828491|NCT02191397|37772055|FG001|Overall Study|Physician Decision|3|||
16828492|NCT02191397|37772054|FG000|Overall Study|Withdrawal by Subject|22|||
16828493|NCT02191397|37772055|FG001|Overall Study|Withdrawal by Subject|27|||
16828494|NCT01630811|37772061|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
16828495|NCT01630811|37772062|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
16828496|NCT01494298|37772072|FG000|Overall Study|Protocol Violation|2|||
16828497|NCT01494298|37772073|FG001|Overall Study|Protocol Violation|8|||
16828498|NCT02170025|37772083|FG000|Overall Study|Adverse Event|2|||
16828499|NCT02170025|37772084|FG001|Overall Study|Adverse Event|0|||
16828500|NCT01493284|37772090|FG000|Overall Study|Death|29|||
16828501|NCT01493284|37772090|FG000|Overall Study|Withdrawal by Subject|32|||
16828502|NCT02169791|37772094|FG000|Overall Study|Death|6|||
16828503|NCT02169791|37772094|FG000|Overall Study|patient withdrew consent|1|||
16828504|NCT02216591|37772100|FG000|Overall Study|Lost to Follow-up|0|||
16828505|NCT02216591|37772101|FG001|Overall Study|Lost to Follow-up|1|||
16828506|NCT02216357|37772109|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
16828507|NCT02216357|37772110|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
16828508|NCT01492426|37772118|FG000|Treatment|Death|0|||
16828509|NCT01492426|37772119|FG001|Treatment|Death|1|||
16828510|NCT01492426|37772118|FG000|Treatment|Other|1|||
16828511|NCT01492426|37772119|FG001|Treatment|Other|0|||
16828512|NCT01492426|37772118|FG000|Treatment|Adverse Event|25|||
16828513|NCT01492426|37772119|FG001|Treatment|Adverse Event|25|||
16828514|NCT01492426|37772118|FG000|Treatment|Lack of Efficacy|38|||
16828515|NCT01492426|37772119|FG001|Treatment|Lack of Efficacy|5|||
16828516|NCT01492426|37772118|FG000|Treatment|Participant withdrew consent|1|||
16828517|NCT01492426|37772119|FG001|Treatment|Participant withdrew consent|2|||
16828518|NCT01492426|37772118|FG000|Treatment|Poor compliance/noncompliance|1|||
16828519|NCT01492426|37772119|FG001|Treatment|Poor compliance/noncompliance|0|||
16828520|NCT01492426|37772118|FG000|Treatment|Subject requested discontinue study drug|7|||
16828521|NCT01492426|37772119|FG001|Treatment|Subject requested discontinue study drug|3|||
16828522|NCT01492426|37772118|FG000|Treatment|Lost to Follow-up|9|||
16828523|NCT01492426|37772119|FG001|Treatment|Lost to Follow-up|4|||
16828524|NCT01492426|37772118|FG000|Treatment|Participant does not meet study criteria|1|||
16828525|NCT01492426|37772119|FG001|Treatment|Participant does not meet study criteria|0|||
16828526|NCT01492426|37772118|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
16828527|NCT01492426|37772119|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
16828528|NCT01492426|37772118|FG000|Follow-Up|Death|1|||
16828529|NCT01492426|37772119|FG001|Follow-Up|Death|0|||
16828530|NCT01492426|37772118|FG000|Follow-Up|Other|4|||
16828531|NCT01492426|37772119|FG001|Follow-Up|Other|2|||
16828532|NCT01492426|37772118|FG000|Follow-Up|Participant Withdrew Consent|6|||
16828533|NCT01492426|37772119|FG001|Follow-Up|Participant Withdrew Consent|1|||
16828534|NCT01492426|37772118|FG000|Follow-Up|Lost to Follow-up|12|||
16828535|NCT01492426|37772119|FG001|Follow-Up|Lost to Follow-up|6|||
16828536|NCT01453348|37772132|FG000|Overall Study|Death|0|||
16828537|NCT01453348|37772133|FG001|Overall Study|Death|0|||
16828538|NCT01453348|37772134|FG002|Overall Study|Death|1|||
16828539|NCT01453348|37772132|FG000|Overall Study|Withdrawal by Subject|0|||
16828540|NCT01453348|37772133|FG001|Overall Study|Withdrawal by Subject|1|||
16828541|NCT01453348|37772134|FG002|Overall Study|Withdrawal by Subject|0|||
16828542|NCT01453348|37772132|FG000|Overall Study|Protocol Violation|1|||
16828543|NCT01453348|37772133|FG001|Overall Study|Protocol Violation|0|||
16828544|NCT01453348|37772134|FG002|Overall Study|Protocol Violation|0|||
16828545|NCT01453036|37772148|FG000|Overall Study|Lost to Follow-up|26|||
16828546|NCT01453036|37772149|FG001|Overall Study|Lost to Follow-up|115|||
16828547|NCT01453036|37772150|FG002|Overall Study|Lost to Follow-up|31|||
16828548|NCT01475734|37772160|FG000|Overall Study|Withdrawal by Subject|1|||
16828549|NCT01475734|37772161|FG001|Overall Study|Withdrawal by Subject|0|||
16828550|NCT01475734|37772160|FG000|Overall Study|Protocol Violation|1|||
16828551|NCT01475734|37772161|FG001|Overall Study|Protocol Violation|0|||
16828552|NCT01475734|37772160|FG000|Overall Study|Physician Decision|0|||
16828553|NCT01475734|37772161|FG001|Overall Study|Physician Decision|1|||
16828554|NCT01452412|37772169|FG000|Overall Study|Withdrawal by Subject|15|||
16828555|NCT01452412|37772170|FG001|Overall Study|Withdrawal by Subject|11|||
16828556|NCT01452412|37772169|FG000|Overall Study|Adverse Event|4|||
16828557|NCT01452412|37772170|FG001|Overall Study|Adverse Event|3|||
16828558|NCT01452412|37772169|FG000|Overall Study|Lost to Follow-up|5|||
16828559|NCT01452412|37772170|FG001|Overall Study|Lost to Follow-up|3|||
16828560|NCT01452412|37772169|FG000|Overall Study|Death|1|||
16828561|NCT01452412|37772170|FG001|Overall Study|Death|0|||
16828562|NCT01452412|37772169|FG000|Overall Study|Initiated dialysis|1|||
16828563|NCT01452412|37772170|FG001|Overall Study|Initiated dialysis|0|||
16828564|NCT01452412|37772169|FG000|Overall Study|Other|2|||
16828565|NCT01452412|37772170|FG001|Overall Study|Other|0|||
16828566|NCT01474876|37772179|FG000|Overall Study|Adverse Event|11|||
16828567|NCT01474876|37772180|FG001|Overall Study|Adverse Event|5|||
16828568|NCT01474876|37772181|FG002|Overall Study|Adverse Event|0|||
16828569|NCT01474876|37772179|FG000|Overall Study|Serious Adverse Event|2|||
16828570|NCT01474876|37772180|FG001|Overall Study|Serious Adverse Event|3|||
16828571|NCT01474876|37772181|FG002|Overall Study|Serious Adverse Event|0|||
16828572|NCT01474876|37772179|FG000|Overall Study|Lost to Follow-up|5|||
16828573|NCT01474876|37772180|FG001|Overall Study|Lost to Follow-up|4|||
16828574|NCT01474876|37772181|FG002|Overall Study|Lost to Follow-up|0|||
16828575|NCT01474876|37772179|FG000|Overall Study|Investigator's decision|28|||
16828576|NCT01474876|37772180|FG001|Overall Study|Investigator's decision|6|||
16828577|NCT01474876|37772181|FG002|Overall Study|Investigator's decision|0|||
16828578|NCT01474876|37772179|FG000|Overall Study|Patient's request|19|||
16828579|NCT01474876|37772180|FG001|Overall Study|Patient's request|5|||
16828580|NCT01474876|37772181|FG002|Overall Study|Patient's request|0|||
16828581|NCT01474876|37772179|FG000|Overall Study|Investigator's decision and pt request|1|||
16828582|NCT01474876|37772180|FG001|Overall Study|Investigator's decision and pt request|0|||
16828583|NCT01474876|37772181|FG002|Overall Study|Investigator's decision and pt request|0|||
16828584|NCT01491802|37772187|FG000|Overall Study|Adverse Event|1|||
16828585|NCT01491802|37772188|FG001|Overall Study|Adverse Event|1|||
16828586|NCT01491802|37772187|FG000|Overall Study|Withdrawal by Subject|0|||
16828587|NCT01491802|37772188|FG001|Overall Study|Withdrawal by Subject|1|||
16828588|NCT02168777|37772198|FG000|Overall Study|Withdrawal by Subject|1|||
16828589|NCT02168777|37772199|FG001|Overall Study|Withdrawal by Subject|0|||
16828590|NCT02168777|37772200|FG002|Overall Study|Withdrawal by Subject|2|||
16828591|NCT02168777|37772198|FG000|Overall Study|Adverse Event|1|||
16828592|NCT02168777|37772199|FG001|Overall Study|Adverse Event|0|||
16828593|NCT02168777|37772200|FG002|Overall Study|Adverse Event|1|||
16828594|NCT02168777|37772198|FG000|Overall Study|Disease recurrence|0|||
16828595|NCT02168777|37772199|FG001|Overall Study|Disease recurrence|0|||
16828596|NCT02168777|37772200|FG002|Overall Study|Disease recurrence|1|||
16828597|NCT02168777|37772198|FG000|Overall Study|Radiological disease progression|0|||
16828598|NCT02168777|37772199|FG001|Overall Study|Radiological disease progression|5|||
16828599|NCT02168777|37772200|FG002|Overall Study|Radiological disease progression|5|||
16828600|NCT02168777|37772198|FG000|Overall Study|Clinical disease progression|0|||
16828601|NCT02168777|37772199|FG001|Overall Study|Clinical disease progression|1|||
16828602|NCT02168777|37772200|FG002|Overall Study|Clinical disease progression|2|||
16828603|NCT02168777|37772198|FG000|Overall Study|Other reason|0|||
16828604|NCT02168777|37772199|FG001|Overall Study|Other reason|1|||
16828605|NCT02168777|37772200|FG002|Overall Study|Other reason|0|||
16828606|NCT01491178|37772211|FG000|Overall Study|Adverse Event|1016|||
16828607|NCT01491178|37772211|FG000|Overall Study|Improvement of NVAF|210|||
16828608|NCT01491178|37772211|FG000|Overall Study|To conduct invasive treatment|59|||
16828609|NCT01491178|37772211|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
16828610|NCT01491178|37772211|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
16828611|NCT01491178|37772211|FG000|Overall Study|To take a contraindication|20|||
16828612|NCT01491178|37772211|FG000|Overall Study|Other than specified above|657|||
16828613|NCT02189837|37772219|FG000|Overall Study|Withdrawal by Subject|2|||
16828614|NCT02189837|37772220|FG001|Overall Study|Withdrawal by Subject|1|||
16828615|NCT02189837|37772221|FG002|Overall Study|Withdrawal by Subject|3|||
16828616|NCT02189837|37772222|FG003|Overall Study|Withdrawal by Subject|1|||
16828617|NCT02189837|37772219|FG000|Overall Study|Sponsor Decision|0|||
16828618|NCT02189837|37772220|FG001|Overall Study|Sponsor Decision|0|||
16828619|NCT02189837|37772221|FG002|Overall Study|Sponsor Decision|0|||
16828620|NCT02189837|37772222|FG003|Overall Study|Sponsor Decision|1|||
16828621|NCT02216123|37772234|FG000|Overall Study|Lost to Follow-up|4|||
16828622|NCT02216123|37772235|FG001|Overall Study|Lost to Follow-up|2|||
16828623|NCT02216123|37772234|FG000|Overall Study|Withdrawal by Subject|2|||
16828624|NCT02216123|37772235|FG001|Overall Study|Withdrawal by Subject|0|||
16828625|NCT02189759|37772249|FG000|Overall Study|Lost to Follow-up|0|||
16828626|NCT02189759|37772250|FG001|Overall Study|Lost to Follow-up|0|||
16828627|NCT02189759|37772251|FG002|Overall Study|Lost to Follow-up|2|||
16828628|NCT02189759|37772252|FG003|Overall Study|Lost to Follow-up|5|||
16828629|NCT01490866|37772264|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
16828630|NCT01490866|37772264|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
16828631|NCT01490866|37772264|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
16828632|NCT01490866|37772264|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
16828633|NCT01490866|37772264|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
16828634|NCT01490866|37772264|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
16828635|NCT01490866|37772264|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
16828636|NCT01490866|37772264|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
16828637|NCT01490866|37772264|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
16828638|NCT01490866|37772264|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
16828639|NCT01490866|37772264|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
16828640|NCT02215967|37772275|FG000|Overall Study|Patient became ineligible for treatment|0|||
16828641|NCT02215967|37772276|FG001|Overall Study|Patient became ineligible for treatment|0|||
16828642|NCT02215967|37772277|FG002|Overall Study|Patient became ineligible for treatment|0|||
16828643|NCT02215967|37772278|FG003|Overall Study|Patient became ineligible for treatment|3|||
16828644|NCT02215967|37772275|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
16828645|NCT02215967|37772276|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
16828646|NCT02215967|37772277|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
16828647|NCT02215967|37772278|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
16828648|NCT02168387|37772290|FG000|Overall Study|Planned exubation|6|||
16828649|NCT02168387|37772291|FG001|Overall Study|Planned exubation|3|||
16828650|NCT02168387|37772290|FG000|Overall Study|Death|1|||
16828651|NCT02168387|37772291|FG001|Overall Study|Death|0|||
16828652|NCT02188589|37772297|FG000|Overall Study|Withdrawal by Subject|5|||
16828653|NCT02167451|37772302|FG000|Overall Study|Withdrawal by Subject|1|||
16828654|NCT02167139|37772308|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
16828655|NCT02167139|37772309|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
16828656|NCT02167139|37772310|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
16828657|NCT02167139|37772311|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
16828658|NCT02167139|37772308|FG000|Randomised, Double-blind|Adverse Event|2|||
16828659|NCT02167139|37772309|FG001|Randomised, Double-blind|Adverse Event|9|||
16828660|NCT02167139|37772310|FG002|Randomised, Double-blind|Adverse Event|0|||
16828661|NCT02167139|37772311|FG003|Randomised, Double-blind|Adverse Event|0|||
16828662|NCT02167139|37772308|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
16828663|NCT02167139|37772309|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
16828664|NCT02167139|37772310|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
16828665|NCT02167139|37772311|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
16828666|NCT02167139|37772308|FG000|Randomised, Double-blind|Other|3|||
16828667|NCT02167139|37772309|FG001|Randomised, Double-blind|Other|0|||
16828668|NCT02167139|37772310|FG002|Randomised, Double-blind|Other|0|||
16828669|NCT02167139|37772311|FG003|Randomised, Double-blind|Other|0|||
16828670|NCT02167139|37772308|FG000|Transition-extension|Adverse Event|2|||
16828671|NCT02167139|37772309|FG001|Transition-extension|Adverse Event|0|||
16828672|NCT02167139|37772310|FG002|Transition-extension|Adverse Event|2|||
16828673|NCT02167139|37772311|FG003|Transition-extension|Adverse Event|3|||
16828674|NCT02167139|37772308|FG000|Transition-extension|Withdrawal by Subject|2|||
16828675|NCT02167139|37772309|FG001|Transition-extension|Withdrawal by Subject|0|||
16828676|NCT02167139|37772310|FG002|Transition-extension|Withdrawal by Subject|4|||
16828677|NCT02167139|37772311|FG003|Transition-extension|Withdrawal by Subject|1|||
16828678|NCT02167139|37772308|FG000|Transition-extension|Lack of Efficacy|0|||
16828679|NCT02167139|37772309|FG001|Transition-extension|Lack of Efficacy|0|||
16828680|NCT02167139|37772310|FG002|Transition-extension|Lack of Efficacy|1|||
16828681|NCT02167139|37772311|FG003|Transition-extension|Lack of Efficacy|1|||
16828682|NCT02167139|37772308|FG000|Transition-extension|Other|1|||
16828683|NCT02167139|37772309|FG001|Transition-extension|Other|0|||
16828684|NCT02167139|37772310|FG002|Transition-extension|Other|1|||
16828685|NCT02167139|37772311|FG003|Transition-extension|Other|0|||
16828686|NCT02167139|37772308|FG000|Transition-extension|Lost to Follow-up|1|||
16828687|NCT02167139|37772309|FG001|Transition-extension|Lost to Follow-up|0|||
16828688|NCT02167139|37772310|FG002|Transition-extension|Lost to Follow-up|0|||
16828689|NCT02167139|37772311|FG003|Transition-extension|Lost to Follow-up|0|||
16828690|NCT02101021|37772330|FG000|Overall Study|Death|4|||
16828691|NCT02101021|37772331|FG001|Overall Study|Death|3|||
16828692|NCT02101021|37772332|FG002|Overall Study|Death|6|||
16828693|NCT02101021|37772333|FG003|Overall Study|Death|0|||
16828694|NCT02101021|37772334|FG004|Overall Study|Death|3|||
16828695|NCT02101021|37772330|FG000|Overall Study|Withdrew Consent from study|1|||
16828696|NCT02101021|37772331|FG001|Overall Study|Withdrew Consent from study|1|||
16828697|NCT02101021|37772332|FG002|Overall Study|Withdrew Consent from study|0|||
16828698|NCT02101021|37772333|FG003|Overall Study|Withdrew Consent from study|2|||
16828699|NCT02101021|37772334|FG004|Overall Study|Withdrew Consent from study|0|||
16828700|NCT02101021|37772330|FG000|Overall Study|Lost to Follow-up|1|||
16828701|NCT02101021|37772331|FG001|Overall Study|Lost to Follow-up|0|||
16828702|NCT02101021|37772332|FG002|Overall Study|Lost to Follow-up|0|||
16828703|NCT02101021|37772333|FG003|Overall Study|Lost to Follow-up|0|||
16828704|NCT02101021|37772334|FG004|Overall Study|Lost to Follow-up|0|||
16828705|NCT02101021|37772330|FG000|Overall Study|Study Terminated by Sponsor|1|||
16828706|NCT02101021|37772331|FG001|Overall Study|Study Terminated by Sponsor|0|||
16828707|NCT02101021|37772332|FG002|Overall Study|Study Terminated by Sponsor|1|||
16828708|NCT02101021|37772333|FG003|Overall Study|Study Terminated by Sponsor|1|||
16828709|NCT02101021|37772334|FG004|Overall Study|Study Terminated by Sponsor|1|||
16828710|NCT02116621|37772348|FG000|Baseline|Withdrawal by Subject|0|||
16828711|NCT02116621|37772349|FG001|Baseline|Withdrawal by Subject|4|||
16828712|NCT02116621|37772348|FG000|Three Month Follow-up|Death|1|||
16828713|NCT02116621|37772349|FG001|Three Month Follow-up|Death|1|||
16828714|NCT02116621|37772348|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
16828715|NCT02116621|37772349|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
16828716|NCT02116621|37772348|FG000|Three Month Follow-up|Lost to Follow-up|0|||
16828717|NCT02116621|37772349|FG001|Three Month Follow-up|Lost to Follow-up|1|||
16828718|NCT02116621|37772348|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
16828719|NCT02116621|37772349|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
16828720|NCT02116621|37772348|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
16828721|NCT02116621|37772349|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
16828722|NCT02116621|37772348|FG000|Six Month Follow-up|Lost to Follow-up|2|||
16828723|NCT02116621|37772349|FG001|Six Month Follow-up|Lost to Follow-up|1|||
16828724|NCT02116621|37772348|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
16828725|NCT02116621|37772349|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
16828726|NCT02116621|37772348|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
16828727|NCT02116621|37772349|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
16828728|NCT02116621|37772348|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
16828729|NCT02116621|37772349|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
16828730|NCT02116621|37772348|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
16828731|NCT02116621|37772349|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
16828732|NCT02116621|37772348|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
16828733|NCT02116621|37772349|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
16828734|NCT02116309|37772357|FG000|Overall Study|Lost to Follow-up|0|||
16828735|NCT02116309|37772358|FG001|Overall Study|Lost to Follow-up|1|||
16828736|NCT02115607|37772364|FG000|Overall Study|Withdrawal by Subject|1|||
16828737|NCT01490632|37772373|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
16828738|NCT01490632|37772374|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
16828739|NCT01490632|37772375|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
16828740|NCT01490632|37772376|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
16828741|NCT01490632|37772377|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
16828742|NCT01490632|37772378|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
16828743|NCT01490632|37772379|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
16828744|NCT01490632|37772380|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
16828745|NCT01490632|37772381|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
16828746|NCT01490632|37772382|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
16828747|NCT01490632|37772383|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
16828748|NCT01490632|37772384|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
16828749|NCT01490632|37772385|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
16828750|NCT01490632|37772386|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
16828751|NCT01490632|37772387|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
16828752|NCT01490632|37772388|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
16828753|NCT01490632|37772389|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
16828754|NCT01490632|37772390|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
16828755|NCT01490632|37772391|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
16828756|NCT01490632|37772392|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
16828757|NCT01490632|37772373|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
16828758|NCT01490632|37772374|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
16828759|NCT01490632|37772375|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
16828760|NCT01490632|37772376|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
16828761|NCT01490632|37772377|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828762|NCT01490632|37772378|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828763|NCT01490632|37772379|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828764|NCT01490632|37772380|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828765|NCT01490632|37772381|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828766|NCT01490632|37772382|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828767|NCT01490632|37772383|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828768|NCT01490632|37772384|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828769|NCT01490632|37772385|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828770|NCT01490632|37772386|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828771|NCT01490632|37772387|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828772|NCT01490632|37772388|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828773|NCT01490632|37772389|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828774|NCT01490632|37772390|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828775|NCT01490632|37772391|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828776|NCT01490632|37772392|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16828777|NCT01490632|37772373|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828778|NCT01490632|37772374|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828779|NCT01490632|37772375|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
16828780|NCT01490632|37772376|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
16828781|NCT01490632|37772377|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
16828782|NCT01490632|37772378|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828783|NCT01490632|37772379|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828784|NCT01490632|37772380|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828785|NCT01490632|37772381|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828786|NCT01490632|37772382|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828787|NCT01490632|37772383|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828788|NCT01490632|37772384|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828789|NCT01490632|37772385|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828790|NCT01490632|37772386|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828791|NCT01490632|37772387|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828792|NCT01490632|37772388|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828793|NCT01490632|37772389|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828794|NCT01490632|37772390|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828795|NCT01490632|37772391|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828796|NCT01490632|37772392|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16828797|NCT01490632|37772373|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
16828798|NCT01490632|37772374|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
16828799|NCT01490632|37772375|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
16828800|NCT01490632|37772376|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
16828801|NCT01490632|37772377|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
16828802|NCT01490632|37772378|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
16828803|NCT01490632|37772379|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
16828804|NCT01490632|37772380|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
16828805|NCT01490632|37772381|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
16828806|NCT01490632|37772382|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
16828807|NCT01490632|37772383|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
16828808|NCT01490632|37772384|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
16828809|NCT01490632|37772385|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
16828810|NCT01490632|37772386|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
16828811|NCT01490632|37772387|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
16828812|NCT01490632|37772388|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
16828813|NCT01490632|37772389|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
16828814|NCT01490632|37772390|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
16828815|NCT01490632|37772391|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
16828816|NCT01490632|37772392|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
16828817|NCT01490632|37772373|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
16828818|NCT01490632|37772374|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828819|NCT01490632|37772375|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828820|NCT01490632|37772376|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828821|NCT01490632|37772377|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828822|NCT01490632|37772378|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828823|NCT01490632|37772379|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828824|NCT01490632|37772380|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828825|NCT01490632|37772381|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828826|NCT01490632|37772382|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828827|NCT01490632|37772383|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828828|NCT01490632|37772384|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828829|NCT01490632|37772385|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828830|NCT01490632|37772386|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828831|NCT01490632|37772387|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828832|NCT01490632|37772388|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828833|NCT01490632|37772389|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828834|NCT01490632|37772390|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828835|NCT01490632|37772391|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828836|NCT01490632|37772392|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
16828837|NCT01490632|37772373|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
16828838|NCT01490632|37772374|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
16828839|NCT01490632|37772375|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828840|NCT01490632|37772376|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
16828841|NCT01490632|37772377|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
16828842|NCT01490632|37772378|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828843|NCT01490632|37772379|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828844|NCT01490632|37772380|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828845|NCT01490632|37772381|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828846|NCT01490632|37772382|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828847|NCT01490632|37772383|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828848|NCT01490632|37772384|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828849|NCT01490632|37772385|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828850|NCT01490632|37772386|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828851|NCT01490632|37772387|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828852|NCT01490632|37772388|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828853|NCT01490632|37772389|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828854|NCT01490632|37772390|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828855|NCT01490632|37772391|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828856|NCT01490632|37772392|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16828857|NCT01490632|37772373|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828858|NCT01490632|37772374|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828859|NCT01490632|37772375|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828860|NCT01490632|37772376|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828861|NCT01490632|37772377|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
16828862|NCT01490632|37772378|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828863|NCT01490632|37772379|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828864|NCT01490632|37772380|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828865|NCT01490632|37772381|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828866|NCT01490632|37772382|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828867|NCT01490632|37772383|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828868|NCT01490632|37772384|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828869|NCT01490632|37772385|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828870|NCT01490632|37772386|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828871|NCT01490632|37772387|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828872|NCT01490632|37772388|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828873|NCT01490632|37772389|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828874|NCT01490632|37772390|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828875|NCT01490632|37772391|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828876|NCT01490632|37772392|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16828877|NCT01490632|37772373|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828878|NCT01490632|37772374|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828879|NCT01490632|37772375|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828880|NCT01490632|37772376|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828881|NCT01490632|37772377|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828882|NCT01490632|37772378|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
16828883|NCT01490632|37772379|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
16828884|NCT01490632|37772380|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828885|NCT01490632|37772381|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828886|NCT01490632|37772382|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
17016737|NCT00854360|38161308|FG002|Overall Study|Other|0|||
17016738|NCT00854360|38161309|FG003|Overall Study|Other|3|||
16828887|NCT01490632|37772383|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
16828888|NCT01490632|37772384|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
16828889|NCT01490632|37772385|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828890|NCT01490632|37772386|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828891|NCT01490632|37772387|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828892|NCT01490632|37772388|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828893|NCT01490632|37772389|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828894|NCT01490632|37772390|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828895|NCT01490632|37772391|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828896|NCT01490632|37772392|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
16828897|NCT01490632|37772373|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828898|NCT01490632|37772374|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828899|NCT01490632|37772375|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828900|NCT01490632|37772376|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828901|NCT01490632|37772377|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828902|NCT01490632|37772378|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828903|NCT01490632|37772379|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
16828904|NCT01490632|37772380|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828905|NCT01490632|37772381|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
16828906|NCT01490632|37772382|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
16828907|NCT01490632|37772383|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
16828908|NCT01490632|37772384|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828909|NCT01490632|37772385|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828910|NCT01490632|37772386|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828911|NCT01490632|37772387|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828912|NCT01490632|37772388|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828913|NCT01490632|37772389|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828914|NCT01490632|37772390|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828915|NCT01490632|37772391|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828916|NCT01490632|37772392|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16828917|NCT01490632|37772373|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828918|NCT01490632|37772374|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828919|NCT01490632|37772375|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828920|NCT01490632|37772376|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828921|NCT01490632|37772377|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828922|NCT01490632|37772378|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828923|NCT01490632|37772379|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
16828924|NCT01490632|37772380|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828925|NCT01490632|37772381|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828926|NCT01490632|37772382|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
16828927|NCT01490632|37772383|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828928|NCT01490632|37772384|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828929|NCT01490632|37772385|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828930|NCT01490632|37772386|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828931|NCT01490632|37772387|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828932|NCT01490632|37772388|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828933|NCT01490632|37772389|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828934|NCT01490632|37772390|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828935|NCT01490632|37772391|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828936|NCT01490632|37772392|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16828937|NCT01490632|37772373|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828938|NCT01490632|37772374|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828939|NCT01490632|37772375|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828940|NCT01490632|37772376|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828941|NCT01490632|37772377|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828942|NCT01490632|37772378|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828943|NCT01490632|37772379|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
16828944|NCT01490632|37772380|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828945|NCT01490632|37772381|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828946|NCT01490632|37772382|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828947|NCT01490632|37772383|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828948|NCT01490632|37772384|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828949|NCT01490632|37772385|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828950|NCT01490632|37772386|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828951|NCT01490632|37772387|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828952|NCT01490632|37772388|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828953|NCT01490632|37772389|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828954|NCT01490632|37772390|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828955|NCT01490632|37772391|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828956|NCT01490632|37772392|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
16828957|NCT01490632|37772373|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828958|NCT01490632|37772374|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828959|NCT01490632|37772375|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828960|NCT01490632|37772376|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828961|NCT01490632|37772377|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828962|NCT01490632|37772378|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
16828963|NCT01490632|37772379|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828964|NCT01490632|37772380|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828965|NCT01490632|37772381|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828966|NCT01490632|37772382|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828967|NCT01490632|37772383|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828968|NCT01490632|37772384|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828969|NCT01490632|37772385|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828970|NCT01490632|37772386|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828971|NCT01490632|37772387|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828972|NCT01490632|37772388|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828973|NCT01490632|37772389|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828974|NCT01490632|37772390|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828975|NCT01490632|37772391|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828976|NCT01490632|37772392|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16828977|NCT01490632|37772373|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828978|NCT01490632|37772374|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828979|NCT01490632|37772375|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828980|NCT01490632|37772376|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828981|NCT01490632|37772377|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828982|NCT01490632|37772378|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828983|NCT01490632|37772379|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
16828984|NCT01490632|37772380|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828985|NCT01490632|37772381|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
16828986|NCT01490632|37772382|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828987|NCT01490632|37772383|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
16828988|NCT01490632|37772384|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
16828989|NCT01490632|37772385|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828990|NCT01490632|37772386|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828991|NCT01490632|37772387|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828992|NCT01490632|37772388|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828993|NCT01490632|37772389|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828994|NCT01490632|37772390|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828995|NCT01490632|37772391|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828996|NCT01490632|37772392|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16828997|NCT01490632|37772373|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16828998|NCT01490632|37772374|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16828999|NCT01490632|37772375|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829000|NCT01490632|37772376|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829001|NCT01490632|37772377|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829002|NCT01490632|37772378|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
16829003|NCT01490632|37772379|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
16829004|NCT01490632|37772380|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
16829005|NCT01490632|37772381|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
16829006|NCT01490632|37772382|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
16829007|NCT01490632|37772383|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
16829008|NCT01490632|37772384|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
16829009|NCT01490632|37772385|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829010|NCT01490632|37772386|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829011|NCT01490632|37772387|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829012|NCT01490632|37772388|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829013|NCT01490632|37772389|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829014|NCT01490632|37772390|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829015|NCT01490632|37772391|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829016|NCT01490632|37772392|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16829017|NCT01490632|37772373|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829018|NCT01490632|37772374|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829019|NCT01490632|37772375|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829020|NCT01490632|37772376|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829021|NCT01490632|37772377|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829022|NCT01490632|37772378|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829023|NCT01490632|37772379|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829024|NCT01490632|37772380|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829025|NCT01490632|37772381|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829026|NCT01490632|37772382|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829027|NCT01490632|37772383|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829028|NCT01490632|37772384|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829029|NCT01490632|37772385|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829030|NCT01490632|37772386|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829031|NCT01490632|37772387|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
16829032|NCT01490632|37772388|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
16829033|NCT01490632|37772389|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829034|NCT01490632|37772390|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829035|NCT01490632|37772391|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829036|NCT01490632|37772392|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
16829037|NCT01490632|37772373|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829038|NCT01490632|37772374|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829039|NCT01490632|37772375|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829040|NCT01490632|37772376|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829041|NCT01490632|37772377|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829042|NCT01490632|37772378|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829043|NCT01490632|37772379|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829044|NCT01490632|37772380|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829045|NCT01490632|37772381|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829046|NCT01490632|37772382|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829047|NCT01490632|37772383|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829048|NCT01490632|37772384|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829049|NCT01490632|37772385|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829050|NCT01490632|37772386|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
16829051|NCT01490632|37772387|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829052|NCT01490632|37772388|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829053|NCT01490632|37772389|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829054|NCT01490632|37772390|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829055|NCT01490632|37772391|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829056|NCT01490632|37772392|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16829057|NCT01490632|37772373|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829058|NCT01490632|37772374|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829059|NCT01490632|37772375|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829060|NCT01490632|37772376|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829061|NCT01490632|37772377|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829062|NCT01490632|37772378|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829063|NCT01490632|37772379|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829064|NCT01490632|37772380|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829065|NCT01490632|37772381|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829066|NCT01490632|37772382|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829067|NCT01490632|37772383|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829068|NCT01490632|37772384|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829069|NCT01490632|37772385|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829070|NCT01490632|37772386|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829071|NCT01490632|37772387|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
16829072|NCT01490632|37772388|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
16829073|NCT01490632|37772389|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829074|NCT01490632|37772390|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829075|NCT01490632|37772391|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829076|NCT01490632|37772392|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16829077|NCT01490632|37772373|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829078|NCT01490632|37772374|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16912183|NCT01480596|38021321|FG000|Overall Study|MG exacerbation or change in medication|2|||
17016739|NCT00853970|38161321|FG000|Overall Study|Withdrawal by Subject|2|||
16829079|NCT01490632|37772375|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829080|NCT01490632|37772376|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829081|NCT01490632|37772377|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829082|NCT01490632|37772378|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829083|NCT01490632|37772379|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829084|NCT01490632|37772380|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829085|NCT01490632|37772381|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829086|NCT01490632|37772382|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829087|NCT01490632|37772383|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829088|NCT01490632|37772384|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829089|NCT01490632|37772385|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
16829090|NCT01490632|37772386|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
16829091|NCT01490632|37772387|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
16829092|NCT01490632|37772388|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
16829093|NCT01490632|37772389|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829094|NCT01490632|37772390|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829095|NCT01490632|37772391|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829096|NCT01490632|37772392|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16829097|NCT01490632|37772373|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
16829098|NCT01490632|37772374|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
16829099|NCT01490632|37772375|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
16829100|NCT01490632|37772376|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
16829101|NCT01490632|37772377|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
16829102|NCT01490632|37772378|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
16829103|NCT01490632|37772379|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
16829104|NCT01490632|37772380|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
16829105|NCT01490632|37772381|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
16829106|NCT01490632|37772382|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
16829107|NCT01490632|37772383|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
16829108|NCT01490632|37772384|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
16829109|NCT01490632|37772385|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
16829110|NCT01490632|37772386|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
16829111|NCT01490632|37772387|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
16829112|NCT01490632|37772388|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
16829113|NCT01490632|37772389|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
16829114|NCT01490632|37772390|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
16829115|NCT01490632|37772391|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
16829116|NCT01490632|37772392|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
16829117|NCT01490632|37772373|FG000|Part D: Re-Treatment Period|Death|0|||
16829118|NCT01490632|37772374|FG001|Part D: Re-Treatment Period|Death|0|||
16829119|NCT01490632|37772375|FG002|Part D: Re-Treatment Period|Death|0|||
16829120|NCT01490632|37772376|FG003|Part D: Re-Treatment Period|Death|0|||
16829121|NCT01490632|37772377|FG004|Part D: Re-Treatment Period|Death|0|||
16829122|NCT01490632|37772378|FG005|Part D: Re-Treatment Period|Death|0|||
16829123|NCT01490632|37772379|FG006|Part D: Re-Treatment Period|Death|0|||
16829124|NCT01490632|37772380|FG007|Part D: Re-Treatment Period|Death|0|||
16829125|NCT01490632|37772381|FG008|Part D: Re-Treatment Period|Death|0|||
16829126|NCT01490632|37772382|FG009|Part D: Re-Treatment Period|Death|0|||
16829127|NCT01490632|37772383|FG010|Part D: Re-Treatment Period|Death|0|||
16829128|NCT01490632|37772384|FG011|Part D: Re-Treatment Period|Death|0|||
16829129|NCT01490632|37772385|FG012|Part D: Re-Treatment Period|Death|0|||
16829130|NCT01490632|37772386|FG013|Part D: Re-Treatment Period|Death|0|||
16829131|NCT01490632|37772387|FG014|Part D: Re-Treatment Period|Death|0|||
16829132|NCT01490632|37772388|FG015|Part D: Re-Treatment Period|Death|0|||
16829133|NCT01490632|37772389|FG016|Part D: Re-Treatment Period|Death|0|||
16829134|NCT01490632|37772390|FG017|Part D: Re-Treatment Period|Death|0|||
16829135|NCT01490632|37772391|FG018|Part D: Re-Treatment Period|Death|1|||
16829136|NCT01490632|37772392|FG019|Part D: Re-Treatment Period|Death|0|||
16829137|NCT01490632|37772373|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829138|NCT01490632|37772374|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829139|NCT01490632|37772375|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829140|NCT01490632|37772376|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829141|NCT01490632|37772377|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829142|NCT01490632|37772378|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829143|NCT01490632|37772379|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829144|NCT01490632|37772380|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829145|NCT01490632|37772381|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829146|NCT01490632|37772382|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
17016740|NCT00853970|38161322|FG001|Overall Study|Withdrawal by Subject|1|||
16829147|NCT01490632|37772383|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829148|NCT01490632|37772384|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829149|NCT01490632|37772385|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829150|NCT01490632|37772386|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829151|NCT01490632|37772387|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829152|NCT01490632|37772388|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829153|NCT01490632|37772389|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16829154|NCT01490632|37772390|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
16829155|NCT01490632|37772391|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
16829156|NCT01490632|37772392|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
16829157|NCT01490632|37772373|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829158|NCT01490632|37772374|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829159|NCT01490632|37772375|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829160|NCT01490632|37772376|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829161|NCT01490632|37772377|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829162|NCT01490632|37772378|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829163|NCT01490632|37772379|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829164|NCT01490632|37772380|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829165|NCT01490632|37772381|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829166|NCT01490632|37772382|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829167|NCT01490632|37772383|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829168|NCT01490632|37772384|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829169|NCT01490632|37772385|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829170|NCT01490632|37772386|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829171|NCT01490632|37772387|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829172|NCT01490632|37772388|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829173|NCT01490632|37772389|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829174|NCT01490632|37772390|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829175|NCT01490632|37772391|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
16829176|NCT01490632|37772392|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16829177|NCT01490632|37772373|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
16829178|NCT01490632|37772374|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
16829179|NCT01490632|37772375|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
16829180|NCT01490632|37772376|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
16829181|NCT01490632|37772377|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
16829182|NCT01490632|37772378|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
16829183|NCT01490632|37772379|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
16829184|NCT01490632|37772380|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
16829185|NCT01490632|37772381|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
16829186|NCT01490632|37772382|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
16829187|NCT01490632|37772383|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
16829188|NCT01490632|37772384|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
16829189|NCT01490632|37772385|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
16829190|NCT01490632|37772386|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
16829191|NCT01490632|37772387|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
16829192|NCT01490632|37772388|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
16829193|NCT01490632|37772389|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
16829194|NCT01490632|37772390|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
16829195|NCT01490632|37772391|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
16829196|NCT01490632|37772392|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
16829197|NCT01490632|37772373|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
16829198|NCT01490632|37772374|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
16829199|NCT01490632|37772375|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
16829200|NCT01490632|37772376|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
16912184|NCT01480596|38021322|FG001|Overall Study|MG exacerbation or change in medication|2|||
16912185|NCT01480284|38021330|FG000|Overall Study|Withdrawal by Subject|2|||
16912186|NCT01480284|38021331|FG001|Overall Study|Withdrawal by Subject|0|||
17016741|NCT00853970|38161321|FG000|Overall Study|Cancelled surgery|4|||
16829201|NCT01490632|37772377|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
16829202|NCT01490632|37772378|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
16829203|NCT01490632|37772379|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
16829204|NCT01490632|37772380|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
16829205|NCT01490632|37772381|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
16829206|NCT01490632|37772382|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
16829207|NCT01490632|37772383|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
16829208|NCT01490632|37772384|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
16829209|NCT01490632|37772385|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
16829210|NCT01490632|37772386|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
16829211|NCT01490632|37772387|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
16829212|NCT01490632|37772388|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
16829213|NCT01490632|37772389|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
16829214|NCT01490632|37772390|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
16829215|NCT01490632|37772391|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
16829216|NCT01490632|37772392|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
16829217|NCT01490632|37772373|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829218|NCT01490632|37772374|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829219|NCT01490632|37772375|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829220|NCT01490632|37772376|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829221|NCT01490632|37772377|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829222|NCT01490632|37772378|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16912187|NCT01480284|38021330|FG000|Overall Study|Adverse Event|1|||
16912188|NCT01480284|38021331|FG001|Overall Study|Adverse Event|0|||
16912189|NCT01480284|38021330|FG000|Overall Study|Study closed/terminated|3|||
16912190|NCT01480284|38021331|FG001|Overall Study|Study closed/terminated|0|||
16912191|NCT01480284|38021330|FG000|Overall Study|Lost to Follow-up|1|||
16912192|NCT01480284|38021331|FG001|Overall Study|Lost to Follow-up|0|||
16912193|NCT01480284|38021330|FG000|Overall Study|Physician Decision|1|||
16912194|NCT01480284|38021331|FG001|Overall Study|Physician Decision|0|||
16912195|NCT01459614|38021339|FG000|Overall Study|Adverse Event|1|||
16912196|NCT01459614|38021340|FG001|Overall Study|Adverse Event|0|||
16912197|NCT01459068|38021348|FG000|Overall Study|Withdrawal by Subject|8|||
16912198|NCT01459068|38021349|FG001|Overall Study|Withdrawal by Subject|18|||
16912199|NCT01459068|38021348|FG000|Overall Study|Lost to Follow-up|31|||
16912200|NCT01459068|38021349|FG001|Overall Study|Lost to Follow-up|15|||
16912201|NCT01459068|38021348|FG000|Overall Study|Death|0|||
16912202|NCT01459068|38021349|FG001|Overall Study|Death|1|||
16912203|NCT01458522|38021357|FG000|Overall Study|Withdrawal by Subject|2|||
16912204|NCT01458522|38021358|FG001|Overall Study|Withdrawal by Subject|2|||
16912205|NCT01458522|38021357|FG000|Overall Study|Physician Decision|1|||
16912206|NCT01458522|38021358|FG001|Overall Study|Physician Decision|9|||
16912207|NCT01505010|38021372|FG000|Overall Study|Protocol Violation|0|||
16912208|NCT01505010|38021373|FG001|Overall Study|Protocol Violation|1|||
16912209|NCT01505010|38021372|FG000|Overall Study|Lost to Follow-up|0|||
16912210|NCT01505010|38021373|FG001|Overall Study|Lost to Follow-up|1|||
16912211|NCT01458366|38021384|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
16912212|NCT01458366|38021385|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
16912213|NCT01458366|38021386|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
16912214|NCT01458366|38021387|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
16912215|NCT01458366|38021388|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
16912216|NCT01458366|38021384|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
16912217|NCT01458366|38021385|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
16912218|NCT01458366|38021386|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
16912219|NCT01458366|38021387|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
16912220|NCT01458366|38021388|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
16912221|NCT01458210|38021396|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
16912222|NCT01458210|38021396|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
16912223|NCT01458210|38021396|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
16912224|NCT01458210|38021396|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
16912225|NCT01478958|38021406|FG000|Overall Study|Withdrawal by Subject|1|||
16912226|NCT01478958|38021407|FG001|Overall Study|Withdrawal by Subject|1|||
16912227|NCT01478958|38021408|FG002|Overall Study|Withdrawal by Subject|1|||
16912228|NCT01478958|38021406|FG000|Overall Study|Weight loss|1|||
16912229|NCT01478958|38021407|FG001|Overall Study|Weight loss|0|||
16912230|NCT01478958|38021408|FG002|Overall Study|Weight loss|0|||
16912231|NCT01478958|38021406|FG000|Overall Study|Re-located|0|||
16912232|NCT01478958|38021407|FG001|Overall Study|Re-located|1|||
16912233|NCT01478958|38021408|FG002|Overall Study|Re-located|0|||
16912234|NCT01478958|38021406|FG000|Overall Study|Unable to comply|0|||
16912235|NCT01478958|38021407|FG001|Overall Study|Unable to comply|0|||
16912236|NCT01478958|38021408|FG002|Overall Study|Unable to comply|2|||
16912237|NCT01458132|38021418|FG000|Overall Study|Other|15|||
16912238|NCT01458132|38021419|FG001|Overall Study|Other|3|||
16912239|NCT01457352|38021427|FG000|Period 1|Adverse Event|2|||
16912240|NCT01457352|38021428|FG001|Period 1|Adverse Event|0|||
16912241|NCT01457352|38021427|FG000|Period 1|Withdrawal by Subject|2|||
16912242|NCT01457352|38021428|FG001|Period 1|Withdrawal by Subject|0|||
16912243|NCT01457352|38021427|FG000|Period 1|Physician Decision|2|||
16912244|NCT01457352|38021428|FG001|Period 1|Physician Decision|0|||
16912245|NCT01457352|38021427|FG000|Period 1|MS related disease progression|1|||
16912246|NCT01457352|38021428|FG001|Period 1|MS related disease progression|0|||
16912247|NCT01457352|38021427|FG000|Period 1|Withdrawn|1|||
16912248|NCT01457352|38021428|FG001|Period 1|Withdrawn|0|||
16912249|NCT01457352|38021427|FG000|Period 1|withdrew per sponsor|1|||
16912250|NCT01457352|38021428|FG001|Period 1|withdrew per sponsor|0|||
16912251|NCT01457352|38021427|FG000|Period 1|Protocol Violation|4|||
16912252|NCT01457352|38021428|FG001|Period 1|Protocol Violation|0|||
16912253|NCT01457352|38021427|FG000|Period 1|Did not meet eligibility criteria|3|||
16829223|NCT01490632|37772379|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829224|NCT01490632|37772380|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829225|NCT01490632|37772381|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829226|NCT01490632|37772382|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829227|NCT01490632|37772383|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829228|NCT01490632|37772384|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829229|NCT01490632|37772385|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829230|NCT01490632|37772386|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829231|NCT01490632|37772387|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829232|NCT01490632|37772388|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829233|NCT01490632|37772389|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16829234|NCT01490632|37772390|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
16829235|NCT01490632|37772391|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
16829236|NCT01490632|37772392|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
16829237|NCT02073643|37772435|FG000|Overall Study|Lost to Follow-up|24|||
16829238|NCT01451554|37772441|FG000|Overall Study|Withdrawal by Subject|14|||
16829239|NCT01451554|37772442|FG001|Overall Study|Withdrawal by Subject|9|||
16829240|NCT01474486|37772448|FG000|Overall Study|Death|2|||
16829241|NCT01474486|37772448|FG000|Overall Study|Withdrawal by Subject|4|||
16829242|NCT01474486|37772448|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
16829243|NCT01451398|37772458|FG000|Overall Study|Adverse Event|7|||
16829244|NCT01451398|37772459|FG001|Overall Study|Adverse Event|9|||
16829245|NCT01451398|37772458|FG000|Overall Study|Protocol Violation|1|||
16829246|NCT01451398|37772459|FG001|Overall Study|Protocol Violation|2|||
16829247|NCT01451398|37772458|FG000|Overall Study|Physician Decision|1|||
16829248|NCT01451398|37772459|FG001|Overall Study|Physician Decision|1|||
16829249|NCT01451398|37772458|FG000|Overall Study|Withdrawal by Subject|10|||
16829250|NCT01451398|37772459|FG001|Overall Study|Withdrawal by Subject|14|||
16829251|NCT01451398|37772458|FG000|Overall Study|Lost to Follow-up|6|||
16829252|NCT01451398|37772459|FG001|Overall Study|Lost to Follow-up|4|||
16829253|NCT01451398|37772458|FG000|Overall Study|Non-compliance with study drug|1|||
16829254|NCT01451398|37772459|FG001|Overall Study|Non-compliance with study drug|3|||
16829255|NCT01451398|37772458|FG000|Overall Study|Non-compliance with protocol|1|||
16829256|NCT01451398|37772459|FG001|Overall Study|Non-compliance with protocol|1|||
16829257|NCT01451398|37772458|FG000|Overall Study|Moved out of country|0|||
16829258|NCT01451398|37772459|FG001|Overall Study|Moved out of country|1|||
16829259|NCT01451398|37772458|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
16829260|NCT01451398|37772459|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
16829261|NCT01451398|37772458|FG000|Overall Study|Lack of Efficacy|0|||
16829262|NCT01451398|37772459|FG001|Overall Study|Lack of Efficacy|1|||
16829263|NCT02073565|37772467|FG000|Cohort A|Withdrawal by Subject|1|||
16829264|NCT02073565|37772468|FG001|Cohort A|Withdrawal by Subject|0|||
16829265|NCT02073565|37772467|FG000|Cohort B|Withdrawal by Subject|1|||
16829266|NCT02073565|37772468|FG001|Cohort B|Withdrawal by Subject|2|||
16829267|NCT02073565|37772467|FG000|Cohort C|Withdrawal by Subject|0|||
16829268|NCT02073565|37772468|FG001|Cohort C|Withdrawal by Subject|2|||
16829269|NCT02073565|37772467|FG000|Cohort C|Lost to Follow-up|0|||
16829270|NCT02073565|37772468|FG001|Cohort C|Lost to Follow-up|2|||
16829271|NCT02072941|37772476|FG000|Overall Study|Withdrawal by Subject|29|||
16829272|NCT02072941|37772477|FG001|Overall Study|Withdrawal by Subject|21|||
16829273|NCT02072941|37772476|FG000|Overall Study|Lost to Follow-up|4|||
16829274|NCT02072941|37772477|FG001|Overall Study|Lost to Follow-up|4|||
16829275|NCT02072941|37772476|FG000|Overall Study|Death|3|||
16829276|NCT02072941|37772477|FG001|Overall Study|Death|2|||
16829277|NCT02072941|37772476|FG000|Overall Study|Removed by Study Staff|2|||
16829278|NCT02072941|37772477|FG001|Overall Study|Removed by Study Staff|2|||
16829279|NCT02100631|37772486|FG000|Overall Study|Withdrawal by Subject|1|||
16829280|NCT02100631|37772487|FG001|Overall Study|Withdrawal by Subject|0|||
16829281|NCT02100631|37772488|FG002|Overall Study|Withdrawal by Subject|0|||
16829282|NCT02100631|37772486|FG000|Overall Study|Lost to Follow-up|3|||
16829283|NCT02100631|37772487|FG001|Overall Study|Lost to Follow-up|4|||
16829284|NCT02100631|37772488|FG002|Overall Study|Lost to Follow-up|0|||
16829285|NCT02100631|37772486|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
16829286|NCT02100631|37772487|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
16829287|NCT02100631|37772488|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
16829288|NCT01451164|37772500|FG000|Overall Study|Adverse Event|19|||
16829289|NCT01451164|37772501|FG001|Overall Study|Adverse Event|12|||
16829290|NCT01451164|37772502|FG002|Overall Study|Adverse Event|18|||
16829291|NCT01451164|37772503|FG003|Overall Study|Adverse Event|21|||
16829292|NCT01451164|37772500|FG000|Overall Study|Withdrawal Criteria|1|||
16829293|NCT01451164|37772501|FG001|Overall Study|Withdrawal Criteria|1|||
16829294|NCT01451164|37772502|FG002|Overall Study|Withdrawal Criteria|1|||
16829295|NCT01451164|37772503|FG003|Overall Study|Withdrawal Criteria|1|||
17102405|NCT00384059|38241317|FG000|Toddler Dose|Failed to return|0|||
16829296|NCT01451164|37772500|FG000|Overall Study|Physician Decision|2|||
16829297|NCT01451164|37772501|FG001|Overall Study|Physician Decision|0|||
16829298|NCT01451164|37772502|FG002|Overall Study|Physician Decision|1|||
16829299|NCT01451164|37772503|FG003|Overall Study|Physician Decision|0|||
16829300|NCT01451164|37772500|FG000|Overall Study|Withdrawal by Subject|14|||
16829301|NCT01451164|37772501|FG001|Overall Study|Withdrawal by Subject|11|||
16829302|NCT01451164|37772502|FG002|Overall Study|Withdrawal by Subject|16|||
16829303|NCT01451164|37772503|FG003|Overall Study|Withdrawal by Subject|17|||
16829304|NCT01451164|37772500|FG000|Overall Study|Protocol Violation|0|||
16829305|NCT01451164|37772501|FG001|Overall Study|Protocol Violation|1|||
16829306|NCT01451164|37772502|FG002|Overall Study|Protocol Violation|0|||
16829307|NCT01451164|37772503|FG003|Overall Study|Protocol Violation|0|||
16829308|NCT01451164|37772500|FG000|Overall Study|Lack of Efficacy|7|||
16829309|NCT01451164|37772501|FG001|Overall Study|Lack of Efficacy|9|||
16829310|NCT01451164|37772502|FG002|Overall Study|Lack of Efficacy|9|||
16829311|NCT01451164|37772503|FG003|Overall Study|Lack of Efficacy|7|||
16829312|NCT02071849|37772513|FG000|6-month Primary Endpoint|Did not receive device|4|||
16829313|NCT02071849|37772513|FG000|6-month Primary Endpoint|Adverse Event|1|||
16829314|NCT02071849|37772513|FG000|2-year Extended Follow-up|Adverse Event|1|||
16829315|NCT02071771|37772517|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
16829316|NCT02071771|37772518|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
16829317|NCT02071771|37772517|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
16829318|NCT02071771|37772518|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
16829319|NCT02071225|37772524|FG000|Overall Study|Withdrawal of Consent|2|||
16829320|NCT02071225|37772524|FG000|Overall Study|Protocol Deviation|1|||
16829321|NCT02071225|37772524|FG000|Overall Study|Lost to Follow-up|2|||
16829322|NCT02071225|37772524|FG000|Overall Study|Death|25|||
16829323|NCT01450696|37772530|FG000|Overall Study|Never Treated|1|||
16829324|NCT01450696|37772531|FG001|Overall Study|Never Treated|1|||
16829325|NCT01450696|37772530|FG000|Overall Study|Death|77|||
16829326|NCT01450696|37772531|FG001|Overall Study|Death|84|||
16829327|NCT01450696|37772530|FG000|Overall Study|Lost to Follow-up|3|||
16829328|NCT01450696|37772531|FG001|Overall Study|Lost to Follow-up|3|||
16829329|NCT01450696|37772530|FG000|Overall Study|Non-Compliance|1|||
16829330|NCT01450696|37772531|FG001|Overall Study|Non-Compliance|0|||
16829331|NCT01450696|37772530|FG000|Overall Study|Withdrawal by Subject|13|||
16829332|NCT01450696|37772531|FG001|Overall Study|Withdrawal by Subject|2|||
16829333|NCT01450696|37772530|FG000|Overall Study|Study Terminated by Sponsor|53|||
16829334|NCT01450696|37772531|FG001|Overall Study|Study Terminated by Sponsor|58|||
16829335|NCT02070991|37772539|FG000|Overall Study|Death|2|||
16829336|NCT02070991|37772540|FG001|Overall Study|Death|0|||
16829337|NCT02070991|37772539|FG000|Overall Study|Withdrawal by Subject|1|||
16829338|NCT02070991|37772540|FG001|Overall Study|Withdrawal by Subject|0|||
16829339|NCT02114515|37772548|FG000|Overall Study|Lost to Follow-up|52|||
16829340|NCT02114515|37772549|FG001|Overall Study|Lost to Follow-up|55|||
16829341|NCT02114515|37772548|FG000|Overall Study|Death|12|||
16829342|NCT02114515|37772549|FG001|Overall Study|Death|12|||
16829343|NCT02114515|37772548|FG000|Overall Study|Withdrawal by Subject|4|||
16829344|NCT02114515|37772549|FG001|Overall Study|Withdrawal by Subject|22|||
16829345|NCT02114515|37772548|FG000|Overall Study|Other|65|||
16829346|NCT02114515|37772549|FG001|Overall Study|Other|61|||
16829347|NCT01490086|37772560|FG000|Overall Study|Consent withdrawn|4|||
16829348|NCT01490086|37772561|FG001|Overall Study|Consent withdrawn|4|||
16829349|NCT01490086|37772562|FG002|Overall Study|Consent withdrawn|3|||
16829350|NCT01490086|37772563|FG003|Overall Study|Consent withdrawn|0|||
16829351|NCT01490086|37772564|FG004|Overall Study|Consent withdrawn|1|||
16829352|NCT01490086|37772560|FG000|Overall Study|Non-compliance|0|||
16829353|NCT01490086|37772561|FG001|Overall Study|Non-compliance|1|||
16829354|NCT01490086|37772562|FG002|Overall Study|Non-compliance|0|||
16829355|NCT01490086|37772563|FG003|Overall Study|Non-compliance|0|||
16829356|NCT01490086|37772564|FG004|Overall Study|Non-compliance|0|||
16829357|NCT01490086|37772560|FG000|Overall Study|Abnormal laboratory findings|1|||
16829358|NCT01490086|37772561|FG001|Overall Study|Abnormal laboratory findings|0|||
16829359|NCT01490086|37772562|FG002|Overall Study|Abnormal laboratory findings|0|||
16829360|NCT01490086|37772563|FG003|Overall Study|Abnormal laboratory findings|0|||
16829361|NCT01490086|37772564|FG004|Overall Study|Abnormal laboratory findings|0|||
16829362|NCT01490086|37772560|FG000|Overall Study|Lost to Follow-up|0|||
16829363|NCT01490086|37772561|FG001|Overall Study|Lost to Follow-up|0|||
16829364|NCT01490086|37772562|FG002|Overall Study|Lost to Follow-up|0|||
16829365|NCT01490086|37772563|FG003|Overall Study|Lost to Follow-up|0|||
16829366|NCT01490086|37772564|FG004|Overall Study|Lost to Follow-up|1|||
17016742|NCT00853970|38161322|FG001|Overall Study|Cancelled surgery|2|||
16829367|NCT01490086|37772560|FG000|Overall Study|Physician Decision|3|||
16829368|NCT01490086|37772561|FG001|Overall Study|Physician Decision|4|||
16829369|NCT01490086|37772562|FG002|Overall Study|Physician Decision|2|||
16829370|NCT01490086|37772563|FG003|Overall Study|Physician Decision|3|||
16829371|NCT01490086|37772564|FG004|Overall Study|Physician Decision|1|||
16829372|NCT01490086|37772560|FG000|Overall Study|Adverse Event|0|||
16829373|NCT01490086|37772561|FG001|Overall Study|Adverse Event|0|||
16829374|NCT01490086|37772562|FG002|Overall Study|Adverse Event|1|||
16829375|NCT01490086|37772563|FG003|Overall Study|Adverse Event|2|||
16829376|NCT01490086|37772564|FG004|Overall Study|Adverse Event|0|||
16829377|NCT01490086|37772560|FG000|Overall Study|Lack of Efficacy|0|||
16829378|NCT01490086|37772561|FG001|Overall Study|Lack of Efficacy|3|||
16829379|NCT01490086|37772562|FG002|Overall Study|Lack of Efficacy|1|||
16829380|NCT01490086|37772563|FG003|Overall Study|Lack of Efficacy|0|||
16829381|NCT01490086|37772564|FG004|Overall Study|Lack of Efficacy|8|||
16829382|NCT01490086|37772560|FG000|Overall Study|Worsening of symptoms|0|||
16829383|NCT01490086|37772561|FG001|Overall Study|Worsening of symptoms|1|||
16829384|NCT01490086|37772562|FG002|Overall Study|Worsening of symptoms|0|||
16829385|NCT01490086|37772563|FG003|Overall Study|Worsening of symptoms|1|||
16829386|NCT01490086|37772564|FG004|Overall Study|Worsening of symptoms|0|||
16829387|NCT01490086|37772560|FG000|Overall Study|Subject uncontrollable and abusive|0|||
16829388|NCT01490086|37772561|FG001|Overall Study|Subject uncontrollable and abusive|1|||
16829389|NCT01490086|37772562|FG002|Overall Study|Subject uncontrollable and abusive|0|||
16829390|NCT01490086|37772563|FG003|Overall Study|Subject uncontrollable and abusive|0|||
16829391|NCT01490086|37772564|FG004|Overall Study|Subject uncontrollable and abusive|0|||
16829392|NCT01490086|37772560|FG000|Overall Study|Subject left hospital|0|||
16829393|NCT01490086|37772561|FG001|Overall Study|Subject left hospital|1|||
16829394|NCT01490086|37772562|FG002|Overall Study|Subject left hospital|0|||
16829395|NCT01490086|37772563|FG003|Overall Study|Subject left hospital|1|||
16829396|NCT01490086|37772564|FG004|Overall Study|Subject left hospital|0|||
16829397|NCT02114203|37772579|FG000|Overall Study|Adverse Event|0|||
16829398|NCT02114203|37772580|FG001|Overall Study|Adverse Event|1|||
16829399|NCT02114203|37772581|FG002|Overall Study|Adverse Event|0|||
16829400|NCT02114203|37772579|FG000|Overall Study|Withdrawal by Subject|0|||
16829401|NCT02114203|37772580|FG001|Overall Study|Withdrawal by Subject|1|||
16829402|NCT02114203|37772581|FG002|Overall Study|Withdrawal by Subject|0|||
16829403|NCT02113579|37772591|FG000|Overall Study|Adverse Event|1|||
16829404|NCT02113579|37772592|FG001|Overall Study|Adverse Event|0|||
16829405|NCT02113579|37772591|FG000|Overall Study|Withdrawal by Subject|3|||
16829406|NCT02113579|37772592|FG001|Overall Study|Withdrawal by Subject|2|||
16829407|NCT02113579|37772591|FG000|Overall Study|Lost to Follow-up|6|||
16829408|NCT02113579|37772592|FG001|Overall Study|Lost to Follow-up|2|||
16829409|NCT01474018|37772600|FG000|Overall Study|Lost to Follow-up|0|||
16829410|NCT01474018|37772601|FG001|Overall Study|Lost to Follow-up|1|||
16829411|NCT01474018|37772600|FG000|Overall Study|Withdrawal by Subject|0|||
16829412|NCT01474018|37772601|FG001|Overall Study|Withdrawal by Subject|2|||
16829413|NCT02100475|37772609|FG000|Overall Study|Unclassified|1|||
16829414|NCT02100475|37772610|FG001|Overall Study|Unclassified|2|||
16829415|NCT02100475|37772609|FG000|Overall Study|Withdrawal criteria|1|||
16829416|NCT02100475|37772610|FG001|Overall Study|Withdrawal criteria|0|||
16829417|NCT02113189|37772619|FG000|Overall Study|Lost to follow up|2|||
16829418|NCT02113189|37772620|FG001|Overall Study|Lost to follow up|1|||
16829419|NCT02113189|37772621|FG002|Overall Study|Lost to follow up|3|||
16829420|NCT01440946|37772634|FG000|Overall Study|Lost to Follow-up|1|||
16829421|NCT01440946|37772635|FG001|Overall Study|Lost to Follow-up|1|||
16829422|NCT01440946|37772634|FG000|Overall Study|Physician Decision|1|||
16829423|NCT01440946|37772635|FG001|Overall Study|Physician Decision|0|||
16829424|NCT01450540|37772644|FG000|Overall Study|Withdrawal by Subject|19|||
16829425|NCT01450540|37772645|FG001|Overall Study|Withdrawal by Subject|13|||
16829426|NCT01450540|37772644|FG000|Overall Study|protocol deviation|3|||
16829427|NCT01450540|37772645|FG001|Overall Study|protocol deviation|23|||
16829428|NCT02070757|37772655|FG000|Overall Study|Adverse Event|107|||
16829429|NCT02070757|37772656|FG001|Overall Study|Adverse Event|99|||
16829430|NCT02070757|37772655|FG000|Overall Study|Lost to Follow-up|7|||
16829431|NCT02070757|37772656|FG001|Overall Study|Lost to Follow-up|4|||
16829432|NCT02070757|37772655|FG000|Overall Study|Protocol Violation|0|||
16829433|NCT02070757|37772656|FG001|Overall Study|Protocol Violation|4|||
16829434|NCT02070757|37772655|FG000|Overall Study|Withdrawal by Subject|1|||
16829435|NCT02070757|37772656|FG001|Overall Study|Withdrawal by Subject|3|||
16829436|NCT02070757|37772655|FG000|Overall Study|Investigator Decision|0|||
16829437|NCT02070757|37772656|FG001|Overall Study|Investigator Decision|2|||
16829438|NCT02070757|37772655|FG000|Overall Study|Discharged from Study Hospital|2|||
16829439|NCT02070757|37772656|FG001|Overall Study|Discharged from Study Hospital|2|||
16829440|NCT02100319|37772662|FG000|Overall Study|Case Report Forms Uncollected|11|||
16829441|NCT02100319|37772662|FG000|Overall Study|Protocol Deviation|5|||
16829442|NCT01625845|37772668|FG000|Overall Study|Adverse Event|1|||
16829443|NCT01625845|37772669|FG001|Overall Study|Adverse Event|2|||
16829444|NCT01625845|37772668|FG000|Overall Study|Lost to Follow-up|2|||
16829445|NCT01625845|37772669|FG001|Overall Study|Lost to Follow-up|1|||
16829446|NCT01625845|37772668|FG000|Overall Study|Withdrawal by Subject|2|||
16829447|NCT01625845|37772669|FG001|Overall Study|Withdrawal by Subject|0|||
16829448|NCT01473940|37772679|FG000|Induction Therapy|Death|0|||
16829449|NCT01473940|37772680|FG001|Induction Therapy|Death|0|||
16829450|NCT01473940|37772681|FG002|Induction Therapy|Death|1|||
16829451|NCT01473940|37772682|FG003|Induction Therapy|Death|1|||
16829452|NCT01473940|37772679|FG000|Induction Therapy|Progressive Disease|0|||
16829453|NCT01473940|37772680|FG001|Induction Therapy|Progressive Disease|1|||
16829454|NCT01473940|37772681|FG002|Induction Therapy|Progressive Disease|1|||
16829455|NCT01473940|37772682|FG003|Induction Therapy|Progressive Disease|0|||
16829456|NCT01473940|37772679|FG000|Maintenance Therapy|Progressive Disease|1|||
16829457|NCT01473940|37772680|FG001|Maintenance Therapy|Progressive Disease|2|||
16829458|NCT01473940|37772681|FG002|Maintenance Therapy|Progressive Disease|1|||
16829459|NCT01473940|37772682|FG003|Maintenance Therapy|Progressive Disease|4|||
16829460|NCT01832727|37772704|FG000|Overall Study|Adverse Event|4|||
16829461|NCT01832727|37772705|FG001|Overall Study|Adverse Event|6|||
16829462|NCT01832727|37772706|FG002|Overall Study|Adverse Event|1|||
16829463|NCT01832727|37772707|FG003|Overall Study|Adverse Event|0|||
16829464|NCT01832727|37772708|FG004|Overall Study|Adverse Event|1|||
16829465|NCT01832727|37772709|FG005|Overall Study|Adverse Event|1|||
16829466|NCT01832727|37772710|FG006|Overall Study|Adverse Event|2|||
16829467|NCT01832727|37772711|FG007|Overall Study|Adverse Event|1|||
16829468|NCT01832727|37772712|FG008|Overall Study|Adverse Event|9|||
16829469|NCT01832727|37772704|FG000|Overall Study|Disease progression|3|||
16829470|NCT01832727|37772705|FG001|Overall Study|Disease progression|0|||
16829471|NCT01832727|37772706|FG002|Overall Study|Disease progression|2|||
16829472|NCT01832727|37772707|FG003|Overall Study|Disease progression|1|||
16829473|NCT01832727|37772708|FG004|Overall Study|Disease progression|3|||
16829474|NCT01832727|37772709|FG005|Overall Study|Disease progression|3|||
16829475|NCT01832727|37772710|FG006|Overall Study|Disease progression|6|||
16829476|NCT01832727|37772711|FG007|Overall Study|Disease progression|2|||
16829477|NCT01832727|37772712|FG008|Overall Study|Disease progression|7|||
16829478|NCT01832727|37772704|FG000|Overall Study|Lost to Follow-up|0|||
16829479|NCT01832727|37772705|FG001|Overall Study|Lost to Follow-up|0|||
16829480|NCT01832727|37772706|FG002|Overall Study|Lost to Follow-up|0|||
16829481|NCT01832727|37772707|FG003|Overall Study|Lost to Follow-up|1|||
16829482|NCT01832727|37772708|FG004|Overall Study|Lost to Follow-up|0|||
16829483|NCT01832727|37772709|FG005|Overall Study|Lost to Follow-up|0|||
16829484|NCT01832727|37772710|FG006|Overall Study|Lost to Follow-up|0|||
16829485|NCT01832727|37772711|FG007|Overall Study|Lost to Follow-up|0|||
16829486|NCT01832727|37772712|FG008|Overall Study|Lost to Follow-up|0|||
16829487|NCT01832727|37772704|FG000|Overall Study|Physician Decision|1|||
16829488|NCT01832727|37772705|FG001|Overall Study|Physician Decision|0|||
16829489|NCT01832727|37772706|FG002|Overall Study|Physician Decision|0|||
16829490|NCT01832727|37772707|FG003|Overall Study|Physician Decision|1|||
16829491|NCT01832727|37772708|FG004|Overall Study|Physician Decision|0|||
16829492|NCT01832727|37772709|FG005|Overall Study|Physician Decision|1|||
16829493|NCT01832727|37772710|FG006|Overall Study|Physician Decision|0|||
16829494|NCT01832727|37772711|FG007|Overall Study|Physician Decision|0|||
16829495|NCT01832727|37772712|FG008|Overall Study|Physician Decision|0|||
16829496|NCT01832727|37772704|FG000|Overall Study|Withdrawal by Subject|1|||
16829497|NCT01832727|37772705|FG001|Overall Study|Withdrawal by Subject|1|||
16829498|NCT01832727|37772706|FG002|Overall Study|Withdrawal by Subject|0|||
16829499|NCT01832727|37772707|FG003|Overall Study|Withdrawal by Subject|1|||
16829500|NCT01832727|37772708|FG004|Overall Study|Withdrawal by Subject|0|||
16829501|NCT01832727|37772709|FG005|Overall Study|Withdrawal by Subject|1|||
16829502|NCT01832727|37772710|FG006|Overall Study|Withdrawal by Subject|0|||
16829503|NCT01832727|37772711|FG007|Overall Study|Withdrawal by Subject|2|||
16829504|NCT01832727|37772712|FG008|Overall Study|Withdrawal by Subject|1|||
16829505|NCT01832727|37772704|FG000|Overall Study|Study terminated by sponsor|0|||
16829506|NCT01832727|37772705|FG001|Overall Study|Study terminated by sponsor|0|||
16829507|NCT01832727|37772706|FG002|Overall Study|Study terminated by sponsor|0|||
16829508|NCT01832727|37772707|FG003|Overall Study|Study terminated by sponsor|0|||
16829509|NCT01832727|37772708|FG004|Overall Study|Study terminated by sponsor|0|||
16829510|NCT01832727|37772709|FG005|Overall Study|Study terminated by sponsor|0|||
16829511|NCT01832727|37772710|FG006|Overall Study|Study terminated by sponsor|0|||
16829512|NCT01832727|37772711|FG007|Overall Study|Study terminated by sponsor|1|||
16829513|NCT01832727|37772712|FG008|Overall Study|Study terminated by sponsor|1|||
16829514|NCT01473394|37772743|FG000|Overall Study|Adverse Event|13|||
16829515|NCT01473394|37772744|FG001|Overall Study|Adverse Event|16|||
16829516|NCT01473394|37772743|FG000|Overall Study|Insufficient Therapeutic Response|4|||
16829517|NCT01473394|37772744|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16829518|NCT01473394|37772743|FG000|Overall Study|Protocol Violation|7|||
16829519|NCT01473394|37772744|FG001|Overall Study|Protocol Violation|5|||
17016743|NCT00865904|38161350|FG000|Overall Study|Randomized but not Treated|2|||
16829520|NCT01473394|37772743|FG000|Overall Study|Withdrew Consent|12|||
16829521|NCT01473394|37772744|FG001|Overall Study|Withdrew Consent|10|||
16829522|NCT01473394|37772743|FG000|Overall Study|Lost to Follow-up|9|||
16829523|NCT01473394|37772744|FG001|Overall Study|Lost to Follow-up|11|||
16829524|NCT01449682|37772752|FG000|Overall Study|Death|0|||
16829525|NCT01449682|37772753|FG001|Overall Study|Death|1|||
16829526|NCT01449682|37772752|FG000|Overall Study|Adverse Event|1|||
16829527|NCT01449682|37772753|FG001|Overall Study|Adverse Event|0|||
16829528|NCT01449526|37772761|FG000|Overall Study|Lost to Follow-up|1|||
16829529|NCT01449526|37772762|FG001|Overall Study|Lost to Follow-up|2|||
16829530|NCT01449526|37772761|FG000|Overall Study|Withdrawal by Subject|1|||
16829531|NCT01449526|37772762|FG001|Overall Study|Withdrawal by Subject|1|||
16829532|NCT01449526|37772761|FG000|Overall Study|Symptoms/complaints|0|||
16829533|NCT01449526|37772762|FG001|Overall Study|Symptoms/complaints|1|||
16829534|NCT01449526|37772761|FG000|Overall Study|Lack of Motivation|0|||
16829535|NCT01449526|37772762|FG001|Overall Study|Lack of Motivation|1|||
16829536|NCT01449526|37772761|FG000|Overall Study|Cannot maintain visits|0|||
16829537|NCT01449526|37772762|FG001|Overall Study|Cannot maintain visits|1|||
16829538|NCT01440322|37772770|FG000|Overall Study|Discomfort|2|||
16829539|NCT01440322|37772771|FG001|Overall Study|Discomfort|0|||
16829540|NCT01440322|37772770|FG000|Overall Study|Biomicroscopy|1|||
16829541|NCT01440322|37772771|FG001|Overall Study|Biomicroscopy|0|||
16829542|NCT01440322|37772770|FG000|Overall Study|Symptoms and Problems|1|||
16829543|NCT01440322|37772771|FG001|Overall Study|Symptoms and Problems|0|||
16829544|NCT01440322|37772770|FG000|Overall Study|Unacceptable Subjective Vision|1|||
16829545|NCT01440322|37772771|FG001|Overall Study|Unacceptable Subjective Vision|0|||
16829546|NCT01440322|37772770|FG000|Overall Study|Other Product Related|1|||
16829547|NCT01440322|37772771|FG001|Overall Study|Other Product Related|0|||
16829548|NCT01440322|37772770|FG000|Overall Study|Unrelated Medical Problem|0|||
16829549|NCT01440322|37772771|FG001|Overall Study|Unrelated Medical Problem|1|||
16829550|NCT01440322|37772770|FG000|Overall Study|Other Non-Product Related|1|||
16829551|NCT01440322|37772771|FG001|Overall Study|Other Non-Product Related|0|||
16829552|NCT01832493|37772777|FG000|Overall Study|Physician Decision|2|||
16829553|NCT01832493|37772777|FG000|Overall Study|Protocol Violation|4|||
16829554|NCT01832493|37772777|FG000|Overall Study|Unable to place LV lead|2|||
16829555|NCT01831791|37772781|FG000|Overall Study|Withdrawal by Subject|10|||
16829556|NCT01857531|37772785|FG000|Overall Study|Withdrawal by Subject|4|||
16829557|NCT02166047|37772801|FG000|Overall Study|Withdrawal by Participant|0|||
16829558|NCT02166047|37772802|FG001|Overall Study|Withdrawal by Participant|1|||
16829559|NCT02166047|37772803|FG002|Overall Study|Withdrawal by Participant|2|||
16829560|NCT02166047|37772804|FG003|Overall Study|Withdrawal by Participant|0|||
16829561|NCT02166047|37772805|FG004|Overall Study|Withdrawal by Participant|0|||
16829562|NCT02166047|37772806|FG005|Overall Study|Withdrawal by Participant|0|||
16829563|NCT02166047|37772807|FG006|Overall Study|Withdrawal by Participant|1|||
16829564|NCT02166047|37772808|FG007|Overall Study|Withdrawal by Participant|0|||
16829565|NCT02166047|37772809|FG008|Overall Study|Withdrawal by Participant|0|||
16829566|NCT02166047|37772810|FG009|Overall Study|Withdrawal by Participant|0|||
16829567|NCT02166047|37772811|FG010|Overall Study|Withdrawal by Participant|0|||
16829568|NCT02166047|37772812|FG011|Overall Study|Withdrawal by Participant|0|||
16829569|NCT02166047|37772801|FG000|Overall Study|Adverse Event|0|||
16829570|NCT02166047|37772802|FG001|Overall Study|Adverse Event|0|||
16829571|NCT02166047|37772803|FG002|Overall Study|Adverse Event|0|||
16829572|NCT02166047|37772804|FG003|Overall Study|Adverse Event|0|||
16829573|NCT02166047|37772805|FG004|Overall Study|Adverse Event|1|||
16829574|NCT02166047|37772806|FG005|Overall Study|Adverse Event|0|||
16829575|NCT02166047|37772807|FG006|Overall Study|Adverse Event|1|||
16829576|NCT02166047|37772808|FG007|Overall Study|Adverse Event|0|||
16829577|NCT02166047|37772809|FG008|Overall Study|Adverse Event|0|||
16829578|NCT02166047|37772810|FG009|Overall Study|Adverse Event|0|||
16829579|NCT02166047|37772811|FG010|Overall Study|Adverse Event|2|||
16829580|NCT02166047|37772812|FG011|Overall Study|Adverse Event|0|||
16829581|NCT02165735|37772840|FG000|Overall Study|Lost to Follow-up|12|||
16829582|NCT02165735|37772841|FG001|Overall Study|Lost to Follow-up|10|||
16829583|NCT02165735|37772840|FG000|Overall Study|Withdrawal by Subject|3|||
16829584|NCT02165735|37772841|FG001|Overall Study|Withdrawal by Subject|0|||
16829585|NCT02165735|37772840|FG000|Overall Study|Participant indicated lack of time|1|||
16829586|NCT02165735|37772841|FG001|Overall Study|Participant indicated lack of time|3|||
16829587|NCT02165735|37772840|FG000|Overall Study|Protocol Violation|0|||
16829588|NCT02165735|37772841|FG001|Overall Study|Protocol Violation|1|||
16829589|NCT02069899|37772850|FG000|Overall Study|Adverse Event|6|||
16829590|NCT02069899|37772851|FG001|Overall Study|Adverse Event|0|||
16829591|NCT02069899|37772852|FG002|Overall Study|Adverse Event|1|||
16829592|NCT02069899|37772850|FG000|Overall Study|Withdrawal by Participant|2|||
16829593|NCT02069899|37772851|FG001|Overall Study|Withdrawal by Participant|0|||
16829594|NCT02069899|37772852|FG002|Overall Study|Withdrawal by Participant|0|||
16829595|NCT02069899|37772850|FG000|Overall Study|Lost to Follow-up|1|||
16829596|NCT02069899|37772851|FG001|Overall Study|Lost to Follow-up|0|||
16829597|NCT02069899|37772852|FG002|Overall Study|Lost to Follow-up|1|||
16829598|NCT02069899|37772850|FG000|Overall Study|Other|4|||
16829599|NCT02069899|37772851|FG001|Overall Study|Other|0|||
16829600|NCT02069899|37772852|FG002|Overall Study|Other|0|||
16829601|NCT02069899|37772850|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
16829602|NCT02069899|37772851|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
16829603|NCT02069899|37772852|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
16829604|NCT02069899|37772850|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
16912254|NCT01457352|38021428|FG001|Period 1|Did not meet eligibility criteria|0|||
16829605|NCT02069899|37772851|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
16829606|NCT02069899|37772852|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
16829607|NCT01831089|37772867|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
16829608|NCT01831089|37772868|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
16829609|NCT01831089|37772869|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
16829610|NCT01831089|37772870|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
16829611|NCT01831089|37772871|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
16829612|NCT01831089|37772872|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
16829613|NCT01831089|37772867|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
16829614|NCT01831089|37772868|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
16829615|NCT01831089|37772869|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
16829616|NCT01831089|37772870|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
16829617|NCT01831089|37772871|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
16829618|NCT01831089|37772872|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
16829619|NCT01831089|37772867|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16829620|NCT01831089|37772868|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
16829621|NCT01831089|37772869|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16829622|NCT01831089|37772870|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16829623|NCT01831089|37772871|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16829624|NCT01831089|37772872|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16829625|NCT01831089|37772867|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
16829626|NCT01831089|37772868|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
16829627|NCT01831089|37772869|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
16829628|NCT01831089|37772870|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
16829629|NCT01831089|37772871|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
16829630|NCT01831089|37772872|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
16829631|NCT01831089|37772867|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16829632|NCT01831089|37772868|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16829633|NCT01831089|37772869|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
16829634|NCT01831089|37772870|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16829635|NCT01831089|37772871|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16829636|NCT01831089|37772872|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16829637|NCT01831089|37772867|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
16829638|NCT01831089|37772868|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
16829639|NCT01831089|37772869|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
16829640|NCT01831089|37772870|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
16829641|NCT01831089|37772871|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
16829642|NCT01831089|37772872|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
16829643|NCT01831089|37772867|FG000|Cohort III: Dose Level 3|Global end of study|0|||
16829644|NCT01831089|37772868|FG001|Cohort III: Dose Level 3|Global end of study|0|||
16829645|NCT01831089|37772869|FG002|Cohort III: Dose Level 3|Global end of study|1|||
16829646|NCT01831089|37772870|FG003|Cohort III: Dose Level 3|Global end of study|0|||
16829647|NCT01831089|37772871|FG004|Cohort III: Dose Level 3|Global end of study|0|||
16829648|NCT01831089|37772872|FG005|Cohort III: Dose Level 3|Global end of study|0|||
16829649|NCT01831089|37772867|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
16829650|NCT01831089|37772868|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
16829651|NCT01831089|37772869|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
16829652|NCT01831089|37772870|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
16829653|NCT01831089|37772871|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
16829654|NCT01831089|37772872|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
16829655|NCT01831089|37772867|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
16829656|NCT01831089|37772868|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
16829657|NCT01831089|37772869|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
16829658|NCT01831089|37772870|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
16829659|NCT01831089|37772871|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
16829660|NCT01831089|37772872|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
16829661|NCT01831089|37772867|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16829662|NCT01831089|37772868|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16829663|NCT01831089|37772869|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16829664|NCT01831089|37772870|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16829665|NCT01831089|37772871|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
16829666|NCT01831089|37772872|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16829667|NCT01831089|37772867|FG000|Cohort V: Dose Level 5|Death|0|||
16829668|NCT01831089|37772868|FG001|Cohort V: Dose Level 5|Death|0|||
16829669|NCT01831089|37772869|FG002|Cohort V: Dose Level 5|Death|0|||
16829670|NCT01831089|37772870|FG003|Cohort V: Dose Level 5|Death|0|||
16829671|NCT01831089|37772871|FG004|Cohort V: Dose Level 5|Death|1|||
16829672|NCT01831089|37772872|FG005|Cohort V: Dose Level 5|Death|0|||
16829673|NCT01831089|37772867|FG000|Cohort V: Dose Level 5|Global end of study|0|||
16829674|NCT01831089|37772868|FG001|Cohort V: Dose Level 5|Global end of study|0|||
16829675|NCT01831089|37772869|FG002|Cohort V: Dose Level 5|Global end of study|0|||
16829676|NCT01831089|37772870|FG003|Cohort V: Dose Level 5|Global end of study|0|||
16829677|NCT01831089|37772871|FG004|Cohort V: Dose Level 5|Global end of study|2|||
16829678|NCT01831089|37772872|FG005|Cohort V: Dose Level 5|Global end of study|0|||
16829679|NCT01831089|37772867|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16829680|NCT01831089|37772868|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16829681|NCT01831089|37772869|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16829682|NCT01831089|37772870|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16829683|NCT01831089|37772871|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
16829684|NCT01831089|37772872|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16829685|NCT01831089|37772867|FG000|Cohort B: Arm B|Progressive disease|0|||
16829686|NCT01831089|37772868|FG001|Cohort B: Arm B|Progressive disease|0|||
16829687|NCT01831089|37772869|FG002|Cohort B: Arm B|Progressive disease|0|||
16829688|NCT01831089|37772870|FG003|Cohort B: Arm B|Progressive disease|0|||
16829689|NCT01831089|37772871|FG004|Cohort B: Arm B|Progressive disease|0|||
16829690|NCT01831089|37772872|FG005|Cohort B: Arm B|Progressive disease|8|||
16829691|NCT01831089|37772867|FG000|Cohort B: Arm B|Physician Decision|0|||
16829692|NCT01831089|37772868|FG001|Cohort B: Arm B|Physician Decision|0|||
16829693|NCT01831089|37772869|FG002|Cohort B: Arm B|Physician Decision|0|||
16829694|NCT01831089|37772870|FG003|Cohort B: Arm B|Physician Decision|0|||
16829695|NCT01831089|37772871|FG004|Cohort B: Arm B|Physician Decision|0|||
16829696|NCT01831089|37772872|FG005|Cohort B: Arm B|Physician Decision|2|||
16829697|NCT01831089|37772867|FG000|Cohort B: Arm B|Never treated|0|||
16829698|NCT01831089|37772868|FG001|Cohort B: Arm B|Never treated|0|||
16829699|NCT01831089|37772869|FG002|Cohort B: Arm B|Never treated|0|||
16829700|NCT01831089|37772870|FG003|Cohort B: Arm B|Never treated|0|||
16829701|NCT01831089|37772871|FG004|Cohort B: Arm B|Never treated|0|||
16829702|NCT01831089|37772872|FG005|Cohort B: Arm B|Never treated|2|||
16829703|NCT01831089|37772867|FG000|Cohort B: Arm B|Adverse Event|0|||
16829704|NCT01831089|37772868|FG001|Cohort B: Arm B|Adverse Event|0|||
16829705|NCT01831089|37772869|FG002|Cohort B: Arm B|Adverse Event|0|||
16829706|NCT01831089|37772870|FG003|Cohort B: Arm B|Adverse Event|0|||
16829707|NCT01831089|37772871|FG004|Cohort B: Arm B|Adverse Event|0|||
16829708|NCT01831089|37772872|FG005|Cohort B: Arm B|Adverse Event|1|||
16829709|NCT01831089|37772867|FG000|Cohort B: Arm B|Global end of study|0|||
16829710|NCT01831089|37772868|FG001|Cohort B: Arm B|Global end of study|0|||
16829711|NCT01831089|37772869|FG002|Cohort B: Arm B|Global end of study|0|||
16829712|NCT01831089|37772870|FG003|Cohort B: Arm B|Global end of study|0|||
16829713|NCT01831089|37772871|FG004|Cohort B: Arm B|Global end of study|0|||
16829714|NCT01831089|37772872|FG005|Cohort B: Arm B|Global end of study|1|||
16829715|NCT02112877|37772889|FG000|Overall Study|Withdrawal by Subject|1|||
16829716|NCT02112877|37772890|FG001|Overall Study|Withdrawal by Subject|7|||
16829717|NCT02112877|37772889|FG000|Overall Study|Visit Missed|1|||
16829718|NCT02112877|37772890|FG001|Overall Study|Visit Missed|6|||
16829719|NCT02098369|37772901|FG000|Overall Study|Withdrawal by Subject|1|||
16829720|NCT02098369|37772902|FG001|Overall Study|Withdrawal by Subject|5|||
16829721|NCT02098369|37772903|FG002|Overall Study|Withdrawal by Subject|0|||
16829722|NCT02098369|37772901|FG000|Overall Study|Lost to Follow-up|5|||
16829723|NCT02098369|37772902|FG001|Overall Study|Lost to Follow-up|1|||
16829724|NCT02098369|37772903|FG002|Overall Study|Lost to Follow-up|3|||
16829725|NCT02098369|37772901|FG000|Overall Study|Death|1|||
16829726|NCT02098369|37772902|FG001|Overall Study|Death|1|||
16829727|NCT02098369|37772903|FG002|Overall Study|Death|1|||
16829728|NCT02098369|37772901|FG000|Overall Study|Other|0|||
16829729|NCT02098369|37772902|FG001|Overall Study|Other|2|||
16829730|NCT02098369|37772903|FG002|Overall Study|Other|1|||
16829731|NCT02111785|37772915|FG000|Overall Study|Death|0|||
16829732|NCT02111785|37772916|FG001|Overall Study|Death|1|||
16829733|NCT02111785|37772917|FG002|Overall Study|Death|0|||
16829734|NCT02111785|37772918|FG003|Overall Study|Death|0|||
16829735|NCT02068885|37772935|FG000|Overall Study|Withdrew|3|||
16829736|NCT02068885|37772936|FG001|Overall Study|Withdrew|5|||
16829737|NCT02068885|37772937|FG002|Overall Study|Withdrew|8|||
16829738|NCT02068495|37772946|FG000|Overall Study|Case Report Forms Uncollected|60|||
16829739|NCT02068495|37772946|FG000|Overall Study|Protocol Deviation|49|||
16829740|NCT02097823|37772952|FG000|Overall Study|Withdrawal by Subject|1|||
16829741|NCT02097823|37772953|FG001|Overall Study|Withdrawal by Subject|1|||
16829742|NCT01830855|37772964|FG000|Overall Study|Other|7|||
16829743|NCT01830855|37772965|FG001|Overall Study|Other|1|||
16829744|NCT01830855|37772966|FG002|Overall Study|Other|4|||
16829745|NCT01830855|37772967|FG003|Overall Study|Other|4|||
17102406|NCT00384059|38241318|FG001|Toddler Dose|Failed to return|1|||
16829746|NCT01830855|37772964|FG000|Overall Study|Medication error without associated AE|1|||
16829747|NCT01830855|37772965|FG001|Overall Study|Medication error without associated AE|0|||
16829748|NCT01830855|37772966|FG002|Overall Study|Medication error without associated AE|0|||
16829749|NCT01830855|37772967|FG003|Overall Study|Medication error without associated AE|1|||
16829750|NCT01830855|37772964|FG000|Overall Study|Pregnancy|3|||
16829751|NCT01830855|37772965|FG001|Overall Study|Pregnancy|1|||
16829752|NCT01830855|37772966|FG002|Overall Study|Pregnancy|2|||
16829753|NCT01830855|37772967|FG003|Overall Study|Pregnancy|1|||
16829754|NCT01830855|37772964|FG000|Overall Study|No longer meets eligibility criteria|11|||
16829755|NCT01830855|37772965|FG001|Overall Study|No longer meets eligibility criteria|2|||
16829756|NCT01830855|37772966|FG002|Overall Study|No longer meets eligibility criteria|3|||
16829757|NCT01830855|37772967|FG003|Overall Study|No longer meets eligibility criteria|5|||
16829758|NCT01830855|37772964|FG000|Overall Study|Adverse Event|11|||
16829759|NCT01830855|37772965|FG001|Overall Study|Adverse Event|5|||
16829760|NCT01830855|37772966|FG002|Overall Study|Adverse Event|6|||
16829761|NCT01830855|37772967|FG003|Overall Study|Adverse Event|3|||
16829762|NCT01830855|37772964|FG000|Overall Study|Protocol deviation|10|||
16829763|NCT01830855|37772965|FG001|Overall Study|Protocol deviation|5|||
16829764|NCT01830855|37772966|FG002|Overall Study|Protocol deviation|6|||
16829765|NCT01830855|37772967|FG003|Overall Study|Protocol deviation|6|||
16829766|NCT01830855|37772964|FG000|Overall Study|Withdrawal by Subject|33|||
16829767|NCT01830855|37772965|FG001|Overall Study|Withdrawal by Subject|14|||
16829768|NCT01830855|37772966|FG002|Overall Study|Withdrawal by Subject|10|||
16829769|NCT01830855|37772967|FG003|Overall Study|Withdrawal by Subject|12|||
16829770|NCT01830855|37772964|FG000|Overall Study|No longer willing to participate|32|||
16829771|NCT01830855|37772965|FG001|Overall Study|No longer willing to participate|13|||
16829772|NCT01830855|37772966|FG002|Overall Study|No longer willing to participate|12|||
16829773|NCT01830855|37772967|FG003|Overall Study|No longer willing to participate|17|||
16829774|NCT01830855|37772964|FG000|Overall Study|Lost to Follow-up|47|||
16829775|NCT01830855|37772965|FG001|Overall Study|Lost to Follow-up|20|||
16829776|NCT01830855|37772966|FG002|Overall Study|Lost to Follow-up|23|||
16829777|NCT01830855|37772967|FG003|Overall Study|Lost to Follow-up|33|||
16829778|NCT01857063|37772984|FG000|Period 1 (7 Days)|Adverse Event|0|||
16829779|NCT01857063|37772985|FG001|Period 1 (7 Days)|Adverse Event|1|||
16829780|NCT01857063|37772984|FG000|Period 1 (7 Days)|Physician Decision|1|||
16829781|NCT01857063|37772985|FG001|Period 1 (7 Days)|Physician Decision|0|||
16829782|NCT01857063|37772984|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
16829783|NCT01857063|37772985|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
16829784|NCT01857063|37772984|FG000|Period 2 (7 Days)|Adverse Event|2|||
16829785|NCT01857063|37772985|FG001|Period 2 (7 Days)|Adverse Event|1|||
16829786|NCT01857063|37772984|FG000|Period 2 (7 Days)|Physician Decision|1|||
16829787|NCT01857063|37772985|FG001|Period 2 (7 Days)|Physician Decision|1|||
16829788|NCT01857063|37772984|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
16829789|NCT01857063|37772985|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
16829790|NCT01856907|37772994|FG000|Overall Study|Pregnancy|0|||
16829791|NCT01856907|37772995|FG001|Overall Study|Pregnancy|1|||
16829792|NCT01856907|37772996|FG002|Overall Study|Pregnancy|0|||
16829793|NCT01856907|37772994|FG000|Overall Study|Pregnancy|0|||
16829794|NCT01856907|37772995|FG001|Overall Study|Pregnancy|1|||
16829795|NCT01856907|37772996|FG002|Overall Study|Pregnancy|0|||
16829796|NCT01856907|37772994|FG000|Overall Study|Withdrawal by Subject|0|||
16829797|NCT01856907|37772995|FG001|Overall Study|Withdrawal by Subject|1|||
16829798|NCT01856907|37772996|FG002|Overall Study|Withdrawal by Subject|0|||
16829799|NCT02212457|37773013|FG000|Overall Study|Adverse Event|1|||
16829800|NCT02212457|37773014|FG001|Overall Study|Adverse Event|2|||
16829801|NCT02212457|37773015|FG002|Overall Study|Adverse Event|2|||
16829802|NCT02212457|37773016|FG003|Overall Study|Adverse Event|2|||
16829803|NCT02212457|37773017|FG004|Overall Study|Adverse Event|0|||
16829804|NCT02212457|37773018|FG005|Overall Study|Adverse Event|1|||
16829805|NCT02212457|37773013|FG000|Overall Study|Withdrawal by Subject|8|||
16829806|NCT02212457|37773014|FG001|Overall Study|Withdrawal by Subject|10|||
16829807|NCT02212457|37773015|FG002|Overall Study|Withdrawal by Subject|8|||
16829808|NCT02212457|37773016|FG003|Overall Study|Withdrawal by Subject|6|||
16829809|NCT02212457|37773017|FG004|Overall Study|Withdrawal by Subject|5|||
16829810|NCT02212457|37773018|FG005|Overall Study|Withdrawal by Subject|4|||
16829811|NCT02212457|37773013|FG000|Overall Study|Lost to Follow-up|6|||
16829812|NCT02212457|37773014|FG001|Overall Study|Lost to Follow-up|7|||
16829813|NCT02212457|37773015|FG002|Overall Study|Lost to Follow-up|4|||
16829814|NCT02212457|37773016|FG003|Overall Study|Lost to Follow-up|1|||
16829815|NCT02212457|37773017|FG004|Overall Study|Lost to Follow-up|8|||
16829816|NCT02212457|37773018|FG005|Overall Study|Lost to Follow-up|4|||
16829817|NCT02212457|37773013|FG000|Overall Study|Protocol Violation|2|||
16829818|NCT02212457|37773014|FG001|Overall Study|Protocol Violation|1|||
16829819|NCT02212457|37773015|FG002|Overall Study|Protocol Violation|0|||
16829820|NCT02212457|37773016|FG003|Overall Study|Protocol Violation|1|||
16829821|NCT02212457|37773017|FG004|Overall Study|Protocol Violation|2|||
16829822|NCT02212457|37773018|FG005|Overall Study|Protocol Violation|3|||
16829823|NCT02212457|37773013|FG000|Overall Study|Other|2|||
16829824|NCT02212457|37773014|FG001|Overall Study|Other|1|||
16829825|NCT02212457|37773015|FG002|Overall Study|Other|2|||
16829826|NCT02212457|37773016|FG003|Overall Study|Other|1|||
16829827|NCT02212457|37773017|FG004|Overall Study|Other|0|||
16829828|NCT02212457|37773018|FG005|Overall Study|Other|1|||
16829829|NCT02097745|37773039|FG000|Overall Study|Adverse Event|25|||
16829830|NCT02097745|37773039|FG000|Overall Study|Death|16|||
16829831|NCT02097745|37773039|FG000|Overall Study|Failure to Return|14|||
16829832|NCT02097745|37773039|FG000|Overall Study|Administrative/Other|27|||
16829833|NCT02097745|37773039|FG000|Overall Study|Reason Not Specified|96|||
16829834|NCT02111083|37773048|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
16829835|NCT02111083|37773049|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
16829836|NCT01629563|37773057|FG000|Overall Study|Adverse Event|16|||
16829837|NCT01629563|37773058|FG001|Overall Study|Adverse Event|16|||
16829838|NCT01629563|37773057|FG000|Overall Study|Death|2|||
16829839|NCT01629563|37773058|FG001|Overall Study|Death|0|||
16829840|NCT01629563|37773057|FG000|Overall Study|Lack of Efficacy|2|||
16829841|NCT01629563|37773058|FG001|Overall Study|Lack of Efficacy|3|||
16829842|NCT01629563|37773057|FG000|Overall Study|Lost to Follow-up|1|||
16829843|NCT01629563|37773058|FG001|Overall Study|Lost to Follow-up|0|||
16829844|NCT01629563|37773057|FG000|Overall Study|Pregnancy|1|||
16829845|NCT01629563|37773058|FG001|Overall Study|Pregnancy|2|||
16829846|NCT01629563|37773057|FG000|Overall Study|Protocol Violation|0|||
16829847|NCT01629563|37773058|FG001|Overall Study|Protocol Violation|1|||
16829848|NCT01629563|37773057|FG000|Overall Study|Withdrawal by Subject|27|||
16829849|NCT01629563|37773058|FG001|Overall Study|Withdrawal by Subject|20|||
16829850|NCT01629563|37773057|FG000|Overall Study|surgery|0|||
16829851|NCT01629563|37773058|FG001|Overall Study|surgery|3|||
16829852|NCT01629563|37773057|FG000|Overall Study|Lack of return of menses|12|||
16829853|NCT01629563|37773058|FG001|Overall Study|Lack of return of menses|7|||
16829854|NCT01629563|37773057|FG000|Overall Study|Protocol Violation|0|||
16829855|NCT01629563|37773058|FG001|Overall Study|Protocol Violation|1|||
16829856|NCT02097277|37773069|FG000|Overall Study|Subject no longer meets study criteria|0|||
16829857|NCT02097277|37773070|FG001|Overall Study|Subject no longer meets study criteria|1|||
16829858|NCT02097277|37773071|FG002|Overall Study|Subject no longer meets study criteria|0|||
16829859|NCT02097277|37773072|FG003|Overall Study|Subject no longer meets study criteria|1|||
16829860|NCT02097277|37773073|FG004|Overall Study|Subject no longer meets study criteria|0|||
16829861|NCT02097277|37773069|FG000|Overall Study|Subject request to discontinue treatment|0|||
16829862|NCT02097277|37773070|FG001|Overall Study|Subject request to discontinue treatment|0|||
16829863|NCT02097277|37773071|FG002|Overall Study|Subject request to discontinue treatment|0|||
16829864|NCT02097277|37773072|FG003|Overall Study|Subject request to discontinue treatment|0|||
16829865|NCT02097277|37773073|FG004|Overall Study|Subject request to discontinue treatment|1|||
16829866|NCT02097277|37773069|FG000|Overall Study|Lost to Follow-up|0|||
16829867|NCT02097277|37773070|FG001|Overall Study|Lost to Follow-up|1|||
16829868|NCT02097277|37773071|FG002|Overall Study|Lost to Follow-up|1|||
16829869|NCT02097277|37773072|FG003|Overall Study|Lost to Follow-up|0|||
16829870|NCT02097277|37773073|FG004|Overall Study|Lost to Follow-up|0|||
16829871|NCT02097277|37773069|FG000|Overall Study|Withdrawal by Subject|2|||
16829872|NCT02097277|37773070|FG001|Overall Study|Withdrawal by Subject|1|||
16829873|NCT02097277|37773071|FG002|Overall Study|Withdrawal by Subject|0|||
16829874|NCT02097277|37773072|FG003|Overall Study|Withdrawal by Subject|1|||
16829875|NCT02097277|37773073|FG004|Overall Study|Withdrawal by Subject|0|||
16829876|NCT02097277|37773069|FG000|Overall Study|Adverse Event|0|||
16829877|NCT02097277|37773070|FG001|Overall Study|Adverse Event|0|||
16829878|NCT02097277|37773071|FG002|Overall Study|Adverse Event|1|||
16829879|NCT02097277|37773072|FG003|Overall Study|Adverse Event|2|||
16829880|NCT02097277|37773073|FG004|Overall Study|Adverse Event|0|||
16829881|NCT02212379|37773089|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
16829882|NCT02212379|37773089|FG000|From Baseline to Week 48|Adverse Event|7|||
16829883|NCT02212379|37773089|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
16829884|NCT02212379|37773089|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
16829885|NCT02212379|37773089|FG000|From Week 48 to Week 96|Adverse Event|1|||
16829886|NCT02212379|37773089|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
16829887|NCT02110693|37773096|FG000|Overall Study|Withdrawal by Subject|6|||
16829888|NCT02110693|37773097|FG001|Overall Study|Withdrawal by Subject|7|||
16829889|NCT02110693|37773096|FG000|Overall Study|skipped assessment|15|||
16829890|NCT02110693|37773097|FG001|Overall Study|skipped assessment|18|||
16829891|NCT02110693|37773096|FG000|Overall Study|technical difficulties|6|||
16829892|NCT02110693|37773097|FG001|Overall Study|technical difficulties|4|||
16829893|NCT02110693|37773096|FG000|Overall Study|Other|1|||
16829894|NCT02110693|37773097|FG001|Overall Study|Other|0|||
16829895|NCT02212301|37773117|FG000|Period 1|Lost to Follow-up|0|||
16829896|NCT02212301|37773118|FG001|Period 1|Lost to Follow-up|1|||
16829897|NCT02211209|37773127|FG000|Overall Study|Investigator judgment|0|||
16829898|NCT02211209|37773128|FG001|Overall Study|Investigator judgment|1|||
16829899|NCT02211209|37773127|FG000|Overall Study|Voluntary withdrawal|1|||
16829900|NCT02211209|37773128|FG001|Overall Study|Voluntary withdrawal|4|||
16829901|NCT02211209|37773127|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
16829902|NCT02211209|37773128|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
16829903|NCT02211209|37773127|FG000|Overall Study|Reason Not Specified|1|||
16829904|NCT02211209|37773128|FG001|Overall Study|Reason Not Specified|0|||
16829905|NCT02187809|37773134|FG000|Overall Study|The study was terminated|3|||
16829906|NCT02110225|37773141|FG000|Overall Study|Lost to Follow-up|0|||
16829907|NCT02110225|37773142|FG001|Overall Study|Lost to Follow-up|1|||
16829908|NCT02110225|37773143|FG002|Overall Study|Lost to Follow-up|0|||
16829909|NCT02187029|37773156|FG000|Overall Study|Adverse Event|0|||
16829910|NCT02187029|37773157|FG001|Overall Study|Adverse Event|1|||
16829911|NCT02187029|37773158|FG002|Overall Study|Adverse Event|1|||
16829912|NCT02187029|37773159|FG003|Overall Study|Adverse Event|0|||
16829913|NCT02187029|37773156|FG000|Overall Study|Study Terminated by Sponsor|0|||
16829914|NCT02187029|37773157|FG001|Overall Study|Study Terminated by Sponsor|0|||
16829915|NCT02187029|37773158|FG002|Overall Study|Study Terminated by Sponsor|10|||
16829916|NCT02187029|37773159|FG003|Overall Study|Study Terminated by Sponsor|3|||
16829917|NCT02187029|37773156|FG000|Overall Study|Withdrawal by Subject|1|||
16829918|NCT02187029|37773157|FG001|Overall Study|Withdrawal by Subject|0|||
16829919|NCT02187029|37773158|FG002|Overall Study|Withdrawal by Subject|0|||
16829920|NCT02187029|37773159|FG003|Overall Study|Withdrawal by Subject|0|||
16829921|NCT02163395|37773169|FG000|Overall Study|Withdrawal by Subject|1|||
16829922|NCT02163395|37773169|FG000|Overall Study|Lost to Follow-up|3|||
16829923|NCT02163395|37773169|FG000|Overall Study|Adverse Event|1|||
16829924|NCT02162771|37773175|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
16829925|NCT02162771|37773176|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
16829926|NCT02162771|37773175|FG000|Core Study Period (Part 2)|Adverse Event|4|||
16829927|NCT02162771|37773176|FG001|Core Study Period (Part 2)|Adverse Event|1|||
16829928|NCT02162771|37773175|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
16829929|NCT02162771|37773176|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
16829930|NCT02162771|37773175|FG000|Core Study Period (Part 2)|Physician Decision|0|||
16829931|NCT02162771|37773176|FG001|Core Study Period (Part 2)|Physician Decision|2|||
16829932|NCT02162771|37773175|FG000|Core Study Period (Part 2)|Death|1|||
16829933|NCT02162771|37773176|FG001|Core Study Period (Part 2)|Death|0|||
16829934|NCT02162771|37773175|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
16829935|NCT02162771|37773176|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
16829936|NCT02162771|37773175|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
16829937|NCT02162771|37773176|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
16829938|NCT02162771|37773175|FG000|Maintenance Study Period (Part 2)|Death|2|||
16829939|NCT02162771|37773176|FG001|Maintenance Study Period (Part 2)|Death|1|||
16829940|NCT02162771|37773175|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
16829941|NCT02162771|37773176|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
16829942|NCT02162771|37773175|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
16829943|NCT02162771|37773176|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
16829944|NCT02162771|37773175|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
16829945|NCT02162771|37773176|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
16829946|NCT02161757|37773185|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
16829947|NCT02161757|37773186|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
16829948|NCT02161757|37773187|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
16829949|NCT02161757|37773185|FG000|Treatment Through Study Completion|Adverse Event|1|||
16829950|NCT02161757|37773186|FG001|Treatment Through Study Completion|Adverse Event|1|||
16829951|NCT02161757|37773187|FG002|Treatment Through Study Completion|Adverse Event|0|||
16829952|NCT02161757|37773185|FG000|Treatment Through Study Completion|Protocol Violation|0|||
16829953|NCT02161757|37773186|FG001|Treatment Through Study Completion|Protocol Violation|1|||
16829954|NCT02161757|37773187|FG002|Treatment Through Study Completion|Protocol Violation|2|||
16829955|NCT02161757|37773185|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
16829956|NCT02161757|37773186|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
16829957|NCT02161757|37773187|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
16829958|NCT02161757|37773185|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
16829959|NCT02161757|37773186|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
16829960|NCT02161757|37773187|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
16829961|NCT02161757|37773185|FG000|Treatment Through Study Completion|Other|20|||
16829962|NCT02161757|37773186|FG001|Treatment Through Study Completion|Other|19|||
16829963|NCT02161757|37773187|FG002|Treatment Through Study Completion|Other|12|||
16829964|NCT02161757|37773185|FG000|Treatment Through Study Completion|Death|2|||
16829965|NCT02161757|37773186|FG001|Treatment Through Study Completion|Death|1|||
16829966|NCT02161757|37773187|FG002|Treatment Through Study Completion|Death|1|||
16829967|NCT02160977|37773197|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
16829968|NCT02160977|37773198|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
16829969|NCT02160977|37773197|FG000|Three Months After Surgery|Lost to Follow-up|0|||
16829970|NCT02160977|37773198|FG001|Three Months After Surgery|Lost to Follow-up|2|||
16829971|NCT02160977|37773197|FG000|Six Months After Surgery|Lost to Follow-up|2|||
16829972|NCT02160977|37773198|FG001|Six Months After Surgery|Lost to Follow-up|1|||
16829973|NCT02160899|37773210|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
16829974|NCT02160899|37773211|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
16829975|NCT02160899|37773212|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
16829976|NCT02160899|37773213|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
16829977|NCT02160899|37773214|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
16829978|NCT02160899|37773215|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
16829979|NCT02160041|37773229|FG000|Overall Study|Adverse Event|11|||
16829980|NCT02160041|37773229|FG000|Overall Study|Death|2|||
16829981|NCT02160041|37773229|FG000|Overall Study|disease progression|57|||
16829982|NCT02160041|37773229|FG000|Overall Study|Protocol Violation|1|||
16829983|NCT02160041|37773229|FG000|Overall Study|non-compliance with study|1|||
16829984|NCT02160041|37773229|FG000|Overall Study|Physician Decision|3|||
16829985|NCT02160041|37773229|FG000|Overall Study|Withdrawal by Subject|8|||
16829986|NCT02160041|37773229|FG000|Overall Study|study terminated by by sponsor|1|||
16829987|NCT02186873|37773235|FG000|Overall Study|Adverse Event|1|||
16829988|NCT02186873|37773236|FG001|Overall Study|Adverse Event|3|||
16829989|NCT02186873|37773235|FG000|Overall Study|Lack of Efficacy|0|||
16829990|NCT02186873|37773236|FG001|Overall Study|Lack of Efficacy|1|||
16829991|NCT02186873|37773235|FG000|Overall Study|Lost to Follow-up|1|||
16829992|NCT02186873|37773236|FG001|Overall Study|Lost to Follow-up|2|||
16829993|NCT02186873|37773235|FG000|Overall Study|Withdrawal by Subject|7|||
16829994|NCT02186873|37773236|FG001|Overall Study|Withdrawal by Subject|2|||
16829995|NCT02096263|37773246|FG000|Overall Study|Adverse Event|1|||
16829996|NCT02096263|37773247|FG001|Overall Study|Adverse Event|0|||
16829997|NCT02096263|37773248|FG002|Overall Study|Adverse Event|1|||
16829998|NCT02096263|37773246|FG000|Overall Study|Lost to Follow-up|14|||
16829999|NCT02096263|37773247|FG001|Overall Study|Lost to Follow-up|18|||
16830000|NCT02096263|37773248|FG002|Overall Study|Lost to Follow-up|15|||
16830001|NCT02096263|37773246|FG000|Overall Study|Other|7|||
16830002|NCT02096263|37773247|FG001|Overall Study|Other|9|||
16830003|NCT02096263|37773248|FG002|Overall Study|Other|6|||
16830004|NCT02096263|37773246|FG000|Overall Study|Sponsor study termination|0|||
16830005|NCT02096263|37773247|FG001|Overall Study|Sponsor study termination|0|||
16830006|NCT02096263|37773248|FG002|Overall Study|Sponsor study termination|1|||
16830007|NCT02096263|37773246|FG000|Overall Study|Protocol Violation|7|||
16830008|NCT02096263|37773247|FG001|Overall Study|Protocol Violation|2|||
16830009|NCT02096263|37773248|FG002|Overall Study|Protocol Violation|8|||
16830010|NCT02096263|37773246|FG000|Overall Study|Withdrawal by Subject|5|||
16830011|NCT02096263|37773247|FG001|Overall Study|Withdrawal by Subject|7|||
16830012|NCT02096263|37773248|FG002|Overall Study|Withdrawal by Subject|8|||
16830013|NCT01830543|37773259|FG000|Overall Study|Subject Decision|19|||
16830014|NCT01830543|37773260|FG001|Overall Study|Subject Decision|21|||
16830015|NCT01830543|37773261|FG002|Overall Study|Subject Decision|57|||
16830016|NCT01830543|37773259|FG000|Overall Study|Adverse Event|91|||
16830017|NCT01830543|37773260|FG001|Overall Study|Adverse Event|77|||
16830018|NCT01830543|37773261|FG002|Overall Study|Adverse Event|76|||
16830019|NCT01830543|37773259|FG000|Overall Study|Death|20|||
16830020|NCT01830543|37773260|FG001|Overall Study|Death|22|||
16830021|NCT01830543|37773261|FG002|Overall Study|Death|22|||
16830022|NCT01830543|37773259|FG000|Overall Study|Protocol Violation|3|||
16830023|NCT01830543|37773260|FG001|Overall Study|Protocol Violation|7|||
16830024|NCT01830543|37773261|FG002|Overall Study|Protocol Violation|7|||
16830025|NCT01830543|37773259|FG000|Overall Study|Physician Decision|11|||
16830026|NCT01830543|37773260|FG001|Overall Study|Physician Decision|5|||
16830027|NCT01830543|37773261|FG002|Overall Study|Physician Decision|12|||
16830028|NCT01830543|37773259|FG000|Overall Study|Withdrawal by consent|3|||
16830029|NCT01830543|37773260|FG001|Overall Study|Withdrawal by consent|3|||
16830030|NCT01830543|37773261|FG002|Overall Study|Withdrawal by consent|3|||
16830031|NCT01830543|37773259|FG000|Overall Study|Other|12|||
16830032|NCT01830543|37773260|FG001|Overall Study|Other|17|||
16830033|NCT01830543|37773261|FG002|Overall Study|Other|37|||
16830034|NCT02109445|37773269|FG000|Overall Study|Symptomatic deterioration|2|||
16830035|NCT02109445|37773269|FG000|Overall Study|Adverse Event|1|||
16830036|NCT02109133|37773275|FG000|Overall Study|Lost to Follow-up|1|||
16830037|NCT02109133|37773276|FG001|Overall Study|Lost to Follow-up|0|||
16830038|NCT01623271|37773284|FG000|Overall Study|Withdrawal by Subject|2|||
16830039|NCT01856673|37773291|FG000|Overall Study|Withdrawal by Subject|44|||
16830040|NCT01856673|37773292|FG001|Overall Study|Withdrawal by Subject|50|||
16830041|NCT01856673|37773293|FG002|Overall Study|Withdrawal by Subject|33|||
16830042|NCT01856673|37773291|FG000|Overall Study|Lost to Follow-up|31|||
16830043|NCT01856673|37773292|FG001|Overall Study|Lost to Follow-up|34|||
16830044|NCT01856673|37773293|FG002|Overall Study|Lost to Follow-up|0|||
16830045|NCT01856673|37773291|FG000|Overall Study|Unknown reasons|9|||
16830046|NCT01856673|37773292|FG001|Overall Study|Unknown reasons|0|||
16830047|NCT01856673|37773293|FG002|Overall Study|Unknown reasons|0|||
16830048|NCT01856673|37773291|FG000|Overall Study|Psychologist decision|1|||
16830049|NCT01856673|37773292|FG001|Overall Study|Psychologist decision|0|||
16830050|NCT01856673|37773293|FG002|Overall Study|Psychologist decision|0|||
16830051|NCT01856673|37773291|FG000|Overall Study|Paperwork errors|8|||
16830052|NCT01856673|37773292|FG001|Overall Study|Paperwork errors|0|||
16830053|NCT01856673|37773293|FG002|Overall Study|Paperwork errors|0|||
16830054|NCT01856673|37773291|FG000|Overall Study|Death|1|||
16830055|NCT01856673|37773292|FG001|Overall Study|Death|1|||
16830056|NCT01856673|37773293|FG002|Overall Study|Death|0|||
16830057|NCT01856673|37773291|FG000|Overall Study|Protocol Violation|1|||
16830058|NCT01856673|37773292|FG001|Overall Study|Protocol Violation|0|||
16830059|NCT01856673|37773293|FG002|Overall Study|Protocol Violation|1|||
16830060|NCT02095951|37773303|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
16830061|NCT02095951|37773304|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
16830062|NCT02095873|37773316|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
16830063|NCT02095873|37773317|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
16830064|NCT02095873|37773316|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
16830065|NCT02095873|37773317|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
16830066|NCT02095873|37773316|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
16830067|NCT02095873|37773317|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
16830068|NCT02094937|37773325|FG000|8 Weeks in Period 1|Adverse Event|9|||
16830069|NCT02094937|37773326|FG001|8 Weeks in Period 1|Adverse Event|0|||
16830070|NCT02094937|37773327|FG002|8 Weeks in Period 1|Adverse Event|0|||
16830071|NCT02094937|37773328|FG003|8 Weeks in Period 1|Adverse Event|0|||
16830072|NCT02094937|37773325|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
16830073|NCT02094937|37773326|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
16830074|NCT02094937|37773327|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
16830075|NCT02094937|37773328|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
16830076|NCT02094937|37773325|FG000|8 Weeks in Period 1|Protocol Violation|2|||
16830077|NCT02094937|37773326|FG001|8 Weeks in Period 1|Protocol Violation|0|||
16830078|NCT02094937|37773327|FG002|8 Weeks in Period 1|Protocol Violation|0|||
16830079|NCT02094937|37773328|FG003|8 Weeks in Period 1|Protocol Violation|0|||
16830080|NCT02094937|37773325|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
16830081|NCT02094937|37773326|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
16830082|NCT02094937|37773327|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
16830083|NCT02094937|37773328|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
16830084|NCT02094937|37773325|FG000|8 Weeks in Period 1|Physician Decision|1|||
16830085|NCT02094937|37773326|FG001|8 Weeks in Period 1|Physician Decision|0|||
16830086|NCT02094937|37773327|FG002|8 Weeks in Period 1|Physician Decision|0|||
16830087|NCT02094937|37773328|FG003|8 Weeks in Period 1|Physician Decision|0|||
16830088|NCT02094937|37773325|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
16830089|NCT02094937|37773326|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
16830090|NCT02094937|37773327|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
16830091|NCT02094937|37773328|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
16830092|NCT02094937|37773325|FG000|12 Weeks in Period 2|Adverse Event|0|||
16830093|NCT02094937|37773326|FG001|12 Weeks in Period 2|Adverse Event|2|||
16830094|NCT02094937|37773327|FG002|12 Weeks in Period 2|Adverse Event|4|||
16830095|NCT02094937|37773328|FG003|12 Weeks in Period 2|Adverse Event|1|||
16830096|NCT02094937|37773325|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
16830097|NCT02094937|37773326|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
16830098|NCT02094937|37773327|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
16830099|NCT02094937|37773328|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
16830100|NCT02094937|37773325|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
16830101|NCT02094937|37773326|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
16830102|NCT02094937|37773327|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
16830103|NCT02094937|37773328|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
16830104|NCT02094937|37773325|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
16830105|NCT02094937|37773326|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
16830106|NCT02094937|37773327|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
16830107|NCT02094937|37773328|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
16830108|NCT02094937|37773325|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
16830109|NCT02094937|37773326|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
16830110|NCT02094937|37773327|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
16830111|NCT02094937|37773328|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
16830112|NCT02093923|37773342|FG000|Overall Study|Lost to Follow-up|0|||
16830113|NCT02093923|37773343|FG001|Overall Study|Lost to Follow-up|0|||
16830114|NCT02093923|37773344|FG002|Overall Study|Lost to Follow-up|0|||
16830115|NCT02093923|37773345|FG003|Overall Study|Lost to Follow-up|1|||
16830116|NCT02093923|37773346|FG004|Overall Study|Lost to Follow-up|0|||
16830117|NCT02093923|37773342|FG000|Overall Study|Screen failure after randomization|0|||
16830118|NCT02093923|37773343|FG001|Overall Study|Screen failure after randomization|0|||
16830119|NCT02093923|37773344|FG002|Overall Study|Screen failure after randomization|0|||
16830120|NCT02093923|37773345|FG003|Overall Study|Screen failure after randomization|1|||
16830121|NCT02093923|37773346|FG004|Overall Study|Screen failure after randomization|0|||
16830122|NCT02186561|37773362|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
16830123|NCT02186561|37773362|FG000|Enrollment|Enrollment Cap Reached|5|||
16830124|NCT02186561|37773362|FG000|Enrollment|Insurance Denial|2|||
16830125|NCT02186561|37773362|FG000|Enrollment|Withdrawal by Subject|2|||
16830126|NCT02186561|37773362|FG000|Enrollment|Investigator Withdrew Consent|1|||
16830127|NCT02186561|37773362|FG000|30-Day Post Index Procedure Visit|Death|1|||
16830128|NCT02186561|37773362|FG000|1- Year Post Index Procedure Visit|Death|1|||
16830129|NCT02186561|37773362|FG000|1- Year Post Index Procedure Visit|Missed|1|||
16830130|NCT02066467|37773368|FG000|Overall Study|Did not undergo implant procedure|24|||
16830131|NCT02066467|37773368|FG000|Overall Study|Attempted to implant withoput success|43|||
16830132|NCT02066467|37773368|FG000|Overall Study|Consent ineligible|1|||
16830133|NCT02066467|37773368|FG000|Overall Study|Death|54|||
16830134|NCT02066467|37773368|FG000|Overall Study|Lost to Follow-up|51|||
16830135|NCT02066467|37773368|FG000|Overall Study|Adverse Event|20|||
16830136|NCT02066467|37773368|FG000|Overall Study|Withdrawal by Subject|16|||
16830137|NCT02066467|37773368|FG000|Overall Study|Physician Decision|2|||
16830138|NCT02066467|37773368|FG000|Overall Study|Not defined|4|||
16830139|NCT02186171|37773374|FG000|Overall Study|Withdrawal by Subject|1|||
16830140|NCT02186171|37773375|FG001|Overall Study|Withdrawal by Subject|9|||
16830141|NCT02186171|37773374|FG000|Overall Study|Lost to Follow-up|2|||
16830142|NCT02186171|37773375|FG001|Overall Study|Lost to Follow-up|2|||
16830143|NCT02186171|37773374|FG000|Overall Study|Death|1|||
16830144|NCT02186171|37773375|FG001|Overall Study|Death|2|||
16830145|NCT02186171|37773374|FG000|Overall Study|Protocol-specified Criteria|0|||
16830146|NCT02186171|37773375|FG001|Overall Study|Protocol-specified Criteria|2|||
16830147|NCT02186015|37773383|FG000|Overall Study|Physician Decision|1|||
16830148|NCT02186015|37773384|FG001|Overall Study|Physician Decision|0|||
16830149|NCT02066389|37773397|FG000|Overall Study|Adverse Event|1|||
16830150|NCT02066389|37773398|FG001|Overall Study|Adverse Event|1|||
16830151|NCT02066389|37773399|FG002|Overall Study|Adverse Event|1|||
16830152|NCT02066389|37773400|FG003|Overall Study|Adverse Event|1|||
16830153|NCT02066389|37773401|FG004|Overall Study|Adverse Event|5|||
16830154|NCT02066389|37773402|FG005|Overall Study|Adverse Event|1|||
16830155|NCT02066389|37773397|FG000|Overall Study|Withdrawal by Subject|4|||
16830156|NCT02066389|37773398|FG001|Overall Study|Withdrawal by Subject|0|||
16830157|NCT02066389|37773399|FG002|Overall Study|Withdrawal by Subject|5|||
16830158|NCT02066389|37773400|FG003|Overall Study|Withdrawal by Subject|1|||
16830159|NCT02066389|37773401|FG004|Overall Study|Withdrawal by Subject|1|||
16830160|NCT02066389|37773402|FG005|Overall Study|Withdrawal by Subject|2|||
16830161|NCT02066389|37773397|FG000|Overall Study|Lost to Follow-up|0|||
16830162|NCT02066389|37773398|FG001|Overall Study|Lost to Follow-up|0|||
16830163|NCT02066389|37773399|FG002|Overall Study|Lost to Follow-up|0|||
16830164|NCT02066389|37773400|FG003|Overall Study|Lost to Follow-up|1|||
16830165|NCT02066389|37773401|FG004|Overall Study|Lost to Follow-up|1|||
16830166|NCT02066389|37773402|FG005|Overall Study|Lost to Follow-up|1|||
16830167|NCT02066389|37773397|FG000|Overall Study|Randomized in Error|0|||
16830168|NCT02066389|37773398|FG001|Overall Study|Randomized in Error|0|||
16830169|NCT02066389|37773399|FG002|Overall Study|Randomized in Error|0|||
16830170|NCT02066389|37773400|FG003|Overall Study|Randomized in Error|0|||
16830171|NCT02066389|37773401|FG004|Overall Study|Randomized in Error|0|||
16830172|NCT02066389|37773402|FG005|Overall Study|Randomized in Error|1|||
16830173|NCT02106403|37773416|FG000|Follow-Up Visit 3|Other Reason|0|||
16830174|NCT02106403|37773417|FG001|Follow-Up Visit 3|Other Reason|0|||
16830175|NCT02106403|37773418|FG002|Follow-Up Visit 3|Other Reason|0|||
16830176|NCT02106403|37773419|FG003|Follow-Up Visit 3|Other Reason|0|||
16830177|NCT02106403|37773420|FG004|Follow-Up Visit 3|Other Reason|0|||
16830178|NCT02106403|37773421|FG005|Follow-Up Visit 3|Other Reason|1|||
16830179|NCT02133131|37773438|FG000|Overall Study|Adverse Event|0|||
16830180|NCT02133131|37773439|FG001|Overall Study|Adverse Event|0|||
16830181|NCT02133131|37773440|FG002|Overall Study|Adverse Event|0|||
16830182|NCT02133131|37773441|FG003|Overall Study|Adverse Event|1|||
16830183|NCT02133131|37773442|FG004|Overall Study|Adverse Event|0|||
16830184|NCT02133131|37773443|FG005|Overall Study|Adverse Event|0|||
16830185|NCT02133131|37773444|FG006|Overall Study|Adverse Event|0|||
16830186|NCT02133131|37773438|FG000|Overall Study|Lost to Follow-up|1|||
16830187|NCT02133131|37773439|FG001|Overall Study|Lost to Follow-up|0|||
16830188|NCT02133131|37773440|FG002|Overall Study|Lost to Follow-up|0|||
16830189|NCT02133131|37773441|FG003|Overall Study|Lost to Follow-up|1|||
16830190|NCT02133131|37773442|FG004|Overall Study|Lost to Follow-up|0|||
16830191|NCT02133131|37773443|FG005|Overall Study|Lost to Follow-up|0|||
16830192|NCT02133131|37773444|FG006|Overall Study|Lost to Follow-up|0|||
16830193|NCT02133131|37773438|FG000|Overall Study|Status not recorded|4|||
16830194|NCT02133131|37773439|FG001|Overall Study|Status not recorded|5|||
16830195|NCT02133131|37773440|FG002|Overall Study|Status not recorded|1|||
16830196|NCT02133131|37773441|FG003|Overall Study|Status not recorded|4|||
16830197|NCT02133131|37773442|FG004|Overall Study|Status not recorded|0|||
16830198|NCT02133131|37773443|FG005|Overall Study|Status not recorded|0|||
16830199|NCT02133131|37773444|FG006|Overall Study|Status not recorded|0|||
16830200|NCT02133131|37773438|FG000|Overall Study|Ongoing in study|0|||
16830201|NCT02133131|37773439|FG001|Overall Study|Ongoing in study|0|||
16830202|NCT02133131|37773440|FG002|Overall Study|Ongoing in study|0|||
16830203|NCT02133131|37773441|FG003|Overall Study|Ongoing in study|0|||
16830204|NCT02133131|37773442|FG004|Overall Study|Ongoing in study|15|||
16830205|NCT02133131|37773443|FG005|Overall Study|Ongoing in study|14|||
16830206|NCT02133131|37773444|FG006|Overall Study|Ongoing in study|11|||
16830207|NCT02133131|37773438|FG000|Overall Study|Protocol Violation|0|||
16830208|NCT02133131|37773439|FG001|Overall Study|Protocol Violation|0|||
16830209|NCT02133131|37773440|FG002|Overall Study|Protocol Violation|0|||
16830210|NCT02133131|37773441|FG003|Overall Study|Protocol Violation|0|||
16830211|NCT02133131|37773442|FG004|Overall Study|Protocol Violation|0|||
16830212|NCT02133131|37773443|FG005|Overall Study|Protocol Violation|0|||
16830213|NCT02133131|37773444|FG006|Overall Study|Protocol Violation|1|||
16830214|NCT02106325|37773462|FG000|Phase 1|Lost to Follow-up|2|||
16830215|NCT02106325|37773463|FG001|Phase 1|Lost to Follow-up|2|||
16830216|NCT02106325|37773462|FG000|Phase 2|Lost to Follow-up|2|||
16830217|NCT02106325|37773463|FG001|Phase 2|Lost to Follow-up|3|||
16830218|NCT02106325|37773462|FG000|Phase 3|Lost to Follow-up|2|||
16830219|NCT02106325|37773463|FG001|Phase 3|Lost to Follow-up|1|||
16830220|NCT01625689|37773471|FG000|Overall Study|Migration|2|||
16830221|NCT01625689|37773472|FG001|Overall Study|Migration|1|||
16830222|NCT02184611|37773480|FG000|Overall Study|Lack of Efficacy|11|||
16830223|NCT02184611|37773481|FG001|Overall Study|Lack of Efficacy|15|||
16830224|NCT02184611|37773480|FG000|Overall Study|Withdrawal by Subject|5|||
16830225|NCT02184611|37773481|FG001|Overall Study|Withdrawal by Subject|6|||
16830226|NCT02184611|37773480|FG000|Overall Study|Adverse Event|4|||
16830227|NCT02184611|37773481|FG001|Overall Study|Adverse Event|5|||
16830228|NCT02184611|37773480|FG000|Overall Study|Protocol Violation|1|||
16830229|NCT02184611|37773481|FG001|Overall Study|Protocol Violation|1|||
16830230|NCT02184611|37773480|FG000|Overall Study|Protocol defined stopping criteria|0|||
16830231|NCT02184611|37773481|FG001|Overall Study|Protocol defined stopping criteria|1|||
16830232|NCT02066311|37773487|FG000|Overall Study|Adverse Event|4|||
16830233|NCT02066311|37773487|FG000|Overall Study|Withdrawal by Subject|1|||
16830234|NCT02184455|37773491|FG000|Overall Study|Lost to Follow-up|1|||
16830235|NCT02184143|37773497|FG000|Overall Study|Withdrawal by Subject|4|||
16830236|NCT02184143|37773498|FG001|Overall Study|Withdrawal by Subject|4|||
16830237|NCT02184143|37773497|FG000|Overall Study|Lost to Follow-up|5|||
16830238|NCT02184143|37773498|FG001|Overall Study|Lost to Follow-up|3|||
16830239|NCT02184143|37773497|FG000|Overall Study|Death|1|||
16830240|NCT02184143|37773498|FG001|Overall Study|Death|0|||
16830241|NCT01625611|37773508|FG000|Overall Study|No adlib drinks Lab 1|3|||
16830242|NCT01625611|37773509|FG001|Overall Study|No adlib drinks Lab 1|0|||
16830243|NCT01625611|37773508|FG000|Overall Study|Technical issues with PET|1|||
16830244|NCT01625611|37773509|FG001|Overall Study|Technical issues with PET|0|||
16830245|NCT01625611|37773508|FG000|Overall Study|Unable to complete study procedures|1|||
16830246|NCT01625611|37773509|FG001|Overall Study|Unable to complete study procedures|0|||
16830247|NCT01625611|37773508|FG000|Overall Study|Withdrawal by Subject|3|||
16830248|NCT01625611|37773509|FG001|Overall Study|Withdrawal by Subject|0|||
16830249|NCT02159807|37773519|FG000|Overall Study|Adverse Event|0|||
16830250|NCT02159807|37773520|FG001|Overall Study|Adverse Event|0|||
16830251|NCT02159807|37773521|FG002|Overall Study|Adverse Event|1|||
16830252|NCT02159807|37773519|FG000|Overall Study|No CSF|1|||
16830253|NCT02159807|37773520|FG001|Overall Study|No CSF|1|||
16830254|NCT02159807|37773521|FG002|Overall Study|No CSF|1|||
16830255|NCT02159807|37773519|FG000|Overall Study|elevated blood pressure|0|||
16830256|NCT02159807|37773520|FG001|Overall Study|elevated blood pressure|0|||
16830257|NCT02159807|37773521|FG002|Overall Study|elevated blood pressure|1|||
16830258|NCT02066233|37773531|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
16830259|NCT02066233|37773532|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
16830260|NCT02159729|37773540|FG000|Overall Study|Adverse Event|0|||
16830261|NCT02159729|37773541|FG001|Overall Study|Adverse Event|1|||
16830262|NCT02159729|37773540|FG000|Overall Study|Subject's Request|13|||
16830263|NCT02159729|37773541|FG001|Overall Study|Subject's Request|10|||
16830264|NCT02159729|37773540|FG000|Overall Study|Lost to Follow-up|24|||
16830265|NCT02159729|37773541|FG001|Overall Study|Lost to Follow-up|9|||
16830266|NCT02159729|37773540|FG000|Overall Study|Non compliance|2|||
16830267|NCT02159729|37773541|FG001|Overall Study|Non compliance|0|||
16830268|NCT02159729|37773540|FG000|Overall Study|Other Unspecified|3|||
16830269|NCT02159729|37773541|FG001|Overall Study|Other Unspecified|1|||
16830270|NCT02159183|37773549|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
16830271|NCT02159183|37773550|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
16830272|NCT02159183|37773549|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
16830273|NCT02159183|37773550|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
16830274|NCT02159183|37773549|FG000|Analysis After the 36 Months Follow-up|Death|0|||
16830275|NCT02159183|37773550|FG001|Analysis After the 36 Months Follow-up|Death|1|||
16830276|NCT02159183|37773549|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
16830277|NCT02159183|37773550|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
16830278|NCT02159183|37773549|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
16830279|NCT02159183|37773550|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
16830280|NCT02183675|37773562|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
16830281|NCT02183675|37773563|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
16830282|NCT02183675|37773564|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
16830283|NCT02183675|37773565|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
16830284|NCT02183675|37773566|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
16830285|NCT02183675|37773567|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
16830286|NCT02183519|37773579|FG000|Overall Study|computer error|3|||
16830287|NCT02183519|37773580|FG001|Overall Study|computer error|0|||
16830288|NCT02183519|37773579|FG000|Overall Study|Did not respond to cough inducter|0|||
16830289|NCT02183519|37773580|FG001|Overall Study|Did not respond to cough inducter|3|||
16830290|NCT02132195|37773589|FG000|Initial Assignment|Relapsed|14|||
16830291|NCT02132195|37773590|FG001|Initial Assignment|Relapsed|0|||
16830292|NCT02132195|37773591|FG002|Initial Assignment|Relapsed|0|||
16830293|NCT02132195|37773589|FG000|Rescue Therapy|Relapsed|0|||
16830294|NCT02132195|37773590|FG001|Rescue Therapy|Relapsed|0|||
16830295|NCT02132195|37773591|FG002|Rescue Therapy|Relapsed|7|||
16830296|NCT02132195|37773589|FG000|Rescue Therapy|Physician Decision|0|||
16830297|NCT02132195|37773590|FG001|Rescue Therapy|Physician Decision|0|||
16830298|NCT02132195|37773591|FG002|Rescue Therapy|Physician Decision|1|||
16830299|NCT02132195|37773589|FG000|Rescue Therapy|Withdrawal by Subject|0|||
16830300|NCT02132195|37773590|FG001|Rescue Therapy|Withdrawal by Subject|0|||
16830301|NCT02132195|37773591|FG002|Rescue Therapy|Withdrawal by Subject|1|||
16830302|NCT02132195|37773589|FG000|Rescue Therapy|Adverse Event|0|||
16830303|NCT02132195|37773590|FG001|Rescue Therapy|Adverse Event|0|||
16830304|NCT02132195|37773591|FG002|Rescue Therapy|Adverse Event|2|||
16830305|NCT02182973|37773601|FG000|Overall Study|Withdrawal by Subject|3|||
16830306|NCT02182973|37773602|FG001|Overall Study|Withdrawal by Subject|0|||
16830307|NCT02182895|37773611|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
16830308|NCT02182895|37773612|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
16830309|NCT01625377|37773620|FG000|Overall Study|Death|1|||
16830310|NCT01625377|37773621|FG001|Overall Study|Death|1|||
16830311|NCT01625377|37773620|FG000|Overall Study|Administrative Problem|1|||
16830312|NCT01625377|37773621|FG001|Overall Study|Administrative Problem|1|||
16830313|NCT01625377|37773620|FG000|Overall Study|Protocol Violation|0|||
16830314|NCT01625377|37773621|FG001|Overall Study|Protocol Violation|3|||
16830315|NCT01625377|37773620|FG000|Overall Study|Adverse Event|3|||
16830316|NCT01625377|37773621|FG001|Overall Study|Adverse Event|16|||
16830317|NCT01625377|37773620|FG000|Overall Study|Graft loss|1|||
16830318|NCT01625377|37773621|FG001|Overall Study|Graft loss|0|||
16830319|NCT01625377|37773620|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16830320|NCT01625377|37773621|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16830321|NCT01625377|37773620|FG000|Overall Study|Abnormal laboratory values|1|||
16830322|NCT01625377|37773621|FG001|Overall Study|Abnormal laboratory values|0|||
16830323|NCT02158949|37773629|FG000|Overall Study|Withdrawal by Subject|1|||
16912255|NCT01457352|38021427|FG000|Period 2|Withdrawal by Subject|23|||
16912256|NCT01457352|38021428|FG001|Period 2|Withdrawal by Subject|0|||
16912257|NCT01457352|38021427|FG000|Period 2|Adverse Event|22|||
16912258|NCT01457352|38021428|FG001|Period 2|Adverse Event|0|||
16912259|NCT01457352|38021427|FG000|Period 2|no analysis|10|||
16912260|NCT01457352|38021428|FG001|Period 2|no analysis|0|||
16912261|NCT01457352|38021427|FG000|Period 2|Lack of Efficacy|8|||
16912262|NCT01457352|38021428|FG001|Period 2|Lack of Efficacy|0|||
16912263|NCT01457352|38021427|FG000|Period 2|Protocol Violation|4|||
16912264|NCT01457352|38021428|FG001|Period 2|Protocol Violation|0|||
16912265|NCT01457352|38021427|FG000|Period 2|Sponsor's withdrawal|7|||
16912266|NCT01457352|38021428|FG001|Period 2|Sponsor's withdrawal|0|||
16912267|NCT01457352|38021427|FG000|Period 2|Lost to Follow-up|1|||
16912268|NCT01457352|38021428|FG001|Period 2|Lost to Follow-up|0|||
16912269|NCT01457352|38021427|FG000|Period 2|dose change|1|||
16830324|NCT02158949|37773630|FG001|Overall Study|Withdrawal by Subject|0|||
16830325|NCT02158949|37773629|FG000|Overall Study|Lost to Follow-up|5|||
16830326|NCT02158949|37773630|FG001|Overall Study|Lost to Follow-up|11|||
16830327|NCT02132117|37773638|FG000|Overall Study|Adverse Event|6|||
16830328|NCT02132117|37773639|FG001|Overall Study|Adverse Event|1|||
16830329|NCT02132117|37773638|FG000|Overall Study|Lost to Follow-up|2|||
16830330|NCT02132117|37773639|FG001|Overall Study|Lost to Follow-up|2|||
16830331|NCT02132117|37773638|FG000|Overall Study|Personal Reasons|1|||
16830332|NCT02132117|37773639|FG001|Overall Study|Personal Reasons|2|||
16830333|NCT02132117|37773638|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16830334|NCT02132117|37773639|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16830335|NCT02093689|37773648|FG000|Overall Study|Physician Decision|4|||
16830336|NCT02093689|37773649|FG001|Overall Study|Physician Decision|0|||
16830337|NCT02093689|37773650|FG002|Overall Study|Physician Decision|0|||
16830338|NCT02047045|37773658|FG000|Baseline|Withdrawal by Subject|3|||
16830339|NCT02047045|37773659|FG001|Baseline|Withdrawal by Subject|2|||
16912270|NCT01457352|38021428|FG001|Period 2|dose change|0|||
16912271|NCT01457352|38021427|FG000|Period 2|Physician Decision|1|||
16912272|NCT01457352|38021428|FG001|Period 2|Physician Decision|0|||
16912273|NCT01457352|38021427|FG000|Period 2|Did not meet eligibility criteria|3|||
16912274|NCT01457352|38021428|FG001|Period 2|Did not meet eligibility criteria|0|||
16912275|NCT01457352|38021427|FG000|Period 3|Adverse Event|1|||
16912276|NCT01457352|38021428|FG001|Period 3|Adverse Event|1|||
16830340|NCT02047045|37773658|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
16830341|NCT02047045|37773659|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
16912277|NCT01457352|38021427|FG000|Period 3|Withdrawal by Subject|0|||
16912278|NCT01457352|38021428|FG001|Period 3|Withdrawal by Subject|2|||
16912279|NCT01457352|38021427|FG000|Period 3|incorrect treatment|0|||
16830342|NCT02047045|37773658|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
16912280|NCT01457352|38021428|FG001|Period 3|incorrect treatment|1|||
16912281|NCT01457352|38021427|FG000|Period 3|Sponsor's withdrawal|0|||
16830343|NCT02047045|37773659|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
16830344|NCT02047045|37773658|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
16830345|NCT02047045|37773659|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
16830346|NCT02047045|37773658|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
16830347|NCT02047045|37773659|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
16830348|NCT02047045|37773658|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
16830349|NCT02047045|37773659|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
16830350|NCT02047045|37773658|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
16830351|NCT02047045|37773659|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
16830352|NCT02047045|37773658|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
16830353|NCT02047045|37773659|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
16830354|NCT02047045|37773658|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
16830355|NCT02047045|37773659|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
16830356|NCT02131259|37773665|FG000|Overall Study|Progressive disease|751|||
16830357|NCT02131259|37773665|FG000|Overall Study|Adverse Event|341|||
16830358|NCT02131259|37773665|FG000|Overall Study|Lost to Follow-up|7|||
16830359|NCT02131259|37773665|FG000|Overall Study|Relocation|32|||
16830360|NCT02131259|37773665|FG000|Overall Study|Other|63|||
16830361|NCT02131259|37773665|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
16830362|NCT02131259|37773665|FG000|Overall Study|Progressive disease/relocation|1|||
16830363|NCT02131259|37773665|FG000|Overall Study|Progressive disease/other|2|||
16830364|NCT02131259|37773665|FG000|Overall Study|AE/lost to follow-up|1|||
16830365|NCT02131259|37773665|FG000|Overall Study|AE/other|1|||
16830366|NCT02131259|37773665|FG000|Overall Study|Progressive disease/AE/other|1|||
16830367|NCT02131259|37773665|FG000|Overall Study|Missing|3|||
16830368|NCT01856595|37773678|FG000|Overall Study|Withdrawal by Subject|0|||
16830369|NCT01856595|37773679|FG001|Overall Study|Withdrawal by Subject|1|||
16830370|NCT01856595|37773680|FG002|Overall Study|Withdrawal by Subject|0|||
16830371|NCT01856595|37773681|FG003|Overall Study|Withdrawal by Subject|0|||
16830372|NCT01856595|37773682|FG004|Overall Study|Withdrawal by Subject|0|||
16830373|NCT01856595|37773683|FG005|Overall Study|Withdrawal by Subject|0|||
16830374|NCT01856595|37773684|FG006|Overall Study|Withdrawal by Subject|1|||
16830375|NCT01856595|37773685|FG007|Overall Study|Withdrawal by Subject|0|||
16830376|NCT01856595|37773686|FG008|Overall Study|Withdrawal by Subject|0|||
16830377|NCT02158247|37773723|FG000|Overall Study|Invisible vocal cords|5|||
16830378|NCT01829295|37773745|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
16830379|NCT01829295|37773746|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
16830380|NCT01829295|37773747|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
16830381|NCT01829295|37773748|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
16830382|NCT01829295|37773745|FG000|6-12 Months|Adverse Event|0|||
16830383|NCT01829295|37773746|FG001|6-12 Months|Adverse Event|0|||
16830384|NCT01829295|37773747|FG002|6-12 Months|Adverse Event|3|||
16830385|NCT01829295|37773748|FG003|6-12 Months|Adverse Event|2|||
16830386|NCT01829295|37773745|FG000|6-12 Months|Lost to Follow-up|2|||
16830387|NCT01829295|37773746|FG001|6-12 Months|Lost to Follow-up|0|||
16830388|NCT01829295|37773747|FG002|6-12 Months|Lost to Follow-up|0|||
16830389|NCT01829295|37773748|FG003|6-12 Months|Lost to Follow-up|0|||
16830390|NCT01829295|37773745|FG000|6-12 Months|Withdrawal by Subject|2|||
16830391|NCT01829295|37773746|FG001|6-12 Months|Withdrawal by Subject|2|||
16830392|NCT01829295|37773747|FG002|6-12 Months|Withdrawal by Subject|0|||
16830393|NCT01829295|37773748|FG003|6-12 Months|Withdrawal by Subject|0|||
16830394|NCT02157935|37773760|FG000|Overall Study|Withdrawal by Subject|25|||
16830395|NCT02157935|37773761|FG001|Overall Study|Withdrawal by Subject|39|||
16830396|NCT02157935|37773760|FG000|Overall Study|Screen failure|1|||
16830397|NCT02157935|37773761|FG001|Overall Study|Screen failure|2|||
16830398|NCT02157935|37773760|FG000|Overall Study|Protocol Violation|1|||
16830399|NCT02157935|37773761|FG001|Overall Study|Protocol Violation|0|||
16830400|NCT02157935|37773760|FG000|Overall Study|Progressive disease|0|||
16830401|NCT02157935|37773761|FG001|Overall Study|Progressive disease|2|||
16830402|NCT02157935|37773760|FG000|Overall Study|Other|5|||
16830403|NCT02157935|37773761|FG001|Overall Study|Other|12|||
16830404|NCT02157935|37773760|FG000|Overall Study|Lack of Efficacy|0|||
16830405|NCT02157935|37773761|FG001|Overall Study|Lack of Efficacy|1|||
16830406|NCT02157935|37773760|FG000|Overall Study|Death|4|||
16830407|NCT02157935|37773761|FG001|Overall Study|Death|4|||
16830408|NCT02157935|37773760|FG000|Overall Study|Adverse Event|3|||
16830409|NCT02157935|37773761|FG001|Overall Study|Adverse Event|5|||
16830410|NCT02157779|37773769|FG000|Overall Study|Logistical|9|||
16830411|NCT02157779|37773770|FG001|Overall Study|Logistical|3|||
16830412|NCT02157779|37773769|FG000|Overall Study|Stopped attending, reason unknown|11|||
16830413|NCT02157779|37773770|FG001|Overall Study|Stopped attending, reason unknown|7|||
16830414|NCT02157779|37773769|FG000|Overall Study|No response to outreach after Baseline|1|||
16830415|NCT02157779|37773770|FG001|Overall Study|No response to outreach after Baseline|1|||
16830416|NCT02157779|37773769|FG000|Overall Study|Moved|1|||
16830417|NCT02157779|37773770|FG001|Overall Study|Moved|0|||
16830418|NCT02157779|37773769|FG000|Overall Study|Medical|1|||
16830419|NCT02157779|37773770|FG001|Overall Study|Medical|0|||
16830420|NCT02157779|37773769|FG000|Overall Study|Legal issue|1|||
16830421|NCT02157779|37773770|FG001|Overall Study|Legal issue|0|||
16830422|NCT02093221|37773784|FG000|Overall Study|Adverse Event|1|||
16830423|NCT02093221|37773785|FG001|Overall Study|Adverse Event|0|||
16830424|NCT02093221|37773786|FG002|Overall Study|Adverse Event|0|||
16830425|NCT02093221|37773787|FG003|Overall Study|Adverse Event|0|||
16830426|NCT02093221|37773788|FG004|Overall Study|Adverse Event|0|||
16830427|NCT02093221|37773784|FG000|Overall Study|Withdrawal by Subject|1|||
16830428|NCT02093221|37773785|FG001|Overall Study|Withdrawal by Subject|1|||
16830429|NCT02093221|37773786|FG002|Overall Study|Withdrawal by Subject|4|||
16830430|NCT02093221|37773787|FG003|Overall Study|Withdrawal by Subject|1|||
16830431|NCT02093221|37773788|FG004|Overall Study|Withdrawal by Subject|1|||
16830432|NCT02093221|37773784|FG000|Overall Study|Lost to Follow-up|2|||
16830433|NCT02093221|37773785|FG001|Overall Study|Lost to Follow-up|0|||
16830434|NCT02093221|37773786|FG002|Overall Study|Lost to Follow-up|1|||
16830435|NCT02093221|37773787|FG003|Overall Study|Lost to Follow-up|1|||
16830436|NCT02093221|37773788|FG004|Overall Study|Lost to Follow-up|0|||
16830437|NCT02093221|37773784|FG000|Overall Study|Death|0|||
16830438|NCT02093221|37773785|FG001|Overall Study|Death|1|||
16830439|NCT02093221|37773786|FG002|Overall Study|Death|0|||
16830440|NCT02093221|37773787|FG003|Overall Study|Death|0|||
16830441|NCT02093221|37773788|FG004|Overall Study|Death|0|||
16830442|NCT02093221|37773784|FG000|Overall Study|Protocol Violation|0|||
16830443|NCT02093221|37773785|FG001|Overall Study|Protocol Violation|1|||
16830444|NCT02093221|37773786|FG002|Overall Study|Protocol Violation|0|||
16830445|NCT02093221|37773787|FG003|Overall Study|Protocol Violation|0|||
16830446|NCT02093221|37773788|FG004|Overall Study|Protocol Violation|0|||
16830447|NCT02093221|37773784|FG000|Overall Study|Study termination|6|||
16830448|NCT02093221|37773785|FG001|Overall Study|Study termination|5|||
16830449|NCT02093221|37773786|FG002|Overall Study|Study termination|4|||
16830450|NCT02093221|37773787|FG003|Overall Study|Study termination|6|||
16830451|NCT02093221|37773788|FG004|Overall Study|Study termination|7|||
16830452|NCT02092909|37773804|FG000|Overall Study|Adverse Event|0|||
16830453|NCT02092909|37773805|FG001|Overall Study|Adverse Event|0|||
16830454|NCT02092909|37773806|FG002|Overall Study|Adverse Event|4|||
16830455|NCT02092909|37773807|FG003|Overall Study|Adverse Event|2|||
16830456|NCT02092909|37773804|FG000|Overall Study|Lack of Efficacy|0|||
16830457|NCT02092909|37773805|FG001|Overall Study|Lack of Efficacy|2|||
16830458|NCT02092909|37773806|FG002|Overall Study|Lack of Efficacy|1|||
16830459|NCT02092909|37773807|FG003|Overall Study|Lack of Efficacy|0|||
16830460|NCT02092909|37773804|FG000|Overall Study|Withdrawal by Subject|0|||
16830461|NCT02092909|37773805|FG001|Overall Study|Withdrawal by Subject|0|||
16830462|NCT02092909|37773806|FG002|Overall Study|Withdrawal by Subject|2|||
16830463|NCT02092909|37773807|FG003|Overall Study|Withdrawal by Subject|1|||
16830464|NCT02092909|37773804|FG000|Overall Study|Study terminated by Sponsor|0|||
16830465|NCT02092909|37773805|FG001|Overall Study|Study terminated by Sponsor|0|||
16830466|NCT02092909|37773806|FG002|Overall Study|Study terminated by Sponsor|0|||
16830467|NCT02092909|37773807|FG003|Overall Study|Study terminated by Sponsor|2|||
16830468|NCT02092909|37773804|FG000|Overall Study|Miscellaneous|1|||
16830469|NCT02092909|37773805|FG001|Overall Study|Miscellaneous|1|||
16830470|NCT02092909|37773806|FG002|Overall Study|Miscellaneous|2|||
16830471|NCT02092909|37773807|FG003|Overall Study|Miscellaneous|1|||
16830472|NCT01623115|37773819|FG000|Overall Study|Randomized but not treated|0|||
16830473|NCT01623115|37773820|FG001|Overall Study|Randomized but not treated|1|||
16830474|NCT01623115|37773819|FG000|Overall Study|Physician Decision|1|||
16830475|NCT01623115|37773820|FG001|Overall Study|Physician Decision|0|||
16830476|NCT01623115|37773819|FG000|Overall Study|Participants moved|1|||
16830477|NCT01623115|37773820|FG001|Overall Study|Participants moved|5|||
16830478|NCT01623115|37773819|FG000|Overall Study|Adverse Event|10|||
16830479|NCT01623115|37773820|FG001|Overall Study|Adverse Event|13|||
16830480|NCT01623115|37773819|FG000|Overall Study|Poor compliance to protocol|4|||
16830481|NCT01623115|37773820|FG001|Overall Study|Poor compliance to protocol|10|||
16830482|NCT01623115|37773819|FG000|Overall Study|Consent withdrawn by participant|2|||
16830483|NCT01623115|37773820|FG001|Overall Study|Consent withdrawn by participant|6|||
16830484|NCT01623115|37773819|FG000|Overall Study|Related to study drug administration|0|||
16830485|NCT01623115|37773820|FG001|Overall Study|Related to study drug administration|2|||
16830486|NCT01623115|37773819|FG000|Overall Study|Last visit outside protocol visit window|14|||
16830487|NCT01623115|37773820|FG001|Overall Study|Last visit outside protocol visit window|26|||
16830488|NCT01623115|37773819|FG000|Overall Study|Site closure|1|||
16830489|NCT01623115|37773820|FG001|Overall Study|Site closure|7|||
16830490|NCT01623115|37773819|FG000|Overall Study|Death|0|||
16830491|NCT01623115|37773820|FG001|Overall Study|Death|4|||
16830492|NCT01623115|37773819|FG000|Overall Study|Other than specified above|0|||
16830493|NCT01623115|37773820|FG001|Overall Study|Other than specified above|3|||
16830494|NCT02092285|37773826|FG000|Induction Phase|Adverse Event|7|||
16830495|NCT02092285|37773826|FG000|Induction Phase|Physician Decision|4|||
16830496|NCT02092285|37773826|FG000|Induction Phase|Pregnancy|1|||
17102407|NCT00383123|38241347|FG000|Overall Study|Adverse Event|1|||
16830497|NCT02092285|37773826|FG000|Induction Phase|Relapse/Recurrence|7|||
16830498|NCT02092285|37773826|FG000|Induction Phase|Withdrawal by Subject|2|||
16830499|NCT02092285|37773826|FG000|Induction Phase|Lack of Efficacy|14|||
16830500|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
16830501|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
16830502|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
16830503|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
16830504|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
16830505|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
16830506|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
16830507|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
16830508|NCT02092285|37773826|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
16830509|NCT02091739|37773833|FG000|MP: 16 Weeks|Adverse Event|1|||
16830510|NCT02091739|37773834|FG001|MP: 16 Weeks|Adverse Event|1|||
16830511|NCT02091739|37773835|FG002|MP: 16 Weeks|Adverse Event|1|||
16830512|NCT02091739|37773836|FG003|MP: 16 Weeks|Adverse Event|0|||
16830513|NCT02091739|37773837|FG004|MP: 16 Weeks|Adverse Event|0|||
16830514|NCT02091739|37773833|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
16830515|NCT02091739|37773834|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
16830516|NCT02091739|37773835|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
16830517|NCT02091739|37773836|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
16830518|NCT02091739|37773837|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
16830519|NCT02091739|37773833|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
16830520|NCT02091739|37773834|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
16830521|NCT02091739|37773835|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
16830522|NCT02091739|37773836|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
16830523|NCT02091739|37773837|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
16830524|NCT02091739|37773833|FG000|EP: 48 Weeks|Other|0|||
16830525|NCT02091739|37773834|FG001|EP: 48 Weeks|Other|0|||
16830526|NCT02091739|37773835|FG002|EP: 48 Weeks|Other|0|||
16830527|NCT02091739|37773836|FG003|EP: 48 Weeks|Other|1|||
16830528|NCT02091739|37773837|FG004|EP: 48 Weeks|Other|0|||
16830529|NCT02091739|37773833|FG000|EP: 48 Weeks|Death|0|||
16830530|NCT02091739|37773834|FG001|EP: 48 Weeks|Death|0|||
16830531|NCT02091739|37773835|FG002|EP: 48 Weeks|Death|0|||
16830532|NCT02091739|37773836|FG003|EP: 48 Weeks|Death|3|||
16830533|NCT02091739|37773837|FG004|EP: 48 Weeks|Death|2|||
16830534|NCT02091739|37773833|FG000|EP: 48 Weeks|Adverse Event|0|||
16830535|NCT02091739|37773834|FG001|EP: 48 Weeks|Adverse Event|0|||
16830536|NCT02091739|37773835|FG002|EP: 48 Weeks|Adverse Event|0|||
16830537|NCT02091739|37773836|FG003|EP: 48 Weeks|Adverse Event|2|||
16830538|NCT02091739|37773837|FG004|EP: 48 Weeks|Adverse Event|6|||
16830539|NCT02091739|37773833|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
16830540|NCT02091739|37773834|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
16830541|NCT02091739|37773835|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
16912282|NCT01457352|38021428|FG001|Period 3|Sponsor's withdrawal|1|||
16912283|NCT01457118|38021442|FG000|Overall Study|Adverse Event|1|||
16912284|NCT01457118|38021443|FG001|Overall Study|Adverse Event|0|||
16912285|NCT01457118|38021444|FG002|Overall Study|Adverse Event|0|||
16912286|NCT01457118|38021445|FG003|Overall Study|Adverse Event|1|||
16912287|NCT01457118|38021442|FG000|Overall Study|Clinical Progression|0|||
16912288|NCT01457118|38021443|FG001|Overall Study|Clinical Progression|1|||
16912289|NCT01457118|38021444|FG002|Overall Study|Clinical Progression|0|||
16912290|NCT01457118|38021445|FG003|Overall Study|Clinical Progression|1|||
16912291|NCT01457118|38021442|FG000|Overall Study|Physician Decision|2|||
16912292|NCT01457118|38021443|FG001|Overall Study|Physician Decision|0|||
16912293|NCT01457118|38021444|FG002|Overall Study|Physician Decision|0|||
16912294|NCT01457118|38021445|FG003|Overall Study|Physician Decision|0|||
16912295|NCT01457118|38021442|FG000|Overall Study|Progressive Disease by RECIST|12|||
16912296|NCT01457118|38021443|FG001|Overall Study|Progressive Disease by RECIST|3|||
16912297|NCT01457118|38021444|FG002|Overall Study|Progressive Disease by RECIST|1|||
16912298|NCT01457118|38021445|FG003|Overall Study|Progressive Disease by RECIST|0|||
16912299|NCT01457118|38021442|FG000|Overall Study|Withdrawal by Subject|5|||
16912300|NCT01457118|38021443|FG001|Overall Study|Withdrawal by Subject|0|||
16912301|NCT01457118|38021444|FG002|Overall Study|Withdrawal by Subject|0|||
16912302|NCT01457118|38021445|FG003|Overall Study|Withdrawal by Subject|0|||
16912303|NCT01456962|38021457|FG000|Overall Study|Lost to Follow-up|2|||
16912304|NCT01456962|38021458|FG001|Overall Study|Lost to Follow-up|1|||
17102408|NCT00383123|38241348|FG001|Overall Study|Adverse Event|0|||
17102409|NCT00383123|38241347|FG000|Overall Study|Lost to Follow-up|68|||
16912305|NCT01501110|38021466|FG000|Overall Study|Death|0|||
16912306|NCT01501110|38021467|FG001|Overall Study|Death|1|||
16912307|NCT01500720|38021475|FG000|Overall Study|Randomized But Not Treated|1|||
17102410|NCT00383123|38241348|FG001|Overall Study|Lost to Follow-up|61|||
16830542|NCT02091739|37773836|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
16830543|NCT02091739|37773837|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
16830544|NCT02045875|37773849|FG000|Overall Study|Lost to Follow-up|3|||
16830545|NCT02045875|37773850|FG001|Overall Study|Lost to Follow-up|0|||
16830546|NCT02045875|37773849|FG000|Overall Study|Withdrawal by Subject|4|||
16830547|NCT02045875|37773850|FG001|Overall Study|Withdrawal by Subject|3|||
16830548|NCT01597635|37773859|FG000|Part A|Adverse Event|3|||
16830549|NCT01597635|37773860|FG001|Part A|Adverse Event|0|||
16830550|NCT01597635|37773861|FG002|Part A|Adverse Event|0|||
16830551|NCT01597635|37773859|FG000|Part B|Adverse Event|0|||
16830552|NCT01597635|37773860|FG001|Part B|Adverse Event|0|||
16830553|NCT01597635|37773861|FG002|Part B|Adverse Event|1|||
16830554|NCT01597635|37773859|FG000|Part B|Protocol Violation|0|||
16830555|NCT01597635|37773860|FG001|Part B|Protocol Violation|1|||
16830556|NCT01597635|37773861|FG002|Part B|Protocol Violation|0|||
16830557|NCT01597635|37773859|FG000|Part B|Protocol-defined stopping criteria|0|||
16830558|NCT01597635|37773860|FG001|Part B|Protocol-defined stopping criteria|4|||
16830559|NCT01597635|37773861|FG002|Part B|Protocol-defined stopping criteria|3|||
16830560|NCT01597635|37773859|FG000|Part B|Withdrawal by Subject|0|||
16830561|NCT01597635|37773860|FG001|Part B|Withdrawal by Subject|1|||
16830562|NCT01597635|37773861|FG002|Part B|Withdrawal by Subject|0|||
16830563|NCT01828281|37773872|FG000|Overall Study|Withdrawal by Subject|1|||
16830564|NCT01828281|37773873|FG001|Overall Study|Withdrawal by Subject|0|||
16830565|NCT01827267|37773882|FG000|Overall Study|Did not receive study drug|1|||
16830566|NCT01827267|37773883|FG001|Overall Study|Did not receive study drug|1|||
16830567|NCT01827267|37773882|FG000|Overall Study|Physician Decision|1|||
16830568|NCT01827267|37773883|FG001|Overall Study|Physician Decision|0|||
16830569|NCT01827267|37773882|FG000|Overall Study|Disease Progression|1|||
16830570|NCT01827267|37773883|FG001|Overall Study|Disease Progression|1|||
16830571|NCT01827267|37773882|FG000|Overall Study|Sponsor Discontinued Study|2|||
16830572|NCT01827267|37773883|FG001|Overall Study|Sponsor Discontinued Study|8|||
16830573|NCT01827267|37773882|FG000|Overall Study|Still on study|0|||
16830574|NCT01827267|37773883|FG001|Overall Study|Still on study|2|||
16830575|NCT01855425|37773890|FG000|Overall Study|Physician Decision|20|||
16830576|NCT01854879|37773894|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
16830577|NCT01854879|37773894|FG000|Overall Study|screen fail|3|||
16830578|NCT01854879|37773894|FG000|Overall Study|incomplete data set|1|||
16830579|NCT01827111|37773898|FG000|Overall Study|Disease Progression|1|||
16830580|NCT02045095|37773902|FG000|Overall Study|Other|0|||
16830581|NCT02045095|37773903|FG001|Overall Study|Other|0|||
16830582|NCT02045095|37773904|FG002|Overall Study|Other|1|||
16830583|NCT02045095|37773905|FG003|Overall Study|Other|0|||
16830584|NCT02045095|37773906|FG004|Overall Study|Other|0|||
16830585|NCT02045095|37773907|FG005|Overall Study|Other|2|||
16830586|NCT02045095|37773908|FG006|Overall Study|Other|0|||
16830587|NCT02045095|37773902|FG000|Overall Study|Progressive Disease|3|||
16830588|NCT02045095|37773903|FG001|Overall Study|Progressive Disease|3|||
16830589|NCT02045095|37773904|FG002|Overall Study|Progressive Disease|2|||
16830590|NCT02045095|37773905|FG003|Overall Study|Progressive Disease|4|||
16830591|NCT02045095|37773906|FG004|Overall Study|Progressive Disease|2|||
16830592|NCT02045095|37773907|FG005|Overall Study|Progressive Disease|4|||
16830593|NCT02045095|37773908|FG006|Overall Study|Progressive Disease|1|||
16830594|NCT02045095|37773902|FG000|Overall Study|Withdrawal by Subject|0|||
16830595|NCT02045095|37773903|FG001|Overall Study|Withdrawal by Subject|0|||
16830596|NCT02045095|37773904|FG002|Overall Study|Withdrawal by Subject|0|||
16830597|NCT02045095|37773905|FG003|Overall Study|Withdrawal by Subject|0|||
16830598|NCT02045095|37773906|FG004|Overall Study|Withdrawal by Subject|3|||
16830599|NCT02045095|37773907|FG005|Overall Study|Withdrawal by Subject|0|||
16830600|NCT02045095|37773908|FG006|Overall Study|Withdrawal by Subject|0|||
16830601|NCT02045095|37773902|FG000|Overall Study|Adverse Event|0|||
16830602|NCT02045095|37773903|FG001|Overall Study|Adverse Event|1|||
16830603|NCT02045095|37773904|FG002|Overall Study|Adverse Event|1|||
16830604|NCT02045095|37773905|FG003|Overall Study|Adverse Event|0|||
16830605|NCT02045095|37773906|FG004|Overall Study|Adverse Event|0|||
16830606|NCT02045095|37773907|FG005|Overall Study|Adverse Event|2|||
16830607|NCT02045095|37773908|FG006|Overall Study|Adverse Event|0|||
16830608|NCT02181803|37773933|FG000|Overall Study|Withdrawal by Subject|0|||
16830609|NCT02181803|37773934|FG001|Overall Study|Withdrawal by Subject|2|||
16830610|NCT02181803|37773935|FG002|Overall Study|Withdrawal by Subject|0|||
16830611|NCT02181803|37773936|FG003|Overall Study|Withdrawal by Subject|0|||
16830612|NCT02181803|37773937|FG004|Overall Study|Withdrawal by Subject|0|||
16830613|NCT02181803|37773938|FG005|Overall Study|Withdrawal by Subject|0|||
16830614|NCT02181803|37773939|FG006|Overall Study|Withdrawal by Subject|0|||
16830615|NCT02181803|37773940|FG007|Overall Study|Withdrawal by Subject|0|||
16830616|NCT02181803|37773941|FG008|Overall Study|Withdrawal by Subject|0|||
16830617|NCT02181803|37773933|FG000|Overall Study|Physician Decision|0|||
16830618|NCT02181803|37773934|FG001|Overall Study|Physician Decision|0|||
16830619|NCT02181803|37773935|FG002|Overall Study|Physician Decision|0|||
16830620|NCT02181803|37773936|FG003|Overall Study|Physician Decision|1|||
16830621|NCT02181803|37773937|FG004|Overall Study|Physician Decision|0|||
16830622|NCT02181803|37773938|FG005|Overall Study|Physician Decision|0|||
16830623|NCT02181803|37773939|FG006|Overall Study|Physician Decision|0|||
16830624|NCT02181803|37773940|FG007|Overall Study|Physician Decision|1|||
16830625|NCT02181803|37773941|FG008|Overall Study|Physician Decision|0|||
16830626|NCT02181803|37773933|FG000|Overall Study|Adverse Event|0|||
16830627|NCT02181803|37773934|FG001|Overall Study|Adverse Event|2|||
16830628|NCT02181803|37773935|FG002|Overall Study|Adverse Event|0|||
16830629|NCT02181803|37773936|FG003|Overall Study|Adverse Event|1|||
16830630|NCT02181803|37773937|FG004|Overall Study|Adverse Event|0|||
16830631|NCT02181803|37773938|FG005|Overall Study|Adverse Event|0|||
16830632|NCT02181803|37773939|FG006|Overall Study|Adverse Event|1|||
16830633|NCT02181803|37773940|FG007|Overall Study|Adverse Event|0|||
16830634|NCT02181803|37773941|FG008|Overall Study|Adverse Event|0|||
16830635|NCT01826487|37773988|FG000|Overall Study|Adverse Event|1|||
16830636|NCT01826487|37773989|FG001|Overall Study|Adverse Event|1|||
16830637|NCT01826487|37773988|FG000|Overall Study|Lost to Follow-up|1|||
16830638|NCT01826487|37773989|FG001|Overall Study|Lost to Follow-up|0|||
16830639|NCT01826487|37773988|FG000|Overall Study|Withdrawal by Subject|1|||
16830640|NCT01826487|37773989|FG001|Overall Study|Withdrawal by Subject|3|||
16830641|NCT01826487|37773988|FG000|Overall Study|Protocol Violation|1|||
16830642|NCT01826487|37773989|FG001|Overall Study|Protocol Violation|1|||
16830643|NCT02064439|37773999|FG000|Overall Study|Adverse Event|51|||
16830644|NCT02064439|37774000|FG001|Overall Study|Adverse Event|47|||
16830645|NCT02064439|37774001|FG002|Overall Study|Adverse Event|46|||
16830646|NCT02064439|37773999|FG000|Overall Study|Death|0|||
16830647|NCT02064439|37774000|FG001|Overall Study|Death|2|||
16830648|NCT02064439|37774001|FG002|Overall Study|Death|3|||
16830649|NCT02064439|37773999|FG000|Overall Study|Withdrawal by Subject|29|||
16830650|NCT02064439|37774000|FG001|Overall Study|Withdrawal by Subject|18|||
16830651|NCT02064439|37774001|FG002|Overall Study|Withdrawal by Subject|26|||
16830652|NCT02064439|37773999|FG000|Overall Study|Protocol Violation|3|||
16830653|NCT02064439|37774000|FG001|Overall Study|Protocol Violation|5|||
16830654|NCT02064439|37774001|FG002|Overall Study|Protocol Violation|3|||
16830655|NCT02064439|37773999|FG000|Overall Study|Lost to Follow-up|1|||
16830656|NCT02064439|37774000|FG001|Overall Study|Lost to Follow-up|3|||
16830657|NCT02064439|37774001|FG002|Overall Study|Lost to Follow-up|4|||
16830658|NCT02064439|37773999|FG000|Overall Study|Non-compliance with study medication|21|||
16830659|NCT02064439|37774000|FG001|Overall Study|Non-compliance with study medication|19|||
16830660|NCT02064439|37774001|FG002|Overall Study|Non-compliance with study medication|23|||
16830661|NCT02064439|37773999|FG000|Overall Study|Physician Decision|0|||
16830662|NCT02064439|37774000|FG001|Overall Study|Physician Decision|1|||
16830663|NCT02064439|37774001|FG002|Overall Study|Physician Decision|1|||
16830664|NCT02064439|37773999|FG000|Overall Study|Logistical difficulties|6|||
16830665|NCT02064439|37774000|FG001|Overall Study|Logistical difficulties|5|||
16830666|NCT02064439|37774001|FG002|Overall Study|Logistical difficulties|2|||
16830667|NCT02064439|37773999|FG000|Overall Study|Efficacy outcome reached|18|||
16830668|NCT02064439|37774000|FG001|Overall Study|Efficacy outcome reached|16|||
16830669|NCT02064439|37774001|FG002|Overall Study|Efficacy outcome reached|57|||
16830670|NCT02064439|37773999|FG000|Overall Study|Safety outcome reached|12|||
16830671|NCT02064439|37774000|FG001|Overall Study|Safety outcome reached|20|||
16830672|NCT02064439|37774001|FG002|Overall Study|Safety outcome reached|10|||
16830673|NCT02064439|37773999|FG000|Overall Study|Other|2|||
16830674|NCT02064439|37774000|FG001|Overall Study|Other|2|||
16830675|NCT02064439|37774001|FG002|Overall Study|Other|7|||
16830676|NCT02130557|37774011|FG000|Overall Study|Withdrawal by Subject|12|||
16830677|NCT02130557|37774012|FG001|Overall Study|Withdrawal by Subject|12|||
16830678|NCT02130557|37774011|FG000|Overall Study|Investigator Request|0|||
16830679|NCT02130557|37774012|FG001|Overall Study|Investigator Request|2|||
16830680|NCT02130557|37774011|FG000|Overall Study|Deceased|14|||
16830681|NCT02130557|37774012|FG001|Overall Study|Deceased|14|||
16830682|NCT02130557|37774011|FG000|Overall Study|Lost to Follow-up|6|||
16830683|NCT02130557|37774012|FG001|Overall Study|Lost to Follow-up|7|||
16830684|NCT02130557|37774011|FG000|Overall Study|Other|2|||
16830685|NCT02130557|37774012|FG001|Overall Study|Other|1|||
16830686|NCT02130557|37774011|FG000|Overall Study|Missing|2|||
16830687|NCT02130557|37774012|FG001|Overall Study|Missing|1|||
16830688|NCT01854645|37774023|FG000|Overall Study|Protocol-Specified Criteria|13|||
16830689|NCT01854645|37774024|FG001|Overall Study|Protocol-Specified Criteria|10|||
16830690|NCT01854645|37774025|FG002|Overall Study|Protocol-Specified Criteria|8|||
16830691|NCT01854645|37774026|FG003|Overall Study|Protocol-Specified Criteria|5|||
16830692|NCT01854645|37774027|FG004|Overall Study|Protocol-Specified Criteria|7|||
16830693|NCT01854645|37774023|FG000|Overall Study|Administrative Reasons / Missing|0|||
16830694|NCT01854645|37774024|FG001|Overall Study|Administrative Reasons / Missing|0|||
16830695|NCT01854645|37774025|FG002|Overall Study|Administrative Reasons / Missing|0|||
16830696|NCT01854645|37774026|FG003|Overall Study|Administrative Reasons / Missing|1|||
16830697|NCT01854645|37774027|FG004|Overall Study|Administrative Reasons / Missing|1|||
16830698|NCT01854645|37774023|FG000|Overall Study|Protocol Violation|3|||
16830699|NCT01854645|37774024|FG001|Overall Study|Protocol Violation|0|||
16830700|NCT01854645|37774025|FG002|Overall Study|Protocol Violation|5|||
16830701|NCT01854645|37774026|FG003|Overall Study|Protocol Violation|4|||
16830702|NCT01854645|37774027|FG004|Overall Study|Protocol Violation|1|||
16830703|NCT01854645|37774023|FG000|Overall Study|Lost to Follow-up|10|||
16830704|NCT01854645|37774024|FG001|Overall Study|Lost to Follow-up|7|||
16830705|NCT01854645|37774025|FG002|Overall Study|Lost to Follow-up|8|||
16830706|NCT01854645|37774026|FG003|Overall Study|Lost to Follow-up|5|||
16830707|NCT01854645|37774027|FG004|Overall Study|Lost to Follow-up|0|||
16830708|NCT01854645|37774023|FG000|Overall Study|Physician Decision|1|||
16830709|NCT01854645|37774024|FG001|Overall Study|Physician Decision|5|||
16830710|NCT01854645|37774025|FG002|Overall Study|Physician Decision|3|||
16830711|NCT01854645|37774026|FG003|Overall Study|Physician Decision|3|||
16830712|NCT01854645|37774027|FG004|Overall Study|Physician Decision|7|||
16830713|NCT01854645|37774023|FG000|Overall Study|Withdrawal by Subject|31|||
16830714|NCT01854645|37774024|FG001|Overall Study|Withdrawal by Subject|41|||
16830715|NCT01854645|37774025|FG002|Overall Study|Withdrawal by Subject|30|||
16830716|NCT01854645|37774026|FG003|Overall Study|Withdrawal by Subject|21|||
16830717|NCT01854645|37774027|FG004|Overall Study|Withdrawal by Subject|24|||
16830718|NCT01854645|37774023|FG000|Overall Study|Lack of Efficacy|7|||
16830719|NCT01854645|37774024|FG001|Overall Study|Lack of Efficacy|12|||
16830720|NCT01854645|37774025|FG002|Overall Study|Lack of Efficacy|9|||
16830721|NCT01854645|37774026|FG003|Overall Study|Lack of Efficacy|3|||
16830722|NCT01854645|37774027|FG004|Overall Study|Lack of Efficacy|9|||
16830723|NCT01854645|37774023|FG000|Overall Study|Adverse Event|33|||
16830724|NCT01854645|37774024|FG001|Overall Study|Adverse Event|31|||
16830725|NCT01854645|37774025|FG002|Overall Study|Adverse Event|19|||
16830726|NCT01854645|37774026|FG003|Overall Study|Adverse Event|20|||
16830727|NCT01854645|37774027|FG004|Overall Study|Adverse Event|11|||
16830728|NCT01825941|37774041|FG000|Overall Study|Lost to Follow-up|4|||
16830729|NCT01825941|37774042|FG001|Overall Study|Lost to Follow-up|1|||
16830730|NCT02064205|37774048|FG000|Overall Study|Withdrawal by Subject|1|||
16830731|NCT02090959|37774064|FG000|Overall Study|Withdrawal by Subject|10|||
16830732|NCT02090959|37774064|FG000|Overall Study|Adverse Event|1|||
16830733|NCT02090959|37774064|FG000|Overall Study|Investigator decision|2|||
16830734|NCT02090959|37774064|FG000|Overall Study|Study termination|6|||
16830735|NCT02090959|37774064|FG000|Overall Study|Enrolled but not treated|1|||
16830736|NCT02090959|37774064|FG000|Overall Study|Transfer for compassionate use medicine|4|||
16830737|NCT02090959|37774064|FG000|Overall Study|Move to medical need program|3|||
16830738|NCT02090959|37774064|FG000|Overall Study|Entered in to other study|34|||
16830739|NCT02090959|37774064|FG000|Overall Study|Switched to commercial supply|88|||
16830740|NCT02090959|37774064|FG000|Overall Study|Other than specified|2|||
16830741|NCT02044159|37774070|FG000|Overall Study|Consent declined (deferred consent)|2|||
16830742|NCT02044159|37774071|FG001|Overall Study|Consent declined (deferred consent)|4|||
16830743|NCT02044159|37774070|FG000|Overall Study|No longer eligible, drug not given|1|||
16830744|NCT02044159|37774071|FG001|Overall Study|No longer eligible, drug not given|0|||
16830745|NCT02044159|37774070|FG000|Overall Study|Nurse declined to give study drug|1|||
16830746|NCT02044159|37774071|FG001|Overall Study|Nurse declined to give study drug|0|||
16830747|NCT02090725|37774080|FG000|Overall Study|Withdrawal by Subject|1|||
16830748|NCT02090725|37774080|FG000|Overall Study|participants moved from area|3|||
16830749|NCT02180165|37774088|FG000|Overall Study|Not Treated|0|||
16830750|NCT02180165|37774089|FG001|Overall Study|Not Treated|0|||
16830751|NCT02180165|37774090|FG002|Overall Study|Not Treated|1|||
16830752|NCT02180165|37774091|FG003|Overall Study|Not Treated|0|||
16830753|NCT02180165|37774088|FG000|Overall Study|Adverse Event|7|||
16830754|NCT02180165|37774089|FG001|Overall Study|Adverse Event|0|||
16830755|NCT02180165|37774090|FG002|Overall Study|Adverse Event|18|||
16830756|NCT02180165|37774091|FG003|Overall Study|Adverse Event|3|||
16830757|NCT02180165|37774088|FG000|Overall Study|Lack of Efficacy|0|||
16830758|NCT02180165|37774089|FG001|Overall Study|Lack of Efficacy|1|||
16830759|NCT02180165|37774090|FG002|Overall Study|Lack of Efficacy|3|||
16830760|NCT02180165|37774091|FG003|Overall Study|Lack of Efficacy|2|||
16830761|NCT02180165|37774088|FG000|Overall Study|Physician Decision|1|||
16830762|NCT02180165|37774089|FG001|Overall Study|Physician Decision|0|||
16830763|NCT02180165|37774090|FG002|Overall Study|Physician Decision|5|||
16830764|NCT02180165|37774091|FG003|Overall Study|Physician Decision|0|||
16830765|NCT02180165|37774088|FG000|Overall Study|Withdrawal by Subject|3|||
16830766|NCT02180165|37774089|FG001|Overall Study|Withdrawal by Subject|0|||
16830767|NCT02180165|37774090|FG002|Overall Study|Withdrawal by Subject|2|||
16830768|NCT02180165|37774091|FG003|Overall Study|Withdrawal by Subject|1|||
16830769|NCT02155985|37774106|FG000|Overall Study|Withdrawal by Subject|0|||
16830770|NCT02155985|37774107|FG001|Overall Study|Withdrawal by Subject|0|||
16830771|NCT02155985|37774108|FG002|Overall Study|Withdrawal by Subject|1|||
16830772|NCT02155985|37774106|FG000|Overall Study|Lost to Follow-up|1|||
16830773|NCT02155985|37774107|FG001|Overall Study|Lost to Follow-up|0|||
16830774|NCT02155985|37774108|FG002|Overall Study|Lost to Follow-up|0|||
16830775|NCT02155829|37774118|FG000|Overall Study|Adverse Event|1|||
16830776|NCT02155829|37774119|FG001|Overall Study|Adverse Event|0|||
16830777|NCT02155829|37774118|FG000|Overall Study|Withdrawal by Subject|3|||
16830778|NCT02155829|37774119|FG001|Overall Study|Withdrawal by Subject|3|||
16830779|NCT02155829|37774118|FG000|Overall Study|Protocol Violation|2|||
16830780|NCT02155829|37774119|FG001|Overall Study|Protocol Violation|0|||
16830781|NCT02129777|37774131|FG000|Double-Blind Period|Adverse Event|0|||
16830782|NCT02129777|37774132|FG001|Double-Blind Period|Adverse Event|0|||
16830783|NCT02129777|37774133|FG002|Double-Blind Period|Adverse Event|0|||
16830784|NCT02129777|37774134|FG003|Double-Blind Period|Adverse Event|0|||
16830785|NCT02129777|37774135|FG004|Double-Blind Period|Adverse Event|1|||
16830786|NCT02129777|37774136|FG005|Double-Blind Period|Adverse Event|0|||
16830787|NCT02129777|37774137|FG006|Double-Blind Period|Adverse Event|0|||
16830788|NCT02129777|37774131|FG000|Double-Blind Period|Lost to Follow-up|1|||
16830789|NCT02129777|37774132|FG001|Double-Blind Period|Lost to Follow-up|1|||
16830790|NCT02129777|37774133|FG002|Double-Blind Period|Lost to Follow-up|1|||
16830791|NCT02129777|37774134|FG003|Double-Blind Period|Lost to Follow-up|2|||
16830792|NCT02129777|37774135|FG004|Double-Blind Period|Lost to Follow-up|0|||
16830793|NCT02129777|37774136|FG005|Double-Blind Period|Lost to Follow-up|0|||
16830794|NCT02129777|37774137|FG006|Double-Blind Period|Lost to Follow-up|0|||
16830795|NCT02129777|37774131|FG000|Double-Blind Period|Withdrawal by Subject|2|||
16830796|NCT02129777|37774132|FG001|Double-Blind Period|Withdrawal by Subject|4|||
16830797|NCT02129777|37774133|FG002|Double-Blind Period|Withdrawal by Subject|3|||
16830798|NCT02129777|37774134|FG003|Double-Blind Period|Withdrawal by Subject|2|||
16830799|NCT02129777|37774135|FG004|Double-Blind Period|Withdrawal by Subject|3|||
16830800|NCT02129777|37774136|FG005|Double-Blind Period|Withdrawal by Subject|0|||
16830801|NCT02129777|37774137|FG006|Double-Blind Period|Withdrawal by Subject|0|||
16830802|NCT02129777|37774131|FG000|Double-Blind Period|Pregnancy|0|||
16830803|NCT02129777|37774132|FG001|Double-Blind Period|Pregnancy|0|||
16830804|NCT02129777|37774133|FG002|Double-Blind Period|Pregnancy|0|||
16830805|NCT02129777|37774134|FG003|Double-Blind Period|Pregnancy|0|||
16830806|NCT02129777|37774135|FG004|Double-Blind Period|Pregnancy|1|||
16830807|NCT02129777|37774136|FG005|Double-Blind Period|Pregnancy|0|||
16830808|NCT02129777|37774137|FG006|Double-Blind Period|Pregnancy|0|||
16830809|NCT02129777|37774131|FG000|Double-Blind Period|Lack of Efficacy|3|||
16830810|NCT02129777|37774132|FG001|Double-Blind Period|Lack of Efficacy|1|||
16830811|NCT02129777|37774133|FG002|Double-Blind Period|Lack of Efficacy|0|||
16830812|NCT02129777|37774134|FG003|Double-Blind Period|Lack of Efficacy|3|||
16830813|NCT02129777|37774135|FG004|Double-Blind Period|Lack of Efficacy|2|||
16830814|NCT02129777|37774136|FG005|Double-Blind Period|Lack of Efficacy|0|||
16830815|NCT02129777|37774137|FG006|Double-Blind Period|Lack of Efficacy|0|||
16830816|NCT02129777|37774131|FG000|Double-Blind Period|Other|1|||
16830817|NCT02129777|37774132|FG001|Double-Blind Period|Other|2|||
16830818|NCT02129777|37774133|FG002|Double-Blind Period|Other|0|||
16830819|NCT02129777|37774134|FG003|Double-Blind Period|Other|0|||
16830820|NCT02129777|37774135|FG004|Double-Blind Period|Other|0|||
16830821|NCT02129777|37774136|FG005|Double-Blind Period|Other|0|||
16830822|NCT02129777|37774137|FG006|Double-Blind Period|Other|0|||
16830823|NCT02129777|37774131|FG000|Open-Label Period|Lack of Efficacy|0|||
16830824|NCT02129777|37774132|FG001|Open-Label Period|Lack of Efficacy|0|||
16830825|NCT02129777|37774133|FG002|Open-Label Period|Lack of Efficacy|0|||
16830826|NCT02129777|37774134|FG003|Open-Label Period|Lack of Efficacy|0|||
16830827|NCT02129777|37774135|FG004|Open-Label Period|Lack of Efficacy|0|||
16830828|NCT02129777|37774136|FG005|Open-Label Period|Lack of Efficacy|0|||
16830829|NCT02129777|37774137|FG006|Open-Label Period|Lack of Efficacy|5|||
16830830|NCT02129777|37774131|FG000|Open-Label Period|Lost to Follow-up|0|||
16830831|NCT02129777|37774132|FG001|Open-Label Period|Lost to Follow-up|0|||
16830832|NCT02129777|37774133|FG002|Open-Label Period|Lost to Follow-up|0|||
16830833|NCT02129777|37774134|FG003|Open-Label Period|Lost to Follow-up|0|||
16830834|NCT02129777|37774135|FG004|Open-Label Period|Lost to Follow-up|0|||
16830835|NCT02129777|37774136|FG005|Open-Label Period|Lost to Follow-up|1|||
16830836|NCT02129777|37774137|FG006|Open-Label Period|Lost to Follow-up|1|||
16830837|NCT02129777|37774131|FG000|Open-Label Period|Withdrawal by Subject|0|||
16830838|NCT02129777|37774132|FG001|Open-Label Period|Withdrawal by Subject|0|||
16830839|NCT02129777|37774133|FG002|Open-Label Period|Withdrawal by Subject|0|||
16830840|NCT02129777|37774134|FG003|Open-Label Period|Withdrawal by Subject|0|||
16830841|NCT02129777|37774135|FG004|Open-Label Period|Withdrawal by Subject|0|||
16830842|NCT02129777|37774136|FG005|Open-Label Period|Withdrawal by Subject|1|||
16830843|NCT02129777|37774137|FG006|Open-Label Period|Withdrawal by Subject|3|||
16830844|NCT02129777|37774131|FG000|Open-Label Period|Study Termination|0|||
16830845|NCT02129777|37774132|FG001|Open-Label Period|Study Termination|0|||
16830846|NCT02129777|37774133|FG002|Open-Label Period|Study Termination|0|||
16830847|NCT02129777|37774134|FG003|Open-Label Period|Study Termination|0|||
16830848|NCT02129777|37774135|FG004|Open-Label Period|Study Termination|0|||
16830849|NCT02129777|37774136|FG005|Open-Label Period|Study Termination|10|||
16830850|NCT02129777|37774137|FG006|Open-Label Period|Study Termination|39|||
16830851|NCT02178995|37774158|FG000|Double Blind|Adverse Event|0|||
16830852|NCT02178995|37774159|FG001|Double Blind|Adverse Event|0|||
16830853|NCT02178995|37774160|FG002|Double Blind|Adverse Event|0|||
16830854|NCT02178995|37774161|FG003|Double Blind|Adverse Event|0|||
16830855|NCT02178995|37774162|FG004|Double Blind|Adverse Event|0|||
16830856|NCT02178995|37774163|FG005|Double Blind|Adverse Event|1|||
16830857|NCT02178995|37774164|FG006|Double Blind|Adverse Event|0|||
16830858|NCT02178995|37774165|FG007|Double Blind|Adverse Event|1|||
16830859|NCT02178995|37774166|FG008|Double Blind|Adverse Event|1|||
16830860|NCT02178995|37774158|FG000|Double Blind|Lost to Follow-up|0|||
16830861|NCT02178995|37774159|FG001|Double Blind|Lost to Follow-up|1|||
16830862|NCT02178995|37774160|FG002|Double Blind|Lost to Follow-up|0|||
16830863|NCT02178995|37774161|FG003|Double Blind|Lost to Follow-up|0|||
16830864|NCT02178995|37774162|FG004|Double Blind|Lost to Follow-up|0|||
16830865|NCT02178995|37774163|FG005|Double Blind|Lost to Follow-up|0|||
16830866|NCT02178995|37774164|FG006|Double Blind|Lost to Follow-up|0|||
16830867|NCT02178995|37774165|FG007|Double Blind|Lost to Follow-up|1|||
16830868|NCT02178995|37774166|FG008|Double Blind|Lost to Follow-up|0|||
16830869|NCT02178995|37774158|FG000|Open Label|Adverse Event|2|||
16830870|NCT02178995|37774159|FG001|Open Label|Adverse Event|0|||
16830871|NCT02178995|37774160|FG002|Open Label|Adverse Event|0|||
16830872|NCT02178995|37774161|FG003|Open Label|Adverse Event|0|||
16830873|NCT02178995|37774162|FG004|Open Label|Adverse Event|0|||
16830874|NCT02178995|37774163|FG005|Open Label|Adverse Event|0|||
16830875|NCT02178995|37774164|FG006|Open Label|Adverse Event|0|||
16830876|NCT02178995|37774165|FG007|Open Label|Adverse Event|0|||
16830877|NCT02178995|37774166|FG008|Open Label|Adverse Event|0|||
16830878|NCT02128997|37774192|FG000|Overall Study|Lost to Follow-up|6|||
16830879|NCT02128997|37774193|FG001|Overall Study|Lost to Follow-up|11|||
16830880|NCT02155283|37774199|FG000|Overall Study|Lost to Follow-up|3|||
16830881|NCT02155283|37774199|FG000|Overall Study|Withdrawal by Subject|1|||
16830882|NCT02155283|37774199|FG000|Overall Study|Protocol Violation|3|||
16830883|NCT02154581|37774205|FG000|Overall Study|Lost to Follow-up|7|||
16830884|NCT02154581|37774206|FG001|Overall Study|Lost to Follow-up|8|||
16830885|NCT02154425|37774214|FG000|Screening Period|Adverse Event|1|||
16830886|NCT02154347|37774224|FG000|Double-blind Period|Adverse Event|1|||
16830887|NCT02154347|37774225|FG001|Double-blind Period|Adverse Event|2|||
16830888|NCT02154347|37774224|FG000|Double-blind Period|Lack of Efficacy|1|||
16830889|NCT02154347|37774225|FG001|Double-blind Period|Lack of Efficacy|0|||
16830890|NCT02154347|37774224|FG000|Double-blind Period|Physician Decision|0|||
16830891|NCT02154347|37774225|FG001|Double-blind Period|Physician Decision|1|||
16830892|NCT02154347|37774224|FG000|Double-blind Period|Withdrawal by Subject|1|||
16830893|NCT02154347|37774225|FG001|Double-blind Period|Withdrawal by Subject|1|||
16830894|NCT02154347|37774224|FG000|Open-label Period|Adverse Event|3|||
16830895|NCT02154347|37774225|FG001|Open-label Period|Adverse Event|4|||
16830896|NCT02154347|37774224|FG000|Open-label Period|Lack of Efficacy|4|||
16830897|NCT02154347|37774225|FG001|Open-label Period|Lack of Efficacy|19|||
16830898|NCT02154347|37774224|FG000|Open-label Period|Protocol Violation|0|||
16830899|NCT02154347|37774225|FG001|Open-label Period|Protocol Violation|1|||
16830900|NCT02154347|37774224|FG000|Open-label Period|Withdrawal by Subject|0|||
16830901|NCT02154347|37774225|FG001|Open-label Period|Withdrawal by Subject|1|||
16830902|NCT01627067|37774232|FG000|Overall Study|Screen Failure|1|||
16830903|NCT02178059|37774238|FG000|Washout|Physician Decision|1|||
16830904|NCT02178059|37774239|FG001|Washout|Physician Decision|0|||
16830905|NCT01626989|37774245|FG000|Screening Period|Screen Failure|15|||
16830906|NCT01626989|37774246|FG001|Screening Period|Screen Failure|0|||
16830907|NCT01626989|37774247|FG002|Screening Period|Screen Failure|0|||
16830908|NCT01626989|37774245|FG000|Screening Period|Withdrawal by Subject|2|||
16830909|NCT01626989|37774246|FG001|Screening Period|Withdrawal by Subject|0|||
16830910|NCT01626989|37774247|FG002|Screening Period|Withdrawal by Subject|0|||
16830911|NCT02128217|37774258|FG000|Overall Study|Lost to Follow-up|0|||
16830912|NCT02128217|37774259|FG001|Overall Study|Lost to Follow-up|1|||
16830913|NCT01629953|37774272|FG000|Overall Study|Death|3|||
16830914|NCT01629953|37774273|FG001|Overall Study|Death|1|||
16830915|NCT01629953|37774272|FG000|Overall Study|Lost to Follow-up|10|||
16830916|NCT01629953|37774273|FG001|Overall Study|Lost to Follow-up|14|||
16830917|NCT02127281|37774281|FG000|Overall Study|Lost to Follow-up|1|||
16830918|NCT02127281|37774282|FG001|Overall Study|Lost to Follow-up|0|||
16830919|NCT01628549|37774292|FG000|Overall Study|Adverse Event|1|||
16830920|NCT01628549|37774293|FG001|Overall Study|Adverse Event|1|||
16830921|NCT01628549|37774294|FG002|Overall Study|Adverse Event|0|||
16830922|NCT01628549|37774295|FG003|Overall Study|Adverse Event|4|||
16830923|NCT01628549|37774292|FG000|Overall Study|Lost to Follow-up|3|||
16830924|NCT01628549|37774293|FG001|Overall Study|Lost to Follow-up|4|||
16830925|NCT01628549|37774294|FG002|Overall Study|Lost to Follow-up|3|||
16830926|NCT01628549|37774295|FG003|Overall Study|Lost to Follow-up|3|||
16830927|NCT01628549|37774292|FG000|Overall Study|Withdrawal by Subject|3|||
16830928|NCT01628549|37774293|FG001|Overall Study|Withdrawal by Subject|4|||
16830929|NCT01628549|37774294|FG002|Overall Study|Withdrawal by Subject|4|||
16830930|NCT01628549|37774295|FG003|Overall Study|Withdrawal by Subject|1|||
16830931|NCT01628549|37774292|FG000|Overall Study|Protocol Violation|2|||
16830932|NCT01628549|37774293|FG001|Overall Study|Protocol Violation|1|||
16830933|NCT01628549|37774294|FG002|Overall Study|Protocol Violation|1|||
16830934|NCT01628549|37774295|FG003|Overall Study|Protocol Violation|0|||
16830935|NCT01628549|37774292|FG000|Overall Study|withdrawn for noncompliance|0|||
16830936|NCT01628549|37774293|FG001|Overall Study|withdrawn for noncompliance|2|||
16830937|NCT01628549|37774294|FG002|Overall Study|withdrawn for noncompliance|1|||
16830938|NCT01628549|37774295|FG003|Overall Study|withdrawn for noncompliance|0|||
16830939|NCT01628549|37774292|FG000|Overall Study|abnormal laboratory test results|0|||
16830940|NCT01628549|37774293|FG001|Overall Study|abnormal laboratory test results|0|||
16830941|NCT01628549|37774294|FG002|Overall Study|abnormal laboratory test results|1|||
16830942|NCT01628549|37774295|FG003|Overall Study|abnormal laboratory test results|0|||
16830943|NCT01628549|37774292|FG000|Overall Study|positive pregnancy test|0|||
16830944|NCT01628549|37774293|FG001|Overall Study|positive pregnancy test|0|||
16830945|NCT01628549|37774294|FG002|Overall Study|positive pregnancy test|0|||
16830946|NCT01628549|37774295|FG003|Overall Study|positive pregnancy test|1|||
16830947|NCT02127125|37774314|FG000|Overall Study|Lost to Follow-up|0|||
16830948|NCT02127125|37774315|FG001|Overall Study|Lost to Follow-up|0|||
16830949|NCT02127125|37774316|FG002|Overall Study|Lost to Follow-up|0|||
16830950|NCT02127125|37774317|FG003|Overall Study|Lost to Follow-up|0|||
16830951|NCT02127125|37774318|FG004|Overall Study|Lost to Follow-up|2|||
16830952|NCT02127125|37774319|FG005|Overall Study|Lost to Follow-up|1|||
16830953|NCT02127125|37774320|FG006|Overall Study|Lost to Follow-up|0|||
16830954|NCT02127125|37774321|FG007|Overall Study|Lost to Follow-up|0|||
16830955|NCT02127125|37774322|FG008|Overall Study|Lost to Follow-up|0|||
16830956|NCT02127125|37774314|FG000|Overall Study|Withdrawal by Subject|0|||
16830957|NCT02127125|37774315|FG001|Overall Study|Withdrawal by Subject|0|||
16830958|NCT02127125|37774316|FG002|Overall Study|Withdrawal by Subject|0|||
16830959|NCT02127125|37774317|FG003|Overall Study|Withdrawal by Subject|1|||
16830960|NCT02127125|37774318|FG004|Overall Study|Withdrawal by Subject|0|||
16830961|NCT02127125|37774319|FG005|Overall Study|Withdrawal by Subject|0|||
16830962|NCT02127125|37774320|FG006|Overall Study|Withdrawal by Subject|0|||
16830963|NCT02127125|37774321|FG007|Overall Study|Withdrawal by Subject|0|||
16830964|NCT02127125|37774322|FG008|Overall Study|Withdrawal by Subject|0|||
16830965|NCT02127125|37774314|FG000|Overall Study|Physician Decision|0|||
16830966|NCT02127125|37774315|FG001|Overall Study|Physician Decision|0|||
16830967|NCT02127125|37774316|FG002|Overall Study|Physician Decision|1|||
16830968|NCT02127125|37774317|FG003|Overall Study|Physician Decision|0|||
16830969|NCT02127125|37774318|FG004|Overall Study|Physician Decision|1|||
16830970|NCT02127125|37774319|FG005|Overall Study|Physician Decision|2|||
16830971|NCT02127125|37774320|FG006|Overall Study|Physician Decision|0|||
16830972|NCT02127125|37774321|FG007|Overall Study|Physician Decision|0|||
16830973|NCT02127125|37774322|FG008|Overall Study|Physician Decision|0|||
16830974|NCT02090413|37774345|FG000|Overall Study|Adverse Event|11|||
16830975|NCT02090413|37774346|FG001|Overall Study|Adverse Event|15|||
16830976|NCT02090413|37774347|FG002|Overall Study|Adverse Event|20|||
16830977|NCT02090413|37774345|FG000|Overall Study|Flushing event|2|||
16830978|NCT02090413|37774346|FG001|Overall Study|Flushing event|0|||
16830979|NCT02090413|37774347|FG002|Overall Study|Flushing event|1|||
16830980|NCT02090413|37774345|FG000|Overall Study|Withdrawal by Subject|2|||
16830981|NCT02090413|37774346|FG001|Overall Study|Withdrawal by Subject|2|||
16830982|NCT02090413|37774347|FG002|Overall Study|Withdrawal by Subject|2|||
16830983|NCT02090413|37774345|FG000|Overall Study|Investigator Decision|1|||
16830984|NCT02090413|37774346|FG001|Overall Study|Investigator Decision|1|||
16830985|NCT02090413|37774347|FG002|Overall Study|Investigator Decision|0|||
16830986|NCT02090413|37774345|FG000|Overall Study|Other|2|||
16830987|NCT02090413|37774346|FG001|Overall Study|Other|1|||
16830988|NCT02090413|37774347|FG002|Overall Study|Other|0|||
16830989|NCT02090413|37774345|FG000|Overall Study|Lost to Follow-up|1|||
16830990|NCT02090413|37774346|FG001|Overall Study|Lost to Follow-up|1|||
16830991|NCT02090413|37774347|FG002|Overall Study|Lost to Follow-up|0|||
16830992|NCT02063737|37774358|FG000|Overall Study|Lost to Follow-up|11|||
16830993|NCT02063737|37774359|FG001|Overall Study|Lost to Follow-up|4|||
16830994|NCT02125877|37774367|FG000|Overall Study|Physician Decision|1|||
16830995|NCT02125877|37774368|FG001|Overall Study|Physician Decision|0|||
16830996|NCT02125877|37774367|FG000|Overall Study|Death|0|||
16830997|NCT02125877|37774368|FG001|Overall Study|Death|1|||
16830998|NCT02125877|37774367|FG000|Overall Study|Administrative problems|0|||
16830999|NCT02125877|37774368|FG001|Overall Study|Administrative problems|1|||
16831000|NCT02125877|37774367|FG000|Overall Study|Participant/guardian decision|0|||
16831001|NCT02125877|37774368|FG001|Overall Study|Participant/guardian decision|2|||
16831002|NCT02125877|37774367|FG000|Overall Study|Withdrawal by Subject|2|||
16831003|NCT02125877|37774368|FG001|Overall Study|Withdrawal by Subject|1|||
16831004|NCT02125877|37774367|FG000|Overall Study|Protocol deviation|4|||
16831005|NCT02125877|37774368|FG001|Overall Study|Protocol deviation|1|||
16831006|NCT02125877|37774367|FG000|Overall Study|Adverse Event|6|||
16831007|NCT02125877|37774368|FG001|Overall Study|Adverse Event|4|||
16831008|NCT01598987|37774374|FG000|Baseline to Month 12|Administrative problems|2|||
16831009|NCT01598987|37774374|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
16831010|NCT01598987|37774374|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
16831011|NCT01598987|37774374|FG000|Baseline to 24 Month|Administrative problems|2|||
16831012|NCT01598987|37774374|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
16831013|NCT02063659|37774388|FG000|Double-Blind Treatment Period|Adverse Event|1|||
16831014|NCT02063659|37774389|FG001|Double-Blind Treatment Period|Adverse Event|2|||
16831015|NCT02063659|37774390|FG002|Double-Blind Treatment Period|Adverse Event|0|||
16831016|NCT02063659|37774391|FG003|Double-Blind Treatment Period|Adverse Event|0|||
16831017|NCT02063659|37774388|FG000|Double-Blind Treatment Period|Physician Decision|1|||
16831018|NCT02063659|37774389|FG001|Double-Blind Treatment Period|Physician Decision|0|||
17102411|NCT00383123|38241347|FG000|Overall Study|Protocol Violation|5|||
16831019|NCT02063659|37774390|FG002|Double-Blind Treatment Period|Physician Decision|0|||
16831020|NCT02063659|37774391|FG003|Double-Blind Treatment Period|Physician Decision|0|||
16831021|NCT02063659|37774388|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
16831022|NCT02063659|37774389|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
16831023|NCT02063659|37774390|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
16831024|NCT02063659|37774391|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
16831025|NCT02063659|37774388|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
16831026|NCT02063659|37774389|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
16831027|NCT02063659|37774390|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
16831028|NCT02063659|37774391|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
16831029|NCT02063659|37774388|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16831030|NCT02063659|37774389|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16831031|NCT02063659|37774390|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16831032|NCT02063659|37774391|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
16831033|NCT02063659|37774388|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16831034|NCT02063659|37774389|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16831035|NCT02063659|37774390|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16831036|NCT02063659|37774391|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
16831037|NCT02063659|37774388|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
16831038|NCT02063659|37774389|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
16831039|NCT02063659|37774390|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
16831040|NCT02063659|37774391|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
16831041|NCT02063659|37774388|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16831042|NCT02063659|37774389|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16831043|NCT02063659|37774390|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16831044|NCT02063659|37774391|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
16831045|NCT02062879|37774407|FG000|Overall Study|Withdrawal by Subject|4|||
16831046|NCT02062879|37774408|FG001|Overall Study|Withdrawal by Subject|1|||
16831047|NCT02062645|37774414|FG000|Overall Study|Adverse Event|2|||
16831048|NCT02062645|37774414|FG000|Overall Study|Protocol Violation|8|||
16831049|NCT02062645|37774414|FG000|Overall Study|Lost to Follow-up|5|||
16831050|NCT02088697|37774420|FG000|Period I|Physician Decision|1|||
16831051|NCT02088697|37774421|FG001|Period I|Physician Decision|4|||
16831052|NCT02088697|37774420|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
16831053|NCT02088697|37774421|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
16831054|NCT01825785|37774434|FG000|Overall Study|Adverse Event|0|||
16831055|NCT01825785|37774435|FG001|Overall Study|Adverse Event|0|||
16831056|NCT01825785|37774436|FG002|Overall Study|Adverse Event|0|||
16831057|NCT01825785|37774437|FG003|Overall Study|Adverse Event|0|||
16831058|NCT01825785|37774438|FG004|Overall Study|Adverse Event|1|||
16831059|NCT01825785|37774439|FG005|Overall Study|Adverse Event|0|||
16831060|NCT01825785|37774440|FG006|Overall Study|Adverse Event|0|||
16831061|NCT01825785|37774434|FG000|Overall Study|Withdrawal by Subject|0|||
16831062|NCT01825785|37774435|FG001|Overall Study|Withdrawal by Subject|0|||
16831063|NCT01825785|37774436|FG002|Overall Study|Withdrawal by Subject|0|||
16831064|NCT01825785|37774437|FG003|Overall Study|Withdrawal by Subject|0|||
16831065|NCT01825785|37774438|FG004|Overall Study|Withdrawal by Subject|1|||
16831066|NCT01825785|37774439|FG005|Overall Study|Withdrawal by Subject|1|||
16831067|NCT01825785|37774440|FG006|Overall Study|Withdrawal by Subject|0|||
16831068|NCT02043301|37774465|FG000|Overall Study|Discontinued|0|||
16831069|NCT02043301|37774466|FG001|Overall Study|Discontinued|1|||
16831070|NCT02043301|37774467|FG002|Overall Study|Discontinued|0|||
16831071|NCT01598753|37774479|FG000|Overall Study|Adverse Event|1|||
16831072|NCT01598753|37774480|FG001|Overall Study|Adverse Event|9|||
16831073|NCT01598753|37774481|FG002|Overall Study|Adverse Event|1|||
16831074|NCT01598753|37774482|FG003|Overall Study|Adverse Event|7|||
16831075|NCT01598753|37774479|FG000|Overall Study|Lost to Follow-up|4|||
16831076|NCT01598753|37774480|FG001|Overall Study|Lost to Follow-up|3|||
16831077|NCT01598753|37774481|FG002|Overall Study|Lost to Follow-up|7|||
16831078|NCT01598753|37774482|FG003|Overall Study|Lost to Follow-up|5|||
16831079|NCT01598753|37774479|FG000|Overall Study|Physician Decision|0|||
16831080|NCT01598753|37774480|FG001|Overall Study|Physician Decision|1|||
16831081|NCT01598753|37774481|FG002|Overall Study|Physician Decision|0|||
16831082|NCT01598753|37774482|FG003|Overall Study|Physician Decision|2|||
16831083|NCT01598753|37774479|FG000|Overall Study|Withdrawal by Subject|7|||
16831084|NCT01598753|37774480|FG001|Overall Study|Withdrawal by Subject|2|||
16831085|NCT01598753|37774481|FG002|Overall Study|Withdrawal by Subject|0|||
16831086|NCT01598753|37774482|FG003|Overall Study|Withdrawal by Subject|1|||
16831087|NCT02177123|37774492|FG000|Overall Study|Lost to Follow-up|6|||
16831088|NCT02177123|37774492|FG000|Overall Study|Withdrawal by Subject|4|||
16831089|NCT02177123|37774492|FG000|Overall Study|Adverse Event|4|||
16831090|NCT02177123|37774492|FG000|Overall Study|Physician Decision|3|||
16831091|NCT02177123|37774492|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
16831092|NCT02177123|37774492|FG000|Overall Study|Excluded for medical reasons|2|||
16831093|NCT02177123|37774492|FG000|Overall Study|Death|1|||
16831094|NCT02177123|37774492|FG000|Overall Study|Other|1|||
16831095|NCT02177123|37774492|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
16831096|NCT01824693|37774502|FG000|Overall Study|Death|0|||
16831097|NCT01824693|37774503|FG001|Overall Study|Death|1|||
16831098|NCT01824693|37774504|FG002|Overall Study|Death|0|||
16831099|NCT01824693|37774502|FG000|Overall Study|Physician Decision|1|||
16831100|NCT01824693|37774503|FG001|Overall Study|Physician Decision|1|||
16831101|NCT01824693|37774504|FG002|Overall Study|Physician Decision|1|||
16831102|NCT01824693|37774502|FG000|Overall Study|Withdrawal by Subject|0|||
16831103|NCT01824693|37774503|FG001|Overall Study|Withdrawal by Subject|0|||
16831104|NCT01824693|37774504|FG002|Overall Study|Withdrawal by Subject|1|||
16831105|NCT01824693|37774502|FG000|Overall Study|Progressive Disease|0|||
16831106|NCT01824693|37774503|FG001|Overall Study|Progressive Disease|5|||
16831107|NCT01824693|37774504|FG002|Overall Study|Progressive Disease|0|||
16831108|NCT01824693|37774502|FG000|Overall Study|Ineligible|0|||
16831109|NCT01824693|37774503|FG001|Overall Study|Ineligible|0|||
16831110|NCT01824693|37774504|FG002|Overall Study|Ineligible|3|||
16831111|NCT01824693|37774502|FG000|Overall Study|No Transplant Planned|0|||
16831112|NCT01824693|37774503|FG001|Overall Study|No Transplant Planned|0|||
16831113|NCT01824693|37774504|FG002|Overall Study|No Transplant Planned|10|||
16831114|NCT02176655|37774511|FG000|Overall Study|Subjects did not treat|6|||
16831115|NCT02125331|37774518|FG000|Overall Study|Protocol Violation|1|||
16831116|NCT02125331|37774519|FG001|Overall Study|Protocol Violation|0|||
16831117|NCT02125331|37774518|FG000|Overall Study|technical problem|2|||
16831118|NCT02125331|37774519|FG001|Overall Study|technical problem|0|||
16831119|NCT02125331|37774518|FG000|Overall Study|screen failure|2|||
16831120|NCT02125331|37774519|FG001|Overall Study|screen failure|0|||
16831121|NCT01853475|37774528|FG000|Overall Study|Withdrawal by Subject|0|||
16831122|NCT01853475|37774529|FG001|Overall Study|Withdrawal by Subject|1|||
16831123|NCT01853475|37774530|FG002|Overall Study|Withdrawal by Subject|0|||
16831124|NCT01622569|37774542|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
16831125|NCT01622569|37774543|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
16831126|NCT01622569|37774544|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
16831127|NCT01622569|37774545|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
16831128|NCT01622569|37774542|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
16831129|NCT01622569|37774543|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
16831130|NCT01622569|37774544|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
16831131|NCT01622569|37774545|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
16831132|NCT01622569|37774542|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
16831133|NCT01622569|37774543|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
16831134|NCT01622569|37774544|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
16831135|NCT01622569|37774545|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
16831136|NCT01622569|37774542|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16831137|NCT01622569|37774543|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
16831138|NCT01622569|37774544|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16831139|NCT01622569|37774545|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
16831140|NCT01622569|37774542|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
16831141|NCT01622569|37774543|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
16831142|NCT01622569|37774544|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
16831143|NCT01622569|37774545|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
16831144|NCT01622569|37774542|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
16831145|NCT01622569|37774543|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
16831146|NCT01622569|37774544|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
16831147|NCT01622569|37774545|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
16831148|NCT01622569|37774542|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
16831149|NCT01622569|37774543|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
16831150|NCT01622569|37774544|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
16831151|NCT01622569|37774545|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
16831152|NCT01622569|37774542|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16831153|NCT01622569|37774543|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16831154|NCT01622569|37774544|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16831155|NCT01622569|37774545|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
16831156|NCT01824303|37774567|FG000|Randomized Study|Withdrawal by Subject|1|||
16831157|NCT01824303|37774568|FG001|Randomized Study|Withdrawal by Subject|1|||
16831158|NCT01824303|37774567|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
16831159|NCT01824303|37774568|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
16831160|NCT01853397|37774580|FG000|Overall Study|Withdrawal by Subject|0|||
16831161|NCT01853397|37774581|FG001|Overall Study|Withdrawal by Subject|0|||
16831162|NCT01853397|37774582|FG002|Overall Study|Withdrawal by Subject|0|||
16831163|NCT01853397|37774583|FG003|Overall Study|Withdrawal by Subject|1|||
16831164|NCT01853397|37774580|FG000|Overall Study|Subject Noncompliance|0|||
16831165|NCT01853397|37774581|FG001|Overall Study|Subject Noncompliance|0|||
16831166|NCT01853397|37774582|FG002|Overall Study|Subject Noncompliance|0|||
16831167|NCT01853397|37774583|FG003|Overall Study|Subject Noncompliance|1|||
16831168|NCT02088073|37774598|FG000|Acute Phase|Withdrawal by Subject|5|||
16831169|NCT02088073|37774599|FG001|Acute Phase|Withdrawal by Subject|0|||
16831170|NCT02088073|37774600|FG002|Acute Phase|Withdrawal by Subject|0|||
16831171|NCT02088073|37774601|FG003|Acute Phase|Withdrawal by Subject|0|||
16831172|NCT02088073|37774602|FG004|Acute Phase|Withdrawal by Subject|0|||
16831173|NCT02088073|37774598|FG000|Acute Phase|Hyperkalemia|2|||
16831174|NCT02088073|37774599|FG001|Acute Phase|Hyperkalemia|0|||
16831175|NCT02088073|37774600|FG002|Acute Phase|Hyperkalemia|0|||
16831176|NCT02088073|37774601|FG003|Acute Phase|Hyperkalemia|0|||
16831177|NCT02088073|37774602|FG004|Acute Phase|Hyperkalemia|0|||
16831178|NCT02088073|37774598|FG000|Maintanance Phase|Withdrawal by Subject|0|||
16831179|NCT02088073|37774599|FG001|Maintanance Phase|Withdrawal by Subject|2|||
16831180|NCT02088073|37774600|FG002|Maintanance Phase|Withdrawal by Subject|0|||
16831181|NCT02088073|37774601|FG003|Maintanance Phase|Withdrawal by Subject|0|||
16831182|NCT02088073|37774602|FG004|Maintanance Phase|Withdrawal by Subject|0|||
16831183|NCT02088073|37774598|FG000|Maintanance Phase|Adverse Event|0|||
16831184|NCT02088073|37774599|FG001|Maintanance Phase|Adverse Event|0|||
16831185|NCT02088073|37774600|FG002|Maintanance Phase|Adverse Event|3|||
16831186|NCT02088073|37774601|FG003|Maintanance Phase|Adverse Event|0|||
16831187|NCT02088073|37774602|FG004|Maintanance Phase|Adverse Event|1|||
16831188|NCT02088073|37774598|FG000|Maintanance Phase|Physician Decision|0|||
16831189|NCT02088073|37774599|FG001|Maintanance Phase|Physician Decision|0|||
16831190|NCT02088073|37774600|FG002|Maintanance Phase|Physician Decision|0|||
16831191|NCT02088073|37774601|FG003|Maintanance Phase|Physician Decision|0|||
16831192|NCT02088073|37774602|FG004|Maintanance Phase|Physician Decision|1|||
16831193|NCT02088073|37774598|FG000|Maintanance Phase|Sponsor's decision|0|||
16831194|NCT02088073|37774599|FG001|Maintanance Phase|Sponsor's decision|2|||
16831195|NCT02088073|37774600|FG002|Maintanance Phase|Sponsor's decision|0|||
16831196|NCT02088073|37774601|FG003|Maintanance Phase|Sponsor's decision|2|||
16831197|NCT02088073|37774602|FG004|Maintanance Phase|Sponsor's decision|1|||
16831198|NCT02088073|37774598|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
16831199|NCT02088073|37774599|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
16831200|NCT02088073|37774600|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
16831201|NCT02088073|37774601|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
16831202|NCT02088073|37774602|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
16831203|NCT02088073|37774598|FG000|Maintanance Phase|Miscellaneous|0|||
16831204|NCT02088073|37774599|FG001|Maintanance Phase|Miscellaneous|2|||
16831205|NCT02088073|37774600|FG002|Maintanance Phase|Miscellaneous|1|||
16831206|NCT02088073|37774601|FG003|Maintanance Phase|Miscellaneous|2|||
16831207|NCT02088073|37774602|FG004|Maintanance Phase|Miscellaneous|1|||
16831208|NCT02088073|37774598|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
16831209|NCT02088073|37774599|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
16831210|NCT02088073|37774600|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
16831211|NCT02088073|37774601|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
16831212|NCT02088073|37774602|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
16831213|NCT02088073|37774598|FG000|Maintanance Phase|Subject compliance|0|||
16831214|NCT02088073|37774599|FG001|Maintanance Phase|Subject compliance|1|||
16831215|NCT02088073|37774600|FG002|Maintanance Phase|Subject compliance|0|||
16831216|NCT02088073|37774601|FG003|Maintanance Phase|Subject compliance|0|||
16831217|NCT02088073|37774602|FG004|Maintanance Phase|Subject compliance|0|||
16831218|NCT01823991|37774617|FG000|Overall Study|Withdrawal by Subject|8|||
16831219|NCT01823991|37774618|FG001|Overall Study|Withdrawal by Subject|5|||
16831220|NCT02087059|37774628|FG000|Overall Study|Disease Progression|1|||
16831221|NCT02087059|37774628|FG000|Overall Study|Adverse Event|5|||
16831222|NCT02087059|37774628|FG000|Overall Study|Lost to Follow-up|1|||
16831223|NCT02152631|37774634|FG000|Overall Study|Adverse Event|32|||
16831224|NCT02152631|37774635|FG001|Overall Study|Adverse Event|4|||
16831225|NCT02152631|37774634|FG000|Overall Study|Withdrawal by Subject|13|||
16831226|NCT02152631|37774635|FG001|Overall Study|Withdrawal by Subject|16|||
16831227|NCT02152631|37774634|FG000|Overall Study|Noncompliance with study drug|1|||
16831228|NCT02152631|37774635|FG001|Overall Study|Noncompliance with study drug|0|||
16831229|NCT02152631|37774634|FG000|Overall Study|Physician Decision|1|||
16831230|NCT02152631|37774635|FG001|Overall Study|Physician Decision|2|||
16831231|NCT02152631|37774634|FG000|Overall Study|Lost to Follow-up|0|||
16831232|NCT02152631|37774635|FG001|Overall Study|Lost to Follow-up|1|||
16831233|NCT02152631|37774634|FG000|Overall Study|On Treatment|19|||
16831234|NCT02152631|37774635|FG001|Overall Study|On Treatment|3|||
16831235|NCT02152163|37774643|FG000|Overall Study|Physician Decision|12|||
16831236|NCT02152163|37774644|FG001|Overall Study|Physician Decision|13|||
16831237|NCT02152007|37774650|FG000|Overall Study|Withdrawal by Subject|1|||
16831238|NCT02151851|37774657|FG000|Overall Study|Lack of Efficacy|67|||
16831239|NCT02151851|37774658|FG001|Overall Study|Lack of Efficacy|94|||
16831240|NCT02151851|37774657|FG000|Overall Study|Protocol Violation|0|||
16831241|NCT02151851|37774658|FG001|Overall Study|Protocol Violation|1|||
16831242|NCT02151851|37774657|FG000|Overall Study|Withdrawal by Subject|2|||
16831243|NCT02151851|37774658|FG001|Overall Study|Withdrawal by Subject|5|||
16831244|NCT02151851|37774657|FG000|Overall Study|Medical impairment|1|||
16831245|NCT02151851|37774658|FG001|Overall Study|Medical impairment|0|||
16831246|NCT02151851|37774657|FG000|Overall Study|Low compliance to study visits|0|||
16831247|NCT02151851|37774658|FG001|Overall Study|Low compliance to study visits|1|||
16831248|NCT02151851|37774657|FG000|Overall Study|Subject entered into study in error|0|||
16831249|NCT02151851|37774658|FG001|Overall Study|Subject entered into study in error|1|||
16831250|NCT02151851|37774657|FG000|Overall Study|Adverse Event|6|||
16831251|NCT02151851|37774658|FG001|Overall Study|Adverse Event|28|||
16831252|NCT02176421|37774664|FG000|Overall Study|Lost to Follow-up|4|||
16831253|NCT02176421|37774664|FG000|Overall Study|Adverse Event|1|||
16831254|NCT02042443|37774670|FG000|Overall Study|Adverse Event|2|||
16831255|NCT02042443|37774671|FG001|Overall Study|Adverse Event|1|||
16831256|NCT02042443|37774670|FG000|Overall Study|Withdrawal by Subject|0|||
16831257|NCT02042443|37774671|FG001|Overall Study|Withdrawal by Subject|1|||
16831258|NCT02042443|37774670|FG000|Overall Study|Progression|21|||
16831259|NCT02042443|37774671|FG001|Overall Study|Progression|17|||
16831260|NCT02042443|37774670|FG000|Overall Study|not protocol specified|1|||
16831261|NCT02042443|37774671|FG001|Overall Study|not protocol specified|1|||
16831262|NCT02042443|37774670|FG000|Overall Study|Not eligible/not analyzable|3|||
16831263|NCT02042443|37774671|FG001|Overall Study|Not eligible/not analyzable|6|||
16831264|NCT02118896|37774688|FG000|Overall Study|Death|4|||
16831265|NCT02118896|37774689|FG001|Overall Study|Death|0|||
16831266|NCT02118896|37774690|FG002|Overall Study|Death|4|||
16831267|NCT02118896|37774691|FG003|Overall Study|Death|6|||
16831268|NCT02118896|37774692|FG004|Overall Study|Death|3|||
16831269|NCT02118896|37774693|FG005|Overall Study|Death|1|||
16831270|NCT02118896|37774694|FG006|Overall Study|Death|0|||
16831271|NCT02118896|37774695|FG007|Overall Study|Death|0|||
16831272|NCT02118896|37774696|FG008|Overall Study|Death|0|||
16831273|NCT02118896|37774697|FG009|Overall Study|Death|0|||
16831274|NCT02118896|37774688|FG000|Overall Study|Adverse Event|5|||
16831275|NCT02118896|37774689|FG001|Overall Study|Adverse Event|4|||
16831276|NCT02118896|37774690|FG002|Overall Study|Adverse Event|4|||
16831277|NCT02118896|37774691|FG003|Overall Study|Adverse Event|5|||
16831278|NCT02118896|37774692|FG004|Overall Study|Adverse Event|5|||
16831279|NCT02118896|37774693|FG005|Overall Study|Adverse Event|9|||
16831280|NCT02118896|37774694|FG006|Overall Study|Adverse Event|1|||
16831281|NCT02118896|37774695|FG007|Overall Study|Adverse Event|1|||
16831282|NCT02118896|37774696|FG008|Overall Study|Adverse Event|4|||
16831283|NCT02118896|37774697|FG009|Overall Study|Adverse Event|0|||
16831284|NCT02118896|37774688|FG000|Overall Study|Consent withdrawn|2|||
16831285|NCT02118896|37774689|FG001|Overall Study|Consent withdrawn|0|||
16831286|NCT02118896|37774690|FG002|Overall Study|Consent withdrawn|3|||
16831287|NCT02118896|37774691|FG003|Overall Study|Consent withdrawn|4|||
16831288|NCT02118896|37774692|FG004|Overall Study|Consent withdrawn|1|||
16831289|NCT02118896|37774693|FG005|Overall Study|Consent withdrawn|4|||
16831290|NCT02118896|37774694|FG006|Overall Study|Consent withdrawn|0|||
16831291|NCT02118896|37774695|FG007|Overall Study|Consent withdrawn|0|||
16831292|NCT02118896|37774696|FG008|Overall Study|Consent withdrawn|0|||
16831293|NCT02118896|37774697|FG009|Overall Study|Consent withdrawn|0|||
16831294|NCT02118896|37774688|FG000|Overall Study|Non-compliance|2|||
16831295|NCT02118896|37774689|FG001|Overall Study|Non-compliance|1|||
16831296|NCT02118896|37774690|FG002|Overall Study|Non-compliance|1|||
16831297|NCT02118896|37774691|FG003|Overall Study|Non-compliance|5|||
16831298|NCT02118896|37774692|FG004|Overall Study|Non-compliance|0|||
16831299|NCT02118896|37774693|FG005|Overall Study|Non-compliance|1|||
16831300|NCT02118896|37774694|FG006|Overall Study|Non-compliance|0|||
16831301|NCT02118896|37774695|FG007|Overall Study|Non-compliance|1|||
16831302|NCT02118896|37774696|FG008|Overall Study|Non-compliance|0|||
16831303|NCT02118896|37774697|FG009|Overall Study|Non-compliance|0|||
16831304|NCT02118896|37774688|FG000|Overall Study|Pregnancy|1|||
16831305|NCT02118896|37774689|FG001|Overall Study|Pregnancy|1|||
16831306|NCT02118896|37774690|FG002|Overall Study|Pregnancy|0|||
16831307|NCT02118896|37774691|FG003|Overall Study|Pregnancy|0|||
16831308|NCT02118896|37774692|FG004|Overall Study|Pregnancy|1|||
16831309|NCT02118896|37774693|FG005|Overall Study|Pregnancy|3|||
16831310|NCT02118896|37774694|FG006|Overall Study|Pregnancy|1|||
16831311|NCT02118896|37774695|FG007|Overall Study|Pregnancy|0|||
16831312|NCT02118896|37774696|FG008|Overall Study|Pregnancy|0|||
16831313|NCT02118896|37774697|FG009|Overall Study|Pregnancy|0|||
16831314|NCT02118896|37774688|FG000|Overall Study|Lost to Follow-up|1|||
16831315|NCT02118896|37774689|FG001|Overall Study|Lost to Follow-up|2|||
16831316|NCT02118896|37774690|FG002|Overall Study|Lost to Follow-up|1|||
16831317|NCT02118896|37774691|FG003|Overall Study|Lost to Follow-up|0|||
16831318|NCT02118896|37774692|FG004|Overall Study|Lost to Follow-up|2|||
16831319|NCT02118896|37774693|FG005|Overall Study|Lost to Follow-up|1|||
16831320|NCT02118896|37774694|FG006|Overall Study|Lost to Follow-up|0|||
16831321|NCT02118896|37774695|FG007|Overall Study|Lost to Follow-up|0|||
16831322|NCT02118896|37774696|FG008|Overall Study|Lost to Follow-up|0|||
16831323|NCT02118896|37774697|FG009|Overall Study|Lost to Follow-up|0|||
16831324|NCT02118896|37774688|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
16831325|NCT02118896|37774689|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
16831326|NCT02118896|37774690|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
16831327|NCT02118896|37774691|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
16831328|NCT02118896|37774692|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
16831329|NCT02118896|37774693|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
16831330|NCT02118896|37774694|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
16831331|NCT02118896|37774695|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
16831332|NCT02118896|37774696|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
16831333|NCT02118896|37774697|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
16831334|NCT02118896|37774688|FG000|Overall Study|Prohibited medication|0|||
16831335|NCT02118896|37774689|FG001|Overall Study|Prohibited medication|0|||
16831336|NCT02118896|37774690|FG002|Overall Study|Prohibited medication|0|||
16831337|NCT02118896|37774691|FG003|Overall Study|Prohibited medication|0|||
16831338|NCT02118896|37774692|FG004|Overall Study|Prohibited medication|1|||
16831339|NCT02118896|37774693|FG005|Overall Study|Prohibited medication|3|||
16831340|NCT02118896|37774694|FG006|Overall Study|Prohibited medication|0|||
16831341|NCT02118896|37774695|FG007|Overall Study|Prohibited medication|0|||
16831342|NCT02118896|37774696|FG008|Overall Study|Prohibited medication|0|||
16831343|NCT02118896|37774697|FG009|Overall Study|Prohibited medication|0|||
16831344|NCT02118896|37774688|FG000|Overall Study|Miscellaneous|1|||
16831345|NCT02118896|37774689|FG001|Overall Study|Miscellaneous|2|||
16831346|NCT02118896|37774690|FG002|Overall Study|Miscellaneous|0|||
16831347|NCT02118896|37774691|FG003|Overall Study|Miscellaneous|2|||
16831348|NCT02118896|37774692|FG004|Overall Study|Miscellaneous|0|||
16831349|NCT02118896|37774693|FG005|Overall Study|Miscellaneous|4|||
16831350|NCT02118896|37774694|FG006|Overall Study|Miscellaneous|0|||
16831351|NCT02118896|37774695|FG007|Overall Study|Miscellaneous|0|||
16831352|NCT02118896|37774696|FG008|Overall Study|Miscellaneous|0|||
16831353|NCT02118896|37774697|FG009|Overall Study|Miscellaneous|0|||
16831354|NCT02124707|37774720|FG000|Overall Study|Adverse Event|5|||
16831355|NCT02124707|37774720|FG000|Overall Study|Physician Decision|1|||
16831356|NCT02124707|37774720|FG000|Overall Study|Death|1|||
16831357|NCT02067728|37774727|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
16831358|NCT02067728|37774728|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
16831359|NCT02067728|37774727|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
16831360|NCT02067728|37774728|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
16831361|NCT02067728|37774727|FG000|6 Month Measurements|Unable to attend|114|||
16831362|NCT02067728|37774728|FG001|6 Month Measurements|Unable to attend|97|||
16831363|NCT02118428|37774736|FG000|Overall Study|Physician Decision|0|||
16831364|NCT02118428|37774737|FG001|Overall Study|Physician Decision|1|||
16831365|NCT02118428|37774738|FG002|Overall Study|Physician Decision|0|||
16831366|NCT02118428|37774736|FG000|Overall Study|Withdrawal by Subject|2|||
16831367|NCT02118428|37774737|FG001|Overall Study|Withdrawal by Subject|2|||
16831368|NCT02118428|37774738|FG002|Overall Study|Withdrawal by Subject|0|||
16831369|NCT02118428|37774736|FG000|Overall Study|Death|7|||
16831370|NCT02118428|37774737|FG001|Overall Study|Death|5|||
16831371|NCT02118428|37774738|FG002|Overall Study|Death|0|||
16831372|NCT02118428|37774736|FG000|Overall Study|Lost to Follow-up|3|||
16831373|NCT02118428|37774737|FG001|Overall Study|Lost to Follow-up|1|||
16831374|NCT02118428|37774738|FG002|Overall Study|Lost to Follow-up|0|||
16831375|NCT02118428|37774736|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
16831376|NCT02118428|37774737|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
16831377|NCT02118428|37774738|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
16831378|NCT02067104|37774746|FG000|Overall Study|Study termination due to low accrual|4|||
16831379|NCT02067104|37774747|FG001|Overall Study|Study termination due to low accrual|5|||
16831380|NCT02092220|37774753|FG000|Period 1|Unrelated Illness|0|||
16831381|NCT02092220|37774754|FG001|Period 1|Unrelated Illness|2|||
16831382|NCT02092220|37774753|FG000|Period 2|Severe Hypoglycaemia|1|||
16831383|NCT02092220|37774754|FG001|Period 2|Severe Hypoglycaemia|0|||
16831384|NCT02092220|37774753|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
16831385|NCT02092220|37774754|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
16831386|NCT02066402|37774764|FG000|Overall Study|Adverse Event|1|||
16831387|NCT02066402|37774765|FG001|Overall Study|Adverse Event|2|||
16831388|NCT02066402|37774764|FG000|Overall Study|Lost to Follow-up|11|||
16831389|NCT02066402|37774765|FG001|Overall Study|Lost to Follow-up|8|||
16831390|NCT02066402|37774764|FG000|Overall Study|Withdrawal by Subject|14|||
16831391|NCT02066402|37774765|FG001|Overall Study|Withdrawal by Subject|11|||
16831392|NCT02066402|37774764|FG000|Overall Study|Progressive disease-clinical progression|0|||
16831393|NCT02066402|37774765|FG001|Overall Study|Progressive disease-clinical progression|1|||
16831394|NCT02066402|37774764|FG000|Overall Study|Protocol driven decision point|0|||
16831395|NCT02066402|37774765|FG001|Overall Study|Protocol driven decision point|1|||
16831396|NCT02060383|37774776|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
16831397|NCT02060383|37774777|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
16831398|NCT02060383|37774778|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
16831399|NCT02060383|37774779|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
16831400|NCT02060383|37774780|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
16831401|NCT02060383|37774776|FG000|Core Phase|Adverse Event|2|||
16831402|NCT02060383|37774777|FG001|Core Phase|Adverse Event|0|||
16831403|NCT02060383|37774778|FG002|Core Phase|Adverse Event|0|||
16831404|NCT02060383|37774779|FG003|Core Phase|Adverse Event|2|||
16831405|NCT02060383|37774780|FG004|Core Phase|Adverse Event|6|||
16831406|NCT02060383|37774776|FG000|Core Phase|Administrative problems|0|||
16831407|NCT02060383|37774777|FG001|Core Phase|Administrative problems|1|||
16831408|NCT02060383|37774778|FG002|Core Phase|Administrative problems|0|||
16831409|NCT02060383|37774779|FG003|Core Phase|Administrative problems|0|||
16831410|NCT02060383|37774780|FG004|Core Phase|Administrative problems|0|||
16831411|NCT02060383|37774776|FG000|Core Phase|Protocol Violation|0|||
16831412|NCT02060383|37774777|FG001|Core Phase|Protocol Violation|0|||
16831413|NCT02060383|37774778|FG002|Core Phase|Protocol Violation|0|||
16831414|NCT02060383|37774779|FG003|Core Phase|Protocol Violation|1|||
16831415|NCT02060383|37774780|FG004|Core Phase|Protocol Violation|0|||
16831416|NCT02060383|37774776|FG000|Core Phase|Withdrawal by Subject|0|||
16831417|NCT02060383|37774777|FG001|Core Phase|Withdrawal by Subject|0|||
16831418|NCT02060383|37774778|FG002|Core Phase|Withdrawal by Subject|0|||
16831419|NCT02060383|37774779|FG003|Core Phase|Withdrawal by Subject|4|||
16831420|NCT02060383|37774780|FG004|Core Phase|Withdrawal by Subject|2|||
16831421|NCT02060383|37774776|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
16831422|NCT02060383|37774777|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
16831423|NCT02060383|37774778|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
16831424|NCT02060383|37774779|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
16831425|NCT02060383|37774780|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
16831426|NCT02060383|37774776|FG000|Extension Phase|Adverse Event|1|||
16831427|NCT02060383|37774777|FG001|Extension Phase|Adverse Event|1|||
16831428|NCT02060383|37774778|FG002|Extension Phase|Adverse Event|2|||
16831429|NCT02060383|37774779|FG003|Extension Phase|Adverse Event|0|||
16831430|NCT02060383|37774780|FG004|Extension Phase|Adverse Event|1|||
16831431|NCT02060383|37774776|FG000|Extension Phase|Withdrawal by Subject|0|||
16831432|NCT02060383|37774777|FG001|Extension Phase|Withdrawal by Subject|1|||
16831433|NCT02060383|37774778|FG002|Extension Phase|Withdrawal by Subject|0|||
16831434|NCT02060383|37774779|FG003|Extension Phase|Withdrawal by Subject|0|||
16831435|NCT02060383|37774780|FG004|Extension Phase|Withdrawal by Subject|2|||
16831436|NCT02060383|37774776|FG000|Extension Phase|Administrative problems|1|||
16831437|NCT02060383|37774777|FG001|Extension Phase|Administrative problems|0|||
16831438|NCT02060383|37774778|FG002|Extension Phase|Administrative problems|0|||
16831439|NCT02060383|37774779|FG003|Extension Phase|Administrative problems|0|||
16831440|NCT02060383|37774780|FG004|Extension Phase|Administrative problems|0|||
16831441|NCT02060383|37774776|FG000|Extension Phase|Death|0|||
16831442|NCT02060383|37774777|FG001|Extension Phase|Death|0|||
16831443|NCT02060383|37774778|FG002|Extension Phase|Death|1|||
16831444|NCT02060383|37774779|FG003|Extension Phase|Death|0|||
16831445|NCT02060383|37774780|FG004|Extension Phase|Death|1|||
16831446|NCT02060383|37774776|FG000|Extension Phase|Protocol Violation|0|||
16831447|NCT02060383|37774777|FG001|Extension Phase|Protocol Violation|0|||
16831448|NCT02060383|37774778|FG002|Extension Phase|Protocol Violation|0|||
16831449|NCT02060383|37774779|FG003|Extension Phase|Protocol Violation|0|||
16831450|NCT02060383|37774780|FG004|Extension Phase|Protocol Violation|1|||
16831451|NCT02086591|37774792|FG000|Overall Study|Adverse Event|1|||
16831452|NCT02086591|37774792|FG000|Overall Study|Withdrawal by Subject|1|||
16831453|NCT02086591|37774792|FG000|Overall Study|protocol terminated|3|||
16831454|NCT02065622|37774798|FG000|Induction Study|Adverse Event|13|||
16831455|NCT02065622|37774799|FG001|Induction Study|Adverse Event|19|||
16831456|NCT02065622|37774800|FG002|Induction Study|Adverse Event|0|||
16831457|NCT02065622|37774801|FG003|Induction Study|Adverse Event|0|||
16831458|NCT02065622|37774802|FG004|Induction Study|Adverse Event|0|||
16831459|NCT02065622|37774798|FG000|Induction Study|Withdrawal by Subject|3|||
16831460|NCT02065622|37774799|FG001|Induction Study|Withdrawal by Subject|5|||
16831461|NCT02065622|37774800|FG002|Induction Study|Withdrawal by Subject|0|||
16831462|NCT02065622|37774801|FG003|Induction Study|Withdrawal by Subject|0|||
16831463|NCT02065622|37774802|FG004|Induction Study|Withdrawal by Subject|0|||
16831464|NCT02065622|37774798|FG000|Induction Study|Lost to Follow-up|1|||
16831465|NCT02065622|37774799|FG001|Induction Study|Lost to Follow-up|0|||
16831466|NCT02065622|37774800|FG002|Induction Study|Lost to Follow-up|0|||
16831467|NCT02065622|37774801|FG003|Induction Study|Lost to Follow-up|0|||
16831468|NCT02065622|37774802|FG004|Induction Study|Lost to Follow-up|0|||
16831469|NCT02065622|37774798|FG000|Induction Study|Lack of Efficacy|22|||
16831470|NCT02065622|37774799|FG001|Induction Study|Lack of Efficacy|27|||
16831471|NCT02065622|37774800|FG002|Induction Study|Lack of Efficacy|0|||
16831472|NCT02065622|37774801|FG003|Induction Study|Lack of Efficacy|0|||
16831473|NCT02065622|37774802|FG004|Induction Study|Lack of Efficacy|0|||
16831474|NCT02065622|37774798|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
16831475|NCT02065622|37774799|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
16831476|NCT02065622|37774800|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
16831477|NCT02065622|37774801|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
16831478|NCT02065622|37774802|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
16831479|NCT02065622|37774798|FG000|Induction Study|Subject Noncompliance|1|||
16831480|NCT02065622|37774799|FG001|Induction Study|Subject Noncompliance|1|||
16831481|NCT02065622|37774800|FG002|Induction Study|Subject Noncompliance|0|||
16831482|NCT02065622|37774801|FG003|Induction Study|Subject Noncompliance|0|||
16831483|NCT02065622|37774802|FG004|Induction Study|Subject Noncompliance|0|||
16831484|NCT02065622|37774798|FG000|Induction Study|Other, Not Specified|3|||
16831485|NCT02065622|37774799|FG001|Induction Study|Other, Not Specified|2|||
16831486|NCT02065622|37774800|FG002|Induction Study|Other, Not Specified|0|||
16831487|NCT02065622|37774801|FG003|Induction Study|Other, Not Specified|0|||
16831488|NCT02065622|37774802|FG004|Induction Study|Other, Not Specified|0|||
16831489|NCT02065622|37774798|FG000|Maintenance Study|Adverse Event|0|||
16831490|NCT02065622|37774799|FG001|Maintenance Study|Adverse Event|0|||
16831491|NCT02065622|37774800|FG002|Maintenance Study|Adverse Event|25|||
16831492|NCT02065622|37774801|FG003|Maintenance Study|Adverse Event|22|||
16831493|NCT02065622|37774802|FG004|Maintenance Study|Adverse Event|11|||
16831494|NCT02065622|37774798|FG000|Maintenance Study|Withdrawal by Subject|0|||
16831495|NCT02065622|37774799|FG001|Maintenance Study|Withdrawal by Subject|0|||
16831496|NCT02065622|37774800|FG002|Maintenance Study|Withdrawal by Subject|11|||
16831497|NCT02065622|37774801|FG003|Maintenance Study|Withdrawal by Subject|5|||
16831498|NCT02065622|37774802|FG004|Maintenance Study|Withdrawal by Subject|7|||
16831499|NCT02065622|37774798|FG000|Maintenance Study|Lost to Follow-up|0|||
16831500|NCT02065622|37774799|FG001|Maintenance Study|Lost to Follow-up|0|||
16831501|NCT02065622|37774800|FG002|Maintenance Study|Lost to Follow-up|4|||
16831502|NCT02065622|37774801|FG003|Maintenance Study|Lost to Follow-up|1|||
16831503|NCT02065622|37774802|FG004|Maintenance Study|Lost to Follow-up|1|||
16831504|NCT02065622|37774798|FG000|Maintenance Study|Lack of Efficacy|0|||
16831505|NCT02065622|37774799|FG001|Maintenance Study|Lack of Efficacy|0|||
16831506|NCT02065622|37774800|FG002|Maintenance Study|Lack of Efficacy|70|||
16831507|NCT02065622|37774801|FG003|Maintenance Study|Lack of Efficacy|55|||
16831508|NCT02065622|37774802|FG004|Maintenance Study|Lack of Efficacy|19|||
16831509|NCT02065622|37774798|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
16831510|NCT02065622|37774799|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
16831511|NCT02065622|37774800|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
16831512|NCT02065622|37774801|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
16831513|NCT02065622|37774802|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
16831514|NCT02065622|37774798|FG000|Maintenance Study|Subject Non-Compliance|0|||
16831515|NCT02065622|37774799|FG001|Maintenance Study|Subject Non-Compliance|0|||
16831516|NCT02065622|37774800|FG002|Maintenance Study|Subject Non-Compliance|1|||
16831517|NCT02065622|37774801|FG003|Maintenance Study|Subject Non-Compliance|3|||
16831518|NCT02065622|37774802|FG004|Maintenance Study|Subject Non-Compliance|2|||
16831519|NCT02065622|37774798|FG000|Maintenance Study|Other, Not Specified|0|||
16831520|NCT02065622|37774799|FG001|Maintenance Study|Other, Not Specified|0|||
16831521|NCT02065622|37774800|FG002|Maintenance Study|Other, Not Specified|6|||
16831522|NCT02065622|37774801|FG003|Maintenance Study|Other, Not Specified|14|||
16831523|NCT02065622|37774802|FG004|Maintenance Study|Other, Not Specified|2|||
16831524|NCT02065622|37774798|FG000|Maintenance Study|Unknown Reason|0|||
16831525|NCT02065622|37774799|FG001|Maintenance Study|Unknown Reason|0|||
16831526|NCT02065622|37774800|FG002|Maintenance Study|Unknown Reason|0|||
16831527|NCT02065622|37774801|FG003|Maintenance Study|Unknown Reason|1|||
16831528|NCT02065622|37774802|FG004|Maintenance Study|Unknown Reason|0|||
16831529|NCT02117648|37774817|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
16831530|NCT02117648|37774817|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
16831531|NCT02117648|37774817|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
16831532|NCT02117648|37774817|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
16831533|NCT02117648|37774817|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
16831534|NCT02117648|37774817|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
16831535|NCT02117648|37774817|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
16831536|NCT02117648|37774817|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
16831537|NCT02117648|37774817|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
16831538|NCT02117648|37774817|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
16831539|NCT02117648|37774817|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
16831540|NCT02124161|37774827|FG000|Overall Study|Other unspecified|0|||
16831541|NCT02124161|37774828|FG001|Overall Study|Other unspecified|1|||
16831542|NCT02124161|37774827|FG000|Overall Study|Death|1|||
16831543|NCT02124161|37774828|FG001|Overall Study|Death|0|||
16831544|NCT02124161|37774827|FG000|Overall Study|Protocol Violation|2|||
16831545|NCT02124161|37774828|FG001|Overall Study|Protocol Violation|1|||
16831546|NCT02124161|37774827|FG000|Overall Study|Withdrawal by Subject|1|||
16831547|NCT02124161|37774828|FG001|Overall Study|Withdrawal by Subject|2|||
16831548|NCT02124161|37774827|FG000|Overall Study|Adverse Event|2|||
16831549|NCT02124161|37774828|FG001|Overall Study|Adverse Event|0|||
16831550|NCT02124161|37774827|FG000|Overall Study|Does not meet entrance criteria|2|||
16831551|NCT02124161|37774828|FG001|Overall Study|Does not meet entrance criteria|3|||
16831552|NCT02124161|37774827|FG000|Overall Study|No longer meets eligibility criteria|5|||
16831553|NCT02124161|37774828|FG001|Overall Study|No longer meets eligibility criteria|4|||
16831554|NCT02124161|37774827|FG000|Overall Study|Lost to Follow-up|3|||
16831555|NCT02124161|37774828|FG001|Overall Study|Lost to Follow-up|4|||
16831556|NCT02175641|37774843|FG000|Overall Study|Death|3|||
16831557|NCT02175641|37774844|FG001|Overall Study|Death|4|||
16831558|NCT02175641|37774843|FG000|Overall Study|Lost to Follow-up|4|||
16831559|NCT02175641|37774844|FG001|Overall Study|Lost to Follow-up|4|||
16831560|NCT02175641|37774843|FG000|Overall Study|Withdrawal by Subject|7|||
16831561|NCT02175641|37774844|FG001|Overall Study|Withdrawal by Subject|4|||
16831562|NCT02175641|37774843|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
16831563|NCT02175641|37774844|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
16831564|NCT02175641|37774843|FG000|Overall Study|Developed Contraindicated Condition|8|||
16831565|NCT02175641|37774844|FG001|Overall Study|Developed Contraindicated Condition|0|||
16831566|NCT02117570|37774853|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
16831567|NCT02117570|37774854|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
16831568|NCT02117570|37774855|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
16831569|NCT02117570|37774853|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
16831570|NCT02117570|37774854|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
16831571|NCT02117570|37774855|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
16831572|NCT02117570|37774853|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
16831573|NCT02117570|37774854|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
16831574|NCT02117570|37774855|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
16831575|NCT02117570|37774853|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
16831576|NCT02117570|37774854|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
16831577|NCT02117570|37774855|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
16831578|NCT02117570|37774853|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
16831579|NCT02117570|37774854|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
16831580|NCT02117570|37774855|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
16831581|NCT02117570|37774853|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
16831582|NCT02117570|37774854|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
16831583|NCT02117570|37774855|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
16831584|NCT02117570|37774853|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
16831585|NCT02117570|37774854|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
16831586|NCT02117570|37774855|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
16831587|NCT02123459|37774866|FG000|Washout Period (1 Day)|Adverse Event|1|||
16831588|NCT02123459|37774867|FG001|Washout Period (1 Day)|Adverse Event|0|||
16831589|NCT02151773|37774873|FG000|Overall Study|Protocol Deviation|64|||
16831590|NCT02151461|37774881|FG000|Overall Study|Adverse Event|5|||
16831591|NCT02151461|37774882|FG001|Overall Study|Adverse Event|1|||
16831592|NCT02151461|37774883|FG002|Overall Study|Adverse Event|0|||
16831593|NCT02151461|37774884|FG003|Overall Study|Adverse Event|2|||
16831594|NCT02151461|37774881|FG000|Overall Study|Lost to Follow-up|0|||
16831595|NCT02151461|37774882|FG001|Overall Study|Lost to Follow-up|0|||
16831596|NCT02151461|37774883|FG002|Overall Study|Lost to Follow-up|1|||
16912308|NCT01500720|38021476|FG001|Overall Study|Randomized But Not Treated|1|||
16912309|NCT01500720|38021475|FG000|Overall Study|Other|4|||
16912310|NCT01500720|38021476|FG001|Overall Study|Other|8|||
16912311|NCT01500252|38021484|FG000|Overall Study|Death|4|||
16912312|NCT01500252|38021485|FG001|Overall Study|Death|2|||
16912313|NCT01500252|38021484|FG000|Overall Study|Lost to Follow-up|5|||
16912314|NCT01500252|38021485|FG001|Overall Study|Lost to Follow-up|4|||
16912315|NCT01476696|38021492|FG000|Overall Study|Sponsor decision|2|||
16912316|NCT01476696|38021493|FG001|Overall Study|Sponsor decision|1|||
16912317|NCT01476696|38021494|FG002|Overall Study|Sponsor decision|0|||
16912318|NCT01476696|38021492|FG000|Overall Study|Withdrawal by Subject|1|||
16912319|NCT01476696|38021493|FG001|Overall Study|Withdrawal by Subject|0|||
16912320|NCT01476696|38021494|FG002|Overall Study|Withdrawal by Subject|0|||
16912321|NCT01500096|38021511|FG000|Overall Study|Lost to Follow-up|1|||
16912322|NCT01500096|38021512|FG001|Overall Study|Lost to Follow-up|0|||
16912323|NCT01500096|38021513|FG002|Overall Study|Lost to Follow-up|0|||
16912324|NCT01500096|38021514|FG003|Overall Study|Lost to Follow-up|2|||
16912325|NCT01455012|38021526|FG000|Overall Study|Adverse Event|0|||
16912326|NCT01455012|38021527|FG001|Overall Study|Adverse Event|2|||
16912327|NCT01455012|38021526|FG000|Overall Study|Lack of Efficacy|6|||
16912328|NCT01455012|38021527|FG001|Overall Study|Lack of Efficacy|1|||
16912329|NCT01455012|38021526|FG000|Overall Study|Withdrawal by Subject|3|||
16912330|NCT01455012|38021527|FG001|Overall Study|Withdrawal by Subject|1|||
16912331|NCT01455012|38021526|FG000|Overall Study|Unknown reason|2|||
17102412|NCT00383123|38241348|FG001|Overall Study|Protocol Violation|1|||
16912332|NCT01455012|38021527|FG001|Overall Study|Unknown reason|0|||
16912333|NCT01454934|38021535|FG000|Overall Study|Clinical progression|28|||
16831597|NCT02151461|37774884|FG003|Overall Study|Lost to Follow-up|1|||
16831598|NCT02151461|37774881|FG000|Overall Study|Withdrawal by Subject|1|||
16831599|NCT02151461|37774882|FG001|Overall Study|Withdrawal by Subject|0|||
16831600|NCT02151461|37774883|FG002|Overall Study|Withdrawal by Subject|1|||
16831601|NCT02151461|37774884|FG003|Overall Study|Withdrawal by Subject|1|||
16831602|NCT02151461|37774881|FG000|Overall Study|Treatment discontinuation|0|||
16831603|NCT02151461|37774882|FG001|Overall Study|Treatment discontinuation|0|||
16831604|NCT02151461|37774883|FG002|Overall Study|Treatment discontinuation|1|||
16831605|NCT02151461|37774884|FG003|Overall Study|Treatment discontinuation|0|||
16831606|NCT02117414|37774896|FG000|Overall Study|Death|5|||
16831607|NCT02117414|37774897|FG001|Overall Study|Death|2|||
16831608|NCT02117414|37774896|FG000|Overall Study|Withdrawal by Subject|10|||
16831609|NCT02117414|37774897|FG001|Overall Study|Withdrawal by Subject|4|||
16831610|NCT02091986|37774908|FG000|Overall Study|7 rand in error 1 patient decision|2|||
16831611|NCT02091986|37774909|FG001|Overall Study|7 rand in error 1 patient decision|3|||
16831612|NCT02091986|37774910|FG002|Overall Study|7 rand in error 1 patient decision|3|||
16831613|NCT02091986|37774908|FG000|Overall Study|Lost to Follow-up|1|||
16831614|NCT02091986|37774909|FG001|Overall Study|Lost to Follow-up|0|||
16831615|NCT02091986|37774910|FG002|Overall Study|Lost to Follow-up|0|||
16831616|NCT02091986|37774908|FG000|Overall Study|Withdrawal by Subject|4|||
16831617|NCT02091986|37774909|FG001|Overall Study|Withdrawal by Subject|8|||
16831618|NCT02091986|37774910|FG002|Overall Study|Withdrawal by Subject|3|||
16831619|NCT02091986|37774908|FG000|Overall Study|Adverse Event|0|||
16831620|NCT02091986|37774909|FG001|Overall Study|Adverse Event|0|||
16831621|NCT02091986|37774910|FG002|Overall Study|Adverse Event|2|||
16831622|NCT02091752|37774918|FG000|Overall Study|Study terminated by Sponsor|2|||
16831623|NCT02091752|37774918|FG000|Overall Study|Adverse Event|1|||
16831624|NCT02117024|37774924|FG000|Overall Study|Progressive Disease|26|||
16831625|NCT02117024|37774925|FG001|Overall Study|Progressive Disease|9|||
16831626|NCT02117024|37774924|FG000|Overall Study|Significant Clinical Progression|7|||
16831627|NCT02117024|37774925|FG001|Overall Study|Significant Clinical Progression|4|||
16831628|NCT02117024|37774924|FG000|Overall Study|Death|5|||
16831629|NCT02117024|37774925|FG001|Overall Study|Death|0|||
16831630|NCT02117024|37774924|FG000|Overall Study|Withdrawal by Subject|3|||
16831631|NCT02117024|37774925|FG001|Overall Study|Withdrawal by Subject|1|||
16831632|NCT02117024|37774924|FG000|Overall Study|Protocol Violation|1|||
16831633|NCT02117024|37774925|FG001|Overall Study|Protocol Violation|0|||
16831634|NCT02117024|37774924|FG000|Overall Study|Adverse Event|1|||
16831635|NCT02117024|37774925|FG001|Overall Study|Adverse Event|2|||
16831636|NCT02117024|37774924|FG000|Overall Study|Randomized in Error|1|||
16831637|NCT02117024|37774925|FG001|Overall Study|Randomized in Error|0|||
16831638|NCT02117024|37774924|FG000|Overall Study|Patient returned to primary oncologist|0|||
16831639|NCT02117024|37774925|FG001|Overall Study|Patient returned to primary oncologist|1|||
16831640|NCT02117024|37774924|FG000|Overall Study|Patient took treatment break|0|||
16831641|NCT02117024|37774925|FG001|Overall Study|Patient took treatment break|1|||
16831642|NCT02117024|37774924|FG000|Overall Study|Physician Decision|0|||
16831643|NCT02117024|37774925|FG001|Overall Study|Physician Decision|2|||
16831644|NCT02091440|37774931|FG000|Overall Study|Death|2|||
16831645|NCT02064920|37774937|FG000|Overall Study|Adverse Event|0|||
16831646|NCT02064920|37774938|FG001|Overall Study|Adverse Event|4|||
16831647|NCT02064920|37774937|FG000|Overall Study|Physician Decision|0|||
16831648|NCT02064920|37774938|FG001|Overall Study|Physician Decision|1|||
16831649|NCT02064920|37774937|FG000|Overall Study|Technical Problems|0|||
16831650|NCT02064920|37774938|FG001|Overall Study|Technical Problems|1|||
16831651|NCT02064920|37774937|FG000|Overall Study|Withdrawal by Subject|1|||
16831652|NCT02064920|37774938|FG001|Overall Study|Withdrawal by Subject|3|||
16831653|NCT02151149|37774946|FG000|Treatment Period|Death|2|||
16831654|NCT02151149|37774947|FG001|Treatment Period|Death|3|||
16831655|NCT02151149|37774946|FG000|Treatment Period|Adverse Event|17|||
16831656|NCT02151149|37774947|FG001|Treatment Period|Adverse Event|14|||
16831657|NCT02151149|37774946|FG000|Treatment Period|Progressive Disease|25|||
16831658|NCT02151149|37774947|FG001|Treatment Period|Progressive Disease|24|||
16831659|NCT02151149|37774946|FG000|Treatment Period|Symptomatic Deterioration|2|||
16831660|NCT02151149|37774947|FG001|Treatment Period|Symptomatic Deterioration|10|||
16831661|NCT02151149|37774946|FG000|Treatment Period|Withdrawal by Subject|13|||
16831662|NCT02151149|37774947|FG001|Treatment Period|Withdrawal by Subject|11|||
16831663|NCT02151149|37774946|FG000|Treatment Period|Miscellaneous|8|||
16831664|NCT02151149|37774947|FG001|Treatment Period|Miscellaneous|7|||
16831665|NCT02151149|37774946|FG000|Treatment Period|Participants randomized but not treated|3|||
16831666|NCT02151149|37774947|FG001|Treatment Period|Participants randomized but not treated|2|||
16831667|NCT02151149|37774946|FG000|Follow-Up Period|Lost to Follow-up|2|||
16831668|NCT02151149|37774947|FG001|Follow-Up Period|Lost to Follow-up|3|||
16831669|NCT02151149|37774946|FG000|Follow-Up Period|Death|37|||
16831670|NCT02151149|37774947|FG001|Follow-Up Period|Death|34|||
16831671|NCT02150213|37774953|FG000|Overall Study|Lost to Follow-up|1|||
16831672|NCT02150213|37774953|FG000|Overall Study|Withdrawal by Subject|1|||
16831673|NCT02091362|37774959|FG000|Period 1|Protocol Violation|1|||
16831674|NCT02091362|37774960|FG001|Period 1|Protocol Violation|0|||
16831675|NCT02091362|37774959|FG000|Period 1|Withdrawal by Subject|2|||
16831676|NCT02091362|37774960|FG001|Period 1|Withdrawal by Subject|3|||
16831677|NCT02091362|37774959|FG000|Period 1|Lost to Follow-up|0|||
16831678|NCT02091362|37774960|FG001|Period 1|Lost to Follow-up|1|||
16831679|NCT02091362|37774959|FG000|Period 1|Adverse Event|2|||
16831680|NCT02091362|37774960|FG001|Period 1|Adverse Event|0|||
16831681|NCT02091362|37774959|FG000|Wash-out|Lost to Follow-up|1|||
16831682|NCT02091362|37774960|FG001|Wash-out|Lost to Follow-up|1|||
16831683|NCT02091362|37774959|FG000|Wash-out|Withdrawal by Subject|0|||
16831684|NCT02091362|37774960|FG001|Wash-out|Withdrawal by Subject|2|||
16831685|NCT02091362|37774959|FG000|Period 2|Adverse Event|1|||
16831686|NCT02091362|37774960|FG001|Period 2|Adverse Event|0|||
16831687|NCT02091362|37774959|FG000|Period 2|Lost to Follow-up|0|||
16831688|NCT02091362|37774960|FG001|Period 2|Lost to Follow-up|1|||
16831689|NCT02091362|37774959|FG000|Period 2|Withdrawal by Subject|1|||
16831690|NCT02091362|37774960|FG001|Period 2|Withdrawal by Subject|1|||
16831691|NCT02150057|37774972|FG000|Overall Study|Lost to Follow-up|6|||
16831692|NCT02150057|37774973|FG001|Overall Study|Lost to Follow-up|4|||
16831693|NCT02064296|37774982|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
16831694|NCT02064296|37774983|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
16831695|NCT02064296|37774984|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
16831696|NCT02064296|37774982|FG000|Intervention|Withdrawal by Subject|0|||
16831697|NCT02064296|37774983|FG001|Intervention|Withdrawal by Subject|1|||
16831698|NCT02064296|37774984|FG002|Intervention|Withdrawal by Subject|2|||
16831699|NCT02063984|37774996|FG000|Overall Study|Lost to Follow-up|6|||
16831700|NCT02063984|37774997|FG001|Overall Study|Lost to Follow-up|5|||
16831701|NCT02091284|37775009|FG000|Overall Study|Withdrawal by Subject|2|||
16831702|NCT02091284|37775010|FG001|Overall Study|Withdrawal by Subject|1|||
16831703|NCT02091284|37775009|FG000|Overall Study|unreliable data|1|||
16831704|NCT02091284|37775010|FG001|Overall Study|unreliable data|0|||
16831705|NCT02115386|37775018|FG000|Overall Study|Protocol Violation|1|||
16831706|NCT02115386|37775018|FG000|Overall Study|Administrative - trial was terminated|6|||
16831707|NCT02091206|37775026|FG000|Treatment Period|Adverse Event|0|||
16831708|NCT02091206|37775027|FG001|Treatment Period|Adverse Event|1|||
16831709|NCT02091206|37775028|FG002|Treatment Period|Adverse Event|0|||
16831710|NCT02091206|37775029|FG003|Treatment Period|Adverse Event|0|||
16831711|NCT02091206|37775026|FG000|Treatment Period|Met withdrawal criteria|0|||
16831712|NCT02091206|37775027|FG001|Treatment Period|Met withdrawal criteria|0|||
16831713|NCT02091206|37775028|FG002|Treatment Period|Met withdrawal criteria|1|||
16831714|NCT02091206|37775029|FG003|Treatment Period|Met withdrawal criteria|0|||
16831715|NCT02091206|37775026|FG000|Taper Period|Participant refused study drug|1|||
16831716|NCT02091206|37775027|FG001|Taper Period|Participant refused study drug|0|||
16831717|NCT02091206|37775028|FG002|Taper Period|Participant refused study drug|0|||
16831718|NCT02091206|37775029|FG003|Taper Period|Participant refused study drug|1|||
16831719|NCT02091206|37775026|FG000|Taper Period|Lost to Follow-up|0|||
16831720|NCT02091206|37775027|FG001|Taper Period|Lost to Follow-up|0|||
16831721|NCT02091206|37775028|FG002|Taper Period|Lost to Follow-up|0|||
16831722|NCT02091206|37775029|FG003|Taper Period|Lost to Follow-up|1|||
16831723|NCT02090426|37775041|FG000|Overall Study|Lost to Follow-up|12|||
16831724|NCT02090426|37775042|FG001|Overall Study|Lost to Follow-up|6|||
16831725|NCT02063828|37775051|FG000|Overall Study|Withdrawal by Subject|4|||
16831726|NCT02063828|37775052|FG001|Overall Study|Withdrawal by Subject|6|||
16831727|NCT02063828|37775053|FG002|Overall Study|Withdrawal by Subject|3|||
16831728|NCT02063828|37775051|FG000|Overall Study|Death|0|||
16831729|NCT02063828|37775052|FG001|Overall Study|Death|0|||
16831730|NCT02063828|37775053|FG002|Overall Study|Death|1|||
16831731|NCT02063672|37775063|FG000|Overall Study|Ongoing Follow-up|27|||
16831732|NCT02063672|37775064|FG001|Overall Study|Ongoing Follow-up|14|||
16831733|NCT02063672|37775063|FG000|Overall Study|Death|5|||
16831734|NCT02063672|37775064|FG001|Overall Study|Death|3|||
16831735|NCT02063672|37775063|FG000|Overall Study|Lost to Follow-up|1|||
16831736|NCT02063672|37775064|FG001|Overall Study|Lost to Follow-up|3|||
16831737|NCT02063672|37775063|FG000|Overall Study|Withdrawal by Subject|2|||
16831738|NCT02063672|37775064|FG001|Overall Study|Withdrawal by Subject|2|||
16831739|NCT02062658|37775070|FG000|Overall Study|Withdrawal by Subject|1|||
16831740|NCT02062658|37775070|FG000|Overall Study|Lack of Efficacy|1|||
16831741|NCT02115308|37775076|FG000|Overall Study|Safety Screening|2|||
16831742|NCT02115308|37775077|FG001|Overall Study|Safety Screening|2|||
16831743|NCT02114684|37775089|FG000|Overall Study|Death|6|||
16831744|NCT02114684|37775090|FG001|Overall Study|Death|4|||
16831745|NCT02114684|37775089|FG000|Overall Study|Lost to Follow-up|1|||
16831746|NCT02114684|37775090|FG001|Overall Study|Lost to Follow-up|2|||
16831747|NCT02114684|37775089|FG000|Overall Study|Withdrawal by Subject|1|||
16831748|NCT02114684|37775090|FG001|Overall Study|Withdrawal by Subject|2|||
16831749|NCT02114684|37775089|FG000|Overall Study|Relocation|3|||
16831750|NCT02114684|37775090|FG001|Overall Study|Relocation|1|||
16831751|NCT02114684|37775089|FG000|Overall Study|Rifampicin resistant on culture|0|||
16831752|NCT02114684|37775090|FG001|Overall Study|Rifampicin resistant on culture|1|||
16831753|NCT02114684|37775089|FG000|Overall Study|Patient Incarcerated|1|||
16831754|NCT02114684|37775090|FG001|Overall Study|Patient Incarcerated|0|||
16831755|NCT02090114|37775104|FG000|Overall Study|Withdrawal by Subject|3|||
16831756|NCT02090114|37775105|FG001|Overall Study|Withdrawal by Subject|6|||
16831757|NCT02090114|37775106|FG002|Overall Study|Withdrawal by Subject|2|||
16831758|NCT02090114|37775107|FG003|Overall Study|Withdrawal by Subject|1|||
16831759|NCT02090114|37775104|FG000|Overall Study|Physician Decision|5|||
16831760|NCT02090114|37775105|FG001|Overall Study|Physician Decision|0|||
16831761|NCT02090114|37775106|FG002|Overall Study|Physician Decision|1|||
16831762|NCT02090114|37775107|FG003|Overall Study|Physician Decision|1|||
16831763|NCT02090114|37775104|FG000|Overall Study|Adverse Event|1|||
16831764|NCT02090114|37775105|FG001|Overall Study|Adverse Event|2|||
16831765|NCT02090114|37775106|FG002|Overall Study|Adverse Event|2|||
16831766|NCT02090114|37775107|FG003|Overall Study|Adverse Event|0|||
16831767|NCT02090114|37775104|FG000|Overall Study|Progressive Disease|20|||
16831768|NCT02090114|37775105|FG001|Overall Study|Progressive Disease|21|||
16831769|NCT02090114|37775106|FG002|Overall Study|Progressive Disease|23|||
16831770|NCT02090114|37775107|FG003|Overall Study|Progressive Disease|6|||
16831771|NCT02090114|37775104|FG000|Overall Study|Death|1|||
16831772|NCT02090114|37775105|FG001|Overall Study|Death|0|||
16831773|NCT02090114|37775106|FG002|Overall Study|Death|1|||
16831774|NCT02090114|37775107|FG003|Overall Study|Death|0|||
16831775|NCT01623050|37775117|FG000|Overall Study|Lost to Follow-up|9|||
16831776|NCT02089334|37775125|FG000|Overall Study|Withdrawal by Subject|0|||
16831777|NCT02089334|37775126|FG001|Overall Study|Withdrawal by Subject|0|||
16831778|NCT02089334|37775127|FG002|Overall Study|Withdrawal by Subject|0|||
16831779|NCT02089334|37775128|FG003|Overall Study|Withdrawal by Subject|2|||
16831780|NCT02089334|37775125|FG000|Overall Study|Adverse Event|0|||
16831781|NCT02089334|37775126|FG001|Overall Study|Adverse Event|0|||
16831782|NCT02089334|37775127|FG002|Overall Study|Adverse Event|0|||
16831783|NCT02089334|37775128|FG003|Overall Study|Adverse Event|2|||
16831784|NCT02089334|37775125|FG000|Overall Study|Progressive disease|0|||
16831785|NCT02089334|37775126|FG001|Overall Study|Progressive disease|0|||
16831786|NCT02089334|37775127|FG002|Overall Study|Progressive disease|0|||
16831787|NCT02089334|37775128|FG003|Overall Study|Progressive disease|2|||
16831788|NCT02089334|37775125|FG000|Overall Study|Physician Decision|0|||
16831789|NCT02089334|37775126|FG001|Overall Study|Physician Decision|0|||
16831790|NCT02089334|37775127|FG002|Overall Study|Physician Decision|1|||
16831791|NCT02089334|37775128|FG003|Overall Study|Physician Decision|1|||
16831792|NCT02114606|37775141|FG000|Overall Study|Unable to swallow Cytosponge|6|||
16831793|NCT02113436|37775147|FG000|Period 1: 8 Weeks|Adverse Event|1|||
16831794|NCT02113436|37775148|FG001|Period 1: 8 Weeks|Adverse Event|0|||
16831795|NCT02113436|37775149|FG002|Period 1: 8 Weeks|Adverse Event|0|||
16831796|NCT02113436|37775150|FG003|Period 1: 8 Weeks|Adverse Event|0|||
16831797|NCT02113436|37775147|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
16831798|NCT02113436|37775148|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
16831799|NCT02113436|37775149|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
16831800|NCT02113436|37775150|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
16831801|NCT02113436|37775147|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
16831802|NCT02113436|37775148|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
16831803|NCT02113436|37775149|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
16831804|NCT02113436|37775150|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
16831805|NCT02113436|37775147|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
16831806|NCT02113436|37775148|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
16831807|NCT02113436|37775149|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
16831808|NCT02113436|37775150|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
16831809|NCT02113436|37775147|FG000|Period 2: 16 Weeks|Adverse Event|0|||
16831810|NCT02113436|37775148|FG001|Period 2: 16 Weeks|Adverse Event|0|||
16831811|NCT02113436|37775149|FG002|Period 2: 16 Weeks|Adverse Event|4|||
16831812|NCT02113436|37775150|FG003|Period 2: 16 Weeks|Adverse Event|5|||
16831813|NCT02113436|37775147|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
16831814|NCT02113436|37775148|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
16831815|NCT02113436|37775149|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
16831816|NCT02113436|37775150|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
16831817|NCT02113436|37775147|FG000|Period 2: 16 Weeks|Physician Decision|0|||
16831818|NCT02113436|37775148|FG001|Period 2: 16 Weeks|Physician Decision|0|||
16831819|NCT02113436|37775149|FG002|Period 2: 16 Weeks|Physician Decision|2|||
16831820|NCT02113436|37775150|FG003|Period 2: 16 Weeks|Physician Decision|0|||
16831821|NCT02113436|37775147|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
16831822|NCT02113436|37775148|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
16831823|NCT02113436|37775149|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
16831824|NCT02113436|37775150|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
16831825|NCT02113124|37775161|FG000|Overall Study|Unable to retrieve blood sample|1|||
16831826|NCT02113124|37775162|FG001|Overall Study|Unable to retrieve blood sample|1|||
16831827|NCT02087774|37775170|FG000|Overall Study|Were absent day of data collection|8|||
16831828|NCT02087774|37775171|FG001|Overall Study|Were absent day of data collection|20|||
16831829|NCT02111564|37775179|FG000|Overall Study|Death|109|||
16831830|NCT02111564|37775180|FG001|Overall Study|Death|120|||
16831831|NCT02111564|37775179|FG000|Overall Study|Lost to Follow-up|2|||
16831832|NCT02111564|37775180|FG001|Overall Study|Lost to Follow-up|3|||
16831833|NCT02111564|37775179|FG000|Overall Study|Withdrawal by Subject|20|||
16831834|NCT02111564|37775180|FG001|Overall Study|Withdrawal by Subject|20|||
16831835|NCT02087150|37775189|FG000|Overall Study|Death|0|||
16831836|NCT02087150|37775190|FG001|Overall Study|Death|1|||
16831837|NCT02087150|37775191|FG002|Overall Study|Death|0|||
16831838|NCT02087150|37775189|FG000|Overall Study|Lost to Follow-up|6|||
16831839|NCT02087150|37775190|FG001|Overall Study|Lost to Follow-up|13|||
16831840|NCT02087150|37775191|FG002|Overall Study|Lost to Follow-up|7|||
16831841|NCT02087150|37775189|FG000|Overall Study|Withdrawal by Subject|2|||
16831842|NCT02087150|37775190|FG001|Overall Study|Withdrawal by Subject|5|||
16831843|NCT02087150|37775191|FG002|Overall Study|Withdrawal by Subject|3|||
16831844|NCT02087150|37775189|FG000|Overall Study|Physician Decision|0|||
16831845|NCT02087150|37775190|FG001|Overall Study|Physician Decision|1|||
16831846|NCT02087150|37775191|FG002|Overall Study|Physician Decision|0|||
16831847|NCT02087150|37775189|FG000|Overall Study|Procedure not done|1|||
16831848|NCT02087150|37775190|FG001|Overall Study|Procedure not done|13|||
16831849|NCT02087150|37775191|FG002|Overall Study|Procedure not done|0|||
16831850|NCT02087150|37775189|FG000|Overall Study|F/U not completed w/in study window|0|||
16831851|NCT02087150|37775190|FG001|Overall Study|F/U not completed w/in study window|0|||
16831852|NCT02087150|37775191|FG002|Overall Study|F/U not completed w/in study window|1|||
16831853|NCT02087150|37775189|FG000|Overall Study|Other|1|||
16831854|NCT02087150|37775190|FG001|Overall Study|Other|0|||
16831855|NCT02087150|37775191|FG002|Overall Study|Other|0|||
16831856|NCT02087150|37775189|FG000|Overall Study|Pt moved out of town|0|||
16831857|NCT02087150|37775190|FG001|Overall Study|Pt moved out of town|1|||
16831858|NCT02087150|37775191|FG002|Overall Study|Pt moved out of town|0|||
16831859|NCT02111174|37775202|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
16831860|NCT02111174|37775203|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
16831861|NCT02111174|37775202|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
16831862|NCT02111174|37775203|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
16831863|NCT02111174|37775202|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
16831864|NCT02111174|37775203|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
16831865|NCT02111174|37775202|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
16831866|NCT02111174|37775203|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
16831867|NCT02111096|37775212|FG000|Overall Study|Adverse Event|4|||
16831868|NCT02111096|37775213|FG001|Overall Study|Adverse Event|1|||
16831869|NCT02111096|37775214|FG002|Overall Study|Adverse Event|2|||
16831870|NCT02111096|37775212|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16831871|NCT02111096|37775213|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16831872|NCT02111096|37775214|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16831873|NCT02111096|37775212|FG000|Overall Study|Lost to Follow Up|1|||
16831874|NCT02111096|37775213|FG001|Overall Study|Lost to Follow Up|1|||
16831875|NCT02111096|37775214|FG002|Overall Study|Lost to Follow Up|1|||
16831876|NCT02111096|37775212|FG000|Overall Study|Physician Decision|0|||
16831877|NCT02111096|37775213|FG001|Overall Study|Physician Decision|1|||
16831878|NCT02111096|37775214|FG002|Overall Study|Physician Decision|0|||
16831879|NCT02111096|37775212|FG000|Overall Study|Protocol Violation|1|||
16831880|NCT02111096|37775213|FG001|Overall Study|Protocol Violation|0|||
16831881|NCT02111096|37775214|FG002|Overall Study|Protocol Violation|1|||
16831882|NCT02111096|37775212|FG000|Overall Study|Terminated by Sponsor|53|||
16831883|NCT02111096|37775213|FG001|Overall Study|Terminated by Sponsor|35|||
16831884|NCT02111096|37775214|FG002|Overall Study|Terminated by Sponsor|54|||
16831885|NCT02111096|37775212|FG000|Overall Study|Withdrawal by Subject|4|||
16831886|NCT02111096|37775213|FG001|Overall Study|Withdrawal by Subject|2|||
16831887|NCT02111096|37775214|FG002|Overall Study|Withdrawal by Subject|8|||
16831888|NCT02110706|37775227|FG000|Overall Study|Adverse Event|2|||
16831889|NCT02110706|37775228|FG001|Overall Study|Adverse Event|3|||
16831890|NCT02110706|37775227|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
16831891|NCT02110706|37775228|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
16831892|NCT02110238|37775238|FG000|12 Week Pivotal Phase|Adverse Event|3|||
16831893|NCT02110238|37775239|FG001|12 Week Pivotal Phase|Adverse Event|0|||
16831894|NCT02110238|37775238|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
16831895|NCT02110238|37775239|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
16831896|NCT02110238|37775238|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
16831897|NCT02110238|37775239|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
16831898|NCT02110238|37775238|FG000|12 Week Pivotal Phase|Physician Decision|0|||
16831899|NCT02110238|37775239|FG001|12 Week Pivotal Phase|Physician Decision|2|||
16831900|NCT02110238|37775238|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
16831901|NCT02110238|37775239|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
16831902|NCT02110238|37775238|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
16831903|NCT02110238|37775239|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
16831904|NCT02110238|37775238|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
16831905|NCT02110238|37775239|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
16831906|NCT02110238|37775238|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
16831907|NCT02110238|37775239|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
16831908|NCT02110238|37775238|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
16831909|NCT02110238|37775239|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
16831910|NCT02110238|37775238|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
16831911|NCT02110238|37775239|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
16831912|NCT02110238|37775238|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
16831913|NCT02110238|37775239|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
16831914|NCT02108912|37775247|FG000|Overall Study|Lost to Follow-up|1|||
16831915|NCT02108912|37775248|FG001|Overall Study|Lost to Follow-up|1|||
16831916|NCT02108912|37775247|FG000|Overall Study|lack of transportation|1|||
16831917|NCT02108912|37775248|FG001|Overall Study|lack of transportation|0|||
16831918|NCT02108912|37775247|FG000|Overall Study|high blood pressure|1|||
16831919|NCT02108912|37775248|FG001|Overall Study|high blood pressure|0|||
16831920|NCT02108600|37775256|FG000|Overall Study|Withdrawal by Subject|2|||
16831921|NCT02108600|37775257|FG001|Overall Study|Withdrawal by Subject|0|||
16831922|NCT02108600|37775256|FG000|Overall Study|Lost to Follow-up|1|||
16831923|NCT02108600|37775257|FG001|Overall Study|Lost to Follow-up|1|||
16831924|NCT02107898|37775265|FG000|Overall Study|Adverse Event|4|||
16831925|NCT02107898|37775266|FG001|Overall Study|Adverse Event|7|||
16831926|NCT02107898|37775265|FG000|Overall Study|Poor compliance to protocol|0|||
16831927|NCT02107898|37775266|FG001|Overall Study|Poor compliance to protocol|1|||
16831928|NCT02107898|37775265|FG000|Overall Study|Participant moved|0|||
16831929|NCT02107898|37775266|FG001|Overall Study|Participant moved|2|||
16831930|NCT02107898|37775265|FG000|Overall Study|Consent withdrawn by participant|2|||
16831931|NCT02107898|37775266|FG001|Overall Study|Consent withdrawn by participant|1|||
16831932|NCT02107898|37775265|FG000|Overall Study|Randomized but not treated|0|||
16831933|NCT02107898|37775266|FG001|Overall Study|Randomized but not treated|1|||
16831934|NCT02059148|37775272|FG000|Treatment 1|Protocol Violation|0|||
16831935|NCT02059148|37775273|FG001|Treatment 1|Protocol Violation|0|||
16831936|NCT02059148|37775274|FG002|Treatment 1|Protocol Violation|0|||
16831937|NCT02059148|37775275|FG003|Treatment 1|Protocol Violation|0|||
16831938|NCT02059148|37775276|FG004|Treatment 1|Protocol Violation|0|||
16831939|NCT02059148|37775277|FG005|Treatment 1|Protocol Violation|1|||
16831940|NCT02058992|37775288|FG000|Overall Study|Lost to Follow-up|4|||
16831941|NCT02058992|37775288|FG000|Overall Study|Protocol Violation|92|||
16831942|NCT02058992|37775288|FG000|Overall Study|CRF Uncollected|20|||
16831943|NCT02058836|37775294|FG000|Overall Study|Withdrawal by Subject|1|||
16831944|NCT02058836|37775295|FG001|Overall Study|Withdrawal by Subject|1|||
16831945|NCT02107274|37775303|FG000|Treatment vs. Placebo|Adverse Event|3|||
16831946|NCT02107274|37775304|FG001|Treatment vs. Placebo|Adverse Event|0|||
16831947|NCT02107274|37775303|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
16831948|NCT02107274|37775304|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
16831949|NCT02107274|37775303|FG000|Control Phase|Lost to Follow-up|1|||
16831950|NCT02107274|37775304|FG001|Control Phase|Lost to Follow-up|1|||
16831951|NCT02107274|37775303|FG000|Control Phase|Death|2|||
16831952|NCT02107274|37775304|FG001|Control Phase|Death|0|||
16831953|NCT02107274|37775303|FG000|Control Phase|Adverse Event|0|||
16831954|NCT02107274|37775304|FG001|Control Phase|Adverse Event|1|||
16831955|NCT02174627|37775312|FG000|Overall Study|Missing|0|||
16831956|NCT02174627|37775313|FG001|Overall Study|Missing|1|||
16831957|NCT02174627|37775312|FG000|Overall Study|Incorrect enrolment before randomization|0|||
16831958|NCT02174627|37775313|FG001|Overall Study|Incorrect enrolment before randomization|1|||
16831959|NCT02174627|37775312|FG000|Overall Study|Participant decision|84|||
16831960|NCT02174627|37775313|FG001|Overall Study|Participant decision|128|||
16831961|NCT02173769|37775319|FG000|Overall Study|Protocol Violation|4|||
16831962|NCT02121509|37775326|FG000|Washout Period (35 Days)|Adverse Event|1|||
16831963|NCT02121509|37775327|FG001|Washout Period (35 Days)|Adverse Event|1|||
16831964|NCT02121509|37775328|FG002|Washout Period (35 Days)|Adverse Event|0|||
16831965|NCT02121509|37775329|FG003|Washout Period (35 Days)|Adverse Event|0|||
16831966|NCT02121509|37775326|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
16831967|NCT02121509|37775327|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
16831968|NCT02121509|37775328|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
16831969|NCT02121509|37775329|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
16831970|NCT02121509|37775326|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
17198440|NCT02783729|38352124|FG000|Overall Study|Participant's choice|2|||
17198441|NCT02783729|38352125|FG001|Overall Study|Participant's choice|1|||
17198442|NCT02783729|38352126|FG002|Overall Study|Participant's choice|2|||
17198443|NCT02783729|38352127|FG003|Overall Study|Participant's choice|1|||
17198444|NCT02783729|38352124|FG000|Overall Study|Lost to Follow-up|2|||
16831971|NCT02121509|37775327|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
16831972|NCT02121509|37775328|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
16831973|NCT02121509|37775329|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
16831974|NCT02149199|37775342|FG000|Overall Study|Study specific withdrawal criteria|4|||
16831975|NCT02149199|37775343|FG001|Overall Study|Study specific withdrawal criteria|21|||
17198445|NCT02783729|38352125|FG001|Overall Study|Lost to Follow-up|1|||
17198446|NCT02783729|38352126|FG002|Overall Study|Lost to Follow-up|1|||
17198447|NCT02783729|38352127|FG003|Overall Study|Lost to Follow-up|0|||
17198448|NCT02784431|38352149|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
17198449|NCT02784431|38352149|FG000|Overall Study|Early Study Termination|19|||
17198450|NCT02590406|38352155|FG000|Overall Study|Adverse Event|1|||
17198451|NCT02590406|38352156|FG001|Overall Study|Adverse Event|0|||
17198452|NCT02590406|38352155|FG000|Overall Study|Saturometer malfunction|0|||
17198453|NCT02590406|38352156|FG001|Overall Study|Saturometer malfunction|1|||
17198454|NCT01359254|38352164|FG000|Overall Study|Death|1|||
17198455|NCT01359254|38352165|FG001|Overall Study|Death|0|||
16831976|NCT02149199|37775344|FG002|Overall Study|Study specific withdrawal criteria|6|||
16831977|NCT02149199|37775342|FG000|Overall Study|Other|20|||
16831978|NCT02149199|37775343|FG001|Overall Study|Other|25|||
16831979|NCT02149199|37775344|FG002|Overall Study|Other|20|||
16831980|NCT02149199|37775342|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
16831981|NCT02149199|37775343|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
16831982|NCT02149199|37775344|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
16831983|NCT02149199|37775342|FG000|Overall Study|Withdrawal by Subject|75|||
16831984|NCT02149199|37775343|FG001|Overall Study|Withdrawal by Subject|93|||
16831985|NCT02149199|37775344|FG002|Overall Study|Withdrawal by Subject|77|||
16831986|NCT02149199|37775342|FG000|Overall Study|Protocol Violation|16|||
16831987|NCT02149199|37775343|FG001|Overall Study|Protocol Violation|13|||
16831988|NCT02149199|37775344|FG002|Overall Study|Protocol Violation|15|||
16831989|NCT02149199|37775342|FG000|Overall Study|Lost to Follow-up|3|||
16831990|NCT02149199|37775343|FG001|Overall Study|Lost to Follow-up|12|||
16831991|NCT02149199|37775344|FG002|Overall Study|Lost to Follow-up|11|||
16831992|NCT02149199|37775342|FG000|Overall Study|Death|0|||
16831993|NCT02149199|37775343|FG001|Overall Study|Death|0|||
16831994|NCT02149199|37775344|FG002|Overall Study|Death|1|||
16831995|NCT02149199|37775342|FG000|Overall Study|Adverse Event|6|||
16831996|NCT02149199|37775343|FG001|Overall Study|Adverse Event|15|||
16831997|NCT02149199|37775344|FG002|Overall Study|Adverse Event|9|||
16831998|NCT02120417|37775354|FG000|Overall Study|Death|5|||
16831999|NCT02120417|37775355|FG001|Overall Study|Death|1|||
16832000|NCT02120417|37775354|FG000|Overall Study|Adverse Event|3|||
16832001|NCT02120417|37775355|FG001|Overall Study|Adverse Event|9|||
16912334|NCT01454934|38021536|FG001|Overall Study|Clinical progression|25|||
16912335|NCT01454934|38021535|FG000|Overall Study|Other|6|||
16912336|NCT01454934|38021536|FG001|Overall Study|Other|17|||
16912337|NCT01454934|38021535|FG000|Overall Study|Adverse Event|28|||
16912338|NCT01454934|38021536|FG001|Overall Study|Adverse Event|24|||
16912339|NCT01454934|38021535|FG000|Overall Study|Withdrawn consent|2|||
16912340|NCT01454934|38021536|FG001|Overall Study|Withdrawn consent|5|||
16912341|NCT01454934|38021535|FG000|Overall Study|Withdrawal by Subject|11|||
16912342|NCT01454934|38021536|FG001|Overall Study|Withdrawal by Subject|15|||
16912343|NCT01454934|38021535|FG000|Overall Study|Disease progression|194|||
16912344|NCT01454934|38021536|FG001|Overall Study|Disease progression|181|||
16912345|NCT01454934|38021535|FG000|Overall Study|Lost to Follow-up|0|||
16912346|NCT01454934|38021536|FG001|Overall Study|Lost to Follow-up|1|||
16912347|NCT01454934|38021535|FG000|Overall Study|Not treated|1|||
16912348|NCT01454934|38021536|FG001|Overall Study|Not treated|2|||
16912349|NCT01454778|38021542|FG000|Overall Study|Lost to Follow-up|2|||
16912350|NCT01454778|38021542|FG000|Overall Study|Death|1|||
16912351|NCT01454076|38021551|FG000|Overall Study|Other|2|||
16912352|NCT01454076|38021552|FG001|Overall Study|Other|0|||
16912353|NCT01454076|38021553|FG002|Overall Study|Other|0|||
16912354|NCT01454076|38021554|FG003|Overall Study|Other|1|||
16912355|NCT01454076|38021555|FG004|Overall Study|Other|2|||
16912356|NCT01454076|38021551|FG000|Overall Study|Withdrawal by Subject|3|||
16912357|NCT01454076|38021552|FG001|Overall Study|Withdrawal by Subject|4|||
16912358|NCT01454076|38021553|FG002|Overall Study|Withdrawal by Subject|2|||
16912359|NCT01454076|38021554|FG003|Overall Study|Withdrawal by Subject|1|||
16912360|NCT01454076|38021555|FG004|Overall Study|Withdrawal by Subject|2|||
16912361|NCT01454076|38021551|FG000|Overall Study|Adverse Event|8|||
16912362|NCT01454076|38021552|FG001|Overall Study|Adverse Event|2|||
16912363|NCT01454076|38021553|FG002|Overall Study|Adverse Event|7|||
16912364|NCT01454076|38021554|FG003|Overall Study|Adverse Event|0|||
16912365|NCT01454076|38021555|FG004|Overall Study|Adverse Event|2|||
16832002|NCT02120417|37775354|FG000|Overall Study|Participant decision|4|||
16832003|NCT02120417|37775355|FG001|Overall Study|Participant decision|4|||
16912366|NCT01453998|38021579|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
16912367|NCT01453998|38021580|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
16912368|NCT01453998|38021581|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
16912369|NCT01453374|38021592|FG000|Overall Study|Adverse Event|7|||
16912370|NCT01453374|38021592|FG000|Overall Study|Lack of Efficacy|1|||
16912371|NCT01453374|38021592|FG000|Overall Study|Lost to Follow-up|3|||
16912372|NCT01453374|38021592|FG000|Overall Study|Withdrawal by Subject|5|||
16912373|NCT01453374|38021592|FG000|Overall Study|Incarcerated|2|||
17198456|NCT01667432|38352171|FG000|Overall Study|Premature Study Termination|26|||
17198457|NCT01667432|38352171|FG000|Overall Study|Failure to Return|10|||
16832004|NCT02120417|37775354|FG000|Overall Study|Disease progression|41|||
16832005|NCT02120417|37775355|FG001|Overall Study|Disease progression|45|||
16832006|NCT02120417|37775354|FG000|Overall Study|Noncompliance with study treatment|0|||
16832007|NCT02120417|37775355|FG001|Overall Study|Noncompliance with study treatment|2|||
16832008|NCT02120417|37775354|FG000|Overall Study|Physician Decision|2|||
16832009|NCT02120417|37775355|FG001|Overall Study|Physician Decision|3|||
16832010|NCT02120417|37775354|FG000|Overall Study|Other unspecified|5|||
16832011|NCT02120417|37775355|FG001|Overall Study|Other unspecified|4|||
16832012|NCT02148263|37775363|FG000|Overall Study|Withdrawal by Subject|3|||
16832013|NCT02148263|37775364|FG001|Overall Study|Withdrawal by Subject|2|||
16832014|NCT02147561|37775370|FG000|Overall Study|Lost to Follow-up|3|||
16832015|NCT02147561|37775370|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
16832016|NCT02058368|37775376|FG000|Overall Study|Adverse Event|15|||
16832017|NCT02058368|37775377|FG001|Overall Study|Adverse Event|20|||
16832018|NCT02058368|37775376|FG000|Overall Study|Lack of Efficacy|0|||
16832019|NCT02058368|37775377|FG001|Overall Study|Lack of Efficacy|1|||
16832020|NCT02058368|37775376|FG000|Overall Study|Protocol Violation|0|||
16832021|NCT02058368|37775377|FG001|Overall Study|Protocol Violation|4|||
16832022|NCT02058368|37775376|FG000|Overall Study|Lost to Follow-up|2|||
16832023|NCT02058368|37775377|FG001|Overall Study|Lost to Follow-up|0|||
16832024|NCT02058368|37775376|FG000|Overall Study|Physician Decision|2|||
16832025|NCT02058368|37775377|FG001|Overall Study|Physician Decision|3|||
16832026|NCT02058368|37775376|FG000|Overall Study|Withdrawal by Subject|22|||
16832027|NCT02058368|37775377|FG001|Overall Study|Withdrawal by Subject|26|||
16832028|NCT02107196|37775385|FG000|12-week Treatment Period|Adverse Event|6|||
16832029|NCT02107196|37775386|FG001|12-week Treatment Period|Adverse Event|3|||
16832030|NCT02107196|37775385|FG000|12-week Treatment Period|Lack of Efficacy|2|||
16832031|NCT02107196|37775386|FG001|12-week Treatment Period|Lack of Efficacy|1|||
16832032|NCT02107196|37775385|FG000|12-week Treatment Period|Lost to Follow-up|3|||
16832033|NCT02107196|37775386|FG001|12-week Treatment Period|Lost to Follow-up|6|||
16832034|NCT02107196|37775385|FG000|12-week Treatment Period|Physician Decision|0|||
16832035|NCT02107196|37775386|FG001|12-week Treatment Period|Physician Decision|1|||
16832036|NCT02107196|37775385|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
16832037|NCT02107196|37775386|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
16832038|NCT02107196|37775385|FG000|12-week Treatment Period|Protocol Violation|7|||
16832039|NCT02107196|37775386|FG001|12-week Treatment Period|Protocol Violation|8|||
16832040|NCT02107196|37775385|FG000|12-week Treatment Period|Reason Missing|11|||
16832041|NCT02107196|37775386|FG001|12-week Treatment Period|Reason Missing|8|||
16832042|NCT02107196|37775385|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
16832043|NCT02107196|37775386|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
16832044|NCT02107196|37775385|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
16832045|NCT02107196|37775386|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
16832046|NCT02107196|37775385|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
16832047|NCT02107196|37775386|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
16832048|NCT02107196|37775385|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
16832049|NCT02107196|37775386|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
16832050|NCT02058290|37775394|FG000|Overall Study|Protocol Violation|2|||
16832051|NCT02058290|37775395|FG001|Overall Study|Protocol Violation|1|||
16832052|NCT02058290|37775394|FG000|Overall Study|Physician Decision|1|||
16832053|NCT02058290|37775395|FG001|Overall Study|Physician Decision|0|||
16832054|NCT02058290|37775394|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
16832055|NCT02058290|37775395|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
16832056|NCT02058290|37775394|FG000|Overall Study|Withdrawal by Subject|0|||
16832057|NCT02058290|37775395|FG001|Overall Study|Withdrawal by Subject|1|||
16832058|NCT02082158|37775407|FG000|Overall Study|Withdrawal by Subject|0|||
16832059|NCT02082158|37775408|FG001|Overall Study|Withdrawal by Subject|0|||
16832060|NCT02082158|37775409|FG002|Overall Study|Withdrawal by Subject|0|||
16832061|NCT02082158|37775410|FG003|Overall Study|Withdrawal by Subject|0|||
16832062|NCT02082158|37775411|FG004|Overall Study|Withdrawal by Subject|1|||
16832063|NCT02082158|37775412|FG005|Overall Study|Withdrawal by Subject|0|||
16832064|NCT02082158|37775407|FG000|Overall Study|Failed Fit-testing|8|||
16832065|NCT02082158|37775408|FG001|Overall Study|Failed Fit-testing|8|||
16832066|NCT02082158|37775409|FG002|Overall Study|Failed Fit-testing|14|||
16832067|NCT02082158|37775410|FG003|Overall Study|Failed Fit-testing|4|||
16832068|NCT02082158|37775411|FG004|Overall Study|Failed Fit-testing|3|||
16832069|NCT02082158|37775412|FG005|Overall Study|Failed Fit-testing|7|||
16832070|NCT02106884|37775434|FG000|Overall Study|Change of diagnosis/exclusion|0|||
16832071|NCT02106884|37775435|FG001|Overall Study|Change of diagnosis/exclusion|1|||
16832072|NCT02081846|37775446|FG000|Overall Study|Withdrawal by Subject|1|||
16832073|NCT02081846|37775447|FG001|Overall Study|Withdrawal by Subject|0|||
16832074|NCT02081846|37775446|FG000|Overall Study|invalid consent|1|||
16832075|NCT02081846|37775447|FG001|Overall Study|invalid consent|0|||
16832076|NCT02081690|37775453|FG000|Overall Study|Death|3|||
16832077|NCT02081690|37775453|FG000|Overall Study|Physician Decision|3|||
16832078|NCT02081690|37775453|FG000|Overall Study|Withdrawal by Subject|1|||
16832079|NCT02057666|37775459|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
16832080|NCT02057666|37775460|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
16832081|NCT02057666|37775459|FG000|Double Blind Treatment Period|Poor tolerability|7|||
16832082|NCT02057666|37775460|FG001|Double Blind Treatment Period|Poor tolerability|2|||
16832083|NCT02057666|37775459|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
16832084|NCT02057666|37775460|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
16832085|NCT02057666|37775459|FG000|Double Blind Treatment Period|Physician Decision|1|||
16832086|NCT02057666|37775460|FG001|Double Blind Treatment Period|Physician Decision|0|||
16832087|NCT02057666|37775459|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
16832088|NCT02057666|37775460|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
16832089|NCT02057666|37775459|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
16832090|NCT02057666|37775460|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
16832091|NCT02057666|37775459|FG000|Double Blind Treatment Period|Sponsor's request|70|||
16832092|NCT02057666|37775460|FG001|Double Blind Treatment Period|Sponsor's request|34|||
16832093|NCT02057666|37775459|FG000|Open-Label Treatment Period|Poor tolerability|0|||
16832094|NCT02057666|37775460|FG001|Open-Label Treatment Period|Poor tolerability|1|||
16832095|NCT02057666|37775459|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
16832096|NCT02057666|37775460|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
16832097|NCT02057666|37775459|FG000|Open-Label Treatment Period|Sponsor's request|0|||
16832098|NCT02057666|37775460|FG001|Open-Label Treatment Period|Sponsor's request|4|||
16832099|NCT01625000|37775471|FG000|Overall Study|Physician Decision|15|||
16832100|NCT01625000|37775472|FG001|Overall Study|Physician Decision|7|||
16832101|NCT01625000|37775473|FG002|Overall Study|Physician Decision|7|||
16832102|NCT01625000|37775474|FG003|Overall Study|Physician Decision|2|||
16832103|NCT01625000|37775475|FG004|Overall Study|Physician Decision|15|||
16832104|NCT01625000|37775471|FG000|Overall Study|Protocol Violation|3|||
16832105|NCT01625000|37775472|FG001|Overall Study|Protocol Violation|10|||
16832106|NCT01625000|37775473|FG002|Overall Study|Protocol Violation|4|||
16832107|NCT01625000|37775474|FG003|Overall Study|Protocol Violation|1|||
16832108|NCT01625000|37775475|FG004|Overall Study|Protocol Violation|2|||
16832109|NCT01625000|37775471|FG000|Overall Study|Withdrawal by Subject|19|||
16832110|NCT01625000|37775472|FG001|Overall Study|Withdrawal by Subject|16|||
16832111|NCT01625000|37775473|FG002|Overall Study|Withdrawal by Subject|11|||
16832112|NCT01625000|37775474|FG003|Overall Study|Withdrawal by Subject|9|||
16832113|NCT01625000|37775475|FG004|Overall Study|Withdrawal by Subject|17|||
16832114|NCT01625000|37775471|FG000|Overall Study|Adverse Event (including Death)|15|||
16832115|NCT01625000|37775472|FG001|Overall Study|Adverse Event (including Death)|19|||
16832116|NCT01625000|37775473|FG002|Overall Study|Adverse Event (including Death)|11|||
16832117|NCT01625000|37775474|FG003|Overall Study|Adverse Event (including Death)|7|||
16832118|NCT01625000|37775475|FG004|Overall Study|Adverse Event (including Death)|21|||
16832119|NCT02081534|37775494|FG000|Overall Study|Adverse Event|5|||
16832120|NCT02081534|37775495|FG001|Overall Study|Adverse Event|4|||
16832121|NCT02081534|37775496|FG002|Overall Study|Adverse Event|3|||
16832122|NCT02081534|37775497|FG003|Overall Study|Adverse Event|10|||
16832123|NCT02081534|37775498|FG004|Overall Study|Adverse Event|2|||
16832124|NCT02081534|37775499|FG005|Overall Study|Adverse Event|8|||
16832125|NCT02081534|37775500|FG006|Overall Study|Adverse Event|2|||
16832126|NCT02081534|37775494|FG000|Overall Study|Withdrawal by Subject|0|||
16832127|NCT02081534|37775495|FG001|Overall Study|Withdrawal by Subject|1|||
16832128|NCT02081534|37775496|FG002|Overall Study|Withdrawal by Subject|1|||
16832129|NCT02081534|37775497|FG003|Overall Study|Withdrawal by Subject|1|||
16832130|NCT02081534|37775498|FG004|Overall Study|Withdrawal by Subject|1|||
16832131|NCT02081534|37775499|FG005|Overall Study|Withdrawal by Subject|0|||
16832132|NCT02081534|37775500|FG006|Overall Study|Withdrawal by Subject|1|||
16832133|NCT02081534|37775494|FG000|Overall Study|Protocol Violation|0|||
16832134|NCT02081534|37775495|FG001|Overall Study|Protocol Violation|3|||
16832135|NCT02081534|37775496|FG002|Overall Study|Protocol Violation|0|||
16832136|NCT02081534|37775497|FG003|Overall Study|Protocol Violation|0|||
16832137|NCT02081534|37775498|FG004|Overall Study|Protocol Violation|0|||
16832138|NCT02081534|37775499|FG005|Overall Study|Protocol Violation|0|||
16832139|NCT02081534|37775500|FG006|Overall Study|Protocol Violation|1|||
16832140|NCT02081534|37775494|FG000|Overall Study|Lost to Follow-up|0|||
16832141|NCT02081534|37775495|FG001|Overall Study|Lost to Follow-up|0|||
16832142|NCT02081534|37775496|FG002|Overall Study|Lost to Follow-up|0|||
16832143|NCT02081534|37775497|FG003|Overall Study|Lost to Follow-up|2|||
16832144|NCT02081534|37775498|FG004|Overall Study|Lost to Follow-up|1|||
16832145|NCT02081534|37775499|FG005|Overall Study|Lost to Follow-up|1|||
16832146|NCT02081534|37775500|FG006|Overall Study|Lost to Follow-up|0|||
16832147|NCT02057198|37775519|FG000|Overall Study|Death|0|||
16832148|NCT02057198|37775520|FG001|Overall Study|Death|0|||
16832149|NCT02057198|37775521|FG002|Overall Study|Death|1|||
16832150|NCT02057198|37775519|FG000|Overall Study|Discharged early; lost to followup|0|||
16832151|NCT02057198|37775520|FG001|Overall Study|Discharged early; lost to followup|1|||
16832152|NCT02057198|37775521|FG002|Overall Study|Discharged early; lost to followup|0|||
16912374|NCT01453296|38021598|FG000|Treatment Period 1|Adverse Event|0|||
16832153|NCT02056652|37775531|FG000|Overall Study|Withdrawal by Subject|1|||
16832154|NCT02056652|37775532|FG001|Overall Study|Withdrawal by Subject|0|||
16832155|NCT02056652|37775531|FG000|Overall Study|Lost to Follow-up|0|||
16832156|NCT02056652|37775532|FG001|Overall Study|Lost to Follow-up|3|||
16832157|NCT02056340|37775540|FG000|Overall Study|Lost to Follow-up|5|||
16832158|NCT02056340|37775541|FG001|Overall Study|Lost to Follow-up|5|||
16832159|NCT02056340|37775540|FG000|Overall Study|Withdrawal by Subject|2|||
16832160|NCT02056340|37775541|FG001|Overall Study|Withdrawal by Subject|6|||
16832161|NCT02046122|37775547|FG000|Overall Study|Physician Decision|8|||
16832162|NCT02046122|37775547|FG000|Overall Study|Withdrawal by Subject|1|||
16832163|NCT02080832|37775554|FG000|Overall Study|Excluded from analysis by MRI|9|||
16832164|NCT02080832|37775555|FG001|Overall Study|Excluded from analysis by MRI|10|||
16832165|NCT02080832|37775556|FG002|Overall Study|Excluded from analysis by MRI|14|||
16832166|NCT02080832|37775554|FG000|Overall Study|Lost to Follow-up|0|||
16832167|NCT02080832|37775555|FG001|Overall Study|Lost to Follow-up|2|||
16832168|NCT02080832|37775556|FG002|Overall Study|Lost to Follow-up|2|||
16832169|NCT02080364|37775570|FG000|Baseline Period|Protocol Violation|2|||
16832170|NCT02080364|37775571|FG001|Baseline Period|Protocol Violation|1|||
16832171|NCT02080364|37775572|FG002|Baseline Period|Protocol Violation|0|||
16832172|NCT02080364|37775573|FG003|Baseline Period|Protocol Violation|0|||
16832173|NCT02080364|37775570|FG000|Baseline Period|Other|0|||
16832174|NCT02080364|37775571|FG001|Baseline Period|Other|1|||
16832175|NCT02080364|37775572|FG002|Baseline Period|Other|1|||
16832176|NCT02080364|37775573|FG003|Baseline Period|Other|0|||
16832177|NCT02080364|37775570|FG000|Treatment Period|Adverse Event|10|||
16832178|NCT02080364|37775571|FG001|Treatment Period|Adverse Event|15|||
16832179|NCT02080364|37775572|FG002|Treatment Period|Adverse Event|11|||
16832180|NCT02080364|37775573|FG003|Treatment Period|Adverse Event|14|||
16832181|NCT02080364|37775570|FG000|Treatment Period|Lost to Follow-up|2|||
16832182|NCT02080364|37775571|FG001|Treatment Period|Lost to Follow-up|3|||
16832183|NCT02080364|37775572|FG002|Treatment Period|Lost to Follow-up|5|||
16832184|NCT02080364|37775573|FG003|Treatment Period|Lost to Follow-up|0|||
16832185|NCT02080364|37775570|FG000|Treatment Period|Protocol Violation|5|||
16832186|NCT02080364|37775571|FG001|Treatment Period|Protocol Violation|3|||
16832187|NCT02080364|37775572|FG002|Treatment Period|Protocol Violation|5|||
16832188|NCT02080364|37775573|FG003|Treatment Period|Protocol Violation|1|||
16832189|NCT02080364|37775570|FG000|Treatment Period|Withdrawal by Subject|16|||
16832190|NCT02080364|37775571|FG001|Treatment Period|Withdrawal by Subject|16|||
16832191|NCT02080364|37775572|FG002|Treatment Period|Withdrawal by Subject|15|||
16832192|NCT02080364|37775573|FG003|Treatment Period|Withdrawal by Subject|10|||
16832193|NCT02080364|37775570|FG000|Treatment Period|Study Terminated by Sponsor|0|||
16832194|NCT02080364|37775571|FG001|Treatment Period|Study Terminated by Sponsor|0|||
16832195|NCT02080364|37775572|FG002|Treatment Period|Study Terminated by Sponsor|180|||
16832196|NCT02080364|37775573|FG003|Treatment Period|Study Terminated by Sponsor|183|||
16832197|NCT02080364|37775570|FG000|Treatment Period|Other|14|||
16832198|NCT02080364|37775571|FG001|Treatment Period|Other|12|||
16832199|NCT02080364|37775572|FG002|Treatment Period|Other|21|||
16832200|NCT02080364|37775573|FG003|Treatment Period|Other|16|||
16832201|NCT02079038|37775585|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
16832202|NCT02079038|37775586|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
16832203|NCT02079038|37775585|FG000|Modified Intent to Treat Population|Death|1|||
16832204|NCT02079038|37775586|FG001|Modified Intent to Treat Population|Death|0|||
16832205|NCT02079038|37775585|FG000|Completed 6 Months|Lost to Follow-up|2|||
16832206|NCT02079038|37775586|FG001|Completed 6 Months|Lost to Follow-up|1|||
16832207|NCT02045732|37775594|FG000|Overall Study|At the discretion of the investigator|1|||
16832208|NCT02045732|37775595|FG001|Overall Study|At the discretion of the investigator|1|||
16832209|NCT02044874|37775604|FG000|Overall Study|Adverse Event|5|||
16832210|NCT02044874|37775605|FG001|Overall Study|Adverse Event|6|||
16832211|NCT02044874|37775606|FG002|Overall Study|Adverse Event|6|||
16832212|NCT02044874|37775604|FG000|Overall Study|Withdrawal by Subject|8|||
16832213|NCT02044874|37775605|FG001|Overall Study|Withdrawal by Subject|16|||
16832214|NCT02044874|37775606|FG002|Overall Study|Withdrawal by Subject|23|||
16832215|NCT02044874|37775604|FG000|Overall Study|Physician Decision|0|||
16832216|NCT02044874|37775605|FG001|Overall Study|Physician Decision|2|||
16832217|NCT02044874|37775606|FG002|Overall Study|Physician Decision|1|||
16832218|NCT02044874|37775604|FG000|Overall Study|Lost to Follow-up|10|||
16832219|NCT02044874|37775605|FG001|Overall Study|Lost to Follow-up|27|||
16832220|NCT02044874|37775606|FG002|Overall Study|Lost to Follow-up|21|||
16832221|NCT02044874|37775604|FG000|Overall Study|Sponsor Decision|0|||
16832222|NCT02044874|37775605|FG001|Overall Study|Sponsor Decision|1|||
16832223|NCT02044874|37775606|FG002|Overall Study|Sponsor Decision|1|||
16832224|NCT02044874|37775604|FG000|Overall Study|Other|7|||
16832225|NCT02044874|37775605|FG001|Overall Study|Other|3|||
16832226|NCT02044874|37775606|FG002|Overall Study|Other|8|||
16832227|NCT02078960|37775619|FG000|Treatment Period|Other|0|||
16832228|NCT02078960|37775620|FG001|Treatment Period|Other|0|||
16832229|NCT02078960|37775621|FG002|Treatment Period|Other|1|||
16832230|NCT02078960|37775619|FG000|Treatment Period|Lack of Efficacy|0|||
16832231|NCT02078960|37775620|FG001|Treatment Period|Lack of Efficacy|1|||
16832232|NCT02078960|37775621|FG002|Treatment Period|Lack of Efficacy|0|||
16832233|NCT02078960|37775619|FG000|Treatment Period|Disease progression - accelerated phase|0|||
16832234|NCT02078960|37775620|FG001|Treatment Period|Disease progression - accelerated phase|1|||
16832235|NCT02078960|37775621|FG002|Treatment Period|Disease progression - accelerated phase|0|||
16832236|NCT02078960|37775619|FG000|Treatment Period|Disease progression - blast phase|1|||
16832237|NCT02078960|37775620|FG001|Treatment Period|Disease progression - blast phase|0|||
16832238|NCT02078960|37775621|FG002|Treatment Period|Disease progression - blast phase|0|||
16832239|NCT02078960|37775619|FG000|Treatment Period|Withdrawal by Subject|0|||
16832240|NCT02078960|37775620|FG001|Treatment Period|Withdrawal by Subject|1|||
16832241|NCT02078960|37775621|FG002|Treatment Period|Withdrawal by Subject|1|||
16832242|NCT02078960|37775619|FG000|Treatment Period|Adverse Event|1|||
16832243|NCT02078960|37775620|FG001|Treatment Period|Adverse Event|0|||
16832244|NCT02078960|37775621|FG002|Treatment Period|Adverse Event|0|||
16832245|NCT02078960|37775619|FG000|Treatment Period|Death|0|||
16832246|NCT02078960|37775620|FG001|Treatment Period|Death|0|||
16832247|NCT02078960|37775621|FG002|Treatment Period|Death|1|||
16832248|NCT02078960|37775619|FG000|Follow-up Period|Death|2|||
16832249|NCT02078960|37775620|FG001|Follow-up Period|Death|0|||
16832250|NCT02078960|37775621|FG002|Follow-up Period|Death|0|||
16832251|NCT02078960|37775619|FG000|Follow-up Period|Lost to Follow-up|0|||
16832252|NCT02078960|37775620|FG001|Follow-up Period|Lost to Follow-up|1|||
16832253|NCT02078960|37775621|FG002|Follow-up Period|Lost to Follow-up|0|||
16832254|NCT02078102|37775633|FG000|Overall Study|Adverse Event|1|||
16832255|NCT02078102|37775634|FG001|Overall Study|Adverse Event|0|||
16832256|NCT02078102|37775633|FG000|Overall Study|Withdrawal by Subject|1|||
16832257|NCT02078102|37775634|FG001|Overall Study|Withdrawal by Subject|0|||
16832258|NCT02078102|37775633|FG000|Overall Study|Physician Decision|0|||
16832259|NCT02078102|37775634|FG001|Overall Study|Physician Decision|1|||
16832260|NCT02054702|37775643|FG000|Overall Study|Lost to Follow-up|3|||
16832261|NCT02054702|37775644|FG001|Overall Study|Lost to Follow-up|5|||
16832262|NCT02054702|37775643|FG000|Overall Study|Adverse Event|3|||
16832263|NCT02054702|37775644|FG001|Overall Study|Adverse Event|1|||
16832264|NCT02054702|37775643|FG000|Overall Study|Met Withdrawal Criteria|4|||
16832265|NCT02054702|37775644|FG001|Overall Study|Met Withdrawal Criteria|1|||
16832266|NCT02054702|37775643|FG000|Overall Study|Physician Decision|0|||
16832267|NCT02054702|37775644|FG001|Overall Study|Physician Decision|1|||
16832268|NCT02054702|37775643|FG000|Overall Study|Withdrawal by Subject|14|||
16832269|NCT02054702|37775644|FG001|Overall Study|Withdrawal by Subject|4|||
16832270|NCT02044094|37775650|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
16832271|NCT02044094|37775650|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
16832272|NCT02044094|37775650|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
16832273|NCT02044094|37775650|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
16832274|NCT02044094|37775650|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
16832275|NCT02044094|37775650|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
16832276|NCT02044094|37775650|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
16832277|NCT02044094|37775650|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
16832278|NCT02043938|37775665|FG000|Overall Study|Withdrawal by Subject|7|||
16832279|NCT02043938|37775665|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
16832280|NCT02043938|37775665|FG000|Overall Study|No show by subject|1|||
16832281|NCT02043938|37775665|FG000|Overall Study|Investigator decision|1|||
16832282|NCT02053610|37775674|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
16832283|NCT02053610|37775675|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
16832284|NCT02053610|37775674|FG000|Overall Study|Withdrew Consent|2|||
16832285|NCT02053610|37775675|FG001|Overall Study|Withdrew Consent|9|||
16832286|NCT02053610|37775674|FG000|Overall Study|Death|5|||
16832287|NCT02053610|37775675|FG001|Overall Study|Death|5|||
16832288|NCT02053610|37775674|FG000|Overall Study|Administrative/Other|1|||
16832289|NCT02053610|37775675|FG001|Overall Study|Administrative/Other|1|||
16832290|NCT02053610|37775674|FG000|Overall Study|Disease Progression|2|||
16832291|NCT02053610|37775675|FG001|Overall Study|Disease Progression|3|||
16832292|NCT02053610|37775674|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
16832293|NCT02053610|37775675|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
16832294|NCT02053610|37775674|FG000|Overall Study|Did not Receive Treatment|4|||
16832295|NCT02053610|37775675|FG001|Overall Study|Did not Receive Treatment|2|||
16832296|NCT02053610|37775674|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16832297|NCT02053610|37775675|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16832298|NCT02053610|37775674|FG000|Overall Study|Violation of Selection Criteria|1|||
16832299|NCT02053610|37775675|FG001|Overall Study|Violation of Selection Criteria|0|||
16832300|NCT02075606|37775681|FG000|Overall Study|Adverse Event|5|||
16832301|NCT02075606|37775681|FG000|Overall Study|Withdrawal by Subject|1|||
16832302|NCT02075606|37775681|FG000|Overall Study|Death|1|||
16832303|NCT02075606|37775681|FG000|Overall Study|Investigator's decision|1|||
17102413|NCT00383123|38241347|FG000|Overall Study|Withdrawal by Subject|27|||
16832304|NCT02075606|37775681|FG000|Overall Study|Symptom management|1|||
16832305|NCT02075606|37775681|FG000|Overall Study|Increasing Symptoms|1|||
16832306|NCT02043782|37775690|FG000|Period 1|Adverse Event|0|||
16832307|NCT02043782|37775691|FG001|Period 1|Adverse Event|0|||
16832308|NCT02043782|37775692|FG002|Period 1|Adverse Event|1|||
16832309|NCT02043782|37775693|FG003|Period 1|Adverse Event|0|||
16832310|NCT02043782|37775694|FG004|Period 1|Adverse Event|0|||
16832311|NCT02043782|37775695|FG005|Period 1|Adverse Event|0|||
16832312|NCT02052596|37775705|FG000|Active Phase|Adverse Event|3|||
16832313|NCT02052596|37775706|FG001|Active Phase|Adverse Event|2|||
16832314|NCT02052596|37775705|FG000|Active Phase|Lost to Follow-up|8|||
16832315|NCT02052596|37775706|FG001|Active Phase|Lost to Follow-up|11|||
16832316|NCT02052596|37775705|FG000|Active Phase|Protocol Violation|1|||
16832317|NCT02052596|37775706|FG001|Active Phase|Protocol Violation|2|||
16832318|NCT02052596|37775705|FG000|Active Phase|Withdrawal by Subject|3|||
16832319|NCT02052596|37775706|FG001|Active Phase|Withdrawal by Subject|4|||
16832320|NCT02052596|37775705|FG000|Active Phase|Enrolled in error|1|||
16832321|NCT02052596|37775706|FG001|Active Phase|Enrolled in error|0|||
16832322|NCT02052596|37775705|FG000|Active Phase|Lost due to Crohn's disease|0|||
16832323|NCT02052596|37775706|FG001|Active Phase|Lost due to Crohn's disease|1|||
16832324|NCT02052596|37775705|FG000|Safety Phase|Adverse Event|6|||
16832325|NCT02052596|37775706|FG001|Safety Phase|Adverse Event|3|||
16832326|NCT02052596|37775705|FG000|Safety Phase|Lost to Follow-up|11|||
16832327|NCT02052596|37775706|FG001|Safety Phase|Lost to Follow-up|18|||
16832328|NCT02052596|37775705|FG000|Safety Phase|Protocol Violation|1|||
16832329|NCT02052596|37775706|FG001|Safety Phase|Protocol Violation|2|||
16832330|NCT02052596|37775705|FG000|Safety Phase|Withdrawal by Subject|8|||
16832331|NCT02052596|37775706|FG001|Safety Phase|Withdrawal by Subject|11|||
16832332|NCT02052596|37775705|FG000|Safety Phase|Enrolled in error|1|||
16832333|NCT02052596|37775706|FG001|Safety Phase|Enrolled in error|0|||
16832334|NCT02052596|37775705|FG000|Safety Phase|Lost due to Crohn's disease|0|||
16832335|NCT02052596|37775706|FG001|Safety Phase|Lost due to Crohn's disease|1|||
16832336|NCT02052440|37775714|FG000|Overall Study|Withdrawal by Subject|0|||
16832337|NCT02052440|37775715|FG001|Overall Study|Withdrawal by Subject|1|||
16832338|NCT02049944|37775721|FG000|Overall Study|Protocol Violation|2|||
16832339|NCT02043548|37775727|FG000|Overall Study|Lack of Efficacy|1|||
16832340|NCT02043548|37775728|FG001|Overall Study|Lack of Efficacy|0|||
16832341|NCT02043548|37775727|FG000|Overall Study|Adverse Event|0|||
16832342|NCT02043548|37775728|FG001|Overall Study|Adverse Event|1|||
16832343|NCT01622348|37775737|FG000|Overall Study|Withdrawal by Subject|1|||
16832344|NCT01622348|37775738|FG001|Overall Study|Withdrawal by Subject|0|||
16832345|NCT01622348|37775739|FG002|Overall Study|Withdrawal by Subject|1|||
16832346|NCT01621880|37775749|FG000|Overall Study|Adverse Event|5|||
16832347|NCT01621880|37775750|FG001|Overall Study|Adverse Event|1|||
16832348|NCT01621880|37775749|FG000|Overall Study|Withdrawal by Subject|5|||
16832349|NCT01621880|37775750|FG001|Overall Study|Withdrawal by Subject|4|||
16832350|NCT01621802|37775763|FG000|Overall Study|Protocol Violation|0|||
16832351|NCT01621802|37775764|FG001|Overall Study|Protocol Violation|0|||
16832352|NCT01621802|37775765|FG002|Overall Study|Protocol Violation|0|||
16832353|NCT01621802|37775766|FG003|Overall Study|Protocol Violation|0|||
16832354|NCT01621802|37775767|FG004|Overall Study|Protocol Violation|0|||
16832355|NCT01621802|37775768|FG005|Overall Study|Protocol Violation|1|||
16832356|NCT01621802|37775763|FG000|Overall Study|Withdrawal by Subject|8|||
16832357|NCT01621802|37775764|FG001|Overall Study|Withdrawal by Subject|4|||
16832358|NCT01621802|37775765|FG002|Overall Study|Withdrawal by Subject|4|||
16832359|NCT01621802|37775766|FG003|Overall Study|Withdrawal by Subject|2|||
16832360|NCT01621802|37775767|FG004|Overall Study|Withdrawal by Subject|2|||
16832361|NCT01621802|37775768|FG005|Overall Study|Withdrawal by Subject|0|||
16832362|NCT01621802|37775763|FG000|Overall Study|Migrated/moved from study area|0|||
16832363|NCT01621802|37775764|FG001|Overall Study|Migrated/moved from study area|0|||
16832364|NCT01621802|37775765|FG002|Overall Study|Migrated/moved from study area|2|||
16832365|NCT01621802|37775766|FG003|Overall Study|Migrated/moved from study area|0|||
16832366|NCT01621802|37775767|FG004|Overall Study|Migrated/moved from study area|1|||
16832367|NCT01621802|37775768|FG005|Overall Study|Migrated/moved from study area|0|||
16832368|NCT01621802|37775763|FG000|Overall Study|Others|3|||
16832369|NCT01621802|37775764|FG001|Overall Study|Others|3|||
16832370|NCT01621802|37775765|FG002|Overall Study|Others|3|||
16832371|NCT01621802|37775766|FG003|Overall Study|Others|2|||
16832372|NCT01621802|37775767|FG004|Overall Study|Others|1|||
16832373|NCT01621802|37775768|FG005|Overall Study|Others|0|||
16832374|NCT01621802|37775763|FG000|Overall Study|Lost to Follow-up|36|||
16832375|NCT01621802|37775764|FG001|Overall Study|Lost to Follow-up|16|||
16832376|NCT01621802|37775765|FG002|Overall Study|Lost to Follow-up|24|||
16832377|NCT01621802|37775766|FG003|Overall Study|Lost to Follow-up|7|||
16832378|NCT01621802|37775767|FG004|Overall Study|Lost to Follow-up|31|||
16832379|NCT01621802|37775768|FG005|Overall Study|Lost to Follow-up|11|||
16832380|NCT02059291|37775794|FG000|Epoch 2|Lack of Efficacy|0|||
16832381|NCT02059291|37775795|FG001|Epoch 2|Lack of Efficacy|0|||
16832382|NCT02059291|37775796|FG002|Epoch 2|Lack of Efficacy|0|||
16832383|NCT02059291|37775797|FG003|Epoch 2|Lack of Efficacy|1|||
16832384|NCT02059291|37775798|FG004|Epoch 2|Lack of Efficacy|0|||
16832385|NCT02059291|37775799|FG005|Epoch 2|Lack of Efficacy|1|||
16832386|NCT02059291|37775800|FG006|Epoch 2|Lack of Efficacy|0|||
16832387|NCT02059291|37775801|FG007|Epoch 2|Lack of Efficacy|0|||
16832388|NCT02059291|37775802|FG008|Epoch 2|Lack of Efficacy|0|||
16832389|NCT02059291|37775803|FG009|Epoch 2|Lack of Efficacy|0|||
16832390|NCT02059291|37775804|FG010|Epoch 2|Lack of Efficacy|0|||
16832391|NCT02059291|37775805|FG011|Epoch 2|Lack of Efficacy|0|||
16832392|NCT02059291|37775806|FG012|Epoch 2|Lack of Efficacy|0|||
16832393|NCT02059291|37775807|FG013|Epoch 2|Lack of Efficacy|0|||
16832394|NCT02059291|37775808|FG014|Epoch 2|Lack of Efficacy|0|||
16832395|NCT02059291|37775809|FG015|Epoch 2|Lack of Efficacy|0|||
16832396|NCT02059291|37775810|FG016|Epoch 2|Lack of Efficacy|0|||
16832397|NCT02059291|37775811|FG017|Epoch 2|Lack of Efficacy|0|||
16832398|NCT02059291|37775812|FG018|Epoch 2|Lack of Efficacy|0|||
16832399|NCT02059291|37775813|FG019|Epoch 2|Lack of Efficacy|0|||
16832400|NCT02059291|37775814|FG020|Epoch 2|Lack of Efficacy|0|||
16832401|NCT02059291|37775815|FG021|Epoch 2|Lack of Efficacy|0|||
16832402|NCT02059291|37775816|FG022|Epoch 2|Lack of Efficacy|0|||
16832403|NCT02059291|37775817|FG023|Epoch 2|Lack of Efficacy|0|||
16832404|NCT02059291|37775818|FG024|Epoch 2|Lack of Efficacy|0|||
16832405|NCT02059291|37775794|FG000|Epoch 2|Adverse Event|0|||
16832406|NCT02059291|37775795|FG001|Epoch 2|Adverse Event|0|||
16832407|NCT02059291|37775796|FG002|Epoch 2|Adverse Event|1|||
16832408|NCT02059291|37775797|FG003|Epoch 2|Adverse Event|1|||
16832409|NCT02059291|37775798|FG004|Epoch 2|Adverse Event|0|||
16832410|NCT02059291|37775799|FG005|Epoch 2|Adverse Event|0|||
16832411|NCT02059291|37775800|FG006|Epoch 2|Adverse Event|0|||
16832412|NCT02059291|37775801|FG007|Epoch 2|Adverse Event|1|||
16832413|NCT02059291|37775802|FG008|Epoch 2|Adverse Event|1|||
16832414|NCT02059291|37775803|FG009|Epoch 2|Adverse Event|0|||
16832415|NCT02059291|37775804|FG010|Epoch 2|Adverse Event|0|||
16832416|NCT02059291|37775805|FG011|Epoch 2|Adverse Event|0|||
16832417|NCT02059291|37775806|FG012|Epoch 2|Adverse Event|0|||
16832418|NCT02059291|37775807|FG013|Epoch 2|Adverse Event|0|||
16832419|NCT02059291|37775808|FG014|Epoch 2|Adverse Event|0|||
16832420|NCT02059291|37775809|FG015|Epoch 2|Adverse Event|0|||
16832421|NCT02059291|37775810|FG016|Epoch 2|Adverse Event|0|||
16832422|NCT02059291|37775811|FG017|Epoch 2|Adverse Event|0|||
16832423|NCT02059291|37775812|FG018|Epoch 2|Adverse Event|0|||
16832424|NCT02059291|37775813|FG019|Epoch 2|Adverse Event|0|||
16832425|NCT02059291|37775814|FG020|Epoch 2|Adverse Event|0|||
16832426|NCT02059291|37775815|FG021|Epoch 2|Adverse Event|0|||
16832427|NCT02059291|37775816|FG022|Epoch 2|Adverse Event|0|||
16832428|NCT02059291|37775817|FG023|Epoch 2|Adverse Event|0|||
16832429|NCT02059291|37775818|FG024|Epoch 2|Adverse Event|0|||
16832430|NCT02059291|37775794|FG000|Epoch 2|Withdrawal by Subject|0|||
16832431|NCT02059291|37775795|FG001|Epoch 2|Withdrawal by Subject|1|||
16832432|NCT02059291|37775796|FG002|Epoch 2|Withdrawal by Subject|0|||
16832433|NCT02059291|37775797|FG003|Epoch 2|Withdrawal by Subject|0|||
16832434|NCT02059291|37775798|FG004|Epoch 2|Withdrawal by Subject|0|||
16832435|NCT02059291|37775799|FG005|Epoch 2|Withdrawal by Subject|1|||
16832436|NCT02059291|37775800|FG006|Epoch 2|Withdrawal by Subject|0|||
16832437|NCT02059291|37775801|FG007|Epoch 2|Withdrawal by Subject|0|||
16832438|NCT02059291|37775802|FG008|Epoch 2|Withdrawal by Subject|1|||
16832439|NCT02059291|37775803|FG009|Epoch 2|Withdrawal by Subject|0|||
16832440|NCT02059291|37775804|FG010|Epoch 2|Withdrawal by Subject|0|||
16832441|NCT02059291|37775805|FG011|Epoch 2|Withdrawal by Subject|0|||
16832442|NCT02059291|37775806|FG012|Epoch 2|Withdrawal by Subject|0|||
16832443|NCT02059291|37775807|FG013|Epoch 2|Withdrawal by Subject|0|||
16832444|NCT02059291|37775808|FG014|Epoch 2|Withdrawal by Subject|0|||
16832445|NCT02059291|37775809|FG015|Epoch 2|Withdrawal by Subject|0|||
16832446|NCT02059291|37775810|FG016|Epoch 2|Withdrawal by Subject|0|||
16832447|NCT02059291|37775811|FG017|Epoch 2|Withdrawal by Subject|0|||
16832448|NCT02059291|37775812|FG018|Epoch 2|Withdrawal by Subject|0|||
16832449|NCT02059291|37775813|FG019|Epoch 2|Withdrawal by Subject|0|||
16832450|NCT02059291|37775814|FG020|Epoch 2|Withdrawal by Subject|0|||
16832451|NCT02059291|37775815|FG021|Epoch 2|Withdrawal by Subject|0|||
16832452|NCT02059291|37775816|FG022|Epoch 2|Withdrawal by Subject|0|||
16832453|NCT02059291|37775817|FG023|Epoch 2|Withdrawal by Subject|0|||
16832454|NCT02059291|37775818|FG024|Epoch 2|Withdrawal by Subject|0|||
16832455|NCT02059291|37775794|FG000|Epoch 3|Physician Decision|0|||
16832456|NCT02059291|37775795|FG001|Epoch 3|Physician Decision|0|||
16832457|NCT02059291|37775796|FG002|Epoch 3|Physician Decision|0|||
16832458|NCT02059291|37775797|FG003|Epoch 3|Physician Decision|0|||
16832459|NCT02059291|37775798|FG004|Epoch 3|Physician Decision|0|||
16832460|NCT02059291|37775799|FG005|Epoch 3|Physician Decision|0|||
16832461|NCT02059291|37775800|FG006|Epoch 3|Physician Decision|0|||
16832462|NCT02059291|37775801|FG007|Epoch 3|Physician Decision|0|||
16832463|NCT02059291|37775802|FG008|Epoch 3|Physician Decision|0|||
16832464|NCT02059291|37775803|FG009|Epoch 3|Physician Decision|0|||
16832465|NCT02059291|37775804|FG010|Epoch 3|Physician Decision|0|||
16832466|NCT02059291|37775805|FG011|Epoch 3|Physician Decision|0|||
16832467|NCT02059291|37775806|FG012|Epoch 3|Physician Decision|0|||
16832468|NCT02059291|37775807|FG013|Epoch 3|Physician Decision|1|||
16832469|NCT02059291|37775808|FG014|Epoch 3|Physician Decision|0|||
16832470|NCT02059291|37775809|FG015|Epoch 3|Physician Decision|1|||
16832471|NCT02059291|37775810|FG016|Epoch 3|Physician Decision|0|||
16832472|NCT02059291|37775811|FG017|Epoch 3|Physician Decision|0|||
16832473|NCT02059291|37775812|FG018|Epoch 3|Physician Decision|0|||
16832474|NCT02059291|37775813|FG019|Epoch 3|Physician Decision|0|||
16832475|NCT02059291|37775814|FG020|Epoch 3|Physician Decision|0|||
16832476|NCT02059291|37775815|FG021|Epoch 3|Physician Decision|0|||
16832477|NCT02059291|37775816|FG022|Epoch 3|Physician Decision|0|||
16832478|NCT02059291|37775817|FG023|Epoch 3|Physician Decision|0|||
16832479|NCT02059291|37775818|FG024|Epoch 3|Physician Decision|0|||
16832480|NCT02059291|37775794|FG000|Epoch 3|Adverse Event|0|||
16832481|NCT02059291|37775795|FG001|Epoch 3|Adverse Event|0|||
16832482|NCT02059291|37775796|FG002|Epoch 3|Adverse Event|0|||
16832483|NCT02059291|37775797|FG003|Epoch 3|Adverse Event|0|||
16832484|NCT02059291|37775798|FG004|Epoch 3|Adverse Event|0|||
16832485|NCT02059291|37775799|FG005|Epoch 3|Adverse Event|0|||
16832486|NCT02059291|37775800|FG006|Epoch 3|Adverse Event|0|||
16832487|NCT02059291|37775801|FG007|Epoch 3|Adverse Event|0|||
16832488|NCT02059291|37775802|FG008|Epoch 3|Adverse Event|0|||
16832489|NCT02059291|37775803|FG009|Epoch 3|Adverse Event|0|||
16832490|NCT02059291|37775804|FG010|Epoch 3|Adverse Event|0|||
16832491|NCT02059291|37775805|FG011|Epoch 3|Adverse Event|0|||
16832492|NCT02059291|37775806|FG012|Epoch 3|Adverse Event|0|||
16832493|NCT02059291|37775807|FG013|Epoch 3|Adverse Event|0|||
16832494|NCT02059291|37775808|FG014|Epoch 3|Adverse Event|0|||
16832495|NCT02059291|37775809|FG015|Epoch 3|Adverse Event|1|||
16832496|NCT02059291|37775810|FG016|Epoch 3|Adverse Event|0|||
16832497|NCT02059291|37775811|FG017|Epoch 3|Adverse Event|0|||
16832498|NCT02059291|37775812|FG018|Epoch 3|Adverse Event|0|||
16832499|NCT02059291|37775813|FG019|Epoch 3|Adverse Event|0|||
16832500|NCT02059291|37775814|FG020|Epoch 3|Adverse Event|0|||
16832501|NCT02059291|37775815|FG021|Epoch 3|Adverse Event|0|||
16832502|NCT02059291|37775816|FG022|Epoch 3|Adverse Event|0|||
16832503|NCT02059291|37775817|FG023|Epoch 3|Adverse Event|0|||
16832504|NCT02059291|37775818|FG024|Epoch 3|Adverse Event|0|||
16832505|NCT02059291|37775794|FG000|Epoch 3|Lack of Efficacy|0|||
16832506|NCT02059291|37775795|FG001|Epoch 3|Lack of Efficacy|0|||
16832507|NCT02059291|37775796|FG002|Epoch 3|Lack of Efficacy|0|||
16832508|NCT02059291|37775797|FG003|Epoch 3|Lack of Efficacy|0|||
16832509|NCT02059291|37775798|FG004|Epoch 3|Lack of Efficacy|0|||
16832510|NCT02059291|37775799|FG005|Epoch 3|Lack of Efficacy|0|||
16832511|NCT02059291|37775800|FG006|Epoch 3|Lack of Efficacy|0|||
16832512|NCT02059291|37775801|FG007|Epoch 3|Lack of Efficacy|0|||
16832513|NCT02059291|37775802|FG008|Epoch 3|Lack of Efficacy|0|||
16832514|NCT02059291|37775803|FG009|Epoch 3|Lack of Efficacy|0|||
16832515|NCT02059291|37775804|FG010|Epoch 3|Lack of Efficacy|0|||
16832516|NCT02059291|37775805|FG011|Epoch 3|Lack of Efficacy|0|||
16832517|NCT02059291|37775806|FG012|Epoch 3|Lack of Efficacy|0|||
16832518|NCT02059291|37775807|FG013|Epoch 3|Lack of Efficacy|0|||
16832519|NCT02059291|37775808|FG014|Epoch 3|Lack of Efficacy|0|||
16832520|NCT02059291|37775809|FG015|Epoch 3|Lack of Efficacy|3|||
16832521|NCT02059291|37775810|FG016|Epoch 3|Lack of Efficacy|0|||
16832522|NCT02059291|37775811|FG017|Epoch 3|Lack of Efficacy|0|||
16832523|NCT02059291|37775812|FG018|Epoch 3|Lack of Efficacy|0|||
16832524|NCT02059291|37775813|FG019|Epoch 3|Lack of Efficacy|0|||
16832525|NCT02059291|37775814|FG020|Epoch 3|Lack of Efficacy|0|||
16832526|NCT02059291|37775815|FG021|Epoch 3|Lack of Efficacy|0|||
16832527|NCT02059291|37775816|FG022|Epoch 3|Lack of Efficacy|0|||
16832528|NCT02059291|37775817|FG023|Epoch 3|Lack of Efficacy|0|||
16832529|NCT02059291|37775818|FG024|Epoch 3|Lack of Efficacy|0|||
16832530|NCT02059291|37775794|FG000|Epoch 3|Withdrawal by Subject|0|||
16832531|NCT02059291|37775795|FG001|Epoch 3|Withdrawal by Subject|0|||
16832532|NCT02059291|37775796|FG002|Epoch 3|Withdrawal by Subject|0|||
16832533|NCT02059291|37775797|FG003|Epoch 3|Withdrawal by Subject|0|||
16832534|NCT02059291|37775798|FG004|Epoch 3|Withdrawal by Subject|0|||
16832535|NCT02059291|37775799|FG005|Epoch 3|Withdrawal by Subject|0|||
16832536|NCT02059291|37775800|FG006|Epoch 3|Withdrawal by Subject|0|||
16832537|NCT02059291|37775801|FG007|Epoch 3|Withdrawal by Subject|0|||
16832538|NCT02059291|37775802|FG008|Epoch 3|Withdrawal by Subject|0|||
16832539|NCT02059291|37775803|FG009|Epoch 3|Withdrawal by Subject|0|||
16832540|NCT02059291|37775804|FG010|Epoch 3|Withdrawal by Subject|0|||
16832541|NCT02059291|37775805|FG011|Epoch 3|Withdrawal by Subject|0|||
16832542|NCT02059291|37775806|FG012|Epoch 3|Withdrawal by Subject|0|||
16832543|NCT02059291|37775807|FG013|Epoch 3|Withdrawal by Subject|0|||
16832544|NCT02059291|37775808|FG014|Epoch 3|Withdrawal by Subject|0|||
16832545|NCT02059291|37775809|FG015|Epoch 3|Withdrawal by Subject|1|||
16832546|NCT02059291|37775810|FG016|Epoch 3|Withdrawal by Subject|0|||
16832547|NCT02059291|37775811|FG017|Epoch 3|Withdrawal by Subject|0|||
16832548|NCT02059291|37775812|FG018|Epoch 3|Withdrawal by Subject|0|||
16832549|NCT02059291|37775813|FG019|Epoch 3|Withdrawal by Subject|0|||
16832550|NCT02059291|37775814|FG020|Epoch 3|Withdrawal by Subject|0|||
16832551|NCT02059291|37775815|FG021|Epoch 3|Withdrawal by Subject|0|||
16832552|NCT02059291|37775816|FG022|Epoch 3|Withdrawal by Subject|0|||
16832553|NCT02059291|37775817|FG023|Epoch 3|Withdrawal by Subject|0|||
16832554|NCT02059291|37775818|FG024|Epoch 3|Withdrawal by Subject|0|||
16832555|NCT02059291|37775794|FG000|Epoch 4|Adverse Event|0|||
16832556|NCT02059291|37775795|FG001|Epoch 4|Adverse Event|0|||
16832557|NCT02059291|37775796|FG002|Epoch 4|Adverse Event|0|||
16832558|NCT02059291|37775797|FG003|Epoch 4|Adverse Event|0|||
16832559|NCT02059291|37775798|FG004|Epoch 4|Adverse Event|0|||
16832560|NCT02059291|37775799|FG005|Epoch 4|Adverse Event|0|||
16832561|NCT02059291|37775800|FG006|Epoch 4|Adverse Event|0|||
16832562|NCT02059291|37775801|FG007|Epoch 4|Adverse Event|0|||
16832563|NCT02059291|37775802|FG008|Epoch 4|Adverse Event|0|||
16832564|NCT02059291|37775803|FG009|Epoch 4|Adverse Event|0|||
16832565|NCT02059291|37775804|FG010|Epoch 4|Adverse Event|0|||
16832566|NCT02059291|37775805|FG011|Epoch 4|Adverse Event|0|||
16832567|NCT02059291|37775806|FG012|Epoch 4|Adverse Event|0|||
16832568|NCT02059291|37775807|FG013|Epoch 4|Adverse Event|0|||
16832569|NCT02059291|37775808|FG014|Epoch 4|Adverse Event|0|||
16832570|NCT02059291|37775809|FG015|Epoch 4|Adverse Event|0|||
16832571|NCT02059291|37775810|FG016|Epoch 4|Adverse Event|1|||
16832572|NCT02059291|37775811|FG017|Epoch 4|Adverse Event|0|||
16832573|NCT02059291|37775812|FG018|Epoch 4|Adverse Event|0|||
16832574|NCT02059291|37775813|FG019|Epoch 4|Adverse Event|0|||
16832575|NCT02059291|37775814|FG020|Epoch 4|Adverse Event|0|||
16832576|NCT02059291|37775815|FG021|Epoch 4|Adverse Event|0|||
16832577|NCT02059291|37775816|FG022|Epoch 4|Adverse Event|1|||
16832578|NCT02059291|37775817|FG023|Epoch 4|Adverse Event|0|||
16832579|NCT02059291|37775818|FG024|Epoch 4|Adverse Event|0|||
16832580|NCT02059291|37775794|FG000|Epoch 4|Pregnancy|0|||
16832581|NCT02059291|37775795|FG001|Epoch 4|Pregnancy|0|||
16832582|NCT02059291|37775796|FG002|Epoch 4|Pregnancy|0|||
16832583|NCT02059291|37775797|FG003|Epoch 4|Pregnancy|0|||
16832584|NCT02059291|37775798|FG004|Epoch 4|Pregnancy|0|||
16832585|NCT02059291|37775799|FG005|Epoch 4|Pregnancy|0|||
16832586|NCT02059291|37775800|FG006|Epoch 4|Pregnancy|0|||
16832587|NCT02059291|37775801|FG007|Epoch 4|Pregnancy|0|||
16832588|NCT02059291|37775802|FG008|Epoch 4|Pregnancy|0|||
16832589|NCT02059291|37775803|FG009|Epoch 4|Pregnancy|0|||
16832590|NCT02059291|37775804|FG010|Epoch 4|Pregnancy|0|||
16832591|NCT02059291|37775805|FG011|Epoch 4|Pregnancy|0|||
16832592|NCT02059291|37775806|FG012|Epoch 4|Pregnancy|0|||
16832593|NCT02059291|37775807|FG013|Epoch 4|Pregnancy|0|||
16832594|NCT02059291|37775808|FG014|Epoch 4|Pregnancy|0|||
16832595|NCT02059291|37775809|FG015|Epoch 4|Pregnancy|0|||
16832596|NCT02059291|37775810|FG016|Epoch 4|Pregnancy|1|||
16832597|NCT02059291|37775811|FG017|Epoch 4|Pregnancy|0|||
16832598|NCT02059291|37775812|FG018|Epoch 4|Pregnancy|0|||
16832599|NCT02059291|37775813|FG019|Epoch 4|Pregnancy|0|||
16832600|NCT02059291|37775814|FG020|Epoch 4|Pregnancy|0|||
16832601|NCT02059291|37775815|FG021|Epoch 4|Pregnancy|0|||
16832602|NCT02059291|37775816|FG022|Epoch 4|Pregnancy|0|||
16832603|NCT02059291|37775817|FG023|Epoch 4|Pregnancy|0|||
16832604|NCT02059291|37775818|FG024|Epoch 4|Pregnancy|0|||
16832605|NCT02059291|37775794|FG000|Epoch 4|Withdrawal by Subject|0|||
16832606|NCT02059291|37775795|FG001|Epoch 4|Withdrawal by Subject|0|||
16832607|NCT02059291|37775796|FG002|Epoch 4|Withdrawal by Subject|0|||
16832608|NCT02059291|37775797|FG003|Epoch 4|Withdrawal by Subject|0|||
16832609|NCT02059291|37775798|FG004|Epoch 4|Withdrawal by Subject|0|||
16832610|NCT02059291|37775799|FG005|Epoch 4|Withdrawal by Subject|0|||
16832611|NCT02059291|37775800|FG006|Epoch 4|Withdrawal by Subject|0|||
16832612|NCT02059291|37775801|FG007|Epoch 4|Withdrawal by Subject|0|||
16832613|NCT02059291|37775802|FG008|Epoch 4|Withdrawal by Subject|0|||
16832614|NCT02059291|37775803|FG009|Epoch 4|Withdrawal by Subject|0|||
16832615|NCT02059291|37775804|FG010|Epoch 4|Withdrawal by Subject|0|||
16832616|NCT02059291|37775805|FG011|Epoch 4|Withdrawal by Subject|0|||
16832617|NCT02059291|37775806|FG012|Epoch 4|Withdrawal by Subject|0|||
16832618|NCT02059291|37775807|FG013|Epoch 4|Withdrawal by Subject|0|||
16832619|NCT02059291|37775808|FG014|Epoch 4|Withdrawal by Subject|0|||
16832620|NCT02059291|37775809|FG015|Epoch 4|Withdrawal by Subject|0|||
16832621|NCT02059291|37775810|FG016|Epoch 4|Withdrawal by Subject|0|||
16832622|NCT02059291|37775811|FG017|Epoch 4|Withdrawal by Subject|0|||
16832623|NCT02059291|37775812|FG018|Epoch 4|Withdrawal by Subject|0|||
16832624|NCT02059291|37775813|FG019|Epoch 4|Withdrawal by Subject|0|||
16832625|NCT02059291|37775814|FG020|Epoch 4|Withdrawal by Subject|1|||
16832626|NCT02059291|37775815|FG021|Epoch 4|Withdrawal by Subject|0|||
16832627|NCT02059291|37775816|FG022|Epoch 4|Withdrawal by Subject|0|||
16832628|NCT02059291|37775817|FG023|Epoch 4|Withdrawal by Subject|0|||
16832629|NCT02059291|37775818|FG024|Epoch 4|Withdrawal by Subject|0|||
16832630|NCT02059291|37775794|FG000|Epoch 4|Lack of Efficacy|0|||
16832631|NCT02059291|37775795|FG001|Epoch 4|Lack of Efficacy|0|||
16832632|NCT02059291|37775796|FG002|Epoch 4|Lack of Efficacy|0|||
16832633|NCT02059291|37775797|FG003|Epoch 4|Lack of Efficacy|0|||
16832634|NCT02059291|37775798|FG004|Epoch 4|Lack of Efficacy|0|||
16832635|NCT02059291|37775799|FG005|Epoch 4|Lack of Efficacy|0|||
16832636|NCT02059291|37775800|FG006|Epoch 4|Lack of Efficacy|0|||
16832637|NCT02059291|37775801|FG007|Epoch 4|Lack of Efficacy|0|||
16832638|NCT02059291|37775802|FG008|Epoch 4|Lack of Efficacy|0|||
16832639|NCT02059291|37775803|FG009|Epoch 4|Lack of Efficacy|0|||
16832640|NCT02059291|37775804|FG010|Epoch 4|Lack of Efficacy|0|||
16832641|NCT02059291|37775805|FG011|Epoch 4|Lack of Efficacy|0|||
16832642|NCT02059291|37775806|FG012|Epoch 4|Lack of Efficacy|0|||
16832643|NCT02059291|37775807|FG013|Epoch 4|Lack of Efficacy|0|||
16832644|NCT02059291|37775808|FG014|Epoch 4|Lack of Efficacy|0|||
16832645|NCT02059291|37775809|FG015|Epoch 4|Lack of Efficacy|0|||
16832646|NCT02059291|37775810|FG016|Epoch 4|Lack of Efficacy|0|||
16832647|NCT02059291|37775811|FG017|Epoch 4|Lack of Efficacy|0|||
16832648|NCT02059291|37775812|FG018|Epoch 4|Lack of Efficacy|0|||
16832649|NCT02059291|37775813|FG019|Epoch 4|Lack of Efficacy|0|||
16832650|NCT02059291|37775814|FG020|Epoch 4|Lack of Efficacy|0|||
16832651|NCT02059291|37775815|FG021|Epoch 4|Lack of Efficacy|0|||
16832652|NCT02059291|37775816|FG022|Epoch 4|Lack of Efficacy|0|||
16832653|NCT02059291|37775817|FG023|Epoch 4|Lack of Efficacy|1|||
16832654|NCT02059291|37775818|FG024|Epoch 4|Lack of Efficacy|0|||
16832655|NCT01621568|37775848|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
16832656|NCT01621568|37775849|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
16832657|NCT01621568|37775848|FG000|Week 5-6 No Treatment|Death|1|||
16832658|NCT01621568|37775849|FG001|Week 5-6 No Treatment|Death|0|||
16832659|NCT02042924|37775858|FG000|Overall Study|Early Death|1|||
16832660|NCT02041520|37775864|FG000|Overall Study|Adverse Event|2|||
16832661|NCT02041520|37775865|FG001|Overall Study|Adverse Event|1|||
16832662|NCT02041520|37775864|FG000|Overall Study|Withdrawal by Subject|3|||
16832663|NCT02041520|37775865|FG001|Overall Study|Withdrawal by Subject|4|||
16832664|NCT02041520|37775864|FG000|Overall Study|Protocol Violation|1|||
16832665|NCT02041520|37775865|FG001|Overall Study|Protocol Violation|0|||
16832666|NCT02041520|37775864|FG000|Overall Study|Lost to Follow-up|0|||
16832667|NCT02041520|37775865|FG001|Overall Study|Lost to Follow-up|1|||
16832668|NCT02041520|37775864|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
16832669|NCT02041520|37775865|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
16832670|NCT02041429|37775877|FG000|Overall Study|Progressive Disease|2|||
16832671|NCT02041429|37775878|FG001|Overall Study|Progressive Disease|2|||
16832672|NCT02041429|37775879|FG002|Overall Study|Progressive Disease|3|||
16832673|NCT02041429|37775880|FG003|Overall Study|Progressive Disease|2|||
16832674|NCT02041429|37775877|FG000|Overall Study|Toxicity|0|||
16832675|NCT02041429|37775878|FG001|Overall Study|Toxicity|1|||
16832676|NCT02041429|37775879|FG002|Overall Study|Toxicity|4|||
16832677|NCT02041429|37775880|FG003|Overall Study|Toxicity|2|||
16832678|NCT02041429|37775877|FG000|Overall Study|Withdrawal by Subject|0|||
16832679|NCT02041429|37775878|FG001|Overall Study|Withdrawal by Subject|1|||
16832680|NCT02041429|37775879|FG002|Overall Study|Withdrawal by Subject|0|||
16832681|NCT02041429|37775880|FG003|Overall Study|Withdrawal by Subject|0|||
16832682|NCT02041429|37775877|FG000|Overall Study|On Maintenance Therapy|1|||
16832683|NCT02041429|37775878|FG001|Overall Study|On Maintenance Therapy|0|||
16832684|NCT02041429|37775879|FG002|Overall Study|On Maintenance Therapy|0|||
16832685|NCT02041429|37775880|FG003|Overall Study|On Maintenance Therapy|2|||
16832686|NCT02083783|37775897|FG000|Overall Study|Withdrawal by Subject|1|||
16832687|NCT02083783|37775898|FG001|Overall Study|Withdrawal by Subject|0|||
16832688|NCT02083081|37775908|FG000|Overall Study|Lost to Follow-up|31|||
16832689|NCT02083081|37775909|FG001|Overall Study|Lost to Follow-up|9|||
16832690|NCT02040805|37775917|FG000|Overall Study|Lost to Follow-up|14|||
16832691|NCT02040805|37775918|FG001|Overall Study|Lost to Follow-up|9|||
16832692|NCT02040805|37775917|FG000|Overall Study|Withdrawal by Subject|28|||
16832693|NCT02040805|37775918|FG001|Overall Study|Withdrawal by Subject|41|||
16832694|NCT02040259|37775924|FG000|Overall Study|Death|280|||
16832695|NCT02040259|37775924|FG000|Overall Study|Lost to Follow-up|76|||
16832696|NCT02040259|37775924|FG000|Overall Study|Assessment not completed|3|||
16832697|NCT02040259|37775924|FG000|Overall Study|Withdrawal by Subject|4|||
16832698|NCT02059135|37775932|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
16832699|NCT02059135|37775933|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
16832700|NCT02059135|37775932|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
16832701|NCT02059135|37775933|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
16832702|NCT02059135|37775932|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
16832703|NCT02059135|37775933|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
16832704|NCT02059135|37775932|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
16832705|NCT02059135|37775933|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
16832706|NCT02059135|37775932|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
16832707|NCT02059135|37775933|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
16832708|NCT02059135|37775932|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
16832709|NCT02059135|37775933|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
16832710|NCT02059135|37775932|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
16832711|NCT02059135|37775933|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
16832712|NCT02059135|37775932|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
16832713|NCT02059135|37775933|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
16832714|NCT02081677|37775945|FG000|Overall Study|Adverse Event|0|||
16832715|NCT02081677|37775946|FG001|Overall Study|Adverse Event|0|||
16832716|NCT02081677|37775947|FG002|Overall Study|Adverse Event|1|||
16832717|NCT02081677|37775948|FG003|Overall Study|Adverse Event|0|||
16832718|NCT02081677|37775945|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16832719|NCT02081677|37775946|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16832720|NCT02081677|37775947|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
16832721|NCT02081677|37775948|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
16832722|NCT02081677|37775945|FG000|Overall Study|Not comfortable with lens care system|1|||
16832723|NCT02081677|37775946|FG001|Overall Study|Not comfortable with lens care system|0|||
16832724|NCT02081677|37775947|FG002|Overall Study|Not comfortable with lens care system|0|||
16832725|NCT02081677|37775948|FG003|Overall Study|Not comfortable with lens care system|0|||
16832726|NCT02081677|37775945|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
16832727|NCT02081677|37775946|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
16832728|NCT02081677|37775947|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
16832729|NCT02081677|37775948|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
16832730|NCT02038933|37775960|FG000|Overall Study|Disease progression|104|||
16832731|NCT02038933|37775960|FG000|Overall Study|Study drug toxicity|6|||
16832732|NCT02038933|37775960|FG000|Overall Study|Adverse event unrelated to study drug|6|||
16832733|NCT02038933|37775960|FG000|Overall Study|Participant request to discontinue treatment|2|||
16832734|NCT02038933|37775960|FG000|Overall Study|Lost to Follow-up|1|||
16832735|NCT02038933|37775960|FG000|Overall Study|Other reasons|2|||
16832736|NCT02081599|37775967|FG000|Period 1：Double-blind Period|Adverse Event|3|||
16832737|NCT02081599|37775968|FG001|Period 1：Double-blind Period|Adverse Event|0|||
16832738|NCT02081599|37775967|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
16832739|NCT02081599|37775968|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
16832740|NCT02081599|37775967|FG000|Period 1：Double-blind Period|Physician Decision|1|||
16832741|NCT02081599|37775968|FG001|Period 1：Double-blind Period|Physician Decision|0|||
16832742|NCT02081599|37775967|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
16832743|NCT02081599|37775968|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
16832744|NCT02081599|37775967|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
16832745|NCT02081599|37775968|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
16832746|NCT02081599|37775967|FG000|Period 1：Double-blind Period|stopping criteria|1|||
16832747|NCT02081599|37775968|FG001|Period 1：Double-blind Period|stopping criteria|0|||
16832748|NCT02081599|37775967|FG000|Period 2：Open-label Period|Adverse Event|1|||
16832749|NCT02081599|37775968|FG001|Period 2：Open-label Period|Adverse Event|0|||
16832750|NCT02081599|37775967|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
16832751|NCT02081599|37775968|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
16832752|NCT02081599|37775967|FG000|Period 2：Open-label Period|Physician Decision|1|||
16832753|NCT02081599|37775968|FG001|Period 2：Open-label Period|Physician Decision|0|||
16832754|NCT02081599|37775967|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
16832755|NCT02081599|37775968|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
16832756|NCT02038543|37775980|FG000|Overall Study|Screen Failure|0|||
16832757|NCT02038543|37775981|FG001|Overall Study|Screen Failure|0|||
16832758|NCT02038543|37775982|FG002|Overall Study|Screen Failure|0|||
16832759|NCT02038543|37775983|FG003|Overall Study|Screen Failure|1|||
16832760|NCT02038543|37775980|FG000|Overall Study|Withdrawal by Subject|0|||
16832761|NCT02038543|37775981|FG001|Overall Study|Withdrawal by Subject|0|||
16832762|NCT02038543|37775982|FG002|Overall Study|Withdrawal by Subject|0|||
16832763|NCT02038543|37775983|FG003|Overall Study|Withdrawal by Subject|1|||
16832764|NCT02038153|37775993|FG000|Overall Study|Withdrawal by Subject|1|||
16832765|NCT02038075|37775999|FG000|Overall Study|Withdrawal by Subject|3|||
16832766|NCT02038075|37776000|FG001|Overall Study|Withdrawal by Subject|0|||
16832767|NCT02058589|37776008|FG000|Overall Study|Serious Adverse Event|1|||
16832768|NCT02058589|37776009|FG001|Overall Study|Serious Adverse Event|1|||
16832769|NCT02058589|37776008|FG000|Overall Study|Non-Serious Adverse Event|1|||
16832770|NCT02058589|37776009|FG001|Overall Study|Non-Serious Adverse Event|0|||
16832771|NCT02058589|37776008|FG000|Overall Study|Withdrawal by Subject|0|||
16832772|NCT02058589|37776009|FG001|Overall Study|Withdrawal by Subject|1|||
16832773|NCT02079805|37776019|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16832774|NCT02079805|37776020|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16832775|NCT02079805|37776019|FG000|Overall Study|Voluntary Withdrawal|0|||
16832776|NCT02079805|37776020|FG001|Overall Study|Voluntary Withdrawal|1|||
16832777|NCT02037295|37776030|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
16832778|NCT02037295|37776031|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
16832779|NCT02037295|37776032|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
16832780|NCT02037295|37776033|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
16832781|NCT02079649|37776049|FG000|Overall Study|Lost to Follow-up|0|||
16832782|NCT02079649|37776050|FG001|Overall Study|Lost to Follow-up|0|||
16832783|NCT02079649|37776051|FG002|Overall Study|Lost to Follow-up|0|||
16832784|NCT02079649|37776052|FG003|Overall Study|Lost to Follow-up|1|||
16832785|NCT02079649|37776049|FG000|Overall Study|Withdrawal by Subject|0|||
16832786|NCT02079649|37776050|FG001|Overall Study|Withdrawal by Subject|0|||
16832787|NCT02079649|37776051|FG002|Overall Study|Withdrawal by Subject|0|||
16832788|NCT02079649|37776052|FG003|Overall Study|Withdrawal by Subject|1|||
16832789|NCT02079649|37776049|FG000|Overall Study|Randomization error (prior to treatment)|1|||
16832790|NCT02079649|37776050|FG001|Overall Study|Randomization error (prior to treatment)|0|||
16832791|NCT02079649|37776051|FG002|Overall Study|Randomization error (prior to treatment)|1|||
16832792|NCT02079649|37776052|FG003|Overall Study|Randomization error (prior to treatment)|0|||
16832793|NCT02036515|37776066|FG000|Overall Study|Adverse Event|1|||
16832794|NCT02036515|37776067|FG001|Overall Study|Adverse Event|1|||
16832795|NCT02036515|37776068|FG002|Overall Study|Adverse Event|2|||
16832796|NCT02036515|37776066|FG000|Overall Study|Lost to Follow-up|0|||
16832797|NCT02036515|37776067|FG001|Overall Study|Lost to Follow-up|2|||
16832798|NCT02036515|37776068|FG002|Overall Study|Lost to Follow-up|0|||
16832799|NCT02036515|37776066|FG000|Overall Study|Non-compliance with study drug|0|||
16832800|NCT02036515|37776067|FG001|Overall Study|Non-compliance with study drug|0|||
16832801|NCT02036515|37776068|FG002|Overall Study|Non-compliance with study drug|2|||
16832802|NCT02036515|37776066|FG000|Overall Study|Screen failure|0|||
16832803|NCT02036515|37776067|FG001|Overall Study|Screen failure|2|||
16832804|NCT02036515|37776068|FG002|Overall Study|Screen failure|0|||
16832805|NCT02036515|37776066|FG000|Overall Study|Withdrawal by Subject|4|||
16832806|NCT02036515|37776067|FG001|Overall Study|Withdrawal by Subject|7|||
16832807|NCT02036515|37776068|FG002|Overall Study|Withdrawal by Subject|9|||
16832808|NCT02036515|37776066|FG000|Overall Study|Hyperglycemia|0|||
16832809|NCT02036515|37776067|FG001|Overall Study|Hyperglycemia|0|||
16832810|NCT02036515|37776068|FG002|Overall Study|Hyperglycemia|1|||
16832811|NCT02078713|37776080|FG000|Overall Study|Lost to Follow-up|49|||
16832812|NCT02078713|37776081|FG001|Overall Study|Lost to Follow-up|55|||
16832813|NCT02078713|37776082|FG002|Overall Study|Lost to Follow-up|0|||
16832814|NCT02078713|37776083|FG003|Overall Study|Lost to Follow-up|0|||
16832815|NCT02078713|37776080|FG000|Overall Study|Pregnant at baseline|3|||
16832816|NCT02078713|37776081|FG001|Overall Study|Pregnant at baseline|5|||
16832817|NCT02078713|37776082|FG002|Overall Study|Pregnant at baseline|0|||
16832818|NCT02078713|37776083|FG003|Overall Study|Pregnant at baseline|0|||
16832819|NCT02078713|37776080|FG000|Overall Study|Enrolled twice|0|||
16832820|NCT02078713|37776081|FG001|Overall Study|Enrolled twice|1|||
16832821|NCT02078713|37776082|FG002|Overall Study|Enrolled twice|0|||
16832822|NCT02078713|37776083|FG003|Overall Study|Enrolled twice|0|||
16832823|NCT02035267|37776099|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
16832824|NCT02035267|37776100|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
16832825|NCT02035267|37776101|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
16832826|NCT02035267|37776102|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
16832827|NCT02035267|37776099|FG000|Overall Study|Adverse Event|0|||
16832828|NCT02035267|37776100|FG001|Overall Study|Adverse Event|0|||
16832829|NCT02035267|37776101|FG002|Overall Study|Adverse Event|1|||
16832830|NCT02035267|37776102|FG003|Overall Study|Adverse Event|0|||
16832831|NCT02035267|37776099|FG000|Overall Study|Lost to Follow-up|0|||
16832832|NCT02035267|37776100|FG001|Overall Study|Lost to Follow-up|0|||
16832833|NCT02035267|37776101|FG002|Overall Study|Lost to Follow-up|0|||
16832834|NCT02035267|37776102|FG003|Overall Study|Lost to Follow-up|1|||
16832835|NCT02035267|37776099|FG000|Overall Study|Other unspecified|0|||
16832836|NCT02035267|37776100|FG001|Overall Study|Other unspecified|1|||
16832837|NCT02035267|37776101|FG002|Overall Study|Other unspecified|0|||
16832838|NCT02035267|37776102|FG003|Overall Study|Other unspecified|0|||
16832839|NCT02034877|37776116|FG000|Overall Study|Lost to Follow-up|0|||
16832840|NCT02034877|37776117|FG001|Overall Study|Lost to Follow-up|3|||
16832841|NCT02034877|37776116|FG000|Overall Study|No Longer Willing to Participate|0|||
16832842|NCT02034877|37776117|FG001|Overall Study|No Longer Willing to Participate|3|||
16832843|NCT02034799|37776125|FG000|Overall Study|Withdrawal by Subject|0|||
16832844|NCT02034799|37776126|FG001|Overall Study|Withdrawal by Subject|2|||
16832845|NCT02034799|37776125|FG000|Overall Study|Lost to Follow-up|0|||
16832846|NCT02034799|37776126|FG001|Overall Study|Lost to Follow-up|1|||
16832847|NCT02034799|37776125|FG000|Overall Study|Death|2|||
16832848|NCT02034799|37776126|FG001|Overall Study|Death|1|||
16832849|NCT02057575|37776136|FG000|Overall Study|Adverse Event|0|||
16832850|NCT02057575|37776137|FG001|Overall Study|Adverse Event|2|||
16832851|NCT02057575|37776138|FG002|Overall Study|Adverse Event|0|||
16832852|NCT02057575|37776139|FG003|Overall Study|Adverse Event|1|||
16832853|NCT02057575|37776136|FG000|Overall Study|Withdrawal by Subject|1|||
16832854|NCT02057575|37776137|FG001|Overall Study|Withdrawal by Subject|0|||
16832855|NCT02057575|37776138|FG002|Overall Study|Withdrawal by Subject|0|||
16832856|NCT02057575|37776139|FG003|Overall Study|Withdrawal by Subject|0|||
16832857|NCT02057575|37776136|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
16832858|NCT02057575|37776137|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
16832859|NCT02057575|37776138|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
16832860|NCT02057575|37776139|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
16832861|NCT02057575|37776136|FG000|Overall Study|Protocol Violation|0|||
16832862|NCT02057575|37776137|FG001|Overall Study|Protocol Violation|1|||
16832863|NCT02057575|37776138|FG002|Overall Study|Protocol Violation|0|||
16832864|NCT02057575|37776139|FG003|Overall Study|Protocol Violation|0|||
16832865|NCT02077465|37776151|FG000|Overall Study|Withdrew Consent|0|||
16832866|NCT02077465|37776152|FG001|Overall Study|Withdrew Consent|1|||
16832867|NCT02077465|37776151|FG000|Overall Study|Lost to Follow-up|1|||
16832868|NCT02077465|37776152|FG001|Overall Study|Lost to Follow-up|0|||
16832869|NCT02034565|37776158|FG000|Overall Study|Adverse Event|1|||
16832870|NCT02034565|37776159|FG001|Overall Study|Adverse Event|0|||
16832871|NCT02075515|37776170|FG000|Overall Study|Serious Adverse Event|1|||
16832872|NCT02075515|37776171|FG001|Overall Study|Serious Adverse Event|1|||
16832873|NCT02075515|37776172|FG002|Overall Study|Serious Adverse Event|1|||
16832874|NCT02075515|37776170|FG000|Overall Study|Non-Serious Adverse Event|0|||
16832875|NCT02075515|37776171|FG001|Overall Study|Non-Serious Adverse Event|1|||
16832876|NCT02075515|37776172|FG002|Overall Study|Non-Serious Adverse Event|0|||
16832877|NCT02075515|37776170|FG000|Overall Study|Withdrawal by Subject|2|||
16832878|NCT02075515|37776171|FG001|Overall Study|Withdrawal by Subject|0|||
16832879|NCT02075515|37776172|FG002|Overall Study|Withdrawal by Subject|1|||
16832880|NCT02075515|37776170|FG000|Overall Study|Lost to Follow-up|1|||
16832881|NCT02075515|37776171|FG001|Overall Study|Lost to Follow-up|3|||
16832882|NCT02075515|37776172|FG002|Overall Study|Lost to Follow-up|6|||
16832883|NCT02034409|37776183|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
16832884|NCT02034409|37776184|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
16832885|NCT02034409|37776183|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
16832886|NCT02034409|37776184|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
16832887|NCT02034409|37776183|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
16832888|NCT02034409|37776184|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
16832889|NCT02034409|37776183|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
16832890|NCT02034409|37776184|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
16832891|NCT02034409|37776183|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
16832892|NCT02034409|37776184|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
16832893|NCT02034409|37776183|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
16832894|NCT02034409|37776184|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
16832895|NCT02021318|37776192|FG000|Overall Study|Adverse Event|2|||
16832896|NCT02021318|37776193|FG001|Overall Study|Adverse Event|1|||
16832897|NCT02021318|37776192|FG000|Overall Study|Death|33|||
16832898|NCT02021318|37776193|FG001|Overall Study|Death|34|||
16832899|NCT02021318|37776192|FG000|Overall Study|Lost to Follow-up|3|||
16832900|NCT02021318|37776193|FG001|Overall Study|Lost to Follow-up|3|||
16832901|NCT02021318|37776192|FG000|Overall Study|Progressive Disease|0|||
16832902|NCT02021318|37776193|FG001|Overall Study|Progressive Disease|1|||
16832903|NCT02021318|37776192|FG000|Overall Study|Withdrawal by Subject|30|||
16832904|NCT02021318|37776193|FG001|Overall Study|Withdrawal by Subject|18|||
16832905|NCT02021318|37776192|FG000|Overall Study|Physician Decision|3|||
16832906|NCT02021318|37776193|FG001|Overall Study|Physician Decision|3|||
16832907|NCT02021318|37776192|FG000|Overall Study|Miscellaneous|2|||
16832908|NCT02021318|37776193|FG001|Overall Study|Miscellaneous|3|||
16832909|NCT02041286|37776200|FG000|Overall Study|Adverse Event|1|||
16832910|NCT02020616|37776213|FG000|Overall Study|Adverse Event|0|||
16832911|NCT02020616|37776214|FG001|Overall Study|Adverse Event|0|||
16832912|NCT02020616|37776215|FG002|Overall Study|Adverse Event|0|||
16832913|NCT02020616|37776216|FG003|Overall Study|Adverse Event|0|||
16832914|NCT02020616|37776217|FG004|Overall Study|Adverse Event|0|||
16832915|NCT02020616|37776218|FG005|Overall Study|Adverse Event|1|||
16832916|NCT02020616|37776219|FG006|Overall Study|Adverse Event|1|||
16832917|NCT02020616|37776213|FG000|Overall Study|Physician Decision|0|||
16832918|NCT02020616|37776214|FG001|Overall Study|Physician Decision|0|||
16832919|NCT02020616|37776215|FG002|Overall Study|Physician Decision|0|||
16832920|NCT02020616|37776216|FG003|Overall Study|Physician Decision|0|||
16832921|NCT02020616|37776217|FG004|Overall Study|Physician Decision|0|||
16832922|NCT02020616|37776218|FG005|Overall Study|Physician Decision|1|||
16912375|NCT01453296|38021599|FG001|Treatment Period 1|Adverse Event|1|||
16912376|NCT01453296|38021598|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
16912377|NCT01453296|38021599|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
16912378|NCT01453296|38021598|FG000|Treatment Period 2|Adverse Event|1|||
16912379|NCT01453296|38021599|FG001|Treatment Period 2|Adverse Event|0|||
16912380|NCT01453296|38021598|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16912381|NCT01453296|38021599|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16912382|NCT01453140|38021605|FG000|Overall Study|Adverse Event|3|||
16912383|NCT01499940|38021613|FG000|Overall Study|Study was withdrawn before completion.|9|||
16912384|NCT01499160|38021617|FG000|Overall Study|Adverse Event|1|||
16912385|NCT01499160|38021617|FG000|Overall Study|Withdrawal by Subject|1|||
16912386|NCT01498692|38021622|FG000|Overall Study|Death|4|||
16912387|NCT01498692|38021622|FG000|Overall Study|Withdrawal by Subject|1|||
16912388|NCT01498692|38021622|FG000|Overall Study|Missed 12-month visit|3|||
16912389|NCT01498068|38021628|FG000|Overall Study|Withdrawal by Subject|1|||
16912390|NCT01498068|38021629|FG001|Overall Study|Withdrawal by Subject|1|||
16912391|NCT01497366|38021637|FG000|Overall Study|Virologic failure|2|||
16912392|NCT01497366|38021638|FG001|Overall Study|Virologic failure|50|||
16912393|NCT01497366|38021637|FG000|Overall Study|Lost to Follow-up|11|||
16832923|NCT02020616|37776219|FG006|Overall Study|Physician Decision|2|||
16832924|NCT02020616|37776213|FG000|Overall Study|Withdrawal by Subject|0|||
16832925|NCT02020616|37776214|FG001|Overall Study|Withdrawal by Subject|0|||
16832926|NCT02020616|37776215|FG002|Overall Study|Withdrawal by Subject|1|||
16832927|NCT02020616|37776216|FG003|Overall Study|Withdrawal by Subject|0|||
16832928|NCT02020616|37776217|FG004|Overall Study|Withdrawal by Subject|0|||
16832929|NCT02020616|37776218|FG005|Overall Study|Withdrawal by Subject|1|||
16832930|NCT02020616|37776219|FG006|Overall Study|Withdrawal by Subject|1|||
16832931|NCT02020616|37776213|FG000|Overall Study|Lost to Follow-up|0|||
16832932|NCT02020616|37776214|FG001|Overall Study|Lost to Follow-up|1|||
16832933|NCT02020616|37776215|FG002|Overall Study|Lost to Follow-up|0|||
16832934|NCT02020616|37776216|FG003|Overall Study|Lost to Follow-up|1|||
16832935|NCT02020616|37776217|FG004|Overall Study|Lost to Follow-up|1|||
16832936|NCT02020616|37776218|FG005|Overall Study|Lost to Follow-up|1|||
16832937|NCT02020616|37776219|FG006|Overall Study|Lost to Follow-up|0|||
16832938|NCT02020616|37776213|FG000|Overall Study|Early Termination Criteria Met|0|||
16832939|NCT02020616|37776214|FG001|Overall Study|Early Termination Criteria Met|0|||
16832940|NCT02020616|37776215|FG002|Overall Study|Early Termination Criteria Met|1|||
16832941|NCT02020616|37776216|FG003|Overall Study|Early Termination Criteria Met|0|||
16832942|NCT02020616|37776217|FG004|Overall Study|Early Termination Criteria Met|0|||
16832943|NCT02020616|37776218|FG005|Overall Study|Early Termination Criteria Met|1|||
16832944|NCT02020616|37776219|FG006|Overall Study|Early Termination Criteria Met|0|||
16832945|NCT02020616|37776213|FG000|Overall Study|Randomized in Error|0|||
16832946|NCT02020616|37776214|FG001|Overall Study|Randomized in Error|0|||
16832947|NCT02020616|37776215|FG002|Overall Study|Randomized in Error|0|||
16832948|NCT02020616|37776216|FG003|Overall Study|Randomized in Error|1|||
16832949|NCT02020616|37776217|FG004|Overall Study|Randomized in Error|0|||
16832950|NCT02020616|37776218|FG005|Overall Study|Randomized in Error|0|||
16832951|NCT02020616|37776219|FG006|Overall Study|Randomized in Error|0|||
16832952|NCT02020616|37776213|FG000|Overall Study|Lack of Efficacy|0|||
16832953|NCT02020616|37776214|FG001|Overall Study|Lack of Efficacy|0|||
16832954|NCT02020616|37776215|FG002|Overall Study|Lack of Efficacy|0|||
16832955|NCT02020616|37776216|FG003|Overall Study|Lack of Efficacy|0|||
16832956|NCT02020616|37776217|FG004|Overall Study|Lack of Efficacy|1|||
16832957|NCT02020616|37776218|FG005|Overall Study|Lack of Efficacy|0|||
16832958|NCT02020616|37776219|FG006|Overall Study|Lack of Efficacy|0|||
16832959|NCT02048072|37776249|FG000|Overall Study|Adverse Event|3|||
16832960|NCT02048072|37776249|FG000|Overall Study|Lost to Follow-up|1|||
16832961|NCT02047604|37776259|FG000|Overall Study|Withdrawal by Subject|0|||
16832962|NCT02047604|37776260|FG001|Overall Study|Withdrawal by Subject|0|||
16832963|NCT02047604|37776261|FG002|Overall Study|Withdrawal by Subject|0|||
16832964|NCT02047604|37776262|FG003|Overall Study|Withdrawal by Subject|0|||
16832965|NCT02047604|37776263|FG004|Overall Study|Withdrawal by Subject|1|||
16832966|NCT02047604|37776264|FG005|Overall Study|Withdrawal by Subject|1|||
16832967|NCT01622660|37776278|FG000|Overall Study|Adverse Event|1|||
16832968|NCT02019602|37776284|FG000|Screening Period|Ineligibility|4|||
16832969|NCT02019602|37776285|FG001|Screening Period|Ineligibility|0|||
16832970|NCT02019602|37776284|FG000|Screening Period|Adverse Event|1|||
16832971|NCT02019602|37776285|FG001|Screening Period|Adverse Event|0|||
16832972|NCT01994954|37776294|FG000|Overall Study|Death|1|||
16832973|NCT01994954|37776295|FG001|Overall Study|Death|0|||
16832974|NCT01994954|37776294|FG000|Overall Study|Withdrawal by Subject|9|||
16832975|NCT01994954|37776295|FG001|Overall Study|Withdrawal by Subject|14|||
16832976|NCT01994954|37776294|FG000|Overall Study|Physician Decision|2|||
16832977|NCT01994954|37776295|FG001|Overall Study|Physician Decision|2|||
16832978|NCT01994954|37776294|FG000|Overall Study|Lost to Follow-up|8|||
16832979|NCT01994954|37776295|FG001|Overall Study|Lost to Follow-up|10|||
16832980|NCT01994954|37776294|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
16832981|NCT01994954|37776295|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
16832982|NCT01994876|37776307|FG000|Test Period 1|Withdrawal by Subject|0|||
16832983|NCT01994876|37776308|FG001|Test Period 1|Withdrawal by Subject|1|||
16832984|NCT01994876|37776307|FG000|Test Period 1|Adverse Event|0|||
16832985|NCT01994876|37776308|FG001|Test Period 1|Adverse Event|1|||
16832986|NCT01994876|37776307|FG000|Test Period 2|Adverse Event|1|||
16832987|NCT01994876|37776308|FG001|Test Period 2|Adverse Event|0|||
16832988|NCT01994876|37776307|FG000|Test Period 2|Protocol Violation|0|||
16832989|NCT01994876|37776308|FG001|Test Period 2|Protocol Violation|1|||
16832990|NCT02040428|37776318|FG000|Overall Study|Death|4|||
16832991|NCT02040428|37776319|FG001|Overall Study|Death|3|||
16832992|NCT02040428|37776318|FG000|Overall Study|Withdrawal by Subject|1|||
16832993|NCT02040428|37776319|FG001|Overall Study|Withdrawal by Subject|1|||
16832994|NCT02018822|37776327|FG000|Overall Study|filling replaced by crown|0|||
16832995|NCT02018822|37776328|FG001|Overall Study|filling replaced by crown|1|||
16832996|NCT02018822|37776329|FG002|Overall Study|filling replaced by crown|0|||
16832997|NCT02018822|37776327|FG000|Overall Study|Physician Decision|0|||
16832998|NCT02018822|37776328|FG001|Overall Study|Physician Decision|1|||
16912394|NCT01497366|38021638|FG001|Overall Study|Lost to Follow-up|10|||
16832999|NCT02018822|37776329|FG002|Overall Study|Physician Decision|1|||
16833000|NCT02018822|37776327|FG000|Overall Study|Lost to Follow-up|6|||
16833001|NCT02018822|37776328|FG001|Overall Study|Lost to Follow-up|6|||
16833002|NCT02018822|37776329|FG002|Overall Study|Lost to Follow-up|5|||
16833003|NCT02055157|37776344|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
16833004|NCT02055157|37776345|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
16833005|NCT02055157|37776346|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
16833006|NCT02055157|37776347|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
16833007|NCT02055157|37776344|FG000|Initial 6 Months|Adverse Event|0|||
16833008|NCT02055157|37776345|FG001|Initial 6 Months|Adverse Event|0|||
16833009|NCT02055157|37776346|FG002|Initial 6 Months|Adverse Event|0|||
16833010|NCT02055157|37776347|FG003|Initial 6 Months|Adverse Event|1|||
16833011|NCT02055157|37776344|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
16833012|NCT02055157|37776345|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
16833013|NCT02055157|37776346|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
16833014|NCT02055157|37776347|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
16833015|NCT02055157|37776344|FG000|18-month Extension|Investigator decision|0|||
16833016|NCT02055157|37776345|FG001|18-month Extension|Investigator decision|1|||
16833017|NCT02055157|37776346|FG002|18-month Extension|Investigator decision|0|||
16833018|NCT02055157|37776347|FG003|18-month Extension|Investigator decision|0|||
16833019|NCT02055157|37776344|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
16833020|NCT02055157|37776345|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
16833021|NCT02055157|37776346|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
16833022|NCT02055157|37776347|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
16833023|NCT02022007|37776371|FG000|Overall Study|Withdrawal by Subject|1|||
16833024|NCT02022007|37776372|FG001|Overall Study|Withdrawal by Subject|1|||
16833025|NCT02022007|37776373|FG002|Overall Study|Withdrawal by Subject|1|||
16833026|NCT02022007|37776371|FG000|Overall Study|Noncompliant|0|||
16833027|NCT02022007|37776372|FG001|Overall Study|Noncompliant|0|||
16833028|NCT02022007|37776373|FG002|Overall Study|Noncompliant|1|||
16833029|NCT02031679|37776383|FG000|Overall Study|Protocol Violation|0|||
16833030|NCT02031679|37776384|FG001|Overall Study|Protocol Violation|1|||
16833031|NCT02031679|37776383|FG000|Overall Study|Lack of Efficacy|0|||
16833032|NCT02031679|37776384|FG001|Overall Study|Lack of Efficacy|1|||
16833033|NCT02053753|37776392|FG000|Overall Study|Withdrawal by Subject|2|||
16833034|NCT02053753|37776393|FG001|Overall Study|Withdrawal by Subject|4|||
16833035|NCT02053753|37776392|FG000|Overall Study|Decision by Sponsor|1|||
16833036|NCT02053753|37776393|FG001|Overall Study|Decision by Sponsor|1|||
16833037|NCT02053753|37776392|FG000|Overall Study|Lost to Follow-up|4|||
16833038|NCT02053753|37776393|FG001|Overall Study|Lost to Follow-up|3|||
16833039|NCT02019979|37776399|FG000|Overall Study|study terminated|14|||
16833040|NCT02019667|37776403|FG000|First Intervention (6 Months)|Adverse Event|0|||
16833041|NCT02019667|37776404|FG001|First Intervention (6 Months)|Adverse Event|1|||
16833042|NCT02019667|37776403|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
16833043|NCT02019667|37776404|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
16833044|NCT02019667|37776403|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
16833045|NCT02019667|37776404|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
16833046|NCT02030821|37776416|FG000|Overall Study|Physician Decision|2|||
16833047|NCT02030821|37776417|FG001|Overall Study|Physician Decision|2|||
16833048|NCT02030821|37776418|FG002|Overall Study|Physician Decision|5|||
16833049|NCT02030821|37776419|FG003|Overall Study|Physician Decision|2|||
16833050|NCT02052739|37776431|FG000|Overall Study|Withdrew due to Adverse Event|3|||
16833051|NCT02052739|37776432|FG001|Overall Study|Withdrew due to Adverse Event|0|||
16833052|NCT02052739|37776431|FG000|Overall Study|Participant Died|2|||
16833053|NCT02052739|37776432|FG001|Overall Study|Participant Died|1|||
16833054|NCT02019277|37776440|FG000|Overall Study|Withdrawal by Subject|3|||
16833055|NCT02019277|37776440|FG000|Overall Study|Death|7|||
16833056|NCT02019277|37776440|FG000|Overall Study|Did no Cooperate|1|||
16833057|NCT02019277|37776440|FG000|Overall Study|Adverse Event|1|||
16833058|NCT02030119|37776448|FG000|Overall Study|Withdrawal by Subject|3|||
16833059|NCT02030119|37776449|FG001|Overall Study|Withdrawal by Subject|1|||
16833060|NCT02030119|37776450|FG002|Overall Study|Withdrawal by Subject|5|||
16833061|NCT02030119|37776451|FG003|Overall Study|Withdrawal by Subject|3|||
16833062|NCT02030119|37776448|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
16833063|NCT02030119|37776449|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
16833064|NCT02030119|37776450|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
16833065|NCT02030119|37776451|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
16833066|NCT01823835|37776476|FG000|Overall Study|Adverse Event|0|||
16833067|NCT01823835|37776477|FG001|Overall Study|Adverse Event|0|||
16833068|NCT01823835|37776478|FG002|Overall Study|Adverse Event|0|||
16833069|NCT01823835|37776479|FG003|Overall Study|Adverse Event|0|||
16833070|NCT01823835|37776480|FG004|Overall Study|Adverse Event|1|||
16833071|NCT01823835|37776481|FG005|Overall Study|Adverse Event|0|||
16833072|NCT01823835|37776482|FG006|Overall Study|Adverse Event|1|||
16833073|NCT01823835|37776483|FG007|Overall Study|Adverse Event|0|||
16833074|NCT01823835|37776484|FG008|Overall Study|Adverse Event|0|||
16833075|NCT01823835|37776485|FG009|Overall Study|Adverse Event|0|||
16833076|NCT01823835|37776486|FG010|Overall Study|Adverse Event|1|||
16833077|NCT01823835|37776487|FG011|Overall Study|Adverse Event|2|||
16833078|NCT01823835|37776488|FG012|Overall Study|Adverse Event|0|||
16833079|NCT01823835|37776489|FG013|Overall Study|Adverse Event|0|||
16833080|NCT01823835|37776490|FG014|Overall Study|Adverse Event|0|||
16833081|NCT01823835|37776476|FG000|Overall Study|Physician Decision|0|||
16833082|NCT01823835|37776477|FG001|Overall Study|Physician Decision|0|||
16833083|NCT01823835|37776478|FG002|Overall Study|Physician Decision|0|||
16833084|NCT01823835|37776479|FG003|Overall Study|Physician Decision|0|||
16833085|NCT01823835|37776480|FG004|Overall Study|Physician Decision|0|||
16833086|NCT01823835|37776481|FG005|Overall Study|Physician Decision|0|||
16833087|NCT01823835|37776482|FG006|Overall Study|Physician Decision|0|||
16833088|NCT01823835|37776483|FG007|Overall Study|Physician Decision|0|||
16833089|NCT01823835|37776484|FG008|Overall Study|Physician Decision|0|||
16833090|NCT01823835|37776485|FG009|Overall Study|Physician Decision|0|||
16833091|NCT01823835|37776486|FG010|Overall Study|Physician Decision|0|||
16833092|NCT01823835|37776487|FG011|Overall Study|Physician Decision|2|||
16833093|NCT01823835|37776488|FG012|Overall Study|Physician Decision|0|||
16833094|NCT01823835|37776489|FG013|Overall Study|Physician Decision|0|||
16833095|NCT01823835|37776490|FG014|Overall Study|Physician Decision|0|||
16833096|NCT01823835|37776476|FG000|Overall Study|Progressive Disease|3|||
16833097|NCT01823835|37776477|FG001|Overall Study|Progressive Disease|4|||
16833098|NCT01823835|37776478|FG002|Overall Study|Progressive Disease|3|||
16833099|NCT01823835|37776479|FG003|Overall Study|Progressive Disease|6|||
16833100|NCT01823835|37776480|FG004|Overall Study|Progressive Disease|4|||
16833101|NCT01823835|37776481|FG005|Overall Study|Progressive Disease|6|||
16833102|NCT01823835|37776482|FG006|Overall Study|Progressive Disease|5|||
16833103|NCT01823835|37776483|FG007|Overall Study|Progressive Disease|3|||
16833104|NCT01823835|37776484|FG008|Overall Study|Progressive Disease|3|||
16833105|NCT01823835|37776485|FG009|Overall Study|Progressive Disease|18|||
16833106|NCT01823835|37776486|FG010|Overall Study|Progressive Disease|8|||
16833107|NCT01823835|37776487|FG011|Overall Study|Progressive Disease|46|||
16833108|NCT01823835|37776488|FG012|Overall Study|Progressive Disease|18|||
16833109|NCT01823835|37776489|FG013|Overall Study|Progressive Disease|4|||
16833110|NCT01823835|37776490|FG014|Overall Study|Progressive Disease|6|||
16833111|NCT01823835|37776476|FG000|Overall Study|Study Termination|0|||
16833112|NCT01823835|37776477|FG001|Overall Study|Study Termination|0|||
16833113|NCT01823835|37776478|FG002|Overall Study|Study Termination|0|||
16833114|NCT01823835|37776479|FG003|Overall Study|Study Termination|0|||
16833115|NCT01823835|37776480|FG004|Overall Study|Study Termination|1|||
16833116|NCT01823835|37776481|FG005|Overall Study|Study Termination|0|||
16833117|NCT01823835|37776482|FG006|Overall Study|Study Termination|0|||
16833118|NCT01823835|37776483|FG007|Overall Study|Study Termination|0|||
16833119|NCT01823835|37776484|FG008|Overall Study|Study Termination|0|||
16833120|NCT01823835|37776485|FG009|Overall Study|Study Termination|0|||
16833121|NCT01823835|37776486|FG010|Overall Study|Study Termination|0|||
16833122|NCT01823835|37776487|FG011|Overall Study|Study Termination|1|||
16833123|NCT01823835|37776488|FG012|Overall Study|Study Termination|0|||
16833124|NCT01823835|37776489|FG013|Overall Study|Study Termination|0|||
16833125|NCT01823835|37776490|FG014|Overall Study|Study Termination|0|||
16833126|NCT01823835|37776476|FG000|Overall Study|Withdrawal by Subject|0|||
16833127|NCT01823835|37776477|FG001|Overall Study|Withdrawal by Subject|0|||
16833128|NCT01823835|37776478|FG002|Overall Study|Withdrawal by Subject|1|||
16833129|NCT01823835|37776479|FG003|Overall Study|Withdrawal by Subject|0|||
16833130|NCT01823835|37776480|FG004|Overall Study|Withdrawal by Subject|0|||
16833131|NCT01823835|37776481|FG005|Overall Study|Withdrawal by Subject|0|||
16833132|NCT01823835|37776482|FG006|Overall Study|Withdrawal by Subject|0|||
16833133|NCT01823835|37776483|FG007|Overall Study|Withdrawal by Subject|0|||
16833134|NCT01823835|37776484|FG008|Overall Study|Withdrawal by Subject|0|||
16833135|NCT01823835|37776485|FG009|Overall Study|Withdrawal by Subject|1|||
16833136|NCT01823835|37776486|FG010|Overall Study|Withdrawal by Subject|1|||
16833137|NCT01823835|37776487|FG011|Overall Study|Withdrawal by Subject|2|||
16833138|NCT01823835|37776488|FG012|Overall Study|Withdrawal by Subject|1|||
16833139|NCT01823835|37776489|FG013|Overall Study|Withdrawal by Subject|0|||
16912395|NCT01497366|38021637|FG000|Overall Study|Withdrawal by Subject|6|||
16833140|NCT01823835|37776490|FG014|Overall Study|Withdrawal by Subject|0|||
16833141|NCT02173379|37776532|FG000|Overall Study|Lost to Follow-up|48|||
16833142|NCT02173379|37776533|FG001|Overall Study|Lost to Follow-up|34|||
16833143|NCT02173379|37776532|FG000|Overall Study|Withdrawal by Subject|14|||
16833144|NCT02173379|37776533|FG001|Overall Study|Withdrawal by Subject|17|||
16833145|NCT02173379|37776532|FG000|Overall Study|Physician Decision|7|||
16833146|NCT02173379|37776533|FG001|Overall Study|Physician Decision|4|||
16833147|NCT02173379|37776532|FG000|Overall Study|Death|22|||
16833148|NCT02173379|37776533|FG001|Overall Study|Death|22|||
16833149|NCT01823679|37776540|FG000|Overall Study|Death|1|||
16833150|NCT01823289|37776545|FG000|Overall Study|Lost to Follow-up|5|||
16833151|NCT01823289|37776545|FG000|Overall Study|Adverse Event|5|||
16833152|NCT01823289|37776545|FG000|Overall Study|Lack of Efficacy|1|||
16833153|NCT01823289|37776545|FG000|Overall Study|Physician Decision|9|||
16833154|NCT01823289|37776545|FG000|Overall Study|Administered contraindicated medicine|1|||
16833155|NCT01823289|37776545|FG000|Overall Study|Transaminase increased more than 3 times|1|||
16833156|NCT01823289|37776545|FG000|Overall Study|Drug affected efficacy and safety|1|||
16833157|NCT01823289|37776545|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
16833158|NCT01822899|37776551|FG000|Overall Study|Adverse Event|6|||
16833159|NCT01822899|37776552|FG001|Overall Study|Adverse Event|5|||
16833160|NCT01822899|37776551|FG000|Overall Study|Lack of Efficacy|6|||
16833161|NCT01822899|37776552|FG001|Overall Study|Lack of Efficacy|3|||
16833162|NCT01822899|37776551|FG000|Overall Study|Protocol Violation|6|||
16833163|NCT01822899|37776552|FG001|Overall Study|Protocol Violation|3|||
16833164|NCT01822899|37776551|FG000|Overall Study|Lost to Follow-up|1|||
16833165|NCT01822899|37776552|FG001|Overall Study|Lost to Follow-up|0|||
16833166|NCT01822899|37776551|FG000|Overall Study|Withdrawal by Subject|5|||
16833167|NCT01822899|37776552|FG001|Overall Study|Withdrawal by Subject|7|||
16833168|NCT01822821|37776560|FG000|Overall Study|Eligible surgery cancelled|1|||
16833169|NCT01822821|37776561|FG001|Overall Study|Eligible surgery cancelled|1|||
16833170|NCT01822821|37776560|FG000|Overall Study|Other reasons|1|||
16833171|NCT01822821|37776561|FG001|Overall Study|Other reasons|0|||
16833172|NCT01822665|37776567|FG000|Overall Study|Adverse Event|3|||
16833173|NCT01822665|37776567|FG000|Overall Study|Other Reason|5|||
16833174|NCT02173301|37776589|FG000|Overall Study|Adverse Event|7|||
16833175|NCT02173301|37776590|FG001|Overall Study|Adverse Event|8|||
16833176|NCT02173301|37776591|FG002|Overall Study|Adverse Event|13|||
16833177|NCT02173301|37776592|FG003|Overall Study|Adverse Event|5|||
16833178|NCT02173301|37776589|FG000|Overall Study|Withdrawal by Subject|8|||
16833179|NCT02173301|37776590|FG001|Overall Study|Withdrawal by Subject|10|||
16833180|NCT02173301|37776591|FG002|Overall Study|Withdrawal by Subject|4|||
16833181|NCT02173301|37776592|FG003|Overall Study|Withdrawal by Subject|8|||
16833182|NCT02173301|37776589|FG000|Overall Study|Lost to Follow-up|4|||
16833183|NCT02173301|37776590|FG001|Overall Study|Lost to Follow-up|4|||
16833184|NCT02173301|37776591|FG002|Overall Study|Lost to Follow-up|2|||
16833185|NCT02173301|37776592|FG003|Overall Study|Lost to Follow-up|2|||
16833186|NCT02173301|37776589|FG000|Overall Study|Protocol Violation|0|||
16833187|NCT02173301|37776590|FG001|Overall Study|Protocol Violation|1|||
16833188|NCT02173301|37776591|FG002|Overall Study|Protocol Violation|0|||
16833189|NCT02173301|37776592|FG003|Overall Study|Protocol Violation|0|||
16833190|NCT02173301|37776589|FG000|Overall Study|Physician Decision|0|||
16833191|NCT02173301|37776590|FG001|Overall Study|Physician Decision|0|||
16833192|NCT02173301|37776591|FG002|Overall Study|Physician Decision|1|||
16833193|NCT02173301|37776592|FG003|Overall Study|Physician Decision|0|||
16833194|NCT02173301|37776589|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
16833195|NCT02173301|37776590|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
16833196|NCT02173301|37776591|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
16833197|NCT02173301|37776592|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
16833198|NCT01822587|37776605|FG000|Overall Study|Lost to Follow-up|7|||
16833199|NCT01822587|37776606|FG001|Overall Study|Lost to Follow-up|9|||
16833200|NCT01822587|37776607|FG002|Overall Study|Lost to Follow-up|12|||
16833201|NCT01822587|37776605|FG000|Overall Study|Physician Decision|9|||
16833202|NCT01822587|37776606|FG001|Overall Study|Physician Decision|6|||
16833203|NCT01822587|37776607|FG002|Overall Study|Physician Decision|6|||
16833204|NCT01822353|37776618|FG000|Overall Study|Adverse Event|1|||
16833205|NCT01822353|37776619|FG001|Overall Study|Adverse Event|3|||
16833206|NCT01822353|37776620|FG002|Overall Study|Adverse Event|1|||
16833207|NCT01822353|37776618|FG000|Overall Study|Pregnancy|0|||
16833208|NCT01822353|37776619|FG001|Overall Study|Pregnancy|1|||
16833209|NCT01822353|37776620|FG002|Overall Study|Pregnancy|0|||
16912396|NCT01497366|38021638|FG001|Overall Study|Withdrawal by Subject|6|||
16912397|NCT01497366|38021637|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
16912398|NCT01497366|38021638|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
16912399|NCT01497366|38021637|FG000|Overall Study|Other|5|||
16912400|NCT01497366|38021638|FG001|Overall Study|Other|0|||
16912401|NCT01497366|38021637|FG000|Overall Study|Death|1|||
17016744|NCT00865904|38161351|FG001|Overall Study|Randomized but not Treated|0|||
17016745|NCT00865904|38161352|FG002|Overall Study|Randomized but not Treated|0|||
17016746|NCT00865904|38161353|FG003|Overall Study|Randomized but not Treated|1|||
17016747|NCT00865904|38161354|FG004|Overall Study|Randomized but not Treated|1|||
17016748|NCT00599339|38161370|FG000|Overall Study|Adverse Event|79|||
17016749|NCT00599339|38161370|FG000|Overall Study|Withdrawal by Subject|137|||
16912402|NCT01497366|38021638|FG001|Overall Study|Death|1|||
16833210|NCT01822353|37776618|FG000|Overall Study|Withdrawal by Subject|3|||
16833211|NCT01822353|37776619|FG001|Overall Study|Withdrawal by Subject|1|||
16833212|NCT01822353|37776620|FG002|Overall Study|Withdrawal by Subject|0|||
16833213|NCT01821963|37776631|FG000|Overall Study|Adverse Event|1|||
16833214|NCT01821807|37776637|FG000|Overall Study|Lost to Follow-up|3|||
17016750|NCT00599339|38161370|FG000|Overall Study|Other Reason|179|||
16833215|NCT01821807|37776638|FG001|Overall Study|Lost to Follow-up|1|||
16833216|NCT01821729|37776644|FG000|Overall Study|Withdrawal by Subject|1|||
16833217|NCT01820637|37776648|FG000|Overall Study|Death|2|||
16833218|NCT01820637|37776648|FG000|Overall Study|Withdrawal by Subject|1|||
16833219|NCT02172911|37776654|FG000|Overall Study|Serious Adverse Event|0|||
16833220|NCT02172911|37776655|FG001|Overall Study|Serious Adverse Event|1|||
16833221|NCT02172911|37776654|FG000|Overall Study|Progression of Disease|0|||
16833222|NCT02172911|37776655|FG001|Overall Study|Progression of Disease|1|||
16833223|NCT02172911|37776654|FG000|Overall Study|Loss of insurance coverage|1|||
16833224|NCT02172911|37776655|FG001|Overall Study|Loss of insurance coverage|0|||
16833225|NCT02120027|37776663|FG000|Overall Study|Adverse Event|4|||
16833226|NCT02120027|37776664|FG001|Overall Study|Adverse Event|5|||
16833227|NCT02120027|37776663|FG000|Overall Study|Lack of Efficacy|3|||
16833228|NCT02120027|37776664|FG001|Overall Study|Lack of Efficacy|5|||
16833229|NCT02120027|37776663|FG000|Overall Study|Lost to Follow-up|5|||
16833230|NCT02120027|37776664|FG001|Overall Study|Lost to Follow-up|13|||
16833231|NCT02120027|37776663|FG000|Overall Study|Other|4|||
16833232|NCT02120027|37776664|FG001|Overall Study|Other|0|||
16833233|NCT02120027|37776663|FG000|Overall Study|Physician Decision|4|||
16833234|NCT02120027|37776664|FG001|Overall Study|Physician Decision|3|||
16833235|NCT02120027|37776663|FG000|Overall Study|Protocol Violation|18|||
16833236|NCT02120027|37776664|FG001|Overall Study|Protocol Violation|21|||
16833237|NCT02120027|37776663|FG000|Overall Study|Study terminated by Sponsor|45|||
16833238|NCT02120027|37776664|FG001|Overall Study|Study terminated by Sponsor|47|||
16833239|NCT02120027|37776663|FG000|Overall Study|Withdrawal by Subject|33|||
16833240|NCT02120027|37776664|FG001|Overall Study|Withdrawal by Subject|25|||
16833241|NCT01850823|37776673|FG000|Overall Study|Early Visit Window|0|||
16833242|NCT01850823|37776674|FG001|Overall Study|Early Visit Window|1|||
16833243|NCT01850823|37776675|FG002|Overall Study|Early Visit Window|4|||
16833244|NCT01850823|37776673|FG000|Overall Study|Enrolled in Error|0|||
16833245|NCT01850823|37776674|FG001|Overall Study|Enrolled in Error|1|||
16833246|NCT01850823|37776675|FG002|Overall Study|Enrolled in Error|2|||
16833247|NCT01850823|37776673|FG000|Overall Study|Lack of Efficacy|1|||
16833248|NCT01850823|37776674|FG001|Overall Study|Lack of Efficacy|0|||
16833249|NCT01850823|37776675|FG002|Overall Study|Lack of Efficacy|0|||
16833250|NCT01850823|37776673|FG000|Overall Study|Lost to Follow-up|0|||
16833251|NCT01850823|37776674|FG001|Overall Study|Lost to Follow-up|0|||
16833252|NCT01850823|37776675|FG002|Overall Study|Lost to Follow-up|1|||
16833253|NCT01850823|37776673|FG000|Overall Study|Restricted Medication|0|||
16833254|NCT01850823|37776674|FG001|Overall Study|Restricted Medication|0|||
16833255|NCT01850823|37776675|FG002|Overall Study|Restricted Medication|2|||
16833256|NCT01850823|37776673|FG000|Overall Study|Significant worstening of SAR|0|||
16833257|NCT01850823|37776674|FG001|Overall Study|Significant worstening of SAR|1|||
16833258|NCT01850823|37776675|FG002|Overall Study|Significant worstening of SAR|0|||
16833259|NCT01850823|37776673|FG000|Overall Study|Withdrawal by Subject|2|||
16833260|NCT01850823|37776674|FG001|Overall Study|Withdrawal by Subject|0|||
16833261|NCT01850823|37776675|FG002|Overall Study|Withdrawal by Subject|1|||
16833262|NCT01820559|37776688|FG000|Overall Study|Adverse Event|4|||
16833263|NCT01820559|37776689|FG001|Overall Study|Adverse Event|6|||
16833264|NCT01820559|37776690|FG002|Overall Study|Adverse Event|13|||
16833265|NCT01820559|37776688|FG000|Overall Study|Withdrawal by Subject|1|||
16833266|NCT01820559|37776689|FG001|Overall Study|Withdrawal by Subject|2|||
16833267|NCT01820559|37776690|FG002|Overall Study|Withdrawal by Subject|5|||
16833268|NCT01820559|37776688|FG000|Overall Study|Protocol Violation|2|||
16833269|NCT01820559|37776689|FG001|Overall Study|Protocol Violation|1|||
16833270|NCT01820559|37776690|FG002|Overall Study|Protocol Violation|3|||
16833271|NCT01820559|37776688|FG000|Overall Study|Subject's non-compliance|1|||
16833272|NCT01820559|37776689|FG001|Overall Study|Subject's non-compliance|0|||
16833273|NCT01820559|37776690|FG002|Overall Study|Subject's non-compliance|2|||
16833274|NCT01820559|37776688|FG000|Overall Study|Lost to Follow-up|3|||
16833275|NCT01820559|37776689|FG001|Overall Study|Lost to Follow-up|2|||
16833276|NCT01820559|37776690|FG002|Overall Study|Lost to Follow-up|2|||
16833277|NCT01820559|37776688|FG000|Overall Study|At sponsor request|0|||
16833278|NCT01820559|37776689|FG001|Overall Study|At sponsor request|0|||
16833279|NCT01820559|37776690|FG002|Overall Study|At sponsor request|1|||
16833280|NCT01820559|37776688|FG000|Overall Study|Lack of Efficacy|3|||
16833281|NCT01820559|37776689|FG001|Overall Study|Lack of Efficacy|2|||
16833282|NCT01820559|37776690|FG002|Overall Study|Lack of Efficacy|3|||
16833283|NCT01818765|37776698|FG000|Overall Study|Death|2|||
16833284|NCT01850589|37776705|FG000|Overall Study|Withdrawal by Subject|8|||
16833285|NCT01850589|37776706|FG001|Overall Study|Withdrawal by Subject|0|||
16833286|NCT01818531|37776714|FG000|Overall Study|Withdrawn for case delay after block|1|||
16833287|NCT01818531|37776715|FG001|Overall Study|Withdrawn for case delay after block|0|||
16833288|NCT01818531|37776714|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
16833289|NCT01818531|37776715|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
16833290|NCT01818531|37776714|FG000|Overall Study|Withdrawn for failure to place block|0|||
16833291|NCT01818531|37776715|FG001|Overall Study|Withdrawn for failure to place block|1|||
16833292|NCT02171429|37776724|FG000|Overall Study|Other|0|||
16833293|NCT02171429|37776725|FG001|Overall Study|Other|1|||
16833294|NCT02171429|37776726|FG002|Overall Study|Other|1|||
16833295|NCT02171429|37776724|FG000|Overall Study|Non-Compliance|0|||
16833296|NCT02171429|37776725|FG001|Overall Study|Non-Compliance|0|||
16833297|NCT02171429|37776726|FG002|Overall Study|Non-Compliance|1|||
16833298|NCT02171429|37776724|FG000|Overall Study|Physician Decision|0|||
16833299|NCT02171429|37776725|FG001|Overall Study|Physician Decision|0|||
16833300|NCT02171429|37776726|FG002|Overall Study|Physician Decision|1|||
16833301|NCT02171429|37776724|FG000|Overall Study|Withdrawal by Subject|1|||
16833302|NCT02171429|37776725|FG001|Overall Study|Withdrawal by Subject|1|||
16833303|NCT02171429|37776726|FG002|Overall Study|Withdrawal by Subject|1|||
16833304|NCT02171429|37776724|FG000|Overall Study|Lost to Follow-up|0|||
16833305|NCT02171429|37776725|FG001|Overall Study|Lost to Follow-up|1|||
16833306|NCT02171429|37776726|FG002|Overall Study|Lost to Follow-up|0|||
16833307|NCT02171429|37776724|FG000|Overall Study|Death|0|||
16833308|NCT02171429|37776725|FG001|Overall Study|Death|0|||
16833309|NCT02171429|37776726|FG002|Overall Study|Death|1|||
16833310|NCT01818297|37776739|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
16833311|NCT01818297|37776740|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
16833312|NCT01818297|37776739|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
16833313|NCT01818297|37776740|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
16833314|NCT01818297|37776739|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
16833315|NCT01818297|37776740|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
16833316|NCT01818141|37776748|FG000|Overall Study|Withdrawal by Subject|2|||
16833317|NCT01818141|37776749|FG001|Overall Study|Withdrawal by Subject|0|||
16833318|NCT01818141|37776748|FG000|Overall Study|No baseline C.diff colonies|1|||
16833319|NCT01818141|37776749|FG001|Overall Study|No baseline C.diff colonies|1|||
16833320|NCT01818141|37776748|FG000|Overall Study|Lost to Follow-up|0|||
16833321|NCT01818141|37776749|FG001|Overall Study|Lost to Follow-up|2|||
16833322|NCT01849497|37776757|FG000|Overall Study|Withdrawal by Subject|1|||
16833323|NCT01849497|37776758|FG001|Overall Study|Withdrawal by Subject|2|||
16833324|NCT01849497|37776757|FG000|Overall Study|Sponsor Decision|0|||
16833325|NCT01849497|37776758|FG001|Overall Study|Sponsor Decision|1|||
16833326|NCT01849497|37776757|FG000|Overall Study|Lost to Follow-up|0|||
16833327|NCT01849497|37776758|FG001|Overall Study|Lost to Follow-up|1|||
16833328|NCT02147093|37776766|FG000|Period 1|Lost to Follow-up|0|||
16833329|NCT02147093|37776767|FG001|Period 1|Lost to Follow-up|1|||
16833330|NCT02147093|37776766|FG000|Period 2|Protocol Violation|2|||
16833331|NCT02147093|37776767|FG001|Period 2|Protocol Violation|0|||
16833332|NCT02119325|37776773|FG000|Washout Period 1|Adverse Event|0|||
16833333|NCT02119325|37776774|FG001|Washout Period 1|Adverse Event|1|||
16833334|NCT01816893|37776784|FG000|Washout Period|Withdrawal by Subject|2|||
16833335|NCT01816893|37776785|FG001|Washout Period|Withdrawal by Subject|0|||
16833336|NCT01848483|37776793|FG000|Overall Study|Death|2|||
16833337|NCT01848483|37776794|FG001|Overall Study|Death|1|||
16833338|NCT01848483|37776793|FG000|Overall Study|Lost to Follow-up|6|||
16833339|NCT01848483|37776794|FG001|Overall Study|Lost to Follow-up|8|||
16833340|NCT01848483|37776793|FG000|Overall Study|Withdrawal by Subject|1|||
16833341|NCT01848483|37776794|FG001|Overall Study|Withdrawal by Subject|0|||
16833342|NCT01848483|37776793|FG000|Overall Study|Incarceration|2|||
16833343|NCT01848483|37776794|FG001|Overall Study|Incarceration|2|||
16833344|NCT01610271|37776803|FG000|Overall Study|Surgery not complete|0|||
16833345|NCT01610271|37776804|FG001|Overall Study|Surgery not complete|1|||
16833346|NCT01610271|37776803|FG000|Overall Study|Prosthesis not implanted|2|||
16833347|NCT01610271|37776804|FG001|Overall Study|Prosthesis not implanted|3|||
16833348|NCT02170727|37776814|FG000|Overall Study|Lost to Follow-up|1|||
16833349|NCT02170727|37776815|FG001|Overall Study|Lost to Follow-up|0|||
16833350|NCT02170727|37776814|FG000|Overall Study|Withdrawal by Subject|2|||
16833351|NCT02170727|37776815|FG001|Overall Study|Withdrawal by Subject|0|||
16833352|NCT01847313|37776826|FG000|Overall Study|Death|0|||
16833353|NCT01847313|37776827|FG001|Overall Study|Death|1|||
16833354|NCT01847313|37776826|FG000|Overall Study|Withdrawal by Subject|0|||
16833355|NCT01847313|37776827|FG001|Overall Study|Withdrawal by Subject|1|||
16833356|NCT02144285|37776843|FG000|Overall Study|Withdrawal by Subject|0|||
16833357|NCT02144285|37776844|FG001|Overall Study|Withdrawal by Subject|0|||
16833358|NCT02144285|37776845|FG002|Overall Study|Withdrawal by Subject|0|||
16833359|NCT02144285|37776846|FG003|Overall Study|Withdrawal by Subject|0|||
16833360|NCT02144285|37776847|FG004|Overall Study|Withdrawal by Subject|1|||
16833361|NCT02144285|37776848|FG005|Overall Study|Withdrawal by Subject|0|||
16833362|NCT02144285|37776849|FG006|Overall Study|Withdrawal by Subject|0|||
16833363|NCT02144285|37776850|FG007|Overall Study|Withdrawal by Subject|0|||
16833364|NCT02144285|37776851|FG008|Overall Study|Withdrawal by Subject|0|||
16833365|NCT02144285|37776852|FG009|Overall Study|Withdrawal by Subject|0|||
16833366|NCT02117687|37776890|FG000|Overall Study|Lost to Follow-up|0|||
16833367|NCT02117687|37776891|FG001|Overall Study|Lost to Follow-up|1|||
16833368|NCT02117687|37776890|FG000|Overall Study|Adverse Event|0|||
16833369|NCT02117687|37776891|FG001|Overall Study|Adverse Event|2|||
16833370|NCT02117687|37776890|FG000|Overall Study|Other Reasons|1|||
16833371|NCT02117687|37776891|FG001|Overall Study|Other Reasons|1|||
16833372|NCT02143583|37776900|FG000|Overall Study|Withdrawal by Subject|1|||
16833373|NCT02143583|37776901|FG001|Overall Study|Withdrawal by Subject|0|||
16833374|NCT02143583|37776902|FG002|Overall Study|Withdrawal by Subject|1|||
16833375|NCT02143583|37776900|FG000|Overall Study|husband illness|0|||
16833376|NCT02143583|37776901|FG001|Overall Study|husband illness|0|||
16833377|NCT02143583|37776902|FG002|Overall Study|husband illness|1|||
16833378|NCT02105987|37776912|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
16833379|NCT02105987|37776913|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16833380|NCT02105987|37776914|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16833381|NCT02105987|37776915|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16833382|NCT02105987|37776916|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16833383|NCT02105987|37776917|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16833384|NCT02105987|37776912|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
16833385|NCT02105987|37776913|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
16833386|NCT02105987|37776914|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
16833387|NCT02105987|37776915|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
16833388|NCT02105987|37776916|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
16833389|NCT02105987|37776917|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
16833390|NCT02105987|37776912|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
16833391|NCT02105987|37776913|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
16833392|NCT02105987|37776914|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16833393|NCT02105987|37776915|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16833394|NCT02105987|37776916|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16833395|NCT02105987|37776917|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16833396|NCT02105987|37776912|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
16833397|NCT02105987|37776913|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
16833398|NCT02105987|37776914|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16833399|NCT02105987|37776915|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16833400|NCT02105987|37776916|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16833401|NCT02105987|37776917|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16833402|NCT02105987|37776912|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
16833403|NCT02105987|37776913|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
16833404|NCT02105987|37776914|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
16833405|NCT02105987|37776915|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
16833406|NCT02105987|37776916|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
16833407|NCT02105987|37776917|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
16833408|NCT02105987|37776912|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16833409|NCT02105987|37776913|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
16833410|NCT02105987|37776914|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16833411|NCT02105987|37776915|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16833412|NCT02105987|37776916|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16833413|NCT02105987|37776917|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16833414|NCT02105987|37776912|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
16833415|NCT02105987|37776913|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
16833416|NCT02105987|37776914|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
16833417|NCT02105987|37776915|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
16833418|NCT02105987|37776916|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
16833419|NCT02105987|37776917|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
16833420|NCT02105987|37776912|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
16833421|NCT02105987|37776913|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
16833422|NCT02105987|37776914|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
16833423|NCT02105987|37776915|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
16833424|NCT02105987|37776916|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
16833425|NCT02105987|37776917|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
16833426|NCT02105987|37776912|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16833427|NCT02105987|37776913|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16833428|NCT02105987|37776914|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
16833429|NCT02105987|37776915|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
16833430|NCT02105987|37776916|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16833431|NCT02105987|37776917|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16833432|NCT02105987|37776912|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16833433|NCT02105987|37776913|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16833434|NCT02105987|37776914|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
16833435|NCT02105987|37776915|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
16833436|NCT02105987|37776916|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16833437|NCT02105987|37776917|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16833438|NCT02105987|37776912|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16833439|NCT02105987|37776913|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16833440|NCT02105987|37776914|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
16833441|NCT02105987|37776915|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16833442|NCT02105987|37776916|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16833443|NCT02105987|37776917|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16833444|NCT02105987|37776912|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16833445|NCT02105987|37776913|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16833446|NCT02105987|37776914|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16833447|NCT02105987|37776915|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
16833448|NCT02105987|37776916|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16912403|NCT01497366|38021637|FG000|Overall Study|Randomized but not treated|7|||
16912404|NCT01497366|38021638|FG001|Overall Study|Randomized but not treated|21|||
16912405|NCT01496976|38021645|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
16912406|NCT01475838|38021651|FG000|Randomized Phase|Randomized but Not Treated|0|||
16912407|NCT01475838|38021652|FG001|Randomized Phase|Randomized but Not Treated|5|||
16912408|NCT01475838|38021651|FG000|Randomized Phase|Adverse Event|6|||
16912409|NCT01475838|38021652|FG001|Randomized Phase|Adverse Event|1|||
16912410|NCT01475838|38021651|FG000|Randomized Phase|Pregnancy|0|||
16912411|NCT01475838|38021652|FG001|Randomized Phase|Pregnancy|1|||
16912412|NCT01475838|38021651|FG000|Randomized Phase|Investigators Discretion|1|||
16912413|NCT01475838|38021652|FG001|Randomized Phase|Investigators Discretion|2|||
16912414|NCT01475838|38021651|FG000|Randomized Phase|Withdrew Consent|10|||
16912415|NCT01475838|38021652|FG001|Randomized Phase|Withdrew Consent|14|||
16912416|NCT01475838|38021651|FG000|Randomized Phase|Lost to Follow-up|3|||
16912417|NCT01475838|38021652|FG001|Randomized Phase|Lost to Follow-up|4|||
16912418|NCT01475838|38021651|FG000|Randomized Phase|Participant Noncompliance|1|||
16912419|NCT01475838|38021652|FG001|Randomized Phase|Participant Noncompliance|5|||
16912420|NCT01475838|38021651|FG000|Randomized Phase|Protocol Violation|9|||
16912421|NCT01475838|38021652|FG001|Randomized Phase|Protocol Violation|4|||
16912422|NCT01475838|38021651|FG000|Extension Phase|Participant Noncompliance|1|||
16912423|NCT01475838|38021652|FG001|Extension Phase|Participant Noncompliance|0|||
16912424|NCT01451814|38021661|FG000|Overall Study|Withdrawal by Subject|1|||
16912425|NCT01451814|38021662|FG001|Overall Study|Withdrawal by Subject|1|||
16912426|NCT01451814|38021661|FG000|Overall Study|Lost to Follow-up|5|||
16912427|NCT01451814|38021662|FG001|Overall Study|Lost to Follow-up|4|||
16912428|NCT01475370|38021671|FG000|Overall Study|Exacerbation of primary disease|2|||
16912429|NCT01475370|38021672|FG001|Overall Study|Exacerbation of primary disease|2|||
16912430|NCT01475370|38021673|FG002|Overall Study|Exacerbation of primary disease|2|||
16912431|NCT01475370|38021671|FG000|Overall Study|Study drug administration difficult|0|||
16912432|NCT01475370|38021672|FG001|Overall Study|Study drug administration difficult|1|||
16912433|NCT01475370|38021673|FG002|Overall Study|Study drug administration difficult|1|||
16912434|NCT01475370|38021671|FG000|Overall Study|Other than specified|1|||
16912435|NCT01475370|38021672|FG001|Overall Study|Other than specified|0|||
16912436|NCT01475370|38021673|FG002|Overall Study|Other than specified|0|||
16912437|NCT01496430|38021684|FG000|Overall Study|Adverse Event|0|||
16912438|NCT01496430|38021685|FG001|Overall Study|Adverse Event|0|||
16912439|NCT01496430|38021686|FG002|Overall Study|Adverse Event|1|||
16912440|NCT01496430|38021684|FG000|Overall Study|Major Protocol Deviation|0|||
16912441|NCT01496430|38021685|FG001|Overall Study|Major Protocol Deviation|0|||
16912442|NCT01496430|38021686|FG002|Overall Study|Major Protocol Deviation|1|||
16912443|NCT01496430|38021684|FG000|Overall Study|Lost to Follow-up|2|||
16912444|NCT01496430|38021685|FG001|Overall Study|Lost to Follow-up|3|||
16912445|NCT01496430|38021686|FG002|Overall Study|Lost to Follow-up|1|||
16912446|NCT01496430|38021684|FG000|Overall Study|Voluntary Withdrawal|2|||
16912447|NCT01496430|38021685|FG001|Overall Study|Voluntary Withdrawal|1|||
16912448|NCT01496430|38021686|FG002|Overall Study|Voluntary Withdrawal|6|||
16912449|NCT01496430|38021684|FG000|Overall Study|Principal Investigator Discretion|0|||
16912450|NCT01496430|38021685|FG001|Overall Study|Principal Investigator Discretion|1|||
16912451|NCT01496430|38021686|FG002|Overall Study|Principal Investigator Discretion|1|||
16912452|NCT01496430|38021684|FG000|Overall Study|Other|2|||
16912453|NCT01496430|38021685|FG001|Overall Study|Other|0|||
16912454|NCT01496430|38021686|FG002|Overall Study|Other|0|||
16912455|NCT01451424|38021698|FG000|Overall Study|Withdrawal by Subject|1|||
16912456|NCT01451424|38021699|FG001|Overall Study|Withdrawal by Subject|1|||
16912457|NCT01451424|38021700|FG002|Overall Study|Withdrawal by Subject|0|||
16912458|NCT01451424|38021701|FG003|Overall Study|Withdrawal by Subject|2|||
16912459|NCT01451424|38021698|FG000|Overall Study|Lost to Follow-up|0|||
16912460|NCT01451424|38021699|FG001|Overall Study|Lost to Follow-up|1|||
16912461|NCT01451424|38021700|FG002|Overall Study|Lost to Follow-up|0|||
16912462|NCT01451424|38021701|FG003|Overall Study|Lost to Follow-up|1|||
16912463|NCT01451424|38021698|FG000|Overall Study|Physician Decision|0|||
16912464|NCT01451424|38021699|FG001|Overall Study|Physician Decision|0|||
16912465|NCT01451424|38021700|FG002|Overall Study|Physician Decision|1|||
16912466|NCT01451424|38021701|FG003|Overall Study|Physician Decision|1|||
16912467|NCT01451424|38021698|FG000|Overall Study|Adverse Event|0|||
16912468|NCT01451424|38021699|FG001|Overall Study|Adverse Event|0|||
16912469|NCT01451424|38021700|FG002|Overall Study|Adverse Event|0|||
16833449|NCT02105987|37776917|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16833450|NCT02105987|37776912|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16833451|NCT02105987|37776913|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16833452|NCT02105987|37776914|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
16833453|NCT02105987|37776915|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16833454|NCT02105987|37776916|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16833455|NCT02105987|37776917|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16833456|NCT02105987|37776912|FG000|Continuation Phase|Protocol Violation|0|||
16833457|NCT02105987|37776913|FG001|Continuation Phase|Protocol Violation|0|||
16833458|NCT02105987|37776914|FG002|Continuation Phase|Protocol Violation|0|||
16833459|NCT02105987|37776915|FG003|Continuation Phase|Protocol Violation|0|||
16833460|NCT02105987|37776916|FG004|Continuation Phase|Protocol Violation|1|||
16833461|NCT02105987|37776917|FG005|Continuation Phase|Protocol Violation|0|||
16833462|NCT02141633|37776925|FG000|Overall Study|Physician Decision|1|||
16833463|NCT02141633|37776926|FG001|Overall Study|Physician Decision|0|||
16833464|NCT01846611|37776934|FG000|Overall Study|Lost to Follow-up|4|||
16833465|NCT01846611|37776935|FG001|Overall Study|Lost to Follow-up|6|||
16833466|NCT01846611|37776934|FG000|Overall Study|Withdrawal by Subject|15|||
16833467|NCT01846611|37776935|FG001|Overall Study|Withdrawal by Subject|19|||
16833468|NCT01846611|37776934|FG000|Overall Study|Other|19|||
16833469|NCT01846611|37776935|FG001|Overall Study|Other|18|||
16833470|NCT02141399|37776941|FG000|Overall Study|Adverse Event|158|||
16833471|NCT02141399|37776941|FG000|Overall Study|Lack of Efficacy|62|||
16833472|NCT02141399|37776941|FG000|Overall Study|Lost to Follow-up|151|||
16833473|NCT02141399|37776941|FG000|Overall Study|Non-compliance with study drug|18|||
16833474|NCT02141399|37776941|FG000|Overall Study|Other|45|||
16833475|NCT02141399|37776941|FG000|Overall Study|Physician Decision|17|||
16833476|NCT02141399|37776941|FG000|Overall Study|Pregnancy|3|||
16833477|NCT02141399|37776941|FG000|Overall Study|Protocol Violation|38|||
16833478|NCT02141399|37776941|FG000|Overall Study|Withdrawal by Subject|238|||
16833479|NCT02141399|37776941|FG000|Overall Study|Failure to meet eligibility criteria|14|||
16833480|NCT01846299|37776947|FG000|Overall Study|Physician Decision|4|||
16833481|NCT01846299|37776948|FG001|Overall Study|Physician Decision|2|||
16833482|NCT01846299|37776947|FG000|Overall Study|Protocol deviation|1|||
16833483|NCT01846299|37776948|FG001|Overall Study|Protocol deviation|0|||
16833484|NCT01846299|37776947|FG000|Overall Study|Death|1|||
16833485|NCT01846299|37776948|FG001|Overall Study|Death|2|||
16833486|NCT01846299|37776947|FG000|Overall Study|Lost to Follow-up|3|||
16833487|NCT01846299|37776948|FG001|Overall Study|Lost to Follow-up|0|||
16833488|NCT01846299|37776947|FG000|Overall Study|Withdrawal by Subject|1|||
16833489|NCT01846299|37776948|FG001|Overall Study|Withdrawal by Subject|6|||
16833490|NCT01846299|37776947|FG000|Overall Study|Adverse Event|2|||
16833491|NCT01846299|37776948|FG001|Overall Study|Adverse Event|0|||
16833492|NCT01628393|37776959|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
16833493|NCT01628393|37776960|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16833494|NCT01628393|37776961|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16833495|NCT01628393|37776962|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16833496|NCT01628393|37776963|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16833497|NCT01628393|37776959|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
16833498|NCT01628393|37776960|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
16833499|NCT01628393|37776961|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
16833500|NCT01628393|37776962|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
16833501|NCT01628393|37776963|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
16833502|NCT01628393|37776959|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
16833503|NCT01628393|37776960|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
16833504|NCT01628393|37776961|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
16833505|NCT01628393|37776962|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
16833506|NCT01628393|37776963|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
16833507|NCT01628393|37776959|FG000|Blinded Active Extension Period|Adverse Event|0|||
16833508|NCT01628393|37776960|FG001|Blinded Active Extension Period|Adverse Event|1|||
16833509|NCT01628393|37776961|FG002|Blinded Active Extension Period|Adverse Event|0|||
16833510|NCT01628393|37776962|FG003|Blinded Active Extension Period|Adverse Event|2|||
16833511|NCT01628393|37776963|FG004|Blinded Active Extension Period|Adverse Event|2|||
16912470|NCT01451424|38021701|FG003|Overall Study|Adverse Event|1|||
16833512|NCT01628393|37776959|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
16833513|NCT01628393|37776960|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
16833514|NCT01628393|37776961|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
16833515|NCT01628393|37776962|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
16833516|NCT01628393|37776963|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
16833517|NCT01628393|37776959|FG000|Blinded Active Extension Period|Physician Decision|0|||
16833518|NCT01628393|37776960|FG001|Blinded Active Extension Period|Physician Decision|3|||
16833519|NCT01628393|37776961|FG002|Blinded Active Extension Period|Physician Decision|0|||
16833520|NCT01628393|37776962|FG003|Blinded Active Extension Period|Physician Decision|1|||
16833521|NCT01628393|37776963|FG004|Blinded Active Extension Period|Physician Decision|0|||
16833522|NCT01628393|37776959|FG000|Blinded Active Extension Period|Protocol Violation|0|||
16833523|NCT01628393|37776960|FG001|Blinded Active Extension Period|Protocol Violation|0|||
16833524|NCT01628393|37776961|FG002|Blinded Active Extension Period|Protocol Violation|2|||
16833525|NCT01628393|37776962|FG003|Blinded Active Extension Period|Protocol Violation|1|||
16833526|NCT01628393|37776963|FG004|Blinded Active Extension Period|Protocol Violation|0|||
16833527|NCT01628393|37776959|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
16833528|NCT01628393|37776960|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
16833529|NCT01628393|37776961|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
16833530|NCT01628393|37776962|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
16833531|NCT01628393|37776963|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
16833532|NCT01846221|37776979|FG000|Overall Study|Catheter Failure|2|||
16833533|NCT01846221|37776980|FG001|Overall Study|Catheter Failure|0|||
16833534|NCT01846221|37776979|FG000|Overall Study|Age Exclusion|1|||
16833535|NCT01846221|37776980|FG001|Overall Study|Age Exclusion|0|||
16833536|NCT01815099|37776986|FG000|Overall Study|Lack of Efficacy|1|||
16833537|NCT01815099|37776986|FG000|Overall Study|unable to attend study visits|1|||
16833538|NCT01845831|37776993|FG000|Inpatient Phase|Withdrawal by Subject|1|||
16833539|NCT01845831|37776994|FG001|Inpatient Phase|Withdrawal by Subject|1|||
16833540|NCT01845831|37776995|FG002|Inpatient Phase|Withdrawal by Subject|0|||
16833541|NCT01845831|37776996|FG003|Inpatient Phase|Withdrawal by Subject|0|||
16833542|NCT01845831|37776997|FG004|Inpatient Phase|Withdrawal by Subject|0|||
16833543|NCT01627691|37777008|FG000|Overall Study|Death|11|||
16833544|NCT01627691|37777008|FG000|Overall Study|Lost to Follow-up|3|||
16833545|NCT01627691|37777008|FG000|Overall Study|Withdrawal by Subject|1|||
16833546|NCT01627691|37777008|FG000|Overall Study|Missed the visit|3|||
16833547|NCT01844895|37777012|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
16833548|NCT01844895|37777012|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
16833549|NCT01844895|37777012|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
16833550|NCT01844895|37777012|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
16833551|NCT01844895|37777012|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
16833552|NCT01844895|37777012|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
16833553|NCT01844895|37777012|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
16833554|NCT02116361|37777029|FG000|Overall Study|Pregnancy|0|||
16833555|NCT02116361|37777030|FG001|Overall Study|Pregnancy|0|||
16833556|NCT02116361|37777031|FG002|Overall Study|Pregnancy|0|||
16833557|NCT02116361|37777032|FG003|Overall Study|Pregnancy|1|||
16833558|NCT02116361|37777029|FG000|Overall Study|Protocol Violation|1|||
16833559|NCT02116361|37777030|FG001|Overall Study|Protocol Violation|0|||
16833560|NCT02116361|37777031|FG002|Overall Study|Protocol Violation|0|||
16833561|NCT02116361|37777032|FG003|Overall Study|Protocol Violation|2|||
16833562|NCT02116361|37777029|FG000|Overall Study|Physician Decision|2|||
16833563|NCT02116361|37777030|FG001|Overall Study|Physician Decision|3|||
16833564|NCT02116361|37777031|FG002|Overall Study|Physician Decision|0|||
16833565|NCT02116361|37777032|FG003|Overall Study|Physician Decision|0|||
16833566|NCT02116361|37777029|FG000|Overall Study|Adverse Event|1|||
16833567|NCT02116361|37777030|FG001|Overall Study|Adverse Event|0|||
16833568|NCT02116361|37777031|FG002|Overall Study|Adverse Event|0|||
16833569|NCT02116361|37777032|FG003|Overall Study|Adverse Event|3|||
16833570|NCT02116361|37777029|FG000|Overall Study|Other Reasons|3|||
16833571|NCT02116361|37777030|FG001|Overall Study|Other Reasons|3|||
16833572|NCT02116361|37777031|FG002|Overall Study|Other Reasons|3|||
16833573|NCT02116361|37777032|FG003|Overall Study|Other Reasons|3|||
16833574|NCT02116361|37777029|FG000|Overall Study|Lack of Efficacy|5|||
16833575|NCT02116361|37777030|FG001|Overall Study|Lack of Efficacy|7|||
16833576|NCT02116361|37777031|FG002|Overall Study|Lack of Efficacy|4|||
16833577|NCT02116361|37777032|FG003|Overall Study|Lack of Efficacy|3|||
16833578|NCT02116361|37777029|FG000|Overall Study|Lost to Follow-up|4|||
16833579|NCT02116361|37777030|FG001|Overall Study|Lost to Follow-up|5|||
16833580|NCT02116361|37777031|FG002|Overall Study|Lost to Follow-up|7|||
16833581|NCT02116361|37777032|FG003|Overall Study|Lost to Follow-up|5|||
16833582|NCT02116361|37777029|FG000|Overall Study|Personal Reasons|6|||
16833583|NCT02116361|37777030|FG001|Overall Study|Personal Reasons|6|||
16833584|NCT02116361|37777031|FG002|Overall Study|Personal Reasons|4|||
16833585|NCT02116361|37777032|FG003|Overall Study|Personal Reasons|9|||
16912471|NCT01475214|38021719|FG000|Overall Study|Lost to Follow-up|1|||
16833586|NCT02116361|37777029|FG000|Overall Study|Investigator Decision - Relapse|9|||
16833587|NCT02116361|37777030|FG001|Overall Study|Investigator Decision - Relapse|7|||
16833588|NCT02116361|37777031|FG002|Overall Study|Investigator Decision - Relapse|8|||
16833589|NCT02116361|37777032|FG003|Overall Study|Investigator Decision - Relapse|5|||
16833590|NCT02140775|37777044|FG000|Overall Study|Withdrawal by Subject|30|||
17016751|NCT00599339|38161370|FG000|Overall Study|Lost to Follow-up|221|||
16833591|NCT02140775|37777045|FG001|Overall Study|Withdrawal by Subject|7|||
16833592|NCT01844817|37777055|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
16833593|NCT01844817|37777056|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
16833594|NCT01844817|37777055|FG000|Treatment|Progressive Disease|27|||
16833595|NCT01844817|37777056|FG001|Treatment|Progressive Disease|36|||
16833596|NCT01844817|37777055|FG000|Treatment|Adverse Event|17|||
16833597|NCT01844817|37777056|FG001|Treatment|Adverse Event|9|||
16833598|NCT01844817|37777055|FG000|Treatment|Withdrawal by Subject|10|||
16833599|NCT01844817|37777056|FG001|Treatment|Withdrawal by Subject|6|||
16833600|NCT01844817|37777055|FG000|Treatment|Death|10|||
16833601|NCT01844817|37777056|FG001|Treatment|Death|8|||
16833602|NCT01844817|37777055|FG000|Treatment|Lost to Follow-up|0|||
16833603|NCT01844817|37777056|FG001|Treatment|Lost to Follow-up|1|||
16833604|NCT01844817|37777055|FG000|Treatment|Other|0|||
16833605|NCT01844817|37777056|FG001|Treatment|Other|3|||
16833606|NCT01814553|37777065|FG000|Overall Study|PD per clinical progression|6|||
16833607|NCT01814553|37777066|FG001|Overall Study|PD per clinical progression|8|||
16833608|NCT01814553|37777065|FG000|Overall Study|Other Adverse Event|4|||
16833609|NCT01814553|37777066|FG001|Overall Study|Other Adverse Event|5|||
16833610|NCT01814553|37777065|FG000|Overall Study|Withdrawal by Subject|1|||
16833611|NCT01814553|37777066|FG001|Overall Study|Withdrawal by Subject|1|||
16833612|NCT01814553|37777065|FG000|Overall Study|Other than stated|7|||
16833613|NCT01814553|37777066|FG001|Overall Study|Other than stated|8|||
16833614|NCT02116205|37777076|FG000|Overall Study|Withdrawal by Subject|2|||
17102414|NCT00383123|38241348|FG001|Overall Study|Withdrawal by Subject|18|||
17102415|NCT00383123|38241347|FG000|Overall Study|Other reason|10|||
17102416|NCT00383123|38241348|FG001|Overall Study|Other reason|6|||
17102417|NCT00382967|38241356|FG000|Overall Study|Protocol Violation|1|||
17102418|NCT00382967|38241357|FG001|Overall Study|Protocol Violation|1|||
17102419|NCT00858364|38241365|FG000|Overall Study|Administrative Decision|3|||
17102420|NCT00858364|38241366|FG001|Overall Study|Administrative Decision|2|||
17102421|NCT00858364|38241365|FG000|Overall Study|Adverse Event|5|||
17102422|NCT00858364|38241366|FG001|Overall Study|Adverse Event|2|||
17102423|NCT00858364|38241365|FG000|Overall Study|Withdrawal by Subject|44|||
17102424|NCT00858364|38241366|FG001|Overall Study|Withdrawal by Subject|118|||
17102425|NCT00858364|38241365|FG000|Overall Study|Ineligibility Determined|1|||
16833615|NCT02116205|37777077|FG001|Overall Study|Withdrawal by Subject|4|||
16833616|NCT02116205|37777078|FG002|Overall Study|Withdrawal by Subject|1|||
16833617|NCT02116205|37777079|FG003|Overall Study|Withdrawal by Subject|3|||
16833618|NCT02116205|37777076|FG000|Overall Study|Lost to Follow-up|0|||
16833619|NCT02116205|37777077|FG001|Overall Study|Lost to Follow-up|2|||
16833620|NCT02116205|37777078|FG002|Overall Study|Lost to Follow-up|1|||
16833621|NCT02116205|37777079|FG003|Overall Study|Lost to Follow-up|2|||
16833622|NCT02116205|37777076|FG000|Overall Study|Physician Decision|0|||
16833623|NCT02116205|37777077|FG001|Overall Study|Physician Decision|1|||
16833624|NCT02116205|37777078|FG002|Overall Study|Physician Decision|1|||
16833625|NCT02116205|37777079|FG003|Overall Study|Physician Decision|1|||
16833626|NCT02116205|37777076|FG000|Overall Study|Exclusion criteria|0|||
16833627|NCT02116205|37777077|FG001|Overall Study|Exclusion criteria|0|||
16833628|NCT02116205|37777078|FG002|Overall Study|Exclusion criteria|1|||
16833629|NCT02116205|37777079|FG003|Overall Study|Exclusion criteria|0|||
16833630|NCT01844583|37777091|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
16833631|NCT01844583|37777092|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
16833632|NCT02115815|37777110|FG000|Overall Study|Withdrawal by Subject|2|||
16833633|NCT02115815|37777111|FG001|Overall Study|Withdrawal by Subject|0|||
16833634|NCT02115815|37777112|FG002|Overall Study|Withdrawal by Subject|0|||
16833635|NCT02115815|37777113|FG003|Overall Study|Withdrawal by Subject|0|||
16833636|NCT02115815|37777114|FG004|Overall Study|Withdrawal by Subject|0|||
16833637|NCT02115815|37777115|FG005|Overall Study|Withdrawal by Subject|0|||
16833638|NCT02115815|37777116|FG006|Overall Study|Withdrawal by Subject|0|||
16833639|NCT02115815|37777110|FG000|Overall Study|Not enough drug to dose participant|0|||
16833640|NCT02115815|37777111|FG001|Overall Study|Not enough drug to dose participant|0|||
16833641|NCT02115815|37777112|FG002|Overall Study|Not enough drug to dose participant|0|||
16833642|NCT02115815|37777113|FG003|Overall Study|Not enough drug to dose participant|0|||
16833643|NCT02115815|37777114|FG004|Overall Study|Not enough drug to dose participant|0|||
16833644|NCT02115815|37777115|FG005|Overall Study|Not enough drug to dose participant|1|||
16833645|NCT02115815|37777116|FG006|Overall Study|Not enough drug to dose participant|0|||
16833646|NCT02115815|37777110|FG000|Overall Study|Missed appointment, randomized in error|0|||
16833647|NCT02115815|37777111|FG001|Overall Study|Missed appointment, randomized in error|0|||
16833648|NCT02115815|37777112|FG002|Overall Study|Missed appointment, randomized in error|0|||
16833649|NCT02115815|37777113|FG003|Overall Study|Missed appointment, randomized in error|0|||
16912472|NCT01475214|38021720|FG001|Overall Study|Lost to Follow-up|0|||
16833650|NCT02115815|37777114|FG004|Overall Study|Missed appointment, randomized in error|0|||
16833651|NCT02115815|37777115|FG005|Overall Study|Missed appointment, randomized in error|1|||
16833652|NCT02115815|37777116|FG006|Overall Study|Missed appointment, randomized in error|0|||
16833653|NCT02115269|37777132|FG000|Overall Study|Lost to Follow-up|43|||
16833654|NCT02115269|37777132|FG000|Overall Study|Did not complete patient diary|3|||
16833655|NCT02115269|37777132|FG000|Overall Study|Moved to another city|7|||
16833656|NCT02115269|37777132|FG000|Overall Study|Withdrawal by Subject|2|||
16833657|NCT02115269|37777132|FG000|Overall Study|Didn't take study drug|2|||
17102426|NCT00858364|38241366|FG001|Overall Study|Ineligibility Determined|10|||
16833658|NCT02115113|37777147|FG000|Participants in Run-in Period|Death|0|||
16833659|NCT02115113|37777148|FG001|Participants in Run-in Period|Death|0|||
16833660|NCT02115113|37777149|FG002|Participants in Run-in Period|Death|1|||
16833661|NCT02115113|37777147|FG000|Participants in Run-in Period|Administrative problems|0|||
16833662|NCT02115113|37777148|FG001|Participants in Run-in Period|Administrative problems|0|||
16833663|NCT02115113|37777149|FG002|Participants in Run-in Period|Administrative problems|1|||
16833664|NCT02115113|37777147|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
16833665|NCT02115113|37777148|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
16833666|NCT02115113|37777149|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
16833667|NCT02115113|37777147|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
16833668|NCT02115113|37777148|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
16833669|NCT02115113|37777149|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
16833670|NCT02115113|37777147|FG000|Participants Randomized|Lost to Follow-up|1|||
16833671|NCT02115113|37777148|FG001|Participants Randomized|Lost to Follow-up|0|||
16833672|NCT02115113|37777149|FG002|Participants Randomized|Lost to Follow-up|0|||
16833673|NCT02115113|37777147|FG000|Participants Randomized|Death|1|||
16833674|NCT02115113|37777148|FG001|Participants Randomized|Death|0|||
16833675|NCT02115113|37777149|FG002|Participants Randomized|Death|0|||
16833676|NCT02114879|37777160|FG000|Overall Study|Withdrawal by Subject|9|||
16833677|NCT02114879|37777161|FG001|Overall Study|Withdrawal by Subject|5|||
16833678|NCT02114879|37777160|FG000|Overall Study|Death|6|||
16833679|NCT02114879|37777161|FG001|Overall Study|Death|11|||
16833680|NCT02114879|37777160|FG000|Overall Study|Lost to Follow-up|4|||
16833681|NCT02114879|37777161|FG001|Overall Study|Lost to Follow-up|6|||
16833682|NCT02114879|37777160|FG000|Overall Study|Physician Decision|0|||
16833683|NCT02114879|37777161|FG001|Overall Study|Physician Decision|2|||
16833684|NCT02114177|37777169|FG000|Overall Study|Lost to Follow-up|1|||
16833685|NCT02114177|37777170|FG001|Overall Study|Lost to Follow-up|2|||
16833686|NCT02114177|37777169|FG000|Overall Study|Withdrawal by Subject|6|||
16833687|NCT02114177|37777170|FG001|Overall Study|Withdrawal by Subject|1|||
16833688|NCT02114177|37777169|FG000|Overall Study|Other|2|||
16833689|NCT02114177|37777170|FG001|Overall Study|Other|1|||
16833690|NCT02138825|37777178|FG000|Main Study Treatment|Adverse Event|11|||
16833691|NCT02138825|37777179|FG001|Main Study Treatment|Adverse Event|3|||
16833692|NCT02138825|37777178|FG000|Main Study Treatment|Death|1|||
16833693|NCT02138825|37777179|FG001|Main Study Treatment|Death|2|||
16833694|NCT02138825|37777178|FG000|Main Study Treatment|Protocol Violation|2|||
16833695|NCT02138825|37777179|FG001|Main Study Treatment|Protocol Violation|2|||
16833696|NCT02138825|37777178|FG000|Main Study Treatment|Sponsor decision|12|||
16833697|NCT02138825|37777179|FG001|Main Study Treatment|Sponsor decision|18|||
16833698|NCT02138825|37777178|FG000|Main Study Treatment|Study terminated by sponsor|10|||
16833699|NCT02138825|37777179|FG001|Main Study Treatment|Study terminated by sponsor|9|||
16833700|NCT02138825|37777178|FG000|Main Study Treatment|Withdrawal by Subject|3|||
16833701|NCT02138825|37777179|FG001|Main Study Treatment|Withdrawal by Subject|1|||
16833702|NCT02138825|37777178|FG000|Main Study Treatment|Medical decision|1|||
16833703|NCT02138825|37777179|FG001|Main Study Treatment|Medical decision|0|||
16833704|NCT02138825|37777178|FG000|Long-term Extension|Study termination by sponsor|32|||
16833705|NCT02138825|37777179|FG001|Long-term Extension|Study termination by sponsor|38|||
16833706|NCT02138825|37777178|FG000|Safety Follow-up|Adverse Event|4|||
16833707|NCT02138825|37777179|FG001|Safety Follow-up|Adverse Event|3|||
16833708|NCT02138825|37777178|FG000|Safety Follow-up|Death|11|||
16833709|NCT02138825|37777179|FG001|Safety Follow-up|Death|5|||
16833710|NCT02138825|37777178|FG000|Safety Follow-up|Withdrawal by Subject|5|||
16833711|NCT02138825|37777179|FG001|Safety Follow-up|Withdrawal by Subject|3|||
16833712|NCT02138825|37777178|FG000|Safety Follow-up|clinic worsening|1|||
16833713|NCT02138825|37777179|FG001|Safety Follow-up|clinic worsening|0|||
16833714|NCT02138825|37777178|FG000|Safety Follow-up|withdrawal by PI|1|||
16833715|NCT02138825|37777179|FG001|Safety Follow-up|withdrawal by PI|0|||
16833716|NCT02138825|37777178|FG000|Safety Follow-up|logistical difficulties|0|||
16833717|NCT02138825|37777179|FG001|Safety Follow-up|logistical difficulties|1|||
16833718|NCT02138825|37777178|FG000|Safety Follow-up|progressive disease|0|||
16833719|NCT02138825|37777179|FG001|Safety Follow-up|progressive disease|2|||
16833720|NCT02138825|37777178|FG000|Safety Follow-up|too unwell to attend the visit|0|||
16833721|NCT02138825|37777179|FG001|Safety Follow-up|too unwell to attend the visit|1|||
16833722|NCT02138825|37777178|FG000|Safety Follow-up|treatment unblinded|0|||
16833723|NCT02138825|37777179|FG001|Safety Follow-up|treatment unblinded|1|||
16833724|NCT02138825|37777178|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
16833725|NCT02138825|37777179|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
16833726|NCT02138747|37777194|FG000|Treatment Period 1|Adverse Event|10|||
16833727|NCT02138747|37777195|FG001|Treatment Period 1|Adverse Event|14|||
16833728|NCT02138747|37777196|FG002|Treatment Period 1|Adverse Event|2|||
16833729|NCT02138747|37777197|FG003|Treatment Period 1|Adverse Event|1|||
16833730|NCT02138747|37777194|FG000|Treatment Period 1|Lost to Follow-up|0|||
16833731|NCT02138747|37777195|FG001|Treatment Period 1|Lost to Follow-up|1|||
16833732|NCT02138747|37777196|FG002|Treatment Period 1|Lost to Follow-up|1|||
16833733|NCT02138747|37777197|FG003|Treatment Period 1|Lost to Follow-up|0|||
16833734|NCT02138747|37777194|FG000|Treatment Period 1|Protocol Violation|0|||
16833735|NCT02138747|37777195|FG001|Treatment Period 1|Protocol Violation|2|||
16833736|NCT02138747|37777196|FG002|Treatment Period 1|Protocol Violation|0|||
16833737|NCT02138747|37777197|FG003|Treatment Period 1|Protocol Violation|0|||
16833738|NCT02138747|37777194|FG000|Treatment Period 1|Withdrawal by Subject|8|||
16833739|NCT02138747|37777195|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16833740|NCT02138747|37777196|FG002|Treatment Period 1|Withdrawal by Subject|1|||
16833741|NCT02138747|37777197|FG003|Treatment Period 1|Withdrawal by Subject|3|||
16833742|NCT02138747|37777194|FG000|Treatment Period 1|Other - Miscellaneous|2|||
16833743|NCT02138747|37777195|FG001|Treatment Period 1|Other - Miscellaneous|4|||
16833744|NCT02138747|37777196|FG002|Treatment Period 1|Other - Miscellaneous|0|||
16833745|NCT02138747|37777197|FG003|Treatment Period 1|Other - Miscellaneous|0|||
16833746|NCT02138747|37777194|FG000|Treatment Period 2|Adverse Event|6|||
16833747|NCT02138747|37777195|FG001|Treatment Period 2|Adverse Event|3|||
16833748|NCT02138747|37777196|FG002|Treatment Period 2|Adverse Event|1|||
16833749|NCT02138747|37777197|FG003|Treatment Period 2|Adverse Event|1|||
16833750|NCT02138747|37777194|FG000|Treatment Period 2|Lost to Follow-up|2|||
16833751|NCT02138747|37777195|FG001|Treatment Period 2|Lost to Follow-up|0|||
16833752|NCT02138747|37777196|FG002|Treatment Period 2|Lost to Follow-up|0|||
16833753|NCT02138747|37777197|FG003|Treatment Period 2|Lost to Follow-up|0|||
16833754|NCT02138747|37777194|FG000|Treatment Period 2|Protocol Violation|1|||
16833755|NCT02138747|37777195|FG001|Treatment Period 2|Protocol Violation|0|||
16833756|NCT02138747|37777196|FG002|Treatment Period 2|Protocol Violation|0|||
16833757|NCT02138747|37777197|FG003|Treatment Period 2|Protocol Violation|0|||
16833758|NCT02138747|37777194|FG000|Treatment Period 2|Withdrawal by Subject|5|||
16833759|NCT02138747|37777195|FG001|Treatment Period 2|Withdrawal by Subject|4|||
16833760|NCT02138747|37777196|FG002|Treatment Period 2|Withdrawal by Subject|1|||
16833761|NCT02138747|37777197|FG003|Treatment Period 2|Withdrawal by Subject|2|||
16833762|NCT02138747|37777194|FG000|Treatment Period 2|Other - Miscellaneous|3|||
16833763|NCT02138747|37777195|FG001|Treatment Period 2|Other - Miscellaneous|0|||
16833764|NCT02138747|37777196|FG002|Treatment Period 2|Other - Miscellaneous|0|||
16833765|NCT02138747|37777197|FG003|Treatment Period 2|Other - Miscellaneous|0|||
16833766|NCT02105285|37777210|FG000|Overall Study|Adverse Event|1|||
16833767|NCT02105285|37777211|FG001|Overall Study|Adverse Event|1|||
16833768|NCT02105285|37777212|FG002|Overall Study|Adverse Event|0|||
16833769|NCT02105285|37777210|FG000|Overall Study|Protocol Violation|0|||
16833770|NCT02105285|37777211|FG001|Overall Study|Protocol Violation|1|||
16833771|NCT02105285|37777212|FG002|Overall Study|Protocol Violation|0|||
16833772|NCT02105285|37777210|FG000|Overall Study|Withdrawal by Subject|1|||
16833773|NCT02105285|37777211|FG001|Overall Study|Withdrawal by Subject|0|||
16833774|NCT02105285|37777212|FG002|Overall Study|Withdrawal by Subject|0|||
16833775|NCT02104895|37777221|FG000|Overall Study|Withdrawal by Subject|0|||
16833776|NCT02104895|37777222|FG001|Overall Study|Withdrawal by Subject|14|||
16912473|NCT01475214|38021721|FG002|Overall Study|Lost to Follow-up|1|||
16912474|NCT01475214|38021719|FG000|Overall Study|Physician Decision|2|||
16912475|NCT01475214|38021720|FG001|Overall Study|Physician Decision|0|||
16912476|NCT01475214|38021721|FG002|Overall Study|Physician Decision|0|||
16912477|NCT01475214|38021719|FG000|Overall Study|Withdrawal by Subject|2|||
16912478|NCT01475214|38021720|FG001|Overall Study|Withdrawal by Subject|4|||
16912479|NCT01475214|38021721|FG002|Overall Study|Withdrawal by Subject|1|||
16912480|NCT01496274|38021732|FG000|Overall Study|Protocol Violation|0|||
16912481|NCT01496274|38021733|FG001|Overall Study|Protocol Violation|1|||
16912482|NCT01496274|38021732|FG000|Overall Study|Adverse Event|1|||
16912483|NCT01496274|38021733|FG001|Overall Study|Adverse Event|1|||
16912484|NCT01496274|38021732|FG000|Overall Study|Withdrawal by Subject|2|||
16912485|NCT01496274|38021733|FG001|Overall Study|Withdrawal by Subject|0|||
16912486|NCT01496274|38021732|FG000|Overall Study|Lost to Follow-up|0|||
16912487|NCT01496274|38021733|FG001|Overall Study|Lost to Follow-up|3|||
16912488|NCT01475136|38021758|FG000|Overall Study|Sponsor Decision|0|||
16912489|NCT01475136|38021759|FG001|Overall Study|Sponsor Decision|1|||
16912490|NCT01475136|38021760|FG002|Overall Study|Sponsor Decision|0|||
16912491|NCT01475136|38021761|FG003|Overall Study|Sponsor Decision|0|||
16912492|NCT01475136|38021758|FG000|Overall Study|Entry Criteria Not Met|0|||
16912493|NCT01475136|38021759|FG001|Overall Study|Entry Criteria Not Met|2|||
16912494|NCT01475136|38021760|FG002|Overall Study|Entry Criteria Not Met|3|||
16912495|NCT01475136|38021761|FG003|Overall Study|Entry Criteria Not Met|1|||
16912496|NCT01475136|38021758|FG000|Overall Study|Withdrawal by Subject|0|||
16912497|NCT01475136|38021759|FG001|Overall Study|Withdrawal by Subject|0|||
16912498|NCT01475136|38021760|FG002|Overall Study|Withdrawal by Subject|0|||
16912499|NCT01475136|38021761|FG003|Overall Study|Withdrawal by Subject|2|||
16912500|NCT01475136|38021758|FG000|Overall Study|Adverse Event|1|||
16912501|NCT01475136|38021759|FG001|Overall Study|Adverse Event|0|||
16912502|NCT01475136|38021760|FG002|Overall Study|Adverse Event|0|||
16912503|NCT01475136|38021761|FG003|Overall Study|Adverse Event|1|||
16912504|NCT01475136|38021758|FG000|Overall Study|Death|0|||
16912505|NCT01475136|38021759|FG001|Overall Study|Death|0|||
16912506|NCT01475136|38021760|FG002|Overall Study|Death|0|||
16912507|NCT01475136|38021761|FG003|Overall Study|Death|1|||
16833777|NCT01621490|37777237|FG000|Overall Study|Participant completed treatment|4|||
16833778|NCT01621490|37777238|FG001|Overall Study|Participant completed treatment|4|||
16833779|NCT01621490|37777239|FG002|Overall Study|Participant completed treatment|1|||
16833780|NCT01621490|37777240|FG003|Overall Study|Participant completed treatment|0|||
16833781|NCT01621490|37777241|FG004|Overall Study|Participant completed treatment|0|||
16833782|NCT01621490|37777242|FG005|Overall Study|Participant completed treatment|0|||
16833783|NCT01621490|37777243|FG006|Overall Study|Participant completed treatment|0|||
16833784|NCT01621490|37777244|FG007|Overall Study|Participant completed treatment|1|||
16833785|NCT01621490|37777245|FG008|Overall Study|Participant completed treatment|0|||
16833786|NCT01621490|37777237|FG000|Overall Study|Patient could not travel|1|||
16833787|NCT01621490|37777238|FG001|Overall Study|Patient could not travel|0|||
16833788|NCT01621490|37777239|FG002|Overall Study|Patient could not travel|0|||
16833789|NCT01621490|37777240|FG003|Overall Study|Patient could not travel|0|||
16833790|NCT01621490|37777241|FG004|Overall Study|Patient could not travel|0|||
16833791|NCT01621490|37777242|FG005|Overall Study|Patient could not travel|0|||
16833792|NCT01621490|37777243|FG006|Overall Study|Patient could not travel|0|||
16833793|NCT01621490|37777244|FG007|Overall Study|Patient could not travel|0|||
16833794|NCT01621490|37777245|FG008|Overall Study|Patient could not travel|0|||
16833795|NCT01621490|37777237|FG000|Overall Study|Subject no longer meets study criteria|0|||
16833796|NCT01621490|37777238|FG001|Overall Study|Subject no longer meets study criteria|0|||
16833797|NCT01621490|37777239|FG002|Overall Study|Subject no longer meets study criteria|0|||
16833798|NCT01621490|37777240|FG003|Overall Study|Subject no longer meets study criteria|0|||
16833799|NCT01621490|37777241|FG004|Overall Study|Subject no longer meets study criteria|1|||
16833800|NCT01621490|37777242|FG005|Overall Study|Subject no longer meets study criteria|0|||
16833801|NCT01621490|37777243|FG006|Overall Study|Subject no longer meets study criteria|0|||
16833802|NCT01621490|37777244|FG007|Overall Study|Subject no longer meets study criteria|0|||
16833803|NCT01621490|37777245|FG008|Overall Study|Subject no longer meets study criteria|0|||
16833804|NCT01621490|37777237|FG000|Overall Study|Maximum clinical benefit|3|||
16833805|NCT01621490|37777238|FG001|Overall Study|Maximum clinical benefit|2|||
16833806|NCT01621490|37777239|FG002|Overall Study|Maximum clinical benefit|0|||
16833807|NCT01621490|37777240|FG003|Overall Study|Maximum clinical benefit|0|||
16833808|NCT01621490|37777241|FG004|Overall Study|Maximum clinical benefit|0|||
16833809|NCT01621490|37777242|FG005|Overall Study|Maximum clinical benefit|0|||
16833810|NCT01621490|37777243|FG006|Overall Study|Maximum clinical benefit|1|||
16833811|NCT01621490|37777244|FG007|Overall Study|Maximum clinical benefit|2|||
16833812|NCT01621490|37777245|FG008|Overall Study|Maximum clinical benefit|0|||
16833813|NCT01621490|37777237|FG000|Overall Study|Withdrawal by Subject|1|||
16833814|NCT01621490|37777238|FG001|Overall Study|Withdrawal by Subject|0|||
16833815|NCT01621490|37777239|FG002|Overall Study|Withdrawal by Subject|0|||
16833816|NCT01621490|37777240|FG003|Overall Study|Withdrawal by Subject|0|||
16833817|NCT01621490|37777241|FG004|Overall Study|Withdrawal by Subject|0|||
16833818|NCT01621490|37777242|FG005|Overall Study|Withdrawal by Subject|3|||
16833819|NCT01621490|37777243|FG006|Overall Study|Withdrawal by Subject|0|||
16833820|NCT01621490|37777244|FG007|Overall Study|Withdrawal by Subject|0|||
16833821|NCT01621490|37777245|FG008|Overall Study|Withdrawal by Subject|0|||
16833822|NCT01621490|37777237|FG000|Overall Study|Subject request to discontinue study|1|||
16833823|NCT01621490|37777238|FG001|Overall Study|Subject request to discontinue study|3|||
16833824|NCT01621490|37777239|FG002|Overall Study|Subject request to discontinue study|1|||
16833825|NCT01621490|37777240|FG003|Overall Study|Subject request to discontinue study|1|||
16833826|NCT01621490|37777241|FG004|Overall Study|Subject request to discontinue study|0|||
16833827|NCT01621490|37777242|FG005|Overall Study|Subject request to discontinue study|2|||
16833828|NCT01621490|37777243|FG006|Overall Study|Subject request to discontinue study|1|||
16833829|NCT01621490|37777244|FG007|Overall Study|Subject request to discontinue study|0|||
16833830|NCT01621490|37777245|FG008|Overall Study|Subject request to discontinue study|1|||
16833831|NCT01621490|37777237|FG000|Overall Study|Adverse event unrelated to study drug|2|||
16833832|NCT01621490|37777238|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16833833|NCT01621490|37777239|FG002|Overall Study|Adverse event unrelated to study drug|0|||
16833834|NCT01621490|37777240|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16833835|NCT01621490|37777241|FG004|Overall Study|Adverse event unrelated to study drug|0|||
16833836|NCT01621490|37777242|FG005|Overall Study|Adverse event unrelated to study drug|0|||
16833837|NCT01621490|37777243|FG006|Overall Study|Adverse event unrelated to study drug|0|||
16833838|NCT01621490|37777244|FG007|Overall Study|Adverse event unrelated to study drug|2|||
16833839|NCT01621490|37777245|FG008|Overall Study|Adverse event unrelated to study drug|1|||
16833840|NCT01621490|37777237|FG000|Overall Study|Disease progression|27|||
16833841|NCT01621490|37777238|FG001|Overall Study|Disease progression|28|||
16833842|NCT01621490|37777239|FG002|Overall Study|Disease progression|1|||
16833843|NCT01621490|37777240|FG003|Overall Study|Disease progression|5|||
16833844|NCT01621490|37777241|FG004|Overall Study|Disease progression|3|||
16833845|NCT01621490|37777242|FG005|Overall Study|Disease progression|8|||
16833846|NCT01621490|37777243|FG006|Overall Study|Disease progression|7|||
16833847|NCT01621490|37777244|FG007|Overall Study|Disease progression|0|||
16833848|NCT01621490|37777245|FG008|Overall Study|Disease progression|4|||
16833849|NCT01621490|37777237|FG000|Overall Study|Study drug toxicity|1|||
16833850|NCT01621490|37777238|FG001|Overall Study|Study drug toxicity|4|||
16833851|NCT01621490|37777239|FG002|Overall Study|Study drug toxicity|5|||
16833852|NCT01621490|37777240|FG003|Overall Study|Study drug toxicity|3|||
16833853|NCT01621490|37777241|FG004|Overall Study|Study drug toxicity|1|||
16833854|NCT01621490|37777242|FG005|Overall Study|Study drug toxicity|10|||
16833855|NCT01621490|37777243|FG006|Overall Study|Study drug toxicity|1|||
16833856|NCT01621490|37777244|FG007|Overall Study|Study drug toxicity|4|||
16833857|NCT01621490|37777245|FG008|Overall Study|Study drug toxicity|1|||
16833858|NCT01621490|37777237|FG000|Overall Study|Death|0|||
16833859|NCT01621490|37777238|FG001|Overall Study|Death|0|||
16833860|NCT01621490|37777239|FG002|Overall Study|Death|0|||
16833861|NCT01621490|37777240|FG003|Overall Study|Death|0|||
16833862|NCT01621490|37777241|FG004|Overall Study|Death|0|||
16833863|NCT01621490|37777242|FG005|Overall Study|Death|0|||
16833864|NCT01621490|37777243|FG006|Overall Study|Death|0|||
16833865|NCT01621490|37777244|FG007|Overall Study|Death|1|||
16833866|NCT01621490|37777245|FG008|Overall Study|Death|0|||
16833867|NCT01621490|37777237|FG000|Overall Study|Grade 4 Lipase elevation|1|||
16833868|NCT01621490|37777238|FG001|Overall Study|Grade 4 Lipase elevation|0|||
16833869|NCT01621490|37777239|FG002|Overall Study|Grade 4 Lipase elevation|0|||
16833870|NCT01621490|37777240|FG003|Overall Study|Grade 4 Lipase elevation|0|||
16833871|NCT01621490|37777241|FG004|Overall Study|Grade 4 Lipase elevation|0|||
16833872|NCT01621490|37777242|FG005|Overall Study|Grade 4 Lipase elevation|0|||
16833873|NCT01621490|37777243|FG006|Overall Study|Grade 4 Lipase elevation|0|||
16833874|NCT01621490|37777244|FG007|Overall Study|Grade 4 Lipase elevation|0|||
16833875|NCT01621490|37777245|FG008|Overall Study|Grade 4 Lipase elevation|0|||
16833876|NCT01621490|37777237|FG000|Overall Study|BMS informed of patient status|0|||
16833877|NCT01621490|37777238|FG001|Overall Study|BMS informed of patient status|0|||
16833878|NCT01621490|37777239|FG002|Overall Study|BMS informed of patient status|1|||
16833879|NCT01621490|37777240|FG003|Overall Study|BMS informed of patient status|0|||
16833880|NCT01621490|37777241|FG004|Overall Study|BMS informed of patient status|0|||
16833881|NCT01621490|37777242|FG005|Overall Study|BMS informed of patient status|0|||
16833882|NCT01621490|37777243|FG006|Overall Study|BMS informed of patient status|0|||
16833883|NCT01621490|37777244|FG007|Overall Study|BMS informed of patient status|0|||
16833884|NCT01621490|37777245|FG008|Overall Study|BMS informed of patient status|0|||
16833885|NCT01621490|37777237|FG000|Overall Study|Investigator decision|0|||
16833886|NCT01621490|37777238|FG001|Overall Study|Investigator decision|0|||
16833887|NCT01621490|37777239|FG002|Overall Study|Investigator decision|1|||
16833888|NCT01621490|37777240|FG003|Overall Study|Investigator decision|0|||
16833889|NCT01621490|37777241|FG004|Overall Study|Investigator decision|1|||
16833890|NCT01621490|37777242|FG005|Overall Study|Investigator decision|0|||
16833891|NCT01621490|37777243|FG006|Overall Study|Investigator decision|1|||
16833892|NCT01621490|37777244|FG007|Overall Study|Investigator decision|0|||
16833893|NCT01621490|37777245|FG008|Overall Study|Investigator decision|0|||
16833894|NCT01621490|37777237|FG000|Overall Study|Documented disease progression|0|||
16833895|NCT01621490|37777238|FG001|Overall Study|Documented disease progression|0|||
16833896|NCT01621490|37777239|FG002|Overall Study|Documented disease progression|1|||
16833897|NCT01621490|37777240|FG003|Overall Study|Documented disease progression|0|||
16833898|NCT01621490|37777241|FG004|Overall Study|Documented disease progression|0|||
16833899|NCT01621490|37777242|FG005|Overall Study|Documented disease progression|0|||
16833900|NCT01621490|37777243|FG006|Overall Study|Documented disease progression|0|||
16833901|NCT01621490|37777244|FG007|Overall Study|Documented disease progression|0|||
16833902|NCT01621490|37777245|FG008|Overall Study|Documented disease progression|0|||
16833903|NCT01621490|37777237|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
16833904|NCT01621490|37777238|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
16833905|NCT01621490|37777239|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
16833906|NCT01621490|37777240|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
16833907|NCT01621490|37777241|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
16833908|NCT01621490|37777242|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
16833909|NCT01621490|37777243|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
16833910|NCT01621490|37777244|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
16833911|NCT01621490|37777245|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
16833912|NCT01621490|37777237|FG000|Overall Study|Clinical deterioration|0|||
16833913|NCT01621490|37777238|FG001|Overall Study|Clinical deterioration|1|||
16833914|NCT01621490|37777239|FG002|Overall Study|Clinical deterioration|0|||
16912508|NCT01474746|38021773|FG000|Overall Study|Lost to Follow-up|1|||
16833915|NCT01621490|37777240|FG003|Overall Study|Clinical deterioration|0|||
16833916|NCT01621490|37777241|FG004|Overall Study|Clinical deterioration|0|||
16833917|NCT01621490|37777242|FG005|Overall Study|Clinical deterioration|0|||
16833918|NCT01621490|37777243|FG006|Overall Study|Clinical deterioration|0|||
16833919|NCT01621490|37777244|FG007|Overall Study|Clinical deterioration|0|||
16833920|NCT01621490|37777245|FG008|Overall Study|Clinical deterioration|0|||
16833921|NCT01621490|37777237|FG000|Overall Study|Complete response|0|||
16833922|NCT01621490|37777238|FG001|Overall Study|Complete response|0|||
16833923|NCT01621490|37777239|FG002|Overall Study|Complete response|0|||
16833924|NCT01621490|37777240|FG003|Overall Study|Complete response|0|||
16833925|NCT01621490|37777241|FG004|Overall Study|Complete response|0|||
16833926|NCT01621490|37777242|FG005|Overall Study|Complete response|0|||
16833927|NCT01621490|37777243|FG006|Overall Study|Complete response|0|||
16833928|NCT01621490|37777244|FG007|Overall Study|Complete response|0|||
16833929|NCT01621490|37777245|FG008|Overall Study|Complete response|1|||
16833930|NCT01621490|37777237|FG000|Overall Study|Patient delayed due to toxicity|0|||
16833931|NCT01621490|37777238|FG001|Overall Study|Patient delayed due to toxicity|0|||
16833932|NCT01621490|37777239|FG002|Overall Study|Patient delayed due to toxicity|0|||
16833933|NCT01621490|37777240|FG003|Overall Study|Patient delayed due to toxicity|0|||
16833934|NCT01621490|37777241|FG004|Overall Study|Patient delayed due to toxicity|0|||
16833935|NCT01621490|37777242|FG005|Overall Study|Patient delayed due to toxicity|1|||
16833936|NCT01621490|37777243|FG006|Overall Study|Patient delayed due to toxicity|0|||
16833937|NCT01621490|37777244|FG007|Overall Study|Patient delayed due to toxicity|0|||
16833938|NCT01621490|37777245|FG008|Overall Study|Patient delayed due to toxicity|0|||
16833939|NCT02018887|37777366|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
16833940|NCT02018887|37777367|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833941|NCT02018887|37777368|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833942|NCT02018887|37777369|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833943|NCT02018887|37777370|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833944|NCT02018887|37777371|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833945|NCT02018887|37777372|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833946|NCT02018887|37777373|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833947|NCT02018887|37777374|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833948|NCT02018887|37777375|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833949|NCT02018887|37777376|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16833950|NCT02018887|37777366|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16833951|NCT02018887|37777367|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16833952|NCT02018887|37777368|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16833953|NCT02018887|37777369|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16833954|NCT02018887|37777370|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
16833955|NCT02018887|37777371|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16833956|NCT02018887|37777372|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
16833957|NCT02018887|37777373|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
16833958|NCT02018887|37777374|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16833959|NCT02018887|37777375|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16833960|NCT02018887|37777376|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16833961|NCT02018887|37777366|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
16833962|NCT02018887|37777367|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
16833963|NCT02018887|37777368|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
16833964|NCT02018887|37777369|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
16833965|NCT02018887|37777370|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
16833966|NCT02018887|37777371|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
16833967|NCT02018887|37777372|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
16833968|NCT02018887|37777373|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
16833969|NCT02018887|37777374|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
16833970|NCT02018887|37777375|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
16833971|NCT02018887|37777376|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
16833972|NCT02018887|37777366|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
16833973|NCT02018887|37777367|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
16833974|NCT02018887|37777368|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
16833975|NCT02018887|37777369|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
16833976|NCT02018887|37777370|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
16833977|NCT02018887|37777371|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
16833978|NCT02018887|37777372|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
16833979|NCT02018887|37777373|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
16833980|NCT02018887|37777374|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
16833981|NCT02018887|37777375|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
16833982|NCT02018887|37777376|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
16833983|NCT02030041|37777445|FG000|Overall Study|Withdrawal by Subject|2|||
16912509|NCT01474746|38021774|FG001|Overall Study|Lost to Follow-up|1|||
16833984|NCT02030041|37777446|FG001|Overall Study|Withdrawal by Subject|2|||
16833985|NCT02030041|37777447|FG002|Overall Study|Withdrawal by Subject|1|||
16833986|NCT01844505|37777458|FG000|Overall Study|Disease progression|170|||
16833987|NCT01844505|37777459|FG001|Overall Study|Disease progression|88|||
16833988|NCT01844505|37777460|FG002|Overall Study|Disease progression|224|||
16833989|NCT01844505|37777458|FG000|Overall Study|Study drug toxicity|40|||
16833990|NCT01844505|37777459|FG001|Overall Study|Study drug toxicity|131|||
16833991|NCT01844505|37777460|FG002|Overall Study|Study drug toxicity|50|||
16833992|NCT01844505|37777458|FG000|Overall Study|Death|1|||
16833993|NCT01844505|37777459|FG001|Overall Study|Death|3|||
16833994|NCT01844505|37777460|FG002|Overall Study|Death|1|||
16833995|NCT01844505|37777458|FG000|Overall Study|Adverse event unrelated to study drug|7|||
16833996|NCT01844505|37777459|FG001|Overall Study|Adverse event unrelated to study drug|15|||
16833997|NCT01844505|37777460|FG002|Overall Study|Adverse event unrelated to study drug|6|||
16833998|NCT01844505|37777458|FG000|Overall Study|Subject request discontinue treatment|17|||
16833999|NCT01844505|37777459|FG001|Overall Study|Subject request discontinue treatment|14|||
16834000|NCT01844505|37777460|FG002|Overall Study|Subject request discontinue treatment|8|||
16834001|NCT01844505|37777458|FG000|Overall Study|Withdrawal by Subject|0|||
16834002|NCT01844505|37777459|FG001|Overall Study|Withdrawal by Subject|3|||
16834003|NCT01844505|37777460|FG002|Overall Study|Withdrawal by Subject|0|||
16834004|NCT01844505|37777458|FG000|Overall Study|Lost to Follow-up|1|||
16834005|NCT01844505|37777459|FG001|Overall Study|Lost to Follow-up|0|||
16834006|NCT01844505|37777460|FG002|Overall Study|Lost to Follow-up|0|||
16834007|NCT01844505|37777458|FG000|Overall Study|Maximum clinical benefit|8|||
16834008|NCT01844505|37777459|FG001|Overall Study|Maximum clinical benefit|11|||
16834009|NCT01844505|37777460|FG002|Overall Study|Maximum clinical benefit|2|||
16834010|NCT01844505|37777458|FG000|Overall Study|Poor/non-compliance|1|||
16834011|NCT01844505|37777459|FG001|Overall Study|Poor/non-compliance|1|||
16834012|NCT01844505|37777460|FG002|Overall Study|Poor/non-compliance|1|||
16834013|NCT01844505|37777458|FG000|Overall Study|Subject no longer meets criteria|0|||
16834014|NCT01844505|37777459|FG001|Overall Study|Subject no longer meets criteria|1|||
16834015|NCT01844505|37777460|FG002|Overall Study|Subject no longer meets criteria|0|||
16834016|NCT01844505|37777458|FG000|Overall Study|Other Reasons|4|||
16834017|NCT01844505|37777459|FG001|Overall Study|Other Reasons|2|||
16834018|NCT01844505|37777460|FG002|Overall Study|Other Reasons|2|||
16834019|NCT01844505|37777458|FG000|Overall Study|Not Reported|0|||
16834020|NCT01844505|37777459|FG001|Overall Study|Not Reported|0|||
16834021|NCT01844505|37777460|FG002|Overall Study|Not Reported|1|||
16834022|NCT01994720|37777470|FG000|Overall Study|Withdrawal by Subject|46|||
16834023|NCT01994720|37777471|FG001|Overall Study|Withdrawal by Subject|56|||
16834024|NCT01814397|37777477|FG000|Overall Study|Adverse Event|7|||
16834025|NCT01814397|37777477|FG000|Overall Study|Withdrawal by Subject|7|||
16834026|NCT01814007|37777481|FG000|Overall Study|Withdrawal by Subject|1|||
16834027|NCT01844115|37777488|FG000|Overall Study|Adverse Event|4|||
16834028|NCT01844115|37777489|FG001|Overall Study|Adverse Event|22|||
16834029|NCT01844115|37777488|FG000|Overall Study|Lack of Efficacy|1|||
16834030|NCT01844115|37777489|FG001|Overall Study|Lack of Efficacy|4|||
16834031|NCT01844115|37777488|FG000|Overall Study|Protocol Violation|12|||
16834032|NCT01844115|37777489|FG001|Overall Study|Protocol Violation|10|||
16834033|NCT01844115|37777488|FG000|Overall Study|Withdrawal by Subject|11|||
16834034|NCT01844115|37777489|FG001|Overall Study|Withdrawal by Subject|11|||
16834035|NCT01844115|37777488|FG000|Overall Study|Lost to Follow-up|11|||
16834036|NCT01844115|37777489|FG001|Overall Study|Lost to Follow-up|10|||
16834037|NCT01844115|37777488|FG000|Overall Study|Pregnancy|0|||
16834038|NCT01844115|37777489|FG001|Overall Study|Pregnancy|1|||
16834039|NCT02018042|37777495|FG000|Overall Study|Withdrawal by Subject|1|||
16834040|NCT01813305|37777501|FG000|Overall Study|Withdrawal by Subject|12|||
16834041|NCT01813305|37777502|FG001|Overall Study|Withdrawal by Subject|5|||
16834042|NCT01813305|37777501|FG000|Overall Study|Safety Concern|4|||
16834043|NCT01813305|37777502|FG001|Overall Study|Safety Concern|0|||
16834044|NCT01813305|37777501|FG000|Overall Study|Ulcer became worse|4|||
16834045|NCT01813305|37777502|FG001|Overall Study|Ulcer became worse|0|||
16834046|NCT01813305|37777501|FG000|Overall Study|Physician Decision|4|||
16834047|NCT01813305|37777502|FG001|Overall Study|Physician Decision|0|||
16834048|NCT01813305|37777501|FG000|Overall Study|Lost to Follow-up|3|||
16834049|NCT01813305|37777502|FG001|Overall Study|Lost to Follow-up|1|||
16834050|NCT01813305|37777501|FG000|Overall Study|Protocol Violation|1|||
16834051|NCT01813305|37777502|FG001|Overall Study|Protocol Violation|0|||
16834052|NCT01813305|37777501|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
16834053|NCT01813305|37777502|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
16834054|NCT01993940|37777512|FG000|Overall Study|Adverse Event|16|||
16834055|NCT01993940|37777513|FG001|Overall Study|Adverse Event|11|||
16834056|NCT01993940|37777512|FG000|Overall Study|Withdrawal by Subject|15|||
16834057|NCT01993940|37777513|FG001|Overall Study|Withdrawal by Subject|19|||
16834058|NCT01993940|37777512|FG000|Overall Study|Lost to Follow-up|2|||
16834059|NCT01993940|37777513|FG001|Overall Study|Lost to Follow-up|5|||
16834060|NCT01993940|37777512|FG000|Overall Study|Protocol Violation|5|||
16834061|NCT01993940|37777513|FG001|Overall Study|Protocol Violation|8|||
16834062|NCT01993940|37777512|FG000|Overall Study|Death|1|||
16834063|NCT01993940|37777513|FG001|Overall Study|Death|0|||
16834064|NCT01993940|37777512|FG000|Overall Study|Other - Miscellaneous|1|||
16834065|NCT01993940|37777513|FG001|Overall Study|Other - Miscellaneous|1|||
16834066|NCT01843803|37777521|FG000|Overall Study|not a Veteran, did not see provider|1|||
16834067|NCT01843803|37777522|FG001|Overall Study|not a Veteran, did not see provider|3|||
16834068|NCT02017171|37777530|FG000|Overall Study|Death|10|||
16834069|NCT02017171|37777531|FG001|Overall Study|Death|4|||
16834070|NCT02017171|37777530|FG000|Overall Study|Withdrawal by Subject|23|||
16834071|NCT02017171|37777531|FG001|Overall Study|Withdrawal by Subject|17|||
16834072|NCT02017171|37777530|FG000|Overall Study|Lost to Follow-up|21|||
16834073|NCT02017171|37777531|FG001|Overall Study|Lost to Follow-up|20|||
16834074|NCT02017171|37777530|FG000|Overall Study|ESKD|6|||
16834075|NCT02017171|37777531|FG001|Overall Study|ESKD|2|||
16834076|NCT02017171|37777530|FG000|Overall Study|Miscellaneous|2|||
16834077|NCT02017171|37777531|FG001|Overall Study|Miscellaneous|3|||
16834078|NCT02029417|37777538|FG000|Overall Study|Death|1|||
16834079|NCT02029417|37777538|FG000|Overall Study|Adverse Event|1|||
16834080|NCT02016716|37777545|FG000|Overall Study|Withdrawal by Subject|5|||
16834081|NCT02016716|37777546|FG001|Overall Study|Withdrawal by Subject|5|||
16834082|NCT02016716|37777547|FG002|Overall Study|Withdrawal by Subject|5|||
16834083|NCT02016716|37777545|FG000|Overall Study|Protocol-specified Criteria|0|||
16834084|NCT02016716|37777546|FG001|Overall Study|Protocol-specified Criteria|1|||
16834085|NCT02016716|37777547|FG002|Overall Study|Protocol-specified Criteria|0|||
16834086|NCT02016716|37777545|FG000|Overall Study|Lost to Follow-up|1|||
16834087|NCT02016716|37777546|FG001|Overall Study|Lost to Follow-up|2|||
16834088|NCT02016716|37777547|FG002|Overall Study|Lost to Follow-up|1|||
16834089|NCT02050321|37777556|FG000|Overall Study|Withdrawal by Subject|1|||
16834090|NCT02050321|37777556|FG000|Overall Study|Adverse Event|1|||
16834091|NCT02039414|37777562|FG000|Overall Study|Delivered|1|||
16834092|NCT02039414|37777563|FG001|Overall Study|Delivered|1|||
16834093|NCT02039414|37777562|FG000|Overall Study|Lost to Follow-up|2|||
16834094|NCT02039414|37777563|FG001|Overall Study|Lost to Follow-up|0|||
16834095|NCT02039414|37777562|FG000|Overall Study|Protocol Violation|3|||
16834096|NCT02039414|37777563|FG001|Overall Study|Protocol Violation|1|||
16834097|NCT02017015|37777569|FG000|Overall Study|Adverse Event|9|||
16834098|NCT02017015|37777569|FG000|Overall Study|Withdrawal by Subject|21|||
16834099|NCT02017015|37777569|FG000|Overall Study|Death|4|||
16834100|NCT02017015|37777569|FG000|Overall Study|Progressive Disease|31|||
16834101|NCT02017015|37777569|FG000|Overall Study|Non-compliance with study drug|2|||
16834102|NCT02017015|37777569|FG000|Overall Study|Physician Decision|2|||
16834103|NCT02016625|37777576|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
16834104|NCT02016625|37777577|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
16834105|NCT02016625|37777576|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
16834106|NCT02016625|37777577|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
16834107|NCT02016625|37777576|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
16834108|NCT02016625|37777577|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
16834109|NCT02016482|37777595|FG000|Period A|Adverse Event|3|||
16834110|NCT02016482|37777596|FG001|Period A|Adverse Event|5|||
16834111|NCT02016482|37777595|FG000|Period A|Withdrawal by Subject|3|||
16834112|NCT02016482|37777596|FG001|Period A|Withdrawal by Subject|4|||
16834113|NCT02016482|37777595|FG000|Period A|Lost to Follow-up|3|||
16834114|NCT02016482|37777596|FG001|Period A|Lost to Follow-up|3|||
16834115|NCT02016482|37777595|FG000|Period A|Lack of Efficacy|2|||
16834116|NCT02016482|37777596|FG001|Period A|Lack of Efficacy|1|||
16834117|NCT02016482|37777595|FG000|Period A|Other|3|||
16834118|NCT02016482|37777596|FG001|Period A|Other|0|||
16834119|NCT02016482|37777595|FG000|Period A|Protocol Violation|0|||
16834120|NCT02016482|37777596|FG001|Period A|Protocol Violation|1|||
16834121|NCT02016482|37777595|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
16834122|NCT02016482|37777596|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
16834123|NCT02016482|37777595|FG000|Period B|Withdrawal by Subject|1|||
16834124|NCT02016482|37777596|FG001|Period B|Withdrawal by Subject|1|||
16834125|NCT02016482|37777595|FG000|Period B|Lost to Follow-up|2|||
16834126|NCT02016482|37777596|FG001|Period B|Lost to Follow-up|0|||
16834127|NCT02016482|37777595|FG000|Period B|Lack of Efficacy|6|||
16834128|NCT02016482|37777596|FG001|Period B|Lack of Efficacy|4|||
16834129|NCT02016482|37777595|FG000|Period B|Other|4|||
16834130|NCT02016482|37777596|FG001|Period B|Other|0|||
16834131|NCT02016482|37777595|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
16834132|NCT02016482|37777596|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
16834133|NCT02028871|37777606|FG000|Overall Study|Positive urine drug screen|1|||
16834134|NCT02028871|37777607|FG001|Overall Study|Positive urine drug screen|1|||
16834135|NCT02028871|37777606|FG000|Overall Study|Withdrawal by Subject|1|||
16834136|NCT02028871|37777607|FG001|Overall Study|Withdrawal by Subject|2|||
16834137|NCT02028871|37777606|FG000|Overall Study|IV placement difficulty|1|||
16834138|NCT02028871|37777607|FG001|Overall Study|IV placement difficulty|0|||
16834139|NCT02028871|37777606|FG000|Overall Study|Current Illness|1|||
16834140|NCT02028871|37777607|FG001|Overall Study|Current Illness|0|||
16834141|NCT02028715|37777618|FG000|Overall Study|Adverse Event|2|||
16834142|NCT02028715|37777619|FG001|Overall Study|Adverse Event|2|||
16834143|NCT02028715|37777618|FG000|Overall Study|Physician Decision|1|||
16834144|NCT02028715|37777619|FG001|Overall Study|Physician Decision|0|||
16834145|NCT02028715|37777618|FG000|Overall Study|Did not complete satisfaction surveys|2|||
16834146|NCT02028715|37777619|FG001|Overall Study|Did not complete satisfaction surveys|2|||
16834147|NCT02016170|37777628|FG000|Overall Study|Adverse Event|1|||
16834148|NCT02016170|37777629|FG001|Overall Study|Adverse Event|1|||
16834149|NCT02016170|37777630|FG002|Overall Study|Adverse Event|0|||
16834150|NCT02016170|37777628|FG000|Overall Study|Protocol Violation|1|||
16834151|NCT02016170|37777629|FG001|Overall Study|Protocol Violation|0|||
16834152|NCT02016170|37777630|FG002|Overall Study|Protocol Violation|0|||
16834153|NCT02028169|37777637|FG000|Overall Study|Lost to Follow-up|21|||
16834154|NCT02028169|37777637|FG000|Overall Study|Lack of Efficacy|2|||
16834155|NCT02028169|37777637|FG000|Overall Study|Withdrawal by Subject|2|||
16834156|NCT02028169|37777637|FG000|Overall Study|Adverse Event|1|||
16834157|NCT02028169|37777637|FG000|Overall Study|Cessation of Drug|1|||
16834158|NCT02028169|37777637|FG000|Overall Study|Concomitant Medication Usage|1|||
16834159|NCT02015546|37777644|FG000|Overall Study|Withdrawal by Subject|1|||
16834160|NCT02015546|37777645|FG001|Overall Study|Withdrawal by Subject|1|||
16834161|NCT02015546|37777646|FG002|Overall Study|Withdrawal by Subject|1|||
16834162|NCT02015546|37777644|FG000|Overall Study|Screem Failure|2|||
16834163|NCT02015546|37777645|FG001|Overall Study|Screem Failure|1|||
16834164|NCT02015546|37777646|FG002|Overall Study|Screem Failure|3|||
16834165|NCT02027701|37777654|FG000|Overall Study|Adverse Event|3|||
16834166|NCT02027701|37777654|FG000|Overall Study|Lack of Efficacy|8|||
16834167|NCT02027701|37777654|FG000|Overall Study|Physician Decision|2|||
16834168|NCT02027701|37777654|FG000|Overall Study|Withdrawal by Subject|3|||
16834169|NCT02038790|37777660|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
16834170|NCT02038790|37777661|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
16834171|NCT02027623|37777670|FG000|Overall Study|Lost to Follow-up|3|||
16834172|NCT02027623|37777671|FG001|Overall Study|Lost to Follow-up|3|||
16834173|NCT02027623|37777670|FG000|Overall Study|Withdrawal by Subject|6|||
16834174|NCT02027623|37777671|FG001|Overall Study|Withdrawal by Subject|9|||
16834175|NCT02027545|37777680|FG000|Overall Study|Failed to sign HIPAA|0|||
16834176|NCT02027545|37777681|FG001|Overall Study|Failed to sign HIPAA|2|||
16834177|NCT02027545|37777680|FG000|Overall Study|Failed to attend study visit|2|||
16834178|NCT02027545|37777681|FG001|Overall Study|Failed to attend study visit|0|||
16834179|NCT02015221|37777689|FG000|Overall Study|Withdrawal by Subject|8|||
16834180|NCT02015221|37777690|FG001|Overall Study|Withdrawal by Subject|6|||
16834181|NCT02015221|37777689|FG000|Overall Study|Lost to Follow-up|1|||
16834182|NCT02015221|37777690|FG001|Overall Study|Lost to Follow-up|0|||
16834183|NCT02027311|37777698|FG000|Overall Study|Protocol Violation|3|||
16834184|NCT02027311|37777699|FG001|Overall Study|Protocol Violation|2|||
16834185|NCT02047903|37777707|FG000|Overall Study|Adverse Event|14|||
16834186|NCT02047903|37777707|FG000|Overall Study|Serious adverse event|10|||
16834187|NCT02047903|37777707|FG000|Overall Study|Withdrawal by Subject|16|||
16834188|NCT02047903|37777707|FG000|Overall Study|Lost to Follow-up|4|||
16834189|NCT02047903|37777707|FG000|Overall Study|Reason not listed|6|||
16834190|NCT02047903|37777707|FG000|Overall Study|Not Treated|9|||
16834191|NCT02015065|37777714|FG000|Overall Study|Death on study|1|||
16834192|NCT02015065|37777715|FG001|Overall Study|Death on study|2|||
16834193|NCT02015065|37777716|FG002|Overall Study|Death on study|1|||
16834194|NCT02026141|37777726|FG000|Overall Study|Protocol Violation|0|||
16834195|NCT02026141|37777727|FG001|Overall Study|Protocol Violation|1|||
16834196|NCT02026063|37777735|FG000|Overall Study|Physician Decision|0|||
16834197|NCT02026063|37777736|FG001|Overall Study|Physician Decision|10|||
16834198|NCT02026063|37777735|FG000|Overall Study|Noncompliance with Study Drug|1|||
16834199|NCT02026063|37777736|FG001|Overall Study|Noncompliance with Study Drug|1|||
16834200|NCT02026063|37777735|FG000|Overall Study|Withdrawal of Consent|1|||
16834201|NCT02026063|37777736|FG001|Overall Study|Withdrawal of Consent|6|||
16834202|NCT02026063|37777735|FG000|Overall Study|Adverse Event|5|||
16834203|NCT02026063|37777736|FG001|Overall Study|Adverse Event|20|||
16834204|NCT02026063|37777735|FG000|Overall Study|Lack of Efficacy|0|||
16834205|NCT02026063|37777736|FG001|Overall Study|Lack of Efficacy|4|||
16834206|NCT02026063|37777735|FG000|Overall Study|Lost to Follow-up|0|||
16834207|NCT02026063|37777736|FG001|Overall Study|Lost to Follow-up|1|||
16834208|NCT02026063|37777735|FG000|Overall Study|Reason not Specified|2|||
16834209|NCT02026063|37777736|FG001|Overall Study|Reason not Specified|7|||
16834210|NCT02025907|37777745|FG000|Overall Study|Lack of Efficacy|1|||
16834211|NCT02025907|37777746|FG001|Overall Study|Lack of Efficacy|0|||
16834212|NCT02025907|37777745|FG000|Overall Study|Withdrawal by Subject|15|||
16834213|NCT02025907|37777746|FG001|Overall Study|Withdrawal by Subject|8|||
16834214|NCT02025907|37777745|FG000|Overall Study|Protocol Violation|2|||
16834215|NCT02025907|37777746|FG001|Overall Study|Protocol Violation|0|||
16834216|NCT02025907|37777745|FG000|Overall Study|Physician Decision|2|||
16834217|NCT02025907|37777746|FG001|Overall Study|Physician Decision|0|||
16834218|NCT02025907|37777745|FG000|Overall Study|Lost to Follow-up|2|||
16834219|NCT02025907|37777746|FG001|Overall Study|Lost to Follow-up|2|||
16834220|NCT02025907|37777745|FG000|Overall Study|Adverse Event|3|||
16834221|NCT02025907|37777746|FG001|Overall Study|Adverse Event|1|||
16834222|NCT02025907|37777745|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
16834223|NCT02025907|37777746|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
16834224|NCT01813071|37777761|FG000|Overall Study|Protocol Violation|0|||
16834225|NCT01813071|37777762|FG001|Overall Study|Protocol Violation|0|||
16834226|NCT01813071|37777763|FG002|Overall Study|Protocol Violation|0|||
16834227|NCT01813071|37777764|FG003|Overall Study|Protocol Violation|0|||
16834228|NCT01813071|37777765|FG004|Overall Study|Protocol Violation|1|||
16834229|NCT01813071|37777766|FG005|Overall Study|Protocol Violation|4|||
16834230|NCT01813071|37777767|FG006|Overall Study|Protocol Violation|2|||
16834231|NCT01813071|37777768|FG007|Overall Study|Protocol Violation|4|||
16834232|NCT01813071|37777769|FG008|Overall Study|Protocol Violation|2|||
16834233|NCT01813071|37777761|FG000|Overall Study|Withdrawal by Subject|0|||
16834234|NCT01813071|37777762|FG001|Overall Study|Withdrawal by Subject|0|||
16834235|NCT01813071|37777763|FG002|Overall Study|Withdrawal by Subject|0|||
16834236|NCT01813071|37777764|FG003|Overall Study|Withdrawal by Subject|0|||
16834237|NCT01813071|37777765|FG004|Overall Study|Withdrawal by Subject|0|||
16834238|NCT01813071|37777766|FG005|Overall Study|Withdrawal by Subject|1|||
16834239|NCT01813071|37777767|FG006|Overall Study|Withdrawal by Subject|0|||
16834240|NCT01813071|37777768|FG007|Overall Study|Withdrawal by Subject|0|||
16834241|NCT01813071|37777769|FG008|Overall Study|Withdrawal by Subject|0|||
16834242|NCT01813071|37777761|FG000|Overall Study|Adverse Event|0|||
16834243|NCT01813071|37777762|FG001|Overall Study|Adverse Event|0|||
16834244|NCT01813071|37777763|FG002|Overall Study|Adverse Event|0|||
16834245|NCT01813071|37777764|FG003|Overall Study|Adverse Event|0|||
16834246|NCT01813071|37777765|FG004|Overall Study|Adverse Event|0|||
16834247|NCT01813071|37777766|FG005|Overall Study|Adverse Event|1|||
16834248|NCT01813071|37777767|FG006|Overall Study|Adverse Event|0|||
16834249|NCT01813071|37777768|FG007|Overall Study|Adverse Event|0|||
16834250|NCT01813071|37777769|FG008|Overall Study|Adverse Event|0|||
16834251|NCT01813071|37777761|FG000|Overall Study|Physician Decision|0|||
16834252|NCT01813071|37777762|FG001|Overall Study|Physician Decision|0|||
16834253|NCT01813071|37777763|FG002|Overall Study|Physician Decision|0|||
16834254|NCT01813071|37777764|FG003|Overall Study|Physician Decision|0|||
16834255|NCT01813071|37777765|FG004|Overall Study|Physician Decision|0|||
16834256|NCT01813071|37777766|FG005|Overall Study|Physician Decision|0|||
16834257|NCT01813071|37777767|FG006|Overall Study|Physician Decision|1|||
16834258|NCT01813071|37777768|FG007|Overall Study|Physician Decision|0|||
16834259|NCT01813071|37777769|FG008|Overall Study|Physician Decision|0|||
16834260|NCT01813071|37777761|FG000|Overall Study|Met inc/exc criteria|0|||
16834261|NCT01813071|37777762|FG001|Overall Study|Met inc/exc criteria|0|||
16834262|NCT01813071|37777763|FG002|Overall Study|Met inc/exc criteria|0|||
16834263|NCT01813071|37777764|FG003|Overall Study|Met inc/exc criteria|0|||
16834264|NCT01813071|37777765|FG004|Overall Study|Met inc/exc criteria|0|||
16834265|NCT01813071|37777766|FG005|Overall Study|Met inc/exc criteria|1|||
16834266|NCT01813071|37777767|FG006|Overall Study|Met inc/exc criteria|0|||
16834267|NCT01813071|37777768|FG007|Overall Study|Met inc/exc criteria|1|||
16834268|NCT01813071|37777769|FG008|Overall Study|Met inc/exc criteria|1|||
16834269|NCT02025751|37777805|FG000|Overall Study|Lost to Follow-up|1|||
16834270|NCT02025751|37777806|FG001|Overall Study|Lost to Follow-up|0|||
16834271|NCT02025751|37777805|FG000|Overall Study|Adverse Event|0|||
16834272|NCT02025751|37777806|FG001|Overall Study|Adverse Event|1|||
16834273|NCT02025751|37777805|FG000|Overall Study|Physician Decision|0|||
16834274|NCT02025751|37777806|FG001|Overall Study|Physician Decision|1|||
16834275|NCT02025751|37777805|FG000|Overall Study|Withdrawal by Subject|0|||
16834276|NCT02025751|37777806|FG001|Overall Study|Withdrawal by Subject|1|||
16834277|NCT02025205|37777814|FG000|Overall Study|Withdrawal by Subject|1|||
16834278|NCT02025205|37777815|FG001|Overall Study|Withdrawal by Subject|1|||
16834279|NCT02025205|37777814|FG000|Overall Study|Protocol Violation|2|||
16834280|NCT02025205|37777815|FG001|Overall Study|Protocol Violation|1|||
16834281|NCT02025205|37777814|FG000|Overall Study|Death|0|||
16834282|NCT02025205|37777815|FG001|Overall Study|Death|1|||
16834283|NCT01812837|37777824|FG000|Overall Study|Lost to Follow-up|1|||
16834284|NCT01812837|37777825|FG001|Overall Study|Lost to Follow-up|1|||
16834285|NCT01812837|37777826|FG002|Overall Study|Lost to Follow-up|0|||
16834286|NCT01812837|37777824|FG000|Overall Study|Protocol Violation|1|||
16834287|NCT01812837|37777825|FG001|Overall Study|Protocol Violation|0|||
16834288|NCT01812837|37777826|FG002|Overall Study|Protocol Violation|0|||
16834289|NCT02024971|37777834|FG000|Overall Study|Data Not Available|30|||
16834290|NCT02024971|37777834|FG000|Overall Study|Lost to Follow-up|6|||
16834291|NCT02014597|37777840|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
16834292|NCT02014597|37777841|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
16834293|NCT01843023|37777849|FG000|Overall Study|Death|1|||
16834294|NCT01843023|37777850|FG001|Overall Study|Death|0|||
16834295|NCT01843023|37777849|FG000|Overall Study|Lost to Follow-up|24|||
16834296|NCT01843023|37777850|FG001|Overall Study|Lost to Follow-up|29|||
16834297|NCT01843023|37777849|FG000|Overall Study|Withdrawal by Subject|8|||
16834298|NCT01843023|37777850|FG001|Overall Study|Withdrawal by Subject|6|||
16834299|NCT01812759|37777859|FG000|Overall Study|Physician Decision|0|||
16834300|NCT01812759|37777860|FG001|Overall Study|Physician Decision|0|||
16834301|NCT01812759|37777861|FG002|Overall Study|Physician Decision|1|||
16834302|NCT01812057|37777871|FG000|Overall Study|Protocol Violation|1|||
16834303|NCT01812057|37777872|FG001|Overall Study|Protocol Violation|0|||
16834304|NCT01812057|37777871|FG000|Overall Study|Physician Decision|1|||
16834305|NCT01812057|37777872|FG001|Overall Study|Physician Decision|0|||
16834306|NCT01842633|37777885|FG000|Overall Study|Screen Failure|1|||
16834307|NCT01842633|37777886|FG001|Overall Study|Screen Failure|0|||
16834308|NCT01842633|37777887|FG002|Overall Study|Screen Failure|0|||
16834309|NCT01842633|37777885|FG000|Overall Study|Adverse Event|1|||
16834310|NCT01842633|37777886|FG001|Overall Study|Adverse Event|1|||
16834311|NCT01842633|37777887|FG002|Overall Study|Adverse Event|0|||
16834312|NCT01842633|37777885|FG000|Overall Study|Withdrawal by Subject|0|||
16834313|NCT01842633|37777886|FG001|Overall Study|Withdrawal by Subject|1|||
16834314|NCT01842633|37777887|FG002|Overall Study|Withdrawal by Subject|0|||
16834315|NCT01842633|37777885|FG000|Overall Study|Technical issues|1|||
16834316|NCT01842633|37777886|FG001|Overall Study|Technical issues|0|||
16834317|NCT01842633|37777887|FG002|Overall Study|Technical issues|0|||
16834318|NCT01810263|37777899|FG000|Overall Study|Lost to Follow-up|8|||
16834319|NCT01810263|37777900|FG001|Overall Study|Lost to Follow-up|7|||
16834320|NCT01841697|37777908|FG000|Overall Study|Death|0|||
16834321|NCT01841697|37777909|FG001|Overall Study|Death|1|||
16834322|NCT01841697|37777908|FG000|Overall Study|Lost to Follow-up|4|||
16834323|NCT01841697|37777909|FG001|Overall Study|Lost to Follow-up|1|||
16834324|NCT01841697|37777908|FG000|Overall Study|Withdrawal by Subject|16|||
16834325|NCT01841697|37777909|FG001|Overall Study|Withdrawal by Subject|16|||
16834326|NCT01841073|37777917|FG000|Overall Study|Adverse Event|1|||
16834327|NCT01841073|37777918|FG001|Overall Study|Adverse Event|1|||
16834328|NCT01841073|37777917|FG000|Overall Study|Physician Decision|1|||
16834329|NCT01841073|37777918|FG001|Overall Study|Physician Decision|0|||
16834330|NCT01841073|37777917|FG000|Overall Study|Lost to Follow-up|0|||
16834331|NCT01841073|37777918|FG001|Overall Study|Lost to Follow-up|2|||
16834332|NCT01809327|37777931|FG000|Overall Study|Lost to Follow-up|5|||
16834333|NCT01809327|37777932|FG001|Overall Study|Lost to Follow-up|2|||
16834334|NCT01809327|37777933|FG002|Overall Study|Lost to Follow-up|4|||
16834335|NCT01809327|37777934|FG003|Overall Study|Lost to Follow-up|2|||
16834336|NCT01809327|37777935|FG004|Overall Study|Lost to Follow-up|3|||
16834337|NCT01809327|37777931|FG000|Overall Study|Withdrawal by Subject|6|||
16834338|NCT01809327|37777932|FG001|Overall Study|Withdrawal by Subject|4|||
16834339|NCT01809327|37777933|FG002|Overall Study|Withdrawal by Subject|4|||
16834340|NCT01809327|37777934|FG003|Overall Study|Withdrawal by Subject|2|||
16834341|NCT01809327|37777935|FG004|Overall Study|Withdrawal by Subject|5|||
16834342|NCT01809327|37777931|FG000|Overall Study|Adverse Event|4|||
16834343|NCT01809327|37777932|FG001|Overall Study|Adverse Event|3|||
16834344|NCT01809327|37777933|FG002|Overall Study|Adverse Event|7|||
16834345|NCT01809327|37777934|FG003|Overall Study|Adverse Event|4|||
16834346|NCT01809327|37777935|FG004|Overall Study|Adverse Event|8|||
16834347|NCT01809327|37777931|FG000|Overall Study|Death|1|||
16834348|NCT01809327|37777932|FG001|Overall Study|Death|0|||
16834349|NCT01809327|37777933|FG002|Overall Study|Death|0|||
16834350|NCT01809327|37777934|FG003|Overall Study|Death|0|||
16834351|NCT01809327|37777935|FG004|Overall Study|Death|0|||
16834352|NCT01809327|37777931|FG000|Overall Study|Protocol Violation|0|||
16834353|NCT01809327|37777932|FG001|Overall Study|Protocol Violation|1|||
16834354|NCT01809327|37777933|FG002|Overall Study|Protocol Violation|0|||
16834355|NCT01809327|37777934|FG003|Overall Study|Protocol Violation|0|||
16834356|NCT01809327|37777935|FG004|Overall Study|Protocol Violation|0|||
16834357|NCT01809327|37777931|FG000|Overall Study|Physician Decision|1|||
16834358|NCT01809327|37777932|FG001|Overall Study|Physician Decision|1|||
16834359|NCT01809327|37777933|FG002|Overall Study|Physician Decision|0|||
16834360|NCT01809327|37777934|FG003|Overall Study|Physician Decision|0|||
16834361|NCT01809327|37777935|FG004|Overall Study|Physician Decision|0|||
16834362|NCT01809327|37777931|FG000|Overall Study|Pregnancy|1|||
16834363|NCT01809327|37777932|FG001|Overall Study|Pregnancy|0|||
16834364|NCT01809327|37777933|FG002|Overall Study|Pregnancy|0|||
16834365|NCT01809327|37777934|FG003|Overall Study|Pregnancy|0|||
16834366|NCT01809327|37777935|FG004|Overall Study|Pregnancy|0|||
16834367|NCT01809327|37777931|FG000|Overall Study|Other|14|||
16834368|NCT01809327|37777932|FG001|Overall Study|Other|15|||
16834369|NCT01809327|37777933|FG002|Overall Study|Other|7|||
16834370|NCT01809327|37777934|FG003|Overall Study|Other|4|||
16834371|NCT01809327|37777935|FG004|Overall Study|Other|9|||
16834372|NCT01808313|37777956|FG000|Overall Study|Adverse Event|5|||
16834373|NCT01808313|37777956|FG000|Overall Study|Protocol Violation|2|||
16834374|NCT01808313|37777956|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16834375|NCT01808313|37777956|FG000|Overall Study|Lost to Follow-up|1|||
16834376|NCT01808313|37777956|FG000|Overall Study|Physician Decision|1|||
16834377|NCT01840605|37777962|FG000|Overall Study|Adverse Event|0|||
16834378|NCT01840605|37777963|FG001|Overall Study|Adverse Event|1|||
16834379|NCT01840605|37777962|FG000|Overall Study|Physician Decision|2|||
16834380|NCT01840605|37777963|FG001|Overall Study|Physician Decision|1|||
16834381|NCT02023879|37777972|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
16834382|NCT02023879|37777973|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
16834383|NCT02023879|37777974|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
16834384|NCT02023879|37777972|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
16834385|NCT02023879|37777973|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
16834386|NCT02023879|37777974|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
17102427|NCT00858364|38241365|FG000|Overall Study|Lost to Follow-up|24|||
16834387|NCT02023879|37777972|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
16834388|NCT02023879|37777973|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
16834389|NCT02023879|37777974|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
16834390|NCT02023879|37777972|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
16834391|NCT02023879|37777973|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
16834392|NCT02023879|37777974|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
16834393|NCT02023879|37777972|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
16834394|NCT02023879|37777973|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
16834395|NCT02023879|37777974|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
16834396|NCT02023879|37777972|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
16834397|NCT02023879|37777973|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
16834398|NCT02023879|37777974|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
16834399|NCT02023879|37777972|FG000|Extension Open Label Treatment|Adverse Event|1|||
16834400|NCT02023879|37777973|FG001|Extension Open Label Treatment|Adverse Event|7|||
16834401|NCT02023879|37777974|FG002|Extension Open Label Treatment|Adverse Event|3|||
16834402|NCT02023879|37777972|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
16834403|NCT02023879|37777973|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
16834404|NCT02023879|37777974|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
16834405|NCT02023879|37777972|FG000|Extension Open Label Treatment|Participant moved|1|||
16834406|NCT02023879|37777973|FG001|Extension Open Label Treatment|Participant moved|2|||
16834407|NCT02023879|37777974|FG002|Extension Open Label Treatment|Participant moved|0|||
16834408|NCT02023879|37777972|FG000|Extension Open Label Treatment|Other than specified above|2|||
16912510|NCT01474746|38021773|FG000|Overall Study|Withdrawal by Subject|2|||
16912511|NCT01474746|38021774|FG001|Overall Study|Withdrawal by Subject|1|||
16912512|NCT01450800|38021782|FG000|Overall Study|Protocol Violation|1|||
16912513|NCT01450800|38021783|FG001|Overall Study|Protocol Violation|3|||
16834409|NCT02023879|37777973|FG001|Extension Open Label Treatment|Other than specified above|7|||
16912514|NCT01474512|38021794|FG000|Induction Period|Adverse Event|6|||
16912515|NCT01474512|38021795|FG001|Induction Period|Adverse Event|10|||
16912516|NCT01474512|38021796|FG002|Induction Period|Adverse Event|10|||
16912517|NCT01474512|38021797|FG003|Induction Period|Adverse Event|0|||
16912518|NCT01474512|38021798|FG004|Induction Period|Adverse Event|0|||
16912519|NCT01474512|38021799|FG005|Induction Period|Adverse Event|0|||
16912520|NCT01474512|38021800|FG006|Induction Period|Adverse Event|0|||
16912521|NCT01474512|38021801|FG007|Induction Period|Adverse Event|0|||
16912522|NCT01474512|38021802|FG008|Induction Period|Adverse Event|0|||
16912523|NCT01474512|38021803|FG009|Induction Period|Adverse Event|0|||
16912524|NCT01474512|38021804|FG010|Induction Period|Adverse Event|0|||
16912525|NCT01474512|38021805|FG011|Induction Period|Adverse Event|0|||
16912526|NCT01474512|38021806|FG012|Induction Period|Adverse Event|0|||
16912527|NCT01474512|38021807|FG013|Induction Period|Adverse Event|0|||
16912528|NCT01474512|38021808|FG014|Induction Period|Adverse Event|0|||
16912529|NCT01474512|38021809|FG015|Induction Period|Adverse Event|0|||
16912530|NCT01474512|38021810|FG016|Induction Period|Adverse Event|0|||
16912531|NCT01474512|38021811|FG017|Induction Period|Adverse Event|0|||
16912532|NCT01474512|38021794|FG000|Induction Period|Lack of Efficacy|7|||
16912533|NCT01474512|38021795|FG001|Induction Period|Lack of Efficacy|1|||
16912534|NCT01474512|38021796|FG002|Induction Period|Lack of Efficacy|0|||
16912535|NCT01474512|38021797|FG003|Induction Period|Lack of Efficacy|0|||
16912536|NCT01474512|38021798|FG004|Induction Period|Lack of Efficacy|0|||
16912537|NCT01474512|38021799|FG005|Induction Period|Lack of Efficacy|0|||
16912538|NCT01474512|38021800|FG006|Induction Period|Lack of Efficacy|0|||
16912539|NCT01474512|38021801|FG007|Induction Period|Lack of Efficacy|0|||
16912540|NCT01474512|38021802|FG008|Induction Period|Lack of Efficacy|0|||
16912541|NCT01474512|38021803|FG009|Induction Period|Lack of Efficacy|0|||
16912542|NCT01474512|38021804|FG010|Induction Period|Lack of Efficacy|0|||
16912543|NCT01474512|38021805|FG011|Induction Period|Lack of Efficacy|0|||
16912544|NCT01474512|38021806|FG012|Induction Period|Lack of Efficacy|0|||
16912545|NCT01474512|38021807|FG013|Induction Period|Lack of Efficacy|0|||
16912546|NCT01474512|38021808|FG014|Induction Period|Lack of Efficacy|0|||
16912547|NCT01474512|38021809|FG015|Induction Period|Lack of Efficacy|0|||
16912548|NCT01474512|38021810|FG016|Induction Period|Lack of Efficacy|0|||
16912549|NCT01474512|38021811|FG017|Induction Period|Lack of Efficacy|0|||
16912550|NCT01474512|38021794|FG000|Induction Period|Withdrawal by Subject|6|||
16912551|NCT01474512|38021795|FG001|Induction Period|Withdrawal by Subject|6|||
16912552|NCT01474512|38021796|FG002|Induction Period|Withdrawal by Subject|5|||
16912553|NCT01474512|38021797|FG003|Induction Period|Withdrawal by Subject|0|||
16912554|NCT01474512|38021798|FG004|Induction Period|Withdrawal by Subject|0|||
16912555|NCT01474512|38021799|FG005|Induction Period|Withdrawal by Subject|0|||
16912556|NCT01474512|38021800|FG006|Induction Period|Withdrawal by Subject|0|||
16912557|NCT01474512|38021801|FG007|Induction Period|Withdrawal by Subject|0|||
16912558|NCT01474512|38021802|FG008|Induction Period|Withdrawal by Subject|0|||
16912559|NCT01474512|38021803|FG009|Induction Period|Withdrawal by Subject|0|||
16834410|NCT02023879|37777974|FG002|Extension Open Label Treatment|Other than specified above|2|||
16834411|NCT02014441|37777989|FG000|Overall Study|Withdrawal by Subject|12|||
16834412|NCT02013817|37777995|FG000|Overall Study|Adverse Event|12|||
16834413|NCT02013817|37777995|FG000|Overall Study|Withdrawal by Subject|4|||
16834414|NCT02013817|37777995|FG000|Overall Study|Death|2|||
16834415|NCT02013817|37777995|FG000|Overall Study|Other|9|||
16834416|NCT01994863|37777999|FG000|Period 1|Adverse Event|4|||
16834417|NCT01994863|37778000|FG001|Period 1|Adverse Event|0|||
16834418|NCT01994863|37777999|FG000|Period 1|Withdrawal by Subject|1|||
16834419|NCT01994863|37778000|FG001|Period 1|Withdrawal by Subject|0|||
16834420|NCT01994863|37777999|FG000|Period 1|Trial stopped by sponsor|1|||
16834421|NCT01994863|37778000|FG001|Period 1|Trial stopped by sponsor|3|||
16834422|NCT01994863|37777999|FG000|Period 1|Lack of Efficacy|1|||
16834423|NCT01994863|37778000|FG001|Period 1|Lack of Efficacy|0|||
16834424|NCT01994863|37777999|FG000|Period 2|Adverse Event|0|||
16834425|NCT01994863|37778000|FG001|Period 2|Adverse Event|1|||
16834426|NCT01994863|37777999|FG000|Period 2|Lack of Efficacy|0|||
16834427|NCT01994863|37778000|FG001|Period 2|Lack of Efficacy|2|||
16834428|NCT01994863|37777999|FG000|Period 2|Withdrawal by Subject|1|||
16834429|NCT01994863|37778000|FG001|Period 2|Withdrawal by Subject|1|||
16834430|NCT02023099|37778009|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
16834431|NCT02023099|37778010|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
16834432|NCT02023099|37778011|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
16834433|NCT02023099|37778009|FG000|Overall Study|Withdrawn Consent|3|||
16834434|NCT02023099|37778010|FG001|Overall Study|Withdrawn Consent|0|||
16834435|NCT02023099|37778011|FG002|Overall Study|Withdrawn Consent|1|||
16834436|NCT02023099|37778009|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
16834437|NCT02023099|37778010|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
16834438|NCT02023099|37778011|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
16834439|NCT02013037|37778019|FG000|Overall Study|Death|6|||
16834440|NCT02013037|37778019|FG000|Overall Study|Withdrawal by Subject|1|||
16834441|NCT02013037|37778019|FG000|Overall Study|Awaiting Transplantation|7|||
16834442|NCT02013037|37778019|FG000|Overall Study|Transplanted without DSA|2|||
16834443|NCT01967719|37778026|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
16834444|NCT01967719|37778027|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
16834445|NCT01967719|37778028|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16834446|NCT01967719|37778029|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
16834447|NCT01967719|37778026|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
16834448|NCT01967719|37778027|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
16834449|NCT01967719|37778028|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
16834450|NCT01967719|37778029|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
16834451|NCT01967173|37778047|FG000|Overall Study|Lost to Follow-up|5|||
16834452|NCT01967173|37778048|FG001|Overall Study|Lost to Follow-up|3|||
16834453|NCT01967173|37778049|FG002|Overall Study|Lost to Follow-up|2|||
16834454|NCT01967173|37778050|FG003|Overall Study|Lost to Follow-up|4|||
16834455|NCT01967173|37778051|FG004|Overall Study|Lost to Follow-up|8|||
16834456|NCT01967173|37778052|FG005|Overall Study|Lost to Follow-up|12|||
16834457|NCT01967173|37778053|FG006|Overall Study|Lost to Follow-up|6|||
16834458|NCT01967173|37778054|FG007|Overall Study|Lost to Follow-up|8|||
16834459|NCT01967173|37778047|FG000|Overall Study|Physician Decision|2|||
16834460|NCT01967173|37778048|FG001|Overall Study|Physician Decision|0|||
16834461|NCT01967173|37778049|FG002|Overall Study|Physician Decision|2|||
16834462|NCT01967173|37778050|FG003|Overall Study|Physician Decision|1|||
16834463|NCT01967173|37778051|FG004|Overall Study|Physician Decision|1|||
16834464|NCT01967173|37778052|FG005|Overall Study|Physician Decision|1|||
16834465|NCT01967173|37778053|FG006|Overall Study|Physician Decision|1|||
17102428|NCT00858364|38241366|FG001|Overall Study|Lost to Follow-up|54|||
17016752|NCT00599339|38161370|FG000|Overall Study|No valid data consent|36|||
17016753|NCT00599339|38161370|FG000|Overall Study|Study Termination Status Unknown|12|||
17016754|NCT00599027|38161394|FG000|Overall Study|Withdrawal by Subject|1|||
17102429|NCT00858364|38241365|FG000|Overall Study|Noncompliance|3|||
17016755|NCT00599027|38161395|FG001|Overall Study|Withdrawal by Subject|1|||
17016756|NCT00599027|38161394|FG000|Overall Study|Adverse Event|0|||
17016757|NCT00599027|38161395|FG001|Overall Study|Adverse Event|1|||
17016758|NCT00599027|38161394|FG000|Overall Study|Treatment Failure|0|||
16834466|NCT01967173|37778054|FG007|Overall Study|Physician Decision|0|||
16834467|NCT01967173|37778047|FG000|Overall Study|Lack of Efficacy|2|||
16834468|NCT01967173|37778048|FG001|Overall Study|Lack of Efficacy|0|||
16834469|NCT01967173|37778049|FG002|Overall Study|Lack of Efficacy|2|||
16834470|NCT01967173|37778050|FG003|Overall Study|Lack of Efficacy|2|||
16834471|NCT01967173|37778051|FG004|Overall Study|Lack of Efficacy|0|||
16834472|NCT01967173|37778052|FG005|Overall Study|Lack of Efficacy|1|||
16834473|NCT01967173|37778053|FG006|Overall Study|Lack of Efficacy|0|||
16834474|NCT01967173|37778054|FG007|Overall Study|Lack of Efficacy|2|||
17016759|NCT00599027|38161395|FG001|Overall Study|Treatment Failure|1|||
17016760|NCT02881151|38161401|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
16834475|NCT01967173|37778047|FG000|Overall Study|Pregnancy|0|||
16834476|NCT01967173|37778048|FG001|Overall Study|Pregnancy|0|||
16834477|NCT01967173|37778049|FG002|Overall Study|Pregnancy|0|||
16834478|NCT01967173|37778050|FG003|Overall Study|Pregnancy|0|||
16834479|NCT01967173|37778051|FG004|Overall Study|Pregnancy|0|||
16834480|NCT01967173|37778052|FG005|Overall Study|Pregnancy|0|||
16834481|NCT01967173|37778053|FG006|Overall Study|Pregnancy|1|||
16834482|NCT01967173|37778054|FG007|Overall Study|Pregnancy|1|||
16834483|NCT01967173|37778047|FG000|Overall Study|Adverse Event|0|||
16834484|NCT01967173|37778048|FG001|Overall Study|Adverse Event|0|||
16834485|NCT01967173|37778049|FG002|Overall Study|Adverse Event|0|||
16834486|NCT01967173|37778050|FG003|Overall Study|Adverse Event|0|||
16834487|NCT01967173|37778051|FG004|Overall Study|Adverse Event|0|||
16834488|NCT01967173|37778052|FG005|Overall Study|Adverse Event|0|||
16834489|NCT01967173|37778053|FG006|Overall Study|Adverse Event|0|||
16834490|NCT01967173|37778054|FG007|Overall Study|Adverse Event|1|||
16834491|NCT01967173|37778047|FG000|Overall Study|Withdrawal by Subject|15|||
16834492|NCT01967173|37778048|FG001|Overall Study|Withdrawal by Subject|14|||
16834493|NCT01967173|37778049|FG002|Overall Study|Withdrawal by Subject|10|||
16834494|NCT01967173|37778050|FG003|Overall Study|Withdrawal by Subject|7|||
16834495|NCT01967173|37778051|FG004|Overall Study|Withdrawal by Subject|8|||
16834496|NCT01967173|37778052|FG005|Overall Study|Withdrawal by Subject|9|||
16834497|NCT01967173|37778053|FG006|Overall Study|Withdrawal by Subject|10|||
16834498|NCT01967173|37778054|FG007|Overall Study|Withdrawal by Subject|12|||
16834499|NCT01994629|37778068|FG000|Overall Study|Withdrawal by Subject|1|||
16834500|NCT01994629|37778069|FG001|Overall Study|Withdrawal by Subject|0|||
16834501|NCT01994629|37778068|FG000|Overall Study|Lost to Follow-up|0|||
16834502|NCT01994629|37778069|FG001|Overall Study|Lost to Follow-up|3|||
16834503|NCT01994395|37778077|FG000|Overall Study|Withdrawal by Subject|1|||
16834504|NCT01994395|37778078|FG001|Overall Study|Withdrawal by Subject|2|||
16834505|NCT01992536|37778094|FG000|Overall Study|Administrative Reason|0|||
16834506|NCT01992536|37778095|FG001|Overall Study|Administrative Reason|0|||
16834507|NCT01992536|37778096|FG002|Overall Study|Administrative Reason|0|||
16834508|NCT01992536|37778097|FG003|Overall Study|Administrative Reason|0|||
16834509|NCT01992536|37778098|FG004|Overall Study|Administrative Reason|0|||
16834510|NCT01992536|37778099|FG005|Overall Study|Administrative Reason|0|||
16834511|NCT01992536|37778100|FG006|Overall Study|Administrative Reason|7|||
16834512|NCT01992536|37778101|FG007|Overall Study|Administrative Reason|0|||
16834513|NCT01992536|37778102|FG008|Overall Study|Administrative Reason|0|||
16834514|NCT01992536|37778103|FG009|Overall Study|Administrative Reason|0|||
16834515|NCT01992536|37778094|FG000|Overall Study|Lost to Follow-up|4|||
16834516|NCT01992536|37778095|FG001|Overall Study|Lost to Follow-up|2|||
16834517|NCT01992536|37778096|FG002|Overall Study|Lost to Follow-up|1|||
16834518|NCT01992536|37778097|FG003|Overall Study|Lost to Follow-up|0|||
16834519|NCT01992536|37778098|FG004|Overall Study|Lost to Follow-up|0|||
16834520|NCT01992536|37778099|FG005|Overall Study|Lost to Follow-up|1|||
16834521|NCT01992536|37778100|FG006|Overall Study|Lost to Follow-up|0|||
16834522|NCT01992536|37778101|FG007|Overall Study|Lost to Follow-up|0|||
16834523|NCT01992536|37778102|FG008|Overall Study|Lost to Follow-up|1|||
16834524|NCT01992536|37778103|FG009|Overall Study|Lost to Follow-up|1|||
16834525|NCT01992536|37778094|FG000|Overall Study|Withdrawal by Subject|0|||
16834526|NCT01992536|37778095|FG001|Overall Study|Withdrawal by Subject|1|||
16834527|NCT01992536|37778096|FG002|Overall Study|Withdrawal by Subject|0|||
16834528|NCT01992536|37778097|FG003|Overall Study|Withdrawal by Subject|2|||
16834529|NCT01992536|37778098|FG004|Overall Study|Withdrawal by Subject|0|||
16834530|NCT01992536|37778099|FG005|Overall Study|Withdrawal by Subject|0|||
16834531|NCT01992536|37778100|FG006|Overall Study|Withdrawal by Subject|0|||
16834532|NCT01992536|37778101|FG007|Overall Study|Withdrawal by Subject|0|||
16834533|NCT01992536|37778102|FG008|Overall Study|Withdrawal by Subject|0|||
16834534|NCT01992536|37778103|FG009|Overall Study|Withdrawal by Subject|0|||
16834535|NCT01993927|37778145|FG000|Overall Study|Case Report Forms Uncollected|18|||
16834536|NCT01993927|37778145|FG000|Overall Study|Protocol Violation|11|||
16834537|NCT02015390|37778151|FG000|Overall Study|Lost to Follow-up|1|||
16834538|NCT02015390|37778152|FG001|Overall Study|Lost to Follow-up|0|||
16834539|NCT02015390|37778151|FG000|Overall Study|Adverse Event|0|||
16834540|NCT02015390|37778152|FG001|Overall Study|Adverse Event|3|||
16834541|NCT02015390|37778151|FG000|Overall Study|Physician Decision|0|||
16834542|NCT02015390|37778152|FG001|Overall Study|Physician Decision|1|||
16834543|NCT02012959|37778159|FG000|Treatment Phase A|Adverse Event|2|||
16834544|NCT02012959|37778160|FG001|Treatment Phase A|Adverse Event|0|||
16834545|NCT02012959|37778161|FG002|Treatment Phase A|Adverse Event|0|||
16834546|NCT02012959|37778162|FG003|Treatment Phase A|Adverse Event|0|||
16834547|NCT02012959|37778163|FG004|Treatment Phase A|Adverse Event|0|||
16834548|NCT01990742|37778175|FG000|Overall Study|Withdrawal by facility|407|||
16834549|NCT01990742|37778176|FG001|Overall Study|Withdrawal by facility|1083|||
16834550|NCT01990742|37778175|FG000|Overall Study|Facility closed|0|||
16834551|NCT01990742|37778176|FG001|Overall Study|Facility closed|270|||
16834552|NCT02012491|37778184|FG000|Overall Study|Lost to Follow-up|1|||
16834553|NCT02012491|37778185|FG001|Overall Study|Lost to Follow-up|0|||
16834554|NCT02012491|37778184|FG000|Overall Study|Protocol Violation|0|||
16834555|NCT02012491|37778185|FG001|Overall Study|Protocol Violation|1|||
16834556|NCT02012491|37778184|FG000|Overall Study|Withdrawal by Subject|1|||
16834557|NCT02012491|37778185|FG001|Overall Study|Withdrawal by Subject|0|||
16834558|NCT01990664|37778193|FG000|Overall Study|Lost to Follow-up|2|||
16834559|NCT01990664|37778194|FG001|Overall Study|Lost to Follow-up|6|||
16834560|NCT01990664|37778193|FG000|Overall Study|Withdrawal by Subject|2|||
16834561|NCT01990664|37778194|FG001|Overall Study|Withdrawal by Subject|3|||
16834562|NCT01990664|37778193|FG000|Overall Study|Protocol Violation|1|||
16834563|NCT01990664|37778194|FG001|Overall Study|Protocol Violation|0|||
16834564|NCT01990664|37778193|FG000|Overall Study|Lens Discomfort|1|||
16834565|NCT01990664|37778194|FG001|Overall Study|Lens Discomfort|1|||
16834566|NCT01990664|37778193|FG000|Overall Study|Lens Handling Difficulties|1|||
16834567|NCT01990664|37778194|FG001|Overall Study|Lens Handling Difficulties|0|||
16834568|NCT01990664|37778193|FG000|Overall Study|Unsatisfactory Visual Response|0|||
16834569|NCT01990664|37778194|FG001|Overall Study|Unsatisfactory Visual Response|1|||
16834570|NCT02038010|37778200|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
16834571|NCT02038010|37778201|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
16834572|NCT02038010|37778202|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
16834573|NCT02038010|37778203|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
16834574|NCT02038010|37778200|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
16834575|NCT02038010|37778201|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
16834576|NCT02038010|37778202|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
16834577|NCT02038010|37778203|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
16834578|NCT02038010|37778200|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
16834579|NCT02038010|37778201|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
16834580|NCT02038010|37778202|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
16834581|NCT02038010|37778203|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
16834582|NCT02038010|37778200|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
16834583|NCT02038010|37778201|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
16834584|NCT02038010|37778202|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
16834585|NCT02038010|37778203|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
16834586|NCT02038010|37778200|FG000|Follow Up|Death|4|||
16834587|NCT02038010|37778201|FG001|Follow Up|Death|3|||
16834588|NCT02038010|37778202|FG002|Follow Up|Death|0|||
16834589|NCT02038010|37778203|FG003|Follow Up|Death|0|||
16834590|NCT02038010|37778200|FG000|Follow Up|Other|3|||
16834591|NCT02038010|37778201|FG001|Follow Up|Other|0|||
16834592|NCT02038010|37778202|FG002|Follow Up|Other|0|||
16834593|NCT02038010|37778203|FG003|Follow Up|Other|0|||
16834594|NCT01989572|37778217|FG000|Overall Study|Lack of Efficacy|35|||
16834595|NCT01989572|37778218|FG001|Overall Study|Lack of Efficacy|48|||
16834596|NCT01989572|37778219|FG002|Overall Study|Lack of Efficacy|48|||
16834597|NCT01989572|37778220|FG003|Overall Study|Lack of Efficacy|43|||
16834598|NCT01989572|37778221|FG004|Overall Study|Lack of Efficacy|71|||
16834599|NCT01989572|37778222|FG005|Overall Study|Lack of Efficacy|79|||
16834600|NCT01989572|37778217|FG000|Overall Study|Adverse Event|2|||
16834601|NCT01989572|37778218|FG001|Overall Study|Adverse Event|1|||
16834602|NCT01989572|37778219|FG002|Overall Study|Adverse Event|3|||
16834603|NCT01989572|37778220|FG003|Overall Study|Adverse Event|0|||
16834604|NCT01989572|37778221|FG004|Overall Study|Adverse Event|3|||
16834605|NCT01989572|37778222|FG005|Overall Study|Adverse Event|0|||
16834606|NCT01989572|37778217|FG000|Overall Study|Death|0|||
16834607|NCT01989572|37778218|FG001|Overall Study|Death|0|||
16834608|NCT01989572|37778219|FG002|Overall Study|Death|0|||
16834609|NCT01989572|37778220|FG003|Overall Study|Death|0|||
16834610|NCT01989572|37778221|FG004|Overall Study|Death|1|||
16834611|NCT01989572|37778222|FG005|Overall Study|Death|0|||
16834612|NCT01989572|37778217|FG000|Overall Study|Withdrawal by Subject|4|||
16834613|NCT01989572|37778218|FG001|Overall Study|Withdrawal by Subject|1|||
16834614|NCT01989572|37778219|FG002|Overall Study|Withdrawal by Subject|5|||
16834615|NCT01989572|37778220|FG003|Overall Study|Withdrawal by Subject|1|||
16834616|NCT01989572|37778221|FG004|Overall Study|Withdrawal by Subject|12|||
16834617|NCT01989572|37778222|FG005|Overall Study|Withdrawal by Subject|4|||
16834618|NCT01989572|37778217|FG000|Overall Study|complicating disease|1|||
16834619|NCT01989572|37778218|FG001|Overall Study|complicating disease|1|||
16834620|NCT01989572|37778219|FG002|Overall Study|complicating disease|2|||
16834621|NCT01989572|37778220|FG003|Overall Study|complicating disease|0|||
16834622|NCT01989572|37778221|FG004|Overall Study|complicating disease|1|||
16834623|NCT01989572|37778222|FG005|Overall Study|complicating disease|0|||
16834624|NCT01989572|37778217|FG000|Overall Study|error|2|||
16834625|NCT01989572|37778218|FG001|Overall Study|error|1|||
16834626|NCT01989572|37778219|FG002|Overall Study|error|1|||
16834627|NCT01989572|37778220|FG003|Overall Study|error|1|||
16834628|NCT01989572|37778221|FG004|Overall Study|error|1|||
16834629|NCT01989572|37778222|FG005|Overall Study|error|1|||
16834630|NCT01989572|37778217|FG000|Overall Study|maximum dose reached|0|||
16834631|NCT01989572|37778218|FG001|Overall Study|maximum dose reached|1|||
16834632|NCT01989572|37778219|FG002|Overall Study|maximum dose reached|0|||
16834633|NCT01989572|37778220|FG003|Overall Study|maximum dose reached|0|||
16834634|NCT01989572|37778221|FG004|Overall Study|maximum dose reached|1|||
16834635|NCT01989572|37778222|FG005|Overall Study|maximum dose reached|0|||
16834636|NCT01989572|37778217|FG000|Overall Study|unknown/not specify|3|||
16834637|NCT01989572|37778218|FG001|Overall Study|unknown/not specify|4|||
16834638|NCT01989572|37778219|FG002|Overall Study|unknown/not specify|1|||
16834639|NCT01989572|37778220|FG003|Overall Study|unknown/not specify|3|||
16834640|NCT01989572|37778221|FG004|Overall Study|unknown/not specify|3|||
16834641|NCT01989572|37778222|FG005|Overall Study|unknown/not specify|5|||
16834642|NCT01989572|37778217|FG000|Overall Study|not start protocol therapy|5|||
16834643|NCT01989572|37778218|FG001|Overall Study|not start protocol therapy|1|||
16834644|NCT01989572|37778219|FG002|Overall Study|not start protocol therapy|2|||
16834645|NCT01989572|37778220|FG003|Overall Study|not start protocol therapy|3|||
16834646|NCT01989572|37778221|FG004|Overall Study|not start protocol therapy|4|||
16834647|NCT01989572|37778222|FG005|Overall Study|not start protocol therapy|18|||
16834648|NCT01989572|37778217|FG000|Overall Study|alternative therapy|3|||
16834649|NCT01989572|37778218|FG001|Overall Study|alternative therapy|0|||
16834650|NCT01989572|37778219|FG002|Overall Study|alternative therapy|0|||
16834651|NCT01989572|37778220|FG003|Overall Study|alternative therapy|0|||
16834652|NCT01989572|37778221|FG004|Overall Study|alternative therapy|1|||
16834653|NCT01989572|37778222|FG005|Overall Study|alternative therapy|3|||
16834654|NCT02036294|37778242|FG000|Overall Study|Death|7|||
16834655|NCT02036294|37778243|FG001|Overall Study|Death|8|||
16834656|NCT02036294|37778242|FG000|Overall Study|Withdrawal by Subject|2|||
16834657|NCT02036294|37778243|FG001|Overall Study|Withdrawal by Subject|3|||
16834658|NCT02035748|37778249|FG000|Overall Study|Adverse Event|5|||
16834659|NCT02035748|37778249|FG000|Overall Study|Death|3|||
16834660|NCT02035748|37778249|FG000|Overall Study|Lost to Follow-up|2|||
16834661|NCT02035748|37778249|FG000|Overall Study|Physician Decision|3|||
16834662|NCT02035748|37778249|FG000|Overall Study|Withdrawal by Subject|6|||
16834663|NCT02035748|37778249|FG000|Overall Study|Progressive Disease|1|||
16834664|NCT02014376|37778257|FG000|Overall Study|Adverse Event|1|||
16834665|NCT02014376|37778258|FG001|Overall Study|Adverse Event|1|||
16834666|NCT02014376|37778259|FG002|Overall Study|Adverse Event|0|||
16834667|NCT02014376|37778257|FG000|Overall Study|Lost to Follow-up|2|||
16834668|NCT02014376|37778258|FG001|Overall Study|Lost to Follow-up|0|||
16834669|NCT02014376|37778259|FG002|Overall Study|Lost to Follow-up|0|||
16834670|NCT02035202|37778270|FG000|Overall Study|Lost to Follow-up|8|||
16834671|NCT02035202|37778271|FG001|Overall Study|Lost to Follow-up|16|||
16834672|NCT02035202|37778272|FG002|Overall Study|Lost to Follow-up|2|||
16834673|NCT01988402|37778282|FG000|Overall Study|Adverse Event|1|||
16834674|NCT01988402|37778283|FG001|Overall Study|Adverse Event|2|||
16834675|NCT01988402|37778282|FG000|Overall Study|Withdrawal by Subject|1|||
16834676|NCT01988402|37778283|FG001|Overall Study|Withdrawal by Subject|0|||
16834677|NCT01988090|37778291|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
16834678|NCT01988090|37778292|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
16834679|NCT01988090|37778291|FG000|Start Treament After Randomization|Protocol Violation|0|||
16834680|NCT01988090|37778292|FG001|Start Treament After Randomization|Protocol Violation|1|||
16834681|NCT01988090|37778291|FG000|Complete Study After Start|Withdrawal by Subject|2|||
16834682|NCT01988090|37778292|FG001|Complete Study After Start|Withdrawal by Subject|0|||
16834683|NCT01988090|37778291|FG000|Complete Study After Start|Protocol Violation|1|||
16834684|NCT01988090|37778292|FG001|Complete Study After Start|Protocol Violation|1|||
16834685|NCT01988012|37778298|FG000|Overall Study|Adverse Event|5|||
16834686|NCT01988012|37778298|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16834687|NCT01988012|37778298|FG000|Overall Study|Patient Withdrawal of Consent|4|||
16834688|NCT01988012|37778298|FG000|Overall Study|Lost to Follow-up|1|||
16834689|NCT01988012|37778298|FG000|Overall Study|Physician Decision|1|||
16834690|NCT01988012|37778298|FG000|Overall Study|Protocol Violation|1|||
16834691|NCT02011945|37778305|FG000|Overall Study|Participant requested to Discontinue|0|||
16834692|NCT02011945|37778306|FG001|Overall Study|Participant requested to Discontinue|1|||
17102430|NCT00858364|38241366|FG001|Overall Study|Noncompliance|4|||
16834693|NCT02011945|37778307|FG002|Overall Study|Participant requested to Discontinue|1|||
16834694|NCT02011945|37778305|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
16834695|NCT02011945|37778306|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
16834696|NCT02011945|37778307|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
16834697|NCT02011945|37778305|FG000|Overall Study|Study Drug Toxicity|0|||
16834698|NCT02011945|37778306|FG001|Overall Study|Study Drug Toxicity|0|||
16834699|NCT02011945|37778307|FG002|Overall Study|Study Drug Toxicity|1|||
16834700|NCT02011945|37778305|FG000|Overall Study|Treatment Failure|0|||
16834701|NCT02011945|37778306|FG001|Overall Study|Treatment Failure|7|||
16834702|NCT02011945|37778307|FG002|Overall Study|Treatment Failure|6|||
16834703|NCT02011945|37778305|FG000|Overall Study|No Longer Meets Study Criteria|1|||
16834704|NCT02011945|37778306|FG001|Overall Study|No Longer Meets Study Criteria|0|||
16834705|NCT02011945|37778307|FG002|Overall Study|No Longer Meets Study Criteria|0|||
16834706|NCT02011945|37778305|FG000|Overall Study|Proceeded to stem cell transplant|0|||
16834707|NCT02011945|37778306|FG001|Overall Study|Proceeded to stem cell transplant|0|||
16834708|NCT02011945|37778307|FG002|Overall Study|Proceeded to stem cell transplant|1|||
16834709|NCT02011945|37778305|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
17102431|NCT00858364|38241365|FG000|Overall Study|Protocol Deviation|0|||
16834710|NCT02011945|37778306|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
16834711|NCT02011945|37778307|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
16834712|NCT02013830|37778315|FG000|Overall Study|Adverse Event|3|||
16834713|NCT02013830|37778315|FG000|Overall Study|Death|1|||
16834714|NCT02013830|37778315|FG000|Overall Study|Insufficient therapeutic response|25|||
16834715|NCT02013830|37778315|FG000|Overall Study|Refused treatment|1|||
16834716|NCT02010775|37778324|FG000|Overall Study|Adverse Event|0|||
16834717|NCT02010775|37778325|FG001|Overall Study|Adverse Event|0|||
16834718|NCT02010775|37778326|FG002|Overall Study|Adverse Event|0|||
16834719|NCT02010775|37778327|FG003|Overall Study|Adverse Event|0|||
16834720|NCT02010775|37778328|FG004|Overall Study|Adverse Event|1|||
16834721|NCT02010775|37778324|FG000|Overall Study|Pregnancy|0|||
16834722|NCT02010775|37778325|FG001|Overall Study|Pregnancy|0|||
16834723|NCT02010775|37778326|FG002|Overall Study|Pregnancy|2|||
16834724|NCT02010775|37778327|FG003|Overall Study|Pregnancy|0|||
16834725|NCT02010775|37778328|FG004|Overall Study|Pregnancy|0|||
16834726|NCT02010775|37778324|FG000|Overall Study|Lost to Follow-up|2|||
16834727|NCT02010775|37778325|FG001|Overall Study|Lost to Follow-up|0|||
16834728|NCT02010775|37778326|FG002|Overall Study|Lost to Follow-up|0|||
16834729|NCT02010775|37778327|FG003|Overall Study|Lost to Follow-up|1|||
16834730|NCT02010775|37778328|FG004|Overall Study|Lost to Follow-up|1|||
16834731|NCT02010775|37778324|FG000|Overall Study|Personal Reasons|3|||
16834732|NCT02010775|37778325|FG001|Overall Study|Personal Reasons|3|||
16834733|NCT02010775|37778326|FG002|Overall Study|Personal Reasons|1|||
16834734|NCT02010775|37778327|FG003|Overall Study|Personal Reasons|2|||
16834735|NCT02010775|37778328|FG004|Overall Study|Personal Reasons|4|||
16834736|NCT01993615|37778342|FG000|Overall Study|Death|1|||
16834737|NCT01993615|37778343|FG001|Overall Study|Death|0|||
16834738|NCT02013674|37778351|FG000|Overall Study|Death|0|||
16834739|NCT02013674|37778352|FG001|Overall Study|Death|1|||
16834740|NCT02013674|37778351|FG000|Overall Study|Lost to Follow-up|1|||
16834741|NCT02013674|37778352|FG001|Overall Study|Lost to Follow-up|0|||
16834742|NCT01619059|37778360|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
16834743|NCT01619059|37778361|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
16834744|NCT01619059|37778360|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
16834745|NCT01619059|37778361|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
16834746|NCT01619059|37778360|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
16834747|NCT01619059|37778361|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
16834748|NCT01619059|37778360|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
16834749|NCT01619059|37778361|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
16834750|NCT01619059|37778360|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
16834751|NCT01619059|37778361|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
16834752|NCT01619059|37778360|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
16834753|NCT01619059|37778361|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
16834754|NCT01619059|37778360|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
16834755|NCT01619059|37778361|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
16834756|NCT01619059|37778360|FG000|Long-Term (LT) Treatment Period|Death|1|||
16834757|NCT01619059|37778361|FG001|Long-Term (LT) Treatment Period|Death|0|||
16834758|NCT01619059|37778360|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
16834759|NCT01619059|37778361|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
16834760|NCT01619059|37778360|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
16834761|NCT01619059|37778361|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
16834762|NCT02013206|37778369|FG000|Overall Study|Progressive disease (PD)|14|||
16834763|NCT02013206|37778370|FG001|Overall Study|Progressive disease (PD)|17|||
16834764|NCT02013206|37778369|FG000|Overall Study|Symptomatic deterioration|3|||
16834765|NCT02013206|37778370|FG001|Overall Study|Symptomatic deterioration|1|||
16834766|NCT02013206|37778369|FG000|Overall Study|Adverse Event|1|||
16834767|NCT02013206|37778370|FG001|Overall Study|Adverse Event|0|||
16834768|NCT02013206|37778369|FG000|Overall Study|Patient refusal|2|||
16834769|NCT02013206|37778370|FG001|Overall Study|Patient refusal|0|||
16834770|NCT02013206|37778369|FG000|Overall Study|Patient non-compliance|1|||
16834771|NCT02013206|37778370|FG001|Overall Study|Patient non-compliance|0|||
16834772|NCT02013206|37778369|FG000|Overall Study|Death|1|||
16834773|NCT02013206|37778370|FG001|Overall Study|Death|2|||
16834774|NCT02013206|37778369|FG000|Overall Study|Other reasons off treatment|5|||
16834775|NCT02013206|37778370|FG001|Overall Study|Other reasons off treatment|2|||
16834776|NCT01807923|37778379|FG000|Overall Study|Adverse Event|2|||
16834777|NCT01807923|37778380|FG001|Overall Study|Adverse Event|1|||
16834778|NCT01807923|37778381|FG002|Overall Study|Adverse Event|2|||
16834779|NCT01807923|37778379|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
16834780|NCT01807923|37778380|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
16834781|NCT01807923|37778381|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
16834782|NCT01807923|37778379|FG000|Overall Study|Physician Decision|0|||
16834783|NCT01807923|37778380|FG001|Overall Study|Physician Decision|0|||
16834784|NCT01807923|37778381|FG002|Overall Study|Physician Decision|1|||
16834785|NCT01807923|37778379|FG000|Overall Study|Not Eligible (Genotype)|0|||
16834786|NCT01807923|37778380|FG001|Overall Study|Not Eligible (Genotype)|0|||
16834787|NCT01807923|37778381|FG002|Overall Study|Not Eligible (Genotype)|1|||
16834788|NCT01807923|37778379|FG000|Overall Study|Randomized But Not Treated|3|||
16834789|NCT01807923|37778380|FG001|Overall Study|Randomized But Not Treated|2|||
16834790|NCT01807923|37778381|FG002|Overall Study|Randomized But Not Treated|5|||
16834791|NCT01966003|37778393|FG000|Overall Study|Death|43|||
16834792|NCT01966003|37778394|FG001|Overall Study|Death|36|||
16834793|NCT01966003|37778393|FG000|Overall Study|Protocol Violation|6|||
16834794|NCT01966003|37778394|FG001|Overall Study|Protocol Violation|4|||
16834795|NCT01966003|37778393|FG000|Overall Study|Lost to Follow-up|4|||
16834796|NCT01966003|37778394|FG001|Overall Study|Lost to Follow-up|3|||
16834797|NCT01966003|37778393|FG000|Overall Study|Physician Decision|12|||
16834798|NCT01966003|37778394|FG001|Overall Study|Physician Decision|13|||
16834799|NCT01966003|37778393|FG000|Overall Study|Withdrawal by Subject|29|||
16834800|NCT01966003|37778394|FG001|Overall Study|Withdrawal by Subject|19|||
16834801|NCT01966003|37778393|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
16834802|NCT01966003|37778394|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
16834803|NCT01966003|37778393|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
16834804|NCT01966003|37778394|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
16834805|NCT01966003|37778393|FG000|Overall Study|Other|1|||
16834806|NCT01966003|37778394|FG001|Overall Study|Other|1|||
16834807|NCT01839279|37778403|FG000|Overall Study|Adverse Event|4|||
16834808|NCT01839279|37778404|FG001|Overall Study|Adverse Event|1|||
16834809|NCT01839279|37778405|FG002|Overall Study|Adverse Event|1|||
16834810|NCT01839279|37778403|FG000|Overall Study|Withdrawal by Subject|4|||
16834811|NCT01839279|37778404|FG001|Overall Study|Withdrawal by Subject|1|||
16834812|NCT01839279|37778405|FG002|Overall Study|Withdrawal by Subject|1|||
16834813|NCT01839279|37778403|FG000|Overall Study|Classified as 'Other'|5|||
16834814|NCT01839279|37778404|FG001|Overall Study|Classified as 'Other'|0|||
16834815|NCT01839279|37778405|FG002|Overall Study|Classified as 'Other'|0|||
16834816|NCT01807299|37778424|FG000|Overall Study|Protocol Violation|3|||
16834817|NCT01807299|37778425|FG001|Overall Study|Protocol Violation|1|||
16834818|NCT01807299|37778426|FG002|Overall Study|Protocol Violation|0|||
16834819|NCT01807299|37778427|FG003|Overall Study|Protocol Violation|2|||
16834820|NCT01965535|37778439|FG000|Overall Study|Lack of Efficacy|2|||
16834821|NCT01965535|37778440|FG001|Overall Study|Lack of Efficacy|1|||
16834822|NCT01964755|37778446|FG000|Overall Study|Death|2|||
16834823|NCT01964521|37778450|FG000|Overall Study|Lost to Follow-up|4|||
16834824|NCT01992757|37778455|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
16834825|NCT01991743|37778464|FG000|Overall Study|external cephalic version not performed|0|||
16834826|NCT01991743|37778465|FG001|Overall Study|external cephalic version not performed|0|||
16834827|NCT01991743|37778466|FG002|Overall Study|external cephalic version not performed|1|||
16834828|NCT01991743|37778467|FG003|Overall Study|external cephalic version not performed|0|||
16834829|NCT01991197|37778479|FG000|Overall Study|Lost to Follow-up|1|||
16834830|NCT01991197|37778480|FG001|Overall Study|Lost to Follow-up|1|||
16834831|NCT01991197|37778479|FG000|Overall Study|Physician Decision|0|||
16834832|NCT01991197|37778480|FG001|Overall Study|Physician Decision|2|||
16834833|NCT01991197|37778479|FG000|Overall Study|Withdrawal by Subject|2|||
16834834|NCT01991197|37778480|FG001|Overall Study|Withdrawal by Subject|0|||
16834835|NCT01990573|37778494|FG000|Overall Study|Physician Decision|0|||
16834836|NCT01990573|37778495|FG001|Overall Study|Physician Decision|0|||
16834837|NCT01990573|37778496|FG002|Overall Study|Physician Decision|1|||
16834838|NCT01990495|37778506|FG000|Overall Study|Physician Decision|5|||
16834839|NCT01990495|37778507|FG001|Overall Study|Physician Decision|4|||
16912560|NCT01474512|38021804|FG010|Induction Period|Withdrawal by Subject|0|||
16834840|NCT01990339|37778515|FG000|Overall Study|Data Not Available|49|||
16834841|NCT01990339|37778515|FG000|Overall Study|Voluntary Withdrawal|1402|||
16834842|NCT01990339|37778515|FG000|Overall Study|Lost to Follow-up|861|||
16834843|NCT02007577|37778521|FG000|Overall Study|Adverse Event|1|||
16834844|NCT02007577|37778522|FG001|Overall Study|Adverse Event|0|||
16834845|NCT02007577|37778521|FG000|Overall Study|Withdrawal by Subject|0|||
16834846|NCT02007577|37778522|FG001|Overall Study|Withdrawal by Subject|1|||
16834847|NCT01990261|37778528|FG000|Overall Study|Death Before Treatment Start|2|||
16834848|NCT01990261|37778528|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
16834849|NCT01990261|37778528|FG000|Overall Study|Death From other Causes|1|||
16834850|NCT01990261|37778528|FG000|Overall Study|Disease Progression (PD)|8|||
16834851|NCT01990261|37778528|FG000|Overall Study|PD Before Treatment Start|1|||
16834852|NCT01990261|37778528|FG000|Overall Study|Dossier not Approved|1|||
16834853|NCT01990261|37778528|FG000|Overall Study|Lost to Follow-up|2|||
16834854|NCT01963117|37778532|FG000|Overall Study|Death|1|||
16834855|NCT02007109|37778536|FG000|Overall Study|Diary not returned or excluded|102|||
16834856|NCT02007109|37778536|FG000|Overall Study|Excluded - Age<7yo|9|||
16834857|NCT02006719|37778545|FG000|Overall Study|Withdrawal by Subject|10|||
16834858|NCT02006719|37778546|FG001|Overall Study|Withdrawal by Subject|2|||
16834859|NCT02006719|37778545|FG000|Overall Study|Lost to Follow-up|5|||
16834860|NCT02006719|37778546|FG001|Overall Study|Lost to Follow-up|1|||
16834861|NCT02006719|37778545|FG000|Overall Study|Protocol Violation|2|||
16834862|NCT02006719|37778546|FG001|Overall Study|Protocol Violation|0|||
16834863|NCT02006719|37778545|FG000|Overall Study|Adverse Event|1|||
16834864|NCT02006719|37778546|FG001|Overall Study|Adverse Event|1|||
16834865|NCT02006719|37778545|FG000|Overall Study|Other/Unknown|0|||
16834866|NCT02006719|37778546|FG001|Overall Study|Other/Unknown|1|||
16834867|NCT01962493|37778554|FG000|Overall Study|Adverse Event|1|||
16834868|NCT01962493|37778555|FG001|Overall Study|Adverse Event|2|||
16834869|NCT01962493|37778554|FG000|Overall Study|Protocol Violation|0|||
16834870|NCT01962493|37778555|FG001|Overall Study|Protocol Violation|1|||
16834871|NCT01962493|37778554|FG000|Overall Study|Withdrawal by Subject|4|||
16834872|NCT01962493|37778555|FG001|Overall Study|Withdrawal by Subject|2|||
16834873|NCT01989169|37778563|FG000|Period 2|Adverse Event|0|||
16834874|NCT01989169|37778564|FG001|Period 2|Adverse Event|1|||
16834875|NCT01988779|37778572|FG000|Overall Study|Withdrawal by Subject|2|||
16834876|NCT01988779|37778573|FG001|Overall Study|Withdrawal by Subject|2|||
16834877|NCT01988779|37778572|FG000|Overall Study|Protocol Violation|1|||
16834878|NCT01988779|37778573|FG001|Overall Study|Protocol Violation|0|||
16834879|NCT01988233|37778581|FG000|Overall Study|Lost to Follow-up|64|||
16834880|NCT01988233|37778582|FG001|Overall Study|Lost to Follow-up|51|||
16834881|NCT01987765|37778588|FG000|Overall Study|Protocol Violation|65|||
16834882|NCT01987765|37778588|FG000|Overall Study|Lost to Follow-up|37|||
16834883|NCT01987609|37778592|FG000|Overall Study|Adverse Event|1|||
16834884|NCT01987232|37778611|FG000|Overall Study|Ongoing in Study|0|||
16834885|NCT01987232|37778612|FG001|Overall Study|Ongoing in Study|0|||
16834886|NCT01987232|37778613|FG002|Overall Study|Ongoing in Study|0|||
16834887|NCT01987232|37778614|FG003|Overall Study|Ongoing in Study|1|||
16834888|NCT01987232|37778615|FG004|Overall Study|Ongoing in Study|0|||
16834889|NCT01986920|37778629|FG000|A- 101 25%|Withdrawal by Subject|1|||
16834890|NCT01986920|37778630|FG001|A- 101 25%|Withdrawal by Subject|0|||
16834891|NCT01986920|37778631|FG002|A- 101 25%|Withdrawal by Subject|0|||
16834892|NCT01986920|37778632|FG003|A- 101 25%|Withdrawal by Subject|0|||
16834893|NCT01986920|37778629|FG000|A-101 32.5%|Withdrawal by Subject|0|||
16834894|NCT01986920|37778630|FG001|A-101 32.5%|Withdrawal by Subject|1|||
16834895|NCT01986920|37778631|FG002|A-101 32.5%|Withdrawal by Subject|0|||
16834896|NCT01986920|37778632|FG003|A-101 32.5%|Withdrawal by Subject|0|||
16834897|NCT01986920|37778629|FG000|A-101 40%|Withdrawal by Subject|0|||
16834898|NCT01986920|37778630|FG001|A-101 40%|Withdrawal by Subject|0|||
16834899|NCT01986920|37778631|FG002|A-101 40%|Withdrawal by Subject|1|||
16834900|NCT01986920|37778632|FG003|A-101 40%|Withdrawal by Subject|0|||
16834901|NCT01986920|37778629|FG000|Placebo|Withdrawal by Subject|0|||
16834902|NCT01986920|37778630|FG001|Placebo|Withdrawal by Subject|0|||
16834903|NCT01986920|37778631|FG002|Placebo|Withdrawal by Subject|0|||
16834904|NCT01986920|37778632|FG003|Placebo|Withdrawal by Subject|1|||
16834905|NCT02010632|37778642|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
16834906|NCT02010632|37778643|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
16834907|NCT01986140|37778651|FG000|Overall Study|Withdrawal by Subject|31|||
16834908|NCT01986140|37778652|FG001|Overall Study|Withdrawal by Subject|25|||
16834909|NCT01986140|37778651|FG000|Overall Study|alternative treatment|1|||
16834910|NCT01986140|37778652|FG001|Overall Study|alternative treatment|1|||
16834911|NCT01986140|37778651|FG000|Overall Study|found not eligible|3|||
16834912|NCT01986140|37778652|FG001|Overall Study|found not eligible|0|||
16834913|NCT01986140|37778651|FG000|Overall Study|Adverse Event|0|||
16834914|NCT01986140|37778652|FG001|Overall Study|Adverse Event|1|||
16834915|NCT01986140|37778651|FG000|Overall Study|progression disease|0|||
16834916|NCT01986140|37778652|FG001|Overall Study|progression disease|1|||
16834917|NCT01986062|37778660|FG000|Overall Study|Lost to Follow-up|1|||
16834918|NCT01986062|37778661|FG001|Overall Study|Lost to Follow-up|0|||
16912561|NCT01474512|38021805|FG011|Induction Period|Withdrawal by Subject|0|||
16834919|NCT01986062|37778660|FG000|Overall Study|Withdrawal by Subject|0|||
16834920|NCT01986062|37778661|FG001|Overall Study|Withdrawal by Subject|1|||
16834921|NCT01985360|37778669|FG000|Overall Study|Withdrawal by Subject|4|||
16834922|NCT01985360|37778670|FG001|Overall Study|Withdrawal by Subject|0|||
16834923|NCT01985360|37778669|FG000|Overall Study|Lost to Follow-up|5|||
16834924|NCT01985360|37778670|FG001|Overall Study|Lost to Follow-up|3|||
16834925|NCT02032706|37778676|FG000|Overall Study|Did not qualify|5|||
16834926|NCT02032706|37778676|FG000|Overall Study|Protocol Violation|1|||
16834927|NCT02032238|37778682|FG000|Overall Study|Lost to Follow-up|2|||
16834928|NCT02032238|37778683|FG001|Overall Study|Lost to Follow-up|0|||
16834929|NCT02031536|37778691|FG000|Overall Study|ineligible|1|||
16834930|NCT02031536|37778692|FG001|Overall Study|ineligible|0|||
16834931|NCT02009930|37778698|FG000|Overall Study|withdrawn|5|||
16834932|NCT01985126|37778711|FG000|Overall Study|Death|15|||
16834933|NCT01985126|37778712|FG001|Overall Study|Death|69|||
16912562|NCT01474512|38021806|FG012|Induction Period|Withdrawal by Subject|0|||
16912563|NCT01474512|38021807|FG013|Induction Period|Withdrawal by Subject|0|||
16912564|NCT01474512|38021808|FG014|Induction Period|Withdrawal by Subject|0|||
16912565|NCT01474512|38021809|FG015|Induction Period|Withdrawal by Subject|0|||
16912566|NCT01474512|38021810|FG016|Induction Period|Withdrawal by Subject|0|||
16912567|NCT01474512|38021811|FG017|Induction Period|Withdrawal by Subject|0|||
16912568|NCT01474512|38021794|FG000|Induction Period|Protocol Violation|3|||
16912569|NCT01474512|38021795|FG001|Induction Period|Protocol Violation|6|||
16912570|NCT01474512|38021796|FG002|Induction Period|Protocol Violation|0|||
16912571|NCT01474512|38021797|FG003|Induction Period|Protocol Violation|0|||
16912572|NCT01474512|38021798|FG004|Induction Period|Protocol Violation|0|||
16912573|NCT01474512|38021799|FG005|Induction Period|Protocol Violation|0|||
16912574|NCT01474512|38021800|FG006|Induction Period|Protocol Violation|0|||
16912575|NCT01474512|38021801|FG007|Induction Period|Protocol Violation|0|||
16912576|NCT01474512|38021802|FG008|Induction Period|Protocol Violation|0|||
16912577|NCT01474512|38021803|FG009|Induction Period|Protocol Violation|0|||
16912578|NCT01474512|38021804|FG010|Induction Period|Protocol Violation|0|||
16912579|NCT01474512|38021805|FG011|Induction Period|Protocol Violation|0|||
17016761|NCT00689728|38161409|FG000|Double-Blind Treatment|Adverse Event|1|||
17016762|NCT00689728|38161410|FG001|Double-Blind Treatment|Adverse Event|0|||
17016763|NCT00689728|38161411|FG002|Double-Blind Treatment|Adverse Event|0|||
17016764|NCT00689728|38161409|FG000|Double-Blind Treatment|Protocol Violation|0|||
17016765|NCT00689728|38161410|FG001|Double-Blind Treatment|Protocol Violation|0|||
17016766|NCT00689728|38161411|FG002|Double-Blind Treatment|Protocol Violation|1|||
17016767|NCT00689728|38161409|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
17016768|NCT00689728|38161410|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
16834934|NCT01985126|37778711|FG000|Overall Study|Lost to Follow-up|0|||
16912580|NCT01474512|38021806|FG012|Induction Period|Protocol Violation|0|||
16912581|NCT01474512|38021807|FG013|Induction Period|Protocol Violation|0|||
16912582|NCT01474512|38021808|FG014|Induction Period|Protocol Violation|0|||
16912583|NCT01474512|38021809|FG015|Induction Period|Protocol Violation|0|||
16912584|NCT01474512|38021810|FG016|Induction Period|Protocol Violation|0|||
16912585|NCT01474512|38021811|FG017|Induction Period|Protocol Violation|0|||
16912586|NCT01474512|38021794|FG000|Induction Period|Sponsor Decision|1|||
16912587|NCT01474512|38021795|FG001|Induction Period|Sponsor Decision|1|||
16912588|NCT01474512|38021796|FG002|Induction Period|Sponsor Decision|1|||
16912589|NCT01474512|38021797|FG003|Induction Period|Sponsor Decision|0|||
16912590|NCT01474512|38021798|FG004|Induction Period|Sponsor Decision|0|||
16912591|NCT01474512|38021799|FG005|Induction Period|Sponsor Decision|0|||
16912592|NCT01474512|38021800|FG006|Induction Period|Sponsor Decision|0|||
16834935|NCT01985126|37778712|FG001|Overall Study|Lost to Follow-up|8|||
16834936|NCT01985126|37778711|FG000|Overall Study|Study Terminated By Sponsor|1|||
16834937|NCT01985126|37778712|FG001|Overall Study|Study Terminated By Sponsor|22|||
16834938|NCT01985126|37778711|FG000|Overall Study|Withdrawal by Subject|2|||
16834939|NCT01985126|37778712|FG001|Overall Study|Withdrawal by Subject|7|||
16912593|NCT01474512|38021801|FG007|Induction Period|Sponsor Decision|0|||
16912594|NCT01474512|38021802|FG008|Induction Period|Sponsor Decision|0|||
16912595|NCT01474512|38021803|FG009|Induction Period|Sponsor Decision|0|||
16912596|NCT01474512|38021804|FG010|Induction Period|Sponsor Decision|0|||
16834940|NCT01984892|37778718|FG000|Overall Study|Progressive disease|7|||
16834941|NCT01807221|37778728|FG000|Overall Study|Progressive disease|1|||
16834942|NCT01807221|37778729|FG001|Overall Study|Progressive disease|0|||
16834943|NCT01807221|37778730|FG002|Overall Study|Progressive disease|1|||
16834944|NCT01807221|37778731|FG003|Overall Study|Progressive disease|0|||
16834945|NCT01807221|37778732|FG004|Overall Study|Progressive disease|0|||
16834946|NCT01807221|37778733|FG005|Overall Study|Progressive disease|0|||
16834947|NCT01807221|37778728|FG000|Overall Study|Death|7|||
16834948|NCT01807221|37778729|FG001|Overall Study|Death|9|||
16912597|NCT01474512|38021805|FG011|Induction Period|Sponsor Decision|0|||
17016769|NCT00689728|38161411|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
17016770|NCT00689728|38161409|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
17016771|NCT00689728|38161410|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
16834949|NCT01807221|37778730|FG002|Overall Study|Death|4|||
16834950|NCT01807221|37778731|FG003|Overall Study|Death|2|||
16834951|NCT01807221|37778732|FG004|Overall Study|Death|1|||
16834952|NCT01807221|37778733|FG005|Overall Study|Death|6|||
16834953|NCT01807221|37778728|FG000|Overall Study|Physician Decision|2|||
16834954|NCT01807221|37778729|FG001|Overall Study|Physician Decision|1|||
16834955|NCT01807221|37778730|FG002|Overall Study|Physician Decision|0|||
16834956|NCT01807221|37778731|FG003|Overall Study|Physician Decision|0|||
16834957|NCT01807221|37778732|FG004|Overall Study|Physician Decision|0|||
16834958|NCT01807221|37778733|FG005|Overall Study|Physician Decision|0|||
16834959|NCT01807221|37778728|FG000|Overall Study|Adverse Event|33|||
16834960|NCT01807221|37778729|FG001|Overall Study|Adverse Event|22|||
16834961|NCT01807221|37778730|FG002|Overall Study|Adverse Event|26|||
16834962|NCT01807221|37778731|FG003|Overall Study|Adverse Event|25|||
16834963|NCT01807221|37778732|FG004|Overall Study|Adverse Event|18|||
16834964|NCT01807221|37778733|FG005|Overall Study|Adverse Event|21|||
16834965|NCT01807221|37778728|FG000|Overall Study|Protocol Violation|0|||
16834966|NCT01807221|37778729|FG001|Overall Study|Protocol Violation|2|||
16834967|NCT01807221|37778730|FG002|Overall Study|Protocol Violation|1|||
16834968|NCT01807221|37778731|FG003|Overall Study|Protocol Violation|2|||
16834969|NCT01807221|37778732|FG004|Overall Study|Protocol Violation|0|||
16834970|NCT01807221|37778733|FG005|Overall Study|Protocol Violation|1|||
16834971|NCT01807221|37778728|FG000|Overall Study|Non-compliance|1|||
16834972|NCT01807221|37778729|FG001|Overall Study|Non-compliance|2|||
16834973|NCT01807221|37778730|FG002|Overall Study|Non-compliance|0|||
16834974|NCT01807221|37778731|FG003|Overall Study|Non-compliance|1|||
16834975|NCT01807221|37778732|FG004|Overall Study|Non-compliance|0|||
16834976|NCT01807221|37778733|FG005|Overall Study|Non-compliance|0|||
16834977|NCT01807221|37778728|FG000|Overall Study|Logistical difficulties|0|||
16834978|NCT01807221|37778729|FG001|Overall Study|Logistical difficulties|1|||
16834979|NCT01807221|37778730|FG002|Overall Study|Logistical difficulties|0|||
16834980|NCT01807221|37778731|FG003|Overall Study|Logistical difficulties|0|||
16834981|NCT01807221|37778732|FG004|Overall Study|Logistical difficulties|1|||
16834982|NCT01807221|37778733|FG005|Overall Study|Logistical difficulties|0|||
16834983|NCT01807221|37778728|FG000|Overall Study|Withdrawal by Subject|33|||
16834984|NCT01807221|37778729|FG001|Overall Study|Withdrawal by Subject|15|||
16834985|NCT01807221|37778730|FG002|Overall Study|Withdrawal by Subject|8|||
16834986|NCT01807221|37778731|FG003|Overall Study|Withdrawal by Subject|14|||
16834987|NCT01807221|37778732|FG004|Overall Study|Withdrawal by Subject|16|||
16834988|NCT01807221|37778733|FG005|Overall Study|Withdrawal by Subject|13|||
16834989|NCT01807221|37778728|FG000|Overall Study|Sponsor decision|2|||
16834990|NCT01807221|37778729|FG001|Overall Study|Sponsor decision|0|||
16834991|NCT01807221|37778730|FG002|Overall Study|Sponsor decision|1|||
16834992|NCT01807221|37778731|FG003|Overall Study|Sponsor decision|1|||
16834993|NCT01807221|37778732|FG004|Overall Study|Sponsor decision|0|||
16834994|NCT01807221|37778733|FG005|Overall Study|Sponsor decision|0|||
16834995|NCT01807221|37778728|FG000|Overall Study|Lost to Follow-up|1|||
16834996|NCT01807221|37778729|FG001|Overall Study|Lost to Follow-up|0|||
16834997|NCT01807221|37778730|FG002|Overall Study|Lost to Follow-up|2|||
16834998|NCT01807221|37778731|FG003|Overall Study|Lost to Follow-up|1|||
16834999|NCT01807221|37778732|FG004|Overall Study|Lost to Follow-up|0|||
16835000|NCT01807221|37778733|FG005|Overall Study|Lost to Follow-up|0|||
16835001|NCT01838499|37778749|FG000|Overall Study|Protocol Violation|0|||
16835002|NCT01838499|37778750|FG001|Overall Study|Protocol Violation|1|||
16835003|NCT01838499|37778749|FG000|Overall Study|Lost to Follow-up|2|||
16835004|NCT01838499|37778750|FG001|Overall Study|Lost to Follow-up|4|||
16835005|NCT01838499|37778749|FG000|Overall Study|Lack of Efficacy|1|||
16835006|NCT01838499|37778750|FG001|Overall Study|Lack of Efficacy|2|||
16835007|NCT01838499|37778749|FG000|Overall Study|Adverse Event|2|||
16835008|NCT01838499|37778750|FG001|Overall Study|Adverse Event|1|||
16835009|NCT01838499|37778749|FG000|Overall Study|Withdrawal by Subject|19|||
16835010|NCT01838499|37778750|FG001|Overall Study|Withdrawal by Subject|9|||
16835011|NCT01807065|37778758|FG000|Overall Study|Receive no sip-T due to IV access|1|||
16835012|NCT01807065|37778759|FG001|Overall Study|Receive no sip-T due to IV access|1|||
16835013|NCT02031458|37778772|FG000|May 8, 2015 to January 11, 2019|Death|89|||
16835014|NCT02031458|37778773|FG001|May 8, 2015 to January 11, 2019|Death|193|||
16835015|NCT02031458|37778774|FG002|May 8, 2015 to January 11, 2019|Death|198|||
16835016|NCT02031458|37778772|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
16835017|NCT02031458|37778773|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
16835018|NCT02031458|37778774|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
16835019|NCT02031458|37778772|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
16835020|NCT02031458|37778773|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
16835021|NCT02031458|37778774|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
16835022|NCT02031458|37778772|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
16835023|NCT02031458|37778773|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
16835024|NCT02031458|37778774|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
16835025|NCT02031458|37778772|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
16835026|NCT02031458|37778773|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
16835027|NCT02031458|37778774|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
16835028|NCT02031458|37778772|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
16835029|NCT02031458|37778773|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
16835030|NCT02031458|37778774|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
16835031|NCT02031458|37778772|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
16835032|NCT02031458|37778773|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
16835033|NCT02031458|37778774|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
16835034|NCT02031458|37778772|FG000|Baseline to May 8, 2015|Death|36|||
16835035|NCT02031458|37778773|FG001|Baseline to May 8, 2015|Death|87|||
16835036|NCT02031458|37778774|FG002|Baseline to May 8, 2015|Death|100|||
16835037|NCT02031458|37778772|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
16835038|NCT02031458|37778773|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
16835039|NCT02031458|37778774|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
16835040|NCT02031458|37778772|FG000|Baseline to May 8, 2015|Physician Decision|0|||
16835041|NCT02031458|37778773|FG001|Baseline to May 8, 2015|Physician Decision|1|||
16835042|NCT02031458|37778774|FG002|Baseline to May 8, 2015|Physician Decision|0|||
16835043|NCT02031458|37778772|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
16835044|NCT02031458|37778773|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
16835045|NCT02031458|37778774|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
16835046|NCT02031458|37778772|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
16835047|NCT02031458|37778773|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
16835048|NCT02031458|37778774|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
16835049|NCT02031458|37778772|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
16835050|NCT02031458|37778773|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
16835051|NCT02031458|37778774|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
16835052|NCT02031458|37778772|FG000|Baseline to May 8, 2015|On Treatment|43|||
16835053|NCT02031458|37778773|FG001|Baseline to May 8, 2015|On Treatment|81|||
16835054|NCT02031458|37778774|FG002|Baseline to May 8, 2015|On Treatment|73|||
16835055|NCT02031458|37778772|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
16835056|NCT02031458|37778773|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
16835057|NCT02031458|37778774|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
16835058|NCT02009696|37778784|FG000|Overall Study|Withdrawal by Subject|2|||
16835059|NCT01806597|37778791|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
16835060|NCT01806597|37778792|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
16835061|NCT01806597|37778793|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
16835062|NCT01806597|37778794|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
16835063|NCT01806597|37778795|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
16835064|NCT01806597|37778796|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
16835065|NCT01806597|37778791|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
16835066|NCT01806597|37778792|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
16835067|NCT01806597|37778793|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
16835068|NCT01806597|37778794|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
16835069|NCT01806597|37778795|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
16835070|NCT01806597|37778796|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
16912598|NCT01474512|38021806|FG012|Induction Period|Sponsor Decision|0|||
16912599|NCT01474512|38021807|FG013|Induction Period|Sponsor Decision|0|||
16912600|NCT01474512|38021808|FG014|Induction Period|Sponsor Decision|0|||
16912601|NCT01474512|38021809|FG015|Induction Period|Sponsor Decision|0|||
16912602|NCT01474512|38021810|FG016|Induction Period|Sponsor Decision|0|||
16912603|NCT01474512|38021811|FG017|Induction Period|Sponsor Decision|0|||
16912604|NCT01474512|38021794|FG000|Induction Period|Lost to Follow-up|1|||
16912605|NCT01474512|38021795|FG001|Induction Period|Lost to Follow-up|0|||
16912606|NCT01474512|38021796|FG002|Induction Period|Lost to Follow-up|2|||
16912607|NCT01474512|38021797|FG003|Induction Period|Lost to Follow-up|0|||
16912608|NCT01474512|38021798|FG004|Induction Period|Lost to Follow-up|0|||
16912609|NCT01474512|38021799|FG005|Induction Period|Lost to Follow-up|0|||
16912610|NCT01474512|38021800|FG006|Induction Period|Lost to Follow-up|0|||
16912611|NCT01474512|38021801|FG007|Induction Period|Lost to Follow-up|0|||
16912612|NCT01474512|38021802|FG008|Induction Period|Lost to Follow-up|0|||
16912613|NCT01474512|38021803|FG009|Induction Period|Lost to Follow-up|0|||
16912614|NCT01474512|38021804|FG010|Induction Period|Lost to Follow-up|0|||
16912615|NCT01474512|38021805|FG011|Induction Period|Lost to Follow-up|0|||
16912616|NCT01474512|38021806|FG012|Induction Period|Lost to Follow-up|0|||
16912617|NCT01474512|38021807|FG013|Induction Period|Lost to Follow-up|0|||
16912618|NCT01474512|38021808|FG014|Induction Period|Lost to Follow-up|0|||
16912619|NCT01474512|38021809|FG015|Induction Period|Lost to Follow-up|0|||
16912620|NCT01474512|38021810|FG016|Induction Period|Lost to Follow-up|0|||
16912621|NCT01474512|38021811|FG017|Induction Period|Lost to Follow-up|0|||
16912622|NCT01474512|38021794|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16835071|NCT01806597|37778791|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16835072|NCT01806597|37778792|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
16912623|NCT01474512|38021795|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912624|NCT01474512|38021796|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912625|NCT01474512|38021797|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
16912626|NCT01474512|38021798|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
16835073|NCT01806597|37778793|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16835074|NCT01806597|37778794|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16835075|NCT01806597|37778795|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16835076|NCT01806597|37778796|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16835077|NCT01806597|37778791|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
16835078|NCT01806597|37778792|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
16835079|NCT01806597|37778793|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
16835080|NCT01806597|37778794|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
16835081|NCT01806597|37778795|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
16835082|NCT01806597|37778796|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
16835083|NCT01806597|37778791|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16835084|NCT01806597|37778792|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
16835085|NCT01806597|37778793|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16835086|NCT01806597|37778794|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16835087|NCT01806597|37778795|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16835088|NCT01806597|37778796|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16835089|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
16835090|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
16835091|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
16835092|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
16835093|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
16835094|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
16835095|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
16835096|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
16835097|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
16835098|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
16835099|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
16835100|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
16835101|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
16835102|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16835103|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16835104|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16835105|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16835106|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16912627|NCT01474512|38021799|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
16912628|NCT01474512|38021800|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
16912629|NCT01474512|38021801|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912630|NCT01474512|38021802|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912631|NCT01474512|38021803|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912632|NCT01474512|38021804|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912633|NCT01474512|38021805|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912634|NCT01474512|38021806|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912635|NCT01474512|38021807|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912636|NCT01474512|38021808|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912637|NCT01474512|38021809|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912638|NCT01474512|38021810|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912639|NCT01474512|38021811|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16912640|NCT01474512|38021794|FG000|Maintenance Period|Adverse Event|0|||
16912641|NCT01474512|38021795|FG001|Maintenance Period|Adverse Event|0|||
16912642|NCT01474512|38021796|FG002|Maintenance Period|Adverse Event|0|||
16912643|NCT01474512|38021797|FG003|Maintenance Period|Adverse Event|4|||
16912644|NCT01474512|38021798|FG004|Maintenance Period|Adverse Event|2|||
16912645|NCT01474512|38021799|FG005|Maintenance Period|Adverse Event|7|||
16912646|NCT01474512|38021800|FG006|Maintenance Period|Adverse Event|0|||
16912647|NCT01474512|38021801|FG007|Maintenance Period|Adverse Event|19|||
16912648|NCT01474512|38021802|FG008|Maintenance Period|Adverse Event|1|||
16912649|NCT01474512|38021803|FG009|Maintenance Period|Adverse Event|3|||
16912650|NCT01474512|38021804|FG010|Maintenance Period|Adverse Event|0|||
16912651|NCT01474512|38021805|FG011|Maintenance Period|Adverse Event|0|||
16912652|NCT01474512|38021806|FG012|Maintenance Period|Adverse Event|0|||
16912653|NCT01474512|38021807|FG013|Maintenance Period|Adverse Event|0|||
16912654|NCT01474512|38021808|FG014|Maintenance Period|Adverse Event|0|||
16912655|NCT01474512|38021809|FG015|Maintenance Period|Adverse Event|0|||
16912656|NCT01474512|38021810|FG016|Maintenance Period|Adverse Event|0|||
16912657|NCT01474512|38021811|FG017|Maintenance Period|Adverse Event|0|||
16912658|NCT01474512|38021794|FG000|Maintenance Period|Withdrawal by Subject|0|||
16912659|NCT01474512|38021795|FG001|Maintenance Period|Withdrawal by Subject|0|||
16912660|NCT01474512|38021796|FG002|Maintenance Period|Withdrawal by Subject|0|||
16912661|NCT01474512|38021797|FG003|Maintenance Period|Withdrawal by Subject|6|||
16912662|NCT01474512|38021798|FG004|Maintenance Period|Withdrawal by Subject|2|||
16912663|NCT01474512|38021799|FG005|Maintenance Period|Withdrawal by Subject|3|||
16912664|NCT01474512|38021800|FG006|Maintenance Period|Withdrawal by Subject|1|||
16835107|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
16835108|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
16835109|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
16835110|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
16835111|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
16835112|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
16835113|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
16835114|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16835115|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16835116|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16835117|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16835118|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16835119|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
16835120|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
16835121|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
16835122|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
16835123|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
16835124|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
16835125|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
16835126|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
16835127|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
16835128|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
16835129|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
16835130|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
16835131|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
16835132|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
16835133|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
16835134|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
16835135|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
16835136|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
16835137|NCT01806597|37778791|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
16835138|NCT01806597|37778792|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16835139|NCT01806597|37778793|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16835140|NCT01806597|37778794|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16835141|NCT01806597|37778795|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16835142|NCT01806597|37778796|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16835143|NCT01806597|37778791|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16835144|NCT01806597|37778792|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16835145|NCT01806597|37778793|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16835146|NCT01806597|37778794|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16835147|NCT01806597|37778795|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16835148|NCT01806597|37778796|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
16835149|NCT01806597|37778791|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16835150|NCT01806597|37778792|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16835151|NCT01806597|37778793|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16835152|NCT01806597|37778794|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16835153|NCT01806597|37778795|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16835154|NCT01806597|37778796|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
16835155|NCT01806597|37778791|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16835156|NCT01806597|37778792|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16835157|NCT01806597|37778793|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16835158|NCT01806597|37778794|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16835159|NCT01806597|37778795|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16835160|NCT01806597|37778796|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
16835161|NCT01806597|37778791|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16835162|NCT01806597|37778792|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16835163|NCT01806597|37778793|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16835164|NCT01806597|37778794|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16835165|NCT01806597|37778795|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16835166|NCT01806597|37778796|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
16835167|NCT01806597|37778791|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16835168|NCT01806597|37778792|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16835169|NCT01806597|37778793|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16835170|NCT01806597|37778794|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16835171|NCT01806597|37778795|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16835172|NCT01806597|37778796|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
16835173|NCT02031302|37778812|FG000|Overall Study|Death|115|||
16835174|NCT02031302|37778813|FG001|Overall Study|Death|0|||
16835175|NCT02031302|37778812|FG000|Overall Study|Not treated with study valve system|18|||
16835176|NCT02031302|37778813|FG001|Overall Study|Not treated with study valve system|0|||
16835177|NCT02031302|37778812|FG000|Overall Study|Missed Follow Up|27|||
16835178|NCT02031302|37778813|FG001|Overall Study|Missed Follow Up|0|||
16835179|NCT02031302|37778812|FG000|Overall Study|Lost to Follow-up|4|||
16835180|NCT02031302|37778813|FG001|Overall Study|Lost to Follow-up|0|||
16835181|NCT01610037|37778823|FG000|All Patients|Adverse Event|27|||
16835182|NCT01610037|37778824|FG001|All Patients|Adverse Event|22|||
16835183|NCT01610037|37778825|FG002|All Patients|Adverse Event|26|||
16835184|NCT01610037|37778823|FG000|All Patients|Withdrawal by Subject|12|||
16835185|NCT01610037|37778824|FG001|All Patients|Withdrawal by Subject|10|||
16835186|NCT01610037|37778825|FG002|All Patients|Withdrawal by Subject|20|||
16835187|NCT01610037|37778823|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
16835188|NCT01610037|37778824|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
16835189|NCT01610037|37778825|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
16835190|NCT01610037|37778823|FG000|All Patients|Death|4|||
16835191|NCT01610037|37778824|FG001|All Patients|Death|2|||
16912665|NCT01474512|38021801|FG007|Maintenance Period|Withdrawal by Subject|6|||
16912666|NCT01474512|38021802|FG008|Maintenance Period|Withdrawal by Subject|3|||
16912667|NCT01474512|38021803|FG009|Maintenance Period|Withdrawal by Subject|1|||
16912668|NCT01474512|38021804|FG010|Maintenance Period|Withdrawal by Subject|0|||
16912669|NCT01474512|38021805|FG011|Maintenance Period|Withdrawal by Subject|0|||
16912670|NCT01474512|38021806|FG012|Maintenance Period|Withdrawal by Subject|0|||
16912671|NCT01474512|38021807|FG013|Maintenance Period|Withdrawal by Subject|0|||
16912672|NCT01474512|38021808|FG014|Maintenance Period|Withdrawal by Subject|0|||
16912673|NCT01474512|38021809|FG015|Maintenance Period|Withdrawal by Subject|0|||
16912674|NCT01474512|38021810|FG016|Maintenance Period|Withdrawal by Subject|0|||
16912675|NCT01474512|38021811|FG017|Maintenance Period|Withdrawal by Subject|0|||
16912676|NCT01474512|38021794|FG000|Maintenance Period|Lost to Follow-up|0|||
16912677|NCT01474512|38021795|FG001|Maintenance Period|Lost to Follow-up|0|||
16912678|NCT01474512|38021796|FG002|Maintenance Period|Lost to Follow-up|0|||
16912679|NCT01474512|38021797|FG003|Maintenance Period|Lost to Follow-up|3|||
16912680|NCT01474512|38021798|FG004|Maintenance Period|Lost to Follow-up|3|||
16912681|NCT01474512|38021799|FG005|Maintenance Period|Lost to Follow-up|0|||
16912682|NCT01474512|38021800|FG006|Maintenance Period|Lost to Follow-up|0|||
16912683|NCT01474512|38021801|FG007|Maintenance Period|Lost to Follow-up|2|||
16912684|NCT01474512|38021802|FG008|Maintenance Period|Lost to Follow-up|1|||
16912685|NCT01474512|38021803|FG009|Maintenance Period|Lost to Follow-up|1|||
16912686|NCT01474512|38021804|FG010|Maintenance Period|Lost to Follow-up|0|||
16912687|NCT01474512|38021805|FG011|Maintenance Period|Lost to Follow-up|0|||
16912688|NCT01474512|38021806|FG012|Maintenance Period|Lost to Follow-up|0|||
16912689|NCT01474512|38021807|FG013|Maintenance Period|Lost to Follow-up|0|||
16912690|NCT01474512|38021808|FG014|Maintenance Period|Lost to Follow-up|0|||
16912691|NCT01474512|38021809|FG015|Maintenance Period|Lost to Follow-up|0|||
16912692|NCT01474512|38021810|FG016|Maintenance Period|Lost to Follow-up|0|||
16912693|NCT01474512|38021811|FG017|Maintenance Period|Lost to Follow-up|0|||
16912694|NCT01474512|38021794|FG000|Maintenance Period|Death|0|||
16912695|NCT01474512|38021795|FG001|Maintenance Period|Death|0|||
16912696|NCT01474512|38021796|FG002|Maintenance Period|Death|0|||
16912697|NCT01474512|38021797|FG003|Maintenance Period|Death|0|||
16912698|NCT01474512|38021798|FG004|Maintenance Period|Death|0|||
16912699|NCT01474512|38021799|FG005|Maintenance Period|Death|2|||
16912700|NCT01474512|38021800|FG006|Maintenance Period|Death|0|||
16912701|NCT01474512|38021801|FG007|Maintenance Period|Death|0|||
16912702|NCT01474512|38021802|FG008|Maintenance Period|Death|0|||
16912703|NCT01474512|38021803|FG009|Maintenance Period|Death|0|||
16912704|NCT01474512|38021804|FG010|Maintenance Period|Death|0|||
16912705|NCT01474512|38021805|FG011|Maintenance Period|Death|0|||
16912706|NCT01474512|38021806|FG012|Maintenance Period|Death|0|||
16912707|NCT01474512|38021807|FG013|Maintenance Period|Death|0|||
16912708|NCT01474512|38021808|FG014|Maintenance Period|Death|0|||
16912709|NCT01474512|38021809|FG015|Maintenance Period|Death|0|||
16912710|NCT01474512|38021810|FG016|Maintenance Period|Death|0|||
16912711|NCT01474512|38021811|FG017|Maintenance Period|Death|0|||
16912712|NCT01474512|38021794|FG000|Maintenance Period|Physician Decision|0|||
16912713|NCT01474512|38021795|FG001|Maintenance Period|Physician Decision|0|||
16912714|NCT01474512|38021796|FG002|Maintenance Period|Physician Decision|0|||
16912715|NCT01474512|38021797|FG003|Maintenance Period|Physician Decision|0|||
16912716|NCT01474512|38021798|FG004|Maintenance Period|Physician Decision|0|||
16835192|NCT01610037|37778825|FG002|All Patients|Death|1|||
16835193|NCT01610037|37778823|FG000|All Patients|Protocol deviation|4|||
16912717|NCT01474512|38021799|FG005|Maintenance Period|Physician Decision|1|||
16835194|NCT01610037|37778824|FG001|All Patients|Protocol deviation|3|||
16835195|NCT01610037|37778825|FG002|All Patients|Protocol deviation|3|||
16835196|NCT01610037|37778823|FG000|All Patients|Abnormal laboratory value|1|||
16835197|NCT01610037|37778824|FG001|All Patients|Abnormal laboratory value|1|||
16835198|NCT01610037|37778825|FG002|All Patients|Abnormal laboratory value|0|||
16835199|NCT01610037|37778823|FG000|All Patients|Administrative problems|1|||
16835200|NCT01610037|37778824|FG001|All Patients|Administrative problems|4|||
16835201|NCT01610037|37778825|FG002|All Patients|Administrative problems|4|||
16835202|NCT01610037|37778823|FG000|All Patients|Lost to Follow-up|1|||
16835203|NCT01610037|37778824|FG001|All Patients|Lost to Follow-up|0|||
16835204|NCT01610037|37778825|FG002|All Patients|Lost to Follow-up|0|||
16835205|NCT01610037|37778823|FG000|All Patients|Abnormal test procedure result(s)|0|||
16835206|NCT01610037|37778824|FG001|All Patients|Abnormal test procedure result(s)|1|||
16835207|NCT01610037|37778825|FG002|All Patients|Abnormal test procedure result(s)|3|||
16835208|NCT01610037|37778823|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
16835209|NCT01610037|37778824|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
16835210|NCT01610037|37778825|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
16835211|NCT01610037|37778823|FG000|Treatment and Follow up Period|Death|10|||
16835212|NCT01610037|37778824|FG001|Treatment and Follow up Period|Death|5|||
16835213|NCT01610037|37778825|FG002|Treatment and Follow up Period|Death|4|||
16835214|NCT01610037|37778823|FG000|Treatment and Follow up Period|Administrative problems|1|||
16835215|NCT01610037|37778824|FG001|Treatment and Follow up Period|Administrative problems|3|||
16835216|NCT01610037|37778825|FG002|Treatment and Follow up Period|Administrative problems|2|||
16835217|NCT01610037|37778823|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
16835218|NCT01610037|37778824|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
16835219|NCT01610037|37778825|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
16835220|NCT01806051|37778833|FG000|Overall Study|Withdrawal by Subject|6|||
16835221|NCT01837797|37778842|FG000|Period 1|Adverse Event|9|||
16835222|NCT01837797|37778843|FG001|Period 1|Adverse Event|0|||
16835223|NCT01837797|37778844|FG002|Period 1|Adverse Event|0|||
16835224|NCT01837797|37778845|FG003|Period 1|Adverse Event|0|||
16835225|NCT01837797|37778846|FG004|Period 1|Adverse Event|0|||
16835226|NCT01837797|37778842|FG000|Period 1|Withdrawal by Subject|6|||
16835227|NCT01837797|37778843|FG001|Period 1|Withdrawal by Subject|0|||
16835228|NCT01837797|37778844|FG002|Period 1|Withdrawal by Subject|0|||
16835229|NCT01837797|37778845|FG003|Period 1|Withdrawal by Subject|0|||
16835230|NCT01837797|37778846|FG004|Period 1|Withdrawal by Subject|0|||
16835231|NCT01837797|37778842|FG000|Period 1|Administrative reasons|76|||
16835232|NCT01837797|37778843|FG001|Period 1|Administrative reasons|0|||
16835233|NCT01837797|37778844|FG002|Period 1|Administrative reasons|0|||
16835234|NCT01837797|37778845|FG003|Period 1|Administrative reasons|0|||
16835235|NCT01837797|37778846|FG004|Period 1|Administrative reasons|0|||
16835236|NCT01837797|37778842|FG000|Period 1|Withdrawal of consent before treatment|1|||
16835237|NCT01837797|37778843|FG001|Period 1|Withdrawal of consent before treatment|0|||
16835238|NCT01837797|37778844|FG002|Period 1|Withdrawal of consent before treatment|0|||
16835239|NCT01837797|37778845|FG003|Period 1|Withdrawal of consent before treatment|0|||
16835240|NCT01837797|37778846|FG004|Period 1|Withdrawal of consent before treatment|0|||
16835241|NCT01837797|37778842|FG000|Period 1|Other|10|||
16835242|NCT01837797|37778843|FG001|Period 1|Other|0|||
16835243|NCT01837797|37778844|FG002|Period 1|Other|0|||
16835244|NCT01837797|37778845|FG003|Period 1|Other|0|||
16835245|NCT01837797|37778846|FG004|Period 1|Other|0|||
16835246|NCT01837797|37778842|FG000|Period 2|Administrative or other reasons|0|||
16835247|NCT01837797|37778843|FG001|Period 2|Administrative or other reasons|5|||
16835248|NCT01837797|37778844|FG002|Period 2|Administrative or other reasons|2|||
16835249|NCT01837797|37778845|FG003|Period 2|Administrative or other reasons|4|||
16835250|NCT01837797|37778846|FG004|Period 2|Administrative or other reasons|0|||
16835251|NCT01837797|37778842|FG000|Period 2|Adverse Event|0|||
16835252|NCT01837797|37778843|FG001|Period 2|Adverse Event|0|||
16835253|NCT01837797|37778844|FG002|Period 2|Adverse Event|0|||
16835254|NCT01837797|37778845|FG003|Period 2|Adverse Event|1|||
16835255|NCT01837797|37778846|FG004|Period 2|Adverse Event|0|||
16835256|NCT01837797|37778842|FG000|Period 3|Adverse Event|0|||
16835257|NCT01837797|37778843|FG001|Period 3|Adverse Event|0|||
16835258|NCT01837797|37778844|FG002|Period 3|Adverse Event|0|||
16835259|NCT01837797|37778845|FG003|Period 3|Adverse Event|0|||
16835260|NCT01837797|37778846|FG004|Period 3|Adverse Event|1|||
16835261|NCT01837797|37778842|FG000|Period 3|Administrative reasons|0|||
16835262|NCT01837797|37778843|FG001|Period 3|Administrative reasons|0|||
16835263|NCT01837797|37778844|FG002|Period 3|Administrative reasons|0|||
16835264|NCT01837797|37778845|FG003|Period 3|Administrative reasons|0|||
16835265|NCT01837797|37778846|FG004|Period 3|Administrative reasons|20|||
16835266|NCT01837797|37778842|FG000|Period 3|Other|0|||
16835267|NCT01837797|37778843|FG001|Period 3|Other|0|||
16835268|NCT01837797|37778844|FG002|Period 3|Other|0|||
16835269|NCT01837797|37778845|FG003|Period 3|Other|0|||
16835270|NCT01837797|37778846|FG004|Period 3|Other|2|||
16835271|NCT01984424|37778856|FG000|Overall Study|Withdrawal by Subject|3|||
16835272|NCT01984424|37778857|FG001|Overall Study|Withdrawal by Subject|5|||
16835273|NCT01984424|37778856|FG000|Overall Study|Sponsor Decision|0|||
16835274|NCT01984424|37778857|FG001|Overall Study|Sponsor Decision|1|||
16835275|NCT01984424|37778856|FG000|Overall Study|Lost to Follow-up|0|||
16835276|NCT01984424|37778857|FG001|Overall Study|Lost to Follow-up|1|||
16835277|NCT01837719|37778863|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
16835278|NCT01837719|37778863|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
16835279|NCT01984268|37778878|FG000|Overall Study|Study Terminated|15|||
16835280|NCT02031146|37778884|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
16835281|NCT02031146|37778885|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
16835282|NCT02031146|37778886|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
16835283|NCT02031146|37778887|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
16835284|NCT02031146|37778888|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
16835285|NCT02031146|37778889|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
16835286|NCT02031146|37778890|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
16835287|NCT02009384|37778900|FG000|Overall Study|Death|2|||
16835288|NCT01805037|37778904|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
16835289|NCT01805037|37778905|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
16835290|NCT01805037|37778904|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
16835291|NCT01805037|37778905|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
16835292|NCT01805037|37778904|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
16835293|NCT01805037|37778905|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
16835294|NCT01805037|37778904|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
16835295|NCT01805037|37778905|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
16835296|NCT01805037|37778904|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
16835297|NCT01805037|37778905|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
16835298|NCT01805037|37778904|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
16912718|NCT01474512|38021800|FG006|Maintenance Period|Physician Decision|0|||
16912719|NCT01474512|38021801|FG007|Maintenance Period|Physician Decision|2|||
16912720|NCT01474512|38021802|FG008|Maintenance Period|Physician Decision|0|||
16912721|NCT01474512|38021803|FG009|Maintenance Period|Physician Decision|0|||
16912722|NCT01474512|38021804|FG010|Maintenance Period|Physician Decision|0|||
16912723|NCT01474512|38021805|FG011|Maintenance Period|Physician Decision|0|||
16912724|NCT01474512|38021806|FG012|Maintenance Period|Physician Decision|0|||
16912725|NCT01474512|38021807|FG013|Maintenance Period|Physician Decision|0|||
16912726|NCT01474512|38021808|FG014|Maintenance Period|Physician Decision|0|||
16912727|NCT01474512|38021809|FG015|Maintenance Period|Physician Decision|0|||
16912728|NCT01474512|38021810|FG016|Maintenance Period|Physician Decision|0|||
16912729|NCT01474512|38021811|FG017|Maintenance Period|Physician Decision|0|||
16912730|NCT01474512|38021794|FG000|Maintenance Period|Clinical Relapse|0|||
16912731|NCT01474512|38021795|FG001|Maintenance Period|Clinical Relapse|0|||
16912732|NCT01474512|38021796|FG002|Maintenance Period|Clinical Relapse|0|||
16912733|NCT01474512|38021797|FG003|Maintenance Period|Clinical Relapse|1|||
16912734|NCT01474512|38021798|FG004|Maintenance Period|Clinical Relapse|0|||
16912735|NCT01474512|38021799|FG005|Maintenance Period|Clinical Relapse|0|||
16912736|NCT01474512|38021800|FG006|Maintenance Period|Clinical Relapse|0|||
16912737|NCT01474512|38021801|FG007|Maintenance Period|Clinical Relapse|0|||
16912738|NCT01474512|38021802|FG008|Maintenance Period|Clinical Relapse|0|||
16912739|NCT01474512|38021803|FG009|Maintenance Period|Clinical Relapse|0|||
16912740|NCT01474512|38021804|FG010|Maintenance Period|Clinical Relapse|0|||
16912741|NCT01474512|38021805|FG011|Maintenance Period|Clinical Relapse|0|||
16912742|NCT01474512|38021806|FG012|Maintenance Period|Clinical Relapse|0|||
16912743|NCT01474512|38021807|FG013|Maintenance Period|Clinical Relapse|0|||
16912744|NCT01474512|38021808|FG014|Maintenance Period|Clinical Relapse|0|||
16912745|NCT01474512|38021809|FG015|Maintenance Period|Clinical Relapse|0|||
16912746|NCT01474512|38021810|FG016|Maintenance Period|Clinical Relapse|0|||
16912747|NCT01474512|38021811|FG017|Maintenance Period|Clinical Relapse|0|||
16912748|NCT01474512|38021794|FG000|Maintenance Period|Lack of Efficacy|0|||
16912749|NCT01474512|38021795|FG001|Maintenance Period|Lack of Efficacy|0|||
16912750|NCT01474512|38021796|FG002|Maintenance Period|Lack of Efficacy|0|||
16912751|NCT01474512|38021797|FG003|Maintenance Period|Lack of Efficacy|1|||
16912752|NCT01474512|38021798|FG004|Maintenance Period|Lack of Efficacy|0|||
16912753|NCT01474512|38021799|FG005|Maintenance Period|Lack of Efficacy|0|||
16912754|NCT01474512|38021800|FG006|Maintenance Period|Lack of Efficacy|0|||
16912755|NCT01474512|38021801|FG007|Maintenance Period|Lack of Efficacy|11|||
16912756|NCT01474512|38021802|FG008|Maintenance Period|Lack of Efficacy|11|||
16912757|NCT01474512|38021803|FG009|Maintenance Period|Lack of Efficacy|12|||
16912758|NCT01474512|38021804|FG010|Maintenance Period|Lack of Efficacy|0|||
16912759|NCT01474512|38021805|FG011|Maintenance Period|Lack of Efficacy|0|||
16912760|NCT01474512|38021806|FG012|Maintenance Period|Lack of Efficacy|0|||
16912761|NCT01474512|38021807|FG013|Maintenance Period|Lack of Efficacy|0|||
16912762|NCT01474512|38021808|FG014|Maintenance Period|Lack of Efficacy|0|||
16912763|NCT01474512|38021809|FG015|Maintenance Period|Lack of Efficacy|0|||
16835299|NCT01805037|37778905|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
16835300|NCT01805037|37778904|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
16835301|NCT01805037|37778905|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
16835302|NCT01805037|37778904|FG000|Follow Up (up to 3 Years)|Death|0|||
16835303|NCT01805037|37778905|FG001|Follow Up (up to 3 Years)|Death|2|||
16835304|NCT01805037|37778904|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
16835305|NCT01805037|37778905|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
16835306|NCT01805037|37778904|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
16835307|NCT01805037|37778905|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
16835308|NCT01803711|37778911|FG000|Overall Study|Adverse Event|1|||
16835309|NCT01803711|37778912|FG001|Overall Study|Adverse Event|1|||
16835310|NCT02030834|37778923|FG000|Overall Study|Death|4|||
16835311|NCT02030834|37778924|FG001|Overall Study|Death|0|||
16835312|NCT02030834|37778925|FG002|Overall Study|Death|0|||
16835313|NCT02030834|37778923|FG000|Overall Study|Manufacturing failure|2|||
16835314|NCT02030834|37778924|FG001|Overall Study|Manufacturing failure|0|||
16835315|NCT02030834|37778925|FG002|Overall Study|Manufacturing failure|1|||
16835316|NCT02030834|37778923|FG000|Overall Study|Disease progression|2|||
16835317|NCT02030834|37778924|FG001|Overall Study|Disease progression|0|||
16835318|NCT02030834|37778925|FG002|Overall Study|Disease progression|2|||
16835319|NCT02030834|37778923|FG000|Overall Study|Lost to Follow-up|1|||
16835320|NCT02030834|37778924|FG001|Overall Study|Lost to Follow-up|0|||
16835321|NCT02030834|37778925|FG002|Overall Study|Lost to Follow-up|0|||
16835322|NCT02030834|37778923|FG000|Overall Study|Withdrawal by Subject|1|||
16835323|NCT02030834|37778924|FG001|Overall Study|Withdrawal by Subject|0|||
16835324|NCT02030834|37778925|FG002|Overall Study|Withdrawal by Subject|0|||
16835325|NCT02030834|37778923|FG000|Overall Study|Lack of funding|1|||
16835326|NCT02030834|37778924|FG001|Overall Study|Lack of funding|0|||
16835327|NCT02030834|37778925|FG002|Overall Study|Lack of funding|0|||
16835328|NCT01836549|37778939|FG000|Overall Study|Did not receive study drug|0|||
16835329|NCT01836549|37778940|FG001|Overall Study|Did not receive study drug|0|||
16835330|NCT01836549|37778941|FG002|Overall Study|Did not receive study drug|1|||
16835331|NCT01836549|37778942|FG003|Overall Study|Did not receive study drug|0|||
16835332|NCT01836549|37778943|FG004|Overall Study|Did not receive study drug|0|||
16835333|NCT01836549|37778944|FG005|Overall Study|Did not receive study drug|0|||
16835334|NCT01836549|37778945|FG006|Overall Study|Did not receive study drug|0|||
16835335|NCT01836549|37778939|FG000|Overall Study|Patient declared ineligible|0|||
16835336|NCT01836549|37778940|FG001|Overall Study|Patient declared ineligible|0|||
16835337|NCT01836549|37778941|FG002|Overall Study|Patient declared ineligible|0|||
16835338|NCT01836549|37778942|FG003|Overall Study|Patient declared ineligible|1|||
16835339|NCT01836549|37778943|FG004|Overall Study|Patient declared ineligible|0|||
16835340|NCT01836549|37778944|FG005|Overall Study|Patient declared ineligible|0|||
16835341|NCT01836549|37778945|FG006|Overall Study|Patient declared ineligible|0|||
16835342|NCT01836549|37778939|FG000|Overall Study|Patient inevaluable to start therapy|0|||
16835343|NCT01836549|37778940|FG001|Overall Study|Patient inevaluable to start therapy|0|||
16835344|NCT01836549|37778941|FG002|Overall Study|Patient inevaluable to start therapy|0|||
16835345|NCT01836549|37778942|FG003|Overall Study|Patient inevaluable to start therapy|0|||
16835346|NCT01836549|37778943|FG004|Overall Study|Patient inevaluable to start therapy|0|||
16835347|NCT01836549|37778944|FG005|Overall Study|Patient inevaluable to start therapy|0|||
16835348|NCT01836549|37778945|FG006|Overall Study|Patient inevaluable to start therapy|1|||
16835349|NCT01836471|37778966|FG000|Overall Study|Pregnancy|1|||
16835350|NCT01836471|37778967|FG001|Overall Study|Pregnancy|0|||
16835351|NCT01836471|37778968|FG002|Overall Study|Pregnancy|0|||
16835352|NCT01836471|37778969|FG003|Overall Study|Pregnancy|0|||
16835353|NCT01836471|37778970|FG004|Overall Study|Pregnancy|0|||
16835354|NCT01836471|37778966|FG000|Overall Study|Withdrawal by Subject|3|||
16835355|NCT01836471|37778967|FG001|Overall Study|Withdrawal by Subject|4|||
16835356|NCT01836471|37778968|FG002|Overall Study|Withdrawal by Subject|1|||
16835357|NCT01836471|37778969|FG003|Overall Study|Withdrawal by Subject|0|||
16835358|NCT01836471|37778970|FG004|Overall Study|Withdrawal by Subject|2|||
16835359|NCT01836471|37778966|FG000|Overall Study|Physician Decision|0|||
16835360|NCT01836471|37778967|FG001|Overall Study|Physician Decision|1|||
16835361|NCT01836471|37778968|FG002|Overall Study|Physician Decision|0|||
16835362|NCT01836471|37778969|FG003|Overall Study|Physician Decision|0|||
16835363|NCT01836471|37778970|FG004|Overall Study|Physician Decision|0|||
16835364|NCT01836471|37778966|FG000|Overall Study|Lost to Follow-up|0|||
16835365|NCT01836471|37778967|FG001|Overall Study|Lost to Follow-up|0|||
16835366|NCT01836471|37778968|FG002|Overall Study|Lost to Follow-up|0|||
16835367|NCT01836471|37778969|FG003|Overall Study|Lost to Follow-up|1|||
16835368|NCT01836471|37778970|FG004|Overall Study|Lost to Follow-up|1|||
16835369|NCT01836471|37778966|FG000|Overall Study|Adverse Event|6|||
16835370|NCT01836471|37778967|FG001|Overall Study|Adverse Event|3|||
16835371|NCT01836471|37778968|FG002|Overall Study|Adverse Event|1|||
16835372|NCT01836471|37778969|FG003|Overall Study|Adverse Event|1|||
16835373|NCT01836471|37778970|FG004|Overall Study|Adverse Event|2|||
16835374|NCT01836471|37778966|FG000|Overall Study|Non compliance with tx|1|||
16835375|NCT01836471|37778967|FG001|Overall Study|Non compliance with tx|1|||
16835376|NCT01836471|37778968|FG002|Overall Study|Non compliance with tx|0|||
16835377|NCT01836471|37778969|FG003|Overall Study|Non compliance with tx|0|||
16835378|NCT01836471|37778970|FG004|Overall Study|Non compliance with tx|0|||
16835379|NCT02030600|37778985|FG000|Treatment Period 1|Adverse Event|5|||
16835380|NCT02030600|37778986|FG001|Treatment Period 1|Adverse Event|7|||
16835381|NCT02030600|37778985|FG000|Treatment Period 1|Lack of Efficacy|0|||
16835382|NCT02030600|37778986|FG001|Treatment Period 1|Lack of Efficacy|1|||
16835383|NCT02030600|37778985|FG000|Treatment Period 1|Lost to Follow-up|11|||
16835384|NCT02030600|37778986|FG001|Treatment Period 1|Lost to Follow-up|3|||
16835385|NCT02030600|37778985|FG000|Treatment Period 1|Protocol Violation|22|||
16835386|NCT02030600|37778986|FG001|Treatment Period 1|Protocol Violation|17|||
16835387|NCT02030600|37778985|FG000|Treatment Period 1|Withdrawal by Subject|13|||
16835388|NCT02030600|37778986|FG001|Treatment Period 1|Withdrawal by Subject|17|||
16835389|NCT02030600|37778985|FG000|Treatment Period 1|Casebook Unsigned|1|||
16835390|NCT02030600|37778986|FG001|Treatment Period 1|Casebook Unsigned|0|||
16835391|NCT02030600|37778985|FG000|Treatment Period 1|Unclassified|1|||
16835392|NCT02030600|37778986|FG001|Treatment Period 1|Unclassified|0|||
16835393|NCT02030600|37778985|FG000|Treatment Period 2|Adverse Event|4|||
16835394|NCT02030600|37778986|FG001|Treatment Period 2|Adverse Event|4|||
16835395|NCT02030600|37778985|FG000|Treatment Period 2|Lack of Efficacy|2|||
16835396|NCT02030600|37778986|FG001|Treatment Period 2|Lack of Efficacy|1|||
16835397|NCT02030600|37778985|FG000|Treatment Period 2|Lost to Follow-up|4|||
16835398|NCT02030600|37778986|FG001|Treatment Period 2|Lost to Follow-up|2|||
16835399|NCT02030600|37778985|FG000|Treatment Period 2|Protocol Violation|1|||
16835400|NCT02030600|37778986|FG001|Treatment Period 2|Protocol Violation|2|||
16835401|NCT02030600|37778985|FG000|Treatment Period 2|Withdrawal by Subject|13|||
16835402|NCT02030600|37778986|FG001|Treatment Period 2|Withdrawal by Subject|9|||
16835403|NCT02030600|37778985|FG000|Treatment Period 2|Unclassified|1|||
16835404|NCT02030600|37778986|FG001|Treatment Period 2|Unclassified|0|||
16835405|NCT01802775|37778996|FG000|Overall Study|Death|0|||
16835406|NCT01802775|37778997|FG001|Overall Study|Death|3|||
16835407|NCT01802775|37778996|FG000|Overall Study|Reason not provided|0|||
16835408|NCT01802775|37778997|FG001|Overall Study|Reason not provided|1|||
16835409|NCT01802775|37778996|FG000|Overall Study|Physician Decision|1|||
16835410|NCT01802775|37778997|FG001|Overall Study|Physician Decision|0|||
16912764|NCT01474512|38021810|FG016|Maintenance Period|Lack of Efficacy|0|||
16912765|NCT01474512|38021811|FG017|Maintenance Period|Lack of Efficacy|0|||
16912766|NCT01474512|38021794|FG000|Maintenance Period|Protocol Violation|0|||
16912767|NCT01474512|38021795|FG001|Maintenance Period|Protocol Violation|0|||
16912768|NCT01474512|38021796|FG002|Maintenance Period|Protocol Violation|0|||
17102432|NCT00858364|38241366|FG001|Overall Study|Protocol Deviation|2|||
17102433|NCT00858364|38241365|FG000|Overall Study|Other|9|||
17102434|NCT00858364|38241366|FG001|Overall Study|Other|17|||
17102435|NCT00858364|38241365|FG000|Overall Study|Missing|1|||
17102436|NCT00858364|38241366|FG001|Overall Study|Missing|1|||
17102437|NCT00858364|38241365|FG000|Overall Study|Still on-study|114|||
17102438|NCT00858364|38241366|FG001|Overall Study|Still on-study|247|||
16912769|NCT01474512|38021797|FG003|Maintenance Period|Protocol Violation|1|||
16912770|NCT01474512|38021798|FG004|Maintenance Period|Protocol Violation|0|||
16912771|NCT01474512|38021799|FG005|Maintenance Period|Protocol Violation|0|||
16912772|NCT01474512|38021800|FG006|Maintenance Period|Protocol Violation|0|||
16912773|NCT01474512|38021801|FG007|Maintenance Period|Protocol Violation|1|||
16912774|NCT01474512|38021802|FG008|Maintenance Period|Protocol Violation|0|||
16912775|NCT01474512|38021803|FG009|Maintenance Period|Protocol Violation|1|||
16912776|NCT01474512|38021804|FG010|Maintenance Period|Protocol Violation|0|||
16912777|NCT01474512|38021805|FG011|Maintenance Period|Protocol Violation|0|||
16912778|NCT01474512|38021806|FG012|Maintenance Period|Protocol Violation|0|||
16912779|NCT01474512|38021807|FG013|Maintenance Period|Protocol Violation|0|||
16912780|NCT01474512|38021808|FG014|Maintenance Period|Protocol Violation|0|||
16912781|NCT01474512|38021809|FG015|Maintenance Period|Protocol Violation|0|||
16912782|NCT01474512|38021810|FG016|Maintenance Period|Protocol Violation|0|||
16912783|NCT01474512|38021811|FG017|Maintenance Period|Protocol Violation|0|||
16912784|NCT01474512|38021794|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
16912785|NCT01474512|38021795|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
16912786|NCT01474512|38021796|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
16912787|NCT01474512|38021797|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
16912788|NCT01474512|38021798|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
16912789|NCT01474512|38021799|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
16912790|NCT01474512|38021800|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
17102439|NCT00382733|38241372|FG000|Overall Study|Withdrawal by Subject|0|||
17102440|NCT00382733|38241373|FG001|Overall Study|Withdrawal by Subject|1|||
17102441|NCT00382733|38241374|FG002|Overall Study|Withdrawal by Subject|0|||
17102442|NCT00382733|38241375|FG003|Overall Study|Withdrawal by Subject|0|||
16912791|NCT01474512|38021801|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
16912792|NCT01474512|38021802|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
17102443|NCT00382733|38241376|FG004|Overall Study|Withdrawal by Subject|0|||
16835411|NCT01802775|37778996|FG000|Overall Study|Adverse Event|1|||
16835412|NCT01802775|37778997|FG001|Overall Study|Adverse Event|1|||
16835413|NCT01802775|37778996|FG000|Overall Study|Withdrawal by Subject|3|||
16835414|NCT01802775|37778997|FG001|Overall Study|Withdrawal by Subject|5|||
16835415|NCT01802775|37778996|FG000|Overall Study|Lost to Follow-up|1|||
16835416|NCT01802775|37778997|FG001|Overall Study|Lost to Follow-up|2|||
16835417|NCT01802385|37779005|FG000|Overall Study|Death|106|||
16835418|NCT01802385|37779006|FG001|Overall Study|Death|120|||
16835419|NCT01773993|37779012|FG000|Overall Study|No Visit After Treatment|35|||
16835420|NCT01802073|37779018|FG000|Overall Study|Lost to Follow-up|0|||
16835421|NCT01802073|37779019|FG001|Overall Study|Lost to Follow-up|1|||
16835422|NCT01802073|37779018|FG000|Overall Study|Non-compliant|4|||
16835423|NCT01802073|37779019|FG001|Overall Study|Non-compliant|2|||
16835424|NCT01802073|37779018|FG000|Overall Study|Withdrawal by Subject|1|||
16835425|NCT01802073|37779019|FG001|Overall Study|Withdrawal by Subject|1|||
16835426|NCT01802073|37779018|FG000|Overall Study|Physician Decision|0|||
16835427|NCT01802073|37779019|FG001|Overall Study|Physician Decision|7|||
16835428|NCT01607073|37779025|FG000|Overall Study|Adverse Event|1|||
16835429|NCT01773291|37779035|FG000|Overall Study|Protocol Violation|1|||
16835430|NCT01773291|37779036|FG001|Overall Study|Protocol Violation|0|||
16835431|NCT01773291|37779037|FG002|Overall Study|Protocol Violation|0|||
16835432|NCT01773291|37779035|FG000|Overall Study|Withdrawal by Subject|0|||
16835433|NCT01773291|37779036|FG001|Overall Study|Withdrawal by Subject|0|||
16835434|NCT01773291|37779037|FG002|Overall Study|Withdrawal by Subject|1|||
16835435|NCT01801917|37779050|FG000|Period 1 - Randomized|Adverse Event|1|||
16835436|NCT01801917|37779051|FG001|Period 1 - Randomized|Adverse Event|0|||
16835437|NCT01801917|37779052|FG002|Period 1 - Randomized|Adverse Event|1|||
16835438|NCT01801917|37779053|FG003|Period 1 - Randomized|Adverse Event|0|||
16835439|NCT02008916|37779067|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
16835440|NCT02008916|37779068|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
16835441|NCT02008916|37779069|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
16835442|NCT02008916|37779067|FG000|Week 16 - 156|Adverse Event|4|||
16835443|NCT02008916|37779068|FG001|Week 16 - 156|Adverse Event|2|||
16835444|NCT02008916|37779069|FG002|Week 16 - 156|Adverse Event|3|||
16835445|NCT02008916|37779067|FG000|Week 16 - 156|Withdrawal by Subject|7|||
16835446|NCT02008916|37779068|FG001|Week 16 - 156|Withdrawal by Subject|3|||
16835447|NCT02008916|37779069|FG002|Week 16 - 156|Withdrawal by Subject|5|||
16835448|NCT02008916|37779067|FG000|Week 16 - 156|No longer requires treatment|0|||
16835449|NCT02008916|37779068|FG001|Week 16 - 156|No longer requires treatment|1|||
16835450|NCT02008916|37779069|FG002|Week 16 - 156|No longer requires treatment|0|||
16835451|NCT02008916|37779067|FG000|Week 16 - 156|Lost to Follow-up|5|||
16835452|NCT02008916|37779068|FG001|Week 16 - 156|Lost to Follow-up|0|||
16835453|NCT02008916|37779069|FG002|Week 16 - 156|Lost to Follow-up|0|||
16835454|NCT02008916|37779067|FG000|Week 16 - 156|Lack of Efficacy|3|||
16835455|NCT02008916|37779068|FG001|Week 16 - 156|Lack of Efficacy|5|||
16835456|NCT02008916|37779069|FG002|Week 16 - 156|Lack of Efficacy|2|||
16835457|NCT02008916|37779067|FG000|Week 16 - 156|Pregnancy|0|||
16835458|NCT02008916|37779068|FG001|Week 16 - 156|Pregnancy|1|||
16835459|NCT02008916|37779069|FG002|Week 16 - 156|Pregnancy|0|||
16835460|NCT02008916|37779067|FG000|Week 16 - 156|Physician Decision|0|||
16835461|NCT02008916|37779068|FG001|Week 16 - 156|Physician Decision|1|||
16835462|NCT02008916|37779069|FG002|Week 16 - 156|Physician Decision|0|||
16835463|NCT01772823|37779080|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
16835464|NCT01772823|37779081|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
16835465|NCT01772823|37779080|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
16835466|NCT01772823|37779081|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
16835467|NCT01772823|37779080|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
16835468|NCT01772823|37779081|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
16835469|NCT01772823|37779080|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
16835470|NCT01772823|37779081|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
16835471|NCT01772823|37779080|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
16835472|NCT01772823|37779081|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
16835473|NCT01772823|37779080|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
16835474|NCT01772823|37779081|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
16835475|NCT01772823|37779080|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
16835476|NCT01772823|37779081|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
16835477|NCT01772823|37779080|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
16835478|NCT01772823|37779081|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
16835479|NCT01772823|37779080|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
16835480|NCT01772823|37779081|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
16835481|NCT01772823|37779080|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
16835482|NCT01772823|37779081|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
16835483|NCT01772823|37779080|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
16835484|NCT01772823|37779081|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
16835485|NCT01772823|37779080|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
16835486|NCT01772823|37779081|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
16835487|NCT01772823|37779080|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
16835488|NCT01772823|37779081|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
16835489|NCT01772823|37779080|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
16835490|NCT01772823|37779081|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
16835491|NCT01772823|37779080|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
16835492|NCT01772823|37779081|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
16835493|NCT01772823|37779080|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
16835494|NCT01772823|37779081|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
16835495|NCT02029976|37779094|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
16835496|NCT02029976|37779095|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
16835497|NCT02029976|37779094|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
16835498|NCT02029976|37779095|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
16835499|NCT02029976|37779094|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
16835500|NCT02029976|37779095|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
16835501|NCT02029976|37779094|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
16835502|NCT02029976|37779095|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
16835503|NCT01983254|37779103|FG000|Overall Study|Death|6|||
16835504|NCT01983254|37779104|FG001|Overall Study|Death|6|||
16835505|NCT01983254|37779103|FG000|Overall Study|Lost to Follow-up|17|||
16835506|NCT01983254|37779104|FG001|Overall Study|Lost to Follow-up|16|||
16835507|NCT01983254|37779103|FG000|Overall Study|too ill|11|||
16835508|NCT01983254|37779104|FG001|Overall Study|too ill|8|||
16835509|NCT01771809|37779112|FG000|Overall Study|Adverse Event|4|||
16835510|NCT01771809|37779113|FG001|Overall Study|Adverse Event|12|||
16835511|NCT01771809|37779112|FG000|Overall Study|Protocol Violation|0|||
16835512|NCT01771809|37779113|FG001|Overall Study|Protocol Violation|1|||
16835513|NCT01771809|37779112|FG000|Overall Study|Withdrawal by Subject|34|||
16835514|NCT01771809|37779113|FG001|Overall Study|Withdrawal by Subject|42|||
16835515|NCT01771809|37779112|FG000|Overall Study|Lost to Follow-up|1|||
16835516|NCT01771809|37779113|FG001|Overall Study|Lost to Follow-up|3|||
16835517|NCT01771809|37779112|FG000|Overall Study|Other (Insufficient clinical response)|22|||
16835518|NCT01771809|37779113|FG001|Overall Study|Other (Insufficient clinical response)|20|||
16835519|NCT01771809|37779112|FG000|Overall Study|Death|1|||
16835520|NCT01771809|37779113|FG001|Overall Study|Death|0|||
16835521|NCT01771809|37779112|FG000|Overall Study|Other (other)|9|||
16912793|NCT01474512|38021803|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
16912794|NCT01474512|38021804|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
16912795|NCT01474512|38021805|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
16912796|NCT01474512|38021806|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
16912797|NCT01474512|38021807|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
16912798|NCT01474512|38021808|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
16912799|NCT01474512|38021809|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
16912800|NCT01474512|38021810|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
16912801|NCT01474512|38021811|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
16912802|NCT01474512|38021794|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
16912803|NCT01474512|38021795|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
16912804|NCT01474512|38021796|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
16912805|NCT01474512|38021797|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
16912806|NCT01474512|38021798|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
16912807|NCT01474512|38021799|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
16912808|NCT01474512|38021800|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
16912809|NCT01474512|38021801|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
16912810|NCT01474512|38021802|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
16912811|NCT01474512|38021803|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
16912812|NCT01474512|38021804|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
16912813|NCT01474512|38021805|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
16912814|NCT01474512|38021806|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
16912815|NCT01474512|38021807|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
16912816|NCT01474512|38021808|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
16912817|NCT01474512|38021809|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
16912818|NCT01474512|38021810|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
16912819|NCT01474512|38021811|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
16912820|NCT01474512|38021794|FG000|Long-Term Extension Period|Adverse Event|0|||
16912821|NCT01474512|38021795|FG001|Long-Term Extension Period|Adverse Event|0|||
16912822|NCT01474512|38021796|FG002|Long-Term Extension Period|Adverse Event|0|||
16912823|NCT01474512|38021797|FG003|Long-Term Extension Period|Adverse Event|0|||
17102444|NCT03631732|38241391|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
16835522|NCT01771809|37779113|FG001|Overall Study|Other (other)|5|||
16835523|NCT01771731|37779121|FG000|Overall Study|Physician Decision|1|||
16835524|NCT01771731|37779122|FG001|Overall Study|Physician Decision|0|||
16835525|NCT01771731|37779121|FG000|Overall Study|Protocol Violation|0|||
16835526|NCT01771731|37779122|FG001|Overall Study|Protocol Violation|1|||
16835527|NCT01771731|37779121|FG000|Overall Study|Adverse event: Pain Crisis|1|||
16835528|NCT01771731|37779122|FG001|Overall Study|Adverse event: Pain Crisis|1|||
16835529|NCT01982942|37779130|FG000|Overall Study|Adverse Event|10|||
16835530|NCT01982942|37779131|FG001|Overall Study|Adverse Event|5|||
16835531|NCT01982942|37779130|FG000|Overall Study|Lost to Follow-up|4|||
16835532|NCT01982942|37779131|FG001|Overall Study|Lost to Follow-up|3|||
16835533|NCT01982942|37779130|FG000|Overall Study|Multiple sclerosis progression|3|||
16835534|NCT01982942|37779131|FG001|Overall Study|Multiple sclerosis progression|2|||
16835535|NCT01982942|37779130|FG000|Overall Study|Wanted to try therapy not permitted|1|||
16835536|NCT01982942|37779131|FG001|Overall Study|Wanted to try therapy not permitted|0|||
16835537|NCT01982942|37779130|FG000|Overall Study|Subject declined future visits|0|||
16835538|NCT01982942|37779131|FG001|Overall Study|Subject declined future visits|1|||
16835539|NCT01982942|37779130|FG000|Overall Study|Left geographical area|2|||
16835540|NCT01982942|37779131|FG001|Overall Study|Left geographical area|0|||
16835541|NCT01982942|37779130|FG000|Overall Study|Too many pills|1|||
16835542|NCT01982942|37779131|FG001|Overall Study|Too many pills|0|||
16835543|NCT01982942|37779130|FG000|Overall Study|MS Relapse|0|||
16835544|NCT01982942|37779131|FG001|Overall Study|MS Relapse|1|||
16835545|NCT01982942|37779130|FG000|Overall Study|Chose to join a stem cell trial|0|||
16835546|NCT01982942|37779131|FG001|Overall Study|Chose to join a stem cell trial|1|||
16835547|NCT01982942|37779130|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
16835548|NCT01982942|37779131|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
16835549|NCT01769469|37779137|FG000|Overall Study|Consent Withdrawn|5|||
16835550|NCT01769469|37779137|FG000|Overall Study|Moved Out Of Area|3|||
16835551|NCT01769469|37779137|FG000|Overall Study|Lost to Follow-up|17|||
16835552|NCT01769469|37779137|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
16835553|NCT01769469|37779137|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
16835554|NCT02008526|37779146|FG000|Overall Study|Death|0|||
16835555|NCT02008526|37779147|FG001|Overall Study|Death|2|||
16835556|NCT02008526|37779148|FG002|Overall Study|Death|1|||
16835557|NCT02008526|37779146|FG000|Overall Study|Withdrawal by Subject|3|||
16835558|NCT02008526|37779147|FG001|Overall Study|Withdrawal by Subject|3|||
16835559|NCT02008526|37779148|FG002|Overall Study|Withdrawal by Subject|2|||
16835560|NCT02008526|37779146|FG000|Overall Study|Lost to Follow-up|5|||
16835561|NCT02008526|37779147|FG001|Overall Study|Lost to Follow-up|9|||
16835562|NCT02008526|37779148|FG002|Overall Study|Lost to Follow-up|6|||
16835563|NCT01769391|37779158|FG000|Overall Study|Death|10|||
16835564|NCT01769391|37779159|FG001|Overall Study|Death|1|||
16835565|NCT01769391|37779158|FG000|Overall Study|Adverse Event|0|||
16835566|NCT01769391|37779159|FG001|Overall Study|Adverse Event|3|||
16835567|NCT01769391|37779158|FG000|Overall Study|Progressive Disease|1|||
16835568|NCT01769391|37779159|FG001|Overall Study|Progressive Disease|2|||
16835569|NCT01769391|37779158|FG000|Overall Study|Withdrawal by Subject|4|||
16835570|NCT01769391|37779159|FG001|Overall Study|Withdrawal by Subject|3|||
16835571|NCT01769391|37779158|FG000|Overall Study|Investigator Decision|2|||
16835572|NCT01769391|37779159|FG001|Overall Study|Investigator Decision|0|||
16835573|NCT01800903|37779171|FG000|Second Test Period|unable to catheterise|1|||
16835574|NCT01800903|37779172|FG001|Second Test Period|unable to catheterise|0|||
16835575|NCT01800903|37779173|FG002|Second Test Period|unable to catheterise|0|||
16835576|NCT01800903|37779174|FG003|Second Test Period|unable to catheterise|0|||
16835577|NCT01800903|37779175|FG004|Second Test Period|unable to catheterise|0|||
16835578|NCT01800903|37779176|FG005|Second Test Period|unable to catheterise|0|||
16835579|NCT01767987|37779184|FG000|Overall Study|Physician Decision|4|||
16835580|NCT01767987|37779185|FG001|Overall Study|Physician Decision|1|||
16835581|NCT01800201|37779193|FG000|Overall Study|Withdrawal by Subject|2|||
16835582|NCT01800201|37779194|FG001|Overall Study|Withdrawal by Subject|0|||
16835583|NCT01800201|37779193|FG000|Overall Study|patient privacy concerns|1|||
16835584|NCT01800201|37779194|FG001|Overall Study|patient privacy concerns|1|||
16835585|NCT01800201|37779193|FG000|Overall Study|did not want to use device|0|||
16835586|NCT01800201|37779194|FG001|Overall Study|did not want to use device|1|||
16835587|NCT01800201|37779193|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
16835588|NCT01800201|37779194|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
16835589|NCT01767909|37779203|FG000|Overall Study|Withdrawal by Subject|4|||
16835590|NCT01767909|37779204|FG001|Overall Study|Withdrawal by Subject|7|||
16835591|NCT01767909|37779203|FG000|Overall Study|Adverse Event|3|||
16912824|NCT01474512|38021798|FG004|Long-Term Extension Period|Adverse Event|0|||
16912825|NCT01474512|38021799|FG005|Long-Term Extension Period|Adverse Event|0|||
16912826|NCT01474512|38021800|FG006|Long-Term Extension Period|Adverse Event|0|||
16912827|NCT01474512|38021801|FG007|Long-Term Extension Period|Adverse Event|0|||
16912828|NCT01474512|38021802|FG008|Long-Term Extension Period|Adverse Event|0|||
16835592|NCT01767909|37779204|FG001|Overall Study|Adverse Event|1|||
16912829|NCT01474512|38021803|FG009|Long-Term Extension Period|Adverse Event|0|||
16835593|NCT01767909|37779203|FG000|Overall Study|Withdrawal by Study Partner|3|||
16835594|NCT01767909|37779204|FG001|Overall Study|Withdrawal by Study Partner|1|||
16835595|NCT01767909|37779203|FG000|Overall Study|Non-Compliance|2|||
16835596|NCT01767909|37779204|FG001|Overall Study|Non-Compliance|0|||
16835597|NCT01767909|37779203|FG000|Overall Study|Perceived Lack of Efficacy|1|||
16835598|NCT01767909|37779204|FG001|Overall Study|Perceived Lack of Efficacy|0|||
16835599|NCT01767909|37779203|FG000|Overall Study|Investigator Recommendation|0|||
16835600|NCT01767909|37779204|FG001|Overall Study|Investigator Recommendation|1|||
16835601|NCT01767909|37779203|FG000|Overall Study|Lost to Follow-up|0|||
16835602|NCT01767909|37779204|FG001|Overall Study|Lost to Follow-up|1|||
16912830|NCT01474512|38021804|FG010|Long-Term Extension Period|Adverse Event|0|||
16912831|NCT01474512|38021805|FG011|Long-Term Extension Period|Adverse Event|1|||
16912832|NCT01474512|38021806|FG012|Long-Term Extension Period|Adverse Event|57|||
16912833|NCT01474512|38021807|FG013|Long-Term Extension Period|Adverse Event|58|||
16912834|NCT01474512|38021808|FG014|Long-Term Extension Period|Adverse Event|0|||
16912835|NCT01474512|38021809|FG015|Long-Term Extension Period|Adverse Event|0|||
16912836|NCT01474512|38021810|FG016|Long-Term Extension Period|Adverse Event|0|||
16912837|NCT01474512|38021811|FG017|Long-Term Extension Period|Adverse Event|0|||
16912838|NCT01474512|38021794|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
16912839|NCT01474512|38021795|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
16912840|NCT01474512|38021796|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
16912841|NCT01474512|38021797|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
16912842|NCT01474512|38021798|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
16912843|NCT01474512|38021799|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
16912844|NCT01474512|38021800|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
16912845|NCT01474512|38021801|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
16912846|NCT01474512|38021802|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
16912847|NCT01474512|38021803|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
16912848|NCT01474512|38021804|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
16912849|NCT01474512|38021805|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
16912850|NCT01474512|38021806|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
16912851|NCT01474512|38021807|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
16912852|NCT01474512|38021808|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
16912853|NCT01474512|38021809|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
16912854|NCT01474512|38021810|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
16912855|NCT01474512|38021811|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
16912856|NCT01474512|38021794|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
16912857|NCT01474512|38021795|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
16912858|NCT01474512|38021796|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
16912859|NCT01474512|38021797|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
16912860|NCT01474512|38021798|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
16912861|NCT01474512|38021799|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
16912862|NCT01474512|38021800|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
16912863|NCT01474512|38021801|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
16912864|NCT01474512|38021802|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
16912865|NCT01474512|38021803|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
16912866|NCT01474512|38021804|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
16912867|NCT01474512|38021805|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
16912868|NCT01474512|38021806|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
16912869|NCT01474512|38021807|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
16912870|NCT01474512|38021808|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
16912871|NCT01474512|38021809|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
16912872|NCT01474512|38021810|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
16912873|NCT01474512|38021811|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
16912874|NCT01474512|38021794|FG000|Long-Term Extension Period|Physician Decision|0|||
16912875|NCT01474512|38021795|FG001|Long-Term Extension Period|Physician Decision|0|||
16912876|NCT01474512|38021796|FG002|Long-Term Extension Period|Physician Decision|0|||
16912877|NCT01474512|38021797|FG003|Long-Term Extension Period|Physician Decision|0|||
16912878|NCT01474512|38021798|FG004|Long-Term Extension Period|Physician Decision|0|||
16835603|NCT01767909|37779203|FG000|Overall Study|LP uncessessful|0|||
16835604|NCT01767909|37779204|FG001|Overall Study|LP uncessessful|1|||
16835605|NCT02029274|37779216|FG000|Overall Study|Adverse Event|1|||
16835606|NCT02029274|37779217|FG001|Overall Study|Adverse Event|0|||
16835607|NCT02029274|37779218|FG002|Overall Study|Adverse Event|2|||
16835608|NCT02029274|37779219|FG003|Overall Study|Adverse Event|2|||
16835609|NCT02008370|37779233|FG000|Overall Study|Lost to Follow-up|7|||
16835610|NCT01981616|37779239|FG000|Overall Study|Adverse Event|0|||
16835611|NCT01981616|37779240|FG001|Overall Study|Adverse Event|1|||
16835612|NCT01981616|37779239|FG000|Overall Study|Protocol Violation|1|||
16835613|NCT01981616|37779240|FG001|Overall Study|Protocol Violation|0|||
16835614|NCT02104817|37779248|FG000|Overall Study|Death|363|||
16835615|NCT02104817|37779249|FG001|Overall Study|Death|330|||
16835616|NCT02104817|37779248|FG000|Overall Study|Lost to Follow-up|3|||
16835617|NCT02104817|37779249|FG001|Overall Study|Lost to Follow-up|2|||
16835618|NCT02104817|37779248|FG000|Overall Study|Protocol Violation|0|||
16835619|NCT02104817|37779249|FG001|Overall Study|Protocol Violation|1|||
16835620|NCT02104817|37779248|FG000|Overall Study|Study terminated by sponsor|5854|||
16835621|NCT02104817|37779249|FG001|Overall Study|Study terminated by sponsor|5901|||
16835622|NCT02104817|37779248|FG000|Overall Study|Withdrawal by Subject|111|||
16835623|NCT02104817|37779249|FG001|Overall Study|Withdrawal by Subject|78|||
16835624|NCT02104817|37779248|FG000|Overall Study|Other reasons|128|||
16835625|NCT02104817|37779249|FG001|Overall Study|Other reasons|135|||
16835626|NCT01962103|37779264|FG000|Phase 1|Adverse Event|4|||
16835627|NCT01962103|37779265|FG001|Phase 1|Adverse Event|0|||
16835628|NCT01962103|37779266|FG002|Phase 1|Adverse Event|2|||
16835629|NCT01962103|37779267|FG003|Phase 1|Adverse Event|1|||
16835630|NCT01962103|37779268|FG004|Phase 1|Adverse Event|2|||
16835631|NCT01962103|37779269|FG005|Phase 1|Adverse Event|2|||
16835632|NCT01962103|37779270|FG006|Phase 1|Adverse Event|0|||
16835633|NCT01962103|37779271|FG007|Phase 1|Adverse Event|0|||
16835634|NCT01962103|37779272|FG008|Phase 1|Adverse Event|0|||
16835635|NCT01962103|37779264|FG000|Phase 1|Progressive Disease|8|||
16835636|NCT01962103|37779265|FG001|Phase 1|Progressive Disease|6|||
16835637|NCT01962103|37779266|FG002|Phase 1|Progressive Disease|8|||
16835638|NCT01962103|37779267|FG003|Phase 1|Progressive Disease|4|||
16835639|NCT01962103|37779268|FG004|Phase 1|Progressive Disease|5|||
16835640|NCT01962103|37779269|FG005|Phase 1|Progressive Disease|4|||
16835641|NCT01962103|37779270|FG006|Phase 1|Progressive Disease|0|||
16835642|NCT01962103|37779271|FG007|Phase 1|Progressive Disease|0|||
16835643|NCT01962103|37779272|FG008|Phase 1|Progressive Disease|0|||
16835644|NCT01962103|37779264|FG000|Phase 1|Withdrawal by Subject|0|||
16835645|NCT01962103|37779265|FG001|Phase 1|Withdrawal by Subject|0|||
16835646|NCT01962103|37779266|FG002|Phase 1|Withdrawal by Subject|0|||
16835647|NCT01962103|37779267|FG003|Phase 1|Withdrawal by Subject|2|||
16835648|NCT01962103|37779268|FG004|Phase 1|Withdrawal by Subject|0|||
16835649|NCT01962103|37779269|FG005|Phase 1|Withdrawal by Subject|0|||
16835650|NCT01962103|37779270|FG006|Phase 1|Withdrawal by Subject|0|||
16835651|NCT01962103|37779271|FG007|Phase 1|Withdrawal by Subject|0|||
16835652|NCT01962103|37779272|FG008|Phase 1|Withdrawal by Subject|0|||
16835653|NCT01962103|37779264|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
16835654|NCT01962103|37779265|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
16835655|NCT01962103|37779266|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
16835656|NCT01962103|37779267|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
16835657|NCT01962103|37779268|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
16835658|NCT01962103|37779269|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
16835659|NCT01962103|37779270|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
16835660|NCT01962103|37779271|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
16835661|NCT01962103|37779272|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
16835662|NCT01962103|37779264|FG000|Phase 1|Physician Decision|0|||
16835663|NCT01962103|37779265|FG001|Phase 1|Physician Decision|0|||
16835664|NCT01962103|37779266|FG002|Phase 1|Physician Decision|0|||
16835665|NCT01962103|37779267|FG003|Phase 1|Physician Decision|1|||
16835666|NCT01962103|37779268|FG004|Phase 1|Physician Decision|0|||
16835667|NCT01962103|37779269|FG005|Phase 1|Physician Decision|0|||
16835668|NCT01962103|37779270|FG006|Phase 1|Physician Decision|0|||
16835669|NCT01962103|37779271|FG007|Phase 1|Physician Decision|0|||
16835670|NCT01962103|37779272|FG008|Phase 1|Physician Decision|0|||
16835671|NCT01962103|37779264|FG000|Phase 1|Symptomatic Deterioration|3|||
16835672|NCT01962103|37779265|FG001|Phase 1|Symptomatic Deterioration|2|||
16835673|NCT01962103|37779266|FG002|Phase 1|Symptomatic Deterioration|2|||
16835674|NCT01962103|37779267|FG003|Phase 1|Symptomatic Deterioration|2|||
16835675|NCT01962103|37779268|FG004|Phase 1|Symptomatic Deterioration|1|||
16835676|NCT01962103|37779269|FG005|Phase 1|Symptomatic Deterioration|1|||
16835677|NCT01962103|37779270|FG006|Phase 1|Symptomatic Deterioration|0|||
16835678|NCT01962103|37779271|FG007|Phase 1|Symptomatic Deterioration|0|||
16835679|NCT01962103|37779272|FG008|Phase 1|Symptomatic Deterioration|0|||
16835680|NCT01962103|37779264|FG000|Phase 1|Miscellaneous|1|||
16835681|NCT01962103|37779265|FG001|Phase 1|Miscellaneous|0|||
16835682|NCT01962103|37779266|FG002|Phase 1|Miscellaneous|0|||
16835683|NCT01962103|37779267|FG003|Phase 1|Miscellaneous|0|||
16835684|NCT01962103|37779268|FG004|Phase 1|Miscellaneous|0|||
16835685|NCT01962103|37779269|FG005|Phase 1|Miscellaneous|0|||
16835686|NCT01962103|37779270|FG006|Phase 1|Miscellaneous|0|||
16835687|NCT01962103|37779271|FG007|Phase 1|Miscellaneous|0|||
16835688|NCT01962103|37779272|FG008|Phase 1|Miscellaneous|0|||
16835689|NCT01962103|37779264|FG000|Phase 2|Adverse Event|0|||
16835690|NCT01962103|37779265|FG001|Phase 2|Adverse Event|0|||
16835691|NCT01962103|37779266|FG002|Phase 2|Adverse Event|0|||
16835692|NCT01962103|37779267|FG003|Phase 2|Adverse Event|0|||
16835693|NCT01962103|37779268|FG004|Phase 2|Adverse Event|0|||
16835694|NCT01962103|37779269|FG005|Phase 2|Adverse Event|0|||
16835695|NCT01962103|37779270|FG006|Phase 2|Adverse Event|1|||
16835696|NCT01962103|37779271|FG007|Phase 2|Adverse Event|0|||
16835697|NCT01962103|37779272|FG008|Phase 2|Adverse Event|3|||
16835698|NCT01962103|37779264|FG000|Phase 2|Progressive Disease|0|||
16835699|NCT01962103|37779265|FG001|Phase 2|Progressive Disease|0|||
16835700|NCT01962103|37779266|FG002|Phase 2|Progressive Disease|0|||
16912879|NCT01474512|38021799|FG005|Long-Term Extension Period|Physician Decision|0|||
16912880|NCT01474512|38021800|FG006|Long-Term Extension Period|Physician Decision|0|||
17102445|NCT03631732|38241392|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
16835701|NCT01962103|37779267|FG003|Phase 2|Progressive Disease|0|||
16835702|NCT01962103|37779268|FG004|Phase 2|Progressive Disease|0|||
16835703|NCT01962103|37779269|FG005|Phase 2|Progressive Disease|0|||
16835704|NCT01962103|37779270|FG006|Phase 2|Progressive Disease|11|||
16835705|NCT01962103|37779271|FG007|Phase 2|Progressive Disease|12|||
16835706|NCT01962103|37779272|FG008|Phase 2|Progressive Disease|11|||
16835707|NCT01962103|37779264|FG000|Phase 2|Symptomatic Deterioration|0|||
16835708|NCT01962103|37779265|FG001|Phase 2|Symptomatic Deterioration|0|||
16835709|NCT01962103|37779266|FG002|Phase 2|Symptomatic Deterioration|0|||
16835710|NCT01962103|37779267|FG003|Phase 2|Symptomatic Deterioration|0|||
16835711|NCT01962103|37779268|FG004|Phase 2|Symptomatic Deterioration|0|||
16835712|NCT01962103|37779269|FG005|Phase 2|Symptomatic Deterioration|0|||
16835713|NCT01962103|37779270|FG006|Phase 2|Symptomatic Deterioration|2|||
16835714|NCT01962103|37779271|FG007|Phase 2|Symptomatic Deterioration|2|||
16835715|NCT01962103|37779272|FG008|Phase 2|Symptomatic Deterioration|0|||
16835716|NCT01961323|37779292|FG000|Overall Study|Withdrawal by Subject|7|||
16835717|NCT01961323|37779292|FG000|Overall Study|Lost to Follow-up|8|||
16835718|NCT01961323|37779292|FG000|Overall Study|screen failure|34|||
16835719|NCT01960855|37779301|FG000|Overall Study|Subject noncompliant|1|||
16835720|NCT01960855|37779302|FG001|Overall Study|Subject noncompliant|0|||
16835721|NCT01960855|37779303|FG002|Overall Study|Subject noncompliant|0|||
16835722|NCT01960855|37779304|FG003|Overall Study|Subject noncompliant|0|||
16835723|NCT01960855|37779305|FG004|Overall Study|Subject noncompliant|0|||
16835724|NCT01960855|37779301|FG000|Overall Study|Adverse Event|2|||
16835725|NCT01960855|37779302|FG001|Overall Study|Adverse Event|0|||
16835726|NCT01960855|37779303|FG002|Overall Study|Adverse Event|6|||
16835727|NCT01960855|37779304|FG003|Overall Study|Adverse Event|2|||
16835728|NCT01960855|37779305|FG004|Overall Study|Adverse Event|2|||
16835729|NCT01960855|37779301|FG000|Overall Study|Lack of Efficacy|1|||
16835730|NCT01960855|37779302|FG001|Overall Study|Lack of Efficacy|1|||
16835731|NCT01960855|37779303|FG002|Overall Study|Lack of Efficacy|0|||
16835732|NCT01960855|37779304|FG003|Overall Study|Lack of Efficacy|0|||
16835733|NCT01960855|37779305|FG004|Overall Study|Lack of Efficacy|0|||
16835734|NCT01960855|37779301|FG000|Overall Study|Other|2|||
16835735|NCT01960855|37779302|FG001|Overall Study|Other|1|||
16835736|NCT01960855|37779303|FG002|Overall Study|Other|1|||
16835737|NCT01960855|37779304|FG003|Overall Study|Other|1|||
16835738|NCT01960855|37779305|FG004|Overall Study|Other|0|||
16835739|NCT01960855|37779301|FG000|Overall Study|Consent withdrawn by subject|3|||
16835740|NCT01960855|37779302|FG001|Overall Study|Consent withdrawn by subject|1|||
16835741|NCT01960855|37779303|FG002|Overall Study|Consent withdrawn by subject|2|||
16835742|NCT01960855|37779304|FG003|Overall Study|Consent withdrawn by subject|1|||
16835743|NCT01960855|37779305|FG004|Overall Study|Consent withdrawn by subject|1|||
16835744|NCT01960855|37779301|FG000|Overall Study|Lost to Follow-up|2|||
16835745|NCT01960855|37779302|FG001|Overall Study|Lost to Follow-up|1|||
16835746|NCT01960855|37779303|FG002|Overall Study|Lost to Follow-up|0|||
16835747|NCT01960855|37779304|FG003|Overall Study|Lost to Follow-up|0|||
16835748|NCT01960855|37779305|FG004|Overall Study|Lost to Follow-up|2|||
16835749|NCT02007434|37779325|FG000|Overall Study|Lost to Follow-up|0|||
16835750|NCT02007434|37779326|FG001|Overall Study|Lost to Follow-up|1|||
16835751|NCT02007434|37779327|FG002|Overall Study|Lost to Follow-up|0|||
16835752|NCT02007434|37779328|FG003|Overall Study|Lost to Follow-up|0|||
16835753|NCT02007434|37779329|FG004|Overall Study|Lost to Follow-up|0|||
16835754|NCT02007434|37779330|FG005|Overall Study|Lost to Follow-up|0|||
16835755|NCT02007434|37779331|FG006|Overall Study|Lost to Follow-up|0|||
16835756|NCT02007434|37779332|FG007|Overall Study|Lost to Follow-up|0|||
16835757|NCT02007434|37779325|FG000|Overall Study|Non-compliance|1|||
16835758|NCT02007434|37779326|FG001|Overall Study|Non-compliance|0|||
16835759|NCT02007434|37779327|FG002|Overall Study|Non-compliance|1|||
16835760|NCT02007434|37779328|FG003|Overall Study|Non-compliance|0|||
16835761|NCT02007434|37779329|FG004|Overall Study|Non-compliance|0|||
16835762|NCT02007434|37779330|FG005|Overall Study|Non-compliance|0|||
16835763|NCT02007434|37779331|FG006|Overall Study|Non-compliance|0|||
16835764|NCT02007434|37779332|FG007|Overall Study|Non-compliance|0|||
16835765|NCT01987453|37779354|FG000|Overall Study|Death|0|||
16835766|NCT01987453|37779355|FG001|Overall Study|Death|0|||
16835767|NCT01987453|37779356|FG002|Overall Study|Death|1|||
16835768|NCT01987453|37779354|FG000|Overall Study|Lack of Efficacy|1|||
16835769|NCT01987453|37779355|FG001|Overall Study|Lack of Efficacy|12|||
16835770|NCT01987453|37779356|FG002|Overall Study|Lack of Efficacy|0|||
16835771|NCT02006641|37779371|FG000|Overall Study|Withdrawal before treatment|2|||
16835772|NCT02006641|37779372|FG001|Overall Study|Withdrawal before treatment|5|||
16835773|NCT02006641|37779373|FG002|Overall Study|Withdrawal before treatment|3|||
16835774|NCT02006641|37779371|FG000|Overall Study|Adverse Event|15|||
16835775|NCT02006641|37779372|FG001|Overall Study|Adverse Event|11|||
16835776|NCT02006641|37779373|FG002|Overall Study|Adverse Event|15|||
16835777|NCT02006641|37779371|FG000|Overall Study|Protocol Violation|0|||
16835778|NCT02006641|37779372|FG001|Overall Study|Protocol Violation|2|||
16835779|NCT02006641|37779373|FG002|Overall Study|Protocol Violation|2|||
16835780|NCT02006641|37779371|FG000|Overall Study|Lost to Follow-up|0|||
16835781|NCT02006641|37779372|FG001|Overall Study|Lost to Follow-up|1|||
16835782|NCT02006641|37779373|FG002|Overall Study|Lost to Follow-up|0|||
16835783|NCT02006641|37779371|FG000|Overall Study|Withdrawal by Subject|7|||
16835784|NCT02006641|37779372|FG001|Overall Study|Withdrawal by Subject|12|||
16835785|NCT02006641|37779373|FG002|Overall Study|Withdrawal by Subject|11|||
16835786|NCT02006641|37779371|FG000|Overall Study|Other reason: patient didn't show up|1|||
16835787|NCT02006641|37779372|FG001|Overall Study|Other reason: patient didn't show up|0|||
16835788|NCT02006641|37779373|FG002|Overall Study|Other reason: patient didn't show up|0|||
16835789|NCT02006641|37779371|FG000|Overall Study|Other reason:patient didn't want to come|0|||
16835790|NCT02006641|37779372|FG001|Overall Study|Other reason:patient didn't want to come|0|||
16835791|NCT02006641|37779373|FG002|Overall Study|Other reason:patient didn't want to come|1|||
16835792|NCT02006641|37779371|FG000|Overall Study|Other reason: patient has moved|1|||
16835793|NCT02006641|37779372|FG001|Overall Study|Other reason: patient has moved|0|||
16835794|NCT02006641|37779373|FG002|Overall Study|Other reason: patient has moved|1|||
16835795|NCT02006641|37779371|FG000|Overall Study|Other reason: caregiver in hospital|0|||
16835796|NCT02006641|37779372|FG001|Overall Study|Other reason: caregiver in hospital|1|||
16835797|NCT02006641|37779373|FG002|Overall Study|Other reason: caregiver in hospital|0|||
16835798|NCT02006641|37779371|FG000|Overall Study|Other reason: patient's wife has died|0|||
16835799|NCT02006641|37779372|FG001|Overall Study|Other reason: patient's wife has died|0|||
16835800|NCT02006641|37779373|FG002|Overall Study|Other reason: patient's wife has died|1|||
16835801|NCT02006641|37779371|FG000|Overall Study|Other reason: hospitalisation|0|||
16835802|NCT02006641|37779372|FG001|Overall Study|Other reason: hospitalisation|1|||
16835803|NCT02006641|37779373|FG002|Overall Study|Other reason: hospitalisation|0|||
16835804|NCT02006641|37779371|FG000|Overall Study|Other reason: caregiver impossibility|0|||
16835805|NCT02006641|37779372|FG001|Overall Study|Other reason: caregiver impossibility|0|||
16835806|NCT02006641|37779373|FG002|Overall Study|Other reason: caregiver impossibility|1|||
16835807|NCT02006641|37779371|FG000|Overall Study|Other reason: protocol non-compliance|0|||
16835808|NCT02006641|37779372|FG001|Overall Study|Other reason: protocol non-compliance|0|||
16835809|NCT02006641|37779373|FG002|Overall Study|Other reason: protocol non-compliance|1|||
16835810|NCT01959919|37779381|FG000|Overall Study|Did not meet the eligibility criteria|2|||
16835811|NCT01986985|37779389|FG000|Overall Study|Withdrawal by Subject|4|||
16835812|NCT01986985|37779389|FG000|Overall Study|Scan not completed due to malfunction|3|||
16835813|NCT01986907|37779393|FG000|Overall Study|Adverse Event|11|||
16835814|NCT01986907|37779393|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
16835815|NCT01986907|37779393|FG000|Overall Study|Protocol Violation|4|||
16835816|NCT01986907|37779393|FG000|Overall Study|Withdrawal by Subject|76|||
16835817|NCT01986907|37779393|FG000|Overall Study|Lost to Follow-up|38|||
16835818|NCT01986907|37779393|FG000|Overall Study|Death|9|||
16835819|NCT01959841|37779403|FG000|Overall Study|Adverse Event|1|||
16835820|NCT01959841|37779404|FG001|Overall Study|Adverse Event|3|||
16835821|NCT01959841|37779405|FG002|Overall Study|Adverse Event|2|||
16835822|NCT01959841|37779403|FG000|Overall Study|Lack of Efficacy|5|||
16835823|NCT01959841|37779404|FG001|Overall Study|Lack of Efficacy|0|||
16835824|NCT01959841|37779405|FG002|Overall Study|Lack of Efficacy|0|||
16835825|NCT01959841|37779403|FG000|Overall Study|Lost to Follow-up|1|||
16835826|NCT01959841|37779404|FG001|Overall Study|Lost to Follow-up|1|||
16835827|NCT01959841|37779405|FG002|Overall Study|Lost to Follow-up|0|||
16835828|NCT01959841|37779403|FG000|Overall Study|Physician Decision|0|||
16835829|NCT01959841|37779404|FG001|Overall Study|Physician Decision|2|||
16835830|NCT01959841|37779405|FG002|Overall Study|Physician Decision|3|||
16835831|NCT01959841|37779403|FG000|Overall Study|Protocol Violation|16|||
16835832|NCT01959841|37779404|FG001|Overall Study|Protocol Violation|23|||
16835833|NCT01959841|37779405|FG002|Overall Study|Protocol Violation|16|||
16835834|NCT01959841|37779403|FG000|Overall Study|Withdrawal by Subject|7|||
16835835|NCT01959841|37779404|FG001|Overall Study|Withdrawal by Subject|7|||
16835836|NCT01959841|37779405|FG002|Overall Study|Withdrawal by Subject|5|||
16835837|NCT01959841|37779403|FG000|Overall Study|Clinical laboratory value|2|||
16835838|NCT01959841|37779404|FG001|Overall Study|Clinical laboratory value|6|||
16835839|NCT01959841|37779405|FG002|Overall Study|Clinical laboratory value|6|||
16835840|NCT01959841|37779403|FG000|Overall Study|Platelet count below on day1 or 4|11|||
16835841|NCT01959841|37779404|FG001|Overall Study|Platelet count below on day1 or 4|15|||
16835842|NCT01959841|37779405|FG002|Overall Study|Platelet count below on day1 or 4|11|||
16835843|NCT02005627|37779415|FG000|Overall Study|Lost to Follow-up|1|||
16835844|NCT02005627|37779416|FG001|Overall Study|Lost to Follow-up|2|||
16835845|NCT02005627|37779415|FG000|Overall Study|Withdrawal by Subject|1|||
16835846|NCT02005627|37779416|FG001|Overall Study|Withdrawal by Subject|2|||
16835847|NCT02104583|37779428|FG000|Overall Study|New ICD or CRT-D implanted|2|||
16835848|NCT02104583|37779429|FG001|Overall Study|New ICD or CRT-D implanted|0|||
16835849|NCT02104583|37779430|FG002|Overall Study|New ICD or CRT-D implanted|1|||
16835850|NCT02104583|37779431|FG003|Overall Study|New ICD or CRT-D implanted|0|||
16835851|NCT02104583|37779432|FG004|Overall Study|New ICD or CRT-D implanted|0|||
16835852|NCT02104583|37779428|FG000|Overall Study|Death|2|||
16835853|NCT02104583|37779429|FG001|Overall Study|Death|1|||
16835854|NCT02104583|37779430|FG002|Overall Study|Death|3|||
16835855|NCT02104583|37779431|FG003|Overall Study|Death|3|||
16835856|NCT02104583|37779432|FG004|Overall Study|Death|5|||
16835857|NCT02104583|37779428|FG000|Overall Study|Subject required cardiac ablation|6|||
16835858|NCT02104583|37779429|FG001|Overall Study|Subject required cardiac ablation|4|||
16835859|NCT02104583|37779430|FG002|Overall Study|Subject required cardiac ablation|4|||
16835860|NCT02104583|37779431|FG003|Overall Study|Subject required cardiac ablation|5|||
16835861|NCT02104583|37779432|FG004|Overall Study|Subject required cardiac ablation|4|||
16835862|NCT02104583|37779428|FG000|Overall Study|Subject required prohibited medication|0|||
16835863|NCT02104583|37779429|FG001|Overall Study|Subject required prohibited medication|1|||
16835864|NCT02104583|37779430|FG002|Overall Study|Subject required prohibited medication|1|||
16835865|NCT02104583|37779431|FG003|Overall Study|Subject required prohibited medication|0|||
16835866|NCT02104583|37779432|FG004|Overall Study|Subject required prohibited medication|1|||
16835867|NCT02104583|37779428|FG000|Overall Study|Withdrew Consent|3|||
16835868|NCT02104583|37779429|FG001|Overall Study|Withdrew Consent|2|||
16835869|NCT02104583|37779430|FG002|Overall Study|Withdrew Consent|0|||
16835870|NCT02104583|37779431|FG003|Overall Study|Withdrew Consent|2|||
16835871|NCT02104583|37779432|FG004|Overall Study|Withdrew Consent|1|||
16835872|NCT02104583|37779428|FG000|Overall Study|Investigator's Discretion|1|||
16835873|NCT02104583|37779429|FG001|Overall Study|Investigator's Discretion|0|||
16835874|NCT02104583|37779430|FG002|Overall Study|Investigator's Discretion|0|||
16835875|NCT02104583|37779431|FG003|Overall Study|Investigator's Discretion|0|||
16835876|NCT02104583|37779432|FG004|Overall Study|Investigator's Discretion|0|||
16835877|NCT02104583|37779428|FG000|Overall Study|Protocol Violation|0|||
16835878|NCT02104583|37779429|FG001|Overall Study|Protocol Violation|0|||
16835879|NCT02104583|37779430|FG002|Overall Study|Protocol Violation|1|||
16835880|NCT02104583|37779431|FG003|Overall Study|Protocol Violation|0|||
16835881|NCT02104583|37779432|FG004|Overall Study|Protocol Violation|0|||
16835882|NCT02104583|37779428|FG000|Overall Study|Adverse Event|3|||
16835883|NCT02104583|37779429|FG001|Overall Study|Adverse Event|3|||
16835884|NCT02104583|37779430|FG002|Overall Study|Adverse Event|6|||
16835885|NCT02104583|37779431|FG003|Overall Study|Adverse Event|6|||
16835886|NCT02104583|37779432|FG004|Overall Study|Adverse Event|1|||
16835887|NCT02104583|37779428|FG000|Overall Study|Lost to Follow-up|1|||
16835888|NCT02104583|37779429|FG001|Overall Study|Lost to Follow-up|0|||
16835889|NCT02104583|37779430|FG002|Overall Study|Lost to Follow-up|0|||
16835890|NCT02104583|37779431|FG003|Overall Study|Lost to Follow-up|0|||
16835891|NCT02104583|37779432|FG004|Overall Study|Lost to Follow-up|0|||
16835892|NCT02104583|37779428|FG000|Overall Study|Randomized but Never Treated|0|||
16835893|NCT02104583|37779429|FG001|Overall Study|Randomized but Never Treated|0|||
16835894|NCT02104583|37779430|FG002|Overall Study|Randomized but Never Treated|0|||
16835895|NCT02104583|37779431|FG003|Overall Study|Randomized but Never Treated|1|||
16835896|NCT02104583|37779432|FG004|Overall Study|Randomized but Never Treated|0|||
16835897|NCT02074553|37779455|FG000|Intervention Period 1|Family Emergency|0|||
16835898|NCT02074553|37779456|FG001|Intervention Period 1|Family Emergency|0|||
16835899|NCT02074553|37779457|FG002|Intervention Period 1|Family Emergency|0|||
16835900|NCT02074553|37779458|FG003|Intervention Period 1|Family Emergency|1|||
16835901|NCT02074553|37779459|FG004|Intervention Period 1|Family Emergency|0|||
16835902|NCT02074553|37779460|FG005|Intervention Period 1|Family Emergency|0|||
16835903|NCT02074553|37779461|FG006|Intervention Period 1|Family Emergency|0|||
16835904|NCT02074553|37779462|FG007|Intervention Period 1|Family Emergency|0|||
16835905|NCT02074553|37779455|FG000|Washout Period 1|Adverse Event|1|||
16835906|NCT02074553|37779456|FG001|Washout Period 1|Adverse Event|0|||
16835907|NCT02074553|37779457|FG002|Washout Period 1|Adverse Event|0|||
16912881|NCT01474512|38021801|FG007|Long-Term Extension Period|Physician Decision|0|||
16912882|NCT01474512|38021802|FG008|Long-Term Extension Period|Physician Decision|0|||
16912883|NCT01474512|38021803|FG009|Long-Term Extension Period|Physician Decision|0|||
16912884|NCT01474512|38021804|FG010|Long-Term Extension Period|Physician Decision|0|||
16912885|NCT01474512|38021805|FG011|Long-Term Extension Period|Physician Decision|0|||
16912886|NCT01474512|38021806|FG012|Long-Term Extension Period|Physician Decision|21|||
16912887|NCT01474512|38021807|FG013|Long-Term Extension Period|Physician Decision|21|||
16912888|NCT01474512|38021808|FG014|Long-Term Extension Period|Physician Decision|0|||
16912889|NCT01474512|38021809|FG015|Long-Term Extension Period|Physician Decision|0|||
16912890|NCT01474512|38021810|FG016|Long-Term Extension Period|Physician Decision|0|||
16912891|NCT01474512|38021811|FG017|Long-Term Extension Period|Physician Decision|0|||
16912892|NCT01474512|38021794|FG000|Long-Term Extension Period|Clinical Relapse|0|||
16912893|NCT01474512|38021795|FG001|Long-Term Extension Period|Clinical Relapse|0|||
16912894|NCT01474512|38021796|FG002|Long-Term Extension Period|Clinical Relapse|0|||
16912895|NCT01474512|38021797|FG003|Long-Term Extension Period|Clinical Relapse|0|||
16912896|NCT01474512|38021798|FG004|Long-Term Extension Period|Clinical Relapse|0|||
16912897|NCT01474512|38021799|FG005|Long-Term Extension Period|Clinical Relapse|0|||
16912898|NCT01474512|38021800|FG006|Long-Term Extension Period|Clinical Relapse|0|||
16912899|NCT01474512|38021801|FG007|Long-Term Extension Period|Clinical Relapse|0|||
16912900|NCT01474512|38021802|FG008|Long-Term Extension Period|Clinical Relapse|0|||
16912901|NCT01474512|38021803|FG009|Long-Term Extension Period|Clinical Relapse|0|||
16912902|NCT01474512|38021804|FG010|Long-Term Extension Period|Clinical Relapse|0|||
16912903|NCT01474512|38021805|FG011|Long-Term Extension Period|Clinical Relapse|0|||
17102446|NCT03631732|38241391|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
16835908|NCT02074553|37779458|FG003|Washout Period 1|Adverse Event|0|||
16835909|NCT02074553|37779459|FG004|Washout Period 1|Adverse Event|0|||
16835910|NCT02074553|37779460|FG005|Washout Period 1|Adverse Event|0|||
16835911|NCT02074553|37779461|FG006|Washout Period 1|Adverse Event|0|||
16835912|NCT02074553|37779462|FG007|Washout Period 1|Adverse Event|0|||
16835913|NCT02074553|37779455|FG000|Washout Period 1|Physician Decision|0|||
16835914|NCT02074553|37779456|FG001|Washout Period 1|Physician Decision|0|||
16835915|NCT02074553|37779457|FG002|Washout Period 1|Physician Decision|0|||
16835916|NCT02074553|37779458|FG003|Washout Period 1|Physician Decision|1|||
16835917|NCT02074553|37779459|FG004|Washout Period 1|Physician Decision|0|||
16835918|NCT02074553|37779460|FG005|Washout Period 1|Physician Decision|0|||
16835919|NCT02074553|37779461|FG006|Washout Period 1|Physician Decision|0|||
16835920|NCT02074553|37779462|FG007|Washout Period 1|Physician Decision|0|||
16835921|NCT02074553|37779455|FG000|Washout Period 1|Other|0|||
16835922|NCT02074553|37779456|FG001|Washout Period 1|Other|0|||
16835923|NCT02074553|37779457|FG002|Washout Period 1|Other|0|||
16835924|NCT02074553|37779458|FG003|Washout Period 1|Other|0|||
16835925|NCT02074553|37779459|FG004|Washout Period 1|Other|0|||
16835926|NCT02074553|37779460|FG005|Washout Period 1|Other|1|||
16835927|NCT02074553|37779461|FG006|Washout Period 1|Other|0|||
16835928|NCT02074553|37779462|FG007|Washout Period 1|Other|0|||
16835929|NCT02074553|37779455|FG000|Washout Period 2|Adverse Event|0|||
16835930|NCT02074553|37779456|FG001|Washout Period 2|Adverse Event|0|||
16835931|NCT02074553|37779457|FG002|Washout Period 2|Adverse Event|0|||
16835932|NCT02074553|37779458|FG003|Washout Period 2|Adverse Event|0|||
16835933|NCT02074553|37779459|FG004|Washout Period 2|Adverse Event|0|||
16835934|NCT02074553|37779460|FG005|Washout Period 2|Adverse Event|0|||
16835935|NCT02074553|37779461|FG006|Washout Period 2|Adverse Event|1|||
16835936|NCT02074553|37779462|FG007|Washout Period 2|Adverse Event|0|||
16835937|NCT02074553|37779455|FG000|Washout Period 2|Physician Decision|0|||
16835938|NCT02074553|37779456|FG001|Washout Period 2|Physician Decision|0|||
16835939|NCT02074553|37779457|FG002|Washout Period 2|Physician Decision|0|||
16835940|NCT02074553|37779458|FG003|Washout Period 2|Physician Decision|0|||
16835941|NCT02074553|37779459|FG004|Washout Period 2|Physician Decision|0|||
16835942|NCT02074553|37779460|FG005|Washout Period 2|Physician Decision|1|||
16835943|NCT02074553|37779461|FG006|Washout Period 2|Physician Decision|0|||
16835944|NCT02074553|37779462|FG007|Washout Period 2|Physician Decision|0|||
16835945|NCT02074553|37779455|FG000|Washout Period 2|Lost to Follow-up|0|||
16835946|NCT02074553|37779456|FG001|Washout Period 2|Lost to Follow-up|0|||
16835947|NCT02074553|37779457|FG002|Washout Period 2|Lost to Follow-up|1|||
16835948|NCT02074553|37779458|FG003|Washout Period 2|Lost to Follow-up|0|||
16835949|NCT02074553|37779459|FG004|Washout Period 2|Lost to Follow-up|0|||
16835950|NCT02074553|37779460|FG005|Washout Period 2|Lost to Follow-up|0|||
16835951|NCT02074553|37779461|FG006|Washout Period 2|Lost to Follow-up|0|||
16835952|NCT02074553|37779462|FG007|Washout Period 2|Lost to Follow-up|0|||
16835953|NCT02074553|37779455|FG000|Washout Period 3|Physician Decision|0|||
16835954|NCT02074553|37779456|FG001|Washout Period 3|Physician Decision|0|||
16835955|NCT02074553|37779457|FG002|Washout Period 3|Physician Decision|0|||
16835956|NCT02074553|37779458|FG003|Washout Period 3|Physician Decision|0|||
16835957|NCT02074553|37779459|FG004|Washout Period 3|Physician Decision|0|||
16835958|NCT02074553|37779460|FG005|Washout Period 3|Physician Decision|0|||
16835959|NCT02074553|37779461|FG006|Washout Period 3|Physician Decision|0|||
16835960|NCT02074553|37779462|FG007|Washout Period 3|Physician Decision|1|||
16835961|NCT02073929|37779482|FG000|Overall Study|Lost to Follow-up|2|||
16835962|NCT02073929|37779483|FG001|Overall Study|Lost to Follow-up|1|||
16835963|NCT02073929|37779482|FG000|Overall Study|Adverse Event|2|||
16835964|NCT02073929|37779483|FG001|Overall Study|Adverse Event|1|||
16835965|NCT02073929|37779482|FG000|Overall Study|Withdrawal by Subject|0|||
16835966|NCT02073929|37779483|FG001|Overall Study|Withdrawal by Subject|1|||
16835967|NCT02113007|37779489|FG000|Overall Study|Progressive disease|2|||
16835968|NCT02005471|37779495|FG000|Overall Study|Ongoing in Study|144|||
16835969|NCT02005471|37779496|FG001|Overall Study|Ongoing in Study|171|||
16835970|NCT02005471|37779495|FG000|Overall Study|Adverse Event|1|||
16835971|NCT02005471|37779496|FG001|Overall Study|Adverse Event|0|||
16835972|NCT02005471|37779495|FG000|Overall Study|Death|26|||
16835973|NCT02005471|37779496|FG001|Overall Study|Death|15|||
16835974|NCT02005471|37779495|FG000|Overall Study|Lost to Follow-up|1|||
16835975|NCT02005471|37779496|FG001|Overall Study|Lost to Follow-up|0|||
16835976|NCT02005471|37779495|FG000|Overall Study|Physician Decision|2|||
16835977|NCT02005471|37779496|FG001|Overall Study|Physician Decision|1|||
16835978|NCT02005471|37779495|FG000|Overall Study|Progressive Disease|3|||
16835979|NCT02005471|37779496|FG001|Overall Study|Progressive Disease|0|||
16835980|NCT02005471|37779495|FG000|Overall Study|Withdrawal by Subject|18|||
16912904|NCT01474512|38021806|FG012|Long-Term Extension Period|Clinical Relapse|9|||
16835981|NCT02005471|37779496|FG001|Overall Study|Withdrawal by Subject|7|||
16835982|NCT02104505|37779507|FG000|First Intervention (14 Days)|Adverse Event|2|||
16835983|NCT02104505|37779508|FG001|First Intervention (14 Days)|Adverse Event|0|||
16912905|NCT01474512|38021807|FG013|Long-Term Extension Period|Clinical Relapse|9|||
16835984|NCT02104505|37779507|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
16835985|NCT02104505|37779508|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
16835986|NCT02104505|37779507|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
16835987|NCT02104505|37779508|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
16835988|NCT02104505|37779507|FG000|First Intervention (14 Days)|exclusionary condition|0|||
16835989|NCT02104505|37779508|FG001|First Intervention (14 Days)|exclusionary condition|1|||
16835990|NCT02104505|37779507|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
16835991|NCT02104505|37779508|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
16835992|NCT02104505|37779507|FG000|Second Intervention (14 Days)|Adverse Event|2|||
16835993|NCT02104505|37779508|FG001|Second Intervention (14 Days)|Adverse Event|0|||
16835994|NCT02111993|37779517|FG000|Overall Study|Physician Decision|5|||
16835995|NCT02111993|37779518|FG001|Overall Study|Physician Decision|4|||
16835996|NCT01959607|37779528|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
16835997|NCT01959607|37779529|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
16835998|NCT01959607|37779530|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16835999|NCT01959607|37779531|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
16836000|NCT02111603|37779540|FG000|Overall Study|Withdrawal by Subject|1|||
16836001|NCT02102399|37779546|FG000|Overall Study|Withdrawal by Subject|6|||
16836002|NCT02102399|37779547|FG001|Overall Study|Withdrawal by Subject|4|||
16836003|NCT02111369|37779558|FG000|Overall Study|Lost to Follow-up|2|||
16836004|NCT02111369|37779558|FG000|Overall Study|Withdrawal by Subject|1|||
16836005|NCT02111213|37779564|FG000|Overall Study|Withdrawal by Subject|3|||
16836006|NCT02111213|37779565|FG001|Overall Study|Withdrawal by Subject|2|||
16836007|NCT02111213|37779564|FG000|Overall Study|Lost to Follow-up|3|||
16836008|NCT02111213|37779565|FG001|Overall Study|Lost to Follow-up|4|||
16836009|NCT02110901|37779573|FG000|Overall Study|Death|6|||
16836010|NCT02110901|37779574|FG001|Overall Study|Death|3|||
16836011|NCT02110901|37779573|FG000|Overall Study|Lost to Follow-up|12|||
16836012|NCT02110901|37779574|FG001|Overall Study|Lost to Follow-up|8|||
16836013|NCT02110901|37779573|FG000|Overall Study|Withdrawal by Subject|7|||
16836014|NCT02110901|37779574|FG001|Overall Study|Withdrawal by Subject|3|||
16836015|NCT02110901|37779573|FG000|Overall Study|received a kidney transplant|5|||
16836016|NCT02110901|37779574|FG001|Overall Study|received a kidney transplant|0|||
16836017|NCT02070965|37779584|FG000|Overall Study|Lost to Follow-up|0|||
16836018|NCT02070965|37779585|FG001|Overall Study|Lost to Follow-up|1|||
16836019|NCT02070965|37779586|FG002|Overall Study|Lost to Follow-up|0|||
16836020|NCT02070965|37779584|FG000|Overall Study|Withdrawal by Subject|1|||
16836021|NCT02070965|37779585|FG001|Overall Study|Withdrawal by Subject|1|||
16836022|NCT02070965|37779586|FG002|Overall Study|Withdrawal by Subject|1|||
16836023|NCT02070965|37779584|FG000|Overall Study|Subject moved|1|||
16836024|NCT02070965|37779585|FG001|Overall Study|Subject moved|0|||
16836025|NCT02070965|37779586|FG002|Overall Study|Subject moved|0|||
16836026|NCT02109107|37779594|FG000|Overall Study|Lost to Follow-up|2|||
16836027|NCT02100839|37779600|FG000|Multiple Ascending Dose|Adverse Event|2|||
16836028|NCT02100839|37779601|FG001|Multiple Ascending Dose|Adverse Event|0|||
16836029|NCT02100839|37779600|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
16836030|NCT02100839|37779601|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
16836031|NCT02069093|37779607|FG000|Overall Study|Disease progression|14|||
16836032|NCT02069093|37779607|FG000|Overall Study|New cancer therapy|1|||
16836033|NCT02069093|37779607|FG000|Overall Study|Death|1|||
16836034|NCT02069093|37779607|FG000|Overall Study|Administrative problems|1|||
16836035|NCT02069093|37779607|FG000|Overall Study|Withdrawal by Subject|2|||
16836036|NCT02069093|37779607|FG000|Overall Study|Abnormal laboratory values|1|||
16836037|NCT02069093|37779607|FG000|Overall Study|Adverse Event|10|||
16836038|NCT02109029|37779614|FG000|Part B|Adverse Event|0|||
16836039|NCT02109029|37779615|FG001|Part B|Adverse Event|0|||
16836040|NCT02109029|37779616|FG002|Part B|Adverse Event|0|||
16836041|NCT02109029|37779617|FG003|Part B|Adverse Event|0|||
16836042|NCT02109029|37779618|FG004|Part B|Adverse Event|1|||
16836043|NCT02109029|37779619|FG005|Part B|Adverse Event|1|||
16836044|NCT02069015|37779632|FG000|Overall Study|Lost to Follow-up|39|||
16836045|NCT02069015|37779633|FG001|Overall Study|Lost to Follow-up|32|||
16912906|NCT01474512|38021808|FG014|Long-Term Extension Period|Clinical Relapse|0|||
16912907|NCT01474512|38021809|FG015|Long-Term Extension Period|Clinical Relapse|0|||
16912908|NCT01474512|38021810|FG016|Long-Term Extension Period|Clinical Relapse|0|||
16912909|NCT01474512|38021811|FG017|Long-Term Extension Period|Clinical Relapse|0|||
16912910|NCT01474512|38021794|FG000|Long-Term Extension Period|Death|0|||
16912911|NCT01474512|38021795|FG001|Long-Term Extension Period|Death|0|||
16912912|NCT01474512|38021796|FG002|Long-Term Extension Period|Death|0|||
16912913|NCT01474512|38021797|FG003|Long-Term Extension Period|Death|0|||
16912914|NCT01474512|38021798|FG004|Long-Term Extension Period|Death|0|||
16836046|NCT02069015|37779632|FG000|Overall Study|Withdrawal by Subject|1|||
16836047|NCT02069015|37779633|FG001|Overall Study|Withdrawal by Subject|1|||
16836048|NCT01598129|37779640|FG000|Overall Study|Disease progression|6|||
16836049|NCT01598129|37779640|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
16836050|NCT01598129|37779640|FG000|Overall Study|Withdrawal by Subject|1|||
16836051|NCT02068547|37779647|FG000|Overall Study|Lost to Follow-up|3|||
16836052|NCT02068547|37779648|FG001|Overall Study|Lost to Follow-up|3|||
16836053|NCT02068547|37779647|FG000|Overall Study|Physician Decision|1|||
16836054|NCT02068547|37779648|FG001|Overall Study|Physician Decision|0|||
16836055|NCT02108951|37779654|FG000|Overall Study|Lost to Follow-up|1|||
16836056|NCT02108951|37779654|FG000|Overall Study|Patient's/guardian's decision|1|||
16836057|NCT02108951|37779654|FG000|Overall Study|Study Terminated by Sponsor|14|||
16836058|NCT02107859|37779658|FG000|Overall Study|Withdrawal by Subject|14|||
16836059|NCT02107859|37779658|FG000|Overall Study|Adverse Event|3|||
16836060|NCT02107859|37779658|FG000|Overall Study|Study closure|41|||
16836061|NCT02107859|37779658|FG000|Overall Study|Other than specified|3|||
16836062|NCT02028884|37779664|FG000|Double-blind Period|Adverse Event|5|||
16836063|NCT02028884|37779665|FG001|Double-blind Period|Adverse Event|3|||
16836064|NCT02028884|37779664|FG000|Double-blind Period|Eligibility Violation|1|||
16836065|NCT02028884|37779665|FG001|Double-blind Period|Eligibility Violation|0|||
16836066|NCT02028884|37779664|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
16836067|NCT02028884|37779665|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
16836068|NCT02028884|37779664|FG000|Double-blind Period|Withdrawal by Subject|2|||
16836069|NCT02028884|37779665|FG001|Double-blind Period|Withdrawal by Subject|0|||
16836070|NCT02028884|37779664|FG000|Double-blind Period|On-going in Study|8|||
16836071|NCT02028884|37779665|FG001|Double-blind Period|On-going in Study|20|||
16836072|NCT02028884|37779664|FG000|Open-label Extension Period|Adverse Event|2|||
16836073|NCT02028884|37779665|FG001|Open-label Extension Period|Adverse Event|1|||
16836074|NCT02028884|37779664|FG000|Open-label Extension Period|Lack of Efficacy|3|||
16836075|NCT02028884|37779665|FG001|Open-label Extension Period|Lack of Efficacy|0|||
16836076|NCT02028884|37779664|FG000|Open-label Extension Period|Non-Compliance With Study Drug|0|||
16836077|NCT02028884|37779665|FG001|Open-label Extension Period|Non-Compliance With Study Drug|1|||
16836078|NCT02028884|37779664|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
16836079|NCT02028884|37779665|FG001|Open-label Extension Period|Withdrawal by Subject|2|||
16836080|NCT02028884|37779664|FG000|Open-label Extension Period|On-going in Study|19|||
16836081|NCT02028884|37779665|FG001|Open-label Extension Period|On-going in Study|14|||
16836082|NCT02107703|37779676|FG000|Overall Study|Withdrawal by Subject|36|||
16836083|NCT02107703|37779677|FG001|Overall Study|Withdrawal by Subject|19|||
16836084|NCT02107703|37779676|FG000|Overall Study|Lost to Follow-up|6|||
16836085|NCT02107703|37779677|FG001|Overall Study|Lost to Follow-up|4|||
16836086|NCT02107703|37779676|FG000|Overall Study|On study treatment/follow up|319|||
16836087|NCT02107703|37779677|FG001|Overall Study|On study treatment/follow up|152|||
16836088|NCT02007278|37779688|FG000|Overall Study|Failure to comply with an eligibility|0|||
16836089|NCT02007278|37779689|FG001|Overall Study|Failure to comply with an eligibility|1|||
16836090|NCT02007278|37779688|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
16836091|NCT02007278|37779689|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
16836092|NCT02007278|37779688|FG000|Overall Study|Incorrect medication administration|1|||
16836093|NCT02007278|37779689|FG001|Overall Study|Incorrect medication administration|0|||
16836094|NCT02007278|37779688|FG000|Overall Study|Mis-randomization|1|||
16836095|NCT02007278|37779689|FG001|Overall Study|Mis-randomization|1|||
16836096|NCT02107313|37779695|FG000|Overall Study|One participant did not do the FED cohor|0|||
16836097|NCT02107313|37779696|FG001|Overall Study|One participant did not do the FED cohor|1|||
16836098|NCT02028338|37779704|FG000|Overall Study|Withdrawal by Subject|3|||
16836099|NCT02028338|37779705|FG001|Overall Study|Withdrawal by Subject|1|||
16836100|NCT02028338|37779704|FG000|Overall Study|Unable to contact participant|1|||
16836101|NCT02028338|37779705|FG001|Overall Study|Unable to contact participant|0|||
16836102|NCT01625897|37779713|FG000|Overall Study|Adverse Event|27|||
16836103|NCT01625897|37779714|FG001|Overall Study|Adverse Event|10|||
16836104|NCT01625897|37779713|FG000|Overall Study|Physician Decision|0|||
16836105|NCT01625897|37779714|FG001|Overall Study|Physician Decision|1|||
16836106|NCT01625897|37779713|FG000|Overall Study|Withdrawal by Subject|25|||
16836107|NCT01625897|37779714|FG001|Overall Study|Withdrawal by Subject|3|||
16836108|NCT02106923|37779723|FG000|Overall Study|Protocol Violation|0|||
16836109|NCT02106923|37779724|FG001|Overall Study|Protocol Violation|0|||
16836110|NCT02106923|37779725|FG002|Overall Study|Protocol Violation|0|||
16836111|NCT02106923|37779726|FG003|Overall Study|Protocol Violation|0|||
16836112|NCT02106923|37779727|FG004|Overall Study|Protocol Violation|0|||
16836113|NCT02106923|37779728|FG005|Overall Study|Protocol Violation|1|||
16836114|NCT02006732|37779746|FG000|Overall Study|Adverse Event|10|||
16836115|NCT02006732|37779747|FG001|Overall Study|Adverse Event|7|||
16836116|NCT02006732|37779748|FG002|Overall Study|Adverse Event|4|||
16836117|NCT02006732|37779749|FG003|Overall Study|Adverse Event|2|||
16836118|NCT02006732|37779746|FG000|Overall Study|Lack of Efficacy|6|||
16836119|NCT02006732|37779747|FG001|Overall Study|Lack of Efficacy|3|||
16836120|NCT02006732|37779748|FG002|Overall Study|Lack of Efficacy|1|||
16836121|NCT02006732|37779749|FG003|Overall Study|Lack of Efficacy|1|||
16836122|NCT02006732|37779746|FG000|Overall Study|Protocol Violation|1|||
16836123|NCT02006732|37779747|FG001|Overall Study|Protocol Violation|1|||
16836124|NCT02006732|37779748|FG002|Overall Study|Protocol Violation|0|||
16836125|NCT02006732|37779749|FG003|Overall Study|Protocol Violation|0|||
16836126|NCT02006732|37779746|FG000|Overall Study|Lost to Follow-up|0|||
16836127|NCT02006732|37779747|FG001|Overall Study|Lost to Follow-up|1|||
16836128|NCT02006732|37779748|FG002|Overall Study|Lost to Follow-up|0|||
16836129|NCT02006732|37779749|FG003|Overall Study|Lost to Follow-up|0|||
16836130|NCT02006732|37779746|FG000|Overall Study|Withdrawal by Subject|3|||
16836131|NCT02006732|37779747|FG001|Overall Study|Withdrawal by Subject|0|||
16836132|NCT02006732|37779748|FG002|Overall Study|Withdrawal by Subject|4|||
16836133|NCT02006732|37779749|FG003|Overall Study|Withdrawal by Subject|1|||
16836134|NCT02098733|37779759|FG000|Overall Study|Data Not Available|5|||
16836135|NCT02098733|37779759|FG000|Overall Study|Lost to Follow-up|5|||
16836136|NCT02028182|37779763|FG000|Overall Study|Protocol Violation|2|||
16836137|NCT02098109|37779770|FG000|Overall Study|Protocol Violation|3|||
16836138|NCT02098109|37779771|FG001|Overall Study|Protocol Violation|0|||
16836139|NCT02097719|37779779|FG000|Overall Study|Subject Withdrew Consent|1|||
16836140|NCT02097719|37779780|FG001|Overall Study|Subject Withdrew Consent|0|||
16836141|NCT02097719|37779779|FG000|Overall Study|Lost to Follow-up|0|||
16836142|NCT02097719|37779780|FG001|Overall Study|Lost to Follow-up|1|||
16836143|NCT02097719|37779779|FG000|Overall Study|Adverse Event|2|||
16836144|NCT02097719|37779780|FG001|Overall Study|Adverse Event|0|||
16836145|NCT01449370|37779811|FG000|Overall Study|Disease Progression|5|||
16836146|NCT01449370|37779812|FG001|Overall Study|Disease Progression|4|||
16836147|NCT01449370|37779813|FG002|Overall Study|Disease Progression|8|||
16836148|NCT01449370|37779814|FG003|Overall Study|Disease Progression|3|||
16836149|NCT01449370|37779815|FG004|Overall Study|Disease Progression|3|||
16836150|NCT01449370|37779816|FG005|Overall Study|Disease Progression|3|||
16836151|NCT01449370|37779817|FG006|Overall Study|Disease Progression|3|||
16836152|NCT01449370|37779818|FG007|Overall Study|Disease Progression|2|||
16836153|NCT01449370|37779819|FG008|Overall Study|Disease Progression|9|||
16836154|NCT01449370|37779820|FG009|Overall Study|Disease Progression|1|||
16836155|NCT01449370|37779821|FG010|Overall Study|Disease Progression|3|||
16836156|NCT01449370|37779822|FG011|Overall Study|Disease Progression|3|||
16836157|NCT01449370|37779823|FG012|Overall Study|Disease Progression|2|||
16836158|NCT01449370|37779824|FG013|Overall Study|Disease Progression|8|||
16836159|NCT01449370|37779825|FG014|Overall Study|Disease Progression|3|||
16836160|NCT01449370|37779826|FG015|Overall Study|Disease Progression|1|||
16836161|NCT01449370|37779827|FG016|Overall Study|Disease Progression|4|||
16836162|NCT01449370|37779828|FG017|Overall Study|Disease Progression|3|||
16836163|NCT01449370|37779829|FG018|Overall Study|Disease Progression|1|||
16836164|NCT01449370|37779830|FG019|Overall Study|Disease Progression|2|||
16836165|NCT01449370|37779831|FG020|Overall Study|Disease Progression|5|||
16836166|NCT01449370|37779832|FG021|Overall Study|Disease Progression|2|||
16836167|NCT01449370|37779833|FG022|Overall Study|Disease Progression|3|||
16836168|NCT01449370|37779834|FG023|Overall Study|Disease Progression|7|||
16836169|NCT01449370|37779835|FG024|Overall Study|Disease Progression|3|||
16836170|NCT01449370|37779811|FG000|Overall Study|Adverse Event|1|||
16836171|NCT01449370|37779812|FG001|Overall Study|Adverse Event|2|||
16836172|NCT01449370|37779813|FG002|Overall Study|Adverse Event|0|||
16836173|NCT01449370|37779814|FG003|Overall Study|Adverse Event|1|||
16836174|NCT01449370|37779815|FG004|Overall Study|Adverse Event|0|||
16836175|NCT01449370|37779816|FG005|Overall Study|Adverse Event|0|||
16836176|NCT01449370|37779817|FG006|Overall Study|Adverse Event|0|||
16836177|NCT01449370|37779818|FG007|Overall Study|Adverse Event|0|||
16836178|NCT01449370|37779819|FG008|Overall Study|Adverse Event|1|||
16836179|NCT01449370|37779820|FG009|Overall Study|Adverse Event|1|||
16836180|NCT01449370|37779821|FG010|Overall Study|Adverse Event|0|||
16836181|NCT01449370|37779822|FG011|Overall Study|Adverse Event|0|||
16836182|NCT01449370|37779823|FG012|Overall Study|Adverse Event|0|||
16836183|NCT01449370|37779824|FG013|Overall Study|Adverse Event|2|||
16836184|NCT01449370|37779825|FG014|Overall Study|Adverse Event|0|||
16836185|NCT01449370|37779826|FG015|Overall Study|Adverse Event|1|||
16836186|NCT01449370|37779827|FG016|Overall Study|Adverse Event|0|||
16836187|NCT01449370|37779828|FG017|Overall Study|Adverse Event|0|||
16836188|NCT01449370|37779829|FG018|Overall Study|Adverse Event|1|||
16836189|NCT01449370|37779830|FG019|Overall Study|Adverse Event|1|||
16836190|NCT01449370|37779831|FG020|Overall Study|Adverse Event|0|||
16836191|NCT01449370|37779832|FG021|Overall Study|Adverse Event|1|||
16836192|NCT01449370|37779833|FG022|Overall Study|Adverse Event|0|||
16836193|NCT01449370|37779834|FG023|Overall Study|Adverse Event|1|||
16836194|NCT01449370|37779835|FG024|Overall Study|Adverse Event|3|||
16836195|NCT01449370|37779811|FG000|Overall Study|Participant Decision|0|||
16836196|NCT01449370|37779812|FG001|Overall Study|Participant Decision|0|||
16912915|NCT01474512|38021799|FG005|Long-Term Extension Period|Death|0|||
16912916|NCT01474512|38021800|FG006|Long-Term Extension Period|Death|0|||
16836197|NCT01449370|37779813|FG002|Overall Study|Participant Decision|0|||
16836198|NCT01449370|37779814|FG003|Overall Study|Participant Decision|0|||
16836199|NCT01449370|37779815|FG004|Overall Study|Participant Decision|0|||
16836200|NCT01449370|37779816|FG005|Overall Study|Participant Decision|0|||
16836201|NCT01449370|37779817|FG006|Overall Study|Participant Decision|0|||
16836202|NCT01449370|37779818|FG007|Overall Study|Participant Decision|1|||
16836203|NCT01449370|37779819|FG008|Overall Study|Participant Decision|1|||
16836204|NCT01449370|37779820|FG009|Overall Study|Participant Decision|0|||
16836205|NCT01449370|37779821|FG010|Overall Study|Participant Decision|0|||
16836206|NCT01449370|37779822|FG011|Overall Study|Participant Decision|0|||
16836207|NCT01449370|37779823|FG012|Overall Study|Participant Decision|1|||
16836208|NCT01449370|37779824|FG013|Overall Study|Participant Decision|1|||
16836209|NCT01449370|37779825|FG014|Overall Study|Participant Decision|0|||
16836210|NCT01449370|37779826|FG015|Overall Study|Participant Decision|1|||
16836211|NCT01449370|37779827|FG016|Overall Study|Participant Decision|3|||
16836212|NCT01449370|37779828|FG017|Overall Study|Participant Decision|0|||
16836213|NCT01449370|37779829|FG018|Overall Study|Participant Decision|1|||
16836214|NCT01449370|37779830|FG019|Overall Study|Participant Decision|0|||
16836215|NCT01449370|37779831|FG020|Overall Study|Participant Decision|0|||
16836216|NCT01449370|37779832|FG021|Overall Study|Participant Decision|1|||
16836217|NCT01449370|37779833|FG022|Overall Study|Participant Decision|0|||
16836218|NCT01449370|37779834|FG023|Overall Study|Participant Decision|0|||
16836219|NCT01449370|37779835|FG024|Overall Study|Participant Decision|1|||
16836220|NCT01449370|37779811|FG000|Overall Study|Lost to Follow-up|0|||
16836221|NCT01449370|37779812|FG001|Overall Study|Lost to Follow-up|0|||
16836222|NCT01449370|37779813|FG002|Overall Study|Lost to Follow-up|0|||
16836223|NCT01449370|37779814|FG003|Overall Study|Lost to Follow-up|0|||
16836224|NCT01449370|37779815|FG004|Overall Study|Lost to Follow-up|0|||
16836225|NCT01449370|37779816|FG005|Overall Study|Lost to Follow-up|0|||
16836226|NCT01449370|37779817|FG006|Overall Study|Lost to Follow-up|0|||
16836227|NCT01449370|37779818|FG007|Overall Study|Lost to Follow-up|0|||
16836228|NCT01449370|37779819|FG008|Overall Study|Lost to Follow-up|0|||
16836229|NCT01449370|37779820|FG009|Overall Study|Lost to Follow-up|0|||
16836230|NCT01449370|37779821|FG010|Overall Study|Lost to Follow-up|0|||
16836231|NCT01449370|37779822|FG011|Overall Study|Lost to Follow-up|0|||
16836232|NCT01449370|37779823|FG012|Overall Study|Lost to Follow-up|0|||
16836233|NCT01449370|37779824|FG013|Overall Study|Lost to Follow-up|0|||
16836234|NCT01449370|37779825|FG014|Overall Study|Lost to Follow-up|0|||
16836235|NCT01449370|37779826|FG015|Overall Study|Lost to Follow-up|0|||
16836236|NCT01449370|37779827|FG016|Overall Study|Lost to Follow-up|0|||
16836237|NCT01449370|37779828|FG017|Overall Study|Lost to Follow-up|0|||
16836238|NCT01449370|37779829|FG018|Overall Study|Lost to Follow-up|0|||
16836239|NCT01449370|37779830|FG019|Overall Study|Lost to Follow-up|0|||
16836240|NCT01449370|37779831|FG020|Overall Study|Lost to Follow-up|1|||
16836241|NCT01449370|37779832|FG021|Overall Study|Lost to Follow-up|0|||
16836242|NCT01449370|37779833|FG022|Overall Study|Lost to Follow-up|0|||
16836243|NCT01449370|37779834|FG023|Overall Study|Lost to Follow-up|0|||
16836244|NCT01449370|37779835|FG024|Overall Study|Lost to Follow-up|0|||
16836245|NCT01449370|37779811|FG000|Overall Study|Other|0|||
16836246|NCT01449370|37779812|FG001|Overall Study|Other|0|||
16836247|NCT01449370|37779813|FG002|Overall Study|Other|0|||
16836248|NCT01449370|37779814|FG003|Overall Study|Other|0|||
16836249|NCT01449370|37779815|FG004|Overall Study|Other|0|||
16836250|NCT01449370|37779816|FG005|Overall Study|Other|0|||
16836251|NCT01449370|37779817|FG006|Overall Study|Other|0|||
16836252|NCT01449370|37779818|FG007|Overall Study|Other|0|||
16836253|NCT01449370|37779819|FG008|Overall Study|Other|1|||
16836254|NCT01449370|37779820|FG009|Overall Study|Other|1|||
16836255|NCT01449370|37779821|FG010|Overall Study|Other|0|||
16836256|NCT01449370|37779822|FG011|Overall Study|Other|0|||
16836257|NCT01449370|37779823|FG012|Overall Study|Other|0|||
16836258|NCT01449370|37779824|FG013|Overall Study|Other|0|||
16836259|NCT01449370|37779825|FG014|Overall Study|Other|0|||
16836260|NCT01449370|37779826|FG015|Overall Study|Other|0|||
16836261|NCT01449370|37779827|FG016|Overall Study|Other|0|||
16836262|NCT01449370|37779828|FG017|Overall Study|Other|0|||
16836263|NCT01449370|37779829|FG018|Overall Study|Other|0|||
16836264|NCT01449370|37779830|FG019|Overall Study|Other|0|||
16836265|NCT01449370|37779831|FG020|Overall Study|Other|0|||
16836266|NCT01449370|37779832|FG021|Overall Study|Other|0|||
16836267|NCT01449370|37779833|FG022|Overall Study|Other|1|||
16836268|NCT01449370|37779834|FG023|Overall Study|Other|1|||
16836269|NCT01449370|37779835|FG024|Overall Study|Other|0|||
16836270|NCT01449370|37779811|FG000|Overall Study|Medication Prohibited by Protocol|0|||
16836271|NCT01449370|37779812|FG001|Overall Study|Medication Prohibited by Protocol|0|||
16836272|NCT01449370|37779813|FG002|Overall Study|Medication Prohibited by Protocol|0|||
16836273|NCT01449370|37779814|FG003|Overall Study|Medication Prohibited by Protocol|0|||
16836274|NCT01449370|37779815|FG004|Overall Study|Medication Prohibited by Protocol|0|||
16836275|NCT01449370|37779816|FG005|Overall Study|Medication Prohibited by Protocol|0|||
16836276|NCT01449370|37779817|FG006|Overall Study|Medication Prohibited by Protocol|0|||
16836277|NCT01449370|37779818|FG007|Overall Study|Medication Prohibited by Protocol|0|||
16836278|NCT01449370|37779819|FG008|Overall Study|Medication Prohibited by Protocol|0|||
16836279|NCT01449370|37779820|FG009|Overall Study|Medication Prohibited by Protocol|0|||
16836280|NCT01449370|37779821|FG010|Overall Study|Medication Prohibited by Protocol|0|||
16836281|NCT01449370|37779822|FG011|Overall Study|Medication Prohibited by Protocol|0|||
16836282|NCT01449370|37779823|FG012|Overall Study|Medication Prohibited by Protocol|0|||
16836283|NCT01449370|37779824|FG013|Overall Study|Medication Prohibited by Protocol|0|||
16836284|NCT01449370|37779825|FG014|Overall Study|Medication Prohibited by Protocol|0|||
16836285|NCT01449370|37779826|FG015|Overall Study|Medication Prohibited by Protocol|0|||
16912917|NCT01474512|38021801|FG007|Long-Term Extension Period|Death|0|||
16836286|NCT01449370|37779827|FG016|Overall Study|Medication Prohibited by Protocol|0|||
16836287|NCT01449370|37779828|FG017|Overall Study|Medication Prohibited by Protocol|0|||
16836288|NCT01449370|37779829|FG018|Overall Study|Medication Prohibited by Protocol|0|||
16836289|NCT01449370|37779830|FG019|Overall Study|Medication Prohibited by Protocol|0|||
16836290|NCT01449370|37779831|FG020|Overall Study|Medication Prohibited by Protocol|0|||
16836291|NCT01449370|37779832|FG021|Overall Study|Medication Prohibited by Protocol|0|||
16836292|NCT01449370|37779833|FG022|Overall Study|Medication Prohibited by Protocol|0|||
16836293|NCT01449370|37779834|FG023|Overall Study|Medication Prohibited by Protocol|1|||
16836294|NCT01449370|37779835|FG024|Overall Study|Medication Prohibited by Protocol|0|||
16836295|NCT01449370|37779811|FG000|Overall Study|Death|0|||
16836296|NCT01449370|37779812|FG001|Overall Study|Death|0|||
16836297|NCT01449370|37779813|FG002|Overall Study|Death|0|||
16836298|NCT01449370|37779814|FG003|Overall Study|Death|0|||
16836299|NCT01449370|37779815|FG004|Overall Study|Death|0|||
16836300|NCT01449370|37779816|FG005|Overall Study|Death|0|||
16836301|NCT01449370|37779817|FG006|Overall Study|Death|0|||
16836302|NCT01449370|37779818|FG007|Overall Study|Death|0|||
16836303|NCT01449370|37779819|FG008|Overall Study|Death|0|||
16836304|NCT01449370|37779820|FG009|Overall Study|Death|0|||
16836305|NCT01449370|37779821|FG010|Overall Study|Death|0|||
16836306|NCT01449370|37779822|FG011|Overall Study|Death|0|||
16836307|NCT01449370|37779823|FG012|Overall Study|Death|0|||
16836308|NCT01449370|37779824|FG013|Overall Study|Death|0|||
16836309|NCT01449370|37779825|FG014|Overall Study|Death|0|||
16836310|NCT01449370|37779826|FG015|Overall Study|Death|0|||
16836311|NCT01449370|37779827|FG016|Overall Study|Death|0|||
16836312|NCT01449370|37779828|FG017|Overall Study|Death|0|||
16836313|NCT01449370|37779829|FG018|Overall Study|Death|0|||
16836314|NCT01449370|37779830|FG019|Overall Study|Death|0|||
16836315|NCT01449370|37779831|FG020|Overall Study|Death|0|||
16836316|NCT01449370|37779832|FG021|Overall Study|Death|0|||
16836317|NCT01449370|37779833|FG022|Overall Study|Death|0|||
16836318|NCT01449370|37779834|FG023|Overall Study|Death|0|||
16836319|NCT01449370|37779835|FG024|Overall Study|Death|1|||
16836320|NCT02067533|37779910|FG000|Overall Study|Lost to Follow-up|4|||
16836321|NCT02067533|37779911|FG001|Overall Study|Lost to Follow-up|2|||
16836322|NCT02066129|37779919|FG000|Overall Study|Lost to Follow-up|13|||
16836323|NCT02066129|37779920|FG001|Overall Study|Lost to Follow-up|12|||
16836324|NCT02066129|37779919|FG000|Overall Study|Withdrawal by Subject|7|||
16836325|NCT02066129|37779920|FG001|Overall Study|Withdrawal by Subject|10|||
16836326|NCT02066129|37779919|FG000|Overall Study|Lack of Efficacy|8|||
16836327|NCT02066129|37779920|FG001|Overall Study|Lack of Efficacy|10|||
16836328|NCT02066129|37779919|FG000|Overall Study|Physician Decision|1|||
16836329|NCT02066129|37779920|FG001|Overall Study|Physician Decision|1|||
16836330|NCT02066051|37779926|FG000|Overall Study|Subject developed active GVHD|1|||
16836331|NCT01980992|37779932|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
16836332|NCT01980992|37779933|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
16836333|NCT01980992|37779932|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
16836334|NCT01980992|37779933|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
16836335|NCT01980992|37779932|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
16836336|NCT01980992|37779933|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
16836337|NCT01980992|37779932|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
16836338|NCT01980992|37779933|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
16836339|NCT01980992|37779932|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
16836340|NCT01980992|37779933|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
16836341|NCT01980992|37779932|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
16836342|NCT01980992|37779933|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
16836343|NCT02065895|37779946|FG000|Overall Study|Protocol Violation|1|||
16836344|NCT02065895|37779947|FG001|Overall Study|Protocol Violation|0|||
16836345|NCT02065895|37779948|FG002|Overall Study|Protocol Violation|0|||
16836346|NCT02065895|37779949|FG003|Overall Study|Protocol Violation|1|||
16836347|NCT02065895|37779950|FG004|Overall Study|Protocol Violation|0|||
16836348|NCT02065895|37779951|FG005|Overall Study|Protocol Violation|0|||
16836349|NCT02065895|37779946|FG000|Overall Study|Scheduling conflicts|0|||
16836350|NCT02065895|37779947|FG001|Overall Study|Scheduling conflicts|1|||
16836351|NCT02065895|37779948|FG002|Overall Study|Scheduling conflicts|0|||
16836352|NCT02065895|37779949|FG003|Overall Study|Scheduling conflicts|0|||
16836353|NCT02065895|37779950|FG004|Overall Study|Scheduling conflicts|0|||
16836354|NCT02065895|37779951|FG005|Overall Study|Scheduling conflicts|0|||
16836355|NCT02106455|37779968|FG000|Overall Study|Case Report Form Uncollected|6|||
16836356|NCT02106455|37779968|FG000|Overall Study|Protocol Deviation|2|||
16836357|NCT02006654|37779974|FG000|Overall Study|Withdrawal before treatment|4|||
16836358|NCT02006654|37779975|FG001|Overall Study|Withdrawal before treatment|2|||
16836359|NCT02006654|37779974|FG000|Overall Study|Adverse Event|16|||
16836360|NCT02006654|37779975|FG001|Overall Study|Adverse Event|17|||
16836361|NCT02006654|37779974|FG000|Overall Study|Death|1|||
16836362|NCT02006654|37779975|FG001|Overall Study|Death|0|||
16836363|NCT02006654|37779974|FG000|Overall Study|Withdrawal by Subject|14|||
16836364|NCT02006654|37779975|FG001|Overall Study|Withdrawal by Subject|12|||
16836365|NCT02006654|37779974|FG000|Overall Study|Protocol Violation|5|||
16836366|NCT02006654|37779975|FG001|Overall Study|Protocol Violation|8|||
16836367|NCT02006654|37779974|FG000|Overall Study|Lost to Follow-up|1|||
16836368|NCT02006654|37779975|FG001|Overall Study|Lost to Follow-up|0|||
16836369|NCT02006654|37779974|FG000|Overall Study|patient's will|2|||
16836370|NCT02006654|37779975|FG001|Overall Study|patient's will|1|||
16836371|NCT02006654|37779974|FG000|Overall Study|insufficient compliance|1|||
16836372|NCT02006654|37779975|FG001|Overall Study|insufficient compliance|0|||
16836373|NCT02006654|37779974|FG000|Overall Study|worsening cognitive condition|0|||
16836374|NCT02006654|37779975|FG001|Overall Study|worsening cognitive condition|1|||
16836375|NCT02006654|37779974|FG000|Overall Study|faecal incontinence|0|||
16836376|NCT02006654|37779975|FG001|Overall Study|faecal incontinence|1|||
16836377|NCT02006654|37779974|FG000|Overall Study|mood disorder|0|||
16836378|NCT02006654|37779975|FG001|Overall Study|mood disorder|1|||
16836379|NCT02006654|37779974|FG000|Overall Study|disallowed medication|1|||
16836380|NCT02006654|37779975|FG001|Overall Study|disallowed medication|0|||
16836381|NCT02006654|37779974|FG000|Overall Study|moving out of state|0|||
16836382|NCT02006654|37779975|FG001|Overall Study|moving out of state|1|||
16836383|NCT01980056|37779985|FG000|Overall Study|Death|1|||
16836384|NCT01980056|37779986|FG001|Overall Study|Death|1|||
16836385|NCT01980056|37779987|FG002|Overall Study|Death|0|||
16836386|NCT02027558|37780001|FG000|Overall Study|Death|0|||
16836387|NCT02027558|37780002|FG001|Overall Study|Death|1|||
16836388|NCT02027558|37780001|FG000|Overall Study|Withdrawal by Subject|2|||
16836389|NCT02027558|37780002|FG001|Overall Study|Withdrawal by Subject|0|||
16836390|NCT02027558|37780001|FG000|Overall Study|Lost to Follow-up|4|||
16836391|NCT02027558|37780002|FG001|Overall Study|Lost to Follow-up|1|||
16836392|NCT02027558|37780001|FG000|Overall Study|Refused assessment|3|||
16836393|NCT02027558|37780002|FG001|Overall Study|Refused assessment|0|||
16836394|NCT02006576|37780013|FG000|Overall Study|Withdrawal by Subject|4|||
16836395|NCT02006576|37780014|FG001|Overall Study|Withdrawal by Subject|6|||
16836396|NCT02006576|37780015|FG002|Overall Study|Withdrawal by Subject|2|||
16836397|NCT02006576|37780013|FG000|Overall Study|Death|0|||
16836398|NCT02006576|37780014|FG001|Overall Study|Death|0|||
16836399|NCT02006576|37780015|FG002|Overall Study|Death|1|||
16836400|NCT02006576|37780013|FG000|Overall Study|Lost to Follow-up|1|||
16836401|NCT02006576|37780014|FG001|Overall Study|Lost to Follow-up|0|||
16836402|NCT02006576|37780015|FG002|Overall Study|Lost to Follow-up|1|||
16836403|NCT02006576|37780013|FG000|Overall Study|Screen Failure, too sick, other|13|||
16836404|NCT02006576|37780014|FG001|Overall Study|Screen Failure, too sick, other|1|||
16836405|NCT02006576|37780015|FG002|Overall Study|Screen Failure, too sick, other|13|||
16836406|NCT02027402|37780025|FG000|Overall Study|Withdrawal by Subject|4|||
16836407|NCT02027402|37780026|FG001|Overall Study|Withdrawal by Subject|1|||
16836408|NCT01448824|37780042|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16836409|NCT01448824|37780043|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16836410|NCT01448824|37780044|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16836411|NCT01448824|37780045|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16836412|NCT01448824|37780046|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16836413|NCT01448824|37780047|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16836414|NCT01448824|37780048|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
16836415|NCT01448824|37780049|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16836416|NCT01448824|37780042|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16836417|NCT01448824|37780043|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16836418|NCT01448824|37780044|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16836419|NCT01448824|37780045|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
16836420|NCT01448824|37780046|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
16836421|NCT01448824|37780047|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
16836422|NCT01448824|37780048|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16836423|NCT01448824|37780049|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16836424|NCT01448824|37780042|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16836425|NCT01448824|37780043|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16836426|NCT01448824|37780044|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16836427|NCT01448824|37780045|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16836428|NCT01448824|37780046|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16836429|NCT01448824|37780047|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
16836430|NCT01448824|37780048|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16836431|NCT01448824|37780049|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16836432|NCT01448824|37780042|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
16836433|NCT01448824|37780043|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
16836434|NCT01448824|37780044|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
16836435|NCT01448824|37780045|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
16912918|NCT01474512|38021802|FG008|Long-Term Extension Period|Death|0|||
16836436|NCT01448824|37780046|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
16836437|NCT01448824|37780047|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
16836438|NCT01448824|37780048|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
16836439|NCT01448824|37780049|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
16836440|NCT01448824|37780042|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16836441|NCT01448824|37780043|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16836442|NCT01448824|37780044|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16836443|NCT01448824|37780045|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16836444|NCT01448824|37780046|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16836445|NCT01448824|37780047|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16836446|NCT01448824|37780048|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16836447|NCT01448824|37780049|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
16836448|NCT01448824|37780042|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16836449|NCT01448824|37780043|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16836450|NCT01448824|37780044|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16836451|NCT01448824|37780045|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16836452|NCT01448824|37780046|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16836453|NCT01448824|37780047|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16836454|NCT01448824|37780048|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16836455|NCT01448824|37780049|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
16836456|NCT01448824|37780042|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16836457|NCT01448824|37780043|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16836458|NCT01448824|37780044|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16836459|NCT01448824|37780045|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16836460|NCT01448824|37780046|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16836461|NCT01448824|37780047|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16836462|NCT01448824|37780048|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16836463|NCT01448824|37780049|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
16836464|NCT01448824|37780042|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16836465|NCT01448824|37780043|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16912919|NCT01474512|38021803|FG009|Long-Term Extension Period|Death|0|||
16836466|NCT01448824|37780044|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16836467|NCT01448824|37780045|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16836468|NCT01448824|37780046|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16836469|NCT01448824|37780047|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16836470|NCT01448824|37780048|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16836471|NCT01448824|37780049|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
16836472|NCT02005562|37780079|FG000|Overall Study|Death|2|||
16836473|NCT02005562|37780080|FG001|Overall Study|Death|2|||
16836474|NCT02005562|37780079|FG000|Overall Study|Graft loss|7|||
16836475|NCT02005562|37780080|FG001|Overall Study|Graft loss|6|||
16836476|NCT02005562|37780079|FG000|Overall Study|Withdrawal by Subject|2|||
16836477|NCT02005562|37780080|FG001|Overall Study|Withdrawal by Subject|2|||
16836478|NCT02005562|37780079|FG000|Overall Study|No transplant|1|||
16836479|NCT02005562|37780080|FG001|Overall Study|No transplant|4|||
16836480|NCT02005562|37780079|FG000|Overall Study|Physician Decision|0|||
16836481|NCT02005562|37780080|FG001|Overall Study|Physician Decision|1|||
16836482|NCT01448044|37780088|FG000|Treatment Period|Adverse Event|4|||
16836483|NCT01448044|37780089|FG001|Treatment Period|Adverse Event|3|||
16836484|NCT01448044|37780088|FG000|Treatment Period|Lack of Efficacy|5|||
16836485|NCT01448044|37780089|FG001|Treatment Period|Lack of Efficacy|12|||
16836486|NCT01448044|37780088|FG000|Treatment Period|Subject requested discontinue study drug|1|||
16836487|NCT01448044|37780089|FG001|Treatment Period|Subject requested discontinue study drug|0|||
16836488|NCT01448044|37780088|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
16836489|NCT01448044|37780089|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
16836490|NCT01448044|37780088|FG000|Treatment Period|Participant does not meet study criteria|1|||
16836491|NCT01448044|37780089|FG001|Treatment Period|Participant does not meet study criteria|0|||
16836492|NCT01448044|37780088|FG000|Treatment Period|Lost to Follow-up|2|||
16836493|NCT01448044|37780089|FG001|Treatment Period|Lost to Follow-up|1|||
16836494|NCT01448044|37780088|FG000|Treatment Period|Other reason|2|||
16836495|NCT01448044|37780089|FG001|Treatment Period|Other reason|0|||
16836496|NCT01448044|37780088|FG000|Follow Up Period|Withdrawal by Subject|1|||
16836497|NCT01448044|37780089|FG001|Follow Up Period|Withdrawal by Subject|1|||
16836498|NCT01448044|37780088|FG000|Follow Up Period|Lost to Follow-up|6|||
16836499|NCT01448044|37780089|FG001|Follow Up Period|Lost to Follow-up|2|||
16912920|NCT01474512|38021804|FG010|Long-Term Extension Period|Death|0|||
16836500|NCT01448044|37780088|FG000|Follow Up Period|Other|5|||
16836501|NCT01448044|37780089|FG001|Follow Up Period|Other|11|||
16836502|NCT02025530|37780097|FG000|Overall Study|No longer met elligibility criteria|5|||
16836503|NCT02025530|37780098|FG001|Overall Study|No longer met elligibility criteria|1|||
16912921|NCT01474512|38021805|FG011|Long-Term Extension Period|Death|0|||
16836504|NCT01472380|37780104|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
16836505|NCT01472380|37780104|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
16836506|NCT01978262|37780111|FG000|Overall Study|Withdrawal by Subject|9|||
16836507|NCT01978262|37780111|FG000|Overall Study|Lost to Follow-up|2|||
16836508|NCT01447576|37780116|FG000|Overall Study|Lost to Follow-up|52|||
16836509|NCT01447576|37780116|FG000|Overall Study|Adverse Event|127|||
16836510|NCT01447576|37780116|FG000|Overall Study|Participant met withdrawal criteria|40|||
16836511|NCT01447576|37780116|FG000|Overall Study|Withdrawal by Subject|100|||
16836512|NCT01447576|37780116|FG000|Overall Study|Protocol deviation|83|||
16836513|NCT01447576|37780116|FG000|Overall Study|Lack of Efficacy|68|||
16836514|NCT01447576|37780116|FG000|Overall Study|Physician Decision|6|||
16836515|NCT01447420|37780123|FG000|Overall Study|Adverse Event|2|||
16836516|NCT01447420|37780124|FG001|Overall Study|Adverse Event|4|||
16836517|NCT01447420|37780125|FG002|Overall Study|Adverse Event|2|||
16836518|NCT01447420|37780123|FG000|Overall Study|Protocol Violation|3|||
16836519|NCT01447420|37780124|FG001|Overall Study|Protocol Violation|3|||
16836520|NCT01447420|37780125|FG002|Overall Study|Protocol Violation|0|||
16836521|NCT01447420|37780123|FG000|Overall Study|Withdrawal by Subject|4|||
16836522|NCT01447420|37780124|FG001|Overall Study|Withdrawal by Subject|1|||
16836523|NCT01447420|37780125|FG002|Overall Study|Withdrawal by Subject|0|||
16836524|NCT01447420|37780123|FG000|Overall Study|Lack of Efficacy|1|||
16836525|NCT01447420|37780124|FG001|Overall Study|Lack of Efficacy|19|||
16836526|NCT01447420|37780125|FG002|Overall Study|Lack of Efficacy|8|||
16836527|NCT01471522|37780134|FG000|Overall Study|Withdrawal by Subject|28|||
16836528|NCT01471522|37780135|FG001|Overall Study|Withdrawal by Subject|22|||
16836529|NCT01471522|37780134|FG000|Overall Study|Lost to Follow-up|36|||
16836530|NCT01471522|37780135|FG001|Overall Study|Lost to Follow-up|26|||
16836531|NCT01446874|37780145|FG000|Overall Study|Not eligible|1|||
16836532|NCT01446874|37780146|FG001|Overall Study|Not eligible|0|||
16912922|NCT01474512|38021806|FG012|Long-Term Extension Period|Death|9|||
16912923|NCT01474512|38021807|FG013|Long-Term Extension Period|Death|9|||
16912924|NCT01474512|38021808|FG014|Long-Term Extension Period|Death|0|||
16912925|NCT01474512|38021809|FG015|Long-Term Extension Period|Death|0|||
16912926|NCT01474512|38021810|FG016|Long-Term Extension Period|Death|0|||
16912927|NCT01474512|38021811|FG017|Long-Term Extension Period|Death|0|||
16912928|NCT01474512|38021794|FG000|Long-Term Extension Period|Sponsor Decision|0|||
16912929|NCT01474512|38021795|FG001|Long-Term Extension Period|Sponsor Decision|0|||
16912930|NCT01474512|38021796|FG002|Long-Term Extension Period|Sponsor Decision|0|||
16912931|NCT01474512|38021797|FG003|Long-Term Extension Period|Sponsor Decision|0|||
16912932|NCT01474512|38021798|FG004|Long-Term Extension Period|Sponsor Decision|0|||
16912933|NCT01474512|38021799|FG005|Long-Term Extension Period|Sponsor Decision|0|||
16912934|NCT01474512|38021800|FG006|Long-Term Extension Period|Sponsor Decision|0|||
16912935|NCT01474512|38021801|FG007|Long-Term Extension Period|Sponsor Decision|0|||
16912936|NCT01474512|38021802|FG008|Long-Term Extension Period|Sponsor Decision|0|||
16836533|NCT01446874|37780147|FG002|Overall Study|Not eligible|0|||
16836534|NCT01446874|37780145|FG000|Overall Study|No surgery/No qualifying surgery|1|||
16836535|NCT01446874|37780146|FG001|Overall Study|No surgery/No qualifying surgery|0|||
16836536|NCT01446874|37780147|FG002|Overall Study|No surgery/No qualifying surgery|12|||
16836537|NCT01446874|37780145|FG000|Overall Study|Non-compliance|0|||
16836538|NCT01446874|37780146|FG001|Overall Study|Non-compliance|4|||
16836539|NCT01446874|37780147|FG002|Overall Study|Non-compliance|0|||
16836540|NCT01446874|37780145|FG000|Overall Study|Antibiotics for pre-op infection|0|||
16836541|NCT01446874|37780146|FG001|Overall Study|Antibiotics for pre-op infection|0|||
16836542|NCT01446874|37780147|FG002|Overall Study|Antibiotics for pre-op infection|2|||
16836543|NCT01446874|37780145|FG000|Overall Study|Withdrawal by Subject|0|||
16836544|NCT01446874|37780146|FG001|Overall Study|Withdrawal by Subject|0|||
16836545|NCT01446874|37780147|FG002|Overall Study|Withdrawal by Subject|4|||
16836546|NCT01446796|37780155|FG000|Overall Study|Withdrawal by Subject|1|||
16836547|NCT01446796|37780156|FG001|Overall Study|Withdrawal by Subject|0|||
16912937|NCT01474512|38021803|FG009|Long-Term Extension Period|Sponsor Decision|0|||
16912938|NCT01474512|38021804|FG010|Long-Term Extension Period|Sponsor Decision|0|||
16912939|NCT01474512|38021805|FG011|Long-Term Extension Period|Sponsor Decision|0|||
16912940|NCT01474512|38021806|FG012|Long-Term Extension Period|Sponsor Decision|6|||
16912941|NCT01474512|38021807|FG013|Long-Term Extension Period|Sponsor Decision|6|||
16912942|NCT01474512|38021808|FG014|Long-Term Extension Period|Sponsor Decision|0|||
16912943|NCT01474512|38021809|FG015|Long-Term Extension Period|Sponsor Decision|0|||
16836548|NCT01439074|37780166|FG000|Overall Study|Lost to Follow-up|3|||
16836549|NCT01439074|37780167|FG001|Overall Study|Lost to Follow-up|4|||
16836550|NCT01439074|37780166|FG000|Overall Study|Subject shedding|1|||
16836551|NCT01439074|37780167|FG001|Overall Study|Subject shedding|0|||
16836552|NCT01439074|37780166|FG000|Overall Study|Withdrawal by Subject|1|||
16836553|NCT01439074|37780167|FG001|Overall Study|Withdrawal by Subject|5|||
16836554|NCT01439074|37780166|FG000|Overall Study|Other|4|||
16836555|NCT01439074|37780167|FG001|Overall Study|Other|4|||
16836556|NCT01438996|37780176|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
16836557|NCT01438996|37780177|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
16912944|NCT01474512|38021810|FG016|Long-Term Extension Period|Sponsor Decision|0|||
16912945|NCT01474512|38021811|FG017|Long-Term Extension Period|Sponsor Decision|0|||
16912946|NCT01474512|38021794|FG000|Long-Term Extension Period|Protocol Violation|0|||
16912947|NCT01474512|38021795|FG001|Long-Term Extension Period|Protocol Violation|0|||
16912948|NCT01474512|38021796|FG002|Long-Term Extension Period|Protocol Violation|0|||
16912949|NCT01474512|38021797|FG003|Long-Term Extension Period|Protocol Violation|0|||
16912950|NCT01474512|38021798|FG004|Long-Term Extension Period|Protocol Violation|0|||
16836558|NCT01438996|37780178|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
16836559|NCT01438840|37780188|FG000|Core Study|Adverse Event|0|||
16836560|NCT01438840|37780189|FG001|Core Study|Adverse Event|3|||
16836561|NCT01438840|37780190|FG002|Core Study|Adverse Event|0|||
16836562|NCT01438840|37780188|FG000|Core Study|Lack of Efficacy|15|||
16836563|NCT01438840|37780189|FG001|Core Study|Lack of Efficacy|7|||
16836564|NCT01438840|37780190|FG002|Core Study|Lack of Efficacy|0|||
16836565|NCT01438840|37780188|FG000|Core Study|Withdrawal of consent|1|||
16836566|NCT01438840|37780189|FG001|Core Study|Withdrawal of consent|0|||
16836567|NCT01438840|37780190|FG002|Core Study|Withdrawal of consent|0|||
16836568|NCT01438840|37780188|FG000|Extension Phase|Adverse Event|0|||
16836569|NCT01438840|37780189|FG001|Extension Phase|Adverse Event|0|||
16836570|NCT01438840|37780190|FG002|Extension Phase|Adverse Event|3|||
16836571|NCT01438840|37780188|FG000|Extension Phase|Lost to Follow-up|0|||
16836572|NCT01438840|37780189|FG001|Extension Phase|Lost to Follow-up|0|||
16836573|NCT01438840|37780190|FG002|Extension Phase|Lost to Follow-up|1|||
16836574|NCT01438840|37780188|FG000|Extension Phase|Withdrawal by Subject|0|||
16836575|NCT01438840|37780189|FG001|Extension Phase|Withdrawal by Subject|0|||
16836576|NCT01438840|37780190|FG002|Extension Phase|Withdrawal by Subject|3|||
16836577|NCT01438840|37780188|FG000|Extension Phase|Lack of Efficacy|0|||
16836578|NCT01438840|37780189|FG001|Extension Phase|Lack of Efficacy|0|||
16912951|NCT01474512|38021799|FG005|Long-Term Extension Period|Protocol Violation|0|||
16912952|NCT01474512|38021800|FG006|Long-Term Extension Period|Protocol Violation|0|||
16912953|NCT01474512|38021801|FG007|Long-Term Extension Period|Protocol Violation|0|||
16912954|NCT01474512|38021802|FG008|Long-Term Extension Period|Protocol Violation|0|||
16912955|NCT01474512|38021803|FG009|Long-Term Extension Period|Protocol Violation|0|||
16912956|NCT01474512|38021804|FG010|Long-Term Extension Period|Protocol Violation|0|||
16836579|NCT01438840|37780190|FG002|Extension Phase|Lack of Efficacy|2|||
16836580|NCT01438840|37780188|FG000|Extension Phase|Other|0|||
16836581|NCT01438840|37780189|FG001|Extension Phase|Other|0|||
16836582|NCT01438840|37780190|FG002|Extension Phase|Other|1|||
16836583|NCT01471054|37780199|FG000|Overall Study|Study terminated prematurely|4|||
16836584|NCT01471054|37780200|FG001|Overall Study|Study terminated prematurely|0|||
16836585|NCT01978184|37780218|FG000|Overall Study|Progressive disease|5|||
16836586|NCT01978184|37780219|FG001|Overall Study|Progressive disease|5|||
16836587|NCT01978184|37780218|FG000|Overall Study|Other than PDA|2|||
16836588|NCT01978184|37780219|FG001|Overall Study|Other than PDA|2|||
16836589|NCT01978184|37780218|FG000|Overall Study|Physician Decision|0|||
16836590|NCT01978184|37780219|FG001|Overall Study|Physician Decision|3|||
16836591|NCT01978184|37780218|FG000|Overall Study|Noncompliance|1|||
16836592|NCT01978184|37780219|FG001|Overall Study|Noncompliance|2|||
16836593|NCT01978184|37780218|FG000|Overall Study|Death|1|||
16836594|NCT01978184|37780219|FG001|Overall Study|Death|0|||
16836595|NCT01978184|37780218|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
16836596|NCT01978184|37780219|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
16836597|NCT01445548|37780225|FG000|Overall Study|Adverse Event|1|||
16836598|NCT01977794|37780231|FG000|Overall Study|Adverse Event|2|||
16836599|NCT01977794|37780232|FG001|Overall Study|Adverse Event|2|||
16836600|NCT01977794|37780231|FG000|Overall Study|Lost to Follow-up|2|||
16836601|NCT01977794|37780232|FG001|Overall Study|Lost to Follow-up|1|||
16836602|NCT01977794|37780231|FG000|Overall Study|Protocol Violation|1|||
16836603|NCT01977794|37780232|FG001|Overall Study|Protocol Violation|0|||
16836604|NCT01977794|37780231|FG000|Overall Study|Death|1|||
16836605|NCT01977794|37780232|FG001|Overall Study|Death|1|||
16836606|NCT01977794|37780231|FG000|Overall Study|Withdrew consent|2|||
16836607|NCT01977794|37780232|FG001|Overall Study|Withdrew consent|1|||
16836608|NCT01977794|37780231|FG000|Overall Study|Other|0|||
16836609|NCT01977794|37780232|FG001|Overall Study|Other|1|||
16836610|NCT02005484|37780238|FG000|Overall Study|Death|1|||
16836611|NCT02005484|37780238|FG000|Overall Study|Disease progression|1|||
16836612|NCT02005484|37780238|FG000|Overall Study|Changed to a Different Study|1|||
16836613|NCT02005484|37780238|FG000|Overall Study|Sponsor decision|1|||
16836614|NCT02005250|37780244|FG000|Overall Study|Lost to Follow-up|15|||
16836615|NCT02005250|37780245|FG001|Overall Study|Lost to Follow-up|5|||
16836616|NCT02024750|37780253|FG000|Overall Study|Withdrawal by Subject|2|||
16836617|NCT02024750|37780254|FG001|Overall Study|Withdrawal by Subject|1|||
16836618|NCT01597973|37780262|FG000|Overall Study|Found ineligible before study medication started|4|||
16836619|NCT01597973|37780263|FG001|Overall Study|Found ineligible before study medication started|2|||
16836620|NCT01597973|37780262|FG000|Overall Study|Eligible pathogen not confirmed|14|||
16836621|NCT01597973|37780263|FG001|Overall Study|Eligible pathogen not confirmed|15|||
16836622|NCT01597973|37780262|FG000|Overall Study|LAR not authorized to consent|0|||
16836623|NCT01597973|37780263|FG001|Overall Study|LAR not authorized to consent|1|||
16836624|NCT01597973|37780262|FG000|Overall Study|Ineligible due to early seizures|1|||
16836625|NCT01597973|37780263|FG001|Overall Study|Ineligible due to early seizures|0|||
16836626|NCT01597973|37780262|FG000|Overall Study|Ineligible due to non-target infection|1|||
16836627|NCT01597973|37780263|FG001|Overall Study|Ineligible due to non-target infection|1|||
16836628|NCT02023268|37780273|FG000|Overall Study|Lack of Efficacy|0|||
16836629|NCT02023268|37780274|FG001|Overall Study|Lack of Efficacy|1|||
16836630|NCT02023268|37780273|FG000|Overall Study|Adverse Event|0|||
16836631|NCT02023268|37780274|FG001|Overall Study|Adverse Event|2|||
16836632|NCT02023268|37780273|FG000|Overall Study|Withdrawal by Subject|0|||
16912957|NCT01474512|38021805|FG011|Long-Term Extension Period|Protocol Violation|0|||
16912958|NCT01474512|38021806|FG012|Long-Term Extension Period|Protocol Violation|5|||
16912959|NCT01474512|38021807|FG013|Long-Term Extension Period|Protocol Violation|5|||
16912960|NCT01474512|38021808|FG014|Long-Term Extension Period|Protocol Violation|0|||
16912961|NCT01474512|38021809|FG015|Long-Term Extension Period|Protocol Violation|0|||
16912962|NCT01474512|38021810|FG016|Long-Term Extension Period|Protocol Violation|0|||
16912963|NCT01474512|38021811|FG017|Long-Term Extension Period|Protocol Violation|0|||
16912964|NCT01474512|38021794|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912965|NCT01474512|38021795|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912966|NCT01474512|38021796|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912967|NCT01474512|38021797|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912968|NCT01474512|38021798|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912969|NCT01474512|38021799|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912970|NCT01474512|38021800|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912971|NCT01474512|38021801|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912972|NCT01474512|38021802|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912973|NCT01474512|38021803|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912974|NCT01474512|38021804|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912975|NCT01474512|38021805|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912976|NCT01474512|38021806|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
16912977|NCT01474512|38021807|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
16912978|NCT01474512|38021808|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912979|NCT01474512|38021809|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912980|NCT01474512|38021810|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912981|NCT01474512|38021811|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16912982|NCT01474512|38021794|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912983|NCT01474512|38021795|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912984|NCT01474512|38021796|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912985|NCT01474512|38021797|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912986|NCT01474512|38021798|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912987|NCT01474512|38021799|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912988|NCT01474512|38021800|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912989|NCT01474512|38021801|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912990|NCT01474512|38021802|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912991|NCT01474512|38021803|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912992|NCT01474512|38021804|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912993|NCT01474512|38021805|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
16912994|NCT01474512|38021806|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912995|NCT01474512|38021807|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912996|NCT01474512|38021808|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912997|NCT01474512|38021809|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912998|NCT01474512|38021810|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16912999|NCT01474512|38021811|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16913000|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
16913001|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
16913002|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
16913003|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
16836633|NCT02023268|37780274|FG001|Overall Study|Withdrawal by Subject|1|||
16836634|NCT02047253|37780280|FG000|Overall Study|Lost to Follow-up|8|||
16836635|NCT02096705|37780286|FG000|Treatment|Adverse Event|6|||
16836636|NCT02096705|37780287|FG001|Treatment|Adverse Event|3|||
16836637|NCT02096705|37780286|FG000|Treatment|Subject request to discontinue treatment|1|||
16836638|NCT02096705|37780287|FG001|Treatment|Subject request to discontinue treatment|1|||
16836639|NCT02096705|37780286|FG000|Treatment|Withdrawal by Subject|1|||
16836640|NCT02096705|37780287|FG001|Treatment|Withdrawal by Subject|0|||
16836641|NCT02096705|37780286|FG000|Treatment|Other|1|||
16836642|NCT02096705|37780287|FG001|Treatment|Other|1|||
16836643|NCT02096705|37780286|FG000|Follow-up|Withdrawal by Subject|1|||
16836644|NCT02096705|37780287|FG001|Follow-up|Withdrawal by Subject|0|||
16836645|NCT02096705|37780286|FG000|Follow-up|Adverse Event|2|||
16836646|NCT02096705|37780287|FG001|Follow-up|Adverse Event|2|||
16836647|NCT02096705|37780286|FG000|Follow-up|Subjects not reporting status|1|||
16836648|NCT02096705|37780287|FG001|Follow-up|Subjects not reporting status|2|||
16836649|NCT02096471|37780293|FG000|Overall Study|Adverse Event|1|||
16836650|NCT02096471|37780293|FG000|Overall Study|Lack of Efficacy|7|||
16836651|NCT02096471|37780293|FG000|Overall Study|Withdrawal by Subject|3|||
16836652|NCT02096471|37780293|FG000|Overall Study|Non-Compliant|2|||
16836653|NCT02096003|37780299|FG000|Overall Study|Protocol Violation|0|||
16836654|NCT02096003|37780300|FG001|Overall Study|Protocol Violation|2|||
16836655|NCT02096003|37780299|FG000|Overall Study|additional surgery|2|||
16836656|NCT02096003|37780300|FG001|Overall Study|additional surgery|1|||
16836657|NCT02062385|37780310|FG000|Overall Study|Adverse Event|19|||
16836658|NCT02062385|37780311|FG001|Overall Study|Adverse Event|13|||
16836659|NCT02062385|37780312|FG002|Overall Study|Adverse Event|1|||
16836660|NCT02062385|37780313|FG003|Overall Study|Adverse Event|0|||
16836661|NCT02062385|37780310|FG000|Overall Study|Protocol Violation|1|||
16836662|NCT02062385|37780311|FG001|Overall Study|Protocol Violation|0|||
16836663|NCT02062385|37780312|FG002|Overall Study|Protocol Violation|0|||
16836664|NCT02062385|37780313|FG003|Overall Study|Protocol Violation|0|||
16836665|NCT02062385|37780310|FG000|Overall Study|Incomplete EPI by database lock|2|||
16836666|NCT02062385|37780311|FG001|Overall Study|Incomplete EPI by database lock|0|||
16836667|NCT02062385|37780312|FG002|Overall Study|Incomplete EPI by database lock|0|||
16836668|NCT02062385|37780313|FG003|Overall Study|Incomplete EPI by database lock|0|||
16836669|NCT02062385|37780310|FG000|Overall Study|Moved|10|||
16836670|NCT02062385|37780311|FG001|Overall Study|Moved|11|||
16836671|NCT02062385|37780312|FG002|Overall Study|Moved|1|||
16836672|NCT02062385|37780313|FG003|Overall Study|Moved|0|||
16836673|NCT02062385|37780310|FG000|Overall Study|Withdrawn by parent/guardian|46|||
16836674|NCT02062385|37780311|FG001|Overall Study|Withdrawn by parent/guardian|41|||
16836675|NCT02062385|37780312|FG002|Overall Study|Withdrawn by parent/guardian|9|||
16836676|NCT02062385|37780313|FG003|Overall Study|Withdrawn by parent/guardian|8|||
16836677|NCT02062385|37780310|FG000|Overall Study|Death|0|||
16836678|NCT02062385|37780311|FG001|Overall Study|Death|0|||
16836679|NCT02062385|37780312|FG002|Overall Study|Death|0|||
16913004|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
16913005|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
16913006|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
16913007|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
16913008|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
16913009|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
16913010|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
16913011|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
16913012|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
16913013|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
16913014|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
16913015|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
16913016|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
16913017|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
16913018|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913019|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913020|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913021|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913022|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913023|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913024|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913025|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913026|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913027|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913028|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913029|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913030|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913031|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16913032|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
16913033|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
16913034|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
16913035|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
16913036|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913037|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913038|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16836680|NCT02062385|37780313|FG003|Overall Study|Death|1|||
16836681|NCT02062385|37780310|FG000|Overall Study|Lost to Follow-up|0|||
16836682|NCT02062385|37780311|FG001|Overall Study|Lost to Follow-up|0|||
16836683|NCT02062385|37780312|FG002|Overall Study|Lost to Follow-up|1|||
16836684|NCT02062385|37780313|FG003|Overall Study|Lost to Follow-up|0|||
16836685|NCT02062151|37780321|FG000|Overall Study|screen failure|1|||
16836686|NCT02060903|37780327|FG000|Overall Study|Lost to Follow-up|4|||
16836687|NCT02060903|37780328|FG001|Overall Study|Lost to Follow-up|0|||
16836688|NCT02060903|37780327|FG000|Overall Study|Withdrawal by Subject|0|||
16836689|NCT02060903|37780328|FG001|Overall Study|Withdrawal by Subject|7|||
16836690|NCT02095691|37780334|FG000|Overall Study|Physician Decision|1|||
16836691|NCT02095535|37780350|FG000|Recruitment|Protocol Violation|2|||
16836692|NCT02095223|37780356|FG000|Overall Study|Withdrawal by Subject|1|||
16836693|NCT02095223|37780357|FG001|Overall Study|Withdrawal by Subject|0|||
16836694|NCT02095145|37780365|FG000|Overall Study|Withdrawal by Subject|1|||
16836695|NCT02095145|37780366|FG001|Overall Study|Withdrawal by Subject|0|||
16836696|NCT02059187|37780376|FG000|Overall Study|Adverse Event|0|||
16836697|NCT02059187|37780377|FG001|Overall Study|Adverse Event|3|||
16836698|NCT02059187|37780376|FG000|Overall Study|Death|1|||
16836699|NCT02059187|37780377|FG001|Overall Study|Death|1|||
16836700|NCT02059187|37780376|FG000|Overall Study|Lost to Follow-up|9|||
16913039|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913040|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913041|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913042|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913043|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913044|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16836701|NCT02059187|37780377|FG001|Overall Study|Lost to Follow-up|8|||
16836702|NCT02059187|37780376|FG000|Overall Study|Non-compliance with study drug|1|||
16836703|NCT02059187|37780377|FG001|Overall Study|Non-compliance with study drug|0|||
16836704|NCT02059187|37780376|FG000|Overall Study|Physician Decision|1|||
16836705|NCT02059187|37780377|FG001|Overall Study|Physician Decision|2|||
16836706|NCT02059187|37780376|FG000|Overall Study|Protocol Violation|1|||
16836707|NCT02059187|37780377|FG001|Overall Study|Protocol Violation|0|||
16836708|NCT02059187|37780376|FG000|Overall Study|Withdrawal by Subject|12|||
16913045|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913046|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913047|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913048|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913049|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16913050|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
16913051|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
16913052|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
16836709|NCT02059187|37780377|FG001|Overall Study|Withdrawal by Subject|8|||
16836710|NCT02043899|37780383|FG000|Overall Study|Adverse Event|3|||
16836711|NCT02043899|37780383|FG000|Overall Study|Physician Decision|1|||
16836712|NCT02043899|37780383|FG000|Overall Study|Withdrawal by Subject|2|||
16836713|NCT02043899|37780383|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
16836714|NCT02043899|37780383|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
16836715|NCT02043899|37780383|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
16836716|NCT02043899|37780383|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
16836717|NCT02043899|37780383|FG000|Overall Study|Treatment delayed|1|||
16836718|NCT02043509|37780389|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
16836719|NCT02043509|37780390|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
16836720|NCT02043509|37780389|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
16836721|NCT02043509|37780390|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
16836722|NCT02043509|37780389|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
16836723|NCT02043509|37780390|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
16836724|NCT02043509|37780389|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
16836725|NCT02043509|37780390|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
16836726|NCT02058563|37780398|FG000|Overall Study|Lost to Follow-up|26|||
16836727|NCT02058563|37780399|FG001|Overall Study|Lost to Follow-up|22|||
16836728|NCT02058563|37780398|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
16836729|NCT02058563|37780399|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
16836730|NCT02058563|37780398|FG000|Overall Study|Consent Withdrawal|1|||
16836731|NCT02058563|37780399|FG001|Overall Study|Consent Withdrawal|1|||
16836732|NCT02058563|37780398|FG000|Overall Study|Other (patient incarcerated)|0|||
16836733|NCT02058563|37780399|FG001|Overall Study|Other (patient incarcerated)|1|||
16836734|NCT01622231|37780405|FG000|Overall Study|Physician Decision|1|||
16836735|NCT01622231|37780405|FG000|Overall Study|Withdrawal by Subject|1|||
16836736|NCT02042183|37780411|FG000|Overall Study|Physician Decision|7|||
16836737|NCT02042183|37780412|FG001|Overall Study|Physician Decision|2|||
16836738|NCT02042183|37780411|FG000|Overall Study|Lack of Efficacy|4|||
16836739|NCT02042183|37780412|FG001|Overall Study|Lack of Efficacy|3|||
16836740|NCT02042183|37780411|FG000|Overall Study|Non-compliance with Study Drug|2|||
16836741|NCT02042183|37780412|FG001|Overall Study|Non-compliance with Study Drug|3|||
16836742|NCT02042183|37780411|FG000|Overall Study|Adverse Event|17|||
16836743|NCT02042183|37780412|FG001|Overall Study|Adverse Event|6|||
16836744|NCT02042183|37780411|FG000|Overall Study|Other|3|||
16836745|NCT02042183|37780412|FG001|Overall Study|Other|3|||
16836746|NCT02042183|37780411|FG000|Overall Study|Withdrawal by Subject|21|||
16836747|NCT02042183|37780412|FG001|Overall Study|Withdrawal by Subject|16|||
16836748|NCT02042183|37780411|FG000|Overall Study|Site Terminated by Sponsor|2|||
16836749|NCT02042183|37780412|FG001|Overall Study|Site Terminated by Sponsor|1|||
16836750|NCT02042183|37780411|FG000|Overall Study|Lost to Follow-up|9|||
16836751|NCT02042183|37780412|FG001|Overall Study|Lost to Follow-up|2|||
16836752|NCT01977482|37780426|FG000|Overall Study|Adverse Event|0|||
16836753|NCT01977482|37780427|FG001|Overall Study|Adverse Event|1|||
16836754|NCT01977482|37780428|FG002|Overall Study|Adverse Event|1|||
16836755|NCT01977482|37780429|FG003|Overall Study|Adverse Event|0|||
16836756|NCT01977482|37780430|FG004|Overall Study|Adverse Event|2|||
16836757|NCT01977482|37780431|FG005|Overall Study|Adverse Event|0|||
16836758|NCT01977482|37780426|FG000|Overall Study|Lost to Follow-up|1|||
16836759|NCT01977482|37780427|FG001|Overall Study|Lost to Follow-up|0|||
16836760|NCT01977482|37780428|FG002|Overall Study|Lost to Follow-up|0|||
16836761|NCT01977482|37780429|FG003|Overall Study|Lost to Follow-up|0|||
16836762|NCT01977482|37780430|FG004|Overall Study|Lost to Follow-up|0|||
16836763|NCT01977482|37780431|FG005|Overall Study|Lost to Follow-up|0|||
16836764|NCT01977482|37780426|FG000|Overall Study|Physician Decision|0|||
16836765|NCT01977482|37780427|FG001|Overall Study|Physician Decision|1|||
16836766|NCT01977482|37780428|FG002|Overall Study|Physician Decision|0|||
16836767|NCT01977482|37780429|FG003|Overall Study|Physician Decision|0|||
16836768|NCT01977482|37780430|FG004|Overall Study|Physician Decision|0|||
16836769|NCT01977482|37780431|FG005|Overall Study|Physician Decision|0|||
16836770|NCT01977482|37780426|FG000|Overall Study|Protocol Violation|0|||
16836771|NCT01977482|37780427|FG001|Overall Study|Protocol Violation|0|||
16836772|NCT01977482|37780428|FG002|Overall Study|Protocol Violation|1|||
16836773|NCT01977482|37780429|FG003|Overall Study|Protocol Violation|0|||
16836774|NCT01977482|37780430|FG004|Overall Study|Protocol Violation|0|||
16836775|NCT01977482|37780431|FG005|Overall Study|Protocol Violation|0|||
16836776|NCT01977482|37780426|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
16836777|NCT01977482|37780427|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
16836778|NCT01977482|37780428|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
16836779|NCT01977482|37780429|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
16836780|NCT01977482|37780430|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
16836781|NCT01977482|37780431|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
16836782|NCT01977482|37780426|FG000|Overall Study|Withdrawal by Subject|2|||
16836783|NCT01977482|37780427|FG001|Overall Study|Withdrawal by Subject|4|||
16836784|NCT01977482|37780428|FG002|Overall Study|Withdrawal by Subject|1|||
16836785|NCT01977482|37780429|FG003|Overall Study|Withdrawal by Subject|3|||
16836786|NCT01977482|37780430|FG004|Overall Study|Withdrawal by Subject|1|||
16836787|NCT01977482|37780431|FG005|Overall Study|Withdrawal by Subject|5|||
16836788|NCT02058095|37780452|FG000|Overall Study|Adverse Event|1|||
16836789|NCT02058095|37780453|FG001|Overall Study|Adverse Event|0|||
16836790|NCT02023112|37780461|FG000|Overall Study|Withdrawal by Subject|2|||
16913053|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
16913054|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913055|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913056|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913057|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913058|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913059|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913060|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913061|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913062|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913063|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913064|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913065|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913066|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913067|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913068|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913069|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16913070|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
16913071|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
16913072|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
16836791|NCT02023112|37780462|FG001|Overall Study|Withdrawal by Subject|1|||
16836792|NCT01977092|37780472|FG000|Overall Study|Death|3|||
16836793|NCT01977092|37780473|FG001|Overall Study|Death|4|||
16836794|NCT01977092|37780472|FG000|Overall Study|Lost to Follow-up|23|||
16836795|NCT01977092|37780473|FG001|Overall Study|Lost to Follow-up|14|||
16836796|NCT01977092|37780472|FG000|Overall Study|Withdrawal by Subject|2|||
16836797|NCT01977092|37780473|FG001|Overall Study|Withdrawal by Subject|1|||
16913073|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
16913074|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
16913075|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
16913076|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
16913077|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
16913078|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
16913079|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
16913080|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
16913081|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
16913082|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
16913083|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
16913084|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
16913085|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
16913086|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
16913087|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
16913088|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
16913089|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
16913090|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913091|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913092|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913093|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913094|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913095|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913096|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913097|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913098|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913099|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913100|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913101|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913102|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913103|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913104|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913105|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
16913106|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
16913107|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
16913108|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
16836798|NCT01977092|37780472|FG000|Overall Study|In prison|3|||
16836799|NCT01977092|37780473|FG001|Overall Study|In prison|11|||
16836800|NCT02004236|37780482|FG000|Overall Study|Lack of Efficacy|0|||
16836801|NCT02004236|37780483|FG001|Overall Study|Lack of Efficacy|0|||
16836802|NCT02004236|37780484|FG002|Overall Study|Lack of Efficacy|16|||
16836803|NCT01976624|37780493|FG000|Overall Study|Participants contraindicated|2|||
16836804|NCT01976624|37780493|FG000|Overall Study|Participants age less than 19 years|12|||
16836805|NCT02041091|37780499|FG000|Treatment|Adverse Event|3|||
16836806|NCT02041091|37780500|FG001|Treatment|Adverse Event|3|||
16836807|NCT02041091|37780499|FG000|Treatment|Withdrawal by Subject|2|||
16836808|NCT02041091|37780500|FG001|Treatment|Withdrawal by Subject|4|||
16836809|NCT02041091|37780499|FG000|Treatment|Physician Decision|1|||
16836810|NCT02041091|37780500|FG001|Treatment|Physician Decision|0|||
16836811|NCT02041091|37780499|FG000|Treatment|Sponsor Decision|15|||
16836812|NCT02041091|37780500|FG001|Treatment|Sponsor Decision|16|||
16836813|NCT02041091|37780499|FG000|Treatment|Lost to Follow-up|1|||
16836814|NCT02041091|37780500|FG001|Treatment|Lost to Follow-up|0|||
16836815|NCT02041091|37780499|FG000|Optional Safety Extension Period|Adverse Event|4|||
16836816|NCT02041091|37780500|FG001|Optional Safety Extension Period|Adverse Event|2|||
16836817|NCT02041091|37780499|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
16836818|NCT02041091|37780500|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
16836819|NCT02041091|37780499|FG000|Optional Safety Extension Period|Protocol Violation|2|||
16836820|NCT02041091|37780500|FG001|Optional Safety Extension Period|Protocol Violation|0|||
16836821|NCT02041091|37780499|FG000|Optional Safety Extension Period|Physician Decision|2|||
16836822|NCT02041091|37780500|FG001|Optional Safety Extension Period|Physician Decision|1|||
16836823|NCT02041091|37780499|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
16836824|NCT02041091|37780500|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
16836825|NCT02041091|37780499|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
16836826|NCT02041091|37780500|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
16836827|NCT02057549|37780514|FG000|Overall Study|Lost to Follow-up|1|||
16836828|NCT02057549|37780515|FG001|Overall Study|Lost to Follow-up|0|||
16836829|NCT02057549|37780514|FG000|Overall Study|Physician Decision|1|||
16836830|NCT02057549|37780515|FG001|Overall Study|Physician Decision|0|||
16836831|NCT02057549|37780514|FG000|Overall Study|Withdrawal by Subject|1|||
16836832|NCT02057549|37780515|FG001|Overall Study|Withdrawal by Subject|0|||
16836833|NCT02057393|37780521|FG000|Overall Study|Withdrawal by Subject|1|||
16836834|NCT02057393|37780521|FG000|Overall Study|Patient did not meet criteria|1|||
16836835|NCT02040779|37780528|FG000|Overall Study|Adverse Event|1|||
16913109|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
16836836|NCT02040779|37780529|FG001|Overall Study|Adverse Event|0|||
16836837|NCT02040779|37780530|FG002|Overall Study|Adverse Event|0|||
16836838|NCT02040779|37780528|FG000|Overall Study|Withdrawal by Subject|4|||
16836839|NCT02040779|37780529|FG001|Overall Study|Withdrawal by Subject|1|||
16836840|NCT02040779|37780530|FG002|Overall Study|Withdrawal by Subject|3|||
16836841|NCT02040779|37780528|FG000|Overall Study|Non-compliance|0|||
16836842|NCT02040779|37780529|FG001|Overall Study|Non-compliance|1|||
16836843|NCT02040779|37780530|FG002|Overall Study|Non-compliance|0|||
16836844|NCT02040779|37780528|FG000|Overall Study|Protocol Violation|2|||
16836845|NCT02040779|37780529|FG001|Overall Study|Protocol Violation|1|||
16836846|NCT02040779|37780530|FG002|Overall Study|Protocol Violation|0|||
16836847|NCT02040779|37780528|FG000|Overall Study|Lost to Follow-up|1|||
16836848|NCT02040779|37780529|FG001|Overall Study|Lost to Follow-up|2|||
16836849|NCT02040779|37780530|FG002|Overall Study|Lost to Follow-up|1|||
16836850|NCT02040779|37780528|FG000|Overall Study|Lack of Efficacy|4|||
16836851|NCT02040779|37780529|FG001|Overall Study|Lack of Efficacy|2|||
16836852|NCT02040779|37780530|FG002|Overall Study|Lack of Efficacy|0|||
16836853|NCT02056301|37780540|FG000|Overall Study|Protocol Violation|1|||
16836854|NCT02056301|37780541|FG001|Overall Study|Protocol Violation|2|||
16836855|NCT02056301|37780540|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
16836856|NCT02056301|37780541|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
16836857|NCT02056301|37780540|FG000|Overall Study|Withdrawal by Subject|0|||
16836858|NCT02056301|37780541|FG001|Overall Study|Withdrawal by Subject|1|||
16836859|NCT02056301|37780540|FG000|Overall Study|Issues with epidural|0|||
16836860|NCT02056301|37780541|FG001|Overall Study|Issues with epidural|3|||
16836861|NCT01967888|37780549|FG000|Overall Study|Lost to Follow-up|6|||
16836862|NCT01967888|37780550|FG001|Overall Study|Lost to Follow-up|4|||
16836863|NCT01967888|37780549|FG000|Overall Study|Withdrawal by Subject|1|||
16836864|NCT01967888|37780550|FG001|Overall Study|Withdrawal by Subject|1|||
16836865|NCT01967888|37780549|FG000|Overall Study|Did Not Have Transplant|1|||
16836866|NCT01967888|37780550|FG001|Overall Study|Did Not Have Transplant|0|||
16836867|NCT01967888|37780549|FG000|Overall Study|Research visit not done, data recorded|1|||
16836868|NCT01967888|37780550|FG001|Overall Study|Research visit not done, data recorded|0|||
16836869|NCT01967888|37780549|FG000|Overall Study|Subject excluded after randomization|1|||
16836870|NCT01967888|37780550|FG001|Overall Study|Subject excluded after randomization|0|||
16836871|NCT01967888|37780549|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
16836872|NCT01967888|37780550|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
16836873|NCT01967888|37780549|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
16836874|NCT01967888|37780550|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
16836875|NCT01967732|37780558|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
16836876|NCT01967732|37780559|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
16836877|NCT01967732|37780560|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
16836878|NCT01967732|37780561|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
16836879|NCT01967732|37780558|FG000|First Intervention (Day 1)|Poor venous access|0|||
16836880|NCT01967732|37780559|FG001|First Intervention (Day 1)|Poor venous access|1|||
16836881|NCT01967732|37780560|FG002|First Intervention (Day 1)|Poor venous access|0|||
16836882|NCT01967732|37780561|FG003|First Intervention (Day 1)|Poor venous access|0|||
16836883|NCT01967576|37780569|FG000|Overall Study|Withdrawal by Subject|3|||
16836884|NCT01967576|37780569|FG000|Overall Study|Progressed/Removed from treatment|1|||
16836885|NCT01967576|37780569|FG000|Overall Study|Study closing at site|1|||
16836886|NCT01967576|37780569|FG000|Overall Study|Adverse Event|1|||
16836887|NCT01967576|37780569|FG000|Overall Study|Refused further treatment|1|||
16836888|NCT02039687|37780577|FG000|Overall Study|Adverse Event|0|||
16836889|NCT02039687|37780578|FG001|Overall Study|Adverse Event|0|||
16836890|NCT02039687|37780579|FG002|Overall Study|Adverse Event|1|||
16836891|NCT02039687|37780580|FG003|Overall Study|Adverse Event|0|||
16836892|NCT02039687|37780577|FG000|Overall Study|Withdrawal by Subject|0|||
16836893|NCT02039687|37780578|FG001|Overall Study|Withdrawal by Subject|1|||
16836894|NCT02039687|37780579|FG002|Overall Study|Withdrawal by Subject|0|||
16836895|NCT02039687|37780580|FG003|Overall Study|Withdrawal by Subject|0|||
16836896|NCT02039687|37780577|FG000|Overall Study|treatment assignment could not be confir|0|||
16836897|NCT02039687|37780578|FG001|Overall Study|treatment assignment could not be confir|0|||
16836898|NCT02039687|37780579|FG002|Overall Study|treatment assignment could not be confir|2|||
16836899|NCT02039687|37780580|FG003|Overall Study|treatment assignment could not be confir|0|||
16836900|NCT02003534|37780590|FG000|Overall Study|Lost to Follow-up|47|||
16836901|NCT02055365|37780594|FG000|Overall Study|Prematurely Withdrawn|1|||
16836902|NCT02039375|37780605|FG000|Overall Study|Lost to Follow-up|2|||
16836903|NCT02054897|37780612|FG000|Overall Study|Withdrawal by Subject|2|||
16836904|NCT02054897|37780613|FG001|Overall Study|Withdrawal by Subject|0|||
16836905|NCT02054897|37780614|FG002|Overall Study|Withdrawal by Subject|2|||
16836906|NCT02054897|37780612|FG000|Overall Study|Missing follow-up information|3|||
16836907|NCT02054897|37780613|FG001|Overall Study|Missing follow-up information|5|||
16836908|NCT02054897|37780614|FG002|Overall Study|Missing follow-up information|3|||
16836909|NCT02054897|37780612|FG000|Overall Study|Lost to Follow-up|4|||
16913110|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
16836910|NCT02054897|37780613|FG001|Overall Study|Lost to Follow-up|2|||
16836911|NCT02054897|37780614|FG002|Overall Study|Lost to Follow-up|7|||
16836912|NCT02054897|37780612|FG000|Overall Study|Randomized but not exposed|1|||
16836913|NCT02054897|37780613|FG001|Overall Study|Randomized but not exposed|0|||
16836914|NCT02054897|37780614|FG002|Overall Study|Randomized but not exposed|0|||
16836915|NCT01976312|37780624|FG000|Overall Study|Pregnancy|0|||
16836916|NCT01976312|37780625|FG001|Overall Study|Pregnancy|1|||
16913111|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
16913112|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
16913113|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
16913114|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
16913115|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
16913116|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
16913117|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
16913118|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
16836917|NCT01976312|37780624|FG000|Overall Study|Lost to Follow-up|2|||
16836918|NCT01976312|37780625|FG001|Overall Study|Lost to Follow-up|0|||
16836919|NCT01976312|37780624|FG000|Overall Study|Withdrawal by Subject|7|||
16836920|NCT01976312|37780625|FG001|Overall Study|Withdrawal by Subject|2|||
16913119|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
16913120|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
16913121|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
16913122|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
16913123|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
16836921|NCT01976312|37780624|FG000|Overall Study|Adverse Event|6|||
16836922|NCT01976312|37780625|FG001|Overall Study|Adverse Event|6|||
16836923|NCT01976312|37780624|FG000|Overall Study|Protocol Violation|2|||
16836924|NCT01976312|37780625|FG001|Overall Study|Protocol Violation|0|||
16836925|NCT02039219|37780634|FG000|Treatment|Withdrawal by Subject|1|||
16836926|NCT02039219|37780635|FG001|Treatment|Withdrawal by Subject|0|||
16836927|NCT02039219|37780634|FG000|Treatment|Adverse Event|0|||
16836928|NCT02039219|37780635|FG001|Treatment|Adverse Event|1|||
16836929|NCT02039219|37780634|FG000|Treatment|Physician Decision|1|||
16836930|NCT02039219|37780635|FG001|Treatment|Physician Decision|0|||
16836931|NCT02039219|37780634|FG000|Treatment|Lost to Follow-up|0|||
16836932|NCT02039219|37780635|FG001|Treatment|Lost to Follow-up|1|||
16836933|NCT02039219|37780634|FG000|Treatment|Protocol Violation|1|||
16836934|NCT02039219|37780635|FG001|Treatment|Protocol Violation|0|||
16836935|NCT02039219|37780634|FG000|Treatment|Death|1|||
16836936|NCT02039219|37780635|FG001|Treatment|Death|0|||
16836937|NCT02039219|37780634|FG000|Follow up|Adverse Event|0|||
16836938|NCT02039219|37780635|FG001|Follow up|Adverse Event|1|||
16836939|NCT02053493|37780643|FG000|Overall Study|Withdrawal by Subject|1|||
16836940|NCT02053493|37780644|FG001|Overall Study|Withdrawal by Subject|1|||
16836941|NCT02003144|37780652|FG000|Open Label Maintenance Phase|Other than specified|2|||
16836942|NCT02003144|37780653|FG001|Open Label Maintenance Phase|Other than specified|4|||
16836943|NCT02003144|37780652|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
16836944|NCT02003144|37780653|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
16836945|NCT02003144|37780652|FG000|Open Label Maintenance Phase|Pregnancy|0|||
16836946|NCT02003144|37780653|FG001|Open Label Maintenance Phase|Pregnancy|2|||
16836947|NCT02003144|37780652|FG000|Open Label Maintenance Phase|Physician Decision|1|||
16836948|NCT02003144|37780653|FG001|Open Label Maintenance Phase|Physician Decision|1|||
16836949|NCT02003144|37780652|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
16836950|NCT02003144|37780653|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
16836951|NCT02003144|37780652|FG000|Open Label Maintenance Phase|Adverse Event|2|||
16836952|NCT02003144|37780653|FG001|Open Label Maintenance Phase|Adverse Event|1|||
16836953|NCT02001194|37780664|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
16836954|NCT02001194|37780665|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
16836955|NCT02001194|37780666|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
16836956|NCT02001194|37780667|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
16836957|NCT02001194|37780664|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
16836958|NCT02001194|37780665|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
16836959|NCT02001194|37780666|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
16836960|NCT02001194|37780667|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
16836961|NCT02038907|37780691|FG000|Overall Study|Protocol Violation|0|||
16836962|NCT02038907|37780692|FG001|Overall Study|Protocol Violation|0|||
16836963|NCT02038907|37780693|FG002|Overall Study|Protocol Violation|0|||
16836964|NCT02038907|37780694|FG003|Overall Study|Protocol Violation|0|||
16836965|NCT02038907|37780695|FG004|Overall Study|Protocol Violation|0|||
16836966|NCT02038907|37780696|FG005|Overall Study|Protocol Violation|0|||
16836967|NCT02038907|37780697|FG006|Overall Study|Protocol Violation|0|||
16836968|NCT02038907|37780698|FG007|Overall Study|Protocol Violation|0|||
16836969|NCT02038907|37780699|FG008|Overall Study|Protocol Violation|0|||
16836970|NCT02038907|37780700|FG009|Overall Study|Protocol Violation|0|||
16836971|NCT02038907|37780701|FG010|Overall Study|Protocol Violation|1|||
16836972|NCT02038907|37780702|FG011|Overall Study|Protocol Violation|0|||
16836973|NCT02038907|37780703|FG012|Overall Study|Protocol Violation|0|||
16836974|NCT02038907|37780704|FG013|Overall Study|Protocol Violation|0|||
16836975|NCT02038907|37780691|FG000|Overall Study|Withdrawal by Subject|0|||
16836976|NCT02038907|37780692|FG001|Overall Study|Withdrawal by Subject|0|||
16836977|NCT02038907|37780693|FG002|Overall Study|Withdrawal by Subject|0|||
16836978|NCT02038907|37780694|FG003|Overall Study|Withdrawal by Subject|0|||
16836979|NCT02038907|37780695|FG004|Overall Study|Withdrawal by Subject|0|||
16836980|NCT02038907|37780696|FG005|Overall Study|Withdrawal by Subject|0|||
16836981|NCT02038907|37780697|FG006|Overall Study|Withdrawal by Subject|0|||
16836982|NCT02038907|37780698|FG007|Overall Study|Withdrawal by Subject|0|||
16836983|NCT02038907|37780699|FG008|Overall Study|Withdrawal by Subject|0|||
16836984|NCT02038907|37780700|FG009|Overall Study|Withdrawal by Subject|0|||
16913124|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
16836985|NCT02038907|37780701|FG010|Overall Study|Withdrawal by Subject|1|||
16836986|NCT02038907|37780702|FG011|Overall Study|Withdrawal by Subject|0|||
16836987|NCT02038907|37780703|FG012|Overall Study|Withdrawal by Subject|0|||
16836988|NCT02038907|37780704|FG013|Overall Study|Withdrawal by Subject|0|||
16836989|NCT02038829|37780736|FG000|Washout Period 1|Death|0|||
16836990|NCT02038829|37780737|FG001|Washout Period 1|Death|0|||
16836991|NCT02038829|37780738|FG002|Washout Period 1|Death|0|||
16836992|NCT02038829|37780739|FG003|Washout Period 1|Death|0|||
16836993|NCT02038829|37780740|FG004|Washout Period 1|Death|1|||
16836994|NCT02038829|37780741|FG005|Washout Period 1|Death|0|||
16836995|NCT02038829|37780742|FG006|Washout Period 1|Death|0|||
16836996|NCT02038829|37780743|FG007|Washout Period 1|Death|0|||
16836997|NCT02038829|37780744|FG008|Washout Period 1|Death|0|||
16836998|NCT02038829|37780745|FG009|Washout Period 1|Death|0|||
16836999|NCT02038829|37780746|FG010|Washout Period 1|Death|0|||
16837000|NCT02038829|37780747|FG011|Washout Period 1|Death|0|||
16837001|NCT02038829|37780736|FG000|Treatment Period 2|Adverse Event|0|||
16837002|NCT02038829|37780737|FG001|Treatment Period 2|Adverse Event|0|||
16837003|NCT02038829|37780738|FG002|Treatment Period 2|Adverse Event|0|||
16837004|NCT02038829|37780739|FG003|Treatment Period 2|Adverse Event|0|||
16837005|NCT02038829|37780740|FG004|Treatment Period 2|Adverse Event|0|||
16837006|NCT02038829|37780741|FG005|Treatment Period 2|Adverse Event|0|||
16837007|NCT02038829|37780742|FG006|Treatment Period 2|Adverse Event|0|||
16837008|NCT02038829|37780743|FG007|Treatment Period 2|Adverse Event|0|||
16837009|NCT02038829|37780744|FG008|Treatment Period 2|Adverse Event|0|||
16837010|NCT02038829|37780745|FG009|Treatment Period 2|Adverse Event|0|||
16837011|NCT02038829|37780746|FG010|Treatment Period 2|Adverse Event|1|||
16837012|NCT02038829|37780747|FG011|Treatment Period 2|Adverse Event|0|||
16837013|NCT02038829|37780736|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16837014|NCT02038829|37780737|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16837015|NCT02038829|37780738|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16837016|NCT02038829|37780739|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16837017|NCT02038829|37780740|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16837018|NCT02038829|37780741|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16837019|NCT02038829|37780742|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16837020|NCT02038829|37780743|FG007|Treatment Period 2|Withdrawal by Subject|0|||
16837021|NCT02038829|37780744|FG008|Treatment Period 2|Withdrawal by Subject|0|||
16837022|NCT02038829|37780745|FG009|Treatment Period 2|Withdrawal by Subject|0|||
16837023|NCT02038829|37780746|FG010|Treatment Period 2|Withdrawal by Subject|0|||
16837024|NCT02038829|37780747|FG011|Treatment Period 2|Withdrawal by Subject|0|||
16837025|NCT02038829|37780736|FG000|Washout Period 2|Adverse Event|0|||
16837026|NCT02038829|37780737|FG001|Washout Period 2|Adverse Event|0|||
16837027|NCT02038829|37780738|FG002|Washout Period 2|Adverse Event|0|||
16837028|NCT02038829|37780739|FG003|Washout Period 2|Adverse Event|0|||
16837029|NCT02038829|37780740|FG004|Washout Period 2|Adverse Event|0|||
16837030|NCT02038829|37780741|FG005|Washout Period 2|Adverse Event|0|||
16837031|NCT02038829|37780742|FG006|Washout Period 2|Adverse Event|0|||
16837032|NCT02038829|37780743|FG007|Washout Period 2|Adverse Event|0|||
16837033|NCT02038829|37780744|FG008|Washout Period 2|Adverse Event|1|||
16837034|NCT02038829|37780745|FG009|Washout Period 2|Adverse Event|0|||
16837035|NCT02038829|37780746|FG010|Washout Period 2|Adverse Event|0|||
16837036|NCT02038829|37780747|FG011|Washout Period 2|Adverse Event|0|||
16837037|NCT02038829|37780736|FG000|Washout Period 2|Withdrawal by Subject|0|||
16837038|NCT02038829|37780737|FG001|Washout Period 2|Withdrawal by Subject|0|||
16837039|NCT02038829|37780738|FG002|Washout Period 2|Withdrawal by Subject|0|||
16837040|NCT02038829|37780739|FG003|Washout Period 2|Withdrawal by Subject|0|||
16837041|NCT02038829|37780740|FG004|Washout Period 2|Withdrawal by Subject|0|||
16837042|NCT02038829|37780741|FG005|Washout Period 2|Withdrawal by Subject|1|||
16837043|NCT02038829|37780742|FG006|Washout Period 2|Withdrawal by Subject|0|||
16837044|NCT02038829|37780743|FG007|Washout Period 2|Withdrawal by Subject|0|||
16837045|NCT02038829|37780744|FG008|Washout Period 2|Withdrawal by Subject|0|||
16837046|NCT02038829|37780745|FG009|Washout Period 2|Withdrawal by Subject|0|||
16913125|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
16913126|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
16837047|NCT02038829|37780746|FG010|Washout Period 2|Withdrawal by Subject|0|||
16837048|NCT02038829|37780747|FG011|Washout Period 2|Withdrawal by Subject|0|||
16913127|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913128|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913129|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913130|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913131|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913132|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913133|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913134|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913135|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913136|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913137|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913138|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913139|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913140|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
16837049|NCT02038829|37780736|FG000|Treatment Period 4|Adverse Event|0|||
16837050|NCT02038829|37780737|FG001|Treatment Period 4|Adverse Event|1|||
16837051|NCT02038829|37780738|FG002|Treatment Period 4|Adverse Event|0|||
16837052|NCT02038829|37780739|FG003|Treatment Period 4|Adverse Event|0|||
16837053|NCT02038829|37780740|FG004|Treatment Period 4|Adverse Event|0|||
16837054|NCT02038829|37780741|FG005|Treatment Period 4|Adverse Event|0|||
16837055|NCT02038829|37780742|FG006|Treatment Period 4|Adverse Event|0|||
16837056|NCT02038829|37780743|FG007|Treatment Period 4|Adverse Event|0|||
16837057|NCT02038829|37780744|FG008|Treatment Period 4|Adverse Event|0|||
16837058|NCT02038829|37780745|FG009|Treatment Period 4|Adverse Event|0|||
16837059|NCT02038829|37780746|FG010|Treatment Period 4|Adverse Event|0|||
16837060|NCT02038829|37780747|FG011|Treatment Period 4|Adverse Event|0|||
16837061|NCT02038829|37780736|FG000|Washout Period 4|Adverse Event|0|||
16837062|NCT02038829|37780737|FG001|Washout Period 4|Adverse Event|0|||
16837063|NCT02038829|37780738|FG002|Washout Period 4|Adverse Event|0|||
16837064|NCT02038829|37780739|FG003|Washout Period 4|Adverse Event|0|||
16837065|NCT02038829|37780740|FG004|Washout Period 4|Adverse Event|0|||
16837066|NCT02038829|37780741|FG005|Washout Period 4|Adverse Event|0|||
16837067|NCT02038829|37780742|FG006|Washout Period 4|Adverse Event|1|||
16837068|NCT02038829|37780743|FG007|Washout Period 4|Adverse Event|0|||
16837069|NCT02038829|37780744|FG008|Washout Period 4|Adverse Event|0|||
16837070|NCT02038829|37780745|FG009|Washout Period 4|Adverse Event|0|||
16837071|NCT02038829|37780746|FG010|Washout Period 4|Adverse Event|0|||
16837072|NCT02038829|37780747|FG011|Washout Period 4|Adverse Event|0|||
16913141|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913142|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
16837073|NCT02038829|37780736|FG000|Treatment Period 6|Adverse Event|0|||
16837074|NCT02038829|37780737|FG001|Treatment Period 6|Adverse Event|0|||
16837075|NCT02038829|37780738|FG002|Treatment Period 6|Adverse Event|1|||
16837076|NCT02038829|37780739|FG003|Treatment Period 6|Adverse Event|0|||
16837077|NCT02038829|37780740|FG004|Treatment Period 6|Adverse Event|0|||
16837078|NCT02038829|37780741|FG005|Treatment Period 6|Adverse Event|0|||
16837079|NCT02038829|37780742|FG006|Treatment Period 6|Adverse Event|0|||
16837080|NCT02038829|37780743|FG007|Treatment Period 6|Adverse Event|0|||
16837081|NCT02038829|37780744|FG008|Treatment Period 6|Adverse Event|0|||
16837082|NCT02038829|37780745|FG009|Treatment Period 6|Adverse Event|0|||
16837083|NCT02038829|37780746|FG010|Treatment Period 6|Adverse Event|0|||
16837084|NCT02038829|37780747|FG011|Treatment Period 6|Adverse Event|0|||
16837085|NCT02038049|37780764|FG000|Overall Study|Lost to Follow-up|1|||
16837086|NCT02038049|37780765|FG001|Overall Study|Lost to Follow-up|0|||
16837087|NCT02052011|37780777|FG000|Overall Study|Lost to Follow-up|3|||
16837088|NCT02052011|37780778|FG001|Overall Study|Lost to Follow-up|0|||
16837089|NCT02052011|37780777|FG000|Overall Study|Withdrawal by Subject|1|||
16837090|NCT02052011|37780778|FG001|Overall Study|Withdrawal by Subject|2|||
16837091|NCT02036645|37780796|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837092|NCT02036645|37780797|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837093|NCT02036645|37780798|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837094|NCT02036645|37780799|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837095|NCT02036645|37780800|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837096|NCT02036645|37780801|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837097|NCT02036645|37780802|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
16837098|NCT02036645|37780803|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837099|NCT02036645|37780804|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16913143|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
16913144|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913145|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913146|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913147|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913148|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913149|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16837100|NCT02036645|37780805|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837101|NCT02036645|37780806|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837102|NCT02036645|37780807|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16837103|NCT02036645|37780796|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837104|NCT02036645|37780797|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837105|NCT02036645|37780798|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837106|NCT02036645|37780799|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
16837107|NCT02036645|37780800|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837108|NCT02036645|37780801|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837109|NCT02036645|37780802|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837110|NCT02036645|37780803|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837111|NCT02036645|37780804|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837112|NCT02036645|37780805|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837113|NCT02036645|37780806|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837114|NCT02036645|37780807|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16837115|NCT02051933|37780847|FG000|Overall Study|Physician Decision|0|||
16837116|NCT02051933|37780848|FG001|Overall Study|Physician Decision|1|||
16837117|NCT02050373|37780861|FG000|Overall Study|Adverse Event|4|||
16837118|NCT02050373|37780862|FG001|Overall Study|Adverse Event|7|||
16837119|NCT02050373|37780861|FG000|Overall Study|Death|3|||
16837120|NCT02050373|37780862|FG001|Overall Study|Death|3|||
16837121|NCT02049437|37780871|FG000|Period 1|Adverse Event|1|||
16837122|NCT02049437|37780872|FG001|Period 1|Adverse Event|1|||
16837123|NCT02049437|37780871|FG000|Period 1|Adverse Event|1|||
16837124|NCT02049437|37780872|FG001|Period 1|Adverse Event|0|||
16837125|NCT02035553|37780880|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
16837126|NCT02035553|37780881|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
16837127|NCT02035553|37780880|FG000|Overall Study|Adverse Event|10|||
16837128|NCT02035553|37780881|FG001|Overall Study|Adverse Event|6|||
16837129|NCT02035553|37780880|FG000|Overall Study|Physician Decision|3|||
16837130|NCT02035553|37780881|FG001|Overall Study|Physician Decision|2|||
16837131|NCT02035553|37780880|FG000|Overall Study|Lack of Efficacy|1|||
16837132|NCT02035553|37780881|FG001|Overall Study|Lack of Efficacy|1|||
16837133|NCT02035553|37780880|FG000|Overall Study|Withdrawal by Subject|4|||
16837134|NCT02035553|37780881|FG001|Overall Study|Withdrawal by Subject|7|||
16837135|NCT02035553|37780880|FG000|Overall Study|Non-compliance with Study Drug|0|||
16837136|NCT02035553|37780881|FG001|Overall Study|Non-compliance with Study Drug|1|||
16837137|NCT02035553|37780880|FG000|Overall Study|Lost to Follow-up|0|||
16837138|NCT02035553|37780881|FG001|Overall Study|Lost to Follow-up|1|||
16837139|NCT02035553|37780880|FG000|Overall Study|Other Reason|0|||
16837140|NCT02035553|37780881|FG001|Overall Study|Other Reason|4|||
16837141|NCT01445080|37780896|FG000|Overall Study|Adverse Event|5|||
16837142|NCT01445080|37780897|FG001|Overall Study|Adverse Event|3|||
16837143|NCT01445080|37780898|FG002|Overall Study|Adverse Event|11|||
16837144|NCT01445080|37780899|FG003|Overall Study|Adverse Event|6|||
16837145|NCT01445080|37780900|FG004|Overall Study|Adverse Event|2|||
16837146|NCT01445080|37780901|FG005|Overall Study|Adverse Event|3|||
16837147|NCT01445080|37780902|FG006|Overall Study|Adverse Event|0|||
16837148|NCT01445080|37780903|FG007|Overall Study|Adverse Event|3|||
16837149|NCT01445080|37780904|FG008|Overall Study|Adverse Event|10|||
16837150|NCT01445080|37780896|FG000|Overall Study|Physician Decision|0|||
16837151|NCT01445080|37780897|FG001|Overall Study|Physician Decision|0|||
16837152|NCT01445080|37780898|FG002|Overall Study|Physician Decision|1|||
16837153|NCT01445080|37780899|FG003|Overall Study|Physician Decision|0|||
16837154|NCT01445080|37780900|FG004|Overall Study|Physician Decision|0|||
16837155|NCT01445080|37780901|FG005|Overall Study|Physician Decision|3|||
16837156|NCT01445080|37780902|FG006|Overall Study|Physician Decision|2|||
16837157|NCT01445080|37780903|FG007|Overall Study|Physician Decision|2|||
16837158|NCT01445080|37780904|FG008|Overall Study|Physician Decision|0|||
16837159|NCT01445080|37780896|FG000|Overall Study|Withdrawal by Subject|1|||
16837160|NCT01445080|37780897|FG001|Overall Study|Withdrawal by Subject|0|||
16837161|NCT01445080|37780898|FG002|Overall Study|Withdrawal by Subject|0|||
16837162|NCT01445080|37780899|FG003|Overall Study|Withdrawal by Subject|1|||
16837163|NCT01445080|37780900|FG004|Overall Study|Withdrawal by Subject|0|||
16837164|NCT01445080|37780901|FG005|Overall Study|Withdrawal by Subject|0|||
16837165|NCT01445080|37780902|FG006|Overall Study|Withdrawal by Subject|0|||
16837166|NCT01445080|37780903|FG007|Overall Study|Withdrawal by Subject|0|||
16837167|NCT01445080|37780904|FG008|Overall Study|Withdrawal by Subject|2|||
16837168|NCT01445080|37780896|FG000|Overall Study|Ineligible/Inevaluable|1|||
16837169|NCT01445080|37780897|FG001|Overall Study|Ineligible/Inevaluable|2|||
16837170|NCT01445080|37780898|FG002|Overall Study|Ineligible/Inevaluable|0|||
16837171|NCT01445080|37780899|FG003|Overall Study|Ineligible/Inevaluable|1|||
16837172|NCT01445080|37780900|FG004|Overall Study|Ineligible/Inevaluable|2|||
16837173|NCT01445080|37780901|FG005|Overall Study|Ineligible/Inevaluable|3|||
16837174|NCT01445080|37780902|FG006|Overall Study|Ineligible/Inevaluable|0|||
16837175|NCT01445080|37780903|FG007|Overall Study|Ineligible/Inevaluable|0|||
16837176|NCT01445080|37780904|FG008|Overall Study|Ineligible/Inevaluable|6|||
16837177|NCT02035475|37780939|FG000|Overall Study|Withdrawal by Subject|4|||
16837178|NCT02035475|37780939|FG000|Overall Study|Physician Decision|1|||
16837179|NCT02035475|37780939|FG000|Overall Study|Equipment Error|1|||
16837180|NCT01444456|37780945|FG000|Overall Study|Withdrawal by Subject|21|||
16837181|NCT01444456|37780945|FG000|Overall Study|Physician Decision|9|||
16837182|NCT01444456|37780945|FG000|Overall Study|Lost to Follow-up|37|||
16837183|NCT01444456|37780945|FG000|Overall Study|Death|73|||
16837184|NCT01444456|37780945|FG000|Overall Study|Ineligibility determined|23|||
16837185|NCT01444456|37780945|FG000|Overall Study|Other|18|||
16837186|NCT01444456|37780945|FG000|Overall Study|Not treated|104|||
16837187|NCT01438294|37780951|FG000|Overall Study|Lost to Follow-up|3|||
16837188|NCT01438294|37780952|FG001|Overall Study|Lost to Follow-up|7|||
16837189|NCT02033759|37780960|FG000|Overall Study|Withdrawal by Subject|2|||
16837190|NCT02033759|37780961|FG001|Overall Study|Withdrawal by Subject|1|||
16837191|NCT02033759|37780960|FG000|Overall Study|Protocol Violation|1|||
16837192|NCT02033759|37780961|FG001|Overall Study|Protocol Violation|1|||
16837193|NCT01959529|37780969|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
16837194|NCT01959529|37780970|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
16837195|NCT01959529|37780969|FG000|Overall Study|Lost to Follow-up|4|||
16837196|NCT01959529|37780970|FG001|Overall Study|Lost to Follow-up|1|||
16837197|NCT01959529|37780969|FG000|Overall Study|Other|70|||
16837198|NCT01959529|37780970|FG001|Overall Study|Other|68|||
16837199|NCT01959529|37780969|FG000|Overall Study|Hypoglycaemia|1|||
16837200|NCT01959529|37780970|FG001|Overall Study|Hypoglycaemia|1|||
16837201|NCT01959529|37780969|FG000|Overall Study|Lack of glycaemic control|1|||
16837202|NCT01959529|37780970|FG001|Overall Study|Lack of glycaemic control|1|||
16837203|NCT02033369|37780978|FG000|Overall Study|Physician Decision|1|||
16837204|NCT02033369|37780979|FG001|Overall Study|Physician Decision|2|||
16837205|NCT02033369|37780978|FG000|Overall Study|Not a good demographic match|0|||
16837206|NCT02033369|37780979|FG001|Overall Study|Not a good demographic match|2|||
16837207|NCT02033369|37780978|FG000|Overall Study|Withdrawal by Subject|1|||
16837208|NCT02033369|37780979|FG001|Overall Study|Withdrawal by Subject|1|||
16837209|NCT02033369|37780978|FG000|Overall Study|Lost to Follow-up|1|||
16837210|NCT02033369|37780979|FG001|Overall Study|Lost to Follow-up|0|||
16837211|NCT02033369|37780978|FG000|Overall Study|Protocol Violation|2|||
16837212|NCT02033369|37780979|FG001|Overall Study|Protocol Violation|0|||
16837213|NCT02032901|37780985|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
16837214|NCT02032901|37780986|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
16837215|NCT02032901|37780985|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
16837216|NCT02032901|37780986|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
16837217|NCT02020967|37780996|FG000|Overall Study|Withdrawal by Subject|51|||
16837218|NCT01986829|37781002|FG000|Overall Study|Death|1|||
16837219|NCT01986751|37781011|FG000|Overall Study|improperly consented|10|||
16837220|NCT01986751|37781012|FG001|Overall Study|improperly consented|2|||
16837221|NCT02004847|37781024|FG000|Overall Study|Protocol Violation|1|||
16837222|NCT02004847|37781025|FG001|Overall Study|Protocol Violation|1|||
16837223|NCT01438060|37781042|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
16837224|NCT01438060|37781043|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
16837225|NCT01438060|37781042|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
16837226|NCT01438060|37781043|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
16837227|NCT01438060|37781042|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
16837228|NCT01438060|37781043|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
16837229|NCT01438060|37781042|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
16837230|NCT01438060|37781043|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
16837231|NCT01438060|37781042|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
16837232|NCT01438060|37781043|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
16837233|NCT01438060|37781042|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
16837234|NCT01438060|37781043|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
16837235|NCT01438060|37781042|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
16837236|NCT01438060|37781043|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
16837237|NCT01438060|37781042|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
16837238|NCT01438060|37781043|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
16837239|NCT01438060|37781042|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
16837240|NCT01438060|37781043|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
16837241|NCT01438060|37781042|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
16837242|NCT01438060|37781043|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
16837243|NCT01438060|37781042|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
16837244|NCT01438060|37781043|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
16837245|NCT01438060|37781042|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
16837246|NCT01438060|37781043|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
16837247|NCT01438060|37781042|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
16837248|NCT01438060|37781043|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
16837249|NCT01438060|37781042|FG000|On Study Beyond Week 140|Adverse Event|0|||
16837250|NCT01438060|37781043|FG001|On Study Beyond Week 140|Adverse Event|2|||
16837251|NCT01438060|37781042|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
16837252|NCT01438060|37781043|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
16837253|NCT01438060|37781042|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
16837254|NCT01438060|37781043|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
16837255|NCT01438060|37781042|FG000|On Study Beyond Week 140|Death|0|||
16837256|NCT01438060|37781043|FG001|On Study Beyond Week 140|Death|1|||
16837257|NCT01438060|37781042|FG000|On Study Beyond Week 140|Other Reason|0|||
16837258|NCT01438060|37781043|FG001|On Study Beyond Week 140|Other Reason|3|||
16837259|NCT01469182|37781056|FG000|Overall Study|Adverse Event|21|||
16837260|NCT01469182|37781057|FG001|Overall Study|Adverse Event|3|||
16837261|NCT01469182|37781056|FG000|Overall Study|Lost to Follow-up|3|||
16837262|NCT01469182|37781057|FG001|Overall Study|Lost to Follow-up|0|||
16837263|NCT01469182|37781056|FG000|Overall Study|Withdrawal by Subject|4|||
16837264|NCT01469182|37781057|FG001|Overall Study|Withdrawal by Subject|1|||
16837265|NCT01469182|37781056|FG000|Overall Study|Protocol Violation|4|||
16837266|NCT01469182|37781057|FG001|Overall Study|Protocol Violation|2|||
16837267|NCT01469182|37781056|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
16837268|NCT01469182|37781057|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
16837269|NCT01444378|37781063|FG000|Overall Study|Lost to Follow-up|1|||
16837270|NCT01444378|37781063|FG000|Overall Study|Withdrawal by Subject|1|||
16837271|NCT01444378|37781063|FG000|Overall Study|Death|3|||
16837272|NCT01444378|37781063|FG000|Overall Study|Administrative Closure Of The Study|2|||
16837273|NCT01444378|37781063|FG000|Overall Study|Missed Visits|10|||
16837274|NCT02020889|37781072|FG000|Overall Study|Adverse Event|0|||
16837275|NCT02020889|37781073|FG001|Overall Study|Adverse Event|1|||
16837276|NCT02020889|37781072|FG000|Overall Study|Lack of Efficacy|1|||
16837277|NCT02020889|37781073|FG001|Overall Study|Lack of Efficacy|0|||
16837278|NCT02020889|37781072|FG000|Overall Study|Lost to Follow-up|1|||
16837279|NCT02020889|37781073|FG001|Overall Study|Lost to Follow-up|0|||
16837280|NCT02020889|37781072|FG000|Overall Study|Physician Decision|2|||
16837281|NCT02020889|37781073|FG001|Overall Study|Physician Decision|0|||
16837282|NCT02020889|37781072|FG000|Overall Study|Withdrawal by Subject|3|||
16837283|NCT02020889|37781073|FG001|Overall Study|Withdrawal by Subject|2|||
16837284|NCT01444300|37781081|FG000|Overall Study|Adverse Event|4|||
16837285|NCT01444300|37781082|FG001|Overall Study|Adverse Event|0|||
16837286|NCT01443364|37781089|FG000|Overall Study|Lack of Efficacy|14|||
16837287|NCT01443364|37781089|FG000|Overall Study|Lost to Follow-up|3|||
16837288|NCT01443364|37781089|FG000|Overall Study|Withdrawal by Subject|5|||
16837289|NCT01443364|37781089|FG000|Overall Study|Other Reason|4|||
16837290|NCT01443364|37781089|FG000|Overall Study|SAE, non-fatal|6|||
16837291|NCT01443364|37781089|FG000|Overall Study|AE, non-serious non-fatal|8|||
16837292|NCT01443364|37781089|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16837293|NCT02020577|37781095|FG000|Overall Study|Progressive disease|3|||
16837294|NCT02020577|37781096|FG001|Overall Study|Progressive disease|38|||
16837295|NCT02020577|37781095|FG000|Overall Study|Other AE or clinical progression|0|||
16837296|NCT02020577|37781096|FG001|Overall Study|Other AE or clinical progression|15|||
16837297|NCT02020577|37781095|FG000|Overall Study|Withdrawal by Subject|0|||
16837298|NCT02020577|37781096|FG001|Overall Study|Withdrawal by Subject|1|||
16837299|NCT02020577|37781095|FG000|Overall Study|Other than stated above|0|||
16837300|NCT02020577|37781096|FG001|Overall Study|Other than stated above|1|||
16837301|NCT02020031|37781106|FG000|Overall Study|Physician Decision|1|||
16837302|NCT02020031|37781107|FG001|Overall Study|Physician Decision|1|||
16837303|NCT02019719|37781118|FG000|Overall Study|Adverse Event|1|||
16837304|NCT02019719|37781119|FG001|Overall Study|Adverse Event|0|||
16837305|NCT02019719|37781120|FG002|Overall Study|Adverse Event|0|||
16837306|NCT02019719|37781121|FG003|Overall Study|Adverse Event|1|||
16837307|NCT02019719|37781122|FG004|Overall Study|Adverse Event|1|||
16837308|NCT02019719|37781118|FG000|Overall Study|Protocol Violation|1|||
16837309|NCT02019719|37781119|FG001|Overall Study|Protocol Violation|1|||
16837310|NCT02019719|37781120|FG002|Overall Study|Protocol Violation|0|||
16837311|NCT02019719|37781121|FG003|Overall Study|Protocol Violation|0|||
16837312|NCT02019719|37781122|FG004|Overall Study|Protocol Violation|0|||
16837313|NCT02019719|37781118|FG000|Overall Study|Protocol defined stopping criteria|2|||
16837314|NCT02019719|37781119|FG001|Overall Study|Protocol defined stopping criteria|0|||
16837315|NCT02019719|37781120|FG002|Overall Study|Protocol defined stopping criteria|0|||
16837316|NCT02019719|37781121|FG003|Overall Study|Protocol defined stopping criteria|1|||
16837317|NCT02019719|37781122|FG004|Overall Study|Protocol defined stopping criteria|1|||
16837318|NCT02019719|37781118|FG000|Overall Study|Physician Decision|2|||
16837319|NCT02019719|37781119|FG001|Overall Study|Physician Decision|0|||
16837320|NCT02019719|37781120|FG002|Overall Study|Physician Decision|0|||
16837321|NCT02019719|37781121|FG003|Overall Study|Physician Decision|0|||
16837322|NCT02019719|37781122|FG004|Overall Study|Physician Decision|0|||
16837323|NCT02030405|37781141|FG000|Overall Study|Withdrawal by Subject|1|||
16837324|NCT02030405|37781141|FG000|Overall Study|Lost to Follow-up|1|||
16837325|NCT01975376|37781148|FG000|Overall Study|Adverse Event|5|||
16837326|NCT01975376|37781149|FG001|Overall Study|Adverse Event|5|||
16837327|NCT01975376|37781148|FG000|Overall Study|Death|65|||
16837328|NCT01975376|37781149|FG001|Overall Study|Death|72|||
16837329|NCT01975376|37781148|FG000|Overall Study|Lost to Follow-up|70|||
16837330|NCT01975376|37781149|FG001|Overall Study|Lost to Follow-up|66|||
16837331|NCT01975376|37781148|FG000|Overall Study|Withdrew consent|68|||
16837332|NCT01975376|37781149|FG001|Overall Study|Withdrew consent|62|||
16837333|NCT01975376|37781148|FG000|Overall Study|Other|2|||
16837334|NCT01975376|37781149|FG001|Overall Study|Other|4|||
16837335|NCT01975376|37781148|FG000|Overall Study|Randomized, Not Treated|16|||
16837336|NCT01975376|37781149|FG001|Overall Study|Randomized, Not Treated|8|||
16837337|NCT01443130|37781161|FG000|Overall Study|Lost to Follow-up|44|||
16837338|NCT01443130|37781162|FG001|Overall Study|Lost to Follow-up|42|||
16837339|NCT01443130|37781163|FG002|Overall Study|Lost to Follow-up|50|||
16837340|NCT01443130|37781164|FG003|Overall Study|Lost to Follow-up|23|||
16837341|NCT01443130|37781165|FG004|Overall Study|Lost to Follow-up|25|||
16837342|NCT01443130|37781166|FG005|Overall Study|Lost to Follow-up|21|||
16837343|NCT01443130|37781161|FG000|Overall Study|Death|0|||
16837344|NCT01443130|37781162|FG001|Overall Study|Death|1|||
16837345|NCT01443130|37781163|FG002|Overall Study|Death|0|||
16837346|NCT01443130|37781164|FG003|Overall Study|Death|7|||
16837347|NCT01443130|37781165|FG004|Overall Study|Death|10|||
16837348|NCT01443130|37781166|FG005|Overall Study|Death|8|||
16837349|NCT01443130|37781161|FG000|Overall Study|Adverse Event|2|||
16837350|NCT01443130|37781162|FG001|Overall Study|Adverse Event|1|||
16837351|NCT01443130|37781163|FG002|Overall Study|Adverse Event|1|||
16837352|NCT01443130|37781164|FG003|Overall Study|Adverse Event|0|||
16837353|NCT01443130|37781165|FG004|Overall Study|Adverse Event|0|||
16837354|NCT01443130|37781166|FG005|Overall Study|Adverse Event|0|||
16837355|NCT01443130|37781161|FG000|Overall Study|Protocol Violation|2|||
16837356|NCT01443130|37781162|FG001|Overall Study|Protocol Violation|1|||
16837357|NCT01443130|37781163|FG002|Overall Study|Protocol Violation|3|||
16837358|NCT01443130|37781164|FG003|Overall Study|Protocol Violation|2|||
16837359|NCT01443130|37781165|FG004|Overall Study|Protocol Violation|2|||
16837360|NCT01443130|37781166|FG005|Overall Study|Protocol Violation|3|||
16837361|NCT01443130|37781161|FG000|Overall Study|Withdrawal by Subject|15|||
16837362|NCT01443130|37781162|FG001|Overall Study|Withdrawal by Subject|14|||
16837363|NCT01443130|37781163|FG002|Overall Study|Withdrawal by Subject|12|||
16837364|NCT01443130|37781164|FG003|Overall Study|Withdrawal by Subject|7|||
16837365|NCT01443130|37781165|FG004|Overall Study|Withdrawal by Subject|7|||
16837366|NCT01443130|37781166|FG005|Overall Study|Withdrawal by Subject|2|||
16837367|NCT01443130|37781161|FG000|Overall Study|Death of Subject's Infant|5|||
16837368|NCT01443130|37781162|FG001|Overall Study|Death of Subject's Infant|10|||
16837369|NCT01443130|37781163|FG002|Overall Study|Death of Subject's Infant|11|||
16837370|NCT01443130|37781164|FG003|Overall Study|Death of Subject's Infant|0|||
16837371|NCT01443130|37781165|FG004|Overall Study|Death of Subject's Infant|0|||
16837372|NCT01443130|37781166|FG005|Overall Study|Death of Subject's Infant|0|||
16837373|NCT01959139|37781184|FG000|Phase II|Disease progression|0|||
16837374|NCT01959139|37781185|FG001|Phase II|Disease progression|0|||
16837375|NCT01959139|37781186|FG002|Phase II|Disease progression|26|||
16837376|NCT01959139|37781187|FG003|Phase II|Disease progression|34|||
16837377|NCT01959139|37781184|FG000|Phase II|Adverse Event|0|||
16837378|NCT01959139|37781185|FG001|Phase II|Adverse Event|0|||
16837379|NCT01959139|37781186|FG002|Phase II|Adverse Event|10|||
16837380|NCT01959139|37781187|FG003|Phase II|Adverse Event|11|||
16837381|NCT01959139|37781184|FG000|Phase II|Patient Refusal|0|||
16837382|NCT01959139|37781185|FG001|Phase II|Patient Refusal|0|||
16837383|NCT01959139|37781186|FG002|Phase II|Patient Refusal|5|||
16837384|NCT01959139|37781187|FG003|Phase II|Patient Refusal|4|||
16837385|NCT01959139|37781184|FG000|Phase II|Death|0|||
16837386|NCT01959139|37781185|FG001|Phase II|Death|0|||
16837387|NCT01959139|37781186|FG002|Phase II|Death|3|||
16837388|NCT01959139|37781187|FG003|Phase II|Death|1|||
16837389|NCT01959139|37781184|FG000|Phase II|Other/Unknown|0|||
16837390|NCT01959139|37781185|FG001|Phase II|Other/Unknown|0|||
16837391|NCT01959139|37781186|FG002|Phase II|Other/Unknown|8|||
16837392|NCT01959139|37781187|FG003|Phase II|Other/Unknown|5|||
16837393|NCT01959139|37781184|FG000|Phase II|On treatment|0|||
16837394|NCT01959139|37781185|FG001|Phase II|On treatment|0|||
16837395|NCT01959139|37781186|FG002|Phase II|On treatment|4|||
16837396|NCT01959139|37781187|FG003|Phase II|On treatment|0|||
16837397|NCT01436500|37781204|FG000|Overall Study|Death|1|||
16837398|NCT01436500|37781205|FG001|Overall Study|Death|0|||
16837399|NCT01436500|37781206|FG002|Overall Study|Death|0|||
16837400|NCT01436500|37781207|FG003|Overall Study|Death|0|||
16837401|NCT01436500|37781208|FG004|Overall Study|Death|0|||
16837402|NCT01436500|37781204|FG000|Overall Study|Adverse Event|0|||
16837403|NCT01436500|37781205|FG001|Overall Study|Adverse Event|2|||
16837404|NCT01436500|37781206|FG002|Overall Study|Adverse Event|2|||
16837405|NCT01436500|37781207|FG003|Overall Study|Adverse Event|0|||
16837406|NCT01436500|37781208|FG004|Overall Study|Adverse Event|1|||
16837407|NCT01436500|37781204|FG000|Overall Study|Withdrawal by Subject|0|||
16837408|NCT01436500|37781205|FG001|Overall Study|Withdrawal by Subject|0|||
16837409|NCT01436500|37781206|FG002|Overall Study|Withdrawal by Subject|2|||
16837410|NCT01436500|37781207|FG003|Overall Study|Withdrawal by Subject|0|||
16837411|NCT01436500|37781208|FG004|Overall Study|Withdrawal by Subject|2|||
16837412|NCT01436500|37781204|FG000|Overall Study|Physician Decision|0|||
16837413|NCT01436500|37781205|FG001|Overall Study|Physician Decision|0|||
16837414|NCT01436500|37781206|FG002|Overall Study|Physician Decision|1|||
16837415|NCT01436500|37781207|FG003|Overall Study|Physician Decision|0|||
16837416|NCT01436500|37781208|FG004|Overall Study|Physician Decision|0|||
16837417|NCT01436500|37781204|FG000|Overall Study|liver transplant|1|||
16837418|NCT01436500|37781205|FG001|Overall Study|liver transplant|0|||
16837419|NCT01436500|37781206|FG002|Overall Study|liver transplant|0|||
16837420|NCT01436500|37781207|FG003|Overall Study|liver transplant|0|||
16837421|NCT01436500|37781208|FG004|Overall Study|liver transplant|0|||
16837422|NCT01436500|37781204|FG000|Overall Study|initiation of dialysis|0|||
16837423|NCT01436500|37781205|FG001|Overall Study|initiation of dialysis|0|||
16837424|NCT01436500|37781206|FG002|Overall Study|initiation of dialysis|0|||
16837425|NCT01436500|37781207|FG003|Overall Study|initiation of dialysis|0|||
16837426|NCT01436500|37781208|FG004|Overall Study|initiation of dialysis|1|||
16837427|NCT01436500|37781204|FG000|Overall Study|discontinued study drug|1|||
16837428|NCT01436500|37781205|FG001|Overall Study|discontinued study drug|0|||
16837429|NCT01436500|37781206|FG002|Overall Study|discontinued study drug|0|||
16837430|NCT01436500|37781207|FG003|Overall Study|discontinued study drug|0|||
16837431|NCT01436500|37781208|FG004|Overall Study|discontinued study drug|0|||
16837432|NCT01436500|37781204|FG000|Overall Study|Other|0|||
16837433|NCT01436500|37781205|FG001|Overall Study|Other|1|||
16837434|NCT01436500|37781206|FG002|Overall Study|Other|0|||
16837435|NCT01436500|37781207|FG003|Overall Study|Other|1|||
16837436|NCT01436500|37781208|FG004|Overall Study|Other|0|||
16837437|NCT01958827|37781221|FG000|Overall Study|Adverse Event|3|||
16837438|NCT01958827|37781221|FG000|Overall Study|Lack of Efficacy|6|||
16837439|NCT01958827|37781221|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
16837440|NCT01620086|37781227|FG000|Overall Study|Withdrawal by Subject|3|||
16837441|NCT01620086|37781228|FG001|Overall Study|Withdrawal by Subject|3|||
16837442|NCT01620086|37781229|FG002|Overall Study|Withdrawal by Subject|0|||
16837443|NCT01620086|37781227|FG000|Overall Study|failed study criteria|1|||
16837444|NCT01620086|37781228|FG001|Overall Study|failed study criteria|4|||
16837445|NCT01620086|37781229|FG002|Overall Study|failed study criteria|0|||
16837446|NCT01620086|37781227|FG000|Overall Study|Physician Decision|1|||
16837447|NCT01620086|37781228|FG001|Overall Study|Physician Decision|0|||
16837448|NCT01620086|37781229|FG002|Overall Study|Physician Decision|0|||
16913150|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913151|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16837449|NCT01436110|37781241|FG000|Overall Study|Lack of Efficacy|23|||
16837450|NCT01436110|37781242|FG001|Overall Study|Lack of Efficacy|14|||
16837451|NCT01436110|37781243|FG002|Overall Study|Lack of Efficacy|9|||
16837452|NCT01436110|37781241|FG000|Overall Study|Withdrawal by Subject|6|||
16837453|NCT01436110|37781242|FG001|Overall Study|Withdrawal by Subject|8|||
16837454|NCT01436110|37781243|FG002|Overall Study|Withdrawal by Subject|4|||
16837455|NCT01436110|37781241|FG000|Overall Study|Adverse Event|2|||
16837456|NCT01436110|37781242|FG001|Overall Study|Adverse Event|1|||
16837457|NCT01436110|37781243|FG002|Overall Study|Adverse Event|2|||
16837458|NCT01436110|37781241|FG000|Overall Study|Physician Decision|3|||
16837459|NCT01436110|37781242|FG001|Overall Study|Physician Decision|1|||
16837460|NCT01436110|37781243|FG002|Overall Study|Physician Decision|1|||
16837461|NCT01436110|37781241|FG000|Overall Study|Lost to Follow-up|1|||
16837462|NCT01436110|37781242|FG001|Overall Study|Lost to Follow-up|1|||
16837463|NCT01436110|37781243|FG002|Overall Study|Lost to Follow-up|3|||
16837464|NCT01436110|37781241|FG000|Overall Study|Protocol Violation|3|||
16837465|NCT01436110|37781242|FG001|Overall Study|Protocol Violation|1|||
16837466|NCT01436110|37781243|FG002|Overall Study|Protocol Violation|1|||
16837467|NCT01436110|37781241|FG000|Overall Study|Did Not Receive Trial Medication|1|||
16837468|NCT01436110|37781242|FG001|Overall Study|Did Not Receive Trial Medication|0|||
16837469|NCT01436110|37781243|FG002|Overall Study|Did Not Receive Trial Medication|3|||
16837470|NCT01619852|37781253|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
16837471|NCT01619852|37781254|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
16837472|NCT01619852|37781253|FG000|3 Month Follow up|Lost to Follow-up|31|||
16837473|NCT01619852|37781254|FG001|3 Month Follow up|Lost to Follow-up|34|||
16837474|NCT02000882|37781261|FG000|Overall Study|Adverse Event|3|||
16837475|NCT02000882|37781261|FG000|Overall Study|Physician Decision|2|||
16837476|NCT02000882|37781261|FG000|Overall Study|Withdrawal by Subject|1|||
16837477|NCT01965938|37781267|FG000|Overall Study|Withdrawal by Subject|1|||
16837478|NCT01965938|37781268|FG001|Overall Study|Withdrawal by Subject|0|||
16837479|NCT01958671|37781279|FG000|Overall Study|Adverse Event|1|||
16837480|NCT01958671|37781280|FG001|Overall Study|Adverse Event|1|||
16837481|NCT01958671|37781281|FG002|Overall Study|Adverse Event|5|||
16837482|NCT01958671|37781279|FG000|Overall Study|Death|1|||
16837483|NCT01958671|37781280|FG001|Overall Study|Death|0|||
16837484|NCT01958671|37781281|FG002|Overall Study|Death|0|||
16837485|NCT01958671|37781279|FG000|Overall Study|Excluded medication|0|||
16837486|NCT01958671|37781280|FG001|Overall Study|Excluded medication|0|||
16837487|NCT01958671|37781281|FG002|Overall Study|Excluded medication|1|||
16837488|NCT01958671|37781279|FG000|Overall Study|Hyperglycemia|0|||
16837489|NCT01958671|37781280|FG001|Overall Study|Hyperglycemia|0|||
16837490|NCT01958671|37781281|FG002|Overall Study|Hyperglycemia|2|||
16837491|NCT01958671|37781279|FG000|Overall Study|Lost to Follow-up|7|||
16837492|NCT01958671|37781280|FG001|Overall Study|Lost to Follow-up|11|||
16837493|NCT01958671|37781281|FG002|Overall Study|Lost to Follow-up|7|||
16837494|NCT01958671|37781279|FG000|Overall Study|Non-compliance with study drug|1|||
16837495|NCT01958671|37781280|FG001|Overall Study|Non-compliance with study drug|1|||
16837496|NCT01958671|37781281|FG002|Overall Study|Non-compliance with study drug|1|||
16837497|NCT01958671|37781279|FG000|Overall Study|Pregnancy|0|||
16913152|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913153|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913154|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913155|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913156|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913157|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913158|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
16913159|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913160|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16913161|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
16913162|NCT01474512|38021794|FG000|Post-Treatment Follow-Up|Death|0|||
16913163|NCT01474512|38021795|FG001|Post-Treatment Follow-Up|Death|0|||
16913164|NCT01474512|38021796|FG002|Post-Treatment Follow-Up|Death|0|||
16913165|NCT01474512|38021797|FG003|Post-Treatment Follow-Up|Death|0|||
16913166|NCT01474512|38021798|FG004|Post-Treatment Follow-Up|Death|0|||
16913167|NCT01474512|38021799|FG005|Post-Treatment Follow-Up|Death|0|||
16913168|NCT01474512|38021800|FG006|Post-Treatment Follow-Up|Death|0|||
16913169|NCT01474512|38021801|FG007|Post-Treatment Follow-Up|Death|0|||
16913170|NCT01474512|38021802|FG008|Post-Treatment Follow-Up|Death|0|||
16913171|NCT01474512|38021803|FG009|Post-Treatment Follow-Up|Death|0|||
16837498|NCT01958671|37781280|FG001|Overall Study|Pregnancy|0|||
16837499|NCT01958671|37781281|FG002|Overall Study|Pregnancy|1|||
16837500|NCT01958671|37781279|FG000|Overall Study|Protocol Violation|0|||
16837501|NCT01958671|37781280|FG001|Overall Study|Protocol Violation|1|||
16837502|NCT01958671|37781281|FG002|Overall Study|Protocol Violation|0|||
16837503|NCT01958671|37781279|FG000|Overall Study|Study site terminated by sponsor|1|||
16837504|NCT01958671|37781280|FG001|Overall Study|Study site terminated by sponsor|0|||
16837505|NCT01958671|37781281|FG002|Overall Study|Study site terminated by sponsor|1|||
16837506|NCT01958671|37781279|FG000|Overall Study|Participant moved|0|||
16837507|NCT01958671|37781280|FG001|Overall Study|Participant moved|0|||
16837508|NCT01958671|37781281|FG002|Overall Study|Participant moved|1|||
16837509|NCT01958671|37781279|FG000|Overall Study|Withdrawal by Subject|8|||
16837510|NCT01958671|37781280|FG001|Overall Study|Withdrawal by Subject|10|||
16837511|NCT01958671|37781281|FG002|Overall Study|Withdrawal by Subject|13|||
16837512|NCT01965860|37781296|FG000|Overall Study|Pregnancy|1|||
16837513|NCT01965860|37781297|FG001|Overall Study|Pregnancy|0|||
16837514|NCT01965860|37781298|FG002|Overall Study|Pregnancy|1|||
16837515|NCT01965860|37781296|FG000|Overall Study|Logistics|1|||
16837516|NCT01965860|37781297|FG001|Overall Study|Logistics|0|||
16837517|NCT01965860|37781298|FG002|Overall Study|Logistics|0|||
16837518|NCT01965704|37781319|FG000|Overall Study|Withdrawal by Subject|2|||
16837519|NCT01965704|37781320|FG001|Overall Study|Withdrawal by Subject|2|||
16837520|NCT01965704|37781321|FG002|Overall Study|Withdrawal by Subject|1|||
16837521|NCT01965704|37781322|FG003|Overall Study|Withdrawal by Subject|1|||
16837522|NCT01965704|37781319|FG000|Overall Study|Delivered at home|1|||
16837523|NCT01965704|37781320|FG001|Overall Study|Delivered at home|1|||
16837524|NCT01965704|37781321|FG002|Overall Study|Delivered at home|0|||
16837525|NCT01965704|37781322|FG003|Overall Study|Delivered at home|0|||
16837526|NCT01965704|37781319|FG000|Overall Study|Experienced complications|0|||
16837527|NCT01965704|37781320|FG001|Overall Study|Experienced complications|0|||
16837528|NCT01965704|37781321|FG002|Overall Study|Experienced complications|2|||
16837529|NCT01965704|37781322|FG003|Overall Study|Experienced complications|2|||
16837530|NCT01965704|37781319|FG000|Overall Study|Adverse Event|0|||
16837531|NCT01965704|37781320|FG001|Overall Study|Adverse Event|0|||
16837532|NCT01965704|37781321|FG002|Overall Study|Adverse Event|1|||
16837533|NCT01965704|37781322|FG003|Overall Study|Adverse Event|1|||
16837534|NCT01965704|37781319|FG000|Overall Study|Did not meet inclusion criteria|0|||
16837535|NCT01965704|37781320|FG001|Overall Study|Did not meet inclusion criteria|0|||
16837536|NCT01965704|37781321|FG002|Overall Study|Did not meet inclusion criteria|1|||
16837537|NCT01965704|37781322|FG003|Overall Study|Did not meet inclusion criteria|1|||
16837538|NCT02003365|37781333|FG000|Overall Study|Lost to Follow-up|0|||
16837539|NCT02003365|37781334|FG001|Overall Study|Lost to Follow-up|0|||
16837540|NCT02003365|37781335|FG002|Overall Study|Lost to Follow-up|1|||
16837541|NCT01975220|37781346|FG000|Test Period 1|Not treated|0|||
16837542|NCT01975220|37781347|FG001|Test Period 1|Not treated|1|||
16837543|NCT01975220|37781348|FG002|Test Period 1|Not treated|0|||
16837544|NCT01975220|37781349|FG003|Test Period 1|Not treated|0|||
16837545|NCT01975220|37781350|FG004|Test Period 1|Not treated|0|||
16837546|NCT01975220|37781351|FG005|Test Period 1|Not treated|0|||
16837547|NCT01958437|37781368|FG000|Overall Study|Incidental MRI findings|0|||
16837548|NCT01958437|37781369|FG001|Overall Study|Incidental MRI findings|0|||
16837549|NCT01958437|37781370|FG002|Overall Study|Incidental MRI findings|1|||
16837550|NCT01958437|37781371|FG003|Overall Study|Incidental MRI findings|1|||
16837551|NCT01974752|37781390|FG000|Overall Study|Death|33|||
16837552|NCT01974752|37781391|FG001|Overall Study|Death|11|||
16837553|NCT01974752|37781390|FG000|Overall Study|Lost to Follow-up|2|||
16837554|NCT01974752|37781391|FG001|Overall Study|Lost to Follow-up|0|||
16837555|NCT01974752|37781390|FG000|Overall Study|Withdrawal by Subject|2|||
16837556|NCT01974752|37781391|FG001|Overall Study|Withdrawal by Subject|3|||
16837557|NCT01974752|37781390|FG000|Overall Study|Other Eligibility Criteria|0|||
16837558|NCT01974752|37781391|FG001|Overall Study|Other Eligibility Criteria|1|||
16837559|NCT01999946|37781400|FG000|Overall Study|Participant not released from jail|2|||
16837560|NCT01999946|37781401|FG001|Overall Study|Participant not released from jail|2|||
16837561|NCT01999946|37781402|FG002|Overall Study|Participant not released from jail|0|||
16837562|NCT01999946|37781400|FG000|Overall Study|Not included in primary outcome analysis|0|||
16837563|NCT01999946|37781401|FG001|Overall Study|Not included in primary outcome analysis|0|||
16837564|NCT01999946|37781402|FG002|Overall Study|Not included in primary outcome analysis|79|||
16837565|NCT01958281|37781412|FG000|Overall Study|Lack of Efficacy|5|||
16837566|NCT01958281|37781413|FG001|Overall Study|Lack of Efficacy|2|||
16837567|NCT01958281|37781414|FG002|Overall Study|Lack of Efficacy|0|||
16837568|NCT01958281|37781412|FG000|Overall Study|Adverse Event|0|||
16837569|NCT01958281|37781413|FG001|Overall Study|Adverse Event|2|||
16837570|NCT01958281|37781414|FG002|Overall Study|Adverse Event|0|||
16837571|NCT01958281|37781412|FG000|Overall Study|Withdrew Consent|1|||
16837572|NCT01958281|37781413|FG001|Overall Study|Withdrew Consent|0|||
16837573|NCT01958281|37781414|FG002|Overall Study|Withdrew Consent|0|||
16837574|NCT01958125|37781425|FG000|Overall Study|Missing diary data|2|||
16837575|NCT01958125|37781426|FG001|Overall Study|Missing diary data|6|||
16837576|NCT01958125|37781425|FG000|Overall Study|No headache attacks|0|||
16837577|NCT01958125|37781426|FG001|Overall Study|No headache attacks|2|||
16837578|NCT02002975|37781432|FG000|Overall Study|Case Report Forms Uncollected|135|||
16837579|NCT02002975|37781432|FG000|Overall Study|Protocol Deviation|437|||
16837580|NCT02001181|37781438|FG000|Overall Study|Adverse Event|0|||
16837581|NCT02001181|37781439|FG001|Overall Study|Adverse Event|2|||
16837582|NCT02001181|37781438|FG000|Overall Study|Lost to Follow-up|1|||
16837583|NCT02001181|37781439|FG001|Overall Study|Lost to Follow-up|0|||
16837584|NCT02001181|37781438|FG000|Overall Study|Withdrawal by Subject|0|||
16837585|NCT02001181|37781439|FG001|Overall Study|Withdrawal by Subject|1|||
16837586|NCT01999465|37781447|FG000|Overall Study|Lost to Follow-up|0|||
16837587|NCT01999465|37781448|FG001|Overall Study|Lost to Follow-up|2|||
16837588|NCT01999465|37781447|FG000|Overall Study|Protocol Violation|0|||
16837589|NCT01999465|37781448|FG001|Overall Study|Protocol Violation|1|||
16837590|NCT01982773|37781456|FG000|Overall Study|Withdrawal by Subject|1|||
16837591|NCT01982773|37781457|FG001|Overall Study|Withdrawal by Subject|3|||
16837592|NCT01982773|37781456|FG000|Overall Study|Lost to Follow-up|7|||
16913172|NCT01474512|38021804|FG010|Post-Treatment Follow-Up|Death|0|||
16913173|NCT01474512|38021805|FG011|Post-Treatment Follow-Up|Death|0|||
16913174|NCT01474512|38021806|FG012|Post-Treatment Follow-Up|Death|0|||
16913175|NCT01474512|38021807|FG013|Post-Treatment Follow-Up|Death|0|||
16913176|NCT01474512|38021808|FG014|Post-Treatment Follow-Up|Death|0|||
16913177|NCT01474512|38021809|FG015|Post-Treatment Follow-Up|Death|0|||
16913178|NCT01474512|38021810|FG016|Post-Treatment Follow-Up|Death|1|||
16913179|NCT01474512|38021811|FG017|Post-Treatment Follow-Up|Death|0|||
16913180|NCT01474434|38021845|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
16913181|NCT01474434|38021846|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
16913182|NCT01474434|38021847|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
16913183|NCT01474434|38021848|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
16913184|NCT01474434|38021845|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
16913185|NCT01474434|38021846|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
16913186|NCT01474434|38021847|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
16913187|NCT01474434|38021848|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
16913188|NCT01474434|38021845|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
16913189|NCT01474434|38021846|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
16913190|NCT01474434|38021847|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
16913191|NCT01474434|38021848|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
16913192|NCT01473732|38021864|FG000|Overall Study|Adverse Event|1|||
16913193|NCT01473732|38021865|FG001|Overall Study|Adverse Event|0|||
16913194|NCT01473732|38021864|FG000|Overall Study|Death|1|||
16913195|NCT01473732|38021865|FG001|Overall Study|Death|0|||
16837593|NCT01982773|37781457|FG001|Overall Study|Lost to Follow-up|1|||
16913196|NCT01450098|38021873|FG000|Period 3|Protocol Violation|0|||
16913197|NCT01450098|38021874|FG001|Period 3|Protocol Violation|1|||
16837594|NCT01974206|37781465|FG000|Overall Study|Did Not Take Study Drug|0|||
16837595|NCT01974206|37781466|FG001|Overall Study|Did Not Take Study Drug|1|||
16913198|NCT01450098|38021873|FG000|Period 3|Withdrawal by Subject|0|||
16913199|NCT01450098|38021874|FG001|Period 3|Withdrawal by Subject|2|||
16913200|NCT01449708|38021889|FG000|Overall Study|Protocol Violation|0|||
16913201|NCT01449708|38021890|FG001|Overall Study|Protocol Violation|1|||
16913202|NCT01449708|38021889|FG000|Overall Study|surgical complication|1|||
16913203|NCT01449708|38021890|FG001|Overall Study|surgical complication|2|||
16913204|NCT01449708|38021889|FG000|Overall Study|respiratory failure|1|||
16913205|NCT01449708|38021890|FG001|Overall Study|respiratory failure|0|||
16913206|NCT01449630|38021908|FG000|Period 1|Physician Decision|1|||
16913207|NCT01449630|38021909|FG001|Period 1|Physician Decision|0|||
16913208|NCT01449630|38021910|FG002|Period 1|Physician Decision|0|||
16913209|NCT01449630|38021911|FG003|Period 1|Physician Decision|1|||
16913210|NCT01449630|38021912|FG004|Period 1|Physician Decision|0|||
16913211|NCT01449630|38021913|FG005|Period 1|Physician Decision|0|||
16913212|NCT01449630|38021914|FG006|Period 1|Physician Decision|0|||
16913213|NCT01449630|38021915|FG007|Period 1|Physician Decision|0|||
16913214|NCT01449630|38021916|FG008|Period 1|Physician Decision|0|||
16913215|NCT01449630|38021908|FG000|Period 1|Sponsor Decision|0|||
16913216|NCT01449630|38021909|FG001|Period 1|Sponsor Decision|0|||
16913217|NCT01449630|38021910|FG002|Period 1|Sponsor Decision|0|||
16913218|NCT01449630|38021911|FG003|Period 1|Sponsor Decision|0|||
16913219|NCT01449630|38021912|FG004|Period 1|Sponsor Decision|0|||
16913220|NCT01449630|38021913|FG005|Period 1|Sponsor Decision|1|||
16913221|NCT01449630|38021914|FG006|Period 1|Sponsor Decision|0|||
16913222|NCT01449630|38021915|FG007|Period 1|Sponsor Decision|0|||
16913223|NCT01449630|38021916|FG008|Period 1|Sponsor Decision|0|||
16913224|NCT01449630|38021908|FG000|Period 2|Sponsor Decision|0|||
16913225|NCT01449630|38021909|FG001|Period 2|Sponsor Decision|0|||
16913226|NCT01449630|38021910|FG002|Period 2|Sponsor Decision|0|||
16913227|NCT01449630|38021911|FG003|Period 2|Sponsor Decision|0|||
16913228|NCT01449630|38021912|FG004|Period 2|Sponsor Decision|0|||
16913229|NCT01449630|38021913|FG005|Period 2|Sponsor Decision|0|||
16913230|NCT01449630|38021914|FG006|Period 2|Sponsor Decision|1|||
16913231|NCT01449630|38021915|FG007|Period 2|Sponsor Decision|0|||
16913232|NCT01449630|38021916|FG008|Period 2|Sponsor Decision|0|||
16913233|NCT01493778|38021938|FG000|Overall Study|Withdrawal by Subject|8|||
16913234|NCT01473420|38021953|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
16913235|NCT01473420|38021954|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
16913236|NCT01473420|38021953|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
16837596|NCT01974206|37781465|FG000|Overall Study|Physician Decision|1|||
16837597|NCT01974206|37781466|FG001|Overall Study|Physician Decision|0|||
16837598|NCT01974206|37781465|FG000|Overall Study|Withdrawal by Subject|3|||
16837599|NCT01974206|37781466|FG001|Overall Study|Withdrawal by Subject|0|||
16837600|NCT01974206|37781465|FG000|Overall Study|Lost to Follow-up|1|||
16837601|NCT01974206|37781466|FG001|Overall Study|Lost to Follow-up|0|||
16837602|NCT01974206|37781465|FG000|Overall Study|Death|1|||
16837603|NCT01974206|37781466|FG001|Overall Study|Death|0|||
16837604|NCT01999868|37781475|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
16837605|NCT01999868|37781476|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
16837606|NCT01999868|37781477|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
16837607|NCT01999868|37781475|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
16837608|NCT01999868|37781476|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
16837609|NCT01999868|37781477|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
16837610|NCT01999868|37781475|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
16837611|NCT01999868|37781476|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
16837612|NCT01999868|37781477|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
16837613|NCT01999868|37781475|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
16837614|NCT01999868|37781476|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
16837615|NCT01999868|37781477|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
16837616|NCT01999868|37781475|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
16837617|NCT01999868|37781476|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
16837618|NCT01999868|37781477|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
16913237|NCT01473420|38021954|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
16913238|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
16913239|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
16913240|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
16913241|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
16913242|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
16913243|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
16913244|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
16913245|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
16913246|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
16913247|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
16913248|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
16913249|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
16913250|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
16913251|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
16913252|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
16913253|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
16913254|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
16913255|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
16913256|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
16913257|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
16913258|NCT01473420|38021953|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
16913259|NCT01473420|38021954|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
16913260|NCT01492686|38021968|FG000|Double-blind Phase|Adverse Event|0|||
16913261|NCT01492686|38021969|FG001|Double-blind Phase|Adverse Event|2|||
16913262|NCT01492686|38021968|FG000|Double-blind Phase|Physician Decision|0|||
16913263|NCT01492686|38021969|FG001|Double-blind Phase|Physician Decision|1|||
16913264|NCT01492686|38021968|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16837619|NCT01999868|37781475|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
16913265|NCT01492686|38021969|FG001|Double-blind Phase|Withdrawal by Subject|2|||
16913266|NCT01492686|38021968|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
16913267|NCT01492686|38021969|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
16913268|NCT01492686|38021968|FG000|Open-label Phase|Adverse Event|1|||
16913269|NCT01492686|38021969|FG001|Open-label Phase|Adverse Event|2|||
16913270|NCT01492686|38021968|FG000|Open-label Phase|Physician Decision|1|||
16913271|NCT01492686|38021969|FG001|Open-label Phase|Physician Decision|0|||
16913272|NCT01492686|38021968|FG000|Open-label Phase|Withdrawal by Subject|6|||
16913273|NCT01492686|38021969|FG001|Open-label Phase|Withdrawal by Subject|7|||
16913274|NCT01492686|38021968|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
16913275|NCT01492686|38021969|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
16913276|NCT01449006|38021979|FG000|Overall Study|Lost to Follow-up|1|||
16913277|NCT01449006|38021980|FG001|Overall Study|Lost to Follow-up|0|||
16913278|NCT01449006|38021979|FG000|Overall Study|Withdrawal by Subject|1|||
16913279|NCT01449006|38021980|FG001|Overall Study|Withdrawal by Subject|0|||
16913280|NCT01449006|38021979|FG000|Overall Study|Protocol Violation|1|||
16913281|NCT01449006|38021980|FG001|Overall Study|Protocol Violation|0|||
16913282|NCT01448850|38021988|FG000|Overall Study|Death|3|||
16837620|NCT01999868|37781476|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
16837621|NCT01999868|37781477|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
16837622|NCT01999868|37781475|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
16837623|NCT01999868|37781476|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
16837624|NCT01999868|37781477|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
16837625|NCT01999868|37781475|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
16837626|NCT01999868|37781476|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
16837627|NCT01999868|37781477|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
16837628|NCT01999868|37781475|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
16837629|NCT01999868|37781476|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
16837630|NCT01999868|37781477|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
16837631|NCT01999868|37781475|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
16837632|NCT01999868|37781476|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
16837633|NCT01999868|37781477|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
16837634|NCT01999868|37781475|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
16837635|NCT01999868|37781476|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
16837636|NCT01999868|37781477|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
16837637|NCT01999868|37781475|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
16837638|NCT01999868|37781476|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
16837639|NCT01999868|37781477|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
16837640|NCT01999868|37781475|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
16837641|NCT01999868|37781476|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
16837642|NCT01999868|37781477|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
16837643|NCT01999868|37781475|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
16837644|NCT01999868|37781476|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
16837645|NCT01999868|37781477|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
16837646|NCT01999868|37781475|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
16837647|NCT01999868|37781476|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
16837648|NCT01999868|37781477|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
16913283|NCT01448850|38021989|FG001|Overall Study|Death|6|||
16913284|NCT01448850|38021988|FG000|Overall Study|Withdrawal by Subject|13|||
16913285|NCT01448850|38021989|FG001|Overall Study|Withdrawal by Subject|21|||
16913286|NCT01448850|38021988|FG000|Overall Study|Lost to Follow-up|3|||
16913287|NCT01448850|38021989|FG001|Overall Study|Lost to Follow-up|1|||
16837649|NCT01957579|37781489|FG000|Overall Study|Withdrawal of concent|0|||
16837650|NCT01957579|37781490|FG001|Overall Study|Withdrawal of concent|1|||
16837651|NCT01957579|37781491|FG002|Overall Study|Withdrawal of concent|0|||
16837652|NCT01957579|37781492|FG003|Overall Study|Withdrawal of concent|0|||
16837653|NCT01957579|37781489|FG000|Overall Study|Death|0|||
16837654|NCT01957579|37781490|FG001|Overall Study|Death|0|||
16837655|NCT01957579|37781491|FG002|Overall Study|Death|2|||
16837656|NCT01957579|37781492|FG003|Overall Study|Death|0|||
16837657|NCT01999322|37781521|FG000|Overall Study|Adverse Event|1|||
16837658|NCT01999322|37781522|FG001|Overall Study|Adverse Event|0|||
16837659|NCT01996982|37781528|FG000|Overall Study|PI/team left institution|7|||
16837660|NCT01965158|37781534|FG000|Overall Study|Adverse Event|14|||
16837661|NCT01965158|37781535|FG001|Overall Study|Adverse Event|5|||
16837662|NCT01965158|37781534|FG000|Overall Study|Withdrawal by Subject|16|||
16837663|NCT01965158|37781535|FG001|Overall Study|Withdrawal by Subject|24|||
16837664|NCT01965158|37781534|FG000|Overall Study|Lost to Follow-up|7|||
16837665|NCT01965158|37781535|FG001|Overall Study|Lost to Follow-up|5|||
16837666|NCT01965158|37781534|FG000|Overall Study|Protocol Violation|1|||
16837667|NCT01965158|37781535|FG001|Overall Study|Protocol Violation|1|||
16837668|NCT01965158|37781534|FG000|Overall Study|Other - Miscellaneous|3|||
16837669|NCT01965158|37781535|FG001|Overall Study|Other - Miscellaneous|0|||
16837670|NCT01964924|37781541|FG000|Trametinib Monotherapy|Progression|19|||
16837671|NCT01964924|37781542|FG001|Trametinib Monotherapy|Progression|0|||
16837672|NCT01964378|37781553|FG000|Overall Study|Disc. due to death before first dosing|0|||
16837673|NCT01964378|37781554|FG001|Overall Study|Disc. due to death before first dosing|1|||
16837674|NCT01964378|37781553|FG000|Overall Study|Disc. due to AE before first dosing|1|||
16837675|NCT01964378|37781554|FG001|Overall Study|Disc. due to AE before first dosing|0|||
16837676|NCT01964378|37781553|FG000|Overall Study|Death|3|||
16913288|NCT01448850|38021988|FG000|Overall Study|Other|15|||
16913289|NCT01448850|38021989|FG001|Overall Study|Other|12|||
16913290|NCT01491672|38021999|FG000|Overall Study|Lost to Follow-up|0|||
16913291|NCT01491672|38022000|FG001|Overall Study|Lost to Follow-up|4|||
16913292|NCT01491672|38022001|FG002|Overall Study|Lost to Follow-up|1|||
16913293|NCT01491672|38021999|FG000|Overall Study|Withdrawal by Subject|6|||
16913294|NCT01491672|38022000|FG001|Overall Study|Withdrawal by Subject|7|||
16913295|NCT01491672|38022001|FG002|Overall Study|Withdrawal by Subject|0|||
16913296|NCT01491672|38021999|FG000|Overall Study|Adverse Event|8|||
16913297|NCT01491672|38022000|FG001|Overall Study|Adverse Event|10|||
16913298|NCT01491672|38022001|FG002|Overall Study|Adverse Event|4|||
16913299|NCT01491672|38021999|FG000|Overall Study|Disease progression|42|||
16913300|NCT01491672|38022000|FG001|Overall Study|Disease progression|34|||
16913301|NCT01491672|38022001|FG002|Overall Study|Disease progression|6|||
16913302|NCT01491672|38021999|FG000|Overall Study|Protocol deviation|0|||
16913303|NCT01491672|38022000|FG001|Overall Study|Protocol deviation|1|||
16913304|NCT01491672|38022001|FG002|Overall Study|Protocol deviation|0|||
16913305|NCT01491672|38021999|FG000|Overall Study|Death|0|||
16913306|NCT01491672|38022000|FG001|Overall Study|Death|4|||
16913307|NCT01491672|38022001|FG002|Overall Study|Death|0|||
16913308|NCT01447446|38022017|FG000|Overall Study|Death|6|||
16913309|NCT01447446|38022018|FG001|Overall Study|Death|3|||
16913310|NCT01447446|38022019|FG002|Overall Study|Death|2|||
16913311|NCT01447446|38022020|FG003|Overall Study|Death|1|||
16913312|NCT01447446|38022021|FG004|Overall Study|Death|7|||
16913313|NCT01447446|38022022|FG005|Overall Study|Death|0|||
16913314|NCT01447446|38022017|FG000|Overall Study|Adverse Event|3|||
16913315|NCT01447446|38022018|FG001|Overall Study|Adverse Event|0|||
16913316|NCT01447446|38022019|FG002|Overall Study|Adverse Event|1|||
16913317|NCT01447446|38022020|FG003|Overall Study|Adverse Event|0|||
16913318|NCT01447446|38022021|FG004|Overall Study|Adverse Event|2|||
16913319|NCT01447446|38022022|FG005|Overall Study|Adverse Event|0|||
16913320|NCT01447446|38022017|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
16913321|NCT01447446|38022018|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
16913322|NCT01447446|38022019|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
16837677|NCT01964378|37781554|FG001|Overall Study|Death|2|||
16837678|NCT01964378|37781553|FG000|Overall Study|Adverse Event|12|||
16837679|NCT01964378|37781554|FG001|Overall Study|Adverse Event|5|||
16837680|NCT01964378|37781553|FG000|Overall Study|Lack of Efficacy|0|||
16837681|NCT01964378|37781554|FG001|Overall Study|Lack of Efficacy|1|||
16913323|NCT01447446|38022020|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
16913324|NCT01447446|38022021|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
16913325|NCT01447446|38022022|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
16913326|NCT01447446|38022017|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
16913327|NCT01447446|38022018|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
16913328|NCT01447446|38022019|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
16913329|NCT01447446|38022020|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
16837682|NCT01964378|37781553|FG000|Overall Study|Protocol Violation|0|||
16913330|NCT01447446|38022021|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
16913331|NCT01447446|38022022|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
16837683|NCT01964378|37781554|FG001|Overall Study|Protocol Violation|1|||
16837684|NCT01964378|37781553|FG000|Overall Study|Lost to Follow-up|0|||
16837685|NCT01964378|37781554|FG001|Overall Study|Lost to Follow-up|1|||
16837686|NCT01964378|37781553|FG000|Overall Study|Withdrawal by Subject|7|||
16837687|NCT01964378|37781554|FG001|Overall Study|Withdrawal by Subject|5|||
16837688|NCT01964378|37781553|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
16837689|NCT01964378|37781554|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
16837690|NCT01964378|37781553|FG000|Overall Study|Other|1|||
16837691|NCT01964378|37781554|FG001|Overall Study|Other|2|||
16837692|NCT01442038|37781562|FG000|Overall Study|Death|35|||
16837693|NCT01442038|37781563|FG001|Overall Study|Death|29|||
16837694|NCT01442038|37781562|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
16837695|NCT01442038|37781563|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
16837696|NCT01442038|37781562|FG000|Overall Study|Participant Withdrew Consent|137|||
16837697|NCT01442038|37781563|FG001|Overall Study|Participant Withdrew Consent|102|||
16837698|NCT01442038|37781562|FG000|Overall Study|Lost to Follow-up|37|||
16837699|NCT01442038|37781563|FG001|Overall Study|Lost to Follow-up|51|||
16837700|NCT01442038|37781562|FG000|Overall Study|Adverse Event|26|||
16837701|NCT01442038|37781563|FG001|Overall Study|Adverse Event|15|||
16837702|NCT01442038|37781562|FG000|Overall Study|Protocol Deviation|9|||
16837703|NCT01442038|37781563|FG001|Overall Study|Protocol Deviation|20|||
16837704|NCT01442038|37781562|FG000|Overall Study|Investigator's Discretion|13|||
16837705|NCT01442038|37781563|FG001|Overall Study|Investigator's Discretion|16|||
16837706|NCT01442038|37781562|FG000|Overall Study|Study Terminated By Sponsor|2|||
16837707|NCT01442038|37781563|FG001|Overall Study|Study Terminated By Sponsor|3|||
16837708|NCT01998919|37781571|FG000|Overall Study|Death|2|||
16837709|NCT01998919|37781572|FG001|Overall Study|Death|2|||
16837710|NCT01998919|37781571|FG000|Overall Study|Adverse Event|0|||
16837711|NCT01998919|37781572|FG001|Overall Study|Adverse Event|5|||
16837712|NCT01998919|37781571|FG000|Overall Study|Disease progression|31|||
16837713|NCT01998919|37781572|FG001|Overall Study|Disease progression|22|||
16837714|NCT01998919|37781571|FG000|Overall Study|Withdrawal by Subject|2|||
16837715|NCT01998919|37781572|FG001|Overall Study|Withdrawal by Subject|4|||
16837716|NCT01998919|37781571|FG000|Overall Study|Lost to Follow-up|2|||
16837717|NCT01998919|37781572|FG001|Overall Study|Lost to Follow-up|0|||
16837718|NCT01998919|37781571|FG000|Overall Study|Other|5|||
16837719|NCT01998919|37781572|FG001|Overall Study|Other|2|||
16837720|NCT01957111|37781580|FG000|Overall Study|Withdrawal by Subject|1|||
16837721|NCT01957111|37781581|FG001|Overall Study|Withdrawal by Subject|1|||
16837722|NCT01964300|37781589|FG000|Overall Study|Ineligible after enrollment|0|||
16837723|NCT01964300|37781590|FG001|Overall Study|Ineligible after enrollment|1|||
16837724|NCT01964300|37781589|FG000|Overall Study|Adverse Event|1|||
16837725|NCT01964300|37781590|FG001|Overall Study|Adverse Event|1|||
16837726|NCT01964300|37781589|FG000|Overall Study|Lack of Efficacy|3|||
16837727|NCT01964300|37781590|FG001|Overall Study|Lack of Efficacy|5|||
16837728|NCT01964300|37781589|FG000|Overall Study|Withdrawal by Subject|0|||
16837729|NCT01964300|37781590|FG001|Overall Study|Withdrawal by Subject|1|||
16837730|NCT01964300|37781589|FG000|Overall Study|To receive alternative therapy|1|||
16837731|NCT01964300|37781590|FG001|Overall Study|To receive alternative therapy|2|||
16837732|NCT01964300|37781589|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
16837733|NCT01964300|37781590|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
16837734|NCT01964300|37781589|FG000|Overall Study|Weight criteria not met|0|||
16837735|NCT01964300|37781590|FG001|Overall Study|Weight criteria not met|1|||
16837736|NCT01964222|37781598|FG000|Overall Study|Lost to Follow-up|7|||
16837737|NCT01964222|37781599|FG001|Overall Study|Lost to Follow-up|5|||
16837738|NCT01964222|37781598|FG000|Overall Study|Withdrawal by Subject|6|||
16837739|NCT01964222|37781599|FG001|Overall Study|Withdrawal by Subject|6|||
16837740|NCT01964222|37781598|FG000|Overall Study|Screening Failure|2|||
16837741|NCT01964222|37781599|FG001|Overall Study|Screening Failure|0|||
16837742|NCT01467700|37781609|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
16837743|NCT01467700|37781610|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
16837744|NCT01467700|37781611|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
16837745|NCT01467700|37781612|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
16837746|NCT01467700|37781609|FG000|Overall Study|Major Protocol Deviation|3|||
16837747|NCT01467700|37781610|FG001|Overall Study|Major Protocol Deviation|3|||
16837748|NCT01467700|37781611|FG002|Overall Study|Major Protocol Deviation|2|||
16837749|NCT01467700|37781612|FG003|Overall Study|Major Protocol Deviation|3|||
16837750|NCT01467700|37781609|FG000|Overall Study|Lost to Follow-up|6|||
16837751|NCT01467700|37781610|FG001|Overall Study|Lost to Follow-up|5|||
16837752|NCT01467700|37781611|FG002|Overall Study|Lost to Follow-up|2|||
16837753|NCT01467700|37781612|FG003|Overall Study|Lost to Follow-up|3|||
16837754|NCT01467700|37781609|FG000|Overall Study|Voluntary Withdrawal|5|||
16837755|NCT01467700|37781610|FG001|Overall Study|Voluntary Withdrawal|7|||
16837756|NCT01467700|37781611|FG002|Overall Study|Voluntary Withdrawal|6|||
16837757|NCT01467700|37781612|FG003|Overall Study|Voluntary Withdrawal|2|||
16837758|NCT01467700|37781609|FG000|Overall Study|Study Termination|6|||
16837759|NCT01467700|37781610|FG001|Overall Study|Study Termination|5|||
16837760|NCT01467700|37781611|FG002|Overall Study|Study Termination|10|||
16837761|NCT01467700|37781612|FG003|Overall Study|Study Termination|7|||
16837762|NCT01467700|37781609|FG000|Overall Study|Pregnancy|0|||
16837763|NCT01467700|37781610|FG001|Overall Study|Pregnancy|1|||
16837764|NCT01467700|37781611|FG002|Overall Study|Pregnancy|1|||
16837765|NCT01467700|37781612|FG003|Overall Study|Pregnancy|0|||
16837766|NCT01467700|37781609|FG000|Overall Study|Lack of Efficacy|2|||
16837767|NCT01467700|37781610|FG001|Overall Study|Lack of Efficacy|0|||
16913332|NCT01447446|38022017|FG000|Overall Study|Administrative/Other|34|||
16913333|NCT01447446|38022018|FG001|Overall Study|Administrative/Other|9|||
16913334|NCT01447446|38022019|FG002|Overall Study|Administrative/Other|10|||
16913335|NCT01447446|38022020|FG003|Overall Study|Administrative/Other|2|||
16913336|NCT01447446|38022021|FG004|Overall Study|Administrative/Other|33|||
16913337|NCT01447446|38022022|FG005|Overall Study|Administrative/Other|4|||
16913338|NCT01447446|38022017|FG000|Overall Study|SVR12 Assessment|13|||
16913339|NCT01447446|38022018|FG001|Overall Study|SVR12 Assessment|1|||
16913340|NCT01447446|38022019|FG002|Overall Study|SVR12 Assessment|2|||
16913341|NCT01447446|38022020|FG003|Overall Study|SVR12 Assessment|1|||
16913342|NCT01447446|38022021|FG004|Overall Study|SVR12 Assessment|5|||
16913343|NCT01447446|38022022|FG005|Overall Study|SVR12 Assessment|5|||
16913344|NCT01447446|38022017|FG000|Overall Study|New Treatment Started|8|||
16913345|NCT01447446|38022018|FG001|Overall Study|New Treatment Started|2|||
16913346|NCT01447446|38022019|FG002|Overall Study|New Treatment Started|1|||
16913347|NCT01447446|38022020|FG003|Overall Study|New Treatment Started|0|||
16913348|NCT01447446|38022021|FG004|Overall Study|New Treatment Started|2|||
16913349|NCT01447446|38022022|FG005|Overall Study|New Treatment Started|0|||
16913350|NCT01447446|38022017|FG000|Overall Study|Reason not Specified|1|||
16913351|NCT01447446|38022018|FG001|Overall Study|Reason not Specified|1|||
16913352|NCT01447446|38022019|FG002|Overall Study|Reason not Specified|1|||
16913353|NCT01447446|38022020|FG003|Overall Study|Reason not Specified|1|||
16913354|NCT01447446|38022021|FG004|Overall Study|Reason not Specified|1|||
16913355|NCT01447446|38022022|FG005|Overall Study|Reason not Specified|0|||
16913356|NCT01490814|38022044|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
16913357|NCT01490814|38022045|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
16913358|NCT01490814|38022044|FG000|Overall Study|Physician Decision|1|||
16913359|NCT01490814|38022045|FG001|Overall Study|Physician Decision|0|||
16913360|NCT01490814|38022044|FG000|Overall Study|Withdrawal by Subject|0|||
16913361|NCT01490814|38022045|FG001|Overall Study|Withdrawal by Subject|5|||
16913362|NCT01471782|38022057|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
16913363|NCT01471782|38022058|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
16913364|NCT01471782|38022059|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
16913365|NCT01471782|38022060|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
16913366|NCT01471782|38022061|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
16913367|NCT01471782|38022062|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
16913368|NCT01471782|38022057|FG000|Overall Study|Lack of Efficacy|1|||
16913369|NCT01471782|38022058|FG001|Overall Study|Lack of Efficacy|2|||
16913370|NCT01471782|38022059|FG002|Overall Study|Lack of Efficacy|1|||
16913371|NCT01471782|38022060|FG003|Overall Study|Lack of Efficacy|1|||
16913372|NCT01471782|38022061|FG004|Overall Study|Lack of Efficacy|5|||
16913373|NCT01471782|38022062|FG005|Overall Study|Lack of Efficacy|18|||
16913374|NCT01471782|38022057|FG000|Overall Study|Adverse Event|1|||
16913375|NCT01471782|38022058|FG001|Overall Study|Adverse Event|1|||
16913376|NCT01471782|38022059|FG002|Overall Study|Adverse Event|2|||
16913377|NCT01471782|38022060|FG003|Overall Study|Adverse Event|2|||
16913378|NCT01471782|38022061|FG004|Overall Study|Adverse Event|3|||
16913379|NCT01471782|38022062|FG005|Overall Study|Adverse Event|1|||
16913380|NCT01471782|38022057|FG000|Overall Study|Other|0|||
16913381|NCT01471782|38022058|FG001|Overall Study|Other|0|||
16913382|NCT01471782|38022059|FG002|Overall Study|Other|1|||
16913383|NCT01471782|38022060|FG003|Overall Study|Other|1|||
16913384|NCT01471782|38022061|FG004|Overall Study|Other|6|||
16913385|NCT01471782|38022062|FG005|Overall Study|Other|5|||
16913386|NCT01471782|38022057|FG000|Overall Study|Change of Chemotherapy|1|||
16913387|NCT01471782|38022058|FG001|Overall Study|Change of Chemotherapy|1|||
16913388|NCT01471782|38022059|FG002|Overall Study|Change of Chemotherapy|0|||
16913389|NCT01471782|38022060|FG003|Overall Study|Change of Chemotherapy|0|||
16913390|NCT01471782|38022061|FG004|Overall Study|Change of Chemotherapy|1|||
16913391|NCT01471782|38022062|FG005|Overall Study|Change of Chemotherapy|4|||
16913392|NCT01471782|38022057|FG000|Overall Study|Disease Relapse|0|||
16913393|NCT01471782|38022058|FG001|Overall Study|Disease Relapse|0|||
16913394|NCT01471782|38022059|FG002|Overall Study|Disease Relapse|0|||
16837768|NCT01467700|37781611|FG002|Overall Study|Lack of Efficacy|2|||
16913395|NCT01471782|38022060|FG003|Overall Study|Disease Relapse|1|||
16913396|NCT01471782|38022061|FG004|Overall Study|Disease Relapse|2|||
16913397|NCT01471782|38022062|FG005|Overall Study|Disease Relapse|1|||
16913398|NCT01471782|38022057|FG000|Overall Study|Physician Decision|0|||
16913399|NCT01471782|38022058|FG001|Overall Study|Physician Decision|0|||
16837769|NCT01467700|37781612|FG003|Overall Study|Lack of Efficacy|1|||
16837770|NCT01467700|37781609|FG000|Overall Study|Reason not Specified|1|||
16837771|NCT01467700|37781610|FG001|Overall Study|Reason not Specified|3|||
16837772|NCT01467700|37781611|FG002|Overall Study|Reason not Specified|2|||
16837773|NCT01467700|37781612|FG003|Overall Study|Reason not Specified|8|||
16837774|NCT01972724|37781625|FG000|Double-Blind|Rescue Criteria Met|1|||
16837775|NCT01972724|37781626|FG001|Double-Blind|Rescue Criteria Met|0|||
16837776|NCT01972724|37781627|FG002|Double-Blind|Rescue Criteria Met|0|||
16837777|NCT01972724|37781625|FG000|Double-Blind|Adverse Event|1|||
16837778|NCT01972724|37781626|FG001|Double-Blind|Adverse Event|0|||
16837779|NCT01972724|37781627|FG002|Double-Blind|Adverse Event|0|||
16837780|NCT01972724|37781625|FG000|Double-Blind|Withdrawal of Consent|2|||
16837781|NCT01972724|37781626|FG001|Double-Blind|Withdrawal of Consent|1|||
16837782|NCT01972724|37781627|FG002|Double-Blind|Withdrawal of Consent|0|||
16837783|NCT01972724|37781625|FG000|Double-Blind|Significant Protocol Deviation|5|||
16837784|NCT01972724|37781626|FG001|Double-Blind|Significant Protocol Deviation|8|||
16837785|NCT01972724|37781627|FG002|Double-Blind|Significant Protocol Deviation|0|||
16913400|NCT01471782|38022059|FG002|Overall Study|Physician Decision|0|||
16913401|NCT01471782|38022060|FG003|Overall Study|Physician Decision|0|||
16913402|NCT01471782|38022061|FG004|Overall Study|Physician Decision|3|||
16913403|NCT01471782|38022062|FG005|Overall Study|Physician Decision|8|||
16913404|NCT01471782|38022057|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16913405|NCT01471782|38022058|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16913406|NCT01471782|38022059|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16913407|NCT01471782|38022060|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16913408|NCT01471782|38022061|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
16913409|NCT01471782|38022062|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
16913410|NCT01471782|38022057|FG000|Overall Study|Death|0|||
16913411|NCT01471782|38022058|FG001|Overall Study|Death|0|||
16913412|NCT01471782|38022059|FG002|Overall Study|Death|0|||
16913413|NCT01471782|38022060|FG003|Overall Study|Death|0|||
16913414|NCT01471782|38022061|FG004|Overall Study|Death|0|||
16913415|NCT01471782|38022062|FG005|Overall Study|Death|1|||
16913416|NCT01490580|38022089|FG000|Overall Study|Parents withdrew consent|0|||
17016772|NCT00689728|38161411|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
16837786|NCT01972724|37781625|FG000|Open-Label|Withdrew Consent|0|||
16837787|NCT01972724|37781626|FG001|Open-Label|Withdrew Consent|0|||
16837788|NCT01972724|37781627|FG002|Open-Label|Withdrew Consent|3|||
16837789|NCT01972724|37781625|FG000|Open-Label|Significant Protocol Deviation|0|||
16837790|NCT01972724|37781626|FG001|Open-Label|Significant Protocol Deviation|0|||
16837791|NCT01972724|37781627|FG002|Open-Label|Significant Protocol Deviation|2|||
16837792|NCT01441960|37781635|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
16837793|NCT01441960|37781636|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
16837794|NCT01441960|37781635|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
16837795|NCT01441960|37781636|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
16837796|NCT01441960|37781635|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
16837797|NCT01441960|37781636|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
16837798|NCT01955707|37781652|FG000|Overall Study|Adverse Event|1|||
16837799|NCT01955707|37781653|FG001|Overall Study|Adverse Event|2|||
16837800|NCT01955707|37781652|FG000|Overall Study|Lost to Follow-up|2|||
16837801|NCT01955707|37781653|FG001|Overall Study|Lost to Follow-up|1|||
16837802|NCT01955707|37781652|FG000|Overall Study|Withdrawal by Subject|0|||
16837803|NCT01955707|37781653|FG001|Overall Study|Withdrawal by Subject|3|||
16837804|NCT01955707|37781652|FG000|Overall Study|Death|13|||
16837805|NCT01955707|37781653|FG001|Overall Study|Death|14|||
16837806|NCT01955707|37781652|FG000|Overall Study|Other|4|||
16837807|NCT01955707|37781653|FG001|Overall Study|Other|2|||
16837808|NCT01435798|37781659|FG000|Overall Study|Withdrawal by Subject|1|||
16837809|NCT01972568|37781672|FG000|Overall Study|Other events|3|||
16837810|NCT01972568|37781673|FG001|Overall Study|Other events|0|||
16837811|NCT01972568|37781674|FG002|Overall Study|Other events|0|||
16837812|NCT01972568|37781672|FG000|Overall Study|Lack of Efficacy|0|||
16837813|NCT01972568|37781673|FG001|Overall Study|Lack of Efficacy|1|||
16837814|NCT01972568|37781674|FG002|Overall Study|Lack of Efficacy|2|||
16837815|NCT01972568|37781672|FG000|Overall Study|Protocol Violation|1|||
16837816|NCT01972568|37781673|FG001|Overall Study|Protocol Violation|2|||
16837817|NCT01972568|37781674|FG002|Overall Study|Protocol Violation|2|||
16837818|NCT01972568|37781672|FG000|Overall Study|Withdrawal by Subject|6|||
16837819|NCT01972568|37781673|FG001|Overall Study|Withdrawal by Subject|3|||
16837820|NCT01972568|37781674|FG002|Overall Study|Withdrawal by Subject|7|||
16837821|NCT01972568|37781672|FG000|Overall Study|Lost to Follow-up|1|||
16837822|NCT01972568|37781673|FG001|Overall Study|Lost to Follow-up|0|||
16837823|NCT01972568|37781674|FG002|Overall Study|Lost to Follow-up|0|||
16837824|NCT01972568|37781672|FG000|Overall Study|Adverse Event|5|||
16837825|NCT01972568|37781673|FG001|Overall Study|Adverse Event|6|||
16837826|NCT01972568|37781674|FG002|Overall Study|Adverse Event|5|||
16913417|NCT01490580|38022090|FG001|Overall Study|Parents withdrew consent|2|||
16913418|NCT01490190|38022100|FG000|Overall Study|Withdrawal by Subject|9|||
16837827|NCT01955161|37781685|FG000|Overall Study|Withdrawal before treatment|2|||
16837828|NCT01955161|37781686|FG001|Overall Study|Withdrawal before treatment|0|||
16837829|NCT01955161|37781687|FG002|Overall Study|Withdrawal before treatment|1|||
16837830|NCT01955161|37781685|FG000|Overall Study|Adverse Event|10|||
16837831|NCT01955161|37781686|FG001|Overall Study|Adverse Event|14|||
16837832|NCT01955161|37781687|FG002|Overall Study|Adverse Event|15|||
16837833|NCT01955161|37781685|FG000|Overall Study|Death|1|||
16837834|NCT01955161|37781686|FG001|Overall Study|Death|1|||
16837835|NCT01955161|37781687|FG002|Overall Study|Death|3|||
16837836|NCT01955161|37781685|FG000|Overall Study|Withdrawal by Subject|9|||
16837837|NCT01955161|37781686|FG001|Overall Study|Withdrawal by Subject|8|||
16837838|NCT01955161|37781687|FG002|Overall Study|Withdrawal by Subject|12|||
16837839|NCT01955161|37781685|FG000|Overall Study|Protocol Violation|2|||
16837840|NCT01955161|37781686|FG001|Overall Study|Protocol Violation|0|||
16837841|NCT01955161|37781687|FG002|Overall Study|Protocol Violation|0|||
16837842|NCT01955161|37781685|FG000|Overall Study|Other reason: physician decision|0|||
16837843|NCT01955161|37781686|FG001|Overall Study|Other reason: physician decision|1|||
16837844|NCT01955161|37781687|FG002|Overall Study|Other reason: physician decision|1|||
16837845|NCT01955161|37781685|FG000|Overall Study|Other reason: disallowed medication|1|||
16837846|NCT01955161|37781686|FG001|Overall Study|Other reason: disallowed medication|0|||
16837847|NCT01955161|37781687|FG002|Overall Study|Other reason: disallowed medication|1|||
16837848|NCT01955161|37781685|FG000|Overall Study|Other reason: caregiver unavailable|1|||
16837849|NCT01955161|37781686|FG001|Overall Study|Other reason: caregiver unavailable|0|||
16837850|NCT01955161|37781687|FG002|Overall Study|Other reason: caregiver unavailable|0|||
16837851|NCT01955161|37781685|FG000|Overall Study|Other reason: moved to nursing home|0|||
16837852|NCT01955161|37781686|FG001|Overall Study|Other reason: moved to nursing home|1|||
16837853|NCT01955161|37781687|FG002|Overall Study|Other reason: moved to nursing home|0|||
16837854|NCT01955161|37781685|FG000|Overall Study|Other reason: insufficient compliance|0|||
16837855|NCT01955161|37781686|FG001|Overall Study|Other reason: insufficient compliance|0|||
16837856|NCT01955161|37781687|FG002|Overall Study|Other reason: insufficient compliance|1|||
16837857|NCT01955161|37781685|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
16837858|NCT01955161|37781686|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
16837859|NCT01955161|37781687|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
16837860|NCT01955161|37781685|FG000|Overall Study|Other reason: patient's will|0|||
16837861|NCT01955161|37781686|FG001|Overall Study|Other reason: patient's will|0|||
16837862|NCT01955161|37781687|FG002|Overall Study|Other reason: patient's will|1|||
16837863|NCT01441414|37781695|FG000|Overall Study|Participant died|9|||
16837864|NCT01441414|37781695|FG000|Overall Study|Other reasons|3|||
16837865|NCT01441414|37781695|FG000|Overall Study|Study terminated by sponsor|2|||
16837866|NCT01441414|37781695|FG000|Overall Study|Subject refused further follow-up|1|||
16837867|NCT01971554|37781715|FG000|Overall Study|Lost to Follow-up|1|||
16837868|NCT01971554|37781716|FG001|Overall Study|Lost to Follow-up|0|||
16837869|NCT01971554|37781717|FG002|Overall Study|Lost to Follow-up|0|||
16837870|NCT01971554|37781718|FG003|Overall Study|Lost to Follow-up|0|||
16837871|NCT01955083|37781730|FG000|Overall Study|Lost to Follow-up|1|||
16837872|NCT01955083|37781731|FG001|Overall Study|Lost to Follow-up|1|||
16837873|NCT01955005|37781763|FG000|Overall Study|Withdrawal by Subject|3|||
16837874|NCT01955005|37781764|FG001|Overall Study|Withdrawal by Subject|5|||
16837875|NCT01954927|37781772|FG000|Overall Study|Withdrawal by Subject|3|||
16837876|NCT01954927|37781773|FG001|Overall Study|Withdrawal by Subject|1|||
16837877|NCT01954771|37781782|FG000|Overall Study|Missing HbA1c of end-point|1|||
16837878|NCT01954771|37781783|FG001|Overall Study|Missing HbA1c of end-point|1|||
16837879|NCT01954771|37781784|FG002|Overall Study|Missing HbA1c of end-point|0|||
16837880|NCT01954771|37781782|FG000|Overall Study|Missing CGMS of end-point|1|||
16837881|NCT01954771|37781783|FG001|Overall Study|Missing CGMS of end-point|1|||
16837882|NCT01954771|37781784|FG002|Overall Study|Missing CGMS of end-point|0|||
16837883|NCT01954771|37781782|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
16837884|NCT01954771|37781783|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
16837885|NCT01954771|37781784|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
16837886|NCT01997281|37781797|FG000|Overall Study|Withdrawal by Subject|1|||
16837887|NCT01997281|37781798|FG001|Overall Study|Withdrawal by Subject|0|||
16837888|NCT01996033|37781804|FG000|Overall Study|Death|1|||
16837889|NCT01996033|37781804|FG000|Overall Study|Physician Decision|1|||
16837890|NCT01996033|37781804|FG000|Overall Study|Withdrawal by Subject|4|||
16837891|NCT01996033|37781804|FG000|Overall Study|Lost to Follow-up|3|||
16837892|NCT01953913|37781808|FG000|Overall Study|Disease Progression|349|||
17102447|NCT03631732|38241392|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
16837893|NCT01953913|37781808|FG000|Overall Study|Worsening of underlying cancer|22|||
16837894|NCT01953913|37781808|FG000|Overall Study|Adverse Event|20|||
16837895|NCT01953913|37781808|FG000|Overall Study|Protocol Violation|6|||
16837896|NCT01953913|37781808|FG000|Overall Study|Lost to Follow-up|4|||
16913419|NCT01490190|38022100|FG000|Overall Study|Adverse Event|17|||
16837897|NCT01953913|37781808|FG000|Overall Study|Withdrawal by Subject|32|||
16837898|NCT01953913|37781808|FG000|Overall Study|Other than listed|108|||
16837899|NCT01953913|37781808|FG000|Overall Study|Not Treated|1|||
16837900|NCT01971476|37781815|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
16837901|NCT01971476|37781816|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
16837902|NCT01971476|37781817|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
16837903|NCT01971476|37781815|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
16837904|NCT01971476|37781816|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
16837905|NCT01971476|37781817|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
16837906|NCT01971476|37781815|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
16837907|NCT01971476|37781816|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
16837908|NCT01971476|37781817|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
16837909|NCT01996904|37781836|FG000|Overall Study|Lost to Follow-up|38|||
16837910|NCT01996904|37781837|FG001|Overall Study|Lost to Follow-up|27|||
16837911|NCT01970540|37781846|FG000|Overall Study|Non-treatment-related AE|0|||
16837912|NCT01970540|37781847|FG001|Overall Study|Non-treatment-related AE|0|||
16837913|NCT01970540|37781848|FG002|Overall Study|Non-treatment-related AE|1|||
16837914|NCT01970540|37781846|FG000|Overall Study|Progressive disease|55|||
16837915|NCT01970540|37781847|FG001|Overall Study|Progressive disease|23|||
16837916|NCT01970540|37781848|FG002|Overall Study|Progressive disease|10|||
16837917|NCT01970540|37781846|FG000|Overall Study|Treatment delay over protocol|0|||
16837918|NCT01970540|37781847|FG001|Overall Study|Treatment delay over protocol|0|||
16837919|NCT01970540|37781848|FG002|Overall Study|Treatment delay over protocol|1|||
16837920|NCT01970540|37781846|FG000|Overall Study|Physician Decision|7|||
16837921|NCT01970540|37781847|FG001|Overall Study|Physician Decision|2|||
16837922|NCT01970540|37781848|FG002|Overall Study|Physician Decision|0|||
16837923|NCT01970540|37781846|FG000|Overall Study|Clinical progression|0|||
16837924|NCT01970540|37781847|FG001|Overall Study|Clinical progression|1|||
16837925|NCT01970540|37781848|FG002|Overall Study|Clinical progression|1|||
16837926|NCT01970540|37781846|FG000|Overall Study|End of study|2|||
16837927|NCT01970540|37781847|FG001|Overall Study|End of study|0|||
16837928|NCT01970540|37781848|FG002|Overall Study|End of study|2|||
16837929|NCT01970540|37781846|FG000|Overall Study|Adverse Event|0|||
16837930|NCT01970540|37781847|FG001|Overall Study|Adverse Event|2|||
16837931|NCT01970540|37781848|FG002|Overall Study|Adverse Event|1|||
16837932|NCT01970540|37781846|FG000|Overall Study|Treatment-related AE|4|||
16837933|NCT01970540|37781847|FG001|Overall Study|Treatment-related AE|0|||
16837934|NCT01970540|37781848|FG002|Overall Study|Treatment-related AE|2|||
16837935|NCT01970540|37781846|FG000|Overall Study|Withdrawal by Subject|4|||
16837936|NCT01970540|37781847|FG001|Overall Study|Withdrawal by Subject|0|||
16837937|NCT01970540|37781848|FG002|Overall Study|Withdrawal by Subject|1|||
16837938|NCT01970540|37781846|FG000|Overall Study|Clinical deterioration|1|||
16837939|NCT01970540|37781847|FG001|Overall Study|Clinical deterioration|0|||
16837940|NCT01970540|37781848|FG002|Overall Study|Clinical deterioration|0|||
16837941|NCT01963676|37781869|FG000|Overall Study|Withdrawal by Subject|1|||
16837942|NCT01963676|37781870|FG001|Overall Study|Withdrawal by Subject|0|||
16837943|NCT01996826|37781878|FG000|Overall Study|Lost to Follow-up|6|||
16837944|NCT01996826|37781879|FG001|Overall Study|Lost to Follow-up|2|||
16837945|NCT01996826|37781878|FG000|Overall Study|Physician Decision|1|||
16837946|NCT01996826|37781879|FG001|Overall Study|Physician Decision|1|||
16837947|NCT01996748|37781887|FG000|Overall Study|Personal reason|1|||
16837948|NCT01996748|37781888|FG001|Overall Study|Personal reason|0|||
16837949|NCT01996748|37781887|FG000|Overall Study|Physician Decision|2|||
16837950|NCT01996748|37781888|FG001|Overall Study|Physician Decision|0|||
16837951|NCT01996748|37781887|FG000|Overall Study|Adverse Event|1|||
16837952|NCT01996748|37781888|FG001|Overall Study|Adverse Event|4|||
16913420|NCT01490190|38022100|FG000|Overall Study|Protocol Violation|5|||
16913421|NCT01490190|38022100|FG000|Overall Study|Lost to Follow-up|13|||
16913422|NCT01490190|38022100|FG000|Overall Study|Relocation|1|||
16913423|NCT01490190|38022100|FG000|Overall Study|Inconvenience|1|||
16913424|NCT01490190|38022100|FG000|Overall Study|Ring expulsion|2|||
16913425|NCT01446042|38022107|FG000|Overall Study|Withdrawal by Subject|12|||
16913426|NCT01446042|38022108|FG001|Overall Study|Withdrawal by Subject|2|||
16913427|NCT01446042|38022109|FG002|Overall Study|Withdrawal by Subject|4|||
16913428|NCT01446042|38022107|FG000|Overall Study|Adverse Event|1|||
16913429|NCT01446042|38022108|FG001|Overall Study|Adverse Event|0|||
16913430|NCT01446042|38022109|FG002|Overall Study|Adverse Event|4|||
16913431|NCT01446042|38022107|FG000|Overall Study|Lost to Follow-up|5|||
16913432|NCT01446042|38022108|FG001|Overall Study|Lost to Follow-up|0|||
16913433|NCT01446042|38022109|FG002|Overall Study|Lost to Follow-up|0|||
16913434|NCT01446042|38022107|FG000|Overall Study|Other reasons|2|||
16913435|NCT01446042|38022108|FG001|Overall Study|Other reasons|1|||
16913436|NCT01446042|38022109|FG002|Overall Study|Other reasons|1|||
16837953|NCT01996748|37781887|FG000|Overall Study|Withdrawal by Subject|0|||
16837954|NCT01996748|37781888|FG001|Overall Study|Withdrawal by Subject|1|||
16837955|NCT01996748|37781887|FG000|Overall Study|Lost to Follow-up|4|||
16837956|NCT01996748|37781888|FG001|Overall Study|Lost to Follow-up|1|||
16913437|NCT01445886|38022117|FG000|Overall Study|Lost to Follow-up|2|||
16913438|NCT01445886|38022117|FG000|Overall Study|Protocol Violation|3|||
16913439|NCT01470612|38022125|FG000|Overall Study|Adverse Event|20|||
16913440|NCT01470612|38022126|FG001|Overall Study|Adverse Event|80|||
16837957|NCT01621178|37781899|FG000|Overall Study|Adverse Event|5|||
16837958|NCT01621178|37781900|FG001|Overall Study|Adverse Event|2|||
16837959|NCT01621178|37781901|FG002|Overall Study|Adverse Event|8|||
16837960|NCT01621178|37781899|FG000|Overall Study|Death|6|||
16837961|NCT01621178|37781900|FG001|Overall Study|Death|7|||
16837962|NCT01621178|37781901|FG002|Overall Study|Death|2|||
16837963|NCT01621178|37781899|FG000|Overall Study|Lost to Follow-up|1|||
16837964|NCT01621178|37781900|FG001|Overall Study|Lost to Follow-up|2|||
16837965|NCT01621178|37781901|FG002|Overall Study|Lost to Follow-up|1|||
16837966|NCT01621178|37781899|FG000|Overall Study|Withdrawal by Subject|14|||
16837967|NCT01621178|37781900|FG001|Overall Study|Withdrawal by Subject|17|||
16837968|NCT01621178|37781901|FG002|Overall Study|Withdrawal by Subject|18|||
16837969|NCT01621178|37781899|FG000|Overall Study|Physician Decision|5|||
16837970|NCT01621178|37781900|FG001|Overall Study|Physician Decision|2|||
16837971|NCT01621178|37781901|FG002|Overall Study|Physician Decision|7|||
16837972|NCT01962974|37781913|FG000|Overall Study|Study termination|7|||
16837973|NCT01996592|37781917|FG000|Overall Study|no response to text/no diary entry|32|||
16837974|NCT01996592|37781917|FG000|Overall Study|change in surgical date|4|||
16837975|NCT01996592|37781917|FG000|Overall Study|Withdrawal by Subject|5|||
16837976|NCT01996592|37781917|FG000|Overall Study|change in mode of delivery|4|||
16837977|NCT01962896|37781926|FG000|Overall Study|Lack of Efficacy|4|||
16837978|NCT01970462|37781933|FG000|Overall Study|Lost to Follow-up|0|||
16837979|NCT01970462|37781934|FG001|Overall Study|Lost to Follow-up|2|||
16837980|NCT01995266|37781940|FG000|Overall Study|Death|1|||
16837981|NCT01995266|37781940|FG000|Overall Study|Lack of Efficacy|6|||
16837982|NCT01995266|37781940|FG000|Overall Study|Adverse Event|2|||
16837983|NCT01969058|37781946|FG000|Overall Study|Withdrawal by Subject|2|||
16837984|NCT01969058|37781947|FG001|Overall Study|Withdrawal by Subject|0|||
16837985|NCT01969058|37781946|FG000|Overall Study|Adverse Event|1|||
16837986|NCT01969058|37781947|FG001|Overall Study|Adverse Event|0|||
16837987|NCT01968980|37781955|FG000|Overall Study|Death|0|||
16837988|NCT01968980|37781956|FG001|Overall Study|Death|1|||
16837989|NCT01968980|37781955|FG000|Overall Study|Adverse Event|1|||
16837990|NCT01968980|37781956|FG001|Overall Study|Adverse Event|3|||
16837991|NCT01968980|37781955|FG000|Overall Study|Does not meet entry criteria|1|||
16837992|NCT01968980|37781956|FG001|Overall Study|Does not meet entry criteria|3|||
16837993|NCT01968980|37781955|FG000|Overall Study|Withdrawal by Subject|13|||
16837994|NCT01968980|37781956|FG001|Overall Study|Withdrawal by Subject|5|||
16837995|NCT01968980|37781955|FG000|Overall Study|Other unspecified|1|||
16837996|NCT01968980|37781956|FG001|Overall Study|Other unspecified|2|||
16837997|NCT01961882|37781965|FG000|Overall Study|Adverse Event|3|||
16837998|NCT01961882|37781966|FG001|Overall Study|Adverse Event|2|||
16837999|NCT01961882|37781965|FG000|Overall Study|Physician Decision|1|||
16838000|NCT01961882|37781966|FG001|Overall Study|Physician Decision|0|||
16838001|NCT01961882|37781965|FG000|Overall Study|Withdrawal by Subject|4|||
16838002|NCT01961882|37781966|FG001|Overall Study|Withdrawal by Subject|1|||
16838003|NCT01961882|37781965|FG000|Overall Study|Relapse of AML|39|||
16838004|NCT01961882|37781966|FG001|Overall Study|Relapse of AML|37|||
16838005|NCT01961882|37781965|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
16838006|NCT01961882|37781966|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
16838007|NCT01961882|37781965|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
16838008|NCT01961882|37781966|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
16838009|NCT01968434|37781974|FG000|Overall Study|Lost to Follow-up|3|||
16838010|NCT01968434|37781975|FG001|Overall Study|Lost to Follow-up|6|||
16838011|NCT01946438|37781985|FG000|Overall Study|Adverse Event|0|||
16838012|NCT01946438|37781986|FG001|Overall Study|Adverse Event|0|||
16838013|NCT01946438|37781987|FG002|Overall Study|Adverse Event|0|||
16838014|NCT01946438|37781988|FG003|Overall Study|Adverse Event|1|||
16838015|NCT01946438|37781985|FG000|Overall Study|Serious Adverse event|1|||
16838016|NCT01946438|37781986|FG001|Overall Study|Serious Adverse event|0|||
16838017|NCT01946438|37781987|FG002|Overall Study|Serious Adverse event|0|||
16838018|NCT01946438|37781988|FG003|Overall Study|Serious Adverse event|0|||
16838019|NCT01946438|37781985|FG000|Overall Study|Protocol Violation|0|||
16838020|NCT01946438|37781986|FG001|Overall Study|Protocol Violation|0|||
16838021|NCT01946438|37781987|FG002|Overall Study|Protocol Violation|1|||
16838022|NCT01946438|37781988|FG003|Overall Study|Protocol Violation|0|||
16838023|NCT01946438|37781985|FG000|Overall Study|Withdrawal by Subject|1|||
16838024|NCT01946438|37781986|FG001|Overall Study|Withdrawal by Subject|0|||
16838025|NCT01946438|37781987|FG002|Overall Study|Withdrawal by Subject|0|||
16838026|NCT01946438|37781988|FG003|Overall Study|Withdrawal by Subject|0|||
16838027|NCT01946282|37782007|FG000|Year 1|Did not return FIT kit|4186|||
16913441|NCT01470612|38022125|FG000|Overall Study|Death|0|||
16838028|NCT01946282|37782008|FG001|Year 1|Did not return FIT kit|608|||
16838029|NCT01946282|37782009|FG002|Year 1|Did not return FIT kit|654|||
16838030|NCT01946282|37782007|FG000|Year 2|Did not return FIT kit|803|||
16838031|NCT01946282|37782008|FG001|Year 2|Did not return FIT kit|131|||
16838032|NCT01946282|37782009|FG002|Year 2|Did not return FIT kit|115|||
16838033|NCT01946282|37782007|FG000|Year 3|Did not return FIT kit|288|||
16838034|NCT01946282|37782008|FG001|Year 3|Did not return FIT kit|43|||
16838035|NCT01946282|37782009|FG002|Year 3|Did not return FIT kit|30|||
16838036|NCT01945580|37782021|FG000|Overall Study|Withdrawal by Subject|13|||
16838037|NCT01945580|37782022|FG001|Overall Study|Withdrawal by Subject|35|||
16838038|NCT01945580|37782021|FG000|Overall Study|Physician Decision|3|||
16838039|NCT01945580|37782022|FG001|Overall Study|Physician Decision|2|||
16838040|NCT01945580|37782021|FG000|Overall Study|Lost to Follow-up|26|||
16838041|NCT01945580|37782022|FG001|Overall Study|Lost to Follow-up|39|||
16838042|NCT01945580|37782021|FG000|Overall Study|Death|7|||
16838043|NCT01945580|37782022|FG001|Overall Study|Death|2|||
16838044|NCT01945580|37782021|FG000|Overall Study|Patient moved out of state|0|||
16838045|NCT01945580|37782022|FG001|Overall Study|Patient moved out of state|1|||
16838046|NCT01945580|37782021|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
16838047|NCT01945580|37782022|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
16838048|NCT01945580|37782021|FG000|Overall Study|Family illness - unable to return|0|||
16838049|NCT01945580|37782022|FG001|Overall Study|Family illness - unable to return|1|||
16838050|NCT01945580|37782021|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
16838051|NCT01945580|37782022|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
16838052|NCT01945580|37782021|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
16838053|NCT01945580|37782022|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
16838054|NCT01945580|37782021|FG000|Overall Study|Noncompliance with 36 month visit|1|||
16838055|NCT01945580|37782022|FG001|Overall Study|Noncompliance with 36 month visit|0|||
16838056|NCT01945580|37782021|FG000|Overall Study|The patient moved.|1|||
16838057|NCT01945580|37782022|FG001|Overall Study|The patient moved.|0|||
16838058|NCT01945580|37782021|FG000|Overall Study|No data available|0|||
16838059|NCT01945580|37782022|FG001|Overall Study|No data available|2|||
16838060|NCT01945034|37782035|FG000|Overall Study|Medication Error|0|||
16838061|NCT01945034|37782036|FG001|Overall Study|Medication Error|1|||
16838062|NCT01945034|37782037|FG002|Overall Study|Medication Error|0|||
16838063|NCT01945034|37782035|FG000|Overall Study|Withdrawal by Subject|0|||
16838064|NCT01945034|37782036|FG001|Overall Study|Withdrawal by Subject|3|||
16838065|NCT01945034|37782037|FG002|Overall Study|Withdrawal by Subject|1|||
16838066|NCT01945034|37782035|FG000|Overall Study|Other|0|||
16838067|NCT01945034|37782036|FG001|Overall Study|Other|1|||
16838068|NCT01945034|37782037|FG002|Overall Study|Other|3|||
16838069|NCT01945034|37782035|FG000|Overall Study|Lost to Follow-up|0|||
16838070|NCT01945034|37782036|FG001|Overall Study|Lost to Follow-up|0|||
16838071|NCT01945034|37782037|FG002|Overall Study|Lost to Follow-up|2|||
16838072|NCT01945034|37782035|FG000|Overall Study|Protocol Violation|1|||
16838073|NCT01945034|37782036|FG001|Overall Study|Protocol Violation|0|||
16838074|NCT01945034|37782037|FG002|Overall Study|Protocol Violation|1|||
16838075|NCT01960790|37782045|FG000|Overall Study|Survey forms could not be recovered|3|||
16838076|NCT01960790|37782045|FG000|Overall Study|Treat with Humira outside survey period|3|||
16838077|NCT01960790|37782045|FG000|Overall Study|Transferred to another hospital|4|||
16838078|NCT01960790|37782045|FG000|Overall Study|Unevaluable for safety|1|||
16838079|NCT01618214|37782051|FG000|Overall Study|Adverse Event|3|||
16838080|NCT01618214|37782052|FG001|Overall Study|Adverse Event|1|||
16838081|NCT01618214|37782051|FG000|Overall Study|Lack of Efficacy|1|||
16838082|NCT01618214|37782052|FG001|Overall Study|Lack of Efficacy|1|||
16838083|NCT01618214|37782051|FG000|Overall Study|Protocol Violation|1|||
16838084|NCT01618214|37782052|FG001|Overall Study|Protocol Violation|4|||
16838085|NCT01618214|37782051|FG000|Overall Study|Withdrawal Criteria|1|||
16838086|NCT01618214|37782052|FG001|Overall Study|Withdrawal Criteria|2|||
16838087|NCT01618214|37782051|FG000|Overall Study|Unclassified|4|||
16838088|NCT01618214|37782052|FG001|Overall Study|Unclassified|5|||
16838089|NCT01917968|37782060|FG000|Overall Study|Death|3|||
16838090|NCT01917968|37782061|FG001|Overall Study|Death|2|||
16838091|NCT01917968|37782060|FG000|Overall Study|Lost to Follow-up|21|||
16838092|NCT01917968|37782061|FG001|Overall Study|Lost to Follow-up|39|||
16838093|NCT01917968|37782060|FG000|Overall Study|Physician Decision|1|||
16838094|NCT01917968|37782061|FG001|Overall Study|Physician Decision|2|||
16838095|NCT01917968|37782060|FG000|Overall Study|Withdrawal by Subject|20|||
16838096|NCT01917968|37782061|FG001|Overall Study|Withdrawal by Subject|35|||
16838097|NCT01917968|37782060|FG000|Overall Study|Subject Relocation|5|||
16838098|NCT01917968|37782061|FG001|Overall Study|Subject Relocation|1|||
16838099|NCT01917968|37782060|FG000|Overall Study|36M Missed Visit|3|||
16838100|NCT01917968|37782061|FG001|Overall Study|36M Missed Visit|2|||
16838101|NCT01917968|37782060|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
16838102|NCT01917968|37782061|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
16838103|NCT01917968|37782060|FG000|Overall Study|Change in Family Circumstances|0|||
16838104|NCT01917968|37782061|FG001|Overall Study|Change in Family Circumstances|1|||
16838105|NCT01917968|37782060|FG000|Overall Study|No Data Available|0|||
16838106|NCT01917968|37782061|FG001|Overall Study|No Data Available|2|||
16838107|NCT01917656|37782076|FG000|Overall Study|Adverse Event|11|||
16838108|NCT01917656|37782077|FG001|Overall Study|Adverse Event|0|||
16838109|NCT01917656|37782076|FG000|Overall Study|Withdrawal criteria|8|||
16838110|NCT01917656|37782077|FG001|Overall Study|Withdrawal criteria|14|||
16838111|NCT01917656|37782076|FG000|Overall Study|Unclassified|0|||
16838112|NCT01917656|37782077|FG001|Overall Study|Unclassified|3|||
16838113|NCT01917656|37782076|FG000|Overall Study|Withdrawal by Subject|4|||
16838114|NCT01917656|37782077|FG001|Overall Study|Withdrawal by Subject|3|||
16838115|NCT01917656|37782076|FG000|Overall Study|Lost to Follow-up|3|||
16838116|NCT01917656|37782077|FG001|Overall Study|Lost to Follow-up|4|||
16838117|NCT02018861|37782093|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16838118|NCT02018861|37782094|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
16838119|NCT02018861|37782095|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
16838120|NCT02018861|37782096|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
16838121|NCT02018861|37782097|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
16838122|NCT02018861|37782098|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
16838123|NCT02018861|37782099|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16838124|NCT02018861|37782100|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16838125|NCT02018861|37782101|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16838126|NCT02018861|37782102|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16838127|NCT02018861|37782093|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16838128|NCT02018861|37782094|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16838129|NCT02018861|37782095|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16838130|NCT02018861|37782096|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
16838131|NCT02018861|37782097|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
16838132|NCT02018861|37782098|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16838133|NCT02018861|37782099|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16838134|NCT02018861|37782100|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16838135|NCT02018861|37782101|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16838136|NCT02018861|37782102|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16838137|NCT02018861|37782093|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16838138|NCT02018861|37782094|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
16838139|NCT02018861|37782095|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
16838140|NCT02018861|37782096|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
16838141|NCT02018861|37782097|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
16838142|NCT02018861|37782098|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
16838143|NCT02018861|37782099|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16838144|NCT02018861|37782100|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16838145|NCT02018861|37782101|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16838146|NCT02018861|37782102|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16838147|NCT02018861|37782093|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
16838148|NCT02018861|37782094|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16838149|NCT02018861|37782095|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16838150|NCT02018861|37782096|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
16838151|NCT02018861|37782097|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
16838152|NCT02018861|37782098|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16838153|NCT02018861|37782099|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16838154|NCT02018861|37782100|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16838155|NCT02018861|37782101|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16838156|NCT02018861|37782102|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16838157|NCT02018861|37782093|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16838158|NCT02018861|37782094|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16838159|NCT02018861|37782095|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
16838160|NCT02018861|37782096|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
16838161|NCT02018861|37782097|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16838162|NCT02018861|37782098|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16838163|NCT02018861|37782099|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16913442|NCT01470612|38022126|FG001|Overall Study|Death|1|||
16913443|NCT01470612|38022125|FG000|Overall Study|Lack of Efficacy|20|||
16913444|NCT01470612|38022126|FG001|Overall Study|Lack of Efficacy|326|||
16913445|NCT01470612|38022125|FG000|Overall Study|Lost to Follow-up|2|||
16913446|NCT01470612|38022126|FG001|Overall Study|Lost to Follow-up|5|||
16913447|NCT01470612|38022125|FG000|Overall Study|Did not meet entrance criteria|0|||
16913448|NCT01470612|38022126|FG001|Overall Study|Did not meet entrance criteria|1|||
16913449|NCT01470612|38022125|FG000|Overall Study|Pregnancy|2|||
16913450|NCT01470612|38022126|FG001|Overall Study|Pregnancy|10|||
16913451|NCT01470612|38022125|FG000|Overall Study|Protocol Violation|2|||
16913452|NCT01470612|38022126|FG001|Overall Study|Protocol Violation|7|||
16913453|NCT01470612|38022125|FG000|Overall Study|Withdrawal by Subject|24|||
16913454|NCT01470612|38022126|FG001|Overall Study|Withdrawal by Subject|79|||
16838164|NCT02018861|37782100|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16838165|NCT02018861|37782101|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16838166|NCT02018861|37782102|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16838167|NCT02018861|37782093|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838168|NCT02018861|37782094|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838169|NCT02018861|37782095|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838170|NCT02018861|37782096|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838171|NCT02018861|37782097|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
16838172|NCT02018861|37782098|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838173|NCT02018861|37782099|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838174|NCT02018861|37782100|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838175|NCT02018861|37782101|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838176|NCT02018861|37782102|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16838177|NCT02018861|37782093|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16838178|NCT02018861|37782094|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16913455|NCT01470612|38022125|FG000|Overall Study|Other|14|||
16913456|NCT01470612|38022126|FG001|Overall Study|Other|156|||
16913457|NCT01445730|38022132|FG000|Overall Study|Adverse Event|1|||
16913458|NCT01445730|38022132|FG000|Overall Study|For the advice of a dentist|1|||
16913459|NCT01445730|38022132|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
16913460|NCT01445652|38022138|FG000|Overall Study|Not comfortable in lenses|5|||
16913461|NCT01445652|38022139|FG001|Overall Study|Not comfortable in lenses|0|||
16913462|NCT01445652|38022138|FG000|Overall Study|Failed to attend scheduled visit|2|||
16913463|NCT01445652|38022139|FG001|Overall Study|Failed to attend scheduled visit|3|||
16913464|NCT01445652|38022138|FG000|Overall Study|Failed teach session|2|||
16913465|NCT01445652|38022139|FG001|Overall Study|Failed teach session|0|||
16913466|NCT01445652|38022138|FG000|Overall Study|Adverse Event|1|||
16913467|NCT01445652|38022139|FG001|Overall Study|Adverse Event|0|||
16913468|NCT01440816|38022147|FG000|Overall Study|Disease Progression|0|||
16913469|NCT01440816|38022148|FG001|Overall Study|Disease Progression|9|||
16913470|NCT01440816|38022147|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
16913471|NCT01440816|38022148|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
16913472|NCT01470144|38022156|FG000|Overall Study|Adverse Event|2|||
16913473|NCT01470144|38022156|FG000|Overall Study|Death|1|||
16913474|NCT01470144|38022156|FG000|Overall Study|Lung transplant|6|||
16838179|NCT02018861|37782095|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16838180|NCT02018861|37782096|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
16838181|NCT02018861|37782097|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
16838182|NCT02018861|37782098|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
16838183|NCT02018861|37782099|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16838184|NCT02018861|37782100|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16838185|NCT02018861|37782101|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16838186|NCT02018861|37782102|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16838187|NCT02018861|37782093|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16838188|NCT02018861|37782094|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16838189|NCT02018861|37782095|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16838190|NCT02018861|37782096|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
16838191|NCT02018861|37782097|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
16838192|NCT02018861|37782098|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16838193|NCT02018861|37782099|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16838194|NCT02018861|37782100|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16838195|NCT02018861|37782101|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16838196|NCT02018861|37782102|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16838197|NCT02018861|37782093|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16838198|NCT02018861|37782094|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16838199|NCT02018861|37782095|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16838200|NCT02018861|37782096|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16838201|NCT02018861|37782097|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16838202|NCT02018861|37782098|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16838203|NCT02018861|37782099|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
16838204|NCT02018861|37782100|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
16838205|NCT02018861|37782101|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16838206|NCT02018861|37782102|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16838207|NCT02018861|37782093|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16838208|NCT02018861|37782094|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16838209|NCT02018861|37782095|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16838210|NCT02018861|37782096|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16838211|NCT02018861|37782097|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16838212|NCT02018861|37782098|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16838213|NCT02018861|37782099|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
16838214|NCT02018861|37782100|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
16838215|NCT02018861|37782101|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16838216|NCT02018861|37782102|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16838217|NCT02018861|37782093|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838218|NCT02018861|37782094|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838219|NCT02018861|37782095|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838220|NCT02018861|37782096|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838221|NCT02018861|37782097|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838222|NCT02018861|37782098|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838223|NCT02018861|37782099|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838224|NCT02018861|37782100|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838225|NCT02018861|37782101|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
16838226|NCT02018861|37782102|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16838227|NCT02018861|37782093|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838228|NCT02018861|37782094|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838229|NCT02018861|37782095|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838230|NCT02018861|37782096|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838231|NCT02018861|37782097|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838232|NCT02018861|37782098|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838233|NCT02018861|37782099|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838234|NCT02018861|37782100|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838235|NCT02018861|37782101|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
16838236|NCT02018861|37782102|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16838237|NCT02018861|37782093|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838238|NCT02018861|37782094|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838239|NCT02018861|37782095|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838240|NCT02018861|37782096|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838241|NCT02018861|37782097|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838242|NCT02018861|37782098|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838243|NCT02018861|37782099|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838244|NCT02018861|37782100|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838245|NCT02018861|37782101|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
16838246|NCT02018861|37782102|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16838247|NCT01944722|37782133|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
16913475|NCT01470144|38022156|FG000|Overall Study|Patient's and investigator's decision|1|||
16913476|NCT01443858|38022163|FG000|Overall Study|Withdrawal by Subject|9|||
16913477|NCT01443858|38022164|FG001|Overall Study|Withdrawal by Subject|8|||
16913478|NCT01443858|38022165|FG002|Overall Study|Withdrawal by Subject|5|||
16913479|NCT01443858|38022163|FG000|Overall Study|Lack of Efficacy|1|||
16913480|NCT01443858|38022164|FG001|Overall Study|Lack of Efficacy|0|||
16913481|NCT01443858|38022165|FG002|Overall Study|Lack of Efficacy|0|||
16913482|NCT01443858|38022163|FG000|Overall Study|Lost to Follow-up|5|||
16913483|NCT01443858|38022164|FG001|Overall Study|Lost to Follow-up|5|||
16913484|NCT01443858|38022165|FG002|Overall Study|Lost to Follow-up|2|||
16913485|NCT01443078|38022173|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
16913486|NCT01443078|38022173|FG000|Overall Study|Withdrawal by Subject|1|||
16913487|NCT01443078|38022173|FG000|Overall Study|Patient had brain mets|1|||
16913488|NCT01439880|38022179|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
16913489|NCT01439880|38022180|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
16913490|NCT01439880|38022179|FG000|SOC-controlled Period (Year 1)|Death|2|||
16913491|NCT01439880|38022180|FG001|SOC-controlled Period (Year 1)|Death|1|||
16913492|NCT01439880|38022179|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
16913493|NCT01439880|38022180|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
16913494|NCT01439880|38022179|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
16913495|NCT01439880|38022180|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
16913496|NCT01439880|38022179|FG000|SOC-controlled Period (Year 1)|Other|8|||
16913497|NCT01439880|38022180|FG001|SOC-controlled Period (Year 1)|Other|13|||
16913498|NCT01439880|38022179|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
16913499|NCT01439880|38022180|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
16838248|NCT01944722|37782133|FG000|Overall Study|Specimen Shipping Issues|34|||
16838249|NCT01944722|37782133|FG000|Overall Study|Improper Storage/Transport|5|||
16838250|NCT01944722|37782133|FG000|Overall Study|Insufficient Volume for Test|1|||
16838251|NCT01944722|37782133|FG000|Overall Study|Missing Specimens|3|||
16838252|NCT01944722|37782133|FG000|Overall Study|Specimens Mislabeled|2|||
16838253|NCT01944722|37782133|FG000|Overall Study|Withdrawal by Subject|8|||
16838254|NCT01944722|37782133|FG000|Overall Study|NILM Subjects <30 years old|8106|||
16838255|NCT01944722|37782133|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
16838256|NCT01944722|37782133|FG000|Overall Study|>ASCUS Cytology|1122|||
16838257|NCT01917344|37782142|FG000|Overall Study|Withdrawal by Subject|1|||
16838258|NCT02017535|37782150|FG000|Overall Study|Withdrawal by Subject|1|||
16838259|NCT02017535|37782151|FG001|Overall Study|Withdrawal by Subject|0|||
16838260|NCT02017535|37782152|FG002|Overall Study|Withdrawal by Subject|0|||
16838261|NCT02017535|37782153|FG003|Overall Study|Withdrawal by Subject|0|||
16838262|NCT01944098|37782165|FG000|Overall Study|Physician Decision|1|||
16838263|NCT01944098|37782166|FG001|Overall Study|Physician Decision|0|||
16838264|NCT02017223|37782172|FG000|Overall Study|Algorithm problems|2|||
16913500|NCT01439880|38022179|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
16913501|NCT01439880|38022180|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
16913502|NCT01439880|38022179|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
16913503|NCT01439880|38022180|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
16913504|NCT01439880|38022179|FG000|All-IP Period (Years 2 to 5)|Death|3|||
16913505|NCT01439880|38022180|FG001|All-IP Period (Years 2 to 5)|Death|13|||
16913506|NCT01439880|38022179|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
16913507|NCT01439880|38022180|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
16913508|NCT01439880|38022179|FG000|All-IP Period (Years 2 to 5)|Other|14|||
16838265|NCT01944020|37782178|FG000|Overall Study|Withdrawal by Subject|5|||
16838266|NCT01944020|37782179|FG001|Overall Study|Withdrawal by Subject|0|||
16838267|NCT01943552|37782187|FG000|Overall Study|Adverse Event|3|||
16838268|NCT01943552|37782188|FG001|Overall Study|Adverse Event|2|||
16838269|NCT01943552|37782187|FG000|Overall Study|Withdrawal by Subject|6|||
16838270|NCT01943552|37782188|FG001|Overall Study|Withdrawal by Subject|6|||
16838271|NCT01943552|37782187|FG000|Overall Study|Other Reasons|16|||
16838272|NCT01943552|37782188|FG001|Overall Study|Other Reasons|17|||
16838273|NCT01915940|37782196|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
16838274|NCT01915940|37782197|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
16838275|NCT01915940|37782198|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
16838276|NCT01915940|37782196|FG000|Treatment Period|Decision of Participant|0|||
16838277|NCT01915940|37782197|FG001|Treatment Period|Decision of Participant|1|||
16838278|NCT01915940|37782198|FG002|Treatment Period|Decision of Participant|3|||
16838279|NCT01915940|37782196|FG000|Treatment Period|Adverse Event|0|||
16838280|NCT01915940|37782197|FG001|Treatment Period|Adverse Event|9|||
16838281|NCT01915940|37782198|FG002|Treatment Period|Adverse Event|1|||
16838282|NCT01915940|37782196|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
16838283|NCT01915940|37782197|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
16838284|NCT01915940|37782198|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
16838285|NCT01914926|37782206|FG000|Overall Study|Adverse Event|1|||
16913509|NCT01439880|38022180|FG001|All-IP Period (Years 2 to 5)|Other|31|||
16913510|NCT01439880|38022179|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
16913511|NCT01439880|38022180|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
16913512|NCT01469364|38022197|FG000|Overall Study|Adverse Event|1|||
16913513|NCT01469364|38022197|FG000|Overall Study|Withdrawal by Subject|1|||
16913514|NCT01439724|38022203|FG000|Overall Study|missing consultation|9|||
16913515|NCT01439724|38022204|FG001|Overall Study|missing consultation|8|||
16913516|NCT01439568|38022212|FG000|Overall Study|Lost to Follow-up|1|||
16913517|NCT01439568|38022213|FG001|Overall Study|Lost to Follow-up|0|||
16913518|NCT01439568|38022212|FG000|Overall Study|Withdrawal by Subject|2|||
16913519|NCT01439568|38022213|FG001|Overall Study|Withdrawal by Subject|2|||
16913520|NCT01469052|38022225|FG000|Overall Study|Adverse Event|2|||
16913521|NCT01469052|38022226|FG001|Overall Study|Adverse Event|3|||
16913522|NCT01469052|38022227|FG002|Overall Study|Adverse Event|0|||
16913523|NCT01469052|38022228|FG003|Overall Study|Adverse Event|2|||
16913524|NCT01469052|38022229|FG004|Overall Study|Adverse Event|0|||
16913525|NCT01469052|38022230|FG005|Overall Study|Adverse Event|1|||
16913526|NCT01469052|38022225|FG000|Overall Study|Progressive disease|3|||
16913527|NCT01469052|38022226|FG001|Overall Study|Progressive disease|0|||
16913528|NCT01469052|38022227|FG002|Overall Study|Progressive disease|5|||
16913529|NCT01469052|38022228|FG003|Overall Study|Progressive disease|3|||
16913530|NCT01469052|38022229|FG004|Overall Study|Progressive disease|7|||
16913531|NCT01469052|38022230|FG005|Overall Study|Progressive disease|2|||
16913532|NCT01469052|38022225|FG000|Overall Study|Lack of Efficacy|0|||
16913533|NCT01469052|38022226|FG001|Overall Study|Lack of Efficacy|0|||
16913534|NCT01469052|38022227|FG002|Overall Study|Lack of Efficacy|0|||
16913535|NCT01469052|38022228|FG003|Overall Study|Lack of Efficacy|0|||
16913536|NCT01469052|38022229|FG004|Overall Study|Lack of Efficacy|0|||
16838286|NCT01914926|37782207|FG001|Overall Study|Adverse Event|0|||
16838287|NCT01914926|37782206|FG000|Overall Study|uncooperative, agitated and removed|0|||
16838288|NCT01914926|37782207|FG001|Overall Study|uncooperative, agitated and removed|1|||
16838289|NCT02016755|37782213|FG000|Overall Study|Major amputation of index limb|2|||
16838290|NCT02016755|37782213|FG000|Overall Study|Adverse Event|2|||
16838291|NCT02016755|37782213|FG000|Overall Study|Physician Decision|1|||
16838292|NCT02016755|37782213|FG000|Overall Study|Death|2|||
16838293|NCT01942148|37782217|FG000|Overall Study|Adverse Event|4|||
16838294|NCT01942148|37782217|FG000|Overall Study|Lack of Efficacy|2|||
16838295|NCT01942148|37782217|FG000|Overall Study|Physician Decision|11|||
16838296|NCT01942148|37782217|FG000|Overall Study|Protocol Violation|1|||
16838297|NCT01942148|37782217|FG000|Overall Study|Withdrawal by Subject|8|||
16838298|NCT01942148|37782217|FG000|Overall Study|Use of the prohibition medicine|1|||
16838299|NCT02030015|37782221|FG000|Overall Study|Withdrawal by Subject|3|||
16838300|NCT02030015|37782221|FG000|Overall Study|Death|13|||
16838301|NCT02029235|37782227|FG000|Overall Study|Non-compliance with study meds or diary|4|||
16838302|NCT02029235|37782228|FG001|Overall Study|Non-compliance with study meds or diary|1|||
16838303|NCT01617434|37782236|FG000|Overall Study|Adverse Event|12|||
16838304|NCT01617434|37782237|FG001|Overall Study|Adverse Event|3|||
16838305|NCT01617434|37782236|FG000|Overall Study|Protocol Violation|8|||
16838306|NCT01617434|37782237|FG001|Overall Study|Protocol Violation|7|||
16838307|NCT01617434|37782236|FG000|Overall Study|Withdrawal Criteria|12|||
16838308|NCT01617434|37782237|FG001|Overall Study|Withdrawal Criteria|37|||
16838309|NCT01617434|37782236|FG000|Overall Study|Unclassified|3|||
16838310|NCT01617434|37782237|FG001|Overall Study|Unclassified|4|||
16838311|NCT01940900|37782245|FG000|Overall Study|Physician Decision|4|||
16838312|NCT01940900|37782246|FG001|Overall Study|Physician Decision|0|||
16838313|NCT01940900|37782245|FG000|Overall Study|Adverse Event|10|||
16838314|NCT01940900|37782246|FG001|Overall Study|Adverse Event|15|||
16838315|NCT01940900|37782245|FG000|Overall Study|Withdrawal by Subject|11|||
16838316|NCT01940900|37782246|FG001|Overall Study|Withdrawal by Subject|15|||
16838317|NCT01940900|37782245|FG000|Overall Study|Lost to Follow-up|1|||
16838318|NCT01940900|37782246|FG001|Overall Study|Lost to Follow-up|0|||
16838319|NCT01940900|37782245|FG000|Overall Study|Sponsor Decision|1|||
16838320|NCT01940900|37782246|FG001|Overall Study|Sponsor Decision|0|||
16838321|NCT01940900|37782245|FG000|Overall Study|subject non-compliance|1|||
16838322|NCT01940900|37782246|FG001|Overall Study|subject non-compliance|1|||
16838323|NCT01940900|37782245|FG000|Overall Study|other|1|||
16838324|NCT01940900|37782246|FG001|Overall Study|other|0|||
16838325|NCT01940354|37782254|FG000|Overall Study|Withdrawal by Subject|4|||
16838326|NCT01940354|37782255|FG001|Overall Study|Withdrawal by Subject|2|||
16838327|NCT01940120|37782261|FG000|Overall Study|Death|40|||
16913537|NCT01469052|38022230|FG005|Overall Study|Lack of Efficacy|2|||
16913538|NCT01469052|38022225|FG000|Overall Study|Moved to rollover protocol|1|||
16838328|NCT01940120|37782261|FG000|Overall Study|Withdrawal by Subject|8|||
16838329|NCT01911260|37782270|FG000|Supplementation Period|transference or evasion of school|7|||
16838330|NCT01911260|37782271|FG001|Supplementation Period|transference or evasion of school|9|||
16838331|NCT01911260|37782272|FG002|Supplementation Period|transference or evasion of school|7|||
16838332|NCT01911260|37782273|FG003|Supplementation Period|transference or evasion of school|6|||
16838333|NCT01911260|37782270|FG000|Supplementation Period|Adverse Event|2|||
16838334|NCT01911260|37782271|FG001|Supplementation Period|Adverse Event|0|||
16838335|NCT01911260|37782272|FG002|Supplementation Period|Adverse Event|1|||
16838336|NCT01911260|37782273|FG003|Supplementation Period|Adverse Event|0|||
16838337|NCT01911260|37782270|FG000|Supplementation Period|refused to receive supplement|1|||
16838338|NCT01911260|37782271|FG001|Supplementation Period|refused to receive supplement|0|||
16838339|NCT01911260|37782272|FG002|Supplementation Period|refused to receive supplement|1|||
16838340|NCT01911260|37782273|FG003|Supplementation Period|refused to receive supplement|0|||
16838341|NCT01911260|37782270|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
16838342|NCT01911260|37782271|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
16838343|NCT01911260|37782272|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
16838344|NCT01911260|37782273|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
16838345|NCT01911260|37782270|FG000|Follow-up Period|transference or evasion of school|13|||
16838346|NCT01911260|37782271|FG001|Follow-up Period|transference or evasion of school|20|||
16838347|NCT01911260|37782272|FG002|Follow-up Period|transference or evasion of school|15|||
16838348|NCT01911260|37782273|FG003|Follow-up Period|transference or evasion of school|12|||
16838349|NCT02015819|37782287|FG000|Overall Study|Rickham catheter was misaligned|0|||
16838350|NCT02015819|37782288|FG001|Overall Study|Rickham catheter was misaligned|0|||
16838351|NCT02015819|37782289|FG002|Overall Study|Rickham catheter was misaligned|0|||
16838352|NCT02015819|37782290|FG003|Overall Study|Rickham catheter was misaligned|1|||
16838353|NCT01939496|37782307|FG000|Overall Study|Adverse Event|2|||
16838354|NCT01939496|37782308|FG001|Overall Study|Adverse Event|0|||
16838355|NCT01939496|37782309|FG002|Overall Study|Adverse Event|0|||
16838356|NCT01939496|37782307|FG000|Overall Study|Lost to Follow-up|1|||
16838357|NCT01939496|37782308|FG001|Overall Study|Lost to Follow-up|1|||
16838358|NCT01939496|37782309|FG002|Overall Study|Lost to Follow-up|0|||
16838359|NCT01939496|37782307|FG000|Overall Study|Physician Decision|1|||
16838360|NCT01939496|37782308|FG001|Overall Study|Physician Decision|0|||
16838361|NCT01939496|37782309|FG002|Overall Study|Physician Decision|0|||
16838362|NCT01939496|37782307|FG000|Overall Study|Protocol Violation|3|||
16838363|NCT01939496|37782308|FG001|Overall Study|Protocol Violation|0|||
16838364|NCT01939496|37782309|FG002|Overall Study|Protocol Violation|0|||
16838365|NCT01939496|37782307|FG000|Overall Study|Withdrawal by Subject|0|||
16838366|NCT01939496|37782308|FG001|Overall Study|Withdrawal by Subject|1|||
16838367|NCT01939496|37782309|FG002|Overall Study|Withdrawal by Subject|1|||
16838368|NCT01939496|37782307|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
16838369|NCT01939496|37782308|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
16838370|NCT01939496|37782309|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
16838371|NCT01939496|37782307|FG000|Overall Study|Other|2|||
16838372|NCT01939496|37782308|FG001|Overall Study|Other|0|||
16838373|NCT01939496|37782309|FG002|Overall Study|Other|1|||
16838374|NCT01939028|37782317|FG000|Overall Study|Withdrawal by Subject|5|||
16838375|NCT01939028|37782317|FG000|Overall Study|Physician Decision|7|||
16838376|NCT01938716|37782321|FG000|Overall Study|Physician Decision|2|||
16838377|NCT01938716|37782321|FG000|Overall Study|Withdrawal by Subject|2|||
16838378|NCT01937390|37782325|FG000|Overall Study|Death|2|||
16838379|NCT01937390|37782325|FG000|Overall Study|Lost to Follow-up|7|||
16838380|NCT01937390|37782325|FG000|Overall Study|Withdrawal by Subject|5|||
16838381|NCT01937390|37782325|FG000|Overall Study|Fail to return|21|||
16838382|NCT02015663|37782331|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
16838383|NCT02015663|37782332|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
16838384|NCT02015663|37782331|FG000|Overall Study|Withdrawal by Subject|1|||
16838385|NCT02015663|37782332|FG001|Overall Study|Withdrawal by Subject|0|||
16838386|NCT02015663|37782331|FG000|Overall Study|Protocol Violation|0|||
16838387|NCT02015663|37782332|FG001|Overall Study|Protocol Violation|1|||
16838388|NCT02015663|37782331|FG000|Overall Study|Adverse Event|3|||
16838389|NCT02015663|37782332|FG001|Overall Study|Adverse Event|0|||
16838390|NCT02015663|37782331|FG000|Overall Study|Administrative problems|10|||
16913539|NCT01469052|38022226|FG001|Overall Study|Moved to rollover protocol|0|||
16913540|NCT01469052|38022227|FG002|Overall Study|Moved to rollover protocol|1|||
16913541|NCT01469052|38022228|FG003|Overall Study|Moved to rollover protocol|0|||
16913542|NCT01469052|38022229|FG004|Overall Study|Moved to rollover protocol|0|||
16838391|NCT02015663|37782332|FG001|Overall Study|Administrative problems|11|||
16838392|NCT02028767|37782339|FG000|Treatment Period 2|Non compliant with protocol|1|||
16838393|NCT02028767|37782340|FG001|Treatment Period 2|Non compliant with protocol|0|||
16838394|NCT02028767|37782339|FG000|Treatment Period 2|Reason other than those specified above|1|||
16838395|NCT02028767|37782340|FG001|Treatment Period 2|Reason other than those specified above|0|||
16838396|NCT01959932|37782349|FG000|Overall Study|Withdrawal by Subject|1|||
16838397|NCT01959932|37782350|FG001|Overall Study|Withdrawal by Subject|0|||
16838398|NCT01959932|37782351|FG002|Overall Study|Withdrawal by Subject|0|||
16838399|NCT02028065|37782363|FG000|Randomization Through Start Treatment|Not treated|1|||
16838400|NCT02028065|37782364|FG001|Randomization Through Start Treatment|Not treated|3|||
16838401|NCT02028065|37782365|FG002|Randomization Through Start Treatment|Not treated|3|||
16838402|NCT02028065|37782363|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
16838403|NCT02028065|37782364|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
16838404|NCT02028065|37782365|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
16838405|NCT02028065|37782363|FG000|Treatment Through Study Completion|Physician Decision|1|||
16838406|NCT02028065|37782364|FG001|Treatment Through Study Completion|Physician Decision|0|||
16838407|NCT02028065|37782365|FG002|Treatment Through Study Completion|Physician Decision|0|||
16838408|NCT02028065|37782363|FG000|Treatment Through Study Completion|Protocol Violation|1|||
16838409|NCT02028065|37782364|FG001|Treatment Through Study Completion|Protocol Violation|4|||
16838410|NCT02028065|37782365|FG002|Treatment Through Study Completion|Protocol Violation|0|||
16838411|NCT02028065|37782363|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
16838412|NCT02028065|37782364|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
16838413|NCT02028065|37782365|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
16838414|NCT02028065|37782363|FG000|Treatment Through Study Completion|Adverse Event|3|||
16838415|NCT02028065|37782364|FG001|Treatment Through Study Completion|Adverse Event|3|||
16838416|NCT02028065|37782365|FG002|Treatment Through Study Completion|Adverse Event|5|||
16838417|NCT02015195|37782380|FG000|Overall Study|Adverse Event|0|||
16838418|NCT02015195|37782381|FG001|Overall Study|Adverse Event|0|||
16838419|NCT02015195|37782382|FG002|Overall Study|Adverse Event|0|||
16838420|NCT02015195|37782383|FG003|Overall Study|Adverse Event|1|||
16838421|NCT02015195|37782384|FG004|Overall Study|Adverse Event|0|||
16838422|NCT02015195|37782385|FG005|Overall Study|Adverse Event|0|||
16838423|NCT02015195|37782386|FG006|Overall Study|Adverse Event|0|||
16838424|NCT02015039|37782403|FG000|Overall Study|Not eligible|0|||
16838425|NCT02015039|37782404|FG001|Overall Study|Not eligible|1|||
16838426|NCT02025725|37782412|FG000|Overall Study|Adverse Event|5|||
16838427|NCT02025725|37782413|FG001|Overall Study|Adverse Event|0|||
16838428|NCT02025725|37782412|FG000|Overall Study|Lost to Follow-up|2|||
16838429|NCT02025725|37782413|FG001|Overall Study|Lost to Follow-up|0|||
16913543|NCT01469052|38022230|FG005|Overall Study|Moved to rollover protocol|1|||
16913544|NCT01469052|38022225|FG000|Overall Study|Other|0|||
16838430|NCT02025725|37782412|FG000|Overall Study|Protocol Violation|1|||
16838431|NCT02025725|37782413|FG001|Overall Study|Protocol Violation|1|||
16838432|NCT02025725|37782412|FG000|Overall Study|Withdrawal by Subject|3|||
16913545|NCT01469052|38022226|FG001|Overall Study|Other|1|||
16913546|NCT01469052|38022227|FG002|Overall Study|Other|0|||
16913547|NCT01469052|38022228|FG003|Overall Study|Other|0|||
16838433|NCT02025725|37782413|FG001|Overall Study|Withdrawal by Subject|2|||
16838434|NCT02025725|37782412|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
16838435|NCT02025725|37782413|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
16838436|NCT02025179|37782424|FG000|Overall Study|Lost to Follow-up|0|||
16838437|NCT02025179|37782425|FG001|Overall Study|Lost to Follow-up|0|||
16838438|NCT02025179|37782426|FG002|Overall Study|Lost to Follow-up|1|||
16838439|NCT02013791|37782443|FG000|Period 1|Lost to Follow-up|0|||
16838440|NCT02013791|37782444|FG001|Period 1|Lost to Follow-up|0|||
16838441|NCT02013791|37782445|FG002|Period 1|Lost to Follow-up|0|||
16838442|NCT02013791|37782446|FG003|Period 1|Lost to Follow-up|1|||
16838443|NCT02013791|37782447|FG004|Period 1|Lost to Follow-up|0|||
16838444|NCT02013791|37782448|FG005|Period 1|Lost to Follow-up|0|||
16838445|NCT02013791|37782449|FG006|Period 1|Lost to Follow-up|1|||
16838446|NCT02013791|37782450|FG007|Period 1|Lost to Follow-up|1|||
16838447|NCT02013791|37782451|FG008|Period 1|Lost to Follow-up|0|||
16838448|NCT02013791|37782443|FG000|Period 1|Other Miscellaneous Reasons|0|||
16838449|NCT02013791|37782444|FG001|Period 1|Other Miscellaneous Reasons|2|||
16838450|NCT02013791|37782445|FG002|Period 1|Other Miscellaneous Reasons|0|||
16838451|NCT02013791|37782446|FG003|Period 1|Other Miscellaneous Reasons|0|||
16838452|NCT02013791|37782447|FG004|Period 1|Other Miscellaneous Reasons|0|||
16838453|NCT02013791|37782448|FG005|Period 1|Other Miscellaneous Reasons|0|||
16838454|NCT02013791|37782449|FG006|Period 1|Other Miscellaneous Reasons|0|||
16838455|NCT02013791|37782450|FG007|Period 1|Other Miscellaneous Reasons|0|||
16838456|NCT02013791|37782451|FG008|Period 1|Other Miscellaneous Reasons|0|||
16838457|NCT02024867|37782474|FG000|Overall Study|Protocol Violation|3|||
16838458|NCT02024867|37782475|FG001|Overall Study|Protocol Violation|3|||
16838459|NCT02024867|37782474|FG000|Overall Study|Lost to Follow-up|6|||
16838460|NCT02024867|37782475|FG001|Overall Study|Lost to Follow-up|4|||
16838461|NCT01953601|37782484|FG000|Part 1 (Base Study)|Adverse Event|24|||
16838462|NCT01953601|37782485|FG001|Part 1 (Base Study)|Adverse Event|37|||
16838463|NCT01953601|37782486|FG002|Part 1 (Base Study)|Adverse Event|15|||
16838464|NCT01953601|37782484|FG000|Part 1 (Base Study)|Death|2|||
16838465|NCT01953601|37782485|FG001|Part 1 (Base Study)|Death|0|||
16838466|NCT01953601|37782486|FG002|Part 1 (Base Study)|Death|3|||
16838467|NCT01953601|37782484|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
16838468|NCT01953601|37782485|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
16838469|NCT01953601|37782486|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
16838470|NCT01953601|37782484|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
16838471|NCT01953601|37782485|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
16838472|NCT01953601|37782486|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
16838473|NCT01953601|37782484|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
16838474|NCT01953601|37782485|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
16838475|NCT01953601|37782486|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
16838476|NCT01953601|37782484|FG000|Part 1 (Base Study)|Physician Decision|3|||
16838477|NCT01953601|37782485|FG001|Part 1 (Base Study)|Physician Decision|7|||
16838478|NCT01953601|37782486|FG002|Part 1 (Base Study)|Physician Decision|4|||
16838479|NCT01953601|37782484|FG000|Part 1 (Base Study)|Screen failure|1|||
16838480|NCT01953601|37782485|FG001|Part 1 (Base Study)|Screen failure|0|||
16838481|NCT01953601|37782486|FG002|Part 1 (Base Study)|Screen failure|1|||
16838482|NCT01953601|37782484|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
16838483|NCT01953601|37782485|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
16838484|NCT01953601|37782486|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
16838485|NCT01953601|37782484|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
16838486|NCT01953601|37782485|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
16838487|NCT01953601|37782486|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
16838488|NCT01953601|37782484|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
16838489|NCT01953601|37782485|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
16838490|NCT01953601|37782486|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
16838491|NCT01953601|37782484|FG000|Part 1 (Base Study)|Subject moved|2|||
16838492|NCT01953601|37782485|FG001|Part 1 (Base Study)|Subject moved|2|||
16838493|NCT01953601|37782486|FG002|Part 1 (Base Study)|Subject moved|1|||
16838494|NCT01953601|37782484|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
16838495|NCT01953601|37782485|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
16838496|NCT01953601|37782486|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
16838497|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Adverse Event|1|||
16838498|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Adverse Event|1|||
16838499|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Adverse Event|10|||
16838500|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Death|0|||
16838501|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Death|3|||
16838502|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Death|0|||
16838503|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
16838504|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
16838505|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
16838506|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
16838507|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
16838508|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
16838509|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Physician Decision|2|||
16838510|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Physician Decision|0|||
16838511|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Physician Decision|2|||
16838512|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
16838513|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
16838514|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
16838515|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
16838516|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
16838517|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
16838518|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
16838519|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
16838520|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
16838521|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Subject moved|0|||
16838522|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Subject moved|0|||
16838523|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Subject moved|1|||
16838524|NCT01953601|37782484|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
16838525|NCT01953601|37782485|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
16838526|NCT01953601|37782486|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
16838527|NCT01952665|37782499|FG000|Overall Study|Physician Decision|3|||
16838528|NCT01952665|37782500|FG001|Overall Study|Physician Decision|2|||
16838529|NCT01952665|37782499|FG000|Overall Study|Lost to Follow-up|1|||
16838530|NCT01952665|37782500|FG001|Overall Study|Lost to Follow-up|2|||
16838531|NCT01952665|37782499|FG000|Overall Study|Adverse Event|2|||
16838532|NCT01952665|37782500|FG001|Overall Study|Adverse Event|1|||
16838533|NCT01952665|37782499|FG000|Overall Study|Protocol Violation|0|||
16838534|NCT01952665|37782500|FG001|Overall Study|Protocol Violation|1|||
16838535|NCT01952041|37782511|FG000|Overall Study|Lost to Follow-up|9|||
16838536|NCT01952041|37782512|FG001|Overall Study|Lost to Follow-up|16|||
16838537|NCT01952041|37782511|FG000|Overall Study|Withdrawal by Subject|7|||
16838538|NCT01952041|37782512|FG001|Overall Study|Withdrawal by Subject|5|||
16838539|NCT01952041|37782511|FG000|Overall Study|Death|1|||
16838540|NCT01952041|37782512|FG001|Overall Study|Death|0|||
16838541|NCT01951573|37782518|FG000|Washout Period|Adverse Event|0|||
16838542|NCT01951573|37782519|FG001|Washout Period|Adverse Event|1|||
16838543|NCT02023697|37782528|FG000|Treatment Period|Radiological progression|13|||
16838544|NCT02023697|37782529|FG001|Treatment Period|Radiological progression|17|||
16838545|NCT02023697|37782530|FG002|Treatment Period|Radiological progression|26|||
16838546|NCT02023697|37782528|FG000|Treatment Period|Never Treated|5|||
16838547|NCT02023697|37782529|FG001|Treatment Period|Never Treated|6|||
16838548|NCT02023697|37782530|FG002|Treatment Period|Never Treated|10|||
16838549|NCT02023697|37782528|FG000|Treatment Period|Adverse Event|13|||
16838550|NCT02023697|37782529|FG001|Treatment Period|Adverse Event|25|||
16838551|NCT02023697|37782530|FG002|Treatment Period|Adverse Event|23|||
16838552|NCT02023697|37782528|FG000|Treatment Period|Logistical difficulties|1|||
16838553|NCT02023697|37782529|FG001|Treatment Period|Logistical difficulties|1|||
16838554|NCT02023697|37782530|FG002|Treatment Period|Logistical difficulties|1|||
16838555|NCT02023697|37782528|FG000|Treatment Period|Clinical progression|10|||
16838556|NCT02023697|37782529|FG001|Treatment Period|Clinical progression|8|||
16838557|NCT02023697|37782530|FG002|Treatment Period|Clinical progression|28|||
16838558|NCT02023697|37782528|FG000|Treatment Period|Withdrawal by Subject|4|||
16838559|NCT02023697|37782529|FG001|Treatment Period|Withdrawal by Subject|5|||
16838560|NCT02023697|37782530|FG002|Treatment Period|Withdrawal by Subject|13|||
16838561|NCT02023697|37782528|FG000|Treatment Period|Safety outcome reached|0|||
16838562|NCT02023697|37782529|FG001|Treatment Period|Safety outcome reached|1|||
16838563|NCT02023697|37782530|FG002|Treatment Period|Safety outcome reached|0|||
16838564|NCT02023697|37782528|FG000|Treatment Period|Physician Decision|0|||
16838565|NCT02023697|37782529|FG001|Treatment Period|Physician Decision|0|||
16838566|NCT02023697|37782530|FG002|Treatment Period|Physician Decision|1|||
16838567|NCT02023697|37782528|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
16838568|NCT02023697|37782529|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
16838569|NCT02023697|37782530|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
16838570|NCT02023697|37782528|FG000|Active Follow-up Period|Lost to Follow-up|1|||
16838571|NCT02023697|37782529|FG001|Active Follow-up Period|Lost to Follow-up|1|||
16838572|NCT02023697|37782530|FG002|Active Follow-up Period|Lost to Follow-up|1|||
17102448|NCT03631732|38241391|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
17102449|NCT03631732|38241392|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
17102450|NCT03631732|38241391|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
17102451|NCT03631732|38241392|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
17102452|NCT03631732|38241391|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
17102453|NCT03631732|38241392|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
17102454|NCT03631732|38241391|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
17198458|NCT01667432|38352171|FG000|Overall Study|Moved to Another Center|3|||
17198459|NCT01667432|38352171|FG000|Overall Study|Lost to Follow-up|3|||
17198460|NCT01667432|38352171|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
17198461|NCT01667432|38352171|FG000|Overall Study|Insufficient Therapeutic Response|4|||
17198462|NCT01667432|38352171|FG000|Overall Study|Adverse Event|1|||
17198463|NCT01667432|38352171|FG000|Overall Study|Protocol Deviation|2|||
17198464|NCT01667432|38352171|FG000|Overall Study|Principal Investigator Decision|1|||
17198465|NCT01667432|38352171|FG000|Overall Study|Reason Not Specified|2|||
17198466|NCT01667432|38352171|FG000|Overall Study|Missing Information|4|||
17198467|NCT01563107|38352179|FG000|Overall Study|Physician Decision|0|||
17198468|NCT01563107|38352180|FG001|Overall Study|Physician Decision|1|||
17198469|NCT01563107|38352181|FG002|Overall Study|Physician Decision|1|||
17198470|NCT01563107|38352182|FG003|Overall Study|Physician Decision|3|||
17198471|NCT01563107|38352179|FG000|Overall Study|Withdrawal by Subject|1|||
17198472|NCT01563107|38352180|FG001|Overall Study|Withdrawal by Subject|2|||
17198473|NCT01563107|38352181|FG002|Overall Study|Withdrawal by Subject|1|||
17198474|NCT01563107|38352182|FG003|Overall Study|Withdrawal by Subject|2|||
17198475|NCT02589626|38352244|FG000|Overall Study|Other than the reason specified|1|||
17198476|NCT02589626|38352245|FG001|Overall Study|Other than the reason specified|0|||
17198477|NCT02589626|38352244|FG000|Overall Study|Withdrawal by Subject|1|||
17198478|NCT02589626|38352245|FG001|Overall Study|Withdrawal by Subject|1|||
17198479|NCT02589626|38352244|FG000|Overall Study|Adverse Event|1|||
17198480|NCT02589626|38352245|FG001|Overall Study|Adverse Event|1|||
17198481|NCT01666730|38352260|FG000|Overall Study|Adverse Event|16|||
17198482|NCT01666730|38352260|FG000|Overall Study|Death|2|||
17198483|NCT01666730|38352260|FG000|Overall Study|Physician Decision|5|||
17198484|NCT01666730|38352260|FG000|Overall Study|Withdrawal by Subject|9|||
17198485|NCT01666730|38352260|FG000|Overall Study|Disease progression/relapse|18|||
17198486|NCT00103285|38352273|FG000|Induction|Adverse Event|14|||
17198487|NCT00103285|38352274|FG001|Induction|Adverse Event|0|||
17198488|NCT00103285|38352275|FG002|Induction|Adverse Event|0|||
17198489|NCT00103285|38352276|FG003|Induction|Adverse Event|0|||
17198490|NCT00103285|38352277|FG004|Induction|Adverse Event|0|||
17198491|NCT00103285|38352278|FG005|Induction|Adverse Event|0|||
17198492|NCT00103285|38352279|FG006|Induction|Adverse Event|0|||
17198493|NCT00103285|38352280|FG007|Induction|Adverse Event|0|||
17198494|NCT00103285|38352273|FG000|Induction|Death|24|||
17198495|NCT00103285|38352274|FG001|Induction|Death|0|||
17198496|NCT00103285|38352275|FG002|Induction|Death|0|||
17198497|NCT00103285|38352276|FG003|Induction|Death|0|||
16838573|NCT02023697|37782528|FG000|Active Follow-up Period|Deterioration of general condition|1|||
16838574|NCT02023697|37782529|FG001|Active Follow-up Period|Deterioration of general condition|1|||
16838575|NCT02023697|37782530|FG002|Active Follow-up Period|Deterioration of general condition|1|||
16838576|NCT02023697|37782528|FG000|Active Follow-up Period|Other unspecified|2|||
16838577|NCT02023697|37782529|FG001|Active Follow-up Period|Other unspecified|0|||
16838578|NCT02023697|37782530|FG002|Active Follow-up Period|Other unspecified|1|||
16838579|NCT02023697|37782528|FG000|Active Follow-up Period|Clinical progression|0|||
16838580|NCT02023697|37782529|FG001|Active Follow-up Period|Clinical progression|2|||
16838581|NCT02023697|37782530|FG002|Active Follow-up Period|Clinical progression|1|||
16838582|NCT02023697|37782528|FG000|Active Follow-up Period|Radiological progression|0|||
16838583|NCT02023697|37782529|FG001|Active Follow-up Period|Radiological progression|0|||
16838584|NCT02023697|37782530|FG002|Active Follow-up Period|Radiological progression|1|||
16838585|NCT02023697|37782528|FG000|Active Follow-up Period|Death|83|||
16838586|NCT02023697|37782529|FG001|Active Follow-up Period|Death|82|||
16838587|NCT02023697|37782530|FG002|Active Follow-up Period|Death|87|||
16838588|NCT02023697|37782528|FG000|Long-term Follow-up Period|Death|9|||
16838589|NCT02023697|37782529|FG001|Long-term Follow-up Period|Death|6|||
16838590|NCT02023697|37782530|FG002|Long-term Follow-up Period|Death|4|||
16838591|NCT02023697|37782528|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
16838592|NCT02023697|37782529|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
16838593|NCT02023697|37782530|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
16838594|NCT02023697|37782528|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
16838595|NCT02023697|37782529|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
16838596|NCT02023697|37782530|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
16838597|NCT02023697|37782528|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
16913548|NCT01469052|38022229|FG004|Overall Study|Other|1|||
16913549|NCT01469052|38022230|FG005|Overall Study|Other|0|||
17198498|NCT00103285|38352277|FG004|Induction|Death|0|||
17198499|NCT00103285|38352278|FG005|Induction|Death|0|||
17198500|NCT00103285|38352279|FG006|Induction|Death|0|||
17198501|NCT00103285|38352280|FG007|Induction|Death|0|||
17198502|NCT00103285|38352273|FG000|Induction|Physician Decision|103|||
17198503|NCT00103285|38352274|FG001|Induction|Physician Decision|0|||
17198504|NCT00103285|38352275|FG002|Induction|Physician Decision|0|||
17198505|NCT00103285|38352276|FG003|Induction|Physician Decision|0|||
17198506|NCT00103285|38352277|FG004|Induction|Physician Decision|0|||
17198507|NCT00103285|38352278|FG005|Induction|Physician Decision|0|||
17198508|NCT00103285|38352279|FG006|Induction|Physician Decision|0|||
16838598|NCT02023697|37782529|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
16838599|NCT02023697|37782530|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
16838600|NCT02023697|37782528|FG000|Long-term Follow-up Period|Technical problems|0|||
16838601|NCT02023697|37782529|FG001|Long-term Follow-up Period|Technical problems|0|||
16838602|NCT02023697|37782530|FG002|Long-term Follow-up Period|Technical problems|1|||
16838603|NCT02023697|37782528|FG000|Long-term Follow-up Period|Other unspecified|6|||
16838604|NCT02023697|37782529|FG001|Long-term Follow-up Period|Other unspecified|3|||
16838605|NCT02023697|37782530|FG002|Long-term Follow-up Period|Other unspecified|5|||
16838606|NCT01951417|37782545|FG000|Overall Study|Withdrawal by Subject|1|||
16838607|NCT01951417|37782545|FG000|Overall Study|Protocol Violation|2|||
16838608|NCT01951417|37782545|FG000|Overall Study|Lost to Follow-up|6|||
16838609|NCT01951261|37782555|FG000|Overall Study|Death|1|||
16838610|NCT01951261|37782556|FG001|Overall Study|Death|0|||
16838611|NCT01951261|37782555|FG000|Overall Study|Lost to Follow-up|4|||
16838612|NCT01951261|37782556|FG001|Overall Study|Lost to Follow-up|3|||
16838613|NCT01951261|37782555|FG000|Overall Study|Protocol Violation|4|||
16838614|NCT01951261|37782556|FG001|Overall Study|Protocol Violation|3|||
16838615|NCT02023151|37782562|FG000|Overall Study|Lost to Follow-up|4|||
16838616|NCT01979185|37782568|FG000|Period 2|Other|0|||
16838617|NCT01979185|37782569|FG001|Period 2|Other|1|||
16838618|NCT01946425|37782577|FG000|Overall Study|Protocol Violation|1|||
16838619|NCT01946425|37782578|FG001|Overall Study|Protocol Violation|0|||
16838620|NCT01946425|37782577|FG000|Overall Study|Withdrawal by Subject|1|||
16838621|NCT01946425|37782578|FG001|Overall Study|Withdrawal by Subject|0|||
16838622|NCT01946191|37782587|FG000|Allocation|Did not complete orientation|1|||
16838623|NCT01946191|37782588|FG001|Allocation|Did not complete orientation|1|||
16838624|NCT01946191|37782587|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
16838625|NCT01946191|37782588|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
16838626|NCT01946191|37782587|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
16838627|NCT01946191|37782588|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
16838628|NCT01946191|37782587|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
16838629|NCT01946191|37782588|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
16838630|NCT01959698|37782602|FG000|Overall Study|Adverse Event|0|||
16838631|NCT01959698|37782603|FG001|Overall Study|Adverse Event|0|||
16838632|NCT01959698|37782604|FG002|Overall Study|Adverse Event|0|||
16838633|NCT01959698|37782605|FG003|Overall Study|Adverse Event|0|||
16838634|NCT01959698|37782606|FG004|Overall Study|Adverse Event|0|||
16838635|NCT01959698|37782607|FG005|Overall Study|Adverse Event|0|||
16838636|NCT01959698|37782608|FG006|Overall Study|Adverse Event|1|||
16838637|NCT01959698|37782602|FG000|Overall Study|Physician Decision|1|||
16838638|NCT01959698|37782603|FG001|Overall Study|Physician Decision|0|||
16838639|NCT01959698|37782604|FG002|Overall Study|Physician Decision|1|||
16838640|NCT01959698|37782605|FG003|Overall Study|Physician Decision|2|||
16838641|NCT01959698|37782606|FG004|Overall Study|Physician Decision|0|||
16838642|NCT01959698|37782607|FG005|Overall Study|Physician Decision|3|||
16913550|NCT01442688|38022244|FG000|First Intervention|Withdrawal by Subject|1|||
16913551|NCT01442688|38022245|FG001|First Intervention|Withdrawal by Subject|0|||
16913552|NCT01442688|38022244|FG000|First Intervention|subject incarcerated|1|||
16913553|NCT01442688|38022245|FG001|First Intervention|subject incarcerated|0|||
16913554|NCT01442688|38022244|FG000|Second Intervention|Adverse Event|1|||
16913555|NCT01442688|38022245|FG001|Second Intervention|Adverse Event|0|||
16913556|NCT01468818|38022251|FG000|Overall Study|Death during treatment|2|||
16913557|NCT01442376|38022258|FG000|Overall Study|Adverse Event|0|||
16913558|NCT01442376|38022259|FG001|Overall Study|Adverse Event|3|||
16913559|NCT01442376|38022260|FG002|Overall Study|Adverse Event|2|||
16913560|NCT01442376|38022258|FG000|Overall Study|Death|0|||
16913561|NCT01442376|38022259|FG001|Overall Study|Death|1|||
16913562|NCT01442376|38022260|FG002|Overall Study|Death|1|||
16913563|NCT01442376|38022258|FG000|Overall Study|Withdrawal of consent|0|||
16913564|NCT01442376|38022259|FG001|Overall Study|Withdrawal of consent|0|||
16913565|NCT01442376|38022260|FG002|Overall Study|Withdrawal of consent|1|||
16913566|NCT01442376|38022258|FG000|Overall Study|Patients not treated|2|||
16913567|NCT01442376|38022259|FG001|Overall Study|Patients not treated|3|||
16913568|NCT01442376|38022260|FG002|Overall Study|Patients not treated|1|||
16913569|NCT01442376|38022258|FG000|Overall Study|Not eligible for subsequent cycles|1|||
16913570|NCT01442376|38022259|FG001|Overall Study|Not eligible for subsequent cycles|2|||
16913571|NCT01442376|38022260|FG002|Overall Study|Not eligible for subsequent cycles|0|||
16913572|NCT01442064|38022274|FG000|Overall Study|Adverse Event|2|||
16913573|NCT01442064|38022275|FG001|Overall Study|Adverse Event|2|||
16913574|NCT01442064|38022276|FG002|Overall Study|Adverse Event|2|||
16913575|NCT01442064|38022277|FG003|Overall Study|Adverse Event|1|||
16913576|NCT01442064|38022278|FG004|Overall Study|Adverse Event|2|||
16913577|NCT01442064|38022279|FG005|Overall Study|Adverse Event|0|||
16913578|NCT01442064|38022274|FG000|Overall Study|Death|0|||
16838643|NCT01959698|37782608|FG006|Overall Study|Physician Decision|3|||
16838644|NCT01910402|37782627|FG000|Randomized Phase|Adverse Event|10|||
16838645|NCT01910402|37782628|FG001|Randomized Phase|Adverse Event|18|||
16913579|NCT01442064|38022275|FG001|Overall Study|Death|1|||
16838646|NCT01910402|37782627|FG000|Randomized Phase|Physician Decision|1|||
16838647|NCT01910402|37782628|FG001|Randomized Phase|Physician Decision|0|||
16838648|NCT01910402|37782627|FG000|Randomized Phase|Lack of Efficacy|5|||
16838649|NCT01910402|37782628|FG001|Randomized Phase|Lack of Efficacy|4|||
16838650|NCT01910402|37782627|FG000|Randomized Phase|Lost to Follow-up|11|||
16838651|NCT01910402|37782628|FG001|Randomized Phase|Lost to Follow-up|13|||
16838652|NCT01910402|37782627|FG000|Randomized Phase|Protocol Violation|10|||
16838653|NCT01910402|37782628|FG001|Randomized Phase|Protocol Violation|13|||
16838654|NCT01910402|37782627|FG000|Randomized Phase|Withdrawal by Subject|5|||
16838655|NCT01910402|37782628|FG001|Randomized Phase|Withdrawal by Subject|7|||
16838656|NCT01910402|37782627|FG000|Continuation Phase|Ongoing|84|||
16838657|NCT01910402|37782628|FG001|Continuation Phase|Ongoing|0|||
16838658|NCT01910402|37782627|FG000|Continuation Phase|Adverse Event|1|||
16838659|NCT01910402|37782628|FG001|Continuation Phase|Adverse Event|0|||
16838660|NCT01910402|37782627|FG000|Continuation Phase|Protocol Violation|3|||
16838661|NCT01910402|37782628|FG001|Continuation Phase|Protocol Violation|0|||
16838662|NCT01910402|37782627|FG000|Continuation Phase|Withdrawal by Subject|2|||
16838663|NCT01910402|37782628|FG001|Continuation Phase|Withdrawal by Subject|0|||
16838664|NCT01937312|37782638|FG000|Overall Study|Adverse Event|10|||
16838665|NCT01937312|37782639|FG001|Overall Study|Adverse Event|1|||
16838666|NCT01937312|37782638|FG000|Overall Study|Lack of Efficacy|0|||
16838667|NCT01937312|37782639|FG001|Overall Study|Lack of Efficacy|1|||
16838668|NCT01937312|37782638|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
16838669|NCT01937312|37782639|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
16838670|NCT01909934|37782646|FG000|Overall Study|Ongoing|23|||
16838671|NCT01909934|37782646|FG000|Overall Study|Withdrawal by Subject|3|||
16838672|NCT01909934|37782646|FG000|Overall Study|Lost to Follow-up|1|||
16838673|NCT01909934|37782646|FG000|Overall Study|Withdrawal of Informed Consent|1|||
16838674|NCT01909934|37782646|FG000|Overall Study|Death|22|||
16838675|NCT01935128|37782650|FG000|Overall Study|Death|1|||
16838676|NCT01935128|37782650|FG000|Overall Study|Adverse Event|6|||
16838677|NCT01934972|37782656|FG000|Overall Study|Withdrawal by Subject|9|||
16838678|NCT01934972|37782657|FG001|Overall Study|Withdrawal by Subject|6|||
16838679|NCT01959230|37782665|FG000|Overall Study|Failure to follow study procedures|0|||
16838680|NCT01959230|37782666|FG001|Overall Study|Failure to follow study procedures|1|||
16838681|NCT01959230|37782665|FG000|Overall Study|Administrative reasons|2|||
16838682|NCT01959230|37782666|FG001|Overall Study|Administrative reasons|0|||
16838683|NCT01959230|37782665|FG000|Overall Study|Withdrawal by Subject|2|||
16838684|NCT01959230|37782666|FG001|Overall Study|Withdrawal by Subject|0|||
16838685|NCT01909778|37782672|FG000|Overall Study|failed screening|1|||
16838686|NCT01978093|37782680|FG000|Overall Study|Death|1|||
16838687|NCT01978093|37782681|FG001|Overall Study|Death|0|||
16838688|NCT01978093|37782680|FG000|Overall Study|Adverse Event|0|||
16838689|NCT01978093|37782681|FG001|Overall Study|Adverse Event|5|||
16838690|NCT01978093|37782680|FG000|Overall Study|Protocol Violation|8|||
16838691|NCT01978093|37782681|FG001|Overall Study|Protocol Violation|2|||
16838692|NCT01978093|37782680|FG000|Overall Study|Withdrawal by Subject|29|||
16838693|NCT01978093|37782681|FG001|Overall Study|Withdrawal by Subject|25|||
16838694|NCT01978093|37782680|FG000|Overall Study|Lost to Follow-up|11|||
16838695|NCT01978093|37782681|FG001|Overall Study|Lost to Follow-up|15|||
16838696|NCT01978093|37782680|FG000|Overall Study|Migrated/moved from study area|11|||
16838697|NCT01978093|37782681|FG001|Overall Study|Migrated/moved from study area|13|||
16838698|NCT01978093|37782680|FG000|Overall Study|Loss of kaiser coverage|4|||
16838699|NCT01978093|37782681|FG001|Overall Study|Loss of kaiser coverage|10|||
16838700|NCT01978093|37782680|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
16838701|NCT01978093|37782681|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
16838702|NCT01978093|37782680|FG000|Overall Study|Mother lost custody of child|0|||
16838703|NCT01978093|37782681|FG001|Overall Study|Mother lost custody of child|1|||
16838704|NCT01978093|37782680|FG000|Overall Study|Child was in care of grandmother|0|||
16838705|NCT01978093|37782681|FG001|Overall Study|Child was in care of grandmother|1|||
16838706|NCT01978093|37782680|FG000|Overall Study|N/A for vaccine administration|0|||
16838707|NCT01978093|37782681|FG001|Overall Study|N/A for vaccine administration|1|||
16838708|NCT01977937|37782692|FG000|Overall Study|Withdrawal by Subject|2|||
16838709|NCT01977937|37782693|FG001|Overall Study|Withdrawal by Subject|1|||
16838710|NCT01977937|37782692|FG000|Overall Study|Adverse Event|1|||
16838711|NCT01977937|37782693|FG001|Overall Study|Adverse Event|0|||
16838712|NCT01977937|37782692|FG000|Overall Study|Physician Decision|0|||
16838713|NCT01977937|37782693|FG001|Overall Study|Physician Decision|1|||
16838714|NCT01951105|37782702|FG000|Overall Study|Adverse Event|0|||
16838715|NCT01951105|37782703|FG001|Overall Study|Adverse Event|5|||
16838716|NCT01951105|37782704|FG002|Overall Study|Adverse Event|0|||
16838717|NCT01951105|37782702|FG000|Overall Study|Lost to Follow-up|0|||
16838718|NCT01951105|37782703|FG001|Overall Study|Lost to Follow-up|1|||
16838719|NCT01951105|37782704|FG002|Overall Study|Lost to Follow-up|0|||
16838720|NCT01951105|37782702|FG000|Overall Study|Protocol Violation|1|||
16838721|NCT01951105|37782703|FG001|Overall Study|Protocol Violation|1|||
16838722|NCT01951105|37782704|FG002|Overall Study|Protocol Violation|1|||
16838723|NCT01951105|37782702|FG000|Overall Study|Withdrawal by Subject|0|||
16838724|NCT01951105|37782703|FG001|Overall Study|Withdrawal by Subject|3|||
16838725|NCT01951105|37782704|FG002|Overall Study|Withdrawal by Subject|1|||
16838726|NCT01958918|37782720|FG000|Overall Study|Death|1|||
16838727|NCT01958918|37782721|FG001|Overall Study|Death|3|||
16838728|NCT01958918|37782720|FG000|Overall Study|Lost to Follow-up|4|||
16838729|NCT01958918|37782721|FG001|Overall Study|Lost to Follow-up|7|||
16838730|NCT01958918|37782720|FG000|Overall Study|Withdrawal by Subject|13|||
16838731|NCT01958918|37782721|FG001|Overall Study|Withdrawal by Subject|8|||
16838732|NCT01958918|37782720|FG000|Overall Study|Lack of Efficacy|13|||
16838733|NCT01958918|37782721|FG001|Overall Study|Lack of Efficacy|10|||
16838734|NCT01958918|37782720|FG000|Overall Study|Adverse Event|12|||
16838735|NCT01958918|37782721|FG001|Overall Study|Adverse Event|12|||
16838736|NCT01958918|37782720|FG000|Overall Study|administrative problems|0|||
16838737|NCT01958918|37782721|FG001|Overall Study|administrative problems|2|||
16838738|NCT01945489|37782729|FG000|Cycle 1|Adverse Event|2|||
16838739|NCT01945489|37782730|FG001|Cycle 1|Adverse Event|0|||
16838740|NCT01945489|37782729|FG000|Cycle 1|Lost to Follow-up|4|||
16838741|NCT01945489|37782730|FG001|Cycle 1|Lost to Follow-up|0|||
16838742|NCT01945489|37782729|FG000|Cycle 1|Personal Reasons|4|||
16838743|NCT01945489|37782730|FG001|Cycle 1|Personal Reasons|2|||
16838744|NCT01945489|37782729|FG000|Cycle 1|Protocol Violation|0|||
16838745|NCT01945489|37782730|FG001|Cycle 1|Protocol Violation|1|||
16838746|NCT01945489|37782729|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
16838747|NCT01945489|37782730|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
16838748|NCT01945489|37782729|FG000|Cycle 2|Adverse Event|1|||
16913580|NCT01442064|38022276|FG002|Overall Study|Death|3|||
16913581|NCT01442064|38022277|FG003|Overall Study|Death|3|||
16913582|NCT01442064|38022278|FG004|Overall Study|Death|1|||
16913583|NCT01442064|38022279|FG005|Overall Study|Death|3|||
16913584|NCT01442064|38022274|FG000|Overall Study|Lost to Follow-up|5|||
16913585|NCT01442064|38022275|FG001|Overall Study|Lost to Follow-up|5|||
16913586|NCT01442064|38022276|FG002|Overall Study|Lost to Follow-up|1|||
16913587|NCT01442064|38022277|FG003|Overall Study|Lost to Follow-up|1|||
16913588|NCT01442064|38022278|FG004|Overall Study|Lost to Follow-up|3|||
16913589|NCT01442064|38022279|FG005|Overall Study|Lost to Follow-up|3|||
16913590|NCT01442064|38022274|FG000|Overall Study|Physician Decision|1|||
16913591|NCT01442064|38022275|FG001|Overall Study|Physician Decision|1|||
16913592|NCT01442064|38022276|FG002|Overall Study|Physician Decision|2|||
16913593|NCT01442064|38022277|FG003|Overall Study|Physician Decision|3|||
16913594|NCT01442064|38022278|FG004|Overall Study|Physician Decision|3|||
16838749|NCT01945489|37782730|FG001|Cycle 2|Adverse Event|0|||
16838750|NCT01945489|37782729|FG000|Cycle 2|Lost to Follow-up|0|||
16838751|NCT01945489|37782730|FG001|Cycle 2|Lost to Follow-up|1|||
16838752|NCT01934894|37782739|FG000|Overall Study|Adverse Event|1|||
16838753|NCT01934894|37782740|FG001|Overall Study|Adverse Event|2|||
16838754|NCT01934894|37782739|FG000|Overall Study|Death|2|||
16838755|NCT01934894|37782740|FG001|Overall Study|Death|0|||
16838756|NCT01934894|37782739|FG000|Overall Study|Withdrawal by Subject|0|||
16838757|NCT01934894|37782740|FG001|Overall Study|Withdrawal by Subject|1|||
16838758|NCT01934894|37782739|FG000|Overall Study|Progressive Disease|3|||
16838759|NCT01934894|37782740|FG001|Overall Study|Progressive Disease|2|||
16838760|NCT01950169|37782752|FG000|Overall Study|Withdrawal by Subject|2|||
16838761|NCT01950169|37782753|FG001|Overall Study|Withdrawal by Subject|8|||
16838762|NCT01950169|37782754|FG002|Overall Study|Withdrawal by Subject|1|||
16838763|NCT01950169|37782752|FG000|Overall Study|Death|1|||
16838764|NCT01950169|37782753|FG001|Overall Study|Death|0|||
16838765|NCT01950169|37782754|FG002|Overall Study|Death|0|||
16838766|NCT01934504|37782767|FG000|Overall Study|Protocol Deviation|0|||
16838767|NCT01934504|37782768|FG001|Overall Study|Protocol Deviation|0|||
16838768|NCT01934504|37782769|FG002|Overall Study|Protocol Deviation|0|||
16838769|NCT01934504|37782770|FG003|Overall Study|Protocol Deviation|2|||
16838770|NCT01934504|37782767|FG000|Overall Study|Study Terminated by Sponsor|1|||
16838771|NCT01934504|37782768|FG001|Overall Study|Study Terminated by Sponsor|0|||
16838772|NCT01934504|37782769|FG002|Overall Study|Study Terminated by Sponsor|5|||
16838773|NCT01934504|37782770|FG003|Overall Study|Study Terminated by Sponsor|5|||
16838774|NCT01950013|37782783|FG000|Overall Study|Withdrawal by Subject|0|||
16838775|NCT01950013|37782784|FG001|Overall Study|Withdrawal by Subject|2|||
16838776|NCT01950013|37782785|FG002|Overall Study|Withdrawal by Subject|0|||
16838777|NCT01949155|37782795|FG000|Overall Study|Lost to Follow-up|1|||
16838778|NCT01949155|37782796|FG001|Overall Study|Lost to Follow-up|0|||
16838779|NCT01949155|37782795|FG000|Overall Study|Protocol Violation|1|||
16838780|NCT01949155|37782796|FG001|Overall Study|Protocol Violation|0|||
16838781|NCT01909466|37782803|FG000|Overall Study|Lost to Follow-up|5|||
16913595|NCT01442064|38022279|FG005|Overall Study|Physician Decision|1|||
16913596|NCT01442064|38022274|FG000|Overall Study|Withdrawal by Subject|6|||
16913597|NCT01442064|38022275|FG001|Overall Study|Withdrawal by Subject|3|||
16838782|NCT01909466|37782804|FG001|Overall Study|Lost to Follow-up|7|||
16838783|NCT01909466|37782803|FG000|Overall Study|Adverse Event|3|||
16838784|NCT01909466|37782804|FG001|Overall Study|Adverse Event|4|||
16838785|NCT01909466|37782803|FG000|Overall Study|Met Withdrawal Criteria|0|||
16838786|NCT01909466|37782804|FG001|Overall Study|Met Withdrawal Criteria|3|||
16913598|NCT01442064|38022276|FG002|Overall Study|Withdrawal by Subject|2|||
16838787|NCT01909466|37782803|FG000|Overall Study|Physician Decision|2|||
16838788|NCT01909466|37782804|FG001|Overall Study|Physician Decision|0|||
16838789|NCT01909466|37782803|FG000|Overall Study|Withdrawal by Subject|11|||
16913599|NCT01442064|38022277|FG003|Overall Study|Withdrawal by Subject|2|||
16838790|NCT01909466|37782804|FG001|Overall Study|Withdrawal by Subject|9|||
16838791|NCT01909466|37782803|FG000|Overall Study|Lack of Efficacy|1|||
16838792|NCT01909466|37782804|FG001|Overall Study|Lack of Efficacy|0|||
16838793|NCT01977625|37782808|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
16838794|NCT01977625|37782809|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
16838795|NCT01977625|37782808|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16838796|NCT01977625|37782809|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16838797|NCT01944631|37782819|FG000|Overall Study|Adverse Event|1|||
16838798|NCT01944631|37782820|FG001|Overall Study|Adverse Event|0|||
16838799|NCT01944631|37782819|FG000|Overall Study|Lost to Follow-up|3|||
16838800|NCT01944631|37782820|FG001|Overall Study|Lost to Follow-up|1|||
16838801|NCT01944631|37782819|FG000|Overall Study|Withdrawal by Subject|0|||
16838802|NCT01944631|37782820|FG001|Overall Study|Withdrawal by Subject|1|||
16838803|NCT01948063|37782828|FG000|Overall Study|Boston MCI halted research protocol|0|||
16838804|NCT01948063|37782829|FG001|Overall Study|Boston MCI halted research protocol|1|||
16838805|NCT01948063|37782828|FG000|Overall Study|Discovered an enrollment in other study|0|||
16838806|NCT01948063|37782829|FG001|Overall Study|Discovered an enrollment in other study|1|||
16838807|NCT01948063|37782828|FG000|Overall Study|Blood samples were accidentally thawed|1|||
16838808|NCT01948063|37782829|FG001|Overall Study|Blood samples were accidentally thawed|0|||
16913600|NCT01442064|38022278|FG004|Overall Study|Withdrawal by Subject|2|||
16913601|NCT01442064|38022279|FG005|Overall Study|Withdrawal by Subject|1|||
16913602|NCT01442064|38022274|FG000|Overall Study|Sponsor decision|82|||
16913603|NCT01442064|38022275|FG001|Overall Study|Sponsor decision|88|||
16913604|NCT01442064|38022276|FG002|Overall Study|Sponsor decision|92|||
16913605|NCT01442064|38022277|FG003|Overall Study|Sponsor decision|88|||
16913606|NCT01442064|38022278|FG004|Overall Study|Sponsor decision|95|||
16913607|NCT01442064|38022279|FG005|Overall Study|Sponsor decision|87|||
16913608|NCT01442064|38022274|FG000|Overall Study|Subject non-compliance|0|||
16913609|NCT01442064|38022275|FG001|Overall Study|Subject non-compliance|0|||
16913610|NCT01442064|38022276|FG002|Overall Study|Subject non-compliance|0|||
16913611|NCT01442064|38022277|FG003|Overall Study|Subject non-compliance|0|||
16913612|NCT01442064|38022278|FG004|Overall Study|Subject non-compliance|0|||
16913613|NCT01442064|38022279|FG005|Overall Study|Subject non-compliance|2|||
16913614|NCT01442064|38022274|FG000|Overall Study|Condition mandated other intervention|1|||
16913615|NCT01442064|38022275|FG001|Overall Study|Condition mandated other intervention|1|||
16913616|NCT01442064|38022276|FG002|Overall Study|Condition mandated other intervention|2|||
16913617|NCT01442064|38022277|FG003|Overall Study|Condition mandated other intervention|0|||
16913618|NCT01442064|38022278|FG004|Overall Study|Condition mandated other intervention|0|||
16913619|NCT01442064|38022279|FG005|Overall Study|Condition mandated other intervention|2|||
16913620|NCT01467960|38022302|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
16913621|NCT01467960|38022303|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
16913622|NCT01467960|38022304|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
16913623|NCT01467960|38022305|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
17016773|NCT00689728|38161409|FG000|Rescue|Adverse Event|0|||
17016774|NCT00689728|38161410|FG001|Rescue|Adverse Event|1|||
17016775|NCT00689728|38161411|FG002|Rescue|Adverse Event|0|||
17016776|NCT00689728|38161409|FG000|Rescue|Withdrawal by Subject|1|||
17016777|NCT00689728|38161410|FG001|Rescue|Withdrawal by Subject|1|||
17016778|NCT00689728|38161411|FG002|Rescue|Withdrawal by Subject|1|||
17016779|NCT00689728|38161409|FG000|Optional Follow-Up|Adverse Event|1|||
17016780|NCT00689728|38161410|FG001|Optional Follow-Up|Adverse Event|0|||
17016781|NCT00689728|38161411|FG002|Optional Follow-Up|Adverse Event|0|||
17016782|NCT00689728|38161409|FG000|Optional Follow-Up|Lack of Efficacy|0|||
17016783|NCT00689728|38161410|FG001|Optional Follow-Up|Lack of Efficacy|1|||
17016784|NCT00689728|38161411|FG002|Optional Follow-Up|Lack of Efficacy|1|||
17016785|NCT00689728|38161409|FG000|Optional Follow-Up|Lost to Follow-up|0|||
17016786|NCT00689728|38161410|FG001|Optional Follow-Up|Lost to Follow-up|1|||
17016787|NCT00689728|38161411|FG002|Optional Follow-Up|Lost to Follow-up|1|||
17016788|NCT00689728|38161409|FG000|Optional Follow-Up|Protocol Violation|0|||
17016789|NCT00689728|38161410|FG001|Optional Follow-Up|Protocol Violation|0|||
17016790|NCT00689728|38161411|FG002|Optional Follow-Up|Protocol Violation|1|||
17016791|NCT00689728|38161409|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
17016792|NCT00689728|38161410|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
17016793|NCT00689728|38161411|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
17016794|NCT00691054|38161440|FG000|Overall Study|Withdrawal by Subject|1|||
17016795|NCT00598871|38161448|FG000|Overall Study|Adverse Event|0|||
16838809|NCT01995071|37782847|FG000|Overall Study|Adverse Event|0|||
16838810|NCT01995071|37782848|FG001|Overall Study|Adverse Event|0|||
16838811|NCT01995071|37782849|FG002|Overall Study|Adverse Event|0|||
16838812|NCT01995071|37782850|FG003|Overall Study|Adverse Event|0|||
16838813|NCT01995071|37782851|FG004|Overall Study|Adverse Event|0|||
16838814|NCT01995071|37782852|FG005|Overall Study|Adverse Event|0|||
16838815|NCT01995071|37782853|FG006|Overall Study|Adverse Event|1|||
16913624|NCT01467960|38022306|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
16913625|NCT01467960|38022307|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
16913626|NCT01441596|38022324|FG000|Overall Study|Other reason not defined below|0|||
16913627|NCT01441596|38022325|FG001|Overall Study|Other reason not defined below|2|||
16913628|NCT01441596|38022326|FG002|Overall Study|Other reason not defined below|1|||
16913629|NCT01441596|38022324|FG000|Overall Study|Withdrawal by Subject|4|||
16913630|NCT01441596|38022325|FG001|Overall Study|Withdrawal by Subject|0|||
16913631|NCT01441596|38022326|FG002|Overall Study|Withdrawal by Subject|2|||
16913632|NCT01441596|38022324|FG000|Overall Study|Not treated|0|||
16913633|NCT01441596|38022325|FG001|Overall Study|Not treated|1|||
16913634|NCT01441596|38022326|FG002|Overall Study|Not treated|1|||
16838816|NCT01995071|37782854|FG007|Overall Study|Adverse Event|0|||
16838817|NCT01995071|37782855|FG008|Overall Study|Adverse Event|0|||
16838818|NCT01995071|37782856|FG009|Overall Study|Adverse Event|0|||
16913635|NCT01441440|38022337|FG000|Overall Study|Death|1|||
16913636|NCT01441440|38022338|FG001|Overall Study|Death|0|||
16838819|NCT01995071|37782857|FG010|Overall Study|Adverse Event|0|||
16838820|NCT01995071|37782858|FG011|Overall Study|Adverse Event|0|||
16838821|NCT01995071|37782847|FG000|Overall Study|Moved|0|||
16838822|NCT01995071|37782848|FG001|Overall Study|Moved|0|||
16838823|NCT01995071|37782849|FG002|Overall Study|Moved|1|||
16838824|NCT01995071|37782850|FG003|Overall Study|Moved|0|||
16838825|NCT01995071|37782851|FG004|Overall Study|Moved|1|||
16838826|NCT01995071|37782852|FG005|Overall Study|Moved|0|||
16838827|NCT01995071|37782853|FG006|Overall Study|Moved|0|||
16838828|NCT01995071|37782854|FG007|Overall Study|Moved|0|||
16838829|NCT01995071|37782855|FG008|Overall Study|Moved|0|||
16838830|NCT01995071|37782856|FG009|Overall Study|Moved|0|||
16838831|NCT01995071|37782857|FG010|Overall Study|Moved|1|||
16838832|NCT01995071|37782858|FG011|Overall Study|Moved|0|||
16838833|NCT01995071|37782847|FG000|Overall Study|Lost to Follow-up|1|||
16838834|NCT01995071|37782848|FG001|Overall Study|Lost to Follow-up|0|||
16838835|NCT01995071|37782849|FG002|Overall Study|Lost to Follow-up|0|||
16838836|NCT01995071|37782850|FG003|Overall Study|Lost to Follow-up|0|||
16838837|NCT01995071|37782851|FG004|Overall Study|Lost to Follow-up|0|||
16838838|NCT01995071|37782852|FG005|Overall Study|Lost to Follow-up|0|||
16838839|NCT01995071|37782853|FG006|Overall Study|Lost to Follow-up|0|||
16838840|NCT01995071|37782854|FG007|Overall Study|Lost to Follow-up|1|||
16838841|NCT01995071|37782855|FG008|Overall Study|Lost to Follow-up|1|||
16838842|NCT01995071|37782856|FG009|Overall Study|Lost to Follow-up|0|||
16838843|NCT01995071|37782857|FG010|Overall Study|Lost to Follow-up|0|||
16838844|NCT01995071|37782858|FG011|Overall Study|Lost to Follow-up|0|||
16838845|NCT01995071|37782847|FG000|Overall Study|Incarcerated|0|||
16838846|NCT01995071|37782848|FG001|Overall Study|Incarcerated|0|||
16838847|NCT01995071|37782849|FG002|Overall Study|Incarcerated|0|||
16838848|NCT01995071|37782850|FG003|Overall Study|Incarcerated|0|||
16838849|NCT01995071|37782851|FG004|Overall Study|Incarcerated|0|||
16838850|NCT01995071|37782852|FG005|Overall Study|Incarcerated|0|||
16838851|NCT01995071|37782853|FG006|Overall Study|Incarcerated|0|||
16838852|NCT01995071|37782854|FG007|Overall Study|Incarcerated|1|||
16838853|NCT01995071|37782855|FG008|Overall Study|Incarcerated|0|||
16838854|NCT01995071|37782856|FG009|Overall Study|Incarcerated|0|||
16838855|NCT01995071|37782857|FG010|Overall Study|Incarcerated|0|||
16838856|NCT01995071|37782858|FG011|Overall Study|Incarcerated|0|||
16838857|NCT01994837|37782890|FG000|Overall Study|Progressive disease per protocol|23|||
16838858|NCT01994837|37782890|FG000|Overall Study|Adv event related to progressive disease|3|||
16838859|NCT01994837|37782890|FG000|Overall Study|Fatal progressive disease|2|||
16838860|NCT01994837|37782890|FG000|Overall Study|Adverse event not related to progression|1|||
16838861|NCT01994837|37782890|FG000|Overall Study|Chose palliative care|1|||
16838862|NCT01994837|37782890|FG000|Overall Study|Proceeded to transplant|1|||
16838863|NCT01994837|37782890|FG000|Overall Study|Removed from study due to no response|1|||
16838864|NCT02010593|37782896|FG000|Overall Study|Lost to Follow-up|1|||
16838865|NCT02010593|37782897|FG001|Overall Study|Lost to Follow-up|0|||
16838866|NCT02010593|37782896|FG000|Overall Study|Physician Decision|1|||
16838867|NCT02010593|37782897|FG001|Overall Study|Physician Decision|0|||
16838868|NCT02010593|37782896|FG000|Overall Study|Unable to adhere to visit schedule|0|||
16838869|NCT02010593|37782897|FG001|Overall Study|Unable to adhere to visit schedule|2|||
16838870|NCT01994291|37782906|FG000|Overall Study|Adverse Event|4|||
16838871|NCT01994291|37782907|FG001|Overall Study|Adverse Event|1|||
16838872|NCT01994291|37782908|FG002|Overall Study|Adverse Event|3|||
16838873|NCT01994291|37782906|FG000|Overall Study|Lost to Follow-up|1|||
16913637|NCT01441440|38022339|FG002|Overall Study|Death|1|||
16913638|NCT01441440|38022337|FG000|Overall Study|Adverse Event|2|||
16913639|NCT01441440|38022338|FG001|Overall Study|Adverse Event|9|||
16838874|NCT01994291|37782907|FG001|Overall Study|Lost to Follow-up|1|||
16838875|NCT01994291|37782908|FG002|Overall Study|Lost to Follow-up|0|||
16838876|NCT01994291|37782906|FG000|Overall Study|Does not meet entrance criteria|1|||
16838877|NCT01994291|37782907|FG001|Overall Study|Does not meet entrance criteria|0|||
16838878|NCT01994291|37782908|FG002|Overall Study|Does not meet entrance criteria|0|||
16838879|NCT01994291|37782906|FG000|Overall Study|Medication error without associated AE|1|||
16838880|NCT01994291|37782907|FG001|Overall Study|Medication error without associated AE|0|||
16838881|NCT01994291|37782908|FG002|Overall Study|Medication error without associated AE|1|||
16838882|NCT01994291|37782906|FG000|Overall Study|Protocol Violation|1|||
16838883|NCT01994291|37782907|FG001|Overall Study|Protocol Violation|0|||
16838884|NCT01994291|37782908|FG002|Overall Study|Protocol Violation|0|||
16838885|NCT01994291|37782906|FG000|Overall Study|Withdrawal by Subject|6|||
16838886|NCT01994291|37782907|FG001|Overall Study|Withdrawal by Subject|3|||
16838887|NCT01994291|37782908|FG002|Overall Study|Withdrawal by Subject|5|||
16913640|NCT01441440|38022339|FG002|Overall Study|Adverse Event|9|||
16913641|NCT01441440|38022337|FG000|Overall Study|Lost to Follow-up|0|||
16838888|NCT01994291|37782906|FG000|Overall Study|Other|1|||
16838889|NCT01994291|37782907|FG001|Overall Study|Other|2|||
16838890|NCT01994291|37782908|FG002|Overall Study|Other|0|||
16838891|NCT02094677|37782919|FG000|Overall Study|Screening|3|||
16838892|NCT02094677|37782920|FG001|Overall Study|Screening|1|||
16838893|NCT01993823|37782935|FG000|Overall Study|Requested by the patient|6|||
16838894|NCT01993823|37782936|FG001|Overall Study|Requested by the patient|11|||
16838895|NCT01993823|37782935|FG000|Overall Study|Protocol Violation|0|||
16838896|NCT01993823|37782936|FG001|Overall Study|Protocol Violation|1|||
16838897|NCT01993823|37782935|FG000|Overall Study|Lost to Follow-up|1|||
16838898|NCT01993823|37782936|FG001|Overall Study|Lost to Follow-up|4|||
16838899|NCT01993667|37782944|FG000|Overall Study|Insufficient data to analyze|16|||
16838900|NCT01993667|37782945|FG001|Overall Study|Insufficient data to analyze|16|||
16838901|NCT01993667|37782944|FG000|Overall Study|Insufficient altitude reached|3|||
16838902|NCT01993667|37782945|FG001|Overall Study|Insufficient altitude reached|1|||
16838903|NCT01993667|37782944|FG000|Overall Study|Lost to Follow-up|2|||
16838904|NCT01993667|37782945|FG001|Overall Study|Lost to Follow-up|2|||
16838905|NCT01992107|37782954|FG000|Overall Study|Administrative reasons|2|||
16838906|NCT01992107|37782955|FG001|Overall Study|Administrative reasons|0|||
16838907|NCT01992107|37782956|FG002|Overall Study|Administrative reasons|0|||
16838908|NCT01992107|37782954|FG000|Overall Study|Adverse Event|0|||
16838909|NCT01992107|37782955|FG001|Overall Study|Adverse Event|1|||
16838910|NCT01992107|37782956|FG002|Overall Study|Adverse Event|0|||
16838911|NCT01992107|37782954|FG000|Overall Study|Lost to Follow-up|46|||
16838912|NCT01992107|37782955|FG001|Overall Study|Lost to Follow-up|22|||
16838913|NCT01992107|37782956|FG002|Overall Study|Lost to Follow-up|26|||
16838914|NCT01992107|37782954|FG000|Overall Study|noncompliance and were unavailable|7|||
16838915|NCT01992107|37782955|FG001|Overall Study|noncompliance and were unavailable|3|||
16838916|NCT01992107|37782956|FG002|Overall Study|noncompliance and were unavailable|2|||
16838917|NCT01992107|37782954|FG000|Overall Study|Withdrawal by Subject|13|||
16838918|NCT01992107|37782955|FG001|Overall Study|Withdrawal by Subject|7|||
16838919|NCT01992107|37782956|FG002|Overall Study|Withdrawal by Subject|8|||
16838920|NCT01934192|37782985|FG000|Overall Study|Protocol Violation|0|||
16838921|NCT01934192|37782986|FG001|Overall Study|Protocol Violation|0|||
16913642|NCT01441440|38022338|FG001|Overall Study|Lost to Follow-up|2|||
17102455|NCT03631732|38241392|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
16838922|NCT01934192|37782987|FG002|Overall Study|Protocol Violation|0|||
16838923|NCT01934192|37782988|FG003|Overall Study|Protocol Violation|1|||
16838924|NCT01934192|37782985|FG000|Overall Study|Other: reached stopping criteria|6|||
16838925|NCT01934192|37782986|FG001|Overall Study|Other: reached stopping criteria|5|||
16838926|NCT01934192|37782987|FG002|Overall Study|Other: reached stopping criteria|1|||
16838927|NCT01934192|37782988|FG003|Overall Study|Other: reached stopping criteria|0|||
16838928|NCT01934192|37782985|FG000|Overall Study|Physician Decision|3|||
16838929|NCT01934192|37782986|FG001|Overall Study|Physician Decision|2|||
16838930|NCT01934192|37782987|FG002|Overall Study|Physician Decision|0|||
16838931|NCT01934192|37782988|FG003|Overall Study|Physician Decision|0|||
16838932|NCT01933880|37783011|FG000|Overall Study|Withdrawal by Subject|5|||
16838933|NCT01933880|37783012|FG001|Overall Study|Withdrawal by Subject|0|||
16838934|NCT01933880|37783011|FG000|Overall Study|Lack of Efficacy|1|||
16838935|NCT01933880|37783012|FG001|Overall Study|Lack of Efficacy|0|||
16838936|NCT01933880|37783011|FG000|Overall Study|Concomitant medication Interference|0|||
16838937|NCT01933880|37783012|FG001|Overall Study|Concomitant medication Interference|1|||
16838938|NCT01933880|37783011|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
16838939|NCT01933880|37783012|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
16838940|NCT01933880|37783011|FG000|Overall Study|Other|4|||
16838941|NCT01933880|37783012|FG001|Overall Study|Other|0|||
16838942|NCT01933880|37783011|FG000|Overall Study|Protocol Violation|1|||
16838943|NCT01933880|37783012|FG001|Overall Study|Protocol Violation|0|||
16838944|NCT02008877|37783023|FG000|Overall Study|Inevaluable|0|||
16838945|NCT02008877|37783024|FG001|Overall Study|Inevaluable|1|||
16838946|NCT02008877|37783025|FG002|Overall Study|Inevaluable|0|||
16913643|NCT01441440|38022339|FG002|Overall Study|Lost to Follow-up|1|||
16913644|NCT01441440|38022337|FG000|Overall Study|Withdrawal by Subject|11|||
16913645|NCT01441440|38022338|FG001|Overall Study|Withdrawal by Subject|9|||
16913646|NCT01441440|38022339|FG002|Overall Study|Withdrawal by Subject|9|||
16913647|NCT01441440|38022337|FG000|Overall Study|Pregnancy|1|||
16913648|NCT01441440|38022338|FG001|Overall Study|Pregnancy|0|||
16913649|NCT01441440|38022339|FG002|Overall Study|Pregnancy|0|||
16913650|NCT01441440|38022337|FG000|Overall Study|Lack of Efficacy|1|||
16913651|NCT01441440|38022338|FG001|Overall Study|Lack of Efficacy|0|||
16913652|NCT01441440|38022339|FG002|Overall Study|Lack of Efficacy|1|||
16838947|NCT01933334|37783036|FG000|Overall Study|Adverse Event|5|||
16838948|NCT01933334|37783037|FG001|Overall Study|Adverse Event|1|||
16838949|NCT01933334|37783036|FG000|Overall Study|Withdrawal by Subject|0|||
16838950|NCT01933334|37783037|FG001|Overall Study|Withdrawal by Subject|1|||
16838951|NCT01932788|37783045|FG000|Overall Study|Protocol Violation|18|||
16838952|NCT01932788|37783046|FG001|Overall Study|Protocol Violation|0|||
16838953|NCT01932788|37783045|FG000|Overall Study|Lost to Follow-up|18|||
16838954|NCT01932788|37783046|FG001|Overall Study|Lost to Follow-up|46|||
16838955|NCT01932788|37783045|FG000|Overall Study|Lack of Efficacy|2|||
16838956|NCT01932788|37783046|FG001|Overall Study|Lack of Efficacy|0|||
16838957|NCT01932788|37783045|FG000|Overall Study|Withdrawal by Subject|0|||
16838958|NCT01932788|37783046|FG001|Overall Study|Withdrawal by Subject|5|||
16838959|NCT01908140|37783054|FG000|Overall Study|Other or Progressive Disease|5|||
16838960|NCT01908140|37783055|FG001|Overall Study|Other or Progressive Disease|12|||
16838961|NCT01908140|37783054|FG000|Overall Study|Lack of Efficacy|7|||
16838962|NCT01908140|37783055|FG001|Overall Study|Lack of Efficacy|5|||
16838963|NCT01908140|37783054|FG000|Overall Study|Withdrawal by Subject|23|||
16838964|NCT01908140|37783055|FG001|Overall Study|Withdrawal by Subject|24|||
16838965|NCT01908140|37783054|FG000|Overall Study|Lost to Follow-up|1|||
16838966|NCT01908140|37783055|FG001|Overall Study|Lost to Follow-up|6|||
16838967|NCT01908140|37783054|FG000|Overall Study|Protocol Violation|8|||
16838968|NCT01908140|37783055|FG001|Overall Study|Protocol Violation|9|||
16838969|NCT01908140|37783054|FG000|Overall Study|Adverse Event|22|||
16838970|NCT01908140|37783055|FG001|Overall Study|Adverse Event|23|||
16838971|NCT02008565|37783065|FG000|Overall Study|Protocol Violation|1|||
16838972|NCT02008565|37783066|FG001|Overall Study|Protocol Violation|1|||
16838973|NCT02008565|37783067|FG002|Overall Study|Protocol Violation|2|||
16838974|NCT02008565|37783068|FG003|Overall Study|Protocol Violation|0|||
16838975|NCT01907906|37783082|FG000|Overall Study|Withdrawal by Subject|1|||
16838976|NCT01907906|37783083|FG001|Overall Study|Withdrawal by Subject|0|||
16838977|NCT01907906|37783082|FG000|Overall Study|Physician Decision|3|||
16838978|NCT01907906|37783083|FG001|Overall Study|Physician Decision|1|||
16838979|NCT01907828|37783093|FG000|Overall Study|Exclusion criteria not met|0|||
16838980|NCT01907828|37783094|FG001|Overall Study|Exclusion criteria not met|1|||
16838981|NCT01907828|37783093|FG000|Overall Study|Withdrawal by Subject|3|||
16838982|NCT01907828|37783094|FG001|Overall Study|Withdrawal by Subject|4|||
16838983|NCT01907828|37783093|FG000|Overall Study|Lost to Follow-up|3|||
16838984|NCT01907828|37783094|FG001|Overall Study|Lost to Follow-up|0|||
16838985|NCT01907828|37783093|FG000|Overall Study|Participant refused 24-month follow-up|1|||
16838986|NCT01907828|37783094|FG001|Overall Study|Participant refused 24-month follow-up|0|||
16838987|NCT01907828|37783093|FG000|Overall Study|Participant met exclusion criteria|0|||
16838988|NCT01907828|37783094|FG001|Overall Study|Participant met exclusion criteria|1|||
16838989|NCT01907516|37783102|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
16838990|NCT01907516|37783103|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
16838991|NCT01907516|37783102|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
16838992|NCT01907516|37783103|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
16838993|NCT01907516|37783102|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
16838994|NCT01907516|37783103|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
16838995|NCT01907516|37783102|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
16838996|NCT01907516|37783103|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
16838997|NCT01931462|37783110|FG000|Overall Study|Withdrawal by Subject|1|||
16913653|NCT01441440|38022337|FG000|Overall Study|Moving|0|||
16913654|NCT01441440|38022338|FG001|Overall Study|Moving|1|||
16913655|NCT01441440|38022339|FG002|Overall Study|Moving|1|||
16913656|NCT01441440|38022337|FG000|Overall Study|Work-related matter|0|||
16913657|NCT01441440|38022338|FG001|Overall Study|Work-related matter|1|||
16913658|NCT01441440|38022339|FG002|Overall Study|Work-related matter|0|||
16913659|NCT01441440|38022337|FG000|Overall Study|Difficllty in keeping the schedule|1|||
16913660|NCT01441440|38022338|FG001|Overall Study|Difficllty in keeping the schedule|1|||
16913661|NCT01441440|38022339|FG002|Overall Study|Difficllty in keeping the schedule|0|||
16913662|NCT01438476|38022349|FG000|Overall Study|Protocol Violation|1|||
16913663|NCT01438476|38022350|FG001|Overall Study|Protocol Violation|0|||
16913664|NCT01438476|38022349|FG000|Overall Study|Withdrawal by Subject|1|||
16913665|NCT01438476|38022350|FG001|Overall Study|Withdrawal by Subject|0|||
16913666|NCT01438476|38022349|FG000|Overall Study|No Surgery- Disease|8|||
16838998|NCT01931150|37783116|FG000|Overall Study|Withdrawal by Subject|1|||
16838999|NCT01931150|37783117|FG001|Overall Study|Withdrawal by Subject|2|||
16839000|NCT01930214|37783126|FG000|Overall Study|Death|4|||
16839001|NCT01930214|37783127|FG001|Overall Study|Death|4|||
16913667|NCT01438476|38022350|FG001|Overall Study|No Surgery- Disease|10|||
16913668|NCT01438476|38022349|FG000|Overall Study|Communication barrier|0|||
16913669|NCT01438476|38022350|FG001|Overall Study|Communication barrier|1|||
16913670|NCT01467570|38022358|FG000|Overall Study|Lost to Follow-up|8|||
16913671|NCT01467570|38022359|FG001|Overall Study|Lost to Follow-up|9|||
16839002|NCT01930214|37783128|FG002|Overall Study|Death|11|||
16839003|NCT01930214|37783126|FG000|Overall Study|Lost to Follow-up|12|||
16839004|NCT01930214|37783127|FG001|Overall Study|Lost to Follow-up|13|||
16839005|NCT01930214|37783128|FG002|Overall Study|Lost to Follow-up|12|||
16839006|NCT01930214|37783126|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
16839007|NCT01930214|37783127|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
16839008|NCT01930214|37783128|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
16839009|NCT01930214|37783126|FG000|Overall Study|Physician Decision|2|||
16913672|NCT01437540|38022369|FG000|Overall Study|Not listed below|7|||
16913673|NCT01437540|38022370|FG001|Overall Study|Not listed below|6|||
16839010|NCT01930214|37783127|FG001|Overall Study|Physician Decision|0|||
16839011|NCT01930214|37783128|FG002|Overall Study|Physician Decision|0|||
16839012|NCT01958294|37783136|FG000|Overall Study|Clinical Circumstances|2|||
16839013|NCT01906346|37783140|FG000|Overall Study|AEs|1|||
16839014|NCT01958060|37783152|FG000|Overall Study|Not treated|2|||
16913674|NCT01437540|38022369|FG000|Overall Study|COPD exacerbation|13|||
16913675|NCT01437540|38022370|FG001|Overall Study|COPD exacerbation|3|||
16913676|NCT01437540|38022369|FG000|Overall Study|Lost to Follow-up|3|||
16913677|NCT01437540|38022370|FG001|Overall Study|Lost to Follow-up|5|||
16913678|NCT01437540|38022369|FG000|Overall Study|Lack of Efficacy|23|||
16913679|NCT01437540|38022370|FG001|Overall Study|Lack of Efficacy|11|||
16913680|NCT01437540|38022369|FG000|Overall Study|Protocol Violation|24|||
16913681|NCT01437540|38022370|FG001|Overall Study|Protocol Violation|12|||
16913682|NCT01437540|38022369|FG000|Overall Study|Adverse Event|26|||
16913683|NCT01437540|38022370|FG001|Overall Study|Adverse Event|13|||
16913684|NCT01437540|38022369|FG000|Overall Study|Withdrawal by Subject|31|||
16913685|NCT01437540|38022370|FG001|Overall Study|Withdrawal by Subject|15|||
16913686|NCT01440972|38022378|FG000|Overall Study|Withdrawal by Subject|3|||
16839015|NCT01958060|37783153|FG001|Overall Study|Not treated|0|||
16839016|NCT01958060|37783154|FG002|Overall Study|Not treated|0|||
16839017|NCT01958060|37783155|FG003|Overall Study|Not treated|0|||
16839018|NCT01958060|37783156|FG004|Overall Study|Not treated|1|||
16839019|NCT01958060|37783157|FG005|Overall Study|Not treated|0|||
16839020|NCT01929980|37783176|FG000|Overall Study|Physician Decision|1|||
16839021|NCT01363076|37783182|FG000|Overall Study|Withdrawal by Subject|0|||
16839022|NCT01363076|37783183|FG001|Overall Study|Withdrawal by Subject|1|||
16839023|NCT01929044|37783191|FG000|Overall Study|Adverse Event|1|||
16839024|NCT01929044|37783192|FG001|Overall Study|Adverse Event|0|||
16839025|NCT01929044|37783191|FG000|Overall Study|Protocol Violation|9|||
16839026|NCT01929044|37783192|FG001|Overall Study|Protocol Violation|14|||
16839027|NCT01929044|37783191|FG000|Overall Study|Not Treated|1|||
16839028|NCT01929044|37783192|FG001|Overall Study|Not Treated|3|||
16839029|NCT01903460|37783202|FG000|Overall Study|Adverse Event|0|||
16839030|NCT01903460|37783203|FG001|Overall Study|Adverse Event|0|||
16913687|NCT01440972|38022379|FG001|Overall Study|Withdrawal by Subject|2|||
16839031|NCT01903460|37783204|FG002|Overall Study|Adverse Event|0|||
16839032|NCT01903460|37783205|FG003|Overall Study|Adverse Event|1|||
16839033|NCT01957202|37783214|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839034|NCT01957202|37783215|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
16839035|NCT01957202|37783216|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839036|NCT01957202|37783217|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839037|NCT01957202|37783218|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839038|NCT01957202|37783219|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839039|NCT01957202|37783220|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839040|NCT01957202|37783221|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839041|NCT01957202|37783222|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16913688|NCT01420536|38022387|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
16913689|NCT01420536|38022388|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
16913690|NCT01420068|38022398|FG000|Overall Study|Administrative problems|1|||
16913691|NCT01420068|38022399|FG001|Overall Study|Administrative problems|3|||
16913692|NCT01420068|38022398|FG000|Overall Study|Withdrawal by Subject|1|||
16839042|NCT01957202|37783223|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839043|NCT01957202|37783224|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839044|NCT01957202|37783225|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839045|NCT01957202|37783226|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839046|NCT01957202|37783227|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839047|NCT01957202|37783228|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16839048|NCT01957202|37783229|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16913693|NCT01420068|38022399|FG001|Overall Study|Withdrawal by Subject|2|||
16913694|NCT01467492|38022407|FG000|Overall Study|Withdrawal by Subject|6|||
16913695|NCT01467492|38022408|FG001|Overall Study|Withdrawal by Subject|4|||
16913696|NCT01467492|38022407|FG000|Overall Study|Study Terminated by Sponsor|6|||
16839049|NCT01957202|37783230|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
16913697|NCT01467492|38022408|FG001|Overall Study|Study Terminated by Sponsor|4|||
16913698|NCT01467492|38022407|FG000|Overall Study|Adverse Event|4|||
16913699|NCT01467492|38022408|FG001|Overall Study|Adverse Event|3|||
16913700|NCT01467492|38022407|FG000|Overall Study|Lost to Follow-up|3|||
16913701|NCT01467492|38022408|FG001|Overall Study|Lost to Follow-up|2|||
16913702|NCT01467492|38022407|FG000|Overall Study|Undefined|2|||
16839050|NCT01957202|37783231|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16913703|NCT01467492|38022408|FG001|Overall Study|Undefined|0|||
16913704|NCT01467492|38022407|FG000|Overall Study|Enrolled But Not Treated|1|||
16913705|NCT01467492|38022408|FG001|Overall Study|Enrolled But Not Treated|0|||
16913706|NCT01466790|38022423|FG000|Overall Study|Adverse Event|1|||
16913707|NCT01466790|38022424|FG001|Overall Study|Adverse Event|0|||
16913708|NCT01466790|38022425|FG002|Overall Study|Adverse Event|0|||
16913709|NCT01466790|38022426|FG003|Overall Study|Adverse Event|0|||
16913710|NCT01466790|38022427|FG004|Overall Study|Adverse Event|2|||
16913711|NCT01466790|38022428|FG005|Overall Study|Adverse Event|0|||
16839051|NCT01957202|37783214|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839052|NCT01957202|37783215|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839053|NCT01957202|37783216|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839054|NCT01957202|37783217|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839055|NCT01957202|37783218|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839056|NCT01957202|37783219|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839057|NCT01957202|37783220|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839058|NCT01957202|37783221|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839059|NCT01957202|37783222|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839060|NCT01957202|37783223|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839061|NCT01957202|37783224|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839062|NCT01957202|37783225|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839063|NCT01957202|37783226|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839064|NCT01957202|37783227|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839065|NCT01957202|37783228|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839066|NCT01957202|37783229|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839067|NCT01957202|37783230|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
16839068|NCT01957202|37783231|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
16839069|NCT01616654|37783246|FG000|Overall Study|Lack of Efficacy|1|||
16839070|NCT01616654|37783247|FG001|Overall Study|Lack of Efficacy|0|||
16839071|NCT01616654|37783248|FG002|Overall Study|Lack of Efficacy|0|||
16839072|NCT01616654|37783249|FG003|Overall Study|Lack of Efficacy|0|||
16839073|NCT01616654|37783250|FG004|Overall Study|Lack of Efficacy|1|||
16839074|NCT01616654|37783246|FG000|Overall Study|Adverse Event|0|||
16839075|NCT01616654|37783247|FG001|Overall Study|Adverse Event|1|||
16839076|NCT01616654|37783248|FG002|Overall Study|Adverse Event|2|||
16839077|NCT01616654|37783249|FG003|Overall Study|Adverse Event|1|||
16839078|NCT01616654|37783250|FG004|Overall Study|Adverse Event|0|||
16839079|NCT01616654|37783246|FG000|Overall Study|Withdrawal by Subject|2|||
16839080|NCT01616654|37783247|FG001|Overall Study|Withdrawal by Subject|2|||
16913712|NCT01466790|38022429|FG006|Overall Study|Adverse Event|0|||
16913713|NCT01466790|38022430|FG007|Overall Study|Adverse Event|0|||
16913714|NCT01466790|38022423|FG000|Overall Study|Lost to Follow-up|2|||
16913715|NCT01466790|38022424|FG001|Overall Study|Lost to Follow-up|0|||
16913716|NCT01466790|38022425|FG002|Overall Study|Lost to Follow-up|0|||
16913717|NCT01466790|38022426|FG003|Overall Study|Lost to Follow-up|0|||
17016796|NCT00598871|38161449|FG001|Overall Study|Adverse Event|1|||
16839081|NCT01616654|37783248|FG002|Overall Study|Withdrawal by Subject|3|||
16839082|NCT01616654|37783249|FG003|Overall Study|Withdrawal by Subject|1|||
16839083|NCT01616654|37783250|FG004|Overall Study|Withdrawal by Subject|5|||
16839084|NCT01616654|37783246|FG000|Overall Study|Protocol Violation|0|||
16839085|NCT01616654|37783247|FG001|Overall Study|Protocol Violation|5|||
16839086|NCT01616654|37783248|FG002|Overall Study|Protocol Violation|2|||
16839087|NCT01616654|37783249|FG003|Overall Study|Protocol Violation|4|||
16839088|NCT01616654|37783250|FG004|Overall Study|Protocol Violation|4|||
16839089|NCT01616654|37783246|FG000|Overall Study|Lost to Follow-up|1|||
16839090|NCT01616654|37783247|FG001|Overall Study|Lost to Follow-up|0|||
16839091|NCT01616654|37783248|FG002|Overall Study|Lost to Follow-up|3|||
16839092|NCT01616654|37783249|FG003|Overall Study|Lost to Follow-up|2|||
16839093|NCT01616654|37783250|FG004|Overall Study|Lost to Follow-up|1|||
16839094|NCT01616654|37783246|FG000|Overall Study|Pregnancy|1|||
16839095|NCT01616654|37783247|FG001|Overall Study|Pregnancy|0|||
16839096|NCT01616654|37783248|FG002|Overall Study|Pregnancy|0|||
16839097|NCT01616654|37783249|FG003|Overall Study|Pregnancy|0|||
16913718|NCT01466790|38022427|FG004|Overall Study|Lost to Follow-up|0|||
16913719|NCT01466790|38022428|FG005|Overall Study|Lost to Follow-up|0|||
16913720|NCT01466790|38022429|FG006|Overall Study|Lost to Follow-up|0|||
16913721|NCT01466790|38022430|FG007|Overall Study|Lost to Follow-up|0|||
16839098|NCT01616654|37783250|FG004|Overall Study|Pregnancy|1|||
16839099|NCT01902290|37783265|FG000|Overall Study|Withdrawal by Subject|19|||
16913722|NCT01466790|38022423|FG000|Overall Study|Withdrawal by Subject|1|||
16913723|NCT01466790|38022424|FG001|Overall Study|Withdrawal by Subject|1|||
16839100|NCT01902290|37783266|FG001|Overall Study|Withdrawal by Subject|27|||
16839101|NCT01902290|37783265|FG000|Overall Study|Lost to Follow-up|2|||
16839102|NCT01902290|37783266|FG001|Overall Study|Lost to Follow-up|2|||
16839103|NCT01902290|37783265|FG000|Overall Study|Death|1|||
16839104|NCT01902290|37783266|FG001|Overall Study|Death|0|||
16839105|NCT01902290|37783265|FG000|Overall Study|Sponsor Decision|26|||
16839106|NCT01902290|37783266|FG001|Overall Study|Sponsor Decision|24|||
16839107|NCT01927562|37783273|FG000|Overall Study|Lost to Follow-up|30|||
16839108|NCT01927562|37783273|FG000|Overall Study|Withdrawal by Subject|3|||
16839109|NCT01927562|37783273|FG000|Overall Study|Physician Decision|5|||
16839110|NCT01467466|37783281|FG000|Overall Study|Withdrawal by Subject|15|||
16839111|NCT01467466|37783282|FG001|Overall Study|Withdrawal by Subject|18|||
16839112|NCT01467466|37783283|FG002|Overall Study|Withdrawal by Subject|13|||
16839113|NCT01467466|37783284|FG003|Overall Study|Withdrawal by Subject|11|||
16839114|NCT01467466|37783281|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
16839115|NCT01467466|37783282|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
16839116|NCT01467466|37783283|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
16839117|NCT01467466|37783284|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
16839118|NCT01467466|37783281|FG000|Overall Study|Procedure Cancelled|46|||
16839119|NCT01467466|37783282|FG001|Overall Study|Procedure Cancelled|45|||
16839120|NCT01467466|37783283|FG002|Overall Study|Procedure Cancelled|25|||
16839121|NCT01467466|37783284|FG003|Overall Study|Procedure Cancelled|29|||
16839122|NCT01467466|37783281|FG000|Overall Study|No Endpoint Blood Draw|38|||
16839123|NCT01467466|37783282|FG001|Overall Study|No Endpoint Blood Draw|32|||
16839124|NCT01467466|37783283|FG002|Overall Study|No Endpoint Blood Draw|51|||
16839125|NCT01467466|37783284|FG003|Overall Study|No Endpoint Blood Draw|43|||
16839126|NCT01441180|37783297|FG000|Overall Study|Lost to Follow-up|1|||
16839127|NCT01441180|37783298|FG001|Overall Study|Lost to Follow-up|1|||
16839128|NCT01441180|37783299|FG002|Overall Study|Lost to Follow-up|1|||
16839129|NCT01441180|37783297|FG000|Overall Study|Discontinued|0|||
16839130|NCT01441180|37783298|FG001|Overall Study|Discontinued|0|||
16839131|NCT01441180|37783299|FG002|Overall Study|Discontinued|2|||
16839132|NCT01441102|37783310|FG000|Overall Study|Adverse Event|1|||
16839133|NCT01441102|37783310|FG000|Overall Study|Withdrawal by Subject|2|||
16839134|NCT01467076|37783317|FG000|Overall Study|Lost to Follow-up|1|||
16839135|NCT01467076|37783318|FG001|Overall Study|Lost to Follow-up|0|||
16839136|NCT01467076|37783319|FG002|Overall Study|Lost to Follow-up|0|||
16839137|NCT01466062|37783327|FG000|Overall Study|Adverse Event|1|||
16839138|NCT01466062|37783327|FG000|Overall Study|Withdrawal by Subject|1|||
16839139|NCT01435018|37783334|FG000|Overall Study|Death|37|||
16839140|NCT01435018|37783335|FG001|Overall Study|Death|18|||
16839141|NCT01435018|37783336|FG002|Overall Study|Death|25|||
16839142|NCT01435018|37783334|FG000|Overall Study|Site is closing|4|||
16839143|NCT01435018|37783335|FG001|Overall Study|Site is closing|9|||
16839144|NCT01435018|37783336|FG002|Overall Study|Site is closing|7|||
16839145|NCT01435018|37783334|FG000|Overall Study|Withdrew consent|0|||
16839146|NCT01435018|37783335|FG001|Overall Study|Withdrew consent|3|||
16839147|NCT01435018|37783336|FG002|Overall Study|Withdrew consent|1|||
16839148|NCT01435018|37783334|FG000|Overall Study|Not willing to adhere to requirements|0|||
16839149|NCT01435018|37783335|FG001|Overall Study|Not willing to adhere to requirements|2|||
16839150|NCT01435018|37783336|FG002|Overall Study|Not willing to adhere to requirements|3|||
16839151|NCT01435018|37783334|FG000|Overall Study|Not able to get to clinic|2|||
16839152|NCT01435018|37783335|FG001|Overall Study|Not able to get to clinic|0|||
16839153|NCT01435018|37783336|FG002|Overall Study|Not able to get to clinic|2|||
16839154|NCT01435018|37783334|FG000|Overall Study|Severe debilitation, unable to continue|0|||
16839155|NCT01435018|37783335|FG001|Overall Study|Severe debilitation, unable to continue|0|||
16839156|NCT01435018|37783336|FG002|Overall Study|Severe debilitation, unable to continue|1|||
16839157|NCT01435018|37783334|FG000|Overall Study|Unable to contact participant/parent|1|||
16839158|NCT01435018|37783335|FG001|Overall Study|Unable to contact participant/parent|1|||
16839159|NCT01435018|37783336|FG002|Overall Study|Unable to contact participant/parent|1|||
16839160|NCT01435018|37783334|FG000|Overall Study|Enrollment Violation|0|||
16839161|NCT01435018|37783335|FG001|Overall Study|Enrollment Violation|1|||
16839162|NCT01435018|37783336|FG002|Overall Study|Enrollment Violation|0|||
16839163|NCT01435018|37783334|FG000|Overall Study|Never started chemotherapy|3|||
16839164|NCT01435018|37783335|FG001|Overall Study|Never started chemotherapy|0|||
16839165|NCT01435018|37783336|FG002|Overall Study|Never started chemotherapy|1|||
16839166|NCT01419184|37783348|FG000|Overall Study|Site data not available|3|||
16839167|NCT01419184|37783349|FG001|Overall Study|Site data not available|2|||
16839168|NCT01419184|37783348|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
16839169|NCT01419184|37783349|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
16839170|NCT01419184|37783348|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
16839171|NCT01419184|37783349|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
16839172|NCT01419184|37783348|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
16839173|NCT01419184|37783349|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
16839174|NCT01419184|37783348|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
17016797|NCT00690820|38161457|FG000|Period 1|Withdrawal by Subject|0|||
16839175|NCT01419184|37783349|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
16839176|NCT01419184|37783348|FG000|Overall Study|Participant randomized, not treated|1|||
16839177|NCT01419184|37783349|FG001|Overall Study|Participant randomized, not treated|0|||
16839178|NCT01417234|37783355|FG000|Overall Study|Subject non-compliant|3|||
16839179|NCT01417156|37783359|FG000|Overall Study|Adverse Event|12|||
16839180|NCT01417156|37783359|FG000|Overall Study|Protocol Violation|2|||
16839181|NCT01417078|37783363|FG000|Overall Study|Withdrawal by Subject|1|||
16839182|NCT01954394|37783371|FG000|Overall Study|Enrolled but not treated|1|||
16839183|NCT01954394|37783372|FG001|Overall Study|Enrolled but not treated|0|||
16839184|NCT01954394|37783371|FG000|Overall Study|Adverse Event|10|||
16839185|NCT01954394|37783372|FG001|Overall Study|Adverse Event|23|||
16839186|NCT01954394|37783371|FG000|Overall Study|Poor compliance to protocol|7|||
16839187|NCT01954394|37783372|FG001|Overall Study|Poor compliance to protocol|7|||
16839188|NCT01954394|37783371|FG000|Overall Study|Participant Moved|0|||
16839189|NCT01954394|37783372|FG001|Overall Study|Participant Moved|4|||
16839190|NCT01954394|37783371|FG000|Overall Study|Related to Study Drug administration|2|||
16839191|NCT01954394|37783372|FG001|Overall Study|Related to Study Drug administration|2|||
16839192|NCT01954394|37783371|FG000|Overall Study|Other than specified above|10|||
16839193|NCT01954394|37783372|FG001|Overall Study|Other than specified above|21|||
16839194|NCT01464424|37783380|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
16839195|NCT01464424|37783381|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
16839196|NCT01902134|37783393|FG000|Overall Study|Adverse Event|3|||
16839197|NCT01902134|37783394|FG001|Overall Study|Adverse Event|1|||
16839198|NCT01902134|37783395|FG002|Overall Study|Adverse Event|2|||
16839199|NCT01902134|37783396|FG003|Overall Study|Adverse Event|1|||
16839200|NCT01902134|37783397|FG004|Overall Study|Adverse Event|1|||
16839201|NCT01902134|37783398|FG005|Overall Study|Adverse Event|3|||
16839202|NCT01902134|37783393|FG000|Overall Study|Lack of Efficacy|0|||
16839203|NCT01902134|37783394|FG001|Overall Study|Lack of Efficacy|0|||
16839204|NCT01902134|37783395|FG002|Overall Study|Lack of Efficacy|2|||
16839205|NCT01902134|37783396|FG003|Overall Study|Lack of Efficacy|0|||
16839206|NCT01902134|37783397|FG004|Overall Study|Lack of Efficacy|0|||
16839207|NCT01902134|37783398|FG005|Overall Study|Lack of Efficacy|1|||
16839208|NCT01902134|37783393|FG000|Overall Study|Physician Decision|0|||
16839209|NCT01902134|37783394|FG001|Overall Study|Physician Decision|1|||
16839210|NCT01902134|37783395|FG002|Overall Study|Physician Decision|0|||
16839211|NCT01902134|37783396|FG003|Overall Study|Physician Decision|0|||
16839212|NCT01902134|37783397|FG004|Overall Study|Physician Decision|0|||
16839213|NCT01902134|37783398|FG005|Overall Study|Physician Decision|0|||
16839214|NCT01902134|37783393|FG000|Overall Study|Protocol Violation|0|||
16839215|NCT01902134|37783394|FG001|Overall Study|Protocol Violation|0|||
16839216|NCT01902134|37783395|FG002|Overall Study|Protocol Violation|0|||
16839217|NCT01902134|37783396|FG003|Overall Study|Protocol Violation|0|||
16839218|NCT01902134|37783397|FG004|Overall Study|Protocol Violation|0|||
16839219|NCT01902134|37783398|FG005|Overall Study|Protocol Violation|1|||
16839220|NCT01902134|37783393|FG000|Overall Study|Withdrawal by Subject|4|||
16839221|NCT01902134|37783394|FG001|Overall Study|Withdrawal by Subject|8|||
16839222|NCT01902134|37783395|FG002|Overall Study|Withdrawal by Subject|9|||
16839223|NCT01902134|37783396|FG003|Overall Study|Withdrawal by Subject|1|||
16839224|NCT01902134|37783397|FG004|Overall Study|Withdrawal by Subject|5|||
16839225|NCT01902134|37783398|FG005|Overall Study|Withdrawal by Subject|4|||
16839226|NCT01902134|37783393|FG000|Overall Study|no compliance|1|||
16839227|NCT01902134|37783394|FG001|Overall Study|no compliance|0|||
16839228|NCT01902134|37783395|FG002|Overall Study|no compliance|0|||
16839229|NCT01902134|37783396|FG003|Overall Study|no compliance|0|||
16839230|NCT01902134|37783397|FG004|Overall Study|no compliance|0|||
16913724|NCT01466790|38022425|FG002|Overall Study|Withdrawal by Subject|0|||
16913725|NCT01466790|38022426|FG003|Overall Study|Withdrawal by Subject|0|||
16913726|NCT01466790|38022427|FG004|Overall Study|Withdrawal by Subject|1|||
16913727|NCT01466790|38022428|FG005|Overall Study|Withdrawal by Subject|0|||
16913728|NCT01466790|38022429|FG006|Overall Study|Withdrawal by Subject|1|||
16913729|NCT01466790|38022430|FG007|Overall Study|Withdrawal by Subject|1|||
16913730|NCT01466166|38022444|FG000|Overall Study|Death|1|||
16913731|NCT01466166|38022444|FG000|Overall Study|Lost to Follow-up|7|||
16913732|NCT01466166|38022444|FG000|Overall Study|Infusion Reaction (IR)|27|||
16913733|NCT01466166|38022444|FG000|Overall Study|Adverse Event (Other than IR)|11|||
16913734|NCT01466166|38022444|FG000|Overall Study|Elevated Serum Uric Acid|78|||
16913735|NCT01466166|38022444|FG000|Overall Study|Withdrawal by Subject|13|||
16913736|NCT01466166|38022444|FG000|Overall Study|Sponsor Decision|4|||
16913737|NCT01466166|38022444|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
16839231|NCT01902134|37783398|FG005|Overall Study|no compliance|0|||
16839232|NCT01902134|37783393|FG000|Overall Study|Other|0|||
16839233|NCT01902134|37783394|FG001|Overall Study|Other|1|||
16839234|NCT01902134|37783395|FG002|Overall Study|Other|2|||
16839235|NCT01902134|37783396|FG003|Overall Study|Other|0|||
16839236|NCT01902134|37783397|FG004|Overall Study|Other|1|||
16839237|NCT01902134|37783398|FG005|Overall Study|Other|0|||
16913738|NCT01466166|38022444|FG000|Overall Study|Other|20|||
16913739|NCT01418352|38022452|FG000|Overall Study|Lost to Follow-up|2|||
16913740|NCT01418352|38022453|FG001|Overall Study|Lost to Follow-up|0|||
16913741|NCT01418352|38022454|FG002|Overall Study|Lost to Follow-up|0|||
16913742|NCT01418352|38022455|FG003|Overall Study|Lost to Follow-up|0|||
16913743|NCT01418352|38022452|FG000|Overall Study|Adverse Event|0|||
16913744|NCT01418352|38022453|FG001|Overall Study|Adverse Event|1|||
16913745|NCT01418352|38022454|FG002|Overall Study|Adverse Event|0|||
16913746|NCT01418352|38022455|FG003|Overall Study|Adverse Event|0|||
16913747|NCT01418352|38022452|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
16913748|NCT01418352|38022453|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
16913749|NCT01418352|38022454|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
16839238|NCT01954082|37783416|FG000|Overall Study|Study Suspension|42|||
16839239|NCT01954082|37783417|FG001|Overall Study|Study Suspension|36|||
16839240|NCT01954082|37783416|FG000|Overall Study|Adverse Event|10|||
16839241|NCT01954082|37783417|FG001|Overall Study|Adverse Event|4|||
16839242|NCT01954082|37783416|FG000|Overall Study|Intolerance|0|||
16839243|NCT01954082|37783417|FG001|Overall Study|Intolerance|1|||
16839244|NCT01954082|37783416|FG000|Overall Study|Non-compliance|6|||
16839245|NCT01954082|37783417|FG001|Overall Study|Non-compliance|4|||
16839246|NCT01954082|37783416|FG000|Overall Study|Physician Decision|2|||
16839247|NCT01954082|37783417|FG001|Overall Study|Physician Decision|0|||
16839248|NCT01954082|37783416|FG000|Overall Study|Parent Decision|1|||
16839249|NCT01954082|37783417|FG001|Overall Study|Parent Decision|0|||
16839250|NCT01954082|37783416|FG000|Overall Study|Withdrawal by Subject|0|||
16839251|NCT01954082|37783417|FG001|Overall Study|Withdrawal by Subject|1|||
16839252|NCT01954082|37783416|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
16839253|NCT01954082|37783417|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
16839254|NCT01954082|37783416|FG000|Overall Study|Redirection of Care|0|||
16839255|NCT01954082|37783417|FG001|Overall Study|Redirection of Care|2|||
16839256|NCT01954082|37783416|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
16839257|NCT01954082|37783417|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
16839258|NCT01954082|37783416|FG000|Overall Study|Comfort Care|0|||
16839259|NCT01954082|37783417|FG001|Overall Study|Comfort Care|1|||
16839260|NCT01954082|37783416|FG000|Overall Study|Infant Moved|0|||
16839261|NCT01954082|37783417|FG001|Overall Study|Infant Moved|1|||
16839262|NCT01954082|37783416|FG000|Overall Study|Randomized not Treated|4|||
16839263|NCT01954082|37783417|FG001|Overall Study|Randomized not Treated|2|||
16839264|NCT01417000|37783425|FG000|Overall Study|Death|59|||
16839265|NCT01417000|37783426|FG001|Overall Study|Death|28|||
16839266|NCT01417000|37783425|FG000|Overall Study|Lost to Follow-up|1|||
16839267|NCT01417000|37783426|FG001|Overall Study|Lost to Follow-up|0|||
16839268|NCT01417000|37783425|FG000|Overall Study|Study Terminated by Sponsor|1|||
16839269|NCT01417000|37783426|FG001|Overall Study|Study Terminated by Sponsor|1|||
16839270|NCT01416610|37783432|FG000|Overall Study|Adverse Event|4|||
16839271|NCT01416610|37783432|FG000|Overall Study|Adverse Event -Patient decision|3|||
16839272|NCT01416610|37783432|FG000|Overall Study|Lack of Efficacy|4|||
16839273|NCT01416610|37783432|FG000|Overall Study|No reason given|5|||
16839274|NCT01416610|37783432|FG000|Overall Study|Withdrawal by Subject|13|||
16839275|NCT01416610|37783432|FG000|Overall Study|Lost to Follow-up|7|||
16839276|NCT01416610|37783432|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
16839277|NCT01416142|37783440|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
16839278|NCT01416142|37783441|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
16839279|NCT01416142|37783442|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
16839280|NCT01415986|37783450|FG000|Overall Study|Lost to Follow-up|1|||
16839281|NCT01415908|37783457|FG000|Overall Study|Withdrawal by Subject|1|||
16839282|NCT01415908|37783458|FG001|Overall Study|Withdrawal by Subject|0|||
16839283|NCT01415518|37783466|FG000|Overall Study|Withdrawal by Subject|2|||
16839284|NCT01415518|37783467|FG001|Overall Study|Withdrawal by Subject|12|||
16913750|NCT01418352|38022455|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
16913751|NCT01418352|38022452|FG000|Overall Study|Subject Withdrew Consent|0|||
16913752|NCT01418352|38022453|FG001|Overall Study|Subject Withdrew Consent|1|||
16913753|NCT01418352|38022454|FG002|Overall Study|Subject Withdrew Consent|2|||
16913754|NCT01418352|38022455|FG003|Overall Study|Subject Withdrew Consent|1|||
16913755|NCT01418352|38022452|FG000|Overall Study|Protocol Deviation|0|||
17016798|NCT00690820|38161458|FG001|Period 1|Withdrawal by Subject|1|||
17016799|NCT00689338|38161464|FG000|Overall Study|Death|65|||
17016800|NCT00689338|38161464|FG000|Overall Study|Adverse Event|13|||
16839285|NCT01415518|37783466|FG000|Overall Study|Protocol Violation|6|||
16839286|NCT01415518|37783467|FG001|Overall Study|Protocol Violation|8|||
16839287|NCT01415518|37783466|FG000|Overall Study|Lost to Follow-up|3|||
16839288|NCT01415518|37783467|FG001|Overall Study|Lost to Follow-up|5|||
16839289|NCT01415518|37783466|FG000|Overall Study|Adverse Event|3|||
16839290|NCT01415518|37783467|FG001|Overall Study|Adverse Event|4|||
16839291|NCT01415518|37783466|FG000|Overall Study|Death|1|||
16839292|NCT01415518|37783467|FG001|Overall Study|Death|1|||
16913756|NCT01418352|38022453|FG001|Overall Study|Protocol Deviation|0|||
16913757|NCT01418352|38022454|FG002|Overall Study|Protocol Deviation|1|||
16913758|NCT01418352|38022455|FG003|Overall Study|Protocol Deviation|0|||
16913759|NCT01418352|38022452|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
16913760|NCT01418352|38022453|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
16913761|NCT01418352|38022454|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
16913762|NCT01418352|38022455|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
16913763|NCT01436370|38022473|FG000|Overall Study|Lost to Follow-up|0|||
16913764|NCT01436370|38022474|FG001|Overall Study|Lost to Follow-up|0|||
16913765|NCT01436370|38022475|FG002|Overall Study|Lost to Follow-up|0|||
16839293|NCT01415518|37783466|FG000|Overall Study|Condition under Investigation Worsened|1|||
16839294|NCT01415518|37783467|FG001|Overall Study|Condition under Investigation Worsened|1|||
16839295|NCT01393600|37783473|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
16839296|NCT01393600|37783474|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
16839297|NCT01393600|37783475|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
16839298|NCT01393600|37783476|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
16839299|NCT01393600|37783473|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
16839300|NCT01393600|37783474|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
16839301|NCT01393600|37783475|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
16913766|NCT01436370|38022476|FG003|Overall Study|Lost to Follow-up|0|||
16913767|NCT01436370|38022477|FG004|Overall Study|Lost to Follow-up|1|||
16913768|NCT01436370|38022478|FG005|Overall Study|Lost to Follow-up|0|||
16913769|NCT01436370|38022479|FG006|Overall Study|Lost to Follow-up|0|||
16913770|NCT01436370|38022480|FG007|Overall Study|Lost to Follow-up|0|||
16913771|NCT01465464|38022508|FG000|Overall Study|Adverse Event|96|||
16913772|NCT01465464|38022509|FG001|Overall Study|Adverse Event|49|||
16913773|NCT01465464|38022508|FG000|Overall Study|Lack of Efficacy|139|||
16913774|NCT01465464|38022509|FG001|Overall Study|Lack of Efficacy|190|||
16913775|NCT01465464|38022508|FG000|Overall Study|Physician Decision|13|||
16839302|NCT01393600|37783476|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
16839303|NCT01393600|37783473|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
16839304|NCT01393600|37783474|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
16839305|NCT01393600|37783475|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
16839306|NCT01393600|37783476|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
16839307|NCT01393600|37783473|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
16839308|NCT01393600|37783474|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
16839309|NCT01393600|37783475|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
16839310|NCT01393600|37783476|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
16839311|NCT01393600|37783473|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
16839312|NCT01393600|37783474|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
16839313|NCT01393600|37783475|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
16839314|NCT01393600|37783476|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
16839315|NCT01393600|37783473|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
16839316|NCT01393600|37783474|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
16839317|NCT01393600|37783475|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
16839318|NCT01393600|37783476|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
16839319|NCT01393600|37783473|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
16839320|NCT01393600|37783474|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
16839321|NCT01393600|37783475|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
16839322|NCT01393600|37783476|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
16839323|NCT01432756|37783492|FG000|Overall Study|Lost to Follow-up|1|||
16839324|NCT01432756|37783493|FG001|Overall Study|Lost to Follow-up|0|||
16839325|NCT01432756|37783494|FG002|Overall Study|Lost to Follow-up|2|||
16839326|NCT01432756|37783495|FG003|Overall Study|Lost to Follow-up|1|||
16839327|NCT01432600|37783506|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
16839328|NCT01432600|37783507|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
16913776|NCT01465464|38022509|FG001|Overall Study|Physician Decision|5|||
17016801|NCT00689338|38161464|FG000|Overall Study|Insufficient Clinical Response|1|||
16839329|NCT01432600|37783508|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
16839330|NCT01432444|37783518|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
16839331|NCT01432444|37783519|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
16839332|NCT01432444|37783520|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
16839333|NCT01432444|37783518|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
16839334|NCT01432444|37783519|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
16839335|NCT01432444|37783520|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
16839336|NCT01432444|37783518|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
16839337|NCT01432444|37783519|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
16839338|NCT01432444|37783520|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
17016802|NCT00689338|38161464|FG000|Overall Study|Lack of Efficacy|6|||
16839339|NCT01432444|37783518|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
16839340|NCT01432444|37783519|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
16913777|NCT01465464|38022508|FG000|Overall Study|Protocol Violation|1|||
16913778|NCT01465464|38022509|FG001|Overall Study|Protocol Violation|1|||
16839341|NCT01432444|37783520|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
16839342|NCT01432444|37783518|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
16839343|NCT01432444|37783519|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
16839344|NCT01432444|37783520|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
16839345|NCT01432444|37783518|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
16839346|NCT01432444|37783519|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
16839347|NCT01432444|37783520|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
16839348|NCT01432444|37783518|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
16839349|NCT01432444|37783519|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
16839350|NCT01432444|37783520|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
16839351|NCT01432444|37783518|FG000|Treatment Phase|Lost to Follow-up|0|||
16839352|NCT01432444|37783519|FG001|Treatment Phase|Lost to Follow-up|33|||
16839353|NCT01432444|37783520|FG002|Treatment Phase|Lost to Follow-up|0|||
16839354|NCT01432444|37783518|FG000|Treatment Phase|Adverse Event|0|||
16839355|NCT01432444|37783519|FG001|Treatment Phase|Adverse Event|37|||
16839356|NCT01432444|37783520|FG002|Treatment Phase|Adverse Event|0|||
16839357|NCT01432444|37783518|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
16839358|NCT01432444|37783519|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
16839359|NCT01432444|37783520|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
16839360|NCT01432444|37783518|FG000|Treatment Phase|Physician Decision|0|||
16839361|NCT01432444|37783519|FG001|Treatment Phase|Physician Decision|5|||
16839362|NCT01432444|37783520|FG002|Treatment Phase|Physician Decision|0|||
16839363|NCT01432444|37783518|FG000|Treatment Phase|Withdrawal by Subject|0|||
16839364|NCT01432444|37783519|FG001|Treatment Phase|Withdrawal by Subject|41|||
16839365|NCT01432444|37783520|FG002|Treatment Phase|Withdrawal by Subject|0|||
16839366|NCT01432444|37783518|FG000|Treatment Phase|Protocol Deviation|0|||
16839367|NCT01432444|37783519|FG001|Treatment Phase|Protocol Deviation|3|||
16839368|NCT01432444|37783520|FG002|Treatment Phase|Protocol Deviation|0|||
16839369|NCT01432444|37783518|FG000|Treatment Phase|Lack of Efficacy|0|||
16839370|NCT01432444|37783519|FG001|Treatment Phase|Lack of Efficacy|10|||
16839371|NCT01432444|37783520|FG002|Treatment Phase|Lack of Efficacy|0|||
16839372|NCT01432444|37783518|FG000|Extension Phase|Lost to Follow-up|0|||
16839373|NCT01432444|37783519|FG001|Extension Phase|Lost to Follow-up|0|||
16839374|NCT01432444|37783520|FG002|Extension Phase|Lost to Follow-up|17|||
16839375|NCT01432444|37783518|FG000|Extension Phase|Adverse Event|0|||
16839376|NCT01432444|37783519|FG001|Extension Phase|Adverse Event|0|||
16839377|NCT01432444|37783520|FG002|Extension Phase|Adverse Event|10|||
16839378|NCT01432444|37783518|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
16839379|NCT01432444|37783519|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
16839380|NCT01432444|37783520|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
16839381|NCT01432444|37783518|FG000|Extension Phase|Met Withdrawal Criteria|0|||
16839382|NCT01432444|37783519|FG001|Extension Phase|Met Withdrawal Criteria|0|||
16839383|NCT01432444|37783520|FG002|Extension Phase|Met Withdrawal Criteria|144|||
16839384|NCT01432444|37783518|FG000|Extension Phase|Physician Decision|0|||
16839385|NCT01432444|37783519|FG001|Extension Phase|Physician Decision|0|||
16839386|NCT01432444|37783520|FG002|Extension Phase|Physician Decision|1|||
16839387|NCT01432444|37783518|FG000|Extension Phase|Withdrawal by Subject|0|||
16839388|NCT01432444|37783519|FG001|Extension Phase|Withdrawal by Subject|0|||
16839389|NCT01432444|37783520|FG002|Extension Phase|Withdrawal by Subject|13|||
16839390|NCT01432366|37783525|FG000|Overall Study|Non-Responder|7|||
16839391|NCT01432366|37783525|FG000|Overall Study|Adverse Event|8|||
16839392|NCT01432366|37783525|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
16839393|NCT01432366|37783525|FG000|Overall Study|Pregnancy|1|||
16839394|NCT01432366|37783525|FG000|Overall Study|Lost to Follow-up|13|||
16839395|NCT01432366|37783525|FG000|Overall Study|Lack of Efficacy|1|||
16839396|NCT01432366|37783525|FG000|Overall Study|Site Closed|20|||
16839397|NCT01432366|37783525|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
16839398|NCT01432366|37783525|FG000|Overall Study|Other|14|||
16839399|NCT01415440|37783532|FG000|Overall Study|Lost to Follow-up|0|||
16839400|NCT01415440|37783533|FG001|Overall Study|Lost to Follow-up|1|||
16839401|NCT01415440|37783534|FG002|Overall Study|Lost to Follow-up|2|||
16839402|NCT01415440|37783532|FG000|Overall Study|Physician Decision|3|||
16839403|NCT01415440|37783533|FG001|Overall Study|Physician Decision|0|||
16839404|NCT01415440|37783534|FG002|Overall Study|Physician Decision|0|||
16839405|NCT01415440|37783532|FG000|Overall Study|Withdrawal by Subject|1|||
16839406|NCT01415440|37783533|FG001|Overall Study|Withdrawal by Subject|0|||
16839407|NCT01415440|37783534|FG002|Overall Study|Withdrawal by Subject|0|||
16839408|NCT01414738|37783550|FG000|Overall Study|Death|26|||
16839409|NCT01414738|37783550|FG000|Overall Study|Refused testing|5|||
16839410|NCT01414738|37783550|FG000|Overall Study|Lost to Follow-up|2|||
16839411|NCT01414738|37783550|FG000|Overall Study|Refused, disease progression|8|||
16839412|NCT01414738|37783550|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
16913779|NCT01465464|38022508|FG000|Overall Study|Withdrawal by Subject|46|||
16913780|NCT01465464|38022509|FG001|Overall Study|Withdrawal by Subject|30|||
16913781|NCT01465464|38022508|FG000|Overall Study|Other|9|||
16913782|NCT01465464|38022509|FG001|Overall Study|Other|3|||
16839413|NCT01414114|37783554|FG000|Overall Study|Adverse Event|2|||
16839414|NCT01414114|37783554|FG000|Overall Study|Withdrawal by Subject|1|||
16839415|NCT01414114|37783554|FG000|Overall Study|Other|2|||
16839416|NCT01393444|37783560|FG000|Overall Study|Withdrawal by Subject|1|||
16839417|NCT01393444|37783560|FG000|Overall Study|Determined ineligible during screening.|2|||
16839418|NCT01431976|37783564|FG000|Overall Study|Adverse Event|6|||
16839419|NCT01431976|37783564|FG000|Overall Study|Lack of Efficacy|2|||
16839420|NCT01431976|37783564|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
16839421|NCT01431976|37783564|FG000|Overall Study|Physician Decision|1|||
16839422|NCT01431976|37783564|FG000|Overall Study|Withdrawal by Subject|1|||
16839423|NCT01392742|37783568|FG000|Overall Study|Premature study termination|42|||
16839424|NCT01392742|37783568|FG000|Overall Study|Failure to return|35|||
16913783|NCT01465464|38022508|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
16913784|NCT01465464|38022509|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
16913785|NCT01417104|38022517|FG000|Overall Study|Withdrawal by Subject|5|||
16913786|NCT01417104|38022518|FG001|Overall Study|Withdrawal by Subject|1|||
16913787|NCT01417104|38022517|FG000|Overall Study|Failure to make contact|0|||
16913788|NCT01417104|38022518|FG001|Overall Study|Failure to make contact|1|||
16913789|NCT01417104|38022517|FG000|Overall Study|Adverse Event|1|||
16913790|NCT01417104|38022518|FG001|Overall Study|Adverse Event|0|||
17198509|NCT00103285|38352280|FG007|Induction|Physician Decision|0|||
17198510|NCT00103285|38352273|FG000|Induction|Withdrawal by Subject|1|||
17198511|NCT00103285|38352274|FG001|Induction|Withdrawal by Subject|0|||
17198512|NCT00103285|38352275|FG002|Induction|Withdrawal by Subject|0|||
17198513|NCT00103285|38352276|FG003|Induction|Withdrawal by Subject|0|||
17198514|NCT00103285|38352277|FG004|Induction|Withdrawal by Subject|0|||
17198515|NCT00103285|38352278|FG005|Induction|Withdrawal by Subject|0|||
17198516|NCT00103285|38352279|FG006|Induction|Withdrawal by Subject|0|||
17198517|NCT00103285|38352280|FG007|Induction|Withdrawal by Subject|0|||
17198518|NCT00103285|38352273|FG000|Induction|Ineligible|43|||
17198519|NCT00103285|38352274|FG001|Induction|Ineligible|0|||
17198520|NCT00103285|38352275|FG002|Induction|Ineligible|0|||
17198521|NCT00103285|38352276|FG003|Induction|Ineligible|0|||
17198522|NCT00103285|38352277|FG004|Induction|Ineligible|0|||
17198523|NCT00103285|38352278|FG005|Induction|Ineligible|0|||
17198524|NCT00103285|38352279|FG006|Induction|Ineligible|0|||
17198525|NCT00103285|38352280|FG007|Induction|Ineligible|0|||
17198526|NCT00103285|38352273|FG000|Induction|Refusal|906|||
16839425|NCT01392742|37783568|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
16839426|NCT01392742|37783568|FG000|Overall Study|Lost to Follow-up|34|||
16839427|NCT01392742|37783568|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
16839428|NCT01392742|37783568|FG000|Overall Study|ITR and Protocol deviation|1|||
16839429|NCT01392742|37783568|FG000|Overall Study|Adverse event/intercurrent illness|17|||
16839430|NCT01392742|37783568|FG000|Overall Study|Protocol Violation|14|||
16913791|NCT01465386|38022524|FG000|Overall Study|Lack of Efficacy|3|||
16913792|NCT01465386|38022524|FG000|Overall Study|Adverse Event|1|||
16839431|NCT01392742|37783568|FG000|Overall Study|Other|3|||
16839432|NCT01392742|37783568|FG000|Overall Study|Missing information|13|||
16839433|NCT01413958|37783574|FG000|Overall Study|Lost to Follow-up|0|||
16839434|NCT01413958|37783575|FG001|Overall Study|Lost to Follow-up|1|||
16839435|NCT01413178|37783584|FG000|Overall Study|Toxicity|1|||
16839436|NCT01413178|37783585|FG001|Overall Study|Toxicity|0|||
16839437|NCT01413178|37783584|FG000|Overall Study|Ineligible|0|||
16839438|NCT01413178|37783585|FG001|Overall Study|Ineligible|2|||
16839439|NCT01799889|37783603|FG000|Overall Study|Adverse Event|4|||
16839440|NCT01799889|37783604|FG001|Overall Study|Adverse Event|4|||
16839441|NCT01799889|37783605|FG002|Overall Study|Adverse Event|5|||
16839442|NCT01799889|37783606|FG003|Overall Study|Adverse Event|1|||
16839443|NCT01799889|37783607|FG004|Overall Study|Adverse Event|11|||
16839444|NCT01799889|37783608|FG005|Overall Study|Adverse Event|1|||
16839445|NCT01799889|37783609|FG006|Overall Study|Adverse Event|5|||
16839446|NCT01799889|37783610|FG007|Overall Study|Adverse Event|2|||
16839447|NCT01799889|37783611|FG008|Overall Study|Adverse Event|3|||
16839448|NCT01799889|37783612|FG009|Overall Study|Adverse Event|1|||
16839449|NCT01799889|37783613|FG010|Overall Study|Adverse Event|1|||
16839450|NCT01799889|37783614|FG011|Overall Study|Adverse Event|0|||
16839451|NCT01799889|37783603|FG000|Overall Study|Death|1|||
16839452|NCT01799889|37783604|FG001|Overall Study|Death|0|||
16839453|NCT01799889|37783605|FG002|Overall Study|Death|5|||
16839454|NCT01799889|37783606|FG003|Overall Study|Death|3|||
16839455|NCT01799889|37783607|FG004|Overall Study|Death|1|||
16839456|NCT01799889|37783608|FG005|Overall Study|Death|0|||
16839457|NCT01799889|37783609|FG006|Overall Study|Death|0|||
16839458|NCT01799889|37783610|FG007|Overall Study|Death|0|||
16839459|NCT01799889|37783611|FG008|Overall Study|Death|1|||
17198527|NCT00103285|38352274|FG001|Induction|Refusal|0|||
17198528|NCT00103285|38352275|FG002|Induction|Refusal|0|||
17198529|NCT00103285|38352276|FG003|Induction|Refusal|0|||
17198530|NCT00103285|38352277|FG004|Induction|Refusal|0|||
17198531|NCT00103285|38352278|FG005|Induction|Refusal|0|||
17198532|NCT00103285|38352279|FG006|Induction|Refusal|0|||
17198533|NCT00103285|38352280|FG007|Induction|Refusal|0|||
16839460|NCT01799889|37783612|FG009|Overall Study|Death|0|||
16839461|NCT01799889|37783613|FG010|Overall Study|Death|1|||
16839462|NCT01799889|37783614|FG011|Overall Study|Death|0|||
16839463|NCT01799889|37783603|FG000|Overall Study|Lack of Efficacy|1|||
16839464|NCT01799889|37783604|FG001|Overall Study|Lack of Efficacy|1|||
16839465|NCT01799889|37783605|FG002|Overall Study|Lack of Efficacy|0|||
16839466|NCT01799889|37783606|FG003|Overall Study|Lack of Efficacy|1|||
16839467|NCT01799889|37783607|FG004|Overall Study|Lack of Efficacy|2|||
16839468|NCT01799889|37783608|FG005|Overall Study|Lack of Efficacy|2|||
16839469|NCT01799889|37783609|FG006|Overall Study|Lack of Efficacy|0|||
16839470|NCT01799889|37783610|FG007|Overall Study|Lack of Efficacy|0|||
16839471|NCT01799889|37783611|FG008|Overall Study|Lack of Efficacy|2|||
16839472|NCT01799889|37783612|FG009|Overall Study|Lack of Efficacy|0|||
16839473|NCT01799889|37783613|FG010|Overall Study|Lack of Efficacy|1|||
16839474|NCT01799889|37783614|FG011|Overall Study|Lack of Efficacy|0|||
16839475|NCT01799889|37783603|FG000|Overall Study|Lost to Follow-up|0|||
16839476|NCT01799889|37783604|FG001|Overall Study|Lost to Follow-up|1|||
16839477|NCT01799889|37783605|FG002|Overall Study|Lost to Follow-up|0|||
16839478|NCT01799889|37783606|FG003|Overall Study|Lost to Follow-up|0|||
16839479|NCT01799889|37783607|FG004|Overall Study|Lost to Follow-up|0|||
16839480|NCT01799889|37783608|FG005|Overall Study|Lost to Follow-up|0|||
16839481|NCT01799889|37783609|FG006|Overall Study|Lost to Follow-up|0|||
16839482|NCT01799889|37783610|FG007|Overall Study|Lost to Follow-up|0|||
16839483|NCT01799889|37783611|FG008|Overall Study|Lost to Follow-up|0|||
16839484|NCT01799889|37783612|FG009|Overall Study|Lost to Follow-up|0|||
16839485|NCT01799889|37783613|FG010|Overall Study|Lost to Follow-up|0|||
16839486|NCT01799889|37783614|FG011|Overall Study|Lost to Follow-up|0|||
16839487|NCT01799889|37783603|FG000|Overall Study|Physician Decision|3|||
16839488|NCT01799889|37783604|FG001|Overall Study|Physician Decision|2|||
16839489|NCT01799889|37783605|FG002|Overall Study|Physician Decision|4|||
16839490|NCT01799889|37783606|FG003|Overall Study|Physician Decision|4|||
16839491|NCT01799889|37783607|FG004|Overall Study|Physician Decision|5|||
16839492|NCT01799889|37783608|FG005|Overall Study|Physician Decision|5|||
16839493|NCT01799889|37783609|FG006|Overall Study|Physician Decision|5|||
16839494|NCT01799889|37783610|FG007|Overall Study|Physician Decision|2|||
16839495|NCT01799889|37783611|FG008|Overall Study|Physician Decision|6|||
16839496|NCT01799889|37783612|FG009|Overall Study|Physician Decision|0|||
16839497|NCT01799889|37783613|FG010|Overall Study|Physician Decision|0|||
16839498|NCT01799889|37783614|FG011|Overall Study|Physician Decision|1|||
16839499|NCT01799889|37783603|FG000|Overall Study|Progressive Disease|30|||
16839500|NCT01799889|37783604|FG001|Overall Study|Progressive Disease|26|||
16913793|NCT01465230|38022528|FG000|Overall Study|Withdrawal by Subject|2|||
16913794|NCT01435356|38022534|FG000|Overall Study|Adverse Event|2|||
16913795|NCT01435356|38022535|FG001|Overall Study|Adverse Event|0|||
16913796|NCT01435356|38022534|FG000|Overall Study|Disease progression/recurrence|17|||
16913797|NCT01435356|38022535|FG001|Overall Study|Disease progression/recurrence|10|||
16913798|NCT01435356|38022534|FG000|Overall Study|Protocol Violation|0|||
16913799|NCT01435356|38022535|FG001|Overall Study|Protocol Violation|1|||
16913800|NCT01435356|38022534|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
16839501|NCT01799889|37783605|FG002|Overall Study|Progressive Disease|25|||
16913801|NCT01435356|38022535|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
16913802|NCT01435356|38022534|FG000|Overall Study|Withdrawal by Subject|1|||
16839502|NCT01799889|37783606|FG003|Overall Study|Progressive Disease|30|||
16839503|NCT01799889|37783607|FG004|Overall Study|Progressive Disease|23|||
16839504|NCT01799889|37783608|FG005|Overall Study|Progressive Disease|9|||
16839505|NCT01799889|37783609|FG006|Overall Study|Progressive Disease|8|||
16839506|NCT01799889|37783610|FG007|Overall Study|Progressive Disease|13|||
16839507|NCT01799889|37783611|FG008|Overall Study|Progressive Disease|18|||
16839508|NCT01799889|37783612|FG009|Overall Study|Progressive Disease|5|||
16839509|NCT01799889|37783613|FG010|Overall Study|Progressive Disease|3|||
16839510|NCT01799889|37783614|FG011|Overall Study|Progressive Disease|1|||
16839511|NCT01799889|37783603|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
16913803|NCT01435356|38022535|FG001|Overall Study|Withdrawal by Subject|1|||
16913804|NCT01435356|38022534|FG000|Overall Study|Facial palsy|1|||
16839512|NCT01799889|37783604|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
16839513|NCT01799889|37783605|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
16839514|NCT01799889|37783606|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
16839515|NCT01799889|37783607|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
16839516|NCT01799889|37783608|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
16839517|NCT01799889|37783609|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
16839518|NCT01799889|37783610|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
16839519|NCT01799889|37783611|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
16839520|NCT01799889|37783612|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
16839521|NCT01799889|37783613|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
16839522|NCT01799889|37783614|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
16839523|NCT01799889|37783603|FG000|Overall Study|Study Terminated By Sponsor|1|||
16839524|NCT01799889|37783604|FG001|Overall Study|Study Terminated By Sponsor|0|||
16839525|NCT01799889|37783605|FG002|Overall Study|Study Terminated By Sponsor|0|||
16839526|NCT01799889|37783606|FG003|Overall Study|Study Terminated By Sponsor|0|||
16839527|NCT01799889|37783607|FG004|Overall Study|Study Terminated By Sponsor|2|||
16839528|NCT01799889|37783608|FG005|Overall Study|Study Terminated By Sponsor|1|||
16913805|NCT01435356|38022535|FG001|Overall Study|Facial palsy|0|||
16913806|NCT01435356|38022534|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
16913807|NCT01435356|38022535|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
16839529|NCT01799889|37783609|FG006|Overall Study|Study Terminated By Sponsor|0|||
16839530|NCT01799889|37783610|FG007|Overall Study|Study Terminated By Sponsor|2|||
16839531|NCT01799889|37783611|FG008|Overall Study|Study Terminated By Sponsor|1|||
16839532|NCT01799889|37783612|FG009|Overall Study|Study Terminated By Sponsor|1|||
16839533|NCT01799889|37783613|FG010|Overall Study|Study Terminated By Sponsor|0|||
16839534|NCT01799889|37783614|FG011|Overall Study|Study Terminated By Sponsor|0|||
16839535|NCT01799889|37783603|FG000|Overall Study|Withdrawal by Subject|1|||
16839536|NCT01799889|37783604|FG001|Overall Study|Withdrawal by Subject|6|||
16839537|NCT01799889|37783605|FG002|Overall Study|Withdrawal by Subject|4|||
16839538|NCT01799889|37783606|FG003|Overall Study|Withdrawal by Subject|0|||
16839539|NCT01799889|37783607|FG004|Overall Study|Withdrawal by Subject|5|||
16839540|NCT01799889|37783608|FG005|Overall Study|Withdrawal by Subject|1|||
16913808|NCT01435356|38022534|FG000|Overall Study|Physician Decision|1|||
16913809|NCT01435356|38022535|FG001|Overall Study|Physician Decision|0|||
16913810|NCT01435356|38022534|FG000|Overall Study|Patient decision|3|||
16913811|NCT01435356|38022535|FG001|Overall Study|Patient decision|0|||
16913812|NCT01435356|38022534|FG000|Overall Study|Patient moved to another city|1|||
16913813|NCT01435356|38022535|FG001|Overall Study|Patient moved to another city|1|||
16913814|NCT01435122|38022541|FG000|Overall Study|Early withdrawal due to toxicity|8|||
16913815|NCT01434810|38022547|FG000|Overall Study|Did not receive treatment|11|||
16913816|NCT01434810|38022548|FG001|Overall Study|Did not receive treatment|3|||
16913817|NCT01434810|38022547|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
16913818|NCT01434810|38022548|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
16913819|NCT01393626|38022558|FG000|Overall Study|Adverse Event|2|||
16913820|NCT01393626|38022559|FG001|Overall Study|Adverse Event|1|||
16913821|NCT01393626|38022560|FG002|Overall Study|Adverse Event|5|||
16913822|NCT01393626|38022561|FG003|Overall Study|Adverse Event|0|||
16913823|NCT01393626|38022558|FG000|Overall Study|Did not meet entrance criteria|1|||
16913824|NCT01393626|38022559|FG001|Overall Study|Did not meet entrance criteria|0|||
16913825|NCT01393626|38022560|FG002|Overall Study|Did not meet entrance criteria|0|||
16913826|NCT01393626|38022561|FG003|Overall Study|Did not meet entrance criteria|0|||
16913827|NCT01393626|38022558|FG000|Overall Study|Lack of Efficacy|6|||
16913828|NCT01393626|38022559|FG001|Overall Study|Lack of Efficacy|6|||
16913829|NCT01393626|38022560|FG002|Overall Study|Lack of Efficacy|4|||
16913830|NCT01393626|38022561|FG003|Overall Study|Lack of Efficacy|1|||
16913831|NCT01393626|38022558|FG000|Overall Study|Lost to Follow-up|1|||
16913832|NCT01393626|38022559|FG001|Overall Study|Lost to Follow-up|1|||
16913833|NCT01393626|38022560|FG002|Overall Study|Lost to Follow-up|1|||
16839541|NCT01799889|37783609|FG006|Overall Study|Withdrawal by Subject|3|||
16839542|NCT01799889|37783610|FG007|Overall Study|Withdrawal by Subject|1|||
16839543|NCT01799889|37783611|FG008|Overall Study|Withdrawal by Subject|2|||
16839544|NCT01799889|37783612|FG009|Overall Study|Withdrawal by Subject|1|||
16839545|NCT01799889|37783613|FG010|Overall Study|Withdrawal by Subject|1|||
16839546|NCT01799889|37783614|FG011|Overall Study|Withdrawal by Subject|1|||
16913834|NCT01393626|38022561|FG003|Overall Study|Lost to Follow-up|0|||
16839547|NCT01799889|37783603|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16839548|NCT01799889|37783604|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16839549|NCT01799889|37783605|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16839550|NCT01799889|37783606|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16913835|NCT01393626|38022558|FG000|Overall Study|Withdrawal by Subject|6|||
16913836|NCT01393626|38022559|FG001|Overall Study|Withdrawal by Subject|4|||
16913837|NCT01393626|38022560|FG002|Overall Study|Withdrawal by Subject|0|||
16913838|NCT01393626|38022561|FG003|Overall Study|Withdrawal by Subject|0|||
16913839|NCT01393626|38022558|FG000|Overall Study|Other|1|||
16913840|NCT01393626|38022559|FG001|Overall Study|Other|0|||
16839551|NCT01799889|37783607|FG004|Overall Study|Non-Compliance With Study Drug|0|||
16839552|NCT01799889|37783608|FG005|Overall Study|Non-Compliance With Study Drug|1|||
16839553|NCT01799889|37783609|FG006|Overall Study|Non-Compliance With Study Drug|0|||
16913841|NCT01393626|38022560|FG002|Overall Study|Other|0|||
16839554|NCT01799889|37783610|FG007|Overall Study|Non-Compliance With Study Drug|0|||
16839555|NCT01799889|37783611|FG008|Overall Study|Non-Compliance With Study Drug|0|||
16839556|NCT01799889|37783612|FG009|Overall Study|Non-Compliance With Study Drug|0|||
16839557|NCT01799889|37783613|FG010|Overall Study|Non-Compliance With Study Drug|0|||
16839558|NCT01799889|37783614|FG011|Overall Study|Non-Compliance With Study Drug|0|||
16839559|NCT01412944|37783653|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16839560|NCT01412944|37783654|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16839561|NCT01412944|37783655|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
16839562|NCT01412944|37783656|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16839563|NCT01412944|37783657|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16913842|NCT01393626|38022561|FG003|Overall Study|Other|0|||
16913843|NCT01393626|38022558|FG000|Overall Study|Protocol Violation|1|||
16839564|NCT01412944|37783658|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16839565|NCT01412944|37783653|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16839566|NCT01412944|37783654|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16839567|NCT01412944|37783655|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16839568|NCT01412944|37783656|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16839569|NCT01412944|37783657|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16839570|NCT01412944|37783658|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
16839571|NCT01412944|37783653|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16839572|NCT01412944|37783654|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16839573|NCT01412944|37783655|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16839574|NCT01412944|37783656|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16839575|NCT01412944|37783657|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16839576|NCT01412944|37783658|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
16839577|NCT01412944|37783653|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
16839578|NCT01412944|37783654|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16839579|NCT01412944|37783655|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16839580|NCT01412944|37783656|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16839581|NCT01412944|37783657|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16839582|NCT01412944|37783658|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16839583|NCT01412944|37783653|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
16839584|NCT01412944|37783654|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
16839585|NCT01412944|37783655|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
16839586|NCT01412944|37783656|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
16839587|NCT01412944|37783657|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
16839588|NCT01412944|37783658|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
16839589|NCT01412944|37783653|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16839590|NCT01412944|37783654|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
16839591|NCT01412944|37783655|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16839592|NCT01412944|37783656|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16839593|NCT01412944|37783657|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16839594|NCT01412944|37783658|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16839595|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16839596|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16839597|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
17016803|NCT00689338|38161464|FG000|Overall Study|Other|8|||
17016804|NCT00689338|38161464|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
17016805|NCT00689338|38161464|FG000|Overall Study|Lost to Follow-up|5|||
17016806|NCT00689338|38161464|FG000|Overall Study|Withdrawal by Subject|3|||
16913844|NCT01393626|38022559|FG001|Overall Study|Protocol Violation|0|||
16913845|NCT01393626|38022560|FG002|Overall Study|Protocol Violation|2|||
16913846|NCT01393626|38022561|FG003|Overall Study|Protocol Violation|0|||
16913847|NCT01434654|38022580|FG000|Overall Study|Withdrawal by Subject|1|||
16913848|NCT01434654|38022581|FG001|Overall Study|Withdrawal by Subject|0|||
16913849|NCT01434654|38022580|FG000|Overall Study|Lost to Follow-up|1|||
16913850|NCT01434654|38022581|FG001|Overall Study|Lost to Follow-up|0|||
16913851|NCT01393158|38022591|FG000|Overall Study|Adverse Event|1|||
16913852|NCT01393158|38022592|FG001|Overall Study|Adverse Event|0|||
16913853|NCT01413360|38022604|FG000|Overall Study|Lost to Follow-up|2|||
16913854|NCT01413360|38022604|FG000|Overall Study|Adverse Event|1|||
16913855|NCT01413204|38022611|FG000|Overall Study|Adverse Event|1|||
16913856|NCT01413204|38022612|FG001|Overall Study|Adverse Event|2|||
16913857|NCT01413204|38022613|FG002|Overall Study|Adverse Event|2|||
16913858|NCT01413204|38022611|FG000|Overall Study|Physician Decision|3|||
16913859|NCT01413204|38022612|FG001|Overall Study|Physician Decision|0|||
16913860|NCT01413204|38022613|FG002|Overall Study|Physician Decision|2|||
16913861|NCT01413204|38022611|FG000|Overall Study|Withdrawal by Subject|1|||
16913862|NCT01413204|38022612|FG001|Overall Study|Withdrawal by Subject|4|||
16913863|NCT01413204|38022613|FG002|Overall Study|Withdrawal by Subject|4|||
16913864|NCT01413204|38022611|FG000|Overall Study|Clearly not eligible for the study|0|||
16913865|NCT01413204|38022612|FG001|Overall Study|Clearly not eligible for the study|0|||
17016807|NCT00689338|38161464|FG000|Overall Study|Protocol Violation|15|||
16913866|NCT01413204|38022613|FG002|Overall Study|Clearly not eligible for the study|1|||
16913867|NCT01413204|38022611|FG000|Overall Study|Fasting plasma glucose level increased|1|||
16913868|NCT01413204|38022612|FG001|Overall Study|Fasting plasma glucose level increased|0|||
16913869|NCT01413204|38022613|FG002|Overall Study|Fasting plasma glucose level increased|10|||
16839598|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
16839599|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
16913870|NCT01392378|38022626|FG000|Infant Series|Adverse Event|0|||
16913871|NCT01392378|38022627|FG001|Infant Series|Adverse Event|0|||
16913872|NCT01392378|38022628|FG002|Infant Series|Adverse Event|0|||
16839600|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16839601|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Adverse Event|0|||
16839602|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Adverse Event|0|||
16839603|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Adverse Event|0|||
16839604|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Adverse Event|0|||
16839605|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Adverse Event|1|||
16839606|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Adverse Event|0|||
16839607|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
16839608|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
16839609|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
16839610|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
16839611|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
16839612|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
16839613|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839614|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839615|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839616|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839617|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839618|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
16839619|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839620|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839621|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839622|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839623|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
16839624|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839625|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
16839626|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
16839627|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16839628|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16839629|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16839630|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16839631|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
16839632|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
16839633|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
16839634|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
16839635|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
16839636|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
16839637|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
16913873|NCT01392378|38022629|FG003|Infant Series|Adverse Event|1|||
16913874|NCT01392378|38022630|FG004|Infant Series|Adverse Event|0|||
16913875|NCT01392378|38022626|FG000|Infant Series|Lost to Follow-up|0|||
16913876|NCT01392378|38022627|FG001|Infant Series|Lost to Follow-up|0|||
16913877|NCT01392378|38022628|FG002|Infant Series|Lost to Follow-up|0|||
16913878|NCT01392378|38022629|FG003|Infant Series|Lost to Follow-up|1|||
16913879|NCT01392378|38022630|FG004|Infant Series|Lost to Follow-up|0|||
16913880|NCT01392378|38022626|FG000|Infant Series|Protocol Violation|0|||
16913881|NCT01392378|38022627|FG001|Infant Series|Protocol Violation|1|||
16913882|NCT01392378|38022628|FG002|Infant Series|Protocol Violation|0|||
16913883|NCT01392378|38022629|FG003|Infant Series|Protocol Violation|0|||
16913884|NCT01392378|38022630|FG004|Infant Series|Protocol Violation|0|||
16913885|NCT01392378|38022626|FG000|Infant Series|Withdrawal by Parent|4|||
16913886|NCT01392378|38022627|FG001|Infant Series|Withdrawal by Parent|1|||
16913887|NCT01392378|38022628|FG002|Infant Series|Withdrawal by Parent|0|||
16913888|NCT01392378|38022629|FG003|Infant Series|Withdrawal by Parent|0|||
16913889|NCT01392378|38022630|FG004|Infant Series|Withdrawal by Parent|0|||
16913890|NCT01392378|38022626|FG000|After Infant Series|Lost to Follow-up|0|||
16913891|NCT01392378|38022627|FG001|After Infant Series|Lost to Follow-up|0|||
16839638|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
16839639|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839640|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839641|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839642|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
16839643|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839644|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
16839645|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
16913892|NCT01392378|38022628|FG002|After Infant Series|Lost to Follow-up|1|||
16913893|NCT01392378|38022629|FG003|After Infant Series|Lost to Follow-up|0|||
16839646|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839647|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839648|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
16839649|NCT01412944|37783653|FG000|Entire: IV + Maintenance|Adverse Event|0|||
16913894|NCT01392378|38022630|FG004|After Infant Series|Lost to Follow-up|0|||
16913895|NCT01392378|38022626|FG000|After Infant Series|Withdrawal by Parent|0|||
16913896|NCT01392378|38022627|FG001|After Infant Series|Withdrawal by Parent|1|||
16839650|NCT01412944|37783654|FG001|Entire: IV + Maintenance|Adverse Event|1|||
16839651|NCT01412944|37783655|FG002|Entire: IV + Maintenance|Adverse Event|0|||
16839652|NCT01412944|37783656|FG003|Entire: IV + Maintenance|Adverse Event|0|||
16839653|NCT01412944|37783657|FG004|Entire: IV + Maintenance|Adverse Event|0|||
16839654|NCT01412944|37783658|FG005|Entire: IV + Maintenance|Adverse Event|0|||
16839655|NCT01798485|37783676|FG000|Overall Study|Adverse Event|32|||
16839656|NCT01798485|37783677|FG001|Overall Study|Adverse Event|40|||
16839657|NCT01798485|37783676|FG000|Overall Study|Withdrawal by Subject|27|||
16839658|NCT01798485|37783677|FG001|Overall Study|Withdrawal by Subject|31|||
16839659|NCT01798485|37783676|FG000|Overall Study|Lost to Follow-up|0|||
16839660|NCT01798485|37783677|FG001|Overall Study|Lost to Follow-up|3|||
16913897|NCT01392378|38022628|FG002|After Infant Series|Withdrawal by Parent|1|||
16913898|NCT01392378|38022629|FG003|After Infant Series|Withdrawal by Parent|0|||
16913899|NCT01392378|38022630|FG004|After Infant Series|Withdrawal by Parent|1|||
16913900|NCT01392378|38022626|FG000|Toddler Dose|Lost to Follow-up|0|||
16839661|NCT01798485|37783676|FG000|Overall Study|Physician Decision|14|||
16839662|NCT01798485|37783677|FG001|Overall Study|Physician Decision|10|||
16839663|NCT01798485|37783676|FG000|Overall Study|Objective Disease Progression|152|||
16913901|NCT01392378|38022627|FG001|Toddler Dose|Lost to Follow-up|0|||
16913902|NCT01392378|38022628|FG002|Toddler Dose|Lost to Follow-up|0|||
16913903|NCT01392378|38022629|FG003|Toddler Dose|Lost to Follow-up|1|||
16913904|NCT01392378|38022630|FG004|Toddler Dose|Lost to Follow-up|0|||
16913905|NCT01392378|38022626|FG000|Toddler Dose|Withdrawal by Parent|0|||
16913906|NCT01392378|38022627|FG001|Toddler Dose|Withdrawal by Parent|1|||
16913907|NCT01392378|38022628|FG002|Toddler Dose|Withdrawal by Parent|0|||
16839664|NCT01798485|37783677|FG001|Overall Study|Objective Disease Progression|106|||
16839665|NCT01798485|37783676|FG000|Overall Study|Death|25|||
16839666|NCT01798485|37783677|FG001|Overall Study|Death|22|||
16839667|NCT01798485|37783676|FG000|Overall Study|Sponsor Decision|61|||
16839668|NCT01798485|37783677|FG001|Overall Study|Sponsor Decision|54|||
16839669|NCT01798485|37783676|FG000|Overall Study|Clinical Progression|35|||
16839670|NCT01798485|37783677|FG001|Overall Study|Clinical Progression|24|||
16839671|NCT01767597|37783685|FG000|Overall Study|Incomplete intervention|3|||
16839672|NCT01767597|37783686|FG001|Overall Study|Incomplete intervention|1|||
16839673|NCT01767597|37783685|FG000|Overall Study|Withdrawal by Subject|1|||
16839674|NCT01767597|37783686|FG001|Overall Study|Withdrawal by Subject|0|||
16839675|NCT01767519|37783695|FG000|Overall Study|Other Reasons|4|||
16839676|NCT01767519|37783696|FG001|Overall Study|Other Reasons|4|||
16839677|NCT01767519|37783697|FG002|Overall Study|Other Reasons|2|||
16839678|NCT01767519|37783695|FG000|Overall Study|Protocol Violation|0|||
16839679|NCT01767519|37783696|FG001|Overall Study|Protocol Violation|3|||
16839680|NCT01767519|37783697|FG002|Overall Study|Protocol Violation|0|||
16839681|NCT01767519|37783695|FG000|Overall Study|Personal Reasons|1|||
16839682|NCT01767519|37783696|FG001|Overall Study|Personal Reasons|0|||
16839683|NCT01767519|37783697|FG002|Overall Study|Personal Reasons|0|||
16839684|NCT01767519|37783695|FG000|Overall Study|Lost to Follow-up|3|||
16839685|NCT01767519|37783696|FG001|Overall Study|Lost to Follow-up|1|||
16839686|NCT01767519|37783697|FG002|Overall Study|Lost to Follow-up|2|||
16839687|NCT01767519|37783695|FG000|Overall Study|Lack of Efficacy|1|||
16839688|NCT01767519|37783696|FG001|Overall Study|Lack of Efficacy|0|||
16839689|NCT01767519|37783697|FG002|Overall Study|Lack of Efficacy|0|||
16839690|NCT01767519|37783695|FG000|Overall Study|Adverse Event|5|||
16839691|NCT01767519|37783696|FG001|Overall Study|Adverse Event|5|||
16839692|NCT01767519|37783697|FG002|Overall Study|Adverse Event|1|||
16839693|NCT01797783|37783707|FG000|Overall Study|Adverse Event|1|||
16839694|NCT01797783|37783708|FG001|Overall Study|Adverse Event|1|||
16839695|NCT01797783|37783707|FG000|Overall Study|Withdrawal by Subject|1|||
16839696|NCT01797783|37783708|FG001|Overall Study|Withdrawal by Subject|0|||
16839697|NCT01766817|37783725|FG000|Overall Study|Drug-related adverse event|1|||
16839698|NCT01766817|37783726|FG001|Overall Study|Drug-related adverse event|2|||
16839699|NCT01766817|37783727|FG002|Overall Study|Drug-related adverse event|1|||
16839700|NCT01766817|37783725|FG000|Overall Study|Drug-unrelated adverse event|3|||
16839701|NCT01766817|37783726|FG001|Overall Study|Drug-unrelated adverse event|3|||
16839702|NCT01766817|37783727|FG002|Overall Study|Drug-unrelated adverse event|3|||
16839703|NCT01766817|37783725|FG000|Overall Study|Death|1|||
16839704|NCT01766817|37783726|FG001|Overall Study|Death|1|||
16839705|NCT01766817|37783727|FG002|Overall Study|Death|0|||
16839706|NCT01766817|37783725|FG000|Overall Study|Unable to take study drug|0|||
16839707|NCT01766817|37783726|FG001|Overall Study|Unable to take study drug|1|||
16839708|NCT01766817|37783727|FG002|Overall Study|Unable to take study drug|0|||
16839709|NCT01766817|37783725|FG000|Overall Study|Withdrawal by Subject|2|||
16839710|NCT01766817|37783726|FG001|Overall Study|Withdrawal by Subject|0|||
16839711|NCT01766817|37783727|FG002|Overall Study|Withdrawal by Subject|3|||
16913908|NCT01392378|38022629|FG003|Toddler Dose|Withdrawal by Parent|1|||
16839712|NCT01766817|37783725|FG000|Overall Study|Subject non-compliance|0|||
16839713|NCT01766817|37783726|FG001|Overall Study|Subject non-compliance|1|||
16839714|NCT01766817|37783727|FG002|Overall Study|Subject non-compliance|2|||
16839715|NCT01766817|37783725|FG000|Overall Study|Physician Decision|3|||
16839716|NCT01766817|37783726|FG001|Overall Study|Physician Decision|3|||
16839717|NCT01766817|37783727|FG002|Overall Study|Physician Decision|4|||
16839718|NCT01766817|37783725|FG000|Overall Study|Other|1|||
16839719|NCT01766817|37783726|FG001|Overall Study|Other|0|||
16839720|NCT01766817|37783727|FG002|Overall Study|Other|0|||
16839721|NCT01797705|37783735|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
16839722|NCT01797705|37783735|FG000|Overall Study|Withdrawal by Subject|1|||
16839723|NCT01797081|37783743|FG000|Overall Study|Adverse Event|1|||
16839724|NCT01797081|37783744|FG001|Overall Study|Adverse Event|0|||
16839725|NCT01797081|37783745|FG002|Overall Study|Adverse Event|1|||
16839726|NCT01797081|37783746|FG003|Overall Study|Adverse Event|0|||
16839727|NCT01797081|37783743|FG000|Overall Study|Pregnancy|1|||
16839728|NCT01797081|37783744|FG001|Overall Study|Pregnancy|0|||
16839729|NCT01797081|37783745|FG002|Overall Study|Pregnancy|0|||
16839730|NCT01797081|37783746|FG003|Overall Study|Pregnancy|0|||
16839731|NCT01797081|37783743|FG000|Overall Study|Personal Reasons|12|||
16839732|NCT01797081|37783744|FG001|Overall Study|Personal Reasons|4|||
16839733|NCT01797081|37783745|FG002|Overall Study|Personal Reasons|4|||
16839734|NCT01797081|37783746|FG003|Overall Study|Personal Reasons|8|||
16839735|NCT01797081|37783743|FG000|Overall Study|Protocol Violation|0|||
16839736|NCT01797081|37783744|FG001|Overall Study|Protocol Violation|0|||
16839737|NCT01797081|37783745|FG002|Overall Study|Protocol Violation|0|||
16839738|NCT01797081|37783746|FG003|Overall Study|Protocol Violation|1|||
16839739|NCT01794117|37783758|FG000|Overall Study|Adverse Event|1|||
16913909|NCT01392378|38022630|FG004|Toddler Dose|Withdrawal by Parent|1|||
16913910|NCT01412424|38022652|FG000|Core Treatment Period|Treatment Failure|24|||
16913911|NCT01412424|38022652|FG000|Core Treatment Period|Adverse Event|21|||
16913912|NCT01412424|38022652|FG000|Core Treatment Period|Patient Request|5|||
16913913|NCT01412424|38022652|FG000|Core Treatment Period|Lost to Follow-up|2|||
16913914|NCT01412424|38022652|FG000|Core Treatment Period|Sponsor Request|1|||
16839740|NCT01794117|37783759|FG001|Overall Study|Adverse Event|0|||
16839741|NCT01794117|37783760|FG002|Overall Study|Adverse Event|0|||
16839742|NCT01794117|37783761|FG003|Overall Study|Adverse Event|0|||
16839743|NCT01794117|37783758|FG000|Overall Study|Participant noncompliance|0|||
16839744|NCT01794117|37783759|FG001|Overall Study|Participant noncompliance|1|||
16839745|NCT01794117|37783760|FG002|Overall Study|Participant noncompliance|0|||
16839746|NCT01794117|37783761|FG003|Overall Study|Participant noncompliance|0|||
16839747|NCT01794117|37783758|FG000|Overall Study|Refused further treatment|0|||
16839748|NCT01794117|37783759|FG001|Overall Study|Refused further treatment|2|||
16839749|NCT01794117|37783760|FG002|Overall Study|Refused further treatment|0|||
16839750|NCT01794117|37783761|FG003|Overall Study|Refused further treatment|0|||
16839751|NCT01766037|37783774|FG000|Overall Study|Adverse Event|1|||
16839752|NCT01766037|37783775|FG001|Overall Study|Adverse Event|0|||
16839753|NCT01766037|37783774|FG000|Overall Study|Lack of Efficacy|1|||
16839754|NCT01766037|37783775|FG001|Overall Study|Lack of Efficacy|0|||
16839755|NCT01766037|37783774|FG000|Overall Study|Lost to Follow-up|0|||
16839756|NCT01766037|37783775|FG001|Overall Study|Lost to Follow-up|10|||
16913915|NCT01412424|38022652|FG000|Extension Treatment Period|Adverse Event|2|||
16913916|NCT01412424|38022652|FG000|Extension Treatment Period|Treatment Failure|2|||
16913917|NCT01412424|38022652|FG000|Extension Treatment Period|Patient Request|2|||
16913918|NCT01433250|38022664|FG000|Overall Study|Protocol Violation|0|||
16913919|NCT01433250|38022665|FG001|Overall Study|Protocol Violation|1|||
16913920|NCT01433250|38022664|FG000|Overall Study|Withdrawal by Subject|3|||
16839757|NCT01766037|37783774|FG000|Overall Study|Physician Decision|0|||
16839758|NCT01766037|37783775|FG001|Overall Study|Physician Decision|1|||
16839759|NCT01766037|37783774|FG000|Overall Study|Withdrawal by Subject|18|||
16839760|NCT01766037|37783775|FG001|Overall Study|Withdrawal by Subject|16|||
16839761|NCT01766037|37783774|FG000|Overall Study|Moved from area|5|||
16839762|NCT01766037|37783775|FG001|Overall Study|Moved from area|0|||
16839763|NCT01766037|37783774|FG000|Overall Study|medical - unrelated|1|||
16839764|NCT01766037|37783775|FG001|Overall Study|medical - unrelated|2|||
16839765|NCT01766037|37783774|FG000|Overall Study|nausea / discomfort|3|||
16839766|NCT01766037|37783775|FG001|Overall Study|nausea / discomfort|0|||
16839767|NCT01765569|37783781|FG000|Period B|Withdrawal by Subject|1|||
16839768|NCT01765569|37783781|FG000|Period C|Death|1|||
16839769|NCT01609257|37783790|FG000|Overall Study|Lost to Follow-up|2|||
16839770|NCT01609257|37783791|FG001|Overall Study|Lost to Follow-up|1|||
16839771|NCT01609257|37783790|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
16839772|NCT01609257|37783791|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
16839773|NCT01609257|37783790|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
16913921|NCT01433250|38022665|FG001|Overall Study|Withdrawal by Subject|2|||
16839774|NCT01609257|37783791|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
16913922|NCT01433172|38022674|FG000|Overall Study|Withdrawal by Subject|0|||
16839775|NCT01609023|37783800|FG000|Overall Study|Lack of Efficacy|3|||
16839776|NCT01609023|37783800|FG000|Overall Study|Withdrawal by Subject|4|||
16839777|NCT01609023|37783800|FG000|Overall Study|Lost to Follow-up|8|||
16839778|NCT01609023|37783800|FG000|Overall Study|Toxicity|3|||
16839779|NCT01609023|37783800|FG000|Overall Study|Disease progression|10|||
16839780|NCT01609023|37783800|FG000|Overall Study|Physician Decision|2|||
16839781|NCT01609023|37783800|FG000|Overall Study|Death|2|||
16839782|NCT01609023|37783800|FG000|Overall Study|Personal reasons|1|||
16839783|NCT01765179|37783804|FG000|Overall Study|Adverse Event|3|||
16839784|NCT01765179|37783804|FG000|Overall Study|Lost to Follow-up|5|||
16839785|NCT01765179|37783804|FG000|Overall Study|Non-compliance with study drug|2|||
16839786|NCT01765179|37783804|FG000|Overall Study|Protocol Violation|1|||
16839787|NCT01765179|37783804|FG000|Overall Study|Withdrawal by Subject|8|||
16839788|NCT01765179|37783804|FG000|Overall Study|Hematocrit >54%|3|||
16839789|NCT01765179|37783804|FG000|Overall Study|prohibited med|1|||
16839790|NCT01765179|37783804|FG000|Overall Study|Out of country unable to finish study|1|||
16839791|NCT01765179|37783804|FG000|Overall Study|lack of venous access|1|||
16839792|NCT01765179|37783804|FG000|Overall Study|work conflict|1|||
16839793|NCT01765179|37783804|FG000|Overall Study|Ca elevated 10.6|1|||
16839794|NCT01764945|37783816|FG000|Overall Study|Adverse Event|0|||
16839795|NCT01764945|37783817|FG001|Overall Study|Adverse Event|1|||
16839796|NCT01764945|37783818|FG002|Overall Study|Adverse Event|0|||
16839797|NCT01764945|37783819|FG003|Overall Study|Adverse Event|0|||
16839798|NCT01764945|37783820|FG004|Overall Study|Adverse Event|0|||
16839799|NCT01764945|37783821|FG005|Overall Study|Adverse Event|0|||
16839800|NCT01764945|37783822|FG006|Overall Study|Adverse Event|1|||
16839801|NCT01764945|37783823|FG007|Overall Study|Adverse Event|0|||
16839802|NCT01793883|37783844|FG000|Overall Study|Withdrawal by Subject|3|||
16839803|NCT01793883|37783845|FG001|Overall Study|Withdrawal by Subject|7|||
16839804|NCT01793883|37783846|FG002|Overall Study|Withdrawal by Subject|3|||
16839805|NCT01793883|37783844|FG000|Overall Study|Subject noncompliance|0|||
16839806|NCT01793883|37783845|FG001|Overall Study|Subject noncompliance|1|||
16839807|NCT01793883|37783846|FG002|Overall Study|Subject noncompliance|1|||
16839808|NCT01793883|37783844|FG000|Overall Study|Lost to Follow-up|5|||
16839809|NCT01793883|37783845|FG001|Overall Study|Lost to Follow-up|1|||
16839810|NCT01793883|37783846|FG002|Overall Study|Lost to Follow-up|3|||
16839811|NCT01793883|37783844|FG000|Overall Study|Randomized in error|1|||
16839812|NCT01793883|37783845|FG001|Overall Study|Randomized in error|0|||
16839813|NCT01793883|37783846|FG002|Overall Study|Randomized in error|0|||
16839814|NCT01793883|37783844|FG000|Overall Study|Unable to complete spriometry|1|||
16839815|NCT01793883|37783845|FG001|Overall Study|Unable to complete spriometry|0|||
16839816|NCT01793883|37783846|FG002|Overall Study|Unable to complete spriometry|0|||
16839817|NCT01793883|37783844|FG000|Overall Study|Unable to complete measurements|1|||
16839818|NCT01793883|37783845|FG001|Overall Study|Unable to complete measurements|0|||
16839819|NCT01793883|37783846|FG002|Overall Study|Unable to complete measurements|0|||
16839820|NCT01793883|37783844|FG000|Overall Study|Met exclusion criteria|1|||
16839821|NCT01793883|37783845|FG001|Overall Study|Met exclusion criteria|0|||
16839822|NCT01793883|37783846|FG002|Overall Study|Met exclusion criteria|0|||
16839823|NCT01793883|37783844|FG000|Overall Study|Dosing error|0|||
16839824|NCT01793883|37783845|FG001|Overall Study|Dosing error|1|||
16839825|NCT01793883|37783846|FG002|Overall Study|Dosing error|0|||
16839826|NCT01793883|37783844|FG000|Overall Study|Respiratory distress during spirometry|0|||
16839827|NCT01793883|37783845|FG001|Overall Study|Respiratory distress during spirometry|0|||
16839828|NCT01793883|37783846|FG002|Overall Study|Respiratory distress during spirometry|1|||
16839829|NCT01792635|37783857|FG000|Part B|Adverse Event|0|||
16839830|NCT01792635|37783858|FG001|Part B|Adverse Event|0|||
16839831|NCT01792635|37783859|FG002|Part B|Adverse Event|1|||
16839832|NCT01792635|37783857|FG000|Part B|Study terminated|0|||
16839833|NCT01792635|37783858|FG001|Part B|Study terminated|4|||
16839834|NCT01792635|37783859|FG002|Part B|Study terminated|3|||
16839835|NCT01953692|37783877|FG000|Overall Study|Adverse Event|5|||
16839836|NCT01953692|37783878|FG001|Overall Study|Adverse Event|2|||
16839837|NCT01953692|37783879|FG002|Overall Study|Adverse Event|4|||
16839838|NCT01953692|37783880|FG003|Overall Study|Adverse Event|2|||
16839839|NCT01953692|37783881|FG004|Overall Study|Adverse Event|1|||
16839840|NCT01953692|37783882|FG005|Overall Study|Adverse Event|2|||
16839841|NCT01953692|37783883|FG006|Overall Study|Adverse Event|0|||
16839842|NCT01953692|37783884|FG007|Overall Study|Adverse Event|0|||
16839843|NCT01953692|37783885|FG008|Overall Study|Adverse Event|0|||
16839844|NCT01953692|37783877|FG000|Overall Study|Clinical Progression|0|||
16839845|NCT01953692|37783878|FG001|Overall Study|Clinical Progression|15|||
16839846|NCT01953692|37783879|FG002|Overall Study|Clinical Progression|7|||
16839847|NCT01953692|37783880|FG003|Overall Study|Clinical Progression|5|||
16839848|NCT01953692|37783881|FG004|Overall Study|Clinical Progression|0|||
16839849|NCT01953692|37783882|FG005|Overall Study|Clinical Progression|7|||
16839850|NCT01953692|37783883|FG006|Overall Study|Clinical Progression|20|||
16913923|NCT01433172|38022675|FG001|Overall Study|Withdrawal by Subject|1|||
16913924|NCT01433172|38022676|FG002|Overall Study|Withdrawal by Subject|0|||
16839851|NCT01953692|37783884|FG007|Overall Study|Clinical Progression|3|||
16839852|NCT01953692|37783885|FG008|Overall Study|Clinical Progression|3|||
16839853|NCT01953692|37783877|FG000|Overall Study|Death|5|||
16839854|NCT01953692|37783878|FG001|Overall Study|Death|0|||
16839855|NCT01953692|37783879|FG002|Overall Study|Death|2|||
16913925|NCT01433172|38022674|FG000|Overall Study|Disease Progression|0|||
16913926|NCT01433172|38022675|FG001|Overall Study|Disease Progression|0|||
16913927|NCT01433172|38022676|FG002|Overall Study|Disease Progression|1|||
16913928|NCT01433172|38022674|FG000|Overall Study|Death|0|||
16913929|NCT01433172|38022675|FG001|Overall Study|Death|2|||
16913930|NCT01433172|38022676|FG002|Overall Study|Death|0|||
16913931|NCT01432938|38022684|FG000|First Intervention|Protocol Violation|1|||
16913932|NCT01432938|38022685|FG001|First Intervention|Protocol Violation|0|||
16913933|NCT01432938|38022684|FG000|First Intervention|Physician Decision|1|||
16913934|NCT01432938|38022685|FG001|First Intervention|Physician Decision|0|||
16913935|NCT01432938|38022684|FG000|Second Intervention|Adverse Event|1|||
16913936|NCT01432938|38022685|FG001|Second Intervention|Adverse Event|0|||
16913937|NCT01392300|38022694|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
16913938|NCT01392300|38022695|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
16913939|NCT01392300|38022696|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
16913940|NCT01392300|38022694|FG000|Main Period (MP)|Withdrawal by Subject|5|||
16913941|NCT01392300|38022695|FG001|Main Period (MP)|Withdrawal by Subject|1|||
16839856|NCT01953692|37783880|FG003|Overall Study|Death|2|||
16839857|NCT01953692|37783881|FG004|Overall Study|Death|1|||
16913942|NCT01392300|38022696|FG002|Main Period (MP)|Withdrawal by Subject|0|||
16913943|NCT01392300|38022694|FG000|Main Period (MP)|Lost to Follow-up|3|||
16839858|NCT01953692|37783882|FG005|Overall Study|Death|3|||
16839859|NCT01953692|37783883|FG006|Overall Study|Death|6|||
16839860|NCT01953692|37783884|FG007|Overall Study|Death|2|||
16839861|NCT01953692|37783885|FG008|Overall Study|Death|1|||
16839862|NCT01953692|37783877|FG000|Overall Study|Excluded Medication|1|||
16839863|NCT01953692|37783878|FG001|Overall Study|Excluded Medication|0|||
16839864|NCT01953692|37783879|FG002|Overall Study|Excluded Medication|0|||
16839865|NCT01953692|37783880|FG003|Overall Study|Excluded Medication|0|||
16839866|NCT01953692|37783881|FG004|Overall Study|Excluded Medication|0|||
16839867|NCT01953692|37783882|FG005|Overall Study|Excluded Medication|0|||
16839868|NCT01953692|37783883|FG006|Overall Study|Excluded Medication|0|||
16839869|NCT01953692|37783884|FG007|Overall Study|Excluded Medication|0|||
16913944|NCT01392300|38022695|FG001|Main Period (MP)|Lost to Follow-up|3|||
16913945|NCT01392300|38022696|FG002|Main Period (MP)|Lost to Follow-up|0|||
16913946|NCT01392300|38022694|FG000|Main Period (MP)|Non-compliance|1|||
16913947|NCT01392300|38022695|FG001|Main Period (MP)|Non-compliance|0|||
16913948|NCT01392300|38022696|FG002|Main Period (MP)|Non-compliance|0|||
16913949|NCT01392300|38022694|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
16913950|NCT01392300|38022695|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
16913951|NCT01392300|38022696|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
16913952|NCT01392300|38022694|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
16913953|NCT01392300|38022695|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
16913954|NCT01392300|38022696|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
16913955|NCT01392300|38022694|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
16913956|NCT01392300|38022695|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
16839870|NCT01953692|37783885|FG008|Overall Study|Excluded Medication|0|||
16839871|NCT01953692|37783877|FG000|Overall Study|Lost to Follow-up|1|||
16839872|NCT01953692|37783878|FG001|Overall Study|Lost to Follow-up|0|||
16839873|NCT01953692|37783879|FG002|Overall Study|Lost to Follow-up|3|||
16839874|NCT01953692|37783880|FG003|Overall Study|Lost to Follow-up|1|||
16839875|NCT01953692|37783881|FG004|Overall Study|Lost to Follow-up|0|||
16839876|NCT01953692|37783882|FG005|Overall Study|Lost to Follow-up|1|||
16839877|NCT01953692|37783883|FG006|Overall Study|Lost to Follow-up|0|||
16839878|NCT01953692|37783884|FG007|Overall Study|Lost to Follow-up|0|||
16839879|NCT01953692|37783885|FG008|Overall Study|Lost to Follow-up|0|||
16913957|NCT01392300|38022696|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
16839880|NCT01953692|37783877|FG000|Overall Study|Physician Decision|11|||
16839881|NCT01953692|37783878|FG001|Overall Study|Physician Decision|4|||
16839882|NCT01953692|37783879|FG002|Overall Study|Physician Decision|2|||
16839883|NCT01953692|37783880|FG003|Overall Study|Physician Decision|2|||
16839884|NCT01953692|37783881|FG004|Overall Study|Physician Decision|1|||
16839885|NCT01953692|37783882|FG005|Overall Study|Physician Decision|2|||
16839886|NCT01953692|37783883|FG006|Overall Study|Physician Decision|4|||
16839887|NCT01953692|37783884|FG007|Overall Study|Physician Decision|1|||
16839888|NCT01953692|37783885|FG008|Overall Study|Physician Decision|0|||
16839889|NCT01953692|37783877|FG000|Overall Study|Protocol Violation|0|||
16839890|NCT01953692|37783878|FG001|Overall Study|Protocol Violation|2|||
16839891|NCT01953692|37783879|FG002|Overall Study|Protocol Violation|1|||
16839892|NCT01953692|37783880|FG003|Overall Study|Protocol Violation|0|||
16839893|NCT01953692|37783881|FG004|Overall Study|Protocol Violation|0|||
16913958|NCT01392300|38022694|FG000|Open Label Extension (OLEX) Period|Death|0|||
16913959|NCT01392300|38022695|FG001|Open Label Extension (OLEX) Period|Death|0|||
16913960|NCT01392300|38022696|FG002|Open Label Extension (OLEX) Period|Death|4|||
16913961|NCT01392300|38022694|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
16839894|NCT01953692|37783882|FG005|Overall Study|Protocol Violation|0|||
16839895|NCT01953692|37783883|FG006|Overall Study|Protocol Violation|0|||
16913962|NCT01392300|38022695|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
16839896|NCT01953692|37783884|FG007|Overall Study|Protocol Violation|1|||
16913963|NCT01392300|38022696|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
16913964|NCT01392300|38022694|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
16913965|NCT01392300|38022695|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
16913966|NCT01392300|38022696|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
16913967|NCT01392300|38022694|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
16913968|NCT01392300|38022695|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
16913969|NCT01392300|38022696|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
16913970|NCT01432626|38022703|FG000|Overall Study|LV function recovered|2|||
16913971|NCT01432626|38022703|FG000|Overall Study|Withdrawal by Subject|2|||
16913972|NCT01432626|38022703|FG000|Overall Study|Only 1 image competed|2|||
16839897|NCT01953692|37783885|FG008|Overall Study|Protocol Violation|0|||
16839898|NCT01953692|37783877|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16913973|NCT01432626|38022703|FG000|Overall Study|Imaging agent not available|1|||
16913974|NCT01391832|38022709|FG000|Overall Study|Withdrawal by Subject|21|||
16913975|NCT01391832|38022710|FG001|Overall Study|Withdrawal by Subject|22|||
16913976|NCT01391832|38022709|FG000|Overall Study|Lost to Follow-up|0|||
16913977|NCT01391832|38022710|FG001|Overall Study|Lost to Follow-up|1|||
16913978|NCT01410474|38022718|FG000|Overall Study|Withdrawal by Subject|0|||
16913979|NCT01410474|38022719|FG001|Overall Study|Withdrawal by Subject|1|||
16913980|NCT01391130|38022734|FG000|Overall Study|Withdrawal by Subject|3|||
16913981|NCT01391130|38022735|FG001|Overall Study|Withdrawal by Subject|2|||
16913982|NCT01391130|38022734|FG000|Overall Study|Physician Decision|2|||
16913983|NCT01391130|38022735|FG001|Overall Study|Physician Decision|3|||
16913984|NCT01391130|38022734|FG000|Overall Study|Did not Receive Drug|1|||
16913985|NCT01391130|38022735|FG001|Overall Study|Did not Receive Drug|1|||
16913986|NCT01410240|38022744|FG000|Overall Study|Physician Decision|0|||
16913987|NCT01410240|38022745|FG001|Overall Study|Physician Decision|0|||
16913988|NCT01410240|38022746|FG002|Overall Study|Physician Decision|1|||
16913989|NCT01410240|38022744|FG000|Overall Study|Missed week 6 assessments|1|||
16913990|NCT01410240|38022745|FG001|Overall Study|Missed week 6 assessments|1|||
16913991|NCT01410240|38022746|FG002|Overall Study|Missed week 6 assessments|1|||
16913992|NCT01409928|38022755|FG000|Overall Study|Physician Decision|12|||
16913993|NCT01390584|38022761|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
16913994|NCT01390584|38022762|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
16913995|NCT01390584|38022763|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
16913996|NCT01431534|38022775|FG000|Treatment Phase|Adverse Event|0|||
16913997|NCT01431534|38022776|FG001|Treatment Phase|Adverse Event|0|||
16913998|NCT01431534|38022777|FG002|Treatment Phase|Adverse Event|1|||
16913999|NCT01431534|38022775|FG000|Treatment Phase|Progressive Disease|4|||
16914000|NCT01431534|38022776|FG001|Treatment Phase|Progressive Disease|3|||
16839899|NCT01953692|37783878|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16839900|NCT01953692|37783879|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16839901|NCT01953692|37783880|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16839902|NCT01953692|37783881|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16839903|NCT01953692|37783882|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16914001|NCT01431534|38022777|FG002|Treatment Phase|Progressive Disease|10|||
16839904|NCT01953692|37783883|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16839905|NCT01953692|37783884|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
16839906|NCT01953692|37783885|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16839907|NCT01953692|37783877|FG000|Overall Study|Withdrawal by Subject|4|||
16839908|NCT01953692|37783878|FG001|Overall Study|Withdrawal by Subject|2|||
16839909|NCT01953692|37783879|FG002|Overall Study|Withdrawal by Subject|1|||
16839910|NCT01953692|37783880|FG003|Overall Study|Withdrawal by Subject|2|||
16839911|NCT01953692|37783881|FG004|Overall Study|Withdrawal by Subject|0|||
16839912|NCT01953692|37783882|FG005|Overall Study|Withdrawal by Subject|3|||
16839913|NCT01953692|37783883|FG006|Overall Study|Withdrawal by Subject|2|||
16914002|NCT01409382|38022787|FG000|Overall Study|Lost to Follow-up|1|||
16914003|NCT01409382|38022788|FG001|Overall Study|Lost to Follow-up|1|||
16914004|NCT01409382|38022787|FG000|Overall Study|Protocol Violation|0|||
16914005|NCT01409382|38022788|FG001|Overall Study|Protocol Violation|3|||
16914006|NCT01409382|38022787|FG000|Overall Study|Multiple pregnancy|2|||
16914007|NCT01409382|38022788|FG001|Overall Study|Multiple pregnancy|4|||
16839914|NCT01953692|37783884|FG007|Overall Study|Withdrawal by Subject|1|||
16839915|NCT01953692|37783885|FG008|Overall Study|Withdrawal by Subject|1|||
16839916|NCT01791153|37783919|FG000|Part 1: Blinded Period|Adverse Event|7|||
16839917|NCT01791153|37783920|FG001|Part 1: Blinded Period|Adverse Event|3|||
16839918|NCT01791153|37783921|FG002|Part 1: Blinded Period|Adverse Event|2|||
16839919|NCT01791153|37783922|FG003|Part 1: Blinded Period|Adverse Event|0|||
16839920|NCT01791153|37783923|FG004|Part 1: Blinded Period|Adverse Event|0|||
16839921|NCT01791153|37783924|FG005|Part 1: Blinded Period|Adverse Event|0|||
16839922|NCT01791153|37783925|FG006|Part 1: Blinded Period|Adverse Event|0|||
16839923|NCT01791153|37783926|FG007|Part 1: Blinded Period|Adverse Event|0|||
16839924|NCT01791153|37783919|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
16839925|NCT01791153|37783920|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
16839926|NCT01791153|37783921|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
16839927|NCT01791153|37783922|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
16839928|NCT01791153|37783923|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
16839929|NCT01791153|37783924|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
16839930|NCT01791153|37783925|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
16839931|NCT01791153|37783926|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
16839932|NCT01791153|37783919|FG000|Part 1: Blinded Period|Non-Compliance|1|||
16839933|NCT01791153|37783920|FG001|Part 1: Blinded Period|Non-Compliance|0|||
16839934|NCT01791153|37783921|FG002|Part 1: Blinded Period|Non-Compliance|0|||
16839935|NCT01791153|37783922|FG003|Part 1: Blinded Period|Non-Compliance|0|||
16839936|NCT01791153|37783923|FG004|Part 1: Blinded Period|Non-Compliance|0|||
16839937|NCT01791153|37783924|FG005|Part 1: Blinded Period|Non-Compliance|0|||
16839938|NCT01791153|37783925|FG006|Part 1: Blinded Period|Non-Compliance|0|||
16839939|NCT01791153|37783926|FG007|Part 1: Blinded Period|Non-Compliance|0|||
16839940|NCT01791153|37783919|FG000|Part 1: Blinded Period|Physician Decision|0|||
16839941|NCT01791153|37783920|FG001|Part 1: Blinded Period|Physician Decision|0|||
16839942|NCT01791153|37783921|FG002|Part 1: Blinded Period|Physician Decision|0|||
16839943|NCT01791153|37783922|FG003|Part 1: Blinded Period|Physician Decision|1|||
16839944|NCT01791153|37783923|FG004|Part 1: Blinded Period|Physician Decision|0|||
16839945|NCT01791153|37783924|FG005|Part 1: Blinded Period|Physician Decision|0|||
16839946|NCT01791153|37783925|FG006|Part 1: Blinded Period|Physician Decision|0|||
16839947|NCT01791153|37783926|FG007|Part 1: Blinded Period|Physician Decision|0|||
16839948|NCT01791153|37783919|FG000|Part 1: Blinded Period|Protocol Violation|0|||
16839949|NCT01791153|37783920|FG001|Part 1: Blinded Period|Protocol Violation|0|||
16839950|NCT01791153|37783921|FG002|Part 1: Blinded Period|Protocol Violation|0|||
16839951|NCT01791153|37783922|FG003|Part 1: Blinded Period|Protocol Violation|1|||
16839952|NCT01791153|37783923|FG004|Part 1: Blinded Period|Protocol Violation|0|||
16839953|NCT01791153|37783924|FG005|Part 1: Blinded Period|Protocol Violation|0|||
16839954|NCT01791153|37783925|FG006|Part 1: Blinded Period|Protocol Violation|0|||
16839955|NCT01791153|37783926|FG007|Part 1: Blinded Period|Protocol Violation|0|||
16839956|NCT01791153|37783919|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
16839957|NCT01791153|37783920|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
16839958|NCT01791153|37783921|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
16839959|NCT01791153|37783922|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
16839960|NCT01791153|37783923|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
16839961|NCT01791153|37783924|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
16914008|NCT01409382|38022787|FG000|Overall Study|Still pregnant when study ended|13|||
16914009|NCT01409382|38022788|FG001|Overall Study|Still pregnant when study ended|2|||
16914010|NCT01409382|38022787|FG000|Overall Study|Did not manage to get pregnant|64|||
16914011|NCT01409382|38022788|FG001|Overall Study|Did not manage to get pregnant|70|||
16839962|NCT01791153|37783925|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
16839963|NCT01791153|37783926|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
16914012|NCT01409382|38022787|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
16914013|NCT01409382|38022788|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
16914014|NCT01408914|38022801|FG000|Overall Study|Could not complete tx in protocol period|5|||
16914015|NCT01408914|38022802|FG001|Overall Study|Could not complete tx in protocol period|5|||
16914016|NCT01408914|38022803|FG002|Overall Study|Could not complete tx in protocol period|6|||
16839964|NCT01791153|37783919|FG000|Part 2: Open-label Period|Adverse Event|0|||
16839965|NCT01791153|37783920|FG001|Part 2: Open-label Period|Adverse Event|0|||
16914017|NCT01408914|38022801|FG000|Overall Study|Lost to Follow-up|4|||
16914018|NCT01408914|38022802|FG001|Overall Study|Lost to Follow-up|1|||
16914019|NCT01408914|38022803|FG002|Overall Study|Lost to Follow-up|2|||
16914020|NCT01408914|38022801|FG000|Overall Study|Physician Decision|1|||
16914021|NCT01408914|38022802|FG001|Overall Study|Physician Decision|1|||
16914022|NCT01408914|38022803|FG002|Overall Study|Physician Decision|0|||
16914023|NCT01408914|38022801|FG000|Overall Study|Withdrawal by Subject|1|||
16914024|NCT01408914|38022802|FG001|Overall Study|Withdrawal by Subject|0|||
16914025|NCT01408914|38022803|FG002|Overall Study|Withdrawal by Subject|1|||
16914026|NCT01408914|38022801|FG000|Overall Study|Moved out of study jurisdiction|1|||
16914027|NCT01408914|38022802|FG001|Overall Study|Moved out of study jurisdiction|1|||
16914028|NCT01408914|38022803|FG002|Overall Study|Moved out of study jurisdiction|0|||
16914029|NCT01408914|38022801|FG000|Overall Study|Late exclusion|0|||
16914030|NCT01408914|38022802|FG001|Overall Study|Late exclusion|3|||
16914031|NCT01408914|38022803|FG002|Overall Study|Late exclusion|3|||
16914032|NCT01408914|38022801|FG000|Overall Study|Change in local TB/HIV norms|0|||
16914033|NCT01408914|38022802|FG001|Overall Study|Change in local TB/HIV norms|1|||
16914034|NCT01408914|38022803|FG002|Overall Study|Change in local TB/HIV norms|1|||
16914035|NCT01431144|38022813|FG000|Overall Study|Implant mobility and removal|2|||
16914036|NCT01431144|38022814|FG001|Overall Study|Implant mobility and removal|0|||
16914037|NCT01430754|38022823|FG000|Run-In Phase|Circadian Period Ineligible|24|||
16839966|NCT01791153|37783921|FG002|Part 2: Open-label Period|Adverse Event|0|||
16839967|NCT01791153|37783922|FG003|Part 2: Open-label Period|Adverse Event|0|||
16839968|NCT01791153|37783923|FG004|Part 2: Open-label Period|Adverse Event|0|||
16839969|NCT01791153|37783924|FG005|Part 2: Open-label Period|Adverse Event|1|||
16839970|NCT01791153|37783925|FG006|Part 2: Open-label Period|Adverse Event|1|||
16839971|NCT01791153|37783926|FG007|Part 2: Open-label Period|Adverse Event|2|||
16839972|NCT01791153|37783919|FG000|Part 2: Open-label Period|Death|0|||
16839973|NCT01791153|37783920|FG001|Part 2: Open-label Period|Death|0|||
16914038|NCT01430754|38022824|FG001|Run-In Phase|Circadian Period Ineligible|0|||
16914039|NCT01430754|38022823|FG000|Run-In Phase|Protocol Violation|6|||
16914040|NCT01430754|38022824|FG001|Run-In Phase|Protocol Violation|0|||
16914041|NCT01430754|38022823|FG000|Run-In Phase|Adverse Event|2|||
16914042|NCT01430754|38022824|FG001|Run-In Phase|Adverse Event|0|||
16914043|NCT01430754|38022823|FG000|Run-In Phase|Other|2|||
16839974|NCT01791153|37783921|FG002|Part 2: Open-label Period|Death|0|||
16839975|NCT01791153|37783922|FG003|Part 2: Open-label Period|Death|0|||
16839976|NCT01791153|37783923|FG004|Part 2: Open-label Period|Death|0|||
16839977|NCT01791153|37783924|FG005|Part 2: Open-label Period|Death|1|||
16839978|NCT01791153|37783925|FG006|Part 2: Open-label Period|Death|1|||
16839979|NCT01791153|37783926|FG007|Part 2: Open-label Period|Death|1|||
16839980|NCT01791153|37783919|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
16839981|NCT01791153|37783920|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
16839982|NCT01791153|37783921|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
16839983|NCT01791153|37783922|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
16839984|NCT01791153|37783923|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
16839985|NCT01791153|37783924|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
16839986|NCT01791153|37783925|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
16839987|NCT01791153|37783926|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
16839988|NCT01791153|37783919|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
16839989|NCT01791153|37783920|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
16839990|NCT01791153|37783921|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
16839991|NCT01791153|37783922|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
16839992|NCT01791153|37783923|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
16839993|NCT01791153|37783924|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
16839994|NCT01791153|37783925|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
16839995|NCT01791153|37783926|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
16839996|NCT01791153|37783919|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
16839997|NCT01791153|37783920|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
16839998|NCT01791153|37783921|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
16839999|NCT01791153|37783922|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
16840000|NCT01791153|37783923|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
16840001|NCT01791153|37783924|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
16840002|NCT01791153|37783925|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
16840003|NCT01791153|37783926|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
16840004|NCT01791153|37783919|FG000|Part 2: Open-label Period|Physician Decision|0|||
16840005|NCT01791153|37783920|FG001|Part 2: Open-label Period|Physician Decision|0|||
16840006|NCT01791153|37783921|FG002|Part 2: Open-label Period|Physician Decision|0|||
16840007|NCT01791153|37783922|FG003|Part 2: Open-label Period|Physician Decision|0|||
16840008|NCT01791153|37783923|FG004|Part 2: Open-label Period|Physician Decision|1|||
16840009|NCT01791153|37783924|FG005|Part 2: Open-label Period|Physician Decision|1|||
16840010|NCT01791153|37783925|FG006|Part 2: Open-label Period|Physician Decision|0|||
16840011|NCT01791153|37783926|FG007|Part 2: Open-label Period|Physician Decision|0|||
16840012|NCT01926782|37783947|FG000|Overall Study|Participant moved|2|||
16840013|NCT01926782|37783948|FG001|Overall Study|Participant moved|0|||
16840014|NCT01926782|37783949|FG002|Overall Study|Participant moved|1|||
16840015|NCT01926782|37783950|FG003|Overall Study|Participant moved|1|||
16840016|NCT01926782|37783951|FG004|Overall Study|Participant moved|0|||
16840017|NCT01926782|37783952|FG005|Overall Study|Participant moved|3|||
16840018|NCT01926782|37783947|FG000|Overall Study|Physician Decision|0|||
16840019|NCT01926782|37783948|FG001|Overall Study|Physician Decision|2|||
16840020|NCT01926782|37783949|FG002|Overall Study|Physician Decision|1|||
16840021|NCT01926782|37783950|FG003|Overall Study|Physician Decision|1|||
16840022|NCT01926782|37783951|FG004|Overall Study|Physician Decision|0|||
16840023|NCT01926782|37783952|FG005|Overall Study|Physician Decision|0|||
16840024|NCT01926782|37783947|FG000|Overall Study|Other than specified|2|||
16840025|NCT01926782|37783948|FG001|Overall Study|Other than specified|3|||
16840026|NCT01926782|37783949|FG002|Overall Study|Other than specified|5|||
16840027|NCT01926782|37783950|FG003|Overall Study|Other than specified|12|||
16840028|NCT01926782|37783951|FG004|Overall Study|Other than specified|4|||
16840029|NCT01926782|37783952|FG005|Overall Study|Other than specified|11|||
16840030|NCT01926782|37783947|FG000|Overall Study|Adverse Event|13|||
16840031|NCT01926782|37783948|FG001|Overall Study|Adverse Event|4|||
16840032|NCT01926782|37783949|FG002|Overall Study|Adverse Event|17|||
16840033|NCT01926782|37783950|FG003|Overall Study|Adverse Event|4|||
16914044|NCT01430754|38022824|FG001|Run-In Phase|Other|0|||
16914045|NCT01430754|38022823|FG000|Run-In Phase|Withdrawal by Subject|2|||
16914046|NCT01430754|38022824|FG001|Run-In Phase|Withdrawal by Subject|0|||
16914047|NCT01430754|38022823|FG000|Run-In Phase|Lost to Follow-up|1|||
16914048|NCT01430754|38022824|FG001|Run-In Phase|Lost to Follow-up|0|||
16914049|NCT01390428|38022838|FG000|Overall Study|Elective Surgery|0|||
16914050|NCT01390428|38022839|FG001|Overall Study|Elective Surgery|0|||
16914051|NCT01390428|38022840|FG002|Overall Study|Elective Surgery|0|||
16914052|NCT01390428|38022841|FG003|Overall Study|Elective Surgery|0|||
16914053|NCT01390428|38022842|FG004|Overall Study|Elective Surgery|1|||
16914054|NCT01390428|38022843|FG005|Overall Study|Elective Surgery|0|||
16914055|NCT01390428|38022838|FG000|Overall Study|Withdrawal by Subject|0|||
16914056|NCT01390428|38022839|FG001|Overall Study|Withdrawal by Subject|0|||
16914057|NCT01390428|38022840|FG002|Overall Study|Withdrawal by Subject|1|||
16914058|NCT01390428|38022841|FG003|Overall Study|Withdrawal by Subject|0|||
16914059|NCT01390428|38022842|FG004|Overall Study|Withdrawal by Subject|0|||
16914060|NCT01390428|38022843|FG005|Overall Study|Withdrawal by Subject|0|||
16914061|NCT01430130|38022857|FG000|Overall Study|Lost to Follow-up|1|||
16914062|NCT01430130|38022857|FG000|Overall Study|Infection on Control Side of Incision|1|||
16914063|NCT01407354|38022863|FG000|First Intervention|Withdrawal by Subject|0|||
16914064|NCT01407354|38022864|FG001|First Intervention|Withdrawal by Subject|2|||
16914065|NCT01407354|38022863|FG000|First Intervention|Adverse Event|1|||
16914066|NCT01407354|38022864|FG001|First Intervention|Adverse Event|0|||
16914067|NCT01407354|38022863|FG000|First Intervention|Physician Decision|1|||
16914068|NCT01407354|38022864|FG001|First Intervention|Physician Decision|0|||
16914069|NCT01407276|38022879|FG000|Overall Study|Withdrawal by Subject|0|||
16840034|NCT01926782|37783951|FG004|Overall Study|Adverse Event|3|||
16840035|NCT01926782|37783952|FG005|Overall Study|Adverse Event|14|||
16914070|NCT01407276|38022880|FG001|Overall Study|Withdrawal by Subject|0|||
16914071|NCT01407276|38022881|FG002|Overall Study|Withdrawal by Subject|0|||
16914072|NCT01407276|38022882|FG003|Overall Study|Withdrawal by Subject|0|||
16914073|NCT01407276|38022883|FG004|Overall Study|Withdrawal by Subject|0|||
16914074|NCT01407276|38022884|FG005|Overall Study|Withdrawal by Subject|0|||
16914075|NCT01407276|38022885|FG006|Overall Study|Withdrawal by Subject|0|||
16914076|NCT01407276|38022886|FG007|Overall Study|Withdrawal by Subject|1|||
16914077|NCT01390272|38022913|FG000|Overall Study|Death|3|||
16914078|NCT01390272|38022914|FG001|Overall Study|Death|2|||
16914079|NCT01390272|38022913|FG000|Overall Study|Withdrawal by Subject|9|||
16914080|NCT01390272|38022914|FG001|Overall Study|Withdrawal by Subject|5|||
16914081|NCT01390272|38022913|FG000|Overall Study|Patient moved, no longer eligible|5|||
16914082|NCT01390272|38022914|FG001|Overall Study|Patient moved, no longer eligible|8|||
16914083|NCT01429584|38022922|FG000|Overall Study|Withdrawal by Subject|1|||
16914084|NCT01429584|38022923|FG001|Overall Study|Withdrawal by Subject|0|||
16914085|NCT01429584|38022922|FG000|Overall Study|Protocol Violation|0|||
16914086|NCT01429584|38022923|FG001|Overall Study|Protocol Violation|1|||
16914087|NCT01406652|38022931|FG000|Overall Study|Lost-to-follow-up|3|||
16914088|NCT01406652|38022932|FG001|Overall Study|Lost-to-follow-up|4|||
16914089|NCT01406652|38022931|FG000|Overall Study|Withdrawal by Subject|2|||
16914090|NCT01406652|38022932|FG001|Overall Study|Withdrawal by Subject|2|||
16914091|NCT01406652|38022931|FG000|Overall Study|Insufficient follow-up|5|||
16914092|NCT01406652|38022932|FG001|Overall Study|Insufficient follow-up|4|||
16914093|NCT01406652|38022931|FG000|Overall Study|Infection not sure|10|||
16914094|NCT01406652|38022932|FG001|Overall Study|Infection not sure|10|||
16914095|NCT01390038|38022940|FG000|Overall Study|Death|1|||
16840036|NCT01926782|37783947|FG000|Overall Study|Poor compliance to protocol|5|||
16840037|NCT01926782|37783948|FG001|Overall Study|Poor compliance to protocol|3|||
16840038|NCT01926782|37783949|FG002|Overall Study|Poor compliance to protocol|8|||
16840039|NCT01926782|37783950|FG003|Overall Study|Poor compliance to protocol|0|||
16840040|NCT01926782|37783951|FG004|Overall Study|Poor compliance to protocol|1|||
16840041|NCT01926782|37783952|FG005|Overall Study|Poor compliance to protocol|6|||
16840042|NCT01926782|37783947|FG000|Overall Study|Randomized and not treated|0|||
16840043|NCT01926782|37783948|FG001|Overall Study|Randomized and not treated|0|||
16840044|NCT01926782|37783949|FG002|Overall Study|Randomized and not treated|0|||
16840045|NCT01926782|37783950|FG003|Overall Study|Randomized and not treated|1|||
16840046|NCT01926782|37783951|FG004|Overall Study|Randomized and not treated|0|||
16840047|NCT01926782|37783952|FG005|Overall Study|Randomized and not treated|0|||
16914096|NCT01390038|38022940|FG000|Overall Study|Lost to Follow-up|1|||
16914097|NCT01390038|38022940|FG000|Overall Study|Withdrawal by Subject|4|||
16914098|NCT01390038|38022940|FG000|Overall Study|Simpliciti System Removal|2|||
16914099|NCT01406574|38022944|FG000|Overall Study|Adverse Event|0|||
16914100|NCT01406574|38022945|FG001|Overall Study|Adverse Event|0|||
16914101|NCT01406574|38022946|FG002|Overall Study|Adverse Event|1|||
16914102|NCT01406574|38022947|FG003|Overall Study|Adverse Event|3|||
16914103|NCT01406574|38022944|FG000|Overall Study|Physician Decision|0|||
16914104|NCT01406574|38022945|FG001|Overall Study|Physician Decision|0|||
16914105|NCT01406574|38022946|FG002|Overall Study|Physician Decision|0|||
16914106|NCT01406574|38022947|FG003|Overall Study|Physician Decision|1|||
16914107|NCT01406574|38022944|FG000|Overall Study|Withdrawal by Subject|0|||
16914108|NCT01406574|38022945|FG001|Overall Study|Withdrawal by Subject|1|||
16840048|NCT01926782|37783947|FG000|Overall Study|Withdrawal by Subject|6|||
16914109|NCT01406574|38022946|FG002|Overall Study|Withdrawal by Subject|0|||
16914110|NCT01406574|38022947|FG003|Overall Study|Withdrawal by Subject|0|||
16914111|NCT01406574|38022944|FG000|Overall Study|Definite progression of primary disease|1|||
16914112|NCT01406574|38022945|FG001|Overall Study|Definite progression of primary disease|0|||
16914113|NCT01406574|38022946|FG002|Overall Study|Definite progression of primary disease|0|||
16914114|NCT01406574|38022947|FG003|Overall Study|Definite progression of primary disease|0|||
16914115|NCT01405950|38022960|FG000|Overall Study|Withdrawal by Subject|1|||
16914116|NCT01405950|38022961|FG001|Overall Study|Withdrawal by Subject|0|||
16914117|NCT01405950|38022962|FG002|Overall Study|Withdrawal by Subject|0|||
16914118|NCT01405950|38022963|FG003|Overall Study|Withdrawal by Subject|0|||
16914119|NCT01405560|38022971|FG000|Overall Study|Physician Decision|1|||
16914120|NCT01428882|38022977|FG000|Overall Study|Lack of Efficacy|2|||
16914121|NCT01428882|38022978|FG001|Overall Study|Lack of Efficacy|7|||
16840049|NCT01926782|37783948|FG001|Overall Study|Withdrawal by Subject|1|||
16840050|NCT01926782|37783949|FG002|Overall Study|Withdrawal by Subject|8|||
16840051|NCT01926782|37783950|FG003|Overall Study|Withdrawal by Subject|1|||
16840052|NCT01926782|37783951|FG004|Overall Study|Withdrawal by Subject|0|||
16840053|NCT01926782|37783952|FG005|Overall Study|Withdrawal by Subject|5|||
16840054|NCT01926782|37783947|FG000|Overall Study|Related to study drug administration|0|||
16840055|NCT01926782|37783948|FG001|Overall Study|Related to study drug administration|0|||
16840056|NCT01926782|37783949|FG002|Overall Study|Related to study drug administration|0|||
16840057|NCT01926782|37783950|FG003|Overall Study|Related to study drug administration|0|||
16840058|NCT01926782|37783951|FG004|Overall Study|Related to study drug administration|0|||
16840059|NCT01926782|37783952|FG005|Overall Study|Related to study drug administration|2|||
16840060|NCT01926626|37783967|FG000|Overall Study|Withdrawal by Subject|15|||
16840061|NCT01926626|37783967|FG000|Overall Study|Lost to Follow-up|7|||
16840062|NCT01953224|37783973|FG000|Overall Study|Lost to Follow-up|1|||
16840063|NCT01953224|37783974|FG001|Overall Study|Lost to Follow-up|1|||
16840064|NCT01953224|37783973|FG000|Overall Study|Withdrawal by Subject|1|||
16840065|NCT01953224|37783974|FG001|Overall Study|Withdrawal by Subject|2|||
16840066|NCT01900730|37783982|FG000|Overall Study|Withdrawal by Subject|1|||
16840067|NCT01900730|37783983|FG001|Overall Study|Withdrawal by Subject|0|||
16840068|NCT01900730|37783982|FG000|Overall Study|Screen Failure|1|||
16914122|NCT01428882|38022977|FG000|Overall Study|Protocol Violation|4|||
16914123|NCT01428882|38022978|FG001|Overall Study|Protocol Violation|3|||
16914124|NCT01428258|38022986|FG000|Intervention 1|Withdrawal by Subject|2|||
16914125|NCT01428258|38022987|FG001|Intervention 1|Withdrawal by Subject|0|||
16914126|NCT01389882|38023003|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
16914127|NCT01389882|38023004|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
16914128|NCT01389882|38023003|FG000|Overall Study|Withdrawal by Subject|0|||
16914129|NCT01389882|38023004|FG001|Overall Study|Withdrawal by Subject|1|||
16914130|NCT01426854|38023012|FG000|Overall Study|Adverse Event|1|||
16914131|NCT01426854|38023013|FG001|Overall Study|Adverse Event|5|||
16914132|NCT01426854|38023012|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
16914133|NCT01426854|38023013|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
16914134|NCT01426854|38023012|FG000|Overall Study|Lost to Follow-up|3|||
16914135|NCT01426854|38023013|FG001|Overall Study|Lost to Follow-up|0|||
16914136|NCT01426854|38023012|FG000|Overall Study|Noncompliance|0|||
16914137|NCT01426854|38023013|FG001|Overall Study|Noncompliance|1|||
16840069|NCT01900730|37783983|FG001|Overall Study|Screen Failure|0|||
16840070|NCT01952834|37783989|FG000|Overall Study|Adverse Event|1|||
16840071|NCT01952366|37783994|FG000|Overall Study|Death|22|||
16840072|NCT01952366|37783994|FG000|Overall Study|Withdrawal by Subject|9|||
16840073|NCT01952054|37784001|FG000|Overall Study|Physician Decision|1|||
16840074|NCT01925768|37784007|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16840075|NCT01925768|37784008|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16840076|NCT01925768|37784007|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16840077|NCT01925768|37784008|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
16840078|NCT01925768|37784007|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
16840079|NCT01925768|37784008|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
16840080|NCT01925768|37784007|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
16840081|NCT01925768|37784008|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
16840082|NCT01925768|37784007|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
16840083|NCT01925768|37784008|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
16840084|NCT01925768|37784007|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
16840085|NCT01925768|37784008|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
16840086|NCT01925768|37784007|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
16840087|NCT01925768|37784008|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
16840088|NCT01925768|37784007|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
16840089|NCT01925768|37784008|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
16840090|NCT01925768|37784007|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
16914138|NCT01426854|38023012|FG000|Overall Study|Treatment Failure|0|||
16914139|NCT01426854|38023013|FG001|Overall Study|Treatment Failure|16|||
16914140|NCT01426854|38023012|FG000|Overall Study|Protocol Deviation|0|||
16840091|NCT01925768|37784008|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
16840092|NCT01925768|37784007|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
16840093|NCT01925768|37784008|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
16840094|NCT01925768|37784007|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
16840095|NCT01925768|37784008|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
16840096|NCT01431274|37784023|FG000|Overall Study|Adverse Event|51|||
16840097|NCT01431274|37784024|FG001|Overall Study|Adverse Event|37|||
16840098|NCT01431274|37784025|FG002|Overall Study|Adverse Event|43|||
16840099|NCT01431274|37784026|FG003|Overall Study|Adverse Event|30|||
16840100|NCT01431274|37784027|FG004|Overall Study|Adverse Event|37|||
16840101|NCT01431274|37784023|FG000|Overall Study|Consent withdrawn not due to AE|29|||
16840102|NCT01431274|37784024|FG001|Overall Study|Consent withdrawn not due to AE|20|||
16840103|NCT01431274|37784025|FG002|Overall Study|Consent withdrawn not due to AE|17|||
16840104|NCT01431274|37784026|FG003|Overall Study|Consent withdrawn not due to AE|20|||
16840105|NCT01431274|37784027|FG004|Overall Study|Consent withdrawn not due to AE|11|||
16840106|NCT01431274|37784023|FG000|Overall Study|Non compliant with protocol|5|||
16840107|NCT01431274|37784024|FG001|Overall Study|Non compliant with protocol|8|||
16840108|NCT01431274|37784025|FG002|Overall Study|Non compliant with protocol|4|||
16840109|NCT01431274|37784026|FG003|Overall Study|Non compliant with protocol|4|||
16840110|NCT01431274|37784027|FG004|Overall Study|Non compliant with protocol|4|||
16840111|NCT01431274|37784023|FG000|Overall Study|Lost to Follow-up|6|||
16914141|NCT01426854|38023013|FG001|Overall Study|Protocol Deviation|1|||
16914142|NCT01426854|38023012|FG000|Overall Study|Other|3|||
16914143|NCT01426854|38023013|FG001|Overall Study|Other|2|||
16914144|NCT01426386|38023025|FG000|Overall Study|Adverse Event|0|||
16840112|NCT01431274|37784024|FG001|Overall Study|Lost to Follow-up|7|||
16840113|NCT01431274|37784025|FG002|Overall Study|Lost to Follow-up|1|||
16840114|NCT01431274|37784026|FG003|Overall Study|Lost to Follow-up|4|||
16840115|NCT01431274|37784027|FG004|Overall Study|Lost to Follow-up|0|||
16840116|NCT01431274|37784023|FG000|Overall Study|Other reason not stated above|6|||
16840117|NCT01431274|37784024|FG001|Overall Study|Other reason not stated above|5|||
16840118|NCT01431274|37784025|FG002|Overall Study|Other reason not stated above|7|||
16840119|NCT01431274|37784026|FG003|Overall Study|Other reason not stated above|2|||
16840120|NCT01431274|37784027|FG004|Overall Study|Other reason not stated above|4|||
16840121|NCT01991795|37784041|FG000|Overall Study|Lost to Follow-up|6|||
16840122|NCT01991795|37784042|FG001|Overall Study|Lost to Follow-up|4|||
16840123|NCT01991795|37784041|FG000|Overall Study|Withdrawal by Subject|117|||
16840124|NCT01991795|37784042|FG001|Overall Study|Withdrawal by Subject|94|||
16840125|NCT01991795|37784041|FG000|Overall Study|Site prematurely closed by sponsor|26|||
16840126|NCT01991795|37784042|FG001|Overall Study|Site prematurely closed by sponsor|25|||
16840127|NCT01411852|37784083|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
16840128|NCT01411852|37784084|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
16840129|NCT01411852|37784083|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
16840130|NCT01411852|37784084|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
16840131|NCT01411852|37784083|FG000|Prehospital Intervention Phase|Found to be under age|0|||
16840132|NCT01411852|37784084|FG001|Prehospital Intervention Phase|Found to be under age|1|||
16840133|NCT01411852|37784083|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
16840134|NCT01411852|37784084|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
16840135|NCT01411852|37784083|FG000|Hospital Intervention Phase|Severe head injury|5|||
16840136|NCT01411852|37784084|FG001|Hospital Intervention Phase|Severe head injury|4|||
16840137|NCT01411852|37784083|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
16840138|NCT01411852|37784084|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
16840139|NCT01411852|37784083|FG000|Hospital Intervention Phase|Miscommunication error|1|||
16840140|NCT01411852|37784084|FG001|Hospital Intervention Phase|Miscommunication error|2|||
16840141|NCT01411852|37784083|FG000|Hospital Intervention Phase|CPR administered|3|||
16840142|NCT01411852|37784084|FG001|Hospital Intervention Phase|CPR administered|1|||
16840143|NCT01411852|37784083|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
16840144|NCT01411852|37784084|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
16840145|NCT01411852|37784083|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
16840146|NCT01411852|37784084|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
16840147|NCT01411852|37784083|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
16840148|NCT01411852|37784084|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
16840149|NCT01411852|37784083|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
16840150|NCT01411852|37784084|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
16840151|NCT01411852|37784083|FG000|Hospital Intervention Phase|Other ineligible|2|||
16840152|NCT01411852|37784084|FG001|Hospital Intervention Phase|Other ineligible|2|||
16840153|NCT01411852|37784083|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
16840154|NCT01411852|37784084|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
16840155|NCT01411852|37784083|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
16840156|NCT01411852|37784084|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
16914145|NCT01426386|38023026|FG001|Overall Study|Adverse Event|1|||
16840157|NCT01411852|37784083|FG000|Hospital Intervention Phase|Vascular access failed|1|||
16840158|NCT01411852|37784084|FG001|Hospital Intervention Phase|Vascular access failed|0|||
16840159|NCT01411774|37784094|FG000|Overall Study|Withdrawal by Subject|0|||
16840160|NCT01411774|37784095|FG001|Overall Study|Withdrawal by Subject|3|||
16840161|NCT01411228|37784104|FG000|Overall Study|Lost to Follow-up|0|||
16840162|NCT01411228|37784105|FG001|Overall Study|Lost to Follow-up|0|||
16840163|NCT01411228|37784106|FG002|Overall Study|Lost to Follow-up|1|||
16840164|NCT01411228|37784104|FG000|Overall Study|Withdrawal by Subject|1|||
16840165|NCT01411228|37784105|FG001|Overall Study|Withdrawal by Subject|0|||
16840166|NCT01411228|37784106|FG002|Overall Study|Withdrawal by Subject|0|||
16840167|NCT01410604|37784116|FG000|Overall Study|Adverse Event|2|||
16840168|NCT01410604|37784117|FG001|Overall Study|Adverse Event|1|||
16840169|NCT01410604|37784116|FG000|Overall Study|Lost to Follow-up|1|||
16840170|NCT01410604|37784117|FG001|Overall Study|Lost to Follow-up|0|||
16840171|NCT01410604|37784116|FG000|Overall Study|Physician Decision|0|||
16840172|NCT01410604|37784117|FG001|Overall Study|Physician Decision|1|||
16840173|NCT01991483|37784127|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
16840174|NCT01991483|37784128|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
16840175|NCT01991483|37784129|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
16840176|NCT01991483|37784130|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
16840177|NCT01991483|37784127|FG000|Dose Level 600 mg|Physician Decision|0|||
16840178|NCT01991483|37784128|FG001|Dose Level 600 mg|Physician Decision|0|||
16840179|NCT01991483|37784129|FG002|Dose Level 600 mg|Physician Decision|1|||
16840180|NCT01991483|37784130|FG003|Dose Level 600 mg|Physician Decision|0|||
16840181|NCT01991483|37784127|FG000|Dose Level 1000 mg|Protocol Violation|0|||
16840182|NCT01991483|37784128|FG001|Dose Level 1000 mg|Protocol Violation|0|||
16840183|NCT01991483|37784129|FG002|Dose Level 1000 mg|Protocol Violation|0|||
16840184|NCT01991483|37784130|FG003|Dose Level 1000 mg|Protocol Violation|1|||
16840185|NCT01410448|37784145|FG000|Overall Study|No conversion to everolimus|0|||
16840186|NCT01410448|37784146|FG001|Overall Study|No conversion to everolimus|24|||
16840187|NCT01410448|37784145|FG000|Overall Study|Graft loss|4|||
16840188|NCT01410448|37784146|FG001|Overall Study|Graft loss|1|||
16914146|NCT01426386|38023027|FG002|Overall Study|Adverse Event|0|||
16914147|NCT01426386|38023028|FG003|Overall Study|Adverse Event|0|||
16914148|NCT01426386|38023029|FG004|Overall Study|Adverse Event|0|||
16914149|NCT01426386|38023030|FG005|Overall Study|Adverse Event|0|||
16914150|NCT01426386|38023025|FG000|Overall Study|Did not attend scheduled visit|1|||
16914151|NCT01426386|38023026|FG001|Overall Study|Did not attend scheduled visit|4|||
16914152|NCT01426386|38023027|FG002|Overall Study|Did not attend scheduled visit|0|||
16914153|NCT01426386|38023028|FG003|Overall Study|Did not attend scheduled visit|0|||
16914154|NCT01426386|38023029|FG004|Overall Study|Did not attend scheduled visit|2|||
16840189|NCT01410448|37784145|FG000|Overall Study|Administrative issues|2|||
16840190|NCT01410448|37784146|FG001|Overall Study|Administrative issues|1|||
16840191|NCT01410448|37784145|FG000|Overall Study|Lost to Follow-up|1|||
16840192|NCT01410448|37784146|FG001|Overall Study|Lost to Follow-up|0|||
16840193|NCT01410448|37784145|FG000|Overall Study|Withdrawal by Subject|3|||
16914155|NCT01426386|38023030|FG005|Overall Study|Did not attend scheduled visit|1|||
16914156|NCT01426386|38023025|FG000|Overall Study|Poor response|2|||
16914157|NCT01426386|38023026|FG001|Overall Study|Poor response|1|||
16914158|NCT01426386|38023027|FG002|Overall Study|Poor response|2|||
16914159|NCT01426386|38023028|FG003|Overall Study|Poor response|0|||
16914160|NCT01426386|38023029|FG004|Overall Study|Poor response|1|||
16914161|NCT01426386|38023030|FG005|Overall Study|Poor response|0|||
16914162|NCT01426386|38023025|FG000|Overall Study|Personal reasons|0|||
16914163|NCT01426386|38023026|FG001|Overall Study|Personal reasons|0|||
16914164|NCT01426386|38023027|FG002|Overall Study|Personal reasons|0|||
16914165|NCT01426386|38023028|FG003|Overall Study|Personal reasons|0|||
16914166|NCT01426386|38023029|FG004|Overall Study|Personal reasons|1|||
16914167|NCT01426386|38023030|FG005|Overall Study|Personal reasons|0|||
16914168|NCT01404234|38023044|FG000|Overall Study|Withdrawal by Subject|2|||
16914169|NCT01403610|38023052|FG000|Overall Study|Withdrawal by Subject|2|||
16914170|NCT01403610|38023053|FG001|Overall Study|Withdrawal by Subject|0|||
16914171|NCT01403610|38023054|FG002|Overall Study|Withdrawal by Subject|0|||
16914172|NCT01403610|38023055|FG003|Overall Study|Withdrawal by Subject|0|||
16840194|NCT01410448|37784146|FG001|Overall Study|Withdrawal by Subject|2|||
16840195|NCT01410448|37784145|FG000|Overall Study|Protocol Violation|0|||
16840196|NCT01410448|37784146|FG001|Overall Study|Protocol Violation|4|||
16840197|NCT01410448|37784145|FG000|Overall Study|Death|2|||
16840198|NCT01410448|37784146|FG001|Overall Study|Death|3|||
16840199|NCT01943851|37784170|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840200|NCT01943851|37784171|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840201|NCT01943851|37784172|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840202|NCT01943851|37784173|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
16840203|NCT01943851|37784174|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840204|NCT01943851|37784175|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
17016808|NCT00686998|38161471|FG000|Overall Study|Adverse Event|3|||
16840205|NCT01943851|37784176|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
16840206|NCT01943851|37784177|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
16840207|NCT01943851|37784178|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
16840208|NCT01943851|37784179|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16914173|NCT01403610|38023052|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
16914174|NCT01403610|38023053|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
16914175|NCT01403610|38023054|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
16914176|NCT01403610|38023055|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
16914177|NCT01403064|38023069|FG000|Overall Study|Death|0|||
16914178|NCT01403064|38023070|FG001|Overall Study|Death|0|||
16914179|NCT01403064|38023071|FG002|Overall Study|Death|1|||
16914180|NCT01403064|38023072|FG003|Overall Study|Death|1|||
16840209|NCT01943851|37784180|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840210|NCT01943851|37784181|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840211|NCT01943851|37784182|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16914181|NCT01403064|38023069|FG000|Overall Study|Withdrawal by Subject|0|||
16914182|NCT01403064|38023070|FG001|Overall Study|Withdrawal by Subject|0|||
16914183|NCT01403064|38023071|FG002|Overall Study|Withdrawal by Subject|1|||
16914184|NCT01403064|38023072|FG003|Overall Study|Withdrawal by Subject|1|||
16914185|NCT01403064|38023069|FG000|Overall Study|Other|1|||
16914186|NCT01403064|38023070|FG001|Overall Study|Other|0|||
16914187|NCT01403064|38023071|FG002|Overall Study|Other|2|||
16914188|NCT01403064|38023072|FG003|Overall Study|Other|1|||
16914189|NCT01402986|38023091|FG000|Overall Study|Withdrawal by Subject|7|||
16914190|NCT01402986|38023092|FG001|Overall Study|Withdrawal by Subject|10|||
16914191|NCT01402986|38023093|FG002|Overall Study|Withdrawal by Subject|7|||
16914192|NCT01402986|38023094|FG003|Overall Study|Withdrawal by Subject|13|||
16914193|NCT01402986|38023091|FG000|Overall Study|Death|0|||
16914194|NCT01402986|38023092|FG001|Overall Study|Death|0|||
16914195|NCT01402986|38023093|FG002|Overall Study|Death|0|||
16914196|NCT01402986|38023094|FG003|Overall Study|Death|2|||
16914197|NCT01402986|38023091|FG000|Overall Study|Lost to Follow-up|0|||
16914198|NCT01402986|38023092|FG001|Overall Study|Lost to Follow-up|0|||
16914199|NCT01402986|38023093|FG002|Overall Study|Lost to Follow-up|0|||
16914200|NCT01402986|38023094|FG003|Overall Study|Lost to Follow-up|1|||
16914201|NCT01402986|38023091|FG000|Overall Study|Other|2|||
16914202|NCT01402986|38023092|FG001|Overall Study|Other|5|||
16914203|NCT01402986|38023093|FG002|Overall Study|Other|1|||
16914204|NCT01402986|38023094|FG003|Overall Study|Other|6|||
16914205|NCT01402908|38023106|FG000|Overall Study|Withdrawal by Subject|30|||
16914206|NCT01402908|38023107|FG001|Overall Study|Withdrawal by Subject|17|||
16914207|NCT01402908|38023106|FG000|Overall Study|Lost to Follow-up|3|||
16914208|NCT01402908|38023107|FG001|Overall Study|Lost to Follow-up|1|||
16840212|NCT01943851|37784183|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840213|NCT01943851|37784184|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840214|NCT01943851|37784185|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840215|NCT01943851|37784186|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840216|NCT01943851|37784187|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16840217|NCT01943851|37784170|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840218|NCT01943851|37784171|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840219|NCT01943851|37784172|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840220|NCT01943851|37784173|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840221|NCT01943851|37784174|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
16840222|NCT01943851|37784175|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840223|NCT01943851|37784176|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840224|NCT01943851|37784177|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
16840225|NCT01943851|37784178|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840226|NCT01943851|37784179|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840227|NCT01943851|37784180|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840228|NCT01943851|37784181|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840229|NCT01943851|37784182|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840230|NCT01943851|37784183|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840231|NCT01943851|37784184|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840232|NCT01943851|37784185|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840233|NCT01943851|37784186|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840234|NCT01943851|37784187|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16840235|NCT01943851|37784170|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840236|NCT01943851|37784171|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840237|NCT01943851|37784172|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16914209|NCT01402908|38023106|FG000|Overall Study|Physician Decision|1|||
16914210|NCT01402908|38023107|FG001|Overall Study|Physician Decision|0|||
16914211|NCT01389258|38023113|FG000|Overall Study|Lost to Follow-up|5|||
16914212|NCT01389102|38023123|FG000|Overall Study|Adverse Event|1|||
16914213|NCT01389102|38023124|FG001|Overall Study|Adverse Event|3|||
16914214|NCT01389102|38023125|FG002|Overall Study|Adverse Event|2|||
16914215|NCT01389102|38023126|FG003|Overall Study|Adverse Event|2|||
16914216|NCT01389102|38023127|FG004|Overall Study|Adverse Event|2|||
16840238|NCT01943851|37784173|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840239|NCT01943851|37784174|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840240|NCT01943851|37784175|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840241|NCT01943851|37784176|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16914217|NCT01389102|38023128|FG005|Overall Study|Adverse Event|2|||
16914218|NCT01389102|38023123|FG000|Overall Study|Hurricane Katrina|4|||
16914219|NCT01389102|38023124|FG001|Overall Study|Hurricane Katrina|2|||
16914220|NCT01389102|38023125|FG002|Overall Study|Hurricane Katrina|3|||
16914221|NCT01389102|38023126|FG003|Overall Study|Hurricane Katrina|0|||
16914222|NCT01389102|38023127|FG004|Overall Study|Hurricane Katrina|3|||
16914223|NCT01389102|38023128|FG005|Overall Study|Hurricane Katrina|1|||
16914224|NCT01389102|38023123|FG000|Overall Study|Lost to Follow-up|4|||
16914225|NCT01389102|38023124|FG001|Overall Study|Lost to Follow-up|1|||
16914226|NCT01389102|38023125|FG002|Overall Study|Lost to Follow-up|1|||
16914227|NCT01389102|38023126|FG003|Overall Study|Lost to Follow-up|2|||
16914228|NCT01389102|38023127|FG004|Overall Study|Lost to Follow-up|4|||
16914229|NCT01389102|38023128|FG005|Overall Study|Lost to Follow-up|1|||
16914230|NCT01389102|38023123|FG000|Overall Study|Protocol Violation|0|||
16914231|NCT01389102|38023124|FG001|Overall Study|Protocol Violation|0|||
16914232|NCT01389102|38023125|FG002|Overall Study|Protocol Violation|3|||
16914233|NCT01389102|38023126|FG003|Overall Study|Protocol Violation|0|||
16914234|NCT01389102|38023127|FG004|Overall Study|Protocol Violation|1|||
16914235|NCT01389102|38023128|FG005|Overall Study|Protocol Violation|1|||
16914236|NCT01389102|38023123|FG000|Overall Study|Withdrawal by Subject|7|||
16914237|NCT01389102|38023124|FG001|Overall Study|Withdrawal by Subject|4|||
16914238|NCT01389102|38023125|FG002|Overall Study|Withdrawal by Subject|9|||
16914239|NCT01389102|38023126|FG003|Overall Study|Withdrawal by Subject|2|||
16914240|NCT01389102|38023127|FG004|Overall Study|Withdrawal by Subject|3|||
16914241|NCT01389102|38023128|FG005|Overall Study|Withdrawal by Subject|3|||
16914242|NCT01389102|38023123|FG000|Overall Study|Subject Traveling Out of Country|0|||
16914243|NCT01389102|38023124|FG001|Overall Study|Subject Traveling Out of Country|0|||
16914244|NCT01389102|38023125|FG002|Overall Study|Subject Traveling Out of Country|0|||
16914245|NCT01389102|38023126|FG003|Overall Study|Subject Traveling Out of Country|1|||
16914246|NCT01389102|38023127|FG004|Overall Study|Subject Traveling Out of Country|0|||
16914247|NCT01389102|38023128|FG005|Overall Study|Subject Traveling Out of Country|0|||
16914248|NCT01389102|38023123|FG000|Overall Study|Subject Moved|2|||
16914249|NCT01389102|38023124|FG001|Overall Study|Subject Moved|0|||
16914250|NCT01389102|38023125|FG002|Overall Study|Subject Moved|1|||
16840242|NCT01943851|37784177|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16914251|NCT01389102|38023126|FG003|Overall Study|Subject Moved|0|||
16914252|NCT01389102|38023127|FG004|Overall Study|Subject Moved|0|||
16840243|NCT01943851|37784178|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840244|NCT01943851|37784179|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840245|NCT01943851|37784180|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840246|NCT01943851|37784181|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840247|NCT01943851|37784182|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840248|NCT01943851|37784183|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
16840249|NCT01943851|37784184|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840250|NCT01943851|37784185|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840251|NCT01943851|37784186|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840252|NCT01943851|37784187|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16840253|NCT01943851|37784170|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840254|NCT01943851|37784171|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840255|NCT01943851|37784172|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840256|NCT01943851|37784173|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840257|NCT01943851|37784174|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840258|NCT01943851|37784175|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840259|NCT01943851|37784176|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840260|NCT01943851|37784177|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840261|NCT01943851|37784178|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840262|NCT01943851|37784179|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840263|NCT01943851|37784180|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840264|NCT01943851|37784181|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840265|NCT01943851|37784182|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840266|NCT01943851|37784183|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840267|NCT01943851|37784184|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840268|NCT01943851|37784185|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
16840269|NCT01943851|37784186|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16914253|NCT01389102|38023128|FG005|Overall Study|Subject Moved|0|||
16914254|NCT01389102|38023123|FG000|Overall Study|Unavailable due to husband's illness|0|||
16914255|NCT01389102|38023124|FG001|Overall Study|Unavailable due to husband's illness|1|||
16914256|NCT01389102|38023125|FG002|Overall Study|Unavailable due to husband's illness|0|||
16914257|NCT01389102|38023126|FG003|Overall Study|Unavailable due to husband's illness|0|||
17016809|NCT00686998|38161472|FG001|Overall Study|Adverse Event|2|||
16840270|NCT01943851|37784187|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16840271|NCT01943851|37784170|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840272|NCT01943851|37784171|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840273|NCT01943851|37784172|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840274|NCT01943851|37784173|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840275|NCT01943851|37784174|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16914258|NCT01389102|38023127|FG004|Overall Study|Unavailable due to husband's illness|0|||
16914259|NCT01389102|38023128|FG005|Overall Study|Unavailable due to husband's illness|0|||
16914260|NCT01389102|38023123|FG000|Overall Study|Investigator Judgement|0|||
16914261|NCT01389102|38023124|FG001|Overall Study|Investigator Judgement|1|||
16914262|NCT01389102|38023125|FG002|Overall Study|Investigator Judgement|0|||
16914263|NCT01389102|38023126|FG003|Overall Study|Investigator Judgement|0|||
16914264|NCT01389102|38023127|FG004|Overall Study|Investigator Judgement|0|||
16914265|NCT01389102|38023128|FG005|Overall Study|Investigator Judgement|0|||
16914266|NCT01402284|38023148|FG000|Overall Study|Withdrawal consent|2|||
16914267|NCT01402284|38023148|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
16914268|NCT01402284|38023148|FG000|Overall Study|Physician Decision|1|||
16914269|NCT01402284|38023148|FG000|Overall Study|Disease progression on study|10|||
16914270|NCT01425528|38023154|FG000|Overall Study|Withdrawal by Subject|1|||
16914271|NCT01425528|38023155|FG001|Overall Study|Withdrawal by Subject|1|||
16914272|NCT01388790|38023161|FG000|Overall Study|Ongoing at data cut-off date|8|||
16914273|NCT01388478|38023165|FG000|Overall Study|Adverse Event|4|||
16914274|NCT01388478|38023165|FG000|Overall Study|Withdrawal by Subject|1|||
16914275|NCT01424670|38023171|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
16914276|NCT01424670|38023172|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
16914277|NCT01424670|38023171|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
16914278|NCT01424670|38023172|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
16914279|NCT01424670|38023171|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
16914280|NCT01424670|38023172|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
16914281|NCT01424670|38023171|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
16914282|NCT01424670|38023172|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
16914283|NCT01424670|38023171|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
16914284|NCT01424670|38023172|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
16914285|NCT01424670|38023171|FG000|Continuation Period|Adverse Event|13|||
16914286|NCT01424670|38023172|FG001|Continuation Period|Adverse Event|5|||
16914287|NCT01424670|38023171|FG000|Continuation Period|Lost to Follow-up|2|||
16914288|NCT01424670|38023172|FG001|Continuation Period|Lost to Follow-up|0|||
16914289|NCT01424670|38023171|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
16914290|NCT01424670|38023172|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
16914291|NCT01424670|38023171|FG000|Continuation Period|Physician Decision|5|||
16914292|NCT01424670|38023172|FG001|Continuation Period|Physician Decision|4|||
16914293|NCT01424670|38023171|FG000|Continuation Period|Withdrawal by Subject|13|||
16914294|NCT01424670|38023172|FG001|Continuation Period|Withdrawal by Subject|4|||
16914295|NCT01424514|38023180|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
16914296|NCT01424514|38023181|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
16914297|NCT01424514|38023180|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
16914298|NCT01424514|38023181|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
16914299|NCT01423812|38023194|FG000|Overall Study|Lost to Follow-up|2|||
16914300|NCT01423812|38023195|FG001|Overall Study|Lost to Follow-up|2|||
17016810|NCT00686998|38161473|FG002|Overall Study|Adverse Event|1|||
17016811|NCT00686998|38161471|FG000|Overall Study|Withdrawal by Subject|2|||
17016812|NCT00686998|38161472|FG001|Overall Study|Withdrawal by Subject|1|||
17016813|NCT00686998|38161473|FG002|Overall Study|Withdrawal by Subject|2|||
17016814|NCT00686998|38161471|FG000|Overall Study|Lack of Efficacy|7|||
17016815|NCT00686998|38161472|FG001|Overall Study|Lack of Efficacy|5|||
17016816|NCT00686998|38161473|FG002|Overall Study|Lack of Efficacy|0|||
17016817|NCT00686998|38161471|FG000|Overall Study|Other|0|||
17016818|NCT00686998|38161472|FG001|Overall Study|Other|0|||
17016819|NCT00686998|38161473|FG002|Overall Study|Other|1|||
16914301|NCT01423812|38023194|FG000|Overall Study|Withdrawal by Subject|1|||
16914302|NCT01423812|38023195|FG001|Overall Study|Withdrawal by Subject|2|||
16914303|NCT01400958|38023205|FG000|Overall Study|Physician Decision|0|||
16914304|NCT01400958|38023206|FG001|Overall Study|Physician Decision|1|||
16914305|NCT01400958|38023205|FG000|Overall Study|Withdrawal by Subject|0|||
16914306|NCT01400958|38023206|FG001|Overall Study|Withdrawal by Subject|1|||
16914307|NCT01400958|38023205|FG000|Overall Study|Adverse Event|1|||
16914308|NCT01400958|38023206|FG001|Overall Study|Adverse Event|0|||
16914309|NCT01388166|38023212|FG000|Overall Study|Adverse Event|16|||
16840276|NCT01943851|37784175|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16914310|NCT01388166|38023212|FG000|Overall Study|Lost to Follow-up|30|||
16914311|NCT01388166|38023212|FG000|Overall Study|Others than specified above|13|||
16914312|NCT01400412|38023218|FG000|Overall Study|Lost to Follow-up|4|||
16840277|NCT01943851|37784176|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840278|NCT01943851|37784177|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840279|NCT01943851|37784178|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840280|NCT01943851|37784179|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840281|NCT01943851|37784180|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840282|NCT01943851|37784181|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840283|NCT01943851|37784182|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840284|NCT01943851|37784183|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840285|NCT01943851|37784184|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16840286|NCT01943851|37784185|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
16840287|NCT01943851|37784186|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
16840288|NCT01943851|37784187|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
16840289|NCT01430104|37784228|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
16840290|NCT01990859|37784235|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
16840291|NCT01990859|37784235|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
16840292|NCT02093897|37784240|FG000|Overall Study|Physician Decision|1|||
16840293|NCT02093897|37784240|FG000|Overall Study|Planned age group closure - no's reached|17|||
16840294|NCT02093897|37784240|FG000|Overall Study|Adverse event, non-fatal|1|||
16840295|NCT01990313|37784251|FG000|Overall Study|Lost to Follow-up|1|||
16840296|NCT01947517|37784257|FG000|Overall Study|Withdrawal by Subject|1|||
16840297|NCT01947517|37784258|FG001|Overall Study|Withdrawal by Subject|1|||
16840298|NCT02006927|37784264|FG000|Overall Study|Adverse Event|2|||
16840299|NCT02006927|37784264|FG000|Overall Study|Withdrawal by Subject|1|||
16840300|NCT01947283|37784275|FG000|Overall Study|Death|1|||
16840301|NCT01947283|37784276|FG001|Overall Study|Death|1|||
16840302|NCT01947283|37784277|FG002|Overall Study|Death|1|||
16840303|NCT01947283|37784278|FG003|Overall Study|Death|0|||
16840304|NCT01947283|37784279|FG004|Overall Study|Death|0|||
16840305|NCT01947283|37784280|FG005|Overall Study|Death|0|||
16840306|NCT01947283|37784281|FG006|Overall Study|Death|0|||
16840307|NCT01947283|37784275|FG000|Overall Study|Lost to Follow-up|4|||
16840308|NCT01947283|37784276|FG001|Overall Study|Lost to Follow-up|6|||
16840309|NCT01947283|37784277|FG002|Overall Study|Lost to Follow-up|5|||
16840310|NCT01947283|37784278|FG003|Overall Study|Lost to Follow-up|5|||
16840311|NCT01947283|37784279|FG004|Overall Study|Lost to Follow-up|0|||
16840312|NCT01947283|37784280|FG005|Overall Study|Lost to Follow-up|2|||
16840313|NCT01947283|37784281|FG006|Overall Study|Lost to Follow-up|5|||
16840314|NCT01947283|37784275|FG000|Overall Study|Withdrawal by Subject|10|||
16840315|NCT01947283|37784276|FG001|Overall Study|Withdrawal by Subject|8|||
16840316|NCT01947283|37784277|FG002|Overall Study|Withdrawal by Subject|4|||
16914313|NCT01400412|38023219|FG001|Overall Study|Lost to Follow-up|7|||
16914314|NCT01400412|38023218|FG000|Overall Study|Withdrawal by Subject|3|||
16914315|NCT01400412|38023219|FG001|Overall Study|Withdrawal by Subject|4|||
16914316|NCT01400412|38023218|FG000|Overall Study|Unable to complete|3|||
16914317|NCT01400412|38023219|FG001|Overall Study|Unable to complete|3|||
16914318|NCT01400412|38023218|FG000|Overall Study|Never started study treatment|0|||
16914319|NCT01400412|38023219|FG001|Overall Study|Never started study treatment|3|||
16914320|NCT01422876|38023237|FG000|Week 24|Lost to Follow-up|1|||
16914321|NCT01422876|38023238|FG001|Week 24|Lost to Follow-up|1|||
16914322|NCT01422876|38023239|FG002|Week 24|Lost to Follow-up|2|||
16914323|NCT01422876|38023240|FG003|Week 24|Lost to Follow-up|4|||
16914324|NCT01422876|38023241|FG004|Week 24|Lost to Follow-up|2|||
16914325|NCT01422876|38023242|FG005|Week 24|Lost to Follow-up|0|||
16914326|NCT01422876|38023243|FG006|Week 24|Lost to Follow-up|1|||
16914327|NCT01422876|38023244|FG007|Week 24|Lost to Follow-up|3|||
16914328|NCT01422876|38023245|FG008|Week 24|Lost to Follow-up|3|||
16914329|NCT01422876|38023246|FG009|Week 24|Lost to Follow-up|4|||
16914330|NCT01422876|38023237|FG000|Week 24|Consent withdrawn|5|||
16914331|NCT01422876|38023238|FG001|Week 24|Consent withdrawn|1|||
16914332|NCT01422876|38023239|FG002|Week 24|Consent withdrawn|3|||
16914333|NCT01422876|38023240|FG003|Week 24|Consent withdrawn|4|||
16914334|NCT01422876|38023241|FG004|Week 24|Consent withdrawn|5|||
16914335|NCT01422876|38023242|FG005|Week 24|Consent withdrawn|6|||
16914336|NCT01422876|38023243|FG006|Week 24|Consent withdrawn|5|||
16914337|NCT01422876|38023244|FG007|Week 24|Consent withdrawn|4|||
16914338|NCT01422876|38023245|FG008|Week 24|Consent withdrawn|3|||
16914339|NCT01422876|38023246|FG009|Week 24|Consent withdrawn|6|||
16914340|NCT01422876|38023237|FG000|Week 24|Death|0|||
16914341|NCT01422876|38023238|FG001|Week 24|Death|1|||
16914342|NCT01422876|38023239|FG002|Week 24|Death|0|||
16914343|NCT01422876|38023240|FG003|Week 24|Death|0|||
16914344|NCT01422876|38023241|FG004|Week 24|Death|0|||
16914345|NCT01422876|38023242|FG005|Week 24|Death|0|||
16914346|NCT01422876|38023243|FG006|Week 24|Death|0|||
16914347|NCT01422876|38023244|FG007|Week 24|Death|0|||
16914348|NCT01422876|38023245|FG008|Week 24|Death|0|||
16840317|NCT01947283|37784278|FG003|Overall Study|Withdrawal by Subject|1|||
16840318|NCT01947283|37784279|FG004|Overall Study|Withdrawal by Subject|0|||
16914349|NCT01422876|38023246|FG009|Week 24|Death|0|||
16914350|NCT01422876|38023237|FG000|Week 52|Lost to Follow-up|3|||
16914351|NCT01422876|38023238|FG001|Week 52|Lost to Follow-up|5|||
16914352|NCT01422876|38023239|FG002|Week 52|Lost to Follow-up|7|||
16914353|NCT01422876|38023240|FG003|Week 52|Lost to Follow-up|5|||
16914354|NCT01422876|38023241|FG004|Week 52|Lost to Follow-up|8|||
16914355|NCT01422876|38023242|FG005|Week 52|Lost to Follow-up|5|||
16914356|NCT01422876|38023243|FG006|Week 52|Lost to Follow-up|5|||
16840319|NCT01947283|37784280|FG005|Overall Study|Withdrawal by Subject|0|||
16840320|NCT01947283|37784281|FG006|Overall Study|Withdrawal by Subject|2|||
16840321|NCT01947283|37784275|FG000|Overall Study|No Clinical Recording|12|||
16840322|NCT01947283|37784276|FG001|Overall Study|No Clinical Recording|6|||
16840323|NCT01947283|37784277|FG002|Overall Study|No Clinical Recording|8|||
16840324|NCT01947283|37784278|FG003|Overall Study|No Clinical Recording|10|||
16840325|NCT01947283|37784279|FG004|Overall Study|No Clinical Recording|0|||
16840326|NCT01947283|37784280|FG005|Overall Study|No Clinical Recording|0|||
16840327|NCT01947283|37784281|FG006|Overall Study|No Clinical Recording|0|||
16840328|NCT01947283|37784275|FG000|Overall Study|Non-coding Clinical Recording language|0|||
16914357|NCT01422876|38023244|FG007|Week 52|Lost to Follow-up|8|||
16914358|NCT01422876|38023245|FG008|Week 52|Lost to Follow-up|7|||
16914359|NCT01422876|38023246|FG009|Week 52|Lost to Follow-up|8|||
16914360|NCT01422876|38023237|FG000|Week 52|Consent withdrawn|9|||
16914361|NCT01422876|38023238|FG001|Week 52|Consent withdrawn|4|||
16914362|NCT01422876|38023239|FG002|Week 52|Consent withdrawn|6|||
16914363|NCT01422876|38023240|FG003|Week 52|Consent withdrawn|12|||
16914364|NCT01422876|38023241|FG004|Week 52|Consent withdrawn|7|||
16914365|NCT01422876|38023242|FG005|Week 52|Consent withdrawn|12|||
16914366|NCT01422876|38023243|FG006|Week 52|Consent withdrawn|10|||
16914367|NCT01422876|38023244|FG007|Week 52|Consent withdrawn|12|||
16914368|NCT01422876|38023245|FG008|Week 52|Consent withdrawn|13|||
16914369|NCT01422876|38023246|FG009|Week 52|Consent withdrawn|9|||
16914370|NCT01422876|38023237|FG000|Week 52|Death|0|||
16914371|NCT01422876|38023238|FG001|Week 52|Death|1|||
16914372|NCT01422876|38023239|FG002|Week 52|Death|0|||
16914373|NCT01422876|38023240|FG003|Week 52|Death|1|||
17016820|NCT00686998|38161471|FG000|Overall Study|Safety Reasons|1|||
16840329|NCT01947283|37784276|FG001|Overall Study|Non-coding Clinical Recording language|0|||
16840330|NCT01947283|37784277|FG002|Overall Study|Non-coding Clinical Recording language|0|||
16840331|NCT01947283|37784278|FG003|Overall Study|Non-coding Clinical Recording language|1|||
16840332|NCT01947283|37784279|FG004|Overall Study|Non-coding Clinical Recording language|0|||
16840333|NCT01947283|37784280|FG005|Overall Study|Non-coding Clinical Recording language|0|||
16840334|NCT01947283|37784281|FG006|Overall Study|Non-coding Clinical Recording language|0|||
16840335|NCT01947283|37784275|FG000|Overall Study|Missing Follow-up Assessment|2|||
16840336|NCT01947283|37784276|FG001|Overall Study|Missing Follow-up Assessment|2|||
16840337|NCT01947283|37784277|FG002|Overall Study|Missing Follow-up Assessment|3|||
16840338|NCT01947283|37784278|FG003|Overall Study|Missing Follow-up Assessment|0|||
16840339|NCT01947283|37784279|FG004|Overall Study|Missing Follow-up Assessment|0|||
16840340|NCT01947283|37784280|FG005|Overall Study|Missing Follow-up Assessment|2|||
16840341|NCT01947283|37784281|FG006|Overall Study|Missing Follow-up Assessment|0|||
16840342|NCT01947283|37784275|FG000|Overall Study|No patients were enrolled in study|0|||
16840343|NCT01947283|37784276|FG001|Overall Study|No patients were enrolled in study|0|||
16840344|NCT01947283|37784277|FG002|Overall Study|No patients were enrolled in study|0|||
16840345|NCT01947283|37784278|FG003|Overall Study|No patients were enrolled in study|0|||
16840346|NCT01947283|37784279|FG004|Overall Study|No patients were enrolled in study|0|||
16840347|NCT01947283|37784280|FG005|Overall Study|No patients were enrolled in study|3|||
16840348|NCT01947283|37784281|FG006|Overall Study|No patients were enrolled in study|1|||
16840349|NCT02006693|37784300|FG000|Overall Study|No Reason Specified|6|||
16840350|NCT02006693|37784301|FG001|Overall Study|No Reason Specified|8|||
16840351|NCT02006693|37784300|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
16840352|NCT02006693|37784301|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
16840353|NCT02006693|37784300|FG000|Overall Study|XEN Implant Explantation|0|||
16840354|NCT02006693|37784301|FG001|Overall Study|XEN Implant Explantation|1|||
16840355|NCT02006693|37784300|FG000|Overall Study|Death|2|||
16840356|NCT02006693|37784301|FG001|Overall Study|Death|2|||
16840357|NCT02006693|37784300|FG000|Overall Study|Lost to Follow-up|4|||
16840358|NCT02006693|37784301|FG001|Overall Study|Lost to Follow-up|1|||
16840359|NCT02006693|37784300|FG000|Overall Study|Patient Decision|4|||
16840360|NCT02006693|37784301|FG001|Overall Study|Patient Decision|0|||
16840361|NCT01947127|37784309|FG000|Overall Study|Protocol Violation|18|||
16840362|NCT01947127|37784310|FG001|Overall Study|Protocol Violation|38|||
16840363|NCT01947127|37784309|FG000|Overall Study|Withdrawal by Subject|1|||
16840364|NCT01947127|37784310|FG001|Overall Study|Withdrawal by Subject|1|||
16840365|NCT01947127|37784309|FG000|Overall Study|Data loss|4|||
16840366|NCT01947127|37784310|FG001|Overall Study|Data loss|4|||
16840367|NCT01976845|37784319|FG000|Overall Study|Physician Decision|8|||
16840368|NCT01976845|37784320|FG001|Overall Study|Physician Decision|8|||
16840369|NCT01976845|37784321|FG002|Overall Study|Physician Decision|3|||
16840370|NCT01989689|37784331|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
16914374|NCT01422876|38023241|FG004|Week 52|Death|0|||
16914375|NCT01422876|38023242|FG005|Week 52|Death|0|||
16914376|NCT01422876|38023243|FG006|Week 52|Death|1|||
16914377|NCT01422876|38023244|FG007|Week 52|Death|3|||
16914378|NCT01422876|38023245|FG008|Week 52|Death|1|||
16840371|NCT01989689|37784332|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
16840372|NCT01989689|37784331|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
16840373|NCT01989689|37784332|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
16840374|NCT01943539|37784340|FG000|Overall Study|Non-compliance with at-home intervention|4|||
16840375|NCT01943539|37784341|FG001|Overall Study|Non-compliance with at-home intervention|0|||
16840376|NCT01942993|37784348|FG000|Overall Study|Lost to Follow-up|1|||
16840377|NCT01942993|37784348|FG000|Overall Study|Physician Decision|1|||
16914379|NCT01422876|38023246|FG009|Week 52|Death|0|||
16840378|NCT01989455|37784357|FG000|Overall Study|Adverse Event|0|||
16840379|NCT01989455|37784358|FG001|Overall Study|Adverse Event|1|||
16840380|NCT01989455|37784359|FG002|Overall Study|Adverse Event|0|||
16840381|NCT01989455|37784360|FG003|Overall Study|Adverse Event|0|||
16840382|NCT01989455|37784361|FG004|Overall Study|Adverse Event|0|||
16840383|NCT01989455|37784357|FG000|Overall Study|Withdrawal by Subject|0|||
16840384|NCT01989455|37784358|FG001|Overall Study|Withdrawal by Subject|1|||
16840385|NCT01989455|37784359|FG002|Overall Study|Withdrawal by Subject|0|||
16840386|NCT01989455|37784360|FG003|Overall Study|Withdrawal by Subject|0|||
16840387|NCT01989455|37784361|FG004|Overall Study|Withdrawal by Subject|0|||
16840388|NCT01989455|37784357|FG000|Overall Study|Technical problems with infusion|0|||
16840389|NCT01989455|37784358|FG001|Overall Study|Technical problems with infusion|0|||
16840390|NCT01989455|37784359|FG002|Overall Study|Technical problems with infusion|1|||
16840391|NCT01989455|37784360|FG003|Overall Study|Technical problems with infusion|0|||
16840392|NCT01989455|37784361|FG004|Overall Study|Technical problems with infusion|1|||
16840393|NCT01942837|37784377|FG000|Overall Study|Death|1|||
16840394|NCT01942837|37784377|FG000|Overall Study|Symptomatic or radiographic progression|49|||
16840395|NCT01942837|37784377|FG000|Overall Study|Adverse Event|6|||
16840396|NCT01942837|37784377|FG000|Overall Study|Physician Decision|3|||
16840397|NCT01942837|37784377|FG000|Overall Study|Withdrawal by Subject|2|||
16840398|NCT01942837|37784377|FG000|Overall Study|Intercurrent Illness|1|||
16840399|NCT01942837|37784377|FG000|Overall Study|On treatment|3|||
16840400|NCT01942837|37784377|FG000|Overall Study|Never initiate the treatment|2|||
16840401|NCT01987895|37784384|FG000|Overall Study|Withdrawal by Subject|12|||
16840402|NCT01987895|37784385|FG001|Overall Study|Withdrawal by Subject|7|||
16840403|NCT01987895|37784384|FG000|Overall Study|Physician Decision|8|||
16840404|NCT01987895|37784385|FG001|Overall Study|Physician Decision|10|||
16840405|NCT01987895|37784384|FG000|Overall Study|Death|7|||
16840406|NCT01987895|37784385|FG001|Overall Study|Death|7|||
16840407|NCT01987895|37784384|FG000|Overall Study|Lost to Follow-up|3|||
16840408|NCT01987895|37784385|FG001|Overall Study|Lost to Follow-up|5|||
16914380|NCT01422720|38023264|FG000|Overall Study|Adverse Event|16|||
16914381|NCT01422720|38023264|FG000|Overall Study|Lack of Efficacy|1|||
16914382|NCT01422720|38023264|FG000|Overall Study|Withdrawal by Subject|4|||
16914383|NCT01422720|38023264|FG000|Overall Study|Ineligibility|1|||
16914384|NCT01387932|38023274|FG000|Randomized and Treated|Physician Decision|3|||
16914385|NCT01387932|38023275|FG001|Randomized and Treated|Physician Decision|2|||
16914386|NCT01387932|38023274|FG000|Randomized and Treated|Withdrawal by Subject|4|||
16914387|NCT01387932|38023275|FG001|Randomized and Treated|Withdrawal by Subject|2|||
16914388|NCT01387932|38023274|FG000|Survival Follow-up|Liver Transplant|24|||
16914389|NCT01387932|38023275|FG001|Survival Follow-up|Liver Transplant|28|||
16914390|NCT01387932|38023274|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
16914391|NCT01387932|38023275|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
16914392|NCT01387932|38023274|FG000|Survival Follow-up|Withdrawal by Subject|2|||
16914393|NCT01387932|38023275|FG001|Survival Follow-up|Withdrawal by Subject|4|||
17016821|NCT00686998|38161472|FG001|Overall Study|Safety Reasons|0|||
16840409|NCT01987895|37784384|FG000|Overall Study|randomized before giving IC|0|||
16840410|NCT01987895|37784385|FG001|Overall Study|randomized before giving IC|1|||
16840411|NCT02005445|37784393|FG000|Overall Study|Dual study enrollment|0|||
16840412|NCT02005445|37784394|FG001|Overall Study|Dual study enrollment|1|||
16840413|NCT01618669|37784402|FG000|Overall Study|Lost to Follow-up|1|||
16840414|NCT01618669|37784403|FG001|Overall Study|Lost to Follow-up|1|||
16840415|NCT01618669|37784402|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
16840416|NCT01618669|37784403|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
16840417|NCT01618669|37784402|FG000|Overall Study|Adverse Event|16|||
16840418|NCT01618669|37784403|FG001|Overall Study|Adverse Event|7|||
16840419|NCT01618669|37784402|FG000|Overall Study|Protocol Violation|5|||
16840420|NCT01618669|37784403|FG001|Overall Study|Protocol Violation|3|||
16840421|NCT01618669|37784402|FG000|Overall Study|Withdrawal by Subject|9|||
17016822|NCT00686998|38161473|FG002|Overall Study|Safety Reasons|0|||
16840422|NCT01618669|37784403|FG001|Overall Study|Withdrawal by Subject|9|||
16840423|NCT01618669|37784402|FG000|Overall Study|Miscellaneous Reason|0|||
16840424|NCT01618669|37784403|FG001|Overall Study|Miscellaneous Reason|1|||
16840425|NCT01390948|37784424|FG000|Overall Study|End of Study|1|||
16840426|NCT01390948|37784425|FG001|Overall Study|End of Study|0|||
16840427|NCT01390948|37784426|FG002|Overall Study|End of Study|0|||
16914394|NCT01387932|38023274|FG000|Survival Follow-up|Lost to Follow-up|6|||
16914395|NCT01387932|38023275|FG001|Survival Follow-up|Lost to Follow-up|5|||
16840428|NCT01390948|37784424|FG000|Overall Study|Withdrew consent|2|||
16840429|NCT01390948|37784425|FG001|Overall Study|Withdrew consent|2|||
16840430|NCT01390948|37784426|FG002|Overall Study|Withdrew consent|0|||
16840431|NCT01390948|37784424|FG000|Overall Study|Progressive Disease|2|||
16840432|NCT01390948|37784425|FG001|Overall Study|Progressive Disease|5|||
16840433|NCT01390948|37784426|FG002|Overall Study|Progressive Disease|0|||
16840434|NCT01390948|37784424|FG000|Overall Study|Death during follow-up|10|||
16840435|NCT01390948|37784425|FG001|Overall Study|Death during follow-up|11|||
16840436|NCT01390948|37784426|FG002|Overall Study|Death during follow-up|1|||
16840437|NCT02005211|37784440|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16840438|NCT02005211|37784441|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16914396|NCT01422408|38023283|FG000|Overall Study|Adverse Event|1|||
16914397|NCT01422408|38023283|FG000|Overall Study|Withdrawal by Subject|3|||
16914398|NCT01399788|38023287|FG000|First Intervention Period|Adverse Event|1|||
16914399|NCT01399788|38023288|FG001|First Intervention Period|Adverse Event|0|||
16914400|NCT01387542|38023294|FG000|Overall Study|Adverse Event|3|||
16914401|NCT01387542|38023294|FG000|Overall Study|Withdrawal by Subject|1|||
16914402|NCT01387542|38023294|FG000|Overall Study|Changed diagnosis|1|||
16914403|NCT01387542|38023294|FG000|Overall Study|Insufficient response|1|||
16914404|NCT01387542|38023294|FG000|Overall Study|Non-compliant|1|||
16914405|NCT01387542|38023294|FG000|Overall Study|Lost to Follow-up|1|||
16914406|NCT01387230|38023301|FG000|Overall Study|Adverse Event|0|||
16914407|NCT01387230|38023302|FG001|Overall Study|Adverse Event|1|||
16914408|NCT01387230|38023303|FG002|Overall Study|Adverse Event|3|||
16914409|NCT01387230|38023301|FG000|Overall Study|Lack of Efficacy|8|||
16914410|NCT01387230|38023302|FG001|Overall Study|Lack of Efficacy|5|||
16914411|NCT01387230|38023303|FG002|Overall Study|Lack of Efficacy|4|||
16914412|NCT01387230|38023301|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
16914413|NCT01387230|38023302|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
16914414|NCT01387230|38023303|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
16914415|NCT01387230|38023301|FG000|Overall Study|Lost to Follow-up|0|||
16914416|NCT01387230|38023302|FG001|Overall Study|Lost to Follow-up|0|||
16914417|NCT01387230|38023303|FG002|Overall Study|Lost to Follow-up|1|||
16914418|NCT01387230|38023301|FG000|Overall Study|Withdrawal by Subject|4|||
16914419|NCT01387230|38023302|FG001|Overall Study|Withdrawal by Subject|1|||
16914420|NCT01387230|38023303|FG002|Overall Study|Withdrawal by Subject|0|||
16914421|NCT01387074|38023311|FG000|Overall Study|Lost to Follow-up|7|||
16914422|NCT01387074|38023311|FG000|Overall Study|Lack of Efficacy|1|||
16914423|NCT01386606|38023319|FG000|Overall Study|Adverse Event|0|||
16914424|NCT01386606|38023320|FG001|Overall Study|Adverse Event|1|||
16914425|NCT01386606|38023321|FG002|Overall Study|Adverse Event|0|||
16914426|NCT01386606|38023322|FG003|Overall Study|Adverse Event|0|||
16914427|NCT01386606|38023319|FG000|Overall Study|Withdrawal by Subject|0|||
16914428|NCT01386606|38023320|FG001|Overall Study|Withdrawal by Subject|1|||
16840439|NCT02005211|37784442|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16840440|NCT02005211|37784443|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16914429|NCT01386606|38023321|FG002|Overall Study|Withdrawal by Subject|1|||
16914430|NCT01386606|38023322|FG003|Overall Study|Withdrawal by Subject|0|||
16914431|NCT01386606|38023319|FG000|Overall Study|Protocol Violation|1|||
16914432|NCT01386606|38023320|FG001|Overall Study|Protocol Violation|0|||
16914433|NCT01386606|38023321|FG002|Overall Study|Protocol Violation|1|||
16914434|NCT01386606|38023322|FG003|Overall Study|Protocol Violation|1|||
16914435|NCT01386606|38023319|FG000|Overall Study|Lost to Follow-up|2|||
16914436|NCT01386606|38023320|FG001|Overall Study|Lost to Follow-up|0|||
16914437|NCT01386606|38023321|FG002|Overall Study|Lost to Follow-up|0|||
16914438|NCT01386606|38023322|FG003|Overall Study|Lost to Follow-up|0|||
16914439|NCT01386606|38023319|FG000|Overall Study|Subject incarcerated|0|||
16914440|NCT01386606|38023320|FG001|Overall Study|Subject incarcerated|1|||
16914441|NCT01386606|38023321|FG002|Overall Study|Subject incarcerated|0|||
16914442|NCT01386606|38023322|FG003|Overall Study|Subject incarcerated|0|||
16914443|NCT01386606|38023319|FG000|Overall Study|Unable to draw PK|1|||
16914444|NCT01386606|38023320|FG001|Overall Study|Unable to draw PK|0|||
16914445|NCT01386606|38023321|FG002|Overall Study|Unable to draw PK|0|||
16914446|NCT01386606|38023322|FG003|Overall Study|Unable to draw PK|0|||
16840441|NCT02005211|37784444|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
16840442|NCT02005211|37784445|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16840443|NCT02005211|37784446|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16840444|NCT01429792|37784469|FG000|Overall Study|Other Reasons|67|||
16840445|NCT01429792|37784469|FG000|Overall Study|Unknown Disposition|94|||
16840446|NCT01429792|37784469|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
16840447|NCT01429792|37784469|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
16840448|NCT01429792|37784469|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
16914447|NCT01386606|38023319|FG000|Overall Study|T levels too high|0|||
16914448|NCT01386606|38023320|FG001|Overall Study|T levels too high|1|||
16914449|NCT01386606|38023321|FG002|Overall Study|T levels too high|1|||
16914450|NCT01386606|38023322|FG003|Overall Study|T levels too high|0|||
17016823|NCT00848718|38161494|FG000|Overall Study|Adverse Event|2|||
16914451|NCT01385748|38023339|FG000|Overall Study|Withdrawal by Subject|7|||
16914452|NCT01385748|38023340|FG001|Overall Study|Withdrawal by Subject|4|||
16914453|NCT01385748|38023341|FG002|Overall Study|Withdrawal by Subject|5|||
16914454|NCT01385748|38023339|FG000|Overall Study|Noncompliance|3|||
16914455|NCT01385748|38023340|FG001|Overall Study|Noncompliance|1|||
16914456|NCT01385748|38023341|FG002|Overall Study|Noncompliance|6|||
16914457|NCT01385748|38023339|FG000|Overall Study|Other|1|||
16914458|NCT01385748|38023340|FG001|Overall Study|Other|7|||
16840449|NCT01429792|37784469|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
16840450|NCT01429792|37784469|FG000|Overall Study|Withdrawal by Subject|70|||
16840451|NCT01429792|37784469|FG000|Overall Study|Lost to Follow-up|88|||
16840452|NCT01409434|37784473|FG000|Overall Study|Protocol Violation|4|||
16914459|NCT01385748|38023341|FG002|Overall Study|Other|1|||
16914460|NCT01385748|38023339|FG000|Overall Study|Adverse Event|4|||
16914461|NCT01385748|38023340|FG001|Overall Study|Adverse Event|2|||
16914462|NCT01385748|38023341|FG002|Overall Study|Adverse Event|1|||
16914463|NCT01397448|38023356|FG000|Overall Study|Adverse Event|4|||
16914464|NCT01397448|38023357|FG001|Overall Study|Adverse Event|4|||
16914465|NCT01397448|38023358|FG002|Overall Study|Adverse Event|6|||
16914466|NCT01397448|38023356|FG000|Overall Study|Withdrawal by Subject|4|||
16914467|NCT01397448|38023357|FG001|Overall Study|Withdrawal by Subject|4|||
16914468|NCT01397448|38023358|FG002|Overall Study|Withdrawal by Subject|3|||
16914469|NCT01397448|38023356|FG000|Overall Study|Lack of Efficacy|2|||
16914470|NCT01397448|38023357|FG001|Overall Study|Lack of Efficacy|0|||
16914471|NCT01397448|38023358|FG002|Overall Study|Lack of Efficacy|5|||
16914472|NCT01397448|38023356|FG000|Overall Study|Other|8|||
16914473|NCT01397448|38023357|FG001|Overall Study|Other|7|||
16914474|NCT01397448|38023358|FG002|Overall Study|Other|4|||
16914475|NCT01385202|38023366|FG000|Overall Study|Lost to Follow-up|6|||
16914476|NCT01385202|38023366|FG000|Overall Study|Not Eligible|11|||
16914477|NCT01385202|38023366|FG000|Overall Study|Withdrawn|1|||
16914478|NCT01384734|38023377|FG000|Overall Study|Adverse Event|0|||
16914479|NCT01384734|38023378|FG001|Overall Study|Adverse Event|3|||
16914480|NCT01384734|38023379|FG002|Overall Study|Adverse Event|0|||
16914481|NCT01384734|38023380|FG003|Overall Study|Adverse Event|2|||
16914482|NCT01384734|38023381|FG004|Overall Study|Adverse Event|7|||
16840453|NCT01940887|37784479|FG000|Year 1|Protocol Violation|0|||
16840454|NCT01940887|37784480|FG001|Year 1|Protocol Violation|1|||
16840455|NCT01940887|37784479|FG000|Year 1|Physician Decision|7|||
16840456|NCT01940887|37784480|FG001|Year 1|Physician Decision|3|||
16840457|NCT01940887|37784479|FG000|Year 1|Death|5|||
16840458|NCT01940887|37784480|FG001|Year 1|Death|3|||
16840459|NCT01940887|37784479|FG000|Year 1|Adverse Event|7|||
16840460|NCT01940887|37784480|FG001|Year 1|Adverse Event|6|||
16840461|NCT01940887|37784479|FG000|Year 1|Withdrawal by Subject|18|||
16840462|NCT01940887|37784480|FG001|Year 1|Withdrawal by Subject|9|||
16840463|NCT01940887|37784479|FG000|Year 1|Lost to Follow-up|2|||
16840464|NCT01940887|37784480|FG001|Year 1|Lost to Follow-up|1|||
16840465|NCT01940887|37784479|FG000|Year 2|Physician Decision|8|||
16840466|NCT01940887|37784480|FG001|Year 2|Physician Decision|1|||
16840467|NCT01940887|37784479|FG000|Year 2|Death|0|||
16840468|NCT01940887|37784480|FG001|Year 2|Death|2|||
16840469|NCT01940887|37784479|FG000|Year 2|Sponsor Decision, early termination|192|||
16840470|NCT01940887|37784480|FG001|Year 2|Sponsor Decision, early termination|203|||
16840471|NCT01940887|37784479|FG000|Year 2|Adverse Event|8|||
16840472|NCT01940887|37784480|FG001|Year 2|Adverse Event|2|||
16840473|NCT01940887|37784479|FG000|Year 2|Withdrawal by Subject|8|||
16840474|NCT01940887|37784480|FG001|Year 2|Withdrawal by Subject|8|||
16840475|NCT01940887|37784479|FG000|Year 2|Lost to Follow-up|1|||
16840476|NCT01940887|37784480|FG001|Year 2|Lost to Follow-up|6|||
16840477|NCT01925612|37784491|FG000|Overall Study|Progressive Disease|1|||
16840478|NCT01925612|37784492|FG001|Overall Study|Progressive Disease|1|||
16840479|NCT01925612|37784493|FG002|Overall Study|Progressive Disease|1|||
16840480|NCT01925612|37784494|FG003|Overall Study|Progressive Disease|0|||
16840481|NCT01925612|37784495|FG004|Overall Study|Progressive Disease|0|||
16840482|NCT01925612|37784491|FG000|Overall Study|Adverse Event|3|||
16840483|NCT01925612|37784492|FG001|Overall Study|Adverse Event|3|||
16840484|NCT01925612|37784493|FG002|Overall Study|Adverse Event|0|||
16840485|NCT01925612|37784494|FG003|Overall Study|Adverse Event|1|||
16840486|NCT01925612|37784495|FG004|Overall Study|Adverse Event|2|||
16840487|NCT02093663|37784507|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
16840488|NCT02093663|37784508|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
16840489|NCT02093663|37784509|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
16840490|NCT02093663|37784510|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
16840491|NCT02093663|37784511|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
16840492|NCT02093663|37784507|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
16840493|NCT02093663|37784508|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16914483|NCT01384734|38023377|FG000|Overall Study|Death|1|||
16914484|NCT01384734|38023378|FG001|Overall Study|Death|0|||
16914485|NCT01384734|38023379|FG002|Overall Study|Death|1|||
16914486|NCT01384734|38023380|FG003|Overall Study|Death|0|||
16914487|NCT01384734|38023381|FG004|Overall Study|Death|0|||
16840494|NCT02093663|37784509|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16840495|NCT02093663|37784510|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16840496|NCT02093663|37784511|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16840497|NCT02093663|37784507|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
16840498|NCT02093663|37784508|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
16840499|NCT02093663|37784509|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
16840500|NCT02093663|37784510|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
16840501|NCT02093663|37784511|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
16840502|NCT02093663|37784507|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
16840503|NCT02093663|37784508|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
16840504|NCT02093663|37784509|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
16840505|NCT02093663|37784510|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
16840506|NCT02093663|37784511|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
16914488|NCT01384734|38023377|FG000|Overall Study|Continuation criteria not met|0|||
16914489|NCT01384734|38023378|FG001|Overall Study|Continuation criteria not met|0|||
16914490|NCT01384734|38023379|FG002|Overall Study|Continuation criteria not met|1|||
16840507|NCT02093663|37784507|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16840508|NCT02093663|37784508|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16840509|NCT02093663|37784509|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
16840510|NCT02093663|37784510|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16840511|NCT02093663|37784511|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16840512|NCT02093663|37784507|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
16840513|NCT02093663|37784508|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
16840514|NCT02093663|37784509|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
16840515|NCT02093663|37784510|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
16840516|NCT02093663|37784511|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
16840517|NCT02093663|37784507|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
16840518|NCT02093663|37784508|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
16840519|NCT02093663|37784509|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
16840520|NCT02093663|37784510|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
16840521|NCT02093663|37784511|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
16840522|NCT02093663|37784507|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
16840523|NCT02093663|37784508|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
16840524|NCT02093663|37784509|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
16840525|NCT02093663|37784510|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
16840526|NCT02093663|37784511|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
16840527|NCT02093663|37784507|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
16840528|NCT02093663|37784508|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
16840529|NCT02093663|37784509|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
16840530|NCT02093663|37784510|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
16840531|NCT02093663|37784511|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
16840532|NCT01408888|37784528|FG000|First Intervention|Adverse Event|0|||
16840533|NCT01408888|37784529|FG001|First Intervention|Adverse Event|1|||
16840534|NCT01408888|37784528|FG000|First Intervention|Withdrawal by Subject|0|||
16840535|NCT01408888|37784529|FG001|First Intervention|Withdrawal by Subject|2|||
16840536|NCT01408888|37784528|FG000|Second Intervention|Withdrawal by Subject|1|||
16840537|NCT01408888|37784529|FG001|Second Intervention|Withdrawal by Subject|0|||
16840538|NCT01408888|37784528|FG000|Second Intervention|Adverse Event|1|||
16840539|NCT01408888|37784529|FG001|Second Intervention|Adverse Event|0|||
16840540|NCT01918033|37784548|FG000|Overall Study|Adverse Event|1|||
16840541|NCT01918033|37784549|FG001|Overall Study|Adverse Event|0|||
16840542|NCT01918033|37784550|FG002|Overall Study|Adverse Event|2|||
16840543|NCT01918033|37784548|FG000|Overall Study|Lost to Follow-up|0|||
16840544|NCT01918033|37784549|FG001|Overall Study|Lost to Follow-up|1|||
16840545|NCT01918033|37784550|FG002|Overall Study|Lost to Follow-up|0|||
16840546|NCT01918033|37784548|FG000|Overall Study|Protocol Violation|2|||
16840547|NCT01918033|37784549|FG001|Overall Study|Protocol Violation|0|||
16840548|NCT01918033|37784550|FG002|Overall Study|Protocol Violation|1|||
16840549|NCT01918033|37784548|FG000|Overall Study|Withdrawal by Subject|2|||
16840550|NCT01918033|37784549|FG001|Overall Study|Withdrawal by Subject|1|||
16840551|NCT01918033|37784550|FG002|Overall Study|Withdrawal by Subject|0|||
16840552|NCT01408732|37784558|FG000|Overall Study|Withdrawal by Subject|2|||
16840553|NCT01408732|37784559|FG001|Overall Study|Withdrawal by Subject|2|||
16840554|NCT01390402|37784565|FG000|Overall Study|Death|1|||
16840555|NCT01390402|37784565|FG000|Overall Study|Disease Progression|4|||
16840556|NCT01976299|37784571|FG000|Overall Study|Withdrawal by Subject|3|||
16840557|NCT01976299|37784572|FG001|Overall Study|Withdrawal by Subject|1|||
16840558|NCT01976299|37784571|FG000|Overall Study|Death|4|||
16840559|NCT01976299|37784572|FG001|Overall Study|Death|2|||
16840560|NCT01976299|37784571|FG000|Overall Study|Lost to Follow-up|7|||
16840561|NCT01976299|37784572|FG001|Overall Study|Lost to Follow-up|1|||
16840562|NCT01976299|37784571|FG000|Overall Study|See clarification above in comments|9|||
16840563|NCT01976299|37784572|FG001|Overall Study|See clarification above in comments|2|||
16840564|NCT01428076|37784580|FG000|Overall Study|Adverse Event|0|||
16840565|NCT01428076|37784581|FG001|Overall Study|Adverse Event|1|||
16840566|NCT01900652|37784591|FG000|Overall Study|Progressive Disease|1|||
16840567|NCT01900652|37784592|FG001|Overall Study|Progressive Disease|0|||
16914491|NCT01384734|38023380|FG003|Overall Study|Continuation criteria not met|1|||
16914492|NCT01384734|38023381|FG004|Overall Study|Continuation criteria not met|0|||
16914493|NCT01384734|38023377|FG000|Overall Study|Lack of Efficacy|3|||
16914494|NCT01384734|38023378|FG001|Overall Study|Lack of Efficacy|7|||
16914495|NCT01384734|38023379|FG002|Overall Study|Lack of Efficacy|4|||
16914496|NCT01384734|38023380|FG003|Overall Study|Lack of Efficacy|4|||
16914497|NCT01384734|38023381|FG004|Overall Study|Lack of Efficacy|2|||
16914498|NCT01384734|38023377|FG000|Overall Study|Lost to Follow-up|5|||
16914499|NCT01384734|38023378|FG001|Overall Study|Lost to Follow-up|3|||
16914500|NCT01384734|38023379|FG002|Overall Study|Lost to Follow-up|3|||
16914501|NCT01384734|38023380|FG003|Overall Study|Lost to Follow-up|8|||
16914502|NCT01384734|38023381|FG004|Overall Study|Lost to Follow-up|5|||
16914503|NCT01384734|38023377|FG000|Overall Study|Non-compliance with study drug|1|||
16914504|NCT01384734|38023378|FG001|Overall Study|Non-compliance with study drug|2|||
16914505|NCT01384734|38023379|FG002|Overall Study|Non-compliance with study drug|6|||
16914506|NCT01384734|38023380|FG003|Overall Study|Non-compliance with study drug|0|||
16914507|NCT01384734|38023381|FG004|Overall Study|Non-compliance with study drug|2|||
16914508|NCT01384734|38023377|FG000|Overall Study|Pregnancy|0|||
16914509|NCT01384734|38023378|FG001|Overall Study|Pregnancy|1|||
16914510|NCT01384734|38023379|FG002|Overall Study|Pregnancy|0|||
16914511|NCT01384734|38023380|FG003|Overall Study|Pregnancy|0|||
16914512|NCT01384734|38023381|FG004|Overall Study|Pregnancy|1|||
16914513|NCT01384734|38023377|FG000|Overall Study|Sponsor terminated|0|||
16914514|NCT01384734|38023378|FG001|Overall Study|Sponsor terminated|0|||
16914515|NCT01384734|38023379|FG002|Overall Study|Sponsor terminated|0|||
16914516|NCT01384734|38023380|FG003|Overall Study|Sponsor terminated|0|||
16914517|NCT01384734|38023381|FG004|Overall Study|Sponsor terminated|1|||
16914518|NCT01384734|38023377|FG000|Overall Study|Withdrawal by Subject|5|||
16914519|NCT01384734|38023378|FG001|Overall Study|Withdrawal by Subject|5|||
16914520|NCT01384734|38023379|FG002|Overall Study|Withdrawal by Subject|6|||
16914521|NCT01384734|38023380|FG003|Overall Study|Withdrawal by Subject|7|||
16914522|NCT01384734|38023381|FG004|Overall Study|Withdrawal by Subject|9|||
16914523|NCT01384734|38023377|FG000|Overall Study|Investigator relocating|0|||
16914524|NCT01384734|38023378|FG001|Overall Study|Investigator relocating|2|||
16914525|NCT01384734|38023379|FG002|Overall Study|Investigator relocating|0|||
16914526|NCT01384734|38023380|FG003|Overall Study|Investigator relocating|3|||
16914527|NCT01384734|38023381|FG004|Overall Study|Investigator relocating|1|||
16914528|NCT01384734|38023377|FG000|Overall Study|Unable to come back for visit|1|||
16914529|NCT01384734|38023378|FG001|Overall Study|Unable to come back for visit|0|||
16914530|NCT01384734|38023379|FG002|Overall Study|Unable to come back for visit|1|||
16914531|NCT01384734|38023380|FG003|Overall Study|Unable to come back for visit|1|||
16840568|NCT01900652|37784591|FG000|Overall Study|Consent withdrawn by subject|1|||
16840569|NCT01900652|37784592|FG001|Overall Study|Consent withdrawn by subject|1|||
16840570|NCT01900652|37784591|FG000|Overall Study|Death|3|||
16840571|NCT01900652|37784592|FG001|Overall Study|Death|0|||
16840572|NCT01900652|37784591|FG000|Overall Study|Adverse Event|2|||
16840573|NCT01900652|37784592|FG001|Overall Study|Adverse Event|1|||
16840574|NCT01900652|37784591|FG000|Overall Study|Physician Decision|1|||
16840575|NCT01900652|37784592|FG001|Overall Study|Physician Decision|1|||
16840576|NCT02093351|37784606|FG000|Part A|Adverse Event|0|||
16840577|NCT02093351|37784607|FG001|Part A|Adverse Event|1|||
16840578|NCT02093351|37784608|FG002|Part A|Adverse Event|1|||
16840579|NCT02093351|37784609|FG003|Part A|Adverse Event|0|||
16840580|NCT02093351|37784606|FG000|Part A|Condition under investigation worsened|2|||
16840581|NCT02093351|37784607|FG001|Part A|Condition under investigation worsened|0|||
16840582|NCT02093351|37784608|FG002|Part A|Condition under investigation worsened|2|||
16840583|NCT02093351|37784609|FG003|Part A|Condition under investigation worsened|0|||
16840584|NCT02093351|37784606|FG000|Part A|Death|0|||
16840585|NCT02093351|37784607|FG001|Part A|Death|1|||
16914532|NCT01384734|38023381|FG004|Overall Study|Unable to come back for visit|0|||
16914533|NCT01384734|38023377|FG000|Overall Study|Prison|0|||
16914534|NCT01384734|38023378|FG001|Overall Study|Prison|0|||
16914535|NCT01384734|38023379|FG002|Overall Study|Prison|1|||
16914536|NCT01384734|38023380|FG003|Overall Study|Prison|0|||
16914537|NCT01384734|38023381|FG004|Overall Study|Prison|0|||
16914538|NCT01384734|38023377|FG000|Overall Study|As per Exclusion criteria|0|||
16840586|NCT02093351|37784608|FG002|Part A|Death|0|||
16840587|NCT02093351|37784609|FG003|Part A|Death|0|||
16840588|NCT02093351|37784606|FG000|Part B|Patient decision|0|||
16840589|NCT02093351|37784607|FG001|Part B|Patient decision|0|||
16840590|NCT02093351|37784608|FG002|Part B|Patient decision|0|||
16840591|NCT02093351|37784609|FG003|Part B|Patient decision|3|||
16840592|NCT02093351|37784606|FG000|Part B|Disease progression|0|||
16914539|NCT01384734|38023378|FG001|Overall Study|As per Exclusion criteria|1|||
16914540|NCT01384734|38023379|FG002|Overall Study|As per Exclusion criteria|0|||
16914541|NCT01384734|38023380|FG003|Overall Study|As per Exclusion criteria|0|||
16914542|NCT01384734|38023381|FG004|Overall Study|As per Exclusion criteria|0|||
16914543|NCT01384734|38023377|FG000|Overall Study|Missed End of treatment visit|0|||
16914544|NCT01384734|38023378|FG001|Overall Study|Missed End of treatment visit|0|||
16914545|NCT01384734|38023379|FG002|Overall Study|Missed End of treatment visit|0|||
16840593|NCT02093351|37784607|FG001|Part B|Disease progression|0|||
16840594|NCT02093351|37784608|FG002|Part B|Disease progression|0|||
16840595|NCT02093351|37784609|FG003|Part B|Disease progression|4|||
16840596|NCT02093351|37784606|FG000|Part B|Complete response|0|||
16840597|NCT02093351|37784607|FG001|Part B|Complete response|0|||
16840598|NCT02093351|37784608|FG002|Part B|Complete response|0|||
16840599|NCT02093351|37784609|FG003|Part B|Complete response|1|||
16840600|NCT02093351|37784606|FG000|Part B|Adverse event + disease progression|0|||
16840601|NCT02093351|37784607|FG001|Part B|Adverse event + disease progression|0|||
16914546|NCT01384734|38023380|FG003|Overall Study|Missed End of treatment visit|1|||
16914547|NCT01384734|38023381|FG004|Overall Study|Missed End of treatment visit|0|||
16914548|NCT01384734|38023377|FG000|Overall Study|Adhesion problem|0|||
16914549|NCT01384734|38023378|FG001|Overall Study|Adhesion problem|0|||
16914550|NCT01384734|38023379|FG002|Overall Study|Adhesion problem|0|||
16914551|NCT01384734|38023380|FG003|Overall Study|Adhesion problem|1|||
16914552|NCT01384734|38023381|FG004|Overall Study|Adhesion problem|0|||
16914553|NCT01384734|38023377|FG000|Overall Study|Early termination|0|||
16914554|NCT01384734|38023378|FG001|Overall Study|Early termination|0|||
16914555|NCT01384734|38023379|FG002|Overall Study|Early termination|0|||
16914556|NCT01384734|38023380|FG003|Overall Study|Early termination|0|||
16914557|NCT01384734|38023381|FG004|Overall Study|Early termination|1|||
16914558|NCT01384734|38023377|FG000|Overall Study|Physician Decision|1|||
16914559|NCT01384734|38023378|FG001|Overall Study|Physician Decision|0|||
16914560|NCT01384734|38023379|FG002|Overall Study|Physician Decision|0|||
16914561|NCT01384734|38023380|FG003|Overall Study|Physician Decision|0|||
16914562|NCT01384734|38023381|FG004|Overall Study|Physician Decision|0|||
16914563|NCT01396512|38023392|FG000|Overall Study|Withdrawal by Subject|0|||
16914564|NCT01396512|38023393|FG001|Overall Study|Withdrawal by Subject|1|||
16914565|NCT01396434|38023402|FG000|Overall Study|Lost to Follow-up|1|||
16914566|NCT01396434|38023403|FG001|Overall Study|Lost to Follow-up|0|||
16914567|NCT01396434|38023404|FG002|Overall Study|Lost to Follow-up|0|||
16914568|NCT01396434|38023402|FG000|Overall Study|Other|10|||
16914569|NCT01396434|38023403|FG001|Overall Study|Other|0|||
16914570|NCT01396434|38023404|FG002|Overall Study|Other|0|||
16914571|NCT01383954|38023412|FG000|Overall Study|Lack of Efficacy|2|||
16914572|NCT01383954|38023412|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
16914573|NCT01383954|38023412|FG000|Overall Study|Adverse Event|1|||
16914574|NCT01383954|38023412|FG000|Overall Study|Reason Not Specified|9|||
16914575|NCT01383486|38023416|FG000|Overall Study|Lost to Follow-up|10|||
16914576|NCT01383486|38023416|FG000|Overall Study|Incomplete information for analysis|2|||
16914577|NCT01383486|38023416|FG000|Overall Study|Did not take any product|6|||
16914578|NCT01383174|38023423|FG000|3 Month Assessment|Death|0|||
16914579|NCT01383174|38023424|FG001|3 Month Assessment|Death|1|||
16914580|NCT01383174|38023423|FG000|3 Month Assessment|Lost to Follow-up|2|||
16914581|NCT01383174|38023424|FG001|3 Month Assessment|Lost to Follow-up|0|||
16914582|NCT01383174|38023423|FG000|3 Month Assessment|Refused to complete|4|||
16914583|NCT01383174|38023424|FG001|3 Month Assessment|Refused to complete|0|||
16914584|NCT01383174|38023423|FG000|6 Month Assessment|Lost to Follow-up|1|||
16914585|NCT01383174|38023424|FG001|6 Month Assessment|Lost to Follow-up|1|||
16914586|NCT01383174|38023423|FG000|6 Month Assessment|Refused to complete|4|||
16914587|NCT01383174|38023424|FG001|6 Month Assessment|Refused to complete|0|||
16914588|NCT01396278|38023435|FG000|Overall Study|Adverse Event|0|||
16914589|NCT01396278|38023436|FG001|Overall Study|Adverse Event|0|||
16914590|NCT01396278|38023437|FG002|Overall Study|Adverse Event|0|||
16914591|NCT01396278|38023438|FG003|Overall Study|Adverse Event|2|||
16914592|NCT01396278|38023439|FG004|Overall Study|Adverse Event|0|||
16914593|NCT01396278|38023435|FG000|Overall Study|Withdraw due to trial termination|2|||
16914594|NCT01396278|38023436|FG001|Overall Study|Withdraw due to trial termination|1|||
16914595|NCT01396278|38023437|FG002|Overall Study|Withdraw due to trial termination|1|||
16914596|NCT01396278|38023438|FG003|Overall Study|Withdraw due to trial termination|0|||
16914597|NCT01396278|38023439|FG004|Overall Study|Withdraw due to trial termination|2|||
16914598|NCT01383096|38023454|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
16914599|NCT01383096|38023455|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
16914600|NCT01383096|38023456|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
16914601|NCT01383096|38023454|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
16914602|NCT01383096|38023455|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
16914603|NCT01383096|38023456|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
17016824|NCT00848718|38161495|FG001|Overall Study|Adverse Event|2|||
16840602|NCT02093351|37784608|FG002|Part B|Adverse event + disease progression|0|||
16914604|NCT01383096|38023454|FG000|Third Intervention (8 Days)|Elevated AST|0|||
16914605|NCT01383096|38023455|FG001|Third Intervention (8 Days)|Elevated AST|1|||
16914606|NCT01383096|38023456|FG002|Third Intervention (8 Days)|Elevated AST|0|||
16914607|NCT01383096|38023454|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
16914608|NCT01383096|38023455|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
16914609|NCT01383096|38023456|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
16914610|NCT01383096|38023454|FG000|Third Intervention (8 Days)|Adverse Event|1|||
16914611|NCT01383096|38023455|FG001|Third Intervention (8 Days)|Adverse Event|0|||
16914612|NCT01383096|38023456|FG002|Third Intervention (8 Days)|Adverse Event|0|||
16914613|NCT01383096|38023454|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
16914614|NCT01383096|38023455|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
16914615|NCT01383096|38023456|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
16914616|NCT01383096|38023454|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
16914617|NCT01383096|38023455|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
16914618|NCT01383096|38023456|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
16914619|NCT01383096|38023454|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
16914620|NCT01383096|38023455|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
16914621|NCT01383096|38023456|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
16914622|NCT01383096|38023454|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
16914623|NCT01383096|38023455|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
16914624|NCT01383096|38023456|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
16914625|NCT01383096|38023454|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
16914626|NCT01383096|38023455|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
16914627|NCT01383096|38023456|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
16914628|NCT01383096|38023454|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
16914629|NCT01383096|38023455|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
16914630|NCT01383096|38023456|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
16914631|NCT01383018|38023493|FG000|Overall Study|Adverse Event|14|||
16914632|NCT01383018|38023493|FG000|Overall Study|Death|10|||
16914633|NCT01383018|38023493|FG000|Overall Study|Lost to Follow-up|5|||
16914634|NCT01383018|38023493|FG000|Overall Study|Physician Decision|5|||
16914635|NCT01383018|38023493|FG000|Overall Study|Withdrawal by Subject|9|||
16914636|NCT01383018|38023493|FG000|Overall Study|Subject not implanted|76|||
16914637|NCT01383018|38023493|FG000|Overall Study|Missed Visit|247|||
16914638|NCT01383018|38023493|FG000|Overall Study|Site closed early-not compliance related|7|||
16914639|NCT01383018|38023493|FG000|Overall Study|Patient moved away from site|1|||
16914640|NCT01383018|38023493|FG000|Overall Study|Subject Incarcerated|1|||
16840603|NCT02093351|37784609|FG003|Part B|Adverse event + disease progression|1|||
16840604|NCT02093351|37784606|FG000|Part B|Lack of therapeutic response|0|||
16840605|NCT02093351|37784607|FG001|Part B|Lack of therapeutic response|0|||
16840606|NCT02093351|37784608|FG002|Part B|Lack of therapeutic response|0|||
16840607|NCT02093351|37784609|FG003|Part B|Lack of therapeutic response|12|||
16840608|NCT02093351|37784606|FG000|Part B|Condition under investigation worsened|0|||
16840609|NCT02093351|37784607|FG001|Part B|Condition under investigation worsened|0|||
16840610|NCT02093351|37784608|FG002|Part B|Condition under investigation worsened|0|||
16840611|NCT02093351|37784609|FG003|Part B|Condition under investigation worsened|39|||
16840612|NCT02093351|37784606|FG000|Part B|Adverse Event|0|||
16840613|NCT02093351|37784607|FG001|Part B|Adverse Event|0|||
16840614|NCT02093351|37784608|FG002|Part B|Adverse Event|0|||
16840615|NCT02093351|37784609|FG003|Part B|Adverse Event|2|||
16840616|NCT02093351|37784606|FG000|Part B|Death|0|||
16840617|NCT02093351|37784607|FG001|Part B|Death|0|||
16840618|NCT02093351|37784608|FG002|Part B|Death|0|||
16840619|NCT02093351|37784609|FG003|Part B|Death|1|||
16840620|NCT02092961|37784648|FG000|Overall Study|Not reported|1|||
16840621|NCT02092961|37784649|FG001|Overall Study|Not reported|0|||
16840622|NCT02092961|37784650|FG002|Overall Study|Not reported|1|||
16840623|NCT02092961|37784648|FG000|Overall Study|Study stopped|13|||
16840624|NCT02092961|37784649|FG001|Overall Study|Study stopped|9|||
16840625|NCT02092961|37784650|FG002|Overall Study|Study stopped|12|||
16840626|NCT02092961|37784648|FG000|Overall Study|Lack of therapeutic response|2|||
16840627|NCT02092961|37784649|FG001|Overall Study|Lack of therapeutic response|1|||
16840628|NCT02092961|37784650|FG002|Overall Study|Lack of therapeutic response|3|||
16840629|NCT02092961|37784648|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
16840630|NCT02092961|37784649|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
16840631|NCT02092961|37784650|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
16840632|NCT02092961|37784648|FG000|Overall Study|Adverse Event|2|||
16840633|NCT02092961|37784649|FG001|Overall Study|Adverse Event|4|||
16840634|NCT02092961|37784650|FG002|Overall Study|Adverse Event|0|||
16914641|NCT01382940|38023507|FG000|Overall Study|Adverse Event|19|||
16914642|NCT01382940|38023507|FG000|Overall Study|Lost to Follow-up|4|||
16840635|NCT01898078|37784661|FG000|Overall Study|Progressive Disease|1|||
16840636|NCT01898078|37784662|FG001|Overall Study|Progressive Disease|5|||
16840637|NCT01898078|37784661|FG000|Overall Study|Adverse Event|2|||
16840638|NCT01898078|37784662|FG001|Overall Study|Adverse Event|1|||
16840639|NCT01898078|37784661|FG000|Overall Study|Withdrawal by Subject|1|||
16840640|NCT01898078|37784662|FG001|Overall Study|Withdrawal by Subject|1|||
16840641|NCT01898078|37784661|FG000|Overall Study|Symptomatic Deterioration|2|||
16840642|NCT01898078|37784662|FG001|Overall Study|Symptomatic Deterioration|0|||
16840643|NCT01898078|37784661|FG000|Overall Study|Reason not Specified|0|||
16840644|NCT01898078|37784662|FG001|Overall Study|Reason not Specified|1|||
16840645|NCT01987817|37784672|FG000|Overall Study|Adverse Event|4|||
16840646|NCT01987817|37784673|FG001|Overall Study|Adverse Event|0|||
16840647|NCT01987817|37784672|FG000|Overall Study|Withdrawal by Subject|1|||
16840648|NCT01987817|37784673|FG001|Overall Study|Withdrawal by Subject|1|||
16840649|NCT01987817|37784672|FG000|Overall Study|Physician Decision|1|||
16840650|NCT01987817|37784673|FG001|Overall Study|Physician Decision|0|||
16840651|NCT01940497|37784682|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
16840652|NCT01940497|37784683|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
16840653|NCT01940497|37784682|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
16840654|NCT01940497|37784683|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
16840655|NCT01940497|37784682|FG000|Overall Study|Violation of Entry Criteria|1|||
16840656|NCT01940497|37784683|FG001|Overall Study|Violation of Entry Criteria|1|||
16840657|NCT01940497|37784682|FG000|Overall Study|Refused Treatment|1|||
16840658|NCT01940497|37784683|FG001|Overall Study|Refused Treatment|3|||
16840659|NCT01940497|37784682|FG000|Overall Study|Withdrew Consent|6|||
16840660|NCT01940497|37784683|FG001|Overall Study|Withdrew Consent|2|||
16840661|NCT01940497|37784682|FG000|Overall Study|Administrative/Other|1|||
16840662|NCT01940497|37784683|FG001|Overall Study|Administrative/Other|1|||
16840663|NCT01924754|37784703|FG000|Overall Study|Lost to Follow-up|1|||
16840664|NCT01924754|37784704|FG001|Overall Study|Lost to Follow-up|2|||
16840665|NCT01924754|37784705|FG002|Overall Study|Lost to Follow-up|1|||
16840666|NCT01924754|37784703|FG000|Overall Study|Pregnancy|0|||
16840667|NCT01924754|37784704|FG001|Overall Study|Pregnancy|1|||
16840668|NCT01924754|37784705|FG002|Overall Study|Pregnancy|2|||
16840669|NCT01924364|37784716|FG000|Overall Study|Physician Decision|3|||
16840670|NCT01987505|37784733|FG000|Overall Study|Other|9|||
16840671|NCT01987505|37784733|FG000|Overall Study|Withdrawal by Subject|2|||
16840672|NCT01987505|37784733|FG000|Overall Study|Other Reason|2|||
16840673|NCT01987505|37784733|FG000|Overall Study|Lost to Follow-up|15|||
16840674|NCT01987505|37784733|FG000|Overall Study|Investigator Decision|2|||
16840675|NCT01987505|37784733|FG000|Overall Study|Death|4|||
16840676|NCT01923896|37784741|FG000|Overall Study|Adverse Event|1|||
16840677|NCT01923896|37784742|FG001|Overall Study|Adverse Event|0|||
16840678|NCT02004353|37784748|FG000|Overall Study|Voluntary participation|1334|||
16840679|NCT01938625|37784754|FG000|Overall Study|Withdrawal by Subject|0|||
16840680|NCT01938625|37784755|FG001|Overall Study|Withdrawal by Subject|1|||
16840681|NCT01938625|37784754|FG000|Overall Study|Adverse Event|0|||
16840682|NCT01938625|37784755|FG001|Overall Study|Adverse Event|1|||
16840683|NCT01975675|37784765|FG000|Overall Study|Death|0|||
16840684|NCT01975675|37784766|FG001|Overall Study|Death|1|||
16840685|NCT01975675|37784767|FG002|Overall Study|Death|0|||
16840686|NCT01975675|37784768|FG003|Overall Study|Death|0|||
16840687|NCT01975285|37784780|FG000|Overall Study|Failed Block and follow up|2|||
16840688|NCT01975285|37784781|FG001|Overall Study|Failed Block and follow up|2|||
16840689|NCT01974895|37784789|FG000|Overall Study|Protocol Violation|1|||
16914643|NCT01382940|38023507|FG000|Overall Study|Physician Decision|7|||
16914644|NCT01382940|38023507|FG000|Overall Study|Withdrawal by Subject|23|||
16914645|NCT01382940|38023507|FG000|Overall Study|Protocol Violation|20|||
16914646|NCT01381926|38023513|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
16914647|NCT01381926|38023514|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
16914648|NCT01381926|38023513|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
16914649|NCT01381926|38023514|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
16914650|NCT01395888|38023524|FG000|2-week Run-in Period|Adverse Event|2|||
16914651|NCT01395888|38023525|FG001|2-week Run-in Period|Adverse Event|0|||
16914652|NCT01395888|38023526|FG002|2-week Run-in Period|Adverse Event|0|||
16914653|NCT01395888|38023524|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
16914654|NCT01395888|38023525|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
16914655|NCT01395888|38023526|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
16914656|NCT01395888|38023524|FG000|2-week Run-in Period|Lost to Follow-up|1|||
16914657|NCT01395888|38023525|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16914658|NCT01395888|38023526|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16914659|NCT01395888|38023524|FG000|2-week Run-in Period|Protocol Violation|2|||
16914660|NCT01395888|38023525|FG001|2-week Run-in Period|Protocol Violation|0|||
16914661|NCT01395888|38023526|FG002|2-week Run-in Period|Protocol Violation|0|||
16914662|NCT01395888|38023524|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
16914663|NCT01395888|38023525|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16914664|NCT01395888|38023526|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16914665|NCT01395888|38023524|FG000|Treatment Period (TP)|Adverse Event|0|||
16914666|NCT01395888|38023525|FG001|Treatment Period (TP)|Adverse Event|7|||
16914667|NCT01395888|38023526|FG002|Treatment Period (TP)|Adverse Event|6|||
16914668|NCT01395888|38023524|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
16914669|NCT01395888|38023525|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
16914670|NCT01395888|38023526|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
16914671|NCT01395888|38023524|FG000|Treatment Period (TP)|Protocol Violation|0|||
16840690|NCT01974895|37784790|FG001|Overall Study|Protocol Violation|0|||
16840691|NCT01974895|37784789|FG000|Overall Study|Lost to Follow-up|4|||
16840692|NCT01974895|37784790|FG001|Overall Study|Lost to Follow-up|6|||
16840693|NCT01974895|37784789|FG000|Overall Study|Withdrawal by Subject|0|||
16840694|NCT01974895|37784790|FG001|Overall Study|Withdrawal by Subject|1|||
16840695|NCT01974895|37784789|FG000|Overall Study|Other (Missed Visit)|1|||
16840696|NCT01974895|37784790|FG001|Overall Study|Other (Missed Visit)|0|||
16840697|NCT01974895|37784789|FG000|Overall Study|Other (Reason unknown)|9|||
16840698|NCT01974895|37784790|FG001|Overall Study|Other (Reason unknown)|8|||
16840699|NCT01974817|37784796|FG000|Overall Study|Death|4|||
16840700|NCT01974817|37784796|FG000|Overall Study|Lost to Follow-up|2|||
16840701|NCT01974817|37784796|FG000|Overall Study|Protocol Violation|2|||
16840702|NCT01915849|37784804|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
16840703|NCT01915849|37784805|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
16840704|NCT01915849|37784806|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
16840705|NCT01915849|37784807|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
16840706|NCT01915849|37784804|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
16840707|NCT01915849|37784805|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16840708|NCT01915849|37784806|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16840709|NCT01915849|37784807|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16840710|NCT01915771|37784817|FG000|Day 1|Withdrawal by Subject|1|||
16840711|NCT01915771|37784817|FG000|Day 15|Withdrawal by Subject|1|||
16840712|NCT01938391|37784825|FG000|6 Month Follow up|Withdrawal by Subject|1|||
16840713|NCT01938391|37784825|FG000|12 Month Follow up|Physician Decision|1|||
16840714|NCT01938391|37784825|FG000|12 Month Follow up|Withdrawal by Subject|1|||
16840715|NCT01915303|37784829|FG000|Core Phase|Adverse Event|7|||
16840716|NCT01915303|37784829|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
16840717|NCT01915303|37784829|FG000|Core Phase|Death|2|||
16840718|NCT01915303|37784829|FG000|Core Phase|Protocol Violation|2|||
16840719|NCT01915303|37784829|FG000|Core Phase|Abnormal lab value|1|||
16840720|NCT01915303|37784829|FG000|Core Phase|Withdrawal by Subject|1|||
16840721|NCT01915303|37784829|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
16914672|NCT01395888|38023525|FG001|Treatment Period (TP)|Protocol Violation|1|||
16914673|NCT01395888|38023526|FG002|Treatment Period (TP)|Protocol Violation|5|||
16914674|NCT01395888|38023524|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
16914675|NCT01395888|38023525|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
16914676|NCT01395888|38023526|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
16914677|NCT01395888|38023524|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
16914678|NCT01395888|38023525|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
16914679|NCT01395888|38023526|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
16914680|NCT01395810|38023536|FG000|Overall Study|Adverse Event|0|||
16914681|NCT01395810|38023537|FG001|Overall Study|Adverse Event|1|||
16914682|NCT01395810|38023538|FG002|Overall Study|Adverse Event|0|||
16914683|NCT01395810|38023539|FG003|Overall Study|Adverse Event|0|||
16914684|NCT01395810|38023536|FG000|Overall Study|Lack of Efficacy|0|||
16914685|NCT01395810|38023537|FG001|Overall Study|Lack of Efficacy|1|||
16840722|NCT01915303|37784829|FG000|Extension Phase|Withdrawal by Subject|4|||
16840723|NCT01915303|37784829|FG000|Extension Phase|Adverse Event|3|||
16840724|NCT01915303|37784829|FG000|Extension Phase|Death|1|||
16840725|NCT01915303|37784829|FG000|Extension Phase|Protocol Violation|1|||
16840726|NCT01987427|37784836|FG000|Overall Study|Adverse Event|4|||
16840727|NCT01987427|37784837|FG001|Overall Study|Adverse Event|2|||
16840728|NCT01987427|37784838|FG002|Overall Study|Adverse Event|8|||
16914686|NCT01395810|38023538|FG002|Overall Study|Lack of Efficacy|0|||
16914687|NCT01395810|38023539|FG003|Overall Study|Lack of Efficacy|0|||
16914688|NCT01395810|38023536|FG000|Overall Study|Withdrawal criteria|0|||
16914689|NCT01395810|38023537|FG001|Overall Study|Withdrawal criteria|2|||
16914690|NCT01395810|38023538|FG002|Overall Study|Withdrawal criteria|0|||
16914691|NCT01395810|38023539|FG003|Overall Study|Withdrawal criteria|0|||
16914692|NCT01395810|38023536|FG000|Overall Study|Unclassified|2|||
16914693|NCT01395810|38023537|FG001|Overall Study|Unclassified|0|||
16914694|NCT01395810|38023538|FG002|Overall Study|Unclassified|0|||
16914695|NCT01395810|38023539|FG003|Overall Study|Unclassified|0|||
16914696|NCT01381692|38023552|FG000|Overall Study|Adverse Event|1|||
16914697|NCT01381692|38023553|FG001|Overall Study|Adverse Event|0|||
16914698|NCT01381692|38023554|FG002|Overall Study|Adverse Event|0|||
16914699|NCT01381692|38023555|FG003|Overall Study|Adverse Event|0|||
16914700|NCT01381692|38023556|FG004|Overall Study|Adverse Event|0|||
16914701|NCT01381692|38023557|FG005|Overall Study|Adverse Event|0|||
16914702|NCT01395030|38023565|FG000|Overall Study|Did not complete FCH PET/CT|7|||
16914703|NCT01381068|38023573|FG000|Overall Study|Death|1|||
16914704|NCT01381068|38023574|FG001|Overall Study|Death|0|||
16914705|NCT01394952|38023582|FG000|Overall Study|Lost to Follow-up|0|||
16914706|NCT01394952|38023583|FG001|Overall Study|Lost to Follow-up|5|||
16914707|NCT01394952|38023582|FG000|Overall Study|Withdrawal by Subject|10|||
16914708|NCT01394952|38023583|FG001|Overall Study|Withdrawal by Subject|5|||
16914709|NCT01394952|38023582|FG000|Overall Study|Physician Decision|2|||
16914710|NCT01394952|38023583|FG001|Overall Study|Physician Decision|0|||
16914711|NCT01394952|38023582|FG000|Overall Study|Sponsor Decision|5|||
16914712|NCT01394952|38023583|FG001|Overall Study|Sponsor Decision|7|||
16914713|NCT01394718|38023591|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
16914714|NCT01394718|38023592|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
16914715|NCT01394250|38023600|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
16914716|NCT01394250|38023601|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
16914717|NCT01394250|38023600|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
16914718|NCT01394250|38023601|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
16914719|NCT01380990|38023609|FG000|Overall Study|Treatment Failure|1|||
16914720|NCT01380990|38023610|FG001|Overall Study|Treatment Failure|0|||
16914721|NCT01380990|38023609|FG000|Overall Study|Death|0|||
16914722|NCT01380990|38023610|FG001|Overall Study|Death|1|||
16914723|NCT01380834|38023622|FG000|Overall Study|Physician Decision|1|||
16914724|NCT01380834|38023623|FG001|Overall Study|Physician Decision|0|||
16914725|NCT00214422|38023632|FG000|Overall Study|Physician Decision|2|||
16840729|NCT01987427|37784836|FG000|Overall Study|Lost to Follow-up|6|||
16840730|NCT01987427|37784837|FG001|Overall Study|Lost to Follow-up|6|||
16840731|NCT01987427|37784838|FG002|Overall Study|Lost to Follow-up|9|||
16840732|NCT01987427|37784836|FG000|Overall Study|Withdrawal by Subject|2|||
16840733|NCT01987427|37784837|FG001|Overall Study|Withdrawal by Subject|1|||
16840734|NCT01987427|37784838|FG002|Overall Study|Withdrawal by Subject|3|||
16840735|NCT01987427|37784836|FG000|Overall Study|Lack of Efficacy|1|||
16840736|NCT01987427|37784837|FG001|Overall Study|Lack of Efficacy|0|||
16840737|NCT01987427|37784838|FG002|Overall Study|Lack of Efficacy|0|||
16840738|NCT01987427|37784836|FG000|Overall Study|Other|1|||
16914726|NCT00214422|38023633|FG001|Overall Study|Physician Decision|0|||
16914727|NCT00214422|38023634|FG002|Overall Study|Physician Decision|0|||
16840739|NCT01987427|37784837|FG001|Overall Study|Other|1|||
16840740|NCT01987427|37784838|FG002|Overall Study|Other|0|||
16840741|NCT01937299|37784848|FG000|Overall Study|Adverse Event|13|||
16840742|NCT01937299|37784849|FG001|Overall Study|Adverse Event|0|||
16840743|NCT01937299|37784848|FG000|Overall Study|Lack of Efficacy|0|||
16914728|NCT00214422|38023632|FG000|Overall Study|Developed esophageal ca|1|||
16914729|NCT00214422|38023633|FG001|Overall Study|Developed esophageal ca|0|||
16914730|NCT00214422|38023634|FG002|Overall Study|Developed esophageal ca|0|||
16914731|NCT00214422|38023632|FG000|Overall Study|Pt taken off study|1|||
16914732|NCT00214422|38023633|FG001|Overall Study|Pt taken off study|1|||
16914733|NCT00214422|38023634|FG002|Overall Study|Pt taken off study|0|||
16914734|NCT00214422|38023632|FG000|Overall Study|Disease progression on study|1|||
16914735|NCT00214422|38023633|FG001|Overall Study|Disease progression on study|0|||
16914736|NCT00214422|38023634|FG002|Overall Study|Disease progression on study|0|||
16914737|NCT00214422|38023632|FG000|Overall Study|Unable to make a radiation treatment|0|||
16914738|NCT00214422|38023633|FG001|Overall Study|Unable to make a radiation treatment|0|||
16914739|NCT00214422|38023634|FG002|Overall Study|Unable to make a radiation treatment|1|||
16914740|NCT00218634|38023648|FG000|Overall Study|Lost to Follow-up|8|||
16914741|NCT00218634|38023649|FG001|Overall Study|Lost to Follow-up|15|||
16914742|NCT00217620|38023658|FG000|Overall Study|Adverse Event|2|||
16914743|NCT00217620|38023658|FG000|Overall Study|Progression|31|||
16840744|NCT01937299|37784849|FG001|Overall Study|Lack of Efficacy|4|||
16840745|NCT01937299|37784848|FG000|Overall Study|Withdrawal by Subject|1|||
16840746|NCT01937299|37784849|FG001|Overall Study|Withdrawal by Subject|0|||
16840747|NCT02003963|37784858|FG000|Overall Study|Lost to Follow-up|2|||
16914744|NCT00217620|38023658|FG000|Overall Study|Not Protocol Specified|4|||
16914745|NCT00217620|38023658|FG000|Overall Study|Ineligible|13|||
16914746|NCT00217620|38023658|FG000|Overall Study|Never received treatment|1|||
16914747|NCT00217464|38023666|FG000|Overall Study|Progression|15|||
16914748|NCT00217464|38023666|FG000|Overall Study|Other|2|||
16914749|NCT00214500|38023670|FG000|Treatment Period|Adverse Event|1|||
16840748|NCT02003963|37784859|FG001|Overall Study|Lost to Follow-up|1|||
16840749|NCT01606761|37784870|FG000|Prior to Week 24|Lost to Follow-up|0|||
16840750|NCT01606761|37784871|FG001|Prior to Week 24|Lost to Follow-up|3|||
16840751|NCT01606761|37784872|FG002|Prior to Week 24|Lost to Follow-up|2|||
16840752|NCT01606761|37784873|FG003|Prior to Week 24|Lost to Follow-up|0|||
16840753|NCT01606761|37784874|FG004|Prior to Week 24|Lost to Follow-up|0|||
16840754|NCT01606761|37784870|FG000|Prior to Week 24|Withdrawal by Subject|12|||
16840755|NCT01606761|37784871|FG001|Prior to Week 24|Withdrawal by Subject|10|||
16840756|NCT01606761|37784872|FG002|Prior to Week 24|Withdrawal by Subject|9|||
16840757|NCT01606761|37784873|FG003|Prior to Week 24|Withdrawal by Subject|0|||
16840758|NCT01606761|37784874|FG004|Prior to Week 24|Withdrawal by Subject|0|||
16840759|NCT01606761|37784870|FG000|Prior to Week 24|Adverse Event|11|||
16840760|NCT01606761|37784871|FG001|Prior to Week 24|Adverse Event|18|||
16840761|NCT01606761|37784872|FG002|Prior to Week 24|Adverse Event|22|||
16840762|NCT01606761|37784873|FG003|Prior to Week 24|Adverse Event|0|||
16840763|NCT01606761|37784874|FG004|Prior to Week 24|Adverse Event|0|||
16840764|NCT01606761|37784870|FG000|Prior to Week 24|Lack of Efficacy|15|||
16840765|NCT01606761|37784871|FG001|Prior to Week 24|Lack of Efficacy|14|||
16840766|NCT01606761|37784872|FG002|Prior to Week 24|Lack of Efficacy|8|||
16840767|NCT01606761|37784873|FG003|Prior to Week 24|Lack of Efficacy|0|||
16840768|NCT01606761|37784874|FG004|Prior to Week 24|Lack of Efficacy|0|||
16840769|NCT01606761|37784870|FG000|Prior to Week 24|Physician Decision|0|||
16840770|NCT01606761|37784871|FG001|Prior to Week 24|Physician Decision|3|||
16840771|NCT01606761|37784872|FG002|Prior to Week 24|Physician Decision|1|||
16840772|NCT01606761|37784873|FG003|Prior to Week 24|Physician Decision|0|||
16840773|NCT01606761|37784874|FG004|Prior to Week 24|Physician Decision|0|||
16840774|NCT01606761|37784870|FG000|Prior to Week 24|Other|4|||
16840775|NCT01606761|37784871|FG001|Prior to Week 24|Other|7|||
16840776|NCT01606761|37784872|FG002|Prior to Week 24|Other|5|||
16840777|NCT01606761|37784873|FG003|Prior to Week 24|Other|0|||
16840778|NCT01606761|37784874|FG004|Prior to Week 24|Other|0|||
16840779|NCT01606761|37784870|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
16840780|NCT01606761|37784871|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
16840781|NCT01606761|37784872|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
16840782|NCT01606761|37784873|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
16840783|NCT01606761|37784874|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
16840784|NCT01606761|37784870|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
16840785|NCT01606761|37784871|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
16840786|NCT01606761|37784872|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
16840787|NCT01606761|37784873|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
16840788|NCT01606761|37784874|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
16840789|NCT01606761|37784870|FG000|Week 24 to Week 52|Adverse Event|0|||
16840790|NCT01606761|37784871|FG001|Week 24 to Week 52|Adverse Event|11|||
16840791|NCT01606761|37784872|FG002|Week 24 to Week 52|Adverse Event|14|||
16840792|NCT01606761|37784873|FG003|Week 24 to Week 52|Adverse Event|3|||
16840793|NCT01606761|37784874|FG004|Week 24 to Week 52|Adverse Event|15|||
16840794|NCT01606761|37784870|FG000|Week 24 to Week 52|Death|0|||
16840795|NCT01606761|37784871|FG001|Week 24 to Week 52|Death|0|||
16840796|NCT01606761|37784872|FG002|Week 24 to Week 52|Death|2|||
16840797|NCT01606761|37784873|FG003|Week 24 to Week 52|Death|1|||
16840798|NCT01606761|37784874|FG004|Week 24 to Week 52|Death|0|||
16840799|NCT01606761|37784870|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
16840800|NCT01606761|37784871|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
16840801|NCT01606761|37784872|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
16840802|NCT01606761|37784873|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
16840803|NCT01606761|37784874|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
16840804|NCT01606761|37784870|FG000|Week 24 to Week 52|Physician Decision|0|||
16840805|NCT01606761|37784871|FG001|Week 24 to Week 52|Physician Decision|1|||
16840806|NCT01606761|37784872|FG002|Week 24 to Week 52|Physician Decision|1|||
16840807|NCT01606761|37784873|FG003|Week 24 to Week 52|Physician Decision|0|||
16840808|NCT01606761|37784874|FG004|Week 24 to Week 52|Physician Decision|0|||
16840809|NCT01606761|37784870|FG000|Week 24 to Week 52|Other|0|||
16840810|NCT01606761|37784871|FG001|Week 24 to Week 52|Other|1|||
16840811|NCT01606761|37784872|FG002|Week 24 to Week 52|Other|5|||
16914750|NCT00214500|38023670|FG000|Extension Period|Withdrawal by Subject|2|||
16914751|NCT00211536|38023679|FG000|Overall Study|Withdrawal by Subject|2|||
16914752|NCT00211536|38023680|FG001|Overall Study|Withdrawal by Subject|2|||
16914753|NCT00211536|38023679|FG000|Overall Study|Physician Decision|0|||
16914754|NCT00211536|38023680|FG001|Overall Study|Physician Decision|5|||
16914755|NCT00211536|38023679|FG000|Overall Study|Adverse Event|2|||
16914756|NCT00211536|38023680|FG001|Overall Study|Adverse Event|0|||
16914757|NCT04194528|38023686|FG000|Overall Study|Adverse Event|1|||
17016825|NCT00848718|38161496|FG002|Overall Study|Adverse Event|1|||
16840812|NCT01606761|37784873|FG003|Week 24 to Week 52|Other|2|||
16840813|NCT01606761|37784874|FG004|Week 24 to Week 52|Other|2|||
16840814|NCT01606761|37784870|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
16914758|NCT04193202|38023692|FG000|Overall Study|Adverse Event|2|||
16914759|NCT04193202|38023693|FG001|Overall Study|Adverse Event|1|||
16914760|NCT04193202|38023692|FG000|Overall Study|Death|0|||
16914761|NCT04193202|38023693|FG001|Overall Study|Death|1|||
16914762|NCT04193202|38023692|FG000|Overall Study|Physician Decision|1|||
16914763|NCT04193202|38023693|FG001|Overall Study|Physician Decision|1|||
16914764|NCT04193202|38023692|FG000|Overall Study|Protocol Violation|2|||
16914765|NCT04193202|38023693|FG001|Overall Study|Protocol Violation|2|||
16914766|NCT04193202|38023692|FG000|Overall Study|Withdrawal by Subject|11|||
16914767|NCT04193202|38023693|FG001|Overall Study|Withdrawal by Subject|5|||
16914768|NCT03028740|38023777|FG000|Overall Study|Did not Receive Study Drug|4|||
16914769|NCT03028740|38023778|FG001|Overall Study|Did not Receive Study Drug|5|||
16914770|NCT03028740|38023777|FG000|Overall Study|Adverse Event|8|||
16914771|NCT03028740|38023778|FG001|Overall Study|Adverse Event|26|||
16914772|NCT03028740|38023777|FG000|Overall Study|Lack of Efficacy|0|||
16914773|NCT03028740|38023778|FG001|Overall Study|Lack of Efficacy|1|||
16914774|NCT03028740|38023777|FG000|Overall Study|Withdrawal by Subject|48|||
16914775|NCT03028740|38023778|FG001|Overall Study|Withdrawal by Subject|101|||
16914776|NCT03028740|38023777|FG000|Overall Study|Lost to Follow-up|30|||
16914777|NCT03028740|38023778|FG001|Overall Study|Lost to Follow-up|54|||
16914778|NCT03028740|38023777|FG000|Overall Study|Physician Decision|4|||
16914779|NCT03028740|38023778|FG001|Overall Study|Physician Decision|11|||
16914780|NCT03028740|38023777|FG000|Overall Study|Protocol Violation|4|||
16914781|NCT03028740|38023778|FG001|Overall Study|Protocol Violation|8|||
16914782|NCT03028740|38023777|FG000|Overall Study|Non-compliance with Study Drug|0|||
16914783|NCT03028740|38023778|FG001|Overall Study|Non-compliance with Study Drug|2|||
16914784|NCT03028740|38023777|FG000|Overall Study|Study Terminated by Sponsor|467|||
16914785|NCT03028740|38023778|FG001|Overall Study|Study Terminated by Sponsor|917|||
16914786|NCT03028740|38023777|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
16914787|NCT03028740|38023778|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
16914788|NCT03028740|38023777|FG000|Overall Study|Reason not Specified|1|||
16914789|NCT03028740|38023778|FG001|Overall Study|Reason not Specified|5|||
16914790|NCT02980692|38023805|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
16914791|NCT02980692|38023806|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
16914792|NCT02980692|38023807|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
16914793|NCT02980692|38023808|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
16914794|NCT02980692|38023809|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
16914795|NCT02980692|38023805|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
16914796|NCT02980692|38023806|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
16914797|NCT02980692|38023807|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
16914798|NCT02980692|38023808|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
16914799|NCT02980692|38023809|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
16914800|NCT02980692|38023805|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
16914801|NCT02980692|38023806|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
16914802|NCT02980692|38023807|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
16914803|NCT02980692|38023808|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
16914804|NCT02980692|38023809|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
16914805|NCT02980692|38023805|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
16840815|NCT01606761|37784871|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
16840816|NCT01606761|37784872|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
16840817|NCT01606761|37784873|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
16840818|NCT01606761|37784874|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
16914806|NCT02980692|38023806|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
16914807|NCT02980692|38023807|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
16914808|NCT02980692|38023808|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
16914809|NCT02980692|38023809|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
16914810|NCT02980692|38023805|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
16914811|NCT02980692|38023806|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
16840819|NCT01606761|37784870|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
16840820|NCT01606761|37784871|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
16840821|NCT01606761|37784872|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
16840822|NCT01606761|37784873|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
16914812|NCT02980692|38023807|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
16914813|NCT02980692|38023808|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
16914814|NCT02980692|38023809|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
16914815|NCT02980692|38023805|FG000|Double Blind Placebo Controlled Period|Other|1|||
17016826|NCT00848718|38161497|FG003|Overall Study|Adverse Event|1|||
16840823|NCT01606761|37784874|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
16840824|NCT01606761|37784870|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
16840825|NCT01606761|37784871|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
16914816|NCT02980692|38023806|FG001|Double Blind Placebo Controlled Period|Other|0|||
16914817|NCT02980692|38023807|FG002|Double Blind Placebo Controlled Period|Other|0|||
16914818|NCT02980692|38023808|FG003|Double Blind Placebo Controlled Period|Other|0|||
16914819|NCT02980692|38023809|FG004|Double Blind Placebo Controlled Period|Other|1|||
16914820|NCT02980692|38023805|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
16914821|NCT02980692|38023806|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
16914822|NCT02980692|38023807|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
16914823|NCT02980692|38023808|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
16914824|NCT02980692|38023809|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
16914825|NCT02980692|38023805|FG000|Double-blind Follow-up Period|Adverse Event|0|||
16914826|NCT02980692|38023806|FG001|Double-blind Follow-up Period|Adverse Event|0|||
16914827|NCT02980692|38023807|FG002|Double-blind Follow-up Period|Adverse Event|0|||
16914828|NCT02980692|38023808|FG003|Double-blind Follow-up Period|Adverse Event|1|||
16914829|NCT02980692|38023809|FG004|Double-blind Follow-up Period|Adverse Event|1|||
16914830|NCT02980692|38023805|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
16914831|NCT02980692|38023806|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
16914832|NCT02980692|38023807|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
16914833|NCT02980692|38023808|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
16914834|NCT02980692|38023809|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
16914835|NCT02980692|38023805|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
16914836|NCT02980692|38023806|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
16914837|NCT02980692|38023807|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
16914838|NCT02980692|38023808|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
16914839|NCT02980692|38023809|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
16914840|NCT02980692|38023805|FG000|Double-blind Follow-up Period|Pregnancy|0|||
16914841|NCT02980692|38023806|FG001|Double-blind Follow-up Period|Pregnancy|0|||
16914842|NCT02980692|38023807|FG002|Double-blind Follow-up Period|Pregnancy|1|||
16914843|NCT02980692|38023808|FG003|Double-blind Follow-up Period|Pregnancy|1|||
16914844|NCT02980692|38023809|FG004|Double-blind Follow-up Period|Pregnancy|0|||
16914845|NCT02980692|38023805|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
16914846|NCT02980692|38023806|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
16840826|NCT01606761|37784872|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
16840827|NCT01606761|37784873|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
16840828|NCT01606761|37784874|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
16840829|NCT01606761|37784870|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
16840830|NCT01606761|37784871|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
16840831|NCT01606761|37784872|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
16840832|NCT01606761|37784873|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
16840833|NCT01606761|37784874|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
16840834|NCT01790295|37784889|FG000|Overall Study|Adverse Event|1|||
16840835|NCT01790295|37784889|FG000|Overall Study|Death|4|||
16840836|NCT01790295|37784889|FG000|Overall Study|Lack of Efficacy|2|||
16840837|NCT01790295|37784889|FG000|Overall Study|Study closure|4|||
16840838|NCT01597557|37784896|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
16840839|NCT01597557|37784897|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
16840840|NCT01760733|37784903|FG000|Waiting List|Death|18|||
16840841|NCT01760733|37784903|FG000|Waiting List|Removed from waiting list|41|||
16840842|NCT01760733|37784903|FG000|Waiting List|Not received a transplant yet|13|||
16840843|NCT01760733|37784903|FG000|Transplanted|Not reached 10 years post transplant|184|||
16840844|NCT01760733|37784903|FG000|Transplanted|Death|26|||
16840845|NCT01760733|37784903|FG000|Transplanted|Graft loss|7|||
16840846|NCT01914757|37784911|FG000|Overall Study|Severe non-compliance to protocol|3|||
16840847|NCT01914757|37784912|FG001|Overall Study|Severe non-compliance to protocol|1|||
16840848|NCT01914757|37784913|FG002|Overall Study|Severe non-compliance to protocol|2|||
16840849|NCT01914757|37784911|FG000|Overall Study|Lost to Follow-up|5|||
16840850|NCT01914757|37784912|FG001|Overall Study|Lost to Follow-up|8|||
16840851|NCT01914757|37784913|FG002|Overall Study|Lost to Follow-up|6|||
16840852|NCT01914757|37784911|FG000|Overall Study|Withdrawal by Subject|15|||
16840853|NCT01914757|37784912|FG001|Overall Study|Withdrawal by Subject|27|||
16840854|NCT01914757|37784913|FG002|Overall Study|Withdrawal by Subject|19|||
16840855|NCT01914757|37784911|FG000|Overall Study|Death|2|||
16840856|NCT01914757|37784912|FG001|Overall Study|Death|2|||
16840857|NCT01914757|37784913|FG002|Overall Study|Death|1|||
16840858|NCT01914757|37784911|FG000|Overall Study|Adverse Event|4|||
16840859|NCT01914757|37784912|FG001|Overall Study|Adverse Event|3|||
16840860|NCT01914757|37784913|FG002|Overall Study|Adverse Event|4|||
16840861|NCT01914757|37784911|FG000|Overall Study|Study specific withdrawal criteria|0|||
16840862|NCT01914757|37784912|FG001|Overall Study|Study specific withdrawal criteria|1|||
16840863|NCT01914757|37784913|FG002|Overall Study|Study specific withdrawal criteria|0|||
16840864|NCT01914757|37784911|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16840865|NCT01914757|37784912|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16840866|NCT01914757|37784913|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
16840867|NCT01914757|37784911|FG000|Overall Study|Other reasons|5|||
16840868|NCT01914757|37784912|FG001|Overall Study|Other reasons|9|||
16840869|NCT01914757|37784913|FG002|Overall Study|Other reasons|4|||
16840870|NCT02003573|37784924|FG000|Overall Study|Progressive disease|2|||
16840871|NCT02003573|37784925|FG001|Overall Study|Progressive disease|0|||
16840872|NCT02003573|37784926|FG002|Overall Study|Progressive disease|1|||
16840873|NCT02003573|37784924|FG000|Overall Study|Other Adverse event|0|||
16914847|NCT02980692|38023807|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
16914848|NCT02980692|38023808|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
16914849|NCT02980692|38023809|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
16914850|NCT02980692|38023805|FG000|Double-blind Follow-up Period|Other|0|||
16914851|NCT02980692|38023806|FG001|Double-blind Follow-up Period|Other|0|||
16914852|NCT02980692|38023807|FG002|Double-blind Follow-up Period|Other|1|||
16914853|NCT02980692|38023808|FG003|Double-blind Follow-up Period|Other|1|||
16914854|NCT02980692|38023809|FG004|Double-blind Follow-up Period|Other|3|||
16914855|NCT00089778|38024115|FG000|Overall Study|Protocol Violation|0|||
16914856|NCT00089778|38024116|FG001|Overall Study|Protocol Violation|0|||
16914857|NCT00089778|38024117|FG002|Overall Study|Protocol Violation|1|||
16914858|NCT00089544|38024129|FG000|Overall Study|Ineligible|1|||
16914859|NCT00089544|38024130|FG001|Overall Study|Ineligible|0|||
16914860|NCT00089076|38024136|FG000|Overall Study|Alternate Therapy|1|||
16914861|NCT00089076|38024136|FG000|Overall Study|Withdrawal by Subject|2|||
16914862|NCT00089076|38024136|FG000|Overall Study|Progression|7|||
16914863|NCT00088374|38024140|FG000|Overall Study|patient did not receive any 17AAG|1|||
16914864|NCT00088374|38024140|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
16914865|NCT00087594|38024146|FG000|Overall Study|Adverse Event|2|||
16914866|NCT00087594|38024147|FG001|Overall Study|Adverse Event|3|||
16914867|NCT00087594|38024146|FG000|Overall Study|Lost to Follow-up|0|||
16914868|NCT00087594|38024147|FG001|Overall Study|Lost to Follow-up|2|||
16914869|NCT00087594|38024146|FG000|Overall Study|Withdrawal by Subject|4|||
16840874|NCT02003573|37784925|FG001|Overall Study|Other Adverse event|1|||
16840875|NCT02003573|37784926|FG002|Overall Study|Other Adverse event|1|||
16840876|NCT02003573|37784924|FG000|Overall Study|Refuse to take trial medication|0|||
16840877|NCT02003573|37784925|FG001|Overall Study|Refuse to take trial medication|1|||
16840878|NCT02003573|37784926|FG002|Overall Study|Refuse to take trial medication|1|||
16840879|NCT02003573|37784924|FG000|Overall Study|Other than specified|1|||
16840880|NCT02003573|37784925|FG001|Overall Study|Other than specified|2|||
16840881|NCT02003573|37784926|FG002|Overall Study|Other than specified|3|||
16840882|NCT01914679|37784936|FG000|Overall Study|Lack of Efficacy|1|||
16840883|NCT01914679|37784936|FG000|Overall Study|Sponsor terminated study|4|||
16840884|NCT01789281|37784942|FG000|Overall Study|Disease progression|15|||
16840885|NCT01789281|37784943|FG001|Overall Study|Disease progression|4|||
16840886|NCT01789281|37784942|FG000|Overall Study|Adverse Event|5|||
16914870|NCT00087594|38024147|FG001|Overall Study|Withdrawal by Subject|2|||
16914871|NCT00087594|38024146|FG000|Overall Study|Lack of Efficacy|2|||
16914872|NCT00087594|38024147|FG001|Overall Study|Lack of Efficacy|5|||
16914873|NCT00087516|38024156|FG000|Overall Study|Adverse Event|10|||
16914874|NCT00087516|38024157|FG001|Overall Study|Adverse Event|10|||
16914875|NCT00087516|38024158|FG002|Overall Study|Adverse Event|3|||
16914876|NCT00087516|38024159|FG003|Overall Study|Adverse Event|6|||
16914877|NCT00087516|38024156|FG000|Overall Study|Lack of Efficacy|82|||
16914878|NCT00087516|38024157|FG001|Overall Study|Lack of Efficacy|80|||
16914879|NCT00087516|38024158|FG002|Overall Study|Lack of Efficacy|39|||
16914880|NCT00087516|38024159|FG003|Overall Study|Lack of Efficacy|29|||
16914881|NCT00087516|38024156|FG000|Overall Study|Lost to Follow-up|8|||
16840887|NCT01789281|37784943|FG001|Overall Study|Adverse Event|5|||
16840888|NCT01789281|37784942|FG000|Overall Study|Withdrawal by Subject|1|||
16840889|NCT01789281|37784943|FG001|Overall Study|Withdrawal by Subject|0|||
16840890|NCT01789281|37784942|FG000|Overall Study|Lost to Follow-up|1|||
16914882|NCT00087516|38024157|FG001|Overall Study|Lost to Follow-up|6|||
16914883|NCT00087516|38024158|FG002|Overall Study|Lost to Follow-up|5|||
16914884|NCT00087516|38024159|FG003|Overall Study|Lost to Follow-up|5|||
16914885|NCT00087516|38024156|FG000|Overall Study|Protocol Violation|4|||
16914886|NCT00087516|38024157|FG001|Overall Study|Protocol Violation|8|||
16914887|NCT00087516|38024158|FG002|Overall Study|Protocol Violation|3|||
16914888|NCT00087516|38024159|FG003|Overall Study|Protocol Violation|6|||
16914889|NCT00087516|38024156|FG000|Overall Study|Withdrawal by Subject|16|||
16914890|NCT00087516|38024157|FG001|Overall Study|Withdrawal by Subject|27|||
16914891|NCT00087516|38024158|FG002|Overall Study|Withdrawal by Subject|11|||
16840891|NCT01789281|37784943|FG001|Overall Study|Lost to Follow-up|0|||
16840892|NCT01789281|37784942|FG000|Overall Study|Administrative problems|0|||
16914892|NCT00087516|38024159|FG003|Overall Study|Withdrawal by Subject|12|||
16914893|NCT00087516|38024156|FG000|Overall Study|Site terminated|0|||
16914894|NCT00087516|38024157|FG001|Overall Study|Site terminated|2|||
16914895|NCT00087516|38024158|FG002|Overall Study|Site terminated|1|||
16914896|NCT00087516|38024159|FG003|Overall Study|Site terminated|0|||
16914897|NCT00087516|38024156|FG000|Overall Study|Protocol specified discontinuation|35|||
16914898|NCT00087516|38024157|FG001|Overall Study|Protocol specified discontinuation|33|||
16914899|NCT00087516|38024158|FG002|Overall Study|Protocol specified discontinuation|33|||
16914900|NCT00087516|38024159|FG003|Overall Study|Protocol specified discontinuation|26|||
16914901|NCT00087516|38024156|FG000|Overall Study|Patient moved|3|||
16914902|NCT00087516|38024157|FG001|Overall Study|Patient moved|2|||
16914903|NCT00087516|38024158|FG002|Overall Study|Patient moved|1|||
16914904|NCT00087516|38024159|FG003|Overall Study|Patient moved|0|||
16914905|NCT00087516|38024156|FG000|Overall Study|Patient was non-compliant|3|||
16914906|NCT00087516|38024157|FG001|Overall Study|Patient was non-compliant|1|||
16914907|NCT00087516|38024158|FG002|Overall Study|Patient was non-compliant|0|||
16840893|NCT01789281|37784943|FG001|Overall Study|Administrative problems|1|||
16840894|NCT01923740|37784952|FG000|Overall Study|Lost to Follow-up|4|||
16840895|NCT01923740|37784953|FG001|Overall Study|Lost to Follow-up|9|||
16840896|NCT01923740|37784952|FG000|Overall Study|Withdrawal by Subject|2|||
16840897|NCT01923740|37784953|FG001|Overall Study|Withdrawal by Subject|0|||
16840898|NCT01789203|37784961|FG000|Overall Study|Adverse Event|2|||
16840899|NCT01789203|37784962|FG001|Overall Study|Adverse Event|2|||
16840900|NCT01789203|37784961|FG000|Overall Study|Withdrawal by Subject|1|||
16840901|NCT01789203|37784962|FG001|Overall Study|Withdrawal by Subject|0|||
16840902|NCT01789203|37784961|FG000|Overall Study|Death|1|||
16840903|NCT01789203|37784962|FG001|Overall Study|Death|0|||
16840904|NCT01789203|37784961|FG000|Overall Study|Protocol Violation|2|||
16840905|NCT01789203|37784962|FG001|Overall Study|Protocol Violation|1|||
16840906|NCT01789203|37784961|FG000|Overall Study|Other|1|||
16840907|NCT01789203|37784962|FG001|Overall Study|Other|1|||
16840908|NCT01789203|37784961|FG000|Overall Study|patient non-adherent|2|||
16840909|NCT01789203|37784962|FG001|Overall Study|patient non-adherent|0|||
16840910|NCT01789047|37784972|FG000|Overall Study|Adverse Event|3|||
16840911|NCT01789047|37784973|FG001|Overall Study|Adverse Event|2|||
16840912|NCT01789047|37784972|FG000|Overall Study|Withdrawal by Subject|1|||
16914908|NCT00087516|38024159|FG003|Overall Study|Patient was non-compliant|0|||
16914909|NCT00087516|38024156|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
16840913|NCT01789047|37784973|FG001|Overall Study|Withdrawal by Subject|2|||
16840914|NCT01788423|37784982|FG000|Overall Study|See Comments in Completed (above)|0|||
16840915|NCT01788423|37784983|FG001|Overall Study|See Comments in Completed (above)|4|||
16840916|NCT01788423|37784984|FG002|Overall Study|See Comments in Completed (above)|5|||
16840917|NCT01617187|37784996|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
16840918|NCT01617187|37784997|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
16840919|NCT01617187|37784998|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
16840920|NCT01617187|37784999|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
16840921|NCT01617187|37784996|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
16840922|NCT01617187|37784997|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
16840923|NCT01617187|37784998|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
16840924|NCT01617187|37784999|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
16840925|NCT01617187|37784996|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
16840926|NCT01617187|37784997|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
16840927|NCT01617187|37784998|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
16840928|NCT01617187|37784999|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
16840929|NCT01617187|37784996|FG000|Treatment Through Study Completion|Adverse Event|1|||
16840930|NCT01617187|37784997|FG001|Treatment Through Study Completion|Adverse Event|1|||
16840931|NCT01617187|37784998|FG002|Treatment Through Study Completion|Adverse Event|0|||
16840932|NCT01617187|37784999|FG003|Treatment Through Study Completion|Adverse Event|1|||
16914910|NCT00087516|38024157|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
16914911|NCT00087516|38024158|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
16914912|NCT00087516|38024159|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
16914913|NCT00087516|38024156|FG000|Overall Study|Other|0|||
16914914|NCT00087516|38024157|FG001|Overall Study|Other|0|||
16914915|NCT00087516|38024158|FG002|Overall Study|Other|1|||
16914916|NCT00087516|38024159|FG003|Overall Study|Other|0|||
16914917|NCT00087126|38024173|FG000|Overall Study|Ineligible - second primary|1|||
16914918|NCT00087126|38024173|FG000|Overall Study|Never treated|1|||
16914919|NCT00086346|38024184|FG000|Randomization|Did not receive test article|4|||
16914920|NCT00086346|38024185|FG001|Randomization|Did not receive test article|4|||
16914921|NCT00086346|38024184|FG000|Patients Dosed With Test Article|Adverse Event|94|||
16914922|NCT00086346|38024185|FG001|Patients Dosed With Test Article|Adverse Event|11|||
16914923|NCT00086346|38024184|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
16914924|NCT00086346|38024185|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
16914925|NCT00086346|38024184|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
16914926|NCT00086346|38024185|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
16914927|NCT00086346|38024184|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
16914928|NCT00086346|38024185|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
16914929|NCT00086346|38024184|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
16840933|NCT01617187|37784996|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
16840934|NCT01617187|37784997|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
16840935|NCT01617187|37784998|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
16840936|NCT01617187|37784999|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
16840937|NCT01617187|37784996|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
16840938|NCT01617187|37784997|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
16840939|NCT01617187|37784998|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
16840940|NCT01617187|37784999|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
16840941|NCT01617187|37784996|FG000|Treatment Through Study Completion|Protocol Violation|1|||
16840942|NCT01617187|37784997|FG001|Treatment Through Study Completion|Protocol Violation|0|||
16840943|NCT01617187|37784998|FG002|Treatment Through Study Completion|Protocol Violation|0|||
16840944|NCT01617187|37784999|FG003|Treatment Through Study Completion|Protocol Violation|1|||
16840945|NCT01759407|37785011|FG000|Overall Study|Protocol Violation|0|||
16840946|NCT01759407|37785012|FG001|Overall Study|Protocol Violation|2|||
16840947|NCT01787331|37785018|FG000|Overall Study|Physician Decision|1|||
16914930|NCT00086346|38024185|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
16914931|NCT00086346|38024184|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
16914932|NCT00086346|38024185|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
16914933|NCT00085566|38024194|FG000|Overall Study|Adverse Event|0|||
16914934|NCT00085566|38024195|FG001|Overall Study|Adverse Event|0|||
16914935|NCT00085566|38024196|FG002|Overall Study|Adverse Event|10|||
16840948|NCT01787331|37785018|FG000|Overall Study|Withdrawal by Subject|1|||
16840949|NCT01757847|37785024|FG000|Overall Study|Withdrawal by Subject|3|||
16840950|NCT01757847|37785025|FG001|Overall Study|Withdrawal by Subject|4|||
16840951|NCT01787097|37785031|FG000|Overall Study|Withdrawal by Subject|1|||
16840952|NCT01787097|37785032|FG001|Overall Study|Withdrawal by Subject|0|||
16840953|NCT01787097|37785033|FG002|Overall Study|Withdrawal by Subject|0|||
16840954|NCT01787097|37785034|FG003|Overall Study|Withdrawal by Subject|0|||
16840955|NCT01757691|37785054|FG000|Overall Study|Administrative problems|2|||
16840956|NCT01757691|37785055|FG001|Overall Study|Administrative problems|0|||
16840957|NCT01786707|37785063|FG000|Overall Study|Lost to Follow-up|1|||
16840958|NCT01786707|37785064|FG001|Overall Study|Lost to Follow-up|1|||
16840959|NCT01786629|37785072|FG000|Overall Study|Lack of Efficacy|0|||
16840960|NCT01786629|37785073|FG001|Overall Study|Lack of Efficacy|4|||
16840961|NCT01786629|37785072|FG000|Overall Study|Adverse Event|0|||
16840962|NCT01786629|37785073|FG001|Overall Study|Adverse Event|1|||
16840963|NCT01786551|37785079|FG000|Overall Study|Participant withdrew consent|2|||
16840964|NCT01973569|37785086|FG000|Overall Study|Adverse Event|9|||
16840965|NCT01973569|37785087|FG001|Overall Study|Adverse Event|2|||
16840966|NCT01973569|37785088|FG002|Overall Study|Adverse Event|4|||
16840967|NCT01973569|37785086|FG000|Overall Study|Protocol Violation|2|||
16840968|NCT01973569|37785087|FG001|Overall Study|Protocol Violation|1|||
16840969|NCT01973569|37785088|FG002|Overall Study|Protocol Violation|3|||
16840970|NCT01973569|37785086|FG000|Overall Study|Withdrawal by Subject|7|||
16840971|NCT01973569|37785087|FG001|Overall Study|Withdrawal by Subject|5|||
16914936|NCT00085566|38024194|FG000|Overall Study|Patient Not treated|0|||
16914937|NCT00085566|38024195|FG001|Overall Study|Patient Not treated|0|||
16914938|NCT00085566|38024196|FG002|Overall Study|Patient Not treated|3|||
16914939|NCT00085566|38024194|FG000|Overall Study|Clinical progression|0|||
16914940|NCT00085566|38024195|FG001|Overall Study|Clinical progression|0|||
16914941|NCT00085566|38024196|FG002|Overall Study|Clinical progression|1|||
16914942|NCT00085098|38024206|FG000|Overall Study|Withdrawal by Subject|0|||
16914943|NCT00085098|38024207|FG001|Overall Study|Withdrawal by Subject|1|||
16914944|NCT00085098|38024206|FG000|Overall Study|Ineligible|1|||
16914945|NCT00085098|38024207|FG001|Overall Study|Ineligible|1|||
16914946|NCT00084864|38024220|FG000|Overall Study|Adverse Event|1|||
16914947|NCT00084864|38024221|FG001|Overall Study|Adverse Event|0|||
16914948|NCT00084864|38024222|FG002|Overall Study|Adverse Event|0|||
16914949|NCT00084864|38024223|FG003|Overall Study|Adverse Event|0|||
16914950|NCT00084318|38024235|FG000|Overall Study|Withdrawal by Subject|5|||
16914951|NCT00084318|38024236|FG001|Overall Study|Withdrawal by Subject|2|||
16914952|NCT00084318|38024235|FG000|Overall Study|Protocol Violation|15|||
16914953|NCT00084318|38024236|FG001|Overall Study|Protocol Violation|11|||
16914954|NCT00084318|38024235|FG000|Overall Study|No protocol treatment|2|||
16914955|NCT00084318|38024236|FG001|Overall Study|No protocol treatment|0|||
16914956|NCT00084084|38024244|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
16914957|NCT00084084|38024244|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
16914958|NCT00083616|38024249|FG000|Overall Study|Disease Progression|16|||
16914959|NCT00083616|38024249|FG000|Overall Study|Lost to Follow-up|1|||
16914960|NCT00083616|38024249|FG000|Overall Study|Physician Decision|2|||
16914961|NCT00083616|38024249|FG000|Overall Study|Withdrawal by Subject|3|||
16914962|NCT00083616|38024249|FG000|Overall Study|Ineligibility determined|2|||
16914963|NCT00083616|38024249|FG000|Overall Study|Non-compliance|1|||
16914964|NCT00083616|38024249|FG000|Overall Study|Other|6|||
16914965|NCT00083226|38024253|FG000|Overall Study|Lack of Efficacy|19|||
16914966|NCT00083226|38024253|FG000|Overall Study|Adverse Event|9|||
16914967|NCT00083226|38024253|FG000|Overall Study|Death|4|||
16914968|NCT00083226|38024253|FG000|Overall Study|Withdrawal by Subject|4|||
16914969|NCT00083226|38024253|FG000|Overall Study|Other|2|||
16914970|NCT00083226|38024253|FG000|Overall Study|ineligible or not receiving treatment|4|||
16914971|NCT00082758|38024260|FG000|Overall Study|Adverse Event|0|||
16914972|NCT00082758|38024261|FG001|Overall Study|Adverse Event|2|||
16914973|NCT00082758|38024262|FG002|Overall Study|Adverse Event|0|||
16914974|NCT00082758|38024260|FG000|Overall Study|Lack of Efficacy|12|||
16914975|NCT00082758|38024261|FG001|Overall Study|Lack of Efficacy|13|||
16914976|NCT00082758|38024262|FG002|Overall Study|Lack of Efficacy|0|||
16914977|NCT00082758|38024260|FG000|Overall Study|Physician Decision|0|||
16840972|NCT01973569|37785088|FG002|Overall Study|Withdrawal by Subject|2|||
16840973|NCT01973569|37785086|FG000|Overall Study|Invasive dental treatment|3|||
16840974|NCT01973569|37785087|FG001|Overall Study|Invasive dental treatment|5|||
16840975|NCT01973569|37785088|FG002|Overall Study|Invasive dental treatment|6|||
16840976|NCT01973569|37785086|FG000|Overall Study|Prohibited concomitant d|1|||
16840977|NCT01973569|37785087|FG001|Overall Study|Prohibited concomitant d|5|||
16840978|NCT01973569|37785088|FG002|Overall Study|Prohibited concomitant d|0|||
16840979|NCT01973569|37785086|FG000|Overall Study|Disease progression|0|||
16840980|NCT01973569|37785087|FG001|Overall Study|Disease progression|3|||
16840981|NCT01973569|37785088|FG002|Overall Study|Disease progression|0|||
16840982|NCT01973569|37785086|FG000|Overall Study|Other|1|||
16840983|NCT01973569|37785087|FG001|Overall Study|Other|1|||
16840984|NCT01973569|37785088|FG002|Overall Study|Other|0|||
16840985|NCT01973569|37785086|FG000|Overall Study|Did not receive study drug|6|||
16840986|NCT01973569|37785087|FG001|Overall Study|Did not receive study drug|3|||
16840987|NCT01973569|37785088|FG002|Overall Study|Did not receive study drug|3|||
16840988|NCT01973491|37785096|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
16840989|NCT01973491|37785096|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
16840990|NCT01973491|37785096|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
16840991|NCT01913353|37785102|FG000|Overall Study|Adverse Event|2|||
16914978|NCT00082758|38024261|FG001|Overall Study|Physician Decision|1|||
16914979|NCT00082758|38024262|FG002|Overall Study|Physician Decision|0|||
16914980|NCT00082758|38024260|FG000|Overall Study|Withdrawal by Subject|3|||
16914981|NCT00082758|38024261|FG001|Overall Study|Withdrawal by Subject|0|||
16914982|NCT00082758|38024262|FG002|Overall Study|Withdrawal by Subject|0|||
16914983|NCT00082758|38024260|FG000|Overall Study|Protocol Violation|0|||
16914984|NCT00082758|38024261|FG001|Overall Study|Protocol Violation|1|||
16914985|NCT00082758|38024262|FG002|Overall Study|Protocol Violation|0|||
16914986|NCT00088452|38024273|FG000|Overall Study|Did not receive intervention|1|||
16914987|NCT00088452|38024274|FG001|Overall Study|Did not receive intervention|0|||
16914988|NCT00088452|38024275|FG002|Overall Study|Did not receive intervention|1|||
16914989|NCT04686084|38024374|FG000|Overall Study|Lost to Follow-up|1|||
16914990|NCT04685538|38024381|FG000|Overall Study|Adverse Event|0|||
16914991|NCT04685538|38024382|FG001|Overall Study|Adverse Event|1|||
16840992|NCT01913353|37785103|FG001|Overall Study|Adverse Event|0|||
16840993|NCT01913353|37785102|FG000|Overall Study|Physician Decision|0|||
16840994|NCT01913353|37785103|FG001|Overall Study|Physician Decision|2|||
16840995|NCT01913353|37785102|FG000|Overall Study|Withdrawal by Subject|20|||
16840996|NCT01913353|37785103|FG001|Overall Study|Withdrawal by Subject|6|||
16840997|NCT01913353|37785102|FG000|Overall Study|multiple reasons|10|||
16840998|NCT01913353|37785103|FG001|Overall Study|multiple reasons|7|||
16840999|NCT01951586|37785118|FG000|Overall Study|Death|61|||
16841000|NCT01951586|37785119|FG001|Overall Study|Death|120|||
16841001|NCT01951586|37785118|FG000|Overall Study|Withdrawal by Subject|8|||
16841002|NCT01951586|37785119|FG001|Overall Study|Withdrawal by Subject|17|||
16841003|NCT01951586|37785118|FG000|Overall Study|Lost to Follow-up|0|||
16841004|NCT01951586|37785119|FG001|Overall Study|Lost to Follow-up|1|||
16841005|NCT01951586|37785118|FG000|Overall Study|Sponsor Decision|9|||
16841006|NCT01951586|37785119|FG001|Overall Study|Sponsor Decision|10|||
16841007|NCT01785849|37785128|FG000|Overall Study|Death|7|||
16841008|NCT01785849|37785129|FG001|Overall Study|Death|9|||
16841009|NCT01785849|37785128|FG000|Overall Study|Protocol Specified Criteria|29|||
16841010|NCT01785849|37785129|FG001|Overall Study|Protocol Specified Criteria|1|||
16841011|NCT01785849|37785128|FG000|Overall Study|Withdrawal by Subject|15|||
17016827|NCT00848718|38161498|FG004|Overall Study|Adverse Event|1|||
16841012|NCT01785849|37785129|FG001|Overall Study|Withdrawal by Subject|12|||
16841013|NCT01785849|37785128|FG000|Overall Study|Sponsor Decision|0|||
16841014|NCT01785849|37785129|FG001|Overall Study|Sponsor Decision|1|||
16841015|NCT01785849|37785128|FG000|Overall Study|Lost to Follow-up|10|||
16841016|NCT01785849|37785129|FG001|Overall Study|Lost to Follow-up|11|||
16841017|NCT01756833|37785137|FG000|Overall Study|Withdrawal by Subject|4|||
16914992|NCT04685538|38024381|FG000|Overall Study|Lost to Follow-up|0|||
16914993|NCT04685538|38024382|FG001|Overall Study|Lost to Follow-up|2|||
16914994|NCT01847274|38024399|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
16914995|NCT01847274|38024400|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
16841018|NCT01756833|37785138|FG001|Overall Study|Withdrawal by Subject|3|||
16841019|NCT01617967|37785150|FG000|Overall Study|Protocol Violation|0|||
16841020|NCT01617967|37785151|FG001|Overall Study|Protocol Violation|0|||
16841021|NCT01617967|37785152|FG002|Overall Study|Protocol Violation|0|||
16841022|NCT01617967|37785153|FG003|Overall Study|Protocol Violation|1|||
16841023|NCT01617967|37785154|FG004|Overall Study|Protocol Violation|0|||
16841024|NCT01617967|37785155|FG005|Overall Study|Protocol Violation|0|||
16841025|NCT01617967|37785150|FG000|Overall Study|Withdrawal by Subject|0|||
16841026|NCT01617967|37785151|FG001|Overall Study|Withdrawal by Subject|0|||
16841027|NCT01617967|37785152|FG002|Overall Study|Withdrawal by Subject|0|||
16841028|NCT01617967|37785153|FG003|Overall Study|Withdrawal by Subject|0|||
16841029|NCT01617967|37785154|FG004|Overall Study|Withdrawal by Subject|0|||
16841030|NCT01617967|37785155|FG005|Overall Study|Withdrawal by Subject|1|||
16841031|NCT01617967|37785150|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
16841032|NCT01617967|37785151|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
16841033|NCT01617967|37785152|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
16841034|NCT01617967|37785153|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
16841035|NCT01617967|37785154|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
16841036|NCT01617967|37785155|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
16841037|NCT01785615|37785173|FG000|Dietary Phase|Lost to Follow-up|0|||
16841038|NCT01785615|37785174|FG001|Dietary Phase|Lost to Follow-up|0|||
16841039|NCT01785615|37785175|FG002|Dietary Phase|Lost to Follow-up|0|||
16841040|NCT01785615|37785176|FG003|Dietary Phase|Lost to Follow-up|24|||
16841041|NCT01913041|37785188|FG000|Overall Study|Protocol Violation|35|||
16841042|NCT01913041|37785188|FG000|Overall Study|Withdrawal by Subject|3|||
16841043|NCT01913041|37785188|FG000|Overall Study|Physician Decision|1|||
16841044|NCT01756053|37785192|FG000|Period 1 (10 Days)|Protocol Violation|1|||
16841045|NCT01756053|37785193|FG001|Period 1 (10 Days)|Protocol Violation|1|||
16841046|NCT01756053|37785192|FG000|Period 2 (10 Days)|Protocol Violation|0|||
16841047|NCT01756053|37785193|FG001|Period 2 (10 Days)|Protocol Violation|2|||
16841048|NCT01785069|37785203|FG000|Overall Study|Implanted with nonstudy device|1|||
16841049|NCT01785069|37785204|FG001|Overall Study|Implanted with nonstudy device|2|||
16841050|NCT01785069|37785205|FG002|Overall Study|Implanted with nonstudy device|1|||
16841051|NCT01785069|37785206|FG003|Overall Study|Implanted with nonstudy device|0|||
16841052|NCT01785069|37785203|FG000|Overall Study|Death|0|||
16841053|NCT01785069|37785204|FG001|Overall Study|Death|0|||
16841054|NCT01785069|37785205|FG002|Overall Study|Death|2|||
16841055|NCT01785069|37785206|FG003|Overall Study|Death|0|||
16841056|NCT01785069|37785203|FG000|Overall Study|Subject choice|2|||
16841057|NCT01785069|37785204|FG001|Overall Study|Subject choice|2|||
16841058|NCT01785069|37785205|FG002|Overall Study|Subject choice|0|||
16841059|NCT01785069|37785206|FG003|Overall Study|Subject choice|1|||
16841060|NCT01785069|37785203|FG000|Overall Study|Lost to Follow-up|1|||
16841061|NCT01785069|37785204|FG001|Overall Study|Lost to Follow-up|2|||
16841062|NCT01785069|37785205|FG002|Overall Study|Lost to Follow-up|4|||
16841063|NCT01785069|37785206|FG003|Overall Study|Lost to Follow-up|1|||
16841064|NCT01785069|37785203|FG000|Overall Study|Reason not Specified|1|||
16841065|NCT01785069|37785204|FG001|Overall Study|Reason not Specified|2|||
16841066|NCT01785069|37785205|FG002|Overall Study|Reason not Specified|1|||
16841067|NCT01785069|37785206|FG003|Overall Study|Reason not Specified|4|||
16841068|NCT01785069|37785203|FG000|Overall Study|Not evaluable|7|||
16841069|NCT01785069|37785204|FG001|Overall Study|Not evaluable|4|||
16841070|NCT01785069|37785205|FG002|Overall Study|Not evaluable|5|||
16841071|NCT01785069|37785206|FG003|Overall Study|Not evaluable|8|||
16841072|NCT01784523|37785218|FG000|Overall Study|Study closed early|7|||
16841073|NCT01784523|37785219|FG001|Overall Study|Study closed early|4|||
16841074|NCT01784211|37785227|FG000|Part A (Days 1-15)|Adverse Event|1|||
16841075|NCT01784211|37785228|FG001|Part A (Days 1-15)|Adverse Event|1|||
16841076|NCT01784211|37785229|FG002|Part A (Days 1-15)|Adverse Event|0|||
16841077|NCT01784211|37785230|FG003|Part A (Days 1-15)|Adverse Event|0|||
16841078|NCT01784211|37785231|FG004|Part A (Days 1-15)|Adverse Event|0|||
16841079|NCT01784211|37785232|FG005|Part A (Days 1-15)|Adverse Event|0|||
16841080|NCT01784211|37785227|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
16841081|NCT01784211|37785228|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
16841082|NCT01784211|37785229|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
16841083|NCT01784211|37785230|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
16841084|NCT01784211|37785231|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
16841085|NCT01784211|37785232|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
16841086|NCT01783821|37785246|FG000|Overall Study|Screen Failure|1|||
16841087|NCT01783821|37785247|FG001|Overall Study|Screen Failure|1|||
16841088|NCT01783743|37785255|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
16841089|NCT01783743|37785256|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
16841090|NCT01783743|37785255|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
16841091|NCT01783743|37785256|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
16841092|NCT01783743|37785255|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
17016828|NCT00848718|38161499|FG005|Overall Study|Adverse Event|0|||
16914996|NCT01847274|38024401|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
16914997|NCT01847274|38024402|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
16914998|NCT01847274|38024403|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16914999|NCT01847274|38024404|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16915000|NCT01847274|38024405|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16915001|NCT01847274|38024399|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
16915002|NCT01847274|38024400|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
16915003|NCT01847274|38024401|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
16915004|NCT01847274|38024402|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
16915005|NCT01847274|38024403|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16915006|NCT01847274|38024404|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16915007|NCT01847274|38024405|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16915008|NCT01847274|38024399|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
16915009|NCT01847274|38024400|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
16915010|NCT01847274|38024401|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
16915011|NCT01847274|38024402|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
16915012|NCT01847274|38024403|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16841093|NCT01783743|37785256|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
16841094|NCT01608321|37785264|FG000|Overall Study|Withdrawal by Subject|1|||
16841095|NCT01608321|37785265|FG001|Overall Study|Withdrawal by Subject|0|||
16841096|NCT01608087|37785274|FG000|Overall Study|Lost to Follow-up|0|||
16841097|NCT01608087|37785275|FG001|Overall Study|Lost to Follow-up|1|||
16841098|NCT01608087|37785276|FG002|Overall Study|Lost to Follow-up|0|||
16841099|NCT01608087|37785274|FG000|Overall Study|Other Reason|0|||
16841100|NCT01608087|37785275|FG001|Overall Study|Other Reason|1|||
16841101|NCT01608087|37785276|FG002|Overall Study|Other Reason|0|||
16841102|NCT01912963|37785287|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
16915013|NCT01847274|38024404|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16915014|NCT01847274|38024405|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16915015|NCT01847274|38024399|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16915016|NCT01847274|38024400|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16915017|NCT01847274|38024401|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16915018|NCT01847274|38024402|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
16915019|NCT01847274|38024403|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16915020|NCT01847274|38024404|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16915021|NCT01847274|38024405|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16915022|NCT01847274|38024399|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
16915023|NCT01847274|38024400|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
16915024|NCT01847274|38024401|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
16915025|NCT01847274|38024402|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
16915026|NCT01847274|38024403|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16915027|NCT01847274|38024404|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16915028|NCT01847274|38024405|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16915029|NCT01847274|38024399|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
16915030|NCT01847274|38024400|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
16915031|NCT01847274|38024401|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
16915032|NCT01847274|38024402|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
16915033|NCT01847274|38024403|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16915034|NCT01847274|38024404|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16915035|NCT01847274|38024405|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16915036|NCT01847274|38024399|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
16915037|NCT01847274|38024400|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
16915038|NCT01847274|38024401|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
16915039|NCT01847274|38024402|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
16915040|NCT01847274|38024403|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16915041|NCT01847274|38024404|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16915042|NCT01847274|38024405|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16915043|NCT01847274|38024399|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16915044|NCT01847274|38024400|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16915045|NCT01847274|38024401|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16841103|NCT01912963|37785288|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
16841104|NCT01912963|37785289|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
16841105|NCT01912963|37785287|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
16841106|NCT01912963|37785288|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
16841107|NCT01912963|37785289|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
16841108|NCT01912963|37785287|FG000|Overall Study|Adverse Event|0|||
16841109|NCT01912963|37785288|FG001|Overall Study|Adverse Event|1|||
16841110|NCT01912963|37785289|FG002|Overall Study|Adverse Event|1|||
16841111|NCT01912963|37785287|FG000|Overall Study|Withdrawal by Subject|0|||
16841112|NCT01912963|37785288|FG001|Overall Study|Withdrawal by Subject|1|||
16841113|NCT01912963|37785289|FG002|Overall Study|Withdrawal by Subject|0|||
16915046|NCT01847274|38024402|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16915047|NCT01847274|38024403|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16915048|NCT01847274|38024404|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
16915049|NCT01847274|38024405|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16841114|NCT01912963|37785287|FG000|Overall Study|Sought treatment locally|0|||
16841115|NCT01912963|37785288|FG001|Overall Study|Sought treatment locally|1|||
16841116|NCT01912963|37785289|FG002|Overall Study|Sought treatment locally|0|||
16841117|NCT01754727|37785297|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
16841118|NCT01912807|37785303|FG000|Overall Study|Did not meet elegibility criteria|6|||
16841119|NCT01912807|37785304|FG001|Overall Study|Did not meet elegibility criteria|4|||
16841120|NCT01912807|37785303|FG000|Overall Study|Lost to Follow-up|36|||
16841121|NCT01912807|37785304|FG001|Overall Study|Lost to Follow-up|37|||
16841122|NCT01782885|37785312|FG000|Overall Study|Lost to Follow-up|4|||
16841123|NCT01782885|37785313|FG001|Overall Study|Lost to Follow-up|6|||
16841124|NCT01912729|37785321|FG000|Overall Study|Withdrawal by Subject|0|||
16841125|NCT01912729|37785322|FG001|Overall Study|Withdrawal by Subject|1|||
16841126|NCT01754493|37785328|FG000|Overall Study|Adverse Event|1|||
16841127|NCT01754493|37785328|FG000|Overall Study|Lost to Follow-up|3|||
16841128|NCT01754493|37785328|FG000|Overall Study|Withdrawal by Subject|1|||
16915050|NCT01847274|38024399|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16915051|NCT01847274|38024400|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16915052|NCT01847274|38024401|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16915053|NCT01847274|38024402|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16915054|NCT01847274|38024403|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
16915055|NCT01847274|38024404|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16915056|NCT01847274|38024405|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16915057|NCT01847274|38024399|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16915058|NCT01847274|38024400|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16915059|NCT01847274|38024401|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16915060|NCT01847274|38024402|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16915061|NCT01847274|38024403|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16915062|NCT01847274|38024404|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16915063|NCT01847274|38024405|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
16915064|NCT01847274|38024399|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16915065|NCT01847274|38024400|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16915066|NCT01847274|38024401|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16915067|NCT01847274|38024402|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16915068|NCT01847274|38024403|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16915069|NCT01847274|38024404|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16915070|NCT01847274|38024405|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
16915071|NCT01847274|38024399|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16915072|NCT01847274|38024400|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16915073|NCT01847274|38024401|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16915074|NCT01847274|38024402|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16915075|NCT01847274|38024403|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16915076|NCT01847274|38024404|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16915077|NCT01847274|38024405|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
16915078|NCT04213326|38024429|FG000|Overall Study|Consent withdrawn|51|||
16915079|NCT04213326|38024430|FG001|Overall Study|Consent withdrawn|241|||
16915080|NCT04213326|38024429|FG000|Overall Study|Lost to Follow-up|50|||
16915081|NCT04213326|38024430|FG001|Overall Study|Lost to Follow-up|902|||
16915082|NCT04213326|38024429|FG000|Overall Study|Protocol Violation|3|||
16915083|NCT04213326|38024430|FG001|Overall Study|Protocol Violation|25|||
16915084|NCT04213326|38024429|FG000|Overall Study|Participant eligibility changed|106|||
16915085|NCT04213326|38024430|FG001|Overall Study|Participant eligibility changed|19|||
16915086|NCT04213326|38024429|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
16915087|NCT04213326|38024430|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
16915088|NCT04213326|38024429|FG000|Overall Study|Incomplete study visit|0|||
16915089|NCT04213326|38024430|FG001|Overall Study|Incomplete study visit|367|||
16915090|NCT01625286|38024443|FG000|Overall Study|Adverse Event|0|||
16915091|NCT01625286|38024444|FG001|Overall Study|Adverse Event|0|||
16915092|NCT01625286|38024445|FG002|Overall Study|Adverse Event|0|||
16915093|NCT01625286|38024446|FG003|Overall Study|Adverse Event|0|||
16915094|NCT01625286|38024447|FG004|Overall Study|Adverse Event|1|||
16841129|NCT01754493|37785328|FG000|Overall Study|Moved out of town|1|||
16915095|NCT01625286|38024448|FG005|Overall Study|Adverse Event|2|||
16915096|NCT01625286|38024449|FG006|Overall Study|Adverse Event|1|||
16915097|NCT01625286|38024443|FG000|Overall Study|Death|0|||
16915098|NCT01625286|38024444|FG001|Overall Study|Death|0|||
16915099|NCT01625286|38024445|FG002|Overall Study|Death|1|||
16915100|NCT01625286|38024446|FG003|Overall Study|Death|1|||
16915101|NCT01625286|38024447|FG004|Overall Study|Death|0|||
16915102|NCT01625286|38024448|FG005|Overall Study|Death|11|||
16915103|NCT01625286|38024449|FG006|Overall Study|Death|16|||
16915104|NCT01625286|38024443|FG000|Overall Study|Withdrawal by Subject|0|||
16915105|NCT01625286|38024444|FG001|Overall Study|Withdrawal by Subject|1|||
16915106|NCT01625286|38024445|FG002|Overall Study|Withdrawal by Subject|0|||
16915107|NCT01625286|38024446|FG003|Overall Study|Withdrawal by Subject|1|||
16915108|NCT01625286|38024447|FG004|Overall Study|Withdrawal by Subject|0|||
16915109|NCT01625286|38024448|FG005|Overall Study|Withdrawal by Subject|0|||
16915110|NCT01625286|38024449|FG006|Overall Study|Withdrawal by Subject|1|||
16915111|NCT01625286|38024443|FG000|Overall Study|Any reason not specifically recorded|0|||
16915112|NCT01625286|38024444|FG001|Overall Study|Any reason not specifically recorded|0|||
16915113|NCT01625286|38024445|FG002|Overall Study|Any reason not specifically recorded|0|||
16915114|NCT01625286|38024446|FG003|Overall Study|Any reason not specifically recorded|0|||
16915115|NCT01625286|38024447|FG004|Overall Study|Any reason not specifically recorded|0|||
16915116|NCT01625286|38024448|FG005|Overall Study|Any reason not specifically recorded|1|||
16915117|NCT01625286|38024449|FG006|Overall Study|Any reason not specifically recorded|0|||
16915118|NCT01625286|38024443|FG000|Overall Study|Progressive disease|6|||
16915119|NCT01625286|38024444|FG001|Overall Study|Progressive disease|3|||
16915120|NCT01625286|38024445|FG002|Overall Study|Progressive disease|4|||
16915121|NCT01625286|38024446|FG003|Overall Study|Progressive disease|5|||
16915122|NCT01625286|38024447|FG004|Overall Study|Progressive disease|5|||
16915123|NCT01625286|38024448|FG005|Overall Study|Progressive disease|0|||
16915124|NCT01625286|38024449|FG006|Overall Study|Progressive disease|0|||
16915125|NCT01625286|38024443|FG000|Overall Study|Lost to Follow-up|0|||
16915126|NCT01625286|38024444|FG001|Overall Study|Lost to Follow-up|0|||
16915127|NCT01625286|38024445|FG002|Overall Study|Lost to Follow-up|0|||
16915128|NCT01625286|38024446|FG003|Overall Study|Lost to Follow-up|0|||
16915129|NCT01625286|38024447|FG004|Overall Study|Lost to Follow-up|0|||
16915130|NCT01625286|38024448|FG005|Overall Study|Lost to Follow-up|0|||
16915131|NCT01625286|38024449|FG006|Overall Study|Lost to Follow-up|1|||
16915132|NCT04083222|38024494|FG000|Overall Study|Voluntary Withdrawal|0|||
16915133|NCT04083222|38024495|FG001|Overall Study|Voluntary Withdrawal|1|||
16915134|NCT04083222|38024494|FG000|Overall Study|Reason not Specified|0|||
16841130|NCT01754493|37785328|FG000|Overall Study|Scheduling conflict|1|||
16841131|NCT01972789|37785334|FG000|Overall Study|Adverse Event|11|||
16841132|NCT01972789|37785335|FG001|Overall Study|Adverse Event|4|||
16841133|NCT01972789|37785334|FG000|Overall Study|Subject withdrew consent|14|||
16841134|NCT01972789|37785335|FG001|Overall Study|Subject withdrew consent|12|||
16841135|NCT01972789|37785334|FG000|Overall Study|Lost to Follow-up|4|||
16841136|NCT01972789|37785335|FG001|Overall Study|Lost to Follow-up|7|||
16841137|NCT01972789|37785334|FG000|Overall Study|Death|7|||
16841138|NCT01972789|37785335|FG001|Overall Study|Death|5|||
16841139|NCT01972789|37785334|FG000|Overall Study|Protocol deviation|1|||
16841140|NCT01972789|37785335|FG001|Overall Study|Protocol deviation|0|||
16841141|NCT01972789|37785334|FG000|Overall Study|Physician Decision|3|||
16841142|NCT01972789|37785335|FG001|Overall Study|Physician Decision|2|||
16841143|NCT01934335|37785343|FG000|Overall Study|Withdrawal by Subject|1|||
16841144|NCT01934335|37785344|FG001|Overall Study|Withdrawal by Subject|1|||
16841145|NCT01912339|37785352|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
16841146|NCT01912339|37785353|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
16841147|NCT01912339|37785354|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
16841148|NCT01912339|37785352|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
16841149|NCT01912339|37785353|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
16841150|NCT01912339|37785354|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
16841151|NCT01912339|37785352|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
16841152|NCT01912339|37785353|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
16841153|NCT01912339|37785354|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
16841154|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
16841155|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
16841156|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
16841157|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
16841158|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
16841159|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
16915135|NCT04083222|38024495|FG001|Overall Study|Reason not Specified|1|||
16915136|NCT03286842|38024501|FG000|Overall Study|Patients rolled over to another study|80|||
16915137|NCT00639678|38024516|FG000|Overall Study|Withdrawal by Subject|3|||
16915138|NCT00639678|38024517|FG001|Overall Study|Withdrawal by Subject|0|||
17016829|NCT00848718|38161500|FG006|Overall Study|Adverse Event|0|||
17016830|NCT00848718|38161501|FG007|Overall Study|Adverse Event|1|||
16841160|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
16841161|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
16841162|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
16841163|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
16841164|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
16841165|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
16841166|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
16841167|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
16841168|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
16841169|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
16841170|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
16841171|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
16841172|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
16841173|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
16841174|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
16841175|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
16841176|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
16841177|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
16841178|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
16841179|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
16841180|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
16841181|NCT01912339|37785352|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
16841182|NCT01912339|37785353|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
16841183|NCT01912339|37785354|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
16841184|NCT01911793|37785362|FG000|Overall Study|Physician Decision|1|||
16841185|NCT01911793|37785363|FG001|Overall Study|Physician Decision|5|||
16841186|NCT01933789|37785378|FG000|Overall Study|Death|0|||
16841187|NCT01933789|37785379|FG001|Overall Study|Death|0|||
16841188|NCT01933789|37785380|FG002|Overall Study|Death|0|||
16841189|NCT01933789|37785381|FG003|Overall Study|Death|0|||
16841190|NCT01933789|37785382|FG004|Overall Study|Death|21|||
16841191|NCT01933789|37785383|FG005|Overall Study|Death|32|||
16841192|NCT01933789|37785384|FG006|Overall Study|Death|0|||
16841193|NCT01933789|37785385|FG007|Overall Study|Death|0|||
16841194|NCT01933789|37785386|FG008|Overall Study|Death|0|||
16841195|NCT01933789|37785378|FG000|Overall Study|Lost to Follow-up|0|||
16841196|NCT01933789|37785379|FG001|Overall Study|Lost to Follow-up|0|||
16841197|NCT01933789|37785380|FG002|Overall Study|Lost to Follow-up|0|||
16841198|NCT01933789|37785381|FG003|Overall Study|Lost to Follow-up|1|||
16841199|NCT01933789|37785382|FG004|Overall Study|Lost to Follow-up|8|||
16841200|NCT01933789|37785383|FG005|Overall Study|Lost to Follow-up|9|||
16915139|NCT00639678|38024518|FG002|Overall Study|Withdrawal by Subject|4|||
16915140|NCT00639678|38024519|FG003|Overall Study|Withdrawal by Subject|0|||
16915141|NCT00639678|38024516|FG000|Overall Study|Lost to Follow-up|1|||
16915142|NCT00639678|38024517|FG001|Overall Study|Lost to Follow-up|0|||
16915143|NCT00639678|38024518|FG002|Overall Study|Lost to Follow-up|6|||
16915144|NCT00639678|38024519|FG003|Overall Study|Lost to Follow-up|0|||
16915145|NCT00639678|38024516|FG000|Overall Study|Adverse Event|0|||
16915146|NCT00639678|38024517|FG001|Overall Study|Adverse Event|1|||
16915147|NCT00639678|38024518|FG002|Overall Study|Adverse Event|0|||
16915148|NCT00639678|38024519|FG003|Overall Study|Adverse Event|0|||
16915149|NCT00639678|38024516|FG000|Overall Study|Lack of Compliance|0|||
16915150|NCT00639678|38024517|FG001|Overall Study|Lack of Compliance|0|||
16915151|NCT00639678|38024518|FG002|Overall Study|Lack of Compliance|1|||
16915152|NCT00639678|38024519|FG003|Overall Study|Lack of Compliance|0|||
16915153|NCT00638508|38024544|FG000|Overall Study|Physician Decision|5|||
16915154|NCT00638508|38024545|FG001|Overall Study|Physician Decision|2|||
16915155|NCT00637806|38024558|FG000|Double-blind Phase|Study Discontinued|2|||
16915156|NCT00637806|38024559|FG001|Double-blind Phase|Study Discontinued|0|||
16915157|NCT00637806|38024560|FG002|Double-blind Phase|Study Discontinued|1|||
16915158|NCT00637806|38024561|FG003|Double-blind Phase|Study Discontinued|0|||
16915159|NCT00637806|38024558|FG000|Extension Phase|Study Discontinued|0|||
16915160|NCT00637806|38024559|FG001|Extension Phase|Study Discontinued|0|||
16915161|NCT00637806|38024560|FG002|Extension Phase|Study Discontinued|0|||
16915162|NCT00637806|38024561|FG003|Extension Phase|Study Discontinued|1|||
16915163|NCT00637728|38024572|FG000|Double-blind Phase|Adverse Event|1|||
16915164|NCT00637728|38024573|FG001|Double-blind Phase|Adverse Event|0|||
16915165|NCT00637728|38024574|FG002|Double-blind Phase|Adverse Event|0|||
16915166|NCT00637728|38024572|FG000|Double-blind Phase|Non-compliance|2|||
16915167|NCT00637728|38024573|FG001|Double-blind Phase|Non-compliance|0|||
16915168|NCT00637728|38024574|FG002|Double-blind Phase|Non-compliance|0|||
16915169|NCT00637728|38024572|FG000|Double-blind Phase|Study Discontinued|1|||
16915170|NCT00637728|38024573|FG001|Double-blind Phase|Study Discontinued|1|||
16915171|NCT00637728|38024574|FG002|Double-blind Phase|Study Discontinued|0|||
16915172|NCT00637572|38024583|FG000|Overall Study|Adverse Event|1|||
16915173|NCT00637572|38024584|FG001|Overall Study|Adverse Event|2|||
16841201|NCT01933789|37785384|FG006|Overall Study|Lost to Follow-up|1|||
16841202|NCT01933789|37785385|FG007|Overall Study|Lost to Follow-up|4|||
16841203|NCT01933789|37785386|FG008|Overall Study|Lost to Follow-up|0|||
16841204|NCT01933789|37785378|FG000|Overall Study|Withdrawal by Subject|2|||
16841205|NCT01933789|37785379|FG001|Overall Study|Withdrawal by Subject|1|||
16841206|NCT01933789|37785380|FG002|Overall Study|Withdrawal by Subject|0|||
16841207|NCT01933789|37785381|FG003|Overall Study|Withdrawal by Subject|0|||
16841208|NCT01933789|37785382|FG004|Overall Study|Withdrawal by Subject|17|||
16841209|NCT01933789|37785383|FG005|Overall Study|Withdrawal by Subject|16|||
16841210|NCT01933789|37785384|FG006|Overall Study|Withdrawal by Subject|1|||
16841211|NCT01933789|37785385|FG007|Overall Study|Withdrawal by Subject|4|||
16841212|NCT01933789|37785386|FG008|Overall Study|Withdrawal by Subject|0|||
16841213|NCT01933789|37785378|FG000|Overall Study|Became Ineligible|4|||
16841214|NCT01933789|37785379|FG001|Overall Study|Became Ineligible|0|||
16915174|NCT00637572|38024583|FG000|Overall Study|Death|0|||
16915175|NCT00637572|38024584|FG001|Overall Study|Death|1|||
16841215|NCT01933789|37785380|FG002|Overall Study|Became Ineligible|0|||
16915176|NCT00637572|38024583|FG000|Overall Study|Lost to Follow-up|0|||
16915177|NCT00637572|38024584|FG001|Overall Study|Lost to Follow-up|1|||
16915178|NCT00637572|38024583|FG000|Overall Study|Physician Decision|1|||
16915179|NCT00637572|38024584|FG001|Overall Study|Physician Decision|1|||
16915180|NCT00637572|38024583|FG000|Overall Study|Withdrawal by Subject|0|||
16915181|NCT00637572|38024584|FG001|Overall Study|Withdrawal by Subject|2|||
16915182|NCT00637572|38024583|FG000|Overall Study|Illicit Drug Use|1|||
16841216|NCT01933789|37785381|FG003|Overall Study|Became Ineligible|0|||
16841217|NCT01933789|37785382|FG004|Overall Study|Became Ineligible|13|||
16915183|NCT00637572|38024584|FG001|Overall Study|Illicit Drug Use|0|||
16915184|NCT00637416|38024592|FG000|Overall Study|Lost to Follow-up|1|||
16915185|NCT00637416|38024593|FG001|Overall Study|Lost to Follow-up|1|||
16915186|NCT00637416|38024592|FG000|Overall Study|Unable to take study drug|0|||
16915187|NCT00637416|38024593|FG001|Overall Study|Unable to take study drug|1|||
16915188|NCT00636792|38024599|FG000|Overall Study|Adverse Event|16|||
16915189|NCT00636792|38024599|FG000|Overall Study|Physician Decision|7|||
16915190|NCT00636792|38024599|FG000|Overall Study|Progressive Disease|4|||
16915191|NCT00636792|38024599|FG000|Overall Study|Withdrawal by Subject|3|||
16915192|NCT00636792|38024599|FG000|Overall Study|Other|3|||
16915193|NCT00636636|38024631|FG000|Overall Study|Other reason|4|||
16915194|NCT00636636|38024632|FG001|Overall Study|Other reason|6|||
16915195|NCT00636636|38024631|FG000|Overall Study|Adverse Event|19|||
16915196|NCT00636636|38024632|FG001|Overall Study|Adverse Event|8|||
16915197|NCT00636636|38024631|FG000|Overall Study|Lack of Efficacy|7|||
16915198|NCT00636636|38024632|FG001|Overall Study|Lack of Efficacy|12|||
16915199|NCT00636636|38024631|FG000|Overall Study|Protocol Violation|2|||
16915200|NCT00636636|38024632|FG001|Overall Study|Protocol Violation|2|||
16915201|NCT00636636|38024631|FG000|Overall Study|Lost to Follow-up|0|||
16915202|NCT00636636|38024632|FG001|Overall Study|Lost to Follow-up|1|||
16915203|NCT00636636|38024631|FG000|Overall Study|Death|0|||
16915204|NCT00636636|38024632|FG001|Overall Study|Death|1|||
16915205|NCT00636636|38024631|FG000|Overall Study|Withdrawal by Subject|4|||
16915206|NCT00636636|38024632|FG001|Overall Study|Withdrawal by Subject|9|||
16915207|NCT00635778|38024645|FG000|Overall Study|Adverse Event|1|||
16915208|NCT00635778|38024646|FG001|Overall Study|Adverse Event|0|||
16915209|NCT00635778|38024647|FG002|Overall Study|Adverse Event|0|||
16915210|NCT00635778|38024648|FG003|Overall Study|Adverse Event|3|||
16915211|NCT00635778|38024649|FG004|Overall Study|Adverse Event|3|||
16915212|NCT00635778|38024650|FG005|Overall Study|Adverse Event|6|||
16841218|NCT01933789|37785383|FG005|Overall Study|Became Ineligible|10|||
16841219|NCT01933789|37785384|FG006|Overall Study|Became Ineligible|13|||
16841220|NCT01933789|37785385|FG007|Overall Study|Became Ineligible|6|||
16841221|NCT01933789|37785386|FG008|Overall Study|Became Ineligible|0|||
16841222|NCT01910389|37785408|FG000|Overall Study|Withdrawal by Subject|2|||
16841223|NCT01910389|37785409|FG001|Overall Study|Withdrawal by Subject|0|||
16841224|NCT01910389|37785408|FG000|Overall Study|Study Closed|13|||
16841225|NCT01910389|37785409|FG001|Overall Study|Study Closed|8|||
16841226|NCT01970995|37785418|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
16841227|NCT01970995|37785419|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
16841228|NCT01970995|37785420|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
16915213|NCT00635778|38024651|FG006|Overall Study|Adverse Event|1|||
16841229|NCT01970995|37785418|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
16841230|NCT01970995|37785419|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
16841231|NCT01970995|37785420|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
16841232|NCT01932697|37785430|FG000|Overall Study|Received a different amount of tx|1|||
16915214|NCT00635778|38024645|FG000|Overall Study|Withdrawal by Subject|0|||
16915215|NCT00635778|38024646|FG001|Overall Study|Withdrawal by Subject|0|||
16915216|NCT00635778|38024647|FG002|Overall Study|Withdrawal by Subject|0|||
16915217|NCT00635778|38024648|FG003|Overall Study|Withdrawal by Subject|1|||
16841233|NCT01932697|37785431|FG001|Overall Study|Received a different amount of tx|0|||
16915218|NCT00635778|38024649|FG004|Overall Study|Withdrawal by Subject|0|||
16915219|NCT00635778|38024650|FG005|Overall Study|Withdrawal by Subject|1|||
16841234|NCT01932697|37785430|FG000|Overall Study|Ineligible|1|||
16915220|NCT00635778|38024651|FG006|Overall Study|Withdrawal by Subject|1|||
16915221|NCT00635778|38024645|FG000|Overall Study|Progressive disease|0|||
16841235|NCT01932697|37785431|FG001|Overall Study|Ineligible|0|||
16841236|NCT01970527|37785441|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
16841237|NCT01970527|37785442|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
16915222|NCT00635778|38024646|FG001|Overall Study|Progressive disease|3|||
16915223|NCT00635778|38024647|FG002|Overall Study|Progressive disease|3|||
16915224|NCT00635778|38024648|FG003|Overall Study|Progressive disease|4|||
16915225|NCT00635778|38024649|FG004|Overall Study|Progressive disease|5|||
16915226|NCT00635778|38024650|FG005|Overall Study|Progressive disease|14|||
16915227|NCT00635778|38024651|FG006|Overall Study|Progressive disease|4|||
16915228|NCT00634920|38024671|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
16915229|NCT00634920|38024672|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
16915230|NCT00634920|38024673|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
16841238|NCT01970527|37785441|FG000|Treatment|Disease progression|0|||
16841239|NCT01970527|37785442|FG001|Treatment|Disease progression|1|||
16841240|NCT01970527|37785441|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
16841241|NCT01970527|37785442|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
16841242|NCT01970527|37785441|FG000|Treatment|Death|0|||
16841243|NCT01970527|37785442|FG001|Treatment|Death|1|||
16841244|NCT01970527|37785441|FG000|Follow-up Clinic Visit|Disease progression|1|||
16841245|NCT01970527|37785442|FG001|Follow-up Clinic Visit|Disease progression|1|||
16841246|NCT01970527|37785441|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
16841247|NCT01970527|37785442|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
16915231|NCT00634920|38024671|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
16915232|NCT00634920|38024672|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
16915233|NCT00634920|38024673|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
16915234|NCT00634920|38024671|FG000|Period 1 - Pre-Randomization|Rejections|0|||
16915235|NCT00634920|38024672|FG001|Period 1 - Pre-Randomization|Rejections|0|||
16915236|NCT00634920|38024673|FG002|Period 1 - Pre-Randomization|Rejections|55|||
16915237|NCT00634920|38024671|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
16915238|NCT00634920|38024672|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
16915239|NCT00634920|38024673|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
16915240|NCT00634920|38024671|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
16915241|NCT00634920|38024672|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
16915242|NCT00634920|38024673|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
16915243|NCT00634920|38024671|FG000|Period 1 - Pre-Randomization|Other issues|0|||
16915244|NCT00634920|38024672|FG001|Period 1 - Pre-Randomization|Other issues|0|||
16915245|NCT00634920|38024673|FG002|Period 1 - Pre-Randomization|Other issues|6|||
16841248|NCT01970527|37785441|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
16841249|NCT01970527|37785442|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
16841250|NCT01931995|37785453|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
16841251|NCT01931995|37785454|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
16841252|NCT01931995|37785453|FG000|First Intervention (1 Day)|Physician Decision|1|||
16841253|NCT01931995|37785454|FG001|First Intervention (1 Day)|Physician Decision|1|||
16841254|NCT01931995|37785453|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
16841255|NCT01931995|37785454|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
16841256|NCT01408576|37785463|FG000|Overall Study|Lack of Efficacy|17|||
16841257|NCT01408576|37785464|FG001|Overall Study|Lack of Efficacy|30|||
16841258|NCT01408576|37785465|FG002|Overall Study|Lack of Efficacy|48|||
16841259|NCT01408576|37785463|FG000|Overall Study|Protocol Violation|1|||
16841260|NCT01408576|37785464|FG001|Overall Study|Protocol Violation|2|||
16841261|NCT01408576|37785465|FG002|Overall Study|Protocol Violation|2|||
16841262|NCT01408576|37785463|FG000|Overall Study|Lost to Follow-up|10|||
16841263|NCT01408576|37785464|FG001|Overall Study|Lost to Follow-up|9|||
16841264|NCT01408576|37785465|FG002|Overall Study|Lost to Follow-up|17|||
16841265|NCT01408576|37785463|FG000|Overall Study|Withdrawal by Subject|34|||
16841266|NCT01408576|37785464|FG001|Overall Study|Withdrawal by Subject|60|||
16841267|NCT01408576|37785465|FG002|Overall Study|Withdrawal by Subject|66|||
16841268|NCT01408576|37785463|FG000|Overall Study|Sponsor terminated study|89|||
16841269|NCT01408576|37785464|FG001|Overall Study|Sponsor terminated study|333|||
16841270|NCT01408576|37785465|FG002|Overall Study|Sponsor terminated study|330|||
16841271|NCT01408576|37785463|FG000|Overall Study|AE, serious fatal|4|||
16841272|NCT01408576|37785464|FG001|Overall Study|AE, serious fatal|4|||
16841273|NCT01408576|37785465|FG002|Overall Study|AE, serious fatal|1|||
16915246|NCT00634920|38024671|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
16915247|NCT00634920|38024672|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
16915248|NCT00634920|38024673|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
16915249|NCT00634920|38024671|FG000|Period 2 - Post-Randomization|Rejection|11|||
16915250|NCT00634920|38024672|FG001|Period 2 - Post-Randomization|Rejection|5|||
16841274|NCT01408576|37785463|FG000|Overall Study|SAE, non-fatal|11|||
16841275|NCT01408576|37785464|FG001|Overall Study|SAE, non-fatal|23|||
16841276|NCT01408576|37785465|FG002|Overall Study|SAE, non-fatal|14|||
16841277|NCT01408576|37785463|FG000|Overall Study|AE, non-serious non-fatal|12|||
16841278|NCT01408576|37785464|FG001|Overall Study|AE, non-serious non-fatal|19|||
16841279|NCT01408576|37785465|FG002|Overall Study|AE, non-serious non-fatal|11|||
16841280|NCT01408576|37785463|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16841281|NCT01408576|37785464|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16841282|NCT01408576|37785465|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16841283|NCT01408576|37785463|FG000|Overall Study|AE, unknown type|0|||
16841284|NCT01408576|37785464|FG001|Overall Study|AE, unknown type|1|||
16841285|NCT01408576|37785465|FG002|Overall Study|AE, unknown type|0|||
16841286|NCT01408576|37785463|FG000|Overall Study|Other|10|||
16841287|NCT01408576|37785464|FG001|Overall Study|Other|16|||
16841288|NCT01408576|37785465|FG002|Overall Study|Other|18|||
16841289|NCT01427920|37785487|FG000|Overall Study|Adverse Event|1|||
16841290|NCT01427920|37785488|FG001|Overall Study|Adverse Event|2|||
16841291|NCT01427920|37785487|FG000|Overall Study|Lack of Efficacy|1|||
16841292|NCT01427920|37785488|FG001|Overall Study|Lack of Efficacy|0|||
16841293|NCT01427920|37785487|FG000|Overall Study|Protocol Violation|1|||
16841294|NCT01427920|37785488|FG001|Overall Study|Protocol Violation|3|||
16841295|NCT01427920|37785487|FG000|Overall Study|Withdrawal Criteria|4|||
16841296|NCT01427920|37785488|FG001|Overall Study|Withdrawal Criteria|4|||
16841297|NCT01427920|37785487|FG000|Overall Study|Unclassified|2|||
16841298|NCT01427920|37785488|FG001|Overall Study|Unclassified|8|||
16841299|NCT01427608|37785496|FG000|Overall Study|Death|1|||
16841300|NCT01427608|37785497|FG001|Overall Study|Death|0|||
16841301|NCT01427608|37785496|FG000|Overall Study|Withdrawal by Subject|7|||
16841302|NCT01427608|37785497|FG001|Overall Study|Withdrawal by Subject|3|||
16841303|NCT01427608|37785496|FG000|Overall Study|Relapsed-all cause|13|||
16841304|NCT01427608|37785497|FG001|Overall Study|Relapsed-all cause|34|||
16841305|NCT01427608|37785496|FG000|Overall Study|Events not attributed to study meds|0|||
16841306|NCT01427608|37785497|FG001|Overall Study|Events not attributed to study meds|1|||
16841307|NCT01408030|37785509|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
16841308|NCT01408030|37785510|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
16841309|NCT01408030|37785511|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
16841310|NCT01408030|37785512|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
16841311|NCT01408030|37785509|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
16841312|NCT01408030|37785510|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
16841313|NCT01408030|37785511|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
16841314|NCT01408030|37785512|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
16841315|NCT01408030|37785509|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
16841316|NCT01408030|37785510|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
16841317|NCT01408030|37785511|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
16841318|NCT01408030|37785512|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
16841319|NCT01408030|37785509|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
16841320|NCT01408030|37785510|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
16841321|NCT01408030|37785511|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
16841322|NCT01408030|37785512|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
16841323|NCT01408030|37785509|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
16841324|NCT01408030|37785510|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
16841325|NCT01408030|37785511|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
16841326|NCT01408030|37785512|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
16841327|NCT01408030|37785509|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
16841328|NCT01408030|37785510|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
16841329|NCT01408030|37785511|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
16841330|NCT01408030|37785512|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
16841331|NCT01408030|37785509|FG000|Observation Phase (Off Drug)|Other|1|||
16841332|NCT01408030|37785510|FG001|Observation Phase (Off Drug)|Other|1|||
16841333|NCT01408030|37785511|FG002|Observation Phase (Off Drug)|Other|1|||
16841334|NCT01408030|37785512|FG003|Observation Phase (Off Drug)|Other|1|||
16841335|NCT01897532|37785524|FG000|Discontinuation From Treatment|Not Treated|7|||
16841336|NCT01897532|37785525|FG001|Discontinuation From Treatment|Not Treated|5|||
16841337|NCT01897532|37785524|FG000|Discontinuation From Treatment|Other reason than specified|196|||
16841338|NCT01897532|37785525|FG001|Discontinuation From Treatment|Other reason than specified|176|||
16841339|NCT01897532|37785524|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
16841340|NCT01897532|37785525|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
16841341|NCT01897532|37785524|FG000|Discontinuation From Treatment|Non compliance|24|||
16841342|NCT01897532|37785525|FG001|Discontinuation From Treatment|Non compliance|15|||
16841343|NCT01897532|37785524|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
16841344|NCT01897532|37785525|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
16841345|NCT01897532|37785524|FG000|Discontinuation From Trial|Not Treated|7|||
16841346|NCT01897532|37785525|FG001|Discontinuation From Trial|Not Treated|5|||
17016831|NCT00848718|38161502|FG008|Overall Study|Adverse Event|1|||
16841347|NCT01897532|37785524|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
16841348|NCT01897532|37785525|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
16841349|NCT01923428|37785535|FG000|Overall Study|Adverse Event|8|||
16841350|NCT01923428|37785536|FG001|Overall Study|Adverse Event|6|||
16841351|NCT01923428|37785537|FG002|Overall Study|Adverse Event|3|||
16841352|NCT01923428|37785538|FG003|Overall Study|Adverse Event|3|||
16841353|NCT01923428|37785535|FG000|Overall Study|Withdrawal by Subject|5|||
16841354|NCT01923428|37785536|FG001|Overall Study|Withdrawal by Subject|3|||
16841355|NCT01923428|37785537|FG002|Overall Study|Withdrawal by Subject|0|||
16841356|NCT01923428|37785538|FG003|Overall Study|Withdrawal by Subject|4|||
16841357|NCT01923428|37785535|FG000|Overall Study|Lost to Follow-up|2|||
16841358|NCT01923428|37785536|FG001|Overall Study|Lost to Follow-up|1|||
16841359|NCT01923428|37785537|FG002|Overall Study|Lost to Follow-up|5|||
16841360|NCT01923428|37785538|FG003|Overall Study|Lost to Follow-up|0|||
16841361|NCT01923428|37785535|FG000|Overall Study|Protocol Violation|3|||
16841362|NCT01923428|37785536|FG001|Overall Study|Protocol Violation|0|||
16841363|NCT01923428|37785537|FG002|Overall Study|Protocol Violation|2|||
16915251|NCT00634920|38024673|FG002|Period 2 - Post-Randomization|Rejection|0|||
16915252|NCT00634920|38024671|FG000|Period 2 - Post-Randomization|Death|2|||
16915253|NCT00634920|38024672|FG001|Period 2 - Post-Randomization|Death|5|||
16915254|NCT00634920|38024673|FG002|Period 2 - Post-Randomization|Death|0|||
16915255|NCT00634920|38024671|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
16915256|NCT00634920|38024672|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
16915257|NCT00634920|38024673|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
16915258|NCT00634920|38024671|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
16915259|NCT00634920|38024672|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
16915260|NCT00634920|38024673|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
16915261|NCT00634842|38024681|FG000|Overall Study|Adverse Event|2|||
16915262|NCT00634842|38024682|FG001|Overall Study|Adverse Event|3|||
16915263|NCT00634842|38024681|FG000|Overall Study|Protocol Violation|8|||
16915264|NCT00634842|38024682|FG001|Overall Study|Protocol Violation|4|||
16915265|NCT00634842|38024681|FG000|Overall Study|Move to another state|1|||
16915266|NCT00634842|38024682|FG001|Overall Study|Move to another state|0|||
16915267|NCT00634842|38024681|FG000|Overall Study|Inclusion criteria were not met|1|||
16915268|NCT00634842|38024682|FG001|Overall Study|Inclusion criteria were not met|0|||
16915269|NCT00634842|38024681|FG000|Overall Study|Lost to Follow-up|1|||
16915270|NCT00634842|38024682|FG001|Overall Study|Lost to Follow-up|2|||
16915271|NCT00634842|38024681|FG000|Overall Study|Physician Decision|1|||
16915272|NCT00634842|38024682|FG001|Overall Study|Physician Decision|0|||
16915273|NCT00634842|38024681|FG000|Overall Study|Withdrawal by Subject|1|||
16915274|NCT00634842|38024682|FG001|Overall Study|Withdrawal by Subject|3|||
16915275|NCT00634842|38024681|FG000|Overall Study|Lack of time and intolerance to drug|0|||
16915276|NCT00634842|38024682|FG001|Overall Study|Lack of time and intolerance to drug|1|||
16915277|NCT00634842|38024681|FG000|Overall Study|Discontinued due to injection|0|||
16915278|NCT00634842|38024682|FG001|Overall Study|Discontinued due to injection|2|||
16915279|NCT00634842|38024681|FG000|Overall Study|No need of study drug to treat diabetes|0|||
16915280|NCT00634842|38024682|FG001|Overall Study|No need of study drug to treat diabetes|1|||
16915281|NCT00634842|38024681|FG000|Overall Study|No wish to keep taking Avandia|0|||
16915282|NCT00634842|38024682|FG001|Overall Study|No wish to keep taking Avandia|1|||
16915283|NCT00634842|38024681|FG000|Overall Study|Subject off study drug for too long|0|||
16841364|NCT01923428|37785538|FG003|Overall Study|Protocol Violation|1|||
16841365|NCT01923428|37785535|FG000|Overall Study|Non Compliance to treatment|1|||
16841366|NCT01923428|37785536|FG001|Overall Study|Non Compliance to treatment|2|||
16841367|NCT01923428|37785537|FG002|Overall Study|Non Compliance to treatment|0|||
16841368|NCT01923428|37785538|FG003|Overall Study|Non Compliance to treatment|1|||
16841369|NCT01923428|37785535|FG000|Overall Study|Lack of Efficacy|0|||
16841370|NCT01923428|37785536|FG001|Overall Study|Lack of Efficacy|0|||
16841371|NCT01923428|37785537|FG002|Overall Study|Lack of Efficacy|1|||
16841372|NCT01923428|37785538|FG003|Overall Study|Lack of Efficacy|1|||
16841373|NCT01896986|37785550|FG000|Overall Study|samples lost|14|||
16841374|NCT01896986|37785551|FG001|Overall Study|samples lost|23|||
16841375|NCT01896128|37785559|FG000|Overall Study|Withdrawal by Subject|3|||
16841376|NCT01896128|37785560|FG001|Overall Study|Withdrawal by Subject|3|||
16841377|NCT01949870|37785566|FG000|Overall Study|Lack of Efficacy|2|||
16841378|NCT01949870|37785566|FG000|Overall Study|Adverse Event|1|||
16841379|NCT01949870|37785566|FG000|Overall Study|Study termination|1|||
16841380|NCT01949870|37785566|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
16841381|NCT01949480|37785572|FG000|Overall Study|Physician Decision|5|||
16841382|NCT01949480|37785573|FG001|Overall Study|Physician Decision|8|||
16841383|NCT01949090|37785584|FG000|Overall Study|Serious Adverse Event|0|||
16841384|NCT01949090|37785585|FG001|Overall Study|Serious Adverse Event|1|||
16841385|NCT01949090|37785586|FG002|Overall Study|Serious Adverse Event|2|||
16841386|NCT01949090|37785587|FG003|Overall Study|Serious Adverse Event|0|||
16841387|NCT01949090|37785588|FG004|Overall Study|Serious Adverse Event|1|||
16841388|NCT01949090|37785584|FG000|Overall Study|Withdrawal by Subject|2|||
16841389|NCT01949090|37785585|FG001|Overall Study|Withdrawal by Subject|0|||
16841390|NCT01949090|37785586|FG002|Overall Study|Withdrawal by Subject|0|||
16841391|NCT01949090|37785587|FG003|Overall Study|Withdrawal by Subject|0|||
16841392|NCT01949090|37785588|FG004|Overall Study|Withdrawal by Subject|1|||
16841393|NCT01949090|37785584|FG000|Overall Study|Protocol non-compliance|0|||
16841394|NCT01949090|37785585|FG001|Overall Study|Protocol non-compliance|0|||
16841395|NCT01949090|37785586|FG002|Overall Study|Protocol non-compliance|0|||
16841396|NCT01949090|37785587|FG003|Overall Study|Protocol non-compliance|0|||
16841397|NCT01949090|37785588|FG004|Overall Study|Protocol non-compliance|1|||
16841398|NCT01949090|37785584|FG000|Overall Study|Lost to Follow-up|2|||
16841399|NCT01949090|37785585|FG001|Overall Study|Lost to Follow-up|1|||
16841400|NCT01949090|37785586|FG002|Overall Study|Lost to Follow-up|0|||
16915284|NCT00634842|38024682|FG001|Overall Study|Subject off study drug for too long|1|||
16915285|NCT00633984|38024690|FG000|Overall Study|Lost to Follow-up|0|||
16915286|NCT00633984|38024691|FG001|Overall Study|Lost to Follow-up|6|||
16915287|NCT00633984|38024690|FG000|Overall Study|Withdrawal by Subject|8|||
16915288|NCT00633984|38024691|FG001|Overall Study|Withdrawal by Subject|7|||
16915289|NCT00633984|38024690|FG000|Overall Study|Hospitalized|1|||
16915290|NCT00633984|38024691|FG001|Overall Study|Hospitalized|0|||
16915291|NCT01921218|38024719|FG000|Overall Study|Death|2|||
16841401|NCT01949090|37785587|FG003|Overall Study|Lost to Follow-up|1|||
16841402|NCT01949090|37785588|FG004|Overall Study|Lost to Follow-up|1|||
16841403|NCT01948076|37785603|FG000|Overall Study|Withdrawal by Subject|0|||
16841404|NCT01948076|37785604|FG001|Overall Study|Withdrawal by Subject|1|||
16841405|NCT01922258|37785614|FG000|Overall Study|Lost to Follow-up|1|||
16841406|NCT01922258|37785615|FG001|Overall Study|Lost to Follow-up|1|||
16841407|NCT01922258|37785614|FG000|Overall Study|Adverse Event|9|||
16841408|NCT01922258|37785615|FG001|Overall Study|Adverse Event|2|||
16841409|NCT01922258|37785614|FG000|Overall Study|Met Withdrawal Criteria|0|||
16841410|NCT01922258|37785615|FG001|Overall Study|Met Withdrawal Criteria|4|||
16841411|NCT01922258|37785614|FG000|Overall Study|Withdrawn by the Investigator|1|||
16841412|NCT01922258|37785615|FG001|Overall Study|Withdrawn by the Investigator|4|||
16841413|NCT01922258|37785614|FG000|Overall Study|Withdrawal by participant|5|||
16841414|NCT01922258|37785615|FG001|Overall Study|Withdrawal by participant|5|||
16841415|NCT01406938|37785623|FG000|Induction Period|Subject/guardian decision|6|||
16841416|NCT01406938|37785624|FG001|Induction Period|Subject/guardian decision|8|||
16841417|NCT01406938|37785625|FG002|Induction Period|Subject/guardian decision|0|||
16841418|NCT01406938|37785626|FG003|Induction Period|Subject/guardian decision|0|||
16841419|NCT01406938|37785627|FG004|Induction Period|Subject/guardian decision|0|||
16841420|NCT01406938|37785628|FG005|Induction Period|Subject/guardian decision|0|||
16841421|NCT01406938|37785623|FG000|Induction Period|Protocol deviation|1|||
16841422|NCT01406938|37785624|FG001|Induction Period|Protocol deviation|0|||
16841423|NCT01406938|37785625|FG002|Induction Period|Protocol deviation|0|||
16841424|NCT01406938|37785626|FG003|Induction Period|Protocol deviation|0|||
16841425|NCT01406938|37785627|FG004|Induction Period|Protocol deviation|0|||
16841426|NCT01406938|37785628|FG005|Induction Period|Protocol deviation|0|||
16841427|NCT01406938|37785623|FG000|Induction Period|Adverse Event|8|||
16841428|NCT01406938|37785624|FG001|Induction Period|Adverse Event|9|||
16841429|NCT01406938|37785625|FG002|Induction Period|Adverse Event|0|||
16841430|NCT01406938|37785626|FG003|Induction Period|Adverse Event|0|||
16841431|NCT01406938|37785627|FG004|Induction Period|Adverse Event|0|||
16841432|NCT01406938|37785628|FG005|Induction Period|Adverse Event|0|||
16841433|NCT01406938|37785623|FG000|Induction Period|Lack of Efficacy|1|||
16841434|NCT01406938|37785624|FG001|Induction Period|Lack of Efficacy|0|||
16841435|NCT01406938|37785625|FG002|Induction Period|Lack of Efficacy|0|||
16841436|NCT01406938|37785626|FG003|Induction Period|Lack of Efficacy|0|||
16841437|NCT01406938|37785627|FG004|Induction Period|Lack of Efficacy|0|||
16841438|NCT01406938|37785628|FG005|Induction Period|Lack of Efficacy|0|||
16841439|NCT01406938|37785623|FG000|Induction Period|Lost to Follow-up|2|||
16841440|NCT01406938|37785624|FG001|Induction Period|Lost to Follow-up|3|||
16841441|NCT01406938|37785625|FG002|Induction Period|Lost to Follow-up|0|||
16841442|NCT01406938|37785626|FG003|Induction Period|Lost to Follow-up|0|||
16841443|NCT01406938|37785627|FG004|Induction Period|Lost to Follow-up|0|||
16841444|NCT01406938|37785628|FG005|Induction Period|Lost to Follow-up|0|||
16841445|NCT01406938|37785623|FG000|Maintenance Period|Adverse Event|0|||
16841446|NCT01406938|37785624|FG001|Maintenance Period|Adverse Event|0|||
16841447|NCT01406938|37785625|FG002|Maintenance Period|Adverse Event|2|||
16841448|NCT01406938|37785626|FG003|Maintenance Period|Adverse Event|8|||
16841449|NCT01406938|37785627|FG004|Maintenance Period|Adverse Event|4|||
16841450|NCT01406938|37785628|FG005|Maintenance Period|Adverse Event|2|||
16841451|NCT01406938|37785623|FG000|Maintenance Period|Death|0|||
16841452|NCT01406938|37785624|FG001|Maintenance Period|Death|0|||
16841453|NCT01406938|37785625|FG002|Maintenance Period|Death|0|||
16841454|NCT01406938|37785626|FG003|Maintenance Period|Death|0|||
16841455|NCT01406938|37785627|FG004|Maintenance Period|Death|1|||
16915292|NCT01921218|38024720|FG001|Overall Study|Death|1|||
16915293|NCT01921218|38024719|FG000|Overall Study|Withdrawal by Subject|0|||
16841456|NCT01406938|37785628|FG005|Maintenance Period|Death|0|||
16841457|NCT01406938|37785623|FG000|Maintenance Period|Subject/guardian decision|0|||
16841458|NCT01406938|37785624|FG001|Maintenance Period|Subject/guardian decision|0|||
16841459|NCT01406938|37785625|FG002|Maintenance Period|Subject/guardian decision|11|||
16841460|NCT01406938|37785626|FG003|Maintenance Period|Subject/guardian decision|7|||
16841461|NCT01406938|37785627|FG004|Maintenance Period|Subject/guardian decision|10|||
16841462|NCT01406938|37785628|FG005|Maintenance Period|Subject/guardian decision|7|||
16841463|NCT01406938|37785623|FG000|Maintenance Period|Protocol Violation|0|||
16841464|NCT01406938|37785624|FG001|Maintenance Period|Protocol Violation|0|||
16841465|NCT01406938|37785625|FG002|Maintenance Period|Protocol Violation|2|||
16841466|NCT01406938|37785626|FG003|Maintenance Period|Protocol Violation|2|||
16841467|NCT01406938|37785627|FG004|Maintenance Period|Protocol Violation|2|||
16841468|NCT01406938|37785628|FG005|Maintenance Period|Protocol Violation|2|||
16841469|NCT01406938|37785623|FG000|Maintenance Period|Pregnancy|0|||
16841470|NCT01406938|37785624|FG001|Maintenance Period|Pregnancy|0|||
16841471|NCT01406938|37785625|FG002|Maintenance Period|Pregnancy|0|||
16841472|NCT01406938|37785626|FG003|Maintenance Period|Pregnancy|0|||
16841473|NCT01406938|37785627|FG004|Maintenance Period|Pregnancy|1|||
16841474|NCT01406938|37785628|FG005|Maintenance Period|Pregnancy|0|||
16841475|NCT01406938|37785623|FG000|Maintenance Period|Lost to Follow-up|0|||
16841476|NCT01406938|37785624|FG001|Maintenance Period|Lost to Follow-up|0|||
16841477|NCT01406938|37785625|FG002|Maintenance Period|Lost to Follow-up|0|||
16841478|NCT01406938|37785626|FG003|Maintenance Period|Lost to Follow-up|0|||
16841479|NCT01406938|37785627|FG004|Maintenance Period|Lost to Follow-up|4|||
16841480|NCT01406938|37785628|FG005|Maintenance Period|Lost to Follow-up|0|||
16841481|NCT01406938|37785623|FG000|Maintenance Period|Lack of Efficacy|0|||
16841482|NCT01406938|37785624|FG001|Maintenance Period|Lack of Efficacy|0|||
16841483|NCT01406938|37785625|FG002|Maintenance Period|Lack of Efficacy|2|||
16841484|NCT01406938|37785626|FG003|Maintenance Period|Lack of Efficacy|1|||
16841485|NCT01406938|37785627|FG004|Maintenance Period|Lack of Efficacy|3|||
16841486|NCT01406938|37785628|FG005|Maintenance Period|Lack of Efficacy|5|||
16841487|NCT01406938|37785623|FG000|Follow up|Lack of Efficacy|3|||
16841488|NCT01406938|37785624|FG001|Follow up|Lack of Efficacy|2|||
16841489|NCT01406938|37785625|FG002|Follow up|Lack of Efficacy|1|||
16841490|NCT01406938|37785626|FG003|Follow up|Lack of Efficacy|0|||
16841491|NCT01406938|37785627|FG004|Follow up|Lack of Efficacy|0|||
16841492|NCT01406938|37785628|FG005|Follow up|Lack of Efficacy|0|||
16841493|NCT01406938|37785623|FG000|Follow up|Patient/guardian decision|4|||
16841494|NCT01406938|37785624|FG001|Follow up|Patient/guardian decision|2|||
16841495|NCT01406938|37785625|FG002|Follow up|Patient/guardian decision|4|||
16841496|NCT01406938|37785626|FG003|Follow up|Patient/guardian decision|2|||
16841497|NCT01406938|37785627|FG004|Follow up|Patient/guardian decision|4|||
16841498|NCT01406938|37785628|FG005|Follow up|Patient/guardian decision|1|||
16841499|NCT01406938|37785623|FG000|Follow up|Protocol Violation|0|||
16841500|NCT01406938|37785624|FG001|Follow up|Protocol Violation|0|||
16841501|NCT01406938|37785625|FG002|Follow up|Protocol Violation|1|||
16841502|NCT01406938|37785626|FG003|Follow up|Protocol Violation|0|||
16841503|NCT01406938|37785627|FG004|Follow up|Protocol Violation|0|||
16841504|NCT01406938|37785628|FG005|Follow up|Protocol Violation|0|||
16841505|NCT01406938|37785623|FG000|Follow up|Physician Decision|0|||
16841506|NCT01406938|37785624|FG001|Follow up|Physician Decision|0|||
16841507|NCT01406938|37785625|FG002|Follow up|Physician Decision|2|||
16841508|NCT01406938|37785626|FG003|Follow up|Physician Decision|0|||
16841509|NCT01406938|37785627|FG004|Follow up|Physician Decision|3|||
16841510|NCT01406938|37785628|FG005|Follow up|Physician Decision|1|||
16841511|NCT01406938|37785623|FG000|Follow up|Lost to Follow-up|1|||
16841512|NCT01406938|37785624|FG001|Follow up|Lost to Follow-up|1|||
16841513|NCT01406938|37785625|FG002|Follow up|Lost to Follow-up|0|||
16841514|NCT01406938|37785626|FG003|Follow up|Lost to Follow-up|1|||
16841515|NCT01406938|37785627|FG004|Follow up|Lost to Follow-up|2|||
16841516|NCT01406938|37785628|FG005|Follow up|Lost to Follow-up|1|||
16841517|NCT01405924|37785648|FG000|Overall Study|Protocol Violation|8|||
16841518|NCT01405924|37785648|FG000|Overall Study|Missing/Incomplete Data|2|||
16841519|NCT01426438|37785656|FG000|Overall Study|Lost to Follow-up|1|||
16841520|NCT01426438|37785657|FG001|Overall Study|Lost to Follow-up|3|||
16841521|NCT01426438|37785656|FG000|Overall Study|Off study Treatment|9|||
16841522|NCT01426438|37785657|FG001|Overall Study|Off study Treatment|3|||
16841523|NCT01426438|37785656|FG000|Overall Study|Poor scan quality|3|||
16841524|NCT01426438|37785657|FG001|Overall Study|Poor scan quality|2|||
16841525|NCT01426438|37785656|FG000|Overall Study|Missed Scan|2|||
16841526|NCT01426438|37785657|FG001|Overall Study|Missed Scan|2|||
16841527|NCT01425814|37785663|FG000|Period 1|Stability criteria not fulfilled|0|||
16841528|NCT01425814|37785664|FG001|Period 1|Stability criteria not fulfilled|1|||
16841529|NCT01425814|37785665|FG002|Period 1|Stability criteria not fulfilled|0|||
16841530|NCT01425814|37785666|FG003|Period 1|Stability criteria not fulfilled|0|||
16841531|NCT01425814|37785667|FG004|Period 1|Stability criteria not fulfilled|0|||
16841532|NCT01425814|37785668|FG005|Period 1|Stability criteria not fulfilled|0|||
16841533|NCT01425814|37785663|FG000|Period 2|Stability criteria not fulfilled|0|||
16841534|NCT01425814|37785664|FG001|Period 2|Stability criteria not fulfilled|1|||
16841535|NCT01425814|37785665|FG002|Period 2|Stability criteria not fulfilled|0|||
16841536|NCT01425814|37785666|FG003|Period 2|Stability criteria not fulfilled|0|||
16841537|NCT01425814|37785667|FG004|Period 2|Stability criteria not fulfilled|0|||
16841538|NCT01425814|37785668|FG005|Period 2|Stability criteria not fulfilled|0|||
16915294|NCT01921218|38024720|FG001|Overall Study|Withdrawal by Subject|2|||
16915295|NCT01921218|38024719|FG000|Overall Study|Kidney transplant|1|||
16915296|NCT01921218|38024720|FG001|Overall Study|Kidney transplant|1|||
16915297|NCT00633750|38024726|FG000|Overall Study|Adverse Event|2|||
16915298|NCT00633750|38024726|FG000|Overall Study|Withdrawal by Subject|3|||
16915299|NCT00633360|38024734|FG000|Overall Study|Lost to Follow-up|1|||
16841539|NCT01425814|37785663|FG000|Period 3|Adverse Event|0|||
16841540|NCT01425814|37785664|FG001|Period 3|Adverse Event|0|||
16841541|NCT01425814|37785665|FG002|Period 3|Adverse Event|0|||
16841542|NCT01425814|37785666|FG003|Period 3|Adverse Event|0|||
16841543|NCT01425814|37785667|FG004|Period 3|Adverse Event|0|||
16841544|NCT01425814|37785668|FG005|Period 3|Adverse Event|1|||
16915300|NCT00633360|38024735|FG001|Overall Study|Lost to Follow-up|1|||
16915301|NCT00633360|38024734|FG000|Overall Study|Adverse Event|3|||
16915302|NCT00633360|38024735|FG001|Overall Study|Adverse Event|1|||
16915303|NCT00633360|38024734|FG000|Overall Study|Protocol Violation|0|||
16915304|NCT00633360|38024735|FG001|Overall Study|Protocol Violation|1|||
16915305|NCT00633126|38024743|FG000|Overall Study|Did not receive full dose|1|||
16915306|NCT00989664|38024747|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
16915307|NCT00989664|38024747|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
16915308|NCT00989664|38024747|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
16915309|NCT00989664|38024747|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
16915310|NCT00989664|38024747|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
16915311|NCT00989664|38024747|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
16915312|NCT00989664|38024747|FG000|Long-Term Follow-Up|Death|3|||
16915313|NCT00632736|38024753|FG000|Overall Study|Adverse Event|104|||
16915314|NCT00632736|38024753|FG000|Overall Study|Lost to Follow-up|15|||
16915315|NCT00632736|38024753|FG000|Overall Study|Protocol Violation|14|||
16915316|NCT00632736|38024753|FG000|Overall Study|Withdrawal by Subject|99|||
16915317|NCT00632736|38024753|FG000|Overall Study|Lack of Efficacy|5|||
16915318|NCT00632736|38024753|FG000|Overall Study|Sponsor terminated study|5|||
16915319|NCT00632736|38024753|FG000|Overall Study|Non-compliance|10|||
16915320|NCT00632736|38024753|FG000|Overall Study|Other|16|||
16915321|NCT00989196|38024757|FG000|Treatment Period|Lost to Follow-up|1|||
16915322|NCT00989196|38024758|FG001|Treatment Period|Lost to Follow-up|0|||
16915323|NCT00632502|38024766|FG000|Overall Study|Adverse Event|0|||
16915324|NCT00632502|38024767|FG001|Overall Study|Adverse Event|1|||
16915325|NCT00632502|38024766|FG000|Overall Study|Randomized not treated|3|||
16915326|NCT00632502|38024767|FG001|Overall Study|Randomized not treated|0|||
16915327|NCT00632424|38024777|FG000|Overall Study|Disease Progression|17|||
16915328|NCT00632424|38024777|FG000|Overall Study|Study Drug Toxicity|1|||
16915329|NCT00631488|38024794|FG000|Overall Study|Adverse Event|1|||
16915330|NCT00631488|38024795|FG001|Overall Study|Adverse Event|0|||
16915331|NCT00631488|38024796|FG002|Overall Study|Adverse Event|0|||
16915332|NCT00631488|38024794|FG000|Overall Study|Lost to Follow-up|2|||
16915333|NCT00631488|38024795|FG001|Overall Study|Lost to Follow-up|2|||
16915334|NCT00631488|38024796|FG002|Overall Study|Lost to Follow-up|0|||
16915335|NCT00631488|38024794|FG000|Overall Study|Physician Decision|1|||
16915336|NCT00631488|38024795|FG001|Overall Study|Physician Decision|0|||
16915337|NCT00631488|38024796|FG002|Overall Study|Physician Decision|1|||
16841545|NCT01425814|37785663|FG000|Period 4|Adverse Event|1|||
16841546|NCT01425814|37785664|FG001|Period 4|Adverse Event|0|||
16841547|NCT01425814|37785665|FG002|Period 4|Adverse Event|1|||
16841548|NCT01425814|37785666|FG003|Period 4|Adverse Event|0|||
16841549|NCT01425814|37785667|FG004|Period 4|Adverse Event|0|||
16841550|NCT01425814|37785668|FG005|Period 4|Adverse Event|0|||
16841551|NCT01425814|37785663|FG000|Period 5|Stability criteria not fulfilled|0|||
16841552|NCT01425814|37785664|FG001|Period 5|Stability criteria not fulfilled|0|||
16841553|NCT01425814|37785665|FG002|Period 5|Stability criteria not fulfilled|1|||
16841554|NCT01425814|37785666|FG003|Period 5|Stability criteria not fulfilled|0|||
16841555|NCT01425814|37785667|FG004|Period 5|Stability criteria not fulfilled|0|||
16841556|NCT01425814|37785668|FG005|Period 5|Stability criteria not fulfilled|1|||
16841557|NCT01782495|37785693|FG000|Overall Study|Adverse Event|0|||
16915338|NCT00631488|38024794|FG000|Overall Study|Protocol Violation|0|||
16915339|NCT00631488|38024795|FG001|Overall Study|Protocol Violation|0|||
16915340|NCT00631488|38024796|FG002|Overall Study|Protocol Violation|1|||
16915341|NCT00988884|38024806|FG000|Overall Study|Adverse Event|0|||
16841558|NCT01782495|37785694|FG001|Overall Study|Adverse Event|0|||
16841559|NCT01782495|37785695|FG002|Overall Study|Adverse Event|0|||
16841560|NCT01782495|37785696|FG003|Overall Study|Adverse Event|0|||
16841561|NCT01782495|37785697|FG004|Overall Study|Adverse Event|0|||
16915342|NCT00988884|38024807|FG001|Overall Study|Adverse Event|1|||
16915343|NCT00988884|38024806|FG000|Overall Study|Lost to Follow-up|20|||
16915344|NCT00988884|38024807|FG001|Overall Study|Lost to Follow-up|16|||
16841562|NCT01782495|37785698|FG005|Overall Study|Adverse Event|0|||
16841563|NCT01782495|37785699|FG006|Overall Study|Adverse Event|0|||
16841564|NCT01782495|37785700|FG007|Overall Study|Adverse Event|2|||
16841565|NCT01782495|37785701|FG008|Overall Study|Adverse Event|0|||
16841566|NCT01782495|37785702|FG009|Overall Study|Adverse Event|0|||
16841567|NCT01782495|37785703|FG010|Overall Study|Adverse Event|0|||
16841568|NCT01782495|37785693|FG000|Overall Study|Withdrew Consent|0|||
16841569|NCT01782495|37785694|FG001|Overall Study|Withdrew Consent|1|||
16841570|NCT01782495|37785695|FG002|Overall Study|Withdrew Consent|0|||
16841571|NCT01782495|37785696|FG003|Overall Study|Withdrew Consent|0|||
16841572|NCT01782495|37785697|FG004|Overall Study|Withdrew Consent|0|||
16841573|NCT01782495|37785698|FG005|Overall Study|Withdrew Consent|0|||
16841574|NCT01782495|37785699|FG006|Overall Study|Withdrew Consent|0|||
16841575|NCT01782495|37785700|FG007|Overall Study|Withdrew Consent|1|||
16841576|NCT01782495|37785701|FG008|Overall Study|Withdrew Consent|0|||
16841577|NCT01782495|37785702|FG009|Overall Study|Withdrew Consent|0|||
16841578|NCT01782495|37785703|FG010|Overall Study|Withdrew Consent|0|||
16841579|NCT01922102|37785730|FG000|Overall Study|Withdrawal by Subject|7|||
16841580|NCT01922102|37785731|FG001|Overall Study|Withdrawal by Subject|3|||
16841581|NCT01922102|37785732|FG002|Overall Study|Withdrawal by Subject|7|||
16841582|NCT01922102|37785730|FG000|Overall Study|Physician Decision|0|||
16841583|NCT01922102|37785731|FG001|Overall Study|Physician Decision|2|||
16841584|NCT01922102|37785732|FG002|Overall Study|Physician Decision|1|||
16841585|NCT01922102|37785730|FG000|Overall Study|Adverse Event|1|||
16841586|NCT01922102|37785731|FG001|Overall Study|Adverse Event|2|||
16841587|NCT01922102|37785732|FG002|Overall Study|Adverse Event|0|||
16841588|NCT01922102|37785730|FG000|Overall Study|Lost to Follow-up|1|||
16841589|NCT01922102|37785731|FG001|Overall Study|Lost to Follow-up|0|||
16841590|NCT01922102|37785732|FG002|Overall Study|Lost to Follow-up|0|||
16841591|NCT01922102|37785730|FG000|Overall Study|Administrative problems|0|||
16841592|NCT01922102|37785731|FG001|Overall Study|Administrative problems|2|||
16841593|NCT01922102|37785732|FG002|Overall Study|Administrative problems|0|||
16841594|NCT01405768|37785746|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
16841595|NCT01405768|37785747|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
16841596|NCT01754259|37785755|FG000|Overall Study|Withdrawal by Subject|2|||
16841597|NCT01754259|37785756|FG001|Overall Study|Withdrawal by Subject|4|||
16841598|NCT01754259|37785755|FG000|Overall Study|Adverse Event|3|||
16841599|NCT01754259|37785756|FG001|Overall Study|Adverse Event|1|||
16841600|NCT01754259|37785755|FG000|Overall Study|Lost to Follow-up|0|||
16841601|NCT01754259|37785756|FG001|Overall Study|Lost to Follow-up|1|||
16841602|NCT01405456|37785764|FG000|Overall Study|Lost to Follow-up|2|||
16841603|NCT01405456|37785765|FG001|Overall Study|Lost to Follow-up|1|||
16841604|NCT01405456|37785764|FG000|Overall Study|Physician Decision|1|||
16841605|NCT01405456|37785765|FG001|Overall Study|Physician Decision|0|||
16841606|NCT01404988|37785774|FG000|Overall Study|Death|2|||
16841607|NCT01404988|37785775|FG001|Overall Study|Death|0|||
16841608|NCT01404988|37785776|FG002|Overall Study|Death|2|||
16841609|NCT01404988|37785774|FG000|Overall Study|Adverse Event|1|||
16841610|NCT01404988|37785775|FG001|Overall Study|Adverse Event|0|||
16841611|NCT01404988|37785776|FG002|Overall Study|Adverse Event|0|||
16841612|NCT01404988|37785774|FG000|Overall Study|Withdrawal by Subject|2|||
16841613|NCT01404988|37785775|FG001|Overall Study|Withdrawal by Subject|2|||
16841614|NCT01404988|37785776|FG002|Overall Study|Withdrawal by Subject|0|||
16841615|NCT01404988|37785774|FG000|Overall Study|Lost to Follow-up|1|||
16841616|NCT01404988|37785775|FG001|Overall Study|Lost to Follow-up|2|||
16841617|NCT01404988|37785776|FG002|Overall Study|Lost to Follow-up|1|||
16841618|NCT01389232|37785787|FG000|Overall Study|Had scaffold removed|15|||
16841619|NCT01389232|37785787|FG000|Overall Study|Personal reasons|2|||
16841620|NCT01389232|37785787|FG000|Overall Study|Adverse Event|1|||
16841621|NCT01389232|37785787|FG000|Overall Study|Death|1|||
16841622|NCT01404208|37785803|FG000|Overall Study|Discontinued|3|||
16841623|NCT01404208|37785804|FG001|Overall Study|Discontinued|0|||
16841624|NCT01617668|37785812|FG000|Overall Study|Adverse Event|7|||
16841625|NCT01617668|37785813|FG001|Overall Study|Adverse Event|0|||
16841626|NCT01617668|37785814|FG002|Overall Study|Adverse Event|12|||
16841627|NCT01617668|37785815|FG003|Overall Study|Adverse Event|5|||
16841628|NCT01617668|37785812|FG000|Overall Study|Physician Decision|1|||
16841629|NCT01617668|37785813|FG001|Overall Study|Physician Decision|2|||
16841630|NCT01617668|37785814|FG002|Overall Study|Physician Decision|3|||
16841631|NCT01617668|37785815|FG003|Overall Study|Physician Decision|0|||
16915345|NCT00988884|38024806|FG000|Overall Study|Protocol Violation|0|||
16841632|NCT01617668|37785812|FG000|Overall Study|Progressive Disease|4|||
16841633|NCT01617668|37785813|FG001|Overall Study|Progressive Disease|4|||
16841634|NCT01617668|37785814|FG002|Overall Study|Progressive Disease|6|||
16841635|NCT01617668|37785815|FG003|Overall Study|Progressive Disease|9|||
16841636|NCT01617668|37785812|FG000|Overall Study|Subject/guardian decision|1|||
16841637|NCT01617668|37785813|FG001|Overall Study|Subject/guardian decision|3|||
16841638|NCT01617668|37785814|FG002|Overall Study|Subject/guardian decision|2|||
16841639|NCT01617668|37785815|FG003|Overall Study|Subject/guardian decision|1|||
16915346|NCT00988884|38024807|FG001|Overall Study|Protocol Violation|1|||
16841640|NCT01425268|37785831|FG000|Overall Study|Withdrawal by Subject|2|||
16841641|NCT01425268|37785832|FG001|Overall Study|Withdrawal by Subject|0|||
16841642|NCT01425268|37785831|FG000|Overall Study|Sponsor Decision|5|||
16841643|NCT01425268|37785832|FG001|Overall Study|Sponsor Decision|0|||
16841644|NCT01425268|37785831|FG000|Overall Study|Physician Decision|1|||
16841645|NCT01425268|37785832|FG001|Overall Study|Physician Decision|0|||
16841646|NCT01896050|37785840|FG000|Overall Study|Adverse Event|37|||
16841647|NCT01896050|37785841|FG001|Overall Study|Adverse Event|2|||
16841648|NCT01896050|37785840|FG000|Overall Study|Death|1|||
16841649|NCT01896050|37785841|FG001|Overall Study|Death|0|||
16841650|NCT01425190|37785852|FG000|Overall Study|Full dose not consumed.|1|||
16841651|NCT01425190|37785853|FG001|Overall Study|Full dose not consumed.|0|||
16841652|NCT01425190|37785854|FG002|Overall Study|Full dose not consumed.|0|||
16841653|NCT01388530|37785862|FG000|Overall Study|Lost to Follow-up|5|||
16841654|NCT01895270|37785868|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
16841655|NCT01895270|37785869|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
16841656|NCT01895270|37785868|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
16841657|NCT01895270|37785869|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
16841658|NCT01895270|37785868|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
16841659|NCT01895270|37785869|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
16841660|NCT01895270|37785868|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
16841661|NCT01895270|37785869|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
16841662|NCT01895270|37785868|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
16841663|NCT01895270|37785869|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
16841664|NCT01895270|37785868|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
16841665|NCT01895270|37785869|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
16841666|NCT01895270|37785868|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
16841667|NCT01895270|37785869|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
16841668|NCT01424722|37785875|FG000|Overall Study|Sponsor terminated investigation|2258|||
16841669|NCT01424644|37785881|FG000|Overall Study|Adverse Event|2|||
16841670|NCT01424644|37785882|FG001|Overall Study|Adverse Event|0|||
16841671|NCT01424644|37785881|FG000|Overall Study|Withdrawal by Subject|9|||
16915347|NCT00988884|38024806|FG000|Overall Study|Withdrawal by Subject|15|||
16915348|NCT00988884|38024807|FG001|Overall Study|Withdrawal by Subject|18|||
16915349|NCT00631020|38024813|FG000|Overall Study|Lost to Follow-up|7|||
16915350|NCT00631020|38024813|FG000|Overall Study|Incarcerated|1|||
16915351|NCT00987402|38024819|FG000|Overall Study|Insufficient data entry|86|||
16915352|NCT00987402|38024820|FG001|Overall Study|Insufficient data entry|98|||
16915353|NCT00630864|38024826|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
16915354|NCT00630864|38024826|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
16915355|NCT00630786|38024833|FG000|Overall Study|Physician Decision|0|||
16915356|NCT00630786|38024834|FG001|Overall Study|Physician Decision|0|||
16915357|NCT00630786|38024835|FG002|Overall Study|Physician Decision|1|||
16915358|NCT00630786|38024833|FG000|Overall Study|Withdrawal by Subject|0|||
16915359|NCT00630786|38024834|FG001|Overall Study|Withdrawal by Subject|1|||
16915360|NCT00630786|38024835|FG002|Overall Study|Withdrawal by Subject|1|||
16915361|NCT00630786|38024833|FG000|Overall Study|Lost to Follow-up|0|||
16915362|NCT00630786|38024834|FG001|Overall Study|Lost to Follow-up|1|||
16915363|NCT00630786|38024835|FG002|Overall Study|Lost to Follow-up|0|||
16915364|NCT00630786|38024833|FG000|Overall Study|Other|1|||
16915365|NCT00630786|38024834|FG001|Overall Study|Other|0|||
16915366|NCT00630786|38024835|FG002|Overall Study|Other|0|||
16915367|NCT00630396|38024841|FG000|Overall Study|Death|4|||
16915368|NCT00630396|38024841|FG000|Overall Study|Lost to Follow-up|3|||
16841672|NCT01424644|37785882|FG001|Overall Study|Withdrawal by Subject|12|||
16841673|NCT01424644|37785881|FG000|Overall Study|Lost to Follow-up|16|||
16841674|NCT01424644|37785882|FG001|Overall Study|Lost to Follow-up|12|||
16841675|NCT01424644|37785881|FG000|Overall Study|Protocol Violation|4|||
16841676|NCT01424644|37785882|FG001|Overall Study|Protocol Violation|3|||
16841677|NCT01424644|37785881|FG000|Overall Study|Administrative Reason|1|||
16841678|NCT01424644|37785882|FG001|Overall Study|Administrative Reason|0|||
16841679|NCT01424644|37785881|FG000|Overall Study|Unable to Classify|1|||
16841680|NCT01424644|37785882|FG001|Overall Study|Unable to Classify|0|||
16841681|NCT01920854|37785895|FG000|Overall Study|Withdrawal by Subject|1|||
16841682|NCT01920854|37785896|FG001|Overall Study|Withdrawal by Subject|0|||
16841683|NCT01920854|37785897|FG002|Overall Study|Withdrawal by Subject|0|||
16841684|NCT01920854|37785898|FG003|Overall Study|Withdrawal by Subject|0|||
16841685|NCT01920854|37785899|FG004|Overall Study|Withdrawal by Subject|1|||
16841686|NCT01920854|37785900|FG005|Overall Study|Withdrawal by Subject|0|||
16841687|NCT01920854|37785901|FG006|Overall Study|Withdrawal by Subject|1|||
16915369|NCT00985686|38024849|FG000|Overall Study|Lost to Follow-up|1|||
16915370|NCT00985686|38024850|FG001|Overall Study|Lost to Follow-up|1|||
16915371|NCT00985686|38024851|FG002|Overall Study|Lost to Follow-up|0|||
16915372|NCT00985686|38024852|FG003|Overall Study|Lost to Follow-up|2|||
16915373|NCT00984594|38024862|FG000|Overall Study|Lost to Follow-up|1|||
16841688|NCT01424566|37785936|FG000|Single-blind Treatment|Adverse Event|71|||
16841689|NCT01424566|37785937|FG001|Single-blind Treatment|Adverse Event|0|||
16841690|NCT01424566|37785938|FG002|Single-blind Treatment|Adverse Event|0|||
16841691|NCT01424566|37785936|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
16841692|NCT01424566|37785937|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
16841693|NCT01424566|37785938|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
16841694|NCT01424566|37785936|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
16841695|NCT01424566|37785937|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
16841696|NCT01424566|37785938|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
16841697|NCT01424566|37785936|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
16841698|NCT01424566|37785937|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
16841699|NCT01424566|37785938|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
16841700|NCT01424566|37785936|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
16841701|NCT01424566|37785937|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
16841702|NCT01424566|37785938|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
16841703|NCT01424566|37785936|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
16841704|NCT01424566|37785937|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
16841705|NCT01424566|37785938|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
16841706|NCT01424566|37785936|FG000|Double-blind Treatment|Adverse Event|0|||
16841707|NCT01424566|37785937|FG001|Double-blind Treatment|Adverse Event|21|||
16841708|NCT01424566|37785938|FG002|Double-blind Treatment|Adverse Event|13|||
16841709|NCT01424566|37785936|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
16841710|NCT01424566|37785937|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
16841711|NCT01424566|37785938|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
16841712|NCT01424566|37785936|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
16841713|NCT01424566|37785937|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
16841714|NCT01424566|37785938|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
16841715|NCT01424566|37785936|FG000|Double-blind Treatment|Lack of Efficacy|0|||
16841716|NCT01424566|37785937|FG001|Double-blind Treatment|Lack of Efficacy|1|||
16841717|NCT01424566|37785938|FG002|Double-blind Treatment|Lack of Efficacy|1|||
16841718|NCT01403194|37785945|FG000|Overall Study|Screen Failure|2|||
16841719|NCT01403194|37785945|FG000|Overall Study|Lost to Follow-up|8|||
16841720|NCT01403116|37785951|FG000|Overall Study|Adverse Event|7|||
16841721|NCT01403116|37785952|FG001|Overall Study|Adverse Event|4|||
16841722|NCT01403116|37785951|FG000|Overall Study|Lost to Follow-up|7|||
16841723|NCT01403116|37785952|FG001|Overall Study|Lost to Follow-up|5|||
16841724|NCT01403116|37785951|FG000|Overall Study|Withdrawal by Subject|12|||
16841725|NCT01403116|37785952|FG001|Overall Study|Withdrawal by Subject|15|||
16841726|NCT01403116|37785951|FG000|Overall Study|Non-compliance of study drug|3|||
16841727|NCT01403116|37785952|FG001|Overall Study|Non-compliance of study drug|0|||
16841728|NCT01403116|37785951|FG000|Overall Study|Protocol Violation|0|||
16841729|NCT01403116|37785952|FG001|Overall Study|Protocol Violation|1|||
16841730|NCT01403116|37785951|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
16841731|NCT01403116|37785952|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
16841732|NCT01403116|37785951|FG000|Overall Study|Hct >54%|2|||
16841733|NCT01403116|37785952|FG001|Overall Study|Hct >54%|0|||
16841734|NCT01403116|37785951|FG000|Overall Study|unable to keep appointments|0|||
16841735|NCT01403116|37785952|FG001|Overall Study|unable to keep appointments|2|||
16841736|NCT01402570|37785958|FG000|Overall Study|Adverse Event|1|||
16841737|NCT01753401|37785965|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
16841738|NCT01753401|37785966|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
16841739|NCT01753401|37785967|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
16841740|NCT01753401|37785968|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
16841741|NCT01753401|37785965|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
16841742|NCT01753401|37785966|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
16841743|NCT01753401|37785967|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
16841744|NCT01753401|37785968|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
16841745|NCT01753401|37785965|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
16841746|NCT01753401|37785966|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
16841747|NCT01753401|37785967|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
16841748|NCT01753401|37785968|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
16915374|NCT00984594|38024863|FG001|Overall Study|Lost to Follow-up|0|||
16915375|NCT00984594|38024862|FG000|Overall Study|Withdrawal by Subject|0|||
16915376|NCT00984594|38024863|FG001|Overall Study|Withdrawal by Subject|1|||
16915377|NCT00984204|38024871|FG000|Overall Study|Death|1|||
16915378|NCT00984204|38024871|FG000|Overall Study|Lost to Follow-up|4|||
16915379|NCT00984204|38024871|FG000|Overall Study|Lack of Efficacy|10|||
16915380|NCT00983892|38024877|FG000|Overall Study|Withdrawal by Subject|10|||
16915381|NCT00983892|38024878|FG001|Overall Study|Withdrawal by Subject|12|||
16841749|NCT01753401|37785965|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
16841750|NCT01753401|37785966|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
16841751|NCT01753401|37785967|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
16915382|NCT00983580|38024886|FG000|Overall Study|Cancel Prior to treatment|1|||
16915383|NCT00983580|38024887|FG001|Overall Study|Cancel Prior to treatment|3|||
16841752|NCT01753401|37785968|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
16841753|NCT01753401|37785965|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
16841754|NCT01753401|37785966|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
16841755|NCT01753401|37785967|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
16841756|NCT01753401|37785968|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
16841757|NCT01753401|37785965|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
16841758|NCT01753401|37785966|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
16841759|NCT01753401|37785967|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
16841760|NCT01753401|37785968|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
16841761|NCT01753401|37785965|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
16915384|NCT00983580|38024886|FG000|Overall Study|Protocol Violation|1|||
16841762|NCT01753401|37785966|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
16841763|NCT01753401|37785967|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
16841764|NCT01753401|37785968|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
16841765|NCT01618916|37785984|FG000|Overall Study|Adverse Event|1|||
16841766|NCT01618916|37785985|FG001|Overall Study|Adverse Event|0|||
16841767|NCT01618916|37785986|FG002|Overall Study|Adverse Event|0|||
16841768|NCT01618916|37785987|FG003|Overall Study|Adverse Event|0|||
16841769|NCT01618916|37785988|FG004|Overall Study|Adverse Event|0|||
16841770|NCT01618916|37785989|FG005|Overall Study|Adverse Event|0|||
16841771|NCT01618916|37785984|FG000|Overall Study|Withdrawal by Subject|0|||
16841772|NCT01618916|37785985|FG001|Overall Study|Withdrawal by Subject|1|||
16841773|NCT01618916|37785986|FG002|Overall Study|Withdrawal by Subject|1|||
16841774|NCT01618916|37785987|FG003|Overall Study|Withdrawal by Subject|0|||
16841775|NCT01618916|37785988|FG004|Overall Study|Withdrawal by Subject|1|||
16841776|NCT01618916|37785989|FG005|Overall Study|Withdrawal by Subject|0|||
16841777|NCT01618916|37785984|FG000|Overall Study|Lost to Follow-up|1|||
16915385|NCT00983580|38024887|FG001|Overall Study|Protocol Violation|1|||
16915386|NCT00983580|38024886|FG000|Overall Study|Ineligible|3|||
16915387|NCT00983580|38024887|FG001|Overall Study|Ineligible|0|||
16915388|NCT00982878|38024894|FG000|Overall Study|Physician Decision|1|||
16915389|NCT00982488|38024903|FG000|Overall Study|Administrative reason by sponsor|81|||
16915390|NCT00982488|38024904|FG001|Overall Study|Administrative reason by sponsor|3|||
16915391|NCT00982488|38024905|FG002|Overall Study|Administrative reason by sponsor|11|||
16915392|NCT00982488|38024906|FG003|Overall Study|Administrative reason by sponsor|0|||
16915393|NCT00982488|38024907|FG004|Overall Study|Administrative reason by sponsor|0|||
16915394|NCT00982488|38024903|FG000|Overall Study|Adverse event unrelated to study drug|5|||
16915395|NCT00982488|38024904|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16915396|NCT00982488|38024905|FG002|Overall Study|Adverse event unrelated to study drug|0|||
16915397|NCT00982488|38024906|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16915398|NCT00982488|38024907|FG004|Overall Study|Adverse event unrelated to study drug|0|||
16915399|NCT00982488|38024903|FG000|Overall Study|Death|11|||
16915400|NCT00982488|38024904|FG001|Overall Study|Death|0|||
16915401|NCT00982488|38024905|FG002|Overall Study|Death|2|||
16915402|NCT00982488|38024906|FG003|Overall Study|Death|0|||
16915403|NCT00982488|38024907|FG004|Overall Study|Death|0|||
16915404|NCT00982488|38024903|FG000|Overall Study|Disease progression|30|||
16915405|NCT00982488|38024904|FG001|Overall Study|Disease progression|5|||
16915406|NCT00982488|38024905|FG002|Overall Study|Disease progression|10|||
16915407|NCT00982488|38024906|FG003|Overall Study|Disease progression|1|||
16915408|NCT00982488|38024907|FG004|Overall Study|Disease progression|1|||
16915409|NCT00982488|38024903|FG000|Overall Study|Lost to Follow-up|1|||
16915410|NCT00982488|38024904|FG001|Overall Study|Lost to Follow-up|0|||
16915411|NCT00982488|38024905|FG002|Overall Study|Lost to Follow-up|0|||
16915412|NCT00982488|38024906|FG003|Overall Study|Lost to Follow-up|0|||
16915413|NCT00982488|38024907|FG004|Overall Study|Lost to Follow-up|0|||
16915414|NCT00982488|38024903|FG000|Overall Study|Maximum clinical benefit|1|||
16915415|NCT00982488|38024904|FG001|Overall Study|Maximum clinical benefit|1|||
16915416|NCT00982488|38024905|FG002|Overall Study|Maximum clinical benefit|1|||
16915417|NCT00982488|38024906|FG003|Overall Study|Maximum clinical benefit|0|||
16915418|NCT00982488|38024907|FG004|Overall Study|Maximum clinical benefit|0|||
16915419|NCT00982488|38024903|FG000|Overall Study|Other|15|||
16915420|NCT00982488|38024904|FG001|Overall Study|Other|1|||
16915421|NCT00982488|38024905|FG002|Overall Study|Other|3|||
16915422|NCT00982488|38024906|FG003|Overall Study|Other|1|||
16915423|NCT00982488|38024907|FG004|Overall Study|Other|0|||
16915424|NCT00982488|38024903|FG000|Overall Study|Poor compliance/noncompliance|0|||
16841778|NCT01618916|37785985|FG001|Overall Study|Lost to Follow-up|0|||
16841779|NCT01618916|37785986|FG002|Overall Study|Lost to Follow-up|0|||
16915425|NCT00982488|38024904|FG001|Overall Study|Poor compliance/noncompliance|1|||
16841780|NCT01618916|37785987|FG003|Overall Study|Lost to Follow-up|2|||
16841781|NCT01618916|37785988|FG004|Overall Study|Lost to Follow-up|0|||
16915426|NCT00982488|38024905|FG002|Overall Study|Poor compliance/noncompliance|0|||
16915427|NCT00982488|38024906|FG003|Overall Study|Poor compliance/noncompliance|0|||
16915428|NCT00982488|38024907|FG004|Overall Study|Poor compliance/noncompliance|0|||
16841782|NCT01618916|37785989|FG005|Overall Study|Lost to Follow-up|0|||
16841783|NCT01753323|37786005|FG000|Overall Study|Lack of Efficacy|0|||
16841784|NCT01753323|37786006|FG001|Overall Study|Lack of Efficacy|0|||
16841785|NCT01753323|37786007|FG002|Overall Study|Lack of Efficacy|8|||
16841786|NCT01753323|37786005|FG000|Overall Study|Protocol deviation|1|||
16841787|NCT01753323|37786006|FG001|Overall Study|Protocol deviation|0|||
16841788|NCT01753323|37786007|FG002|Overall Study|Protocol deviation|0|||
16841789|NCT01753323|37786005|FG000|Overall Study|Adverse Event|0|||
16841790|NCT01753323|37786006|FG001|Overall Study|Adverse Event|0|||
16841791|NCT01753323|37786007|FG002|Overall Study|Adverse Event|1|||
16841792|NCT01894568|37786018|FG000|Overall Study|Adverse Event|2|||
16841793|NCT01894568|37786019|FG001|Overall Study|Adverse Event|3|||
16841794|NCT01894568|37786018|FG000|Overall Study|Protocol required discontinuation|2|||
16841795|NCT01894568|37786019|FG001|Overall Study|Protocol required discontinuation|1|||
16841796|NCT01894568|37786018|FG000|Overall Study|Withdrawal by Subject|5|||
16841797|NCT01894568|37786019|FG001|Overall Study|Withdrawal by Subject|5|||
16841798|NCT01894568|37786018|FG000|Overall Study|Physician Decision|1|||
16841799|NCT01894568|37786019|FG001|Overall Study|Physician Decision|0|||
16841800|NCT01894568|37786018|FG000|Overall Study|Lost to Follow-up|0|||
16841801|NCT01894568|37786019|FG001|Overall Study|Lost to Follow-up|1|||
16841802|NCT01618838|37786026|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
16841803|NCT01920152|37786033|FG000|Overall Study|Withdrawal by Subject|1|||
16841804|NCT01920152|37786034|FG001|Overall Study|Withdrawal by Subject|2|||
16841805|NCT01752933|37786042|FG000|Treatment|Disease Progression|3|||
16841806|NCT01752933|37786043|FG001|Treatment|Disease Progression|29|||
16841807|NCT01752933|37786042|FG000|Treatment|Withdrawal by Subject|0|||
16841808|NCT01752933|37786043|FG001|Treatment|Withdrawal by Subject|5|||
16841809|NCT01752933|37786042|FG000|Treatment|Adverse Event|1|||
16841810|NCT01752933|37786043|FG001|Treatment|Adverse Event|4|||
16841811|NCT01752933|37786042|FG000|Treatment|Physician Decision|0|||
16841812|NCT01752933|37786043|FG001|Treatment|Physician Decision|3|||
16841813|NCT01752933|37786042|FG000|Treatment|Death|0|||
16841814|NCT01752933|37786043|FG001|Treatment|Death|2|||
16841815|NCT01752933|37786042|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
16841816|NCT01752933|37786043|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
16841817|NCT01752933|37786042|FG000|Treatment|Patient noncompliant|0|||
16841818|NCT01752933|37786043|FG001|Treatment|Patient noncompliant|1|||
16841819|NCT01752933|37786042|FG000|Treatment|Patient unable to travel to appointments|0|||
16841820|NCT01752933|37786043|FG001|Treatment|Patient unable to travel to appointments|1|||
16841821|NCT01752933|37786042|FG000|Overall Study and Follow-up|Death|4|||
16841822|NCT01752933|37786043|FG001|Overall Study and Follow-up|Death|34|||
16915429|NCT00982488|38024903|FG000|Overall Study|Stem cell transplant|2|||
16915430|NCT00982488|38024904|FG001|Overall Study|Stem cell transplant|0|||
16915431|NCT00982488|38024905|FG002|Overall Study|Stem cell transplant|0|||
16915432|NCT00982488|38024906|FG003|Overall Study|Stem cell transplant|1|||
16915433|NCT00982488|38024907|FG004|Overall Study|Stem cell transplant|0|||
16915434|NCT00982488|38024903|FG000|Overall Study|Study drug toxicity|34|||
16915435|NCT00982488|38024904|FG001|Overall Study|Study drug toxicity|1|||
16915436|NCT00982488|38024905|FG002|Overall Study|Study drug toxicity|6|||
16915437|NCT00982488|38024906|FG003|Overall Study|Study drug toxicity|0|||
17016832|NCT00848718|38161503|FG009|Overall Study|Adverse Event|0|||
17016833|NCT00848718|38161504|FG010|Overall Study|Adverse Event|0|||
17016834|NCT00848718|38161505|FG011|Overall Study|Adverse Event|0|||
17016835|NCT00848718|38161506|FG012|Overall Study|Adverse Event|2|||
16915438|NCT00982488|38024907|FG004|Overall Study|Study drug toxicity|0|||
16915439|NCT00982488|38024903|FG000|Overall Study|Withdrawal by Subject|5|||
16915440|NCT00982488|38024904|FG001|Overall Study|Withdrawal by Subject|1|||
16915441|NCT00982488|38024905|FG002|Overall Study|Withdrawal by Subject|1|||
16915442|NCT00982488|38024906|FG003|Overall Study|Withdrawal by Subject|0|||
16915443|NCT00982488|38024907|FG004|Overall Study|Withdrawal by Subject|0|||
17016836|NCT00848718|38161494|FG000|Overall Study|Lack of Efficacy|0|||
17016837|NCT00848718|38161495|FG001|Overall Study|Lack of Efficacy|0|||
17016838|NCT00848718|38161496|FG002|Overall Study|Lack of Efficacy|1|||
17016839|NCT00848718|38161497|FG003|Overall Study|Lack of Efficacy|0|||
17016840|NCT00848718|38161498|FG004|Overall Study|Lack of Efficacy|0|||
17016841|NCT00848718|38161499|FG005|Overall Study|Lack of Efficacy|0|||
16915444|NCT00982410|38024921|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
16915445|NCT00982410|38024922|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
16915446|NCT00982410|38024921|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
16915447|NCT00982410|38024922|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
16915448|NCT00982410|38024921|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
16915449|NCT00982410|38024922|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
16915450|NCT00982410|38024921|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
16915451|NCT00982410|38024922|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
16915452|NCT00982410|38024921|FG000|6-month Follow-up Assessment|participant no transportation|1|||
16915453|NCT00982410|38024922|FG001|6-month Follow-up Assessment|participant no transportation|0|||
17016842|NCT00848718|38161500|FG006|Overall Study|Lack of Efficacy|1|||
16915454|NCT00982410|38024921|FG000|6-month Follow-up Assessment|incarceration|0|||
16915455|NCT00982410|38024922|FG001|6-month Follow-up Assessment|incarceration|2|||
16915456|NCT00982410|38024921|FG000|6-month Follow-up Assessment|patent surgery|0|||
16915457|NCT00982410|38024922|FG001|6-month Follow-up Assessment|patent surgery|1|||
16915458|NCT00982410|38024921|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
16915459|NCT00982410|38024922|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
16915460|NCT00982410|38024921|FG000|12-month Follow-up Assessment|Death|0|||
16915461|NCT00982410|38024922|FG001|12-month Follow-up Assessment|Death|2|||
16915462|NCT00982410|38024921|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
16915463|NCT00982410|38024922|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
16915464|NCT00982410|38024921|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
16915465|NCT00982410|38024922|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
16915466|NCT00982410|38024921|FG000|12-month Follow-up Assessment|incarceration|2|||
16915467|NCT00982410|38024922|FG001|12-month Follow-up Assessment|incarceration|1|||
16915468|NCT00982410|38024921|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
16915469|NCT00982410|38024922|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
16915470|NCT00982020|38024931|FG000|Overall Study|Adverse Event|19|||
16915471|NCT00982020|38024932|FG001|Overall Study|Adverse Event|15|||
16915472|NCT00982020|38024931|FG000|Overall Study|Withdrawal by Subject|11|||
16915473|NCT00982020|38024932|FG001|Overall Study|Withdrawal by Subject|14|||
16915474|NCT00982020|38024931|FG000|Overall Study|Lost to Follow-up|5|||
16915475|NCT00982020|38024932|FG001|Overall Study|Lost to Follow-up|11|||
16915476|NCT00982020|38024931|FG000|Overall Study|Lack of Efficacy|10|||
16915477|NCT00982020|38024932|FG001|Overall Study|Lack of Efficacy|4|||
16841823|NCT01752933|37786042|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
16841824|NCT01752933|37786043|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
16841825|NCT01752933|37786042|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
16841826|NCT01752933|37786043|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
16841827|NCT01752933|37786042|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
16841828|NCT01752933|37786043|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
16915478|NCT00982020|38024931|FG000|Overall Study|Parent/Caregiver Decision|5|||
16841829|NCT01752855|37786052|FG000|Overall Study|Adverse Event|1|||
16841830|NCT01752855|37786053|FG001|Overall Study|Adverse Event|0|||
16915479|NCT00982020|38024932|FG001|Overall Study|Parent/Caregiver Decision|5|||
16915480|NCT00982020|38024931|FG000|Overall Study|Treatment Non-compliance|3|||
16915481|NCT00982020|38024932|FG001|Overall Study|Treatment Non-compliance|6|||
16915482|NCT00982020|38024931|FG000|Overall Study|Physician Decision|2|||
16841831|NCT01752855|37786052|FG000|Overall Study|Withdrew Consent|0|||
16841832|NCT01752855|37786053|FG001|Overall Study|Withdrew Consent|2|||
16915483|NCT00982020|38024932|FG001|Overall Study|Physician Decision|5|||
16915484|NCT00982020|38024931|FG000|Overall Study|Entry Criteria Not Met|2|||
16915485|NCT00982020|38024932|FG001|Overall Study|Entry Criteria Not Met|1|||
16915486|NCT00982020|38024931|FG000|Overall Study|Protocol Violation|0|||
16915487|NCT00982020|38024932|FG001|Overall Study|Protocol Violation|2|||
16915488|NCT00982020|38024931|FG000|Overall Study|Clinical Relapse|0|||
16915489|NCT00982020|38024932|FG001|Overall Study|Clinical Relapse|1|||
16915490|NCT00981084|38024945|FG000|Post Intervention (Data Analysis)|poor effort|1|||
16915491|NCT00981084|38024946|FG001|Post Intervention (Data Analysis)|poor effort|1|||
16915492|NCT00981084|38024945|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
16841833|NCT01752855|37786052|FG000|Overall Study|Lack of Efficacy|0|||
16841834|NCT01752855|37786053|FG001|Overall Study|Lack of Efficacy|2|||
16841835|NCT01402492|37786062|FG000|Overall Study|Withdrawal by Subject|17|||
16841836|NCT01402492|37786063|FG001|Overall Study|Withdrawal by Subject|11|||
16915493|NCT00981084|38024946|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
16915494|NCT00980148|38024956|FG000|Overall Study|Discharged from facility|89|||
16841837|NCT01402492|37786064|FG002|Overall Study|Withdrawal by Subject|11|||
16841838|NCT01402492|37786062|FG000|Overall Study|Adverse Event|2|||
16841839|NCT01402492|37786063|FG001|Overall Study|Adverse Event|3|||
16841840|NCT01402492|37786064|FG002|Overall Study|Adverse Event|4|||
16841841|NCT01402492|37786062|FG000|Overall Study|Physician Decision|0|||
16915495|NCT00980148|38024957|FG001|Overall Study|Discharged from facility|96|||
16915496|NCT00980148|38024956|FG000|Overall Study|Received other antichlamydia treatment|20|||
16915497|NCT00980148|38024957|FG001|Overall Study|Received other antichlamydia treatment|14|||
16915498|NCT00980148|38024956|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
16915499|NCT00980148|38024957|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
16915500|NCT00980148|38024956|FG000|Overall Study|Various other reasons|8|||
16915501|NCT00980148|38024957|FG001|Overall Study|Various other reasons|9|||
16915502|NCT04553406|38025017|FG000|Overall Study|Study Discontinuation|0|||
16915503|NCT04553406|38025018|FG001|Overall Study|Study Discontinuation|1|||
16915504|NCT04129944|38025036|FG000|Overall Study|Death|0|||
16915505|NCT04129944|38025037|FG001|Overall Study|Death|0|||
16915506|NCT04129944|38025038|FG002|Overall Study|Death|0|||
16915507|NCT04129944|38025039|FG003|Overall Study|Death|1|||
16915508|NCT04129944|38025036|FG000|Overall Study|Lost to Follow-up|1|||
16915509|NCT04129944|38025037|FG001|Overall Study|Lost to Follow-up|0|||
16915510|NCT04129944|38025038|FG002|Overall Study|Lost to Follow-up|0|||
16915511|NCT04129944|38025039|FG003|Overall Study|Lost to Follow-up|0|||
16841842|NCT01402492|37786063|FG001|Overall Study|Physician Decision|3|||
16915512|NCT04129944|38025036|FG000|Overall Study|Withdrawal by Subject|1|||
16841843|NCT01402492|37786064|FG002|Overall Study|Physician Decision|0|||
16841844|NCT01402492|37786062|FG000|Overall Study|Incarcerated (N=3)|2|||
16841845|NCT01402492|37786063|FG001|Overall Study|Incarcerated (N=3)|0|||
16841846|NCT01402492|37786064|FG002|Overall Study|Incarcerated (N=3)|1|||
16841847|NCT01402102|37786074|FG000|Overall Study|Protocol Violation|1|||
16841848|NCT01402102|37786075|FG001|Overall Study|Protocol Violation|0|||
16841849|NCT01402102|37786074|FG000|Overall Study|Insufficiency of compliance|1|||
16841850|NCT01402102|37786075|FG001|Overall Study|Insufficiency of compliance|1|||
16841851|NCT01402102|37786074|FG000|Overall Study|Withdrawal by Subject|0|||
16841852|NCT01402102|37786075|FG001|Overall Study|Withdrawal by Subject|2|||
16841853|NCT01423084|37786085|FG000|Overall Study|Adverse Event|0|||
16841854|NCT01423084|37786086|FG001|Overall Study|Adverse Event|1|||
16841855|NCT01423084|37786085|FG000|Overall Study|Withdrawal by Subject|2|||
16841856|NCT01423084|37786086|FG001|Overall Study|Withdrawal by Subject|3|||
16841857|NCT01894256|37786096|FG000|Part A|Adverse Event|0|||
16841858|NCT01894256|37786097|FG001|Part A|Adverse Event|1|||
16841859|NCT01894256|37786098|FG002|Part A|Adverse Event|0|||
16841860|NCT01894256|37786096|FG000|Part B|Death|0|||
16841861|NCT01894256|37786097|FG001|Part B|Death|1|||
16841862|NCT01894256|37786098|FG002|Part B|Death|1|||
16841863|NCT01894256|37786096|FG000|Part B|Withdrawal by Subject|0|||
16841864|NCT01894256|37786097|FG001|Part B|Withdrawal by Subject|1|||
16841865|NCT01894256|37786098|FG002|Part B|Withdrawal by Subject|0|||
16841866|NCT01894256|37786096|FG000|Part B|Lack of Efficacy|15|||
16841867|NCT01894256|37786097|FG001|Part B|Lack of Efficacy|12|||
16841868|NCT01894256|37786098|FG002|Part B|Lack of Efficacy|13|||
16841869|NCT01780935|37786111|FG000|Overall Study|Admin problems due to early termination|321|||
16841870|NCT01780935|37786112|FG001|Overall Study|Admin problems due to early termination|309|||
16841871|NCT01780935|37786111|FG000|Overall Study|Adverse Event|2|||
16915513|NCT04129944|38025037|FG001|Overall Study|Withdrawal by Subject|0|||
16915514|NCT04129944|38025038|FG002|Overall Study|Withdrawal by Subject|1|||
16915515|NCT04129944|38025039|FG003|Overall Study|Withdrawal by Subject|2|||
16915516|NCT03829332|38025103|FG000|Overall Study|Death|145|||
16915517|NCT03829332|38025104|FG001|Overall Study|Death|135|||
16915518|NCT03829332|38025103|FG000|Overall Study|Withdrawal by Subject|10|||
16915519|NCT03829332|38025104|FG001|Overall Study|Withdrawal by Subject|4|||
16915520|NCT03829332|38025103|FG000|Overall Study|Ongoing in Study|154|||
16915521|NCT03829332|38025104|FG001|Overall Study|Ongoing in Study|175|||
16915522|NCT01899144|38026777|FG000|Treatment Period 2|Other|1|||
16915523|NCT01899144|38026777|FG000|Treatment Period 3|Other|2|||
16915524|NCT01899144|38026777|FG000|Treatment Period 5|Other|1|||
16915525|NCT03062358|38027518|FG000|Overall Study|Death|220|||
16915526|NCT03062358|38027519|FG001|Overall Study|Death|127|||
16915527|NCT03062358|38027518|FG000|Overall Study|Withdrawal by Subject|2|||
16915528|NCT03062358|38027519|FG001|Overall Study|Withdrawal by Subject|1|||
16915529|NCT03062358|38027518|FG000|Overall Study|Ongoing in Trial|78|||
16915530|NCT03062358|38027519|FG001|Overall Study|Ongoing in Trial|25|||
16915531|NCT01168219|38030045|FG000|Overall Study|off study before starting treatment|2|||
16915532|NCT01168219|38030045|FG000|Overall Study|withdrew before transplant|1|||
16915533|NCT01168219|38030045|FG000|Overall Study|ineligible due to CML|2|||
16915534|NCT01115803|38030056|FG000|Overall Study|Withdrawal by Subject|0|||
16915535|NCT01115803|38030057|FG001|Overall Study|Withdrawal by Subject|0|||
16915536|NCT01115803|38030058|FG002|Overall Study|Withdrawal by Subject|0|||
16915537|NCT01115803|38030059|FG003|Overall Study|Withdrawal by Subject|0|||
17016843|NCT00848718|38161501|FG007|Overall Study|Lack of Efficacy|0|||
17016844|NCT00848718|38161502|FG008|Overall Study|Lack of Efficacy|0|||
17016845|NCT00848718|38161503|FG009|Overall Study|Lack of Efficacy|0|||
17016846|NCT00848718|38161504|FG010|Overall Study|Lack of Efficacy|0|||
17016847|NCT00848718|38161505|FG011|Overall Study|Lack of Efficacy|0|||
16841872|NCT01780935|37786112|FG001|Overall Study|Adverse Event|4|||
16915538|NCT01115803|38030060|FG004|Overall Study|Withdrawal by Subject|0|||
16915539|NCT01115803|38030061|FG005|Overall Study|Withdrawal by Subject|0|||
16915540|NCT01115803|38030062|FG006|Overall Study|Withdrawal by Subject|1|||
16915541|NCT01115803|38030056|FG000|Overall Study|Lost to Follow-up|0|||
16915542|NCT01115803|38030057|FG001|Overall Study|Lost to Follow-up|0|||
16915543|NCT01115803|38030058|FG002|Overall Study|Lost to Follow-up|1|||
16915544|NCT01115803|38030059|FG003|Overall Study|Lost to Follow-up|0|||
16915545|NCT01115803|38030060|FG004|Overall Study|Lost to Follow-up|0|||
16915546|NCT01115803|38030061|FG005|Overall Study|Lost to Follow-up|0|||
16841873|NCT01780935|37786111|FG000|Overall Study|Death|1|||
17016848|NCT00848718|38161506|FG012|Overall Study|Lack of Efficacy|0|||
16841874|NCT01780935|37786112|FG001|Overall Study|Death|6|||
16915547|NCT01115803|38030062|FG006|Overall Study|Lost to Follow-up|0|||
16915548|NCT01115803|38030056|FG000|Overall Study|Progressive Disease during Cycle1|0|||
16915549|NCT01115803|38030057|FG001|Overall Study|Progressive Disease during Cycle1|0|||
16915550|NCT01115803|38030058|FG002|Overall Study|Progressive Disease during Cycle1|0|||
16915551|NCT01115803|38030059|FG003|Overall Study|Progressive Disease during Cycle1|0|||
16915552|NCT01115803|38030060|FG004|Overall Study|Progressive Disease during Cycle1|0|||
16915553|NCT01115803|38030061|FG005|Overall Study|Progressive Disease during Cycle1|0|||
16915554|NCT01115803|38030062|FG006|Overall Study|Progressive Disease during Cycle1|1|||
16915555|NCT01115569|38030083|FG000|Conversion/Titration Phase|Adverse Event|59|||
16915556|NCT01115569|38030084|FG001|Conversion/Titration Phase|Adverse Event|0|||
16841875|NCT01780935|37786111|FG000|Overall Study|Lost to Follow-up|2|||
16841876|NCT01780935|37786112|FG001|Overall Study|Lost to Follow-up|6|||
16841877|NCT01780935|37786111|FG000|Overall Study|Physician Decision|1|||
16841878|NCT01780935|37786112|FG001|Overall Study|Physician Decision|1|||
16915557|NCT01115569|38030083|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
16915558|NCT01115569|38030084|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
16915559|NCT01115569|38030083|FG000|Conversion/Titration Phase|Physician Decision|5|||
16915560|NCT01115569|38030084|FG001|Conversion/Titration Phase|Physician Decision|0|||
16915561|NCT01115569|38030083|FG000|Conversion/Titration Phase|Protocol Violation|68|||
16841879|NCT01780935|37786111|FG000|Overall Study|Protocol deviation|0|||
16841880|NCT01780935|37786112|FG001|Overall Study|Protocol deviation|1|||
16841881|NCT01780935|37786111|FG000|Overall Study|Patient withdrew consent|8|||
16841882|NCT01780935|37786112|FG001|Overall Study|Patient withdrew consent|9|||
16841883|NCT01894100|37786120|FG000|Overall Study|Lost to Follow-up|0|||
16841884|NCT01894100|37786121|FG001|Overall Study|Lost to Follow-up|1|||
16841885|NCT01894100|37786120|FG000|Overall Study|Withdrawal by Subject|3|||
16915562|NCT01115569|38030084|FG001|Conversion/Titration Phase|Protocol Violation|0|||
16915563|NCT01115569|38030083|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
16915564|NCT01115569|38030084|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
16915565|NCT01115569|38030083|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
16915566|NCT01115569|38030084|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
16915567|NCT01115569|38030083|FG000|Maintenance Phase|Adverse Event|0|||
16915568|NCT01115569|38030084|FG001|Maintenance Phase|Adverse Event|43|||
16915569|NCT01115569|38030083|FG000|Maintenance Phase|Lost to Follow-up|0|||
16915570|NCT01115569|38030084|FG001|Maintenance Phase|Lost to Follow-up|8|||
16915571|NCT01115569|38030083|FG000|Maintenance Phase|Physician Decision|0|||
16915572|NCT01115569|38030084|FG001|Maintenance Phase|Physician Decision|3|||
16915573|NCT01115569|38030083|FG000|Maintenance Phase|Protocol Violation|0|||
16915574|NCT01115569|38030084|FG001|Maintenance Phase|Protocol Violation|9|||
16915575|NCT01115569|38030083|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16915576|NCT01115569|38030084|FG001|Maintenance Phase|Withdrawal by Subject|27|||
16915577|NCT01115569|38030083|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
16915578|NCT01115569|38030084|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
16915579|NCT01115569|38030083|FG000|Maintenance Phase|Administrative|0|||
16915580|NCT01115569|38030084|FG001|Maintenance Phase|Administrative|1|||
16915581|NCT01107886|38030091|FG000|Overall Study|Lost to Follow-up|15|||
16915582|NCT01107886|38030092|FG001|Overall Study|Lost to Follow-up|13|||
16915583|NCT01107886|38030091|FG000|Overall Study|Withdrawal by Subject|180|||
16915584|NCT01107886|38030092|FG001|Overall Study|Withdrawal by Subject|196|||
16915585|NCT01107886|38030091|FG000|Overall Study|Administrative withdrawal of consent|7|||
16915586|NCT01107886|38030092|FG001|Overall Study|Administrative withdrawal of consent|5|||
16915587|NCT01107457|38030103|FG000|Part A|Adverse Event|1|||
16915588|NCT01107457|38030104|FG001|Part A|Adverse Event|2|||
16915589|NCT01107457|38030105|FG002|Part A|Adverse Event|1|||
16915590|NCT01107457|38030106|FG003|Part A|Adverse Event|0|||
16915591|NCT01107457|38030107|FG004|Part A|Adverse Event|0|||
16915592|NCT01107457|38030108|FG005|Part A|Adverse Event|0|||
16915593|NCT01107457|38030103|FG000|Part A|Withdrawal by Subject|3|||
16915594|NCT01107457|38030104|FG001|Part A|Withdrawal by Subject|3|||
16915595|NCT01107457|38030105|FG002|Part A|Withdrawal by Subject|0|||
16915596|NCT01107457|38030106|FG003|Part A|Withdrawal by Subject|3|||
16915597|NCT01107457|38030107|FG004|Part A|Withdrawal by Subject|1|||
16915598|NCT01107457|38030108|FG005|Part A|Withdrawal by Subject|0|||
16915599|NCT01107457|38030103|FG000|Part A|Lost to Follow-up|0|||
16915600|NCT01107457|38030104|FG001|Part A|Lost to Follow-up|1|||
16915601|NCT01107457|38030105|FG002|Part A|Lost to Follow-up|0|||
16915602|NCT01107457|38030106|FG003|Part A|Lost to Follow-up|0|||
16915603|NCT01107457|38030107|FG004|Part A|Lost to Follow-up|0|||
16915604|NCT01107457|38030108|FG005|Part A|Lost to Follow-up|0|||
16915605|NCT01107457|38030103|FG000|Part A|Lack of Efficacy|1|||
16915606|NCT01107457|38030104|FG001|Part A|Lack of Efficacy|0|||
16915607|NCT01107457|38030105|FG002|Part A|Lack of Efficacy|0|||
16915608|NCT01107457|38030106|FG003|Part A|Lack of Efficacy|0|||
16915609|NCT01107457|38030107|FG004|Part A|Lack of Efficacy|0|||
16915610|NCT01107457|38030108|FG005|Part A|Lack of Efficacy|0|||
16915611|NCT01107457|38030103|FG000|Part A|Protocol Violation|0|||
16841886|NCT01894100|37786121|FG001|Overall Study|Withdrawal by Subject|0|||
16841887|NCT01401478|37786167|FG000|Overall Study|Study drug not available|6|||
16841888|NCT01401478|37786167|FG000|Overall Study|Adverse Event|5|||
16915612|NCT01107457|38030104|FG001|Part A|Protocol Violation|1|||
16915613|NCT01107457|38030105|FG002|Part A|Protocol Violation|0|||
16915614|NCT01107457|38030106|FG003|Part A|Protocol Violation|0|||
16915615|NCT01107457|38030107|FG004|Part A|Protocol Violation|0|||
16915616|NCT01107457|38030108|FG005|Part A|Protocol Violation|0|||
16915617|NCT01107457|38030103|FG000|Part B and C|Adverse Event|0|||
16915618|NCT01107457|38030104|FG001|Part B and C|Adverse Event|0|||
16915619|NCT01107457|38030105|FG002|Part B and C|Adverse Event|0|||
16915620|NCT01107457|38030106|FG003|Part B and C|Adverse Event|0|||
16915621|NCT01107457|38030107|FG004|Part B and C|Adverse Event|0|||
16915622|NCT01107457|38030108|FG005|Part B and C|Adverse Event|12|||
16915623|NCT01107457|38030103|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16915624|NCT01107457|38030104|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16915625|NCT01107457|38030105|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16915626|NCT01107457|38030106|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16915627|NCT01107457|38030107|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16915628|NCT01107457|38030108|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
16915629|NCT01107457|38030103|FG000|Part B and C|Physician Decision|0|||
16915630|NCT01107457|38030104|FG001|Part B and C|Physician Decision|0|||
16915631|NCT01107457|38030105|FG002|Part B and C|Physician Decision|0|||
16841889|NCT01401478|37786167|FG000|Overall Study|Hyperphosphatemia|5|||
16841890|NCT01401478|37786167|FG000|Overall Study|Lost to Follow-up|5|||
16841891|NCT01401478|37786167|FG000|Overall Study|Kidney transplantation|3|||
16841892|NCT01401478|37786167|FG000|Overall Study|Withdrawal by Subject|3|||
16841893|NCT01401478|37786167|FG000|Overall Study|Blood samples not available|1|||
16841894|NCT01401478|37786167|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
16841895|NCT01401478|37786167|FG000|Overall Study|Low intact parathyroid hormone|1|||
16841896|NCT01401478|37786167|FG000|Overall Study|Serious adverse event|1|||
16915632|NCT01107457|38030106|FG003|Part B and C|Physician Decision|0|||
16915633|NCT01107457|38030107|FG004|Part B and C|Physician Decision|0|||
16915634|NCT01107457|38030108|FG005|Part B and C|Physician Decision|3|||
16915635|NCT01107457|38030103|FG000|Part B and C|Lack of Efficacy|0|||
16915636|NCT01107457|38030104|FG001|Part B and C|Lack of Efficacy|0|||
16915637|NCT01107457|38030105|FG002|Part B and C|Lack of Efficacy|0|||
16915638|NCT01107457|38030106|FG003|Part B and C|Lack of Efficacy|0|||
16915639|NCT01107457|38030107|FG004|Part B and C|Lack of Efficacy|0|||
16915640|NCT01107457|38030108|FG005|Part B and C|Lack of Efficacy|7|||
16841897|NCT01422850|37786171|FG000|Overall Study|Physician Decision|3|||
16841898|NCT01422538|37786180|FG000|Overall Study|Lost to Follow-up|0|||
16841899|NCT01422538|37786181|FG001|Overall Study|Lost to Follow-up|1|||
16841900|NCT01422538|37786182|FG002|Overall Study|Lost to Follow-up|1|||
16841901|NCT01422538|37786180|FG000|Overall Study|Missed visit|0|||
16841902|NCT01422538|37786181|FG001|Overall Study|Missed visit|1|||
16841903|NCT01422538|37786182|FG002|Overall Study|Missed visit|1|||
16841904|NCT01422382|37786191|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
16841905|NCT01401322|37786195|FG000|Overall Study|Withdrawal by Subject|1|||
16841906|NCT01401322|37786195|FG000|Overall Study|Physician Decision|1|||
16915641|NCT01107457|38030103|FG000|Part B and C|Lost to Follow-up|0|||
16915642|NCT01107457|38030104|FG001|Part B and C|Lost to Follow-up|0|||
16915643|NCT01107457|38030105|FG002|Part B and C|Lost to Follow-up|0|||
16915644|NCT01107457|38030106|FG003|Part B and C|Lost to Follow-up|0|||
16915645|NCT01107457|38030107|FG004|Part B and C|Lost to Follow-up|0|||
16915646|NCT01107457|38030108|FG005|Part B and C|Lost to Follow-up|10|||
16841907|NCT01387594|37786201|FG000|Overall Study|Withdrawal by Subject|0|||
16841908|NCT01387594|37786202|FG001|Overall Study|Withdrawal by Subject|2|||
16841909|NCT01387594|37786201|FG000|Overall Study|Lost to Follow-up|0|||
16841910|NCT01387594|37786202|FG001|Overall Study|Lost to Follow-up|1|||
16841911|NCT01401010|37786213|FG000|Overall Study|Could not interpret assay results|1|||
16841912|NCT01401010|37786214|FG001|Overall Study|Could not interpret assay results|0|||
16841913|NCT01400932|37786227|FG000|Overall Study|Adverse Event|10|||
16841914|NCT01400932|37786228|FG001|Overall Study|Adverse Event|5|||
16841915|NCT01400932|37786227|FG000|Overall Study|Lack of Efficacy|0|||
16841916|NCT01400932|37786228|FG001|Overall Study|Lack of Efficacy|3|||
16841917|NCT01400932|37786227|FG000|Overall Study|Withdrawal by Subject|2|||
16841918|NCT01400932|37786228|FG001|Overall Study|Withdrawal by Subject|6|||
16841919|NCT01400932|37786227|FG000|Overall Study|Lost to Follow-up|1|||
16841920|NCT01400932|37786228|FG001|Overall Study|Lost to Follow-up|0|||
16841921|NCT01400932|37786227|FG000|Overall Study|Protocol Deviation|0|||
16841922|NCT01400932|37786228|FG001|Overall Study|Protocol Deviation|1|||
16841923|NCT01400932|37786227|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16841924|NCT01400932|37786228|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16841925|NCT01400698|37786238|FG000|Overall Study|Lost to Follow-up|2|||
16841926|NCT01400698|37786239|FG001|Overall Study|Lost to Follow-up|5|||
16841927|NCT01400698|37786240|FG002|Overall Study|Lost to Follow-up|2|||
16841928|NCT01400698|37786241|FG003|Overall Study|Lost to Follow-up|1|||
16841929|NCT01400698|37786242|FG004|Overall Study|Lost to Follow-up|4|||
16841930|NCT01400698|37786243|FG005|Overall Study|Lost to Follow-up|3|||
16841931|NCT01400698|37786238|FG000|Overall Study|Withdrawal by Subject|8|||
16841932|NCT01400698|37786239|FG001|Overall Study|Withdrawal by Subject|2|||
16915647|NCT01107457|38030103|FG000|Part B and C|Protocol Violation|0|||
16841933|NCT01400698|37786240|FG002|Overall Study|Withdrawal by Subject|0|||
16841934|NCT01400698|37786241|FG003|Overall Study|Withdrawal by Subject|4|||
16841935|NCT01400698|37786242|FG004|Overall Study|Withdrawal by Subject|1|||
16841936|NCT01400698|37786243|FG005|Overall Study|Withdrawal by Subject|3|||
16841937|NCT01400698|37786238|FG000|Overall Study|Protocol Violation|0|||
16841938|NCT01400698|37786239|FG001|Overall Study|Protocol Violation|1|||
16841939|NCT01400698|37786240|FG002|Overall Study|Protocol Violation|0|||
16841940|NCT01400698|37786241|FG003|Overall Study|Protocol Violation|0|||
16841941|NCT01400698|37786242|FG004|Overall Study|Protocol Violation|1|||
16841942|NCT01400698|37786243|FG005|Overall Study|Protocol Violation|0|||
16841943|NCT01400698|37786238|FG000|Overall Study|Non-compliance|0|||
16841944|NCT01400698|37786239|FG001|Overall Study|Non-compliance|1|||
16841945|NCT01400698|37786240|FG002|Overall Study|Non-compliance|0|||
16841946|NCT01400698|37786241|FG003|Overall Study|Non-compliance|1|||
16841947|NCT01400698|37786242|FG004|Overall Study|Non-compliance|0|||
16841948|NCT01400698|37786243|FG005|Overall Study|Non-compliance|0|||
16841949|NCT01400698|37786238|FG000|Overall Study|Adverse Event|1|||
16841950|NCT01400698|37786239|FG001|Overall Study|Adverse Event|0|||
16841951|NCT01400698|37786240|FG002|Overall Study|Adverse Event|0|||
16841952|NCT01400698|37786241|FG003|Overall Study|Adverse Event|0|||
16841953|NCT01400698|37786242|FG004|Overall Study|Adverse Event|0|||
16841954|NCT01400698|37786243|FG005|Overall Study|Adverse Event|0|||
16841955|NCT01400698|37786238|FG000|Overall Study|Other|4|||
16841956|NCT01400698|37786239|FG001|Overall Study|Other|2|||
16841957|NCT01400698|37786240|FG002|Overall Study|Other|0|||
16841958|NCT01400698|37786241|FG003|Overall Study|Other|2|||
16841959|NCT01400698|37786242|FG004|Overall Study|Other|1|||
16841960|NCT01400698|37786243|FG005|Overall Study|Other|0|||
16841961|NCT01890746|37786255|FG000|Overall Study|Death|39|||
16841962|NCT01890746|37786256|FG001|Overall Study|Death|30|||
16841963|NCT01890746|37786255|FG000|Overall Study|Adverse Event|1|||
16841964|NCT01890746|37786256|FG001|Overall Study|Adverse Event|0|||
16841965|NCT01890746|37786255|FG000|Overall Study|Lost to Follow-up|4|||
16841966|NCT01890746|37786256|FG001|Overall Study|Lost to Follow-up|1|||
16841967|NCT01890746|37786255|FG000|Overall Study|Physician Decision|3|||
16841968|NCT01890746|37786256|FG001|Overall Study|Physician Decision|2|||
16841969|NCT01890746|37786255|FG000|Overall Study|Withdrawal by Subject|5|||
16841970|NCT01890746|37786256|FG001|Overall Study|Withdrawal by Subject|8|||
16841971|NCT01422304|37786264|FG000|Overall Study|Adverse Event|0|||
16841972|NCT01422304|37786265|FG001|Overall Study|Adverse Event|1|||
16841973|NCT01422304|37786264|FG000|Overall Study|Lost to Follow-up|14|||
16841974|NCT01422304|37786265|FG001|Overall Study|Lost to Follow-up|20|||
16841975|NCT01422304|37786264|FG000|Overall Study|Never Entered Follow-up|2|||
16841976|NCT01422304|37786265|FG001|Overall Study|Never Entered Follow-up|1|||
16841977|NCT01422304|37786264|FG000|Overall Study|Protocol Violation|1|||
16841978|NCT01422304|37786265|FG001|Overall Study|Protocol Violation|0|||
16841979|NCT01422304|37786264|FG000|Overall Study|Withdrawal by Subject|4|||
16841980|NCT01422304|37786265|FG001|Overall Study|Withdrawal by Subject|2|||
16841981|NCT01422304|37786264|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
16841982|NCT01422304|37786265|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
16841983|NCT01422304|37786264|FG000|Overall Study|Not Treated|3|||
16841984|NCT01422304|37786265|FG001|Overall Study|Not Treated|11|||
16841985|NCT01387516|37786275|FG000|Overall Study|Lost to Follow-up|4|||
16841986|NCT01387516|37786276|FG001|Overall Study|Lost to Follow-up|4|||
16841987|NCT01387516|37786277|FG002|Overall Study|Lost to Follow-up|2|||
16841988|NCT01387516|37786278|FG003|Overall Study|Lost to Follow-up|3|||
16841989|NCT01387516|37786275|FG000|Overall Study|Withdrawal by Subject|1|||
16841990|NCT01387516|37786276|FG001|Overall Study|Withdrawal by Subject|1|||
16841991|NCT01387516|37786277|FG002|Overall Study|Withdrawal by Subject|2|||
16841992|NCT01387516|37786278|FG003|Overall Study|Withdrawal by Subject|0|||
16841993|NCT01387516|37786275|FG000|Overall Study|Death|0|||
16841994|NCT01387516|37786276|FG001|Overall Study|Death|0|||
16841995|NCT01387516|37786277|FG002|Overall Study|Death|0|||
16841996|NCT01387516|37786278|FG003|Overall Study|Death|1|||
16841997|NCT01421134|37786299|FG000|Overall Study|Adverse Event|3|||
16841998|NCT01421134|37786300|FG001|Overall Study|Adverse Event|5|||
16841999|NCT01421134|37786299|FG000|Overall Study|Lack of Efficacy|2|||
16842000|NCT01421134|37786300|FG001|Overall Study|Lack of Efficacy|4|||
16842001|NCT01421134|37786299|FG000|Overall Study|Protocol Violation|0|||
16842002|NCT01421134|37786300|FG001|Overall Study|Protocol Violation|3|||
16842003|NCT01421134|37786299|FG000|Overall Study|Withdrawal by Subject|1|||
16842004|NCT01421134|37786300|FG001|Overall Study|Withdrawal by Subject|1|||
16842005|NCT01421134|37786299|FG000|Overall Study|Administrative|0|||
16842006|NCT01421134|37786300|FG001|Overall Study|Administrative|1|||
16842007|NCT01421134|37786299|FG000|Overall Study|Lost to Follow-up|1|||
16842008|NCT01421134|37786300|FG001|Overall Study|Lost to Follow-up|1|||
16842009|NCT01894022|37786308|FG000|Overall Study|Death|1|||
16842010|NCT01894022|37786309|FG001|Overall Study|Death|0|||
16842011|NCT01894022|37786308|FG000|Overall Study|Adverse Event, non-fatal|1|||
16842012|NCT01894022|37786309|FG001|Overall Study|Adverse Event, non-fatal|0|||
16842013|NCT01894022|37786308|FG000|Overall Study|Study Closed/terminated|7|||
16842014|NCT01894022|37786309|FG001|Overall Study|Study Closed/terminated|10|||
16842015|NCT01615328|37786318|FG000|Overall Study|Lost to Follow-up|3|||
16915648|NCT01107457|38030104|FG001|Part B and C|Protocol Violation|0|||
16915649|NCT01107457|38030105|FG002|Part B and C|Protocol Violation|0|||
16915650|NCT01107457|38030106|FG003|Part B and C|Protocol Violation|0|||
16915651|NCT01107457|38030107|FG004|Part B and C|Protocol Violation|0|||
16915652|NCT01107457|38030108|FG005|Part B and C|Protocol Violation|1|||
16915653|NCT01107457|38030103|FG000|Part B and C|Sponsor Decision|0|||
16915654|NCT01107457|38030104|FG001|Part B and C|Sponsor Decision|0|||
17016849|NCT00848718|38161494|FG000|Overall Study|Physician Decision|0|||
17016850|NCT00848718|38161495|FG001|Overall Study|Physician Decision|1|||
17016851|NCT00848718|38161496|FG002|Overall Study|Physician Decision|0|||
17016852|NCT00848718|38161497|FG003|Overall Study|Physician Decision|0|||
17016853|NCT00848718|38161498|FG004|Overall Study|Physician Decision|1|||
17016854|NCT00848718|38161499|FG005|Overall Study|Physician Decision|1|||
17016855|NCT00848718|38161500|FG006|Overall Study|Physician Decision|0|||
17016856|NCT00848718|38161501|FG007|Overall Study|Physician Decision|0|||
17016857|NCT00848718|38161502|FG008|Overall Study|Physician Decision|1|||
17016858|NCT00848718|38161503|FG009|Overall Study|Physician Decision|2|||
17016859|NCT00848718|38161504|FG010|Overall Study|Physician Decision|0|||
17016860|NCT00848718|38161505|FG011|Overall Study|Physician Decision|0|||
17016861|NCT00848718|38161506|FG012|Overall Study|Physician Decision|1|||
17016862|NCT00848718|38161494|FG000|Overall Study|Progressive disease before treatment|1|||
17016863|NCT00848718|38161495|FG001|Overall Study|Progressive disease before treatment|5|||
17016864|NCT00848718|38161496|FG002|Overall Study|Progressive disease before treatment|1|||
17016865|NCT00848718|38161497|FG003|Overall Study|Progressive disease before treatment|3|||
17016866|NCT00848718|38161498|FG004|Overall Study|Progressive disease before treatment|4|||
17016867|NCT00848718|38161499|FG005|Overall Study|Progressive disease before treatment|4|||
17016868|NCT00848718|38161500|FG006|Overall Study|Progressive disease before treatment|2|||
16915655|NCT01107457|38030105|FG002|Part B and C|Sponsor Decision|0|||
17016869|NCT00848718|38161501|FG007|Overall Study|Progressive disease before treatment|1|||
17016870|NCT00848718|38161502|FG008|Overall Study|Progressive disease before treatment|2|||
17016871|NCT00848718|38161503|FG009|Overall Study|Progressive disease before treatment|7|||
17016872|NCT00848718|38161504|FG010|Overall Study|Progressive disease before treatment|3|||
17016873|NCT00848718|38161505|FG011|Overall Study|Progressive disease before treatment|6|||
17016874|NCT00848718|38161506|FG012|Overall Study|Progressive disease before treatment|2|||
17016875|NCT00848718|38161494|FG000|Overall Study|Protocol Violation|0|||
17016876|NCT00848718|38161495|FG001|Overall Study|Protocol Violation|1|||
17016877|NCT00848718|38161496|FG002|Overall Study|Protocol Violation|0|||
17016878|NCT00848718|38161497|FG003|Overall Study|Protocol Violation|0|||
17016879|NCT00848718|38161498|FG004|Overall Study|Protocol Violation|0|||
17016880|NCT00848718|38161499|FG005|Overall Study|Protocol Violation|0|||
17016881|NCT00848718|38161500|FG006|Overall Study|Protocol Violation|0|||
17016882|NCT00848718|38161501|FG007|Overall Study|Protocol Violation|1|||
17016883|NCT00848718|38161502|FG008|Overall Study|Protocol Violation|0|||
17016884|NCT00848718|38161503|FG009|Overall Study|Protocol Violation|0|||
17016885|NCT00848718|38161504|FG010|Overall Study|Protocol Violation|0|||
17016886|NCT00848718|38161505|FG011|Overall Study|Protocol Violation|0|||
17016887|NCT00848718|38161506|FG012|Overall Study|Protocol Violation|1|||
17016888|NCT00848718|38161494|FG000|Overall Study|Withdrawal by Subject|1|||
17016889|NCT00848718|38161495|FG001|Overall Study|Withdrawal by Subject|0|||
17016890|NCT00848718|38161496|FG002|Overall Study|Withdrawal by Subject|0|||
17016891|NCT00848718|38161497|FG003|Overall Study|Withdrawal by Subject|1|||
17016892|NCT00848718|38161498|FG004|Overall Study|Withdrawal by Subject|0|||
17016893|NCT00848718|38161499|FG005|Overall Study|Withdrawal by Subject|0|||
17016894|NCT00848718|38161500|FG006|Overall Study|Withdrawal by Subject|0|||
17016895|NCT00848718|38161501|FG007|Overall Study|Withdrawal by Subject|0|||
17016896|NCT00848718|38161502|FG008|Overall Study|Withdrawal by Subject|0|||
17016897|NCT00848718|38161503|FG009|Overall Study|Withdrawal by Subject|0|||
17016898|NCT00848718|38161504|FG010|Overall Study|Withdrawal by Subject|1|||
17016899|NCT00848718|38161505|FG011|Overall Study|Withdrawal by Subject|0|||
17016900|NCT00848718|38161506|FG012|Overall Study|Withdrawal by Subject|0|||
17016901|NCT00848718|38161494|FG000|Overall Study|Progressive disease during treatment|3|||
17016902|NCT00848718|38161495|FG001|Overall Study|Progressive disease during treatment|0|||
16842016|NCT01615328|37786319|FG001|Overall Study|Lost to Follow-up|5|||
16842017|NCT01890512|37786329|FG000|Overall Study|Physician Decision|1|||
16842018|NCT01890512|37786329|FG000|Overall Study|Withdrawal by Subject|1|||
16842019|NCT01890512|37786329|FG000|Overall Study|Protocol Violation|1|||
16842020|NCT01387282|37786335|FG000|Overall Study|Death|47|||
16842021|NCT01387282|37786336|FG001|Overall Study|Death|16|||
16842022|NCT01387282|37786335|FG000|Overall Study|Other|5|||
16842023|NCT01387282|37786336|FG001|Overall Study|Other|1|||
16915656|NCT01107457|38030106|FG003|Part B and C|Sponsor Decision|0|||
17016903|NCT00848718|38161496|FG002|Overall Study|Progressive disease during treatment|3|||
17016904|NCT00848718|38161497|FG003|Overall Study|Progressive disease during treatment|0|||
17016905|NCT00848718|38161498|FG004|Overall Study|Progressive disease during treatment|0|||
16842024|NCT01387282|37786335|FG000|Overall Study|Unrelated AE|6|||
16842025|NCT01387282|37786336|FG001|Overall Study|Unrelated AE|4|||
16842026|NCT01387282|37786335|FG000|Overall Study|Withdrawal by patient|33|||
16842027|NCT01387282|37786336|FG001|Overall Study|Withdrawal by patient|23|||
16842028|NCT01387282|37786335|FG000|Overall Study|Study drug-related AE|2|||
16842029|NCT01387282|37786336|FG001|Overall Study|Study drug-related AE|2|||
16842030|NCT01387282|37786335|FG000|Overall Study|Lost to Follow-up|4|||
16842031|NCT01387282|37786336|FG001|Overall Study|Lost to Follow-up|1|||
16842032|NCT01386970|37786344|FG000|Overall Study|Withdrawal by Subject|0|||
16842033|NCT01386970|37786345|FG001|Overall Study|Withdrawal by Subject|1|||
16842034|NCT01386970|37786344|FG000|Overall Study|Adverse Event|4|||
16842035|NCT01386970|37786345|FG001|Overall Study|Adverse Event|1|||
16842036|NCT01890434|37786353|FG000|Overall Study|Adverse Event|8|||
16842037|NCT01890434|37786353|FG000|Overall Study|PCI at external hospital|1|||
16842038|NCT01890434|37786353|FG000|Overall Study|Assessment discrepancy|1|||
16842039|NCT01890434|37786353|FG000|Overall Study|CRC didn't contact participant for FU|1|||
16842040|NCT01890434|37786353|FG000|Overall Study|Could not get whole set of images|1|||
16842041|NCT01890434|37786353|FG000|Overall Study|Decline to return for GSPECT|1|||
16915657|NCT01107457|38030107|FG004|Part B and C|Sponsor Decision|0|||
16915658|NCT01107457|38030108|FG005|Part B and C|Sponsor Decision|66|||
16915659|NCT01107457|38030103|FG000|Part B and C|Withdrawal by Subject|0|||
16915660|NCT01107457|38030104|FG001|Part B and C|Withdrawal by Subject|0|||
16915661|NCT01107457|38030105|FG002|Part B and C|Withdrawal by Subject|0|||
16915662|NCT01107457|38030106|FG003|Part B and C|Withdrawal by Subject|0|||
16842042|NCT01890434|37786353|FG000|Overall Study|GSPECT at rest was not done|1|||
16842043|NCT01890434|37786353|FG000|Overall Study|Participant didn't complete MRI|1|||
16842044|NCT01890434|37786353|FG000|Overall Study|Uncontactable by phone|1|||
16842045|NCT01890434|37786353|FG000|Overall Study|Moved out of position|1|||
16842046|NCT01890434|37786353|FG000|Overall Study|Unable to contact|1|||
16842047|NCT01890434|37786353|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
16842048|NCT01385566|37786363|FG000|Overall Study|Lost to Follow-up|1|||
16842049|NCT01385566|37786364|FG001|Overall Study|Lost to Follow-up|0|||
16842050|NCT01385566|37786365|FG002|Overall Study|Lost to Follow-up|0|||
16842051|NCT01385566|37786366|FG003|Overall Study|Lost to Follow-up|0|||
16842052|NCT01385566|37786367|FG004|Overall Study|Lost to Follow-up|0|||
16842053|NCT01385566|37786368|FG005|Overall Study|Lost to Follow-up|0|||
16842054|NCT01385566|37786363|FG000|Overall Study|Withdrawal by Subject|0|||
16842055|NCT01385566|37786364|FG001|Overall Study|Withdrawal by Subject|0|||
16842056|NCT01385566|37786365|FG002|Overall Study|Withdrawal by Subject|0|||
16842057|NCT01385566|37786366|FG003|Overall Study|Withdrawal by Subject|1|||
16842058|NCT01385566|37786367|FG004|Overall Study|Withdrawal by Subject|0|||
16842059|NCT01385566|37786368|FG005|Overall Study|Withdrawal by Subject|0|||
16842060|NCT01780545|37786386|FG000|Overall Study|Withdrawal by Subject|3|||
16842061|NCT01780545|37786387|FG001|Overall Study|Withdrawal by Subject|1|||
16842062|NCT01780545|37786386|FG000|Overall Study|Lost to Follow-up|1|||
16842063|NCT01780545|37786387|FG001|Overall Study|Lost to Follow-up|1|||
16842064|NCT01780389|37786396|FG000|Overall Study|Adverse Event|1|||
16842065|NCT01778985|37786403|FG000|Overall Study|Lost to Follow-up|1|||
16842066|NCT01778985|37786404|FG001|Overall Study|Lost to Follow-up|0|||
16842067|NCT01778985|37786403|FG000|Overall Study|Physician Decision|2|||
16842068|NCT01778985|37786404|FG001|Overall Study|Physician Decision|2|||
16842069|NCT01778985|37786403|FG000|Overall Study|Protocol Violation|4|||
16842070|NCT01778985|37786404|FG001|Overall Study|Protocol Violation|1|||
16842071|NCT01778751|37786412|FG000|Overall Study|Lost to Follow-up|1|||
16842072|NCT01778751|37786413|FG001|Overall Study|Lost to Follow-up|0|||
16842073|NCT01778751|37786412|FG000|Overall Study|Withdrawal by Subject|0|||
16842074|NCT01778751|37786413|FG001|Overall Study|Withdrawal by Subject|2|||
16842075|NCT01778751|37786412|FG000|Overall Study|Transfered care|1|||
16842076|NCT01778751|37786413|FG001|Overall Study|Transfered care|0|||
16842077|NCT01865084|37786422|FG000|Double Blind Period (DB)|Adverse Event|2|||
16842078|NCT01865084|37786423|FG001|Double Blind Period (DB)|Adverse Event|2|||
16842079|NCT01865084|37786424|FG002|Double Blind Period (DB)|Adverse Event|1|||
16842080|NCT01865084|37786422|FG000|Double Blind Period (DB)|Protocol Violation|0|||
16842081|NCT01865084|37786423|FG001|Double Blind Period (DB)|Protocol Violation|0|||
16842082|NCT01865084|37786424|FG002|Double Blind Period (DB)|Protocol Violation|1|||
16842083|NCT01865084|37786422|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
16842084|NCT01865084|37786423|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
16842085|NCT01865084|37786424|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
16842086|NCT01865084|37786422|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
16842087|NCT01865084|37786423|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
16842088|NCT01865084|37786424|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
16842089|NCT01865084|37786422|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
16842090|NCT01865084|37786423|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
16842091|NCT01865084|37786424|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
16915663|NCT01107457|38030107|FG004|Part B and C|Withdrawal by Subject|0|||
16915664|NCT01107457|38030108|FG005|Part B and C|Withdrawal by Subject|16|||
16842092|NCT01865084|37786422|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
16842093|NCT01865084|37786423|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
17016906|NCT00848718|38161499|FG005|Overall Study|Progressive disease during treatment|0|||
17016907|NCT00848718|38161500|FG006|Overall Study|Progressive disease during treatment|0|||
17016908|NCT00848718|38161501|FG007|Overall Study|Progressive disease during treatment|2|||
16915665|NCT01107457|38030103|FG000|Part B and C|Clinical Relapse|0|||
16915666|NCT01107457|38030104|FG001|Part B and C|Clinical Relapse|0|||
16915667|NCT01107457|38030105|FG002|Part B and C|Clinical Relapse|0|||
16915668|NCT01107457|38030106|FG003|Part B and C|Clinical Relapse|0|||
16915669|NCT01107457|38030107|FG004|Part B and C|Clinical Relapse|0|||
16915670|NCT01107457|38030108|FG005|Part B and C|Clinical Relapse|4|||
16915671|NCT05490771|38030126|FG000|Overall Study|Disease progression|18|||
16915672|NCT05490771|38030126|FG000|Overall Study|Adverse Event|3|||
16915673|NCT05490771|38030126|FG000|Overall Study|Other complicating disease|1|||
16915674|NCT05490771|38030126|FG000|Overall Study|Withdrawal by Subject|3|||
16915675|NCT05490771|38030126|FG000|Overall Study|Physician Decision|1|||
16915676|NCT05490771|38030126|FG000|Overall Study|Still on treatment|2|||
16915677|NCT05490771|38030126|FG000|Overall Study|Never start protocol therapy|5|||
16915678|NCT05490771|38030126|FG000|Overall Study|Ineligible|2|||
16915679|NCT04545385|38030142|FG000|Overall Study|Withdrawal by Subject|2|||
16915680|NCT04545385|38030143|FG001|Overall Study|Withdrawal by Subject|0|||
16915681|NCT04545385|38030142|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
16915682|NCT04545385|38030143|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
16915683|NCT04545385|38030142|FG000|Overall Study|Study termination|10|||
16915684|NCT04545385|38030143|FG001|Overall Study|Study termination|10|||
16915685|NCT04545385|38030142|FG000|Overall Study|Sponsor decision|2|||
16915686|NCT04545385|38030143|FG001|Overall Study|Sponsor decision|2|||
16915687|NCT04545385|38030142|FG000|Overall Study|Other than specified|1|||
16915688|NCT04545385|38030143|FG001|Overall Study|Other than specified|0|||
16915689|NCT04439136|38030158|FG000|Overall Study|Ineligible|1|||
16915690|NCT04439136|38030158|FG000|Overall Study|Never Started Treatment|2|||
16915691|NCT04439136|38030158|FG000|Overall Study|Adverse Event|4|||
16915692|NCT04439136|38030158|FG000|Overall Study|Death|3|||
16915693|NCT04439136|38030158|FG000|Overall Study|Disease Progression|27|||
16915694|NCT04439136|38030158|FG000|Overall Study|Alternative Therapy|1|||
16915695|NCT04439136|38030158|FG000|Overall Study|Increased Tumor Burden|1|||
16915696|NCT04439136|38030158|FG000|Overall Study|Symptomatic Detrioration|1|||
16915697|NCT03783026|38030162|FG000|Treatment Phase|Adverse Event|15|||
16915698|NCT03783026|38030162|FG000|Treatment Phase|Lack of Efficacy|11|||
16915699|NCT03783026|38030162|FG000|Treatment Phase|Withdrawal by Subject|6|||
16915700|NCT03783026|38030162|FG000|Treatment Phase|Lost to Follow-up|2|||
16915701|NCT03783026|38030162|FG000|Treatment Phase|Protocol Deviation|8|||
16915702|NCT03783026|38030162|FG000|Treatment Phase|Did Not Receive Treatment|1|||
16915703|NCT03783026|38030162|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
16842094|NCT01865084|37786424|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
16842095|NCT01865084|37786422|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
16842096|NCT01865084|37786423|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
16842097|NCT01865084|37786424|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
16842098|NCT01865084|37786422|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
16842099|NCT01865084|37786423|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
16842100|NCT01865084|37786424|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
16842101|NCT01865084|37786422|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
16842102|NCT01865084|37786423|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
16842103|NCT01865084|37786424|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
16842104|NCT01778127|37786439|FG000|Overall Study|Lost to Follow-up|5|||
16842105|NCT01778127|37786440|FG001|Overall Study|Lost to Follow-up|1|||
16842106|NCT01778127|37786441|FG002|Overall Study|Lost to Follow-up|2|||
16842107|NCT01778127|37786439|FG000|Overall Study|Withdrawal by Subject|3|||
16842108|NCT01778127|37786440|FG001|Overall Study|Withdrawal by Subject|1|||
16842109|NCT01778127|37786441|FG002|Overall Study|Withdrawal by Subject|4|||
16842110|NCT01892540|37786452|FG000|Overall Study|Did not complete PET/MRI|0|||
16842111|NCT01892540|37786453|FG001|Overall Study|Did not complete PET/MRI|0|||
16842112|NCT01892540|37786454|FG002|Overall Study|Did not complete PET/MRI|2|||
16842113|NCT01892540|37786452|FG000|Overall Study|Did not fit in scanner|0|||
16842114|NCT01892540|37786453|FG001|Overall Study|Did not fit in scanner|0|||
16842115|NCT01892540|37786454|FG002|Overall Study|Did not fit in scanner|1|||
16842116|NCT01399372|37786464|FG000|Overall Study|Protocol Violation|3|||
16842117|NCT01399372|37786465|FG001|Overall Study|Protocol Violation|1|||
16842118|NCT01385098|37786471|FG000|Overall Study|Adverse Event|10|||
16842119|NCT01385098|37786471|FG000|Overall Study|Lost to Follow-up|4|||
16842120|NCT01398514|37786479|FG000|Overall Study|Adverse Event|1|||
16842121|NCT01398514|37786480|FG001|Overall Study|Adverse Event|0|||
16915704|NCT03635112|38030179|FG000|Overall Study|Adverse Event|5|||
16915705|NCT03635112|38030180|FG001|Overall Study|Adverse Event|9|||
16915706|NCT03635112|38030181|FG002|Overall Study|Adverse Event|14|||
16842122|NCT01398514|37786479|FG000|Overall Study|Non-compliance with study procedures|2|||
16842123|NCT01398514|37786480|FG001|Overall Study|Non-compliance with study procedures|0|||
16842124|NCT01398514|37786479|FG000|Overall Study|Physiologic non-responsiveness|1|||
16842125|NCT01398514|37786480|FG001|Overall Study|Physiologic non-responsiveness|3|||
16842126|NCT01398514|37786479|FG000|Overall Study|Failure to show a conditioned response|4|||
16842127|NCT01398514|37786480|FG001|Overall Study|Failure to show a conditioned response|3|||
16842128|NCT01398358|37786491|FG000|Overall Study|Lost to Follow-up|11|||
16842129|NCT01398358|37786492|FG001|Overall Study|Lost to Follow-up|21|||
16842130|NCT01398358|37786493|FG002|Overall Study|Lost to Follow-up|18|||
16915707|NCT03635112|38030179|FG000|Overall Study|Lost to Follow-up|1|||
16915708|NCT03635112|38030180|FG001|Overall Study|Lost to Follow-up|0|||
16915709|NCT03635112|38030181|FG002|Overall Study|Lost to Follow-up|1|||
16915710|NCT03635112|38030179|FG000|Overall Study|Physician Decision|5|||
16915711|NCT03635112|38030180|FG001|Overall Study|Physician Decision|7|||
16915712|NCT03635112|38030181|FG002|Overall Study|Physician Decision|5|||
16915713|NCT03635112|38030179|FG000|Overall Study|Protocol Violation|0|||
16915714|NCT03635112|38030180|FG001|Overall Study|Protocol Violation|0|||
16915715|NCT03635112|38030181|FG002|Overall Study|Protocol Violation|1|||
16915716|NCT03635112|38030179|FG000|Overall Study|Study Terminated by Sponsor|11|||
16915717|NCT03635112|38030180|FG001|Overall Study|Study Terminated by Sponsor|17|||
16915718|NCT03635112|38030181|FG002|Overall Study|Study Terminated by Sponsor|21|||
16915719|NCT03635112|38030179|FG000|Overall Study|Withdrawal by Subject|4|||
16915720|NCT03635112|38030180|FG001|Overall Study|Withdrawal by Subject|9|||
16915721|NCT03635112|38030181|FG002|Overall Study|Withdrawal by Subject|7|||
16915722|NCT03635112|38030179|FG000|Overall Study|Miscellaneous|0|||
16915723|NCT03635112|38030180|FG001|Overall Study|Miscellaneous|0|||
16842131|NCT01398358|37786491|FG000|Overall Study|Withdrawal by Subject|3|||
16842132|NCT01398358|37786492|FG001|Overall Study|Withdrawal by Subject|2|||
16842133|NCT01398358|37786493|FG002|Overall Study|Withdrawal by Subject|2|||
16842134|NCT01398358|37786491|FG000|Overall Study|no longer eligible|1|||
16842135|NCT01398358|37786492|FG001|Overall Study|no longer eligible|0|||
16842136|NCT01398358|37786493|FG002|Overall Study|no longer eligible|1|||
16915724|NCT03635112|38030181|FG002|Overall Study|Miscellaneous|1|||
16915725|NCT03588728|38030194|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
16842137|NCT01778049|37786503|FG000|Open Label Treatment Period|Adverse Event|5|||
16842138|NCT01778049|37786504|FG001|Open Label Treatment Period|Adverse Event|15|||
16842139|NCT01778049|37786505|FG002|Open Label Treatment Period|Adverse Event|0|||
16842140|NCT01778049|37786506|FG003|Open Label Treatment Period|Adverse Event|0|||
16842141|NCT01778049|37786507|FG004|Open Label Treatment Period|Adverse Event|0|||
16842142|NCT01778049|37786508|FG005|Open Label Treatment Period|Adverse Event|0|||
16842143|NCT01778049|37786503|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
16842144|NCT01778049|37786504|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
16842145|NCT01778049|37786505|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
16842146|NCT01778049|37786506|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
16842147|NCT01778049|37786507|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
16842148|NCT01778049|37786508|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
16842149|NCT01778049|37786503|FG000|Open Label Treatment Period|Protocol Violation|5|||
16842150|NCT01778049|37786504|FG001|Open Label Treatment Period|Protocol Violation|5|||
16842151|NCT01778049|37786505|FG002|Open Label Treatment Period|Protocol Violation|0|||
16842152|NCT01778049|37786506|FG003|Open Label Treatment Period|Protocol Violation|0|||
16915726|NCT03588728|38030195|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
16915727|NCT03588728|38030196|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
16915728|NCT03588728|38030197|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
16915729|NCT03588728|38030194|FG000|Overall Study|Lab shut down due to COVID-19|0|||
16842153|NCT01778049|37786507|FG004|Open Label Treatment Period|Protocol Violation|0|||
16842154|NCT01778049|37786508|FG005|Open Label Treatment Period|Protocol Violation|0|||
16842155|NCT01778049|37786503|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
16842156|NCT01778049|37786504|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
16842157|NCT01778049|37786505|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
16842158|NCT01778049|37786506|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
16842159|NCT01778049|37786507|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
16842160|NCT01778049|37786508|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
16842161|NCT01778049|37786503|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
16842162|NCT01778049|37786504|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
16842163|NCT01778049|37786505|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
16915730|NCT03588728|38030195|FG001|Overall Study|Lab shut down due to COVID-19|0|||
16915731|NCT03588728|38030196|FG002|Overall Study|Lab shut down due to COVID-19|0|||
16915732|NCT03588728|38030197|FG003|Overall Study|Lab shut down due to COVID-19|1|||
16915733|NCT03588728|38030194|FG000|Overall Study|multiple technical issues|1|||
16915734|NCT03588728|38030195|FG001|Overall Study|multiple technical issues|0|||
16915735|NCT03588728|38030196|FG002|Overall Study|multiple technical issues|0|||
16915736|NCT03588728|38030197|FG003|Overall Study|multiple technical issues|0|||
16915737|NCT03588728|38030194|FG000|Overall Study|Hospitalized for COVID|1|||
16915738|NCT03588728|38030195|FG001|Overall Study|Hospitalized for COVID|0|||
16842164|NCT01778049|37786506|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
16842165|NCT01778049|37786507|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
16842166|NCT01778049|37786508|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
16842167|NCT01778049|37786503|FG000|Open Label Treatment Period|Not treated|2|||
16842168|NCT01778049|37786504|FG001|Open Label Treatment Period|Not treated|1|||
16842169|NCT01778049|37786505|FG002|Open Label Treatment Period|Not treated|0|||
16842170|NCT01778049|37786506|FG003|Open Label Treatment Period|Not treated|0|||
16842171|NCT01778049|37786507|FG004|Open Label Treatment Period|Not treated|0|||
16842172|NCT01778049|37786508|FG005|Open Label Treatment Period|Not treated|0|||
16842173|NCT01778049|37786503|FG000|Open Label Treatment Period|Other reason not defined above|77|||
16842174|NCT01778049|37786504|FG001|Open Label Treatment Period|Other reason not defined above|94|||
16842175|NCT01778049|37786505|FG002|Open Label Treatment Period|Other reason not defined above|0|||
16915739|NCT03588728|38030196|FG002|Overall Study|Hospitalized for COVID|0|||
16915740|NCT03588728|38030197|FG003|Overall Study|Hospitalized for COVID|0|||
16915741|NCT03588728|38030194|FG000|Overall Study|Schedule change unable to attend sessions|1|||
16842176|NCT01778049|37786506|FG003|Open Label Treatment Period|Other reason not defined above|0|||
16842177|NCT01778049|37786507|FG004|Open Label Treatment Period|Other reason not defined above|0|||
16842178|NCT01778049|37786508|FG005|Open Label Treatment Period|Other reason not defined above|0|||
16915742|NCT03588728|38030195|FG001|Overall Study|Schedule change unable to attend sessions|0|||
16915743|NCT03588728|38030196|FG002|Overall Study|Schedule change unable to attend sessions|0|||
16915744|NCT03588728|38030197|FG003|Overall Study|Schedule change unable to attend sessions|0|||
16915745|NCT03194646|38030219|FG000|Overall Study|Adverse Event|24|||
16915746|NCT03194646|38030220|FG001|Overall Study|Adverse Event|25|||
16915747|NCT03194646|38030221|FG002|Overall Study|Adverse Event|14|||
16915748|NCT03194646|38030222|FG003|Overall Study|Adverse Event|17|||
16915749|NCT03194646|38030219|FG000|Overall Study|Lack of Efficacy|4|||
16915750|NCT03194646|38030220|FG001|Overall Study|Lack of Efficacy|2|||
16915751|NCT03194646|38030221|FG002|Overall Study|Lack of Efficacy|2|||
16915752|NCT03194646|38030222|FG003|Overall Study|Lack of Efficacy|12|||
16915753|NCT03194646|38030219|FG000|Overall Study|Lost to Follow-up|30|||
16915754|NCT03194646|38030220|FG001|Overall Study|Lost to Follow-up|22|||
16915755|NCT03194646|38030221|FG002|Overall Study|Lost to Follow-up|12|||
16915756|NCT03194646|38030222|FG003|Overall Study|Lost to Follow-up|35|||
16915757|NCT03194646|38030219|FG000|Overall Study|Non-compliance with study drug|4|||
16915758|NCT03194646|38030220|FG001|Overall Study|Non-compliance with study drug|0|||
16915759|NCT03194646|38030221|FG002|Overall Study|Non-compliance with study drug|1|||
16915760|NCT03194646|38030222|FG003|Overall Study|Non-compliance with study drug|1|||
16915761|NCT03194646|38030219|FG000|Overall Study|Other|87|||
16915762|NCT03194646|38030220|FG001|Overall Study|Other|67|||
16915763|NCT03194646|38030221|FG002|Overall Study|Other|34|||
16915764|NCT03194646|38030222|FG003|Overall Study|Other|31|||
16915765|NCT03194646|38030219|FG000|Overall Study|Physician Decision|7|||
16842179|NCT01778049|37786503|FG000|Double Blind Treatment Period|Adverse Event|0|||
16842180|NCT01778049|37786504|FG001|Double Blind Treatment Period|Adverse Event|0|||
16842181|NCT01778049|37786505|FG002|Double Blind Treatment Period|Adverse Event|4|||
16915766|NCT03194646|38030220|FG001|Overall Study|Physician Decision|9|||
16915767|NCT03194646|38030221|FG002|Overall Study|Physician Decision|5|||
16915768|NCT03194646|38030222|FG003|Overall Study|Physician Decision|4|||
16915769|NCT03194646|38030219|FG000|Overall Study|Pregnancy|4|||
16915770|NCT03194646|38030220|FG001|Overall Study|Pregnancy|5|||
16915771|NCT03194646|38030221|FG002|Overall Study|Pregnancy|1|||
16842182|NCT01778049|37786506|FG003|Double Blind Treatment Period|Adverse Event|5|||
16842183|NCT01778049|37786507|FG004|Double Blind Treatment Period|Adverse Event|3|||
16842184|NCT01778049|37786508|FG005|Double Blind Treatment Period|Adverse Event|2|||
16842185|NCT01778049|37786503|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
16842186|NCT01778049|37786504|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
16842187|NCT01778049|37786505|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
16842188|NCT01778049|37786506|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
16842189|NCT01778049|37786507|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
16842190|NCT01778049|37786508|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
16842191|NCT01778049|37786503|FG000|Double Blind Treatment Period|Protocol Violation|0|||
16842192|NCT01778049|37786504|FG001|Double Blind Treatment Period|Protocol Violation|0|||
16842193|NCT01778049|37786505|FG002|Double Blind Treatment Period|Protocol Violation|2|||
16842194|NCT01778049|37786506|FG003|Double Blind Treatment Period|Protocol Violation|0|||
16842195|NCT01778049|37786507|FG004|Double Blind Treatment Period|Protocol Violation|0|||
16842196|NCT01778049|37786508|FG005|Double Blind Treatment Period|Protocol Violation|0|||
16842197|NCT01778049|37786503|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
16842198|NCT01778049|37786504|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
16842199|NCT01778049|37786505|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
16842200|NCT01778049|37786506|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
16842201|NCT01778049|37786507|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
16842202|NCT01778049|37786508|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
16915772|NCT03194646|38030222|FG003|Overall Study|Pregnancy|2|||
16842203|NCT01778049|37786503|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
16842204|NCT01778049|37786504|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
16842205|NCT01778049|37786505|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
16842206|NCT01778049|37786506|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
16842207|NCT01778049|37786507|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
16842208|NCT01778049|37786508|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
17016909|NCT00848718|38161502|FG008|Overall Study|Progressive disease during treatment|0|||
17016910|NCT00848718|38161503|FG009|Overall Study|Progressive disease during treatment|0|||
17016911|NCT00848718|38161504|FG010|Overall Study|Progressive disease during treatment|0|||
17016912|NCT00848718|38161505|FG011|Overall Study|Progressive disease during treatment|0|||
17016913|NCT00848718|38161506|FG012|Overall Study|Progressive disease during treatment|2|||
17016914|NCT00883337|38161543|FG000|Core Treatment Period|Adverse Event|9|||
17016915|NCT00883337|38161544|FG001|Core Treatment Period|Adverse Event|12|||
17016916|NCT00883337|38161545|FG002|Core Treatment Period|Adverse Event|22|||
17016917|NCT00883337|38161543|FG000|Core Treatment Period|Lack of Efficacy|7|||
17016918|NCT00883337|38161544|FG001|Core Treatment Period|Lack of Efficacy|4|||
17016919|NCT00883337|38161545|FG002|Core Treatment Period|Lack of Efficacy|2|||
17016920|NCT00883337|38161543|FG000|Core Treatment Period|Lost to Follow-up|1|||
17016921|NCT00883337|38161544|FG001|Core Treatment Period|Lost to Follow-up|1|||
17016922|NCT00883337|38161545|FG002|Core Treatment Period|Lost to Follow-up|0|||
17016923|NCT00883337|38161543|FG000|Core Treatment Period|Withdrawal by Subject|2|||
17016924|NCT00883337|38161544|FG001|Core Treatment Period|Withdrawal by Subject|2|||
17016925|NCT00883337|38161545|FG002|Core Treatment Period|Withdrawal by Subject|6|||
16842209|NCT01778049|37786503|FG000|Double Blind Treatment Period|Not treated|0|||
16842210|NCT01778049|37786504|FG001|Double Blind Treatment Period|Not treated|0|||
16842211|NCT01778049|37786505|FG002|Double Blind Treatment Period|Not treated|0|||
16842212|NCT01778049|37786506|FG003|Double Blind Treatment Period|Not treated|2|||
16842213|NCT01778049|37786507|FG004|Double Blind Treatment Period|Not treated|2|||
16842214|NCT01778049|37786508|FG005|Double Blind Treatment Period|Not treated|0|||
16842215|NCT01778049|37786503|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
16842216|NCT01778049|37786504|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
16842217|NCT01778049|37786505|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
16842218|NCT01778049|37786506|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
16842219|NCT01778049|37786507|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
16842220|NCT01778049|37786508|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
16842221|NCT01777581|37786522|FG000|Overall Study|Lost to Follow-up|1|||
16842222|NCT01777581|37786523|FG001|Overall Study|Lost to Follow-up|1|||
16842223|NCT01777581|37786522|FG000|Overall Study|Adverse Event|2|||
16842224|NCT01777581|37786523|FG001|Overall Study|Adverse Event|0|||
16842225|NCT01777581|37786522|FG000|Overall Study|Lack of Efficacy|0|||
16842226|NCT01777581|37786523|FG001|Overall Study|Lack of Efficacy|1|||
16842227|NCT01864148|37786534|FG000|Overall Study|Other|2|||
16842228|NCT01864148|37786535|FG001|Overall Study|Other|1|||
16842229|NCT01864148|37786536|FG002|Overall Study|Other|1|||
16842230|NCT01864148|37786537|FG003|Overall Study|Other|3|||
16842231|NCT01864148|37786538|FG004|Overall Study|Other|1|||
16842232|NCT01864148|37786534|FG000|Overall Study|Death|0|||
16842233|NCT01864148|37786535|FG001|Overall Study|Death|0|||
16842234|NCT01864148|37786536|FG002|Overall Study|Death|0|||
16842235|NCT01864148|37786537|FG003|Overall Study|Death|1|||
16842236|NCT01864148|37786538|FG004|Overall Study|Death|0|||
16842237|NCT01864148|37786534|FG000|Overall Study|Investigator Decision|5|||
16842238|NCT01864148|37786535|FG001|Overall Study|Investigator Decision|0|||
16842239|NCT01864148|37786536|FG002|Overall Study|Investigator Decision|0|||
16842240|NCT01864148|37786537|FG003|Overall Study|Investigator Decision|4|||
16842241|NCT01864148|37786538|FG004|Overall Study|Investigator Decision|6|||
16842242|NCT01864148|37786534|FG000|Overall Study|Withdrawal by Subject|9|||
16842243|NCT01864148|37786535|FG001|Overall Study|Withdrawal by Subject|2|||
16842244|NCT01864148|37786536|FG002|Overall Study|Withdrawal by Subject|6|||
16842245|NCT01864148|37786537|FG003|Overall Study|Withdrawal by Subject|8|||
16842246|NCT01864148|37786538|FG004|Overall Study|Withdrawal by Subject|8|||
16842247|NCT01864148|37786534|FG000|Overall Study|Lost to Follow-up|0|||
16842248|NCT01864148|37786535|FG001|Overall Study|Lost to Follow-up|0|||
16842249|NCT01864148|37786536|FG002|Overall Study|Lost to Follow-up|0|||
16842250|NCT01864148|37786537|FG003|Overall Study|Lost to Follow-up|2|||
16842251|NCT01864148|37786538|FG004|Overall Study|Lost to Follow-up|1|||
16842252|NCT01864148|37786534|FG000|Overall Study|Adverse Event|4|||
16842253|NCT01864148|37786535|FG001|Overall Study|Adverse Event|2|||
16842254|NCT01864148|37786536|FG002|Overall Study|Adverse Event|4|||
16842255|NCT01864148|37786537|FG003|Overall Study|Adverse Event|7|||
16842256|NCT01864148|37786538|FG004|Overall Study|Adverse Event|7|||
16842257|NCT01864148|37786534|FG000|Overall Study|Not Dosed|0|||
16842258|NCT01864148|37786535|FG001|Overall Study|Not Dosed|0|||
16842259|NCT01864148|37786536|FG002|Overall Study|Not Dosed|0|||
17016926|NCT00883337|38161543|FG000|Core Treatment Period|Wish to be pregnant|1|||
16842260|NCT01864148|37786537|FG003|Overall Study|Not Dosed|1|||
16842261|NCT01864148|37786538|FG004|Overall Study|Not Dosed|0|||
16842262|NCT01751139|37786555|FG000|Overall Study|Other|135|||
16842263|NCT01751139|37786555|FG000|Overall Study|Sponsor study termination|1609|||
16842264|NCT01751139|37786555|FG000|Overall Study|Lost to Follow-up|240|||
16842265|NCT01751139|37786555|FG000|Overall Study|Withdrawal by Subject|251|||
16842266|NCT01751139|37786555|FG000|Overall Study|Adverse Event|1|||
16842267|NCT01751139|37786555|FG000|Overall Study|Death|31|||
16842268|NCT01890122|37786563|FG000|Overall Study|Adverse Event|1|||
16842269|NCT01890122|37786564|FG001|Overall Study|Adverse Event|1|||
16842270|NCT01890122|37786565|FG002|Overall Study|Adverse Event|1|||
16842271|NCT01890122|37786566|FG003|Overall Study|Adverse Event|2|||
16842272|NCT01890122|37786563|FG000|Overall Study|Major Protocol Deviation|3|||
16842273|NCT01890122|37786564|FG001|Overall Study|Major Protocol Deviation|1|||
16842274|NCT01890122|37786565|FG002|Overall Study|Major Protocol Deviation|0|||
16842275|NCT01890122|37786566|FG003|Overall Study|Major Protocol Deviation|1|||
16842276|NCT01890122|37786563|FG000|Overall Study|Lost to Follow-up|0|||
16842277|NCT01890122|37786564|FG001|Overall Study|Lost to Follow-up|1|||
16842278|NCT01890122|37786565|FG002|Overall Study|Lost to Follow-up|2|||
16842279|NCT01890122|37786566|FG003|Overall Study|Lost to Follow-up|2|||
16842280|NCT01890122|37786563|FG000|Overall Study|Voluntary Withdrawal|8|||
16842281|NCT01890122|37786564|FG001|Overall Study|Voluntary Withdrawal|8|||
16842282|NCT01890122|37786565|FG002|Overall Study|Voluntary Withdrawal|2|||
16842283|NCT01890122|37786566|FG003|Overall Study|Voluntary Withdrawal|11|||
16842284|NCT01890122|37786563|FG000|Overall Study|Lack of Efficacy|14|||
16842285|NCT01890122|37786564|FG001|Overall Study|Lack of Efficacy|24|||
16842286|NCT01890122|37786565|FG002|Overall Study|Lack of Efficacy|7|||
16842287|NCT01890122|37786566|FG003|Overall Study|Lack of Efficacy|41|||
16842288|NCT01890122|37786563|FG000|Overall Study|Reason not Specified|0|||
16842289|NCT01890122|37786564|FG001|Overall Study|Reason not Specified|1|||
16842290|NCT01890122|37786565|FG002|Overall Study|Reason not Specified|1|||
16842291|NCT01890122|37786566|FG003|Overall Study|Reason not Specified|2|||
16842292|NCT01890122|37786563|FG000|Overall Study|Randomized but not Treated|1|||
16842293|NCT01890122|37786564|FG001|Overall Study|Randomized but not Treated|1|||
16842294|NCT01890122|37786565|FG002|Overall Study|Randomized but not Treated|0|||
16842295|NCT01890122|37786566|FG003|Overall Study|Randomized but not Treated|0|||
16842296|NCT01397890|37786578|FG000|Overall Study|Withdrawal by Subject|7|||
16842297|NCT01397890|37786579|FG001|Overall Study|Withdrawal by Subject|11|||
16915773|NCT03194646|38030219|FG000|Overall Study|Protocol Violation|4|||
16915774|NCT03194646|38030220|FG001|Overall Study|Protocol Violation|2|||
16915775|NCT03194646|38030221|FG002|Overall Study|Protocol Violation|1|||
16915776|NCT03194646|38030222|FG003|Overall Study|Protocol Violation|1|||
16915777|NCT03194646|38030219|FG000|Overall Study|Site terminated by sponsor|0|||
16915778|NCT03194646|38030220|FG001|Overall Study|Site terminated by sponsor|0|||
16915779|NCT03194646|38030221|FG002|Overall Study|Site terminated by sponsor|2|||
16915780|NCT03194646|38030222|FG003|Overall Study|Site terminated by sponsor|0|||
16915781|NCT03194646|38030219|FG000|Overall Study|Study terminated by sponsor|60|||
16915782|NCT03194646|38030220|FG001|Overall Study|Study terminated by sponsor|61|||
16915783|NCT03194646|38030221|FG002|Overall Study|Study terminated by sponsor|30|||
16915784|NCT03194646|38030222|FG003|Overall Study|Study terminated by sponsor|34|||
16915785|NCT03194646|38030219|FG000|Overall Study|Withdrawal by Subject|74|||
16915786|NCT03194646|38030220|FG001|Overall Study|Withdrawal by Subject|75|||
16842298|NCT01397890|37786578|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
16842299|NCT01397890|37786579|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
16915787|NCT03194646|38030221|FG002|Overall Study|Withdrawal by Subject|36|||
16915788|NCT03194646|38030222|FG003|Overall Study|Withdrawal by Subject|131|||
16915789|NCT03194646|38030219|FG000|Overall Study|Missing|4|||
16915790|NCT03194646|38030220|FG001|Overall Study|Missing|0|||
16915791|NCT03194646|38030221|FG002|Overall Study|Missing|1|||
16915792|NCT03194646|38030222|FG003|Overall Study|Missing|12|||
16915793|NCT02987543|38030241|FG000|Overall Study|Ongoing study at data cut off|49|||
16915794|NCT02987543|38030242|FG001|Overall Study|Ongoing study at data cut off|21|||
16915795|NCT02987543|38030243|FG002|Overall Study|Ongoing study at data cut off|19|||
16915796|NCT02987543|38030244|FG003|Overall Study|Ongoing study at data cut off|12|||
16915797|NCT02987543|38030241|FG000|Overall Study|Death|88|||
16915798|NCT02987543|38030242|FG001|Overall Study|Death|54|||
16915799|NCT02987543|38030243|FG002|Overall Study|Death|67|||
16915800|NCT02987543|38030244|FG003|Overall Study|Death|28|||
16915801|NCT02987543|38030241|FG000|Overall Study|Lost to Follow-up|3|||
16842300|NCT01397890|37786578|FG000|Overall Study|Death|2|||
16915802|NCT02987543|38030242|FG001|Overall Study|Lost to Follow-up|0|||
17198534|NCT00103285|38352273|FG000|Induction|Other|258|||
16915803|NCT02987543|38030243|FG002|Overall Study|Lost to Follow-up|1|||
16915804|NCT02987543|38030244|FG003|Overall Study|Lost to Follow-up|0|||
16915805|NCT02987543|38030241|FG000|Overall Study|Screen failure|0|||
16915806|NCT02987543|38030242|FG001|Overall Study|Screen failure|0|||
16842301|NCT01397890|37786579|FG001|Overall Study|Death|3|||
16842302|NCT01397890|37786578|FG000|Overall Study|Lost to Follow-up|1|||
16915807|NCT02987543|38030243|FG002|Overall Study|Screen failure|0|||
16842303|NCT01397890|37786579|FG001|Overall Study|Lost to Follow-up|4|||
16842304|NCT01397890|37786578|FG000|Overall Study|Condition under Investigation Worsened|1|||
16842305|NCT01397890|37786579|FG001|Overall Study|Condition under Investigation Worsened|3|||
16842306|NCT01397890|37786578|FG000|Overall Study|Adverse Event|1|||
16842307|NCT01397890|37786579|FG001|Overall Study|Adverse Event|2|||
16842308|NCT01397890|37786578|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
16842309|NCT01397890|37786579|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
16842310|NCT01397890|37786578|FG000|Overall Study|Others|2|||
16842311|NCT01397890|37786579|FG001|Overall Study|Others|1|||
16842312|NCT01777269|37786587|FG000|Overall Study|Adverse Event|24|||
16842313|NCT01777269|37786588|FG001|Overall Study|Adverse Event|33|||
16842314|NCT01777269|37786587|FG000|Overall Study|Lack of Efficacy|8|||
16842315|NCT01777269|37786588|FG001|Overall Study|Lack of Efficacy|10|||
16842316|NCT01777269|37786587|FG000|Overall Study|Protocol Violation|4|||
16842317|NCT01777269|37786588|FG001|Overall Study|Protocol Violation|4|||
16842318|NCT01777269|37786587|FG000|Overall Study|Participants reached stopping criteria|1|||
16842319|NCT01777269|37786588|FG001|Overall Study|Participants reached stopping criteria|1|||
16842320|NCT01777269|37786587|FG000|Overall Study|Lost to Follow-up|4|||
16842321|NCT01777269|37786588|FG001|Overall Study|Lost to Follow-up|0|||
16842322|NCT01777269|37786587|FG000|Overall Study|Physician Decision|5|||
16842323|NCT01777269|37786588|FG001|Overall Study|Physician Decision|2|||
16842324|NCT01777269|37786587|FG000|Overall Study|Withdrawal by Subject|9|||
16842325|NCT01777269|37786588|FG001|Overall Study|Withdrawal by Subject|9|||
16842326|NCT01751061|37786596|FG000|Overall Study|Death|1|||
16842327|NCT01751061|37786597|FG001|Overall Study|Death|0|||
16842328|NCT01751061|37786596|FG000|Overall Study|patient death|5|||
16842329|NCT01751061|37786597|FG001|Overall Study|patient death|0|||
16842330|NCT01751061|37786596|FG000|Overall Study|Lost to Follow-up|40|||
16842331|NCT01751061|37786597|FG001|Overall Study|Lost to Follow-up|25|||
16842332|NCT01751061|37786596|FG000|Overall Study|patient regained decisional capacity|4|||
16842333|NCT01751061|37786597|FG001|Overall Study|patient regained decisional capacity|8|||
16842334|NCT01751061|37786596|FG000|Overall Study|Withdrawal by Subject|4|||
16842335|NCT01751061|37786597|FG001|Overall Study|Withdrawal by Subject|1|||
16915808|NCT02987543|38030244|FG003|Overall Study|Screen failure|1|||
16915809|NCT02987543|38030241|FG000|Overall Study|Withdrawal by Subject|21|||
16915810|NCT02987543|38030242|FG001|Overall Study|Withdrawal by Subject|7|||
16915811|NCT02987543|38030243|FG002|Overall Study|Withdrawal by Subject|7|||
16915812|NCT02987543|38030244|FG003|Overall Study|Withdrawal by Subject|6|||
16915813|NCT02987543|38030241|FG000|Overall Study|Study terminated by sponsor|1|||
16915814|NCT02987543|38030242|FG001|Overall Study|Study terminated by sponsor|0|||
16915815|NCT02987543|38030243|FG002|Overall Study|Study terminated by sponsor|0|||
16915816|NCT02987543|38030244|FG003|Overall Study|Study terminated by sponsor|0|||
16915817|NCT02987543|38030241|FG000|Overall Study|Investigator decision|0|||
16915818|NCT02987543|38030242|FG001|Overall Study|Investigator decision|1|||
16915819|NCT02987543|38030243|FG002|Overall Study|Investigator decision|0|||
16915820|NCT02987543|38030244|FG003|Overall Study|Investigator decision|0|||
16915821|NCT02987543|38030241|FG000|Overall Study|Disease progression|0|||
16915822|NCT02987543|38030242|FG001|Overall Study|Disease progression|0|||
16915823|NCT02987543|38030243|FG002|Overall Study|Disease progression|0|||
16842336|NCT01751061|37786596|FG000|Overall Study|Physician Decision|2|||
16842337|NCT01751061|37786597|FG001|Overall Study|Physician Decision|0|||
16842338|NCT01777191|37786605|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
16842339|NCT01777191|37786606|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
16842340|NCT01777191|37786605|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
16915824|NCT02987543|38030244|FG003|Overall Study|Disease progression|1|||
16915825|NCT02983045|38030260|FG000|Overall Study|Withdrawal by Subject|0|||
16915826|NCT02983045|38030261|FG001|Overall Study|Withdrawal by Subject|1|||
16915827|NCT02983045|38030262|FG002|Overall Study|Withdrawal by Subject|0|||
16915828|NCT02983045|38030263|FG003|Overall Study|Withdrawal by Subject|5|||
16915829|NCT02983045|38030264|FG004|Overall Study|Withdrawal by Subject|0|||
16915830|NCT02983045|38030265|FG005|Overall Study|Withdrawal by Subject|72|||
16915831|NCT02983045|38030266|FG006|Overall Study|Withdrawal by Subject|0|||
16915832|NCT02983045|38030267|FG007|Overall Study|Withdrawal by Subject|0|||
16915833|NCT02983045|38030268|FG008|Overall Study|Withdrawal by Subject|0|||
16915834|NCT02983045|38030269|FG009|Overall Study|Withdrawal by Subject|2|||
16915835|NCT02983045|38030260|FG000|Overall Study|Lost to Follow-up|0|||
16915836|NCT02983045|38030261|FG001|Overall Study|Lost to Follow-up|0|||
16915837|NCT02983045|38030262|FG002|Overall Study|Lost to Follow-up|0|||
16915838|NCT02983045|38030263|FG003|Overall Study|Lost to Follow-up|0|||
16915839|NCT02983045|38030264|FG004|Overall Study|Lost to Follow-up|0|||
16915840|NCT02983045|38030265|FG005|Overall Study|Lost to Follow-up|10|||
16915841|NCT02983045|38030266|FG006|Overall Study|Lost to Follow-up|0|||
16915842|NCT02983045|38030267|FG007|Overall Study|Lost to Follow-up|0|||
16915843|NCT02983045|38030268|FG008|Overall Study|Lost to Follow-up|0|||
16915844|NCT02983045|38030269|FG009|Overall Study|Lost to Follow-up|0|||
16915845|NCT02564263|38030293|FG000|Overall Study|Adverse Event|31|||
16915846|NCT02564263|38030294|FG001|Overall Study|Adverse Event|29|||
16915847|NCT02564263|38030293|FG000|Overall Study|Death|270|||
16842341|NCT01777191|37786606|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
16842342|NCT01777191|37786605|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
16842343|NCT01777191|37786606|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
16842344|NCT01777191|37786605|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
16842345|NCT01777191|37786606|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
16842346|NCT01777191|37786605|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
16842347|NCT01777191|37786606|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
16842348|NCT01777191|37786605|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
16842349|NCT01777191|37786606|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
16842350|NCT01777191|37786605|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
16842351|NCT01777191|37786606|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
16842352|NCT01777191|37786605|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
16842353|NCT01777191|37786606|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
16842354|NCT01777191|37786605|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
16842355|NCT01777191|37786606|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
16842356|NCT01777191|37786605|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
16842357|NCT01777191|37786606|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
16842358|NCT01777191|37786605|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
16842359|NCT01777191|37786606|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
16842360|NCT01775787|37786615|FG000|First 7-10 Days|Adverse Event|0|||
16842361|NCT01775787|37786616|FG001|First 7-10 Days|Adverse Event|1|||
16842362|NCT01775787|37786615|FG000|First 7-10 Days|family emergency|0|||
16842363|NCT01775787|37786616|FG001|First 7-10 Days|family emergency|1|||
16842364|NCT01775787|37786615|FG000|First 7-10 Days|time commitment|0|||
16842365|NCT01775787|37786616|FG001|First 7-10 Days|time commitment|2|||
16842366|NCT01775787|37786615|FG000|First 7-10 Days|concerns with using IV|1|||
16842367|NCT01775787|37786616|FG001|First 7-10 Days|concerns with using IV|2|||
16842368|NCT01775787|37786615|FG000|Second 7-10 Days|time commitment|0|||
16842369|NCT01775787|37786616|FG001|Second 7-10 Days|time commitment|1|||
16842370|NCT01775787|37786615|FG000|Second 7-10 Days|concerns with using IV|0|||
16842371|NCT01775787|37786616|FG001|Second 7-10 Days|concerns with using IV|1|||
16842372|NCT01775553|37786624|FG000|Overall Study|Adverse Event|1|||
16842373|NCT01775553|37786624|FG000|Overall Study|Disease Progression|12|||
16842374|NCT01775475|37786630|FG000|Overall Study|Death|3|||
16842375|NCT01775475|37786631|FG001|Overall Study|Death|3|||
16842376|NCT01774929|37786637|FG000|Overall Study|Adverse Event|3|||
16842377|NCT01888874|37786648|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
16842378|NCT01888874|37786649|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
16842379|NCT01888874|37786650|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
16842380|NCT01888874|37786651|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
16842381|NCT01888874|37786652|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
16842382|NCT01888874|37786653|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
16842383|NCT01888874|37786654|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
16915848|NCT02564263|38030294|FG001|Overall Study|Death|262|||
16915849|NCT02564263|38030293|FG000|Overall Study|Withdrawal by Subject|4|||
16915850|NCT02564263|38030294|FG001|Overall Study|Withdrawal by Subject|19|||
16915851|NCT02564263|38030293|FG000|Overall Study|Sponsor's decision|9|||
16842384|NCT01888874|37786648|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
16842385|NCT01888874|37786649|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
16842386|NCT01888874|37786650|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
16842387|NCT01888874|37786651|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
16842388|NCT01888874|37786652|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
16842389|NCT01888874|37786653|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
16842390|NCT01888874|37786654|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
16842391|NCT01888874|37786648|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16842392|NCT01888874|37786649|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16842393|NCT01888874|37786650|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16842394|NCT01888874|37786651|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16842395|NCT01888874|37786652|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16842396|NCT01888874|37786653|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16842397|NCT01888874|37786654|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
16842398|NCT01888874|37786648|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
16842399|NCT01888874|37786649|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
16842400|NCT01888874|37786650|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
16842401|NCT01888874|37786651|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
16842402|NCT01888874|37786652|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
16842403|NCT01888874|37786653|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
16842404|NCT01888874|37786654|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
16915852|NCT02564263|38030294|FG001|Overall Study|Sponsor's decision|4|||
16915853|NCT02379819|38030301|FG000|Overall Study|Withdrawal by Subject|10|||
16842405|NCT01888874|37786648|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16842406|NCT01888874|37786649|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16842407|NCT01888874|37786650|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16842408|NCT01888874|37786651|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16842409|NCT01888874|37786652|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
16842410|NCT01888874|37786653|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16842411|NCT01888874|37786654|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16842412|NCT01888874|37786648|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16842413|NCT01888874|37786649|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
16842414|NCT01888874|37786650|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16842415|NCT01888874|37786651|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16842416|NCT01888874|37786652|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16842417|NCT01888874|37786653|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16842418|NCT01888874|37786654|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16842419|NCT01888874|37786648|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16842420|NCT01888874|37786649|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
16842421|NCT01888874|37786650|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16842422|NCT01888874|37786651|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16842423|NCT01888874|37786652|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16842424|NCT01888874|37786653|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
16842425|NCT01888874|37786654|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16842426|NCT01888874|37786648|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
16842427|NCT01888874|37786649|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
16842428|NCT01888874|37786650|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
16842429|NCT01888874|37786651|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16842430|NCT01888874|37786652|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
16842431|NCT01888874|37786653|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16842432|NCT01888874|37786654|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16842433|NCT01888874|37786648|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16842434|NCT01888874|37786649|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16842435|NCT01888874|37786650|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16842436|NCT01888874|37786651|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16842437|NCT01888874|37786652|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
16842438|NCT01888874|37786653|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16842439|NCT01888874|37786654|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16842440|NCT01888874|37786648|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16842441|NCT01888874|37786649|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16842442|NCT01888874|37786650|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
16842443|NCT01888874|37786651|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16842444|NCT01888874|37786652|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16842445|NCT01888874|37786653|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
16842446|NCT01888874|37786654|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16842447|NCT01888874|37786648|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16842448|NCT01888874|37786649|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16842449|NCT01888874|37786650|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
16842450|NCT01888874|37786651|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16842451|NCT01888874|37786652|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16842452|NCT01888874|37786653|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16842453|NCT01888874|37786654|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16842454|NCT01888874|37786648|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
16842455|NCT01888874|37786649|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
16842456|NCT01888874|37786650|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
16842457|NCT01888874|37786651|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
16842458|NCT01888874|37786652|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
16842459|NCT01888874|37786653|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
16842460|NCT01888874|37786654|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
16842461|NCT01888874|37786648|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16842462|NCT01888874|37786649|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
16842463|NCT01888874|37786650|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16842464|NCT01888874|37786651|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16842465|NCT01888874|37786652|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16915854|NCT02379819|38030301|FG000|Overall Study|Death|2|||
16915855|NCT02379819|38030301|FG000|Overall Study|Lack of Efficacy|1|||
16915856|NCT02379819|38030301|FG000|Overall Study|Lost to Follow-up|1|||
16842466|NCT01888874|37786653|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
16842467|NCT01888874|37786654|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16842468|NCT01749735|37786673|FG000|Overall Study|Withdrawal by Subject|1|||
16842469|NCT01749735|37786674|FG001|Overall Study|Withdrawal by Subject|0|||
16842470|NCT01749033|37786683|FG000|Overall Study|Did not receive allocated intervention|3|||
16842471|NCT01749033|37786684|FG001|Overall Study|Did not receive allocated intervention|3|||
16842472|NCT01749033|37786685|FG002|Overall Study|Did not receive allocated intervention|0|||
16842473|NCT01749033|37786683|FG000|Overall Study|Lost to Follow-up|0|||
16842474|NCT01749033|37786684|FG001|Overall Study|Lost to Follow-up|2|||
16842475|NCT01749033|37786685|FG002|Overall Study|Lost to Follow-up|1|||
16842476|NCT01774305|37786696|FG000|Overall Study|Physician Decision|1|||
16842477|NCT01774305|37786697|FG001|Overall Study|Physician Decision|0|||
16842478|NCT01737021|37786705|FG000|Overall Study|Lost to Follow-up|5|||
16842479|NCT01737021|37786706|FG001|Overall Study|Lost to Follow-up|3|||
16842480|NCT01397422|37786716|FG000|Overall Study|Adverse Event|0|||
16842481|NCT01397422|37786717|FG001|Overall Study|Adverse Event|3|||
16842482|NCT01397422|37786718|FG002|Overall Study|Adverse Event|3|||
16842483|NCT01397422|37786719|FG003|Overall Study|Adverse Event|8|||
16842484|NCT01397422|37786716|FG000|Overall Study|Withdrawal by Subject|1|||
16915857|NCT02368886|38030309|FG000|Overall Study|Cancel|1|||
16915858|NCT02368886|38030310|FG001|Overall Study|Cancel|1|||
16915859|NCT02368886|38030311|FG002|Overall Study|Cancel|1|||
16915860|NCT02368886|38030312|FG003|Overall Study|Cancel|3|||
16915861|NCT02368886|38030309|FG000|Overall Study|Ineligible|0|||
16915862|NCT02368886|38030310|FG001|Overall Study|Ineligible|0|||
16915863|NCT02368886|38030311|FG002|Overall Study|Ineligible|0|||
16842485|NCT01397422|37786717|FG001|Overall Study|Withdrawal by Subject|0|||
16842486|NCT01397422|37786718|FG002|Overall Study|Withdrawal by Subject|0|||
16842487|NCT01397422|37786719|FG003|Overall Study|Withdrawal by Subject|0|||
16842488|NCT01397422|37786716|FG000|Overall Study|Increased bradykinesia related to PD|1|||
16842489|NCT01397422|37786717|FG001|Overall Study|Increased bradykinesia related to PD|0|||
16842490|NCT01397422|37786718|FG002|Overall Study|Increased bradykinesia related to PD|0|||
16842491|NCT01397422|37786719|FG003|Overall Study|Increased bradykinesia related to PD|0|||
16842492|NCT01736553|37786733|FG000|Overall Study|Death|12|||
16842493|NCT01736553|37786734|FG001|Overall Study|Death|0|||
16842494|NCT01736553|37786733|FG000|Overall Study|Withdrawal by Subject|5|||
16842495|NCT01736553|37786734|FG001|Overall Study|Withdrawal by Subject|2|||
16842496|NCT01736553|37786733|FG000|Overall Study|Lost to Follow-up|2|||
16842497|NCT01736553|37786734|FG001|Overall Study|Lost to Follow-up|2|||
16842498|NCT01888640|37786761|FG000|Overall Study|Lost to Follow-up|1|||
16842499|NCT01888640|37786762|FG001|Overall Study|Lost to Follow-up|2|||
16842500|NCT01888640|37786763|FG002|Overall Study|Lost to Follow-up|0|||
16842501|NCT01888640|37786761|FG000|Overall Study|Withdrawal by Subject|15|||
16842502|NCT01888640|37786762|FG001|Overall Study|Withdrawal by Subject|11|||
16915864|NCT02368886|38030312|FG003|Overall Study|Ineligible|1|||
16915865|NCT02231749|38030322|FG000|Overall Study|Disease progression|229|||
16915866|NCT02231749|38030323|FG001|Overall Study|Disease progression|297|||
16915867|NCT02231749|38030322|FG000|Overall Study|Study Drug Toxicity|134|||
16915868|NCT02231749|38030323|FG001|Overall Study|Study Drug Toxicity|63|||
16915869|NCT02231749|38030322|FG000|Overall Study|Death|1|||
16915870|NCT02231749|38030323|FG001|Overall Study|Death|1|||
16842503|NCT01888640|37786763|FG002|Overall Study|Withdrawal by Subject|4|||
16842504|NCT01888640|37786761|FG000|Overall Study|Minimum dose not met|10|||
16842505|NCT01888640|37786762|FG001|Overall Study|Minimum dose not met|16|||
16842506|NCT01888640|37786763|FG002|Overall Study|Minimum dose not met|0|||
16842507|NCT01888640|37786761|FG000|Overall Study|Given wrong unit (placebo)|1|||
16842508|NCT01888640|37786762|FG001|Overall Study|Given wrong unit (placebo)|0|||
16842509|NCT01888640|37786763|FG002|Overall Study|Given wrong unit (placebo)|0|||
16842510|NCT01888640|37786761|FG000|Overall Study|Excluded for prior TENS|0|||
16842511|NCT01888640|37786762|FG001|Overall Study|Excluded for prior TENS|1|||
16842512|NCT01888640|37786763|FG002|Overall Study|Excluded for prior TENS|0|||
16842513|NCT01888640|37786761|FG000|Overall Study|Researcher Termination of Participant|0|||
16842514|NCT01888640|37786762|FG001|Overall Study|Researcher Termination of Participant|1|||
16842515|NCT01888640|37786763|FG002|Overall Study|Researcher Termination of Participant|1|||
16842516|NCT01736475|37786776|FG000|Overall Study|Adverse Event|4|||
16842517|NCT01736475|37786777|FG001|Overall Study|Adverse Event|0|||
16842518|NCT01736475|37786776|FG000|Overall Study|Withdrawal by Subject|2|||
16842519|NCT01736475|37786777|FG001|Overall Study|Withdrawal by Subject|0|||
16842520|NCT01736475|37786776|FG000|Overall Study|Protocol Violation|4|||
16842521|NCT01736475|37786777|FG001|Overall Study|Protocol Violation|0|||
16915871|NCT02231749|38030322|FG000|Overall Study|AE unrelated to Study drug|32|||
16915872|NCT02231749|38030323|FG001|Overall Study|AE unrelated to Study drug|31|||
16915873|NCT02231749|38030322|FG000|Overall Study|Participant's request to discontinue|10|||
16915874|NCT02231749|38030323|FG001|Overall Study|Participant's request to discontinue|21|||
16842522|NCT01736475|37786776|FG000|Overall Study|Other - Screen failure|1|||
16842523|NCT01736475|37786777|FG001|Overall Study|Other - Screen failure|0|||
16915875|NCT02231749|38030322|FG000|Overall Study|Participant withdrew Consent|8|||
16915876|NCT02231749|38030323|FG001|Overall Study|Participant withdrew Consent|15|||
16915877|NCT02231749|38030322|FG000|Overall Study|Lost to Follow-up|1|||
16915878|NCT02231749|38030323|FG001|Overall Study|Lost to Follow-up|2|||
16915879|NCT02231749|38030322|FG000|Overall Study|Maximum Clinical Benefit|5|||
16915880|NCT02231749|38030323|FG001|Overall Study|Maximum Clinical Benefit|8|||
16915881|NCT02231749|38030322|FG000|Overall Study|Poor/Non-Compliance|0|||
16915882|NCT02231749|38030323|FG001|Overall Study|Poor/Non-Compliance|3|||
16915883|NCT02231749|38030322|FG000|Overall Study|Pregnancy|1|||
16915884|NCT02231749|38030323|FG001|Overall Study|Pregnancy|0|||
16915885|NCT02231749|38030322|FG000|Overall Study|other|0|||
16915886|NCT02231749|38030323|FG001|Overall Study|other|8|||
16915887|NCT02231749|38030322|FG000|Overall Study|No longer meets Study Criteria|1|||
16915888|NCT02231749|38030323|FG001|Overall Study|No longer meets Study Criteria|0|||
16915889|NCT02227238|38030331|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
16915890|NCT02227238|38030332|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
16915891|NCT02227238|38030333|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
16915892|NCT02227238|38030331|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
16915893|NCT02227238|38030332|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
16915894|NCT02227238|38030333|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
16915895|NCT02227238|38030331|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
16915896|NCT02227238|38030332|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
16915897|NCT02227238|38030333|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
16915898|NCT02227238|38030331|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
16915899|NCT02227238|38030332|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
16915900|NCT02227238|38030333|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
16915901|NCT02227238|38030331|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
16915902|NCT02227238|38030332|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
16915903|NCT02227238|38030333|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
16915904|NCT02227238|38030331|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
16915905|NCT02227238|38030332|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
16915906|NCT02227238|38030333|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
16842524|NCT01736475|37786776|FG000|Overall Study|Other - Surgical procedure|1|||
16842525|NCT01736475|37786777|FG001|Overall Study|Other - Surgical procedure|0|||
16842526|NCT01863758|37786794|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
16915907|NCT02227238|38030331|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
16915908|NCT02227238|38030332|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
16915909|NCT02227238|38030333|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
16915910|NCT02227238|38030331|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
16915911|NCT02227238|38030332|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
16915912|NCT02227238|38030333|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
16915913|NCT02227238|38030331|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
16915914|NCT02227238|38030332|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
16915915|NCT02227238|38030333|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
16915916|NCT02227238|38030331|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
16915917|NCT02227238|38030332|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
16915918|NCT02227238|38030333|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
16915919|NCT02227238|38030331|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
16915920|NCT02227238|38030332|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
16915921|NCT02227238|38030333|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
16915922|NCT02227238|38030331|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
16915923|NCT02227238|38030332|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
16915924|NCT02227238|38030333|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
16915925|NCT02227238|38030331|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
16915926|NCT02227238|38030332|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
17016927|NCT00883337|38161544|FG001|Core Treatment Period|Wish to be pregnant|2|||
17016928|NCT00883337|38161545|FG002|Core Treatment Period|Wish to be pregnant|1|||
16915927|NCT02227238|38030333|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
16915928|NCT02227238|38030331|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
16915929|NCT02227238|38030332|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
16915930|NCT02227238|38030333|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
16915931|NCT02126969|38030354|FG000|Overall Study|Withdrawal by Subject|1|||
16915932|NCT02126969|38030355|FG001|Overall Study|Withdrawal by Subject|2|||
17016929|NCT00883337|38161543|FG000|Core Treatment Period|Poor compliance to protocol|0|||
16842527|NCT01863758|37786794|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
16842528|NCT01863680|37786798|FG000|Overall Study|Adverse Event|17|||
16842529|NCT01863680|37786798|FG000|Overall Study|Risk of OHSS|17|||
16842530|NCT01863680|37786798|FG000|Overall Study|Spontaneous pregnancy|2|||
16842531|NCT01863680|37786798|FG000|Overall Study|Withdrawal by Subject|1|||
16842532|NCT01863680|37786798|FG000|Overall Study|Did not undergo IVF/ET|14|||
16842533|NCT01863680|37786798|FG000|Overall Study|Other|6|||
16842534|NCT01747629|37786804|FG000|Overall Study|Adverse Event|1|||
16842535|NCT01747629|37786805|FG001|Overall Study|Adverse Event|2|||
16842536|NCT01747629|37786804|FG000|Overall Study|Withdrawal by Subject|2|||
16842537|NCT01747629|37786805|FG001|Overall Study|Withdrawal by Subject|2|||
16842538|NCT01747629|37786804|FG000|Overall Study|Noncompliance|1|||
16842539|NCT01747629|37786805|FG001|Overall Study|Noncompliance|1|||
16842540|NCT01747629|37786804|FG000|Overall Study|Inclusion criteria not met|1|||
16842541|NCT01747629|37786805|FG001|Overall Study|Inclusion criteria not met|0|||
16842542|NCT01747629|37786804|FG000|Overall Study|Not treated|1|||
16842543|NCT01747629|37786805|FG001|Overall Study|Not treated|0|||
16842544|NCT01747629|37786804|FG000|Overall Study|Other|2|||
16842545|NCT01747629|37786805|FG001|Overall Study|Other|1|||
16842546|NCT01863368|37786813|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
16842547|NCT01863368|37786814|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
16842548|NCT01863368|37786813|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
16842549|NCT01863368|37786814|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
16842550|NCT01863368|37786813|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
16842551|NCT01863368|37786814|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
16842552|NCT01863368|37786813|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
16842553|NCT01863368|37786814|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
16842554|NCT01863368|37786813|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
16842555|NCT01863368|37786814|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
16842556|NCT01863368|37786813|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
16842557|NCT01863368|37786814|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
16915933|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
16915934|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
16915935|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
16915936|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
16915937|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
16915938|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
16915939|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
16915940|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
16915941|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
16915942|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
16915943|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
16915944|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
16915945|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
16915946|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
16915947|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
16915948|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
16915949|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
16915950|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
16842558|NCT01886690|37786823|FG000|Overall Study|Protocol Violation|0|||
16842559|NCT01886690|37786824|FG001|Overall Study|Protocol Violation|1|||
16842560|NCT01886690|37786823|FG000|Overall Study|Personal Reasons|0|||
16842561|NCT01886690|37786824|FG001|Overall Study|Personal Reasons|1|||
16915951|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
16915952|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
16915953|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
16915954|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
16842562|NCT01886378|37786830|FG000|Overall Study|Adverse Event|1|||
16842563|NCT01886378|37786830|FG000|Overall Study|Withdrawal by Subject|4|||
16842564|NCT01886300|37786834|FG000|Overall Study|Trial terminated by sponsor|16|||
16915955|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
16915956|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
16915957|NCT01715285|38030363|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
16915958|NCT01715285|38030364|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
16915959|NCT01715285|38030365|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
16915960|NCT01715285|38030363|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
16915961|NCT01715285|38030364|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
16915962|NCT01715285|38030365|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
16915963|NCT01715285|38030363|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
16915964|NCT01715285|38030364|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
16915965|NCT01715285|38030365|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
16915966|NCT01715285|38030363|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
16915967|NCT01715285|38030364|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
16915968|NCT01715285|38030365|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
16915969|NCT01715285|38030363|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
16915970|NCT01715285|38030364|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
16842565|NCT01885208|37786840|FG000|Overall Study|Unclassified|32|||
16842566|NCT01885208|37786841|FG001|Overall Study|Unclassified|38|||
16842567|NCT01859702|37786847|FG000|Overall Study|Protocol deviation|3|||
16842568|NCT01859702|37786847|FG000|Overall Study|Adverse Event|2|||
16915971|NCT01715285|38030365|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
16915972|NCT01715285|38030363|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
16915973|NCT01715285|38030364|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
16915974|NCT01715285|38030365|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
16915975|NCT01250496|38030374|FG000|Overall Study|Study terminated|124|||
16915976|NCT01250496|38030375|FG001|Overall Study|Study terminated|124|||
16915977|NCT01105975|38030391|FG000|Overall Study|Adverse Event|2|||
16915978|NCT01105975|38030392|FG001|Overall Study|Adverse Event|1|||
16915979|NCT01105975|38030393|FG002|Overall Study|Adverse Event|5|||
16915980|NCT01105975|38030394|FG003|Overall Study|Adverse Event|1|||
16915981|NCT01105975|38030395|FG004|Overall Study|Adverse Event|0|||
16915982|NCT01105975|38030396|FG005|Overall Study|Adverse Event|1|||
16915983|NCT01105975|38030397|FG006|Overall Study|Adverse Event|2|||
16915984|NCT01105975|38030398|FG007|Overall Study|Adverse Event|4|||
16915985|NCT01105975|38030399|FG008|Overall Study|Adverse Event|1|||
16915986|NCT01105975|38030400|FG009|Overall Study|Adverse Event|4|||
16915987|NCT01105975|38030391|FG000|Overall Study|Withdrawal by Subject|2|||
16915988|NCT01105975|38030392|FG001|Overall Study|Withdrawal by Subject|2|||
16842569|NCT01835132|37786851|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
16915989|NCT01105975|38030393|FG002|Overall Study|Withdrawal by Subject|2|||
16915990|NCT01105975|38030394|FG003|Overall Study|Withdrawal by Subject|0|||
16915991|NCT01105975|38030395|FG004|Overall Study|Withdrawal by Subject|4|||
16915992|NCT01105975|38030396|FG005|Overall Study|Withdrawal by Subject|1|||
16915993|NCT01105975|38030397|FG006|Overall Study|Withdrawal by Subject|2|||
16915994|NCT01105975|38030398|FG007|Overall Study|Withdrawal by Subject|1|||
16915995|NCT01105975|38030399|FG008|Overall Study|Withdrawal by Subject|0|||
16915996|NCT01105975|38030400|FG009|Overall Study|Withdrawal by Subject|3|||
16915997|NCT01105975|38030391|FG000|Overall Study|Lost to Follow-up|1|||
16915998|NCT01105975|38030392|FG001|Overall Study|Lost to Follow-up|0|||
16915999|NCT01105975|38030393|FG002|Overall Study|Lost to Follow-up|0|||
16916000|NCT01105975|38030394|FG003|Overall Study|Lost to Follow-up|1|||
16916001|NCT01105975|38030395|FG004|Overall Study|Lost to Follow-up|1|||
16916002|NCT01105975|38030396|FG005|Overall Study|Lost to Follow-up|0|||
16916003|NCT01105975|38030397|FG006|Overall Study|Lost to Follow-up|0|||
16916004|NCT01105975|38030398|FG007|Overall Study|Lost to Follow-up|0|||
16916005|NCT01105975|38030399|FG008|Overall Study|Lost to Follow-up|1|||
16916006|NCT01105975|38030400|FG009|Overall Study|Lost to Follow-up|0|||
16916007|NCT01105975|38030391|FG000|Overall Study|Physician Decision|0|||
16916008|NCT01105975|38030392|FG001|Overall Study|Physician Decision|0|||
16916009|NCT01105975|38030393|FG002|Overall Study|Physician Decision|0|||
16916010|NCT01105975|38030394|FG003|Overall Study|Physician Decision|0|||
16916011|NCT01105975|38030395|FG004|Overall Study|Physician Decision|0|||
16916012|NCT01105975|38030396|FG005|Overall Study|Physician Decision|0|||
16916013|NCT01105975|38030397|FG006|Overall Study|Physician Decision|2|||
16916014|NCT01105975|38030398|FG007|Overall Study|Physician Decision|0|||
16916015|NCT01105975|38030399|FG008|Overall Study|Physician Decision|0|||
16916016|NCT01105975|38030400|FG009|Overall Study|Physician Decision|0|||
16916017|NCT01105975|38030391|FG000|Overall Study|Protocol Violation|0|||
16916018|NCT01105975|38030392|FG001|Overall Study|Protocol Violation|2|||
16916019|NCT01105975|38030393|FG002|Overall Study|Protocol Violation|2|||
16916020|NCT01105975|38030394|FG003|Overall Study|Protocol Violation|0|||
16916021|NCT01105975|38030395|FG004|Overall Study|Protocol Violation|1|||
16916022|NCT01105975|38030396|FG005|Overall Study|Protocol Violation|1|||
16916023|NCT01105975|38030397|FG006|Overall Study|Protocol Violation|1|||
16842570|NCT01747551|37786857|FG000|Overall Study|Progressive Disease|24|||
16842571|NCT01747551|37786858|FG001|Overall Study|Progressive Disease|17|||
16842572|NCT01747551|37786857|FG000|Overall Study|Death|3|||
16842573|NCT01747551|37786858|FG001|Overall Study|Death|1|||
16842574|NCT01747551|37786857|FG000|Overall Study|Adverse Event|7|||
16842575|NCT01747551|37786858|FG001|Overall Study|Adverse Event|1|||
16842576|NCT01747551|37786857|FG000|Overall Study|Prolonged Treatment Delay|2|||
16842577|NCT01747551|37786858|FG001|Overall Study|Prolonged Treatment Delay|0|||
16842578|NCT01747551|37786857|FG000|Overall Study|Withdrawal by Subject|3|||
16842579|NCT01747551|37786858|FG001|Overall Study|Withdrawal by Subject|1|||
16842580|NCT01747551|37786857|FG000|Overall Study|Physician Decision|2|||
16842581|NCT01747551|37786858|FG001|Overall Study|Physician Decision|1|||
16842582|NCT01747551|37786857|FG000|Overall Study|Other|2|||
16842583|NCT01747551|37786858|FG001|Overall Study|Other|0|||
16842584|NCT01736397|37786866|FG000|Overall Study|Lack of Efficacy|1|||
16842585|NCT01736397|37786867|FG001|Overall Study|Lack of Efficacy|11|||
16916024|NCT01105975|38030398|FG007|Overall Study|Protocol Violation|1|||
16916025|NCT01105975|38030399|FG008|Overall Study|Protocol Violation|2|||
16842586|NCT01736397|37786866|FG000|Overall Study|Withdrawal by Subject|6|||
16842587|NCT01736397|37786867|FG001|Overall Study|Withdrawal by Subject|5|||
16842588|NCT01736397|37786866|FG000|Overall Study|Lost to Follow-up|0|||
16916026|NCT01105975|38030400|FG009|Overall Study|Protocol Violation|2|||
16916027|NCT01105975|38030391|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16916028|NCT01105975|38030392|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16916029|NCT01105975|38030393|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16842589|NCT01736397|37786867|FG001|Overall Study|Lost to Follow-up|1|||
16842590|NCT01736397|37786866|FG000|Overall Study|Adverse Event|6|||
16842591|NCT01736397|37786867|FG001|Overall Study|Adverse Event|3|||
16916030|NCT01105975|38030394|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16916031|NCT01105975|38030395|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16842592|NCT01736397|37786866|FG000|Overall Study|Not stated|1|||
16842593|NCT01736397|37786867|FG001|Overall Study|Not stated|4|||
16842594|NCT01859390|37786875|FG000|Overall Study|Insufficient Sputum Collected|1|||
16916032|NCT01105975|38030396|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
16916033|NCT01105975|38030397|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16916034|NCT01105975|38030398|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16916035|NCT01105975|38030399|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
16916036|NCT01105975|38030400|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16916037|NCT01063517|38030443|FG000|Overall Study|Consent withdrawal|1|||
16916038|NCT01063517|38030444|FG001|Overall Study|Consent withdrawal|0|||
16916039|NCT01063517|38030443|FG000|Overall Study|Study reached data cut-off|19|||
16842595|NCT01859390|37786876|FG001|Overall Study|Insufficient Sputum Collected|3|||
16842596|NCT01859390|37786875|FG000|Overall Study|Sample Missing Collection Date|0|||
16842597|NCT01859390|37786876|FG001|Overall Study|Sample Missing Collection Date|1|||
16842598|NCT01859390|37786875|FG000|Overall Study|Tube Cracked|0|||
16842599|NCT01859390|37786876|FG001|Overall Study|Tube Cracked|2|||
16842600|NCT01859390|37786875|FG000|Overall Study|Shipment Error|0|||
16842601|NCT01859390|37786876|FG001|Overall Study|Shipment Error|1|||
16842602|NCT01746225|37786885|FG000|Overall Study|Death|1|||
16842603|NCT01746225|37786886|FG001|Overall Study|Death|0|||
16842604|NCT01746225|37786887|FG002|Overall Study|Death|1|||
16842605|NCT01746225|37786885|FG000|Overall Study|Withdrawal by Subject|5|||
16842606|NCT01746225|37786886|FG001|Overall Study|Withdrawal by Subject|15|||
16842607|NCT01746225|37786887|FG002|Overall Study|Withdrawal by Subject|19|||
16842608|NCT01746225|37786885|FG000|Overall Study|Physician Decision|14|||
16842609|NCT01746225|37786886|FG001|Overall Study|Physician Decision|11|||
16916040|NCT01063517|38030444|FG001|Overall Study|Study reached data cut-off|7|||
16916041|NCT01063517|38030443|FG000|Overall Study|Lost to Follow-up|4|||
16842610|NCT01746225|37786887|FG002|Overall Study|Physician Decision|3|||
16842611|NCT01746225|37786885|FG000|Overall Study|Adverse Event|15|||
16842612|NCT01746225|37786886|FG001|Overall Study|Adverse Event|12|||
16842613|NCT01746225|37786887|FG002|Overall Study|Adverse Event|17|||
16916042|NCT01063517|38030444|FG001|Overall Study|Lost to Follow-up|3|||
16916043|NCT01063517|38030443|FG000|Overall Study|Withdrawal by Subject|1|||
16916044|NCT01063517|38030444|FG001|Overall Study|Withdrawal by Subject|2|||
16916045|NCT01063517|38030443|FG000|Overall Study|Death|33|||
16916046|NCT01063517|38030444|FG001|Overall Study|Death|48|||
16916047|NCT00831623|38030450|FG000|Overall Study|Withdrawal by Subject|9|||
16916048|NCT00831623|38030450|FG000|Overall Study|Lost to Follow-up|1|||
16916049|NCT00831623|38030450|FG000|Overall Study|Not 2 years post-treatment|12|||
16916050|NCT00079417|38030467|FG000|Overall Study|Physician Decision|2|||
16916051|NCT00079417|38030467|FG000|Overall Study|Ineligible|7|||
16842614|NCT01746225|37786885|FG000|Overall Study|Continuing Treatment|5|||
16842615|NCT01746225|37786886|FG001|Overall Study|Continuing Treatment|8|||
16842616|NCT01746225|37786887|FG002|Overall Study|Continuing Treatment|3|||
16842617|NCT01858766|37786914|FG000|Overall Study|Randomized but Never Treated|0|||
16842618|NCT01858766|37786915|FG001|Overall Study|Randomized but Never Treated|0|||
16842619|NCT01858766|37786916|FG002|Overall Study|Randomized but Never Treated|0|||
16842620|NCT01858766|37786917|FG003|Overall Study|Randomized but Never Treated|0|||
16842621|NCT01858766|37786918|FG004|Overall Study|Randomized but Never Treated|0|||
16842622|NCT01858766|37786919|FG005|Overall Study|Randomized but Never Treated|1|||
16842623|NCT01858766|37786920|FG006|Overall Study|Randomized but Never Treated|0|||
16842624|NCT01858766|37786921|FG007|Overall Study|Randomized but Never Treated|0|||
16842625|NCT01858766|37786922|FG008|Overall Study|Randomized but Never Treated|0|||
16842626|NCT01858766|37786923|FG009|Overall Study|Randomized but Never Treated|0|||
16842627|NCT01858766|37786924|FG010|Overall Study|Randomized but Never Treated|0|||
16842628|NCT01858766|37786925|FG011|Overall Study|Randomized but Never Treated|0|||
17016930|NCT00883337|38161544|FG001|Core Treatment Period|Poor compliance to protocol|0|||
17016931|NCT00883337|38161545|FG002|Core Treatment Period|Poor compliance to protocol|1|||
17016932|NCT00883337|38161543|FG000|Core Treatment Period|Other than above|0|||
17016933|NCT00883337|38161544|FG001|Core Treatment Period|Other than above|1|||
16842629|NCT01858766|37786926|FG012|Overall Study|Randomized but Never Treated|0|||
16842630|NCT01858766|37786927|FG013|Overall Study|Randomized but Never Treated|0|||
16842631|NCT01858766|37786928|FG014|Overall Study|Randomized but Never Treated|0|||
16842632|NCT01858766|37786929|FG015|Overall Study|Randomized but Never Treated|0|||
16842633|NCT01858766|37786930|FG016|Overall Study|Randomized but Never Treated|0|||
16842634|NCT01858766|37786931|FG017|Overall Study|Randomized but Never Treated|1|||
16916052|NCT03180840|38041124|FG000|Overall Study|Withdrawal by Subject|1|||
16916053|NCT02538666|38041136|FG000|Pre-Treatment|Disease progression|1|||
16916054|NCT02538666|38041137|FG001|Pre-Treatment|Disease progression|0|||
16916055|NCT02538666|38041138|FG002|Pre-Treatment|Disease progression|0|||
16842635|NCT01858766|37786932|FG018|Overall Study|Randomized but Never Treated|0|||
16842636|NCT01858766|37786914|FG000|Overall Study|Death|0|||
16842637|NCT01858766|37786915|FG001|Overall Study|Death|0|||
16842638|NCT01858766|37786916|FG002|Overall Study|Death|1|||
16842639|NCT01858766|37786917|FG003|Overall Study|Death|0|||
16842640|NCT01858766|37786918|FG004|Overall Study|Death|0|||
16842641|NCT01858766|37786919|FG005|Overall Study|Death|0|||
16842642|NCT01858766|37786920|FG006|Overall Study|Death|0|||
16842643|NCT01858766|37786921|FG007|Overall Study|Death|0|||
16842644|NCT01858766|37786922|FG008|Overall Study|Death|0|||
16842645|NCT01858766|37786923|FG009|Overall Study|Death|0|||
16842646|NCT01858766|37786924|FG010|Overall Study|Death|0|||
16842647|NCT01858766|37786925|FG011|Overall Study|Death|0|||
16842648|NCT01858766|37786926|FG012|Overall Study|Death|0|||
16842649|NCT01858766|37786927|FG013|Overall Study|Death|0|||
16842650|NCT01858766|37786928|FG014|Overall Study|Death|0|||
16842651|NCT01858766|37786929|FG015|Overall Study|Death|0|||
16842652|NCT01858766|37786930|FG016|Overall Study|Death|0|||
16842653|NCT01858766|37786931|FG017|Overall Study|Death|0|||
16842654|NCT01858766|37786932|FG018|Overall Study|Death|0|||
16842655|NCT01858766|37786914|FG000|Overall Study|Lack of Efficacy|1|||
16842656|NCT01858766|37786915|FG001|Overall Study|Lack of Efficacy|0|||
16842657|NCT01858766|37786916|FG002|Overall Study|Lack of Efficacy|0|||
16916056|NCT02538666|38041136|FG000|Pre-Treatment|no longer meets study criteria|1|||
16916057|NCT02538666|38041137|FG001|Pre-Treatment|no longer meets study criteria|0|||
16916058|NCT02538666|38041138|FG002|Pre-Treatment|no longer meets study criteria|0|||
16916059|NCT02538666|38041136|FG000|Pre-Treatment|Withdrew Consent|0|||
16916060|NCT02538666|38041137|FG001|Pre-Treatment|Withdrew Consent|1|||
16916061|NCT02538666|38041138|FG002|Pre-Treatment|Withdrew Consent|1|||
16916062|NCT02538666|38041136|FG000|Treatment|Disease progression|270|||
16916063|NCT02538666|38041137|FG001|Treatment|Disease progression|227|||
16916064|NCT02538666|38041138|FG002|Treatment|Disease progression|165|||
16916065|NCT02538666|38041136|FG000|Treatment|Study drug toxicity|1|||
16916066|NCT02538666|38041137|FG001|Treatment|Study drug toxicity|29|||
16916067|NCT02538666|38041138|FG002|Treatment|Study drug toxicity|92|||
16916068|NCT02538666|38041136|FG000|Treatment|Death|0|||
16916069|NCT02538666|38041137|FG001|Treatment|Death|2|||
16916070|NCT02538666|38041138|FG002|Treatment|Death|3|||
16916071|NCT02538666|38041136|FG000|Treatment|Adverse event unrelated to study drug|8|||
16916072|NCT02538666|38041137|FG001|Treatment|Adverse event unrelated to study drug|10|||
16916073|NCT02538666|38041138|FG002|Treatment|Adverse event unrelated to study drug|15|||
16916074|NCT02538666|38041136|FG000|Treatment|Participant request to discontinue study treatment|3|||
16916075|NCT02538666|38041137|FG001|Treatment|Participant request to discontinue study treatment|6|||
16916076|NCT02538666|38041138|FG002|Treatment|Participant request to discontinue study treatment|11|||
16842658|NCT01858766|37786917|FG003|Overall Study|Lack of Efficacy|0|||
16842659|NCT01858766|37786918|FG004|Overall Study|Lack of Efficacy|1|||
16842660|NCT01858766|37786919|FG005|Overall Study|Lack of Efficacy|2|||
16842661|NCT01858766|37786920|FG006|Overall Study|Lack of Efficacy|0|||
16842662|NCT01858766|37786921|FG007|Overall Study|Lack of Efficacy|0|||
16842663|NCT01858766|37786922|FG008|Overall Study|Lack of Efficacy|0|||
16842664|NCT01858766|37786923|FG009|Overall Study|Lack of Efficacy|0|||
16842665|NCT01858766|37786924|FG010|Overall Study|Lack of Efficacy|0|||
16842666|NCT01858766|37786925|FG011|Overall Study|Lack of Efficacy|3|||
16842667|NCT01858766|37786926|FG012|Overall Study|Lack of Efficacy|5|||
16842668|NCT01858766|37786927|FG013|Overall Study|Lack of Efficacy|3|||
16916077|NCT02538666|38041136|FG000|Treatment|Participant withdrew consent|2|||
17016934|NCT00883337|38161545|FG002|Core Treatment Period|Other than above|1|||
16842669|NCT01858766|37786928|FG014|Overall Study|Lack of Efficacy|5|||
16842670|NCT01858766|37786929|FG015|Overall Study|Lack of Efficacy|5|||
16916078|NCT02538666|38041137|FG001|Treatment|Participant withdrew consent|5|||
16916079|NCT02538666|38041138|FG002|Treatment|Participant withdrew consent|3|||
16916080|NCT02538666|38041136|FG000|Treatment|Lost to Follow-up|0|||
16916081|NCT02538666|38041137|FG001|Treatment|Lost to Follow-up|1|||
16916082|NCT02538666|38041138|FG002|Treatment|Lost to Follow-up|1|||
16916083|NCT02538666|38041136|FG000|Treatment|Maximum clinical benefit|4|||
16842671|NCT01858766|37786930|FG016|Overall Study|Lack of Efficacy|2|||
16842672|NCT01858766|37786931|FG017|Overall Study|Lack of Efficacy|3|||
16842673|NCT01858766|37786932|FG018|Overall Study|Lack of Efficacy|3|||
16842674|NCT01858766|37786914|FG000|Overall Study|Lost to Follow-up|0|||
16842675|NCT01858766|37786915|FG001|Overall Study|Lost to Follow-up|0|||
16842676|NCT01858766|37786916|FG002|Overall Study|Lost to Follow-up|0|||
16842677|NCT01858766|37786917|FG003|Overall Study|Lost to Follow-up|0|||
16842678|NCT01858766|37786918|FG004|Overall Study|Lost to Follow-up|0|||
16842679|NCT01858766|37786919|FG005|Overall Study|Lost to Follow-up|1|||
16842680|NCT01858766|37786920|FG006|Overall Study|Lost to Follow-up|0|||
16916084|NCT02538666|38041137|FG001|Treatment|Maximum clinical benefit|3|||
16916085|NCT02538666|38041138|FG002|Treatment|Maximum clinical benefit|4|||
16916086|NCT02538666|38041136|FG000|Treatment|Poor/non-compliance|0|||
16916087|NCT02538666|38041137|FG001|Treatment|Poor/non-compliance|1|||
16916088|NCT02538666|38041138|FG002|Treatment|Poor/non-compliance|0|||
16916089|NCT02538666|38041136|FG000|Treatment|Participant no longer meets study criteria|0|||
16916090|NCT02538666|38041137|FG001|Treatment|Participant no longer meets study criteria|2|||
16842681|NCT01858766|37786921|FG007|Overall Study|Lost to Follow-up|2|||
16842682|NCT01858766|37786922|FG008|Overall Study|Lost to Follow-up|0|||
16842683|NCT01858766|37786923|FG009|Overall Study|Lost to Follow-up|0|||
16842684|NCT01858766|37786924|FG010|Overall Study|Lost to Follow-up|0|||
16842685|NCT01858766|37786925|FG011|Overall Study|Lost to Follow-up|1|||
16842686|NCT01858766|37786926|FG012|Overall Study|Lost to Follow-up|0|||
16842687|NCT01858766|37786927|FG013|Overall Study|Lost to Follow-up|0|||
16842688|NCT01858766|37786928|FG014|Overall Study|Lost to Follow-up|3|||
16916091|NCT02538666|38041138|FG002|Treatment|Participant no longer meets study criteria|0|||
16916092|NCT02538666|38041136|FG000|Treatment|Administrative reason by sponsor|0|||
16916093|NCT02538666|38041137|FG001|Treatment|Administrative reason by sponsor|0|||
16916094|NCT02538666|38041138|FG002|Treatment|Administrative reason by sponsor|1|||
16916095|NCT02538666|38041136|FG000|Treatment|Other reasons|8|||
16916096|NCT02538666|38041137|FG001|Treatment|Other reasons|15|||
16842689|NCT01858766|37786929|FG015|Overall Study|Lost to Follow-up|1|||
16842690|NCT01858766|37786930|FG016|Overall Study|Lost to Follow-up|1|||
16842691|NCT01858766|37786931|FG017|Overall Study|Lost to Follow-up|0|||
16842692|NCT01858766|37786932|FG018|Overall Study|Lost to Follow-up|1|||
16842693|NCT01858766|37786914|FG000|Overall Study|Withdrew Consent|0|||
16842694|NCT01858766|37786915|FG001|Overall Study|Withdrew Consent|0|||
16842695|NCT01858766|37786916|FG002|Overall Study|Withdrew Consent|0|||
16842696|NCT01858766|37786917|FG003|Overall Study|Withdrew Consent|0|||
16842697|NCT01858766|37786918|FG004|Overall Study|Withdrew Consent|0|||
16842698|NCT01858766|37786919|FG005|Overall Study|Withdrew Consent|0|||
16842699|NCT01858766|37786920|FG006|Overall Study|Withdrew Consent|0|||
16842700|NCT01858766|37786921|FG007|Overall Study|Withdrew Consent|0|||
16842701|NCT01858766|37786922|FG008|Overall Study|Withdrew Consent|0|||
16842702|NCT01858766|37786923|FG009|Overall Study|Withdrew Consent|0|||
16842703|NCT01858766|37786924|FG010|Overall Study|Withdrew Consent|0|||
16842704|NCT01858766|37786925|FG011|Overall Study|Withdrew Consent|1|||
16842705|NCT01858766|37786926|FG012|Overall Study|Withdrew Consent|0|||
16842706|NCT01858766|37786927|FG013|Overall Study|Withdrew Consent|0|||
16842707|NCT01858766|37786928|FG014|Overall Study|Withdrew Consent|0|||
16916097|NCT02538666|38041138|FG002|Treatment|Other reasons|5|||
16916098|NCT02538666|38041136|FG000|Treatment|Not reported|2|||
16916099|NCT02538666|38041137|FG001|Treatment|Not reported|2|||
16916100|NCT02538666|38041138|FG002|Treatment|Not reported|2|||
16916101|NCT02407236|38041192|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
16916102|NCT02407236|38041193|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
16916103|NCT02407236|38041194|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
16916104|NCT02407236|38041195|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
16916105|NCT02407236|38041196|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
16916106|NCT02407236|38041197|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
16916107|NCT02407236|38041198|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
16916108|NCT02407236|38041199|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
16916109|NCT02407236|38041200|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
16916110|NCT02407236|38041201|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
16916111|NCT02407236|38041202|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
16916112|NCT02407236|38041203|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
16916113|NCT02407236|38041204|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
16916114|NCT02407236|38041192|FG000|Induction Study (8 Weeks)|Death|0|||
16916115|NCT02407236|38041193|FG001|Induction Study (8 Weeks)|Death|0|||
16916116|NCT02407236|38041194|FG002|Induction Study (8 Weeks)|Death|1|||
16916117|NCT02407236|38041195|FG003|Induction Study (8 Weeks)|Death|0|||
16916118|NCT02407236|38041196|FG004|Induction Study (8 Weeks)|Death|0|||
16916119|NCT02407236|38041197|FG005|Induction Study (8 Weeks)|Death|0|||
16916120|NCT02407236|38041198|FG006|Induction Study (8 Weeks)|Death|0|||
16916121|NCT02407236|38041199|FG007|Induction Study (8 Weeks)|Death|0|||
16916122|NCT02407236|38041200|FG008|Induction Study (8 Weeks)|Death|0|||
16916123|NCT02407236|38041201|FG009|Induction Study (8 Weeks)|Death|0|||
17102456|NCT03631732|38241391|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
16916124|NCT02407236|38041202|FG010|Induction Study (8 Weeks)|Death|0|||
16916125|NCT02407236|38041203|FG011|Induction Study (8 Weeks)|Death|0|||
16916126|NCT02407236|38041204|FG012|Induction Study (8 Weeks)|Death|0|||
16916127|NCT02407236|38041192|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
16842708|NCT01858766|37786929|FG015|Overall Study|Withdrew Consent|0|||
16916128|NCT02407236|38041193|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
16916129|NCT02407236|38041194|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
16916130|NCT02407236|38041195|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16842709|NCT01858766|37786930|FG016|Overall Study|Withdrew Consent|0|||
16842710|NCT01858766|37786931|FG017|Overall Study|Withdrew Consent|0|||
16916131|NCT02407236|38041196|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16916132|NCT02407236|38041197|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16842711|NCT01858766|37786932|FG018|Overall Study|Withdrew Consent|0|||
16842712|NCT01858688|37786965|FG000|Overall Study|Withdrawal by Subject|8|||
16916133|NCT02407236|38041198|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16916134|NCT02407236|38041199|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16916135|NCT02407236|38041200|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16916136|NCT02407236|38041201|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16916137|NCT02407236|38041202|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16916138|NCT02407236|38041203|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16916139|NCT02407236|38041204|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16916140|NCT02407236|38041192|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916141|NCT02407236|38041193|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916142|NCT02407236|38041194|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
16916143|NCT02407236|38041195|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916144|NCT02407236|38041196|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916145|NCT02407236|38041197|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916146|NCT02407236|38041198|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916147|NCT02407236|38041199|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916148|NCT02407236|38041200|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916149|NCT02407236|38041201|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916150|NCT02407236|38041202|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916151|NCT02407236|38041203|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916152|NCT02407236|38041204|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16916153|NCT02407236|38041192|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
16916154|NCT02407236|38041193|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
16916155|NCT02407236|38041194|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
16916156|NCT02407236|38041195|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
16842713|NCT01858688|37786965|FG000|Overall Study|Participant began another therapy|3|||
16842714|NCT01858688|37786965|FG000|Overall Study|Physician Decision|2|||
16842715|NCT01858688|37786965|FG000|Overall Study|Progressive Disease|2|||
16916157|NCT02407236|38041196|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
16916158|NCT02407236|38041197|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
16916159|NCT02407236|38041198|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
16916160|NCT02407236|38041199|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
16916161|NCT02407236|38041200|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
16916162|NCT02407236|38041201|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
16916163|NCT02407236|38041202|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
16916164|NCT02407236|38041203|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
16916165|NCT02407236|38041204|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
16916166|NCT02407236|38041192|FG000|Induction Study (8 Weeks)|Other|2|||
16916167|NCT02407236|38041193|FG001|Induction Study (8 Weeks)|Other|1|||
16916168|NCT02407236|38041194|FG002|Induction Study (8 Weeks)|Other|5|||
16842716|NCT01858688|37786965|FG000|Overall Study|Reason not reproted|5|||
16916169|NCT02407236|38041195|FG003|Induction Study (8 Weeks)|Other|0|||
16916170|NCT02407236|38041196|FG004|Induction Study (8 Weeks)|Other|0|||
16916171|NCT02407236|38041197|FG005|Induction Study (8 Weeks)|Other|0|||
16916172|NCT02407236|38041198|FG006|Induction Study (8 Weeks)|Other|0|||
16916173|NCT02407236|38041199|FG007|Induction Study (8 Weeks)|Other|0|||
16842717|NCT01734993|37786969|FG000|Overall Study|Adverse Event|1|||
16842718|NCT01734993|37786969|FG000|Overall Study|Lack of Efficacy|1|||
16842719|NCT01745367|37786976|FG000|Overall Study|Death|1|||
16842720|NCT01745367|37786977|FG001|Overall Study|Death|0|||
16842721|NCT01745367|37786976|FG000|Overall Study|Withdrawal by Subject|1|||
16842722|NCT01745367|37786977|FG001|Overall Study|Withdrawal by Subject|2|||
16842723|NCT01745367|37786976|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
16842724|NCT01745367|37786977|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
16842725|NCT01745367|37786976|FG000|Overall Study|Other Reasons Unspecified|0|||
16842726|NCT01745367|37786977|FG001|Overall Study|Other Reasons Unspecified|2|||
16842727|NCT01733121|37786985|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
16842728|NCT01733121|37786986|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
16842729|NCT01733121|37786985|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
16842730|NCT01733121|37786986|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
16842731|NCT01733121|37786985|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
16842732|NCT01733121|37786986|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
16842733|NCT01733121|37786985|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
16842734|NCT01733121|37786986|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
16842735|NCT01744977|37786996|FG000|Overall Study|Withdrawal by Subject|1|||
16842736|NCT01744977|37786997|FG001|Overall Study|Withdrawal by Subject|2|||
16842737|NCT01744977|37786996|FG000|Overall Study|Death|2|||
16842738|NCT01744977|37786997|FG001|Overall Study|Death|3|||
16842739|NCT01744977|37786996|FG000|Overall Study|Lost to Follow-up|2|||
16842740|NCT01744977|37786997|FG001|Overall Study|Lost to Follow-up|0|||
16842741|NCT01744977|37786996|FG000|Overall Study|No longer meets inclusion|6|||
16842742|NCT01744977|37786997|FG001|Overall Study|No longer meets inclusion|0|||
16842743|NCT01383928|37787006|FG000|Overall Study|Initiation of ASCT|2|||
16842744|NCT01383928|37787007|FG001|Overall Study|Initiation of ASCT|1|||
16842745|NCT01383928|37787008|FG002|Overall Study|Initiation of ASCT|18|||
16842746|NCT01383928|37787006|FG000|Overall Study|Adverse Event|1|||
16842747|NCT01383928|37787007|FG001|Overall Study|Adverse Event|2|||
16842748|NCT01383928|37787008|FG002|Overall Study|Adverse Event|8|||
16842749|NCT01383928|37787006|FG000|Overall Study|Other|1|||
16842750|NCT01383928|37787007|FG001|Overall Study|Other|3|||
16842751|NCT01383928|37787008|FG002|Overall Study|Other|4|||
16842752|NCT01383928|37787006|FG000|Overall Study|Progressive Disease|1|||
16842753|NCT01383928|37787007|FG001|Overall Study|Progressive Disease|1|||
16842754|NCT01383928|37787008|FG002|Overall Study|Progressive Disease|5|||
16842755|NCT01383928|37787006|FG000|Overall Study|Withdrawal by Subject|0|||
16842756|NCT01383928|37787007|FG001|Overall Study|Withdrawal by Subject|0|||
16842757|NCT01383928|37787008|FG002|Overall Study|Withdrawal by Subject|4|||
16842758|NCT01383928|37787006|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
16842759|NCT01383928|37787007|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
16842760|NCT01383928|37787008|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
16842761|NCT01606137|37787018|FG000|Overall Study|Adverse Event|85|||
16842762|NCT01606137|37787018|FG000|Overall Study|Withdrawal by Subject|74|||
16842763|NCT01606137|37787018|FG000|Overall Study|Lack of Efficacy|56|||
16842764|NCT01606137|37787018|FG000|Overall Study|Lost to Follow-up|15|||
16842765|NCT01606137|37787018|FG000|Overall Study|Protocol Violation|1|||
16842766|NCT01606137|37787018|FG000|Overall Study|Patient non-compliance|9|||
16842767|NCT01606137|37787018|FG000|Overall Study|Death|1|||
16842768|NCT01606137|37787018|FG000|Overall Study|Decreased/no pain|4|||
16842769|NCT01606137|37787018|FG000|Overall Study|Issues with driving|4|||
16842770|NCT01606137|37787018|FG000|Overall Study|multiple sclerosis less stable|1|||
16842771|NCT01606137|37787018|FG000|Overall Study|Increased bilirubin|1|||
17198535|NCT00103285|38352274|FG001|Induction|Other|0|||
17198536|NCT00103285|38352275|FG002|Induction|Other|0|||
17198537|NCT00103285|38352276|FG003|Induction|Other|0|||
17198538|NCT00103285|38352277|FG004|Induction|Other|0|||
17198539|NCT00103285|38352278|FG005|Induction|Other|0|||
17198540|NCT00103285|38352279|FG006|Induction|Other|0|||
17198541|NCT00103285|38352280|FG007|Induction|Other|0|||
17198542|NCT00103285|38352273|FG000|Response Assignment|Adverse Event|0|||
16842772|NCT01606137|37787018|FG000|Overall Study|Spray causes nausea|1|||
16916174|NCT02407236|38041200|FG008|Induction Study (8 Weeks)|Other|0|||
16916175|NCT02407236|38041201|FG009|Induction Study (8 Weeks)|Other|0|||
16842773|NCT01606137|37787018|FG000|Overall Study|Not enough improvement|4|||
16842774|NCT01606137|37787018|FG000|Overall Study|Wanted to try another treatment|1|||
16842775|NCT01606137|37787018|FG000|Overall Study|Patient leaving country|1|||
16842776|NCT01606137|37787018|FG000|Overall Study|Personal reasons|1|||
16842777|NCT01606137|37787018|FG000|Overall Study|Unable to tolerate study med. taste|1|||
16916176|NCT02407236|38041202|FG010|Induction Study (8 Weeks)|Other|0|||
17198543|NCT00103285|38352274|FG001|Response Assignment|Adverse Event|8|||
17198544|NCT00103285|38352275|FG002|Response Assignment|Adverse Event|3|||
17198545|NCT00103285|38352276|FG003|Response Assignment|Adverse Event|2|||
17198546|NCT00103285|38352277|FG004|Response Assignment|Adverse Event|3|||
17198547|NCT00103285|38352278|FG005|Response Assignment|Adverse Event|1|||
17198548|NCT00103285|38352279|FG006|Response Assignment|Adverse Event|1|||
17198549|NCT00103285|38352280|FG007|Response Assignment|Adverse Event|2|||
17198550|NCT00103285|38352273|FG000|Response Assignment|Death|0|||
17198551|NCT00103285|38352274|FG001|Response Assignment|Death|5|||
17198552|NCT00103285|38352275|FG002|Response Assignment|Death|2|||
17198553|NCT00103285|38352276|FG003|Response Assignment|Death|2|||
17198554|NCT00103285|38352277|FG004|Response Assignment|Death|3|||
17198555|NCT00103285|38352278|FG005|Response Assignment|Death|1|||
17198556|NCT00103285|38352279|FG006|Response Assignment|Death|0|||
17198557|NCT00103285|38352280|FG007|Response Assignment|Death|8|||
17198558|NCT00103285|38352273|FG000|Response Assignment|Lost to Follow-up|0|||
17198559|NCT00103285|38352274|FG001|Response Assignment|Lost to Follow-up|9|||
17198560|NCT00103285|38352275|FG002|Response Assignment|Lost to Follow-up|5|||
17198561|NCT00103285|38352276|FG003|Response Assignment|Lost to Follow-up|5|||
17198562|NCT00103285|38352277|FG004|Response Assignment|Lost to Follow-up|1|||
17198563|NCT00103285|38352278|FG005|Response Assignment|Lost to Follow-up|2|||
17198564|NCT00103285|38352279|FG006|Response Assignment|Lost to Follow-up|2|||
17198565|NCT00103285|38352280|FG007|Response Assignment|Lost to Follow-up|5|||
17198566|NCT00103285|38352273|FG000|Response Assignment|Physician Decision|0|||
17198567|NCT00103285|38352274|FG001|Response Assignment|Physician Decision|13|||
17198568|NCT00103285|38352275|FG002|Response Assignment|Physician Decision|14|||
16842778|NCT01606137|37787018|FG000|Overall Study|Patient moving|1|||
16842779|NCT01606137|37787018|FG000|Overall Study|Unable to collect consistent data|1|||
17198569|NCT00103285|38352276|FG003|Response Assignment|Physician Decision|9|||
17198570|NCT00103285|38352277|FG004|Response Assignment|Physician Decision|13|||
17198571|NCT00103285|38352278|FG005|Response Assignment|Physician Decision|7|||
17198572|NCT00103285|38352279|FG006|Response Assignment|Physician Decision|4|||
17198573|NCT00103285|38352280|FG007|Response Assignment|Physician Decision|35|||
16916177|NCT02407236|38041203|FG011|Induction Study (8 Weeks)|Other|0|||
16916178|NCT02407236|38041204|FG012|Induction Study (8 Weeks)|Other|0|||
16916179|NCT02407236|38041192|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
16916180|NCT02407236|38041193|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
16916181|NCT02407236|38041194|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
16916182|NCT02407236|38041195|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
16916183|NCT02407236|38041196|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
16916184|NCT02407236|38041197|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
16916185|NCT02407236|38041198|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
16916186|NCT02407236|38041199|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
16916187|NCT02407236|38041200|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
16916188|NCT02407236|38041201|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
16916189|NCT02407236|38041202|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
16916190|NCT02407236|38041203|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
16916191|NCT02407236|38041204|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
16916192|NCT02407236|38041192|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16916193|NCT02407236|38041193|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16916194|NCT02407236|38041194|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16842780|NCT01382602|37787024|FG000|Overall Study|Protocol Violation|0|||
16842781|NCT01382602|37787025|FG001|Overall Study|Protocol Violation|3|||
16916195|NCT02407236|38041195|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
16916196|NCT02407236|38041196|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
16916197|NCT02407236|38041197|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
16916198|NCT02407236|38041198|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
16916199|NCT02407236|38041199|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
16916200|NCT02407236|38041200|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16916201|NCT02407236|38041201|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16916202|NCT02407236|38041202|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16916203|NCT02407236|38041203|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16916204|NCT02407236|38041204|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16842782|NCT01382602|37787024|FG000|Overall Study|Withdrawal by Subject|0|||
16842783|NCT01382602|37787025|FG001|Overall Study|Withdrawal by Subject|1|||
16916205|NCT02407236|38041192|FG000|Maintenance Study (44 Weeks)|Other|0|||
16916206|NCT02407236|38041193|FG001|Maintenance Study (44 Weeks)|Other|0|||
16916207|NCT02407236|38041194|FG002|Maintenance Study (44 Weeks)|Other|0|||
16916208|NCT02407236|38041195|FG003|Maintenance Study (44 Weeks)|Other|5|||
16916209|NCT02407236|38041196|FG004|Maintenance Study (44 Weeks)|Other|7|||
16916210|NCT02407236|38041197|FG005|Maintenance Study (44 Weeks)|Other|8|||
16916211|NCT02407236|38041198|FG006|Maintenance Study (44 Weeks)|Other|4|||
16916212|NCT02407236|38041199|FG007|Maintenance Study (44 Weeks)|Other|6|||
16916213|NCT02407236|38041200|FG008|Maintenance Study (44 Weeks)|Other|0|||
16916214|NCT02407236|38041201|FG009|Maintenance Study (44 Weeks)|Other|0|||
16916215|NCT02407236|38041202|FG010|Maintenance Study (44 Weeks)|Other|0|||
16916216|NCT02407236|38041203|FG011|Maintenance Study (44 Weeks)|Other|0|||
16916217|NCT02407236|38041204|FG012|Maintenance Study (44 Weeks)|Other|0|||
16916218|NCT02407236|38041192|FG000|Maintenance Study (44 Weeks)|Death|0|||
16916219|NCT02407236|38041193|FG001|Maintenance Study (44 Weeks)|Death|0|||
16916220|NCT02407236|38041194|FG002|Maintenance Study (44 Weeks)|Death|0|||
16916221|NCT02407236|38041195|FG003|Maintenance Study (44 Weeks)|Death|0|||
16916222|NCT02407236|38041196|FG004|Maintenance Study (44 Weeks)|Death|0|||
16916223|NCT02407236|38041197|FG005|Maintenance Study (44 Weeks)|Death|0|||
16916224|NCT02407236|38041198|FG006|Maintenance Study (44 Weeks)|Death|0|||
16916225|NCT02407236|38041199|FG007|Maintenance Study (44 Weeks)|Death|1|||
16916226|NCT02407236|38041200|FG008|Maintenance Study (44 Weeks)|Death|0|||
16916227|NCT02407236|38041201|FG009|Maintenance Study (44 Weeks)|Death|0|||
16916228|NCT02407236|38041202|FG010|Maintenance Study (44 Weeks)|Death|0|||
16916229|NCT02407236|38041203|FG011|Maintenance Study (44 Weeks)|Death|0|||
16916230|NCT02407236|38041204|FG012|Maintenance Study (44 Weeks)|Death|0|||
16916231|NCT02407236|38041192|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16916232|NCT02407236|38041193|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16916233|NCT02407236|38041194|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16916234|NCT02407236|38041195|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16916235|NCT02407236|38041196|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16916236|NCT02407236|38041197|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16916237|NCT02407236|38041198|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
17198574|NCT00103285|38352273|FG000|Response Assignment|Protocol Violation|0|||
16842784|NCT01382446|37787033|FG000|Overall Study|Withdrawal by Subject|0|||
16842785|NCT01382446|37787034|FG001|Overall Study|Withdrawal by Subject|1|||
16842786|NCT01382446|37787033|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
16842787|NCT01382446|37787034|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
16842788|NCT01382212|37787040|FG000|Overall Study|Kidney transplant|1|||
16916238|NCT02407236|38041199|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16916239|NCT02407236|38041200|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
16916240|NCT02407236|38041201|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
16916241|NCT02407236|38041202|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
16916242|NCT02407236|38041203|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
16916243|NCT02407236|38041204|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
16916244|NCT02407236|38041192|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916245|NCT02407236|38041193|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916246|NCT02407236|38041194|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916247|NCT02407236|38041195|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916248|NCT02407236|38041196|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916249|NCT02407236|38041197|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916250|NCT02407236|38041198|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916251|NCT02407236|38041199|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916252|NCT02407236|38041200|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916253|NCT02407236|38041201|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916254|NCT02407236|38041202|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
16916255|NCT02407236|38041203|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16842789|NCT01382212|37787040|FG000|Overall Study|Withdrew consent|1|||
16842790|NCT01381900|37787047|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
16842791|NCT01381900|37787048|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
16842792|NCT01381900|37787049|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
16842793|NCT01381900|37787047|FG000|Overall Study|Adverse Event|4|||
16842794|NCT01381900|37787048|FG001|Overall Study|Adverse Event|6|||
16842795|NCT01381900|37787049|FG002|Overall Study|Adverse Event|7|||
16842796|NCT01381900|37787047|FG000|Overall Study|Noncompliance with study drug|0|||
16842797|NCT01381900|37787048|FG001|Overall Study|Noncompliance with study drug|0|||
16842798|NCT01381900|37787049|FG002|Overall Study|Noncompliance with study drug|1|||
16842799|NCT01381900|37787047|FG000|Overall Study|Physician Decision|0|||
16842800|NCT01381900|37787048|FG001|Overall Study|Physician Decision|1|||
16842801|NCT01381900|37787049|FG002|Overall Study|Physician Decision|1|||
16842802|NCT01381900|37787047|FG000|Overall Study|Protocol Violation|0|||
16842803|NCT01381900|37787048|FG001|Overall Study|Protocol Violation|1|||
16842804|NCT01381900|37787049|FG002|Overall Study|Protocol Violation|1|||
16842805|NCT01381900|37787047|FG000|Overall Study|Withdrawal by Subject|0|||
16842806|NCT01381900|37787048|FG001|Overall Study|Withdrawal by Subject|0|||
16842807|NCT01381900|37787049|FG002|Overall Study|Withdrawal by Subject|1|||
16842808|NCT01381900|37787047|FG000|Overall Study|Early withdraw|3|||
16842809|NCT01381900|37787048|FG001|Overall Study|Early withdraw|1|||
16842810|NCT01381900|37787049|FG002|Overall Study|Early withdraw|1|||
16842811|NCT01744665|37787057|FG000|Monitoring Phase|Adverse Event|4|||
16842812|NCT01744665|37787057|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
16842813|NCT01744665|37787057|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
16842814|NCT01744665|37787057|FG000|Monitoring Phase|Withdrawal by Subject|5|||
16842815|NCT01744665|37787057|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
16842816|NCT01744665|37787057|FG000|Consolidation Phase|Adverse Event|2|||
16842817|NCT01744665|37787057|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
16842818|NCT01744665|37787057|FG000|Consolidation Phase|Withdrawal by Subject|4|||
16842819|NCT01744665|37787057|FG000|Consolidation Phase|Administrative problems|9|||
16842820|NCT01744665|37787057|FG000|Re-initiation Phase|Administrative problems|10|||
16916256|NCT02407236|38041204|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16916257|NCT02407236|38041192|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16916258|NCT02407236|38041193|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16916259|NCT02407236|38041194|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16916260|NCT02407236|38041195|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16916261|NCT02407236|38041196|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16916262|NCT02407236|38041197|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16916263|NCT02407236|38041198|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16916264|NCT02407236|38041199|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16916265|NCT02407236|38041200|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
16916266|NCT02407236|38041201|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
16916267|NCT02407236|38041202|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
16916268|NCT02407236|38041203|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
16916269|NCT02407236|38041204|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
16916270|NCT02407236|38041192|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
16916271|NCT02407236|38041193|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
16916272|NCT02407236|38041194|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
16916273|NCT02407236|38041195|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
16916274|NCT02407236|38041196|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
17102457|NCT03631732|38241392|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
16916275|NCT02407236|38041197|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
16916276|NCT02407236|38041198|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
16916277|NCT02407236|38041199|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
16916278|NCT02407236|38041200|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
16916279|NCT02407236|38041201|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
16916280|NCT02407236|38041202|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
16916281|NCT02407236|38041203|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
16916282|NCT02407236|38041204|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
16916283|NCT01893138|38041232|FG000|Double-Blind Period|Withdrawal by Subject|1|||
16916284|NCT01893138|38041233|FG001|Double-Blind Period|Withdrawal by Subject|1|||
16916285|NCT01893138|38041232|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
16916286|NCT01893138|38041233|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
16916287|NCT01893138|38041232|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
16916288|NCT01893138|38041233|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
16916289|NCT01893138|38041232|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
16916290|NCT01893138|38041233|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
16916291|NCT01893138|38041232|FG000|Open Label - Unblinded Period|Adverse Event|1|||
16916292|NCT01893138|38041233|FG001|Open Label - Unblinded Period|Adverse Event|0|||
16916293|NCT04309500|38041245|FG000|Overall Study|Lost to Follow-up|1|||
16916294|NCT04309500|38041246|FG001|Overall Study|Lost to Follow-up|0|||
16916295|NCT04309500|38041247|FG002|Overall Study|Lost to Follow-up|0|||
16916296|NCT04309500|38041248|FG003|Overall Study|Lost to Follow-up|0|||
16916297|NCT03671304|38042583|FG000|Overall Study|study terminated|7|||
16916298|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
16916299|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
16916300|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Death|0|||
16916301|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Death|4|||
16916302|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
16916303|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
16916304|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
16916305|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
16916306|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
16916307|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
16916308|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
16916309|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
16916310|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
16916311|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
16916312|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Other|4|||
16916313|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Other|3|||
16916314|NCT03517722|38042589|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
16916315|NCT03517722|38042590|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
16916316|NCT03517722|38042589|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
16916317|NCT03517722|38042590|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
16916318|NCT03517722|38042589|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
16916319|NCT03517722|38042590|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
16916320|NCT03517722|38042589|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
16916321|NCT03517722|38042590|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
16916322|NCT03517722|38042589|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
16916323|NCT03517722|38042590|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
16916324|NCT03447990|38042604|FG000|Overall Study|Withdrawal by Subject|0|||
16916325|NCT03447990|38042605|FG001|Overall Study|Withdrawal by Subject|0|||
16916326|NCT03447990|38042606|FG002|Overall Study|Withdrawal by Subject|0|||
16916327|NCT03447990|38042607|FG003|Overall Study|Withdrawal by Subject|0|||
16916328|NCT03447990|38042608|FG004|Overall Study|Withdrawal by Subject|0|||
16916329|NCT03447990|38042609|FG005|Overall Study|Withdrawal by Subject|0|||
16916330|NCT03447990|38042610|FG006|Overall Study|Withdrawal by Subject|1|||
16842821|NCT01744665|37787057|FG000|Re-initiation Phase|Adverse Event|1|||
16842822|NCT01744665|37787057|FG000|Re-initiation Phase|No longer required treatment|1|||
16842823|NCT01744665|37787057|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
16842824|NCT01744197|37787066|FG000|Overall Study|Received 1 patch|2|||
16842825|NCT01744197|37787067|FG001|Overall Study|Received 1 patch|1|||
16842826|NCT01744197|37787066|FG000|Overall Study|No patch received|2|||
16842827|NCT01744197|37787067|FG001|Overall Study|No patch received|2|||
16842828|NCT01732107|37787073|FG000|Overall Study|Adverse Event|2|||
16842829|NCT01732107|37787073|FG000|Overall Study|Disease Progression|8|||
16842830|NCT01732107|37787073|FG000|Overall Study|Physician Decision|1|||
16842831|NCT01732107|37787073|FG000|Overall Study|Withdrawal by Subject|2|||
16842832|NCT01743027|37787081|FG000|Overall Study|Adverse Event|2|||
16842833|NCT01743027|37787082|FG001|Overall Study|Adverse Event|0|||
16842834|NCT01743027|37787083|FG002|Overall Study|Adverse Event|0|||
16842835|NCT01743027|37787084|FG003|Overall Study|Adverse Event|0|||
16842836|NCT01743027|37787081|FG000|Overall Study|Lost to Follow-up|0|||
16842837|NCT01743027|37787082|FG001|Overall Study|Lost to Follow-up|0|||
16842838|NCT01743027|37787083|FG002|Overall Study|Lost to Follow-up|2|||
16842839|NCT01743027|37787084|FG003|Overall Study|Lost to Follow-up|0|||
16842840|NCT01743027|37787081|FG000|Overall Study|Progressive Disease|1|||
16842841|NCT01743027|37787082|FG001|Overall Study|Progressive Disease|4|||
16916331|NCT01376778|38042662|FG000|Overall Study|Lost to Follow-up|3|||
16916332|NCT01376778|38042663|FG001|Overall Study|Lost to Follow-up|2|||
16916333|NCT01074294|38042672|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
16916334|NCT01074294|38042673|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
16916335|NCT01074294|38042674|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
16916336|NCT01074294|38042675|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
16916337|NCT01074294|38042672|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
16916338|NCT01074294|38042673|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
16916339|NCT01074294|38042674|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
16916340|NCT01074294|38042675|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
16916341|NCT01074294|38042672|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
16916342|NCT01074294|38042673|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
16916343|NCT01074294|38042674|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
16916344|NCT01074294|38042675|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
16916345|NCT01074294|38042672|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
16916346|NCT01074294|38042673|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
16916347|NCT01074294|38042674|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
16916348|NCT01074294|38042675|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
16916349|NCT01074294|38042672|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
16916350|NCT01074294|38042673|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
16916351|NCT01074294|38042674|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
16916352|NCT01074294|38042675|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
16916353|NCT01074294|38042672|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
16916354|NCT01074294|38042673|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
16916355|NCT01074294|38042674|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
16916356|NCT01074294|38042675|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
16916357|NCT01074294|38042672|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
16916358|NCT01074294|38042673|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
16916359|NCT01074294|38042674|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
16916360|NCT01074294|38042675|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
16916361|NCT01074294|38042672|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
16916362|NCT01074294|38042673|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
16916363|NCT01074294|38042674|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
16916364|NCT01074294|38042675|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
16916365|NCT01074294|38042672|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
16916366|NCT01074294|38042673|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
16916367|NCT01074294|38042674|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
16916368|NCT01074294|38042675|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
16916369|NCT01074294|38042672|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
16916370|NCT01074294|38042673|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
16916371|NCT01074294|38042674|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
16916372|NCT01074294|38042675|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
16916373|NCT01074294|38042672|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
16916374|NCT01074294|38042673|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
16916375|NCT01074294|38042674|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
16916376|NCT01074294|38042675|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
16842842|NCT01743027|37787083|FG002|Overall Study|Progressive Disease|3|||
16842843|NCT01743027|37787084|FG003|Overall Study|Progressive Disease|0|||
16842844|NCT01743027|37787081|FG000|Overall Study|Protocol Violation|1|||
16842845|NCT01743027|37787082|FG001|Overall Study|Protocol Violation|1|||
16842846|NCT01743027|37787083|FG002|Overall Study|Protocol Violation|1|||
16842847|NCT01743027|37787084|FG003|Overall Study|Protocol Violation|0|||
16842848|NCT01743027|37787081|FG000|Overall Study|Withdrawal by Subject|1|||
16842849|NCT01743027|37787082|FG001|Overall Study|Withdrawal by Subject|0|||
16842850|NCT01743027|37787083|FG002|Overall Study|Withdrawal by Subject|3|||
16842851|NCT01743027|37787084|FG003|Overall Study|Withdrawal by Subject|1|||
16842852|NCT01380730|37787102|FG000|Overall Study|Death|0|||
16842853|NCT01380730|37787103|FG001|Overall Study|Death|0|||
16842854|NCT01380730|37787104|FG002|Overall Study|Death|0|||
16842855|NCT01380730|37787105|FG003|Overall Study|Death|0|||
16842856|NCT01380730|37787106|FG004|Overall Study|Death|1|||
16842857|NCT01380730|37787107|FG005|Overall Study|Death|0|||
16842858|NCT01380730|37787108|FG006|Overall Study|Death|0|||
16842859|NCT01380730|37787109|FG007|Overall Study|Death|0|||
16842860|NCT01395784|37787127|FG000|Overall Study|Lost to Follow-up|7|||
16842861|NCT01395784|37787127|FG000|Overall Study|Withdrawal by Subject|3|||
16842862|NCT01395784|37787127|FG000|Overall Study|Physician Decision|5|||
16842863|NCT01380184|37787131|FG000|Part 1 (19 Days)|Adverse Event|1|||
16842864|NCT01380184|37787131|FG000|Part 2|Adverse Event|5|||
16842865|NCT01380184|37787131|FG000|Part 2|Disease Progression|8|||
16842866|NCT01380184|37787131|FG000|Part 2|Lost to Follow-up|1|||
16842867|NCT01395394|37787138|FG000|Baseline Study Visit|Protocol Violation|1|||
16842868|NCT01395394|37787139|FG001|Baseline Study Visit|Protocol Violation|0|||
16842869|NCT01395394|37787140|FG002|Baseline Study Visit|Protocol Violation|0|||
16842870|NCT01395316|37787148|FG000|Overall Study|Lost to Follow-up|2|||
16916377|NCT01074294|38042672|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
16916378|NCT01074294|38042673|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
16842871|NCT01395316|37787148|FG000|Overall Study|poor MRI quality|1|||
16842872|NCT01742091|37787158|FG000|Overall Study|Adverse Event|0|||
16916379|NCT01074294|38042674|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
16916380|NCT01074294|38042675|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
16916381|NCT01074294|38042672|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
16916382|NCT01074294|38042673|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
16916383|NCT01074294|38042674|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
16916384|NCT01074294|38042675|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
16916385|NCT04556838|38044496|FG000|Overall Study|Withdrawal by Subject|3|||
16916386|NCT04556838|38044497|FG001|Overall Study|Withdrawal by Subject|1|||
16916387|NCT04556838|38044498|FG002|Overall Study|Withdrawal by Subject|2|||
16916388|NCT04556838|38044496|FG000|Overall Study|Adverse Event|0|||
16916389|NCT04556838|38044497|FG001|Overall Study|Adverse Event|1|||
16916390|NCT04556838|38044498|FG002|Overall Study|Adverse Event|1|||
16916391|NCT04556838|38044496|FG000|Overall Study|Lost to Follow-up|0|||
16916392|NCT04556838|38044497|FG001|Overall Study|Lost to Follow-up|0|||
16916393|NCT04556838|38044498|FG002|Overall Study|Lost to Follow-up|2|||
16916394|NCT04556838|38044496|FG000|Overall Study|Subject travel|0|||
16916395|NCT04556838|38044497|FG001|Overall Study|Subject travel|1|||
16916396|NCT04556838|38044498|FG002|Overall Study|Subject travel|0|||
16916397|NCT04556838|38044496|FG000|Overall Study|Physician Decision|1|||
16916398|NCT04556838|38044497|FG001|Overall Study|Physician Decision|0|||
16916399|NCT04556838|38044498|FG002|Overall Study|Physician Decision|0|||
16916400|NCT03671148|38044521|FG000|Overall Study|Adverse Event|3|||
16916401|NCT03671148|38044522|FG001|Overall Study|Adverse Event|2|||
16916402|NCT03671148|38044521|FG000|Overall Study|Withdrawal by Subject|8|||
16916403|NCT03671148|38044522|FG001|Overall Study|Withdrawal by Subject|2|||
16916404|NCT03671148|38044521|FG000|Overall Study|Lost to Follow-up|1|||
16916405|NCT03671148|38044522|FG001|Overall Study|Lost to Follow-up|2|||
16916406|NCT03671148|38044521|FG000|Overall Study|Lack of Efficacy|7|||
16916407|NCT03671148|38044522|FG001|Overall Study|Lack of Efficacy|2|||
16916408|NCT03671148|38044521|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
16842873|NCT01742091|37787159|FG001|Overall Study|Adverse Event|0|||
16842874|NCT01742091|37787160|FG002|Overall Study|Adverse Event|0|||
16842875|NCT01742091|37787161|FG003|Overall Study|Adverse Event|0|||
16842876|NCT01742091|37787162|FG004|Overall Study|Adverse Event|1|||
16842877|NCT01742091|37787163|FG005|Overall Study|Adverse Event|0|||
16842878|NCT01742091|37787158|FG000|Overall Study|Physician Decision|0|||
16842879|NCT01742091|37787159|FG001|Overall Study|Physician Decision|0|||
16842880|NCT01742091|37787160|FG002|Overall Study|Physician Decision|0|||
16842881|NCT01742091|37787161|FG003|Overall Study|Physician Decision|0|||
16842882|NCT01742091|37787162|FG004|Overall Study|Physician Decision|0|||
16842883|NCT01742091|37787163|FG005|Overall Study|Physician Decision|1|||
16842884|NCT01742091|37787158|FG000|Overall Study|Withdrawal by Subject|0|||
16842885|NCT01742091|37787159|FG001|Overall Study|Withdrawal by Subject|0|||
16842886|NCT01742091|37787160|FG002|Overall Study|Withdrawal by Subject|0|||
16842887|NCT01742091|37787161|FG003|Overall Study|Withdrawal by Subject|1|||
16842888|NCT01742091|37787162|FG004|Overall Study|Withdrawal by Subject|0|||
16842889|NCT01742091|37787163|FG005|Overall Study|Withdrawal by Subject|0|||
16842890|NCT01742091|37787158|FG000|Overall Study|Lost to Follow-up|0|||
16842891|NCT01742091|37787159|FG001|Overall Study|Lost to Follow-up|0|||
16842892|NCT01742091|37787160|FG002|Overall Study|Lost to Follow-up|0|||
16842893|NCT01742091|37787161|FG003|Overall Study|Lost to Follow-up|0|||
16916409|NCT03671148|38044522|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
16916410|NCT03671148|38044521|FG000|Overall Study|Other|1|||
16916411|NCT03671148|38044522|FG001|Overall Study|Other|0|||
16916412|NCT03671148|38044521|FG000|Overall Study|Incomplete Randomization Visit|1|||
16916413|NCT03671148|38044522|FG001|Overall Study|Incomplete Randomization Visit|0|||
16916414|NCT02004522|38044539|FG000|Overall Study|Adverse Event|55|||
16916415|NCT02004522|38044540|FG001|Overall Study|Adverse Event|6|||
16916416|NCT02004522|38044539|FG000|Overall Study|Withdrawal by Subject|13|||
16916417|NCT02004522|38044540|FG001|Overall Study|Withdrawal by Subject|7|||
16842894|NCT01742091|37787162|FG004|Overall Study|Lost to Follow-up|0|||
16916418|NCT02004522|38044539|FG000|Overall Study|Death|12|||
16916419|NCT02004522|38044540|FG001|Overall Study|Death|3|||
16916420|NCT02004522|38044539|FG000|Overall Study|Physician Decision|3|||
16916421|NCT02004522|38044540|FG001|Overall Study|Physician Decision|4|||
16916422|NCT02004522|38044539|FG000|Overall Study|Protocol Violation|1|||
16916423|NCT02004522|38044540|FG001|Overall Study|Protocol Violation|0|||
16916424|NCT02004522|38044539|FG000|Overall Study|Other is reason listed by PI|4|||
16916425|NCT02004522|38044540|FG001|Overall Study|Other is reason listed by PI|1|||
16916426|NCT02004522|38044539|FG000|Overall Study|Never Dosed|2|||
16916427|NCT02004522|38044540|FG001|Overall Study|Never Dosed|4|||
16916428|NCT02004522|38044539|FG000|Overall Study|Disease Progression|35|||
16916429|NCT02004522|38044540|FG001|Overall Study|Disease Progression|31|||
16916430|NCT02004522|38044539|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
16916431|NCT02004522|38044540|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
16916432|NCT02000622|38044548|FG000|Overall Study|Withdrawal by Subject|5|||
16916433|NCT02000622|38044549|FG001|Overall Study|Withdrawal by Subject|7|||
16916434|NCT02000622|38044548|FG000|Overall Study|Lost to Follow-up|4|||
16916435|NCT02000622|38044549|FG001|Overall Study|Lost to Follow-up|0|||
16916436|NCT02000622|38044548|FG000|Overall Study|Death|159|||
16916437|NCT02000622|38044549|FG001|Overall Study|Death|73|||
16916438|NCT02000622|38044548|FG000|Overall Study|Withdrawn due to site closure|1|||
16916439|NCT02000622|38044549|FG001|Overall Study|Withdrawn due to site closure|0|||
16916440|NCT01430442|38044567|FG000|Overall Study|Subject Withdrew Consent|3|||
16916441|NCT01430442|38044568|FG001|Overall Study|Subject Withdrew Consent|0|||
16916442|NCT01430442|38044569|FG002|Overall Study|Subject Withdrew Consent|1|||
16916443|NCT01430442|38044570|FG003|Overall Study|Subject Withdrew Consent|0|||
16916444|NCT01430442|38044571|FG004|Overall Study|Subject Withdrew Consent|2|||
16916445|NCT01430442|38044572|FG005|Overall Study|Subject Withdrew Consent|1|||
16916446|NCT01430442|38044573|FG006|Overall Study|Subject Withdrew Consent|5|||
16916447|NCT01430442|38044574|FG007|Overall Study|Subject Withdrew Consent|2|||
16916448|NCT01430442|38044567|FG000|Overall Study|Lost to Follow-up|2|||
16916449|NCT01430442|38044568|FG001|Overall Study|Lost to Follow-up|0|||
16916450|NCT01430442|38044569|FG002|Overall Study|Lost to Follow-up|1|||
16916451|NCT01430442|38044570|FG003|Overall Study|Lost to Follow-up|2|||
16916452|NCT01430442|38044571|FG004|Overall Study|Lost to Follow-up|2|||
16916453|NCT01430442|38044572|FG005|Overall Study|Lost to Follow-up|1|||
16916454|NCT01430442|38044573|FG006|Overall Study|Lost to Follow-up|5|||
16916455|NCT01430442|38044574|FG007|Overall Study|Lost to Follow-up|1|||
16916456|NCT01430442|38044567|FG000|Overall Study|Pregnancy|1|||
16916457|NCT01430442|38044568|FG001|Overall Study|Pregnancy|0|||
16916458|NCT01430442|38044569|FG002|Overall Study|Pregnancy|0|||
16916459|NCT01430442|38044570|FG003|Overall Study|Pregnancy|0|||
16916460|NCT01430442|38044571|FG004|Overall Study|Pregnancy|0|||
16916461|NCT01430442|38044572|FG005|Overall Study|Pregnancy|1|||
16916462|NCT01430442|38044573|FG006|Overall Study|Pregnancy|0|||
16842895|NCT01742091|37787163|FG005|Overall Study|Lost to Follow-up|1|||
16842896|NCT01731951|37787183|FG000|Overall Study|Documented Disease Progression|1|||
16842897|NCT01731951|37787184|FG001|Overall Study|Documented Disease Progression|0|||
16842898|NCT01731951|37787185|FG002|Overall Study|Documented Disease Progression|0|||
16842899|NCT01731951|37787186|FG003|Overall Study|Documented Disease Progression|0|||
16842900|NCT01731951|37787187|FG004|Overall Study|Documented Disease Progression|0|||
16842901|NCT01731951|37787188|FG005|Overall Study|Documented Disease Progression|0|||
16842902|NCT01731951|37787183|FG000|Overall Study|Lost to Follow-up|2|||
16842903|NCT01731951|37787184|FG001|Overall Study|Lost to Follow-up|0|||
16842904|NCT01731951|37787185|FG002|Overall Study|Lost to Follow-up|0|||
16842905|NCT01731951|37787186|FG003|Overall Study|Lost to Follow-up|1|||
16842906|NCT01731951|37787187|FG004|Overall Study|Lost to Follow-up|3|||
16842907|NCT01731951|37787188|FG005|Overall Study|Lost to Follow-up|1|||
16916463|NCT01430442|38044574|FG007|Overall Study|Pregnancy|0|||
16916464|NCT01430442|38044567|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
16916465|NCT01430442|38044568|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
16916466|NCT01430442|38044569|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
16916467|NCT01430442|38044570|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
16916468|NCT01430442|38044571|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
16916469|NCT01430442|38044572|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
16916470|NCT01430442|38044573|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
16916471|NCT01430442|38044574|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
16916472|NCT01420926|38044594|FG000|Overall Study|Adverse Event|6|||
16916473|NCT01420926|38044595|FG001|Overall Study|Adverse Event|4|||
16916474|NCT01420926|38044594|FG000|Overall Study|Death|18|||
16916475|NCT01420926|38044595|FG001|Overall Study|Death|17|||
16916476|NCT01420926|38044594|FG000|Overall Study|Withdrawal by Subject|11|||
16916477|NCT01420926|38044595|FG001|Overall Study|Withdrawal by Subject|17|||
16916478|NCT01420926|38044594|FG000|Overall Study|Non-protocol treatment|17|||
16916479|NCT01420926|38044595|FG001|Overall Study|Non-protocol treatment|20|||
16916480|NCT01420926|38044594|FG000|Overall Study|Physician Decision|8|||
16916481|NCT01420926|38044595|FG001|Overall Study|Physician Decision|5|||
16916482|NCT04303572|38045151|FG000|Overall Study|Study closed due to poor enrollment|1|||
16916483|NCT04150068|38045158|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
16916484|NCT04150068|38045159|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
16916485|NCT04150068|38045160|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
16916486|NCT04150068|38045158|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
16916487|NCT04150068|38045159|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
16916488|NCT04150068|38045160|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
16916489|NCT03551730|38045195|FG000|Overall Study|Adverse Event|1|||
16916490|NCT03551730|38045196|FG001|Overall Study|Adverse Event|0|||
16916491|NCT03551730|38045197|FG002|Overall Study|Adverse Event|0|||
16916492|NCT03551730|38045198|FG003|Overall Study|Adverse Event|0|||
16916493|NCT02656290|38045208|FG000|Overall Study|Subjects Remain On Study|26|||
16916494|NCT02534844|38045214|FG000|Part B|Withdrawal by Subject|0|||
16916495|NCT02534844|38045215|FG001|Part B|Withdrawal by Subject|0|||
16916496|NCT02534844|38045216|FG002|Part B|Withdrawal by Subject|0|||
16916497|NCT02534844|38045217|FG003|Part B|Withdrawal by Subject|0|||
16916498|NCT02534844|38045218|FG004|Part B|Withdrawal by Subject|2|||
16916499|NCT02534844|38045219|FG005|Part B|Withdrawal by Subject|1|||
16916500|NCT02043678|38045238|FG000|Overall Study|Never treated|11|||
16916501|NCT02043678|38045239|FG001|Overall Study|Never treated|9|||
16916502|NCT02043678|38045238|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
16916503|NCT02043678|38045239|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
16916504|NCT02043678|38045238|FG000|Overall Study|AE without clinical PD|51|||
16916505|NCT02043678|38045239|FG001|Overall Study|AE without clinical PD|34|||
16916506|NCT02043678|38045238|FG000|Overall Study|Lost to Follow-up|1|||
16916507|NCT02043678|38045239|FG001|Overall Study|Lost to Follow-up|1|||
16916508|NCT02043678|38045238|FG000|Overall Study|Other|19|||
16916509|NCT02043678|38045239|FG001|Overall Study|Other|16|||
16842908|NCT01731951|37787183|FG000|Overall Study|Withdrawal of Consent|1|||
16842909|NCT01731951|37787184|FG001|Overall Study|Withdrawal of Consent|0|||
16842910|NCT01731951|37787185|FG002|Overall Study|Withdrawal of Consent|0|||
16842911|NCT01731951|37787186|FG003|Overall Study|Withdrawal of Consent|0|||
16842912|NCT01731951|37787187|FG004|Overall Study|Withdrawal of Consent|0|||
16842913|NCT01731951|37787188|FG005|Overall Study|Withdrawal of Consent|2|||
16842914|NCT01731951|37787183|FG000|Overall Study|Death|13|||
16842915|NCT01731951|37787184|FG001|Overall Study|Death|15|||
16842916|NCT01731951|37787185|FG002|Overall Study|Death|9|||
16842917|NCT01731951|37787186|FG003|Overall Study|Death|8|||
16842918|NCT01731951|37787187|FG004|Overall Study|Death|9|||
16842919|NCT01731951|37787188|FG005|Overall Study|Death|6|||
16842920|NCT01731171|37787208|FG000|Overall Study|Withdrawal by Subject|4|||
16842921|NCT01731171|37787209|FG001|Overall Study|Withdrawal by Subject|1|||
16842922|NCT01731171|37787208|FG000|Overall Study|Lost to Follow-up|3|||
16842923|NCT01731171|37787209|FG001|Overall Study|Lost to Follow-up|2|||
16842924|NCT01731171|37787208|FG000|Overall Study|Moved out of Area|0|||
16842925|NCT01731171|37787209|FG001|Overall Study|Moved out of Area|2|||
16842926|NCT01731171|37787208|FG000|Overall Study|Terminated for Lack of Adherence|0|||
16842927|NCT01731171|37787209|FG001|Overall Study|Terminated for Lack of Adherence|1|||
16842928|NCT01731171|37787208|FG000|Overall Study|Terminated for Safety Reasons|0|||
16842929|NCT01731171|37787209|FG001|Overall Study|Terminated for Safety Reasons|1|||
16842930|NCT01741701|37787217|FG000|Overall Study|Adverse Event|5|||
16842931|NCT01741701|37787218|FG001|Overall Study|Adverse Event|1|||
16842932|NCT01741701|37787217|FG000|Overall Study|Withdrawal by Subject|0|||
16842933|NCT01741701|37787218|FG001|Overall Study|Withdrawal by Subject|1|||
16842934|NCT01741545|37787226|FG000|Treatment Period|Lack of Efficacy|0|||
16842935|NCT01741545|37787227|FG001|Treatment Period|Lack of Efficacy|1|||
16842936|NCT01741545|37787226|FG000|Treatment Period|Adverse event, non-fatal|1|||
16916510|NCT02043678|38045238|FG000|Overall Study|Clinical PD|108|||
16916511|NCT02043678|38045239|FG001|Overall Study|Clinical PD|138|||
16916512|NCT02043678|38045238|FG000|Overall Study|Radiological PD|91|||
16916513|NCT02043678|38045239|FG001|Overall Study|Radiological PD|80|||
16916514|NCT02043678|38045238|FG000|Overall Study|Protocol-driven decision point|56|||
16916515|NCT02043678|38045239|FG001|Overall Study|Protocol-driven decision point|56|||
16916516|NCT02043678|38045238|FG000|Overall Study|Withdrawal by Subject|12|||
16916517|NCT02043678|38045239|FG001|Overall Study|Withdrawal by Subject|15|||
16916518|NCT02043678|38045238|FG000|Overall Study|Ongoing with treatment|34|||
16916519|NCT02043678|38045239|FG001|Overall Study|Ongoing with treatment|38|||
16916520|NCT01818492|38045245|FG000|Overall Study|Adverse Event|2|||
16916521|NCT01818492|38045245|FG000|Overall Study|Death|3|||
16842937|NCT01741545|37787227|FG001|Treatment Period|Adverse event, non-fatal|3|||
16842938|NCT01741545|37787226|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
16842939|NCT01741545|37787227|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
16842940|NCT01741545|37787226|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
16842941|NCT01741545|37787227|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
16916522|NCT01818492|38045245|FG000|Overall Study|Withdrawal by Subject|1|||
16916523|NCT01818492|38045245|FG000|Overall Study|Additional therapy when not allowed PP|4|||
16916524|NCT01239030|38045255|FG000|Double Blind|Adverse Event|0|||
16916525|NCT01239030|38045256|FG001|Double Blind|Adverse Event|1|||
16916526|NCT01239030|38045257|FG002|Double Blind|Adverse Event|0|||
16842942|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
16842943|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
16842944|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
16842945|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
16842946|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
16842947|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
16842948|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
16842949|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
16842950|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
16842951|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
16916527|NCT01239030|38045258|FG003|Double Blind|Adverse Event|2|||
16916528|NCT01239030|38045259|FG004|Double Blind|Adverse Event|0|||
16916529|NCT01239030|38045255|FG000|Double Blind|Withdrawal by Subject|0|||
16916530|NCT01239030|38045256|FG001|Double Blind|Withdrawal by Subject|1|||
16916531|NCT01239030|38045257|FG002|Double Blind|Withdrawal by Subject|1|||
16916532|NCT01239030|38045258|FG003|Double Blind|Withdrawal by Subject|0|||
16916533|NCT01239030|38045259|FG004|Double Blind|Withdrawal by Subject|1|||
16916534|NCT01239030|38045255|FG000|Double Blind|Lost to Follow-up|1|||
16916535|NCT01239030|38045256|FG001|Double Blind|Lost to Follow-up|1|||
16916536|NCT01239030|38045257|FG002|Double Blind|Lost to Follow-up|0|||
16916537|NCT01239030|38045258|FG003|Double Blind|Lost to Follow-up|0|||
16916538|NCT01239030|38045259|FG004|Double Blind|Lost to Follow-up|0|||
16842952|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
16842953|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
16842954|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
16842955|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
16842956|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
16842957|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
16842958|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
16842959|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
16842960|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
16842961|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
16842962|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
16842963|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
16842964|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
16842965|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
16842966|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
16842967|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
16842968|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
16842969|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
16842970|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
16842971|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
16842972|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
16842973|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
16842974|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
16842975|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
16842976|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
16842977|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
16842978|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
16842979|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
16842980|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
16842981|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
16842982|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
16842983|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
16842984|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
16842985|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
16842986|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
16842987|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
16842988|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
16842989|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
16842990|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
16842991|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
16916539|NCT01239030|38045255|FG000|Double Blind|Physician Decision|0|||
16916540|NCT01239030|38045256|FG001|Double Blind|Physician Decision|1|||
16916541|NCT01239030|38045257|FG002|Double Blind|Physician Decision|0|||
16842992|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
16842993|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
16842994|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
16842995|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
16842996|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
16842997|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
16842998|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
16842999|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
16843000|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
16843001|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
16843002|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
16843003|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
16843004|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
16843005|NCT01884350|37787235|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
16843006|NCT01884350|37787236|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
16843007|NCT01884350|37787237|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
16843008|NCT01614795|37787251|FG000|Overall Study|Adverse Event|0|||
16843009|NCT01614795|37787252|FG001|Overall Study|Adverse Event|0|||
16843010|NCT01614795|37787253|FG002|Overall Study|Adverse Event|1|||
16843011|NCT01614795|37787254|FG003|Overall Study|Adverse Event|1|||
16843012|NCT01614795|37787251|FG000|Overall Study|Lack of Efficacy|10|||
16843013|NCT01614795|37787252|FG001|Overall Study|Lack of Efficacy|10|||
16843014|NCT01614795|37787253|FG002|Overall Study|Lack of Efficacy|9|||
16843015|NCT01614795|37787254|FG003|Overall Study|Lack of Efficacy|8|||
16843016|NCT01614795|37787251|FG000|Overall Study|Physician Decision|1|||
16843017|NCT01614795|37787252|FG001|Overall Study|Physician Decision|0|||
16843018|NCT01614795|37787253|FG002|Overall Study|Physician Decision|1|||
16843019|NCT01614795|37787254|FG003|Overall Study|Physician Decision|1|||
16843020|NCT01614795|37787251|FG000|Overall Study|Withdrawal by Subject|0|||
16843021|NCT01614795|37787252|FG001|Overall Study|Withdrawal by Subject|1|||
16843022|NCT01614795|37787253|FG002|Overall Study|Withdrawal by Subject|0|||
16843023|NCT01614795|37787254|FG003|Overall Study|Withdrawal by Subject|2|||
16843024|NCT01614795|37787251|FG000|Overall Study|Ineligible|0|||
16843025|NCT01614795|37787252|FG001|Overall Study|Ineligible|1|||
16843026|NCT01614795|37787253|FG002|Overall Study|Ineligible|0|||
16843027|NCT01614795|37787254|FG003|Overall Study|Ineligible|0|||
16843028|NCT01834586|37787265|FG000|Overall Study|Adverse Event|1|||
16843029|NCT01614249|37787271|FG000|Overall Study|Lost to Follow-up|11|||
16843030|NCT01614249|37787272|FG001|Overall Study|Lost to Follow-up|23|||
16843031|NCT01597778|37787280|FG000|Overall Study|Death|7|||
16843032|NCT01597778|37787281|FG001|Overall Study|Death|10|||
16843033|NCT01597778|37787280|FG000|Overall Study|Withdrawal by Subject|3|||
16843034|NCT01597778|37787281|FG001|Overall Study|Withdrawal by Subject|4|||
16843035|NCT01597778|37787280|FG000|Overall Study|Adverse Event|1|||
16843036|NCT01597778|37787281|FG001|Overall Study|Adverse Event|1|||
16843037|NCT01597778|37787280|FG000|Overall Study|Protocol Violation|1|||
16843038|NCT01597778|37787281|FG001|Overall Study|Protocol Violation|11|||
16843039|NCT01597778|37787280|FG000|Overall Study|Transplanted off protocol|2|||
16843040|NCT01597778|37787281|FG001|Overall Study|Transplanted off protocol|3|||
16843041|NCT01614093|37787287|FG000|Overall Study|Withdrawal by Subject|1|||
16843042|NCT01834274|37787294|FG000|Overall Study|Study Termination|41|||
16843043|NCT01834274|37787295|FG001|Overall Study|Study Termination|38|||
16843044|NCT01834274|37787294|FG000|Overall Study|Withdrawal by Subject|1|||
16843045|NCT01834274|37787295|FG001|Overall Study|Withdrawal by Subject|1|||
16843046|NCT01834274|37787294|FG000|Overall Study|Lost to Follow-up|3|||
16843047|NCT01834274|37787295|FG001|Overall Study|Lost to Follow-up|1|||
16843048|NCT01834274|37787294|FG000|Overall Study|Other|2|||
16843049|NCT01834274|37787295|FG001|Overall Study|Other|1|||
16843050|NCT01739595|37787304|FG000|Overall Study|Adverse Event|3|||
16843051|NCT01739595|37787305|FG001|Overall Study|Adverse Event|0|||
16843052|NCT01739595|37787306|FG002|Overall Study|Adverse Event|0|||
16843053|NCT01739595|37787304|FG000|Overall Study|Lost to Follow-up|2|||
16843054|NCT01739595|37787305|FG001|Overall Study|Lost to Follow-up|0|||
16843055|NCT01739595|37787306|FG002|Overall Study|Lost to Follow-up|0|||
16843056|NCT01739595|37787304|FG000|Overall Study|Withdrawal by Subject|2|||
16843057|NCT01739595|37787305|FG001|Overall Study|Withdrawal by Subject|1|||
16843058|NCT01739595|37787306|FG002|Overall Study|Withdrawal by Subject|2|||
16843059|NCT01739595|37787304|FG000|Overall Study|Eligibility issue|3|||
16843060|NCT01739595|37787305|FG001|Overall Study|Eligibility issue|0|||
16843061|NCT01739595|37787306|FG002|Overall Study|Eligibility issue|0|||
16843062|NCT01739595|37787304|FG000|Overall Study|Protocol Violation|1|||
16843063|NCT01739595|37787305|FG001|Overall Study|Protocol Violation|0|||
16843064|NCT01739595|37787306|FG002|Overall Study|Protocol Violation|0|||
16843065|NCT01739595|37787304|FG000|Overall Study|Lab assessment|1|||
16843066|NCT01739595|37787305|FG001|Overall Study|Lab assessment|0|||
16843067|NCT01739595|37787306|FG002|Overall Study|Lab assessment|0|||
16843068|NCT01739595|37787304|FG000|Overall Study|Drug discrepancy|1|||
16843069|NCT01739595|37787305|FG001|Overall Study|Drug discrepancy|0|||
16843070|NCT01739595|37787306|FG002|Overall Study|Drug discrepancy|0|||
16843071|NCT01833494|37787313|FG000|Overall Study|Adverse Event|24|||
16843072|NCT01833494|37787313|FG000|Overall Study|Physician Decision|6|||
16843073|NCT01833494|37787313|FG000|Overall Study|Withdrawal by Subject|6|||
16843074|NCT01833494|37787313|FG000|Overall Study|Decrease in serum phosphorus|4|||
16843075|NCT01833494|37787313|FG000|Overall Study|Decrease in serum calcium|4|||
16843076|NCT01833494|37787313|FG000|Overall Study|Increase in serum ferritin|1|||
16843077|NCT01738971|37787320|FG000|Overall Study|Lost to Follow-up|19|||
16843078|NCT01738971|37787321|FG001|Overall Study|Lost to Follow-up|30|||
16843079|NCT01738971|37787322|FG002|Overall Study|Lost to Follow-up|17|||
16843080|NCT01738581|37787332|FG000|Overall Study|Lost to Follow-up|1|||
16843081|NCT01738581|37787333|FG001|Overall Study|Lost to Follow-up|0|||
16843082|NCT01738503|37787345|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
16843083|NCT01738503|37787346|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
16843084|NCT01738503|37787347|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
16843085|NCT01738503|37787348|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
16843086|NCT01738503|37787349|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
16843087|NCT01738503|37787350|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
16843088|NCT01738503|37787351|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
16843089|NCT01738503|37787345|FG000|Treatment Period|Adverse Event|0|||
16843090|NCT01738503|37787346|FG001|Treatment Period|Adverse Event|1|||
16843091|NCT01738503|37787347|FG002|Treatment Period|Adverse Event|0|||
16843092|NCT01738503|37787348|FG003|Treatment Period|Adverse Event|1|||
16843093|NCT01738503|37787349|FG004|Treatment Period|Adverse Event|2|||
16843094|NCT01738503|37787350|FG005|Treatment Period|Adverse Event|2|||
16843095|NCT01738503|37787351|FG006|Treatment Period|Adverse Event|2|||
16843096|NCT01738503|37787345|FG000|Treatment Period|Lost to Follow-up|0|||
16843097|NCT01738503|37787346|FG001|Treatment Period|Lost to Follow-up|0|||
16843098|NCT01738503|37787347|FG002|Treatment Period|Lost to Follow-up|3|||
16843099|NCT01738503|37787348|FG003|Treatment Period|Lost to Follow-up|4|||
16843100|NCT01738503|37787349|FG004|Treatment Period|Lost to Follow-up|1|||
16843101|NCT01738503|37787350|FG005|Treatment Period|Lost to Follow-up|1|||
16843102|NCT01738503|37787351|FG006|Treatment Period|Lost to Follow-up|5|||
16843103|NCT01738503|37787345|FG000|Treatment Period|Withdrawal by Subject|0|||
16843104|NCT01738503|37787346|FG001|Treatment Period|Withdrawal by Subject|1|||
16843105|NCT01738503|37787347|FG002|Treatment Period|Withdrawal by Subject|0|||
16843106|NCT01738503|37787348|FG003|Treatment Period|Withdrawal by Subject|1|||
16843107|NCT01738503|37787349|FG004|Treatment Period|Withdrawal by Subject|1|||
16843108|NCT01738503|37787350|FG005|Treatment Period|Withdrawal by Subject|1|||
16843109|NCT01738503|37787351|FG006|Treatment Period|Withdrawal by Subject|1|||
16843110|NCT01738503|37787345|FG000|Treatment Period|Protocol Violation|0|||
16843111|NCT01738503|37787346|FG001|Treatment Period|Protocol Violation|3|||
16843112|NCT01738503|37787347|FG002|Treatment Period|Protocol Violation|1|||
16843113|NCT01738503|37787348|FG003|Treatment Period|Protocol Violation|0|||
16843114|NCT01738503|37787349|FG004|Treatment Period|Protocol Violation|4|||
16843115|NCT01738503|37787350|FG005|Treatment Period|Protocol Violation|2|||
16843116|NCT01738503|37787351|FG006|Treatment Period|Protocol Violation|0|||
16843117|NCT01738503|37787345|FG000|Treatment Period|Other|0|||
16843118|NCT01738503|37787346|FG001|Treatment Period|Other|0|||
16843119|NCT01738503|37787347|FG002|Treatment Period|Other|1|||
16843120|NCT01738503|37787348|FG003|Treatment Period|Other|0|||
16843121|NCT01738503|37787349|FG004|Treatment Period|Other|0|||
16843122|NCT01738503|37787350|FG005|Treatment Period|Other|0|||
16843123|NCT01738503|37787351|FG006|Treatment Period|Other|0|||
16843124|NCT01738503|37787345|FG000|PET Imaging Sub-study|Adverse Event|0|||
16843125|NCT01738503|37787346|FG001|PET Imaging Sub-study|Adverse Event|0|||
16843126|NCT01738503|37787347|FG002|PET Imaging Sub-study|Adverse Event|0|||
16843127|NCT01738503|37787348|FG003|PET Imaging Sub-study|Adverse Event|0|||
16843128|NCT01738503|37787349|FG004|PET Imaging Sub-study|Adverse Event|0|||
16843129|NCT01738503|37787350|FG005|PET Imaging Sub-study|Adverse Event|1|||
16916542|NCT01239030|38045258|FG003|Double Blind|Physician Decision|0|||
16916543|NCT01239030|38045259|FG004|Double Blind|Physician Decision|0|||
16916544|NCT01239030|38045255|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
16916545|NCT01239030|38045256|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
16916546|NCT01239030|38045257|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
16916547|NCT01239030|38045258|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
16916548|NCT01239030|38045259|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
16916549|NCT01239030|38045255|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
16916550|NCT01239030|38045256|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
16843130|NCT01738503|37787351|FG006|PET Imaging Sub-study|Adverse Event|0|||
16843131|NCT01738503|37787345|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16916551|NCT01239030|38045257|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
16916552|NCT01239030|38045258|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
16843132|NCT01738503|37787346|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16843133|NCT01738503|37787347|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16843134|NCT01738503|37787348|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16843135|NCT01738503|37787349|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16843136|NCT01738503|37787350|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
16843137|NCT01738503|37787351|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
16843138|NCT01738191|37787375|FG000|Overall Study|Withdrawal by Subject|4|||
16843139|NCT01738191|37787376|FG001|Overall Study|Withdrawal by Subject|1|||
16843140|NCT01737879|37787382|FG000|Overall Study|Death|1|||
16843141|NCT01737879|37787382|FG000|Overall Study|Sponsor decision|40|||
16843142|NCT01879683|37787386|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
16843143|NCT01605825|37787392|FG000|Overall Study|Adverse Event|4|||
16843144|NCT01605825|37787393|FG001|Overall Study|Adverse Event|2|||
16843145|NCT01605825|37787392|FG000|Overall Study|Withdrawal by Subject|0|||
16843146|NCT01605825|37787393|FG001|Overall Study|Withdrawal by Subject|1|||
16843147|NCT01605825|37787392|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
16843148|NCT01605825|37787393|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
16916553|NCT01239030|38045259|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
16916554|NCT01239030|38045255|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
16916555|NCT01239030|38045256|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
16916556|NCT01239030|38045257|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
16916557|NCT01239030|38045258|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
16916558|NCT01239030|38045259|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
16916559|NCT01239030|38045255|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
16916560|NCT01239030|38045256|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
16916561|NCT01239030|38045257|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
16916562|NCT01239030|38045258|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
16916563|NCT01239030|38045259|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
16916564|NCT01086540|38045274|FG000|Overall Study|Death|3|||
16916565|NCT01086540|38045275|FG001|Overall Study|Death|1|||
16916566|NCT01086540|38045274|FG000|Overall Study|Physician Decision|2|||
16916567|NCT01086540|38045275|FG001|Overall Study|Physician Decision|1|||
16916568|NCT01086540|38045274|FG000|Overall Study|Addition of new therapy for PAH|1|||
16916569|NCT01086540|38045275|FG001|Overall Study|Addition of new therapy for PAH|0|||
16916570|NCT04567524|38048612|FG000|Overall Study|Adverse Event|1|||
16916571|NCT04567524|38048613|FG001|Overall Study|Adverse Event|1|||
16916572|NCT04567524|38048614|FG002|Overall Study|Adverse Event|0|||
16916573|NCT04567524|38048615|FG003|Overall Study|Adverse Event|0|||
16916574|NCT04567524|38048612|FG000|Overall Study|Withdrawal by Subject|2|||
16916575|NCT04567524|38048613|FG001|Overall Study|Withdrawal by Subject|0|||
16916576|NCT04567524|38048614|FG002|Overall Study|Withdrawal by Subject|0|||
16916577|NCT04567524|38048615|FG003|Overall Study|Withdrawal by Subject|1|||
16916578|NCT03370302|38048651|FG000|Dose Escalation Phase|Other|0|||
16916579|NCT03370302|38048652|FG001|Dose Escalation Phase|Other|1|||
16916580|NCT03370302|38048653|FG002|Dose Escalation Phase|Other|1|||
16916581|NCT03370302|38048654|FG003|Dose Escalation Phase|Other|0|||
16916582|NCT03370302|38048655|FG004|Dose Escalation Phase|Other|0|||
16916583|NCT03370302|38048656|FG005|Dose Escalation Phase|Other|0|||
16916584|NCT03370302|38048651|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16916585|NCT03370302|38048652|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
16916586|NCT03370302|38048653|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
16916587|NCT03370302|38048654|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16916588|NCT03370302|38048655|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
16916589|NCT03370302|38048656|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
16916590|NCT03370302|38048651|FG000|Dose Escalation Phase|Adverse Event|1|||
16916591|NCT03370302|38048652|FG001|Dose Escalation Phase|Adverse Event|0|||
16916592|NCT03370302|38048653|FG002|Dose Escalation Phase|Adverse Event|2|||
16916593|NCT03370302|38048654|FG003|Dose Escalation Phase|Adverse Event|0|||
16916594|NCT03370302|38048655|FG004|Dose Escalation Phase|Adverse Event|0|||
16916595|NCT03370302|38048656|FG005|Dose Escalation Phase|Adverse Event|0|||
16843149|NCT01605825|37787392|FG000|Overall Study|Non-Compliance with Protocol|3|||
16843150|NCT01605825|37787393|FG001|Overall Study|Non-Compliance with Protocol|0|||
16843151|NCT01727505|37787399|FG000|First 24 Hours|Adverse Event|0|||
16843152|NCT01727505|37787400|FG001|First 24 Hours|Adverse Event|1|||
16843153|NCT01727505|37787399|FG000|Second 24 Hours|Missing data|0|||
16843154|NCT01727505|37787400|FG001|Second 24 Hours|Missing data|1|||
16843155|NCT01726803|37787408|FG000|Overall Study|Lost to Follow-up|6|||
16843156|NCT01726803|37787409|FG001|Overall Study|Lost to Follow-up|1|||
16916596|NCT03370302|38048651|FG000|Dose Escalation Phase|Progressive Disease|2|||
16916597|NCT03370302|38048652|FG001|Dose Escalation Phase|Progressive Disease|4|||
16916598|NCT03370302|38048653|FG002|Dose Escalation Phase|Progressive Disease|2|||
16916599|NCT03370302|38048654|FG003|Dose Escalation Phase|Progressive Disease|0|||
16916600|NCT03370302|38048655|FG004|Dose Escalation Phase|Progressive Disease|3|||
16916601|NCT03370302|38048656|FG005|Dose Escalation Phase|Progressive Disease|1|||
16916602|NCT03370302|38048651|FG000|Dose Expansion Phase|Progressive Disease|0|||
16916603|NCT03370302|38048652|FG001|Dose Expansion Phase|Progressive Disease|0|||
16916604|NCT03370302|38048653|FG002|Dose Expansion Phase|Progressive Disease|0|||
16916605|NCT03370302|38048654|FG003|Dose Expansion Phase|Progressive Disease|6|||
16916606|NCT03370302|38048655|FG004|Dose Expansion Phase|Progressive Disease|0|||
16916607|NCT03370302|38048656|FG005|Dose Expansion Phase|Progressive Disease|0|||
16916608|NCT03327324|38048680|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916609|NCT03327324|38048681|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
16916610|NCT03327324|38048682|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916611|NCT03327324|38048683|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
16916612|NCT03327324|38048684|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916613|NCT03327324|38048685|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
16916614|NCT03327324|38048680|FG000|Baseline (Month 0-Month 3)|Refused|0|||
16916615|NCT03327324|38048681|FG001|Baseline (Month 0-Month 3)|Refused|0|||
16916616|NCT03327324|38048682|FG002|Baseline (Month 0-Month 3)|Refused|0|||
16916617|NCT03327324|38048683|FG003|Baseline (Month 0-Month 3)|Refused|0|||
16916618|NCT03327324|38048684|FG004|Baseline (Month 0-Month 3)|Refused|1|||
16916619|NCT03327324|38048685|FG005|Baseline (Month 0-Month 3)|Refused|0|||
16916620|NCT03327324|38048680|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16916621|NCT03327324|38048681|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
16916622|NCT03327324|38048682|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16916623|NCT03327324|38048683|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16916624|NCT03327324|38048684|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16916625|NCT03327324|38048685|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16916626|NCT03327324|38048680|FG000|Baseline (Month 0-Month 3)|Death|0|||
16916627|NCT03327324|38048681|FG001|Baseline (Month 0-Month 3)|Death|0|||
16916628|NCT03327324|38048682|FG002|Baseline (Month 0-Month 3)|Death|0|||
16916629|NCT03327324|38048683|FG003|Baseline (Month 0-Month 3)|Death|0|||
16916630|NCT03327324|38048684|FG004|Baseline (Month 0-Month 3)|Death|1|||
16916631|NCT03327324|38048685|FG005|Baseline (Month 0-Month 3)|Death|0|||
16916632|NCT03327324|38048680|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916633|NCT03327324|38048681|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916634|NCT03327324|38048682|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916635|NCT03327324|38048683|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916636|NCT03327324|38048684|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916637|NCT03327324|38048685|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
16916638|NCT03327324|38048680|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916639|NCT03327324|38048681|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916640|NCT03327324|38048682|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
16916641|NCT03327324|38048683|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916642|NCT03327324|38048684|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916643|NCT03327324|38048685|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916644|NCT03327324|38048680|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
16916645|NCT03327324|38048681|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
16916646|NCT03327324|38048682|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
16916647|NCT03327324|38048683|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
16916648|NCT03327324|38048684|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
16916649|NCT03327324|38048685|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
16916650|NCT03327324|38048680|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
16916651|NCT03327324|38048681|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16916652|NCT03327324|38048682|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16916653|NCT03327324|38048683|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16916654|NCT03327324|38048684|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16916655|NCT03327324|38048685|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16916656|NCT03327324|38048680|FG000|Intervention (Month 3-Month 6)|Death|1|||
16916657|NCT03327324|38048681|FG001|Intervention (Month 3-Month 6)|Death|0|||
16916658|NCT03327324|38048682|FG002|Intervention (Month 3-Month 6)|Death|1|||
16916659|NCT03327324|38048683|FG003|Intervention (Month 3-Month 6)|Death|1|||
17016935|NCT00883337|38161543|FG000|Extension Treatment Period|Adverse Event|8|||
17016936|NCT00883337|38161544|FG001|Extension Treatment Period|Adverse Event|5|||
16916660|NCT03327324|38048684|FG004|Intervention (Month 3-Month 6)|Death|1|||
16916661|NCT03327324|38048685|FG005|Intervention (Month 3-Month 6)|Death|0|||
16916662|NCT03327324|38048680|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916663|NCT03327324|38048681|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916664|NCT03327324|38048682|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916665|NCT03327324|38048683|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916666|NCT03327324|38048684|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916667|NCT03327324|38048685|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
16916668|NCT03327324|38048680|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
16916669|NCT03327324|38048681|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16843157|NCT01726803|37787408|FG000|Overall Study|Withdrawal by Subject|1|||
16843158|NCT01726803|37787409|FG001|Overall Study|Withdrawal by Subject|0|||
16843159|NCT01726335|37787415|FG000|Overall Study|Lost to Follow-up|2|||
16843160|NCT01726335|37787415|FG000|Overall Study|Withdrawal by Subject|15|||
16843161|NCT01726335|37787415|FG000|Overall Study|Adverse Event|4|||
16843162|NCT01726335|37787415|FG000|Overall Study|Lost to Follow-up|2|||
16843163|NCT01726335|37787415|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
16843164|NCT01877421|37787451|FG000|Phase 2|Lost to Follow-up|0|||
16843165|NCT01877421|37787452|FG001|Phase 2|Lost to Follow-up|0|||
16843166|NCT01877421|37787453|FG002|Phase 2|Lost to Follow-up|0|||
16843167|NCT01877421|37787454|FG003|Phase 2|Lost to Follow-up|0|||
16843168|NCT01877421|37787455|FG004|Phase 2|Lost to Follow-up|0|||
16843169|NCT01877421|37787456|FG005|Phase 2|Lost to Follow-up|0|||
16843170|NCT01877421|37787457|FG006|Phase 2|Lost to Follow-up|1|||
16843171|NCT01877421|37787458|FG007|Phase 2|Lost to Follow-up|0|||
16843172|NCT01877421|37787459|FG008|Phase 2|Lost to Follow-up|0|||
16843173|NCT01877421|37787460|FG009|Phase 2|Lost to Follow-up|0|||
16843174|NCT01877421|37787461|FG010|Phase 2|Lost to Follow-up|0|||
16843175|NCT01877421|37787462|FG011|Phase 2|Lost to Follow-up|0|||
16843176|NCT01877421|37787463|FG012|Phase 2|Lost to Follow-up|0|||
16843177|NCT01877421|37787464|FG013|Phase 2|Lost to Follow-up|0|||
16843178|NCT01877421|37787465|FG014|Phase 2|Lost to Follow-up|0|||
16843179|NCT01877421|37787466|FG015|Phase 2|Lost to Follow-up|0|||
16843180|NCT01877421|37787467|FG016|Phase 2|Lost to Follow-up|0|||
16843181|NCT01877421|37787468|FG017|Phase 2|Lost to Follow-up|0|||
16843182|NCT01877421|37787451|FG000|Phase 2|Withdrawal by Subject|0|||
16843183|NCT01877421|37787452|FG001|Phase 2|Withdrawal by Subject|0|||
16843184|NCT01877421|37787453|FG002|Phase 2|Withdrawal by Subject|0|||
16843185|NCT01877421|37787454|FG003|Phase 2|Withdrawal by Subject|0|||
16843186|NCT01877421|37787455|FG004|Phase 2|Withdrawal by Subject|0|||
16843187|NCT01877421|37787456|FG005|Phase 2|Withdrawal by Subject|0|||
16843188|NCT01877421|37787457|FG006|Phase 2|Withdrawal by Subject|0|||
16843189|NCT01877421|37787458|FG007|Phase 2|Withdrawal by Subject|0|||
16843190|NCT01877421|37787459|FG008|Phase 2|Withdrawal by Subject|1|||
16843191|NCT01877421|37787460|FG009|Phase 2|Withdrawal by Subject|0|||
16843192|NCT01877421|37787461|FG010|Phase 2|Withdrawal by Subject|1|||
16843193|NCT01877421|37787462|FG011|Phase 2|Withdrawal by Subject|0|||
16843194|NCT01877421|37787463|FG012|Phase 2|Withdrawal by Subject|1|||
16843195|NCT01877421|37787464|FG013|Phase 2|Withdrawal by Subject|0|||
16843196|NCT01877421|37787465|FG014|Phase 2|Withdrawal by Subject|0|||
16843197|NCT01877421|37787466|FG015|Phase 2|Withdrawal by Subject|1|||
16843198|NCT01877421|37787467|FG016|Phase 2|Withdrawal by Subject|0|||
16843199|NCT01877421|37787468|FG017|Phase 2|Withdrawal by Subject|0|||
16843200|NCT01877421|37787451|FG000|Phase 2|Protocol Violation|0|||
16843201|NCT01877421|37787452|FG001|Phase 2|Protocol Violation|0|||
16843202|NCT01877421|37787453|FG002|Phase 2|Protocol Violation|0|||
16843203|NCT01877421|37787454|FG003|Phase 2|Protocol Violation|0|||
16843204|NCT01877421|37787455|FG004|Phase 2|Protocol Violation|0|||
16843205|NCT01877421|37787456|FG005|Phase 2|Protocol Violation|0|||
16843206|NCT01877421|37787457|FG006|Phase 2|Protocol Violation|0|||
16843207|NCT01877421|37787458|FG007|Phase 2|Protocol Violation|0|||
16843208|NCT01877421|37787459|FG008|Phase 2|Protocol Violation|0|||
16843209|NCT01877421|37787460|FG009|Phase 2|Protocol Violation|0|||
16843210|NCT01877421|37787461|FG010|Phase 2|Protocol Violation|1|||
16843211|NCT01877421|37787462|FG011|Phase 2|Protocol Violation|0|||
16843212|NCT01877421|37787463|FG012|Phase 2|Protocol Violation|0|||
16843213|NCT01877421|37787464|FG013|Phase 2|Protocol Violation|0|||
16843214|NCT01877421|37787465|FG014|Phase 2|Protocol Violation|0|||
16843215|NCT01877421|37787466|FG015|Phase 2|Protocol Violation|0|||
16843216|NCT01877421|37787467|FG016|Phase 2|Protocol Violation|0|||
16843217|NCT01877421|37787468|FG017|Phase 2|Protocol Violation|0|||
16843218|NCT01726023|37787550|FG000|Overall Study|Death|1|||
16843219|NCT01726023|37787551|FG001|Overall Study|Death|1|||
16843220|NCT01726023|37787550|FG000|Overall Study|Lost to Follow-up|5|||
16843221|NCT01726023|37787551|FG001|Overall Study|Lost to Follow-up|10|||
16843222|NCT01726023|37787550|FG000|Overall Study|Other Eligibility criteria|7|||
16843223|NCT01726023|37787551|FG001|Overall Study|Other Eligibility criteria|7|||
16843224|NCT01726023|37787550|FG000|Overall Study|Withdrawal by Subject|16|||
16843225|NCT01726023|37787551|FG001|Overall Study|Withdrawal by Subject|8|||
16843226|NCT01877265|37787564|FG000|Treatment Period 1|Sponsor Decision|0|||
16916670|NCT03327324|38048682|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916671|NCT03327324|38048683|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916672|NCT03327324|38048684|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916673|NCT03327324|38048685|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16916674|NCT03327324|38048680|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
16916675|NCT03327324|38048681|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
16916676|NCT03327324|38048682|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
16916677|NCT03327324|38048683|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
16916678|NCT03327324|38048684|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
16916679|NCT03327324|38048685|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
16843227|NCT01877265|37787565|FG001|Treatment Period 1|Sponsor Decision|0|||
16843228|NCT01877265|37787566|FG002|Treatment Period 1|Sponsor Decision|1|||
16843229|NCT01877265|37787567|FG003|Treatment Period 1|Sponsor Decision|0|||
16843230|NCT01877265|37787568|FG004|Treatment Period 1|Sponsor Decision|0|||
16843231|NCT01877265|37787569|FG005|Treatment Period 1|Sponsor Decision|0|||
16843232|NCT01877265|37787564|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16843233|NCT01877265|37787565|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16843234|NCT01877265|37787566|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16843235|NCT01877265|37787567|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16843236|NCT01877265|37787568|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16843237|NCT01877265|37787569|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
16843238|NCT01877265|37787564|FG000|Treatment Period 3|Lost to Follow-up|1|||
16843239|NCT01877265|37787565|FG001|Treatment Period 3|Lost to Follow-up|0|||
16843240|NCT01877265|37787566|FG002|Treatment Period 3|Lost to Follow-up|0|||
16843241|NCT01877265|37787567|FG003|Treatment Period 3|Lost to Follow-up|0|||
16843242|NCT01877265|37787568|FG004|Treatment Period 3|Lost to Follow-up|0|||
16843243|NCT01877265|37787569|FG005|Treatment Period 3|Lost to Follow-up|0|||
16843244|NCT01877187|37787580|FG000|Overall Study|Death|2|||
16843245|NCT01877187|37787580|FG000|Overall Study|Withdrawal by Subject|4|||
16843246|NCT01877187|37787580|FG000|Overall Study|Lost to Follow-up|3|||
16843247|NCT01877187|37787580|FG000|Overall Study|Declining clinical status|11|||
16843248|NCT01877187|37787580|FG000|Overall Study|Liver transplant|2|||
16843249|NCT01858532|37787591|FG000|Overall Study|Adverse Event|58|||
16843250|NCT01858532|37787592|FG001|Overall Study|Adverse Event|50|||
16843251|NCT01858532|37787593|FG002|Overall Study|Adverse Event|23|||
16843252|NCT01858532|37787594|FG003|Overall Study|Adverse Event|28|||
16843253|NCT01858532|37787591|FG000|Overall Study|Withdrew consent|71|||
16843254|NCT01858532|37787592|FG001|Overall Study|Withdrew consent|93|||
16843255|NCT01858532|37787593|FG002|Overall Study|Withdrew consent|46|||
16843256|NCT01858532|37787594|FG003|Overall Study|Withdrew consent|27|||
16843257|NCT01858532|37787591|FG000|Overall Study|Lost to Follow-up|17|||
16843258|NCT01858532|37787592|FG001|Overall Study|Lost to Follow-up|26|||
16843259|NCT01858532|37787593|FG002|Overall Study|Lost to Follow-up|11|||
16843260|NCT01858532|37787594|FG003|Overall Study|Lost to Follow-up|14|||
16843261|NCT01858532|37787591|FG000|Overall Study|Deterioration of medical status|3|||
16843262|NCT01858532|37787592|FG001|Overall Study|Deterioration of medical status|4|||
16843263|NCT01858532|37787593|FG002|Overall Study|Deterioration of medical status|3|||
16843264|NCT01858532|37787594|FG003|Overall Study|Deterioration of medical status|7|||
16843265|NCT01858532|37787591|FG000|Overall Study|Investigator request|3|||
16843266|NCT01858532|37787592|FG001|Overall Study|Investigator request|4|||
16843267|NCT01858532|37787593|FG002|Overall Study|Investigator request|2|||
16843268|NCT01858532|37787594|FG003|Overall Study|Investigator request|6|||
16843269|NCT01858532|37787591|FG000|Overall Study|Other, not specified|29|||
16843270|NCT01858532|37787592|FG001|Overall Study|Other, not specified|15|||
16843271|NCT01858532|37787593|FG002|Overall Study|Other, not specified|13|||
16843272|NCT01858532|37787594|FG003|Overall Study|Other, not specified|11|||
16843273|NCT01883492|37787606|FG000|Overall Study|Lost to Follow-up|3|||
16843274|NCT01883492|37787607|FG001|Overall Study|Lost to Follow-up|4|||
16843275|NCT01883492|37787606|FG000|Overall Study|Surgery on contra-lateral hip|0|||
16843276|NCT01883492|37787607|FG001|Overall Study|Surgery on contra-lateral hip|1|||
16843277|NCT01883492|37787606|FG000|Overall Study|Poor X-ray quality|7|||
16843278|NCT01883492|37787607|FG001|Overall Study|Poor X-ray quality|4|||
16843279|NCT01883492|37787606|FG000|Overall Study|Withdrawal by Subject|1|||
16843280|NCT01883492|37787607|FG001|Overall Study|Withdrawal by Subject|0|||
16843281|NCT01883492|37787606|FG000|Overall Study|inappropriate implant used|1|||
16843282|NCT01883492|37787607|FG001|Overall Study|inappropriate implant used|1|||
16843283|NCT01883492|37787606|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
16843284|NCT01883492|37787607|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
16843285|NCT01832480|37787615|FG000|Overall Study|Lost to Follow-up|33|||
16843286|NCT01832480|37787616|FG001|Overall Study|Lost to Follow-up|30|||
16843287|NCT01832480|37787615|FG000|Overall Study|Withdrawal by Subject|0|||
16843288|NCT01832480|37787616|FG001|Overall Study|Withdrawal by Subject|2|||
16843289|NCT01832480|37787615|FG000|Overall Study|post randomization ineligible|8|||
16843290|NCT01832480|37787616|FG001|Overall Study|post randomization ineligible|10|||
16843291|NCT01858376|37787622|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
16843292|NCT01831856|37787628|FG000|Overall Study|Adverse Event|5|||
16843293|NCT01831856|37787629|FG001|Overall Study|Adverse Event|8|||
16843294|NCT01831856|37787628|FG000|Overall Study|Lack of Efficacy|13|||
16843295|NCT01831856|37787629|FG001|Overall Study|Lack of Efficacy|11|||
16843296|NCT01831856|37787628|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
16843297|NCT01831856|37787629|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
16843298|NCT01831544|37787635|FG000|Overall Study|Death|1|||
16843299|NCT01831544|37787635|FG000|Overall Study|Still on original MVAD device|2|||
16843300|NCT01857206|37787641|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
16843301|NCT01857206|37787642|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
16843302|NCT01857206|37787641|FG000|Overall Study|Lost to Follow-up|9|||
16843303|NCT01857206|37787642|FG001|Overall Study|Lost to Follow-up|6|||
16843304|NCT01857206|37787641|FG000|Overall Study|Unclassified|3|||
16843305|NCT01857206|37787642|FG001|Overall Study|Unclassified|3|||
16843306|NCT01857206|37787641|FG000|Overall Study|Withdrawal by Subject|1|||
16843307|NCT01857206|37787642|FG001|Overall Study|Withdrawal by Subject|0|||
16843308|NCT01882088|37787652|FG000|Overall Study|Intolerance of esophageal manometry|1|||
16843309|NCT01882088|37787652|FG000|Overall Study|no possibility to place the catheter|1|||
16843310|NCT01882088|37787652|FG000|Overall Study|Protocol Violation|1|||
16843311|NCT01882088|37787652|FG000|Overall Study|inadequate pH-impedance tracings|2|||
16843312|NCT01881776|37787659|FG000|Overall Study|Lost to Follow-up|1|||
16843313|NCT01881776|37787660|FG001|Overall Study|Lost to Follow-up|2|||
16843314|NCT01881776|37787661|FG002|Overall Study|Lost to Follow-up|1|||
16843315|NCT01881776|37787659|FG000|Overall Study|Protocol Violation|0|||
16843316|NCT01881776|37787660|FG001|Overall Study|Protocol Violation|2|||
16843317|NCT01881776|37787661|FG002|Overall Study|Protocol Violation|1|||
17016937|NCT00883337|38161545|FG002|Extension Treatment Period|Adverse Event|5|||
17016938|NCT00883337|38161543|FG000|Extension Treatment Period|Lack of Efficacy|8|||
17016939|NCT00883337|38161544|FG001|Extension Treatment Period|Lack of Efficacy|8|||
17016940|NCT00883337|38161545|FG002|Extension Treatment Period|Lack of Efficacy|8|||
17016941|NCT00883337|38161543|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
17016942|NCT00883337|38161544|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
17016943|NCT00883337|38161545|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
17016944|NCT00883337|38161543|FG000|Extension Treatment Period|Lost to Follow-up|1|||
17016945|NCT00883337|38161544|FG001|Extension Treatment Period|Lost to Follow-up|0|||
17016946|NCT00883337|38161545|FG002|Extension Treatment Period|Lost to Follow-up|0|||
17016947|NCT00883337|38161543|FG000|Extension Treatment Period|Other than above|10|||
17016948|NCT00883337|38161544|FG001|Extension Treatment Period|Other than above|9|||
17016949|NCT00883337|38161545|FG002|Extension Treatment Period|Other than above|5|||
17016950|NCT00838110|38161561|FG000|Overall Study|Death|0|||
17016951|NCT00838110|38161562|FG001|Overall Study|Death|0|||
17016952|NCT00838110|38161563|FG002|Overall Study|Death|1|||
17016953|NCT00838110|38161564|FG003|Overall Study|Death|2|||
17016954|NCT00838110|38161561|FG000|Overall Study|Adverse Event|11|||
17016955|NCT00838110|38161562|FG001|Overall Study|Adverse Event|10|||
17016956|NCT00838110|38161563|FG002|Overall Study|Adverse Event|8|||
17016957|NCT00838110|38161564|FG003|Overall Study|Adverse Event|7|||
17016958|NCT00838110|38161561|FG000|Overall Study|Withdrawal by Subject|5|||
17016959|NCT00838110|38161562|FG001|Overall Study|Withdrawal by Subject|6|||
17016960|NCT00838110|38161563|FG002|Overall Study|Withdrawal by Subject|3|||
17016961|NCT00838110|38161564|FG003|Overall Study|Withdrawal by Subject|4|||
17016962|NCT00838110|38161561|FG000|Overall Study|Other|3|||
17016963|NCT00838110|38161562|FG001|Overall Study|Other|3|||
17016964|NCT00838110|38161563|FG002|Overall Study|Other|3|||
17016965|NCT00838110|38161564|FG003|Overall Study|Other|2|||
17016966|NCT00838110|38161561|FG000|Overall Study|Protocol Violation|0|||
17016967|NCT00838110|38161562|FG001|Overall Study|Protocol Violation|2|||
16843350|NCT01708161|37787692|FG000|Overall Study|Adverse Event|1|||
16843351|NCT01708161|37787693|FG001|Overall Study|Adverse Event|3|||
16916680|NCT03327324|38048680|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
16916681|NCT03327324|38048681|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
16916682|NCT03327324|38048682|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
16843352|NCT01708161|37787694|FG002|Overall Study|Adverse Event|4|||
16843353|NCT01708161|37787695|FG003|Overall Study|Adverse Event|2|||
16843354|NCT01708161|37787696|FG004|Overall Study|Adverse Event|3|||
16843355|NCT01708161|37787697|FG005|Overall Study|Adverse Event|0|||
16916683|NCT03327324|38048683|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
16916684|NCT03327324|38048684|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
16916685|NCT03327324|38048685|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
16916686|NCT03327324|38048680|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916687|NCT03327324|38048681|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916688|NCT03327324|38048682|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916689|NCT03327324|38048683|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
16916690|NCT03327324|38048684|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
16916691|NCT03327324|38048685|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16916692|NCT03327324|38048680|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
16916693|NCT03327324|38048681|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16916694|NCT03327324|38048682|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16916695|NCT03327324|38048683|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16916696|NCT03327324|38048684|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16916697|NCT03327324|38048685|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16916698|NCT03327324|38048680|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
16916699|NCT03327324|38048681|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16916700|NCT03327324|38048682|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16916701|NCT03327324|38048683|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16916702|NCT03327324|38048684|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16916703|NCT03327324|38048685|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16916704|NCT03252522|38048691|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
16916705|NCT03252522|38048692|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
16916706|NCT03252522|38048693|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
16916707|NCT03252522|38048691|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
16916708|NCT03252522|38048692|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
16916709|NCT03252522|38048693|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
16916710|NCT03252522|38048691|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
16916711|NCT03252522|38048692|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
16916712|NCT03252522|38048693|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
16916713|NCT03252522|38048691|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
16916714|NCT03252522|38048692|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
16916715|NCT03252522|38048693|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
16916716|NCT03252522|38048691|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
16916717|NCT03252522|38048692|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
16916718|NCT03252522|38048693|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
16916719|NCT03252522|38048691|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
16916720|NCT03252522|38048692|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
16916721|NCT03252522|38048693|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
16916722|NCT03252522|38048691|FG000|Phase 2: Open Label|Adverse Event|0|||
16843356|NCT01708161|37787692|FG000|Overall Study|Death|0|||
16843357|NCT01708161|37787693|FG001|Overall Study|Death|0|||
16843358|NCT01708161|37787694|FG002|Overall Study|Death|0|||
16843359|NCT01708161|37787695|FG003|Overall Study|Death|1|||
16843360|NCT01708161|37787696|FG004|Overall Study|Death|0|||
16843361|NCT01708161|37787697|FG005|Overall Study|Death|1|||
16843362|NCT01708161|37787692|FG000|Overall Study|Withdrawal by Subject|0|||
16843363|NCT01708161|37787693|FG001|Overall Study|Withdrawal by Subject|1|||
16843364|NCT01708161|37787694|FG002|Overall Study|Withdrawal by Subject|1|||
16843365|NCT01708161|37787695|FG003|Overall Study|Withdrawal by Subject|0|||
16843366|NCT01708161|37787696|FG004|Overall Study|Withdrawal by Subject|0|||
16843367|NCT01708161|37787697|FG005|Overall Study|Withdrawal by Subject|0|||
16843368|NCT01708161|37787692|FG000|Overall Study|Administrative problems|0|||
16843369|NCT01708161|37787693|FG001|Overall Study|Administrative problems|1|||
16843370|NCT01708161|37787694|FG002|Overall Study|Administrative problems|0|||
16843371|NCT01708161|37787695|FG003|Overall Study|Administrative problems|0|||
16843372|NCT01708161|37787696|FG004|Overall Study|Administrative problems|0|||
16843373|NCT01708161|37787697|FG005|Overall Study|Administrative problems|0|||
16843374|NCT01708161|37787692|FG000|Overall Study|Disease progression|3|||
16843375|NCT01708161|37787693|FG001|Overall Study|Disease progression|5|||
16843376|NCT01708161|37787694|FG002|Overall Study|Disease progression|5|||
16843377|NCT01708161|37787695|FG003|Overall Study|Disease progression|13|||
16843378|NCT01708161|37787696|FG004|Overall Study|Disease progression|3|||
16843379|NCT01708161|37787697|FG005|Overall Study|Disease progression|0|||
16843380|NCT01707693|37787713|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
16843381|NCT01707693|37787714|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
16843382|NCT01707693|37787713|FG000|Overall Study Allocation|Protocol Violation|4|||
16843383|NCT01707693|37787714|FG001|Overall Study Allocation|Protocol Violation|3|||
16843384|NCT01707693|37787713|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
16843385|NCT01707693|37787714|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
16843386|NCT01707693|37787713|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
16843387|NCT01707693|37787714|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
16843388|NCT01722669|37787727|FG000|Overall Study|Withdrawal by Subject|0|||
16843389|NCT01722669|37787728|FG001|Overall Study|Withdrawal by Subject|0|||
16843390|NCT01722669|37787729|FG002|Overall Study|Withdrawal by Subject|0|||
16843391|NCT01722669|37787730|FG003|Overall Study|Withdrawal by Subject|0|||
16843392|NCT01722669|37787731|FG004|Overall Study|Withdrawal by Subject|0|||
16843393|NCT01722669|37787732|FG005|Overall Study|Withdrawal by Subject|2|||
16843394|NCT01707147|37787752|FG000|Overall Study|Administered Trajenta prior to contract|5|||
16843395|NCT01707147|37787752|FG000|Overall Study|Patients who have not taken Trajenta|1|||
16843396|NCT01707147|37787752|FG000|Overall Study|Follow-up failure|17|||
16843397|NCT01707147|37787752|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
16843398|NCT01876251|37787759|FG000|Overall Study|Clinical progression|1|||
16843399|NCT01876251|37787760|FG001|Overall Study|Clinical progression|0|||
16843400|NCT01876251|37787761|FG002|Overall Study|Clinical progression|0|||
16843401|NCT01876251|37787759|FG000|Overall Study|Death|2|||
16843402|NCT01876251|37787760|FG001|Overall Study|Death|0|||
16843403|NCT01876251|37787761|FG002|Overall Study|Death|1|||
16843404|NCT01876251|37787759|FG000|Overall Study|Participant started new treatment|1|||
16843405|NCT01876251|37787760|FG001|Overall Study|Participant started new treatment|0|||
16843406|NCT01876251|37787761|FG002|Overall Study|Participant started new treatment|1|||
16843407|NCT01876251|37787759|FG000|Overall Study|Participant refused further follow-up|0|||
16843408|NCT01876251|37787760|FG001|Overall Study|Participant refused further follow-up|0|||
16843409|NCT01876251|37787761|FG002|Overall Study|Participant refused further follow-up|1|||
16843410|NCT01876251|37787759|FG000|Overall Study|Study terminated|1|||
16843411|NCT01876251|37787760|FG001|Overall Study|Study terminated|0|||
16843412|NCT01876251|37787761|FG002|Overall Study|Study terminated|0|||
16843413|NCT01876251|37787759|FG000|Overall Study|Objective progression or relapse|10|||
16843414|NCT01876251|37787760|FG001|Overall Study|Objective progression or relapse|3|||
16843415|NCT01876251|37787761|FG002|Overall Study|Objective progression or relapse|8|||
16843416|NCT01875471|37787772|FG000|Overall Study|Adverse Event|0|||
16843417|NCT01875471|37787773|FG001|Overall Study|Adverse Event|1|||
16916723|NCT03252522|38048692|FG001|Phase 2: Open Label|Adverse Event|0|||
16916724|NCT03252522|38048693|FG002|Phase 2: Open Label|Adverse Event|2|||
16916725|NCT03252522|38048691|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
16916726|NCT03252522|38048692|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
16916727|NCT03252522|38048693|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
16916728|NCT02828358|38048707|FG000|Overall Study|Physician Decision|7|||
16916729|NCT02828358|38048708|FG001|Overall Study|Physician Decision|1|||
16916730|NCT02828358|38048707|FG000|Overall Study|Treatment Failure|6|||
16916731|NCT02828358|38048708|FG001|Overall Study|Treatment Failure|0|||
16916732|NCT02828358|38048707|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
16916733|NCT02828358|38048708|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
16916734|NCT02828358|38048707|FG000|Overall Study|Refusal of further protocol therapy|2|||
16916735|NCT02828358|38048708|FG001|Overall Study|Refusal of further protocol therapy|0|||
16916736|NCT02828358|38048707|FG000|Overall Study|Relapse|25|||
16916737|NCT02828358|38048708|FG001|Overall Study|Relapse|0|||
16916738|NCT02828358|38048707|FG000|Overall Study|Still on therapy|5|||
16916739|NCT02828358|38048708|FG001|Overall Study|Still on therapy|0|||
16916740|NCT02756364|38048716|FG000|Overall Study|Site Terminated by Sponsor|24|||
16916741|NCT02756364|38048717|FG001|Overall Study|Site Terminated by Sponsor|30|||
16916742|NCT02756364|38048718|FG002|Overall Study|Site Terminated by Sponsor|21|||
16916743|NCT02756364|38048716|FG000|Overall Study|Death|20|||
16916744|NCT02756364|38048717|FG001|Overall Study|Death|15|||
16916745|NCT02756364|38048718|FG002|Overall Study|Death|18|||
17016968|NCT00838110|38161563|FG002|Overall Study|Protocol Violation|1|||
16843418|NCT01875471|37787772|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
16843419|NCT01875471|37787773|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
16843420|NCT01875237|37787781|FG000|Overall Study|GVDH before DLI|1|||
16843421|NCT01875237|37787782|FG001|Overall Study|GVDH before DLI|0|||
16843422|NCT01875237|37787781|FG000|Overall Study|DLI cells could not be produced|1|||
16843423|NCT01875237|37787782|FG001|Overall Study|DLI cells could not be produced|0|||
16843424|NCT01874535|37787792|FG000|Overall Study|Lost to Follow-up|10|||
16843425|NCT01874535|37787793|FG001|Overall Study|Lost to Follow-up|9|||
16843426|NCT01874535|37787792|FG000|Overall Study|incomplete symptom resolution|45|||
16843427|NCT01874535|37787793|FG001|Overall Study|incomplete symptom resolution|35|||
16843428|NCT01722045|37787799|FG000|Overall Study|Adverse Event|8|||
16843429|NCT01722045|37787799|FG000|Overall Study|Death|3|||
16843430|NCT01722045|37787799|FG000|Overall Study|Withdrawal by Subject|8|||
16916746|NCT02756364|38048716|FG000|Overall Study|Withdrawal by Patient|2|||
16916747|NCT02756364|38048717|FG001|Overall Study|Withdrawal by Patient|1|||
16916748|NCT02756364|38048718|FG002|Overall Study|Withdrawal by Patient|8|||
16916749|NCT02756364|38048716|FG000|Overall Study|Lost to Follow-up|0|||
16916750|NCT02756364|38048717|FG001|Overall Study|Lost to Follow-up|1|||
16843431|NCT01722045|37787799|FG000|Overall Study|Lost to Follow-up|4|||
16843432|NCT01722045|37787799|FG000|Overall Study|Protocol Deviation|1|||
16843433|NCT01722045|37787799|FG000|Overall Study|Physician Decision|3|||
16843434|NCT01722045|37787799|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
16843435|NCT01721109|37787803|FG000|Overall Study|Lack of Efficacy|1|||
16843436|NCT01721109|37787803|FG000|Overall Study|Non- Compliance with Study Drug|3|||
16843437|NCT01721109|37787803|FG000|Overall Study|Withdrew Consent|1|||
16843438|NCT01721109|37787803|FG000|Overall Study|Lost to Follow-up|2|||
16843439|NCT01874145|37787809|FG000|Core Period|Non-compliance|1|||
16843440|NCT01874145|37787810|FG001|Core Period|Non-compliance|0|||
16843441|NCT01874145|37787809|FG000|Core Period|Protocol Violation|1|||
16843442|NCT01874145|37787810|FG001|Core Period|Protocol Violation|1|||
16843443|NCT01874145|37787809|FG000|Core Period|Physician Decision|1|||
16843444|NCT01874145|37787810|FG001|Core Period|Physician Decision|1|||
16843445|NCT01874145|37787809|FG000|Core Period|Adverse Event|0|||
16843446|NCT01874145|37787810|FG001|Core Period|Adverse Event|1|||
16843447|NCT01874145|37787809|FG000|Core Period|Withdrawal by Subject|0|||
16843448|NCT01874145|37787810|FG001|Core Period|Withdrawal by Subject|4|||
16843449|NCT01874145|37787809|FG000|Extension Period|Adverse Event|3|||
16843450|NCT01874145|37787810|FG001|Extension Period|Adverse Event|2|||
16843451|NCT01874145|37787809|FG000|Extension Period|Withdrawal by Subject|2|||
16843452|NCT01874145|37787810|FG001|Extension Period|Withdrawal by Subject|1|||
16843453|NCT01874145|37787809|FG000|Extension Period|Lost to Follow-up|1|||
16843454|NCT01874145|37787810|FG001|Extension Period|Lost to Follow-up|1|||
16843455|NCT01720797|37787822|FG000|Overall Study|Withdrawal by Subject|3|||
16843456|NCT01720797|37787823|FG001|Overall Study|Withdrawal by Subject|0|||
16843457|NCT01831466|37787841|FG000|Overall Study|Protocol Violation|1|||
16843458|NCT01831466|37787842|FG001|Overall Study|Protocol Violation|1|||
16843459|NCT01831466|37787843|FG002|Overall Study|Protocol Violation|2|||
16843460|NCT01831466|37787844|FG003|Overall Study|Protocol Violation|0|||
16843461|NCT01831466|37787845|FG004|Overall Study|Protocol Violation|0|||
16843462|NCT01831466|37787846|FG005|Overall Study|Protocol Violation|1|||
16843463|NCT01831466|37787847|FG006|Overall Study|Protocol Violation|0|||
16843464|NCT01831466|37787848|FG007|Overall Study|Protocol Violation|0|||
16843465|NCT01831466|37787849|FG008|Overall Study|Protocol Violation|0|||
16843466|NCT01831466|37787850|FG009|Overall Study|Protocol Violation|0|||
16843467|NCT01831466|37787851|FG010|Overall Study|Protocol Violation|0|||
16843468|NCT01831466|37787852|FG011|Overall Study|Protocol Violation|0|||
16843469|NCT01831466|37787841|FG000|Overall Study|Other|2|||
16843470|NCT01831466|37787842|FG001|Overall Study|Other|3|||
16843471|NCT01831466|37787843|FG002|Overall Study|Other|2|||
16843472|NCT01831466|37787844|FG003|Overall Study|Other|2|||
16843473|NCT01831466|37787845|FG004|Overall Study|Other|2|||
16843474|NCT01831466|37787846|FG005|Overall Study|Other|1|||
16843475|NCT01831466|37787847|FG006|Overall Study|Other|0|||
16843476|NCT01831466|37787848|FG007|Overall Study|Other|0|||
16843477|NCT01831466|37787849|FG008|Overall Study|Other|0|||
16843478|NCT01831466|37787850|FG009|Overall Study|Other|0|||
16916751|NCT02756364|38048718|FG002|Overall Study|Lost to Follow-up|1|||
16916752|NCT02272842|38048728|FG000|Overall Study|Lost to Follow-up|8|||
16916753|NCT02272842|38048729|FG001|Overall Study|Lost to Follow-up|8|||
16916754|NCT02272842|38048728|FG000|Overall Study|Withdrawal by Subject|8|||
16916755|NCT02272842|38048729|FG001|Overall Study|Withdrawal by Subject|2|||
16916756|NCT01906476|38048738|FG000|Overall Study|Lost to Follow-up|17|||
16916757|NCT01906476|38048739|FG001|Overall Study|Lost to Follow-up|16|||
16916758|NCT05343624|38048745|FG000|Overall Study|Chart review not completed|1|||
16916759|NCT04208412|38048787|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
16916760|NCT04208412|38048788|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
16843479|NCT01831466|37787851|FG010|Overall Study|Other|0|||
16843480|NCT01831466|37787852|FG011|Overall Study|Other|0|||
16843481|NCT01831466|37787841|FG000|Overall Study|Non-compliance with study treatment|2|||
16843482|NCT01831466|37787842|FG001|Overall Study|Non-compliance with study treatment|1|||
16843483|NCT01831466|37787843|FG002|Overall Study|Non-compliance with study treatment|1|||
16843484|NCT01831466|37787844|FG003|Overall Study|Non-compliance with study treatment|0|||
16843485|NCT01831466|37787845|FG004|Overall Study|Non-compliance with study treatment|0|||
16843486|NCT01831466|37787846|FG005|Overall Study|Non-compliance with study treatment|1|||
16843487|NCT01831466|37787847|FG006|Overall Study|Non-compliance with study treatment|0|||
16843488|NCT01831466|37787848|FG007|Overall Study|Non-compliance with study treatment|0|||
16843489|NCT01831466|37787849|FG008|Overall Study|Non-compliance with study treatment|0|||
16843490|NCT01831466|37787850|FG009|Overall Study|Non-compliance with study treatment|0|||
16843491|NCT01831466|37787851|FG010|Overall Study|Non-compliance with study treatment|0|||
16843492|NCT01831466|37787852|FG011|Overall Study|Non-compliance with study treatment|0|||
16843493|NCT01831466|37787841|FG000|Overall Study|Death|0|||
16843494|NCT01831466|37787842|FG001|Overall Study|Death|1|||
16843495|NCT01831466|37787843|FG002|Overall Study|Death|0|||
16843496|NCT01831466|37787844|FG003|Overall Study|Death|0|||
16843497|NCT01831466|37787845|FG004|Overall Study|Death|0|||
16843498|NCT01831466|37787846|FG005|Overall Study|Death|0|||
16843499|NCT01831466|37787847|FG006|Overall Study|Death|0|||
16843500|NCT01831466|37787848|FG007|Overall Study|Death|0|||
16843501|NCT01831466|37787849|FG008|Overall Study|Death|0|||
16843502|NCT01831466|37787850|FG009|Overall Study|Death|0|||
16843503|NCT01831466|37787851|FG010|Overall Study|Death|0|||
16843504|NCT01831466|37787852|FG011|Overall Study|Death|0|||
16843505|NCT01831466|37787841|FG000|Overall Study|Withdrawal by Subject|6|||
16843506|NCT01831466|37787842|FG001|Overall Study|Withdrawal by Subject|3|||
16843507|NCT01831466|37787843|FG002|Overall Study|Withdrawal by Subject|3|||
16843508|NCT01831466|37787844|FG003|Overall Study|Withdrawal by Subject|3|||
16843509|NCT01831466|37787845|FG004|Overall Study|Withdrawal by Subject|3|||
16843510|NCT01831466|37787846|FG005|Overall Study|Withdrawal by Subject|5|||
16843511|NCT01831466|37787847|FG006|Overall Study|Withdrawal by Subject|0|||
16843512|NCT01831466|37787848|FG007|Overall Study|Withdrawal by Subject|0|||
16843513|NCT01831466|37787849|FG008|Overall Study|Withdrawal by Subject|0|||
16843514|NCT01831466|37787850|FG009|Overall Study|Withdrawal by Subject|1|||
16843515|NCT01831466|37787851|FG010|Overall Study|Withdrawal by Subject|0|||
16843516|NCT01831466|37787852|FG011|Overall Study|Withdrawal by Subject|1|||
16843517|NCT01831466|37787841|FG000|Overall Study|Lost to Follow-up|0|||
16843518|NCT01831466|37787842|FG001|Overall Study|Lost to Follow-up|1|||
16843519|NCT01831466|37787843|FG002|Overall Study|Lost to Follow-up|4|||
16843520|NCT01831466|37787844|FG003|Overall Study|Lost to Follow-up|2|||
16843521|NCT01831466|37787845|FG004|Overall Study|Lost to Follow-up|0|||
16843522|NCT01831466|37787846|FG005|Overall Study|Lost to Follow-up|3|||
16843523|NCT01831466|37787847|FG006|Overall Study|Lost to Follow-up|0|||
16843524|NCT01831466|37787848|FG007|Overall Study|Lost to Follow-up|0|||
16843525|NCT01831466|37787849|FG008|Overall Study|Lost to Follow-up|0|||
16843526|NCT01831466|37787850|FG009|Overall Study|Lost to Follow-up|1|||
16843527|NCT01831466|37787851|FG010|Overall Study|Lost to Follow-up|0|||
16843528|NCT01831466|37787852|FG011|Overall Study|Lost to Follow-up|1|||
16843529|NCT01831466|37787841|FG000|Overall Study|Lack of Efficacy|5|||
16843530|NCT01831466|37787842|FG001|Overall Study|Lack of Efficacy|8|||
16843531|NCT01831466|37787843|FG002|Overall Study|Lack of Efficacy|7|||
16843532|NCT01831466|37787844|FG003|Overall Study|Lack of Efficacy|6|||
16843533|NCT01831466|37787845|FG004|Overall Study|Lack of Efficacy|9|||
16843534|NCT01831466|37787846|FG005|Overall Study|Lack of Efficacy|8|||
16843535|NCT01831466|37787847|FG006|Overall Study|Lack of Efficacy|1|||
16843536|NCT01831466|37787848|FG007|Overall Study|Lack of Efficacy|1|||
16843537|NCT01831466|37787849|FG008|Overall Study|Lack of Efficacy|2|||
16843538|NCT01831466|37787850|FG009|Overall Study|Lack of Efficacy|2|||
16843539|NCT01831466|37787851|FG010|Overall Study|Lack of Efficacy|2|||
16843540|NCT01831466|37787852|FG011|Overall Study|Lack of Efficacy|0|||
16843541|NCT01831466|37787841|FG000|Overall Study|Adverse Event|0|||
16843542|NCT01831466|37787842|FG001|Overall Study|Adverse Event|0|||
16843543|NCT01831466|37787843|FG002|Overall Study|Adverse Event|4|||
16843544|NCT01831466|37787844|FG003|Overall Study|Adverse Event|6|||
16843545|NCT01831466|37787845|FG004|Overall Study|Adverse Event|3|||
16843546|NCT01831466|37787846|FG005|Overall Study|Adverse Event|7|||
16843547|NCT01831466|37787847|FG006|Overall Study|Adverse Event|0|||
16843548|NCT01831466|37787848|FG007|Overall Study|Adverse Event|1|||
16843549|NCT01831466|37787849|FG008|Overall Study|Adverse Event|1|||
16843550|NCT01831466|37787850|FG009|Overall Study|Adverse Event|1|||
16843551|NCT01831466|37787851|FG010|Overall Study|Adverse Event|0|||
16843552|NCT01831466|37787852|FG011|Overall Study|Adverse Event|2|||
16843553|NCT01881620|37787872|FG000|Overall Study|Protocol Violation|4|||
16843554|NCT01830920|37787881|FG000|Overall Study|Adverse Event|1|||
16843555|NCT01830920|37787882|FG001|Overall Study|Adverse Event|0|||
16843556|NCT01830920|37787883|FG002|Overall Study|Adverse Event|1|||
16843557|NCT01830920|37787884|FG003|Overall Study|Adverse Event|0|||
16843558|NCT01830920|37787885|FG004|Overall Study|Adverse Event|0|||
16916761|NCT04208412|38048787|FG000|Overall Study|Withdrawal by Subject|1|||
16916762|NCT04208412|38048788|FG001|Overall Study|Withdrawal by Subject|0|||
16916763|NCT04208412|38048787|FG000|Overall Study|Lost to Follow-up|0|||
16916764|NCT04208412|38048788|FG001|Overall Study|Lost to Follow-up|1|||
16916765|NCT04095858|38048798|FG000|Overall Study|Death|1|||
16916766|NCT04095858|38048799|FG001|Overall Study|Death|0|||
16843559|NCT01830920|37787881|FG000|Overall Study|Withdrawal by Subject|2|||
16843560|NCT01830920|37787882|FG001|Overall Study|Withdrawal by Subject|2|||
16843561|NCT01830920|37787883|FG002|Overall Study|Withdrawal by Subject|1|||
16843562|NCT01830920|37787884|FG003|Overall Study|Withdrawal by Subject|7|||
16843563|NCT01830920|37787885|FG004|Overall Study|Withdrawal by Subject|1|||
16843564|NCT01830920|37787881|FG000|Overall Study|Death|3|||
16843565|NCT01830920|37787882|FG001|Overall Study|Death|3|||
16843566|NCT01830920|37787883|FG002|Overall Study|Death|5|||
16843567|NCT01830920|37787884|FG003|Overall Study|Death|4|||
16843568|NCT01830920|37787885|FG004|Overall Study|Death|4|||
16843569|NCT01830920|37787881|FG000|Overall Study|Other|15|||
16843570|NCT01830920|37787882|FG001|Overall Study|Other|1|||
16916767|NCT04095858|38048798|FG000|Overall Study|Study terminated by Sponsor|2|||
16916768|NCT04095858|38048799|FG001|Overall Study|Study terminated by Sponsor|4|||
16916769|NCT03937986|38048805|FG000|Overall Study|COVID-19 Pandemic|1|||
16916770|NCT03738150|38048820|FG000|Base Study|Withdrawal by Subject|1|||
16916771|NCT03738150|38048820|FG000|Extension Study|Withdrawal by Subject|1|||
16916772|NCT03567174|38048836|FG000|Overall Study|Death|24|||
16916773|NCT03567174|38048837|FG001|Overall Study|Death|31|||
16916774|NCT03567174|38048836|FG000|Overall Study|Lost to Follow-up|165|||
16916775|NCT03567174|38048837|FG001|Overall Study|Lost to Follow-up|174|||
16916776|NCT03529110|38048848|FG000|Overall Study|Progressive Disease|66|||
16916777|NCT03529110|38048849|FG001|Overall Study|Progressive Disease|158|||
16916778|NCT03529110|38048848|FG000|Overall Study|Clinical Progression|4|||
16916779|NCT03529110|38048849|FG001|Overall Study|Clinical Progression|12|||
16916780|NCT03529110|38048848|FG000|Overall Study|Adverse Event|35|||
16916781|NCT03529110|38048849|FG001|Overall Study|Adverse Event|17|||
16916782|NCT03529110|38048848|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
16916783|NCT03529110|38048849|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
16916784|NCT03529110|38048848|FG000|Overall Study|Lack of Efficacy|3|||
16916785|NCT03529110|38048849|FG001|Overall Study|Lack of Efficacy|3|||
16916786|NCT03529110|38048848|FG000|Overall Study|Physician Decision|2|||
16916787|NCT03529110|38048849|FG001|Overall Study|Physician Decision|8|||
16916788|NCT03529110|38048848|FG000|Overall Study|Miscellaneous|2|||
16843571|NCT01830920|37787883|FG002|Overall Study|Other|1|||
16843572|NCT01830920|37787884|FG003|Overall Study|Other|5|||
16843573|NCT01830920|37787885|FG004|Overall Study|Other|3|||
16843574|NCT01881230|37787900|FG000|Overall Study|Death|2|||
16843575|NCT01881230|37787901|FG001|Overall Study|Death|0|||
16843576|NCT01881230|37787902|FG002|Overall Study|Death|1|||
16843577|NCT01881230|37787900|FG000|Overall Study|Adverse Event|9|||
16916789|NCT03529110|38048849|FG001|Overall Study|Miscellaneous|5|||
16916790|NCT03317496|38048867|FG000|Phase 1b Lead-in: Treatment|Adverse Event|2|||
16916791|NCT03317496|38048868|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
16916792|NCT03317496|38048869|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
16916793|NCT03317496|38048870|FG003|Phase 1b Lead-in: Treatment|Adverse Event|0|||
16843578|NCT01881230|37787901|FG001|Overall Study|Adverse Event|13|||
16843579|NCT01881230|37787902|FG002|Overall Study|Adverse Event|12|||
16843580|NCT01881230|37787900|FG000|Overall Study|Progressive Disease|31|||
16843581|NCT01881230|37787901|FG001|Overall Study|Progressive Disease|35|||
16843582|NCT01881230|37787902|FG002|Overall Study|Progressive Disease|36|||
16843583|NCT01881230|37787900|FG000|Overall Study|Symptomatic Deterioration|3|||
16843584|NCT01881230|37787901|FG001|Overall Study|Symptomatic Deterioration|3|||
16843585|NCT01881230|37787902|FG002|Overall Study|Symptomatic Deterioration|1|||
16843586|NCT01881230|37787900|FG000|Overall Study|Withdrawal by Subject|6|||
16843587|NCT01881230|37787901|FG001|Overall Study|Withdrawal by Subject|4|||
16843588|NCT01881230|37787902|FG002|Overall Study|Withdrawal by Subject|6|||
16916794|NCT03317496|38048871|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
16916795|NCT03317496|38048867|FG000|Phase 1b Lead-in: Treatment|Physician Decision|1|||
16916796|NCT03317496|38048868|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
16916797|NCT03317496|38048869|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
16916798|NCT03317496|38048870|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
16916799|NCT03317496|38048871|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
16916800|NCT03317496|38048867|FG000|Phase 1b Lead-in: Treatment|Death|0|||
16916801|NCT03317496|38048868|FG001|Phase 1b Lead-in: Treatment|Death|0|||
16916802|NCT03317496|38048869|FG002|Phase 1b Lead-in: Treatment|Death|1|||
16916803|NCT03317496|38048870|FG003|Phase 1b Lead-in: Treatment|Death|0|||
16916804|NCT03317496|38048871|FG004|Phase 1b Lead-in: Treatment|Death|0|||
16916805|NCT03317496|38048867|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
16916806|NCT03317496|38048868|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
16916807|NCT03317496|38048869|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
16916808|NCT03317496|38048870|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
16916809|NCT03317496|38048871|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
16916810|NCT03317496|38048867|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
16916811|NCT03317496|38048868|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
16916812|NCT03317496|38048869|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
16916813|NCT03317496|38048870|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
16916814|NCT03317496|38048871|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
16916815|NCT03317496|38048867|FG000|Phase 1b Lead-in: Treatment|Other|0|||
16916816|NCT03317496|38048868|FG001|Phase 1b Lead-in: Treatment|Other|1|||
16916817|NCT03317496|38048869|FG002|Phase 1b Lead-in: Treatment|Other|0|||
16916818|NCT03317496|38048870|FG003|Phase 1b Lead-in: Treatment|Other|0|||
16843589|NCT01881230|37787900|FG000|Overall Study|Physician Decision|4|||
16843590|NCT01881230|37787901|FG001|Overall Study|Physician Decision|3|||
16843591|NCT01881230|37787902|FG002|Overall Study|Physician Decision|6|||
16843592|NCT01881230|37787900|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16843593|NCT01881230|37787901|FG001|Overall Study|Non-Compliance with Study Drug|2|||
16916819|NCT03317496|38048871|FG004|Phase 1b Lead-in: Treatment|Other|0|||
16916820|NCT03317496|38048867|FG000|Phase 1b Lead-in: Treatment|Ongoing|2|||
16916821|NCT03317496|38048868|FG001|Phase 1b Lead-in: Treatment|Ongoing|1|||
16916822|NCT03317496|38048869|FG002|Phase 1b Lead-in: Treatment|Ongoing|0|||
16843594|NCT01881230|37787902|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16843595|NCT01881230|37787900|FG000|Overall Study|Given Commercially Available Drug|0|||
16843596|NCT01881230|37787901|FG001|Overall Study|Given Commercially Available Drug|0|||
16843597|NCT01881230|37787902|FG002|Overall Study|Given Commercially Available Drug|2|||
16843598|NCT01881230|37787900|FG000|Overall Study|Protocol Violation|1|||
16843599|NCT01881230|37787901|FG001|Overall Study|Protocol Violation|1|||
16843600|NCT01881230|37787902|FG002|Overall Study|Protocol Violation|0|||
16843601|NCT01881230|37787900|FG000|Overall Study|Miscellaneous|3|||
16843602|NCT01881230|37787901|FG001|Overall Study|Miscellaneous|3|||
16843603|NCT01881230|37787902|FG002|Overall Study|Miscellaneous|0|||
16843604|NCT01881230|37787900|FG000|Overall Study|Untreated: Other|0|||
16843605|NCT01881230|37787901|FG001|Overall Study|Untreated: Other|0|||
16843606|NCT01881230|37787902|FG002|Overall Study|Untreated: Other|1|||
16843607|NCT01881230|37787900|FG000|Overall Study|Untreated: Death|0|||
16843608|NCT01881230|37787901|FG001|Overall Study|Untreated: Death|0|||
16843609|NCT01881230|37787902|FG002|Overall Study|Untreated: Death|1|||
16843610|NCT01881230|37787900|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
16843611|NCT01881230|37787901|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
16843612|NCT01881230|37787902|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
16843613|NCT01856582|37787910|FG000|Overall Study|Died prior to Boost infusion|1|||
16843614|NCT01829360|37787918|FG000|Overall Study|Protocol Violation|0|||
16843615|NCT01829360|37787919|FG001|Overall Study|Protocol Violation|0|||
16843616|NCT01829360|37787920|FG002|Overall Study|Protocol Violation|1|||
16843617|NCT01829360|37787921|FG003|Overall Study|Protocol Violation|0|||
16843618|NCT01856114|37787937|FG000|Overall Study|Withdrawal by Subject|1|||
16916823|NCT03317496|38048870|FG003|Phase 1b Lead-in: Treatment|Ongoing|2|||
16916824|NCT03317496|38048871|FG004|Phase 1b Lead-in: Treatment|Ongoing|0|||
16916825|NCT03317496|38048867|FG000|Phase 1b Lead-in: Follow-up|Death|2|||
16916826|NCT03317496|38048868|FG001|Phase 1b Lead-in: Follow-up|Death|7|||
16916827|NCT03317496|38048869|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
16916828|NCT03317496|38048870|FG003|Phase 1b Lead-in: Follow-up|Death|3|||
16916829|NCT03317496|38048871|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
16916830|NCT03317496|38048867|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
16916831|NCT03317496|38048868|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
16916832|NCT03317496|38048869|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
16916833|NCT03317496|38048870|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
16916834|NCT03317496|38048871|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
16916835|NCT03317496|38048867|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
16916836|NCT03317496|38048868|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
16916837|NCT03317496|38048869|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
16916838|NCT03317496|38048870|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
16916839|NCT03317496|38048871|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
16916840|NCT03317496|38048867|FG000|Phase 1b Lead-in: Follow-up|Other|1|||
16916841|NCT03317496|38048868|FG001|Phase 1b Lead-in: Follow-up|Other|3|||
16916842|NCT03317496|38048869|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
16916843|NCT03317496|38048870|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
16916844|NCT03317496|38048871|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
16916845|NCT03317496|38048867|FG000|Phase 1b Lead-in: Follow-up|Ongoing|0|||
16916846|NCT03317496|38048868|FG001|Phase 1b Lead-in: Follow-up|Ongoing|1|||
16916847|NCT03317496|38048869|FG002|Phase 1b Lead-in: Follow-up|Ongoing|0|||
16916848|NCT03317496|38048870|FG003|Phase 1b Lead-in: Follow-up|Ongoing|0|||
16916849|NCT03317496|38048871|FG004|Phase 1b Lead-in: Follow-up|Ongoing|0|||
16916850|NCT03317496|38048867|FG000|Phase 2: Treatment|Adverse Event|0|||
16916851|NCT03317496|38048868|FG001|Phase 2: Treatment|Adverse Event|0|||
16916852|NCT03317496|38048869|FG002|Phase 2: Treatment|Adverse Event|0|||
16916853|NCT03317496|38048870|FG003|Phase 2: Treatment|Adverse Event|0|||
16916854|NCT03317496|38048871|FG004|Phase 2: Treatment|Adverse Event|4|||
16916855|NCT03317496|38048867|FG000|Phase 2: Treatment|Death|0|||
16916856|NCT03317496|38048868|FG001|Phase 2: Treatment|Death|0|||
16916857|NCT03317496|38048869|FG002|Phase 2: Treatment|Death|0|||
16916858|NCT03317496|38048870|FG003|Phase 2: Treatment|Death|0|||
16916859|NCT03317496|38048871|FG004|Phase 2: Treatment|Death|1|||
16916860|NCT03317496|38048867|FG000|Phase 2: Treatment|Physician Decision|0|||
16916861|NCT03317496|38048868|FG001|Phase 2: Treatment|Physician Decision|0|||
16916862|NCT03317496|38048869|FG002|Phase 2: Treatment|Physician Decision|0|||
16916863|NCT03317496|38048870|FG003|Phase 2: Treatment|Physician Decision|0|||
16916864|NCT03317496|38048871|FG004|Phase 2: Treatment|Physician Decision|1|||
16916865|NCT03317496|38048867|FG000|Phase 2: Treatment|Progressive Disease|0|||
16916866|NCT03317496|38048868|FG001|Phase 2: Treatment|Progressive Disease|0|||
16916867|NCT03317496|38048869|FG002|Phase 2: Treatment|Progressive Disease|0|||
16843619|NCT01856114|37787938|FG001|Overall Study|Withdrawal by Subject|0|||
16843620|NCT01856114|37787937|FG000|Overall Study|Adverse Event|1|||
16843621|NCT01856114|37787938|FG001|Overall Study|Adverse Event|0|||
16916868|NCT03317496|38048870|FG003|Phase 2: Treatment|Progressive Disease|0|||
16916869|NCT03317496|38048871|FG004|Phase 2: Treatment|Progressive Disease|18|||
16916870|NCT03317496|38048867|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
16916871|NCT03317496|38048868|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
16916872|NCT03317496|38048869|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
16916873|NCT03317496|38048870|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
16916874|NCT03317496|38048871|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
16916875|NCT03317496|38048867|FG000|Phase 2: Treatment|Other|0|||
16916876|NCT03317496|38048868|FG001|Phase 2: Treatment|Other|0|||
16916877|NCT03317496|38048869|FG002|Phase 2: Treatment|Other|0|||
16843622|NCT01855958|37787946|FG000|Overall Study|Withdrawal by Subject|1|||
16843623|NCT01855958|37787947|FG001|Overall Study|Withdrawal by Subject|0|||
16916878|NCT03317496|38048870|FG003|Phase 2: Treatment|Other|0|||
16916879|NCT03317496|38048871|FG004|Phase 2: Treatment|Other|2|||
16916880|NCT03317496|38048867|FG000|Phase 2: Treatment|Ongoing|0|||
16916881|NCT03317496|38048868|FG001|Phase 2: Treatment|Ongoing|0|||
16916882|NCT03317496|38048869|FG002|Phase 2: Treatment|Ongoing|0|||
16916883|NCT03317496|38048870|FG003|Phase 2: Treatment|Ongoing|0|||
16916884|NCT03317496|38048871|FG004|Phase 2: Treatment|Ongoing|8|||
16916885|NCT03317496|38048867|FG000|Phase 2: Follow-up|Death|0|||
16916886|NCT03317496|38048868|FG001|Phase 2: Follow-up|Death|0|||
16916887|NCT03317496|38048869|FG002|Phase 2: Follow-up|Death|0|||
16916888|NCT03317496|38048870|FG003|Phase 2: Follow-up|Death|0|||
16916889|NCT03317496|38048871|FG004|Phase 2: Follow-up|Death|16|||
16916890|NCT03317496|38048867|FG000|Phase 2: Follow-up|Withdrawal by Subject|0|||
16916891|NCT03317496|38048868|FG001|Phase 2: Follow-up|Withdrawal by Subject|0|||
16916892|NCT03317496|38048869|FG002|Phase 2: Follow-up|Withdrawal by Subject|0|||
16916893|NCT03317496|38048870|FG003|Phase 2: Follow-up|Withdrawal by Subject|0|||
16916894|NCT03317496|38048871|FG004|Phase 2: Follow-up|Withdrawal by Subject|1|||
16916895|NCT03317496|38048867|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
16916896|NCT03317496|38048868|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
16916897|NCT03317496|38048869|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
16916898|NCT03317496|38048870|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
16916899|NCT03317496|38048871|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
16916900|NCT03317496|38048867|FG000|Phase 2: Follow-up|Other|0|||
16916901|NCT03317496|38048868|FG001|Phase 2: Follow-up|Other|0|||
16916902|NCT03317496|38048869|FG002|Phase 2: Follow-up|Other|0|||
16916903|NCT03317496|38048870|FG003|Phase 2: Follow-up|Other|0|||
16916904|NCT03317496|38048871|FG004|Phase 2: Follow-up|Other|6|||
16916905|NCT03317496|38048867|FG000|Phase 2: Follow-up|Ongoing|0|||
16916906|NCT03317496|38048868|FG001|Phase 2: Follow-up|Ongoing|0|||
16916907|NCT03317496|38048869|FG002|Phase 2: Follow-up|Ongoing|0|||
16916908|NCT03317496|38048870|FG003|Phase 2: Follow-up|Ongoing|0|||
16916909|NCT03317496|38048871|FG004|Phase 2: Follow-up|Ongoing|1|||
16916910|NCT02663622|38048912|FG000|Overall Study|Death|3|||
16916911|NCT02663622|38048913|FG001|Overall Study|Death|1|||
16916912|NCT02663622|38048914|FG002|Overall Study|Death|1|||
16916913|NCT02663622|38048915|FG003|Overall Study|Death|8|||
16916914|NCT02663622|38048912|FG000|Overall Study|Protocol Violation|0|||
16916915|NCT02663622|38048913|FG001|Overall Study|Protocol Violation|0|||
16916916|NCT02663622|38048914|FG002|Overall Study|Protocol Violation|0|||
16916917|NCT02663622|38048915|FG003|Overall Study|Protocol Violation|1|||
16843624|NCT01855412|37787958|FG000|Overall Study|Death|77|||
16843625|NCT01855412|37787959|FG001|Overall Study|Death|123|||
16843626|NCT01855412|37787960|FG002|Overall Study|Death|30|||
16843627|NCT01855412|37787958|FG000|Overall Study|Lost to Follow-up|28|||
16843628|NCT01855412|37787959|FG001|Overall Study|Lost to Follow-up|46|||
16843629|NCT01855412|37787960|FG002|Overall Study|Lost to Follow-up|15|||
16843630|NCT01855412|37787958|FG000|Overall Study|Withdrawal by Subject|77|||
16843631|NCT01855412|37787959|FG001|Overall Study|Withdrawal by Subject|123|||
16843632|NCT01855412|37787960|FG002|Overall Study|Withdrawal by Subject|24|||
16843633|NCT01855412|37787958|FG000|Overall Study|Physician Decision|25|||
16843634|NCT01855412|37787959|FG001|Overall Study|Physician Decision|31|||
16843635|NCT01855412|37787960|FG002|Overall Study|Physician Decision|3|||
16843636|NCT01855412|37787958|FG000|Overall Study|Site Closure|4|||
16843637|NCT01855412|37787959|FG001|Overall Study|Site Closure|18|||
16843638|NCT01855412|37787960|FG002|Overall Study|Site Closure|1|||
16843639|NCT01855412|37787958|FG000|Overall Study|Reason not Specified|1|||
16843640|NCT01855412|37787959|FG001|Overall Study|Reason not Specified|2|||
16843641|NCT01855412|37787960|FG002|Overall Study|Reason not Specified|3|||
16843642|NCT01614470|37787976|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
16843643|NCT01614470|37787977|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16843644|NCT01614470|37787978|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16843645|NCT01614470|37787976|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
16843646|NCT01614470|37787977|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
16843647|NCT01614470|37787978|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
16843648|NCT01880528|37787989|FG000|Overall Study|Other|1|||
16843649|NCT01880528|37787990|FG001|Overall Study|Other|1|||
16843650|NCT01854944|37787999|FG000|Overall Study|Withdrawal by Subject|0|||
16843651|NCT01854944|37788000|FG001|Overall Study|Withdrawal by Subject|0|||
16843652|NCT01854944|37788001|FG002|Overall Study|Withdrawal by Subject|1|||
16843653|NCT01829048|37788028|FG000|Overall Study|Withdrawal by Subject|0|||
16843654|NCT01829048|37788029|FG001|Overall Study|Withdrawal by Subject|0|||
16843655|NCT01829048|37788030|FG002|Overall Study|Withdrawal by Subject|0|||
16843656|NCT01829048|37788031|FG003|Overall Study|Withdrawal by Subject|2|||
16843657|NCT01829048|37788032|FG004|Overall Study|Withdrawal by Subject|0|||
16843658|NCT01854710|37788045|FG000|Overall Study|Withdrawal by Subject|2|||
16916931|NCT02545998|38048952|FG000|Overall Study|Lost to Follow-up|12|||
16916932|NCT02545998|38048953|FG001|Overall Study|Lost to Follow-up|3|||
16916933|NCT02545998|38048952|FG000|Overall Study|Withdrawal by Subject|3|||
16916934|NCT02545998|38048953|FG001|Overall Study|Withdrawal by Subject|2|||
16916935|NCT02257242|38048977|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
16916936|NCT02257242|38048978|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16916937|NCT02257242|38048979|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16916938|NCT02257242|38048980|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16916939|NCT02257242|38048981|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16916940|NCT02257242|38048982|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16916941|NCT02257242|38048983|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16916942|NCT02257242|38048984|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16916943|NCT02257242|38048985|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16916944|NCT01943916|38049015|FG000|Overall Study|Technically invalid images|10|||
16916945|NCT01943916|38049015|FG000|Overall Study|Enrollment Failure|23|||
16916946|NCT01943916|38049015|FG000|Overall Study|Pilot Phase exclusion|100|||
16916947|NCT01943916|38049015|FG000|Overall Study|Quality Assurance Reader Fail|130|||
16916948|NCT01943916|38049015|FG000|Overall Study|Technical Failure|39|||
16916949|NCT01943916|38049015|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
16916950|NCT01943916|38049015|FG000|Overall Study|No Truth Panel Review|38|||
16916951|NCT01943916|38049015|FG000|Overall Study|Protocol Deviation|1|||
16916952|NCT01564368|38049024|FG000|Overall Study|Ineligible|18|||
16916953|NCT01564368|38049024|FG000|Overall Study|Not Randomized in Parent study|116|||
16916954|NCT01564368|38049024|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
16916955|NCT01564368|38049024|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
16916956|NCT00777036|38049033|FG000|On Treatment|Reason Not Specified|4|||
16916957|NCT00777036|38049034|FG001|On Treatment|Reason Not Specified|7|||
16916958|NCT00777036|38049035|FG002|On Treatment|Reason Not Specified|12|||
16916959|NCT00777036|38049033|FG000|On Treatment|Failure to Meet Study Criteria|0|||
16916960|NCT00777036|38049034|FG001|On Treatment|Failure to Meet Study Criteria|1|||
16916961|NCT00777036|38049035|FG002|On Treatment|Failure to Meet Study Criteria|0|||
16916962|NCT00777036|38049033|FG000|On Treatment|Non-compliance with Study Drug|1|||
16916963|NCT00777036|38049034|FG001|On Treatment|Non-compliance with Study Drug|0|||
16916964|NCT00777036|38049035|FG002|On Treatment|Non-compliance with Study Drug|0|||
16916965|NCT00777036|38049033|FG000|On Treatment|Maximum Clinical Benefit|2|||
16916966|NCT00777036|38049034|FG001|On Treatment|Maximum Clinical Benefit|0|||
16916967|NCT00777036|38049035|FG002|On Treatment|Maximum Clinical Benefit|1|||
16916968|NCT00777036|38049033|FG000|On Treatment|Withdrawal by Subject|3|||
16916969|NCT00777036|38049034|FG001|On Treatment|Withdrawal by Subject|2|||
16916970|NCT00777036|38049035|FG002|On Treatment|Withdrawal by Subject|3|||
16916971|NCT00777036|38049033|FG000|On Treatment|Death|0|||
16916972|NCT00777036|38049034|FG001|On Treatment|Death|2|||
16916973|NCT00777036|38049035|FG002|On Treatment|Death|0|||
16916974|NCT00777036|38049033|FG000|On Treatment|Study Drug Toxicity|0|||
16916975|NCT00777036|38049034|FG001|On Treatment|Study Drug Toxicity|0|||
16916976|NCT00777036|38049035|FG002|On Treatment|Study Drug Toxicity|1|||
16916977|NCT00777036|38049033|FG000|On Treatment|Progressive Disease|5|||
16916978|NCT00777036|38049034|FG001|On Treatment|Progressive Disease|4|||
16916979|NCT00777036|38049035|FG002|On Treatment|Progressive Disease|6|||
16843659|NCT01854710|37788046|FG001|Overall Study|Withdrawal by Subject|1|||
16916980|NCT00777036|38049033|FG000|Follow-Up|Lost to Follow-up|1|||
16916981|NCT00777036|38049034|FG001|Follow-Up|Lost to Follow-up|0|||
16916982|NCT00777036|38049035|FG002|Follow-Up|Lost to Follow-up|0|||
16916983|NCT00777036|38049033|FG000|Follow-Up|Reason Not Specified|2|||
16916984|NCT00777036|38049034|FG001|Follow-Up|Reason Not Specified|0|||
16916985|NCT00777036|38049035|FG002|Follow-Up|Reason Not Specified|0|||
16916986|NCT00777036|38049033|FG000|Follow-Up|Withdrawal by Subject|1|||
16916987|NCT00777036|38049034|FG001|Follow-Up|Withdrawal by Subject|0|||
16916988|NCT00777036|38049035|FG002|Follow-Up|Withdrawal by Subject|4|||
16916989|NCT00777036|38049033|FG000|Follow-Up|Death|1|||
16916990|NCT00777036|38049034|FG001|Follow-Up|Death|8|||
16916991|NCT00777036|38049035|FG002|Follow-Up|Death|0|||
16916992|NCT00281658|38049052|FG000|Randomized Phase|Adverse Event|0|||
16843660|NCT01854710|37788047|FG002|Overall Study|Withdrawal by Subject|0|||
16843661|NCT01854710|37788048|FG003|Overall Study|Withdrawal by Subject|0|||
16843662|NCT01854710|37788049|FG004|Overall Study|Withdrawal by Subject|0|||
16843663|NCT01854710|37788050|FG005|Overall Study|Withdrawal by Subject|0|||
16843664|NCT01854710|37788045|FG000|Overall Study|CRI procedural error|2|||
16843665|NCT01854710|37788046|FG001|Overall Study|CRI procedural error|2|||
16843666|NCT01854710|37788047|FG002|Overall Study|CRI procedural error|2|||
16843667|NCT01854710|37788048|FG003|Overall Study|CRI procedural error|2|||
16843668|NCT01854710|37788049|FG004|Overall Study|CRI procedural error|2|||
16843669|NCT01854710|37788050|FG005|Overall Study|CRI procedural error|2|||
16843670|NCT01828034|37788064|FG000|Overall Study|Withdrawal by Subject|0|||
16843671|NCT01828034|37788065|FG001|Overall Study|Withdrawal by Subject|0|||
16843672|NCT01828034|37788066|FG002|Overall Study|Withdrawal by Subject|0|||
16843673|NCT01828034|37788067|FG003|Overall Study|Withdrawal by Subject|1|||
16843674|NCT01853696|37788076|FG000|Overall Study|Withdrawal by Subject|1|||
16843675|NCT01853696|37788077|FG001|Overall Study|Withdrawal by Subject|1|||
16843676|NCT01853696|37788076|FG000|Overall Study|Lost to Follow-up|5|||
16843677|NCT01853696|37788077|FG001|Overall Study|Lost to Follow-up|4|||
16843678|NCT01871805|37788089|FG000|Phase I|Death|7|||
16843679|NCT01871805|37788090|FG001|Phase I|Death|4|||
16843680|NCT01871805|37788091|FG002|Phase I|Death|6|||
16843681|NCT01871805|37788092|FG003|Phase I|Death|2|||
16843682|NCT01871805|37788093|FG004|Phase I|Death|9|||
16843683|NCT01871805|37788094|FG005|Phase I|Death|0|||
16843684|NCT01871805|37788089|FG000|Phase I|Alive in Survival Follow-up|0|||
16843685|NCT01871805|37788090|FG001|Phase I|Alive in Survival Follow-up|2|||
16843686|NCT01871805|37788091|FG002|Phase I|Alive in Survival Follow-up|4|||
16843687|NCT01871805|37788092|FG003|Phase I|Alive in Survival Follow-up|5|||
16843688|NCT01871805|37788093|FG004|Phase I|Alive in Survival Follow-up|4|||
16843689|NCT01871805|37788094|FG005|Phase I|Alive in Survival Follow-up|0|||
16843690|NCT01871805|37788089|FG000|Phase I|Lost to Follow-up|0|||
16843691|NCT01871805|37788090|FG001|Phase I|Lost to Follow-up|1|||
16843692|NCT01871805|37788091|FG002|Phase I|Lost to Follow-up|3|||
16843693|NCT01871805|37788092|FG003|Phase I|Lost to Follow-up|0|||
16843694|NCT01871805|37788093|FG004|Phase I|Lost to Follow-up|0|||
16843695|NCT01871805|37788094|FG005|Phase I|Lost to Follow-up|0|||
16843696|NCT01871805|37788089|FG000|Phase II|Death|0|||
16843697|NCT01871805|37788090|FG001|Phase II|Death|0|||
16843698|NCT01871805|37788091|FG002|Phase II|Death|0|||
16843699|NCT01871805|37788092|FG003|Phase II|Death|0|||
16843700|NCT01871805|37788093|FG004|Phase II|Death|0|||
16843701|NCT01871805|37788094|FG005|Phase II|Death|45|||
16843702|NCT01871805|37788089|FG000|Phase II|Alive in Survival Follow-up|0|||
16843703|NCT01871805|37788090|FG001|Phase II|Alive in Survival Follow-up|0|||
16843704|NCT01871805|37788091|FG002|Phase II|Alive in Survival Follow-up|0|||
16843705|NCT01871805|37788092|FG003|Phase II|Alive in Survival Follow-up|0|||
16843706|NCT01871805|37788093|FG004|Phase II|Alive in Survival Follow-up|0|||
16843707|NCT01871805|37788094|FG005|Phase II|Alive in Survival Follow-up|29|||
16843708|NCT01871805|37788089|FG000|Phase II|Lost to Follow-up|0|||
16916993|NCT00281658|38049053|FG001|Randomized Phase|Adverse Event|2|||
16916994|NCT00281658|38049054|FG002|Randomized Phase|Adverse Event|0|||
16916995|NCT00281658|38049055|FG003|Randomized Phase|Adverse Event|0|||
16916996|NCT00281658|38049052|FG000|Randomized Phase|Lost to Follow-up|34|||
16916997|NCT00281658|38049053|FG001|Randomized Phase|Lost to Follow-up|27|||
16843709|NCT01871805|37788090|FG001|Phase II|Lost to Follow-up|0|||
16843710|NCT01871805|37788091|FG002|Phase II|Lost to Follow-up|0|||
16843711|NCT01871805|37788092|FG003|Phase II|Lost to Follow-up|0|||
16843712|NCT01871805|37788093|FG004|Phase II|Lost to Follow-up|0|||
16843713|NCT01871805|37788094|FG005|Phase II|Lost to Follow-up|13|||
16843714|NCT01719861|37788125|FG000|Cycle 1|Death|4|||
16843715|NCT01719861|37788125|FG000|Cycle 2|Death|1|||
16843716|NCT01853618|37788135|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
16843717|NCT01853618|37788136|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
16843718|NCT01853618|37788137|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
16843719|NCT01853618|37788138|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
16916998|NCT00281658|38049054|FG002|Randomized Phase|Lost to Follow-up|0|||
16916999|NCT00281658|38049055|FG003|Randomized Phase|Lost to Follow-up|0|||
16917000|NCT00281658|38049052|FG000|Randomized Phase|Withdrawal by Subject|8|||
16917001|NCT00281658|38049053|FG001|Randomized Phase|Withdrawal by Subject|7|||
16917002|NCT00281658|38049054|FG002|Randomized Phase|Withdrawal by Subject|0|||
16917003|NCT00281658|38049055|FG003|Randomized Phase|Withdrawal by Subject|0|||
16917004|NCT00281658|38049052|FG000|Randomized Phase|Study closed/terminated|1|||
16917005|NCT00281658|38049053|FG001|Randomized Phase|Study closed/terminated|1|||
16917006|NCT00281658|38049054|FG002|Randomized Phase|Study closed/terminated|0|||
16917007|NCT00281658|38049055|FG003|Randomized Phase|Study closed/terminated|0|||
16917008|NCT00281658|38049052|FG000|Randomized Phase|Disease progression|36|||
16917009|NCT00281658|38049053|FG001|Randomized Phase|Disease progression|27|||
16917010|NCT00281658|38049054|FG002|Randomized Phase|Disease progression|0|||
16917011|NCT00281658|38049055|FG003|Randomized Phase|Disease progression|0|||
16917012|NCT00281658|38049052|FG000|Randomized Phase|Physician Decision|1|||
16917013|NCT00281658|38049053|FG001|Randomized Phase|Physician Decision|1|||
16917014|NCT00281658|38049054|FG002|Randomized Phase|Physician Decision|0|||
16917015|NCT00281658|38049055|FG003|Randomized Phase|Physician Decision|0|||
16917016|NCT00281658|38049052|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
16917017|NCT00281658|38049053|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
16917018|NCT00281658|38049054|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
16917019|NCT00281658|38049055|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
16917020|NCT00281658|38049052|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
16917021|NCT00281658|38049053|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
16917022|NCT00281658|38049054|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
16917023|NCT00281658|38049055|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
16917024|NCT00281658|38049052|FG000|Randomized Phase|Treatment ongoing|1|||
16917025|NCT00281658|38049053|FG001|Randomized Phase|Treatment ongoing|0|||
16917026|NCT00281658|38049054|FG002|Randomized Phase|Treatment ongoing|0|||
16917027|NCT00281658|38049055|FG003|Randomized Phase|Treatment ongoing|0|||
16917028|NCT00281658|38049052|FG000|Open Label Phase|Adverse Event|0|||
16917029|NCT00281658|38049053|FG001|Open Label Phase|Adverse Event|0|||
16917030|NCT00281658|38049054|FG002|Open Label Phase|Adverse Event|1|||
16917031|NCT00281658|38049055|FG003|Open Label Phase|Adverse Event|0|||
16917032|NCT00281658|38049052|FG000|Open Label Phase|Lost to Follow-up|0|||
16917033|NCT00281658|38049053|FG001|Open Label Phase|Lost to Follow-up|0|||
16917034|NCT00281658|38049054|FG002|Open Label Phase|Lost to Follow-up|16|||
16917035|NCT00281658|38049055|FG003|Open Label Phase|Lost to Follow-up|2|||
16917036|NCT00281658|38049052|FG000|Open Label Phase|Withdrawal by Subject|0|||
16917037|NCT00281658|38049053|FG001|Open Label Phase|Withdrawal by Subject|0|||
16917038|NCT00281658|38049054|FG002|Open Label Phase|Withdrawal by Subject|3|||
16917039|NCT00281658|38049055|FG003|Open Label Phase|Withdrawal by Subject|2|||
16917040|NCT00281658|38049052|FG000|Open Label Phase|Disease progression|0|||
16917041|NCT00281658|38049053|FG001|Open Label Phase|Disease progression|0|||
16917042|NCT00281658|38049054|FG002|Open Label Phase|Disease progression|18|||
16917043|NCT00281658|38049055|FG003|Open Label Phase|Disease progression|0|||
16917044|NCT00281658|38049052|FG000|Open Label Phase|Physician Decision|0|||
16917045|NCT00281658|38049053|FG001|Open Label Phase|Physician Decision|0|||
16917046|NCT00281658|38049054|FG002|Open Label Phase|Physician Decision|1|||
16917047|NCT00281658|38049055|FG003|Open Label Phase|Physician Decision|0|||
16917048|NCT00281658|38049052|FG000|Open Label Phase|Relocation of patient|0|||
16917049|NCT00281658|38049053|FG001|Open Label Phase|Relocation of patient|0|||
16917050|NCT00281658|38049054|FG002|Open Label Phase|Relocation of patient|1|||
16917051|NCT00281658|38049055|FG003|Open Label Phase|Relocation of patient|0|||
16917052|NCT00281658|38049052|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
16917053|NCT00281658|38049053|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
16917054|NCT00281658|38049054|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
16843720|NCT01853618|37788139|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
16843721|NCT01853618|37788135|FG000|Overall Study|Progressive disease|1|||
16843722|NCT01853618|37788136|FG001|Overall Study|Progressive disease|1|||
16843723|NCT01853618|37788137|FG002|Overall Study|Progressive disease|1|||
16917055|NCT00281658|38049055|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
16917056|NCT02758626|38050464|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
16917057|NCT02758626|38050465|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
16917058|NCT02758626|38050464|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
17016969|NCT00838110|38161564|FG003|Overall Study|Protocol Violation|1|||
16843724|NCT01853618|37788138|FG003|Overall Study|Progressive disease|1|||
16843725|NCT01853618|37788139|FG004|Overall Study|Progressive disease|2|||
16843726|NCT01853618|37788135|FG000|Overall Study|Physician Decision|0|||
16843727|NCT01853618|37788136|FG001|Overall Study|Physician Decision|1|||
16843728|NCT01853618|37788137|FG002|Overall Study|Physician Decision|1|||
16843729|NCT01853618|37788138|FG003|Overall Study|Physician Decision|0|||
16843730|NCT01853618|37788139|FG004|Overall Study|Physician Decision|0|||
16843731|NCT01853618|37788135|FG000|Overall Study|Refused further treatment|0|||
16843732|NCT01853618|37788136|FG001|Overall Study|Refused further treatment|0|||
16843733|NCT01853618|37788137|FG002|Overall Study|Refused further treatment|0|||
16843734|NCT01853618|37788138|FG003|Overall Study|Refused further treatment|0|||
16917059|NCT02758626|38050465|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
16917060|NCT02758626|38050464|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
16917061|NCT02758626|38050465|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
16917062|NCT02758626|38050464|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
16917063|NCT02758626|38050465|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
16917064|NCT02432196|38050471|FG000|Overall Study|Not Implanted with Device|1|||
16917065|NCT02432196|38050471|FG000|Overall Study|Death|2|||
16917066|NCT02432196|38050471|FG000|Overall Study|Reoperation|3|||
16917067|NCT02432196|38050471|FG000|Overall Study|On Study|20|||
16917068|NCT02357784|38050475|FG000|Overall Study|Withdrawal by Subject|1|||
16917069|NCT01448616|38050482|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
16917070|NCT01448616|38050483|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
16917071|NCT01448616|38050484|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
16917072|NCT01448616|38050485|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
16917073|NCT01448616|38050482|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
16917074|NCT01448616|38050483|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
16917075|NCT01448616|38050484|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
16843735|NCT01853618|37788139|FG004|Overall Study|Refused further treatment|1|||
16843736|NCT01853462|37788154|FG000|Overall Study|Withdrawal by Subject|1|||
16843737|NCT01853462|37788155|FG001|Overall Study|Withdrawal by Subject|1|||
16917076|NCT01448616|38050485|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
16917077|NCT01448616|38050482|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
16917078|NCT01448616|38050483|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
16917079|NCT01448616|38050484|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
16917080|NCT01448616|38050485|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
16917081|NCT01448616|38050482|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
16917082|NCT01448616|38050483|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
16917083|NCT01448616|38050484|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
16917084|NCT01448616|38050485|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
16917085|NCT01448616|38050482|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
16917086|NCT01448616|38050483|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
16917087|NCT01448616|38050484|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
16917088|NCT01448616|38050485|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
16917089|NCT00074412|38050522|FG000|Overall Study|Death|30|||
16917090|NCT00074412|38050523|FG001|Overall Study|Death|26|||
16917091|NCT00074412|38050522|FG000|Overall Study|Lost to Follow-up|52|||
16917092|NCT00074412|38050523|FG001|Overall Study|Lost to Follow-up|58|||
16917093|NCT04521114|38058036|FG000|Overall Study|Lost to Follow-up|1|||
16917094|NCT04521114|38058037|FG001|Overall Study|Lost to Follow-up|2|||
16917095|NCT04521114|38058038|FG002|Overall Study|Lost to Follow-up|0|||
16843738|NCT01719783|37788165|FG000|Dose 2|Physician Decision|1|||
16843739|NCT01719783|37788166|FG001|Dose 2|Physician Decision|0|||
16843740|NCT01719237|37788194|FG000|Overall Study|Physician Decision|0|||
16843741|NCT01719237|37788195|FG001|Overall Study|Physician Decision|1|||
16843742|NCT01853384|37788203|FG000|Randomized|Adverse Event|5|||
16843743|NCT01853384|37788204|FG001|Randomized|Adverse Event|3|||
16843744|NCT01853384|37788203|FG000|Randomized|Death|1|||
16843745|NCT01853384|37788204|FG001|Randomized|Death|2|||
16843746|NCT01853384|37788203|FG000|Randomized|Lost to Follow-up|1|||
16843747|NCT01853384|37788204|FG001|Randomized|Lost to Follow-up|1|||
16843748|NCT01853384|37788203|FG000|Randomized|Withdrawal by Subject|5|||
16843749|NCT01853384|37788204|FG001|Randomized|Withdrawal by Subject|3|||
16843750|NCT01853384|37788203|FG000|Randomized|Sponsor Decision|47|||
16843751|NCT01853384|37788204|FG001|Randomized|Sponsor Decision|34|||
16843752|NCT01853384|37788203|FG000|Randomized|Other|3|||
16843753|NCT01853384|37788204|FG001|Randomized|Other|3|||
16843754|NCT01853384|37788203|FG000|Completed Follow up Visit 1|Early Termination|13|||
16843755|NCT01853384|37788204|FG001|Completed Follow up Visit 1|Early Termination|9|||
16843756|NCT01853384|37788203|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
16843757|NCT01853384|37788204|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
16843758|NCT01853384|37788203|FG000|Completed Follow up Visit 2|Adverse Event|1|||
16843759|NCT01853384|37788204|FG001|Completed Follow up Visit 2|Adverse Event|0|||
16843760|NCT01853384|37788203|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
16843761|NCT01853384|37788204|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
16843762|NCT01853384|37788203|FG000|Completed Follow up Visit 2|Death|1|||
16843763|NCT01853384|37788204|FG001|Completed Follow up Visit 2|Death|0|||
16843764|NCT01853384|37788203|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
16843765|NCT01853384|37788204|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
16843766|NCT01878890|37788214|FG000|Overall Study|Protocol Violation|0|||
16843767|NCT01878890|37788215|FG001|Overall Study|Protocol Violation|1|||
16843768|NCT01878890|37788216|FG002|Overall Study|Protocol Violation|0|||
16843769|NCT01878890|37788217|FG003|Overall Study|Protocol Violation|0|||
16843770|NCT01827332|37788230|FG000|Overall Study|Lost to Follow-up|2|||
16843771|NCT01827332|37788231|FG001|Overall Study|Lost to Follow-up|1|||
16843772|NCT01719003|37788245|FG000|Overall Study|Non compliant with protocol|1|||
16843773|NCT01719003|37788246|FG001|Overall Study|Non compliant with protocol|1|||
16843774|NCT01719003|37788247|FG002|Overall Study|Non compliant with protocol|0|||
16843775|NCT01719003|37788248|FG003|Overall Study|Non compliant with protocol|1|||
16843776|NCT01719003|37788249|FG004|Overall Study|Non compliant with protocol|2|||
16843777|NCT01719003|37788250|FG005|Overall Study|Non compliant with protocol|1|||
16843778|NCT01719003|37788251|FG006|Overall Study|Non compliant with protocol|2|||
16843779|NCT01719003|37788252|FG007|Overall Study|Non compliant with protocol|3|||
16843780|NCT01719003|37788253|FG008|Overall Study|Non compliant with protocol|0|||
16843781|NCT01719003|37788245|FG000|Overall Study|Adverse Event|6|||
16843782|NCT01719003|37788246|FG001|Overall Study|Adverse Event|5|||
16843783|NCT01719003|37788247|FG002|Overall Study|Adverse Event|4|||
16843784|NCT01719003|37788248|FG003|Overall Study|Adverse Event|3|||
16843785|NCT01719003|37788249|FG004|Overall Study|Adverse Event|4|||
16843786|NCT01719003|37788250|FG005|Overall Study|Adverse Event|3|||
16843787|NCT01719003|37788251|FG006|Overall Study|Adverse Event|6|||
16843788|NCT01719003|37788252|FG007|Overall Study|Adverse Event|5|||
16843789|NCT01719003|37788253|FG008|Overall Study|Adverse Event|0|||
16843790|NCT01719003|37788245|FG000|Overall Study|Lost to Follow-up|0|||
16843791|NCT01719003|37788246|FG001|Overall Study|Lost to Follow-up|6|||
16843792|NCT01719003|37788247|FG002|Overall Study|Lost to Follow-up|7|||
16843793|NCT01719003|37788248|FG003|Overall Study|Lost to Follow-up|2|||
16843794|NCT01719003|37788249|FG004|Overall Study|Lost to Follow-up|3|||
16843795|NCT01719003|37788250|FG005|Overall Study|Lost to Follow-up|4|||
16843796|NCT01719003|37788251|FG006|Overall Study|Lost to Follow-up|3|||
16843797|NCT01719003|37788252|FG007|Overall Study|Lost to Follow-up|2|||
16843798|NCT01719003|37788253|FG008|Overall Study|Lost to Follow-up|2|||
16843799|NCT01719003|37788245|FG000|Overall Study|Refusal to continue, not due to AE|2|||
16843800|NCT01719003|37788246|FG001|Overall Study|Refusal to continue, not due to AE|5|||
16843801|NCT01719003|37788247|FG002|Overall Study|Refusal to continue, not due to AE|4|||
16843802|NCT01719003|37788248|FG003|Overall Study|Refusal to continue, not due to AE|4|||
16843803|NCT01719003|37788249|FG004|Overall Study|Refusal to continue, not due to AE|4|||
16843804|NCT01719003|37788250|FG005|Overall Study|Refusal to continue, not due to AE|3|||
16843805|NCT01719003|37788251|FG006|Overall Study|Refusal to continue, not due to AE|8|||
16843806|NCT01719003|37788252|FG007|Overall Study|Refusal to continue, not due to AE|7|||
16843807|NCT01719003|37788253|FG008|Overall Study|Refusal to continue, not due to AE|1|||
16843808|NCT01719003|37788245|FG000|Overall Study|Reason other than those specified|0|||
16843809|NCT01719003|37788246|FG001|Overall Study|Reason other than those specified|0|||
16843810|NCT01719003|37788247|FG002|Overall Study|Reason other than those specified|2|||
16843811|NCT01719003|37788248|FG003|Overall Study|Reason other than those specified|3|||
16843812|NCT01719003|37788249|FG004|Overall Study|Reason other than those specified|4|||
16843813|NCT01719003|37788250|FG005|Overall Study|Reason other than those specified|1|||
16843814|NCT01719003|37788251|FG006|Overall Study|Reason other than those specified|0|||
16843815|NCT01719003|37788252|FG007|Overall Study|Reason other than those specified|3|||
16843816|NCT01719003|37788253|FG008|Overall Study|Reason other than those specified|1|||
16843817|NCT01719003|37788245|FG000|Overall Study|Lack of Efficacy|0|||
16843818|NCT01719003|37788246|FG001|Overall Study|Lack of Efficacy|0|||
16843819|NCT01719003|37788247|FG002|Overall Study|Lack of Efficacy|0|||
16843820|NCT01719003|37788248|FG003|Overall Study|Lack of Efficacy|0|||
16843821|NCT01719003|37788249|FG004|Overall Study|Lack of Efficacy|0|||
16843822|NCT01719003|37788250|FG005|Overall Study|Lack of Efficacy|0|||
16843823|NCT01719003|37788251|FG006|Overall Study|Lack of Efficacy|1|||
16843824|NCT01719003|37788252|FG007|Overall Study|Lack of Efficacy|0|||
16843825|NCT01719003|37788253|FG008|Overall Study|Lack of Efficacy|0|||
16843826|NCT01853228|37788272|FG000|Phase 1|Lack of Efficacy|8|||
16843827|NCT01853228|37788273|FG001|Phase 1|Lack of Efficacy|0|||
16843828|NCT01853228|37788272|FG000|Phase 1|Other|1|||
16843829|NCT01853228|37788273|FG001|Phase 1|Other|0|||
16843830|NCT01853228|37788272|FG000|Phase 2|Physician Decision|0|||
16843831|NCT01853228|37788273|FG001|Phase 2|Physician Decision|1|||
16843832|NCT01853228|37788272|FG000|Phase 2|Proceed To Transplant|0|||
16843833|NCT01853228|37788273|FG001|Phase 2|Proceed To Transplant|3|||
16843834|NCT01853228|37788272|FG000|Phase 2|Lack of Efficacy|0|||
16843835|NCT01853228|37788273|FG001|Phase 2|Lack of Efficacy|4|||
16843836|NCT01705587|37788280|FG000|Overall Study|Withdrawal by Subject|0|||
16843837|NCT01705587|37788281|FG001|Overall Study|Withdrawal by Subject|1|||
16843838|NCT01718535|37788297|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
16843839|NCT01718535|37788298|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
16843840|NCT01718535|37788299|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
16843841|NCT01718535|37788300|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
16843842|NCT01718535|37788301|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
16843843|NCT01718535|37788302|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
16843844|NCT01718535|37788303|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
16843845|NCT01718535|37788304|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
16843846|NCT01718535|37788305|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
16843847|NCT01718535|37788306|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
16843848|NCT01717989|37788328|FG000|Overall Study|Ineligibility determined|6|||
16843849|NCT01717989|37788328|FG000|Overall Study|Protocol deviation|6|||
16843850|NCT01717989|37788328|FG000|Overall Study|Withdrawal by Subject|11|||
16843851|NCT01717989|37788328|FG000|Overall Study|Physician Decision|2|||
16843852|NCT01717989|37788328|FG000|Overall Study|Lost to Follow-up|11|||
16843853|NCT01717989|37788328|FG000|Overall Study|Death|439|||
16843854|NCT01717989|37788328|FG000|Overall Study|Protocol-specified criteria|551|||
16843855|NCT01717989|37788328|FG000|Overall Study|Other|40|||
16843856|NCT01705509|37788347|FG000|Inclusion CPET|Screen Failure|5|||
16843857|NCT01705509|37788347|FG000|Inclusion CPET|Withdrawal by Subject|2|||
16843858|NCT01705509|37788347|FG000|CPET w/ Ranexa|Screen Failure|2|||
16843859|NCT01853072|37788353|FG000|Overall Study|Adverse event prior to treatment|0|||
16843860|NCT01853072|37788354|FG001|Overall Study|Adverse event prior to treatment|1|||
16843861|NCT01853072|37788353|FG000|Overall Study|Adverse Event|0|||
16843862|NCT01853072|37788354|FG001|Overall Study|Adverse Event|3|||
16843863|NCT01853072|37788353|FG000|Overall Study|Death|1|||
16843864|NCT01853072|37788354|FG001|Overall Study|Death|4|||
16843865|NCT01853072|37788353|FG000|Overall Study|Lost to Follow-up|0|||
16843866|NCT01853072|37788354|FG001|Overall Study|Lost to Follow-up|3|||
16843867|NCT01853072|37788353|FG000|Overall Study|Non-compliance with study drug|0|||
16843868|NCT01853072|37788354|FG001|Overall Study|Non-compliance with study drug|1|||
16843869|NCT01853072|37788353|FG000|Overall Study|Physician Decision|1|||
16843870|NCT01853072|37788354|FG001|Overall Study|Physician Decision|1|||
16843871|NCT01853072|37788353|FG000|Overall Study|Withdrawal by Subject|1|||
16843872|NCT01853072|37788354|FG001|Overall Study|Withdrawal by Subject|2|||
16843873|NCT01853072|37788353|FG000|Overall Study|Reason not specified|9|||
16843874|NCT01853072|37788354|FG001|Overall Study|Reason not specified|6|||
16843875|NCT01877720|37788362|FG000|Overall Study|Adverse Event|1|||
16843876|NCT01877720|37788363|FG001|Overall Study|Adverse Event|0|||
16843877|NCT01870869|37788373|FG000|Overall Study|Implanted with nonstudy device|1|||
16843878|NCT01870869|37788374|FG001|Overall Study|Implanted with nonstudy device|3|||
16843879|NCT01870869|37788375|FG002|Overall Study|Implanted with nonstudy device|14|||
16843880|NCT01870869|37788376|FG003|Overall Study|Implanted with nonstudy device|4|||
16843881|NCT01870869|37788373|FG000|Overall Study|Death|0|||
16843882|NCT01870869|37788374|FG001|Overall Study|Death|0|||
16843883|NCT01870869|37788375|FG002|Overall Study|Death|7|||
16843884|NCT01870869|37788376|FG003|Overall Study|Death|1|||
16843885|NCT01870869|37788373|FG000|Overall Study|Subject choice|6|||
16843886|NCT01870869|37788374|FG001|Overall Study|Subject choice|2|||
16843887|NCT01870869|37788375|FG002|Overall Study|Subject choice|22|||
16843888|NCT01870869|37788376|FG003|Overall Study|Subject choice|8|||
16843889|NCT01870869|37788373|FG000|Overall Study|Lost to Follow-up|10|||
16843890|NCT01870869|37788374|FG001|Overall Study|Lost to Follow-up|2|||
16843891|NCT01870869|37788375|FG002|Overall Study|Lost to Follow-up|25|||
16843892|NCT01870869|37788376|FG003|Overall Study|Lost to Follow-up|3|||
16843893|NCT01870869|37788373|FG000|Overall Study|Reason not Specified|1|||
16843894|NCT01870869|37788374|FG001|Overall Study|Reason not Specified|2|||
16843895|NCT01870869|37788375|FG002|Overall Study|Reason not Specified|20|||
16843896|NCT01870869|37788376|FG003|Overall Study|Reason not Specified|4|||
16843897|NCT01870869|37788373|FG000|Overall Study|Not evaluable|10|||
16843898|NCT01870869|37788374|FG001|Overall Study|Not evaluable|5|||
16843899|NCT01870869|37788375|FG002|Overall Study|Not evaluable|42|||
16843900|NCT01870869|37788376|FG003|Overall Study|Not evaluable|10|||
16843901|NCT01877408|37788388|FG000|Overall Study|Lost to Follow-up|0|||
16843902|NCT01877408|37788389|FG001|Overall Study|Lost to Follow-up|2|||
16843903|NCT01717287|37788398|FG000|Overall Study|Lost to Follow-up|0|||
16843904|NCT01717287|37788399|FG001|Overall Study|Lost to Follow-up|2|||
16843905|NCT01717287|37788398|FG000|Overall Study|Protocol Violation|0|||
16843906|NCT01717287|37788399|FG001|Overall Study|Protocol Violation|1|||
16843907|NCT01827254|37788405|FG000|Overall Study|Death|10|||
16843908|NCT01827254|37788405|FG000|Overall Study|Case report form not completed|4|||
16843909|NCT01827254|37788405|FG000|Overall Study|Invalidated centre|3|||
16843910|NCT01827254|37788405|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
16843911|NCT01827254|37788405|FG000|Overall Study|Did not complete re-challenge|1|||
16843912|NCT01827254|37788405|FG000|Overall Study|Disease progression|36|||
16917096|NCT04521114|38058036|FG000|Overall Study|Withdrawal by Subject|1|||
16917097|NCT04521114|38058037|FG001|Overall Study|Withdrawal by Subject|2|||
16917098|NCT04521114|38058038|FG002|Overall Study|Withdrawal by Subject|2|||
16917099|NCT04521114|38058036|FG000|Overall Study|Adverse Event|1|||
16917100|NCT04521114|38058037|FG001|Overall Study|Adverse Event|0|||
16917101|NCT04521114|38058038|FG002|Overall Study|Adverse Event|0|||
16917102|NCT04521114|38058036|FG000|Overall Study|Sponsor Wish|1|||
16917103|NCT04521114|38058037|FG001|Overall Study|Sponsor Wish|0|||
16843913|NCT01827254|37788405|FG000|Overall Study|Intolerance to treatment|4|||
16843914|NCT01824602|37788417|FG000|Overall Study|Withdrawal by Subject|0|||
16843915|NCT01824602|37788418|FG001|Overall Study|Withdrawal by Subject|0|||
16843916|NCT01824602|37788419|FG002|Overall Study|Withdrawal by Subject|1|||
16843917|NCT01824602|37788420|FG003|Overall Study|Withdrawal by Subject|2|||
16843918|NCT01824602|37788417|FG000|Overall Study|Patient non-compliance|0|||
16843919|NCT01824602|37788418|FG001|Overall Study|Patient non-compliance|0|||
16843920|NCT01824602|37788419|FG002|Overall Study|Patient non-compliance|1|||
16843921|NCT01824602|37788420|FG003|Overall Study|Patient non-compliance|0|||
16843922|NCT01824602|37788417|FG000|Overall Study|Adverse Event|1|||
16843923|NCT01824602|37788418|FG001|Overall Study|Adverse Event|0|||
16843924|NCT01824602|37788419|FG002|Overall Study|Adverse Event|2|||
16843925|NCT01824602|37788420|FG003|Overall Study|Adverse Event|2|||
16843926|NCT01824602|37788417|FG000|Overall Study|Treatment failure|0|||
16843927|NCT01824602|37788418|FG001|Overall Study|Treatment failure|0|||
16843928|NCT01824602|37788419|FG002|Overall Study|Treatment failure|0|||
16843929|NCT01824602|37788420|FG003|Overall Study|Treatment failure|1|||
16843930|NCT01704651|37788432|FG000|Overall Study|Pre-op withdrawal by subject|1|||
16843931|NCT01704651|37788433|FG001|Overall Study|Pre-op withdrawal by subject|1|||
16843932|NCT01704651|37788432|FG000|Overall Study|Pre-op change in treatment plan|1|||
16843933|NCT01704651|37788433|FG001|Overall Study|Pre-op change in treatment plan|4|||
16917104|NCT04521114|38058038|FG002|Overall Study|Sponsor Wish|0|||
16917105|NCT04521114|38058036|FG000|Overall Study|Withdrawal of Consent|2|||
16917106|NCT04521114|38058037|FG001|Overall Study|Withdrawal of Consent|2|||
16917107|NCT04521114|38058038|FG002|Overall Study|Withdrawal of Consent|0|||
16917108|NCT04360824|38058060|FG000|Overall Study|Withdrawal by Subject|2|||
16917109|NCT04360824|38058061|FG001|Overall Study|Withdrawal by Subject|1|||
16917110|NCT04360824|38058060|FG000|Overall Study|Did not receive assigned treatment|1|||
16917111|NCT04360824|38058061|FG001|Overall Study|Did not receive assigned treatment|3|||
16917112|NCT03711786|38058070|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
16917113|NCT03711786|38058071|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
16917114|NCT03711786|38058070|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
16917115|NCT03711786|38058071|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
16917116|NCT03711786|38058070|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
16917117|NCT03711786|38058071|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
16917118|NCT03711786|38058070|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
16917119|NCT03711786|38058071|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
16843934|NCT01704651|37788432|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
16843935|NCT01704651|37788433|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
16843936|NCT01704651|37788432|FG000|Overall Study|Post-op did not have laparotomy|2|||
16843937|NCT01704651|37788433|FG001|Overall Study|Post-op did not have laparotomy|1|||
16843938|NCT01876706|37788439|FG000|Overall Study|BPH Intervention|9|||
16843939|NCT01876706|37788439|FG000|Overall Study|Lost to Follow-up|7|||
16843940|NCT01876706|37788439|FG000|Overall Study|Withdrawals|6|||
16843941|NCT01876706|37788439|FG000|Overall Study|Death|3|||
16843942|NCT01876082|37788445|FG000|Overall Study|Withdrawal by Subject|0|||
16843943|NCT01876082|37788446|FG001|Overall Study|Withdrawal by Subject|2|||
16843944|NCT01876082|37788445|FG000|Overall Study|Protocol Violation|1|||
16843945|NCT01876082|37788446|FG001|Overall Study|Protocol Violation|0|||
16843946|NCT01876082|37788445|FG000|Overall Study|Adverse Event|1|||
16843947|NCT01876082|37788446|FG001|Overall Study|Adverse Event|1|||
16843948|NCT01876082|37788445|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
16843949|NCT01876082|37788446|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
16917120|NCT03711786|38058070|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
16843950|NCT01704495|37788456|FG000|Subjects Randomized|Other Reason|3|||
16843951|NCT01704495|37788457|FG001|Subjects Randomized|Other Reason|2|||
16843952|NCT01704495|37788458|FG002|Subjects Randomized|Other Reason|3|||
16843953|NCT01704495|37788459|FG003|Subjects Randomized|Other Reason|2|||
16843954|NCT01704495|37788456|FG000|Subjects Randomized|Discontinuation criteria met|4|||
16917121|NCT03711786|38058071|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
16917122|NCT03711786|38058070|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
16843955|NCT01704495|37788457|FG001|Subjects Randomized|Discontinuation criteria met|2|||
16843956|NCT01704495|37788458|FG002|Subjects Randomized|Discontinuation criteria met|2|||
16843957|NCT01704495|37788459|FG003|Subjects Randomized|Discontinuation criteria met|0|||
16843958|NCT01704495|37788456|FG000|Subjects Randomized|Adverse Event|8|||
16843959|NCT01704495|37788457|FG001|Subjects Randomized|Adverse Event|2|||
16843960|NCT01704495|37788458|FG002|Subjects Randomized|Adverse Event|0|||
16843961|NCT01704495|37788459|FG003|Subjects Randomized|Adverse Event|7|||
16843962|NCT01704495|37788456|FG000|Subjects Randomized|Withdrawal by Subject|5|||
16843963|NCT01704495|37788457|FG001|Subjects Randomized|Withdrawal by Subject|5|||
16843964|NCT01704495|37788458|FG002|Subjects Randomized|Withdrawal by Subject|5|||
16843965|NCT01704495|37788459|FG003|Subjects Randomized|Withdrawal by Subject|5|||
16843966|NCT01704495|37788456|FG000|Subjects Randomized|Protocol Violation|1|||
16843967|NCT01704495|37788457|FG001|Subjects Randomized|Protocol Violation|1|||
16843968|NCT01704495|37788458|FG002|Subjects Randomized|Protocol Violation|2|||
16843969|NCT01704495|37788459|FG003|Subjects Randomized|Protocol Violation|0|||
16843970|NCT01704495|37788456|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
16843971|NCT01704495|37788457|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
16843972|NCT01704495|37788458|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
16843973|NCT01704495|37788459|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
16843974|NCT01704495|37788456|FG000|Optional Safety Extension|Adverse Event|0|||
16843975|NCT01704495|37788457|FG001|Optional Safety Extension|Adverse Event|4|||
16843976|NCT01704495|37788458|FG002|Optional Safety Extension|Adverse Event|0|||
16843977|NCT01704495|37788459|FG003|Optional Safety Extension|Adverse Event|1|||
16843978|NCT01704495|37788456|FG000|Optional Safety Extension|Other reason|27|||
16843979|NCT01704495|37788457|FG001|Optional Safety Extension|Other reason|29|||
16843980|NCT01704495|37788458|FG002|Optional Safety Extension|Other reason|30|||
16843981|NCT01704495|37788459|FG003|Optional Safety Extension|Other reason|28|||
16843982|NCT01704495|37788456|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
16843983|NCT01704495|37788457|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
16843984|NCT01704495|37788458|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
16843985|NCT01704495|37788459|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
16843986|NCT01716663|37788469|FG000|Overall Study|Withdrawn prior to procedure|4|||
16843987|NCT01716663|37788469|FG000|Overall Study|Treated with non-study catheter|2|||
16843988|NCT01716585|37788475|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
16843989|NCT01716585|37788476|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
16843990|NCT01716585|37788475|FG000|Double-blind Treatment|Adverse Event|2|||
16843991|NCT01716585|37788476|FG001|Double-blind Treatment|Adverse Event|1|||
16843992|NCT01716585|37788475|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
16843993|NCT01716585|37788476|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
16843994|NCT01716585|37788475|FG000|Double-blind Treatment|Lost to Follow-up|2|||
16843995|NCT01716585|37788476|FG001|Double-blind Treatment|Lost to Follow-up|0|||
16843996|NCT01716585|37788475|FG000|Double-blind Treatment|Subject Noncompliant|1|||
16843997|NCT01716585|37788476|FG001|Double-blind Treatment|Subject Noncompliant|0|||
16843998|NCT01716585|37788475|FG000|Double-blind Treatment|Other|1|||
16843999|NCT01716585|37788476|FG001|Double-blind Treatment|Other|0|||
16844000|NCT01716585|37788475|FG000|Open-label Treatment|Adverse Event|0|||
16844001|NCT01716585|37788476|FG001|Open-label Treatment|Adverse Event|2|||
16844002|NCT01716585|37788475|FG000|Open-label Treatment|Virologic Failure|0|||
16844003|NCT01716585|37788476|FG001|Open-label Treatment|Virologic Failure|2|||
16844004|NCT01716585|37788475|FG000|Open-label Treatment|Withdrawal by Subject|0|||
16844005|NCT01716585|37788476|FG001|Open-label Treatment|Withdrawal by Subject|3|||
16844006|NCT01852292|37788485|FG000|Overall Study|Untreated - did not receive study drug|3|||
16844007|NCT01852292|37788486|FG001|Overall Study|Untreated - did not receive study drug|1|||
16844008|NCT01852292|37788485|FG000|Overall Study|Death|9|||
16844009|NCT01852292|37788486|FG001|Overall Study|Death|8|||
16844010|NCT01852292|37788485|FG000|Overall Study|Patient/guardian decision|8|||
16844011|NCT01852292|37788486|FG001|Overall Study|Patient/guardian decision|4|||
16844012|NCT01852292|37788485|FG000|Overall Study|Adverse Event|8|||
16844013|NCT01852292|37788486|FG001|Overall Study|Adverse Event|11|||
16844014|NCT01852292|37788485|FG000|Overall Study|Physician Decision|6|||
16917123|NCT03711786|38058071|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
16917124|NCT03691974|38058081|FG000|Overall Study|Physician Decision|1|||
16844015|NCT01852292|37788486|FG001|Overall Study|Physician Decision|2|||
16917125|NCT03691974|38058082|FG001|Overall Study|Physician Decision|0|||
16917126|NCT03691974|38058081|FG000|Overall Study|Adverse Event|1|||
16917127|NCT03691974|38058082|FG001|Overall Study|Adverse Event|0|||
16917128|NCT03691974|38058081|FG000|Overall Study|Withdrawal by Subject|11|||
16917129|NCT03691974|38058082|FG001|Overall Study|Withdrawal by Subject|9|||
16917130|NCT03691974|38058081|FG000|Overall Study|Protocol Violation|1|||
16917131|NCT03691974|38058082|FG001|Overall Study|Protocol Violation|0|||
16917132|NCT03691974|38058081|FG000|Overall Study|Lost to Follow-up|8|||
16917133|NCT03691974|38058082|FG001|Overall Study|Lost to Follow-up|7|||
16917134|NCT03525678|38058103|FG000|Overall Study|Ongoing at the time of interim analysis|60|||
16917135|NCT03525678|38058104|FG001|Overall Study|Ongoing at the time of interim analysis|65|||
16917136|NCT03525678|38058105|FG002|Overall Study|Ongoing at the time of interim analysis|21|||
16917137|NCT03525678|38058103|FG000|Overall Study|Withdrawal by Subject|3|||
16917138|NCT03525678|38058104|FG001|Overall Study|Withdrawal by Subject|1|||
16917139|NCT03525678|38058105|FG002|Overall Study|Withdrawal by Subject|0|||
16917140|NCT03525678|38058103|FG000|Overall Study|Physician Decision|1|||
16917141|NCT03525678|38058104|FG001|Overall Study|Physician Decision|2|||
16917142|NCT03525678|38058105|FG002|Overall Study|Physician Decision|0|||
16917143|NCT03525678|38058103|FG000|Overall Study|Lost to Follow-up|1|||
16917144|NCT03525678|38058104|FG001|Overall Study|Lost to Follow-up|0|||
16917145|NCT03525678|38058105|FG002|Overall Study|Lost to Follow-up|0|||
16917146|NCT03525678|38058103|FG000|Overall Study|Death|32|||
16917147|NCT03525678|38058104|FG001|Overall Study|Death|31|||
16844016|NCT01852292|37788485|FG000|Overall Study|Protocol Violation|2|||
16844017|NCT01852292|37788486|FG001|Overall Study|Protocol Violation|0|||
16844018|NCT01852292|37788485|FG000|Overall Study|Non-compliance with study treatment|1|||
16844019|NCT01852292|37788486|FG001|Overall Study|Non-compliance with study treatment|0|||
16844020|NCT01852292|37788485|FG000|Overall Study|Study terminated by Sponsor|0|||
16844021|NCT01852292|37788486|FG001|Overall Study|Study terminated by Sponsor|1|||
16917148|NCT03525678|38058105|FG002|Overall Study|Death|4|||
16844022|NCT01852292|37788485|FG000|Overall Study|Progressive disease|42|||
16844023|NCT01852292|37788486|FG001|Overall Study|Progressive disease|52|||
16844024|NCT01715805|37788492|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
16844025|NCT01715805|37788493|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
16844026|NCT01715805|37788494|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
16844027|NCT01715805|37788495|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
16844028|NCT01715805|37788492|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
16844029|NCT01715805|37788493|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
16844030|NCT01715805|37788494|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
16844031|NCT01715805|37788495|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
16844032|NCT01715805|37788492|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
16844033|NCT01715805|37788493|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
16844034|NCT01715805|37788494|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
16844035|NCT01715805|37788495|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
16844036|NCT01715805|37788492|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
16844037|NCT01715805|37788493|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
16844038|NCT01715805|37788494|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
16917149|NCT02829918|38058113|FG000|Overall Study|Death|2|||
16917150|NCT02829918|38058113|FG000|Overall Study|Withdrawal by Subject|4|||
16917151|NCT02829918|38058113|FG000|Overall Study|Adverse Event|1|||
16917152|NCT02829918|38058113|FG000|Overall Study|Progression|1|||
16917153|NCT02743494|38058119|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
16917154|NCT02743494|38058120|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
16917155|NCT02743494|38058119|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
16917156|NCT02743494|38058120|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
16844039|NCT01715805|37788495|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
16844040|NCT01715805|37788492|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
16844041|NCT01715805|37788493|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
16844042|NCT01715805|37788494|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
16844043|NCT01715805|37788495|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
16844044|NCT01715805|37788492|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
16844045|NCT01715805|37788493|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
16844046|NCT01715805|37788494|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
16844047|NCT01715805|37788495|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
16844048|NCT01715805|37788492|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
16844049|NCT01715805|37788493|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
16844050|NCT01715805|37788494|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
16844051|NCT01715805|37788495|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
16844052|NCT01715805|37788492|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
16844053|NCT01715805|37788493|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
16844054|NCT01715805|37788494|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
16844055|NCT01715805|37788495|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
16844056|NCT01715805|37788492|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
16844057|NCT01715805|37788493|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
16844058|NCT01715805|37788494|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
16844059|NCT01715805|37788495|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
16844060|NCT01715805|37788492|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
16844061|NCT01715805|37788493|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
16844062|NCT01715805|37788494|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
16844063|NCT01715805|37788495|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
16844064|NCT01715805|37788492|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
16844065|NCT01715805|37788493|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
16844066|NCT01715805|37788494|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
16844067|NCT01715805|37788495|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
16844068|NCT01715805|37788492|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
16844069|NCT01715805|37788493|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
16844070|NCT01715805|37788494|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
16844071|NCT01715805|37788495|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
16844072|NCT01715805|37788492|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
16844073|NCT01715805|37788493|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
16844074|NCT01715805|37788494|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
16917157|NCT02743494|38058119|FG000|Treatment Period|Completed treatment|229|||
16917158|NCT02743494|38058120|FG001|Treatment Period|Completed treatment|99|||
16917159|NCT02743494|38058119|FG000|Treatment Period|Disease recurrence|149|||
16917160|NCT02743494|38058120|FG001|Treatment Period|Disease recurrence|113|||
16917161|NCT02743494|38058119|FG000|Treatment Period|Study drug toxicity|57|||
17016970|NCT00838110|38161561|FG000|Overall Study|Lost to Follow-up|3|||
16844075|NCT01715805|37788495|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
16844076|NCT01715805|37788492|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
16844077|NCT01715805|37788493|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
16844078|NCT01715805|37788494|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
16844079|NCT01715805|37788495|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
16917162|NCT02743494|38058120|FG001|Treatment Period|Study drug toxicity|8|||
16917163|NCT02743494|38058119|FG000|Treatment Period|Death|1|||
16844080|NCT01852214|37788503|FG000|Period 1|Adverse Event|1|||
16917164|NCT02743494|38058120|FG001|Treatment Period|Death|0|||
16917165|NCT02743494|38058119|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
16917166|NCT02743494|38058120|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
16917167|NCT02743494|38058119|FG000|Treatment Period|Participant request to discontinue treatment|30|||
16844081|NCT01852214|37788504|FG001|Period 1|Adverse Event|2|||
16844082|NCT01852214|37788503|FG000|Period 1|Withdrawal by Subject|0|||
16844083|NCT01852214|37788504|FG001|Period 1|Withdrawal by Subject|1|||
16844084|NCT01852214|37788503|FG000|Washout Period|Withdrawal by Subject|0|||
16844085|NCT01852214|37788504|FG001|Washout Period|Withdrawal by Subject|1|||
16844086|NCT01393990|37788529|FG000|Overall Study|Adverse Event|0|||
16917168|NCT02743494|38058120|FG001|Treatment Period|Participant request to discontinue treatment|5|||
16917169|NCT02743494|38058119|FG000|Treatment Period|Participant withdrew consent|12|||
16917170|NCT02743494|38058120|FG001|Treatment Period|Participant withdrew consent|4|||
16917171|NCT02743494|38058119|FG000|Treatment Period|Lost to Follow-up|0|||
16917172|NCT02743494|38058120|FG001|Treatment Period|Lost to Follow-up|1|||
16917173|NCT02743494|38058119|FG000|Treatment Period|Poor/Non-compliance|1|||
16917174|NCT02743494|38058120|FG001|Treatment Period|Poor/Non-compliance|0|||
16917175|NCT02743494|38058119|FG000|Treatment Period|Other reasons|7|||
16917176|NCT02743494|38058120|FG001|Treatment Period|Other reasons|2|||
16917177|NCT02454972|38058135|FG000|Overall Study|Progressive disease|17|||
16917178|NCT02454972|38058136|FG001|Overall Study|Progressive disease|16|||
16917179|NCT02454972|38058137|FG002|Overall Study|Progressive disease|59|||
16844087|NCT01393990|37788530|FG001|Overall Study|Adverse Event|0|||
16917180|NCT02454972|38058138|FG003|Overall Study|Progressive disease|23|||
16917181|NCT02454972|38058139|FG004|Overall Study|Progressive disease|16|||
16917182|NCT02454972|38058140|FG005|Overall Study|Progressive disease|12|||
16844088|NCT01393990|37788531|FG002|Overall Study|Adverse Event|0|||
16844089|NCT01393990|37788532|FG003|Overall Study|Adverse Event|0|||
16844090|NCT01393990|37788533|FG004|Overall Study|Adverse Event|0|||
16844091|NCT01393990|37788534|FG005|Overall Study|Adverse Event|0|||
16844092|NCT01393990|37788535|FG006|Overall Study|Adverse Event|0|||
16844093|NCT01393990|37788536|FG007|Overall Study|Adverse Event|0|||
16844094|NCT01393990|37788537|FG008|Overall Study|Adverse Event|0|||
16844095|NCT01393990|37788538|FG009|Overall Study|Adverse Event|0|||
16844096|NCT01393990|37788539|FG010|Overall Study|Adverse Event|0|||
16844097|NCT01393990|37788540|FG011|Overall Study|Adverse Event|0|||
16844098|NCT01393990|37788541|FG012|Overall Study|Adverse Event|0|||
16844099|NCT01393990|37788542|FG013|Overall Study|Adverse Event|0|||
16844100|NCT01393990|37788543|FG014|Overall Study|Adverse Event|1|||
16844101|NCT01393990|37788544|FG015|Overall Study|Adverse Event|1|||
16844102|NCT01393990|37788545|FG016|Overall Study|Adverse Event|0|||
16844103|NCT01393990|37788546|FG017|Overall Study|Adverse Event|0|||
16844104|NCT01393990|37788529|FG000|Overall Study|Progressive Disease|1|||
16844105|NCT01393990|37788530|FG001|Overall Study|Progressive Disease|0|||
16844106|NCT01393990|37788531|FG002|Overall Study|Progressive Disease|0|||
16844107|NCT01393990|37788532|FG003|Overall Study|Progressive Disease|1|||
16844108|NCT01393990|37788533|FG004|Overall Study|Progressive Disease|1|||
16844109|NCT01393990|37788534|FG005|Overall Study|Progressive Disease|1|||
16844110|NCT01393990|37788535|FG006|Overall Study|Progressive Disease|1|||
16844111|NCT01393990|37788536|FG007|Overall Study|Progressive Disease|1|||
16844112|NCT01393990|37788537|FG008|Overall Study|Progressive Disease|3|||
16844113|NCT01393990|37788538|FG009|Overall Study|Progressive Disease|1|||
16844114|NCT01393990|37788539|FG010|Overall Study|Progressive Disease|0|||
16844115|NCT01393990|37788540|FG011|Overall Study|Progressive Disease|0|||
16844116|NCT01393990|37788541|FG012|Overall Study|Progressive Disease|0|||
16844117|NCT01393990|37788542|FG013|Overall Study|Progressive Disease|1|||
16844118|NCT01393990|37788543|FG014|Overall Study|Progressive Disease|6|||
16844119|NCT01393990|37788544|FG015|Overall Study|Progressive Disease|1|||
16844120|NCT01393990|37788545|FG016|Overall Study|Progressive Disease|0|||
16844121|NCT01393990|37788546|FG017|Overall Study|Progressive Disease|0|||
16844122|NCT01393990|37788529|FG000|Overall Study|Death|0|||
16844123|NCT01393990|37788530|FG001|Overall Study|Death|0|||
16844124|NCT01393990|37788531|FG002|Overall Study|Death|0|||
16844125|NCT01393990|37788532|FG003|Overall Study|Death|0|||
16844126|NCT01393990|37788533|FG004|Overall Study|Death|1|||
16844127|NCT01393990|37788534|FG005|Overall Study|Death|0|||
16844128|NCT01393990|37788535|FG006|Overall Study|Death|0|||
16844129|NCT01393990|37788536|FG007|Overall Study|Death|0|||
16844130|NCT01393990|37788537|FG008|Overall Study|Death|0|||
16844131|NCT01393990|37788538|FG009|Overall Study|Death|0|||
16844132|NCT01393990|37788539|FG010|Overall Study|Death|0|||
16844133|NCT01393990|37788540|FG011|Overall Study|Death|0|||
16844134|NCT01393990|37788541|FG012|Overall Study|Death|0|||
16844135|NCT01393990|37788542|FG013|Overall Study|Death|1|||
16844136|NCT01393990|37788543|FG014|Overall Study|Death|1|||
16844137|NCT01393990|37788544|FG015|Overall Study|Death|0|||
16844138|NCT01393990|37788545|FG016|Overall Study|Death|0|||
16844139|NCT01393990|37788546|FG017|Overall Study|Death|0|||
16844140|NCT01393990|37788529|FG000|Overall Study|Withdrawal by Subject|0|||
16844141|NCT01393990|37788530|FG001|Overall Study|Withdrawal by Subject|0|||
16844142|NCT01393990|37788531|FG002|Overall Study|Withdrawal by Subject|0|||
16844143|NCT01393990|37788532|FG003|Overall Study|Withdrawal by Subject|0|||
16844144|NCT01393990|37788533|FG004|Overall Study|Withdrawal by Subject|0|||
16844145|NCT01393990|37788534|FG005|Overall Study|Withdrawal by Subject|0|||
16844146|NCT01393990|37788535|FG006|Overall Study|Withdrawal by Subject|0|||
16844147|NCT01393990|37788536|FG007|Overall Study|Withdrawal by Subject|0|||
16844148|NCT01393990|37788537|FG008|Overall Study|Withdrawal by Subject|0|||
16844149|NCT01393990|37788538|FG009|Overall Study|Withdrawal by Subject|0|||
16844150|NCT01393990|37788539|FG010|Overall Study|Withdrawal by Subject|0|||
16844151|NCT01393990|37788540|FG011|Overall Study|Withdrawal by Subject|0|||
16844152|NCT01393990|37788541|FG012|Overall Study|Withdrawal by Subject|0|||
16844153|NCT01393990|37788542|FG013|Overall Study|Withdrawal by Subject|0|||
16844154|NCT01393990|37788543|FG014|Overall Study|Withdrawal by Subject|1|||
16844155|NCT01393990|37788544|FG015|Overall Study|Withdrawal by Subject|1|||
16844156|NCT01393990|37788545|FG016|Overall Study|Withdrawal by Subject|0|||
16844157|NCT01393990|37788546|FG017|Overall Study|Withdrawal by Subject|0|||
16844158|NCT00210184|37788595|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
16844159|NCT00210106|37788599|FG000|Overall Study|Death|1|||
16844160|NCT00210106|37788599|FG000|Overall Study|Protocol Violation|13|||
16844161|NCT01852058|37788607|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
16844162|NCT01852058|37788608|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844163|NCT01852058|37788609|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844164|NCT01852058|37788610|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844165|NCT01852058|37788611|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844166|NCT01852058|37788612|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844167|NCT01852058|37788613|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844168|NCT01852058|37788614|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844169|NCT01852058|37788615|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844170|NCT01852058|37788616|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844171|NCT01852058|37788617|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844172|NCT01852058|37788618|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16844173|NCT01852058|37788607|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844174|NCT01852058|37788608|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844175|NCT01852058|37788609|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844176|NCT01852058|37788610|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844177|NCT01852058|37788611|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
16844178|NCT01852058|37788612|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844179|NCT01852058|37788613|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844180|NCT01852058|37788614|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844181|NCT01852058|37788615|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844182|NCT01852058|37788616|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844183|NCT01852058|37788617|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844184|NCT01852058|37788618|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16844185|NCT01852058|37788607|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844186|NCT01852058|37788608|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844187|NCT01852058|37788609|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844188|NCT01852058|37788610|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844189|NCT01852058|37788611|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
16844190|NCT01852058|37788612|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
16844191|NCT01852058|37788613|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844192|NCT01852058|37788614|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844193|NCT01852058|37788615|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844194|NCT01852058|37788616|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844195|NCT01852058|37788617|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844196|NCT01852058|37788618|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16844197|NCT01852058|37788607|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16917183|NCT02454972|38058141|FG006|Overall Study|Progressive disease|19|||
17102458|NCT03631732|38241391|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
17102459|NCT03631732|38241392|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
16917184|NCT02454972|38058142|FG007|Overall Study|Progressive disease|27|||
16917185|NCT02454972|38058143|FG008|Overall Study|Progressive disease|0|||
16917186|NCT02454972|38058135|FG000|Overall Study|Death|0|||
16917187|NCT02454972|38058136|FG001|Overall Study|Death|0|||
16917188|NCT02454972|38058137|FG002|Overall Study|Death|5|||
16917189|NCT02454972|38058138|FG003|Overall Study|Death|1|||
16917190|NCT02454972|38058139|FG004|Overall Study|Death|0|||
16917191|NCT02454972|38058140|FG005|Overall Study|Death|0|||
16917192|NCT02454972|38058141|FG006|Overall Study|Death|0|||
16917193|NCT02454972|38058142|FG007|Overall Study|Death|0|||
16917194|NCT02454972|38058143|FG008|Overall Study|Death|95|||
16917195|NCT02454972|38058135|FG000|Overall Study|Physician Decision|0|||
16917196|NCT02454972|38058136|FG001|Overall Study|Physician Decision|1|||
16917197|NCT02454972|38058137|FG002|Overall Study|Physician Decision|2|||
16917198|NCT02454972|38058138|FG003|Overall Study|Physician Decision|1|||
16917199|NCT02454972|38058139|FG004|Overall Study|Physician Decision|2|||
16917200|NCT02454972|38058140|FG005|Overall Study|Physician Decision|0|||
16917201|NCT02454972|38058141|FG006|Overall Study|Physician Decision|0|||
16917202|NCT02454972|38058142|FG007|Overall Study|Physician Decision|1|||
16917203|NCT02454972|38058143|FG008|Overall Study|Physician Decision|0|||
16917204|NCT02454972|38058135|FG000|Overall Study|Non treatment-related adverse event|2|||
16917205|NCT02454972|38058136|FG001|Overall Study|Non treatment-related adverse event|0|||
16917206|NCT02454972|38058137|FG002|Overall Study|Non treatment-related adverse event|1|||
16917207|NCT02454972|38058138|FG003|Overall Study|Non treatment-related adverse event|0|||
16917208|NCT02454972|38058139|FG004|Overall Study|Non treatment-related adverse event|0|||
16917209|NCT02454972|38058140|FG005|Overall Study|Non treatment-related adverse event|1|||
16917210|NCT02454972|38058141|FG006|Overall Study|Non treatment-related adverse event|0|||
16917211|NCT02454972|38058142|FG007|Overall Study|Non treatment-related adverse event|1|||
16917212|NCT02454972|38058143|FG008|Overall Study|Non treatment-related adverse event|0|||
16917213|NCT02454972|38058135|FG000|Overall Study|Treatment-related adverse events|0|||
16917214|NCT02454972|38058136|FG001|Overall Study|Treatment-related adverse events|1|||
16917215|NCT02454972|38058137|FG002|Overall Study|Treatment-related adverse events|1|||
16917216|NCT02454972|38058138|FG003|Overall Study|Treatment-related adverse events|0|||
16917217|NCT02454972|38058139|FG004|Overall Study|Treatment-related adverse events|2|||
16917218|NCT02454972|38058140|FG005|Overall Study|Treatment-related adverse events|0|||
16917219|NCT02454972|38058141|FG006|Overall Study|Treatment-related adverse events|0|||
16917220|NCT02454972|38058142|FG007|Overall Study|Treatment-related adverse events|2|||
17016971|NCT00838110|38161562|FG001|Overall Study|Lost to Follow-up|0|||
17016972|NCT00838110|38161563|FG002|Overall Study|Lost to Follow-up|0|||
17016973|NCT00838110|38161564|FG003|Overall Study|Lost to Follow-up|0|||
17016974|NCT00838110|38161561|FG000|Overall Study|Did not meet eligibility criteria|0|||
17016975|NCT00838110|38161562|FG001|Overall Study|Did not meet eligibility criteria|0|||
17016976|NCT00838110|38161563|FG002|Overall Study|Did not meet eligibility criteria|1|||
17016977|NCT00838110|38161564|FG003|Overall Study|Did not meet eligibility criteria|2|||
17016978|NCT00838110|38161561|FG000|Overall Study|Randomized but not treated|0|||
17016979|NCT00838110|38161562|FG001|Overall Study|Randomized but not treated|1|||
17016980|NCT00838110|38161563|FG002|Overall Study|Randomized but not treated|0|||
17016981|NCT00838110|38161564|FG003|Overall Study|Randomized but not treated|0|||
17016982|NCT00837876|38161574|FG000|Overall Study|Death|2|||
17016983|NCT00837876|38161574|FG000|Overall Study|Adverse Event|7|||
17016984|NCT00837876|38161574|FG000|Overall Study|Physician Decision|1|||
17016985|NCT00837876|38161574|FG000|Overall Study|Withdrawal by Subject|3|||
17016986|NCT00837876|38161574|FG000|Overall Study|disease progression|24|||
17016987|NCT00686920|38161580|FG000|Overall Study|Death|45|||
17016988|NCT00686920|38161581|FG001|Overall Study|Death|14|||
17016989|NCT00686920|38161580|FG000|Overall Study|Liver Transplant|23|||
17016990|NCT00686920|38161581|FG001|Overall Study|Liver Transplant|8|||
17016991|NCT00686920|38161580|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
17016992|NCT00686920|38161581|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
17016993|NCT00686920|38161580|FG000|Overall Study|Withdrawal by Subject|23|||
17016994|NCT00686920|38161581|FG001|Overall Study|Withdrawal by Subject|5|||
17016995|NCT00686920|38161580|FG000|Overall Study|Protocol Violation|2|||
17016996|NCT00686920|38161581|FG001|Overall Study|Protocol Violation|1|||
17016997|NCT00686920|38161580|FG000|Overall Study|Adverse Event|10|||
17016998|NCT00686920|38161581|FG001|Overall Study|Adverse Event|2|||
17016999|NCT00686920|38161580|FG000|Overall Study|Personal Reason|0|||
17017000|NCT00686920|38161581|FG001|Overall Study|Personal Reason|1|||
17017001|NCT00686920|38161580|FG000|Overall Study|Lost to Follow-up|15|||
17017002|NCT00686920|38161581|FG001|Overall Study|Lost to Follow-up|3|||
17017003|NCT00686920|38161580|FG000|Overall Study|Moved to Another State|1|||
17017004|NCT00686920|38161581|FG001|Overall Study|Moved to Another State|0|||
17017005|NCT00686920|38161580|FG000|Overall Study|Transferred to Nursing Home|1|||
17017006|NCT00686920|38161581|FG001|Overall Study|Transferred to Nursing Home|0|||
17017007|NCT00686920|38161580|FG000|Overall Study|Noncompliance|9|||
17017008|NCT00686920|38161581|FG001|Overall Study|Noncompliance|0|||
17017009|NCT00686920|38161580|FG000|Overall Study|Principal Investigator Decision|2|||
17017010|NCT00686920|38161581|FG001|Overall Study|Principal Investigator Decision|0|||
17102460|NCT03631732|38241391|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
17102461|NCT03631732|38241392|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
17102462|NCT03631732|38241391|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
17102463|NCT03631732|38241392|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
17102464|NCT03630016|38241402|FG000|Overall Study|Poor Sensor Placement|1|||
17102465|NCT03628924|38241409|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
17102466|NCT03628924|38241410|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
17102467|NCT03628924|38241411|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
16917221|NCT02454972|38058143|FG008|Overall Study|Treatment-related adverse events|0|||
16917222|NCT02454972|38058135|FG000|Overall Study|Patient moves to compassionate use|0|||
16917223|NCT02454972|38058136|FG001|Overall Study|Patient moves to compassionate use|0|||
16917224|NCT02454972|38058137|FG002|Overall Study|Patient moves to compassionate use|0|||
16917225|NCT02454972|38058138|FG003|Overall Study|Patient moves to compassionate use|0|||
16917226|NCT02454972|38058139|FG004|Overall Study|Patient moves to compassionate use|0|||
16917227|NCT02454972|38058140|FG005|Overall Study|Patient moves to compassionate use|0|||
16917228|NCT02454972|38058141|FG006|Overall Study|Patient moves to compassionate use|2|||
16917229|NCT02454972|38058142|FG007|Overall Study|Patient moves to compassionate use|0|||
16917230|NCT02454972|38058143|FG008|Overall Study|Patient moves to compassionate use|0|||
16917231|NCT02454972|38058135|FG000|Overall Study|Withdrawal by Subject|0|||
16917232|NCT02454972|38058136|FG001|Overall Study|Withdrawal by Subject|1|||
16917233|NCT02454972|38058137|FG002|Overall Study|Withdrawal by Subject|5|||
16917234|NCT02454972|38058138|FG003|Overall Study|Withdrawal by Subject|2|||
16917235|NCT02454972|38058139|FG004|Overall Study|Withdrawal by Subject|3|||
16917236|NCT02454972|38058140|FG005|Overall Study|Withdrawal by Subject|2|||
16917237|NCT02454972|38058141|FG006|Overall Study|Withdrawal by Subject|0|||
16917238|NCT02454972|38058142|FG007|Overall Study|Withdrawal by Subject|1|||
16917239|NCT02454972|38058143|FG008|Overall Study|Withdrawal by Subject|2|||
16917240|NCT02454972|38058135|FG000|Overall Study|Multiple delay/holds on treatment|0|||
16917241|NCT02454972|38058136|FG001|Overall Study|Multiple delay/holds on treatment|0|||
16917242|NCT02454972|38058137|FG002|Overall Study|Multiple delay/holds on treatment|0|||
16917243|NCT02454972|38058138|FG003|Overall Study|Multiple delay/holds on treatment|1|||
16917244|NCT02454972|38058139|FG004|Overall Study|Multiple delay/holds on treatment|0|||
16917245|NCT02454972|38058140|FG005|Overall Study|Multiple delay/holds on treatment|0|||
16917246|NCT02454972|38058141|FG006|Overall Study|Multiple delay/holds on treatment|0|||
16917247|NCT02454972|38058142|FG007|Overall Study|Multiple delay/holds on treatment|0|||
16917248|NCT02454972|38058143|FG008|Overall Study|Multiple delay/holds on treatment|0|||
16917249|NCT02454972|38058135|FG000|Overall Study|Never treated|0|||
16917250|NCT02454972|38058136|FG001|Overall Study|Never treated|0|||
16917251|NCT02454972|38058137|FG002|Overall Study|Never treated|3|||
16917252|NCT02454972|38058138|FG003|Overall Study|Never treated|1|||
16917253|NCT02454972|38058139|FG004|Overall Study|Never treated|1|||
16917254|NCT02454972|38058140|FG005|Overall Study|Never treated|0|||
16917255|NCT02454972|38058141|FG006|Overall Study|Never treated|0|||
16917256|NCT02454972|38058142|FG007|Overall Study|Never treated|0|||
16917257|NCT02454972|38058143|FG008|Overall Study|Never treated|5|||
16917258|NCT02454972|38058135|FG000|Overall Study|Lost to Follow-up|0|||
16917259|NCT02454972|38058136|FG001|Overall Study|Lost to Follow-up|0|||
16917260|NCT02454972|38058137|FG002|Overall Study|Lost to Follow-up|0|||
16917261|NCT02454972|38058138|FG003|Overall Study|Lost to Follow-up|0|||
16917262|NCT02454972|38058139|FG004|Overall Study|Lost to Follow-up|0|||
16917263|NCT02454972|38058140|FG005|Overall Study|Lost to Follow-up|0|||
16917264|NCT02454972|38058141|FG006|Overall Study|Lost to Follow-up|0|||
16917265|NCT02454972|38058142|FG007|Overall Study|Lost to Follow-up|0|||
16917266|NCT02454972|38058143|FG008|Overall Study|Lost to Follow-up|2|||
16917267|NCT02454972|38058135|FG000|Overall Study|Study termination|0|||
16917268|NCT02454972|38058136|FG001|Overall Study|Study termination|0|||
16917269|NCT02454972|38058137|FG002|Overall Study|Study termination|0|||
16917270|NCT02454972|38058138|FG003|Overall Study|Study termination|0|||
16917271|NCT02454972|38058139|FG004|Overall Study|Study termination|0|||
16917272|NCT02454972|38058140|FG005|Overall Study|Study termination|0|||
16917273|NCT02454972|38058141|FG006|Overall Study|Study termination|0|||
16917274|NCT02454972|38058142|FG007|Overall Study|Study termination|0|||
16917275|NCT02454972|38058143|FG008|Overall Study|Study termination|6|||
16917276|NCT01096368|38058160|FG000|Overall Study|Death|0|||
16917277|NCT01096368|38058161|FG001|Overall Study|Death|1|||
16917278|NCT01096368|38058162|FG002|Overall Study|Death|0|||
16917279|NCT01096368|38058163|FG003|Overall Study|Death|0|||
16917280|NCT01096368|38058164|FG004|Overall Study|Death|0|||
16917281|NCT01096368|38058160|FG000|Overall Study|Physician Decision|0|||
16917282|NCT01096368|38058161|FG001|Overall Study|Physician Decision|13|||
16917283|NCT01096368|38058162|FG002|Overall Study|Physician Decision|2|||
16917284|NCT01096368|38058163|FG003|Overall Study|Physician Decision|4|||
16917285|NCT01096368|38058164|FG004|Overall Study|Physician Decision|6|||
16917286|NCT01096368|38058160|FG000|Overall Study|Withdrawal by Subject|0|||
16917287|NCT01096368|38058161|FG001|Overall Study|Withdrawal by Subject|52|||
16917288|NCT01096368|38058162|FG002|Overall Study|Withdrawal by Subject|0|||
16917289|NCT01096368|38058163|FG003|Overall Study|Withdrawal by Subject|10|||
16917290|NCT01096368|38058164|FG004|Overall Study|Withdrawal by Subject|14|||
16917291|NCT01096368|38058160|FG000|Overall Study|Ineligible|0|||
16917292|NCT01096368|38058161|FG001|Overall Study|Ineligible|3|||
16917293|NCT01096368|38058162|FG002|Overall Study|Ineligible|2|||
16917294|NCT01096368|38058163|FG003|Overall Study|Ineligible|0|||
16917295|NCT01096368|38058164|FG004|Overall Study|Ineligible|25|||
16917296|NCT01096368|38058160|FG000|Overall Study|Did not start treatment|0|||
16917297|NCT01096368|38058161|FG001|Overall Study|Did not start treatment|4|||
16917298|NCT01096368|38058162|FG002|Overall Study|Did not start treatment|4|||
16917299|NCT01096368|38058163|FG003|Overall Study|Did not start treatment|0|||
17017011|NCT00845832|38161590|FG000|Treatment Period|Adverse Event|0|||
17017012|NCT00845832|38161591|FG001|Treatment Period|Adverse Event|2|||
17102468|NCT03628924|38241412|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
17102469|NCT03628924|38241413|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
17102470|NCT03628924|38241414|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
17102471|NCT03628924|38241415|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
17102472|NCT03628924|38241409|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
17102473|NCT03628924|38241410|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
17102474|NCT03628924|38241411|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
17102475|NCT03628924|38241412|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
17102476|NCT03628924|38241413|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
17102477|NCT03628924|38241414|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
17102478|NCT03628924|38241415|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
17102479|NCT03628924|38241409|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
17102480|NCT03628924|38241410|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
17017013|NCT00845832|38161592|FG002|Treatment Period|Adverse Event|0|||
17017014|NCT00845832|38161590|FG000|Treatment Period|Protocol Violation|1|||
17017015|NCT00845832|38161591|FG001|Treatment Period|Protocol Violation|1|||
17017016|NCT00845832|38161592|FG002|Treatment Period|Protocol Violation|0|||
17017017|NCT00845832|38161590|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
17017018|NCT00845832|38161591|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
17017019|NCT00845832|38161592|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
17017020|NCT00845832|38161590|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
17017021|NCT00845832|38161591|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
17017022|NCT00845832|38161592|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
17017023|NCT00591864|38161600|FG000|Overall Study|Incomplete Imaging|5|||
17017024|NCT00885755|38161608|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
17017025|NCT00885755|38161609|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
17017026|NCT00885755|38161610|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
17017027|NCT00885755|38161608|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
17017028|NCT00885755|38161609|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
17017029|NCT00885755|38161610|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
17017030|NCT00885755|38161608|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
17017031|NCT00885755|38161609|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
17017032|NCT00885755|38161610|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
17017033|NCT00885755|38161608|FG000|Part I: Trastuzumab+Taxane|Death|0|||
17017034|NCT00885755|38161609|FG001|Part I: Trastuzumab+Taxane|Death|0|||
17017035|NCT00885755|38161610|FG002|Part I: Trastuzumab+Taxane|Death|1|||
17017036|NCT00885755|38161608|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
17017037|NCT00885755|38161609|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
17017038|NCT00885755|38161610|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
17017039|NCT00837486|38161620|FG000|Blinded-treatment Phase|Physician Decision|1|||
17017040|NCT00837486|38161621|FG001|Blinded-treatment Phase|Physician Decision|0|||
17102481|NCT03628924|38241411|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
17102482|NCT03628924|38241412|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
17102483|NCT03628924|38241413|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
17102484|NCT03628924|38241414|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
17102485|NCT03628924|38241415|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
17102486|NCT03628924|38241409|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
17017041|NCT00837486|38161620|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
17017042|NCT00837486|38161621|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
17017043|NCT00837486|38161620|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
17017044|NCT00837486|38161621|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
17017045|NCT00837486|38161620|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
17102487|NCT03628924|38241410|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
17102488|NCT03628924|38241411|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16917300|NCT01096368|38058164|FG004|Overall Study|Did not start treatment|0|||
16917301|NCT01096368|38058160|FG000|Overall Study|Progressive disease|0|||
16917302|NCT01096368|38058161|FG001|Overall Study|Progressive disease|6|||
16917303|NCT01096368|38058162|FG002|Overall Study|Progressive disease|0|||
16917304|NCT01096368|38058163|FG003|Overall Study|Progressive disease|10|||
16917305|NCT01096368|38058164|FG004|Overall Study|Progressive disease|3|||
16917306|NCT01096368|38058160|FG000|Overall Study|Other|0|||
16917307|NCT01096368|38058161|FG001|Overall Study|Other|0|||
16917308|NCT01096368|38058162|FG002|Overall Study|Other|1|||
16917309|NCT01096368|38058163|FG003|Overall Study|Other|0|||
16917310|NCT01096368|38058164|FG004|Overall Study|Other|0|||
16917311|NCT01096368|38058160|FG000|Overall Study|Treated with institutional review|0|||
16917312|NCT01096368|38058161|FG001|Overall Study|Treated with institutional review|0|||
16917313|NCT01096368|38058162|FG002|Overall Study|Treated with institutional review|0|||
16917314|NCT01096368|38058163|FG003|Overall Study|Treated with institutional review|0|||
16917315|NCT01096368|38058164|FG004|Overall Study|Treated with institutional review|1|||
16917316|NCT00063882|38058185|FG000|Overall Study|Protocol Violation|3|||
16917317|NCT00063882|38058186|FG001|Overall Study|Protocol Violation|3|||
16917318|NCT00063882|38058185|FG000|Overall Study|Withdrawal by Subject|2|||
16917319|NCT00063882|38058186|FG001|Overall Study|Withdrawal by Subject|1|||
16917320|NCT01279044|38058195|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
17102489|NCT03628924|38241412|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
17102490|NCT03628924|38241413|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16917321|NCT01279044|38058196|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
16917322|NCT01279044|38058197|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
16917323|NCT01279044|38058195|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
16917324|NCT01279044|38058196|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
16917325|NCT01279044|38058197|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
16917326|NCT01279044|38058195|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
16917327|NCT01279044|38058196|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
16917328|NCT01279044|38058197|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
16917329|NCT01278342|38058206|FG000|Overall Study|Physician Decision|0|||
16917330|NCT01278342|38058207|FG001|Overall Study|Physician Decision|1|||
16917331|NCT01278342|38058208|FG002|Overall Study|Physician Decision|0|||
16917332|NCT01278342|38058206|FG000|Overall Study|Lost to Follow-up|1|||
16917333|NCT01278342|38058207|FG001|Overall Study|Lost to Follow-up|0|||
16917334|NCT01278342|38058208|FG002|Overall Study|Lost to Follow-up|0|||
16917335|NCT01278342|38058206|FG000|Overall Study|Administrative problems|2|||
16917336|NCT01278342|38058207|FG001|Overall Study|Administrative problems|0|||
16917337|NCT01278342|38058208|FG002|Overall Study|Administrative problems|0|||
16917338|NCT01278342|38058206|FG000|Overall Study|Other|1|||
16917339|NCT01278342|38058207|FG001|Overall Study|Other|0|||
16917340|NCT01278342|38058208|FG002|Overall Study|Other|0|||
16917341|NCT01278030|38058218|FG000|Overall Study|Withdrawal by Subject|8|||
16917342|NCT01278030|38058219|FG001|Overall Study|Withdrawal by Subject|4|||
16917343|NCT01277718|38058225|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
16917344|NCT01277718|38058226|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
16917345|NCT01277718|38058225|FG000|Period 2 - Second Intervention|Physician Decision|0|||
16917346|NCT01277718|38058226|FG001|Period 2 - Second Intervention|Physician Decision|2|||
16917347|NCT01276236|38058234|FG000|Overall Study|Lack of Efficacy|2|||
16917348|NCT01276236|38058234|FG000|Overall Study|Withdrawal by Subject|4|||
17102491|NCT03628924|38241414|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
17102492|NCT03628924|38241415|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
17102493|NCT03628924|38241409|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
17102494|NCT03628924|38241410|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
17102495|NCT03628924|38241411|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
17102496|NCT03628924|38241412|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
17102497|NCT03628924|38241413|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
17102498|NCT03628924|38241414|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
17102499|NCT03628924|38241415|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
17102500|NCT03628924|38241409|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
17102501|NCT03628924|38241410|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
17102502|NCT03628924|38241411|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
17102503|NCT03628924|38241412|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
16844198|NCT01852058|37788608|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844199|NCT01852058|37788609|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844200|NCT01852058|37788610|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844201|NCT01852058|37788611|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
16844202|NCT01852058|37788612|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844203|NCT01852058|37788613|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16917349|NCT01275222|38058244|FG000|Phase l by Treatment|Adverse Event|1|||
16917350|NCT01275222|38058245|FG001|Phase l by Treatment|Adverse Event|4|||
16917351|NCT01275222|38058246|FG002|Phase l by Treatment|Adverse Event|2|||
16917352|NCT01275222|38058247|FG003|Phase l by Treatment|Adverse Event|3|||
16844204|NCT01852058|37788614|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844205|NCT01852058|37788615|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844206|NCT01852058|37788616|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844207|NCT01852058|37788617|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844208|NCT01852058|37788618|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16844209|NCT01852058|37788607|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844210|NCT01852058|37788608|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844211|NCT01852058|37788609|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16917353|NCT01275222|38058248|FG004|Phase l by Treatment|Adverse Event|0|||
16917354|NCT01275222|38058249|FG005|Phase l by Treatment|Adverse Event|0|||
16917355|NCT01275222|38058244|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16917356|NCT01275222|38058245|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16917357|NCT01275222|38058246|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
16917358|NCT01275222|38058247|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16917359|NCT01275222|38058248|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16917360|NCT01275222|38058249|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16917361|NCT01275222|38058244|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16917362|NCT01275222|38058245|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16917363|NCT01275222|38058246|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16917364|NCT01275222|38058247|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
16917365|NCT01275222|38058248|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16917366|NCT01275222|38058249|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16917367|NCT01275222|38058244|FG000|Phase l by Treatment|Disease progression|12|||
16917368|NCT01275222|38058245|FG001|Phase l by Treatment|Disease progression|8|||
16917369|NCT01275222|38058246|FG002|Phase l by Treatment|Disease progression|2|||
16917370|NCT01275222|38058247|FG003|Phase l by Treatment|Disease progression|5|||
16917371|NCT01275222|38058248|FG004|Phase l by Treatment|Disease progression|0|||
16917372|NCT01275222|38058249|FG005|Phase l by Treatment|Disease progression|0|||
16917373|NCT01275222|38058244|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
16917374|NCT01275222|38058245|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
16917375|NCT01275222|38058246|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
16917376|NCT01275222|38058247|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
17017046|NCT00837486|38161621|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
17017047|NCT00845676|38161629|FG000|Overall Study|Virologic breakthrough at week 20|1|||
17017048|NCT00845676|38161629|FG000|Overall Study|Adverse Event|1|||
17017049|NCT00883181|38161634|FG000|Overall Study|Hematological Adverse Event|26|||
17017050|NCT00883181|38161634|FG000|Overall Study|Non-hematological Adverse Event|55|||
17017051|NCT00883181|38161634|FG000|Overall Study|Disease Progression|94|||
17017052|NCT00883181|38161634|FG000|Overall Study|Administrative Reason|24|||
17017053|NCT00883181|38161634|FG000|Overall Study|Withdrawal by Subject|4|||
17017054|NCT00883181|38161634|FG000|Overall Study|Death|31|||
17017055|NCT00883181|38161634|FG000|Overall Study|Other|38|||
17017056|NCT00883181|38161634|FG000|Overall Study|Protocol Deviation|3|||
17017057|NCT00883181|38161634|FG000|Overall Study|Noncompliance|3|||
17017058|NCT00845520|38161654|FG000|Overall Study|Death|1|||
17017059|NCT00845520|38161655|FG001|Overall Study|Death|2|||
16844212|NCT01852058|37788610|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844213|NCT01852058|37788611|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
16844214|NCT01852058|37788612|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
16844215|NCT01852058|37788613|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844216|NCT01852058|37788614|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844217|NCT01852058|37788615|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844218|NCT01852058|37788616|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844219|NCT01852058|37788617|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844220|NCT01852058|37788618|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16844221|NCT01852058|37788607|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844222|NCT01852058|37788608|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844223|NCT01852058|37788609|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844224|NCT01852058|37788610|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
16844225|NCT01852058|37788611|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844226|NCT01852058|37788612|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844227|NCT01852058|37788613|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844228|NCT01852058|37788614|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844229|NCT01852058|37788615|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844230|NCT01852058|37788616|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
17017060|NCT00845520|38161656|FG002|Overall Study|Death|0|||
17017061|NCT00845520|38161654|FG000|Overall Study|Lost to Follow-up|1|||
17017062|NCT00845520|38161655|FG001|Overall Study|Lost to Follow-up|0|||
17017063|NCT00845520|38161656|FG002|Overall Study|Lost to Follow-up|0|||
16844231|NCT01852058|37788617|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844232|NCT01852058|37788618|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16844233|NCT01852058|37788607|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844234|NCT01852058|37788608|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844235|NCT01852058|37788609|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844236|NCT01852058|37788610|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844237|NCT01852058|37788611|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
16844238|NCT01852058|37788612|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
16844239|NCT01852058|37788613|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844240|NCT01852058|37788614|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844241|NCT01852058|37788615|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844242|NCT01852058|37788616|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844243|NCT01852058|37788617|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844244|NCT01852058|37788618|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16844245|NCT01852058|37788607|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844246|NCT01852058|37788608|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844247|NCT01852058|37788609|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844248|NCT01852058|37788610|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844249|NCT01852058|37788611|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844250|NCT01852058|37788612|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844251|NCT01852058|37788613|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844252|NCT01852058|37788614|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
16844253|NCT01852058|37788615|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844254|NCT01852058|37788616|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844255|NCT01852058|37788617|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844256|NCT01852058|37788618|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16844257|NCT01852058|37788607|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844258|NCT01852058|37788608|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844259|NCT01852058|37788609|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844260|NCT01852058|37788610|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844261|NCT01852058|37788611|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844262|NCT01852058|37788612|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844263|NCT01852058|37788613|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844264|NCT01852058|37788614|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844265|NCT01852058|37788615|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
16844266|NCT01852058|37788616|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844267|NCT01852058|37788617|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16917377|NCT01275222|38058248|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
16917378|NCT01275222|38058249|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
16917379|NCT01275222|38058244|FG000|Phase l by Treatment|Death|0|||
16917380|NCT01275222|38058245|FG001|Phase l by Treatment|Death|1|||
16917381|NCT01275222|38058246|FG002|Phase l by Treatment|Death|0|||
16917382|NCT01275222|38058247|FG003|Phase l by Treatment|Death|1|||
16917383|NCT01275222|38058248|FG004|Phase l by Treatment|Death|0|||
16917384|NCT01275222|38058249|FG005|Phase l by Treatment|Death|0|||
16917385|NCT01275222|38058244|FG000|Phase ll by Stratum|Adverse Event|0|||
16917386|NCT01275222|38058245|FG001|Phase ll by Stratum|Adverse Event|0|||
16917387|NCT01275222|38058246|FG002|Phase ll by Stratum|Adverse Event|0|||
16917388|NCT01275222|38058247|FG003|Phase ll by Stratum|Adverse Event|0|||
16917389|NCT01275222|38058248|FG004|Phase ll by Stratum|Adverse Event|2|||
16917390|NCT01275222|38058249|FG005|Phase ll by Stratum|Adverse Event|10|||
16917391|NCT01275222|38058244|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
16917392|NCT01275222|38058245|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
16917393|NCT01275222|38058246|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
16917394|NCT01275222|38058247|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
16917395|NCT01275222|38058248|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
16917396|NCT01275222|38058249|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
16917397|NCT01275222|38058244|FG000|Phase ll by Stratum|Disease progression|0|||
16917398|NCT01275222|38058245|FG001|Phase ll by Stratum|Disease progression|0|||
16917399|NCT01275222|38058246|FG002|Phase ll by Stratum|Disease progression|0|||
16917400|NCT01275222|38058247|FG003|Phase ll by Stratum|Disease progression|0|||
16917401|NCT01275222|38058248|FG004|Phase ll by Stratum|Disease progression|23|||
16917402|NCT01275222|38058249|FG005|Phase ll by Stratum|Disease progression|31|||
16917403|NCT01275222|38058244|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
16917404|NCT01275222|38058245|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
16917405|NCT01275222|38058246|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
16917406|NCT01275222|38058247|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
16844268|NCT01852058|37788618|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16844269|NCT01851590|37788656|FG000|Overall Study|Withdrawal by Subject|0|||
16844270|NCT01851590|37788657|FG001|Overall Study|Withdrawal by Subject|0|||
16844271|NCT01851590|37788658|FG002|Overall Study|Withdrawal by Subject|1|||
16844272|NCT01851590|37788656|FG000|Overall Study|Adverse Event|0|||
16844273|NCT01851590|37788657|FG001|Overall Study|Adverse Event|0|||
16844274|NCT01851590|37788658|FG002|Overall Study|Adverse Event|2|||
16844275|NCT01851590|37788656|FG000|Overall Study|Lack of Efficacy|0|||
16844276|NCT01851590|37788657|FG001|Overall Study|Lack of Efficacy|1|||
16844277|NCT01851590|37788658|FG002|Overall Study|Lack of Efficacy|0|||
16844278|NCT00218296|37788672|FG000|Overall Study|Lost to Follow-up|9|||
16844279|NCT00218296|37788673|FG001|Overall Study|Lost to Follow-up|7|||
16844280|NCT00218296|37788672|FG000|Overall Study|Withdrawal by Subject|36|||
16844281|NCT00218296|37788673|FG001|Overall Study|Withdrawal by Subject|47|||
16844282|NCT00218296|37788672|FG000|Overall Study|Randomized but did not enter treatment|66|||
16844283|NCT00218296|37788673|FG001|Overall Study|Randomized but did not enter treatment|67|||
16844284|NCT01824290|37788683|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
16844285|NCT01824290|37788684|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
16844286|NCT01824290|37788685|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
16844287|NCT01824290|37788686|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
16844288|NCT01824290|37788683|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
16844289|NCT01824290|37788684|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
16844290|NCT01824290|37788685|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
16844291|NCT01824290|37788686|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
16844292|NCT01824290|37788683|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
16844293|NCT01824290|37788684|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
16844294|NCT01824290|37788685|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
16844295|NCT01824290|37788686|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
16844296|NCT01824290|37788683|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
16844297|NCT01824290|37788684|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
16844298|NCT01824290|37788685|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
16844299|NCT01824290|37788686|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
16844300|NCT01824290|37788683|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
16844301|NCT01824290|37788684|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
16844302|NCT01824290|37788685|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
16844303|NCT01824290|37788686|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
16844304|NCT01824290|37788683|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
16844305|NCT01824290|37788684|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
16917407|NCT01275222|38058248|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
16917408|NCT01275222|38058249|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
16917409|NCT01275222|38058244|FG000|Phase ll by Stratum|Death|0|||
16917410|NCT01275222|38058245|FG001|Phase ll by Stratum|Death|0|||
16917411|NCT01275222|38058246|FG002|Phase ll by Stratum|Death|0|||
16917412|NCT01275222|38058247|FG003|Phase ll by Stratum|Death|0|||
16917413|NCT01275222|38058248|FG004|Phase ll by Stratum|Death|1|||
16917414|NCT01275222|38058249|FG005|Phase ll by Stratum|Death|1|||
16917415|NCT01275144|38058267|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
17017064|NCT00845520|38161654|FG000|Overall Study|Adverse Event|0|||
16844306|NCT01824290|37788685|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
16844307|NCT01824290|37788686|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
16844308|NCT00217672|37788698|FG000|Allocation|Ineligible|2|||
16844309|NCT00217672|37788699|FG001|Allocation|Ineligible|0|||
16844310|NCT00217672|37788698|FG000|Treatment|disease progression|33|||
16844311|NCT00217672|37788699|FG001|Treatment|disease progression|4|||
16844312|NCT00217672|37788698|FG000|Treatment|Adverse Event|18|||
16844313|NCT00217672|37788699|FG001|Treatment|Adverse Event|2|||
16844314|NCT00217672|37788698|FG000|Treatment|reqd treatment not permitted by protocol|6|||
16844315|NCT00217672|37788699|FG001|Treatment|reqd treatment not permitted by protocol|0|||
16844316|NCT00217672|37788698|FG000|Treatment|Physician Decision|6|||
16844317|NCT00217672|37788699|FG001|Treatment|Physician Decision|0|||
16844318|NCT00217672|37788698|FG000|Treatment|insurance issues|1|||
16844319|NCT00217672|37788699|FG001|Treatment|insurance issues|1|||
16844320|NCT00217672|37788698|FG000|Treatment|Death|2|||
16844321|NCT00217672|37788699|FG001|Treatment|Death|0|||
16844322|NCT00217672|37788698|FG000|Treatment|secondary malignancy|1|||
16844323|NCT00217672|37788699|FG001|Treatment|secondary malignancy|0|||
16844324|NCT00217672|37788698|FG000|Follow-up|Withdrawal by Subject|4|||
16844325|NCT00217672|37788699|FG001|Follow-up|Withdrawal by Subject|0|||
16844326|NCT00217672|37788698|FG000|Follow-up|Lost to Follow-up|1|||
16844327|NCT00217672|37788699|FG001|Follow-up|Lost to Follow-up|0|||
16844328|NCT00216736|37788705|FG000|Overall Study|Lost to Follow-up|1|||
16844329|NCT00216736|37788706|FG001|Overall Study|Lost to Follow-up|1|||
16844330|NCT01850030|37788714|FG000|Overall Study|Adverse Event|64|||
16844331|NCT01850030|37788715|FG001|Overall Study|Adverse Event|82|||
16917416|NCT01275144|38058268|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
16844332|NCT01850030|37788714|FG000|Overall Study|Lack of Efficacy|3|||
16844333|NCT01850030|37788715|FG001|Overall Study|Lack of Efficacy|1|||
16844334|NCT01850030|37788714|FG000|Overall Study|Lost to Follow-up|5|||
16844335|NCT01850030|37788715|FG001|Overall Study|Lost to Follow-up|5|||
16844336|NCT01850030|37788714|FG000|Overall Study|Withdrawal by Subject|3|||
16844337|NCT01850030|37788715|FG001|Overall Study|Withdrawal by Subject|4|||
16844338|NCT01850030|37788714|FG000|Overall Study|Protocol Violation|24|||
16844339|NCT01850030|37788715|FG001|Overall Study|Protocol Violation|28|||
16844340|NCT01850030|37788714|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
16844341|NCT01850030|37788715|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
16844342|NCT00215644|37788723|FG000|Overall Study|Disease Progression|28|||
16844343|NCT00215644|37788724|FG001|Overall Study|Disease Progression|10|||
16844344|NCT00215644|37788723|FG000|Overall Study|Adverse Event|2|||
16844345|NCT00215644|37788724|FG001|Overall Study|Adverse Event|9|||
16844346|NCT00215644|37788723|FG000|Overall Study|Death|1|||
16844347|NCT00215644|37788724|FG001|Overall Study|Death|2|||
16844348|NCT00215644|37788723|FG000|Overall Study|Withdrawal by Subject|1|||
16844349|NCT00215644|37788724|FG001|Overall Study|Withdrawal by Subject|0|||
16844350|NCT00215644|37788723|FG000|Overall Study|Other|3|||
16844351|NCT00215644|37788724|FG001|Overall Study|Other|15|||
16844352|NCT00215644|37788723|FG000|Overall Study|Randomized but Not Treated|1|||
16844353|NCT00215644|37788724|FG001|Overall Study|Randomized but Not Treated|0|||
16844354|NCT01870401|37788732|FG000|Overall Study|Death|48|||
16844355|NCT01870401|37788733|FG001|Overall Study|Death|24|||
16844356|NCT01870401|37788732|FG000|Overall Study|Withdrawal by Subject|39|||
16844357|NCT01870401|37788733|FG001|Overall Study|Withdrawal by Subject|26|||
16844358|NCT01870401|37788732|FG000|Overall Study|Lost to Follow-up|19|||
16844359|NCT01870401|37788733|FG001|Overall Study|Lost to Follow-up|14|||
16844360|NCT01870401|37788732|FG000|Overall Study|Other|9|||
16917417|NCT01275066|38058279|FG000|Overall Study|Withdrawal by Subject|0|||
16917418|NCT01275066|38058280|FG001|Overall Study|Withdrawal by Subject|0|||
16917419|NCT01275066|38058281|FG002|Overall Study|Withdrawal by Subject|1|||
16917420|NCT01275066|38058279|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
16917421|NCT01275066|38058280|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
16917422|NCT01275066|38058281|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
16917423|NCT01273038|38058291|FG000|Second Intervention (14 Days)|Adverse Event|0|||
16917424|NCT01273038|38058292|FG001|Second Intervention (14 Days)|Adverse Event|1|||
16917425|NCT01273038|38058291|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
16917426|NCT01273038|38058292|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
16917427|NCT01272180|38058302|FG000|Overall Study|Adverse Event|0|||
16917428|NCT01272180|38058303|FG001|Overall Study|Adverse Event|0|||
16917429|NCT01272180|38058304|FG002|Overall Study|Adverse Event|1|||
16917430|NCT01272180|38058305|FG003|Overall Study|Adverse Event|0|||
16917431|NCT01272180|38058302|FG000|Overall Study|Withdrawal by Subject|2|||
16917432|NCT01272180|38058303|FG001|Overall Study|Withdrawal by Subject|6|||
16917433|NCT01272180|38058304|FG002|Overall Study|Withdrawal by Subject|3|||
16917434|NCT01272180|38058305|FG003|Overall Study|Withdrawal by Subject|2|||
16917435|NCT01272180|38058302|FG000|Overall Study|Lost to Follow-up|15|||
16917436|NCT01272180|38058303|FG001|Overall Study|Lost to Follow-up|14|||
16917437|NCT01272180|38058304|FG002|Overall Study|Lost to Follow-up|8|||
16917438|NCT01272180|38058305|FG003|Overall Study|Lost to Follow-up|10|||
16917439|NCT01272180|38058302|FG000|Overall Study|Inappropriate enrollment|0|||
16917440|NCT01272180|38058303|FG001|Overall Study|Inappropriate enrollment|0|||
16917441|NCT01272180|38058304|FG002|Overall Study|Inappropriate enrollment|1|||
16917442|NCT01272180|38058305|FG003|Overall Study|Inappropriate enrollment|1|||
16917443|NCT01272180|38058302|FG000|Overall Study|Protocol Violation|0|||
16917444|NCT01272180|38058303|FG001|Overall Study|Protocol Violation|1|||
16917445|NCT01272180|38058304|FG002|Overall Study|Protocol Violation|0|||
16917446|NCT01272180|38058305|FG003|Overall Study|Protocol Violation|1|||
16917447|NCT01271712|38058321|FG000|Double Blind Treatment|Death|2|||
16917448|NCT01271712|38058322|FG001|Double Blind Treatment|Death|0|||
16917449|NCT01271712|38058321|FG000|Double Blind Treatment|Lack of Efficacy|1|||
16917450|NCT01271712|38058322|FG001|Double Blind Treatment|Lack of Efficacy|0|||
16917451|NCT01271712|38058321|FG000|Double Blind Treatment|Adverse Event|9|||
16917452|NCT01271712|38058322|FG001|Double Blind Treatment|Adverse Event|4|||
16917453|NCT01271712|38058321|FG000|Double Blind Treatment|Progressive disease|23|||
16917454|NCT01271712|38058322|FG001|Double Blind Treatment|Progressive disease|3|||
16917455|NCT01271712|38058321|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
16917456|NCT01271712|38058322|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
16917457|NCT01271712|38058321|FG000|Double Blind Treatment|Non compliance with study drug|2|||
16917458|NCT01271712|38058322|FG001|Double Blind Treatment|Non compliance with study drug|0|||
16917459|NCT01271712|38058321|FG000|Double Blind Treatment|receive no study drug|1|||
16917460|NCT01271712|38058322|FG001|Double Blind Treatment|receive no study drug|0|||
16917461|NCT01271712|38058321|FG000|Open Label Treatment|Death|6|||
16844361|NCT01870401|37788733|FG001|Overall Study|Other|7|||
16844362|NCT01870401|37788732|FG000|Overall Study|On-going in the Study|35|||
16844363|NCT01870401|37788733|FG001|Overall Study|On-going in the Study|25|||
16917462|NCT01271712|38058322|FG001|Open Label Treatment|Death|5|||
16917463|NCT01271712|38058321|FG000|Open Label Treatment|Withdrawal by Subject|6|||
16917464|NCT01271712|38058322|FG001|Open Label Treatment|Withdrawal by Subject|11|||
16917465|NCT01271712|38058321|FG000|Open Label Treatment|Physician Decision|2|||
16917466|NCT01271712|38058322|FG001|Open Label Treatment|Physician Decision|0|||
16917467|NCT01271712|38058321|FG000|Open Label Treatment|Adverse Event|14|||
16917468|NCT01271712|38058322|FG001|Open Label Treatment|Adverse Event|8|||
16917469|NCT01271712|38058321|FG000|Open Label Treatment|Progressive disease|59|||
16917470|NCT01271712|38058322|FG001|Open Label Treatment|Progressive disease|32|||
16917471|NCT01271712|38058321|FG000|Open Label Treatment|transferred to rollover study|1|||
16917472|NCT01271712|38058322|FG001|Open Label Treatment|transferred to rollover study|0|||
16917473|NCT01271712|38058321|FG000|Open Label Treatment|Non-compliance with study drug|1|||
16917474|NCT01271712|38058322|FG001|Open Label Treatment|Non-compliance with study drug|0|||
16917475|NCT01271712|38058321|FG000|Open Label Treatment|Protocol Violation|0|||
16917476|NCT01271712|38058322|FG001|Open Label Treatment|Protocol Violation|1|||
16917477|NCT01271712|38058321|FG000|Open Label Treatment|Switching to other therapy|2|||
16917478|NCT01271712|38058322|FG001|Open Label Treatment|Switching to other therapy|1|||
16917479|NCT01271712|38058321|FG000|Safety Follow-up|Death|11|||
16917480|NCT01271712|38058322|FG001|Safety Follow-up|Death|7|||
16917481|NCT01271712|38058321|FG000|Safety Follow-up|Withdrawal by Subject|4|||
16917482|NCT01271712|38058322|FG001|Safety Follow-up|Withdrawal by Subject|2|||
16917483|NCT01271712|38058321|FG000|Safety Follow-up|Protocol Violation|1|||
16917484|NCT01271712|38058322|FG001|Safety Follow-up|Protocol Violation|1|||
16917485|NCT01271712|38058321|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
16917486|NCT01271712|38058322|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
16917487|NCT01271712|38058321|FG000|Safety Follow-up|No follow-up|1|||
16917488|NCT01271712|38058322|FG001|Safety Follow-up|No follow-up|1|||
16917489|NCT01271712|38058321|FG000|Safety Follow-up|Progressive disease|1|||
16917490|NCT01271712|38058322|FG001|Safety Follow-up|Progressive disease|0|||
16917491|NCT01271712|38058321|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
16917492|NCT01271712|38058322|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
16917493|NCT01271010|38058331|FG000|Overall Study|Reason not specified|11|||
16917494|NCT01271010|38058331|FG000|Overall Study|Start of new CLL therapy|1|||
16917495|NCT01271010|38058331|FG000|Overall Study|Protocol Violation|1|||
16917496|NCT01271010|38058331|FG000|Overall Study|Death|2|||
16917497|NCT01271010|38058331|FG000|Overall Study|Progression and relapse of disease|1|||
16917498|NCT01271010|38058331|FG000|Overall Study|Withdrawal by Subject|18|||
16917499|NCT01271010|38058331|FG000|Overall Study|Disease progression|27|||
16917500|NCT01270620|38058337|FG000|Overall Study|Withdrawal by Subject|1|||
16917501|NCT01270620|38058338|FG001|Overall Study|Withdrawal by Subject|3|||
16917502|NCT01270464|38058353|FG000|Overall Study|Protocol Violation|4|||
16917503|NCT01270464|38058354|FG001|Overall Study|Protocol Violation|3|||
16917504|NCT01270464|38058355|FG002|Overall Study|Protocol Violation|2|||
16917505|NCT01270464|38058353|FG000|Overall Study|Lack of Efficacy|2|||
16917506|NCT01270464|38058354|FG001|Overall Study|Lack of Efficacy|3|||
16917507|NCT01270464|38058355|FG002|Overall Study|Lack of Efficacy|1|||
16917508|NCT01270464|38058353|FG000|Overall Study|Adverse Event|9|||
16917509|NCT01270464|38058354|FG001|Overall Study|Adverse Event|1|||
16917510|NCT01270464|38058355|FG002|Overall Study|Adverse Event|7|||
16917511|NCT01270464|38058353|FG000|Overall Study|Withdrawal by Subject|2|||
16917512|NCT01270464|38058354|FG001|Overall Study|Withdrawal by Subject|1|||
16844364|NCT00213148|37788745|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
16844365|NCT00213148|37788746|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
16844366|NCT00213148|37788747|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
16844367|NCT00213148|37788748|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
16844368|NCT00213148|37788749|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
16844369|NCT00213148|37788745|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
16844370|NCT00213148|37788746|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
16844371|NCT00213148|37788747|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
16844372|NCT00213148|37788748|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
16844373|NCT00213148|37788749|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
16844374|NCT00213148|37788745|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
16844375|NCT00213148|37788746|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
16844376|NCT00213148|37788747|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
16844377|NCT00213148|37788748|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
16844378|NCT00213148|37788749|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
16844379|NCT00213148|37788745|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
16844380|NCT00213148|37788746|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
16844381|NCT00213148|37788747|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
16844382|NCT00213148|37788748|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
16917513|NCT01270464|38058355|FG002|Overall Study|Withdrawal by Subject|4|||
16917514|NCT01270464|38058353|FG000|Overall Study|Lost to Follow-up|2|||
16917515|NCT01270464|38058354|FG001|Overall Study|Lost to Follow-up|3|||
16917516|NCT01270464|38058355|FG002|Overall Study|Lost to Follow-up|1|||
16917517|NCT01270464|38058353|FG000|Overall Study|Other|1|||
16917518|NCT01270464|38058354|FG001|Overall Study|Other|1|||
16844383|NCT00213148|37788749|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
16844384|NCT00213148|37788745|FG000|Cycle 1 (1 Month)|Other|3|||
16844385|NCT00213148|37788746|FG001|Cycle 1 (1 Month)|Other|0|||
16844386|NCT00213148|37788747|FG002|Cycle 1 (1 Month)|Other|2|||
16844387|NCT00213148|37788748|FG003|Cycle 1 (1 Month)|Other|2|||
16844388|NCT00213148|37788749|FG004|Cycle 1 (1 Month)|Other|7|||
16844389|NCT00213148|37788745|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16844390|NCT00213148|37788746|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16844391|NCT00213148|37788747|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16844392|NCT00213148|37788748|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
16844393|NCT00213148|37788749|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16844394|NCT00213148|37788745|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
16844395|NCT00213148|37788746|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
16844396|NCT00213148|37788747|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
16844397|NCT00213148|37788748|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
16844398|NCT00213148|37788749|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
16917519|NCT01270464|38058355|FG002|Overall Study|Other|3|||
16917520|NCT00249834|38058371|FG000|Overall Study|Ovarian stimulation failed|1|||
16917521|NCT00249834|38058372|FG001|Overall Study|Ovarian stimulation failed|0|||
16917522|NCT00249834|38058373|FG002|Overall Study|Ovarian stimulation failed|0|||
16917523|NCT00249834|38058374|FG003|Overall Study|Ovarian stimulation failed|0|||
16917524|NCT00249834|38058375|FG004|Overall Study|Ovarian stimulation failed|0|||
16917525|NCT00249834|38058376|FG005|Overall Study|Ovarian stimulation failed|0|||
16917526|NCT00249834|38058377|FG006|Overall Study|Ovarian stimulation failed|0|||
16917527|NCT00249834|38058378|FG007|Overall Study|Ovarian stimulation failed|0|||
16917528|NCT00249834|38058371|FG000|Overall Study|Failure of down-regulation|0|||
16917529|NCT00249834|38058372|FG001|Overall Study|Failure of down-regulation|0|||
16917530|NCT00249834|38058373|FG002|Overall Study|Failure of down-regulation|0|||
16917531|NCT00249834|38058374|FG003|Overall Study|Failure of down-regulation|0|||
16917532|NCT00249834|38058375|FG004|Overall Study|Failure of down-regulation|0|||
16917533|NCT00249834|38058376|FG005|Overall Study|Failure of down-regulation|0|||
16917534|NCT00249834|38058377|FG006|Overall Study|Failure of down-regulation|1|||
16917535|NCT00249834|38058378|FG007|Overall Study|Failure of down-regulation|0|||
16917536|NCT00249834|38058371|FG000|Overall Study|Protocol Violation|0|||
16917537|NCT00249834|38058372|FG001|Overall Study|Protocol Violation|19|||
16844399|NCT00213148|37788745|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
16844400|NCT00213148|37788746|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
16844401|NCT00213148|37788747|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
16917538|NCT00249834|38058373|FG002|Overall Study|Protocol Violation|14|||
16917539|NCT00249834|38058374|FG003|Overall Study|Protocol Violation|8|||
16917540|NCT00249834|38058375|FG004|Overall Study|Protocol Violation|5|||
16917541|NCT00249834|38058376|FG005|Overall Study|Protocol Violation|2|||
16917542|NCT00249834|38058377|FG006|Overall Study|Protocol Violation|0|||
16917543|NCT00249834|38058378|FG007|Overall Study|Protocol Violation|0|||
16917544|NCT00249444|38058392|FG000|Overall Study|Lost to Follow-up|2|||
16917545|NCT00249444|38058393|FG001|Overall Study|Lost to Follow-up|2|||
16917546|NCT00249444|38058392|FG000|Overall Study|non-compliant|9|||
16917547|NCT00249444|38058393|FG001|Overall Study|non-compliant|11|||
16917548|NCT00249444|38058392|FG000|Overall Study|Adverse Event|1|||
16917549|NCT00249444|38058393|FG001|Overall Study|Adverse Event|1|||
16917550|NCT00249444|38058392|FG000|Overall Study|life event|0|||
16917551|NCT00249444|38058393|FG001|Overall Study|life event|1|||
16917552|NCT00249288|38058401|FG000|Overall Study|Lost to Follow-up|3|||
16917553|NCT00249288|38058402|FG001|Overall Study|Lost to Follow-up|3|||
16917554|NCT00249288|38058401|FG000|Overall Study|Withdrawal by Subject|2|||
16917555|NCT00249288|38058402|FG001|Overall Study|Withdrawal by Subject|2|||
16917556|NCT00248040|38058419|FG000|Overall Study|transplantectomy|2|||
16917557|NCT00248040|38058420|FG001|Overall Study|transplantectomy|1|||
16917558|NCT00248040|38058421|FG002|Overall Study|transplantectomy|3|||
16917559|NCT00248040|38058419|FG000|Overall Study|transplant cancelled post treat start|1|||
16917560|NCT00248040|38058420|FG001|Overall Study|transplant cancelled post treat start|0|||
16917561|NCT00248040|38058421|FG002|Overall Study|transplant cancelled post treat start|0|||
16917562|NCT00248040|38058419|FG000|Overall Study|Death|0|||
16917563|NCT00248040|38058420|FG001|Overall Study|Death|0|||
16917564|NCT00248040|38058421|FG002|Overall Study|Death|1|||
16917565|NCT00247962|38058432|FG000|Overall Study|Adverse Event|15|||
16917566|NCT00247962|38058433|FG001|Overall Study|Adverse Event|12|||
16917567|NCT00247962|38058432|FG000|Overall Study|Lost to Follow-up|3|||
16917568|NCT00247962|38058433|FG001|Overall Study|Lost to Follow-up|1|||
16917569|NCT00247962|38058432|FG000|Overall Study|Physician Decision|0|||
16917570|NCT00247962|38058433|FG001|Overall Study|Physician Decision|1|||
16917571|NCT00247962|38058432|FG000|Overall Study|Protocol Violation|1|||
16917572|NCT00247962|38058433|FG001|Overall Study|Protocol Violation|1|||
16844402|NCT00213148|37788748|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
16844403|NCT00213148|37788749|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
16917573|NCT00247962|38058432|FG000|Overall Study|Withdrawal by Subject|3|||
16917574|NCT00247962|38058433|FG001|Overall Study|Withdrawal by Subject|2|||
16917575|NCT00247962|38058432|FG000|Overall Study|Lack of Efficacy|4|||
16917576|NCT00247962|38058433|FG001|Overall Study|Lack of Efficacy|2|||
16917577|NCT00247416|38058441|FG000|Overall Study|3 patients were found to be ineligible|1|||
16917578|NCT00247416|38058442|FG001|Overall Study|3 patients were found to be ineligible|2|||
16917579|NCT00246090|38058450|FG000|Overall Study|Adverse Event|25|||
16917580|NCT00246090|38058450|FG000|Overall Study|Withdrawal by Subject|7|||
16917581|NCT00246090|38058450|FG000|Overall Study|Progressive Disease|212|||
16917582|NCT00246090|38058450|FG000|Overall Study|Clinical Progression|30|||
16917583|NCT00246090|38058450|FG000|Overall Study|Physician Decision|11|||
16917584|NCT00246090|38058450|FG000|Overall Study|Not Otherwise Specified|10|||
16917585|NCT00246012|38058463|FG000|Overall Study|Adverse Event|0|||
16917586|NCT00246012|38058464|FG001|Overall Study|Adverse Event|0|||
16917587|NCT00246012|38058465|FG002|Overall Study|Adverse Event|0|||
16917588|NCT00246012|38058466|FG003|Overall Study|Adverse Event|0|||
16917589|NCT00246012|38058467|FG004|Overall Study|Adverse Event|0|||
16917590|NCT00246012|38058468|FG005|Overall Study|Adverse Event|1|||
16917591|NCT00246012|38058469|FG006|Overall Study|Adverse Event|0|||
16844404|NCT00213148|37788745|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
16844405|NCT00213148|37788746|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
16917592|NCT00246012|38058470|FG007|Overall Study|Adverse Event|0|||
16917593|NCT00246012|38058471|FG008|Overall Study|Adverse Event|2|||
16917594|NCT00246012|38058463|FG000|Overall Study|Withdrawal by Subject|0|||
16917595|NCT00246012|38058464|FG001|Overall Study|Withdrawal by Subject|0|||
16917596|NCT00246012|38058465|FG002|Overall Study|Withdrawal by Subject|0|||
16917597|NCT00246012|38058466|FG003|Overall Study|Withdrawal by Subject|0|||
16917598|NCT00246012|38058467|FG004|Overall Study|Withdrawal by Subject|0|||
16917599|NCT00246012|38058468|FG005|Overall Study|Withdrawal by Subject|1|||
16917600|NCT00246012|38058469|FG006|Overall Study|Withdrawal by Subject|0|||
16917601|NCT00246012|38058470|FG007|Overall Study|Withdrawal by Subject|0|||
16844406|NCT00213148|37788747|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
16844407|NCT00213148|37788748|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
16844408|NCT00213148|37788749|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
16844409|NCT00213148|37788745|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
16844410|NCT00213148|37788746|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
16844411|NCT00213148|37788747|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
16917602|NCT00246012|38058471|FG008|Overall Study|Withdrawal by Subject|0|||
16917603|NCT00246012|38058463|FG000|Overall Study|Disease progression|3|||
16917604|NCT00246012|38058464|FG001|Overall Study|Disease progression|1|||
16917605|NCT00246012|38058465|FG002|Overall Study|Disease progression|2|||
16917606|NCT00246012|38058466|FG003|Overall Study|Disease progression|3|||
16917607|NCT00246012|38058467|FG004|Overall Study|Disease progression|3|||
16917608|NCT00246012|38058468|FG005|Overall Study|Disease progression|25|||
16917609|NCT00246012|38058469|FG006|Overall Study|Disease progression|30|||
16917610|NCT00246012|38058470|FG007|Overall Study|Disease progression|27|||
16917611|NCT00246012|38058471|FG008|Overall Study|Disease progression|26|||
16917612|NCT00246012|38058463|FG000|Overall Study|Other|0|||
16917613|NCT00246012|38058464|FG001|Overall Study|Other|0|||
16917614|NCT00246012|38058465|FG002|Overall Study|Other|0|||
16917615|NCT00246012|38058466|FG003|Overall Study|Other|0|||
16844412|NCT00213148|37788748|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
16844413|NCT00213148|37788749|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
16844414|NCT00213148|37788745|FG000|Cycle 2 (1 Month)|Other|2|||
16844415|NCT00213148|37788746|FG001|Cycle 2 (1 Month)|Other|1|||
16844416|NCT00213148|37788747|FG002|Cycle 2 (1 Month)|Other|2|||
16917616|NCT00246012|38058467|FG004|Overall Study|Other|0|||
16917617|NCT00246012|38058468|FG005|Overall Study|Other|0|||
16917618|NCT00246012|38058469|FG006|Overall Study|Other|0|||
16917619|NCT00246012|38058470|FG007|Overall Study|Other|1|||
16917620|NCT00246012|38058471|FG008|Overall Study|Other|0|||
16844417|NCT00213148|37788748|FG003|Cycle 2 (1 Month)|Other|8|||
16844418|NCT00213148|37788749|FG004|Cycle 2 (1 Month)|Other|7|||
16844419|NCT00213148|37788745|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16844420|NCT00213148|37788746|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
16844421|NCT00213148|37788747|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16844422|NCT00213148|37788748|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16844423|NCT00213148|37788749|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16844424|NCT00213148|37788745|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
16844425|NCT00213148|37788746|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
16844426|NCT00213148|37788747|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
16844427|NCT00213148|37788748|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
16844428|NCT00213148|37788749|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
16844429|NCT00213148|37788745|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
16844430|NCT00213148|37788746|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
16844431|NCT00213148|37788747|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
16844432|NCT00213148|37788748|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
16917621|NCT00246012|38058463|FG000|Overall Study|Randomly assigned but not treated|0|||
16917622|NCT00246012|38058464|FG001|Overall Study|Randomly assigned but not treated|0|||
16917623|NCT00246012|38058465|FG002|Overall Study|Randomly assigned but not treated|0|||
16917624|NCT00246012|38058466|FG003|Overall Study|Randomly assigned but not treated|0|||
16917625|NCT00246012|38058467|FG004|Overall Study|Randomly assigned but not treated|0|||
16917626|NCT00246012|38058468|FG005|Overall Study|Randomly assigned but not treated|1|||
16917627|NCT00246012|38058469|FG006|Overall Study|Randomly assigned but not treated|1|||
16917628|NCT00246012|38058470|FG007|Overall Study|Randomly assigned but not treated|0|||
16917629|NCT00246012|38058471|FG008|Overall Study|Randomly assigned but not treated|0|||
16917630|NCT00245856|38058493|FG000|Period Two|Withdrawal by Subject|0|||
16917631|NCT00245856|38058494|FG001|Period Two|Withdrawal by Subject|1|||
16917632|NCT00245466|38058504|FG000|Overall Study|Adverse Event|2|||
16917633|NCT00245466|38058505|FG001|Overall Study|Adverse Event|8|||
16917634|NCT00245466|38058506|FG002|Overall Study|Adverse Event|4|||
16917635|NCT00245466|38058504|FG000|Overall Study|Low prostate specific antigen suppr|16|||
16917636|NCT00245466|38058505|FG001|Overall Study|Low prostate specific antigen suppr|14|||
16917637|NCT00245466|38058506|FG002|Overall Study|Low prostate specific antigen suppr|5|||
16917638|NCT00245466|38058504|FG000|Overall Study|Insufficient testosterone suppr|12|||
16917639|NCT00245466|38058505|FG001|Overall Study|Insufficient testosterone suppr|12|||
16917640|NCT00245466|38058506|FG002|Overall Study|Insufficient testosterone suppr|21|||
16917641|NCT00245466|38058504|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
16917642|NCT00245466|38058505|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
16917643|NCT00245466|38058506|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
16917644|NCT00245466|38058504|FG000|Overall Study|Withdrawal by Subject|2|||
16917645|NCT00245466|38058505|FG001|Overall Study|Withdrawal by Subject|2|||
16917646|NCT00245466|38058506|FG002|Overall Study|Withdrawal by Subject|1|||
16917647|NCT00245466|38058504|FG000|Overall Study|Lost to Follow-up|3|||
16917648|NCT00245466|38058505|FG001|Overall Study|Lost to Follow-up|0|||
16917649|NCT00245466|38058506|FG002|Overall Study|Lost to Follow-up|0|||
16917650|NCT00245466|38058504|FG000|Overall Study|Disease progression|0|||
16917651|NCT00245466|38058505|FG001|Overall Study|Disease progression|3|||
16917652|NCT00245466|38058506|FG002|Overall Study|Disease progression|1|||
16917653|NCT00245466|38058504|FG000|Overall Study|Protocol Violation|1|||
16917654|NCT00245466|38058505|FG001|Overall Study|Protocol Violation|2|||
16917655|NCT00245466|38058506|FG002|Overall Study|Protocol Violation|2|||
16917656|NCT00245466|38058504|FG000|Overall Study|Death|0|||
16917657|NCT00245466|38058505|FG001|Overall Study|Death|2|||
16917658|NCT00245466|38058506|FG002|Overall Study|Death|0|||
16917659|NCT00245466|38058504|FG000|Overall Study|Administrative reasons|0|||
16917660|NCT00245466|38058505|FG001|Overall Study|Administrative reasons|1|||
16917661|NCT00245466|38058506|FG002|Overall Study|Administrative reasons|0|||
16917662|NCT00244764|38058514|FG000|Overall Study|Adverse Event|37|||
16917663|NCT00244764|38058514|FG000|Overall Study|Lost to Follow-up|23|||
16917664|NCT00244764|38058514|FG000|Overall Study|Withdrawal by Subject|12|||
16917665|NCT00244764|38058514|FG000|Overall Study|Disease Progression|13|||
16917666|NCT00244764|38058514|FG000|Overall Study|Protocol Violation|2|||
16917667|NCT00244764|38058514|FG000|Overall Study|Death|1|||
16917668|NCT00244764|38058514|FG000|Overall Study|Off Study Medication for >21 Days|1|||
16917669|NCT00244764|38058514|FG000|Overall Study|Declining Performance Status|1|||
16917670|NCT00244764|38058514|FG000|Overall Study|Participant was Hospitalized until Death|1|||
16917671|NCT00244764|38058514|FG000|Overall Study|Primary Investigator Discretion|2|||
16917672|NCT00244764|38058514|FG000|Overall Study|Sponsor Terminated Study|2|||
16917673|NCT00244764|38058514|FG000|Overall Study|Developed Secondary Malignancy|1|||
16917674|NCT00244374|38058519|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
16917675|NCT00244374|38058520|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
16917676|NCT00244374|38058521|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
16917677|NCT00244374|38058522|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
16917678|NCT00244374|38058523|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
16844433|NCT00213148|37788749|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
16844434|NCT00213148|37788745|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
16844435|NCT00213148|37788746|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
16844436|NCT00213148|37788747|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
16844437|NCT00213148|37788748|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
16844438|NCT00213148|37788749|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
16844439|NCT00213148|37788745|FG000|Cycle 3 (1 Month)|Other|0|||
16844440|NCT00213148|37788746|FG001|Cycle 3 (1 Month)|Other|0|||
16844441|NCT00213148|37788747|FG002|Cycle 3 (1 Month)|Other|1|||
16844442|NCT00213148|37788748|FG003|Cycle 3 (1 Month)|Other|1|||
16844443|NCT00213148|37788749|FG004|Cycle 3 (1 Month)|Other|0|||
16844444|NCT01704261|37788771|FG000|Overall Study|Withdrawal by Subject|12|||
16844445|NCT01704261|37788772|FG001|Overall Study|Withdrawal by Subject|15|||
16844446|NCT01704261|37788771|FG000|Overall Study|Lost to Follow-up|1|||
16844447|NCT01704261|37788772|FG001|Overall Study|Lost to Follow-up|0|||
16844448|NCT01715571|37788778|FG000|Overall Study|Lost to Follow-up|8|||
16917679|NCT00244374|38058519|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
16917680|NCT00244374|38058520|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
16844449|NCT00212758|37788782|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
16844450|NCT00212758|37788783|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
16844451|NCT00212758|37788782|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
16844452|NCT00212758|37788783|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
16917681|NCT00244374|38058521|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
16917682|NCT00244374|38058522|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
16917683|NCT00244374|38058523|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
16917684|NCT00244374|38058519|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
16844453|NCT01715415|37788791|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
16844454|NCT01715415|37788792|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
16844455|NCT01715415|37788791|FG000|Double-blind Treatment|Adverse Event|3|||
16844456|NCT01715415|37788792|FG001|Double-blind Treatment|Adverse Event|0|||
16844457|NCT01715415|37788791|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
16844458|NCT01715415|37788792|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
16844459|NCT01715415|37788791|FG000|Double-blind Treatment|Other|1|||
16844460|NCT01715415|37788792|FG001|Double-blind Treatment|Other|0|||
16844461|NCT01715415|37788791|FG000|Open-label Treatment|Adverse Event|0|||
16844462|NCT01715415|37788792|FG001|Open-label Treatment|Adverse Event|1|||
16844463|NCT01715415|37788791|FG000|Open-label Treatment|Subject Noncompliant|0|||
16844464|NCT01715415|37788792|FG001|Open-label Treatment|Subject Noncompliant|1|||
16844465|NCT00211510|37788801|FG000|Overall Study|Physician Decision|3|||
16844466|NCT00211510|37788802|FG001|Overall Study|Physician Decision|1|||
16844467|NCT00211510|37788801|FG000|Overall Study|Withdrawal by Subject|3|||
16844468|NCT00211510|37788802|FG001|Overall Study|Withdrawal by Subject|1|||
16917685|NCT00244374|38058520|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
16917686|NCT00244374|38058521|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
16917687|NCT00244374|38058522|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
16917688|NCT00244374|38058523|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
16917689|NCT00244374|38058519|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
16917690|NCT00244374|38058520|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
16917691|NCT00244374|38058521|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
16917692|NCT00244374|38058522|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
16917693|NCT00244374|38058523|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
16917694|NCT00244374|38058519|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
16917695|NCT00244374|38058520|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
16917696|NCT00244374|38058521|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
16917697|NCT00244374|38058522|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
16917698|NCT00244374|38058523|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
16844469|NCT01869777|37788811|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
16844470|NCT01714947|37788815|FG000|Part B|Progressive Disease|3|||
16844471|NCT01869699|37788821|FG000|Overall Study|Withdrawal by Subject|1|||
16844472|NCT01869699|37788822|FG001|Overall Study|Withdrawal by Subject|0|||
16844473|NCT01714635|37788831|FG000|Overall Study|Discontinued|1|||
16844474|NCT01714635|37788832|FG001|Overall Study|Discontinued|0|||
16844475|NCT01714635|37788833|FG002|Overall Study|Discontinued|2|||
16844476|NCT01714635|37788831|FG000|Overall Study|Missed 6-month exam|1|||
16844477|NCT01714635|37788832|FG001|Overall Study|Missed 6-month exam|0|||
16844478|NCT01714635|37788833|FG002|Overall Study|Missed 6-month exam|0|||
16844479|NCT01849874|37788843|FG000|Overall Study|Death|34|||
16844480|NCT01849874|37788844|FG001|Overall Study|Death|16|||
16844481|NCT01849874|37788843|FG000|Overall Study|Withdrawal by Subject|4|||
16844482|NCT01849874|37788844|FG001|Overall Study|Withdrawal by Subject|8|||
16844483|NCT01849874|37788843|FG000|Overall Study|Lost to Follow-up|0|||
16844484|NCT01849874|37788844|FG001|Overall Study|Lost to Follow-up|1|||
16844485|NCT01849874|37788843|FG000|Overall Study|Randomized but Never Treated|1|||
16844486|NCT01849874|37788844|FG001|Overall Study|Randomized but Never Treated|8|||
16844487|NCT01849874|37788843|FG000|Overall Study|Ongoing|162|||
16844488|NCT01849874|37788844|FG001|Overall Study|Ongoing|69|||
16844489|NCT01713933|37788850|FG000|Overall Study|Lost to Follow-up|2|||
16844490|NCT01713933|37788850|FG000|Overall Study|Withdrawal by Subject|3|||
16844491|NCT01713933|37788850|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
16844492|NCT01868997|37788856|FG000|Overall Study|Adverse Event|2|||
16844493|NCT01868997|37788857|FG001|Overall Study|Adverse Event|5|||
16844494|NCT01868997|37788856|FG000|Overall Study|Lack of Efficacy|2|||
16844495|NCT01868997|37788857|FG001|Overall Study|Lack of Efficacy|0|||
16844496|NCT01868997|37788856|FG000|Overall Study|Other|3|||
16844497|NCT01868997|37788857|FG001|Overall Study|Other|1|||
16844498|NCT01875848|37788865|FG000|Overall Study|Withdrawal by Subject|2|||
16844499|NCT01875848|37788866|FG001|Overall Study|Withdrawal by Subject|0|||
16844500|NCT04191382|37788875|FG000|Overall Study|Withdrawal by Subject|1|||
16844501|NCT04191382|37788876|FG001|Overall Study|Withdrawal by Subject|0|||
16844502|NCT04191382|37788877|FG002|Overall Study|Withdrawal by Subject|0|||
16844503|NCT01703091|37788887|FG000|Overall Study|Adverse Event|5|||
16844504|NCT01703091|37788888|FG001|Overall Study|Adverse Event|3|||
16844505|NCT01703091|37788887|FG000|Overall Study|Physician Decision|2|||
16844506|NCT01703091|37788888|FG001|Overall Study|Physician Decision|1|||
16844507|NCT01703091|37788887|FG000|Overall Study|Withdrawal by Subject|1|||
16844508|NCT01703091|37788888|FG001|Overall Study|Withdrawal by Subject|0|||
16917699|NCT00244374|38058519|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
16917700|NCT00244374|38058520|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
16917701|NCT00244374|38058521|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
16917702|NCT00244374|38058522|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
16917703|NCT00244374|38058523|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
16917704|NCT00244374|38058519|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
16917705|NCT00244374|38058520|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
16917706|NCT00244374|38058521|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
16917707|NCT00244374|38058522|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
16917708|NCT00244374|38058523|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
16917709|NCT00244374|38058519|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
16917710|NCT00244374|38058520|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
16917711|NCT00244374|38058521|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
16917712|NCT00244374|38058522|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
16917713|NCT00244374|38058523|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
16917714|NCT00244374|38058519|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
16917715|NCT00244374|38058520|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
16917716|NCT00244374|38058521|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
16917717|NCT00244374|38058522|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
16917718|NCT00244374|38058523|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
16917719|NCT00242658|38058541|FG000|Overall Study|Lost to Follow-up|22|||
16917720|NCT00242658|38058542|FG001|Overall Study|Lost to Follow-up|19|||
16917721|NCT00242580|38058551|FG000|Overall Study|Adverse Event|3|||
16917722|NCT00242580|38058552|FG001|Overall Study|Adverse Event|0|||
16917723|NCT00242580|38058553|FG002|Overall Study|Adverse Event|2|||
16917724|NCT00242580|38058551|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16917725|NCT00242580|38058552|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
16917726|NCT00242580|38058553|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
16917727|NCT00242580|38058551|FG000|Overall Study|Protocol Violation|0|||
16917728|NCT00242580|38058552|FG001|Overall Study|Protocol Violation|0|||
16917729|NCT00242580|38058553|FG002|Overall Study|Protocol Violation|1|||
16844509|NCT01703091|37788887|FG000|Overall Study|Sponsor Decision|1|||
16844510|NCT01703091|37788888|FG001|Overall Study|Sponsor Decision|0|||
16844511|NCT01712685|37788894|FG000|Overall Study|pt declined to participate before trmt|1|||
16844512|NCT01867671|37788900|FG000|Overall Study|Adverse Event|5|||
16844513|NCT01867671|37788901|FG001|Overall Study|Adverse Event|3|||
16844514|NCT01867671|37788900|FG000|Overall Study|Anaphylaxis|0|||
16844515|NCT01867671|37788901|FG001|Overall Study|Anaphylaxis|1|||
16844516|NCT01867671|37788900|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
16844517|NCT01867671|37788901|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
16844518|NCT01867671|37788900|FG000|Overall Study|Lost to Follow-up|0|||
16844519|NCT01867671|37788901|FG001|Overall Study|Lost to Follow-up|1|||
16844520|NCT01867671|37788900|FG000|Overall Study|Non-compliance with Study Drug|1|||
16844521|NCT01867671|37788901|FG001|Overall Study|Non-compliance with Study Drug|2|||
16844522|NCT01867671|37788900|FG000|Overall Study|Withdrawal by Subject|21|||
16844523|NCT01867671|37788901|FG001|Overall Study|Withdrawal by Subject|21|||
16844524|NCT01702311|37788909|FG000|Overall Study|Withdrawal by Subject|3|||
16844525|NCT01702311|37788910|FG001|Overall Study|Withdrawal by Subject|2|||
16844526|NCT01702311|37788909|FG000|Overall Study|Discharge less than 24 hours|10|||
16844527|NCT01702311|37788910|FG001|Overall Study|Discharge less than 24 hours|7|||
16844528|NCT01702311|37788909|FG000|Overall Study|Physician Decision|3|||
16844529|NCT01702311|37788910|FG001|Overall Study|Physician Decision|4|||
16844530|NCT01712061|37788926|FG000|Overall Study|Adverse Event|4|||
16844531|NCT01712061|37788927|FG001|Overall Study|Adverse Event|9|||
16844532|NCT01712061|37788928|FG002|Overall Study|Adverse Event|5|||
16844533|NCT01712061|37788926|FG000|Overall Study|Death|0|||
16844534|NCT01712061|37788927|FG001|Overall Study|Death|0|||
16844535|NCT01712061|37788928|FG002|Overall Study|Death|1|||
16844536|NCT01712061|37788926|FG000|Overall Study|Lost to Follow-up|1|||
16844537|NCT01712061|37788927|FG001|Overall Study|Lost to Follow-up|0|||
16844538|NCT01712061|37788928|FG002|Overall Study|Lost to Follow-up|1|||
16844539|NCT01712061|37788926|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
16844540|NCT01712061|37788927|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
16844541|NCT01712061|37788928|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
16844542|NCT01712061|37788926|FG000|Overall Study|Medication Error Without Associated AE|0|||
16844543|NCT01712061|37788927|FG001|Overall Study|Medication Error Without Associated AE|1|||
16844544|NCT01712061|37788928|FG002|Overall Study|Medication Error Without Associated AE|0|||
16844545|NCT01712061|37788926|FG000|Overall Study|Withdrawal by Subject|1|||
16844546|NCT01712061|37788927|FG001|Overall Study|Withdrawal by Subject|7|||
16844547|NCT01712061|37788928|FG002|Overall Study|Withdrawal by Subject|1|||
16844548|NCT01712061|37788926|FG000|Overall Study|Other|0|||
16844549|NCT01712061|37788927|FG001|Overall Study|Other|3|||
16844550|NCT01712061|37788928|FG002|Overall Study|Other|0|||
16844551|NCT03592186|37788939|FG000|Overall Study|Withdrawal by Subject|1|||
16844552|NCT03592186|37788940|FG001|Overall Study|Withdrawal by Subject|0|||
16844553|NCT03592186|37788939|FG000|Overall Study|Lost to Follow-up|16|||
16844554|NCT03592186|37788940|FG001|Overall Study|Lost to Follow-up|11|||
16844555|NCT01711983|37788946|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
16844556|NCT01711983|37788946|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
16844557|NCT01711983|37788946|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
16844558|NCT01711983|37788946|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
16844559|NCT01874288|37788960|FG000|Overall Study|Withdrawal by Subject|1|||
16844560|NCT01874288|37788961|FG001|Overall Study|Withdrawal by Subject|0|||
16844561|NCT01874288|37788962|FG002|Overall Study|Withdrawal by Subject|2|||
16844562|NCT01874288|37788963|FG003|Overall Study|Withdrawal by Subject|1|||
16844563|NCT01874288|37788964|FG004|Overall Study|Withdrawal by Subject|1|||
16844564|NCT01874288|37788960|FG000|Overall Study|Physician Decision|0|||
16844565|NCT01874288|37788961|FG001|Overall Study|Physician Decision|0|||
16844566|NCT01874288|37788962|FG002|Overall Study|Physician Decision|0|||
16844567|NCT01874288|37788963|FG003|Overall Study|Physician Decision|1|||
16844568|NCT01874288|37788964|FG004|Overall Study|Physician Decision|0|||
16844569|NCT01874288|37788960|FG000|Overall Study|Progressive disease|2|||
16844570|NCT01874288|37788961|FG001|Overall Study|Progressive disease|0|||
16844571|NCT01874288|37788962|FG002|Overall Study|Progressive disease|3|||
16844572|NCT01874288|37788963|FG003|Overall Study|Progressive disease|5|||
16844573|NCT01874288|37788964|FG004|Overall Study|Progressive disease|1|||
16844574|NCT01874054|37788993|FG000|Overall Study|Withdrawal by Subject|3|||
16844575|NCT01874054|37788993|FG000|Overall Study|Study Termination by Sponsor|42|||
16844576|NCT01874054|37788993|FG000|Overall Study|Lost to Follow-up|5|||
16844577|NCT01874054|37788993|FG000|Overall Study|Death|5|||
16844578|NCT01873742|37788999|FG000|Overall Study|Lost to Follow-up|68|||
16844579|NCT01873742|37789000|FG001|Overall Study|Lost to Follow-up|76|||
16844580|NCT01873586|37789006|FG000|Overall Study|Lost to Follow-up|3|||
16844581|NCT01849562|37789016|FG000|Overall Study|Lost to Follow-up|1|||
16844582|NCT01849562|37789017|FG001|Overall Study|Lost to Follow-up|0|||
16844583|NCT01849562|37789018|FG002|Overall Study|Lost to Follow-up|0|||
16844584|NCT01849562|37789016|FG000|Overall Study|Non-compliance with Study Drug|1|||
16844585|NCT01849562|37789017|FG001|Overall Study|Non-compliance with Study Drug|0|||
16844586|NCT01849562|37789018|FG002|Overall Study|Non-compliance with Study Drug|0|||
16844587|NCT04027348|37789054|FG000|Overall Study|Adverse Event|2|||
16844588|NCT04196686|37789067|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
16844589|NCT04196686|37789068|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
16844590|NCT01611974|37789077|FG000|Overall Study|Death|10|||
16844591|NCT01611974|37789078|FG001|Overall Study|Death|12|||
16844592|NCT01611974|37789079|FG002|Overall Study|Death|10|||
16844593|NCT01611974|37789077|FG000|Overall Study|Lost to Follow-up|0|||
16844594|NCT01611974|37789078|FG001|Overall Study|Lost to Follow-up|1|||
16844595|NCT01611974|37789079|FG002|Overall Study|Lost to Follow-up|0|||
16844596|NCT01611974|37789077|FG000|Overall Study|Physician Decision|5|||
16844597|NCT01611974|37789078|FG001|Overall Study|Physician Decision|1|||
16844598|NCT01611974|37789079|FG002|Overall Study|Physician Decision|2|||
16844599|NCT01611974|37789077|FG000|Overall Study|Withdrawal by Subject|0|||
16844600|NCT01611974|37789078|FG001|Overall Study|Withdrawal by Subject|1|||
16844601|NCT01611974|37789079|FG002|Overall Study|Withdrawal by Subject|4|||
16844602|NCT01848938|37789089|FG000|Overall Study|Lost to Follow-up|1|||
16917730|NCT00242580|38058551|FG000|Overall Study|Subject withdrew consent|2|||
16917731|NCT00242580|38058552|FG001|Overall Study|Subject withdrew consent|2|||
16917732|NCT00242580|38058553|FG002|Overall Study|Subject withdrew consent|5|||
16917733|NCT00242580|38058551|FG000|Overall Study|Lost to Follow-up|0|||
16917734|NCT00242580|38058552|FG001|Overall Study|Lost to Follow-up|3|||
16917735|NCT00242580|38058553|FG002|Overall Study|Lost to Follow-up|0|||
16917736|NCT00242580|38058551|FG000|Overall Study|Death|1|||
16917737|NCT00242580|38058552|FG001|Overall Study|Death|2|||
16917738|NCT00242580|38058553|FG002|Overall Study|Death|1|||
16844603|NCT01848938|37789090|FG001|Overall Study|Lost to Follow-up|1|||
16844604|NCT01871870|37789096|FG000|Overall Study|Hardware issues|7|||
16844605|NCT01871870|37789096|FG000|Overall Study|hyperglycemia|2|||
16917739|NCT00241644|38058565|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
16917740|NCT00241644|38058566|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
16917741|NCT00241644|38058567|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
16917742|NCT00241644|38058568|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
16917743|NCT00241644|38058565|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
16917744|NCT00241644|38058566|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
16917745|NCT00241644|38058567|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
16844606|NCT01871558|37789109|FG000|Overall Study|Other reason|0|||
16844607|NCT01871558|37789110|FG001|Overall Study|Other reason|1|||
16844608|NCT01871558|37789109|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
16844609|NCT01871558|37789110|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
16844610|NCT01871558|37789109|FG000|Overall Study|Withdrawal by Subject|2|||
16844611|NCT01871558|37789110|FG001|Overall Study|Withdrawal by Subject|0|||
16844612|NCT01711359|37789119|FG000|Treatment Period|Withdrawal by Subject|18|||
16917746|NCT00241644|38058568|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
16917747|NCT00241644|38058565|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
16917748|NCT00241644|38058566|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
16917749|NCT00241644|38058567|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
16917750|NCT00241644|38058568|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
16917751|NCT00241644|38058565|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
16917752|NCT00241644|38058566|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
16917753|NCT00241644|38058567|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
16917754|NCT00241644|38058568|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
16917755|NCT00241644|38058565|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
16917756|NCT00241644|38058566|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
16917757|NCT00241644|38058567|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
16917758|NCT00241644|38058568|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
16917759|NCT00241644|38058565|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
16917760|NCT00241644|38058566|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
16917761|NCT00241644|38058567|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
16917762|NCT00241644|38058568|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
16917763|NCT00241644|38058565|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
16917764|NCT00241644|38058566|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
16917765|NCT00241644|38058567|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
16917766|NCT00241644|38058568|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
16917767|NCT00241644|38058565|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
16917768|NCT00241644|38058566|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
16917769|NCT00241644|38058567|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
16917770|NCT00241644|38058568|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
16917771|NCT00241644|38058565|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
16917772|NCT00241644|38058566|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
16917773|NCT00241644|38058567|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
16917774|NCT00241644|38058568|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
16917775|NCT00241644|38058565|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
16917776|NCT00241644|38058566|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
16917777|NCT00241644|38058567|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
17017065|NCT00845520|38161655|FG001|Overall Study|Adverse Event|0|||
17017066|NCT00845520|38161656|FG002|Overall Study|Adverse Event|1|||
17017067|NCT00844896|38161672|FG000|Overall Study|Lost to Follow-up|12|||
17017068|NCT00844896|38161673|FG001|Overall Study|Lost to Follow-up|16|||
17017069|NCT00844896|38161672|FG000|Overall Study|Parents did not have time to complete|0|||
17017070|NCT00844896|38161673|FG001|Overall Study|Parents did not have time to complete|1|||
16844613|NCT01711359|37789120|FG001|Treatment Period|Withdrawal by Subject|7|||
16844614|NCT01711359|37789121|FG002|Treatment Period|Withdrawal by Subject|13|||
16917778|NCT00241644|38058568|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
16917779|NCT00241644|38058565|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
16917780|NCT00241644|38058566|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
16917781|NCT00241644|38058567|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
16917782|NCT00241644|38058568|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
16917783|NCT00241644|38058565|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
16917784|NCT00241644|38058566|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
16917785|NCT00241644|38058567|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
16917786|NCT00241644|38058568|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
16917787|NCT00241644|38058565|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
16917788|NCT00241644|38058566|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
17017071|NCT00827502|38161680|FG000|Overall Study|randomized but not treated|11|||
16844615|NCT01711359|37789119|FG000|Treatment Period|Lack of Efficacy|13|||
16844616|NCT01711359|37789120|FG001|Treatment Period|Lack of Efficacy|2|||
16844617|NCT01711359|37789121|FG002|Treatment Period|Lack of Efficacy|2|||
16844618|NCT01711359|37789119|FG000|Treatment Period|Adverse Event|8|||
16844619|NCT01711359|37789120|FG001|Treatment Period|Adverse Event|10|||
16844620|NCT01711359|37789121|FG002|Treatment Period|Adverse Event|24|||
16844621|NCT01711359|37789119|FG000|Treatment Period|Physician Decision|4|||
16844622|NCT01711359|37789120|FG001|Treatment Period|Physician Decision|3|||
16844623|NCT01711359|37789121|FG002|Treatment Period|Physician Decision|2|||
16844624|NCT01711359|37789119|FG000|Treatment Period|Death|3|||
16844625|NCT01711359|37789120|FG001|Treatment Period|Death|0|||
16844626|NCT01711359|37789121|FG002|Treatment Period|Death|0|||
16844627|NCT01711359|37789119|FG000|Treatment Period|Entry Criteria Not Met|1|||
16844628|NCT01711359|37789120|FG001|Treatment Period|Entry Criteria Not Met|0|||
16844629|NCT01711359|37789121|FG002|Treatment Period|Entry Criteria Not Met|0|||
16844630|NCT01711359|37789119|FG000|Treatment Period|Sponsor Decision|1|||
16844631|NCT01711359|37789120|FG001|Treatment Period|Sponsor Decision|0|||
16844632|NCT01711359|37789121|FG002|Treatment Period|Sponsor Decision|0|||
16844633|NCT01711359|37789119|FG000|Treatment Period|Lost to Follow-up|1|||
16844634|NCT01711359|37789120|FG001|Treatment Period|Lost to Follow-up|1|||
16844635|NCT01711359|37789121|FG002|Treatment Period|Lost to Follow-up|1|||
16844636|NCT01711359|37789119|FG000|Treatment Period|Randomized, Not Treated|3|||
16844637|NCT01711359|37789120|FG001|Treatment Period|Randomized, Not Treated|1|||
16844638|NCT01711359|37789121|FG002|Treatment Period|Randomized, Not Treated|0|||
16844639|NCT01710657|37789148|FG000|Overall Study|Lost to Follow-up|2|||
16844640|NCT01710657|37789149|FG001|Overall Study|Lost to Follow-up|0|||
16844641|NCT01710657|37789150|FG002|Overall Study|Lost to Follow-up|1|||
16844642|NCT01710657|37789148|FG000|Overall Study|Protocol Violation|2|||
16844643|NCT01710657|37789149|FG001|Overall Study|Protocol Violation|2|||
16844644|NCT01710657|37789150|FG002|Overall Study|Protocol Violation|0|||
16844645|NCT01710657|37789148|FG000|Overall Study|Adverse Event|14|||
16844646|NCT01710657|37789149|FG001|Overall Study|Adverse Event|8|||
16844647|NCT01710657|37789150|FG002|Overall Study|Adverse Event|28|||
16844648|NCT01710657|37789148|FG000|Overall Study|Withdrawal by Subject|0|||
16844649|NCT01710657|37789149|FG001|Overall Study|Withdrawal by Subject|1|||
16844650|NCT01710657|37789150|FG002|Overall Study|Withdrawal by Subject|2|||
16844651|NCT01710657|37789148|FG000|Overall Study|Lack of Efficacy|0|||
16917789|NCT00241644|38058567|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
16917790|NCT00241644|38058568|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
16917791|NCT03804684|38058589|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
16917792|NCT03804684|38058590|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
16917793|NCT04295772|38058605|FG000|Overall Study|Protocol Violation|1|||
16917794|NCT04295772|38058606|FG001|Overall Study|Protocol Violation|0|||
16917795|NCT04295772|38058605|FG000|Overall Study|Ongoing for safety monitoring|14|||
16917796|NCT04295772|38058606|FG001|Overall Study|Ongoing for safety monitoring|1|||
16917797|NCT04295772|38058605|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
16917798|NCT04295772|38058606|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
16917799|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #1|24|||
16917800|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #1|0|||
16917801|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
16917802|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
16917803|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16917804|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917805|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
16917806|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
17017072|NCT00827502|38161680|FG000|Overall Study|Adverse Event|1|||
17017073|NCT00827502|38161680|FG000|Overall Study|Lost to Follow-up|4|||
17017074|NCT00827502|38161680|FG000|Overall Study|Withdrawal by Subject|5|||
16917807|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
16917808|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
16917809|NCT03888066|38058615|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16917810|NCT03888066|38058616|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
17017075|NCT00837330|38161686|FG000|Overall Study|Lost to Follow-up|1|||
17017076|NCT00837330|38161687|FG001|Overall Study|Lost to Follow-up|3|||
17017077|NCT00837096|38161695|FG000|Overall Study|Physician Decision|1|||
17017078|NCT00837096|38161696|FG001|Overall Study|Physician Decision|1|||
17017079|NCT00837096|38161695|FG000|Overall Study|Not reported|9|||
17017080|NCT00837096|38161696|FG001|Overall Study|Not reported|8|||
17017081|NCT00885677|38161704|FG000|Overall Study|Death|40|||
17017082|NCT00885677|38161705|FG001|Overall Study|Death|34|||
17017083|NCT00885677|38161704|FG000|Overall Study|Lost to Follow-up|15|||
17017084|NCT00885677|38161705|FG001|Overall Study|Lost to Follow-up|13|||
16844652|NCT01710657|37789149|FG001|Overall Study|Lack of Efficacy|1|||
16844653|NCT01710657|37789150|FG002|Overall Study|Lack of Efficacy|1|||
16844654|NCT01701063|37789161|FG000|Overall Study|Lost to Follow-up|0|||
16844655|NCT01701063|37789162|FG001|Overall Study|Lost to Follow-up|1|||
16844656|NCT01701063|37789163|FG002|Overall Study|Lost to Follow-up|0|||
16844657|NCT01701063|37789161|FG000|Overall Study|Withdrawal by Subject|0|||
16844658|NCT01701063|37789162|FG001|Overall Study|Withdrawal by Subject|0|||
16844659|NCT01701063|37789163|FG002|Overall Study|Withdrawal by Subject|1|||
16844660|NCT01701063|37789161|FG000|Overall Study|Other|0|||
16844661|NCT01701063|37789162|FG001|Overall Study|Other|0|||
16844662|NCT01701063|37789163|FG002|Overall Study|Other|1|||
17017085|NCT00885677|38161704|FG000|Overall Study|Protocol Violation|54|||
16917811|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16917812|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917813|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
16917814|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
17017086|NCT00885677|38161705|FG001|Overall Study|Protocol Violation|54|||
17017087|NCT00885677|38161704|FG000|Overall Study|premature study closure|41|||
17017088|NCT00885677|38161705|FG001|Overall Study|premature study closure|44|||
17017089|NCT00885677|38161704|FG000|Overall Study|device/lead revision or replacement|7|||
17017090|NCT00885677|38161705|FG001|Overall Study|device/lead revision or replacement|6|||
17017091|NCT00885677|38161704|FG000|Overall Study|Heart transplantation|1|||
17017092|NCT00885677|38161705|FG001|Overall Study|Heart transplantation|0|||
17017093|NCT00885677|38161704|FG000|Overall Study|Inclusion/exclusion not met|25|||
17017094|NCT00885677|38161705|FG001|Overall Study|Inclusion/exclusion not met|27|||
17017095|NCT00885365|38161713|FG000|4 Weeks ON Treatment|Adverse Event|2|||
17017096|NCT00885365|38161714|FG001|4 Weeks ON Treatment|Adverse Event|4|||
17017097|NCT00885365|38161713|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
17017098|NCT00885365|38161714|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
17017099|NCT00885365|38161713|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
17017100|NCT00885365|38161714|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
17017101|NCT00827112|38161722|FG000|Overall Study|Adverse Event|2|||
16917815|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16917816|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917817|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
16917818|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917819|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #2|5|||
16917820|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #2|0|||
16917821|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
16917822|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
16917823|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
17017102|NCT00827112|38161723|FG001|Overall Study|Adverse Event|0|||
17017103|NCT00827112|38161722|FG000|Overall Study|Lack of Efficacy|2|||
16844663|NCT01700985|37789174|FG000|Overall Study|Incarcerated|0|||
16844664|NCT01700985|37789175|FG001|Overall Study|Incarcerated|1|||
16844665|NCT01710501|37789184|FG000|Overall Study|Lost to Follow-up|2|||
16844666|NCT01710501|37789185|FG001|Overall Study|Lost to Follow-up|0|||
16844667|NCT01710501|37789186|FG002|Overall Study|Lost to Follow-up|0|||
16844668|NCT01700829|37789196|FG000|Overall Study|Withdrawal by Subject|1|||
16844669|NCT01700829|37789197|FG001|Overall Study|Withdrawal by Subject|1|||
16844670|NCT01710345|37789206|FG000|Overall Study|Adverse Event|0|||
16844671|NCT01710345|37789207|FG001|Overall Study|Adverse Event|2|||
16844672|NCT01710345|37789208|FG002|Overall Study|Adverse Event|0|||
16844673|NCT01710345|37789206|FG000|Overall Study|Lack of Efficacy|2|||
16844674|NCT01710345|37789207|FG001|Overall Study|Lack of Efficacy|3|||
16844675|NCT01710345|37789208|FG002|Overall Study|Lack of Efficacy|1|||
16844676|NCT01710345|37789206|FG000|Overall Study|Drug Dosing Error|1|||
16844677|NCT01710345|37789207|FG001|Overall Study|Drug Dosing Error|0|||
16844678|NCT01710345|37789208|FG002|Overall Study|Drug Dosing Error|0|||
16844679|NCT01710033|37789224|FG000|Stage 2|Adverse Event|0|||
16917824|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
16917825|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
16917826|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
16917827|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #3|11|||
16917828|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #3|0|||
16917829|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
16917830|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
16917831|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
16917832|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16917833|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16917834|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917835|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #4|3|||
16917836|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #4|0|||
17017104|NCT00827112|38161723|FG001|Overall Study|Lack of Efficacy|0|||
17017105|NCT00827112|38161722|FG000|Overall Study|Lost to Follow-up|3|||
17017106|NCT00827112|38161723|FG001|Overall Study|Lost to Follow-up|2|||
16844680|NCT01710033|37789225|FG001|Stage 2|Adverse Event|0|||
16844681|NCT01710033|37789226|FG002|Stage 2|Adverse Event|0|||
16844682|NCT01710033|37789227|FG003|Stage 2|Adverse Event|0|||
16844683|NCT01710033|37789228|FG004|Stage 2|Adverse Event|1|||
16844684|NCT01822496|37789245|FG000|Overall Study|Protocol Violation|2|||
16844685|NCT01822496|37789246|FG001|Overall Study|Protocol Violation|2|||
16844686|NCT01822496|37789247|FG002|Overall Study|Protocol Violation|0|||
16844687|NCT01822496|37789248|FG003|Overall Study|Protocol Violation|1|||
16844688|NCT01822496|37789245|FG000|Overall Study|Withdrawal by Subject|0|||
16844689|NCT01822496|37789246|FG001|Overall Study|Withdrawal by Subject|0|||
16844690|NCT01822496|37789247|FG002|Overall Study|Withdrawal by Subject|0|||
16844691|NCT01822496|37789248|FG003|Overall Study|Withdrawal by Subject|3|||
16844692|NCT01867047|37789260|FG000|Overall Study|Lost to Follow-up|3|||
16844693|NCT01867047|37789261|FG001|Overall Study|Lost to Follow-up|3|||
16844694|NCT01867047|37789260|FG000|Overall Study|Withdrawal by Subject|2|||
16844695|NCT01867047|37789261|FG001|Overall Study|Withdrawal by Subject|0|||
16844696|NCT01867047|37789260|FG000|Overall Study|Physician Decision|2|||
16844697|NCT01867047|37789261|FG001|Overall Study|Physician Decision|0|||
16844698|NCT01867047|37789260|FG000|Overall Study|surgery not indicated in protocol|1|||
16844699|NCT01867047|37789261|FG001|Overall Study|surgery not indicated in protocol|2|||
16844700|NCT01821560|37789273|FG000|Overall Study|Lost to Follow-up|5|||
16917837|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
16917838|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
16917839|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
16917840|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
16917841|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
16917842|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16917843|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
16917844|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
16917845|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
16917846|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917847|NCT03888066|38058615|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
16917848|NCT03888066|38058616|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16917849|NCT03888066|38058615|FG000|Run-in Phase|AE (Adverse Event)|17|||
16917850|NCT03888066|38058616|FG001|Run-in Phase|AE (Adverse Event)|0|||
16917851|NCT03888066|38058615|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
16917852|NCT03888066|38058616|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
16917853|NCT03888066|38058615|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16917854|NCT03888066|38058616|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917855|NCT03888066|38058615|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16917856|NCT03888066|38058616|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917857|NCT03888066|38058615|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
16917858|NCT03888066|38058616|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16917859|NCT03888066|38058615|FG000|Run-in Phase|Withdrawal by Subject|43|||
16917860|NCT03888066|38058616|FG001|Run-in Phase|Withdrawal by Subject|0|||
16917861|NCT03888066|38058615|FG000|Run-in Phase|AE; Physician Decision|1|||
16917862|NCT03888066|38058616|FG001|Run-in Phase|AE; Physician Decision|0|||
16917863|NCT03888066|38058615|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
16917864|NCT03888066|38058616|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16917865|NCT03888066|38058615|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
16917866|NCT03888066|38058616|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
16917867|NCT03888066|38058615|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
16917868|NCT03888066|38058616|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16917869|NCT03888066|38058615|FG000|Run-in Phase|Death|1|||
16917870|NCT03888066|38058616|FG001|Run-in Phase|Death|0|||
16917871|NCT03888066|38058615|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
16917872|NCT03888066|38058616|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
16917873|NCT03888066|38058615|FG000|Run-in Phase|Physician Decision|1|||
16917874|NCT03888066|38058616|FG001|Run-in Phase|Physician Decision|0|||
16917875|NCT03888066|38058615|FG000|Run-in Phase|Protocol Violation|13|||
16917876|NCT03888066|38058616|FG001|Run-in Phase|Protocol Violation|0|||
16917877|NCT03888066|38058615|FG000|Run-in Phase|Sponsor Request|34|||
16917878|NCT03888066|38058616|FG001|Run-in Phase|Sponsor Request|0|||
16917879|NCT03888066|38058615|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
16844701|NCT01821560|37789274|FG001|Overall Study|Lost to Follow-up|5|||
16844702|NCT01821560|37789273|FG000|Overall Study|Withdrawal by Subject|1|||
16844703|NCT01821560|37789274|FG001|Overall Study|Withdrawal by Subject|1|||
16844704|NCT01821560|37789273|FG000|Overall Study|Protocol Violation|0|||
16844705|NCT01821560|37789274|FG001|Overall Study|Protocol Violation|1|||
16917880|NCT03888066|38058616|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
16917881|NCT03888066|38058615|FG000|Run-in Phase|Withdrawal Of Consent|1|||
16917882|NCT03888066|38058616|FG001|Run-in Phase|Withdrawal Of Consent|0|||
16917883|NCT03888066|38058615|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
16917884|NCT03888066|38058616|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
16917885|NCT03888066|38058615|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
16917886|NCT03888066|38058616|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
16917887|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
16917888|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
16917889|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
16917890|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
16917891|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
16917892|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
16917893|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
16917894|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
16917895|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
16917896|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
16917897|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
16917898|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
16917899|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
16917900|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
16917901|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
16917902|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
16917903|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
16917904|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
16917905|NCT03888066|38058615|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
16917906|NCT03888066|38058616|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
16917907|NCT02017704|38058625|FG000|Overall Study|Withdrawal by Subject|2|||
16917908|NCT02017704|38058626|FG001|Overall Study|Withdrawal by Subject|0|||
17017107|NCT00827112|38161722|FG000|Overall Study|Pregnancy|0|||
17017108|NCT00827112|38161723|FG001|Overall Study|Pregnancy|1|||
17017109|NCT00827112|38161722|FG000|Overall Study|Protocol Violation|0|||
17017110|NCT00827112|38161723|FG001|Overall Study|Protocol Violation|2|||
17017111|NCT00827112|38161722|FG000|Overall Study|Withdrawal by Subject|2|||
17017112|NCT00827112|38161723|FG001|Overall Study|Withdrawal by Subject|1|||
16917915|NCT01049334|38058645|FG000|Overall Study|Withdrawal by Subject|5|||
16917916|NCT01049334|38058646|FG001|Overall Study|Withdrawal by Subject|3|||
16917917|NCT01049334|38058645|FG000|Overall Study|Adverse Event|2|||
16917918|NCT01049334|38058646|FG001|Overall Study|Adverse Event|3|||
16917919|NCT01049334|38058645|FG000|Overall Study|Physician Decision|2|||
16917920|NCT01049334|38058646|FG001|Overall Study|Physician Decision|0|||
16917921|NCT01049334|38058645|FG000|Overall Study|Protocol Violation|0|||
16917922|NCT01049334|38058646|FG001|Overall Study|Protocol Violation|1|||
16917923|NCT01048944|38058656|FG000|Overall Study|Protocol Violation|8|||
16917924|NCT01048944|38058657|FG001|Overall Study|Protocol Violation|10|||
16917925|NCT01048944|38058658|FG002|Overall Study|Protocol Violation|10|||
16917926|NCT01048944|38058659|FG003|Overall Study|Protocol Violation|2|||
16917927|NCT01048866|38058671|FG000|Overall Study|Adverse Event|1|||
16917928|NCT01048866|38058672|FG001|Overall Study|Adverse Event|0|||
16917929|NCT01048866|38058671|FG000|Overall Study|Protocol Violation|1|||
16917930|NCT01048866|38058672|FG001|Overall Study|Protocol Violation|0|||
16917931|NCT01048866|38058671|FG000|Overall Study|Physician Decision|1|||
16917932|NCT01048866|38058672|FG001|Overall Study|Physician Decision|0|||
16917933|NCT01048866|38058671|FG000|Overall Study|Withdrawal by Subject|0|||
16917934|NCT01048866|38058672|FG001|Overall Study|Withdrawal by Subject|2|||
16917935|NCT01048866|38058671|FG000|Overall Study|Lost to Follow-up|0|||
16917936|NCT01048866|38058672|FG001|Overall Study|Lost to Follow-up|2|||
16917937|NCT01048866|38058671|FG000|Overall Study|Other|1|||
16917938|NCT01048866|38058672|FG001|Overall Study|Other|1|||
16917939|NCT01048788|38058681|FG000|Overall Study|Adverse Event|5|||
16917940|NCT01048788|38058682|FG001|Overall Study|Adverse Event|1|||
16917941|NCT01048788|38058683|FG002|Overall Study|Adverse Event|1|||
16917942|NCT01048788|38058681|FG000|Overall Study|Lack of Efficacy|0|||
16917943|NCT01048788|38058682|FG001|Overall Study|Lack of Efficacy|0|||
16917944|NCT01048788|38058683|FG002|Overall Study|Lack of Efficacy|1|||
16917945|NCT01048788|38058681|FG000|Overall Study|Withdrawal by Subject|0|||
16917946|NCT01048788|38058682|FG001|Overall Study|Withdrawal by Subject|1|||
16917947|NCT01048788|38058683|FG002|Overall Study|Withdrawal by Subject|0|||
16917948|NCT01048242|38058693|FG000|Overall Study|See study flow chart|4|||
16917949|NCT01048242|38058694|FG001|Overall Study|See study flow chart|2|||
16917950|NCT01047306|38058702|FG000|Overall Study|Withdrawal by Subject|2|||
16917951|NCT01047306|38058703|FG001|Overall Study|Withdrawal by Subject|0|||
16917952|NCT01047306|38058702|FG000|Overall Study|Lost to Follow-up|1|||
16917953|NCT01047306|38058703|FG001|Overall Study|Lost to Follow-up|0|||
16917954|NCT01046682|38058713|FG000|Overall Study|Adverse Event|2|||
16917955|NCT01046682|38058714|FG001|Overall Study|Adverse Event|0|||
16917956|NCT01044732|38058722|FG000|Overall Study|Lost to Follow-up|2|||
16917957|NCT01044732|38058723|FG001|Overall Study|Lost to Follow-up|1|||
16844706|NCT01871402|37789282|FG000|Overall Study|Lost to Follow-up|1|||
16844707|NCT01871402|37789283|FG001|Overall Study|Lost to Follow-up|0|||
16844708|NCT01871402|37789282|FG000|Overall Study|Withdrawal by Subject|0|||
16844709|NCT01871402|37789283|FG001|Overall Study|Withdrawal by Subject|2|||
16844710|NCT01871402|37789282|FG000|Overall Study|Non-compliance|0|||
16844711|NCT01871402|37789283|FG001|Overall Study|Non-compliance|1|||
16844712|NCT01846442|37789302|FG000|Overall Study|Adverse Event|2|||
16844713|NCT01846442|37789303|FG001|Overall Study|Adverse Event|4|||
16844714|NCT01846442|37789304|FG002|Overall Study|Adverse Event|2|||
16844715|NCT01846442|37789305|FG003|Overall Study|Adverse Event|1|||
16844716|NCT01846442|37789302|FG000|Overall Study|Lost to Follow-up|0|||
16844717|NCT01846442|37789303|FG001|Overall Study|Lost to Follow-up|0|||
16844718|NCT01846442|37789304|FG002|Overall Study|Lost to Follow-up|1|||
16844719|NCT01846442|37789305|FG003|Overall Study|Lost to Follow-up|0|||
16844720|NCT01846442|37789302|FG000|Overall Study|Withdrawal by Subject|3|||
16844721|NCT01846442|37789303|FG001|Overall Study|Withdrawal by Subject|2|||
16844722|NCT01846442|37789304|FG002|Overall Study|Withdrawal by Subject|0|||
16844723|NCT01846442|37789305|FG003|Overall Study|Withdrawal by Subject|1|||
16917958|NCT01044732|38058722|FG000|Overall Study|Physician Decision|5|||
16917959|NCT01044732|38058723|FG001|Overall Study|Physician Decision|3|||
16917960|NCT01044732|38058722|FG000|Overall Study|Protocol Violation|11|||
16917961|NCT01044732|38058723|FG001|Overall Study|Protocol Violation|12|||
16917962|NCT01044732|38058722|FG000|Overall Study|Withdrawal by Subject|0|||
16917963|NCT01044732|38058723|FG001|Overall Study|Withdrawal by Subject|1|||
16917964|NCT01044732|38058722|FG000|Overall Study|Inadequate bowel preparation|11|||
16917965|NCT01044732|38058723|FG001|Overall Study|Inadequate bowel preparation|17|||
16917966|NCT01044732|38058722|FG000|Overall Study|Inability to reach cecum|5|||
16917967|NCT01044732|38058723|FG001|Overall Study|Inability to reach cecum|2|||
16917968|NCT01044732|38058722|FG000|Overall Study|Technical error or malfunction|15|||
16917969|NCT01044732|38058723|FG001|Overall Study|Technical error or malfunction|14|||
16917970|NCT01044498|38058733|FG000|Overall Study|Withdrew consent|1|||
16917971|NCT01044498|38058734|FG001|Overall Study|Withdrew consent|1|||
16917972|NCT01044498|38058733|FG000|Overall Study|Adverse Event|1|||
16917973|NCT01044498|38058734|FG001|Overall Study|Adverse Event|1|||
16917974|NCT01044498|38058733|FG000|Overall Study|Other|1|||
16917975|NCT01044498|38058734|FG001|Overall Study|Other|0|||
16917976|NCT01043874|38058740|FG000|Overall Study|Adverse Event|3|||
16917977|NCT01043874|38058740|FG000|Overall Study|Withdrawal by Subject|1|||
16917978|NCT01043874|38058740|FG000|Overall Study|Lack of Efficacy|1|||
16917979|NCT01043874|38058740|FG000|Overall Study|Administrative Problems|1|||
16917980|NCT01042938|38058746|FG000|Overall Study|Withdrawal by Subject|1|||
16917981|NCT01042938|38058747|FG001|Overall Study|Withdrawal by Subject|1|||
16917982|NCT01042938|38058746|FG000|Overall Study|Protocol Violation|1|||
16917983|NCT01042938|38058747|FG001|Overall Study|Protocol Violation|1|||
16917984|NCT01042938|38058746|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
16917985|NCT01042938|38058747|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
16917986|NCT01042158|38058755|FG000|Overall Study|Physician Decision|1|||
16917987|NCT01047540|38058764|FG000|Overall Study|Protocol Violation|1|||
16917988|NCT01047540|38058765|FG001|Overall Study|Protocol Violation|0|||
16917989|NCT01047540|38058766|FG002|Overall Study|Protocol Violation|0|||
16917990|NCT01047540|38058767|FG003|Overall Study|Protocol Violation|0|||
16917991|NCT01047540|38058768|FG004|Overall Study|Protocol Violation|0|||
16917992|NCT01047540|38058764|FG000|Overall Study|Lost to Follow-up|1|||
16917993|NCT01047540|38058765|FG001|Overall Study|Lost to Follow-up|0|||
16917994|NCT01047540|38058766|FG002|Overall Study|Lost to Follow-up|0|||
16917995|NCT01047540|38058767|FG003|Overall Study|Lost to Follow-up|0|||
16917996|NCT01047540|38058768|FG004|Overall Study|Lost to Follow-up|0|||
16917997|NCT01047540|38058764|FG000|Overall Study|Withdrawal by Subject|1|||
16917998|NCT01047540|38058765|FG001|Overall Study|Withdrawal by Subject|0|||
16917999|NCT01047540|38058766|FG002|Overall Study|Withdrawal by Subject|3|||
16918000|NCT01047540|38058767|FG003|Overall Study|Withdrawal by Subject|0|||
16918001|NCT01047540|38058768|FG004|Overall Study|Withdrawal by Subject|1|||
16918002|NCT01047540|38058764|FG000|Overall Study|Pregnancy|1|||
16918003|NCT01047540|38058765|FG001|Overall Study|Pregnancy|0|||
16918004|NCT01047540|38058766|FG002|Overall Study|Pregnancy|0|||
16918005|NCT01047540|38058767|FG003|Overall Study|Pregnancy|0|||
16844724|NCT01846442|37789302|FG000|Overall Study|Left the city/Lost medication|1|||
16844725|NCT01846442|37789303|FG001|Overall Study|Left the city/Lost medication|0|||
16844726|NCT01846442|37789304|FG002|Overall Study|Left the city/Lost medication|1|||
16844727|NCT01846442|37789305|FG003|Overall Study|Left the city/Lost medication|1|||
16844728|NCT01709721|37789318|FG000|Open Label Phase|Withdrawal by Subject|0|||
16844729|NCT01709721|37789319|FG001|Open Label Phase|Withdrawal by Subject|0|||
16918006|NCT01047540|38058768|FG004|Overall Study|Pregnancy|0|||
16918007|NCT01047540|38058764|FG000|Overall Study|Adverse Event|1|||
16844730|NCT01709721|37789320|FG002|Open Label Phase|Withdrawal by Subject|5|||
16844731|NCT01709721|37789318|FG000|Open Label Phase|Adverse Event|0|||
17017113|NCT00827112|38161722|FG000|Overall Study|Randomized but not treated|5|||
17017114|NCT00827112|38161723|FG001|Overall Study|Randomized but not treated|3|||
17017115|NCT00827112|38161722|FG000|Overall Study|Other|1|||
17017116|NCT00827112|38161723|FG001|Overall Study|Other|3|||
16844732|NCT01709721|37789319|FG001|Open Label Phase|Adverse Event|0|||
16844733|NCT01709721|37789320|FG002|Open Label Phase|Adverse Event|8|||
16844734|NCT01709721|37789318|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
16844735|NCT01709721|37789319|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
16844736|NCT01709721|37789320|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
16844737|NCT01709721|37789318|FG000|Open Label Phase|Investigator Decision|0|||
16844738|NCT01709721|37789319|FG001|Open Label Phase|Investigator Decision|0|||
16844739|NCT01709721|37789320|FG002|Open Label Phase|Investigator Decision|1|||
16844740|NCT01709721|37789318|FG000|Open Label Phase|Sponsor Decision|0|||
16844741|NCT01709721|37789319|FG001|Open Label Phase|Sponsor Decision|0|||
16844742|NCT01709721|37789320|FG002|Open Label Phase|Sponsor Decision|2|||
16844743|NCT01709721|37789318|FG000|Open Label Phase|Protocol Violation|0|||
16844744|NCT01709721|37789319|FG001|Open Label Phase|Protocol Violation|0|||
16844745|NCT01709721|37789320|FG002|Open Label Phase|Protocol Violation|1|||
16844746|NCT01709721|37789318|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
16844747|NCT01709721|37789319|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
16844748|NCT01709721|37789320|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
16844749|NCT01709721|37789318|FG000|Open Label Phase|Inadequate Pain Control|0|||
16844750|NCT01709721|37789319|FG001|Open Label Phase|Inadequate Pain Control|0|||
16844751|NCT01709721|37789320|FG002|Open Label Phase|Inadequate Pain Control|37|||
16844752|NCT01709721|37789318|FG000|Open Label Phase|Other, Specify in text field in database|0|||
16844753|NCT01709721|37789319|FG001|Open Label Phase|Other, Specify in text field in database|0|||
16844754|NCT01709721|37789320|FG002|Open Label Phase|Other, Specify in text field in database|14|||
16844755|NCT01709721|37789318|FG000|Randomized Phase|Adverse Event|0|||
16844756|NCT01709721|37789319|FG001|Randomized Phase|Adverse Event|1|||
16844757|NCT01709721|37789320|FG002|Randomized Phase|Adverse Event|0|||
16844758|NCT01709721|37789318|FG000|Randomized Phase|Lost to Follow-up|1|||
16844759|NCT01709721|37789319|FG001|Randomized Phase|Lost to Follow-up|0|||
16844760|NCT01709721|37789320|FG002|Randomized Phase|Lost to Follow-up|0|||
16844761|NCT01709721|37789318|FG000|Randomized Phase|Inadequate Pain Control|1|||
16844762|NCT01709721|37789319|FG001|Randomized Phase|Inadequate Pain Control|2|||
16844763|NCT01709721|37789320|FG002|Randomized Phase|Inadequate Pain Control|0|||
16844764|NCT01709721|37789318|FG000|Randomized Phase|Other, Specify text field in database|1|||
16844765|NCT01709721|37789319|FG001|Randomized Phase|Other, Specify text field in database|3|||
16844766|NCT01709721|37789320|FG002|Randomized Phase|Other, Specify text field in database|0|||
16844767|NCT01866657|37789330|FG000|Overall Study|Surgery canceled|2|||
16844768|NCT01866657|37789331|FG001|Overall Study|Surgery canceled|0|||
16844769|NCT01700205|37789339|FG000|Overall Study|Withdrawal by Subject|13|||
16844770|NCT01700205|37789340|FG001|Overall Study|Withdrawal by Subject|13|||
16844771|NCT01700205|37789339|FG000|Overall Study|Protocol Violation|2|||
16844772|NCT01700205|37789340|FG001|Overall Study|Protocol Violation|2|||
16844773|NCT01700049|37789346|FG000|Overall Study|Withdrawal by Subject|1|||
16844774|NCT01699815|37789353|FG000|Overall Study|Protocol Violation|4|||
16844775|NCT01699815|37789354|FG001|Overall Study|Protocol Violation|7|||
16844776|NCT01699815|37789353|FG000|Overall Study|record could not be located|1|||
16844777|NCT01699815|37789354|FG001|Overall Study|record could not be located|0|||
16844778|NCT01699815|37789353|FG000|Overall Study|Adverse Event|0|||
16844779|NCT01699815|37789354|FG001|Overall Study|Adverse Event|1|||
16844780|NCT01866423|37789360|FG000|Overall Study|Lack of Efficacy|3|||
16844781|NCT01866423|37789360|FG000|Overall Study|Sponsor Decision|1|||
16844782|NCT01846208|37789367|FG000|Overall Study|Withdrew prior to treatment|1|||
16844783|NCT01846208|37789368|FG001|Overall Study|Withdrew prior to treatment|1|||
16844784|NCT01846208|37789369|FG002|Overall Study|Withdrew prior to treatment|1|||
16844785|NCT01846208|37789367|FG000|Overall Study|Dosing Symptoms|1|||
16844786|NCT01846208|37789368|FG001|Overall Study|Dosing Symptoms|2|||
16844787|NCT01846208|37789369|FG002|Overall Study|Dosing Symptoms|6|||
16918008|NCT01047540|38058765|FG001|Overall Study|Adverse Event|0|||
16918009|NCT01047540|38058766|FG002|Overall Study|Adverse Event|0|||
16918010|NCT01047540|38058767|FG003|Overall Study|Adverse Event|0|||
16918011|NCT01047540|38058768|FG004|Overall Study|Adverse Event|0|||
16918012|NCT03408444|38058784|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
16918013|NCT03408444|38058785|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
16918014|NCT03408444|38058786|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
16918015|NCT03408444|38058787|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
17017117|NCT00689104|38161733|FG000|Overall Study|Eligibility criterion not met|5|||
16844788|NCT01846208|37789367|FG000|Overall Study|Withdrawal by Subject|5|||
16844789|NCT01846208|37789368|FG001|Overall Study|Withdrawal by Subject|0|||
16844790|NCT01846208|37789369|FG002|Overall Study|Withdrawal by Subject|0|||
16844791|NCT01846208|37789367|FG000|Overall Study|Non-compliance|1|||
16844792|NCT01846208|37789368|FG001|Overall Study|Non-compliance|1|||
16844793|NCT01846208|37789369|FG002|Overall Study|Non-compliance|0|||
16844794|NCT01846208|37789367|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
16844795|NCT01846208|37789368|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
16844796|NCT01846208|37789369|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
16844797|NCT01846208|37789367|FG000|Overall Study|Refused SU OFC|0|||
16844798|NCT01846208|37789368|FG001|Overall Study|Refused SU OFC|0|||
16844799|NCT01846208|37789369|FG002|Overall Study|Refused SU OFC|1|||
16844800|NCT01845974|37789379|FG000|Overall Study|screen failure|1|||
16844801|NCT01845974|37789380|FG001|Overall Study|screen failure|0|||
16844802|NCT01865487|37789392|FG000|Overall Study|Lost to Follow-up|0|||
16844803|NCT01865487|37789393|FG001|Overall Study|Lost to Follow-up|0|||
16844804|NCT01865487|37789394|FG002|Overall Study|Lost to Follow-up|0|||
16844805|NCT01865487|37789395|FG003|Overall Study|Lost to Follow-up|1|||
16844806|NCT01865487|37789396|FG004|Overall Study|Lost to Follow-up|0|||
16844807|NCT01865487|37789397|FG005|Overall Study|Lost to Follow-up|0|||
16844808|NCT01865487|37789398|FG006|Overall Study|Lost to Follow-up|1|||
16844809|NCT01865487|37789399|FG007|Overall Study|Lost to Follow-up|0|||
16844810|NCT01865487|37789400|FG008|Overall Study|Lost to Follow-up|0|||
16844811|NCT01865487|37789401|FG009|Overall Study|Lost to Follow-up|0|||
16844812|NCT01865487|37789392|FG000|Overall Study|Withdrawal by Subject|0|||
16844813|NCT01865487|37789393|FG001|Overall Study|Withdrawal by Subject|0|||
16844814|NCT01865487|37789394|FG002|Overall Study|Withdrawal by Subject|0|||
16844815|NCT01865487|37789395|FG003|Overall Study|Withdrawal by Subject|0|||
16844816|NCT01865487|37789396|FG004|Overall Study|Withdrawal by Subject|1|||
16844817|NCT01865487|37789397|FG005|Overall Study|Withdrawal by Subject|0|||
16844818|NCT01865487|37789398|FG006|Overall Study|Withdrawal by Subject|0|||
16844819|NCT01865487|37789399|FG007|Overall Study|Withdrawal by Subject|0|||
16844820|NCT01865487|37789400|FG008|Overall Study|Withdrawal by Subject|0|||
16844821|NCT01865487|37789401|FG009|Overall Study|Withdrawal by Subject|0|||
16844822|NCT01699503|37789431|FG000|Overall Study|Death|31|||
16844823|NCT01699503|37789432|FG001|Overall Study|Death|40|||
16844824|NCT01699503|37789431|FG000|Overall Study|Withdrawal by Subject|65|||
16844825|NCT01699503|37789432|FG001|Overall Study|Withdrawal by Subject|57|||
16844826|NCT01699503|37789431|FG000|Overall Study|Lost to Follow-up|121|||
16844827|NCT01699503|37789432|FG001|Overall Study|Lost to Follow-up|117|||
16844828|NCT01699503|37789431|FG000|Overall Study|Excluded due to quality|783|||
16844829|NCT01699503|37789432|FG001|Overall Study|Excluded due to quality|791|||
16844830|NCT01709409|37789440|FG000|Overall Study|Protocol Violation|1|||
16844831|NCT01709409|37789441|FG001|Overall Study|Protocol Violation|0|||
16844832|NCT01698879|37789450|FG000|Overall Study|Withdrawal by Subject|1|||
16844833|NCT01698879|37789451|FG001|Overall Study|Withdrawal by Subject|0|||
16844834|NCT01698879|37789452|FG002|Overall Study|Withdrawal by Subject|0|||
16844835|NCT01698801|37789491|FG000|Treatment Phase|Adverse Event|4|||
16844836|NCT01698801|37789491|FG000|Treatment Phase|Protocol Violation|1|||
16844837|NCT01698801|37789491|FG000|Treatment Phase|Other|4|||
16844838|NCT01698801|37789491|FG000|Treatment Phase|Withdrawal by Subject|1|||
16844839|NCT01698801|37789491|FG000|Treatment Phase|Disease progression|1|||
16918016|NCT03408444|38058784|FG000|Overall Study|Lens Discomfort|0|||
16918017|NCT03408444|38058785|FG001|Overall Study|Lens Discomfort|1|||
16918018|NCT03408444|38058786|FG002|Overall Study|Lens Discomfort|0|||
16918019|NCT03408444|38058787|FG003|Overall Study|Lens Discomfort|0|||
16918020|NCT03408444|38058784|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
16918021|NCT03408444|38058785|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
16918022|NCT03408444|38058786|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
16918023|NCT03408444|38058787|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
16918024|NCT03408444|38058784|FG000|Overall Study|Withdrawal by Subject|0|||
16918025|NCT03408444|38058785|FG001|Overall Study|Withdrawal by Subject|2|||
16918026|NCT03408444|38058786|FG002|Overall Study|Withdrawal by Subject|3|||
16918027|NCT03408444|38058787|FG003|Overall Study|Withdrawal by Subject|0|||
16918028|NCT03408444|38058784|FG000|Overall Study|Lost to Follow-up|0|||
16918029|NCT03408444|38058785|FG001|Overall Study|Lost to Follow-up|0|||
16918030|NCT03408444|38058786|FG002|Overall Study|Lost to Follow-up|1|||
16844840|NCT01698801|37789491|FG000|Follow Up Phase|Withdrawal by Subject|1|||
16844841|NCT01698801|37789491|FG000|Follow Up Phase|Death|4|||
16844842|NCT01682811|37789503|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16844843|NCT01682811|37789504|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16844844|NCT01682811|37789505|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16844845|NCT01682811|37789506|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16844846|NCT01682811|37789507|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
16844847|NCT01682811|37789508|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16844848|NCT01682811|37789509|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16844849|NCT01682811|37789503|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
16844850|NCT01682811|37789504|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
16844851|NCT01682811|37789505|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
16844852|NCT01682811|37789506|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
16844853|NCT01682811|37789507|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
16844854|NCT01682811|37789508|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
16844855|NCT01682811|37789509|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
16844856|NCT01682811|37789503|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
16844857|NCT01682811|37789504|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
16844858|NCT01682811|37789505|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
16844859|NCT01682811|37789506|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
16844860|NCT01682811|37789507|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
16844861|NCT01682811|37789508|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
16844862|NCT01682811|37789509|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
16844863|NCT01682811|37789503|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
16844864|NCT01682811|37789504|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
16844865|NCT01682811|37789505|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
16844866|NCT01682811|37789506|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
16844867|NCT01682811|37789507|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
16844868|NCT01682811|37789508|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
16844869|NCT01682811|37789509|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
16844870|NCT01682031|37789530|FG000|Overall Study|Withdrawal by Subject|0|||
16844871|NCT01682031|37789531|FG001|Overall Study|Withdrawal by Subject|1|||
16844872|NCT01682031|37789530|FG000|Overall Study|Adverse Event|0|||
16844873|NCT01682031|37789531|FG001|Overall Study|Adverse Event|2|||
16844874|NCT01682031|37789530|FG000|Overall Study|MRI results indicate increased nodul|0|||
16844875|NCT01682031|37789531|FG001|Overall Study|MRI results indicate increased nodul|1|||
16844876|NCT01682031|37789530|FG000|Overall Study|Patient could not swallow tablets|1|||
16844877|NCT01682031|37789531|FG001|Overall Study|Patient could not swallow tablets|0|||
16844878|NCT01682031|37789530|FG000|Overall Study|Patient stopped selenium on his own|0|||
16918031|NCT03408444|38058787|FG003|Overall Study|Lost to Follow-up|0|||
16918032|NCT03408444|38058784|FG000|Overall Study|Adverse Event|0|||
16918033|NCT03408444|38058785|FG001|Overall Study|Adverse Event|0|||
16918034|NCT03408444|38058786|FG002|Overall Study|Adverse Event|0|||
16918035|NCT03408444|38058787|FG003|Overall Study|Adverse Event|1|||
16918036|NCT03408444|38058784|FG000|Overall Study|Lens Handling Difficulties|0|||
16918037|NCT03408444|38058785|FG001|Overall Study|Lens Handling Difficulties|0|||
16918038|NCT03408444|38058786|FG002|Overall Study|Lens Handling Difficulties|1|||
16918039|NCT03408444|38058787|FG003|Overall Study|Lens Handling Difficulties|0|||
16918040|NCT03408444|38058784|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
16918041|NCT03408444|38058785|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
16918042|NCT03408444|38058786|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
16918043|NCT03408444|38058787|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
16918044|NCT03400956|38058817|FG000|Treatment Period 1|Adverse Event|0|||
16918045|NCT03400956|38058818|FG001|Treatment Period 1|Adverse Event|1|||
16918046|NCT03400956|38058819|FG002|Treatment Period 1|Adverse Event|0|||
16918047|NCT03400956|38058817|FG000|Treatment Period 1|Lost to Follow-up|0|||
16918048|NCT03400956|38058818|FG001|Treatment Period 1|Lost to Follow-up|0|||
16918049|NCT03400956|38058819|FG002|Treatment Period 1|Lost to Follow-up|1|||
16918050|NCT03400956|38058817|FG000|Treatment Period 1|Protocol Violation|0|||
16918051|NCT03400956|38058818|FG001|Treatment Period 1|Protocol Violation|2|||
16918052|NCT03400956|38058819|FG002|Treatment Period 1|Protocol Violation|0|||
16918053|NCT03400956|38058817|FG000|Treatment Period 1|Study terminated by sponsor|3|||
16918054|NCT03400956|38058818|FG001|Treatment Period 1|Study terminated by sponsor|1|||
16918055|NCT03400956|38058819|FG002|Treatment Period 1|Study terminated by sponsor|1|||
16918056|NCT03400956|38058817|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16918057|NCT03400956|38058818|FG001|Treatment Period 1|Withdrawal by Subject|2|||
16918058|NCT03400956|38058819|FG002|Treatment Period 1|Withdrawal by Subject|4|||
16918059|NCT03400956|38058817|FG000|Treatment Period 1|Other|1|||
16918060|NCT03400956|38058818|FG001|Treatment Period 1|Other|2|||
16918061|NCT03400956|38058819|FG002|Treatment Period 1|Other|3|||
16918062|NCT03400956|38058817|FG000|Post-treatment Period 1|Adverse Event|0|||
16918063|NCT03400956|38058818|FG001|Post-treatment Period 1|Adverse Event|0|||
16844879|NCT01682031|37789531|FG001|Overall Study|Patient stopped selenium on his own|1|||
16844880|NCT01567527|37789552|FG000|Conversion Phase.|Protocol deviation|3|||
16844881|NCT01567527|37789553|FG001|Conversion Phase.|Protocol deviation|0|||
16844882|NCT01567527|37789554|FG002|Conversion Phase.|Protocol deviation|0|||
16844883|NCT01567527|37789555|FG003|Conversion Phase.|Protocol deviation|0|||
16844884|NCT01567527|37789556|FG004|Conversion Phase.|Protocol deviation|0|||
16844885|NCT01567527|37789552|FG000|Conversion Phase.|Met withdrawal criteria|10|||
16844886|NCT01567527|37789553|FG001|Conversion Phase.|Met withdrawal criteria|0|||
16844887|NCT01567527|37789554|FG002|Conversion Phase.|Met withdrawal criteria|0|||
16844888|NCT01567527|37789555|FG003|Conversion Phase.|Met withdrawal criteria|0|||
16844889|NCT01567527|37789556|FG004|Conversion Phase.|Met withdrawal criteria|0|||
16844890|NCT01567527|37789552|FG000|Conversion Phase.|Withdrawal by Subject|32|||
16844891|NCT01567527|37789553|FG001|Conversion Phase.|Withdrawal by Subject|0|||
16844892|NCT01567527|37789554|FG002|Conversion Phase.|Withdrawal by Subject|0|||
16844893|NCT01567527|37789555|FG003|Conversion Phase.|Withdrawal by Subject|0|||
16844894|NCT01567527|37789556|FG004|Conversion Phase.|Withdrawal by Subject|0|||
16844895|NCT01567527|37789552|FG000|Conversion Phase.|Lost to Follow-up|16|||
16844896|NCT01567527|37789553|FG001|Conversion Phase.|Lost to Follow-up|0|||
16844897|NCT01567527|37789554|FG002|Conversion Phase.|Lost to Follow-up|0|||
16844898|NCT01567527|37789555|FG003|Conversion Phase.|Lost to Follow-up|0|||
16844899|NCT01567527|37789556|FG004|Conversion Phase.|Lost to Follow-up|0|||
16844900|NCT01567527|37789552|FG000|Conversion Phase.|Lack of Efficacy|2|||
16844901|NCT01567527|37789553|FG001|Conversion Phase.|Lack of Efficacy|0|||
16844902|NCT01567527|37789554|FG002|Conversion Phase.|Lack of Efficacy|0|||
16844903|NCT01567527|37789555|FG003|Conversion Phase.|Lack of Efficacy|0|||
16844904|NCT01567527|37789556|FG004|Conversion Phase.|Lack of Efficacy|0|||
16844905|NCT01567527|37789552|FG000|Conversion Phase.|Adverse Event|33|||
16844906|NCT01567527|37789553|FG001|Conversion Phase.|Adverse Event|0|||
16844907|NCT01567527|37789554|FG002|Conversion Phase.|Adverse Event|0|||
16844908|NCT01567527|37789555|FG003|Conversion Phase.|Adverse Event|0|||
16844909|NCT01567527|37789556|FG004|Conversion Phase.|Adverse Event|0|||
16844910|NCT01567527|37789552|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
16844911|NCT01567527|37789553|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
16918064|NCT03400956|38058819|FG002|Post-treatment Period 1|Adverse Event|1|||
16918065|NCT03400956|38058817|FG000|Post-treatment Period 1|Physician Decision|2|||
16918066|NCT03400956|38058818|FG001|Post-treatment Period 1|Physician Decision|3|||
16918067|NCT03400956|38058819|FG002|Post-treatment Period 1|Physician Decision|0|||
16918068|NCT03400956|38058817|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
16918069|NCT03400956|38058818|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
16918070|NCT03400956|38058819|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
16918071|NCT03400956|38058817|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
16918072|NCT03400956|38058818|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
16918073|NCT03400956|38058819|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
16918074|NCT03400956|38058817|FG000|Post-treatment Period 1|Other|4|||
17017118|NCT00689104|38161734|FG001|Overall Study|Eligibility criterion not met|8|||
17017119|NCT00689104|38161735|FG002|Overall Study|Eligibility criterion not met|0|||
17017120|NCT00689104|38161736|FG003|Overall Study|Eligibility criterion not met|4|||
17017121|NCT00689104|38161733|FG000|Overall Study|Adverse Event|13|||
17017122|NCT00689104|38161734|FG001|Overall Study|Adverse Event|25|||
16918075|NCT03400956|38058818|FG001|Post-treatment Period 1|Other|3|||
16918076|NCT03400956|38058819|FG002|Post-treatment Period 1|Other|4|||
16918077|NCT03400956|38058817|FG000|Treatment Period 2|Adverse Event|2|||
16918078|NCT03400956|38058818|FG001|Treatment Period 2|Adverse Event|1|||
16918079|NCT03400956|38058819|FG002|Treatment Period 2|Adverse Event|1|||
16918080|NCT03400956|38058817|FG000|Treatment Period 2|Lost to Follow-up|1|||
16918081|NCT03400956|38058818|FG001|Treatment Period 2|Lost to Follow-up|1|||
16918082|NCT03400956|38058819|FG002|Treatment Period 2|Lost to Follow-up|0|||
16918083|NCT03400956|38058817|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16918084|NCT03400956|38058818|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16918085|NCT03400956|38058819|FG002|Treatment Period 2|Withdrawal by Subject|3|||
16918086|NCT03400956|38058817|FG000|Treatment Period 2|Other|1|||
16918087|NCT03400956|38058818|FG001|Treatment Period 2|Other|1|||
16918088|NCT03400956|38058819|FG002|Treatment Period 2|Other|0|||
16918089|NCT03400956|38058817|FG000|Follow-up Period|Withdrawal by Subject|0|||
16918090|NCT03400956|38058818|FG001|Follow-up Period|Withdrawal by Subject|0|||
16918091|NCT03400956|38058819|FG002|Follow-up Period|Withdrawal by Subject|1|||
16918092|NCT03400956|38058817|FG000|Follow-up Period|Other|0|||
16918093|NCT03400956|38058818|FG001|Follow-up Period|Other|0|||
16918094|NCT03400956|38058819|FG002|Follow-up Period|Other|1|||
16918095|NCT00012012|38058832|FG000|Overall Study|Protocol Violation|1|||
16918096|NCT00012012|38058833|FG001|Overall Study|Protocol Violation|1|||
16918097|NCT00012012|38058832|FG000|Overall Study|Withdrawal by Subject|0|||
16918098|NCT00012012|38058833|FG001|Overall Study|Withdrawal by Subject|2|||
16918099|NCT00010374|38058839|FG000|Overall Study|False positive phrenic nerve test|1|||
16918100|NCT00559962|38058861|FG000|Overall Study|Adverse Event|1|||
16918101|NCT00559962|38058862|FG001|Overall Study|Adverse Event|7|||
16918102|NCT00559962|38058863|FG002|Overall Study|Adverse Event|8|||
16918103|NCT00559962|38058864|FG003|Overall Study|Adverse Event|5|||
16918104|NCT00559962|38058865|FG004|Overall Study|Adverse Event|11|||
16918105|NCT00559962|38058866|FG005|Overall Study|Adverse Event|4|||
16918106|NCT00559962|38058867|FG006|Overall Study|Adverse Event|4|||
16918107|NCT00559962|38058868|FG007|Overall Study|Adverse Event|2|||
16918108|NCT00559962|38058861|FG000|Overall Study|Lost to Follow-up|0|||
16918109|NCT00559962|38058862|FG001|Overall Study|Lost to Follow-up|1|||
16918110|NCT00559962|38058863|FG002|Overall Study|Lost to Follow-up|0|||
16918111|NCT00559962|38058864|FG003|Overall Study|Lost to Follow-up|0|||
16918112|NCT00559962|38058865|FG004|Overall Study|Lost to Follow-up|0|||
16918113|NCT00559962|38058866|FG005|Overall Study|Lost to Follow-up|0|||
16918114|NCT00559962|38058867|FG006|Overall Study|Lost to Follow-up|0|||
16918115|NCT00559962|38058868|FG007|Overall Study|Lost to Follow-up|0|||
17102504|NCT03628924|38241413|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
16844912|NCT01567527|37789554|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
16918116|NCT00559962|38058861|FG000|Overall Study|Withdrawal by Subject|1|||
16918117|NCT00559962|38058862|FG001|Overall Study|Withdrawal by Subject|1|||
16918118|NCT00559962|38058863|FG002|Overall Study|Withdrawal by Subject|2|||
16918119|NCT00559962|38058864|FG003|Overall Study|Withdrawal by Subject|0|||
16918120|NCT00559962|38058865|FG004|Overall Study|Withdrawal by Subject|3|||
16918121|NCT00559962|38058866|FG005|Overall Study|Withdrawal by Subject|1|||
16918122|NCT00559962|38058867|FG006|Overall Study|Withdrawal by Subject|0|||
16918123|NCT00559962|38058868|FG007|Overall Study|Withdrawal by Subject|2|||
16918124|NCT00559962|38058861|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
16918125|NCT00559962|38058862|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
16918126|NCT00559962|38058863|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
16918127|NCT00559962|38058864|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
16918128|NCT00559962|38058865|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
16918129|NCT00559962|38058866|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
16844913|NCT01567527|37789555|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
16844914|NCT01567527|37789556|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
16844915|NCT01567527|37789552|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
16844916|NCT01567527|37789553|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
16918130|NCT00559962|38058867|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
16918131|NCT00559962|38058868|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
16918132|NCT00559104|38058889|FG000|Overall Study|Lack of Efficacy|9|||
16918133|NCT00559104|38058890|FG001|Overall Study|Lack of Efficacy|0|||
16918134|NCT00558636|38058898|FG000|Treatment|Adverse Event|9|||
16918135|NCT00558636|38058899|FG001|Treatment|Adverse Event|2|||
16918136|NCT00558636|38058898|FG000|Treatment|Withdrawal by Subject|2|||
16844917|NCT01567527|37789554|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
16844918|NCT01567527|37789555|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
16844919|NCT01567527|37789556|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
16844920|NCT01567527|37789552|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
16844921|NCT01567527|37789553|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
16844922|NCT01567527|37789554|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
16844923|NCT01567527|37789555|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
16844924|NCT01567527|37789556|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
16844925|NCT01567527|37789552|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
16844926|NCT01567527|37789553|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
16844927|NCT01567527|37789554|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
16844928|NCT01567527|37789555|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
16844929|NCT01567527|37789556|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
16844930|NCT01567527|37789552|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
16844931|NCT01567527|37789553|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
16844932|NCT01567527|37789554|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
16844933|NCT01567527|37789555|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
16918137|NCT00558636|38058899|FG001|Treatment|Withdrawal by Subject|0|||
16918138|NCT00558636|38058898|FG000|Treatment|Premature termination of the study|35|||
16918139|NCT00558636|38058899|FG001|Treatment|Premature termination of the study|37|||
16918140|NCT00558636|38058898|FG000|Treatment|Disease progression|1|||
16918141|NCT00558636|38058899|FG001|Treatment|Disease progression|5|||
16918142|NCT00558636|38058898|FG000|Follow-up|Premature termination of the study|12|||
16918143|NCT00558636|38058899|FG001|Follow-up|Premature termination of the study|7|||
16918144|NCT00558558|38058905|FG000|Overall Study|Unable to swallow|1|||
16918145|NCT00558558|38058905|FG000|Overall Study|Withdrawal by Subject|1|||
16918146|NCT00558558|38058905|FG000|Overall Study|Lack of Efficacy|4|||
16844934|NCT01567527|37789556|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
16844935|NCT01567527|37789552|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
16844936|NCT01567527|37789553|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
16844937|NCT01567527|37789554|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
16918147|NCT00557622|38058911|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
16918148|NCT00557622|38058912|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
16918149|NCT00557622|38058911|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
16918150|NCT00557622|38058912|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
16918151|NCT00557622|38058911|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
16918152|NCT00557622|38058912|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
16918153|NCT00557466|38058924|FG000|Overall Study|Adverse Event|3|||
16918154|NCT00557466|38058925|FG001|Overall Study|Adverse Event|1|||
16918155|NCT00557466|38058926|FG002|Overall Study|Adverse Event|4|||
16918156|NCT00557466|38058927|FG003|Overall Study|Adverse Event|1|||
16918157|NCT00557466|38058928|FG004|Overall Study|Adverse Event|2|||
17017123|NCT00689104|38161735|FG002|Overall Study|Adverse Event|16|||
17017124|NCT00689104|38161736|FG003|Overall Study|Adverse Event|24|||
17017125|NCT00689104|38161733|FG000|Overall Study|Lack of Efficacy|5|||
17017126|NCT00689104|38161734|FG001|Overall Study|Lack of Efficacy|6|||
16918158|NCT00557466|38058929|FG005|Overall Study|Adverse Event|4|||
16918159|NCT00557466|38058924|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16918160|NCT00557466|38058925|FG001|Overall Study|Abnormal laboratory value(s)|2|||
16918161|NCT00557466|38058926|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16918162|NCT00557466|38058927|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16918163|NCT00557466|38058928|FG004|Overall Study|Abnormal laboratory value(s)|0|||
16918164|NCT00557466|38058929|FG005|Overall Study|Abnormal laboratory value(s)|0|||
16918165|NCT00557466|38058924|FG000|Overall Study|Protocol deviation|0|||
16918166|NCT00557466|38058925|FG001|Overall Study|Protocol deviation|1|||
16918167|NCT00557466|38058926|FG002|Overall Study|Protocol deviation|0|||
16918168|NCT00557466|38058927|FG003|Overall Study|Protocol deviation|2|||
16918169|NCT00557466|38058928|FG004|Overall Study|Protocol deviation|0|||
16844938|NCT01567527|37789555|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
16844939|NCT01567527|37789556|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
16844940|NCT01567527|37789552|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
16844941|NCT01567527|37789553|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
16844942|NCT01567527|37789554|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
16844943|NCT01567527|37789555|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
16844944|NCT01567527|37789556|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
16844945|NCT01567527|37789552|FG000|IM Depot Stabilization.|Protocol deviation|0|||
16844946|NCT01567527|37789553|FG001|IM Depot Stabilization.|Protocol deviation|0|||
16844947|NCT01567527|37789554|FG002|IM Depot Stabilization.|Protocol deviation|5|||
16844948|NCT01567527|37789555|FG003|IM Depot Stabilization.|Protocol deviation|0|||
16844949|NCT01567527|37789556|FG004|IM Depot Stabilization.|Protocol deviation|0|||
16844950|NCT01567527|37789552|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
16844951|NCT01567527|37789553|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
16844952|NCT01567527|37789554|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
16844953|NCT01567527|37789555|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
16844954|NCT01567527|37789556|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
16844955|NCT01567527|37789552|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
16844956|NCT01567527|37789553|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
16844957|NCT01567527|37789554|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
16844958|NCT01567527|37789555|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
16844959|NCT01567527|37789556|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
16844960|NCT01567527|37789552|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
16844961|NCT01567527|37789553|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
16844962|NCT01567527|37789554|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
16844963|NCT01567527|37789555|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
16844964|NCT01567527|37789556|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
16844965|NCT01567527|37789552|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
16844966|NCT01567527|37789553|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
16844967|NCT01567527|37789554|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
16844968|NCT01567527|37789555|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
16844969|NCT01567527|37789556|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
16844970|NCT01567527|37789552|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
16844971|NCT01567527|37789553|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
16844972|NCT01567527|37789554|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
16844973|NCT01567527|37789555|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
16844974|NCT01567527|37789556|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
16844975|NCT01567527|37789552|FG000|IM Depot Stabilization.|Adverse Event|0|||
16844976|NCT01567527|37789553|FG001|IM Depot Stabilization.|Adverse Event|0|||
16844977|NCT01567527|37789554|FG002|IM Depot Stabilization.|Adverse Event|37|||
16844978|NCT01567527|37789555|FG003|IM Depot Stabilization.|Adverse Event|0|||
16844979|NCT01567527|37789556|FG004|IM Depot Stabilization.|Adverse Event|0|||
16844980|NCT01567527|37789552|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
16844981|NCT01567527|37789553|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
16844982|NCT01567527|37789554|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
16844983|NCT01567527|37789555|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
16844984|NCT01567527|37789556|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
16844985|NCT01567527|37789552|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
16844986|NCT01567527|37789553|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
16844987|NCT01567527|37789554|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
16844988|NCT01567527|37789555|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
16844989|NCT01567527|37789556|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
16844990|NCT01567527|37789552|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
16844991|NCT01567527|37789553|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
16844992|NCT01567527|37789554|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
16844993|NCT01567527|37789555|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
16918170|NCT00557466|38058929|FG005|Overall Study|Protocol deviation|0|||
16844994|NCT01567527|37789556|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
16918171|NCT00557466|38058924|FG000|Overall Study|Subject withdrew consent|0|||
16918172|NCT00557466|38058925|FG001|Overall Study|Subject withdrew consent|0|||
16918173|NCT00557466|38058926|FG002|Overall Study|Subject withdrew consent|0|||
16918174|NCT00557466|38058927|FG003|Overall Study|Subject withdrew consent|0|||
16918175|NCT00557466|38058928|FG004|Overall Study|Subject withdrew consent|1|||
16918176|NCT00557466|38058929|FG005|Overall Study|Subject withdrew consent|2|||
16918177|NCT00557466|38058924|FG000|Overall Study|Administrative problems|0|||
16918178|NCT00557466|38058925|FG001|Overall Study|Administrative problems|1|||
16918179|NCT00557466|38058926|FG002|Overall Study|Administrative problems|1|||
16918180|NCT00557466|38058927|FG003|Overall Study|Administrative problems|0|||
16918181|NCT00557466|38058928|FG004|Overall Study|Administrative problems|0|||
16918182|NCT00557466|38058929|FG005|Overall Study|Administrative problems|0|||
16918183|NCT00557466|38058924|FG000|Overall Study|Abnormal test procedure results|0|||
16918184|NCT00557466|38058925|FG001|Overall Study|Abnormal test procedure results|0|||
16918185|NCT00557466|38058926|FG002|Overall Study|Abnormal test procedure results|1|||
16918186|NCT00557466|38058927|FG003|Overall Study|Abnormal test procedure results|0|||
16918187|NCT00557466|38058928|FG004|Overall Study|Abnormal test procedure results|0|||
16918188|NCT00557466|38058929|FG005|Overall Study|Abnormal test procedure results|0|||
16918189|NCT00557466|38058924|FG000|Overall Study|Lost to Follow-up|0|||
16918190|NCT00557466|38058925|FG001|Overall Study|Lost to Follow-up|0|||
16918191|NCT00557466|38058926|FG002|Overall Study|Lost to Follow-up|0|||
16918192|NCT00557466|38058927|FG003|Overall Study|Lost to Follow-up|1|||
16918193|NCT00557466|38058928|FG004|Overall Study|Lost to Follow-up|0|||
16918194|NCT00557466|38058929|FG005|Overall Study|Lost to Follow-up|0|||
16918195|NCT00557310|38058943|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
16918196|NCT00557310|38058943|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
16918197|NCT00557310|38058943|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
16918198|NCT00557310|38058943|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
16918199|NCT00557310|38058943|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
16918200|NCT00557310|38058943|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
16918201|NCT00555438|38058947|FG000|10 Days Post-operative|Death|4|||
16918202|NCT00555438|38058947|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
16918203|NCT00553644|38058951|FG000|Overall Study|Adverse Event|17|||
16918204|NCT00553644|38058951|FG000|Overall Study|Withdrawal by Subject|4|||
16918205|NCT00553644|38058951|FG000|Overall Study|Physician Decision|1|||
16918206|NCT00553644|38058951|FG000|Overall Study|Alternative therapy|6|||
16918207|NCT00553332|38058955|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
16918208|NCT00552396|38058966|FG000|Overall Study|protocol withdrawal criteria|3|||
16918209|NCT00552396|38058967|FG001|Overall Study|protocol withdrawal criteria|3|||
16918210|NCT00552396|38058968|FG002|Overall Study|protocol withdrawal criteria|3|||
16918211|NCT00552396|38058969|FG003|Overall Study|protocol withdrawal criteria|6|||
16918212|NCT00552396|38058970|FG004|Overall Study|protocol withdrawal criteria|3|||
16918213|NCT00552396|38058971|FG005|Overall Study|protocol withdrawal criteria|3|||
16918214|NCT00552396|38058972|FG006|Overall Study|protocol withdrawal criteria|9|||
16918215|NCT00552240|38059008|FG000|Overall Study|Adverse Event|9|||
16918216|NCT00552240|38059009|FG001|Overall Study|Adverse Event|9|||
16918217|NCT00552240|38059008|FG000|Overall Study|Protocol Violation|1|||
16918218|NCT00552240|38059009|FG001|Overall Study|Protocol Violation|1|||
16918219|NCT00552240|38059008|FG000|Overall Study|Lost to Follow-up|5|||
16918220|NCT00552240|38059009|FG001|Overall Study|Lost to Follow-up|6|||
16918221|NCT00552240|38059008|FG000|Overall Study|Withdrawal by Subject|2|||
16918222|NCT00552240|38059009|FG001|Overall Study|Withdrawal by Subject|2|||
16918223|NCT00552240|38059008|FG000|Overall Study|Lack of Efficacy|6|||
16844995|NCT01567527|37789552|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
16844996|NCT01567527|37789553|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
16844997|NCT01567527|37789554|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
16844998|NCT01567527|37789555|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
16844999|NCT01567527|37789556|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
16845000|NCT01567527|37789552|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
16845001|NCT01567527|37789553|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
16845002|NCT01567527|37789554|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
16845003|NCT01567527|37789555|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
16845004|NCT01567527|37789556|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
16845005|NCT01567527|37789552|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16845006|NCT01567527|37789553|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16845007|NCT01567527|37789554|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16845008|NCT01567527|37789555|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
16845009|NCT01567527|37789556|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
16845010|NCT01567527|37789552|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
16918224|NCT00552240|38059009|FG001|Overall Study|Lack of Efficacy|0|||
16918225|NCT00552240|38059008|FG000|Overall Study|Other|1|||
16918226|NCT00552240|38059009|FG001|Overall Study|Other|0|||
16918227|NCT00552084|38059017|FG000|Overall Study|Adverse Event|2|||
16918228|NCT00552084|38059018|FG001|Overall Study|Adverse Event|3|||
16918229|NCT00552084|38059017|FG000|Overall Study|Withdrawal by Subject|4|||
16918230|NCT00552084|38059018|FG001|Overall Study|Withdrawal by Subject|5|||
16918231|NCT00552084|38059017|FG000|Overall Study|Protocol Violation|1|||
16918232|NCT00552084|38059018|FG001|Overall Study|Protocol Violation|0|||
16918233|NCT00552084|38059017|FG000|Overall Study|change in anti-arrythmic drug|1|||
16918234|NCT00552084|38059018|FG001|Overall Study|change in anti-arrythmic drug|1|||
16918235|NCT00550836|38059026|FG000|Overall Study|Withdrawal by Subject|3|||
16918236|NCT00550836|38059027|FG001|Overall Study|Withdrawal by Subject|9|||
16918237|NCT00550680|38059033|FG000|Overall Study|Administrative Reasons|1|||
16918238|NCT00550680|38059033|FG000|Overall Study|Adverse Event|5|||
16918239|NCT00550680|38059033|FG000|Overall Study|Death|3|||
16918240|NCT00550680|38059033|FG000|Overall Study|Early Improvement|1|||
16918241|NCT00550680|38059033|FG000|Overall Study|Lost to Follow-up|3|||
16918242|NCT00550680|38059033|FG000|Overall Study|Lack of Efficacy|1|||
16918243|NCT00550680|38059033|FG000|Overall Study|Other|10|||
16918244|NCT00550680|38059033|FG000|Overall Study|Protocol Violation|7|||
16918245|NCT00550680|38059033|FG000|Overall Study|Refused Treatment|19|||
16918246|NCT00550680|38059033|FG000|Overall Study|Screen Failure|6|||
16918247|NCT00554190|38059037|FG000|Overall Study|Termination forms not completed|10|||
16918248|NCT00556374|38059043|FG000|Overall Study|Withdrawal by Subject|190|||
16918249|NCT00556374|38059044|FG001|Overall Study|Withdrawal by Subject|172|||
16918250|NCT00556374|38059043|FG000|Overall Study|Death|50|||
16918251|NCT00556374|38059044|FG001|Overall Study|Death|43|||
16918252|NCT00556374|38059043|FG000|Overall Study|Lost to Follow-up|7|||
16918253|NCT00556374|38059044|FG001|Overall Study|Lost to Follow-up|5|||
16918254|NCT04677959|38059073|FG000|Overall Study|Adverse Event|1|||
16918255|NCT04677959|38059074|FG001|Overall Study|Adverse Event|9|||
16918256|NCT04677959|38059073|FG000|Overall Study|Withdrawal by Subject|2|||
16918257|NCT04677959|38059074|FG001|Overall Study|Withdrawal by Subject|15|||
16918258|NCT04677959|38059073|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16918259|NCT04677959|38059074|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16918260|NCT04677959|38059073|FG000|Overall Study|Non-compliance with study drug|0|||
16918261|NCT04677959|38059074|FG001|Overall Study|Non-compliance with study drug|2|||
16918262|NCT04677959|38059073|FG000|Overall Study|Protocol deviation|0|||
16918263|NCT04677959|38059074|FG001|Overall Study|Protocol deviation|11|||
16918264|NCT04677959|38059073|FG000|Overall Study|Lost to Follow-up|9|||
16918265|NCT04677959|38059074|FG001|Overall Study|Lost to Follow-up|13|||
16918266|NCT04677959|38059073|FG000|Overall Study|Other than specified|0|||
16918267|NCT04677959|38059074|FG001|Overall Study|Other than specified|8|||
16918268|NCT04330638|38059101|FG000|Overall Study|Adverse Event|9|||
16918269|NCT04330638|38059102|FG001|Overall Study|Adverse Event|10|||
16918270|NCT04330638|38059103|FG002|Overall Study|Adverse Event|15|||
16918271|NCT04330638|38059104|FG003|Overall Study|Adverse Event|6|||
16918272|NCT04330638|38059105|FG004|Overall Study|Adverse Event|10|||
16918273|NCT04330638|38059106|FG005|Overall Study|Adverse Event|5|||
16845011|NCT01567527|37789553|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
16845012|NCT01567527|37789554|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
16845013|NCT01567527|37789555|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
16845014|NCT01567527|37789556|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
16845015|NCT01567527|37789552|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
16845016|NCT01567527|37789553|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
16845017|NCT01567527|37789554|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
16918274|NCT04330638|38059101|FG000|Overall Study|Other|2|||
16918275|NCT04330638|38059102|FG001|Overall Study|Other|2|||
16918276|NCT04330638|38059103|FG002|Overall Study|Other|5|||
16918277|NCT04330638|38059104|FG003|Overall Study|Other|1|||
16918278|NCT04330638|38059105|FG004|Overall Study|Other|3|||
16918279|NCT04330638|38059106|FG005|Overall Study|Other|2|||
16918280|NCT04330638|38059101|FG000|Overall Study|Withdrawal by Subject|4|||
16918281|NCT04330638|38059102|FG001|Overall Study|Withdrawal by Subject|0|||
16918282|NCT04330638|38059103|FG002|Overall Study|Withdrawal by Subject|0|||
16918283|NCT04330638|38059104|FG003|Overall Study|Withdrawal by Subject|0|||
16918284|NCT04330638|38059105|FG004|Overall Study|Withdrawal by Subject|0|||
16918285|NCT04330638|38059106|FG005|Overall Study|Withdrawal by Subject|0|||
16918286|NCT04330638|38059101|FG000|Overall Study|Lost to Follow-up|3|||
16918287|NCT04330638|38059102|FG001|Overall Study|Lost to Follow-up|2|||
16918288|NCT04330638|38059103|FG002|Overall Study|Lost to Follow-up|3|||
16918289|NCT04330638|38059104|FG003|Overall Study|Lost to Follow-up|2|||
16918290|NCT04330638|38059105|FG004|Overall Study|Lost to Follow-up|3|||
16918291|NCT04330638|38059106|FG005|Overall Study|Lost to Follow-up|0|||
16918292|NCT04194541|38059127|FG000|Day 1 Through 13|Lost to Follow-up|3|||
16918293|NCT04194541|38059127|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
16918294|NCT04194541|38059127|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
16918295|NCT04006392|38059145|FG000|Overall Study|Lost to Follow-up|0|||
16918296|NCT04006392|38059146|FG001|Overall Study|Lost to Follow-up|1|||
16918297|NCT03959423|38059154|FG000|Overall Study|Withdrawal by Subject|2|||
16918298|NCT03959423|38059155|FG001|Overall Study|Withdrawal by Subject|3|||
16918299|NCT03959423|38059154|FG000|Overall Study|Physician Decision|0|||
16918300|NCT03959423|38059155|FG001|Overall Study|Physician Decision|1|||
16918301|NCT03959423|38059154|FG000|Overall Study|Lost to Follow-up|1|||
16918302|NCT03959423|38059155|FG001|Overall Study|Lost to Follow-up|0|||
16918303|NCT03959423|38059154|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
16918304|NCT03959423|38059155|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16918305|NCT03786783|38059161|FG000|Overall Study|Death|1|||
16918306|NCT03786783|38059161|FG000|Overall Study|Physician Decision|6|||
16918307|NCT03786783|38059161|FG000|Overall Study|Withdrawal by Subject|2|||
16918308|NCT03786783|38059161|FG000|Overall Study|Disease Progression|7|||
16918309|NCT03786783|38059161|FG000|Overall Study|Patient/Parent Refusal|4|||
16918310|NCT03432494|38059175|FG000|Overall Study|Death|1|||
16918311|NCT03432494|38059175|FG000|Overall Study|Noncompliance|1|||
16918312|NCT03312634|38059181|FG000|Overall Study|Adverse Event|6|||
16918313|NCT03312634|38059182|FG001|Overall Study|Adverse Event|0|||
16918314|NCT03312634|38059181|FG000|Overall Study|Sponsor request|2|||
16918315|NCT03312634|38059182|FG001|Overall Study|Sponsor request|0|||
16918316|NCT03312634|38059181|FG000|Overall Study|Withdrawal by Subject|11|||
16918317|NCT03312634|38059182|FG001|Overall Study|Withdrawal by Subject|9|||
16845018|NCT01567527|37789555|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
16845019|NCT01567527|37789556|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
16845020|NCT01567527|37789552|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16845021|NCT01567527|37789553|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16845022|NCT01567527|37789554|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16845023|NCT01567527|37789555|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
16845024|NCT01567527|37789556|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
16845025|NCT01818752|37789567|FG000|Overall Study|Adverse Event|64|||
16918318|NCT03312634|38059181|FG000|Overall Study|Ongoing in study at DCO|88|||
16918319|NCT03312634|38059182|FG001|Overall Study|Ongoing in study at DCO|0|||
16918320|NCT03312634|38059181|FG000|Overall Study|Enrolled in an interventional study|0|||
16918321|NCT03312634|38059182|FG001|Overall Study|Enrolled in an interventional study|52|||
16918322|NCT03312634|38059181|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
16918323|NCT03312634|38059182|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
17017127|NCT00689104|38161735|FG002|Overall Study|Lack of Efficacy|2|||
17017128|NCT00689104|38161736|FG003|Overall Study|Lack of Efficacy|3|||
17017129|NCT00689104|38161733|FG000|Overall Study|Withdrawal by Subject|12|||
17017130|NCT00689104|38161734|FG001|Overall Study|Withdrawal by Subject|11|||
17017131|NCT00689104|38161735|FG002|Overall Study|Withdrawal by Subject|18|||
17017132|NCT00689104|38161736|FG003|Overall Study|Withdrawal by Subject|11|||
17017133|NCT00689104|38161733|FG000|Overall Study|Lost to Follow-up|4|||
17017134|NCT00689104|38161734|FG001|Overall Study|Lost to Follow-up|3|||
17017135|NCT00689104|38161735|FG002|Overall Study|Lost to Follow-up|2|||
17017136|NCT00689104|38161736|FG003|Overall Study|Lost to Follow-up|5|||
17017137|NCT00689104|38161733|FG000|Overall Study|Protocol Violation|2|||
17017138|NCT00689104|38161734|FG001|Overall Study|Protocol Violation|3|||
17017139|NCT00689104|38161735|FG002|Overall Study|Protocol Violation|5|||
17017140|NCT00689104|38161736|FG003|Overall Study|Protocol Violation|3|||
16918324|NCT03312634|38059181|FG000|Overall Study|Death|0|||
16918325|NCT03312634|38059182|FG001|Overall Study|Death|1|||
16918326|NCT03312634|38059181|FG000|Overall Study|Non-compliance|0|||
16918327|NCT03312634|38059182|FG001|Overall Study|Non-compliance|2|||
16918328|NCT03312634|38059181|FG000|Overall Study|Lost to Follow-up|0|||
16918329|NCT03312634|38059182|FG001|Overall Study|Lost to Follow-up|1|||
16918330|NCT03312634|38059181|FG000|Overall Study|Enrolled into non-interventional study|0|||
16918331|NCT03312634|38059182|FG001|Overall Study|Enrolled into non-interventional study|5|||
16918332|NCT03312634|38059181|FG000|Overall Study|Worsening clinical condition|0|||
16918333|NCT03312634|38059182|FG001|Overall Study|Worsening clinical condition|1|||
16918334|NCT03312634|38059181|FG000|Overall Study|Participant did not want to travel|0|||
16918335|NCT03312634|38059182|FG001|Overall Study|Participant did not want to travel|1|||
16918336|NCT03287830|38059193|FG000|Overall Study|Withdrawal by Subject|1|||
16918337|NCT03287830|38059194|FG001|Overall Study|Withdrawal by Subject|1|||
16918338|NCT03287830|38059193|FG000|Overall Study|not meeting inclusion criteria|5|||
16918339|NCT03287830|38059194|FG001|Overall Study|not meeting inclusion criteria|12|||
16918340|NCT03181633|38059204|FG000|Overall Study|Withdrawal by Subject|1|||
16918341|NCT03181633|38059204|FG000|Overall Study|Missing follow-up visit|1|||
16918342|NCT03122223|38059221|FG000|Overall Study|Withdrawal by Subject|2|||
16918343|NCT03122223|38059222|FG001|Overall Study|Withdrawal by Subject|2|||
16918344|NCT03122223|38059223|FG002|Overall Study|Withdrawal by Subject|1|||
17017141|NCT00689104|38161733|FG000|Overall Study|Randomized but never received study drug|2|||
16845026|NCT01818752|37789568|FG001|Overall Study|Adverse Event|74|||
16845027|NCT01818752|37789567|FG000|Overall Study|Death|14|||
16845028|NCT01818752|37789568|FG001|Overall Study|Death|18|||
16845029|NCT01818752|37789567|FG000|Overall Study|Non-compliance|16|||
16845030|NCT01818752|37789568|FG001|Overall Study|Non-compliance|20|||
16845031|NCT01818752|37789567|FG000|Overall Study|Withdrawal by Subject|15|||
16845032|NCT01818752|37789568|FG001|Overall Study|Withdrawal by Subject|14|||
16845033|NCT01818752|37789567|FG000|Overall Study|Physician Decision|9|||
16845034|NCT01818752|37789568|FG001|Overall Study|Physician Decision|8|||
16845035|NCT01818752|37789567|FG000|Overall Study|Disease Progression|54|||
16845036|NCT01818752|37789568|FG001|Overall Study|Disease Progression|48|||
16845037|NCT01818752|37789567|FG000|Overall Study|Other|7|||
16845038|NCT01818752|37789568|FG001|Overall Study|Other|8|||
16918345|NCT03122223|38059224|FG003|Overall Study|Withdrawal by Subject|0|||
16918346|NCT03122223|38059221|FG000|Overall Study|Lost to Follow-up|0|||
16918347|NCT03122223|38059222|FG001|Overall Study|Lost to Follow-up|2|||
16918348|NCT03122223|38059223|FG002|Overall Study|Lost to Follow-up|2|||
16918349|NCT03122223|38059224|FG003|Overall Study|Lost to Follow-up|0|||
16918350|NCT03122223|38059221|FG000|Overall Study|Participant unable to adhere|1|||
16918351|NCT03122223|38059222|FG001|Overall Study|Participant unable to adhere|1|||
16918352|NCT03122223|38059223|FG002|Overall Study|Participant unable to adhere|1|||
16918353|NCT03122223|38059224|FG003|Overall Study|Participant unable to adhere|0|||
16918354|NCT03077087|38059234|FG000|Overall Study|Physician Decision|2|||
16918355|NCT03075527|38059238|FG000|Overall Study|Ongoing treatment|2|||
16918356|NCT02853604|38059244|FG000|Overall Study|Withdrawal by Subject|12|||
16918357|NCT02853604|38059245|FG001|Overall Study|Withdrawal by Subject|35|||
16918358|NCT02853604|38059244|FG000|Overall Study|Lost to Follow-up|4|||
16918359|NCT02853604|38059245|FG001|Overall Study|Lost to Follow-up|8|||
16918360|NCT02853604|38059244|FG000|Overall Study|Death|1|||
16918361|NCT02853604|38059245|FG001|Overall Study|Death|5|||
16918362|NCT02853604|38059244|FG000|Overall Study|Miscellaneous|11|||
16918363|NCT02853604|38059245|FG001|Overall Study|Miscellaneous|2|||
16918364|NCT02853604|38059244|FG000|Overall Study|Progressive Disease|0|||
16918365|NCT02853604|38059245|FG001|Overall Study|Progressive Disease|2|||
16918366|NCT02632552|38059271|FG000|Overall Study|Lost to Follow-up|14|||
16918367|NCT02632552|38059272|FG001|Overall Study|Lost to Follow-up|8|||
16918368|NCT02632552|38059271|FG000|Overall Study|Withdrawal by Subject|2|||
16918369|NCT02632552|38059272|FG001|Overall Study|Withdrawal by Subject|0|||
16918370|NCT02632552|38059271|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
16918371|NCT02632552|38059272|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
16845039|NCT01818752|37789567|FG000|Overall Study|Continuing Treatment|1|||
16845040|NCT01818752|37789568|FG001|Overall Study|Continuing Treatment|4|||
16845041|NCT01818752|37789567|FG000|Overall Study|Randomized but not Dosed|7|||
16845042|NCT01818752|37789568|FG001|Overall Study|Randomized but not Dosed|4|||
16845043|NCT01845818|37789576|FG000|Overall Study|Withdrawal by Subject|0|||
16845044|NCT01845818|37789577|FG001|Overall Study|Withdrawal by Subject|1|||
16845045|NCT01845818|37789576|FG000|Overall Study|Lost to Follow-up|7|||
16845046|NCT01845818|37789577|FG001|Overall Study|Lost to Follow-up|5|||
16845047|NCT01845818|37789576|FG000|Overall Study|Administrative Reasons|3|||
16845048|NCT01845818|37789577|FG001|Overall Study|Administrative Reasons|1|||
16918372|NCT02525562|38059319|FG000|Overall Study|Death|9|||
16918373|NCT02525562|38059320|FG001|Overall Study|Death|0|||
16918374|NCT02525562|38059321|FG002|Overall Study|Death|0|||
16918375|NCT02525562|38059319|FG000|Overall Study|Lost to Follow-up|19|||
16918376|NCT02525562|38059320|FG001|Overall Study|Lost to Follow-up|0|||
16918377|NCT02525562|38059321|FG002|Overall Study|Lost to Follow-up|0|||
16918378|NCT02525562|38059319|FG000|Overall Study|Withdrawal by Subject|37|||
16918379|NCT02525562|38059320|FG001|Overall Study|Withdrawal by Subject|0|||
16918380|NCT02525562|38059321|FG002|Overall Study|Withdrawal by Subject|0|||
16918381|NCT02525562|38059319|FG000|Overall Study|Revision/Removal of Study Device|4|||
16918382|NCT02525562|38059320|FG001|Overall Study|Revision/Removal of Study Device|0|||
16918383|NCT02525562|38059321|FG002|Overall Study|Revision/Removal of Study Device|0|||
16918384|NCT02525562|38059319|FG000|Overall Study|Study Closed by Sponsor|154|||
16918385|NCT02525562|38059320|FG001|Overall Study|Study Closed by Sponsor|0|||
16918386|NCT02525562|38059321|FG002|Overall Study|Study Closed by Sponsor|0|||
16918387|NCT02028455|38059334|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16918388|NCT02028455|38059335|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16918389|NCT02028455|38059336|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16918390|NCT02028455|38059337|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16918391|NCT02028455|38059338|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16918392|NCT02028455|38059339|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16918393|NCT02028455|38059340|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
16845049|NCT01845818|37789576|FG000|Overall Study|Serious Adverse Event|1|||
16918394|NCT02028455|38059341|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
16918395|NCT02028455|38059334|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
16845050|NCT01845818|37789577|FG001|Overall Study|Serious Adverse Event|1|||
16845051|NCT01845818|37789576|FG000|Overall Study|Other|25|||
16845052|NCT01845818|37789577|FG001|Overall Study|Other|8|||
16845053|NCT01845818|37789576|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
16845054|NCT01845818|37789577|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
16845055|NCT01845818|37789576|FG000|Overall Study|No Follow-Up Data Available|4|||
16845056|NCT01845818|37789577|FG001|Overall Study|No Follow-Up Data Available|1|||
16845057|NCT01362608|37789587|FG000|Overall Study|Protocol Violation|0|||
16845058|NCT01362608|37789588|FG001|Overall Study|Protocol Violation|1|||
16845059|NCT01362608|37789587|FG000|Overall Study|Lost to Follow-up|3|||
16845060|NCT01362608|37789588|FG001|Overall Study|Lost to Follow-up|1|||
16845061|NCT01362608|37789587|FG000|Overall Study|Withdrawal by Subject|1|||
16845062|NCT01362608|37789588|FG001|Overall Study|Withdrawal by Subject|2|||
16845063|NCT01362608|37789587|FG000|Overall Study|Lack of Efficacy|0|||
16845064|NCT01362608|37789588|FG001|Overall Study|Lack of Efficacy|2|||
16845065|NCT01362608|37789587|FG000|Overall Study|Adverse Event|0|||
16845066|NCT01362608|37789588|FG001|Overall Study|Adverse Event|2|||
16845067|NCT01871090|37789596|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
16918396|NCT02028455|38059335|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
16918397|NCT02028455|38059336|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
16918398|NCT02028455|38059337|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
16918399|NCT02028455|38059338|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
16918400|NCT02028455|38059339|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
16918401|NCT02028455|38059340|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
16918402|NCT02028455|38059341|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
16918403|NCT02028455|38059334|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16918404|NCT02028455|38059335|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16918405|NCT02028455|38059336|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16845068|NCT01871090|37789597|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
16845069|NCT01871090|37789596|FG000|Overall Study|Interrogation not completed correctly|1|||
16845070|NCT01871090|37789597|FG001|Overall Study|Interrogation not completed correctly|0|||
16845071|NCT01871090|37789596|FG000|Overall Study|Subject Non-Compliance|0|||
16845072|NCT01871090|37789597|FG001|Overall Study|Subject Non-Compliance|1|||
16845073|NCT01818596|37789605|FG000|Overall Study|Enrolled but Not Treated|4|||
16918406|NCT02028455|38059337|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16918407|NCT02028455|38059338|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16918408|NCT02028455|38059339|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
16918409|NCT02028455|38059340|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16918410|NCT02028455|38059341|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
16918411|NCT02028455|38059334|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
16918412|NCT02028455|38059335|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
16918413|NCT02028455|38059336|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
16918414|NCT02028455|38059337|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
16918415|NCT02028455|38059338|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
16918416|NCT02028455|38059339|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
16918417|NCT02028455|38059340|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
16918418|NCT02028455|38059341|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
16918419|NCT01992653|38059371|FG000|Overall Study|Death|0|||
16918420|NCT01992653|38059372|FG001|Overall Study|Death|0|||
16918421|NCT01992653|38059373|FG002|Overall Study|Death|1|||
16918422|NCT01992653|38059374|FG003|Overall Study|Death|0|||
16918423|NCT01992653|38059375|FG004|Overall Study|Death|1|||
16918424|NCT01992653|38059376|FG005|Overall Study|Death|0|||
16918425|NCT01992653|38059377|FG006|Overall Study|Death|4|||
16918426|NCT01992653|38059378|FG007|Overall Study|Death|2|||
16918427|NCT01992653|38059371|FG000|Overall Study|Lost to Follow-up|0|||
16918428|NCT01992653|38059372|FG001|Overall Study|Lost to Follow-up|0|||
16918429|NCT01992653|38059373|FG002|Overall Study|Lost to Follow-up|0|||
16918430|NCT01992653|38059374|FG003|Overall Study|Lost to Follow-up|0|||
16918431|NCT01992653|38059375|FG004|Overall Study|Lost to Follow-up|0|||
16918432|NCT01992653|38059376|FG005|Overall Study|Lost to Follow-up|0|||
16918433|NCT01992653|38059377|FG006|Overall Study|Lost to Follow-up|0|||
16918434|NCT01992653|38059378|FG007|Overall Study|Lost to Follow-up|1|||
16918435|NCT01992653|38059371|FG000|Overall Study|Study Completed|0|||
16918436|NCT01992653|38059372|FG001|Overall Study|Study Completed|0|||
16918437|NCT01992653|38059373|FG002|Overall Study|Study Completed|0|||
16918438|NCT01992653|38059374|FG003|Overall Study|Study Completed|0|||
16918439|NCT01992653|38059375|FG004|Overall Study|Study Completed|0|||
17102505|NCT03628924|38241414|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
16845074|NCT01818596|37789606|FG001|Overall Study|Enrolled but Not Treated|0|||
16845075|NCT01818596|37789605|FG000|Overall Study|Adverse Event|7|||
16918440|NCT01992653|38059376|FG005|Overall Study|Study Completed|0|||
16918441|NCT01992653|38059377|FG006|Overall Study|Study Completed|0|||
16918442|NCT01992653|38059378|FG007|Overall Study|Study Completed|1|||
16918443|NCT01992653|38059371|FG000|Overall Study|Disease Progression|0|||
16918444|NCT01992653|38059372|FG001|Overall Study|Disease Progression|0|||
16918445|NCT01992653|38059373|FG002|Overall Study|Disease Progression|0|||
16918446|NCT01992653|38059374|FG003|Overall Study|Disease Progression|0|||
16918447|NCT01992653|38059375|FG004|Overall Study|Disease Progression|0|||
16918448|NCT01992653|38059376|FG005|Overall Study|Disease Progression|0|||
16918449|NCT01992653|38059377|FG006|Overall Study|Disease Progression|4|||
16918450|NCT01992653|38059378|FG007|Overall Study|Disease Progression|0|||
16918451|NCT01972217|38059400|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
16918452|NCT01972217|38059401|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
16918453|NCT01972217|38059402|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
16918454|NCT01972217|38059403|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
16918455|NCT01972217|38059400|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
16918456|NCT01972217|38059401|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
16918457|NCT01972217|38059402|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
16918458|NCT01972217|38059403|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
16918459|NCT01972217|38059400|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
16918460|NCT01972217|38059401|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
16918461|NCT01972217|38059402|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
16918462|NCT01972217|38059403|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
16918463|NCT01972217|38059400|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
16918464|NCT01972217|38059401|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
17017142|NCT00689104|38161734|FG001|Overall Study|Randomized but never received study drug|1|||
17017143|NCT00689104|38161735|FG002|Overall Study|Randomized but never received study drug|1|||
17017144|NCT00689104|38161736|FG003|Overall Study|Randomized but never received study drug|0|||
17017145|NCT00689104|38161733|FG000|Overall Study|Physician Decision|1|||
17017146|NCT00689104|38161734|FG001|Overall Study|Physician Decision|0|||
17017147|NCT00689104|38161735|FG002|Overall Study|Physician Decision|0|||
17017148|NCT00689104|38161736|FG003|Overall Study|Physician Decision|0|||
17017149|NCT00689104|38161733|FG000|Overall Study|Non-compliance with study procedures|0|||
17017150|NCT00689104|38161734|FG001|Overall Study|Non-compliance with study procedures|0|||
17017151|NCT00689104|38161735|FG002|Overall Study|Non-compliance with study procedures|1|||
16845076|NCT01818596|37789606|FG001|Overall Study|Adverse Event|0|||
16845077|NCT01818596|37789605|FG000|Overall Study|Death|3|||
16845078|NCT01818596|37789606|FG001|Overall Study|Death|0|||
16845079|NCT01818596|37789605|FG000|Overall Study|Investigator's Discretion|4|||
16845080|NCT01818596|37789606|FG001|Overall Study|Investigator's Discretion|0|||
16845081|NCT01818596|37789605|FG000|Overall Study|Protocol Violation|1|||
16845082|NCT01818596|37789606|FG001|Overall Study|Protocol Violation|0|||
16845083|NCT01818596|37789605|FG000|Overall Study|Withdrew Consent|5|||
16845084|NCT01818596|37789606|FG001|Overall Study|Withdrew Consent|0|||
16845085|NCT01818596|37789605|FG000|Overall Study|Lost to Follow-up|7|||
16845086|NCT01818596|37789606|FG001|Overall Study|Lost to Follow-up|0|||
16845087|NCT04577794|37789619|FG000|Overall Study|Adverse Event|1|||
16845088|NCT04577794|37789620|FG001|Overall Study|Adverse Event|1|||
16845089|NCT01594281|37789637|FG000|Interventional Core Phase|Protocol Deviation|1|||
16845090|NCT01594281|37789638|FG001|Interventional Core Phase|Protocol Deviation|0|||
16845091|NCT01594281|37789639|FG002|Interventional Core Phase|Protocol Deviation|0|||
16845092|NCT01594281|37789637|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
16845093|NCT01594281|37789638|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
16845094|NCT01594281|37789639|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
16845095|NCT01594281|37789637|FG000|Interventional Core Phase|Death|1|||
16845096|NCT01594281|37789638|FG001|Interventional Core Phase|Death|1|||
16845097|NCT01594281|37789639|FG002|Interventional Core Phase|Death|2|||
16845098|NCT01594281|37789637|FG000|Interventional Core Phase|Lost to Follow-up|1|||
16845099|NCT01594281|37789638|FG001|Interventional Core Phase|Lost to Follow-up|4|||
16845100|NCT01594281|37789639|FG002|Interventional Core Phase|Lost to Follow-up|1|||
16845101|NCT01594281|37789637|FG000|Interventional Core Phase|Adverse Event|4|||
16845102|NCT01594281|37789638|FG001|Interventional Core Phase|Adverse Event|4|||
16845103|NCT01594281|37789639|FG002|Interventional Core Phase|Adverse Event|4|||
16845104|NCT01594281|37789637|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
16845105|NCT01594281|37789638|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
16845106|NCT01594281|37789639|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
16845107|NCT01594281|37789637|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
16845108|NCT01594281|37789638|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
16845109|NCT01594281|37789639|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
16845110|NCT01594281|37789637|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
16918465|NCT01972217|38059402|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
16918466|NCT01972217|38059403|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
16918467|NCT01972217|38059400|FG000|Part B Double-blind, Randomised Period|Death|0|||
16918468|NCT01972217|38059401|FG001|Part B Double-blind, Randomised Period|Death|0|||
16918469|NCT01972217|38059402|FG002|Part B Double-blind, Randomised Period|Death|43|||
16918470|NCT01972217|38059403|FG003|Part B Double-blind, Randomised Period|Death|44|||
16918471|NCT01972217|38059400|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
16918472|NCT01972217|38059401|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
16918473|NCT01972217|38059402|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
16918474|NCT01972217|38059403|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
16918475|NCT01972217|38059400|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
16918476|NCT01972217|38059401|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
16918477|NCT01972217|38059402|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
16918478|NCT01972217|38059403|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
16918479|NCT01972217|38059400|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
16918480|NCT01972217|38059401|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
16918481|NCT01972217|38059402|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
16918482|NCT01972217|38059403|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
16918483|NCT01972217|38059400|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
16918484|NCT01972217|38059401|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
16918485|NCT01972217|38059402|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
16918486|NCT01972217|38059403|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
16918487|NCT01682083|38059434|FG000|Overall Study|Lost to Follow-up|11|||
16918488|NCT01682083|38059435|FG001|Overall Study|Lost to Follow-up|18|||
16918489|NCT01682083|38059434|FG000|Overall Study|Withdrawal by Subject|31|||
16918490|NCT01682083|38059435|FG001|Overall Study|Withdrawal by Subject|40|||
16918491|NCT01682083|38059434|FG000|Overall Study|Death|60|||
16918492|NCT01682083|38059435|FG001|Overall Study|Death|93|||
16918493|NCT01682083|38059434|FG000|Overall Study|Physician Decision|5|||
16918494|NCT01682083|38059435|FG001|Overall Study|Physician Decision|4|||
16918495|NCT01654276|38059441|FG000|Overall Study|Lack of Efficacy|1|||
16918496|NCT01654276|38059441|FG000|Overall Study|Lost to Follow-up|4|||
16918497|NCT01654276|38059441|FG000|Overall Study|Withdrawal by Subject|1|||
16918498|NCT01399658|38059445|FG000|Overall Study|Ineligible|1|||
16918499|NCT01399658|38059445|FG000|Overall Study|Machine Technical Issue|3|||
16918500|NCT01399658|38059445|FG000|Overall Study|Alternative therapy|1|||
16918501|NCT01399658|38059445|FG000|Overall Study|No reason given|1|||
16918502|NCT00590122|38059451|FG000|Overall Study|swallowed oral dissolving dose|1|||
16918503|NCT00590122|38059452|FG001|Overall Study|swallowed oral dissolving dose|0|||
16918504|NCT01386658|38059494|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
16918505|NCT01386658|38059495|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
16918506|NCT01386658|38059494|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
16918507|NCT01386658|38059495|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
16918508|NCT01386684|38059505|FG000|Overall Study|Lost to Follow-up|51|||
16918509|NCT01386684|38059505|FG000|Overall Study|Other|51|||
16918510|NCT01386684|38059505|FG000|Overall Study|Death|47|||
16918511|NCT01386684|38059505|FG000|Overall Study|Withdrawal of Consent|44|||
16918512|NCT01386684|38059505|FG000|Overall Study|Alternative Therapy Required|37|||
16918513|NCT01386684|38059505|FG000|Overall Study|Disease Progression|28|||
16918514|NCT01386684|38059505|FG000|Overall Study|Adverse Event|20|||
16918515|NCT01386684|38059505|FG000|Overall Study|Noncompliance|8|||
16918516|NCT01386684|38059505|FG000|Overall Study|Protocol Violation|4|||
16918517|NCT01386684|38059505|FG000|Overall Study|Missing|3|||
16918518|NCT04980014|38059522|FG000|Overall Study|Participants who are Duplicated|1|||
16918519|NCT04980014|38059522|FG000|Overall Study|Follow-up Failure|13|||
16918520|NCT04980014|38059522|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
16918521|NCT04980014|38059522|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
16918522|NCT04980014|38059522|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
16918523|NCT03735849|38059546|FG000|Overall Study|Lost to Follow-up|1|||
16918524|NCT03735849|38059547|FG001|Overall Study|Lost to Follow-up|0|||
16918525|NCT03735849|38059548|FG002|Overall Study|Lost to Follow-up|0|||
16918526|NCT03735849|38059546|FG000|Overall Study|Participant unable to adhere to visit|1|||
16918527|NCT03735849|38059547|FG001|Overall Study|Participant unable to adhere to visit|0|||
16918528|NCT03735849|38059548|FG002|Overall Study|Participant unable to adhere to visit|0|||
16918529|NCT03735849|38059546|FG000|Overall Study|Not Randomized|0|||
16918530|NCT03735849|38059547|FG001|Overall Study|Not Randomized|0|||
16918531|NCT03735849|38059548|FG002|Overall Study|Not Randomized|4|||
16918532|NCT03552393|38059555|FG000|Core Period|Kidney Transplant|1|||
16918533|NCT03552393|38059555|FG000|Core Period|Prohibited Medication|1|||
16918534|NCT03552393|38059555|FG000|Safety Extension Period|Kidney Transplant|4|||
16918535|NCT03333382|38059561|FG000|Overall Study|Lost to Follow-up|1|||
16918536|NCT03333382|38059562|FG001|Overall Study|Lost to Follow-up|0|||
16918537|NCT03107611|38059601|FG000|Overall Study|Adverse Event|1|||
16918538|NCT03107611|38059602|FG001|Overall Study|Adverse Event|0|||
16918539|NCT03107611|38059603|FG002|Overall Study|Adverse Event|2|||
16918540|NCT03107611|38059601|FG000|Overall Study|Lost to Follow-up|3|||
16918541|NCT03107611|38059602|FG001|Overall Study|Lost to Follow-up|3|||
16918542|NCT03107611|38059603|FG002|Overall Study|Lost to Follow-up|3|||
16918543|NCT03107611|38059601|FG000|Overall Study|Protocol Violation|0|||
16918544|NCT03107611|38059602|FG001|Overall Study|Protocol Violation|0|||
16918545|NCT03107611|38059603|FG002|Overall Study|Protocol Violation|1|||
16918546|NCT03107611|38059601|FG000|Overall Study|Withdrawal by Subject|1|||
16918547|NCT03107611|38059602|FG001|Overall Study|Withdrawal by Subject|0|||
16918548|NCT03107611|38059603|FG002|Overall Study|Withdrawal by Subject|1|||
16918549|NCT03107611|38059601|FG000|Overall Study|Worsening signs/symptoms|2|||
16918550|NCT03107611|38059602|FG001|Overall Study|Worsening signs/symptoms|1|||
16845111|NCT01594281|37789638|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
16845112|NCT01594281|37789639|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
16845113|NCT01566981|37789652|FG000|Overall Study|Lost to Follow-up|5|||
16918551|NCT03107611|38059603|FG002|Overall Study|Worsening signs/symptoms|2|||
16918552|NCT02720016|38059614|FG000|Overall Study|Separation of couple|6|||
16918553|NCT02720016|38059615|FG001|Overall Study|Separation of couple|8|||
16918554|NCT02720016|38059616|FG002|Overall Study|Separation of couple|2|||
16918555|NCT02720016|38059614|FG000|Overall Study|Withdrawal by Subject|6|||
16918556|NCT02720016|38059615|FG001|Overall Study|Withdrawal by Subject|6|||
16918557|NCT02720016|38059616|FG002|Overall Study|Withdrawal by Subject|4|||
16918558|NCT02720016|38059614|FG000|Overall Study|Scheduling issues|2|||
16918559|NCT02720016|38059615|FG001|Overall Study|Scheduling issues|4|||
16918560|NCT02720016|38059616|FG002|Overall Study|Scheduling issues|7|||
16918561|NCT02720016|38059614|FG000|Overall Study|Childcare|2|||
16918562|NCT02720016|38059615|FG001|Overall Study|Childcare|0|||
16918563|NCT02720016|38059616|FG002|Overall Study|Childcare|2|||
16918564|NCT02720016|38059614|FG000|Overall Study|Withdrawal by PI|2|||
16918565|NCT02720016|38059615|FG001|Overall Study|Withdrawal by PI|2|||
16918566|NCT02720016|38059616|FG002|Overall Study|Withdrawal by PI|0|||
16918567|NCT02720016|38059614|FG000|Overall Study|Moved away|2|||
16918568|NCT02720016|38059615|FG001|Overall Study|Moved away|0|||
16845114|NCT01566981|37789653|FG001|Overall Study|Lost to Follow-up|8|||
16845115|NCT01870778|37789663|FG000|Overall Study|Withdrawal by Subject|8|||
16845116|NCT01870778|37789664|FG001|Overall Study|Withdrawal by Subject|7|||
16845117|NCT01870778|37789663|FG000|Overall Study|Lost to Follow-up|0|||
16845118|NCT01870778|37789664|FG001|Overall Study|Lost to Follow-up|2|||
16845119|NCT01818284|37789677|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
16845120|NCT01818284|37789678|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
16845121|NCT01818284|37789677|FG000|Overall Study|Death|0|||
16845122|NCT01818284|37789678|FG001|Overall Study|Death|2|||
16845123|NCT01610492|37789714|FG000|Overall Study|Adverse Event|1|||
16845124|NCT01610492|37789714|FG000|Overall Study|Lack of Efficacy|3|||
16845125|NCT01610492|37789714|FG000|Overall Study|Other: Reached stopping criteria|1|||
16845126|NCT01610492|37789714|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
16845127|NCT01817582|37789721|FG000|Overall Study|Withdrawal by Subject|0|||
16845128|NCT01817582|37789722|FG001|Overall Study|Withdrawal by Subject|1|||
16845129|NCT01817582|37789723|FG002|Overall Study|Withdrawal by Subject|0|||
16845130|NCT01817582|37789721|FG000|Overall Study|Participant revealed masked treatment|1|||
16845131|NCT01817582|37789722|FG001|Overall Study|Participant revealed masked treatment|0|||
16845132|NCT01817582|37789723|FG002|Overall Study|Participant revealed masked treatment|0|||
16845133|NCT01817582|37789721|FG000|Overall Study|Randomized but exclusion criteria met|1|||
16845134|NCT01817582|37789722|FG001|Overall Study|Randomized but exclusion criteria met|0|||
16845135|NCT01817582|37789723|FG002|Overall Study|Randomized but exclusion criteria met|0|||
16845136|NCT01594125|37789736|FG000|Overall Study|Withdrawal by Subject|1|||
16845137|NCT01594125|37789737|FG001|Overall Study|Withdrawal by Subject|0|||
16918569|NCT02720016|38059616|FG002|Overall Study|Moved away|0|||
16918570|NCT02720016|38059614|FG000|Overall Study|Not Primary Health Concern|0|||
16918571|NCT02720016|38059615|FG001|Overall Study|Not Primary Health Concern|0|||
16918572|NCT02720016|38059616|FG002|Overall Study|Not Primary Health Concern|2|||
16918573|NCT02720016|38059614|FG000|Overall Study|Transportation issues|0|||
16918574|NCT02720016|38059615|FG001|Overall Study|Transportation issues|0|||
16918575|NCT02720016|38059616|FG002|Overall Study|Transportation issues|1|||
16918576|NCT02720016|38059614|FG000|Overall Study|Other|0|||
16918577|NCT02720016|38059615|FG001|Overall Study|Other|0|||
16918578|NCT02720016|38059616|FG002|Overall Study|Other|2|||
16918579|NCT02607956|38059627|FG000|Double-Blinded Phase|Withdrew Consent|17|||
16918580|NCT02607956|38059628|FG001|Double-Blinded Phase|Withdrew Consent|19|||
16918581|NCT02607956|38059629|FG002|Double-Blinded Phase|Withdrew Consent|0|||
16918582|NCT02607956|38059630|FG003|Double-Blinded Phase|Withdrew Consent|0|||
16918583|NCT02607956|38059627|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
16918584|NCT02607956|38059628|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
16918585|NCT02607956|38059629|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
16918586|NCT02607956|38059630|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
16918587|NCT02607956|38059627|FG000|Double-Blinded Phase|Randomized but never treated|7|||
16918588|NCT02607956|38059628|FG001|Double-Blinded Phase|Randomized but never treated|5|||
16918589|NCT02607956|38059629|FG002|Double-Blinded Phase|Randomized but never treated|0|||
16918590|NCT02607956|38059630|FG003|Double-Blinded Phase|Randomized but never treated|0|||
16918591|NCT02607956|38059627|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
16918592|NCT02607956|38059628|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
16918593|NCT02607956|38059629|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
16918594|NCT02607956|38059630|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
16918595|NCT02607956|38059627|FG000|Double-Blinded Phase|Death|4|||
16918596|NCT02607956|38059628|FG001|Double-Blinded Phase|Death|4|||
16918597|NCT02607956|38059629|FG002|Double-Blinded Phase|Death|0|||
16918598|NCT02607956|38059630|FG003|Double-Blinded Phase|Death|0|||
16918599|NCT02607956|38059627|FG000|Double-Blinded Phase|Adverse Event|4|||
16918600|NCT02607956|38059628|FG001|Double-Blinded Phase|Adverse Event|3|||
16918601|NCT02607956|38059629|FG002|Double-Blinded Phase|Adverse Event|0|||
16918602|NCT02607956|38059630|FG003|Double-Blinded Phase|Adverse Event|0|||
16918603|NCT02607956|38059627|FG000|Double-Blinded Phase|Protocol Violation|3|||
16918604|NCT02607956|38059628|FG001|Double-Blinded Phase|Protocol Violation|1|||
16918605|NCT02607956|38059629|FG002|Double-Blinded Phase|Protocol Violation|0|||
16918606|NCT02607956|38059630|FG003|Double-Blinded Phase|Protocol Violation|0|||
16918607|NCT02607956|38059627|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
16918608|NCT02607956|38059628|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
16918609|NCT02607956|38059629|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
16918610|NCT02607956|38059630|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
16918611|NCT02607956|38059627|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
16918612|NCT02607956|38059628|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
16918613|NCT02607956|38059629|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
16918614|NCT02607956|38059630|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
16918615|NCT02607956|38059627|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
16918616|NCT02607956|38059628|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
16918617|NCT02607956|38059629|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
16918618|NCT02607956|38059630|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
16918619|NCT02607956|38059627|FG000|Open-Label Extension Phase|Death|0|||
16918620|NCT02607956|38059628|FG001|Open-Label Extension Phase|Death|0|||
16918621|NCT02607956|38059629|FG002|Open-Label Extension Phase|Death|1|||
16918622|NCT02607956|38059630|FG003|Open-Label Extension Phase|Death|3|||
16918623|NCT02607956|38059627|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
16918624|NCT02607956|38059628|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
16918625|NCT02607956|38059629|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
16918626|NCT02607956|38059630|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
16918627|NCT02607956|38059627|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
16918628|NCT02607956|38059628|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
16918629|NCT02607956|38059629|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
16918630|NCT02607956|38059630|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
16918631|NCT02607956|38059627|FG000|Open-Label Extension Phase|Protocol Violation|0|||
16918632|NCT02607956|38059628|FG001|Open-Label Extension Phase|Protocol Violation|0|||
16918633|NCT02607956|38059629|FG002|Open-Label Extension Phase|Protocol Violation|0|||
16918634|NCT02607956|38059630|FG003|Open-Label Extension Phase|Protocol Violation|2|||
16918635|NCT02607956|38059627|FG000|Open-Label Extension Phase|Pregnancy|0|||
16918636|NCT02607956|38059628|FG001|Open-Label Extension Phase|Pregnancy|0|||
16918637|NCT02607956|38059629|FG002|Open-Label Extension Phase|Pregnancy|0|||
16918638|NCT02607956|38059630|FG003|Open-Label Extension Phase|Pregnancy|1|||
16918639|NCT02564523|38059660|FG000|Overall Study|Withdrawal by Subject|3|||
16918640|NCT02564523|38059661|FG001|Overall Study|Withdrawal by Subject|0|||
16918641|NCT02564523|38059662|FG002|Overall Study|Withdrawal by Subject|1|||
16918642|NCT02564523|38059663|FG003|Overall Study|Withdrawal by Subject|0|||
16918643|NCT02564523|38059664|FG004|Overall Study|Withdrawal by Subject|1|||
16918644|NCT02564523|38059665|FG005|Overall Study|Withdrawal by Subject|0|||
16918645|NCT02564523|38059666|FG006|Overall Study|Withdrawal by Subject|1|||
16918646|NCT02564523|38059667|FG007|Overall Study|Withdrawal by Subject|0|||
16918647|NCT02564523|38059668|FG008|Overall Study|Withdrawal by Subject|0|||
16918648|NCT02564523|38059669|FG009|Overall Study|Withdrawal by Subject|0|||
16918649|NCT02564523|38059670|FG010|Overall Study|Withdrawal by Subject|1|||
16918650|NCT02564523|38059671|FG011|Overall Study|Withdrawal by Subject|0|||
16918651|NCT02564523|38059672|FG012|Overall Study|Withdrawal by Subject|1|||
16918652|NCT02564523|38059673|FG013|Overall Study|Withdrawal by Subject|0|||
16918653|NCT02564523|38059674|FG014|Overall Study|Withdrawal by Subject|0|||
16918654|NCT02564523|38059675|FG015|Overall Study|Withdrawal by Subject|0|||
16918655|NCT02564523|38059676|FG016|Overall Study|Withdrawal by Subject|0|||
16918656|NCT02564523|38059677|FG017|Overall Study|Withdrawal by Subject|0|||
16918657|NCT02564523|38059660|FG000|Overall Study|Adverse Event|0|||
16918658|NCT02564523|38059661|FG001|Overall Study|Adverse Event|0|||
16918659|NCT02564523|38059662|FG002|Overall Study|Adverse Event|0|||
16918660|NCT02564523|38059663|FG003|Overall Study|Adverse Event|0|||
16918661|NCT02564523|38059664|FG004|Overall Study|Adverse Event|0|||
16918662|NCT02564523|38059665|FG005|Overall Study|Adverse Event|0|||
16918663|NCT02564523|38059666|FG006|Overall Study|Adverse Event|0|||
16918664|NCT02564523|38059667|FG007|Overall Study|Adverse Event|0|||
16918665|NCT02564523|38059668|FG008|Overall Study|Adverse Event|0|||
16918666|NCT02564523|38059669|FG009|Overall Study|Adverse Event|0|||
16918667|NCT02564523|38059670|FG010|Overall Study|Adverse Event|0|||
16918668|NCT02564523|38059671|FG011|Overall Study|Adverse Event|0|||
16918669|NCT02564523|38059672|FG012|Overall Study|Adverse Event|0|||
16918670|NCT02564523|38059673|FG013|Overall Study|Adverse Event|0|||
16918671|NCT02564523|38059674|FG014|Overall Study|Adverse Event|0|||
16918672|NCT02564523|38059675|FG015|Overall Study|Adverse Event|0|||
16918673|NCT02564523|38059676|FG016|Overall Study|Adverse Event|0|||
16918674|NCT02564523|38059677|FG017|Overall Study|Adverse Event|1|||
16918675|NCT02564523|38059660|FG000|Overall Study|Death|0|||
16918676|NCT02564523|38059661|FG001|Overall Study|Death|0|||
16918677|NCT02564523|38059662|FG002|Overall Study|Death|0|||
16918678|NCT02564523|38059663|FG003|Overall Study|Death|0|||
16918679|NCT02564523|38059664|FG004|Overall Study|Death|0|||
16918680|NCT02564523|38059665|FG005|Overall Study|Death|0|||
16918681|NCT02564523|38059666|FG006|Overall Study|Death|1|||
16918682|NCT02564523|38059667|FG007|Overall Study|Death|0|||
16918683|NCT02564523|38059668|FG008|Overall Study|Death|0|||
16918684|NCT02564523|38059669|FG009|Overall Study|Death|0|||
16918685|NCT02564523|38059670|FG010|Overall Study|Death|1|||
16918686|NCT02564523|38059671|FG011|Overall Study|Death|0|||
16918687|NCT02564523|38059672|FG012|Overall Study|Death|0|||
16918688|NCT02564523|38059673|FG013|Overall Study|Death|0|||
16918689|NCT02564523|38059674|FG014|Overall Study|Death|0|||
16918690|NCT02564523|38059675|FG015|Overall Study|Death|0|||
16918691|NCT02564523|38059676|FG016|Overall Study|Death|0|||
16918692|NCT02564523|38059677|FG017|Overall Study|Death|0|||
16918693|NCT02564523|38059660|FG000|Overall Study|Lost to Follow-up|2|||
16918694|NCT02564523|38059661|FG001|Overall Study|Lost to Follow-up|1|||
16918695|NCT02564523|38059662|FG002|Overall Study|Lost to Follow-up|4|||
16918696|NCT02564523|38059663|FG003|Overall Study|Lost to Follow-up|0|||
16918697|NCT02564523|38059664|FG004|Overall Study|Lost to Follow-up|1|||
16918698|NCT02564523|38059665|FG005|Overall Study|Lost to Follow-up|0|||
16918699|NCT02564523|38059666|FG006|Overall Study|Lost to Follow-up|1|||
16918700|NCT02564523|38059667|FG007|Overall Study|Lost to Follow-up|0|||
16845138|NCT01594125|37789738|FG002|Overall Study|Withdrawal by Subject|0|||
16845139|NCT01594125|37789739|FG003|Overall Study|Withdrawal by Subject|1|||
16845140|NCT01594125|37789740|FG004|Overall Study|Withdrawal by Subject|0|||
16845141|NCT01594125|37789736|FG000|Overall Study|Progressive Disease|3|||
16845142|NCT01594125|37789737|FG001|Overall Study|Progressive Disease|12|||
16845143|NCT01594125|37789738|FG002|Overall Study|Progressive Disease|3|||
16845144|NCT01594125|37789739|FG003|Overall Study|Progressive Disease|3|||
16845145|NCT01594125|37789740|FG004|Overall Study|Progressive Disease|7|||
16845146|NCT01870076|37789756|FG000|Overall Study|Withdrawal by Subject|1|||
16845147|NCT01870076|37789757|FG001|Overall Study|Withdrawal by Subject|0|||
16845148|NCT01870076|37789758|FG002|Overall Study|Withdrawal by Subject|1|||
16845149|NCT01870076|37789759|FG003|Overall Study|Withdrawal by Subject|0|||
16845150|NCT01592721|37789769|FG000|Long-term Follow-up|Death|1|||
16845151|NCT01613378|37789773|FG000|Overall Study|Lack of Efficacy|13|||
16845152|NCT01613378|37789773|FG000|Overall Study|Adverse Event|11|||
16845153|NCT01613378|37789773|FG000|Overall Study|Withdrawal by Subject|8|||
16845154|NCT01613378|37789773|FG000|Overall Study|Death|2|||
16845155|NCT01613378|37789773|FG000|Overall Study|Lost to Follow-up|1|||
16845156|NCT01613378|37789773|FG000|Overall Study|Other Reason|4|||
16845157|NCT01592409|37789779|FG000|Overall Study|Withdrawal by Subject|0|||
16845158|NCT01592409|37789780|FG001|Overall Study|Withdrawal by Subject|1|||
16845159|NCT01697319|37789799|FG000|Primary Phase|Withdrawal by Subject|1|||
16845160|NCT01697319|37789799|FG000|Extension Phase|Terminated by Sponsor|15|||
16845161|NCT01566435|37789814|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
16845162|NCT01696929|37789822|FG000|Overall Study|Physician Decision|1|||
16845163|NCT01696773|37789832|FG000|Days 15-27, Washout|Adverse Event|1|||
16845164|NCT01696773|37789833|FG001|Days 15-27, Washout|Adverse Event|0|||
16845165|NCT01696695|37789839|FG000|Overall Study|Disease progression|373|||
16845166|NCT01696695|37789839|FG000|Overall Study|Death|29|||
16845167|NCT01696695|37789839|FG000|Overall Study|Adverse Event|74|||
16845168|NCT01696695|37789839|FG000|Overall Study|Withdrawal by Subject|92|||
16918701|NCT02564523|38059668|FG008|Overall Study|Lost to Follow-up|0|||
16918702|NCT02564523|38059669|FG009|Overall Study|Lost to Follow-up|0|||
16918703|NCT02564523|38059670|FG010|Overall Study|Lost to Follow-up|0|||
16918704|NCT02564523|38059671|FG011|Overall Study|Lost to Follow-up|1|||
16918705|NCT02564523|38059672|FG012|Overall Study|Lost to Follow-up|1|||
16918706|NCT02564523|38059673|FG013|Overall Study|Lost to Follow-up|0|||
16918707|NCT02564523|38059674|FG014|Overall Study|Lost to Follow-up|0|||
16918708|NCT02564523|38059675|FG015|Overall Study|Lost to Follow-up|0|||
16918709|NCT02564523|38059676|FG016|Overall Study|Lost to Follow-up|0|||
16918710|NCT02564523|38059677|FG017|Overall Study|Lost to Follow-up|0|||
16918711|NCT02564523|38059660|FG000|Overall Study|Physician Decision|0|||
16918712|NCT02564523|38059661|FG001|Overall Study|Physician Decision|0|||
16918713|NCT02564523|38059662|FG002|Overall Study|Physician Decision|0|||
16845169|NCT01696695|37789839|FG000|Overall Study|Lost to Follow-up|48|||
16845170|NCT01696695|37789839|FG000|Overall Study|Other|74|||
16845171|NCT01696695|37789839|FG000|Overall Study|Major Protocol Violation|192|||
16845172|NCT01565889|37789858|FG000|Part A|Withdrawal by Subject|1|||
16845173|NCT01565889|37789859|FG001|Part A|Withdrawal by Subject|0|||
16845174|NCT01565889|37789860|FG002|Part A|Withdrawal by Subject|0|||
16845175|NCT01565889|37789861|FG003|Part A|Withdrawal by Subject|0|||
16845176|NCT01565889|37789862|FG004|Part A|Withdrawal by Subject|0|||
16845177|NCT01565889|37789863|FG005|Part A|Withdrawal by Subject|0|||
16918714|NCT02564523|38059663|FG003|Overall Study|Physician Decision|0|||
16918715|NCT02564523|38059664|FG004|Overall Study|Physician Decision|1|||
16918716|NCT02564523|38059665|FG005|Overall Study|Physician Decision|0|||
16918717|NCT02564523|38059666|FG006|Overall Study|Physician Decision|0|||
16918718|NCT02564523|38059667|FG007|Overall Study|Physician Decision|0|||
16918719|NCT02564523|38059668|FG008|Overall Study|Physician Decision|0|||
16918720|NCT02564523|38059669|FG009|Overall Study|Physician Decision|0|||
16918721|NCT02564523|38059670|FG010|Overall Study|Physician Decision|1|||
16918722|NCT02564523|38059671|FG011|Overall Study|Physician Decision|0|||
16918723|NCT02564523|38059672|FG012|Overall Study|Physician Decision|0|||
16845178|NCT01565889|37789858|FG000|Part B|Withdrawal by Subject|0|||
16845179|NCT01565889|37789859|FG001|Part B|Withdrawal by Subject|0|||
16845180|NCT01565889|37789860|FG002|Part B|Withdrawal by Subject|0|||
16845181|NCT01565889|37789861|FG003|Part B|Withdrawal by Subject|0|||
16845182|NCT01565889|37789862|FG004|Part B|Withdrawal by Subject|0|||
16845183|NCT01565889|37789863|FG005|Part B|Withdrawal by Subject|1|||
16845184|NCT01565889|37789858|FG000|Part B|Lack of Efficacy|0|||
16845185|NCT01565889|37789859|FG001|Part B|Lack of Efficacy|0|||
16845186|NCT01565889|37789860|FG002|Part B|Lack of Efficacy|0|||
16845187|NCT01565889|37789861|FG003|Part B|Lack of Efficacy|0|||
16845188|NCT01565889|37789862|FG004|Part B|Lack of Efficacy|0|||
16845189|NCT01565889|37789863|FG005|Part B|Lack of Efficacy|2|||
16845190|NCT01565889|37789858|FG000|Part B|Lost to Follow-up|0|||
16845191|NCT01565889|37789859|FG001|Part B|Lost to Follow-up|0|||
16918724|NCT02564523|38059673|FG013|Overall Study|Physician Decision|0|||
16918725|NCT02564523|38059674|FG014|Overall Study|Physician Decision|0|||
16918726|NCT02564523|38059675|FG015|Overall Study|Physician Decision|0|||
16918727|NCT02564523|38059676|FG016|Overall Study|Physician Decision|0|||
16918728|NCT02564523|38059677|FG017|Overall Study|Physician Decision|0|||
16918729|NCT02564523|38059660|FG000|Overall Study|Protocol Violation|2|||
16918730|NCT02564523|38059661|FG001|Overall Study|Protocol Violation|2|||
16918731|NCT02564523|38059662|FG002|Overall Study|Protocol Violation|5|||
16918732|NCT02564523|38059663|FG003|Overall Study|Protocol Violation|0|||
16918733|NCT02564523|38059664|FG004|Overall Study|Protocol Violation|1|||
16918734|NCT02564523|38059665|FG005|Overall Study|Protocol Violation|0|||
16918735|NCT02564523|38059666|FG006|Overall Study|Protocol Violation|0|||
16918736|NCT02564523|38059667|FG007|Overall Study|Protocol Violation|0|||
16918737|NCT02564523|38059668|FG008|Overall Study|Protocol Violation|0|||
16918738|NCT02564523|38059669|FG009|Overall Study|Protocol Violation|0|||
16845192|NCT01565889|37789860|FG002|Part B|Lost to Follow-up|0|||
16845193|NCT01565889|37789861|FG003|Part B|Lost to Follow-up|0|||
16845194|NCT01565889|37789862|FG004|Part B|Lost to Follow-up|0|||
16845195|NCT01565889|37789863|FG005|Part B|Lost to Follow-up|1|||
16845196|NCT01696071|37789878|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
16845197|NCT01696071|37789879|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
16845198|NCT01591863|37789890|FG000|Overall Study|Adverse Event|3|||
16845199|NCT01591863|37789890|FG000|Overall Study|Withdrawal by Subject|1|||
16845200|NCT01591863|37789890|FG000|Overall Study|recurrence|9|||
16845201|NCT01591863|37789890|FG000|Overall Study|Lack of Efficacy|1|||
16845202|NCT01591785|37789896|FG000|Overall Study|worsening condition|1|||
16845203|NCT01591785|37789897|FG001|Overall Study|worsening condition|2|||
16918739|NCT02564523|38059670|FG010|Overall Study|Protocol Violation|0|||
16918740|NCT02564523|38059671|FG011|Overall Study|Protocol Violation|0|||
16918741|NCT02564523|38059672|FG012|Overall Study|Protocol Violation|0|||
16918742|NCT02564523|38059673|FG013|Overall Study|Protocol Violation|0|||
16918743|NCT02564523|38059674|FG014|Overall Study|Protocol Violation|0|||
16918744|NCT02564523|38059675|FG015|Overall Study|Protocol Violation|0|||
16918745|NCT02564523|38059676|FG016|Overall Study|Protocol Violation|0|||
16918746|NCT02564523|38059677|FG017|Overall Study|Protocol Violation|0|||
16918747|NCT02564523|38059660|FG000|Overall Study|Other|3|||
16918748|NCT02564523|38059661|FG001|Overall Study|Other|0|||
16918749|NCT02564523|38059662|FG002|Overall Study|Other|0|||
16918750|NCT02564523|38059663|FG003|Overall Study|Other|1|||
16918751|NCT02564523|38059664|FG004|Overall Study|Other|0|||
16918752|NCT02564523|38059665|FG005|Overall Study|Other|0|||
16918753|NCT02564523|38059666|FG006|Overall Study|Other|0|||
16918754|NCT02564523|38059667|FG007|Overall Study|Other|0|||
16918755|NCT02564523|38059668|FG008|Overall Study|Other|0|||
16918756|NCT02564523|38059669|FG009|Overall Study|Other|0|||
16918757|NCT02564523|38059670|FG010|Overall Study|Other|0|||
16918758|NCT02564523|38059671|FG011|Overall Study|Other|0|||
16918759|NCT02564523|38059672|FG012|Overall Study|Other|0|||
16918760|NCT02564523|38059673|FG013|Overall Study|Other|0|||
16918761|NCT02564523|38059674|FG014|Overall Study|Other|0|||
16918762|NCT02564523|38059675|FG015|Overall Study|Other|0|||
16918763|NCT02564523|38059676|FG016|Overall Study|Other|0|||
16918764|NCT02564523|38059677|FG017|Overall Study|Other|0|||
16918765|NCT01447628|38059784|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
16918766|NCT01447628|38059785|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
16918767|NCT01447628|38059786|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
16918768|NCT01447628|38059787|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
16918769|NCT01175356|38059807|FG000|Overall Study|Death|1|||
16918770|NCT01175356|38059807|FG000|Overall Study|Lack of Efficacy|12|||
16918771|NCT01175356|38059807|FG000|Overall Study|Lost to Follow-up|1|||
16918772|NCT01175356|38059807|FG000|Overall Study|Physician Decision|23|||
16918773|NCT01175356|38059807|FG000|Overall Study|Ineligible|1|||
16918774|NCT01175356|38059807|FG000|Overall Study|Treatment Slot Not Available|18|||
16918775|NCT01175356|38059807|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
16918776|NCT01175356|38059807|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
16918777|NCT01175356|38059807|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
16918778|NCT01175356|38059807|FG000|Overall Study|Inadequate stem cell for transplant|1|||
16918779|NCT01175356|38059807|FG000|Overall Study|Initiation other tx prior to completion|9|||
16918780|NCT00515853|38059813|FG000|Overall Study|Lost to Follow-up|9|||
16918781|NCT00515853|38059814|FG001|Overall Study|Lost to Follow-up|13|||
16918782|NCT00515853|38059813|FG000|Overall Study|Withdrawal by Subject|6|||
16918783|NCT00515853|38059814|FG001|Overall Study|Withdrawal by Subject|4|||
16918784|NCT00003458|38059820|FG000|Overall Study|Not evaluable|4|||
16918785|NCT04613739|38059845|FG000|Overall Study|Lost to Follow-up|6|||
16845204|NCT01591785|37789896|FG000|Overall Study|Protocol Violation|2|||
16845205|NCT01591785|37789897|FG001|Overall Study|Protocol Violation|0|||
16845206|NCT01591785|37789896|FG000|Overall Study|Lost to Follow-up|1|||
16845207|NCT01591785|37789897|FG001|Overall Study|Lost to Follow-up|0|||
16918786|NCT04613739|38059846|FG001|Overall Study|Lost to Follow-up|9|||
16918787|NCT04613739|38059845|FG000|Overall Study|potentially duplicative/fraudulent|1|||
16918788|NCT04613739|38059846|FG001|Overall Study|potentially duplicative/fraudulent|3|||
16918789|NCT04573972|38059854|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
16918790|NCT04573972|38059855|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
16918791|NCT04407806|38059873|FG000|Overall Study|Withdrawal by Subject|1|||
16918792|NCT04407806|38059874|FG001|Overall Study|Withdrawal by Subject|2|||
16918793|NCT04324021|38059883|FG000|Overall Study|Adverse Event|1|||
16918794|NCT04324021|38059884|FG001|Overall Study|Adverse Event|0|||
16918795|NCT04324021|38059885|FG002|Overall Study|Adverse Event|0|||
16918796|NCT04324021|38059883|FG000|Overall Study|Lack of Efficacy|0|||
16918797|NCT04324021|38059884|FG001|Overall Study|Lack of Efficacy|0|||
16918798|NCT04324021|38059885|FG002|Overall Study|Lack of Efficacy|1|||
16918799|NCT04324021|38059883|FG000|Overall Study|Death|1|||
16918800|NCT04324021|38059884|FG001|Overall Study|Death|1|||
16918801|NCT04324021|38059885|FG002|Overall Study|Death|0|||
16918802|NCT04209621|38059896|FG000|Overall Study|Death|1|||
16918803|NCT04209621|38059896|FG000|Overall Study|Study Terminated Early|2|||
16918804|NCT04186663|38059901|FG000|Overall Study|Lost to Follow-up|1|||
16845211|NCT01695993|37789910|FG000|Overall Study|Lost to Follow-up|2|||
16918805|NCT04186663|38059901|FG000|Overall Study|Unable to complete blood draw|3|||
16918806|NCT04158219|38059905|FG000|Overall Study|Lost to Follow-up|1|||
16918807|NCT03954743|38059938|FG000|Overall Study|Adverse Event|1|||
16918808|NCT03954743|38059939|FG001|Overall Study|Adverse Event|0|||
16918809|NCT03954743|38059938|FG000|Overall Study|Lost to Follow-up|6|||
16918810|NCT03954743|38059939|FG001|Overall Study|Lost to Follow-up|4|||
16918811|NCT03954743|38059938|FG000|Overall Study|Protocol Violation|1|||
16918812|NCT03954743|38059939|FG001|Overall Study|Protocol Violation|0|||
16918813|NCT03954743|38059938|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
16918814|NCT03954743|38059939|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
16918815|NCT03954743|38059938|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
16918816|NCT03954743|38059939|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16918817|NCT03880565|38059947|FG000|Overall Study|Withdrawal by Subject|1|||
16918818|NCT03880565|38059948|FG001|Overall Study|Withdrawal by Subject|0|||
16918819|NCT03782792|38059956|FG000|Overall Study|Patient left the country|0|||
16918820|NCT03782792|38059957|FG001|Overall Study|Patient left the country|1|||
16918821|NCT03782792|38059956|FG000|Overall Study|Withdrawal by Subject|1|||
16918822|NCT03782792|38059957|FG001|Overall Study|Withdrawal by Subject|2|||
16918823|NCT03733119|38059967|FG000|Overall Study|Physician Decision|2|||
16918824|NCT03733119|38059968|FG001|Overall Study|Physician Decision|1|||
16918825|NCT03733119|38059967|FG000|Overall Study|ineligible to treat per protocol|0|||
16918826|NCT03733119|38059968|FG001|Overall Study|ineligible to treat per protocol|1|||
16918827|NCT03661996|38059979|FG000|Overall Study|Adverse Event|0|||
16845212|NCT01695993|37789911|FG001|Overall Study|Lost to Follow-up|1|||
16845213|NCT01695993|37789912|FG002|Overall Study|Lost to Follow-up|3|||
16845214|NCT01695993|37789910|FG000|Overall Study|Withdrawal by Subject|2|||
16918828|NCT03661996|38059980|FG001|Overall Study|Adverse Event|0|||
16918829|NCT03661996|38059981|FG002|Overall Study|Adverse Event|1|||
16918830|NCT03661996|38059982|FG003|Overall Study|Adverse Event|1|||
16918831|NCT03661996|38059983|FG004|Overall Study|Adverse Event|0|||
16845215|NCT01695993|37789911|FG001|Overall Study|Withdrawal by Subject|2|||
16845216|NCT01695993|37789912|FG002|Overall Study|Withdrawal by Subject|2|||
16845217|NCT01695993|37789910|FG000|Overall Study|To ill to continue|1|||
16845218|NCT01695993|37789911|FG001|Overall Study|To ill to continue|2|||
16845219|NCT01695993|37789912|FG002|Overall Study|To ill to continue|0|||
16845220|NCT01695993|37789910|FG000|Overall Study|Changed Medical Facility|0|||
16845221|NCT01695993|37789911|FG001|Overall Study|Changed Medical Facility|0|||
16845222|NCT01695993|37789912|FG002|Overall Study|Changed Medical Facility|1|||
16845223|NCT01565343|37789923|FG000|Overall Study|Administrative decision/technical issues|1|||
16845224|NCT01565343|37789924|FG001|Overall Study|Administrative decision/technical issues|0|||
16845225|NCT01565343|37789925|FG002|Overall Study|Administrative decision/technical issues|0|||
16845226|NCT01695135|37789950|FG000|Double-blind Treatment Phase|Progressive disease|50|||
16845227|NCT01695135|37789951|FG001|Double-blind Treatment Phase|Progressive disease|110|||
16845228|NCT01695135|37789952|FG002|Double-blind Treatment Phase|Progressive disease|0|||
16918832|NCT03661996|38059979|FG000|Overall Study|Lost to Follow-up|5|||
16918833|NCT03661996|38059980|FG001|Overall Study|Lost to Follow-up|1|||
16845229|NCT01695135|37789953|FG003|Double-blind Treatment Phase|Progressive disease|0|||
16845230|NCT01695135|37789950|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
16845231|NCT01695135|37789951|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
16845232|NCT01695135|37789952|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16845233|NCT01695135|37789953|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16845234|NCT01695135|37789950|FG000|Double-blind Treatment Phase|Adverse Event|7|||
16845235|NCT01695135|37789951|FG001|Double-blind Treatment Phase|Adverse Event|7|||
16845236|NCT01695135|37789952|FG002|Double-blind Treatment Phase|Adverse Event|0|||
16845237|NCT01695135|37789953|FG003|Double-blind Treatment Phase|Adverse Event|0|||
16845238|NCT01695135|37789950|FG000|Double-blind Treatment Phase|Other|1|||
16845239|NCT01695135|37789951|FG001|Double-blind Treatment Phase|Other|3|||
16918834|NCT03661996|38059981|FG002|Overall Study|Lost to Follow-up|2|||
16918835|NCT03661996|38059982|FG003|Overall Study|Lost to Follow-up|2|||
16918836|NCT03661996|38059983|FG004|Overall Study|Lost to Follow-up|6|||
16918837|NCT03661996|38059979|FG000|Overall Study|Physician Decision|1|||
16918838|NCT03661996|38059980|FG001|Overall Study|Physician Decision|1|||
16918839|NCT03661996|38059981|FG002|Overall Study|Physician Decision|1|||
16918840|NCT03661996|38059982|FG003|Overall Study|Physician Decision|2|||
16918841|NCT03661996|38059983|FG004|Overall Study|Physician Decision|0|||
16918842|NCT03661996|38059979|FG000|Overall Study|Protocol Violation|0|||
16918843|NCT03661996|38059980|FG001|Overall Study|Protocol Violation|0|||
16918844|NCT03661996|38059981|FG002|Overall Study|Protocol Violation|0|||
16918845|NCT03661996|38059982|FG003|Overall Study|Protocol Violation|0|||
16918846|NCT03661996|38059983|FG004|Overall Study|Protocol Violation|1|||
16918847|NCT03661996|38059979|FG000|Overall Study|Withdrawal by Subject|3|||
16918848|NCT03661996|38059980|FG001|Overall Study|Withdrawal by Subject|5|||
16918849|NCT03661996|38059981|FG002|Overall Study|Withdrawal by Subject|1|||
16918850|NCT03661996|38059982|FG003|Overall Study|Withdrawal by Subject|7|||
16918851|NCT03661996|38059983|FG004|Overall Study|Withdrawal by Subject|7|||
16918852|NCT03661996|38059979|FG000|Overall Study|Sponsors Decision|2|||
16918853|NCT03661996|38059980|FG001|Overall Study|Sponsors Decision|0|||
16918854|NCT03661996|38059981|FG002|Overall Study|Sponsors Decision|0|||
16918855|NCT03661996|38059982|FG003|Overall Study|Sponsors Decision|0|||
16918856|NCT03661996|38059983|FG004|Overall Study|Sponsors Decision|0|||
16918857|NCT03661996|38059979|FG000|Overall Study|Other|1|||
16845240|NCT01695135|37789952|FG002|Double-blind Treatment Phase|Other|0|||
16918858|NCT03661996|38059980|FG001|Overall Study|Other|1|||
16918859|NCT03661996|38059981|FG002|Overall Study|Other|1|||
16918860|NCT03661996|38059982|FG003|Overall Study|Other|1|||
16918861|NCT03661996|38059983|FG004|Overall Study|Other|0|||
16918862|NCT03633461|38060000|FG000|Overall Study|Lost to Follow-up|0|||
16918863|NCT03633461|38060001|FG001|Overall Study|Lost to Follow-up|1|||
16918864|NCT03499314|38060029|FG000|Overall Study|Time Commitment|1|||
16918865|NCT03499314|38060030|FG001|Overall Study|Time Commitment|2|||
16918866|NCT03499314|38060029|FG000|Overall Study|Medical issue unrelated to research study|1|||
16918867|NCT03499314|38060030|FG001|Overall Study|Medical issue unrelated to research study|1|||
16918868|NCT03439124|38060038|FG000|Overall Study|Adverse Event|2|||
16918869|NCT03439124|38060039|FG001|Overall Study|Adverse Event|0|||
16918870|NCT03439124|38060038|FG000|Overall Study|Lost to Follow-up|1|||
16918871|NCT03439124|38060039|FG001|Overall Study|Lost to Follow-up|0|||
16918872|NCT03439124|38060038|FG000|Overall Study|Other reasons|1|||
16918873|NCT03439124|38060039|FG001|Overall Study|Other reasons|0|||
16918874|NCT03369431|38060047|FG000|Overall Study|Lost to Follow-up|1|||
16918875|NCT03369431|38060048|FG001|Overall Study|Lost to Follow-up|3|||
16918876|NCT03369431|38060047|FG000|Overall Study|Withdrawal by Subject|2|||
16918877|NCT03369431|38060048|FG001|Overall Study|Withdrawal by Subject|3|||
16918878|NCT03369431|38060047|FG000|Overall Study|Protocol Violation|1|||
16918879|NCT03369431|38060048|FG001|Overall Study|Protocol Violation|1|||
16918880|NCT03336866|38060057|FG000|Overall Study|Lost to Follow-up|2|||
16918881|NCT03336866|38060058|FG001|Overall Study|Lost to Follow-up|0|||
16918882|NCT03336866|38060059|FG002|Overall Study|Lost to Follow-up|3|||
16918883|NCT03336866|38060057|FG000|Overall Study|Withdrawal by Subject|1|||
16918884|NCT03336866|38060058|FG001|Overall Study|Withdrawal by Subject|1|||
16918885|NCT03336866|38060059|FG002|Overall Study|Withdrawal by Subject|0|||
16918886|NCT03336866|38060057|FG000|Overall Study|Noncompliance with clinic house rules|0|||
16918887|NCT03336866|38060058|FG001|Overall Study|Noncompliance with clinic house rules|0|||
16918888|NCT03336866|38060059|FG002|Overall Study|Noncompliance with clinic house rules|1|||
16918889|NCT03332173|38060072|FG000|Overall Study|Death|7|||
16918890|NCT03332173|38060072|FG000|Overall Study|Withdrawal by Subject|6|||
16918891|NCT03332173|38060072|FG000|Overall Study|Lost to Follow-up|2|||
16918892|NCT03332173|38060072|FG000|Overall Study|Transferred to long-term extension study|29|||
16918893|NCT03322293|38060079|FG000|Overall Study|Lost to Follow-up|0|||
16918894|NCT03322293|38060080|FG001|Overall Study|Lost to Follow-up|0|||
16918895|NCT03322293|38060081|FG002|Overall Study|Lost to Follow-up|1|||
16918896|NCT03254394|38060103|FG000|Overall Study|Withdrawal by Subject|0|||
16918897|NCT03254394|38060104|FG001|Overall Study|Withdrawal by Subject|2|||
16918898|NCT03253809|38060110|FG000|Overall Study|Unable to obtain study related data|14|||
16918899|NCT03137173|38060130|FG000|Overall Study|Withdrawal by Subject|8|||
16918900|NCT03137173|38060131|FG001|Overall Study|Withdrawal by Subject|13|||
16918901|NCT03137173|38060130|FG000|Overall Study|Death|1|||
16918902|NCT03137173|38060131|FG001|Overall Study|Death|3|||
16918903|NCT03137173|38060130|FG000|Overall Study|Physician Decision|1|||
16918904|NCT03137173|38060131|FG001|Overall Study|Physician Decision|0|||
16845241|NCT01695135|37789953|FG003|Double-blind Treatment Phase|Other|0|||
16918905|NCT03137173|38060130|FG000|Overall Study|Lost to Follow-up|13|||
16845242|NCT01695135|37789950|FG000|Double-blind Treatment Phase|Physician Decision|6|||
16845243|NCT01695135|37789951|FG001|Double-blind Treatment Phase|Physician Decision|3|||
16918906|NCT03137173|38060131|FG001|Overall Study|Lost to Follow-up|18|||
16918907|NCT03137173|38060130|FG000|Overall Study|Other reasons|3|||
16918908|NCT03137173|38060131|FG001|Overall Study|Other reasons|2|||
16918909|NCT02998476|38060190|FG000|Overall Study|Lost to Follow-up|1|||
16845244|NCT01695135|37789952|FG002|Double-blind Treatment Phase|Physician Decision|0|||
16845245|NCT01695135|37789953|FG003|Double-blind Treatment Phase|Physician Decision|0|||
16845246|NCT01695135|37789950|FG000|Double-blind Treatment Phase|Death|1|||
16845247|NCT01695135|37789951|FG001|Double-blind Treatment Phase|Death|1|||
16845248|NCT01695135|37789952|FG002|Double-blind Treatment Phase|Death|0|||
16845249|NCT01695135|37789953|FG003|Double-blind Treatment Phase|Death|0|||
16845250|NCT01695135|37789950|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
16918910|NCT02998476|38060191|FG001|Overall Study|Lost to Follow-up|0|||
16918911|NCT02998476|38060190|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
16918912|NCT02998476|38060191|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
16918913|NCT02998476|38060190|FG000|Overall Study|Withdrawal by Subject|1|||
16918914|NCT02998476|38060191|FG001|Overall Study|Withdrawal by Subject|2|||
16918915|NCT02998476|38060190|FG000|Overall Study|Death|45|||
16918916|NCT02998476|38060191|FG001|Overall Study|Death|2|||
16918917|NCT02998476|38060190|FG000|Overall Study|Other|6|||
16918918|NCT02998476|38060191|FG001|Overall Study|Other|1|||
16918919|NCT02924064|38060209|FG000|Overall Study|Adverse Event|2|||
16918920|NCT02924064|38060210|FG001|Overall Study|Adverse Event|2|||
16918921|NCT02924064|38060209|FG000|Overall Study|Lost to Follow-up|0|||
16918922|NCT02924064|38060210|FG001|Overall Study|Lost to Follow-up|2|||
16918923|NCT02924064|38060209|FG000|Overall Study|Physician Decision|0|||
16918924|NCT02924064|38060210|FG001|Overall Study|Physician Decision|2|||
16845251|NCT01695135|37789951|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
16918925|NCT02924064|38060209|FG000|Overall Study|Protocol Violation|1|||
16918926|NCT02924064|38060210|FG001|Overall Study|Protocol Violation|3|||
16918927|NCT02924064|38060209|FG000|Overall Study|Withdrawal by Subject|4|||
16918928|NCT02924064|38060210|FG001|Overall Study|Withdrawal by Subject|5|||
16918929|NCT02924064|38060209|FG000|Overall Study|Other|17|||
16918930|NCT02924064|38060210|FG001|Overall Study|Other|29|||
16918931|NCT02916706|38060218|FG000|Overall Study|Adverse Event|0|||
16918932|NCT02916706|38060219|FG001|Overall Study|Adverse Event|1|||
16918933|NCT02916706|38060218|FG000|Overall Study|Lost to Follow-up|0|||
16918934|NCT02916706|38060219|FG001|Overall Study|Lost to Follow-up|1|||
16918935|NCT02916706|38060218|FG000|Overall Study|Physician Decision|1|||
16918936|NCT02916706|38060219|FG001|Overall Study|Physician Decision|0|||
16918937|NCT02916706|38060218|FG000|Overall Study|Protocol Violation|3|||
16918938|NCT02916706|38060219|FG001|Overall Study|Protocol Violation|1|||
16918939|NCT02916706|38060218|FG000|Overall Study|Withdrawal by Subject|6|||
16918940|NCT02916706|38060219|FG001|Overall Study|Withdrawal by Subject|9|||
16918941|NCT02916706|38060218|FG000|Overall Study|Other|5|||
16918942|NCT02916706|38060219|FG001|Overall Study|Other|19|||
16918943|NCT02889900|38060225|FG000|Overall Study|Adverse Event|11|||
16918944|NCT02889900|38060225|FG000|Overall Study|Condition under investigation worsened|32|||
16918945|NCT02889900|38060225|FG000|Overall Study|Other|5|||
16918946|NCT02889900|38060225|FG000|Overall Study|Withdrawal by Subject|7|||
16918947|NCT02889900|38060225|FG000|Overall Study|Not treated|2|||
16918948|NCT02866695|38060229|FG000|Overall Study|Adverse Event|1|||
16918949|NCT02866695|38060229|FG000|Overall Study|Lost to Follow-up|1|||
16918950|NCT02834793|38060235|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
16918951|NCT02834793|38060236|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
16918952|NCT02834793|38060237|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
16918953|NCT02834793|38060238|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
16918954|NCT02834793|38060235|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
16918955|NCT02834793|38060236|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
16918956|NCT02834793|38060237|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
16918957|NCT02834793|38060238|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
16845252|NCT01695135|37789952|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
16918958|NCT02834793|38060235|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
16918959|NCT02834793|38060236|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
16918960|NCT02834793|38060237|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
16918961|NCT02834793|38060238|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
16918962|NCT02834793|38060235|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
16918963|NCT02834793|38060236|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
16918964|NCT02834793|38060237|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
16918965|NCT02834793|38060238|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
16918966|NCT02834793|38060235|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
16918967|NCT02834793|38060236|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
16918968|NCT02834793|38060237|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
16918969|NCT02834793|38060238|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
16918970|NCT02834793|38060235|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
16918971|NCT02834793|38060236|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
16918972|NCT02834793|38060237|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
16918973|NCT02834793|38060238|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
16918974|NCT02834793|38060235|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
16918975|NCT02834793|38060236|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
16918976|NCT02834793|38060237|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
16918977|NCT02834793|38060238|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
16918978|NCT02834793|38060235|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
16918979|NCT02834793|38060236|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
16918980|NCT02834793|38060237|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
16918981|NCT02834793|38060238|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
16918982|NCT02834793|38060235|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
16918983|NCT02834793|38060236|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
16918984|NCT02834793|38060237|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
16918985|NCT02834793|38060238|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
16918986|NCT02834793|38060235|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
16918987|NCT02834793|38060236|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
16918988|NCT02834793|38060237|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
16918989|NCT02834793|38060238|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
16845253|NCT01695135|37789953|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
16845254|NCT01695135|37789950|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
16845255|NCT01695135|37789951|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
16845256|NCT01695135|37789952|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
16845257|NCT01695135|37789953|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
16845258|NCT01695135|37789950|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
16845259|NCT01695135|37789951|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
16845260|NCT01695135|37789952|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
16845261|NCT01695135|37789953|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
16845262|NCT01695135|37789950|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
16918990|NCT02834793|38060235|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
16918991|NCT02834793|38060236|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
16918992|NCT02834793|38060237|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
16918993|NCT02834793|38060238|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
16918994|NCT02834793|38060235|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
16918995|NCT02834793|38060236|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
16918996|NCT02834793|38060237|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
16918997|NCT02834793|38060238|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
16918998|NCT02834793|38060235|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
16918999|NCT02834793|38060236|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
16919000|NCT02834793|38060237|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
16919001|NCT02834793|38060238|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
16919002|NCT02834793|38060235|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
16919003|NCT02834793|38060236|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
16919004|NCT02834793|38060237|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
16919005|NCT02834793|38060238|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
16919006|NCT02834793|38060235|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
16919007|NCT02834793|38060236|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
16919008|NCT02834793|38060237|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
16919009|NCT02834793|38060238|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
16919010|NCT02810457|38060248|FG000|Overall Study|Randomised but no treatment received|2|||
16919011|NCT02810457|38060249|FG001|Overall Study|Randomised but no treatment received|1|||
16919012|NCT02810457|38060248|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
16919013|NCT02810457|38060249|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
16919014|NCT02810457|38060248|FG000|Overall Study|Adverse Event|37|||
16919015|NCT02810457|38060249|FG001|Overall Study|Adverse Event|43|||
16919016|NCT02810457|38060248|FG000|Overall Study|Patient decision|31|||
16919017|NCT02810457|38060249|FG001|Overall Study|Patient decision|35|||
16919018|NCT02810457|38060248|FG000|Overall Study|Patient lost to follow-up|2|||
16919019|NCT02810457|38060249|FG001|Overall Study|Patient lost to follow-up|2|||
16919020|NCT02810457|38060248|FG000|Overall Study|Death|39|||
16919021|NCT02810457|38060249|FG001|Overall Study|Death|28|||
16919022|NCT02810457|38060248|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
16919023|NCT02810457|38060249|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
16919024|NCT02810457|38060248|FG000|Overall Study|Clinical progression|15|||
16919025|NCT02810457|38060249|FG001|Overall Study|Clinical progression|16|||
16919026|NCT02810457|38060248|FG000|Overall Study|Investigator decision|3|||
16919027|NCT02810457|38060249|FG001|Overall Study|Investigator decision|2|||
16919028|NCT02810457|38060248|FG000|Overall Study|Patient ineligibility|3|||
16919029|NCT02810457|38060249|FG001|Overall Study|Patient ineligibility|0|||
16919030|NCT02810457|38060248|FG000|Overall Study|Miscalculated PD|1|||
16919031|NCT02810457|38060249|FG001|Overall Study|Miscalculated PD|0|||
16919032|NCT02810457|38060248|FG000|Overall Study|Physician Decision|0|||
16919033|NCT02810457|38060249|FG001|Overall Study|Physician Decision|1|||
16919034|NCT02745535|38060279|FG000|Overall Study|Death|1|||
16919035|NCT02745535|38060279|FG000|Overall Study|Adverse Event|3|||
16919036|NCT02745535|38060279|FG000|Overall Study|Lost to Follow-up|2|||
16919037|NCT02625090|38060313|FG000|Overall Study|Participant wants to be pregnant|2|||
17102506|NCT03628924|38241415|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
16845263|NCT01695135|37789951|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
16845264|NCT01695135|37789952|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
16845265|NCT01695135|37789953|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
16845266|NCT01695135|37789950|FG000|Open Label Extension Treatment Phase|Other|0|||
16845267|NCT01695135|37789951|FG001|Open Label Extension Treatment Phase|Other|0|||
16845268|NCT01695135|37789952|FG002|Open Label Extension Treatment Phase|Other|4|||
16845269|NCT01695135|37789953|FG003|Open Label Extension Treatment Phase|Other|7|||
16845270|NCT01695135|37789950|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
16845271|NCT01695135|37789951|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
16845272|NCT01695135|37789952|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
16845273|NCT01695135|37789953|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
16845274|NCT01695135|37789950|FG000|Open Label Extension Treatment Phase|Death|0|||
16845275|NCT01695135|37789951|FG001|Open Label Extension Treatment Phase|Death|0|||
16845276|NCT01695135|37789952|FG002|Open Label Extension Treatment Phase|Death|2|||
16845277|NCT01695135|37789953|FG003|Open Label Extension Treatment Phase|Death|7|||
16845278|NCT01695135|37789950|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
16845279|NCT01695135|37789951|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
16919038|NCT02625090|38060313|FG000|Overall Study|For the Promoter|1|||
16919039|NCT02625090|38060313|FG000|Overall Study|Sponsor's Decision|9|||
16919040|NCT02625090|38060313|FG000|Overall Study|Somnolence|1|||
16919041|NCT02625090|38060313|FG000|Overall Study|Study terminated by Sponsor|7|||
16919042|NCT02625090|38060313|FG000|Overall Study|Negative Benefit/Risk|1|||
16919043|NCT02625090|38060313|FG000|Overall Study|Protocol Deviation|2|||
16919044|NCT02625090|38060313|FG000|Overall Study|Lack of Efficacy|16|||
16919045|NCT02625090|38060313|FG000|Overall Study|Adverse Event|3|||
16919046|NCT02539225|38060320|FG000|Part A|Adverse Event|13|||
16919047|NCT02539225|38060321|FG001|Part A|Adverse Event|4|||
16919048|NCT02539225|38060320|FG000|Part A|Withdrawal by Subject|2|||
16919049|NCT02539225|38060321|FG001|Part A|Withdrawal by Subject|4|||
16919050|NCT02539225|38060320|FG000|Part A|Physician Decision|4|||
16845280|NCT01695135|37789952|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
16845281|NCT01695135|37789953|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
16845282|NCT01610414|37789963|FG000|Study Start - Month 13|Serious Adverse Event|65|||
16845283|NCT01610414|37789964|FG001|Study Start - Month 13|Serious Adverse Event|67|||
16845284|NCT01610414|37789963|FG000|Study Start - Month 13|Adverse Event|14|||
16845285|NCT01610414|37789964|FG001|Study Start - Month 13|Adverse Event|14|||
16845286|NCT01610414|37789963|FG000|Study Start - Month 13|Protocol Violation|3|||
16919051|NCT02539225|38060321|FG001|Part A|Physician Decision|7|||
16919052|NCT02539225|38060320|FG000|Part A|Did Not Receive study Drug|1|||
16919053|NCT02539225|38060321|FG001|Part A|Did Not Receive study Drug|1|||
16919054|NCT02539225|38060320|FG000|Pre Treatment for Part B|Progressive disease|1|||
16919055|NCT02539225|38060321|FG001|Pre Treatment for Part B|Progressive disease|1|||
16919056|NCT02539225|38060320|FG000|Pre Treatment for Part B|Adverse Event|1|||
16919057|NCT02539225|38060321|FG001|Pre Treatment for Part B|Adverse Event|1|||
16919058|NCT02539225|38060320|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
16919059|NCT02539225|38060321|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
16919060|NCT02539225|38060320|FG000|Pre Treatment for Part B|Physician Decision|2|||
16919061|NCT02539225|38060321|FG001|Pre Treatment for Part B|Physician Decision|0|||
16919062|NCT02539225|38060320|FG000|Part B|Adverse Event|4|||
16919063|NCT02539225|38060321|FG001|Part B|Adverse Event|4|||
16919064|NCT02539225|38060320|FG000|Part B|Withdrawal by Subject|0|||
16919065|NCT02539225|38060321|FG001|Part B|Withdrawal by Subject|3|||
16919066|NCT02539225|38060320|FG000|Part B|Physician Decision|0|||
16919067|NCT02539225|38060321|FG001|Part B|Physician Decision|9|||
16919068|NCT02526017|38060345|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16919069|NCT02526017|38060346|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16919070|NCT02526017|38060347|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16919071|NCT02526017|38060348|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16919072|NCT02526017|38060349|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
16919073|NCT02526017|38060350|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16919074|NCT02526017|38060351|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16919075|NCT02526017|38060352|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
17017152|NCT00689104|38161736|FG003|Overall Study|Non-compliance with study procedures|0|||
17017153|NCT00689026|38161748|FG000|Overall Study|Withdrawal by Subject|13|||
17017154|NCT00689026|38161749|FG001|Overall Study|Withdrawal by Subject|6|||
17017155|NCT00598559|38161758|FG000|Overall Study|Adverse Event|11|||
17017156|NCT00598559|38161759|FG001|Overall Study|Adverse Event|7|||
17017157|NCT00598559|38161760|FG002|Overall Study|Adverse Event|0|||
17017158|NCT00598559|38161758|FG000|Overall Study|Withdrawal by Subject|2|||
17017159|NCT00598559|38161759|FG001|Overall Study|Withdrawal by Subject|2|||
17017160|NCT00598559|38161760|FG002|Overall Study|Withdrawal by Subject|0|||
17017161|NCT00598559|38161758|FG000|Overall Study|Protocol Non-compliance|1|||
16919076|NCT02526017|38060353|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16919077|NCT02369653|38060422|FG000|Overall Study|Lost to Follow-up|0|||
16919078|NCT02369653|38060423|FG001|Overall Study|Lost to Follow-up|1|||
16919079|NCT02369653|38060422|FG000|Overall Study|Administrative reason by sponsor|0|||
16919080|NCT02369653|38060423|FG001|Overall Study|Administrative reason by sponsor|1|||
16919081|NCT02369653|38060422|FG000|Overall Study|Death|1|||
16919082|NCT02369653|38060423|FG001|Overall Study|Death|2|||
16919083|NCT02369653|38060422|FG000|Overall Study|Participant withdrew consent|13|||
16919084|NCT02369653|38060423|FG001|Overall Study|Participant withdrew consent|3|||
16919085|NCT02326974|38060433|FG000|Overall Study|Withdrawal by Subject|2|||
16919086|NCT02326974|38060433|FG000|Overall Study|failed heterogenity evaluation|5|||
16919087|NCT02284568|38060444|FG000|Overall Study|Adverse Event|2|||
16919088|NCT02284568|38060445|FG001|Overall Study|Adverse Event|9|||
16919089|NCT02284568|38060446|FG002|Overall Study|Adverse Event|4|||
16919090|NCT02284568|38060444|FG000|Overall Study|Withdrawal by Subject|22|||
16919091|NCT02284568|38060445|FG001|Overall Study|Withdrawal by Subject|21|||
16919092|NCT02284568|38060446|FG002|Overall Study|Withdrawal by Subject|1|||
16919093|NCT02284568|38060444|FG000|Overall Study|Noncompliance with study drug admin|1|||
16919094|NCT02284568|38060445|FG001|Overall Study|Noncompliance with study drug admin|2|||
16919095|NCT02284568|38060446|FG002|Overall Study|Noncompliance with study drug admin|0|||
16919096|NCT02284568|38060444|FG000|Overall Study|Noncompliance|1|||
16919097|NCT02284568|38060445|FG001|Overall Study|Noncompliance|0|||
16919098|NCT02284568|38060446|FG002|Overall Study|Noncompliance|0|||
16919099|NCT02284568|38060444|FG000|Overall Study|Protocol Violation|0|||
16919100|NCT02284568|38060445|FG001|Overall Study|Protocol Violation|1|||
16919101|NCT02284568|38060446|FG002|Overall Study|Protocol Violation|0|||
16919102|NCT02284568|38060444|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
16919103|NCT02284568|38060445|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
16919104|NCT02284568|38060446|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
16919105|NCT02284568|38060444|FG000|Overall Study|Lost to Follow-up|0|||
16919106|NCT02284568|38060445|FG001|Overall Study|Lost to Follow-up|3|||
16919107|NCT02284568|38060446|FG002|Overall Study|Lost to Follow-up|0|||
16919108|NCT02284568|38060444|FG000|Overall Study|Lack of Efficacy|4|||
16919109|NCT02284568|38060445|FG001|Overall Study|Lack of Efficacy|7|||
16919110|NCT02284568|38060446|FG002|Overall Study|Lack of Efficacy|0|||
16919111|NCT02284568|38060444|FG000|Overall Study|Other|1|||
16919112|NCT02284568|38060445|FG001|Overall Study|Other|2|||
16919113|NCT02284568|38060446|FG002|Overall Study|Other|0|||
16919114|NCT02284568|38060444|FG000|Overall Study|Withdrew before taking study drug|0|||
16919115|NCT02284568|38060445|FG001|Overall Study|Withdrew before taking study drug|1|||
16919116|NCT02284568|38060446|FG002|Overall Study|Withdrew before taking study drug|0|||
16919117|NCT02195986|38060461|FG000|Overall Study|Adverse Event|3|||
16919118|NCT02195986|38060462|FG001|Overall Study|Adverse Event|0|||
16919119|NCT02195986|38060463|FG002|Overall Study|Adverse Event|0|||
16919120|NCT02195986|38060461|FG000|Overall Study|Withdrawal by Subject|0|||
16919121|NCT02195986|38060462|FG001|Overall Study|Withdrawal by Subject|3|||
16919122|NCT02195986|38060463|FG002|Overall Study|Withdrawal by Subject|0|||
16919123|NCT02195986|38060461|FG000|Overall Study|Family Emergency|0|||
16919124|NCT02195986|38060462|FG001|Overall Study|Family Emergency|0|||
16919125|NCT02195986|38060463|FG002|Overall Study|Family Emergency|1|||
16919126|NCT02195986|38060461|FG000|Overall Study|Protocol Violation|0|||
16919127|NCT02195986|38060462|FG001|Overall Study|Protocol Violation|1|||
16919128|NCT02195986|38060463|FG002|Overall Study|Protocol Violation|1|||
16919129|NCT02195986|38060461|FG000|Overall Study|Non-compliance|0|||
16919130|NCT02195986|38060462|FG001|Overall Study|Non-compliance|1|||
16919131|NCT02195986|38060463|FG002|Overall Study|Non-compliance|0|||
16919132|NCT01982630|38060479|FG000|Overall Study|Adverse Event|2|||
16919133|NCT01982630|38060480|FG001|Overall Study|Adverse Event|0|||
16919134|NCT01982630|38060481|FG002|Overall Study|Adverse Event|1|||
16919135|NCT01982630|38060482|FG003|Overall Study|Adverse Event|0|||
16919136|NCT01982630|38060483|FG004|Overall Study|Adverse Event|1|||
16919137|NCT01982630|38060484|FG005|Overall Study|Adverse Event|2|||
16919138|NCT01982630|38060485|FG006|Overall Study|Adverse Event|1|||
16919139|NCT01982630|38060486|FG007|Overall Study|Adverse Event|0|||
16919140|NCT01982630|38060479|FG000|Overall Study|Physician Decision|1|||
16845287|NCT01610414|37789964|FG001|Study Start - Month 13|Protocol Violation|1|||
16845288|NCT01610414|37789963|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
16845289|NCT01610414|37789964|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
16845290|NCT01610414|37789963|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
16845291|NCT01610414|37789964|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
16845292|NCT01610414|37789963|FG000|Study Start - Month 13|Lost to Follow-up|4|||
16845293|NCT01610414|37789964|FG001|Study Start - Month 13|Lost to Follow-up|6|||
16845294|NCT01610414|37789963|FG000|Study Start - Month 13|Suspected HZ episode|1|||
16845295|NCT01610414|37789964|FG001|Study Start - Month 13|Suspected HZ episode|3|||
16845296|NCT01610414|37789963|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
16845297|NCT01610414|37789964|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
16845298|NCT01610414|37789963|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
16845299|NCT01610414|37789964|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
16845300|NCT01610414|37789963|FG000|Month 13 - Month 25|Adverse Event|8|||
16845301|NCT01610414|37789964|FG001|Month 13 - Month 25|Adverse Event|4|||
16845302|NCT01610414|37789963|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
16845303|NCT01610414|37789964|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
16845304|NCT01610414|37789963|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
16845305|NCT01610414|37789964|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
16845306|NCT01610414|37789963|FG000|Month 13 - Month 25|Protocol Violation|0|||
16845307|NCT01610414|37789964|FG001|Month 13 - Month 25|Protocol Violation|2|||
16845308|NCT01610414|37789963|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
16845309|NCT01610414|37789964|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
16919141|NCT01982630|38060480|FG001|Overall Study|Physician Decision|0|||
16919142|NCT01982630|38060481|FG002|Overall Study|Physician Decision|2|||
16919143|NCT01982630|38060482|FG003|Overall Study|Physician Decision|1|||
16919144|NCT01982630|38060483|FG004|Overall Study|Physician Decision|2|||
16919145|NCT01982630|38060484|FG005|Overall Study|Physician Decision|0|||
16919146|NCT01982630|38060485|FG006|Overall Study|Physician Decision|0|||
16919147|NCT01982630|38060486|FG007|Overall Study|Physician Decision|0|||
16919148|NCT01982630|38060479|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16919149|NCT01982630|38060480|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16919150|NCT01982630|38060481|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
16919151|NCT01982630|38060482|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16919152|NCT01982630|38060483|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16919153|NCT01982630|38060484|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16919154|NCT01982630|38060485|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16919155|NCT01982630|38060486|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16919156|NCT01982630|38060479|FG000|Overall Study|Withdrawal by Subject|0|||
16919157|NCT01982630|38060480|FG001|Overall Study|Withdrawal by Subject|0|||
16919158|NCT01982630|38060481|FG002|Overall Study|Withdrawal by Subject|0|||
16919159|NCT01982630|38060482|FG003|Overall Study|Withdrawal by Subject|0|||
16919160|NCT01982630|38060483|FG004|Overall Study|Withdrawal by Subject|0|||
16919161|NCT01982630|38060484|FG005|Overall Study|Withdrawal by Subject|1|||
16919162|NCT01982630|38060485|FG006|Overall Study|Withdrawal by Subject|0|||
16919163|NCT01982630|38060486|FG007|Overall Study|Withdrawal by Subject|0|||
16919164|NCT01982448|38060541|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
16919165|NCT01982448|38060542|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
16919166|NCT01982448|38060541|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
16845310|NCT01610414|37789963|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
16845311|NCT01610414|37789964|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
16845312|NCT01610414|37789963|FG000|After Month 25|Study end not reached|48|||
16845313|NCT01610414|37789964|FG001|After Month 25|Study end not reached|53|||
16845314|NCT01564407|37789992|FG000|Overall Study|Lost to Follow-up|0|||
16845315|NCT01564407|37789993|FG001|Overall Study|Lost to Follow-up|1|||
16845316|NCT01564407|37789994|FG002|Overall Study|Lost to Follow-up|0|||
16845317|NCT01564407|37789995|FG003|Overall Study|Lost to Follow-up|0|||
16845318|NCT01564407|37789996|FG004|Overall Study|Lost to Follow-up|0|||
16845319|NCT01564407|37789992|FG000|Overall Study|Withdrawal by Subject|0|||
16845320|NCT01564407|37789993|FG001|Overall Study|Withdrawal by Subject|1|||
16845321|NCT01564407|37789994|FG002|Overall Study|Withdrawal by Subject|0|||
16845322|NCT01564407|37789995|FG003|Overall Study|Withdrawal by Subject|0|||
16845323|NCT01564407|37789996|FG004|Overall Study|Withdrawal by Subject|0|||
16919167|NCT01982448|38060542|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
16919168|NCT01982448|38060541|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
16919169|NCT01982448|38060542|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
16919170|NCT01982448|38060541|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
16919171|NCT01982448|38060542|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
16919172|NCT01752920|38060565|FG000|Overall Study|Adverse Event|1|||
16919173|NCT01752920|38060566|FG001|Overall Study|Adverse Event|0|||
16919174|NCT01752920|38060567|FG002|Overall Study|Adverse Event|5|||
16919175|NCT01752920|38060568|FG003|Overall Study|Adverse Event|10|||
16919176|NCT01752920|38060565|FG000|Overall Study|Clinical Disease Progression|6|||
16919177|NCT01752920|38060566|FG001|Overall Study|Clinical Disease Progression|4|||
16919178|NCT01752920|38060567|FG002|Overall Study|Clinical Disease Progression|1|||
16919179|NCT01752920|38060568|FG003|Overall Study|Clinical Disease Progression|13|||
17102507|NCT03628924|38241409|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
16845324|NCT01564407|37789992|FG000|Overall Study|funding lost, study ended|0|||
16845325|NCT01564407|37789993|FG001|Overall Study|funding lost, study ended|0|||
16845326|NCT01564407|37789994|FG002|Overall Study|funding lost, study ended|0|||
16845327|NCT01564407|37789995|FG003|Overall Study|funding lost, study ended|1|||
16845328|NCT01564407|37789996|FG004|Overall Study|funding lost, study ended|0|||
16845329|NCT01590771|37790019|FG000|Overall Study|Other Protocol Specified Criteria|5|||
16845330|NCT01590771|37790020|FG001|Overall Study|Other Protocol Specified Criteria|14|||
16845331|NCT01590771|37790019|FG000|Overall Study|Withdrawal by Subject|8|||
16845332|NCT01590771|37790020|FG001|Overall Study|Withdrawal by Subject|15|||
16845333|NCT01590771|37790019|FG000|Overall Study|Protocol Violation|1|||
16845334|NCT01590771|37790020|FG001|Overall Study|Protocol Violation|2|||
16845335|NCT01590771|37790019|FG000|Overall Study|Lost to Follow-up|1|||
16845336|NCT01590771|37790020|FG001|Overall Study|Lost to Follow-up|1|||
16845337|NCT01590771|37790019|FG000|Overall Study|Lack of Efficacy|1|||
16845338|NCT01590771|37790020|FG001|Overall Study|Lack of Efficacy|0|||
16845339|NCT01590771|37790019|FG000|Overall Study|Adverse Event|3|||
16845340|NCT01590771|37790020|FG001|Overall Study|Adverse Event|7|||
16845341|NCT01563237|37790026|FG000|Overall Study|Lost to Follow-up|6|||
16845342|NCT01563237|37790027|FG001|Overall Study|Lost to Follow-up|0|||
16845343|NCT01563237|37790026|FG000|Overall Study|Withdrawal by Subject|1|||
16845344|NCT01563237|37790027|FG001|Overall Study|Withdrawal by Subject|0|||
16845345|NCT01563237|37790026|FG000|Overall Study|Adverse Event|1|||
16845346|NCT01563237|37790027|FG001|Overall Study|Adverse Event|0|||
16845347|NCT01563237|37790026|FG000|Overall Study|Medical Reasons|1|||
16845348|NCT01563237|37790027|FG001|Overall Study|Medical Reasons|0|||
16845349|NCT01563237|37790026|FG000|Overall Study|Death|1|||
16845350|NCT01563237|37790027|FG001|Overall Study|Death|0|||
16845351|NCT01694433|37790034|FG000|Overall Study|Adverse Event|7|||
16919180|NCT01752920|38060565|FG000|Overall Study|Physician Decision|1|||
16919181|NCT01752920|38060566|FG001|Overall Study|Physician Decision|0|||
16919182|NCT01752920|38060567|FG002|Overall Study|Physician Decision|0|||
16919183|NCT01752920|38060568|FG003|Overall Study|Physician Decision|3|||
16919184|NCT01752920|38060565|FG000|Overall Study|Radiographic Disease Progression|20|||
16919185|NCT01752920|38060566|FG001|Overall Study|Radiographic Disease Progression|7|||
16919186|NCT01752920|38060567|FG002|Overall Study|Radiographic Disease Progression|12|||
16919187|NCT01752920|38060568|FG003|Overall Study|Radiographic Disease Progression|29|||
16919188|NCT01752920|38060565|FG000|Overall Study|Study Terminated by Sponsor|0|||
16919189|NCT01752920|38060566|FG001|Overall Study|Study Terminated by Sponsor|0|||
16919190|NCT01752920|38060567|FG002|Overall Study|Study Terminated by Sponsor|0|||
16919191|NCT01752920|38060568|FG003|Overall Study|Study Terminated by Sponsor|1|||
16919192|NCT01752920|38060565|FG000|Overall Study|Withdrawal by Subject|0|||
16919193|NCT01752920|38060566|FG001|Overall Study|Withdrawal by Subject|1|||
16919194|NCT01752920|38060567|FG002|Overall Study|Withdrawal by Subject|0|||
16919195|NCT01752920|38060568|FG003|Overall Study|Withdrawal by Subject|1|||
16919196|NCT01752920|38060565|FG000|Overall Study|Lack of clinical benefit|1|||
16919197|NCT01752920|38060566|FG001|Overall Study|Lack of clinical benefit|1|||
16919198|NCT01752920|38060567|FG002|Overall Study|Lack of clinical benefit|1|||
16919199|NCT01752920|38060568|FG003|Overall Study|Lack of clinical benefit|1|||
16919200|NCT01740297|38060583|FG000|Overall Study|Withdrawal by Subject|4|||
16919201|NCT01740297|38060584|FG001|Overall Study|Withdrawal by Subject|16|||
16919202|NCT01740297|38060585|FG002|Overall Study|Withdrawal by Subject|17|||
16919203|NCT01740297|38060583|FG000|Overall Study|Death|8|||
16919204|NCT01740297|38060584|FG001|Overall Study|Death|46|||
16845352|NCT01694433|37790035|FG001|Overall Study|Adverse Event|0|||
16845353|NCT01694433|37790034|FG000|Overall Study|Physician Decision|1|||
16845354|NCT01694433|37790035|FG001|Overall Study|Physician Decision|0|||
16845355|NCT01694433|37790034|FG000|Overall Study|Withdrawal by Subject|3|||
16919205|NCT01740297|38060585|FG002|Overall Study|Death|40|||
16919206|NCT01740297|38060583|FG000|Overall Study|Lost to Follow-up|1|||
16919207|NCT01740297|38060584|FG001|Overall Study|Lost to Follow-up|2|||
16919208|NCT01740297|38060585|FG002|Overall Study|Lost to Follow-up|4|||
16919209|NCT01729754|38060599|FG000|Part 1|Adverse Event|2|||
16919210|NCT01729754|38060600|FG001|Part 1|Adverse Event|0|||
16845356|NCT01694433|37790035|FG001|Overall Study|Withdrawal by Subject|4|||
16845357|NCT01694121|37790043|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
16845358|NCT01694121|37790044|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
16845359|NCT01562613|37790050|FG000|Overall Study|Lost to Follow-up|2|||
16845360|NCT01562613|37790050|FG000|Overall Study|Withdrawal by Subject|2|||
16845361|NCT01693185|37790056|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
16845362|NCT01693185|37790057|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
16845363|NCT01693029|37790072|FG000|Overall Study|Withdrawal by Subject|15|||
16845364|NCT01693029|37790073|FG001|Overall Study|Withdrawal by Subject|22|||
16845365|NCT01693029|37790072|FG000|Overall Study|Kidney transplantation|7|||
16845366|NCT01693029|37790073|FG001|Overall Study|Kidney transplantation|7|||
16845367|NCT01693029|37790072|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
16845368|NCT01693029|37790073|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
16845369|NCT01693029|37790072|FG000|Overall Study|Protocol Violation|6|||
16845370|NCT01693029|37790073|FG001|Overall Study|Protocol Violation|7|||
16845371|NCT01693029|37790072|FG000|Overall Study|Change in dialysis modality|2|||
16845372|NCT01693029|37790073|FG001|Overall Study|Change in dialysis modality|1|||
16845373|NCT01693029|37790072|FG000|Overall Study|Physician Decision|0|||
16845374|NCT01693029|37790073|FG001|Overall Study|Physician Decision|2|||
16845375|NCT01693029|37790072|FG000|Overall Study|Lost to Follow-up|0|||
16845376|NCT01693029|37790073|FG001|Overall Study|Lost to Follow-up|1|||
16845377|NCT01693029|37790072|FG000|Overall Study|Adverse Event|1|||
16845378|NCT01693029|37790073|FG001|Overall Study|Adverse Event|6|||
16845379|NCT01693029|37790072|FG000|Overall Study|Death|5|||
16845380|NCT01693029|37790073|FG001|Overall Study|Death|8|||
16845381|NCT01693029|37790072|FG000|Overall Study|Non-compliance|2|||
16845382|NCT01693029|37790073|FG001|Overall Study|Non-compliance|1|||
16845383|NCT01589445|37790079|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
16845384|NCT01589445|37790079|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
16845385|NCT01589445|37790079|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
16919211|NCT01729754|38060601|FG002|Part 1|Adverse Event|0|||
16919212|NCT01729754|38060602|FG003|Part 1|Adverse Event|1|||
16919213|NCT01729754|38060603|FG004|Part 1|Adverse Event|0|||
16845386|NCT01589445|37790079|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
16845387|NCT01589445|37790079|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
16845388|NCT01589445|37790079|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
16845389|NCT01589445|37790079|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
16919214|NCT01729754|38060604|FG005|Part 1|Adverse Event|0|||
16919215|NCT01729754|38060605|FG006|Part 1|Adverse Event|2|||
16919216|NCT01729754|38060606|FG007|Part 1|Adverse Event|0|||
16919217|NCT01729754|38060607|FG008|Part 1|Adverse Event|0|||
16919218|NCT01729754|38060608|FG009|Part 1|Adverse Event|5|||
16845390|NCT01589445|37790079|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
16845391|NCT01589445|37790079|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
16845392|NCT01589445|37790079|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
16845393|NCT01588509|37790096|FG000|Overall Study|Lost to Follow-up|1|||
16845394|NCT01588509|37790097|FG001|Overall Study|Lost to Follow-up|0|||
16845395|NCT01588353|37790106|FG000|Step2|Withdrawal by Subject|0|||
16845396|NCT01588353|37790107|FG001|Step2|Withdrawal by Subject|1|||
16845397|NCT01588353|37790108|FG002|Step2|Withdrawal by Subject|0|||
16845398|NCT01588353|37790106|FG000|Step3|Adverse Event|0|||
16845399|NCT01588353|37790107|FG001|Step3|Adverse Event|0|||
16845400|NCT01588353|37790108|FG002|Step3|Adverse Event|2|||
16845401|NCT01588197|37790117|FG000|Overall Study|Lack of Efficacy|0|||
16845402|NCT01588197|37790118|FG001|Overall Study|Lack of Efficacy|1|||
16845403|NCT01588197|37790117|FG000|Overall Study|No MRI|1|||
16845404|NCT01588197|37790118|FG001|Overall Study|No MRI|0|||
16845405|NCT01561989|37790126|FG000|Overall Study|accural target not met.|5|||
16845406|NCT01561989|37790127|FG001|Overall Study|accural target not met.|6|||
16845407|NCT01587885|37790142|FG000|Treatment Period 1|Failure to Return|0|||
16845408|NCT01587885|37790143|FG001|Treatment Period 1|Failure to Return|1|||
16845409|NCT01587885|37790142|FG000|Treatment Period 1|Protocol Violation|0|||
16845410|NCT01587885|37790143|FG001|Treatment Period 1|Protocol Violation|2|||
16845411|NCT01587651|37790153|FG000|Overall Study|Adverse Event|0|||
16845412|NCT01587651|37790154|FG001|Overall Study|Adverse Event|1|||
16845413|NCT01587651|37790155|FG002|Overall Study|Adverse Event|0|||
16845414|NCT01587651|37790153|FG000|Overall Study|Protocol Violation|0|||
16845415|NCT01587651|37790154|FG001|Overall Study|Protocol Violation|1|||
16845416|NCT01587651|37790155|FG002|Overall Study|Protocol Violation|1|||
16845417|NCT01587651|37790153|FG000|Overall Study|Withdrawal by Subject|0|||
16845418|NCT01587651|37790154|FG001|Overall Study|Withdrawal by Subject|1|||
16845419|NCT01587651|37790155|FG002|Overall Study|Withdrawal by Subject|0|||
16845420|NCT01691859|37790177|FG000|Overall Study|Adverse Event|19|||
16845421|NCT01691859|37790177|FG000|Overall Study|Lack of Efficacy|11|||
16845422|NCT01691859|37790177|FG000|Overall Study|Protocol Violation|4|||
16845423|NCT01691859|37790177|FG000|Overall Study|Product commercially available|221|||
16845424|NCT01691859|37790177|FG000|Overall Study|Study closed/terminated|50|||
16845425|NCT01691859|37790177|FG000|Overall Study|Lost to Follow-up|5|||
16845426|NCT01691859|37790177|FG000|Overall Study|Physician Decision|6|||
16845427|NCT01691859|37790177|FG000|Overall Study|Withdrawal by Subject|31|||
16845428|NCT01691781|37790221|FG000|Overall Study|Withdrawal by Subject|4|||
16845429|NCT01691781|37790222|FG001|Overall Study|Withdrawal by Subject|3|||
16845430|NCT01691781|37790221|FG000|Overall Study|Physician Decision|1|||
16845431|NCT01691781|37790222|FG001|Overall Study|Physician Decision|1|||
16845432|NCT01691781|37790221|FG000|Overall Study|Protocol Violation|2|||
16845433|NCT01691781|37790222|FG001|Overall Study|Protocol Violation|2|||
16845434|NCT01691781|37790221|FG000|Overall Study|Adverse Event|0|||
16845435|NCT01691781|37790222|FG001|Overall Study|Adverse Event|1|||
16845436|NCT01561755|37790230|FG000|Overall Study|Lost to Follow-up|0|||
16845437|NCT01561755|37790231|FG001|Overall Study|Lost to Follow-up|1|||
16845438|NCT01560819|37790239|FG000|Overall Study|Physician Decision|1|||
16845439|NCT01560819|37790240|FG001|Overall Study|Physician Decision|0|||
16845440|NCT01585155|37790258|FG000|Overall Study|Adverse Event|1|||
16845441|NCT01585155|37790258|FG000|Overall Study|Lack of Efficacy|2|||
16845442|NCT01585155|37790258|FG000|Overall Study|Worsening ulcerative colitis|2|||
16845443|NCT01560507|37790265|FG000|Overall Study|Lost to Follow-up|3|||
16845444|NCT01560507|37790266|FG001|Overall Study|Lost to Follow-up|1|||
16845445|NCT01560507|37790267|FG002|Overall Study|Lost to Follow-up|2|||
16845446|NCT01560507|37790265|FG000|Overall Study|Withdrawal by Subject|1|||
16845447|NCT01560507|37790266|FG001|Overall Study|Withdrawal by Subject|1|||
16845448|NCT01560507|37790267|FG002|Overall Study|Withdrawal by Subject|0|||
16845449|NCT01584843|37790282|FG000|First Treatment Period|Adverse Event|0|||
16845450|NCT01584843|37790283|FG001|First Treatment Period|Adverse Event|0|||
16845451|NCT01584843|37790284|FG002|First Treatment Period|Adverse Event|1|||
16845452|NCT01584843|37790285|FG003|First Treatment Period|Adverse Event|0|||
16845453|NCT01584843|37790286|FG004|First Treatment Period|Adverse Event|0|||
16845454|NCT01584843|37790287|FG005|First Treatment Period|Adverse Event|0|||
16845455|NCT01584843|37790282|FG000|First Treatment Period|Protocol Violation|0|||
16845456|NCT01584843|37790283|FG001|First Treatment Period|Protocol Violation|0|||
16845457|NCT01584843|37790284|FG002|First Treatment Period|Protocol Violation|0|||
16845458|NCT01584843|37790285|FG003|First Treatment Period|Protocol Violation|0|||
16919219|NCT01729754|38060599|FG000|Part 1|Lack of Efficacy|1|||
16919220|NCT01729754|38060600|FG001|Part 1|Lack of Efficacy|0|||
16919221|NCT01729754|38060601|FG002|Part 1|Lack of Efficacy|0|||
16919222|NCT01729754|38060602|FG003|Part 1|Lack of Efficacy|0|||
16919223|NCT01729754|38060603|FG004|Part 1|Lack of Efficacy|0|||
16919224|NCT01729754|38060604|FG005|Part 1|Lack of Efficacy|0|||
16919225|NCT01729754|38060605|FG006|Part 1|Lack of Efficacy|2|||
16919226|NCT01729754|38060606|FG007|Part 1|Lack of Efficacy|0|||
16845459|NCT01584843|37790286|FG004|First Treatment Period|Protocol Violation|0|||
16919227|NCT01729754|38060607|FG008|Part 1|Lack of Efficacy|0|||
16919228|NCT01729754|38060608|FG009|Part 1|Lack of Efficacy|0|||
16919229|NCT01729754|38060599|FG000|Part 1|Lost to Follow-up|1|||
16919230|NCT01729754|38060600|FG001|Part 1|Lost to Follow-up|0|||
16919231|NCT01729754|38060601|FG002|Part 1|Lost to Follow-up|0|||
16919232|NCT01729754|38060602|FG003|Part 1|Lost to Follow-up|2|||
16919233|NCT01729754|38060603|FG004|Part 1|Lost to Follow-up|0|||
16919234|NCT01729754|38060604|FG005|Part 1|Lost to Follow-up|0|||
16919235|NCT01729754|38060605|FG006|Part 1|Lost to Follow-up|3|||
16919236|NCT01729754|38060606|FG007|Part 1|Lost to Follow-up|0|||
16919237|NCT01729754|38060607|FG008|Part 1|Lost to Follow-up|0|||
16919238|NCT01729754|38060608|FG009|Part 1|Lost to Follow-up|3|||
16919239|NCT01729754|38060599|FG000|Part 1|Non-compliance with Study Drug|1|||
16919240|NCT01729754|38060600|FG001|Part 1|Non-compliance with Study Drug|0|||
16919241|NCT01729754|38060601|FG002|Part 1|Non-compliance with Study Drug|0|||
16919242|NCT01729754|38060602|FG003|Part 1|Non-compliance with Study Drug|0|||
16919243|NCT01729754|38060603|FG004|Part 1|Non-compliance with Study Drug|0|||
16919244|NCT01729754|38060604|FG005|Part 1|Non-compliance with Study Drug|0|||
16919245|NCT01729754|38060605|FG006|Part 1|Non-compliance with Study Drug|0|||
16919246|NCT01729754|38060606|FG007|Part 1|Non-compliance with Study Drug|0|||
16919247|NCT01729754|38060607|FG008|Part 1|Non-compliance with Study Drug|0|||
16919248|NCT01729754|38060608|FG009|Part 1|Non-compliance with Study Drug|0|||
16919249|NCT01729754|38060599|FG000|Part 1|Physician Decision|0|||
16919250|NCT01729754|38060600|FG001|Part 1|Physician Decision|0|||
16919251|NCT01729754|38060601|FG002|Part 1|Physician Decision|0|||
16919252|NCT01729754|38060602|FG003|Part 1|Physician Decision|0|||
16919253|NCT01729754|38060603|FG004|Part 1|Physician Decision|0|||
16919254|NCT01729754|38060604|FG005|Part 1|Physician Decision|0|||
16919255|NCT01729754|38060605|FG006|Part 1|Physician Decision|0|||
16919256|NCT01729754|38060606|FG007|Part 1|Physician Decision|0|||
16919257|NCT01729754|38060607|FG008|Part 1|Physician Decision|0|||
16919258|NCT01729754|38060608|FG009|Part 1|Physician Decision|4|||
16919259|NCT01729754|38060599|FG000|Part 1|Pregnancy|0|||
16919260|NCT01729754|38060600|FG001|Part 1|Pregnancy|0|||
16919261|NCT01729754|38060601|FG002|Part 1|Pregnancy|0|||
16919262|NCT01729754|38060602|FG003|Part 1|Pregnancy|1|||
16919263|NCT01729754|38060603|FG004|Part 1|Pregnancy|0|||
16919264|NCT01729754|38060604|FG005|Part 1|Pregnancy|0|||
16919265|NCT01729754|38060605|FG006|Part 1|Pregnancy|0|||
16919266|NCT01729754|38060606|FG007|Part 1|Pregnancy|0|||
16919267|NCT01729754|38060607|FG008|Part 1|Pregnancy|0|||
16919268|NCT01729754|38060608|FG009|Part 1|Pregnancy|1|||
16919269|NCT01729754|38060599|FG000|Part 1|Progressive Disease|0|||
16919270|NCT01729754|38060600|FG001|Part 1|Progressive Disease|0|||
16919271|NCT01729754|38060601|FG002|Part 1|Progressive Disease|0|||
16919272|NCT01729754|38060602|FG003|Part 1|Progressive Disease|0|||
16919273|NCT01729754|38060603|FG004|Part 1|Progressive Disease|0|||
16919274|NCT01729754|38060604|FG005|Part 1|Progressive Disease|0|||
16919275|NCT01729754|38060605|FG006|Part 1|Progressive Disease|0|||
16919276|NCT01729754|38060606|FG007|Part 1|Progressive Disease|0|||
16919277|NCT01729754|38060607|FG008|Part 1|Progressive Disease|0|||
16919278|NCT01729754|38060608|FG009|Part 1|Progressive Disease|1|||
16919279|NCT01729754|38060599|FG000|Part 1|Protocol Violation|2|||
16919280|NCT01729754|38060600|FG001|Part 1|Protocol Violation|0|||
16919281|NCT01729754|38060601|FG002|Part 1|Protocol Violation|0|||
16919282|NCT01729754|38060602|FG003|Part 1|Protocol Violation|1|||
16919283|NCT01729754|38060603|FG004|Part 1|Protocol Violation|0|||
16919284|NCT01729754|38060604|FG005|Part 1|Protocol Violation|0|||
16919285|NCT01729754|38060605|FG006|Part 1|Protocol Violation|1|||
16919286|NCT01729754|38060606|FG007|Part 1|Protocol Violation|0|||
16919287|NCT01729754|38060607|FG008|Part 1|Protocol Violation|0|||
16919288|NCT01729754|38060608|FG009|Part 1|Protocol Violation|0|||
16919289|NCT01729754|38060599|FG000|Part 1|Withdrawal by Subject|5|||
16919290|NCT01729754|38060600|FG001|Part 1|Withdrawal by Subject|0|||
16919291|NCT01729754|38060601|FG002|Part 1|Withdrawal by Subject|0|||
16919292|NCT01729754|38060602|FG003|Part 1|Withdrawal by Subject|7|||
16919293|NCT01729754|38060603|FG004|Part 1|Withdrawal by Subject|0|||
16919294|NCT01729754|38060604|FG005|Part 1|Withdrawal by Subject|0|||
16919295|NCT01729754|38060605|FG006|Part 1|Withdrawal by Subject|5|||
16919296|NCT01729754|38060606|FG007|Part 1|Withdrawal by Subject|0|||
16919297|NCT01729754|38060607|FG008|Part 1|Withdrawal by Subject|0|||
16919298|NCT01729754|38060608|FG009|Part 1|Withdrawal by Subject|6|||
16919299|NCT01729754|38060599|FG000|Part 1|Other Protocol Specified Criteria|2|||
16919300|NCT01729754|38060600|FG001|Part 1|Other Protocol Specified Criteria|0|||
16919301|NCT01729754|38060601|FG002|Part 1|Other Protocol Specified Criteria|0|||
16919302|NCT01729754|38060602|FG003|Part 1|Other Protocol Specified Criteria|0|||
16919303|NCT01729754|38060603|FG004|Part 1|Other Protocol Specified Criteria|0|||
16919304|NCT01729754|38060604|FG005|Part 1|Other Protocol Specified Criteria|0|||
16919305|NCT01729754|38060605|FG006|Part 1|Other Protocol Specified Criteria|1|||
16919306|NCT01729754|38060606|FG007|Part 1|Other Protocol Specified Criteria|0|||
16919307|NCT01729754|38060607|FG008|Part 1|Other Protocol Specified Criteria|0|||
16919308|NCT01729754|38060608|FG009|Part 1|Other Protocol Specified Criteria|4|||
16919309|NCT01729754|38060599|FG000|Part 2|Adverse Event|2|||
16919310|NCT01729754|38060600|FG001|Part 2|Adverse Event|0|||
16919311|NCT01729754|38060601|FG002|Part 2|Adverse Event|0|||
16919312|NCT01729754|38060602|FG003|Part 2|Adverse Event|0|||
16919313|NCT01729754|38060603|FG004|Part 2|Adverse Event|0|||
16919314|NCT01729754|38060604|FG005|Part 2|Adverse Event|0|||
16919315|NCT01729754|38060605|FG006|Part 2|Adverse Event|0|||
16919316|NCT01729754|38060606|FG007|Part 2|Adverse Event|0|||
16919317|NCT01729754|38060607|FG008|Part 2|Adverse Event|1|||
16919318|NCT01729754|38060608|FG009|Part 2|Adverse Event|2|||
16919319|NCT01729754|38060599|FG000|Part 2|Lack of Efficacy|0|||
16919320|NCT01729754|38060600|FG001|Part 2|Lack of Efficacy|0|||
16919321|NCT01729754|38060601|FG002|Part 2|Lack of Efficacy|0|||
16919322|NCT01729754|38060602|FG003|Part 2|Lack of Efficacy|0|||
16919323|NCT01729754|38060603|FG004|Part 2|Lack of Efficacy|0|||
16919324|NCT01729754|38060604|FG005|Part 2|Lack of Efficacy|0|||
16919325|NCT01729754|38060605|FG006|Part 2|Lack of Efficacy|0|||
16919326|NCT01729754|38060606|FG007|Part 2|Lack of Efficacy|0|||
16919327|NCT01729754|38060607|FG008|Part 2|Lack of Efficacy|2|||
16919328|NCT01729754|38060608|FG009|Part 2|Lack of Efficacy|2|||
16919329|NCT01729754|38060599|FG000|Part 2|Lost to Follow-up|0|||
16919330|NCT01729754|38060600|FG001|Part 2|Lost to Follow-up|0|||
16919331|NCT01729754|38060601|FG002|Part 2|Lost to Follow-up|0|||
16919332|NCT01729754|38060602|FG003|Part 2|Lost to Follow-up|2|||
16919333|NCT01729754|38060603|FG004|Part 2|Lost to Follow-up|0|||
16919334|NCT01729754|38060604|FG005|Part 2|Lost to Follow-up|0|||
16919335|NCT01729754|38060605|FG006|Part 2|Lost to Follow-up|0|||
16919336|NCT01729754|38060606|FG007|Part 2|Lost to Follow-up|1|||
16845460|NCT01584843|37790287|FG005|First Treatment Period|Protocol Violation|1|||
16845461|NCT01584843|37790282|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16845462|NCT01584843|37790283|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16845463|NCT01584843|37790284|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16845464|NCT01584843|37790285|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16845465|NCT01584843|37790286|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16919337|NCT01729754|38060607|FG008|Part 2|Lost to Follow-up|0|||
16919338|NCT01729754|38060608|FG009|Part 2|Lost to Follow-up|2|||
16919339|NCT01729754|38060599|FG000|Part 2|Non-Compliance with Study Drug|0|||
16919340|NCT01729754|38060600|FG001|Part 2|Non-Compliance with Study Drug|0|||
16919341|NCT01729754|38060601|FG002|Part 2|Non-Compliance with Study Drug|0|||
16919342|NCT01729754|38060602|FG003|Part 2|Non-Compliance with Study Drug|0|||
16919343|NCT01729754|38060603|FG004|Part 2|Non-Compliance with Study Drug|0|||
16919344|NCT01729754|38060604|FG005|Part 2|Non-Compliance with Study Drug|0|||
16919345|NCT01729754|38060605|FG006|Part 2|Non-Compliance with Study Drug|0|||
16919346|NCT01729754|38060606|FG007|Part 2|Non-Compliance with Study Drug|0|||
16919347|NCT01729754|38060607|FG008|Part 2|Non-Compliance with Study Drug|0|||
16919348|NCT01729754|38060608|FG009|Part 2|Non-Compliance with Study Drug|1|||
16919349|NCT01729754|38060599|FG000|Part 2|Pregnancy|0|||
16919350|NCT01729754|38060600|FG001|Part 2|Pregnancy|0|||
16919351|NCT01729754|38060601|FG002|Part 2|Pregnancy|0|||
16919352|NCT01729754|38060602|FG003|Part 2|Pregnancy|1|||
16919353|NCT01729754|38060603|FG004|Part 2|Pregnancy|0|||
16919354|NCT01729754|38060604|FG005|Part 2|Pregnancy|0|||
16919355|NCT01729754|38060605|FG006|Part 2|Pregnancy|0|||
16919356|NCT01729754|38060606|FG007|Part 2|Pregnancy|0|||
16919357|NCT01729754|38060607|FG008|Part 2|Pregnancy|0|||
16919358|NCT01729754|38060608|FG009|Part 2|Pregnancy|1|||
16919359|NCT01729754|38060599|FG000|Part 2|Withdrawal by Subject|3|||
16919360|NCT01729754|38060600|FG001|Part 2|Withdrawal by Subject|0|||
16919361|NCT01729754|38060601|FG002|Part 2|Withdrawal by Subject|0|||
16919362|NCT01729754|38060602|FG003|Part 2|Withdrawal by Subject|2|||
16919363|NCT01729754|38060603|FG004|Part 2|Withdrawal by Subject|0|||
16919364|NCT01729754|38060604|FG005|Part 2|Withdrawal by Subject|0|||
16919365|NCT01729754|38060605|FG006|Part 2|Withdrawal by Subject|0|||
16919366|NCT01729754|38060606|FG007|Part 2|Withdrawal by Subject|1|||
16919367|NCT01729754|38060607|FG008|Part 2|Withdrawal by Subject|1|||
16919368|NCT01729754|38060608|FG009|Part 2|Withdrawal by Subject|4|||
16919369|NCT01729754|38060599|FG000|Part 2|Other Protocol Specified Criteria|1|||
16919370|NCT01729754|38060600|FG001|Part 2|Other Protocol Specified Criteria|0|||
16919371|NCT01729754|38060601|FG002|Part 2|Other Protocol Specified Criteria|0|||
16845466|NCT01584843|37790287|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
16919372|NCT01729754|38060602|FG003|Part 2|Other Protocol Specified Criteria|0|||
16919373|NCT01729754|38060603|FG004|Part 2|Other Protocol Specified Criteria|0|||
16919374|NCT01729754|38060604|FG005|Part 2|Other Protocol Specified Criteria|0|||
16919375|NCT01729754|38060605|FG006|Part 2|Other Protocol Specified Criteria|0|||
16919376|NCT01729754|38060606|FG007|Part 2|Other Protocol Specified Criteria|1|||
16919377|NCT01729754|38060607|FG008|Part 2|Other Protocol Specified Criteria|0|||
16919378|NCT01729754|38060608|FG009|Part 2|Other Protocol Specified Criteria|0|||
17017162|NCT00598559|38161759|FG001|Overall Study|Protocol Non-compliance|0|||
17017163|NCT00598559|38161760|FG002|Overall Study|Protocol Non-compliance|0|||
16919379|NCT01729754|38060599|FG000|Part 3|Adverse Event|0|||
16919380|NCT01729754|38060600|FG001|Part 3|Adverse Event|0|||
16919381|NCT01729754|38060601|FG002|Part 3|Adverse Event|1|||
16919382|NCT01729754|38060602|FG003|Part 3|Adverse Event|0|||
16919383|NCT01729754|38060603|FG004|Part 3|Adverse Event|0|||
16919384|NCT01729754|38060604|FG005|Part 3|Adverse Event|5|||
16845467|NCT01584843|37790282|FG000|Second Treatment Period|Withdrawal by Subject|0|||
16845468|NCT01584843|37790283|FG001|Second Treatment Period|Withdrawal by Subject|0|||
16845469|NCT01584843|37790284|FG002|Second Treatment Period|Withdrawal by Subject|0|||
16845470|NCT01584843|37790285|FG003|Second Treatment Period|Withdrawal by Subject|0|||
16845471|NCT01584843|37790286|FG004|Second Treatment Period|Withdrawal by Subject|0|||
16845472|NCT01584843|37790287|FG005|Second Treatment Period|Withdrawal by Subject|1|||
16845473|NCT01560429|37790305|FG000|Overall Study|Protocol Violation|3|||
16845474|NCT01560429|37790306|FG001|Overall Study|Protocol Violation|6|||
16845475|NCT01582971|37790316|FG000|Overall Study|Death|2|||
16845476|NCT01582971|37790317|FG001|Overall Study|Death|1|||
16845477|NCT01582971|37790316|FG000|Overall Study|Lost to Follow-up|18|||
16845478|NCT01582971|37790317|FG001|Overall Study|Lost to Follow-up|21|||
16845479|NCT01582971|37790316|FG000|Overall Study|Withdrawal by Subject|4|||
16845480|NCT01582971|37790317|FG001|Overall Study|Withdrawal by Subject|2|||
16845481|NCT01582971|37790316|FG000|Overall Study|Other|15|||
16845482|NCT01582971|37790317|FG001|Overall Study|Other|13|||
16845483|NCT01690299|37790332|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
16845484|NCT01690299|37790333|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
16845485|NCT01690299|37790334|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
16845486|NCT01690299|37790335|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
16845487|NCT01690299|37790336|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
16845488|NCT01690299|37790337|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
16845489|NCT01690299|37790332|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
16845490|NCT01690299|37790333|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16845491|NCT01690299|37790334|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16845492|NCT01690299|37790335|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16845493|NCT01690299|37790336|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16919385|NCT01729754|38060605|FG006|Part 3|Adverse Event|0|||
16919386|NCT01729754|38060606|FG007|Part 3|Adverse Event|0|||
16919387|NCT01729754|38060607|FG008|Part 3|Adverse Event|0|||
16919388|NCT01729754|38060608|FG009|Part 3|Adverse Event|3|||
16919389|NCT01729754|38060599|FG000|Part 3|Death|0|||
16919390|NCT01729754|38060600|FG001|Part 3|Death|0|||
16919391|NCT01729754|38060601|FG002|Part 3|Death|0|||
16919392|NCT01729754|38060602|FG003|Part 3|Death|0|||
16919393|NCT01729754|38060603|FG004|Part 3|Death|0|||
16919394|NCT01729754|38060604|FG005|Part 3|Death|2|||
16919395|NCT01729754|38060605|FG006|Part 3|Death|0|||
16919396|NCT01729754|38060606|FG007|Part 3|Death|0|||
16919397|NCT01729754|38060607|FG008|Part 3|Death|0|||
17017164|NCT00598559|38161758|FG000|Overall Study|Early discharge from hospital|9|||
17017165|NCT00598559|38161759|FG001|Overall Study|Early discharge from hospital|12|||
17017166|NCT00598559|38161760|FG002|Overall Study|Early discharge from hospital|3|||
17017167|NCT00598559|38161758|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
17017168|NCT00598559|38161759|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
17017169|NCT00598559|38161760|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
17017170|NCT00686686|38161768|FG000|Overall Study|Non-compliance|1|||
17017171|NCT00686686|38161768|FG000|Overall Study|Adverse Event|2|||
17017172|NCT00686686|38161768|FG000|Overall Study|Lost to Follow-up|3|||
17017173|NCT04160195|38161774|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
17017174|NCT04160195|38161775|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
17017175|NCT00686374|38161783|FG000|Overall Study|Lack of Efficacy|10|||
17017176|NCT00686374|38161783|FG000|Overall Study|Adverse Event|8|||
17017177|NCT00686374|38161783|FG000|Overall Study|Withdrew consent|5|||
17017178|NCT00686374|38161783|FG000|Overall Study|Lost to Follow-up|1|||
17017179|NCT00686374|38161783|FG000|Overall Study|Missing reason|33|||
17017180|NCT00686374|38161783|FG000|Overall Study|Other, not specified|4|||
17017181|NCT00571948|38161789|FG000|Overall Study|Lost to Follow-up|2|||
17017182|NCT00571948|38161790|FG001|Overall Study|Lost to Follow-up|0|||
17017183|NCT00571948|38161789|FG000|Overall Study|Withdrawal by Subject|1|||
17017184|NCT00571948|38161790|FG001|Overall Study|Withdrawal by Subject|2|||
17017185|NCT00571948|38161789|FG000|Overall Study|Protocol Violation|3|||
17017186|NCT00571948|38161790|FG001|Overall Study|Protocol Violation|3|||
17017187|NCT00571948|38161789|FG000|Overall Study|infant refused study meal|3|||
17017188|NCT00571948|38161790|FG001|Overall Study|infant refused study meal|4|||
17017189|NCT00571948|38161789|FG000|Overall Study|Parent were afraid of blood colection|2|||
17017190|NCT00571948|38161790|FG001|Overall Study|Parent were afraid of blood colection|5|||
17017191|NCT00684424|38161796|FG000|Overall Study|Adverse Event|1|||
17017192|NCT00684424|38161796|FG000|Overall Study|Lost to Follow-up|2|||
17017193|NCT00684424|38161796|FG000|Overall Study|Other|2|||
17017194|NCT00685750|38161808|FG000|Overall Study|Tumor sampling failure|0|||
17017195|NCT00685750|38161809|FG001|Overall Study|Tumor sampling failure|0|||
17017196|NCT00685750|38161810|FG002|Overall Study|Tumor sampling failure|1|||
17017197|NCT00685750|38161811|FG003|Overall Study|Tumor sampling failure|0|||
16919398|NCT01729754|38060608|FG009|Part 3|Death|0|||
17017198|NCT00685750|38161812|FG004|Overall Study|Tumor sampling failure|0|||
16919399|NCT01729754|38060599|FG000|Part 3|Lack of Efficacy|0|||
16919400|NCT01729754|38060600|FG001|Part 3|Lack of Efficacy|0|||
16919401|NCT01729754|38060601|FG002|Part 3|Lack of Efficacy|0|||
16919402|NCT01729754|38060602|FG003|Part 3|Lack of Efficacy|0|||
16919403|NCT01729754|38060603|FG004|Part 3|Lack of Efficacy|2|||
16919404|NCT01729754|38060604|FG005|Part 3|Lack of Efficacy|0|||
16919405|NCT01729754|38060605|FG006|Part 3|Lack of Efficacy|0|||
16919406|NCT01729754|38060606|FG007|Part 3|Lack of Efficacy|0|||
16919407|NCT01729754|38060607|FG008|Part 3|Lack of Efficacy|0|||
16919408|NCT01729754|38060608|FG009|Part 3|Lack of Efficacy|4|||
16919409|NCT01729754|38060599|FG000|Part 3|Lost to Follow-up|0|||
16919410|NCT01729754|38060600|FG001|Part 3|Lost to Follow-up|1|||
16919411|NCT01729754|38060601|FG002|Part 3|Lost to Follow-up|2|||
16919412|NCT01729754|38060602|FG003|Part 3|Lost to Follow-up|0|||
16919413|NCT01729754|38060603|FG004|Part 3|Lost to Follow-up|0|||
16919414|NCT01729754|38060604|FG005|Part 3|Lost to Follow-up|3|||
16919415|NCT01729754|38060605|FG006|Part 3|Lost to Follow-up|0|||
16845494|NCT01690299|37790337|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16845495|NCT01690299|37790332|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
16845496|NCT01690299|37790333|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
16845497|NCT01690299|37790334|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16919416|NCT01729754|38060606|FG007|Part 3|Lost to Follow-up|0|||
16919417|NCT01729754|38060607|FG008|Part 3|Lost to Follow-up|1|||
16919418|NCT01729754|38060608|FG009|Part 3|Lost to Follow-up|0|||
16919419|NCT01729754|38060599|FG000|Part 3|Physician Decision|0|||
16919420|NCT01729754|38060600|FG001|Part 3|Physician Decision|0|||
16919421|NCT01729754|38060601|FG002|Part 3|Physician Decision|1|||
16919422|NCT01729754|38060602|FG003|Part 3|Physician Decision|0|||
16919423|NCT01729754|38060603|FG004|Part 3|Physician Decision|0|||
16919424|NCT01729754|38060604|FG005|Part 3|Physician Decision|0|||
17017199|NCT00685750|38161813|FG005|Overall Study|Tumor sampling failure|0|||
17017200|NCT00685750|38161814|FG006|Overall Study|Tumor sampling failure|0|||
17017201|NCT00685750|38161808|FG000|Overall Study|Patient didn't receive the treatment|0|||
17017202|NCT00685750|38161809|FG001|Overall Study|Patient didn't receive the treatment|0|||
17017203|NCT00685750|38161810|FG002|Overall Study|Patient didn't receive the treatment|0|||
17017204|NCT00685750|38161811|FG003|Overall Study|Patient didn't receive the treatment|0|||
17017205|NCT00685750|38161812|FG004|Overall Study|Patient didn't receive the treatment|0|||
17017206|NCT00685750|38161813|FG005|Overall Study|Patient didn't receive the treatment|0|||
17017207|NCT00685750|38161814|FG006|Overall Study|Patient didn't receive the treatment|1|||
17017208|NCT00685750|38161808|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
17017209|NCT00685750|38161809|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
17017210|NCT00685750|38161810|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
17017211|NCT00685750|38161811|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
17017212|NCT00685750|38161812|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
17017213|NCT00685750|38161813|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
17017214|NCT00685750|38161814|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
17017215|NCT00576628|38161834|FG000|Overall Study|Adverse Event|11|||
17017216|NCT00576628|38161834|FG000|Overall Study|Death|2|||
17017217|NCT00576628|38161834|FG000|Overall Study|Failure to return|1|||
17017218|NCT00576628|38161834|FG000|Overall Study|Refused Treatment|8|||
17017219|NCT00576628|38161834|FG000|Overall Study|Pregnancy|1|||
17017220|NCT00576628|38161834|FG000|Overall Study|RBC transfusion|1|||
17017221|NCT00576628|38161834|FG000|Overall Study|Progression of Kidney Disease|1|||
17017222|NCT00576628|38161834|FG000|Overall Study|Progression of Renal Failure|1|||
17017223|NCT00576628|38161834|FG000|Overall Study|The patient move into other town|1|||
17017224|NCT00576628|38161834|FG000|Overall Study|Transplantation|1|||
17017225|NCT00576628|38161834|FG000|Overall Study|Dialysis|15|||
17017226|NCT00683878|38161842|FG000|Overall Study|Lack of Efficacy|3|||
17017227|NCT00683878|38161843|FG001|Overall Study|Lack of Efficacy|0|||
17017228|NCT00683878|38161844|FG002|Overall Study|Lack of Efficacy|1|||
17017229|NCT00683878|38161842|FG000|Overall Study|Adverse Event|4|||
17017230|NCT00683878|38161843|FG001|Overall Study|Adverse Event|3|||
17017231|NCT00683878|38161844|FG002|Overall Study|Adverse Event|3|||
17017232|NCT00683878|38161842|FG000|Overall Study|Withdrawal by Subject|9|||
17017233|NCT00683878|38161843|FG001|Overall Study|Withdrawal by Subject|8|||
16845498|NCT01690299|37790335|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16845499|NCT01690299|37790336|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16845500|NCT01690299|37790337|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16845501|NCT01690299|37790332|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
16845502|NCT01690299|37790333|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
16919425|NCT01729754|38060605|FG006|Part 3|Physician Decision|0|||
16919426|NCT01729754|38060606|FG007|Part 3|Physician Decision|0|||
16919427|NCT01729754|38060607|FG008|Part 3|Physician Decision|0|||
16919428|NCT01729754|38060608|FG009|Part 3|Physician Decision|0|||
17017234|NCT00683878|38161844|FG002|Overall Study|Withdrawal by Subject|6|||
17017235|NCT00683878|38161842|FG000|Overall Study|Death|0|||
17017236|NCT00683878|38161843|FG001|Overall Study|Death|1|||
17017237|NCT00683878|38161844|FG002|Overall Study|Death|0|||
16919429|NCT01729754|38060599|FG000|Part 3|Withdrawal by Subject|0|||
16919430|NCT01729754|38060600|FG001|Part 3|Withdrawal by Subject|4|||
16919431|NCT01729754|38060601|FG002|Part 3|Withdrawal by Subject|1|||
16919432|NCT01729754|38060602|FG003|Part 3|Withdrawal by Subject|0|||
16919433|NCT01729754|38060603|FG004|Part 3|Withdrawal by Subject|2|||
16919434|NCT01729754|38060604|FG005|Part 3|Withdrawal by Subject|1|||
16919435|NCT01729754|38060605|FG006|Part 3|Withdrawal by Subject|0|||
16919436|NCT01729754|38060606|FG007|Part 3|Withdrawal by Subject|2|||
16919437|NCT01729754|38060607|FG008|Part 3|Withdrawal by Subject|0|||
16919438|NCT01729754|38060608|FG009|Part 3|Withdrawal by Subject|0|||
16919439|NCT01729754|38060599|FG000|Part 3|Other Protocol Specified Criteria|0|||
16919440|NCT01729754|38060600|FG001|Part 3|Other Protocol Specified Criteria|0|||
16919441|NCT01729754|38060601|FG002|Part 3|Other Protocol Specified Criteria|0|||
16919442|NCT01729754|38060602|FG003|Part 3|Other Protocol Specified Criteria|0|||
16919443|NCT01729754|38060603|FG004|Part 3|Other Protocol Specified Criteria|0|||
16919444|NCT01729754|38060604|FG005|Part 3|Other Protocol Specified Criteria|2|||
16919445|NCT01729754|38060605|FG006|Part 3|Other Protocol Specified Criteria|0|||
16919446|NCT01729754|38060606|FG007|Part 3|Other Protocol Specified Criteria|1|||
16919447|NCT01729754|38060607|FG008|Part 3|Other Protocol Specified Criteria|0|||
16919448|NCT01729754|38060608|FG009|Part 3|Other Protocol Specified Criteria|0|||
16919449|NCT01515306|38060653|FG000|Overall Study|Adverse Event|3|||
16919450|NCT01515306|38060654|FG001|Overall Study|Adverse Event|2|||
16919451|NCT01515306|38060653|FG000|Overall Study|Progressive Disease|19|||
16919452|NCT01515306|38060654|FG001|Overall Study|Progressive Disease|9|||
16919453|NCT01515306|38060653|FG000|Overall Study|Withdrawal by Subject|1|||
16919454|NCT01515306|38060654|FG001|Overall Study|Withdrawal by Subject|2|||
16919455|NCT01515306|38060653|FG000|Overall Study|Physician Decision|1|||
16919456|NCT01515306|38060654|FG001|Overall Study|Physician Decision|1|||
16919457|NCT01423851|38060675|FG000|Whole Study|Disease progression|2|||
16919458|NCT01423851|38060676|FG001|Whole Study|Disease progression|1|||
16919459|NCT01423851|38060677|FG002|Whole Study|Disease progression|1|||
16919460|NCT01423851|38060678|FG003|Whole Study|Disease progression|4|||
16919461|NCT01423851|38060679|FG004|Whole Study|Disease progression|1|||
16919462|NCT01423851|38060680|FG005|Whole Study|Disease progression|3|||
16919463|NCT01423851|38060681|FG006|Whole Study|Disease progression|1|||
16919464|NCT01423851|38060682|FG007|Whole Study|Disease progression|4|||
16919465|NCT01423851|38060683|FG008|Whole Study|Disease progression|0|||
16919466|NCT01423851|38060684|FG009|Whole Study|Disease progression|2|||
16919467|NCT01423851|38060685|FG010|Whole Study|Disease progression|10|||
16919468|NCT01423851|38060675|FG000|Whole Study|Physician Decision|0|||
16919469|NCT01423851|38060676|FG001|Whole Study|Physician Decision|1|||
16919470|NCT01423851|38060677|FG002|Whole Study|Physician Decision|2|||
16919471|NCT01423851|38060678|FG003|Whole Study|Physician Decision|0|||
16919472|NCT01423851|38060679|FG004|Whole Study|Physician Decision|2|||
16919473|NCT01423851|38060680|FG005|Whole Study|Physician Decision|0|||
16919474|NCT01423851|38060681|FG006|Whole Study|Physician Decision|2|||
16919475|NCT01423851|38060682|FG007|Whole Study|Physician Decision|1|||
16919476|NCT01423851|38060683|FG008|Whole Study|Physician Decision|3|||
16919477|NCT01423851|38060684|FG009|Whole Study|Physician Decision|4|||
16919478|NCT01423851|38060685|FG010|Whole Study|Physician Decision|12|||
16919479|NCT01423851|38060675|FG000|Whole Study|Withdrawal by Subject|1|||
16919480|NCT01423851|38060676|FG001|Whole Study|Withdrawal by Subject|1|||
16919481|NCT01423851|38060677|FG002|Whole Study|Withdrawal by Subject|0|||
16919482|NCT01423851|38060678|FG003|Whole Study|Withdrawal by Subject|0|||
16919483|NCT01423851|38060679|FG004|Whole Study|Withdrawal by Subject|0|||
16919484|NCT01423851|38060680|FG005|Whole Study|Withdrawal by Subject|0|||
16919485|NCT01423851|38060681|FG006|Whole Study|Withdrawal by Subject|0|||
16919486|NCT01423851|38060682|FG007|Whole Study|Withdrawal by Subject|0|||
16919487|NCT01423851|38060683|FG008|Whole Study|Withdrawal by Subject|2|||
16919488|NCT01423851|38060684|FG009|Whole Study|Withdrawal by Subject|0|||
16919489|NCT01423851|38060685|FG010|Whole Study|Withdrawal by Subject|4|||
16919490|NCT01423851|38060675|FG000|Whole Study|Adverse Event|0|||
16919491|NCT01423851|38060676|FG001|Whole Study|Adverse Event|0|||
16919492|NCT01423851|38060677|FG002|Whole Study|Adverse Event|0|||
16919493|NCT01423851|38060678|FG003|Whole Study|Adverse Event|2|||
16919494|NCT01423851|38060679|FG004|Whole Study|Adverse Event|0|||
16919495|NCT01423851|38060680|FG005|Whole Study|Adverse Event|0|||
16919496|NCT01423851|38060681|FG006|Whole Study|Adverse Event|0|||
16919497|NCT01423851|38060682|FG007|Whole Study|Adverse Event|3|||
16919498|NCT01423851|38060683|FG008|Whole Study|Adverse Event|3|||
16919499|NCT01423851|38060684|FG009|Whole Study|Adverse Event|2|||
16919500|NCT01423851|38060685|FG010|Whole Study|Adverse Event|3|||
16919501|NCT01334606|38060727|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
17017238|NCT00683878|38161842|FG000|Overall Study|Lost to Follow-up|4|||
16919502|NCT01317875|38060743|FG000|Overall Study|Other|0|||
16919503|NCT01317875|38060744|FG001|Overall Study|Other|0|||
16919504|NCT01317875|38060745|FG002|Overall Study|Other|1|||
16919505|NCT01317875|38060746|FG003|Overall Study|Other|0|||
16919506|NCT01317875|38060747|FG004|Overall Study|Other|0|||
16919507|NCT01317875|38060748|FG005|Overall Study|Other|0|||
16919508|NCT01317875|38060749|FG006|Overall Study|Other|0|||
16919509|NCT01317875|38060750|FG007|Overall Study|Other|0|||
16919510|NCT01317875|38060751|FG008|Overall Study|Other|0|||
16919511|NCT01317875|38060752|FG009|Overall Study|Other|0|||
16919512|NCT01317875|38060743|FG000|Overall Study|Noncompliance with study drug|0|||
16919513|NCT01317875|38060744|FG001|Overall Study|Noncompliance with study drug|0|||
16919514|NCT01317875|38060745|FG002|Overall Study|Noncompliance with study drug|1|||
16919515|NCT01317875|38060746|FG003|Overall Study|Noncompliance with study drug|0|||
16919516|NCT01317875|38060747|FG004|Overall Study|Noncompliance with study drug|0|||
16919517|NCT01317875|38060748|FG005|Overall Study|Noncompliance with study drug|0|||
16919518|NCT01317875|38060749|FG006|Overall Study|Noncompliance with study drug|0|||
16919519|NCT01317875|38060750|FG007|Overall Study|Noncompliance with study drug|0|||
16919520|NCT01317875|38060751|FG008|Overall Study|Noncompliance with study drug|0|||
16919521|NCT01317875|38060752|FG009|Overall Study|Noncompliance with study drug|0|||
16919522|NCT01317875|38060743|FG000|Overall Study|Progressive Disease|1|||
17017239|NCT00683878|38161843|FG001|Overall Study|Lost to Follow-up|2|||
17017240|NCT00683878|38161844|FG002|Overall Study|Lost to Follow-up|4|||
17017241|NCT00683878|38161842|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
17017242|NCT00683878|38161843|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
16919523|NCT01317875|38060744|FG001|Overall Study|Progressive Disease|0|||
16919524|NCT01317875|38060745|FG002|Overall Study|Progressive Disease|2|||
16919525|NCT01317875|38060746|FG003|Overall Study|Progressive Disease|0|||
16919526|NCT01317875|38060747|FG004|Overall Study|Progressive Disease|1|||
16919527|NCT01317875|38060748|FG005|Overall Study|Progressive Disease|0|||
16919528|NCT01317875|38060749|FG006|Overall Study|Progressive Disease|0|||
16919529|NCT01317875|38060750|FG007|Overall Study|Progressive Disease|1|||
16919530|NCT01317875|38060751|FG008|Overall Study|Progressive Disease|0|||
16919531|NCT01317875|38060752|FG009|Overall Study|Progressive Disease|0|||
16919532|NCT01317875|38060743|FG000|Overall Study|Withdrawal by Subject|0|||
16919533|NCT01317875|38060744|FG001|Overall Study|Withdrawal by Subject|0|||
16919534|NCT01317875|38060745|FG002|Overall Study|Withdrawal by Subject|0|||
16919535|NCT01317875|38060746|FG003|Overall Study|Withdrawal by Subject|0|||
16919536|NCT01317875|38060747|FG004|Overall Study|Withdrawal by Subject|1|||
16919537|NCT01317875|38060748|FG005|Overall Study|Withdrawal by Subject|0|||
16919538|NCT01317875|38060749|FG006|Overall Study|Withdrawal by Subject|0|||
16919539|NCT01317875|38060750|FG007|Overall Study|Withdrawal by Subject|3|||
16919540|NCT01317875|38060751|FG008|Overall Study|Withdrawal by Subject|0|||
16919541|NCT01317875|38060752|FG009|Overall Study|Withdrawal by Subject|0|||
16919542|NCT01317875|38060743|FG000|Overall Study|Physician Decision|0|||
16919543|NCT01317875|38060744|FG001|Overall Study|Physician Decision|1|||
16919544|NCT01317875|38060745|FG002|Overall Study|Physician Decision|1|||
16919545|NCT01317875|38060746|FG003|Overall Study|Physician Decision|0|||
16919546|NCT01317875|38060747|FG004|Overall Study|Physician Decision|2|||
16919547|NCT01317875|38060748|FG005|Overall Study|Physician Decision|0|||
16919548|NCT01317875|38060749|FG006|Overall Study|Physician Decision|0|||
16919549|NCT01317875|38060750|FG007|Overall Study|Physician Decision|2|||
16919550|NCT01317875|38060751|FG008|Overall Study|Physician Decision|0|||
16919551|NCT01317875|38060752|FG009|Overall Study|Physician Decision|0|||
16919552|NCT01317875|38060743|FG000|Overall Study|Death|0|||
16919553|NCT01317875|38060744|FG001|Overall Study|Death|0|||
16919554|NCT01317875|38060745|FG002|Overall Study|Death|2|||
16919555|NCT01317875|38060746|FG003|Overall Study|Death|1|||
16919556|NCT01317875|38060747|FG004|Overall Study|Death|0|||
16919557|NCT01317875|38060748|FG005|Overall Study|Death|1|||
16919558|NCT01317875|38060749|FG006|Overall Study|Death|0|||
16919559|NCT01317875|38060750|FG007|Overall Study|Death|4|||
16919560|NCT01317875|38060751|FG008|Overall Study|Death|0|||
16919561|NCT01317875|38060752|FG009|Overall Study|Death|0|||
16919562|NCT01317875|38060743|FG000|Overall Study|Adverse Event|2|||
16919563|NCT01317875|38060744|FG001|Overall Study|Adverse Event|1|||
16919564|NCT01317875|38060745|FG002|Overall Study|Adverse Event|2|||
16919565|NCT01317875|38060746|FG003|Overall Study|Adverse Event|1|||
16919566|NCT01317875|38060747|FG004|Overall Study|Adverse Event|5|||
16919567|NCT01317875|38060748|FG005|Overall Study|Adverse Event|1|||
16919568|NCT01317875|38060749|FG006|Overall Study|Adverse Event|2|||
16919569|NCT01317875|38060750|FG007|Overall Study|Adverse Event|5|||
16919570|NCT01317875|38060751|FG008|Overall Study|Adverse Event|0|||
16919571|NCT01317875|38060752|FG009|Overall Study|Adverse Event|0|||
16919572|NCT00920621|38060818|FG000|Overall Study|Lost to Follow-up|16|||
16919573|NCT00920621|38060819|FG001|Overall Study|Lost to Follow-up|17|||
16919574|NCT00920621|38060820|FG002|Overall Study|Lost to Follow-up|19|||
16919575|NCT00920621|38060821|FG003|Overall Study|Lost to Follow-up|21|||
16919576|NCT00920621|38060818|FG000|Overall Study|Fetal/neonatal deaths|16|||
16919577|NCT00920621|38060819|FG001|Overall Study|Fetal/neonatal deaths|14|||
16919578|NCT00920621|38060820|FG002|Overall Study|Fetal/neonatal deaths|16|||
16919579|NCT00920621|38060821|FG003|Overall Study|Fetal/neonatal deaths|14|||
16919580|NCT00920621|38060818|FG000|Overall Study|Blood sample not collected|22|||
16919581|NCT00920621|38060819|FG001|Overall Study|Blood sample not collected|14|||
16919582|NCT00920621|38060820|FG002|Overall Study|Blood sample not collected|0|||
16919583|NCT00920621|38060821|FG003|Overall Study|Blood sample not collected|0|||
16919584|NCT00500071|38060846|FG000|Screening and Washout Phase|Protocol Violation|1|||
16919585|NCT00500071|38060846|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
16919586|NCT00500071|38060846|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
16919587|NCT00500071|38060846|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
16919588|NCT00500071|38060846|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
16919589|NCT00500071|38060846|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
16919590|NCT00500071|38060846|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
16919591|NCT00447122|38060854|FG000|Overall Study|worsening medical condition -came off|0|||
16919592|NCT00447122|38060855|FG001|Overall Study|worsening medical condition -came off|1|||
16919593|NCT00447122|38060856|FG002|Overall Study|worsening medical condition -came off|0|||
16919594|NCT00447122|38060857|FG003|Overall Study|worsening medical condition -came off|0|||
16919595|NCT00382252|38060867|FG000|Overall Study|Death|4|||
16919596|NCT00382252|38060867|FG000|Overall Study|Protocol Violation|8|||
16919597|NCT00382252|38060867|FG000|Overall Study|Not treated by RFA|1|||
16919598|NCT00290251|38060874|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16919599|NCT00290251|38060875|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16919600|NCT00290251|38060876|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16919601|NCT00290251|38060877|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16919602|NCT00290251|38060878|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16919603|NCT00290251|38060879|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
16919604|NCT00290251|38060874|FG000|Treatment 1 (Months 2-4)|headache|0|||
16919605|NCT00290251|38060875|FG001|Treatment 1 (Months 2-4)|headache|0|||
16919606|NCT00290251|38060876|FG002|Treatment 1 (Months 2-4)|headache|0|||
16919607|NCT00290251|38060877|FG003|Treatment 1 (Months 2-4)|headache|0|||
16919608|NCT00290251|38060878|FG004|Treatment 1 (Months 2-4)|headache|1|||
16919609|NCT00290251|38060879|FG005|Treatment 1 (Months 2-4)|headache|0|||
16919610|NCT00290251|38060874|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
16919611|NCT00290251|38060875|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
16919612|NCT00290251|38060876|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
16919613|NCT00290251|38060877|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
16919614|NCT00290251|38060878|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
16919615|NCT00290251|38060879|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
16919616|NCT01403948|38060915|FG000|Overall Study|Progressive disease|0|||
16919617|NCT01403948|38060916|FG001|Overall Study|Progressive disease|2|||
16919618|NCT01403948|38060917|FG002|Overall Study|Progressive disease|2|||
16919619|NCT01403948|38060918|FG003|Overall Study|Progressive disease|4|||
16919620|NCT01403948|38060919|FG004|Overall Study|Progressive disease|2|||
16919621|NCT01403948|38060920|FG005|Overall Study|Progressive disease|6|||
16919622|NCT01403948|38060921|FG006|Overall Study|Progressive disease|2|||
16919623|NCT01403948|38060922|FG007|Overall Study|Progressive disease|4|||
16919624|NCT01403948|38060923|FG008|Overall Study|Progressive disease|5|||
16919625|NCT01403948|38060924|FG009|Overall Study|Progressive disease|5|||
16919626|NCT01403948|38060915|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
16919627|NCT01403948|38060916|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
16919628|NCT01403948|38060917|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
16919629|NCT01403948|38060918|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
16919630|NCT01403948|38060919|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
16919631|NCT01403948|38060920|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
16919632|NCT01403948|38060921|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
16919633|NCT01403948|38060922|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
16919634|NCT01403948|38060923|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
16919635|NCT01403948|38060924|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
16919636|NCT01403948|38060915|FG000|Overall Study|Lost to Follow-up|0|||
16919637|NCT01403948|38060916|FG001|Overall Study|Lost to Follow-up|0|||
16919638|NCT01403948|38060917|FG002|Overall Study|Lost to Follow-up|0|||
16919639|NCT01403948|38060918|FG003|Overall Study|Lost to Follow-up|0|||
16919640|NCT01403948|38060919|FG004|Overall Study|Lost to Follow-up|0|||
16919641|NCT01403948|38060920|FG005|Overall Study|Lost to Follow-up|0|||
16919642|NCT01403948|38060921|FG006|Overall Study|Lost to Follow-up|0|||
16919643|NCT01403948|38060922|FG007|Overall Study|Lost to Follow-up|0|||
16919644|NCT01403948|38060923|FG008|Overall Study|Lost to Follow-up|0|||
16919645|NCT01403948|38060924|FG009|Overall Study|Lost to Follow-up|1|||
16919646|NCT01403948|38060915|FG000|Overall Study|Refused cont. medication|0|||
17102508|NCT03628924|38241410|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
17102509|NCT03628924|38241411|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
17102510|NCT03628924|38241412|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
17102511|NCT03628924|38241413|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
17102512|NCT03628924|38241414|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
17102513|NCT03628924|38241415|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
17102514|NCT03628924|38241409|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
17102515|NCT03628924|38241410|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
16919647|NCT01403948|38060916|FG001|Overall Study|Refused cont. medication|0|||
16919648|NCT01403948|38060917|FG002|Overall Study|Refused cont. medication|0|||
16919649|NCT01403948|38060918|FG003|Overall Study|Refused cont. medication|0|||
16919650|NCT01403948|38060919|FG004|Overall Study|Refused cont. medication|1|||
16919651|NCT01403948|38060920|FG005|Overall Study|Refused cont. medication|0|||
16919652|NCT01403948|38060921|FG006|Overall Study|Refused cont. medication|0|||
16919653|NCT01403948|38060922|FG007|Overall Study|Refused cont. medication|0|||
16919654|NCT01403948|38060923|FG008|Overall Study|Refused cont. medication|0|||
16919655|NCT01403948|38060924|FG009|Overall Study|Refused cont. medication|1|||
16919656|NCT01403948|38060915|FG000|Overall Study|other than above|1|||
16919657|NCT01403948|38060916|FG001|Overall Study|other than above|2|||
16919658|NCT01403948|38060917|FG002|Overall Study|other than above|1|||
16919659|NCT01403948|38060918|FG003|Overall Study|other than above|0|||
16919660|NCT01403948|38060919|FG004|Overall Study|other than above|1|||
16919661|NCT01403948|38060920|FG005|Overall Study|other than above|1|||
16919662|NCT01403948|38060921|FG006|Overall Study|other than above|2|||
16919663|NCT01403948|38060922|FG007|Overall Study|other than above|0|||
16919664|NCT01403948|38060923|FG008|Overall Study|other than above|0|||
16919665|NCT01403948|38060924|FG009|Overall Study|other than above|0|||
16919666|NCT01404312|38060952|FG000|Overall Study|Death|21|||
16919667|NCT01404312|38060953|FG001|Overall Study|Death|27|||
16919668|NCT01404312|38060952|FG000|Overall Study|Withdrawal by Subject|15|||
16919669|NCT01404312|38060953|FG001|Overall Study|Withdrawal by Subject|18|||
16919670|NCT01404312|38060952|FG000|Overall Study|Participant Unable to get to clinic|93|||
16919671|NCT01404312|38060953|FG001|Overall Study|Participant Unable to get to clinic|103|||
16919672|NCT01404312|38060952|FG000|Overall Study|Lost to Follow-up|115|||
16919673|NCT01404312|38060953|FG001|Overall Study|Lost to Follow-up|111|||
16919674|NCT01404312|38060952|FG000|Overall Study|Site closed|22|||
16919675|NCT01404312|38060953|FG001|Overall Study|Site closed|21|||
16919676|NCT01404312|38060952|FG000|Overall Study|Participant not willing to adhere to req|31|||
16919677|NCT01404312|38060953|FG001|Overall Study|Participant not willing to adhere to req|29|||
16919678|NCT01404312|38060952|FG000|Overall Study|Severe debilitation, unable to continue|1|||
16919679|NCT01404312|38060953|FG001|Overall Study|Severe debilitation, unable to continue|2|||
16919680|NCT01414608|38060962|FG000|Overall Study|Ineligible|5|||
16919681|NCT01414608|38060963|FG001|Overall Study|Ineligible|2|||
16919682|NCT01425008|38060992|FG000|Dose Escalation Phase|Progressive Disease|2|||
16919683|NCT01425008|38060993|FG001|Dose Escalation Phase|Progressive Disease|3|||
16919684|NCT01425008|38060994|FG002|Dose Escalation Phase|Progressive Disease|2|||
16919685|NCT01425008|38060995|FG003|Dose Escalation Phase|Progressive Disease|3|||
16919686|NCT01425008|38060996|FG004|Dose Escalation Phase|Progressive Disease|5|||
16919687|NCT01425008|38060997|FG005|Dose Escalation Phase|Progressive Disease|4|||
16919688|NCT01425008|38060998|FG006|Dose Escalation Phase|Progressive Disease|0|||
16919689|NCT01425008|38060999|FG007|Dose Escalation Phase|Progressive Disease|2|||
16919690|NCT01425008|38061000|FG008|Dose Escalation Phase|Progressive Disease|6|||
16919691|NCT01425008|38061001|FG009|Dose Escalation Phase|Progressive Disease|2|||
16919692|NCT01425008|38061002|FG010|Dose Escalation Phase|Progressive Disease|0|||
16919693|NCT01425008|38061003|FG011|Dose Escalation Phase|Progressive Disease|0|||
16919694|NCT01425008|38061004|FG012|Dose Escalation Phase|Progressive Disease|0|||
16919695|NCT01425008|38061005|FG013|Dose Escalation Phase|Progressive Disease|0|||
16919696|NCT01425008|38061006|FG014|Dose Escalation Phase|Progressive Disease|0|||
16919697|NCT01425008|38061007|FG015|Dose Escalation Phase|Progressive Disease|0|||
16919698|NCT01425008|38061008|FG016|Dose Escalation Phase|Progressive Disease|0|||
16919699|NCT01425008|38061009|FG017|Dose Escalation Phase|Progressive Disease|0|||
16919700|NCT01425008|38061010|FG018|Dose Escalation Phase|Progressive Disease|0|||
16919701|NCT01425008|38060992|FG000|Dose Escalation Phase|Adverse Event|2|||
16919702|NCT01425008|38060993|FG001|Dose Escalation Phase|Adverse Event|0|||
16919703|NCT01425008|38060994|FG002|Dose Escalation Phase|Adverse Event|0|||
16919704|NCT01425008|38060995|FG003|Dose Escalation Phase|Adverse Event|0|||
16919705|NCT01425008|38060996|FG004|Dose Escalation Phase|Adverse Event|0|||
16919706|NCT01425008|38060997|FG005|Dose Escalation Phase|Adverse Event|2|||
16919707|NCT01425008|38060998|FG006|Dose Escalation Phase|Adverse Event|0|||
16919708|NCT01425008|38060999|FG007|Dose Escalation Phase|Adverse Event|0|||
16919709|NCT01425008|38061000|FG008|Dose Escalation Phase|Adverse Event|2|||
16919710|NCT01425008|38061001|FG009|Dose Escalation Phase|Adverse Event|0|||
16919711|NCT01425008|38061002|FG010|Dose Escalation Phase|Adverse Event|0|||
16919712|NCT01425008|38061003|FG011|Dose Escalation Phase|Adverse Event|0|||
16919713|NCT01425008|38061004|FG012|Dose Escalation Phase|Adverse Event|0|||
16919714|NCT01425008|38061005|FG013|Dose Escalation Phase|Adverse Event|0|||
16919715|NCT01425008|38061006|FG014|Dose Escalation Phase|Adverse Event|0|||
16919716|NCT01425008|38061007|FG015|Dose Escalation Phase|Adverse Event|0|||
16919717|NCT01425008|38061008|FG016|Dose Escalation Phase|Adverse Event|0|||
16919718|NCT01425008|38061009|FG017|Dose Escalation Phase|Adverse Event|0|||
16919719|NCT01425008|38061010|FG018|Dose Escalation Phase|Adverse Event|0|||
16919720|NCT01425008|38060992|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
17102516|NCT03628924|38241411|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
16919721|NCT01425008|38060993|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919722|NCT01425008|38060994|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919723|NCT01425008|38060995|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919724|NCT01425008|38060996|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
16919725|NCT01425008|38060997|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919726|NCT01425008|38060998|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
16919727|NCT01425008|38060999|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
16919728|NCT01425008|38061000|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
16919729|NCT01425008|38061001|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919730|NCT01425008|38061002|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919731|NCT01425008|38061003|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919732|NCT01425008|38061004|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919733|NCT01425008|38061005|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919734|NCT01425008|38061006|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919735|NCT01425008|38061007|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919736|NCT01425008|38061008|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919737|NCT01425008|38061009|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919738|NCT01425008|38061010|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16919739|NCT01425008|38060992|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16919740|NCT01425008|38060993|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16919741|NCT01425008|38060994|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16919742|NCT01425008|38060995|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16919743|NCT01425008|38060996|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
16919744|NCT01425008|38060997|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
16919745|NCT01425008|38060998|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
16919746|NCT01425008|38060999|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
16919747|NCT01425008|38061000|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
16919748|NCT01425008|38061001|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
16919749|NCT01425008|38061002|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
16919750|NCT01425008|38061003|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
16919751|NCT01425008|38061004|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
16919752|NCT01425008|38061005|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
16919753|NCT01425008|38061006|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
16919754|NCT01425008|38061007|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
16919755|NCT01425008|38061008|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
16919756|NCT01425008|38061009|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
16845503|NCT01690299|37790334|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
16845504|NCT01690299|37790335|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
16845505|NCT01690299|37790336|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
16845506|NCT01690299|37790337|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
16845507|NCT01690299|37790332|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
16845508|NCT01690299|37790333|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
16845509|NCT01690299|37790334|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
16845510|NCT01690299|37790335|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
16845511|NCT01690299|37790336|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
16845512|NCT01690299|37790337|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
16845513|NCT01690299|37790332|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
16845514|NCT01690299|37790333|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
16845515|NCT01690299|37790334|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
16845516|NCT01690299|37790335|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
16845517|NCT01690299|37790336|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
16845518|NCT01690299|37790337|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
16845519|NCT01690299|37790332|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
16845520|NCT01690299|37790333|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
16845521|NCT01690299|37790334|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
16845522|NCT01690299|37790335|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
16845523|NCT01690299|37790336|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
16845524|NCT01690299|37790337|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
16845525|NCT01690299|37790332|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
16845526|NCT01690299|37790333|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
16845527|NCT01690299|37790334|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
16845528|NCT01690299|37790335|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
16845529|NCT01690299|37790336|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
16845530|NCT01690299|37790337|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
16845531|NCT01690299|37790332|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
16845532|NCT01690299|37790333|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
16845533|NCT01690299|37790334|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
16845534|NCT01690299|37790335|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
16845535|NCT01690299|37790336|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
16845536|NCT01690299|37790337|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
16845537|NCT01690299|37790332|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16845538|NCT01690299|37790333|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16845539|NCT01690299|37790334|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16845540|NCT01690299|37790335|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16845541|NCT01690299|37790336|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16845542|NCT01690299|37790337|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
16845543|NCT01690143|37790366|FG000|Overall Study|Withdrawal by Subject|1|||
16845544|NCT01559259|37790389|FG000|Overall Study|Withdrawal by Subject|0|||
16845545|NCT01559259|37790390|FG001|Overall Study|Withdrawal by Subject|0|||
16845546|NCT01559259|37790391|FG002|Overall Study|Withdrawal by Subject|0|||
16845547|NCT01559259|37790392|FG003|Overall Study|Withdrawal by Subject|1|||
16845548|NCT01559259|37790393|FG004|Overall Study|Withdrawal by Subject|0|||
16845549|NCT01559259|37790389|FG000|Overall Study|Adverse Event|0|||
16845550|NCT01559259|37790390|FG001|Overall Study|Adverse Event|1|||
16845551|NCT01559259|37790391|FG002|Overall Study|Adverse Event|1|||
16845552|NCT01559259|37790392|FG003|Overall Study|Adverse Event|0|||
16845553|NCT01559259|37790393|FG004|Overall Study|Adverse Event|0|||
16845554|NCT01670500|37790417|FG000|Overall Study|Withdrawal by Subject|1|||
16845555|NCT01670500|37790418|FG001|Overall Study|Withdrawal by Subject|0|||
16919757|NCT01425008|38061010|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
16919758|NCT01425008|38060992|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919759|NCT01425008|38060993|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919760|NCT01425008|38060994|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
16919761|NCT01425008|38060995|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919762|NCT01425008|38060996|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919763|NCT01425008|38060997|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919764|NCT01425008|38060998|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919765|NCT01425008|38060999|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919766|NCT01425008|38061000|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
16919767|NCT01425008|38061001|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
16919768|NCT01425008|38061002|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919769|NCT01425008|38061003|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919770|NCT01425008|38061004|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919771|NCT01425008|38061005|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919772|NCT01425008|38061006|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919773|NCT01425008|38061007|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919774|NCT01425008|38061008|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919775|NCT01425008|38061009|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919776|NCT01425008|38061010|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
16919777|NCT01425008|38060992|FG000|Dose Escalation Phase|Other|0|||
16919778|NCT01425008|38060993|FG001|Dose Escalation Phase|Other|0|||
16919779|NCT01425008|38060994|FG002|Dose Escalation Phase|Other|0|||
16919780|NCT01425008|38060995|FG003|Dose Escalation Phase|Other|0|||
16919781|NCT01425008|38060996|FG004|Dose Escalation Phase|Other|0|||
16919782|NCT01425008|38060997|FG005|Dose Escalation Phase|Other|0|||
16919783|NCT01425008|38060998|FG006|Dose Escalation Phase|Other|0|||
16919784|NCT01425008|38060999|FG007|Dose Escalation Phase|Other|0|||
16919785|NCT01425008|38061000|FG008|Dose Escalation Phase|Other|1|||
16919786|NCT01425008|38061001|FG009|Dose Escalation Phase|Other|0|||
16919787|NCT01425008|38061002|FG010|Dose Escalation Phase|Other|0|||
16919788|NCT01425008|38061003|FG011|Dose Escalation Phase|Other|0|||
16919789|NCT01425008|38061004|FG012|Dose Escalation Phase|Other|0|||
16919790|NCT01425008|38061005|FG013|Dose Escalation Phase|Other|0|||
16919791|NCT01425008|38061006|FG014|Dose Escalation Phase|Other|0|||
16919792|NCT01425008|38061007|FG015|Dose Escalation Phase|Other|0|||
16919793|NCT01425008|38061008|FG016|Dose Escalation Phase|Other|0|||
16919794|NCT01425008|38061009|FG017|Dose Escalation Phase|Other|0|||
16919795|NCT01425008|38061010|FG018|Dose Escalation Phase|Other|0|||
16919796|NCT01425008|38060992|FG000|Dose Expansion Phase|Progressive Disease|0|||
16919797|NCT01425008|38060993|FG001|Dose Expansion Phase|Progressive Disease|0|||
16919798|NCT01425008|38060994|FG002|Dose Expansion Phase|Progressive Disease|0|||
16919799|NCT01425008|38060995|FG003|Dose Expansion Phase|Progressive Disease|0|||
16845556|NCT02400736|37790426|FG000|Overall Study|Lost to Follow-up|6|||
16919800|NCT01425008|38060996|FG004|Dose Expansion Phase|Progressive Disease|0|||
16919801|NCT01425008|38060997|FG005|Dose Expansion Phase|Progressive Disease|0|||
16919802|NCT01425008|38060998|FG006|Dose Expansion Phase|Progressive Disease|0|||
16919803|NCT01425008|38060999|FG007|Dose Expansion Phase|Progressive Disease|0|||
16919804|NCT01425008|38061000|FG008|Dose Expansion Phase|Progressive Disease|0|||
16919805|NCT01425008|38061001|FG009|Dose Expansion Phase|Progressive Disease|0|||
16919806|NCT01425008|38061002|FG010|Dose Expansion Phase|Progressive Disease|10|||
16919807|NCT01425008|38061003|FG011|Dose Expansion Phase|Progressive Disease|4|||
16919808|NCT01425008|38061004|FG012|Dose Expansion Phase|Progressive Disease|12|||
16919809|NCT01425008|38061005|FG013|Dose Expansion Phase|Progressive Disease|1|||
16845557|NCT02400736|37790427|FG001|Overall Study|Lost to Follow-up|6|||
16845558|NCT02400736|37790426|FG000|Overall Study|Withdrawal by Subject|2|||
16845559|NCT02400736|37790427|FG001|Overall Study|Withdrawal by Subject|1|||
16845560|NCT02400736|37790426|FG000|Overall Study|Moved from the area|3|||
16845561|NCT02400736|37790427|FG001|Overall Study|Moved from the area|1|||
16845562|NCT01689519|37790439|FG000|Intent to Treat|Death|157|||
16845563|NCT01689519|37790440|FG001|Intent to Treat|Death|167|||
16845564|NCT01689519|37790439|FG000|Intent to Treat|Lost to Follow-up|4|||
16845565|NCT01689519|37790440|FG001|Intent to Treat|Lost to Follow-up|8|||
16845566|NCT01689519|37790439|FG000|Intent to Treat|Other|2|||
16845567|NCT01689519|37790440|FG001|Intent to Treat|Other|4|||
16845568|NCT01689519|37790439|FG000|Intent to Treat|Physician Decision|4|||
16845569|NCT01689519|37790440|FG001|Intent to Treat|Physician Decision|1|||
16845570|NCT01689519|37790439|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
16845571|NCT01689519|37790440|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
16845572|NCT01689519|37790439|FG000|Intent to Treat|Withdrawal by Subject|21|||
16845573|NCT01689519|37790440|FG001|Intent to Treat|Withdrawal by Subject|20|||
16845574|NCT01689519|37790439|FG000|Safety Population|Death|158|||
16919810|NCT01425008|38061006|FG014|Dose Expansion Phase|Progressive Disease|5|||
16919811|NCT01425008|38061007|FG015|Dose Expansion Phase|Progressive Disease|8|||
16919812|NCT01425008|38061008|FG016|Dose Expansion Phase|Progressive Disease|9|||
16919813|NCT01425008|38061009|FG017|Dose Expansion Phase|Progressive Disease|2|||
16919814|NCT01425008|38061010|FG018|Dose Expansion Phase|Progressive Disease|10|||
16919815|NCT01425008|38060992|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
16919816|NCT01425008|38060993|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
16919817|NCT01425008|38060994|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
16919818|NCT01425008|38060995|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
16919819|NCT01425008|38060996|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
16919820|NCT01425008|38060997|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
16919821|NCT01425008|38060998|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
16919822|NCT01425008|38060999|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
16919823|NCT01425008|38061000|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
16919824|NCT01425008|38061001|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
16845575|NCT01689519|37790440|FG001|Safety Population|Death|165|||
16845576|NCT01689519|37790439|FG000|Safety Population|Lost to Follow-up|4|||
16845577|NCT01689519|37790440|FG001|Safety Population|Lost to Follow-up|8|||
16845578|NCT01689519|37790439|FG000|Safety Population|Other|2|||
16845579|NCT01689519|37790440|FG001|Safety Population|Other|4|||
16845580|NCT01689519|37790439|FG000|Safety Population|Physician Decision|4|||
16845581|NCT01689519|37790440|FG001|Safety Population|Physician Decision|1|||
16845582|NCT01689519|37790439|FG000|Safety Population|Study Terminated By Sponsor|60|||
16845583|NCT01689519|37790440|FG001|Safety Population|Study Terminated By Sponsor|47|||
16845584|NCT01689519|37790439|FG000|Safety Population|Withdrawal by Subject|20|||
16845585|NCT01689519|37790440|FG001|Safety Population|Withdrawal by Subject|20|||
16845586|NCT01689363|37790446|FG000|Overall Study|Protocol Violation|0|||
16845587|NCT01689363|37790447|FG001|Overall Study|Protocol Violation|1|||
16845588|NCT01689363|37790448|FG002|Overall Study|Protocol Violation|0|||
16845589|NCT01689363|37790449|FG003|Overall Study|Protocol Violation|0|||
16845590|NCT01689363|37790450|FG004|Overall Study|Protocol Violation|0|||
16845591|NCT01689363|37790451|FG005|Overall Study|Protocol Violation|0|||
16845592|NCT01689363|37790452|FG006|Overall Study|Protocol Violation|0|||
16845593|NCT01689363|37790453|FG007|Overall Study|Protocol Violation|0|||
16845594|NCT01558635|37790469|FG000|Overall Study|Death|1|||
16919825|NCT01425008|38061002|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
16919826|NCT01425008|38061003|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
16919827|NCT01425008|38061004|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
16919828|NCT01425008|38061005|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
16919829|NCT01425008|38061006|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
16919830|NCT01425008|38061007|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
16919831|NCT01425008|38061008|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
16919832|NCT01425008|38061009|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
16919833|NCT01425008|38061010|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
16919834|NCT01425008|38060992|FG000|Dose Expansion Phase|Other|0|||
16919835|NCT01425008|38060993|FG001|Dose Expansion Phase|Other|0|||
16919836|NCT01425008|38060994|FG002|Dose Expansion Phase|Other|0|||
16919837|NCT01425008|38060995|FG003|Dose Expansion Phase|Other|0|||
16919838|NCT01425008|38060996|FG004|Dose Expansion Phase|Other|0|||
16919839|NCT01425008|38060997|FG005|Dose Expansion Phase|Other|0|||
16919840|NCT01425008|38060998|FG006|Dose Expansion Phase|Other|0|||
16919841|NCT01425008|38060999|FG007|Dose Expansion Phase|Other|0|||
16919842|NCT01425008|38061000|FG008|Dose Expansion Phase|Other|0|||
16845595|NCT01558635|37790469|FG000|Overall Study|Withdrawal by Subject|2|||
16919843|NCT01425008|38061001|FG009|Dose Expansion Phase|Other|0|||
16919844|NCT01425008|38061002|FG010|Dose Expansion Phase|Other|0|||
16919845|NCT01425008|38061003|FG011|Dose Expansion Phase|Other|0|||
16919846|NCT01425008|38061004|FG012|Dose Expansion Phase|Other|1|||
16919847|NCT01425008|38061005|FG013|Dose Expansion Phase|Other|0|||
16919848|NCT01425008|38061006|FG014|Dose Expansion Phase|Other|0|||
16919849|NCT01425008|38061007|FG015|Dose Expansion Phase|Other|0|||
16919850|NCT01425008|38061008|FG016|Dose Expansion Phase|Other|2|||
16919851|NCT01425008|38061009|FG017|Dose Expansion Phase|Other|0|||
16919852|NCT01425008|38061010|FG018|Dose Expansion Phase|Other|4|||
16919853|NCT01425008|38060992|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919854|NCT01425008|38060993|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919855|NCT01425008|38060994|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919856|NCT01425008|38060995|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919857|NCT01425008|38060996|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919858|NCT01425008|38060997|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919859|NCT01425008|38060998|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919860|NCT01425008|38060999|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919861|NCT01425008|38061000|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919862|NCT01425008|38061001|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919863|NCT01425008|38061002|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
16919864|NCT01425008|38061003|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
16919865|NCT01425008|38061004|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919866|NCT01425008|38061005|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919867|NCT01425008|38061006|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919868|NCT01425008|38061007|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
16919869|NCT01425008|38061008|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
16919870|NCT01425008|38061009|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
16919871|NCT01425008|38061010|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
16919872|NCT01425008|38060992|FG000|Dose Expansion Phase|Adverse Event|0|||
16919873|NCT01425008|38060993|FG001|Dose Expansion Phase|Adverse Event|0|||
16919874|NCT01425008|38060994|FG002|Dose Expansion Phase|Adverse Event|0|||
16919875|NCT01425008|38060995|FG003|Dose Expansion Phase|Adverse Event|0|||
16919876|NCT01425008|38060996|FG004|Dose Expansion Phase|Adverse Event|0|||
16919877|NCT01425008|38060997|FG005|Dose Expansion Phase|Adverse Event|0|||
16919878|NCT01425008|38060998|FG006|Dose Expansion Phase|Adverse Event|0|||
16919879|NCT01425008|38060999|FG007|Dose Expansion Phase|Adverse Event|0|||
16919880|NCT01425008|38061000|FG008|Dose Expansion Phase|Adverse Event|0|||
16919881|NCT01425008|38061001|FG009|Dose Expansion Phase|Adverse Event|0|||
16919882|NCT01425008|38061002|FG010|Dose Expansion Phase|Adverse Event|2|||
16919883|NCT01425008|38061003|FG011|Dose Expansion Phase|Adverse Event|3|||
16919884|NCT01425008|38061004|FG012|Dose Expansion Phase|Adverse Event|3|||
16919885|NCT01425008|38061005|FG013|Dose Expansion Phase|Adverse Event|0|||
16919886|NCT01425008|38061006|FG014|Dose Expansion Phase|Adverse Event|1|||
16919887|NCT01425008|38061007|FG015|Dose Expansion Phase|Adverse Event|1|||
16919888|NCT01425008|38061008|FG016|Dose Expansion Phase|Adverse Event|5|||
16919889|NCT01425008|38061009|FG017|Dose Expansion Phase|Adverse Event|0|||
16919890|NCT01425008|38061010|FG018|Dose Expansion Phase|Adverse Event|3|||
16919891|NCT01425008|38060992|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
16919892|NCT01425008|38060993|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
16919893|NCT01425008|38060994|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
16919894|NCT01425008|38060995|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
16919895|NCT01425008|38060996|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
16919896|NCT01425008|38060997|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
17017243|NCT00683878|38161844|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
17017244|NCT00884741|38161855|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
17017245|NCT00884741|38161856|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
17017246|NCT00884741|38161857|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
17017247|NCT00884741|38161858|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
17017248|NCT00884741|38161855|FG000|Step 1 Registration: Tissue Screening|Death|3|||
17017249|NCT00884741|38161856|FG001|Step 1 Registration: Tissue Screening|Death|0|||
16919897|NCT01425008|38060998|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
16919898|NCT01425008|38060999|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
16919899|NCT01425008|38061000|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
16919900|NCT01425008|38061001|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
16919901|NCT01425008|38061002|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
16919902|NCT01425008|38061003|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
16919903|NCT01425008|38061004|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
16919904|NCT01425008|38061005|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
16919905|NCT01425008|38061006|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
16919906|NCT01425008|38061007|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
16919907|NCT01425008|38061008|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
16919908|NCT01425008|38061009|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
16919909|NCT01425008|38061010|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
16919910|NCT01425008|38060992|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919911|NCT01425008|38060993|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919912|NCT01425008|38060994|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919913|NCT01425008|38060995|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919914|NCT01425008|38060996|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919915|NCT01425008|38060997|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919916|NCT01425008|38060998|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919917|NCT01425008|38060999|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919918|NCT01425008|38061000|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919919|NCT01425008|38061001|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919920|NCT01425008|38061002|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919921|NCT01425008|38061003|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919922|NCT01425008|38061004|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919923|NCT01425008|38061005|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919924|NCT01425008|38061006|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919925|NCT01425008|38061007|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919926|NCT01425008|38061008|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919927|NCT01425008|38061009|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16919928|NCT01425008|38061010|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
16919929|NCT04425902|38061063|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
16919930|NCT04072146|38061076|FG000|Overall Study|Adverse Event|0|||
16919931|NCT04072146|38061077|FG001|Overall Study|Adverse Event|1|||
16919932|NCT03861481|38061091|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
16919933|NCT03861481|38061092|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
16919934|NCT03861481|38061091|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
16919935|NCT03861481|38061092|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
16919936|NCT03861481|38061091|FG000|Overall Study|Relapse|1|||
16919937|NCT03861481|38061092|FG001|Overall Study|Relapse|0|||
16919938|NCT03861481|38061091|FG000|Overall Study|Withdrawal by Subject|0|||
16919939|NCT03861481|38061092|FG001|Overall Study|Withdrawal by Subject|1|||
16919940|NCT03861481|38061091|FG000|Overall Study|Lack of Efficacy|4|||
16919941|NCT03861481|38061092|FG001|Overall Study|Lack of Efficacy|5|||
16919942|NCT03648476|38061104|FG000|Overall Study|Withdrawal by Subject|2|||
16919943|NCT03648476|38061105|FG001|Overall Study|Withdrawal by Subject|1|||
16919944|NCT01231906|38061118|FG000|Overall Study|Lack of Efficacy|75|||
16919945|NCT01231906|38061119|FG001|Overall Study|Lack of Efficacy|68|||
16919946|NCT01231906|38061118|FG000|Overall Study|Lost to Follow-up|1|||
17017250|NCT00884741|38161857|FG002|Step 1 Registration: Tissue Screening|Death|0|||
17017251|NCT00884741|38161858|FG003|Step 1 Registration: Tissue Screening|Death|0|||
17017252|NCT00884741|38161855|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
17017253|NCT00884741|38161856|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
17017254|NCT00884741|38161857|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
17017255|NCT00884741|38161858|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
17017256|NCT00884741|38161855|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
17017257|NCT00884741|38161856|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
17017258|NCT00884741|38161857|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
17017259|NCT00884741|38161858|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
17017260|NCT00884741|38161855|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
17017261|NCT00884741|38161856|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
17017262|NCT00884741|38161857|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
17017263|NCT00884741|38161858|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
17017264|NCT00884741|38161855|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
17017265|NCT00884741|38161856|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
17017266|NCT00884741|38161857|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
17017267|NCT00884741|38161858|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
17017268|NCT00884741|38161855|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
17017269|NCT00884741|38161856|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
17017270|NCT00884741|38161857|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
17017271|NCT00884741|38161858|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
17017272|NCT00884741|38161855|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
17017273|NCT00884741|38161856|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
17017274|NCT00884741|38161857|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
17017275|NCT00884741|38161858|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
17017276|NCT00884741|38161855|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
17017277|NCT00884741|38161856|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
17017278|NCT00884741|38161857|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
16919947|NCT01231906|38061119|FG001|Overall Study|Lost to Follow-up|0|||
16919948|NCT01231906|38061118|FG000|Overall Study|Physician Decision|34|||
16919949|NCT01231906|38061119|FG001|Overall Study|Physician Decision|24|||
16919950|NCT01231906|38061118|FG000|Overall Study|Withdrawal by Subject|0|||
16919951|NCT01231906|38061119|FG001|Overall Study|Withdrawal by Subject|4|||
16919952|NCT01231906|38061118|FG000|Overall Study|Ineligible|10|||
16919953|NCT01231906|38061119|FG001|Overall Study|Ineligible|3|||
16919954|NCT01231906|38061118|FG000|Overall Study|No treatment|1|||
16919955|NCT01231906|38061119|FG001|Overall Study|No treatment|2|||
16919956|NCT04545060|38061127|FG000|Overall Study|Adverse Event|0|||
16919957|NCT04545060|38061128|FG001|Overall Study|Adverse Event|1|||
16919958|NCT04545060|38061127|FG000|Overall Study|Death|0|||
16919959|NCT04545060|38061128|FG001|Overall Study|Death|5|||
16919960|NCT04545060|38061127|FG000|Overall Study|Lost to Follow-up|10|||
16919961|NCT04545060|38061128|FG001|Overall Study|Lost to Follow-up|13|||
16919962|NCT04545060|38061127|FG000|Overall Study|Physician Decision|3|||
16919963|NCT04545060|38061128|FG001|Overall Study|Physician Decision|0|||
16919964|NCT04545060|38061127|FG000|Overall Study|Withdrawal by Subject|17|||
16919965|NCT04545060|38061128|FG001|Overall Study|Withdrawal by Subject|22|||
16919966|NCT03533660|38061184|FG000|Overall Study|Withdrawal by Subject|2|||
16919967|NCT03533660|38061185|FG001|Overall Study|Withdrawal by Subject|2|||
16919968|NCT03533660|38061184|FG000|Overall Study|Death|2|||
16919969|NCT03533660|38061185|FG001|Overall Study|Death|4|||
16919970|NCT03533660|38061184|FG000|Overall Study|Adverse Event|0|||
16919971|NCT03533660|38061185|FG001|Overall Study|Adverse Event|2|||
16919972|NCT03416127|38061199|FG000|Overall Study|Withdrawal by Subject|0|||
16919973|NCT03416127|38061200|FG001|Overall Study|Withdrawal by Subject|1|||
16919974|NCT03416127|38061201|FG002|Overall Study|Withdrawal by Subject|1|||
16919975|NCT03260140|38061212|FG000|Overall Study|Death|4|||
16919976|NCT03260140|38061213|FG001|Overall Study|Death|1|||
16919977|NCT03260140|38061212|FG000|Overall Study|Withdrawal by Subject|1|||
16919978|NCT03260140|38061213|FG001|Overall Study|Withdrawal by Subject|4|||
16919979|NCT02986334|38061244|FG000|Overall Study|Withdrawal by Subject|0|||
16919980|NCT02986334|38061245|FG001|Overall Study|Withdrawal by Subject|1|||
16919981|NCT02986334|38061246|FG002|Overall Study|Withdrawal by Subject|2|||
16919982|NCT02986334|38061244|FG000|Overall Study|Lost to Follow-up|1|||
16919983|NCT02986334|38061245|FG001|Overall Study|Lost to Follow-up|2|||
16919984|NCT02986334|38061246|FG002|Overall Study|Lost to Follow-up|1|||
16919985|NCT02986334|38061244|FG000|Overall Study|Adverse Event|0|||
16919986|NCT02986334|38061245|FG001|Overall Study|Adverse Event|2|||
16919987|NCT02986334|38061246|FG002|Overall Study|Adverse Event|1|||
16919988|NCT02986334|38061244|FG000|Overall Study|non compliance in phone ratings|2|||
16919989|NCT02986334|38061245|FG001|Overall Study|non compliance in phone ratings|1|||
16919990|NCT02986334|38061246|FG002|Overall Study|non compliance in phone ratings|2|||
16919991|NCT02986334|38061244|FG000|Overall Study|undisclosed comorbidities|0|||
16919992|NCT02986334|38061245|FG001|Overall Study|undisclosed comorbidities|1|||
16845596|NCT01558635|37790469|FG000|Overall Study|Physician Decision|1|||
16845597|NCT01558635|37790469|FG000|Overall Study|Subject received other treatment|1|||
16845598|NCT01558635|37790469|FG000|Overall Study|Reveal XT was explanted|1|||
16845599|NCT00089986|37790483|FG000|Overall Study|Adverse Event|6|||
16919993|NCT02986334|38061246|FG002|Overall Study|undisclosed comorbidities|1|||
16919994|NCT02210221|38061268|FG000|Overall Study|Lack of Efficacy|7|||
16919995|NCT02210221|38061268|FG000|Overall Study|Withdrawal by Subject|43|||
16919996|NCT02124902|38061281|FG000|Overall Study|Adverse Event|7|||
16919997|NCT02124902|38061282|FG001|Overall Study|Adverse Event|2|||
16919998|NCT02124902|38061281|FG000|Overall Study|Went to alternative treatment|4|||
16919999|NCT02124902|38061282|FG001|Overall Study|Went to alternative treatment|0|||
16920000|NCT02124902|38061281|FG000|Overall Study|Withdrawal by Subject|2|||
16920001|NCT02124902|38061282|FG001|Overall Study|Withdrawal by Subject|1|||
16920002|NCT02124902|38061281|FG000|Overall Study|Physician Decision|2|||
16920003|NCT02124902|38061282|FG001|Overall Study|Physician Decision|0|||
16920004|NCT02124902|38061281|FG000|Overall Study|Not eligible|1|||
16845600|NCT00089986|37790484|FG001|Overall Study|Adverse Event|9|||
16845601|NCT00089986|37790485|FG002|Overall Study|Adverse Event|6|||
16845602|NCT00089986|37790483|FG000|Overall Study|Lost to Follow-up|3|||
16845603|NCT00089986|37790484|FG001|Overall Study|Lost to Follow-up|1|||
16845604|NCT00089986|37790485|FG002|Overall Study|Lost to Follow-up|1|||
16845605|NCT00089986|37790483|FG000|Overall Study|Protocol Violation|0|||
16845606|NCT00089986|37790484|FG001|Overall Study|Protocol Violation|1|||
16845607|NCT00089986|37790485|FG002|Overall Study|Protocol Violation|0|||
16845608|NCT00089986|37790483|FG000|Overall Study|Patient transferred to another hospital|2|||
16845609|NCT00089986|37790484|FG001|Overall Study|Patient transferred to another hospital|1|||
16845610|NCT00089986|37790485|FG002|Overall Study|Patient transferred to another hospital|0|||
16845611|NCT00089986|37790483|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
16845612|NCT00089986|37790484|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
16845613|NCT00089986|37790485|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
16845614|NCT00089986|37790483|FG000|Overall Study|Hemohlobin stopping rule|0|||
16845615|NCT00089986|37790484|FG001|Overall Study|Hemohlobin stopping rule|1|||
16845616|NCT00089986|37790485|FG002|Overall Study|Hemohlobin stopping rule|0|||
16920005|NCT02124902|38061282|FG001|Overall Study|Not eligible|0|||
16920006|NCT02124902|38061281|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
16920007|NCT02124902|38061282|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
16845617|NCT00089986|37790483|FG000|Overall Study|Investigator decision to withdrew|0|||
16845618|NCT00089986|37790484|FG001|Overall Study|Investigator decision to withdrew|1|||
16845619|NCT00089986|37790485|FG002|Overall Study|Investigator decision to withdrew|0|||
16845620|NCT00089986|37790483|FG000|Overall Study|Enrollment in another study|0|||
16845621|NCT00089986|37790484|FG001|Overall Study|Enrollment in another study|1|||
16845622|NCT00089986|37790485|FG002|Overall Study|Enrollment in another study|0|||
16845623|NCT00089986|37790483|FG000|Overall Study|Family decision|0|||
16845624|NCT00089986|37790484|FG001|Overall Study|Family decision|1|||
16845625|NCT00089986|37790485|FG002|Overall Study|Family decision|0|||
16845626|NCT00089986|37790483|FG000|Overall Study|Do not resuscitate (DNR)|0|||
16845627|NCT00089986|37790484|FG001|Overall Study|Do not resuscitate (DNR)|0|||
16845628|NCT00089986|37790485|FG002|Overall Study|Do not resuscitate (DNR)|1|||
16845629|NCT00089986|37790483|FG000|Overall Study|Withdrawal by Subject|3|||
16845630|NCT00089986|37790484|FG001|Overall Study|Withdrawal by Subject|6|||
17017279|NCT00884741|38161858|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
17017280|NCT00884741|38161855|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
17017281|NCT00884741|38161856|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
17017282|NCT00884741|38161857|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
17017283|NCT00884741|38161858|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
17017284|NCT00884741|38161855|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
17017285|NCT00884741|38161856|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
17017286|NCT00884741|38161857|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
17017287|NCT00884741|38161858|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
16920008|NCT01940341|38061290|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
16920009|NCT01940341|38061291|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
16920010|NCT01940341|38061290|FG000|Double-Blind Phase|Adverse Event|3|||
16920011|NCT01940341|38061291|FG001|Double-Blind Phase|Adverse Event|2|||
16920012|NCT01940341|38061290|FG000|Double-Blind Phase|Withdrew Consent|3|||
16920013|NCT01940341|38061291|FG001|Double-Blind Phase|Withdrew Consent|2|||
16920014|NCT01940341|38061290|FG000|Double-Blind Phase|Lost to Follow-up|4|||
16920015|NCT01940341|38061291|FG001|Double-Blind Phase|Lost to Follow-up|1|||
16920016|NCT01940341|38061290|FG000|Double-Blind Phase|Pregnancy|0|||
16920017|NCT01940341|38061291|FG001|Double-Blind Phase|Pregnancy|1|||
16920018|NCT01940341|38061290|FG000|Double-Blind Phase|Investigator's Discretion|1|||
16920019|NCT01940341|38061291|FG001|Double-Blind Phase|Investigator's Discretion|0|||
16920020|NCT01940341|38061290|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0|||
16920021|NCT01940341|38061291|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
17017288|NCT00884741|38161855|FG000|Randomization|Protocol Violation|0|||
17017289|NCT00884741|38161856|FG001|Randomization|Protocol Violation|0|||
17017290|NCT00884741|38161857|FG002|Randomization|Protocol Violation|8|||
17017291|NCT00884741|38161858|FG003|Randomization|Protocol Violation|8|||
17017292|NCT00598481|38161865|FG000|Treatment|Physician Decision|1|||
17017293|NCT00880763|38161876|FG000|Extension Period (Part 2)|Adverse Event|0|||
17017294|NCT00880763|38161877|FG001|Extension Period (Part 2)|Adverse Event|0|||
17017295|NCT00880763|38161878|FG002|Extension Period (Part 2)|Adverse Event|1|||
17017296|NCT00880763|38161879|FG003|Extension Period (Part 2)|Adverse Event|1|||
17017297|NCT00880763|38161876|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
17017298|NCT00880763|38161877|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
17017299|NCT00880763|38161878|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
17017300|NCT00880763|38161879|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
17017301|NCT00880763|38161876|FG000|Extension Period (Part 2)|Physician Decision|0|||
17017302|NCT00880763|38161877|FG001|Extension Period (Part 2)|Physician Decision|1|||
17017303|NCT00880763|38161878|FG002|Extension Period (Part 2)|Physician Decision|1|||
17017304|NCT00880763|38161879|FG003|Extension Period (Part 2)|Physician Decision|0|||
17017305|NCT00880763|38161876|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
17017306|NCT00880763|38161877|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
17017307|NCT00880763|38161878|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
17017308|NCT00880763|38161879|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
17017309|NCT00884273|38161891|FG000|Overall Study|Adverse Event|0|||
17017310|NCT00884273|38161892|FG001|Overall Study|Adverse Event|2|||
17017311|NCT00884273|38161891|FG000|Overall Study|Protocol Violation|1|||
16845631|NCT00089986|37790485|FG002|Overall Study|Withdrawal by Subject|2|||
16845632|NCT01689207|37790508|FG000|Overall Study|Adverse Event|0|||
16920022|NCT01940341|38061290|FG000|Double-Blind Phase|Protocol Specified Criteria|1|||
17017312|NCT00884273|38161892|FG001|Overall Study|Protocol Violation|3|||
17017313|NCT00884273|38161891|FG000|Overall Study|Practical reasons|1|||
17017314|NCT00884273|38161892|FG001|Overall Study|Practical reasons|0|||
17017315|NCT00884117|38161898|FG000|Overall Study|Adverse Event|2|||
17017316|NCT00884117|38161898|FG000|Overall Study|Withdrawal by Subject|89|||
17017317|NCT00884117|38161898|FG000|Overall Study|Death|3|||
17017318|NCT00884117|38161898|FG000|Overall Study|Lost to Follow-up|143|||
17017319|NCT00884117|38161898|FG000|Overall Study|Other|12|||
16845633|NCT01689207|37790509|FG001|Overall Study|Adverse Event|1|||
16845634|NCT01689207|37790510|FG002|Overall Study|Adverse Event|0|||
16845635|NCT01689207|37790511|FG003|Overall Study|Adverse Event|0|||
16845636|NCT01689207|37790512|FG004|Overall Study|Adverse Event|2|||
16845637|NCT01689207|37790513|FG005|Overall Study|Adverse Event|1|||
16845638|NCT01689207|37790514|FG006|Overall Study|Adverse Event|0|||
16845639|NCT01689207|37790515|FG007|Overall Study|Adverse Event|0|||
16845640|NCT01689207|37790516|FG008|Overall Study|Adverse Event|1|||
16845641|NCT01689207|37790517|FG009|Overall Study|Adverse Event|0|||
16845642|NCT01689207|37790518|FG010|Overall Study|Adverse Event|0|||
16845643|NCT00089284|37790553|FG000|Overall Study|Adverse event before starting treatment|0|||
16845644|NCT00089284|37790554|FG001|Overall Study|Adverse event before starting treatment|0|||
16845645|NCT00089284|37790555|FG002|Overall Study|Adverse event before starting treatment|0|||
16845646|NCT00089284|37790556|FG003|Overall Study|Adverse event before starting treatment|0|||
16845647|NCT00089284|37790557|FG004|Overall Study|Adverse event before starting treatment|0|||
16845648|NCT00089284|37790558|FG005|Overall Study|Adverse event before starting treatment|0|||
16845649|NCT00089284|37790559|FG006|Overall Study|Adverse event before starting treatment|1|||
16845650|NCT01688973|37790583|FG000|Overall Study|Ineligible|2|||
16845651|NCT01688973|37790584|FG001|Overall Study|Ineligible|3|||
16845652|NCT00087646|37790595|FG000|Overall Study|Adverse Event|37|||
16845653|NCT00087646|37790596|FG001|Overall Study|Adverse Event|6|||
16845654|NCT00087646|37790597|FG002|Overall Study|Adverse Event|18|||
16845655|NCT00087646|37790598|FG003|Overall Study|Adverse Event|20|||
16845656|NCT00087646|37790595|FG000|Overall Study|Death|0|||
16845657|NCT00087646|37790596|FG001|Overall Study|Death|1|||
16845658|NCT00087646|37790597|FG002|Overall Study|Death|0|||
16845659|NCT00087646|37790598|FG003|Overall Study|Death|0|||
16845660|NCT00087646|37790595|FG000|Overall Study|Withdrawal by Subject|6|||
16845661|NCT00087646|37790596|FG001|Overall Study|Withdrawal by Subject|1|||
16845662|NCT00087646|37790597|FG002|Overall Study|Withdrawal by Subject|2|||
16845663|NCT00087646|37790598|FG003|Overall Study|Withdrawal by Subject|2|||
16845664|NCT00087646|37790595|FG000|Overall Study|Insufficient therapeutic response|64|||
16845665|NCT00087646|37790596|FG001|Overall Study|Insufficient therapeutic response|24|||
16845666|NCT00087646|37790597|FG002|Overall Study|Insufficient therapeutic response|38|||
16845667|NCT00087646|37790598|FG003|Overall Study|Insufficient therapeutic response|51|||
16845668|NCT00087646|37790595|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
16845669|NCT00087646|37790596|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
16845670|NCT00087646|37790597|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
16845671|NCT00087646|37790598|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
16845672|NCT00087646|37790595|FG000|Overall Study|Failure to Return|5|||
16845673|NCT00087646|37790596|FG001|Overall Study|Failure to Return|2|||
16845674|NCT00087646|37790597|FG002|Overall Study|Failure to Return|2|||
16845675|NCT00087646|37790598|FG003|Overall Study|Failure to Return|3|||
16920023|NCT01940341|38061291|FG001|Double-Blind Phase|Protocol Specified Criteria|0|||
16920024|NCT01940341|38061290|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269|||
16920025|NCT01940341|38061291|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132|||
16920026|NCT01940341|38061290|FG000|Open-label Extension Phase|Still on Study|4|||
16920027|NCT01940341|38061291|FG001|Open-label Extension Phase|Still on Study|1|||
16920028|NCT01877837|38061299|FG000|Overall Study|Lost to Follow-up|1|||
16920029|NCT01877837|38061299|FG000|Overall Study|Ineligible|4|||
16920030|NCT01624142|38061319|FG000|Overall Study|Withdrawal by Subject|14|||
16920031|NCT01624142|38061320|FG001|Overall Study|Withdrawal by Subject|4|||
16920032|NCT01624142|38061319|FG000|Overall Study|Death|3|||
16920033|NCT01624142|38061320|FG001|Overall Study|Death|6|||
16920034|NCT01624142|38061319|FG000|Overall Study|Study Closure|12|||
16920035|NCT01624142|38061320|FG001|Overall Study|Study Closure|6|||
16920036|NCT01624142|38061319|FG000|Overall Study|Lost to Follow-up|2|||
16920037|NCT01624142|38061320|FG001|Overall Study|Lost to Follow-up|0|||
16920038|NCT01624142|38061319|FG000|Overall Study|Other|1|||
16920039|NCT01624142|38061320|FG001|Overall Study|Other|0|||
16920040|NCT01535807|38061329|FG000|Overall Study|Withdrawal by Subject|1|||
16920041|NCT01535807|38061330|FG001|Overall Study|Withdrawal by Subject|1|||
17017320|NCT00884039|38161917|FG000|Overall Study|Withdrawal by Subject|0|||
17017321|NCT00884039|38161918|FG001|Overall Study|Withdrawal by Subject|1|||
17017322|NCT00884039|38161917|FG000|Overall Study|Lack of Efficacy|2|||
17017323|NCT00884039|38161918|FG001|Overall Study|Lack of Efficacy|0|||
17017324|NCT00835770|38161926|FG000|Overall Study|MS Relapse|17|||
17017325|NCT00835770|38161927|FG001|Overall Study|MS Relapse|23|||
17017326|NCT00835770|38161926|FG000|Overall Study|MS Progression|14|||
17017327|NCT00835770|38161927|FG001|Overall Study|MS Progression|9|||
17017328|NCT00835770|38161926|FG000|Overall Study|Adverse Event|113|||
17017329|NCT00835770|38161927|FG001|Overall Study|Adverse Event|124|||
17017330|NCT00835770|38161926|FG000|Overall Study|Lost to Follow-up|22|||
16845676|NCT00087646|37790595|FG000|Overall Study|Administrative/Other|6|||
16845677|NCT00087646|37790596|FG001|Overall Study|Administrative/Other|1|||
16845678|NCT00087646|37790597|FG002|Overall Study|Administrative/Other|1|||
16920042|NCT01535807|38061329|FG000|Overall Study|Data collection error|1|||
16920043|NCT01535807|38061330|FG001|Overall Study|Data collection error|1|||
16920044|NCT01375764|38061342|FG000|Overall Study|Lost to Follow-up|0|||
16920045|NCT01375764|38061343|FG001|Overall Study|Lost to Follow-up|1|||
16920046|NCT01375764|38061344|FG002|Overall Study|Lost to Follow-up|0|||
16920047|NCT01375764|38061345|FG003|Overall Study|Lost to Follow-up|0|||
16920048|NCT01375764|38061346|FG004|Overall Study|Lost to Follow-up|0|||
16920049|NCT01375764|38061342|FG000|Overall Study|Withdrawal by Subject|2|||
16920050|NCT01375764|38061343|FG001|Overall Study|Withdrawal by Subject|0|||
16920051|NCT01375764|38061344|FG002|Overall Study|Withdrawal by Subject|0|||
16920052|NCT01375764|38061345|FG003|Overall Study|Withdrawal by Subject|0|||
16920053|NCT01375764|38061346|FG004|Overall Study|Withdrawal by Subject|1|||
16920054|NCT01375764|38061342|FG000|Overall Study|Other|0|||
16920055|NCT01375764|38061343|FG001|Overall Study|Other|0|||
16920056|NCT01375764|38061344|FG002|Overall Study|Other|0|||
16920057|NCT01375764|38061345|FG003|Overall Study|Other|1|||
16920058|NCT01375764|38061346|FG004|Overall Study|Other|0|||
16920059|NCT00722046|38061365|FG000|Overall Study|Adverse Event|0|||
16920060|NCT00722046|38061366|FG001|Overall Study|Adverse Event|1|||
16920061|NCT00722046|38061367|FG002|Overall Study|Adverse Event|2|||
16920062|NCT00722046|38061368|FG003|Overall Study|Adverse Event|1|||
16920063|NCT00722046|38061369|FG004|Overall Study|Adverse Event|2|||
16920064|NCT00722046|38061370|FG005|Overall Study|Adverse Event|1|||
16920065|NCT00722046|38061371|FG006|Overall Study|Adverse Event|0|||
16920066|NCT00722046|38061365|FG000|Overall Study|Death|0|||
16920067|NCT00722046|38061366|FG001|Overall Study|Death|1|||
16920068|NCT00722046|38061367|FG002|Overall Study|Death|0|||
16920069|NCT00722046|38061368|FG003|Overall Study|Death|0|||
16920070|NCT00722046|38061369|FG004|Overall Study|Death|0|||
16920071|NCT00722046|38061370|FG005|Overall Study|Death|0|||
16920072|NCT00722046|38061371|FG006|Overall Study|Death|2|||
16920073|NCT00722046|38061365|FG000|Overall Study|Protocol Violation|1|||
16920074|NCT00722046|38061366|FG001|Overall Study|Protocol Violation|0|||
17017331|NCT00835770|38161927|FG001|Overall Study|Lost to Follow-up|19|||
17017332|NCT00835770|38161926|FG000|Overall Study|Consent Withdrawn|144|||
17017333|NCT00835770|38161927|FG001|Overall Study|Consent Withdrawn|156|||
17017334|NCT00835770|38161926|FG000|Overall Study|Investigator Decision|42|||
17017335|NCT00835770|38161927|FG001|Overall Study|Investigator Decision|42|||
17017336|NCT00835770|38161926|FG000|Overall Study|Participant Non-Compliance|11|||
16920075|NCT00722046|38061367|FG002|Overall Study|Protocol Violation|0|||
16920076|NCT00722046|38061368|FG003|Overall Study|Protocol Violation|0|||
16920077|NCT00722046|38061369|FG004|Overall Study|Protocol Violation|0|||
16920078|NCT00722046|38061370|FG005|Overall Study|Protocol Violation|1|||
16920079|NCT00722046|38061371|FG006|Overall Study|Protocol Violation|0|||
16920080|NCT00722046|38061365|FG000|Overall Study|Withdrawal by Subject|3|||
16920081|NCT00722046|38061366|FG001|Overall Study|Withdrawal by Subject|3|||
16920082|NCT00722046|38061367|FG002|Overall Study|Withdrawal by Subject|4|||
16920083|NCT00722046|38061368|FG003|Overall Study|Withdrawal by Subject|4|||
16920084|NCT00722046|38061369|FG004|Overall Study|Withdrawal by Subject|4|||
17017337|NCT00835770|38161927|FG001|Overall Study|Participant Non-Compliance|9|||
17017338|NCT00835770|38161926|FG000|Overall Study|Death|4|||
17017339|NCT00835770|38161927|FG001|Overall Study|Death|6|||
17017340|NCT00835770|38161926|FG000|Overall Study|Other|115|||
17017341|NCT00835770|38161927|FG001|Overall Study|Other|104|||
16920085|NCT00722046|38061370|FG005|Overall Study|Withdrawal by Subject|7|||
16920086|NCT00722046|38061371|FG006|Overall Study|Withdrawal by Subject|3|||
17017342|NCT00835770|38161926|FG000|Overall Study|Other|2|||
17017343|NCT00835770|38161927|FG001|Overall Study|Other|1|||
17017344|NCT00880685|38161939|FG000|Memantine 10mg|Lost to Follow-up|2|||
17017345|NCT00880685|38161939|FG000|Memantine 20mg|Withdrawal by Subject|1|||
17017346|NCT00835380|38161946|FG000|Overall Study|Withdrawal by Subject|2|||
17017347|NCT00880607|38161952|FG000|Overall Study|Physician Decision|2|||
17017348|NCT00880607|38161953|FG001|Overall Study|Physician Decision|2|||
17017349|NCT00880607|38161952|FG000|Overall Study|Protocol Violation|2|||
17017350|NCT00880607|38161953|FG001|Overall Study|Protocol Violation|1|||
17017351|NCT00880607|38161952|FG000|Overall Study|surgery did not extend past L1 level|3|||
17017352|NCT00880607|38161953|FG001|Overall Study|surgery did not extend past L1 level|0|||
17017353|NCT00835068|38161963|FG000|Overall Study|Death|1|||
17017354|NCT00835068|38161964|FG001|Overall Study|Death|0|||
17017355|NCT00835068|38161963|FG000|Overall Study|Adverse Event|0|||
17017356|NCT00835068|38161964|FG001|Overall Study|Adverse Event|1|||
16920087|NCT00722046|38061365|FG000|Overall Study|Randomized, but not treated|1|||
16920088|NCT00722046|38061366|FG001|Overall Study|Randomized, but not treated|1|||
16920089|NCT00722046|38061367|FG002|Overall Study|Randomized, but not treated|0|||
16920090|NCT00722046|38061368|FG003|Overall Study|Randomized, but not treated|2|||
16920091|NCT00722046|38061369|FG004|Overall Study|Randomized, but not treated|0|||
16920092|NCT00722046|38061370|FG005|Overall Study|Randomized, but not treated|0|||
16920093|NCT00722046|38061371|FG006|Overall Study|Randomized, but not treated|0|||
16920094|NCT00722046|38061365|FG000|Overall Study|Other|0|||
16920095|NCT00722046|38061366|FG001|Overall Study|Other|0|||
17017357|NCT00835068|38161963|FG000|Overall Study|Other|8|||
17017358|NCT00835068|38161964|FG001|Overall Study|Other|0|||
16920096|NCT00722046|38061367|FG002|Overall Study|Other|1|||
16920097|NCT00722046|38061368|FG003|Overall Study|Other|1|||
16920098|NCT00722046|38061369|FG004|Overall Study|Other|3|||
16920099|NCT00722046|38061370|FG005|Overall Study|Other|2|||
16920100|NCT00722046|38061371|FG006|Overall Study|Other|1|||
16920101|NCT00614523|38061391|FG000|Overall Study|Adverse Event|4|||
16920102|NCT00614523|38061392|FG001|Overall Study|Adverse Event|20|||
16920103|NCT00614523|38061391|FG000|Overall Study|Death|5|||
16920104|NCT00614523|38061392|FG001|Overall Study|Death|8|||
16920105|NCT00614523|38061391|FG000|Overall Study|Lack of Efficacy|9|||
16920106|NCT00614523|38061392|FG001|Overall Study|Lack of Efficacy|11|||
16920107|NCT00614523|38061391|FG000|Overall Study|Lost to Follow-up|0|||
16920108|NCT00614523|38061392|FG001|Overall Study|Lost to Follow-up|1|||
16920109|NCT00614523|38061391|FG000|Overall Study|Protocol Violation|3|||
16920110|NCT00614523|38061392|FG001|Overall Study|Protocol Violation|2|||
16920111|NCT00614523|38061391|FG000|Overall Study|Withdrawal by Subject|12|||
16920112|NCT00614523|38061392|FG001|Overall Study|Withdrawal by Subject|22|||
16920113|NCT00614523|38061391|FG000|Overall Study|Other|6|||
16920114|NCT00614523|38061392|FG001|Overall Study|Other|11|||
16920115|NCT00614523|38061391|FG000|Overall Study|Ineligibility Determined|1|||
16920116|NCT00614523|38061392|FG001|Overall Study|Ineligibility Determined|2|||
16920117|NCT00614523|38061391|FG000|Overall Study|Disease Progression|0|||
16920118|NCT00614523|38061392|FG001|Overall Study|Disease Progression|8|||
16920119|NCT00614523|38061391|FG000|Overall Study|Administrative Decision|23|||
16920120|NCT00614523|38061392|FG001|Overall Study|Administrative Decision|46|||
16920121|NCT00523341|38061400|FG000|Overall Study|Withdrawal by Subject|399|||
16920122|NCT00523341|38061401|FG001|Overall Study|Withdrawal by Subject|427|||
16920123|NCT00523341|38061400|FG000|Overall Study|Other|181|||
16920124|NCT00523341|38061401|FG001|Overall Study|Other|198|||
16920125|NCT00523341|38061400|FG000|Overall Study|Adverse Event|122|||
16920126|NCT00523341|38061401|FG001|Overall Study|Adverse Event|155|||
16920127|NCT00523341|38061400|FG000|Overall Study|Death|101|||
16920128|NCT00523341|38061401|FG001|Overall Study|Death|110|||
16920129|NCT00523341|38061400|FG000|Overall Study|Lost to Follow-up|73|||
16920130|NCT00523341|38061401|FG001|Overall Study|Lost to Follow-up|61|||
16920131|NCT00523341|38061400|FG000|Overall Study|Non-compliance|20|||
16920132|NCT00523341|38061401|FG001|Overall Study|Non-compliance|13|||
16920133|NCT00523341|38061400|FG000|Overall Study|Physician Decision|14|||
16920134|NCT00523341|38061401|FG001|Overall Study|Physician Decision|13|||
16920135|NCT00523341|38061400|FG000|Overall Study|Requirement for Alternative Therapy|4|||
16920136|NCT00523341|38061401|FG001|Overall Study|Requirement for Alternative Therapy|14|||
16920137|NCT00523341|38061400|FG000|Overall Study|Protocol Deviation|6|||
16920138|NCT00523341|38061401|FG001|Overall Study|Protocol Deviation|5|||
16920139|NCT00523341|38061400|FG000|Overall Study|Ineligibility Determined|3|||
16920140|NCT00523341|38061401|FG001|Overall Study|Ineligibility Determined|4|||
16920141|NCT00523341|38061400|FG000|Overall Study|Disease Progression|1|||
16920142|NCT00523341|38061401|FG001|Overall Study|Disease Progression|0|||
16920143|NCT00364013|38061409|FG000|Overall Study|Ineligibility determined|4|||
16920144|NCT00364013|38061410|FG001|Overall Study|Ineligibility determined|2|||
16920145|NCT00364013|38061409|FG000|Overall Study|Adverse Event|4|||
16920146|NCT00364013|38061410|FG001|Overall Study|Adverse Event|3|||
16920147|NCT00364013|38061409|FG000|Overall Study|Withdrawal by Subject|13|||
16920148|NCT00364013|38061410|FG001|Overall Study|Withdrawal by Subject|18|||
16920149|NCT00364013|38061409|FG000|Overall Study|Physician Decision|3|||
16920150|NCT00364013|38061410|FG001|Overall Study|Physician Decision|3|||
16920151|NCT00364013|38061409|FG000|Overall Study|Lost to Follow-up|10|||
16845679|NCT00087646|37790598|FG003|Overall Study|Administrative/Other|2|||
16920152|NCT00364013|38061410|FG001|Overall Study|Lost to Follow-up|3|||
16845680|NCT00087646|37790595|FG000|Overall Study|Other Protocol Violation|3|||
16845681|NCT00087646|37790596|FG001|Overall Study|Other Protocol Violation|1|||
16845682|NCT00087646|37790597|FG002|Overall Study|Other Protocol Violation|0|||
16845683|NCT00087646|37790598|FG003|Overall Study|Other Protocol Violation|0|||
16845684|NCT00087646|37790595|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
16845685|NCT00087646|37790596|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
16845686|NCT00087646|37790597|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
16845687|NCT00087646|37790598|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
16845688|NCT00087568|37790615|FG000|Overall Study|Adverse Event|4|||
16845689|NCT00087568|37790616|FG001|Overall Study|Adverse Event|0|||
16845690|NCT00087568|37790615|FG000|Overall Study|Withdrawal by Subject|1|||
16845691|NCT00087568|37790616|FG001|Overall Study|Withdrawal by Subject|1|||
16845692|NCT00087568|37790615|FG000|Overall Study|Lost to Follow-up|1|||
16845693|NCT00087568|37790616|FG001|Overall Study|Lost to Follow-up|0|||
16845694|NCT00087568|37790615|FG000|Overall Study|Lack of Efficacy|24|||
16845695|NCT00087568|37790616|FG001|Overall Study|Lack of Efficacy|1|||
16920153|NCT00364013|38061409|FG000|Overall Study|Protocol-specified criteria|6|||
16920154|NCT00364013|38061410|FG001|Overall Study|Protocol-specified criteria|6|||
16920155|NCT00364013|38061409|FG000|Overall Study|Other|41|||
16920156|NCT00364013|38061410|FG001|Overall Study|Other|47|||
16845696|NCT00085540|37790628|FG000|Overall Study|Withdrawal by Subject|0|||
16920157|NCT00364013|38061409|FG000|Overall Study|Ongoing|20|||
16920158|NCT00364013|38061410|FG001|Overall Study|Ongoing|13|||
16920159|NCT00345839|38061422|FG000|Overall Study|Withdrawal by Subject|91|||
16920160|NCT00345839|38061423|FG001|Overall Study|Withdrawal by Subject|98|||
16920161|NCT00345839|38061422|FG000|Overall Study|Lost to Follow-up|58|||
16845697|NCT00085540|37790629|FG001|Overall Study|Withdrawal by Subject|1|||
16845698|NCT00085540|37790628|FG000|Overall Study|Protocol Violation|0|||
16845699|NCT00085540|37790629|FG001|Overall Study|Protocol Violation|1|||
16845700|NCT01688739|37790645|FG000|Overall Study|Administrative Decision|1|||
16845701|NCT01688739|37790646|FG001|Overall Study|Administrative Decision|0|||
16845702|NCT01688739|37790647|FG002|Overall Study|Administrative Decision|0|||
16845703|NCT01688739|37790648|FG003|Overall Study|Administrative Decision|0|||
16845704|NCT01688739|37790649|FG004|Overall Study|Administrative Decision|0|||
16845705|NCT01688739|37790650|FG005|Overall Study|Administrative Decision|0|||
16845706|NCT01688739|37790651|FG006|Overall Study|Administrative Decision|0|||
16845707|NCT01688739|37790652|FG007|Overall Study|Administrative Decision|0|||
16845708|NCT01688739|37790653|FG008|Overall Study|Administrative Decision|0|||
16845709|NCT01688739|37790654|FG009|Overall Study|Administrative Decision|0|||
16845710|NCT00084838|37790684|FG000|Overall Study|Death|1|||
16845711|NCT00084838|37790684|FG000|Overall Study|Adverse Event|2|||
16845712|NCT00084838|37790684|FG000|Overall Study|Withdrawal by Subject|1|||
16845713|NCT00084838|37790684|FG000|Overall Study|Progressive Disease|4|||
16845714|NCT00084838|37790684|FG000|Overall Study|Pt Non-Compliance|1|||
16920162|NCT00345839|38061423|FG001|Overall Study|Lost to Follow-up|61|||
16920163|NCT00330759|38061431|FG000|Overall Study|Death|316|||
16920164|NCT00330759|38061432|FG001|Overall Study|Death|310|||
16920165|NCT00330759|38061431|FG000|Overall Study|Disease progression|104|||
16920166|NCT00330759|38061432|FG001|Overall Study|Disease progression|126|||
16920167|NCT00330759|38061431|FG000|Overall Study|Withdrawal by Subject|143|||
16920168|NCT00330759|38061432|FG001|Overall Study|Withdrawal by Subject|124|||
16920169|NCT00330759|38061431|FG000|Overall Study|Adverse Event|48|||
16920170|NCT00330759|38061432|FG001|Overall Study|Adverse Event|36|||
16920171|NCT00330759|38061431|FG000|Overall Study|Participant request|31|||
16920172|NCT00330759|38061432|FG001|Overall Study|Participant request|22|||
16920173|NCT00330759|38061431|FG000|Overall Study|Lost to Follow-up|16|||
16920174|NCT00330759|38061432|FG001|Overall Study|Lost to Follow-up|22|||
16920175|NCT00330759|38061431|FG000|Overall Study|Noncompliance|15|||
16920176|NCT00330759|38061432|FG001|Overall Study|Noncompliance|17|||
16920177|NCT00330759|38061431|FG000|Overall Study|Physician Decision|1|||
16920178|NCT00330759|38061432|FG001|Overall Study|Physician Decision|2|||
16920179|NCT00330759|38061431|FG000|Overall Study|Protocol deviation|0|||
16920180|NCT00330759|38061432|FG001|Overall Study|Protocol deviation|2|||
16920181|NCT00330759|38061431|FG000|Overall Study|Ineligibility determined|2|||
16920182|NCT00330759|38061432|FG001|Overall Study|Ineligibility determined|1|||
16920183|NCT00330759|38061431|FG000|Overall Study|Other|36|||
16920184|NCT00330759|38061432|FG001|Overall Study|Other|44|||
16920185|NCT00113763|38061440|FG000|Overall Study|Adverse Event|5|||
16920186|NCT00113763|38061441|FG001|Overall Study|Adverse Event|2|||
16920187|NCT00113763|38061440|FG000|Overall Study|Disease Progression|28|||
16920188|NCT00113763|38061441|FG001|Overall Study|Disease Progression|14|||
16845715|NCT00084838|37790684|FG000|Overall Study|Ineligible|4|||
16920189|NCT00113763|38061440|FG000|Overall Study|Lost to Follow-up|10|||
16920190|NCT00113763|38061441|FG001|Overall Study|Lost to Follow-up|0|||
16920191|NCT00113763|38061440|FG000|Overall Study|Withdrawal by Subject|1|||
16920192|NCT00113763|38061441|FG001|Overall Study|Withdrawal by Subject|4|||
16920193|NCT00113763|38061440|FG000|Overall Study|Other|27|||
16920194|NCT00113763|38061441|FG001|Overall Study|Other|6|||
16920195|NCT00113763|38061440|FG000|Overall Study|Non-compliance|1|||
16920196|NCT00113763|38061441|FG001|Overall Study|Non-compliance|0|||
16920197|NCT00113763|38061440|FG000|Overall Study|Ongoing|1|||
16920198|NCT00113763|38061441|FG001|Overall Study|Ongoing|0|||
16845716|NCT01558089|37790690|FG000|Overall Study|Adverse Event|1|||
16845717|NCT01558089|37790690|FG000|Overall Study|Lack of Efficacy|1|||
16845718|NCT01558089|37790690|FG000|Overall Study|Lost to Follow-up|5|||
16845719|NCT01558089|37790690|FG000|Overall Study|Withdrawal by Subject|6|||
16845720|NCT01581021|37790696|FG000|Overall Study|Lost to Follow-up|4|||
16845721|NCT01581021|37790697|FG001|Overall Study|Lost to Follow-up|6|||
16845722|NCT01581021|37790696|FG000|Overall Study|More than 2 hooks in thoracic|3|||
16845723|NCT01581021|37790697|FG001|Overall Study|More than 2 hooks in thoracic|0|||
16845724|NCT01581021|37790696|FG000|Overall Study|Neuromuscular|2|||
16845725|NCT01581021|37790697|FG001|Overall Study|Neuromuscular|1|||
16845726|NCT01581021|37790696|FG000|Overall Study|Not Randomized|1|||
16845727|NCT01581021|37790697|FG001|Overall Study|Not Randomized|2|||
16845728|NCT01581021|37790696|FG000|Overall Study|Lenke 6 Classification|0|||
16845729|NCT01581021|37790697|FG001|Overall Study|Lenke 6 Classification|1|||
17017359|NCT00835068|38161963|FG000|Overall Study|Withdrawal by Subject|1|||
17017360|NCT00835068|38161964|FG001|Overall Study|Withdrawal by Subject|0|||
17017361|NCT00834912|38161976|FG000|Treatment Period 1|Adverse Event|0|||
17017362|NCT00834912|38161977|FG001|Treatment Period 1|Adverse Event|1|||
17017363|NCT00834912|38161978|FG002|Treatment Period 1|Adverse Event|0|||
16845730|NCT01581021|37790696|FG000|Overall Study|Lack of Efficacy|0|||
16845731|NCT01581021|37790697|FG001|Overall Study|Lack of Efficacy|1|||
16845732|NCT00084682|37790703|FG000|Overall Study|Withdrawal by Subject|1|||
16845733|NCT01556997|37790711|FG000|Overall Study|Adverse Event|10|||
16845734|NCT01556997|37790712|FG001|Overall Study|Adverse Event|12|||
16845735|NCT01556997|37790713|FG002|Overall Study|Adverse Event|12|||
16845736|NCT01556997|37790711|FG000|Overall Study|Lost to Follow-up|6|||
16845737|NCT01556997|37790712|FG001|Overall Study|Lost to Follow-up|6|||
16845738|NCT01556997|37790713|FG002|Overall Study|Lost to Follow-up|4|||
16920199|NCT01470326|38061448|FG000|Overall Study|Protocol Violation|32|||
16920200|NCT01470326|38061448|FG000|Overall Study|No Drug Administration Information|2|||
16920201|NCT01470326|38061448|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
16920202|NCT01480180|38061454|FG000|Main Phase|Withdrawal criteria|12|||
16920203|NCT01480180|38061455|FG001|Main Phase|Withdrawal criteria|1|||
16920204|NCT01480180|38061456|FG002|Main Phase|Withdrawal criteria|0|||
16920205|NCT01480180|38061457|FG003|Main Phase|Withdrawal criteria|0|||
16920206|NCT01480180|38061458|FG004|Main Phase|Withdrawal criteria|0|||
16920207|NCT01480180|38061459|FG005|Main Phase|Withdrawal criteria|0|||
16920208|NCT01480180|38061454|FG000|Main Phase|Lack of Efficacy|1|||
16920209|NCT01480180|38061455|FG001|Main Phase|Lack of Efficacy|0|||
16920210|NCT01480180|38061456|FG002|Main Phase|Lack of Efficacy|0|||
16920211|NCT01480180|38061457|FG003|Main Phase|Lack of Efficacy|0|||
16920212|NCT01480180|38061458|FG004|Main Phase|Lack of Efficacy|0|||
16920213|NCT01480180|38061459|FG005|Main Phase|Lack of Efficacy|0|||
16920214|NCT01480180|38061454|FG000|Main Phase|Non-compliance|3|||
16920215|NCT01480180|38061455|FG001|Main Phase|Non-compliance|0|||
16920216|NCT01480180|38061456|FG002|Main Phase|Non-compliance|0|||
16920217|NCT01480180|38061457|FG003|Main Phase|Non-compliance|0|||
16920218|NCT01480180|38061458|FG004|Main Phase|Non-compliance|0|||
16920219|NCT01480180|38061459|FG005|Main Phase|Non-compliance|0|||
16920220|NCT01480180|38061454|FG000|Main Phase|Unclassified|3|||
16920221|NCT01480180|38061455|FG001|Main Phase|Unclassified|0|||
16920222|NCT01480180|38061456|FG002|Main Phase|Unclassified|0|||
16920223|NCT01480180|38061457|FG003|Main Phase|Unclassified|0|||
16920224|NCT01480180|38061458|FG004|Main Phase|Unclassified|0|||
16920225|NCT01480180|38061459|FG005|Main Phase|Unclassified|0|||
16920226|NCT01480180|38061454|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
16920227|NCT01480180|38061455|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
16920228|NCT01480180|38061456|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
16920229|NCT01480180|38061457|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
16920230|NCT01480180|38061458|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
16920231|NCT01480180|38061459|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
16920232|NCT01480180|38061454|FG000|Extension Phase, Part 1|Unclassified|0|||
16920233|NCT01480180|38061455|FG001|Extension Phase, Part 1|Unclassified|0|||
16920234|NCT01480180|38061456|FG002|Extension Phase, Part 1|Unclassified|1|||
16920235|NCT01480180|38061457|FG003|Extension Phase, Part 1|Unclassified|0|||
16845739|NCT01556997|37790711|FG000|Overall Study|Physician Decision|1|||
16845740|NCT01556997|37790712|FG001|Overall Study|Physician Decision|1|||
16845741|NCT01556997|37790713|FG002|Overall Study|Physician Decision|1|||
16920236|NCT01480180|38061458|FG004|Extension Phase, Part 1|Unclassified|0|||
16920237|NCT01480180|38061459|FG005|Extension Phase, Part 1|Unclassified|0|||
16920238|NCT01480180|38061454|FG000|Extension Phase, Part 1|Adverse Event|0|||
16920239|NCT01480180|38061455|FG001|Extension Phase, Part 1|Adverse Event|0|||
16920240|NCT01480180|38061456|FG002|Extension Phase, Part 1|Adverse Event|4|||
16920241|NCT01480180|38061457|FG003|Extension Phase, Part 1|Adverse Event|1|||
16920242|NCT01480180|38061458|FG004|Extension Phase, Part 1|Adverse Event|0|||
16920243|NCT01480180|38061459|FG005|Extension Phase, Part 1|Adverse Event|0|||
16920244|NCT01480180|38061454|FG000|Extension Phase, Part 1|Change of treatment|0|||
16920245|NCT01480180|38061455|FG001|Extension Phase, Part 1|Change of treatment|0|||
16920246|NCT01480180|38061456|FG002|Extension Phase, Part 1|Change of treatment|0|||
16920247|NCT01480180|38061457|FG003|Extension Phase, Part 1|Change of treatment|9|||
16920248|NCT01480180|38061458|FG004|Extension Phase, Part 1|Change of treatment|0|||
16920249|NCT01480180|38061459|FG005|Extension Phase, Part 1|Change of treatment|0|||
16920250|NCT01480180|38061454|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
16920251|NCT01480180|38061455|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
16920252|NCT01480180|38061456|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
16920253|NCT01480180|38061457|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
16920254|NCT01480180|38061458|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
16920255|NCT01480180|38061459|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
16920256|NCT01480180|38061454|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
16920257|NCT01480180|38061455|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
16920258|NCT01480180|38061456|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
16920259|NCT01480180|38061457|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
16920260|NCT01480180|38061458|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
16920261|NCT01480180|38061459|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
16845742|NCT01556997|37790711|FG000|Overall Study|Withdrawal by Subject|7|||
16845743|NCT01556997|37790712|FG001|Overall Study|Withdrawal by Subject|6|||
16920262|NCT01480180|38061454|FG000|Extension Phase, Part 2|Unclassified|0|||
16920263|NCT01480180|38061455|FG001|Extension Phase, Part 2|Unclassified|0|||
16920264|NCT01480180|38061456|FG002|Extension Phase, Part 2|Unclassified|3|||
16920265|NCT01480180|38061457|FG003|Extension Phase, Part 2|Unclassified|1|||
16920266|NCT01480180|38061458|FG004|Extension Phase, Part 2|Unclassified|1|||
16920267|NCT01480180|38061459|FG005|Extension Phase, Part 2|Unclassified|0|||
16920268|NCT01545050|38061495|FG000|Overall Study|Lack of Efficacy|0|||
16920269|NCT01545050|38061496|FG001|Overall Study|Lack of Efficacy|0|||
16920270|NCT01545050|38061497|FG002|Overall Study|Lack of Efficacy|0|||
16920271|NCT01545050|38061498|FG003|Overall Study|Lack of Efficacy|3|||
16920272|NCT01545050|38061499|FG004|Overall Study|Lack of Efficacy|2|||
16920273|NCT01545050|38061495|FG000|Overall Study|Adverse Event|1|||
16920274|NCT01545050|38061496|FG001|Overall Study|Adverse Event|1|||
16920275|NCT01545050|38061497|FG002|Overall Study|Adverse Event|2|||
16920276|NCT01545050|38061498|FG003|Overall Study|Adverse Event|2|||
16920277|NCT01545050|38061499|FG004|Overall Study|Adverse Event|0|||
16845744|NCT01556997|37790713|FG002|Overall Study|Withdrawal by Subject|8|||
16845745|NCT01556997|37790711|FG000|Overall Study|Other|2|||
16845746|NCT01556997|37790712|FG001|Overall Study|Other|3|||
16845747|NCT01556997|37790713|FG002|Overall Study|Other|7|||
16845748|NCT00082888|37790724|FG000|Overall Study|Ineligible|1|||
16920278|NCT01545050|38061495|FG000|Overall Study|Discontinued study treatment|1|||
16920279|NCT01545050|38061496|FG001|Overall Study|Discontinued study treatment|0|||
16920280|NCT01545050|38061497|FG002|Overall Study|Discontinued study treatment|0|||
16920281|NCT01545050|38061498|FG003|Overall Study|Discontinued study treatment|0|||
16920282|NCT01545050|38061499|FG004|Overall Study|Discontinued study treatment|0|||
16920283|NCT01545050|38061495|FG000|Overall Study|Withdrawal by Subject|1|||
16920284|NCT01545050|38061496|FG001|Overall Study|Withdrawal by Subject|0|||
16920285|NCT01545050|38061497|FG002|Overall Study|Withdrawal by Subject|0|||
16920286|NCT01545050|38061498|FG003|Overall Study|Withdrawal by Subject|2|||
16920287|NCT01545050|38061499|FG004|Overall Study|Withdrawal by Subject|1|||
16920288|NCT01545050|38061495|FG000|Overall Study|Participant no longer meets study criteria|0|||
16920289|NCT01545050|38061496|FG001|Overall Study|Participant no longer meets study criteria|2|||
16920290|NCT01545050|38061497|FG002|Overall Study|Participant no longer meets study criteria|0|||
16920291|NCT01545050|38061498|FG003|Overall Study|Participant no longer meets study criteria|0|||
16920292|NCT01545050|38061499|FG004|Overall Study|Participant no longer meets study criteria|1|||
16920293|NCT01545050|38061495|FG000|Overall Study|Administrative reason by sponsor|4|||
16920294|NCT01545050|38061496|FG001|Overall Study|Administrative reason by sponsor|2|||
16920295|NCT01545050|38061497|FG002|Overall Study|Administrative reason by sponsor|3|||
16920296|NCT01545050|38061498|FG003|Overall Study|Administrative reason by sponsor|5|||
16920297|NCT01545050|38061499|FG004|Overall Study|Administrative reason by sponsor|5|||
16920298|NCT01555021|38061526|FG000|Overall Study|Lost to Follow-up|1|||
16920299|NCT01555021|38061527|FG001|Overall Study|Lost to Follow-up|2|||
17017364|NCT00834912|38161979|FG003|Treatment Period 1|Adverse Event|1|||
16920300|NCT04705051|38061539|FG000|Overall Study|Enrolled but not treated|1|||
16920301|NCT04705051|38061539|FG000|Overall Study|Study terminated by sponsor|23|||
16920302|NCT04464421|38061546|FG000|Overall Study|Lost to Follow-up|2|||
16920303|NCT04464421|38061547|FG001|Overall Study|Lost to Follow-up|2|||
16920304|NCT04112784|38061565|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
16920305|NCT04112784|38061565|FG000|Overall Study|Screen Failures|4|||
16920306|NCT04049617|38061575|FG000|Overall Study|Adverse Event|0|||
16920307|NCT04049617|38061576|FG001|Overall Study|Adverse Event|0|||
16920308|NCT04049617|38061577|FG002|Overall Study|Adverse Event|0|||
16920309|NCT04049617|38061578|FG003|Overall Study|Adverse Event|1|||
16920310|NCT04049617|38061579|FG004|Overall Study|Adverse Event|0|||
16920311|NCT04049617|38061580|FG005|Overall Study|Adverse Event|0|||
16920312|NCT04049617|38061575|FG000|Overall Study|Death|0|||
16845749|NCT00082888|37790725|FG001|Overall Study|Ineligible|0|||
16845750|NCT00082888|37790726|FG002|Overall Study|Ineligible|0|||
16845751|NCT00082810|37790735|FG000|Overall Study|Adverse Event|3|||
16845752|NCT00082810|37790735|FG000|Overall Study|Progressive disease|24|||
16845753|NCT00082810|37790735|FG000|Overall Study|Withdrawal by Subject|4|||
16845754|NCT01577745|37790746|FG000|Overall Study|Withdrawal by Subject|0|||
16845755|NCT01577745|37790747|FG001|Overall Study|Withdrawal by Subject|1|||
16845756|NCT01577745|37790748|FG002|Overall Study|Withdrawal by Subject|0|||
16845757|NCT01577745|37790749|FG003|Overall Study|Withdrawal by Subject|3|||
16845758|NCT01577745|37790750|FG004|Overall Study|Withdrawal by Subject|2|||
16845759|NCT01577745|37790751|FG005|Overall Study|Withdrawal by Subject|0|||
16845760|NCT01577745|37790746|FG000|Overall Study|Death|3|||
16845761|NCT01577745|37790747|FG001|Overall Study|Death|2|||
16845762|NCT01577745|37790748|FG002|Overall Study|Death|2|||
16845763|NCT01577745|37790749|FG003|Overall Study|Death|1|||
16845764|NCT01577745|37790750|FG004|Overall Study|Death|1|||
16845765|NCT01577745|37790751|FG005|Overall Study|Death|3|||
16845766|NCT01577745|37790746|FG000|Overall Study|Physician Decision|0|||
16845767|NCT01577745|37790747|FG001|Overall Study|Physician Decision|0|||
16845768|NCT01577745|37790748|FG002|Overall Study|Physician Decision|0|||
16920313|NCT04049617|38061576|FG001|Overall Study|Death|0|||
16920314|NCT04049617|38061577|FG002|Overall Study|Death|0|||
16920315|NCT04049617|38061578|FG003|Overall Study|Death|0|||
16920316|NCT04049617|38061579|FG004|Overall Study|Death|0|||
16920317|NCT04049617|38061580|FG005|Overall Study|Death|1|||
16920318|NCT04049617|38061575|FG000|Overall Study|Lost to Follow-up|0|||
16920319|NCT04049617|38061576|FG001|Overall Study|Lost to Follow-up|0|||
16845769|NCT01577745|37790749|FG003|Overall Study|Physician Decision|1|||
16845770|NCT01577745|37790750|FG004|Overall Study|Physician Decision|1|||
16845771|NCT01577745|37790751|FG005|Overall Study|Physician Decision|0|||
16845772|NCT01577745|37790746|FG000|Overall Study|Lost to Follow-up|0|||
16845773|NCT01577745|37790747|FG001|Overall Study|Lost to Follow-up|0|||
16845774|NCT01577745|37790748|FG002|Overall Study|Lost to Follow-up|0|||
16845775|NCT01577745|37790749|FG003|Overall Study|Lost to Follow-up|0|||
16845776|NCT01577745|37790750|FG004|Overall Study|Lost to Follow-up|0|||
16845777|NCT01577745|37790751|FG005|Overall Study|Lost to Follow-up|1|||
16845778|NCT01577745|37790746|FG000|Overall Study|Alternative Therapy|0|||
16845779|NCT01577745|37790747|FG001|Overall Study|Alternative Therapy|0|||
16920320|NCT04049617|38061577|FG002|Overall Study|Lost to Follow-up|0|||
16920321|NCT04049617|38061578|FG003|Overall Study|Lost to Follow-up|1|||
16920322|NCT04049617|38061579|FG004|Overall Study|Lost to Follow-up|0|||
16920323|NCT04049617|38061580|FG005|Overall Study|Lost to Follow-up|0|||
16920324|NCT04049617|38061575|FG000|Overall Study|Withdrew consent|0|||
16920325|NCT04049617|38061576|FG001|Overall Study|Withdrew consent|0|||
16920326|NCT04049617|38061577|FG002|Overall Study|Withdrew consent|1|||
16920327|NCT04049617|38061578|FG003|Overall Study|Withdrew consent|0|||
16920328|NCT04049617|38061579|FG004|Overall Study|Withdrew consent|0|||
16920329|NCT04049617|38061580|FG005|Overall Study|Withdrew consent|0|||
16920330|NCT03911154|38061596|FG000|Overall Study|Withdrawal by Subject|1|||
16920331|NCT03782064|38061612|FG000|Overall Study|Lack of Efficacy|2|||
16920332|NCT03782064|38061612|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
16920333|NCT03781778|38061618|FG000|Overall Study|Withdrawal by Subject|2|||
16920334|NCT03781778|38061619|FG001|Overall Study|Withdrawal by Subject|2|||
16920335|NCT03710590|38061627|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
16920336|NCT03710590|38061628|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
16920337|NCT03470922|38061689|FG000|Overall Study|Death|107|||
16920338|NCT03470922|38061690|FG001|Overall Study|Death|118|||
16845780|NCT01577745|37790748|FG002|Overall Study|Alternative Therapy|0|||
16845781|NCT01577745|37790749|FG003|Overall Study|Alternative Therapy|1|||
16845782|NCT01577745|37790750|FG004|Overall Study|Alternative Therapy|1|||
16845783|NCT01577745|37790751|FG005|Overall Study|Alternative Therapy|0|||
16920339|NCT03470922|38061689|FG000|Overall Study|Lost to Follow-up|5|||
16920340|NCT03470922|38061690|FG001|Overall Study|Lost to Follow-up|5|||
16920341|NCT03470922|38061689|FG000|Overall Study|Participant Withdrew Consent|4|||
16920342|NCT03470922|38061690|FG001|Overall Study|Participant Withdrew Consent|9|||
16920343|NCT03470922|38061689|FG000|Overall Study|Other reasons|1|||
16920344|NCT03470922|38061690|FG001|Overall Study|Other reasons|0|||
16920345|NCT03470922|38061689|FG000|Overall Study|Not reported|1|||
16920346|NCT03470922|38061690|FG001|Overall Study|Not reported|0|||
16920347|NCT03465722|38061698|FG000|Overall Study|Withdrawal by Subject|21|||
16920348|NCT03465722|38061699|FG001|Overall Study|Withdrawal by Subject|14|||
16920349|NCT03465722|38061698|FG000|Overall Study|Death|89|||
16920350|NCT03465722|38061699|FG001|Overall Study|Death|87|||
16920351|NCT03465722|38061698|FG000|Overall Study|Lost to Follow-up|5|||
16920352|NCT03465722|38061699|FG001|Overall Study|Lost to Follow-up|3|||
16920353|NCT03465722|38061698|FG000|Overall Study|Administrative/Other|33|||
16920354|NCT03465722|38061699|FG001|Overall Study|Administrative/Other|32|||
16920355|NCT03465722|38061698|FG000|Overall Study|Not treated|1|||
16920356|NCT03465722|38061699|FG001|Overall Study|Not treated|2|||
16920357|NCT03465722|38061698|FG000|Overall Study|Sponsor decision|91|||
16920358|NCT03465722|38061699|FG001|Overall Study|Sponsor decision|98|||
16920359|NCT03205423|38061705|FG000|Overall Study|Personal|1|||
16920360|NCT03205423|38061706|FG001|Overall Study|Personal|1|||
16920361|NCT03205423|38061705|FG000|Overall Study|Physician Decision|0|||
16920362|NCT03205423|38061706|FG001|Overall Study|Physician Decision|2|||
16845784|NCT00080938|37790770|FG000|Overall Study|Adverse Event|3|||
16845785|NCT00080938|37790770|FG000|Overall Study|Withdrawal by Subject|6|||
16920363|NCT03104400|38061717|FG000|Overall Study|Adverse Event|5|||
16920364|NCT03104400|38061718|FG001|Overall Study|Adverse Event|7|||
16920365|NCT03104400|38061719|FG002|Overall Study|Adverse Event|11|||
16920366|NCT03104400|38061720|FG003|Overall Study|Adverse Event|9|||
16920367|NCT03104400|38061721|FG004|Overall Study|Adverse Event|21|||
16920368|NCT03104400|38061717|FG000|Overall Study|Withdrawal by Subject|17|||
16920369|NCT03104400|38061718|FG001|Overall Study|Withdrawal by Subject|19|||
16920370|NCT03104400|38061719|FG002|Overall Study|Withdrawal by Subject|29|||
16920371|NCT03104400|38061720|FG003|Overall Study|Withdrawal by Subject|25|||
16920372|NCT03104400|38061721|FG004|Overall Study|Withdrawal by Subject|24|||
16920373|NCT03104400|38061717|FG000|Overall Study|Lost to Follow-up|4|||
16920374|NCT03104400|38061718|FG001|Overall Study|Lost to Follow-up|1|||
16920375|NCT03104400|38061719|FG002|Overall Study|Lost to Follow-up|4|||
16920376|NCT03104400|38061720|FG003|Overall Study|Lost to Follow-up|8|||
16920377|NCT03104400|38061721|FG004|Overall Study|Lost to Follow-up|7|||
16920378|NCT03104400|38061717|FG000|Overall Study|Lack of Efficacy|6|||
16920379|NCT03104400|38061718|FG001|Overall Study|Lack of Efficacy|3|||
16920380|NCT03104400|38061719|FG002|Overall Study|Lack of Efficacy|8|||
16920381|NCT03104400|38061720|FG003|Overall Study|Lack of Efficacy|2|||
16920382|NCT03104400|38061721|FG004|Overall Study|Lack of Efficacy|1|||
16920383|NCT03104400|38061717|FG000|Overall Study|COVID Logistical Restrictions|0|||
16920384|NCT03104400|38061718|FG001|Overall Study|COVID Logistical Restrictions|0|||
16920385|NCT03104400|38061719|FG002|Overall Study|COVID Logistical Restrictions|0|||
16920386|NCT03104400|38061720|FG003|Overall Study|COVID Logistical Restrictions|1|||
16920387|NCT03104400|38061721|FG004|Overall Study|COVID Logistical Restrictions|0|||
16845786|NCT00080938|37790770|FG000|Overall Study|Death|2|||
16845787|NCT00080938|37790770|FG000|Overall Study|Lack of Efficacy|7|||
16845788|NCT00080938|37790770|FG000|Overall Study|other disease|1|||
16845789|NCT00080938|37790770|FG000|Overall Study|Not started protocol therapy|1|||
16845790|NCT00080938|37790770|FG000|Overall Study|Ineligible|4|||
16845791|NCT01688037|37790777|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
16845792|NCT01688037|37790778|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
16845793|NCT01688037|37790779|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
16845794|NCT01688037|37790777|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
16845795|NCT01688037|37790778|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
16845796|NCT01688037|37790779|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
16845797|NCT01688037|37790777|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
16845798|NCT01688037|37790778|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
16845799|NCT01688037|37790779|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
16845800|NCT01688037|37790777|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
16845801|NCT01688037|37790778|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
16845802|NCT01688037|37790779|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
16845803|NCT01688037|37790777|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
16845804|NCT01688037|37790778|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
16845805|NCT01688037|37790779|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
16845806|NCT01688037|37790777|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
16845807|NCT01688037|37790778|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
16845808|NCT01688037|37790779|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
16845809|NCT01688037|37790777|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
16845810|NCT01688037|37790778|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
16845811|NCT01688037|37790779|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
16845812|NCT01688037|37790777|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
16845813|NCT01688037|37790778|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
16845814|NCT01688037|37790779|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
16845815|NCT01688037|37790777|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
16845816|NCT01688037|37790778|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
16845817|NCT01688037|37790779|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
16845818|NCT01688037|37790777|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
16845819|NCT01688037|37790778|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
16845820|NCT01688037|37790779|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
16845821|NCT01610336|37790812|FG000|Overall Study|Progressive Disease|4|||
16845822|NCT01610336|37790813|FG001|Overall Study|Progressive Disease|6|||
16845823|NCT01610336|37790814|FG002|Overall Study|Progressive Disease|6|||
16845824|NCT01610336|37790815|FG003|Overall Study|Progressive Disease|5|||
16845825|NCT01610336|37790816|FG004|Overall Study|Progressive Disease|3|||
16845826|NCT01610336|37790817|FG005|Overall Study|Progressive Disease|10|||
16845827|NCT01610336|37790818|FG006|Overall Study|Progressive Disease|1|||
16845828|NCT01610336|37790819|FG007|Overall Study|Progressive Disease|6|||
16845829|NCT01610336|37790820|FG008|Overall Study|Progressive Disease|6|||
16845830|NCT01610336|37790821|FG009|Overall Study|Progressive Disease|40|||
16845831|NCT01610336|37790822|FG010|Overall Study|Progressive Disease|36|||
16845832|NCT01610336|37790812|FG000|Overall Study|Adverse Event|0|||
16845833|NCT01610336|37790813|FG001|Overall Study|Adverse Event|0|||
16845834|NCT01610336|37790814|FG002|Overall Study|Adverse Event|0|||
16845835|NCT01610336|37790815|FG003|Overall Study|Adverse Event|1|||
16845836|NCT01610336|37790816|FG004|Overall Study|Adverse Event|1|||
16845837|NCT01610336|37790817|FG005|Overall Study|Adverse Event|1|||
16845838|NCT01610336|37790818|FG006|Overall Study|Adverse Event|0|||
16845839|NCT01610336|37790819|FG007|Overall Study|Adverse Event|0|||
16920388|NCT03104400|38061717|FG000|Overall Study|Other|2|||
16845840|NCT01610336|37790820|FG008|Overall Study|Adverse Event|2|||
16845841|NCT01610336|37790821|FG009|Overall Study|Adverse Event|8|||
16920389|NCT03104400|38061718|FG001|Overall Study|Other|3|||
16920390|NCT03104400|38061719|FG002|Overall Study|Other|7|||
16920391|NCT03104400|38061720|FG003|Overall Study|Other|6|||
16920392|NCT03104400|38061721|FG004|Overall Study|Other|4|||
16920393|NCT03104400|38061717|FG000|Overall Study|Other|0|||
16920394|NCT03104400|38061718|FG001|Overall Study|Other|1|||
16920395|NCT03104400|38061719|FG002|Overall Study|Other|0|||
16920396|NCT03104400|38061720|FG003|Overall Study|Other|0|||
16920397|NCT03104400|38061721|FG004|Overall Study|Other|0|||
16920398|NCT03104374|38061738|FG000|Overall Study|Adverse Event|7|||
16920399|NCT03104374|38061739|FG001|Overall Study|Adverse Event|6|||
16920400|NCT03104374|38061740|FG002|Overall Study|Adverse Event|12|||
16920401|NCT03104374|38061741|FG003|Overall Study|Adverse Event|15|||
16920402|NCT03104374|38061738|FG000|Overall Study|Withdrawal by Subject|18|||
16920403|NCT03104374|38061739|FG001|Overall Study|Withdrawal by Subject|10|||
16920404|NCT03104374|38061740|FG002|Overall Study|Withdrawal by Subject|10|||
16920405|NCT03104374|38061741|FG003|Overall Study|Withdrawal by Subject|17|||
16920406|NCT03104374|38061738|FG000|Overall Study|Lost to Follow-up|4|||
16920407|NCT03104374|38061739|FG001|Overall Study|Lost to Follow-up|4|||
16920408|NCT03104374|38061740|FG002|Overall Study|Lost to Follow-up|6|||
16920409|NCT03104374|38061741|FG003|Overall Study|Lost to Follow-up|8|||
16920410|NCT03104374|38061738|FG000|Overall Study|Lack of Efficacy|6|||
16920411|NCT03104374|38061739|FG001|Overall Study|Lack of Efficacy|7|||
16920412|NCT03104374|38061740|FG002|Overall Study|Lack of Efficacy|12|||
16920413|NCT03104374|38061741|FG003|Overall Study|Lack of Efficacy|6|||
16920414|NCT03104374|38061738|FG000|Overall Study|Other|2|||
16920415|NCT03104374|38061739|FG001|Overall Study|Other|2|||
16920416|NCT03104374|38061740|FG002|Overall Study|Other|4|||
16920417|NCT03104374|38061741|FG003|Overall Study|Other|7|||
16920418|NCT03073603|38061753|FG000|Overall Study|Noncompliance|3|||
16920419|NCT03073603|38061754|FG001|Overall Study|Noncompliance|1|||
16920420|NCT03073603|38061753|FG000|Overall Study|Adverse Event|5|||
16920421|NCT03073603|38061754|FG001|Overall Study|Adverse Event|3|||
16920422|NCT03073603|38061753|FG000|Overall Study|Physician Decision|1|||
16920423|NCT03073603|38061754|FG001|Overall Study|Physician Decision|2|||
16920424|NCT03073603|38061753|FG000|Overall Study|Required treatment not allowed by protocol|1|||
16920425|NCT03073603|38061754|FG001|Overall Study|Required treatment not allowed by protocol|0|||
16920426|NCT03073603|38061753|FG000|Overall Study|Financial or insurance-related|8|||
16920427|NCT03073603|38061754|FG001|Overall Study|Financial or insurance-related|0|||
16920428|NCT03073603|38061753|FG000|Overall Study|Withdrawal by Subject|0|||
16920429|NCT03073603|38061754|FG001|Overall Study|Withdrawal by Subject|1|||
16920430|NCT03073603|38061753|FG000|Overall Study|Discontinued DMT|4|||
16920431|NCT03073603|38061754|FG001|Overall Study|Discontinued DMT|0|||
16920432|NCT03073603|38061753|FG000|Overall Study|Restarted DMT|0|||
16920433|NCT03073603|38061754|FG001|Overall Study|Restarted DMT|1|||
16920434|NCT03002155|38061766|FG000|Overall Study|Lost to Follow-up|1|||
16920435|NCT03002155|38061767|FG001|Overall Study|Lost to Follow-up|2|||
16920436|NCT03002155|38061766|FG000|Overall Study|Withdrawal by Subject|1|||
16920437|NCT03002155|38061767|FG001|Overall Study|Withdrawal by Subject|0|||
16920438|NCT03002155|38061766|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
16920439|NCT03002155|38061767|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
16920440|NCT02918006|38061790|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
16920441|NCT02918006|38061791|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
16920442|NCT02918006|38061792|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
16920443|NCT02918006|38061790|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
16920444|NCT02918006|38061791|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
16920445|NCT02918006|38061792|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
16920446|NCT02918006|38061790|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
16845842|NCT01610336|37790822|FG010|Overall Study|Adverse Event|6|||
16845843|NCT01610336|37790812|FG000|Overall Study|Subject/Guardian decision|1|||
16845844|NCT01610336|37790813|FG001|Overall Study|Subject/Guardian decision|1|||
16845845|NCT01610336|37790814|FG002|Overall Study|Subject/Guardian decision|0|||
16845846|NCT01610336|37790815|FG003|Overall Study|Subject/Guardian decision|1|||
16845847|NCT01610336|37790816|FG004|Overall Study|Subject/Guardian decision|0|||
16845848|NCT01610336|37790817|FG005|Overall Study|Subject/Guardian decision|0|||
16845849|NCT01610336|37790818|FG006|Overall Study|Subject/Guardian decision|0|||
16845850|NCT01610336|37790819|FG007|Overall Study|Subject/Guardian decision|1|||
16920447|NCT02918006|38061791|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
16920448|NCT02918006|38061792|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
16920449|NCT02918006|38061790|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
16920450|NCT02918006|38061791|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
16920451|NCT02918006|38061792|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
16920452|NCT02918006|38061790|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
16845851|NCT01610336|37790820|FG008|Overall Study|Subject/Guardian decision|0|||
16920453|NCT02918006|38061791|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
16920454|NCT02918006|38061792|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
16920455|NCT02918006|38061790|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
16920456|NCT02918006|38061791|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
16920457|NCT02918006|38061792|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
16920458|NCT02918006|38061790|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
16920459|NCT02918006|38061791|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
16920460|NCT02918006|38061792|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
16920461|NCT02918006|38061790|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
16920462|NCT02918006|38061791|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
16920463|NCT02918006|38061792|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
16920464|NCT02918006|38061790|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
16920465|NCT02918006|38061791|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
16920466|NCT02918006|38061792|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
16920467|NCT02658487|38061817|FG000|Overall Study|Death|2|||
16920468|NCT02658487|38061817|FG000|Overall Study|Disease progression|10|||
16920469|NCT02658487|38061817|FG000|Overall Study|Alternative therapy|1|||
16920470|NCT02658487|38061817|FG000|Overall Study|Adverse Event|1|||
16920471|NCT02658487|38061817|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
16920472|NCT02658487|38061817|FG000|Overall Study|Refractory AML|1|||
16920473|NCT02179749|38061846|FG000|Overall Study|Adverse Event|0|||
16920474|NCT02179749|38061847|FG001|Overall Study|Adverse Event|0|||
16920475|NCT02179749|38061848|FG002|Overall Study|Adverse Event|1|||
16920476|NCT02179749|38061846|FG000|Overall Study|Withdrawal by Subject|0|||
16920477|NCT02179749|38061847|FG001|Overall Study|Withdrawal by Subject|0|||
16920478|NCT02179749|38061848|FG002|Overall Study|Withdrawal by Subject|1|||
16920479|NCT02075593|38061859|FG000|Overall Study|Withdrawal by Subject|1|||
16920480|NCT00700882|38061892|FG000|Overall Study|Never received treatment|6|||
16920481|NCT00700882|38061892|FG000|Overall Study|Ineligible|2|||
16920482|NCT00700882|38061892|FG000|Overall Study|No KIT mutation|51|||
16920483|NCT00641186|38061896|FG000|Overall Study|Adverse Event|3|||
16920484|NCT01595009|38061902|FG000|Core|Patients completed per protocol|85|||
16920485|NCT01595009|38061903|FG001|Core|Patients completed per protocol|44|||
16920486|NCT01595009|38061904|FG002|Core|Patients completed per protocol|0|||
16920487|NCT01595009|38061905|FG003|Core|Patients completed per protocol|0|||
16920488|NCT01595009|38061902|FG000|Core|Adverse Event|19|||
16920489|NCT01595009|38061903|FG001|Core|Adverse Event|23|||
16920490|NCT01595009|38061904|FG002|Core|Adverse Event|0|||
16920491|NCT01595009|38061905|FG003|Core|Adverse Event|0|||
16920492|NCT01595009|38061902|FG000|Core|Disease progression|14|||
16920493|NCT01595009|38061903|FG001|Core|Disease progression|26|||
16920494|NCT01595009|38061904|FG002|Core|Disease progression|0|||
16920495|NCT01595009|38061905|FG003|Core|Disease progression|0|||
16920496|NCT01595009|38061902|FG000|Core|Withdrawal by Subject|4|||
16920497|NCT01595009|38061903|FG001|Core|Withdrawal by Subject|17|||
16920498|NCT01595009|38061904|FG002|Core|Withdrawal by Subject|0|||
16920499|NCT01595009|38061905|FG003|Core|Withdrawal by Subject|0|||
16920500|NCT01595009|38061902|FG000|Core|Death|3|||
16920501|NCT01595009|38061903|FG001|Core|Death|6|||
16920502|NCT01595009|38061904|FG002|Core|Death|0|||
16920503|NCT01595009|38061905|FG003|Core|Death|0|||
16920504|NCT01595009|38061902|FG000|Core|Lost to Follow-up|1|||
16920505|NCT01595009|38061903|FG001|Core|Lost to Follow-up|2|||
16920506|NCT01595009|38061904|FG002|Core|Lost to Follow-up|0|||
16920507|NCT01595009|38061905|FG003|Core|Lost to Follow-up|0|||
16920508|NCT01595009|38061902|FG000|Core|Protocol deviation|0|||
16920509|NCT01595009|38061903|FG001|Core|Protocol deviation|1|||
16920510|NCT01595009|38061904|FG002|Core|Protocol deviation|0|||
16920511|NCT01595009|38061905|FG003|Core|Protocol deviation|0|||
16920512|NCT01595009|38061902|FG000|Core|Administrative problems|0|||
16920513|NCT01595009|38061903|FG001|Core|Administrative problems|1|||
16920514|NCT01595009|38061904|FG002|Core|Administrative problems|0|||
16920515|NCT01595009|38061905|FG003|Core|Administrative problems|0|||
16920516|NCT01595009|38061902|FG000|Extension|Administrative problems|0|||
16920517|NCT01595009|38061903|FG001|Extension|Administrative problems|0|||
16920518|NCT01595009|38061904|FG002|Extension|Administrative problems|0|||
16920519|NCT01595009|38061905|FG003|Extension|Administrative problems|1|||
16920520|NCT01595009|38061902|FG000|Extension|Patients completed per protocol|0|||
16920521|NCT01595009|38061903|FG001|Extension|Patients completed per protocol|0|||
16920522|NCT01595009|38061904|FG002|Extension|Patients completed per protocol|0|||
16920523|NCT01595009|38061905|FG003|Extension|Patients completed per protocol|2|||
16920524|NCT01595009|38061902|FG000|Extension|Disease progression|0|||
16920525|NCT01595009|38061903|FG001|Extension|Disease progression|0|||
16920526|NCT01595009|38061904|FG002|Extension|Disease progression|4|||
16920527|NCT01595009|38061905|FG003|Extension|Disease progression|7|||
16920528|NCT01595009|38061902|FG000|Extension|Adverse Event|0|||
16920529|NCT01595009|38061903|FG001|Extension|Adverse Event|0|||
16920530|NCT01595009|38061904|FG002|Extension|Adverse Event|0|||
16920531|NCT01595009|38061905|FG003|Extension|Adverse Event|1|||
16920532|NCT05553808|38061922|FG000|Overall Study|Death|25|||
16920533|NCT05553808|38061923|FG001|Overall Study|Death|62|||
16920534|NCT05553808|38061922|FG000|Overall Study|Site Closed|6|||
16920535|NCT05553808|38061923|FG001|Overall Study|Site Closed|6|||
16920536|NCT05553808|38061922|FG000|Overall Study|Lost to Follow-up|1|||
16920537|NCT05553808|38061923|FG001|Overall Study|Lost to Follow-up|0|||
16920538|NCT05553808|38061922|FG000|Overall Study|Withdrawal by Subject|3|||
16920539|NCT05553808|38061923|FG001|Overall Study|Withdrawal by Subject|2|||
16920540|NCT04997161|38061939|FG000|Overall Study|Study terminated by sponsor|3|||
16920541|NCT04753216|38061947|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
16920542|NCT04753216|38061947|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
16920543|NCT04753216|38061947|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
16920544|NCT04530747|38061980|FG000|Overall Study|Withdrawal by Subject|1|||
16920545|NCT04530747|38061981|FG001|Overall Study|Withdrawal by Subject|0|||
16920546|NCT04040751|38062002|FG000|Overall Study|Withdrawal by Subject|2|||
16920547|NCT04040751|38062003|FG001|Overall Study|Withdrawal by Subject|0|||
16920548|NCT04040751|38062004|FG002|Overall Study|Withdrawal by Subject|2|||
16920549|NCT04040751|38062005|FG003|Overall Study|Withdrawal by Subject|0|||
16920550|NCT04003103|38062018|FG000|Overall Study|Death|1|||
16920551|NCT04003103|38062019|FG001|Overall Study|Death|0|||
16920552|NCT04003103|38062020|FG002|Overall Study|Death|0|||
16920553|NCT04003103|38062018|FG000|Overall Study|Lost to Follow-up|4|||
16920554|NCT04003103|38062019|FG001|Overall Study|Lost to Follow-up|3|||
16920555|NCT04003103|38062020|FG002|Overall Study|Lost to Follow-up|2|||
16920556|NCT04003103|38062018|FG000|Overall Study|Withdrawal by Subject|10|||
16920557|NCT04003103|38062019|FG001|Overall Study|Withdrawal by Subject|1|||
16920558|NCT04003103|38062020|FG002|Overall Study|Withdrawal by Subject|1|||
16920559|NCT04003103|38062018|FG000|Overall Study|Status not recorded|0|||
16920560|NCT04003103|38062019|FG001|Overall Study|Status not recorded|2|||
16920561|NCT04003103|38062020|FG002|Overall Study|Status not recorded|0|||
16920562|NCT03997916|38062028|FG000|Overall Study|Protocol Violation|35|||
16920563|NCT03596177|38062066|FG000|Single Blind Period|Withdrawal by Subject|1|||
16920564|NCT03596177|38062067|FG001|Single Blind Period|Withdrawal by Subject|1|||
16920565|NCT03596177|38062066|FG000|Single Blind Period|Other|1|||
16920566|NCT03596177|38062067|FG001|Single Blind Period|Other|0|||
16920567|NCT03596177|38062066|FG000|Double Blind Period|Withdrawal by Subject|0|||
16920568|NCT03596177|38062067|FG001|Double Blind Period|Withdrawal by Subject|1|||
16920569|NCT03596177|38062066|FG000|Double Blind Period|Other|0|||
16920570|NCT03596177|38062067|FG001|Double Blind Period|Other|4|||
16920571|NCT03596177|38062066|FG000|Double Blind Period|Death during safety follow-up|0|||
16920572|NCT03596177|38062067|FG001|Double Blind Period|Death during safety follow-up|1|||
16920573|NCT03579459|38062077|FG000|Overall Study|Adverse Event|7|||
16920574|NCT03579459|38062078|FG001|Overall Study|Adverse Event|6|||
16920575|NCT03579459|38062079|FG002|Overall Study|Adverse Event|2|||
16920576|NCT03579459|38062080|FG003|Overall Study|Adverse Event|6|||
16920577|NCT03579459|38062077|FG000|Overall Study|Death|1|||
16920578|NCT03579459|38062078|FG001|Overall Study|Death|0|||
16920579|NCT03579459|38062079|FG002|Overall Study|Death|1|||
16920580|NCT03579459|38062080|FG003|Overall Study|Death|2|||
16920581|NCT03579459|38062077|FG000|Overall Study|Lost to Follow-up|6|||
16920582|NCT03579459|38062078|FG001|Overall Study|Lost to Follow-up|2|||
16920583|NCT03579459|38062079|FG002|Overall Study|Lost to Follow-up|4|||
16920584|NCT03579459|38062080|FG003|Overall Study|Lost to Follow-up|1|||
16920585|NCT03579459|38062077|FG000|Overall Study|Physician Decision|0|||
16920586|NCT03579459|38062078|FG001|Overall Study|Physician Decision|1|||
16920587|NCT03579459|38062079|FG002|Overall Study|Physician Decision|0|||
16920588|NCT03579459|38062080|FG003|Overall Study|Physician Decision|1|||
16920589|NCT03579459|38062077|FG000|Overall Study|Protocol Violation|1|||
16920590|NCT03579459|38062078|FG001|Overall Study|Protocol Violation|2|||
16920591|NCT03579459|38062079|FG002|Overall Study|Protocol Violation|3|||
16920592|NCT03579459|38062080|FG003|Overall Study|Protocol Violation|5|||
16920593|NCT03579459|38062077|FG000|Overall Study|Withdrawal by Subject|12|||
16920594|NCT03579459|38062078|FG001|Overall Study|Withdrawal by Subject|8|||
16920595|NCT03579459|38062079|FG002|Overall Study|Withdrawal by Subject|11|||
16920596|NCT03579459|38062080|FG003|Overall Study|Withdrawal by Subject|8|||
16920597|NCT03579459|38062077|FG000|Overall Study|Medication error without associated adverse event|2|||
16920598|NCT03579459|38062078|FG001|Overall Study|Medication error without associated adverse event|1|||
16920599|NCT03579459|38062079|FG002|Overall Study|Medication error without associated adverse event|1|||
16845852|NCT01610336|37790821|FG009|Overall Study|Subject/Guardian decision|2|||
16845853|NCT01610336|37790822|FG010|Overall Study|Subject/Guardian decision|2|||
16845854|NCT01610336|37790812|FG000|Overall Study|Death|0|||
16845855|NCT01610336|37790813|FG001|Overall Study|Death|0|||
16845856|NCT01610336|37790814|FG002|Overall Study|Death|0|||
16845857|NCT01610336|37790815|FG003|Overall Study|Death|0|||
16845858|NCT01610336|37790816|FG004|Overall Study|Death|0|||
16845859|NCT01610336|37790817|FG005|Overall Study|Death|1|||
16845860|NCT01610336|37790818|FG006|Overall Study|Death|3|||
16845861|NCT01610336|37790819|FG007|Overall Study|Death|0|||
16920600|NCT03579459|38062080|FG003|Overall Study|Medication error without associated adverse event|0|||
16920601|NCT03579459|38062077|FG000|Overall Study|Other|0|||
16920602|NCT03579459|38062078|FG001|Overall Study|Other|1|||
16920603|NCT03579459|38062079|FG002|Overall Study|Other|1|||
16920604|NCT03579459|38062080|FG003|Overall Study|Other|0|||
16920605|NCT03579459|38062077|FG000|Overall Study|Randomized not vaccinated|0|||
16920606|NCT03579459|38062078|FG001|Overall Study|Randomized not vaccinated|2|||
16920607|NCT03579459|38062079|FG002|Overall Study|Randomized not vaccinated|0|||
16920608|NCT03579459|38062080|FG003|Overall Study|Randomized not vaccinated|1|||
16920609|NCT03340766|38062093|FG000|Overall Study|Death|6|||
16920610|NCT03340766|38062094|FG001|Overall Study|Death|6|||
16920611|NCT03340766|38062095|FG002|Overall Study|Death|2|||
16920612|NCT03340766|38062093|FG000|Overall Study|Withdrawal by Subject|2|||
16920613|NCT03340766|38062094|FG001|Overall Study|Withdrawal by Subject|1|||
16920614|NCT03340766|38062095|FG002|Overall Study|Withdrawal by Subject|2|||
16920615|NCT03340766|38062093|FG000|Overall Study|Continuing Study|3|||
16920616|NCT03340766|38062094|FG001|Overall Study|Continuing Study|3|||
16920617|NCT03340766|38062095|FG002|Overall Study|Continuing Study|5|||
16920618|NCT04449276|38062126|FG000|Overall Study|Adverse Event|1|||
16920619|NCT04449276|38062127|FG001|Overall Study|Adverse Event|2|||
16920620|NCT04449276|38062128|FG002|Overall Study|Adverse Event|0|||
16920621|NCT04449276|38062129|FG003|Overall Study|Adverse Event|0|||
16920622|NCT04449276|38062130|FG004|Overall Study|Adverse Event|2|||
16920623|NCT04449276|38062131|FG005|Overall Study|Adverse Event|0|||
16920624|NCT04449276|38062132|FG006|Overall Study|Adverse Event|0|||
16920625|NCT04449276|38062133|FG007|Overall Study|Adverse Event|1|||
16920626|NCT04449276|38062126|FG000|Overall Study|Withdrawal by Subject|2|||
16920627|NCT04449276|38062127|FG001|Overall Study|Withdrawal by Subject|0|||
16920628|NCT04449276|38062128|FG002|Overall Study|Withdrawal by Subject|0|||
16920629|NCT04449276|38062129|FG003|Overall Study|Withdrawal by Subject|1|||
16920630|NCT04449276|38062130|FG004|Overall Study|Withdrawal by Subject|0|||
16920631|NCT04449276|38062131|FG005|Overall Study|Withdrawal by Subject|0|||
16845862|NCT01610336|37790820|FG008|Overall Study|Death|0|||
16845863|NCT01610336|37790821|FG009|Overall Study|Death|1|||
16845864|NCT01610336|37790822|FG010|Overall Study|Death|2|||
16845865|NCT01610336|37790812|FG000|Overall Study|Non-Compliance with study treatment|0|||
16845866|NCT01610336|37790813|FG001|Overall Study|Non-Compliance with study treatment|0|||
16845867|NCT01610336|37790814|FG002|Overall Study|Non-Compliance with study treatment|0|||
16845868|NCT01610336|37790815|FG003|Overall Study|Non-Compliance with study treatment|0|||
16845869|NCT01610336|37790816|FG004|Overall Study|Non-Compliance with study treatment|0|||
16845870|NCT01610336|37790817|FG005|Overall Study|Non-Compliance with study treatment|0|||
16845871|NCT01610336|37790818|FG006|Overall Study|Non-Compliance with study treatment|0|||
16845872|NCT01610336|37790819|FG007|Overall Study|Non-Compliance with study treatment|0|||
16845873|NCT01610336|37790820|FG008|Overall Study|Non-Compliance with study treatment|0|||
16845874|NCT01610336|37790821|FG009|Overall Study|Non-Compliance with study treatment|1|||
16845875|NCT01610336|37790822|FG010|Overall Study|Non-Compliance with study treatment|0|||
16845876|NCT01610336|37790812|FG000|Overall Study|Physician Decision|0|||
16845877|NCT01610336|37790813|FG001|Overall Study|Physician Decision|0|||
16845878|NCT01610336|37790814|FG002|Overall Study|Physician Decision|0|||
16845879|NCT01610336|37790815|FG003|Overall Study|Physician Decision|0|||
16845880|NCT01610336|37790816|FG004|Overall Study|Physician Decision|0|||
16845881|NCT01610336|37790817|FG005|Overall Study|Physician Decision|0|||
16845882|NCT01610336|37790818|FG006|Overall Study|Physician Decision|1|||
16845883|NCT01610336|37790819|FG007|Overall Study|Physician Decision|0|||
16845884|NCT01610336|37790820|FG008|Overall Study|Physician Decision|0|||
16845885|NCT01610336|37790821|FG009|Overall Study|Physician Decision|0|||
16845886|NCT01610336|37790822|FG010|Overall Study|Physician Decision|0|||
16845887|NCT01610336|37790812|FG000|Overall Study|Protocol Deviation|0|||
16845888|NCT01610336|37790813|FG001|Overall Study|Protocol Deviation|0|||
16845889|NCT01610336|37790814|FG002|Overall Study|Protocol Deviation|0|||
16845890|NCT01610336|37790815|FG003|Overall Study|Protocol Deviation|0|||
16845891|NCT01610336|37790816|FG004|Overall Study|Protocol Deviation|0|||
16845892|NCT01610336|37790817|FG005|Overall Study|Protocol Deviation|0|||
16845893|NCT01610336|37790818|FG006|Overall Study|Protocol Deviation|0|||
16845894|NCT01610336|37790819|FG007|Overall Study|Protocol Deviation|0|||
16845895|NCT01610336|37790820|FG008|Overall Study|Protocol Deviation|0|||
16920632|NCT04449276|38062132|FG006|Overall Study|Withdrawal by Subject|0|||
16845896|NCT01610336|37790821|FG009|Overall Study|Protocol Deviation|1|||
16845897|NCT01610336|37790822|FG010|Overall Study|Protocol Deviation|0|||
16845898|NCT01610336|37790812|FG000|Overall Study|Transfer to another trial|0|||
16845899|NCT01610336|37790813|FG001|Overall Study|Transfer to another trial|0|||
16845900|NCT01610336|37790814|FG002|Overall Study|Transfer to another trial|0|||
16845901|NCT01610336|37790815|FG003|Overall Study|Transfer to another trial|0|||
16845902|NCT01610336|37790816|FG004|Overall Study|Transfer to another trial|0|||
16845903|NCT01610336|37790817|FG005|Overall Study|Transfer to another trial|0|||
16845904|NCT01610336|37790818|FG006|Overall Study|Transfer to another trial|0|||
16845905|NCT01610336|37790819|FG007|Overall Study|Transfer to another trial|0|||
16845906|NCT01610336|37790820|FG008|Overall Study|Transfer to another trial|0|||
16845907|NCT01610336|37790821|FG009|Overall Study|Transfer to another trial|0|||
16845908|NCT01610336|37790822|FG010|Overall Study|Transfer to another trial|1|||
16845909|NCT01613222|37790850|FG000|Overall Study|Physician Decision|1|||
16845910|NCT01613222|37790850|FG000|Overall Study|Unable to place arterial line|1|||
16845911|NCT01613222|37790850|FG000|Overall Study|Reused disposable sensors|10|||
16920633|NCT04449276|38062133|FG007|Overall Study|Withdrawal by Subject|0|||
16920634|NCT04449276|38062126|FG000|Overall Study|Other|0|||
16920635|NCT04449276|38062127|FG001|Overall Study|Other|2|||
16920636|NCT04449276|38062128|FG002|Overall Study|Other|3|||
16920637|NCT04449276|38062129|FG003|Overall Study|Other|2|||
16920638|NCT04449276|38062130|FG004|Overall Study|Other|0|||
16920639|NCT04449276|38062131|FG005|Overall Study|Other|0|||
16920640|NCT04449276|38062132|FG006|Overall Study|Other|0|||
16920641|NCT04449276|38062133|FG007|Overall Study|Other|1|||
16920642|NCT04391894|38062173|FG000|Overall Study|Adverse Event|1|||
16920643|NCT04391894|38062174|FG001|Overall Study|Adverse Event|1|||
16920644|NCT04391894|38062175|FG002|Overall Study|Adverse Event|1|||
16920645|NCT04391894|38062176|FG003|Overall Study|Adverse Event|1|||
16920646|NCT04391894|38062177|FG004|Overall Study|Adverse Event|1|||
16920647|NCT04391894|38062173|FG000|Overall Study|Lost to Follow-up|1|||
16920648|NCT04391894|38062174|FG001|Overall Study|Lost to Follow-up|0|||
16920649|NCT04391894|38062175|FG002|Overall Study|Lost to Follow-up|0|||
16920650|NCT04391894|38062176|FG003|Overall Study|Lost to Follow-up|0|||
16920651|NCT04391894|38062177|FG004|Overall Study|Lost to Follow-up|0|||
16920652|NCT04391894|38062173|FG000|Overall Study|Protocol Violation|0|||
16920653|NCT04391894|38062174|FG001|Overall Study|Protocol Violation|0|||
16920654|NCT04391894|38062175|FG002|Overall Study|Protocol Violation|0|||
16920655|NCT04391894|38062176|FG003|Overall Study|Protocol Violation|1|||
16920656|NCT04391894|38062177|FG004|Overall Study|Protocol Violation|0|||
17017365|NCT00834912|38161980|FG004|Treatment Period 1|Adverse Event|0|||
17017366|NCT00834912|38161981|FG005|Treatment Period 1|Adverse Event|0|||
17017367|NCT00834912|38161976|FG000|Treatment Period 2|Withdrawal by Subject|0|||
17017368|NCT00834912|38161977|FG001|Treatment Period 2|Withdrawal by Subject|0|||
17017369|NCT00834912|38161978|FG002|Treatment Period 2|Withdrawal by Subject|1|||
17017370|NCT00834912|38161979|FG003|Treatment Period 2|Withdrawal by Subject|0|||
17017371|NCT00834912|38161980|FG004|Treatment Period 2|Withdrawal by Subject|1|||
17017372|NCT00834912|38161981|FG005|Treatment Period 2|Withdrawal by Subject|0|||
17017373|NCT00883493|38161991|FG000|Overall Study|Adverse Event|11|||
17017374|NCT00883493|38161992|FG001|Overall Study|Adverse Event|12|||
17017375|NCT00883493|38161991|FG000|Overall Study|Lack of Efficacy|4|||
17017376|NCT00883493|38161992|FG001|Overall Study|Lack of Efficacy|3|||
17017377|NCT00883493|38161991|FG000|Overall Study|Lost to Follow-up|7|||
17017378|NCT00883493|38161992|FG001|Overall Study|Lost to Follow-up|6|||
17017379|NCT00883493|38161991|FG000|Overall Study|Withdrawal by Subject|11|||
17017380|NCT00883493|38161992|FG001|Overall Study|Withdrawal by Subject|20|||
17017381|NCT00883493|38161991|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
17017382|NCT00883493|38161992|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
17017383|NCT00883493|38161991|FG000|Overall Study|Study specific disc. criteria|2|||
17017384|NCT00883493|38161992|FG001|Overall Study|Study specific disc. criteria|0|||
17017385|NCT00883493|38161991|FG000|Overall Study|Other|5|||
16845912|NCT01612676|37790897|FG000|Overall Study|Adverse Event|2|||
16845913|NCT01612676|37790898|FG001|Overall Study|Adverse Event|3|||
16845914|NCT01612676|37790899|FG002|Overall Study|Adverse Event|1|||
16845915|NCT01612676|37790900|FG003|Overall Study|Adverse Event|3|||
16845916|NCT01612676|37790897|FG000|Overall Study|Protocol Violation|0|||
16845917|NCT01612676|37790898|FG001|Overall Study|Protocol Violation|1|||
17017386|NCT00883493|38161992|FG001|Overall Study|Other|3|||
17017387|NCT00844428|38161998|FG000|Screening Period|Screen Failure|3|||
17017388|NCT00844428|38161998|FG000|Extension Treatment Period|Death|1|||
17017389|NCT00844428|38161998|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
17017390|NCT00834834|38162004|FG000|Overall Study|Withdrawal by Subject|4|||
17017391|NCT00834834|38162005|FG001|Overall Study|Withdrawal by Subject|3|||
17017392|NCT00834366|38162013|FG000|Treatment Period 1|Adverse Event|1|||
16920657|NCT04391894|38062173|FG000|Overall Study|Withdrawal by Subject|2|||
16920658|NCT04391894|38062174|FG001|Overall Study|Withdrawal by Subject|0|||
17017393|NCT00834366|38162014|FG001|Treatment Period 1|Adverse Event|1|||
17017394|NCT00844194|38162022|FG000|Overall Study|Adverse Event|17|||
17017395|NCT00844194|38162023|FG001|Overall Study|Adverse Event|5|||
16845918|NCT01612676|37790899|FG002|Overall Study|Protocol Violation|0|||
16845919|NCT01612676|37790900|FG003|Overall Study|Protocol Violation|0|||
16845920|NCT01869764|37790914|FG000|Overall Study|Withdrawal by Subject|0|||
16845921|NCT01869764|37790915|FG001|Overall Study|Withdrawal by Subject|2|||
16845922|NCT01842620|37790921|FG000|Period 1|Withdrawal by Subject|1|||
16845923|NCT01842620|37790922|FG001|Period 1|Withdrawal by Subject|0|||
16845924|NCT01931839|37790948|FG000|Overall Study|Death|0|||
16845925|NCT01931839|37790949|FG001|Overall Study|Death|1|||
16845926|NCT01931839|37790950|FG002|Overall Study|Death|2|||
16845927|NCT01931839|37790951|FG003|Overall Study|Death|0|||
16845928|NCT01931839|37790952|FG004|Overall Study|Death|0|||
16845929|NCT01931839|37790953|FG005|Overall Study|Death|0|||
16845930|NCT01931839|37790954|FG006|Overall Study|Death|0|||
16845931|NCT01931839|37790948|FG000|Overall Study|Physician Decision|1|||
16845932|NCT01931839|37790949|FG001|Overall Study|Physician Decision|0|||
16845933|NCT01931839|37790950|FG002|Overall Study|Physician Decision|1|||
16845934|NCT01931839|37790951|FG003|Overall Study|Physician Decision|0|||
16845935|NCT01931839|37790952|FG004|Overall Study|Physician Decision|0|||
16845936|NCT01931839|37790953|FG005|Overall Study|Physician Decision|0|||
16845937|NCT01931839|37790954|FG006|Overall Study|Physician Decision|1|||
16845938|NCT01931839|37790948|FG000|Overall Study|Withdrawal of consent|0|||
16845939|NCT01931839|37790949|FG001|Overall Study|Withdrawal of consent|0|||
16845940|NCT01931839|37790950|FG002|Overall Study|Withdrawal of consent|0|||
16845941|NCT01931839|37790951|FG003|Overall Study|Withdrawal of consent|0|||
16845942|NCT01931839|37790952|FG004|Overall Study|Withdrawal of consent|1|||
16845943|NCT01931839|37790953|FG005|Overall Study|Withdrawal of consent|0|||
16845944|NCT01931839|37790954|FG006|Overall Study|Withdrawal of consent|0|||
16845945|NCT01931839|37790948|FG000|Overall Study|Adverse Event|9|||
16845946|NCT01931839|37790949|FG001|Overall Study|Adverse Event|4|||
16845947|NCT01931839|37790950|FG002|Overall Study|Adverse Event|1|||
16920659|NCT04391894|38062175|FG002|Overall Study|Withdrawal by Subject|3|||
16920660|NCT04391894|38062176|FG003|Overall Study|Withdrawal by Subject|0|||
16920661|NCT04391894|38062177|FG004|Overall Study|Withdrawal by Subject|1|||
16920662|NCT04391894|38062173|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
16920663|NCT04391894|38062174|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
16920664|NCT04391894|38062175|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
16920665|NCT04391894|38062176|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
16920666|NCT04391894|38062177|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
16920667|NCT04166435|38062193|FG000|Overall Study|2 patients ineligible for response|2|||
16920668|NCT03851705|38062199|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
16920669|NCT03851705|38062200|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
16920670|NCT03851705|38062201|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
16920671|NCT03851705|38062202|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
16920672|NCT03851705|38062199|FG000|Part 1: Double-Blind Period|Other reason|1|||
16920673|NCT03851705|38062200|FG001|Part 1: Double-Blind Period|Other reason|0|||
16920674|NCT03851705|38062201|FG002|Part 1: Double-Blind Period|Other reason|0|||
16920675|NCT03851705|38062202|FG003|Part 1: Double-Blind Period|Other reason|0|||
16920676|NCT03851705|38062199|FG000|Part 2: Open-Label Period|Other reason|0|||
16920677|NCT03851705|38062200|FG001|Part 2: Open-Label Period|Other reason|0|||
16920678|NCT03851705|38062201|FG002|Part 2: Open-Label Period|Other reason|0|||
16920679|NCT03851705|38062202|FG003|Part 2: Open-Label Period|Other reason|1|||
16920680|NCT03851705|38062199|FG000|Part 2: Open-Label Period|Death|0|||
16920681|NCT03851705|38062200|FG001|Part 2: Open-Label Period|Death|0|||
16920682|NCT03851705|38062201|FG002|Part 2: Open-Label Period|Death|3|||
16920683|NCT03851705|38062202|FG003|Part 2: Open-Label Period|Death|0|||
16920684|NCT03851705|38062199|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
16920685|NCT03851705|38062200|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
16920686|NCT03851705|38062201|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
16920687|NCT03851705|38062202|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
16920688|NCT03824366|38062215|FG000|Overall Study|Death|1|||
16920689|NCT03824366|38062215|FG000|Overall Study|Previously unidentified metal artifact|1|||
16920690|NCT03824366|38062215|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
16920691|NCT03824366|38062215|FG000|Overall Study|Withdrawal by Subject|1|||
16920692|NCT03810313|38062221|FG000|Overall Study|Study terminated by sponsor|164|||
16920693|NCT03810313|38062222|FG001|Overall Study|Study terminated by sponsor|159|||
16920694|NCT03810313|38062221|FG000|Overall Study|Subject decision|10|||
16920695|NCT03810313|38062222|FG001|Overall Study|Subject decision|11|||
16920696|NCT03810313|38062221|FG000|Overall Study|Lost to Follow-up|3|||
16920697|NCT03810313|38062222|FG001|Overall Study|Lost to Follow-up|3|||
16920698|NCT03810313|38062221|FG000|Overall Study|Adverse Event|2|||
16920699|NCT03810313|38062222|FG001|Overall Study|Adverse Event|1|||
16845948|NCT01931839|37790951|FG003|Overall Study|Adverse Event|3|||
16845949|NCT01931839|37790952|FG004|Overall Study|Adverse Event|0|||
16845950|NCT01931839|37790953|FG005|Overall Study|Adverse Event|0|||
16845951|NCT01931839|37790954|FG006|Overall Study|Adverse Event|1|||
16845952|NCT01931839|37790948|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
16845953|NCT01931839|37790949|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
16920700|NCT03810313|38062221|FG000|Overall Study|Death|2|||
16920701|NCT03810313|38062222|FG001|Overall Study|Death|1|||
16920702|NCT03810313|38062221|FG000|Overall Study|Physician Decision|0|||
16920703|NCT03810313|38062222|FG001|Overall Study|Physician Decision|1|||
16920704|NCT03802630|38062231|FG000|Overall Study|Study terminated by sponsor|130|||
16920705|NCT03802630|38062232|FG001|Overall Study|Study terminated by sponsor|134|||
16920706|NCT03802630|38062231|FG000|Overall Study|Subject decision|16|||
16920707|NCT03802630|38062232|FG001|Overall Study|Subject decision|9|||
16920708|NCT03802630|38062231|FG000|Overall Study|Adverse Event|3|||
16920709|NCT03802630|38062232|FG001|Overall Study|Adverse Event|1|||
16920710|NCT03802630|38062231|FG000|Overall Study|Lost to Follow-up|2|||
16920711|NCT03802630|38062232|FG001|Overall Study|Lost to Follow-up|2|||
16920712|NCT03802630|38062231|FG000|Overall Study|Physician Decision|2|||
16920713|NCT03802630|38062232|FG001|Overall Study|Physician Decision|0|||
16920714|NCT03802630|38062231|FG000|Overall Study|Death|0|||
16920715|NCT03802630|38062232|FG001|Overall Study|Death|2|||
16920716|NCT03775213|38062241|FG000|Overall Study|Withdrawal by Subject|51|||
16920717|NCT03775213|38062242|FG001|Overall Study|Withdrawal by Subject|53|||
16920718|NCT03775213|38062241|FG000|Overall Study|Incomplete Survey|7|||
16920719|NCT03775213|38062242|FG001|Overall Study|Incomplete Survey|7|||
16920720|NCT03710564|38062250|FG000|Overall Study|Study Terminated by Sponsor|104|||
16920721|NCT03710564|38062251|FG001|Overall Study|Study Terminated by Sponsor|55|||
16920722|NCT03710564|38062250|FG000|Overall Study|Withdrawal by Subject|57|||
16920723|NCT03710564|38062251|FG001|Overall Study|Withdrawal by Subject|25|||
16920724|NCT03710564|38062250|FG000|Overall Study|Death|10|||
16920725|NCT03710564|38062251|FG001|Overall Study|Death|4|||
16920726|NCT03710564|38062250|FG000|Overall Study|Lost to Follow-up|5|||
16920727|NCT03710564|38062251|FG001|Overall Study|Lost to Follow-up|4|||
16920728|NCT03710564|38062250|FG000|Overall Study|Protocol Violation|3|||
16920729|NCT03710564|38062251|FG001|Overall Study|Protocol Violation|2|||
16920730|NCT03710564|38062250|FG000|Overall Study|Adverse Event|3|||
16920731|NCT03710564|38062251|FG001|Overall Study|Adverse Event|0|||
16920732|NCT03710564|38062250|FG000|Overall Study|Physician Decision|2|||
16920733|NCT03710564|38062251|FG001|Overall Study|Physician Decision|3|||
16920734|NCT03624127|38062261|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
16920735|NCT03624127|38062262|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
16920736|NCT03624127|38062263|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
16920737|NCT03624127|38062261|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
16920738|NCT03624127|38062262|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
16920739|NCT03624127|38062263|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
16920740|NCT03624127|38062261|FG000|Treatment Week 0 - Week 16|Death|0|||
16920741|NCT03624127|38062262|FG001|Treatment Week 0 - Week 16|Death|1|||
16920742|NCT03624127|38062263|FG002|Treatment Week 0 - Week 16|Death|0|||
16920743|NCT03624127|38062261|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
16920744|NCT03624127|38062262|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
16920745|NCT03624127|38062263|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
16920746|NCT03624127|38062261|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
16920747|NCT03624127|38062262|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
16920748|NCT03624127|38062263|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
16920749|NCT03624127|38062261|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
16920750|NCT03624127|38062262|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
16920751|NCT03624127|38062263|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
16920752|NCT03624127|38062261|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
16920753|NCT03624127|38062262|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
16920754|NCT03624127|38062263|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
16920755|NCT03624127|38062261|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
16920756|NCT03624127|38062262|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
16920757|NCT03624127|38062263|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
16920758|NCT03624127|38062261|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
16920759|NCT03624127|38062262|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
16920760|NCT03624127|38062263|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
16920761|NCT03624127|38062261|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
16920762|NCT03624127|38062262|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
16920763|NCT03624127|38062263|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
16920764|NCT03624127|38062261|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
16920765|NCT03624127|38062262|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
16920766|NCT03624127|38062263|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
16920767|NCT03624127|38062261|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
16920768|NCT03624127|38062262|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
16920769|NCT03624127|38062263|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
16920770|NCT03624127|38062261|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
16920771|NCT03624127|38062262|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
16920772|NCT03624127|38062263|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
16920773|NCT03624127|38062261|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
16920774|NCT03624127|38062262|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
16920775|NCT03624127|38062263|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
16920776|NCT03624127|38062261|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
16920777|NCT03624127|38062262|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
16920778|NCT03624127|38062263|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
16920779|NCT03624127|38062261|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
16920780|NCT03624127|38062262|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
16920781|NCT03624127|38062263|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
16920782|NCT03624127|38062261|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
16920783|NCT03624127|38062262|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
16920784|NCT03624127|38062263|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
16920785|NCT03624127|38062261|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
16920786|NCT03624127|38062262|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
16920787|NCT03624127|38062263|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
16920788|NCT03624127|38062261|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
16920789|NCT03624127|38062262|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
16920790|NCT03624127|38062263|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
16920791|NCT03624127|38062261|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
16920792|NCT03624127|38062262|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
16920793|NCT03624127|38062263|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
16920794|NCT03624127|38062261|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
16920795|NCT03624127|38062262|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
16920796|NCT03624127|38062263|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
16920797|NCT03616912|38062281|FG000|Overall Study|Adverse Event|17|||
16920798|NCT03616912|38062282|FG001|Overall Study|Adverse Event|21|||
16920799|NCT03616912|38062283|FG002|Overall Study|Adverse Event|9|||
16920800|NCT03616912|38062284|FG003|Overall Study|Adverse Event|0|||
16920801|NCT03616912|38062285|FG004|Overall Study|Adverse Event|0|||
16920802|NCT03616912|38062286|FG005|Overall Study|Adverse Event|0|||
16920803|NCT03616912|38062281|FG000|Overall Study|Death|1|||
16920804|NCT03616912|38062282|FG001|Overall Study|Death|1|||
16920805|NCT03616912|38062283|FG002|Overall Study|Death|0|||
16920806|NCT03616912|38062284|FG003|Overall Study|Death|0|||
16920807|NCT03616912|38062285|FG004|Overall Study|Death|0|||
16920808|NCT03616912|38062286|FG005|Overall Study|Death|0|||
16920809|NCT03616912|38062281|FG000|Overall Study|Lack of Efficacy|13|||
16920810|NCT03616912|38062282|FG001|Overall Study|Lack of Efficacy|6|||
16920811|NCT03616912|38062283|FG002|Overall Study|Lack of Efficacy|8|||
16920812|NCT03616912|38062284|FG003|Overall Study|Lack of Efficacy|4|||
16920813|NCT03616912|38062285|FG004|Overall Study|Lack of Efficacy|5|||
16920814|NCT03616912|38062286|FG005|Overall Study|Lack of Efficacy|1|||
16920815|NCT03616912|38062281|FG000|Overall Study|Lost to Follow-up|1|||
16920816|NCT03616912|38062282|FG001|Overall Study|Lost to Follow-up|2|||
16920817|NCT03616912|38062283|FG002|Overall Study|Lost to Follow-up|3|||
16920818|NCT03616912|38062284|FG003|Overall Study|Lost to Follow-up|0|||
16920819|NCT03616912|38062285|FG004|Overall Study|Lost to Follow-up|0|||
16920820|NCT03616912|38062286|FG005|Overall Study|Lost to Follow-up|0|||
16920821|NCT03616912|38062281|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
16920822|NCT03616912|38062282|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
16920823|NCT03616912|38062283|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
16920824|NCT03616912|38062284|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
16920825|NCT03616912|38062285|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
16920826|NCT03616912|38062286|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
16920827|NCT03616912|38062281|FG000|Overall Study|Withdrawal by Subject|12|||
16920828|NCT03616912|38062282|FG001|Overall Study|Withdrawal by Subject|12|||
16920829|NCT03616912|38062283|FG002|Overall Study|Withdrawal by Subject|15|||
16920830|NCT03616912|38062284|FG003|Overall Study|Withdrawal by Subject|2|||
16920831|NCT03616912|38062285|FG004|Overall Study|Withdrawal by Subject|0|||
16920832|NCT03616912|38062286|FG005|Overall Study|Withdrawal by Subject|2|||
16920833|NCT03616912|38062281|FG000|Overall Study|Study Terminated by Sponsor|0|||
16920834|NCT03616912|38062282|FG001|Overall Study|Study Terminated by Sponsor|0|||
16845954|NCT01931839|37790950|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
16845955|NCT01931839|37790951|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
16845956|NCT01931839|37790952|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
16845957|NCT01931839|37790953|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
16845958|NCT01931839|37790954|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
16845959|NCT01931839|37790948|FG000|Overall Study|Other non-compliance|15|||
16845960|NCT01931839|37790949|FG001|Overall Study|Other non-compliance|9|||
16845961|NCT01931839|37790950|FG002|Overall Study|Other non-compliance|12|||
16920835|NCT03616912|38062283|FG002|Overall Study|Study Terminated by Sponsor|0|||
16920836|NCT03616912|38062284|FG003|Overall Study|Study Terminated by Sponsor|10|||
16920837|NCT03616912|38062285|FG004|Overall Study|Study Terminated by Sponsor|9|||
16920838|NCT03616912|38062286|FG005|Overall Study|Study Terminated by Sponsor|11|||
16920839|NCT03616912|38062281|FG000|Overall Study|Protocol Deviation|1|||
16920840|NCT03616912|38062282|FG001|Overall Study|Protocol Deviation|1|||
16920841|NCT03616912|38062283|FG002|Overall Study|Protocol Deviation|0|||
16845962|NCT01931839|37790951|FG003|Overall Study|Other non-compliance|3|||
16845963|NCT01931839|37790952|FG004|Overall Study|Other non-compliance|0|||
16845964|NCT01931839|37790953|FG005|Overall Study|Other non-compliance|3|||
16845965|NCT01931839|37790954|FG006|Overall Study|Other non-compliance|0|||
16845966|NCT01931839|37790948|FG000|Overall Study|Lost to Follow-up|1|||
16845967|NCT01931839|37790949|FG001|Overall Study|Lost to Follow-up|2|||
16845968|NCT01931839|37790950|FG002|Overall Study|Lost to Follow-up|4|||
16845969|NCT01931839|37790951|FG003|Overall Study|Lost to Follow-up|5|||
16845970|NCT01931839|37790952|FG004|Overall Study|Lost to Follow-up|0|||
16845971|NCT01931839|37790953|FG005|Overall Study|Lost to Follow-up|0|||
16845972|NCT01931839|37790954|FG006|Overall Study|Lost to Follow-up|0|||
16845973|NCT01931839|37790948|FG000|Overall Study|Other|4|||
16845974|NCT01931839|37790949|FG001|Overall Study|Other|2|||
16845975|NCT01931839|37790950|FG002|Overall Study|Other|6|||
16845976|NCT01931839|37790951|FG003|Overall Study|Other|0|||
16845977|NCT01931839|37790952|FG004|Overall Study|Other|0|||
16845978|NCT01931839|37790953|FG005|Overall Study|Other|0|||
16845979|NCT01931839|37790954|FG006|Overall Study|Other|0|||
16920842|NCT03616912|38062284|FG003|Overall Study|Protocol Deviation|0|||
16920843|NCT03616912|38062285|FG004|Overall Study|Protocol Deviation|0|||
16920844|NCT03616912|38062286|FG005|Overall Study|Protocol Deviation|0|||
16920845|NCT03616912|38062281|FG000|Overall Study|Pregnancy|1|||
16920846|NCT03616912|38062282|FG001|Overall Study|Pregnancy|0|||
16920847|NCT03616912|38062283|FG002|Overall Study|Pregnancy|4|||
16920848|NCT03616912|38062284|FG003|Overall Study|Pregnancy|0|||
17017396|NCT00844194|38162022|FG000|Overall Study|Protocol Violation|1|||
17017397|NCT00844194|38162023|FG001|Overall Study|Protocol Violation|1|||
17017398|NCT00844194|38162022|FG000|Overall Study|Lost to Follow-up|1|||
17017399|NCT00844194|38162023|FG001|Overall Study|Lost to Follow-up|1|||
17017400|NCT00844194|38162022|FG000|Overall Study|Withdrawal by Subject|2|||
17017401|NCT00844194|38162023|FG001|Overall Study|Withdrawal by Subject|1|||
17017402|NCT00844194|38162022|FG000|Overall Study|Lack of Efficacy|3|||
17017403|NCT00844194|38162023|FG001|Overall Study|Lack of Efficacy|0|||
17017404|NCT00844194|38162022|FG000|Overall Study|Other reason (not specified)|1|||
17017405|NCT00844194|38162023|FG001|Overall Study|Other reason (not specified)|0|||
17017406|NCT00826176|38162035|FG000|Overall Study|Lost to Follow-up|1|||
17017407|NCT00826176|38162036|FG001|Overall Study|Lost to Follow-up|0|||
17017408|NCT00826176|38162035|FG000|Overall Study|Subject Withdrew Consent|3|||
17017409|NCT00826176|38162036|FG001|Overall Study|Subject Withdrew Consent|0|||
17017410|NCT00826176|38162035|FG000|Overall Study|Administrative|9|||
17017411|NCT00826176|38162036|FG001|Overall Study|Administrative|0|||
17017412|NCT00878969|38162045|FG000|Overall Study|Physician Decision|5|||
17017413|NCT00878969|38162046|FG001|Overall Study|Physician Decision|3|||
16845980|NCT01842308|37790979|FG000|Overall Study|Withdrawal by Subject|0|||
16845981|NCT01842308|37790980|FG001|Overall Study|Withdrawal by Subject|0|||
16845982|NCT01842308|37790981|FG002|Overall Study|Withdrawal by Subject|0|||
16920849|NCT03616912|38062285|FG004|Overall Study|Pregnancy|0|||
16920850|NCT03616912|38062286|FG005|Overall Study|Pregnancy|0|||
16920851|NCT03616912|38062281|FG000|Overall Study|Protocol Violation|1|||
16920852|NCT03616912|38062282|FG001|Overall Study|Protocol Violation|0|||
16920853|NCT03616912|38062283|FG002|Overall Study|Protocol Violation|2|||
16920854|NCT03616912|38062284|FG003|Overall Study|Protocol Violation|0|||
16920855|NCT03616912|38062285|FG004|Overall Study|Protocol Violation|0|||
16920856|NCT03616912|38062286|FG005|Overall Study|Protocol Violation|0|||
16920857|NCT03616912|38062281|FG000|Overall Study|Physician Decision|2|||
16920858|NCT03616912|38062282|FG001|Overall Study|Physician Decision|0|||
16920859|NCT03616912|38062283|FG002|Overall Study|Physician Decision|0|||
16920860|NCT03616912|38062284|FG003|Overall Study|Physician Decision|0|||
16920861|NCT03616912|38062285|FG004|Overall Study|Physician Decision|1|||
16920862|NCT03616912|38062286|FG005|Overall Study|Physician Decision|0|||
16920863|NCT03616912|38062281|FG000|Overall Study|Randomized But Never Treated|0|||
16920864|NCT03616912|38062282|FG001|Overall Study|Randomized But Never Treated|2|||
16920865|NCT03616912|38062283|FG002|Overall Study|Randomized But Never Treated|0|||
16920866|NCT03616912|38062284|FG003|Overall Study|Randomized But Never Treated|0|||
16920867|NCT03616912|38062285|FG004|Overall Study|Randomized But Never Treated|0|||
16920868|NCT03616912|38062286|FG005|Overall Study|Randomized But Never Treated|0|||
16920869|NCT03499899|38062303|FG000|Overall Study|Adverse Event|2|||
16920870|NCT03499899|38062304|FG001|Overall Study|Adverse Event|3|||
16920871|NCT03499899|38062305|FG002|Overall Study|Adverse Event|3|||
16920872|NCT03499899|38062303|FG000|Overall Study|Death|0|||
16920873|NCT03499899|38062304|FG001|Overall Study|Death|0|||
16920874|NCT03499899|38062305|FG002|Overall Study|Death|1|||
16920875|NCT03499899|38062303|FG000|Overall Study|Physician Decision|3|||
16920876|NCT03499899|38062304|FG001|Overall Study|Physician Decision|6|||
16920877|NCT03499899|38062305|FG002|Overall Study|Physician Decision|6|||
17017414|NCT00878969|38162047|FG002|Overall Study|Physician Decision|2|||
17017415|NCT00878969|38162045|FG000|Overall Study|Withdrawal by Subject|1|||
17017416|NCT00878969|38162046|FG001|Overall Study|Withdrawal by Subject|6|||
16845983|NCT01842308|37790982|FG003|Overall Study|Withdrawal by Subject|0|||
16920878|NCT03499899|38062303|FG000|Overall Study|Progressive disease|15|||
16845984|NCT01842308|37790983|FG004|Overall Study|Withdrawal by Subject|1|||
16845985|NCT01931059|37790998|FG000|Day 1|Pregnancy|0|||
16845986|NCT01931059|37790999|FG001|Day 1|Pregnancy|1|||
16845987|NCT01931059|37790998|FG000|Day3|Lost to Follow-up|1|||
16845988|NCT01931059|37790999|FG001|Day3|Lost to Follow-up|0|||
16845989|NCT01841762|37791011|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
16845990|NCT01841762|37791011|FG000|Treatment Period|Adverse Event|16|||
16845991|NCT01841762|37791011|FG000|Treatment Period|Death|1|||
16845992|NCT01841762|37791011|FG000|Treatment Period|Withdrawal by Subject|7|||
16845993|NCT01841762|37791011|FG000|Treatment Period|Lost to Follow-up|1|||
16845994|NCT01841762|37791011|FG000|Treatment Period|Physician Decision|2|||
16845995|NCT01841762|37791011|FG000|Treatment Period|Other, including non-compliance|5|||
16845996|NCT01841762|37791011|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
16845997|NCT01841762|37791011|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
16845998|NCT01841762|37791011|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
16845999|NCT01841762|37791011|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
16846000|NCT01841060|37791028|FG000|Overall Study|Protocol Violation|10|||
16846001|NCT01814696|37791034|FG000|Overall Study|Withdrawal by Subject|1|||
16846002|NCT01814696|37791035|FG001|Overall Study|Withdrawal by Subject|0|||
16846003|NCT01814696|37791034|FG000|Overall Study|Randomized to wrong group|1|||
16846004|NCT01814696|37791035|FG001|Overall Study|Randomized to wrong group|0|||
16846005|NCT01970371|37791044|FG000|Overall Study|Death|8|||
16846006|NCT01970371|37791045|FG001|Overall Study|Death|13|||
16846007|NCT01970371|37791046|FG002|Overall Study|Death|12|||
16846008|NCT01970371|37791044|FG000|Overall Study|Lost to Follow-up|0|||
16846009|NCT01970371|37791045|FG001|Overall Study|Lost to Follow-up|0|||
16846010|NCT01970371|37791046|FG002|Overall Study|Lost to Follow-up|1|||
16846011|NCT01868594|37791067|FG000|Overall Study|Do not meet inclusion criteria|4|||
16846012|NCT01868594|37791068|FG001|Overall Study|Do not meet inclusion criteria|3|||
16846013|NCT01616953|37791078|FG000|Overall Study|Lost to Follow-up|1|||
16846014|NCT01616953|37791079|FG001|Overall Study|Lost to Follow-up|0|||
16846015|NCT01616953|37791078|FG000|Overall Study|lack of bone and soft tissue|1|||
16846016|NCT01616953|37791079|FG001|Overall Study|lack of bone and soft tissue|0|||
16846017|NCT01867658|37791085|FG000|Overall Study|Withdrawal by Subject|6|||
16846018|NCT01867658|37791085|FG000|Overall Study|Death|2|||
16846019|NCT01867658|37791085|FG000|Overall Study|Subject could not be contacted|1|||
16846020|NCT01867580|37791091|FG000|Overall Study|Withdrawal by Subject|2|||
16846021|NCT01867580|37791092|FG001|Overall Study|Withdrawal by Subject|3|||
16846022|NCT01867580|37791091|FG000|Overall Study|Physician Decision|17|||
16846023|NCT01867580|37791092|FG001|Overall Study|Physician Decision|12|||
16846024|NCT01867580|37791091|FG000|Overall Study|Lost to Follow-up|3|||
16846025|NCT01867580|37791092|FG001|Overall Study|Lost to Follow-up|5|||
16846026|NCT01867580|37791091|FG000|Overall Study|Sponsor terminated study|1|||
16846027|NCT01867580|37791092|FG001|Overall Study|Sponsor terminated study|0|||
16846028|NCT01867580|37791091|FG000|Overall Study|Missed follow-up assessment|2|||
16846029|NCT01867580|37791092|FG001|Overall Study|Missed follow-up assessment|1|||
16846030|NCT01867580|37791091|FG000|Overall Study|Interruption to therapy|3|||
16846031|NCT01867580|37791092|FG001|Overall Study|Interruption to therapy|0|||
16846032|NCT01867580|37791091|FG000|Overall Study|Osteomyelitis|0|||
16846033|NCT01867580|37791092|FG001|Overall Study|Osteomyelitis|1|||
16846034|NCT01867580|37791091|FG000|Overall Study|Continuation of therapy|0|||
16846035|NCT01867580|37791092|FG001|Overall Study|Continuation of therapy|1|||
16846036|NCT01867580|37791091|FG000|Overall Study|Wound recurrence|0|||
16846037|NCT01867580|37791092|FG001|Overall Study|Wound recurrence|1|||
16846038|NCT01839656|37791106|FG000|Overall Study|Withdrawal by Subject|1|||
16846039|NCT01839656|37791107|FG001|Overall Study|Withdrawal by Subject|1|||
16846040|NCT01839656|37791106|FG000|Overall Study|Adverse event, serious fatal|1|||
16846041|NCT01839656|37791107|FG001|Overall Study|Adverse event, serious fatal|4|||
16846042|NCT01839656|37791106|FG000|Overall Study|Early study closure|0|||
16920879|NCT03499899|38062304|FG001|Overall Study|Progressive disease|23|||
16920880|NCT03499899|38062305|FG002|Overall Study|Progressive disease|23|||
16920881|NCT03499899|38062303|FG000|Overall Study|Patient decision|0|||
16920882|NCT03499899|38062304|FG001|Overall Study|Patient decision|1|||
16920883|NCT03499899|38062305|FG002|Overall Study|Patient decision|1|||
16920884|NCT03499899|38062303|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
16920885|NCT03499899|38062304|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
16920886|NCT03499899|38062305|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
16920887|NCT03481634|38062321|FG000|Overall Study|Withdrawal by Subject|16|||
16920888|NCT03481634|38062322|FG001|Overall Study|Withdrawal by Subject|19|||
16920889|NCT03481634|38062323|FG002|Overall Study|Withdrawal by Subject|14|||
16920890|NCT03481634|38062321|FG000|Overall Study|Protocol Violation|1|||
16920891|NCT03481634|38062322|FG001|Overall Study|Protocol Violation|0|||
16920892|NCT03481634|38062323|FG002|Overall Study|Protocol Violation|1|||
16920893|NCT03481634|38062321|FG000|Overall Study|Progressive disease|0|||
16920894|NCT03481634|38062322|FG001|Overall Study|Progressive disease|1|||
16846043|NCT01839656|37791107|FG001|Overall Study|Early study closure|11|||
16920895|NCT03481634|38062323|FG002|Overall Study|Progressive disease|0|||
16920896|NCT03481634|38062321|FG000|Overall Study|Physician Decision|3|||
16920897|NCT03481634|38062322|FG001|Overall Study|Physician Decision|0|||
16920898|NCT03481634|38062323|FG002|Overall Study|Physician Decision|1|||
16920899|NCT03481634|38062321|FG000|Overall Study|Lost to Follow-up|3|||
16920900|NCT03481634|38062322|FG001|Overall Study|Lost to Follow-up|4|||
16920901|NCT03481634|38062323|FG002|Overall Study|Lost to Follow-up|4|||
16920902|NCT03481634|38062321|FG000|Overall Study|Death|4|||
16920903|NCT03481634|38062322|FG001|Overall Study|Death|8|||
16920904|NCT03481634|38062323|FG002|Overall Study|Death|7|||
16920905|NCT03481634|38062321|FG000|Overall Study|Adverse Event|6|||
16920906|NCT03481634|38062322|FG001|Overall Study|Adverse Event|3|||
16920907|NCT03481634|38062323|FG002|Overall Study|Adverse Event|7|||
16920908|NCT03460756|38062336|FG000|Overall Study|Adverse Event|0|||
16920909|NCT03460756|38062337|FG001|Overall Study|Adverse Event|0|||
16920910|NCT03460756|38062338|FG002|Overall Study|Adverse Event|0|||
16920911|NCT03460756|38062339|FG003|Overall Study|Adverse Event|1|||
16920912|NCT03460756|38062336|FG000|Overall Study|Lack of Efficacy|0|||
16920913|NCT03460756|38062337|FG001|Overall Study|Lack of Efficacy|0|||
16920914|NCT03460756|38062338|FG002|Overall Study|Lack of Efficacy|0|||
16920915|NCT03460756|38062339|FG003|Overall Study|Lack of Efficacy|2|||
16920916|NCT03460756|38062336|FG000|Overall Study|Lost to Follow-up|0|||
16920917|NCT03460756|38062337|FG001|Overall Study|Lost to Follow-up|1|||
16920918|NCT03460756|38062338|FG002|Overall Study|Lost to Follow-up|2|||
16920919|NCT03460756|38062339|FG003|Overall Study|Lost to Follow-up|1|||
16920920|NCT03460756|38062336|FG000|Overall Study|Pregnancy|0|||
16920921|NCT03460756|38062337|FG001|Overall Study|Pregnancy|0|||
16920922|NCT03460756|38062338|FG002|Overall Study|Pregnancy|0|||
16920923|NCT03460756|38062339|FG003|Overall Study|Pregnancy|1|||
16920924|NCT03460756|38062336|FG000|Overall Study|Protocol Violation|0|||
16920925|NCT03460756|38062337|FG001|Overall Study|Protocol Violation|0|||
16920926|NCT03460756|38062338|FG002|Overall Study|Protocol Violation|0|||
16920927|NCT03460756|38062339|FG003|Overall Study|Protocol Violation|1|||
16920928|NCT03460756|38062336|FG000|Overall Study|Withdrawal by Subject|0|||
16920929|NCT03460756|38062337|FG001|Overall Study|Withdrawal by Subject|4|||
16920930|NCT03460756|38062338|FG002|Overall Study|Withdrawal by Subject|7|||
16920931|NCT03460756|38062339|FG003|Overall Study|Withdrawal by Subject|3|||
16920932|NCT03373461|38062356|FG000|Part 2|Adverse Event|0|||
16920933|NCT03373461|38062357|FG001|Part 2|Adverse Event|1|||
16920934|NCT03373461|38062358|FG002|Part 2|Adverse Event|0|||
16920935|NCT03373461|38062359|FG003|Part 2|Adverse Event|0|||
16920936|NCT03373461|38062360|FG004|Part 2|Adverse Event|1|||
16920937|NCT03364751|38062411|FG000|Overall Study|Withdrawal by Subject|1|||
16920938|NCT03364751|38062412|FG001|Overall Study|Withdrawal by Subject|0|||
16920939|NCT03364751|38062413|FG002|Overall Study|Withdrawal by Subject|0|||
16920940|NCT03364751|38062414|FG003|Overall Study|Withdrawal by Subject|0|||
16920941|NCT03364751|38062411|FG000|Overall Study|Lost to Follow-up|0|||
16920942|NCT03364751|38062412|FG001|Overall Study|Lost to Follow-up|1|||
16920943|NCT03364751|38062413|FG002|Overall Study|Lost to Follow-up|0|||
16920944|NCT03364751|38062414|FG003|Overall Study|Lost to Follow-up|0|||
16920945|NCT03149003|38062435|FG000|Overall Study|Randomized but not treated|0|||
16920946|NCT03149003|38062436|FG001|Overall Study|Randomized but not treated|1|||
16920947|NCT03149003|38062437|FG002|Overall Study|Randomized but not treated|18|||
16920948|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
16920949|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
16920950|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
16920951|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
16920952|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
16920953|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
16920954|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
16920955|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
16920956|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
16920957|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
16920958|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
16920959|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
16920960|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16920961|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16920962|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
16920963|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
16920964|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
16920965|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
16920966|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
16920967|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
16920968|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
16920969|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
16920970|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
16920971|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
16920972|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
16920973|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
16920974|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
16920975|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
16920976|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Death|0|||
16920977|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Death|1|||
16846044|NCT01839656|37791106|FG000|Overall Study|Adverse Event|1|||
16846045|NCT01839656|37791107|FG001|Overall Study|Adverse Event|0|||
16846046|NCT01839188|37791113|FG000|Overall Study|Withdrawal by Subject|1|||
16846047|NCT01838876|37791122|FG000|Overall Study|Adverse Event|49|||
16920978|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Death|0|||
16920979|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Death|0|||
16920980|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
16920981|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
16920982|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
16920983|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
16920984|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
16920985|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
16920986|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
16920987|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
16920988|NCT02990806|38062447|FG000|Stage 1 (22 Weeks)|Other|1|||
16920989|NCT02990806|38062448|FG001|Stage 1 (22 Weeks)|Other|3|||
16920990|NCT02990806|38062449|FG002|Stage 1 (22 Weeks)|Other|0|||
16920991|NCT02990806|38062450|FG003|Stage 1 (22 Weeks)|Other|0|||
16920992|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
16920993|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
16920994|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
16920995|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
16920996|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Death|1|||
16920997|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Death|0|||
16920998|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Death|0|||
16920999|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Death|0|||
16921000|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
16921001|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
16921002|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
16921003|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
16921004|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
16921005|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
16921006|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
16921007|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
16846048|NCT01838876|37791122|FG000|Overall Study|Insufficient Therapeutic Response|10|||
16846049|NCT01838876|37791122|FG000|Overall Study|Protocol Violation|34|||
16846050|NCT01838876|37791122|FG000|Overall Study|Withdrawal of Consent|33|||
16846051|NCT01838876|37791122|FG000|Overall Study|Lost to Follow-up|21|||
16846052|NCT01838876|37791122|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
16846053|NCT01838876|37791122|FG000|Overall Study|Reason not Specified|7|||
16846054|NCT01838876|37791122|FG000|Overall Study|Did not meet eligibility criteria|78|||
16846055|NCT01838642|37791137|FG000|Overall Study|Died on study|1|||
16846056|NCT01611194|37791144|FG000|Overall Study|Lost to Follow-up|0|||
16846057|NCT01611194|37791145|FG001|Overall Study|Lost to Follow-up|1|||
16846058|NCT01611194|37791144|FG000|Overall Study|Withdrawal by Subject|0|||
16846059|NCT01611194|37791145|FG001|Overall Study|Withdrawal by Subject|1|||
16846060|NCT01611194|37791144|FG000|Overall Study|drug use|0|||
16846061|NCT01611194|37791145|FG001|Overall Study|drug use|1|||
16846062|NCT01813058|37791153|FG000|Overall Study|Withdrawal by Subject|5|||
16846063|NCT01813058|37791154|FG001|Overall Study|Withdrawal by Subject|4|||
16846064|NCT01867424|37791162|FG000|Overall Study|Patient noncompliance|2|||
16846065|NCT01867424|37791163|FG001|Overall Study|Patient noncompliance|1|||
16921008|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
16921009|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
16921010|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
16921011|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
16921012|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
16921013|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
16921014|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
16921015|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
16921016|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16921017|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
16921018|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
16846066|NCT01811732|37791171|FG000|Overall Study|Lost to Follow-up|24|||
16846067|NCT01811732|37791172|FG001|Overall Study|Lost to Follow-up|30|||
16846068|NCT01811732|37791171|FG000|Overall Study|Withdrawal by Subject|16|||
16846069|NCT01811732|37791172|FG001|Overall Study|Withdrawal by Subject|10|||
16846070|NCT01811732|37791171|FG000|Overall Study|Adverse Event|3|||
16846071|NCT01811732|37791172|FG001|Overall Study|Adverse Event|9|||
16846072|NCT01811732|37791171|FG000|Overall Study|Lack of Efficacy|3|||
16846073|NCT01811732|37791172|FG001|Overall Study|Lack of Efficacy|1|||
16846074|NCT01811732|37791171|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
16846075|NCT01811732|37791172|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
16846076|NCT01811732|37791171|FG000|Overall Study|Physician Decision|2|||
16846077|NCT01811732|37791172|FG001|Overall Study|Physician Decision|0|||
16846078|NCT01811732|37791171|FG000|Overall Study|Death|1|||
16846079|NCT01811732|37791172|FG001|Overall Study|Death|1|||
16846080|NCT01811732|37791171|FG000|Overall Study|Insufficient venous access|0|||
16846081|NCT01811732|37791172|FG001|Overall Study|Insufficient venous access|1|||
16846082|NCT01811732|37791171|FG000|Overall Study|Protocol Violation|0|||
16846083|NCT01811732|37791172|FG001|Overall Study|Protocol Violation|1|||
16846084|NCT01811732|37791171|FG000|Overall Study|Subject incarcerated|1|||
16921019|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
16921020|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
16921021|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
16921022|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
16921023|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
16921024|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
16921025|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
16921026|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
16921027|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
16921028|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
16921029|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
16921030|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
16921031|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
16921032|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
16921033|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
16921034|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
16921035|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
16921036|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Other|3|||
16921037|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Other|0|||
16921038|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Other|4|||
16921039|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Other|1|||
16921040|NCT02990806|38062447|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
16921041|NCT02990806|38062448|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
16921042|NCT02990806|38062449|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
16921043|NCT02990806|38062450|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
16921044|NCT02990806|38062447|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
16921045|NCT02990806|38062448|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
16921046|NCT02990806|38062449|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
16921047|NCT02990806|38062450|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
16921048|NCT02990806|38062447|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
16921049|NCT02990806|38062448|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
16921050|NCT02990806|38062449|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
16921051|NCT02990806|38062450|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
16921052|NCT02990806|38062447|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16921053|NCT02990806|38062448|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
16921054|NCT02990806|38062449|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16921055|NCT02990806|38062450|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16921056|NCT02990806|38062447|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
16921057|NCT02990806|38062448|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
16921058|NCT02990806|38062449|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
16921059|NCT02990806|38062450|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
16921060|NCT02990806|38062447|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
16921061|NCT02990806|38062448|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
16921062|NCT02990806|38062449|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
16921063|NCT02990806|38062450|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
16921064|NCT02990806|38062447|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
16921065|NCT02990806|38062448|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
16921066|NCT02990806|38062449|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
16921067|NCT02990806|38062450|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
16921068|NCT02990806|38062447|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
16921069|NCT02990806|38062448|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
17102517|NCT03628924|38241412|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
16846085|NCT01811732|37791172|FG001|Overall Study|Subject incarcerated|2|||
16846086|NCT01811732|37791171|FG000|Overall Study|Admitted to another facility|1|||
16921070|NCT02990806|38062449|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
16921071|NCT02990806|38062450|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
16921072|NCT02990806|38062447|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
16921073|NCT02990806|38062448|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
16921074|NCT02990806|38062449|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
16921075|NCT02990806|38062450|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
16846087|NCT01811732|37791172|FG001|Overall Study|Admitted to another facility|0|||
16846088|NCT01811732|37791171|FG000|Overall Study|Correct study drug not available on site|1|||
16846089|NCT01811732|37791172|FG001|Overall Study|Correct study drug not available on site|0|||
16846090|NCT01836458|37791183|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16846091|NCT01836458|37791184|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16846092|NCT01836458|37791185|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
16846093|NCT01836458|37791186|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
16846094|NCT01811186|37791198|FG000|Overall Study|Adverse Event|54|||
16846095|NCT01811186|37791199|FG001|Overall Study|Adverse Event|38|||
16846096|NCT01811186|37791198|FG000|Overall Study|Protocol Violation|5|||
16846097|NCT01811186|37791199|FG001|Overall Study|Protocol Violation|6|||
16846098|NCT01811186|37791198|FG000|Overall Study|Withdrawal by Subject|5|||
16846099|NCT01811186|37791199|FG001|Overall Study|Withdrawal by Subject|10|||
16846100|NCT01811186|37791198|FG000|Overall Study|Lack of Efficacy|3|||
16846101|NCT01811186|37791199|FG001|Overall Study|Lack of Efficacy|6|||
16846102|NCT01811186|37791198|FG000|Overall Study|Lost to Follow-up|4|||
16846103|NCT01811186|37791199|FG001|Overall Study|Lost to Follow-up|2|||
16846104|NCT01866098|37791212|FG000|Overall Study|Lost to Follow-up|11|||
16846105|NCT01866098|37791213|FG001|Overall Study|Lost to Follow-up|18|||
16846106|NCT01866098|37791214|FG002|Overall Study|Lost to Follow-up|13|||
16846107|NCT01866098|37791212|FG000|Overall Study|Physician Decision|0|||
16921076|NCT02420821|38062532|FG000|Overall Study|Lost to Follow-up|6|||
16921077|NCT02420821|38062533|FG001|Overall Study|Lost to Follow-up|6|||
16921078|NCT02420821|38062532|FG000|Overall Study|Non-compliance|0|||
16921079|NCT02420821|38062533|FG001|Overall Study|Non-compliance|2|||
16921080|NCT02420821|38062532|FG000|Overall Study|Physician Decision|6|||
16921081|NCT02420821|38062533|FG001|Overall Study|Physician Decision|2|||
16921082|NCT02420821|38062532|FG000|Overall Study|Withdrawal by Subject|32|||
16921083|NCT02420821|38062533|FG001|Overall Study|Withdrawal by Subject|25|||
16921084|NCT02420821|38062532|FG000|Overall Study|Death|270|||
16921085|NCT02420821|38062533|FG001|Overall Study|Death|263|||
16921086|NCT02420821|38062532|FG000|Overall Study|Study Terminated By Sponsor|145|||
16921087|NCT02420821|38062533|FG001|Overall Study|Study Terminated By Sponsor|149|||
16921088|NCT02420821|38062532|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
16921089|NCT02420821|38062533|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
16921090|NCT02420821|38062532|FG000|Overall Study|Adverse Event|0|||
16921091|NCT02420821|38062533|FG001|Overall Study|Adverse Event|1|||
16921092|NCT02420821|38062532|FG000|Overall Study|Protinuria|0|||
16921093|NCT02420821|38062533|FG001|Overall Study|Protinuria|1|||
16921094|NCT02420821|38062532|FG000|Overall Study|Progressive Disease|1|||
16921095|NCT02420821|38062533|FG001|Overall Study|Progressive Disease|1|||
16921096|NCT02420821|38062532|FG000|Overall Study|Disease Progression|0|||
16921097|NCT02420821|38062533|FG001|Overall Study|Disease Progression|1|||
16921098|NCT02420821|38062532|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
16921099|NCT02420821|38062533|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
16921100|NCT02066181|38062551|FG000|Overall Study|Withdrawal by Subject|1|||
16921101|NCT02066181|38062552|FG001|Overall Study|Withdrawal by Subject|1|||
16921102|NCT02059265|38062561|FG000|Overall Study|Ineligible|4|||
16921103|NCT02039063|38062569|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
16921104|NCT02039063|38062570|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
16921105|NCT02039063|38062571|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
16921106|NCT02039063|38062572|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
16921107|NCT02039063|38062569|FG000|Treatment Phase|Progression of disease|0|||
16921108|NCT02039063|38062570|FG001|Treatment Phase|Progression of disease|0|||
16921109|NCT02039063|38062571|FG002|Treatment Phase|Progression of disease|1|||
16921110|NCT02039063|38062572|FG003|Treatment Phase|Progression of disease|1|||
16921111|NCT02039063|38062569|FG000|Extension Phase|Inadequate therapeutic effect|0|||
16846108|NCT01866098|37791213|FG001|Overall Study|Physician Decision|1|||
16921112|NCT02039063|38062570|FG001|Extension Phase|Inadequate therapeutic effect|1|||
16921113|NCT02039063|38062571|FG002|Extension Phase|Inadequate therapeutic effect|2|||
16921114|NCT02039063|38062572|FG003|Extension Phase|Inadequate therapeutic effect|0|||
16921115|NCT02039063|38062569|FG000|Extension Phase|Progression of disease|0|||
16921116|NCT02039063|38062570|FG001|Extension Phase|Progression of disease|0|||
16921117|NCT02039063|38062571|FG002|Extension Phase|Progression of disease|0|||
16921118|NCT02039063|38062572|FG003|Extension Phase|Progression of disease|1|||
16846109|NCT01866098|37791214|FG002|Overall Study|Physician Decision|2|||
16846110|NCT01866098|37791212|FG000|Overall Study|Adverse Event|1|||
16846111|NCT01866098|37791213|FG001|Overall Study|Adverse Event|5|||
16846112|NCT01866098|37791214|FG002|Overall Study|Adverse Event|4|||
16846113|NCT01866098|37791212|FG000|Overall Study|Protocol Violation|1|||
16921119|NCT02039063|38062569|FG000|Extension Phase|Adverse Event|0|||
16921120|NCT02039063|38062570|FG001|Extension Phase|Adverse Event|0|||
16921121|NCT02039063|38062571|FG002|Extension Phase|Adverse Event|1|||
16921122|NCT02039063|38062572|FG003|Extension Phase|Adverse Event|0|||
16921123|NCT01746173|38062593|FG000|Overall Study|Disease Progression|2|||
16921124|NCT02995733|38062633|FG000|Overall Study|Study site closed|9|||
16921125|NCT02995733|38062634|FG001|Overall Study|Study site closed|10|||
16921126|NCT02995733|38062633|FG000|Overall Study|Death|3|||
16921127|NCT02995733|38062634|FG001|Overall Study|Death|4|||
16921128|NCT02995733|38062633|FG000|Overall Study|Withdrawal by Subject|6|||
16921129|NCT02995733|38062634|FG001|Overall Study|Withdrawal by Subject|2|||
16921130|NCT02995733|38062633|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
16921131|NCT02995733|38062634|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
16921132|NCT02995733|38062633|FG000|Overall Study|Lost to Follow-up|48|||
16921133|NCT02995733|38062634|FG001|Overall Study|Lost to Follow-up|37|||
16921134|NCT02995733|38062633|FG000|Overall Study|Other|0|||
16921135|NCT02995733|38062634|FG001|Overall Study|Other|1|||
16921136|NCT02815566|38062651|FG000|Overall Study|Adverse Event|1|||
16921137|NCT02815566|38062652|FG001|Overall Study|Adverse Event|1|||
16921138|NCT02815566|38062651|FG000|Overall Study|Withdrawal by Subject|1|||
16921139|NCT02815566|38062652|FG001|Overall Study|Withdrawal by Subject|0|||
16921140|NCT02815566|38062651|FG000|Overall Study|Lost to Follow-up|0|||
16921141|NCT02815566|38062652|FG001|Overall Study|Lost to Follow-up|1|||
16921142|NCT02578680|38062661|FG000|Overall Study|Death|124|||
16921143|NCT02578680|38062662|FG001|Overall Study|Death|104|||
16921144|NCT02578680|38062661|FG000|Overall Study|Protocol Violation|1|||
16921145|NCT02578680|38062662|FG001|Overall Study|Protocol Violation|1|||
16921146|NCT02578680|38062661|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16846114|NCT01866098|37791213|FG001|Overall Study|Protocol Violation|0|||
16846115|NCT01866098|37791214|FG002|Overall Study|Protocol Violation|0|||
16846116|NCT01866098|37791212|FG000|Overall Study|Withdrawal by Subject|1|||
16846117|NCT01866098|37791213|FG001|Overall Study|Withdrawal by Subject|2|||
16846118|NCT01866098|37791214|FG002|Overall Study|Withdrawal by Subject|0|||
16846119|NCT01866098|37791212|FG000|Overall Study|Unrelated Hospitalization|2|||
16921147|NCT02578680|38062662|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
17017417|NCT00878969|38162047|FG002|Overall Study|Withdrawal by Subject|3|||
17017418|NCT00878969|38162045|FG000|Overall Study|kidney transplant|2|||
17017419|NCT00878969|38162046|FG001|Overall Study|kidney transplant|3|||
17017420|NCT00878969|38162047|FG002|Overall Study|kidney transplant|2|||
17017421|NCT00878969|38162045|FG000|Overall Study|Adverse Event|3|||
17017422|NCT00878969|38162046|FG001|Overall Study|Adverse Event|1|||
17017423|NCT00878969|38162047|FG002|Overall Study|Adverse Event|2|||
17017424|NCT00878969|38162045|FG000|Overall Study|Lost to Follow-up|2|||
17017425|NCT00878969|38162046|FG001|Overall Study|Lost to Follow-up|1|||
17017426|NCT00878969|38162047|FG002|Overall Study|Lost to Follow-up|0|||
17017427|NCT00878969|38162045|FG000|Overall Study|Protocol Violation|2|||
17017428|NCT00878969|38162046|FG001|Overall Study|Protocol Violation|0|||
17017429|NCT00878969|38162047|FG002|Overall Study|Protocol Violation|0|||
17017430|NCT00878969|38162045|FG000|Overall Study|Death|0|||
17017431|NCT00878969|38162046|FG001|Overall Study|Death|0|||
17017432|NCT00878969|38162047|FG002|Overall Study|Death|2|||
17017433|NCT00878969|38162045|FG000|Overall Study|Pregnancy|0|||
17017434|NCT00878969|38162046|FG001|Overall Study|Pregnancy|1|||
17017435|NCT00878969|38162047|FG002|Overall Study|Pregnancy|0|||
17017436|NCT00843726|38162061|FG000|Overall Study|Death|1|||
17017437|NCT00843726|38162062|FG001|Overall Study|Death|0|||
17017438|NCT00843726|38162061|FG000|Overall Study|Withdrawal by Subject|0|||
17017439|NCT00843726|38162062|FG001|Overall Study|Withdrawal by Subject|1|||
17017440|NCT00843492|38162071|FG000|Overall Study|Adverse Event|0|||
17017441|NCT00843492|38162072|FG001|Overall Study|Adverse Event|3|||
17017442|NCT00843492|38162071|FG000|Overall Study|Lost to Follow-up|4|||
17017443|NCT00843492|38162072|FG001|Overall Study|Lost to Follow-up|4|||
17017444|NCT00843492|38162071|FG000|Overall Study|Withdrawal by Subject|0|||
17017445|NCT00843492|38162072|FG001|Overall Study|Withdrawal by Subject|4|||
17017446|NCT00843492|38162071|FG000|Overall Study|Immobilization Stopped|1|||
17017447|NCT00843492|38162072|FG001|Overall Study|Immobilization Stopped|0|||
17017448|NCT00843492|38162071|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
17017449|NCT00843492|38162072|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
17017450|NCT00843492|38162071|FG000|Overall Study|Orthopedic Surgery|0|||
17017451|NCT00843492|38162072|FG001|Overall Study|Orthopedic Surgery|2|||
17017452|NCT00843492|38162071|FG000|Overall Study|Visit Not Performed|1|||
17017453|NCT00843492|38162072|FG001|Overall Study|Visit Not Performed|0|||
17017454|NCT00843492|38162071|FG000|Overall Study|Deep-vein Thrombosis|1|||
16921148|NCT02578680|38062661|FG000|Overall Study|Withdrawal by Subject|8|||
16921149|NCT02578680|38062662|FG001|Overall Study|Withdrawal by Subject|5|||
16921150|NCT02578680|38062661|FG000|Overall Study|Ongoing in Study|276|||
16921151|NCT02578680|38062662|FG001|Overall Study|Ongoing in Study|96|||
16846120|NCT01866098|37791213|FG001|Overall Study|Unrelated Hospitalization|0|||
16846121|NCT01866098|37791214|FG002|Overall Study|Unrelated Hospitalization|1|||
16846122|NCT01866098|37791212|FG000|Overall Study|Non-compliance|1|||
16846123|NCT01866098|37791213|FG001|Overall Study|Non-compliance|0|||
16846124|NCT01866098|37791214|FG002|Overall Study|Non-compliance|1|||
16846125|NCT01866098|37791212|FG000|Overall Study|Pregnancy|2|||
16846126|NCT01866098|37791213|FG001|Overall Study|Pregnancy|0|||
16846127|NCT01866098|37791214|FG002|Overall Study|Pregnancy|0|||
16921152|NCT02525783|38062668|FG000|Overall Study|Lost to Follow-up|10|||
16921153|NCT02466243|38062684|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
16921154|NCT02466243|38062685|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
16921155|NCT02466243|38062684|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
16921156|NCT02466243|38062685|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
16921157|NCT02466243|38062684|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
16921158|NCT02466243|38062685|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
16921159|NCT02466243|38062684|FG000|Part B Open-label Treatment Period|Missing|2|||
16921160|NCT02466243|38062685|FG001|Part B Open-label Treatment Period|Missing|2|||
16921161|NCT02321098|38062698|FG000|12 Weeks Treament|Lost to Follow-up|1|||
16921162|NCT02321098|38062699|FG001|12 Weeks Treament|Lost to Follow-up|1|||
16921163|NCT02321098|38062700|FG002|12 Weeks Treament|Lost to Follow-up|0|||
16921164|NCT02321098|38062698|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
17017455|NCT00843492|38162072|FG001|Overall Study|Deep-vein Thrombosis|0|||
17017456|NCT00833976|38162078|FG000|Overall Study|Withdrawal by Subject|5|||
17017457|NCT00833976|38162078|FG000|Overall Study|Lost to Follow-up|4|||
17017458|NCT00833976|38162078|FG000|Overall Study|Did not meet eligibility criteria|41|||
17017459|NCT00833976|38162078|FG000|Overall Study|Physician Decision|1|||
17017460|NCT00833898|38162084|FG000|Overall Study|Withdrawal by Subject|33|||
17017461|NCT00833898|38162085|FG001|Overall Study|Withdrawal by Subject|27|||
17017462|NCT00833898|38162084|FG000|Overall Study|Lost to Follow-up|7|||
17017463|NCT00833898|38162085|FG001|Overall Study|Lost to Follow-up|7|||
17017464|NCT00833898|38162084|FG000|Overall Study|Patient did not receive transplant|0|||
17017465|NCT00833898|38162085|FG001|Overall Study|Patient did not receive transplant|2|||
17017466|NCT00825162|38162094|FG000|Overall Study|Withdrawal by Subject|11|||
17017467|NCT00825162|38162095|FG001|Overall Study|Withdrawal by Subject|13|||
17017468|NCT00825162|38162096|FG002|Overall Study|Withdrawal by Subject|3|||
17017469|NCT00825162|38162094|FG000|Overall Study|Lost to Follow-up|9|||
17017470|NCT00825162|38162095|FG001|Overall Study|Lost to Follow-up|6|||
17017471|NCT00825162|38162096|FG002|Overall Study|Lost to Follow-up|3|||
17017472|NCT00825162|38162094|FG000|Overall Study|Physician Decision|2|||
17017473|NCT00825162|38162095|FG001|Overall Study|Physician Decision|0|||
17017474|NCT00825162|38162096|FG002|Overall Study|Physician Decision|0|||
17017475|NCT00825162|38162094|FG000|Overall Study|Move away from the study area|1|||
17017476|NCT00825162|38162095|FG001|Overall Study|Move away from the study area|0|||
17017477|NCT00825162|38162096|FG002|Overall Study|Move away from the study area|0|||
17017478|NCT00825162|38162094|FG000|Overall Study|Unable to attend the study visit|5|||
17017479|NCT00825162|38162095|FG001|Overall Study|Unable to attend the study visit|2|||
17017480|NCT00825162|38162096|FG002|Overall Study|Unable to attend the study visit|0|||
17017481|NCT00824850|38162111|FG000|Overall Study|Withdrawal by Subject|0|||
17017482|NCT00824850|38162112|FG001|Overall Study|Withdrawal by Subject|1|||
17017483|NCT00596687|38162126|FG000|Overall Study|< 24 hours of insulin treatment|8|||
17017484|NCT00596687|38162127|FG001|Overall Study|< 24 hours of insulin treatment|6|||
17017485|NCT00596687|38162126|FG000|Overall Study|continuous insulin infusion during TPN|2|||
17017486|NCT00596687|38162127|FG001|Overall Study|continuous insulin infusion during TPN|1|||
17017487|NCT00596687|38162126|FG000|Overall Study|Withdrawal by Subject|3|||
17017488|NCT00596687|38162127|FG001|Overall Study|Withdrawal by Subject|1|||
17017489|NCT00596687|38162126|FG000|Overall Study|cancelled surgery|1|||
17017490|NCT00596687|38162127|FG001|Overall Study|cancelled surgery|1|||
17017491|NCT00824772|38162133|FG000|Overall Study|Withdrawal by Subject|8|||
17017492|NCT00824616|38162139|FG000|Overall Study|Adverse Event|2|||
17017493|NCT00824616|38162140|FG001|Overall Study|Adverse Event|1|||
17017494|NCT00824616|38162139|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
17017495|NCT00824616|38162140|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
16846128|NCT01866098|37791212|FG000|Overall Study|Death|0|||
16846129|NCT01866098|37791213|FG001|Overall Study|Death|1|||
16846130|NCT01866098|37791214|FG002|Overall Study|Death|0|||
16846131|NCT01865552|37791228|FG000|Period 1|Adverse Event|1|||
16921165|NCT02321098|38062699|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
16921166|NCT02321098|38062700|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
17017496|NCT00824616|38162139|FG000|Overall Study|Hyperglycemia|1|||
17017497|NCT00824616|38162140|FG001|Overall Study|Hyperglycemia|1|||
17017498|NCT00824616|38162139|FG000|Overall Study|Lack of Efficacy|2|||
17017499|NCT00824616|38162140|FG001|Overall Study|Lack of Efficacy|1|||
17017500|NCT00824616|38162139|FG000|Overall Study|Lost to Follow-up|0|||
17017501|NCT00824616|38162140|FG001|Overall Study|Lost to Follow-up|1|||
17017502|NCT00824616|38162139|FG000|Overall Study|Withdrawal by Subject|1|||
16846132|NCT01865552|37791229|FG001|Period 1|Adverse Event|0|||
16846133|NCT01865552|37791230|FG002|Period 1|Adverse Event|0|||
16846134|NCT01865552|37791231|FG003|Period 1|Adverse Event|1|||
16846135|NCT01865552|37791232|FG004|Period 1|Adverse Event|1|||
16846136|NCT01865552|37791233|FG005|Period 1|Adverse Event|1|||
16846137|NCT01865552|37791228|FG000|Period 1|Pathological lab|0|||
16921167|NCT02321098|38062698|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
16921168|NCT02321098|38062699|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
16921169|NCT02321098|38062700|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
16921170|NCT02321098|38062698|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
16921171|NCT02321098|38062699|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
16921172|NCT02321098|38062700|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
16921173|NCT02213926|38062709|FG000|Overall Study|Death|59|||
16921174|NCT02213926|38062709|FG000|Overall Study|Withdrawal by Subject|10|||
16846138|NCT01865552|37791229|FG001|Period 1|Pathological lab|0|||
16846139|NCT01865552|37791230|FG002|Period 1|Pathological lab|0|||
16846140|NCT01865552|37791231|FG003|Period 1|Pathological lab|0|||
16846141|NCT01865552|37791232|FG004|Period 1|Pathological lab|1|||
16846142|NCT01865552|37791233|FG005|Period 1|Pathological lab|0|||
16846143|NCT01865552|37791228|FG000|Period 1|Other|0|||
16846144|NCT01865552|37791229|FG001|Period 1|Other|0|||
16846145|NCT01865552|37791230|FG002|Period 1|Other|0|||
16846146|NCT01865552|37791231|FG003|Period 1|Other|0|||
16846147|NCT01865552|37791232|FG004|Period 1|Other|1|||
16846148|NCT01865552|37791233|FG005|Period 1|Other|0|||
16846149|NCT01809314|37791247|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
16846150|NCT01809314|37791247|FG000|Overall Study|Adverse Event|6|||
16846151|NCT01809314|37791247|FG000|Overall Study|Insufficient Therapeutic Response|14|||
16846152|NCT01809314|37791247|FG000|Overall Study|Lost to Follow-up|724|||
16846153|NCT01803464|37791255|FG000|Overall Study|Incomplete data|0|||
16921175|NCT02213926|38062709|FG000|Overall Study|study terminated by sponsor|51|||
16921176|NCT02213926|38062709|FG000|Overall Study|Lost to Follow-up|3|||
16921177|NCT02213926|38062709|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
16921178|NCT01966731|38062713|FG000|Overall Study|Death|2|||
16921179|NCT01966731|38062713|FG000|Overall Study|Lost to Follow-up|1|||
16921180|NCT01966731|38062713|FG000|Overall Study|Physician Decision|2|||
16921181|NCT01966731|38062713|FG000|Overall Study|Follow up is not complete|600|||
16921182|NCT01966731|38062713|FG000|Overall Study|Screening Failure|29|||
16921183|NCT01966731|38062713|FG000|Overall Study|Found to be ineligible|1|||
16921184|NCT01843374|38062719|FG000|Overall Study|Death|155|||
16921185|NCT01843374|38062720|FG001|Overall Study|Death|313|||
16921186|NCT01843374|38062719|FG000|Overall Study|Withdrawal by Subject|14|||
16921187|NCT01843374|38062720|FG001|Overall Study|Withdrawal by Subject|20|||
17017503|NCT00824616|38162140|FG001|Overall Study|Withdrawal by Subject|1|||
17017504|NCT00824382|38162150|FG000|Overall Study|Adverse Event|4|||
16846154|NCT01803464|37791256|FG001|Overall Study|Incomplete data|0|||
17017505|NCT00824382|38162151|FG001|Overall Study|Adverse Event|1|||
17017506|NCT00824382|38162152|FG002|Overall Study|Adverse Event|1|||
17017507|NCT00824382|38162153|FG003|Overall Study|Adverse Event|4|||
17017508|NCT00824382|38162150|FG000|Overall Study|Protocol Violation|1|||
17017509|NCT00824382|38162151|FG001|Overall Study|Protocol Violation|0|||
17017510|NCT00824382|38162152|FG002|Overall Study|Protocol Violation|0|||
17017511|NCT00824382|38162153|FG003|Overall Study|Protocol Violation|1|||
17017512|NCT00824382|38162150|FG000|Overall Study|Investigator's decision|0|||
17017513|NCT00824382|38162151|FG001|Overall Study|Investigator's decision|1|||
17017514|NCT00824382|38162152|FG002|Overall Study|Investigator's decision|2|||
17017515|NCT00824382|38162153|FG003|Overall Study|Investigator's decision|0|||
17017516|NCT00833040|38162165|FG000|Overall Study|Adverse Event|0|||
17017517|NCT00833040|38162166|FG001|Overall Study|Adverse Event|0|||
17017518|NCT00833040|38162167|FG002|Overall Study|Adverse Event|0|||
17017519|NCT00833040|38162168|FG003|Overall Study|Adverse Event|0|||
17017520|NCT00833040|38162169|FG004|Overall Study|Adverse Event|0|||
17017521|NCT00833040|38162170|FG005|Overall Study|Adverse Event|1|||
17017522|NCT00843024|38162179|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
17017523|NCT00843024|38162180|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
17017524|NCT00843024|38162181|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
17017525|NCT00843024|38162182|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
17017526|NCT00843024|38162183|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
17017527|NCT00843024|38162184|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
17017528|NCT00843024|38162179|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
16846155|NCT01803464|37791257|FG002|Overall Study|Incomplete data|4|||
16846156|NCT01803464|37791258|FG003|Overall Study|Incomplete data|0|||
16846157|NCT01803464|37791255|FG000|Overall Study|Withdrawal by Subject|1|||
16846158|NCT01803464|37791256|FG001|Overall Study|Withdrawal by Subject|0|||
17017529|NCT00843024|38162180|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
16846159|NCT01803464|37791257|FG002|Overall Study|Withdrawal by Subject|0|||
16846160|NCT01803464|37791258|FG003|Overall Study|Withdrawal by Subject|0|||
16846161|NCT01808690|37791274|FG000|Overall Study|Withdrawal by Subject|1|||
16846162|NCT01808690|37791275|FG001|Overall Study|Withdrawal by Subject|2|||
16921188|NCT01843374|38062719|FG000|Overall Study|Withdrawing due to Other reason|20|||
16921189|NCT01843374|38062720|FG001|Overall Study|Withdrawing due to Other reason|46|||
16921190|NCT01620944|38062742|FG000|Overall Study|Early termination of Study|2|||
16921191|NCT01620944|38062743|FG001|Overall Study|Early termination of Study|1|||
16846163|NCT01363297|37791286|FG000|Overall Study|Other|0|||
16846164|NCT01363297|37791287|FG001|Overall Study|Other|0|||
16846165|NCT01363297|37791288|FG002|Overall Study|Other|0|||
16846166|NCT01363297|37791289|FG003|Overall Study|Other|0|||
16846167|NCT01363297|37791290|FG004|Overall Study|Other|1|||
16846168|NCT01363297|37791286|FG000|Overall Study|Death|3|||
16846169|NCT01363297|37791287|FG001|Overall Study|Death|6|||
16921192|NCT01627561|38062751|FG000|Overall Study|Lost to Follow-up|1|||
16921193|NCT01627561|38062752|FG001|Overall Study|Lost to Follow-up|0|||
16921194|NCT01627561|38062751|FG000|Overall Study|Withdrawal by Subject|0|||
16921195|NCT01627561|38062752|FG001|Overall Study|Withdrawal by Subject|1|||
16921196|NCT01627561|38062751|FG000|Overall Study|Migrated/moved from study area|0|||
16921197|NCT01627561|38062752|FG001|Overall Study|Migrated/moved from study area|2|||
16846170|NCT01363297|37791288|FG002|Overall Study|Death|6|||
16846171|NCT01363297|37791289|FG003|Overall Study|Death|10|||
16921198|NCT01652534|38062777|FG000|Overall Study|Lack of Efficacy|1|||
16921199|NCT01652534|38062778|FG001|Overall Study|Lack of Efficacy|0|||
16921200|NCT04709575|38062786|FG000|Overall Study|Withdrawal by Subject|6|||
16921201|NCT04709575|38062787|FG001|Overall Study|Withdrawal by Subject|2|||
16921202|NCT04709575|38062786|FG000|Overall Study|Lost to Follow-up|2|||
16921203|NCT04709575|38062787|FG001|Overall Study|Lost to Follow-up|2|||
16921204|NCT04709575|38062786|FG000|Overall Study|Adverse Event|1|||
16921205|NCT04709575|38062787|FG001|Overall Study|Adverse Event|0|||
16921206|NCT04709575|38062786|FG000|Overall Study|Protocol Violation|1|||
16921207|NCT04709575|38062787|FG001|Overall Study|Protocol Violation|1|||
16921208|NCT04450407|38062796|FG000|Overall Study|Withdrawal by Subject|10|||
16846172|NCT01363297|37791290|FG004|Overall Study|Death|30|||
16846173|NCT01908907|37791309|FG000|Overall Study|Physician Decision|1|||
16846174|NCT01908907|37791310|FG001|Overall Study|Physician Decision|0|||
16846175|NCT01908907|37791309|FG000|Overall Study|Protocol Violation|1|||
16846176|NCT01908907|37791310|FG001|Overall Study|Protocol Violation|0|||
16846177|NCT01808612|37791323|FG000|Treatment Period|Adverse Event|8|||
16921209|NCT04450407|38062797|FG001|Overall Study|Withdrawal by Subject|1|||
16921210|NCT04450407|38062798|FG002|Overall Study|Withdrawal by Subject|4|||
16921211|NCT04450407|38062796|FG000|Overall Study|Adverse Event|0|||
16921212|NCT04450407|38062797|FG001|Overall Study|Adverse Event|0|||
16921213|NCT04450407|38062798|FG002|Overall Study|Adverse Event|1|||
16921214|NCT04450407|38062796|FG000|Overall Study|Lost to Follow-up|1|||
16921215|NCT04450407|38062797|FG001|Overall Study|Lost to Follow-up|0|||
16921216|NCT04450407|38062798|FG002|Overall Study|Lost to Follow-up|0|||
16921217|NCT04450407|38062796|FG000|Overall Study|Physician Decision|0|||
16921218|NCT04450407|38062797|FG001|Overall Study|Physician Decision|0|||
16921219|NCT04450407|38062798|FG002|Overall Study|Physician Decision|1|||
16921220|NCT04450407|38062796|FG000|Overall Study|Pregnancy|1|||
16921221|NCT04450407|38062797|FG001|Overall Study|Pregnancy|0|||
16921222|NCT04450407|38062798|FG002|Overall Study|Pregnancy|0|||
16921223|NCT04450407|38062796|FG000|Overall Study|Protocol Violation|2|||
16921224|NCT04450407|38062797|FG001|Overall Study|Protocol Violation|0|||
16921225|NCT04450407|38062798|FG002|Overall Study|Protocol Violation|0|||
16921226|NCT04450407|38062796|FG000|Overall Study|Investigational site terminated by sponsor|3|||
16921227|NCT04450407|38062797|FG001|Overall Study|Investigational site terminated by sponsor|0|||
16921228|NCT04450407|38062798|FG002|Overall Study|Investigational site terminated by sponsor|2|||
16921229|NCT04418765|38062808|FG000|Overall Study|Adverse Event|1|||
16921230|NCT04418765|38062809|FG001|Overall Study|Adverse Event|1|||
16921231|NCT04418765|38062810|FG002|Overall Study|Adverse Event|6|||
16921232|NCT04418765|38062808|FG000|Overall Study|Lack of Efficacy|1|||
16921233|NCT04418765|38062809|FG001|Overall Study|Lack of Efficacy|3|||
16921234|NCT04418765|38062810|FG002|Overall Study|Lack of Efficacy|0|||
16921235|NCT04418765|38062808|FG000|Overall Study|Protocol Violation|0|||
16921236|NCT04418765|38062809|FG001|Overall Study|Protocol Violation|1|||
16921237|NCT04418765|38062810|FG002|Overall Study|Protocol Violation|1|||
16921238|NCT04418765|38062808|FG000|Overall Study|Withdrawal by Subject|1|||
16921239|NCT04418765|38062809|FG001|Overall Study|Withdrawal by Subject|5|||
16921240|NCT04418765|38062810|FG002|Overall Study|Withdrawal by Subject|2|||
16921241|NCT04418765|38062808|FG000|Overall Study|Lost to Follow-up|0|||
16921242|NCT04418765|38062809|FG001|Overall Study|Lost to Follow-up|1|||
16921243|NCT04418765|38062810|FG002|Overall Study|Lost to Follow-up|0|||
16921244|NCT04418765|38062808|FG000|Overall Study|Other than specified|2|||
16921245|NCT04418765|38062809|FG001|Overall Study|Other than specified|0|||
16921246|NCT04418765|38062810|FG002|Overall Study|Other than specified|1|||
16921247|NCT04418765|38062808|FG000|Overall Study|Randomized but not treated|1|||
16921248|NCT04418765|38062809|FG001|Overall Study|Randomized but not treated|0|||
16921249|NCT04418765|38062810|FG002|Overall Study|Randomized but not treated|0|||
16846178|NCT01808612|37791324|FG001|Treatment Period|Adverse Event|4|||
16921250|NCT04388826|38062820|FG000|Overall Study|Lost to Follow-up|3|||
16921251|NCT04388826|38062821|FG001|Overall Study|Lost to Follow-up|2|||
16846179|NCT01808612|37791325|FG002|Treatment Period|Adverse Event|3|||
16846180|NCT01808612|37791323|FG000|Treatment Period|Lost to Follow-up|2|||
16846181|NCT01808612|37791324|FG001|Treatment Period|Lost to Follow-up|2|||
16846182|NCT01808612|37791325|FG002|Treatment Period|Lost to Follow-up|1|||
16846183|NCT01808612|37791323|FG000|Treatment Period|Protocol Violation|1|||
16846184|NCT01808612|37791324|FG001|Treatment Period|Protocol Violation|0|||
16846185|NCT01808612|37791325|FG002|Treatment Period|Protocol Violation|0|||
16846186|NCT01808612|37791323|FG000|Treatment Period|Withdrawal by Subject|1|||
16846187|NCT01808612|37791324|FG001|Treatment Period|Withdrawal by Subject|0|||
16846188|NCT01808612|37791325|FG002|Treatment Period|Withdrawal by Subject|4|||
16846189|NCT01808612|37791323|FG000|Treatment Period|Physician Decision|1|||
16846190|NCT01808612|37791324|FG001|Treatment Period|Physician Decision|0|||
16846191|NCT01808612|37791325|FG002|Treatment Period|Physician Decision|4|||
16846192|NCT01808612|37791323|FG000|Treatment Period|Sponsor Decision|1|||
16846193|NCT01808612|37791324|FG001|Treatment Period|Sponsor Decision|0|||
16846194|NCT01808612|37791325|FG002|Treatment Period|Sponsor Decision|0|||
16846195|NCT01808612|37791323|FG000|Treatment Period|Lack of Efficacy|1|||
16846196|NCT01808612|37791324|FG001|Treatment Period|Lack of Efficacy|1|||
16846197|NCT01808612|37791325|FG002|Treatment Period|Lack of Efficacy|2|||
16846198|NCT01808612|37791323|FG000|Discontinuation Period|Adverse Event|1|||
16846199|NCT01808612|37791324|FG001|Discontinuation Period|Adverse Event|0|||
16846200|NCT01808612|37791325|FG002|Discontinuation Period|Adverse Event|0|||
16846201|NCT01808612|37791323|FG000|Discontinuation Period|Physician Decision|1|||
16846202|NCT01808612|37791324|FG001|Discontinuation Period|Physician Decision|0|||
16846203|NCT01808612|37791325|FG002|Discontinuation Period|Physician Decision|0|||
16846204|NCT01808612|37791323|FG000|Discontinuation Period|Lost to Follow-up|0|||
16846205|NCT01808612|37791324|FG001|Discontinuation Period|Lost to Follow-up|1|||
16846206|NCT01808612|37791325|FG002|Discontinuation Period|Lost to Follow-up|0|||
16846207|NCT01908829|37791339|FG000|Overall Study|Adverse Event|13|||
16846208|NCT01908829|37791340|FG001|Overall Study|Adverse Event|11|||
16846209|NCT01908829|37791341|FG002|Overall Study|Adverse Event|13|||
16846210|NCT01908829|37791339|FG000|Overall Study|Lost to Follow-up|4|||
16846211|NCT01908829|37791340|FG001|Overall Study|Lost to Follow-up|2|||
16846212|NCT01908829|37791341|FG002|Overall Study|Lost to Follow-up|1|||
16846213|NCT01908829|37791339|FG000|Overall Study|Randomized no double-blind drug received|1|||
16846214|NCT01908829|37791340|FG001|Overall Study|Randomized no double-blind drug received|0|||
16846215|NCT01908829|37791341|FG002|Overall Study|Randomized no double-blind drug received|1|||
16846216|NCT01908829|37791339|FG000|Overall Study|Discontinued (no EoT page)|2|||
16846217|NCT01908829|37791340|FG001|Overall Study|Discontinued (no EoT page)|0|||
16846218|NCT01908829|37791341|FG002|Overall Study|Discontinued (no EoT page)|0|||
16846219|NCT01908829|37791339|FG000|Overall Study|Miscellaneous|0|||
16846220|NCT01908829|37791340|FG001|Overall Study|Miscellaneous|2|||
16846221|NCT01908829|37791341|FG002|Overall Study|Miscellaneous|0|||
16846222|NCT01908829|37791339|FG000|Overall Study|Protocol Violation|2|||
16846223|NCT01908829|37791340|FG001|Overall Study|Protocol Violation|2|||
16846224|NCT01908829|37791341|FG002|Overall Study|Protocol Violation|0|||
16846225|NCT01908829|37791339|FG000|Overall Study|Lack of Efficacy|1|||
16846226|NCT01908829|37791340|FG001|Overall Study|Lack of Efficacy|3|||
16846227|NCT01908829|37791341|FG002|Overall Study|Lack of Efficacy|2|||
16846228|NCT01908829|37791339|FG000|Overall Study|Withdrawal by Subject|26|||
16846229|NCT01908829|37791340|FG001|Overall Study|Withdrawal by Subject|29|||
16846230|NCT01908829|37791341|FG002|Overall Study|Withdrawal by Subject|22|||
16846231|NCT01773122|37791353|FG000|Overall Study|Due to amended age eligibility criteria|3|||
16846232|NCT01773122|37791354|FG001|Overall Study|Due to amended age eligibility criteria|1|||
16846233|NCT01773122|37791355|FG002|Overall Study|Due to amended age eligibility criteria|0|||
16846234|NCT01773122|37791356|FG003|Overall Study|Due to amended age eligibility criteria|1|||
16846235|NCT01808534|37791366|FG000|Overall Study|Disease progression|3|||
16846236|NCT01808534|37791366|FG000|Overall Study|Physician Decision|1|||
16846237|NCT01808222|37791370|FG000|Overall Study|mpMR scan was not performed|1|||
16846238|NCT01772576|37791374|FG000|Overall Study|Death|15|||
16846239|NCT01772576|37791374|FG000|Overall Study|Protocol Violation|1|||
16846240|NCT01772576|37791374|FG000|Overall Study|Lost to Follow-up|3|||
16846241|NCT01772576|37791374|FG000|Overall Study|Study device not used|3|||
16846242|NCT01772576|37791374|FG000|Overall Study|Adverse Event|6|||
16846243|NCT01772576|37791374|FG000|Overall Study|Withdrawal by Subject|6|||
16846244|NCT01802216|37791401|FG000|4 Month Visit|Participant did not show to visit|3|||
16846245|NCT01802216|37791402|FG001|4 Month Visit|Participant did not show to visit|4|||
16846246|NCT01802216|37791401|FG000|8 Month Visit|Participant did not show to visit|3|||
16846247|NCT01802216|37791402|FG001|8 Month Visit|Participant did not show to visit|5|||
16846248|NCT01802216|37791401|FG000|12 Month Visit|Participant did not show to visit|3|||
16846249|NCT01802216|37791402|FG001|12 Month Visit|Participant did not show to visit|4|||
16846250|NCT01808144|37791410|FG000|Overall Study|Death|1|||
16846251|NCT01808144|37791411|FG001|Overall Study|Death|0|||
16846252|NCT01808144|37791410|FG000|Overall Study|Withdrawal by Subject|16|||
16846253|NCT01808144|37791411|FG001|Overall Study|Withdrawal by Subject|23|||
16846254|NCT01808144|37791410|FG000|Overall Study|Lost to Follow-up|6|||
16846255|NCT01808144|37791411|FG001|Overall Study|Lost to Follow-up|3|||
16846256|NCT01808144|37791410|FG000|Overall Study|Protocol Violation|6|||
16846257|NCT01808144|37791411|FG001|Overall Study|Protocol Violation|6|||
16846258|NCT01808144|37791410|FG000|Overall Study|Gout flare|0|||
16846259|NCT01808144|37791411|FG001|Overall Study|Gout flare|1|||
16846260|NCT01808144|37791410|FG000|Overall Study|Adverse Event|11|||
16846261|NCT01808144|37791411|FG001|Overall Study|Adverse Event|15|||
16846262|NCT01801982|37791417|FG000|Overall Study|Lost to Follow-up|1|||
16846263|NCT01808066|37791430|FG000|Overall Study|Withdrawal by Subject|15|||
16846264|NCT01604343|37791438|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
16846265|NCT01604343|37791439|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
16921252|NCT04388826|38062820|FG000|Overall Study|Adverse Event|1|||
16921253|NCT04388826|38062821|FG001|Overall Study|Adverse Event|0|||
16921254|NCT04218266|38062843|FG000|Overall Study|Death|1|||
16921255|NCT04218266|38062844|FG001|Overall Study|Death|2|||
16921256|NCT04218266|38062845|FG002|Overall Study|Death|3|||
16921257|NCT04218266|38062843|FG000|Overall Study|Adverse Event|13|||
16921258|NCT04218266|38062844|FG001|Overall Study|Adverse Event|14|||
16921259|NCT04218266|38062845|FG002|Overall Study|Adverse Event|11|||
16921260|NCT04218266|38062843|FG000|Overall Study|Other|7|||
16921261|NCT04218266|38062844|FG001|Overall Study|Other|5|||
16921262|NCT04218266|38062845|FG002|Overall Study|Other|14|||
16921263|NCT04218266|38062843|FG000|Overall Study|Physician Decision|1|||
16921264|NCT04218266|38062844|FG001|Overall Study|Physician Decision|3|||
16921265|NCT04218266|38062845|FG002|Overall Study|Physician Decision|2|||
16921266|NCT04218266|38062843|FG000|Overall Study|Non-compliance with study drug|0|||
16921267|NCT04218266|38062844|FG001|Overall Study|Non-compliance with study drug|0|||
16921268|NCT04218266|38062845|FG002|Overall Study|Non-compliance with study drug|1|||
16921269|NCT04218266|38062843|FG000|Overall Study|Withdrawal by Subject|1|||
16921270|NCT04218266|38062844|FG001|Overall Study|Withdrawal by Subject|3|||
16921271|NCT04218266|38062845|FG002|Overall Study|Withdrawal by Subject|1|||
16921272|NCT04218266|38062843|FG000|Overall Study|Study drug never administered|2|||
16921273|NCT04218266|38062844|FG001|Overall Study|Study drug never administered|0|||
16921274|NCT04218266|38062845|FG002|Overall Study|Study drug never administered|0|||
16921275|NCT03894904|38062867|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
16921276|NCT03894904|38062868|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
16921277|NCT03894904|38062867|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
16921278|NCT03894904|38062868|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
16921279|NCT03518086|38062885|FG000|Overall Study|Adverse Event|23|||
16921280|NCT03518086|38062886|FG001|Overall Study|Adverse Event|15|||
16921281|NCT03518086|38062887|FG002|Overall Study|Adverse Event|0|||
16921282|NCT03518086|38062888|FG003|Overall Study|Adverse Event|0|||
16921283|NCT03518086|38062885|FG000|Overall Study|Withdrawal by Subject|8|||
16921284|NCT03518086|38062886|FG001|Overall Study|Withdrawal by Subject|5|||
16921285|NCT03518086|38062887|FG002|Overall Study|Withdrawal by Subject|0|||
16921286|NCT03518086|38062888|FG003|Overall Study|Withdrawal by Subject|0|||
16921287|NCT03518086|38062885|FG000|Overall Study|Lack of Efficacy|5|||
16921288|NCT03518086|38062886|FG001|Overall Study|Lack of Efficacy|5|||
16921289|NCT03518086|38062887|FG002|Overall Study|Lack of Efficacy|0|||
16921290|NCT03518086|38062888|FG003|Overall Study|Lack of Efficacy|0|||
16921291|NCT03518086|38062885|FG000|Overall Study|Protocol Violation|1|||
16921292|NCT03518086|38062886|FG001|Overall Study|Protocol Violation|5|||
16921293|NCT03518086|38062887|FG002|Overall Study|Protocol Violation|0|||
16921294|NCT03518086|38062888|FG003|Overall Study|Protocol Violation|0|||
16921295|NCT03518086|38062885|FG000|Overall Study|Lost to Follow-up|0|||
16921296|NCT03518086|38062886|FG001|Overall Study|Lost to Follow-up|3|||
16921297|NCT03518086|38062887|FG002|Overall Study|Lost to Follow-up|0|||
16921298|NCT03518086|38062888|FG003|Overall Study|Lost to Follow-up|0|||
16921299|NCT03518086|38062885|FG000|Overall Study|Insufficient Diary Data|0|||
16921300|NCT03518086|38062886|FG001|Overall Study|Insufficient Diary Data|2|||
16921301|NCT03518086|38062887|FG002|Overall Study|Insufficient Diary Data|0|||
16921302|NCT03518086|38062888|FG003|Overall Study|Insufficient Diary Data|0|||
16921303|NCT03518086|38062885|FG000|Overall Study|Non- compliance to Protocol|0|||
16921304|NCT03518086|38062886|FG001|Overall Study|Non- compliance to Protocol|1|||
16921305|NCT03518086|38062887|FG002|Overall Study|Non- compliance to Protocol|0|||
16846266|NCT01604343|37791440|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
16921306|NCT03518086|38062888|FG003|Overall Study|Non- compliance to Protocol|0|||
16846267|NCT01604343|37791441|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
16846268|NCT01604343|37791442|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
16846269|NCT01604343|37791438|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
16846270|NCT01604343|37791439|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
16921307|NCT03518086|38062885|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
16846271|NCT01604343|37791440|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
16846272|NCT01604343|37791441|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
16846273|NCT01604343|37791442|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
16846274|NCT01604343|37791438|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
16846275|NCT01604343|37791439|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
16846276|NCT01604343|37791440|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
16846277|NCT01604343|37791441|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
16846278|NCT01604343|37791442|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
16846279|NCT01604343|37791438|FG000|Prior to W52 Administration(Through W52)|Death|5|||
16846280|NCT01604343|37791439|FG001|Prior to W52 Administration(Through W52)|Death|0|||
16846281|NCT01604343|37791440|FG002|Prior to W52 Administration(Through W52)|Death|2|||
16846282|NCT01604343|37791441|FG003|Prior to W52 Administration(Through W52)|Death|0|||
16846283|NCT01604343|37791442|FG004|Prior to W52 Administration(Through W52)|Death|4|||
16846284|NCT01604343|37791438|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
16846285|NCT01604343|37791439|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
16846286|NCT01604343|37791440|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
16846287|NCT01604343|37791441|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
16846288|NCT01604343|37791442|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
16846289|NCT01604343|37791438|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
16846290|NCT01604343|37791439|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
16846291|NCT01604343|37791440|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
16846292|NCT01604343|37791441|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
16846293|NCT01604343|37791442|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
16921308|NCT03518086|38062886|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
16921309|NCT03518086|38062887|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
16921310|NCT03518086|38062888|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
16921311|NCT03518086|38062885|FG000|Overall Study|Site Terminated by Sponsor|0|||
16921312|NCT03518086|38062886|FG001|Overall Study|Site Terminated by Sponsor|1|||
16921313|NCT03518086|38062887|FG002|Overall Study|Site Terminated by Sponsor|0|||
16921314|NCT03518086|38062888|FG003|Overall Study|Site Terminated by Sponsor|0|||
16921315|NCT03225287|38062903|FG000|Overall Study|Adverse Event|0|||
16921316|NCT03225287|38062904|FG001|Overall Study|Adverse Event|0|||
16921317|NCT03225287|38062905|FG002|Overall Study|Adverse Event|1|||
16921318|NCT03225287|38062903|FG000|Overall Study|Protocol non-compliance|0|||
16921319|NCT03225287|38062904|FG001|Overall Study|Protocol non-compliance|0|||
16921320|NCT03225287|38062905|FG002|Overall Study|Protocol non-compliance|1|||
16921321|NCT03225287|38062903|FG000|Overall Study|Subject withdraws consent|3|||
16921322|NCT03225287|38062904|FG001|Overall Study|Subject withdraws consent|0|||
16921323|NCT03225287|38062905|FG002|Overall Study|Subject withdraws consent|0|||
16921324|NCT03225287|38062903|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
16921325|NCT03225287|38062904|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
16921326|NCT03225287|38062905|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
16921327|NCT03225287|38062903|FG000|Overall Study|Trial drug not effective|0|||
16921328|NCT03225287|38062904|FG001|Overall Study|Trial drug not effective|1|||
16921329|NCT03225287|38062905|FG002|Overall Study|Trial drug not effective|0|||
16921330|NCT03225287|38062903|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
16921331|NCT03225287|38062904|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
16921332|NCT03225287|38062905|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
16921333|NCT03225287|38062903|FG000|Overall Study|Stem cell transplantation|0|||
16921334|NCT03225287|38062904|FG001|Overall Study|Stem cell transplantation|1|||
16921335|NCT03225287|38062905|FG002|Overall Study|Stem cell transplantation|0|||
16921336|NCT03099265|38062913|FG000|Overall Study|Adverse Event|1|||
16921337|NCT02658656|38062931|FG000|Screening|Failed eligibility criteria|0|||
16921338|NCT02658656|38062932|FG001|Screening|Failed eligibility criteria|0|||
16921339|NCT02658656|38062933|FG002|Screening|Failed eligibility criteria|263|||
16921340|NCT02658656|38062931|FG000|Randomization|Withdrawal by Subject|8|||
16921341|NCT02658656|38062932|FG001|Randomization|Withdrawal by Subject|7|||
16921342|NCT02658656|38062933|FG002|Randomization|Withdrawal by Subject|0|||
16921343|NCT02658656|38062931|FG000|Randomization|Lost to Follow-up|1|||
16921344|NCT02658656|38062932|FG001|Randomization|Lost to Follow-up|3|||
16921345|NCT02658656|38062933|FG002|Randomization|Lost to Follow-up|0|||
16921346|NCT02658656|38062931|FG000|Randomization|Adverse Event|4|||
16921347|NCT02658656|38062932|FG001|Randomization|Adverse Event|0|||
16921348|NCT02658656|38062933|FG002|Randomization|Adverse Event|0|||
16921349|NCT02658656|38062931|FG000|Randomization|Administrative Termination|3|||
16921350|NCT02658656|38062932|FG001|Randomization|Administrative Termination|1|||
16921351|NCT02658656|38062933|FG002|Randomization|Administrative Termination|0|||
16921352|NCT02658656|38062931|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
16921353|NCT02658656|38062932|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
16921354|NCT02658656|38062933|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
16921355|NCT02658656|38062931|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
16921356|NCT02658656|38062932|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
16921357|NCT02658656|38062933|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
16921358|NCT02658656|38062931|FG000|Randomization|Not eligible for Randomization|1|||
16921359|NCT02658656|38062932|FG001|Randomization|Not eligible for Randomization|0|||
16921360|NCT02658656|38062933|FG002|Randomization|Not eligible for Randomization|0|||
16921361|NCT02658656|38062931|FG000|Randomization|Protocol Violation|1|||
16921362|NCT02658656|38062932|FG001|Randomization|Protocol Violation|0|||
16921363|NCT02658656|38062933|FG002|Randomization|Protocol Violation|0|||
16921364|NCT02066636|38062980|FG000|Overall Study|Disease progression|51|||
16921365|NCT02066636|38062981|FG001|Overall Study|Disease progression|60|||
16921366|NCT02066636|38062982|FG002|Overall Study|Disease progression|700|||
16921367|NCT02066636|38062980|FG000|Overall Study|Study drug toxicity|13|||
16921368|NCT02066636|38062981|FG001|Overall Study|Study drug toxicity|2|||
16921369|NCT02066636|38062982|FG002|Overall Study|Study drug toxicity|58|||
16921370|NCT02066636|38062980|FG000|Overall Study|Death|4|||
16921371|NCT02066636|38062981|FG001|Overall Study|Death|2|||
16921372|NCT02066636|38062982|FG002|Overall Study|Death|158|||
16921373|NCT02066636|38062980|FG000|Overall Study|Adverse event unrelated to study drug|6|||
16921374|NCT02066636|38062981|FG001|Overall Study|Adverse event unrelated to study drug|4|||
16846294|NCT01604343|37791438|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
16846295|NCT01604343|37791439|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
16846296|NCT01604343|37791440|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
16846297|NCT01604343|37791441|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
16846298|NCT01604343|37791442|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
16846299|NCT01604343|37791438|FG000|Prior to W52 Administration(Through W52)|Other|15|||
16846300|NCT01604343|37791439|FG001|Prior to W52 Administration(Through W52)|Other|0|||
16846301|NCT01604343|37791440|FG002|Prior to W52 Administration(Through W52)|Other|10|||
16846302|NCT01604343|37791441|FG003|Prior to W52 Administration(Through W52)|Other|0|||
16846303|NCT01604343|37791442|FG004|Prior to W52 Administration(Through W52)|Other|6|||
16846304|NCT01604343|37791438|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
16846305|NCT01604343|37791439|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
16846306|NCT01604343|37791440|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
16846307|NCT01604343|37791441|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
16846308|NCT01604343|37791442|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
16846309|NCT01604343|37791438|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
16846310|NCT01604343|37791439|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
16846311|NCT01604343|37791440|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
16846312|NCT01604343|37791441|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
16846313|NCT01604343|37791442|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
16846314|NCT01604343|37791438|FG000|Week 52 to Week 104|Adverse Event|0|||
16846315|NCT01604343|37791439|FG001|Week 52 to Week 104|Adverse Event|12|||
16846316|NCT01604343|37791440|FG002|Week 52 to Week 104|Adverse Event|26|||
16846317|NCT01604343|37791441|FG003|Week 52 to Week 104|Adverse Event|21|||
16846318|NCT01604343|37791442|FG004|Week 52 to Week 104|Adverse Event|27|||
16846319|NCT01604343|37791438|FG000|Week 52 to Week 104|Death|0|||
16846320|NCT01604343|37791439|FG001|Week 52 to Week 104|Death|4|||
16846321|NCT01604343|37791440|FG002|Week 52 to Week 104|Death|2|||
16846322|NCT01604343|37791441|FG003|Week 52 to Week 104|Death|5|||
16846323|NCT01604343|37791442|FG004|Week 52 to Week 104|Death|0|||
16846324|NCT01604343|37791438|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
16846325|NCT01604343|37791439|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
17017530|NCT00843024|38162181|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
17017531|NCT00843024|38162182|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
17017532|NCT00843024|38162183|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
17017533|NCT00843024|38162184|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
17017534|NCT00843024|38162179|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
17017535|NCT00843024|38162180|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
17017536|NCT00843024|38162181|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
17017537|NCT00843024|38162182|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
17017538|NCT00843024|38162183|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
17017539|NCT00843024|38162184|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
17017540|NCT00843024|38162179|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
17017541|NCT00843024|38162180|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
16921375|NCT02066636|38062982|FG002|Overall Study|Adverse event unrelated to study drug|45|||
16846326|NCT01604343|37791440|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
16846327|NCT01604343|37791441|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
16846328|NCT01604343|37791442|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
16846329|NCT01604343|37791438|FG000|Week 52 to Week 104|Physician Decision|0|||
16846330|NCT01604343|37791439|FG001|Week 52 to Week 104|Physician Decision|1|||
16846331|NCT01604343|37791440|FG002|Week 52 to Week 104|Physician Decision|0|||
16921376|NCT02066636|38062980|FG000|Overall Study|Participant request to discontinue treatment|12|||
16846332|NCT01604343|37791441|FG003|Week 52 to Week 104|Physician Decision|0|||
16846333|NCT01604343|37791442|FG004|Week 52 to Week 104|Physician Decision|2|||
16846334|NCT01604343|37791438|FG000|Week 52 to Week 104|Pregnancy|0|||
16846335|NCT01604343|37791439|FG001|Week 52 to Week 104|Pregnancy|0|||
16846336|NCT01604343|37791440|FG002|Week 52 to Week 104|Pregnancy|1|||
16846337|NCT01604343|37791441|FG003|Week 52 to Week 104|Pregnancy|2|||
16846338|NCT01604343|37791442|FG004|Week 52 to Week 104|Pregnancy|1|||
16846339|NCT01604343|37791438|FG000|Week 52 to Week 104|Other|0|||
16846340|NCT01604343|37791439|FG001|Week 52 to Week 104|Other|11|||
16846341|NCT01604343|37791440|FG002|Week 52 to Week 104|Other|11|||
16846342|NCT01604343|37791441|FG003|Week 52 to Week 104|Other|6|||
16846343|NCT01604343|37791442|FG004|Week 52 to Week 104|Other|3|||
16846344|NCT01604343|37791438|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
16846345|NCT01604343|37791439|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
16846346|NCT01604343|37791440|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
16846347|NCT01604343|37791441|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
16846348|NCT01604343|37791442|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
16846349|NCT01604343|37791438|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
16846350|NCT01604343|37791439|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
16846351|NCT01604343|37791440|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
16846352|NCT01604343|37791441|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
16846353|NCT01604343|37791442|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
16846354|NCT01604343|37791438|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
16846355|NCT01604343|37791439|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
16846356|NCT01604343|37791440|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
16846357|NCT01604343|37791441|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
16846358|NCT01604343|37791442|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
16846359|NCT01801436|37791452|FG000|Overall Study|Withdrawal by Subject|3|||
16846360|NCT01801436|37791452|FG000|Overall Study|Adverse Event|2|||
16846361|NCT01801436|37791452|FG000|Overall Study|Progressive disease|4|||
16846362|NCT01771250|37791456|FG000|Period 1|Met exclusion criteria|1|||
16846363|NCT01771250|37791457|FG001|Period 1|Met exclusion criteria|0|||
16846364|NCT01770860|37791463|FG000|Overall Study|Withdrawal by Subject|4|||
16846365|NCT01770860|37791463|FG000|Overall Study|Lost to Follow-up|1|||
16846366|NCT01770860|37791463|FG000|Overall Study|Administrative decision made by the PI|1|||
16846367|NCT01603875|37791474|FG000|Overall Study|Preexisting rabies antibody|3|||
16846368|NCT01603875|37791475|FG001|Overall Study|Preexisting rabies antibody|4|||
16846369|NCT01603875|37791476|FG002|Overall Study|Preexisting rabies antibody|3|||
16846370|NCT01603875|37791474|FG000|Overall Study|Lost to Follow-up|4|||
16846371|NCT01603875|37791475|FG001|Overall Study|Lost to Follow-up|3|||
16846372|NCT01603875|37791476|FG002|Overall Study|Lost to Follow-up|6|||
16846373|NCT01603875|37791474|FG000|Overall Study|Protocol Violation|0|||
16846374|NCT01603875|37791475|FG001|Overall Study|Protocol Violation|1|||
16846375|NCT01603875|37791476|FG002|Overall Study|Protocol Violation|0|||
16846376|NCT01770392|37791484|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
16846377|NCT01603641|37791494|FG000|Overall Study|Did not Receive Treatment|3|||
16846378|NCT01603641|37791494|FG000|Overall Study|Adverse Event|1|||
16846379|NCT01603641|37791494|FG000|Overall Study|Lack of Efficacy|1|||
16846380|NCT01603641|37791494|FG000|Overall Study|Lost to Follow-up|6|||
16846381|NCT01603641|37791494|FG000|Overall Study|Personal Reasons|18|||
16846382|NCT01603641|37791494|FG000|Overall Study|Other Miscellaneous Reasons|6|||
16846383|NCT01556763|37791501|FG000|Overall Study|Withdrawal by Subject|0|||
16846384|NCT01556763|37791502|FG001|Overall Study|Withdrawal by Subject|1|||
16846385|NCT01556763|37791503|FG002|Overall Study|Withdrawal by Subject|0|||
16846386|NCT01576575|37791513|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
16846387|NCT01576575|37791513|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
16846388|NCT01576575|37791513|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
16846389|NCT01555983|37791523|FG000|Overall Study|Withdrawal by Subject|1|||
16846390|NCT01555983|37791524|FG001|Overall Study|Withdrawal by Subject|0|||
16846391|NCT01555983|37791525|FG002|Overall Study|Withdrawal by Subject|0|||
16846392|NCT01555983|37791526|FG003|Overall Study|Withdrawal by Subject|0|||
16846393|NCT01555983|37791527|FG004|Overall Study|Withdrawal by Subject|1|||
16846394|NCT01555983|37791528|FG005|Overall Study|Withdrawal by Subject|1|||
16921377|NCT02066636|38062981|FG001|Overall Study|Participant request to discontinue treatment|12|||
16921378|NCT02066636|38062982|FG002|Overall Study|Participant request to discontinue treatment|70|||
16921379|NCT02066636|38062980|FG000|Overall Study|Participant withdrew consent|10|||
16921380|NCT02066636|38062981|FG001|Overall Study|Participant withdrew consent|18|||
16921381|NCT02066636|38062982|FG002|Overall Study|Participant withdrew consent|61|||
16921382|NCT02066636|38062980|FG000|Overall Study|Lost to Follow-up|0|||
16921383|NCT02066636|38062981|FG001|Overall Study|Lost to Follow-up|2|||
16921384|NCT02066636|38062982|FG002|Overall Study|Lost to Follow-up|2|||
16921385|NCT02066636|38062980|FG000|Overall Study|Maximum clinical benefit|2|||
16921386|NCT02066636|38062981|FG001|Overall Study|Maximum clinical benefit|2|||
16921387|NCT02066636|38062982|FG002|Overall Study|Maximum clinical benefit|3|||
16921388|NCT02066636|38062980|FG000|Overall Study|Poor/non-compliance|2|||
16921389|NCT02066636|38062981|FG001|Overall Study|Poor/non-compliance|1|||
16921390|NCT02066636|38062982|FG002|Overall Study|Poor/non-compliance|1|||
16921391|NCT02066636|38062980|FG000|Overall Study|Participant no loner meets study criteria|3|||
16921392|NCT02066636|38062981|FG001|Overall Study|Participant no loner meets study criteria|2|||
16921393|NCT02066636|38062982|FG002|Overall Study|Participant no loner meets study criteria|28|||
16921394|NCT02066636|38062980|FG000|Overall Study|Administrative reasons by sponsor|8|||
16921395|NCT02066636|38062981|FG001|Overall Study|Administrative reasons by sponsor|5|||
16846395|NCT01576341|37791536|FG000|Overall Study|Withdrawal by Subject|24|||
16846396|NCT01576341|37791536|FG000|Overall Study|Adverse Event|10|||
16846397|NCT01576341|37791536|FG000|Overall Study|Death|21|||
16921396|NCT02066636|38062982|FG002|Overall Study|Administrative reasons by sponsor|0|||
16921397|NCT02066636|38062980|FG000|Overall Study|Other reasons|16|||
16921398|NCT02066636|38062981|FG001|Overall Study|Other reasons|15|||
16921399|NCT02066636|38062982|FG002|Overall Study|Other reasons|50|||
16921400|NCT01486264|38062994|FG000|Overall Study|Death|1|||
16921401|NCT01486264|38062995|FG001|Overall Study|Death|1|||
16921402|NCT01486264|38062994|FG000|Overall Study|Adverse Event|3|||
16921403|NCT01486264|38062995|FG001|Overall Study|Adverse Event|3|||
16921404|NCT01486264|38062994|FG000|Overall Study|Lack of Efficacy|6|||
16921405|NCT01486264|38062995|FG001|Overall Study|Lack of Efficacy|10|||
16921406|NCT01486264|38062994|FG000|Overall Study|Withdrawal by Subject|7|||
16921407|NCT01486264|38062995|FG001|Overall Study|Withdrawal by Subject|18|||
16921408|NCT01486264|38062994|FG000|Overall Study|Physician Decision|1|||
16921409|NCT01486264|38062995|FG001|Overall Study|Physician Decision|1|||
16921410|NCT01486264|38062994|FG000|Overall Study|Protocol Violation|3|||
16921411|NCT01486264|38062995|FG001|Overall Study|Protocol Violation|0|||
16921412|NCT01486264|38062994|FG000|Overall Study|Lost to Follow-up|3|||
16921413|NCT01486264|38062995|FG001|Overall Study|Lost to Follow-up|2|||
16921414|NCT01486264|38062994|FG000|Overall Study|Other|5|||
16921415|NCT01486264|38062995|FG001|Overall Study|Other|11|||
16921416|NCT01486264|38062994|FG000|Overall Study|Not treated|0|||
16921417|NCT01486264|38062995|FG001|Overall Study|Not treated|1|||
17017542|NCT00843024|38162181|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
17017543|NCT00843024|38162182|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
16846398|NCT01576341|37791536|FG000|Overall Study|Physician Decision|2|||
17017544|NCT00843024|38162183|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
17017545|NCT00843024|38162184|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
17017546|NCT00843024|38162179|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
17017547|NCT00843024|38162180|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
17017548|NCT00843024|38162181|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
17017549|NCT00843024|38162182|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
17017550|NCT00843024|38162183|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
17017551|NCT00843024|38162184|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
17017552|NCT00843024|38162179|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
17017553|NCT00843024|38162180|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
17017554|NCT00843024|38162181|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
17017555|NCT00843024|38162182|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
17017556|NCT00843024|38162183|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
17017557|NCT00843024|38162184|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
17017558|NCT00843024|38162179|FG000|Single-blind Placebo Run-In Phase|Other|0|||
17017559|NCT00843024|38162180|FG001|Single-blind Placebo Run-In Phase|Other|1|||
17017560|NCT00843024|38162181|FG002|Single-blind Placebo Run-In Phase|Other|0|||
17017561|NCT00843024|38162182|FG003|Single-blind Placebo Run-In Phase|Other|0|||
17017562|NCT00843024|38162183|FG004|Single-blind Placebo Run-In Phase|Other|0|||
17017563|NCT00843024|38162184|FG005|Single-blind Placebo Run-In Phase|Other|0|||
17017564|NCT00843024|38162179|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
17017565|NCT00843024|38162180|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
17017566|NCT00843024|38162181|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
16846399|NCT01576341|37791536|FG000|Overall Study|Lost to Follow-up|2|||
16846400|NCT01576341|37791536|FG000|Overall Study|Kidney transplantation|10|||
16846401|NCT01576341|37791536|FG000|Overall Study|Protocol Violation|12|||
16846402|NCT01576341|37791536|FG000|Overall Study|Other|12|||
16846403|NCT04276090|37791545|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
16846404|NCT04276090|37791546|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
16846405|NCT01892722|37791554|FG000|Overall Study|Protocol deviation|0|||
16846406|NCT01892722|37791555|FG001|Overall Study|Protocol deviation|1|||
16846407|NCT01892722|37791554|FG000|Overall Study|Administrative problems|0|||
16846408|NCT01892722|37791555|FG001|Overall Study|Administrative problems|1|||
16921418|NCT01323270|38063003|FG000|Overall Study|Withdrawal by Subject|19|||
16921419|NCT01323270|38063004|FG001|Overall Study|Withdrawal by Subject|10|||
16921420|NCT01323270|38063003|FG000|Overall Study|Protocol Violation|9|||
16921421|NCT01323270|38063004|FG001|Overall Study|Protocol Violation|7|||
16846409|NCT01892722|37791554|FG000|Overall Study|Patient/guardian decision|0|||
16846410|NCT01892722|37791555|FG001|Overall Study|Patient/guardian decision|2|||
16846411|NCT01892722|37791554|FG000|Overall Study|Physician Decision|1|||
16846412|NCT01892722|37791555|FG001|Overall Study|Physician Decision|2|||
16846413|NCT01892722|37791554|FG000|Overall Study|Adverse Event|3|||
16846414|NCT01892722|37791555|FG001|Overall Study|Adverse Event|2|||
16846415|NCT01892722|37791554|FG000|Overall Study|Lack of Efficacy|0|||
16846416|NCT01892722|37791555|FG001|Overall Study|Lack of Efficacy|7|||
16846417|NCT01892722|37791554|FG000|Overall Study|Withdrawal by Subject|3|||
16846418|NCT01892722|37791555|FG001|Overall Study|Withdrawal by Subject|5|||
16846419|NCT01687413|37791572|FG000|Overall Study|Withdrawal by Subject|0|||
16846420|NCT01687413|37791573|FG001|Overall Study|Withdrawal by Subject|2|||
16846421|NCT01687413|37791572|FG000|Overall Study|Not eligible|0|||
16846422|NCT01687413|37791573|FG001|Overall Study|Not eligible|2|||
16846423|NCT01687413|37791572|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
16846424|NCT01687413|37791573|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
16921422|NCT01323270|38063003|FG000|Overall Study|Lost to Follow-up|4|||
16921423|NCT01323270|38063004|FG001|Overall Study|Lost to Follow-up|6|||
16921424|NCT01323270|38063003|FG000|Overall Study|Adverse Event|8|||
16921425|NCT01323270|38063004|FG001|Overall Study|Adverse Event|0|||
16921426|NCT01323270|38063003|FG000|Overall Study|Other|0|||
16921427|NCT01323270|38063004|FG001|Overall Study|Other|3|||
16921428|NCT01323270|38063003|FG000|Overall Study|Physician Decision|0|||
16921429|NCT01323270|38063004|FG001|Overall Study|Physician Decision|2|||
16921430|NCT01323270|38063003|FG000|Overall Study|Not eligible|1|||
16921431|NCT01323270|38063004|FG001|Overall Study|Not eligible|1|||
16846425|NCT01555671|37791599|FG000|Overall Study|Physician Decision|20|||
16846426|NCT01555671|37791600|FG001|Overall Study|Physician Decision|25|||
16846427|NCT01801358|37791614|FG000|Overall Study|Adverse Event|0|||
16846428|NCT01801358|37791615|FG001|Overall Study|Adverse Event|2|||
16846429|NCT01801358|37791616|FG002|Overall Study|Adverse Event|1|||
16921432|NCT01323270|38063003|FG000|Overall Study|Death|1|||
16921433|NCT01323270|38063004|FG001|Overall Study|Death|0|||
16921434|NCT01323270|38063003|FG000|Overall Study|Randomized, but not vaccinated|1|||
16921435|NCT01323270|38063004|FG001|Overall Study|Randomized, but not vaccinated|0|||
16921436|NCT01300728|38063013|FG000|Overall Study|Withdrawal by Subject|1|||
16921437|NCT01300728|38063014|FG001|Overall Study|Withdrawal by Subject|1|||
16921438|NCT01300728|38063013|FG000|Overall Study|Physician Decision|1|||
16921439|NCT01300728|38063014|FG001|Overall Study|Physician Decision|0|||
16921440|NCT01299480|38063025|FG000|Overall Study|No longer willing to participate|19|||
16921441|NCT01299480|38063026|FG001|Overall Study|No longer willing to participate|17|||
16921442|NCT01299480|38063027|FG002|Overall Study|No longer willing to participate|14|||
16921443|NCT01299480|38063028|FG003|Overall Study|No longer willing to participate|13|||
16921444|NCT01299480|38063029|FG004|Overall Study|No longer willing to participate|10|||
16921445|NCT01299480|38063025|FG000|Overall Study|Protocol Violation|7|||
16921446|NCT01299480|38063026|FG001|Overall Study|Protocol Violation|5|||
16921447|NCT01299480|38063027|FG002|Overall Study|Protocol Violation|8|||
16921448|NCT01299480|38063028|FG003|Overall Study|Protocol Violation|1|||
16921449|NCT01299480|38063029|FG004|Overall Study|Protocol Violation|1|||
16921450|NCT01299480|38063025|FG000|Overall Study|Withdrawal by Subject|3|||
16921451|NCT01299480|38063026|FG001|Overall Study|Withdrawal by Subject|4|||
16921452|NCT01299480|38063027|FG002|Overall Study|Withdrawal by Subject|7|||
16921453|NCT01299480|38063028|FG003|Overall Study|Withdrawal by Subject|3|||
16921454|NCT01299480|38063029|FG004|Overall Study|Withdrawal by Subject|4|||
16921455|NCT01299480|38063025|FG000|Overall Study|Adverse Event|6|||
16921456|NCT01299480|38063026|FG001|Overall Study|Adverse Event|4|||
16921457|NCT01299480|38063027|FG002|Overall Study|Adverse Event|5|||
16921458|NCT01299480|38063028|FG003|Overall Study|Adverse Event|4|||
16846430|NCT01801358|37791617|FG003|Overall Study|Adverse Event|0|||
16921459|NCT01299480|38063029|FG004|Overall Study|Adverse Event|0|||
16921460|NCT01299480|38063025|FG000|Overall Study|Withdrawal due to pregnancy|0|||
16921461|NCT01299480|38063026|FG001|Overall Study|Withdrawal due to pregnancy|1|||
16921462|NCT01299480|38063027|FG002|Overall Study|Withdrawal due to pregnancy|1|||
16921463|NCT01299480|38063028|FG003|Overall Study|Withdrawal due to pregnancy|0|||
16921464|NCT01299480|38063029|FG004|Overall Study|Withdrawal due to pregnancy|0|||
16921465|NCT01299480|38063025|FG000|Overall Study|Physician Decision|1|||
16846431|NCT01801358|37791618|FG004|Overall Study|Adverse Event|0|||
16846432|NCT01801358|37791619|FG005|Overall Study|Adverse Event|1|||
16846433|NCT01801358|37791614|FG000|Overall Study|Physician Decision|0|||
16846434|NCT01801358|37791615|FG001|Overall Study|Physician Decision|0|||
16846435|NCT01801358|37791616|FG002|Overall Study|Physician Decision|1|||
16846436|NCT01801358|37791617|FG003|Overall Study|Physician Decision|0|||
16846437|NCT01801358|37791618|FG004|Overall Study|Physician Decision|0|||
16846438|NCT01801358|37791619|FG005|Overall Study|Physician Decision|0|||
16846439|NCT01801358|37791614|FG000|Overall Study|Progressive Disease|6|||
16921466|NCT01299480|38063026|FG001|Overall Study|Physician Decision|1|||
16921467|NCT01299480|38063027|FG002|Overall Study|Physician Decision|0|||
16921468|NCT01299480|38063028|FG003|Overall Study|Physician Decision|2|||
16846440|NCT01801358|37791615|FG001|Overall Study|Progressive Disease|4|||
16846441|NCT01801358|37791616|FG002|Overall Study|Progressive Disease|4|||
16846442|NCT01801358|37791617|FG003|Overall Study|Progressive Disease|5|||
16846443|NCT01801358|37791618|FG004|Overall Study|Progressive Disease|6|||
16846444|NCT01801358|37791619|FG005|Overall Study|Progressive Disease|5|||
16846445|NCT01801358|37791614|FG000|Overall Study|Withdrawal by Subject|0|||
16846446|NCT01801358|37791615|FG001|Overall Study|Withdrawal by Subject|0|||
16846447|NCT01801358|37791616|FG002|Overall Study|Withdrawal by Subject|0|||
16846448|NCT01801358|37791617|FG003|Overall Study|Withdrawal by Subject|1|||
16846449|NCT01801358|37791618|FG004|Overall Study|Withdrawal by Subject|0|||
16846450|NCT01801358|37791619|FG005|Overall Study|Withdrawal by Subject|2|||
16846451|NCT01807598|37791654|FG000|Overall Study|Withdrawal by Subject|4|||
16921469|NCT01299480|38063029|FG004|Overall Study|Physician Decision|0|||
16921470|NCT01299480|38063025|FG000|Overall Study|Lost to Follow-up|3|||
16921471|NCT01299480|38063026|FG001|Overall Study|Lost to Follow-up|1|||
16921472|NCT01299480|38063027|FG002|Overall Study|Lost to Follow-up|2|||
16846452|NCT01807598|37791654|FG000|Overall Study|Adverse Event|1|||
16846453|NCT01807598|37791654|FG000|Overall Study|Other Physician Decision|1|||
16846454|NCT01801280|37791662|FG000|Period 1|Withdrawal by Subject|0|||
16921473|NCT01299480|38063028|FG003|Overall Study|Lost to Follow-up|1|||
16921474|NCT01299480|38063029|FG004|Overall Study|Lost to Follow-up|2|||
16846455|NCT01801280|37791663|FG001|Period 1|Withdrawal by Subject|1|||
16846456|NCT01801280|37791664|FG002|Period 1|Withdrawal by Subject|0|||
16846457|NCT01801280|37791665|FG003|Period 1|Withdrawal by Subject|0|||
16846458|NCT01801280|37791662|FG000|Period 2|Withdrawal by Subject|1|||
16846459|NCT01801280|37791663|FG001|Period 2|Withdrawal by Subject|0|||
16846460|NCT01801280|37791664|FG002|Period 2|Withdrawal by Subject|0|||
16846461|NCT01801280|37791665|FG003|Period 2|Withdrawal by Subject|0|||
16846462|NCT01801280|37791662|FG000|Period 4|Protocol Violation|0|||
16846463|NCT01801280|37791663|FG001|Period 4|Protocol Violation|0|||
16846464|NCT01801280|37791664|FG002|Period 4|Protocol Violation|1|||
16846465|NCT01801280|37791665|FG003|Period 4|Protocol Violation|0|||
16846466|NCT01769456|37791675|FG000|Overall Study|Lost to Follow-up|19|||
16921475|NCT01299480|38063025|FG000|Overall Study|Other|3|||
16921476|NCT01299480|38063026|FG001|Overall Study|Other|2|||
16921477|NCT01299480|38063027|FG002|Overall Study|Other|3|||
16921478|NCT01299480|38063028|FG003|Overall Study|Other|0|||
16921479|NCT01299480|38063029|FG004|Overall Study|Other|3|||
16921480|NCT01299480|38063025|FG000|Overall Study|Started, but not vaccinated|0|||
16921481|NCT01299480|38063026|FG001|Overall Study|Started, but not vaccinated|0|||
16921482|NCT01299480|38063027|FG002|Overall Study|Started, but not vaccinated|1|||
16921483|NCT01299480|38063028|FG003|Overall Study|Started, but not vaccinated|1|||
16921484|NCT01299480|38063029|FG004|Overall Study|Started, but not vaccinated|0|||
16921485|NCT04799405|38063051|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
16921486|NCT04529499|38063061|FG000|Overall Study|Withdrawal by Subject|9|||
16921487|NCT04529499|38063062|FG001|Overall Study|Withdrawal by Subject|11|||
16921488|NCT04529499|38063061|FG000|Overall Study|Physician Decision|1|||
16921489|NCT04529499|38063062|FG001|Overall Study|Physician Decision|2|||
16921490|NCT04529499|38063061|FG000|Overall Study|Adverse Event|4|||
16921491|NCT04529499|38063062|FG001|Overall Study|Adverse Event|4|||
16921492|NCT04529499|38063061|FG000|Overall Study|Death|14|||
16921493|NCT04529499|38063062|FG001|Overall Study|Death|11|||
16921494|NCT04529499|38063061|FG000|Overall Study|Lost to Follow-up|1|||
16921495|NCT04529499|38063062|FG001|Overall Study|Lost to Follow-up|1|||
16921496|NCT04529499|38063061|FG000|Overall Study|Others|7|||
16921497|NCT04529499|38063062|FG001|Overall Study|Others|11|||
16921498|NCT04501094|38063070|FG000|Overall Study|Death (unrelated to research)|1|||
16921499|NCT04501094|38063071|FG001|Overall Study|Death (unrelated to research)|0|||
16921500|NCT04414618|38063079|FG000|Overall Study|Death|3|||
16921501|NCT04414618|38063080|FG001|Overall Study|Death|3|||
16921502|NCT04414618|38063079|FG000|Overall Study|Withdrawal by Subject|2|||
16921503|NCT04414618|38063080|FG001|Overall Study|Withdrawal by Subject|1|||
16921504|NCT04414618|38063079|FG000|Overall Study|Lost to Follow-up|2|||
16921505|NCT04414618|38063080|FG001|Overall Study|Lost to Follow-up|3|||
16921506|NCT04414618|38063079|FG000|Overall Study|Physician Decision|1|||
16846467|NCT01769456|37791675|FG000|Overall Study|Withdrawal by Subject|3|||
16846468|NCT01769456|37791675|FG000|Overall Study|Did not receive PCC intervention|6|||
16846469|NCT01769456|37791675|FG000|Overall Study|Moved out of the area|3|||
16846470|NCT01769456|37791675|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
16846471|NCT01769456|37791675|FG000|Overall Study|Parental request to youth to withdraw|1|||
16846472|NCT01769378|37791682|FG000|Overall Study|Adverse Event|10|||
16846473|NCT01769378|37791683|FG001|Overall Study|Adverse Event|0|||
16921507|NCT04414618|38063080|FG001|Overall Study|Physician Decision|0|||
16921508|NCT04412057|38063089|FG000|Overall Study|Death|3|||
16921509|NCT04412057|38063090|FG001|Overall Study|Death|7|||
16921510|NCT04412057|38063089|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
16921511|NCT04412057|38063090|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
16921512|NCT04402060|38063099|FG000|Overall Study|Death|1|||
16921513|NCT04402060|38063100|FG001|Overall Study|Death|12|||
16921514|NCT04402060|38063101|FG002|Overall Study|Death|7|||
16921515|NCT04402060|38063099|FG000|Overall Study|Adverse Event|0|||
16921516|NCT04402060|38063100|FG001|Overall Study|Adverse Event|0|||
16921517|NCT04402060|38063101|FG002|Overall Study|Adverse Event|1|||
16921518|NCT04402060|38063099|FG000|Overall Study|Withdrawal by Subject|0|||
16921519|NCT04402060|38063100|FG001|Overall Study|Withdrawal by Subject|1|||
16921520|NCT04402060|38063101|FG002|Overall Study|Withdrawal by Subject|2|||
16921521|NCT04402060|38063099|FG000|Overall Study|Sponsor Request|0|||
16921522|NCT04402060|38063100|FG001|Overall Study|Sponsor Request|2|||
16846474|NCT01769378|37791682|FG000|Overall Study|Entry criteria not met|1|||
16846475|NCT01769378|37791683|FG001|Overall Study|Entry criteria not met|0|||
16846476|NCT01769378|37791682|FG000|Overall Study|Protocol Violation|1|||
16846477|NCT01769378|37791683|FG001|Overall Study|Protocol Violation|1|||
16846478|NCT01769378|37791682|FG000|Overall Study|Withdrawal by Subject|10|||
16846479|NCT01769378|37791683|FG001|Overall Study|Withdrawal by Subject|3|||
16846480|NCT01769378|37791682|FG000|Overall Study|Sponsor Decision|1|||
16846481|NCT01769378|37791683|FG001|Overall Study|Sponsor Decision|0|||
16846482|NCT01769378|37791682|FG000|Overall Study|Lost to Follow-up|2|||
16846483|NCT01769378|37791683|FG001|Overall Study|Lost to Follow-up|0|||
16846484|NCT01807520|37791692|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16846485|NCT01807520|37791693|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
16846486|NCT01807520|37791694|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
16846487|NCT01807520|37791695|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16846488|NCT01807520|37791696|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16846489|NCT01807520|37791697|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16846490|NCT01807520|37791698|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16846491|NCT01807520|37791692|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
16921523|NCT04402060|38063101|FG002|Overall Study|Sponsor Request|0|||
16921524|NCT04402060|38063099|FG000|Overall Study|Physician Decision|0|||
16921525|NCT04402060|38063100|FG001|Overall Study|Physician Decision|0|||
16921526|NCT04402060|38063101|FG002|Overall Study|Physician Decision|1|||
16921527|NCT04402060|38063099|FG000|Overall Study|Other|0|||
16921528|NCT04402060|38063100|FG001|Overall Study|Other|1|||
16921529|NCT04402060|38063101|FG002|Overall Study|Other|0|||
16921530|NCT04396626|38063114|FG000|Overall Study|Premature termination of study|975|||
16846492|NCT01807520|37791693|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16846493|NCT01807520|37791694|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
16846494|NCT01807520|37791695|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16846495|NCT01807520|37791696|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16846496|NCT01807520|37791697|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16846497|NCT01807520|37791698|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16846498|NCT01807520|37791692|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16846499|NCT01807520|37791693|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16846500|NCT01807520|37791694|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
16846501|NCT01807520|37791695|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16846502|NCT01807520|37791696|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16846503|NCT01807520|37791697|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16846504|NCT01807520|37791698|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16846505|NCT01807520|37791692|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
16846506|NCT01807520|37791693|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16846507|NCT01807520|37791694|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16846508|NCT01807520|37791695|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16846509|NCT01807520|37791696|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16921531|NCT04376684|38063140|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
16921532|NCT04376684|38063141|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
16921533|NCT04376684|38063142|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
16921534|NCT04376684|38063143|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
16921535|NCT04376684|38063140|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
16921536|NCT04376684|38063141|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
16846510|NCT01807520|37791697|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16846511|NCT01807520|37791698|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16846512|NCT01807520|37791692|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16846513|NCT01807520|37791693|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16846514|NCT01807520|37791694|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
16846515|NCT01807520|37791695|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16846516|NCT01807520|37791696|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16921537|NCT04376684|38063142|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
16921538|NCT04376684|38063143|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
16921539|NCT04376684|38063140|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
16921540|NCT04376684|38063141|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
16921541|NCT04376684|38063142|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
16921542|NCT04376684|38063143|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
16921543|NCT04376684|38063140|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
16921544|NCT04376684|38063141|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
16921545|NCT04376684|38063142|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
16921546|NCT04376684|38063143|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
16921547|NCT04376684|38063140|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
16921548|NCT04376684|38063141|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
16921549|NCT04376684|38063142|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
16921550|NCT04376684|38063143|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
16921551|NCT04376684|38063140|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
16921552|NCT04376684|38063141|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
16921553|NCT04376684|38063142|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
16921554|NCT04376684|38063143|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
16921555|NCT04376684|38063140|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
16921556|NCT04376684|38063141|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
16921557|NCT04376684|38063142|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
16921558|NCT04376684|38063143|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
16921559|NCT04353284|38063155|FG000|Overall Study|Adverse Event|1|||
16921560|NCT04353284|38063156|FG001|Overall Study|Adverse Event|1|||
16921561|NCT04353284|38063155|FG000|Overall Study|Lost to Follow-up|1|||
16921562|NCT04353284|38063156|FG001|Overall Study|Lost to Follow-up|0|||
16846517|NCT01807520|37791697|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16846518|NCT01807520|37791698|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16921563|NCT04294147|38063164|FG000|Overall Study|Protocol Violation|2|||
16921564|NCT04294147|38063165|FG001|Overall Study|Protocol Violation|0|||
16846519|NCT01807520|37791692|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
16846520|NCT01807520|37791693|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16846521|NCT01807520|37791694|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16846522|NCT01807520|37791695|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16846523|NCT01807520|37791696|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16846524|NCT01807520|37791697|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16846525|NCT01807520|37791698|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16846526|NCT01807520|37791692|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
16846527|NCT01807520|37791693|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
16846528|NCT01807520|37791694|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
16846529|NCT01807520|37791695|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
16846530|NCT01807520|37791696|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
16846531|NCT01807520|37791697|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
16846532|NCT01807520|37791698|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
16846533|NCT01807520|37791692|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16846534|NCT01807520|37791693|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16846535|NCT01807520|37791694|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16846536|NCT01807520|37791695|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
16846537|NCT01807520|37791696|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16846538|NCT01807520|37791697|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16846539|NCT01807520|37791698|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16846540|NCT01807520|37791692|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
16846541|NCT01807520|37791693|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16846542|NCT01807520|37791694|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16846543|NCT01807520|37791695|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16846544|NCT01807520|37791696|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16846545|NCT01807520|37791697|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16846546|NCT01807520|37791698|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16846547|NCT01807520|37791692|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16846548|NCT01807520|37791693|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
16846549|NCT01807520|37791694|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16846550|NCT01807520|37791695|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16846551|NCT01807520|37791696|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16846552|NCT01807520|37791697|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16846553|NCT01807520|37791698|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16846554|NCT01807520|37791692|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
16846555|NCT01807520|37791693|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16846556|NCT01807520|37791694|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16846557|NCT01807520|37791695|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
16921565|NCT04231825|38063177|FG000|Overall Study|Protocol Violation|3|||
16921566|NCT04231825|38063178|FG001|Overall Study|Protocol Violation|3|||
16921567|NCT04231825|38063177|FG000|Overall Study|Lost to Follow-up|0|||
16921568|NCT04231825|38063178|FG001|Overall Study|Lost to Follow-up|1|||
16921569|NCT04178772|38063184|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
16921570|NCT04178772|38063184|FG000|Overall Study|study terminated early due to COVID-19|7|||
16921571|NCT04148651|38063188|FG000|Overall Study|Lost to Follow-up|2|||
16846558|NCT01807520|37791696|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16846559|NCT01807520|37791697|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16846560|NCT01807520|37791698|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16846561|NCT01807520|37791692|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
16846562|NCT01807520|37791693|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
16846563|NCT01807520|37791694|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
16846564|NCT01807520|37791695|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
16846565|NCT01807520|37791696|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
16846566|NCT01807520|37791697|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
16846567|NCT01807520|37791698|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
16846568|NCT01807520|37791692|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
16846569|NCT01807520|37791693|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
16846570|NCT01807520|37791694|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
16846571|NCT01807520|37791695|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
16846572|NCT01807520|37791696|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
16846573|NCT01807520|37791697|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
16846574|NCT01807520|37791698|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
16846575|NCT01807520|37791692|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
16846576|NCT01807520|37791693|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
16921572|NCT03924427|38063201|FG000|Overall Study|Adverse Event|4|||
16921573|NCT03924427|38063201|FG000|Overall Study|Lack of Efficacy|1|||
16921574|NCT03924427|38063201|FG000|Overall Study|Withdrawal by Subject|1|||
16921575|NCT03893448|38063209|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
16921576|NCT03893448|38063210|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
16921577|NCT03893448|38063209|FG000|Overall Study|Physician Decision|8|||
16921578|NCT03893448|38063210|FG001|Overall Study|Physician Decision|14|||
16921579|NCT03893448|38063209|FG000|Overall Study|Lost to Follow-up|34|||
16921580|NCT03893448|38063210|FG001|Overall Study|Lost to Follow-up|27|||
16921581|NCT03893448|38063209|FG000|Overall Study|Death|1|||
16921582|NCT03893448|38063210|FG001|Overall Study|Death|0|||
16921583|NCT03811574|38063250|FG000|Overall Study|Withdrawal by Subject|2|||
16921584|NCT03811574|38063251|FG001|Overall Study|Withdrawal by Subject|4|||
16921585|NCT03811574|38063252|FG002|Overall Study|Withdrawal by Subject|0|||
16921586|NCT03727750|38063275|FG000|Overall Study|Death|45|||
16921587|NCT03727750|38063275|FG000|Overall Study|Withdrawal by Subject|2|||
16921588|NCT03727750|38063275|FG000|Overall Study|Lost to Follow-up|1|||
16921589|NCT03727750|38063275|FG000|Overall Study|Other|1|||
16921590|NCT03715829|38063285|FG000|Dose Ranging Period|Adverse Event|2|||
16921591|NCT03715829|38063286|FG001|Dose Ranging Period|Adverse Event|4|||
16846577|NCT01807520|37791694|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
16846578|NCT01807520|37791695|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
16846579|NCT01807520|37791696|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
16846580|NCT01807520|37791697|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
16846581|NCT01807520|37791698|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
16846582|NCT01807520|37791692|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16846583|NCT01807520|37791693|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16921592|NCT03715829|38063287|FG002|Dose Ranging Period|Adverse Event|5|||
16921593|NCT03715829|38063288|FG003|Dose Ranging Period|Adverse Event|2|||
16921594|NCT03715829|38063289|FG004|Dose Ranging Period|Adverse Event|3|||
16921595|NCT03715829|38063290|FG005|Dose Ranging Period|Adverse Event|3|||
16921596|NCT03715829|38063291|FG006|Dose Ranging Period|Adverse Event|0|||
16921597|NCT03715829|38063292|FG007|Dose Ranging Period|Adverse Event|0|||
16921598|NCT03715829|38063293|FG008|Dose Ranging Period|Adverse Event|0|||
16921599|NCT03715829|38063294|FG009|Dose Ranging Period|Adverse Event|0|||
16921600|NCT03715829|38063295|FG010|Dose Ranging Period|Adverse Event|0|||
16921601|NCT03715829|38063285|FG000|Dose Ranging Period|Lack of Efficacy|0|||
16921602|NCT03715829|38063286|FG001|Dose Ranging Period|Lack of Efficacy|1|||
16921603|NCT03715829|38063287|FG002|Dose Ranging Period|Lack of Efficacy|0|||
16921604|NCT03715829|38063288|FG003|Dose Ranging Period|Lack of Efficacy|1|||
17017567|NCT00843024|38162182|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
17017568|NCT00843024|38162183|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
17017569|NCT00843024|38162184|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
17017570|NCT00843024|38162179|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
17017571|NCT00843024|38162180|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
17017572|NCT00843024|38162181|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
17017573|NCT00843024|38162182|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
17017574|NCT00843024|38162183|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
17017575|NCT00843024|38162184|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
17017576|NCT00843024|38162179|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
17017577|NCT00843024|38162180|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
17017578|NCT00843024|38162181|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16921605|NCT03715829|38063289|FG004|Dose Ranging Period|Lack of Efficacy|0|||
16921606|NCT03715829|38063290|FG005|Dose Ranging Period|Lack of Efficacy|0|||
16921607|NCT03715829|38063291|FG006|Dose Ranging Period|Lack of Efficacy|0|||
16921608|NCT03715829|38063292|FG007|Dose Ranging Period|Lack of Efficacy|0|||
16921609|NCT03715829|38063293|FG008|Dose Ranging Period|Lack of Efficacy|0|||
16921610|NCT03715829|38063294|FG009|Dose Ranging Period|Lack of Efficacy|0|||
16921611|NCT03715829|38063295|FG010|Dose Ranging Period|Lack of Efficacy|0|||
16921612|NCT03715829|38063285|FG000|Dose Ranging Period|Lost to Follow-up|2|||
16921613|NCT03715829|38063286|FG001|Dose Ranging Period|Lost to Follow-up|0|||
16921614|NCT03715829|38063287|FG002|Dose Ranging Period|Lost to Follow-up|1|||
16921615|NCT03715829|38063288|FG003|Dose Ranging Period|Lost to Follow-up|1|||
16921616|NCT03715829|38063289|FG004|Dose Ranging Period|Lost to Follow-up|1|||
16921617|NCT03715829|38063290|FG005|Dose Ranging Period|Lost to Follow-up|2|||
16921618|NCT03715829|38063291|FG006|Dose Ranging Period|Lost to Follow-up|0|||
16921619|NCT03715829|38063292|FG007|Dose Ranging Period|Lost to Follow-up|0|||
16921620|NCT03715829|38063293|FG008|Dose Ranging Period|Lost to Follow-up|0|||
16921621|NCT03715829|38063294|FG009|Dose Ranging Period|Lost to Follow-up|0|||
16921622|NCT03715829|38063295|FG010|Dose Ranging Period|Lost to Follow-up|0|||
16921623|NCT03715829|38063285|FG000|Dose Ranging Period|Protocol Violation|0|||
16921624|NCT03715829|38063286|FG001|Dose Ranging Period|Protocol Violation|0|||
16921625|NCT03715829|38063287|FG002|Dose Ranging Period|Protocol Violation|0|||
16921626|NCT03715829|38063288|FG003|Dose Ranging Period|Protocol Violation|1|||
16921627|NCT03715829|38063289|FG004|Dose Ranging Period|Protocol Violation|0|||
16846584|NCT01807520|37791694|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16846585|NCT01807520|37791695|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16846586|NCT01807520|37791696|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16846587|NCT01807520|37791697|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
16846588|NCT01807520|37791698|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16846589|NCT01807520|37791692|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16846590|NCT01807520|37791693|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16846591|NCT01807520|37791694|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16846592|NCT01807520|37791695|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16846593|NCT01807520|37791696|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16846594|NCT01807520|37791697|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
16846595|NCT01807520|37791698|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16846596|NCT01807520|37791692|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16846597|NCT01807520|37791693|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16846598|NCT01807520|37791694|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16846599|NCT01807520|37791695|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16846600|NCT01807520|37791696|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16846601|NCT01807520|37791697|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
16846602|NCT01807520|37791698|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
16846603|NCT01806896|37791711|FG000|Overall Study|Adverse Event|2|||
16846604|NCT01806896|37791712|FG001|Overall Study|Adverse Event|0|||
16846605|NCT01806896|37791711|FG000|Overall Study|Other|1|||
16846606|NCT01806896|37791712|FG001|Overall Study|Other|0|||
16846607|NCT01768676|37791720|FG000|Overall Study|Adverse Event|3|||
16846608|NCT01768676|37791721|FG001|Overall Study|Adverse Event|3|||
16846609|NCT01768676|37791720|FG000|Overall Study|Lost to Follow-up|13|||
16846610|NCT01768676|37791721|FG001|Overall Study|Lost to Follow-up|16|||
16846611|NCT01768676|37791720|FG000|Overall Study|Protocol Violation|1|||
16846612|NCT01768676|37791721|FG001|Overall Study|Protocol Violation|1|||
16846613|NCT01768676|37791720|FG000|Overall Study|Physician Decision|4|||
16846614|NCT01768676|37791721|FG001|Overall Study|Physician Decision|1|||
16846615|NCT01768676|37791720|FG000|Overall Study|Withdrawal by Subject|3|||
16846616|NCT01768676|37791721|FG001|Overall Study|Withdrawal by Subject|10|||
16846617|NCT01555125|37791730|FG000|Induction Period|Lost to Follow-up|0|||
16846618|NCT01555125|37791731|FG001|Induction Period|Lost to Follow-up|2|||
16846619|NCT01555125|37791732|FG002|Induction Period|Lost to Follow-up|0|||
16846620|NCT01555125|37791733|FG003|Induction Period|Lost to Follow-up|0|||
16846621|NCT01555125|37791734|FG004|Induction Period|Lost to Follow-up|0|||
17017579|NCT00843024|38162182|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
16921628|NCT03715829|38063290|FG005|Dose Ranging Period|Protocol Violation|0|||
16921629|NCT03715829|38063291|FG006|Dose Ranging Period|Protocol Violation|0|||
16921630|NCT03715829|38063292|FG007|Dose Ranging Period|Protocol Violation|0|||
16921631|NCT03715829|38063293|FG008|Dose Ranging Period|Protocol Violation|0|||
16921632|NCT03715829|38063294|FG009|Dose Ranging Period|Protocol Violation|0|||
17017580|NCT00843024|38162183|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
17017581|NCT00843024|38162184|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
16846622|NCT01555125|37791730|FG000|Induction Period|Adverse Event|0|||
16846623|NCT01555125|37791731|FG001|Induction Period|Adverse Event|1|||
16846624|NCT01555125|37791732|FG002|Induction Period|Adverse Event|0|||
16846625|NCT01555125|37791733|FG003|Induction Period|Adverse Event|0|||
16846626|NCT01555125|37791734|FG004|Induction Period|Adverse Event|1|||
16846627|NCT01555125|37791730|FG000|Induction Period|Subject / guardian decision|0|||
16846628|NCT01555125|37791731|FG001|Induction Period|Subject / guardian decision|0|||
16846629|NCT01555125|37791732|FG002|Induction Period|Subject / guardian decision|0|||
16846630|NCT01555125|37791733|FG003|Induction Period|Subject / guardian decision|0|||
16846631|NCT01555125|37791734|FG004|Induction Period|Subject / guardian decision|2|||
16846632|NCT01555125|37791730|FG000|Induction Period|Death|1|||
16846633|NCT01555125|37791731|FG001|Induction Period|Death|0|||
16846634|NCT01555125|37791732|FG002|Induction Period|Death|0|||
16846635|NCT01555125|37791733|FG003|Induction Period|Death|0|||
16846636|NCT01555125|37791734|FG004|Induction Period|Death|0|||
16846637|NCT01555125|37791730|FG000|Maintenance Period|Adverse Event|1|||
16846638|NCT01555125|37791731|FG001|Maintenance Period|Adverse Event|1|||
16846639|NCT01555125|37791732|FG002|Maintenance Period|Adverse Event|0|||
16846640|NCT01555125|37791733|FG003|Maintenance Period|Adverse Event|0|||
16846641|NCT01555125|37791734|FG004|Maintenance Period|Adverse Event|0|||
16846642|NCT01555125|37791730|FG000|Maintenance Period|Subject / guardian decision|1|||
16846643|NCT01555125|37791731|FG001|Maintenance Period|Subject / guardian decision|2|||
16846644|NCT01555125|37791732|FG002|Maintenance Period|Subject / guardian decision|0|||
16846645|NCT01555125|37791733|FG003|Maintenance Period|Subject / guardian decision|0|||
16846646|NCT01555125|37791734|FG004|Maintenance Period|Subject / guardian decision|0|||
16846647|NCT01555125|37791730|FG000|Maintenance Period|Lost to Follow-up|2|||
16846648|NCT01555125|37791731|FG001|Maintenance Period|Lost to Follow-up|0|||
16846649|NCT01555125|37791732|FG002|Maintenance Period|Lost to Follow-up|0|||
16846650|NCT01555125|37791733|FG003|Maintenance Period|Lost to Follow-up|1|||
16846651|NCT01555125|37791734|FG004|Maintenance Period|Lost to Follow-up|0|||
16846652|NCT01555125|37791730|FG000|Maintenance Period|Lack of Efficacy|6|||
16846653|NCT01555125|37791731|FG001|Maintenance Period|Lack of Efficacy|1|||
16846654|NCT01555125|37791732|FG002|Maintenance Period|Lack of Efficacy|3|||
16846655|NCT01555125|37791733|FG003|Maintenance Period|Lack of Efficacy|0|||
16846656|NCT01555125|37791734|FG004|Maintenance Period|Lack of Efficacy|0|||
16846657|NCT01555125|37791730|FG000|Maintenance Period|Physician Decision|0|||
16846658|NCT01555125|37791731|FG001|Maintenance Period|Physician Decision|0|||
16846659|NCT01555125|37791732|FG002|Maintenance Period|Physician Decision|1|||
16846660|NCT01555125|37791733|FG003|Maintenance Period|Physician Decision|0|||
16846661|NCT01555125|37791734|FG004|Maintenance Period|Physician Decision|0|||
16846662|NCT01555125|37791730|FG000|Maintenance Period|Death|0|||
16846663|NCT01555125|37791731|FG001|Maintenance Period|Death|0|||
16846664|NCT01555125|37791732|FG002|Maintenance Period|Death|0|||
16846665|NCT01555125|37791733|FG003|Maintenance Period|Death|1|||
16846666|NCT01555125|37791734|FG004|Maintenance Period|Death|0|||
16846667|NCT01555125|37791730|FG000|Extension|Adverse Event|1|||
16846668|NCT01555125|37791731|FG001|Extension|Adverse Event|2|||
16846669|NCT01555125|37791732|FG002|Extension|Adverse Event|1|||
17017582|NCT00843024|38162179|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
17017583|NCT00843024|38162180|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
17017584|NCT00843024|38162181|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
17017585|NCT00843024|38162182|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
16921633|NCT03715829|38063295|FG010|Dose Ranging Period|Protocol Violation|0|||
17017586|NCT00843024|38162183|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
17017587|NCT00843024|38162184|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
16921634|NCT03715829|38063285|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
16921635|NCT03715829|38063286|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
16921636|NCT03715829|38063287|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
16921637|NCT03715829|38063288|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
16921638|NCT03715829|38063289|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
16921639|NCT03715829|38063290|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
16921640|NCT03715829|38063291|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
16921641|NCT03715829|38063292|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
16921642|NCT03715829|38063293|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
16921643|NCT03715829|38063294|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
16921644|NCT03715829|38063295|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
16921645|NCT03715829|38063285|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16921646|NCT03715829|38063286|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16921647|NCT03715829|38063287|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
16921648|NCT03715829|38063288|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
17017588|NCT00843024|38162179|FG000|Double-blind Treatment Phase|Physician Decision|0|||
17017589|NCT00843024|38162180|FG001|Double-blind Treatment Phase|Physician Decision|0|||
17017590|NCT00843024|38162181|FG002|Double-blind Treatment Phase|Physician Decision|0|||
16846670|NCT01555125|37791733|FG003|Extension|Adverse Event|1|||
16846671|NCT01555125|37791734|FG004|Extension|Adverse Event|0|||
16846672|NCT01555125|37791730|FG000|Extension|Protocol deviation|1|||
16846673|NCT01555125|37791731|FG001|Extension|Protocol deviation|0|||
16846674|NCT01555125|37791732|FG002|Extension|Protocol deviation|0|||
16846675|NCT01555125|37791733|FG003|Extension|Protocol deviation|0|||
16846676|NCT01555125|37791734|FG004|Extension|Protocol deviation|0|||
16846677|NCT01555125|37791730|FG000|Extension|Lack of Efficacy|7|||
16846678|NCT01555125|37791731|FG001|Extension|Lack of Efficacy|6|||
16846679|NCT01555125|37791732|FG002|Extension|Lack of Efficacy|3|||
16846680|NCT01555125|37791733|FG003|Extension|Lack of Efficacy|0|||
16846681|NCT01555125|37791734|FG004|Extension|Lack of Efficacy|0|||
16846682|NCT01555125|37791730|FG000|Extension|Lost to Follow-up|2|||
16846683|NCT01555125|37791731|FG001|Extension|Lost to Follow-up|1|||
16846684|NCT01555125|37791732|FG002|Extension|Lost to Follow-up|2|||
16846685|NCT01555125|37791733|FG003|Extension|Lost to Follow-up|0|||
16846686|NCT01555125|37791734|FG004|Extension|Lost to Follow-up|0|||
16846687|NCT01555125|37791730|FG000|Extension|Study terminated by sponsor|32|||
16846688|NCT01555125|37791731|FG001|Extension|Study terminated by sponsor|33|||
16846689|NCT01555125|37791732|FG002|Extension|Study terminated by sponsor|16|||
16846690|NCT01555125|37791733|FG003|Extension|Study terminated by sponsor|20|||
16846691|NCT01555125|37791734|FG004|Extension|Study terminated by sponsor|0|||
16846692|NCT01555125|37791730|FG000|Extension|Subject/guardian decision|1|||
16846693|NCT01555125|37791731|FG001|Extension|Subject/guardian decision|9|||
16846694|NCT01555125|37791732|FG002|Extension|Subject/guardian decision|1|||
16846695|NCT01555125|37791733|FG003|Extension|Subject/guardian decision|0|||
16846696|NCT01555125|37791734|FG004|Extension|Subject/guardian decision|0|||
16846697|NCT01555125|37791730|FG000|Extension|Technical Problems|1|||
16846698|NCT01555125|37791731|FG001|Extension|Technical Problems|0|||
16846699|NCT01555125|37791732|FG002|Extension|Technical Problems|0|||
16846700|NCT01555125|37791733|FG003|Extension|Technical Problems|1|||
16846701|NCT01555125|37791734|FG004|Extension|Technical Problems|0|||
16846702|NCT01555125|37791730|FG000|Follow-Up Period|Lost to Follow-up|1|||
16846703|NCT01555125|37791731|FG001|Follow-Up Period|Lost to Follow-up|0|||
16846704|NCT01555125|37791732|FG002|Follow-Up Period|Lost to Follow-up|0|||
16846705|NCT01555125|37791733|FG003|Follow-Up Period|Lost to Follow-up|0|||
16846706|NCT01555125|37791734|FG004|Follow-Up Period|Lost to Follow-up|0|||
16846707|NCT01555125|37791730|FG000|Follow-Up Period|Subject / guardian decision|3|||
16846708|NCT01555125|37791731|FG001|Follow-Up Period|Subject / guardian decision|1|||
16846709|NCT01555125|37791732|FG002|Follow-Up Period|Subject / guardian decision|1|||
16846710|NCT01555125|37791733|FG003|Follow-Up Period|Subject / guardian decision|1|||
16846711|NCT01555125|37791734|FG004|Follow-Up Period|Subject / guardian decision|0|||
16846712|NCT01768286|37791753|FG000|Overall Study|Randomized But Not Treated|0|||
16846713|NCT01768286|37791754|FG001|Overall Study|Randomized But Not Treated|0|||
16846714|NCT01768286|37791755|FG002|Overall Study|Randomized But Not Treated|1|||
16846715|NCT01768286|37791756|FG003|Overall Study|Randomized But Not Treated|0|||
16846716|NCT01768286|37791753|FG000|Overall Study|Lack of Efficacy|7|||
16846717|NCT01768286|37791754|FG001|Overall Study|Lack of Efficacy|4|||
16846718|NCT01768286|37791755|FG002|Overall Study|Lack of Efficacy|0|||
16846719|NCT01768286|37791756|FG003|Overall Study|Lack of Efficacy|1|||
16846720|NCT01768286|37791753|FG000|Overall Study|Withdrew Consent|0|||
16846721|NCT01768286|37791754|FG001|Overall Study|Withdrew Consent|0|||
16846722|NCT01768286|37791755|FG002|Overall Study|Withdrew Consent|1|||
16846723|NCT01768286|37791756|FG003|Overall Study|Withdrew Consent|0|||
16846724|NCT01800968|37791768|FG000|Overall Study|Death|23|||
16846725|NCT01800968|37791769|FG001|Overall Study|Death|16|||
16846726|NCT01800968|37791768|FG000|Overall Study|Lost to Follow-up|5|||
16846727|NCT01800968|37791769|FG001|Overall Study|Lost to Follow-up|7|||
16846728|NCT01800968|37791768|FG000|Overall Study|Withdrawal by Subject|7|||
16846729|NCT01800968|37791769|FG001|Overall Study|Withdrawal by Subject|9|||
16921649|NCT03715829|38063289|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16921650|NCT03715829|38063290|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
17017591|NCT00843024|38162182|FG003|Double-blind Treatment Phase|Physician Decision|3|||
17017592|NCT00843024|38162183|FG004|Double-blind Treatment Phase|Physician Decision|1|||
17017593|NCT00843024|38162184|FG005|Double-blind Treatment Phase|Physician Decision|1|||
17017594|NCT00843024|38162179|FG000|Double-blind Treatment Phase|Adverse Event|0|||
17017595|NCT00843024|38162180|FG001|Double-blind Treatment Phase|Adverse Event|0|||
17017596|NCT00843024|38162181|FG002|Double-blind Treatment Phase|Adverse Event|0|||
17017597|NCT00843024|38162182|FG003|Double-blind Treatment Phase|Adverse Event|0|||
17017598|NCT00843024|38162183|FG004|Double-blind Treatment Phase|Adverse Event|1|||
17017599|NCT00843024|38162184|FG005|Double-blind Treatment Phase|Adverse Event|1|||
17017600|NCT00843024|38162179|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
17017601|NCT00843024|38162180|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
17017602|NCT00843024|38162181|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
16846730|NCT01800968|37791768|FG000|Overall Study|Physician Decision|1|||
16846731|NCT01800968|37791769|FG001|Overall Study|Physician Decision|0|||
16846732|NCT01799720|37791778|FG000|Overall Study|Withdrawal by Subject|3|||
16846733|NCT01799720|37791779|FG001|Overall Study|Withdrawal by Subject|0|||
16846734|NCT01799720|37791780|FG002|Overall Study|Withdrawal by Subject|0|||
16846735|NCT01799720|37791778|FG000|Overall Study|Protocol Violation|0|||
16846736|NCT01799720|37791779|FG001|Overall Study|Protocol Violation|1|||
16846737|NCT01799720|37791780|FG002|Overall Study|Protocol Violation|0|||
16846738|NCT01799720|37791778|FG000|Overall Study|Pregnancy|0|||
16846739|NCT01799720|37791779|FG001|Overall Study|Pregnancy|0|||
16921651|NCT03715829|38063291|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16921652|NCT03715829|38063292|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16921653|NCT03715829|38063293|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16921654|NCT03715829|38063294|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16921655|NCT03715829|38063295|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16921656|NCT03715829|38063285|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16921657|NCT03715829|38063286|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16921658|NCT03715829|38063287|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
16921659|NCT03715829|38063288|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16921660|NCT03715829|38063289|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
16921661|NCT03715829|38063290|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16921662|NCT03715829|38063291|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16921663|NCT03715829|38063292|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16921664|NCT03715829|38063293|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16921665|NCT03715829|38063294|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16921666|NCT03715829|38063295|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16846740|NCT01799720|37791780|FG002|Overall Study|Pregnancy|1|||
16846741|NCT01687257|37791790|FG000|Overall Study|Efficacy Failure|6|||
16846742|NCT01687257|37791791|FG001|Overall Study|Efficacy Failure|0|||
16846743|NCT01687257|37791792|FG002|Overall Study|Efficacy Failure|5|||
16846744|NCT01687257|37791790|FG000|Overall Study|Subject Withdrew Consent|1|||
16846745|NCT01687257|37791791|FG001|Overall Study|Subject Withdrew Consent|1|||
16846746|NCT01687257|37791792|FG002|Overall Study|Subject Withdrew Consent|1|||
16846747|NCT01687257|37791790|FG000|Overall Study|Adverse Event|1|||
16846748|NCT01687257|37791791|FG001|Overall Study|Adverse Event|0|||
16921667|NCT03715829|38063285|FG000|Dose Ranging Period|Other|0|||
16921668|NCT03715829|38063286|FG001|Dose Ranging Period|Other|0|||
16921669|NCT03715829|38063287|FG002|Dose Ranging Period|Other|2|||
16921670|NCT03715829|38063288|FG003|Dose Ranging Period|Other|0|||
16921671|NCT03715829|38063289|FG004|Dose Ranging Period|Other|0|||
16921672|NCT03715829|38063290|FG005|Dose Ranging Period|Other|3|||
16921673|NCT03715829|38063291|FG006|Dose Ranging Period|Other|0|||
16921674|NCT03715829|38063292|FG007|Dose Ranging Period|Other|0|||
16921675|NCT03715829|38063293|FG008|Dose Ranging Period|Other|0|||
16921676|NCT03715829|38063294|FG009|Dose Ranging Period|Other|0|||
16921677|NCT03715829|38063295|FG010|Dose Ranging Period|Other|0|||
16921678|NCT03715829|38063285|FG000|Extension Period|Adverse Event|0|||
16921679|NCT03715829|38063286|FG001|Extension Period|Adverse Event|0|||
16921680|NCT03715829|38063287|FG002|Extension Period|Adverse Event|0|||
16921681|NCT03715829|38063288|FG003|Extension Period|Adverse Event|0|||
16921682|NCT03715829|38063289|FG004|Extension Period|Adverse Event|0|||
16846749|NCT01687257|37791792|FG002|Overall Study|Adverse Event|0|||
16846750|NCT01687257|37791790|FG000|Overall Study|Investigator's Discretion|0|||
16846751|NCT01687257|37791791|FG001|Overall Study|Investigator's Discretion|3|||
16921683|NCT03715829|38063290|FG005|Extension Period|Adverse Event|0|||
16921684|NCT03715829|38063291|FG006|Extension Period|Adverse Event|3|||
16921685|NCT03715829|38063292|FG007|Extension Period|Adverse Event|1|||
16921686|NCT03715829|38063293|FG008|Extension Period|Adverse Event|6|||
17017603|NCT00843024|38162182|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
17017604|NCT00843024|38162183|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
17017605|NCT00843024|38162184|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
17017606|NCT00832650|38162200|FG000|Overall Study|Randomized but not treated|0|||
17017607|NCT00832650|38162201|FG001|Overall Study|Randomized but not treated|0|||
17017608|NCT00832650|38162202|FG002|Overall Study|Randomized but not treated|1|||
17017609|NCT00595517|38162210|FG000|Overall Study|Adverse Event|6|||
17017610|NCT00595517|38162210|FG000|Overall Study|Withdrawal by Subject|4|||
17017611|NCT00595517|38162210|FG000|Overall Study|Protocol Violation|2|||
17017612|NCT00595517|38162210|FG000|Overall Study|Recurrence of ulcer|5|||
17017613|NCT00595517|38162210|FG000|Overall Study|usage of prohibited treatment|1|||
17017614|NCT00595517|38162210|FG000|Overall Study|No intention to attend regularly|1|||
17017615|NCT00823836|38162216|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
17017616|NCT00823836|38162217|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
17017617|NCT00823836|38162216|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
16921687|NCT03715829|38063294|FG009|Extension Period|Adverse Event|0|||
16921688|NCT03715829|38063295|FG010|Extension Period|Adverse Event|0|||
16921689|NCT03715829|38063285|FG000|Extension Period|Lack of Efficacy|0|||
16921690|NCT03715829|38063286|FG001|Extension Period|Lack of Efficacy|0|||
16846752|NCT01687257|37791792|FG002|Overall Study|Investigator's Discretion|0|||
16921691|NCT03715829|38063287|FG002|Extension Period|Lack of Efficacy|0|||
16921692|NCT03715829|38063288|FG003|Extension Period|Lack of Efficacy|0|||
16921693|NCT03715829|38063289|FG004|Extension Period|Lack of Efficacy|0|||
16921694|NCT03715829|38063290|FG005|Extension Period|Lack of Efficacy|0|||
16921695|NCT03715829|38063291|FG006|Extension Period|Lack of Efficacy|1|||
16921696|NCT03715829|38063292|FG007|Extension Period|Lack of Efficacy|9|||
16846753|NCT01806740|37791806|FG000|Overall Study|Withdrawal by Subject|4|||
16846754|NCT01806740|37791806|FG000|Overall Study|Physician Decision|1|||
16846755|NCT01806740|37791806|FG000|Overall Study|Patient's refusal of treatment|1|||
16921697|NCT03715829|38063293|FG008|Extension Period|Lack of Efficacy|2|||
16921698|NCT03715829|38063294|FG009|Extension Period|Lack of Efficacy|0|||
16921699|NCT03715829|38063295|FG010|Extension Period|Lack of Efficacy|0|||
16921700|NCT03715829|38063285|FG000|Extension Period|Lost to Follow-up|0|||
16921701|NCT03715829|38063286|FG001|Extension Period|Lost to Follow-up|0|||
16921702|NCT03715829|38063287|FG002|Extension Period|Lost to Follow-up|0|||
16921703|NCT03715829|38063288|FG003|Extension Period|Lost to Follow-up|0|||
16921704|NCT03715829|38063289|FG004|Extension Period|Lost to Follow-up|0|||
16921705|NCT03715829|38063290|FG005|Extension Period|Lost to Follow-up|0|||
16921706|NCT03715829|38063291|FG006|Extension Period|Lost to Follow-up|0|||
16921707|NCT03715829|38063292|FG007|Extension Period|Lost to Follow-up|0|||
16921708|NCT03715829|38063293|FG008|Extension Period|Lost to Follow-up|2|||
16921709|NCT03715829|38063294|FG009|Extension Period|Lost to Follow-up|0|||
16921710|NCT03715829|38063295|FG010|Extension Period|Lost to Follow-up|0|||
16921711|NCT03715829|38063285|FG000|Extension Period|Protocol Violation|0|||
16921712|NCT03715829|38063286|FG001|Extension Period|Protocol Violation|0|||
16921713|NCT03715829|38063287|FG002|Extension Period|Protocol Violation|0|||
16921714|NCT03715829|38063288|FG003|Extension Period|Protocol Violation|0|||
16846756|NCT01687101|37791813|FG000|Overall Study|Lost to Follow-up|7|||
16846757|NCT01968967|37791819|FG000|Treatment Period|Other|22|||
16846758|NCT01968967|37791820|FG001|Treatment Period|Other|22|||
16846759|NCT01968967|37791821|FG002|Treatment Period|Other|0|||
16846760|NCT01968967|37791822|FG003|Treatment Period|Other|0|||
16846761|NCT01968967|37791823|FG004|Treatment Period|Other|0|||
16846762|NCT01968967|37791819|FG000|Treatment Period|Withdrawal by Subject|71|||
16846763|NCT01968967|37791820|FG001|Treatment Period|Withdrawal by Subject|61|||
16921715|NCT03715829|38063289|FG004|Extension Period|Protocol Violation|0|||
16921716|NCT03715829|38063290|FG005|Extension Period|Protocol Violation|0|||
16921717|NCT03715829|38063291|FG006|Extension Period|Protocol Violation|0|||
16921718|NCT03715829|38063292|FG007|Extension Period|Protocol Violation|0|||
16921719|NCT03715829|38063293|FG008|Extension Period|Protocol Violation|1|||
16921720|NCT03715829|38063294|FG009|Extension Period|Protocol Violation|0|||
16921721|NCT03715829|38063295|FG010|Extension Period|Protocol Violation|0|||
16921722|NCT03715829|38063285|FG000|Extension Period|Withdrawal by Subject|0|||
16921723|NCT03715829|38063286|FG001|Extension Period|Withdrawal by Subject|0|||
16921724|NCT03715829|38063287|FG002|Extension Period|Withdrawal by Subject|0|||
16921725|NCT03715829|38063288|FG003|Extension Period|Withdrawal by Subject|0|||
16921726|NCT03715829|38063289|FG004|Extension Period|Withdrawal by Subject|0|||
16921727|NCT03715829|38063290|FG005|Extension Period|Withdrawal by Subject|0|||
16921728|NCT03715829|38063291|FG006|Extension Period|Withdrawal by Subject|3|||
16921729|NCT03715829|38063292|FG007|Extension Period|Withdrawal by Subject|3|||
16921730|NCT03715829|38063293|FG008|Extension Period|Withdrawal by Subject|12|||
16921731|NCT03715829|38063294|FG009|Extension Period|Withdrawal by Subject|3|||
16846764|NCT01968967|37791821|FG002|Treatment Period|Withdrawal by Subject|0|||
16921732|NCT03715829|38063295|FG010|Extension Period|Withdrawal by Subject|0|||
16846765|NCT01968967|37791822|FG003|Treatment Period|Withdrawal by Subject|0|||
16846766|NCT01968967|37791823|FG004|Treatment Period|Withdrawal by Subject|0|||
16846767|NCT01968967|37791819|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
16846768|NCT01968967|37791820|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
16846769|NCT01968967|37791821|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
16846770|NCT01968967|37791822|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
16846771|NCT01968967|37791823|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
16846772|NCT01968967|37791819|FG000|Treatment Period|Lost to Follow-up|26|||
16846773|NCT01968967|37791820|FG001|Treatment Period|Lost to Follow-up|31|||
16846774|NCT01968967|37791821|FG002|Treatment Period|Lost to Follow-up|0|||
16846775|NCT01968967|37791822|FG003|Treatment Period|Lost to Follow-up|0|||
16846776|NCT01968967|37791823|FG004|Treatment Period|Lost to Follow-up|0|||
16846777|NCT01968967|37791819|FG000|Treatment Period|Protocol Violation|1|||
16846778|NCT01968967|37791820|FG001|Treatment Period|Protocol Violation|2|||
16846779|NCT01968967|37791821|FG002|Treatment Period|Protocol Violation|0|||
16846780|NCT01968967|37791822|FG003|Treatment Period|Protocol Violation|0|||
16846781|NCT01968967|37791823|FG004|Treatment Period|Protocol Violation|0|||
16846782|NCT01968967|37791819|FG000|Treatment Period|Adverse Event|9|||
16921733|NCT03715829|38063285|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
16921734|NCT03715829|38063286|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
16921735|NCT03715829|38063287|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
16921736|NCT03715829|38063288|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
16921737|NCT03715829|38063289|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
16921738|NCT03715829|38063290|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
16846783|NCT01968967|37791820|FG001|Treatment Period|Adverse Event|8|||
16846784|NCT01968967|37791821|FG002|Treatment Period|Adverse Event|0|||
16846785|NCT01968967|37791822|FG003|Treatment Period|Adverse Event|0|||
16921739|NCT03715829|38063291|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
16921740|NCT03715829|38063292|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
16921741|NCT03715829|38063293|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
16921742|NCT03715829|38063294|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
16921743|NCT03715829|38063295|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
16921744|NCT03715829|38063285|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921745|NCT03715829|38063286|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921746|NCT03715829|38063287|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921747|NCT03715829|38063288|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921748|NCT03715829|38063289|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921749|NCT03715829|38063290|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921750|NCT03715829|38063291|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921751|NCT03715829|38063292|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921752|NCT03715829|38063293|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
16921753|NCT03715829|38063294|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921754|NCT03715829|38063295|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
16921755|NCT03715829|38063285|FG000|Extension Period|Other|0|||
16921756|NCT03715829|38063286|FG001|Extension Period|Other|0|||
16921757|NCT03715829|38063287|FG002|Extension Period|Other|0|||
16921758|NCT03715829|38063288|FG003|Extension Period|Other|0|||
16921759|NCT03715829|38063289|FG004|Extension Period|Other|0|||
16921760|NCT03715829|38063290|FG005|Extension Period|Other|0|||
16921761|NCT03715829|38063291|FG006|Extension Period|Other|1|||
16921762|NCT03715829|38063292|FG007|Extension Period|Other|2|||
16921763|NCT03715829|38063293|FG008|Extension Period|Other|4|||
16921764|NCT03715829|38063294|FG009|Extension Period|Other|0|||
16921765|NCT03715829|38063295|FG010|Extension Period|Other|0|||
16921766|NCT03575104|38063357|FG000|Overall Study|Adverse Event|4|||
16921767|NCT03575104|38063358|FG001|Overall Study|Adverse Event|3|||
16921768|NCT03575104|38063359|FG002|Overall Study|Adverse Event|4|||
16921769|NCT03575104|38063357|FG000|Overall Study|Withdrawal by Subject|13|||
16921770|NCT03575104|38063358|FG001|Overall Study|Withdrawal by Subject|16|||
17017618|NCT00823836|38162217|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
17017619|NCT00823836|38162216|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
17017620|NCT00823836|38162217|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
17017621|NCT00823836|38162216|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
17017622|NCT00823836|38162217|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
17017623|NCT00823836|38162216|FG000|Long-term Phase|Adverse Event|3|||
17017624|NCT00823836|38162217|FG001|Long-term Phase|Adverse Event|2|||
17017625|NCT00823836|38162216|FG000|Long-term Phase|Physician Decision|1|||
17017626|NCT00823836|38162217|FG001|Long-term Phase|Physician Decision|2|||
17017627|NCT00823836|38162216|FG000|Long-term Phase|Withdrawal by Subject|1|||
17017628|NCT00823836|38162217|FG001|Long-term Phase|Withdrawal by Subject|1|||
17017629|NCT00879437|38162226|FG000|Overall Study|Protocol Violation|0|||
17017630|NCT00879437|38162227|FG001|Overall Study|Protocol Violation|1|||
17017631|NCT00879437|38162226|FG000|Overall Study|Death|1|||
17102518|NCT03628924|38241413|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
17102519|NCT03628924|38241414|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
17102520|NCT03628924|38241415|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
17102521|NCT03628924|38241409|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
17102522|NCT03628924|38241410|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
17102523|NCT03628924|38241411|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
17102524|NCT03628924|38241412|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
17102525|NCT03628924|38241413|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
17102526|NCT03628924|38241414|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
17102527|NCT03628924|38241415|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
17102528|NCT03628924|38241409|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
17102529|NCT03628924|38241410|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
17102530|NCT03628924|38241411|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
17102531|NCT03628924|38241412|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
17102532|NCT03628924|38241413|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
17102533|NCT03628924|38241414|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
17102534|NCT03628924|38241415|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
16921771|NCT03575104|38063359|FG002|Overall Study|Withdrawal by Subject|11|||
16921772|NCT03575104|38063357|FG000|Overall Study|Other reasons|6|||
16921773|NCT03575104|38063358|FG001|Overall Study|Other reasons|8|||
16921774|NCT03575104|38063359|FG002|Overall Study|Other reasons|6|||
16921775|NCT03575104|38063357|FG000|Overall Study|Lost to Follow-up|1|||
16921776|NCT03575104|38063358|FG001|Overall Study|Lost to Follow-up|2|||
16921777|NCT03575104|38063359|FG002|Overall Study|Lost to Follow-up|1|||
16921778|NCT03569475|38063370|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
16921779|NCT03569475|38063371|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
16921780|NCT03569475|38063372|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
16921781|NCT03569475|38063370|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
16921782|NCT03569475|38063371|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
16921783|NCT03569475|38063372|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
16846786|NCT01968967|37791823|FG004|Treatment Period|Adverse Event|0|||
16846787|NCT01968967|37791819|FG000|Treatment Period|Death|9|||
16846788|NCT01968967|37791820|FG001|Treatment Period|Death|2|||
16846789|NCT01968967|37791821|FG002|Treatment Period|Death|0|||
16846790|NCT01968967|37791822|FG003|Treatment Period|Death|0|||
16846791|NCT01968967|37791823|FG004|Treatment Period|Death|0|||
16846792|NCT01968967|37791819|FG000|Treatment Period|Randomized Not Treated|6|||
16846793|NCT01968967|37791820|FG001|Treatment Period|Randomized Not Treated|5|||
16846794|NCT01968967|37791821|FG002|Treatment Period|Randomized Not Treated|0|||
16846795|NCT01968967|37791822|FG003|Treatment Period|Randomized Not Treated|0|||
16846796|NCT01968967|37791823|FG004|Treatment Period|Randomized Not Treated|0|||
16846797|NCT01968967|37791819|FG000|Extension Period|Withdrew Consent|0|||
16921784|NCT03569475|38063370|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
16921785|NCT03569475|38063371|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
16921786|NCT03569475|38063372|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
16921787|NCT03569475|38063370|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
16921788|NCT03569475|38063371|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
16921789|NCT03569475|38063372|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
16921790|NCT03569475|38063370|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
16846798|NCT01968967|37791820|FG001|Extension Period|Withdrew Consent|0|||
16921791|NCT03569475|38063371|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
16921792|NCT03569475|38063372|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
16921793|NCT03569475|38063370|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
16921794|NCT03569475|38063371|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
16921795|NCT03569475|38063372|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
16921796|NCT03569475|38063370|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
16921797|NCT03569475|38063371|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
16921798|NCT03569475|38063372|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
16921799|NCT03569475|38063370|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
16921800|NCT03569475|38063371|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
16921801|NCT03569475|38063372|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
16921802|NCT03569475|38063370|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
16921803|NCT03569475|38063371|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
16921804|NCT03569475|38063372|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
16921805|NCT03545191|38063426|FG000|Overall Study|Death|1|||
16921806|NCT03545191|38063427|FG001|Overall Study|Death|0|||
16921807|NCT03545191|38063428|FG002|Overall Study|Death|0|||
16921808|NCT03545191|38063426|FG000|Overall Study|Adverse Event|4|||
16921809|NCT03545191|38063427|FG001|Overall Study|Adverse Event|2|||
16921810|NCT03545191|38063428|FG002|Overall Study|Adverse Event|7|||
16921811|NCT03545191|38063426|FG000|Overall Study|Other reasons|3|||
16921812|NCT03545191|38063427|FG001|Overall Study|Other reasons|11|||
16921813|NCT03545191|38063428|FG002|Overall Study|Other reasons|8|||
16921814|NCT03545191|38063426|FG000|Overall Study|Withdrawal by Subject|13|||
16921815|NCT03545191|38063427|FG001|Overall Study|Withdrawal by Subject|10|||
16921816|NCT03545191|38063428|FG002|Overall Study|Withdrawal by Subject|12|||
16921817|NCT03545191|38063426|FG000|Overall Study|Lost to Follow-up|1|||
16921818|NCT03545191|38063427|FG001|Overall Study|Lost to Follow-up|2|||
16921819|NCT03545191|38063428|FG002|Overall Study|Lost to Follow-up|3|||
16921820|NCT03500549|38063438|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
16921821|NCT03500549|38063439|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
16921822|NCT03500549|38063438|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
16921823|NCT03500549|38063439|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
17102535|NCT03627832|38241429|FG000|Overall Study|Withdrawal by Subject|10|||
17102536|NCT03627832|38241430|FG001|Overall Study|Withdrawal by Subject|1|||
16921826|NCT03387150|38063475|FG000|Overall Study|Withdrawal by Subject|3|||
16921827|NCT03387150|38063476|FG001|Overall Study|Withdrawal by Subject|0|||
16921828|NCT03387150|38063477|FG002|Overall Study|Withdrawal by Subject|3|||
16921829|NCT03387150|38063478|FG003|Overall Study|Withdrawal by Subject|4|||
16921830|NCT03387150|38063479|FG004|Overall Study|Withdrawal by Subject|1|||
16921831|NCT03387150|38063480|FG005|Overall Study|Withdrawal by Subject|2|||
16921832|NCT03387150|38063481|FG006|Overall Study|Withdrawal by Subject|0|||
16921833|NCT03387150|38063475|FG000|Overall Study|Lost to Follow-up|3|||
16921834|NCT03387150|38063476|FG001|Overall Study|Lost to Follow-up|2|||
16921835|NCT03387150|38063477|FG002|Overall Study|Lost to Follow-up|2|||
16921836|NCT03387150|38063478|FG003|Overall Study|Lost to Follow-up|3|||
16846799|NCT01968967|37791821|FG002|Extension Period|Withdrew Consent|2|||
16921837|NCT03387150|38063479|FG004|Overall Study|Lost to Follow-up|3|||
16921838|NCT03387150|38063480|FG005|Overall Study|Lost to Follow-up|3|||
16921839|NCT03387150|38063481|FG006|Overall Study|Lost to Follow-up|0|||
16921840|NCT03387150|38063475|FG000|Overall Study|Participant unable to adhere to visit|0|||
16921841|NCT03387150|38063476|FG001|Overall Study|Participant unable to adhere to visit|1|||
16921842|NCT03387150|38063477|FG002|Overall Study|Participant unable to adhere to visit|0|||
16921843|NCT03387150|38063478|FG003|Overall Study|Participant unable to adhere to visit|0|||
16921844|NCT03387150|38063479|FG004|Overall Study|Participant unable to adhere to visit|2|||
16921845|NCT03387150|38063480|FG005|Overall Study|Participant unable to adhere to visit|2|||
16921846|NCT03387150|38063481|FG006|Overall Study|Participant unable to adhere to visit|0|||
16921847|NCT03366792|38063497|FG000|Overall Study|Withdrawal by Subject|7|||
16921848|NCT03366792|38063497|FG000|Overall Study|Lost to Follow-up|2|||
16921849|NCT03366792|38063497|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
16921850|NCT03366792|38063497|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
16921851|NCT03366337|38063505|FG000|Overall Study|Lost to Follow-up|1|||
16921852|NCT03366337|38063506|FG001|Overall Study|Lost to Follow-up|0|||
16846800|NCT01968967|37791822|FG003|Extension Period|Withdrew Consent|0|||
16846801|NCT01968967|37791823|FG004|Extension Period|Withdrew Consent|5|||
16846802|NCT01554579|37791839|FG000|Overall Study|Adverse Event|6|||
16846803|NCT01554579|37791840|FG001|Overall Study|Adverse Event|25|||
16846804|NCT01554579|37791839|FG000|Overall Study|Lack of Efficacy|2|||
16846805|NCT01554579|37791840|FG001|Overall Study|Lack of Efficacy|1|||
16846806|NCT01554579|37791839|FG000|Overall Study|Withdrawal by Subject|2|||
16846807|NCT01554579|37791840|FG001|Overall Study|Withdrawal by Subject|1|||
16846808|NCT01806662|37791847|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
16846809|NCT01806662|37791848|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
16846810|NCT01806662|37791847|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
16846811|NCT01806662|37791848|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
16846812|NCT01806662|37791847|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
16846813|NCT01806662|37791848|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
16846814|NCT01806662|37791847|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
16846815|NCT01806662|37791848|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
16846816|NCT01930123|37791856|FG000|Overall Study|Adverse Event|1|||
16846817|NCT01930123|37791857|FG001|Overall Study|Adverse Event|0|||
16846818|NCT01930123|37791856|FG000|Overall Study|Physician Decision|21|||
16846819|NCT01930123|37791857|FG001|Overall Study|Physician Decision|8|||
16846820|NCT01930123|37791856|FG000|Overall Study|Withdrawal by Subject|1|||
16846821|NCT01930123|37791857|FG001|Overall Study|Withdrawal by Subject|0|||
16846822|NCT01930045|37791863|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16846823|NCT01930045|37791864|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16846824|NCT01930045|37791865|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16846825|NCT01930045|37791866|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16846826|NCT01930045|37791867|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16846827|NCT01930045|37791868|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
16921853|NCT03366337|38063507|FG002|Overall Study|Lost to Follow-up|1|||
16921854|NCT03366337|38063508|FG003|Overall Study|Lost to Follow-up|0|||
16921855|NCT03366337|38063505|FG000|Overall Study|Withdrawal by Subject|2|||
16921856|NCT03366337|38063506|FG001|Overall Study|Withdrawal by Subject|0|||
16921857|NCT03366337|38063507|FG002|Overall Study|Withdrawal by Subject|1|||
16921858|NCT03366337|38063508|FG003|Overall Study|Withdrawal by Subject|1|||
16921859|NCT03342053|38063520|FG000|Overall Study|Adverse Event|2|||
16921860|NCT03342053|38063521|FG001|Overall Study|Adverse Event|0|||
16921861|NCT03342053|38063520|FG000|Overall Study|Withdrawal by Subject|0|||
16921862|NCT03342053|38063521|FG001|Overall Study|Withdrawal by Subject|1|||
16921863|NCT03283241|38063529|FG000|Overall Study|Adverse Event|4|||
16921864|NCT03283241|38063530|FG001|Overall Study|Adverse Event|1|||
16846828|NCT01930045|37791863|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
16921865|NCT03283241|38063529|FG000|Overall Study|Withdrawal by Subject|0|||
16921866|NCT03283241|38063530|FG001|Overall Study|Withdrawal by Subject|1|||
16921867|NCT03283241|38063529|FG000|Overall Study|Subject relocated to Finland|0|||
16921868|NCT03283241|38063530|FG001|Overall Study|Subject relocated to Finland|1|||
16921869|NCT03242772|38063538|FG000|Overall Study|Lost to Follow-up|2|||
16921870|NCT03242772|38063539|FG001|Overall Study|Lost to Follow-up|0|||
16921871|NCT03242772|38063538|FG000|Overall Study|Physician Decision|0|||
16921872|NCT03242772|38063539|FG001|Overall Study|Physician Decision|1|||
16921873|NCT03242772|38063538|FG000|Overall Study|Withdrawal by Subject|1|||
16921874|NCT03242772|38063539|FG001|Overall Study|Withdrawal by Subject|0|||
16846829|NCT01930045|37791864|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
16846830|NCT01930045|37791865|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
16846831|NCT01930045|37791866|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
16846832|NCT01930045|37791867|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
16846833|NCT01930045|37791868|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
16846834|NCT01929343|37791883|FG000|Overall Study|Physician Decision|0|||
16846835|NCT01929343|37791884|FG001|Overall Study|Physician Decision|2|||
16846836|NCT01929343|37791885|FG002|Overall Study|Physician Decision|0|||
16921875|NCT03236311|38063547|FG000|Overall Study|Study terminated by sponsor|0|||
16921876|NCT03236311|38063548|FG001|Overall Study|Study terminated by sponsor|2|||
16921877|NCT03236311|38063547|FG000|Overall Study|Adverse Event|0|||
16921878|NCT03236311|38063548|FG001|Overall Study|Adverse Event|1|||
16921879|NCT03192046|38063556|FG000|Overall Study|Withdrawal by Subject|1|||
16921880|NCT03192046|38063557|FG001|Overall Study|Withdrawal by Subject|1|||
16921881|NCT03190369|38063565|FG000|Overall Study|Poor compliance to protocol|0|||
16921882|NCT03190369|38063566|FG001|Overall Study|Poor compliance to protocol|1|||
16846837|NCT01929343|37791883|FG000|Overall Study|Withdrawal by Subject|1|||
16846838|NCT01929343|37791884|FG001|Overall Study|Withdrawal by Subject|0|||
16846839|NCT01929343|37791885|FG002|Overall Study|Withdrawal by Subject|0|||
16846840|NCT01968811|37791893|FG000|Overall Study|Protocol Violation|4|||
16846841|NCT01968811|37791893|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
16846842|NCT01806584|37791899|FG000|Overall Study|Adverse Event|2|||
16846843|NCT01806584|37791900|FG001|Overall Study|Adverse Event|1|||
16846844|NCT01806584|37791899|FG000|Overall Study|Death|1|||
16846845|NCT01806584|37791900|FG001|Overall Study|Death|0|||
16921883|NCT03190369|38063565|FG000|Overall Study|Withdraw before treatment|1|||
16921884|NCT03190369|38063566|FG001|Overall Study|Withdraw before treatment|5|||
16921885|NCT03190369|38063565|FG000|Overall Study|Randomized but not treated|0|||
16921886|NCT03190369|38063566|FG001|Overall Study|Randomized but not treated|2|||
16921887|NCT04657198|38063575|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
16921888|NCT04657198|38063576|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
16921889|NCT04657198|38063577|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
16921890|NCT04590586|38063591|FG000|Overall Study|Death|7|||
16921891|NCT04590586|38063592|FG001|Overall Study|Death|1|||
16921892|NCT04590586|38063593|FG002|Overall Study|Death|37|||
16921893|NCT04590586|38063594|FG003|Overall Study|Death|34|||
16921894|NCT04590586|38063595|FG004|Overall Study|Death|19|||
16921895|NCT04590586|38063596|FG005|Overall Study|Death|3|||
16921896|NCT04590586|38063591|FG000|Overall Study|Lost to Follow-up|3|||
16921897|NCT04590586|38063592|FG001|Overall Study|Lost to Follow-up|0|||
16921898|NCT04590586|38063593|FG002|Overall Study|Lost to Follow-up|11|||
16921899|NCT04590586|38063594|FG003|Overall Study|Lost to Follow-up|11|||
16921900|NCT04590586|38063595|FG004|Overall Study|Lost to Follow-up|6|||
16921901|NCT04590586|38063596|FG005|Overall Study|Lost to Follow-up|0|||
16921902|NCT04590586|38063591|FG000|Overall Study|Withdrawal by Subject|0|||
16921903|NCT04590586|38063592|FG001|Overall Study|Withdrawal by Subject|0|||
16921904|NCT04590586|38063593|FG002|Overall Study|Withdrawal by Subject|6|||
16846846|NCT01806584|37791899|FG000|Overall Study|Lost to Follow-up|0|||
16846847|NCT01806584|37791900|FG001|Overall Study|Lost to Follow-up|2|||
16846848|NCT01806584|37791899|FG000|Overall Study|Study terminated by sponsor|9|||
16846849|NCT01806584|37791900|FG001|Overall Study|Study terminated by sponsor|14|||
16846850|NCT01806584|37791899|FG000|Overall Study|Withdrawal by Subject|1|||
16846851|NCT01806584|37791900|FG001|Overall Study|Withdrawal by Subject|1|||
16846852|NCT01806584|37791899|FG000|Overall Study|Other unspecified|1|||
16846853|NCT01806584|37791900|FG001|Overall Study|Other unspecified|0|||
17017632|NCT00879437|38162227|FG001|Overall Study|Death|0|||
17017633|NCT00877799|38162240|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
17017634|NCT00877799|38162241|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
17017635|NCT00877799|38162242|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
17017636|NCT00877799|38162243|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
17017637|NCT00877799|38162244|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
17017638|NCT00877799|38162240|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
17017639|NCT00877799|38162241|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
17017640|NCT00877799|38162242|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
17017641|NCT00877799|38162243|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
17017642|NCT00877799|38162244|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
17017643|NCT00877799|38162240|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
17017644|NCT00877799|38162241|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
17017645|NCT00877799|38162242|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
17017646|NCT00877799|38162243|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
16921905|NCT04590586|38063594|FG003|Overall Study|Withdrawal by Subject|0|||
16921906|NCT04590586|38063595|FG004|Overall Study|Withdrawal by Subject|3|||
16921907|NCT04590586|38063596|FG005|Overall Study|Withdrawal by Subject|0|||
16921908|NCT04590586|38063591|FG000|Overall Study|Other|3|||
16921909|NCT04590586|38063592|FG001|Overall Study|Other|0|||
16921910|NCT04590586|38063593|FG002|Overall Study|Other|1|||
16921911|NCT04590586|38063594|FG003|Overall Study|Other|1|||
16921912|NCT04590586|38063595|FG004|Overall Study|Other|2|||
16921913|NCT04590586|38063596|FG005|Overall Study|Other|1|||
16921914|NCT04312009|38063622|FG000|Overall Study|Withdrawal by Subject|2|||
16921915|NCT04312009|38063623|FG001|Overall Study|Withdrawal by Subject|1|||
16921916|NCT03937466|38063638|FG000|Overall Study|not eligbile after the 2-week diary|9|||
17017647|NCT00877799|38162244|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
17017648|NCT00877799|38162240|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
17017649|NCT00877799|38162241|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
17017650|NCT00877799|38162242|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
17017651|NCT00877799|38162243|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
17017652|NCT00877799|38162244|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
17017653|NCT00877799|38162240|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
17017654|NCT00877799|38162241|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
17017655|NCT00877799|38162242|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
17017656|NCT00877799|38162243|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
17017657|NCT00877799|38162244|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
17017658|NCT00595127|38162255|FG000|Overall Study|Death|6|||
17017659|NCT00595127|38162255|FG000|Overall Study|Relapsed|3|||
17017660|NCT00595127|38162255|FG000|Overall Study|joined another trial|1|||
17017661|NCT00877487|38162259|FG000|Open-label Treatment Phase|Adverse Event|1|||
17017662|NCT00877487|38162260|FG001|Open-label Treatment Phase|Adverse Event|0|||
17017663|NCT00877487|38162259|FG000|Open-label Treatment Phase|Protocol Violation|3|||
17017664|NCT00877487|38162260|FG001|Open-label Treatment Phase|Protocol Violation|0|||
17017665|NCT00877487|38162259|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
17017666|NCT00877487|38162260|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
17017667|NCT00877487|38162259|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
17017668|NCT00877487|38162260|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
16846902|NCT01798706|37791925|FG000|Overall Study|Adverse Event|15|||
16846903|NCT01798706|37791926|FG001|Overall Study|Adverse Event|10|||
16846904|NCT01798706|37791925|FG000|Overall Study|Lack of Efficacy|0|||
16846905|NCT01798706|37791926|FG001|Overall Study|Lack of Efficacy|2|||
16846906|NCT01798706|37791925|FG000|Overall Study|Poor compliance to protocol|1|||
16846907|NCT01798706|37791926|FG001|Overall Study|Poor compliance to protocol|0|||
16846908|NCT01798706|37791925|FG000|Overall Study|Other than specified above|5|||
16846909|NCT01798706|37791926|FG001|Overall Study|Other than specified above|9|||
16846910|NCT01767194|37791934|FG000|Overall Study|Adverse Event|1|||
16846911|NCT01767194|37791935|FG001|Overall Study|Adverse Event|1|||
16846912|NCT01767194|37791934|FG000|Overall Study|Death|0|||
16846913|NCT01767194|37791935|FG001|Overall Study|Death|1|||
16846914|NCT01767194|37791934|FG000|Overall Study|Lack of Efficacy|12|||
16846915|NCT01767194|37791935|FG001|Overall Study|Lack of Efficacy|11|||
16846916|NCT01767194|37791934|FG000|Overall Study|Physician Decision|2|||
16846917|NCT01767194|37791935|FG001|Overall Study|Physician Decision|23|||
16846918|NCT01767194|37791934|FG000|Overall Study|Withdrawal by Subject|0|||
16846919|NCT01767194|37791935|FG001|Overall Study|Withdrawal by Subject|1|||
16846920|NCT01767194|37791934|FG000|Overall Study|Ineligible|1|||
16846921|NCT01767194|37791935|FG001|Overall Study|Ineligible|1|||
16846922|NCT01767194|37791934|FG000|Overall Study|Refusal by patient/parent|2|||
16846923|NCT01767194|37791935|FG001|Overall Study|Refusal by patient/parent|4|||
16846924|NCT01767194|37791934|FG000|Overall Study|Criteria not met on time for next cycle|0|||
16846925|NCT01767194|37791935|FG001|Overall Study|Criteria not met on time for next cycle|1|||
16846926|NCT03091192|37791944|FG000|Overall Study|Study terminated by sponsor|21|||
16846927|NCT03091192|37791945|FG001|Overall Study|Study terminated by sponsor|14|||
16846928|NCT03091192|37791944|FG000|Overall Study|Death|9|||
16846929|NCT03091192|37791945|FG001|Overall Study|Death|13|||
16846930|NCT03091192|37791944|FG000|Overall Study|Withdrawal by Subject|2|||
16846931|NCT03091192|37791945|FG001|Overall Study|Withdrawal by Subject|0|||
16846932|NCT03091192|37791944|FG000|Overall Study|Lost to Follow-up|1|||
16846933|NCT03091192|37791945|FG001|Overall Study|Lost to Follow-up|0|||
16846934|NCT01575873|37791955|FG000|Overall Study|Withdrawal by Subject|15|||
16921917|NCT03937466|38063638|FG000|Overall Study|never returned their diary|6|||
16921918|NCT03937466|38063638|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
16921919|NCT03937466|38063638|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
16921920|NCT03850483|38063651|FG000|Treatment for Stage 1|Adverse Event|1|||
16921921|NCT03850483|38063652|FG001|Treatment for Stage 1|Adverse Event|1|||
16921922|NCT03850483|38063653|FG002|Treatment for Stage 1|Adverse Event|3|||
16921923|NCT03850483|38063654|FG003|Treatment for Stage 1|Adverse Event|0|||
16921924|NCT03850483|38063655|FG004|Treatment for Stage 1|Adverse Event|2|||
16921925|NCT03850483|38063656|FG005|Treatment for Stage 1|Adverse Event|0|||
16921926|NCT03850483|38063657|FG006|Treatment for Stage 1|Adverse Event|2|||
16921927|NCT03850483|38063658|FG007|Treatment for Stage 1|Adverse Event|2|||
16846935|NCT01575873|37791956|FG001|Overall Study|Withdrawal by Subject|20|||
16846936|NCT01575873|37791957|FG002|Overall Study|Withdrawal by Subject|34|||
16846937|NCT01575873|37791958|FG003|Overall Study|Withdrawal by Subject|34|||
16846938|NCT01575873|37791955|FG000|Overall Study|Adverse Event|7|||
16846939|NCT01575873|37791956|FG001|Overall Study|Adverse Event|7|||
16921928|NCT03850483|38063659|FG008|Treatment for Stage 1|Adverse Event|0|||
16921929|NCT03850483|38063660|FG009|Treatment for Stage 1|Adverse Event|0|||
16846940|NCT01575873|37791957|FG002|Overall Study|Adverse Event|9|||
16846941|NCT01575873|37791958|FG003|Overall Study|Adverse Event|12|||
16846942|NCT01575873|37791955|FG000|Overall Study|Lost to Follow-up|1|||
16846943|NCT01575873|37791956|FG001|Overall Study|Lost to Follow-up|3|||
16846944|NCT01575873|37791957|FG002|Overall Study|Lost to Follow-up|13|||
16846945|NCT01575873|37791958|FG003|Overall Study|Lost to Follow-up|5|||
16846946|NCT01575873|37791955|FG000|Overall Study|Death|3|||
16921930|NCT03850483|38063651|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
16921931|NCT03850483|38063652|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
16921932|NCT03850483|38063653|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
16921933|NCT03850483|38063654|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
16921934|NCT03850483|38063655|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
16921935|NCT03850483|38063656|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
16846947|NCT01575873|37791956|FG001|Overall Study|Death|2|||
16846948|NCT01575873|37791957|FG002|Overall Study|Death|8|||
16846949|NCT01575873|37791958|FG003|Overall Study|Death|9|||
16846950|NCT01575873|37791955|FG000|Overall Study|Noncompliance|1|||
16846951|NCT01575873|37791956|FG001|Overall Study|Noncompliance|2|||
16846952|NCT01575873|37791957|FG002|Overall Study|Noncompliance|4|||
16846953|NCT01575873|37791958|FG003|Overall Study|Noncompliance|3|||
16846954|NCT01575873|37791955|FG000|Overall Study|Administrative decision|1|||
16846955|NCT01575873|37791956|FG001|Overall Study|Administrative decision|1|||
16846956|NCT01575873|37791957|FG002|Overall Study|Administrative decision|1|||
16846957|NCT01575873|37791958|FG003|Overall Study|Administrative decision|0|||
16846958|NCT01575873|37791955|FG000|Overall Study|Protocol deviation|0|||
16846959|NCT01575873|37791956|FG001|Overall Study|Protocol deviation|1|||
16846960|NCT01575873|37791957|FG002|Overall Study|Protocol deviation|0|||
16846961|NCT01575873|37791958|FG003|Overall Study|Protocol deviation|1|||
16846962|NCT01575873|37791955|FG000|Overall Study|Requirement for Alternative Therapy|0|||
16846963|NCT01575873|37791956|FG001|Overall Study|Requirement for Alternative Therapy|0|||
16846964|NCT01575873|37791957|FG002|Overall Study|Requirement for Alternative Therapy|1|||
16846965|NCT01575873|37791958|FG003|Overall Study|Requirement for Alternative Therapy|1|||
16846966|NCT01575873|37791955|FG000|Overall Study|Other|0|||
16846967|NCT01575873|37791956|FG001|Overall Study|Other|0|||
16846968|NCT01575873|37791957|FG002|Overall Study|Other|4|||
16846969|NCT01575873|37791958|FG003|Overall Study|Other|2|||
16846970|NCT01575561|37791966|FG000|Overall Study|Adverse Event|9|||
16846971|NCT01575561|37791966|FG000|Overall Study|Lack of Efficacy|8|||
16846972|NCT01575561|37791966|FG000|Overall Study|Lost to Follow-up|6|||
16846973|NCT01575561|37791966|FG000|Overall Study|Protocol Violation|4|||
16846974|NCT01575561|37791966|FG000|Overall Study|Withdrawal by Subject|11|||
16846975|NCT01575561|37791966|FG000|Overall Study|administration|1|||
16846976|NCT01609790|37791973|FG000|Overall Study|Protocol Violation|1|||
16846977|NCT01609790|37791974|FG001|Overall Study|Protocol Violation|7|||
16846978|NCT01609790|37791975|FG002|Overall Study|Protocol Violation|8|||
16846979|NCT01767116|37791985|FG000|Overall Study|Lost to Follow-up|2|||
16846980|NCT01767116|37791986|FG001|Overall Study|Lost to Follow-up|2|||
16846981|NCT01574703|37791996|FG000|Overall Study|Adverse Event|0|||
16846982|NCT01574703|37791997|FG001|Overall Study|Adverse Event|2|||
16846983|NCT01574703|37791998|FG002|Overall Study|Adverse Event|1|||
16846984|NCT01574703|37791999|FG003|Overall Study|Adverse Event|1|||
16846985|NCT01574703|37791996|FG000|Overall Study|Protocol Violation|0|||
16846986|NCT01574703|37791997|FG001|Overall Study|Protocol Violation|0|||
16846987|NCT01574703|37791998|FG002|Overall Study|Protocol Violation|0|||
16846988|NCT01574703|37791999|FG003|Overall Study|Protocol Violation|1|||
16846989|NCT01574703|37791996|FG000|Overall Study|Unspecified Reason|27|||
16846990|NCT01574703|37791997|FG001|Overall Study|Unspecified Reason|15|||
16846991|NCT01574703|37791998|FG002|Overall Study|Unspecified Reason|20|||
16846992|NCT01574703|37791999|FG003|Overall Study|Unspecified Reason|16|||
16846993|NCT01574703|37791996|FG000|Overall Study|Withdrawal by Subject|53|||
16846994|NCT01574703|37791997|FG001|Overall Study|Withdrawal by Subject|52|||
16846995|NCT01574703|37791998|FG002|Overall Study|Withdrawal by Subject|36|||
16846996|NCT01574703|37791999|FG003|Overall Study|Withdrawal by Subject|61|||
16846997|NCT01574703|37791996|FG000|Overall Study|Met Withdrawal Criteria|0|||
16846998|NCT01574703|37791997|FG001|Overall Study|Met Withdrawal Criteria|1|||
16846999|NCT01574703|37791998|FG002|Overall Study|Met Withdrawal Criteria|1|||
16847000|NCT01574703|37791999|FG003|Overall Study|Met Withdrawal Criteria|0|||
16847001|NCT01574703|37791996|FG000|Overall Study|Lost to Follow-up|43|||
16847002|NCT01574703|37791997|FG001|Overall Study|Lost to Follow-up|41|||
16847003|NCT01574703|37791998|FG002|Overall Study|Lost to Follow-up|46|||
16847004|NCT01574703|37791999|FG003|Overall Study|Lost to Follow-up|35|||
16847005|NCT01574703|37791996|FG000|Overall Study|Death|2|||
16847006|NCT01574703|37791997|FG001|Overall Study|Death|1|||
16847007|NCT01574703|37791998|FG002|Overall Study|Death|1|||
16847008|NCT01574703|37791999|FG003|Overall Study|Death|0|||
16847009|NCT01686633|37792012|FG000|Overall Study|Lack of Efficacy|33|||
16847010|NCT01686633|37792013|FG001|Overall Study|Lack of Efficacy|13|||
16847011|NCT01686633|37792014|FG002|Overall Study|Lack of Efficacy|11|||
16847012|NCT01686633|37792012|FG000|Overall Study|Withdrawal by Subject|8|||
16847013|NCT01686633|37792013|FG001|Overall Study|Withdrawal by Subject|8|||
16847014|NCT01686633|37792014|FG002|Overall Study|Withdrawal by Subject|5|||
16847015|NCT01686633|37792012|FG000|Overall Study|Physician Decision|3|||
16847016|NCT01686633|37792013|FG001|Overall Study|Physician Decision|4|||
16847017|NCT01686633|37792014|FG002|Overall Study|Physician Decision|4|||
16847018|NCT01686633|37792012|FG000|Overall Study|Adverse Event|4|||
16847019|NCT01686633|37792013|FG001|Overall Study|Adverse Event|3|||
16847020|NCT01686633|37792014|FG002|Overall Study|Adverse Event|3|||
16847021|NCT01686633|37792012|FG000|Overall Study|Protocol Violation|2|||
16847022|NCT01686633|37792013|FG001|Overall Study|Protocol Violation|3|||
16847023|NCT01686633|37792014|FG002|Overall Study|Protocol Violation|0|||
16847024|NCT01686633|37792012|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
16847025|NCT01686633|37792013|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
16847026|NCT01686633|37792014|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
16847027|NCT01686633|37792012|FG000|Overall Study|Lost to Follow-up|0|||
16847028|NCT01686633|37792013|FG001|Overall Study|Lost to Follow-up|1|||
16847029|NCT01686633|37792014|FG002|Overall Study|Lost to Follow-up|1|||
16921936|NCT03850483|38063657|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
16921937|NCT03850483|38063658|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
16921938|NCT03850483|38063659|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
16921939|NCT03850483|38063660|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
16921940|NCT03850483|38063651|FG000|Treatment for Stage 1|Protocol Violation|1|||
16921941|NCT03850483|38063652|FG001|Treatment for Stage 1|Protocol Violation|0|||
16921942|NCT03850483|38063653|FG002|Treatment for Stage 1|Protocol Violation|0|||
16921943|NCT03850483|38063654|FG003|Treatment for Stage 1|Protocol Violation|0|||
16921944|NCT03850483|38063655|FG004|Treatment for Stage 1|Protocol Violation|0|||
16921945|NCT03850483|38063656|FG005|Treatment for Stage 1|Protocol Violation|0|||
16921946|NCT03850483|38063657|FG006|Treatment for Stage 1|Protocol Violation|1|||
16921947|NCT03850483|38063658|FG007|Treatment for Stage 1|Protocol Violation|0|||
16921948|NCT03850483|38063659|FG008|Treatment for Stage 1|Protocol Violation|0|||
16921949|NCT03850483|38063660|FG009|Treatment for Stage 1|Protocol Violation|0|||
16921950|NCT03850483|38063651|FG000|Treatment for Stage 1|Physician Decision|0|||
16921951|NCT03850483|38063652|FG001|Treatment for Stage 1|Physician Decision|0|||
16921952|NCT03850483|38063653|FG002|Treatment for Stage 1|Physician Decision|0|||
16921953|NCT03850483|38063654|FG003|Treatment for Stage 1|Physician Decision|0|||
16921954|NCT03850483|38063655|FG004|Treatment for Stage 1|Physician Decision|0|||
16847030|NCT02511106|37792024|FG000|Overall Study|Lost to Follow-up|1|||
16847031|NCT02511106|37792025|FG001|Overall Study|Lost to Follow-up|2|||
16847032|NCT02511106|37792024|FG000|Overall Study|Withdrawal by Subject|19|||
16847033|NCT02511106|37792025|FG001|Overall Study|Withdrawal by Subject|14|||
16847034|NCT02511106|37792024|FG000|Overall Study|Ongoing study at data cut-off|309|||
16847035|NCT02511106|37792025|FG001|Overall Study|Ongoing study at data cut-off|307|||
16847036|NCT02511106|37792024|FG000|Overall Study|Without specified reason|1|||
16847037|NCT02511106|37792025|FG001|Overall Study|Without specified reason|0|||
16847038|NCT02511106|37792024|FG000|Overall Study|Missing|1|||
16847039|NCT02511106|37792025|FG001|Overall Study|Missing|0|||
16847040|NCT01685697|37792035|FG000|Overall Study|Protocol Violation|3|||
16847041|NCT01685697|37792036|FG001|Overall Study|Protocol Violation|3|||
16847042|NCT02395120|37792047|FG000|Overall Study|Missed follow-up dental exam|57|||
16847043|NCT02395120|37792048|FG001|Overall Study|Missed follow-up dental exam|62|||
16847044|NCT02395120|37792049|FG002|Overall Study|Missed follow-up dental exam|6|||
16847045|NCT02395120|37792050|FG003|Overall Study|Missed follow-up dental exam|6|||
16847046|NCT02395120|37792051|FG004|Overall Study|Missed follow-up dental exam|51|||
16847047|NCT01685229|37792065|FG000|Overall Study|Subjects missing Study Exit form|3|||
16847048|NCT01685229|37792066|FG001|Overall Study|Subjects missing Study Exit form|1|||
16847049|NCT01685229|37792065|FG000|Overall Study|Lost to Follow-up|16|||
16847050|NCT01685229|37792066|FG001|Overall Study|Lost to Follow-up|10|||
16847051|NCT01685229|37792065|FG000|Overall Study|Withdrawal by Subject|6|||
16847052|NCT01685229|37792066|FG001|Overall Study|Withdrawal by Subject|5|||
16847053|NCT01685229|37792065|FG000|Overall Study|Death|1|||
16847054|NCT01685229|37792066|FG001|Overall Study|Death|0|||
16847055|NCT01551693|37792077|FG000|Overall Study|Disease Progression|1|||
16847056|NCT01551693|37792078|FG001|Overall Study|Disease Progression|0|||
16921955|NCT03850483|38063656|FG005|Treatment for Stage 1|Physician Decision|1|||
16921956|NCT03850483|38063657|FG006|Treatment for Stage 1|Physician Decision|0|||
16921957|NCT03850483|38063658|FG007|Treatment for Stage 1|Physician Decision|0|||
16921958|NCT03850483|38063659|FG008|Treatment for Stage 1|Physician Decision|0|||
16921959|NCT03850483|38063660|FG009|Treatment for Stage 1|Physician Decision|0|||
16921960|NCT03850483|38063651|FG000|Treatment for Stage 1|Other|0|||
16921961|NCT03850483|38063652|FG001|Treatment for Stage 1|Other|0|||
16921962|NCT03850483|38063653|FG002|Treatment for Stage 1|Other|0|||
16921963|NCT03850483|38063654|FG003|Treatment for Stage 1|Other|0|||
16921964|NCT03850483|38063655|FG004|Treatment for Stage 1|Other|2|||
16921965|NCT03850483|38063656|FG005|Treatment for Stage 1|Other|1|||
16921966|NCT03850483|38063657|FG006|Treatment for Stage 1|Other|0|||
16847057|NCT01551693|37792077|FG000|Overall Study|Adverse Event|0|||
16847058|NCT01551693|37792078|FG001|Overall Study|Adverse Event|1|||
16921967|NCT03850483|38063658|FG007|Treatment for Stage 1|Other|0|||
16921968|NCT03850483|38063659|FG008|Treatment for Stage 1|Other|0|||
16921969|NCT03850483|38063660|FG009|Treatment for Stage 1|Other|0|||
16921970|NCT03850483|38063651|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921971|NCT03850483|38063652|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921972|NCT03850483|38063653|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
16847059|NCT01551693|37792077|FG000|Overall Study|Withdrawal by Subject|0|||
16847060|NCT01551693|37792078|FG001|Overall Study|Withdrawal by Subject|1|||
16847061|NCT01574157|37792086|FG000|Overall Study|Withdrawal by Subject|4|||
16847062|NCT01574157|37792087|FG001|Overall Study|Withdrawal by Subject|5|||
16847063|NCT01574157|37792086|FG000|Overall Study|Lost to Follow-up|0|||
16847064|NCT01574157|37792087|FG001|Overall Study|Lost to Follow-up|3|||
16847065|NCT01574079|37792099|FG000|Overall Study|Physician Decision|0|||
16847066|NCT01574079|37792100|FG001|Overall Study|Physician Decision|2|||
16847067|NCT01574079|37792099|FG000|Overall Study|Lost to Follow-up|1|||
16847068|NCT01574079|37792100|FG001|Overall Study|Lost to Follow-up|0|||
16847069|NCT01573767|37792110|FG000|Overall Study|Adverse Event|0|||
16847070|NCT01573767|37792111|FG001|Overall Study|Adverse Event|1|||
16847071|NCT01573767|37792112|FG002|Overall Study|Adverse Event|0|||
16847072|NCT01573767|37792113|FG003|Overall Study|Adverse Event|1|||
16847073|NCT01573767|37792110|FG000|Overall Study|Lack of Efficacy|18|||
16847074|NCT01573767|37792111|FG001|Overall Study|Lack of Efficacy|15|||
16847075|NCT01573767|37792112|FG002|Overall Study|Lack of Efficacy|12|||
16847076|NCT01573767|37792113|FG003|Overall Study|Lack of Efficacy|17|||
16847077|NCT01573767|37792110|FG000|Overall Study|Protocol Violation|3|||
16847078|NCT01573767|37792111|FG001|Overall Study|Protocol Violation|1|||
16847079|NCT01573767|37792112|FG002|Overall Study|Protocol Violation|1|||
16847080|NCT01573767|37792113|FG003|Overall Study|Protocol Violation|3|||
16847081|NCT01573767|37792110|FG000|Overall Study|Lost to Follow-up|0|||
16847082|NCT01573767|37792111|FG001|Overall Study|Lost to Follow-up|1|||
16847083|NCT01573767|37792112|FG002|Overall Study|Lost to Follow-up|1|||
16847084|NCT01573767|37792113|FG003|Overall Study|Lost to Follow-up|1|||
16847085|NCT01573767|37792110|FG000|Overall Study|Physician Decision|1|||
16847086|NCT01573767|37792111|FG001|Overall Study|Physician Decision|2|||
16847087|NCT01573767|37792112|FG002|Overall Study|Physician Decision|0|||
16847088|NCT01573767|37792113|FG003|Overall Study|Physician Decision|2|||
16847089|NCT01573767|37792110|FG000|Overall Study|Withdrawal by Subject|0|||
16847090|NCT01573767|37792111|FG001|Overall Study|Withdrawal by Subject|1|||
16847091|NCT01573767|37792112|FG002|Overall Study|Withdrawal by Subject|0|||
16847092|NCT01573767|37792113|FG003|Overall Study|Withdrawal by Subject|0|||
16847093|NCT01551303|37792125|FG000|Overall Study|failed awareness check on vision test|4|||
16847094|NCT01551303|37792126|FG001|Overall Study|failed awareness check on vision test|7|||
16847095|NCT00638404|37792134|FG000|Overall Study|Physician Decision|8|||
16847096|NCT00638404|37792135|FG001|Overall Study|Physician Decision|0|||
16847097|NCT01550757|37792149|FG000|Overall Study|Lost to Follow-up|21|||
16847098|NCT01550757|37792150|FG001|Overall Study|Lost to Follow-up|14|||
16847099|NCT01550757|37792151|FG002|Overall Study|Lost to Follow-up|42|||
16921973|NCT03850483|38063654|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921974|NCT03850483|38063655|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921975|NCT03850483|38063656|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921976|NCT03850483|38063657|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921977|NCT03850483|38063658|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921978|NCT03850483|38063659|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921979|NCT03850483|38063660|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16921980|NCT03850483|38063651|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16847100|NCT01550757|37792152|FG003|Overall Study|Lost to Follow-up|53|||
16847101|NCT01550757|37792149|FG000|Overall Study|Withdrawal by Subject|2|||
16847102|NCT01550757|37792150|FG001|Overall Study|Withdrawal by Subject|0|||
16847103|NCT01550757|37792151|FG002|Overall Study|Withdrawal by Subject|3|||
16847104|NCT01550757|37792152|FG003|Overall Study|Withdrawal by Subject|1|||
16847105|NCT01685073|37792164|FG000|Overall Study|Lost to Follow-up|6|||
16921981|NCT03850483|38063652|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16921982|NCT03850483|38063653|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16921983|NCT03850483|38063654|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16921984|NCT03850483|38063655|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16921985|NCT03850483|38063656|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
16921986|NCT03850483|38063657|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16847106|NCT01685073|37792165|FG001|Overall Study|Lost to Follow-up|8|||
16847107|NCT01685073|37792164|FG000|Overall Study|Withdrawal by Subject|24|||
16847108|NCT01685073|37792165|FG001|Overall Study|Withdrawal by Subject|24|||
16847109|NCT01572909|37792173|FG000|Overall Study|Adverse Event|7|||
16847110|NCT01572909|37792174|FG001|Overall Study|Adverse Event|2|||
16847111|NCT01572909|37792173|FG000|Overall Study|Death|3|||
16847112|NCT01572909|37792174|FG001|Overall Study|Death|1|||
16847113|NCT01572909|37792173|FG000|Overall Study|Lost to Follow-up|8|||
16847114|NCT01572909|37792174|FG001|Overall Study|Lost to Follow-up|7|||
16847115|NCT01572909|37792173|FG000|Overall Study|Physician Decision|1|||
16847116|NCT01572909|37792174|FG001|Overall Study|Physician Decision|1|||
16921987|NCT03850483|38063658|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16921988|NCT03850483|38063659|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16921989|NCT03850483|38063660|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16921990|NCT03850483|38063651|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
16921991|NCT03850483|38063652|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
16921992|NCT03850483|38063653|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
16847117|NCT01572909|37792173|FG000|Overall Study|Technical Issues|1|||
16847118|NCT01572909|37792174|FG001|Overall Study|Technical Issues|0|||
16847119|NCT01572909|37792173|FG000|Overall Study|Withdrawal by Subject|12|||
16847120|NCT01572909|37792174|FG001|Overall Study|Withdrawal by Subject|11|||
16847121|NCT01572909|37792173|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
16847122|NCT01572909|37792174|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
16847123|NCT01572675|37792184|FG000|Overall Study|End of prescribed treatment|140|||
16847124|NCT01572675|37792185|FG001|Overall Study|End of prescribed treatment|118|||
16847125|NCT01572675|37792184|FG000|Overall Study|Recovery|16|||
16847126|NCT01572675|37792185|FG001|Overall Study|Recovery|23|||
16847127|NCT01572675|37792184|FG000|Overall Study|Lack of Efficacy|31|||
16847128|NCT01572675|37792185|FG001|Overall Study|Lack of Efficacy|31|||
16847129|NCT01572675|37792184|FG000|Overall Study|Intolerance|6|||
16847130|NCT01572675|37792185|FG001|Overall Study|Intolerance|5|||
16847131|NCT01572675|37792184|FG000|Overall Study|Improved symptoms|8|||
16847132|NCT01572675|37792185|FG001|Overall Study|Improved symptoms|2|||
16847133|NCT01572675|37792184|FG000|Overall Study|Surgical intervention|3|||
16847134|NCT01572675|37792185|FG001|Overall Study|Surgical intervention|6|||
16847135|NCT01572675|37792184|FG000|Overall Study|Withdrawal by Subject|5|||
16847136|NCT01572675|37792185|FG001|Overall Study|Withdrawal by Subject|1|||
16921993|NCT03850483|38063654|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
16921994|NCT03850483|38063655|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
16921995|NCT03850483|38063656|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
16921996|NCT03850483|38063657|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
16921997|NCT03850483|38063658|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
16921998|NCT03850483|38063659|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
16921999|NCT03850483|38063660|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
16922000|NCT03850483|38063651|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
16922001|NCT03850483|38063652|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
16922002|NCT03850483|38063653|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
16922003|NCT03850483|38063654|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
16922004|NCT03850483|38063655|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
16922005|NCT03850483|38063656|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
16922006|NCT03850483|38063657|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
16922007|NCT03850483|38063658|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
16922008|NCT03850483|38063659|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
16922009|NCT03850483|38063660|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
16922010|NCT03850483|38063651|FG000|Treatment for Stage 1|Death|0|||
16922011|NCT03850483|38063652|FG001|Treatment for Stage 1|Death|0|||
16922012|NCT03850483|38063653|FG002|Treatment for Stage 1|Death|0|||
16922013|NCT03850483|38063654|FG003|Treatment for Stage 1|Death|0|||
16922014|NCT03850483|38063655|FG004|Treatment for Stage 1|Death|0|||
16922015|NCT03850483|38063656|FG005|Treatment for Stage 1|Death|1|||
16922016|NCT03850483|38063657|FG006|Treatment for Stage 1|Death|0|||
16922017|NCT03850483|38063658|FG007|Treatment for Stage 1|Death|0|||
16922018|NCT03850483|38063659|FG008|Treatment for Stage 1|Death|0|||
16922019|NCT03850483|38063660|FG009|Treatment for Stage 1|Death|0|||
16922020|NCT03850483|38063651|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
16922021|NCT03850483|38063652|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
16922022|NCT03850483|38063653|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
16922023|NCT03850483|38063654|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
16922024|NCT03850483|38063655|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
16922025|NCT03850483|38063656|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
16922026|NCT03850483|38063657|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
16922027|NCT03850483|38063658|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
16922028|NCT03850483|38063659|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
16922029|NCT03850483|38063660|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
16922030|NCT03850483|38063651|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
16922031|NCT03850483|38063652|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
16922032|NCT03850483|38063653|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
16922033|NCT03850483|38063654|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
16922034|NCT03850483|38063655|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
16847137|NCT01572675|37792184|FG000|Overall Study|Physician Decision|2|||
16847138|NCT01572675|37792185|FG001|Overall Study|Physician Decision|2|||
16847139|NCT01572675|37792184|FG000|Overall Study|Death unrelated to coxibs|1|||
16922035|NCT03850483|38063656|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
16922036|NCT03850483|38063657|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
16922037|NCT03850483|38063658|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
16922038|NCT03850483|38063659|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
16922039|NCT03850483|38063660|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
16922040|NCT03850483|38063651|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
16922041|NCT03850483|38063652|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
16922042|NCT03850483|38063653|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
16922043|NCT03850483|38063654|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
16922044|NCT03850483|38063655|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
16922045|NCT03850483|38063656|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
16922046|NCT03850483|38063657|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
16922047|NCT03850483|38063658|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
16922048|NCT03850483|38063659|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
16922049|NCT03850483|38063660|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
16922050|NCT03850483|38063651|FG000|Follow-up for Stage 1|Physician Decision|0|||
16922051|NCT03850483|38063652|FG001|Follow-up for Stage 1|Physician Decision|0|||
16922052|NCT03850483|38063653|FG002|Follow-up for Stage 1|Physician Decision|0|||
16922053|NCT03850483|38063654|FG003|Follow-up for Stage 1|Physician Decision|0|||
16922054|NCT03850483|38063655|FG004|Follow-up for Stage 1|Physician Decision|1|||
16922055|NCT03850483|38063656|FG005|Follow-up for Stage 1|Physician Decision|0|||
16922056|NCT03850483|38063657|FG006|Follow-up for Stage 1|Physician Decision|1|||
16922057|NCT03850483|38063658|FG007|Follow-up for Stage 1|Physician Decision|0|||
16922058|NCT03850483|38063659|FG008|Follow-up for Stage 1|Physician Decision|0|||
16922059|NCT03850483|38063660|FG009|Follow-up for Stage 1|Physician Decision|0|||
16922060|NCT03850483|38063651|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
16922061|NCT03850483|38063652|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
16922062|NCT03850483|38063653|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
16922063|NCT03850483|38063654|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
16922064|NCT03850483|38063655|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
16922065|NCT03850483|38063656|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
16922066|NCT03850483|38063657|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
16922067|NCT03850483|38063658|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
16922068|NCT03850483|38063659|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
16922069|NCT03850483|38063660|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
16922070|NCT03850483|38063651|FG000|Follow-up for Stage 1|Adverse Event|0|||
16922071|NCT03850483|38063652|FG001|Follow-up for Stage 1|Adverse Event|0|||
16922072|NCT03850483|38063653|FG002|Follow-up for Stage 1|Adverse Event|1|||
16922073|NCT03850483|38063654|FG003|Follow-up for Stage 1|Adverse Event|0|||
16922074|NCT03850483|38063655|FG004|Follow-up for Stage 1|Adverse Event|0|||
16922075|NCT03850483|38063656|FG005|Follow-up for Stage 1|Adverse Event|1|||
16922076|NCT03850483|38063657|FG006|Follow-up for Stage 1|Adverse Event|0|||
16922077|NCT03850483|38063658|FG007|Follow-up for Stage 1|Adverse Event|0|||
16922078|NCT03850483|38063659|FG008|Follow-up for Stage 1|Adverse Event|0|||
16922079|NCT03850483|38063660|FG009|Follow-up for Stage 1|Adverse Event|0|||
16922080|NCT03850483|38063651|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16922081|NCT03850483|38063652|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
16922082|NCT03850483|38063653|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16922083|NCT03850483|38063654|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16922084|NCT03850483|38063655|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
16922085|NCT03850483|38063656|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
16922086|NCT03850483|38063657|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16922087|NCT03850483|38063658|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16922088|NCT03850483|38063659|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16922089|NCT03850483|38063660|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16922090|NCT03850483|38063651|FG000|Follow-up for Stage 1|Other|0|||
16922091|NCT03850483|38063652|FG001|Follow-up for Stage 1|Other|2|||
16922092|NCT03850483|38063653|FG002|Follow-up for Stage 1|Other|0|||
16922093|NCT03850483|38063654|FG003|Follow-up for Stage 1|Other|2|||
16922094|NCT03850483|38063655|FG004|Follow-up for Stage 1|Other|0|||
16922095|NCT03850483|38063656|FG005|Follow-up for Stage 1|Other|1|||
17017669|NCT00877487|38162259|FG000|Open-label Treatment Phase|Out of country for business|1|||
17017670|NCT00877487|38162260|FG001|Open-label Treatment Phase|Out of country for business|0|||
16922096|NCT03850483|38063657|FG006|Follow-up for Stage 1|Other|0|||
16922097|NCT03850483|38063658|FG007|Follow-up for Stage 1|Other|0|||
16922098|NCT03850483|38063659|FG008|Follow-up for Stage 1|Other|0|||
16922099|NCT03850483|38063660|FG009|Follow-up for Stage 1|Other|0|||
16922100|NCT03850483|38063651|FG000|Treatment for Stage 2|Adverse Event|0|||
16922101|NCT03850483|38063652|FG001|Treatment for Stage 2|Adverse Event|0|||
16922102|NCT03850483|38063653|FG002|Treatment for Stage 2|Adverse Event|0|||
16922103|NCT03850483|38063654|FG003|Treatment for Stage 2|Adverse Event|0|||
16922104|NCT03850483|38063655|FG004|Treatment for Stage 2|Adverse Event|0|||
16922105|NCT03850483|38063656|FG005|Treatment for Stage 2|Adverse Event|0|||
16922106|NCT03850483|38063657|FG006|Treatment for Stage 2|Adverse Event|0|||
16922107|NCT03850483|38063658|FG007|Treatment for Stage 2|Adverse Event|0|||
16922108|NCT03850483|38063659|FG008|Treatment for Stage 2|Adverse Event|0|||
16922109|NCT03850483|38063660|FG009|Treatment for Stage 2|Adverse Event|1|||
16922110|NCT03850483|38063651|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
16922111|NCT03850483|38063652|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
16922112|NCT03850483|38063653|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
16847140|NCT01572675|37792185|FG001|Overall Study|Death unrelated to coxibs|1|||
16847141|NCT01572675|37792184|FG000|Overall Study|Other disease detected|1|||
16847142|NCT01572675|37792185|FG001|Overall Study|Other disease detected|1|||
16847143|NCT01572675|37792184|FG000|Overall Study|Unknown reason|1|||
16847144|NCT01572675|37792185|FG001|Overall Study|Unknown reason|1|||
16922113|NCT03850483|38063654|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
16922114|NCT03850483|38063655|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
16922115|NCT03850483|38063656|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
16922116|NCT03850483|38063657|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
16922117|NCT03850483|38063658|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
16922118|NCT03850483|38063659|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
16847145|NCT01572675|37792184|FG000|Overall Study|Rheumatologist new evaluation|0|||
16847146|NCT01572675|37792185|FG001|Overall Study|Rheumatologist new evaluation|1|||
16847147|NCT01572675|37792184|FG000|Overall Study|Missing data|1|||
16847148|NCT01572675|37792185|FG001|Overall Study|Missing data|4|||
16847149|NCT01572675|37792184|FG000|Overall Study|Lost to Follow-up|22|||
16847150|NCT01572675|37792185|FG001|Overall Study|Lost to Follow-up|27|||
16847151|NCT01550289|37792206|FG000|Overall Study|Protocol Violation|1|||
16847152|NCT01550289|37792207|FG001|Overall Study|Protocol Violation|0|||
16922119|NCT03850483|38063660|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
16922120|NCT03850483|38063651|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
16922121|NCT03850483|38063652|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
16922122|NCT03850483|38063653|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
16922123|NCT03850483|38063654|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
16922124|NCT03850483|38063655|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
16922125|NCT03850483|38063656|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
16922126|NCT03850483|38063657|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
16922127|NCT03850483|38063658|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
16922128|NCT03850483|38063659|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
16922129|NCT03850483|38063660|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
16922130|NCT03850483|38063651|FG000|Treatment for Stage 2|Physician Decision|0|||
16922131|NCT03850483|38063652|FG001|Treatment for Stage 2|Physician Decision|0|||
16922132|NCT03850483|38063653|FG002|Treatment for Stage 2|Physician Decision|0|||
16922133|NCT03850483|38063654|FG003|Treatment for Stage 2|Physician Decision|0|||
16922134|NCT03850483|38063655|FG004|Treatment for Stage 2|Physician Decision|0|||
16922135|NCT03850483|38063656|FG005|Treatment for Stage 2|Physician Decision|0|||
16922136|NCT03850483|38063657|FG006|Treatment for Stage 2|Physician Decision|0|||
16922137|NCT03850483|38063658|FG007|Treatment for Stage 2|Physician Decision|0|||
16922138|NCT03850483|38063659|FG008|Treatment for Stage 2|Physician Decision|0|||
16922139|NCT03850483|38063660|FG009|Treatment for Stage 2|Physician Decision|1|||
16922140|NCT03850483|38063651|FG000|Treatment for Stage 2|Protocol Violation|0|||
16922141|NCT03850483|38063652|FG001|Treatment for Stage 2|Protocol Violation|0|||
16922142|NCT03850483|38063653|FG002|Treatment for Stage 2|Protocol Violation|0|||
16922143|NCT03850483|38063654|FG003|Treatment for Stage 2|Protocol Violation|0|||
16922144|NCT03850483|38063655|FG004|Treatment for Stage 2|Protocol Violation|0|||
16922145|NCT03850483|38063656|FG005|Treatment for Stage 2|Protocol Violation|0|||
16922146|NCT03850483|38063657|FG006|Treatment for Stage 2|Protocol Violation|0|||
16922147|NCT03850483|38063658|FG007|Treatment for Stage 2|Protocol Violation|0|||
16922148|NCT03850483|38063659|FG008|Treatment for Stage 2|Protocol Violation|1|||
16922149|NCT03850483|38063660|FG009|Treatment for Stage 2|Protocol Violation|0|||
16922150|NCT03850483|38063651|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
16922151|NCT03850483|38063652|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
16922152|NCT03850483|38063653|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
16922153|NCT03850483|38063654|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
16922154|NCT03850483|38063655|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
16922155|NCT03850483|38063656|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
16922156|NCT03850483|38063657|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
16922157|NCT03850483|38063658|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
16922158|NCT03850483|38063659|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
16847153|NCT01550289|37792206|FG000|Overall Study|Lost to Follow-up|1|||
16847154|NCT01550289|37792207|FG001|Overall Study|Lost to Follow-up|1|||
16922159|NCT03850483|38063660|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
16922160|NCT03850483|38063651|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16922161|NCT03850483|38063652|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16922162|NCT03850483|38063653|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16847155|NCT01550289|37792206|FG000|Overall Study|Withdrawal by Subject|11|||
16847156|NCT01550289|37792207|FG001|Overall Study|Withdrawal by Subject|3|||
16847157|NCT01968031|37792218|FG000|Overall Study|Adverse Event|13|||
16847158|NCT01968031|37792219|FG001|Overall Study|Adverse Event|10|||
16847159|NCT01968031|37792220|FG002|Overall Study|Adverse Event|22|||
16847160|NCT01968031|37792218|FG000|Overall Study|Withdrawal by Subject|3|||
16847161|NCT01968031|37792219|FG001|Overall Study|Withdrawal by Subject|7|||
16922163|NCT03850483|38063654|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16922164|NCT03850483|38063655|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16922165|NCT03850483|38063656|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16922166|NCT03850483|38063657|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16922167|NCT03850483|38063658|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16922168|NCT03850483|38063659|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
17017671|NCT00877487|38162259|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
17017672|NCT00877487|38162260|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
16922169|NCT03850483|38063660|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
16922170|NCT03850483|38063651|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
16922171|NCT03850483|38063652|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
16922172|NCT03850483|38063653|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
16922173|NCT03850483|38063654|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
16922174|NCT03850483|38063655|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
16922175|NCT03850483|38063656|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
16922176|NCT03850483|38063657|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
16922177|NCT03850483|38063658|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
16922178|NCT03850483|38063659|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
16922179|NCT03850483|38063660|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
16922180|NCT03850483|38063651|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
16922181|NCT03850483|38063652|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
16922182|NCT03850483|38063653|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
16922183|NCT03850483|38063654|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
16922184|NCT03850483|38063655|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
16922185|NCT03850483|38063656|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
16922186|NCT03850483|38063657|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
16922187|NCT03850483|38063658|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
16922188|NCT03850483|38063659|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
16922189|NCT03850483|38063660|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
16922190|NCT03850483|38063651|FG000|Follow-up For Stage 2|Other|0|||
16922191|NCT03850483|38063652|FG001|Follow-up For Stage 2|Other|0|||
16922192|NCT03850483|38063653|FG002|Follow-up For Stage 2|Other|0|||
16922193|NCT03850483|38063654|FG003|Follow-up For Stage 2|Other|0|||
16922194|NCT03850483|38063655|FG004|Follow-up For Stage 2|Other|0|||
16922195|NCT03850483|38063656|FG005|Follow-up For Stage 2|Other|0|||
16922196|NCT03850483|38063657|FG006|Follow-up For Stage 2|Other|0|||
16922197|NCT03850483|38063658|FG007|Follow-up For Stage 2|Other|0|||
16922198|NCT03850483|38063659|FG008|Follow-up For Stage 2|Other|0|||
16922199|NCT03850483|38063660|FG009|Follow-up For Stage 2|Other|1|||
16922200|NCT03473925|38063704|FG000|Overall Study|Death|48|||
16922201|NCT03473925|38063705|FG001|Overall Study|Death|44|||
16922202|NCT03473925|38063704|FG000|Overall Study|Sponsor Decision|2|||
16922203|NCT03473925|38063705|FG001|Overall Study|Sponsor Decision|7|||
16922204|NCT03473925|38063704|FG000|Overall Study|Withdrawal by Subject|1|||
17017673|NCT00877487|38162259|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
17017674|NCT00877487|38162260|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
17017675|NCT00877487|38162259|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
17017676|NCT00877487|38162260|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
17017677|NCT00877487|38162259|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
17017678|NCT00877487|38162260|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
16847162|NCT01968031|37792220|FG002|Overall Study|Withdrawal by Subject|3|||
16847163|NCT01968031|37792218|FG000|Overall Study|Did not meet entry criteria|1|||
16847164|NCT01968031|37792219|FG001|Overall Study|Did not meet entry criteria|1|||
16847165|NCT01968031|37792220|FG002|Overall Study|Did not meet entry criteria|1|||
16847166|NCT01968031|37792218|FG000|Overall Study|Noncompliance|0|||
16847167|NCT01968031|37792219|FG001|Overall Study|Noncompliance|0|||
16847168|NCT01968031|37792220|FG002|Overall Study|Noncompliance|2|||
16922205|NCT03473925|38063705|FG001|Overall Study|Withdrawal by Subject|3|||
16922206|NCT03473925|38063704|FG000|Overall Study|Not Treated|1|||
16922207|NCT03473925|38063705|FG001|Overall Study|Not Treated|1|||
16922208|NCT03230097|38063713|FG000|Overall Study|Adverse Event|2|||
16922209|NCT03230097|38063714|FG001|Overall Study|Adverse Event|1|||
16922210|NCT03230097|38063713|FG000|Overall Study|non-compliance|0|||
16922211|NCT03230097|38063714|FG001|Overall Study|non-compliance|1|||
16922212|NCT03230097|38063713|FG000|Overall Study|Lost to Follow-up|2|||
16922213|NCT03230097|38063714|FG001|Overall Study|Lost to Follow-up|4|||
16922214|NCT03230097|38063713|FG000|Overall Study|Withdrawal by Subject|7|||
16922215|NCT03230097|38063714|FG001|Overall Study|Withdrawal by Subject|3|||
16922216|NCT03230097|38063713|FG000|Overall Study|Trial termination|4|||
16922217|NCT03230097|38063714|FG001|Overall Study|Trial termination|5|||
16922218|NCT03230097|38063713|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
16922219|NCT03230097|38063714|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
16922220|NCT03230097|38063713|FG000|Overall Study|outcome event|0|||
16922221|NCT03230097|38063714|FG001|Overall Study|outcome event|1|||
16922222|NCT02803593|38063739|FG000|Overall Study|Lost to Follow-up|17|||
16922223|NCT02803593|38063740|FG001|Overall Study|Lost to Follow-up|35|||
16922224|NCT02663908|38063748|FG000|Overall Study|Withdrawal by Subject|8|||
16922225|NCT02663908|38063749|FG001|Overall Study|Withdrawal by Subject|5|||
16922226|NCT02663908|38063748|FG000|Overall Study|Lost to Follow-up|1|||
16922227|NCT02663908|38063749|FG001|Overall Study|Lost to Follow-up|5|||
16922228|NCT02663908|38063748|FG000|Overall Study|Adverse Event|13|||
16922229|NCT02663908|38063749|FG001|Overall Study|Adverse Event|11|||
16922230|NCT02663908|38063748|FG000|Overall Study|Protocol Violation|1|||
16922231|NCT02663908|38063749|FG001|Overall Study|Protocol Violation|2|||
16922232|NCT02663908|38063748|FG000|Overall Study|Lack of therapeutic response|2|||
16922233|NCT02663908|38063749|FG001|Overall Study|Lack of therapeutic response|0|||
16922234|NCT02663908|38063748|FG000|Overall Study|COVID-19|1|||
16922235|NCT02663908|38063749|FG001|Overall Study|COVID-19|0|||
16922236|NCT02663908|38063748|FG000|Overall Study|Site closed|1|||
16922237|NCT02663908|38063749|FG001|Overall Study|Site closed|0|||
16922238|NCT02663908|38063748|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
16922239|NCT02663908|38063749|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
16922240|NCT02663908|38063748|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
16922241|NCT02663908|38063749|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
16922242|NCT02663908|38063748|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
16922243|NCT02663908|38063749|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
16922244|NCT02663908|38063748|FG000|Overall Study|Death|1|||
16922245|NCT02663908|38063749|FG001|Overall Study|Death|0|||
16922246|NCT02663908|38063748|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
16922247|NCT02663908|38063749|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
16922248|NCT02663908|38063748|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
16922249|NCT02663908|38063749|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
16922250|NCT02650284|38063757|FG000|Overall Study|Lost to Follow-up|3|||
16922251|NCT02650284|38063758|FG001|Overall Study|Lost to Follow-up|3|||
16922252|NCT02650284|38063757|FG000|Overall Study|Consent incorrectly taken|0|||
16922253|NCT02650284|38063758|FG001|Overall Study|Consent incorrectly taken|1|||
16922254|NCT02175030|38063766|FG000|Overall Study|Failed screen after consent|7|||
16922255|NCT02175030|38063767|FG001|Overall Study|Failed screen after consent|6|||
16922256|NCT02175030|38063766|FG000|Overall Study|Failed IUD Insertion|20|||
16922257|NCT02175030|38063767|FG001|Overall Study|Failed IUD Insertion|21|||
16922258|NCT02175030|38063766|FG000|Overall Study|Physician Decision|1|||
16922259|NCT02175030|38063767|FG001|Overall Study|Physician Decision|1|||
16922260|NCT02175030|38063766|FG000|Overall Study|Lost to Follow-up|6|||
16922261|NCT02175030|38063767|FG001|Overall Study|Lost to Follow-up|6|||
16922262|NCT02175030|38063766|FG000|Overall Study|Withdrawal by Subject|1|||
16922263|NCT02175030|38063767|FG001|Overall Study|Withdrawal by Subject|4|||
16922264|NCT02017717|38063782|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16922265|NCT02017717|38063783|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16922266|NCT02017717|38063784|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16922267|NCT02017717|38063785|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
16922268|NCT02017717|38063786|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16922269|NCT02017717|38063787|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16922270|NCT02017717|38063788|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16922271|NCT02017717|38063789|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16922272|NCT02017717|38063790|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16922273|NCT02017717|38063782|FG000|Before Treatment Period|Participant request to stop therapy|0|||
16922274|NCT02017717|38063783|FG001|Before Treatment Period|Participant request to stop therapy|0|||
16922275|NCT02017717|38063784|FG002|Before Treatment Period|Participant request to stop therapy|0|||
16922276|NCT02017717|38063785|FG003|Before Treatment Period|Participant request to stop therapy|0|||
16922277|NCT02017717|38063786|FG004|Before Treatment Period|Participant request to stop therapy|5|||
16847169|NCT01968031|37792218|FG000|Overall Study|Failed inclusion criteria|0|||
16847170|NCT01968031|37792219|FG001|Overall Study|Failed inclusion criteria|2|||
16847171|NCT01968031|37792220|FG002|Overall Study|Failed inclusion criteria|0|||
16847172|NCT01968031|37792218|FG000|Overall Study|Death|0|||
16847173|NCT01968031|37792219|FG001|Overall Study|Death|0|||
16847174|NCT01968031|37792220|FG002|Overall Study|Death|1|||
16847175|NCT01968031|37792218|FG000|Overall Study|Prohibited concomitant medication|1|||
16847176|NCT01968031|37792219|FG001|Overall Study|Prohibited concomitant medication|0|||
16847177|NCT01968031|37792220|FG002|Overall Study|Prohibited concomitant medication|0|||
16847178|NCT01684215|37792232|FG000|Phase 1, Part 1|Adverse Event|1|||
16847179|NCT01684215|37792233|FG001|Phase 1, Part 1|Adverse Event|0|||
16847180|NCT01684215|37792234|FG002|Phase 1, Part 1|Adverse Event|0|||
16847181|NCT01684215|37792235|FG003|Phase 1, Part 1|Adverse Event|0|||
16847182|NCT01684215|37792232|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
16847183|NCT01684215|37792233|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
16922278|NCT02017717|38063787|FG005|Before Treatment Period|Participant request to stop therapy|0|||
16922279|NCT02017717|38063788|FG006|Before Treatment Period|Participant request to stop therapy|0|||
16922280|NCT02017717|38063789|FG007|Before Treatment Period|Participant request to stop therapy|0|||
16922281|NCT02017717|38063790|FG008|Before Treatment Period|Participant request to stop therapy|0|||
16922282|NCT02017717|38063782|FG000|Before Treatment Period|Participant withdrew consent|0|||
16922283|NCT02017717|38063783|FG001|Before Treatment Period|Participant withdrew consent|0|||
16922284|NCT02017717|38063784|FG002|Before Treatment Period|Participant withdrew consent|0|||
16922285|NCT02017717|38063785|FG003|Before Treatment Period|Participant withdrew consent|0|||
16922286|NCT02017717|38063786|FG004|Before Treatment Period|Participant withdrew consent|11|||
16922287|NCT02017717|38063787|FG005|Before Treatment Period|Participant withdrew consent|0|||
16922288|NCT02017717|38063788|FG006|Before Treatment Period|Participant withdrew consent|0|||
16922289|NCT02017717|38063789|FG007|Before Treatment Period|Participant withdrew consent|0|||
16922290|NCT02017717|38063790|FG008|Before Treatment Period|Participant withdrew consent|2|||
16922291|NCT02017717|38063782|FG000|Before Treatment Period|Lost to Follow-up|0|||
16922292|NCT02017717|38063783|FG001|Before Treatment Period|Lost to Follow-up|0|||
16922293|NCT02017717|38063784|FG002|Before Treatment Period|Lost to Follow-up|0|||
16922294|NCT02017717|38063785|FG003|Before Treatment Period|Lost to Follow-up|0|||
16922295|NCT02017717|38063786|FG004|Before Treatment Period|Lost to Follow-up|1|||
16922296|NCT02017717|38063787|FG005|Before Treatment Period|Lost to Follow-up|0|||
16922297|NCT02017717|38063788|FG006|Before Treatment Period|Lost to Follow-up|0|||
16922298|NCT02017717|38063789|FG007|Before Treatment Period|Lost to Follow-up|0|||
16922299|NCT02017717|38063790|FG008|Before Treatment Period|Lost to Follow-up|0|||
16922300|NCT02017717|38063782|FG000|Before Treatment Period|Participant no longer met criteria|0|||
16922301|NCT02017717|38063783|FG001|Before Treatment Period|Participant no longer met criteria|0|||
16922302|NCT02017717|38063784|FG002|Before Treatment Period|Participant no longer met criteria|0|||
16922303|NCT02017717|38063785|FG003|Before Treatment Period|Participant no longer met criteria|1|||
16922304|NCT02017717|38063786|FG004|Before Treatment Period|Participant no longer met criteria|2|||
16922305|NCT02017717|38063787|FG005|Before Treatment Period|Participant no longer met criteria|0|||
16922306|NCT02017717|38063788|FG006|Before Treatment Period|Participant no longer met criteria|0|||
16922307|NCT02017717|38063789|FG007|Before Treatment Period|Participant no longer met criteria|1|||
16922308|NCT02017717|38063790|FG008|Before Treatment Period|Participant no longer met criteria|0|||
16922309|NCT02017717|38063782|FG000|Before Treatment Period|other reason|0|||
16922310|NCT02017717|38063783|FG001|Before Treatment Period|other reason|0|||
16922311|NCT02017717|38063784|FG002|Before Treatment Period|other reason|0|||
16922312|NCT02017717|38063785|FG003|Before Treatment Period|other reason|0|||
16922313|NCT02017717|38063786|FG004|Before Treatment Period|other reason|1|||
16922314|NCT02017717|38063787|FG005|Before Treatment Period|other reason|0|||
16922315|NCT02017717|38063788|FG006|Before Treatment Period|other reason|0|||
16922316|NCT02017717|38063789|FG007|Before Treatment Period|other reason|0|||
17017679|NCT00878501|38162269|FG000|Overall Study|Adverse Event|11|||
17017680|NCT00878501|38162270|FG001|Overall Study|Adverse Event|3|||
17017681|NCT00878501|38162271|FG002|Overall Study|Adverse Event|3|||
17017682|NCT00878501|38162269|FG000|Overall Study|Lack of Efficacy|2|||
16922317|NCT02017717|38063790|FG008|Before Treatment Period|other reason|0|||
16922318|NCT02017717|38063782|FG000|Treatment Period|Disease progression|7|||
16922319|NCT02017717|38063783|FG001|Treatment Period|Disease progression|9|||
16922320|NCT02017717|38063784|FG002|Treatment Period|Disease progression|12|||
16922321|NCT02017717|38063785|FG003|Treatment Period|Disease progression|165|||
16922322|NCT02017717|38063786|FG004|Treatment Period|Disease progression|134|||
16922323|NCT02017717|38063787|FG005|Treatment Period|Disease progression|20|||
16922324|NCT02017717|38063788|FG006|Treatment Period|Disease progression|26|||
16922325|NCT02017717|38063789|FG007|Treatment Period|Disease progression|17|||
16847184|NCT01684215|37792234|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
16847185|NCT01684215|37792235|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
16847186|NCT01684215|37792232|FG000|Phase 1, Part 2|Adverse Event|0|||
16922326|NCT02017717|38063790|FG008|Treatment Period|Disease progression|22|||
16922327|NCT02017717|38063782|FG000|Treatment Period|Study drug toxicity|3|||
16922328|NCT02017717|38063783|FG001|Treatment Period|Study drug toxicity|0|||
16922329|NCT02017717|38063784|FG002|Treatment Period|Study drug toxicity|1|||
16922330|NCT02017717|38063785|FG003|Treatment Period|Study drug toxicity|7|||
16922331|NCT02017717|38063786|FG004|Treatment Period|Study drug toxicity|11|||
16922332|NCT02017717|38063787|FG005|Treatment Period|Study drug toxicity|4|||
16922333|NCT02017717|38063788|FG006|Treatment Period|Study drug toxicity|4|||
16922334|NCT02017717|38063789|FG007|Treatment Period|Study drug toxicity|5|||
16922335|NCT02017717|38063790|FG008|Treatment Period|Study drug toxicity|3|||
16922336|NCT02017717|38063782|FG000|Treatment Period|Death|0|||
16922337|NCT02017717|38063783|FG001|Treatment Period|Death|0|||
16922338|NCT02017717|38063784|FG002|Treatment Period|Death|1|||
16922339|NCT02017717|38063785|FG003|Treatment Period|Death|0|||
16922340|NCT02017717|38063786|FG004|Treatment Period|Death|0|||
16922341|NCT02017717|38063787|FG005|Treatment Period|Death|0|||
16922342|NCT02017717|38063788|FG006|Treatment Period|Death|0|||
16922343|NCT02017717|38063789|FG007|Treatment Period|Death|1|||
17017683|NCT00878501|38162270|FG001|Overall Study|Lack of Efficacy|1|||
17017684|NCT00878501|38162271|FG002|Overall Study|Lack of Efficacy|0|||
17017685|NCT00878501|38162269|FG000|Overall Study|Withdrawal by Subject|2|||
17017686|NCT00878501|38162270|FG001|Overall Study|Withdrawal by Subject|1|||
17017687|NCT00878501|38162271|FG002|Overall Study|Withdrawal by Subject|2|||
17017688|NCT00878501|38162269|FG000|Overall Study|Protocol Violation|0|||
16922344|NCT02017717|38063790|FG008|Treatment Period|Death|0|||
16922345|NCT02017717|38063782|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
16922346|NCT02017717|38063783|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
16922347|NCT02017717|38063784|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
16922348|NCT02017717|38063785|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
16922349|NCT02017717|38063786|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
16922350|NCT02017717|38063787|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
16922351|NCT02017717|38063788|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
16922352|NCT02017717|38063789|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
16922353|NCT02017717|38063790|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
16922354|NCT02017717|38063782|FG000|Treatment Period|Participant request to stop therapy|0|||
16922355|NCT02017717|38063783|FG001|Treatment Period|Participant request to stop therapy|0|||
16922356|NCT02017717|38063784|FG002|Treatment Period|Participant request to stop therapy|3|||
16922357|NCT02017717|38063785|FG003|Treatment Period|Participant request to stop therapy|4|||
16922358|NCT02017717|38063786|FG004|Treatment Period|Participant request to stop therapy|7|||
16922359|NCT02017717|38063787|FG005|Treatment Period|Participant request to stop therapy|5|||
16922360|NCT02017717|38063788|FG006|Treatment Period|Participant request to stop therapy|0|||
16922361|NCT02017717|38063789|FG007|Treatment Period|Participant request to stop therapy|2|||
16922362|NCT02017717|38063790|FG008|Treatment Period|Participant request to stop therapy|1|||
16922363|NCT02017717|38063782|FG000|Treatment Period|Participant withdrew consent|0|||
16922364|NCT02017717|38063783|FG001|Treatment Period|Participant withdrew consent|0|||
16922365|NCT02017717|38063784|FG002|Treatment Period|Participant withdrew consent|1|||
16922366|NCT02017717|38063785|FG003|Treatment Period|Participant withdrew consent|1|||
16922367|NCT02017717|38063786|FG004|Treatment Period|Participant withdrew consent|4|||
16922368|NCT02017717|38063787|FG005|Treatment Period|Participant withdrew consent|0|||
16922369|NCT02017717|38063788|FG006|Treatment Period|Participant withdrew consent|0|||
16922370|NCT02017717|38063789|FG007|Treatment Period|Participant withdrew consent|2|||
16922371|NCT02017717|38063790|FG008|Treatment Period|Participant withdrew consent|0|||
16922372|NCT02017717|38063782|FG000|Treatment Period|Participant no longer met criteria|0|||
16922373|NCT02017717|38063783|FG001|Treatment Period|Participant no longer met criteria|0|||
17017689|NCT00878501|38162270|FG001|Overall Study|Protocol Violation|0|||
17017690|NCT00878501|38162271|FG002|Overall Study|Protocol Violation|1|||
17017691|NCT00878501|38162269|FG000|Overall Study|Incorrect enrolment|1|||
17017692|NCT00878501|38162270|FG001|Overall Study|Incorrect enrolment|2|||
17017693|NCT00878501|38162271|FG002|Overall Study|Incorrect enrolment|0|||
17017694|NCT00878501|38162269|FG000|Overall Study|Intake of prohibited concom. medication|0|||
17017695|NCT00878501|38162270|FG001|Overall Study|Intake of prohibited concom. medication|0|||
17017696|NCT00878501|38162271|FG002|Overall Study|Intake of prohibited concom. medication|1|||
17017697|NCT00878501|38162269|FG000|Overall Study|Mis-randomisation of patient|1|||
17017698|NCT00878501|38162270|FG001|Overall Study|Mis-randomisation of patient|0|||
17017699|NCT00878501|38162271|FG002|Overall Study|Mis-randomisation of patient|0|||
17017700|NCT00878501|38162269|FG000|Overall Study|Administrative|0|||
17017701|NCT00878501|38162270|FG001|Overall Study|Administrative|0|||
17017702|NCT00878501|38162271|FG002|Overall Study|Administrative|1|||
17017703|NCT00882713|38162279|FG000|Overall Study|Adverse Event|2|||
17017704|NCT00882713|38162279|FG000|Overall Study|Death|3|||
17017705|NCT00882713|38162279|FG000|Overall Study|Administrative reasons|4|||
17017706|NCT00882713|38162279|FG000|Overall Study|refused treatment/withdrew consent|4|||
17017707|NCT00882713|38162279|FG000|Overall Study|Blood transfusion|2|||
16922374|NCT02017717|38063784|FG002|Treatment Period|Participant no longer met criteria|0|||
16922375|NCT02017717|38063785|FG003|Treatment Period|Participant no longer met criteria|0|||
16922376|NCT02017717|38063786|FG004|Treatment Period|Participant no longer met criteria|1|||
16922377|NCT02017717|38063787|FG005|Treatment Period|Participant no longer met criteria|0|||
16922378|NCT02017717|38063788|FG006|Treatment Period|Participant no longer met criteria|0|||
16922379|NCT02017717|38063789|FG007|Treatment Period|Participant no longer met criteria|0|||
16922380|NCT02017717|38063790|FG008|Treatment Period|Participant no longer met criteria|0|||
16922381|NCT02017717|38063782|FG000|Treatment Period|other reasons|0|||
16922382|NCT02017717|38063783|FG001|Treatment Period|other reasons|0|||
16922383|NCT02017717|38063784|FG002|Treatment Period|other reasons|0|||
16922384|NCT02017717|38063785|FG003|Treatment Period|other reasons|0|||
16922385|NCT02017717|38063786|FG004|Treatment Period|other reasons|1|||
16922386|NCT02017717|38063787|FG005|Treatment Period|other reasons|0|||
16922387|NCT02017717|38063788|FG006|Treatment Period|other reasons|0|||
16922388|NCT02017717|38063789|FG007|Treatment Period|other reasons|1|||
16922389|NCT02017717|38063790|FG008|Treatment Period|other reasons|1|||
16922390|NCT02017717|38063782|FG000|Treatment Period|Maximum clinical benefit|0|||
16922391|NCT02017717|38063783|FG001|Treatment Period|Maximum clinical benefit|0|||
16922392|NCT02017717|38063784|FG002|Treatment Period|Maximum clinical benefit|0|||
16922393|NCT02017717|38063785|FG003|Treatment Period|Maximum clinical benefit|0|||
16922394|NCT02017717|38063786|FG004|Treatment Period|Maximum clinical benefit|1|||
16922395|NCT02017717|38063787|FG005|Treatment Period|Maximum clinical benefit|0|||
16922396|NCT02017717|38063788|FG006|Treatment Period|Maximum clinical benefit|0|||
16922397|NCT02017717|38063789|FG007|Treatment Period|Maximum clinical benefit|0|||
16922398|NCT02017717|38063790|FG008|Treatment Period|Maximum clinical benefit|0|||
16922399|NCT00316888|38063837|FG000|Overall Study|Adverse Event|4|||
16922400|NCT00316888|38063838|FG001|Overall Study|Adverse Event|5|||
16922401|NCT00316888|38063837|FG000|Overall Study|Withdrawal by Subject|2|||
16922402|NCT00316888|38063838|FG001|Overall Study|Withdrawal by Subject|2|||
16922403|NCT00316888|38063837|FG000|Overall Study|Not start protocol therapy|0|||
16922404|NCT00316888|38063838|FG001|Overall Study|Not start protocol therapy|1|||
16922405|NCT03096834|38063846|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
16922406|NCT03096834|38063847|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
16922407|NCT03096834|38063848|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
16922408|NCT03096834|38063849|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
16922409|NCT03096834|38063846|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
16922410|NCT03096834|38063847|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
16922411|NCT03096834|38063848|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
16922412|NCT03096834|38063849|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
16847187|NCT01684215|37792233|FG001|Phase 1, Part 2|Adverse Event|0|||
16847188|NCT01684215|37792234|FG002|Phase 1, Part 2|Adverse Event|1|||
16847189|NCT01684215|37792235|FG003|Phase 1, Part 2|Adverse Event|0|||
16847190|NCT01684215|37792232|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
16847191|NCT01684215|37792233|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
16847192|NCT01684215|37792234|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
16847193|NCT01684215|37792235|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
16847194|NCT01684215|37792232|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
16847195|NCT01684215|37792233|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
16847196|NCT01684215|37792234|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
16847197|NCT01684215|37792235|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
16847198|NCT01684215|37792232|FG000|Phase 2|Death|0|||
16847199|NCT01684215|37792233|FG001|Phase 2|Death|0|||
16847200|NCT01684215|37792234|FG002|Phase 2|Death|0|||
16847201|NCT01684215|37792235|FG003|Phase 2|Death|8|||
16847202|NCT01684215|37792232|FG000|Phase 2|Study terminated by sponsor|0|||
16847203|NCT01684215|37792233|FG001|Phase 2|Study terminated by sponsor|0|||
16847204|NCT01684215|37792234|FG002|Phase 2|Study terminated by sponsor|0|||
16847205|NCT01684215|37792235|FG003|Phase 2|Study terminated by sponsor|30|||
16847206|NCT01684215|37792232|FG000|Phase 2|Enrolled but not treated|0|||
16847207|NCT01684215|37792233|FG001|Phase 2|Enrolled but not treated|0|||
16847208|NCT01684215|37792234|FG002|Phase 2|Enrolled but not treated|0|||
16847209|NCT01684215|37792235|FG003|Phase 2|Enrolled but not treated|1|||
16922413|NCT03096834|38063846|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
16922414|NCT03096834|38063847|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
16922415|NCT03096834|38063848|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
16922416|NCT03096834|38063849|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
16922417|NCT03096834|38063846|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
16922418|NCT03096834|38063847|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
16922419|NCT03096834|38063848|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
16922420|NCT03096834|38063849|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
16922421|NCT03096834|38063846|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
16847210|NCT01684215|37792232|FG000|Phase 2|Lost to Follow-up|0|||
16847211|NCT01684215|37792233|FG001|Phase 2|Lost to Follow-up|0|||
16847212|NCT01684215|37792234|FG002|Phase 2|Lost to Follow-up|0|||
16847213|NCT01684215|37792235|FG003|Phase 2|Lost to Follow-up|4|||
16922422|NCT03096834|38063847|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
16922423|NCT03096834|38063848|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
16922424|NCT03096834|38063849|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
16922425|NCT03096834|38063846|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
16922426|NCT03096834|38063847|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
16922427|NCT03096834|38063848|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
16922428|NCT03096834|38063849|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
16922429|NCT03096834|38063846|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
16922430|NCT03096834|38063847|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
16922431|NCT03096834|38063848|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
16922432|NCT03096834|38063849|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
16922433|NCT03096834|38063846|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
16922434|NCT03096834|38063847|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
16922435|NCT03096834|38063848|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
16922436|NCT03096834|38063849|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
16922437|NCT03096834|38063846|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
16922438|NCT03096834|38063847|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
16922439|NCT03096834|38063848|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
16922440|NCT03096834|38063849|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
16922441|NCT03096834|38063846|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
16922442|NCT03096834|38063847|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
16922443|NCT03096834|38063848|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
16922444|NCT03096834|38063849|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
16922445|NCT03096834|38063846|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
16922446|NCT03096834|38063847|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
16922447|NCT03096834|38063848|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
16922448|NCT03096834|38063849|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
16922449|NCT03096834|38063846|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
16922450|NCT03096834|38063847|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
16922451|NCT03096834|38063848|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
16922452|NCT03096834|38063849|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
16922453|NCT03015194|38063858|FG000|Overall Study|Death|10|||
16922454|NCT03015194|38063858|FG000|Overall Study|Withdrawal by Subject|2|||
16922455|NCT03012815|38063865|FG000|Overall Study|Lost to Follow-up|1|||
16922456|NCT03012815|38063866|FG001|Overall Study|Lost to Follow-up|0|||
16922457|NCT03012815|38063865|FG000|Overall Study|Physician Decision|3|||
16922458|NCT03012815|38063866|FG001|Overall Study|Physician Decision|2|||
16922459|NCT03012815|38063865|FG000|Overall Study|Adverse Event|1|||
16922460|NCT03012815|38063866|FG001|Overall Study|Adverse Event|0|||
16922461|NCT03001011|38063875|FG000|Overall Study|Adverse Event|9|||
16922462|NCT03001011|38063876|FG001|Overall Study|Adverse Event|3|||
16922463|NCT03001011|38063875|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
16922464|NCT03001011|38063876|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
16922465|NCT03001011|38063875|FG000|Overall Study|Other than specified above|3|||
16922466|NCT03001011|38063876|FG001|Overall Study|Other than specified above|8|||
16922467|NCT02993757|38063885|FG000|Overall Study|Non compliance with the protocol|155|||
16922468|NCT02993757|38063886|FG001|Overall Study|Non compliance with the protocol|170|||
16922469|NCT02993757|38063885|FG000|Overall Study|Lost to Follow-up|1|||
16922470|NCT02993757|38063886|FG001|Overall Study|Lost to Follow-up|0|||
16922471|NCT02993757|38063885|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
16922472|NCT02993757|38063886|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
16922473|NCT02979535|38063894|FG000|Overall Study|Non compliance with the protocol|78|||
16922474|NCT02979535|38063895|FG001|Overall Study|Non compliance with the protocol|82|||
16922475|NCT02979535|38063894|FG000|Overall Study|Consent withdrawn by participant|11|||
16922476|NCT02979535|38063895|FG001|Overall Study|Consent withdrawn by participant|18|||
16922477|NCT02979535|38063894|FG000|Overall Study|Lost to Follow-up|6|||
16922478|NCT02979535|38063895|FG001|Overall Study|Lost to Follow-up|1|||
16922479|NCT02978716|38063904|FG000|Overall Study|Death|25|||
16922480|NCT02978716|38063905|FG001|Overall Study|Death|13|||
16922481|NCT02978716|38063906|FG002|Overall Study|Death|20|||
16922482|NCT02978716|38063904|FG000|Overall Study|Lost to Follow-up|0|||
16922483|NCT02978716|38063905|FG001|Overall Study|Lost to Follow-up|0|||
16922484|NCT02978716|38063906|FG002|Overall Study|Lost to Follow-up|1|||
16922485|NCT02978716|38063904|FG000|Overall Study|Withdrawal by Subject|6|||
16922486|NCT02978716|38063905|FG001|Overall Study|Withdrawal by Subject|4|||
16922487|NCT02978716|38063906|FG002|Overall Study|Withdrawal by Subject|5|||
16922488|NCT02978716|38063904|FG000|Overall Study|Sponsor terminated|2|||
16922489|NCT02978716|38063905|FG001|Overall Study|Sponsor terminated|13|||
16922490|NCT02978716|38063906|FG002|Overall Study|Sponsor terminated|9|||
16922491|NCT02978716|38063904|FG000|Overall Study|Other|1|||
16922492|NCT02978716|38063905|FG001|Overall Study|Other|3|||
16922493|NCT02978716|38063906|FG002|Overall Study|Other|0|||
16922494|NCT02973321|38063921|FG000|Overall Study|Other than specified|0|||
16922495|NCT02973321|38063922|FG001|Overall Study|Other than specified|5|||
16847214|NCT01549275|37792250|FG000|Overall Study|Lost to Follow-up|1|||
16847215|NCT01549275|37792251|FG001|Overall Study|Lost to Follow-up|0|||
16847216|NCT01908205|37792263|FG000|Overall Study|Lost to Follow-up|2|||
16847217|NCT01908205|37792264|FG001|Overall Study|Lost to Follow-up|0|||
16847218|NCT01908205|37792263|FG000|Overall Study|Withdrawal by Subject|3|||
16847219|NCT01908205|37792264|FG001|Overall Study|Withdrawal by Subject|1|||
16847220|NCT01549041|37792285|FG000|Overall Study|Lack of Efficacy|2|||
16847221|NCT01549041|37792286|FG001|Overall Study|Lack of Efficacy|4|||
16922496|NCT02973321|38063923|FG002|Overall Study|Other than specified|3|||
16847222|NCT01549041|37792285|FG000|Overall Study|Adverse Event|0|||
16847223|NCT01549041|37792286|FG001|Overall Study|Adverse Event|4|||
16847224|NCT01907815|37792294|FG000|Overall Study|Withdrawal by Subject|1|||
16847225|NCT01907815|37792295|FG001|Overall Study|Withdrawal by Subject|0|||
16847226|NCT01548573|37792303|FG000|Overall Study|Death|3|||
16847227|NCT01548573|37792303|FG000|Overall Study|Withdrawal by Subject|2|||
16847228|NCT01907737|37792308|FG000|Overall Study|Withdrawal by Subject|1|||
16847229|NCT01570491|37792320|FG000|Overall Study|Lost to Follow-up|3|||
16847230|NCT01570491|37792321|FG001|Overall Study|Lost to Follow-up|1|||
16847231|NCT01570491|37792320|FG000|Overall Study|treatment: not given or discontinued|2|||
16847232|NCT01570491|37792321|FG001|Overall Study|treatment: not given or discontinued|0|||
16847233|NCT01929109|37792332|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
16847234|NCT01929109|37792333|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
16847235|NCT01929109|37792334|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
16847236|NCT01929109|37792335|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
16847237|NCT01929109|37792336|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
16847238|NCT01518153|37792351|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
16847239|NCT01518153|37792352|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
16847240|NCT01518153|37792353|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
16847241|NCT01518153|37792351|FG000|Stem Cell Transplant|Death|2|||
16847242|NCT01518153|37792352|FG001|Stem Cell Transplant|Death|0|||
16847243|NCT01518153|37792353|FG002|Stem Cell Transplant|Death|0|||
16847244|NCT01518153|37792351|FG000|Stem Cell Transplant|Secondary graft failure|1|||
16847245|NCT01518153|37792352|FG001|Stem Cell Transplant|Secondary graft failure|0|||
16847246|NCT01518153|37792353|FG002|Stem Cell Transplant|Secondary graft failure|0|||
16847247|NCT01518153|37792351|FG000|Stem Cell Transplant|Adverse Event|1|||
16847248|NCT01518153|37792352|FG001|Stem Cell Transplant|Adverse Event|0|||
16847249|NCT01518153|37792353|FG002|Stem Cell Transplant|Adverse Event|0|||
16847250|NCT01518153|37792351|FG000|Donor Lymphocyte Infusion|Death|0|||
16847251|NCT01518153|37792352|FG001|Donor Lymphocyte Infusion|Death|2|||
16847252|NCT01518153|37792353|FG002|Donor Lymphocyte Infusion|Death|1|||
16847253|NCT01906489|37792363|FG000|Overall Study|Adverse Event|10|||
16847254|NCT01906489|37792364|FG001|Overall Study|Adverse Event|3|||
16847255|NCT01906489|37792363|FG000|Overall Study|Worsening of CKD|6|||
16847256|NCT01906489|37792364|FG001|Overall Study|Worsening of CKD|4|||
16847257|NCT01906489|37792363|FG000|Overall Study|Withdrawal by Subject|5|||
16847258|NCT01906489|37792364|FG001|Overall Study|Withdrawal by Subject|0|||
16847259|NCT01906489|37792363|FG000|Overall Study|Worsening of Anemia|1|||
16847260|NCT01906489|37792364|FG001|Overall Study|Worsening of Anemia|0|||
16847261|NCT01906489|37792363|FG000|Overall Study|Protocol Violation|0|||
16847262|NCT01906489|37792364|FG001|Overall Study|Protocol Violation|1|||
16847263|NCT01906489|37792363|FG000|Overall Study|Non- Compliance|1|||
16847264|NCT01906489|37792364|FG001|Overall Study|Non- Compliance|0|||
16847265|NCT01906489|37792363|FG000|Overall Study|Sponsor Decision|1|||
16847266|NCT01906489|37792364|FG001|Overall Study|Sponsor Decision|0|||
16847267|NCT01906489|37792363|FG000|Overall Study|Lost to Follow-up|1|||
16847268|NCT01906489|37792364|FG001|Overall Study|Lost to Follow-up|1|||
16847269|NCT01906489|37792363|FG000|Overall Study|Other|1|||
16847270|NCT01906489|37792364|FG001|Overall Study|Other|0|||
16847271|NCT01517373|37792375|FG000|Run-in Period|Death|1|||
16847272|NCT01517373|37792376|FG001|Run-in Period|Death|0|||
16847273|NCT01517373|37792377|FG002|Run-in Period|Death|0|||
16847274|NCT01517373|37792378|FG003|Run-in Period|Death|0|||
16847275|NCT01517373|37792379|FG004|Run-in Period|Death|0|||
16847276|NCT01517373|37792380|FG005|Run-in Period|Death|0|||
16847277|NCT01517373|37792375|FG000|Run-in Period|Adverse Event|5|||
16847278|NCT01517373|37792376|FG001|Run-in Period|Adverse Event|0|||
16847279|NCT01517373|37792377|FG002|Run-in Period|Adverse Event|0|||
16847280|NCT01517373|37792378|FG003|Run-in Period|Adverse Event|0|||
16847281|NCT01517373|37792379|FG004|Run-in Period|Adverse Event|0|||
16847282|NCT01517373|37792380|FG005|Run-in Period|Adverse Event|0|||
16847283|NCT01517373|37792375|FG000|Run-in Period|Did not meet eligibility criteria|34|||
16847284|NCT01517373|37792376|FG001|Run-in Period|Did not meet eligibility criteria|0|||
16847285|NCT01517373|37792377|FG002|Run-in Period|Did not meet eligibility criteria|0|||
16847286|NCT01517373|37792378|FG003|Run-in Period|Did not meet eligibility criteria|0|||
16847287|NCT01517373|37792379|FG004|Run-in Period|Did not meet eligibility criteria|0|||
16847288|NCT01517373|37792380|FG005|Run-in Period|Did not meet eligibility criteria|0|||
16847289|NCT01517373|37792375|FG000|Run-in Period|Lost to Follow-up|1|||
16847290|NCT01517373|37792376|FG001|Run-in Period|Lost to Follow-up|0|||
16847291|NCT01517373|37792377|FG002|Run-in Period|Lost to Follow-up|0|||
16847292|NCT01517373|37792378|FG003|Run-in Period|Lost to Follow-up|0|||
16847293|NCT01517373|37792379|FG004|Run-in Period|Lost to Follow-up|0|||
16847294|NCT01517373|37792380|FG005|Run-in Period|Lost to Follow-up|0|||
16847295|NCT01517373|37792375|FG000|Run-in Period|Withdrawal by Subject|12|||
16847296|NCT01517373|37792376|FG001|Run-in Period|Withdrawal by Subject|0|||
16847297|NCT01517373|37792377|FG002|Run-in Period|Withdrawal by Subject|0|||
16847298|NCT01517373|37792378|FG003|Run-in Period|Withdrawal by Subject|0|||
16847299|NCT01517373|37792379|FG004|Run-in Period|Withdrawal by Subject|0|||
16847300|NCT01517373|37792380|FG005|Run-in Period|Withdrawal by Subject|0|||
16847301|NCT01517373|37792375|FG000|Run-in Period|Sponsor Decision|3|||
16847302|NCT01517373|37792376|FG001|Run-in Period|Sponsor Decision|0|||
16847303|NCT01517373|37792377|FG002|Run-in Period|Sponsor Decision|0|||
16847304|NCT01517373|37792378|FG003|Run-in Period|Sponsor Decision|0|||
16847305|NCT01517373|37792379|FG004|Run-in Period|Sponsor Decision|0|||
16847306|NCT01517373|37792380|FG005|Run-in Period|Sponsor Decision|0|||
16847307|NCT01517373|37792375|FG000|Run-in Period|Other|1|||
16847308|NCT01517373|37792376|FG001|Run-in Period|Other|0|||
16847309|NCT01517373|37792377|FG002|Run-in Period|Other|0|||
16847310|NCT01517373|37792378|FG003|Run-in Period|Other|0|||
16847311|NCT01517373|37792379|FG004|Run-in Period|Other|0|||
16847312|NCT01517373|37792380|FG005|Run-in Period|Other|0|||
16847313|NCT01517373|37792375|FG000|Treatment Period|Adverse Event|0|||
16847314|NCT01517373|37792376|FG001|Treatment Period|Adverse Event|0|||
16847315|NCT01517373|37792377|FG002|Treatment Period|Adverse Event|0|||
16847316|NCT01517373|37792378|FG003|Treatment Period|Adverse Event|0|||
16847317|NCT01517373|37792379|FG004|Treatment Period|Adverse Event|0|||
16847318|NCT01517373|37792380|FG005|Treatment Period|Adverse Event|2|||
16847319|NCT01517373|37792375|FG000|Treatment Period|Lost to Follow-up|0|||
16847320|NCT01517373|37792376|FG001|Treatment Period|Lost to Follow-up|0|||
16847321|NCT01517373|37792377|FG002|Treatment Period|Lost to Follow-up|1|||
16847322|NCT01517373|37792378|FG003|Treatment Period|Lost to Follow-up|1|||
16847323|NCT01517373|37792379|FG004|Treatment Period|Lost to Follow-up|0|||
16847324|NCT01517373|37792380|FG005|Treatment Period|Lost to Follow-up|0|||
16922497|NCT02973321|38063924|FG003|Overall Study|Other than specified|3|||
16922498|NCT02973321|38063925|FG004|Overall Study|Other than specified|1|||
16922499|NCT02973321|38063921|FG000|Overall Study|Lack of Efficacy|0|||
16922500|NCT02973321|38063922|FG001|Overall Study|Lack of Efficacy|0|||
16922501|NCT02973321|38063923|FG002|Overall Study|Lack of Efficacy|0|||
16922502|NCT02973321|38063924|FG003|Overall Study|Lack of Efficacy|0|||
16922503|NCT02973321|38063925|FG004|Overall Study|Lack of Efficacy|1|||
16922504|NCT02973321|38063921|FG000|Overall Study|Adverse Event|1|||
16922505|NCT02973321|38063922|FG001|Overall Study|Adverse Event|10|||
16922506|NCT02973321|38063923|FG002|Overall Study|Adverse Event|11|||
16922507|NCT02973321|38063924|FG003|Overall Study|Adverse Event|13|||
16922508|NCT02973321|38063925|FG004|Overall Study|Adverse Event|3|||
16922509|NCT02943785|38063940|FG000|Overall Study|Adverse Event|112|||
16922510|NCT02943785|38063941|FG001|Overall Study|Adverse Event|97|||
16922511|NCT02943785|38063940|FG000|Overall Study|Withdrawal by Subject|63|||
16922512|NCT02943785|38063941|FG001|Overall Study|Withdrawal by Subject|126|||
16922513|NCT02943785|38063940|FG000|Overall Study|Physician Decision|23|||
16922514|NCT02943785|38063941|FG001|Overall Study|Physician Decision|47|||
16922515|NCT02943785|38063940|FG000|Overall Study|Death|46|||
16922516|NCT02943785|38063941|FG001|Overall Study|Death|46|||
16922517|NCT02943785|38063940|FG000|Overall Study|Lost to Follow-up|1|||
16922518|NCT02943785|38063941|FG001|Overall Study|Lost to Follow-up|0|||
16922519|NCT02943785|38063940|FG000|Overall Study|Other|16|||
16922520|NCT02943785|38063941|FG001|Overall Study|Other|19|||
16922521|NCT02943785|38063940|FG000|Overall Study|Did not receive any study medication|21|||
16922522|NCT02943785|38063941|FG001|Overall Study|Did not receive any study medication|28|||
16922523|NCT02923674|38063950|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
16922524|NCT02923674|38063951|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
16922525|NCT02923674|38063952|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
16922526|NCT02923674|38063950|FG000|Overall Study|Lost to Follow-up|7|||
16922527|NCT02923674|38063951|FG001|Overall Study|Lost to Follow-up|12|||
16922528|NCT02923674|38063952|FG002|Overall Study|Lost to Follow-up|7|||
16922529|NCT02923674|38063950|FG000|Overall Study|Problem with intervention|2|||
16922530|NCT02923674|38063951|FG001|Overall Study|Problem with intervention|2|||
16847325|NCT01517373|37792375|FG000|Treatment Period|Withdrawal by Subject|0|||
16922531|NCT02923674|38063952|FG002|Overall Study|Problem with intervention|1|||
16922532|NCT02923674|38063950|FG000|Overall Study|Adverse Event|3|||
16922533|NCT02923674|38063951|FG001|Overall Study|Adverse Event|1|||
16922534|NCT02923674|38063952|FG002|Overall Study|Adverse Event|1|||
16922535|NCT02923674|38063950|FG000|Overall Study|Withdrawal by Subject|2|||
16922536|NCT02923674|38063951|FG001|Overall Study|Withdrawal by Subject|2|||
16847326|NCT01517373|37792376|FG001|Treatment Period|Withdrawal by Subject|3|||
16847327|NCT01517373|37792377|FG002|Treatment Period|Withdrawal by Subject|2|||
16847328|NCT01517373|37792378|FG003|Treatment Period|Withdrawal by Subject|2|||
16847329|NCT01517373|37792379|FG004|Treatment Period|Withdrawal by Subject|2|||
16847330|NCT01517373|37792380|FG005|Treatment Period|Withdrawal by Subject|3|||
16847331|NCT01517373|37792375|FG000|Treatment Period|Other|0|||
16847332|NCT01517373|37792376|FG001|Treatment Period|Other|0|||
16847333|NCT01517373|37792377|FG002|Treatment Period|Other|0|||
16847334|NCT01517373|37792378|FG003|Treatment Period|Other|0|||
16847335|NCT01517373|37792379|FG004|Treatment Period|Other|1|||
16847336|NCT01517373|37792380|FG005|Treatment Period|Other|0|||
16847337|NCT01517373|37792375|FG000|Treatment Period|Protocol Violation|0|||
16847338|NCT01517373|37792376|FG001|Treatment Period|Protocol Violation|0|||
16847339|NCT01517373|37792377|FG002|Treatment Period|Protocol Violation|0|||
16847340|NCT01517373|37792378|FG003|Treatment Period|Protocol Violation|0|||
16847341|NCT01517373|37792379|FG004|Treatment Period|Protocol Violation|1|||
16847342|NCT01517373|37792380|FG005|Treatment Period|Protocol Violation|0|||
16847343|NCT01517373|37792375|FG000|Treatment Period|Lack of Efficacy|0|||
16847344|NCT01517373|37792376|FG001|Treatment Period|Lack of Efficacy|1|||
16847345|NCT01517373|37792377|FG002|Treatment Period|Lack of Efficacy|1|||
16847346|NCT01517373|37792378|FG003|Treatment Period|Lack of Efficacy|3|||
16847347|NCT01517373|37792379|FG004|Treatment Period|Lack of Efficacy|2|||
16847348|NCT01517373|37792380|FG005|Treatment Period|Lack of Efficacy|0|||
16847349|NCT01517373|37792375|FG000|Treatment Period|Medication error without AEs|0|||
16847350|NCT01517373|37792376|FG001|Treatment Period|Medication error without AEs|0|||
16847351|NCT01517373|37792377|FG002|Treatment Period|Medication error without AEs|2|||
16847352|NCT01517373|37792378|FG003|Treatment Period|Medication error without AEs|1|||
16847353|NCT01517373|37792379|FG004|Treatment Period|Medication error without AEs|0|||
16847354|NCT01517373|37792380|FG005|Treatment Period|Medication error without AEs|2|||
16847355|NCT01517295|37792395|FG000|Overall Study|Physician Decision|1|||
16922537|NCT02923674|38063952|FG002|Overall Study|Withdrawal by Subject|2|||
16922538|NCT02921971|38063962|FG000|Overall Study|Adverse Event|1|||
16922539|NCT02921971|38063963|FG001|Overall Study|Adverse Event|2|||
16922540|NCT02921971|38063962|FG000|Overall Study|Lack of Efficacy|3|||
16922541|NCT02921971|38063963|FG001|Overall Study|Lack of Efficacy|1|||
16922542|NCT02921971|38063962|FG000|Overall Study|Other than specified above|2|||
16922543|NCT02921971|38063963|FG001|Overall Study|Other than specified above|1|||
16922544|NCT02886286|38063971|FG000|Overall Study|pump motor stall|0|||
16922545|NCT02886286|38063972|FG001|Overall Study|pump motor stall|1|||
16922546|NCT02865187|38063980|FG000|Overall Study|Lost to Follow-up|12|||
16922547|NCT02865187|38063981|FG001|Overall Study|Lost to Follow-up|7|||
16922548|NCT02865187|38063980|FG000|Overall Study|Adverse Event|1|||
16922549|NCT02865187|38063981|FG001|Overall Study|Adverse Event|0|||
16922550|NCT02824198|38063989|FG000|Overall Study|Non-compliance with the protocol|5|||
16922551|NCT02824198|38063990|FG001|Overall Study|Non-compliance with the protocol|1|||
16922552|NCT02824198|38063989|FG000|Overall Study|Lost to Follow-up|5|||
16922553|NCT02824198|38063990|FG001|Overall Study|Lost to Follow-up|2|||
16922554|NCT02824198|38063989|FG000|Overall Study|Withdrawal by Subject|5|||
16922555|NCT02824198|38063990|FG001|Overall Study|Withdrawal by Subject|0|||
17102537|NCT00112437|38241441|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
17102538|NCT00112437|38241442|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
17102539|NCT00112437|38241443|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
17102540|NCT00112437|38241444|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
17102541|NCT00112437|38241445|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
17102542|NCT00112437|38241446|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102543|NCT00112437|38241447|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102544|NCT00112437|38241448|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102545|NCT00112437|38241449|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102546|NCT00112437|38241450|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102547|NCT00112437|38241451|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102548|NCT00112437|38241452|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102549|NCT00112437|38241453|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102550|NCT00112437|38241454|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102551|NCT00112437|38241455|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
16922571|NCT02787551|38064011|FG000|Core Period: 26 Weeks|Adverse Event|10|||
16922572|NCT02787551|38064012|FG001|Core Period: 26 Weeks|Adverse Event|0|||
16922573|NCT02787551|38064011|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
16922574|NCT02787551|38064012|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
16922575|NCT02787551|38064011|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
16922576|NCT02787551|38064012|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
16922577|NCT02787551|38064011|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
16922578|NCT02787551|38064012|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
16922579|NCT02787551|38064011|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
17102552|NCT00112437|38241456|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102553|NCT00112437|38241457|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
16847356|NCT01517295|37792396|FG001|Overall Study|Physician Decision|0|||
16847357|NCT01541865|37792402|FG000|Overall Study|Lost to Follow-up|11|||
16847358|NCT01541865|37792402|FG000|Overall Study|Withdrawal by Subject|9|||
16922580|NCT02787551|38064012|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
16922581|NCT02787551|38064011|FG000|Core Period: 26 Weeks|Other than specified|3|||
16922582|NCT02787551|38064012|FG001|Core Period: 26 Weeks|Other than specified|1|||
16922583|NCT02787551|38064011|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
16922584|NCT02787551|38064012|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
16922585|NCT02787551|38064011|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
16922586|NCT02787551|38064012|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
16922587|NCT02787551|38064011|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
16922588|NCT02787551|38064012|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
16922589|NCT02735044|38064032|FG000|Overall Study|Adverse Event|3|||
16922590|NCT02735044|38064033|FG001|Overall Study|Adverse Event|3|||
16922591|NCT02735044|38064032|FG000|Overall Study|Lack of Efficacy|1|||
16922592|NCT02735044|38064033|FG001|Overall Study|Lack of Efficacy|0|||
16922593|NCT02735044|38064032|FG000|Overall Study|Poor compliance to protocol|7|||
16922594|NCT02735044|38064033|FG001|Overall Study|Poor compliance to protocol|7|||
16922595|NCT02735044|38064032|FG000|Overall Study|Randomized and not treated|0|||
16922596|NCT02735044|38064033|FG001|Overall Study|Randomized and not treated|2|||
16922597|NCT02735044|38064032|FG000|Overall Study|Other, not specified above|5|||
16922598|NCT02735044|38064033|FG001|Overall Study|Other, not specified above|11|||
16922599|NCT02720744|38064041|FG000|Overall Study|Protocol Violation|0|||
16922600|NCT02720744|38064042|FG001|Overall Study|Protocol Violation|2|||
16922601|NCT02720744|38064041|FG000|Overall Study|Pregnancy|2|||
16922602|NCT02720744|38064042|FG001|Overall Study|Pregnancy|0|||
16922603|NCT02720744|38064041|FG000|Overall Study|Lack of Efficacy|2|||
16922604|NCT02720744|38064042|FG001|Overall Study|Lack of Efficacy|8|||
16922605|NCT02720744|38064041|FG000|Overall Study|Adverse Event|21|||
16922606|NCT02720744|38064042|FG001|Overall Study|Adverse Event|3|||
16922607|NCT02720744|38064041|FG000|Overall Study|Withdrawal by Subject|11|||
16922608|NCT02720744|38064042|FG001|Overall Study|Withdrawal by Subject|11|||
16922609|NCT02720744|38064041|FG000|Overall Study|Lost to follow up|2|||
16922610|NCT02720744|38064042|FG001|Overall Study|Lost to follow up|0|||
16922611|NCT02720744|38064041|FG000|Overall Study|Non Compliance with Investigational Product|0|||
16922612|NCT02720744|38064042|FG001|Overall Study|Non Compliance with Investigational Product|1|||
16922613|NCT02720744|38064041|FG000|Overall Study|Excluded Concomitant Medication|0|||
16922614|NCT02720744|38064042|FG001|Overall Study|Excluded Concomitant Medication|1|||
16922615|NCT02694185|38064050|FG000|Overall Study|Withdrawal by Subject|45|||
16922616|NCT02694185|38064051|FG001|Overall Study|Withdrawal by Subject|0|||
16922617|NCT02692651|38064059|FG000|Study Treatment|Death|7|||
16922618|NCT02692651|38064060|FG001|Study Treatment|Death|3|||
16922619|NCT02692651|38064059|FG000|Study Treatment|comfort care|1|||
16922620|NCT02692651|38064060|FG001|Study Treatment|comfort care|1|||
16922621|NCT02692651|38064059|FG000|Study Treatment|Protocol violation per treating team preference|8|||
16922622|NCT02692651|38064060|FG001|Study Treatment|Protocol violation per treating team preference|6|||
16922623|NCT02692651|38064059|FG000|Post Study Treatment Follow-up|Death|4|||
16922624|NCT02692651|38064060|FG001|Post Study Treatment Follow-up|Death|4|||
16922625|NCT02674061|38064068|FG000|Overall Study|Death|229|||
16922626|NCT02674061|38064069|FG001|Overall Study|Death|77|||
16922627|NCT02674061|38064068|FG000|Overall Study|Lost to Follow-up|3|||
16922628|NCT02674061|38064069|FG001|Overall Study|Lost to Follow-up|3|||
16922629|NCT02674061|38064068|FG000|Overall Study|Withdrawal by Subject|9|||
16922630|NCT02674061|38064069|FG001|Overall Study|Withdrawal by Subject|1|||
16922631|NCT02674061|38064068|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
16922632|NCT02674061|38064069|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
16922633|NCT02628444|38064089|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
16922634|NCT02628444|38064090|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16922635|NCT02628444|38064091|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16922636|NCT02628444|38064092|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16922637|NCT02628444|38064093|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16922638|NCT02628444|38064094|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16922639|NCT02628444|38064095|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16922640|NCT02628444|38064096|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16922641|NCT02628444|38064097|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16922642|NCT02628444|38064089|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16922643|NCT02628444|38064090|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
16922644|NCT02628444|38064091|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
16922645|NCT02628444|38064092|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16922646|NCT02628444|38064093|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16922647|NCT02628444|38064094|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16922648|NCT02628444|38064095|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16922649|NCT02628444|38064096|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16922650|NCT02628444|38064097|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16847359|NCT01541865|37792402|FG000|Overall Study|Adverse Event|1|||
16847360|NCT01541865|37792402|FG000|Overall Study|Protocol Violation|1|||
16847361|NCT01541397|37792408|FG000|Overall Study|Study ended prior to data collection|4|||
16847362|NCT01541397|37792409|FG001|Overall Study|Study ended prior to data collection|2|||
16847363|NCT01548417|37792417|FG000|Overall Study|Withdrawal by Subject|0|||
16847364|NCT01548417|37792418|FG001|Overall Study|Withdrawal by Subject|2|||
16847365|NCT01546857|37792426|FG000|Overall Study|Withdrawal by Subject|2|||
16847366|NCT01546857|37792427|FG001|Overall Study|Withdrawal by Subject|3|||
16847367|NCT01540851|37792436|FG000|Overall Study|Lost to Follow-up|14|||
16847368|NCT01540851|37792437|FG001|Overall Study|Lost to Follow-up|15|||
16847369|NCT01540851|37792436|FG000|Overall Study|Withdrawal by Subject|7|||
16847370|NCT01540851|37792437|FG001|Overall Study|Withdrawal by Subject|3|||
16847371|NCT01516749|37792445|FG000|Active Therapy|Lost to Follow-up|1|||
16847372|NCT01516749|37792445|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
16847373|NCT01516437|37792453|FG000|Overall Study|Reason not specified|0|||
16847374|NCT01516437|37792454|FG001|Overall Study|Reason not specified|0|||
16922651|NCT02628444|38064089|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
16922652|NCT02628444|38064090|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
16922653|NCT02628444|38064091|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
16922654|NCT02628444|38064092|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922655|NCT02628444|38064093|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922656|NCT02628444|38064094|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922657|NCT02628444|38064095|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922658|NCT02628444|38064096|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922659|NCT02628444|38064097|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922660|NCT02628444|38064089|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
16922661|NCT02628444|38064090|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
16922662|NCT02628444|38064091|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
16922663|NCT02628444|38064092|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16922664|NCT02628444|38064093|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16922665|NCT02628444|38064094|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16922666|NCT02628444|38064095|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16922667|NCT02628444|38064096|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16922668|NCT02628444|38064097|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16922669|NCT02628444|38064089|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
16922670|NCT02628444|38064090|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
16922671|NCT02628444|38064091|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
16922672|NCT02628444|38064092|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
17017708|NCT00882713|38162279|FG000|Overall Study|Insufficient therapeutic response|3|||
17017709|NCT00882713|38162279|FG000|Overall Study|Failure to return|2|||
17017710|NCT00882713|38162279|FG000|Overall Study|Other - Reasons|2|||
17017711|NCT00809133|38162298|FG000|Overall Study|Progressive disease|2|||
17017712|NCT00809133|38162299|FG001|Overall Study|Progressive disease|5|||
17017713|NCT00809133|38162300|FG002|Overall Study|Progressive disease|5|||
17017714|NCT00809133|38162301|FG003|Overall Study|Progressive disease|3|||
17017715|NCT00809133|38162302|FG004|Overall Study|Progressive disease|4|||
17017716|NCT00809133|38162303|FG005|Overall Study|Progressive disease|1|||
17017717|NCT00809133|38162304|FG006|Overall Study|Progressive disease|3|||
17017718|NCT00809133|38162305|FG007|Overall Study|Progressive disease|3|||
17017719|NCT00809133|38162306|FG008|Overall Study|Progressive disease|3|||
16847375|NCT01516437|37792455|FG002|Overall Study|Reason not specified|1|||
16847376|NCT01516437|37792456|FG003|Overall Study|Reason not specified|1|||
16847377|NCT01515423|37792470|FG000|Open Label Phase|Adverse Event|57|||
16847378|NCT01515423|37792471|FG001|Open Label Phase|Adverse Event|0|||
16847379|NCT01515423|37792472|FG002|Open Label Phase|Adverse Event|0|||
17017720|NCT00809133|38162307|FG009|Overall Study|Progressive disease|9|||
17017721|NCT00809133|38162308|FG010|Overall Study|Progressive disease|5|||
17017722|NCT00809133|38162309|FG011|Overall Study|Progressive disease|7|||
17017723|NCT00809133|38162310|FG012|Overall Study|Progressive disease|5|||
17017724|NCT00809133|38162311|FG013|Overall Study|Progressive disease|4|||
17017725|NCT00809133|38162298|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017726|NCT00809133|38162299|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017727|NCT00809133|38162300|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017728|NCT00809133|38162301|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017729|NCT00809133|38162302|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16847380|NCT01515423|37792470|FG000|Open Label Phase|Death|2|||
16847381|NCT01515423|37792471|FG001|Open Label Phase|Death|0|||
16922673|NCT02628444|38064093|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16922674|NCT02628444|38064094|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16922675|NCT02628444|38064095|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16922676|NCT02628444|38064096|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16922677|NCT02628444|38064097|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16922678|NCT02628444|38064089|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16922679|NCT02628444|38064090|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16922680|NCT02628444|38064091|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16922681|NCT02628444|38064092|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
16922682|NCT02628444|38064093|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16922683|NCT02628444|38064094|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16847382|NCT01515423|37792472|FG002|Open Label Phase|Death|0|||
16847383|NCT01515423|37792470|FG000|Open Label Phase|Lack of Efficacy|117|||
16847384|NCT01515423|37792471|FG001|Open Label Phase|Lack of Efficacy|0|||
16847385|NCT01515423|37792472|FG002|Open Label Phase|Lack of Efficacy|0|||
16847386|NCT01515423|37792470|FG000|Open Label Phase|Lost to Follow-up|21|||
16847387|NCT01515423|37792471|FG001|Open Label Phase|Lost to Follow-up|0|||
16922684|NCT02628444|38064095|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16922685|NCT02628444|38064096|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16922686|NCT02628444|38064097|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16922687|NCT02628444|38064089|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
16922688|NCT02628444|38064090|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
16847388|NCT01515423|37792472|FG002|Open Label Phase|Lost to Follow-up|0|||
16847389|NCT01515423|37792470|FG000|Open Label Phase|Withdrawal by Subject|118|||
16922689|NCT02628444|38064091|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
16922690|NCT02628444|38064092|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
16922691|NCT02628444|38064093|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
16922692|NCT02628444|38064094|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
16922693|NCT02628444|38064095|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
16922694|NCT02628444|38064096|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
16922695|NCT02628444|38064097|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
16922696|NCT02628444|38064089|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922697|NCT02628444|38064090|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922698|NCT02628444|38064091|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
16922699|NCT02628444|38064092|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
16922700|NCT02628444|38064093|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
16922701|NCT02628444|38064094|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
16922702|NCT02628444|38064095|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
16922703|NCT02628444|38064096|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
16922704|NCT02628444|38064097|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
16922705|NCT02628444|38064089|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16922706|NCT02628444|38064090|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16847390|NCT01515423|37792471|FG001|Open Label Phase|Withdrawal by Subject|0|||
16847391|NCT01515423|37792472|FG002|Open Label Phase|Withdrawal by Subject|0|||
16847392|NCT01515423|37792470|FG000|Open Label Phase|excluded from DB Phase|70|||
16847393|NCT01515423|37792471|FG001|Open Label Phase|excluded from DB Phase|0|||
16847394|NCT01515423|37792472|FG002|Open Label Phase|excluded from DB Phase|0|||
16847395|NCT01515423|37792470|FG000|Open Label Phase|Other|28|||
16847396|NCT01515423|37792471|FG001|Open Label Phase|Other|0|||
16847397|NCT01515423|37792472|FG002|Open Label Phase|Other|0|||
16847398|NCT01515423|37792470|FG000|DOUBLE BLIND|Adverse Event|0|||
16847399|NCT01515423|37792471|FG001|DOUBLE BLIND|Adverse Event|15|||
16847400|NCT01515423|37792472|FG002|DOUBLE BLIND|Adverse Event|13|||
16847401|NCT01515423|37792470|FG000|DOUBLE BLIND|Death|0|||
16847402|NCT01515423|37792471|FG001|DOUBLE BLIND|Death|1|||
16847403|NCT01515423|37792472|FG002|DOUBLE BLIND|Death|2|||
16847404|NCT01515423|37792470|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
16847405|NCT01515423|37792471|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
16847406|NCT01515423|37792472|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
16847407|NCT01515423|37792470|FG000|DOUBLE BLIND|Pregnancy|0|||
16847408|NCT01515423|37792471|FG001|DOUBLE BLIND|Pregnancy|2|||
16847409|NCT01515423|37792472|FG002|DOUBLE BLIND|Pregnancy|0|||
16922707|NCT02628444|38064091|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16922708|NCT02628444|38064092|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16922709|NCT02628444|38064093|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
16922710|NCT02628444|38064094|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16922711|NCT02628444|38064095|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16847410|NCT01515423|37792470|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
16847411|NCT01515423|37792471|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
16922712|NCT02628444|38064096|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
16922713|NCT02628444|38064097|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
16922714|NCT02628444|38064089|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
16922715|NCT02628444|38064090|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
16922716|NCT02628444|38064091|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
16922717|NCT02628444|38064092|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
16922718|NCT02628444|38064093|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
16922719|NCT02628444|38064094|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
16922720|NCT02628444|38064095|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
16922721|NCT02628444|38064096|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
16922722|NCT02628444|38064097|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
16922723|NCT02623725|38064133|FG000|Overall Study|Non compliance with protocol|9|||
16922724|NCT02623725|38064134|FG001|Overall Study|Non compliance with protocol|3|||
16922725|NCT02623725|38064133|FG000|Overall Study|Serious adverse event|0|||
16922726|NCT02623725|38064134|FG001|Overall Study|Serious adverse event|2|||
16922727|NCT02623725|38064133|FG000|Overall Study|Withdrawal by Subject|7|||
16922728|NCT02623725|38064134|FG001|Overall Study|Withdrawal by Subject|1|||
16922729|NCT02608684|38064142|FG000|Overall Study|Physician Decision|2|||
16922730|NCT02608684|38064142|FG000|Overall Study|Withdrawal by Subject|1|||
16922734|NCT02587520|38064168|FG000|Overall Study|Protocol Violation|2|||
16922735|NCT02587520|38064169|FG001|Overall Study|Protocol Violation|0|||
16922736|NCT02587520|38064170|FG002|Overall Study|Protocol Violation|0|||
16922737|NCT02587520|38064171|FG003|Overall Study|Protocol Violation|2|||
16922738|NCT02587520|38064172|FG004|Overall Study|Protocol Violation|0|||
16922739|NCT02587520|38064173|FG005|Overall Study|Protocol Violation|1|||
16922740|NCT02587520|38064174|FG006|Overall Study|Protocol Violation|1|||
16922741|NCT02587520|38064175|FG007|Overall Study|Protocol Violation|1|||
16922742|NCT02587520|38064176|FG008|Overall Study|Protocol Violation|3|||
16922743|NCT02587520|38064177|FG009|Overall Study|Protocol Violation|3|||
16922744|NCT02587520|38064178|FG010|Overall Study|Protocol Violation|1|||
16922745|NCT02587520|38064179|FG011|Overall Study|Protocol Violation|2|||
16922746|NCT02587520|38064180|FG012|Overall Study|Protocol Violation|0|||
16922747|NCT02587520|38064181|FG013|Overall Study|Protocol Violation|0|||
16922748|NCT02587520|38064182|FG014|Overall Study|Protocol Violation|0|||
16922749|NCT02587520|38064183|FG015|Overall Study|Protocol Violation|0|||
16922750|NCT02587520|38064184|FG016|Overall Study|Protocol Violation|0|||
16922751|NCT02587520|38064185|FG017|Overall Study|Protocol Violation|0|||
16922752|NCT02587520|38064168|FG000|Overall Study|Adverse Event|0|||
16922753|NCT02587520|38064169|FG001|Overall Study|Adverse Event|0|||
16922754|NCT02587520|38064170|FG002|Overall Study|Adverse Event|0|||
16922755|NCT02587520|38064171|FG003|Overall Study|Adverse Event|0|||
16922756|NCT02587520|38064172|FG004|Overall Study|Adverse Event|0|||
16922757|NCT02587520|38064173|FG005|Overall Study|Adverse Event|0|||
16847412|NCT01515423|37792472|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
16847413|NCT01515423|37792470|FG000|DOUBLE BLIND|Other|0|||
16922758|NCT02587520|38064174|FG006|Overall Study|Adverse Event|0|||
16922759|NCT02587520|38064175|FG007|Overall Study|Adverse Event|0|||
16922760|NCT02587520|38064176|FG008|Overall Study|Adverse Event|0|||
16922761|NCT02587520|38064177|FG009|Overall Study|Adverse Event|0|||
16922762|NCT02587520|38064178|FG010|Overall Study|Adverse Event|0|||
16922763|NCT02587520|38064179|FG011|Overall Study|Adverse Event|1|||
16922764|NCT02587520|38064180|FG012|Overall Study|Adverse Event|0|||
16922765|NCT02587520|38064181|FG013|Overall Study|Adverse Event|0|||
16922766|NCT02587520|38064182|FG014|Overall Study|Adverse Event|0|||
16922767|NCT02587520|38064183|FG015|Overall Study|Adverse Event|0|||
16922768|NCT02587520|38064184|FG016|Overall Study|Adverse Event|0|||
16922769|NCT02587520|38064185|FG017|Overall Study|Adverse Event|0|||
16922770|NCT02587520|38064168|FG000|Overall Study|Withdrawal by Subject|0|||
16922771|NCT02587520|38064169|FG001|Overall Study|Withdrawal by Subject|0|||
16922772|NCT02587520|38064170|FG002|Overall Study|Withdrawal by Subject|1|||
16922773|NCT02587520|38064171|FG003|Overall Study|Withdrawal by Subject|1|||
16847414|NCT01515423|37792471|FG001|DOUBLE BLIND|Other|6|||
16847415|NCT01515423|37792472|FG002|DOUBLE BLIND|Other|12|||
16847416|NCT01515423|37792470|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
16847417|NCT01515423|37792471|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
16847418|NCT01515423|37792472|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
16847419|NCT00637156|37792481|FG000|Overall Study|Withdrawal by Subject|0|||
16847420|NCT00637156|37792482|FG001|Overall Study|Withdrawal by Subject|7|||
16847421|NCT00637156|37792481|FG000|Overall Study|Death|0|||
16922774|NCT02587520|38064172|FG004|Overall Study|Withdrawal by Subject|0|||
16922775|NCT02587520|38064173|FG005|Overall Study|Withdrawal by Subject|1|||
16922776|NCT02587520|38064174|FG006|Overall Study|Withdrawal by Subject|1|||
16922777|NCT02587520|38064175|FG007|Overall Study|Withdrawal by Subject|0|||
16922778|NCT02587520|38064176|FG008|Overall Study|Withdrawal by Subject|0|||
16922779|NCT02587520|38064177|FG009|Overall Study|Withdrawal by Subject|0|||
16922780|NCT02587520|38064178|FG010|Overall Study|Withdrawal by Subject|0|||
16922781|NCT02587520|38064179|FG011|Overall Study|Withdrawal by Subject|0|||
16922782|NCT02587520|38064180|FG012|Overall Study|Withdrawal by Subject|0|||
16922783|NCT02587520|38064181|FG013|Overall Study|Withdrawal by Subject|1|||
16922784|NCT02587520|38064182|FG014|Overall Study|Withdrawal by Subject|0|||
16922785|NCT02587520|38064183|FG015|Overall Study|Withdrawal by Subject|0|||
16922786|NCT02587520|38064184|FG016|Overall Study|Withdrawal by Subject|0|||
16922787|NCT02587520|38064185|FG017|Overall Study|Withdrawal by Subject|0|||
16922788|NCT02587520|38064168|FG000|Overall Study|Lost to Follow-up|0|||
16922789|NCT02587520|38064169|FG001|Overall Study|Lost to Follow-up|2|||
16922790|NCT02587520|38064170|FG002|Overall Study|Lost to Follow-up|0|||
16922791|NCT02587520|38064171|FG003|Overall Study|Lost to Follow-up|2|||
16922792|NCT02587520|38064172|FG004|Overall Study|Lost to Follow-up|0|||
16922793|NCT02587520|38064173|FG005|Overall Study|Lost to Follow-up|1|||
16922794|NCT02587520|38064174|FG006|Overall Study|Lost to Follow-up|1|||
16922795|NCT02587520|38064175|FG007|Overall Study|Lost to Follow-up|1|||
16922796|NCT02587520|38064176|FG008|Overall Study|Lost to Follow-up|0|||
16922797|NCT02587520|38064177|FG009|Overall Study|Lost to Follow-up|2|||
16922798|NCT02587520|38064178|FG010|Overall Study|Lost to Follow-up|2|||
16922799|NCT02587520|38064179|FG011|Overall Study|Lost to Follow-up|1|||
16922800|NCT02587520|38064180|FG012|Overall Study|Lost to Follow-up|0|||
16922801|NCT02587520|38064181|FG013|Overall Study|Lost to Follow-up|0|||
16922802|NCT02587520|38064182|FG014|Overall Study|Lost to Follow-up|0|||
16922803|NCT02587520|38064183|FG015|Overall Study|Lost to Follow-up|0|||
16922804|NCT02587520|38064184|FG016|Overall Study|Lost to Follow-up|0|||
16922805|NCT02587520|38064185|FG017|Overall Study|Lost to Follow-up|0|||
16922806|NCT02584829|38064225|FG000|Overall Study|Physician Decision|1|||
16922807|NCT02584829|38064226|FG001|Overall Study|Physician Decision|0|||
16922808|NCT02584829|38064225|FG000|Overall Study|Withdrawal by Subject|0|||
16922809|NCT02584829|38064226|FG001|Overall Study|Withdrawal by Subject|1|||
16922810|NCT02584829|38064225|FG000|Overall Study|Progressive Disease|0|||
16922811|NCT02584829|38064226|FG001|Overall Study|Progressive Disease|3|||
16922812|NCT02570308|38064239|FG000|Overall Study|Death|1|||
16922813|NCT02570308|38064240|FG001|Overall Study|Death|5|||
16922814|NCT02570308|38064241|FG002|Overall Study|Death|4|||
16922815|NCT02570308|38064242|FG003|Overall Study|Death|4|||
16922816|NCT02570308|38064243|FG004|Overall Study|Death|69|||
16922817|NCT02570308|38064239|FG000|Overall Study|Lost to Follow-up|0|||
16922818|NCT02570308|38064240|FG001|Overall Study|Lost to Follow-up|0|||
16922819|NCT02570308|38064241|FG002|Overall Study|Lost to Follow-up|0|||
16922820|NCT02570308|38064242|FG003|Overall Study|Lost to Follow-up|0|||
16922821|NCT02570308|38064243|FG004|Overall Study|Lost to Follow-up|2|||
16922822|NCT02570308|38064239|FG000|Overall Study|Withdrawal by Subject|0|||
16922823|NCT02570308|38064240|FG001|Overall Study|Withdrawal by Subject|0|||
16922824|NCT02570308|38064241|FG002|Overall Study|Withdrawal by Subject|0|||
16922825|NCT02570308|38064242|FG003|Overall Study|Withdrawal by Subject|0|||
16922826|NCT02570308|38064243|FG004|Overall Study|Withdrawal by Subject|1|||
16922827|NCT02570308|38064239|FG000|Overall Study|Other|0|||
16922828|NCT02570308|38064240|FG001|Overall Study|Other|0|||
16922829|NCT02570308|38064241|FG002|Overall Study|Other|0|||
16922830|NCT02570308|38064242|FG003|Overall Study|Other|0|||
16922831|NCT02570308|38064243|FG004|Overall Study|Other|2|||
16922832|NCT02497612|38064265|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
16922833|NCT02497612|38064266|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
16922834|NCT02497612|38064267|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
16922835|NCT02497612|38064268|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
16922836|NCT02497612|38064265|FG000|Overall Study|Participant's request|2|||
16922837|NCT02497612|38064266|FG001|Overall Study|Participant's request|3|||
16922838|NCT02497612|38064267|FG002|Overall Study|Participant's request|4|||
16922839|NCT02497612|38064268|FG003|Overall Study|Participant's request|1|||
16922840|NCT02497612|38064265|FG000|Overall Study|Investigator's judgement|1|||
16922841|NCT02497612|38064266|FG001|Overall Study|Investigator's judgement|0|||
16922842|NCT02497612|38064267|FG002|Overall Study|Investigator's judgement|0|||
16922843|NCT02497612|38064268|FG003|Overall Study|Investigator's judgement|2|||
16922844|NCT02497612|38064265|FG000|Overall Study|Adverse Event|3|||
16922845|NCT02497612|38064266|FG001|Overall Study|Adverse Event|1|||
16922846|NCT02497612|38064267|FG002|Overall Study|Adverse Event|4|||
17017730|NCT00809133|38162303|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
17017731|NCT00809133|38162304|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
17017732|NCT00809133|38162305|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
17017733|NCT00809133|38162306|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017734|NCT00809133|38162307|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017735|NCT00809133|38162308|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017736|NCT00809133|38162309|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017737|NCT00809133|38162310|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
17017738|NCT00809133|38162311|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16922847|NCT02497612|38064268|FG003|Overall Study|Adverse Event|1|||
16922848|NCT02497612|38064265|FG000|Overall Study|Lost to Follow-up|1|||
16922849|NCT02497612|38064266|FG001|Overall Study|Lost to Follow-up|1|||
16847422|NCT00637156|37792482|FG001|Overall Study|Death|1|||
16847423|NCT00637156|37792481|FG000|Overall Study|Lost to Follow-up|10|||
16847424|NCT00637156|37792482|FG001|Overall Study|Lost to Follow-up|16|||
16847425|NCT00637000|37792490|FG000|Overall Study|Withdrawal by Subject|4|||
16847426|NCT00637000|37792491|FG001|Overall Study|Withdrawal by Subject|3|||
16847427|NCT01515189|37792499|FG000|Induction|Disease Progression|109|||
16922850|NCT02497612|38064267|FG002|Overall Study|Lost to Follow-up|0|||
16922851|NCT02497612|38064268|FG003|Overall Study|Lost to Follow-up|1|||
16922852|NCT02497612|38064265|FG000|Overall Study|Other unspecified|1|||
16922853|NCT02497612|38064266|FG001|Overall Study|Other unspecified|1|||
16922854|NCT02497612|38064267|FG002|Overall Study|Other unspecified|2|||
16922855|NCT02497612|38064268|FG003|Overall Study|Other unspecified|0|||
16922856|NCT02497612|38064265|FG000|Overall Study|Not eligible|1|||
16922857|NCT02497612|38064266|FG001|Overall Study|Not eligible|0|||
16922858|NCT02497612|38064267|FG002|Overall Study|Not eligible|0|||
16922859|NCT02497612|38064268|FG003|Overall Study|Not eligible|1|||
16922860|NCT02460458|38064278|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
16922861|NCT02460458|38064278|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
16922862|NCT02460458|38064278|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
16922863|NCT02460458|38064278|FG000|First Prospective Phase|Lost to Follow-up|16|||
16922864|NCT02460458|38064278|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
16922865|NCT02457559|38064293|FG000|Overall Study|Progressive Disease|1|||
16922866|NCT02457559|38064294|FG001|Overall Study|Progressive Disease|2|||
16922867|NCT02457559|38064295|FG002|Overall Study|Progressive Disease|3|||
16922868|NCT02457559|38064296|FG003|Overall Study|Progressive Disease|0|||
16922869|NCT02457559|38064297|FG004|Overall Study|Progressive Disease|0|||
16922870|NCT02457559|38064298|FG005|Overall Study|Progressive Disease|2|||
16922871|NCT02457559|38064299|FG006|Overall Study|Progressive Disease|1|||
16922872|NCT02457559|38064300|FG007|Overall Study|Progressive Disease|0|||
16922873|NCT02457559|38064301|FG008|Overall Study|Progressive Disease|1|||
16922874|NCT02457559|38064302|FG009|Overall Study|Progressive Disease|1|||
16922875|NCT02457559|38064303|FG010|Overall Study|Progressive Disease|1|||
16922876|NCT02457559|38064293|FG000|Overall Study|Investigator's Discretion|0|||
16922877|NCT02457559|38064294|FG001|Overall Study|Investigator's Discretion|0|||
16922878|NCT02457559|38064295|FG002|Overall Study|Investigator's Discretion|2|||
16922879|NCT02457559|38064296|FG003|Overall Study|Investigator's Discretion|0|||
16922880|NCT02457559|38064297|FG004|Overall Study|Investigator's Discretion|1|||
16922881|NCT02457559|38064298|FG005|Overall Study|Investigator's Discretion|0|||
16922882|NCT02457559|38064299|FG006|Overall Study|Investigator's Discretion|1|||
16922883|NCT02457559|38064300|FG007|Overall Study|Investigator's Discretion|0|||
16922884|NCT02457559|38064301|FG008|Overall Study|Investigator's Discretion|1|||
16922885|NCT02457559|38064302|FG009|Overall Study|Investigator's Discretion|0|||
16922886|NCT02457559|38064303|FG010|Overall Study|Investigator's Discretion|1|||
16922887|NCT02457559|38064293|FG000|Overall Study|Adverse Event|0|||
16922888|NCT02457559|38064294|FG001|Overall Study|Adverse Event|1|||
16847428|NCT01515189|37792500|FG001|Induction|Disease Progression|155|||
16847429|NCT01515189|37792499|FG000|Induction|Study drug toxicity|86|||
16847430|NCT01515189|37792500|FG001|Induction|Study drug toxicity|36|||
16847431|NCT01515189|37792499|FG000|Induction|Death|24|||
16847432|NCT01515189|37792500|FG001|Induction|Death|17|||
16847433|NCT01515189|37792499|FG000|Induction|Adverse Event|14|||
16847434|NCT01515189|37792500|FG001|Induction|Adverse Event|9|||
16847435|NCT01515189|37792499|FG000|Induction|Withdrawal by Subject|3|||
16847436|NCT01515189|37792500|FG001|Induction|Withdrawal by Subject|9|||
16847437|NCT01515189|37792499|FG000|Induction|No longer meets study criteria|0|||
16847438|NCT01515189|37792500|FG001|Induction|No longer meets study criteria|2|||
16847439|NCT01515189|37792499|FG000|Induction|Lost to Follow-up|1|||
16847440|NCT01515189|37792500|FG001|Induction|Lost to Follow-up|0|||
16847441|NCT01515189|37792499|FG000|Induction|Other|0|||
16847442|NCT01515189|37792500|FG001|Induction|Other|4|||
16847443|NCT01515189|37792499|FG000|First Re-Induction Phase|Disease progression|6|||
16847444|NCT01515189|37792500|FG001|First Re-Induction Phase|Disease progression|14|||
16847445|NCT01515189|37792499|FG000|First Re-Induction Phase|Study drug toxicity|5|||
16847446|NCT01515189|37792500|FG001|First Re-Induction Phase|Study drug toxicity|0|||
16847447|NCT01515189|37792499|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
16847448|NCT01515189|37792500|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
16847449|NCT01515189|37792499|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
16847450|NCT01515189|37792500|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
16847451|NCT01515189|37792499|FG000|First Re-Induction Phase|Other|1|||
16847452|NCT01515189|37792500|FG001|First Re-Induction Phase|Other|0|||
16922889|NCT02457559|38064295|FG002|Overall Study|Adverse Event|2|||
16922890|NCT02457559|38064296|FG003|Overall Study|Adverse Event|0|||
16922891|NCT02457559|38064297|FG004|Overall Study|Adverse Event|0|||
16922892|NCT02457559|38064298|FG005|Overall Study|Adverse Event|0|||
16847453|NCT01546623|37792508|FG000|Overall Study|Adverse Event|2|||
16847454|NCT01546623|37792509|FG001|Overall Study|Adverse Event|3|||
16847455|NCT01546623|37792508|FG000|Overall Study|Major Protocol Deviation|1|||
16847456|NCT01546623|37792509|FG001|Overall Study|Major Protocol Deviation|1|||
16847457|NCT01546623|37792508|FG000|Overall Study|High Prostate specific antigen|2|||
16847458|NCT01546623|37792509|FG001|Overall Study|High Prostate specific antigen|1|||
16847459|NCT01546623|37792508|FG000|Overall Study|Did Not Receive Study Drug|1|||
16847460|NCT01546623|37792509|FG001|Overall Study|Did Not Receive Study Drug|1|||
16847461|NCT01546155|37792515|FG000|Overall Study|could not tolerate long scan duration|3|||
16847462|NCT00636610|37792521|FG000|Overall Study|Adverse Event|4|||
16847463|NCT00636610|37792522|FG001|Overall Study|Adverse Event|4|||
16847464|NCT00636610|37792521|FG000|Overall Study|Death|6|||
16847465|NCT00636610|37792522|FG001|Overall Study|Death|3|||
16847466|NCT00636610|37792521|FG000|Overall Study|Physician decision to withdraw patient|15|||
16847467|NCT00636610|37792522|FG001|Overall Study|Physician decision to withdraw patient|9|||
16847468|NCT00636610|37792521|FG000|Overall Study|Subject decision to withdraw|15|||
16847469|NCT00636610|37792522|FG001|Overall Study|Subject decision to withdraw|11|||
16922893|NCT02457559|38064299|FG006|Overall Study|Adverse Event|0|||
16922894|NCT02457559|38064300|FG007|Overall Study|Adverse Event|0|||
16922895|NCT02457559|38064301|FG008|Overall Study|Adverse Event|0|||
16922896|NCT02457559|38064302|FG009|Overall Study|Adverse Event|0|||
16922897|NCT02457559|38064303|FG010|Overall Study|Adverse Event|0|||
16922898|NCT02457559|38064293|FG000|Overall Study|Reason not Specified|1|||
16922899|NCT02457559|38064294|FG001|Overall Study|Reason not Specified|0|||
16922900|NCT02457559|38064295|FG002|Overall Study|Reason not Specified|0|||
16922901|NCT02457559|38064296|FG003|Overall Study|Reason not Specified|0|||
16922902|NCT02457559|38064297|FG004|Overall Study|Reason not Specified|0|||
16922903|NCT02457559|38064298|FG005|Overall Study|Reason not Specified|0|||
16922904|NCT02457559|38064299|FG006|Overall Study|Reason not Specified|0|||
16922905|NCT02457559|38064300|FG007|Overall Study|Reason not Specified|0|||
16922906|NCT02457559|38064301|FG008|Overall Study|Reason not Specified|0|||
16922907|NCT02457559|38064302|FG009|Overall Study|Reason not Specified|2|||
16922908|NCT02457559|38064303|FG010|Overall Study|Reason not Specified|0|||
16922909|NCT02457559|38064293|FG000|Overall Study|Death|0|||
16922910|NCT02457559|38064294|FG001|Overall Study|Death|0|||
16847470|NCT00636610|37792521|FG000|Overall Study|Disease progression - radiographic|41|||
16922911|NCT02457559|38064295|FG002|Overall Study|Death|0|||
16922912|NCT02457559|38064296|FG003|Overall Study|Death|0|||
16922913|NCT02457559|38064297|FG004|Overall Study|Death|0|||
16922914|NCT02457559|38064298|FG005|Overall Study|Death|0|||
16922915|NCT02457559|38064299|FG006|Overall Study|Death|0|||
16922916|NCT02457559|38064300|FG007|Overall Study|Death|0|||
16922917|NCT02457559|38064301|FG008|Overall Study|Death|1|||
16922918|NCT02457559|38064302|FG009|Overall Study|Death|1|||
16922919|NCT02457559|38064303|FG010|Overall Study|Death|0|||
16922920|NCT02381652|38064353|FG000|Overall Study|Withdrawal by Subject|0|||
16922921|NCT02381652|38064354|FG001|Overall Study|Withdrawal by Subject|0|||
16922922|NCT02381652|38064355|FG002|Overall Study|Withdrawal by Subject|1|||
16922923|NCT02367794|38064364|FG000|Overall Study|Death|252|||
16922924|NCT02367794|38064365|FG001|Overall Study|Death|245|||
16922925|NCT02367794|38064366|FG002|Overall Study|Death|243|||
16922926|NCT02367794|38064364|FG000|Overall Study|Lost to Follow-up|1|||
16847471|NCT00636610|37792522|FG001|Overall Study|Disease progression - radiographic|51|||
16847472|NCT00636610|37792521|FG000|Overall Study|Disease progression - clinical|8|||
16847473|NCT00636610|37792522|FG001|Overall Study|Disease progression - clinical|3|||
16847474|NCT00636610|37792521|FG000|Overall Study|Reason for discontinuation not available|3|||
16847475|NCT00636610|37792522|FG001|Overall Study|Reason for discontinuation not available|2|||
16847476|NCT00635050|37792530|FG000|Overall Study|Withdrawal by Subject|1|||
16847477|NCT00634504|37792539|FG000|Overall Study|Protocol Violation|1|||
16847478|NCT00634504|37792540|FG001|Overall Study|Protocol Violation|0|||
16847479|NCT00634114|37792549|FG000|Overall Study|Adverse Event|6|||
16847480|NCT00634114|37792550|FG001|Overall Study|Adverse Event|8|||
16847481|NCT00634114|37792551|FG002|Overall Study|Adverse Event|3|||
16847482|NCT00634114|37792549|FG000|Overall Study|Withdrawal by Subject|9|||
16847483|NCT00634114|37792550|FG001|Overall Study|Withdrawal by Subject|6|||
16847484|NCT00634114|37792551|FG002|Overall Study|Withdrawal by Subject|11|||
16847485|NCT00634114|37792549|FG000|Overall Study|Lost to Follow-up|0|||
16847486|NCT00634114|37792550|FG001|Overall Study|Lost to Follow-up|0|||
16847487|NCT00634114|37792551|FG002|Overall Study|Lost to Follow-up|1|||
16847488|NCT00634114|37792549|FG000|Overall Study|Protocol Violation|3|||
16847489|NCT00634114|37792550|FG001|Overall Study|Protocol Violation|3|||
16922927|NCT02367794|38064365|FG001|Overall Study|Lost to Follow-up|2|||
16922928|NCT02367794|38064366|FG002|Overall Study|Lost to Follow-up|2|||
16922929|NCT02367794|38064364|FG000|Overall Study|Physician Decision|0|||
16922930|NCT02367794|38064365|FG001|Overall Study|Physician Decision|5|||
16922931|NCT02367794|38064366|FG002|Overall Study|Physician Decision|3|||
16922932|NCT02367794|38064364|FG000|Overall Study|Protocol Violation|1|||
16922933|NCT02367794|38064365|FG001|Overall Study|Protocol Violation|0|||
16922934|NCT02367794|38064366|FG002|Overall Study|Protocol Violation|1|||
16922935|NCT02367794|38064364|FG000|Overall Study|Withdrawal by Subject|25|||
16922936|NCT02367794|38064365|FG001|Overall Study|Withdrawal by Subject|12|||
16922937|NCT02367794|38064366|FG002|Overall Study|Withdrawal by Subject|20|||
16922938|NCT02367794|38064364|FG000|Overall Study|Brain metastasis|1|||
16847490|NCT00634114|37792551|FG002|Overall Study|Protocol Violation|1|||
16847491|NCT00634114|37792549|FG000|Overall Study|Pregnancy|1|||
16847492|NCT00634114|37792550|FG001|Overall Study|Pregnancy|0|||
16847493|NCT00634114|37792551|FG002|Overall Study|Pregnancy|0|||
16847494|NCT00634114|37792549|FG000|Overall Study|Incorrect enrolment|0|||
16847495|NCT00634114|37792550|FG001|Overall Study|Incorrect enrolment|1|||
16847496|NCT00634114|37792551|FG002|Overall Study|Incorrect enrolment|0|||
16847497|NCT00634114|37792549|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
16847498|NCT00634114|37792550|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
16922939|NCT02367794|38064365|FG001|Overall Study|Brain metastasis|0|||
16922940|NCT02367794|38064366|FG002|Overall Study|Brain metastasis|0|||
16922941|NCT02367794|38064364|FG000|Overall Study|Randomized in error|0|||
16922942|NCT02367794|38064365|FG001|Overall Study|Randomized in error|0|||
16922943|NCT02367794|38064366|FG002|Overall Study|Randomized in error|1|||
16922944|NCT02367794|38064364|FG000|Overall Study|Patient unable to receive carboplatin|0|||
16922945|NCT02367794|38064365|FG001|Overall Study|Patient unable to receive carboplatin|0|||
16922946|NCT02367794|38064366|FG002|Overall Study|Patient unable to receive carboplatin|1|||
16922947|NCT02367794|38064364|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
16922948|NCT02367794|38064365|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
16922949|NCT02367794|38064366|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
16922950|NCT02367794|38064364|FG000|Overall Study|Adverse Event|0|||
16922951|NCT02367794|38064365|FG001|Overall Study|Adverse Event|0|||
16922952|NCT02367794|38064366|FG002|Overall Study|Adverse Event|2|||
16922953|NCT02367794|38064364|FG000|Overall Study|Study Terminated By Sponsor|0|||
16922954|NCT02367794|38064365|FG001|Overall Study|Study Terminated By Sponsor|1|||
16847499|NCT00634114|37792551|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
16847500|NCT00634114|37792549|FG000|Overall Study|Difficult to continue|3|||
16847501|NCT00634114|37792550|FG001|Overall Study|Difficult to continue|1|||
16847502|NCT00634114|37792551|FG002|Overall Study|Difficult to continue|1|||
16847503|NCT00634114|37792549|FG000|Overall Study|Other reason|1|||
16847504|NCT00634114|37792550|FG001|Overall Study|Other reason|1|||
16847505|NCT00634114|37792551|FG002|Overall Study|Other reason|1|||
16847506|NCT00634036|37792561|FG000|Overall Study|Lost to Follow-up|1|||
16847507|NCT00634036|37792562|FG001|Overall Study|Lost to Follow-up|1|||
16847508|NCT00634036|37792561|FG000|Overall Study|Withdrawal by Subject|1|||
16847509|NCT00634036|37792562|FG001|Overall Study|Withdrawal by Subject|1|||
16847510|NCT01545375|37792570|FG000|Overall Study|Adverse Event|2|||
16847511|NCT01545375|37792571|FG001|Overall Study|Adverse Event|1|||
16847512|NCT01545375|37792570|FG000|Overall Study|Lost to Follow-up|34|||
16847513|NCT01545375|37792571|FG001|Overall Study|Lost to Follow-up|31|||
16847514|NCT01545375|37792570|FG000|Overall Study|Protocol Violation|3|||
16847515|NCT01545375|37792571|FG001|Overall Study|Protocol Violation|3|||
16847516|NCT01545375|37792570|FG000|Overall Study|Withdrawal by Subject|58|||
16847517|NCT01545375|37792571|FG001|Overall Study|Withdrawal by Subject|55|||
16847518|NCT01539837|37792580|FG000|Overall Study|reduce neutrophil level|0|||
16847519|NCT01539837|37792581|FG001|Overall Study|reduce neutrophil level|1|||
16847520|NCT01539837|37792582|FG002|Overall Study|reduce neutrophil level|1|||
16847521|NCT01539837|37792580|FG000|Overall Study|bad compliance|0|||
16847522|NCT01539837|37792581|FG001|Overall Study|bad compliance|0|||
16847523|NCT01539837|37792582|FG002|Overall Study|bad compliance|1|||
16847524|NCT01539759|37792592|FG000|Overall Study|Lost to Follow-up|6|||
16847525|NCT01539759|37792593|FG001|Overall Study|Lost to Follow-up|8|||
16847526|NCT00633022|37792602|FG000|Overall Study|Adverse Event|1|||
16847527|NCT00633022|37792603|FG001|Overall Study|Adverse Event|0|||
16847528|NCT00633022|37792604|FG002|Overall Study|Adverse Event|5|||
16847529|NCT00633022|37792602|FG000|Overall Study|Physician Decision|0|||
16847530|NCT00633022|37792603|FG001|Overall Study|Physician Decision|1|||
16922955|NCT02367794|38064366|FG002|Overall Study|Study Terminated By Sponsor|1|||
16922956|NCT02367794|38064364|FG000|Overall Study|Moved to Roll-Over Study|0|||
16922957|NCT02367794|38064365|FG001|Overall Study|Moved to Roll-Over Study|15|||
16847531|NCT00633022|37792604|FG002|Overall Study|Physician Decision|0|||
16847532|NCT00630994|37792612|FG000|Overall Study|Adverse Event|1|||
16847533|NCT00630994|37792612|FG000|Overall Study|Disease Progression|1|||
16847534|NCT00630994|37792612|FG000|Overall Study|Lack of Efficacy|1|||
16847535|NCT00630994|37792612|FG000|Overall Study|Other|1|||
16847536|NCT00630838|37792618|FG000|Overall Study|Death|0|||
16847537|NCT00630838|37792619|FG001|Overall Study|Death|1|||
16847538|NCT00630838|37792618|FG000|Overall Study|Lost to Follow-up|0|||
16847539|NCT00630838|37792619|FG001|Overall Study|Lost to Follow-up|1|||
16847540|NCT00630058|37792629|FG000|Overall Study|Adverse Event|1|||
16847541|NCT00630058|37792630|FG001|Overall Study|Adverse Event|1|||
16922958|NCT02367794|38064366|FG002|Overall Study|Moved to Roll-Over Study|13|||
16922959|NCT02367794|38064364|FG000|Overall Study|Sponsor Request|60|||
16922960|NCT02367794|38064365|FG001|Overall Study|Sponsor Request|57|||
16922961|NCT02367794|38064366|FG002|Overall Study|Sponsor Request|45|||
16922962|NCT02367794|38064364|FG000|Overall Study|Moved into PTAP Study|0|||
16922963|NCT02367794|38064365|FG001|Overall Study|Moved into PTAP Study|2|||
16922964|NCT02367794|38064366|FG002|Overall Study|Moved into PTAP Study|3|||
16922965|NCT02367794|38064364|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
16922966|NCT02367794|38064365|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
16922967|NCT02367794|38064366|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
16922968|NCT02367794|38064364|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
16922969|NCT02367794|38064365|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
16922970|NCT02367794|38064366|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
16922971|NCT02367794|38064364|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
16922972|NCT02367794|38064365|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
16922973|NCT02367794|38064366|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
16922974|NCT02367794|38064364|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
16922975|NCT02367794|38064365|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
16922976|NCT02367794|38064366|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
16922977|NCT02353832|38064399|FG000|Overall Study|Ineligible after enrollment|1|||
16922978|NCT02353832|38064399|FG000|Overall Study|Lost to Follow-up|1|||
16922979|NCT02353728|38064403|FG000|Overall Study|Subject non-compliance|1|||
16922980|NCT02345070|38064410|FG000|Overall Study|Adverse Event|12|||
16922981|NCT02345070|38064411|FG001|Overall Study|Adverse Event|8|||
16922982|NCT02345070|38064412|FG002|Overall Study|Adverse Event|16|||
16922983|NCT02345070|38064410|FG000|Overall Study|Poor compliance to protocol|2|||
16922984|NCT02345070|38064411|FG001|Overall Study|Poor compliance to protocol|0|||
16922985|NCT02345070|38064412|FG002|Overall Study|Poor compliance to protocol|0|||
16922986|NCT02345070|38064410|FG000|Overall Study|Other than specified above|6|||
16922987|NCT02345070|38064411|FG001|Overall Study|Other than specified above|3|||
16922988|NCT02345070|38064412|FG002|Overall Study|Other than specified above|7|||
16922989|NCT02325466|38064420|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
16922990|NCT02325466|38064421|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
16922991|NCT02325466|38064422|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
16922992|NCT02325466|38064420|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
16922993|NCT02325466|38064421|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
16847542|NCT00630058|37792629|FG000|Overall Study|Withdrawal by Subject|0|||
16847543|NCT00630058|37792630|FG001|Overall Study|Withdrawal by Subject|1|||
16847544|NCT00630058|37792629|FG000|Overall Study|stopping criteria|3|||
16847545|NCT00630058|37792630|FG001|Overall Study|stopping criteria|2|||
16847546|NCT01925794|37792636|FG000|180 Days|Death|2|||
16847547|NCT01925794|37792636|FG000|180 Days|Withdrawal by Subject|2|||
16847548|NCT01925794|37792636|FG000|270 Days|Death|2|||
16847549|NCT01925794|37792636|FG000|270 Days|Protocol Violation|3|||
16847550|NCT00989950|37792648|FG000|Randomized Phase|Protocol Violation|1|||
16847551|NCT00989950|37792649|FG001|Randomized Phase|Protocol Violation|0|||
16922994|NCT02325466|38064422|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
16922995|NCT02325466|38064420|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
16922996|NCT02325466|38064421|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
16922997|NCT02325466|38064422|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
16922998|NCT02325466|38064420|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
16922999|NCT02325466|38064421|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
16923000|NCT02325466|38064422|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
16923001|NCT02325466|38064420|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
16923002|NCT02325466|38064421|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
17017739|NCT00809133|38162298|FG000|Overall Study|Other adverse event|1|||
17017740|NCT00809133|38162299|FG001|Overall Study|Other adverse event|1|||
17017741|NCT00809133|38162300|FG002|Overall Study|Other adverse event|1|||
17017742|NCT00809133|38162301|FG003|Overall Study|Other adverse event|0|||
17017743|NCT00809133|38162302|FG004|Overall Study|Other adverse event|0|||
17017744|NCT00809133|38162303|FG005|Overall Study|Other adverse event|3|||
17017745|NCT00809133|38162304|FG006|Overall Study|Other adverse event|2|||
17017746|NCT00809133|38162305|FG007|Overall Study|Other adverse event|4|||
17017747|NCT00809133|38162306|FG008|Overall Study|Other adverse event|0|||
17017748|NCT00809133|38162307|FG009|Overall Study|Other adverse event|0|||
16847552|NCT00989950|37792650|FG002|Randomized Phase|Protocol Violation|0|||
16847553|NCT00989950|37792651|FG003|Randomized Phase|Protocol Violation|0|||
16847554|NCT00989950|37792648|FG000|Randomized Phase|Adverse Event|0|||
16847555|NCT00989950|37792649|FG001|Randomized Phase|Adverse Event|1|||
16847556|NCT00989950|37792650|FG002|Randomized Phase|Adverse Event|0|||
16847557|NCT00989950|37792651|FG003|Randomized Phase|Adverse Event|0|||
17017749|NCT00809133|38162308|FG010|Overall Study|Other adverse event|1|||
17017750|NCT00809133|38162309|FG011|Overall Study|Other adverse event|1|||
16847558|NCT01905943|37792661|FG000|Overall Study|Withdrawal of consent|90|||
16923003|NCT02325466|38064422|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
16923004|NCT02325466|38064420|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
16923005|NCT02325466|38064421|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
16923006|NCT02325466|38064422|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
16923007|NCT02325466|38064420|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
16923008|NCT02325466|38064421|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
16923009|NCT02325466|38064422|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
16923010|NCT02325466|38064420|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
16923011|NCT02325466|38064421|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
16847559|NCT01905943|37792661|FG000|Overall Study|Lost to Follow-up|16|||
16847560|NCT01905943|37792661|FG000|Overall Study|Investigator discretion|7|||
16847561|NCT01905943|37792661|FG000|Overall Study|Death|186|||
16847562|NCT01905943|37792661|FG000|Overall Study|Adverse Event|3|||
16847563|NCT01905943|37792661|FG000|Overall Study|Other|12|||
16847564|NCT01905553|37792682|FG000|Period 2|Adverse Event|1|||
16847565|NCT01905553|37792683|FG001|Period 2|Adverse Event|0|||
16847566|NCT01929031|37792693|FG000|Overall Study|Adverse Event|3|||
16847567|NCT01929031|37792694|FG001|Overall Study|Adverse Event|1|||
16923012|NCT02325466|38064422|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
16923013|NCT02325466|38064420|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
17017751|NCT00809133|38162310|FG012|Overall Study|Other adverse event|0|||
17017752|NCT00809133|38162311|FG013|Overall Study|Other adverse event|1|||
17017753|NCT00809133|38162298|FG000|Overall Study|Lost to Follow-up|0|||
17017754|NCT00809133|38162299|FG001|Overall Study|Lost to Follow-up|0|||
17017755|NCT00809133|38162300|FG002|Overall Study|Lost to Follow-up|0|||
17017756|NCT00809133|38162301|FG003|Overall Study|Lost to Follow-up|0|||
17017757|NCT00809133|38162302|FG004|Overall Study|Lost to Follow-up|0|||
17017758|NCT00809133|38162303|FG005|Overall Study|Lost to Follow-up|1|||
17017759|NCT00809133|38162304|FG006|Overall Study|Lost to Follow-up|0|||
17017760|NCT00809133|38162305|FG007|Overall Study|Lost to Follow-up|0|||
17017761|NCT00809133|38162306|FG008|Overall Study|Lost to Follow-up|0|||
17017762|NCT00809133|38162307|FG009|Overall Study|Lost to Follow-up|0|||
17017763|NCT00809133|38162308|FG010|Overall Study|Lost to Follow-up|0|||
17017764|NCT00809133|38162309|FG011|Overall Study|Lost to Follow-up|0|||
17017765|NCT00809133|38162310|FG012|Overall Study|Lost to Follow-up|0|||
17017766|NCT00809133|38162311|FG013|Overall Study|Lost to Follow-up|0|||
17017767|NCT00809133|38162298|FG000|Overall Study|Consent withdrawn|0|||
17017768|NCT00809133|38162299|FG001|Overall Study|Consent withdrawn|0|||
17017769|NCT00809133|38162300|FG002|Overall Study|Consent withdrawn|0|||
17017770|NCT00809133|38162301|FG003|Overall Study|Consent withdrawn|0|||
17017771|NCT00809133|38162302|FG004|Overall Study|Consent withdrawn|1|||
17017772|NCT00809133|38162303|FG005|Overall Study|Consent withdrawn|0|||
17017773|NCT00809133|38162304|FG006|Overall Study|Consent withdrawn|0|||
17017774|NCT00809133|38162305|FG007|Overall Study|Consent withdrawn|0|||
17017775|NCT00809133|38162306|FG008|Overall Study|Consent withdrawn|0|||
17017776|NCT00809133|38162307|FG009|Overall Study|Consent withdrawn|0|||
17017777|NCT00809133|38162308|FG010|Overall Study|Consent withdrawn|0|||
17017778|NCT00809133|38162309|FG011|Overall Study|Consent withdrawn|0|||
17017779|NCT00809133|38162310|FG012|Overall Study|Consent withdrawn|0|||
17017780|NCT00809133|38162311|FG013|Overall Study|Consent withdrawn|0|||
17017781|NCT00809133|38162298|FG000|Overall Study|Other not mentioned above|0|||
17017782|NCT00809133|38162299|FG001|Overall Study|Other not mentioned above|1|||
17017783|NCT00809133|38162300|FG002|Overall Study|Other not mentioned above|0|||
17017784|NCT00809133|38162301|FG003|Overall Study|Other not mentioned above|0|||
17017785|NCT00809133|38162302|FG004|Overall Study|Other not mentioned above|0|||
17017786|NCT00809133|38162303|FG005|Overall Study|Other not mentioned above|1|||
17017787|NCT00809133|38162304|FG006|Overall Study|Other not mentioned above|0|||
17017788|NCT00809133|38162305|FG007|Overall Study|Other not mentioned above|0|||
17017789|NCT00809133|38162306|FG008|Overall Study|Other not mentioned above|0|||
17017790|NCT00809133|38162307|FG009|Overall Study|Other not mentioned above|0|||
17017791|NCT00809133|38162308|FG010|Overall Study|Other not mentioned above|0|||
17017792|NCT00809133|38162309|FG011|Overall Study|Other not mentioned above|0|||
17017793|NCT00809133|38162310|FG012|Overall Study|Other not mentioned above|0|||
17017794|NCT00809133|38162311|FG013|Overall Study|Other not mentioned above|0|||
17017795|NCT00882557|38162356|FG000|Overall Study|Withdrawal by Subject|1|||
17017796|NCT00882557|38162357|FG001|Overall Study|Withdrawal by Subject|0|||
17017797|NCT00882557|38162356|FG000|Overall Study|Trouble with Vein Access|1|||
17017798|NCT00882557|38162357|FG001|Overall Study|Trouble with Vein Access|0|||
17017799|NCT00882557|38162356|FG000|Overall Study|Randomized Not Treated|0|||
17017800|NCT00882557|38162357|FG001|Overall Study|Randomized Not Treated|1|||
17017801|NCT00808899|38162363|FG000|Overall Study|Death|1|||
17017802|NCT00808899|38162363|FG000|Overall Study|Physician Decision|3|||
17017803|NCT00808665|38162369|FG000|Overall Study|Withdrawal by Subject|1|||
16847568|NCT01929031|37792695|FG002|Overall Study|Adverse Event|1|||
16847569|NCT01929031|37792696|FG003|Overall Study|Adverse Event|0|||
16847570|NCT01929031|37792697|FG004|Overall Study|Adverse Event|0|||
17017804|NCT00808665|38162370|FG001|Overall Study|Withdrawal by Subject|0|||
16847571|NCT01929031|37792698|FG005|Overall Study|Adverse Event|0|||
16847572|NCT01929031|37792693|FG000|Overall Study|Protocol Violation|1|||
16847573|NCT01929031|37792694|FG001|Overall Study|Protocol Violation|0|||
16847574|NCT01929031|37792695|FG002|Overall Study|Protocol Violation|0|||
16847575|NCT01929031|37792696|FG003|Overall Study|Protocol Violation|0|||
16847576|NCT01929031|37792697|FG004|Overall Study|Protocol Violation|0|||
16847577|NCT01929031|37792698|FG005|Overall Study|Protocol Violation|1|||
16847578|NCT01929031|37792693|FG000|Overall Study|Reason other than specified above|0|||
16847579|NCT01929031|37792694|FG001|Overall Study|Reason other than specified above|1|||
16847580|NCT01929031|37792695|FG002|Overall Study|Reason other than specified above|0|||
16847581|NCT01929031|37792696|FG003|Overall Study|Reason other than specified above|0|||
16847582|NCT01929031|37792697|FG004|Overall Study|Reason other than specified above|1|||
16847583|NCT01929031|37792698|FG005|Overall Study|Reason other than specified above|0|||
16847584|NCT00989092|37792710|FG000|Overall Study|Physician Decision|9|||
16847585|NCT00989092|37792711|FG001|Overall Study|Physician Decision|6|||
16847586|NCT00989092|37792710|FG000|Overall Study|Adverse Event|20|||
16847587|NCT00989092|37792711|FG001|Overall Study|Adverse Event|1|||
16847588|NCT00989092|37792710|FG000|Overall Study|Chemotherapy initiated|12|||
16847589|NCT00989092|37792711|FG001|Overall Study|Chemotherapy initiated|4|||
16847590|NCT00989092|37792710|FG000|Overall Study|Withdrawal by Subject|17|||
16847591|NCT00989092|37792711|FG001|Overall Study|Withdrawal by Subject|9|||
16847592|NCT00989092|37792710|FG000|Overall Study|Death|14|||
16847593|NCT00989092|37792711|FG001|Overall Study|Death|2|||
16847594|NCT00989092|37792710|FG000|Overall Study|Ineligibility determined|3|||
16847595|NCT00989092|37792711|FG001|Overall Study|Ineligibility determined|3|||
16847596|NCT00989092|37792710|FG000|Overall Study|Lost to Follow-up|6|||
16847597|NCT00989092|37792711|FG001|Overall Study|Lost to Follow-up|2|||
16847598|NCT00989092|37792710|FG000|Overall Study|Other|3|||
16847599|NCT00989092|37792711|FG001|Overall Study|Other|1|||
16847600|NCT00989092|37792710|FG000|Overall Study|Protocol deviation|2|||
16847601|NCT00989092|37792711|FG001|Overall Study|Protocol deviation|0|||
16847602|NCT00989092|37792710|FG000|Overall Study|Erythropoietin therapy initiated|2|||
16847603|NCT00989092|37792711|FG001|Overall Study|Erythropoietin therapy initiated|0|||
16847604|NCT00989092|37792710|FG000|Overall Study|Did not receive study drug|2|||
16847605|NCT00989092|37792711|FG001|Overall Study|Did not receive study drug|0|||
16847606|NCT00988858|37792718|FG000|Overall Study|Adverse Event|7|||
16847607|NCT00988858|37792718|FG000|Overall Study|Death|1|||
16847608|NCT00988858|37792718|FG000|Overall Study|Physician Decision|1|||
16847609|NCT00988858|37792718|FG000|Overall Study|Sponsor Decision|1|||
16847610|NCT00986986|37792724|FG000|Overall Study|Lost to Follow-up|0|||
16847611|NCT00986986|37792725|FG001|Overall Study|Lost to Follow-up|1|||
16847612|NCT01904773|37792732|FG000|Screen|Screen failure|3|||
16847613|NCT01904773|37792733|FG001|Screen|Screen failure|0|||
16847614|NCT01904773|37792734|FG002|Screen|Screen failure|0|||
16847615|NCT01904773|37792735|FG003|Screen|Screen failure|0|||
16847616|NCT01904773|37792736|FG004|Screen|Screen failure|0|||
16923014|NCT02325466|38064421|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
16923015|NCT02325466|38064422|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
16923016|NCT02322710|38064433|FG000|Overall Study|No efficacy assessment post-baseline|0|||
16923017|NCT02322710|38064434|FG001|Overall Study|No efficacy assessment post-baseline|1|||
16847617|NCT01904773|37792737|FG005|Screen|Screen failure|0|||
16847618|NCT01904773|37792738|FG006|Screen|Screen failure|0|||
16847619|NCT01904773|37792739|FG007|Screen|Screen failure|0|||
16847620|NCT01904773|37792740|FG008|Screen|Screen failure|0|||
16923018|NCT02322710|38064433|FG000|Overall Study|Protocol Violation|20|||
16923019|NCT02322710|38064434|FG001|Overall Study|Protocol Violation|25|||
16923020|NCT02234310|38064477|FG000|Overall Study|Physician Decision|1|||
16923021|NCT02234310|38064477|FG000|Overall Study|Adverse Event|1|||
16923022|NCT02234310|38064477|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
16923023|NCT02234310|38064477|FG000|Overall Study|Withdrawal by Subject|2|||
16923024|NCT02106195|38064510|FG000|Overall Study|Adverse Event|2|||
16923025|NCT02106195|38064510|FG000|Overall Study|Protocol Violation|1|||
16923026|NCT02104180|38064522|FG000|Overall Study|Protocol Violation|1|||
16923027|NCT02104180|38064523|FG001|Overall Study|Protocol Violation|0|||
16923028|NCT02040857|38064533|FG000|Overall Study|Adverse Event|14|||
16923029|NCT02040857|38064533|FG000|Overall Study|Physician Decision|5|||
16923030|NCT02040857|38064533|FG000|Overall Study|Withdrawal by Subject|31|||
16923031|NCT02040857|38064533|FG000|Overall Study|patient non-compliance|3|||
16847621|NCT01904773|37792732|FG000|Screen|Withdrawal by Subject|1|||
16847622|NCT01904773|37792733|FG001|Screen|Withdrawal by Subject|0|||
16847623|NCT01904773|37792734|FG002|Screen|Withdrawal by Subject|0|||
16847624|NCT01904773|37792735|FG003|Screen|Withdrawal by Subject|0|||
16847625|NCT01904773|37792736|FG004|Screen|Withdrawal by Subject|0|||
16847626|NCT01904773|37792737|FG005|Screen|Withdrawal by Subject|0|||
16847627|NCT01904773|37792738|FG006|Screen|Withdrawal by Subject|0|||
16847628|NCT01904773|37792739|FG007|Screen|Withdrawal by Subject|0|||
16923032|NCT02040857|38064533|FG000|Overall Study|Lost to Follow-up|2|||
16923033|NCT02040857|38064533|FG000|Overall Study|recurrence|4|||
16923034|NCT02040857|38064533|FG000|Overall Study|ineligible|1|||
16847629|NCT01904773|37792740|FG008|Screen|Withdrawal by Subject|0|||
16847630|NCT01904773|37792732|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
16847631|NCT01904773|37792733|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16923035|NCT01943825|38064553|FG000|Overall Study|Lost to Follow-up|9|||
16923036|NCT01943825|38064554|FG001|Overall Study|Lost to Follow-up|3|||
16923037|NCT01943825|38064555|FG002|Overall Study|Lost to Follow-up|12|||
16923038|NCT01943825|38064556|FG003|Overall Study|Lost to Follow-up|8|||
16923039|NCT01943825|38064553|FG000|Overall Study|Withdrawal by Subject|1|||
16923040|NCT01943825|38064554|FG001|Overall Study|Withdrawal by Subject|0|||
17017805|NCT00808665|38162369|FG000|Overall Study|only required minimally invasive surgery|1|||
17017806|NCT00808665|38162370|FG001|Overall Study|only required minimally invasive surgery|0|||
17017807|NCT00808665|38162369|FG000|Overall Study|surgery cancelled|1|||
17017808|NCT00808665|38162370|FG001|Overall Study|surgery cancelled|0|||
17017809|NCT00808665|38162369|FG000|Overall Study|required an additional procedure|0|||
17017810|NCT00808665|38162370|FG001|Overall Study|required an additional procedure|1|||
17017811|NCT00808665|38162369|FG000|Overall Study|Physician Decision|3|||
17017812|NCT00808665|38162370|FG001|Overall Study|Physician Decision|1|||
17017813|NCT00808665|38162369|FG000|Overall Study|Medication stopped by resident|0|||
17017814|NCT00808665|38162370|FG001|Overall Study|Medication stopped by resident|1|||
17017815|NCT00808509|38162378|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
17017816|NCT00808509|38162379|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
17017817|NCT00808509|38162378|FG000|Randomized Phase|Reduced methotrexate dose|1|||
17017818|NCT00808509|38162379|FG001|Randomized Phase|Reduced methotrexate dose|2|||
17017819|NCT00808509|38162378|FG000|Randomized Phase|Patient refused rescue therapy|0|||
17017820|NCT00808509|38162379|FG001|Randomized Phase|Patient refused rescue therapy|3|||
17017821|NCT00807885|38162396|FG000|Overall Study|Lost to Follow-up|0|||
17017822|NCT00807885|38162397|FG001|Overall Study|Lost to Follow-up|0|||
17017823|NCT00807885|38162398|FG002|Overall Study|Lost to Follow-up|0|||
17017824|NCT00807885|38162399|FG003|Overall Study|Lost to Follow-up|0|||
17017825|NCT00807885|38162400|FG004|Overall Study|Lost to Follow-up|0|||
17017826|NCT00807885|38162401|FG005|Overall Study|Lost to Follow-up|1|||
17017827|NCT00807885|38162402|FG006|Overall Study|Lost to Follow-up|0|||
17017828|NCT00807885|38162403|FG007|Overall Study|Lost to Follow-up|0|||
17017829|NCT00807885|38162404|FG008|Overall Study|Lost to Follow-up|0|||
16847632|NCT01904773|37792734|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16847633|NCT01904773|37792735|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16847634|NCT01904773|37792736|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16847635|NCT01904773|37792737|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16847636|NCT01904773|37792738|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16847637|NCT01904773|37792739|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16847638|NCT01904773|37792740|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16847639|NCT01904773|37792732|FG000|First Intervention|Adverse Event|0|||
16847640|NCT01904773|37792733|FG001|First Intervention|Adverse Event|0|||
16847641|NCT01904773|37792734|FG002|First Intervention|Adverse Event|0|||
16847642|NCT01904773|37792735|FG003|First Intervention|Adverse Event|0|||
16847643|NCT01904773|37792736|FG004|First Intervention|Adverse Event|0|||
16847644|NCT01904773|37792737|FG005|First Intervention|Adverse Event|0|||
16847645|NCT01904773|37792738|FG006|First Intervention|Adverse Event|1|||
16847646|NCT01904773|37792739|FG007|First Intervention|Adverse Event|0|||
16847647|NCT01904773|37792740|FG008|First Intervention|Adverse Event|0|||
16847648|NCT01904773|37792732|FG000|Placebo Washout First Intervention|Condition worsened|0|||
16847649|NCT01904773|37792733|FG001|Placebo Washout First Intervention|Condition worsened|1|||
16847650|NCT01904773|37792734|FG002|Placebo Washout First Intervention|Condition worsened|0|||
16847651|NCT01904773|37792735|FG003|Placebo Washout First Intervention|Condition worsened|0|||
16847652|NCT01904773|37792736|FG004|Placebo Washout First Intervention|Condition worsened|0|||
16847653|NCT01904773|37792737|FG005|Placebo Washout First Intervention|Condition worsened|0|||
16847654|NCT01904773|37792738|FG006|Placebo Washout First Intervention|Condition worsened|0|||
16847655|NCT01904773|37792739|FG007|Placebo Washout First Intervention|Condition worsened|0|||
16923041|NCT01943825|38064555|FG002|Overall Study|Withdrawal by Subject|3|||
16923042|NCT01943825|38064556|FG003|Overall Study|Withdrawal by Subject|2|||
16923043|NCT01943825|38064553|FG000|Overall Study|Other than specified above|0|||
16923044|NCT01943825|38064554|FG001|Overall Study|Other than specified above|1|||
16923045|NCT01943825|38064555|FG002|Overall Study|Other than specified above|0|||
16923046|NCT01943825|38064556|FG003|Overall Study|Other than specified above|1|||
16923047|NCT01817751|38064585|FG000|Overall Study|Physician Decision|1|||
16923048|NCT01722331|38064592|FG000|Part 1|Adverse Event|5|||
16923049|NCT01722331|38064593|FG001|Part 1|Adverse Event|0|||
16923050|NCT01722331|38064594|FG002|Part 1|Adverse Event|0|||
16923051|NCT01722331|38064595|FG003|Part 1|Adverse Event|0|||
16923052|NCT01722331|38064596|FG004|Part 1|Adverse Event|0|||
16923053|NCT01722331|38064597|FG005|Part 1|Adverse Event|0|||
16923054|NCT01722331|38064598|FG006|Part 1|Adverse Event|0|||
16923055|NCT01722331|38064592|FG000|Part 1|Lack of Efficacy|0|||
16923056|NCT01722331|38064593|FG001|Part 1|Lack of Efficacy|0|||
16923057|NCT01722331|38064594|FG002|Part 1|Lack of Efficacy|1|||
16923058|NCT01722331|38064595|FG003|Part 1|Lack of Efficacy|0|||
16923059|NCT01722331|38064596|FG004|Part 1|Lack of Efficacy|2|||
16923060|NCT01722331|38064597|FG005|Part 1|Lack of Efficacy|0|||
16923061|NCT01722331|38064598|FG006|Part 1|Lack of Efficacy|0|||
16923062|NCT01722331|38064592|FG000|Part 1|Lost to Follow-up|1|||
16923063|NCT01722331|38064593|FG001|Part 1|Lost to Follow-up|0|||
16923064|NCT01722331|38064594|FG002|Part 1|Lost to Follow-up|2|||
16923065|NCT01722331|38064595|FG003|Part 1|Lost to Follow-up|0|||
16923066|NCT01722331|38064596|FG004|Part 1|Lost to Follow-up|1|||
16923067|NCT01722331|38064597|FG005|Part 1|Lost to Follow-up|0|||
16923068|NCT01722331|38064598|FG006|Part 1|Lost to Follow-up|0|||
16923069|NCT01722331|38064592|FG000|Part 1|Physician Decision|0|||
16923070|NCT01722331|38064593|FG001|Part 1|Physician Decision|0|||
16923071|NCT01722331|38064594|FG002|Part 1|Physician Decision|3|||
16847656|NCT01904773|37792740|FG008|Placebo Washout First Intervention|Condition worsened|0|||
16847657|NCT01904773|37792732|FG000|Fifth Intervention|Adverse Event|0|||
16847658|NCT01904773|37792733|FG001|Fifth Intervention|Adverse Event|0|||
16847659|NCT01904773|37792734|FG002|Fifth Intervention|Adverse Event|0|||
16847660|NCT01904773|37792735|FG003|Fifth Intervention|Adverse Event|0|||
16847661|NCT01904773|37792736|FG004|Fifth Intervention|Adverse Event|0|||
16923072|NCT01722331|38064595|FG003|Part 1|Physician Decision|0|||
16923073|NCT01722331|38064596|FG004|Part 1|Physician Decision|1|||
16923074|NCT01722331|38064597|FG005|Part 1|Physician Decision|0|||
16923075|NCT01722331|38064598|FG006|Part 1|Physician Decision|0|||
16923076|NCT01722331|38064592|FG000|Part 1|Pregnancy|1|||
16923077|NCT01722331|38064593|FG001|Part 1|Pregnancy|0|||
16923078|NCT01722331|38064594|FG002|Part 1|Pregnancy|0|||
16923079|NCT01722331|38064595|FG003|Part 1|Pregnancy|0|||
16923080|NCT01722331|38064596|FG004|Part 1|Pregnancy|0|||
16923081|NCT01722331|38064597|FG005|Part 1|Pregnancy|0|||
16923082|NCT01722331|38064598|FG006|Part 1|Pregnancy|0|||
16923083|NCT01722331|38064592|FG000|Part 1|Progressive Disease|0|||
16923084|NCT01722331|38064593|FG001|Part 1|Progressive Disease|0|||
16847662|NCT01904773|37792737|FG005|Fifth Intervention|Adverse Event|0|||
16923085|NCT01722331|38064594|FG002|Part 1|Progressive Disease|0|||
16923086|NCT01722331|38064595|FG003|Part 1|Progressive Disease|0|||
16923087|NCT01722331|38064596|FG004|Part 1|Progressive Disease|1|||
16923088|NCT01722331|38064597|FG005|Part 1|Progressive Disease|0|||
16923089|NCT01722331|38064598|FG006|Part 1|Progressive Disease|0|||
16923090|NCT01722331|38064592|FG000|Part 1|Protocol Violation|1|||
16923091|NCT01722331|38064593|FG001|Part 1|Protocol Violation|0|||
16923092|NCT01722331|38064594|FG002|Part 1|Protocol Violation|0|||
16923093|NCT01722331|38064595|FG003|Part 1|Protocol Violation|0|||
16923094|NCT01722331|38064596|FG004|Part 1|Protocol Violation|1|||
16923095|NCT01722331|38064597|FG005|Part 1|Protocol Violation|0|||
16923096|NCT01722331|38064598|FG006|Part 1|Protocol Violation|0|||
16923097|NCT01722331|38064592|FG000|Part 1|Withdrawal by Subject|2|||
16923098|NCT01722331|38064593|FG001|Part 1|Withdrawal by Subject|0|||
16923099|NCT01722331|38064594|FG002|Part 1|Withdrawal by Subject|3|||
16923100|NCT01722331|38064595|FG003|Part 1|Withdrawal by Subject|0|||
16923101|NCT01722331|38064596|FG004|Part 1|Withdrawal by Subject|3|||
16923102|NCT01722331|38064597|FG005|Part 1|Withdrawal by Subject|0|||
16923103|NCT01722331|38064598|FG006|Part 1|Withdrawal by Subject|0|||
16923104|NCT01722331|38064592|FG000|Part 2|Adverse Event|3|||
16923105|NCT01722331|38064593|FG001|Part 2|Adverse Event|0|||
16923106|NCT01722331|38064594|FG002|Part 2|Adverse Event|0|||
16923107|NCT01722331|38064595|FG003|Part 2|Adverse Event|0|||
16923108|NCT01722331|38064596|FG004|Part 2|Adverse Event|0|||
16923109|NCT01722331|38064597|FG005|Part 2|Adverse Event|1|||
16923110|NCT01722331|38064598|FG006|Part 2|Adverse Event|0|||
16923111|NCT01722331|38064592|FG000|Part 2|Lack of Efficacy|3|||
16923112|NCT01722331|38064593|FG001|Part 2|Lack of Efficacy|0|||
16923113|NCT01722331|38064594|FG002|Part 2|Lack of Efficacy|11|||
16923114|NCT01722331|38064595|FG003|Part 2|Lack of Efficacy|0|||
16923115|NCT01722331|38064596|FG004|Part 2|Lack of Efficacy|0|||
16923116|NCT01722331|38064597|FG005|Part 2|Lack of Efficacy|3|||
16923117|NCT01722331|38064598|FG006|Part 2|Lack of Efficacy|3|||
16923118|NCT01722331|38064592|FG000|Part 2|Lost to Follow-up|0|||
16923119|NCT01722331|38064593|FG001|Part 2|Lost to Follow-up|0|||
16923120|NCT01722331|38064594|FG002|Part 2|Lost to Follow-up|3|||
16923121|NCT01722331|38064595|FG003|Part 2|Lost to Follow-up|0|||
16923122|NCT01722331|38064596|FG004|Part 2|Lost to Follow-up|0|||
16923123|NCT01722331|38064597|FG005|Part 2|Lost to Follow-up|1|||
16923124|NCT01722331|38064598|FG006|Part 2|Lost to Follow-up|1|||
16847663|NCT01904773|37792738|FG006|Fifth Intervention|Adverse Event|0|||
16847664|NCT01904773|37792739|FG007|Fifth Intervention|Adverse Event|1|||
16923125|NCT01722331|38064592|FG000|Part 2|Non-Compliance with Study Drug|1|||
16923126|NCT01722331|38064593|FG001|Part 2|Non-Compliance with Study Drug|0|||
16923127|NCT01722331|38064594|FG002|Part 2|Non-Compliance with Study Drug|1|||
16923128|NCT01722331|38064595|FG003|Part 2|Non-Compliance with Study Drug|0|||
16923129|NCT01722331|38064596|FG004|Part 2|Non-Compliance with Study Drug|0|||
16923130|NCT01722331|38064597|FG005|Part 2|Non-Compliance with Study Drug|0|||
16923131|NCT01722331|38064598|FG006|Part 2|Non-Compliance with Study Drug|0|||
16923132|NCT01722331|38064592|FG000|Part 2|Physician Decision|0|||
16923133|NCT01722331|38064593|FG001|Part 2|Physician Decision|0|||
16923134|NCT01722331|38064594|FG002|Part 2|Physician Decision|2|||
16923135|NCT01722331|38064595|FG003|Part 2|Physician Decision|0|||
16923136|NCT01722331|38064596|FG004|Part 2|Physician Decision|0|||
16923137|NCT01722331|38064597|FG005|Part 2|Physician Decision|0|||
16923138|NCT01722331|38064598|FG006|Part 2|Physician Decision|0|||
16923139|NCT01722331|38064592|FG000|Part 2|Pregnancy|0|||
16923140|NCT01722331|38064593|FG001|Part 2|Pregnancy|0|||
16923141|NCT01722331|38064594|FG002|Part 2|Pregnancy|0|||
16923142|NCT01722331|38064595|FG003|Part 2|Pregnancy|0|||
16923143|NCT01722331|38064596|FG004|Part 2|Pregnancy|0|||
16923144|NCT01722331|38064597|FG005|Part 2|Pregnancy|1|||
16923145|NCT01722331|38064598|FG006|Part 2|Pregnancy|0|||
16923146|NCT01722331|38064592|FG000|Part 2|Progressive Disease|0|||
16923147|NCT01722331|38064593|FG001|Part 2|Progressive Disease|0|||
16923148|NCT01722331|38064594|FG002|Part 2|Progressive Disease|1|||
16923149|NCT01722331|38064595|FG003|Part 2|Progressive Disease|0|||
16923150|NCT01722331|38064596|FG004|Part 2|Progressive Disease|0|||
16923151|NCT01722331|38064597|FG005|Part 2|Progressive Disease|0|||
16923152|NCT01722331|38064598|FG006|Part 2|Progressive Disease|0|||
16923153|NCT01722331|38064592|FG000|Part 2|Protocol Violation|1|||
16923154|NCT01722331|38064593|FG001|Part 2|Protocol Violation|0|||
16923155|NCT01722331|38064594|FG002|Part 2|Protocol Violation|0|||
16923156|NCT01722331|38064595|FG003|Part 2|Protocol Violation|0|||
16923157|NCT01722331|38064596|FG004|Part 2|Protocol Violation|0|||
16923158|NCT01722331|38064597|FG005|Part 2|Protocol Violation|0|||
16923159|NCT01722331|38064598|FG006|Part 2|Protocol Violation|0|||
16923160|NCT01722331|38064592|FG000|Part 2|Withdrawal by Subject|5|||
16923161|NCT01722331|38064593|FG001|Part 2|Withdrawal by Subject|0|||
16923162|NCT01722331|38064594|FG002|Part 2|Withdrawal by Subject|3|||
16923163|NCT01722331|38064595|FG003|Part 2|Withdrawal by Subject|0|||
16923164|NCT01722331|38064596|FG004|Part 2|Withdrawal by Subject|0|||
16923165|NCT01722331|38064597|FG005|Part 2|Withdrawal by Subject|2|||
16923166|NCT01722331|38064598|FG006|Part 2|Withdrawal by Subject|2|||
16923167|NCT01722331|38064592|FG000|Part 2|Other Protocol Specified Criteria|6|||
16923168|NCT01722331|38064593|FG001|Part 2|Other Protocol Specified Criteria|0|||
16923169|NCT01722331|38064594|FG002|Part 2|Other Protocol Specified Criteria|10|||
16923170|NCT01722331|38064595|FG003|Part 2|Other Protocol Specified Criteria|0|||
16923171|NCT01722331|38064596|FG004|Part 2|Other Protocol Specified Criteria|0|||
16923172|NCT01722331|38064597|FG005|Part 2|Other Protocol Specified Criteria|2|||
16923173|NCT01722331|38064598|FG006|Part 2|Other Protocol Specified Criteria|1|||
16923174|NCT01722331|38064592|FG000|Part 3|Adverse Event|2|||
16923175|NCT01722331|38064593|FG001|Part 3|Adverse Event|2|||
16923176|NCT01722331|38064594|FG002|Part 3|Adverse Event|0|||
16923177|NCT01722331|38064595|FG003|Part 3|Adverse Event|1|||
16923178|NCT01722331|38064596|FG004|Part 3|Adverse Event|0|||
16923179|NCT01722331|38064597|FG005|Part 3|Adverse Event|0|||
16923180|NCT01722331|38064598|FG006|Part 3|Adverse Event|0|||
16923181|NCT01722331|38064592|FG000|Part 3|Death|1|||
16923182|NCT01722331|38064593|FG001|Part 3|Death|0|||
16847665|NCT01904773|37792740|FG008|Fifth Intervention|Adverse Event|0|||
16847666|NCT01904773|37792732|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16847667|NCT01904773|37792733|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
16847668|NCT01904773|37792734|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16847669|NCT01904773|37792735|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16847670|NCT01904773|37792736|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16923183|NCT01722331|38064594|FG002|Part 3|Death|0|||
16923184|NCT01722331|38064595|FG003|Part 3|Death|0|||
16923185|NCT01722331|38064596|FG004|Part 3|Death|0|||
16923186|NCT01722331|38064597|FG005|Part 3|Death|0|||
16923187|NCT01722331|38064598|FG006|Part 3|Death|0|||
16923188|NCT01722331|38064592|FG000|Part 3|Lack of Efficacy|1|||
16923189|NCT01722331|38064593|FG001|Part 3|Lack of Efficacy|0|||
16923190|NCT01722331|38064594|FG002|Part 3|Lack of Efficacy|0|||
16923191|NCT01722331|38064595|FG003|Part 3|Lack of Efficacy|0|||
16923192|NCT01722331|38064596|FG004|Part 3|Lack of Efficacy|0|||
16923193|NCT01722331|38064597|FG005|Part 3|Lack of Efficacy|0|||
16923194|NCT01722331|38064598|FG006|Part 3|Lack of Efficacy|0|||
16923195|NCT01722331|38064592|FG000|Part 3|Lost to Follow-up|3|||
16923196|NCT01722331|38064593|FG001|Part 3|Lost to Follow-up|4|||
16847671|NCT01904773|37792737|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16847672|NCT01904773|37792738|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16847673|NCT01904773|37792739|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16847674|NCT01904773|37792740|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16847675|NCT01928719|37792754|FG000|Overall Study|Lost to Follow-up|26|||
16923197|NCT01722331|38064594|FG002|Part 3|Lost to Follow-up|0|||
16923198|NCT01722331|38064595|FG003|Part 3|Lost to Follow-up|0|||
16923199|NCT01722331|38064596|FG004|Part 3|Lost to Follow-up|0|||
16923200|NCT01722331|38064597|FG005|Part 3|Lost to Follow-up|1|||
16923201|NCT01722331|38064598|FG006|Part 3|Lost to Follow-up|0|||
16923202|NCT01722331|38064592|FG000|Part 3|Non-Compliance with Study Drug|0|||
16923203|NCT01722331|38064593|FG001|Part 3|Non-Compliance with Study Drug|1|||
16847676|NCT01928719|37792755|FG001|Overall Study|Lost to Follow-up|11|||
16847677|NCT01928719|37792754|FG000|Overall Study|Withdrawal by Subject|22|||
16847678|NCT01928719|37792755|FG001|Overall Study|Withdrawal by Subject|7|||
16847679|NCT01928719|37792754|FG000|Overall Study|Protocol Violation|3|||
16847680|NCT01928719|37792755|FG001|Overall Study|Protocol Violation|1|||
16847681|NCT01928719|37792754|FG000|Overall Study|Adverse Event|1|||
16847682|NCT01928719|37792755|FG001|Overall Study|Adverse Event|0|||
16923204|NCT01722331|38064594|FG002|Part 3|Non-Compliance with Study Drug|0|||
16923205|NCT01722331|38064595|FG003|Part 3|Non-Compliance with Study Drug|0|||
16923206|NCT01722331|38064596|FG004|Part 3|Non-Compliance with Study Drug|0|||
16923207|NCT01722331|38064597|FG005|Part 3|Non-Compliance with Study Drug|0|||
16923208|NCT01722331|38064598|FG006|Part 3|Non-Compliance with Study Drug|0|||
16847683|NCT00986674|37792766|FG000|Overall Study|Lack of Efficacy|28|||
16847684|NCT00986674|37792767|FG001|Overall Study|Lack of Efficacy|25|||
16847685|NCT00986674|37792768|FG002|Overall Study|Lack of Efficacy|23|||
16923209|NCT01722331|38064592|FG000|Part 3|Physician Decision|1|||
16923210|NCT01722331|38064593|FG001|Part 3|Physician Decision|1|||
16923211|NCT01722331|38064594|FG002|Part 3|Physician Decision|0|||
16923212|NCT01722331|38064595|FG003|Part 3|Physician Decision|0|||
16923213|NCT01722331|38064596|FG004|Part 3|Physician Decision|0|||
16923214|NCT01722331|38064597|FG005|Part 3|Physician Decision|0|||
16923215|NCT01722331|38064598|FG006|Part 3|Physician Decision|1|||
16923216|NCT01722331|38064592|FG000|Part 3|Protocol Violation|2|||
16923217|NCT01722331|38064593|FG001|Part 3|Protocol Violation|1|||
16923218|NCT01722331|38064594|FG002|Part 3|Protocol Violation|0|||
16923219|NCT01722331|38064595|FG003|Part 3|Protocol Violation|0|||
16923220|NCT01722331|38064596|FG004|Part 3|Protocol Violation|0|||
16923221|NCT01722331|38064597|FG005|Part 3|Protocol Violation|0|||
16923222|NCT01722331|38064598|FG006|Part 3|Protocol Violation|0|||
16923223|NCT01722331|38064592|FG000|Part 3|Withdrawal by Subject|4|||
16923224|NCT01722331|38064593|FG001|Part 3|Withdrawal by Subject|7|||
16923225|NCT01722331|38064594|FG002|Part 3|Withdrawal by Subject|0|||
16923226|NCT01722331|38064595|FG003|Part 3|Withdrawal by Subject|0|||
16923227|NCT01722331|38064596|FG004|Part 3|Withdrawal by Subject|0|||
16923228|NCT01722331|38064597|FG005|Part 3|Withdrawal by Subject|2|||
16923229|NCT01722331|38064598|FG006|Part 3|Withdrawal by Subject|1|||
16923230|NCT01722331|38064592|FG000|Part 3|Other Protocol Specified Criteria|1|||
16923231|NCT01722331|38064593|FG001|Part 3|Other Protocol Specified Criteria|1|||
16923232|NCT01722331|38064594|FG002|Part 3|Other Protocol Specified Criteria|0|||
16923233|NCT01722331|38064595|FG003|Part 3|Other Protocol Specified Criteria|0|||
16923234|NCT01722331|38064596|FG004|Part 3|Other Protocol Specified Criteria|0|||
16923235|NCT01722331|38064597|FG005|Part 3|Other Protocol Specified Criteria|0|||
16923236|NCT01722331|38064598|FG006|Part 3|Other Protocol Specified Criteria|0|||
16923237|NCT01630590|38064610|FG000|Overall Study|Adverse Event|9|||
16923238|NCT01630590|38064610|FG000|Overall Study|Lack of Efficacy|37|||
16923239|NCT01630590|38064610|FG000|Overall Study|Withdrawal by Subject|4|||
16923240|NCT01630590|38064610|FG000|Overall Study|2nd primary tumor|2|||
16923241|NCT01630590|38064610|FG000|Overall Study|Automobile accident|1|||
16923242|NCT01630590|38064610|FG000|Overall Study|Maximum benefit|4|||
16923243|NCT01619085|38064614|FG000|Overall Study|Adverse Event|231|||
16923244|NCT01619085|38064614|FG000|Overall Study|Protocol Violation|4|||
16923245|NCT01619085|38064614|FG000|Overall Study|Lost to Follow-up|3|||
16923246|NCT01619085|38064614|FG000|Overall Study|Withdrawal by Subject|45|||
16923247|NCT01619085|38064614|FG000|Overall Study|Other than specified|96|||
16923248|NCT01619085|38064614|FG000|Overall Study|Not treated|1|||
16923249|NCT01619085|38064614|FG000|Overall Study|Death|145|||
16923250|NCT01499095|38064627|FG000|Overall Study|Randomized But Not Treated|1|||
16923251|NCT01499095|38064628|FG001|Overall Study|Randomized But Not Treated|1|||
16923252|NCT01499095|38064627|FG000|Overall Study|Adverse Event|12|||
16923253|NCT01499095|38064628|FG001|Overall Study|Adverse Event|7|||
16923254|NCT01499095|38064627|FG000|Overall Study|Lack of Efficacy|2|||
16923255|NCT01499095|38064628|FG001|Overall Study|Lack of Efficacy|1|||
16923256|NCT01499095|38064627|FG000|Overall Study|Protocol Violation|6|||
16923257|NCT01499095|38064628|FG001|Overall Study|Protocol Violation|7|||
16923258|NCT01499095|38064627|FG000|Overall Study|Received Rescue Therapy|32|||
16923259|NCT01499095|38064628|FG001|Overall Study|Received Rescue Therapy|40|||
16923260|NCT01499095|38064627|FG000|Overall Study|Diverse Reasons|22|||
16923261|NCT01499095|38064628|FG001|Overall Study|Diverse Reasons|25|||
16923262|NCT01499095|38064627|FG000|Overall Study|Lost to Follow-up|6|||
16923263|NCT01499095|38064628|FG001|Overall Study|Lost to Follow-up|4|||
16923264|NCT01499095|38064627|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
16923265|NCT01499095|38064628|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
16923266|NCT01499095|38064627|FG000|Overall Study|Hypoglycemia|3|||
16923267|NCT01499095|38064628|FG001|Overall Study|Hypoglycemia|1|||
16923268|NCT01499095|38064627|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
16923269|NCT01499095|38064628|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
16923270|NCT01499095|38064627|FG000|Overall Study|Change in Injection Schedule|2|||
16923271|NCT01499095|38064628|FG001|Overall Study|Change in Injection Schedule|0|||
16923272|NCT01499095|38064627|FG000|Overall Study|Perceived Lack of Efficacy|1|||
16923273|NCT01499095|38064628|FG001|Overall Study|Perceived Lack of Efficacy|1|||
16923274|NCT01499082|38064639|FG000|Overall Study|Randomized but not Treated|0|||
16923275|NCT01499082|38064640|FG001|Overall Study|Randomized but not Treated|1|||
16923276|NCT01499082|38064639|FG000|Overall Study|Adverse Event|12|||
16923277|NCT01499082|38064640|FG001|Overall Study|Adverse Event|16|||
16923278|NCT01499082|38064639|FG000|Overall Study|Lack of Efficacy|1|||
16923279|NCT01499082|38064640|FG001|Overall Study|Lack of Efficacy|1|||
16923280|NCT01499082|38064639|FG000|Overall Study|Protocol Violation|6|||
16923281|NCT01499082|38064640|FG001|Overall Study|Protocol Violation|8|||
16923282|NCT01499082|38064639|FG000|Overall Study|Diverse Reasons|18|||
16923283|NCT01499082|38064640|FG001|Overall Study|Diverse Reasons|14|||
16923284|NCT01499082|38064639|FG000|Overall Study|Site Closure for Noncompliance|5|||
16923285|NCT01499082|38064640|FG001|Overall Study|Site Closure for Noncompliance|2|||
16923286|NCT01499082|38064639|FG000|Overall Study|Hypoglycemia|2|||
16923287|NCT01499082|38064640|FG001|Overall Study|Hypoglycemia|3|||
16923288|NCT01499082|38064639|FG000|Overall Study|Lost to Follow-up|1|||
16923289|NCT01499082|38064640|FG001|Overall Study|Lost to Follow-up|3|||
16923290|NCT01488890|38064652|FG000|Overall Study|Serious adverse event|2|||
16923291|NCT01488890|38064653|FG001|Overall Study|Serious adverse event|0|||
16923292|NCT01488890|38064654|FG002|Overall Study|Serious adverse event|0|||
16923293|NCT01488890|38064655|FG003|Overall Study|Serious adverse event|0|||
16923294|NCT01488890|38064652|FG000|Overall Study|Protocol Violation|3|||
16923295|NCT01488890|38064653|FG001|Overall Study|Protocol Violation|0|||
16923296|NCT01488890|38064654|FG002|Overall Study|Protocol Violation|4|||
16923297|NCT01488890|38064655|FG003|Overall Study|Protocol Violation|0|||
16923298|NCT01488890|38064652|FG000|Overall Study|Lost to Follow-up|13|||
16923299|NCT01488890|38064653|FG001|Overall Study|Lost to Follow-up|10|||
16923300|NCT01488890|38064654|FG002|Overall Study|Lost to Follow-up|20|||
16923301|NCT01488890|38064655|FG003|Overall Study|Lost to Follow-up|3|||
16923302|NCT01488890|38064652|FG000|Overall Study|Withdrawal by Subject|14|||
16923303|NCT01488890|38064653|FG001|Overall Study|Withdrawal by Subject|10|||
16923304|NCT01488890|38064654|FG002|Overall Study|Withdrawal by Subject|11|||
16923305|NCT01488890|38064655|FG003|Overall Study|Withdrawal by Subject|2|||
16923306|NCT01436396|38064671|FG000|Overall Study|Protocol Violation|7|||
16923307|NCT01436396|38064672|FG001|Overall Study|Protocol Violation|5|||
16923308|NCT01436396|38064671|FG000|Overall Study|Adverse Event|1|||
16923309|NCT01436396|38064672|FG001|Overall Study|Adverse Event|2|||
16923310|NCT01436396|38064671|FG000|Overall Study|Withdrawal by Subject|19|||
16923311|NCT01436396|38064672|FG001|Overall Study|Withdrawal by Subject|29|||
16923312|NCT01436396|38064671|FG000|Overall Study|Serious adverse event|2|||
16923313|NCT01436396|38064672|FG001|Overall Study|Serious adverse event|3|||
16923314|NCT01436396|38064671|FG000|Overall Study|Lost to Follow-up|3|||
16923315|NCT01436396|38064672|FG001|Overall Study|Lost to Follow-up|3|||
16923316|NCT01411241|38064680|FG000|Overall Study|Protocol Violation|0|||
16923317|NCT01411241|38064681|FG001|Overall Study|Protocol Violation|5|||
16923318|NCT01411241|38064680|FG000|Overall Study|Withdrawal by Subject|9|||
16923319|NCT01411241|38064681|FG001|Overall Study|Withdrawal by Subject|10|||
16923320|NCT01411241|38064680|FG000|Overall Study|Serious Adverse Event|0|||
16923321|NCT01411241|38064681|FG001|Overall Study|Serious Adverse Event|3|||
16923322|NCT01411241|38064680|FG000|Overall Study|Lost to Follow-up|2|||
16923323|NCT01411241|38064681|FG001|Overall Study|Lost to Follow-up|4|||
16923324|NCT01374516|38064689|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
16923325|NCT01374516|38064690|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
16923326|NCT01374516|38064689|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
16923327|NCT01374516|38064690|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
16923328|NCT01374516|38064689|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
16923329|NCT01374516|38064690|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
16923330|NCT01374516|38064689|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
16923331|NCT01374516|38064690|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
16923332|NCT01374516|38064689|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
16923333|NCT01374516|38064690|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
16923334|NCT01374516|38064689|FG000|Surveillance Expansion Period|Protocol Violation|386|||
16923335|NCT01374516|38064690|FG001|Surveillance Expansion Period|Protocol Violation|217|||
16923336|NCT01374516|38064689|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
16923337|NCT01374516|38064690|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
16923338|NCT01374516|38064689|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
16923339|NCT01374516|38064690|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
16923340|NCT01374516|38064689|FG000|Surveillance Expansion Period|Serious adverse event|20|||
16923341|NCT01374516|38064690|FG001|Surveillance Expansion Period|Serious adverse event|5|||
16923342|NCT01373281|38064705|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
16923343|NCT01373281|38064706|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
16923344|NCT01373281|38064705|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
16923345|NCT01373281|38064706|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
16923346|NCT01373281|38064705|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
16923347|NCT01373281|38064706|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
16923348|NCT01373281|38064705|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
16923349|NCT01373281|38064706|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
16923350|NCT01373281|38064705|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
16923351|NCT01373281|38064706|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
16923352|NCT01373281|38064705|FG000|Surveillance Expansion Period|Protocol Violation|9|||
16923353|NCT01373281|38064706|FG001|Surveillance Expansion Period|Protocol Violation|1|||
16923354|NCT01373281|38064705|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
16923355|NCT01373281|38064706|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
16923356|NCT01373281|38064705|FG000|Surveillance Expansion Period|Serious adverse event|3|||
16923357|NCT01373281|38064706|FG001|Surveillance Expansion Period|Serious adverse event|4|||
16923358|NCT01287611|38064721|FG000|Overall Study|Lost to Follow-up|29|||
16923359|NCT01287611|38064722|FG001|Overall Study|Lost to Follow-up|16|||
16923360|NCT01287611|38064721|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
16923361|NCT01287611|38064722|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
16923362|NCT01254422|38064732|FG000|Overall Study|Protocol Violation|1|||
16923363|NCT01254422|38064733|FG001|Overall Study|Protocol Violation|0|||
16923364|NCT01254422|38064732|FG000|Overall Study|Adverse Event|1|||
16923365|NCT01254422|38064733|FG001|Overall Study|Adverse Event|0|||
16923366|NCT01254422|38064732|FG000|Overall Study|Serious adverse event|0|||
16923367|NCT01254422|38064733|FG001|Overall Study|Serious adverse event|1|||
16923368|NCT01254422|38064732|FG000|Overall Study|Lost to Follow-up|1|||
16923369|NCT01254422|38064733|FG001|Overall Study|Lost to Follow-up|0|||
16923370|NCT01187433|38064741|FG000|Overall Study|Protocol Violation|6|||
16923371|NCT01187433|38064742|FG001|Overall Study|Protocol Violation|2|||
16923372|NCT01187433|38064741|FG000|Overall Study|Withdrawal by Subject|5|||
16923373|NCT01187433|38064742|FG001|Overall Study|Withdrawal by Subject|2|||
16923374|NCT01150045|38064752|FG000|Overall Study|Protocol Violation|0|||
16923375|NCT01150045|38064753|FG001|Overall Study|Protocol Violation|1|||
16847686|NCT00986674|37792766|FG000|Overall Study|Adverse Event|4|||
16847687|NCT00986674|37792767|FG001|Overall Study|Adverse Event|8|||
16847688|NCT00986674|37792768|FG002|Overall Study|Adverse Event|9|||
16847689|NCT00986674|37792766|FG000|Overall Study|Death|5|||
16847690|NCT00986674|37792767|FG001|Overall Study|Death|0|||
16847691|NCT00986674|37792768|FG002|Overall Study|Death|4|||
16847692|NCT00986674|37792766|FG000|Overall Study|Withdrawal by Subject|6|||
16847693|NCT00986674|37792767|FG001|Overall Study|Withdrawal by Subject|2|||
16847694|NCT00986674|37792768|FG002|Overall Study|Withdrawal by Subject|1|||
16847695|NCT00986674|37792766|FG000|Overall Study|alternative therapy|0|||
16847696|NCT00986674|37792767|FG001|Overall Study|alternative therapy|0|||
16847697|NCT00986674|37792768|FG002|Overall Study|alternative therapy|1|||
16847698|NCT00986674|37792766|FG000|Overall Study|not start protocol therapy|4|||
16847699|NCT00986674|37792767|FG001|Overall Study|not start protocol therapy|3|||
16847700|NCT00986674|37792768|FG002|Overall Study|not start protocol therapy|1|||
16847701|NCT00986674|37792766|FG000|Overall Study|unknown/not specify|0|||
16847702|NCT00986674|37792767|FG001|Overall Study|unknown/not specify|7|||
16847703|NCT00986674|37792768|FG002|Overall Study|unknown/not specify|9|||
16847704|NCT00986440|37792778|FG000|Overall Study|Progressive disease|27|||
16847705|NCT00986440|37792779|FG001|Overall Study|Progressive disease|37|||
16847706|NCT00986440|37792778|FG000|Overall Study|Serious adverse event or adverse event|9|||
16847707|NCT00986440|37792779|FG001|Overall Study|Serious adverse event or adverse event|2|||
16847708|NCT00986440|37792778|FG000|Overall Study|Withdrawal by Subject|1|||
16847709|NCT00986440|37792779|FG001|Overall Study|Withdrawal by Subject|2|||
16847710|NCT00986440|37792778|FG000|Overall Study|Screen failure (not dosed)|4|||
16847711|NCT00986440|37792779|FG001|Overall Study|Screen failure (not dosed)|2|||
16923376|NCT01150045|38064754|FG002|Overall Study|Protocol Violation|0|||
16923377|NCT01150045|38064755|FG003|Overall Study|Protocol Violation|1|||
16923378|NCT01098032|38064765|FG000|Overall Study|Withdrawal by Subject|1|||
16923379|NCT01098032|38064766|FG001|Overall Study|Withdrawal by Subject|1|||
16923380|NCT01034306|38064774|FG000|Overall Study|Adverse Event|1|||
16923381|NCT01034306|38064775|FG001|Overall Study|Adverse Event|0|||
16847712|NCT01904383|37792785|FG000|Overall Study|CRF not collected|117|||
16847713|NCT01904383|37792785|FG000|Overall Study|Reason not listed|147|||
16847714|NCT01904383|37792785|FG000|Overall Study|Lost to Follow-up|674|||
16847715|NCT01904383|37792785|FG000|Overall Study|Lack of Efficacy|370|||
16847716|NCT01904383|37792785|FG000|Overall Study|Improvement|141|||
16847717|NCT01904383|37792785|FG000|Overall Study|Adverse Event|271|||
16923382|NCT01034306|38064774|FG000|Overall Study|Lost to Follow-up|0|||
16923383|NCT01034306|38064775|FG001|Overall Study|Lost to Follow-up|1|||
16923384|NCT01034306|38064774|FG000|Overall Study|Withdrawal by Subject|2|||
16923385|NCT01034306|38064775|FG001|Overall Study|Withdrawal by Subject|2|||
16923386|NCT01034306|38064774|FG000|Overall Study|hospitalized and decided to stop|1|||
16847718|NCT01904383|37792785|FG000|Overall Study|No patient visit after entry|54|||
16847719|NCT01904149|37792795|FG000|Overall Study|Adverse Event|3|||
16923387|NCT01034306|38064775|FG001|Overall Study|hospitalized and decided to stop|0|||
16923388|NCT01034306|38064774|FG000|Overall Study|Noncomplience|1|||
16847720|NCT01904149|37792796|FG001|Overall Study|Adverse Event|4|||
16847721|NCT01904149|37792797|FG002|Overall Study|Adverse Event|0|||
16847722|NCT01904149|37792798|FG003|Overall Study|Adverse Event|1|||
16847723|NCT01904149|37792799|FG004|Overall Study|Adverse Event|1|||
16847724|NCT01904149|37792800|FG005|Overall Study|Adverse Event|2|||
16847725|NCT01904149|37792795|FG000|Overall Study|Lack of Efficacy|0|||
16847726|NCT01904149|37792796|FG001|Overall Study|Lack of Efficacy|3|||
16847727|NCT01904149|37792797|FG002|Overall Study|Lack of Efficacy|1|||
16923389|NCT01034306|38064775|FG001|Overall Study|Noncomplience|0|||
16923390|NCT00993447|38064783|FG000|Overall Study|Withdrawal by Subject|23|||
16923391|NCT00993447|38064784|FG001|Overall Study|Withdrawal by Subject|8|||
16923392|NCT00993447|38064783|FG000|Overall Study|Protocol Violation|12|||
16923393|NCT00993447|38064784|FG001|Overall Study|Protocol Violation|8|||
16923394|NCT00993447|38064783|FG000|Overall Study|Lost to Follow-up|1|||
16923395|NCT00993447|38064784|FG001|Overall Study|Lost to Follow-up|3|||
16923396|NCT00993447|38064783|FG000|Overall Study|Adverse Event|1|||
16923397|NCT00993447|38064784|FG001|Overall Study|Adverse Event|0|||
16923398|NCT00945009|38064793|FG000|Overall Study|Lack of Efficacy|10|||
16923399|NCT00945009|38064794|FG001|Overall Study|Lack of Efficacy|0|||
16923400|NCT00945009|38064795|FG002|Overall Study|Lack of Efficacy|0|||
16923401|NCT00945009|38064793|FG000|Overall Study|Physician Decision|21|||
16923402|NCT00945009|38064794|FG001|Overall Study|Physician Decision|4|||
16923403|NCT00945009|38064795|FG002|Overall Study|Physician Decision|3|||
16923404|NCT00945009|38064793|FG000|Overall Study|Protocol Violation|6|||
16923405|NCT00945009|38064794|FG001|Overall Study|Protocol Violation|1|||
16923406|NCT00945009|38064795|FG002|Overall Study|Protocol Violation|0|||
16923407|NCT00945009|38064793|FG000|Overall Study|Withdrawal by Subject|1|||
16923408|NCT00945009|38064794|FG001|Overall Study|Withdrawal by Subject|0|||
16923409|NCT00945009|38064795|FG002|Overall Study|Withdrawal by Subject|0|||
16923410|NCT00945009|38064793|FG000|Overall Study|Ineligible|6|||
16923411|NCT00945009|38064794|FG001|Overall Study|Ineligible|1|||
16923412|NCT00945009|38064795|FG002|Overall Study|Ineligible|0|||
16923413|NCT00945009|38064793|FG000|Overall Study|Inevaluable|0|||
16923414|NCT00945009|38064794|FG001|Overall Study|Inevaluable|1|||
16923415|NCT00945009|38064795|FG002|Overall Study|Inevaluable|0|||
16923416|NCT00945009|38064793|FG000|Overall Study|Refusal of further protocol|1|||
16923417|NCT00945009|38064794|FG001|Overall Study|Refusal of further protocol|0|||
16923418|NCT00945009|38064795|FG002|Overall Study|Refusal of further protocol|0|||
16923419|NCT00942877|38064805|FG000|Overall Study|Refused further treatment|1|||
16923420|NCT00942877|38064806|FG001|Overall Study|Refused further treatment|1|||
16923421|NCT00942877|38064805|FG000|Overall Study|Patient was not treated|1|||
16923422|NCT00942877|38064806|FG001|Overall Study|Patient was not treated|0|||
16923423|NCT00942877|38064805|FG000|Overall Study|Adverse Event|1|||
16923424|NCT00942877|38064806|FG001|Overall Study|Adverse Event|0|||
16923425|NCT00942877|38064805|FG000|Overall Study|Progressive disease|42|||
16923426|NCT00942877|38064806|FG001|Overall Study|Progressive disease|3|||
16923427|NCT00880893|38064821|FG000|Overall Study|Protocol Violation|13|||
16923428|NCT00880893|38064822|FG001|Overall Study|Protocol Violation|1|||
16923429|NCT00880893|38064821|FG000|Overall Study|Withdrawal by Subject|15|||
16923430|NCT00880893|38064822|FG001|Overall Study|Withdrawal by Subject|11|||
16923431|NCT00880893|38064821|FG000|Overall Study|Lost to Follow-up|76|||
16923432|NCT00880893|38064822|FG001|Overall Study|Lost to Follow-up|33|||
16923433|NCT00880893|38064821|FG000|Overall Study|Serious adverse event|3|||
16923434|NCT00880893|38064822|FG001|Overall Study|Serious adverse event|0|||
16923435|NCT00587301|38064828|FG000|Overall Study|Screen Failure|9|||
16923436|NCT00587301|38064828|FG000|Overall Study|Lost to Follow-up|22|||
16923437|NCT00587301|38064828|FG000|Overall Study|Withdrawal by Subject|7|||
16923438|NCT00587301|38064828|FG000|Overall Study|Protocol Violation|7|||
16923439|NCT00579527|38064832|FG000|Overall Study|Death|4|||
16923440|NCT00576836|38064837|FG000|Overall Study|Death|0|||
16923441|NCT00576836|38064838|FG001|Overall Study|Death|1|||
16923442|NCT00576836|38064837|FG000|Overall Study|Physician Decision|0|||
16923443|NCT00576836|38064838|FG001|Overall Study|Physician Decision|1|||
16923444|NCT00576407|38064842|FG000|Overall Study|Death|7|||
16923445|NCT00576407|38064842|FG000|Overall Study|Physician Decision|1|||
16923446|NCT00531232|38064850|FG000|Overall Study|Investigator decision|0|||
16923447|NCT00531232|38064851|FG001|Overall Study|Investigator decision|0|||
16923448|NCT00531232|38064852|FG002|Overall Study|Investigator decision|4|||
16923449|NCT00531232|38064850|FG000|Overall Study|Participants refused further treatment|0|||
16923450|NCT00531232|38064851|FG001|Overall Study|Participants refused further treatment|1|||
16923451|NCT00531232|38064852|FG002|Overall Study|Participants refused further treatment|2|||
16923452|NCT00531232|38064850|FG000|Overall Study|Adverse events (AEs)|1|||
16847728|NCT01904149|37792798|FG003|Overall Study|Lack of Efficacy|3|||
16923453|NCT00531232|38064851|FG001|Overall Study|Adverse events (AEs)|2|||
16923454|NCT00531232|38064852|FG002|Overall Study|Adverse events (AEs)|2|||
16923455|NCT00531232|38064850|FG000|Overall Study|Treatment failure|1|||
16923456|NCT00531232|38064851|FG001|Overall Study|Treatment failure|3|||
16847729|NCT01904149|37792799|FG004|Overall Study|Lack of Efficacy|3|||
16923457|NCT00531232|38064852|FG002|Overall Study|Treatment failure|7|||
16923458|NCT00531232|38064850|FG000|Overall Study|Disease recurrence|0|||
16923459|NCT00531232|38064851|FG001|Overall Study|Disease recurrence|0|||
16923460|NCT00531232|38064852|FG002|Overall Study|Disease recurrence|1|||
16923461|NCT00531232|38064850|FG000|Overall Study|Deceased|2|||
16923462|NCT00531232|38064851|FG001|Overall Study|Deceased|2|||
16923463|NCT00531232|38064852|FG002|Overall Study|Deceased|2|||
16923464|NCT00531232|38064850|FG000|Overall Study|Withdrawal by Subject|0|||
16923465|NCT00531232|38064851|FG001|Overall Study|Withdrawal by Subject|1|||
16923466|NCT00531232|38064852|FG002|Overall Study|Withdrawal by Subject|2|||
16923467|NCT00531232|38064850|FG000|Overall Study|Other|0|||
16923468|NCT00531232|38064851|FG001|Overall Study|Other|0|||
16923469|NCT00531232|38064852|FG002|Overall Study|Other|5|||
16923470|NCT00379340|38064868|FG000|Overall Study|Death|0|||
16923471|NCT00379340|38064869|FG001|Overall Study|Death|0|||
16923472|NCT00379340|38064870|FG002|Overall Study|Death|0|||
16923473|NCT00379340|38064871|FG003|Overall Study|Death|2|||
16923474|NCT00379340|38064872|FG004|Overall Study|Death|0|||
16923475|NCT00379340|38064868|FG000|Overall Study|Lack of Efficacy|6|||
16923476|NCT00379340|38064869|FG001|Overall Study|Lack of Efficacy|1|||
16923477|NCT00379340|38064870|FG002|Overall Study|Lack of Efficacy|0|||
16923478|NCT00379340|38064871|FG003|Overall Study|Lack of Efficacy|4|||
16923479|NCT00379340|38064872|FG004|Overall Study|Lack of Efficacy|3|||
16923480|NCT00379340|38064868|FG000|Overall Study|Physician Decision|6|||
16923481|NCT00379340|38064869|FG001|Overall Study|Physician Decision|2|||
16923482|NCT00379340|38064870|FG002|Overall Study|Physician Decision|1|||
16923483|NCT00379340|38064871|FG003|Overall Study|Physician Decision|2|||
16923484|NCT00379340|38064872|FG004|Overall Study|Physician Decision|3|||
16923485|NCT00379340|38064868|FG000|Overall Study|Withdrawal by Subject|0|||
16923486|NCT00379340|38064869|FG001|Overall Study|Withdrawal by Subject|0|||
16923487|NCT00379340|38064870|FG002|Overall Study|Withdrawal by Subject|0|||
16923488|NCT00379340|38064871|FG003|Overall Study|Withdrawal by Subject|1|||
16847730|NCT01904149|37792800|FG005|Overall Study|Lack of Efficacy|1|||
16847731|NCT01904149|37792795|FG000|Overall Study|Withdrawal by Subject|1|||
16847732|NCT01904149|37792796|FG001|Overall Study|Withdrawal by Subject|3|||
16923489|NCT00379340|38064872|FG004|Overall Study|Withdrawal by Subject|0|||
16923490|NCT00379340|38064868|FG000|Overall Study|Refusal of further protocol therapy|1|||
16923491|NCT00379340|38064869|FG001|Overall Study|Refusal of further protocol therapy|0|||
16923492|NCT00379340|38064870|FG002|Overall Study|Refusal of further protocol therapy|1|||
16923493|NCT00379340|38064871|FG003|Overall Study|Refusal of further protocol therapy|1|||
16923494|NCT00379340|38064872|FG004|Overall Study|Refusal of further protocol therapy|7|||
16923495|NCT00379340|38064868|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
16923496|NCT00379340|38064869|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
16923497|NCT00379340|38064870|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
16923498|NCT00379340|38064871|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
16923499|NCT00379340|38064872|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
16923500|NCT00379340|38064868|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
16923501|NCT00379340|38064869|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
16923502|NCT00379340|38064870|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
16923503|NCT00379340|38064871|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
16923504|NCT00379340|38064872|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
16923505|NCT00304070|38064888|FG000|Overall Study|Death|0|||
16923506|NCT00304070|38064889|FG001|Overall Study|Death|0|||
16923507|NCT00304070|38064890|FG002|Overall Study|Death|3|||
16923508|NCT00304070|38064888|FG000|Overall Study|Lost to Follow-up|0|||
16923509|NCT00304070|38064889|FG001|Overall Study|Lost to Follow-up|0|||
16923510|NCT00304070|38064890|FG002|Overall Study|Lost to Follow-up|1|||
16923511|NCT00304070|38064888|FG000|Overall Study|Physician Decision|0|||
16923512|NCT00304070|38064889|FG001|Overall Study|Physician Decision|0|||
16923513|NCT00304070|38064890|FG002|Overall Study|Physician Decision|3|||
16923514|NCT00304070|38064888|FG000|Overall Study|Withdrawal by Subject|0|||
16923515|NCT00304070|38064889|FG001|Overall Study|Withdrawal by Subject|0|||
16923516|NCT00304070|38064890|FG002|Overall Study|Withdrawal by Subject|1|||
16923517|NCT00304070|38064888|FG000|Overall Study|Progressive Disease|3|||
16923518|NCT00304070|38064889|FG001|Overall Study|Progressive Disease|7|||
16923519|NCT00304070|38064890|FG002|Overall Study|Progressive Disease|4|||
16847733|NCT01904149|37792797|FG002|Overall Study|Withdrawal by Subject|1|||
16847734|NCT01904149|37792798|FG003|Overall Study|Withdrawal by Subject|0|||
16847735|NCT01904149|37792799|FG004|Overall Study|Withdrawal by Subject|1|||
16847736|NCT01904149|37792800|FG005|Overall Study|Withdrawal by Subject|0|||
16847737|NCT01904149|37792795|FG000|Overall Study|Protocol Violation|0|||
16847738|NCT01904149|37792796|FG001|Overall Study|Protocol Violation|1|||
16847739|NCT01904149|37792797|FG002|Overall Study|Protocol Violation|0|||
16847740|NCT01904149|37792798|FG003|Overall Study|Protocol Violation|0|||
16847741|NCT01904149|37792799|FG004|Overall Study|Protocol Violation|0|||
16923520|NCT01701583|38064904|FG000|Overall Study|Withdrawal by Subject|2|||
16923521|NCT01701583|38064905|FG001|Overall Study|Withdrawal by Subject|0|||
16923522|NCT01714817|38064914|FG000|Year 1 Period|Lack of Efficacy|11|||
16847742|NCT01904149|37792800|FG005|Overall Study|Protocol Violation|0|||
16923523|NCT01714817|38064915|FG001|Year 1 Period|Lack of Efficacy|9|||
16923524|NCT01714817|38064914|FG000|Year 1 Period|Adverse Event|20|||
16923525|NCT01714817|38064915|FG001|Year 1 Period|Adverse Event|17|||
16923526|NCT01714817|38064914|FG000|Year 1 Period|Withdrawal by Subject|6|||
16923527|NCT01714817|38064915|FG001|Year 1 Period|Withdrawal by Subject|7|||
16923528|NCT01714817|38064914|FG000|Year 1 Period|Death|1|||
16923529|NCT01714817|38064915|FG001|Year 1 Period|Death|1|||
16923530|NCT01714817|38064914|FG000|Year 1 Period|Lost to Follow-up|0|||
16923531|NCT01714817|38064915|FG001|Year 1 Period|Lost to Follow-up|2|||
16923532|NCT01714817|38064914|FG000|Year 1 Period|Poor / non-compliance|0|||
16923533|NCT01714817|38064915|FG001|Year 1 Period|Poor / non-compliance|1|||
16923534|NCT01714817|38064914|FG000|Year 1 Period|Pregnancy|2|||
16923535|NCT01714817|38064915|FG001|Year 1 Period|Pregnancy|0|||
16923536|NCT01714817|38064914|FG000|Year 1 Period|Participant no longer meets criteria|6|||
16923537|NCT01714817|38064915|FG001|Year 1 Period|Participant no longer meets criteria|2|||
16923538|NCT01714817|38064914|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
16847743|NCT01904149|37792795|FG000|Overall Study|non compliance with study drug|1|||
16847744|NCT01904149|37792796|FG001|Overall Study|non compliance with study drug|0|||
16847745|NCT01904149|37792797|FG002|Overall Study|non compliance with study drug|0|||
16847746|NCT01904149|37792798|FG003|Overall Study|non compliance with study drug|0|||
16847747|NCT01904149|37792799|FG004|Overall Study|non compliance with study drug|0|||
16847748|NCT01904149|37792800|FG005|Overall Study|non compliance with study drug|0|||
16847749|NCT00986362|37792818|FG000|Overall Study|Death|2|||
16847750|NCT00986362|37792819|FG001|Overall Study|Death|0|||
16847751|NCT00986362|37792818|FG000|Overall Study|Lost to Follow-up|0|||
16847752|NCT00986362|37792819|FG001|Overall Study|Lost to Follow-up|1|||
16847753|NCT01890421|37792825|FG000|Overall Study|Adverse Event|1|||
16847754|NCT01890421|37792825|FG000|Overall Study|Other reason|10|||
16847755|NCT00985738|37792831|FG000|Overall Study|Study closed prematurely|8|||
16847756|NCT00985738|37792832|FG001|Overall Study|Study closed prematurely|8|||
16847757|NCT01928485|37792840|FG000|Overall Study|Physician Decision|0|||
16847758|NCT01928485|37792841|FG001|Overall Study|Physician Decision|1|||
16847759|NCT00985504|37792849|FG000|Acute Treatment Period|Adverse Event|3|||
16847760|NCT00985504|37792850|FG001|Acute Treatment Period|Adverse Event|4|||
16847761|NCT00985504|37792849|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
16847762|NCT00985504|37792850|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
16847763|NCT00985504|37792849|FG000|Acute Treatment Period|Protocol Violation|2|||
16847764|NCT00985504|37792850|FG001|Acute Treatment Period|Protocol Violation|0|||
16847765|NCT00985504|37792849|FG000|Acute Treatment Period|Sponsor Decision|0|||
16847766|NCT00985504|37792850|FG001|Acute Treatment Period|Sponsor Decision|1|||
16847767|NCT00985504|37792849|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
16847768|NCT00985504|37792850|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
16847769|NCT00985504|37792849|FG000|Optimization Period|Adverse Event|7|||
16847770|NCT00985504|37792850|FG001|Optimization Period|Adverse Event|9|||
16847771|NCT00985504|37792849|FG000|Optimization Period|Death|0|||
16847772|NCT00985504|37792850|FG001|Optimization Period|Death|1|||
16847773|NCT00985504|37792849|FG000|Optimization Period|Lack of Efficacy|5|||
16847774|NCT00985504|37792850|FG001|Optimization Period|Lack of Efficacy|3|||
16847775|NCT00985504|37792849|FG000|Optimization Period|Lost to Follow-up|0|||
16847776|NCT00985504|37792850|FG001|Optimization Period|Lost to Follow-up|1|||
16847777|NCT00985504|37792849|FG000|Optimization Period|Physician Decision|1|||
16847778|NCT00985504|37792850|FG001|Optimization Period|Physician Decision|0|||
16923539|NCT01714817|38064915|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
16923540|NCT01714817|38064914|FG000|Year 1 Period|Change in Concomitant Medication|0|||
16923541|NCT01714817|38064915|FG001|Year 1 Period|Change in Concomitant Medication|1|||
16923542|NCT01714817|38064914|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
16923543|NCT01714817|38064915|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
16847779|NCT00985504|37792849|FG000|Optimization Period|Protocol Violation|3|||
16847780|NCT00985504|37792850|FG001|Optimization Period|Protocol Violation|1|||
16847781|NCT00985504|37792849|FG000|Optimization Period|Withdrawal by Subject|10|||
16847782|NCT00985504|37792850|FG001|Optimization Period|Withdrawal by Subject|8|||
16847783|NCT00985426|37792858|FG000|Overall Study|Adverse Event|0|||
16847784|NCT00985426|37792859|FG001|Overall Study|Adverse Event|1|||
16847785|NCT00985426|37792858|FG000|Overall Study|Subject Non-Compliance|3|||
16847786|NCT00985426|37792859|FG001|Overall Study|Subject Non-Compliance|3|||
16847787|NCT00985426|37792858|FG000|Overall Study|Withdrawal by Subject|12|||
16847788|NCT00985426|37792859|FG001|Overall Study|Withdrawal by Subject|16|||
16847789|NCT00985426|37792858|FG000|Overall Study|Lost to Follow-up|8|||
16847790|NCT00985426|37792859|FG001|Overall Study|Lost to Follow-up|10|||
16847791|NCT00985426|37792858|FG000|Overall Study|Death|7|||
16847792|NCT00985426|37792859|FG001|Overall Study|Death|3|||
16847793|NCT00985426|37792858|FG000|Overall Study|Protocol Violation|2|||
16847794|NCT00985426|37792859|FG001|Overall Study|Protocol Violation|0|||
16847795|NCT00985426|37792858|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
16847796|NCT00985426|37792859|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
16847797|NCT00985192|37792865|FG000|Overall Study|Withdrawal by Subject|1|||
16847798|NCT00985192|37792865|FG000|Overall Study|Disease Progression|1|||
16847799|NCT00985192|37792865|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
16847800|NCT00985114|37792871|FG000|Overall Study|Adverse Event|1|||
16847801|NCT00985114|37792872|FG001|Overall Study|Adverse Event|0|||
16847802|NCT00985114|37792871|FG000|Overall Study|Withdrawal by Subject|0|||
16847803|NCT00985114|37792872|FG001|Overall Study|Withdrawal by Subject|2|||
16847804|NCT00984568|37792880|FG000|Overall Study|Withdrawal by Subject|1|||
16847805|NCT00984568|37792881|FG001|Overall Study|Withdrawal by Subject|2|||
16847806|NCT00984568|37792880|FG000|Overall Study|Lack of Efficacy|2|||
16847807|NCT00984568|37792881|FG001|Overall Study|Lack of Efficacy|0|||
16847808|NCT00984568|37792880|FG000|Overall Study|Adverse Event|2|||
16847809|NCT00984568|37792881|FG001|Overall Study|Adverse Event|0|||
16847810|NCT00984568|37792880|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
16847811|NCT00984568|37792881|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
16847812|NCT00984568|37792880|FG000|Overall Study|Lost to Follow-up|0|||
16847813|NCT00984568|37792881|FG001|Overall Study|Lost to Follow-up|1|||
16847814|NCT00984568|37792880|FG000|Overall Study|Opportunistic Infection|1|||
16847815|NCT00984568|37792881|FG001|Overall Study|Opportunistic Infection|0|||
16847816|NCT00984568|37792880|FG000|Overall Study|Unknown Reason|1|||
16847817|NCT00984568|37792881|FG001|Overall Study|Unknown Reason|3|||
16847818|NCT00984256|37792889|FG000|Overall Study|Withdrawal by Subject|0|||
16847819|NCT00984256|37792890|FG001|Overall Study|Withdrawal by Subject|1|||
16847820|NCT00984022|37792907|FG000|Overall Study|Lost to Follow-up|10|||
16923544|NCT01714817|38064914|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
16923545|NCT01714817|38064915|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
16923546|NCT01714817|38064914|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
16923547|NCT01714817|38064915|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
16923548|NCT01714817|38064914|FG000|Year 2 Period|Lack of Efficacy|4|||
16923549|NCT01714817|38064915|FG001|Year 2 Period|Lack of Efficacy|12|||
16923550|NCT01714817|38064914|FG000|Year 2 Period|Adverse Event|7|||
16923551|NCT01714817|38064915|FG001|Year 2 Period|Adverse Event|6|||
16923552|NCT01714817|38064914|FG000|Year 2 Period|Participant request to stop treatment|4|||
16923553|NCT01714817|38064915|FG001|Year 2 Period|Participant request to stop treatment|4|||
16847821|NCT00984022|37792908|FG001|Overall Study|Lost to Follow-up|14|||
16847822|NCT01890265|37792920|FG000|Overall Study|Other (Unspecified reason)|0|||
16847823|NCT01890265|37792921|FG001|Overall Study|Other (Unspecified reason)|1|||
16847824|NCT01890265|37792922|FG002|Overall Study|Other (Unspecified reason)|0|||
16847825|NCT01890265|37792923|FG003|Overall Study|Other (Unspecified reason)|0|||
16847826|NCT01890265|37792924|FG004|Overall Study|Other (Unspecified reason)|0|||
16847827|NCT01890265|37792925|FG005|Overall Study|Other (Unspecified reason)|0|||
16847828|NCT01890265|37792920|FG000|Overall Study|Progressive disease|6|||
16847829|NCT01890265|37792921|FG001|Overall Study|Progressive disease|6|||
16847830|NCT01890265|37792922|FG002|Overall Study|Progressive disease|0|||
16847831|NCT01890265|37792923|FG003|Overall Study|Progressive disease|0|||
16847832|NCT01890265|37792924|FG004|Overall Study|Progressive disease|0|||
16847833|NCT01890265|37792925|FG005|Overall Study|Progressive disease|0|||
16847834|NCT01890265|37792920|FG000|Overall Study|Adverse Event|2|||
16847835|NCT01890265|37792921|FG001|Overall Study|Adverse Event|1|||
16847836|NCT01890265|37792922|FG002|Overall Study|Adverse Event|0|||
16847837|NCT01890265|37792923|FG003|Overall Study|Adverse Event|0|||
16847838|NCT01890265|37792924|FG004|Overall Study|Adverse Event|0|||
16847839|NCT01890265|37792925|FG005|Overall Study|Adverse Event|0|||
16847840|NCT01890265|37792920|FG000|Overall Study|Death|2|||
16847841|NCT01890265|37792921|FG001|Overall Study|Death|3|||
16847842|NCT01890265|37792922|FG002|Overall Study|Death|1|||
16847843|NCT01890265|37792923|FG003|Overall Study|Death|0|||
16847844|NCT01890265|37792924|FG004|Overall Study|Death|0|||
16847845|NCT01890265|37792925|FG005|Overall Study|Death|0|||
16847846|NCT01890265|37792920|FG000|Overall Study|Withdrawal by Subject|0|||
16847847|NCT01890265|37792921|FG001|Overall Study|Withdrawal by Subject|2|||
16847848|NCT01890265|37792922|FG002|Overall Study|Withdrawal by Subject|3|||
16847849|NCT01890265|37792923|FG003|Overall Study|Withdrawal by Subject|0|||
16847850|NCT01890265|37792924|FG004|Overall Study|Withdrawal by Subject|2|||
16847851|NCT01890265|37792925|FG005|Overall Study|Withdrawal by Subject|0|||
16847852|NCT01928329|37792946|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
16847853|NCT01928329|37792947|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
16847854|NCT01928329|37792946|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
16847855|NCT01928329|37792947|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
16847856|NCT01928329|37792946|FG000|Overall Study|Adverse Event|5|||
16847857|NCT01928329|37792947|FG001|Overall Study|Adverse Event|3|||
16847858|NCT01928329|37792946|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
16847859|NCT01928329|37792947|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
16847860|NCT01928329|37792946|FG000|Overall Study|Withdrawal by Subject|1|||
16847861|NCT01928329|37792947|FG001|Overall Study|Withdrawal by Subject|5|||
16847862|NCT01928329|37792946|FG000|Overall Study|Physician Decision|1|||
16847863|NCT01928329|37792947|FG001|Overall Study|Physician Decision|1|||
16847864|NCT01890109|37792955|FG000|Overall Study|Withdrawal by Subject|0|||
16847865|NCT01890109|37792956|FG001|Overall Study|Withdrawal by Subject|3|||
16847866|NCT01890109|37792955|FG000|Overall Study|Lost to Follow-up|1|||
16847867|NCT01890109|37792956|FG001|Overall Study|Lost to Follow-up|2|||
16847868|NCT00982930|37792963|FG000|Overall Study|Adverse Event|1|||
16847869|NCT00982930|37792963|FG000|Overall Study|Withdrawal by Subject|1|||
16847870|NCT00982930|37792963|FG000|Overall Study|Administrative Problems|2|||
16847871|NCT00981682|37792967|FG000|Overall Study|Adverse Event|48|||
16847872|NCT00981682|37792967|FG000|Overall Study|Withdrawal by Subject|52|||
16847873|NCT00981682|37792967|FG000|Overall Study|Lost to Follow-up|14|||
16847874|NCT00981682|37792967|FG000|Overall Study|Lack of Efficacy|13|||
16847875|NCT00981682|37792967|FG000|Overall Study|Protocol Violation|6|||
16847876|NCT00981682|37792967|FG000|Overall Study|administrative|9|||
16847877|NCT01903993|37792973|FG000|Overall Study|Death|118|||
16847878|NCT01903993|37792974|FG001|Overall Study|Death|121|||
16847879|NCT01903993|37792973|FG000|Overall Study|Withdrawal by Subject|15|||
16847880|NCT01903993|37792974|FG001|Overall Study|Withdrawal by Subject|4|||
16847881|NCT01903993|37792973|FG000|Overall Study|Lost to Follow-up|2|||
16847882|NCT01903993|37792974|FG001|Overall Study|Lost to Follow-up|3|||
16847883|NCT01903993|37792973|FG000|Overall Study|Study Terminated by Sponsor|8|||
16847884|NCT01903993|37792974|FG001|Overall Study|Study Terminated by Sponsor|14|||
16847885|NCT01903993|37792973|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
16847886|NCT01903993|37792974|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
16847887|NCT00981292|37792987|FG000|Day 1|Protocol Violation|1|||
16847888|NCT00981292|37792988|FG001|Day 1|Protocol Violation|0|||
16847889|NCT00981292|37792989|FG002|Day 1|Protocol Violation|0|||
16847890|NCT00981292|37792990|FG003|Day 1|Protocol Violation|0|||
16847891|NCT00981292|37792991|FG004|Day 1|Protocol Violation|0|||
16847892|NCT00981292|37792992|FG005|Day 1|Protocol Violation|2|||
16847893|NCT00981292|37792987|FG000|Day 2|Protocol Violation|2|||
16847894|NCT00981292|37792988|FG001|Day 2|Protocol Violation|0|||
16847895|NCT00981292|37792989|FG002|Day 2|Protocol Violation|0|||
16847896|NCT00981292|37792990|FG003|Day 2|Protocol Violation|0|||
16847897|NCT00981292|37792991|FG004|Day 2|Protocol Violation|0|||
16847898|NCT00981292|37792992|FG005|Day 2|Protocol Violation|0|||
16847899|NCT00981292|37792987|FG000|Day 3|Protocol Violation|0|||
16847900|NCT00981292|37792988|FG001|Day 3|Protocol Violation|0|||
16847901|NCT00981292|37792989|FG002|Day 3|Protocol Violation|0|||
16847902|NCT00981292|37792990|FG003|Day 3|Protocol Violation|0|||
16847903|NCT00981292|37792991|FG004|Day 3|Protocol Violation|0|||
16847904|NCT00981292|37792992|FG005|Day 3|Protocol Violation|1|||
16847905|NCT00980044|37793007|FG000|Overall Study|Withdrawal by Subject|5|||
16847906|NCT00980044|37793008|FG001|Overall Study|Withdrawal by Subject|7|||
16847907|NCT00980044|37793009|FG002|Overall Study|Withdrawal by Subject|3|||
16847908|NCT00980044|37793007|FG000|Overall Study|Protocol Violation|0|||
16847909|NCT00980044|37793008|FG001|Overall Study|Protocol Violation|0|||
16847910|NCT00980044|37793009|FG002|Overall Study|Protocol Violation|2|||
16847911|NCT01903837|37793024|FG000|Part A|Withdrawal by Subject|4|||
16847912|NCT01903837|37793025|FG001|Part A|Withdrawal by Subject|9|||
16847913|NCT01903837|37793026|FG002|Part A|Withdrawal by Subject|8|||
16847914|NCT01903837|37793027|FG003|Part A|Withdrawal by Subject|5|||
16847915|NCT01903837|37793024|FG000|Part A|Adverse Event|3|||
16847916|NCT01903837|37793025|FG001|Part A|Adverse Event|6|||
16847917|NCT01903837|37793026|FG002|Part A|Adverse Event|9|||
16847918|NCT01903837|37793027|FG003|Part A|Adverse Event|6|||
16847919|NCT01903837|37793024|FG000|Part A|Lost to Follow-up|9|||
16847920|NCT01903837|37793025|FG001|Part A|Lost to Follow-up|7|||
16847921|NCT01903837|37793026|FG002|Part A|Lost to Follow-up|7|||
16847922|NCT01903837|37793027|FG003|Part A|Lost to Follow-up|2|||
16847923|NCT01903837|37793024|FG000|Part A|Non-compliance with study drug|1|||
16847924|NCT01903837|37793025|FG001|Part A|Non-compliance with study drug|4|||
16847925|NCT01903837|37793026|FG002|Part A|Non-compliance with study drug|4|||
16847926|NCT01903837|37793027|FG003|Part A|Non-compliance with study drug|0|||
16847927|NCT01903837|37793024|FG000|Part A|Physician Decision|1|||
16923554|NCT01714817|38064914|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
16923555|NCT01714817|38064915|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
16923556|NCT01714817|38064914|FG000|Year 2 Period|Participant withdrew consent|1|||
16847928|NCT01903837|37793025|FG001|Part A|Physician Decision|1|||
16847929|NCT01903837|37793026|FG002|Part A|Physician Decision|0|||
16847930|NCT01903837|37793027|FG003|Part A|Physician Decision|0|||
16847931|NCT01903837|37793024|FG000|Part A|Protocol Violation|1|||
16847932|NCT01903837|37793025|FG001|Part A|Protocol Violation|1|||
16847933|NCT01903837|37793026|FG002|Part A|Protocol Violation|0|||
16847934|NCT01903837|37793027|FG003|Part A|Protocol Violation|0|||
16847935|NCT01903837|37793024|FG000|Part B|Lost to Follow-up|0|||
16847936|NCT01903837|37793025|FG001|Part B|Lost to Follow-up|3|||
16847937|NCT01903837|37793026|FG002|Part B|Lost to Follow-up|3|||
16847938|NCT01903837|37793027|FG003|Part B|Lost to Follow-up|4|||
16847939|NCT01903837|37793024|FG000|Part B|Withdrawal by Subject|1|||
16847940|NCT01903837|37793025|FG001|Part B|Withdrawal by Subject|2|||
16847941|NCT01903837|37793026|FG002|Part B|Withdrawal by Subject|0|||
16847942|NCT01903837|37793027|FG003|Part B|Withdrawal by Subject|3|||
16847943|NCT01903837|37793024|FG000|Part B|Adverse Event|3|||
16847944|NCT01903837|37793025|FG001|Part B|Adverse Event|0|||
16847945|NCT01903837|37793026|FG002|Part B|Adverse Event|2|||
16847946|NCT01903837|37793027|FG003|Part B|Adverse Event|0|||
16847947|NCT01903837|37793024|FG000|Part B|Non-compliance with study drug|2|||
16847948|NCT01903837|37793025|FG001|Part B|Non-compliance with study drug|0|||
16847949|NCT01903837|37793026|FG002|Part B|Non-compliance with study drug|0|||
16847950|NCT01903837|37793027|FG003|Part B|Non-compliance with study drug|1|||
16847951|NCT01903837|37793024|FG000|Part B|Incarceration|2|||
16847952|NCT01903837|37793025|FG001|Part B|Incarceration|0|||
16847953|NCT01903837|37793026|FG002|Part B|Incarceration|0|||
16847954|NCT01903837|37793027|FG003|Part B|Incarceration|1|||
16847955|NCT01903837|37793024|FG000|Part B|Physician Decision|1|||
16847956|NCT01903837|37793025|FG001|Part B|Physician Decision|0|||
16847957|NCT01903837|37793026|FG002|Part B|Physician Decision|0|||
16847958|NCT01903837|37793027|FG003|Part B|Physician Decision|2|||
16847959|NCT01903837|37793024|FG000|Part B|Lack of Efficacy|0|||
16847960|NCT01903837|37793025|FG001|Part B|Lack of Efficacy|1|||
16847961|NCT01903837|37793026|FG002|Part B|Lack of Efficacy|0|||
16847962|NCT01903837|37793027|FG003|Part B|Lack of Efficacy|0|||
16847963|NCT01903525|37793060|FG000|Overall Study|Lost to Follow-up|5|||
16847964|NCT01903525|37793061|FG001|Overall Study|Lost to Follow-up|9|||
16847965|NCT01903525|37793060|FG000|Overall Study|Adverse Event|0|||
16847966|NCT01903525|37793061|FG001|Overall Study|Adverse Event|1|||
16847967|NCT00981526|37793069|FG000|Overall Study|Withdrawal by Subject|0|||
16847968|NCT00981526|37793070|FG001|Overall Study|Withdrawal by Subject|2|||
16847969|NCT00981526|37793069|FG000|Overall Study|Physician Decision|4|||
16847970|NCT00981526|37793070|FG001|Overall Study|Physician Decision|4|||
16847971|NCT01927861|37793080|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
16847972|NCT01927861|37793081|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
16847973|NCT01927861|37793080|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
16847974|NCT01927861|37793081|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
16847975|NCT01927627|37793087|FG000|Overall Study|Adverse Event|3|||
16847976|NCT01927627|37793087|FG000|Overall Study|Lack of Efficacy|1|||
16847977|NCT01927627|37793087|FG000|Overall Study|Financial Concerns|1|||
16847978|NCT01889251|37793093|FG000|Overall Study|Adverse Event|1|||
16847979|NCT01889251|37793094|FG001|Overall Study|Adverse Event|0|||
16847980|NCT01616563|37793100|FG000|Overall Study|Lost to Follow-up|40|||
16847981|NCT01616173|37793108|FG000|Overall Study|Lost to Follow-up|0|||
16847982|NCT01616173|37793109|FG001|Overall Study|Lost to Follow-up|2|||
16847983|NCT01616173|37793110|FG002|Overall Study|Lost to Follow-up|0|||
16847984|NCT01544595|37793124|FG000|Status at Week 68|Adverse Event|3|||
16847985|NCT01544595|37793125|FG001|Status at Week 68|Adverse Event|2|||
16847986|NCT01544595|37793126|FG002|Status at Week 68|Adverse Event|1|||
16847987|NCT01544595|37793127|FG003|Status at Week 68|Adverse Event|0|||
16847988|NCT01544595|37793128|FG004|Status at Week 68|Adverse Event|0|||
16847989|NCT01544595|37793129|FG005|Status at Week 68|Adverse Event|0|||
16847990|NCT01544595|37793124|FG000|Status at Week 68|Lack of Efficacy|1|||
16847991|NCT01544595|37793125|FG001|Status at Week 68|Lack of Efficacy|0|||
16847992|NCT01544595|37793126|FG002|Status at Week 68|Lack of Efficacy|0|||
16847993|NCT01544595|37793127|FG003|Status at Week 68|Lack of Efficacy|0|||
16847994|NCT01544595|37793128|FG004|Status at Week 68|Lack of Efficacy|0|||
16847995|NCT01544595|37793129|FG005|Status at Week 68|Lack of Efficacy|0|||
16847996|NCT01544595|37793124|FG000|Status at Week 68|Lost to Follow-up|1|||
16847997|NCT01544595|37793125|FG001|Status at Week 68|Lost to Follow-up|1|||
16847998|NCT01544595|37793126|FG002|Status at Week 68|Lost to Follow-up|0|||
16847999|NCT01544595|37793127|FG003|Status at Week 68|Lost to Follow-up|0|||
16848000|NCT01544595|37793128|FG004|Status at Week 68|Lost to Follow-up|0|||
16848001|NCT01544595|37793129|FG005|Status at Week 68|Lost to Follow-up|0|||
16848002|NCT01544595|37793124|FG000|Status at Week 68|Non-compliance with study treatment|1|||
16848003|NCT01544595|37793125|FG001|Status at Week 68|Non-compliance with study treatment|0|||
16848004|NCT01544595|37793126|FG002|Status at Week 68|Non-compliance with study treatment|0|||
16848005|NCT01544595|37793127|FG003|Status at Week 68|Non-compliance with study treatment|1|||
16848006|NCT01544595|37793128|FG004|Status at Week 68|Non-compliance with study treatment|0|||
16848007|NCT01544595|37793129|FG005|Status at Week 68|Non-compliance with study treatment|0|||
16848008|NCT01544595|37793124|FG000|Status at Week 68|Protocol Violation|2|||
16848009|NCT01544595|37793125|FG001|Status at Week 68|Protocol Violation|0|||
16848010|NCT01544595|37793126|FG002|Status at Week 68|Protocol Violation|1|||
16848011|NCT01544595|37793127|FG003|Status at Week 68|Protocol Violation|1|||
16848012|NCT01544595|37793128|FG004|Status at Week 68|Protocol Violation|0|||
16848013|NCT01544595|37793129|FG005|Status at Week 68|Protocol Violation|0|||
16848014|NCT01544595|37793124|FG000|Status at Week 68|Technical problems|1|||
16848015|NCT01544595|37793125|FG001|Status at Week 68|Technical problems|0|||
17017830|NCT00807573|38162424|FG000|Overall Study|Withdrawal by Subject|1|||
16848016|NCT01544595|37793126|FG002|Status at Week 68|Technical problems|0|||
16848017|NCT01544595|37793127|FG003|Status at Week 68|Technical problems|1|||
16848018|NCT01544595|37793128|FG004|Status at Week 68|Technical problems|0|||
16848019|NCT01544595|37793129|FG005|Status at Week 68|Technical problems|0|||
16848020|NCT01544595|37793124|FG000|Status at Week 68|Withdrawal by Subject|0|||
16848021|NCT01544595|37793125|FG001|Status at Week 68|Withdrawal by Subject|1|||
16848022|NCT01544595|37793126|FG002|Status at Week 68|Withdrawal by Subject|1|||
16848023|NCT01544595|37793127|FG003|Status at Week 68|Withdrawal by Subject|2|||
16848024|NCT01544595|37793128|FG004|Status at Week 68|Withdrawal by Subject|0|||
16848025|NCT01544595|37793129|FG005|Status at Week 68|Withdrawal by Subject|0|||
16923557|NCT01714817|38064915|FG001|Year 2 Period|Participant withdrew consent|5|||
16923558|NCT01714817|38064914|FG000|Year 2 Period|Participant no longer meets criteria|1|||
16923559|NCT01714817|38064915|FG001|Year 2 Period|Participant no longer meets criteria|4|||
16923560|NCT01714817|38064914|FG000|Year 2 Period|Lost to Follow-up|2|||
16923561|NCT01714817|38064915|FG001|Year 2 Period|Lost to Follow-up|0|||
16923562|NCT01714817|38064914|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
16923563|NCT01714817|38064915|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
16923564|NCT01714817|38064914|FG000|Year 2 Period|Pregnancy|1|||
16923565|NCT01714817|38064915|FG001|Year 2 Period|Pregnancy|1|||
16923566|NCT01714817|38064914|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
16923567|NCT01714817|38064915|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
16923568|NCT01714817|38064914|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
16848026|NCT01544595|37793124|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
16848027|NCT01544595|37793125|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
16848028|NCT01544595|37793126|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
16848029|NCT01544595|37793127|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
16923569|NCT01714817|38064915|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
16923570|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
16923571|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
16923572|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
16923573|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
16923574|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
16923575|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
16923576|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
16923577|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
16923578|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
16923579|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
16923580|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
16923581|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
16923582|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
16923583|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
16923584|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
16923585|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
16923586|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
16923587|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
16923588|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
16923589|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
16923590|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
16923591|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
16923592|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
16923593|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
16923594|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
16923595|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
16923596|NCT01714817|38064914|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
16923597|NCT01714817|38064915|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
16923598|NCT01755689|38064939|FG000|Overall Study|Withdrawal by Subject|1|||
16923599|NCT01755689|38064940|FG001|Overall Study|Withdrawal by Subject|3|||
16923600|NCT01755689|38064941|FG002|Overall Study|Withdrawal by Subject|2|||
16923601|NCT01755689|38064942|FG003|Overall Study|Withdrawal by Subject|1|||
16923602|NCT01755689|38064943|FG004|Overall Study|Withdrawal by Subject|1|||
16923603|NCT01755689|38064939|FG000|Overall Study|Migrated/moved from study area|0|||
16923604|NCT01755689|38064940|FG001|Overall Study|Migrated/moved from study area|1|||
16923605|NCT01755689|38064941|FG002|Overall Study|Migrated/moved from study area|1|||
16923606|NCT01755689|38064942|FG003|Overall Study|Migrated/moved from study area|1|||
16923607|NCT01755689|38064943|FG004|Overall Study|Migrated/moved from study area|1|||
16923608|NCT01755689|38064939|FG000|Overall Study|Lost to Follow-up|1|||
16923609|NCT01755689|38064940|FG001|Overall Study|Lost to Follow-up|0|||
16923610|NCT01755689|38064941|FG002|Overall Study|Lost to Follow-up|1|||
16848030|NCT01544595|37793128|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
16848031|NCT01544595|37793129|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
16923611|NCT01755689|38064942|FG003|Overall Study|Lost to Follow-up|0|||
16923612|NCT01755689|38064943|FG004|Overall Study|Lost to Follow-up|2|||
16923613|NCT01755689|38064939|FG000|Overall Study|Pregnancy|1|||
16923614|NCT01755689|38064940|FG001|Overall Study|Pregnancy|1|||
16923615|NCT01755689|38064941|FG002|Overall Study|Pregnancy|2|||
16923616|NCT01755689|38064942|FG003|Overall Study|Pregnancy|4|||
16923617|NCT01755689|38064943|FG004|Overall Study|Pregnancy|2|||
16923618|NCT01762761|38064965|FG000|Overall Study|Adverse Event|15|||
16923619|NCT01762761|38064966|FG001|Overall Study|Adverse Event|17|||
16923620|NCT01762761|38064965|FG000|Overall Study|Lack of Efficacy|9|||
16923621|NCT01762761|38064966|FG001|Overall Study|Lack of Efficacy|25|||
16923622|NCT01762761|38064965|FG000|Overall Study|Protocol Violation|1|||
16923623|NCT01762761|38064966|FG001|Overall Study|Protocol Violation|1|||
16923624|NCT01762761|38064965|FG000|Overall Study|Study closed/terminated|0|||
16923625|NCT01762761|38064966|FG001|Overall Study|Study closed/terminated|2|||
16923626|NCT01762761|38064965|FG000|Overall Study|Lost to Follow-up|3|||
16923627|NCT01762761|38064966|FG001|Overall Study|Lost to Follow-up|6|||
16923628|NCT01762761|38064965|FG000|Overall Study|Physician Decision|4|||
16923629|NCT01762761|38064966|FG001|Overall Study|Physician Decision|6|||
16923630|NCT01762761|38064965|FG000|Overall Study|Withdrawal by Subject|7|||
16923631|NCT01762761|38064966|FG001|Overall Study|Withdrawal by Subject|8|||
16848032|NCT01544595|37793124|FG000|Status at Week 156|Withdrawal by Subject|9|||
16848033|NCT01544595|37793125|FG001|Status at Week 156|Withdrawal by Subject|10|||
16848034|NCT01544595|37793126|FG002|Status at Week 156|Withdrawal by Subject|4|||
16848035|NCT01544595|37793127|FG003|Status at Week 156|Withdrawal by Subject|9|||
16848036|NCT01544595|37793128|FG004|Status at Week 156|Withdrawal by Subject|20|||
16848037|NCT01544595|37793129|FG005|Status at Week 156|Withdrawal by Subject|6|||
16848038|NCT01544595|37793124|FG000|Status at Week 156|Adverse Event|9|||
16848039|NCT01544595|37793125|FG001|Status at Week 156|Adverse Event|11|||
16848040|NCT01544595|37793126|FG002|Status at Week 156|Adverse Event|1|||
16848041|NCT01544595|37793127|FG003|Status at Week 156|Adverse Event|3|||
16848042|NCT01544595|37793128|FG004|Status at Week 156|Adverse Event|4|||
16848043|NCT01544595|37793129|FG005|Status at Week 156|Adverse Event|2|||
16848044|NCT01544595|37793124|FG000|Status at Week 156|Lost to Follow-up|4|||
16848045|NCT01544595|37793125|FG001|Status at Week 156|Lost to Follow-up|4|||
16848046|NCT01544595|37793126|FG002|Status at Week 156|Lost to Follow-up|0|||
16848047|NCT01544595|37793127|FG003|Status at Week 156|Lost to Follow-up|1|||
16848048|NCT01544595|37793128|FG004|Status at Week 156|Lost to Follow-up|4|||
16848049|NCT01544595|37793129|FG005|Status at Week 156|Lost to Follow-up|1|||
16848050|NCT01544595|37793124|FG000|Status at Week 156|Non-compliance with study treatement|0|||
16848051|NCT01544595|37793125|FG001|Status at Week 156|Non-compliance with study treatement|1|||
16848052|NCT01544595|37793126|FG002|Status at Week 156|Non-compliance with study treatement|0|||
16848053|NCT01544595|37793127|FG003|Status at Week 156|Non-compliance with study treatement|1|||
16848054|NCT01544595|37793128|FG004|Status at Week 156|Non-compliance with study treatement|0|||
16848055|NCT01544595|37793129|FG005|Status at Week 156|Non-compliance with study treatement|1|||
16848056|NCT01544595|37793124|FG000|Status at Week 156|Physician Decision|0|||
16848057|NCT01544595|37793125|FG001|Status at Week 156|Physician Decision|3|||
16848058|NCT01544595|37793126|FG002|Status at Week 156|Physician Decision|1|||
16848059|NCT01544595|37793127|FG003|Status at Week 156|Physician Decision|0|||
16848060|NCT01544595|37793128|FG004|Status at Week 156|Physician Decision|0|||
16848061|NCT01544595|37793129|FG005|Status at Week 156|Physician Decision|0|||
16848062|NCT01544595|37793124|FG000|Status at Week 156|Pregnancy|2|||
16848063|NCT01544595|37793125|FG001|Status at Week 156|Pregnancy|3|||
16848064|NCT01544595|37793126|FG002|Status at Week 156|Pregnancy|0|||
16848065|NCT01544595|37793127|FG003|Status at Week 156|Pregnancy|0|||
16848066|NCT01544595|37793128|FG004|Status at Week 156|Pregnancy|0|||
16848067|NCT01544595|37793129|FG005|Status at Week 156|Pregnancy|0|||
16848068|NCT01544595|37793124|FG000|Status at Week 156|Protocol Violation|3|||
16848069|NCT01544595|37793125|FG001|Status at Week 156|Protocol Violation|1|||
16848070|NCT01544595|37793126|FG002|Status at Week 156|Protocol Violation|2|||
16848071|NCT01544595|37793127|FG003|Status at Week 156|Protocol Violation|2|||
16848072|NCT01544595|37793128|FG004|Status at Week 156|Protocol Violation|0|||
16848073|NCT01544595|37793129|FG005|Status at Week 156|Protocol Violation|0|||
16848074|NCT01544595|37793124|FG000|Status at Week 156|Technical problems|3|||
16848075|NCT01544595|37793125|FG001|Status at Week 156|Technical problems|1|||
16848076|NCT01544595|37793126|FG002|Status at Week 156|Technical problems|0|||
16848077|NCT01544595|37793127|FG003|Status at Week 156|Technical problems|1|||
16848078|NCT01544595|37793128|FG004|Status at Week 156|Technical problems|0|||
16848079|NCT01544595|37793129|FG005|Status at Week 156|Technical problems|0|||
16848080|NCT01544595|37793124|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
16848081|NCT01544595|37793125|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
16848082|NCT01544595|37793126|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
16848083|NCT01544595|37793127|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
16848084|NCT01544595|37793128|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
16923632|NCT01763788|38064977|FG000|Overall Study|Lost to Follow-up|0|||
16923633|NCT01763788|38064978|FG001|Overall Study|Lost to Follow-up|0|||
16848085|NCT01544595|37793129|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
16848086|NCT01544595|37793124|FG000|Status at Week 156|Lack of Efficacy|1|||
16848087|NCT01544595|37793125|FG001|Status at Week 156|Lack of Efficacy|0|||
16848088|NCT01544595|37793126|FG002|Status at Week 156|Lack of Efficacy|1|||
16848089|NCT01544595|37793127|FG003|Status at Week 156|Lack of Efficacy|4|||
16848090|NCT01544595|37793128|FG004|Status at Week 156|Lack of Efficacy|10|||
16923634|NCT01763788|38064979|FG002|Overall Study|Lost to Follow-up|1|||
16923635|NCT01763788|38064980|FG003|Overall Study|Lost to Follow-up|0|||
16923636|NCT01774370|38064990|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
16923637|NCT01774370|38064990|FG000|Overall Study|Administered prior to the contract date|4|||
16923638|NCT01774370|38064990|FG000|Overall Study|Subjects of contraindications|34|||
16923639|NCT01774370|38064990|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
16923640|NCT01774370|38064990|FG000|Overall Study|Follow-up failure|34|||
16923641|NCT01777295|38064996|FG000|Overall Study|Withdrawal by Subject|2|||
16923642|NCT01777295|38064997|FG001|Overall Study|Withdrawal by Subject|2|||
16923643|NCT01777295|38064996|FG000|Overall Study|Pregnancy|0|||
16923644|NCT01777295|38064997|FG001|Overall Study|Pregnancy|1|||
16923645|NCT01777295|38064996|FG000|Overall Study|Personal problem|1|||
16923646|NCT01777295|38064997|FG001|Overall Study|Personal problem|0|||
16923647|NCT01777295|38064996|FG000|Overall Study|Investigator call for AEs check|1|||
16923648|NCT01777295|38064997|FG001|Overall Study|Investigator call for AEs check|0|||
16923649|NCT01787552|38065017|FG000|Overall Study|Withdrawal by Subject|2|||
16923650|NCT01787552|38065018|FG001|Overall Study|Withdrawal by Subject|0|||
16923651|NCT01787552|38065019|FG002|Overall Study|Withdrawal by Subject|0|||
16923652|NCT01787552|38065020|FG003|Overall Study|Withdrawal by Subject|4|||
16923653|NCT01787552|38065017|FG000|Overall Study|Physician Decision|2|||
16923654|NCT01787552|38065018|FG001|Overall Study|Physician Decision|2|||
16923655|NCT01787552|38065019|FG002|Overall Study|Physician Decision|1|||
16923656|NCT01787552|38065020|FG003|Overall Study|Physician Decision|2|||
16923657|NCT01787552|38065017|FG000|Overall Study|Death|0|||
16923658|NCT01787552|38065018|FG001|Overall Study|Death|0|||
16923659|NCT01787552|38065019|FG002|Overall Study|Death|0|||
16923660|NCT01787552|38065020|FG003|Overall Study|Death|1|||
16923661|NCT01787552|38065017|FG000|Overall Study|Adverse Event|2|||
16923662|NCT01787552|38065018|FG001|Overall Study|Adverse Event|5|||
16923663|NCT01787552|38065019|FG002|Overall Study|Adverse Event|2|||
16923664|NCT01787552|38065020|FG003|Overall Study|Adverse Event|16|||
16923665|NCT01787552|38065017|FG000|Overall Study|Study terminated by Sponsor|0|||
16923666|NCT01787552|38065018|FG001|Overall Study|Study terminated by Sponsor|0|||
16923667|NCT01787552|38065019|FG002|Overall Study|Study terminated by Sponsor|1|||
16923668|NCT01787552|38065020|FG003|Overall Study|Study terminated by Sponsor|3|||
16923669|NCT01787552|38065017|FG000|Overall Study|Progressive Disease|2|||
16923670|NCT01787552|38065018|FG001|Overall Study|Progressive Disease|2|||
16923671|NCT01787552|38065019|FG002|Overall Study|Progressive Disease|1|||
16923672|NCT01787552|38065020|FG003|Overall Study|Progressive Disease|1|||
16923673|NCT01808261|38065037|FG000|Overall Study|Physician Decision|0|||
16848091|NCT01544595|37793129|FG005|Status at Week 156|Lack of Efficacy|5|||
16848092|NCT01539525|37793150|FG000|Overall Study|Lost to Follow-up|19|||
16848093|NCT01539525|37793151|FG001|Overall Study|Lost to Follow-up|12|||
16848094|NCT01539525|37793152|FG002|Overall Study|Lost to Follow-up|11|||
16848095|NCT01539525|37793150|FG000|Overall Study|Withdrawal by Subject|0|||
16848096|NCT01539525|37793151|FG001|Overall Study|Withdrawal by Subject|3|||
16848097|NCT01539525|37793152|FG002|Overall Study|Withdrawal by Subject|2|||
16848098|NCT01539525|37793150|FG000|Overall Study|Protocol Violation|1|||
16848099|NCT01539525|37793151|FG001|Overall Study|Protocol Violation|1|||
16848100|NCT01539525|37793152|FG002|Overall Study|Protocol Violation|4|||
16848101|NCT01513551|37793166|FG000|Overall Study|Death|0|||
16848102|NCT01513551|37793167|FG001|Overall Study|Death|1|||
16848103|NCT01513551|37793168|FG002|Overall Study|Death|0|||
16848104|NCT01513551|37793166|FG000|Overall Study|Lost to Follow-up|3|||
16848105|NCT01513551|37793167|FG001|Overall Study|Lost to Follow-up|5|||
16848106|NCT01513551|37793168|FG002|Overall Study|Lost to Follow-up|2|||
16848107|NCT01513551|37793166|FG000|Overall Study|Withdrawal by Subject|1|||
16848108|NCT01513551|37793167|FG001|Overall Study|Withdrawal by Subject|0|||
16848109|NCT01513551|37793168|FG002|Overall Study|Withdrawal by Subject|2|||
16848110|NCT01513551|37793166|FG000|Overall Study|Randomized but not vaccinated|0|||
16848111|NCT01513551|37793167|FG001|Overall Study|Randomized but not vaccinated|0|||
16848112|NCT01513551|37793168|FG002|Overall Study|Randomized but not vaccinated|1|||
16848113|NCT01513473|37793178|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
16848114|NCT01513473|37793179|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
16848115|NCT01513473|37793178|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
16923674|NCT01808261|38065038|FG001|Overall Study|Physician Decision|2|||
16923675|NCT01808261|38065037|FG000|Overall Study|Study Closed/Terminated|25|||
16923676|NCT01808261|38065038|FG001|Overall Study|Study Closed/Terminated|23|||
16923677|NCT01808261|38065037|FG000|Overall Study|Adverse event, non-fatal|2|||
16923678|NCT01808261|38065038|FG001|Overall Study|Adverse event, non-fatal|0|||
16923679|NCT01808261|38065037|FG000|Overall Study|Consent withdrawn by subject|6|||
16848116|NCT01513473|37793179|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
16848117|NCT01513473|37793178|FG000|Main Trial (26 Weeks)|Unclassified|0|||
16848118|NCT01513473|37793179|FG001|Main Trial (26 Weeks)|Unclassified|2|||
16848119|NCT01513473|37793178|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
16848120|NCT01513473|37793179|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
16848121|NCT01513473|37793178|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
16848122|NCT01513473|37793179|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
16848123|NCT01513317|37793187|FG000|Overall Study|Withdrawal by Subject|15|||
16848124|NCT01513317|37793188|FG001|Overall Study|Withdrawal by Subject|4|||
16848125|NCT01513317|37793187|FG000|Overall Study|Death|1|||
16848126|NCT01513317|37793188|FG001|Overall Study|Death|1|||
16848127|NCT01513317|37793187|FG000|Overall Study|Study terminated by sponsor|18|||
16848128|NCT01513317|37793188|FG001|Overall Study|Study terminated by sponsor|18|||
16848129|NCT01513317|37793187|FG000|Overall Study|Other|0|||
16848130|NCT01513317|37793188|FG001|Overall Study|Other|1|||
16848131|NCT01901653|37793207|FG000|Overall Study|Death|2|||
16848132|NCT01901653|37793208|FG001|Overall Study|Death|1|||
16848133|NCT01901653|37793209|FG002|Overall Study|Death|8|||
16848134|NCT01901653|37793210|FG003|Overall Study|Death|3|||
16848135|NCT01901653|37793211|FG004|Overall Study|Death|2|||
16848136|NCT01901653|37793212|FG005|Overall Study|Death|2|||
16848137|NCT01901653|37793213|FG006|Overall Study|Death|6|||
16923680|NCT01808261|38065038|FG001|Overall Study|Consent withdrawn by subject|7|||
16923681|NCT01808261|38065037|FG000|Overall Study|Lost to Follow-up|3|||
16923682|NCT01808261|38065038|FG001|Overall Study|Lost to Follow-up|1|||
16923683|NCT01814826|38065057|FG000|Overall Study|Other|3|||
16923684|NCT01814826|38065058|FG001|Overall Study|Other|5|||
16923685|NCT01814826|38065059|FG002|Overall Study|Other|0|||
16923686|NCT01814826|38065057|FG000|Overall Study|Death|29|||
16923687|NCT01814826|38065058|FG001|Overall Study|Death|24|||
16923688|NCT01814826|38065059|FG002|Overall Study|Death|3|||
16923689|NCT01829711|38065068|FG000|Overall Study|Lost to Follow-up|2|||
16923690|NCT01829711|38065068|FG000|Overall Study|Withdrawal by Subject|3|||
16923691|NCT01829711|38065068|FG000|Overall Study|Death|4|||
16923692|NCT01829711|38065068|FG000|Overall Study|Started new therapies|17|||
16923693|NCT01829711|38065068|FG000|Overall Study|Adverse Event|3|||
16923694|NCT01829711|38065068|FG000|Overall Study|Due to progression of disease|13|||
16923695|NCT01829711|38065068|FG000|Overall Study|Due to lack of response|1|||
16923696|NCT01846273|38065075|FG000|Overall Study|Adverse Event|9|||
16923697|NCT01846273|38065076|FG001|Overall Study|Adverse Event|7|||
16923698|NCT01846273|38065077|FG002|Overall Study|Adverse Event|0|||
16923699|NCT01846273|38065075|FG000|Overall Study|Subject withdrew consent|5|||
16923700|NCT01846273|38065076|FG001|Overall Study|Subject withdrew consent|8|||
16923701|NCT01846273|38065077|FG002|Overall Study|Subject withdrew consent|0|||
16923702|NCT01846273|38065075|FG000|Overall Study|Lost to Follow-up|2|||
16923703|NCT01846273|38065076|FG001|Overall Study|Lost to Follow-up|1|||
16923704|NCT01846273|38065077|FG002|Overall Study|Lost to Follow-up|0|||
16923705|NCT01846273|38065075|FG000|Overall Study|Administrative problems|1|||
16923706|NCT01846273|38065076|FG001|Overall Study|Administrative problems|0|||
16923707|NCT01846273|38065077|FG002|Overall Study|Administrative problems|0|||
16923708|NCT01846273|38065075|FG000|Overall Study|Death|2|||
16923709|NCT01846273|38065076|FG001|Overall Study|Death|1|||
16923710|NCT01846273|38065077|FG002|Overall Study|Death|0|||
16923711|NCT01846273|38065075|FG000|Overall Study|Disease Progression|0|||
16923712|NCT01846273|38065076|FG001|Overall Study|Disease Progression|4|||
16923713|NCT01846273|38065077|FG002|Overall Study|Disease Progression|0|||
16923714|NCT01846273|38065075|FG000|Overall Study|Protocol Deviation|2|||
16923715|NCT01846273|38065076|FG001|Overall Study|Protocol Deviation|3|||
16923716|NCT01846273|38065077|FG002|Overall Study|Protocol Deviation|0|||
16923717|NCT01846273|38065075|FG000|Overall Study|Physician Decision|1|||
16923718|NCT01846273|38065076|FG001|Overall Study|Physician Decision|2|||
16923719|NCT01846273|38065077|FG002|Overall Study|Physician Decision|0|||
16923720|NCT01875185|38065087|FG000|Overall Study|study was terminated|52|||
16923721|NCT01875185|38065088|FG001|Overall Study|study was terminated|48|||
16923722|NCT01901432|38065117|FG000|Overall Study|Adverse Event|0|||
16923723|NCT01901432|38065118|FG001|Overall Study|Adverse Event|1|||
16848138|NCT01901653|37793214|FG007|Overall Study|Death|9|||
16848139|NCT01901653|37793215|FG008|Overall Study|Death|1|||
16848140|NCT01901653|37793216|FG009|Overall Study|Death|16|||
16848141|NCT01901653|37793217|FG010|Overall Study|Death|2|||
16848142|NCT01901653|37793218|FG011|Overall Study|Death|15|||
16848143|NCT01901653|37793219|FG012|Overall Study|Death|4|||
16923724|NCT01901432|38065119|FG002|Overall Study|Adverse Event|1|||
16848144|NCT01901653|37793207|FG000|Overall Study|Lost to Follow-up|1|||
16848145|NCT01901653|37793208|FG001|Overall Study|Lost to Follow-up|0|||
16923725|NCT01901432|38065120|FG003|Overall Study|Adverse Event|0|||
16923726|NCT01901432|38065121|FG004|Overall Study|Adverse Event|1|||
16923727|NCT01901432|38065117|FG000|Overall Study|Withdrawal by Subject|0|||
16923728|NCT01901432|38065118|FG001|Overall Study|Withdrawal by Subject|0|||
16848146|NCT01901653|37793209|FG002|Overall Study|Lost to Follow-up|2|||
16848147|NCT01901653|37793210|FG003|Overall Study|Lost to Follow-up|0|||
16848148|NCT01901653|37793211|FG004|Overall Study|Lost to Follow-up|0|||
16848149|NCT01901653|37793212|FG005|Overall Study|Lost to Follow-up|1|||
16848150|NCT01901653|37793213|FG006|Overall Study|Lost to Follow-up|0|||
16848151|NCT01901653|37793214|FG007|Overall Study|Lost to Follow-up|1|||
16848152|NCT01901653|37793215|FG008|Overall Study|Lost to Follow-up|0|||
16848153|NCT01901653|37793216|FG009|Overall Study|Lost to Follow-up|0|||
16848154|NCT01901653|37793217|FG010|Overall Study|Lost to Follow-up|0|||
16848155|NCT01901653|37793218|FG011|Overall Study|Lost to Follow-up|0|||
16848156|NCT01901653|37793219|FG012|Overall Study|Lost to Follow-up|0|||
16848157|NCT01901653|37793207|FG000|Overall Study|Withdrawal by Subject|0|||
16848158|NCT01901653|37793208|FG001|Overall Study|Withdrawal by Subject|0|||
16848159|NCT01901653|37793209|FG002|Overall Study|Withdrawal by Subject|0|||
16848160|NCT01901653|37793210|FG003|Overall Study|Withdrawal by Subject|0|||
16848161|NCT01901653|37793211|FG004|Overall Study|Withdrawal by Subject|0|||
16848162|NCT01901653|37793212|FG005|Overall Study|Withdrawal by Subject|0|||
16848163|NCT01901653|37793213|FG006|Overall Study|Withdrawal by Subject|1|||
16848164|NCT01901653|37793214|FG007|Overall Study|Withdrawal by Subject|0|||
16848165|NCT01901653|37793215|FG008|Overall Study|Withdrawal by Subject|0|||
16848166|NCT01901653|37793216|FG009|Overall Study|Withdrawal by Subject|0|||
16848167|NCT01901653|37793217|FG010|Overall Study|Withdrawal by Subject|0|||
16848168|NCT01901653|37793218|FG011|Overall Study|Withdrawal by Subject|0|||
16848169|NCT01901653|37793219|FG012|Overall Study|Withdrawal by Subject|0|||
16848170|NCT01901653|37793207|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
16848171|NCT01901653|37793208|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
16848172|NCT01901653|37793209|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
16848173|NCT01901653|37793210|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
16848174|NCT01901653|37793211|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
16848175|NCT01901653|37793212|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
16848176|NCT01901653|37793213|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
16848177|NCT01901653|37793214|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
16923729|NCT01901432|38065119|FG002|Overall Study|Withdrawal by Subject|1|||
16923730|NCT01901432|38065120|FG003|Overall Study|Withdrawal by Subject|0|||
16848178|NCT01901653|37793215|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
16923731|NCT01901432|38065121|FG004|Overall Study|Withdrawal by Subject|5|||
16923732|NCT01901432|38065117|FG000|Overall Study|Physician Decision|0|||
16923733|NCT01901432|38065118|FG001|Overall Study|Physician Decision|0|||
16923734|NCT01901432|38065119|FG002|Overall Study|Physician Decision|0|||
16923735|NCT01901432|38065120|FG003|Overall Study|Physician Decision|0|||
16923736|NCT01901432|38065121|FG004|Overall Study|Physician Decision|2|||
16923737|NCT01901432|38065117|FG000|Overall Study|Patient decision to stop study drug|0|||
16923738|NCT01901432|38065118|FG001|Overall Study|Patient decision to stop study drug|0|||
16923739|NCT01901432|38065119|FG002|Overall Study|Patient decision to stop study drug|0|||
16923740|NCT01901432|38065120|FG003|Overall Study|Patient decision to stop study drug|0|||
16923741|NCT01901432|38065121|FG004|Overall Study|Patient decision to stop study drug|1|||
16923742|NCT01904279|38065142|FG000|Overall Study|Lack of Efficacy|2|||
16923743|NCT01904279|38065143|FG001|Overall Study|Lack of Efficacy|3|||
16923744|NCT01904279|38065142|FG000|Overall Study|Withdrawal by Subject|1|||
16923745|NCT01904279|38065143|FG001|Overall Study|Withdrawal by Subject|0|||
16923746|NCT01917318|38065152|FG000|First Treatment|Withdrawal by Subject|0|||
16923747|NCT01917318|38065153|FG001|First Treatment|Withdrawal by Subject|1|||
16923748|NCT01923168|38065162|FG000|Overall Study|Protocol Violation|1|||
16923749|NCT01923168|38065163|FG001|Overall Study|Protocol Violation|1|||
16923750|NCT01923168|38065164|FG002|Overall Study|Protocol Violation|0|||
16923751|NCT01923168|38065162|FG000|Overall Study|Subject/guardian decision|14|||
16923752|NCT01923168|38065163|FG001|Overall Study|Subject/guardian decision|14|||
16923753|NCT01923168|38065164|FG002|Overall Study|Subject/guardian decision|4|||
16923754|NCT01923168|38065162|FG000|Overall Study|Adverse Event|12|||
16923755|NCT01923168|38065163|FG001|Overall Study|Adverse Event|12|||
16923756|NCT01923168|38065164|FG002|Overall Study|Adverse Event|0|||
16923757|NCT01923168|38065162|FG000|Overall Study|Physician Decision|6|||
16923758|NCT01923168|38065163|FG001|Overall Study|Physician Decision|9|||
16923759|NCT01923168|38065164|FG002|Overall Study|Physician Decision|5|||
16923760|NCT01923168|38065162|FG000|Overall Study|Progressive disease|4|||
16923761|NCT01923168|38065163|FG001|Overall Study|Progressive disease|3|||
16923762|NCT01923168|38065164|FG002|Overall Study|Progressive disease|7|||
16923763|NCT01923168|38065162|FG000|Overall Study|Death|0|||
16923764|NCT01923168|38065163|FG001|Overall Study|Death|0|||
16923765|NCT01923168|38065164|FG002|Overall Study|Death|1|||
16923766|NCT01931098|38065174|FG000|Overall Study|Withdrawal by Subject|0|||
16923767|NCT01931098|38065175|FG001|Overall Study|Withdrawal by Subject|1|||
16923768|NCT01931098|38065174|FG000|Overall Study|Enrolled in different protocol|0|||
16923769|NCT01931098|38065175|FG001|Overall Study|Enrolled in different protocol|1|||
16923770|NCT01931098|38065174|FG000|Overall Study|Unable to begin trmt:active infection|0|||
16923771|NCT01931098|38065175|FG001|Overall Study|Unable to begin trmt:active infection|1|||
16923772|NCT01931098|38065174|FG000|Overall Study|Refused further treatment|0|||
16923773|NCT01931098|38065175|FG001|Overall Study|Refused further treatment|1|||
16923774|NCT01945021|38065183|FG000|Overall Study|Adverse Event|1|||
16923775|NCT01945021|38065183|FG000|Overall Study|Withdrawal of consent|12|||
16923776|NCT01945021|38065183|FG000|Overall Study|Lost to Follow-up|5|||
16923777|NCT01945021|38065183|FG000|Overall Study|Death|65|||
16923778|NCT03951077|38065224|FG000|Overall Study|Adverse Event|1|||
16923779|NCT03951077|38065225|FG001|Overall Study|Adverse Event|0|||
16923780|NCT03951077|38065226|FG002|Overall Study|Adverse Event|0|||
16923781|NCT03951077|38065227|FG003|Overall Study|Adverse Event|0|||
16923782|NCT03951077|38065228|FG004|Overall Study|Adverse Event|0|||
16923783|NCT03951077|38065229|FG005|Overall Study|Adverse Event|0|||
16923784|NCT03951077|38065224|FG000|Overall Study|Withdrawal by Subject|3|||
16923785|NCT03951077|38065225|FG001|Overall Study|Withdrawal by Subject|3|||
16848179|NCT01901653|37793216|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
16848180|NCT01901653|37793217|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
16923786|NCT03951077|38065226|FG002|Overall Study|Withdrawal by Subject|0|||
16923787|NCT03951077|38065227|FG003|Overall Study|Withdrawal by Subject|3|||
16923788|NCT03951077|38065228|FG004|Overall Study|Withdrawal by Subject|3|||
16923789|NCT03951077|38065229|FG005|Overall Study|Withdrawal by Subject|2|||
16923790|NCT03951077|38065224|FG000|Overall Study|Lost to Follow-up|1|||
16923791|NCT03951077|38065225|FG001|Overall Study|Lost to Follow-up|1|||
16923792|NCT03951077|38065226|FG002|Overall Study|Lost to Follow-up|2|||
16923793|NCT03951077|38065227|FG003|Overall Study|Lost to Follow-up|3|||
16923794|NCT03951077|38065228|FG004|Overall Study|Lost to Follow-up|2|||
16923795|NCT03951077|38065229|FG005|Overall Study|Lost to Follow-up|3|||
16923796|NCT03951077|38065224|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
16923797|NCT03951077|38065225|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
16923798|NCT03951077|38065226|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
16923799|NCT03951077|38065227|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
16923800|NCT03951077|38065228|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
16923801|NCT03951077|38065229|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
16923802|NCT03951077|38065224|FG000|Overall Study|Other, Not Specified|12|||
16923803|NCT03951077|38065225|FG001|Overall Study|Other, Not Specified|10|||
16923804|NCT03951077|38065226|FG002|Overall Study|Other, Not Specified|10|||
16923805|NCT03951077|38065227|FG003|Overall Study|Other, Not Specified|5|||
16923806|NCT03951077|38065228|FG004|Overall Study|Other, Not Specified|9|||
16923807|NCT03951077|38065229|FG005|Overall Study|Other, Not Specified|6|||
16923808|NCT03951077|38065224|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
16923809|NCT03951077|38065225|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
16923810|NCT03951077|38065226|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
16923811|NCT03951077|38065227|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
16923812|NCT03951077|38065228|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
16923813|NCT03951077|38065229|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
16923814|NCT03873246|38065246|FG000|Overall Study|Adverse Event|1|||
16923815|NCT03873246|38065247|FG001|Overall Study|Adverse Event|3|||
16923816|NCT03873246|38065248|FG002|Overall Study|Adverse Event|3|||
16923817|NCT03873246|38065246|FG000|Overall Study|Lost to Follow-up|4|||
16923818|NCT03873246|38065247|FG001|Overall Study|Lost to Follow-up|4|||
16923819|NCT03873246|38065248|FG002|Overall Study|Lost to Follow-up|5|||
16923820|NCT03873246|38065246|FG000|Overall Study|Protocol Violation|0|||
16923821|NCT03873246|38065247|FG001|Overall Study|Protocol Violation|1|||
16923822|NCT03873246|38065248|FG002|Overall Study|Protocol Violation|0|||
16923823|NCT03873246|38065246|FG000|Overall Study|Withdrawal by Subject|0|||
16923824|NCT03873246|38065247|FG001|Overall Study|Withdrawal by Subject|4|||
16923825|NCT03873246|38065248|FG002|Overall Study|Withdrawal by Subject|1|||
16923826|NCT03769649|38065257|FG000|Overall Study|Lost to Follow-up|4|||
16923827|NCT02862548|38065283|FG000|Randomized Phase (Up to Week 48)|Death|0|||
16923828|NCT02862548|38065284|FG001|Randomized Phase (Up to Week 48)|Death|1|||
16923829|NCT02862548|38065283|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
16923830|NCT02862548|38065284|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
16923831|NCT02862548|38065283|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
16923832|NCT02862548|38065284|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
16923833|NCT02862548|38065283|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
16923834|NCT02862548|38065284|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
16923835|NCT02335099|38065303|FG000|Treatment|Withdrawal by Subject|1|||
16923836|NCT02335099|38065304|FG001|Treatment|Withdrawal by Subject|3|||
16923837|NCT02335099|38065303|FG000|Treatment|Lost to Follow-up|2|||
16848181|NCT01901653|37793218|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
16848182|NCT01901653|37793219|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
16848183|NCT01925989|37793247|FG000|Period 1|Sponsor Decision|1|||
16848184|NCT01925989|37793248|FG001|Period 1|Sponsor Decision|1|||
16848185|NCT01925989|37793249|FG002|Period 1|Sponsor Decision|0|||
16848186|NCT01925989|37793247|FG000|Period 1|Withdrawal by Subject|0|||
16848187|NCT01925989|37793248|FG001|Period 1|Withdrawal by Subject|1|||
16848188|NCT01925989|37793249|FG002|Period 1|Withdrawal by Subject|0|||
16848189|NCT01901419|37793263|FG000|Overall Study|Protocol Violation|2|||
16848190|NCT01901419|37793264|FG001|Overall Study|Protocol Violation|6|||
16923838|NCT02335099|38065304|FG001|Treatment|Lost to Follow-up|0|||
16923839|NCT02335099|38065303|FG000|Treatment|Death|1|||
16923840|NCT02335099|38065304|FG001|Treatment|Death|0|||
16923841|NCT02335099|38065303|FG000|Treatment|Adverse Event|1|||
16923842|NCT02335099|38065304|FG001|Treatment|Adverse Event|2|||
16923843|NCT02335099|38065303|FG000|Follow-up|Death|0|||
16923844|NCT02335099|38065304|FG001|Follow-up|Death|1|||
16848191|NCT01901419|37793263|FG000|Overall Study|unavailable researchers|6|||
16848192|NCT01901419|37793264|FG001|Overall Study|unavailable researchers|3|||
16848193|NCT01901341|37793291|FG000|Overall Study|Adverse Event|4|||
16848194|NCT01901341|37793292|FG001|Overall Study|Adverse Event|2|||
16848195|NCT01901341|37793291|FG000|Overall Study|Lack of Efficacy|0|||
16848196|NCT01901341|37793292|FG001|Overall Study|Lack of Efficacy|2|||
16848197|NCT01901341|37793291|FG000|Overall Study|Lost to Follow-up|0|||
16848198|NCT01901341|37793292|FG001|Overall Study|Lost to Follow-up|1|||
16848199|NCT01901341|37793291|FG000|Overall Study|Protocol Violation|2|||
16848200|NCT01901341|37793292|FG001|Overall Study|Protocol Violation|0|||
16848201|NCT01901341|37793291|FG000|Overall Study|Study Terminated by Sponsor|13|||
16848202|NCT01901341|37793292|FG001|Overall Study|Study Terminated by Sponsor|15|||
16923845|NCT02330562|38065321|FG000|Overall Study|Adverse Event|0|||
16923846|NCT02330562|38065322|FG001|Overall Study|Adverse Event|0|||
16923847|NCT02330562|38065323|FG002|Overall Study|Adverse Event|3|||
16923848|NCT02330562|38065324|FG003|Overall Study|Adverse Event|0|||
16923849|NCT02330562|38065325|FG004|Overall Study|Adverse Event|3|||
16923850|NCT02330562|38065326|FG005|Overall Study|Adverse Event|1|||
16923851|NCT02330562|38065327|FG006|Overall Study|Adverse Event|0|||
16923852|NCT02330562|38065328|FG007|Overall Study|Adverse Event|0|||
16923853|NCT02330562|38065329|FG008|Overall Study|Adverse Event|0|||
16923854|NCT02330562|38065330|FG009|Overall Study|Adverse Event|1|||
16923855|NCT02330562|38065331|FG010|Overall Study|Adverse Event|1|||
16923856|NCT02330562|38065321|FG000|Overall Study|Participant decision|1|||
16923857|NCT02330562|38065322|FG001|Overall Study|Participant decision|0|||
16923858|NCT02330562|38065323|FG002|Overall Study|Participant decision|4|||
16923859|NCT02330562|38065324|FG003|Overall Study|Participant decision|1|||
16923860|NCT02330562|38065325|FG004|Overall Study|Participant decision|5|||
16923861|NCT02330562|38065326|FG005|Overall Study|Participant decision|2|||
16923862|NCT02330562|38065327|FG006|Overall Study|Participant decision|0|||
16848203|NCT01901341|37793291|FG000|Overall Study|Withdrawal by Subject|1|||
16848204|NCT01901341|37793292|FG001|Overall Study|Withdrawal by Subject|1|||
16923863|NCT02330562|38065328|FG007|Overall Study|Participant decision|0|||
16923864|NCT02330562|38065329|FG008|Overall Study|Participant decision|0|||
16923865|NCT02330562|38065330|FG009|Overall Study|Participant decision|3|||
16923866|NCT02330562|38065331|FG010|Overall Study|Participant decision|0|||
16923867|NCT02330562|38065321|FG000|Overall Study|Disease progression|5|||
16923868|NCT02330562|38065322|FG001|Overall Study|Disease progression|3|||
16923869|NCT02330562|38065323|FG002|Overall Study|Disease progression|20|||
16923870|NCT02330562|38065324|FG003|Overall Study|Disease progression|28|||
16923871|NCT02330562|38065325|FG004|Overall Study|Disease progression|23|||
16923872|NCT02330562|38065326|FG005|Overall Study|Disease progression|7|||
16923873|NCT02330562|38065327|FG006|Overall Study|Disease progression|1|||
16923874|NCT02330562|38065328|FG007|Overall Study|Disease progression|1|||
16923875|NCT02330562|38065329|FG008|Overall Study|Disease progression|1|||
16923876|NCT02330562|38065330|FG009|Overall Study|Disease progression|0|||
16923877|NCT02330562|38065331|FG010|Overall Study|Disease progression|5|||
16923878|NCT02330562|38065321|FG000|Overall Study|Other reasons|0|||
16923879|NCT02330562|38065322|FG001|Overall Study|Other reasons|0|||
16923880|NCT02330562|38065323|FG002|Overall Study|Other reasons|0|||
16923881|NCT02330562|38065324|FG003|Overall Study|Other reasons|1|||
16848205|NCT01615939|37793301|FG000|Overall Study|Lost to Follow-up|5|||
16848206|NCT01615939|37793302|FG001|Overall Study|Lost to Follow-up|0|||
16848207|NCT01901185|37793308|FG000|Overall Study|Withdrawal by Subject|2|||
16848208|NCT01888003|37793315|FG000|Overall Study|Study Terminated|5|||
16848209|NCT01888003|37793316|FG001|Overall Study|Study Terminated|6|||
16848210|NCT01888003|37793317|FG002|Overall Study|Study Terminated|40|||
16848211|NCT01925209|37793383|FG000|Treatment Epoch|Physician Decision|1|||
16848212|NCT01925209|37793384|FG001|Treatment Epoch|Physician Decision|0|||
16848213|NCT01925209|37793385|FG002|Treatment Epoch|Physician Decision|0|||
16848214|NCT01925209|37793386|FG003|Treatment Epoch|Physician Decision|0|||
16848215|NCT01925209|37793383|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
16923882|NCT02330562|38065325|FG004|Overall Study|Other reasons|0|||
16923883|NCT02330562|38065326|FG005|Overall Study|Other reasons|0|||
16848216|NCT01925209|37793384|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
16848217|NCT01925209|37793385|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
16848218|NCT01925209|37793386|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
16923884|NCT02330562|38065327|FG006|Overall Study|Other reasons|0|||
16923885|NCT02330562|38065328|FG007|Overall Study|Other reasons|0|||
16848219|NCT01925209|37793383|FG000|Treatment Epoch|Death|1|||
16848220|NCT01925209|37793384|FG001|Treatment Epoch|Death|0|||
16848221|NCT01925209|37793385|FG002|Treatment Epoch|Death|0|||
16923886|NCT02330562|38065329|FG008|Overall Study|Other reasons|0|||
16848222|NCT01925209|37793386|FG003|Treatment Epoch|Death|0|||
16848223|NCT01925209|37793383|FG000|Treatment Epoch|Protocol deviation|0|||
16848224|NCT01925209|37793384|FG001|Treatment Epoch|Protocol deviation|0|||
16848225|NCT01925209|37793385|FG002|Treatment Epoch|Protocol deviation|1|||
16923887|NCT02330562|38065330|FG009|Overall Study|Other reasons|0|||
16923888|NCT02330562|38065331|FG010|Overall Study|Other reasons|0|||
16923889|NCT02330562|38065321|FG000|Overall Study|Withdrawal by Subject|0|||
16923890|NCT02330562|38065322|FG001|Overall Study|Withdrawal by Subject|0|||
16923891|NCT02330562|38065323|FG002|Overall Study|Withdrawal by Subject|0|||
16923892|NCT02330562|38065324|FG003|Overall Study|Withdrawal by Subject|0|||
16923893|NCT02330562|38065325|FG004|Overall Study|Withdrawal by Subject|0|||
16923894|NCT02330562|38065326|FG005|Overall Study|Withdrawal by Subject|0|||
16923895|NCT02330562|38065327|FG006|Overall Study|Withdrawal by Subject|0|||
16923896|NCT02330562|38065328|FG007|Overall Study|Withdrawal by Subject|0|||
16923897|NCT02330562|38065329|FG008|Overall Study|Withdrawal by Subject|0|||
16923898|NCT02330562|38065330|FG009|Overall Study|Withdrawal by Subject|1|||
16923899|NCT02330562|38065331|FG010|Overall Study|Withdrawal by Subject|0|||
16923900|NCT03703102|38065445|FG000|Overall Study|Adverse Event|4|||
16923901|NCT03703102|38065446|FG001|Overall Study|Adverse Event|3|||
16923902|NCT03703102|38065447|FG002|Overall Study|Adverse Event|7|||
16923903|NCT03703102|38065448|FG003|Overall Study|Adverse Event|3|||
16848226|NCT01925209|37793386|FG003|Treatment Epoch|Protocol deviation|1|||
16848227|NCT01925209|37793383|FG000|Treatment Epoch|Withdrawal by Subject|4|||
16848228|NCT01925209|37793384|FG001|Treatment Epoch|Withdrawal by Subject|3|||
16848229|NCT01925209|37793385|FG002|Treatment Epoch|Withdrawal by Subject|3|||
16923904|NCT03703102|38065449|FG004|Overall Study|Adverse Event|13|||
16923905|NCT03703102|38065445|FG000|Overall Study|Lack of Efficacy|4|||
16923906|NCT03703102|38065446|FG001|Overall Study|Lack of Efficacy|0|||
16923907|NCT03703102|38065447|FG002|Overall Study|Lack of Efficacy|1|||
16923908|NCT03703102|38065448|FG003|Overall Study|Lack of Efficacy|4|||
16923909|NCT03703102|38065449|FG004|Overall Study|Lack of Efficacy|1|||
16923910|NCT03703102|38065445|FG000|Overall Study|Lost to Follow-up|0|||
16923911|NCT03703102|38065446|FG001|Overall Study|Lost to Follow-up|0|||
16923912|NCT03703102|38065447|FG002|Overall Study|Lost to Follow-up|1|||
16923913|NCT03703102|38065448|FG003|Overall Study|Lost to Follow-up|2|||
16923914|NCT03703102|38065449|FG004|Overall Study|Lost to Follow-up|2|||
16923915|NCT03703102|38065445|FG000|Overall Study|Physician Decision|2|||
16923916|NCT03703102|38065446|FG001|Overall Study|Physician Decision|2|||
16923917|NCT03703102|38065447|FG002|Overall Study|Physician Decision|2|||
16923918|NCT03703102|38065448|FG003|Overall Study|Physician Decision|2|||
16923919|NCT03703102|38065449|FG004|Overall Study|Physician Decision|4|||
16923920|NCT03703102|38065445|FG000|Overall Study|Withdrawal by Subject|7|||
16923921|NCT03703102|38065446|FG001|Overall Study|Withdrawal by Subject|5|||
16923922|NCT03703102|38065447|FG002|Overall Study|Withdrawal by Subject|5|||
16923923|NCT03703102|38065448|FG003|Overall Study|Withdrawal by Subject|5|||
16848230|NCT01925209|37793386|FG003|Treatment Epoch|Withdrawal by Subject|2|||
16848231|NCT01925209|37793383|FG000|Treatment Epoch|Adverse Event|3|||
16848232|NCT01925209|37793384|FG001|Treatment Epoch|Adverse Event|5|||
16848233|NCT01925209|37793385|FG002|Treatment Epoch|Adverse Event|3|||
16848234|NCT01925209|37793386|FG003|Treatment Epoch|Adverse Event|1|||
16848235|NCT01925209|37793383|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
16848236|NCT01925209|37793384|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
16848237|NCT01925209|37793385|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
16848238|NCT01925209|37793386|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
16848239|NCT01925209|37793383|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
16848240|NCT01925209|37793384|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
16848241|NCT01925209|37793385|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
16848242|NCT01925209|37793386|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
16848243|NCT01925209|37793383|FG000|Follow-up|Adverse Event|1|||
16848244|NCT01925209|37793384|FG001|Follow-up|Adverse Event|4|||
16923924|NCT03703102|38065449|FG004|Overall Study|Withdrawal by Subject|9|||
16923925|NCT03703102|38065445|FG000|Overall Study|Ineligibility|0|||
16923926|NCT03703102|38065446|FG001|Overall Study|Ineligibility|0|||
16923927|NCT03703102|38065447|FG002|Overall Study|Ineligibility|1|||
16923928|NCT03703102|38065448|FG003|Overall Study|Ineligibility|0|||
16848245|NCT01925209|37793385|FG002|Follow-up|Adverse Event|0|||
16923929|NCT03703102|38065449|FG004|Overall Study|Ineligibility|0|||
16923930|NCT03703102|38065445|FG000|Overall Study|Protocol Deviation|4|||
16848246|NCT01925209|37793386|FG003|Follow-up|Adverse Event|1|||
16848247|NCT01925209|37793383|FG000|Follow-up|Physician Decision|0|||
16848248|NCT01925209|37793384|FG001|Follow-up|Physician Decision|0|||
16848249|NCT01925209|37793385|FG002|Follow-up|Physician Decision|1|||
16848250|NCT01925209|37793386|FG003|Follow-up|Physician Decision|0|||
16848251|NCT01925209|37793383|FG000|Follow-up|Non-compliance with study treatment|0|||
16848252|NCT01925209|37793384|FG001|Follow-up|Non-compliance with study treatment|0|||
16848253|NCT01925209|37793385|FG002|Follow-up|Non-compliance with study treatment|0|||
16923931|NCT03703102|38065446|FG001|Overall Study|Protocol Deviation|4|||
16923932|NCT03703102|38065447|FG002|Overall Study|Protocol Deviation|3|||
16848254|NCT01925209|37793386|FG003|Follow-up|Non-compliance with study treatment|1|||
16848255|NCT01925209|37793383|FG000|Follow-up|Withdrawal by Subject|0|||
16848256|NCT01925209|37793384|FG001|Follow-up|Withdrawal by Subject|2|||
16848257|NCT01925209|37793385|FG002|Follow-up|Withdrawal by Subject|0|||
16848258|NCT01925209|37793386|FG003|Follow-up|Withdrawal by Subject|2|||
16848259|NCT01614925|37793398|FG000|Overall Study|Withdrawal by Subject|1|||
16848260|NCT01614925|37793399|FG001|Overall Study|Withdrawal by Subject|0|||
16848261|NCT01614925|37793398|FG000|Overall Study|Protocol Violation|3|||
16848262|NCT01614925|37793399|FG001|Overall Study|Protocol Violation|2|||
16848263|NCT01886833|37793405|FG000|Overall Study|IgA not available from both periods|204|||
16848264|NCT01898923|37793414|FG000|Overall Study|Lack of Efficacy|5|||
16848265|NCT01898923|37793415|FG001|Overall Study|Lack of Efficacy|6|||
16848266|NCT01898923|37793414|FG000|Overall Study|Adverse Event|3|||
16848267|NCT01898923|37793415|FG001|Overall Study|Adverse Event|1|||
16848268|NCT01898923|37793414|FG000|Overall Study|Lost to Follow-up|0|||
16848269|NCT01898923|37793415|FG001|Overall Study|Lost to Follow-up|1|||
16848270|NCT01898923|37793414|FG000|Overall Study|Withdrawal by Subject|4|||
16923933|NCT03703102|38065448|FG003|Overall Study|Protocol Deviation|0|||
16923934|NCT03703102|38065449|FG004|Overall Study|Protocol Deviation|0|||
16923935|NCT03703102|38065445|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16923936|NCT03703102|38065446|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16923937|NCT03703102|38065447|FG002|Overall Study|Non-Compliance with Study Drug|2|||
16923938|NCT03703102|38065448|FG003|Overall Study|Non-Compliance with Study Drug|1|||
16848271|NCT01898923|37793415|FG001|Overall Study|Withdrawal by Subject|7|||
16848272|NCT01898923|37793414|FG000|Overall Study|Physician Decision|3|||
16923939|NCT03703102|38065449|FG004|Overall Study|Non-Compliance with Study Drug|4|||
16923940|NCT03395704|38065468|FG000|Overall Study|Adverse Event|2|||
16923941|NCT03395704|38065469|FG001|Overall Study|Adverse Event|1|||
16923942|NCT03395704|38065468|FG000|Overall Study|Withdrawal by Subject|2|||
16923943|NCT03395704|38065469|FG001|Overall Study|Withdrawal by Subject|1|||
16923944|NCT03395704|38065468|FG000|Overall Study|Physician Decision|0|||
16923945|NCT03395704|38065469|FG001|Overall Study|Physician Decision|1|||
16923946|NCT03335813|38065475|FG000|Overall Study|Withdrawal by Subject|1|||
16923947|NCT03246503|38065479|FG000|Overall Study|Lost to Follow-up|23|||
16923948|NCT03246503|38065479|FG000|Overall Study|Withdrawal by Subject|20|||
16923949|NCT03246503|38065479|FG000|Overall Study|Physician Decision|5|||
16923950|NCT03246503|38065479|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
16923951|NCT02514447|38065540|FG000|Overall Study|Withdrawal by Subject|3|||
16923952|NCT02514447|38065541|FG001|Overall Study|Withdrawal by Subject|1|||
16848273|NCT01898923|37793415|FG001|Overall Study|Physician Decision|4|||
16848274|NCT01898923|37793414|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
16848275|NCT01898923|37793415|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
16848276|NCT01924429|37793423|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
16848277|NCT01924429|37793424|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
16848278|NCT01898299|37793434|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
16848279|NCT01898299|37793435|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
16848280|NCT01886287|37793441|FG000|Overall Study|Radiographic disease progression|1|||
16848281|NCT01886287|37793441|FG000|Overall Study|Clinical progression due to disease|1|||
16848282|NCT01885195|37793445|FG000|Overall Study|Adverse Event|29|||
16848283|NCT01885195|37793445|FG000|Overall Study|Death|1|||
16848284|NCT01885195|37793445|FG000|Overall Study|Disease Progression|67|||
16848285|NCT01885195|37793445|FG000|Overall Study|Protocol Deviation|2|||
16848286|NCT01885195|37793445|FG000|Overall Study|Physician Decision|3|||
16848287|NCT01885195|37793445|FG000|Overall Study|Patient/guardian decision|8|||
16848288|NCT01896895|37793452|FG000|Double-blind MP|Physician Decision|0|||
16848289|NCT01896895|37793453|FG001|Double-blind MP|Physician Decision|0|||
16848290|NCT01896895|37793454|FG002|Double-blind MP|Physician Decision|1|||
16848291|NCT01896895|37793455|FG003|Double-blind MP|Physician Decision|0|||
16848292|NCT01896895|37793452|FG000|Double-blind MP|Withdrawal by Subject|0|||
16848293|NCT01896895|37793453|FG001|Double-blind MP|Withdrawal by Subject|2|||
16848294|NCT01896895|37793454|FG002|Double-blind MP|Withdrawal by Subject|1|||
16848295|NCT01896895|37793455|FG003|Double-blind MP|Withdrawal by Subject|0|||
16848296|NCT01896895|37793452|FG000|Double-blind MP|Lost to Follow-up|1|||
16848297|NCT01896895|37793453|FG001|Double-blind MP|Lost to Follow-up|0|||
16848298|NCT01896895|37793454|FG002|Double-blind MP|Lost to Follow-up|1|||
16848299|NCT01896895|37793455|FG003|Double-blind MP|Lost to Follow-up|0|||
16848300|NCT01923181|37793498|FG000|Overall Study|Protocol Violation|2|||
16848301|NCT01923181|37793499|FG001|Overall Study|Protocol Violation|2|||
16848302|NCT01923181|37793500|FG002|Overall Study|Protocol Violation|0|||
16848303|NCT01923181|37793501|FG003|Overall Study|Protocol Violation|2|||
16848304|NCT01923181|37793502|FG004|Overall Study|Protocol Violation|2|||
16848305|NCT01923181|37793503|FG005|Overall Study|Protocol Violation|1|||
16848306|NCT01923181|37793504|FG006|Overall Study|Protocol Violation|1|||
16848307|NCT01923181|37793505|FG007|Overall Study|Protocol Violation|2|||
16923953|NCT02514447|38065542|FG002|Overall Study|Withdrawal by Subject|1|||
16923954|NCT02514447|38065543|FG003|Overall Study|Withdrawal by Subject|0|||
16923955|NCT02514447|38065544|FG004|Overall Study|Withdrawal by Subject|0|||
16923956|NCT02514447|38065545|FG005|Overall Study|Withdrawal by Subject|0|||
16923957|NCT02514447|38065546|FG006|Overall Study|Withdrawal by Subject|0|||
16923958|NCT02514447|38065547|FG007|Overall Study|Withdrawal by Subject|1|||
16923959|NCT02514447|38065548|FG008|Overall Study|Withdrawal by Subject|1|||
16923960|NCT02514447|38065540|FG000|Overall Study|Death|24|||
16848308|NCT01923181|37793506|FG008|Overall Study|Protocol Violation|1|||
16848309|NCT01923181|37793498|FG000|Overall Study|Withdrawal by Subject|0|||
16923961|NCT02514447|38065541|FG001|Overall Study|Death|28|||
16923962|NCT02514447|38065542|FG002|Overall Study|Death|29|||
16923963|NCT02514447|38065543|FG003|Overall Study|Death|0|||
16923964|NCT02514447|38065544|FG004|Overall Study|Death|3|||
16923965|NCT02514447|38065545|FG005|Overall Study|Death|4|||
16923966|NCT02514447|38065546|FG006|Overall Study|Death|8|||
16848310|NCT01923181|37793499|FG001|Overall Study|Withdrawal by Subject|1|||
16848311|NCT01923181|37793500|FG002|Overall Study|Withdrawal by Subject|0|||
16848312|NCT01923181|37793501|FG003|Overall Study|Withdrawal by Subject|1|||
16848313|NCT01923181|37793502|FG004|Overall Study|Withdrawal by Subject|4|||
16848314|NCT01923181|37793503|FG005|Overall Study|Withdrawal by Subject|2|||
16848315|NCT01923181|37793504|FG006|Overall Study|Withdrawal by Subject|4|||
16848316|NCT01923181|37793505|FG007|Overall Study|Withdrawal by Subject|3|||
16848317|NCT01923181|37793506|FG008|Overall Study|Withdrawal by Subject|1|||
16848318|NCT01923181|37793498|FG000|Overall Study|Other|1|||
16848319|NCT01923181|37793499|FG001|Overall Study|Other|0|||
16848320|NCT01923181|37793500|FG002|Overall Study|Other|0|||
16848321|NCT01923181|37793501|FG003|Overall Study|Other|1|||
16848322|NCT01923181|37793502|FG004|Overall Study|Other|0|||
16848323|NCT01923181|37793503|FG005|Overall Study|Other|0|||
16848324|NCT01923181|37793504|FG006|Overall Study|Other|0|||
16848325|NCT01923181|37793505|FG007|Overall Study|Other|0|||
16848326|NCT01923181|37793506|FG008|Overall Study|Other|0|||
16848327|NCT01923181|37793498|FG000|Overall Study|Lost to Follow-up|0|||
16848328|NCT01923181|37793499|FG001|Overall Study|Lost to Follow-up|3|||
16848329|NCT01923181|37793500|FG002|Overall Study|Lost to Follow-up|2|||
16848330|NCT01923181|37793501|FG003|Overall Study|Lost to Follow-up|1|||
16848331|NCT01923181|37793502|FG004|Overall Study|Lost to Follow-up|2|||
16848332|NCT01923181|37793503|FG005|Overall Study|Lost to Follow-up|1|||
16848333|NCT01923181|37793504|FG006|Overall Study|Lost to Follow-up|3|||
16848334|NCT01923181|37793505|FG007|Overall Study|Lost to Follow-up|3|||
16848335|NCT01923181|37793506|FG008|Overall Study|Lost to Follow-up|1|||
16848336|NCT01896271|37793529|FG000|Overall Study|Physician Decision|10|||
16848337|NCT01884571|37793542|FG000|Overall Study|Adverse Event|1|||
16848338|NCT01884571|37793542|FG000|Overall Study|Death|2|||
16848339|NCT01884571|37793542|FG000|Overall Study|Withdrawal by Subject|2|||
16848340|NCT01884571|37793542|FG000|Overall Study|Disease progression|3|||
16848341|NCT01884337|37793548|FG000|Treatment|Adverse Event|2|||
16848342|NCT01884337|37793549|FG001|Treatment|Adverse Event|2|||
16848343|NCT01884337|37793548|FG000|Treatment|Subj. request to discont. treatment|2|||
16848344|NCT01884337|37793549|FG001|Treatment|Subj. request to discont. treatment|0|||
16848345|NCT01884337|37793548|FG000|Follow-up Period|Lost to Follow-up|1|||
16848346|NCT01884337|37793549|FG001|Follow-up Period|Lost to Follow-up|1|||
16848347|NCT01922089|37793557|FG000|Overall Study|Adverse Event|18|||
16848348|NCT01922089|37793558|FG001|Overall Study|Adverse Event|13|||
16848349|NCT01922089|37793557|FG000|Overall Study|Protocol Deviation|10|||
16848350|NCT01922089|37793558|FG001|Overall Study|Protocol Deviation|7|||
16923967|NCT02514447|38065547|FG007|Overall Study|Death|6|||
16923968|NCT02514447|38065548|FG008|Overall Study|Death|5|||
16923969|NCT02514447|38065540|FG000|Overall Study|Lost to Follow-up|1|||
16923970|NCT02514447|38065541|FG001|Overall Study|Lost to Follow-up|0|||
16923971|NCT02514447|38065542|FG002|Overall Study|Lost to Follow-up|0|||
16923972|NCT02514447|38065543|FG003|Overall Study|Lost to Follow-up|0|||
16923973|NCT02514447|38065544|FG004|Overall Study|Lost to Follow-up|0|||
16923974|NCT02514447|38065545|FG005|Overall Study|Lost to Follow-up|0|||
16923975|NCT02514447|38065546|FG006|Overall Study|Lost to Follow-up|0|||
16923976|NCT02514447|38065547|FG007|Overall Study|Lost to Follow-up|0|||
16923977|NCT02514447|38065548|FG008|Overall Study|Lost to Follow-up|1|||
16923978|NCT02514447|38065540|FG000|Overall Study|Sponsor Termination of Study|0|||
16923979|NCT02514447|38065541|FG001|Overall Study|Sponsor Termination of Study|1|||
16923980|NCT02514447|38065542|FG002|Overall Study|Sponsor Termination of Study|1|||
16923981|NCT02514447|38065543|FG003|Overall Study|Sponsor Termination of Study|0|||
16923982|NCT02514447|38065544|FG004|Overall Study|Sponsor Termination of Study|0|||
16923983|NCT02514447|38065545|FG005|Overall Study|Sponsor Termination of Study|0|||
17017831|NCT00807573|38162424|FG000|Overall Study|Adverse Event|1|||
16848351|NCT01922089|37793557|FG000|Overall Study|Withdrawal by Subject|3|||
16848352|NCT01922089|37793558|FG001|Overall Study|Withdrawal by Subject|4|||
16923984|NCT02514447|38065546|FG006|Overall Study|Sponsor Termination of Study|0|||
16923985|NCT02514447|38065547|FG007|Overall Study|Sponsor Termination of Study|0|||
16923986|NCT02514447|38065548|FG008|Overall Study|Sponsor Termination of Study|0|||
17017832|NCT00842712|38162435|FG000|Safety Run-in Part|Adverse Event|0|||
16848353|NCT01922089|37793557|FG000|Overall Study|administrative problems|4|||
16848354|NCT01922089|37793558|FG001|Overall Study|administrative problems|1|||
16848355|NCT01922089|37793557|FG000|Overall Study|Physician Decision|2|||
16848356|NCT01922089|37793558|FG001|Overall Study|Physician Decision|3|||
16848357|NCT01922089|37793557|FG000|Overall Study|Death|2|||
16848358|NCT01922089|37793558|FG001|Overall Study|Death|1|||
16923987|NCT02514447|38065540|FG000|Overall Study|Study completion per Investigator|1|||
16923988|NCT02514447|38065541|FG001|Overall Study|Study completion per Investigator|0|||
16923989|NCT02514447|38065542|FG002|Overall Study|Study completion per Investigator|1|||
16923990|NCT02514447|38065543|FG003|Overall Study|Study completion per Investigator|2|||
16848359|NCT01922089|37793557|FG000|Overall Study|Lost to Follow-up|0|||
16848360|NCT01922089|37793558|FG001|Overall Study|Lost to Follow-up|1|||
16848361|NCT01884025|37793566|FG000|Overall Study|Lost to Follow-up|3|||
16923991|NCT02514447|38065544|FG004|Overall Study|Study completion per Investigator|0|||
16923992|NCT02514447|38065545|FG005|Overall Study|Study completion per Investigator|0|||
16923993|NCT02514447|38065546|FG006|Overall Study|Study completion per Investigator|0|||
16923994|NCT02514447|38065547|FG007|Overall Study|Study completion per Investigator|0|||
16923995|NCT02514447|38065548|FG008|Overall Study|Study completion per Investigator|1|||
16923996|NCT01785563|38065592|FG000|Overall Study|Physician Decision|10|||
16923997|NCT01785563|38065592|FG000|Overall Study|Withdrawal by Subject|1|||
16923998|NCT01785563|38065592|FG000|Overall Study|Protocol Violation|2|||
16923999|NCT01434290|38065607|FG000|Overall Study|Protocol Violation|6|||
16924000|NCT01434290|38065608|FG001|Overall Study|Protocol Violation|3|||
16924001|NCT01434290|38065607|FG000|Overall Study|No protocol treatment|2|||
16924002|NCT01434290|38065608|FG001|Overall Study|No protocol treatment|4|||
16924003|NCT00750269|38065620|FG000|Overall Study|Protocol Violation|0|||
16924004|NCT00750269|38065621|FG001|Overall Study|Protocol Violation|1|||
16924005|NCT00750269|38065622|FG002|Overall Study|Protocol Violation|1|||
16924006|NCT00750269|38065623|FG003|Overall Study|Protocol Violation|2|||
16924007|NCT00750269|38065624|FG004|Overall Study|Protocol Violation|4|||
16924008|NCT00750269|38065620|FG000|Overall Study|Withdrawal by Subject|0|||
16924009|NCT00750269|38065621|FG001|Overall Study|Withdrawal by Subject|0|||
16924010|NCT00750269|38065622|FG002|Overall Study|Withdrawal by Subject|2|||
16924011|NCT00750269|38065623|FG003|Overall Study|Withdrawal by Subject|2|||
16924012|NCT00750269|38065624|FG004|Overall Study|Withdrawal by Subject|2|||
16924013|NCT00750269|38065620|FG000|Overall Study|Physician Decision|0|||
16924014|NCT00750269|38065621|FG001|Overall Study|Physician Decision|0|||
16924015|NCT00750269|38065622|FG002|Overall Study|Physician Decision|0|||
16924016|NCT00750269|38065623|FG003|Overall Study|Physician Decision|0|||
16924017|NCT00750269|38065624|FG004|Overall Study|Physician Decision|2|||
16924018|NCT00750269|38065620|FG000|Overall Study|Patient too large for positioning|0|||
16924019|NCT00750269|38065621|FG001|Overall Study|Patient too large for positioning|0|||
16924020|NCT00750269|38065622|FG002|Overall Study|Patient too large for positioning|1|||
16924021|NCT00750269|38065623|FG003|Overall Study|Patient too large for positioning|0|||
16924022|NCT00750269|38065624|FG004|Overall Study|Patient too large for positioning|0|||
16924023|NCT00750269|38065620|FG000|Overall Study|Site error|0|||
16924024|NCT00750269|38065621|FG001|Overall Study|Site error|0|||
16924025|NCT00750269|38065622|FG002|Overall Study|Site error|0|||
16924026|NCT00750269|38065623|FG003|Overall Study|Site error|1|||
16924027|NCT00750269|38065624|FG004|Overall Study|Site error|0|||
16924028|NCT00750269|38065620|FG000|Overall Study|SBRT plan could not be drawn|0|||
16924029|NCT00750269|38065621|FG001|Overall Study|SBRT plan could not be drawn|0|||
16924030|NCT00750269|38065622|FG002|Overall Study|SBRT plan could not be drawn|0|||
16924031|NCT00750269|38065623|FG003|Overall Study|SBRT plan could not be drawn|0|||
16924032|NCT00750269|38065624|FG004|Overall Study|SBRT plan could not be drawn|1|||
16924033|NCT00750269|38065620|FG000|Overall Study|Fiducials could not be placed|0|||
16924034|NCT00750269|38065621|FG001|Overall Study|Fiducials could not be placed|0|||
16924035|NCT00750269|38065622|FG002|Overall Study|Fiducials could not be placed|0|||
16924036|NCT00750269|38065623|FG003|Overall Study|Fiducials could not be placed|0|||
16924037|NCT00750269|38065624|FG004|Overall Study|Fiducials could not be placed|1|||
16924038|NCT00712322|38065646|FG000|Overall Study|Protocol deviation|0|||
16924039|NCT00712322|38065647|FG001|Overall Study|Protocol deviation|1|||
16924040|NCT00712322|38065648|FG002|Overall Study|Protocol deviation|0|||
16924041|NCT00323856|38065656|FG000|Overall Study|Withdrawal by Subject|1|||
16924042|NCT00323856|38065656|FG000|Overall Study|Was uncooperative and noncompliant|1|||
17017833|NCT00842712|38162436|FG001|Safety Run-in Part|Adverse Event|1|||
16848362|NCT01884025|37793567|FG001|Overall Study|Lost to Follow-up|4|||
16848363|NCT01896193|37793577|FG000|Overall Study|Lack of Efficacy|20|||
16848364|NCT01896193|37793578|FG001|Overall Study|Lack of Efficacy|11|||
16924043|NCT00323856|38065656|FG000|Overall Study|Reason not specified|1|||
16924044|NCT00323856|38065656|FG000|Overall Study|Missing|2|||
16924045|NCT04524663|38065669|FG000|Overall Study|Withdrawal by Subject|0|||
16924046|NCT04524663|38065670|FG001|Overall Study|Withdrawal by Subject|2|||
16924047|NCT03738423|38065703|FG000|Overall Study|Withdrawal by Subject|9|||
16924048|NCT03738423|38065704|FG001|Overall Study|Withdrawal by Subject|12|||
16924049|NCT03738423|38065705|FG002|Overall Study|Withdrawal by Subject|9|||
16848365|NCT01896193|37793577|FG000|Overall Study|Protocol Violation|0|||
16848366|NCT01896193|37793578|FG001|Overall Study|Protocol Violation|1|||
16924050|NCT03738423|38065706|FG003|Overall Study|Withdrawal by Subject|12|||
16924051|NCT03738423|38065707|FG004|Overall Study|Withdrawal by Subject|10|||
16924052|NCT03738423|38065703|FG000|Overall Study|Lack of Efficacy|3|||
16924053|NCT03738423|38065704|FG001|Overall Study|Lack of Efficacy|1|||
16924054|NCT03738423|38065705|FG002|Overall Study|Lack of Efficacy|1|||
16924055|NCT03738423|38065706|FG003|Overall Study|Lack of Efficacy|1|||
16924056|NCT03738423|38065707|FG004|Overall Study|Lack of Efficacy|2|||
16924057|NCT03738423|38065703|FG000|Overall Study|Lost to Follow-up|1|||
16924058|NCT03738423|38065704|FG001|Overall Study|Lost to Follow-up|0|||
16924059|NCT03738423|38065705|FG002|Overall Study|Lost to Follow-up|1|||
16924060|NCT03738423|38065706|FG003|Overall Study|Lost to Follow-up|1|||
16924061|NCT03738423|38065707|FG004|Overall Study|Lost to Follow-up|0|||
16924062|NCT03738423|38065703|FG000|Overall Study|Protocol Violation|1|||
16924063|NCT03738423|38065704|FG001|Overall Study|Protocol Violation|0|||
16924064|NCT03738423|38065705|FG002|Overall Study|Protocol Violation|0|||
16924065|NCT03738423|38065706|FG003|Overall Study|Protocol Violation|0|||
16924066|NCT03738423|38065707|FG004|Overall Study|Protocol Violation|1|||
16924067|NCT03738423|38065703|FG000|Overall Study|Physician Decision|0|||
16924068|NCT03738423|38065704|FG001|Overall Study|Physician Decision|0|||
16924069|NCT03738423|38065705|FG002|Overall Study|Physician Decision|1|||
16924070|NCT03738423|38065706|FG003|Overall Study|Physician Decision|0|||
16924071|NCT03738423|38065707|FG004|Overall Study|Physician Decision|1|||
16924072|NCT03738423|38065703|FG000|Overall Study|Death|0|||
16924073|NCT03738423|38065704|FG001|Overall Study|Death|0|||
16924074|NCT03738423|38065705|FG002|Overall Study|Death|0|||
16924075|NCT03738423|38065706|FG003|Overall Study|Death|0|||
16924076|NCT03738423|38065707|FG004|Overall Study|Death|1|||
16924077|NCT03738423|38065703|FG000|Overall Study|Randomized but never treated|0|||
16924078|NCT03738423|38065704|FG001|Overall Study|Randomized but never treated|0|||
16924079|NCT03738423|38065705|FG002|Overall Study|Randomized but never treated|1|||
16924080|NCT03738423|38065706|FG003|Overall Study|Randomized but never treated|1|||
16924081|NCT03738423|38065707|FG004|Overall Study|Randomized but never treated|0|||
16924082|NCT03712228|38065725|FG000|Treatment Period 1|Lack of Efficacy|0|||
16924083|NCT03712228|38065726|FG001|Treatment Period 1|Lack of Efficacy|0|||
16924084|NCT03712228|38065727|FG002|Treatment Period 1|Lack of Efficacy|0|||
16924085|NCT03712228|38065728|FG003|Treatment Period 1|Lack of Efficacy|0|||
16924086|NCT03712228|38065729|FG004|Treatment Period 1|Lack of Efficacy|0|||
16924087|NCT03712228|38065730|FG005|Treatment Period 1|Lack of Efficacy|1|||
16924088|NCT03712228|38065725|FG000|Treatment Period 2|Pregnancy|0|||
16924089|NCT03712228|38065726|FG001|Treatment Period 2|Pregnancy|0|||
16924090|NCT03712228|38065727|FG002|Treatment Period 2|Pregnancy|0|||
16924091|NCT03712228|38065728|FG003|Treatment Period 2|Pregnancy|1|||
16924092|NCT03712228|38065729|FG004|Treatment Period 2|Pregnancy|0|||
16924093|NCT03712228|38065730|FG005|Treatment Period 2|Pregnancy|0|||
16924094|NCT03712228|38065725|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16924095|NCT03712228|38065726|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16924096|NCT03712228|38065727|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16924097|NCT03712228|38065728|FG003|Treatment Period 2|Withdrawal by Subject|1|||
16924098|NCT03712228|38065729|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16924099|NCT03712228|38065730|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16924100|NCT03600818|38065749|FG000|Overall Study|Adverse Event|4|||
16848367|NCT01896193|37793577|FG000|Overall Study|Withdrew Consent|1|||
16848368|NCT01896193|37793578|FG001|Overall Study|Withdrew Consent|0|||
16848369|NCT01922011|37793588|FG000|Overall Study|Protocol Violation|0|||
16848370|NCT01922011|37793589|FG001|Overall Study|Protocol Violation|1|||
16848371|NCT01922011|37793588|FG000|Overall Study|Physician Decision|0|||
16848372|NCT01922011|37793589|FG001|Overall Study|Physician Decision|1|||
16848373|NCT01922011|37793588|FG000|Overall Study|Parent/Guardian Decision|3|||
16848374|NCT01922011|37793589|FG001|Overall Study|Parent/Guardian Decision|0|||
16848375|NCT01922011|37793588|FG000|Overall Study|Lost to Follow-up|0|||
16848376|NCT01922011|37793589|FG001|Overall Study|Lost to Follow-up|1|||
16848377|NCT01922011|37793588|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
16848378|NCT01922011|37793589|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
16848379|NCT01922011|37793588|FG000|Overall Study|Not Treated|1|||
16848380|NCT01922011|37793589|FG001|Overall Study|Not Treated|0|||
16848381|NCT01922011|37793588|FG000|Overall Study|Lack of willing home health agency|1|||
16848382|NCT01922011|37793589|FG001|Overall Study|Lack of willing home health agency|0|||
16848383|NCT01922011|37793588|FG000|Overall Study|Randomized in error|1|||
16848384|NCT01922011|37793589|FG001|Overall Study|Randomized in error|0|||
16848385|NCT01883635|37793603|FG000|Overall Study|Withdrawal by Subject|4|||
16848386|NCT01883635|37793604|FG001|Overall Study|Withdrawal by Subject|0|||
16848387|NCT01921387|37793612|FG000|Overall Study|Adverse Event|1|||
16848388|NCT01895335|37793616|FG000|Overall Study|Adverse Event|106|||
16848389|NCT01895335|37793616|FG000|Overall Study|Lack of Efficacy|53|||
16848390|NCT01895335|37793616|FG000|Overall Study|Poor Compliance to Protocol|11|||
16848391|NCT01895335|37793616|FG000|Overall Study|Included But Not treated|1|||
16924101|NCT03600818|38065750|FG001|Overall Study|Adverse Event|7|||
16924102|NCT03600818|38065749|FG000|Overall Study|Lack of Efficacy|9|||
16924103|NCT03600818|38065750|FG001|Overall Study|Lack of Efficacy|4|||
16924104|NCT03600818|38065749|FG000|Overall Study|Withdrawal by Subject|4|||
16924105|NCT03600818|38065750|FG001|Overall Study|Withdrawal by Subject|3|||
16924106|NCT03600818|38065749|FG000|Overall Study|Other-unspecified|5|||
16924107|NCT03600818|38065750|FG001|Overall Study|Other-unspecified|3|||
16924108|NCT03600818|38065749|FG000|Overall Study|Randomized and not treated|0|||
16924109|NCT03600818|38065750|FG001|Overall Study|Randomized and not treated|1|||
16924110|NCT03578276|38065759|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
16924111|NCT03578276|38065760|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
16924112|NCT02971761|38065775|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
16924113|NCT01627574|38065811|FG000|Overall Study|Withdrawal by Subject|8|||
16924114|NCT01627574|38065812|FG001|Overall Study|Withdrawal by Subject|5|||
16924115|NCT01627574|38065811|FG000|Overall Study|Lost to Follow-up|13|||
16924116|NCT01627574|38065812|FG001|Overall Study|Lost to Follow-up|13|||
16924117|NCT01498458|38065818|FG000|Overall Study|Adverse Event|4|||
16924118|NCT01498458|38065818|FG000|Overall Study|Physician Decision|3|||
16924119|NCT01427712|38065827|FG000|Overall Study|Transfer to a different hospital|2|||
16924120|NCT01427712|38065827|FG000|Overall Study|Lost to Follow-up|1|||
16924121|NCT01427712|38065827|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
16924122|NCT01427712|38065827|FG000|Overall Study|Failure to visit|1|||
16924123|NCT01369147|38065834|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
16924124|NCT01369147|38065835|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
16924125|NCT01369147|38065836|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
16848392|NCT01895335|37793616|FG000|Overall Study|Other than Specified Above|44|||
16848393|NCT01617655|37793622|FG000|Overall Study|Adverse Event|2|||
16848394|NCT01617655|37793623|FG001|Overall Study|Adverse Event|3|||
16848395|NCT01617655|37793622|FG000|Overall Study|Poor compliance to protocol|1|||
16848396|NCT01617655|37793623|FG001|Overall Study|Poor compliance to protocol|4|||
16848397|NCT01617655|37793622|FG000|Overall Study|Participants moved|0|||
16848398|NCT01617655|37793623|FG001|Overall Study|Participants moved|4|||
16848399|NCT01617655|37793622|FG000|Overall Study|Consent withdrawn by participant|1|||
16848400|NCT01617655|37793623|FG001|Overall Study|Consent withdrawn by participant|1|||
16924126|NCT01079780|38065847|FG000|Overall Study|Disease progression|43|||
16924127|NCT01079780|38065848|FG001|Overall Study|Disease progression|7|||
16924128|NCT01079780|38065849|FG002|Overall Study|Disease progression|31|||
16924129|NCT01079780|38065847|FG000|Overall Study|Adverse Event|13|||
16924130|NCT01079780|38065848|FG001|Overall Study|Adverse Event|5|||
16924131|NCT01079780|38065849|FG002|Overall Study|Adverse Event|7|||
16924132|NCT01079780|38065847|FG000|Overall Study|Death|2|||
16924133|NCT01079780|38065848|FG001|Overall Study|Death|0|||
16924134|NCT01079780|38065849|FG002|Overall Study|Death|2|||
16924135|NCT01079780|38065847|FG000|Overall Study|Withdrawal by Subject|6|||
16924136|NCT01079780|38065848|FG001|Overall Study|Withdrawal by Subject|4|||
16924137|NCT01079780|38065849|FG002|Overall Study|Withdrawal by Subject|4|||
16924138|NCT01079780|38065847|FG000|Overall Study|Alternative therapy|2|||
16924139|NCT01079780|38065848|FG001|Overall Study|Alternative therapy|0|||
16924140|NCT01079780|38065849|FG002|Overall Study|Alternative therapy|2|||
16924141|NCT01079780|38065847|FG000|Overall Study|Physician Decision|1|||
16924142|NCT01079780|38065848|FG001|Overall Study|Physician Decision|0|||
16924143|NCT01079780|38065849|FG002|Overall Study|Physician Decision|1|||
16924144|NCT01079780|38065847|FG000|Overall Study|Error made in lesion measurement|1|||
16924145|NCT01079780|38065848|FG001|Overall Study|Error made in lesion measurement|0|||
16924146|NCT01079780|38065849|FG002|Overall Study|Error made in lesion measurement|0|||
16924147|NCT01079780|38065847|FG000|Overall Study|Patient had surgery|1|||
16924148|NCT01079780|38065848|FG001|Overall Study|Patient had surgery|0|||
16924149|NCT01079780|38065849|FG002|Overall Study|Patient had surgery|0|||
16924150|NCT01079780|38065847|FG000|Overall Study|Treatment cycle delay|0|||
16924151|NCT01079780|38065848|FG001|Overall Study|Treatment cycle delay|0|||
16924152|NCT01079780|38065849|FG002|Overall Study|Treatment cycle delay|1|||
16924153|NCT01079780|38065847|FG000|Overall Study|Never started treatment|1|||
16924154|NCT01079780|38065848|FG001|Overall Study|Never started treatment|0|||
16924155|NCT01079780|38065849|FG002|Overall Study|Never started treatment|2|||
16924156|NCT00075946|38065861|FG000|Overall Study|Path ineligible: undetermined histology|0|||
16924157|NCT00075946|38065862|FG001|Overall Study|Path ineligible: undetermined histology|0|||
16924158|NCT00075946|38065863|FG002|Overall Study|Path ineligible: undetermined histology|0|||
16924159|NCT00075946|38065864|FG003|Overall Study|Path ineligible: undetermined histology|0|||
16924160|NCT00075946|38065865|FG004|Overall Study|Path ineligible: undetermined histology|6|||
16924161|NCT00075946|38065861|FG000|Overall Study|Did not achieve response after induction|0|||
16924162|NCT00075946|38065862|FG001|Overall Study|Did not achieve response after induction|0|||
16924163|NCT00075946|38065863|FG002|Overall Study|Did not achieve response after induction|0|||
16924164|NCT00075946|38065864|FG003|Overall Study|Did not achieve response after induction|0|||
16924165|NCT00075946|38065865|FG004|Overall Study|Did not achieve response after induction|182|||
17017834|NCT00842712|38162437|FG002|Safety Run-in Part|Adverse Event|0|||
16924166|NCT00075946|38065861|FG000|Overall Study|Incorrectly randomized (no response)|5|||
16924167|NCT00075946|38065862|FG001|Overall Study|Incorrectly randomized (no response)|5|||
16924168|NCT00075946|38065863|FG002|Overall Study|Incorrectly randomized (no response)|5|||
16924169|NCT00075946|38065864|FG003|Overall Study|Incorrectly randomized (no response)|1|||
16924170|NCT00075946|38065865|FG004|Overall Study|Incorrectly randomized (no response)|0|||
16924171|NCT00075946|38065861|FG000|Overall Study|Still on treatment at time of analysis|52|||
16924172|NCT00075946|38065862|FG001|Overall Study|Still on treatment at time of analysis|19|||
16924173|NCT00075946|38065863|FG002|Overall Study|Still on treatment at time of analysis|3|||
16924174|NCT00075946|38065864|FG003|Overall Study|Still on treatment at time of analysis|9|||
16924175|NCT00075946|38065865|FG004|Overall Study|Still on treatment at time of analysis|0|||
16924176|NCT00075946|38065861|FG000|Overall Study|Adverse Event|2|||
16848401|NCT01617655|37793622|FG000|Overall Study|Last visit outside protocol visit window|1|||
16848402|NCT01617655|37793623|FG001|Overall Study|Last visit outside protocol visit window|10|||
16848403|NCT01617655|37793622|FG000|Overall Study|Site closure|3|||
16848404|NCT01617655|37793623|FG001|Overall Study|Site closure|5|||
16848405|NCT01617655|37793622|FG000|Overall Study|Other than specified above|1|||
16848406|NCT01617655|37793623|FG001|Overall Study|Other than specified above|2|||
16848407|NCT01895101|37793634|FG000|Overall Study|OPCAB procedure|1|||
16848408|NCT01895101|37793635|FG001|Overall Study|OPCAB procedure|1|||
16848409|NCT01895101|37793636|FG002|Overall Study|OPCAB procedure|3|||
16848410|NCT01895101|37793634|FG000|Overall Study|Withdrawal by Subject|0|||
16924177|NCT00075946|38065862|FG001|Overall Study|Adverse Event|10|||
16924178|NCT00075946|38065863|FG002|Overall Study|Adverse Event|0|||
16924179|NCT00075946|38065864|FG003|Overall Study|Adverse Event|2|||
16848411|NCT01895101|37793635|FG001|Overall Study|Withdrawal by Subject|1|||
16848412|NCT01895101|37793636|FG002|Overall Study|Withdrawal by Subject|2|||
16848413|NCT01895101|37793634|FG000|Overall Study|another study, enrolled in other study|0|||
16848414|NCT01895101|37793635|FG001|Overall Study|another study, enrolled in other study|1|||
16848415|NCT01895101|37793636|FG002|Overall Study|another study, enrolled in other study|0|||
16848416|NCT01895101|37793634|FG000|Overall Study|Death|0|||
16924180|NCT00075946|38065865|FG004|Overall Study|Adverse Event|0|||
16924181|NCT00075946|38065861|FG000|Overall Study|Death|0|||
16924182|NCT00075946|38065862|FG001|Overall Study|Death|1|||
16924183|NCT00075946|38065863|FG002|Overall Study|Death|0|||
16924184|NCT00075946|38065864|FG003|Overall Study|Death|0|||
16924185|NCT00075946|38065865|FG004|Overall Study|Death|0|||
16924186|NCT00075946|38065861|FG000|Overall Study|Withdrawal by Subject|23|||
16924187|NCT00075946|38065862|FG001|Overall Study|Withdrawal by Subject|58|||
16924188|NCT00075946|38065863|FG002|Overall Study|Withdrawal by Subject|4|||
16924189|NCT00075946|38065864|FG003|Overall Study|Withdrawal by Subject|9|||
16924190|NCT00075946|38065865|FG004|Overall Study|Withdrawal by Subject|0|||
16924191|NCT00075946|38065861|FG000|Overall Study|Alternative therapy|16|||
16924192|NCT00075946|38065862|FG001|Overall Study|Alternative therapy|2|||
16924193|NCT00075946|38065863|FG002|Overall Study|Alternative therapy|5|||
16924194|NCT00075946|38065864|FG003|Overall Study|Alternative therapy|0|||
16924195|NCT00075946|38065865|FG004|Overall Study|Alternative therapy|0|||
16924196|NCT00075946|38065861|FG000|Overall Study|Other complicating disease|7|||
16924197|NCT00075946|38065862|FG001|Overall Study|Other complicating disease|13|||
16924198|NCT00075946|38065863|FG002|Overall Study|Other complicating disease|1|||
16924199|NCT00075946|38065864|FG003|Overall Study|Other complicating disease|4|||
16924200|NCT00075946|38065865|FG004|Overall Study|Other complicating disease|0|||
16924201|NCT00075946|38065861|FG000|Overall Study|No response to retreatment|23|||
16924202|NCT00075946|38065862|FG001|Overall Study|No response to retreatment|0|||
16924203|NCT00075946|38065863|FG002|Overall Study|No response to retreatment|2|||
16924204|NCT00075946|38065864|FG003|Overall Study|No response to retreatment|0|||
16924205|NCT00075946|38065865|FG004|Overall Study|No response to retreatment|0|||
16924206|NCT00075946|38065861|FG000|Overall Study|Time to progression less than 6 months|15|||
16924207|NCT00075946|38065862|FG001|Overall Study|Time to progression less than 6 months|30|||
16924208|NCT00075946|38065863|FG002|Overall Study|Time to progression less than 6 months|8|||
16924209|NCT00075946|38065864|FG003|Overall Study|Time to progression less than 6 months|3|||
16924210|NCT00075946|38065865|FG004|Overall Study|Time to progression less than 6 months|0|||
16924211|NCT00075946|38065861|FG000|Overall Study|Other|5|||
16924212|NCT00075946|38065862|FG001|Overall Study|Other|13|||
16924213|NCT00075946|38065863|FG002|Overall Study|Other|0|||
16924214|NCT00075946|38065864|FG003|Overall Study|Other|2|||
16924215|NCT00075946|38065865|FG004|Overall Study|Other|0|||
16924216|NCT00003641|38065878|FG000|Overall Study|Withdrawal by Subject|0|||
16924217|NCT00003641|38065879|FG001|Overall Study|Withdrawal by Subject|100|||
16924218|NCT00003641|38065878|FG000|Overall Study|Adverse Event|0|||
16924219|NCT00003641|38065879|FG001|Overall Study|Adverse Event|38|||
16924220|NCT00003641|38065878|FG000|Overall Study|Disease progression|0|||
16924221|NCT00003641|38065879|FG001|Overall Study|Disease progression|2|||
16924222|NCT00003641|38065878|FG000|Overall Study|Unknown/missing|0|||
16924223|NCT00003641|38065879|FG001|Overall Study|Unknown/missing|22|||
16924224|NCT00003641|38065878|FG000|Overall Study|Should not receive interferon therapy|2|||
16924225|NCT00003641|38065879|FG001|Overall Study|Should not receive interferon therapy|0|||
16924226|NCT00003641|38065878|FG000|Overall Study|Never started interferon|567|||
16924227|NCT00003641|38065879|FG001|Overall Study|Never started interferon|12|||
16924228|NCT01956669|38065892|FG000|Overall Study|Disease Progression|12|||
16924229|NCT01956669|38065893|FG001|Overall Study|Disease Progression|7|||
16924230|NCT01956669|38065894|FG002|Overall Study|Disease Progression|7|||
16924231|NCT01956669|38065895|FG003|Overall Study|Disease Progression|8|||
16924232|NCT01956669|38065896|FG004|Overall Study|Disease Progression|4|||
16848417|NCT01895101|37793635|FG001|Overall Study|Death|1|||
16848418|NCT01895101|37793636|FG002|Overall Study|Death|0|||
16848419|NCT01895101|37793634|FG000|Overall Study|coagulation disorder|0|||
16848420|NCT01895101|37793635|FG001|Overall Study|coagulation disorder|1|||
16924233|NCT01956669|38065897|FG005|Overall Study|Disease Progression|3|||
16848421|NCT01895101|37793636|FG002|Overall Study|coagulation disorder|0|||
16848422|NCT01894477|37793646|FG000|Overall Study|Protocol Violation|0|||
16848423|NCT01894477|37793647|FG001|Overall Study|Protocol Violation|1|||
16848424|NCT01894477|37793646|FG000|Overall Study|protocol changed due SC changed to cord|0|||
16924234|NCT01956669|38065898|FG006|Overall Study|Disease Progression|5|||
16924235|NCT01956669|38065892|FG000|Overall Study|Adverse Event|0|||
16848425|NCT01894477|37793647|FG001|Overall Study|protocol changed due SC changed to cord|1|||
16848426|NCT01894243|37793656|FG000|Overall Study|Adverse Event|0|||
16924236|NCT01956669|38065893|FG001|Overall Study|Adverse Event|2|||
16924237|NCT01956669|38065894|FG002|Overall Study|Adverse Event|2|||
16924238|NCT01956669|38065895|FG003|Overall Study|Adverse Event|1|||
16924239|NCT01956669|38065896|FG004|Overall Study|Adverse Event|0|||
16924240|NCT01956669|38065897|FG005|Overall Study|Adverse Event|0|||
16924241|NCT01956669|38065898|FG006|Overall Study|Adverse Event|0|||
16924242|NCT01956669|38065892|FG000|Overall Study|Physician Decision|0|||
16924243|NCT01956669|38065893|FG001|Overall Study|Physician Decision|2|||
16924244|NCT01956669|38065894|FG002|Overall Study|Physician Decision|0|||
16924245|NCT01956669|38065895|FG003|Overall Study|Physician Decision|0|||
16924246|NCT01956669|38065896|FG004|Overall Study|Physician Decision|0|||
16924247|NCT01956669|38065897|FG005|Overall Study|Physician Decision|1|||
16924248|NCT01956669|38065898|FG006|Overall Study|Physician Decision|0|||
16924249|NCT01956669|38065892|FG000|Overall Study|Withdrawal by Subject|0|||
16924250|NCT01956669|38065893|FG001|Overall Study|Withdrawal by Subject|0|||
16924251|NCT01956669|38065894|FG002|Overall Study|Withdrawal by Subject|1|||
16924252|NCT01956669|38065895|FG003|Overall Study|Withdrawal by Subject|1|||
16924253|NCT01956669|38065896|FG004|Overall Study|Withdrawal by Subject|0|||
16924254|NCT01956669|38065897|FG005|Overall Study|Withdrawal by Subject|0|||
16924255|NCT01956669|38065898|FG006|Overall Study|Withdrawal by Subject|1|||
16924256|NCT01967823|38065923|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
16924257|NCT01989676|38065933|FG000|Overall Study|Death|52|||
16924258|NCT01989676|38065934|FG001|Overall Study|Death|60|||
16924259|NCT01989676|38065933|FG000|Overall Study|Protocol Violation|2|||
16924260|NCT01989676|38065934|FG001|Overall Study|Protocol Violation|1|||
16924261|NCT01989676|38065933|FG000|Overall Study|Lost to Follow-up|8|||
16924262|NCT01989676|38065934|FG001|Overall Study|Lost to Follow-up|18|||
16924263|NCT01989676|38065933|FG000|Overall Study|No longer willing to participate in study|26|||
16924264|NCT01989676|38065934|FG001|Overall Study|No longer willing to participate in study|26|||
16924265|NCT01989676|38065933|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
16924266|NCT01989676|38065934|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
16924267|NCT01989676|38065933|FG000|Overall Study|Other|4|||
16924268|NCT01989676|38065934|FG001|Overall Study|Other|3|||
16924269|NCT02001974|38065944|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
16924270|NCT02001974|38065945|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
16924271|NCT02001974|38065946|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
16924272|NCT02001974|38065944|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
16924273|NCT02001974|38065945|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
16924274|NCT02001974|38065946|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
16924275|NCT02001974|38065944|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
16924276|NCT02001974|38065945|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
16924277|NCT02001974|38065946|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
16924278|NCT02001974|38065944|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
16924279|NCT02001974|38065945|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
16924280|NCT02001974|38065946|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
16924281|NCT04983589|38065956|FG000|Overall Study|Withdrawal by Subject|0|||
16924282|NCT04983589|38065957|FG001|Overall Study|Withdrawal by Subject|3|||
16924283|NCT04983589|38065956|FG000|Overall Study|COVID-19 Infection|1|||
16924284|NCT04983589|38065957|FG001|Overall Study|COVID-19 Infection|0|||
16924285|NCT04983589|38065956|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
16924286|NCT04983589|38065957|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
16924287|NCT04556591|38065977|FG000|Overall Study|Lost to Follow-up|1|||
16924288|NCT04556591|38065978|FG001|Overall Study|Lost to Follow-up|0|||
17017835|NCT00842712|38162438|FG003|Safety Run-in Part|Adverse Event|0|||
16848427|NCT01894243|37793657|FG001|Overall Study|Adverse Event|1|||
16848428|NCT01894243|37793658|FG002|Overall Study|Adverse Event|2|||
16848429|NCT01894243|37793656|FG000|Overall Study|Death|0|||
16848430|NCT01894243|37793657|FG001|Overall Study|Death|0|||
16848431|NCT01894243|37793658|FG002|Overall Study|Death|3|||
16848432|NCT01894243|37793656|FG000|Overall Study|Lack of Efficacy|3|||
16848433|NCT01894243|37793657|FG001|Overall Study|Lack of Efficacy|3|||
16848434|NCT01894243|37793658|FG002|Overall Study|Lack of Efficacy|1|||
16848435|NCT01894243|37793656|FG000|Overall Study|Condition under investigation worsened|8|||
16848436|NCT01894243|37793657|FG001|Overall Study|Condition under investigation worsened|6|||
16848437|NCT01894243|37793658|FG002|Overall Study|Condition under investigation worsened|2|||
16848438|NCT01894243|37793656|FG000|Overall Study|Subject decision|1|||
16848439|NCT01894243|37793657|FG001|Overall Study|Subject decision|0|||
16924289|NCT04556591|38065977|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
16924290|NCT04556591|38065978|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
16924291|NCT04428034|38065987|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
16924292|NCT04364984|38065998|FG000|Overall Study|Death|2|||
16924293|NCT04364984|38065999|FG001|Overall Study|Death|2|||
16924294|NCT04364984|38066000|FG002|Overall Study|Death|0|||
16924295|NCT04294095|38066010|FG000|Overall Study|Adverse Event|1|||
16924296|NCT04294095|38066011|FG001|Overall Study|Adverse Event|0|||
16848440|NCT01894243|37793658|FG002|Overall Study|Subject decision|0|||
16848441|NCT01894243|37793656|FG000|Overall Study|Other|1|||
16848442|NCT01894243|37793657|FG001|Overall Study|Other|0|||
16848443|NCT01894243|37793658|FG002|Overall Study|Other|0|||
16848444|NCT03822832|37793675|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
16848445|NCT03822832|37793676|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
16848446|NCT03822832|37793675|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
16848447|NCT03822832|37793676|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
16848448|NCT03822832|37793675|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
16848449|NCT03822832|37793676|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
16848450|NCT03822832|37793675|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
16848451|NCT03822832|37793676|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
16848452|NCT03822832|37793675|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
16848453|NCT03822832|37793676|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
16848454|NCT03822832|37793675|FG000|Re-allocation|Not re-allocated to open label period|2|||
16848455|NCT03822832|37793676|FG001|Re-allocation|Not re-allocated to open label period|6|||
16924297|NCT04266028|38066027|FG000|Overall Study|Adverse Event|0|||
16924298|NCT04266028|38066028|FG001|Overall Study|Adverse Event|0|||
16848456|NCT03822832|37793675|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
16848457|NCT03822832|37793676|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
16848458|NCT03822832|37793675|FG000|Period 2 - Open Label Period|Adverse Event|0|||
16848459|NCT03822832|37793676|FG001|Period 2 - Open Label Period|Adverse Event|3|||
16848460|NCT01513239|37793686|FG000|Period 1: Main Phase|Adverse Event|1|||
16924299|NCT04266028|38066029|FG002|Overall Study|Adverse Event|1|||
16924300|NCT04266028|38066030|FG003|Overall Study|Adverse Event|0|||
16924301|NCT04266028|38066031|FG004|Overall Study|Adverse Event|1|||
16924302|NCT04266028|38066032|FG005|Overall Study|Adverse Event|0|||
16848461|NCT01513239|37793687|FG001|Period 1: Main Phase|Adverse Event|1|||
16848462|NCT01513239|37793688|FG002|Period 1: Main Phase|Adverse Event|2|||
16848463|NCT01513239|37793689|FG003|Period 1: Main Phase|Adverse Event|0|||
16848464|NCT01513239|37793690|FG004|Period 1: Main Phase|Adverse Event|0|||
16924303|NCT04266028|38066033|FG006|Overall Study|Adverse Event|2|||
16924304|NCT04266028|38066034|FG007|Overall Study|Adverse Event|0|||
16924305|NCT04266028|38066027|FG000|Overall Study|temporary halt of the study|0|||
16924306|NCT04266028|38066028|FG001|Overall Study|temporary halt of the study|0|||
16924307|NCT04266028|38066029|FG002|Overall Study|temporary halt of the study|0|||
16924308|NCT04266028|38066030|FG003|Overall Study|temporary halt of the study|0|||
16924309|NCT04266028|38066031|FG004|Overall Study|temporary halt of the study|0|||
16924310|NCT04266028|38066032|FG005|Overall Study|temporary halt of the study|0|||
16924311|NCT04266028|38066033|FG006|Overall Study|temporary halt of the study|2|||
16924312|NCT04266028|38066034|FG007|Overall Study|temporary halt of the study|1|||
16924313|NCT04266028|38066027|FG000|Overall Study|Onset of birch pollen season|0|||
16924314|NCT04266028|38066028|FG001|Overall Study|Onset of birch pollen season|0|||
16924315|NCT04266028|38066029|FG002|Overall Study|Onset of birch pollen season|0|||
16924316|NCT04266028|38066030|FG003|Overall Study|Onset of birch pollen season|0|||
16924317|NCT04266028|38066031|FG004|Overall Study|Onset of birch pollen season|1|||
16924318|NCT04266028|38066032|FG005|Overall Study|Onset of birch pollen season|0|||
16924319|NCT04266028|38066033|FG006|Overall Study|Onset of birch pollen season|0|||
16924320|NCT04266028|38066034|FG007|Overall Study|Onset of birch pollen season|0|||
16924321|NCT03994731|38066084|FG000|Pegloticase + IMM Period|Death|2|||
16924322|NCT03994731|38066085|FG001|Pegloticase + IMM Period|Death|0|||
16848465|NCT01513239|37793691|FG005|Period 1: Main Phase|Adverse Event|0|||
16848466|NCT01513239|37793686|FG000|Period 1: Main Phase|Death|29|||
16924323|NCT03994731|38066084|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
16924324|NCT03994731|38066085|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
16924325|NCT03994731|38066084|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
16924326|NCT03994731|38066085|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
16924327|NCT03829683|38066109|FG000|Overall Study|Lost to Follow-up|1|||
16924328|NCT03829683|38066110|FG001|Overall Study|Lost to Follow-up|0|||
16924329|NCT03829683|38066109|FG000|Overall Study|Physician Decision|3|||
16924330|NCT03829683|38066110|FG001|Overall Study|Physician Decision|1|||
16924331|NCT03829683|38066109|FG000|Overall Study|Withdrawal by Subject|0|||
16924332|NCT03829683|38066110|FG001|Overall Study|Withdrawal by Subject|1|||
16924333|NCT03829683|38066109|FG000|Overall Study|Discharge from hospital|1|||
16924334|NCT03829683|38066110|FG001|Overall Study|Discharge from hospital|0|||
16924335|NCT03801915|38066119|FG000|Overall Study|Screen failure|0|||
16924336|NCT03801915|38066120|FG001|Overall Study|Screen failure|0|||
16924337|NCT03801915|38066121|FG002|Overall Study|Screen failure|1|||
16924338|NCT03801915|38066119|FG000|Overall Study|Ineligible|1|||
16924339|NCT03801915|38066120|FG001|Overall Study|Ineligible|0|||
16924340|NCT03801915|38066121|FG002|Overall Study|Ineligible|0|||
16924341|NCT03801915|38066119|FG000|Overall Study|Physician Decision|2|||
16924342|NCT03801915|38066120|FG001|Overall Study|Physician Decision|1|||
16924343|NCT03801915|38066121|FG002|Overall Study|Physician Decision|0|||
16924344|NCT03639311|38066135|FG000|Overall Study|Ongoing at the time of analysis|88|||
16924345|NCT03639311|38066136|FG001|Overall Study|Ongoing at the time of analysis|0|||
16924346|NCT03639311|38066135|FG000|Overall Study|Lost to Follow-up|1|||
16924347|NCT03639311|38066136|FG001|Overall Study|Lost to Follow-up|0|||
16924348|NCT03639311|38066135|FG000|Overall Study|Adverse Event|1|||
16924349|NCT03639311|38066136|FG001|Overall Study|Adverse Event|0|||
16924350|NCT03581305|38066147|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
16924351|NCT03581305|38066148|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
16924352|NCT03581305|38066147|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
16924353|NCT03581305|38066148|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
16924354|NCT03581305|38066147|FG000|Serotonergic Study|Withdrawal by Subject|5|||
16924355|NCT03581305|38066148|FG001|Serotonergic Study|Withdrawal by Subject|1|||
16924356|NCT03556202|38066159|FG000|Extension Treatment Period|Adverse Event|18|||
16924357|NCT03556202|38066160|FG001|Extension Treatment Period|Adverse Event|14|||
16924358|NCT03556202|38066161|FG002|Extension Treatment Period|Adverse Event|9|||
16924359|NCT03556202|38066159|FG000|Extension Treatment Period|Death|2|||
16924360|NCT03556202|38066160|FG001|Extension Treatment Period|Death|6|||
16924361|NCT03556202|38066161|FG002|Extension Treatment Period|Death|0|||
16924362|NCT03556202|38066159|FG000|Extension Treatment Period|Lack of Efficacy|5|||
16924363|NCT03556202|38066160|FG001|Extension Treatment Period|Lack of Efficacy|12|||
16924364|NCT03556202|38066161|FG002|Extension Treatment Period|Lack of Efficacy|18|||
16924365|NCT03556202|38066159|FG000|Extension Treatment Period|Lost to Follow-up|9|||
16924366|NCT03556202|38066160|FG001|Extension Treatment Period|Lost to Follow-up|20|||
16924367|NCT03556202|38066161|FG002|Extension Treatment Period|Lost to Follow-up|2|||
16924368|NCT03556202|38066159|FG000|Extension Treatment Period|Pregnancy|2|||
16924369|NCT03556202|38066160|FG001|Extension Treatment Period|Pregnancy|4|||
16924370|NCT03556202|38066161|FG002|Extension Treatment Period|Pregnancy|3|||
16924371|NCT03556202|38066159|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
16924372|NCT03556202|38066160|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
16924373|NCT03556202|38066161|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
16924374|NCT03556202|38066159|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
16848467|NCT01513239|37793687|FG001|Period 1: Main Phase|Death|22|||
16848468|NCT01513239|37793688|FG002|Period 1: Main Phase|Death|32|||
16848469|NCT01513239|37793689|FG003|Period 1: Main Phase|Death|0|||
16848470|NCT01513239|37793690|FG004|Period 1: Main Phase|Death|0|||
16848471|NCT01513239|37793691|FG005|Period 1: Main Phase|Death|0|||
16848472|NCT01513239|37793686|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
16848473|NCT01513239|37793687|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
16848474|NCT01513239|37793688|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
16848475|NCT01513239|37793689|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
16848476|NCT01513239|37793690|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
16848477|NCT01513239|37793691|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
16848478|NCT01513239|37793686|FG000|Period 1: Main Phase|Physician Decision|4|||
16848479|NCT01513239|37793687|FG001|Period 1: Main Phase|Physician Decision|4|||
16848480|NCT01513239|37793688|FG002|Period 1: Main Phase|Physician Decision|4|||
16848481|NCT01513239|37793689|FG003|Period 1: Main Phase|Physician Decision|0|||
16848482|NCT01513239|37793690|FG004|Period 1: Main Phase|Physician Decision|0|||
16848483|NCT01513239|37793691|FG005|Period 1: Main Phase|Physician Decision|0|||
16924375|NCT03556202|38066160|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
16924376|NCT03556202|38066161|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
16924377|NCT03556202|38066159|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
16924378|NCT03556202|38066160|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
16924379|NCT03556202|38066161|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
16924380|NCT03556202|38066159|FG000|Extension Treatment Period|Physician Decision|0|||
16848484|NCT01513239|37793686|FG000|Period 1: Main Phase|Protocol Violation|2|||
16848485|NCT01513239|37793687|FG001|Period 1: Main Phase|Protocol Violation|2|||
16848486|NCT01513239|37793688|FG002|Period 1: Main Phase|Protocol Violation|2|||
16848487|NCT01513239|37793689|FG003|Period 1: Main Phase|Protocol Violation|0|||
16848488|NCT01513239|37793690|FG004|Period 1: Main Phase|Protocol Violation|0|||
16848489|NCT01513239|37793691|FG005|Period 1: Main Phase|Protocol Violation|0|||
16848490|NCT01513239|37793686|FG000|Period 1: Main Phase|Technical Problems|1|||
16848491|NCT01513239|37793687|FG001|Period 1: Main Phase|Technical Problems|2|||
16848492|NCT01513239|37793688|FG002|Period 1: Main Phase|Technical Problems|0|||
16848493|NCT01513239|37793689|FG003|Period 1: Main Phase|Technical Problems|0|||
16848494|NCT01513239|37793690|FG004|Period 1: Main Phase|Technical Problems|0|||
16848495|NCT01513239|37793691|FG005|Period 1: Main Phase|Technical Problems|0|||
16848496|NCT01513239|37793686|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
16848497|NCT01513239|37793687|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
16848498|NCT01513239|37793688|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
16848499|NCT01513239|37793689|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
16848500|NCT01513239|37793690|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
16848501|NCT01513239|37793691|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
16848502|NCT01513239|37793686|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
16924381|NCT03556202|38066160|FG001|Extension Treatment Period|Physician Decision|8|||
16924382|NCT03556202|38066161|FG002|Extension Treatment Period|Physician Decision|2|||
16924383|NCT03556202|38066159|FG000|Extension Treatment Period|Protocol Violation|0|||
16924384|NCT03556202|38066160|FG001|Extension Treatment Period|Protocol Violation|1|||
16924385|NCT03556202|38066161|FG002|Extension Treatment Period|Protocol Violation|1|||
16924386|NCT03556202|38066159|FG000|Extension Treatment Period|Sponsor Decision|0|||
16924387|NCT03556202|38066160|FG001|Extension Treatment Period|Sponsor Decision|1|||
16924388|NCT03556202|38066161|FG002|Extension Treatment Period|Sponsor Decision|0|||
16924389|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
16924390|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
16924391|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
16924392|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Death|1|||
16924393|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Death|0|||
16924394|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Death|0|||
16848503|NCT01513239|37793687|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
16848504|NCT01513239|37793688|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
16848505|NCT01513239|37793689|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
16848506|NCT01513239|37793690|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
16848507|NCT01513239|37793691|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
16848508|NCT01513239|37793686|FG000|Period 2: 9 Month Extension Phase|Death|0|||
16924395|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
16924396|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
16924397|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
16924398|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
16924399|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
16924400|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
16924401|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
16924402|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
16924403|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
16924404|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
16924405|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
16924406|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
16924407|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
16924408|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
16924409|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
16924410|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
16924411|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
16924412|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
16924413|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
16924414|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
16924415|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
16924416|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
16924417|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
16924418|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
16924419|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
17017836|NCT00842712|38162439|FG004|Safety Run-in Part|Adverse Event|0|||
16848509|NCT01513239|37793687|FG001|Period 2: 9 Month Extension Phase|Death|0|||
16848510|NCT01513239|37793688|FG002|Period 2: 9 Month Extension Phase|Death|0|||
16848511|NCT01513239|37793689|FG003|Period 2: 9 Month Extension Phase|Death|2|||
16848512|NCT01513239|37793690|FG004|Period 2: 9 Month Extension Phase|Death|5|||
16848513|NCT01513239|37793691|FG005|Period 2: 9 Month Extension Phase|Death|2|||
16848514|NCT01513239|37793686|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
16848515|NCT01513239|37793687|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
16848516|NCT01513239|37793688|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
16848517|NCT01513239|37793689|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
16848518|NCT01513239|37793690|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
16848519|NCT01513239|37793691|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
16848520|NCT01513239|37793686|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16848521|NCT01513239|37793687|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16848522|NCT01513239|37793688|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16848523|NCT01513239|37793689|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
16924420|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
16924421|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
16924422|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
16924423|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
16924424|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
16924425|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
16924426|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
16924427|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
16924428|NCT03556202|38066159|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
16924429|NCT03556202|38066160|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
16924430|NCT03556202|38066161|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
16924431|NCT03541174|38066175|FG000|Part 1 Double-Blind|Adverse Event|6|||
16924432|NCT03541174|38066176|FG001|Part 1 Double-Blind|Adverse Event|5|||
16924433|NCT03541174|38066177|FG002|Part 1 Double-Blind|Adverse Event|2|||
16924434|NCT03541174|38066178|FG003|Part 1 Double-Blind|Adverse Event|0|||
16924435|NCT03541174|38066179|FG004|Part 1 Double-Blind|Adverse Event|0|||
16924436|NCT03541174|38066180|FG005|Part 1 Double-Blind|Adverse Event|0|||
16924437|NCT03541174|38066175|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
16924438|NCT03541174|38066176|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
16924439|NCT03541174|38066177|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
16924440|NCT03541174|38066178|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
16924441|NCT03541174|38066179|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
16924442|NCT03541174|38066180|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
16924443|NCT03541174|38066175|FG000|Part 1 Double-Blind|Other reasons|3|||
16924444|NCT03541174|38066176|FG001|Part 1 Double-Blind|Other reasons|2|||
16924445|NCT03541174|38066177|FG002|Part 1 Double-Blind|Other reasons|3|||
16924446|NCT03541174|38066178|FG003|Part 1 Double-Blind|Other reasons|0|||
16924447|NCT03541174|38066179|FG004|Part 1 Double-Blind|Other reasons|0|||
16924448|NCT03541174|38066180|FG005|Part 1 Double-Blind|Other reasons|0|||
16924449|NCT03541174|38066175|FG000|Part 2 Single-Blind|Adverse Event|0|||
16924450|NCT03541174|38066176|FG001|Part 2 Single-Blind|Adverse Event|0|||
16924451|NCT03541174|38066177|FG002|Part 2 Single-Blind|Adverse Event|0|||
16924452|NCT03541174|38066178|FG003|Part 2 Single-Blind|Adverse Event|25|||
16924453|NCT03541174|38066179|FG004|Part 2 Single-Blind|Adverse Event|0|||
16924454|NCT03541174|38066180|FG005|Part 2 Single-Blind|Adverse Event|0|||
16924455|NCT03541174|38066175|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
16924456|NCT03541174|38066176|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
16924457|NCT03541174|38066177|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
16924458|NCT03541174|38066178|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
16924459|NCT03541174|38066179|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
16924460|NCT03541174|38066180|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
16924461|NCT03541174|38066175|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
16924462|NCT03541174|38066176|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
16924463|NCT03541174|38066177|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
16924464|NCT03541174|38066178|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
16924465|NCT03541174|38066179|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
16924466|NCT03541174|38066180|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
16924467|NCT03541174|38066175|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
16924468|NCT03541174|38066176|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
16924469|NCT03541174|38066177|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
16924470|NCT03541174|38066178|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
16924471|NCT03541174|38066179|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
16924472|NCT03541174|38066180|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
16924473|NCT03541174|38066175|FG000|Part 2 Single-Blind|Death|0|||
16924474|NCT03541174|38066176|FG001|Part 2 Single-Blind|Death|0|||
16924475|NCT03541174|38066177|FG002|Part 2 Single-Blind|Death|0|||
16924476|NCT03541174|38066178|FG003|Part 2 Single-Blind|Death|5|||
16924477|NCT03541174|38066179|FG004|Part 2 Single-Blind|Death|0|||
16924478|NCT03541174|38066180|FG005|Part 2 Single-Blind|Death|0|||
16924479|NCT03541174|38066175|FG000|Part 2 Single-Blind|Pregnancy|0|||
16924480|NCT03541174|38066176|FG001|Part 2 Single-Blind|Pregnancy|0|||
16924481|NCT03541174|38066177|FG002|Part 2 Single-Blind|Pregnancy|0|||
16848524|NCT01513239|37793690|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16924482|NCT03541174|38066178|FG003|Part 2 Single-Blind|Pregnancy|1|||
16924483|NCT03541174|38066179|FG004|Part 2 Single-Blind|Pregnancy|0|||
16924484|NCT03541174|38066180|FG005|Part 2 Single-Blind|Pregnancy|0|||
16924485|NCT03541174|38066175|FG000|Part 2 Single-Blind|Other reasons|0|||
16924486|NCT03541174|38066176|FG001|Part 2 Single-Blind|Other reasons|0|||
16924487|NCT03541174|38066177|FG002|Part 2 Single-Blind|Other reasons|0|||
16924488|NCT03541174|38066178|FG003|Part 2 Single-Blind|Other reasons|32|||
16924489|NCT03541174|38066179|FG004|Part 2 Single-Blind|Other reasons|0|||
16924490|NCT03541174|38066180|FG005|Part 2 Single-Blind|Other reasons|0|||
16924491|NCT03541174|38066175|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
16924492|NCT03541174|38066176|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
16924493|NCT03541174|38066177|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
16924494|NCT03541174|38066178|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
16924495|NCT03541174|38066179|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
16924496|NCT03541174|38066180|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
16924497|NCT03541174|38066175|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
16924498|NCT03541174|38066176|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
16924499|NCT03541174|38066177|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
16924500|NCT03541174|38066178|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
16924501|NCT03541174|38066179|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
16924502|NCT03541174|38066180|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
16924503|NCT03541174|38066175|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16924504|NCT03541174|38066176|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16924505|NCT03541174|38066177|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16924506|NCT03541174|38066178|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16924507|NCT03541174|38066179|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16924508|NCT03541174|38066180|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
16924509|NCT03541174|38066175|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
16924510|NCT03541174|38066176|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
16848525|NCT01513239|37793691|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16848526|NCT01513239|37793686|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
16848527|NCT01513239|37793687|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
16848528|NCT01513239|37793688|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
16924511|NCT03541174|38066177|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
16924512|NCT03541174|38066178|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
16924513|NCT03541174|38066179|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
16924514|NCT03541174|38066180|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
16924515|NCT03541174|38066175|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16924516|NCT03541174|38066176|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16848529|NCT01513239|37793689|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
16848530|NCT01513239|37793690|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
16848531|NCT01513239|37793691|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
16848532|NCT01544127|37793706|FG000|Overall Study|Lost to Follow-up|4|||
16848533|NCT01544127|37793707|FG001|Overall Study|Lost to Follow-up|2|||
16848534|NCT01544127|37793708|FG002|Overall Study|Lost to Follow-up|9|||
16848535|NCT01544127|37793706|FG000|Overall Study|Withdrawal by Subject|2|||
16848536|NCT01544127|37793707|FG001|Overall Study|Withdrawal by Subject|2|||
16848537|NCT01544127|37793708|FG002|Overall Study|Withdrawal by Subject|1|||
16848538|NCT01544127|37793706|FG000|Overall Study|Discharged out of catchment area|1|||
16848539|NCT01544127|37793707|FG001|Overall Study|Discharged out of catchment area|1|||
16848540|NCT01544127|37793708|FG002|Overall Study|Discharged out of catchment area|1|||
16848541|NCT01544127|37793706|FG000|Overall Study|Death|1|||
16848542|NCT01544127|37793707|FG001|Overall Study|Death|0|||
16848543|NCT01544127|37793708|FG002|Overall Study|Death|0|||
16848544|NCT01544127|37793706|FG000|Overall Study|Jail or Prison|1|||
16848545|NCT01544127|37793707|FG001|Overall Study|Jail or Prison|1|||
16848546|NCT01544127|37793708|FG002|Overall Study|Jail or Prison|2|||
16848547|NCT01544127|37793706|FG000|Overall Study|Became Psychotic|1|||
16848548|NCT01544127|37793707|FG001|Overall Study|Became Psychotic|0|||
16848549|NCT01544127|37793708|FG002|Overall Study|Became Psychotic|0|||
16848550|NCT01544127|37793706|FG000|Overall Study|Researcher withdrew|1|||
16848551|NCT01544127|37793707|FG001|Overall Study|Researcher withdrew|0|||
16848552|NCT01544127|37793708|FG002|Overall Study|Researcher withdrew|0|||
16848553|NCT01544127|37793706|FG000|Overall Study|Went active duty|0|||
16848554|NCT01544127|37793707|FG001|Overall Study|Went active duty|0|||
16924517|NCT03541174|38066177|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16924518|NCT03541174|38066178|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16848555|NCT01544127|37793708|FG002|Overall Study|Went active duty|1|||
16848556|NCT01512693|37793719|FG000|Overall Study|Withdrawal by Subject|0|||
16848557|NCT01512693|37793720|FG001|Overall Study|Withdrawal by Subject|1|||
16848558|NCT01458340|37793729|FG000|Overall Study|Adverse Event|5|||
16848559|NCT01458340|37793730|FG001|Overall Study|Adverse Event|4|||
16924519|NCT03541174|38066179|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
16924520|NCT03541174|38066180|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16924521|NCT03459846|38066195|FG000|Overall Study|Death|52|||
16924522|NCT03459846|38066196|FG001|Overall Study|Death|46|||
16924523|NCT03459846|38066195|FG000|Overall Study|Study terminated by sponsor|24|||
16924524|NCT03459846|38066196|FG001|Overall Study|Study terminated by sponsor|28|||
16924525|NCT03459846|38066195|FG000|Overall Study|Withdrawal by Subject|2|||
16924526|NCT03459846|38066196|FG001|Overall Study|Withdrawal by Subject|2|||
16924527|NCT03289039|38066230|FG000|Overall Study|Withdrawal by Subject|0|||
16924528|NCT03289039|38066231|FG001|Overall Study|Withdrawal by Subject|1|||
16924529|NCT03289039|38066230|FG000|Overall Study|Became ineligible prior to treatment start|0|||
16924530|NCT03289039|38066231|FG001|Overall Study|Became ineligible prior to treatment start|1|||
16924531|NCT03289039|38066230|FG000|Overall Study|progressed before treatment start|1|||
16924532|NCT03289039|38066231|FG001|Overall Study|progressed before treatment start|0|||
16924533|NCT03281304|38066239|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
16924534|NCT03281304|38066240|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
16924535|NCT03281304|38066239|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
16924536|NCT03281304|38066240|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
16924537|NCT03281304|38066239|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
16924538|NCT03281304|38066240|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
16924539|NCT03281304|38066239|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
16924540|NCT03281304|38066240|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
16924541|NCT03281304|38066239|FG000|Treatment Phase (up to 42 Months)|Death|0|||
16924542|NCT03281304|38066240|FG001|Treatment Phase (up to 42 Months)|Death|1|||
16924543|NCT03281304|38066239|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
16924544|NCT03281304|38066240|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
16924545|NCT03281304|38066239|FG000|Treatment Phase (up to 42 Months)|Other|0|||
16924546|NCT03281304|38066240|FG001|Treatment Phase (up to 42 Months)|Other|2|||
16924547|NCT03281304|38066239|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
16924548|NCT03281304|38066240|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
16924549|NCT03204305|38066249|FG000|Overall Study|Lost to Follow-up|6|||
16924550|NCT03204305|38066250|FG001|Overall Study|Lost to Follow-up|4|||
16924551|NCT03204305|38066251|FG002|Overall Study|Lost to Follow-up|0|||
16924552|NCT03204305|38066252|FG003|Overall Study|Lost to Follow-up|0|||
16924553|NCT03204305|38066249|FG000|Overall Study|Physician Decision|1|||
16924554|NCT03204305|38066250|FG001|Overall Study|Physician Decision|0|||
16924555|NCT03204305|38066251|FG002|Overall Study|Physician Decision|0|||
16924556|NCT03204305|38066252|FG003|Overall Study|Physician Decision|0|||
16924557|NCT03204305|38066249|FG000|Overall Study|failure to place arterial line|2|||
16924558|NCT03204305|38066250|FG001|Overall Study|failure to place arterial line|1|||
16924559|NCT03204305|38066251|FG002|Overall Study|failure to place arterial line|0|||
16924560|NCT03204305|38066252|FG003|Overall Study|failure to place arterial line|0|||
16924561|NCT03204305|38066249|FG000|Overall Study|Withdrawal by Subject|2|||
16924562|NCT03204305|38066250|FG001|Overall Study|Withdrawal by Subject|0|||
16924563|NCT03204305|38066251|FG002|Overall Study|Withdrawal by Subject|0|||
16924564|NCT03204305|38066252|FG003|Overall Study|Withdrawal by Subject|0|||
16924565|NCT03200717|38066264|FG000|Overall Study|Progressive disease|24|||
16924566|NCT03200717|38066265|FG001|Overall Study|Progressive disease|5|||
16924567|NCT03200717|38066264|FG000|Overall Study|Adverse Event|11|||
16924568|NCT03200717|38066265|FG001|Overall Study|Adverse Event|8|||
16924569|NCT03200717|38066264|FG000|Overall Study|Physician Decision|3|||
16924570|NCT03200717|38066265|FG001|Overall Study|Physician Decision|2|||
16924571|NCT03200717|38066264|FG000|Overall Study|Death|2|||
16924572|NCT03200717|38066265|FG001|Overall Study|Death|0|||
16924573|NCT03200717|38066264|FG000|Overall Study|Subject/Guardian Decision|1|||
16848560|NCT01458340|37793731|FG002|Overall Study|Adverse Event|2|||
16848561|NCT01458340|37793729|FG000|Overall Study|Lost to Follow-up|3|||
16848562|NCT01458340|37793730|FG001|Overall Study|Lost to Follow-up|3|||
16848563|NCT01458340|37793731|FG002|Overall Study|Lost to Follow-up|10|||
16848564|NCT01458340|37793729|FG000|Overall Study|Miscellaneous|0|||
16848565|NCT01458340|37793730|FG001|Overall Study|Miscellaneous|1|||
16848566|NCT01458340|37793731|FG002|Overall Study|Miscellaneous|0|||
16848567|NCT01458340|37793729|FG000|Overall Study|Physician Decision|1|||
16848568|NCT01458340|37793730|FG001|Overall Study|Physician Decision|1|||
16848569|NCT01458340|37793731|FG002|Overall Study|Physician Decision|2|||
16848570|NCT01458340|37793729|FG000|Overall Study|Protocol Violation|6|||
16848571|NCT01458340|37793730|FG001|Overall Study|Protocol Violation|6|||
16848572|NCT01458340|37793731|FG002|Overall Study|Protocol Violation|5|||
16848573|NCT01458340|37793729|FG000|Overall Study|Withdrawal by Subject|12|||
16848574|NCT01458340|37793730|FG001|Overall Study|Withdrawal by Subject|6|||
16924574|NCT03200717|38066265|FG001|Overall Study|Subject/Guardian Decision|0|||
16924575|NCT03105700|38066274|FG000|Overall Study|screen fail|3|||
16924576|NCT03105700|38066274|FG000|Overall Study|Lost to Follow-up|4|||
16848575|NCT01458340|37793731|FG002|Overall Study|Withdrawal by Subject|4|||
16848576|NCT01539291|37793786|FG000|Study GS-US-312-0116|Adverse Event|9|||
16848577|NCT01539291|37793787|FG001|Study GS-US-312-0116|Adverse Event|0|||
16848578|NCT01539291|37793788|FG002|Study GS-US-312-0116|Adverse Event|0|||
16848579|NCT01539291|37793789|FG003|Study GS-US-312-0116|Adverse Event|0|||
16848580|NCT01539291|37793786|FG000|Study GS-US-312-0116|Physician Decision|1|||
16848581|NCT01539291|37793787|FG001|Study GS-US-312-0116|Physician Decision|0|||
16848582|NCT01539291|37793788|FG002|Study GS-US-312-0116|Physician Decision|0|||
16848583|NCT01539291|37793789|FG003|Study GS-US-312-0116|Physician Decision|0|||
16848584|NCT01539291|37793786|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
16848585|NCT01539291|37793787|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
16848586|NCT01539291|37793788|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
16848587|NCT01539291|37793789|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
16848588|NCT01539291|37793786|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
16848589|NCT01539291|37793787|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
16848590|NCT01539291|37793788|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
16848591|NCT01539291|37793789|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
16848592|NCT01539291|37793786|FG000|Study GS-US-312-0116|Other|1|||
16924607|NCT02738853|38066325|FG000|Enrollment|Inclusion/Exclusion not met|21|||
16924608|NCT02738853|38066325|FG000|Enrollment|Withdrawal by Subject|3|||
16924609|NCT02738853|38066325|FG000|Enrollment|Subject treated with commercially available device|6|||
16924610|NCT02738853|38066325|FG000|Enrollment|Study Enrollment Closed|3|||
16924611|NCT02738853|38066325|FG000|Procedure|Death|1|||
16924612|NCT02738853|38066325|FG000|1 Month|Death|2|||
16924613|NCT02738853|38066325|FG000|6 Month|Death|4|||
16924614|NCT02738853|38066325|FG000|6 Month|Withdrawal by Subject|2|||
16924615|NCT02738853|38066325|FG000|1 Year|Death|6|||
16924616|NCT02738853|38066325|FG000|1 Year|Withdrawal by Subject|1|||
16924617|NCT02738853|38066325|FG000|2 Year|Death|2|||
16924618|NCT02738853|38066325|FG000|2 Year|Lost to Follow-up|1|||
16924619|NCT02738853|38066325|FG000|3 Year|Death|2|||
17102554|NCT00112437|38241458|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
16848593|NCT01539291|37793787|FG001|Study GS-US-312-0116|Other|0|||
16848594|NCT01539291|37793788|FG002|Study GS-US-312-0116|Other|0|||
16848595|NCT01539291|37793789|FG003|Study GS-US-312-0116|Other|0|||
16848596|NCT01539291|37793786|FG000|Study GS-US-312-0117|Adverse Event|22|||
16848597|NCT01539291|37793787|FG001|Study GS-US-312-0117|Adverse Event|1|||
16848598|NCT01539291|37793788|FG002|Study GS-US-312-0117|Adverse Event|9|||
16848599|NCT01539291|37793789|FG003|Study GS-US-312-0117|Adverse Event|12|||
16848600|NCT01539291|37793786|FG000|Study GS-US-312-0117|Physician Decision|9|||
16848601|NCT01539291|37793787|FG001|Study GS-US-312-0117|Physician Decision|0|||
17102555|NCT00112437|38241459|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
16924620|NCT02738853|38066325|FG000|3 Year|Withdrawal by Subject|1|||
16924621|NCT02738853|38066325|FG000|4 Year|Death|9|||
16924622|NCT02738853|38066325|FG000|5 Year|Lost to Follow-up|4|||
16924623|NCT02562235|38066329|FG000|Overall Study|Adverse Event|3|||
16924624|NCT02358538|38066342|FG000|Through Week 26|Adverse Event|0|||
16924625|NCT02358538|38066343|FG001|Through Week 26|Adverse Event|1|||
16924626|NCT02358538|38066344|FG002|Through Week 26|Adverse Event|1|||
16848602|NCT01539291|37793788|FG002|Study GS-US-312-0117|Physician Decision|6|||
16848603|NCT01539291|37793789|FG003|Study GS-US-312-0117|Physician Decision|4|||
16924627|NCT02358538|38066345|FG003|Through Week 26|Adverse Event|2|||
16924628|NCT02358538|38066342|FG000|Through Week 26|Lack of Efficacy|1|||
16924629|NCT02358538|38066343|FG001|Through Week 26|Lack of Efficacy|1|||
16924630|NCT02358538|38066344|FG002|Through Week 26|Lack of Efficacy|3|||
16924631|NCT02358538|38066345|FG003|Through Week 26|Lack of Efficacy|3|||
16924632|NCT02358538|38066342|FG000|Through Week 26|Withdrawal by Subject|1|||
16924633|NCT02358538|38066343|FG001|Through Week 26|Withdrawal by Subject|0|||
16924634|NCT02358538|38066344|FG002|Through Week 26|Withdrawal by Subject|0|||
16924635|NCT02358538|38066345|FG003|Through Week 26|Withdrawal by Subject|0|||
16924636|NCT02358538|38066342|FG000|Through Week 26|Non-Compliance|0|||
16924637|NCT02358538|38066343|FG001|Through Week 26|Non-Compliance|0|||
16924638|NCT02358538|38066344|FG002|Through Week 26|Non-Compliance|1|||
16924639|NCT02358538|38066345|FG003|Through Week 26|Non-Compliance|0|||
16924640|NCT02358538|38066342|FG000|Through Week 26|Family did not see benefit from IP|1|||
16924641|NCT02358538|38066343|FG001|Through Week 26|Family did not see benefit from IP|0|||
16924642|NCT02358538|38066344|FG002|Through Week 26|Family did not see benefit from IP|0|||
16924643|NCT02358538|38066345|FG003|Through Week 26|Family did not see benefit from IP|0|||
16924644|NCT02358538|38066342|FG000|52 Week Extension Period|Lack of Efficacy|0|||
16924645|NCT02358538|38066343|FG001|52 Week Extension Period|Lack of Efficacy|0|||
16924646|NCT02358538|38066344|FG002|52 Week Extension Period|Lack of Efficacy|2|||
16924647|NCT02358538|38066345|FG003|52 Week Extension Period|Lack of Efficacy|4|||
16924648|NCT02197234|38066378|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
16924649|NCT02197234|38066378|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
16924650|NCT02197234|38066378|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
16924651|NCT02197234|38066378|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
16924652|NCT02197234|38066378|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
16924653|NCT02197234|38066378|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
16924654|NCT02197234|38066378|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
16924655|NCT02157883|38066385|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
16924656|NCT02157883|38066385|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
16924657|NCT02157883|38066385|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
16924658|NCT02157883|38066385|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
16924659|NCT02157883|38066385|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
16924660|NCT02056119|38066394|FG000|Overall Study|Death|1|||
16924661|NCT02056119|38066395|FG001|Overall Study|Death|2|||
16924662|NCT02056119|38066394|FG000|Overall Study|Intubated for less than 24 hrs|2|||
16924663|NCT02056119|38066395|FG001|Overall Study|Intubated for less than 24 hrs|7|||
16924664|NCT02056119|38066394|FG000|Overall Study|No aerosol treatments were given.|3|||
16924665|NCT02056119|38066395|FG001|Overall Study|No aerosol treatments were given.|2|||
16924666|NCT02056119|38066394|FG000|Overall Study|Received Metaneb treatment|0|||
16924667|NCT02056119|38066395|FG001|Overall Study|Received Metaneb treatment|2|||
16924668|NCT02056119|38066394|FG000|Overall Study|Protocol Violation|4|||
16924669|NCT02056119|38066395|FG001|Overall Study|Protocol Violation|7|||
16924670|NCT02038452|38066403|FG000|Overall Study|Withdrawal by Subject|7|||
16924671|NCT02038452|38066404|FG001|Overall Study|Withdrawal by Subject|9|||
16924672|NCT02038452|38066403|FG000|Overall Study|Lost to Follow-up|31|||
16924673|NCT02038452|38066404|FG001|Overall Study|Lost to Follow-up|28|||
16924674|NCT01933932|38066416|FG000|Overall Study|Death|173|||
16924675|NCT01933932|38066417|FG001|Overall Study|Death|163|||
16924676|NCT01933932|38066416|FG000|Overall Study|Withdrawal by Subject|11|||
16924677|NCT01933932|38066417|FG001|Overall Study|Withdrawal by Subject|14|||
16924678|NCT01933932|38066416|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16848604|NCT01539291|37793786|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
16848605|NCT01539291|37793787|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
16848606|NCT01539291|37793788|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
16848607|NCT01539291|37793789|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
16848608|NCT01539291|37793786|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
16848609|NCT01539291|37793787|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
16848610|NCT01539291|37793788|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
16848611|NCT01539291|37793789|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
16848612|NCT01539291|37793786|FG000|Study GS-US-312-0117|Other|2|||
16848613|NCT01539291|37793787|FG001|Study GS-US-312-0117|Other|1|||
16848614|NCT01539291|37793788|FG002|Study GS-US-312-0117|Other|1|||
16848615|NCT01539291|37793789|FG003|Study GS-US-312-0117|Other|1|||
16848616|NCT01538199|37793812|FG000|Overall Study|Lost to Follow-up|1|||
16848617|NCT01538199|37793813|FG001|Overall Study|Lost to Follow-up|2|||
16848618|NCT01538199|37793814|FG002|Overall Study|Lost to Follow-up|1|||
16848619|NCT01538199|37793815|FG003|Overall Study|Lost to Follow-up|0|||
16924679|NCT01933932|38066417|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16924680|NCT01898494|38066427|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
16924681|NCT01898494|38066428|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
16924682|NCT01898494|38066429|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
16924683|NCT01898494|38066430|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
16924684|NCT01898494|38066431|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
16924685|NCT01898494|38066427|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
16924686|NCT01898494|38066428|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
16924687|NCT01898494|38066429|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
16924688|NCT01898494|38066430|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
16924689|NCT01898494|38066431|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
16924690|NCT01898494|38066427|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
16924691|NCT01898494|38066428|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
16924692|NCT01898494|38066429|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
16924693|NCT01898494|38066430|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
16924694|NCT01898494|38066431|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
16924695|NCT01898494|38066427|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
16924696|NCT01898494|38066428|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
16924697|NCT01898494|38066429|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
16924698|NCT01898494|38066430|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
16924699|NCT01898494|38066431|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
16924700|NCT01898494|38066427|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
16924701|NCT01898494|38066428|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
16924702|NCT01898494|38066429|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
16924703|NCT01898494|38066430|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
16924704|NCT01898494|38066431|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
16924705|NCT01898494|38066427|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
16924706|NCT01898494|38066428|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
16924707|NCT01898494|38066429|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
16924708|NCT01898494|38066430|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
16924709|NCT01898494|38066431|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
16924710|NCT01898494|38066427|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
16848620|NCT01538199|37793812|FG000|Overall Study|participant did not have time|1|||
16848621|NCT01538199|37793813|FG001|Overall Study|participant did not have time|0|||
16848622|NCT01538199|37793814|FG002|Overall Study|participant did not have time|0|||
16848623|NCT01538199|37793815|FG003|Overall Study|participant did not have time|2|||
16848624|NCT01538199|37793812|FG000|Overall Study|Lack of Efficacy|0|||
16848625|NCT01538199|37793813|FG001|Overall Study|Lack of Efficacy|1|||
16848626|NCT01538199|37793814|FG002|Overall Study|Lack of Efficacy|0|||
16848627|NCT01538199|37793815|FG003|Overall Study|Lack of Efficacy|0|||
16848628|NCT01511445|37793834|FG000|Overall Study|Lost to Follow-up|3|||
16848629|NCT01511445|37793835|FG001|Overall Study|Lost to Follow-up|1|||
16848630|NCT01511445|37793834|FG000|Overall Study|Protocol Violation|1|||
16848631|NCT01511445|37793835|FG001|Overall Study|Protocol Violation|3|||
16848632|NCT01511445|37793834|FG000|Overall Study|Protocol Violation|1|||
16848633|NCT01511445|37793835|FG001|Overall Study|Protocol Violation|0|||
16848634|NCT01543503|37793843|FG000|Overall Study|Lost to Follow-up|32|||
16848635|NCT01543503|37793844|FG001|Overall Study|Lost to Follow-up|36|||
16848636|NCT01543503|37793843|FG000|Overall Study|Adverse Event|9|||
16848637|NCT01543503|37793844|FG001|Overall Study|Adverse Event|13|||
16848638|NCT01543503|37793843|FG000|Overall Study|Lack of Efficacy|4|||
16848639|NCT01543503|37793844|FG001|Overall Study|Lack of Efficacy|16|||
16924711|NCT01898494|38066428|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
16924712|NCT01898494|38066429|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
16924713|NCT01898494|38066430|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
16924714|NCT01898494|38066431|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
16924715|NCT01898494|38066427|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
16924716|NCT01898494|38066428|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
16924717|NCT01898494|38066429|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
16924718|NCT01898494|38066430|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
16924719|NCT01898494|38066431|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
16924720|NCT01898494|38066427|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
17017837|NCT00842712|38162440|FG005|Safety Run-in Part|Adverse Event|0|||
16848640|NCT01543503|37793843|FG000|Overall Study|Participant withdrew informed consent|8|||
16848641|NCT01543503|37793844|FG001|Overall Study|Participant withdrew informed consent|10|||
16848642|NCT01543503|37793843|FG000|Overall Study|Change of jobs|0|||
16848643|NCT01543503|37793844|FG001|Overall Study|Change of jobs|1|||
16848644|NCT01543503|37793843|FG000|Overall Study|Intolerance to the biologic treatment|0|||
16848645|NCT01543503|37793844|FG001|Overall Study|Intolerance to the biologic treatment|1|||
16848646|NCT01543503|37793843|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
16848647|NCT01543503|37793844|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
16848648|NCT01543503|37793843|FG000|Overall Study|Participant did not complete last visit|0|||
16848649|NCT01543503|37793844|FG001|Overall Study|Participant did not complete last visit|2|||
16848650|NCT01543503|37793843|FG000|Overall Study|Refused to continue treatment|7|||
16848651|NCT01543503|37793844|FG001|Overall Study|Refused to continue treatment|0|||
16848652|NCT01543503|37793843|FG000|Overall Study|Incorrect medication received|1|||
16848653|NCT01543503|37793844|FG001|Overall Study|Incorrect medication received|0|||
16848654|NCT01543503|37793843|FG000|Overall Study|Participant moved to another city|2|||
16848655|NCT01543503|37793844|FG001|Overall Study|Participant moved to another city|0|||
16848656|NCT01543503|37793843|FG000|Overall Study|Participant will not return for visits|0|||
16848657|NCT01543503|37793844|FG001|Overall Study|Participant will not return for visits|2|||
16848658|NCT01543503|37793843|FG000|Overall Study|Participant transferred to another city|1|||
16848659|NCT01543503|37793844|FG001|Overall Study|Participant transferred to another city|0|||
16848660|NCT01543503|37793843|FG000|Overall Study|Participant moved to Scotland|1|||
16848661|NCT01543503|37793844|FG001|Overall Study|Participant moved to Scotland|0|||
16924721|NCT01898494|38066428|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
16924722|NCT01898494|38066429|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
16924723|NCT01898494|38066430|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
16924724|NCT01898494|38066431|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
16924725|NCT01898494|38066427|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
16924726|NCT01898494|38066428|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
16924727|NCT01898494|38066429|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
16924728|NCT01898494|38066430|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
16924729|NCT01898494|38066431|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
16924730|NCT01898494|38066427|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
16924731|NCT01898494|38066428|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
16924732|NCT01898494|38066429|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
16924733|NCT01898494|38066430|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
16924734|NCT01898494|38066431|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
16924735|NCT01898494|38066427|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
16924736|NCT01898494|38066428|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
16924737|NCT01898494|38066429|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
16924738|NCT01898494|38066430|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
16924739|NCT01898494|38066431|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
16924740|NCT01898494|38066427|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
16924741|NCT01898494|38066428|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
16924742|NCT01898494|38066429|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
16924743|NCT01898494|38066430|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
16924744|NCT01898494|38066431|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
16924745|NCT01898494|38066427|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
16924746|NCT01898494|38066428|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
16924747|NCT01898494|38066429|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
16924748|NCT01898494|38066430|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
16924749|NCT01898494|38066431|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
16924750|NCT01238172|38066472|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
16924751|NCT01238172|38066473|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
16924752|NCT01238172|38066472|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
16924753|NCT01238172|38066473|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
16924754|NCT00967005|38066481|FG000|Overall Study|Lost to Follow-up|7|||
16924755|NCT00967005|38066482|FG001|Overall Study|Lost to Follow-up|10|||
16924756|NCT00203996|38066531|FG000|Overall Study|Lost to Follow-up|0|||
16848662|NCT01543503|37793843|FG000|Overall Study|Participant decision to stop treatment|1|||
16848663|NCT01543503|37793844|FG001|Overall Study|Participant decision to stop treatment|0|||
16848664|NCT01543503|37793843|FG000|Overall Study|Investigator did not wish to participate|1|||
16848665|NCT01543503|37793844|FG001|Overall Study|Investigator did not wish to participate|1|||
16848666|NCT01543503|37793843|FG000|Overall Study|Participant recruited after closing date|0|||
16848667|NCT01543503|37793844|FG001|Overall Study|Participant recruited after closing date|1|||
16848668|NCT01543503|37793843|FG000|Overall Study|Site stopped participation|5|||
16848669|NCT01543503|37793844|FG001|Overall Study|Site stopped participation|1|||
16924757|NCT00203996|38066532|FG001|Overall Study|Lost to Follow-up|0|||
16924758|NCT00203996|38066533|FG002|Overall Study|Lost to Follow-up|0|||
16924759|NCT00203996|38066534|FG003|Overall Study|Lost to Follow-up|1|||
16924760|NCT00203996|38066535|FG004|Overall Study|Lost to Follow-up|0|||
16924761|NCT00203996|38066536|FG005|Overall Study|Lost to Follow-up|0|||
16924762|NCT00203996|38066537|FG006|Overall Study|Lost to Follow-up|0|||
16924763|NCT00203996|38066538|FG007|Overall Study|Lost to Follow-up|0|||
16924764|NCT00203996|38066539|FG008|Overall Study|Lost to Follow-up|0|||
16924765|NCT00203996|38066540|FG009|Overall Study|Lost to Follow-up|0|||
16924766|NCT00203996|38066531|FG000|Overall Study|Protocol Violation|0|||
16848670|NCT01543503|37793843|FG000|Overall Study|Participant did not attend a visit|1|||
16848671|NCT01543503|37793844|FG001|Overall Study|Participant did not attend a visit|0|||
16848672|NCT01543503|37793843|FG000|Overall Study|Moved to other rheumatologic site|0|||
16848673|NCT01543503|37793844|FG001|Overall Study|Moved to other rheumatologic site|1|||
16924767|NCT00203996|38066532|FG001|Overall Study|Protocol Violation|0|||
16924768|NCT00203996|38066533|FG002|Overall Study|Protocol Violation|0|||
16848674|NCT01543503|37793843|FG000|Overall Study|Participant consented to another study|0|||
16848675|NCT01543503|37793844|FG001|Overall Study|Participant consented to another study|2|||
16848676|NCT01543503|37793843|FG000|Overall Study|Participant went to United States|1|||
16848677|NCT01543503|37793844|FG001|Overall Study|Participant went to United States|0|||
16848678|NCT01543503|37793843|FG000|Overall Study|Screen failure|1|||
16848679|NCT01543503|37793844|FG001|Overall Study|Screen failure|0|||
16848680|NCT01511055|37793850|FG000|Overall Study|Withdrawal by Subject|6|||
16848681|NCT01537887|37793863|FG000|Period 1|Physician Decision|0|||
16848682|NCT01537887|37793864|FG001|Period 1|Physician Decision|0|||
16848683|NCT01537887|37793865|FG002|Period 1|Physician Decision|0|||
16848684|NCT01537887|37793866|FG003|Period 1|Physician Decision|0|||
16848685|NCT01537887|37793867|FG004|Period 1|Physician Decision|1|||
16848686|NCT01537887|37793868|FG005|Period 1|Physician Decision|1|||
16924769|NCT00203996|38066534|FG003|Overall Study|Protocol Violation|6|||
16924770|NCT00203996|38066535|FG004|Overall Study|Protocol Violation|1|||
16924771|NCT00203996|38066536|FG005|Overall Study|Protocol Violation|0|||
16848687|NCT01537887|37793863|FG000|Period 1|Did not receive treatment|0|||
16848688|NCT01537887|37793864|FG001|Period 1|Did not receive treatment|0|||
16848689|NCT01537887|37793865|FG002|Period 1|Did not receive treatment|1|||
16848690|NCT01537887|37793866|FG003|Period 1|Did not receive treatment|0|||
16848691|NCT01537887|37793867|FG004|Period 1|Did not receive treatment|0|||
16848692|NCT01537887|37793868|FG005|Period 1|Did not receive treatment|0|||
16848693|NCT01537887|37793863|FG000|Period 2|Withdrawal by Subject|0|||
16848694|NCT01537887|37793864|FG001|Period 2|Withdrawal by Subject|1|||
16848695|NCT01537887|37793865|FG002|Period 2|Withdrawal by Subject|0|||
17102556|NCT00112437|38241460|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102557|NCT00112437|38241461|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102558|NCT00112437|38241462|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102559|NCT00112437|38241463|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
17102560|NCT00112437|38241464|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
17198575|NCT00103285|38352274|FG001|Response Assignment|Protocol Violation|2|||
17198576|NCT00103285|38352275|FG002|Response Assignment|Protocol Violation|0|||
17017838|NCT00842712|38162441|FG006|Safety Run-in Part|Adverse Event|0|||
17017839|NCT00842712|38162435|FG000|Safety Run-in Part|Progressive disease|3|||
17017840|NCT00842712|38162436|FG001|Safety Run-in Part|Progressive disease|1|||
17017841|NCT00842712|38162437|FG002|Safety Run-in Part|Progressive disease|0|||
17017842|NCT00842712|38162438|FG003|Safety Run-in Part|Progressive disease|1|||
17198577|NCT00103285|38352276|FG003|Response Assignment|Protocol Violation|0|||
17198578|NCT00103285|38352277|FG004|Response Assignment|Protocol Violation|0|||
17198579|NCT00103285|38352278|FG005|Response Assignment|Protocol Violation|0|||
17198580|NCT00103285|38352279|FG006|Response Assignment|Protocol Violation|0|||
17198581|NCT00103285|38352280|FG007|Response Assignment|Protocol Violation|0|||
17198582|NCT00103285|38352273|FG000|Response Assignment|Withdrawal by Subject|0|||
17198583|NCT00103285|38352274|FG001|Response Assignment|Withdrawal by Subject|4|||
17198584|NCT00103285|38352275|FG002|Response Assignment|Withdrawal by Subject|1|||
17198585|NCT00103285|38352276|FG003|Response Assignment|Withdrawal by Subject|1|||
17198586|NCT00103285|38352277|FG004|Response Assignment|Withdrawal by Subject|2|||
17198587|NCT00103285|38352278|FG005|Response Assignment|Withdrawal by Subject|2|||
17198588|NCT00103285|38352279|FG006|Response Assignment|Withdrawal by Subject|0|||
17198589|NCT00103285|38352280|FG007|Response Assignment|Withdrawal by Subject|2|||
17198590|NCT00103285|38352273|FG000|Response Assignment|Ineligible|0|||
17198591|NCT00103285|38352274|FG001|Response Assignment|Ineligible|8|||
17198592|NCT00103285|38352275|FG002|Response Assignment|Ineligible|6|||
16848696|NCT01537887|37793866|FG003|Period 2|Withdrawal by Subject|0|||
16848697|NCT01537887|37793867|FG004|Period 2|Withdrawal by Subject|0|||
16848698|NCT01537887|37793868|FG005|Period 2|Withdrawal by Subject|0|||
16848699|NCT01537887|37793863|FG000|Period 3|Adverse Event|0|||
16848700|NCT01537887|37793864|FG001|Period 3|Adverse Event|0|||
16848701|NCT01537887|37793865|FG002|Period 3|Adverse Event|1|||
16848702|NCT01537887|37793866|FG003|Period 3|Adverse Event|0|||
16848703|NCT01537887|37793867|FG004|Period 3|Adverse Event|0|||
16924772|NCT00203996|38066537|FG006|Overall Study|Protocol Violation|0|||
16924773|NCT00203996|38066538|FG007|Overall Study|Protocol Violation|0|||
17017843|NCT00842712|38162439|FG004|Safety Run-in Part|Progressive disease|0|||
17017844|NCT00842712|38162440|FG005|Safety Run-in Part|Progressive disease|0|||
17017845|NCT00842712|38162441|FG006|Safety Run-in Part|Progressive disease|0|||
17017846|NCT00842712|38162435|FG000|Randomized Part|Randomized but not treated|0|||
17017847|NCT00842712|38162436|FG001|Randomized Part|Randomized but not treated|0|||
17017848|NCT00842712|38162437|FG002|Randomized Part|Randomized but not treated|0|||
17017849|NCT00842712|38162438|FG003|Randomized Part|Randomized but not treated|0|||
17017850|NCT00842712|38162439|FG004|Randomized Part|Randomized but not treated|0|||
17017851|NCT00842712|38162440|FG005|Randomized Part|Randomized but not treated|1|||
17017852|NCT00842712|38162441|FG006|Randomized Part|Randomized but not treated|4|||
17017853|NCT00842712|38162435|FG000|Randomized Part|Ongoing at cut-off date|0|||
17017854|NCT00842712|38162436|FG001|Randomized Part|Ongoing at cut-off date|0|||
17017855|NCT00842712|38162437|FG002|Randomized Part|Ongoing at cut-off date|0|||
16848704|NCT01537887|37793868|FG005|Period 3|Adverse Event|0|||
16848705|NCT01537887|37793863|FG000|Period 3|Withdrawal by Subject|0|||
16848706|NCT01537887|37793864|FG001|Period 3|Withdrawal by Subject|1|||
16848707|NCT01537887|37793865|FG002|Period 3|Withdrawal by Subject|0|||
16848708|NCT01537887|37793866|FG003|Period 3|Withdrawal by Subject|0|||
16848709|NCT01537887|37793867|FG004|Period 3|Withdrawal by Subject|0|||
16848710|NCT01537887|37793868|FG005|Period 3|Withdrawal by Subject|0|||
16848711|NCT01489527|37793878|FG000|Overall Study|Pregnancy|9|||
16848712|NCT01489527|37793879|FG001|Overall Study|Pregnancy|14|||
16848713|NCT01489527|37793878|FG000|Overall Study|Participant moved|6|||
16848714|NCT01489527|37793879|FG001|Overall Study|Participant moved|7|||
16848715|NCT01489527|37793878|FG000|Overall Study|Withdrawal by Subject|0|||
16848716|NCT01489527|37793879|FG001|Overall Study|Withdrawal by Subject|4|||
16848717|NCT01489527|37793878|FG000|Overall Study|Lost to Follow-up|5|||
16848718|NCT01489527|37793879|FG001|Overall Study|Lost to Follow-up|1|||
16848719|NCT01489527|37793878|FG000|Overall Study|Procedures|1|||
16848720|NCT01489527|37793879|FG001|Overall Study|Procedures|0|||
16848721|NCT01489527|37793878|FG000|Overall Study|Not compliant|1|||
16848722|NCT01489527|37793879|FG001|Overall Study|Not compliant|0|||
16848723|NCT01487577|37793892|FG000|Overall Study|Became ineligible after signing consent|1|||
16848724|NCT01536951|37793898|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16848725|NCT01536951|37793899|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16848726|NCT01536951|37793900|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
16848727|NCT01536951|37793901|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16848728|NCT01536951|37793902|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16848729|NCT01536951|37793903|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16848730|NCT01536951|37793904|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16848731|NCT01536951|37793905|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16848732|NCT01536951|37793906|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16848733|NCT01536951|37793898|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
16848734|NCT01536951|37793899|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
16848735|NCT01536951|37793900|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
16848736|NCT01536951|37793901|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
16848737|NCT01536951|37793902|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
16848738|NCT01536951|37793903|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
16848739|NCT01536951|37793904|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
16848740|NCT01536951|37793905|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
16848741|NCT01536951|37793906|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
16848742|NCT01536795|37793931|FG000|Overall Study|Lost to Follow-up|0|||
16848743|NCT01536795|37793932|FG001|Overall Study|Lost to Follow-up|2|||
16848744|NCT01536795|37793931|FG000|Overall Study|Lack of Efficacy|1|||
16848745|NCT01536795|37793932|FG001|Overall Study|Lack of Efficacy|0|||
16848746|NCT01536561|37793960|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
16848747|NCT01536561|37793960|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
16848748|NCT01536561|37793960|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
16848749|NCT01536561|37793960|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
16848750|NCT01536561|37793960|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
16848751|NCT01536561|37793960|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
16848752|NCT01536405|37793978|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
16848753|NCT01536405|37793979|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
16848754|NCT01536405|37793978|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
16848755|NCT01536405|37793979|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
16848756|NCT01536405|37793978|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
16848757|NCT01536405|37793979|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
16848758|NCT01536405|37793978|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
16848759|NCT01536405|37793979|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
16848760|NCT01536405|37793978|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
16848761|NCT01536405|37793979|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
16924774|NCT00203996|38066539|FG008|Overall Study|Protocol Violation|0|||
16924775|NCT00203996|38066540|FG009|Overall Study|Protocol Violation|0|||
16848762|NCT01536405|37793978|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
16848763|NCT01536405|37793979|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
16848764|NCT01536405|37793978|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
16848765|NCT01536405|37793979|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
16848766|NCT01536405|37793978|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
16848767|NCT01536405|37793979|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
16848768|NCT01536405|37793978|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
16848769|NCT01536405|37793979|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
16848770|NCT01536405|37793978|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
16848771|NCT01536405|37793979|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
16848772|NCT01536405|37793978|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
16848773|NCT01536405|37793979|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
16848774|NCT01536405|37793978|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
16848775|NCT01536405|37793979|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
16848776|NCT01536405|37793978|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
16848777|NCT01536405|37793979|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
16848778|NCT01487265|37793985|FG000|Overall Study|Adverse Event|8|||
16848779|NCT01487265|37793985|FG000|Overall Study|Withdrawal by Subject|5|||
16848780|NCT01487265|37793985|FG000|Overall Study|Disease Progression|21|||
16848781|NCT01487265|37793985|FG000|Overall Study|Death|2|||
16848782|NCT01487265|37793985|FG000|Overall Study|Still on Treatment|1|||
16848783|NCT01485627|37793991|FG000|Overall Study|Patient withdrew|6|||
16924776|NCT00203996|38066531|FG000|Overall Study|Physician Decision|0|||
16848784|NCT01485627|37793992|FG001|Overall Study|Patient withdrew|5|||
16848785|NCT01485627|37793991|FG000|Overall Study|Patient died|3|||
16848786|NCT01485627|37793992|FG001|Overall Study|Patient died|1|||
16848787|NCT01485627|37793991|FG000|Overall Study|Patient lost to followup|0|||
16924777|NCT00203996|38066532|FG001|Overall Study|Physician Decision|0|||
16924778|NCT00203996|38066533|FG002|Overall Study|Physician Decision|0|||
16924779|NCT00203996|38066534|FG003|Overall Study|Physician Decision|2|||
16924780|NCT00203996|38066535|FG004|Overall Study|Physician Decision|0|||
16924781|NCT00203996|38066536|FG005|Overall Study|Physician Decision|0|||
16924782|NCT00203996|38066537|FG006|Overall Study|Physician Decision|0|||
16924783|NCT00203996|38066538|FG007|Overall Study|Physician Decision|0|||
16924784|NCT00203996|38066539|FG008|Overall Study|Physician Decision|0|||
16848788|NCT01485627|37793992|FG001|Overall Study|Patient lost to followup|1|||
16848789|NCT01485627|37793991|FG000|Overall Study|Caregiver withdrew|3|||
16848790|NCT01485627|37793992|FG001|Overall Study|Caregiver withdrew|3|||
16848791|NCT01485627|37793991|FG000|Overall Study|Caregiver lost to follow up|11|||
16848792|NCT01485627|37793992|FG001|Overall Study|Caregiver lost to follow up|12|||
16848793|NCT01485627|37793991|FG000|Overall Study|Caregiver died|1|||
16848794|NCT01485627|37793992|FG001|Overall Study|Caregiver died|0|||
16848795|NCT01485627|37793991|FG000|Overall Study|caregiver was not bereaved|42|||
16848796|NCT01485627|37793992|FG001|Overall Study|caregiver was not bereaved|35|||
16848797|NCT01508325|37794015|FG000|Overall Study|Withdrawal by Subject|8|||
16848798|NCT01508325|37794016|FG001|Overall Study|Withdrawal by Subject|9|||
16848799|NCT01508325|37794015|FG000|Overall Study|Protocol Violation|0|||
16848800|NCT01508325|37794016|FG001|Overall Study|Protocol Violation|3|||
16848801|NCT01508325|37794015|FG000|Overall Study|Physician Decision|2|||
16848802|NCT01508325|37794016|FG001|Overall Study|Physician Decision|1|||
16848803|NCT01508325|37794015|FG000|Overall Study|Adverse Event|1|||
16848804|NCT01508325|37794016|FG001|Overall Study|Adverse Event|0|||
16924785|NCT00203996|38066540|FG009|Overall Study|Physician Decision|1|||
16924786|NCT00203996|38066531|FG000|Overall Study|CPAP machine malfunction|0|||
16924787|NCT00203996|38066532|FG001|Overall Study|CPAP machine malfunction|0|||
16924788|NCT00203996|38066533|FG002|Overall Study|CPAP machine malfunction|0|||
16924789|NCT00203996|38066534|FG003|Overall Study|CPAP machine malfunction|1|||
16924790|NCT00203996|38066535|FG004|Overall Study|CPAP machine malfunction|0|||
16924791|NCT00203996|38066536|FG005|Overall Study|CPAP machine malfunction|0|||
16924792|NCT00203996|38066537|FG006|Overall Study|CPAP machine malfunction|0|||
16924793|NCT00203996|38066538|FG007|Overall Study|CPAP machine malfunction|0|||
16924794|NCT00203996|38066539|FG008|Overall Study|CPAP machine malfunction|0|||
16924795|NCT00203996|38066540|FG009|Overall Study|CPAP machine malfunction|0|||
16848805|NCT01508325|37794015|FG000|Overall Study|Lost to Follow-up|5|||
16848806|NCT01508325|37794016|FG001|Overall Study|Lost to Follow-up|6|||
16848807|NCT01508325|37794015|FG000|Overall Study|Other|2|||
16848808|NCT01508325|37794016|FG001|Overall Study|Other|2|||
16848809|NCT01508169|37794024|FG000|Overall Study|Adverse Event|1|||
16848810|NCT01508169|37794025|FG001|Overall Study|Adverse Event|0|||
16848811|NCT01508169|37794024|FG000|Overall Study|Withdrawal by Subject|1|||
16848812|NCT01508169|37794025|FG001|Overall Study|Withdrawal by Subject|0|||
16848813|NCT01508169|37794024|FG000|Overall Study|Lost to Follow-up|1|||
16848814|NCT01508169|37794025|FG001|Overall Study|Lost to Follow-up|2|||
16848815|NCT01536171|37794037|FG000|Overall Study|Withdrawal by Subject|1|||
16848816|NCT01536093|37794044|FG000|Overall Study|Death|1|||
16848817|NCT01536093|37794045|FG001|Overall Study|Death|2|||
16848818|NCT01536093|37794044|FG000|Overall Study|absence of maternal colostrum|2|||
16848819|NCT01536093|37794045|FG001|Overall Study|absence of maternal colostrum|0|||
16848820|NCT01536093|37794044|FG000|Overall Study|Withdrawal by Subject|0|||
16848821|NCT01536093|37794045|FG001|Overall Study|Withdrawal by Subject|1|||
16848822|NCT01536015|37794053|FG000|Overall Study|Adverse Event|1|||
16848823|NCT01536015|37794054|FG001|Overall Study|Adverse Event|4|||
16848824|NCT01536015|37794053|FG000|Overall Study|Lost to Follow-up|0|||
16848825|NCT01536015|37794054|FG001|Overall Study|Lost to Follow-up|1|||
16848826|NCT01536015|37794053|FG000|Overall Study|Inclusion Criterion not met|2|||
16848827|NCT01536015|37794054|FG001|Overall Study|Inclusion Criterion not met|0|||
16848828|NCT01536015|37794053|FG000|Overall Study|Study closure|5|||
16848829|NCT01536015|37794054|FG001|Overall Study|Study closure|5|||
16848830|NCT01484691|37794063|FG000|Overall Study|Withdrawal by Subject|1|||
16848831|NCT01484691|37794064|FG001|Overall Study|Withdrawal by Subject|1|||
16848832|NCT01484691|37794065|FG002|Overall Study|Withdrawal by Subject|1|||
16848833|NCT01484691|37794063|FG000|Overall Study|Physician Decision|0|||
16848834|NCT01484691|37794064|FG001|Overall Study|Physician Decision|2|||
16848835|NCT01484691|37794065|FG002|Overall Study|Physician Decision|1|||
16848836|NCT01535235|37794076|FG000|Overall Study|Adverse Event|1|||
16848837|NCT01535235|37794077|FG001|Overall Study|Adverse Event|0|||
16848838|NCT01483599|37794121|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
16848839|NCT01483599|37794122|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848840|NCT01483599|37794123|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848841|NCT01483599|37794124|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
16848842|NCT01483599|37794125|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
16848843|NCT01483599|37794126|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
16848844|NCT01483599|37794127|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
16848845|NCT01483599|37794128|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848846|NCT01483599|37794129|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848847|NCT01483599|37794130|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848848|NCT01483599|37794131|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848849|NCT01483599|37794132|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848850|NCT01483599|37794133|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848851|NCT01483599|37794134|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16848852|NCT01483599|37794121|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848853|NCT01483599|37794122|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
16848854|NCT01483599|37794123|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848855|NCT01483599|37794124|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
16848856|NCT01483599|37794125|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848857|NCT01483599|37794126|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848858|NCT01483599|37794127|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
16848859|NCT01483599|37794128|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848860|NCT01483599|37794129|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848861|NCT01483599|37794130|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848862|NCT01483599|37794131|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16924796|NCT00203996|38066531|FG000|Overall Study|Scheduling issue|0|||
16924797|NCT00203996|38066532|FG001|Overall Study|Scheduling issue|0|||
16924798|NCT00203996|38066533|FG002|Overall Study|Scheduling issue|0|||
16924799|NCT00203996|38066534|FG003|Overall Study|Scheduling issue|0|||
16848863|NCT01483599|37794132|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848864|NCT01483599|37794133|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848865|NCT01483599|37794134|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16848866|NCT01483599|37794121|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
16848867|NCT01483599|37794122|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848868|NCT01483599|37794123|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848869|NCT01483599|37794124|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848870|NCT01483599|37794125|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16924800|NCT00203996|38066535|FG004|Overall Study|Scheduling issue|0|||
16924801|NCT00203996|38066536|FG005|Overall Study|Scheduling issue|0|||
16924802|NCT00203996|38066537|FG006|Overall Study|Scheduling issue|0|||
16924803|NCT00203996|38066538|FG007|Overall Study|Scheduling issue|2|||
16924804|NCT00203996|38066539|FG008|Overall Study|Scheduling issue|0|||
16924805|NCT00203996|38066540|FG009|Overall Study|Scheduling issue|0|||
16924806|NCT00099437|38066558|FG000|Overall Study|Lost to Follow-up|30|||
16924807|NCT00099437|38066559|FG001|Overall Study|Lost to Follow-up|33|||
16924808|NCT00099437|38066558|FG000|Overall Study|Death|293|||
16924809|NCT00099437|38066559|FG001|Overall Study|Death|261|||
16924810|NCT00099437|38066558|FG000|Overall Study|Withdrawal by Subject|6|||
16924811|NCT00099437|38066559|FG001|Overall Study|Withdrawal by Subject|10|||
16924812|NCT00099437|38066558|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
16924813|NCT00099437|38066559|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
16924814|NCT02014558|38066578|FG000|Overall Study|Never Received Study Drug|0|||
16924815|NCT02014558|38066579|FG001|Overall Study|Never Received Study Drug|0|||
16924816|NCT02014558|38066580|FG002|Overall Study|Never Received Study Drug|0|||
16924817|NCT02014558|38066581|FG003|Overall Study|Never Received Study Drug|0|||
16924818|NCT02014558|38066582|FG004|Overall Study|Never Received Study Drug|1|||
16924819|NCT02014558|38066583|FG005|Overall Study|Never Received Study Drug|0|||
16924820|NCT02014558|38066584|FG006|Overall Study|Never Received Study Drug|1|||
16924821|NCT02014558|38066585|FG007|Overall Study|Never Received Study Drug|0|||
16924822|NCT02014558|38066586|FG008|Overall Study|Never Received Study Drug|2|||
16924823|NCT02014558|38066587|FG009|Overall Study|Never Received Study Drug|0|||
16924824|NCT02014558|38066588|FG010|Overall Study|Never Received Study Drug|2|||
16924825|NCT02014558|38066589|FG011|Overall Study|Never Received Study Drug|2|||
16924826|NCT02014558|38066590|FG012|Overall Study|Never Received Study Drug|0|||
16848871|NCT01483599|37794126|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16924827|NCT02014558|38066578|FG000|Overall Study|Adverse Event|0|||
16924828|NCT02014558|38066579|FG001|Overall Study|Adverse Event|0|||
16924829|NCT02014558|38066580|FG002|Overall Study|Adverse Event|0|||
16924830|NCT02014558|38066581|FG003|Overall Study|Adverse Event|0|||
16924831|NCT02014558|38066582|FG004|Overall Study|Adverse Event|1|||
16924832|NCT02014558|38066583|FG005|Overall Study|Adverse Event|0|||
16924833|NCT02014558|38066584|FG006|Overall Study|Adverse Event|0|||
16924834|NCT02014558|38066585|FG007|Overall Study|Adverse Event|0|||
16924835|NCT02014558|38066586|FG008|Overall Study|Adverse Event|2|||
16924836|NCT02014558|38066587|FG009|Overall Study|Adverse Event|2|||
16924837|NCT02014558|38066588|FG010|Overall Study|Adverse Event|5|||
16924838|NCT02014558|38066589|FG011|Overall Study|Adverse Event|21|||
16924839|NCT02014558|38066590|FG012|Overall Study|Adverse Event|3|||
16924840|NCT02014558|38066578|FG000|Overall Study|Death|1|||
16924841|NCT02014558|38066579|FG001|Overall Study|Death|0|||
16924842|NCT02014558|38066580|FG002|Overall Study|Death|0|||
16924843|NCT02014558|38066581|FG003|Overall Study|Death|0|||
16924844|NCT02014558|38066582|FG004|Overall Study|Death|0|||
16924845|NCT02014558|38066583|FG005|Overall Study|Death|0|||
16924846|NCT02014558|38066584|FG006|Overall Study|Death|1|||
16924847|NCT02014558|38066585|FG007|Overall Study|Death|1|||
16924848|NCT02014558|38066586|FG008|Overall Study|Death|2|||
16924849|NCT02014558|38066587|FG009|Overall Study|Death|5|||
16924850|NCT02014558|38066588|FG010|Overall Study|Death|5|||
16848872|NCT01483599|37794127|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848873|NCT01483599|37794128|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848874|NCT01483599|37794129|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848875|NCT01483599|37794130|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848876|NCT01483599|37794131|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848877|NCT01483599|37794132|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848878|NCT01483599|37794133|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848879|NCT01483599|37794134|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16848880|NCT01483599|37794121|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
16848881|NCT01483599|37794122|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
16848882|NCT01483599|37794123|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
16848883|NCT01483599|37794124|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
16848884|NCT01483599|37794125|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
16848885|NCT01483599|37794126|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
16848886|NCT01483599|37794127|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
16848887|NCT01483599|37794128|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
16848888|NCT01483599|37794129|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
16848889|NCT01483599|37794130|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
16848890|NCT01483599|37794131|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
16848891|NCT01483599|37794132|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
16848892|NCT01483599|37794133|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
16848893|NCT01483599|37794134|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
16848894|NCT01483599|37794121|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
16848895|NCT01483599|37794122|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
16848896|NCT01483599|37794123|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
16848897|NCT01483599|37794124|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
16848898|NCT01483599|37794125|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
16848899|NCT01483599|37794126|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
16848900|NCT01483599|37794127|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
16848901|NCT01483599|37794128|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
16848902|NCT01483599|37794129|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
16848903|NCT01483599|37794130|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
16848904|NCT01483599|37794131|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
16848905|NCT01483599|37794132|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
16848906|NCT01483599|37794133|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
16848907|NCT01483599|37794134|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
16848908|NCT01483599|37794121|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848909|NCT01483599|37794122|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848910|NCT01483599|37794123|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16924851|NCT02014558|38066589|FG011|Overall Study|Death|19|||
16924852|NCT02014558|38066590|FG012|Overall Study|Death|2|||
16924853|NCT02014558|38066578|FG000|Overall Study|Lack of Efficacy|1|||
16924854|NCT02014558|38066579|FG001|Overall Study|Lack of Efficacy|2|||
16924855|NCT02014558|38066580|FG002|Overall Study|Lack of Efficacy|1|||
16924856|NCT02014558|38066581|FG003|Overall Study|Lack of Efficacy|1|||
16924857|NCT02014558|38066582|FG004|Overall Study|Lack of Efficacy|0|||
16924858|NCT02014558|38066583|FG005|Overall Study|Lack of Efficacy|0|||
16924859|NCT02014558|38066584|FG006|Overall Study|Lack of Efficacy|1|||
16924860|NCT02014558|38066585|FG007|Overall Study|Lack of Efficacy|3|||
16924861|NCT02014558|38066586|FG008|Overall Study|Lack of Efficacy|3|||
16924862|NCT02014558|38066587|FG009|Overall Study|Lack of Efficacy|3|||
16924863|NCT02014558|38066588|FG010|Overall Study|Lack of Efficacy|16|||
16924864|NCT02014558|38066589|FG011|Overall Study|Lack of Efficacy|8|||
16924865|NCT02014558|38066590|FG012|Overall Study|Lack of Efficacy|5|||
16924866|NCT02014558|38066578|FG000|Overall Study|Lost to Follow-up|0|||
16924867|NCT02014558|38066579|FG001|Overall Study|Lost to Follow-up|0|||
16848911|NCT01483599|37794124|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848912|NCT01483599|37794125|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848913|NCT01483599|37794126|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848914|NCT01483599|37794127|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848915|NCT01483599|37794128|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
16848916|NCT01483599|37794129|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
16848917|NCT01483599|37794130|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848918|NCT01483599|37794131|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848919|NCT01483599|37794132|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16848920|NCT01483599|37794133|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
16848921|NCT01483599|37794134|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
16848922|NCT01483599|37794121|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848923|NCT01483599|37794122|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848924|NCT01483599|37794123|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848925|NCT01483599|37794124|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848926|NCT01483599|37794125|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848927|NCT01483599|37794126|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848928|NCT01483599|37794127|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848929|NCT01483599|37794128|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848930|NCT01483599|37794129|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
16848931|NCT01483599|37794130|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848932|NCT01483599|37794131|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848933|NCT01483599|37794132|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
16848934|NCT01483599|37794133|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16848935|NCT01483599|37794134|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
16848936|NCT01483599|37794121|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16924868|NCT02014558|38066580|FG002|Overall Study|Lost to Follow-up|0|||
16924869|NCT02014558|38066581|FG003|Overall Study|Lost to Follow-up|0|||
16924870|NCT02014558|38066582|FG004|Overall Study|Lost to Follow-up|0|||
16924871|NCT02014558|38066583|FG005|Overall Study|Lost to Follow-up|0|||
16924872|NCT02014558|38066584|FG006|Overall Study|Lost to Follow-up|0|||
16924873|NCT02014558|38066585|FG007|Overall Study|Lost to Follow-up|0|||
16924874|NCT02014558|38066586|FG008|Overall Study|Lost to Follow-up|0|||
16924875|NCT02014558|38066587|FG009|Overall Study|Lost to Follow-up|0|||
17017856|NCT00842712|38162438|FG003|Randomized Part|Ongoing at cut-off date|0|||
17017857|NCT00842712|38162439|FG004|Randomized Part|Ongoing at cut-off date|0|||
17017858|NCT00842712|38162440|FG005|Randomized Part|Ongoing at cut-off date|0|||
17017859|NCT00842712|38162441|FG006|Randomized Part|Ongoing at cut-off date|2|||
17017860|NCT00842244|38162457|FG000|Overall Study|Death|3|||
17017861|NCT00842244|38162457|FG000|Overall Study|Withdrawal by Subject|1|||
17017862|NCT00842244|38162457|FG000|Overall Study|Other|17|||
17017863|NCT00832416|38162468|FG000|Overall Study|Lack of Efficacy|17|||
17017864|NCT00832416|38162469|FG001|Overall Study|Lack of Efficacy|15|||
17017865|NCT00832416|38162470|FG002|Overall Study|Lack of Efficacy|13|||
17017866|NCT00832416|38162471|FG003|Overall Study|Lack of Efficacy|52|||
17017867|NCT00832416|38162468|FG000|Overall Study|Withdrawal by Subject|5|||
17017868|NCT00832416|38162469|FG001|Overall Study|Withdrawal by Subject|7|||
17017869|NCT00832416|38162470|FG002|Overall Study|Withdrawal by Subject|2|||
17017870|NCT00832416|38162471|FG003|Overall Study|Withdrawal by Subject|10|||
17017871|NCT00832416|38162468|FG000|Overall Study|Physician Decision|2|||
17017872|NCT00832416|38162469|FG001|Overall Study|Physician Decision|12|||
17017873|NCT00832416|38162470|FG002|Overall Study|Physician Decision|5|||
17017874|NCT00832416|38162471|FG003|Overall Study|Physician Decision|10|||
17017875|NCT00832416|38162468|FG000|Overall Study|Administrative|0|||
17017876|NCT00832416|38162469|FG001|Overall Study|Administrative|0|||
17017877|NCT00832416|38162470|FG002|Overall Study|Administrative|0|||
17017878|NCT00832416|38162471|FG003|Overall Study|Administrative|1|||
17017879|NCT00832416|38162468|FG000|Overall Study|Adverse Event|21|||
17017880|NCT00832416|38162469|FG001|Overall Study|Adverse Event|19|||
17017881|NCT00832416|38162470|FG002|Overall Study|Adverse Event|41|||
17017882|NCT00832416|38162471|FG003|Overall Study|Adverse Event|10|||
17017883|NCT00832416|38162468|FG000|Overall Study|Death|1|||
17017884|NCT00832416|38162469|FG001|Overall Study|Death|0|||
17017885|NCT00832416|38162470|FG002|Overall Study|Death|0|||
17017886|NCT00832416|38162471|FG003|Overall Study|Death|0|||
17017887|NCT00841776|38162483|FG000|Overall Study|Lack of Efficacy|0|||
17102561|NCT00112437|38241465|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
16848937|NCT01483599|37794122|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848938|NCT01483599|37794123|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848939|NCT01483599|37794124|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848940|NCT01483599|37794125|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848941|NCT01483599|37794126|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848942|NCT01483599|37794127|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848943|NCT01483599|37794128|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848944|NCT01483599|37794129|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
16848945|NCT01483599|37794130|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848946|NCT01483599|37794131|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
16924876|NCT02014558|38066588|FG010|Overall Study|Lost to Follow-up|1|||
16924877|NCT02014558|38066589|FG011|Overall Study|Lost to Follow-up|0|||
16924878|NCT02014558|38066590|FG012|Overall Study|Lost to Follow-up|0|||
16924879|NCT02014558|38066578|FG000|Overall Study|Progressive Disease|1|||
16924880|NCT02014558|38066579|FG001|Overall Study|Progressive Disease|0|||
16924881|NCT02014558|38066580|FG002|Overall Study|Progressive Disease|1|||
16924882|NCT02014558|38066581|FG003|Overall Study|Progressive Disease|1|||
16924883|NCT02014558|38066582|FG004|Overall Study|Progressive Disease|1|||
16924884|NCT02014558|38066583|FG005|Overall Study|Progressive Disease|2|||
16924885|NCT02014558|38066584|FG006|Overall Study|Progressive Disease|1|||
16924886|NCT02014558|38066585|FG007|Overall Study|Progressive Disease|6|||
16924887|NCT02014558|38066586|FG008|Overall Study|Progressive Disease|5|||
16924888|NCT02014558|38066587|FG009|Overall Study|Progressive Disease|6|||
16924889|NCT02014558|38066588|FG010|Overall Study|Progressive Disease|22|||
16924890|NCT02014558|38066589|FG011|Overall Study|Progressive Disease|31|||
16924891|NCT02014558|38066590|FG012|Overall Study|Progressive Disease|6|||
16924892|NCT02014558|38066578|FG000|Overall Study|Withdrawal by Subject|0|||
16924893|NCT02014558|38066579|FG001|Overall Study|Withdrawal by Subject|0|||
16924894|NCT02014558|38066580|FG002|Overall Study|Withdrawal by Subject|0|||
16924895|NCT02014558|38066581|FG003|Overall Study|Withdrawal by Subject|0|||
16924896|NCT02014558|38066582|FG004|Overall Study|Withdrawal by Subject|1|||
16924897|NCT02014558|38066583|FG005|Overall Study|Withdrawal by Subject|0|||
16924898|NCT02014558|38066584|FG006|Overall Study|Withdrawal by Subject|0|||
16924899|NCT02014558|38066585|FG007|Overall Study|Withdrawal by Subject|0|||
16924900|NCT02014558|38066586|FG008|Overall Study|Withdrawal by Subject|0|||
16924901|NCT02014558|38066587|FG009|Overall Study|Withdrawal by Subject|2|||
16924902|NCT02014558|38066588|FG010|Overall Study|Withdrawal by Subject|6|||
16924903|NCT02014558|38066589|FG011|Overall Study|Withdrawal by Subject|10|||
16924904|NCT02014558|38066590|FG012|Overall Study|Withdrawal by Subject|0|||
16924905|NCT02014558|38066578|FG000|Overall Study|Miscellaneous|2|||
16924906|NCT02014558|38066579|FG001|Overall Study|Miscellaneous|1|||
16848947|NCT01483599|37794132|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16924907|NCT02014558|38066580|FG002|Overall Study|Miscellaneous|1|||
16924908|NCT02014558|38066581|FG003|Overall Study|Miscellaneous|1|||
16924909|NCT02014558|38066582|FG004|Overall Study|Miscellaneous|0|||
16924910|NCT02014558|38066583|FG005|Overall Study|Miscellaneous|1|||
16924911|NCT02014558|38066584|FG006|Overall Study|Miscellaneous|0|||
16924912|NCT02014558|38066585|FG007|Overall Study|Miscellaneous|1|||
16848948|NCT01483599|37794133|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16848949|NCT01483599|37794134|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
16924913|NCT02014558|38066586|FG008|Overall Study|Miscellaneous|1|||
16924914|NCT02014558|38066587|FG009|Overall Study|Miscellaneous|3|||
16924915|NCT02014558|38066588|FG010|Overall Study|Miscellaneous|12|||
16924916|NCT02014558|38066589|FG011|Overall Study|Miscellaneous|11|||
16924917|NCT02014558|38066590|FG012|Overall Study|Miscellaneous|1|||
16924918|NCT02024555|38066645|FG000|Overall Study|Lost to Follow-up|1|||
16924919|NCT02024555|38066646|FG001|Overall Study|Lost to Follow-up|1|||
16924920|NCT02024555|38066645|FG000|Overall Study|Withdrawal by Subject|5|||
16924921|NCT02024555|38066646|FG001|Overall Study|Withdrawal by Subject|1|||
16924922|NCT02025010|38066652|FG000|Overall Study|Symptomatic or radiographic progression|36|||
16924923|NCT02025010|38066652|FG000|Overall Study|Adverse Event|6|||
16924924|NCT02025010|38066652|FG000|Overall Study|Physician Decision|7|||
16924925|NCT02025010|38066652|FG000|Overall Study|Withdrawal by Subject|3|||
16924926|NCT02025010|38066652|FG000|Overall Study|Intercurrent illness|3|||
16924927|NCT02025010|38066652|FG000|Overall Study|Patients still on treatment|3|||
16924928|NCT02025010|38066652|FG000|Overall Study|Never initiate the treatment|2|||
16924929|NCT02040584|38066660|FG000|Overall Study|Adverse Event|13|||
16924930|NCT02040584|38066661|FG001|Overall Study|Adverse Event|6|||
16924931|NCT02040584|38066660|FG000|Overall Study|Protocol Violation|9|||
16924932|NCT02040584|38066661|FG001|Overall Study|Protocol Violation|11|||
16924933|NCT02040584|38066660|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16924934|NCT02040584|38066661|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16924935|NCT02040584|38066660|FG000|Overall Study|Death|6|||
16924936|NCT02040584|38066661|FG001|Overall Study|Death|3|||
16924937|NCT02040584|38066660|FG000|Overall Study|Transplant rejection/retransplant|0|||
16924938|NCT02040584|38066661|FG001|Overall Study|Transplant rejection/retransplant|1|||
16924939|NCT02040584|38066660|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
16924940|NCT02040584|38066661|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
16924941|NCT02045797|38066680|FG000|Overall Study|Adverse Event|3|||
16924942|NCT02045797|38066681|FG001|Overall Study|Adverse Event|1|||
16924943|NCT02045797|38066682|FG002|Overall Study|Adverse Event|0|||
16924944|NCT02045797|38066680|FG000|Overall Study|Lack of Efficacy|1|||
16924945|NCT02045797|38066681|FG001|Overall Study|Lack of Efficacy|0|||
16924946|NCT02045797|38066682|FG002|Overall Study|Lack of Efficacy|0|||
16924947|NCT02045797|38066680|FG000|Overall Study|Lost to Follow-up|2|||
16924948|NCT02045797|38066681|FG001|Overall Study|Lost to Follow-up|3|||
16924949|NCT02045797|38066682|FG002|Overall Study|Lost to Follow-up|1|||
16924950|NCT02045797|38066680|FG000|Overall Study|Physician Decision|0|||
16924951|NCT02045797|38066681|FG001|Overall Study|Physician Decision|1|||
16848950|NCT01483599|37794121|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848951|NCT01483599|37794122|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16924952|NCT02045797|38066682|FG002|Overall Study|Physician Decision|0|||
16924953|NCT02045797|38066680|FG000|Overall Study|Withdrawal by Subject|1|||
16924954|NCT02045797|38066681|FG001|Overall Study|Withdrawal by Subject|2|||
16924955|NCT02045797|38066682|FG002|Overall Study|Withdrawal by Subject|0|||
16924956|NCT03530124|38066709|FG000|Overall Study|Withdrawal by Subject|0|||
16924957|NCT03530124|38066710|FG001|Overall Study|Withdrawal by Subject|1|||
16848952|NCT01483599|37794123|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848953|NCT01483599|37794124|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848954|NCT01483599|37794125|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848955|NCT01483599|37794126|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848956|NCT01483599|37794127|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848957|NCT01483599|37794128|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848958|NCT01483599|37794129|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
16924958|NCT03530124|38066709|FG000|Overall Study|Protocol Violation|1|||
16924959|NCT03530124|38066710|FG001|Overall Study|Protocol Violation|0|||
16848959|NCT01483599|37794130|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848960|NCT01483599|37794131|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848961|NCT01483599|37794132|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16848962|NCT01483599|37794133|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
16848963|NCT01483599|37794134|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
16848964|NCT01483599|37794121|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
16848965|NCT01483599|37794122|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
16848966|NCT01483599|37794123|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
16848967|NCT01483599|37794124|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
16848968|NCT01483599|37794125|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
16848969|NCT01483599|37794126|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
16848970|NCT01483599|37794127|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
16848971|NCT01483599|37794128|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
16924960|NCT03530124|38066709|FG000|Overall Study|Discharged prior to study completion|1|||
16924961|NCT03530124|38066710|FG001|Overall Study|Discharged prior to study completion|0|||
16924962|NCT03385239|38066721|FG000|Overall Study|Voluntary Withdrawal|2|||
16924963|NCT03385239|38066722|FG001|Overall Study|Voluntary Withdrawal|3|||
16924964|NCT03385239|38066723|FG002|Overall Study|Voluntary Withdrawal|2|||
16924965|NCT03385239|38066724|FG003|Overall Study|Voluntary Withdrawal|3|||
16924966|NCT03385239|38066725|FG004|Overall Study|Voluntary Withdrawal|0|||
16924967|NCT03385239|38066721|FG000|Overall Study|Adverse Event|0|||
16924968|NCT03385239|38066722|FG001|Overall Study|Adverse Event|0|||
16924969|NCT03385239|38066723|FG002|Overall Study|Adverse Event|1|||
16924970|NCT03385239|38066724|FG003|Overall Study|Adverse Event|0|||
16924971|NCT03385239|38066725|FG004|Overall Study|Adverse Event|0|||
16924972|NCT03385239|38066721|FG000|Overall Study|Other|0|||
16924973|NCT03385239|38066722|FG001|Overall Study|Other|0|||
16924974|NCT03385239|38066723|FG002|Overall Study|Other|0|||
16924975|NCT03385239|38066724|FG003|Overall Study|Other|1|||
16924976|NCT03385239|38066725|FG004|Overall Study|Other|0|||
16924977|NCT03020160|38066743|FG000|Overall Study|Withdrawal by Subject|1|||
16924978|NCT03020160|38066744|FG001|Overall Study|Withdrawal by Subject|0|||
16924979|NCT02593110|38066755|FG000|Overall Study|Withdrawal by Subject|0|||
16924980|NCT02593110|38066756|FG001|Overall Study|Withdrawal by Subject|3|||
16924981|NCT02593110|38066757|FG002|Overall Study|Withdrawal by Subject|3|||
16924982|NCT02593110|38066758|FG003|Overall Study|Withdrawal by Subject|2|||
16924983|NCT02593110|38066755|FG000|Overall Study|Death|0|||
16924984|NCT02593110|38066756|FG001|Overall Study|Death|0|||
16924985|NCT02593110|38066757|FG002|Overall Study|Death|1|||
16924986|NCT02593110|38066758|FG003|Overall Study|Death|0|||
16924987|NCT02373813|38066771|FG000|Run-In Period|Other, Not Specified|5|||
16924988|NCT02373813|38066772|FG001|Run-In Period|Other, Not Specified|0|||
16924989|NCT02373813|38066773|FG002|Run-In Period|Other, Not Specified|0|||
16924990|NCT02373813|38066774|FG003|Run-In Period|Other, Not Specified|0|||
16924991|NCT02373813|38066771|FG000|Run-In Period|Withdrawal by Subject|16|||
16924992|NCT02373813|38066772|FG001|Run-In Period|Withdrawal by Subject|0|||
16924993|NCT02373813|38066773|FG002|Run-In Period|Withdrawal by Subject|0|||
16924994|NCT02373813|38066774|FG003|Run-In Period|Withdrawal by Subject|0|||
16924995|NCT02373813|38066771|FG000|Run-In Period|Decision by Sponsor|11|||
16924996|NCT02373813|38066772|FG001|Run-In Period|Decision by Sponsor|0|||
16924997|NCT02373813|38066773|FG002|Run-In Period|Decision by Sponsor|0|||
16924998|NCT02373813|38066774|FG003|Run-In Period|Decision by Sponsor|0|||
16924999|NCT02373813|38066771|FG000|Run-In Period|Protocol Violation|75|||
16925000|NCT02373813|38066772|FG001|Run-In Period|Protocol Violation|0|||
16925001|NCT02373813|38066773|FG002|Run-In Period|Protocol Violation|0|||
16925002|NCT02373813|38066774|FG003|Run-In Period|Protocol Violation|0|||
16925003|NCT02373813|38066771|FG000|Run-In Period|Lost to Follow-up|2|||
16925004|NCT02373813|38066772|FG001|Run-In Period|Lost to Follow-up|0|||
16925005|NCT02373813|38066773|FG002|Run-In Period|Lost to Follow-up|0|||
16925006|NCT02373813|38066774|FG003|Run-In Period|Lost to Follow-up|0|||
16925007|NCT02373813|38066771|FG000|Run-In Period|Adverse Event|3|||
16925008|NCT02373813|38066772|FG001|Run-In Period|Adverse Event|0|||
16925009|NCT02373813|38066773|FG002|Run-In Period|Adverse Event|0|||
16925010|NCT02373813|38066774|FG003|Run-In Period|Adverse Event|0|||
16925011|NCT02373813|38066771|FG000|Run-In Period|Noncompliance|1|||
16925012|NCT02373813|38066772|FG001|Run-In Period|Noncompliance|0|||
16925013|NCT02373813|38066773|FG002|Run-In Period|Noncompliance|0|||
16925014|NCT02373813|38066774|FG003|Run-In Period|Noncompliance|0|||
16925015|NCT02373813|38066771|FG000|Run-In Period|Ineligibility Determined|3|||
16925016|NCT02373813|38066772|FG001|Run-In Period|Ineligibility Determined|0|||
17017888|NCT00841776|38162484|FG001|Overall Study|Lack of Efficacy|1|||
17017889|NCT00841776|38162483|FG000|Overall Study|Lost to Follow-up|2|||
17017890|NCT00841776|38162484|FG001|Overall Study|Lost to Follow-up|1|||
17017891|NCT00841776|38162483|FG000|Overall Study|Withdrawal by Subject|0|||
17017892|NCT00841776|38162484|FG001|Overall Study|Withdrawal by Subject|1|||
17017893|NCT00683800|38162492|FG000|Overall Study|Adverse Event|195|||
17017894|NCT00683800|38162493|FG001|Overall Study|Adverse Event|102|||
17017895|NCT00683800|38162492|FG000|Overall Study|Death|0|||
17017896|NCT00683800|38162493|FG001|Overall Study|Death|1|||
17017897|NCT00683800|38162492|FG000|Overall Study|Lost to Follow-up|57|||
17017898|NCT00683800|38162493|FG001|Overall Study|Lost to Follow-up|44|||
17017899|NCT00683800|38162492|FG000|Overall Study|Other|5|||
17017900|NCT00683800|38162493|FG001|Overall Study|Other|2|||
17017901|NCT00683800|38162492|FG000|Overall Study|Protocol Violation|13|||
17017902|NCT00683800|38162493|FG001|Overall Study|Protocol Violation|16|||
17017903|NCT00683800|38162492|FG000|Overall Study|Withdrawal by Subject|66|||
17017904|NCT00683800|38162493|FG001|Overall Study|Withdrawal by Subject|64|||
17017905|NCT00683800|38162492|FG000|Overall Study|Lack of Efficacy|61|||
17017906|NCT00683800|38162493|FG001|Overall Study|Lack of Efficacy|104|||
17017907|NCT00683800|38162492|FG000|Overall Study|Randomized, not treated|35|||
16848972|NCT01483599|37794129|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
16848973|NCT01483599|37794130|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
16848974|NCT01483599|37794131|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
16848975|NCT01483599|37794132|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
16848976|NCT01483599|37794133|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
16848977|NCT01483599|37794134|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
16848978|NCT01507545|37794227|FG000|Overall Study|Withdrawal by Subject|6|||
16848979|NCT01507545|37794228|FG001|Overall Study|Withdrawal by Subject|2|||
16848980|NCT01507545|37794227|FG000|Overall Study|Lost to Follow-up|1|||
16848981|NCT01507545|37794228|FG001|Overall Study|Lost to Follow-up|0|||
16848982|NCT01507545|37794227|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
16848983|NCT01507545|37794228|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
16848984|NCT01507545|37794227|FG000|Overall Study|Progressive disease|60|||
16848985|NCT01507545|37794228|FG001|Overall Study|Progressive disease|27|||
16848986|NCT01507545|37794227|FG000|Overall Study|Other|6|||
16848987|NCT01507545|37794228|FG001|Overall Study|Other|4|||
16848988|NCT01482819|37794234|FG000|Overall Study|Lost to Follow-up|2|||
16848989|NCT01534533|37794246|FG000|Overall Study|Lost to Follow-up|3|||
16848990|NCT01534533|37794247|FG001|Overall Study|Lost to Follow-up|0|||
16848991|NCT01534533|37794248|FG002|Overall Study|Lost to Follow-up|4|||
16848992|NCT01534533|37794249|FG003|Overall Study|Lost to Follow-up|3|||
16848993|NCT01534533|37794246|FG000|Overall Study|Withdrawal by Subject|5|||
16848994|NCT01534533|37794247|FG001|Overall Study|Withdrawal by Subject|3|||
16848995|NCT01534533|37794248|FG002|Overall Study|Withdrawal by Subject|4|||
16848996|NCT01534533|37794249|FG003|Overall Study|Withdrawal by Subject|1|||
16925017|NCT02373813|38066773|FG002|Run-In Period|Ineligibility Determined|0|||
16925018|NCT02373813|38066774|FG003|Run-In Period|Ineligibility Determined|0|||
16925019|NCT02373813|38066771|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
16925020|NCT02373813|38066772|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
17017908|NCT00683800|38162493|FG001|Overall Study|Randomized, not treated|33|||
17017909|NCT00683644|38162501|FG000|Overall Study|Withdrawal by Subject|4|||
16848997|NCT01506609|37794383|FG000|Overall Study|Adverse Event Related to Progression|0|||
16925021|NCT02373813|38066773|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
16925022|NCT02373813|38066774|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
16925023|NCT02373813|38066771|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16925024|NCT02373813|38066772|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
16925025|NCT02373813|38066773|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
16925026|NCT02373813|38066774|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
16925027|NCT02373813|38066771|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16925028|NCT02373813|38066772|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
16925029|NCT02373813|38066773|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
16925030|NCT02373813|38066774|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
16925031|NCT02373813|38066771|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16925032|NCT02373813|38066772|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
16925033|NCT02373813|38066773|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
16925034|NCT02373813|38066774|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
16925035|NCT01853748|38066791|FG000|Allocation|Withdrawal by Subject|1|||
16925036|NCT01853748|38066792|FG001|Allocation|Withdrawal by Subject|13|||
16925037|NCT01853748|38066791|FG000|Allocation|not sufficient to receive intervention|0|||
16925038|NCT01853748|38066792|FG001|Allocation|not sufficient to receive intervention|1|||
16925039|NCT01853748|38066791|FG000|Follow-Up|Withdrawal by Subject|7|||
16925040|NCT01853748|38066792|FG001|Follow-Up|Withdrawal by Subject|6|||
16925041|NCT01853748|38066791|FG000|Follow-Up|Adverse Event|67|||
16925042|NCT01853748|38066792|FG001|Follow-Up|Adverse Event|7|||
16925043|NCT01853748|38066791|FG000|Follow-Up|not available for data collection|16|||
16925044|NCT01853748|38066792|FG001|Follow-Up|not available for data collection|4|||
16925045|NCT03116347|38066839|FG000|Overall Study|Withdrawal by Subject|1|||
16925046|NCT03116347|38066840|FG001|Overall Study|Withdrawal by Subject|2|||
16925047|NCT01575808|38066848|FG000|Overall Study|Death|2|||
16925048|NCT01575808|38066849|FG001|Overall Study|Death|0|||
16925049|NCT01575808|38066848|FG000|Overall Study|Withdrawal by Subject|1|||
16925050|NCT01575808|38066849|FG001|Overall Study|Withdrawal by Subject|0|||
16925051|NCT00001213|38066897|FG000|Overall Study|Death|18|||
16925052|NCT00000135|38066903|FG000|Overall Study|Death|27|||
16925053|NCT00000135|38066904|FG001|Overall Study|Death|14|||
16925054|NCT00001723|38066912|FG000|Overall Study|Lack of Efficacy|6|||
16925055|NCT00001723|38066913|FG001|Overall Study|Lack of Efficacy|7|||
16925056|NCT00001723|38066912|FG000|Overall Study|Lack of family interest|4|||
16925057|NCT00001723|38066913|FG001|Overall Study|Lack of family interest|5|||
16925058|NCT00001723|38066912|FG000|Overall Study|Lost to Follow-up|2|||
16925059|NCT00001723|38066913|FG001|Overall Study|Lost to Follow-up|2|||
16925060|NCT00001723|38066912|FG000|Overall Study|medication intolerance|1|||
16925061|NCT00001723|38066913|FG001|Overall Study|medication intolerance|2|||
16925062|NCT00000378|38066935|FG000|Overall Study|Lack of Efficacy|16|||
16848998|NCT01506609|37794384|FG001|Overall Study|Adverse Event Related to Progression|0|||
16848999|NCT01506609|37794385|FG002|Overall Study|Adverse Event Related to Progression|0|||
16849000|NCT01506609|37794386|FG003|Overall Study|Adverse Event Related to Progression|3|||
16849001|NCT01506609|37794387|FG004|Overall Study|Adverse Event Related to Progression|7|||
16849002|NCT01506609|37794388|FG005|Overall Study|Adverse Event Related to Progression|3|||
16849003|NCT01506609|37794383|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
16849004|NCT01506609|37794384|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
16849005|NCT01506609|37794385|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
16849006|NCT01506609|37794386|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
16849007|NCT01506609|37794387|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
16925063|NCT00000378|38066936|FG001|Overall Study|Lack of Efficacy|14|||
16925064|NCT01350115|38066944|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
16925065|NCT01350115|38066945|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
16925066|NCT01350115|38066944|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
16925067|NCT01350115|38066945|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
16925068|NCT01350115|38066944|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
16925069|NCT01350115|38066945|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
16925070|NCT04142983|38066953|FG000|Overall Study|Lost to Follow-up|73|||
16925071|NCT04142983|38066953|FG000|Overall Study|Withdrawal by Subject|10|||
16925072|NCT04142983|38066953|FG000|Overall Study|Physician Decision|1|||
16925073|NCT04142983|38066953|FG000|Overall Study|Adverse Event|1|||
16925074|NCT04142983|38066953|FG000|Overall Study|No longer eligible|4|||
16925075|NCT04142983|38066953|FG000|Overall Study|Screen Failure|10|||
16925076|NCT03801031|38066960|FG000|Overall Study|Lost to Follow-up|1|||
16849008|NCT01506609|37794388|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
16849009|NCT01506609|37794383|FG000|Overall Study|Withdrawal by Subject|0|||
16849010|NCT01506609|37794384|FG001|Overall Study|Withdrawal by Subject|0|||
16849011|NCT01506609|37794385|FG002|Overall Study|Withdrawal by Subject|0|||
16849012|NCT01506609|37794386|FG003|Overall Study|Withdrawal by Subject|9|||
16849013|NCT01506609|37794387|FG004|Overall Study|Withdrawal by Subject|7|||
16849014|NCT01506609|37794388|FG005|Overall Study|Withdrawal by Subject|7|||
16849015|NCT01506609|37794383|FG000|Overall Study|Lost to Follow-up|0|||
16849016|NCT01506609|37794384|FG001|Overall Study|Lost to Follow-up|0|||
16849017|NCT01506609|37794385|FG002|Overall Study|Lost to Follow-up|0|||
16849018|NCT01506609|37794386|FG003|Overall Study|Lost to Follow-up|1|||
16849019|NCT01506609|37794387|FG004|Overall Study|Lost to Follow-up|2|||
16849020|NCT01506609|37794388|FG005|Overall Study|Lost to Follow-up|0|||
16849021|NCT01506609|37794383|FG000|Overall Study|Sponsor Discontinued Study|0|||
16849022|NCT01506609|37794384|FG001|Overall Study|Sponsor Discontinued Study|0|||
16849023|NCT01506609|37794385|FG002|Overall Study|Sponsor Discontinued Study|0|||
16849024|NCT01506609|37794386|FG003|Overall Study|Sponsor Discontinued Study|2|||
16849025|NCT01506609|37794387|FG004|Overall Study|Sponsor Discontinued Study|2|||
16849026|NCT01506609|37794388|FG005|Overall Study|Sponsor Discontinued Study|0|||
16849027|NCT01506609|37794383|FG000|Overall Study|Progressive Disease per Protocol|1|||
16849028|NCT01506609|37794384|FG001|Overall Study|Progressive Disease per Protocol|0|||
16849029|NCT01506609|37794385|FG002|Overall Study|Progressive Disease per Protocol|0|||
16849030|NCT01506609|37794386|FG003|Overall Study|Progressive Disease per Protocol|64|||
16849031|NCT01506609|37794387|FG004|Overall Study|Progressive Disease per Protocol|57|||
16849032|NCT01506609|37794388|FG005|Overall Study|Progressive Disease per Protocol|74|||
16849033|NCT01506609|37794383|FG000|Overall Study|Other, Not Specified|0|||
16849034|NCT01506609|37794384|FG001|Overall Study|Other, Not Specified|0|||
16849035|NCT01506609|37794385|FG002|Overall Study|Other, Not Specified|0|||
16849036|NCT01506609|37794386|FG003|Overall Study|Other, Not Specified|10|||
16849037|NCT01506609|37794387|FG004|Overall Study|Other, Not Specified|7|||
16849038|NCT01506609|37794388|FG005|Overall Study|Other, Not Specified|3|||
16849039|NCT01506609|37794383|FG000|Overall Study|Missing / Unknown Reason|1|||
16849040|NCT01506609|37794384|FG001|Overall Study|Missing / Unknown Reason|0|||
16849041|NCT01506609|37794385|FG002|Overall Study|Missing / Unknown Reason|1|||
16849042|NCT01506609|37794386|FG003|Overall Study|Missing / Unknown Reason|4|||
16849043|NCT01506609|37794387|FG004|Overall Study|Missing / Unknown Reason|4|||
16849044|NCT01506609|37794388|FG005|Overall Study|Missing / Unknown Reason|2|||
16849045|NCT01506453|37794412|FG000|Overall Study|Withdrawal prior to treatment|0|||
16849046|NCT01506453|37794413|FG001|Overall Study|Withdrawal prior to treatment|2|||
16849047|NCT01482429|37794421|FG000|Care Usual|Protocol Violation|0|||
16849048|NCT01482429|37794422|FG001|Care Usual|Protocol Violation|172|||
16849049|NCT01482429|37794421|FG000|Care Usual|Lost to Follow-up|0|||
16925077|NCT03801031|38066961|FG001|Overall Study|Lost to Follow-up|0|||
16925078|NCT03801031|38066960|FG000|Overall Study|Unable to comply|1|||
16849050|NCT01482429|37794422|FG001|Care Usual|Lost to Follow-up|1|||
16849051|NCT01482429|37794421|FG000|Protocol|Protocol Violation|275|||
16849052|NCT01482429|37794422|FG001|Protocol|Protocol Violation|0|||
16849053|NCT01504971|37794428|FG000|Overall Study|Physician Decision|13|||
16849054|NCT01479777|37794436|FG000|Overall Study|Physician Decision|2|||
16925079|NCT03801031|38066961|FG001|Overall Study|Unable to comply|0|||
16925080|NCT03801031|38066960|FG000|Overall Study|Withdrawal by Subject|0|||
16925081|NCT03801031|38066961|FG001|Overall Study|Withdrawal by Subject|1|||
16925082|NCT03357952|38066969|FG000|Overall Study|Withdrawal by Subject|0|||
16925083|NCT03357952|38066970|FG001|Overall Study|Withdrawal by Subject|1|||
16925084|NCT03357952|38066969|FG000|Overall Study|Sponsor Decision|9|||
17017910|NCT00683644|38162502|FG001|Overall Study|Withdrawal by Subject|2|||
17017911|NCT00683644|38162501|FG000|Overall Study|Lost to Follow-up|1|||
17017912|NCT00683644|38162502|FG001|Overall Study|Lost to Follow-up|4|||
17017913|NCT00683644|38162501|FG000|Overall Study|Adverse Event|1|||
17017914|NCT00683644|38162502|FG001|Overall Study|Adverse Event|2|||
17017915|NCT00683644|38162501|FG000|Overall Study|Low copper, other health problems,|7|||
17017916|NCT00683644|38162502|FG001|Overall Study|Low copper, other health problems,|6|||
17017917|NCT00685360|38162515|FG000|Overall Study|Lost to Follow-up|0|||
17017918|NCT00685360|38162516|FG001|Overall Study|Lost to Follow-up|1|||
17017919|NCT00685360|38162517|FG002|Overall Study|Lost to Follow-up|2|||
17017920|NCT00685360|38162515|FG000|Overall Study|Adverse Event|4|||
17017921|NCT00685360|38162516|FG001|Overall Study|Adverse Event|6|||
17017922|NCT00685360|38162517|FG002|Overall Study|Adverse Event|4|||
17017923|NCT00685360|38162515|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
17017924|NCT00685360|38162516|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
17017925|NCT00685360|38162517|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
17017926|NCT00685360|38162515|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
17102562|NCT00112437|38241466|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
16925085|NCT03357952|38066970|FG001|Overall Study|Sponsor Decision|0|||
16925086|NCT03055858|38066976|FG000|Overall Study|Death|9|||
16925087|NCT03055858|38066976|FG000|Overall Study|Withdrawal by Subject|11|||
16925088|NCT03055858|38066976|FG000|Overall Study|Lost to Follow-up|6|||
16925089|NCT03055858|38066976|FG000|Overall Study|Missed Follow-Up Visits|18|||
16925090|NCT02773849|38067003|FG000|Overall Study|Adverse Event|3|||
16925091|NCT02773849|38067003|FG000|Overall Study|Lack of Efficacy|89|||
16925092|NCT02773849|38067003|FG000|Overall Study|Withdrawal by Subject|1|||
16925093|NCT02773849|38067003|FG000|Overall Study|Withdrawal of Consent|1|||
16925094|NCT02393716|38067011|FG000|Overall Study|Death|29|||
16849055|NCT01479621|37794446|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
16849056|NCT01479621|37794447|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16849057|NCT01479621|37794448|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16849058|NCT01479621|37794449|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
17017927|NCT00685360|38162516|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
17017928|NCT00685360|38162517|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
17017929|NCT00685360|38162515|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
17017930|NCT00685360|38162516|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
17017931|NCT00685360|38162517|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
17017932|NCT00685360|38162515|FG000|Overall Study|Protocol Deviation|0|||
17017933|NCT00685360|38162516|FG001|Overall Study|Protocol Deviation|1|||
17017934|NCT00685360|38162517|FG002|Overall Study|Protocol Deviation|1|||
17017935|NCT00684814|38162525|FG000|Washout Period of 7 Days|Adverse Event|1|||
17017936|NCT00684814|38162526|FG001|Washout Period of 7 Days|Adverse Event|2|||
17017937|NCT00684814|38162525|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
17017938|NCT00684814|38162526|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
17017939|NCT00684814|38162525|FG000|Second Intervention|Adverse Event|1|||
17017940|NCT00684814|38162526|FG001|Second Intervention|Adverse Event|0|||
17017941|NCT00576472|38162547|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017942|NCT00576472|38162548|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017943|NCT00576472|38162549|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017944|NCT00576472|38162550|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
17017945|NCT00576472|38162551|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017946|NCT00576472|38162552|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017947|NCT00576472|38162553|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017948|NCT00576472|38162554|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017949|NCT00576472|38162555|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017950|NCT00576472|38162556|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017951|NCT00576472|38162557|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017952|NCT00576472|38162558|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017953|NCT00576472|38162559|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017954|NCT00576472|38162560|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017955|NCT00576472|38162561|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
17017956|NCT00576472|38162547|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
17017957|NCT00576472|38162548|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
17017958|NCT00576472|38162549|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
17017959|NCT00576472|38162550|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
17017960|NCT00576472|38162551|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
17017961|NCT00576472|38162552|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
17017962|NCT00576472|38162553|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
17017963|NCT00576472|38162554|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
17017964|NCT00576472|38162555|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
17017965|NCT00576472|38162556|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
17017966|NCT00576472|38162557|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
17017967|NCT00576472|38162558|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
17017968|NCT00576472|38162559|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
17017969|NCT00576472|38162560|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
16925095|NCT02393716|38067011|FG000|Overall Study|Withdrawal by Subject|8|||
16925096|NCT02393716|38067011|FG000|Overall Study|Device Explanted|8|||
16925097|NCT02393716|38067011|FG000|Overall Study|Missed visit|16|||
16925098|NCT01804816|38067016|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
16925099|NCT01804816|38067016|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
16925100|NCT00584233|38067023|FG000|Overall Study|Withdrawal by Subject|5|||
16849059|NCT01479621|37794450|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16849060|NCT01479621|37794451|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16849061|NCT01479621|37794452|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16849062|NCT01479621|37794446|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
16849063|NCT01479621|37794447|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16849064|NCT01479621|37794448|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16849065|NCT01479621|37794449|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16849066|NCT01479621|37794450|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16849067|NCT01479621|37794451|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16849068|NCT01479621|37794452|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16925101|NCT00584233|38067023|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
16925102|NCT00001566|38067035|FG000|Overall Study|patients' choice to discontinue protocol|3|||
16849069|NCT01479621|37794446|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
16849070|NCT01479621|37794447|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16925103|NCT00001566|38067035|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
16925104|NCT00001566|38067035|FG000|Overall Study|Death|13|||
16925105|NCT00001566|38067035|FG000|Overall Study|Lost to Follow-up|1|||
16925106|NCT00001566|38067035|FG000|Overall Study|unable to complete initial apheresis|1|||
16925107|NCT00001575|38067039|FG000|Overall Study|Screening failures-Ph I portion|22|||
16925108|NCT00001575|38067039|FG000|Overall Study|Withdrawn/deaths|23|||
16925109|NCT00001596|38067045|FG000|Overall Study|Death|1|||
16925110|NCT00001596|38067046|FG001|Overall Study|Death|0|||
16925111|NCT00001596|38067045|FG000|Overall Study|Withdrawal by Subject|3|||
16925112|NCT00001596|38067046|FG001|Overall Study|Withdrawal by Subject|1|||
16925113|NCT00001596|38067045|FG000|Overall Study|Study Termination|12|||
16925114|NCT00001596|38067046|FG001|Overall Study|Study Termination|9|||
16925115|NCT00001596|38067045|FG000|Overall Study|Adverse Event|1|||
16925116|NCT00001596|38067046|FG001|Overall Study|Adverse Event|0|||
16925117|NCT01349803|38067096|FG000|Overall Study|Adverse Event|0|||
16925118|NCT01349803|38067097|FG001|Overall Study|Adverse Event|0|||
16925119|NCT01349803|38067098|FG002|Overall Study|Adverse Event|0|||
16925120|NCT01349803|38067099|FG003|Overall Study|Adverse Event|2|||
16925121|NCT01349803|38067096|FG000|Overall Study|Withdrawal by Subject|1|||
16925122|NCT01349803|38067097|FG001|Overall Study|Withdrawal by Subject|0|||
16925123|NCT01349803|38067098|FG002|Overall Study|Withdrawal by Subject|0|||
16925124|NCT01349803|38067099|FG003|Overall Study|Withdrawal by Subject|0|||
16925125|NCT01349803|38067096|FG000|Overall Study|Protocol-specified criteria|0|||
16925126|NCT01349803|38067097|FG001|Overall Study|Protocol-specified criteria|1|||
16925127|NCT01349803|38067098|FG002|Overall Study|Protocol-specified criteria|3|||
16925128|NCT01349803|38067099|FG003|Overall Study|Protocol-specified criteria|0|||
16925129|NCT04059146|38067245|FG000|Overall Study|Withdrawal by Subject|0|||
16925130|NCT04059146|38067246|FG001|Overall Study|Withdrawal by Subject|1|||
16925131|NCT03969641|38067267|FG000|Overall Study|Lost to Follow-up|5|||
16925132|NCT03969641|38067268|FG001|Overall Study|Lost to Follow-up|3|||
16925133|NCT03969641|38067267|FG000|Overall Study|Withdrawal by Subject|1|||
16925134|NCT03969641|38067268|FG001|Overall Study|Withdrawal by Subject|2|||
16925135|NCT03969641|38067267|FG000|Overall Study|Found to be ineligible|1|||
16849071|NCT01479621|37794448|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16849072|NCT01479621|37794449|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16849073|NCT01479621|37794450|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16849074|NCT01479621|37794451|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16925136|NCT03969641|38067268|FG001|Overall Study|Found to be ineligible|1|||
16925137|NCT03969641|38067267|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
16849075|NCT01479621|37794452|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16849076|NCT01479621|37794446|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
16849077|NCT01479621|37794447|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16849078|NCT01479621|37794448|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16849079|NCT01479621|37794449|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16849080|NCT01479621|37794450|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16849081|NCT01479621|37794451|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16849082|NCT01479621|37794452|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16849083|NCT01479621|37794446|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
16925138|NCT03969641|38067268|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
16925139|NCT03969641|38067267|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
16849084|NCT01479621|37794447|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16849085|NCT01479621|37794448|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16849086|NCT01479621|37794449|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16925140|NCT03969641|38067268|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
16925141|NCT03969641|38067267|FG000|Overall Study|Elective termination|0|||
16925142|NCT03969641|38067268|FG001|Overall Study|Elective termination|1|||
16925143|NCT03721172|38067314|FG000|Placebo-controlled Phase|Adverse Event|7|||
16925144|NCT03721172|38067315|FG001|Placebo-controlled Phase|Adverse Event|7|||
16925145|NCT03721172|38067316|FG002|Placebo-controlled Phase|Adverse Event|0|||
16925146|NCT03721172|38067314|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
16925147|NCT03721172|38067315|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
16925148|NCT03721172|38067316|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
16925149|NCT03721172|38067314|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
16925150|NCT03721172|38067315|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
16925151|NCT03721172|38067316|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
16925152|NCT03721172|38067314|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
16925153|NCT03721172|38067315|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
16925154|NCT03721172|38067316|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
16925155|NCT03721172|38067314|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
16925156|NCT03721172|38067315|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
16925157|NCT03721172|38067316|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
16925158|NCT03721172|38067314|FG000|Placebo-controlled Phase|Other|3|||
16849087|NCT01479621|37794450|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16849088|NCT01479621|37794451|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16849089|NCT01479621|37794452|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16849090|NCT01479621|37794446|FG000|Treatment Period|Adverse Event|0|||
16849091|NCT01479621|37794447|FG001|Treatment Period|Adverse Event|0|||
16849092|NCT01479621|37794448|FG002|Treatment Period|Adverse Event|0|||
16849093|NCT01479621|37794449|FG003|Treatment Period|Adverse Event|0|||
16849094|NCT01479621|37794450|FG004|Treatment Period|Adverse Event|1|||
16849095|NCT01479621|37794451|FG005|Treatment Period|Adverse Event|2|||
16849096|NCT01479621|37794452|FG006|Treatment Period|Adverse Event|2|||
16849097|NCT01479621|37794446|FG000|Treatment Period|Withdrawal by Subject|0|||
16849098|NCT01479621|37794447|FG001|Treatment Period|Withdrawal by Subject|4|||
16925159|NCT03721172|38067315|FG001|Placebo-controlled Phase|Other|0|||
16925160|NCT03721172|38067316|FG002|Placebo-controlled Phase|Other|0|||
16925161|NCT03721172|38067314|FG000|Apremilast Extension Phase|Adverse Event|0|||
16925162|NCT03721172|38067315|FG001|Apremilast Extension Phase|Adverse Event|0|||
16925163|NCT03721172|38067316|FG002|Apremilast Extension Phase|Adverse Event|10|||
16925164|NCT03721172|38067314|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
16925165|NCT03721172|38067315|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
16925166|NCT03721172|38067316|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
16925167|NCT03721172|38067314|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
16925168|NCT03721172|38067315|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
16925169|NCT03721172|38067316|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
16925170|NCT03721172|38067314|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
16925171|NCT03721172|38067315|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
16925172|NCT03721172|38067316|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
16849099|NCT01479621|37794448|FG002|Treatment Period|Withdrawal by Subject|2|||
16925173|NCT03721172|38067314|FG000|Apremilast Extension Phase|Protocol Violation|0|||
16849100|NCT01479621|37794449|FG003|Treatment Period|Withdrawal by Subject|2|||
16849101|NCT01479621|37794450|FG004|Treatment Period|Withdrawal by Subject|5|||
16925174|NCT03721172|38067315|FG001|Apremilast Extension Phase|Protocol Violation|0|||
16925175|NCT03721172|38067316|FG002|Apremilast Extension Phase|Protocol Violation|1|||
16925176|NCT03721172|38067314|FG000|Apremilast Extension Phase|Physician Decision|0|||
16925177|NCT03721172|38067315|FG001|Apremilast Extension Phase|Physician Decision|0|||
16925178|NCT03721172|38067316|FG002|Apremilast Extension Phase|Physician Decision|1|||
16925179|NCT03721172|38067314|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
16925180|NCT03721172|38067315|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
16925181|NCT03721172|38067316|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
16925182|NCT03721172|38067314|FG000|Apremilast Extension Phase|Other|0|||
16925183|NCT03721172|38067315|FG001|Apremilast Extension Phase|Other|0|||
16925184|NCT03721172|38067316|FG002|Apremilast Extension Phase|Other|3|||
16925185|NCT03721172|38067314|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
16925186|NCT03721172|38067315|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
16925187|NCT03721172|38067316|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
16925188|NCT03089606|38067346|FG000|Overall Study|Progression after Cycle 1|1|||
16925189|NCT02337686|38067362|FG000|Overall Study|Adverse Event|1|||
16925190|NCT04540887|38067388|FG000|Overall Study|Withdrawal by Subject|2|||
16925191|NCT04294680|38067399|FG000|Overall Study|Withdrawal by Subject|2|||
16925192|NCT04294680|38067400|FG001|Overall Study|Withdrawal by Subject|1|||
16925193|NCT04294680|38067399|FG000|Overall Study|Follow-up visits completed outside of window|1|||
16925194|NCT04294680|38067400|FG001|Overall Study|Follow-up visits completed outside of window|0|||
16925195|NCT01350102|38067410|FG000|Overall Study|Adverse Event|0|||
16925196|NCT01350102|38067411|FG001|Overall Study|Adverse Event|0|||
16925197|NCT01350102|38067412|FG002|Overall Study|Adverse Event|1|||
16925198|NCT01350102|38067413|FG003|Overall Study|Adverse Event|0|||
16925199|NCT04059549|38067427|FG000|Overall Study|Withdrawal by Subject|2|||
16925200|NCT04059549|38067428|FG001|Overall Study|Withdrawal by Subject|0|||
16925201|NCT04041570|38067440|FG000|Overall Study|Moved from Area|0|||
16925202|NCT04041570|38067441|FG001|Overall Study|Moved from Area|2|||
16925203|NCT03879408|38067453|FG000|Overall Study|Lost to Follow-up|0|||
16925204|NCT03879408|38067454|FG001|Overall Study|Lost to Follow-up|3|||
16925205|NCT03879408|38067455|FG002|Overall Study|Lost to Follow-up|2|||
16925206|NCT03879408|38067456|FG003|Overall Study|Lost to Follow-up|1|||
16925207|NCT03879408|38067457|FG004|Overall Study|Lost to Follow-up|0|||
16925208|NCT03879408|38067453|FG000|Overall Study|Withdrawal by Subject|2|||
16925209|NCT03879408|38067454|FG001|Overall Study|Withdrawal by Subject|1|||
16925210|NCT03879408|38067455|FG002|Overall Study|Withdrawal by Subject|1|||
16925211|NCT03879408|38067456|FG003|Overall Study|Withdrawal by Subject|0|||
16925212|NCT03879408|38067457|FG004|Overall Study|Withdrawal by Subject|1|||
16925213|NCT02706873|38067477|FG000|Overall Study|Adverse Event|13|||
16925214|NCT02706873|38067478|FG001|Overall Study|Adverse Event|3|||
16925215|NCT02706873|38067479|FG002|Overall Study|Adverse Event|13|||
16925216|NCT02706873|38067480|FG003|Overall Study|Adverse Event|12|||
16925217|NCT02706873|38067477|FG000|Overall Study|Withdrawal by Subject|15|||
16849102|NCT01479621|37794451|FG005|Treatment Period|Withdrawal by Subject|5|||
16925218|NCT02706873|38067478|FG001|Overall Study|Withdrawal by Subject|0|||
16925219|NCT02706873|38067479|FG002|Overall Study|Withdrawal by Subject|8|||
16925220|NCT02706873|38067480|FG003|Overall Study|Withdrawal by Subject|11|||
16925221|NCT02706873|38067477|FG000|Overall Study|Lost to Follow-up|3|||
16925222|NCT02706873|38067478|FG001|Overall Study|Lost to Follow-up|0|||
16925223|NCT02706873|38067479|FG002|Overall Study|Lost to Follow-up|4|||
16925224|NCT02706873|38067480|FG003|Overall Study|Lost to Follow-up|2|||
16925225|NCT02706873|38067477|FG000|Overall Study|Lack of Efficacy|10|||
16925226|NCT02706873|38067478|FG001|Overall Study|Lack of Efficacy|0|||
16925227|NCT02706873|38067479|FG002|Overall Study|Lack of Efficacy|0|||
16925228|NCT02706873|38067480|FG003|Overall Study|Lack of Efficacy|3|||
16925229|NCT02706873|38067477|FG000|Overall Study|Other|5|||
16925230|NCT02706873|38067478|FG001|Overall Study|Other|1|||
16925231|NCT02706873|38067479|FG002|Overall Study|Other|2|||
16925232|NCT02706873|38067480|FG003|Overall Study|Other|3|||
16925233|NCT02706873|38067477|FG000|Overall Study|Not Dosed|1|||
17017970|NCT00576472|38162561|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
17017971|NCT00576472|38162547|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017972|NCT00576472|38162548|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017973|NCT00576472|38162549|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017974|NCT00576472|38162550|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
17017975|NCT00576472|38162551|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017976|NCT00576472|38162552|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017977|NCT00576472|38162553|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017978|NCT00576472|38162554|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017979|NCT00576472|38162555|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017980|NCT00576472|38162556|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017981|NCT00576472|38162557|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017982|NCT00576472|38162558|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017983|NCT00576472|38162559|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017984|NCT00576472|38162560|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017985|NCT00576472|38162561|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
17017986|NCT00576472|38162547|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
17017987|NCT00576472|38162548|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
17017988|NCT00576472|38162549|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
17017989|NCT00576472|38162550|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
17017990|NCT00576472|38162551|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
17017991|NCT00576472|38162552|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
17017992|NCT00576472|38162553|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
17017993|NCT00576472|38162554|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
17017994|NCT00576472|38162555|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
17017995|NCT00576472|38162556|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
17017996|NCT00576472|38162557|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
17017997|NCT00576472|38162558|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
17017998|NCT00576472|38162559|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
17017999|NCT00576472|38162560|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
17018000|NCT00576472|38162561|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
17018001|NCT00576472|38162547|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018002|NCT00576472|38162548|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018003|NCT00576472|38162549|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018004|NCT00576472|38162550|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
17018005|NCT00576472|38162551|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018006|NCT00576472|38162552|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018007|NCT00576472|38162553|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018008|NCT00576472|38162554|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018009|NCT00576472|38162555|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018010|NCT00576472|38162556|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018011|NCT00576472|38162557|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018012|NCT00576472|38162558|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018013|NCT00576472|38162559|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018014|NCT00576472|38162560|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018015|NCT00576472|38162561|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
17018016|NCT00576472|38162547|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
16925234|NCT02706873|38067478|FG001|Overall Study|Not Dosed|0|||
16925235|NCT02706873|38067479|FG002|Overall Study|Not Dosed|0|||
16925236|NCT02706873|38067480|FG003|Overall Study|Not Dosed|1|||
16925237|NCT02706873|38067477|FG000|Overall Study|Ongoing|0|||
17018017|NCT00576472|38162548|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018018|NCT00576472|38162549|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018019|NCT00576472|38162550|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018020|NCT00576472|38162551|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018021|NCT00576472|38162552|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
17102563|NCT00112437|38241441|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16925238|NCT02706873|38067478|FG001|Overall Study|Ongoing|0|||
16925239|NCT02706873|38067479|FG002|Overall Study|Ongoing|0|||
16925240|NCT02706873|38067480|FG003|Overall Study|Ongoing|1|||
16925241|NCT02454933|38067494|FG000|Overall Study|Progressive disease|7|||
16925242|NCT02454933|38067495|FG001|Overall Study|Progressive disease|5|||
16925243|NCT02454933|38067494|FG000|Overall Study|Adverse Event|1|||
16925244|NCT02454933|38067495|FG001|Overall Study|Adverse Event|1|||
16925245|NCT02454933|38067494|FG000|Overall Study|Withdrawal by Subject|0|||
16925246|NCT02454933|38067495|FG001|Overall Study|Withdrawal by Subject|2|||
17018022|NCT00576472|38162553|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
17018023|NCT00576472|38162554|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018024|NCT00576472|38162555|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018025|NCT00576472|38162556|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018026|NCT00576472|38162557|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018027|NCT00576472|38162558|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018028|NCT00576472|38162559|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018029|NCT00576472|38162560|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018030|NCT00576472|38162561|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
17018031|NCT00576472|38162547|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
17018032|NCT00576472|38162548|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
17018033|NCT00576472|38162549|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
17018034|NCT00576472|38162550|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
17018035|NCT00576472|38162551|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
17018036|NCT00576472|38162552|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
17018037|NCT00576472|38162553|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
17018038|NCT00576472|38162554|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
17018039|NCT00576472|38162555|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
17018040|NCT00576472|38162556|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
17018041|NCT00576472|38162557|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
17018042|NCT00576472|38162558|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
17018043|NCT00576472|38162559|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
17018044|NCT00576472|38162560|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
16925247|NCT02362464|38067500|FG000|Overall Study|Switched to alternative therapy|1|||
17018045|NCT00576472|38162561|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
17018046|NCT00576472|38162547|FG000|MPH Cross Over Phase|Physician Decision|0|||
17018047|NCT00576472|38162548|FG001|MPH Cross Over Phase|Physician Decision|0|||
17018048|NCT00576472|38162549|FG002|MPH Cross Over Phase|Physician Decision|0|||
17018049|NCT00576472|38162550|FG003|MPH Cross Over Phase|Physician Decision|0|||
17018050|NCT00576472|38162551|FG004|MPH Cross Over Phase|Physician Decision|0|||
17018051|NCT00576472|38162552|FG005|MPH Cross Over Phase|Physician Decision|0|||
17018052|NCT00576472|38162553|FG006|MPH Cross Over Phase|Physician Decision|4|||
17018053|NCT00576472|38162554|FG007|MPH Cross Over Phase|Physician Decision|0|||
17018054|NCT00576472|38162555|FG008|MPH Cross Over Phase|Physician Decision|0|||
17018055|NCT00576472|38162556|FG009|MPH Cross Over Phase|Physician Decision|0|||
17102564|NCT00112437|38241442|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
17102565|NCT00112437|38241443|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102566|NCT00112437|38241444|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102567|NCT00112437|38241445|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102568|NCT00112437|38241446|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102569|NCT00112437|38241447|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102570|NCT00112437|38241448|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102571|NCT00112437|38241449|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102572|NCT00112437|38241450|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102573|NCT00112437|38241451|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102574|NCT00112437|38241452|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102575|NCT00112437|38241453|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102576|NCT00112437|38241454|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102577|NCT00112437|38241455|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102578|NCT00112437|38241456|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102579|NCT00112437|38241457|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102580|NCT00112437|38241458|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102581|NCT00112437|38241459|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102582|NCT00112437|38241460|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102583|NCT00112437|38241461|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102584|NCT00112437|38241462|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102585|NCT00112437|38241463|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102586|NCT00112437|38241464|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102587|NCT00112437|38241465|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102588|NCT00112437|38241466|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
17102589|NCT00112437|38241441|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16925248|NCT02362464|38067500|FG000|Overall Study|Refused further treatment|1|||
16925249|NCT02362464|38067500|FG000|Overall Study|Physician Decision|4|||
16925250|NCT01696968|38067512|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
16925251|NCT01696968|38067513|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
16925252|NCT01696968|38067512|FG000|Overall Study|Died Before Randomization|3|||
16925253|NCT01696968|38067513|FG001|Overall Study|Died Before Randomization|8|||
16925254|NCT01696968|38067512|FG000|Overall Study|Died Before ASU (Control)|278|||
16925255|NCT01696968|38067513|FG001|Overall Study|Died Before ASU (Control)|0|||
16925256|NCT01696968|38067512|FG000|Overall Study|Refused ASU (Control)|920|||
16925257|NCT01696968|38067513|FG001|Overall Study|Refused ASU (Control)|0|||
16925258|NCT01696968|38067512|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
16925259|NCT01696968|38067513|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
16925260|NCT00819780|38067522|FG000|Overall Study|Did not receive study drug|3|||
16925261|NCT00819780|38067523|FG001|Overall Study|Did not receive study drug|4|||
16925262|NCT00819780|38067522|FG000|Overall Study|Still in treatment|25|||
16925263|NCT00819780|38067523|FG001|Overall Study|Still in treatment|17|||
16925264|NCT00000620|38067662|FG000|Overall Study|Death|86|||
16925265|NCT00000620|38067663|FG001|Overall Study|Death|67|||
16925266|NCT00000620|38067664|FG002|Overall Study|Death|112|||
16925267|NCT00000620|38067665|FG003|Overall Study|Death|126|||
16925268|NCT00000620|38067666|FG004|Overall Study|Death|64|||
16925269|NCT00000620|38067667|FG005|Overall Study|Death|77|||
16925270|NCT00000620|38067668|FG006|Overall Study|Death|91|||
16925271|NCT00000620|38067669|FG007|Overall Study|Death|95|||
16925272|NCT00000620|38067662|FG000|Overall Study|Lost to Follow-up|14|||
16925273|NCT00000620|38067663|FG001|Overall Study|Lost to Follow-up|14|||
16925274|NCT00000620|38067664|FG002|Overall Study|Lost to Follow-up|14|||
16925275|NCT00000620|38067665|FG003|Overall Study|Lost to Follow-up|14|||
16925276|NCT00000620|38067666|FG004|Overall Study|Lost to Follow-up|15|||
16925277|NCT00000620|38067667|FG005|Overall Study|Lost to Follow-up|15|||
16925278|NCT00000620|38067668|FG006|Overall Study|Lost to Follow-up|13|||
16925279|NCT00000620|38067669|FG007|Overall Study|Lost to Follow-up|14|||
16925280|NCT00000620|38067662|FG000|Overall Study|Withdrawal by Subject|40|||
16925281|NCT00000620|38067663|FG001|Overall Study|Withdrawal by Subject|27|||
16925282|NCT00000620|38067664|FG002|Overall Study|Withdrawal by Subject|28|||
16925283|NCT00000620|38067665|FG003|Overall Study|Withdrawal by Subject|27|||
16925284|NCT00000620|38067666|FG004|Overall Study|Withdrawal by Subject|30|||
16925285|NCT00000620|38067667|FG005|Overall Study|Withdrawal by Subject|32|||
16925286|NCT00000620|38067668|FG006|Overall Study|Withdrawal by Subject|32|||
16925287|NCT00000620|38067669|FG007|Overall Study|Withdrawal by Subject|21|||
16925288|NCT00000620|38067662|FG000|Overall Study|missed closeout visit|22|||
16925289|NCT00000620|38067663|FG001|Overall Study|missed closeout visit|28|||
16925290|NCT00000620|38067664|FG002|Overall Study|missed closeout visit|16|||
16925291|NCT00000620|38067665|FG003|Overall Study|missed closeout visit|11|||
16925292|NCT00000620|38067666|FG004|Overall Study|missed closeout visit|26|||
16925293|NCT00000620|38067667|FG005|Overall Study|missed closeout visit|28|||
16925294|NCT00000620|38067668|FG006|Overall Study|missed closeout visit|13|||
16925295|NCT00000620|38067669|FG007|Overall Study|missed closeout visit|16|||
16925296|NCT00001262|38067741|FG000|Overall Study|Death|10|||
16925297|NCT00001262|38067742|FG001|Overall Study|Death|11|||
16925298|NCT00001262|38067743|FG002|Overall Study|Death|0|||
16925299|NCT00001262|38067741|FG000|Overall Study|Withdrawal by Subject|0|||
16925300|NCT00001262|38067742|FG001|Overall Study|Withdrawal by Subject|3|||
16925301|NCT00001262|38067743|FG002|Overall Study|Withdrawal by Subject|0|||
16925302|NCT00001277|38067760|FG000|Overall Study|Adverse Event|0|||
16925303|NCT00001277|38067761|FG001|Overall Study|Adverse Event|0|||
16925304|NCT00001277|38067762|FG002|Overall Study|Adverse Event|1|||
16925305|NCT00001277|38067760|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
16925306|NCT00001277|38067761|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
16925307|NCT00001277|38067762|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
16925308|NCT00001703|38067808|FG000|Overall Study|progressed disease|2|||
16925309|NCT00001703|38067808|FG000|Overall Study|No evidence of disease|1|||
16925310|NCT00001703|38067808|FG000|Overall Study|recurrent disease|2|||
16925311|NCT01349907|38067832|FG000|Overall Study|Adverse Event|37|||
16925312|NCT01349907|38067833|FG001|Overall Study|Adverse Event|11|||
16925313|NCT01349907|38067832|FG000|Overall Study|Treatment failure|13|||
16925314|NCT01349907|38067833|FG001|Overall Study|Treatment failure|4|||
16925315|NCT01349907|38067832|FG000|Overall Study|Lost to Follow-up|25|||
16925316|NCT01349907|38067833|FG001|Overall Study|Lost to Follow-up|6|||
16925317|NCT01349907|38067832|FG000|Overall Study|Withdrawal by Subject|30|||
16925318|NCT01349907|38067833|FG001|Overall Study|Withdrawal by Subject|8|||
16925319|NCT01349907|38067832|FG000|Overall Study|Protocol Violation|33|||
16925320|NCT01349907|38067833|FG001|Overall Study|Protocol Violation|13|||
16925321|NCT01349907|38067832|FG000|Overall Study|Administrative|1|||
16925322|NCT01349907|38067833|FG001|Overall Study|Administrative|1|||
16925323|NCT04847141|38067842|FG000|Overall Study|Adverse Event|1|||
16925324|NCT04847141|38067843|FG001|Overall Study|Adverse Event|0|||
16925325|NCT04847141|38067844|FG002|Overall Study|Adverse Event|1|||
16925326|NCT04847141|38067842|FG000|Overall Study|Withdrawal by Subject|2|||
16925327|NCT04847141|38067843|FG001|Overall Study|Withdrawal by Subject|4|||
16925328|NCT04847141|38067844|FG002|Overall Study|Withdrawal by Subject|3|||
16925329|NCT04847141|38067842|FG000|Overall Study|Lost to Follow-up|7|||
16925330|NCT04847141|38067843|FG001|Overall Study|Lost to Follow-up|5|||
16925331|NCT04847141|38067844|FG002|Overall Study|Lost to Follow-up|7|||
16925332|NCT04847141|38067842|FG000|Overall Study|Reason not Specified|0|||
16925333|NCT04847141|38067843|FG001|Overall Study|Reason not Specified|1|||
16925334|NCT04847141|38067844|FG002|Overall Study|Reason not Specified|0|||
16925335|NCT01349829|38067854|FG000|Overall Study|Lost to Follow-up|4|||
16925336|NCT01349829|38067855|FG001|Overall Study|Lost to Follow-up|8|||
16925337|NCT01349829|38067854|FG000|Overall Study|Consent withdrawal|3|||
16925338|NCT01349829|38067855|FG001|Overall Study|Consent withdrawal|8|||
16925339|NCT01349829|38067854|FG000|Overall Study|Migrated/moved|2|||
16925340|NCT01349829|38067855|FG001|Overall Study|Migrated/moved|7|||
16925341|NCT01350128|38067863|FG000|Overall Study|Withdrawal by Subject|3|||
16925342|NCT01350128|38067863|FG000|Overall Study|Protocol discontinuation criteria|8|||
16925343|NCT01350128|38067863|FG000|Overall Study|Physician Decision|1|||
16925344|NCT01350128|38067863|FG000|Overall Study|Lost to Follow-up|2|||
16925345|NCT03893825|38067943|FG000|Overall Study|Death|2|||
16925346|NCT03893825|38067944|FG001|Overall Study|Death|1|||
16925347|NCT03893825|38067943|FG000|Overall Study|Adverse Event|0|||
16925348|NCT03893825|38067944|FG001|Overall Study|Adverse Event|2|||
16925349|NCT03893825|38067943|FG000|Overall Study|Withdrawal by Subject|19|||
16925350|NCT03893825|38067944|FG001|Overall Study|Withdrawal by Subject|21|||
16925351|NCT03893825|38067943|FG000|Overall Study|Protocol deviation|1|||
16925352|NCT03893825|38067944|FG001|Overall Study|Protocol deviation|0|||
16925353|NCT03893825|38067943|FG000|Overall Study|Lost to Follow-up|10|||
16925354|NCT03893825|38067944|FG001|Overall Study|Lost to Follow-up|10|||
17018056|NCT00576472|38162557|FG010|MPH Cross Over Phase|Physician Decision|0|||
17018057|NCT00576472|38162558|FG011|MPH Cross Over Phase|Physician Decision|0|||
17018058|NCT00576472|38162559|FG012|MPH Cross Over Phase|Physician Decision|0|||
17018059|NCT00576472|38162560|FG013|MPH Cross Over Phase|Physician Decision|0|||
17018060|NCT00576472|38162561|FG014|MPH Cross Over Phase|Physician Decision|0|||
17018061|NCT00576472|38162547|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018062|NCT00576472|38162548|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018063|NCT00576472|38162549|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018064|NCT00576472|38162550|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018065|NCT00576472|38162551|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018066|NCT00576472|38162552|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018067|NCT00576472|38162553|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018068|NCT00576472|38162554|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018069|NCT00576472|38162555|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
17018070|NCT00576472|38162556|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018071|NCT00576472|38162557|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
17018072|NCT00576472|38162558|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
17018073|NCT00576472|38162559|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018074|NCT00576472|38162560|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018075|NCT00576472|38162561|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
17018076|NCT00576472|38162547|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018077|NCT00576472|38162548|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018078|NCT00576472|38162549|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018079|NCT00576472|38162550|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018080|NCT00576472|38162551|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018081|NCT00576472|38162552|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018082|NCT00576472|38162553|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018083|NCT00576472|38162554|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018084|NCT00576472|38162555|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018085|NCT00576472|38162556|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018086|NCT00576472|38162557|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018087|NCT00576472|38162558|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018088|NCT00576472|38162559|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018089|NCT00576472|38162560|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
16925355|NCT03893825|38067943|FG000|Overall Study|Other than specified|7|||
16925356|NCT03893825|38067944|FG001|Overall Study|Other than specified|6|||
16925357|NCT03890666|38067952|FG000|Overall Study|Withdrawal by Subject|0|||
16925358|NCT03890666|38067953|FG001|Overall Study|Withdrawal by Subject|1|||
16925359|NCT03890666|38067952|FG000|Overall Study|Protocol deviation|1|||
16925360|NCT03890666|38067953|FG001|Overall Study|Protocol deviation|4|||
16925361|NCT03890666|38067952|FG000|Overall Study|Lost to Follow-up|2|||
16925362|NCT03890666|38067953|FG001|Overall Study|Lost to Follow-up|5|||
17018090|NCT00576472|38162561|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
17018091|NCT00576472|38162547|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
17018092|NCT00576472|38162548|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
16925363|NCT03890666|38067952|FG000|Overall Study|Other than specified|1|||
16925364|NCT03890666|38067953|FG001|Overall Study|Other than specified|8|||
16925365|NCT03276572|38068007|FG000|Overall Study|In follow-up|0|||
16925366|NCT03276572|38068008|FG001|Overall Study|In follow-up|0|||
16925367|NCT03276572|38068009|FG002|Overall Study|In follow-up|0|||
16925368|NCT03276572|38068010|FG003|Overall Study|In follow-up|0|||
16925369|NCT03276572|38068011|FG004|Overall Study|In follow-up|0|||
16925370|NCT03276572|38068012|FG005|Overall Study|In follow-up|1|||
16925371|NCT03276572|38068013|FG006|Overall Study|In follow-up|1|||
16925372|NCT03276572|38068007|FG000|Overall Study|Lost to Follow-up|0|||
16925373|NCT03276572|38068008|FG001|Overall Study|Lost to Follow-up|0|||
16925374|NCT03276572|38068009|FG002|Overall Study|Lost to Follow-up|0|||
16925375|NCT03276572|38068010|FG003|Overall Study|Lost to Follow-up|0|||
16925376|NCT03276572|38068011|FG004|Overall Study|Lost to Follow-up|0|||
16925377|NCT03276572|38068012|FG005|Overall Study|Lost to Follow-up|0|||
16925378|NCT03276572|38068013|FG006|Overall Study|Lost to Follow-up|1|||
16925379|NCT03090737|38068038|FG000|Overall Study|Other reasons|1|||
16925380|NCT03090737|38068038|FG000|Overall Study|Completed treatment as per protocol|17|||
16925381|NCT03090737|38068038|FG000|Overall Study|Maximum clinical benefit|2|||
16925382|NCT03090737|38068038|FG000|Overall Study|Adverse event unrelated to study drug|7|||
16925383|NCT03090737|38068038|FG000|Overall Study|Study drug toxicity|4|||
16925384|NCT03090737|38068038|FG000|Overall Study|Disease progression|98|||
16925385|NCT03004976|38068083|FG000|Overall Study|Lost to Follow-up|7|||
16925386|NCT03004976|38068084|FG001|Overall Study|Lost to Follow-up|5|||
16925387|NCT03004976|38068083|FG000|Overall Study|Physician Decision|1|||
16925388|NCT03004976|38068084|FG001|Overall Study|Physician Decision|0|||
16925389|NCT03004976|38068083|FG000|Overall Study|Withdrawal by Subject|1|||
16925390|NCT03004976|38068084|FG001|Overall Study|Withdrawal by Subject|0|||
16925391|NCT03004976|38068083|FG000|Overall Study|Death|4|||
16925392|NCT03004976|38068084|FG001|Overall Study|Death|1|||
16849103|NCT01479621|37794452|FG006|Treatment Period|Withdrawal by Subject|1|||
16849104|NCT01479621|37794446|FG000|Treatment Period|Physician Decision|0|||
16849105|NCT01479621|37794447|FG001|Treatment Period|Physician Decision|0|||
16849106|NCT01479621|37794448|FG002|Treatment Period|Physician Decision|0|||
16849107|NCT01479621|37794449|FG003|Treatment Period|Physician Decision|0|||
16849108|NCT01479621|37794450|FG004|Treatment Period|Physician Decision|1|||
16849109|NCT01479621|37794451|FG005|Treatment Period|Physician Decision|1|||
16849110|NCT01479621|37794452|FG006|Treatment Period|Physician Decision|0|||
16925393|NCT02985866|38068092|FG000|Overall Study|Poor CGM data|1|||
17018093|NCT00576472|38162549|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
17018094|NCT00576472|38162550|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
17018095|NCT00576472|38162551|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
17018096|NCT00576472|38162552|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
17018097|NCT00576472|38162553|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
17018098|NCT00576472|38162554|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
17018099|NCT00576472|38162555|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
17018100|NCT00576472|38162556|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
17018101|NCT00576472|38162557|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
17018102|NCT00576472|38162558|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
17018103|NCT00576472|38162559|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
17018104|NCT00576472|38162560|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
17018105|NCT00576472|38162561|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
17018106|NCT00576472|38162547|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
17018107|NCT00576472|38162548|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
17018108|NCT00576472|38162549|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
17018109|NCT00576472|38162550|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
17018110|NCT00576472|38162551|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
17018111|NCT00576472|38162552|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
17018112|NCT00576472|38162553|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
17018113|NCT00576472|38162554|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
17018114|NCT00576472|38162555|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
17018115|NCT00576472|38162556|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
17018116|NCT00576472|38162557|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
17018117|NCT00576472|38162558|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
17018118|NCT00576472|38162559|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
17018119|NCT00576472|38162560|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
16925394|NCT02985866|38068093|FG001|Overall Study|Poor CGM data|1|||
16925395|NCT02762981|38068118|FG000|Overall Study|Adverse Event|2|||
17018120|NCT00576472|38162561|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
17018121|NCT00576472|38162547|FG000|MPH Home Maintenance Phase|Side effects|0|||
17018122|NCT00576472|38162548|FG001|MPH Home Maintenance Phase|Side effects|0|||
16925396|NCT02762981|38068119|FG001|Overall Study|Adverse Event|3|||
16925397|NCT02762981|38068120|FG002|Overall Study|Adverse Event|1|||
16925398|NCT02762981|38068121|FG003|Overall Study|Adverse Event|1|||
16849111|NCT01479621|37794446|FG000|Treatment Period|Non-compliance to study drug|0|||
16849112|NCT01479621|37794447|FG001|Treatment Period|Non-compliance to study drug|1|||
16849113|NCT01479621|37794448|FG002|Treatment Period|Non-compliance to study drug|0|||
16925399|NCT02762981|38068122|FG004|Overall Study|Adverse Event|3|||
16925400|NCT02762981|38068118|FG000|Overall Study|Physician Decision|0|||
16925401|NCT02762981|38068119|FG001|Overall Study|Physician Decision|1|||
16925402|NCT02762981|38068120|FG002|Overall Study|Physician Decision|0|||
16925403|NCT02762981|38068121|FG003|Overall Study|Physician Decision|0|||
16925404|NCT02762981|38068122|FG004|Overall Study|Physician Decision|1|||
16925405|NCT02762981|38068118|FG000|Overall Study|Disease progression|11|||
16925406|NCT02762981|38068119|FG001|Overall Study|Disease progression|23|||
16925407|NCT02762981|38068120|FG002|Overall Study|Disease progression|4|||
16925408|NCT02762981|38068121|FG003|Overall Study|Disease progression|10|||
16849114|NCT01479621|37794449|FG003|Treatment Period|Non-compliance to study drug|0|||
16849115|NCT01479621|37794450|FG004|Treatment Period|Non-compliance to study drug|0|||
16849116|NCT01479621|37794451|FG005|Treatment Period|Non-compliance to study drug|0|||
16849117|NCT01479621|37794452|FG006|Treatment Period|Non-compliance to study drug|1|||
16849118|NCT01479621|37794446|FG000|Treatment Period|Protocol Violation|0|||
16849119|NCT01479621|37794447|FG001|Treatment Period|Protocol Violation|9|||
16849120|NCT01479621|37794448|FG002|Treatment Period|Protocol Violation|6|||
16849121|NCT01479621|37794449|FG003|Treatment Period|Protocol Violation|5|||
16849122|NCT01479621|37794450|FG004|Treatment Period|Protocol Violation|2|||
16849123|NCT01479621|37794451|FG005|Treatment Period|Protocol Violation|10|||
16925409|NCT02762981|38068122|FG004|Overall Study|Disease progression|1|||
16925410|NCT02762981|38068118|FG000|Overall Study|Enrolled not treated|1|||
16925411|NCT02762981|38068119|FG001|Overall Study|Enrolled not treated|5|||
16925412|NCT02762981|38068120|FG002|Overall Study|Enrolled not treated|0|||
16925413|NCT02762981|38068121|FG003|Overall Study|Enrolled not treated|2|||
16925414|NCT02762981|38068122|FG004|Overall Study|Enrolled not treated|0|||
16925415|NCT02762981|38068118|FG000|Overall Study|Other|2|||
16925416|NCT02762981|38068119|FG001|Overall Study|Other|3|||
16925417|NCT02762981|38068120|FG002|Overall Study|Other|1|||
16925418|NCT02762981|38068121|FG003|Overall Study|Other|0|||
16925419|NCT02762981|38068122|FG004|Overall Study|Other|0|||
16925420|NCT02762981|38068118|FG000|Overall Study|Missing|1|||
16925421|NCT02762981|38068119|FG001|Overall Study|Missing|0|||
16849124|NCT01479621|37794452|FG006|Treatment Period|Protocol Violation|6|||
16849125|NCT01479621|37794446|FG000|Treatment Period|Pregnancy|0|||
16849126|NCT01479621|37794447|FG001|Treatment Period|Pregnancy|0|||
16849127|NCT01479621|37794448|FG002|Treatment Period|Pregnancy|2|||
16849128|NCT01479621|37794449|FG003|Treatment Period|Pregnancy|0|||
17018123|NCT00576472|38162549|FG002|MPH Home Maintenance Phase|Side effects|0|||
17018124|NCT00576472|38162550|FG003|MPH Home Maintenance Phase|Side effects|0|||
17018125|NCT00576472|38162551|FG004|MPH Home Maintenance Phase|Side effects|0|||
17018126|NCT00576472|38162552|FG005|MPH Home Maintenance Phase|Side effects|0|||
17018127|NCT00576472|38162553|FG006|MPH Home Maintenance Phase|Side effects|0|||
17018128|NCT00576472|38162554|FG007|MPH Home Maintenance Phase|Side effects|0|||
17018129|NCT00576472|38162555|FG008|MPH Home Maintenance Phase|Side effects|0|||
17018130|NCT00576472|38162556|FG009|MPH Home Maintenance Phase|Side effects|0|||
17018131|NCT00576472|38162557|FG010|MPH Home Maintenance Phase|Side effects|0|||
17018132|NCT00576472|38162558|FG011|MPH Home Maintenance Phase|Side effects|0|||
17018133|NCT00576472|38162559|FG012|MPH Home Maintenance Phase|Side effects|0|||
17018134|NCT00576472|38162560|FG013|MPH Home Maintenance Phase|Side effects|0|||
17018135|NCT00576472|38162561|FG014|MPH Home Maintenance Phase|Side effects|8|||
17018136|NCT00576472|38162547|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018137|NCT00576472|38162548|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018138|NCT00576472|38162549|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018139|NCT00576472|38162550|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018140|NCT00576472|38162551|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018141|NCT00576472|38162552|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018142|NCT00576472|38162553|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018143|NCT00576472|38162554|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018144|NCT00576472|38162555|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018145|NCT00576472|38162556|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018146|NCT00576472|38162557|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018147|NCT00576472|38162558|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018148|NCT00576472|38162559|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018149|NCT00576472|38162560|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
17018150|NCT00576472|38162561|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
17018151|NCT00576472|38162547|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
16925422|NCT02762981|38068120|FG002|Overall Study|Missing|0|||
17018152|NCT00576472|38162548|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
17018153|NCT00576472|38162549|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
16849129|NCT01479621|37794450|FG004|Treatment Period|Pregnancy|0|||
16925423|NCT02762981|38068121|FG003|Overall Study|Missing|0|||
16925424|NCT02762981|38068122|FG004|Overall Study|Missing|0|||
16849130|NCT01479621|37794451|FG005|Treatment Period|Pregnancy|0|||
16849131|NCT01479621|37794452|FG006|Treatment Period|Pregnancy|0|||
16849132|NCT01479621|37794446|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
16849133|NCT01479621|37794447|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
16849134|NCT01479621|37794448|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
16849135|NCT01479621|37794449|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
16849136|NCT01479621|37794450|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
16849137|NCT01479621|37794451|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
16849138|NCT01479621|37794452|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
16849139|NCT01479621|37794446|FG000|Treatment Period|Lost to Follow-up|0|||
16925425|NCT02762981|38068118|FG000|Overall Study|Withdrawal by Subject|0|||
16925426|NCT02762981|38068119|FG001|Overall Study|Withdrawal by Subject|5|||
16925427|NCT02762981|38068120|FG002|Overall Study|Withdrawal by Subject|1|||
16925428|NCT02762981|38068121|FG003|Overall Study|Withdrawal by Subject|3|||
16925429|NCT02762981|38068122|FG004|Overall Study|Withdrawal by Subject|0|||
16925430|NCT02255435|38068162|FG000|Overall Study|Patient's Limited Time Availability|0|||
16925431|NCT02255435|38068163|FG001|Overall Study|Patient's Limited Time Availability|0|||
16925432|NCT02255435|38068164|FG002|Overall Study|Patient's Limited Time Availability|0|||
16925433|NCT02255435|38068165|FG003|Overall Study|Patient's Limited Time Availability|0|||
16925434|NCT02255435|38068166|FG004|Overall Study|Patient's Limited Time Availability|0|||
16925435|NCT02255435|38068167|FG005|Overall Study|Patient's Limited Time Availability|0|||
16925436|NCT02255435|38068168|FG006|Overall Study|Patient's Limited Time Availability|0|||
16925437|NCT02255435|38068169|FG007|Overall Study|Patient's Limited Time Availability|1|||
16925438|NCT02255435|38068170|FG008|Overall Study|Patient's Limited Time Availability|0|||
16925439|NCT02255435|38068171|FG009|Overall Study|Patient's Limited Time Availability|0|||
16925440|NCT02255435|38068162|FG000|Overall Study|Withdrawal by Subject|0|||
16925441|NCT02255435|38068163|FG001|Overall Study|Withdrawal by Subject|0|||
16925442|NCT02255435|38068164|FG002|Overall Study|Withdrawal by Subject|0|||
16925443|NCT02255435|38068165|FG003|Overall Study|Withdrawal by Subject|0|||
16925444|NCT02255435|38068166|FG004|Overall Study|Withdrawal by Subject|0|||
16925445|NCT02255435|38068167|FG005|Overall Study|Withdrawal by Subject|0|||
16925446|NCT02255435|38068168|FG006|Overall Study|Withdrawal by Subject|0|||
16925447|NCT02255435|38068169|FG007|Overall Study|Withdrawal by Subject|0|||
16925448|NCT02255435|38068170|FG008|Overall Study|Withdrawal by Subject|1|||
16925449|NCT02255435|38068171|FG009|Overall Study|Withdrawal by Subject|4|||
16925450|NCT02255435|38068162|FG000|Overall Study|Administrative reasons|0|||
16925451|NCT02255435|38068163|FG001|Overall Study|Administrative reasons|0|||
16925452|NCT02255435|38068164|FG002|Overall Study|Administrative reasons|0|||
16925453|NCT02255435|38068165|FG003|Overall Study|Administrative reasons|0|||
16925454|NCT02255435|38068166|FG004|Overall Study|Administrative reasons|0|||
16925455|NCT02255435|38068167|FG005|Overall Study|Administrative reasons|0|||
16925456|NCT02255435|38068168|FG006|Overall Study|Administrative reasons|0|||
16925457|NCT02255435|38068169|FG007|Overall Study|Administrative reasons|0|||
16925458|NCT02255435|38068170|FG008|Overall Study|Administrative reasons|0|||
16925459|NCT02255435|38068171|FG009|Overall Study|Administrative reasons|2|||
16925460|NCT01902173|38068199|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
16925461|NCT01902173|38068200|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16925462|NCT01902173|38068201|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16925463|NCT01902173|38068202|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16925464|NCT01902173|38068203|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16849140|NCT01479621|37794447|FG001|Treatment Period|Lost to Follow-up|0|||
16849141|NCT01479621|37794448|FG002|Treatment Period|Lost to Follow-up|1|||
16849142|NCT01479621|37794449|FG003|Treatment Period|Lost to Follow-up|0|||
16849143|NCT01479621|37794450|FG004|Treatment Period|Lost to Follow-up|2|||
16849144|NCT01479621|37794451|FG005|Treatment Period|Lost to Follow-up|2|||
16849145|NCT01479621|37794452|FG006|Treatment Period|Lost to Follow-up|1|||
16849146|NCT01479621|37794446|FG000|Treatment Period|Met stopping criteria|0|||
16849147|NCT01479621|37794447|FG001|Treatment Period|Met stopping criteria|8|||
16849148|NCT01479621|37794448|FG002|Treatment Period|Met stopping criteria|7|||
16849149|NCT01479621|37794449|FG003|Treatment Period|Met stopping criteria|4|||
16849150|NCT01479621|37794450|FG004|Treatment Period|Met stopping criteria|9|||
16849151|NCT01479621|37794451|FG005|Treatment Period|Met stopping criteria|20|||
16849152|NCT01479621|37794452|FG006|Treatment Period|Met stopping criteria|6|||
16849153|NCT01479465|37794500|FG000|Overall Study|Disease Progression|9|||
16849154|NCT01479465|37794501|FG001|Overall Study|Disease Progression|61|||
16849155|NCT01479465|37794502|FG002|Overall Study|Disease Progression|65|||
16849156|NCT01479465|37794503|FG003|Overall Study|Disease Progression|70|||
16849157|NCT01479465|37794500|FG000|Overall Study|Study Discontinued by Sponsor|0|||
16849158|NCT01479465|37794501|FG001|Overall Study|Study Discontinued by Sponsor|7|||
16925465|NCT01902173|38068204|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16925466|NCT01902173|38068199|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
16925467|NCT01902173|38068200|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16925468|NCT01902173|38068201|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16925469|NCT01902173|38068202|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16925470|NCT01902173|38068203|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16925471|NCT01902173|38068204|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16925472|NCT01902173|38068199|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16925473|NCT01902173|38068200|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
16925474|NCT01902173|38068201|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16925475|NCT01902173|38068202|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16925476|NCT01902173|38068203|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16925477|NCT01902173|38068204|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16925478|NCT01902173|38068199|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16849159|NCT01479465|37794502|FG002|Overall Study|Study Discontinued by Sponsor|5|||
16849160|NCT01479465|37794503|FG003|Overall Study|Study Discontinued by Sponsor|3|||
16849161|NCT01479465|37794500|FG000|Overall Study|Adverse Event|0|||
16849162|NCT01479465|37794501|FG001|Overall Study|Adverse Event|3|||
16849163|NCT01479465|37794502|FG002|Overall Study|Adverse Event|6|||
16849164|NCT01479465|37794503|FG003|Overall Study|Adverse Event|4|||
16849165|NCT01479465|37794500|FG000|Overall Study|Investigator Discretion|1|||
16849166|NCT01479465|37794501|FG001|Overall Study|Investigator Discretion|4|||
16925479|NCT01902173|38068200|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
16925480|NCT01902173|38068201|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16925481|NCT01902173|38068202|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16925482|NCT01902173|38068203|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16925483|NCT01902173|38068204|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16925484|NCT01902173|38068199|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16925485|NCT01902173|38068200|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
16925486|NCT01902173|38068201|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16925487|NCT01902173|38068202|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16925488|NCT01902173|38068203|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16925489|NCT01902173|38068204|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16925490|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16925491|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16925492|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
16925493|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16925494|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16925495|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16925496|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16925497|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16925498|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
16925499|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16925500|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16925501|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16925502|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16925503|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16925504|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16849167|NCT01479465|37794502|FG002|Overall Study|Investigator Discretion|2|||
16849168|NCT01479465|37794503|FG003|Overall Study|Investigator Discretion|4|||
16849169|NCT01479465|37794500|FG000|Overall Study|Subject Request|1|||
16849170|NCT01479465|37794501|FG001|Overall Study|Subject Request|3|||
16849171|NCT01479465|37794502|FG002|Overall Study|Subject Request|4|||
16849172|NCT01479465|37794503|FG003|Overall Study|Subject Request|2|||
16849173|NCT01479465|37794500|FG000|Overall Study|Subject Withdrew Consent|0|||
16849174|NCT01479465|37794501|FG001|Overall Study|Subject Withdrew Consent|5|||
16849175|NCT01479465|37794502|FG002|Overall Study|Subject Withdrew Consent|2|||
16849176|NCT01479465|37794503|FG003|Overall Study|Subject Withdrew Consent|1|||
16849177|NCT01479465|37794500|FG000|Overall Study|Protocol Violation|0|||
16849178|NCT01479465|37794501|FG001|Overall Study|Protocol Violation|1|||
16925505|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
16925506|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16925507|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16849179|NCT01479465|37794502|FG002|Overall Study|Protocol Violation|1|||
16849180|NCT01479465|37794503|FG003|Overall Study|Protocol Violation|0|||
16849181|NCT01479465|37794500|FG000|Overall Study|Death|0|||
16849182|NCT01479465|37794501|FG001|Overall Study|Death|0|||
16849183|NCT01479465|37794502|FG002|Overall Study|Death|0|||
16849184|NCT01479465|37794503|FG003|Overall Study|Death|1|||
16849185|NCT01479465|37794500|FG000|Overall Study|Lost to Follow-up|0|||
16849186|NCT01479465|37794501|FG001|Overall Study|Lost to Follow-up|0|||
16849187|NCT01479465|37794502|FG002|Overall Study|Lost to Follow-up|1|||
16849188|NCT01479465|37794503|FG003|Overall Study|Lost to Follow-up|0|||
16849189|NCT01503021|37794567|FG000|Overall Study|Adverse Event|7|||
16849190|NCT01503021|37794568|FG001|Overall Study|Adverse Event|6|||
16849191|NCT01503021|37794567|FG000|Overall Study|Death|0|||
16925508|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16925509|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16925510|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16925511|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
16925512|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16925513|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16925514|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16925515|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16925516|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16925517|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16925518|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
16925519|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16925520|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16925521|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16925522|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16925523|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16925524|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
16925525|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16925526|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16925527|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16925528|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16925529|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16925530|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16925531|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
16925532|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16925533|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
17018154|NCT00576472|38162550|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
17018155|NCT00576472|38162551|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
16849192|NCT01503021|37794568|FG001|Overall Study|Death|2|||
16849193|NCT01503021|37794567|FG000|Overall Study|Lost to Follow-up|2|||
16849194|NCT01503021|37794568|FG001|Overall Study|Lost to Follow-up|0|||
16849195|NCT01503021|37794567|FG000|Overall Study|Physician Decision|3|||
16849196|NCT01503021|37794568|FG001|Overall Study|Physician Decision|0|||
16849197|NCT01503021|37794567|FG000|Overall Study|Protocol Violation|1|||
16849198|NCT01503021|37794568|FG001|Overall Study|Protocol Violation|3|||
16849199|NCT01503021|37794567|FG000|Overall Study|Withdrawal by Subject|9|||
16849200|NCT01503021|37794568|FG001|Overall Study|Withdrawal by Subject|8|||
16849201|NCT01503021|37794567|FG000|Overall Study|Moved, received transplant, etc.|5|||
16849202|NCT01503021|37794568|FG001|Overall Study|Moved, received transplant, etc.|7|||
16849203|NCT01531725|37794579|FG000|Overall Study|Protocol Violation|5|||
16849204|NCT01478373|37794583|FG000|Treatment Phase|Protocol Violation|1|||
16849205|NCT01478373|37794583|FG000|Survival Phase|Adverse Event|8|||
16849206|NCT01478373|37794583|FG000|Survival Phase|Protocol Violation|1|||
16849207|NCT01478373|37794583|FG000|Survival Phase|crossover to another study|2|||
16849208|NCT01478373|37794583|FG000|Survival Phase|Progressive Disease|27|||
16849209|NCT01502709|37794589|FG000|Overall Study|Lost to Follow-up|4|||
16849210|NCT01502709|37794590|FG001|Overall Study|Lost to Follow-up|0|||
16849211|NCT01477749|37794597|FG000|Overall Study|Physician Decision|4|||
16849212|NCT01502631|37794627|FG000|Overall Study|Adverse Event|5|||
16849213|NCT01502631|37794628|FG001|Overall Study|Adverse Event|8|||
16849214|NCT01502631|37794627|FG000|Overall Study|Lost to Follow-up|2|||
16849215|NCT01502631|37794628|FG001|Overall Study|Lost to Follow-up|2|||
16849216|NCT01502631|37794627|FG000|Overall Study|Participant withdrew consent|2|||
16849217|NCT01502631|37794628|FG001|Overall Study|Participant withdrew consent|4|||
16849218|NCT01502631|37794627|FG000|Overall Study|Participant non-compliant|1|||
16849219|NCT01502631|37794628|FG001|Overall Study|Participant non-compliant|0|||
16849220|NCT01502631|37794627|FG000|Overall Study|Investigator's decision|0|||
16849221|NCT01502631|37794628|FG001|Overall Study|Investigator's decision|1|||
16849222|NCT01502631|37794627|FG000|Overall Study|Other|10|||
16849223|NCT01502631|37794628|FG001|Overall Study|Other|5|||
16849224|NCT01475721|37794688|FG000|Overall Study|Death|3|||
16849225|NCT01475721|37794689|FG001|Overall Study|Death|6|||
16849226|NCT01475721|37794688|FG000|Overall Study|Withdrawal by Subject|8|||
16849227|NCT01475721|37794689|FG001|Overall Study|Withdrawal by Subject|8|||
16849228|NCT01530087|37794713|FG000|Overall Study|Physician Decision|2|||
16849229|NCT01475487|37794731|FG000|Overall Study|had to leave early for personal reasons|2|||
16849230|NCT01475487|37794732|FG001|Overall Study|had to leave early for personal reasons|1|||
16849231|NCT01475331|37794740|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
16849232|NCT01475331|37794741|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
16849233|NCT01475331|37794740|FG000|Overall Study|excessive main duct communication|1|||
16849234|NCT01475331|37794741|FG001|Overall Study|excessive main duct communication|1|||
16849235|NCT01475331|37794740|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
16849236|NCT01475331|37794741|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
16925534|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16925535|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16925536|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16925537|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
16925538|NCT01902173|38068199|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16925539|NCT01902173|38068200|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16925540|NCT01902173|38068201|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16925541|NCT01902173|38068202|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16925542|NCT01902173|38068203|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16925543|NCT01902173|38068204|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
16925544|NCT00640133|38068236|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
16925545|NCT00640133|38068237|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
16925546|NCT00640133|38068236|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
16925547|NCT00640133|38068237|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
16849237|NCT01475331|37794740|FG000|Overall Study|Sign of malignancy during the procedure|2|||
16849238|NCT01475331|37794741|FG001|Overall Study|Sign of malignancy during the procedure|0|||
16849239|NCT01475331|37794740|FG000|Overall Study|cyst found to be prohibitively small|0|||
16849240|NCT01475331|37794741|FG001|Overall Study|cyst found to be prohibitively small|1|||
16849241|NCT01500213|37794749|FG000|Overall Study|Adverse Event|35|||
16849242|NCT01500213|37794750|FG001|Overall Study|Adverse Event|35|||
16925548|NCT00640133|38068236|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
16925549|NCT00640133|38068237|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
16925550|NCT00001832|38068281|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
16925551|NCT00001832|38068282|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
16925552|NCT00001832|38068283|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
16925553|NCT00001832|38068284|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
16925554|NCT00001832|38068285|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
16925555|NCT00001832|38068286|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
16925556|NCT00001832|38068287|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
16925557|NCT00001832|38068288|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
16925558|NCT00001832|38068289|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
16925559|NCT00001832|38068290|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
16925560|NCT00001832|38068291|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
16925561|NCT00001832|38068292|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
16925562|NCT00001832|38068293|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
16925563|NCT00001832|38068294|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
16925564|NCT00001832|38068295|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
16925565|NCT00001832|38068281|FG000|Treatment Period|Death during treatment|0|||
16925566|NCT00001832|38068282|FG001|Treatment Period|Death during treatment|0|||
16925567|NCT00001832|38068283|FG002|Treatment Period|Death during treatment|0|||
16925568|NCT00001832|38068284|FG003|Treatment Period|Death during treatment|0|||
16925569|NCT00001832|38068285|FG004|Treatment Period|Death during treatment|0|||
16925570|NCT00001832|38068286|FG005|Treatment Period|Death during treatment|1|||
16925571|NCT00001832|38068287|FG006|Treatment Period|Death during treatment|0|||
16925572|NCT00001832|38068288|FG007|Treatment Period|Death during treatment|0|||
16925573|NCT00001832|38068289|FG008|Treatment Period|Death during treatment|0|||
16925574|NCT00001832|38068290|FG009|Treatment Period|Death during treatment|0|||
16925575|NCT00001832|38068291|FG010|Treatment Period|Death during treatment|0|||
16925576|NCT00001832|38068292|FG011|Treatment Period|Death during treatment|0|||
16925577|NCT00001832|38068293|FG012|Treatment Period|Death during treatment|0|||
16925578|NCT00001832|38068294|FG013|Treatment Period|Death during treatment|0|||
16925579|NCT00001832|38068295|FG014|Treatment Period|Death during treatment|0|||
16925580|NCT00001832|38068281|FG000|Treatment Period|Not treated|0|||
16925581|NCT00001832|38068282|FG001|Treatment Period|Not treated|0|||
16925582|NCT00001832|38068283|FG002|Treatment Period|Not treated|0|||
16925583|NCT00001832|38068284|FG003|Treatment Period|Not treated|0|||
16925584|NCT00001832|38068285|FG004|Treatment Period|Not treated|0|||
16925585|NCT00001832|38068286|FG005|Treatment Period|Not treated|0|||
16925586|NCT00001832|38068287|FG006|Treatment Period|Not treated|0|||
17018156|NCT00576472|38162552|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
16849243|NCT01500213|37794749|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
16849244|NCT01500213|37794750|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
16849245|NCT01500213|37794749|FG000|Overall Study|Withdrawal by Subject|28|||
16849246|NCT01500213|37794750|FG001|Overall Study|Withdrawal by Subject|37|||
16925587|NCT00001832|38068288|FG007|Treatment Period|Not treated|1|||
16925588|NCT00001832|38068289|FG008|Treatment Period|Not treated|0|||
16925589|NCT00001832|38068290|FG009|Treatment Period|Not treated|0|||
16925590|NCT00001832|38068291|FG010|Treatment Period|Not treated|0|||
16925591|NCT00001832|38068292|FG011|Treatment Period|Not treated|0|||
16925592|NCT00001832|38068293|FG012|Treatment Period|Not treated|0|||
16925593|NCT00001832|38068294|FG013|Treatment Period|Not treated|0|||
16925594|NCT00001832|38068295|FG014|Treatment Period|Not treated|0|||
16925595|NCT01349816|38068534|FG000|Overall Study|Withdrawal by Subject|4|||
16925596|NCT01349816|38068534|FG000|Overall Study|Physician Decision|1|||
16925597|NCT01349816|38068534|FG000|Overall Study|Adverse Event|14|||
16925598|NCT01349816|38068534|FG000|Overall Study|Lost to Follow-up|2|||
16925599|NCT01349816|38068534|FG000|Overall Study|Protocol Violation|1|||
16925600|NCT01349816|38068534|FG000|Overall Study|Protocol-specified criteria|8|||
16925601|NCT02971137|38068650|FG000|Overall Study|Lost to Follow-up|44|||
16925602|NCT02971137|38068651|FG001|Overall Study|Lost to Follow-up|56|||
16925603|NCT05201807|38068722|FG000|Overall Study|Adverse Event|1|||
16925604|NCT05201807|38068722|FG000|Overall Study|COVID-19 Related|1|||
16925605|NCT04828707|38068728|FG000|Overall Study|Lost to Follow-up|3|||
16925606|NCT04828707|38068729|FG001|Overall Study|Lost to Follow-up|2|||
16925607|NCT04828707|38068728|FG000|Overall Study|Withdrawal by Subject|2|||
16925608|NCT04828707|38068729|FG001|Overall Study|Withdrawal by Subject|1|||
16925609|NCT04629534|38068748|FG000|Overall Study|Physician Decision|1|||
16925610|NCT04629534|38068749|FG001|Overall Study|Physician Decision|0|||
16925611|NCT04629534|38068748|FG000|Overall Study|Protocol Violation|0|||
16925612|NCT04629534|38068749|FG001|Overall Study|Protocol Violation|2|||
16925613|NCT04481191|38068761|FG000|Overall Study|Withdrawn by parent/guardian|15|||
16925614|NCT04481191|38068762|FG001|Overall Study|Withdrawn by parent/guardian|10|||
16925615|NCT03695185|38068785|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
16925616|NCT03695185|38068785|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
16925617|NCT03695185|38068785|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
17198593|NCT00103285|38352276|FG003|Response Assignment|Ineligible|2|||
17198594|NCT00103285|38352277|FG004|Response Assignment|Ineligible|0|||
17198595|NCT00103285|38352278|FG005|Response Assignment|Ineligible|3|||
17198596|NCT00103285|38352279|FG006|Response Assignment|Ineligible|1|||
17198597|NCT00103285|38352280|FG007|Response Assignment|Ineligible|5|||
17198598|NCT00103285|38352273|FG000|Response Assignment|Refusal|0|||
17198599|NCT00103285|38352274|FG001|Response Assignment|Refusal|53|||
17198600|NCT00103285|38352275|FG002|Response Assignment|Refusal|5|||
17198601|NCT00103285|38352276|FG003|Response Assignment|Refusal|3|||
17198602|NCT00103285|38352277|FG004|Response Assignment|Refusal|25|||
16849247|NCT01500213|37794749|FG000|Overall Study|Death|7|||
16849248|NCT01500213|37794750|FG001|Overall Study|Death|3|||
16849249|NCT01500213|37794749|FG000|Overall Study|Disease Progression|13|||
16849250|NCT01500213|37794750|FG001|Overall Study|Disease Progression|21|||
16849251|NCT01500213|37794749|FG000|Overall Study|Protocol Violation|19|||
16849252|NCT01500213|37794750|FG001|Overall Study|Protocol Violation|19|||
16849253|NCT01500213|37794749|FG000|Overall Study|Physician Decision|12|||
16849254|NCT01500213|37794750|FG001|Overall Study|Physician Decision|10|||
16849255|NCT01500213|37794749|FG000|Overall Study|Lack of Efficacy|9|||
17198603|NCT00103285|38352278|FG005|Response Assignment|Refusal|15|||
17198604|NCT00103285|38352279|FG006|Response Assignment|Refusal|30|||
16849256|NCT01500213|37794750|FG001|Overall Study|Lack of Efficacy|7|||
16849257|NCT01500213|37794749|FG000|Overall Study|Lost to Follow-up|3|||
16849258|NCT01500213|37794750|FG001|Overall Study|Lost to Follow-up|6|||
16849259|NCT01500213|37794749|FG000|Overall Study|Other Reasons|7|||
16849260|NCT01500213|37794750|FG001|Overall Study|Other Reasons|5|||
16849261|NCT01475253|37794780|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
16849262|NCT01475253|37794781|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
16849263|NCT01475253|37794782|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
16849264|NCT01475253|37794783|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
16849265|NCT01475253|37794780|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
16849266|NCT01475253|37794781|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
16849267|NCT01475253|37794782|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
16849268|NCT01475253|37794783|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
16849269|NCT01500135|37794841|FG000|Overall Study|Withdrawal of Consent|4|||
16849270|NCT01500135|37794842|FG001|Overall Study|Withdrawal of Consent|0|||
16849271|NCT01500135|37794841|FG000|Overall Study|Lost to Follow-up|6|||
16849272|NCT01500135|37794842|FG001|Overall Study|Lost to Follow-up|4|||
16849273|NCT01500135|37794841|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
16849274|NCT01500135|37794842|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
16849275|NCT01500135|37794841|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
16849276|NCT01500135|37794842|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
16849277|NCT01500135|37794841|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
16849278|NCT01500135|37794842|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
16849279|NCT01500135|37794841|FG000|Overall Study|Participant was a Safety Concern|1|||
16849280|NCT01500135|37794842|FG001|Overall Study|Participant was a Safety Concern|0|||
16849281|NCT01500135|37794841|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
16849282|NCT01500135|37794842|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
16849283|NCT01475097|37794854|FG000|Overall Study|Protocol Violation|1|||
16925618|NCT03695185|38068785|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
17198605|NCT00103285|38352280|FG007|Response Assignment|Refusal|10|||
16849284|NCT01475097|37794855|FG001|Overall Study|Protocol Violation|1|||
16849285|NCT01529385|37794863|FG000|Overall Study|Lost to Follow-up|2|||
16849286|NCT01529385|37794864|FG001|Overall Study|Lost to Follow-up|1|||
16849287|NCT01474551|37794870|FG000|Overall Study|Death|1|||
16849288|NCT01500057|37794905|FG000|Overall Study|Lost to Follow-up|6|||
16849289|NCT01500057|37794906|FG001|Overall Study|Lost to Follow-up|4|||
16849290|NCT01499667|37794924|FG000|Overall Study|administrative problems|4|||
16849291|NCT01499667|37794925|FG001|Overall Study|administrative problems|5|||
16849292|NCT01499667|37794926|FG002|Overall Study|administrative problems|5|||
16849293|NCT01499667|37794924|FG000|Overall Study|Protocol Violation|1|||
16925619|NCT03695185|38068785|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
16925620|NCT03695185|38068785|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
16925621|NCT03635983|38068796|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
16925622|NCT03635983|38068797|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
16925623|NCT03635983|38068796|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
16925624|NCT03635983|38068797|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
16925625|NCT03635983|38068796|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16925626|NCT03635983|38068797|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16925627|NCT03635983|38068796|FG000|Pre-Treatment Period|Other reasons|1|||
16925628|NCT03635983|38068797|FG001|Pre-Treatment Period|Other reasons|2|||
16925629|NCT03635983|38068796|FG000|Pre-Treatment Period|Disease Progression|0|||
16925630|NCT03635983|38068797|FG001|Pre-Treatment Period|Disease Progression|1|||
16925631|NCT03635983|38068796|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
16925632|NCT03635983|38068797|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
16925633|NCT03635983|38068796|FG000|Treatment Period|Completed treatment period|13|||
16925634|NCT03635983|38068797|FG001|Treatment Period|Completed treatment period|20|||
16925635|NCT03635983|38068796|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
16925636|NCT03635983|38068797|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
16925637|NCT03635983|38068796|FG000|Treatment Period|Withdrawal by Subject|2|||
16925638|NCT03635983|38068797|FG001|Treatment Period|Withdrawal by Subject|4|||
16925639|NCT03635983|38068796|FG000|Treatment Period|Death|3|||
16925640|NCT03635983|38068797|FG001|Treatment Period|Death|4|||
16925641|NCT03635983|38068796|FG000|Treatment Period|Poor/Non-compliance|1|||
16925642|NCT03635983|38068797|FG001|Treatment Period|Poor/Non-compliance|0|||
16925643|NCT03635983|38068796|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
16925644|NCT03635983|38068797|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
16925645|NCT03635983|38068796|FG000|Treatment Period|Other reasons|5|||
16925646|NCT03635983|38068797|FG001|Treatment Period|Other reasons|2|||
16925647|NCT03635983|38068796|FG000|Treatment Period|Disease progression|184|||
16925648|NCT03635983|38068797|FG001|Treatment Period|Disease progression|168|||
16849294|NCT01499667|37794925|FG001|Overall Study|Protocol Violation|3|||
16849295|NCT01499667|37794926|FG002|Overall Study|Protocol Violation|2|||
16849296|NCT01499667|37794924|FG000|Overall Study|Adverse Event|0|||
16849297|NCT01499667|37794925|FG001|Overall Study|Adverse Event|2|||
16849298|NCT01499667|37794926|FG002|Overall Study|Adverse Event|2|||
16849299|NCT01499667|37794924|FG000|Overall Study|Withdrawal by Subject|2|||
16925649|NCT03635983|38068796|FG000|Treatment Period|Study drug toxicity|26|||
16925650|NCT03635983|38068797|FG001|Treatment Period|Study drug toxicity|29|||
16925651|NCT03635983|38068796|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
16849300|NCT01499667|37794925|FG001|Overall Study|Withdrawal by Subject|1|||
16849301|NCT01499667|37794926|FG002|Overall Study|Withdrawal by Subject|1|||
16849302|NCT01499667|37794924|FG000|Overall Study|Lack of Efficacy|2|||
16849303|NCT01499667|37794925|FG001|Overall Study|Lack of Efficacy|0|||
16849304|NCT01499667|37794926|FG002|Overall Study|Lack of Efficacy|0|||
16849305|NCT01499511|37794936|FG000|Overall Study|Death|1|||
16849306|NCT01499511|37794937|FG001|Overall Study|Death|0|||
16849307|NCT01474317|37794957|FG000|Overall Study|Adverse Event|1|||
16849308|NCT01474317|37794957|FG000|Overall Study|Subject ineligible for study|1|||
16849309|NCT01499355|37795053|FG000|Run-In Period|Study Termination|15|||
16925652|NCT03635983|38068797|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
16925653|NCT03635983|38068796|FG000|Treatment Period|Maximum clinical benefit|3|||
16925654|NCT03635983|38068797|FG001|Treatment Period|Maximum clinical benefit|2|||
16925655|NCT03596164|38068805|FG000|Overall Study|Adverse Event|0|||
17018157|NCT00576472|38162553|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
17018158|NCT00576472|38162554|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
17018159|NCT00576472|38162555|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
17018160|NCT00576472|38162556|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
17018161|NCT00576472|38162557|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
16849310|NCT01499355|37795054|FG001|Run-In Period|Study Termination|0|||
16925656|NCT03596164|38068806|FG001|Overall Study|Adverse Event|1|||
16849311|NCT01499355|37795055|FG002|Run-In Period|Study Termination|0|||
16849312|NCT01499355|37795056|FG003|Run-In Period|Study Termination|0|||
16849313|NCT01499355|37795053|FG000|Run-In Period|Other|3|||
16849314|NCT01499355|37795054|FG001|Run-In Period|Other|0|||
16925657|NCT03596164|38068805|FG000|Overall Study|Death|1|||
16925658|NCT03596164|38068806|FG001|Overall Study|Death|0|||
16849315|NCT01499355|37795055|FG002|Run-In Period|Other|0|||
16849316|NCT01499355|37795056|FG003|Run-In Period|Other|0|||
16849317|NCT01499355|37795053|FG000|Run-In Period|Death|2|||
16925659|NCT03547908|38068816|FG000|Overall Study|Still On Study|115|||
16925660|NCT03547908|38068817|FG001|Overall Study|Still On Study|118|||
16925661|NCT03547908|38068816|FG000|Overall Study|Lost to Follow-up|2|||
16925662|NCT03547908|38068817|FG001|Overall Study|Lost to Follow-up|2|||
16849318|NCT01499355|37795054|FG001|Run-In Period|Death|0|||
16849319|NCT01499355|37795055|FG002|Run-In Period|Death|0|||
16849320|NCT01499355|37795056|FG003|Run-In Period|Death|0|||
16849321|NCT01499355|37795053|FG000|Run-In Period|Investigator Decision|2|||
16849322|NCT01499355|37795054|FG001|Run-In Period|Investigator Decision|0|||
16849323|NCT01499355|37795055|FG002|Run-In Period|Investigator Decision|0|||
16849324|NCT01499355|37795056|FG003|Run-In Period|Investigator Decision|0|||
16849325|NCT01499355|37795053|FG000|Run-In Period|Consent Withdrawn|1|||
16849326|NCT01499355|37795054|FG001|Run-In Period|Consent Withdrawn|0|||
16849327|NCT01499355|37795055|FG002|Run-In Period|Consent Withdrawn|0|||
16849328|NCT01499355|37795056|FG003|Run-In Period|Consent Withdrawn|0|||
16849329|NCT01499355|37795053|FG000|Run-In Period|Adverse Event|8|||
16849330|NCT01499355|37795054|FG001|Run-In Period|Adverse Event|0|||
16925663|NCT03547908|38068816|FG000|Overall Study|Withdrew Consent|2|||
16925664|NCT03547908|38068817|FG001|Overall Study|Withdrew Consent|1|||
16925665|NCT03547908|38068816|FG000|Overall Study|Adverse Event|1|||
16849331|NCT01499355|37795055|FG002|Run-In Period|Adverse Event|0|||
16849332|NCT01499355|37795056|FG003|Run-In Period|Adverse Event|0|||
16849333|NCT01499355|37795053|FG000|Double-Blind Period|Adverse Event|0|||
16849334|NCT01499355|37795054|FG001|Double-Blind Period|Adverse Event|2|||
16849335|NCT01499355|37795055|FG002|Double-Blind Period|Adverse Event|3|||
16849336|NCT01499355|37795056|FG003|Double-Blind Period|Adverse Event|2|||
16849337|NCT01499355|37795053|FG000|Double-Blind Period|Study Termination|0|||
16849338|NCT01499355|37795054|FG001|Double-Blind Period|Study Termination|18|||
16849339|NCT01499355|37795055|FG002|Double-Blind Period|Study Termination|16|||
16849340|NCT01499355|37795056|FG003|Double-Blind Period|Study Termination|14|||
16849341|NCT01499355|37795053|FG000|Double-Blind Period|Other|0|||
16849342|NCT01499355|37795054|FG001|Double-Blind Period|Other|1|||
16925666|NCT03547908|38068817|FG001|Overall Study|Adverse Event|0|||
16849343|NCT01499355|37795055|FG002|Double-Blind Period|Other|2|||
16849344|NCT01499355|37795056|FG003|Double-Blind Period|Other|2|||
16849345|NCT01499355|37795053|FG000|Double-Blind Period|Death|0|||
16849346|NCT01499355|37795054|FG001|Double-Blind Period|Death|1|||
16925667|NCT03547908|38068816|FG000|Overall Study|Death|1|||
16925668|NCT03547908|38068817|FG001|Overall Study|Death|0|||
16925669|NCT03547908|38068816|FG000|Overall Study|Investigator's Discretion|0|||
16849347|NCT01499355|37795055|FG002|Double-Blind Period|Death|0|||
16849348|NCT01499355|37795056|FG003|Double-Blind Period|Death|0|||
16849349|NCT01499355|37795053|FG000|Double-Blind Period|Investigator Decision|0|||
16849350|NCT01499355|37795054|FG001|Double-Blind Period|Investigator Decision|0|||
16849351|NCT01499355|37795055|FG002|Double-Blind Period|Investigator Decision|3|||
16849352|NCT01499355|37795056|FG003|Double-Blind Period|Investigator Decision|3|||
16849353|NCT01499355|37795053|FG000|Double-Blind Period|Consent Withdrawn|0|||
16849354|NCT01499355|37795054|FG001|Double-Blind Period|Consent Withdrawn|0|||
16849355|NCT01499355|37795055|FG002|Double-Blind Period|Consent Withdrawn|1|||
16849356|NCT01499355|37795056|FG003|Double-Blind Period|Consent Withdrawn|2|||
16849357|NCT01499355|37795053|FG000|Double-Blind Period|Lost to Follow-up|0|||
16849358|NCT01499355|37795054|FG001|Double-Blind Period|Lost to Follow-up|1|||
16849359|NCT01499355|37795055|FG002|Double-Blind Period|Lost to Follow-up|0|||
16849360|NCT01499355|37795056|FG003|Double-Blind Period|Lost to Follow-up|0|||
16849361|NCT01474239|37795077|FG000|Overall Study|Disease Progression|37|||
16849362|NCT01474239|37795078|FG001|Overall Study|Disease Progression|25|||
16925670|NCT03547908|38068817|FG001|Overall Study|Investigator's Discretion|1|||
16925671|NCT03547908|38068816|FG000|Overall Study|Randomized But Never Treated|1|||
17198606|NCT00103285|38352273|FG000|Response Assignment|Other|0|||
16849363|NCT01474239|37795077|FG000|Overall Study|Adverse Event|12|||
16849364|NCT01474239|37795078|FG001|Overall Study|Adverse Event|3|||
16849365|NCT01474239|37795077|FG000|Overall Study|Withdrawal by Subject|1|||
16849366|NCT01474239|37795078|FG001|Overall Study|Withdrawal by Subject|2|||
16849367|NCT01474239|37795077|FG000|Overall Study|Death|1|||
16849368|NCT01474239|37795078|FG001|Overall Study|Death|1|||
16925672|NCT03547908|38068817|FG001|Overall Study|Randomized But Never Treated|0|||
16925673|NCT03476798|38068823|FG000|Overall Study|Death|1|||
16925674|NCT03476798|38068823|FG000|Overall Study|Withdrawal by Subject|2|||
16925675|NCT03476798|38068823|FG000|Overall Study|Protocol Violation|2|||
16925676|NCT03412565|38068831|FG000|Overall Study|Other|0|||
16925677|NCT03412565|38068832|FG001|Overall Study|Other|0|||
16925678|NCT03412565|38068833|FG002|Overall Study|Other|0|||
16925679|NCT03412565|38068834|FG003|Overall Study|Other|3|||
16925680|NCT03412565|38068831|FG000|Overall Study|Withdrawal by Subject|0|||
16925681|NCT03412565|38068832|FG001|Overall Study|Withdrawal by Subject|0|||
16925682|NCT03412565|38068833|FG002|Overall Study|Withdrawal by Subject|1|||
16849369|NCT01474239|37795077|FG000|Overall Study|Clinical Disease Progression|7|||
16849370|NCT01474239|37795078|FG001|Overall Study|Clinical Disease Progression|1|||
16849371|NCT01474239|37795077|FG000|Overall Study|Withdrawal for Economic Reason|1|||
16849372|NCT01474239|37795078|FG001|Overall Study|Withdrawal for Economic Reason|0|||
16849373|NCT01473381|37795088|FG000|Overall Study|Adverse Event|8|||
16849374|NCT01473381|37795089|FG001|Overall Study|Adverse Event|20|||
16849375|NCT01473381|37795090|FG002|Overall Study|Adverse Event|25|||
16849376|NCT01473381|37795091|FG003|Overall Study|Adverse Event|17|||
16849377|NCT01473381|37795088|FG000|Overall Study|Insufficient Therapeutic Response|10|||
16849378|NCT01473381|37795089|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16849379|NCT01473381|37795090|FG002|Overall Study|Insufficient Therapeutic Response|2|||
16849380|NCT01473381|37795091|FG003|Overall Study|Insufficient Therapeutic Response|3|||
16849381|NCT01473381|37795088|FG000|Overall Study|Protocol Violation|17|||
16849382|NCT01473381|37795089|FG001|Overall Study|Protocol Violation|23|||
16925683|NCT03412565|38068834|FG003|Overall Study|Withdrawal by Subject|5|||
16925684|NCT03412565|38068831|FG000|Overall Study|Physician Decision|0|||
16925685|NCT03412565|38068832|FG001|Overall Study|Physician Decision|1|||
16925686|NCT03412565|38068833|FG002|Overall Study|Physician Decision|0|||
16925687|NCT03412565|38068834|FG003|Overall Study|Physician Decision|1|||
16925688|NCT03412565|38068831|FG000|Overall Study|Death|1|||
16925689|NCT03412565|38068832|FG001|Overall Study|Death|2|||
16925690|NCT03412565|38068833|FG002|Overall Study|Death|2|||
16925691|NCT03412565|38068834|FG003|Overall Study|Death|4|||
16925692|NCT03412565|38068831|FG000|Overall Study|Still ongoing|0|||
16925693|NCT03412565|38068832|FG001|Overall Study|Still ongoing|62|||
16925694|NCT03412565|38068833|FG002|Overall Study|Still ongoing|59|||
16925695|NCT03412565|38068834|FG003|Overall Study|Still ongoing|41|||
16925696|NCT03277105|38068851|FG000|Overall Study|Death|77|||
16925697|NCT03277105|38068852|FG001|Overall Study|Death|73|||
16925698|NCT03277105|38068851|FG000|Overall Study|Lost to Follow-up|0|||
16925699|NCT03277105|38068852|FG001|Overall Study|Lost to Follow-up|3|||
16925700|NCT03277105|38068851|FG000|Overall Study|Withdrawal by Subject|10|||
16925701|NCT03277105|38068852|FG001|Overall Study|Withdrawal by Subject|9|||
16925702|NCT03277105|38068851|FG000|Overall Study|Other|1|||
16925703|NCT03277105|38068852|FG001|Overall Study|Other|3|||
16925704|NCT03277105|38068851|FG000|Overall Study|Ongoing|171|||
16925705|NCT03277105|38068852|FG001|Overall Study|Ongoing|175|||
16925706|NCT03240874|38068862|FG000|Overall Study|Lost to Follow-up|0|||
16925707|NCT03240874|38068863|FG001|Overall Study|Lost to Follow-up|2|||
16925708|NCT03240874|38068864|FG002|Overall Study|Lost to Follow-up|4|||
16925709|NCT03240874|38068865|FG003|Overall Study|Lost to Follow-up|1|||
16925710|NCT03173560|38068875|FG000|Overall Study|Ongoing on Treatment|38|||
16925711|NCT03173560|38068876|FG001|Overall Study|Ongoing on Treatment|50|||
16925712|NCT03173560|38068875|FG000|Overall Study|Ongoing Survival Follow-up|56|||
16925713|NCT03173560|38068876|FG001|Overall Study|Ongoing Survival Follow-up|57|||
16925714|NCT03173560|38068875|FG000|Overall Study|Lost to Follow-up|1|||
16925715|NCT03173560|38068876|FG001|Overall Study|Lost to Follow-up|4|||
16925716|NCT03173560|38068875|FG000|Overall Study|Withdrawal by Subject|10|||
16925717|NCT03173560|38068876|FG001|Overall Study|Withdrawal by Subject|5|||
16925718|NCT03173560|38068875|FG000|Overall Study|Other|0|||
16925719|NCT03173560|38068876|FG001|Overall Study|Other|1|||
16925720|NCT02990468|38068892|FG000|Phase 2: MTD|Change in treatment|0|||
16925721|NCT02990468|38068893|FG001|Phase 2: MTD|Change in treatment|0|||
16925722|NCT02990468|38068894|FG002|Phase 2: MTD|Change in treatment|1|||
16925723|NCT02899299|38068904|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
16849383|NCT01473381|37795090|FG002|Overall Study|Protocol Violation|19|||
16925724|NCT02899299|38068905|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
16925725|NCT02899299|38068904|FG000|Pre-treatment|Participant withdrew consent|1|||
16925726|NCT02899299|38068905|FG001|Pre-treatment|Participant withdrew consent|11|||
16925727|NCT02899299|38068904|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
16925728|NCT02899299|38068905|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
16925729|NCT02899299|38068904|FG000|Pre-treatment|Not reported|0|||
16925730|NCT02899299|38068905|FG001|Pre-treatment|Not reported|1|||
16925731|NCT02899299|38068904|FG000|Treatment|Disease Progression|182|||
16925732|NCT02899299|38068905|FG001|Treatment|Disease Progression|44|||
16925733|NCT02899299|38068904|FG000|Treatment|Study Drug Toxicity|59|||
16925734|NCT02899299|38068905|FG001|Treatment|Study Drug Toxicity|24|||
16925735|NCT02899299|38068904|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
16925736|NCT02899299|38068905|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
16925737|NCT02899299|38068904|FG000|Treatment|Participant request to discontinue Study treatment|4|||
16925738|NCT02899299|38068905|FG001|Treatment|Participant request to discontinue Study treatment|10|||
16925739|NCT02899299|38068904|FG000|Treatment|Participant withdrew consent|6|||
16925740|NCT02899299|38068905|FG001|Treatment|Participant withdrew consent|3|||
16849384|NCT01473381|37795091|FG003|Overall Study|Protocol Violation|17|||
16849385|NCT01473381|37795088|FG000|Overall Study|Withdrawal of Consent|20|||
16925741|NCT02899299|38068904|FG000|Treatment|Lost to Follow-up|0|||
16849386|NCT01473381|37795089|FG001|Overall Study|Withdrawal of Consent|21|||
16849387|NCT01473381|37795090|FG002|Overall Study|Withdrawal of Consent|20|||
16849388|NCT01473381|37795091|FG003|Overall Study|Withdrawal of Consent|26|||
16849389|NCT01473381|37795088|FG000|Overall Study|Lost to Follow-up|25|||
16849390|NCT01473381|37795089|FG001|Overall Study|Lost to Follow-up|28|||
16849391|NCT01473381|37795090|FG002|Overall Study|Lost to Follow-up|35|||
16849392|NCT01473381|37795091|FG003|Overall Study|Lost to Follow-up|23|||
16925742|NCT02899299|38068905|FG001|Treatment|Lost to Follow-up|1|||
16925743|NCT02899299|38068904|FG000|Treatment|Maximum Clinical Benefit|10|||
16849393|NCT01473381|37795088|FG000|Overall Study|Other Reasons|0|||
16849394|NCT01473381|37795089|FG001|Overall Study|Other Reasons|0|||
16849395|NCT01473381|37795090|FG002|Overall Study|Other Reasons|1|||
16849396|NCT01473381|37795091|FG003|Overall Study|Other Reasons|3|||
16849397|NCT01499277|37795133|FG000|Overall Study|Adverse Event|3|||
16849398|NCT01499277|37795134|FG001|Overall Study|Adverse Event|6|||
16849399|NCT01499277|37795133|FG000|Overall Study|Death|3|||
16849400|NCT01499277|37795134|FG001|Overall Study|Death|2|||
16849401|NCT01499277|37795133|FG000|Overall Study|Lost to Follow-up|15|||
16849402|NCT01499277|37795134|FG001|Overall Study|Lost to Follow-up|8|||
16849403|NCT01499277|37795133|FG000|Overall Study|Protocol Violation|2|||
16849404|NCT01499277|37795134|FG001|Overall Study|Protocol Violation|3|||
16849405|NCT01499277|37795133|FG000|Overall Study|Withdrawal by Subject|16|||
16849406|NCT01499277|37795134|FG001|Overall Study|Withdrawal by Subject|6|||
16849407|NCT01499277|37795133|FG000|Overall Study|Lack of therapeutic response and other|8|||
16849408|NCT01499277|37795134|FG001|Overall Study|Lack of therapeutic response and other|7|||
16849409|NCT01499199|37795159|FG000|Overall Study|Adverse Event|1|||
16849410|NCT01499199|37795159|FG000|Overall Study|Lack of Efficacy|1|||
16849411|NCT01499043|37795163|FG000|Overall Study|Progressive disease (radiographic)|2|||
16849412|NCT01499043|37795163|FG000|Overall Study|Progressive disease (clinical)|1|||
16925744|NCT02899299|38068905|FG001|Treatment|Maximum Clinical Benefit|2|||
16925745|NCT02899299|38068904|FG000|Treatment|Poor/Non-compliance|1|||
16925746|NCT02899299|38068905|FG001|Treatment|Poor/Non-compliance|0|||
16925747|NCT02899299|38068904|FG000|Treatment|Participant no longer meets Study criteria|4|||
16925748|NCT02899299|38068905|FG001|Treatment|Participant no longer meets Study criteria|0|||
16925749|NCT02899299|38068904|FG000|Treatment|Administrative reason by Sponsor|2|||
16925750|NCT02899299|38068905|FG001|Treatment|Administrative reason by Sponsor|0|||
16925751|NCT02899299|38068904|FG000|Treatment|Other reasons|11|||
16925752|NCT02899299|38068905|FG001|Treatment|Other reasons|2|||
16925753|NCT02899299|38068904|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
16925754|NCT02899299|38068905|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
16925755|NCT02855944|38068913|FG000|Period 1: Treatment|Ongoing|14|||
16925756|NCT02855944|38068914|FG001|Period 1: Treatment|Ongoing|0|||
16925757|NCT02855944|38068913|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
16925758|NCT02855944|38068914|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
16925759|NCT02855944|38068913|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
16925760|NCT02855944|38068914|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
16925761|NCT02854436|38068921|FG000|Overall Study|Adverse Event|1|||
16925762|NCT02854436|38068921|FG000|Overall Study|Death|208|||
16925763|NCT02854436|38068921|FG000|Overall Study|Lost to Follow-up|5|||
16925764|NCT02854436|38068921|FG000|Overall Study|Withdrawal by Subject|12|||
16925765|NCT02854436|38068921|FG000|Overall Study|Other|45|||
16925766|NCT02854436|38068921|FG000|Overall Study|Ongoing|18|||
16925767|NCT02681055|38068929|FG000|Weeks 5-12|Adverse Event|1|||
16925768|NCT02577354|38068947|FG000|Overall Study|Lack of Efficacy|4|||
16925769|NCT02577354|38068948|FG001|Overall Study|Lack of Efficacy|4|||
16925770|NCT02577354|38068947|FG000|Overall Study|Lost to Follow-up|3|||
16925771|NCT02577354|38068948|FG001|Overall Study|Lost to Follow-up|1|||
16925772|NCT02577354|38068947|FG000|Overall Study|Missed Visit|4|||
16925773|NCT02577354|38068948|FG001|Overall Study|Missed Visit|3|||
16925774|NCT02577354|38068947|FG000|Overall Study|Adverse Event|4|||
16925775|NCT02577354|38068948|FG001|Overall Study|Adverse Event|5|||
16849413|NCT01499043|37795163|FG000|Overall Study|Withdrawal by Subject|2|||
16849414|NCT01499043|37795163|FG000|Overall Study|Adverse Event|1|||
16849415|NCT01498887|37795247|FG000|Overall Study|Administrative problems|1|||
16925776|NCT02489318|38068966|FG000|Randomized|Withdrawal by Subject|0|||
16925777|NCT02489318|38068967|FG001|Randomized|Withdrawal by Subject|1|||
16925778|NCT02489318|38068966|FG000|Treated|Adverse Event|19|||
16925779|NCT02489318|38068967|FG001|Treated|Adverse Event|62|||
16925780|NCT02489318|38068966|FG000|Treated|Death|13|||
16925781|NCT02489318|38068967|FG001|Treated|Death|11|||
16925782|NCT02489318|38068966|FG000|Treated|Physician Decision|4|||
16925783|NCT02489318|38068967|FG001|Treated|Physician Decision|6|||
16849416|NCT01498887|37795248|FG001|Overall Study|Administrative problems|0|||
16849417|NCT01498887|37795247|FG000|Overall Study|Lost to Follow-up|1|||
16849418|NCT01498887|37795248|FG001|Overall Study|Lost to Follow-up|1|||
16849419|NCT01498887|37795247|FG000|Overall Study|Withdrawal by Subject|1|||
16925784|NCT02489318|38068966|FG000|Treated|Protocol Violation|1|||
16925785|NCT02489318|38068967|FG001|Treated|Protocol Violation|2|||
16925786|NCT02489318|38068966|FG000|Treated|Withdrawal by Subject|37|||
16925787|NCT02489318|38068967|FG001|Treated|Withdrawal by Subject|36|||
16925788|NCT02489318|38068966|FG000|Treated|Other: Progressive Disease|245|||
16925789|NCT02489318|38068967|FG001|Treated|Other: Progressive Disease|138|||
16925790|NCT02489318|38068966|FG000|Treated|Other|0|||
16925791|NCT02489318|38068967|FG001|Treated|Other|2|||
16925792|NCT02489318|38068966|FG000|Treated|Ongoing|0|||
16925793|NCT02489318|38068967|FG001|Treated|Ongoing|267|||
16925794|NCT02477696|38068976|FG000|Overall Study|Adverse Event|40|||
16925795|NCT02477696|38068977|FG001|Overall Study|Adverse Event|59|||
16925796|NCT02477696|38068976|FG000|Overall Study|CLL Disease Progression|82|||
16925797|NCT02477696|38068977|FG001|Overall Study|CLL Disease Progression|68|||
16925798|NCT02477696|38068976|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2|||
16925799|NCT02477696|38068977|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10|||
16925800|NCT02477696|38068976|FG000|Overall Study|Death|5|||
16925801|NCT02477696|38068977|FG001|Overall Study|Death|6|||
16925802|NCT02477696|38068976|FG000|Overall Study|Withdrawal by Subject|7|||
16925803|NCT02477696|38068977|FG001|Overall Study|Withdrawal by Subject|7|||
16925804|NCT02477696|38068976|FG000|Overall Study|Physician Decision|5|||
16925805|NCT02477696|38068977|FG001|Overall Study|Physician Decision|5|||
16925806|NCT02451943|38068985|FG000|Overall Study|On Treatment|4|||
16925807|NCT02451943|38068986|FG001|Overall Study|On Treatment|4|||
16925808|NCT02451943|38068985|FG000|Overall Study|Withdrawal by Subject|13|||
16925809|NCT02451943|38068986|FG001|Overall Study|Withdrawal by Subject|16|||
16925810|NCT02451943|38068985|FG000|Overall Study|Lost to Follow-up|3|||
16925811|NCT02451943|38068986|FG001|Overall Study|Lost to Follow-up|4|||
16925812|NCT02421939|38068994|FG000|Overall Study|Progressive disease|70|||
16925813|NCT02421939|38068995|FG001|Overall Study|Progressive disease|16|||
16925814|NCT02421939|38068994|FG000|Overall Study|Lack of Efficacy|21|||
16925815|NCT02421939|38068995|FG001|Overall Study|Lack of Efficacy|31|||
16925816|NCT02421939|38068994|FG000|Overall Study|Death|36|||
16925817|NCT02421939|38068995|FG001|Overall Study|Death|10|||
16925818|NCT02421939|38068994|FG000|Overall Study|Disease relapse|33|||
16925819|NCT02421939|38068995|FG001|Overall Study|Disease relapse|2|||
16925820|NCT02421939|38068994|FG000|Overall Study|Adverse Event|28|||
16925821|NCT02421939|38068995|FG001|Overall Study|Adverse Event|5|||
16925822|NCT02421939|38068994|FG000|Overall Study|Withdrawal by Subject|5|||
16925823|NCT02421939|38068995|FG001|Overall Study|Withdrawal by Subject|24|||
16925824|NCT02421939|38068994|FG000|Overall Study|Physician Decision|11|||
16925825|NCT02421939|38068995|FG001|Overall Study|Physician Decision|11|||
16925826|NCT02421939|38068994|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
16925827|NCT02421939|38068995|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
16925828|NCT02421939|38068994|FG000|Overall Study|Miscellaneous|4|||
16925829|NCT02421939|38068995|FG001|Overall Study|Miscellaneous|5|||
16925830|NCT02421939|38068994|FG000|Overall Study|Protocol deviation|1|||
16925831|NCT02421939|38068995|FG001|Overall Study|Protocol deviation|1|||
16925832|NCT02409342|38069003|FG000|Overall Study|Death|211|||
16925833|NCT02409342|38069004|FG001|Overall Study|Death|201|||
16925834|NCT02409342|38069003|FG000|Overall Study|Withdrawal by Subject|24|||
16925835|NCT02409342|38069004|FG001|Overall Study|Withdrawal by Subject|17|||
16925836|NCT02409342|38069003|FG000|Overall Study|Study Terminated By Sponsor|48|||
16925837|NCT02409342|38069004|FG001|Overall Study|Study Terminated By Sponsor|59|||
16925838|NCT02409342|38069003|FG000|Overall Study|Lost to Follow-up|3|||
16925839|NCT02409342|38069004|FG001|Overall Study|Lost to Follow-up|5|||
16925840|NCT02409342|38069003|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
16849420|NCT01498887|37795248|FG001|Overall Study|Withdrawal by Subject|0|||
16849421|NCT01498887|37795247|FG000|Overall Study|Protocol Violation|1|||
16849422|NCT01498887|37795248|FG001|Overall Study|Protocol Violation|3|||
16849423|NCT01498887|37795247|FG000|Overall Study|Lack of Efficacy|5|||
16849424|NCT01498887|37795248|FG001|Overall Study|Lack of Efficacy|3|||
16849425|NCT01498887|37795247|FG000|Overall Study|Abnormal result from test procedure|1|||
16849426|NCT01498887|37795248|FG001|Overall Study|Abnormal result from test procedure|1|||
16849427|NCT01498887|37795247|FG000|Overall Study|Abnormal laboratory value|2|||
16849428|NCT01498887|37795248|FG001|Overall Study|Abnormal laboratory value|2|||
16849429|NCT01498887|37795247|FG000|Overall Study|Adverse Event|4|||
16849430|NCT01498887|37795248|FG001|Overall Study|Adverse Event|1|||
16849431|NCT01498653|37795257|FG000|Overall Study|Adverse Event|2|||
16849432|NCT01498653|37795258|FG001|Overall Study|Adverse Event|2|||
16849433|NCT01498653|37795257|FG000|Overall Study|Lack of Efficacy|12|||
16925841|NCT02409342|38069004|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
16849434|NCT01498653|37795258|FG001|Overall Study|Lack of Efficacy|26|||
16849435|NCT01498653|37795257|FG000|Overall Study|Protocol Violation|0|||
16849436|NCT01498653|37795258|FG001|Overall Study|Protocol Violation|4|||
16849437|NCT01498653|37795257|FG000|Overall Study|Lost to Follow-up|1|||
16849438|NCT01498653|37795258|FG001|Overall Study|Lost to Follow-up|0|||
16849439|NCT01498653|37795257|FG000|Overall Study|Physician Decision|2|||
16849440|NCT01498653|37795258|FG001|Overall Study|Physician Decision|0|||
16849441|NCT01498653|37795257|FG000|Overall Study|Withdrawal by Subject|2|||
16849442|NCT01498653|37795258|FG001|Overall Study|Withdrawal by Subject|3|||
16849443|NCT01498575|37795266|FG000|Overall Sample|Withdrawal by Subject|60|||
16925842|NCT02409342|38069003|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
16925843|NCT02409342|38069004|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
16925844|NCT02409342|38069003|FG000|Overall Study|Sponsor Decision|1|||
16925845|NCT02409342|38069004|FG001|Overall Study|Sponsor Decision|0|||
16925846|NCT02336503|38069020|FG000|Overall Study|Lost to Follow-up|0|||
16849444|NCT01498575|37795267|FG001|Overall Sample|Withdrawal by Subject|14|||
16925847|NCT02336503|38069021|FG001|Overall Study|Lost to Follow-up|3|||
16925848|NCT02336503|38069022|FG002|Overall Study|Lost to Follow-up|0|||
16925849|NCT02336503|38069023|FG003|Overall Study|Lost to Follow-up|2|||
16925850|NCT02336503|38069020|FG000|Overall Study|Withdrawal by Subject|2|||
16925851|NCT02336503|38069021|FG001|Overall Study|Withdrawal by Subject|0|||
16925852|NCT02336503|38069022|FG002|Overall Study|Withdrawal by Subject|0|||
16925853|NCT02336503|38069023|FG003|Overall Study|Withdrawal by Subject|4|||
16925854|NCT02336503|38069020|FG000|Overall Study|Adverse Event|0|||
16925855|NCT02336503|38069021|FG001|Overall Study|Adverse Event|0|||
16925856|NCT02336503|38069022|FG002|Overall Study|Adverse Event|1|||
16925857|NCT02336503|38069023|FG003|Overall Study|Adverse Event|0|||
16925858|NCT02288247|38069037|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
16925859|NCT02288247|38069038|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
16925860|NCT02288247|38069037|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
16925861|NCT02288247|38069038|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
16925862|NCT02288247|38069037|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
16925863|NCT02288247|38069038|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
16925864|NCT02288247|38069037|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
16925865|NCT02288247|38069038|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
16925866|NCT02288247|38069037|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
16925867|NCT02288247|38069038|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
16925868|NCT02288247|38069037|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
16925869|NCT02288247|38069038|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
16925870|NCT02288247|38069037|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
16925871|NCT02288247|38069038|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
16925872|NCT02288247|38069037|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
16925873|NCT02288247|38069038|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
16925874|NCT02288247|38069037|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
16925875|NCT02288247|38069038|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
16925876|NCT02288247|38069037|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
16925877|NCT02288247|38069038|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
16925878|NCT02288247|38069037|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
16925879|NCT02288247|38069038|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
16925880|NCT02288247|38069037|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
16925881|NCT02288247|38069038|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
16925882|NCT02288247|38069037|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
16925883|NCT02288247|38069038|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
16925884|NCT02288247|38069037|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
16925885|NCT02288247|38069038|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
16925886|NCT02288247|38069037|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
16925887|NCT02288247|38069038|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
16925888|NCT02277444|38069046|FG000|Overall Study|Adverse Event|10|||
16925889|NCT02277444|38069046|FG000|Overall Study|Withdrawal by Subject|3|||
16925890|NCT02277444|38069046|FG000|Overall Study|Other|1|||
16925891|NCT02277444|38069046|FG000|Overall Study|Enrolled and not Treated|3|||
16925892|NCT02277444|38069046|FG000|Overall Study|Ongoing|113|||
16925893|NCT02257736|38069052|FG000|Overall Study|Progressive disease|365|||
16925894|NCT02257736|38069053|FG001|Overall Study|Progressive disease|327|||
16925895|NCT02257736|38069052|FG000|Overall Study|Adverse Event|45|||
16925896|NCT02257736|38069053|FG001|Overall Study|Adverse Event|56|||
16925897|NCT02257736|38069052|FG000|Overall Study|Withdrawal by Subject|21|||
16925898|NCT02257736|38069053|FG001|Overall Study|Withdrawal by Subject|38|||
16849445|NCT01498575|37795266|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
16849446|NCT01498575|37795267|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
16849447|NCT01498575|37795266|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
16925899|NCT02257736|38069052|FG000|Overall Study|Death|11|||
16925900|NCT02257736|38069053|FG001|Overall Study|Death|6|||
16925901|NCT02257736|38069052|FG000|Overall Study|Physician Decision|5|||
16925902|NCT02257736|38069053|FG001|Overall Study|Physician Decision|9|||
16925903|NCT02257736|38069052|FG000|Overall Study|Non-Compliance with study drug|1|||
16925904|NCT02257736|38069053|FG001|Overall Study|Non-Compliance with study drug|2|||
16925905|NCT02257736|38069052|FG000|Overall Study|Protocol Violation|1|||
16925906|NCT02257736|38069053|FG001|Overall Study|Protocol Violation|0|||
16925907|NCT02257736|38069052|FG000|Overall Study|Other|1|||
16925908|NCT02257736|38069053|FG001|Overall Study|Other|7|||
16925909|NCT02257736|38069052|FG000|Overall Study|Randomized, not treated|1|||
16925910|NCT02257736|38069053|FG001|Overall Study|Randomized, not treated|2|||
16925911|NCT02255409|38069061|FG000|Overall Study|Administrative Reason|3|||
16925912|NCT02255409|38069062|FG001|Overall Study|Administrative Reason|7|||
16925913|NCT02255409|38069061|FG000|Overall Study|Withdrawal by Subject|1|||
16925914|NCT02255409|38069062|FG001|Overall Study|Withdrawal by Subject|5|||
16925915|NCT02255409|38069061|FG000|Overall Study|Lost to Follow-up|10|||
16925916|NCT02255409|38069062|FG001|Overall Study|Lost to Follow-up|19|||
16925917|NCT02252172|38069075|FG000|Overall Study|Lost to Follow-up|3|||
16925918|NCT02252172|38069076|FG001|Overall Study|Lost to Follow-up|1|||
16925919|NCT02252172|38069075|FG000|Overall Study|Ongoing|276|||
16925920|NCT02252172|38069076|FG001|Overall Study|Ongoing|298|||
16925921|NCT02195479|38069093|FG000|Overall Study|Lost to Follow-up|3|||
16925922|NCT02195479|38069094|FG001|Overall Study|Lost to Follow-up|0|||
16925923|NCT02195479|38069093|FG000|Overall Study|Death|48|||
16925924|NCT02195479|38069094|FG001|Overall Study|Death|45|||
16925925|NCT02195479|38069093|FG000|Overall Study|Physician Decision|1|||
16925926|NCT02195479|38069094|FG001|Overall Study|Physician Decision|0|||
16925927|NCT02195479|38069093|FG000|Overall Study|Withdrawal by Subject|11|||
16925928|NCT02195479|38069094|FG001|Overall Study|Withdrawal by Subject|6|||
16925929|NCT02195479|38069093|FG000|Overall Study|Other|2|||
16925930|NCT02195479|38069094|FG001|Overall Study|Other|2|||
16925931|NCT02195479|38069093|FG000|Overall Study|Ongoing|291|||
16925932|NCT02195479|38069094|FG001|Overall Study|Ongoing|297|||
16925933|NCT02136134|38069102|FG000|Overall Study|Death|35|||
16925934|NCT02136134|38069103|FG001|Overall Study|Death|29|||
16925935|NCT02136134|38069102|FG000|Overall Study|Withdrawal by Subject|14|||
16925936|NCT02136134|38069103|FG001|Overall Study|Withdrawal by Subject|4|||
16925937|NCT02136134|38069102|FG000|Overall Study|Other|3|||
16925938|NCT02136134|38069103|FG001|Overall Study|Other|3|||
16925939|NCT02136134|38069102|FG000|Overall Study|Ongoing|185|||
16925940|NCT02136134|38069103|FG001|Overall Study|Ongoing|207|||
16925941|NCT02136134|38069102|FG000|Overall Study|Subjects randomized but not treated|10|||
16925942|NCT02136134|38069103|FG001|Overall Study|Subjects randomized but not treated|8|||
16925943|NCT02076009|38069111|FG000|Overall Study|Death|44|||
16925944|NCT02076009|38069112|FG001|Overall Study|Death|30|||
16925945|NCT02076009|38069111|FG000|Overall Study|Withdrawal by Subject|9|||
16925946|NCT02076009|38069112|FG001|Overall Study|Withdrawal by Subject|3|||
16925947|NCT02076009|38069111|FG000|Overall Study|Lost to Follow-up|1|||
16925948|NCT02076009|38069112|FG001|Overall Study|Lost to Follow-up|1|||
16925949|NCT02076009|38069111|FG000|Overall Study|Progressive disease|1|||
16925950|NCT02076009|38069112|FG001|Overall Study|Progressive disease|0|||
16925951|NCT02076009|38069111|FG000|Overall Study|Ongoing|226|||
16925952|NCT02076009|38069112|FG001|Overall Study|Ongoing|249|||
16925953|NCT02076009|38069111|FG000|Overall Study|Subjects randomized but not treated|2|||
16925954|NCT02076009|38069112|FG001|Overall Study|Subjects randomized but not treated|3|||
16925955|NCT01946204|38069120|FG000|Overall Study|Death|38|||
16925956|NCT01946204|38069121|FG001|Overall Study|Death|59|||
16925957|NCT01946204|38069120|FG000|Overall Study|Withdrawal by Subject|37|||
16925958|NCT01946204|38069121|FG001|Overall Study|Withdrawal by Subject|50|||
16925959|NCT01946204|38069120|FG000|Overall Study|Lost to Follow-up|3|||
16925960|NCT01946204|38069121|FG001|Overall Study|Lost to Follow-up|7|||
16925961|NCT01946204|38069120|FG000|Overall Study|Ongoing|316|||
16925962|NCT01946204|38069121|FG001|Overall Study|Ongoing|687|||
16925963|NCT01946204|38069120|FG000|Overall Study|Other|7|||
16925964|NCT01946204|38069121|FG001|Overall Study|Other|3|||
16925965|NCT01615029|38069141|FG000|Overall Study|Adverse Event|0|||
16925966|NCT01615029|38069142|FG001|Overall Study|Adverse Event|0|||
16925967|NCT01615029|38069143|FG002|Overall Study|Adverse Event|0|||
16925968|NCT01615029|38069144|FG003|Overall Study|Adverse Event|0|||
16925969|NCT01615029|38069145|FG004|Overall Study|Adverse Event|1|||
16925970|NCT01615029|38069141|FG000|Overall Study|Death|0|||
16925971|NCT01615029|38069142|FG001|Overall Study|Death|0|||
16925972|NCT01615029|38069143|FG002|Overall Study|Death|0|||
16925973|NCT01615029|38069144|FG003|Overall Study|Death|0|||
16925974|NCT01615029|38069145|FG004|Overall Study|Death|1|||
16925975|NCT01615029|38069141|FG000|Overall Study|Lost to Follow-up|0|||
16925976|NCT01615029|38069142|FG001|Overall Study|Lost to Follow-up|0|||
16925977|NCT01615029|38069143|FG002|Overall Study|Lost to Follow-up|0|||
16925978|NCT01615029|38069144|FG003|Overall Study|Lost to Follow-up|0|||
16925979|NCT01615029|38069145|FG004|Overall Study|Lost to Follow-up|1|||
16925980|NCT01615029|38069141|FG000|Overall Study|Progressive disease|2|||
16925981|NCT01615029|38069142|FG001|Overall Study|Progressive disease|1|||
16925982|NCT01615029|38069143|FG002|Overall Study|Progressive disease|1|||
16925983|NCT01615029|38069144|FG003|Overall Study|Progressive disease|1|||
16925984|NCT01615029|38069145|FG004|Overall Study|Progressive disease|5|||
16925985|NCT01615029|38069141|FG000|Overall Study|Physician Decision|0|||
16925986|NCT01615029|38069142|FG001|Overall Study|Physician Decision|0|||
16925987|NCT01615029|38069143|FG002|Overall Study|Physician Decision|0|||
16925988|NCT01615029|38069144|FG003|Overall Study|Physician Decision|0|||
16925989|NCT01615029|38069145|FG004|Overall Study|Physician Decision|1|||
16925990|NCT01615029|38069141|FG000|Overall Study|Ongoing|1|||
16925991|NCT01615029|38069142|FG001|Overall Study|Ongoing|2|||
16925992|NCT01615029|38069143|FG002|Overall Study|Ongoing|3|||
16925993|NCT01615029|38069144|FG003|Overall Study|Ongoing|2|||
16925994|NCT01615029|38069145|FG004|Overall Study|Ongoing|23|||
16925995|NCT01314118|38069157|FG000|Overall Study|Adverse Event|9|||
16925996|NCT01314118|38069157|FG000|Overall Study|Progressive disease|27|||
16849448|NCT01498575|37795267|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
16925997|NCT01314118|38069157|FG000|Overall Study|Physician Decision|11|||
16925998|NCT01314118|38069157|FG000|Overall Study|Death|4|||
16925999|NCT01314118|38069157|FG000|Overall Study|Protocol Violation|5|||
16926000|NCT01314118|38069157|FG000|Overall Study|Withdrawal by Subject|11|||
16926001|NCT01314118|38069157|FG000|Overall Study|Other|2|||
16926002|NCT01314118|38069157|FG000|Overall Study|Ongoing|62|||
16926003|NCT01171898|38069165|FG000|Overall Study|Death|0|||
16849449|NCT01498185|37795278|FG000|Overall Study|Adverse Event|0|||
16849450|NCT01498185|37795279|FG001|Overall Study|Adverse Event|0|||
16849451|NCT01498185|37795280|FG002|Overall Study|Adverse Event|0|||
16849452|NCT01498185|37795281|FG003|Overall Study|Adverse Event|1|||
16849453|NCT01498185|37795282|FG004|Overall Study|Adverse Event|0|||
16849454|NCT01498185|37795278|FG000|Overall Study|Withdrawal by Subject|1|||
16926004|NCT01171898|38069166|FG001|Overall Study|Death|0|||
16926005|NCT01171898|38069167|FG002|Overall Study|Death|2|||
16926006|NCT01171898|38069168|FG003|Overall Study|Death|0|||
16926007|NCT01171898|38069165|FG000|Overall Study|Lost to Follow-up|0|||
16926008|NCT01171898|38069166|FG001|Overall Study|Lost to Follow-up|1|||
16926009|NCT01171898|38069167|FG002|Overall Study|Lost to Follow-up|1|||
16926010|NCT01171898|38069168|FG003|Overall Study|Lost to Follow-up|1|||
16926011|NCT01171898|38069165|FG000|Overall Study|Withdrawal by Subject|1|||
16926012|NCT01171898|38069166|FG001|Overall Study|Withdrawal by Subject|4|||
16926013|NCT01171898|38069167|FG002|Overall Study|Withdrawal by Subject|6|||
16926014|NCT01171898|38069168|FG003|Overall Study|Withdrawal by Subject|3|||
16926015|NCT01171898|38069165|FG000|Overall Study|Terminated by Sponsor|1|||
16926016|NCT01171898|38069166|FG001|Overall Study|Terminated by Sponsor|0|||
16926017|NCT01171898|38069167|FG002|Overall Study|Terminated by Sponsor|0|||
16926018|NCT01171898|38069168|FG003|Overall Study|Terminated by Sponsor|0|||
16926019|NCT01171898|38069165|FG000|Overall Study|Ongoing|1|||
16926020|NCT01171898|38069166|FG001|Overall Study|Ongoing|9|||
16926021|NCT01171898|38069167|FG002|Overall Study|Ongoing|3|||
16926022|NCT01171898|38069168|FG003|Overall Study|Ongoing|0|||
16926023|NCT01171898|38069165|FG000|Overall Study|Other|1|||
16926024|NCT01171898|38069166|FG001|Overall Study|Other|5|||
16926025|NCT01171898|38069167|FG002|Overall Study|Other|0|||
16926026|NCT01171898|38069168|FG003|Overall Study|Other|2|||
16926027|NCT00981058|38069183|FG000|Overall Study|Adverse Event|1|||
16926028|NCT00981058|38069184|FG001|Overall Study|Adverse Event|1|||
16926029|NCT00981058|38069183|FG000|Overall Study|Progressive Disease|61|||
16926030|NCT00981058|38069184|FG001|Overall Study|Progressive Disease|49|||
16926031|NCT00981058|38069183|FG000|Overall Study|Lost to Follow-up|16|||
16926032|NCT00981058|38069184|FG001|Overall Study|Lost to Follow-up|15|||
16926033|NCT00981058|38069183|FG000|Overall Study|New Anticancer Therapy|6|||
16926034|NCT00981058|38069184|FG001|Overall Study|New Anticancer Therapy|6|||
16926035|NCT00981058|38069183|FG000|Overall Study|Noncompliance|1|||
16926036|NCT00981058|38069184|FG001|Overall Study|Noncompliance|0|||
16926037|NCT00981058|38069183|FG000|Overall Study|Radiologist Error|0|||
16926038|NCT00981058|38069184|FG001|Overall Study|Radiologist Error|1|||
16926039|NCT00981058|38069183|FG000|Overall Study|Randomization Error|1|||
16926040|NCT00981058|38069184|FG001|Overall Study|Randomization Error|2|||
16926041|NCT00981058|38069183|FG000|Overall Study|Withdrawal by Subject|25|||
16926042|NCT00981058|38069184|FG001|Overall Study|Withdrawal by Subject|23|||
16926043|NCT00981058|38069183|FG000|Overall Study|On study treatment at conclusion|9|||
16926044|NCT00981058|38069184|FG001|Overall Study|On study treatment at conclusion|0|||
16926045|NCT00980538|38069190|FG000|Overall Study|Lost to Follow-up|20|||
16926046|NCT00980538|38069190|FG000|Overall Study|Sponsor's Decision|4|||
16849455|NCT01498185|37795279|FG001|Overall Study|Withdrawal by Subject|1|||
16849456|NCT01498185|37795280|FG002|Overall Study|Withdrawal by Subject|0|||
16849457|NCT01498185|37795281|FG003|Overall Study|Withdrawal by Subject|2|||
16926047|NCT00980538|38069190|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
16926048|NCT00980538|38069190|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
16926049|NCT00980538|38069190|FG000|Overall Study|Switch to Commercially Available Medication|25|||
16926050|NCT00980538|38069190|FG000|Overall Study|Participant Non-Compliant|9|||
16849458|NCT01498185|37795282|FG004|Overall Study|Withdrawal by Subject|1|||
16849459|NCT01498185|37795278|FG000|Overall Study|No longer met criteria, etc|0|||
16849460|NCT01498185|37795279|FG001|Overall Study|No longer met criteria, etc|0|||
16849461|NCT01498185|37795280|FG002|Overall Study|No longer met criteria, etc|0|||
16849462|NCT01498185|37795281|FG003|Overall Study|No longer met criteria, etc|0|||
16849463|NCT01498185|37795282|FG004|Overall Study|No longer met criteria, etc|2|||
16849464|NCT01528605|37795304|FG000|Overall Study|Lost to Follow-up|1|||
16849465|NCT01528605|37795305|FG001|Overall Study|Lost to Follow-up|0|||
16926051|NCT00980538|38069190|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
16926052|NCT00980538|38069190|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
16926053|NCT00980538|38069190|FG000|Overall Study|Other|60|||
16926054|NCT00980538|38069190|FG000|Overall Study|Other|1|||
16926055|NCT00630032|38069205|FG000|Overall Study|Death|55|||
16926056|NCT00630032|38069206|FG001|Overall Study|Death|49|||
16926057|NCT00630032|38069205|FG000|Overall Study|Withdrawal by Subject|3|||
16926058|NCT00630032|38069206|FG001|Overall Study|Withdrawal by Subject|2|||
16926059|NCT00630032|38069205|FG000|Overall Study|Lost to Follow-up|18|||
16926060|NCT00630032|38069206|FG001|Overall Study|Lost to Follow-up|31|||
16926061|NCT00630032|38069205|FG000|Overall Study|Protocol Violation|1|||
16926062|NCT00630032|38069206|FG001|Overall Study|Protocol Violation|0|||
16926063|NCT00630032|38069205|FG000|Overall Study|Patient has moved|1|||
16926064|NCT00630032|38069206|FG001|Overall Study|Patient has moved|1|||
16849466|NCT01528605|37795306|FG002|Overall Study|Lost to Follow-up|1|||
16849467|NCT01528605|37795307|FG003|Overall Study|Lost to Follow-up|1|||
16849468|NCT01528605|37795308|FG004|Overall Study|Lost to Follow-up|0|||
16849469|NCT01528605|37795309|FG005|Overall Study|Lost to Follow-up|0|||
16926065|NCT00630032|38069205|FG000|Overall Study|Disease progression|1|||
16926066|NCT00630032|38069206|FG001|Overall Study|Disease progression|1|||
16926067|NCT00630032|38069205|FG000|Overall Study|End of monitoring in US centers|11|||
16926068|NCT00630032|38069206|FG001|Overall Study|End of monitoring in US centers|11|||
16926069|NCT00465517|38069214|FG000|Overall Study|Adverse Event|7|||
16926070|NCT00465517|38069215|FG001|Overall Study|Adverse Event|3|||
16926071|NCT00465517|38069214|FG000|Overall Study|Lost to Follow-up|1|||
16926072|NCT00465517|38069215|FG001|Overall Study|Lost to Follow-up|0|||
16926073|NCT00465517|38069214|FG000|Overall Study|Withdrawal by Subject|4|||
16926074|NCT00465517|38069215|FG001|Overall Study|Withdrawal by Subject|1|||
16926075|NCT05050578|38069223|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
16926076|NCT05050578|38069224|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
16926077|NCT05050578|38069223|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
16926078|NCT05050578|38069224|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
16926079|NCT05050578|38069223|FG000|Period 2, 30 Days|Protocol Violation|0|||
16926080|NCT05050578|38069224|FG001|Period 2, 30 Days|Protocol Violation|1|||
16926081|NCT04571060|38069235|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
16926082|NCT04571060|38069236|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
16926083|NCT04571060|38069235|FG000|Overall Study|Never treated migraine|47|||
16926084|NCT04571060|38069236|FG001|Overall Study|Never treated migraine|36|||
16926085|NCT04571060|38069235|FG000|Overall Study|Protocol Violation|4|||
16926086|NCT04571060|38069236|FG001|Overall Study|Protocol Violation|2|||
16926087|NCT04571060|38069235|FG000|Overall Study|Withdrawal by Subject|6|||
16926088|NCT04571060|38069236|FG001|Overall Study|Withdrawal by Subject|2|||
16926089|NCT04571060|38069235|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
16926090|NCT04571060|38069236|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
16926091|NCT04490278|38069242|FG000|Overall Study|Lost to Follow-up|6|||
16926092|NCT04408794|38069246|FG000|Overall Study|Adverse Event|43|||
16926093|NCT04408794|38069246|FG000|Overall Study|Infrequent study drug usage|43|||
16926094|NCT04408794|38069246|FG000|Overall Study|Lack of Efficacy|61|||
16926095|NCT04408794|38069246|FG000|Overall Study|Lost to Follow-up|33|||
16926096|NCT04408794|38069246|FG000|Overall Study|Non-compliance|6|||
16926097|NCT04408794|38069246|FG000|Overall Study|Physician Decision|1|||
16926098|NCT04408794|38069246|FG000|Overall Study|Pregnancy|6|||
16926099|NCT04408794|38069246|FG000|Overall Study|Protocol Deviation|9|||
16926100|NCT04408794|38069246|FG000|Overall Study|Sheehan-STS Result|1|||
16926101|NCT04408794|38069246|FG000|Overall Study|Withdrawal by Subject|57|||
16926102|NCT04408794|38069246|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
16926103|NCT04408794|38069246|FG000|Overall Study|Never Treated Migraine|5|||
16926104|NCT04004221|38069250|FG000|Overall Study|Death|89|||
16926105|NCT04004221|38069250|FG000|Overall Study|Withdrawal by Subject|5|||
16926106|NCT04004221|38069250|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
16926107|NCT04004221|38069250|FG000|Overall Study|Sponsor Decision|9|||
16926108|NCT04004221|38069250|FG000|Overall Study|Participant refused to enter LTE|1|||
16926109|NCT03775512|38069276|FG000|Overall Study|Death|1|||
16926110|NCT03775512|38069277|FG001|Overall Study|Death|1|||
16926111|NCT03775512|38069276|FG000|Overall Study|Withdrawal by Subject|7|||
16849470|NCT01528605|37795304|FG000|Overall Study|Death|1|||
16849471|NCT01528605|37795305|FG001|Overall Study|Death|0|||
16926112|NCT03775512|38069277|FG001|Overall Study|Withdrawal by Subject|4|||
16926113|NCT03775512|38069276|FG000|Overall Study|Lost to Follow-up|5|||
16926114|NCT03775512|38069277|FG001|Overall Study|Lost to Follow-up|5|||
16926115|NCT03775512|38069276|FG000|Overall Study|Excluded before Catheter insertion|14|||
16926116|NCT03775512|38069277|FG001|Overall Study|Excluded before Catheter insertion|5|||
16926117|NCT03775512|38069276|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
16926118|NCT03775512|38069277|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
16926119|NCT03775512|38069276|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
16926120|NCT03775512|38069277|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
16926121|NCT03620747|38069306|FG000|Overall Study|Participant decision|7|||
16926122|NCT03620747|38069306|FG000|Overall Study|Adverse Event|6|||
16926123|NCT03620747|38069306|FG000|Overall Study|Lack of Efficacy|1|||
16926124|NCT03620747|38069306|FG000|Overall Study|Poor compliance to protocol|2|||
16926125|NCT03620747|38069306|FG000|Overall Study|Other-unspecified|3|||
16926126|NCT03338790|38069331|FG000|Overall Study|Disease Progression|65|||
16926127|NCT03338790|38069332|FG001|Overall Study|Disease Progression|43|||
16926128|NCT03338790|38069333|FG002|Overall Study|Disease Progression|50|||
16926129|NCT03338790|38069334|FG003|Overall Study|Disease Progression|37|||
16926130|NCT03338790|38069331|FG000|Overall Study|Study Drug Toxicity|9|||
16926131|NCT03338790|38069332|FG001|Overall Study|Study Drug Toxicity|8|||
16926132|NCT03338790|38069333|FG002|Overall Study|Study Drug Toxicity|15|||
16849472|NCT01528605|37795306|FG002|Overall Study|Death|0|||
16849473|NCT01528605|37795307|FG003|Overall Study|Death|0|||
16849474|NCT01528605|37795308|FG004|Overall Study|Death|0|||
16849475|NCT01528605|37795309|FG005|Overall Study|Death|0|||
16849476|NCT01528215|37795325|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
16849477|NCT01528215|37795326|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
16849478|NCT01528215|37795325|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
16926133|NCT03338790|38069334|FG003|Overall Study|Study Drug Toxicity|0|||
16926134|NCT03338790|38069331|FG000|Overall Study|Death|1|||
16926135|NCT03338790|38069332|FG001|Overall Study|Death|1|||
16926136|NCT03338790|38069333|FG002|Overall Study|Death|1|||
16926137|NCT03338790|38069334|FG003|Overall Study|Death|0|||
16926138|NCT03338790|38069331|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
16926139|NCT03338790|38069332|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
16926140|NCT03338790|38069333|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
16926141|NCT03338790|38069334|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
16926142|NCT03338790|38069331|FG000|Overall Study|Participant request to discontinue study treatment|3|||
16926143|NCT03338790|38069332|FG001|Overall Study|Participant request to discontinue study treatment|3|||
16926144|NCT03338790|38069333|FG002|Overall Study|Participant request to discontinue study treatment|2|||
16926145|NCT03338790|38069334|FG003|Overall Study|Participant request to discontinue study treatment|1|||
16926146|NCT03338790|38069331|FG000|Overall Study|Poor/non-compliance|0|||
16926147|NCT03338790|38069332|FG001|Overall Study|Poor/non-compliance|1|||
16849479|NCT01528215|37795326|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
16849480|NCT01528215|37795325|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
16849481|NCT01528215|37795326|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
16926148|NCT03338790|38069333|FG002|Overall Study|Poor/non-compliance|0|||
16926149|NCT03338790|38069334|FG003|Overall Study|Poor/non-compliance|0|||
16926150|NCT03338790|38069331|FG000|Overall Study|Participant withdrew consent|1|||
17198607|NCT00103285|38352274|FG001|Response Assignment|Other|30|||
17198608|NCT00103285|38352275|FG002|Response Assignment|Other|48|||
17198609|NCT00103285|38352276|FG003|Response Assignment|Other|38|||
17198610|NCT00103285|38352277|FG004|Response Assignment|Other|37|||
16926151|NCT03338790|38069332|FG001|Overall Study|Participant withdrew consent|0|||
16926152|NCT03338790|38069333|FG002|Overall Study|Participant withdrew consent|1|||
16926153|NCT03338790|38069334|FG003|Overall Study|Participant withdrew consent|1|||
16926154|NCT03338790|38069331|FG000|Overall Study|Other reasons|0|||
16926155|NCT03338790|38069332|FG001|Overall Study|Other reasons|5|||
16926156|NCT03338790|38069333|FG002|Overall Study|Other reasons|0|||
16926157|NCT03338790|38069334|FG003|Overall Study|Other reasons|2|||
16926158|NCT03338790|38069331|FG000|Overall Study|Not reported|0|||
16926159|NCT03338790|38069332|FG001|Overall Study|Not reported|0|||
16926160|NCT03338790|38069333|FG002|Overall Study|Not reported|1|||
16926161|NCT03338790|38069334|FG003|Overall Study|Not reported|0|||
16926162|NCT03338790|38069331|FG000|Overall Study|Completed treatment period|1|||
16926163|NCT03338790|38069332|FG001|Overall Study|Completed treatment period|2|||
16926164|NCT03338790|38069333|FG002|Overall Study|Completed treatment period|0|||
16926165|NCT03338790|38069334|FG003|Overall Study|Completed treatment period|0|||
17018162|NCT00576472|38162558|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
17018163|NCT00576472|38162559|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
17018164|NCT00576472|38162560|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
17018165|NCT00576472|38162561|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
17018166|NCT00576472|38162547|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17198611|NCT00103285|38352278|FG005|Response Assignment|Other|17|||
16849482|NCT01528215|37795325|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
16926166|NCT03155997|38069363|FG000|Overall Study|Withdrawal by Subject|119|||
16926167|NCT03155997|38069364|FG001|Overall Study|Withdrawal by Subject|134|||
16926168|NCT03155997|38069363|FG000|Overall Study|Lost to Follow-up|12|||
16926169|NCT03155997|38069364|FG001|Overall Study|Lost to Follow-up|13|||
16926170|NCT03155997|38069363|FG000|Overall Study|Missing disposition data|0|||
16926171|NCT03155997|38069364|FG001|Overall Study|Missing disposition data|1|||
16926172|NCT03155997|38069363|FG000|Overall Study|On study treatment|2027|||
16926173|NCT03155997|38069364|FG001|Overall Study|On study treatment|2074|||
16926174|NCT02954536|38069370|FG000|Overall Study|Adverse Event|2|||
16926175|NCT02954536|38069370|FG000|Overall Study|Death|12|||
16926176|NCT02919670|38069376|FG000|Overall Study|Only 17 participants met compliance|43|||
16926177|NCT02919670|38069377|FG001|Overall Study|Only 17 participants met compliance|39|||
16926178|NCT02632409|38069399|FG000|Randomized|AE unrelated to study Drug|0|||
16926179|NCT02632409|38069400|FG001|Randomized|AE unrelated to study Drug|1|||
16926180|NCT02632409|38069399|FG000|Randomized|Participant withdrew consent|2|||
16926181|NCT02632409|38069400|FG001|Randomized|Participant withdrew consent|1|||
16926182|NCT02632409|38069399|FG000|Randomized|No Longer meets study criteria|5|||
16849483|NCT01528215|37795326|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
16849484|NCT01527357|37795334|FG000|Overall Study|Death|8|||
16849485|NCT01527357|37795335|FG001|Overall Study|Death|2|||
16849486|NCT01527357|37795334|FG000|Overall Study|Lost to Follow-up|6|||
16849487|NCT01527357|37795335|FG001|Overall Study|Lost to Follow-up|4|||
16849488|NCT01527357|37795334|FG000|Overall Study|Withdrew Consent|1|||
16926183|NCT02632409|38069400|FG001|Randomized|No Longer meets study criteria|0|||
16926184|NCT02632409|38069399|FG000|Randomized|other reasons|1|||
16926185|NCT02632409|38069400|FG001|Randomized|other reasons|0|||
16926186|NCT02632409|38069399|FG000|Treatment Period|Ongoing Treatment|20|||
16926187|NCT02632409|38069400|FG001|Treatment Period|Ongoing Treatment|21|||
16926188|NCT02632409|38069399|FG000|Treatment Period|Disease Recurrence|147|||
16926189|NCT02632409|38069400|FG001|Treatment Period|Disease Recurrence|90|||
16926190|NCT02632409|38069399|FG000|Treatment Period|Study Drug Toxicity|8|||
16926191|NCT02632409|38069400|FG001|Treatment Period|Study Drug Toxicity|49|||
16926192|NCT02632409|38069399|FG000|Treatment Period|Death|1|||
16926193|NCT02632409|38069400|FG001|Treatment Period|Death|0|||
16926194|NCT02632409|38069399|FG000|Treatment Period|AE unrelated to study drug|15|||
16926195|NCT02632409|38069400|FG001|Treatment Period|AE unrelated to study drug|16|||
16926196|NCT02632409|38069399|FG000|Treatment Period|Request to discontinue treatment|4|||
16926197|NCT02632409|38069400|FG001|Treatment Period|Request to discontinue treatment|19|||
16926198|NCT02632409|38069399|FG000|Treatment Period|Participant withdrew consent|7|||
16926199|NCT02632409|38069400|FG001|Treatment Period|Participant withdrew consent|5|||
16926200|NCT02632409|38069399|FG000|Treatment Period|Lost to Follow-up|0|||
16926201|NCT02632409|38069400|FG001|Treatment Period|Lost to Follow-up|1|||
16926202|NCT02632409|38069399|FG000|Treatment Period|Maximum clinical benefit|1|||
16926203|NCT02632409|38069400|FG001|Treatment Period|Maximum clinical benefit|0|||
16926204|NCT02632409|38069399|FG000|Treatment Period|No longer meets study criteria|3|||
16926205|NCT02632409|38069400|FG001|Treatment Period|No longer meets study criteria|0|||
16926206|NCT02632409|38069399|FG000|Treatment Period|Administrative Reason by sponsor|0|||
16926207|NCT02632409|38069400|FG001|Treatment Period|Administrative Reason by sponsor|1|||
16926208|NCT02632409|38069399|FG000|Treatment Period|Other Reasons|10|||
16926209|NCT02632409|38069400|FG001|Treatment Period|Other Reasons|6|||
16926210|NCT02250326|38069485|FG000|Treatment Period|Death|1|||
16926211|NCT02250326|38069486|FG001|Treatment Period|Death|12|||
16926212|NCT02250326|38069487|FG002|Treatment Period|Death|2|||
16849489|NCT01527357|37795335|FG001|Overall Study|Withdrew Consent|1|||
16849490|NCT01527357|37795334|FG000|Overall Study|Non-compliance|0|||
16849491|NCT01527357|37795335|FG001|Overall Study|Non-compliance|1|||
16849492|NCT01527357|37795334|FG000|Overall Study|No Day 29 Visit|0|||
16849493|NCT01527357|37795335|FG001|Overall Study|No Day 29 Visit|1|||
16849494|NCT01527357|37795334|FG000|Overall Study|Did Not Receive Treatment|2|||
16849495|NCT01527357|37795335|FG001|Overall Study|Did Not Receive Treatment|0|||
16849496|NCT01526889|37795354|FG000|Treatment Period|Adverse Event|2|||
16849497|NCT01526889|37795355|FG001|Treatment Period|Adverse Event|0|||
16849498|NCT01526889|37795354|FG000|Treatment Extension Period|Administrative problems|1|||
16849499|NCT01526889|37795355|FG001|Treatment Extension Period|Administrative problems|0|||
16849500|NCT01472835|37795367|FG000|Overall Study|Lost to Follow-up|2|||
16926213|NCT02250326|38069485|FG000|Treatment Period|Adverse Event|8|||
16849501|NCT01472835|37795368|FG001|Overall Study|Lost to Follow-up|0|||
16849502|NCT01526733|37795381|FG000|Phase 1|Protocol Violation|1|||
16849503|NCT01526733|37795382|FG001|Phase 1|Protocol Violation|0|||
16849504|NCT01526733|37795381|FG000|Phase 1|Withdrawal by Subject|1|||
16849505|NCT01526733|37795382|FG001|Phase 1|Withdrawal by Subject|1|||
16849506|NCT01472757|37795427|FG000|Overall Study|Withdrawal by Subject|1|||
16926214|NCT02250326|38069486|FG001|Treatment Period|Adverse Event|4|||
16926215|NCT02250326|38069487|FG002|Treatment Period|Adverse Event|8|||
16926216|NCT02250326|38069485|FG000|Treatment Period|Progressive Disease|42|||
16926217|NCT02250326|38069486|FG001|Treatment Period|Progressive Disease|36|||
16926218|NCT02250326|38069487|FG002|Treatment Period|Progressive Disease|45|||
16849507|NCT01472757|37795428|FG001|Overall Study|Withdrawal by Subject|2|||
16849508|NCT01472757|37795429|FG002|Overall Study|Withdrawal by Subject|2|||
16849509|NCT01472757|37795430|FG003|Overall Study|Withdrawal by Subject|0|||
16849510|NCT01472757|37795427|FG000|Overall Study|Asthma exacerbation|4|||
16849511|NCT01472757|37795428|FG001|Overall Study|Asthma exacerbation|1|||
16849512|NCT01472757|37795429|FG002|Overall Study|Asthma exacerbation|2|||
16849513|NCT01472757|37795430|FG003|Overall Study|Asthma exacerbation|1|||
16849514|NCT01472757|37795427|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
16849515|NCT01472757|37795428|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
16849516|NCT01472757|37795429|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
16849517|NCT01472757|37795430|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
16926219|NCT02250326|38069485|FG000|Treatment Period|Symptomatic Deterioration|9|||
16926220|NCT02250326|38069486|FG001|Treatment Period|Symptomatic Deterioration|4|||
16926221|NCT02250326|38069487|FG002|Treatment Period|Symptomatic Deterioration|10|||
16926222|NCT02250326|38069485|FG000|Treatment Period|Withdrawal by Subject|11|||
16926223|NCT02250326|38069486|FG001|Treatment Period|Withdrawal by Subject|5|||
16926224|NCT02250326|38069487|FG002|Treatment Period|Withdrawal by Subject|4|||
16926225|NCT02250326|38069485|FG000|Treatment Period|Miscellaneous|8|||
16926226|NCT02250326|38069486|FG001|Treatment Period|Miscellaneous|2|||
16926227|NCT02250326|38069487|FG002|Treatment Period|Miscellaneous|7|||
16926228|NCT02250326|38069485|FG000|Treatment Period|Randomized or assigned; not treated|2|||
16926229|NCT02250326|38069486|FG001|Treatment Period|Randomized or assigned; not treated|1|||
16926230|NCT02250326|38069487|FG002|Treatment Period|Randomized or assigned; not treated|1|||
16926231|NCT02250326|38069485|FG000|Follow-Up Period|Death|46|||
16926232|NCT02250326|38069486|FG001|Follow-Up Period|Death|26|||
16926233|NCT02250326|38069487|FG002|Follow-Up Period|Death|32|||
16926234|NCT02250326|38069485|FG000|Follow-Up Period|Unknown or Missing|2|||
16926235|NCT02250326|38069486|FG001|Follow-Up Period|Unknown or Missing|3|||
16926236|NCT02250326|38069487|FG002|Follow-Up Period|Unknown or Missing|3|||
16926237|NCT02250326|38069485|FG000|Follow-Up Period|Lost to Follow-up|1|||
16926238|NCT02250326|38069486|FG001|Follow-Up Period|Lost to Follow-up|1|||
16926239|NCT02250326|38069487|FG002|Follow-Up Period|Lost to Follow-up|3|||
16926240|NCT01567722|38069499|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
16926241|NCT01567722|38069500|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
16926242|NCT01567722|38069501|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
16849518|NCT01472757|37795427|FG000|Overall Study|Protocol Violation|3|||
16849519|NCT01472757|37795428|FG001|Overall Study|Protocol Violation|2|||
16849520|NCT01472757|37795429|FG002|Overall Study|Protocol Violation|4|||
16849521|NCT01472757|37795430|FG003|Overall Study|Protocol Violation|4|||
16849522|NCT01472757|37795427|FG000|Overall Study|Other reasons|1|||
16849523|NCT01472757|37795428|FG001|Overall Study|Other reasons|0|||
16849524|NCT01472757|37795429|FG002|Overall Study|Other reasons|2|||
16849525|NCT01472757|37795430|FG003|Overall Study|Other reasons|2|||
16849526|NCT01472289|37795449|FG000|Overall Study|Death|2|||
16849527|NCT01525875|37795468|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
16849528|NCT01525875|37795469|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
16849529|NCT01525875|37795468|FG000|Open-label Period|Lost to Follow-up|0|||
16849530|NCT01525875|37795469|FG001|Open-label Period|Lost to Follow-up|2|||
16849531|NCT01525641|37795475|FG000|Overall Study|Case report form not collected|25|||
16849532|NCT01525641|37795475|FG000|Overall Study|No visit since the first visit|16|||
16849533|NCT01525641|37795475|FG000|Overall Study|Adverse Event|73|||
16849534|NCT01525641|37795475|FG000|Overall Study|Lack of Efficacy|24|||
16849535|NCT01525641|37795475|FG000|Overall Study|Improvement|5|||
16849536|NCT01525641|37795475|FG000|Overall Study|Lost to follow-up (relocation)|1|||
16849537|NCT01525641|37795475|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
16849538|NCT01525641|37795475|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
16849539|NCT01525641|37795475|FG000|Overall Study|Other than stated above|7|||
16849540|NCT01496469|37795490|FG000|Overall Study|Adverse Event|1|||
16849541|NCT01496469|37795491|FG001|Overall Study|Adverse Event|0|||
16849542|NCT01496469|37795490|FG000|Overall Study|Protocol Violation|2|||
16849543|NCT01496469|37795491|FG001|Overall Study|Protocol Violation|0|||
16849544|NCT01496469|37795490|FG000|Overall Study|Lost to Follow-up|1|||
16849545|NCT01496469|37795491|FG001|Overall Study|Lost to Follow-up|1|||
16849546|NCT01496469|37795490|FG000|Overall Study|Withdrawal by Subject|4|||
16849547|NCT01496469|37795491|FG001|Overall Study|Withdrawal by Subject|4|||
16849548|NCT01496469|37795490|FG000|Overall Study|BP exceeds protocol limits|1|||
16849549|NCT01496469|37795491|FG001|Overall Study|BP exceeds protocol limits|2|||
16849550|NCT01496469|37795490|FG000|Overall Study|Other|1|||
16849551|NCT01496469|37795491|FG001|Overall Study|Other|1|||
16849552|NCT01471353|37795506|FG000|Overall Study|remain on study|3|||
16849553|NCT01525407|37795512|FG000|Overall Study|Change in recipient treatment plan|2|||
16849554|NCT01525407|37795513|FG001|Overall Study|Change in recipient treatment plan|2|||
16849555|NCT01525407|37795512|FG000|Overall Study|Withdrawal by Subject|0|||
16849556|NCT01525407|37795513|FG001|Overall Study|Withdrawal by Subject|1|||
16849557|NCT01525407|37795512|FG000|Overall Study|Transplant was delayed|0|||
16849558|NCT01525407|37795513|FG001|Overall Study|Transplant was delayed|1|||
16849559|NCT01525407|37795512|FG000|Overall Study|Delay in Transplant|1|||
16849560|NCT01525407|37795513|FG001|Overall Study|Delay in Transplant|0|||
16849561|NCT01471197|37795521|FG000|Overall Study|Disease Progression|4|||
16849562|NCT01471197|37795522|FG001|Overall Study|Disease Progression|2|||
16849563|NCT01471197|37795521|FG000|Overall Study|Death|1|||
16849564|NCT01471197|37795522|FG001|Overall Study|Death|0|||
16849565|NCT01471197|37795521|FG000|Overall Study|Study Drug Toxicity|1|||
16849566|NCT01471197|37795522|FG001|Overall Study|Study Drug Toxicity|0|||
16849567|NCT01524783|37795556|FG000|Blinded Period|Adverse Event|64|||
16849568|NCT01524783|37795557|FG001|Blinded Period|Adverse Event|7|||
16849569|NCT01524783|37795558|FG002|Blinded Period|Adverse Event|0|||
16849570|NCT01524783|37795556|FG000|Blinded Period|Disease Progression|89|||
16849571|NCT01524783|37795557|FG001|Blinded Period|Disease Progression|75|||
16926243|NCT01567722|38069499|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
16926244|NCT01567722|38069500|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
16926245|NCT01567722|38069501|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
16926246|NCT01567722|38069499|FG000|Overall Study|Protocol closure by the OCG|2|||
16926247|NCT01567722|38069500|FG001|Overall Study|Protocol closure by the OCG|0|||
16926248|NCT01567722|38069501|FG002|Overall Study|Protocol closure by the OCG|0|||
16926249|NCT01567722|38069499|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
16926250|NCT01567722|38069500|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
16926251|NCT01567722|38069501|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
16926252|NCT01194570|38069511|FG000|Overall Study|Death|1|||
16926253|NCT01194570|38069512|FG001|Overall Study|Death|3|||
16926254|NCT01194570|38069511|FG000|Overall Study|Ongoing at CCOD|162|||
16926255|NCT01194570|38069512|FG001|Overall Study|Ongoing at CCOD|387|||
16926256|NCT01194570|38069511|FG000|Overall Study|Physician Decision|2|||
16926257|NCT01194570|38069512|FG001|Overall Study|Physician Decision|6|||
16926258|NCT01194570|38069511|FG000|Overall Study|Reason not specified|13|||
16926259|NCT01194570|38069512|FG001|Overall Study|Reason not specified|20|||
16926260|NCT01194570|38069511|FG000|Overall Study|Protocol Violation|0|||
16926261|NCT01194570|38069512|FG001|Overall Study|Protocol Violation|2|||
16926262|NCT01194570|38069511|FG000|Overall Study|Non-compliance with study drug|2|||
16926263|NCT01194570|38069512|FG001|Overall Study|Non-compliance with study drug|2|||
16926264|NCT01194570|38069511|FG000|Overall Study|Adverse Event|12|||
16926265|NCT01194570|38069512|FG001|Overall Study|Adverse Event|18|||
16926266|NCT01194570|38069511|FG000|Overall Study|Non-compliance|2|||
16926267|NCT01194570|38069512|FG001|Overall Study|Non-compliance|2|||
16926268|NCT01194570|38069511|FG000|Overall Study|Lack of Efficacy|27|||
16926269|NCT01194570|38069512|FG001|Overall Study|Lack of Efficacy|21|||
16926270|NCT01194570|38069511|FG000|Overall Study|Withdrawal by Subject|21|||
16926271|NCT01194570|38069512|FG001|Overall Study|Withdrawal by Subject|22|||
16926272|NCT01194570|38069511|FG000|Overall Study|Pregnancy|1|||
16926273|NCT01194570|38069512|FG001|Overall Study|Pregnancy|1|||
16926274|NCT01194570|38069511|FG000|Overall Study|Lost to Follow-up|1|||
16926275|NCT01194570|38069512|FG001|Overall Study|Lost to Follow-up|4|||
16926276|NCT01124695|38069518|FG000|Overall Study|Disease progression|77|||
16926277|NCT01124695|38069518|FG000|Overall Study|Adverse Event|11|||
16926278|NCT01124695|38069518|FG000|Overall Study|Death|1|||
16926279|NCT01124695|38069518|FG000|Overall Study|Withdrawal by Subject|7|||
16926280|NCT01124695|38069518|FG000|Overall Study|Physician Decision|3|||
16926281|NCT01124695|38069518|FG000|Overall Study|Alternative therapy|9|||
16926282|NCT01124695|38069518|FG000|Overall Study|No documentation that patient went off treatment|4|||
16926283|NCT01124695|38069518|FG000|Overall Study|Ineligible|9|||
16926284|NCT01124695|38069518|FG000|Overall Study|Ineligible and never start treatment|2|||
16926285|NCT01349790|38069546|FG000|Overall Study|Investigator Judgement|3|||
16926286|NCT01349790|38069546|FG000|Overall Study|Death|2|||
16926287|NCT01349790|38069546|FG000|Overall Study|Withdrawal by Patient|2|||
16926288|NCT01349790|38069546|FG000|Overall Study|Adverse Event|1|||
16926289|NCT01349790|38069546|FG000|Overall Study|Lost to Follow-up|1|||
16926290|NCT01349595|38069552|FG000|Overall Study|Lack of funding|2|||
16926291|NCT01349595|38069553|FG001|Overall Study|Lack of funding|2|||
16926292|NCT01349673|38069563|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
16926293|NCT01349673|38069563|FG000|Overall Study|No Longer Qualified For Study|1|||
16926294|NCT01349673|38069563|FG000|Overall Study|Site Closure|10|||
16926295|NCT01349673|38069563|FG000|Overall Study|Withdrawal by Subject|21|||
16926296|NCT01349673|38069563|FG000|Overall Study|Lost to Follow-up|6|||
16926297|NCT01349673|38069563|FG000|Overall Study|Adverse Event|17|||
16926298|NCT01349673|38069563|FG000|Overall Study|Study Terminated By Sponsor|50|||
16926299|NCT01349673|38069563|FG000|Overall Study|Lack of Efficacy|8|||
16926300|NCT01349660|38069672|FG000|Overall Study|Still Receiving Study Treatment|0|||
16926301|NCT01349660|38069673|FG001|Overall Study|Still Receiving Study Treatment|0|||
17198612|NCT00103285|38352279|FG006|Response Assignment|Other|11|||
16849572|NCT01524783|37795558|FG002|Blinded Period|Disease Progression|0|||
16849573|NCT01524783|37795556|FG000|Blinded Period|Withdrawal by Subject|19|||
16849574|NCT01524783|37795557|FG001|Blinded Period|Withdrawal by Subject|6|||
16926302|NCT01349660|38069674|FG002|Overall Study|Still Receiving Study Treatment|1|||
16849575|NCT01524783|37795558|FG002|Blinded Period|Withdrawal by Subject|0|||
16849576|NCT01524783|37795556|FG000|Blinded Period|Protocol deviation|2|||
16849577|NCT01524783|37795557|FG001|Blinded Period|Protocol deviation|1|||
16849578|NCT01524783|37795558|FG002|Blinded Period|Protocol deviation|0|||
16849579|NCT01524783|37795556|FG000|Blinded Period|Death|5|||
16849580|NCT01524783|37795557|FG001|Blinded Period|Death|2|||
16849581|NCT01524783|37795558|FG002|Blinded Period|Death|0|||
16849582|NCT01524783|37795556|FG000|Open-label Period|Disease progression|13|||
16849583|NCT01524783|37795557|FG001|Open-label Period|Disease progression|0|||
16849584|NCT01524783|37795558|FG002|Open-label Period|Disease progression|2|||
16926303|NCT01349660|38069672|FG000|Overall Study|Disease Progression|2|||
16926304|NCT01349660|38069673|FG001|Overall Study|Disease Progression|4|||
16926305|NCT01349660|38069674|FG002|Overall Study|Disease Progression|50|||
16926306|NCT01349660|38069672|FG000|Overall Study|Adverse Event|1|||
16926307|NCT01349660|38069673|FG001|Overall Study|Adverse Event|1|||
16926308|NCT01349660|38069674|FG002|Overall Study|Adverse Event|12|||
16926309|NCT01349660|38069672|FG000|Overall Study|Withdrawal by Subject|2|||
16926310|NCT01349660|38069673|FG001|Overall Study|Withdrawal by Subject|0|||
16926311|NCT01349660|38069674|FG002|Overall Study|Withdrawal by Subject|9|||
16926312|NCT01349660|38069672|FG000|Overall Study|Death|1|||
16926313|NCT01349660|38069673|FG001|Overall Study|Death|1|||
16926314|NCT01349660|38069674|FG002|Overall Study|Death|0|||
16926315|NCT01349660|38069672|FG000|Overall Study|Non-Permitted Interventions|0|||
16926316|NCT01349660|38069673|FG001|Overall Study|Non-Permitted Interventions|0|||
16926317|NCT01349660|38069674|FG002|Overall Study|Non-Permitted Interventions|2|||
16926318|NCT01349660|38069672|FG000|Overall Study|Study Compliance|0|||
16926319|NCT01349660|38069673|FG001|Overall Study|Study Compliance|0|||
16926320|NCT01349660|38069674|FG002|Overall Study|Study Compliance|1|||
16926321|NCT01349660|38069672|FG000|Overall Study|Declining Performance Status|0|||
16926322|NCT01349660|38069673|FG001|Overall Study|Declining Performance Status|0|||
16926323|NCT01349660|38069674|FG002|Overall Study|Declining Performance Status|1|||
16926324|NCT01349569|38069693|FG000|Overall Study|Lack of Efficacy|4|||
16926325|NCT01058863|38069813|FG000|Overall Study|Lost to Follow-up|1|||
16926326|NCT01058863|38069813|FG000|Overall Study|Withdrawal by Subject|1|||
16926327|NCT01058863|38069813|FG000|Overall Study|Sponsor requested withdrawal|1|||
16926328|NCT01058863|38069813|FG000|Overall Study|Randomized in error|1|||
16926329|NCT01058395|38069828|FG000|Overall Study|Death|2|||
16926330|NCT01058395|38069829|FG001|Overall Study|Death|1|||
16926331|NCT01058395|38069828|FG000|Overall Study|Lost to Follow-up|1|||
16926332|NCT01058395|38069829|FG001|Overall Study|Lost to Follow-up|0|||
16926333|NCT01058356|38069835|FG000|Overall Study|Adverse Event|5|||
16926334|NCT01058356|38069835|FG000|Overall Study|Administration of contraindicated drugs|12|||
16926335|NCT01058356|38069835|FG000|Overall Study|Withdrawal by Subject|21|||
16926336|NCT01058356|38069835|FG000|Overall Study|Lost to Follow-up|4|||
16849585|NCT01524783|37795556|FG000|Open-label Period|Administrative problems|5|||
16849586|NCT01524783|37795557|FG001|Open-label Period|Administrative problems|0|||
16849587|NCT01524783|37795558|FG002|Open-label Period|Administrative problems|2|||
16849588|NCT01524783|37795556|FG000|Open-label Period|Adverse Event|5|||
16849589|NCT01524783|37795557|FG001|Open-label Period|Adverse Event|0|||
16849590|NCT01524783|37795558|FG002|Open-label Period|Adverse Event|1|||
16849591|NCT01524783|37795556|FG000|Open-label Period|Withdrawal by Subject|2|||
16849592|NCT01524783|37795557|FG001|Open-label Period|Withdrawal by Subject|0|||
16849593|NCT01524783|37795558|FG002|Open-label Period|Withdrawal by Subject|1|||
16849594|NCT01524783|37795556|FG000|Open-label Period|Protocol deviation|1|||
16849595|NCT01524783|37795557|FG001|Open-label Period|Protocol deviation|0|||
16849596|NCT01524783|37795558|FG002|Open-label Period|Protocol deviation|0|||
16849597|NCT01494987|37795572|FG000|Overall Study|Adverse Event|6|||
16849598|NCT01494987|37795573|FG001|Overall Study|Adverse Event|5|||
16849599|NCT01494987|37795572|FG000|Overall Study|Hyperglycemia|6|||
16849600|NCT01494987|37795573|FG001|Overall Study|Hyperglycemia|4|||
16849601|NCT01494987|37795572|FG000|Overall Study|Investigator's Discretion|1|||
16849602|NCT01494987|37795573|FG001|Overall Study|Investigator's Discretion|2|||
16849603|NCT01494987|37795572|FG000|Overall Study|Lost to Follow-up|1|||
16849604|NCT01494987|37795573|FG001|Overall Study|Lost to Follow-up|1|||
16849605|NCT01494987|37795572|FG000|Overall Study|Protocol Violation|3|||
16849606|NCT01494987|37795573|FG001|Overall Study|Protocol Violation|3|||
16849607|NCT01494987|37795572|FG000|Overall Study|Subject Non-Compliance|9|||
16849608|NCT01494987|37795573|FG001|Overall Study|Subject Non-Compliance|10|||
16849609|NCT01494987|37795572|FG000|Overall Study|Subject Withdrew Consent|2|||
16849610|NCT01494987|37795573|FG001|Overall Study|Subject Withdrew Consent|3|||
16849611|NCT01470417|37795581|FG000|Overall Study|Disease progression|0|||
16849612|NCT01470417|37795582|FG001|Overall Study|Disease progression|2|||
16849613|NCT01524627|37795590|FG000|Overall Study|Physician Decision|0|||
16849614|NCT01524627|37795591|FG001|Overall Study|Physician Decision|1|||
16849615|NCT01524627|37795590|FG000|Overall Study|Lost to Follow-up|1|||
16849616|NCT01524627|37795591|FG001|Overall Study|Lost to Follow-up|1|||
16926337|NCT01058005|38069842|FG000|Overall Study|Adverse Event|0|||
16926338|NCT01058005|38069843|FG001|Overall Study|Adverse Event|2|||
16849617|NCT01469637|37795599|FG000|First Intervention|Unacceptable behavior|0|||
16849618|NCT01469637|37795600|FG001|First Intervention|Unacceptable behavior|1|||
16849619|NCT01469637|37795599|FG000|Second Intervention|Incarcerated|1|||
16849620|NCT01469637|37795600|FG001|Second Intervention|Incarcerated|0|||
16849621|NCT01469013|37796330|FG000|Part A (Treatment Period)|Adverse Event|1|||
16849622|NCT01469013|37796331|FG001|Part A (Treatment Period)|Adverse Event|0|||
16849623|NCT01469013|37796332|FG002|Part A (Treatment Period)|Adverse Event|0|||
16849624|NCT01469013|37796333|FG003|Part A (Treatment Period)|Adverse Event|0|||
16849625|NCT01469013|37796334|FG004|Part A (Treatment Period)|Adverse Event|1|||
16849626|NCT01469013|37796335|FG005|Part A (Treatment Period)|Adverse Event|0|||
16849627|NCT01469013|37796336|FG006|Part A (Treatment Period)|Adverse Event|0|||
16849628|NCT01469013|37796337|FG007|Part A (Treatment Period)|Adverse Event|0|||
16849629|NCT01469013|37796338|FG008|Part A (Treatment Period)|Adverse Event|0|||
16849630|NCT01469013|37796339|FG009|Part A (Treatment Period)|Adverse Event|0|||
16849631|NCT01469013|37796340|FG010|Part A (Treatment Period)|Adverse Event|0|||
16849632|NCT01469013|37796341|FG011|Part A (Treatment Period)|Adverse Event|0|||
16849633|NCT01469013|37796342|FG012|Part A (Treatment Period)|Adverse Event|0|||
16849634|NCT01469013|37796330|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849635|NCT01469013|37796331|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849636|NCT01469013|37796332|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
16849637|NCT01469013|37796333|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849638|NCT01469013|37796334|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849639|NCT01469013|37796335|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849640|NCT01469013|37796336|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849641|NCT01469013|37796337|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849642|NCT01469013|37796338|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849643|NCT01469013|37796339|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849644|NCT01469013|37796340|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849645|NCT01469013|37796341|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849646|NCT01469013|37796342|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
16849647|NCT01469013|37796330|FG000|Part B (Extension Period)|Adverse Event|0|||
16849648|NCT01469013|37796331|FG001|Part B (Extension Period)|Adverse Event|0|||
16849649|NCT01469013|37796332|FG002|Part B (Extension Period)|Adverse Event|0|||
16849650|NCT01469013|37796333|FG003|Part B (Extension Period)|Adverse Event|0|||
16849651|NCT01469013|37796334|FG004|Part B (Extension Period)|Adverse Event|0|||
16849652|NCT01469013|37796335|FG005|Part B (Extension Period)|Adverse Event|2|||
16849653|NCT01469013|37796336|FG006|Part B (Extension Period)|Adverse Event|5|||
16849654|NCT01469013|37796337|FG007|Part B (Extension Period)|Adverse Event|5|||
16849655|NCT01469013|37796338|FG008|Part B (Extension Period)|Adverse Event|3|||
16849656|NCT01469013|37796339|FG009|Part B (Extension Period)|Adverse Event|3|||
16849657|NCT01469013|37796340|FG010|Part B (Extension Period)|Adverse Event|1|||
16849658|NCT01469013|37796341|FG011|Part B (Extension Period)|Adverse Event|6|||
16849659|NCT01469013|37796342|FG012|Part B (Extension Period)|Adverse Event|3|||
16849660|NCT01469013|37796330|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
16849661|NCT01469013|37796331|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
16849662|NCT01469013|37796332|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
16849663|NCT01469013|37796333|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
16849664|NCT01469013|37796334|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
16849665|NCT01469013|37796335|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
16849666|NCT01469013|37796336|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
16849667|NCT01469013|37796337|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
16849668|NCT01469013|37796338|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
16849669|NCT01469013|37796339|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
16849670|NCT01469013|37796340|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
16849671|NCT01469013|37796341|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
16849672|NCT01469013|37796342|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
16849673|NCT01493427|37796369|FG000|Overall Study|Adverse Event|10|||
16849674|NCT01493427|37796369|FG000|Overall Study|Personal Reasons|4|||
16849675|NCT01493427|37796369|FG000|Overall Study|Lost to Follow-up|2|||
16849676|NCT01493427|37796369|FG000|Overall Study|Inability to Follow Instructions|2|||
16849677|NCT01493427|37796369|FG000|Overall Study|Other|2|||
16849678|NCT01523457|37796375|FG000|Overall Study|Withdrawal by Subject|7|||
16849679|NCT01523457|37796376|FG001|Overall Study|Withdrawal by Subject|2|||
16849680|NCT01523301|37796384|FG000|Overall Study|Adverse Event|25|||
16849681|NCT01523301|37796385|FG001|Overall Study|Adverse Event|16|||
16849682|NCT01523301|37796384|FG000|Overall Study|Lack of Efficacy|0|||
16849683|NCT01523301|37796385|FG001|Overall Study|Lack of Efficacy|2|||
16849684|NCT01523301|37796384|FG000|Overall Study|Protocol Violation|3|||
16849685|NCT01523301|37796385|FG001|Overall Study|Protocol Violation|4|||
16849686|NCT01523301|37796384|FG000|Overall Study|Lost to Follow-up|1|||
16849687|NCT01523301|37796385|FG001|Overall Study|Lost to Follow-up|0|||
16849688|NCT01523301|37796384|FG000|Overall Study|Withdrawal by Subject|6|||
16849689|NCT01523301|37796385|FG001|Overall Study|Withdrawal by Subject|8|||
16849690|NCT01523301|37796384|FG000|Overall Study|Other Reason|0|||
16849691|NCT01523301|37796385|FG001|Overall Study|Other Reason|2|||
16849692|NCT01609556|37796407|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16926339|NCT01058005|38069844|FG002|Overall Study|Adverse Event|1|||
16926340|NCT01058005|38069842|FG000|Overall Study|Physician Decision|2|||
16926341|NCT01058005|38069843|FG001|Overall Study|Physician Decision|2|||
16926342|NCT01058005|38069844|FG002|Overall Study|Physician Decision|0|||
16926343|NCT01058005|38069842|FG000|Overall Study|Withdrawal by Subject|4|||
16926344|NCT01058005|38069843|FG001|Overall Study|Withdrawal by Subject|5|||
16926345|NCT01058005|38069844|FG002|Overall Study|Withdrawal by Subject|11|||
16926346|NCT01058005|38069842|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
16926347|NCT01058005|38069843|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
16926348|NCT01058005|38069844|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
16926349|NCT01058005|38069842|FG000|Overall Study|Reason Missing|5|||
16926350|NCT01058005|38069843|FG001|Overall Study|Reason Missing|3|||
16926351|NCT01058005|38069844|FG002|Overall Study|Reason Missing|1|||
16926352|NCT01056640|38069854|FG000|Overall Study|Withdrawal by Subject|11|||
16926353|NCT01056640|38069855|FG001|Overall Study|Withdrawal by Subject|8|||
16926354|NCT01056640|38069854|FG000|Overall Study|Death|15|||
16926355|NCT01056640|38069855|FG001|Overall Study|Death|4|||
16926356|NCT01056523|38069861|FG000|Overall Study|Death|1|||
16926357|NCT01056523|38069862|FG001|Overall Study|Death|0|||
16926358|NCT01056523|38069863|FG002|Overall Study|Death|2|||
16926359|NCT01056523|38069864|FG003|Overall Study|Death|3|||
16926360|NCT01056523|38069865|FG004|Overall Study|Death|0|||
16926361|NCT01056523|38069866|FG005|Overall Study|Death|0|||
16926362|NCT01056523|38069867|FG006|Overall Study|Death|1|||
16926363|NCT01056484|38069874|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
16926364|NCT01056484|38069875|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
16926365|NCT01056484|38069874|FG000|Randomized Controlled Trial|Physician Decision|1|||
16926366|NCT01056484|38069875|FG001|Randomized Controlled Trial|Physician Decision|0|||
16926367|NCT01056484|38069874|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
16926368|NCT01056484|38069875|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
16926369|NCT01055314|38069884|FG000|Overall Study|Adverse Event|7|||
16926370|NCT01055314|38069885|FG001|Overall Study|Adverse Event|4|||
16926371|NCT01055314|38069884|FG000|Overall Study|Death|2|||
16926372|NCT01055314|38069885|FG001|Overall Study|Death|1|||
16926373|NCT01055314|38069884|FG000|Overall Study|Lack of Efficacy|11|||
16926374|NCT01055314|38069885|FG001|Overall Study|Lack of Efficacy|19|||
16926375|NCT01055314|38069884|FG000|Overall Study|Physician Decision|10|||
16926376|NCT01055314|38069885|FG001|Overall Study|Physician Decision|5|||
16926377|NCT01055314|38069884|FG000|Overall Study|Withdrawal by Subject|1|||
16926378|NCT01055314|38069885|FG001|Overall Study|Withdrawal by Subject|0|||
16926379|NCT01055314|38069884|FG000|Overall Study|Ineligible|3|||
16926380|NCT01055314|38069885|FG001|Overall Study|Ineligible|5|||
16926381|NCT01055314|38069884|FG000|Overall Study|Refusal of further protocol therapy|10|||
16926382|NCT01055314|38069885|FG001|Overall Study|Refusal of further protocol therapy|4|||
16926383|NCT01055314|38069884|FG000|Overall Study|No treatment|1|||
16926384|NCT01055314|38069885|FG001|Overall Study|No treatment|0|||
16926385|NCT01055197|38069894|FG000|Overall Study|Protocol Violation|7|||
16926386|NCT01055197|38069895|FG001|Overall Study|Protocol Violation|2|||
16926387|NCT01055197|38069894|FG000|Overall Study|Withdrawal by Subject|2|||
16926388|NCT01055197|38069895|FG001|Overall Study|Withdrawal by Subject|0|||
16926389|NCT01054885|38069907|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
16926390|NCT01054885|38069908|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926391|NCT01054885|38069909|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926392|NCT01054885|38069910|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926393|NCT01054885|38069911|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926394|NCT01054885|38069912|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926395|NCT01054885|38069913|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926396|NCT01054885|38069907|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
16926397|NCT01054885|38069908|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926398|NCT01054885|38069909|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
17018167|NCT00576472|38162548|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16926399|NCT01054885|38069910|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926400|NCT01054885|38069911|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926401|NCT01054885|38069912|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926402|NCT01054885|38069913|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926403|NCT01054885|38069907|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
16849693|NCT01609556|37796408|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849694|NCT01609556|37796409|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849695|NCT01609556|37796410|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849696|NCT01609556|37796411|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16849697|NCT01609556|37796412|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849698|NCT01609556|37796413|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849699|NCT01609556|37796414|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16849700|NCT01609556|37796415|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16849701|NCT01609556|37796416|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849702|NCT01609556|37796417|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16849703|NCT01609556|37796418|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16849704|NCT01609556|37796419|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849705|NCT01609556|37796420|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849706|NCT01609556|37796421|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849707|NCT01609556|37796422|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16849708|NCT01609556|37796407|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16849709|NCT01609556|37796408|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
16849710|NCT01609556|37796409|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
16849711|NCT01609556|37796410|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
16849712|NCT01609556|37796411|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
16849713|NCT01609556|37796412|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
16849714|NCT01609556|37796413|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
16849715|NCT01609556|37796414|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
16849716|NCT01609556|37796415|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
16849717|NCT01609556|37796416|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
16849718|NCT01609556|37796417|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
16849719|NCT01609556|37796418|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
16849720|NCT01609556|37796419|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16849721|NCT01609556|37796420|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16849722|NCT01609556|37796421|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16849723|NCT01609556|37796422|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16849724|NCT01609556|37796407|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849725|NCT01609556|37796408|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849726|NCT01609556|37796409|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849727|NCT01609556|37796410|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849728|NCT01609556|37796411|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849729|NCT01609556|37796412|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
16849730|NCT01609556|37796413|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
16849731|NCT01609556|37796414|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849732|NCT01609556|37796415|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849733|NCT01609556|37796416|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
16849734|NCT01609556|37796417|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
16849735|NCT01609556|37796418|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
16849736|NCT01609556|37796419|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849737|NCT01609556|37796420|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849738|NCT01609556|37796421|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849739|NCT01609556|37796422|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16849740|NCT01609556|37796407|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849741|NCT01609556|37796408|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849742|NCT01609556|37796409|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849743|NCT01609556|37796410|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849744|NCT01609556|37796411|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849745|NCT01609556|37796412|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
16849746|NCT01609556|37796413|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849747|NCT01609556|37796414|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849748|NCT01609556|37796415|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849749|NCT01609556|37796416|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849750|NCT01609556|37796417|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849751|NCT01609556|37796418|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
16849752|NCT01609556|37796419|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849753|NCT01609556|37796420|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849754|NCT01609556|37796421|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849755|NCT01609556|37796422|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16849756|NCT01609556|37796407|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849757|NCT01609556|37796408|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849758|NCT01609556|37796409|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849759|NCT01609556|37796410|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849760|NCT01609556|37796411|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849761|NCT01609556|37796412|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
16849762|NCT01609556|37796413|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16926404|NCT01054885|38069908|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926405|NCT01054885|38069909|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926406|NCT01054885|38069910|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926407|NCT01054885|38069911|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926408|NCT01054885|38069912|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926409|NCT01054885|38069913|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926410|NCT01054885|38069907|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
16849763|NCT01609556|37796414|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849764|NCT01609556|37796415|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849765|NCT01609556|37796416|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849766|NCT01609556|37796417|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849767|NCT01609556|37796418|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849768|NCT01609556|37796419|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849769|NCT01609556|37796420|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16926411|NCT01054885|38069908|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926412|NCT01054885|38069909|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16849770|NCT01609556|37796421|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16849771|NCT01609556|37796422|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16926413|NCT01054885|38069910|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926414|NCT01054885|38069911|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926415|NCT01054885|38069912|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926416|NCT01054885|38069913|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926417|NCT01054885|38069907|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
16926418|NCT01054885|38069908|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926419|NCT01054885|38069909|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926420|NCT01054885|38069910|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926421|NCT01054885|38069911|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926422|NCT01054885|38069912|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926423|NCT01054885|38069913|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926424|NCT01054885|38069907|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
16926425|NCT01054885|38069908|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926426|NCT01054885|38069909|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926427|NCT01054885|38069910|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926428|NCT01054885|38069911|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926429|NCT01054885|38069912|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926430|NCT01054885|38069913|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926431|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
16926432|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
16926433|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
16926434|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
16926435|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
16926436|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
16926437|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
16926438|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16926439|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16926440|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
17018168|NCT00576472|38162549|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018169|NCT00576472|38162550|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018170|NCT00576472|38162551|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018171|NCT00576472|38162552|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018172|NCT00576472|38162553|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018173|NCT00576472|38162554|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018174|NCT00576472|38162555|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018175|NCT00576472|38162556|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018176|NCT00576472|38162557|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16849772|NCT01609556|37796407|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849773|NCT01609556|37796408|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849774|NCT01609556|37796409|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849775|NCT01609556|37796410|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849776|NCT01609556|37796411|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849777|NCT01609556|37796412|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849778|NCT01609556|37796413|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
17018177|NCT00576472|38162558|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018178|NCT00576472|38162559|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16849779|NCT01609556|37796414|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849780|NCT01609556|37796415|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
16849781|NCT01609556|37796416|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849782|NCT01609556|37796417|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849783|NCT01609556|37796418|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849784|NCT01609556|37796419|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849785|NCT01609556|37796420|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849786|NCT01609556|37796421|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849787|NCT01609556|37796422|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16849788|NCT01609556|37796407|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
16849789|NCT01609556|37796408|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849790|NCT01609556|37796409|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849791|NCT01609556|37796410|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849792|NCT01609556|37796411|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849793|NCT01609556|37796412|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
16849794|NCT01609556|37796413|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849795|NCT01609556|37796414|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849796|NCT01609556|37796415|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849797|NCT01609556|37796416|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849798|NCT01609556|37796417|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
16849799|NCT01609556|37796418|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849800|NCT01609556|37796419|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849801|NCT01609556|37796420|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849802|NCT01609556|37796421|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849803|NCT01609556|37796422|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16849804|NCT01609556|37796407|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849805|NCT01609556|37796408|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849806|NCT01609556|37796409|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849807|NCT01609556|37796410|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849808|NCT01609556|37796411|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849809|NCT01609556|37796412|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849810|NCT01609556|37796413|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849811|NCT01609556|37796414|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849812|NCT01609556|37796415|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849813|NCT01609556|37796416|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849814|NCT01609556|37796417|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849815|NCT01609556|37796418|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16849816|NCT01609556|37796419|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
16849817|NCT01609556|37796420|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
16849818|NCT01609556|37796421|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
16849819|NCT01609556|37796422|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
16849820|NCT01609556|37796407|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849821|NCT01609556|37796408|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849822|NCT01609556|37796409|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849823|NCT01609556|37796410|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16926441|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
16926442|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16926443|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
16926444|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16926445|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
16926446|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
16926447|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
17018179|NCT00576472|38162560|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
17018180|NCT00576472|38162561|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
17018181|NCT00823212|38162594|FG000|Overall Study|Death|8|||
17018182|NCT00823212|38162595|FG001|Overall Study|Death|10|||
17018183|NCT00823212|38162594|FG000|Overall Study|Withdrawal by Subject|6|||
17018184|NCT00823212|38162595|FG001|Overall Study|Withdrawal by Subject|1|||
17018185|NCT00823212|38162594|FG000|Overall Study|Incarcerated|0|||
17018186|NCT00823212|38162595|FG001|Overall Study|Incarcerated|1|||
17018187|NCT00823212|38162594|FG000|Overall Study|Missed 12-month visit|21|||
17018188|NCT00823212|38162595|FG001|Overall Study|Missed 12-month visit|21|||
17018189|NCT00807495|38162608|FG000|Overall Study|Adverse Event|6|||
17018190|NCT00807495|38162609|FG001|Overall Study|Adverse Event|3|||
17018191|NCT00807495|38162610|FG002|Overall Study|Adverse Event|1|||
16926448|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
16926449|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
17018192|NCT00807495|38162611|FG003|Overall Study|Adverse Event|1|||
16926450|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
16926451|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
16926452|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16926453|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
16926454|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
16926455|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
16926456|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
16926457|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
16926458|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
16926459|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
16926460|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
16926461|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
16926462|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
16926463|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
16926464|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
16926465|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
16926466|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16926467|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16926468|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
16926469|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16926470|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16926471|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16926472|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
16926473|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16926474|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
16926475|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
16926476|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16926477|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16926478|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
16926479|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16926480|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
16926481|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
16926482|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
16849824|NCT01609556|37796411|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849825|NCT01609556|37796412|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849826|NCT01609556|37796413|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849827|NCT01609556|37796414|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16926483|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
16926484|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
16926485|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
16926486|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
17018193|NCT00807495|38162612|FG004|Overall Study|Adverse Event|2|||
17018194|NCT00807495|38162608|FG000|Overall Study|Withdrawal by Patient|2|||
17018195|NCT00807495|38162609|FG001|Overall Study|Withdrawal by Patient|0|||
17018196|NCT00807495|38162610|FG002|Overall Study|Withdrawal by Patient|1|||
17018197|NCT00807495|38162611|FG003|Overall Study|Withdrawal by Patient|0|||
17018198|NCT00807495|38162612|FG004|Overall Study|Withdrawal by Patient|0|||
17018199|NCT00807495|38162608|FG000|Overall Study|Reason Not Specified|0|||
17018200|NCT00807495|38162609|FG001|Overall Study|Reason Not Specified|3|||
17018201|NCT00807495|38162610|FG002|Overall Study|Reason Not Specified|2|||
17018202|NCT00807495|38162611|FG003|Overall Study|Reason Not Specified|0|||
17018203|NCT00807495|38162612|FG004|Overall Study|Reason Not Specified|3|||
17018204|NCT00576316|38162624|FG000|Overall Study|Adverse Event|9|||
17018205|NCT00576316|38162624|FG000|Overall Study|Withdrawal by Subject|2|||
17018206|NCT00576316|38162624|FG000|Overall Study|Protocol Violation|9|||
17018207|NCT00823134|38162628|FG000|Overall Study|Invalid measurement|1|||
16849828|NCT01609556|37796415|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849829|NCT01609556|37796416|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849830|NCT01609556|37796417|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849831|NCT01609556|37796418|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16849832|NCT01609556|37796419|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
16849833|NCT01609556|37796420|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
16849834|NCT01609556|37796421|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
16849835|NCT01609556|37796422|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
16849836|NCT01609556|37796407|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849837|NCT01609556|37796408|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16926487|NCT01054885|38069907|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16849838|NCT01609556|37796409|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849839|NCT01609556|37796410|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849840|NCT01609556|37796411|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849841|NCT01609556|37796412|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849842|NCT01609556|37796413|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849843|NCT01609556|37796414|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849844|NCT01609556|37796415|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849845|NCT01609556|37796416|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849846|NCT01609556|37796417|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16849847|NCT01609556|37796418|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16926488|NCT01054885|38069908|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
16926489|NCT01054885|38069909|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16926490|NCT01054885|38069910|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
16926491|NCT01054885|38069911|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
16926492|NCT01054885|38069912|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16926493|NCT01054885|38069913|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
16926494|NCT01054846|38069930|FG000|Overall Study|Lost to Follow-up|76|||
16926495|NCT01054846|38069931|FG001|Overall Study|Lost to Follow-up|17|||
16926496|NCT01054729|38069940|FG000|Overall Study|Randomized but Not Treated|0|||
16926497|NCT01054729|38069941|FG001|Overall Study|Randomized but Not Treated|1|||
16926498|NCT01054729|38069942|FG002|Overall Study|Randomized but Not Treated|0|||
16926499|NCT01054729|38069943|FG003|Overall Study|Randomized but Not Treated|0|||
16926500|NCT01054729|38069940|FG000|Overall Study|Adverse Event|1|||
16926501|NCT01054729|38069941|FG001|Overall Study|Adverse Event|1|||
16926502|NCT01054729|38069942|FG002|Overall Study|Adverse Event|2|||
16926503|NCT01054729|38069943|FG003|Overall Study|Adverse Event|1|||
16926504|NCT01054729|38069940|FG000|Overall Study|Withdrawal by Subject|1|||
16926505|NCT01054729|38069941|FG001|Overall Study|Withdrawal by Subject|0|||
16926506|NCT01054729|38069942|FG002|Overall Study|Withdrawal by Subject|1|||
16926507|NCT01054729|38069943|FG003|Overall Study|Withdrawal by Subject|0|||
16926508|NCT01054729|38069940|FG000|Overall Study|Lost to Follow-up|0|||
16926509|NCT01054729|38069941|FG001|Overall Study|Lost to Follow-up|1|||
16926510|NCT01054729|38069942|FG002|Overall Study|Lost to Follow-up|0|||
16926511|NCT01054729|38069943|FG003|Overall Study|Lost to Follow-up|0|||
16926512|NCT01054729|38069940|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
16926513|NCT01054729|38069941|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
16926514|NCT01054729|38069942|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
16926515|NCT01054729|38069943|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
16926516|NCT01054729|38069940|FG000|Overall Study|Non-responder|1|||
16926517|NCT01054729|38069941|FG001|Overall Study|Non-responder|0|||
16926518|NCT01054729|38069942|FG002|Overall Study|Non-responder|1|||
16926519|NCT01054729|38069943|FG003|Overall Study|Non-responder|1|||
16926520|NCT01054729|38069940|FG000|Overall Study|PEG/RBV Non-responder|1|||
16926521|NCT01054729|38069941|FG001|Overall Study|PEG/RBV Non-responder|0|||
16926522|NCT01054729|38069942|FG002|Overall Study|PEG/RBV Non-responder|1|||
16926523|NCT01054729|38069943|FG003|Overall Study|PEG/RBV Non-responder|0|||
16849848|NCT01609556|37796419|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
16926524|NCT01054729|38069940|FG000|Overall Study|Personal/Obligations|0|||
16926525|NCT01054729|38069941|FG001|Overall Study|Personal/Obligations|1|||
16926526|NCT01054729|38069942|FG002|Overall Study|Personal/Obligations|0|||
16926527|NCT01054729|38069943|FG003|Overall Study|Personal/Obligations|0|||
16926528|NCT01054729|38069940|FG000|Overall Study|Subject moved|0|||
16926529|NCT01054729|38069941|FG001|Overall Study|Subject moved|0|||
16926530|NCT01054729|38069942|FG002|Overall Study|Subject moved|1|||
16926531|NCT01054729|38069943|FG003|Overall Study|Subject moved|0|||
16926532|NCT01054729|38069940|FG000|Overall Study|Lack of Efficacy|0|||
16926533|NCT01054729|38069941|FG001|Overall Study|Lack of Efficacy|0|||
16849849|NCT01609556|37796420|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
16849850|NCT01609556|37796421|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
16849851|NCT01609556|37796422|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
16926534|NCT01054729|38069942|FG002|Overall Study|Lack of Efficacy|0|||
16926535|NCT01054729|38069943|FG003|Overall Study|Lack of Efficacy|1|||
16926536|NCT01054573|38069957|FG000|Overall Study|Adverse Event|1|||
16926537|NCT01054573|38069958|FG001|Overall Study|Adverse Event|0|||
16926538|NCT01054573|38069959|FG002|Overall Study|Adverse Event|1|||
16926539|NCT01054573|38069960|FG003|Overall Study|Adverse Event|1|||
16926540|NCT01054573|38069957|FG000|Overall Study|Lost to Follow-up|0|||
16926541|NCT01054573|38069958|FG001|Overall Study|Lost to Follow-up|2|||
16926542|NCT01054573|38069959|FG002|Overall Study|Lost to Follow-up|0|||
16926543|NCT01054573|38069960|FG003|Overall Study|Lost to Follow-up|0|||
16926544|NCT01054573|38069957|FG000|Overall Study|Withdrawal by Subject|0|||
16926545|NCT01054573|38069958|FG001|Overall Study|Withdrawal by Subject|2|||
16849852|NCT01609556|37796407|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16926546|NCT01054573|38069959|FG002|Overall Study|Withdrawal by Subject|2|||
16926547|NCT01054573|38069960|FG003|Overall Study|Withdrawal by Subject|1|||
16926548|NCT01054456|38069979|FG000|Overall Study|Other|1|||
16926549|NCT01054300|38069985|FG000|Period 1|Adverse Event|1|||
16926550|NCT01054300|38069986|FG001|Period 1|Adverse Event|0|||
16926551|NCT01054300|38069987|FG002|Period 1|Adverse Event|0|||
16849853|NCT01609556|37796408|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849854|NCT01609556|37796409|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849855|NCT01609556|37796410|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849856|NCT01609556|37796411|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849857|NCT01609556|37796412|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849858|NCT01609556|37796413|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849859|NCT01609556|37796414|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849860|NCT01609556|37796415|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849861|NCT01609556|37796416|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849862|NCT01609556|37796417|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16926552|NCT01054300|38069988|FG003|Period 1|Adverse Event|0|||
16926553|NCT01054300|38069985|FG000|Period 2|Withdrawal by Subject|0|||
16926554|NCT01054300|38069986|FG001|Period 2|Withdrawal by Subject|0|||
16926555|NCT01054300|38069987|FG002|Period 2|Withdrawal by Subject|1|||
16926556|NCT01054300|38069988|FG003|Period 2|Withdrawal by Subject|0|||
16926557|NCT01053988|38070003|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
16926558|NCT01053988|38070004|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926559|NCT01053988|38070005|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926560|NCT01053988|38070006|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926561|NCT01053988|38070007|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926562|NCT01053988|38070008|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16926563|NCT01053988|38070003|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
16926564|NCT01053988|38070004|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16849863|NCT01609556|37796418|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849864|NCT01609556|37796419|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
16849865|NCT01609556|37796420|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849866|NCT01609556|37796421|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849867|NCT01609556|37796422|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16849868|NCT01609556|37796407|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849869|NCT01609556|37796408|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849870|NCT01609556|37796409|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849871|NCT01609556|37796410|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849872|NCT01609556|37796411|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849873|NCT01609556|37796412|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849874|NCT01609556|37796413|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849875|NCT01609556|37796414|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849876|NCT01609556|37796415|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16926565|NCT01053988|38070005|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926566|NCT01053988|38070006|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926567|NCT01053988|38070007|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926568|NCT01053988|38070008|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16926569|NCT01053988|38070003|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
16926570|NCT01053988|38070004|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926571|NCT01053988|38070005|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16849877|NCT01609556|37796416|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16926572|NCT01053988|38070006|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926573|NCT01053988|38070007|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926574|NCT01053988|38070008|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16926575|NCT01053988|38070003|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
16926576|NCT01053988|38070004|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926577|NCT01053988|38070005|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926578|NCT01053988|38070006|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926579|NCT01053988|38070007|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926580|NCT01053988|38070008|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
16926581|NCT01053988|38070003|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
16926582|NCT01053988|38070004|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926583|NCT01053988|38070005|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926584|NCT01053988|38070006|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926585|NCT01053988|38070007|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926586|NCT01053988|38070008|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
16926587|NCT01053988|38070003|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
16926588|NCT01053988|38070004|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926589|NCT01053988|38070005|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926590|NCT01053988|38070006|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926591|NCT01053988|38070007|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926592|NCT01053988|38070008|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16926593|NCT01053988|38070003|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
16926594|NCT01053988|38070004|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
16926595|NCT01053988|38070005|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
16926596|NCT01053988|38070006|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
16926597|NCT01053988|38070007|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
16926598|NCT01053988|38070008|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
16926599|NCT01053988|38070003|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16926600|NCT01053988|38070004|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
16926601|NCT01053988|38070005|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
16926602|NCT01053988|38070006|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
16926603|NCT01053988|38070007|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
16926604|NCT01053988|38070008|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16926605|NCT01053988|38070003|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
16926606|NCT01053988|38070004|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
16926607|NCT01053988|38070005|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
16926608|NCT01053988|38070006|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
16926609|NCT01053988|38070007|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
16926610|NCT01053988|38070008|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
16926611|NCT01053988|38070003|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16926612|NCT01053988|38070004|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
16926613|NCT01053988|38070005|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
16926614|NCT01053988|38070006|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
16926615|NCT01053988|38070007|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
16926616|NCT01053988|38070008|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
16926617|NCT01053988|38070003|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16926618|NCT01053988|38070004|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
16926619|NCT01053988|38070005|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
16926620|NCT01053988|38070006|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
16926621|NCT01053988|38070007|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
16926622|NCT01053988|38070008|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
16926623|NCT01053988|38070003|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16849878|NCT01609556|37796417|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849879|NCT01609556|37796418|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16849880|NCT01609556|37796419|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
16849881|NCT01609556|37796420|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
16849882|NCT01609556|37796421|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
16849883|NCT01609556|37796422|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
16849884|NCT01609556|37796407|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16926624|NCT01053988|38070004|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
16926625|NCT01053988|38070005|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16926626|NCT01053988|38070006|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
16926627|NCT01053988|38070007|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16926628|NCT01053988|38070008|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
16926629|NCT01053988|38070003|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
16926630|NCT01053988|38070004|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
16926631|NCT01053988|38070005|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
16926632|NCT01053988|38070006|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
16926633|NCT01053988|38070007|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
16926634|NCT01053988|38070008|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
16926635|NCT01053988|38070003|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16926636|NCT01053988|38070004|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
16926637|NCT01053988|38070005|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16926638|NCT01053988|38070006|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
16926639|NCT01053988|38070007|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
16926640|NCT01053988|38070008|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16926641|NCT01053247|38070023|FG000|Overall Study|Withdrawal by Subject|9|||
16926642|NCT01053247|38070024|FG001|Overall Study|Withdrawal by Subject|4|||
16849885|NCT01609556|37796408|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849886|NCT01609556|37796409|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849887|NCT01609556|37796410|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849888|NCT01609556|37796411|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849889|NCT01609556|37796412|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849890|NCT01609556|37796413|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849891|NCT01609556|37796414|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849892|NCT01609556|37796415|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849893|NCT01609556|37796416|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849894|NCT01609556|37796417|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849895|NCT01609556|37796418|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849896|NCT01609556|37796419|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
17018208|NCT00831792|38162633|FG000|Overall Study|Not Eligible|3|||
17018209|NCT00831792|38162633|FG000|Overall Study|Adverse Event|1|||
17018210|NCT00831792|38162633|FG000|Overall Study|Death|1|||
17018211|NCT00831792|38162633|FG000|Overall Study|Lack of Efficacy|1|||
17018212|NCT00575380|38162639|FG000|Overall Study|Withdrawal by Subject|1|||
17018213|NCT00575380|38162640|FG001|Overall Study|Withdrawal by Subject|0|||
17018214|NCT00575380|38162639|FG000|Overall Study|Adverse Event|0|||
17018215|NCT00575380|38162640|FG001|Overall Study|Adverse Event|1|||
17018216|NCT00575380|38162639|FG000|Overall Study|Various|0|||
17018217|NCT00575380|38162640|FG001|Overall Study|Various|2|||
17018218|NCT00840996|38162648|FG000|Overall Study|Withdrawal by Subject|1|||
17018219|NCT00840996|38162649|FG001|Overall Study|Withdrawal by Subject|0|||
17018220|NCT00680914|38162657|FG000|Overall Study|Consent withdrawal|6|||
17018221|NCT00680914|38162658|FG001|Overall Study|Consent withdrawal|3|||
17018222|NCT00680914|38162657|FG000|Overall Study|Lost to Follow-up|4|||
17018223|NCT00680914|38162658|FG001|Overall Study|Lost to Follow-up|0|||
17018224|NCT00680914|38162657|FG000|Overall Study|serious adverse event (SAE)|0|||
17018225|NCT00680914|38162658|FG001|Overall Study|serious adverse event (SAE)|1|||
17018226|NCT00680836|38162666|FG000|Overall Study|Withdrawal by Subject|3|||
17018227|NCT00680836|38162667|FG001|Overall Study|Withdrawal by Subject|0|||
17018228|NCT00680836|38162666|FG000|Overall Study|Lost to Follow-up|3|||
17018229|NCT00680836|38162667|FG001|Overall Study|Lost to Follow-up|1|||
17018230|NCT00680836|38162666|FG000|Overall Study|Physician Decision|2|||
17018231|NCT00680836|38162667|FG001|Overall Study|Physician Decision|1|||
17018232|NCT00679432|38162678|FG000|Overall Study|Adverse Event|5|||
17018233|NCT00679432|38162679|FG001|Overall Study|Adverse Event|6|||
17018234|NCT00679432|38162680|FG002|Overall Study|Adverse Event|10|||
17018235|NCT00679432|38162681|FG003|Overall Study|Adverse Event|7|||
17018236|NCT00679432|38162678|FG000|Overall Study|Protocol Violation|1|||
17018237|NCT00679432|38162679|FG001|Overall Study|Protocol Violation|1|||
17018238|NCT00679432|38162680|FG002|Overall Study|Protocol Violation|2|||
17018239|NCT00679432|38162681|FG003|Overall Study|Protocol Violation|1|||
17018240|NCT00679432|38162678|FG000|Overall Study|Withdrawal by Subject|8|||
17018241|NCT00679432|38162679|FG001|Overall Study|Withdrawal by Subject|11|||
17018242|NCT00679432|38162680|FG002|Overall Study|Withdrawal by Subject|10|||
17018243|NCT00679432|38162681|FG003|Overall Study|Withdrawal by Subject|9|||
17018244|NCT00679432|38162678|FG000|Overall Study|Lost to Follow-up|1|||
17018245|NCT00679432|38162679|FG001|Overall Study|Lost to Follow-up|5|||
17018246|NCT00679432|38162680|FG002|Overall Study|Lost to Follow-up|4|||
17018247|NCT00679432|38162681|FG003|Overall Study|Lost to Follow-up|2|||
17018248|NCT00679432|38162678|FG000|Overall Study|Physician Decision|3|||
17018249|NCT00679432|38162679|FG001|Overall Study|Physician Decision|2|||
17018250|NCT00679432|38162680|FG002|Overall Study|Physician Decision|2|||
17018251|NCT00679432|38162681|FG003|Overall Study|Physician Decision|2|||
17018252|NCT00679432|38162678|FG000|Overall Study|Sponsor decision|1|||
17018253|NCT00679432|38162679|FG001|Overall Study|Sponsor decision|0|||
17018254|NCT00679432|38162680|FG002|Overall Study|Sponsor decision|0|||
17018255|NCT00679432|38162681|FG003|Overall Study|Sponsor decision|0|||
17018256|NCT00679432|38162678|FG000|Overall Study|Lack of Efficacy|13|||
17018257|NCT00679432|38162679|FG001|Overall Study|Lack of Efficacy|9|||
16926643|NCT01053247|38070025|FG002|Overall Study|Withdrawal by Subject|15|||
16926644|NCT01053247|38070023|FG000|Overall Study|Lack of Efficacy|1|||
16926645|NCT01053247|38070024|FG001|Overall Study|Lack of Efficacy|0|||
16926646|NCT01053247|38070025|FG002|Overall Study|Lack of Efficacy|1|||
16926647|NCT01053247|38070023|FG000|Overall Study|Protocol Violation|2|||
16926648|NCT01053247|38070024|FG001|Overall Study|Protocol Violation|1|||
16926649|NCT01053247|38070025|FG002|Overall Study|Protocol Violation|2|||
16926650|NCT01053247|38070023|FG000|Overall Study|Lost to Follow-up|8|||
16926651|NCT01053247|38070024|FG001|Overall Study|Lost to Follow-up|5|||
16926652|NCT01053247|38070025|FG002|Overall Study|Lost to Follow-up|7|||
17018258|NCT00679432|38162680|FG002|Overall Study|Lack of Efficacy|14|||
17018259|NCT00679432|38162681|FG003|Overall Study|Lack of Efficacy|8|||
17018260|NCT00679432|38162678|FG000|Overall Study|Infectious colitis, normal histology|5|||
16849897|NCT01609556|37796420|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16926653|NCT01053247|38070023|FG000|Overall Study|Adverse Event|0|||
16926654|NCT01053247|38070024|FG001|Overall Study|Adverse Event|9|||
16926655|NCT01053247|38070025|FG002|Overall Study|Adverse Event|3|||
16926656|NCT01052779|38070035|FG000|Overall Study|Adverse Event|1|||
16926657|NCT01052779|38070036|FG001|Overall Study|Adverse Event|4|||
16926658|NCT01052779|38070035|FG000|Overall Study|Withdrawal by Subject|1|||
16926659|NCT01052779|38070036|FG001|Overall Study|Withdrawal by Subject|2|||
16926660|NCT01052779|38070035|FG000|Overall Study|Other-Protocol Violation|1|||
16926661|NCT01052779|38070036|FG001|Overall Study|Other-Protocol Violation|1|||
16926662|NCT01052779|38070035|FG000|Overall Study|Other-Surgery|0|||
16926663|NCT01052779|38070036|FG001|Overall Study|Other-Surgery|2|||
16926664|NCT01052779|38070035|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
16926665|NCT01052779|38070036|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
16926666|NCT01052662|38070045|FG000|Overall Study|Lost to Follow-up|15|||
16926667|NCT01052662|38070046|FG001|Overall Study|Lost to Follow-up|13|||
16849898|NCT01609556|37796421|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16849899|NCT01609556|37796422|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
16849900|NCT01609556|37796407|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849901|NCT01609556|37796408|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849902|NCT01609556|37796409|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849903|NCT01609556|37796410|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849904|NCT01609556|37796411|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849905|NCT01609556|37796412|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849906|NCT01609556|37796413|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849907|NCT01609556|37796414|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849908|NCT01609556|37796415|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849909|NCT01609556|37796416|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
16926668|NCT01052662|38070047|FG002|Overall Study|Lost to Follow-up|18|||
16926669|NCT01052662|38070045|FG000|Overall Study|Withdrawal by Subject|3|||
16926670|NCT01052662|38070046|FG001|Overall Study|Withdrawal by Subject|2|||
16926671|NCT01052662|38070047|FG002|Overall Study|Withdrawal by Subject|1|||
16926672|NCT01052662|38070045|FG000|Overall Study|Pharmacy issue|1|||
16926673|NCT01052662|38070046|FG001|Overall Study|Pharmacy issue|3|||
16926674|NCT01052662|38070047|FG002|Overall Study|Pharmacy issue|3|||
16926675|NCT01052662|38070045|FG000|Overall Study|Adverse Event|1|||
16926676|NCT01052662|38070046|FG001|Overall Study|Adverse Event|1|||
16926677|NCT01052662|38070047|FG002|Overall Study|Adverse Event|0|||
16926678|NCT01052662|38070045|FG000|Overall Study|Legal Problem|2|||
16926679|NCT01052662|38070046|FG001|Overall Study|Legal Problem|0|||
16926680|NCT01052662|38070047|FG002|Overall Study|Legal Problem|0|||
16926681|NCT01052662|38070045|FG000|Overall Study|Administrative|0|||
16926682|NCT01052662|38070046|FG001|Overall Study|Administrative|3|||
16926683|NCT01052662|38070047|FG002|Overall Study|Administrative|0|||
16926684|NCT01052116|38070057|FG000|Overall Study|Lost to Follow-up|11|||
16926685|NCT01052116|38070058|FG001|Overall Study|Lost to Follow-up|17|||
16926686|NCT01052116|38070057|FG000|Overall Study|Withdrawal by Subject|3|||
16926687|NCT01052116|38070058|FG001|Overall Study|Withdrawal by Subject|6|||
16926688|NCT01052116|38070057|FG000|Overall Study|Spirometry not performed|0|||
16926689|NCT01052116|38070058|FG001|Overall Study|Spirometry not performed|4|||
16926690|NCT01052077|38070066|FG000|Phase A|Lost to Follow-up|22|||
16926691|NCT01052077|38070067|FG001|Phase A|Lost to Follow-up|0|||
16926692|NCT01052077|38070068|FG002|Phase A|Lost to Follow-up|0|||
16926693|NCT01052077|38070069|FG003|Phase A|Lost to Follow-up|0|||
16926694|NCT01052077|38070066|FG000|Phase A|Adverse Event|32|||
16926695|NCT01052077|38070067|FG001|Phase A|Adverse Event|0|||
16926696|NCT01052077|38070068|FG002|Phase A|Adverse Event|0|||
16926697|NCT01052077|38070069|FG003|Phase A|Adverse Event|0|||
16926698|NCT01052077|38070066|FG000|Phase A|Met Withdrawal Criteria|26|||
16926699|NCT01052077|38070067|FG001|Phase A|Met Withdrawal Criteria|0|||
16849910|NCT01609556|37796417|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849911|NCT01609556|37796418|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
16926700|NCT01052077|38070068|FG002|Phase A|Met Withdrawal Criteria|0|||
16926701|NCT01052077|38070069|FG003|Phase A|Met Withdrawal Criteria|0|||
16849912|NCT01609556|37796419|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
16849913|NCT01609556|37796420|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
16849914|NCT01609556|37796421|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
16849915|NCT01609556|37796422|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
16849916|NCT01609556|37796407|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849917|NCT01609556|37796408|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849918|NCT01609556|37796409|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849919|NCT01609556|37796410|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849920|NCT01609556|37796411|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849921|NCT01609556|37796412|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16926702|NCT01052077|38070066|FG000|Phase A|Physician Decision|10|||
16926703|NCT01052077|38070067|FG001|Phase A|Physician Decision|0|||
16926704|NCT01052077|38070068|FG002|Phase A|Physician Decision|0|||
16849922|NCT01609556|37796413|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849923|NCT01609556|37796414|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
17018261|NCT00679432|38162679|FG001|Overall Study|Infectious colitis, normal histology|4|||
17018262|NCT00679432|38162680|FG002|Overall Study|Infectious colitis, normal histology|8|||
17018263|NCT00679432|38162681|FG003|Overall Study|Infectious colitis, normal histology|3|||
16926705|NCT01052077|38070069|FG003|Phase A|Physician Decision|0|||
16926706|NCT01052077|38070066|FG000|Phase A|Withdrawal by Subject|29|||
16926707|NCT01052077|38070067|FG001|Phase A|Withdrawal by Subject|0|||
16926708|NCT01052077|38070068|FG002|Phase A|Withdrawal by Subject|0|||
16926709|NCT01052077|38070069|FG003|Phase A|Withdrawal by Subject|0|||
16926710|NCT01052077|38070066|FG000|Phase A|Protocol Deviation|27|||
16926711|NCT01052077|38070067|FG001|Phase A|Protocol Deviation|0|||
16926712|NCT01052077|38070068|FG002|Phase A|Protocol Deviation|0|||
16926713|NCT01052077|38070069|FG003|Phase A|Protocol Deviation|0|||
16926714|NCT01052077|38070066|FG000|Phase B|Lost to Follow-up|0|||
16926715|NCT01052077|38070067|FG001|Phase B|Lost to Follow-up|2|||
16926716|NCT01052077|38070068|FG002|Phase B|Lost to Follow-up|3|||
17018264|NCT00679432|38162678|FG000|Overall Study|Randomization error, return to prior Rx|0|||
17018265|NCT00679432|38162679|FG001|Overall Study|Randomization error, return to prior Rx|0|||
17018266|NCT00679432|38162680|FG002|Overall Study|Randomization error, return to prior Rx|3|||
17018267|NCT00679432|38162681|FG003|Overall Study|Randomization error, return to prior Rx|0|||
17018268|NCT00679354|38162691|FG000|Overall Study|Death|3|||
17018269|NCT00679354|38162691|FG000|Overall Study|Lack of Efficacy|22|||
17018270|NCT00679354|38162691|FG000|Overall Study|Physician Decision|4|||
17018271|NCT00679354|38162691|FG000|Overall Study|Ineligible|1|||
17018272|NCT00822900|38162698|FG000|Overall Study|Withdrawal by Subject|14|||
17018273|NCT00822900|38162699|FG001|Overall Study|Withdrawal by Subject|14|||
17018274|NCT00822900|38162698|FG000|Overall Study|Lost to Follow-up|9|||
17018275|NCT00822900|38162699|FG001|Overall Study|Lost to Follow-up|9|||
17018276|NCT00822900|38162698|FG000|Overall Study|Death|83|||
16849924|NCT01609556|37796415|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849925|NCT01609556|37796416|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849926|NCT01609556|37796417|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849927|NCT01609556|37796418|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849928|NCT01609556|37796419|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
16849929|NCT01609556|37796420|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849930|NCT01609556|37796421|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849931|NCT01609556|37796422|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16849932|NCT01806506|37796465|FG000|Overall Study|Lost to Follow-up|2|||
16849933|NCT01806506|37796466|FG001|Overall Study|Lost to Follow-up|1|||
16849934|NCT01766336|37796474|FG000|Overall Study|Adverse Event|11|||
16849935|NCT01766336|37796475|FG001|Overall Study|Adverse Event|8|||
16849936|NCT01766336|37796474|FG000|Overall Study|Death|4|||
16849937|NCT01766336|37796475|FG001|Overall Study|Death|3|||
16849938|NCT01766336|37796474|FG000|Overall Study|Lost to Follow-up|1|||
16849939|NCT01766336|37796475|FG001|Overall Study|Lost to Follow-up|3|||
16849940|NCT01766336|37796474|FG000|Overall Study|Physician Decision|4|||
16849941|NCT01766336|37796475|FG001|Overall Study|Physician Decision|2|||
16849942|NCT01766336|37796474|FG000|Overall Study|Protocol Violation|0|||
16849943|NCT01766336|37796475|FG001|Overall Study|Protocol Violation|1|||
16849944|NCT01766336|37796474|FG000|Overall Study|Sponsor Decision|52|||
16849945|NCT01766336|37796475|FG001|Overall Study|Sponsor Decision|43|||
16849946|NCT01766336|37796474|FG000|Overall Study|Withdrawal by Subject|18|||
16849947|NCT01766336|37796475|FG001|Overall Study|Withdrawal by Subject|15|||
16849948|NCT01797536|37796485|FG000|Overall Study|Adverse Event|0|||
16849949|NCT01797536|37796486|FG001|Overall Study|Adverse Event|1|||
16849950|NCT01797536|37796487|FG002|Overall Study|Adverse Event|0|||
16849951|NCT01797536|37796488|FG003|Overall Study|Adverse Event|0|||
16849952|NCT01797302|37796501|FG000|Overall Study|Lost to Follow-up|16|||
16849953|NCT01797302|37796502|FG001|Overall Study|Lost to Follow-up|23|||
16849954|NCT01797302|37796503|FG002|Overall Study|Lost to Follow-up|22|||
16849955|NCT01797302|37796501|FG000|Overall Study|Withdrawal by Subject|1|||
16849956|NCT01797302|37796502|FG001|Overall Study|Withdrawal by Subject|3|||
16849957|NCT01797302|37796503|FG002|Overall Study|Withdrawal by Subject|4|||
16849958|NCT01805180|37796513|FG000|Lead-in Donor Phase|screen failure|1|||
16849959|NCT01805180|37796514|FG001|Lead-in Donor Phase|screen failure|0|||
16849960|NCT01805180|37796515|FG002|Lead-in Donor Phase|screen failure|0|||
16849961|NCT01804946|37796525|FG000|Overall Study|Protocol Violation|1|||
16849962|NCT01804946|37796526|FG001|Overall Study|Protocol Violation|0|||
16849963|NCT01804946|37796525|FG000|Overall Study|Adverse Event|0|||
16849964|NCT01804946|37796526|FG001|Overall Study|Adverse Event|1|||
16849965|NCT01804946|37796525|FG000|Overall Study|Insufficient data available|0|||
16849966|NCT01804946|37796526|FG001|Overall Study|Insufficient data available|1|||
16926717|NCT01052077|38070069|FG003|Phase B|Lost to Follow-up|0|||
16926718|NCT01052077|38070066|FG000|Phase B|Adverse Event|0|||
16926719|NCT01052077|38070067|FG001|Phase B|Adverse Event|9|||
16926720|NCT01052077|38070068|FG002|Phase B|Adverse Event|2|||
16926721|NCT01052077|38070069|FG003|Phase B|Adverse Event|0|||
16926722|NCT01052077|38070066|FG000|Phase B|Met Withdrawal Criteria|0|||
16926723|NCT01052077|38070067|FG001|Phase B|Met Withdrawal Criteria|2|||
16926724|NCT01052077|38070068|FG002|Phase B|Met Withdrawal Criteria|1|||
16926725|NCT01052077|38070069|FG003|Phase B|Met Withdrawal Criteria|0|||
16926726|NCT01052077|38070066|FG000|Phase B|Physician Decision|0|||
16926727|NCT01052077|38070067|FG001|Phase B|Physician Decision|1|||
16926728|NCT01052077|38070068|FG002|Phase B|Physician Decision|1|||
16926729|NCT01052077|38070069|FG003|Phase B|Physician Decision|0|||
16926730|NCT01052077|38070066|FG000|Phase B|Withdrawal by Subject|0|||
16926731|NCT01052077|38070067|FG001|Phase B|Withdrawal by Subject|0|||
16926732|NCT01052077|38070068|FG002|Phase B|Withdrawal by Subject|5|||
16926733|NCT01052077|38070069|FG003|Phase B|Withdrawal by Subject|0|||
16926734|NCT01052077|38070066|FG000|Phase B|Protocol Deviation|0|||
16849967|NCT01804946|37796525|FG000|Overall Study|Do not meet inclusion criteria|1|||
16849968|NCT01804946|37796526|FG001|Overall Study|Do not meet inclusion criteria|2|||
16849969|NCT01737398|37796536|FG000|Overall Study|Adverse event or SAE|16|||
16849970|NCT01737398|37796537|FG001|Overall Study|Adverse event or SAE|1|||
16849971|NCT01737398|37796536|FG000|Overall Study|Stopping rule met|2|||
16849972|NCT01737398|37796537|FG001|Overall Study|Stopping rule met|1|||
16926735|NCT01052077|38070067|FG001|Phase B|Protocol Deviation|3|||
16926736|NCT01052077|38070068|FG002|Phase B|Protocol Deviation|4|||
16926737|NCT01052077|38070069|FG003|Phase B|Protocol Deviation|0|||
16926738|NCT01052077|38070066|FG000|Phase B|Lack of Efficacy|0|||
16926739|NCT01052077|38070067|FG001|Phase B|Lack of Efficacy|1|||
16926740|NCT01052077|38070068|FG002|Phase B|Lack of Efficacy|0|||
16926741|NCT01052077|38070069|FG003|Phase B|Lack of Efficacy|0|||
16926742|NCT01052077|38070066|FG000|Phase A+|Lost to Follow-up|0|||
16926743|NCT01052077|38070067|FG001|Phase A+|Lost to Follow-up|0|||
16926744|NCT01052077|38070068|FG002|Phase A+|Lost to Follow-up|0|||
16926745|NCT01052077|38070069|FG003|Phase A+|Lost to Follow-up|8|||
16926746|NCT01052077|38070066|FG000|Phase A+|Adverse Event|0|||
16926747|NCT01052077|38070067|FG001|Phase A+|Adverse Event|0|||
16926748|NCT01052077|38070068|FG002|Phase A+|Adverse Event|0|||
16849973|NCT01737398|37796536|FG000|Overall Study|Voluntary withdrawal|2|||
16849974|NCT01737398|37796537|FG001|Overall Study|Voluntary withdrawal|3|||
16849975|NCT01737398|37796536|FG000|Overall Study|Ineligibility|1|||
16849976|NCT01737398|37796537|FG001|Overall Study|Ineligibility|0|||
16849977|NCT01737398|37796536|FG000|Overall Study|Liver transplant|1|||
16849978|NCT01737398|37796537|FG001|Overall Study|Liver transplant|0|||
16849979|NCT01737398|37796536|FG000|Overall Study|Disease progression|2|||
16849980|NCT01737398|37796537|FG001|Overall Study|Disease progression|3|||
16849981|NCT01737398|37796536|FG000|Overall Study|Sponsor's decision|2|||
16849982|NCT01737398|37796537|FG001|Overall Study|Sponsor's decision|0|||
16849983|NCT01795898|37796546|FG000|Overall Study|Adverse Event|27|||
16849984|NCT01795898|37796546|FG000|Overall Study|Lost to Follow-up|20|||
16849985|NCT01795898|37796546|FG000|Overall Study|Withdrawal of consent|6|||
16849986|NCT01795898|37796546|FG000|Overall Study|Diagnosed with metastasis|1|||
16849987|NCT01795898|37796546|FG000|Overall Study|No pain|1|||
16849988|NCT01795898|37796546|FG000|Overall Study|Death|1|||
16849989|NCT01795898|37796546|FG000|Overall Study|Withdrew consent & had adverse events|3|||
16849990|NCT01795898|37796546|FG000|Overall Study|Physician Decision|1|||
16849991|NCT01736696|37796557|FG000|Overall Study|Withdrawal by Subject|0|||
16849992|NCT01736696|37796558|FG001|Overall Study|Withdrawal by Subject|0|||
16849993|NCT01736696|37796559|FG002|Overall Study|Withdrawal by Subject|1|||
16849994|NCT01736696|37796560|FG003|Overall Study|Withdrawal by Subject|0|||
16849995|NCT01736696|37796561|FG004|Overall Study|Withdrawal by Subject|0|||
16849996|NCT01736696|37796562|FG005|Overall Study|Withdrawal by Subject|0|||
16849997|NCT01736696|37796563|FG006|Overall Study|Withdrawal by Subject|0|||
16849998|NCT01736540|37796587|FG000|Overall Study|Did not complete scan within 45 days|2|||
16849999|NCT01736540|37796587|FG000|Overall Study|Death|1|||
16850000|NCT01736540|37796587|FG000|Overall Study|Abnormal test procedure|1|||
16850001|NCT01736540|37796587|FG000|Overall Study|Withdrawal by Subject|5|||
16850002|NCT01736540|37796587|FG000|Overall Study|Protocol Violation|1|||
16850003|NCT01736540|37796587|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
16850004|NCT01736540|37796587|FG000|Overall Study|No show for MRI appointment|1|||
16850005|NCT01736540|37796587|FG000|Overall Study|Unable to make MRI appointment|3|||
16850006|NCT01794338|37796600|FG000|Overall Study|Death|2|||
16850007|NCT01794338|37796601|FG001|Overall Study|Death|0|||
16850008|NCT01794338|37796600|FG000|Overall Study|Lost to Follow-up|6|||
16850009|NCT01794338|37796601|FG001|Overall Study|Lost to Follow-up|9|||
16850010|NCT01609478|37796610|FG000|Overall Study|Adverse Event|3|||
16850011|NCT01609478|37796611|FG001|Overall Study|Adverse Event|1|||
16850012|NCT01609478|37796612|FG002|Overall Study|Adverse Event|5|||
16850013|NCT01609478|37796610|FG000|Overall Study|Protocol Deviation|0|||
16926749|NCT01052077|38070069|FG003|Phase A+|Adverse Event|4|||
16926750|NCT01052077|38070066|FG000|Phase A+|Met Withdrawal Criteria|0|||
17018277|NCT00822900|38162699|FG001|Overall Study|Death|69|||
16850014|NCT01609478|37796611|FG001|Overall Study|Protocol Deviation|1|||
16926751|NCT01052077|38070067|FG001|Phase A+|Met Withdrawal Criteria|0|||
16850015|NCT01609478|37796612|FG002|Overall Study|Protocol Deviation|1|||
16850016|NCT01609478|37796610|FG000|Overall Study|Non-Compliance with study treatment|1|||
16850017|NCT01609478|37796611|FG001|Overall Study|Non-Compliance with study treatment|0|||
16850018|NCT01609478|37796612|FG002|Overall Study|Non-Compliance with study treatment|0|||
16850019|NCT01609478|37796610|FG000|Overall Study|Physician Decision|1|||
16850020|NCT01609478|37796611|FG001|Overall Study|Physician Decision|0|||
16850021|NCT01609478|37796612|FG002|Overall Study|Physician Decision|1|||
16850022|NCT01609478|37796610|FG000|Overall Study|Withdrawal by Subject|2|||
16850023|NCT01609478|37796611|FG001|Overall Study|Withdrawal by Subject|0|||
16850024|NCT01609478|37796612|FG002|Overall Study|Withdrawal by Subject|2|||
16850025|NCT01764854|37796624|FG000|Overall Study|Adverse Event|0|||
16850026|NCT01764854|37796625|FG001|Overall Study|Adverse Event|0|||
16850027|NCT01764854|37796626|FG002|Overall Study|Adverse Event|2|||
16850028|NCT01764854|37796627|FG003|Overall Study|Adverse Event|0|||
16850029|NCT01764854|37796624|FG000|Overall Study|Withdrawal by Subject|0|||
16850030|NCT01764854|37796625|FG001|Overall Study|Withdrawal by Subject|0|||
16850031|NCT01764854|37796626|FG002|Overall Study|Withdrawal by Subject|1|||
16850032|NCT01764854|37796627|FG003|Overall Study|Withdrawal by Subject|0|||
16850033|NCT01764854|37796624|FG000|Overall Study|relocation|0|||
16850034|NCT01764854|37796625|FG001|Overall Study|relocation|0|||
16850035|NCT01764854|37796626|FG002|Overall Study|relocation|2|||
16850036|NCT01764854|37796627|FG003|Overall Study|relocation|0|||
16850037|NCT01764854|37796624|FG000|Overall Study|Protocol Violation|0|||
16850038|NCT01764854|37796625|FG001|Overall Study|Protocol Violation|0|||
16850039|NCT01764854|37796626|FG002|Overall Study|Protocol Violation|1|||
16850040|NCT01764854|37796627|FG003|Overall Study|Protocol Violation|2|||
16850041|NCT01764464|37796639|FG000|First Intervention|Withdrawal by Subject|1|||
16850042|NCT01764464|37796640|FG001|First Intervention|Withdrawal by Subject|0|||
16850043|NCT01764464|37796639|FG000|First Intervention|Lost to Follow-up|1|||
16850044|NCT01764464|37796640|FG001|First Intervention|Lost to Follow-up|0|||
16850045|NCT01764464|37796639|FG000|First Intervention|Adverse Event|0|||
16850046|NCT01764464|37796640|FG001|First Intervention|Adverse Event|2|||
16850047|NCT01764464|37796639|FG000|First Intervention|did not receive study drug|0|||
16850048|NCT01764464|37796640|FG001|First Intervention|did not receive study drug|1|||
16850049|NCT01764464|37796639|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
16850050|NCT01764464|37796640|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
16850051|NCT01764386|37796648|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
16850052|NCT01764386|37796649|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
16850053|NCT01764386|37796648|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
16850054|NCT01764386|37796649|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
16850055|NCT01764386|37796648|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
16850056|NCT01764386|37796649|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
16850057|NCT01764386|37796648|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
16850058|NCT01764386|37796649|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
16850059|NCT01764386|37796648|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
16850060|NCT01764386|37796649|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
16850061|NCT01764386|37796648|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
16850062|NCT01764386|37796649|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
16850063|NCT01764386|37796648|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
16850064|NCT01764386|37796649|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
16850065|NCT01764386|37796648|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
16850066|NCT01764386|37796649|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
16850067|NCT01763996|37796656|FG000|Treatment Period 2|Adverse Event|0|||
16850068|NCT01763996|37796657|FG001|Treatment Period 2|Adverse Event|1|||
16850069|NCT01763918|37796667|FG000|Overall Study|Withdrawal by Subject|2|||
16850070|NCT01763918|37796668|FG001|Overall Study|Withdrawal by Subject|1|||
16850071|NCT01763918|37796669|FG002|Overall Study|Withdrawal by Subject|1|||
16850072|NCT01763918|37796670|FG003|Overall Study|Withdrawal by Subject|2|||
16850073|NCT01763918|37796667|FG000|Overall Study|Sponsor Decision|4|||
16850074|NCT01763918|37796668|FG001|Overall Study|Sponsor Decision|0|||
16850075|NCT01763918|37796669|FG002|Overall Study|Sponsor Decision|9|||
16850076|NCT01763918|37796670|FG003|Overall Study|Sponsor Decision|0|||
16850077|NCT01763684|37796682|FG000|Overall Study|Study terminated early due to low enrollment|126|||
16850078|NCT01763684|37796683|FG001|Overall Study|Study terminated early due to low enrollment|127|||
16850079|NCT01763684|37796682|FG000|Overall Study|Study surgery not performed|7|||
16850080|NCT01763684|37796683|FG001|Overall Study|Study surgery not performed|6|||
16850081|NCT01606748|37796691|FG000|Overall Study|Adverse Event|1|||
16850082|NCT01606748|37796692|FG001|Overall Study|Adverse Event|0|||
16850083|NCT01606748|37796691|FG000|Overall Study|Progressive Disease|1|||
16850084|NCT01606748|37796692|FG001|Overall Study|Progressive Disease|0|||
16850085|NCT01606748|37796691|FG000|Overall Study|Withdrawal by Subject|1|||
16850086|NCT01606748|37796692|FG001|Overall Study|Withdrawal by Subject|0|||
16850087|NCT01597622|37796710|FG000|Overall Study|Adverse Event|7|||
16850088|NCT01597622|37796710|FG000|Overall Study|Lack of Efficacy|3|||
16850089|NCT01597622|37796710|FG000|Overall Study|Protocol Violation|1|||
16850090|NCT01597622|37796710|FG000|Overall Study|Lost to Follow-up|1|||
16926752|NCT01052077|38070068|FG002|Phase A+|Met Withdrawal Criteria|0|||
16926753|NCT01052077|38070069|FG003|Phase A+|Met Withdrawal Criteria|2|||
16926754|NCT01052077|38070066|FG000|Phase A+|Withdrawal by Subject|0|||
16926755|NCT01052077|38070067|FG001|Phase A+|Withdrawal by Subject|0|||
16926756|NCT01052077|38070068|FG002|Phase A+|Withdrawal by Subject|0|||
16926757|NCT01052077|38070069|FG003|Phase A+|Withdrawal by Subject|7|||
16926758|NCT01052038|38070078|FG000|Overall Study|Lost to Follow-up|2|||
16926759|NCT01052038|38070079|FG001|Overall Study|Lost to Follow-up|3|||
16926760|NCT01052038|38070080|FG002|Overall Study|Lost to Follow-up|1|||
16926761|NCT01052038|38070078|FG000|Overall Study|Protocol Violation|2|||
16926762|NCT01052038|38070079|FG001|Overall Study|Protocol Violation|3|||
16926763|NCT01052038|38070080|FG002|Overall Study|Protocol Violation|3|||
16926764|NCT01051960|38070088|FG000|Overall Study|Adverse Event|1|||
16926765|NCT01051921|38070092|FG000|Overall Study|Physician Decision|9|||
16926766|NCT01051921|38070092|FG000|Overall Study|Adverse Event|8|||
16926767|NCT01051921|38070092|FG000|Overall Study|Withdrawal by Subject|7|||
16926768|NCT01051921|38070092|FG000|Overall Study|Lost to Follow-up|4|||
16926769|NCT01051921|38070092|FG000|Overall Study|virological failure|1|||
16926770|NCT01051921|38070092|FG000|Overall Study|patient moved|1|||
16926771|NCT01051063|38070098|FG000|Overall Study|Death|2|||
16926772|NCT01051063|38070099|FG001|Overall Study|Death|2|||
16926773|NCT01051063|38070098|FG000|Overall Study|Withdrawal by Subject|1|||
16926774|NCT01051063|38070099|FG001|Overall Study|Withdrawal by Subject|1|||
16926775|NCT01051063|38070098|FG000|Overall Study|Termination of the study|5|||
16926776|NCT01051063|38070099|FG001|Overall Study|Termination of the study|0|||
16926777|NCT01051063|38070098|FG000|Overall Study|Moved from the study site area|1|||
16926778|NCT01051063|38070099|FG001|Overall Study|Moved from the study site area|0|||
16926779|NCT01051063|38070098|FG000|Overall Study|Other|1|||
16926780|NCT01051063|38070099|FG001|Overall Study|Other|0|||
16926781|NCT01051063|38070098|FG000|Overall Study|Lost to Follow-up|0|||
16926782|NCT01051063|38070099|FG001|Overall Study|Lost to Follow-up|1|||
16926783|NCT01050790|38070106|FG000|Overall Study|Adverse Event|1|||
16926784|NCT01050673|38070113|FG000|Overall Study|Physician Decision|4|||
16926785|NCT01050673|38070114|FG001|Overall Study|Physician Decision|5|||
16926786|NCT01050205|38070122|FG000|Overall Study|Lost to Follow-up|7|||
16926787|NCT01050205|38070123|FG001|Overall Study|Lost to Follow-up|1|||
16926788|NCT01050205|38070122|FG000|Overall Study|Withdrawal by Subject|1|||
16926789|NCT01050205|38070123|FG001|Overall Study|Withdrawal by Subject|1|||
16926790|NCT01050205|38070122|FG000|Overall Study|Relocated from area|1|||
16926791|NCT01050205|38070123|FG001|Overall Study|Relocated from area|2|||
16926792|NCT01050205|38070122|FG000|Overall Study|Discontinued Intervention|2|||
16926793|NCT01050205|38070123|FG001|Overall Study|Discontinued Intervention|0|||
16926794|NCT01059448|38070133|FG000|Overall Study|Adverse Event|1|||
16926795|NCT01059448|38070134|FG001|Overall Study|Adverse Event|3|||
16926796|NCT01059448|38070135|FG002|Overall Study|Adverse Event|0|||
16926797|NCT01059448|38070136|FG003|Overall Study|Adverse Event|1|||
16926798|NCT01059448|38070133|FG000|Overall Study|Withdrawal by Subject|2|||
16926799|NCT01059448|38070134|FG001|Overall Study|Withdrawal by Subject|0|||
16926800|NCT01059448|38070135|FG002|Overall Study|Withdrawal by Subject|2|||
16926801|NCT01059448|38070136|FG003|Overall Study|Withdrawal by Subject|4|||
16926802|NCT01059448|38070133|FG000|Overall Study|Disease Progression|2|||
16926803|NCT01059448|38070134|FG001|Overall Study|Disease Progression|1|||
16926804|NCT01059448|38070135|FG002|Overall Study|Disease Progression|4|||
16926805|NCT01059448|38070136|FG003|Overall Study|Disease Progression|2|||
16926806|NCT01059448|38070133|FG000|Overall Study|Administrative Decision|43|||
16926807|NCT01059448|38070134|FG001|Overall Study|Administrative Decision|49|||
16926808|NCT01059448|38070135|FG002|Overall Study|Administrative Decision|45|||
16926809|NCT01059448|38070136|FG003|Overall Study|Administrative Decision|46|||
16926810|NCT01059448|38070133|FG000|Overall Study|Lost to Follow-up|0|||
16926811|NCT01059448|38070134|FG001|Overall Study|Lost to Follow-up|0|||
16926812|NCT01059448|38070135|FG002|Overall Study|Lost to Follow-up|2|||
16926813|NCT01059448|38070136|FG003|Overall Study|Lost to Follow-up|0|||
16926814|NCT01059448|38070133|FG000|Overall Study|Death|0|||
16850091|NCT01597622|37796710|FG000|Overall Study|Investigator Discretion|5|||
16850092|NCT01597622|37796710|FG000|Overall Study|Withdrawal by Subject|20|||
16850093|NCT01597622|37796710|FG000|Overall Study|Death|1|||
16850094|NCT01761266|37796716|FG000|Overall Study|Death|415|||
16850095|NCT01761266|37796717|FG001|Overall Study|Death|402|||
16850096|NCT01761266|37796716|FG000|Overall Study|Lost to Follow-up|8|||
16850097|NCT01761266|37796717|FG001|Overall Study|Lost to Follow-up|12|||
16850098|NCT01761266|37796716|FG000|Overall Study|Withdrawal by Subject|14|||
16926815|NCT01059448|38070134|FG001|Overall Study|Death|1|||
16926816|NCT01059448|38070135|FG002|Overall Study|Death|0|||
16926817|NCT01059448|38070136|FG003|Overall Study|Death|0|||
16926818|NCT01059448|38070133|FG000|Overall Study|Other|1|||
16926819|NCT01059448|38070134|FG001|Overall Study|Other|1|||
16926820|NCT01059448|38070135|FG002|Overall Study|Other|0|||
16926821|NCT01059448|38070136|FG003|Overall Study|Other|1|||
16926822|NCT01058707|38070153|FG000|Overall Study|Disease Progression|15|||
16926823|NCT01058707|38070154|FG001|Overall Study|Disease Progression|20|||
16926824|NCT01058707|38070155|FG002|Overall Study|Disease Progression|20|||
16926825|NCT01058707|38070156|FG003|Overall Study|Disease Progression|15|||
16926826|NCT01058707|38070157|FG004|Overall Study|Disease Progression|23|||
16926827|NCT01058707|38070158|FG005|Overall Study|Disease Progression|10|||
16926828|NCT01058707|38070159|FG006|Overall Study|Disease Progression|12|||
16926829|NCT01058707|38070153|FG000|Overall Study|Adverse Event|11|||
16926830|NCT01058707|38070154|FG001|Overall Study|Adverse Event|4|||
16926831|NCT01058707|38070155|FG002|Overall Study|Adverse Event|7|||
16926832|NCT01058707|38070156|FG003|Overall Study|Adverse Event|6|||
16926833|NCT01058707|38070157|FG004|Overall Study|Adverse Event|7|||
16926834|NCT01058707|38070158|FG005|Overall Study|Adverse Event|3|||
16926835|NCT01058707|38070159|FG006|Overall Study|Adverse Event|1|||
16926836|NCT01058707|38070153|FG000|Overall Study|Subject Decision|5|||
16926837|NCT01058707|38070154|FG001|Overall Study|Subject Decision|3|||
16926838|NCT01058707|38070155|FG002|Overall Study|Subject Decision|3|||
16926839|NCT01058707|38070156|FG003|Overall Study|Subject Decision|1|||
16926840|NCT01058707|38070157|FG004|Overall Study|Subject Decision|2|||
16926841|NCT01058707|38070158|FG005|Overall Study|Subject Decision|3|||
16926842|NCT01058707|38070159|FG006|Overall Study|Subject Decision|6|||
16926843|NCT01058707|38070153|FG000|Overall Study|Lost to Follow-up|0|||
16926844|NCT01058707|38070154|FG001|Overall Study|Lost to Follow-up|0|||
16926845|NCT01058707|38070155|FG002|Overall Study|Lost to Follow-up|1|||
16926846|NCT01058707|38070156|FG003|Overall Study|Lost to Follow-up|0|||
16926847|NCT01058707|38070157|FG004|Overall Study|Lost to Follow-up|0|||
16926848|NCT01058707|38070158|FG005|Overall Study|Lost to Follow-up|0|||
16926849|NCT01058707|38070159|FG006|Overall Study|Lost to Follow-up|0|||
16926850|NCT01058707|38070153|FG000|Overall Study|Reason Not Specified|0|||
16926851|NCT01058707|38070154|FG001|Overall Study|Reason Not Specified|3|||
17018278|NCT00822900|38162698|FG000|Overall Study|Became a ward of the state|2|||
17018279|NCT00822900|38162699|FG001|Overall Study|Became a ward of the state|1|||
16926852|NCT01058707|38070155|FG002|Overall Study|Reason Not Specified|2|||
16926853|NCT01058707|38070156|FG003|Overall Study|Reason Not Specified|0|||
16926854|NCT01058707|38070157|FG004|Overall Study|Reason Not Specified|7|||
16926855|NCT01058707|38070158|FG005|Overall Study|Reason Not Specified|1|||
16926856|NCT01058707|38070159|FG006|Overall Study|Reason Not Specified|7|||
16926857|NCT01054144|38070197|FG000|Overall Study|Death|2|||
16926858|NCT00105586|38070206|FG000|Overall Study|Adverse Event|4|||
16926859|NCT00105586|38070207|FG001|Overall Study|Adverse Event|3|||
16926860|NCT00105586|38070206|FG000|Overall Study|Physician Decision|13|||
16926861|NCT00105586|38070207|FG001|Overall Study|Physician Decision|13|||
16926862|NCT01059643|38070215|FG000|Overall Study|Adverse Event|3|||
16926863|NCT01059643|38070215|FG000|Overall Study|Withdrawal by Subject|2|||
16926864|NCT01059643|38070215|FG000|Overall Study|Physician Decision|1|||
16926865|NCT01059565|38070224|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
16926866|NCT01059565|38070225|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
16926867|NCT01059565|38070224|FG000|24-Week Randomized Phase|Adverse Event|5|||
16926868|NCT01059565|38070225|FG001|24-Week Randomized Phase|Adverse Event|0|||
16926869|NCT01059565|38070224|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
16926870|NCT01059565|38070225|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
16926871|NCT01059565|38070224|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
16926872|NCT01059565|38070225|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
16926873|NCT01059565|38070224|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
16926874|NCT01059565|38070225|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
16926875|NCT01059565|38070224|FG000|24-Week Open-Label Phase|Adverse Event|2|||
16926876|NCT01059565|38070225|FG001|24-Week Open-Label Phase|Adverse Event|0|||
16926877|NCT01059565|38070224|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
16926878|NCT01059565|38070225|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
16926879|NCT01059565|38070224|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
16926880|NCT01059565|38070225|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
16926881|NCT01059565|38070224|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
16926882|NCT01059565|38070225|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
16926883|NCT01059565|38070224|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
16926884|NCT01059565|38070225|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
16926885|NCT01059565|38070224|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
16926886|NCT01059565|38070225|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
16926887|NCT01059526|38070235|FG000|Overall Study|Patient enrolled but not treated|20|||
16926888|NCT01059526|38070236|FG001|Overall Study|Patient enrolled but not treated|17|||
16926889|NCT01059526|38070235|FG000|Overall Study|Adverse Event|2|||
16926890|NCT01059526|38070236|FG001|Overall Study|Adverse Event|2|||
16926891|NCT01059526|38070235|FG000|Overall Study|Protocol Violation|0|||
16926892|NCT01059526|38070236|FG001|Overall Study|Protocol Violation|1|||
16926893|NCT01059526|38070235|FG000|Overall Study|Withdrawal by Subject|3|||
16926894|NCT01059526|38070236|FG001|Overall Study|Withdrawal by Subject|1|||
16926895|NCT01059526|38070235|FG000|Overall Study|Lost to Follow-up|4|||
16926896|NCT01059526|38070236|FG001|Overall Study|Lost to Follow-up|1|||
16926897|NCT01059526|38070235|FG000|Overall Study|Patient found to be dermatographic|1|||
16926898|NCT01059526|38070236|FG001|Overall Study|Patient found to be dermatographic|0|||
16926899|NCT03277261|38070244|FG000|Overall Study|Adverse Event|17|||
16926900|NCT03277261|38070245|FG001|Overall Study|Adverse Event|1|||
16926901|NCT03277261|38070244|FG000|Overall Study|Participant Withdrawal of Consent|6|||
16926902|NCT03277261|38070245|FG001|Overall Study|Participant Withdrawal of Consent|15|||
16926903|NCT03277261|38070244|FG000|Overall Study|Investigator / Sponsor Decision|4|||
16926904|NCT03277261|38070245|FG001|Overall Study|Investigator / Sponsor Decision|2|||
16926905|NCT03277261|38070244|FG000|Overall Study|Pregnancy|2|||
16926906|NCT03277261|38070245|FG001|Overall Study|Pregnancy|0|||
16926907|NCT03277261|38070244|FG000|Overall Study|Lost to Follow-up|2|||
16926908|NCT03277261|38070245|FG001|Overall Study|Lost to Follow-up|2|||
16926909|NCT03277261|38070244|FG000|Overall Study|Lack of Efficacy|2|||
16926910|NCT03277261|38070245|FG001|Overall Study|Lack of Efficacy|2|||
16926911|NCT03277261|38070244|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
16926912|NCT03277261|38070245|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
16926913|NCT03277690|38070267|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
16926914|NCT03277690|38070268|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
16926915|NCT03277690|38070267|FG000|Dose Titration and Maintenance|Physician Decision|1|||
16926916|NCT03277690|38070268|FG001|Dose Titration and Maintenance|Physician Decision|0|||
16926917|NCT03277690|38070267|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
16926918|NCT03277690|38070268|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
16926919|NCT03277690|38070267|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
16926920|NCT03277690|38070268|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
16926921|NCT03277690|38070267|FG000|Dose Titration and Maintenance|Adverse Event|15|||
16926922|NCT03277690|38070268|FG001|Dose Titration and Maintenance|Adverse Event|0|||
16926923|NCT03277690|38070267|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
16926924|NCT03277690|38070268|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
16926925|NCT03277690|38070267|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
16926926|NCT03277690|38070268|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
16926927|NCT03271021|38070277|FG000|Overall Study|Adverse Event|3|||
16926928|NCT03271021|38070278|FG001|Overall Study|Adverse Event|2|||
16926929|NCT03271021|38070277|FG000|Overall Study|Withdrawal by Subject|36|||
16926930|NCT03271021|38070278|FG001|Overall Study|Withdrawal by Subject|53|||
16926931|NCT03271021|38070277|FG000|Overall Study|Lost to Follow-up|34|||
16926932|NCT03271021|38070278|FG001|Overall Study|Lost to Follow-up|39|||
16926933|NCT03271021|38070277|FG000|Overall Study|Protocol Violation|6|||
16926934|NCT03271021|38070278|FG001|Overall Study|Protocol Violation|4|||
16926935|NCT03271021|38070277|FG000|Overall Study|Abnormal Lab Results|1|||
16926936|NCT03271021|38070278|FG001|Overall Study|Abnormal Lab Results|0|||
16926937|NCT03271021|38070277|FG000|Overall Study|Miscellaneous|9|||
16926938|NCT03271021|38070278|FG001|Overall Study|Miscellaneous|8|||
16926939|NCT01249651|38070299|FG000|Overall Study|Withdrawal by Subject|4|||
16926940|NCT01249651|38070299|FG000|Overall Study|Adverse Event|1|||
16926941|NCT01249651|38070299|FG000|Overall Study|Protocol Violation|1|||
16926942|NCT01249651|38070299|FG000|Overall Study|Sponsor Decision|1|||
16926943|NCT01249417|38070306|FG000|Randomised Population|Study treatment not received|0|||
16926944|NCT01249417|38070307|FG001|Randomised Population|Study treatment not received|0|||
16926945|NCT01249417|38070308|FG002|Randomised Population|Study treatment not received|2|||
16850099|NCT01761266|37796717|FG001|Overall Study|Withdrawal by Subject|10|||
16850100|NCT01761266|37796716|FG000|Overall Study|Sponsor Decision|41|||
16850101|NCT01761266|37796717|FG001|Overall Study|Sponsor Decision|52|||
16850102|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
16850103|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
16850104|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
16850105|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
16850106|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Adverse Event|5|||
16850107|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Adverse Event|3|||
16850108|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Adverse Event|4|||
16850109|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Adverse Event|10|||
16850110|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
16850111|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
16850112|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
16850113|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
16850114|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
16850115|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
16850116|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
16850117|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
16850118|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Pregnancy|5|||
16850119|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Pregnancy|0|||
16850120|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Pregnancy|3|||
16850121|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Pregnancy|2|||
16850122|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Non-compliance|1|||
16850123|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Non-compliance|4|||
16850124|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Non-compliance|0|||
16850125|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Non-compliance|3|||
16850126|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Other|0|||
16850127|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Other|3|||
16850128|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Other|3|||
16850129|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Other|1|||
16850130|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
16850131|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
16850132|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
16850133|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
16850134|NCT01760954|37796730|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
16850135|NCT01760954|37796731|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
16850136|NCT01760954|37796732|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
16850137|NCT01760954|37796733|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
16850138|NCT01760954|37796730|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
16926946|NCT01249417|38070306|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
16926947|NCT01249417|38070307|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
16926948|NCT01249417|38070308|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
16926949|NCT01249417|38070306|FG000|Treatment Phase - ITT Population|Other|0|||
16926950|NCT01249417|38070307|FG001|Treatment Phase - ITT Population|Other|0|||
16926951|NCT01249417|38070308|FG002|Treatment Phase - ITT Population|Other|1|||
16926952|NCT01249417|38070306|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
16926953|NCT01249417|38070307|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
16926954|NCT01249417|38070308|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
16926955|NCT01249417|38070306|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
16926956|NCT01249417|38070307|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
16926957|NCT01249417|38070308|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
16926958|NCT01249417|38070306|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
16926959|NCT01249417|38070307|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
16926960|NCT01249417|38070308|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
16926961|NCT01249261|38070318|FG000|Overall Study|Withdrawal by Subject|1|||
16926962|NCT01249261|38070319|FG001|Overall Study|Withdrawal by Subject|0|||
16926963|NCT01248949|38070343|FG000|Overall Study|Lost to Follow-up|2|||
16926964|NCT01248949|38070344|FG001|Overall Study|Lost to Follow-up|2|||
16926965|NCT01248949|38070345|FG002|Overall Study|Lost to Follow-up|2|||
16926966|NCT01248949|38070346|FG003|Overall Study|Lost to Follow-up|1|||
16926967|NCT01248949|38070347|FG004|Overall Study|Lost to Follow-up|0|||
16926968|NCT01248949|38070343|FG000|Overall Study|Withdrawal by Subject|5|||
16926969|NCT01248949|38070344|FG001|Overall Study|Withdrawal by Subject|3|||
16926970|NCT01248949|38070345|FG002|Overall Study|Withdrawal by Subject|11|||
16926971|NCT01248949|38070346|FG003|Overall Study|Withdrawal by Subject|3|||
16926972|NCT01248949|38070347|FG004|Overall Study|Withdrawal by Subject|1|||
16850139|NCT01760954|37796731|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
16850140|NCT01760954|37796732|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
16850141|NCT01760954|37796733|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
16850142|NCT01760954|37796730|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
16926973|NCT01248949|38070343|FG000|Overall Study|Death|22|||
16926974|NCT01248949|38070344|FG001|Overall Study|Death|7|||
16926975|NCT01248949|38070345|FG002|Overall Study|Death|21|||
16926976|NCT01248949|38070346|FG003|Overall Study|Death|6|||
16926977|NCT01248949|38070347|FG004|Overall Study|Death|2|||
16926978|NCT01248949|38070343|FG000|Overall Study|Alternative Therapy|1|||
16926979|NCT01248949|38070344|FG001|Overall Study|Alternative Therapy|0|||
16850143|NCT01760954|37796731|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
16850144|NCT01760954|37796732|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
16850145|NCT01760954|37796733|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
16850146|NCT01760954|37796730|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
16850147|NCT01760954|37796731|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
16926980|NCT01248949|38070345|FG002|Overall Study|Alternative Therapy|0|||
16926981|NCT01248949|38070346|FG003|Overall Study|Alternative Therapy|0|||
16926982|NCT01248949|38070347|FG004|Overall Study|Alternative Therapy|0|||
16926983|NCT01248949|38070343|FG000|Overall Study|Alternative Therapy.|1|||
16926984|NCT01248949|38070344|FG001|Overall Study|Alternative Therapy.|0|||
16926985|NCT01248949|38070345|FG002|Overall Study|Alternative Therapy.|0|||
16926986|NCT01248949|38070346|FG003|Overall Study|Alternative Therapy.|0|||
17018280|NCT00682786|38162707|FG000|Overall Study|Withdrawal by Subject|2|||
16926987|NCT01248949|38070347|FG004|Overall Study|Alternative Therapy.|0|||
16926988|NCT01248949|38070343|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
16926989|NCT01248949|38070344|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
16926990|NCT01248949|38070345|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
16926991|NCT01248949|38070346|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
16850148|NCT01760954|37796732|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
16850149|NCT01760954|37796733|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
16850150|NCT01760954|37796730|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
16850151|NCT01760954|37796731|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
16850152|NCT01760954|37796732|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
16926992|NCT01248949|38070347|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
16926993|NCT01248949|38070343|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
16926994|NCT01248949|38070344|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
16926995|NCT01248949|38070345|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
16926996|NCT01248949|38070346|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
16926997|NCT01248949|38070347|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
16926998|NCT01248949|38070343|FG000|Overall Study|Participant Went To Hospice|0|||
16926999|NCT01248949|38070344|FG001|Overall Study|Participant Went To Hospice|0|||
16927000|NCT01248949|38070345|FG002|Overall Study|Participant Went To Hospice|1|||
16927001|NCT01248949|38070346|FG003|Overall Study|Participant Went To Hospice|0|||
16927002|NCT01248949|38070347|FG004|Overall Study|Participant Went To Hospice|0|||
16927003|NCT01248949|38070343|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
16927004|NCT01248949|38070344|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
16927005|NCT01248949|38070345|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
16927006|NCT01248949|38070346|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
16927007|NCT01248949|38070347|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
16927008|NCT01248949|38070343|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
16927009|NCT01248949|38070344|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
16927010|NCT01248949|38070345|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
16927011|NCT01248949|38070346|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
16927012|NCT01248949|38070347|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
16927013|NCT01248949|38070343|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
16927014|NCT01248949|38070344|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
16927015|NCT01248949|38070345|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
16927016|NCT01248949|38070346|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
16927017|NCT01248949|38070347|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
16927018|NCT01248949|38070343|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
16927019|NCT01248949|38070344|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
16927020|NCT01248949|38070345|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
16927021|NCT01248949|38070346|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
16927022|NCT01248949|38070347|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
16927023|NCT01248793|38070361|FG000|Overall Study|Lost to Follow-up|0|||
16927024|NCT01248793|38070362|FG001|Overall Study|Lost to Follow-up|1|||
16927025|NCT01248793|38070361|FG000|Overall Study|Adverse Event|1|||
16927026|NCT01248793|38070362|FG001|Overall Study|Adverse Event|1|||
16927027|NCT01248793|38070361|FG000|Overall Study|Protocol Violation|0|||
16927028|NCT01248793|38070362|FG001|Overall Study|Protocol Violation|1|||
16927029|NCT01248793|38070361|FG000|Overall Study|Withdrawal by Subject|3|||
16927030|NCT01248793|38070362|FG001|Overall Study|Withdrawal by Subject|3|||
16927031|NCT01248715|38070370|FG000|Overall Study|Not influenza positive|501|||
16927032|NCT01248715|38070371|FG001|Overall Study|Not influenza positive|510|||
16850153|NCT01760954|37796733|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
16850154|NCT01760954|37796730|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
16850155|NCT01760954|37796731|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
16850156|NCT01760954|37796732|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
16850157|NCT01760954|37796733|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
16850158|NCT01760954|37796730|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
16927033|NCT01248364|38070381|FG000|Overall Study|Adverse Event|0|||
16927034|NCT01248364|38070382|FG001|Overall Study|Adverse Event|1|||
16927035|NCT01248364|38070383|FG002|Overall Study|Adverse Event|0|||
16927036|NCT01248364|38070384|FG003|Overall Study|Adverse Event|0|||
16927037|NCT01248130|38070396|FG000|Overall Study|Protocol Violation|1|||
16927038|NCT01248130|38070397|FG001|Overall Study|Protocol Violation|0|||
16927039|NCT01248130|38070396|FG000|Overall Study|Ineligible|1|||
16927040|NCT01248130|38070397|FG001|Overall Study|Ineligible|0|||
16927041|NCT01248013|38070403|FG000|Overall Study|Withdrawal by Subject|14|||
16927042|NCT01247350|38070412|FG000|Overall Study|Adverse Event|0|||
16927043|NCT01247350|38070413|FG001|Overall Study|Adverse Event|0|||
16927044|NCT01247350|38070414|FG002|Overall Study|Adverse Event|1|||
16927045|NCT01247350|38070415|FG003|Overall Study|Adverse Event|0|||
16927046|NCT01247350|38070416|FG004|Overall Study|Adverse Event|0|||
16927047|NCT01247350|38070412|FG000|Overall Study|Withdrawal by Subject|0|||
16927048|NCT01247350|38070413|FG001|Overall Study|Withdrawal by Subject|0|||
16927049|NCT01247350|38070414|FG002|Overall Study|Withdrawal by Subject|0|||
16927050|NCT01247350|38070415|FG003|Overall Study|Withdrawal by Subject|1|||
16927051|NCT01247350|38070416|FG004|Overall Study|Withdrawal by Subject|0|||
16927052|NCT01247350|38070412|FG000|Overall Study|Entry criteria not met|0|||
16927053|NCT01247350|38070413|FG001|Overall Study|Entry criteria not met|0|||
16927054|NCT01247350|38070414|FG002|Overall Study|Entry criteria not met|0|||
16927055|NCT01247350|38070415|FG003|Overall Study|Entry criteria not met|0|||
16850159|NCT01760954|37796731|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
16850160|NCT01760954|37796732|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
16850161|NCT01760954|37796733|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
16850162|NCT01760876|37796743|FG000|Overall Study|Non-cardiac death (head injury)|1|||
16850163|NCT01760876|37796743|FG000|Overall Study|Carcinoma of prostate|1|||
16850164|NCT01760876|37796743|FG000|Overall Study|Impaired renal function|1|||
16850165|NCT01760876|37796743|FG000|Overall Study|Major depression|1|||
16850166|NCT01760876|37796743|FG000|Overall Study|Very poor baseline OCT quality|2|||
16927056|NCT01247350|38070416|FG004|Overall Study|Entry criteria not met|1|||
16927057|NCT01246999|38070446|FG000|Overall Study|Lost to Follow-up|0|||
16927058|NCT01246999|38070447|FG001|Overall Study|Lost to Follow-up|1|||
16927059|NCT01246999|38070448|FG002|Overall Study|Lost to Follow-up|0|||
16927060|NCT01246999|38070449|FG003|Overall Study|Lost to Follow-up|0|||
16927061|NCT01246999|38070446|FG000|Overall Study|Withdrawal by Subject|0|||
16927062|NCT01246999|38070447|FG001|Overall Study|Withdrawal by Subject|0|||
16927063|NCT01246999|38070448|FG002|Overall Study|Withdrawal by Subject|0|||
16927064|NCT01246999|38070449|FG003|Overall Study|Withdrawal by Subject|2|||
16927065|NCT01245751|38070471|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
17018281|NCT00682786|38162708|FG001|Overall Study|Withdrawal by Subject|2|||
17018282|NCT00682786|38162707|FG000|Overall Study|Did not receive irinotecan|0|||
17018283|NCT00682786|38162708|FG001|Overall Study|Did not receive irinotecan|1|||
17018284|NCT00840450|38162720|FG000|Overall Study|Adverse Event|1|||
17018285|NCT00840450|38162720|FG000|Overall Study|Lack of Efficacy|2|||
17018286|NCT00840294|38162726|FG000|Overall Study|Withdrawal by Subject|2|||
17018287|NCT00840294|38162727|FG001|Overall Study|Withdrawal by Subject|1|||
17018288|NCT00840294|38162726|FG000|Overall Study|Protocol Violation|1|||
17018289|NCT00840294|38162727|FG001|Overall Study|Protocol Violation|3|||
17018290|NCT00840294|38162726|FG000|Overall Study|Illness|0|||
17018291|NCT00840294|38162727|FG001|Overall Study|Illness|1|||
17018292|NCT00679042|38162733|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
17018293|NCT00679042|38162733|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
17018294|NCT00679042|38162733|FG000|5-Year Follow Up|Death|1|||
17018295|NCT00679042|38162733|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
17018296|NCT00679042|38162733|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
17018297|NCT00680368|38162737|FG000|Overall Study|not supervised, not eligible|15|||
17018298|NCT00680056|38162745|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
17018299|NCT00680056|38162746|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
17018300|NCT00680056|38162745|FG000|Second Intervention|Protocol Violation|3|||
17018301|NCT00680056|38162746|FG001|Second Intervention|Protocol Violation|1|||
17018302|NCT00680992|38162756|FG000|Overall Study|Complete Resection (as per protocol)|25|||
17018303|NCT00680992|38162757|FG001|Overall Study|Complete Resection (as per protocol)|121|||
17018304|NCT00680992|38162758|FG002|Overall Study|Complete Resection (as per protocol)|0|||
17018305|NCT00680992|38162756|FG000|Overall Study|Administrative Decision|83|||
17018306|NCT00680992|38162757|FG001|Overall Study|Administrative Decision|42|||
17018307|NCT00680992|38162758|FG002|Overall Study|Administrative Decision|5|||
17018308|NCT00680992|38162756|FG000|Overall Study|End of Trial|32|||
17018309|NCT00680992|38162757|FG001|Overall Study|End of Trial|12|||
17018310|NCT00680992|38162758|FG002|Overall Study|End of Trial|3|||
17018311|NCT00680992|38162756|FG000|Overall Study|Withdrawal by Subject|33|||
17018312|NCT00680992|38162757|FG001|Overall Study|Withdrawal by Subject|11|||
17018313|NCT00680992|38162758|FG002|Overall Study|Withdrawal by Subject|1|||
17018314|NCT00680992|38162756|FG000|Overall Study|Adverse Event|21|||
17018315|NCT00680992|38162757|FG001|Overall Study|Adverse Event|19|||
17018316|NCT00680992|38162758|FG002|Overall Study|Adverse Event|1|||
17018317|NCT00680992|38162756|FG000|Overall Study|Other|19|||
17018318|NCT00680992|38162757|FG001|Overall Study|Other|14|||
17018319|NCT00680992|38162758|FG002|Overall Study|Other|1|||
16850167|NCT01759862|37796749|FG000|Overall Study|Physician Decision|3|||
17018320|NCT00680992|38162756|FG000|Overall Study|Disease Progression|21|||
17018321|NCT00680992|38162757|FG001|Overall Study|Disease Progression|9|||
17018322|NCT00680992|38162758|FG002|Overall Study|Disease Progression|0|||
17018323|NCT00680992|38162756|FG000|Overall Study|Lost to Follow-up|12|||
16850168|NCT01759862|37796750|FG001|Overall Study|Physician Decision|1|||
16927066|NCT01245751|38070472|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
16927067|NCT01245751|38070473|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
16927068|NCT01245751|38070474|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
16850169|NCT01759862|37796749|FG000|Overall Study|Adverse Event|0|||
16850170|NCT01759862|37796750|FG001|Overall Study|Adverse Event|1|||
16927069|NCT01245751|38070471|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
16927070|NCT01245751|38070472|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
16927071|NCT01245751|38070473|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
16927072|NCT01245751|38070474|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
16927073|NCT01245751|38070471|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
16927074|NCT01245751|38070472|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
16927075|NCT01245751|38070473|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
16927076|NCT01245751|38070474|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
17018324|NCT00680992|38162757|FG001|Overall Study|Lost to Follow-up|14|||
17018325|NCT00680992|38162758|FG002|Overall Study|Lost to Follow-up|0|||
17018326|NCT00680992|38162756|FG000|Overall Study|Noncompliance|4|||
17018327|NCT00680992|38162757|FG001|Overall Study|Noncompliance|6|||
17018328|NCT00680992|38162758|FG002|Overall Study|Noncompliance|0|||
17018329|NCT00680992|38162756|FG000|Overall Study|Requirement for Alternative Therapy|8|||
17018330|NCT00680992|38162757|FG001|Overall Study|Requirement for Alternative Therapy|2|||
17018331|NCT00680992|38162758|FG002|Overall Study|Requirement for Alternative Therapy|0|||
17018332|NCT00680992|38162756|FG000|Overall Study|Pregnancy|5|||
17018333|NCT00680992|38162757|FG001|Overall Study|Pregnancy|0|||
17018334|NCT00680992|38162758|FG002|Overall Study|Pregnancy|1|||
17018335|NCT00680992|38162756|FG000|Overall Study|Death|5|||
17018336|NCT00680992|38162757|FG001|Overall Study|Death|1|||
17018337|NCT00680992|38162758|FG002|Overall Study|Death|0|||
17018338|NCT00680992|38162756|FG000|Overall Study|Ineligibility Determined|0|||
17018339|NCT00680992|38162757|FG001|Overall Study|Ineligibility Determined|1|||
17018340|NCT00680992|38162758|FG002|Overall Study|Ineligibility Determined|0|||
17018341|NCT00805389|38162772|FG000|Overall Study|Adverse Event|0|||
17018342|NCT00805389|38162773|FG001|Overall Study|Adverse Event|0|||
17018343|NCT00805389|38162774|FG002|Overall Study|Adverse Event|1|||
17018344|NCT00805389|38162775|FG003|Overall Study|Adverse Event|2|||
17018345|NCT00805389|38162776|FG004|Overall Study|Adverse Event|0|||
17018346|NCT00805389|38162772|FG000|Overall Study|Lost to Follow-up|4|||
17018347|NCT00805389|38162773|FG001|Overall Study|Lost to Follow-up|3|||
17018348|NCT00805389|38162774|FG002|Overall Study|Lost to Follow-up|6|||
17018349|NCT00805389|38162775|FG003|Overall Study|Lost to Follow-up|10|||
17018350|NCT00805389|38162776|FG004|Overall Study|Lost to Follow-up|9|||
17018351|NCT00805389|38162772|FG000|Overall Study|Protocol Violation|0|||
17018352|NCT00805389|38162773|FG001|Overall Study|Protocol Violation|0|||
17018353|NCT00805389|38162774|FG002|Overall Study|Protocol Violation|1|||
17018354|NCT00805389|38162775|FG003|Overall Study|Protocol Violation|0|||
17018355|NCT00805389|38162776|FG004|Overall Study|Protocol Violation|0|||
17018356|NCT00805389|38162772|FG000|Overall Study|Withdrawal by Subject|3|||
17018357|NCT00805389|38162773|FG001|Overall Study|Withdrawal by Subject|2|||
17018358|NCT00805389|38162774|FG002|Overall Study|Withdrawal by Subject|4|||
17018359|NCT00805389|38162775|FG003|Overall Study|Withdrawal by Subject|5|||
17018360|NCT00805389|38162776|FG004|Overall Study|Withdrawal by Subject|4|||
16927077|NCT01245673|38070485|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
16927078|NCT01245283|38070492|FG000|Overall Study|Lost to Follow-up|14|||
17018361|NCT00678886|38162800|FG000|Overall Study|Withdrawal by Subject|0|||
17018362|NCT00678886|38162801|FG001|Overall Study|Withdrawal by Subject|0|||
17018363|NCT00678886|38162802|FG002|Overall Study|Withdrawal by Subject|4|||
17018364|NCT00678886|38162803|FG003|Overall Study|Withdrawal by Subject|6|||
17018365|NCT00678886|38162800|FG000|Overall Study|Physician Decision|0|||
17018366|NCT00678886|38162801|FG001|Overall Study|Physician Decision|0|||
17018367|NCT00678886|38162802|FG002|Overall Study|Physician Decision|1|||
17018368|NCT00678886|38162803|FG003|Overall Study|Physician Decision|1|||
17018369|NCT00678886|38162800|FG000|Overall Study|Lost to Follow-up|0|||
17018370|NCT00678886|38162801|FG001|Overall Study|Lost to Follow-up|0|||
17018371|NCT00678886|38162802|FG002|Overall Study|Lost to Follow-up|3|||
17018372|NCT00678886|38162803|FG003|Overall Study|Lost to Follow-up|2|||
17018373|NCT00678886|38162800|FG000|Overall Study|Other|0|||
17018374|NCT00678886|38162801|FG001|Overall Study|Other|0|||
17018375|NCT00678886|38162802|FG002|Overall Study|Other|1|||
16850171|NCT01606670|37796756|FG000|Overall Study|Adverse Event|6|||
16850172|NCT01606670|37796756|FG000|Overall Study|Lack of Efficacy|2|||
16850173|NCT01606670|37796756|FG000|Overall Study|Lost to Follow-up|3|||
16850174|NCT01606670|37796756|FG000|Overall Study|Withdrawal by Subject|3|||
16850175|NCT01606670|37796756|FG000|Overall Study|Other Reason|2|||
16850176|NCT01793792|37796760|FG000|Overall Study|Death|5|||
16850177|NCT01793792|37796760|FG000|Overall Study|Lost to Follow-up|5|||
16850178|NCT01793792|37796760|FG000|Overall Study|Withdrawal by Subject|1|||
16927079|NCT01245283|38070493|FG001|Overall Study|Lost to Follow-up|11|||
16927080|NCT01245283|38070494|FG002|Overall Study|Lost to Follow-up|11|||
17018376|NCT00678886|38162803|FG003|Overall Study|Other|0|||
16850179|NCT01793792|37796760|FG000|Overall Study|Device Not Implanted|1|||
17018377|NCT00804843|38162814|FG000|Overall Study|Protocol Violation|1|||
17018378|NCT00804843|38162815|FG001|Overall Study|Protocol Violation|0|||
16927081|NCT01245049|38070507|FG000|Overall Study|Migrated/moved from study area|0|||
16927082|NCT01245049|38070508|FG001|Overall Study|Migrated/moved from study area|1|||
16927083|NCT01245049|38070507|FG000|Overall Study|Withdrawal by Subject|0|||
16927084|NCT01245049|38070508|FG001|Overall Study|Withdrawal by Subject|1|||
16927085|NCT01245049|38070507|FG000|Overall Study|Lost to Follow-up|1|||
16927086|NCT01245049|38070508|FG001|Overall Study|Lost to Follow-up|2|||
16927087|NCT01244893|38070514|FG000|Baseline|Protocol Violation|0|||
16927088|NCT01244893|38070515|FG001|Baseline|Protocol Violation|1|||
16927089|NCT01244893|38070514|FG000|1-Week Follow Up|Lost to Follow-up|1|||
16927090|NCT01244893|38070515|FG001|1-Week Follow Up|Lost to Follow-up|0|||
16927091|NCT01244815|38070530|FG000|Overall Study|Not Treated|0|||
16850180|NCT01790984|37796766|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
16850181|NCT01790984|37796767|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
16850182|NCT01790984|37796768|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
16850183|NCT01790984|37796769|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
16850184|NCT01735994|37796794|FG000|Overall Study|Withdrawal by Subject|6|||
16850185|NCT01735994|37796795|FG001|Overall Study|Withdrawal by Subject|4|||
16850186|NCT01735994|37796794|FG000|Overall Study|Injury|2|||
16850187|NCT01735994|37796795|FG001|Overall Study|Injury|0|||
16850188|NCT01735994|37796794|FG000|Overall Study|Kicked off team|5|||
16850189|NCT01735994|37796795|FG001|Overall Study|Kicked off team|0|||
16850190|NCT01735994|37796794|FG000|Overall Study|Lost to Follow-up|50|||
16850191|NCT01735994|37796795|FG001|Overall Study|Lost to Follow-up|62|||
16850192|NCT01790828|37796801|FG000|Overall Study|Other|34|||
16850193|NCT01790594|37796807|FG000|Overall Study|Death|1|||
16927092|NCT01244815|38070531|FG001|Overall Study|Not Treated|1|||
16927093|NCT01244815|38070532|FG002|Overall Study|Not Treated|0|||
16927094|NCT01244815|38070533|FG003|Overall Study|Not Treated|0|||
16927095|NCT01244815|38070530|FG000|Overall Study|Adverse Event|4|||
16927096|NCT01244815|38070531|FG001|Overall Study|Adverse Event|7|||
16927097|NCT01244815|38070532|FG002|Overall Study|Adverse Event|5|||
16927098|NCT01244815|38070533|FG003|Overall Study|Adverse Event|5|||
16927099|NCT01244815|38070530|FG000|Overall Study|Treatment Failure|0|||
16927100|NCT01244815|38070531|FG001|Overall Study|Treatment Failure|0|||
16927101|NCT01244815|38070532|FG002|Overall Study|Treatment Failure|0|||
16927102|NCT01244815|38070533|FG003|Overall Study|Treatment Failure|1|||
16927103|NCT01244815|38070530|FG000|Overall Study|Lost to Follow-up|3|||
16927104|NCT01244815|38070531|FG001|Overall Study|Lost to Follow-up|2|||
16927105|NCT01244815|38070532|FG002|Overall Study|Lost to Follow-up|3|||
16927106|NCT01244815|38070533|FG003|Overall Study|Lost to Follow-up|2|||
16927107|NCT01244815|38070530|FG000|Overall Study|Withdrawal by Subject|0|||
16927108|NCT01244815|38070531|FG001|Overall Study|Withdrawal by Subject|2|||
16927109|NCT01244815|38070532|FG002|Overall Study|Withdrawal by Subject|0|||
16927110|NCT01244815|38070533|FG003|Overall Study|Withdrawal by Subject|3|||
16927111|NCT01244815|38070530|FG000|Overall Study|Protocol Violation|7|||
16927112|NCT01244815|38070531|FG001|Overall Study|Protocol Violation|4|||
16927113|NCT01244815|38070532|FG002|Overall Study|Protocol Violation|3|||
16927114|NCT01244815|38070533|FG003|Overall Study|Protocol Violation|1|||
16927115|NCT01244815|38070530|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
16927116|NCT01244815|38070531|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
16927117|NCT01244815|38070532|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
16927118|NCT01244815|38070533|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
16927119|NCT01244425|38070545|FG000|Overall Study|Withdrawal by Subject|2|||
16927120|NCT01244425|38070546|FG001|Overall Study|Withdrawal by Subject|2|||
16927121|NCT01244425|38070545|FG000|Overall Study|Adverse Event|1|||
16927122|NCT01244425|38070546|FG001|Overall Study|Adverse Event|1|||
16850194|NCT01790594|37796808|FG001|Overall Study|Death|0|||
16850195|NCT01790594|37796809|FG002|Overall Study|Death|0|||
16850196|NCT01790594|37796807|FG000|Overall Study|Physician Decision|2|||
16850197|NCT01790594|37796808|FG001|Overall Study|Physician Decision|1|||
16927123|NCT01244191|38070562|FG000|Overall Study|Progressive disease|295|||
16927124|NCT01244191|38070563|FG001|Overall Study|Progressive disease|350|||
16927125|NCT01244191|38070562|FG000|Overall Study|Clinical disease progression|54|||
16927126|NCT01244191|38070563|FG001|Overall Study|Clinical disease progression|36|||
16927127|NCT01244191|38070562|FG000|Overall Study|Adverse Event|65|||
17018379|NCT00804843|38162814|FG000|Overall Study|Adverse Event|8|||
16850198|NCT01790594|37796809|FG002|Overall Study|Physician Decision|0|||
16850199|NCT01790594|37796807|FG000|Overall Study|Withdrawal by Subject|2|||
16850200|NCT01790594|37796808|FG001|Overall Study|Withdrawal by Subject|0|||
16850201|NCT01790594|37796809|FG002|Overall Study|Withdrawal by Subject|0|||
16850202|NCT01790594|37796807|FG000|Overall Study|Transplant was not done|0|||
16850203|NCT01790594|37796808|FG001|Overall Study|Transplant was not done|0|||
16850204|NCT01790594|37796809|FG002|Overall Study|Transplant was not done|3|||
17018380|NCT00804843|38162815|FG001|Overall Study|Adverse Event|5|||
16927128|NCT01244191|38070563|FG001|Overall Study|Adverse Event|48|||
16927129|NCT01244191|38070562|FG000|Overall Study|Death|22|||
16927130|NCT01244191|38070563|FG001|Overall Study|Death|29|||
16927131|NCT01244191|38070562|FG000|Overall Study|Lost to Follow-up|0|||
16850205|NCT01790594|37796807|FG000|Overall Study|Terminated prior to week 76|0|||
16850206|NCT01790594|37796808|FG001|Overall Study|Terminated prior to week 76|2|||
16850207|NCT01790594|37796809|FG002|Overall Study|Terminated prior to week 76|0|||
16927132|NCT01244191|38070563|FG001|Overall Study|Lost to Follow-up|2|||
16927133|NCT01244191|38070562|FG000|Overall Study|Protocol Violation|1|||
16927134|NCT01244191|38070563|FG001|Overall Study|Protocol Violation|2|||
16927135|NCT01244191|38070562|FG000|Overall Study|Withdrawal by Subject|31|||
16927136|NCT01244191|38070563|FG001|Overall Study|Withdrawal by Subject|23|||
16927137|NCT01244191|38070562|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
16927138|NCT01244191|38070563|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
16927139|NCT01244035|38070569|FG000|Part 1: Period 1|Adverse Event|0|||
16927140|NCT01244035|38070570|FG001|Part 1: Period 1|Adverse Event|0|||
16927141|NCT01244035|38070571|FG002|Part 1: Period 1|Adverse Event|0|||
16927142|NCT01244035|38070572|FG003|Part 1: Period 1|Adverse Event|0|||
16927143|NCT01244035|38070573|FG004|Part 1: Period 1|Adverse Event|0|||
16927144|NCT01244035|38070574|FG005|Part 1: Period 1|Adverse Event|1|||
16927145|NCT01244035|38070569|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
16927146|NCT01244035|38070570|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
16927147|NCT01244035|38070571|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
16927148|NCT01244035|38070572|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
16927149|NCT01244035|38070573|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
16927150|NCT01244035|38070574|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
16927151|NCT01244035|38070569|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
16927152|NCT01244035|38070570|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
16927153|NCT01244035|38070571|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
16927154|NCT01244035|38070572|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
16927155|NCT01244035|38070573|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
16927156|NCT01244035|38070574|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
16927157|NCT01244035|38070569|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16850208|NCT01790516|37796818|FG000|Overall Study|Physician Decision|1|||
16850209|NCT01790516|37796819|FG001|Overall Study|Physician Decision|0|||
16850210|NCT01790438|37796827|FG000|Overall Study|Adverse Event|3|||
16850211|NCT01790438|37796828|FG001|Overall Study|Adverse Event|2|||
16850212|NCT01790438|37796827|FG000|Overall Study|Death|4|||
16850213|NCT01790438|37796828|FG001|Overall Study|Death|0|||
16850214|NCT01790438|37796827|FG000|Overall Study|Lost to Follow-up|5|||
16850215|NCT01790438|37796828|FG001|Overall Study|Lost to Follow-up|2|||
16850216|NCT01790438|37796827|FG000|Overall Study|Withdrawal by Subject|13|||
16850217|NCT01790438|37796828|FG001|Overall Study|Withdrawal by Subject|2|||
16850218|NCT01790438|37796827|FG000|Overall Study|Physician Decision|3|||
16850219|NCT01790438|37796828|FG001|Overall Study|Physician Decision|1|||
16850220|NCT01790438|37796827|FG000|Overall Study|Sponsor Decision|0|||
16850221|NCT01790438|37796828|FG001|Overall Study|Sponsor Decision|3|||
16850222|NCT01790438|37796827|FG000|Overall Study|Protocol Required Discontinuation|7|||
16850223|NCT01790438|37796828|FG001|Overall Study|Protocol Required Discontinuation|1|||
16850224|NCT01735916|37796839|FG000|Overall Study|Subject not eligible to be randomized|11|||
16850225|NCT01735916|37796840|FG001|Overall Study|Subject not eligible to be randomized|0|||
16850226|NCT01735916|37796841|FG002|Overall Study|Subject not eligible to be randomized|0|||
16850227|NCT01735916|37796839|FG000|Overall Study|Early termination of study by sponsor|4|||
16850228|NCT01735916|37796840|FG001|Overall Study|Early termination of study by sponsor|19|||
16850229|NCT01735916|37796841|FG002|Overall Study|Early termination of study by sponsor|7|||
16850230|NCT01735916|37796839|FG000|Overall Study|Withdrawal by Subject|3|||
16850231|NCT01735916|37796840|FG001|Overall Study|Withdrawal by Subject|0|||
16927158|NCT01244035|38070570|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16927159|NCT01244035|38070571|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
16927160|NCT01244035|38070572|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16927161|NCT01244035|38070573|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16927162|NCT01244035|38070574|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16927163|NCT01244035|38070569|FG000|Part 1: Period 3|Adverse Event|0|||
16927164|NCT01244035|38070570|FG001|Part 1: Period 3|Adverse Event|0|||
16927165|NCT01244035|38070571|FG002|Part 1: Period 3|Adverse Event|0|||
16927166|NCT01244035|38070572|FG003|Part 1: Period 3|Adverse Event|0|||
16927167|NCT01244035|38070573|FG004|Part 1: Period 3|Adverse Event|0|||
16927168|NCT01244035|38070574|FG005|Part 1: Period 3|Adverse Event|1|||
16927169|NCT01244035|38070569|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
16927170|NCT01244035|38070570|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
16927171|NCT01244035|38070571|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
16850232|NCT01735916|37796841|FG002|Overall Study|Withdrawal by Subject|0|||
16850233|NCT01790126|37796851|FG000|Overall Study|PSA Progression|12|||
16927172|NCT01244035|38070572|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
16927173|NCT01244035|38070573|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
16927174|NCT01244035|38070574|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
16927175|NCT01244035|38070569|FG000|Part 1: Period 3|Protocol Deviation|0|||
17102590|NCT00112437|38241442|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
16850234|NCT01790126|37796852|FG001|Overall Study|PSA Progression|16|||
16927176|NCT01244035|38070570|FG001|Part 1: Period 3|Protocol Deviation|1|||
16927177|NCT01244035|38070571|FG002|Part 1: Period 3|Protocol Deviation|0|||
16927178|NCT01244035|38070572|FG003|Part 1: Period 3|Protocol Deviation|0|||
16927179|NCT01244035|38070573|FG004|Part 1: Period 3|Protocol Deviation|0|||
16927180|NCT01244035|38070574|FG005|Part 1: Period 3|Protocol Deviation|0|||
16927181|NCT01243762|38070610|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
16927182|NCT01243762|38070611|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
16927183|NCT01243762|38070612|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
16927184|NCT01243762|38070613|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
16927185|NCT01243762|38070614|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
16927186|NCT01243762|38070615|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
16927187|NCT01243762|38070616|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
16927188|NCT01243762|38070610|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16927189|NCT01243762|38070611|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
16927190|NCT01243762|38070612|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16927191|NCT01243762|38070613|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
16927192|NCT01243762|38070614|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16927193|NCT01243762|38070615|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16927194|NCT01243762|38070616|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16927195|NCT01243762|38070610|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
16927196|NCT01243762|38070611|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
16927197|NCT01243762|38070612|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
16927198|NCT01243762|38070613|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
16927199|NCT01243762|38070614|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
16927200|NCT01243762|38070615|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
16927201|NCT01243762|38070616|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
16927202|NCT01243762|38070610|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16927203|NCT01243762|38070611|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
16927204|NCT01243762|38070612|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16927205|NCT01243762|38070613|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16927206|NCT01243762|38070614|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16927207|NCT01243762|38070615|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16927208|NCT01243762|38070616|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16927209|NCT01243762|38070610|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16927210|NCT01243762|38070611|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
16927211|NCT01243762|38070612|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16927212|NCT01243762|38070613|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16927213|NCT01243762|38070614|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16927214|NCT01243762|38070615|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16927215|NCT01243762|38070616|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
16927216|NCT01243762|38070610|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
16927217|NCT01243762|38070611|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
16927218|NCT01243762|38070612|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
16927219|NCT01243762|38070613|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
16927220|NCT01243762|38070614|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
16927221|NCT01243762|38070615|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
16927222|NCT01243762|38070616|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
16927223|NCT01243762|38070610|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16927224|NCT01243762|38070611|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
16927225|NCT01243762|38070612|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16927226|NCT01243762|38070613|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16927227|NCT01243762|38070614|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
16927228|NCT01243762|38070615|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16927229|NCT01243762|38070616|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16927230|NCT01243762|38070610|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16927231|NCT01243762|38070611|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16927232|NCT01243762|38070612|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16927233|NCT01243762|38070613|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
16927234|NCT01243762|38070614|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
16927235|NCT01243762|38070615|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16927236|NCT01243762|38070616|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16927237|NCT01243411|38070635|FG000|Overall Study|Withdrawal by Subject|18|||
16927238|NCT01243411|38070635|FG000|Overall Study|Lost to Follow-up|10|||
16927239|NCT01243411|38070635|FG000|Overall Study|Adverse Event|5|||
16927240|NCT01243411|38070635|FG000|Overall Study|Other|8|||
16927241|NCT01243177|38070641|FG000|Overall Study|Lack of Efficacy|47|||
16927242|NCT01243177|38070642|FG001|Overall Study|Lack of Efficacy|31|||
16927243|NCT01243177|38070641|FG000|Overall Study|Protocol Violation|11|||
16927244|NCT01243177|38070642|FG001|Overall Study|Protocol Violation|10|||
16927245|NCT01243177|38070641|FG000|Overall Study|Lost to Follow-up|15|||
16927246|NCT01243177|38070642|FG001|Overall Study|Lost to Follow-up|18|||
16927247|NCT01243177|38070641|FG000|Overall Study|Withdrawal by Subject|46|||
16927248|NCT01243177|38070642|FG001|Overall Study|Withdrawal by Subject|38|||
16927249|NCT01243177|38070641|FG000|Overall Study|AE, serious fatal|0|||
16927250|NCT01243177|38070642|FG001|Overall Study|AE, serious fatal|1|||
16927251|NCT01243177|38070641|FG000|Overall Study|SAE, non-fatal|7|||
16927252|NCT01243177|38070642|FG001|Overall Study|SAE, non-fatal|9|||
16927253|NCT01243177|38070641|FG000|Overall Study|AE, non-serious non-fatal|40|||
16927254|NCT01243177|38070642|FG001|Overall Study|AE, non-serious non-fatal|58|||
16927255|NCT01243177|38070641|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
16927256|NCT01243177|38070642|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
16927257|NCT01243177|38070641|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
16927258|NCT01243177|38070642|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
16927259|NCT01243177|38070641|FG000|Overall Study|Other Reason|11|||
16927260|NCT01243177|38070642|FG001|Overall Study|Other Reason|12|||
16927261|NCT01242748|38070650|FG000|Overall Study|Adverse Event|10|||
16927262|NCT01242748|38070651|FG001|Overall Study|Adverse Event|5|||
16927263|NCT01242748|38070650|FG000|Overall Study|Lost to Follow-up|6|||
16927264|NCT01242748|38070651|FG001|Overall Study|Lost to Follow-up|2|||
16927265|NCT01242748|38070650|FG000|Overall Study|Physician Decision|3|||
16927266|NCT01242748|38070651|FG001|Overall Study|Physician Decision|2|||
16927267|NCT01242748|38070650|FG000|Overall Study|Protocol Violation|1|||
16927268|NCT01242748|38070651|FG001|Overall Study|Protocol Violation|0|||
16927269|NCT01242748|38070650|FG000|Overall Study|Withdrawal by Subject|10|||
16927270|NCT01242748|38070651|FG001|Overall Study|Withdrawal by Subject|2|||
16927271|NCT01242748|38070650|FG000|Overall Study|Miscellaneous reasons|8|||
16927272|NCT01242748|38070651|FG001|Overall Study|Miscellaneous reasons|3|||
16927273|NCT01242514|38070660|FG000|Overall Study|e.g., project closure|1042|||
16927274|NCT01242514|38070661|FG001|Overall Study|e.g., project closure|305|||
16927275|NCT01242514|38070662|FG002|Overall Study|e.g., project closure|171|||
16927276|NCT01242514|38070660|FG000|Overall Study|Subject decision|33|||
16927277|NCT01242514|38070661|FG001|Overall Study|Subject decision|8|||
16927278|NCT01242514|38070662|FG002|Overall Study|Subject decision|2|||
16927279|NCT01242514|38070660|FG000|Overall Study|Severe non-compliance to protocol|5|||
16927280|NCT01242514|38070661|FG001|Overall Study|Severe non-compliance to protocol|2|||
16927281|NCT01242514|38070662|FG002|Overall Study|Severe non-compliance to protocol|1|||
16927282|NCT01242514|38070660|FG000|Overall Study|Lack of therapeutic response|99|||
16927283|NCT01242514|38070661|FG001|Overall Study|Lack of therapeutic response|16|||
16927284|NCT01242514|38070662|FG002|Overall Study|Lack of therapeutic response|10|||
16927285|NCT01242514|38070660|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
16927286|NCT01242514|38070661|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
16927287|NCT01242514|38070662|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
16927288|NCT01242514|38070660|FG000|Overall Study|Lost to Follow-up|14|||
16927289|NCT01242514|38070661|FG001|Overall Study|Lost to Follow-up|5|||
16927290|NCT01242514|38070662|FG002|Overall Study|Lost to Follow-up|4|||
16927291|NCT01242514|38070660|FG000|Overall Study|Adverse Event|129|||
16927292|NCT01242514|38070661|FG001|Overall Study|Adverse Event|18|||
16927293|NCT01242514|38070662|FG002|Overall Study|Adverse Event|19|||
16927294|NCT01242085|38070673|FG000|Overall Study|Withdrawal by Subject|4|||
16927295|NCT01242085|38070674|FG001|Overall Study|Withdrawal by Subject|2|||
16927296|NCT01242085|38070675|FG002|Overall Study|Withdrawal by Subject|0|||
16927297|NCT01242085|38070673|FG000|Overall Study|medically unable to have surgery|4|||
16927298|NCT01242085|38070674|FG001|Overall Study|medically unable to have surgery|5|||
16927299|NCT01242085|38070675|FG002|Overall Study|medically unable to have surgery|0|||
16927300|NCT01241461|38070683|FG000|Overall Study|Progressive Disease|3|||
16927301|NCT01241461|38070684|FG001|Overall Study|Progressive Disease|6|||
16927302|NCT01240135|38070696|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
16927303|NCT01240135|38070697|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
16927304|NCT01240135|38070696|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
16927305|NCT01240135|38070697|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
16927306|NCT01247701|38070703|FG000|Overall Study|Death|2|||
16927307|NCT01247701|38070703|FG000|Overall Study|Relapsed|8|||
16927308|NCT01248247|38070711|FG000|Overall Study|Adverse Event|2|||
16927309|NCT01248247|38070712|FG001|Overall Study|Adverse Event|4|||
16927310|NCT01248247|38070713|FG002|Overall Study|Adverse Event|4|||
16927311|NCT01248247|38070714|FG003|Overall Study|Adverse Event|2|||
16927312|NCT01248247|38070711|FG000|Overall Study|Death|0|||
16927313|NCT01248247|38070712|FG001|Overall Study|Death|1|||
16927314|NCT01248247|38070713|FG002|Overall Study|Death|4|||
16927315|NCT01248247|38070714|FG003|Overall Study|Death|7|||
16927316|NCT01248247|38070711|FG000|Overall Study|Lost to Follow-up|0|||
16927317|NCT01248247|38070712|FG001|Overall Study|Lost to Follow-up|1|||
16927318|NCT01248247|38070713|FG002|Overall Study|Lost to Follow-up|1|||
16927319|NCT01248247|38070714|FG003|Overall Study|Lost to Follow-up|0|||
16927320|NCT01248247|38070711|FG000|Overall Study|Alternative treatment|0|||
16927321|NCT01248247|38070712|FG001|Overall Study|Alternative treatment|1|||
16927322|NCT01248247|38070713|FG002|Overall Study|Alternative treatment|0|||
16927323|NCT01248247|38070714|FG003|Overall Study|Alternative treatment|0|||
16927324|NCT01248247|38070711|FG000|Overall Study|Other|2|||
17018381|NCT00804843|38162814|FG000|Overall Study|Withdrawal by Subject|1|||
16927325|NCT01248247|38070712|FG001|Overall Study|Other|8|||
16927326|NCT01248247|38070713|FG002|Overall Study|Other|8|||
16927327|NCT01248247|38070714|FG003|Overall Study|Other|5|||
16927328|NCT01248247|38070711|FG000|Overall Study|Progression|18|||
16927329|NCT01248247|38070712|FG001|Overall Study|Progression|27|||
16927330|NCT01248247|38070713|FG002|Overall Study|Progression|56|||
16927331|NCT01248247|38070714|FG003|Overall Study|Progression|44|||
16927332|NCT01248247|38070711|FG000|Overall Study|Refuse further treatment|0|||
16927333|NCT01248247|38070712|FG001|Overall Study|Refuse further treatment|0|||
16927334|NCT01248247|38070713|FG002|Overall Study|Refuse further treatment|1|||
16927335|NCT01248247|38070714|FG003|Overall Study|Refuse further treatment|2|||
16927336|NCT01248247|38070711|FG000|Overall Study|Complicating disease|0|||
16927337|NCT01248247|38070712|FG001|Overall Study|Complicating disease|0|||
16927338|NCT01248247|38070713|FG002|Overall Study|Complicating disease|1|||
16927339|NCT01248247|38070714|FG003|Overall Study|Complicating disease|1|||
16927340|NCT02598583|38070726|FG000|Extension Period|Withdrawal by Subject|1|||
16927341|NCT02598583|38070727|FG001|Extension Period|Withdrawal by Subject|0|||
16927342|NCT04967885|38070757|FG000|Overall Study|Lost to Follow-up|16|||
16927343|NCT04967885|38070758|FG001|Overall Study|Lost to Follow-up|10|||
16927344|NCT04834726|38070773|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
16927345|NCT04834726|38070774|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
16927346|NCT04834726|38070775|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
16927347|NCT04834726|38070776|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
16927348|NCT04834726|38070777|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
16927349|NCT04834726|38070778|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
16927350|NCT04834726|38070779|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
16927351|NCT04834726|38070780|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
16927352|NCT04834726|38070781|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
16927353|NCT04732949|38070797|FG000|Overall Study|Withdrawal by Subject|23|||
16927354|NCT04732949|38070798|FG001|Overall Study|Withdrawal by Subject|27|||
16927355|NCT04732949|38070797|FG000|Overall Study|Protocol Violation|0|||
16927356|NCT04732949|38070798|FG001|Overall Study|Protocol Violation|1|||
16927357|NCT04732949|38070797|FG000|Overall Study|Non-compliance|0|||
16927358|NCT04732949|38070798|FG001|Overall Study|Non-compliance|2|||
16927359|NCT04732949|38070797|FG000|Overall Study|Physician Decision|2|||
16927360|NCT04732949|38070798|FG001|Overall Study|Physician Decision|1|||
16927361|NCT04732949|38070797|FG000|Overall Study|Serious adverse event (Fatal)|16|||
16927362|NCT04732949|38070798|FG001|Overall Study|Serious adverse event (Fatal)|18|||
16927363|NCT04732949|38070797|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
16927364|NCT04732949|38070798|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
16927365|NCT04732949|38070797|FG000|Overall Study|Non-serious adverse event|1|||
16927366|NCT04732949|38070798|FG001|Overall Study|Non-serious adverse event|3|||
16927367|NCT04732949|38070797|FG000|Overall Study|Lost to Follow-up|26|||
16927368|NCT04732949|38070798|FG001|Overall Study|Lost to Follow-up|27|||
16927369|NCT04732949|38070797|FG000|Overall Study|Other|6|||
16927370|NCT04732949|38070798|FG001|Overall Study|Other|3|||
16927371|NCT04235504|38070853|FG000|Study Phase|Withdrawal by Subject|5|||
16927372|NCT04235504|38070854|FG001|Study Phase|Withdrawal by Subject|2|||
16927373|NCT04235504|38070855|FG002|Study Phase|Withdrawal by Subject|0|||
16927374|NCT04235504|38070856|FG003|Study Phase|Withdrawal by Subject|0|||
16927375|NCT04235504|38070853|FG000|Continuation Phase|Withdrawal by Subject|0|||
16927376|NCT04235504|38070854|FG001|Continuation Phase|Withdrawal by Subject|4|||
16927377|NCT04235504|38070855|FG002|Continuation Phase|Withdrawal by Subject|0|||
16927378|NCT04235504|38070856|FG003|Continuation Phase|Withdrawal by Subject|0|||
16927379|NCT04235504|38070853|FG000|Continuation Phase|Adverse Event|0|||
16927380|NCT04235504|38070854|FG001|Continuation Phase|Adverse Event|1|||
16927381|NCT04235504|38070855|FG002|Continuation Phase|Adverse Event|0|||
16927382|NCT04235504|38070856|FG003|Continuation Phase|Adverse Event|0|||
16927383|NCT04235504|38070853|FG000|Continuation Phase|Physician Decision|1|||
16927384|NCT04235504|38070854|FG001|Continuation Phase|Physician Decision|2|||
16927385|NCT04235504|38070855|FG002|Continuation Phase|Physician Decision|1|||
16927386|NCT04235504|38070856|FG003|Continuation Phase|Physician Decision|0|||
16927387|NCT04172987|38070871|FG000|Lead In Period|Adverse Event|1|||
16927388|NCT04172987|38070871|FG000|Lead In Period|Protocol Violation|1|||
16927389|NCT04172987|38070871|FG000|Period 1|Physician Decision|1|||
16927390|NCT04172987|38070871|FG000|Period 2|Adverse Event|5|||
16927391|NCT04172987|38070871|FG000|Period 2|Dosing Termination by Sponsor|4|||
16927392|NCT03705832|38070880|FG000|Overall Study|Physician Decision|0|||
16927393|NCT03705832|38070881|FG001|Overall Study|Physician Decision|1|||
16927394|NCT03705832|38070880|FG000|Overall Study|Withdrawal by Subject|1|||
16927395|NCT03705832|38070881|FG001|Overall Study|Withdrawal by Subject|0|||
16927396|NCT03447743|38070887|FG000|Overall Study|Withdrawal by Subject|2|||
16927397|NCT03447743|38070887|FG000|Overall Study|Lost to Follow-up|3|||
16927398|NCT03447743|38070887|FG000|Overall Study|Adverse Event|1|||
16927399|NCT03447743|38070887|FG000|Overall Study|Did not meet criteria to continue|1|||
16927400|NCT03433755|38070895|FG000|Overall Study|Lost to Follow-up|1|||
16927401|NCT03433755|38070896|FG001|Overall Study|Lost to Follow-up|0|||
16927402|NCT03433755|38070897|FG002|Overall Study|Lost to Follow-up|0|||
16927403|NCT03433755|38070898|FG003|Overall Study|Lost to Follow-up|0|||
16927404|NCT03433755|38070895|FG000|Overall Study|Decision by Sponsor|1|||
16927405|NCT03433755|38070896|FG001|Overall Study|Decision by Sponsor|0|||
16927406|NCT03433755|38070897|FG002|Overall Study|Decision by Sponsor|0|||
16927407|NCT03433755|38070898|FG003|Overall Study|Decision by Sponsor|0|||
16927408|NCT03406507|38070921|FG000|Extension Period|Lack of Efficacy|0|||
16927409|NCT03406507|38070922|FG001|Extension Period|Lack of Efficacy|1|||
16927410|NCT03283150|38070931|FG000|Overall Study|Withdrawal by Subject|6|||
16927411|NCT03283150|38070932|FG001|Overall Study|Withdrawal by Subject|0|||
16927412|NCT03283150|38070933|FG002|Overall Study|Withdrawal by Subject|0|||
16927413|NCT03218917|38070944|FG000|Overall Study|Adverse Event|3|||
16927414|NCT03218917|38070945|FG001|Overall Study|Adverse Event|3|||
16927415|NCT03218917|38070946|FG002|Overall Study|Adverse Event|2|||
16927416|NCT03218917|38070944|FG000|Overall Study|Subject withdrew consent|2|||
16927417|NCT03218917|38070945|FG001|Overall Study|Subject withdrew consent|4|||
16927418|NCT03218917|38070946|FG002|Overall Study|Subject withdrew consent|10|||
16927419|NCT03218917|38070944|FG000|Overall Study|Physician Decision|0|||
16927420|NCT03218917|38070945|FG001|Overall Study|Physician Decision|1|||
16927421|NCT03218917|38070946|FG002|Overall Study|Physician Decision|1|||
16927422|NCT03218917|38070944|FG000|Overall Study|Lost to Follow-up|1|||
16927423|NCT03218917|38070945|FG001|Overall Study|Lost to Follow-up|0|||
16927424|NCT03218917|38070946|FG002|Overall Study|Lost to Follow-up|0|||
16927425|NCT03218917|38070944|FG000|Overall Study|Reason Missing|0|||
16927426|NCT03218917|38070945|FG001|Overall Study|Reason Missing|2|||
16927427|NCT03218917|38070946|FG002|Overall Study|Reason Missing|0|||
16927428|NCT03218917|38070944|FG000|Overall Study|Death|0|||
16927429|NCT03218917|38070945|FG001|Overall Study|Death|1|||
16927430|NCT03218917|38070946|FG002|Overall Study|Death|0|||
16927431|NCT03218917|38070944|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16927432|NCT03218917|38070945|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16927433|NCT03218917|38070946|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16927434|NCT03201965|38070958|FG000|Overall Study|Death|5|||
17018382|NCT00804843|38162815|FG001|Overall Study|Withdrawal by Subject|2|||
17018383|NCT00822120|38162824|FG000|Initial Registration|Adverse Event|1|||
17018384|NCT00822120|38162825|FG001|Initial Registration|Adverse Event|0|||
17018385|NCT00822120|38162826|FG002|Initial Registration|Adverse Event|0|||
17018386|NCT00822120|38162827|FG003|Initial Registration|Adverse Event|0|||
17018387|NCT00822120|38162828|FG004|Initial Registration|Adverse Event|0|||
17018388|NCT00822120|38162829|FG005|Initial Registration|Adverse Event|0|||
17018389|NCT00822120|38162824|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
17018390|NCT00822120|38162825|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
17018391|NCT00822120|38162826|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
17018392|NCT00822120|38162827|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
17018393|NCT00822120|38162828|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
17018394|NCT00822120|38162829|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
17018395|NCT00822120|38162824|FG000|Initial Registration|Reasons not Protocol Specified|2|||
17018396|NCT00822120|38162825|FG001|Initial Registration|Reasons not Protocol Specified|0|||
17018397|NCT00822120|38162826|FG002|Initial Registration|Reasons not Protocol Specified|0|||
17018398|NCT00822120|38162827|FG003|Initial Registration|Reasons not Protocol Specified|0|||
17018399|NCT00822120|38162828|FG004|Initial Registration|Reasons not Protocol Specified|0|||
17018400|NCT00822120|38162829|FG005|Initial Registration|Reasons not Protocol Specified|0|||
17018401|NCT00822120|38162824|FG000|Initial Registration|Ineligible|22|||
17018402|NCT00822120|38162825|FG001|Initial Registration|Ineligible|1|||
17018403|NCT00822120|38162826|FG002|Initial Registration|Ineligible|0|||
17018404|NCT00822120|38162827|FG003|Initial Registration|Ineligible|0|||
17018405|NCT00822120|38162828|FG004|Initial Registration|Ineligible|0|||
17018406|NCT00822120|38162829|FG005|Initial Registration|Ineligible|0|||
17018407|NCT00822120|38162824|FG000|PET-directed Therapy|Adverse Event|0|||
17018408|NCT00822120|38162825|FG001|PET-directed Therapy|Adverse Event|0|||
17018409|NCT00822120|38162826|FG002|PET-directed Therapy|Adverse Event|0|||
17018410|NCT00822120|38162827|FG003|PET-directed Therapy|Adverse Event|1|||
17018411|NCT00822120|38162828|FG004|PET-directed Therapy|Adverse Event|0|||
17018412|NCT00822120|38162829|FG005|PET-directed Therapy|Adverse Event|0|||
17018413|NCT00822120|38162824|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
17018414|NCT00822120|38162825|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
17018415|NCT00822120|38162826|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
16927435|NCT03201965|38070959|FG001|Overall Study|Death|27|||
16927436|NCT03201965|38070960|FG002|Overall Study|Death|27|||
16927437|NCT03201965|38070958|FG000|Overall Study|Lost to Follow-up|0|||
17018416|NCT00822120|38162827|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
16927438|NCT03201965|38070959|FG001|Overall Study|Lost to Follow-up|1|||
16850235|NCT01790126|37796853|FG002|Overall Study|PSA Progression|16|||
16850236|NCT01790126|37796851|FG000|Overall Study|Other|5|||
16927439|NCT03201965|38070960|FG002|Overall Study|Lost to Follow-up|0|||
16850237|NCT01790126|37796852|FG001|Overall Study|Other|4|||
16850238|NCT01790126|37796853|FG002|Overall Study|Other|8|||
16850239|NCT01790126|37796851|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
16850240|NCT01790126|37796852|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
16850241|NCT01790126|37796853|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
16850242|NCT01790126|37796851|FG000|Overall Study|Withdrawal by Physician|1|||
16850243|NCT01790126|37796852|FG001|Overall Study|Withdrawal by Physician|1|||
16927440|NCT03201965|38070958|FG000|Overall Study|Withdrawal by Subject|3|||
16927441|NCT03201965|38070959|FG001|Overall Study|Withdrawal by Subject|13|||
16927442|NCT03201965|38070960|FG002|Overall Study|Withdrawal by Subject|4|||
16927443|NCT03201965|38070958|FG000|Overall Study|Ongoing|20|||
16927444|NCT03201965|38070959|FG001|Overall Study|Ongoing|152|||
16927445|NCT03201965|38070960|FG002|Overall Study|Ongoing|164|||
16927446|NCT03056040|38070969|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
16927447|NCT03056040|38070970|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
16927448|NCT03056040|38070969|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
16927449|NCT03056040|38070970|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
16927450|NCT03056040|38070969|FG000|Primary Evaluation Period|Pregnancy|0|||
16927451|NCT03056040|38070970|FG001|Primary Evaluation Period|Pregnancy|1|||
16927452|NCT03056040|38070969|FG000|Extension Period|Physician Decision|3|||
16927453|NCT03056040|38070970|FG001|Extension Period|Physician Decision|3|||
16927454|NCT03056040|38070969|FG000|Extension Period|Lost to Follow-up|0|||
16927455|NCT03056040|38070970|FG001|Extension Period|Lost to Follow-up|1|||
16927456|NCT03056040|38070969|FG000|Extension Period|Death|0|||
16927457|NCT03056040|38070970|FG001|Extension Period|Death|3|||
16927458|NCT03056040|38070969|FG000|Extension Period|Withdrawal by Subject|1|||
16927459|NCT03056040|38070970|FG001|Extension Period|Withdrawal by Subject|0|||
16927460|NCT03021499|38070981|FG000|Overall Study|Adverse Event|1|||
16927461|NCT03021499|38070982|FG001|Overall Study|Adverse Event|0|||
16927462|NCT03021499|38070981|FG000|Overall Study|Death|1|||
16850244|NCT01790126|37796853|FG002|Overall Study|Withdrawal by Physician|2|||
16850245|NCT01790126|37796851|FG000|Overall Study|Withdrawal by Subject|3|||
16850246|NCT01790126|37796852|FG001|Overall Study|Withdrawal by Subject|1|||
16850247|NCT01790126|37796853|FG002|Overall Study|Withdrawal by Subject|2|||
16850248|NCT01790126|37796851|FG000|Overall Study|Lost to Follow-up|1|||
16850249|NCT01790126|37796852|FG001|Overall Study|Lost to Follow-up|0|||
16850250|NCT01790126|37796853|FG002|Overall Study|Lost to Follow-up|1|||
16850251|NCT01790126|37796851|FG000|Overall Study|Adverse Event|0|||
16927463|NCT03021499|38070982|FG001|Overall Study|Death|5|||
16850252|NCT01790126|37796852|FG001|Overall Study|Adverse Event|2|||
16850253|NCT01790126|37796853|FG002|Overall Study|Adverse Event|0|||
16850254|NCT01790126|37796851|FG000|Overall Study|Death|2|||
16850255|NCT01790126|37796852|FG001|Overall Study|Death|0|||
16850256|NCT01790126|37796853|FG002|Overall Study|Death|0|||
16850257|NCT01790126|37796851|FG000|Overall Study|Radiographic Progression|3|||
16850258|NCT01790126|37796852|FG001|Overall Study|Radiographic Progression|1|||
16850259|NCT01790126|37796853|FG002|Overall Study|Radiographic Progression|0|||
16850260|NCT01734902|37796864|FG000|Overall Study|Other than listed|0|||
16850261|NCT01734902|37796865|FG001|Overall Study|Other than listed|2|||
16850262|NCT01790048|37796873|FG000|Overall Study|Incorrect Age|9|||
16850263|NCT01790048|37796874|FG001|Overall Study|Incorrect Age|14|||
16850264|NCT01790048|37796873|FG000|Overall Study|data entry error|0|||
16850265|NCT01790048|37796874|FG001|Overall Study|data entry error|1|||
16850266|NCT01790048|37796873|FG000|Overall Study|Other|0|||
16850267|NCT01790048|37796874|FG001|Overall Study|Other|2|||
16850268|NCT01790048|37796873|FG000|Overall Study|SAM at Enrollment|2|||
16850269|NCT01790048|37796874|FG001|Overall Study|SAM at Enrollment|0|||
16850270|NCT01790048|37796873|FG000|Overall Study|Measurement error|1|||
16850271|NCT01790048|37796874|FG001|Overall Study|Measurement error|0|||
16850272|NCT01789970|37796884|FG000|Open-label Titration Period|Adverse Event|68|||
16850273|NCT01789970|37796885|FG001|Open-label Titration Period|Adverse Event|0|||
16850274|NCT01789970|37796886|FG002|Open-label Titration Period|Adverse Event|0|||
16850275|NCT01789970|37796884|FG000|Open-label Titration Period|Lack of Efficacy|31|||
16850276|NCT01789970|37796885|FG001|Open-label Titration Period|Lack of Efficacy|0|||
16850277|NCT01789970|37796886|FG002|Open-label Titration Period|Lack of Efficacy|0|||
16850278|NCT01789970|37796884|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
16850279|NCT01789970|37796885|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
16850280|NCT01789970|37796886|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
16850281|NCT01789970|37796884|FG000|Open-label Titration Period|Protocol Violation|18|||
16850282|NCT01789970|37796885|FG001|Open-label Titration Period|Protocol Violation|0|||
16850283|NCT01789970|37796886|FG002|Open-label Titration Period|Protocol Violation|0|||
16850284|NCT01789970|37796884|FG000|Open-label Titration Period|Lost to Follow-up|5|||
16927464|NCT03021499|38070981|FG000|Overall Study|Lack of Efficacy|0|||
16927465|NCT03021499|38070982|FG001|Overall Study|Lack of Efficacy|1|||
16850285|NCT01789970|37796885|FG001|Open-label Titration Period|Lost to Follow-up|0|||
16850286|NCT01789970|37796886|FG002|Open-label Titration Period|Lost to Follow-up|0|||
16850287|NCT01789970|37796884|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
16850288|NCT01789970|37796885|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
16850289|NCT01789970|37796886|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
16850290|NCT01789970|37796884|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
16850291|NCT01789970|37796885|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
16850292|NCT01789970|37796886|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
16850293|NCT01789970|37796884|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
16850294|NCT01789970|37796885|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
16850295|NCT01789970|37796886|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
16850296|NCT01789970|37796884|FG000|Open-label Titration Period|Pregnancy|2|||
16850297|NCT01789970|37796885|FG001|Open-label Titration Period|Pregnancy|0|||
16850298|NCT01789970|37796886|FG002|Open-label Titration Period|Pregnancy|0|||
16850299|NCT01789970|37796884|FG000|Open-label Titration Period|Other|76|||
16850300|NCT01789970|37796885|FG001|Open-label Titration Period|Other|0|||
16850301|NCT01789970|37796886|FG002|Open-label Titration Period|Other|0|||
16850302|NCT01789970|37796884|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
16850303|NCT01789970|37796885|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
16850304|NCT01789970|37796886|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
16850305|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
16850306|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
16850307|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
16850308|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
16850309|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
16850310|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
16850311|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16850312|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
16850313|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
16850314|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
16850315|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
16850316|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
16850317|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
16850318|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
16850319|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
16850320|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
16850321|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
16850322|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
16850323|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
16850324|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
16850325|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
16850326|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
16850327|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
16850328|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
16850329|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
16850330|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
16850331|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
16850332|NCT01789970|37796884|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
16850333|NCT01789970|37796885|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
16850334|NCT01789970|37796886|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
16927466|NCT03021499|38070981|FG000|Overall Study|Lost to Follow-up|1|||
16927467|NCT03021499|38070982|FG001|Overall Study|Lost to Follow-up|3|||
16927468|NCT03021499|38070981|FG000|Overall Study|Physician Decision|2|||
16927469|NCT03021499|38070982|FG001|Overall Study|Physician Decision|3|||
16927470|NCT03021499|38070981|FG000|Overall Study|Pregnancy|1|||
16927471|NCT03021499|38070982|FG001|Overall Study|Pregnancy|0|||
16927472|NCT03021499|38070981|FG000|Overall Study|Withdrawal by Subject|7|||
16927473|NCT03021499|38070982|FG001|Overall Study|Withdrawal by Subject|14|||
16927474|NCT03021499|38070981|FG000|Overall Study|Prohibited medication required|1|||
16927475|NCT03021499|38070982|FG001|Overall Study|Prohibited medication required|0|||
16927476|NCT03021499|38070981|FG000|Overall Study|Protocol non-compliance|1|||
16927477|NCT03021499|38070982|FG001|Overall Study|Protocol non-compliance|1|||
16927478|NCT03021499|38070981|FG000|Overall Study|None of the above|0|||
16927479|NCT03021499|38070982|FG001|Overall Study|None of the above|4|||
17018417|NCT00822120|38162828|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
17018418|NCT00822120|38162829|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
16927480|NCT03021499|38070981|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
16927481|NCT03021499|38070982|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
16927482|NCT02726581|38071020|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
16927483|NCT02726581|38071021|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
16927484|NCT02726581|38071022|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
16927485|NCT02726581|38071020|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
16927486|NCT02726581|38071021|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
16927487|NCT02726581|38071022|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
16927488|NCT02726581|38071020|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16927489|NCT02726581|38071021|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16927490|NCT02726581|38071022|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16927491|NCT02726581|38071020|FG000|Treatment Period|Disease progression|47|||
16850335|NCT01734434|37796904|FG000|Overall Study|Death Infant|3|||
16927492|NCT02726581|38071021|FG001|Treatment Period|Disease progression|50|||
16927493|NCT02726581|38071022|FG002|Treatment Period|Disease progression|16|||
16927494|NCT02726581|38071020|FG000|Treatment Period|Other reasons|9|||
16927495|NCT02726581|38071021|FG001|Treatment Period|Other reasons|8|||
16927496|NCT02726581|38071022|FG002|Treatment Period|Other reasons|2|||
16927497|NCT02726581|38071020|FG000|Treatment Period|Study drug toxicity|6|||
16927498|NCT02726581|38071021|FG001|Treatment Period|Study drug toxicity|3|||
16927499|NCT02726581|38071022|FG002|Treatment Period|Study drug toxicity|2|||
16927500|NCT02726581|38071020|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
16927501|NCT02726581|38071021|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
16927502|NCT02726581|38071022|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
16927503|NCT02726581|38071020|FG000|Treatment Period|Participant withdrew consent|3|||
17018419|NCT00822120|38162824|FG000|PET-directed Therapy|Death|0|||
17018420|NCT00822120|38162825|FG001|PET-directed Therapy|Death|0|||
17018421|NCT00822120|38162826|FG002|PET-directed Therapy|Death|0|||
17018422|NCT00822120|38162827|FG003|PET-directed Therapy|Death|2|||
17018423|NCT00822120|38162828|FG004|PET-directed Therapy|Death|0|||
17018424|NCT00822120|38162829|FG005|PET-directed Therapy|Death|0|||
17018425|NCT00822120|38162824|FG000|PET-directed Therapy|Protocol Violation|0|||
17018426|NCT00822120|38162825|FG001|PET-directed Therapy|Protocol Violation|0|||
17018427|NCT00822120|38162826|FG002|PET-directed Therapy|Protocol Violation|0|||
17018428|NCT00822120|38162827|FG003|PET-directed Therapy|Protocol Violation|6|||
17018429|NCT00822120|38162828|FG004|PET-directed Therapy|Protocol Violation|0|||
17018430|NCT00822120|38162829|FG005|PET-directed Therapy|Protocol Violation|0|||
17018431|NCT00804687|38162850|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
17018432|NCT00804687|38162851|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
17018433|NCT00804687|38162852|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
17018434|NCT00804687|38162853|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
17018435|NCT00804687|38162854|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
17018436|NCT00804687|38162855|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
17018437|NCT00804687|38162850|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
17018438|NCT00804687|38162851|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
17018439|NCT00804687|38162852|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
17018440|NCT00804687|38162853|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
17018441|NCT00804687|38162854|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
17018442|NCT00804687|38162855|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
17018443|NCT00804687|38162850|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
17018444|NCT00804687|38162851|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
17018445|NCT00804687|38162852|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
17018446|NCT00804687|38162853|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
17018447|NCT00804687|38162854|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
17018448|NCT00804687|38162855|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
17018449|NCT00804687|38162850|FG000|Period 5: Treatment Period|Positive drug test|1|||
17018450|NCT00804687|38162851|FG001|Period 5: Treatment Period|Positive drug test|0|||
17018451|NCT00804687|38162852|FG002|Period 5: Treatment Period|Positive drug test|0|||
16850336|NCT01734434|37796905|FG001|Overall Study|Death Infant|1|||
16850337|NCT01734434|37796906|FG002|Overall Study|Death Infant|17|||
16850338|NCT01734434|37796907|FG003|Overall Study|Death Infant|5|||
16850339|NCT01734434|37796904|FG000|Overall Study|Lost to Follow-up|2|||
16850340|NCT01734434|37796905|FG001|Overall Study|Lost to Follow-up|9|||
16850341|NCT01734434|37796906|FG002|Overall Study|Lost to Follow-up|67|||
16850342|NCT01734434|37796907|FG003|Overall Study|Lost to Follow-up|11|||
16850343|NCT01734434|37796904|FG000|Overall Study|No Live Birth|1|||
16850344|NCT01734434|37796905|FG001|Overall Study|No Live Birth|2|||
16850345|NCT01734434|37796906|FG002|Overall Study|No Live Birth|32|||
16850346|NCT01734434|37796907|FG003|Overall Study|No Live Birth|6|||
16850347|NCT01734434|37796904|FG000|Overall Study|Withdrawal by Subject|4|||
16850348|NCT01734434|37796905|FG001|Overall Study|Withdrawal by Subject|0|||
16850349|NCT01734434|37796906|FG002|Overall Study|Withdrawal by Subject|8|||
16850350|NCT01734434|37796907|FG003|Overall Study|Withdrawal by Subject|1|||
16850351|NCT01734434|37796904|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
16850352|NCT01734434|37796905|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
16850353|NCT01734434|37796906|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
16850354|NCT01734434|37796907|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
16850355|NCT01734434|37796904|FG000|Overall Study|Subject Not Reachable|0|||
16850356|NCT01734434|37796905|FG001|Overall Study|Subject Not Reachable|0|||
16850357|NCT01734434|37796906|FG002|Overall Study|Subject Not Reachable|1|||
16850358|NCT01734434|37796907|FG003|Overall Study|Subject Not Reachable|0|||
16850359|NCT01734434|37796904|FG000|Overall Study|Treatment Defaulter|0|||
16850360|NCT01734434|37796905|FG001|Overall Study|Treatment Defaulter|0|||
16850361|NCT01734434|37796906|FG002|Overall Study|Treatment Defaulter|1|||
16850362|NCT01734434|37796907|FG003|Overall Study|Treatment Defaulter|0|||
16850363|NCT01734434|37796904|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
16850364|NCT01734434|37796905|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
16850365|NCT01734434|37796906|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
16850366|NCT01734434|37796907|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
16850367|NCT01734434|37796904|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
16850368|NCT01734434|37796905|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
16850369|NCT01734434|37796906|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
16850370|NCT01734434|37796907|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
16850371|NCT01788566|37796925|FG000|Overall Study|Death|4|||
16850372|NCT01788566|37796925|FG000|Overall Study|Adverse Event|1|||
16850373|NCT01788566|37796925|FG000|Overall Study|Clinical Progressive Disease|3|||
16850374|NCT01733732|37796931|FG000|Overall Study|Adverse Event|1|||
16850375|NCT01733732|37796932|FG001|Overall Study|Adverse Event|0|||
16850376|NCT01733732|37796931|FG000|Overall Study|Did not attend all study visits|1|||
16850377|NCT01733732|37796932|FG001|Overall Study|Did not attend all study visits|0|||
16850378|NCT01732874|37796950|FG000|Overall Study|Withdrawal by Subject|5|||
16850379|NCT01732874|37796951|FG001|Overall Study|Withdrawal by Subject|1|||
16850380|NCT01732874|37796950|FG000|Overall Study|Death of Infant|3|||
16927504|NCT02726581|38071021|FG001|Treatment Period|Participant withdrew consent|1|||
16927505|NCT02726581|38071022|FG002|Treatment Period|Participant withdrew consent|1|||
16927506|NCT02726581|38071020|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
16927507|NCT02726581|38071021|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
16927508|NCT02726581|38071022|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
16927509|NCT02726581|38071020|FG000|Treatment Period|Maximum clinical benefit|0|||
16927510|NCT02726581|38071021|FG001|Treatment Period|Maximum clinical benefit|2|||
16850381|NCT01732874|37796951|FG001|Overall Study|Death of Infant|2|||
16850382|NCT01732796|37796960|FG000|Overall Study|Adverse Event|16|||
16850383|NCT01732796|37796961|FG001|Overall Study|Adverse Event|16|||
16850384|NCT01732796|37796962|FG002|Overall Study|Adverse Event|4|||
16850385|NCT01732796|37796960|FG000|Overall Study|Lack of Efficacy|21|||
16850386|NCT01732796|37796961|FG001|Overall Study|Lack of Efficacy|18|||
16850387|NCT01732796|37796962|FG002|Overall Study|Lack of Efficacy|5|||
16927511|NCT02726581|38071022|FG002|Treatment Period|Maximum clinical benefit|0|||
16927512|NCT02726581|38071020|FG000|Treatment Period|Death|1|||
16927513|NCT02726581|38071021|FG001|Treatment Period|Death|0|||
16927514|NCT02726581|38071022|FG002|Treatment Period|Death|0|||
16927515|NCT02726581|38071020|FG000|Treatment Period|Poor/non-compliance|1|||
16927516|NCT02726581|38071021|FG001|Treatment Period|Poor/non-compliance|0|||
16927517|NCT02726581|38071022|FG002|Treatment Period|Poor/non-compliance|0|||
16927518|NCT02726581|38071020|FG000|Treatment Period|Participant no longer meets study criteria|0|||
16927519|NCT02726581|38071021|FG001|Treatment Period|Participant no longer meets study criteria|1|||
16927520|NCT02726581|38071022|FG002|Treatment Period|Participant no longer meets study criteria|0|||
16927521|NCT02700048|38071032|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
16850388|NCT01732796|37796960|FG000|Overall Study|Lost to Follow-up|2|||
16850389|NCT01732796|37796961|FG001|Overall Study|Lost to Follow-up|0|||
16850390|NCT01732796|37796962|FG002|Overall Study|Lost to Follow-up|0|||
16850391|NCT01732796|37796960|FG000|Overall Study|Withdrawal by Subject|6|||
16850392|NCT01732796|37796961|FG001|Overall Study|Withdrawal by Subject|8|||
16850393|NCT01732796|37796962|FG002|Overall Study|Withdrawal by Subject|2|||
16850394|NCT01732796|37796960|FG000|Overall Study|Other reason not defined above|1|||
16850395|NCT01732796|37796961|FG001|Overall Study|Other reason not defined above|0|||
16850396|NCT01732796|37796962|FG002|Overall Study|Other reason not defined above|2|||
16850397|NCT01732640|37796972|FG000|Overall Study|Adverse Event|0|||
16850398|NCT01732640|37796973|FG001|Overall Study|Adverse Event|1|||
16850399|NCT01732640|37796972|FG000|Overall Study|Death|0|||
16850400|NCT01732640|37796973|FG001|Overall Study|Death|1|||
16927522|NCT02700048|38071033|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
16927523|NCT02425904|38071059|FG000|Overall Study|Lost to Follow-up|1|||
16927524|NCT02425904|38071060|FG001|Overall Study|Lost to Follow-up|0|||
16927525|NCT02425904|38071059|FG000|Overall Study|Withdrawal by Subject|2|||
16927526|NCT02425904|38071060|FG001|Overall Study|Withdrawal by Subject|0|||
16927527|NCT02425904|38071059|FG000|Overall Study|Death|0|||
16927528|NCT02425904|38071060|FG001|Overall Study|Death|3|||
16927529|NCT02296125|38071082|FG000|Overall Study|Withdrawal by Subject|18|||
16927530|NCT02296125|38071083|FG001|Overall Study|Withdrawal by Subject|8|||
16927531|NCT02296125|38071084|FG002|Overall Study|Withdrawal by Subject|6|||
16927532|NCT02296125|38071085|FG003|Overall Study|Withdrawal by Subject|2|||
16927533|NCT02296125|38071082|FG000|Overall Study|Adverse Event|41|||
16927534|NCT02296125|38071083|FG001|Overall Study|Adverse Event|52|||
16927535|NCT02296125|38071084|FG002|Overall Study|Adverse Event|9|||
16927536|NCT02296125|38071085|FG003|Overall Study|Adverse Event|4|||
16927537|NCT02296125|38071082|FG000|Overall Study|Severe non-compliance to protocol|0|||
16927538|NCT02296125|38071083|FG001|Overall Study|Severe non-compliance to protocol|1|||
16927539|NCT02296125|38071084|FG002|Overall Study|Severe non-compliance to protocol|0|||
16927540|NCT02296125|38071085|FG003|Overall Study|Severe non-compliance to protocol|0|||
16927541|NCT02296125|38071082|FG000|Overall Study|Condition under investigation worsened|153|||
16927542|NCT02296125|38071083|FG001|Overall Study|Condition under investigation worsened|199|||
16927543|NCT02296125|38071084|FG002|Overall Study|Condition under investigation worsened|39|||
16850401|NCT01732484|37796983|FG000|Overall Study|Death|7|||
16850402|NCT01732484|37796983|FG000|Overall Study|Lost to Follow-up|14|||
16850403|NCT01732484|37796983|FG000|Overall Study|chronical illness|5|||
16850404|NCT01786148|37796991|FG000|Overall Study|Lost to Follow-up|21|||
16850405|NCT01786148|37796992|FG001|Overall Study|Lost to Follow-up|13|||
16850406|NCT01786148|37796991|FG000|Overall Study|Death|0|||
16927544|NCT02296125|38071085|FG003|Overall Study|Condition under investigation worsened|56|||
16927545|NCT02296125|38071082|FG000|Overall Study|Any reason not specifically recorded|6|||
16927546|NCT02296125|38071083|FG001|Overall Study|Any reason not specifically recorded|4|||
16927547|NCT02296125|38071084|FG002|Overall Study|Any reason not specifically recorded|2|||
16927548|NCT02296125|38071085|FG003|Overall Study|Any reason not specifically recorded|0|||
16927549|NCT02242942|38071099|FG000|Overall Study|Death|17|||
16927550|NCT02242942|38071100|FG001|Overall Study|Death|20|||
16927551|NCT02242942|38071101|FG002|Overall Study|Death|2|||
16927552|NCT02242942|38071099|FG000|Overall Study|Physician Decision|1|||
16927553|NCT02242942|38071100|FG001|Overall Study|Physician Decision|0|||
16927554|NCT02242942|38071101|FG002|Overall Study|Physician Decision|0|||
16927555|NCT02242942|38071099|FG000|Overall Study|Withdrawal by Subject|8|||
16927556|NCT02242942|38071100|FG001|Overall Study|Withdrawal by Subject|10|||
16927557|NCT02242942|38071101|FG002|Overall Study|Withdrawal by Subject|0|||
16927558|NCT02242942|38071099|FG000|Overall Study|On-going in Study|190|||
16927559|NCT02242942|38071100|FG001|Overall Study|On-going in Study|186|||
16927560|NCT02242942|38071101|FG002|Overall Study|On-going in Study|11|||
16927561|NCT02097420|38071111|FG000|Overall Study|Death|4|||
16927562|NCT02097420|38071111|FG000|Overall Study|Device explanted|3|||
16927563|NCT02097420|38071111|FG000|Overall Study|Not reached 12-month visit|7|||
16850407|NCT01786148|37796992|FG001|Overall Study|Death|1|||
16850408|NCT01786148|37796991|FG000|Overall Study|Withdrawal by Subject|0|||
16850409|NCT01786148|37796992|FG001|Overall Study|Withdrawal by Subject|7|||
16850410|NCT01786148|37796991|FG000|Overall Study|Incarceration|1|||
16850411|NCT01786148|37796992|FG001|Overall Study|Incarceration|1|||
16850412|NCT01785602|37797004|FG000|Overall Study|Withdrawal by Subject|2|||
16850413|NCT01785602|37797005|FG001|Overall Study|Withdrawal by Subject|0|||
16850414|NCT01785602|37797004|FG000|Overall Study|Lost to Follow-up|1|||
16850415|NCT01785602|37797005|FG001|Overall Study|Lost to Follow-up|1|||
16850416|NCT01785602|37797004|FG000|Overall Study|Adverse Event|3|||
16850417|NCT01785602|37797005|FG001|Overall Study|Adverse Event|5|||
16850418|NCT01785602|37797004|FG000|Overall Study|Administrative problems|7|||
16927564|NCT01964989|38071117|FG000|Overall Study|Protocol Violation|3|||
16927565|NCT01964989|38071118|FG001|Overall Study|Protocol Violation|4|||
16927566|NCT01964989|38071117|FG000|Overall Study|Administrative Reason|103|||
16927567|NCT01964989|38071118|FG001|Overall Study|Administrative Reason|95|||
16927568|NCT01964989|38071117|FG000|Overall Study|Adverse Event|0|||
16927569|NCT01964989|38071118|FG001|Overall Study|Adverse Event|1|||
16927570|NCT01964989|38071117|FG000|Overall Study|Death|1|||
16850419|NCT01785602|37797005|FG001|Overall Study|Administrative problems|3|||
16850420|NCT01785524|37797013|FG000|Overall Study|Withdrawal by Subject|2|||
17018452|NCT00804687|38162853|FG003|Period 5: Treatment Period|Positive drug test|0|||
17018453|NCT00804687|38162854|FG004|Period 5: Treatment Period|Positive drug test|0|||
17018454|NCT00804687|38162855|FG005|Period 5: Treatment Period|Positive drug test|0|||
17018455|NCT00678652|38162867|FG000|Overall Study|Protocol Violation|2|||
16927571|NCT01964989|38071118|FG001|Overall Study|Death|3|||
16927572|NCT01964989|38071117|FG000|Overall Study|Withdrawal by Subject|156|||
16927573|NCT01964989|38071118|FG001|Overall Study|Withdrawal by Subject|160|||
16927574|NCT01964989|38071117|FG000|Overall Study|Lost to Follow-up|254|||
17018456|NCT00678652|38162868|FG001|Overall Study|Protocol Violation|0|||
16927575|NCT01964989|38071118|FG001|Overall Study|Lost to Follow-up|232|||
16927576|NCT01964989|38071117|FG000|Overall Study|Other|267|||
16927577|NCT01964989|38071118|FG001|Overall Study|Other|252|||
16927578|NCT01776840|38071148|FG000|Overall Study|Lost to Follow-up|4|||
16927579|NCT01776840|38071149|FG001|Overall Study|Lost to Follow-up|4|||
16927580|NCT01776840|38071148|FG000|Overall Study|Withdrawal by Subject|42|||
16927581|NCT01776840|38071149|FG001|Overall Study|Withdrawal by Subject|22|||
16927582|NCT01776840|38071148|FG000|Overall Study|Ongoing|112|||
16927583|NCT01776840|38071149|FG001|Overall Study|Ongoing|129|||
16927584|NCT01708941|38071159|FG000|Overall Study|Adverse Event|4|||
16927585|NCT01708941|38071160|FG001|Overall Study|Adverse Event|6|||
16927586|NCT01708941|38071161|FG002|Overall Study|Adverse Event|1|||
16927587|NCT01708941|38071162|FG003|Overall Study|Adverse Event|0|||
16927588|NCT01708941|38071159|FG000|Overall Study|Death|1|||
16927589|NCT01708941|38071160|FG001|Overall Study|Death|1|||
16850421|NCT01785524|37797014|FG001|Overall Study|Withdrawal by Subject|2|||
16850422|NCT01757288|37797023|FG000|Overall Study|Consent withdrawal|0|||
16927590|NCT01708941|38071161|FG002|Overall Study|Death|2|||
16927591|NCT01708941|38071162|FG003|Overall Study|Death|14|||
16927592|NCT01708941|38071159|FG000|Overall Study|Withdrawal by Subject|1|||
16927593|NCT01708941|38071160|FG001|Overall Study|Withdrawal by Subject|0|||
16927594|NCT01708941|38071161|FG002|Overall Study|Withdrawal by Subject|3|||
16927595|NCT01708941|38071162|FG003|Overall Study|Withdrawal by Subject|4|||
16850423|NCT01757288|37797024|FG001|Overall Study|Consent withdrawal|4|||
16850424|NCT01757288|37797025|FG002|Overall Study|Consent withdrawal|4|||
16850425|NCT01757288|37797023|FG000|Overall Study|Patient off study, IRB hold.|0|||
16850426|NCT01757288|37797024|FG001|Overall Study|Patient off study, IRB hold.|0|||
16850427|NCT01757288|37797025|FG002|Overall Study|Patient off study, IRB hold.|1|||
16850428|NCT01757288|37797023|FG000|Overall Study|Patient death prior to starting treatment|0|||
16850429|NCT01757288|37797024|FG001|Overall Study|Patient death prior to starting treatment|0|||
16850430|NCT01757288|37797025|FG002|Overall Study|Patient death prior to starting treatment|1|||
16850431|NCT01757288|37797023|FG000|Overall Study|Wrong medication administered|0|||
16850432|NCT01757288|37797024|FG001|Overall Study|Wrong medication administered|1|||
16850433|NCT01757288|37797025|FG002|Overall Study|Wrong medication administered|0|||
16850434|NCT01757288|37797023|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
16850435|NCT01757288|37797024|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
16850436|NCT01757288|37797025|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
16850437|NCT01757288|37797023|FG000|Overall Study|Not meeting protocol constraints|0|||
16850438|NCT01757288|37797024|FG001|Overall Study|Not meeting protocol constraints|1|||
16850439|NCT01757288|37797025|FG002|Overall Study|Not meeting protocol constraints|1|||
16850440|NCT01757288|37797023|FG000|Overall Study|Multiple missed appointments|0|||
16850441|NCT01757288|37797024|FG001|Overall Study|Multiple missed appointments|1|||
16850442|NCT01757288|37797025|FG002|Overall Study|Multiple missed appointments|0|||
16850443|NCT01757288|37797023|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
16850444|NCT01757288|37797024|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
16850445|NCT01757288|37797025|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
16850446|NCT01757288|37797023|FG000|Overall Study|>2 weeks treatment break|0|||
16927596|NCT01708941|38071159|FG000|Overall Study|Disease progression|9|||
16927597|NCT01708941|38071160|FG001|Overall Study|Disease progression|10|||
16927598|NCT01708941|38071161|FG002|Overall Study|Disease progression|8|||
16927599|NCT01708941|38071162|FG003|Overall Study|Disease progression|0|||
16927600|NCT01708941|38071159|FG000|Overall Study|Alternative therapy|0|||
16927601|NCT01708941|38071160|FG001|Overall Study|Alternative therapy|0|||
16927602|NCT01708941|38071161|FG002|Overall Study|Alternative therapy|2|||
16927603|NCT01708941|38071162|FG003|Overall Study|Alternative therapy|0|||
16927604|NCT01708941|38071159|FG000|Overall Study|Ineligible and never started treatment|1|||
16927605|NCT01708941|38071160|FG001|Overall Study|Ineligible and never started treatment|0|||
16850447|NCT01757288|37797024|FG001|Overall Study|>2 weeks treatment break|0|||
16927606|NCT01708941|38071161|FG002|Overall Study|Ineligible and never started treatment|1|||
16927607|NCT01708941|38071162|FG003|Overall Study|Ineligible and never started treatment|0|||
16927608|NCT01708941|38071159|FG000|Overall Study|Never started treatment|2|||
16927609|NCT01708941|38071160|FG001|Overall Study|Never started treatment|1|||
16927610|NCT01708941|38071161|FG002|Overall Study|Never started treatment|0|||
16927611|NCT01708941|38071162|FG003|Overall Study|Never started treatment|0|||
16927612|NCT01708941|38071159|FG000|Overall Study|Ineligible|0|||
16927613|NCT01708941|38071160|FG001|Overall Study|Ineligible|0|||
16927614|NCT01708941|38071161|FG002|Overall Study|Ineligible|2|||
16927615|NCT01708941|38071162|FG003|Overall Study|Ineligible|0|||
16927616|NCT01575860|38071172|FG000|Overall Study|Withdrawal by Subject|1|||
16927617|NCT01575860|38071172|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
16927618|NCT01416831|38071179|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
16927619|NCT01416831|38071180|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
16927620|NCT01386385|38071191|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
17198613|NCT00103285|38352280|FG007|Response Assignment|Other|53|||
16927621|NCT01386385|38071192|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16927622|NCT01386385|38071193|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16927623|NCT01386385|38071194|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16927624|NCT01386385|38071195|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16927625|NCT01386385|38071196|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16927626|NCT01386385|38071197|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16927627|NCT01386385|38071198|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16927628|NCT01386385|38071191|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
16927629|NCT01386385|38071192|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16927630|NCT01386385|38071193|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16927631|NCT01386385|38071194|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16927632|NCT01386385|38071195|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16927633|NCT01386385|38071196|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16927634|NCT01386385|38071197|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16927635|NCT01386385|38071198|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16927636|NCT01386385|38071191|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16927637|NCT01386385|38071192|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16927638|NCT01386385|38071193|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
16927639|NCT01386385|38071194|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16927640|NCT01386385|38071195|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16927641|NCT01386385|38071196|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16927642|NCT01386385|38071197|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16927643|NCT01386385|38071198|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16927644|NCT01386385|38071191|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16850448|NCT01757288|37797025|FG002|Overall Study|>2 weeks treatment break|1|||
16850449|NCT01756898|37797038|FG000|Overall Study|Adverse Event|7|||
16850450|NCT01756898|37797039|FG001|Overall Study|Adverse Event|1|||
16850451|NCT01756898|37797040|FG002|Overall Study|Adverse Event|0|||
16850452|NCT01756898|37797041|FG003|Overall Study|Adverse Event|0|||
16850453|NCT01756898|37797038|FG000|Overall Study|Lack of Efficacy|4|||
16850454|NCT01756898|37797039|FG001|Overall Study|Lack of Efficacy|7|||
16850455|NCT01756898|37797040|FG002|Overall Study|Lack of Efficacy|6|||
16850456|NCT01756898|37797041|FG003|Overall Study|Lack of Efficacy|6|||
16850457|NCT01756898|37797038|FG000|Overall Study|Lost to Follow-up|2|||
16850458|NCT01756898|37797039|FG001|Overall Study|Lost to Follow-up|4|||
16850459|NCT01756898|37797040|FG002|Overall Study|Lost to Follow-up|2|||
16850460|NCT01756898|37797041|FG003|Overall Study|Lost to Follow-up|3|||
16850461|NCT01756898|37797038|FG000|Overall Study|Protocol Violation|1|||
16850462|NCT01756898|37797039|FG001|Overall Study|Protocol Violation|2|||
16850463|NCT01756898|37797040|FG002|Overall Study|Protocol Violation|2|||
16927645|NCT01386385|38071192|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16927646|NCT01386385|38071193|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16927647|NCT01386385|38071194|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16927648|NCT01386385|38071195|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
16927649|NCT01386385|38071196|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16927650|NCT01386385|38071197|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16927651|NCT01386385|38071198|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16927652|NCT01386385|38071191|FG000|Phase II Concurrent CRT|Adverse Event|0|||
16927653|NCT01386385|38071192|FG001|Phase II Concurrent CRT|Adverse Event|0|||
16927654|NCT01386385|38071193|FG002|Phase II Concurrent CRT|Adverse Event|0|||
16927655|NCT01386385|38071194|FG003|Phase II Concurrent CRT|Adverse Event|0|||
16927656|NCT01386385|38071195|FG004|Phase II Concurrent CRT|Adverse Event|0|||
16927657|NCT01386385|38071196|FG005|Phase II Concurrent CRT|Adverse Event|0|||
16927658|NCT01386385|38071197|FG006|Phase II Concurrent CRT|Adverse Event|3|||
16927659|NCT01386385|38071198|FG007|Phase II Concurrent CRT|Adverse Event|3|||
16927660|NCT01386385|38071191|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16927661|NCT01386385|38071192|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16927662|NCT01386385|38071193|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16927663|NCT01386385|38071194|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16927664|NCT01386385|38071195|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16927665|NCT01386385|38071196|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16927666|NCT01386385|38071197|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
16927667|NCT01386385|38071198|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16927668|NCT01386385|38071191|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
16927669|NCT01386385|38071192|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
16927670|NCT01386385|38071193|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
16927671|NCT01386385|38071194|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
16927672|NCT01386385|38071195|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
16927673|NCT01386385|38071196|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
16927674|NCT01386385|38071197|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
16927675|NCT01386385|38071198|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
16927676|NCT01386385|38071191|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16927677|NCT01386385|38071192|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16927678|NCT01386385|38071193|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16850464|NCT01756898|37797041|FG003|Overall Study|Protocol Violation|1|||
16927679|NCT01386385|38071194|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16927680|NCT01386385|38071195|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16927681|NCT01386385|38071196|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16850465|NCT01756898|37797038|FG000|Overall Study|Withdrew Consent|5|||
16850466|NCT01756898|37797039|FG001|Overall Study|Withdrew Consent|3|||
16850467|NCT01756898|37797040|FG002|Overall Study|Withdrew Consent|5|||
16927682|NCT01386385|38071197|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
16927683|NCT01386385|38071198|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16927684|NCT01386385|38071191|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
16927685|NCT01386385|38071192|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
16927686|NCT01386385|38071193|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
16927687|NCT01386385|38071194|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
16927688|NCT01386385|38071195|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
16927689|NCT01386385|38071196|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
16927690|NCT01386385|38071197|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
16927691|NCT01386385|38071198|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
16927692|NCT01267955|38071219|FG000|Stage 1 (6 Months)|Death|3|||
16927693|NCT01267955|38071219|FG000|Stage 2 (6 Months)|Death|5|||
16927694|NCT01267955|38071219|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
16927695|NCT01065454|38071227|FG000|Treatment|Adverse Event|7|||
16927696|NCT01065454|38071228|FG001|Treatment|Adverse Event|4|||
16927697|NCT01065454|38071229|FG002|Treatment|Adverse Event|3|||
16927698|NCT01065454|38071230|FG003|Treatment|Adverse Event|6|||
16927699|NCT01065454|38071227|FG000|Treatment|Death|1|||
16927700|NCT01065454|38071228|FG001|Treatment|Death|0|||
16927701|NCT01065454|38071229|FG002|Treatment|Death|0|||
16927702|NCT01065454|38071230|FG003|Treatment|Death|0|||
16927703|NCT01065454|38071227|FG000|Treatment|Non-compliance|1|||
16927704|NCT01065454|38071228|FG001|Treatment|Non-compliance|0|||
16927705|NCT01065454|38071229|FG002|Treatment|Non-compliance|0|||
16927706|NCT01065454|38071230|FG003|Treatment|Non-compliance|1|||
16927707|NCT01065454|38071227|FG000|Treatment|Protocol Decision|0|||
16927708|NCT01065454|38071228|FG001|Treatment|Protocol Decision|0|||
16927709|NCT01065454|38071229|FG002|Treatment|Protocol Decision|3|||
16927710|NCT01065454|38071230|FG003|Treatment|Protocol Decision|2|||
16927711|NCT01065454|38071227|FG000|Treatment|Protocol Violation|1|||
16927712|NCT01065454|38071228|FG001|Treatment|Protocol Violation|0|||
16927713|NCT01065454|38071229|FG002|Treatment|Protocol Violation|1|||
16927714|NCT01065454|38071230|FG003|Treatment|Protocol Violation|0|||
16927715|NCT01065454|38071227|FG000|Treatment|Withdrawal by Subject|3|||
16927716|NCT01065454|38071228|FG001|Treatment|Withdrawal by Subject|1|||
16927717|NCT01065454|38071229|FG002|Treatment|Withdrawal by Subject|2|||
16927718|NCT01065454|38071230|FG003|Treatment|Withdrawal by Subject|3|||
17018457|NCT00678652|38162869|FG002|Overall Study|Protocol Violation|0|||
17018458|NCT00678652|38162870|FG003|Overall Study|Protocol Violation|0|||
16850468|NCT01756898|37797041|FG003|Overall Study|Withdrew Consent|6|||
16850469|NCT01756898|37797038|FG000|Overall Study|Other|0|||
17018459|NCT00678652|38162867|FG000|Overall Study|Pregnancy|0|||
17018460|NCT00678652|38162868|FG001|Overall Study|Pregnancy|0|||
17018461|NCT00678652|38162869|FG002|Overall Study|Pregnancy|1|||
17018462|NCT00678652|38162870|FG003|Overall Study|Pregnancy|0|||
17018463|NCT00678652|38162867|FG000|Overall Study|Relocation|1|||
17018464|NCT00678652|38162868|FG001|Overall Study|Relocation|0|||
17018465|NCT00678652|38162869|FG002|Overall Study|Relocation|0|||
17018466|NCT00678652|38162870|FG003|Overall Study|Relocation|0|||
17018467|NCT00840060|38162891|FG000|Overall Study|Withdrawal by Subject|1|||
17018468|NCT00840060|38162892|FG001|Overall Study|Withdrawal by Subject|0|||
17018469|NCT00840060|38162891|FG000|Overall Study|Change in emotional/behavioral status|0|||
17018470|NCT00840060|38162892|FG001|Overall Study|Change in emotional/behavioral status|1|||
17018471|NCT00574912|38162898|FG000|Overall Study|Could not place IV lines.|3|||
17018472|NCT00574912|38162898|FG000|Overall Study|scheduling conflicts|3|||
17018473|NCT00574912|38162898|FG000|Overall Study|Physician Decision|2|||
17018474|NCT00674128|38162912|FG000|Overall Study|Withdrawal by Subject|25|||
17018475|NCT00674128|38162913|FG001|Overall Study|Withdrawal by Subject|23|||
17018476|NCT00804141|38162919|FG000|Overall Study|Adverse Event|157|||
17018477|NCT00804141|38162919|FG000|Overall Study|Death|4|||
16850470|NCT01756898|37797039|FG001|Overall Study|Other|2|||
16850471|NCT01756898|37797040|FG002|Overall Study|Other|2|||
16850472|NCT01756898|37797041|FG003|Overall Study|Other|0|||
16850473|NCT01731938|37797058|FG000|Preliminary Part I|Withdrawal by Subject|2|||
16850474|NCT01731938|37797059|FG001|Preliminary Part I|Withdrawal by Subject|2|||
16850475|NCT01731938|37797058|FG000|Preliminary Part I|Physician Decision|1|||
16850476|NCT01731938|37797059|FG001|Preliminary Part I|Physician Decision|0|||
17018478|NCT00804141|38162919|FG000|Overall Study|Failed to return|96|||
16850477|NCT01731938|37797058|FG000|Preliminary Part I|Lost to Follow-up|0|||
16927719|NCT01065454|38071227|FG000|Follow up|Adverse Event|1|||
16927720|NCT01065454|38071228|FG001|Follow up|Adverse Event|0|||
16927721|NCT01065454|38071229|FG002|Follow up|Adverse Event|0|||
16927722|NCT01065454|38071230|FG003|Follow up|Adverse Event|1|||
16927723|NCT01065454|38071227|FG000|Follow up|Death|0|||
16927724|NCT01065454|38071228|FG001|Follow up|Death|1|||
16927725|NCT01065454|38071229|FG002|Follow up|Death|1|||
16927726|NCT01065454|38071230|FG003|Follow up|Death|0|||
16927727|NCT01065454|38071227|FG000|Follow up|Lost to Follow-up|0|||
16927728|NCT01065454|38071228|FG001|Follow up|Lost to Follow-up|0|||
16927729|NCT01065454|38071229|FG002|Follow up|Lost to Follow-up|0|||
16927730|NCT01065454|38071230|FG003|Follow up|Lost to Follow-up|1|||
16927731|NCT01065454|38071227|FG000|Follow up|Progressive disease|0|||
16927732|NCT01065454|38071228|FG001|Follow up|Progressive disease|0|||
16927733|NCT01065454|38071229|FG002|Follow up|Progressive disease|0|||
16927734|NCT01065454|38071230|FG003|Follow up|Progressive disease|1|||
16927735|NCT01065454|38071227|FG000|Follow up|Withdrawal by Subject|1|||
16927736|NCT01065454|38071228|FG001|Follow up|Withdrawal by Subject|1|||
16927737|NCT01065454|38071229|FG002|Follow up|Withdrawal by Subject|1|||
16927738|NCT01065454|38071230|FG003|Follow up|Withdrawal by Subject|0|||
16927739|NCT01065454|38071227|FG000|Follow up|study ongoing|37|||
16927740|NCT01065454|38071228|FG001|Follow up|study ongoing|22|||
16927741|NCT01065454|38071229|FG002|Follow up|study ongoing|15|||
16927742|NCT01065454|38071230|FG003|Follow up|study ongoing|41|||
16927743|NCT01064648|38071243|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
16927744|NCT01064648|38071244|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
16927745|NCT01064648|38071245|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
16927746|NCT01064648|38071246|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
16927747|NCT01064648|38071243|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
17018479|NCT00804141|38162919|FG000|Overall Study|Investigator request|8|||
17018480|NCT00804141|38162919|FG000|Overall Study|Protocol Violation|85|||
17018481|NCT00804141|38162919|FG000|Overall Study|Withdrawal by Subject|131|||
17018482|NCT00804141|38162919|FG000|Overall Study|Lack of Efficacy|46|||
17018483|NCT00804141|38162919|FG000|Overall Study|Other than specified|30|||
17018484|NCT00804141|38162919|FG000|Overall Study|Enrolled but not treated|6|||
17018485|NCT00677092|38162923|FG000|Overall Study|Adverse Event|1|||
17018486|NCT00677092|38162923|FG000|Overall Study|Lost to Follow-up|1|||
17018487|NCT00677092|38162923|FG000|Overall Study|Withdrawal by Subject|3|||
17018488|NCT00677092|38162923|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
17018489|NCT00677014|38162931|FG000|Overall Study|Lost to Follow-up|20|||
17018490|NCT00677014|38162932|FG001|Overall Study|Lost to Follow-up|12|||
17018491|NCT00677014|38162933|FG002|Overall Study|Lost to Follow-up|24|||
17018492|NCT00677014|38162931|FG000|Overall Study|Death|6|||
17018493|NCT00677014|38162932|FG001|Overall Study|Death|15|||
17018494|NCT00677014|38162933|FG002|Overall Study|Death|7|||
17018495|NCT00677014|38162931|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
17018496|NCT00677014|38162932|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
17018497|NCT00677014|38162933|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
17018498|NCT00839436|38162944|FG000|Overall Study|Developed exclusionary condition|1|||
17018499|NCT00839436|38162945|FG001|Overall Study|Developed exclusionary condition|0|||
17018500|NCT00839436|38162946|FG002|Overall Study|Developed exclusionary condition|0|||
17018501|NCT00839436|38162944|FG000|Overall Study|Withdrawal by Subject|0|||
17018502|NCT00839436|38162945|FG001|Overall Study|Withdrawal by Subject|1|||
17018503|NCT00839436|38162946|FG002|Overall Study|Withdrawal by Subject|0|||
17018504|NCT00839436|38162944|FG000|Overall Study|Study drug no longer available|0|||
17018505|NCT00839436|38162945|FG001|Overall Study|Study drug no longer available|0|||
17018506|NCT00839436|38162946|FG002|Overall Study|Study drug no longer available|1|||
17018507|NCT00675766|38162967|FG000|Overall Study|Lost to Follow-up|6|||
17018508|NCT00675766|38162968|FG001|Overall Study|Lost to Follow-up|5|||
17018509|NCT00675766|38162969|FG002|Overall Study|Lost to Follow-up|21|||
17018510|NCT00675766|38162970|FG003|Overall Study|Lost to Follow-up|26|||
17018511|NCT00673894|38162982|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
17018512|NCT00673894|38162983|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
17018513|NCT00673894|38162982|FG000|First Intervention 4 Weeks|Adverse Event|1|||
17018514|NCT00673894|38162983|FG001|First Intervention 4 Weeks|Adverse Event|0|||
17018515|NCT00674986|38162991|FG000|Overall Study|Adverse Event|2|||
17018516|NCT00674986|38162992|FG001|Overall Study|Adverse Event|1|||
17018517|NCT00674986|38162991|FG000|Overall Study|Subject withdrew consent|12|||
17018518|NCT00674986|38162992|FG001|Overall Study|Subject withdrew consent|19|||
17018519|NCT00674986|38162991|FG000|Overall Study|Lost to Follow-up|25|||
17018520|NCT00674986|38162992|FG001|Overall Study|Lost to Follow-up|53|||
17018521|NCT00674986|38162991|FG000|Overall Study|Other reasons|4|||
17018522|NCT00674986|38162992|FG001|Overall Study|Other reasons|8|||
17018523|NCT00673816|38162999|FG000|Overall Study|Adverse Event|1|||
17018524|NCT00673816|38162999|FG000|Overall Study|Withdrawal by Subject|1|||
17018525|NCT00673660|38163004|FG000|Overall Study|Lost to Follow-up|107|||
17018526|NCT00672958|38163015|FG000|Overall Study|Adverse Event|11|||
17102591|NCT00112437|38241443|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102592|NCT00112437|38241444|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16927748|NCT01064648|38071244|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
16927749|NCT01064648|38071245|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
16927750|NCT01064648|38071246|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
16927751|NCT01064648|38071243|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
16927752|NCT01064648|38071244|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
16927753|NCT01064648|38071245|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
16927754|NCT01064648|38071246|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
16927755|NCT01064648|38071243|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
16927756|NCT01064648|38071244|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
16927757|NCT01064648|38071245|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
16927758|NCT01064648|38071246|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
16927759|NCT01064648|38071243|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
16927760|NCT01064648|38071244|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
16927761|NCT01064648|38071245|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
16927762|NCT01064648|38071246|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
16927763|NCT01064648|38071243|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
16927764|NCT01064648|38071244|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
16927765|NCT01064648|38071245|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
16927766|NCT01064648|38071246|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
16927767|NCT01064648|38071243|FG000|Phase II|Adverse Event|0|||
16927768|NCT01064648|38071244|FG001|Phase II|Adverse Event|0|||
16927769|NCT01064648|38071245|FG002|Phase II|Adverse Event|15|||
16927770|NCT01064648|38071246|FG003|Phase II|Adverse Event|8|||
16927771|NCT01064648|38071243|FG000|Phase II|Death|0|||
16927772|NCT01064648|38071244|FG001|Phase II|Death|0|||
16927773|NCT01064648|38071245|FG002|Phase II|Death|4|||
16927774|NCT01064648|38071246|FG003|Phase II|Death|5|||
16927775|NCT01064648|38071243|FG000|Phase II|Withdrawal by Subject|0|||
16927776|NCT01064648|38071244|FG001|Phase II|Withdrawal by Subject|0|||
16927777|NCT01064648|38071245|FG002|Phase II|Withdrawal by Subject|2|||
16927778|NCT01064648|38071246|FG003|Phase II|Withdrawal by Subject|5|||
16927779|NCT01064648|38071243|FG000|Phase II|Progression|0|||
16927780|NCT01064648|38071244|FG001|Phase II|Progression|0|||
16927781|NCT01064648|38071245|FG002|Phase II|Progression|21|||
16927782|NCT01064648|38071246|FG003|Phase II|Progression|27|||
16927783|NCT01064648|38071243|FG000|Phase II|Non-protocol specified|0|||
16927784|NCT01064648|38071244|FG001|Phase II|Non-protocol specified|0|||
16927785|NCT01064648|38071245|FG002|Phase II|Non-protocol specified|5|||
16927786|NCT01064648|38071246|FG003|Phase II|Non-protocol specified|3|||
16927787|NCT01064648|38071243|FG000|Phase II|Under Review|0|||
16927788|NCT01064648|38071244|FG001|Phase II|Under Review|0|||
16927789|NCT01064648|38071245|FG002|Phase II|Under Review|2|||
16927790|NCT01064648|38071246|FG003|Phase II|Under Review|0|||
16927791|NCT00542451|38071272|FG000|Overall Study|Adverse Event|31|||
16927792|NCT00542451|38071272|FG000|Overall Study|Withdrawal by Subject|30|||
16927793|NCT00542451|38071272|FG000|Overall Study|Physician Decision|4|||
16927794|NCT00542451|38071272|FG000|Overall Study|Recurrent disease|1|||
16927795|NCT00542451|38071272|FG000|Overall Study|unknown reason|1|||
16927796|NCT00542451|38071272|FG000|Overall Study|Death|2|||
16927797|NCT00542451|38071272|FG000|Overall Study|Lost to Follow-up|10|||
16927798|NCT00382070|38071281|FG000|Overall Study|No follow up data mapped to Other|17|||
16927799|NCT00382070|38071282|FG001|Overall Study|No follow up data mapped to Other|19|||
16927800|NCT00382070|38071281|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
16927801|NCT00382070|38071282|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
16927802|NCT00382070|38071281|FG000|Overall Study|No clinical assessment|9|||
16927803|NCT00382070|38071282|FG001|Overall Study|No clinical assessment|11|||
17018527|NCT00672958|38163016|FG001|Overall Study|Adverse Event|9|||
17018528|NCT00672958|38163015|FG000|Overall Study|Lack of Efficacy|6|||
17018529|NCT00672958|38163016|FG001|Overall Study|Lack of Efficacy|11|||
17018530|NCT00672958|38163015|FG000|Overall Study|Non-compliance with study drug|2|||
17018531|NCT00672958|38163016|FG001|Overall Study|Non-compliance with study drug|3|||
16850478|NCT01731938|37797059|FG001|Preliminary Part I|Lost to Follow-up|3|||
16850479|NCT01731938|37797058|FG000|Preliminary Part I|Missed Week 6 visit|0|||
16850480|NCT01731938|37797059|FG001|Preliminary Part I|Missed Week 6 visit|3|||
16850481|NCT01731938|37797058|FG000|Primary Part II|Withdrawal by Subject|5|||
16850482|NCT01731938|37797059|FG001|Primary Part II|Withdrawal by Subject|4|||
16850483|NCT01731938|37797058|FG000|Primary Part II|Lost to Follow-up|4|||
16850484|NCT01731938|37797059|FG001|Primary Part II|Lost to Follow-up|5|||
16850485|NCT01731938|37797058|FG000|Primary Part II|Death|2|||
16850486|NCT01731938|37797059|FG001|Primary Part II|Death|1|||
16850487|NCT01731938|37797058|FG000|Primary Part II|Missed Week 6 visit|2|||
16850488|NCT01731938|37797059|FG001|Primary Part II|Missed Week 6 visit|3|||
17018532|NCT00672958|38163015|FG000|Overall Study|Protocol deviations|11|||
17018533|NCT00672958|38163016|FG001|Overall Study|Protocol deviations|5|||
17018534|NCT00672958|38163015|FG000|Overall Study|Voluntary withdrawal|12|||
17018535|NCT00672958|38163016|FG001|Overall Study|Voluntary withdrawal|8|||
17018536|NCT00672958|38163015|FG000|Overall Study|Lost to Follow-up|22|||
17018537|NCT00672958|38163016|FG001|Overall Study|Lost to Follow-up|17|||
17018538|NCT00672958|38163015|FG000|Overall Study|Reason not specified|0|||
17018539|NCT00672958|38163016|FG001|Overall Study|Reason not specified|3|||
16850489|NCT01731470|37797066|FG000|Overall Study|Withdrawal by Subject|1|||
16850490|NCT01731470|37797066|FG000|Overall Study|Did not meet study criteria|1|||
16927804|NCT02921269|38071305|FG000|Overall Study|Did not complete DLT period|1|||
16927805|NCT01356940|38071367|FG000|First Intervention (28 Days)|Adverse Event|1|||
16927806|NCT01356940|38071368|FG001|First Intervention (28 Days)|Adverse Event|0|||
16850491|NCT01756352|37797070|FG000|Overall Study|moved away and lost to followup|1|||
16850492|NCT01756274|37797074|FG000|Overall Study|Protocol Violation|2|||
16850493|NCT01756274|37797074|FG000|Overall Study|Laboratory error|1|||
16850494|NCT01731002|37797082|FG000|Overall Study|Adverse Event|0|||
16850495|NCT01731002|37797083|FG001|Overall Study|Adverse Event|2|||
16850496|NCT01731002|37797084|FG002|Overall Study|Adverse Event|2|||
16850497|NCT01731002|37797082|FG000|Overall Study|Non-Compliant|0|||
16850498|NCT01731002|37797083|FG001|Overall Study|Non-Compliant|1|||
16850499|NCT01731002|37797084|FG002|Overall Study|Non-Compliant|0|||
16850500|NCT01731002|37797082|FG000|Overall Study|Lost to Follow-up|1|||
16850501|NCT01731002|37797083|FG001|Overall Study|Lost to Follow-up|0|||
16850502|NCT01731002|37797084|FG002|Overall Study|Lost to Follow-up|0|||
16850503|NCT01731002|37797082|FG000|Overall Study|Test Agent Discontinuation|0|||
16850504|NCT01731002|37797083|FG001|Overall Study|Test Agent Discontinuation|1|||
16850505|NCT01731002|37797084|FG002|Overall Study|Test Agent Discontinuation|0|||
16850506|NCT01731002|37797082|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
16850507|NCT01731002|37797083|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
16850508|NCT01731002|37797084|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
16850509|NCT01731002|37797082|FG000|Overall Study|Elevated IOP|1|||
16850510|NCT01731002|37797083|FG001|Overall Study|Elevated IOP|0|||
16850511|NCT01731002|37797084|FG002|Overall Study|Elevated IOP|0|||
16850512|NCT01731002|37797082|FG000|Overall Study|Inappropriate use of study medications|0|||
16850513|NCT01731002|37797083|FG001|Overall Study|Inappropriate use of study medications|0|||
16850514|NCT01731002|37797084|FG002|Overall Study|Inappropriate use of study medications|1|||
16927807|NCT01356940|38071367|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
16927808|NCT01356940|38071368|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
16927809|NCT01330030|38071387|FG000|Overall Study|Lost to Follow-up|16|||
16927810|NCT01330030|38071388|FG001|Overall Study|Lost to Follow-up|17|||
16850515|NCT01783886|37797095|FG000|Overall Study|Lost to Follow-up|0|||
16850516|NCT01783886|37797096|FG001|Overall Study|Lost to Follow-up|3|||
16850517|NCT01783886|37797097|FG002|Overall Study|Lost to Follow-up|0|||
16850518|NCT01783886|37797095|FG000|Overall Study|Protocol deviation|0|||
16927811|NCT00477295|38071508|FG000|Overall Study|Adverse Event|31|||
16927812|NCT00477295|38071509|FG001|Overall Study|Adverse Event|35|||
16927813|NCT00477295|38071508|FG000|Overall Study|Withdrawal by Subject|35|||
16927814|NCT00477295|38071509|FG001|Overall Study|Withdrawal by Subject|24|||
16927815|NCT00477295|38071508|FG000|Overall Study|Lack of Efficacy|23|||
16927816|NCT00477295|38071509|FG001|Overall Study|Lack of Efficacy|23|||
16927817|NCT00477295|38071508|FG000|Overall Study|Protocol Violation|3|||
16927818|NCT00477295|38071509|FG001|Overall Study|Protocol Violation|8|||
16927819|NCT00477295|38071508|FG000|Overall Study|Physician Decision|4|||
16927820|NCT00477295|38071509|FG001|Overall Study|Physician Decision|5|||
16927821|NCT00477295|38071508|FG000|Overall Study|Lost to Follow-up|21|||
16927822|NCT00477295|38071509|FG001|Overall Study|Lost to Follow-up|11|||
16927823|NCT00477295|38071508|FG000|Overall Study|Other|4|||
16927824|NCT00477295|38071509|FG001|Overall Study|Other|3|||
16927825|NCT00476593|38071521|FG000|Overall Study|Lost to Follow-up|10|||
17018540|NCT00672646|38163025|FG000|Overall Study|Lost to Follow-up|0|||
17018541|NCT00672646|38163026|FG001|Overall Study|Lost to Follow-up|1|||
17018542|NCT00672646|38163027|FG002|Overall Study|Lost to Follow-up|2|||
16850519|NCT01783886|37797096|FG001|Overall Study|Protocol deviation|0|||
16850520|NCT01783886|37797097|FG002|Overall Study|Protocol deviation|2|||
16850521|NCT01783886|37797095|FG000|Overall Study|Withdrawal of consent by participant|1|||
16850522|NCT01783886|37797096|FG001|Overall Study|Withdrawal of consent by participant|3|||
16850523|NCT01783886|37797097|FG002|Overall Study|Withdrawal of consent by participant|4|||
16850524|NCT01783886|37797095|FG000|Overall Study|Adverse Event|4|||
16850525|NCT01783886|37797096|FG001|Overall Study|Adverse Event|5|||
17018543|NCT00672646|38163025|FG000|Overall Study|Withdrawal by Subject|0|||
17018544|NCT00672646|38163026|FG001|Overall Study|Withdrawal by Subject|0|||
17018545|NCT00672646|38163027|FG002|Overall Study|Withdrawal by Subject|1|||
17018546|NCT00672490|38163037|FG000|Overall Study|Withdrawal by Subject|8|||
17018547|NCT00672490|38163038|FG001|Overall Study|Withdrawal by Subject|8|||
17018548|NCT00672490|38163037|FG000|Overall Study|Lack of Compliance|2|||
17018549|NCT00672490|38163038|FG001|Overall Study|Lack of Compliance|7|||
17018550|NCT00672490|38163037|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
16850526|NCT01783886|37797097|FG002|Overall Study|Adverse Event|4|||
16850527|NCT01468701|37797879|FG000|Overall Study|Not eligible|91|||
16927826|NCT00476593|38071522|FG001|Overall Study|Lost to Follow-up|2|||
16927827|NCT00476593|38071523|FG002|Overall Study|Lost to Follow-up|8|||
16927828|NCT00476593|38071524|FG003|Overall Study|Lost to Follow-up|22|||
16927829|NCT00476476|38071536|FG000|Overall Study|Adverse Event|2|||
17018551|NCT00672490|38163038|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
16850528|NCT01468701|37797880|FG001|Overall Study|Not eligible|140|||
16850529|NCT01468701|37797881|FG002|Overall Study|Not eligible|29|||
16850530|NCT01468701|37797882|FG003|Overall Study|Not eligible|12|||
16850531|NCT01468701|37797883|FG004|Overall Study|Not eligible|22|||
16850532|NCT01468701|37797884|FG005|Overall Study|Not eligible|2|||
16850533|NCT01468701|37797885|FG006|Overall Study|Not eligible|39|||
16850534|NCT01468701|37797886|FG007|Overall Study|Not eligible|1|||
16850535|NCT01468701|37797887|FG008|Overall Study|Not eligible|40|||
16850536|NCT01468701|37797888|FG009|Overall Study|Not eligible|126|||
16850537|NCT01468701|37797889|FG010|Overall Study|Not eligible|39|||
16850538|NCT01468701|37797890|FG011|Overall Study|Not eligible|33|||
16850539|NCT01468701|37797891|FG012|Overall Study|Not eligible|1|||
16850540|NCT01468701|37797892|FG013|Overall Study|Not eligible|19|||
16850541|NCT01468701|37797893|FG014|Overall Study|Not eligible|1|||
16850542|NCT01468701|37797894|FG015|Overall Study|Not eligible|32|||
16850543|NCT01468701|37797895|FG016|Overall Study|Not eligible|0|||
16850544|NCT01468701|37797879|FG000|Overall Study|Lost to Follow-up|306|||
16850545|NCT01468701|37797880|FG001|Overall Study|Lost to Follow-up|0|||
16850546|NCT01468701|37797881|FG002|Overall Study|Lost to Follow-up|0|||
16850547|NCT01468701|37797882|FG003|Overall Study|Lost to Follow-up|0|||
16850548|NCT01468701|37797883|FG004|Overall Study|Lost to Follow-up|0|||
16850549|NCT01468701|37797884|FG005|Overall Study|Lost to Follow-up|0|||
16850550|NCT01468701|37797885|FG006|Overall Study|Lost to Follow-up|0|||
16850551|NCT01468701|37797886|FG007|Overall Study|Lost to Follow-up|0|||
16850552|NCT01468701|37797887|FG008|Overall Study|Lost to Follow-up|215|||
16850553|NCT01468701|37797888|FG009|Overall Study|Lost to Follow-up|309|||
16850554|NCT01468701|37797889|FG010|Overall Study|Lost to Follow-up|224|||
16850555|NCT01468701|37797890|FG011|Overall Study|Lost to Follow-up|212|||
16850556|NCT01468701|37797891|FG012|Overall Study|Lost to Follow-up|11|||
16850557|NCT01468701|37797892|FG013|Overall Study|Lost to Follow-up|164|||
16850558|NCT01468701|37797893|FG014|Overall Study|Lost to Follow-up|17|||
16850559|NCT01468701|37797894|FG015|Overall Study|Lost to Follow-up|127|||
16850560|NCT01468701|37797895|FG016|Overall Study|Lost to Follow-up|1|||
16850561|NCT01468701|37797879|FG000|Overall Study|Withdrawal by Subject|165|||
16850562|NCT01468701|37797880|FG001|Overall Study|Withdrawal by Subject|0|||
16850563|NCT01468701|37797881|FG002|Overall Study|Withdrawal by Subject|0|||
16850564|NCT01468701|37797882|FG003|Overall Study|Withdrawal by Subject|0|||
16850565|NCT01468701|37797883|FG004|Overall Study|Withdrawal by Subject|0|||
16850566|NCT01468701|37797884|FG005|Overall Study|Withdrawal by Subject|0|||
16850567|NCT01468701|37797885|FG006|Overall Study|Withdrawal by Subject|0|||
16850568|NCT01468701|37797886|FG007|Overall Study|Withdrawal by Subject|0|||
16850569|NCT01468701|37797887|FG008|Overall Study|Withdrawal by Subject|83|||
16850570|NCT01468701|37797888|FG009|Overall Study|Withdrawal by Subject|88|||
16850571|NCT01468701|37797889|FG010|Overall Study|Withdrawal by Subject|100|||
16850572|NCT01468701|37797890|FG011|Overall Study|Withdrawal by Subject|114|||
16850573|NCT01468701|37797891|FG012|Overall Study|Withdrawal by Subject|9|||
16850574|NCT01468701|37797892|FG013|Overall Study|Withdrawal by Subject|47|||
16850575|NCT01468701|37797893|FG014|Overall Study|Withdrawal by Subject|6|||
16850576|NCT01468701|37797894|FG015|Overall Study|Withdrawal by Subject|31|||
16850577|NCT01468701|37797895|FG016|Overall Study|Withdrawal by Subject|0|||
16850578|NCT01468701|37797879|FG000|Overall Study|Other reasons than listed|437|||
16850579|NCT01468701|37797880|FG001|Overall Study|Other reasons than listed|0|||
16850580|NCT01468701|37797881|FG002|Overall Study|Other reasons than listed|0|||
16850581|NCT01468701|37797882|FG003|Overall Study|Other reasons than listed|0|||
16850582|NCT01468701|37797883|FG004|Overall Study|Other reasons than listed|0|||
16850583|NCT01468701|37797884|FG005|Overall Study|Other reasons than listed|0|||
16850584|NCT01468701|37797885|FG006|Overall Study|Other reasons than listed|0|||
16850585|NCT01468701|37797886|FG007|Overall Study|Other reasons than listed|0|||
17018552|NCT00672490|38163037|FG000|Overall Study|Adverse Event|5|||
17018553|NCT00672490|38163038|FG001|Overall Study|Adverse Event|8|||
17018554|NCT00672490|38163037|FG000|Overall Study|Violation of Concomitant Medicine|1|||
17018555|NCT00672490|38163038|FG001|Overall Study|Violation of Concomitant Medicine|0|||
17018556|NCT00672490|38163037|FG000|Overall Study|Intolerance|0|||
17018557|NCT00672490|38163038|FG001|Overall Study|Intolerance|2|||
17018558|NCT00672490|38163037|FG000|Overall Study|Lost to Follow-up|1|||
16850586|NCT01468701|37797887|FG008|Overall Study|Other reasons than listed|318|||
16850587|NCT01468701|37797888|FG009|Overall Study|Other reasons than listed|658|||
16850588|NCT01468701|37797889|FG010|Overall Study|Other reasons than listed|433|||
16850589|NCT01468701|37797890|FG011|Overall Study|Other reasons than listed|504|||
16850590|NCT01468701|37797891|FG012|Overall Study|Other reasons than listed|28|||
16850591|NCT01468701|37797892|FG013|Overall Study|Other reasons than listed|239|||
16850592|NCT01468701|37797893|FG014|Overall Study|Other reasons than listed|39|||
16850593|NCT01468701|37797894|FG015|Overall Study|Other reasons than listed|172|||
16850594|NCT01468701|37797895|FG016|Overall Study|Other reasons than listed|0|||
16850595|NCT01468701|37797879|FG000|Overall Study|No end of study case report form|0|||
16850596|NCT01468701|37797880|FG001|Overall Study|No end of study case report form|0|||
16850597|NCT01468701|37797881|FG002|Overall Study|No end of study case report form|0|||
16850598|NCT01468701|37797882|FG003|Overall Study|No end of study case report form|0|||
16850599|NCT01468701|37797883|FG004|Overall Study|No end of study case report form|0|||
16850600|NCT01468701|37797884|FG005|Overall Study|No end of study case report form|0|||
16850601|NCT01468701|37797885|FG006|Overall Study|No end of study case report form|0|||
16850602|NCT01468701|37797886|FG007|Overall Study|No end of study case report form|0|||
16850603|NCT01468701|37797887|FG008|Overall Study|No end of study case report form|4|||
16850604|NCT01468701|37797888|FG009|Overall Study|No end of study case report form|1|||
16850605|NCT01468701|37797889|FG010|Overall Study|No end of study case report form|2|||
16850606|NCT01468701|37797890|FG011|Overall Study|No end of study case report form|3|||
16850607|NCT01468701|37797891|FG012|Overall Study|No end of study case report form|0|||
16850608|NCT01468701|37797892|FG013|Overall Study|No end of study case report form|1|||
16850609|NCT01468701|37797893|FG014|Overall Study|No end of study case report form|0|||
16850610|NCT01468701|37797894|FG015|Overall Study|No end of study case report form|0|||
16850611|NCT01468701|37797895|FG016|Overall Study|No end of study case report form|0|||
16850612|NCT01468701|37797879|FG000|Overall Study|Not being followed up|0|||
16850613|NCT01468701|37797880|FG001|Overall Study|Not being followed up|4963|||
16850614|NCT01468701|37797881|FG002|Overall Study|Not being followed up|1755|||
16850615|NCT01468701|37797882|FG003|Overall Study|Not being followed up|703|||
16850616|NCT01468701|37797883|FG004|Overall Study|Not being followed up|1714|||
16850617|NCT01468701|37797884|FG005|Overall Study|Not being followed up|126|||
16850618|NCT01468701|37797885|FG006|Overall Study|Not being followed up|1170|||
16850619|NCT01468701|37797886|FG007|Overall Study|Not being followed up|4|||
16850620|NCT01468701|37797887|FG008|Overall Study|Not being followed up|0|||
16850621|NCT01468701|37797888|FG009|Overall Study|Not being followed up|0|||
16927830|NCT00476476|38071537|FG001|Overall Study|Adverse Event|7|||
16927831|NCT00476476|38071536|FG000|Overall Study|Progressive Disease|0|||
16927832|NCT00476476|38071537|FG001|Overall Study|Progressive Disease|17|||
16927833|NCT00476086|38071542|FG000|Overall Study|Alternative therapy|1|||
16927834|NCT00476086|38071542|FG000|Overall Study|Progressive Disease|4|||
16927835|NCT00476047|38071548|FG000|Overall Study|Lost to Follow-up|1|||
16927836|NCT00476008|38071556|FG000|Overall Study|Adverse Event|4|||
16927837|NCT00476008|38071557|FG001|Overall Study|Adverse Event|4|||
16927838|NCT00476008|38071556|FG000|Overall Study|Placebo concerns|2|||
16927839|NCT00476008|38071557|FG001|Overall Study|Placebo concerns|2|||
16850622|NCT01468701|37797889|FG010|Overall Study|Not being followed up|0|||
16850623|NCT01468701|37797890|FG011|Overall Study|Not being followed up|0|||
16850624|NCT01468701|37797891|FG012|Overall Study|Not being followed up|0|||
16850625|NCT01468701|37797892|FG013|Overall Study|Not being followed up|0|||
16850626|NCT01468701|37797893|FG014|Overall Study|Not being followed up|0|||
16850627|NCT01468701|37797894|FG015|Overall Study|Not being followed up|0|||
16850628|NCT01468701|37797895|FG016|Overall Study|Not being followed up|0|||
16850629|NCT01492101|37797910|FG000|Overall Study|Death|323|||
16850630|NCT01492101|37797911|FG001|Overall Study|Death|322|||
16850631|NCT01492101|37797910|FG000|Overall Study|Withdrawal by Subject|14|||
16850632|NCT01492101|37797911|FG001|Overall Study|Withdrawal by Subject|18|||
16850633|NCT01492101|37797910|FG000|Overall Study|Lost to Follow-up|0|||
16927840|NCT00476008|38071556|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
16927841|NCT00476008|38071557|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
16927842|NCT00476008|38071556|FG000|Overall Study|Withdrawal by Subject|0|||
16927843|NCT00476008|38071557|FG001|Overall Study|Withdrawal by Subject|1|||
16927844|NCT00476008|38071556|FG000|Overall Study|Death|1|||
16927845|NCT00476008|38071557|FG001|Overall Study|Death|0|||
16927846|NCT00475735|38071573|FG000|Treatment Period 1|Adverse Event|2|||
16927847|NCT00475735|38071574|FG001|Treatment Period 1|Adverse Event|0|||
16927848|NCT00475735|38071575|FG002|Treatment Period 1|Adverse Event|0|||
16927849|NCT00475735|38071576|FG003|Treatment Period 1|Adverse Event|0|||
16927850|NCT00475735|38071577|FG004|Treatment Period 1|Adverse Event|0|||
16927851|NCT00475735|38071578|FG005|Treatment Period 1|Adverse Event|0|||
16927852|NCT00475735|38071573|FG000|Treatment Period 1|Lack of Efficacy|1|||
16927853|NCT00475735|38071574|FG001|Treatment Period 1|Lack of Efficacy|0|||
16927854|NCT00475735|38071575|FG002|Treatment Period 1|Lack of Efficacy|0|||
16927855|NCT00475735|38071576|FG003|Treatment Period 1|Lack of Efficacy|0|||
16927856|NCT00475735|38071577|FG004|Treatment Period 1|Lack of Efficacy|0|||
16927857|NCT00475735|38071578|FG005|Treatment Period 1|Lack of Efficacy|0|||
16927858|NCT00475735|38071573|FG000|Treatment Period 1|Lost to Follow-up|0|||
16927859|NCT00475735|38071574|FG001|Treatment Period 1|Lost to Follow-up|0|||
16850634|NCT01492101|37797911|FG001|Overall Study|Lost to Follow-up|2|||
16850635|NCT01468311|37797917|FG000|Overall Study|mobilization failure|1|||
16850636|NCT01468311|37797917|FG000|Overall Study|Withdrawal by Subject|1|||
16850637|NCT01730534|37798028|FG000|Overall Study|Withdrawal by Subject|97|||
16850638|NCT01730534|37798029|FG001|Overall Study|Withdrawal by Subject|127|||
16850639|NCT01730534|37798028|FG000|Overall Study|Lost to Follow-up|12|||
16927860|NCT00475735|38071575|FG002|Treatment Period 1|Lost to Follow-up|0|||
16927861|NCT00475735|38071576|FG003|Treatment Period 1|Lost to Follow-up|0|||
16927862|NCT00475735|38071577|FG004|Treatment Period 1|Lost to Follow-up|0|||
16850640|NCT01730534|37798029|FG001|Overall Study|Lost to Follow-up|18|||
16927863|NCT00475735|38071578|FG005|Treatment Period 1|Lost to Follow-up|1|||
16927864|NCT00475735|38071573|FG000|Treatment Period 1|Protocol Violation|0|||
16927865|NCT00475735|38071574|FG001|Treatment Period 1|Protocol Violation|0|||
16927866|NCT00475735|38071575|FG002|Treatment Period 1|Protocol Violation|0|||
16927867|NCT00475735|38071576|FG003|Treatment Period 1|Protocol Violation|1|||
16927868|NCT00475735|38071577|FG004|Treatment Period 1|Protocol Violation|0|||
16927869|NCT00475735|38071578|FG005|Treatment Period 1|Protocol Violation|0|||
16927870|NCT00475735|38071573|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16927871|NCT00475735|38071574|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16927872|NCT00475735|38071575|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16927873|NCT00475735|38071576|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16927874|NCT00475735|38071577|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16927875|NCT00475735|38071578|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16927876|NCT00475735|38071573|FG000|Treatment Period 1|DC due to AE but continuing|0|||
16927877|NCT00475735|38071574|FG001|Treatment Period 1|DC due to AE but continuing|0|||
16927878|NCT00475735|38071575|FG002|Treatment Period 1|DC due to AE but continuing|0|||
16927879|NCT00475735|38071576|FG003|Treatment Period 1|DC due to AE but continuing|1|||
16927880|NCT00475735|38071577|FG004|Treatment Period 1|DC due to AE but continuing|2|||
16927881|NCT00475735|38071578|FG005|Treatment Period 1|DC due to AE but continuing|2|||
16927882|NCT00475735|38071573|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16927883|NCT00475735|38071574|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
16927884|NCT00475735|38071575|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16927885|NCT00475735|38071576|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16927886|NCT00475735|38071577|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16927887|NCT00475735|38071578|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16927888|NCT00475735|38071573|FG000|Treatment Washout|Lost to Follow-up|0|||
16927889|NCT00475735|38071574|FG001|Treatment Washout|Lost to Follow-up|1|||
16927890|NCT00475735|38071575|FG002|Treatment Washout|Lost to Follow-up|0|||
16927891|NCT00475735|38071576|FG003|Treatment Washout|Lost to Follow-up|0|||
16927892|NCT00475735|38071577|FG004|Treatment Washout|Lost to Follow-up|0|||
16927893|NCT00475735|38071578|FG005|Treatment Washout|Lost to Follow-up|0|||
16927894|NCT00475735|38071573|FG000|Treatment Washout|Protocol Violation|0|||
16927895|NCT00475735|38071574|FG001|Treatment Washout|Protocol Violation|1|||
16927896|NCT00475735|38071575|FG002|Treatment Washout|Protocol Violation|0|||
16927897|NCT00475735|38071576|FG003|Treatment Washout|Protocol Violation|0|||
16927898|NCT00475735|38071577|FG004|Treatment Washout|Protocol Violation|0|||
16927899|NCT00475735|38071578|FG005|Treatment Washout|Protocol Violation|0|||
16927900|NCT00475735|38071573|FG000|Treatment Period 2|Adverse Event|0|||
16927901|NCT00475735|38071574|FG001|Treatment Period 2|Adverse Event|1|||
16927902|NCT00475735|38071575|FG002|Treatment Period 2|Adverse Event|0|||
16927903|NCT00475735|38071576|FG003|Treatment Period 2|Adverse Event|2|||
16927904|NCT00475735|38071577|FG004|Treatment Period 2|Adverse Event|0|||
16927905|NCT00475735|38071578|FG005|Treatment Period 2|Adverse Event|0|||
16927906|NCT00475735|38071573|FG000|Treatment Period 2|Lack of Efficacy|0|||
16927907|NCT00475735|38071574|FG001|Treatment Period 2|Lack of Efficacy|0|||
16927908|NCT00475735|38071575|FG002|Treatment Period 2|Lack of Efficacy|0|||
16927909|NCT00475735|38071576|FG003|Treatment Period 2|Lack of Efficacy|0|||
16927910|NCT00475735|38071577|FG004|Treatment Period 2|Lack of Efficacy|0|||
16927911|NCT00475735|38071578|FG005|Treatment Period 2|Lack of Efficacy|1|||
16927912|NCT00475735|38071573|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16927913|NCT00475735|38071574|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16927914|NCT00475735|38071575|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16927915|NCT00475735|38071576|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16927916|NCT00475735|38071577|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16927917|NCT00475735|38071578|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16927918|NCT00475657|38071586|FG000|Overall Study|Death|1|||
16927919|NCT00475657|38071586|FG000|Overall Study|Sponsor's Decision|3|||
16927920|NCT00475423|38071590|FG000|Overall Study|Protocol Violation|5|||
16927921|NCT00475423|38071590|FG000|Overall Study|Adverse Event|4|||
16927922|NCT00475423|38071590|FG000|Overall Study|Withdrawal by Subject|6|||
16927923|NCT00475423|38071590|FG000|Overall Study|Lack of Efficacy|8|||
16927924|NCT00475423|38071590|FG000|Overall Study|Death|1|||
16927925|NCT00475423|38071590|FG000|Overall Study|Reason not specified|1|||
16927926|NCT00475423|38071590|FG000|Overall Study|Lost to Follow-up|7|||
16927927|NCT00475306|38071598|FG000|Overall Study|Protocol Violation|1|||
16927928|NCT00475306|38071599|FG001|Overall Study|Protocol Violation|1|||
16927929|NCT00475306|38071600|FG002|Overall Study|Protocol Violation|0|||
16927930|NCT00475306|38071601|FG003|Overall Study|Protocol Violation|1|||
16927931|NCT00475228|38071613|FG000|Overall Study|Lost to Follow-up|17|||
16927932|NCT00475228|38071614|FG001|Overall Study|Lost to Follow-up|17|||
16927933|NCT00475033|38071626|FG000|Infant Series|Failed to return|3|||
16927934|NCT00475033|38071627|FG001|Infant Series|Failed to return|4|||
16927935|NCT00475033|38071626|FG000|Infant Series|Parent or legal guardian request|1|||
16927936|NCT00475033|38071627|FG001|Infant Series|Parent or legal guardian request|5|||
16927937|NCT00475033|38071626|FG000|Infant Series|Protocol Violation|1|||
16927938|NCT00475033|38071627|FG001|Infant Series|Protocol Violation|2|||
16927939|NCT00475033|38071626|FG000|Infant Series|Lost to Follow-up|2|||
16927940|NCT00475033|38071627|FG001|Infant Series|Lost to Follow-up|0|||
16927941|NCT00475033|38071626|FG000|Infant Series|Adverse Event|0|||
16927942|NCT00475033|38071627|FG001|Infant Series|Adverse Event|2|||
16927943|NCT00475033|38071626|FG000|After the Infant Series|Adverse Event|0|||
16927944|NCT00475033|38071627|FG001|After the Infant Series|Adverse Event|4|||
16927945|NCT00475033|38071626|FG000|After the Infant Series|Parent or legal guardian request|2|||
16927946|NCT00475033|38071627|FG001|After the Infant Series|Parent or legal guardian request|2|||
16927947|NCT00475033|38071626|FG000|After the Infant Series|Failed to return|2|||
16927948|NCT00475033|38071627|FG001|After the Infant Series|Failed to return|1|||
16927949|NCT00475033|38071626|FG000|After the Infant Series|Protocol Violation|1|||
16927950|NCT00475033|38071627|FG001|After the Infant Series|Protocol Violation|0|||
16927951|NCT00475033|38071626|FG000|After the Infant Series|Lost to Follow-up|1|||
16927952|NCT00475033|38071627|FG001|After the Infant Series|Lost to Follow-up|0|||
16927953|NCT00475033|38071626|FG000|After the Infant Series|Other|0|||
16927954|NCT00475033|38071627|FG001|After the Infant Series|Other|1|||
16927955|NCT00475033|38071626|FG000|Toddler Dose|Parent or legal guardian request|2|||
16927956|NCT00475033|38071627|FG001|Toddler Dose|Parent or legal guardian request|0|||
16927957|NCT00475033|38071626|FG000|Toddler Dose|Failed to return|1|||
16927958|NCT00475033|38071627|FG001|Toddler Dose|Failed to return|0|||
16927959|NCT00475033|38071626|FG000|Toddler Dose|Lost to Follow-up|1|||
16927960|NCT00475033|38071627|FG001|Toddler Dose|Lost to Follow-up|0|||
16927961|NCT00474994|38071640|FG000|Overall Study|Patient Not treated|1|||
16927962|NCT00474994|38071640|FG000|Overall Study|Patient evaluable for toxicity only|3|||
16927963|NCT00474994|38071640|FG000|Overall Study|Patient found to be ineligible|1|||
16927964|NCT00474955|38071644|FG000|Overall Study|Adverse Event|2|||
16927965|NCT00474955|38071644|FG000|Overall Study|Drug unavailability|1|||
16927966|NCT00474955|38071644|FG000|Overall Study|Personal reasons|5|||
16927967|NCT00474487|38071652|FG000|Overall Study|Withdrawal by Subject|6|||
16927968|NCT00474487|38071653|FG001|Overall Study|Withdrawal by Subject|0|||
16927969|NCT00474487|38071654|FG002|Overall Study|Withdrawal by Subject|0|||
16927970|NCT00474487|38071655|FG003|Overall Study|Withdrawal by Subject|0|||
16927971|NCT00474487|38071652|FG000|Overall Study|Lost to Follow-up|20|||
16927972|NCT00474487|38071653|FG001|Overall Study|Lost to Follow-up|1|||
16927973|NCT00474487|38071654|FG002|Overall Study|Lost to Follow-up|7|||
16927974|NCT00474487|38071655|FG003|Overall Study|Lost to Follow-up|0|||
16927975|NCT00474487|38071652|FG000|Overall Study|Inappropriate enrollment|4|||
16927976|NCT00474487|38071653|FG001|Overall Study|Inappropriate enrollment|0|||
16927977|NCT00474487|38071654|FG002|Overall Study|Inappropriate enrollment|7|||
16927978|NCT00474487|38071655|FG003|Overall Study|Inappropriate enrollment|0|||
16927979|NCT00474487|38071652|FG000|Overall Study|Death|0|||
16927980|NCT00474487|38071653|FG001|Overall Study|Death|1|||
16927981|NCT00474487|38071654|FG002|Overall Study|Death|0|||
16927982|NCT00474487|38071655|FG003|Overall Study|Death|0|||
16927983|NCT00474253|38071667|FG000|Overall Study|Withdrew consent|2|||
16927984|NCT00474253|38071668|FG001|Overall Study|Withdrew consent|0|||
16927985|NCT00474253|38071667|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
16927986|NCT00474253|38071668|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
16927987|NCT00474253|38071667|FG000|Overall Study|Lost to Follow-up|1|||
16927988|NCT00474253|38071668|FG001|Overall Study|Lost to Follow-up|0|||
16927989|NCT00474253|38071667|FG000|Overall Study|Discharged prior to study completion|0|||
16927990|NCT00474253|38071668|FG001|Overall Study|Discharged prior to study completion|1|||
16927991|NCT00474058|38071676|FG000|Overall Study|Adverse Event|11|||
16927992|NCT00474058|38071677|FG001|Overall Study|Adverse Event|6|||
16850641|NCT01783730|37798049|FG000|Overall Study|Failed to meet inclusion criteria|6|||
16850642|NCT01730378|37798055|FG000|Overall Study|Lost to Follow-up|1|||
16850643|NCT01730378|37798056|FG001|Overall Study|Lost to Follow-up|0|||
16850644|NCT01783496|37798069|FG000|Overall Study|Lost to Follow-up|0|||
16850645|NCT01783496|37798070|FG001|Overall Study|Lost to Follow-up|0|||
16927993|NCT00474058|38071676|FG000|Overall Study|Lack of Efficacy|0|||
16927994|NCT00474058|38071677|FG001|Overall Study|Lack of Efficacy|4|||
16927995|NCT00474058|38071676|FG000|Overall Study|Withdrawal by Subject|11|||
16927996|NCT00474058|38071677|FG001|Overall Study|Withdrawal by Subject|7|||
16927997|NCT00474058|38071676|FG000|Overall Study|Other|2|||
16927998|NCT00474058|38071677|FG001|Overall Study|Other|0|||
16850646|NCT01783496|37798071|FG002|Overall Study|Lost to Follow-up|0|||
16850647|NCT01783496|37798072|FG003|Overall Study|Lost to Follow-up|2|||
16850648|NCT01783496|37798073|FG004|Overall Study|Lost to Follow-up|0|||
16850649|NCT01783496|37798074|FG005|Overall Study|Lost to Follow-up|1|||
16850650|NCT01783496|37798069|FG000|Overall Study|Withdrawal by Subject|1|||
16850651|NCT01783496|37798070|FG001|Overall Study|Withdrawal by Subject|0|||
16850652|NCT01783496|37798071|FG002|Overall Study|Withdrawal by Subject|0|||
16850653|NCT01783496|37798072|FG003|Overall Study|Withdrawal by Subject|0|||
16850654|NCT01783496|37798073|FG004|Overall Study|Withdrawal by Subject|0|||
16850655|NCT01783496|37798074|FG005|Overall Study|Withdrawal by Subject|0|||
16850656|NCT01729208|37798099|FG000|Baseline|Physician Decision|5|||
16850657|NCT01729208|37798100|FG001|Baseline|Physician Decision|4|||
16927999|NCT00473824|38071685|FG000|Overall Study|Virologic Breakthrough|1|||
16928000|NCT00473824|38071686|FG001|Overall Study|Virologic Breakthrough|0|||
16928001|NCT00473824|38071685|FG000|Overall Study|Adverse Event|1|||
16928002|NCT00473824|38071686|FG001|Overall Study|Adverse Event|0|||
16928003|NCT00473824|38071685|FG000|Overall Study|Death|1|||
16928004|NCT00473824|38071686|FG001|Overall Study|Death|0|||
16928005|NCT00473824|38071685|FG000|Overall Study|Lost to Follow-up|1|||
16928006|NCT00473824|38071686|FG001|Overall Study|Lost to Follow-up|0|||
16850658|NCT01729208|37798099|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
16850659|NCT01729208|37798100|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
16850660|NCT01729208|37798099|FG000|12 Months Follow-up|Lost to Follow-up|3|||
16850661|NCT01729208|37798100|FG001|12 Months Follow-up|Lost to Follow-up|3|||
16850662|NCT01729208|37798099|FG000|24 Months Follow-up|Lost to Follow-up|3|||
16928007|NCT00473824|38071685|FG000|Overall Study|Withdrawal by physician|1|||
16928008|NCT00473824|38071686|FG001|Overall Study|Withdrawal by physician|0|||
16928009|NCT00473746|38071697|FG000|Period 1 (Phase 1)|Adverse Event|1|||
16928010|NCT00473746|38071698|FG001|Period 1 (Phase 1)|Adverse Event|0|||
16928011|NCT00473746|38071699|FG002|Period 1 (Phase 1)|Adverse Event|0|||
16928012|NCT00473746|38071700|FG003|Period 1 (Phase 1)|Adverse Event|0|||
16928013|NCT00473746|38071701|FG004|Period 1 (Phase 1)|Adverse Event|0|||
16928014|NCT00473746|38071697|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
16928015|NCT00473746|38071698|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
16928016|NCT00473746|38071699|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
16928017|NCT00473746|38071700|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
16928018|NCT00473746|38071701|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
16928019|NCT00473746|38071697|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
16928020|NCT00473746|38071698|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
16928021|NCT00473746|38071699|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
16928022|NCT00473746|38071700|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
16928023|NCT00473746|38071701|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
16928024|NCT00473746|38071697|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
16928025|NCT00473746|38071698|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
16928026|NCT00473746|38071699|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
16928027|NCT00473746|38071700|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
16928028|NCT00473746|38071701|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
16928029|NCT00473746|38071697|FG000|Period 1 (Phase 1)|Reason not specified|0|||
16928030|NCT00473746|38071698|FG001|Period 1 (Phase 1)|Reason not specified|1|||
16928031|NCT00473746|38071699|FG002|Period 1 (Phase 1)|Reason not specified|0|||
16928032|NCT00473746|38071700|FG003|Period 1 (Phase 1)|Reason not specified|0|||
16928033|NCT00473746|38071701|FG004|Period 1 (Phase 1)|Reason not specified|0|||
16928034|NCT00473746|38071697|FG000|Period 2 (Phase 2)|Adverse Event|0|||
16928035|NCT00473746|38071698|FG001|Period 2 (Phase 2)|Adverse Event|0|||
16928036|NCT00473746|38071699|FG002|Period 2 (Phase 2)|Adverse Event|0|||
16928037|NCT00473746|38071700|FG003|Period 2 (Phase 2)|Adverse Event|0|||
16928038|NCT00473746|38071701|FG004|Period 2 (Phase 2)|Adverse Event|3|||
16928039|NCT00473746|38071697|FG000|Period 2 (Phase 2)|Death|0|||
16928040|NCT00473746|38071698|FG001|Period 2 (Phase 2)|Death|0|||
16928041|NCT00473746|38071699|FG002|Period 2 (Phase 2)|Death|0|||
16928042|NCT00473746|38071700|FG003|Period 2 (Phase 2)|Death|0|||
16928043|NCT00473746|38071701|FG004|Period 2 (Phase 2)|Death|1|||
16928044|NCT00473746|38071697|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
16928045|NCT00473746|38071698|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
16928046|NCT00473746|38071699|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
16928047|NCT00473746|38071700|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
16928048|NCT00473746|38071701|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
16928049|NCT00473746|38071697|FG000|Period 2 (Phase 2)|Reason not specified|0|||
16928050|NCT00473746|38071698|FG001|Period 2 (Phase 2)|Reason not specified|0|||
16928051|NCT00473746|38071699|FG002|Period 2 (Phase 2)|Reason not specified|0|||
16928052|NCT00473746|38071700|FG003|Period 2 (Phase 2)|Reason not specified|0|||
16928053|NCT00473746|38071701|FG004|Period 2 (Phase 2)|Reason not specified|3|||
16928054|NCT00473668|38071718|FG000|Overall Study|Withdrawal by Subject|0|||
16928055|NCT00473668|38071719|FG001|Overall Study|Withdrawal by Subject|2|||
16928056|NCT00473668|38071720|FG002|Overall Study|Withdrawal by Subject|0|||
16928057|NCT00473668|38071718|FG000|Overall Study|Migrated/moved from study area|3|||
16928058|NCT00473668|38071719|FG001|Overall Study|Migrated/moved from study area|2|||
16928059|NCT00473668|38071720|FG002|Overall Study|Migrated/moved from study area|0|||
16928060|NCT00473668|38071718|FG000|Overall Study|Lost to Follow-up|0|||
17018559|NCT00672490|38163038|FG001|Overall Study|Lost to Follow-up|5|||
16850663|NCT01729208|37798100|FG001|24 Months Follow-up|Lost to Follow-up|0|||
16850664|NCT01729208|37798099|FG000|36 Months Follow-up|Physician Decision|1|||
16850665|NCT01729208|37798100|FG001|36 Months Follow-up|Physician Decision|0|||
16850666|NCT01729208|37798099|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
16850667|NCT01729208|37798100|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
16850668|NCT01609010|37798117|FG000|Overall Study|Stable disease (SD)|22|||
16928061|NCT00473668|38071719|FG001|Overall Study|Lost to Follow-up|4|||
16928062|NCT00473668|38071720|FG002|Overall Study|Lost to Follow-up|6|||
16928063|NCT00473668|38071718|FG000|Overall Study|Other|2|||
16928064|NCT00473668|38071719|FG001|Overall Study|Other|3|||
16928065|NCT00473668|38071720|FG002|Overall Study|Other|4|||
16928066|NCT00473590|38071730|FG000|Overall Study|Adverse Event|3|||
16928067|NCT00473590|38071731|FG001|Overall Study|Adverse Event|3|||
16928068|NCT00473590|38071730|FG000|Overall Study|Death|4|||
16928069|NCT00473590|38071731|FG001|Overall Study|Death|2|||
16928070|NCT00473590|38071730|FG000|Overall Study|Progression not resulting in death|24|||
16928071|NCT00473590|38071731|FG001|Overall Study|Progression not resulting in death|20|||
16928072|NCT00473590|38071730|FG000|Overall Study|Non-protocol-specified therapy|7|||
16928073|NCT00473590|38071731|FG001|Overall Study|Non-protocol-specified therapy|5|||
16928074|NCT00473590|38071730|FG000|Overall Study|Physician Decision|2|||
16928075|NCT00473590|38071731|FG001|Overall Study|Physician Decision|4|||
16928076|NCT00473590|38071730|FG000|Overall Study|Withdrawal by Subject|5|||
16928077|NCT00473590|38071731|FG001|Overall Study|Withdrawal by Subject|3|||
16928078|NCT00473590|38071730|FG000|Overall Study|Other|0|||
16928079|NCT00473590|38071731|FG001|Overall Study|Other|1|||
16928080|NCT00473512|38071742|FG000|Period 1 (Phase 1)|Adverse Event|0|||
16928081|NCT00473512|38071743|FG001|Period 1 (Phase 1)|Adverse Event|0|||
16928082|NCT00473512|38071744|FG002|Period 1 (Phase 1)|Adverse Event|0|||
16928083|NCT00473512|38071745|FG003|Period 1 (Phase 1)|Adverse Event|5|||
16928084|NCT00473512|38071746|FG004|Period 1 (Phase 1)|Adverse Event|0|||
16928085|NCT00473512|38071742|FG000|Period 1 (Phase 1)|Death|0|||
16928086|NCT00473512|38071743|FG001|Period 1 (Phase 1)|Death|0|||
16928087|NCT00473512|38071744|FG002|Period 1 (Phase 1)|Death|0|||
16928088|NCT00473512|38071745|FG003|Period 1 (Phase 1)|Death|1|||
16928089|NCT00473512|38071746|FG004|Period 1 (Phase 1)|Death|0|||
16928090|NCT00473512|38071742|FG000|Period 1 (Phase 1)|Disease Progression|1|||
16928091|NCT00473512|38071743|FG001|Period 1 (Phase 1)|Disease Progression|1|||
16928092|NCT00473512|38071744|FG002|Period 1 (Phase 1)|Disease Progression|0|||
16928093|NCT00473512|38071745|FG003|Period 1 (Phase 1)|Disease Progression|10|||
16928094|NCT00473512|38071746|FG004|Period 1 (Phase 1)|Disease Progression|1|||
16928095|NCT00473512|38071742|FG000|Period 1 (Phase 1)|Other|0|||
16928096|NCT00473512|38071743|FG001|Period 1 (Phase 1)|Other|0|||
16928097|NCT00473512|38071744|FG002|Period 1 (Phase 1)|Other|0|||
16928098|NCT00473512|38071745|FG003|Period 1 (Phase 1)|Other|1|||
16928099|NCT00473512|38071746|FG004|Period 1 (Phase 1)|Other|0|||
16928100|NCT00473512|38071742|FG000|Period 2 (Phase 2)|Adverse Event|0|||
16928101|NCT00473512|38071743|FG001|Period 2 (Phase 2)|Adverse Event|0|||
16928102|NCT00473512|38071744|FG002|Period 2 (Phase 2)|Adverse Event|0|||
16928103|NCT00473512|38071745|FG003|Period 2 (Phase 2)|Adverse Event|1|||
16928104|NCT00473512|38071746|FG004|Period 2 (Phase 2)|Adverse Event|0|||
16928105|NCT00473512|38071742|FG000|Period 2 (Phase 2)|Death|0|||
16928106|NCT00473512|38071743|FG001|Period 2 (Phase 2)|Death|0|||
16928107|NCT00473512|38071744|FG002|Period 2 (Phase 2)|Death|0|||
16928108|NCT00473512|38071745|FG003|Period 2 (Phase 2)|Death|1|||
16928109|NCT00473512|38071746|FG004|Period 2 (Phase 2)|Death|1|||
16928110|NCT00473512|38071742|FG000|Period 2 (Phase 2)|Disease Progression|0|||
16928111|NCT00473512|38071743|FG001|Period 2 (Phase 2)|Disease Progression|2|||
16928112|NCT00473512|38071744|FG002|Period 2 (Phase 2)|Disease Progression|2|||
16928113|NCT00473512|38071745|FG003|Period 2 (Phase 2)|Disease Progression|17|||
16928114|NCT00473512|38071746|FG004|Period 2 (Phase 2)|Disease Progression|1|||
16928115|NCT00473512|38071742|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
16928116|NCT00473512|38071743|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
16928117|NCT00473512|38071744|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
16928118|NCT00473512|38071745|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
16928119|NCT00473512|38071746|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
16928120|NCT00473512|38071742|FG000|Period 2 (Phase 2)|Other|1|||
16928121|NCT00473512|38071743|FG001|Period 2 (Phase 2)|Other|0|||
16928122|NCT00473512|38071744|FG002|Period 2 (Phase 2)|Other|0|||
16928123|NCT00473512|38071745|FG003|Period 2 (Phase 2)|Other|3|||
16928124|NCT00473512|38071746|FG004|Period 2 (Phase 2)|Other|0|||
16928125|NCT00473434|38071766|FG000|Overall Study|Physician Decision|3|||
16928126|NCT00473434|38071766|FG000|Overall Study|Withdrawal by Subject|9|||
16928127|NCT00473434|38071766|FG000|Overall Study|Compliance|3|||
16928128|NCT00473434|38071766|FG000|Overall Study|Lack of Efficacy|3|||
16928129|NCT00473434|38071766|FG000|Overall Study|Adverse Event|3|||
16928130|NCT00473434|38071766|FG000|Overall Study|Patient was selling medication to others|1|||
16928131|NCT00473434|38071766|FG000|Overall Study|Safety evaluation|1|||
16928132|NCT00473434|38071766|FG000|Overall Study|Reason not specified|6|||
16928133|NCT00473434|38071766|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
16928134|NCT00473434|38071766|FG000|Overall Study|Switching to trial medication|1|||
16928135|NCT00473434|38071766|FG000|Overall Study|No longer required|1|||
16928136|NCT00473083|38071786|FG000|Overall Study|Adverse Event|1|||
16928137|NCT00473083|38071787|FG001|Overall Study|Adverse Event|0|||
16928138|NCT00473083|38071788|FG002|Overall Study|Adverse Event|0|||
16928139|NCT00472420|38071799|FG000|Induction Treatment Period|Physician Decision|9|||
16928140|NCT00472420|38071799|FG000|Induction Treatment Period|Adverse Event|3|||
16928141|NCT00472420|38071799|FG000|Induction Treatment Period|Non-compliance|1|||
16928142|NCT00472420|38071799|FG000|Induction Treatment Period|Death|3|||
16928143|NCT00472420|38071799|FG000|Follow-up Period|Death|5|||
16928144|NCT00472420|38071799|FG000|Follow-up Period|Physician Decision|9|||
16928145|NCT00472420|38071799|FG000|Follow-up Period|Lost to Follow-up|2|||
16928146|NCT00472420|38071799|FG000|Follow-up Period|Protocol Violation|1|||
16928147|NCT00472303|38071805|FG000|Titration Phase|Adverse Event|22|||
16928148|NCT00472303|38071806|FG001|Titration Phase|Adverse Event|12|||
16928149|NCT00472303|38071807|FG002|Titration Phase|Adverse Event|0|||
17018560|NCT00672490|38163037|FG000|Overall Study|No reason was provided|6|||
17018561|NCT00672490|38163038|FG001|Overall Study|No reason was provided|2|||
17018562|NCT00670930|38163046|FG000|Overall Study|Adminstrative Problem|0|||
17018563|NCT00670930|38163047|FG001|Overall Study|Adminstrative Problem|1|||
17018564|NCT00670930|38163046|FG000|Overall Study|Lost to Follow-up|1|||
17018565|NCT00670930|38163047|FG001|Overall Study|Lost to Follow-up|0|||
17018566|NCT00670540|38163053|FG000|Overall Study|ineligible|17|||
17018567|NCT00670540|38163053|FG000|Overall Study|not living in France|348|||
17018568|NCT00670540|38163053|FG000|Overall Study|refused to participate|189|||
17018569|NCT00670540|38163053|FG000|Overall Study|controls randomised for no follow up|2770|||
17018570|NCT00670540|38163053|FG000|Overall Study|missing information inclusion criteria|1|||
17018571|NCT00591786|38163067|FG000|Overall Study|Withdrawal of Informed Consent|0|||
17018572|NCT00591786|38163068|FG001|Overall Study|Withdrawal of Informed Consent|0|||
17018573|NCT00591786|38163069|FG002|Overall Study|Withdrawal of Informed Consent|1|||
16850669|NCT01609010|37798118|FG001|Overall Study|Stable disease (SD)|16|||
16850670|NCT01609010|37798117|FG000|Overall Study|Progressive disease (PD)|8|||
16850671|NCT01609010|37798118|FG001|Overall Study|Progressive disease (PD)|10|||
17018574|NCT00591786|38163070|FG003|Overall Study|Withdrawal of Informed Consent|0|||
17018575|NCT00591786|38163071|FG004|Overall Study|Withdrawal of Informed Consent|0|||
17018576|NCT00591786|38163072|FG005|Overall Study|Withdrawal of Informed Consent|0|||
17018577|NCT00591786|38163073|FG006|Overall Study|Withdrawal of Informed Consent|0|||
17018578|NCT00591786|38163074|FG007|Overall Study|Withdrawal of Informed Consent|0|||
17018579|NCT00591786|38163075|FG008|Overall Study|Withdrawal of Informed Consent|0|||
17018580|NCT00591786|38163076|FG009|Overall Study|Withdrawal of Informed Consent|0|||
17018581|NCT00674362|38163100|FG000|Double Blind|Adverse Event|6|||
17018582|NCT00674362|38163101|FG001|Double Blind|Adverse Event|6|||
17018583|NCT00674362|38163100|FG000|Double Blind|Lack of Efficacy|2|||
17018584|NCT00674362|38163101|FG001|Double Blind|Lack of Efficacy|6|||
17018585|NCT00674362|38163100|FG000|Double Blind|Loss of efficacy|0|||
17018586|NCT00674362|38163101|FG001|Double Blind|Loss of efficacy|1|||
17018587|NCT00674362|38163100|FG000|Double Blind|Withdrawal by Subject|4|||
17018588|NCT00674362|38163101|FG001|Double Blind|Withdrawal by Subject|3|||
17018589|NCT00674362|38163100|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
17018590|NCT00674362|38163101|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
17018591|NCT00674362|38163100|FG000|Double Blind|Other: Surgery|0|||
17018592|NCT00674362|38163101|FG001|Double Blind|Other: Surgery|1|||
17018593|NCT00674362|38163100|FG000|Open Label|Adverse Event|1|||
17018594|NCT00674362|38163101|FG001|Open Label|Adverse Event|0|||
17018595|NCT00674362|38163100|FG000|Open Label|Other: Subject moved to extension study|1|||
17018596|NCT00674362|38163101|FG001|Open Label|Other: Subject moved to extension study|0|||
17018597|NCT00820950|38163113|FG000|Overall Study|Scheduling Conflict|0|||
17018598|NCT00820950|38163114|FG001|Overall Study|Scheduling Conflict|0|||
17018599|NCT00820950|38163115|FG002|Overall Study|Scheduling Conflict|0|||
17018600|NCT00820950|38163116|FG003|Overall Study|Scheduling Conflict|0|||
16850672|NCT01609010|37798117|FG000|Overall Study|Adverse Event|3|||
16850673|NCT01609010|37798118|FG001|Overall Study|Adverse Event|6|||
16850674|NCT01609010|37798117|FG000|Overall Study|Withdrawal by Subject|2|||
16850675|NCT01609010|37798118|FG001|Overall Study|Withdrawal by Subject|2|||
16850676|NCT01609010|37798117|FG000|Overall Study|Other|2|||
16850677|NCT01609010|37798118|FG001|Overall Study|Other|0|||
16850678|NCT01609010|37798117|FG000|Overall Study|Other malignancy|1|||
16850679|NCT01609010|37798118|FG001|Overall Study|Other malignancy|0|||
16850680|NCT01609010|37798117|FG000|Overall Study|Pathology review|2|||
16850681|NCT01609010|37798118|FG001|Overall Study|Pathology review|1|||
16850682|NCT01609010|37798117|FG000|Overall Study|Protocol Violation|1|||
16850683|NCT01609010|37798118|FG001|Overall Study|Protocol Violation|1|||
16850684|NCT01609010|37798117|FG000|Overall Study|New cancer|1|||
16850685|NCT01609010|37798118|FG001|Overall Study|New cancer|0|||
16850686|NCT01609010|37798117|FG000|Overall Study|Lost to Follow-up|1|||
16850687|NCT01609010|37798118|FG001|Overall Study|Lost to Follow-up|1|||
16850688|NCT01608308|37798126|FG000|Overall Study|pretreatment medical and billing reasons|0|||
16850689|NCT01608308|37798127|FG001|Overall Study|pretreatment medical and billing reasons|2|||
16850690|NCT01755416|37798158|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
16850691|NCT01755416|37798159|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
16928150|NCT00472303|38071805|FG000|Titration Phase|Death|4|||
16928151|NCT00472303|38071806|FG001|Titration Phase|Death|2|||
16928152|NCT00472303|38071807|FG002|Titration Phase|Death|0|||
16928153|NCT00472303|38071805|FG000|Titration Phase|Lack of Efficacy|10|||
16928154|NCT00472303|38071806|FG001|Titration Phase|Lack of Efficacy|0|||
16928155|NCT00472303|38071807|FG002|Titration Phase|Lack of Efficacy|0|||
16928156|NCT00472303|38071805|FG000|Titration Phase|Withdrawal by Subject|16|||
16928157|NCT00472303|38071806|FG001|Titration Phase|Withdrawal by Subject|13|||
16928158|NCT00472303|38071807|FG002|Titration Phase|Withdrawal by Subject|0|||
16928159|NCT00472303|38071805|FG000|Titration Phase|Trial Medication non-compliant|4|||
16928160|NCT00472303|38071806|FG001|Titration Phase|Trial Medication non-compliant|1|||
16928161|NCT00472303|38071807|FG002|Titration Phase|Trial Medication non-compliant|0|||
16928162|NCT00472303|38071805|FG000|Titration Phase|Other|3|||
16928163|NCT00472303|38071806|FG001|Titration Phase|Other|1|||
16928164|NCT00472303|38071807|FG002|Titration Phase|Other|0|||
16928165|NCT00472303|38071805|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
16928166|NCT00472303|38071806|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
16928167|NCT00472303|38071807|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
16928168|NCT00472303|38071805|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
16928169|NCT00472303|38071806|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
16928170|NCT00472303|38071807|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
16928171|NCT00472303|38071805|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
16928172|NCT00472303|38071806|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
16928173|NCT00472303|38071807|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
16928174|NCT00472303|38071805|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
16928175|NCT00472303|38071806|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
16928176|NCT00472303|38071807|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
16928177|NCT00472303|38071805|FG000|Discontinuations After Titration Phase|Other|5|||
16928178|NCT00472303|38071806|FG001|Discontinuations After Titration Phase|Other|0|||
16928179|NCT00472303|38071807|FG002|Discontinuations After Titration Phase|Other|0|||
16928180|NCT00472303|38071805|FG000|Maintenance Phase|Adverse Event|5|||
16928181|NCT00472303|38071806|FG001|Maintenance Phase|Adverse Event|6|||
16928182|NCT00472303|38071807|FG002|Maintenance Phase|Adverse Event|6|||
16928183|NCT00472303|38071805|FG000|Maintenance Phase|Death|3|||
16928184|NCT00472303|38071806|FG001|Maintenance Phase|Death|0|||
16928185|NCT00472303|38071807|FG002|Maintenance Phase|Death|2|||
16928186|NCT00472303|38071805|FG000|Maintenance Phase|Lack of Efficacy|2|||
16928187|NCT00472303|38071806|FG001|Maintenance Phase|Lack of Efficacy|2|||
16928188|NCT00472303|38071807|FG002|Maintenance Phase|Lack of Efficacy|4|||
16928189|NCT00472303|38071805|FG000|Maintenance Phase|Withdrawal by Subject|6|||
16928190|NCT00472303|38071806|FG001|Maintenance Phase|Withdrawal by Subject|7|||
16928191|NCT00472303|38071807|FG002|Maintenance Phase|Withdrawal by Subject|3|||
16928192|NCT00472303|38071805|FG000|Maintenance Phase|Trial medication non-compliant|0|||
16928193|NCT00472303|38071806|FG001|Maintenance Phase|Trial medication non-compliant|0|||
16928194|NCT00472303|38071807|FG002|Maintenance Phase|Trial medication non-compliant|1|||
16850692|NCT01755026|37798167|FG000|Overall Study|Adverse Event|1|||
16850693|NCT01755026|37798168|FG001|Overall Study|Adverse Event|0|||
16850694|NCT01755026|37798167|FG000|Overall Study|Withdrawal by Subject|1|||
16850695|NCT01755026|37798168|FG001|Overall Study|Withdrawal by Subject|1|||
16850696|NCT01491945|37798183|FG000|Overall Study|Death|30|||
16850697|NCT01491945|37798183|FG000|Overall Study|Withdrwan/LTF|16|||
16850698|NCT01491945|37798183|FG000|Overall Study|Conversion|4|||
16850699|NCT01491945|37798183|FG000|Overall Study|Missed Visit|1|||
16850700|NCT01728584|37798205|FG000|Overall Study|Adverse Event|1|||
16850701|NCT01728584|37798206|FG001|Overall Study|Adverse Event|0|||
16850702|NCT01728584|37798207|FG002|Overall Study|Adverse Event|0|||
16850703|NCT01728584|37798208|FG003|Overall Study|Adverse Event|0|||
16850704|NCT01728584|37798205|FG000|Overall Study|Physician Decision|4|||
16850705|NCT01728584|37798206|FG001|Overall Study|Physician Decision|0|||
16850706|NCT01728584|37798207|FG002|Overall Study|Physician Decision|1|||
16850707|NCT01728584|37798208|FG003|Overall Study|Physician Decision|0|||
16850708|NCT01728584|37798205|FG000|Overall Study|Withdrawal by Subject|1|||
16850709|NCT01728584|37798206|FG001|Overall Study|Withdrawal by Subject|0|||
16928195|NCT00472303|38071805|FG000|Maintenance Phase|Resolution of pain|0|||
16928196|NCT00472303|38071806|FG001|Maintenance Phase|Resolution of pain|0|||
16928197|NCT00472303|38071807|FG002|Maintenance Phase|Resolution of pain|1|||
16928198|NCT00472303|38071805|FG000|Maintenance Phase|Other|1|||
16928199|NCT00472303|38071806|FG001|Maintenance Phase|Other|1|||
16928200|NCT00472303|38071807|FG002|Maintenance Phase|Other|0|||
16928201|NCT00471718|38071835|FG000|Overall Study|Adverse Event|3|||
16928202|NCT00471718|38071835|FG000|Overall Study|other complicating disease|1|||
16928203|NCT00471718|38071835|FG000|Overall Study|disease progression|22|||
16928204|NCT00471718|38071835|FG000|Overall Study|Withdrawal by Subject|1|||
16928205|NCT00471445|38071845|FG000|Overall Study|Withdrawal by Subject|1|||
16928206|NCT00471445|38071846|FG001|Overall Study|Withdrawal by Subject|1|||
16928207|NCT00471445|38071845|FG000|Overall Study|Ineligible|1|||
16928208|NCT00471445|38071846|FG001|Overall Study|Ineligible|0|||
16928209|NCT00471445|38071845|FG000|Overall Study|Protocol Violation|0|||
16850710|NCT01728584|37798207|FG002|Overall Study|Withdrawal by Subject|0|||
16850711|NCT01728584|37798208|FG003|Overall Study|Withdrawal by Subject|0|||
16850712|NCT01728584|37798205|FG000|Overall Study|Screen failure|1|||
16850713|NCT01728584|37798206|FG001|Overall Study|Screen failure|0|||
16850714|NCT01728584|37798207|FG002|Overall Study|Screen failure|0|||
16928210|NCT00471445|38071846|FG001|Overall Study|Protocol Violation|1|||
16928211|NCT00471328|38071854|FG000|Core Phase|Adverse Event|18|||
16928212|NCT00471328|38071855|FG001|Core Phase|Adverse Event|6|||
16928213|NCT00471328|38071854|FG000|Core Phase|Death|8|||
16928214|NCT00471328|38071855|FG001|Core Phase|Death|4|||
16928215|NCT00471328|38071854|FG000|Core Phase|Withdrawal by Subject|2|||
16928216|NCT00471328|38071855|FG001|Core Phase|Withdrawal by Subject|2|||
16928217|NCT00471328|38071854|FG000|Core Phase|Abnormal laboratory value|1|||
16928218|NCT00471328|38071855|FG001|Core Phase|Abnormal laboratory value|0|||
16928219|NCT00471328|38071854|FG000|Core Phase|Disease Progression|78|||
16928220|NCT00471328|38071855|FG001|Core Phase|Disease Progression|53|||
16928221|NCT00471328|38071854|FG000|Core Phase|Administrative Problem|0|||
16928222|NCT00471328|38071855|FG001|Core Phase|Administrative Problem|1|||
16928223|NCT00471328|38071854|FG000|Core Phase|Protocol Deviation|0|||
16928224|NCT00471328|38071855|FG001|Core Phase|Protocol Deviation|1|||
16928225|NCT00471328|38071854|FG000|Extension Phase|Adverse Event|3|||
16928226|NCT00471328|38071855|FG001|Extension Phase|Adverse Event|12|||
16928227|NCT00471328|38071854|FG000|Extension Phase|Withdrawal by Subject|0|||
16928228|NCT00471328|38071855|FG001|Extension Phase|Withdrawal by Subject|2|||
16928229|NCT00471328|38071854|FG000|Extension Phase|Death|1|||
16928230|NCT00471328|38071855|FG001|Extension Phase|Death|7|||
16928231|NCT00471328|38071854|FG000|Extension Phase|Protocol Deviation|3|||
16928232|NCT00471328|38071855|FG001|Extension Phase|Protocol Deviation|1|||
16928233|NCT00471328|38071854|FG000|Extension Phase|Treatment duration as per protocol|0|||
16928234|NCT00471328|38071855|FG001|Extension Phase|Treatment duration as per protocol|1|||
16928235|NCT00471328|38071854|FG000|Extension Phase|Disease Progression|32|||
16928236|NCT00471328|38071855|FG001|Extension Phase|Disease Progression|44|||
16928237|NCT00471328|38071854|FG000|Extension Phase|New cancer Therapy|1|||
16928238|NCT00471328|38071855|FG001|Extension Phase|New cancer Therapy|0|||
16928239|NCT00471328|38071854|FG000|Extension Phase|Administrative Problem|1|||
16928240|NCT00471328|38071855|FG001|Extension Phase|Administrative Problem|0|||
16928241|NCT00470704|38071865|FG000|Overall Study|Withdrawal by Subject|4|||
16928242|NCT00470704|38071866|FG001|Overall Study|Withdrawal by Subject|3|||
16928243|NCT00470704|38071865|FG000|Overall Study|Relapse/Progression|37|||
16850715|NCT01728584|37798208|FG003|Overall Study|Screen failure|0|||
16850716|NCT01728584|37798205|FG000|Overall Study|Other reason (not specified)|1|||
16850717|NCT01728584|37798206|FG001|Overall Study|Other reason (not specified)|0|||
16850718|NCT01728584|37798207|FG002|Overall Study|Other reason (not specified)|0|||
16850719|NCT01728584|37798208|FG003|Overall Study|Other reason (not specified)|1|||
16850720|NCT01522443|37798241|FG000|Overall Study|No longer receiving clinical benefit|36|||
16850721|NCT01522443|37798242|FG001|Overall Study|No longer receiving clinical benefit|28|||
16850722|NCT01522443|37798241|FG000|Overall Study|Adverse Event|10|||
16850723|NCT01522443|37798242|FG001|Overall Study|Adverse Event|15|||
16850724|NCT01522443|37798241|FG000|Overall Study|Withdrawal by Subject|5|||
16850725|NCT01522443|37798242|FG001|Overall Study|Withdrawal by Subject|8|||
16928244|NCT00470704|38071866|FG001|Overall Study|Relapse/Progression|42|||
16928245|NCT00470704|38071865|FG000|Overall Study|toxicity|0|||
16928246|NCT00470704|38071866|FG001|Overall Study|toxicity|1|||
16928247|NCT00470470|38071872|FG000|Overall Study|Adverse Event|2|||
16928248|NCT00470470|38071872|FG000|Overall Study|Death|2|||
16928249|NCT00470470|38071872|FG000|Overall Study|Not treated|1|||
16928250|NCT00470275|38071876|FG000|Overall Study|Death|1|||
16928251|NCT00470275|38071876|FG000|Overall Study|Lack of Efficacy|7|||
16928252|NCT00470275|38071876|FG000|Overall Study|Withdrawal by Subject|2|||
16928253|NCT00470158|38071885|FG000|Overall Study|Death|0|||
16850726|NCT01522443|37798241|FG000|Overall Study|No study treatment given|1|||
16850727|NCT01522443|37798242|FG001|Overall Study|No study treatment given|1|||
16850728|NCT01522443|37798241|FG000|Overall Study|Other|1|||
16850729|NCT01522443|37798242|FG001|Overall Study|Other|3|||
16850730|NCT01468233|37798263|FG000|Treatment Period 1|Adverse Event|5|||
16850731|NCT01468233|37798264|FG001|Treatment Period 1|Adverse Event|3|||
16850732|NCT01468233|37798265|FG002|Treatment Period 1|Adverse Event|0|||
16850733|NCT01468233|37798266|FG003|Treatment Period 1|Adverse Event|0|||
16850734|NCT01468233|37798267|FG004|Treatment Period 1|Adverse Event|0|||
16850735|NCT01468233|37798268|FG005|Treatment Period 1|Adverse Event|0|||
16850736|NCT01468233|37798263|FG000|Treatment Period 1|Withdrawal by Subject|3|||
16850737|NCT01468233|37798264|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16850738|NCT01468233|37798265|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16850739|NCT01468233|37798266|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16850740|NCT01468233|37798267|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16850741|NCT01468233|37798268|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16850742|NCT01468233|37798263|FG000|Treatment Period 1|Lost to Follow-up|3|||
16850743|NCT01468233|37798264|FG001|Treatment Period 1|Lost to Follow-up|0|||
16928254|NCT00470158|38071886|FG001|Overall Study|Death|0|||
16928255|NCT00470158|38071887|FG002|Overall Study|Death|0|||
16928256|NCT00470158|38071888|FG003|Overall Study|Death|0|||
16928257|NCT00470158|38071889|FG004|Overall Study|Death|2|||
16928258|NCT00470158|38071885|FG000|Overall Study|Lost to Follow-up|7|||
16928259|NCT00470158|38071886|FG001|Overall Study|Lost to Follow-up|8|||
16850744|NCT01468233|37798265|FG002|Treatment Period 1|Lost to Follow-up|0|||
16850745|NCT01468233|37798266|FG003|Treatment Period 1|Lost to Follow-up|0|||
16850746|NCT01468233|37798267|FG004|Treatment Period 1|Lost to Follow-up|0|||
16850747|NCT01468233|37798268|FG005|Treatment Period 1|Lost to Follow-up|0|||
16850748|NCT01468233|37798263|FG000|Treatment Period 1|Other|1|||
16850749|NCT01468233|37798264|FG001|Treatment Period 1|Other|1|||
16850750|NCT01468233|37798265|FG002|Treatment Period 1|Other|0|||
16850751|NCT01468233|37798266|FG003|Treatment Period 1|Other|0|||
16850752|NCT01468233|37798267|FG004|Treatment Period 1|Other|0|||
16850753|NCT01468233|37798268|FG005|Treatment Period 1|Other|0|||
16850754|NCT01468233|37798263|FG000|Treatment Period 2|Adverse Event|0|||
16850755|NCT01468233|37798264|FG001|Treatment Period 2|Adverse Event|0|||
16850756|NCT01468233|37798265|FG002|Treatment Period 2|Adverse Event|3|||
16850757|NCT01468233|37798266|FG003|Treatment Period 2|Adverse Event|0|||
16850758|NCT01468233|37798267|FG004|Treatment Period 2|Adverse Event|2|||
16850759|NCT01468233|37798268|FG005|Treatment Period 2|Adverse Event|1|||
16850760|NCT01468233|37798263|FG000|Treatment Period 2|Lack of Efficacy|0|||
16850761|NCT01468233|37798264|FG001|Treatment Period 2|Lack of Efficacy|0|||
16928260|NCT00470158|38071887|FG002|Overall Study|Lost to Follow-up|8|||
16928261|NCT00470158|38071888|FG003|Overall Study|Lost to Follow-up|5|||
16928262|NCT00470158|38071889|FG004|Overall Study|Lost to Follow-up|4|||
16928263|NCT00470158|38071885|FG000|Overall Study|Protocol Violation|1|||
16928264|NCT00470158|38071886|FG001|Overall Study|Protocol Violation|0|||
16928265|NCT00470158|38071887|FG002|Overall Study|Protocol Violation|0|||
16928266|NCT00470158|38071888|FG003|Overall Study|Protocol Violation|0|||
16928267|NCT00470158|38071889|FG004|Overall Study|Protocol Violation|0|||
16850762|NCT01468233|37798265|FG002|Treatment Period 2|Lack of Efficacy|9|||
16928268|NCT00475540|38071903|FG000|36 Months|Lost to Follow-up|4|||
16928269|NCT00475540|38071904|FG001|36 Months|Lost to Follow-up|4|||
16928270|NCT00475540|38071903|FG000|36 Months|Death|1|||
16928271|NCT00475540|38071904|FG001|36 Months|Death|2|||
16928272|NCT00475540|38071903|FG000|36 Months|Censored due to reoperation|3|||
16928273|NCT00475540|38071904|FG001|36 Months|Censored due to reoperation|0|||
16928274|NCT00472186|38071912|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
16928275|NCT00472186|38071913|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
16928276|NCT00479713|38071923|FG000|Overall Study|Adverse Event|8|||
16928277|NCT00479713|38071924|FG001|Overall Study|Adverse Event|6|||
16928278|NCT00479713|38071923|FG000|Overall Study|Death|1|||
16928279|NCT00479713|38071924|FG001|Overall Study|Death|0|||
16850763|NCT01468233|37798266|FG003|Treatment Period 2|Lack of Efficacy|2|||
16850764|NCT01468233|37798267|FG004|Treatment Period 2|Lack of Efficacy|0|||
16850765|NCT01468233|37798268|FG005|Treatment Period 2|Lack of Efficacy|1|||
16850766|NCT01468233|37798263|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16850767|NCT01468233|37798264|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16850768|NCT01468233|37798265|FG002|Treatment Period 2|Withdrawal by Subject|9|||
16850769|NCT01468233|37798266|FG003|Treatment Period 2|Withdrawal by Subject|1|||
16850770|NCT01468233|37798267|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16850771|NCT01468233|37798268|FG005|Treatment Period 2|Withdrawal by Subject|1|||
16850772|NCT01468233|37798263|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
16850773|NCT01468233|37798264|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
16850774|NCT01468233|37798265|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
16928280|NCT00479713|38071923|FG000|Overall Study|Lost to Follow-up|0|||
16928281|NCT00479713|38071924|FG001|Overall Study|Lost to Follow-up|1|||
16928282|NCT00479713|38071923|FG000|Overall Study|Protocol Violation|0|||
16928283|NCT00479713|38071924|FG001|Overall Study|Protocol Violation|1|||
16928284|NCT00479713|38071923|FG000|Overall Study|Withdrawal by Subject|4|||
16928285|NCT00479713|38071924|FG001|Overall Study|Withdrawal by Subject|1|||
16928286|NCT00474526|38071956|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
16928287|NCT00474526|38071957|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
16928288|NCT00474526|38071958|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
16928289|NCT00474526|38071959|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
16928290|NCT00474526|38071960|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
16928291|NCT00474526|38071961|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
16928292|NCT00474526|38071962|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
16928293|NCT00474526|38071963|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
16928294|NCT00474526|38071964|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
16928295|NCT00474526|38071965|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
16928296|NCT00474526|38071966|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
16928297|NCT00474526|38071967|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
16928298|NCT00474526|38071968|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
16928299|NCT00474526|38071969|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
16928300|NCT00474526|38071970|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
16928301|NCT00474526|38071971|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
16928302|NCT00474526|38071972|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
16928303|NCT00474526|38071956|FG000|Overall Study|Adverse Event|2|||
16928304|NCT00474526|38071957|FG001|Overall Study|Adverse Event|0|||
16928305|NCT00474526|38071958|FG002|Overall Study|Adverse Event|2|||
16928306|NCT00474526|38071959|FG003|Overall Study|Adverse Event|4|||
16928307|NCT00474526|38071960|FG004|Overall Study|Adverse Event|2|||
16928308|NCT00474526|38071961|FG005|Overall Study|Adverse Event|1|||
16928309|NCT00474526|38071962|FG006|Overall Study|Adverse Event|1|||
16928310|NCT00474526|38071963|FG007|Overall Study|Adverse Event|0|||
16928311|NCT00474526|38071964|FG008|Overall Study|Adverse Event|0|||
16928312|NCT00474526|38071965|FG009|Overall Study|Adverse Event|0|||
16928313|NCT00474526|38071966|FG010|Overall Study|Adverse Event|0|||
16928314|NCT00474526|38071967|FG011|Overall Study|Adverse Event|0|||
16928315|NCT00474526|38071968|FG012|Overall Study|Adverse Event|0|||
16928316|NCT00474526|38071969|FG013|Overall Study|Adverse Event|0|||
16928317|NCT00474526|38071970|FG014|Overall Study|Adverse Event|1|||
16928318|NCT00474526|38071971|FG015|Overall Study|Adverse Event|1|||
16928319|NCT00474526|38071972|FG016|Overall Study|Adverse Event|0|||
16928320|NCT00474526|38071956|FG000|Overall Study|Death|0|||
16928321|NCT00474526|38071957|FG001|Overall Study|Death|0|||
16928322|NCT00474526|38071958|FG002|Overall Study|Death|0|||
16928323|NCT00474526|38071959|FG003|Overall Study|Death|0|||
16928324|NCT00474526|38071960|FG004|Overall Study|Death|0|||
16928325|NCT00474526|38071961|FG005|Overall Study|Death|0|||
16928326|NCT00474526|38071962|FG006|Overall Study|Death|0|||
16928327|NCT00474526|38071963|FG007|Overall Study|Death|0|||
16928328|NCT00474526|38071964|FG008|Overall Study|Death|0|||
16928329|NCT00474526|38071965|FG009|Overall Study|Death|0|||
16928330|NCT00474526|38071966|FG010|Overall Study|Death|0|||
16928331|NCT00474526|38071967|FG011|Overall Study|Death|0|||
16928332|NCT00474526|38071968|FG012|Overall Study|Death|0|||
16928333|NCT00474526|38071969|FG013|Overall Study|Death|3|||
16928334|NCT00474526|38071970|FG014|Overall Study|Death|0|||
16928335|NCT00474526|38071971|FG015|Overall Study|Death|0|||
17018601|NCT00820950|38163117|FG004|Overall Study|Scheduling Conflict|0|||
17018602|NCT00820950|38163118|FG005|Overall Study|Scheduling Conflict|0|||
17018603|NCT00820950|38163119|FG006|Overall Study|Scheduling Conflict|1|||
17018604|NCT00820950|38163120|FG007|Overall Study|Scheduling Conflict|1|||
17018605|NCT00820950|38163121|FG008|Overall Study|Scheduling Conflict|0|||
17018606|NCT00820950|38163122|FG009|Overall Study|Scheduling Conflict|0|||
17018607|NCT00820950|38163113|FG000|Overall Study|Protocol Violation|1|||
17018608|NCT00820950|38163114|FG001|Overall Study|Protocol Violation|1|||
17018609|NCT00820950|38163115|FG002|Overall Study|Protocol Violation|0|||
17018610|NCT00820950|38163116|FG003|Overall Study|Protocol Violation|0|||
17018611|NCT00820950|38163117|FG004|Overall Study|Protocol Violation|0|||
17018612|NCT00820950|38163118|FG005|Overall Study|Protocol Violation|0|||
17018613|NCT00820950|38163119|FG006|Overall Study|Protocol Violation|0|||
17018614|NCT00820950|38163120|FG007|Overall Study|Protocol Violation|0|||
17018615|NCT00820950|38163121|FG008|Overall Study|Protocol Violation|0|||
17018616|NCT00820950|38163122|FG009|Overall Study|Protocol Violation|0|||
17018617|NCT00670306|38163162|FG000|Overall Study|Adverse Event|8|||
17018618|NCT00670306|38163162|FG000|Overall Study|Lack of Efficacy|10|||
17018619|NCT00670306|38163162|FG000|Overall Study|Withdrawal by Subject|9|||
16928336|NCT00474526|38071972|FG016|Overall Study|Death|0|||
16928337|NCT00474526|38071956|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928338|NCT00474526|38071957|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
16928339|NCT00474526|38071958|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928340|NCT00474526|38071959|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
16928341|NCT00474526|38071960|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
17018620|NCT00670306|38163162|FG000|Overall Study|Physician Decision|1|||
17018621|NCT00670306|38163162|FG000|Overall Study|Lost to Follow-up|8|||
17018622|NCT00670306|38163162|FG000|Overall Study|incl/excl criterias did not meet|19|||
17018623|NCT00672256|38163166|FG000|Overall Study|PI dropped, bad data|44|||
17018624|NCT00591630|38163174|FG000|Overall Study|Death|0|||
17018625|NCT00591630|38163175|FG001|Overall Study|Death|0|||
17018626|NCT00591630|38163176|FG002|Overall Study|Death|1|||
17018627|NCT00591630|38163177|FG003|Overall Study|Death|0|||
17018628|NCT00670228|38163189|FG000|Overall Study|Adverse Event|1|||
17018629|NCT00670228|38163190|FG001|Overall Study|Adverse Event|0|||
17018630|NCT00670228|38163189|FG000|Overall Study|Death or MACE|0|||
17018631|NCT00670228|38163190|FG001|Overall Study|Death or MACE|1|||
17018632|NCT00670228|38163189|FG000|Overall Study|Not treated|2|||
17018633|NCT00670228|38163190|FG001|Overall Study|Not treated|2|||
17018634|NCT00670228|38163189|FG000|Overall Study|Not meeting the selection criteria|2|||
17018635|NCT00670228|38163190|FG001|Overall Study|Not meeting the selection criteria|0|||
17018636|NCT00570778|38163196|FG000|Overall Study|Protocol deviation|2|||
17018637|NCT00570778|38163197|FG001|Overall Study|Protocol deviation|1|||
17018638|NCT00570778|38163198|FG002|Overall Study|Protocol deviation|2|||
16928342|NCT00474526|38071961|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928343|NCT00474526|38071962|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928344|NCT00474526|38071963|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928345|NCT00474526|38071964|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928346|NCT00474526|38071965|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928347|NCT00474526|38071966|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
17018639|NCT00570778|38163199|FG003|Overall Study|Protocol deviation|2|||
17018640|NCT00570778|38163196|FG000|Overall Study|Adverse Event|0|||
16928348|NCT00474526|38071967|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928349|NCT00474526|38071968|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928350|NCT00474526|38071969|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
16928351|NCT00474526|38071970|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
16928352|NCT00474526|38071971|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928353|NCT00474526|38071972|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16928354|NCT00474526|38071956|FG000|Overall Study|Lost to Follow-up|8|||
16928355|NCT00474526|38071957|FG001|Overall Study|Lost to Follow-up|6|||
16850775|NCT01468233|37798266|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
16850776|NCT01468233|37798267|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
16850777|NCT01468233|37798268|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
16850778|NCT01468233|37798263|FG000|Treatment Period 2|Lost to Follow-up|0|||
16850779|NCT01468233|37798264|FG001|Treatment Period 2|Lost to Follow-up|0|||
16850780|NCT01468233|37798265|FG002|Treatment Period 2|Lost to Follow-up|3|||
16850781|NCT01468233|37798266|FG003|Treatment Period 2|Lost to Follow-up|0|||
16850782|NCT01468233|37798267|FG004|Treatment Period 2|Lost to Follow-up|2|||
16850783|NCT01468233|37798268|FG005|Treatment Period 2|Lost to Follow-up|0|||
16850784|NCT01468233|37798263|FG000|Treatment Period 2|Other|0|||
16850785|NCT01468233|37798264|FG001|Treatment Period 2|Other|0|||
16850786|NCT01468233|37798265|FG002|Treatment Period 2|Other|3|||
16850787|NCT01468233|37798266|FG003|Treatment Period 2|Other|0|||
16850788|NCT01468233|37798267|FG004|Treatment Period 2|Other|1|||
16850789|NCT01468233|37798268|FG005|Treatment Period 2|Other|0|||
16850790|NCT01468077|37798288|FG000|Overall Study|Adverse Event|2|||
16850791|NCT01468077|37798289|FG001|Overall Study|Adverse Event|2|||
16850792|NCT01468077|37798288|FG000|Overall Study|Lack of Efficacy|1|||
16850793|NCT01468077|37798289|FG001|Overall Study|Lack of Efficacy|1|||
16850794|NCT01468077|37798288|FG000|Overall Study|Physician Decision|1|||
16850795|NCT01468077|37798289|FG001|Overall Study|Physician Decision|0|||
16850796|NCT01522365|37798297|FG000|Overall Study|Withdrawal by Subject|1|||
16850797|NCT01522365|37798298|FG001|Overall Study|Withdrawal by Subject|1|||
16850798|NCT01522365|37798297|FG000|Overall Study|Lost to Follow-up|1|||
16850799|NCT01522365|37798298|FG001|Overall Study|Lost to Follow-up|1|||
16850800|NCT01754402|37798308|FG000|Overall Study|Death|0|||
16850801|NCT01754402|37798309|FG001|Overall Study|Death|0|||
16850802|NCT01754402|37798310|FG002|Overall Study|Death|1|||
16850803|NCT01754402|37798308|FG000|Overall Study|Adverse Event|2|||
16850804|NCT01754402|37798309|FG001|Overall Study|Adverse Event|2|||
16850805|NCT01754402|37798310|FG002|Overall Study|Adverse Event|1|||
16850806|NCT01754402|37798308|FG000|Overall Study|Withdrawal by Subject|0|||
16850807|NCT01754402|37798309|FG001|Overall Study|Withdrawal by Subject|0|||
16850808|NCT01754402|37798310|FG002|Overall Study|Withdrawal by Subject|1|||
16850809|NCT01754402|37798308|FG000|Overall Study|Lack of Efficacy|0|||
16850810|NCT01754402|37798309|FG001|Overall Study|Lack of Efficacy|0|||
16850811|NCT01754402|37798310|FG002|Overall Study|Lack of Efficacy|1|||
16850812|NCT01783418|37798321|FG000|Overall Study|Withdrawal by Subject|1|||
16850813|NCT01783418|37798322|FG001|Overall Study|Withdrawal by Subject|0|||
16850814|NCT01521897|37798328|FG000|Overall Study|Protocol Violation|18|||
16850815|NCT01521897|37798328|FG000|Overall Study|Lost to Follow-up|5|||
16850816|NCT01782872|37798336|FG000|Overall Study|Protocol Violation|0|||
16850817|NCT01782872|37798337|FG001|Overall Study|Protocol Violation|0|||
16850818|NCT01782872|37798338|FG002|Overall Study|Protocol Violation|0|||
16850819|NCT01782872|37798339|FG003|Overall Study|Protocol Violation|1|||
16850820|NCT01782872|37798336|FG000|Overall Study|Withdrawal by Subject|0|||
16928356|NCT00474526|38071958|FG002|Overall Study|Lost to Follow-up|13|||
16928357|NCT00474526|38071959|FG003|Overall Study|Lost to Follow-up|29|||
16928358|NCT00474526|38071960|FG004|Overall Study|Lost to Follow-up|11|||
16928359|NCT00474526|38071961|FG005|Overall Study|Lost to Follow-up|5|||
16928360|NCT00474526|38071962|FG006|Overall Study|Lost to Follow-up|8|||
16928361|NCT00474526|38071963|FG007|Overall Study|Lost to Follow-up|1|||
16928362|NCT00474526|38071964|FG008|Overall Study|Lost to Follow-up|0|||
16928363|NCT00474526|38071965|FG009|Overall Study|Lost to Follow-up|6|||
16928364|NCT00474526|38071966|FG010|Overall Study|Lost to Follow-up|2|||
16928365|NCT00474526|38071967|FG011|Overall Study|Lost to Follow-up|4|||
16928366|NCT00474526|38071968|FG012|Overall Study|Lost to Follow-up|6|||
16928367|NCT00474526|38071969|FG013|Overall Study|Lost to Follow-up|74|||
16850821|NCT01782872|37798337|FG001|Overall Study|Withdrawal by Subject|1|||
16850822|NCT01782872|37798338|FG002|Overall Study|Withdrawal by Subject|0|||
16850823|NCT01782872|37798339|FG003|Overall Study|Withdrawal by Subject|0|||
16850824|NCT01490697|37798351|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
16850825|NCT01490697|37798352|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
16850826|NCT01728194|37798360|FG000|Overall Study|Lost to Follow-up|4|||
16850827|NCT01728194|37798361|FG001|Overall Study|Lost to Follow-up|3|||
16850828|NCT01728194|37798360|FG000|Overall Study|Physician Decision|4|||
16850829|NCT01728194|37798361|FG001|Overall Study|Physician Decision|0|||
16850830|NCT01728194|37798360|FG000|Overall Study|Withdrawal by Subject|7|||
16850831|NCT01728194|37798361|FG001|Overall Study|Withdrawal by Subject|3|||
16850832|NCT01728194|37798360|FG000|Overall Study|Perceived Medication Side Effects|4|||
16850833|NCT01728194|37798361|FG001|Overall Study|Perceived Medication Side Effects|0|||
16850834|NCT01728194|37798360|FG000|Overall Study|Family Member Request|1|||
16850835|NCT01728194|37798361|FG001|Overall Study|Family Member Request|0|||
16850836|NCT01782482|37798369|FG000|Overall Study|Adverse Event|2|||
16850837|NCT01782482|37798370|FG001|Overall Study|Adverse Event|1|||
16850838|NCT01782482|37798369|FG000|Overall Study|Lost to Follow-up|2|||
16850839|NCT01782482|37798370|FG001|Overall Study|Lost to Follow-up|3|||
16850840|NCT01782482|37798369|FG000|Overall Study|Physician Decision|1|||
16850841|NCT01782482|37798370|FG001|Overall Study|Physician Decision|0|||
16850842|NCT01782482|37798369|FG000|Overall Study|Protocol Violation|1|||
16850843|NCT01782482|37798370|FG001|Overall Study|Protocol Violation|0|||
16850844|NCT01782482|37798369|FG000|Overall Study|Withdrawal by Subject|2|||
16850845|NCT01782482|37798370|FG001|Overall Study|Withdrawal by Subject|3|||
16850846|NCT01782482|37798369|FG000|Overall Study|Randomized in Error|2|||
16850847|NCT01782482|37798370|FG001|Overall Study|Randomized in Error|2|||
16850848|NCT01782482|37798369|FG000|Overall Study|Habitually wearing toric lens OS|0|||
16850849|NCT01782482|37798370|FG001|Overall Study|Habitually wearing toric lens OS|1|||
16850850|NCT01466673|37798378|FG000|Overall Study|Non-compliance with study treatment|2|||
16850851|NCT01466673|37798379|FG001|Overall Study|Non-compliance with study treatment|0|||
16850852|NCT01466673|37798378|FG000|Overall Study|Lost to Follow-up|3|||
16850853|NCT01466673|37798379|FG001|Overall Study|Lost to Follow-up|5|||
16850854|NCT01466673|37798378|FG000|Overall Study|Adverse Event|2|||
16850855|NCT01466673|37798379|FG001|Overall Study|Adverse Event|1|||
16850856|NCT01753856|37798387|FG000|Overall Study|Adverse Event|1|||
17018641|NCT00570778|38163197|FG001|Overall Study|Adverse Event|1|||
17018642|NCT00570778|38163198|FG002|Overall Study|Adverse Event|4|||
17018643|NCT00570778|38163199|FG003|Overall Study|Adverse Event|1|||
17018644|NCT00570778|38163196|FG000|Overall Study|Subject withdrew consent|0|||
17018645|NCT00570778|38163197|FG001|Overall Study|Subject withdrew consent|1|||
17018646|NCT00570778|38163198|FG002|Overall Study|Subject withdrew consent|0|||
17018647|NCT00570778|38163199|FG003|Overall Study|Subject withdrew consent|1|||
17018648|NCT00570778|38163196|FG000|Overall Study|Abnormal test procedure|1|||
17018649|NCT00570778|38163197|FG001|Overall Study|Abnormal test procedure|0|||
17018650|NCT00570778|38163198|FG002|Overall Study|Abnormal test procedure|0|||
17018651|NCT00570778|38163199|FG003|Overall Study|Abnormal test procedure|0|||
17018652|NCT00570778|38163196|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17018653|NCT00570778|38163197|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17018654|NCT00570778|38163198|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
17018655|NCT00570778|38163199|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
17018656|NCT00570778|38163196|FG000|Overall Study|Lost to Follow-up|0|||
17018657|NCT00570778|38163197|FG001|Overall Study|Lost to Follow-up|0|||
17018658|NCT00570778|38163198|FG002|Overall Study|Lost to Follow-up|1|||
17018659|NCT00570778|38163199|FG003|Overall Study|Lost to Follow-up|0|||
17018660|NCT00570778|38163196|FG000|Overall Study|Subject no longer requires study drug|0|||
17018661|NCT00570778|38163197|FG001|Overall Study|Subject no longer requires study drug|1|||
17018662|NCT00570778|38163198|FG002|Overall Study|Subject no longer requires study drug|0|||
17018663|NCT00570778|38163199|FG003|Overall Study|Subject no longer requires study drug|0|||
17018664|NCT00668746|38163211|FG000|Overall Study|Lost to Follow-up|2|||
17018665|NCT00668746|38163212|FG001|Overall Study|Lost to Follow-up|1|||
17018666|NCT00878189|38163230|FG000|Overall Study|Death|0|||
17018667|NCT00878189|38163231|FG001|Overall Study|Death|1|||
17018668|NCT00878189|38163232|FG002|Overall Study|Death|0|||
17018669|NCT00878189|38163233|FG003|Overall Study|Death|1|||
17018670|NCT00878189|38163234|FG004|Overall Study|Death|0|||
17018671|NCT00878189|38163235|FG005|Overall Study|Death|0|||
17018672|NCT00878189|38163236|FG006|Overall Study|Death|0|||
17018673|NCT00878189|38163237|FG007|Overall Study|Death|0|||
17018674|NCT00878189|38163238|FG008|Overall Study|Death|1|||
17018675|NCT00878189|38163230|FG000|Overall Study|Participant Refused to Follow-up|0|||
17018676|NCT00878189|38163231|FG001|Overall Study|Participant Refused to Follow-up|0|||
17018677|NCT00878189|38163232|FG002|Overall Study|Participant Refused to Follow-up|0|||
17018678|NCT00878189|38163233|FG003|Overall Study|Participant Refused to Follow-up|0|||
16850857|NCT01753856|37798388|FG001|Overall Study|Adverse Event|0|||
16850858|NCT01753856|37798387|FG000|Overall Study|Withdrawal by Subject|0|||
16928368|NCT00474526|38071970|FG014|Overall Study|Lost to Follow-up|29|||
16928369|NCT00474526|38071971|FG015|Overall Study|Lost to Follow-up|4|||
16928370|NCT00474526|38071972|FG016|Overall Study|Lost to Follow-up|5|||
16928371|NCT00474526|38071956|FG000|Overall Study|Protocol Violation|2|||
16928372|NCT00474526|38071957|FG001|Overall Study|Protocol Violation|6|||
16928373|NCT00474526|38071958|FG002|Overall Study|Protocol Violation|4|||
16928374|NCT00474526|38071959|FG003|Overall Study|Protocol Violation|12|||
16928375|NCT00474526|38071960|FG004|Overall Study|Protocol Violation|3|||
16928376|NCT00474526|38071961|FG005|Overall Study|Protocol Violation|1|||
16928377|NCT00474526|38071962|FG006|Overall Study|Protocol Violation|3|||
16928378|NCT00474526|38071963|FG007|Overall Study|Protocol Violation|0|||
17018679|NCT00878189|38163234|FG004|Overall Study|Participant Refused to Follow-up|0|||
17018680|NCT00878189|38163235|FG005|Overall Study|Participant Refused to Follow-up|4|||
16850859|NCT01753856|37798388|FG001|Overall Study|Withdrawal by Subject|2|||
16850860|NCT01753856|37798387|FG000|Overall Study|Sponsor Decision|2|||
16850861|NCT01753856|37798388|FG001|Overall Study|Sponsor Decision|0|||
16850862|NCT01464333|37798397|FG000|Overall Study|Adverse Event|34|||
16850863|NCT01464333|37798397|FG000|Overall Study|Lack of Efficacy|72|||
16850864|NCT01464333|37798397|FG000|Overall Study|Withdrawal by Subject|11|||
16850865|NCT01464333|37798397|FG000|Overall Study|Other|4|||
16850866|NCT01464333|37798397|FG000|Overall Study|No Hospital Visit|42|||
16850867|NCT01464255|37798403|FG000|Overall Study|unresolve corneal staining|0|||
16850868|NCT01464255|37798404|FG001|Overall Study|unresolve corneal staining|1|||
16850869|NCT01464021|37798411|FG000|Overall Study|Withdrawal by Subject|13|||
16850870|NCT01464021|37798411|FG000|Overall Study|Lost to Follow-up|1|||
16850871|NCT01464021|37798411|FG000|Overall Study|Lack of Efficacy|1|||
16850872|NCT01464021|37798411|FG000|Overall Study|various|11|||
16850873|NCT01753310|37798417|FG000|Overall Study|Entered into open label extension study|25|||
16850874|NCT01753310|37798418|FG001|Overall Study|Entered into open label extension study|22|||
16850875|NCT01753310|37798417|FG000|Overall Study|Adverse Event|1|||
16928379|NCT00474526|38071964|FG008|Overall Study|Protocol Violation|0|||
16928380|NCT00474526|38071965|FG009|Overall Study|Protocol Violation|4|||
16928381|NCT00474526|38071966|FG010|Overall Study|Protocol Violation|2|||
16928382|NCT00474526|38071967|FG011|Overall Study|Protocol Violation|2|||
16928383|NCT00474526|38071968|FG012|Overall Study|Protocol Violation|4|||
16928384|NCT00474526|38071969|FG013|Overall Study|Protocol Violation|19|||
16850876|NCT01753310|37798418|FG001|Overall Study|Adverse Event|0|||
16850877|NCT01753310|37798417|FG000|Overall Study|Lost to Follow-up|2|||
16850878|NCT01753310|37798418|FG001|Overall Study|Lost to Follow-up|0|||
16850879|NCT01753310|37798417|FG000|Overall Study|Subject decision|2|||
16850880|NCT01753310|37798418|FG001|Overall Study|Subject decision|2|||
16850881|NCT01753310|37798417|FG000|Overall Study|Sponsor decision|1|||
16850882|NCT01753310|37798418|FG001|Overall Study|Sponsor decision|0|||
16850883|NCT01753310|37798417|FG000|Overall Study|Withdrawal by Subject|1|||
16850884|NCT01753310|37798418|FG001|Overall Study|Withdrawal by Subject|0|||
16850885|NCT01463631|37798428|FG000|Overall Study|Withdrawal by Subject|0|||
16850886|NCT01463631|37798429|FG001|Overall Study|Withdrawal by Subject|0|||
16850887|NCT01463631|37798430|FG002|Overall Study|Withdrawal by Subject|0|||
16850888|NCT01463631|37798431|FG003|Overall Study|Withdrawal by Subject|1|||
16850889|NCT01463631|37798428|FG000|Overall Study|Death|0|||
16850890|NCT01463631|37798429|FG001|Overall Study|Death|0|||
16850891|NCT01463631|37798430|FG002|Overall Study|Death|1|||
16850892|NCT01463631|37798431|FG003|Overall Study|Death|0|||
16850893|NCT01463631|37798428|FG000|Overall Study|Progressive Disease|0|||
16928385|NCT00474526|38071970|FG014|Overall Study|Protocol Violation|9|||
16928386|NCT00474526|38071971|FG015|Overall Study|Protocol Violation|6|||
16928387|NCT00474526|38071972|FG016|Overall Study|Protocol Violation|2|||
16928388|NCT00474526|38071956|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
17018681|NCT00878189|38163236|FG006|Overall Study|Participant Refused to Follow-up|0|||
17018682|NCT00878189|38163237|FG007|Overall Study|Participant Refused to Follow-up|0|||
17018683|NCT00878189|38163238|FG008|Overall Study|Participant Refused to Follow-up|0|||
16928389|NCT00474526|38071957|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
16928390|NCT00474526|38071958|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
16928391|NCT00474526|38071959|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
16928392|NCT00474526|38071960|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
16928393|NCT00474526|38071961|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
16928394|NCT00474526|38071962|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
16928395|NCT00474526|38071963|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
16928396|NCT00474526|38071964|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
16928397|NCT00474526|38071965|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
16928398|NCT00474526|38071966|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
16928399|NCT00474526|38071967|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
16928400|NCT00474526|38071968|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
16928401|NCT00474526|38071969|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
16928402|NCT00474526|38071970|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
16928403|NCT00474526|38071971|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
16928404|NCT00474526|38071972|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
17018684|NCT00878189|38163230|FG000|Overall Study|Other|3|||
17018685|NCT00878189|38163231|FG001|Overall Study|Other|2|||
17018686|NCT00878189|38163232|FG002|Overall Study|Other|4|||
17018687|NCT00878189|38163233|FG003|Overall Study|Other|7|||
17018688|NCT00878189|38163234|FG004|Overall Study|Other|4|||
17018689|NCT00878189|38163235|FG005|Overall Study|Other|18|||
17018690|NCT00878189|38163236|FG006|Overall Study|Other|15|||
17018691|NCT00878189|38163237|FG007|Overall Study|Other|3|||
17018692|NCT00878189|38163238|FG008|Overall Study|Other|4|||
16850894|NCT01463631|37798429|FG001|Overall Study|Progressive Disease|0|||
16850895|NCT01463631|37798430|FG002|Overall Study|Progressive Disease|0|||
16850896|NCT01463631|37798431|FG003|Overall Study|Progressive Disease|5|||
16928405|NCT00474526|38071956|FG000|Overall Study|Withdrawal by Subject|9|||
16928406|NCT00474526|38071957|FG001|Overall Study|Withdrawal by Subject|24|||
17018693|NCT00878189|38163230|FG000|Overall Study|Lost to Follow-up|0|||
17018694|NCT00878189|38163231|FG001|Overall Study|Lost to Follow-up|0|||
16850897|NCT01521507|37798445|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
16850898|NCT01521507|37798446|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
16850899|NCT01521507|37798445|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
16850900|NCT01521507|37798446|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
16850901|NCT01521507|37798445|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
16850902|NCT01521507|37798446|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
16850903|NCT01521507|37798445|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
17018695|NCT00878189|38163232|FG002|Overall Study|Lost to Follow-up|0|||
17018696|NCT00878189|38163233|FG003|Overall Study|Lost to Follow-up|0|||
17018697|NCT00878189|38163234|FG004|Overall Study|Lost to Follow-up|0|||
17018698|NCT00878189|38163235|FG005|Overall Study|Lost to Follow-up|1|||
17018699|NCT00878189|38163236|FG006|Overall Study|Lost to Follow-up|1|||
17018700|NCT00878189|38163237|FG007|Overall Study|Lost to Follow-up|0|||
17018701|NCT00878189|38163238|FG008|Overall Study|Lost to Follow-up|0|||
17018702|NCT00878189|38163230|FG000|Overall Study|Objection Progression or Relapse|0|||
17018703|NCT00878189|38163231|FG001|Overall Study|Objection Progression or Relapse|0|||
17018704|NCT00878189|38163232|FG002|Overall Study|Objection Progression or Relapse|0|||
17018705|NCT00878189|38163233|FG003|Overall Study|Objection Progression or Relapse|0|||
17018706|NCT00878189|38163234|FG004|Overall Study|Objection Progression or Relapse|0|||
17018707|NCT00878189|38163235|FG005|Overall Study|Objection Progression or Relapse|0|||
17018708|NCT00878189|38163236|FG006|Overall Study|Objection Progression or Relapse|0|||
17018709|NCT00878189|38163237|FG007|Overall Study|Objection Progression or Relapse|0|||
17018710|NCT00878189|38163238|FG008|Overall Study|Objection Progression or Relapse|3|||
17018711|NCT00668200|38163272|FG000|Overall Study|Withdrawal by Subject|2|||
17018712|NCT00668200|38163272|FG000|Overall Study|Lost to Follow-up|1|||
17018713|NCT00838578|38163276|FG000|Overall Study|Protocol Violation|2|||
17018714|NCT00829296|38163286|FG000|Overall Study|Adverse Event|5|||
17018715|NCT00829296|38163287|FG001|Overall Study|Adverse Event|4|||
16928407|NCT00474526|38071958|FG002|Overall Study|Withdrawal by Subject|21|||
16928408|NCT00474526|38071959|FG003|Overall Study|Withdrawal by Subject|52|||
16928409|NCT00474526|38071960|FG004|Overall Study|Withdrawal by Subject|38|||
16928410|NCT00474526|38071961|FG005|Overall Study|Withdrawal by Subject|6|||
16928411|NCT00474526|38071962|FG006|Overall Study|Withdrawal by Subject|12|||
16928412|NCT00474526|38071963|FG007|Overall Study|Withdrawal by Subject|4|||
16928413|NCT00474526|38071964|FG008|Overall Study|Withdrawal by Subject|4|||
16928414|NCT00474526|38071965|FG009|Overall Study|Withdrawal by Subject|13|||
16928415|NCT00474526|38071966|FG010|Overall Study|Withdrawal by Subject|5|||
16928416|NCT00474526|38071967|FG011|Overall Study|Withdrawal by Subject|4|||
16928417|NCT00474526|38071968|FG012|Overall Study|Withdrawal by Subject|4|||
16928418|NCT00474526|38071969|FG013|Overall Study|Withdrawal by Subject|37|||
16928419|NCT00474526|38071970|FG014|Overall Study|Withdrawal by Subject|22|||
16928420|NCT00474526|38071971|FG015|Overall Study|Withdrawal by Subject|1|||
16928421|NCT00474526|38071972|FG016|Overall Study|Withdrawal by Subject|1|||
16928422|NCT00478426|38072058|FG000|Overall Study|Withdrawal by Subject|1|||
16928423|NCT00477412|38072066|FG000|Overall Study|Death|0|||
16928424|NCT00477412|38072067|FG001|Overall Study|Death|0|||
16928425|NCT00477412|38072068|FG002|Overall Study|Death|0|||
16928426|NCT00477412|38072069|FG003|Overall Study|Death|4|||
16928427|NCT00477412|38072066|FG000|Overall Study|Lost to Follow-up|0|||
16928428|NCT00477412|38072067|FG001|Overall Study|Lost to Follow-up|0|||
16928429|NCT00477412|38072068|FG002|Overall Study|Lost to Follow-up|0|||
16928430|NCT00477412|38072069|FG003|Overall Study|Lost to Follow-up|1|||
16928431|NCT00477412|38072066|FG000|Overall Study|Withdrawal by Subject|0|||
16928432|NCT00477412|38072067|FG001|Overall Study|Withdrawal by Subject|0|||
16928433|NCT00477412|38072068|FG002|Overall Study|Withdrawal by Subject|0|||
16928434|NCT00477412|38072069|FG003|Overall Study|Withdrawal by Subject|2|||
16928435|NCT00477412|38072066|FG000|Overall Study|Second Malignancy|0|||
16928436|NCT00477412|38072067|FG001|Overall Study|Second Malignancy|0|||
16928437|NCT00477412|38072068|FG002|Overall Study|Second Malignancy|0|||
16928438|NCT00477412|38072069|FG003|Overall Study|Second Malignancy|1|||
16928439|NCT00477412|38072066|FG000|Overall Study|Adverse Event|1|||
16928440|NCT00477412|38072067|FG001|Overall Study|Adverse Event|0|||
16928441|NCT00477412|38072068|FG002|Overall Study|Adverse Event|1|||
16928442|NCT00477412|38072069|FG003|Overall Study|Adverse Event|0|||
16928443|NCT01089556|38072079|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
16928444|NCT01089556|38072080|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
16928445|NCT01089556|38072081|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
16928446|NCT01089556|38072082|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
16928447|NCT01089556|38072083|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
16928448|NCT01089556|38072084|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
16928449|NCT01089556|38072079|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
16928450|NCT01089556|38072080|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
16928451|NCT01089556|38072081|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
16928452|NCT01089556|38072082|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
16928453|NCT01089556|38072083|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
16850904|NCT01521507|37798446|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
16850905|NCT01521507|37798445|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
16850906|NCT01521507|37798446|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
16850907|NCT01521507|37798445|FG000|Stage 2: Observational Design|Physician Decision|1|||
16850908|NCT01521507|37798446|FG001|Stage 2: Observational Design|Physician Decision|0|||
16850909|NCT01521117|37798459|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
16850910|NCT01521117|37798460|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
16850911|NCT01521117|37798459|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
16850912|NCT01521117|37798460|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
16928454|NCT01089556|38072084|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
16928455|NCT01089556|38072079|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
16928456|NCT01089556|38072080|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
16928457|NCT01089556|38072081|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
16928458|NCT01089556|38072082|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
16928459|NCT01089556|38072083|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
16928460|NCT01089556|38072084|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
16928461|NCT01089556|38072079|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16928462|NCT01089556|38072080|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
16928463|NCT01089556|38072081|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16928464|NCT01089556|38072082|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16928465|NCT01089556|38072083|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16928466|NCT01089556|38072084|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16928467|NCT01089556|38072079|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
16928468|NCT01089556|38072080|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
16928469|NCT01089556|38072081|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
16928470|NCT01089556|38072082|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
16928471|NCT01089556|38072083|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
16928472|NCT01089556|38072084|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
16928473|NCT01089556|38072079|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
16928474|NCT01089556|38072080|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
16928475|NCT01089556|38072081|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
16928476|NCT01089556|38072082|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
16928477|NCT01089556|38072083|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
16928478|NCT01089556|38072084|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
16928479|NCT01089556|38072079|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
16928480|NCT01089556|38072080|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
16928481|NCT01089556|38072081|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
16928482|NCT01089556|38072082|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
16928483|NCT01089556|38072083|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
16928484|NCT01089556|38072084|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
16928485|NCT01089556|38072079|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
16928486|NCT01089556|38072080|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
16928487|NCT01089556|38072081|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
16928488|NCT01089556|38072082|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
16928489|NCT01089556|38072083|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
16928490|NCT01089556|38072084|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
16928491|NCT01089556|38072079|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
16928492|NCT01089556|38072080|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
16928493|NCT01089556|38072081|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
16928494|NCT01089556|38072082|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
16928495|NCT01089556|38072083|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
16928496|NCT01089556|38072084|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
16928497|NCT01089556|38072079|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
16928498|NCT01089556|38072080|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
16928499|NCT01089556|38072081|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
16928500|NCT01089556|38072082|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
16928501|NCT01089556|38072083|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
16928502|NCT01089556|38072084|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
16928503|NCT01089556|38072079|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
16928504|NCT01089556|38072080|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
16928505|NCT01089556|38072081|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
16928506|NCT01089556|38072082|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
16928507|NCT01089556|38072083|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
16928508|NCT01089556|38072084|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
16928509|NCT01089556|38072079|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16928510|NCT01089556|38072080|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16928511|NCT01089556|38072081|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
16928512|NCT01089556|38072082|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16928513|NCT01089556|38072083|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16850913|NCT01521117|37798459|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
16850914|NCT01521117|37798460|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
16850915|NCT01466595|37798468|FG000|Overall Study|Withdrawal by Subject|0|||
16850916|NCT01466595|37798469|FG001|Overall Study|Withdrawal by Subject|1|||
16850917|NCT01728116|37798486|FG000|Overall Study|Sponsor Terminated Study|106|||
16850918|NCT01728116|37798487|FG001|Overall Study|Sponsor Terminated Study|35|||
16850919|NCT01728116|37798486|FG000|Overall Study|Withdrawal by Subject|16|||
16850920|NCT01728116|37798487|FG001|Overall Study|Withdrawal by Subject|9|||
16850921|NCT01728116|37798486|FG000|Overall Study|Adverse Event|13|||
16850922|NCT01728116|37798487|FG001|Overall Study|Adverse Event|0|||
16850923|NCT01728116|37798486|FG000|Overall Study|Procedure/device failure|7|||
16850924|NCT01728116|37798487|FG001|Overall Study|Procedure/device failure|0|||
16850925|NCT01728116|37798486|FG000|Overall Study|Lost to Follow-up|9|||
16850926|NCT01728116|37798487|FG001|Overall Study|Lost to Follow-up|2|||
16850927|NCT01728116|37798486|FG000|Overall Study|Physician Decision|2|||
16850928|NCT01728116|37798487|FG001|Overall Study|Physician Decision|0|||
16928514|NCT01089556|38072084|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16928515|NCT01089556|38072079|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
16928516|NCT01089556|38072080|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
16928517|NCT01089556|38072081|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
16928518|NCT01089556|38072082|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
16928519|NCT01089556|38072083|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
16850929|NCT01728116|37798486|FG000|Overall Study|Subject Non-Compliance|2|||
16928520|NCT01089556|38072084|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
16928521|NCT01089556|38072079|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
16928522|NCT01089556|38072080|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
16928523|NCT01089556|38072081|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
16928524|NCT01089556|38072082|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
16928525|NCT01089556|38072083|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
16928526|NCT01089556|38072084|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
16928527|NCT01089556|38072079|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
16928528|NCT01089556|38072080|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
16928529|NCT01089556|38072081|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
16928530|NCT01089556|38072082|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
16928531|NCT01089556|38072083|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
16928532|NCT01089556|38072084|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
16928533|NCT01089127|38072102|FG000|Overall Study|Adverse Event|5|||
16928534|NCT01089127|38072103|FG001|Overall Study|Adverse Event|1|||
16928535|NCT01089127|38072104|FG002|Overall Study|Adverse Event|1|||
16928536|NCT01089127|38072105|FG003|Overall Study|Adverse Event|0|||
16928537|NCT01089127|38072106|FG004|Overall Study|Adverse Event|0|||
16928538|NCT01089127|38072107|FG005|Overall Study|Adverse Event|1|||
16928539|NCT01089127|38072102|FG000|Overall Study|Subject withdrew consent|0|||
16928540|NCT01089127|38072103|FG001|Overall Study|Subject withdrew consent|1|||
16928541|NCT01089127|38072104|FG002|Overall Study|Subject withdrew consent|1|||
16928542|NCT01089127|38072105|FG003|Overall Study|Subject withdrew consent|1|||
16928543|NCT01089127|38072106|FG004|Overall Study|Subject withdrew consent|0|||
16928544|NCT01089127|38072107|FG005|Overall Study|Subject withdrew consent|2|||
16928545|NCT01089127|38072102|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16928546|NCT01089127|38072103|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16928547|NCT01089127|38072104|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16928548|NCT01089127|38072105|FG003|Overall Study|Abnormal test procedure result(s)|0|||
16928549|NCT01089127|38072106|FG004|Overall Study|Abnormal test procedure result(s)|0|||
16928550|NCT01089127|38072107|FG005|Overall Study|Abnormal test procedure result(s)|0|||
16928551|NCT01089127|38072102|FG000|Overall Study|Lost to Follow-up|1|||
16928552|NCT01089127|38072103|FG001|Overall Study|Lost to Follow-up|1|||
16928553|NCT01089127|38072104|FG002|Overall Study|Lost to Follow-up|0|||
16928554|NCT01089127|38072105|FG003|Overall Study|Lost to Follow-up|0|||
16928555|NCT01089127|38072106|FG004|Overall Study|Lost to Follow-up|1|||
16928556|NCT01089127|38072107|FG005|Overall Study|Lost to Follow-up|0|||
16928557|NCT01089127|38072102|FG000|Overall Study|Protocol deviation|0|||
16928558|NCT01089127|38072103|FG001|Overall Study|Protocol deviation|1|||
16928559|NCT01089127|38072104|FG002|Overall Study|Protocol deviation|0|||
16928560|NCT01089127|38072105|FG003|Overall Study|Protocol deviation|0|||
16928561|NCT01089127|38072106|FG004|Overall Study|Protocol deviation|1|||
16928562|NCT01089127|38072107|FG005|Overall Study|Protocol deviation|0|||
16928563|NCT01087957|38072123|FG000|Overall Study|Death|2|||
16928564|NCT01087957|38072124|FG001|Overall Study|Death|2|||
16928565|NCT01087957|38072123|FG000|Overall Study|Lost to Follow-up|3|||
16928566|NCT01087957|38072124|FG001|Overall Study|Lost to Follow-up|4|||
16928567|NCT01087957|38072123|FG000|Overall Study|Protocol Violation|13|||
16928568|NCT01087957|38072124|FG001|Overall Study|Protocol Violation|25|||
16928569|NCT01087957|38072123|FG000|Overall Study|Withdrawal by Subject|18|||
17018716|NCT00881621|38163293|FG000|Overall Study|Physician Decision|34|||
16850930|NCT01728116|37798487|FG001|Overall Study|Subject Non-Compliance|0|||
16928570|NCT01087957|38072124|FG001|Overall Study|Withdrawal by Subject|15|||
16928571|NCT01087957|38072123|FG000|Overall Study|Physician Decision|5|||
16850931|NCT01728116|37798486|FG000|Overall Study|Inter-current finding at procedure|1|||
16850932|NCT01728116|37798487|FG001|Overall Study|Inter-current finding at procedure|0|||
16850933|NCT01728116|37798486|FG000|Overall Study|Incorrectly enrolled in Study|0|||
16850934|NCT01728116|37798487|FG001|Overall Study|Incorrectly enrolled in Study|1|||
16850935|NCT01728116|37798486|FG000|Overall Study|various not noted previously|5|||
16850936|NCT01728116|37798487|FG001|Overall Study|various not noted previously|0|||
16850937|NCT01465659|37798498|FG000|Completed 1 Cycle of Treatment|Death|0|||
16850938|NCT01465659|37798499|FG001|Completed 1 Cycle of Treatment|Death|1|||
16850939|NCT01465659|37798500|FG002|Completed 1 Cycle of Treatment|Death|0|||
16850940|NCT01465659|37798501|FG003|Completed 1 Cycle of Treatment|Death|0|||
16850941|NCT01465659|37798498|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
16850942|NCT01465659|37798499|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
16850943|NCT01465659|37798500|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
16928572|NCT01087957|38072124|FG001|Overall Study|Physician Decision|9|||
16928573|NCT01087723|38072132|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
16928574|NCT01087723|38072133|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
16928575|NCT01087723|38072132|FG000|Overall Study|Withdrawal by Subject|10|||
16928576|NCT01087723|38072133|FG001|Overall Study|Withdrawal by Subject|13|||
16928577|NCT01087723|38072132|FG000|Overall Study|Physician Decision|2|||
16928578|NCT01087723|38072133|FG001|Overall Study|Physician Decision|0|||
16928579|NCT01087723|38072132|FG000|Overall Study|Lost to Follow-up|1|||
16928580|NCT01087723|38072133|FG001|Overall Study|Lost to Follow-up|4|||
16928581|NCT01087723|38072132|FG000|Overall Study|Reason Not Specified|1|||
16928582|NCT01087723|38072133|FG001|Overall Study|Reason Not Specified|2|||
16928583|NCT01087528|38072139|FG000|Overall Study|Withdrawal by Subject|1|||
16928584|NCT01087528|38072139|FG000|Overall Study|Incomplete CE procedure|6|||
16928585|NCT01085812|38072145|FG000|Open-Label Period|Adverse Event|0|||
16850944|NCT01465659|37798501|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
16850945|NCT01465659|37798498|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
16850946|NCT01465659|37798499|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
16850947|NCT01465659|37798500|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
16928586|NCT01085812|38072146|FG001|Open-Label Period|Adverse Event|80|||
16928587|NCT01085812|38072145|FG000|Open-Label Period|Lack of Efficacy|0|||
16928588|NCT01085812|38072146|FG001|Open-Label Period|Lack of Efficacy|26|||
16928589|NCT01085812|38072145|FG000|Open-Label Period|Protocol Violation|0|||
16928590|NCT01085812|38072146|FG001|Open-Label Period|Protocol Violation|39|||
16928591|NCT01085812|38072145|FG000|Open-Label Period|Withdrawal by Subject|0|||
16928592|NCT01085812|38072146|FG001|Open-Label Period|Withdrawal by Subject|53|||
16928593|NCT01085812|38072145|FG000|Open-Label Period|Lost to Follow-up|0|||
16928594|NCT01085812|38072146|FG001|Open-Label Period|Lost to Follow-up|42|||
16850948|NCT01465659|37798501|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
16850949|NCT01465659|37798498|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
16850950|NCT01465659|37798499|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
16850951|NCT01465659|37798500|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
16850952|NCT01465659|37798501|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
16850953|NCT01465659|37798498|FG000|Completed Follow for 1 Year|Death|6|||
16850954|NCT01465659|37798499|FG001|Completed Follow for 1 Year|Death|3|||
16850955|NCT01465659|37798500|FG002|Completed Follow for 1 Year|Death|2|||
16850956|NCT01465659|37798501|FG003|Completed Follow for 1 Year|Death|4|||
16850957|NCT01753076|37798516|FG000|Overall Study|Adverse Event|17|||
16850958|NCT01753076|37798517|FG001|Overall Study|Adverse Event|18|||
16850959|NCT01753076|37798516|FG000|Overall Study|Lack of Efficacy|3|||
16850960|NCT01753076|37798517|FG001|Overall Study|Lack of Efficacy|1|||
16850961|NCT01753076|37798516|FG000|Overall Study|Lost to Follow-up|2|||
16850962|NCT01753076|37798517|FG001|Overall Study|Lost to Follow-up|1|||
16850963|NCT01753076|37798516|FG000|Overall Study|Physician Decision|4|||
16928595|NCT01085812|38072145|FG000|Double-Blind Period|Adverse Event|3|||
16928596|NCT01085812|38072146|FG001|Double-Blind Period|Adverse Event|8|||
16928597|NCT01085812|38072145|FG000|Double-Blind Period|Protocol Violation|2|||
16928598|NCT01085812|38072146|FG001|Double-Blind Period|Protocol Violation|7|||
16928599|NCT01085812|38072145|FG000|Double-Blind Period|Withdrawal by Subject|11|||
16928600|NCT01085812|38072146|FG001|Double-Blind Period|Withdrawal by Subject|24|||
16928601|NCT01085812|38072145|FG000|Double-Blind Period|Lost to Follow-up|5|||
16928602|NCT01085812|38072146|FG001|Double-Blind Period|Lost to Follow-up|17|||
16928603|NCT01085812|38072145|FG000|Double-Blind Period|Other Reasons|0|||
16928604|NCT01085812|38072146|FG001|Double-Blind Period|Other Reasons|2|||
16928605|NCT01085812|38072145|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
16928606|NCT01085812|38072146|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
16928607|NCT01085812|38072145|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
16928608|NCT01085812|38072146|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
16928609|NCT01085812|38072145|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
16928610|NCT01085812|38072146|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
16928611|NCT01085812|38072145|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
16928612|NCT01085812|38072146|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
16928613|NCT01085812|38072145|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
16928614|NCT01085812|38072146|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
16928615|NCT01085734|38072155|FG000|Overall Study|Adverse Event|0|||
16928616|NCT01085734|38072156|FG001|Overall Study|Adverse Event|2|||
16928617|NCT01085734|38072155|FG000|Overall Study|Death|1|||
16928618|NCT01085734|38072156|FG001|Overall Study|Death|0|||
16928619|NCT01085734|38072155|FG000|Overall Study|Lost to Follow-up|0|||
16928620|NCT01085734|38072156|FG001|Overall Study|Lost to Follow-up|1|||
16928621|NCT01085734|38072155|FG000|Overall Study|Withdrawal by Subject|0|||
16928622|NCT01085734|38072156|FG001|Overall Study|Withdrawal by Subject|1|||
16928623|NCT01084603|38072163|FG000|Baseline|Withdrawal by Subject|2|||
16928624|NCT01084603|38072163|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
16928625|NCT01084603|38072163|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
16928626|NCT01084603|38072163|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
16928627|NCT01084603|38072163|FG000|Washout Period 4|Adverse Event|1|||
16928628|NCT01084174|38072178|FG000|Overall Study|gastrointestinal symptoms|1|||
16928629|NCT01084174|38072179|FG001|Overall Study|gastrointestinal symptoms|1|||
16928630|NCT01084174|38072178|FG000|Overall Study|Eosinophilic esophagitis|0|||
16928631|NCT01084174|38072179|FG001|Overall Study|Eosinophilic esophagitis|1|||
16928632|NCT01084174|38072178|FG000|Overall Study|Anaphylaxis|0|||
16928633|NCT01084174|38072179|FG001|Overall Study|Anaphylaxis|1|||
16928634|NCT01084174|38072178|FG000|Overall Study|Participant noncompliance|0|||
16928635|NCT01084174|38072179|FG001|Overall Study|Participant noncompliance|1|||
16928636|NCT01084135|38072189|FG000|20 Week|Physician Decision|0|||
16928637|NCT01084135|38072190|FG001|20 Week|Physician Decision|1|||
16928638|NCT01083316|38072198|FG000|Overall Study|Adverse Event|2|||
16928639|NCT01083316|38072198|FG000|Overall Study|Withdrawal by Subject|1|||
16928640|NCT01083160|38072203|FG000|Overall Study|Adverse Event|1|||
16928641|NCT01083121|38072207|FG000|Overall Study|Use of Humira outside the approved label|81|||
16928642|NCT01082614|38072217|FG000|Overall Study|Adverse Event|1|||
16928643|NCT01082614|38072218|FG001|Overall Study|Adverse Event|4|||
16928644|NCT01082614|38072217|FG000|Overall Study|Equipment Malfunction|0|||
16928645|NCT01082614|38072218|FG001|Overall Study|Equipment Malfunction|1|||
16928646|NCT01082614|38072217|FG000|Overall Study|Physician Decision|2|||
16928647|NCT01082614|38072218|FG001|Overall Study|Physician Decision|0|||
16928648|NCT01081873|38072224|FG000|Overall Study|Death|86|||
16928649|NCT01081873|38072224|FG000|Overall Study|Withdrawal by Subject|10|||
16928650|NCT01081873|38072224|FG000|Overall Study|Lost to Follow-up|142|||
16928651|NCT01081873|38072224|FG000|Overall Study|Progression of prostate cancer|13|||
16928652|NCT01081873|38072224|FG000|Overall Study|Other|47|||
16928653|NCT01081795|38072256|FG000|Overall Study|Adverse Event|18|||
16928654|NCT01081795|38072257|FG001|Overall Study|Adverse Event|23|||
16928655|NCT01081795|38072258|FG002|Overall Study|Adverse Event|6|||
16928656|NCT01081795|38072256|FG000|Overall Study|Lack of Efficacy|7|||
16928657|NCT01081795|38072257|FG001|Overall Study|Lack of Efficacy|5|||
16928658|NCT01081795|38072258|FG002|Overall Study|Lack of Efficacy|19|||
16928659|NCT01081795|38072256|FG000|Overall Study|Subject's schedule|1|||
16928660|NCT01081795|38072257|FG001|Overall Study|Subject's schedule|1|||
16928661|NCT01081795|38072258|FG002|Overall Study|Subject's schedule|2|||
16928662|NCT01081795|38072256|FG000|Overall Study|Revocation of informed consent|2|||
16928663|NCT01081795|38072257|FG001|Overall Study|Revocation of informed consent|0|||
16928664|NCT01081795|38072258|FG002|Overall Study|Revocation of informed consent|0|||
16928665|NCT01081795|38072256|FG000|Overall Study|Ineligible for participation|1|||
16928666|NCT01081795|38072257|FG001|Overall Study|Ineligible for participation|0|||
16928667|NCT01081795|38072258|FG002|Overall Study|Ineligible for participation|0|||
16928668|NCT01081795|38072256|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
16928669|NCT01081795|38072257|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
16928670|NCT01081795|38072258|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
16928671|NCT01081795|38072256|FG000|Overall Study|Using drug with restricted days of use|2|||
16928672|NCT01081795|38072257|FG001|Overall Study|Using drug with restricted days of use|3|||
16928673|NCT01081795|38072258|FG002|Overall Study|Using drug with restricted days of use|2|||
16928674|NCT01081795|38072256|FG000|Overall Study|Other|1|||
16928675|NCT01081795|38072257|FG001|Overall Study|Other|2|||
16928676|NCT01081795|38072258|FG002|Overall Study|Other|0|||
16928677|NCT01081678|38072270|FG000|Overall Study|Ineligibility Determined|0|||
16928678|NCT01081678|38072271|FG001|Overall Study|Ineligibility Determined|0|||
16928679|NCT01081678|38072272|FG002|Overall Study|Ineligibility Determined|1|||
16928680|NCT01081678|38072273|FG003|Overall Study|Ineligibility Determined|1|||
16928681|NCT01081678|38072270|FG000|Overall Study|Noncompliance|3|||
16928682|NCT01081678|38072271|FG001|Overall Study|Noncompliance|4|||
16928683|NCT01081678|38072272|FG002|Overall Study|Noncompliance|5|||
16928684|NCT01081678|38072273|FG003|Overall Study|Noncompliance|2|||
16928685|NCT01081678|38072270|FG000|Overall Study|Adverse Event|2|||
16928686|NCT01081678|38072271|FG001|Overall Study|Adverse Event|1|||
16928687|NCT01081678|38072272|FG002|Overall Study|Adverse Event|2|||
16928688|NCT01081678|38072273|FG003|Overall Study|Adverse Event|2|||
16928689|NCT01081678|38072270|FG000|Overall Study|Withdrawal by Subject|15|||
16928690|NCT01081678|38072271|FG001|Overall Study|Withdrawal by Subject|7|||
16928691|NCT01081678|38072272|FG002|Overall Study|Withdrawal by Subject|17|||
16928692|NCT01081678|38072273|FG003|Overall Study|Withdrawal by Subject|14|||
16928693|NCT01081678|38072270|FG000|Overall Study|Administrative Decision|1|||
16928694|NCT01081678|38072271|FG001|Overall Study|Administrative Decision|0|||
16928695|NCT01081678|38072272|FG002|Overall Study|Administrative Decision|0|||
16928696|NCT01081678|38072273|FG003|Overall Study|Administrative Decision|1|||
16928697|NCT01081678|38072270|FG000|Overall Study|Lost to Follow-up|4|||
16928698|NCT01081678|38072271|FG001|Overall Study|Lost to Follow-up|1|||
16928699|NCT01081678|38072272|FG002|Overall Study|Lost to Follow-up|4|||
16928700|NCT01081678|38072273|FG003|Overall Study|Lost to Follow-up|3|||
16928701|NCT01081678|38072270|FG000|Overall Study|Death|2|||
16928702|NCT01081678|38072271|FG001|Overall Study|Death|2|||
16928703|NCT01081678|38072272|FG002|Overall Study|Death|2|||
16928704|NCT01081678|38072273|FG003|Overall Study|Death|6|||
16928705|NCT01081678|38072270|FG000|Overall Study|Other|0|||
16928706|NCT01081678|38072271|FG001|Overall Study|Other|1|||
16928707|NCT01081678|38072272|FG002|Overall Study|Other|0|||
16928708|NCT01081678|38072273|FG003|Overall Study|Other|0|||
16928709|NCT01081249|38072283|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
16928710|NCT01081249|38072284|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
16928711|NCT01081132|38072292|FG000|Overall Study|Lack of Efficacy|25|||
16928712|NCT01081132|38072293|FG001|Overall Study|Lack of Efficacy|9|||
16928713|NCT01081132|38072292|FG000|Overall Study|Withdrawal by Subject|13|||
16928714|NCT01081132|38072293|FG001|Overall Study|Withdrawal by Subject|16|||
16928715|NCT01081132|38072292|FG000|Overall Study|Lost to Follow-up|4|||
16928716|NCT01081132|38072293|FG001|Overall Study|Lost to Follow-up|11|||
16928717|NCT01081132|38072292|FG000|Overall Study|Adverse Event|3|||
16928718|NCT01081132|38072293|FG001|Overall Study|Adverse Event|9|||
16928719|NCT01081132|38072292|FG000|Overall Study|Non Compliance|4|||
16928720|NCT01081132|38072293|FG001|Overall Study|Non Compliance|2|||
16928721|NCT01081132|38072292|FG000|Overall Study|Lack Of Compliance|0|||
16928722|NCT01081132|38072293|FG001|Overall Study|Lack Of Compliance|1|||
16928723|NCT01081132|38072292|FG000|Overall Study|Missed Visits|1|||
16850964|NCT01753076|37798517|FG001|Overall Study|Physician Decision|2|||
16850965|NCT01753076|37798516|FG000|Overall Study|Withdrawal by Subject|14|||
16850966|NCT01753076|37798517|FG001|Overall Study|Withdrawal by Subject|24|||
16928724|NCT01081132|38072293|FG001|Overall Study|Missed Visits|1|||
16928725|NCT01081132|38072292|FG000|Overall Study|Stopped Taking Meds|2|||
16928726|NCT01081132|38072293|FG001|Overall Study|Stopped Taking Meds|0|||
16928727|NCT01081132|38072292|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
16928728|NCT01081132|38072293|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
16928729|NCT01081132|38072292|FG000|Overall Study|Declined Taper Phase|0|||
16928730|NCT01081132|38072293|FG001|Overall Study|Declined Taper Phase|1|||
16928731|NCT01081132|38072292|FG000|Overall Study|Protocol Violation|3|||
16928732|NCT01081132|38072293|FG001|Overall Study|Protocol Violation|1|||
16928733|NCT01080625|38072302|FG000|Overall Study|Physician Decision|0|||
16928734|NCT01080625|38072303|FG001|Overall Study|Physician Decision|2|||
16928735|NCT01080625|38072304|FG002|Overall Study|Physician Decision|1|||
16928736|NCT01059903|38072314|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
16928737|NCT01059903|38072315|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
16928738|NCT03456700|38072362|FG000|Overall Study|Withdrawal by Subject|1|||
16928739|NCT00199888|38072370|FG000|Overall Study|Lost to Follow-up|1|||
16928740|NCT00199849|38072377|FG000|Overall Study|Unrelated illness or complication|0|||
16928741|NCT00199849|38072378|FG001|Overall Study|Unrelated illness or complication|1|||
16928742|NCT00199849|38072379|FG002|Overall Study|Unrelated illness or complication|0|||
16928743|NCT00199849|38072377|FG000|Overall Study|Progressive disease requiring intervention|0|||
16928744|NCT00199849|38072378|FG001|Overall Study|Progressive disease requiring intervention|0|||
16928745|NCT00199849|38072379|FG002|Overall Study|Progressive disease requiring intervention|1|||
16928746|NCT00199849|38072377|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
16928747|NCT00199849|38072378|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
16928748|NCT00199849|38072379|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
16850967|NCT01753076|37798516|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
16850968|NCT01753076|37798517|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
16928749|NCT00199381|38072387|FG000|Overall Study|Withdrawal by Subject|38|||
16928750|NCT00199381|38072387|FG000|Overall Study|Adverse Event|73|||
16928751|NCT00199381|38072387|FG000|Overall Study|Protocol Violation|6|||
16850969|NCT01463007|37798525|FG000|Overall Study|Physician Decision|1|||
16850970|NCT01462929|37798533|FG000|Overall Study|Adverse Event|3|||
16850971|NCT01462929|37798534|FG001|Overall Study|Adverse Event|3|||
16850972|NCT01462929|37798535|FG002|Overall Study|Adverse Event|4|||
16850973|NCT01462929|37798533|FG000|Overall Study|Withdrawal by Subject|2|||
16928752|NCT00199381|38072387|FG000|Overall Study|Lack of Efficacy|27|||
16850974|NCT01462929|37798534|FG001|Overall Study|Withdrawal by Subject|1|||
16850975|NCT01462929|37798535|FG002|Overall Study|Withdrawal by Subject|0|||
16850976|NCT01462929|37798533|FG000|Overall Study|Lack of Efficacy|0|||
16850977|NCT01462929|37798534|FG001|Overall Study|Lack of Efficacy|0|||
16850978|NCT01462929|37798535|FG002|Overall Study|Lack of Efficacy|1|||
16850979|NCT01462695|37798545|FG000|Overall Study|Adverse Event|1|||
16850980|NCT01462695|37798546|FG001|Overall Study|Adverse Event|1|||
16850981|NCT01462695|37798545|FG000|Overall Study|Death|2|||
16850982|NCT01462695|37798546|FG001|Overall Study|Death|0|||
16850983|NCT01462695|37798545|FG000|Overall Study|Lack of Efficacy|6|||
16850984|NCT01462695|37798546|FG001|Overall Study|Lack of Efficacy|12|||
16850985|NCT01462695|37798545|FG000|Overall Study|Physician Decision|5|||
16850986|NCT01462695|37798546|FG001|Overall Study|Physician Decision|0|||
16850987|NCT01462695|37798545|FG000|Overall Study|Withdrawal by Subject|2|||
16850988|NCT01462695|37798546|FG001|Overall Study|Withdrawal by Subject|0|||
16850989|NCT01462695|37798545|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
16850990|NCT01462695|37798546|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
16850991|NCT01465347|37798552|FG000|Overall Study|Withdrawal by Subject|1|||
16850992|NCT01465347|37798553|FG001|Overall Study|Withdrawal by Subject|1|||
16850993|NCT01465347|37798552|FG000|Overall Study|Physician Decision|0|||
16850994|NCT01465347|37798553|FG001|Overall Study|Physician Decision|1|||
16850995|NCT01465347|37798552|FG000|Overall Study|Admitted to hospice|0|||
16850996|NCT01465347|37798553|FG001|Overall Study|Admitted to hospice|1|||
16850997|NCT01465191|37798565|FG000|Overall Study|Protocol Violation|6|||
16850998|NCT01465191|37798566|FG001|Overall Study|Protocol Violation|3|||
16850999|NCT01465191|37798567|FG002|Overall Study|Protocol Violation|3|||
16851000|NCT01465191|37798565|FG000|Overall Study|Lost to Follow-up|3|||
16851001|NCT01465191|37798566|FG001|Overall Study|Lost to Follow-up|6|||
16851002|NCT01465191|37798567|FG002|Overall Study|Lost to Follow-up|4|||
16851003|NCT01519947|37798582|FG000|Overall Study|Death|0|||
16851004|NCT01519947|37798583|FG001|Overall Study|Death|0|||
16851005|NCT01519947|37798584|FG002|Overall Study|Death|0|||
16851006|NCT01519947|37798585|FG003|Overall Study|Death|1|||
16851007|NCT01519947|37798582|FG000|Overall Study|Protocol Violation|0|||
16851008|NCT01519947|37798583|FG001|Overall Study|Protocol Violation|0|||
16851009|NCT01519947|37798584|FG002|Overall Study|Protocol Violation|2|||
16851010|NCT01519947|37798585|FG003|Overall Study|Protocol Violation|1|||
16851011|NCT01519947|37798582|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
16851012|NCT01519947|37798583|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
16851013|NCT01519947|37798584|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
16851014|NCT01519947|37798585|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
16851015|NCT01519947|37798582|FG000|Overall Study|Development of Anemia|0|||
16851016|NCT01519947|37798583|FG001|Overall Study|Development of Anemia|1|||
16851017|NCT01519947|37798584|FG002|Overall Study|Development of Anemia|0|||
16851018|NCT01519947|37798585|FG003|Overall Study|Development of Anemia|1|||
16851019|NCT01519947|37798582|FG000|Overall Study|Blood Transfusion|0|||
16851020|NCT01519947|37798583|FG001|Overall Study|Blood Transfusion|1|||
16851021|NCT01519947|37798584|FG002|Overall Study|Blood Transfusion|1|||
16851022|NCT01519947|37798585|FG003|Overall Study|Blood Transfusion|0|||
16851023|NCT01519947|37798582|FG000|Overall Study|Withdrawal by Subject|0|||
16851024|NCT01519947|37798583|FG001|Overall Study|Withdrawal by Subject|1|||
16851025|NCT01519947|37798584|FG002|Overall Study|Withdrawal by Subject|0|||
16851026|NCT01519947|37798585|FG003|Overall Study|Withdrawal by Subject|1|||
16851027|NCT01519947|37798582|FG000|Overall Study|Lost to Follow-up|0|||
16851028|NCT01519947|37798583|FG001|Overall Study|Lost to Follow-up|0|||
16851029|NCT01519947|37798584|FG002|Overall Study|Lost to Follow-up|3|||
16851030|NCT01519947|37798585|FG003|Overall Study|Lost to Follow-up|2|||
16851031|NCT01519947|37798582|FG000|Overall Study|Poor Response|1|||
16851032|NCT01519947|37798583|FG001|Overall Study|Poor Response|0|||
16851033|NCT01519947|37798584|FG002|Overall Study|Poor Response|0|||
16851034|NCT01519947|37798585|FG003|Overall Study|Poor Response|1|||
16851035|NCT01519947|37798582|FG000|Overall Study|Adverse Event|1|||
16851036|NCT01519947|37798583|FG001|Overall Study|Adverse Event|0|||
16851037|NCT01519947|37798584|FG002|Overall Study|Adverse Event|1|||
16851038|NCT01519947|37798585|FG003|Overall Study|Adverse Event|1|||
16851039|NCT01462227|37798597|FG000|Second Assignment|Lost to Follow-up|1|||
16851040|NCT01462227|37798598|FG001|Second Assignment|Lost to Follow-up|0|||
16851041|NCT01462227|37798599|FG002|Second Assignment|Lost to Follow-up|0|||
16851042|NCT01462227|37798600|FG003|Second Assignment|Lost to Follow-up|0|||
16851043|NCT01462227|37798597|FG000|Second Assignment|Protocol Violation|0|||
16851044|NCT01462227|37798598|FG001|Second Assignment|Protocol Violation|1|||
16851045|NCT01462227|37798599|FG002|Second Assignment|Protocol Violation|1|||
16851046|NCT01462227|37798600|FG003|Second Assignment|Protocol Violation|0|||
16851047|NCT01464879|37798608|FG000|Overall Study|Physician Decision|1|||
16851048|NCT01464879|37798608|FG000|Overall Study|Non-compliance|1|||
16851049|NCT01519869|37798618|FG000|Overall Study|Lost to Follow-up|1|||
16851050|NCT01519791|37798624|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
16851051|NCT01519791|37798625|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
16851052|NCT01519791|37798624|FG000|Overall Study|Protocol Violation|6|||
16851053|NCT01519791|37798625|FG001|Overall Study|Protocol Violation|19|||
16851054|NCT01519791|37798624|FG000|Overall Study|Other Reason|87|||
16851055|NCT01519791|37798625|FG001|Overall Study|Other Reason|222|||
16851056|NCT01519791|37798624|FG000|Overall Study|subjects randomized in error|2|||
16851057|NCT01519791|37798625|FG001|Overall Study|subjects randomized in error|0|||
16851058|NCT01519791|37798624|FG000|Overall Study|Lack of Efficacy|16|||
16851059|NCT01519791|37798625|FG001|Overall Study|Lack of Efficacy|20|||
16851060|NCT01519791|37798624|FG000|Overall Study|SAE, non-fatal|6|||
16851061|NCT01519791|37798625|FG001|Overall Study|SAE, non-fatal|22|||
16851062|NCT01519791|37798624|FG000|Overall Study|AE, serious fatal|0|||
16851063|NCT01519791|37798625|FG001|Overall Study|AE, serious fatal|1|||
16851064|NCT01519791|37798624|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
16851065|NCT01519791|37798625|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
16851066|NCT01519791|37798624|FG000|Overall Study|AE, non-serious non-fatal|12|||
16851067|NCT01519791|37798625|FG001|Overall Study|AE, non-serious non-fatal|31|||
16851068|NCT01519791|37798624|FG000|Overall Study|Withdrawal by Subject|15|||
16928753|NCT00199381|38072387|FG000|Overall Study|Not including due to early termination|37|||
16928754|NCT00199381|38072387|FG000|Overall Study|Study termination by Sponsor|323|||
16928755|NCT00198133|38072393|FG000|Overall Study|Disease progression|2|||
16928756|NCT00198133|38072394|FG001|Overall Study|Disease progression|5|||
16928757|NCT00198133|38072393|FG000|Overall Study|Adverse Event|1|||
16928758|NCT00198133|38072394|FG001|Overall Study|Adverse Event|3|||
16928759|NCT00198133|38072393|FG000|Overall Study|Withdrawal by Subject|1|||
16928760|NCT00198133|38072394|FG001|Overall Study|Withdrawal by Subject|0|||
16928761|NCT00198133|38072393|FG000|Overall Study|Physician Decision|1|||
16928762|NCT00198133|38072394|FG001|Overall Study|Physician Decision|0|||
16928763|NCT00197236|38072403|FG000|Overall Study|Adverse Event|1|||
16928764|NCT00197236|38072404|FG001|Overall Study|Adverse Event|0|||
16851069|NCT01519791|37798625|FG001|Overall Study|Withdrawal by Subject|37|||
16851070|NCT01519791|37798624|FG000|Overall Study|Lost to Follow-up|6|||
16851071|NCT01519791|37798625|FG001|Overall Study|Lost to Follow-up|14|||
16851072|NCT01461993|37798636|FG000|Overall Study|Withdrawal by Subject|60|||
16928765|NCT00197236|38072405|FG002|Overall Study|Adverse Event|1|||
16928766|NCT00197236|38072403|FG000|Overall Study|Lost to Follow-up|5|||
16928767|NCT00197236|38072404|FG001|Overall Study|Lost to Follow-up|14|||
16928768|NCT00197236|38072405|FG002|Overall Study|Lost to Follow-up|6|||
16928769|NCT00197236|38072403|FG000|Overall Study|Protocol Violation|0|||
16928770|NCT00197236|38072404|FG001|Overall Study|Protocol Violation|0|||
16928771|NCT00197236|38072405|FG002|Overall Study|Protocol Violation|1|||
16928772|NCT00197236|38072403|FG000|Overall Study|Withdrawal by Subject|7|||
16928773|NCT00197236|38072404|FG001|Overall Study|Withdrawal by Subject|3|||
16928774|NCT00197236|38072405|FG002|Overall Study|Withdrawal by Subject|11|||
16928775|NCT00197236|38072403|FG000|Overall Study|Study drug/medication expiration|1|||
16928776|NCT00197236|38072404|FG001|Overall Study|Study drug/medication expiration|0|||
16928777|NCT00197236|38072405|FG002|Overall Study|Study drug/medication expiration|3|||
16928778|NCT00197236|38072403|FG000|Overall Study|Returned out of specified time window|0|||
16928779|NCT00197236|38072404|FG001|Overall Study|Returned out of specified time window|0|||
16851073|NCT01461993|37798637|FG001|Overall Study|Withdrawal by Subject|53|||
16851074|NCT01461993|37798638|FG002|Overall Study|Withdrawal by Subject|16|||
16851075|NCT01461993|37798636|FG000|Overall Study|Lost to Follow-up|44|||
16851076|NCT01461993|37798637|FG001|Overall Study|Lost to Follow-up|48|||
16851077|NCT01461993|37798638|FG002|Overall Study|Lost to Follow-up|22|||
16851078|NCT01461993|37798636|FG000|Overall Study|Protocol Violation|10|||
16851079|NCT01461993|37798637|FG001|Overall Study|Protocol Violation|9|||
16851080|NCT01461993|37798638|FG002|Overall Study|Protocol Violation|7|||
16851081|NCT01461993|37798636|FG000|Overall Study|Adverse Event|9|||
16851082|NCT01461993|37798637|FG001|Overall Study|Adverse Event|11|||
16851083|NCT01461993|37798638|FG002|Overall Study|Adverse Event|3|||
16851084|NCT01461993|37798636|FG000|Overall Study|No longer met eligibility criteria|13|||
16851085|NCT01461993|37798637|FG001|Overall Study|No longer met eligibility criteria|18|||
16928780|NCT00197236|38072405|FG002|Overall Study|Returned out of specified time window|1|||
16928781|NCT00197002|38072419|FG000|Overall Study|Adverse Event|0|||
16928782|NCT00197002|38072420|FG001|Overall Study|Adverse Event|1|||
16928783|NCT00197002|38072421|FG002|Overall Study|Adverse Event|0|||
16928784|NCT00197002|38072419|FG000|Overall Study|Protocol Violation|1|||
16928785|NCT00197002|38072420|FG001|Overall Study|Protocol Violation|0|||
16928786|NCT00197002|38072421|FG002|Overall Study|Protocol Violation|2|||
16928787|NCT00197002|38072419|FG000|Overall Study|Withdrawal by Subject|9|||
16928788|NCT00197002|38072420|FG001|Overall Study|Withdrawal by Subject|5|||
16928789|NCT00197002|38072421|FG002|Overall Study|Withdrawal by Subject|7|||
16928790|NCT00197002|38072419|FG000|Overall Study|Migrated/moved from study area|3|||
16928791|NCT00197002|38072420|FG001|Overall Study|Migrated/moved from study area|5|||
16928792|NCT00197002|38072421|FG002|Overall Study|Migrated/moved from study area|1|||
16928793|NCT00197002|38072419|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
16928794|NCT00197002|38072420|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
16928795|NCT00197002|38072421|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
16928796|NCT00197002|38072419|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
16928797|NCT00197002|38072420|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
16928798|NCT00197002|38072421|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
16928799|NCT00197002|38072419|FG000|Overall Study|Others|3|||
16928800|NCT00197002|38072420|FG001|Overall Study|Others|1|||
16928801|NCT00197002|38072421|FG002|Overall Study|Others|1|||
16928802|NCT00196105|38072435|FG000|Overall Study|Lost to Follow-up|4|||
16928803|NCT00196105|38072436|FG001|Overall Study|Lost to Follow-up|5|||
16928804|NCT00196105|38072437|FG002|Overall Study|Lost to Follow-up|7|||
16928805|NCT00195715|38072445|FG000|Overall Study|Adverse Event|122|||
16928806|NCT00195715|38072445|FG000|Overall Study|Withdrawal by Subject|58|||
16928807|NCT00195715|38072445|FG000|Overall Study|Lost to Follow-up|27|||
16928808|NCT00195715|38072445|FG000|Overall Study|Protocol Violation|13|||
16928809|NCT00195715|38072445|FG000|Overall Study|Lack of Efficacy|93|||
16928810|NCT00195715|38072445|FG000|Overall Study|Pregnancy|14|||
16928811|NCT00195715|38072445|FG000|Overall Study|Investigative site closure|8|||
16928812|NCT00195715|38072445|FG000|Overall Study|Subject moved/relocated|7|||
16928813|NCT00195715|38072445|FG000|Overall Study|Subject non-compliance|6|||
16928814|NCT00195715|38072445|FG000|Overall Study|Subject started commercial Humira|5|||
16928815|NCT00195715|38072445|FG000|Overall Study|Subject choice|3|||
16928816|NCT00195715|38072445|FG000|Overall Study|Loss of response/no improvement|3|||
16928817|NCT00195715|38072445|FG000|Overall Study|Sponsor stopped study|1|||
16928818|NCT00195715|38072445|FG000|Overall Study|Administrative reasons|2|||
16928819|NCT00195715|38072445|FG000|Overall Study|Investigator's decision|2|||
16928820|NCT00195715|38072445|FG000|Overall Study|Subject wants to get pregnant|4|||
16928821|NCT00195715|38072445|FG000|Overall Study|Use of prohibited medication|2|||
16928822|NCT00195715|38072445|FG000|Overall Study|Planned surgery|2|||
16928823|NCT00195715|38072445|FG000|Overall Study|Increased infection rate|1|||
16928824|NCT00195715|38072445|FG000|Overall Study|Ineligible|1|||
16928825|NCT00195715|38072445|FG000|Overall Study|Colonic stricture|1|||
16928826|NCT00195715|38072445|FG000|Overall Study|Sponsor discontinued trial|1|||
16928827|NCT00195715|38072445|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
16928828|NCT00195676|38072449|FG000|Period O - Open-label Treatment|Adverse Event|82|||
16928829|NCT00195676|38072449|FG000|Period O - Open-label Treatment|Death|6|||
16928830|NCT00195676|38072449|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
16928831|NCT00195676|38072449|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
16928832|NCT00195676|38072449|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
16851086|NCT01461993|37798638|FG002|Overall Study|No longer met eligibility criteria|10|||
16851087|NCT01461993|37798636|FG000|Overall Study|Did not meet entrance criteria|2|||
16928833|NCT00195676|38072449|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
16928834|NCT00195676|38072449|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
16928835|NCT00195676|38072449|FG000|Period O - Open-label Treatment|Other reasons|68|||
16928836|NCT00195676|38072449|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
16928837|NCT00195676|38072449|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
16851088|NCT01461993|37798637|FG001|Overall Study|Did not meet entrance criteria|3|||
16851089|NCT01461993|37798638|FG002|Overall Study|Did not meet entrance criteria|0|||
16851090|NCT01461993|37798636|FG000|Overall Study|Other|13|||
16851091|NCT01461993|37798637|FG001|Overall Study|Other|15|||
16851092|NCT01461993|37798638|FG002|Overall Study|Other|6|||
16851093|NCT01782326|37798649|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
16851094|NCT01782326|37798650|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
16851095|NCT01782326|37798649|FG000|Planned Treatment Epoch|Death|29|||
16851096|NCT01782326|37798650|FG001|Planned Treatment Epoch|Death|30|||
16851097|NCT01782326|37798649|FG000|Planned Treatment Epoch|Physician Decision|18|||
16851098|NCT01782326|37798650|FG001|Planned Treatment Epoch|Physician Decision|16|||
16851099|NCT01782326|37798649|FG000|Planned Treatment Epoch|Protocol deviation|2|||
16851100|NCT01782326|37798650|FG001|Planned Treatment Epoch|Protocol deviation|3|||
16851101|NCT01782326|37798649|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
16851102|NCT01782326|37798650|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
16851103|NCT01782326|37798649|FG000|Planned Treatment Epoch|Technical problems|0|||
16851104|NCT01782326|37798650|FG001|Planned Treatment Epoch|Technical problems|4|||
16851105|NCT01782326|37798649|FG000|Double-blind Treatment|Adverse Event|129|||
16851106|NCT01782326|37798650|FG001|Double-blind Treatment|Adverse Event|145|||
16851107|NCT01782326|37798649|FG000|Double-blind Treatment|Subject/guardian decision|111|||
16851108|NCT01782326|37798650|FG001|Double-blind Treatment|Subject/guardian decision|125|||
16851109|NCT01782326|37798649|FG000|Double-blind Treatment|Lack of Efficacy|17|||
16851110|NCT01782326|37798650|FG001|Double-blind Treatment|Lack of Efficacy|22|||
16851111|NCT01782326|37798649|FG000|Double-blind Treatment|Physician Decision|13|||
16851112|NCT01782326|37798650|FG001|Double-blind Treatment|Physician Decision|16|||
16851113|NCT01782326|37798649|FG000|Double-blind Treatment|Protocol deviation|8|||
16851114|NCT01782326|37798650|FG001|Double-blind Treatment|Protocol deviation|7|||
16851115|NCT01782326|37798649|FG000|Double-blind Treatment|Technical problems|0|||
16851116|NCT01782326|37798650|FG001|Double-blind Treatment|Technical problems|5|||
16928838|NCT00195676|38072449|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
16928839|NCT00195676|38072449|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
16928840|NCT00195676|38072449|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
16928841|NCT00195676|38072449|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
16928842|NCT00195676|38072449|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
16928843|NCT00195676|38072449|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
16928844|NCT00195676|38072449|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
16928845|NCT00195676|38072449|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
16928846|NCT00195676|38072449|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
16928847|NCT00195676|38072449|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
16928848|NCT00195676|38072449|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
16928849|NCT00194077|38072459|FG000|Overall Study|Lack of Efficacy|22|||
16928850|NCT00194077|38072460|FG001|Overall Study|Lack of Efficacy|29|||
16928851|NCT00194077|38072459|FG000|Overall Study|Study nonadherence|1|||
16928852|NCT00194077|38072460|FG001|Overall Study|Study nonadherence|0|||
16928853|NCT00194077|38072459|FG000|Overall Study|Withdrawal by Subject|1|||
16928854|NCT00194077|38072460|FG001|Overall Study|Withdrawal by Subject|1|||
16928855|NCT00193609|38072466|FG000|Overall Study|Lack of Efficacy|2|||
16928856|NCT00193609|38072466|FG000|Overall Study|Adverse Event|2|||
16928857|NCT00193180|38072470|FG000|Overall Study|Lack of Efficacy|1|||
16928858|NCT00193180|38072470|FG000|Overall Study|Adverse Event|8|||
16928859|NCT00193180|38072470|FG000|Overall Study|Protocol Violation|1|||
16851117|NCT01439373|37798658|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
16851118|NCT01439373|37798659|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
16851119|NCT01439373|37798658|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
16851120|NCT01439373|37798659|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
16851121|NCT01461369|37798672|FG000|Overall Study|Lack of Efficacy|2|||
16851122|NCT01461369|37798673|FG001|Overall Study|Lack of Efficacy|0|||
16851123|NCT01461369|37798674|FG002|Overall Study|Lack of Efficacy|6|||
16851124|NCT01461369|37798672|FG000|Overall Study|Lost to Follow-up|0|||
16928860|NCT00193063|38072475|FG000|Overall Study|Lack of Efficacy|3|||
16928861|NCT00193063|38072475|FG000|Overall Study|Adverse Event|1|||
16928862|NCT00191854|38072482|FG000|Overall Study|Death|26|||
16928863|NCT00191854|38072483|FG001|Overall Study|Death|23|||
16928864|NCT00191854|38072484|FG002|Overall Study|Death|29|||
16928865|NCT00191854|38072482|FG000|Overall Study|Lost to Follow-up|7|||
16928866|NCT00191854|38072483|FG001|Overall Study|Lost to Follow-up|5|||
16928867|NCT00191854|38072484|FG002|Overall Study|Lost to Follow-up|5|||
16928868|NCT00191854|38072482|FG000|Overall Study|Withdrawal by Subject|4|||
16928869|NCT00191854|38072483|FG001|Overall Study|Withdrawal by Subject|2|||
16851125|NCT01461369|37798673|FG001|Overall Study|Lost to Follow-up|0|||
16851126|NCT01461369|37798674|FG002|Overall Study|Lost to Follow-up|3|||
16851127|NCT01461369|37798672|FG000|Overall Study|Adverse Event|9|||
16851128|NCT01461369|37798673|FG001|Overall Study|Adverse Event|12|||
16851129|NCT01461369|37798674|FG002|Overall Study|Adverse Event|4|||
16851130|NCT01461369|37798672|FG000|Overall Study|Protocol Violation|1|||
16851131|NCT01461369|37798673|FG001|Overall Study|Protocol Violation|2|||
16851132|NCT01461369|37798674|FG002|Overall Study|Protocol Violation|2|||
16851133|NCT01461369|37798672|FG000|Overall Study|Withdrawal by Subject|1|||
16851134|NCT01461369|37798673|FG001|Overall Study|Withdrawal by Subject|3|||
16928870|NCT00191854|38072484|FG002|Overall Study|Withdrawal by Subject|3|||
16928871|NCT00191854|38072482|FG000|Overall Study|Sponsor Decision|0|||
16928872|NCT00191854|38072483|FG001|Overall Study|Sponsor Decision|0|||
16928873|NCT00191854|38072484|FG002|Overall Study|Sponsor Decision|1|||
16928874|NCT00191854|38072482|FG000|Overall Study|Screen Failure|0|||
16928875|NCT00191854|38072483|FG001|Overall Study|Screen Failure|0|||
16928876|NCT00191854|38072484|FG002|Overall Study|Screen Failure|1|||
16928877|NCT00191815|38072492|FG000|Overall Study|Adverse Event|2|||
16928878|NCT00191815|38072492|FG000|Overall Study|Disease progression or relapse|24|||
16928879|NCT00191815|38072492|FG000|Overall Study|Death|2|||
16928880|NCT00191815|38072492|FG000|Overall Study|Protocol Violation|3|||
16928881|NCT00191815|38072492|FG000|Overall Study|Physician Decision|2|||
16928882|NCT00191815|38072492|FG000|Overall Study|Withdrawal by Subject|7|||
16928883|NCT00191386|38072496|FG000|Overall Study|Adverse Event|16|||
16928884|NCT00191386|38072496|FG000|Overall Study|Lost to Follow-up|1|||
16928885|NCT00191386|38072496|FG000|Overall Study|Entry Criteria Exclusion|3|||
16928886|NCT00191386|38072496|FG000|Overall Study|Protocol Violation|18|||
16928887|NCT00191386|38072496|FG000|Overall Study|Withdrawal by Subject|96|||
16928888|NCT00191386|38072496|FG000|Overall Study|Physician Decision|11|||
16928889|NCT00191386|38072496|FG000|Overall Study|Lack of Efficacy|15|||
16928890|NCT00191308|38072500|FG000|Overall Study|Adverse Event|1|||
16928891|NCT00191269|38072506|FG000|Overall Study|Protocol Violation|0|||
17018717|NCT00818766|38163299|FG000|Overall Study|Could not be Contacted on Day 28|11|||
16851135|NCT01461369|37798674|FG002|Overall Study|Withdrawal by Subject|2|||
16851136|NCT01727258|37798685|FG000|Overall Study|Adverse Event|0|||
16851137|NCT01727258|37798686|FG001|Overall Study|Adverse Event|2|||
16928892|NCT00191269|38072507|FG001|Overall Study|Protocol Violation|2|||
16928893|NCT00191269|38072506|FG000|Overall Study|Adverse Event|1|||
16851138|NCT01727258|37798687|FG002|Overall Study|Adverse Event|0|||
16851139|NCT01727258|37798685|FG000|Overall Study|Noncompliance with Study Drug|0|||
16851140|NCT01727258|37798686|FG001|Overall Study|Noncompliance with Study Drug|0|||
16851141|NCT01727258|37798687|FG002|Overall Study|Noncompliance with Study Drug|1|||
16851142|NCT01727258|37798685|FG000|Overall Study|Withdrawal by Subject|1|||
16851143|NCT01727258|37798686|FG001|Overall Study|Withdrawal by Subject|1|||
16851144|NCT01727258|37798687|FG002|Overall Study|Withdrawal by Subject|0|||
16851145|NCT01727258|37798685|FG000|Overall Study|Lost to Follow-up|1|||
16851146|NCT01727258|37798686|FG001|Overall Study|Lost to Follow-up|0|||
16851147|NCT01727258|37798687|FG002|Overall Study|Lost to Follow-up|0|||
16851148|NCT01781390|37798698|FG000|Overall Study|Withdrawal of Consent|0|||
16851149|NCT01781390|37798699|FG001|Overall Study|Withdrawal of Consent|3|||
16851150|NCT01781390|37798700|FG002|Overall Study|Withdrawal of Consent|1|||
16851151|NCT01781390|37798698|FG000|Overall Study|Lost to Follow-up|1|||
16851152|NCT01781390|37798699|FG001|Overall Study|Lost to Follow-up|1|||
16851153|NCT01781390|37798700|FG002|Overall Study|Lost to Follow-up|1|||
16851154|NCT01781390|37798698|FG000|Overall Study|Adverse Event|1|||
16851155|NCT01781390|37798699|FG001|Overall Study|Adverse Event|2|||
16851156|NCT01781390|37798700|FG002|Overall Study|Adverse Event|1|||
16851157|NCT01781390|37798698|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
16928894|NCT00191269|38072507|FG001|Overall Study|Adverse Event|4|||
16928895|NCT00191269|38072506|FG000|Overall Study|Progression of Disease|4|||
16928896|NCT00191269|38072507|FG001|Overall Study|Progression of Disease|42|||
16928897|NCT00191269|38072506|FG000|Overall Study|Lack of Efficacy|1|||
16928898|NCT00191269|38072507|FG001|Overall Study|Lack of Efficacy|5|||
16928899|NCT00191269|38072506|FG000|Overall Study|Withdrawal by Subject|0|||
16928900|NCT00191269|38072507|FG001|Overall Study|Withdrawal by Subject|1|||
16928901|NCT00191269|38072506|FG000|Overall Study|Pathologic Aggrevation|0|||
16928902|NCT00191269|38072507|FG001|Overall Study|Pathologic Aggrevation|1|||
16928903|NCT00191269|38072506|FG000|Overall Study|Physician Decision|0|||
16928904|NCT00191269|38072507|FG001|Overall Study|Physician Decision|3|||
16928905|NCT00191191|38072516|FG000|Overall Study|Entry Criteria Exclusion|2|||
16928906|NCT00191191|38072517|FG001|Overall Study|Entry Criteria Exclusion|0|||
16928907|NCT00191191|38072516|FG000|Overall Study|Treated with Another Systemic Agent|1|||
16928908|NCT00191191|38072517|FG001|Overall Study|Treated with Another Systemic Agent|1|||
16928909|NCT00191191|38072516|FG000|Overall Study|Adverse Event|11|||
16928910|NCT00191191|38072517|FG001|Overall Study|Adverse Event|21|||
16928911|NCT00191191|38072516|FG000|Overall Study|Progressive Disease|84|||
16928912|NCT00191191|38072517|FG001|Overall Study|Progressive Disease|72|||
16928913|NCT00191191|38072516|FG000|Overall Study|Toxicity After Dose Reduction|7|||
16928914|NCT00191191|38072517|FG001|Overall Study|Toxicity After Dose Reduction|8|||
16928915|NCT00191191|38072516|FG000|Overall Study|Family/Caregiver Decision|5|||
16928916|NCT00191191|38072517|FG001|Overall Study|Family/Caregiver Decision|7|||
16928917|NCT00191191|38072516|FG000|Overall Study|Lost to Follow-up|1|||
16928918|NCT00191191|38072517|FG001|Overall Study|Lost to Follow-up|0|||
16928919|NCT00191191|38072516|FG000|Overall Study|Physician Decision|3|||
16928920|NCT00191191|38072517|FG001|Overall Study|Physician Decision|2|||
16928921|NCT00191191|38072516|FG000|Overall Study|Good Clinical Practice Violation|0|||
16928922|NCT00191191|38072517|FG001|Overall Study|Good Clinical Practice Violation|1|||
16928923|NCT00191152|38072525|FG000|Initial Treatment|Adverse Event|43|||
16928924|NCT00191152|38072526|FG001|Initial Treatment|Adverse Event|67|||
16928925|NCT00191152|38072525|FG000|Initial Treatment|Physician Decision|40|||
16928926|NCT00191152|38072526|FG001|Initial Treatment|Physician Decision|31|||
16928927|NCT00191152|38072525|FG000|Initial Treatment|Withdrawal by Subject|40|||
16928928|NCT00191152|38072526|FG001|Initial Treatment|Withdrawal by Subject|28|||
16928929|NCT00191152|38072525|FG000|Initial Treatment|Lost to Follow-up|0|||
16928930|NCT00191152|38072526|FG001|Initial Treatment|Lost to Follow-up|6|||
16928931|NCT00191152|38072525|FG000|Initial Treatment|Other|18|||
16928932|NCT00191152|38072526|FG001|Initial Treatment|Other|21|||
16928933|NCT00191152|38072525|FG000|Crossover Treatment|Adverse Event|8|||
16928934|NCT00191152|38072526|FG001|Crossover Treatment|Adverse Event|8|||
16928935|NCT00191152|38072525|FG000|Crossover Treatment|Physician Decision|7|||
16928936|NCT00191152|38072526|FG001|Crossover Treatment|Physician Decision|7|||
16928937|NCT00191152|38072525|FG000|Crossover Treatment|Withdrawal by Subject|6|||
16928938|NCT00191152|38072526|FG001|Crossover Treatment|Withdrawal by Subject|9|||
16928939|NCT00191152|38072525|FG000|Crossover Treatment|Lost to Follow-up|2|||
16928940|NCT00191152|38072526|FG001|Crossover Treatment|Lost to Follow-up|1|||
16928941|NCT00191152|38072525|FG000|Crossover Treatment|Other|4|||
16928942|NCT00191152|38072526|FG001|Crossover Treatment|Other|3|||
16928943|NCT00190684|38072544|FG000|Overall Study|Adverse Event|86|||
16928944|NCT00190684|38072544|FG000|Overall Study|Satisfactory response|80|||
16928945|NCT00190684|38072544|FG000|Overall Study|Lack of efficacy|204|||
16928946|NCT00190684|38072544|FG000|Overall Study|Lost to Follow-up|232|||
16928947|NCT00190684|38072544|FG000|Overall Study|Patient moved|60|||
16928948|NCT00190684|38072544|FG000|Overall Study|Patient Decision|432|||
16851158|NCT01781390|37798699|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
16928949|NCT00190684|38072544|FG000|Overall Study|Clinical relapse|67|||
16928950|NCT00190684|38072544|FG000|Overall Study|Sponsor's decision|17|||
16928951|NCT00190684|38072544|FG000|Overall Study|Physician Decision|84|||
16928952|NCT00190684|38072544|FG000|Overall Study|Protocol Violation|123|||
16928953|NCT00190684|38072544|FG000|Overall Study|Study Period III Completed|103|||
16928954|NCT00190684|38072544|FG000|Overall Study|Study Period V Completed|1|||
16928955|NCT00179959|38072555|FG000|Overall Study|Lost to Follow-up|3|||
16928956|NCT00179959|38072556|FG001|Overall Study|Lost to Follow-up|1|||
16928957|NCT00179959|38072555|FG000|Overall Study|Withdrawal by Subject|3|||
16928958|NCT00179959|38072556|FG001|Overall Study|Withdrawal by Subject|2|||
16928959|NCT00179647|38072562|FG000|Overall Study|Adverse Event|294|||
16851159|NCT01781390|37798700|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
16851160|NCT01781234|37798710|FG000|Overall Study|Adverse Event|2|||
16928960|NCT00179647|38072562|FG000|Overall Study|Lack of Efficacy|478|||
16928961|NCT00179647|38072562|FG000|Overall Study|Withdrawal by Subject|83|||
16928962|NCT00179647|38072562|FG000|Overall Study|Lost to Follow-up|4|||
16928963|NCT00179647|38072562|FG000|Overall Study|Death|94|||
16928964|NCT00179647|38072562|FG000|Overall Study|Other|960|||
16928965|NCT00179413|38072568|FG000|Overall Study|Adverse Event|38|||
16928966|NCT00179413|38072569|FG001|Overall Study|Adverse Event|20|||
16928967|NCT00179413|38072568|FG000|Overall Study|Withdrawal by Subject|87|||
16928968|NCT00179413|38072569|FG001|Overall Study|Withdrawal by Subject|95|||
16928969|NCT00178633|38072575|FG000|Overall Study|Lost to Follow-up|6|||
16928970|NCT00178399|38072580|FG000|Overall Study|Physician Decision|4|||
16928971|NCT00178399|38072580|FG000|Overall Study|Withdrawal by Subject|8|||
16928972|NCT00178399|38072580|FG000|Overall Study|Lost to Follow-up|1|||
16928973|NCT00178126|38072587|FG000|Overall Study|Lost to Follow-up|21|||
16851161|NCT01781234|37798711|FG001|Overall Study|Adverse Event|0|||
16851162|NCT01781234|37798710|FG000|Overall Study|Protocol Violation|3|||
16851163|NCT01781234|37798711|FG001|Overall Study|Protocol Violation|0|||
16851164|NCT01781234|37798710|FG000|Overall Study|Withdrawal by Subject|4|||
16851165|NCT01781234|37798711|FG001|Overall Study|Withdrawal by Subject|3|||
16851166|NCT01752842|37798721|FG000|Overall Study|Adverse Event|3|||
16851167|NCT01752842|37798722|FG001|Overall Study|Adverse Event|0|||
16851168|NCT01752842|37798721|FG000|Overall Study|Withdrawal by Subject|0|||
16851169|NCT01752842|37798722|FG001|Overall Study|Withdrawal by Subject|2|||
16851170|NCT01461057|37798730|FG000|Overall Study|Death|10|||
16851171|NCT01461057|37798731|FG001|Overall Study|Death|9|||
16851172|NCT01461057|37798730|FG000|Overall Study|Withdrawal by Subject|2|||
16851173|NCT01461057|37798731|FG001|Overall Study|Withdrawal by Subject|3|||
16851174|NCT01461057|37798730|FG000|Overall Study|Physician Decision|0|||
16851175|NCT01461057|37798731|FG001|Overall Study|Physician Decision|2|||
16851176|NCT01461057|37798730|FG000|Overall Study|Adverse Event|0|||
16851177|NCT01461057|37798731|FG001|Overall Study|Adverse Event|1|||
16851178|NCT01461057|37798730|FG000|Overall Study|Progression of Disease|1|||
16851179|NCT01461057|37798731|FG001|Overall Study|Progression of Disease|0|||
16851180|NCT01461057|37798730|FG000|Overall Study|Study Terminated by Sponsor|2|||
16851181|NCT01461057|37798731|FG001|Overall Study|Study Terminated by Sponsor|0|||
16851182|NCT01460901|37798737|FG000|Overall Study|Withdrawal by Subject|2|||
16851183|NCT01519635|37798746|FG000|Overall Study|Withdrawal by Subject|0|||
16851184|NCT01519635|37798747|FG001|Overall Study|Withdrawal by Subject|1|||
16851185|NCT01519635|37798746|FG000|Overall Study|No possibility to put a catheter|1|||
16851186|NCT01519635|37798747|FG001|Overall Study|No possibility to put a catheter|2|||
16851187|NCT01519323|37798753|FG000|Overall Study|Death|3|||
16851188|NCT01519323|37798754|FG001|Overall Study|Death|2|||
16851189|NCT01519323|37798753|FG000|Overall Study|Study terminated by sponsor|0|||
16851190|NCT01519323|37798754|FG001|Overall Study|Study terminated by sponsor|1|||
16851191|NCT01519245|37798762|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
16851192|NCT01519245|37798763|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
16851193|NCT01519167|37798773|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
16851194|NCT01519167|37798774|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
16851195|NCT01519167|37798773|FG000|Overall Study|Adverse Event|0|||
16851196|NCT01519167|37798774|FG001|Overall Study|Adverse Event|1|||
16851197|NCT01519167|37798773|FG000|Overall Study|Lack of Efficacy|0|||
16851198|NCT01519167|37798774|FG001|Overall Study|Lack of Efficacy|1|||
16851199|NCT01519167|37798773|FG000|Overall Study|Medical condition changes&deep sedation|0|||
16851200|NCT01519167|37798774|FG001|Overall Study|Medical condition changes&deep sedation|2|||
16851201|NCT01519167|37798773|FG000|Overall Study|Physician Decision|0|||
16851202|NCT01519167|37798774|FG001|Overall Study|Physician Decision|1|||
16928974|NCT00178126|38072588|FG001|Overall Study|Lost to Follow-up|21|||
16928975|NCT00178126|38072587|FG000|Overall Study|did not receive intervention|4|||
16928976|NCT00178126|38072588|FG001|Overall Study|did not receive intervention|6|||
16928977|NCT00177307|38072594|FG000|Overall Study|Withdrawal by Subject|1|||
16928978|NCT00176644|38072598|FG000|Overall Study|Withdrawal by Subject|1|||
16928979|NCT00176605|38072606|FG000|Overall Study|Withdrawal by Subject|2|||
16928980|NCT00176488|38072610|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
16928981|NCT00176254|38072614|FG000|Overall Study|Lost to Follow-up|1|||
16928982|NCT00175825|38072622|FG000|Overall Study|Adverse Event|3|||
16928983|NCT00175825|38072623|FG001|Overall Study|Adverse Event|2|||
16928984|NCT00175825|38072624|FG002|Overall Study|Adverse Event|1|||
16928985|NCT00175825|38072625|FG003|Overall Study|Adverse Event|1|||
16928986|NCT00175825|38072622|FG000|Overall Study|Lost to Follow-up|1|||
16928987|NCT00175825|38072623|FG001|Overall Study|Lost to Follow-up|2|||
16928988|NCT00175825|38072624|FG002|Overall Study|Lost to Follow-up|0|||
16928989|NCT00175825|38072625|FG003|Overall Study|Lost to Follow-up|0|||
16928990|NCT00175825|38072622|FG000|Overall Study|Withdrawal by Subject|1|||
16928991|NCT00175825|38072623|FG001|Overall Study|Withdrawal by Subject|0|||
16928992|NCT00175825|38072624|FG002|Overall Study|Withdrawal by Subject|0|||
16928993|NCT00175825|38072625|FG003|Overall Study|Withdrawal by Subject|0|||
16928994|NCT00174967|38072639|FG000|Overall Study|Adverse Event|1|||
16928995|NCT00174967|38072640|FG001|Overall Study|Adverse Event|2|||
16928996|NCT00174967|38072641|FG002|Overall Study|Adverse Event|2|||
16928997|NCT00174967|38072642|FG003|Overall Study|Adverse Event|1|||
16928998|NCT00174967|38072639|FG000|Overall Study|Gout Flare|0|||
16851203|NCT01519089|37799015|FG000|Overall Study|Adverse Event|4|||
16851204|NCT01519089|37799016|FG001|Overall Study|Adverse Event|4|||
16851205|NCT01519089|37799015|FG000|Overall Study|Lack of Efficacy|0|||
16851206|NCT01519089|37799016|FG001|Overall Study|Lack of Efficacy|2|||
16928999|NCT00174967|38072640|FG001|Overall Study|Gout Flare|0|||
16929000|NCT00174967|38072641|FG002|Overall Study|Gout Flare|0|||
16929001|NCT00174967|38072642|FG003|Overall Study|Gout Flare|1|||
16929002|NCT00174967|38072639|FG000|Overall Study|Other|0|||
16929003|NCT00174967|38072640|FG001|Overall Study|Other|1|||
16929004|NCT00174967|38072641|FG002|Overall Study|Other|0|||
16929005|NCT00174967|38072642|FG003|Overall Study|Other|0|||
16929006|NCT00174265|38072654|FG000|Overall Study|Adverse Event|7|||
16929007|NCT00174265|38072655|FG001|Overall Study|Adverse Event|4|||
16929008|NCT00174265|38072654|FG000|Overall Study|Lack of Efficacy|2|||
16929009|NCT00174265|38072655|FG001|Overall Study|Lack of Efficacy|2|||
16929010|NCT00174265|38072654|FG000|Overall Study|Withdrawal by Subject|3|||
16929011|NCT00174265|38072655|FG001|Overall Study|Withdrawal by Subject|5|||
16929012|NCT00174265|38072654|FG000|Overall Study|Lost to Follow-up|1|||
16929013|NCT00174265|38072655|FG001|Overall Study|Lost to Follow-up|0|||
16929014|NCT00174265|38072654|FG000|Overall Study|Other (Not specified)|16|||
16929015|NCT00174265|38072655|FG001|Overall Study|Other (Not specified)|10|||
16929016|NCT00172042|38072663|FG000|Overall Study|Adverse Event|27|||
16929017|NCT00172042|38072664|FG001|Overall Study|Adverse Event|13|||
16929018|NCT00172042|38072663|FG000|Overall Study|Abnormal laboratory value(s)|5|||
16929019|NCT00172042|38072664|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16929020|NCT00172042|38072663|FG000|Overall Study|Abnormal test procedure(s)|0|||
16929021|NCT00172042|38072664|FG001|Overall Study|Abnormal test procedure(s)|3|||
16929022|NCT00172042|38072663|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
16929023|NCT00172042|38072664|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
16929024|NCT00172042|38072663|FG000|Overall Study|Patient no longer requires study drug|10|||
16929025|NCT00172042|38072664|FG001|Overall Study|Patient no longer requires study drug|8|||
16929026|NCT00172042|38072663|FG000|Overall Study|Protocol Violation|8|||
16929027|NCT00172042|38072664|FG001|Overall Study|Protocol Violation|7|||
16929028|NCT00172042|38072663|FG000|Overall Study|Withdrawal by Subject|37|||
16929029|NCT00172042|38072664|FG001|Overall Study|Withdrawal by Subject|25|||
16929030|NCT00172042|38072663|FG000|Overall Study|Lost to Follow-up|3|||
16929031|NCT00172042|38072664|FG001|Overall Study|Lost to Follow-up|5|||
16929032|NCT00172042|38072663|FG000|Overall Study|Administrative problems|13|||
16929033|NCT00172042|38072664|FG001|Overall Study|Administrative problems|10|||
16929034|NCT00172042|38072663|FG000|Overall Study|Death|42|||
16929035|NCT00172042|38072664|FG001|Overall Study|Death|42|||
17018718|NCT00818766|38163300|FG001|Overall Study|Could not be Contacted on Day 28|10|||
16929036|NCT00171925|38072672|FG000|Overall Study|Adverse Event|10|||
16929037|NCT00171925|38072673|FG001|Overall Study|Adverse Event|6|||
16929038|NCT00171925|38072672|FG000|Overall Study|Protocol Violation|1|||
16929039|NCT00171925|38072673|FG001|Overall Study|Protocol Violation|1|||
16929040|NCT00171925|38072672|FG000|Overall Study|Withdrawal by Subject|6|||
17018719|NCT00818766|38163299|FG000|Overall Study|Death|1|||
17018720|NCT00818766|38163300|FG001|Overall Study|Death|0|||
16851207|NCT01519089|37799015|FG000|Overall Study|Lost to Follow-up|1|||
16851208|NCT01519089|37799016|FG001|Overall Study|Lost to Follow-up|0|||
16851209|NCT01519089|37799015|FG000|Overall Study|Withdrawal by Subject|0|||
16851210|NCT01519089|37799016|FG001|Overall Study|Withdrawal by Subject|2|||
16851211|NCT01519089|37799015|FG000|Overall Study|Other|2|||
16851212|NCT01519089|37799016|FG001|Overall Study|Other|6|||
16851213|NCT01519089|37799015|FG000|Overall Study|Not received study drug|0|||
16851214|NCT01519089|37799016|FG001|Overall Study|Not received study drug|1|||
16851215|NCT01518699|37799038|FG000|Period 2|Protocol Violation|1|||
16851216|NCT01518699|37799039|FG001|Period 2|Protocol Violation|1|||
16929041|NCT00171925|38072673|FG001|Overall Study|Withdrawal by Subject|9|||
16929042|NCT00171925|38072672|FG000|Overall Study|Lost to Follow-up|2|||
16851217|NCT01518699|37799040|FG002|Period 2|Protocol Violation|0|||
16851218|NCT01518699|37799041|FG003|Period 2|Protocol Violation|0|||
16851219|NCT01518699|37799042|FG004|Period 2|Protocol Violation|0|||
16851220|NCT01518699|37799043|FG005|Period 2|Protocol Violation|0|||
16851221|NCT01518699|37799038|FG000|Period 2|Lost to Follow-up|0|||
16851222|NCT01518699|37799039|FG001|Period 2|Lost to Follow-up|1|||
16851223|NCT01518699|37799040|FG002|Period 2|Lost to Follow-up|0|||
16851224|NCT01518699|37799041|FG003|Period 2|Lost to Follow-up|0|||
16851225|NCT01518699|37799042|FG004|Period 2|Lost to Follow-up|0|||
16851226|NCT01518699|37799043|FG005|Period 2|Lost to Follow-up|0|||
16851227|NCT01518699|37799038|FG000|Period 2|Adverse Event|1|||
16851228|NCT01518699|37799039|FG001|Period 2|Adverse Event|0|||
16851229|NCT01518699|37799040|FG002|Period 2|Adverse Event|0|||
16851230|NCT01518699|37799041|FG003|Period 2|Adverse Event|0|||
16851231|NCT01518699|37799042|FG004|Period 2|Adverse Event|0|||
16851232|NCT01518699|37799043|FG005|Period 2|Adverse Event|0|||
16851233|NCT01518309|37799051|FG000|Overall Study|Adverse Event|6|||
16851234|NCT01518309|37799051|FG000|Overall Study|Death|6|||
16851235|NCT01518309|37799051|FG000|Overall Study|Lack of Efficacy|7|||
16851236|NCT01518309|37799051|FG000|Overall Study|Withdrawal by Subject|6|||
16851237|NCT01518309|37799051|FG000|Overall Study|Physician Decision|3|||
16851238|NCT01518309|37799051|FG000|Overall Study|Sponsor Decision|2|||
16851239|NCT01518309|37799051|FG000|Overall Study|Not in Predefined Categories|9|||
16851240|NCT01419717|37799055|FG000|Overall Study|Protocol-specified Criteria|62|||
16851241|NCT01419717|37799055|FG000|Overall Study|Adverse Event|19|||
16851242|NCT01419717|37799055|FG000|Overall Study|Death|17|||
16851243|NCT01419717|37799055|FG000|Overall Study|Withdrawal by Subject|10|||
16851244|NCT01419717|37799055|FG000|Overall Study|Disease Progression|9|||
16851245|NCT01419717|37799055|FG000|Overall Study|Other|4|||
16851246|NCT01419717|37799055|FG000|Overall Study|Lost to Follow-up|2|||
16851247|NCT01419717|37799055|FG000|Overall Study|Administrative Decision|1|||
16851248|NCT01419717|37799055|FG000|Overall Study|Noncompliance|1|||
16851249|NCT01458951|37799062|FG000|Overall Study|Other|1|||
16929043|NCT00171925|38072673|FG001|Overall Study|Lost to Follow-up|2|||
16929044|NCT00171925|38072672|FG000|Overall Study|Administrative problems|10|||
16929045|NCT00171925|38072673|FG001|Overall Study|Administrative problems|11|||
16929046|NCT00171925|38072672|FG000|Overall Study|Death|1|||
16929047|NCT00171925|38072673|FG001|Overall Study|Death|2|||
16929048|NCT00171340|38072681|FG000|Overall Study|Adverse Event|46|||
16929049|NCT00171340|38072682|FG001|Overall Study|Adverse Event|42|||
16929050|NCT00171340|38072681|FG000|Overall Study|Lack of Efficacy|29|||
16929051|NCT00171340|38072682|FG001|Overall Study|Lack of Efficacy|41|||
16929052|NCT00171340|38072681|FG000|Overall Study|Protocol Violation|7|||
16929053|NCT00171340|38072682|FG001|Overall Study|Protocol Violation|8|||
16929054|NCT00171340|38072681|FG000|Overall Study|Withdrawal by Subject|22|||
16929055|NCT00171340|38072682|FG001|Overall Study|Withdrawal by Subject|19|||
16929056|NCT00171340|38072681|FG000|Overall Study|Lost to Follow-up|0|||
16929057|NCT00171340|38072682|FG001|Overall Study|Lost to Follow-up|5|||
16929058|NCT00171340|38072681|FG000|Overall Study|Abnormal Laboratory Results|2|||
16929059|NCT00171340|38072682|FG001|Overall Study|Abnormal Laboratory Results|0|||
16929060|NCT00171340|38072681|FG000|Overall Study|Abnormal Test Procedure Results|6|||
16851250|NCT01458951|37799063|FG001|Overall Study|Other|0|||
16851251|NCT01458951|37799064|FG002|Overall Study|Other|0|||
16851252|NCT01458951|37799062|FG000|Overall Study|Protocol Violation|5|||
16851253|NCT01458951|37799063|FG001|Overall Study|Protocol Violation|1|||
16851254|NCT01458951|37799064|FG002|Overall Study|Protocol Violation|0|||
16851255|NCT01458951|37799062|FG000|Overall Study|Withdrawal by Subject|2|||
16851256|NCT01458951|37799063|FG001|Overall Study|Withdrawal by Subject|0|||
16851257|NCT01458951|37799064|FG002|Overall Study|Withdrawal by Subject|2|||
16851258|NCT01458951|37799062|FG000|Overall Study|Adverse Event|7|||
16851259|NCT01458951|37799063|FG001|Overall Study|Adverse Event|0|||
16851260|NCT01458951|37799064|FG002|Overall Study|Adverse Event|2|||
16851261|NCT01458951|37799062|FG000|Overall Study|Insufficient Clinical Response|17|||
16851262|NCT01458951|37799063|FG001|Overall Study|Insufficient Clinical Response|0|||
16851263|NCT01458951|37799064|FG002|Overall Study|Insufficient Clinical Response|11|||
16851264|NCT01458639|37799071|FG000|Overall Study|Physician Decision|4|||
16929061|NCT00171340|38072682|FG001|Overall Study|Abnormal Test Procedure Results|11|||
17018721|NCT00818766|38163299|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
17018722|NCT00818766|38163300|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
17018723|NCT00667888|38163308|FG000|Overall Study|Death|1|||
17018724|NCT00667888|38163309|FG001|Overall Study|Death|1|||
17018725|NCT00667888|38163308|FG000|Overall Study|Withdrawal by Subject|6|||
17018726|NCT00667888|38163309|FG001|Overall Study|Withdrawal by Subject|3|||
17018727|NCT00667888|38163308|FG000|Overall Study|Proceed with other treatment|3|||
16851265|NCT01458639|37799071|FG000|Overall Study|Equipment issue|1|||
16851266|NCT01458639|37799071|FG000|Overall Study|Inability to obtain subject blood sample|1|||
16851267|NCT01437423|37799075|FG000|Overall Study|Lost to Follow-up|12|||
16851268|NCT01437423|37799075|FG000|Overall Study|Off label usage|3|||
16851269|NCT01458249|37799106|FG000|Overall Study|Not treated|1|||
16851270|NCT01458249|37799106|FG000|Overall Study|Adverse Event|4|||
16851271|NCT01458249|37799106|FG000|Overall Study|Other|2|||
16929062|NCT00171340|38072681|FG000|Overall Study|No Longer Required Study Drug|1|||
16929063|NCT00171340|38072682|FG001|Overall Study|No Longer Required Study Drug|1|||
16929064|NCT00171340|38072681|FG000|Overall Study|Administrative Problems|5|||
16929065|NCT00171340|38072682|FG001|Overall Study|Administrative Problems|2|||
16929066|NCT00171340|38072681|FG000|Overall Study|Death|6|||
16929067|NCT00171340|38072682|FG001|Overall Study|Death|6|||
16929068|NCT00171301|38072692|FG000|Overall Study|Death|1|||
16929069|NCT00171301|38072693|FG001|Overall Study|Death|2|||
16929070|NCT00171301|38072692|FG000|Overall Study|Adverse Event|1|||
16929071|NCT00171301|38072693|FG001|Overall Study|Adverse Event|2|||
16929072|NCT00171301|38072692|FG000|Overall Study|Lost to Follow-up|6|||
16929073|NCT00171301|38072693|FG001|Overall Study|Lost to Follow-up|2|||
16929074|NCT00171301|38072692|FG000|Overall Study|Protocol Violation|0|||
16929075|NCT00171301|38072693|FG001|Overall Study|Protocol Violation|2|||
16929076|NCT00171301|38072692|FG000|Overall Study|Withdrawal by Subject|0|||
16929077|NCT00171301|38072693|FG001|Overall Study|Withdrawal by Subject|1|||
16929078|NCT00171223|38072703|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
16929079|NCT00171223|38072704|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
16929080|NCT00171223|38072705|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
16929081|NCT00171223|38072703|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
16929082|NCT00171223|38072704|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
16929083|NCT00171223|38072705|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
16929084|NCT00171223|38072703|FG000|Overall Study|Abnormal Procedure|1|||
16929085|NCT00171223|38072704|FG001|Overall Study|Abnormal Procedure|0|||
16929086|NCT00171223|38072705|FG002|Overall Study|Abnormal Procedure|0|||
16929087|NCT00171223|38072703|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
16929088|NCT00171223|38072704|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
16929089|NCT00171223|38072705|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
16929090|NCT00171223|38072703|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
16929091|NCT00171223|38072704|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
16929092|NCT00171223|38072705|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
16929093|NCT00171223|38072703|FG000|Overall Study|Protocol Violation|2|||
16929094|NCT00171223|38072704|FG001|Overall Study|Protocol Violation|2|||
16929095|NCT00171223|38072705|FG002|Overall Study|Protocol Violation|3|||
16929096|NCT00171223|38072703|FG000|Overall Study|Participant Withdrew Consent|12|||
16929097|NCT00171223|38072704|FG001|Overall Study|Participant Withdrew Consent|21|||
16929098|NCT00171223|38072705|FG002|Overall Study|Participant Withdrew Consent|15|||
16929099|NCT00171223|38072703|FG000|Overall Study|Lost to Follow-up|5|||
16929100|NCT00171223|38072704|FG001|Overall Study|Lost to Follow-up|2|||
16851272|NCT01458249|37799106|FG000|Overall Study|Ongoing|1|||
16851273|NCT01458171|37799122|FG000|Overall Study|Adverse Event|1|||
16851274|NCT01457703|37799139|FG000|Overall Study|Screen Failure|5|||
16851275|NCT01457703|37799140|FG001|Overall Study|Screen Failure|7|||
16851276|NCT01457703|37799139|FG000|Overall Study|Withdrawal by Subject|1|||
16851277|NCT01457703|37799140|FG001|Overall Study|Withdrawal by Subject|4|||
16851278|NCT01419015|37799158|FG000|Overall Study|Death|2|||
16851279|NCT01418937|37799179|FG000|Overall Study|Lost to Follow-up|5|||
16851280|NCT01418937|37799179|FG000|Overall Study|Protocol Violation|1|||
16851281|NCT01418937|37799179|FG000|Overall Study|Pregnancy|1|||
16929101|NCT00171223|38072705|FG002|Overall Study|Lost to Follow-up|3|||
16929102|NCT00171223|38072703|FG000|Overall Study|Administrative Problems|4|||
16929103|NCT00171223|38072704|FG001|Overall Study|Administrative Problems|7|||
16929104|NCT00171223|38072705|FG002|Overall Study|Administrative Problems|6|||
16851282|NCT01418937|37799179|FG000|Overall Study|Withdrawal by Subject|1|||
16851283|NCT01417377|37799192|FG000|Overall Study|Lost to Follow-up|12|||
16929105|NCT00171223|38072703|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
16929106|NCT00171223|38072704|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
16929107|NCT00171223|38072705|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
16929108|NCT00171223|38072703|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
16851284|NCT01417377|37799192|FG000|Overall Study|Enrolled, but not treated|1|||
16851285|NCT01437267|37799239|FG000|Overall Study|Withdrawal by Subject|0|||
16929109|NCT00171223|38072704|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
16929110|NCT00171223|38072705|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
16929111|NCT00479674|38072711|FG000|Overall Study|Adverse Event|18|||
16929112|NCT00479674|38072711|FG000|Overall Study|Withdrawal by Subject|6|||
16929113|NCT00479674|38072711|FG000|Overall Study|Physician Decision|14|||
16929114|NCT00479674|38072711|FG000|Overall Study|none provided|3|||
16929115|NCT00479401|38072718|FG000|Overall Study|Adverse Event|24|||
16929116|NCT00479401|38072719|FG001|Overall Study|Adverse Event|20|||
16929117|NCT00479401|38072720|FG002|Overall Study|Adverse Event|4|||
16929118|NCT00479401|38072718|FG000|Overall Study|Lack of Efficacy|2|||
16929119|NCT00479401|38072719|FG001|Overall Study|Lack of Efficacy|2|||
16929120|NCT00479401|38072720|FG002|Overall Study|Lack of Efficacy|4|||
16929121|NCT00479401|38072718|FG000|Overall Study|Protocol Violation|2|||
16929122|NCT00479401|38072719|FG001|Overall Study|Protocol Violation|1|||
16851286|NCT01437267|37799240|FG001|Overall Study|Withdrawal by Subject|0|||
16929123|NCT00479401|38072720|FG002|Overall Study|Protocol Violation|1|||
16929124|NCT00479401|38072718|FG000|Overall Study|Lost to Follow-up|1|||
16929125|NCT00479401|38072719|FG001|Overall Study|Lost to Follow-up|1|||
16929126|NCT00479401|38072720|FG002|Overall Study|Lost to Follow-up|1|||
16929127|NCT00479401|38072718|FG000|Overall Study|Withdrawal by Subject|16|||
16929128|NCT00479401|38072719|FG001|Overall Study|Withdrawal by Subject|10|||
16929129|NCT00479401|38072720|FG002|Overall Study|Withdrawal by Subject|2|||
16929130|NCT00479401|38072718|FG000|Overall Study|Exclusion criteria, relocation|4|||
16929131|NCT00479401|38072719|FG001|Overall Study|Exclusion criteria, relocation|3|||
16929132|NCT00479401|38072720|FG002|Overall Study|Exclusion criteria, relocation|0|||
16929133|NCT00478777|38072728|FG000|Overall Study|Adverse Event|29|||
16929134|NCT00478777|38072728|FG000|Overall Study|Lack of Efficacy|23|||
16929135|NCT00478777|38072728|FG000|Overall Study|Withdrawal by Subject|4|||
16929136|NCT00478777|38072728|FG000|Overall Study|Death|3|||
16929137|NCT00478777|38072728|FG000|Overall Study|Protocol Violation|3|||
16929138|NCT00478777|38072728|FG000|Overall Study|Lost to Follow-up|3|||
16929139|NCT00478777|38072728|FG000|Overall Study|Physician Decision|1|||
16929140|NCT00478777|38072728|FG000|Overall Study|Intolerance of therapy|1|||
16929141|NCT00478777|38072728|FG000|Overall Study|Lack of compliance|1|||
16851287|NCT01437267|37799241|FG002|Overall Study|Withdrawal by Subject|0|||
16851288|NCT01437267|37799242|FG003|Overall Study|Withdrawal by Subject|1|||
16851289|NCT01437267|37799243|FG004|Overall Study|Withdrawal by Subject|0|||
16851290|NCT01437267|37799244|FG005|Overall Study|Withdrawal by Subject|0|||
16851291|NCT01437267|37799239|FG000|Overall Study|Protocol Violation|0|||
16851292|NCT01437267|37799240|FG001|Overall Study|Protocol Violation|1|||
16929142|NCT00478777|38072728|FG000|Overall Study|Lymphocytes infusion|1|||
16929143|NCT00478777|38072728|FG000|Overall Study|End of therapy|2|||
16929144|NCT00478777|38072728|FG000|Overall Study|Not treated with lenalidomide|6|||
16929145|NCT00477607|38072734|FG000|Overall Study|Lost to Follow-up|7|||
16929146|NCT00477607|38072735|FG001|Overall Study|Lost to Follow-up|7|||
16851293|NCT01437267|37799241|FG002|Overall Study|Protocol Violation|0|||
16851294|NCT01437267|37799242|FG003|Overall Study|Protocol Violation|0|||
16851295|NCT01437267|37799243|FG004|Overall Study|Protocol Violation|0|||
16851296|NCT01437267|37799244|FG005|Overall Study|Protocol Violation|0|||
16851297|NCT01456221|37799273|FG000|Overall Study|Withdrawal by Subject|56|||
16851298|NCT01456221|37799274|FG001|Overall Study|Withdrawal by Subject|49|||
16851299|NCT01456221|37799273|FG000|Overall Study|Lost to Follow-up|1|||
16851300|NCT01456221|37799274|FG001|Overall Study|Lost to Follow-up|4|||
16851301|NCT01456221|37799273|FG000|Overall Study|Received medication|3|||
16851302|NCT01456221|37799274|FG001|Overall Study|Received medication|2|||
16851303|NCT01456221|37799273|FG000|Overall Study|Incomplete data|4|||
16851304|NCT01456221|37799274|FG001|Overall Study|Incomplete data|2|||
16851305|NCT01437111|37799280|FG000|Overall Study|Adverse Event|2|||
16851306|NCT01437111|37799280|FG000|Overall Study|Withdrawal by Subject|4|||
16851307|NCT01437111|37799280|FG000|Overall Study|Not reported|5|||
16851308|NCT01437111|37799280|FG000|Overall Study|Physician Decision|1|||
16929147|NCT00477490|38072746|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
16929148|NCT00477490|38072747|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
16929149|NCT00477490|38072748|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
16929150|NCT00477490|38072749|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
16929151|NCT00477490|38072750|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
16929152|NCT00477490|38072751|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
16929153|NCT00477490|38072752|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
16929154|NCT00477490|38072753|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
16929155|NCT00477490|38072754|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
16929156|NCT00477490|38072746|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
16929157|NCT00477490|38072747|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16929158|NCT00477490|38072748|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16929159|NCT00477490|38072749|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
16929160|NCT00477490|38072750|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
16929161|NCT00477490|38072751|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16929162|NCT00477490|38072752|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16929163|NCT00477490|38072753|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16929164|NCT00477490|38072754|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16929165|NCT00477490|38072746|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
16929166|NCT00477490|38072747|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
16929167|NCT00477490|38072748|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
16929168|NCT00477490|38072749|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
16929169|NCT00477490|38072750|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
16929170|NCT00477490|38072751|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
16929171|NCT00477490|38072752|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
16929172|NCT00477490|38072753|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
16851309|NCT01437111|37799280|FG000|Overall Study|Lost to Follow-up|5|||
16851310|NCT01437111|37799280|FG000|Overall Study|Protocol Violation|1|||
16851311|NCT01436643|37799328|FG000|2-week Pre-treatment|Abnormal test result|0|||
16851312|NCT01436643|37799329|FG001|2-week Pre-treatment|Abnormal test result|0|||
16929173|NCT00477490|38072754|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
16929174|NCT00477490|38072746|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
16929175|NCT00477490|38072747|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
16929176|NCT00477490|38072748|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
16929177|NCT00477490|38072749|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
16929178|NCT00477490|38072750|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
16929179|NCT00477490|38072751|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
16929180|NCT00477490|38072752|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
16929181|NCT00477490|38072753|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
16929182|NCT00477490|38072754|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
16929183|NCT00477490|38072746|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
16929184|NCT00477490|38072747|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
16929185|NCT00477490|38072748|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
16929186|NCT00477490|38072749|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
16929187|NCT00477490|38072750|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
16929188|NCT00477490|38072751|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
16929189|NCT00477490|38072752|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
16929190|NCT00477490|38072753|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
16929191|NCT00477490|38072754|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
16929192|NCT00477490|38072746|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
16929193|NCT00477490|38072747|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
16929194|NCT00477490|38072748|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
16929195|NCT00477490|38072749|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
16929196|NCT00477490|38072750|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
16929197|NCT00477490|38072751|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
16929198|NCT00477490|38072752|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
16929199|NCT00477490|38072753|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
16929200|NCT00477490|38072754|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
17018728|NCT00667888|38163309|FG001|Overall Study|Proceed with other treatment|3|||
17018729|NCT00667888|38163308|FG000|Overall Study|Ineligible after SIM|0|||
17018730|NCT00667888|38163309|FG001|Overall Study|Ineligible after SIM|2|||
17018731|NCT00594815|38163315|FG000|Overall Study|Never Treated|3|||
17018732|NCT00594815|38163315|FG000|Overall Study|Withdrawal by Subject|2|||
17018733|NCT00594815|38163315|FG000|Overall Study|Toxicity|4|||
17018734|NCT00820248|38163321|FG000|Overall Study|No treated|4|||
17018735|NCT00820248|38163322|FG001|Overall Study|No treated|1|||
17018736|NCT00820170|38163333|FG000|Overall Study|Adverse Event|0|||
17018737|NCT00820170|38163334|FG001|Overall Study|Adverse Event|0|||
17018738|NCT00820170|38163335|FG002|Overall Study|Adverse Event|0|||
17018739|NCT00820170|38163336|FG003|Overall Study|Adverse Event|0|||
17018740|NCT00820170|38163337|FG004|Overall Study|Adverse Event|2|||
17018741|NCT00820170|38163333|FG000|Overall Study|Progressive Disease|0|||
17018742|NCT00820170|38163334|FG001|Overall Study|Progressive Disease|0|||
17018743|NCT00820170|38163335|FG002|Overall Study|Progressive Disease|0|||
17018744|NCT00820170|38163336|FG003|Overall Study|Progressive Disease|0|||
17018745|NCT00820170|38163337|FG004|Overall Study|Progressive Disease|2|||
17018746|NCT00818454|38163354|FG000|Treatment Period 1|Adverse Event|0|||
17018747|NCT00818454|38163355|FG001|Treatment Period 1|Adverse Event|1|||
17198614|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
17198615|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
17018748|NCT00818454|38163356|FG002|Treatment Period 1|Adverse Event|0|||
17018749|NCT00818454|38163357|FG003|Treatment Period 1|Adverse Event|0|||
17018750|NCT00818454|38163354|FG000|Treatment Period 1|Other|3|||
17018751|NCT00818454|38163355|FG001|Treatment Period 1|Other|0|||
17018752|NCT00818454|38163356|FG002|Treatment Period 1|Other|0|||
17018753|NCT00818454|38163357|FG003|Treatment Period 1|Other|0|||
17018754|NCT00818454|38163354|FG000|Washout Period of 1 Week|Adverse Event|1|||
17018755|NCT00818454|38163355|FG001|Washout Period of 1 Week|Adverse Event|1|||
17018756|NCT00818454|38163356|FG002|Washout Period of 1 Week|Adverse Event|0|||
17018757|NCT00818454|38163357|FG003|Washout Period of 1 Week|Adverse Event|0|||
17018758|NCT00818454|38163354|FG000|Washout Period of 1 Week|Protocol Violation|2|||
17018759|NCT00818454|38163355|FG001|Washout Period of 1 Week|Protocol Violation|0|||
17018760|NCT00818454|38163356|FG002|Washout Period of 1 Week|Protocol Violation|0|||
17018761|NCT00818454|38163357|FG003|Washout Period of 1 Week|Protocol Violation|0|||
17018762|NCT00818454|38163354|FG000|Washout Period of 1 Week|Other|1|||
17018763|NCT00818454|38163355|FG001|Washout Period of 1 Week|Other|2|||
16929201|NCT00477490|38072746|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
16929202|NCT00477490|38072747|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
16929203|NCT00477490|38072748|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
17018764|NCT00818454|38163356|FG002|Washout Period of 1 Week|Other|0|||
17018765|NCT00818454|38163357|FG003|Washout Period of 1 Week|Other|0|||
17018766|NCT00818454|38163354|FG000|Treatment Period 2|Other|2|||
17018767|NCT00818454|38163355|FG001|Treatment Period 2|Other|1|||
17018768|NCT00818454|38163356|FG002|Treatment Period 2|Other|0|||
17018769|NCT00818454|38163357|FG003|Treatment Period 2|Other|0|||
17018770|NCT00818454|38163354|FG000|Treatment Period 3|Adverse Event|0|||
16929204|NCT00477490|38072749|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
16929205|NCT00477490|38072750|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
16929206|NCT00477490|38072751|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
16929207|NCT00477490|38072752|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
16929208|NCT00477490|38072753|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
16929209|NCT00477490|38072754|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
16929210|NCT00477490|38072746|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
16929211|NCT00477490|38072747|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
16929212|NCT00477490|38072748|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
16929213|NCT00477490|38072749|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
16929214|NCT00477490|38072750|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
17018771|NCT00818454|38163355|FG001|Treatment Period 3|Adverse Event|0|||
17018772|NCT00818454|38163356|FG002|Treatment Period 3|Adverse Event|0|||
17018773|NCT00818454|38163357|FG003|Treatment Period 3|Adverse Event|1|||
17018774|NCT00828984|38163370|FG000|Overall Study|Adverse Event|2|||
17018775|NCT00828984|38163371|FG001|Overall Study|Adverse Event|3|||
17018776|NCT00828984|38163372|FG002|Overall Study|Adverse Event|0|||
17018777|NCT00828984|38163370|FG000|Overall Study|Lost to Follow-up|5|||
17018778|NCT00828984|38163371|FG001|Overall Study|Lost to Follow-up|3|||
17018779|NCT00828984|38163372|FG002|Overall Study|Lost to Follow-up|1|||
17018780|NCT00828984|38163370|FG000|Overall Study|Withdrawal by Subject|4|||
17018781|NCT00828984|38163371|FG001|Overall Study|Withdrawal by Subject|4|||
17018782|NCT00828984|38163372|FG002|Overall Study|Withdrawal by Subject|4|||
17018783|NCT00828984|38163370|FG000|Overall Study|Ineligable|1|||
17018784|NCT00828984|38163371|FG001|Overall Study|Ineligable|2|||
17018785|NCT00828984|38163372|FG002|Overall Study|Ineligable|0|||
17018786|NCT00828984|38163370|FG000|Overall Study|Medical Contraindication|0|||
17018787|NCT00828984|38163371|FG001|Overall Study|Medical Contraindication|1|||
17018788|NCT00828984|38163372|FG002|Overall Study|Medical Contraindication|0|||
17018789|NCT00828984|38163370|FG000|Overall Study|Noncompliant|1|||
17018790|NCT00828984|38163371|FG001|Overall Study|Noncompliant|2|||
17018791|NCT00828984|38163372|FG002|Overall Study|Noncompliant|3|||
17018792|NCT00828984|38163370|FG000|Overall Study|ConMed|1|||
17018793|NCT00828984|38163371|FG001|Overall Study|ConMed|1|||
17018794|NCT00828984|38163372|FG002|Overall Study|ConMed|1|||
17018795|NCT00828750|38163380|FG000|Overall Study|Lack of Efficacy|3|||
17018796|NCT00828750|38163380|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
17018797|NCT00667810|38163389|FG000|Overall Study|Adverse Event|13|||
17018798|NCT00667810|38163390|FG001|Overall Study|Adverse Event|14|||
17018799|NCT00667810|38163391|FG002|Overall Study|Adverse Event|19|||
17018800|NCT00667810|38163392|FG003|Overall Study|Adverse Event|1|||
17018801|NCT00667810|38163389|FG000|Overall Study|Death|1|||
17018802|NCT00667810|38163390|FG001|Overall Study|Death|1|||
17018803|NCT00667810|38163391|FG002|Overall Study|Death|3|||
17018804|NCT00667810|38163392|FG003|Overall Study|Death|0|||
17018805|NCT00667810|38163389|FG000|Overall Study|Lack of Efficacy|1|||
17018806|NCT00667810|38163390|FG001|Overall Study|Lack of Efficacy|0|||
17018807|NCT00667810|38163391|FG002|Overall Study|Lack of Efficacy|2|||
17018808|NCT00667810|38163392|FG003|Overall Study|Lack of Efficacy|0|||
17018809|NCT00667810|38163389|FG000|Overall Study|Lost to Follow-up|1|||
17018810|NCT00667810|38163390|FG001|Overall Study|Lost to Follow-up|4|||
17018811|NCT00667810|38163391|FG002|Overall Study|Lost to Follow-up|2|||
17018812|NCT00667810|38163392|FG003|Overall Study|Lost to Follow-up|0|||
17018813|NCT00667810|38163389|FG000|Overall Study|Physician Decision|1|||
17018814|NCT00667810|38163390|FG001|Overall Study|Physician Decision|1|||
17018815|NCT00667810|38163391|FG002|Overall Study|Physician Decision|2|||
16929215|NCT00477490|38072751|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
16929216|NCT00477490|38072752|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
16929217|NCT00477490|38072753|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
16929218|NCT00477490|38072754|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
16929219|NCT00477490|38072746|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
16929220|NCT00477490|38072747|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
16929221|NCT00477490|38072748|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
16929222|NCT00477490|38072749|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16929223|NCT00477490|38072750|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16929224|NCT00477490|38072751|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16929225|NCT00477490|38072752|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16929226|NCT00477490|38072753|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
17018816|NCT00667810|38163392|FG003|Overall Study|Physician Decision|0|||
17018817|NCT00667810|38163389|FG000|Overall Study|Protocol Violation|0|||
17018818|NCT00667810|38163390|FG001|Overall Study|Protocol Violation|2|||
17018819|NCT00667810|38163391|FG002|Overall Study|Protocol Violation|0|||
17018820|NCT00667810|38163392|FG003|Overall Study|Protocol Violation|0|||
17018821|NCT00667810|38163389|FG000|Overall Study|Withdrawal by Subject|14|||
17018822|NCT00667810|38163390|FG001|Overall Study|Withdrawal by Subject|20|||
17018823|NCT00667810|38163391|FG002|Overall Study|Withdrawal by Subject|29|||
16929227|NCT00477490|38072754|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
16929228|NCT00477490|38072746|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16929229|NCT00477490|38072747|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
16929230|NCT00477490|38072748|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
16929231|NCT00477490|38072749|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16929232|NCT00477490|38072750|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
16929233|NCT00477490|38072751|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16929234|NCT00477490|38072752|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
16929235|NCT00477490|38072753|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16929236|NCT00477490|38072754|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16929237|NCT00477490|38072746|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16929238|NCT00477490|38072747|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16929239|NCT00477490|38072748|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16929240|NCT00477490|38072749|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16929241|NCT00477490|38072750|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
16929242|NCT00477490|38072751|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16929243|NCT00477490|38072752|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16929244|NCT00477490|38072753|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
16929245|NCT00477490|38072754|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
16929246|NCT00477490|38072746|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16929247|NCT00477490|38072747|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
16929248|NCT00477490|38072748|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16929249|NCT00477490|38072749|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16929250|NCT00477490|38072750|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16929251|NCT00477490|38072751|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16929252|NCT00477490|38072752|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16929253|NCT00477490|38072753|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16929254|NCT00477490|38072754|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16929255|NCT00477490|38072746|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
16929256|NCT00477490|38072747|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
16929257|NCT00477490|38072748|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
16929258|NCT00477490|38072749|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
16929259|NCT00477490|38072750|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
16929260|NCT00477490|38072751|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
16929261|NCT00477490|38072752|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
16929262|NCT00477490|38072753|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
16929263|NCT00477490|38072754|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
16929264|NCT00477490|38072746|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16929265|NCT00477490|38072747|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
16929266|NCT00477490|38072748|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
16929267|NCT00477490|38072749|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16929268|NCT00477490|38072750|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
16929269|NCT00477490|38072751|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16929270|NCT00477490|38072752|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16929271|NCT00477490|38072753|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16929272|NCT00477490|38072754|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16929273|NCT00477334|38072784|FG000|Overall Study|Discontinued prior to taking study drug|106|||
16929274|NCT00477334|38072785|FG001|Overall Study|Discontinued prior to taking study drug|53|||
16929275|NCT00477334|38072784|FG000|Overall Study|Adverse Event|1|||
16929276|NCT00477334|38072785|FG001|Overall Study|Adverse Event|2|||
16929277|NCT00477334|38072784|FG000|Overall Study|Withdrawal by Subject|2|||
16929278|NCT00477334|38072785|FG001|Overall Study|Withdrawal by Subject|1|||
16929279|NCT00477334|38072784|FG000|Overall Study|Lost to Follow-up|15|||
16929280|NCT00477334|38072785|FG001|Overall Study|Lost to Follow-up|4|||
16929281|NCT00477334|38072784|FG000|Overall Study|Administrative Problems|39|||
16929282|NCT00477334|38072785|FG001|Overall Study|Administrative Problems|15|||
16929283|NCT00477334|38072784|FG000|Overall Study|Protocol Violation|7|||
17198616|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
16851313|NCT01436643|37799330|FG002|2-week Pre-treatment|Abnormal test result|0|||
16851314|NCT01436643|37799331|FG003|2-week Pre-treatment|Abnormal test result|1|||
16851315|NCT01436643|37799328|FG000|2-week Pre-treatment|Adverse Event|0|||
16851316|NCT01436643|37799329|FG001|2-week Pre-treatment|Adverse Event|0|||
16851317|NCT01436643|37799330|FG002|2-week Pre-treatment|Adverse Event|0|||
16851318|NCT01436643|37799331|FG003|2-week Pre-treatment|Adverse Event|5|||
16851319|NCT01436643|37799328|FG000|2-week Pre-treatment|Protocol Violation|0|||
16851320|NCT01436643|37799329|FG001|2-week Pre-treatment|Protocol Violation|0|||
16851321|NCT01436643|37799330|FG002|2-week Pre-treatment|Protocol Violation|0|||
16851322|NCT01436643|37799331|FG003|2-week Pre-treatment|Protocol Violation|4|||
16851323|NCT01436643|37799328|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
16851324|NCT01436643|37799329|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
16851325|NCT01436643|37799330|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
16851326|NCT01436643|37799331|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
16851327|NCT01436643|37799328|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
16851328|NCT01436643|37799329|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
16851329|NCT01436643|37799330|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
16851330|NCT01436643|37799331|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
16851331|NCT01436643|37799328|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
16851332|NCT01436643|37799329|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
16851333|NCT01436643|37799330|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
16851334|NCT01436643|37799331|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
16929284|NCT00477334|38072785|FG001|Overall Study|Protocol Violation|1|||
16929285|NCT02277106|38072927|FG000|Stage 2|Adverse Event|0|||
16929286|NCT02277106|38072928|FG001|Stage 2|Adverse Event|0|||
16929287|NCT02277106|38072929|FG002|Stage 2|Adverse Event|1|||
16929288|NCT02215096|38072952|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
16929289|NCT02215096|38072953|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
16929290|NCT02215096|38072954|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
16929291|NCT02215096|38072955|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
16929292|NCT02215096|38072956|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
16929293|NCT02215096|38072952|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
16929294|NCT02215096|38072953|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
16929295|NCT02215096|38072954|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
16929296|NCT02215096|38072955|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
16929297|NCT02215096|38072956|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
16929298|NCT02215096|38072952|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
16929299|NCT02215096|38072953|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
16929300|NCT02215096|38072954|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
16929301|NCT02215096|38072955|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
16929302|NCT02215096|38072956|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
16929303|NCT02215096|38072952|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
16929304|NCT02215096|38072953|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
16929305|NCT02215096|38072954|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
16929306|NCT02215096|38072955|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
16929307|NCT02215096|38072956|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
16929308|NCT02214160|38072975|FG000|Overall Study|Withdrawal by Subject|1|||
16929309|NCT02214160|38072976|FG001|Overall Study|Withdrawal by Subject|0|||
16929310|NCT02214160|38072977|FG002|Overall Study|Withdrawal by Subject|6|||
16929311|NCT02214160|38072975|FG000|Overall Study|Death|2|||
16929312|NCT02214160|38072976|FG001|Overall Study|Death|2|||
16929313|NCT02214160|38072977|FG002|Overall Study|Death|1|||
16929314|NCT02214160|38072975|FG000|Overall Study|Subject Non-Compliance|0|||
16929315|NCT02214160|38072976|FG001|Overall Study|Subject Non-Compliance|3|||
16929316|NCT02214160|38072977|FG002|Overall Study|Subject Non-Compliance|1|||
16851335|NCT01454739|37799429|FG000|Overall Study|Protocol Violation|2|||
16851336|NCT01454739|37799430|FG001|Overall Study|Protocol Violation|3|||
16851337|NCT01454739|37799429|FG000|Overall Study|Withdrawal by Subject|2|||
16851338|NCT01454739|37799430|FG001|Overall Study|Withdrawal by Subject|6|||
16851339|NCT01454739|37799429|FG000|Overall Study|Other|3|||
16851340|NCT01454739|37799430|FG001|Overall Study|Other|5|||
16851341|NCT01454739|37799429|FG000|Overall Study|Physician Decision|0|||
16851342|NCT01454739|37799430|FG001|Overall Study|Physician Decision|5|||
16851343|NCT01454739|37799429|FG000|Overall Study|Lost to Follow-up|0|||
16851344|NCT01454739|37799430|FG001|Overall Study|Lost to Follow-up|1|||
16851345|NCT01454739|37799429|FG000|Overall Study|Adverse Event|0|||
16851346|NCT01454739|37799430|FG001|Overall Study|Adverse Event|1|||
16929317|NCT02214160|38072975|FG000|Overall Study|Adverse Event|0|||
16929318|NCT02214160|38072976|FG001|Overall Study|Adverse Event|1|||
16929319|NCT02214160|38072977|FG002|Overall Study|Adverse Event|1|||
16929320|NCT02214160|38072975|FG000|Overall Study|Sponsor Decision|0|||
16929321|NCT02214160|38072976|FG001|Overall Study|Sponsor Decision|2|||
16929322|NCT02214160|38072977|FG002|Overall Study|Sponsor Decision|0|||
16929323|NCT02214160|38072975|FG000|Overall Study|Protocol Violation|1|||
16929324|NCT02214160|38072976|FG001|Overall Study|Protocol Violation|0|||
16929325|NCT02214160|38072977|FG002|Overall Study|Protocol Violation|0|||
16929326|NCT02214160|38072975|FG000|Overall Study|Physician Decision|0|||
16929327|NCT02214160|38072976|FG001|Overall Study|Physician Decision|0|||
16929328|NCT02214160|38072977|FG002|Overall Study|Physician Decision|1|||
17018824|NCT00667810|38163392|FG003|Overall Study|Withdrawal by Subject|1|||
17018825|NCT00667810|38163389|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
17018826|NCT00667810|38163390|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
16851349|NCT01416441|37799477|FG000|Overall Study|Lost to Follow-up|5|||
16929329|NCT03189862|38072995|FG000|Overall Study|Withdrawal by Subject|1|||
16929330|NCT03189862|38072996|FG001|Overall Study|Withdrawal by Subject|0|||
16929331|NCT03189862|38072995|FG000|Overall Study|Lost to Follow-up|54|||
16929332|NCT03189862|38072996|FG001|Overall Study|Lost to Follow-up|62|||
16929333|NCT00107614|38073028|FG000|Overall Study|Physician Decision|10|||
16929334|NCT00107614|38073028|FG000|Overall Study|Death|2|||
16929335|NCT00107380|38073032|FG000|Overall Study|Adverse Event|7|||
16929336|NCT00107380|38073032|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
16929337|NCT00107380|38073032|FG000|Overall Study|Progression/relapse|4|||
16929338|NCT00107380|38073032|FG000|Overall Study|Death|3|||
16929339|NCT00107380|38073032|FG000|Overall Study|Other - not protocol specified|7|||
16929340|NCT00107380|38073032|FG000|Overall Study|Ineligible|2|||
16929341|NCT01340014|38073039|FG000|Period 1, First 7 Days|Adverse Event|1|||
16929342|NCT01340014|38073040|FG001|Period 1, First 7 Days|Adverse Event|0|||
16929343|NCT01340014|38073039|FG000|Period 1, First 7 Days|Personal Reasons|1|||
16851350|NCT01416441|37799477|FG000|Overall Study|Adverse Event|6|||
16851351|NCT01416441|37799477|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
16851352|NCT01416441|37799477|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
16851353|NCT01416441|37799477|FG000|Overall Study|Investigator Withdrew Subject|2|||
16851354|NCT01416441|37799477|FG000|Overall Study|Subject Withdrew Consent|12|||
16851355|NCT01416441|37799477|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
16851356|NCT01436253|37799486|FG000|Overall Study|Lost to Follow-up|182|||
16851357|NCT01436253|37799486|FG000|Overall Study|Not meeting all eligibility criteria|117|||
16851358|NCT01454583|37800399|FG000|1st Year|Lost to Follow-up|1057|||
16851359|NCT01454583|37800400|FG001|1st Year|Lost to Follow-up|318|||
16851360|NCT01454583|37800401|FG002|1st Year|Lost to Follow-up|180|||
16851361|NCT01454583|37800399|FG000|2nd Year|Lost to Follow-up|3965|||
16929344|NCT01340014|38073040|FG001|Period 1, First 7 Days|Personal Reasons|0|||
16929345|NCT01340014|38073039|FG000|Period 2, Second 7 Days|Adverse Event|0|||
16929346|NCT01340014|38073040|FG001|Period 2, Second 7 Days|Adverse Event|1|||
16929347|NCT01339897|38073050|FG000|Overall Study|Adverse Event|1|||
16929348|NCT01339897|38073051|FG001|Overall Study|Adverse Event|0|||
16929349|NCT01339897|38073052|FG002|Overall Study|Adverse Event|0|||
16929350|NCT01339897|38073053|FG003|Overall Study|Adverse Event|1|||
16929351|NCT01339429|38073065|FG000|Overall Study|Withdrawal by Subject|1|||
16929352|NCT01339429|38073065|FG000|Overall Study|Physician Decision|3|||
16929353|NCT01339390|38073071|FG000|Overall Study|Death|32|||
16929354|NCT01339390|38073072|FG001|Overall Study|Death|29|||
16929355|NCT01339390|38073071|FG000|Overall Study|Lost to Follow-up|125|||
16929356|NCT01339390|38073072|FG001|Overall Study|Lost to Follow-up|127|||
16929357|NCT01339273|38073080|FG000|Overall Study|Lost to Follow-up|8|||
16929358|NCT01339273|38073081|FG001|Overall Study|Lost to Follow-up|8|||
16929359|NCT01334866|38073087|FG000|Overall Study|Withdrawal by Subject|10|||
16929360|NCT01334866|38073087|FG000|Overall Study|Lost to Follow-up|3|||
16929361|NCT01334866|38073087|FG000|Overall Study|Physician Decision|3|||
16929362|NCT01334866|38073087|FG000|Overall Study|medically necessary prior to procedure|2|||
16929363|NCT01334866|38073087|FG000|Overall Study|medically necessary post-procedure|1|||
16851362|NCT01454583|37800400|FG001|2nd Year|Lost to Follow-up|1049|||
16851363|NCT01454583|37800401|FG002|2nd Year|Lost to Follow-up|737|||
16851364|NCT01454583|37800399|FG000|3rd Year|Lost to Follow-up|1959|||
16851365|NCT01454583|37800400|FG001|3rd Year|Lost to Follow-up|512|||
16851366|NCT01454583|37800401|FG002|3rd Year|Lost to Follow-up|297|||
16851367|NCT01436175|37800424|FG000|Overall Study|Adverse Event|111|||
16851368|NCT01436175|37800424|FG000|Overall Study|Protocol Violation|49|||
16851369|NCT01436175|37800424|FG000|Overall Study|Withdrawal by Subject|108|||
16851370|NCT01436175|37800424|FG000|Overall Study|Lost to Follow-up|89|||
16851371|NCT01436175|37800424|FG000|Overall Study|Lack of Efficacy|24|||
16851372|NCT01436175|37800424|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
16929364|NCT01334710|38073093|FG000|Overall Study|Trial was terminated|3|||
16929365|NCT01334554|38073100|FG000|Overall Study|Adverse Event|4|||
16929366|NCT01334554|38073101|FG001|Overall Study|Adverse Event|2|||
16929367|NCT01332799|38073111|FG000|Overall Study|Insufficient funding|10|||
16929368|NCT01332799|38073112|FG001|Overall Study|Insufficient funding|10|||
16929369|NCT01332331|38073120|FG000|Overall Study|Lost to Follow-up|0|||
16929370|NCT01332331|38073121|FG001|Overall Study|Lost to Follow-up|1|||
16929371|NCT01332331|38073120|FG000|Overall Study|Adverse Event|1|||
16929372|NCT01332331|38073121|FG001|Overall Study|Adverse Event|1|||
16929373|NCT01332331|38073120|FG000|Overall Study|Physician Decision|1|||
16929374|NCT01332331|38073121|FG001|Overall Study|Physician Decision|0|||
16929375|NCT01332292|38073128|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
16929376|NCT01332292|38073129|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
16929377|NCT01332292|38073128|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
16929378|NCT01332292|38073129|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
16929379|NCT01332292|38073128|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
16929380|NCT01332292|38073129|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
16851373|NCT01436175|37800424|FG000|Overall Study|Other|826|||
16851374|NCT01453725|37800452|FG000|Overall Study|Adverse Event|3|||
16929381|NCT01332019|38073139|FG000|Overall Study|Was Not Dosed|1|||
16929382|NCT01332019|38073140|FG001|Overall Study|Was Not Dosed|0|||
16929383|NCT01332019|38073139|FG000|Overall Study|Other|16|||
16929384|NCT01332019|38073140|FG001|Overall Study|Other|18|||
16929385|NCT01332019|38073139|FG000|Overall Study|Death|2|||
16929386|NCT01332019|38073140|FG001|Overall Study|Death|1|||
16929387|NCT01332019|38073139|FG000|Overall Study|Physician Decision|4|||
16929388|NCT01332019|38073140|FG001|Overall Study|Physician Decision|3|||
16929389|NCT01332019|38073139|FG000|Overall Study|Withdrawal by Subject|73|||
16929390|NCT01332019|38073140|FG001|Overall Study|Withdrawal by Subject|71|||
16929391|NCT01332019|38073139|FG000|Overall Study|Lost to Follow-up|4|||
16929392|NCT01332019|38073140|FG001|Overall Study|Lost to Follow-up|7|||
16929393|NCT01332019|38073139|FG000|Overall Study|Adverse Event|13|||
16929394|NCT01332019|38073140|FG001|Overall Study|Adverse Event|22|||
16929395|NCT01331239|38073148|FG000|Part II: Core Study|Adverse Event|0|||
16929396|NCT01331239|38073149|FG001|Part II: Core Study|Adverse Event|3|||
16929397|NCT01331239|38073150|FG002|Part II: Core Study|Adverse Event|0|||
16929398|NCT01331239|38073148|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
16929399|NCT01331239|38073149|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
16929400|NCT01331239|38073150|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
16929401|NCT01331239|38073148|FG000|Part II: Core Study|Withdrawal by Subject|0|||
16929402|NCT01331239|38073149|FG001|Part II: Core Study|Withdrawal by Subject|2|||
16929403|NCT01331239|38073150|FG002|Part II: Core Study|Withdrawal by Subject|0|||
16929404|NCT01331239|38073148|FG000|Part II: Core Study|Administrative problems|0|||
16929405|NCT01331239|38073149|FG001|Part II: Core Study|Administrative problems|1|||
16929406|NCT01331239|38073150|FG002|Part II: Core Study|Administrative problems|0|||
16929407|NCT01331161|38073168|FG000|Overall Study|Physician Decision|1|||
16929408|NCT01331161|38073169|FG001|Overall Study|Physician Decision|0|||
16929409|NCT01331161|38073168|FG000|Overall Study|Lost to Follow-up|0|||
16929410|NCT01331161|38073169|FG001|Overall Study|Lost to Follow-up|1|||
16929411|NCT01331161|38073168|FG000|Overall Study|Pregnancy|0|||
16929412|NCT01331161|38073169|FG001|Overall Study|Pregnancy|1|||
16929413|NCT01331005|38073179|FG000|Overall Study|Lost to Follow-up|2|||
16929414|NCT01331005|38073180|FG001|Overall Study|Lost to Follow-up|1|||
16929415|NCT01331005|38073179|FG000|Overall Study|Withdrawal by Subject|2|||
16929416|NCT01331005|38073180|FG001|Overall Study|Withdrawal by Subject|3|||
16929417|NCT01330459|38073188|FG000|Overall Study|Physician Decision|0|||
16929418|NCT01330459|38073189|FG001|Overall Study|Physician Decision|2|||
16929419|NCT01330381|38073199|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
16929420|NCT01330381|38073200|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
16929421|NCT01330381|38073201|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
16929422|NCT01330381|38073199|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
16929423|NCT01330381|38073200|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
16929424|NCT01330381|38073201|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
16929425|NCT01330381|38073199|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
16929426|NCT01330381|38073200|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
16929427|NCT01330381|38073201|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
16929428|NCT01330381|38073199|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
16929429|NCT01330381|38073200|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
16929430|NCT01330381|38073201|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
16929431|NCT01330381|38073199|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
16929432|NCT01330381|38073200|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
16929433|NCT01330381|38073201|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
16929434|NCT01330381|38073199|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
16929435|NCT01330381|38073200|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
16929436|NCT01330381|38073201|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
16929437|NCT01330381|38073199|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
16929438|NCT01330381|38073200|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
16929439|NCT01330381|38073201|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
16929440|NCT01330381|38073199|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
16929441|NCT01330381|38073200|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
16929442|NCT01330381|38073201|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
16929443|NCT01330381|38073199|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
16851375|NCT01453725|37800453|FG001|Overall Study|Adverse Event|3|||
16851376|NCT01453725|37800452|FG000|Overall Study|Lost to Follow-up|4|||
16851377|NCT01453725|37800453|FG001|Overall Study|Lost to Follow-up|0|||
16851378|NCT01453725|37800452|FG000|Overall Study|Non-compliance With Protocol|1|||
16851379|NCT01453725|37800453|FG001|Overall Study|Non-compliance With Protocol|2|||
16851380|NCT01453725|37800452|FG000|Overall Study|Protocol Violation|1|||
16851381|NCT01453725|37800453|FG001|Overall Study|Protocol Violation|0|||
16851382|NCT01453725|37800452|FG000|Overall Study|Withdrawal by Subject|2|||
16851383|NCT01453725|37800453|FG001|Overall Study|Withdrawal by Subject|3|||
16851384|NCT01453725|37800452|FG000|Overall Study|Pregnancy Wish|0|||
16851385|NCT01453725|37800453|FG001|Overall Study|Pregnancy Wish|2|||
16851386|NCT01453725|37800452|FG000|Overall Study|Pregnancy|1|||
16851387|NCT01453725|37800453|FG001|Overall Study|Pregnancy|0|||
16851388|NCT01453725|37800452|FG000|Overall Study|Physician Decision|1|||
16851389|NCT01453725|37800453|FG001|Overall Study|Physician Decision|1|||
16851390|NCT01415349|37800492|FG000|Treatment Period 1|Adverse Event|0|||
16851391|NCT01415349|37800493|FG001|Treatment Period 1|Adverse Event|1|||
16929444|NCT01330381|38073200|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
16929445|NCT01330381|38073201|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
16929446|NCT01330381|38073199|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
16929447|NCT01330381|38073200|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
16929448|NCT01330381|38073201|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
16929449|NCT01330303|38073210|FG000|Period 1|Adverse Event|1|||
16929450|NCT01330303|38073211|FG001|Period 1|Adverse Event|0|||
16929451|NCT01330303|38073210|FG000|Period 1|Protocol Violation|0|||
16929452|NCT01330303|38073211|FG001|Period 1|Protocol Violation|1|||
16929453|NCT01330303|38073210|FG000|Period 1|Withdrawal by Subject|0|||
16929454|NCT01330303|38073211|FG001|Period 1|Withdrawal by Subject|1|||
16929455|NCT01330108|38073218|FG000|Overall Study|Withdrawal by Subject|4|||
16929456|NCT01059825|38073228|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16929457|NCT01059825|38073229|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16929458|NCT01059825|38073230|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16929459|NCT01059825|38073231|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16929460|NCT01059825|38073232|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16929461|NCT01059825|38073233|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16929462|NCT01059825|38073234|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
16929463|NCT01059825|38073228|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16929464|NCT01059825|38073229|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16929465|NCT01059825|38073230|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16929466|NCT01059825|38073231|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16929467|NCT01059825|38073232|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16929468|NCT01059825|38073233|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16929469|NCT01059825|38073234|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
16929470|NCT01059825|38073228|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
16929471|NCT01059825|38073229|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
16929472|NCT01059825|38073230|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
16929473|NCT01059825|38073231|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
16929474|NCT01059825|38073232|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
16929475|NCT01059825|38073233|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
16929476|NCT01059825|38073234|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
16929477|NCT01059825|38073228|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16929478|NCT01059825|38073229|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16929479|NCT01059825|38073230|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16851392|NCT01415349|37800492|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16851393|NCT01415349|37800493|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16851394|NCT01453023|37800547|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
16851395|NCT01453023|37800548|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
16851396|NCT01453023|37800547|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
16851397|NCT01453023|37800548|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
16851398|NCT01453023|37800547|FG000|Treatment Period 2|Protocol Violation|0|||
16851399|NCT01453023|37800548|FG001|Treatment Period 2|Protocol Violation|1|||
16851400|NCT01452789|37800556|FG000|Overall Study|Withdrawal by Subject|3|||
16851401|NCT01452789|37800557|FG001|Overall Study|Withdrawal by Subject|2|||
16851402|NCT01451931|37800566|FG000|Overall Study|Lost to Follow-up|17|||
16851403|NCT01451931|37800567|FG001|Overall Study|Lost to Follow-up|36|||
16851404|NCT01451931|37800568|FG002|Overall Study|Lost to Follow-up|21|||
16851405|NCT01451931|37800566|FG000|Overall Study|Withdrawal by Subject|16|||
16851406|NCT01451931|37800567|FG001|Overall Study|Withdrawal by Subject|22|||
16929480|NCT01059825|38073231|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16929481|NCT01059825|38073232|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16929482|NCT01059825|38073233|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16929483|NCT01059825|38073234|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
16929484|NCT01059825|38073228|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
16929485|NCT01059825|38073229|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
16929486|NCT01059825|38073230|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
16929487|NCT01059825|38073231|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
16929488|NCT01059825|38073232|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
16851407|NCT01451931|37800568|FG002|Overall Study|Withdrawal by Subject|22|||
16851408|NCT01414257|37800591|FG000|Overall Study|No Visit After First Day of Treatment|12|||
16851409|NCT01414257|37800591|FG000|Overall Study|Protocol Violation|10|||
16929489|NCT01059825|38073233|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
16929490|NCT01059825|38073234|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
16929491|NCT01059825|38073228|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
16929492|NCT01059825|38073229|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
16929493|NCT01059825|38073230|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
16929494|NCT01059825|38073231|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
16929495|NCT01059825|38073232|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
16929496|NCT01059825|38073233|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
16929497|NCT01059825|38073234|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
16929498|NCT01059825|38073228|FG000|Treatment Period|Lost to Follow-up|2|||
16929499|NCT01059825|38073229|FG001|Treatment Period|Lost to Follow-up|1|||
16929500|NCT01059825|38073230|FG002|Treatment Period|Lost to Follow-up|0|||
16929501|NCT01059825|38073231|FG003|Treatment Period|Lost to Follow-up|1|||
16929502|NCT01059825|38073232|FG004|Treatment Period|Lost to Follow-up|2|||
16929503|NCT01059825|38073233|FG005|Treatment Period|Lost to Follow-up|0|||
16929504|NCT01059825|38073234|FG006|Treatment Period|Lost to Follow-up|0|||
16929505|NCT01059825|38073228|FG000|Treatment Period|Withdrawal by Subject|3|||
16929506|NCT01059825|38073229|FG001|Treatment Period|Withdrawal by Subject|0|||
16929507|NCT01059825|38073230|FG002|Treatment Period|Withdrawal by Subject|1|||
16929508|NCT01059825|38073231|FG003|Treatment Period|Withdrawal by Subject|5|||
16929509|NCT01059825|38073232|FG004|Treatment Period|Withdrawal by Subject|4|||
16929510|NCT01059825|38073233|FG005|Treatment Period|Withdrawal by Subject|1|||
16929511|NCT01059825|38073234|FG006|Treatment Period|Withdrawal by Subject|0|||
16929512|NCT01059825|38073228|FG000|Treatment Period|Other reason not specified|1|||
16929513|NCT01059825|38073229|FG001|Treatment Period|Other reason not specified|2|||
16929514|NCT01059825|38073230|FG002|Treatment Period|Other reason not specified|1|||
16929515|NCT01059825|38073231|FG003|Treatment Period|Other reason not specified|2|||
16929516|NCT01059825|38073232|FG004|Treatment Period|Other reason not specified|0|||
16929517|NCT01059825|38073233|FG005|Treatment Period|Other reason not specified|0|||
16929518|NCT01059825|38073234|FG006|Treatment Period|Other reason not specified|0|||
16929519|NCT01059825|38073228|FG000|Treatment Period|Protocol Violation|0|||
16929520|NCT01059825|38073229|FG001|Treatment Period|Protocol Violation|0|||
16851410|NCT01434693|37800634|FG000|Overall Study|Adverse Event|1|||
16851411|NCT01434693|37800635|FG001|Overall Study|Adverse Event|0|||
16851412|NCT01434693|37800636|FG002|Overall Study|Adverse Event|0|||
16929521|NCT01059825|38073230|FG002|Treatment Period|Protocol Violation|1|||
16929522|NCT01059825|38073231|FG003|Treatment Period|Protocol Violation|1|||
16929523|NCT01059825|38073232|FG004|Treatment Period|Protocol Violation|1|||
16929524|NCT01059825|38073233|FG005|Treatment Period|Protocol Violation|1|||
16929525|NCT01059825|38073234|FG006|Treatment Period|Protocol Violation|0|||
16929526|NCT01059825|38073228|FG000|Treatment Period|Adverse event related to study drug|1|||
16929527|NCT01059825|38073229|FG001|Treatment Period|Adverse event related to study drug|0|||
16929528|NCT01059825|38073230|FG002|Treatment Period|Adverse event related to study drug|1|||
16929529|NCT01059825|38073231|FG003|Treatment Period|Adverse event related to study drug|1|||
16929530|NCT01059825|38073232|FG004|Treatment Period|Adverse event related to study drug|0|||
16929531|NCT01059825|38073233|FG005|Treatment Period|Adverse event related to study drug|0|||
16929532|NCT01059825|38073234|FG006|Treatment Period|Adverse event related to study drug|0|||
16929533|NCT01059825|38073228|FG000|Treatment Period|Insufficient clinical response|3|||
16929534|NCT01059825|38073229|FG001|Treatment Period|Insufficient clinical response|0|||
16929535|NCT01059825|38073230|FG002|Treatment Period|Insufficient clinical response|0|||
16929536|NCT01059825|38073231|FG003|Treatment Period|Insufficient clinical response|0|||
16929537|NCT01059825|38073232|FG004|Treatment Period|Insufficient clinical response|0|||
16929538|NCT01059825|38073233|FG005|Treatment Period|Insufficient clinical response|0|||
16929539|NCT01059825|38073234|FG006|Treatment Period|Insufficient clinical response|0|||
16929540|NCT01059825|38073228|FG000|Treatment Period|Adverse event not related to study drug|0|||
16929541|NCT01059825|38073229|FG001|Treatment Period|Adverse event not related to study drug|1|||
16929542|NCT01059825|38073230|FG002|Treatment Period|Adverse event not related to study drug|2|||
17018827|NCT00667810|38163391|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
17018828|NCT00667810|38163392|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
17018829|NCT00667810|38163389|FG000|Overall Study|Failed to Return|0|||
17102593|NCT00112437|38241445|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102594|NCT00112437|38241446|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102595|NCT00112437|38241447|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102596|NCT00112437|38241448|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16851413|NCT01434693|37800637|FG003|Overall Study|Adverse Event|0|||
16851414|NCT01434693|37800634|FG000|Overall Study|Withdrawal by Subject|1|||
16851415|NCT01434693|37800635|FG001|Overall Study|Withdrawal by Subject|0|||
16851416|NCT01434693|37800636|FG002|Overall Study|Withdrawal by Subject|1|||
16851417|NCT01434693|37800637|FG003|Overall Study|Withdrawal by Subject|1|||
16851418|NCT01434693|37800634|FG000|Overall Study|Lost to Follow-up|1|||
16851419|NCT01434693|37800635|FG001|Overall Study|Lost to Follow-up|0|||
16851420|NCT01434693|37800636|FG002|Overall Study|Lost to Follow-up|0|||
16851421|NCT01434693|37800637|FG003|Overall Study|Lost to Follow-up|0|||
16851422|NCT01451541|37800654|FG000|Overall Study|Adverse Event|4|||
16851423|NCT01451541|37800655|FG001|Overall Study|Adverse Event|3|||
16851424|NCT01451541|37800656|FG002|Overall Study|Adverse Event|6|||
16851425|NCT01451541|37800654|FG000|Overall Study|Lack of Efficacy|2|||
16851426|NCT01451541|37800655|FG001|Overall Study|Lack of Efficacy|0|||
16851427|NCT01451541|37800656|FG002|Overall Study|Lack of Efficacy|0|||
16851428|NCT01451541|37800654|FG000|Overall Study|Lost to Follow-up|4|||
16851429|NCT01451541|37800655|FG001|Overall Study|Lost to Follow-up|4|||
16929543|NCT01059825|38073231|FG003|Treatment Period|Adverse event not related to study drug|1|||
16929544|NCT01059825|38073232|FG004|Treatment Period|Adverse event not related to study drug|1|||
16929545|NCT01059825|38073233|FG005|Treatment Period|Adverse event not related to study drug|1|||
16929546|NCT01059825|38073234|FG006|Treatment Period|Adverse event not related to study drug|0|||
16929547|NCT01059773|38073293|FG000|Overall Study|Adverse Event|2|||
16929548|NCT01059773|38073294|FG001|Overall Study|Adverse Event|2|||
16929549|NCT01059773|38073293|FG000|Overall Study|Withdrawal by Subject|1|||
16929550|NCT01059773|38073294|FG001|Overall Study|Withdrawal by Subject|5|||
16929551|NCT01059773|38073293|FG000|Overall Study|Lost to Follow-up|1|||
16929552|NCT01059773|38073294|FG001|Overall Study|Lost to Follow-up|1|||
16929553|NCT01059773|38073293|FG000|Overall Study|Pregnancy|1|||
16929554|NCT01059773|38073294|FG001|Overall Study|Pregnancy|1|||
16929555|NCT01059773|38073293|FG000|Overall Study|Protocol Violation|6|||
16929556|NCT01059773|38073294|FG001|Overall Study|Protocol Violation|2|||
16929557|NCT01059773|38073293|FG000|Overall Study|Physician Decision|5|||
16929558|NCT01059773|38073294|FG001|Overall Study|Physician Decision|4|||
16929559|NCT01059773|38073293|FG000|Overall Study|Lack of Efficacy|3|||
16929560|NCT01059773|38073294|FG001|Overall Study|Lack of Efficacy|3|||
16929561|NCT01059773|38073293|FG000|Overall Study|Death|0|||
17018830|NCT00667810|38163390|FG001|Overall Study|Failed to Return|0|||
17018831|NCT00667810|38163391|FG002|Overall Study|Failed to Return|2|||
17018832|NCT00667810|38163392|FG003|Overall Study|Failed to Return|0|||
17018833|NCT00667810|38163389|FG000|Overall Study|Loss of Caregiver|0|||
17018834|NCT00667810|38163390|FG001|Overall Study|Loss of Caregiver|1|||
17018835|NCT00667810|38163391|FG002|Overall Study|Loss of Caregiver|3|||
17018836|NCT00667810|38163392|FG003|Overall Study|Loss of Caregiver|0|||
17018837|NCT00667810|38163389|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
17018838|NCT00667810|38163390|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
17018839|NCT00667810|38163391|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
17018840|NCT00667810|38163392|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
17018841|NCT00667810|38163389|FG000|Overall Study|Other|6|||
17018842|NCT00667810|38163390|FG001|Overall Study|Other|6|||
17018843|NCT00667810|38163391|FG002|Overall Study|Other|5|||
17018844|NCT00667810|38163392|FG003|Overall Study|Other|0|||
17018845|NCT00819390|38163411|FG000|Overall Study|Lost to Follow-up|1|||
17018846|NCT00819390|38163412|FG001|Overall Study|Lost to Follow-up|1|||
17018847|NCT00819390|38163413|FG002|Overall Study|Lost to Follow-up|0|||
17018848|NCT00819390|38163414|FG003|Overall Study|Lost to Follow-up|0|||
17018849|NCT00819390|38163411|FG000|Overall Study|Withdrawal by Subject|2|||
17018850|NCT00819390|38163412|FG001|Overall Study|Withdrawal by Subject|0|||
17018851|NCT00819390|38163413|FG002|Overall Study|Withdrawal by Subject|0|||
17018852|NCT00819390|38163414|FG003|Overall Study|Withdrawal by Subject|0|||
17018853|NCT00819390|38163411|FG000|Overall Study|Adverse Event|0|||
17018854|NCT00819390|38163412|FG001|Overall Study|Adverse Event|0|||
17018855|NCT00819390|38163413|FG002|Overall Study|Adverse Event|1|||
17018856|NCT00819390|38163414|FG003|Overall Study|Adverse Event|0|||
17018857|NCT00876395|38163429|FG000|Overall Study|Untreated|8|||
17018858|NCT00876395|38163430|FG001|Overall Study|Untreated|1|||
17018859|NCT00876395|38163429|FG000|Overall Study|Adverse Event|63|||
16929562|NCT01059773|38073294|FG001|Overall Study|Death|1|||
16929563|NCT01059773|38073293|FG000|Overall Study|Malignancy including squamous cell skin|0|||
16929564|NCT01059773|38073294|FG001|Overall Study|Malignancy including squamous cell skin|1|||
16929565|NCT01059773|38073293|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
16929566|NCT01059773|38073294|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
16929567|NCT01059773|38073293|FG000|Overall Study|Other|1|||
17018860|NCT00876395|38163430|FG001|Overall Study|Adverse Event|11|||
17018861|NCT00876395|38163429|FG000|Overall Study|Abnormal test procedure result(s)|1|||
17018862|NCT00876395|38163430|FG001|Overall Study|Abnormal test procedure result(s)|0|||
17018863|NCT00876395|38163429|FG000|Overall Study|Disease progression|259|||
17018864|NCT00876395|38163430|FG001|Overall Study|Disease progression|162|||
17018865|NCT00876395|38163429|FG000|Overall Study|New cancer therapy|25|||
17018866|NCT00876395|38163430|FG001|Overall Study|New cancer therapy|7|||
17018867|NCT00876395|38163429|FG000|Overall Study|Protocol Violation|5|||
17018868|NCT00876395|38163430|FG001|Overall Study|Protocol Violation|2|||
17018869|NCT00876395|38163429|FG000|Overall Study|Withdrawal by Subject|66|||
16851430|NCT01451541|37800656|FG002|Overall Study|Lost to Follow-up|7|||
16851431|NCT01451541|37800654|FG000|Overall Study|Withdrawal by Subject|15|||
16929568|NCT01059773|38073294|FG001|Overall Study|Other|3|||
16929569|NCT01059318|38073305|FG000|Core Study (26 Week)|Adverse Event|3|||
17018870|NCT00876395|38163430|FG001|Overall Study|Withdrawal by Subject|33|||
16851432|NCT01451541|37800655|FG001|Overall Study|Withdrawal by Subject|8|||
16851433|NCT01451541|37800656|FG002|Overall Study|Withdrawal by Subject|6|||
17018871|NCT00876395|38163429|FG000|Overall Study|Lost to Follow-up|2|||
17018872|NCT00876395|38163430|FG001|Overall Study|Lost to Follow-up|0|||
17102597|NCT00112437|38241449|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102598|NCT00112437|38241450|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102599|NCT00112437|38241451|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102600|NCT00112437|38241452|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102601|NCT00112437|38241453|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102602|NCT00112437|38241454|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102603|NCT00112437|38241455|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102604|NCT00112437|38241456|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102605|NCT00112437|38241457|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102606|NCT00112437|38241458|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102607|NCT00112437|38241459|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102608|NCT00112437|38241460|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102609|NCT00112437|38241461|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102610|NCT00112437|38241462|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102611|NCT00112437|38241463|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102612|NCT00112437|38241464|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102613|NCT00112437|38241465|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102614|NCT00112437|38241466|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
17102615|NCT00112437|38241441|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
17102616|NCT00112437|38241442|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102617|NCT00112437|38241443|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
17102618|NCT00112437|38241444|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
17102619|NCT00112437|38241445|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
17102620|NCT00112437|38241446|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102621|NCT00112437|38241447|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102622|NCT00112437|38241448|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102623|NCT00112437|38241449|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102624|NCT00112437|38241450|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102625|NCT00112437|38241451|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102626|NCT00112437|38241452|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17018873|NCT00876395|38163429|FG000|Overall Study|Administrative problems|39|||
17018874|NCT00876395|38163430|FG001|Overall Study|Administrative problems|23|||
17018875|NCT00876395|38163429|FG000|Overall Study|Death|12|||
17018876|NCT00876395|38163430|FG001|Overall Study|Death|0|||
17018877|NCT00594659|38163444|FG000|Overall Study|Lost to Follow-up|13|||
17018878|NCT00594659|38163445|FG001|Overall Study|Lost to Follow-up|9|||
17102627|NCT00112437|38241453|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102628|NCT00112437|38241454|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102629|NCT00112437|38241455|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17018879|NCT00594659|38163446|FG002|Overall Study|Lost to Follow-up|7|||
17018880|NCT00667732|38163456|FG000|Run -In (8 Weeks)|Adverse Event|4|||
17102630|NCT00112437|38241456|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102631|NCT00112437|38241457|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102632|NCT00112437|38241458|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16851434|NCT01451541|37800654|FG000|Overall Study|randomization error, noncompliance|11|||
16851435|NCT01451541|37800655|FG001|Overall Study|randomization error, noncompliance|10|||
16851436|NCT01451541|37800656|FG002|Overall Study|randomization error, noncompliance|8|||
16851437|NCT01450761|37800784|FG000|Randomization|Subject no longer meets study criteria|1|||
16851438|NCT01450761|37800785|FG001|Randomization|Subject no longer meets study criteria|2|||
16851439|NCT01450761|37800784|FG000|Randomization|Withdrawal by Subject|2|||
16851440|NCT01450761|37800785|FG001|Randomization|Withdrawal by Subject|0|||
16851441|NCT01450761|37800784|FG000|Randomization|Disease progression|0|||
16851442|NCT01450761|37800785|FG001|Randomization|Disease progression|2|||
16851443|NCT01450761|37800784|FG000|Randomization|Adverse Event unrelated to study drug|1|||
16851444|NCT01450761|37800785|FG001|Randomization|Adverse Event unrelated to study drug|0|||
16851445|NCT01450761|37800784|FG000|Randomization|Other|0|||
16851446|NCT01450761|37800785|FG001|Randomization|Other|1|||
16851447|NCT01450761|37800784|FG000|Lead-in Chemotherapy|Disease progression|33|||
16851448|NCT01450761|37800785|FG001|Lead-in Chemotherapy|Disease progression|32|||
16851449|NCT01450761|37800784|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
16851450|NCT01450761|37800785|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
16851451|NCT01450761|37800784|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
16851452|NCT01450761|37800785|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
16851453|NCT01450761|37800784|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
16851454|NCT01450761|37800785|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
16851455|NCT01450761|37800784|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
16851456|NCT01450761|37800785|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
16851457|NCT01450761|37800784|FG000|Lead-in Chemotherapy|Death|3|||
16851458|NCT01450761|37800785|FG001|Lead-in Chemotherapy|Death|3|||
16929570|NCT01059318|38073305|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
16929571|NCT01059318|38073305|FG000|Extension (36 Week)|Adverse Event|3|||
16929572|NCT01058655|38073316|FG000|Overall Study|Withdrawal by Subject|1|||
16929573|NCT01058655|38073317|FG001|Overall Study|Withdrawal by Subject|0|||
16929574|NCT01058655|38073318|FG002|Overall Study|Withdrawal by Subject|3|||
16929575|NCT01058655|38073319|FG003|Overall Study|Withdrawal by Subject|4|||
16929576|NCT01058655|38073316|FG000|Overall Study|Prolonged Treatment Delay|0|||
16929577|NCT01058655|38073317|FG001|Overall Study|Prolonged Treatment Delay|0|||
16929578|NCT01058655|38073318|FG002|Overall Study|Prolonged Treatment Delay|0|||
16929579|NCT01058655|38073319|FG003|Overall Study|Prolonged Treatment Delay|2|||
16929580|NCT01058655|38073316|FG000|Overall Study|Symptomatic Deterioration|0|||
16929581|NCT01058655|38073317|FG001|Overall Study|Symptomatic Deterioration|0|||
16929582|NCT01058655|38073318|FG002|Overall Study|Symptomatic Deterioration|0|||
16929583|NCT01058655|38073319|FG003|Overall Study|Symptomatic Deterioration|1|||
16929584|NCT01058655|38073316|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
16929585|NCT01058655|38073317|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
16929586|NCT01058655|38073318|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
16929587|NCT01058655|38073319|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
16929588|NCT01058655|38073316|FG000|Overall Study|Death|0|||
16929589|NCT01058655|38073317|FG001|Overall Study|Death|1|||
16929590|NCT01058655|38073318|FG002|Overall Study|Death|1|||
16929591|NCT01058655|38073319|FG003|Overall Study|Death|0|||
16929592|NCT01058655|38073316|FG000|Overall Study|Disease Progression|1|||
16929593|NCT01058655|38073317|FG001|Overall Study|Disease Progression|2|||
16929594|NCT01058655|38073318|FG002|Overall Study|Disease Progression|4|||
16929595|NCT01058655|38073319|FG003|Overall Study|Disease Progression|24|||
16929596|NCT01058655|38073316|FG000|Overall Study|Other|0|||
16929597|NCT01058655|38073317|FG001|Overall Study|Other|0|||
16929598|NCT01058655|38073318|FG002|Overall Study|Other|0|||
16929599|NCT01058655|38073319|FG003|Overall Study|Other|4|||
16929600|NCT01058421|38073332|FG000|1 Month Outcomes|Death|10|||
16929601|NCT01058421|38073333|FG001|1 Month Outcomes|Death|6|||
16929602|NCT01058421|38073332|FG000|1 Month Outcomes|Lost to Follow-up|8|||
16929603|NCT01058421|38073333|FG001|1 Month Outcomes|Lost to Follow-up|7|||
16929604|NCT01058421|38073332|FG000|1 Month Outcomes|Remained in Hospital|5|||
16929605|NCT01058421|38073333|FG001|1 Month Outcomes|Remained in Hospital|12|||
16929606|NCT01058421|38073332|FG000|1 Month Outcomes|Remained in Other Facility|16|||
16929607|NCT01058421|38073333|FG001|1 Month Outcomes|Remained in Other Facility|17|||
16929608|NCT01058421|38073332|FG000|3 Month Outcomes|Death|3|||
16929609|NCT01058421|38073333|FG001|3 Month Outcomes|Death|5|||
16929610|NCT01058421|38073332|FG000|3 Month Outcomes|Lost to Follow-up|12|||
16929611|NCT01058421|38073333|FG001|3 Month Outcomes|Lost to Follow-up|11|||
16929612|NCT01058421|38073332|FG000|3 Month Outcomes|Remained in Hospital|0|||
16929613|NCT01058421|38073333|FG001|3 Month Outcomes|Remained in Hospital|2|||
16851459|NCT01450761|37800784|FG000|Lead-in Chemotherapy|Other|2|||
16851460|NCT01450761|37800785|FG001|Lead-in Chemotherapy|Other|2|||
16851461|NCT01450761|37800784|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
16851462|NCT01450761|37800785|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
16851463|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
16851464|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
16851465|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
16851466|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
16851467|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
16851468|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
16851469|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
16851470|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
16851471|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
16851472|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
16851473|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Death|5|||
16851474|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Death|6|||
16851475|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
16851476|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
16851477|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
16851478|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
16851479|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
16851480|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
16851481|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
16929614|NCT01058421|38073332|FG000|3 Month Outcomes|Remained in Other Facility|5|||
17198617|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Death|4|||
16929615|NCT01058421|38073333|FG001|3 Month Outcomes|Remained in Other Facility|8|||
16929616|NCT01058421|38073332|FG000|6 Month Outcomes|Death|2|||
16929617|NCT01058421|38073333|FG001|6 Month Outcomes|Death|2|||
16929618|NCT01058421|38073332|FG000|6 Month Outcomes|Lost to Follow-up|16|||
16929619|NCT01058421|38073333|FG001|6 Month Outcomes|Lost to Follow-up|21|||
16929620|NCT01058421|38073332|FG000|6 Month Outcomes|Remained in Other Facility|1|||
16929621|NCT01058421|38073333|FG001|6 Month Outcomes|Remained in Other Facility|3|||
16929622|NCT01058304|38073341|FG000|Overall Study|Withdrawal by Subject|8|||
16929623|NCT01058304|38073342|FG001|Overall Study|Withdrawal by Subject|5|||
16929624|NCT01058304|38073341|FG000|Overall Study|Lost to Follow-up|13|||
16929625|NCT01058304|38073342|FG001|Overall Study|Lost to Follow-up|16|||
16929626|NCT01058304|38073341|FG000|Overall Study|Developed exclusion criterion|6|||
16929627|NCT01058304|38073342|FG001|Overall Study|Developed exclusion criterion|12|||
16929628|NCT01058265|38073350|FG000|Overall Study|Lost to Follow-up|11|||
16929629|NCT01058265|38073351|FG001|Overall Study|Lost to Follow-up|12|||
16929630|NCT01057251|38073359|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
16929631|NCT01057251|38073360|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
16929632|NCT01057251|38073359|FG000|Overall Study|Adverse Event|4|||
16929633|NCT01057251|38073360|FG001|Overall Study|Adverse Event|2|||
16929634|NCT01057251|38073359|FG000|Overall Study|Lack of Efficacy|2|||
16929635|NCT01057251|38073360|FG001|Overall Study|Lack of Efficacy|11|||
16929636|NCT01057251|38073359|FG000|Overall Study|Protocol Violation|6|||
16929637|NCT01057251|38073360|FG001|Overall Study|Protocol Violation|2|||
16929638|NCT01057251|38073359|FG000|Overall Study|Withdrawal by Subject|4|||
16929639|NCT01057251|38073360|FG001|Overall Study|Withdrawal by Subject|5|||
16929640|NCT01057251|38073359|FG000|Overall Study|Lost to Follow-up|7|||
16929641|NCT01057251|38073360|FG001|Overall Study|Lost to Follow-up|6|||
16929642|NCT01057251|38073359|FG000|Overall Study|Other Reason|1|||
16929643|NCT01057251|38073360|FG001|Overall Study|Other Reason|1|||
16929644|NCT01056822|38073368|FG000|Overall Study|Adverse Event|0|||
16929645|NCT01056822|38073369|FG001|Overall Study|Adverse Event|1|||
16929646|NCT01056822|38073368|FG000|Overall Study|Protocol Violation|6|||
16929647|NCT01056822|38073369|FG001|Overall Study|Protocol Violation|5|||
16929648|NCT01056822|38073368|FG000|Overall Study|Withdrawal by Subject|1|||
16929649|NCT01056822|38073369|FG001|Overall Study|Withdrawal by Subject|1|||
16929650|NCT01056822|38073368|FG000|Overall Study|Lost to Follow-up|1|||
16929651|NCT01056822|38073369|FG001|Overall Study|Lost to Follow-up|0|||
16929652|NCT01051791|38073376|FG000|Overall Study|Failed screening|3|||
16929653|NCT01051791|38073376|FG000|Overall Study|Withdrawal by Subject|1|||
16929654|NCT01056510|38073388|FG000|Overall Study|Dropout Before Start of Treatment|1|||
16929655|NCT01056510|38073389|FG001|Overall Study|Dropout Before Start of Treatment|1|||
16929656|NCT01056510|38073388|FG000|Overall Study|Withdrawal by Subject|4|||
16929657|NCT01056510|38073389|FG001|Overall Study|Withdrawal by Subject|2|||
16929658|NCT01056510|38073388|FG000|Overall Study|Death|29|||
16929659|NCT01056510|38073389|FG001|Overall Study|Death|34|||
16929660|NCT01056510|38073388|FG000|Overall Study|Noncompliance|1|||
16929661|NCT01056510|38073389|FG001|Overall Study|Noncompliance|3|||
16929662|NCT01056510|38073388|FG000|Overall Study|Physician Decision|4|||
16929663|NCT01056510|38073389|FG001|Overall Study|Physician Decision|5|||
16929664|NCT01056510|38073388|FG000|Overall Study|Lost to Follow-up|5|||
16929665|NCT01056510|38073389|FG001|Overall Study|Lost to Follow-up|6|||
16929666|NCT01056510|38073388|FG000|Overall Study|Other|10|||
16929667|NCT01056510|38073389|FG001|Overall Study|Other|12|||
16929668|NCT01056510|38073388|FG000|Overall Study|Missing|0|||
16929669|NCT01056510|38073389|FG001|Overall Study|Missing|1|||
16929670|NCT01051323|38073397|FG000|Overall Study|Discontinuation of treatment|103|||
16929671|NCT01051323|38073397|FG000|Overall Study|Transplantation|28|||
16929672|NCT01051323|38073397|FG000|Overall Study|Dialysis dependency|22|||
16929673|NCT01051323|38073397|FG000|Overall Study|Withdrawal by Subject|13|||
16929674|NCT01051323|38073397|FG000|Overall Study|Lost to Follow-up|31|||
16929675|NCT01051323|38073397|FG000|Overall Study|Death|129|||
16929676|NCT01051323|38073397|FG000|Overall Study|Hospitalization|28|||
16929677|NCT01051323|38073397|FG000|Overall Study|Other|148|||
16929678|NCT01051323|38073397|FG000|Overall Study|Missing|37|||
16929679|NCT01056276|38073407|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
16929680|NCT01056276|38073408|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
16929681|NCT01056276|38073407|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
16929682|NCT01056276|38073408|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
16929683|NCT01056276|38073407|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
16929684|NCT01056276|38073408|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
16929685|NCT01056276|38073407|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
16929686|NCT01056276|38073408|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
16929687|NCT01056276|38073407|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
16929688|NCT01056276|38073408|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
16929689|NCT01056276|38073407|FG000|Treatment Period-Cycles 1-8|Death|3|||
16929690|NCT01056276|38073408|FG001|Treatment Period-Cycles 1-8|Death|1|||
16929691|NCT01056276|38073407|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
16929692|NCT01056276|38073408|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
16929693|NCT01056276|38073407|FG000|Maintenance Therapy|Toxicity|0|||
16929694|NCT01056276|38073408|FG001|Maintenance Therapy|Toxicity|2|||
16929695|NCT01056276|38073407|FG000|Maintenance Therapy|Progressive Disease|0|||
16929696|NCT01056276|38073408|FG001|Maintenance Therapy|Progressive Disease|9|||
16929697|NCT01056276|38073407|FG000|Maintenance Therapy|Physician Decision|0|||
16929698|NCT01056276|38073408|FG001|Maintenance Therapy|Physician Decision|1|||
16929699|NCT01056276|38073407|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
16929700|NCT01056276|38073408|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
16929701|NCT01056276|38073407|FG000|Maintenance Therapy|Intercurrent Illness|0|||
16929702|NCT01056276|38073408|FG001|Maintenance Therapy|Intercurrent Illness|1|||
16929703|NCT01056276|38073407|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
16929704|NCT01056276|38073408|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
16929705|NCT01055886|38073421|FG000|Overall Study|Withdrawal by Subject|4|||
16929706|NCT01055886|38073422|FG001|Overall Study|Withdrawal by Subject|9|||
16929707|NCT01055886|38073421|FG000|Overall Study|Lost to Follow-up|1|||
16929708|NCT01055886|38073422|FG001|Overall Study|Lost to Follow-up|1|||
16929709|NCT01055886|38073421|FG000|Overall Study|Withdrawal by PI|0|||
16929710|NCT01055886|38073422|FG001|Overall Study|Withdrawal by PI|1|||
16929711|NCT01055613|38073430|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
16929712|NCT01055613|38073431|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16929713|NCT01055613|38073430|FG000|Overall Study|Unacceptable lens fit|1|||
16929714|NCT01055613|38073431|FG001|Overall Study|Unacceptable lens fit|0|||
16929715|NCT01055613|38073430|FG000|Overall Study|Discomfort|2|||
16929716|NCT01055613|38073431|FG001|Overall Study|Discomfort|1|||
16929717|NCT01055613|38073430|FG000|Overall Study|Lost to Follow-up|1|||
16929718|NCT01055613|38073431|FG001|Overall Study|Lost to Follow-up|1|||
16929719|NCT01055613|38073430|FG000|Overall Study|Protocol Violation|1|||
16929720|NCT01055613|38073431|FG001|Overall Study|Protocol Violation|1|||
16929721|NCT01055613|38073430|FG000|Overall Study|Subject Disinterest|1|||
16929722|NCT01055613|38073431|FG001|Overall Study|Subject Disinterest|1|||
16929723|NCT01055457|38073447|FG000|Overall Study|Lost to Follow-up|0|||
16929724|NCT01055457|38073448|FG001|Overall Study|Lost to Follow-up|1|||
16929725|NCT01055457|38073449|FG002|Overall Study|Lost to Follow-up|0|||
16929726|NCT01055457|38073450|FG003|Overall Study|Lost to Follow-up|0|||
16929727|NCT01055457|38073451|FG004|Overall Study|Lost to Follow-up|0|||
16929728|NCT01055457|38073452|FG005|Overall Study|Lost to Follow-up|1|||
16929729|NCT01055457|38073453|FG006|Overall Study|Lost to Follow-up|0|||
16929730|NCT01055457|38073454|FG007|Overall Study|Lost to Follow-up|0|||
16929731|NCT01055457|38073455|FG008|Overall Study|Lost to Follow-up|0|||
16929732|NCT01055457|38073456|FG009|Overall Study|Lost to Follow-up|0|||
16929733|NCT01055457|38073447|FG000|Overall Study|Protocol Violation|0|||
16929734|NCT01055457|38073448|FG001|Overall Study|Protocol Violation|0|||
16929735|NCT01055457|38073449|FG002|Overall Study|Protocol Violation|1|||
16929736|NCT01055457|38073450|FG003|Overall Study|Protocol Violation|1|||
16929737|NCT01055457|38073451|FG004|Overall Study|Protocol Violation|1|||
16929738|NCT01055457|38073452|FG005|Overall Study|Protocol Violation|2|||
16851482|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
16851483|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
16851484|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
16851485|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
16929739|NCT01055457|38073453|FG006|Overall Study|Protocol Violation|1|||
16929740|NCT01055457|38073454|FG007|Overall Study|Protocol Violation|0|||
16929741|NCT01055457|38073455|FG008|Overall Study|Protocol Violation|0|||
16929742|NCT01055457|38073456|FG009|Overall Study|Protocol Violation|1|||
16929743|NCT01055457|38073447|FG000|Overall Study|Subject Disinterest|0|||
16929744|NCT01055457|38073448|FG001|Overall Study|Subject Disinterest|0|||
16929745|NCT01055457|38073449|FG002|Overall Study|Subject Disinterest|0|||
16929746|NCT01055457|38073450|FG003|Overall Study|Subject Disinterest|0|||
16929747|NCT01055457|38073451|FG004|Overall Study|Subject Disinterest|0|||
16929748|NCT01055457|38073452|FG005|Overall Study|Subject Disinterest|0|||
16929749|NCT01055457|38073453|FG006|Overall Study|Subject Disinterest|0|||
16929750|NCT01055457|38073454|FG007|Overall Study|Subject Disinterest|1|||
16929751|NCT01055457|38073455|FG008|Overall Study|Subject Disinterest|0|||
16929752|NCT01055457|38073456|FG009|Overall Study|Subject Disinterest|0|||
16929753|NCT01055457|38073447|FG000|Overall Study|Subject Ineligible|1|||
16929754|NCT01055457|38073448|FG001|Overall Study|Subject Ineligible|0|||
16929755|NCT01055457|38073449|FG002|Overall Study|Subject Ineligible|1|||
16929756|NCT01055457|38073450|FG003|Overall Study|Subject Ineligible|0|||
16851486|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
16851487|NCT01450761|37800784|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
16851488|NCT01450761|37800785|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
16851489|NCT01433991|37800835|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
16851490|NCT01433991|37800836|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
16851491|NCT01433991|37800837|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
16851492|NCT01433991|37800838|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
16929757|NCT01055457|38073451|FG004|Overall Study|Subject Ineligible|1|||
16929758|NCT01055457|38073452|FG005|Overall Study|Subject Ineligible|0|||
16929759|NCT01055457|38073453|FG006|Overall Study|Subject Ineligible|0|||
16929760|NCT01055457|38073454|FG007|Overall Study|Subject Ineligible|0|||
16929761|NCT01055457|38073455|FG008|Overall Study|Subject Ineligible|0|||
16929762|NCT01055457|38073456|FG009|Overall Study|Subject Ineligible|0|||
16929763|NCT01055457|38073447|FG000|Overall Study|Discomfort|0|||
16929764|NCT01055457|38073448|FG001|Overall Study|Discomfort|0|||
16929765|NCT01055457|38073449|FG002|Overall Study|Discomfort|0|||
16929766|NCT01055457|38073450|FG003|Overall Study|Discomfort|0|||
16929767|NCT01055457|38073451|FG004|Overall Study|Discomfort|1|||
16929768|NCT01055457|38073452|FG005|Overall Study|Discomfort|0|||
16929769|NCT01055457|38073453|FG006|Overall Study|Discomfort|0|||
16929770|NCT01055457|38073454|FG007|Overall Study|Discomfort|0|||
16929771|NCT01055457|38073455|FG008|Overall Study|Discomfort|0|||
16929772|NCT01055457|38073456|FG009|Overall Study|Discomfort|0|||
16929773|NCT01055457|38073447|FG000|Overall Study|Pregnancy|0|||
16929774|NCT01055457|38073448|FG001|Overall Study|Pregnancy|0|||
16929775|NCT01055457|38073449|FG002|Overall Study|Pregnancy|0|||
16929776|NCT01055457|38073450|FG003|Overall Study|Pregnancy|1|||
16929777|NCT01055457|38073451|FG004|Overall Study|Pregnancy|0|||
16929778|NCT01055457|38073452|FG005|Overall Study|Pregnancy|0|||
16929779|NCT01055457|38073453|FG006|Overall Study|Pregnancy|0|||
16929780|NCT01055457|38073454|FG007|Overall Study|Pregnancy|0|||
16929781|NCT01055457|38073455|FG008|Overall Study|Pregnancy|0|||
16929782|NCT01055457|38073456|FG009|Overall Study|Pregnancy|0|||
16929783|NCT01055457|38073447|FG000|Overall Study|Adverse Event|0|||
16929784|NCT01055457|38073448|FG001|Overall Study|Adverse Event|0|||
16929785|NCT01055457|38073449|FG002|Overall Study|Adverse Event|0|||
16929786|NCT01055457|38073450|FG003|Overall Study|Adverse Event|1|||
16929787|NCT01055457|38073451|FG004|Overall Study|Adverse Event|0|||
16929788|NCT01055457|38073452|FG005|Overall Study|Adverse Event|0|||
16929789|NCT01055457|38073453|FG006|Overall Study|Adverse Event|0|||
16929790|NCT01055457|38073454|FG007|Overall Study|Adverse Event|0|||
16929791|NCT01055457|38073455|FG008|Overall Study|Adverse Event|0|||
16929792|NCT01055457|38073456|FG009|Overall Study|Adverse Event|0|||
16929793|NCT01055028|38073480|FG000|Screening|Screen Failure|1|||
16929794|NCT01055028|38073481|FG001|Screening|Screen Failure|1|||
16929795|NCT01055028|38073480|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
16929796|NCT01055028|38073481|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
16929797|NCT01055028|38073480|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
16929798|NCT01055028|38073481|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
16851493|NCT01433991|37800835|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
16851494|NCT01433991|37800836|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
16851495|NCT01433991|37800837|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
16851496|NCT01433991|37800838|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
16851497|NCT01433991|37800835|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
16851498|NCT01433991|37800836|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
16851499|NCT01433991|37800837|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
16851500|NCT01433991|37800838|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
16851501|NCT01433991|37800835|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
16851502|NCT01433991|37800836|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
16851503|NCT01433991|37800837|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
16851504|NCT01433991|37800838|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
16851505|NCT01433991|37800835|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
16851506|NCT01433991|37800836|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
16851507|NCT01433991|37800837|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
16851508|NCT01433991|37800838|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
16851509|NCT01433991|37800835|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
16851510|NCT01433991|37800836|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
16851511|NCT01433991|37800837|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
16851512|NCT01433991|37800838|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
16929799|NCT01055028|38073480|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
16929800|NCT01055028|38073481|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
16929801|NCT01050816|38073513|FG000|Overall Study|Lost to Follow-up|2|||
16929802|NCT01050816|38073513|FG000|Overall Study|patient's refusal|2|||
16929803|NCT01054560|38073519|FG000|Overall Study|Death|10|||
16929804|NCT01054560|38073520|FG001|Overall Study|Death|21|||
16929805|NCT01054560|38073519|FG000|Overall Study|Lost to Follow-up|2|||
16929806|NCT01054560|38073520|FG001|Overall Study|Lost to Follow-up|5|||
16929807|NCT01054560|38073519|FG000|Overall Study|Withdrawal by Subject|0|||
16929808|NCT01054560|38073520|FG001|Overall Study|Withdrawal by Subject|2|||
16929809|NCT01054560|38073519|FG000|Overall Study|Physician Decision|1|||
16929810|NCT01054560|38073520|FG001|Overall Study|Physician Decision|0|||
16929811|NCT01054443|38073532|FG000|Overall Study|Withdrawal by Subject|0|||
16929812|NCT01054443|38073533|FG001|Overall Study|Withdrawal by Subject|0|||
16929813|NCT01054443|38073534|FG002|Overall Study|Withdrawal by Subject|0|||
16929814|NCT01054443|38073535|FG003|Overall Study|Withdrawal by Subject|1|||
16929815|NCT01050543|38073550|FG000|Overall Study|Withdrawal by Subject|0|||
16929816|NCT01050543|38073551|FG001|Overall Study|Withdrawal by Subject|2|||
16929817|NCT01050543|38073550|FG000|Overall Study|Protocol Violation|0|||
16929818|NCT01050543|38073551|FG001|Overall Study|Protocol Violation|1|||
16929819|NCT01050543|38073550|FG000|Overall Study|Administrative|4|||
16929820|NCT01050543|38073551|FG001|Overall Study|Administrative|1|||
16929821|NCT01051557|38073564|FG000|Overall Study|Physician Decision|1|||
16929822|NCT01051557|38073565|FG001|Overall Study|Physician Decision|0|||
16929823|NCT01051557|38073566|FG002|Overall Study|Physician Decision|0|||
16929824|NCT01051557|38073567|FG003|Overall Study|Physician Decision|0|||
16929825|NCT01051557|38073568|FG004|Overall Study|Physician Decision|0|||
16929826|NCT01051557|38073569|FG005|Overall Study|Physician Decision|0|||
16929827|NCT01051557|38073570|FG006|Overall Study|Physician Decision|0|||
16929828|NCT01051557|38073564|FG000|Overall Study|disease progression|3|||
16929829|NCT01051557|38073565|FG001|Overall Study|disease progression|3|||
16929830|NCT01051557|38073566|FG002|Overall Study|disease progression|5|||
16929831|NCT01051557|38073567|FG003|Overall Study|disease progression|2|||
16929832|NCT01051557|38073568|FG004|Overall Study|disease progression|4|||
16929833|NCT01051557|38073569|FG005|Overall Study|disease progression|3|||
16851513|NCT01433991|37800835|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
16851514|NCT01433991|37800836|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
16851515|NCT01433991|37800837|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
16851516|NCT01433991|37800838|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
16851517|NCT01450683|37800854|FG000|Overall Study|Adverse Event|2|||
16929834|NCT01051557|38073570|FG006|Overall Study|disease progression|1|||
16929835|NCT01051557|38073564|FG000|Overall Study|Withdrawal by Subject|0|||
16929836|NCT01051557|38073565|FG001|Overall Study|Withdrawal by Subject|0|||
16851518|NCT01433055|37800860|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
16851519|NCT01433055|37800861|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
16851520|NCT01433055|37800860|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
16851521|NCT01433055|37800861|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
16851522|NCT01450137|37800869|FG000|Up to Week 12|Adverse Event|2|||
16851523|NCT01450137|37800870|FG001|Up to Week 12|Adverse Event|1|||
16851524|NCT01450137|37800869|FG000|Up to Week 12|Withdrawal by Subject|0|||
16851525|NCT01450137|37800870|FG001|Up to Week 12|Withdrawal by Subject|2|||
16851526|NCT01450137|37800869|FG000|Week 12 to Study End|Death|0|||
16851527|NCT01450137|37800870|FG001|Week 12 to Study End|Death|1|||
16851528|NCT01450137|37800869|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
16851529|NCT01450137|37800870|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
16851530|NCT01412229|37800876|FG000|Overall Study|Physician Decision|1|||
16851531|NCT01412151|37800881|FG000|Week 0 - 306 - Treatment Period|Death|1|||
16851532|NCT01412151|37800881|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
16851533|NCT01412151|37800881|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
16851534|NCT01412151|37800881|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
16851535|NCT01432275|37800887|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
16851536|NCT01432275|37800888|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
16851537|NCT01432275|37800887|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
16929837|NCT01051557|38073566|FG002|Overall Study|Withdrawal by Subject|1|||
16929838|NCT01051557|38073567|FG003|Overall Study|Withdrawal by Subject|0|||
16929839|NCT01051557|38073568|FG004|Overall Study|Withdrawal by Subject|2|||
16929840|NCT01051557|38073569|FG005|Overall Study|Withdrawal by Subject|0|||
16929841|NCT01051557|38073570|FG006|Overall Study|Withdrawal by Subject|1|||
16929842|NCT01051557|38073564|FG000|Overall Study|Adverse Event|0|||
16929843|NCT01051557|38073565|FG001|Overall Study|Adverse Event|0|||
16929844|NCT01051557|38073566|FG002|Overall Study|Adverse Event|0|||
16929845|NCT01051557|38073567|FG003|Overall Study|Adverse Event|1|||
16929846|NCT01051557|38073568|FG004|Overall Study|Adverse Event|1|||
16929847|NCT01051557|38073569|FG005|Overall Study|Adverse Event|3|||
16929848|NCT01051557|38073570|FG006|Overall Study|Adverse Event|4|||
16929849|NCT01054170|38073589|FG000|Overall Study|Protocol Violation|1|||
16929850|NCT01054170|38073590|FG001|Overall Study|Protocol Violation|0|||
16929851|NCT01054170|38073589|FG000|Overall Study|Withdrawal by Subject|3|||
16929852|NCT01054170|38073590|FG001|Overall Study|Withdrawal by Subject|2|||
16929853|NCT01054170|38073589|FG000|Overall Study|Adverse Event|0|||
16929854|NCT01054170|38073590|FG001|Overall Study|Adverse Event|4|||
16929855|NCT01053741|38073598|FG000|2nd Study Intervention|Physician Decision|0|||
16929856|NCT01053741|38073599|FG001|2nd Study Intervention|Physician Decision|1|||
16929857|NCT01052493|38073605|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
16929858|NCT01052493|38073606|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
16929859|NCT01052493|38073607|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
16929860|NCT01052103|38073622|FG000|Overall Study|Adverse Event|10|||
16929861|NCT01052103|38073623|FG001|Overall Study|Adverse Event|6|||
16929862|NCT01052103|38073622|FG000|Overall Study|Entry Criteria Not Met|3|||
16929863|NCT01052103|38073623|FG001|Overall Study|Entry Criteria Not Met|1|||
16929864|NCT01052103|38073622|FG000|Overall Study|Lost to Follow-up|3|||
16929865|NCT01052103|38073623|FG001|Overall Study|Lost to Follow-up|5|||
16929866|NCT01052103|38073622|FG000|Overall Study|Protocol Violation|10|||
16929867|NCT01052103|38073623|FG001|Overall Study|Protocol Violation|4|||
16929868|NCT01052103|38073622|FG000|Overall Study|Scheduling conflict|2|||
16851538|NCT01432275|37800888|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
16851539|NCT01432275|37800887|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
16851540|NCT01432275|37800888|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
17018881|NCT00667732|38163457|FG001|Run -In (8 Weeks)|Adverse Event|0|||
17018882|NCT00667732|38163458|FG002|Run -In (8 Weeks)|Adverse Event|0|||
17018883|NCT00667732|38163456|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
17018884|NCT00667732|38163457|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
17018885|NCT00667732|38163458|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
17018886|NCT00667732|38163456|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
17018887|NCT00667732|38163457|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
17018888|NCT00667732|38163458|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
17018889|NCT00671788|38163468|FG000|Overall Study|Adverse Event|8|||
17018890|NCT00671788|38163468|FG000|Overall Study|Refused further treatment|3|||
17018891|NCT00671788|38163468|FG000|Overall Study|Ineligible|1|||
17018892|NCT00671788|38163468|FG000|Overall Study|MD Decision|1|||
17018893|NCT00671788|38163468|FG000|Overall Study|Other|1|||
17018894|NCT00875615|38163472|FG000|Overall Study|Withdrawal by Subject|1|||
17018895|NCT00597701|38163478|FG000|Overall Study|Withdrawal by Subject|5|||
17018896|NCT00597701|38163479|FG001|Overall Study|Withdrawal by Subject|5|||
17018897|NCT00597701|38163478|FG000|Overall Study|Death|0|||
17018898|NCT00597701|38163479|FG001|Overall Study|Death|1|||
17018899|NCT00597701|38163478|FG000|Overall Study|Physician Decision|2|||
17018900|NCT00597701|38163479|FG001|Overall Study|Physician Decision|0|||
17018901|NCT00597701|38163478|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
17018902|NCT00597701|38163479|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
17018903|NCT00671554|38163485|FG000|Overall Study|Disease progression|3|||
17018904|NCT00667576|38163495|FG000|Overall Study|Withdrawal by Subject|1|||
17018905|NCT00667576|38163496|FG001|Overall Study|Withdrawal by Subject|0|||
17018906|NCT00667576|38163497|FG002|Overall Study|Withdrawal by Subject|1|||
17018907|NCT00667576|38163498|FG003|Overall Study|Withdrawal by Subject|1|||
17018908|NCT00667576|38163499|FG004|Overall Study|Withdrawal by Subject|1|||
17018909|NCT00667576|38163495|FG000|Overall Study|Adverse Event|1|||
17018910|NCT00667576|38163496|FG001|Overall Study|Adverse Event|1|||
17018911|NCT00667576|38163497|FG002|Overall Study|Adverse Event|0|||
17018912|NCT00667576|38163498|FG003|Overall Study|Adverse Event|0|||
17018913|NCT00667576|38163499|FG004|Overall Study|Adverse Event|0|||
17018914|NCT00667576|38163495|FG000|Overall Study|Lost to Follow-up|0|||
17018915|NCT00667576|38163496|FG001|Overall Study|Lost to Follow-up|0|||
17018916|NCT00667576|38163497|FG002|Overall Study|Lost to Follow-up|1|||
17018917|NCT00667576|38163498|FG003|Overall Study|Lost to Follow-up|0|||
17018918|NCT00667576|38163499|FG004|Overall Study|Lost to Follow-up|0|||
17018919|NCT00667576|38163495|FG000|Overall Study|Protocol Violation|0|||
17018920|NCT00667576|38163496|FG001|Overall Study|Protocol Violation|0|||
17018921|NCT00667576|38163497|FG002|Overall Study|Protocol Violation|0|||
17018922|NCT00667576|38163498|FG003|Overall Study|Protocol Violation|1|||
17018923|NCT00667576|38163499|FG004|Overall Study|Protocol Violation|0|||
17018924|NCT00667576|38163495|FG000|Overall Study|Physician Decision|0|||
16929869|NCT01052103|38073623|FG001|Overall Study|Scheduling conflict|1|||
16929870|NCT01052103|38073622|FG000|Overall Study|Sponsor Decision|2|||
16929871|NCT01052103|38073623|FG001|Overall Study|Sponsor Decision|0|||
16929872|NCT01052103|38073622|FG000|Overall Study|Withdrawal by Subject|3|||
16929873|NCT01052103|38073623|FG001|Overall Study|Withdrawal by Subject|6|||
16929874|NCT01052103|38073622|FG000|Overall Study|Perceived Lack of Efficacy|1|||
16929875|NCT01052103|38073623|FG001|Overall Study|Perceived Lack of Efficacy|0|||
16929876|NCT01051986|38073632|FG000|Overall Study|Death|1|||
16929877|NCT01051986|38073633|FG001|Overall Study|Death|0|||
16929878|NCT01051986|38073632|FG000|Overall Study|Withdrawal by Subject|2|||
16929879|NCT01051986|38073633|FG001|Overall Study|Withdrawal by Subject|1|||
16929880|NCT01051986|38073632|FG000|Overall Study|Protocol Violation|2|||
16929881|NCT01051986|38073633|FG001|Overall Study|Protocol Violation|3|||
16929882|NCT00105534|38073645|FG000|Overall Study|Adverse Event|2|||
16851541|NCT01432275|37800887|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
16851542|NCT01432275|37800888|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
16851543|NCT01432275|37800887|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
16851544|NCT01432275|37800888|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
16851545|NCT01432275|37800887|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
16851546|NCT01432275|37800888|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
16851547|NCT01432275|37800887|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
16851548|NCT01432275|37800888|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
16929883|NCT00105534|38073646|FG001|Overall Study|Adverse Event|5|||
16929884|NCT00105534|38073645|FG000|Overall Study|Protocol Violation|1|||
16929885|NCT00105534|38073646|FG001|Overall Study|Protocol Violation|4|||
17018925|NCT00667576|38163496|FG001|Overall Study|Physician Decision|0|||
17018926|NCT00667576|38163497|FG002|Overall Study|Physician Decision|0|||
17018927|NCT00667576|38163498|FG003|Overall Study|Physician Decision|1|||
17018928|NCT00667576|38163499|FG004|Overall Study|Physician Decision|0|||
17018929|NCT00667576|38163495|FG000|Overall Study|Missed Visit|0|||
16851549|NCT01432275|37800887|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
16851550|NCT01432275|37800888|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
16851551|NCT01432275|37800887|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
16851552|NCT01432275|37800888|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
16851553|NCT01411995|37800896|FG000|Overall Study|Failed IUD insertion|0|||
16851554|NCT01411995|37800897|FG001|Overall Study|Failed IUD insertion|1|||
16851555|NCT01411917|37800905|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
16851556|NCT01411917|37800906|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
16851557|NCT01411839|37800914|FG000|Overall Study|Lost to Follow-up|4|||
16851558|NCT01411839|37800915|FG001|Overall Study|Lost to Follow-up|3|||
16851559|NCT01411215|37800923|FG000|Overall Study|Adverse Event|1|||
16851560|NCT01411215|37800924|FG001|Overall Study|Adverse Event|2|||
16851561|NCT01411215|37800923|FG000|Overall Study|Lack of Efficacy|2|||
16851562|NCT01411215|37800924|FG001|Overall Study|Lack of Efficacy|4|||
16851563|NCT01411215|37800923|FG000|Overall Study|Lost to Follow-up|12|||
16929886|NCT00105534|38073645|FG000|Overall Study|Withdrawal by Subject|6|||
16929887|NCT00105534|38073646|FG001|Overall Study|Withdrawal by Subject|6|||
16929888|NCT00105534|38073645|FG000|Overall Study|Lost to Follow-up|5|||
16929889|NCT00105534|38073646|FG001|Overall Study|Lost to Follow-up|1|||
16929890|NCT00105534|38073645|FG000|Overall Study|Lack of Efficacy|7|||
16929891|NCT00105534|38073646|FG001|Overall Study|Lack of Efficacy|15|||
16929892|NCT00105534|38073645|FG000|Overall Study|Treatment unmasked|1|||
16929893|NCT00105534|38073646|FG001|Overall Study|Treatment unmasked|0|||
16929894|NCT00105534|38073645|FG000|Overall Study|Other Reason|0|||
16929895|NCT00105534|38073646|FG001|Overall Study|Other Reason|2|||
16929896|NCT00105183|38073655|FG000|Overall Study|Death|19|||
16929897|NCT00105183|38073656|FG001|Overall Study|Death|13|||
16929898|NCT00105183|38073657|FG002|Overall Study|Death|15|||
16929899|NCT00105183|38073655|FG000|Overall Study|Withdrawal by Subject|1|||
16929900|NCT00105183|38073656|FG001|Overall Study|Withdrawal by Subject|1|||
16929901|NCT00105183|38073657|FG002|Overall Study|Withdrawal by Subject|4|||
16929902|NCT00105183|38073655|FG000|Overall Study|Physician Decision|1|||
16929903|NCT00105183|38073656|FG001|Overall Study|Physician Decision|2|||
16929904|NCT00105183|38073657|FG002|Overall Study|Physician Decision|3|||
16851564|NCT01411215|37800924|FG001|Overall Study|Lost to Follow-up|18|||
16851565|NCT01411215|37800923|FG000|Overall Study|Did not meet entrance criteria|0|||
16851566|NCT01411215|37800924|FG001|Overall Study|Did not meet entrance criteria|1|||
16851567|NCT01411215|37800923|FG000|Overall Study|Study terminated by sponsor|2|||
16851568|NCT01411215|37800924|FG001|Overall Study|Study terminated by sponsor|15|||
16851569|NCT01411215|37800923|FG000|Overall Study|Protocol Violation|3|||
16851570|NCT01411215|37800924|FG001|Overall Study|Protocol Violation|5|||
16851571|NCT01411215|37800923|FG000|Overall Study|Withdrawal by Subject|34|||
16851572|NCT01411215|37800924|FG001|Overall Study|Withdrawal by Subject|21|||
16851573|NCT01411215|37800923|FG000|Overall Study|Other|12|||
16929905|NCT00105183|38073655|FG000|Overall Study|Lost to Follow-up|0|||
16929906|NCT00105183|38073656|FG001|Overall Study|Lost to Follow-up|1|||
16929907|NCT00105183|38073657|FG002|Overall Study|Lost to Follow-up|1|||
16929908|NCT00105183|38073655|FG000|Overall Study|Other reason|1|||
16929909|NCT00105183|38073656|FG001|Overall Study|Other reason|2|||
16929910|NCT00105183|38073657|FG002|Overall Study|Other reason|0|||
16929911|NCT01059617|38073669|FG000|Overall Study|Other|7|||
16929912|NCT01059617|38073670|FG001|Overall Study|Other|1|||
16929913|NCT01059617|38073671|FG002|Overall Study|Other|8|||
16929914|NCT01059617|38073672|FG003|Overall Study|Other|6|||
16929915|NCT01059344|38073692|FG000|Overall Study|Adverse Event|12|||
16929916|NCT01059344|38073693|FG001|Overall Study|Adverse Event|30|||
16929917|NCT01059344|38073692|FG000|Overall Study|Withdrawal by Subject|6|||
16929918|NCT01059344|38073693|FG001|Overall Study|Withdrawal by Subject|9|||
16929919|NCT01059344|38073692|FG000|Overall Study|Lost to Follow-up|1|||
16929920|NCT01059344|38073693|FG001|Overall Study|Lost to Follow-up|1|||
16929921|NCT01059344|38073692|FG000|Overall Study|Other|3|||
16929922|NCT01059344|38073693|FG001|Overall Study|Other|6|||
16929923|NCT01059071|38073701|FG000|Overall Study|Lack of Efficacy|1|||
16929924|NCT01059071|38073702|FG001|Overall Study|Lack of Efficacy|4|||
16851574|NCT01411215|37800924|FG001|Overall Study|Other|17|||
16851575|NCT01411215|37800923|FG000|Overall Study|Screen failure|0|||
16851576|NCT01411215|37800924|FG001|Overall Study|Screen failure|1|||
16851577|NCT01449279|37800930|FG000|Overall Study|Lack of Efficacy|5|||
16929925|NCT01059071|38073703|FG002|Overall Study|Lack of Efficacy|2|||
16929926|NCT01059071|38073704|FG003|Overall Study|Lack of Efficacy|3|||
16929927|NCT01059071|38073701|FG000|Overall Study|Withdrawal by Subject|1|||
16929928|NCT01059071|38073702|FG001|Overall Study|Withdrawal by Subject|0|||
16929929|NCT01059071|38073703|FG002|Overall Study|Withdrawal by Subject|0|||
16929930|NCT01059071|38073704|FG003|Overall Study|Withdrawal by Subject|2|||
16929931|NCT01059071|38073701|FG000|Overall Study|Physician Decision|0|||
16929932|NCT01059071|38073702|FG001|Overall Study|Physician Decision|0|||
16929933|NCT01059071|38073703|FG002|Overall Study|Physician Decision|0|||
16929934|NCT01059071|38073704|FG003|Overall Study|Physician Decision|1|||
16929935|NCT01058642|38073716|FG000|Treatment Period 1|Adverse Event|0|||
16929936|NCT01058642|38073717|FG001|Treatment Period 1|Adverse Event|1|||
16929937|NCT01058642|38073718|FG002|Treatment Period 1|Adverse Event|1|||
16929938|NCT01058642|38073719|FG003|Treatment Period 1|Adverse Event|0|||
16929939|NCT01058642|38073716|FG000|Treatment Period 1|Physician Decision|0|||
16929940|NCT01058642|38073717|FG001|Treatment Period 1|Physician Decision|0|||
16929941|NCT01058642|38073718|FG002|Treatment Period 1|Physician Decision|1|||
16929942|NCT01058642|38073719|FG003|Treatment Period 1|Physician Decision|0|||
16929943|NCT01058642|38073716|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16929944|NCT01058642|38073717|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16929945|NCT01058642|38073718|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16929946|NCT01058642|38073719|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16929947|NCT01058642|38073716|FG000|Treatment Period 1|Lack of Efficacy|0|||
16929948|NCT01058642|38073717|FG001|Treatment Period 1|Lack of Efficacy|0|||
16929949|NCT01058642|38073718|FG002|Treatment Period 1|Lack of Efficacy|0|||
16929950|NCT01058642|38073719|FG003|Treatment Period 1|Lack of Efficacy|1|||
16929951|NCT01058642|38073716|FG000|Treatment Period 1|Protocol Violation|0|||
16929952|NCT01058642|38073717|FG001|Treatment Period 1|Protocol Violation|0|||
16929953|NCT01058642|38073718|FG002|Treatment Period 1|Protocol Violation|0|||
16929954|NCT01058642|38073719|FG003|Treatment Period 1|Protocol Violation|1|||
16929955|NCT01058642|38073716|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
16929956|NCT01058642|38073717|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
16929957|NCT01058642|38073718|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
16929958|NCT01058642|38073719|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
16929959|NCT01058369|38073727|FG000|Overall Study|Adverse Event|1|||
16929960|NCT01058369|38073727|FG000|Overall Study|Early termination study|1|||
16929961|NCT01057433|38073731|FG000|Overall Study|Adverse Event|1|||
16929962|NCT01057394|38073735|FG000|Overall Study|Not eligible|0|||
16929963|NCT01057394|38073736|FG001|Overall Study|Not eligible|2|||
17018930|NCT00667576|38163496|FG001|Overall Study|Missed Visit|0|||
17018931|NCT00667576|38163497|FG002|Overall Study|Missed Visit|0|||
17018932|NCT00667576|38163498|FG003|Overall Study|Missed Visit|1|||
17018933|NCT00667576|38163499|FG004|Overall Study|Missed Visit|0|||
17018934|NCT00666718|38163513|FG000|Overall Study|Adverse Event|0|||
17018935|NCT00666718|38163514|FG001|Overall Study|Adverse Event|1|||
17018936|NCT00666718|38163513|FG000|Overall Study|Death|1|||
17018937|NCT00666718|38163514|FG001|Overall Study|Death|0|||
17018938|NCT00666718|38163513|FG000|Overall Study|Lost to Follow-up|1|||
17018939|NCT00666718|38163514|FG001|Overall Study|Lost to Follow-up|0|||
17018940|NCT00666718|38163513|FG000|Overall Study|Entry Criteria Not Met|2|||
17018941|NCT00666718|38163514|FG001|Overall Study|Entry Criteria Not Met|0|||
17018942|NCT00666718|38163513|FG000|Overall Study|Protocol Violation|1|||
17018943|NCT00666718|38163514|FG001|Overall Study|Protocol Violation|3|||
17018944|NCT00666718|38163513|FG000|Overall Study|Withdrawal by Subject|7|||
17018945|NCT00666718|38163514|FG001|Overall Study|Withdrawal by Subject|12|||
17018946|NCT00666718|38163513|FG000|Overall Study|Physician Decision|0|||
17018947|NCT00666718|38163514|FG001|Overall Study|Physician Decision|2|||
17018948|NCT00667420|38163520|FG000|Overall Study|Adverse Event|2|||
17018949|NCT00667420|38163520|FG000|Overall Study|Lack of Efficacy|5|||
17018950|NCT00667420|38163520|FG000|Overall Study|Physician Decision|1|||
16929964|NCT01056653|38073743|FG000|Overall Study|Lost to Follow-up|0|||
16929965|NCT01056653|38073744|FG001|Overall Study|Lost to Follow-up|0|||
16929966|NCT01056653|38073745|FG002|Overall Study|Lost to Follow-up|2|||
16929967|NCT01056536|38073757|FG000|Overall Study|Lost to Follow-up|202|||
16929968|NCT01056536|38073758|FG001|Overall Study|Lost to Follow-up|116|||
16929969|NCT01056536|38073759|FG002|Overall Study|Lost to Follow-up|248|||
16929970|NCT01056380|38073769|FG000|Overall Study|Lost to Follow-up|2|||
16929971|NCT01056380|38073770|FG001|Overall Study|Lost to Follow-up|3|||
16929972|NCT01055834|38073780|FG000|Treatment Period I|Adverse Event|1|||
16929973|NCT01055834|38073781|FG001|Treatment Period I|Adverse Event|0|||
16929974|NCT01055639|38073792|FG000|Overall Study|Adverse Event|0|||
16929975|NCT01055639|38073793|FG001|Overall Study|Adverse Event|1|||
16929976|NCT01055639|38073792|FG000|Overall Study|Lack of Efficacy|0|||
16929977|NCT01055639|38073793|FG001|Overall Study|Lack of Efficacy|1|||
16929978|NCT01055639|38073792|FG000|Overall Study|Lost to Follow-up|8|||
17018951|NCT00667420|38163520|FG000|Overall Study|Withdrawal by Subject|2|||
16929979|NCT01055639|38073793|FG001|Overall Study|Lost to Follow-up|11|||
16929980|NCT01055639|38073792|FG000|Overall Study|Protocol Violation|5|||
16929981|NCT01055639|38073793|FG001|Overall Study|Protocol Violation|5|||
16929982|NCT01055639|38073792|FG000|Overall Study|Withdrawal by Subject|8|||
16929983|NCT01055639|38073793|FG001|Overall Study|Withdrawal by Subject|11|||
16929984|NCT01055132|38073808|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
16929985|NCT01055132|38073809|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
17018952|NCT00853658|38163528|FG000|Overall Study|Death|713|||
17018953|NCT00853658|38163529|FG001|Overall Study|Death|768|||
17018954|NCT00853658|38163530|FG002|Overall Study|Death|753|||
17018955|NCT00853658|38163528|FG000|Overall Study|Lost to Follow-up|11|||
17018956|NCT00853658|38163529|FG001|Overall Study|Lost to Follow-up|6|||
17018957|NCT00853658|38163530|FG002|Overall Study|Lost to Follow-up|11|||
16851578|NCT01449279|37800930|FG000|Overall Study|Toxicity|2|||
16929986|NCT01055132|38073808|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
16929987|NCT01055132|38073809|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
16929988|NCT01054976|38073819|FG000|Overall Study|Adverse Event|16|||
16929989|NCT01054976|38073819|FG000|Overall Study|Uncooperative participations to study|7|||
16929990|NCT01054976|38073819|FG000|Overall Study|Withdrawal by Subject|4|||
16929991|NCT01054976|38073819|FG000|Overall Study|Other|8|||
16929992|NCT01053962|38073828|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
16929993|NCT01053962|38073829|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
16929994|NCT01053962|38073830|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
16929995|NCT01053962|38073831|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
16929996|NCT01053962|38073832|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
16929997|NCT01053962|38073828|FG000|Pretreatment Period|Venipuncture Failure|0|||
16929998|NCT01053962|38073829|FG001|Pretreatment Period|Venipuncture Failure|0|||
16929999|NCT01053962|38073830|FG002|Pretreatment Period|Venipuncture Failure|1|||
16930000|NCT01053962|38073831|FG003|Pretreatment Period|Venipuncture Failure|0|||
16930001|NCT01053962|38073832|FG004|Pretreatment Period|Venipuncture Failure|0|||
16930002|NCT01053962|38073828|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
16930003|NCT01053962|38073829|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
16930004|NCT01053962|38073830|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
16930005|NCT01053962|38073831|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
16930006|NCT01053962|38073832|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
16930007|NCT01053962|38073828|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
16930008|NCT01053962|38073829|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
16930009|NCT01053962|38073830|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
16930010|NCT01053962|38073831|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
16930011|NCT01053962|38073832|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
16930012|NCT01053962|38073828|FG000|Treatment Period|Lack of Efficacy|0|||
16930013|NCT01053962|38073829|FG001|Treatment Period|Lack of Efficacy|0|||
16930014|NCT01053962|38073830|FG002|Treatment Period|Lack of Efficacy|0|||
16930015|NCT01053962|38073831|FG003|Treatment Period|Lack of Efficacy|0|||
16930016|NCT01053962|38073832|FG004|Treatment Period|Lack of Efficacy|1|||
16930017|NCT01053962|38073828|FG000|Treatment Period|Adverse Event|0|||
16930018|NCT01053962|38073829|FG001|Treatment Period|Adverse Event|0|||
16930019|NCT01053962|38073830|FG002|Treatment Period|Adverse Event|0|||
16930020|NCT01053962|38073831|FG003|Treatment Period|Adverse Event|0|||
17102633|NCT00112437|38241459|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16851579|NCT01447719|37800934|FG000|Overall Study|Image acquisition failure|2|||
16851580|NCT01447719|37800934|FG000|Overall Study|Invalid image or not imaged|3|||
16851581|NCT01447719|37800934|FG000|Overall Study|Subject still living at end of study|79|||
16851582|NCT01447719|37800934|FG000|Overall Study|Withdrawal by Subject|2|||
16851583|NCT01447719|37800934|FG000|Overall Study|Family withdrew autopsy consent|7|||
16851584|NCT01431963|37800943|FG000|Overall Study|Adverse Event|18|||
16851585|NCT01431963|37800943|FG000|Overall Study|Lack of Efficacy|7|||
16851586|NCT01431963|37800943|FG000|Overall Study|Protocol Violation|1|||
16851587|NCT01431963|37800943|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
16851588|NCT01431963|37800943|FG000|Overall Study|Physician Decision|4|||
16851589|NCT01431963|37800943|FG000|Overall Study|Withdrawal by Subject|3|||
16851590|NCT01447407|37800951|FG000|Overall Study|Withdrawal by Subject|2|||
16851591|NCT01447407|37800952|FG001|Overall Study|Withdrawal by Subject|0|||
16851592|NCT01447407|37800953|FG002|Overall Study|Withdrawal by Subject|0|||
16851593|NCT01447407|37800954|FG003|Overall Study|Withdrawal by Subject|1|||
16851594|NCT01447407|37800951|FG000|Overall Study|Physician Decision|0|||
16851595|NCT01447407|37800952|FG001|Overall Study|Physician Decision|0|||
16851596|NCT01447407|37800953|FG002|Overall Study|Physician Decision|1|||
16851597|NCT01447407|37800954|FG003|Overall Study|Physician Decision|1|||
16851598|NCT01446237|37800964|FG000|Overall Study|Adverse Event|1|||
16851599|NCT01446237|37800964|FG000|Overall Study|Lost to Follow-up|2|||
16851600|NCT01446237|37800964|FG000|Overall Study|Withdrawal by Subject|7|||
16851601|NCT01446159|37801112|FG000|Overall Study|Withdrawal by Subject|1|||
16851602|NCT01446159|37801113|FG001|Overall Study|Withdrawal by Subject|0|||
16851603|NCT01446159|37801114|FG002|Overall Study|Withdrawal by Subject|14|||
16851604|NCT01446159|37801115|FG003|Overall Study|Withdrawal by Subject|11|||
16851605|NCT01446159|37801112|FG000|Overall Study|Lost to Follow-up|0|||
16851606|NCT01446159|37801113|FG001|Overall Study|Lost to Follow-up|0|||
16851607|NCT01446159|37801114|FG002|Overall Study|Lost to Follow-up|1|||
16851608|NCT01446159|37801115|FG003|Overall Study|Lost to Follow-up|2|||
16851609|NCT01446159|37801112|FG000|Overall Study|Death|2|||
16851610|NCT01446159|37801113|FG001|Overall Study|Death|3|||
16851611|NCT01446159|37801114|FG002|Overall Study|Death|43|||
16851612|NCT01446159|37801115|FG003|Overall Study|Death|36|||
16851613|NCT01446159|37801112|FG000|Overall Study|Other|0|||
16851614|NCT01446159|37801113|FG001|Overall Study|Other|0|||
16851615|NCT01446159|37801114|FG002|Overall Study|Other|13|||
16851616|NCT01446159|37801115|FG003|Overall Study|Other|13|||
16851617|NCT01446003|37801151|FG000|Period 1|Protocol Violation|2|||
16851618|NCT01446003|37801152|FG001|Period 1|Protocol Violation|0|||
16851619|NCT01446003|37801151|FG000|Period 2|Adverse Event|1|||
16851620|NCT01446003|37801152|FG001|Period 2|Adverse Event|0|||
16851621|NCT01430559|37801169|FG000|Overall Study|Adverse Event|7|||
16851622|NCT01430559|37801170|FG001|Overall Study|Adverse Event|3|||
16851623|NCT01430559|37801169|FG000|Overall Study|Entry criteria not met|1|||
16851624|NCT01430559|37801170|FG001|Overall Study|Entry criteria not met|1|||
16851625|NCT01430559|37801169|FG000|Overall Study|Lost to Follow-up|1|||
16851626|NCT01430559|37801170|FG001|Overall Study|Lost to Follow-up|0|||
16851627|NCT01430559|37801169|FG000|Overall Study|Medication error|1|||
16930021|NCT01053962|38073832|FG004|Treatment Period|Adverse Event|1|||
16930022|NCT01053962|38073828|FG000|Treatment Period|Withdrawal by Subject|0|||
16930023|NCT01053962|38073829|FG001|Treatment Period|Withdrawal by Subject|0|||
16930024|NCT01053962|38073830|FG002|Treatment Period|Withdrawal by Subject|0|||
16930025|NCT01053962|38073831|FG003|Treatment Period|Withdrawal by Subject|0|||
16930026|NCT01053962|38073832|FG004|Treatment Period|Withdrawal by Subject|1|||
16930027|NCT01053962|38073828|FG000|Treatment Period|Noncompliance with protocol|1|||
16930028|NCT01053962|38073829|FG001|Treatment Period|Noncompliance with protocol|0|||
16930029|NCT01053962|38073830|FG002|Treatment Period|Noncompliance with protocol|0|||
16930030|NCT01053962|38073831|FG003|Treatment Period|Noncompliance with protocol|0|||
16930031|NCT01053962|38073832|FG004|Treatment Period|Noncompliance with protocol|0|||
16930032|NCT01053221|38073851|FG000|Overall Study|The study was closed prematurely|5|||
16930033|NCT01053221|38073852|FG001|Overall Study|The study was closed prematurely|9|||
16930034|NCT01052012|38073864|FG000|Overall Study|Not treated|2|||
16930035|NCT01052012|38073865|FG001|Overall Study|Not treated|5|||
16930036|NCT01052012|38073866|FG002|Overall Study|Not treated|0|||
16930037|NCT01052012|38073867|FG003|Overall Study|Not treated|0|||
16930038|NCT01052012|38073868|FG004|Overall Study|Not treated|11|||
16930039|NCT01052012|38073869|FG005|Overall Study|Not treated|8|||
16930040|NCT01052012|38073864|FG000|Overall Study|Adverse Event|1|||
16930041|NCT01052012|38073865|FG001|Overall Study|Adverse Event|0|||
16930042|NCT01052012|38073866|FG002|Overall Study|Adverse Event|0|||
16930043|NCT01052012|38073867|FG003|Overall Study|Adverse Event|1|||
16930044|NCT01052012|38073868|FG004|Overall Study|Adverse Event|0|||
16930045|NCT01052012|38073869|FG005|Overall Study|Adverse Event|0|||
16930046|NCT01052012|38073864|FG000|Overall Study|Lost to Follow-up|0|||
16930047|NCT01052012|38073865|FG001|Overall Study|Lost to Follow-up|0|||
16930048|NCT01052012|38073866|FG002|Overall Study|Lost to Follow-up|0|||
16930049|NCT01052012|38073867|FG003|Overall Study|Lost to Follow-up|0|||
16930050|NCT01052012|38073868|FG004|Overall Study|Lost to Follow-up|1|||
16930051|NCT01052012|38073869|FG005|Overall Study|Lost to Follow-up|0|||
16930052|NCT01052012|38073864|FG000|Overall Study|Withdrawal by Subject|1|||
16930053|NCT01052012|38073865|FG001|Overall Study|Withdrawal by Subject|1|||
16930054|NCT01052012|38073866|FG002|Overall Study|Withdrawal by Subject|0|||
16930055|NCT01052012|38073867|FG003|Overall Study|Withdrawal by Subject|0|||
16930056|NCT01052012|38073868|FG004|Overall Study|Withdrawal by Subject|3|||
16930057|NCT01052012|38073869|FG005|Overall Study|Withdrawal by Subject|1|||
16930058|NCT01052012|38073864|FG000|Overall Study|Physician Decision|0|||
16930059|NCT01052012|38073865|FG001|Overall Study|Physician Decision|0|||
16930060|NCT01052012|38073866|FG002|Overall Study|Physician Decision|0|||
16930061|NCT01052012|38073867|FG003|Overall Study|Physician Decision|0|||
16930062|NCT01052012|38073868|FG004|Overall Study|Physician Decision|0|||
16930063|NCT01052012|38073869|FG005|Overall Study|Physician Decision|1|||
16930064|NCT01052012|38073864|FG000|Overall Study|Other|0|||
16930065|NCT01052012|38073865|FG001|Overall Study|Other|0|||
16930066|NCT01052012|38073866|FG002|Overall Study|Other|0|||
16930067|NCT01052012|38073867|FG003|Overall Study|Other|0|||
16930068|NCT01052012|38073868|FG004|Overall Study|Other|1|||
16930069|NCT01052012|38073869|FG005|Overall Study|Other|0|||
16930070|NCT01051856|38073885|FG000|Overall Study|Withdrawal by Subject|1|||
16930071|NCT01051856|38073886|FG001|Overall Study|Withdrawal by Subject|0|||
16930072|NCT01051817|38073894|FG000|Overall Study|Adverse Event|0|||
16930073|NCT01051817|38073895|FG001|Overall Study|Adverse Event|2|||
16930074|NCT01051817|38073894|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
16930075|NCT01051817|38073895|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
16930076|NCT01051817|38073894|FG000|Overall Study|Withdrawal by Subject|3|||
16930077|NCT01051817|38073895|FG001|Overall Study|Withdrawal by Subject|5|||
16930078|NCT01051817|38073894|FG000|Overall Study|Protocol Violation|0|||
16930079|NCT01051817|38073895|FG001|Overall Study|Protocol Violation|1|||
16930080|NCT01327846|38073905|FG000|Core Phase|Subject decision (vital status: missing)|1|||
16930081|NCT01327846|38073906|FG001|Core Phase|Subject decision (vital status: missing)|2|||
16930082|NCT01327846|38073907|FG002|Core Phase|Subject decision (vital status: missing)|2|||
16930083|NCT01327846|38073908|FG003|Core Phase|Subject decision (vital status: missing)|1|||
16930084|NCT01327846|38073905|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
16930085|NCT01327846|38073906|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
16851628|NCT01430559|37801170|FG001|Overall Study|Medication error|0|||
16851629|NCT01430559|37801169|FG000|Overall Study|Withdrawal by Subject|3|||
16930086|NCT01327846|38073907|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
16930087|NCT01327846|38073908|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
16930088|NCT01327846|38073905|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
16930089|NCT01327846|38073906|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
16930090|NCT01327846|38073907|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
16930091|NCT01327846|38073908|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
16930092|NCT01327846|38073905|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
16930093|NCT01327846|38073906|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
16930094|NCT01327846|38073907|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
16930095|NCT01327846|38073908|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
16930096|NCT01327846|38073905|FG000|Core Phase|Lost to Follow-up|3|||
16930097|NCT01327846|38073906|FG001|Core Phase|Lost to Follow-up|3|||
16930098|NCT01327846|38073907|FG002|Core Phase|Lost to Follow-up|4|||
16930099|NCT01327846|38073908|FG003|Core Phase|Lost to Follow-up|5|||
16930100|NCT01327846|38073905|FG000|Extension Phase|Study terminated by sponsor|1073|||
16930101|NCT01327846|38073906|FG001|Extension Phase|Study terminated by sponsor|1124|||
16930102|NCT01327846|38073907|FG002|Extension Phase|Study terminated by sponsor|1067|||
16930103|NCT01327846|38073908|FG003|Extension Phase|Study terminated by sponsor|1660|||
16930104|NCT01327846|38073905|FG000|Extension Phase|Withdrawal by Subject|20|||
16930105|NCT01327846|38073906|FG001|Extension Phase|Withdrawal by Subject|13|||
16930106|NCT01327846|38073907|FG002|Extension Phase|Withdrawal by Subject|19|||
16930107|NCT01327846|38073908|FG003|Extension Phase|Withdrawal by Subject|37|||
16930108|NCT01327846|38073905|FG000|Extension Phase|Lost to Follow-up|4|||
16930109|NCT01327846|38073906|FG001|Extension Phase|Lost to Follow-up|3|||
16930110|NCT01327846|38073907|FG002|Extension Phase|Lost to Follow-up|4|||
16930111|NCT01327846|38073908|FG003|Extension Phase|Lost to Follow-up|7|||
16930112|NCT01327846|38073905|FG000|Extension Phase|Technical Problems|2|||
16930113|NCT01327846|38073906|FG001|Extension Phase|Technical Problems|4|||
16930114|NCT01327846|38073907|FG002|Extension Phase|Technical Problems|2|||
16930115|NCT01327846|38073908|FG003|Extension Phase|Technical Problems|2|||
16851630|NCT01430559|37801170|FG001|Overall Study|Withdrawal by Subject|2|||
16851631|NCT01430559|37801169|FG000|Overall Study|Protocol Violation|1|||
16851632|NCT01430559|37801170|FG001|Overall Study|Protocol Violation|0|||
16851633|NCT01430559|37801169|FG000|Overall Study|Other|3|||
16851634|NCT01430559|37801170|FG001|Overall Study|Other|3|||
16851635|NCT01430559|37801169|FG000|Overall Study|Randomized, Not Treated|3|||
16930116|NCT01051739|38073921|FG000|Overall Study|Death|3|||
16930117|NCT01051739|38073922|FG001|Overall Study|Death|3|||
16930118|NCT01051739|38073921|FG000|Overall Study|Withdrawal by Subject|25|||
16930119|NCT01051739|38073922|FG001|Overall Study|Withdrawal by Subject|10|||
16930120|NCT01051661|38073934|FG000|Overall Study|Adverse Event|1|||
16930121|NCT01051661|38073935|FG001|Overall Study|Adverse Event|1|||
16930122|NCT01051661|38073936|FG002|Overall Study|Adverse Event|1|||
16930123|NCT01051661|38073937|FG003|Overall Study|Adverse Event|1|||
16930124|NCT01051661|38073938|FG004|Overall Study|Adverse Event|0|||
16930125|NCT01051661|38073939|FG005|Overall Study|Adverse Event|0|||
16930126|NCT01051661|38073934|FG000|Overall Study|Lost to Follow-up|13|||
16930127|NCT01051661|38073935|FG001|Overall Study|Lost to Follow-up|22|||
16930128|NCT01051661|38073936|FG002|Overall Study|Lost to Follow-up|15|||
16851636|NCT01430559|37801170|FG001|Overall Study|Randomized, Not Treated|3|||
16851637|NCT01410357|37801183|FG000|Overall Study|Death|2|||
16851638|NCT01410357|37801184|FG001|Overall Study|Death|1|||
16851639|NCT01410357|37801183|FG000|Overall Study|Withdrawal by Subject|1|||
16851640|NCT01410357|37801184|FG001|Overall Study|Withdrawal by Subject|2|||
16851641|NCT01410357|37801183|FG000|Overall Study|Lost to Follow-up|23|||
16851642|NCT01410357|37801184|FG001|Overall Study|Lost to Follow-up|21|||
16851643|NCT01409811|37801209|FG000|Overall Study|Insurance denial|1|||
16851644|NCT01445847|37801215|FG000|Overall Study|Protocol Violation|13|||
16851645|NCT01445847|37801216|FG001|Overall Study|Protocol Violation|14|||
16851646|NCT01445847|37801215|FG000|Overall Study|Missed Data|1|||
16851647|NCT01445847|37801216|FG001|Overall Study|Missed Data|0|||
16851648|NCT01445769|37801235|FG000|Overall Study|Consent Withdrawn|2|||
16851649|NCT01445769|37801235|FG000|Overall Study|Disease Progression|1|||
16851650|NCT01445769|37801235|FG000|Overall Study|Lost to Follow-up|5|||
16851651|NCT01445613|37801317|FG000|30-day Follow-up|Withdrawal by Subject|6|||
16851652|NCT01445613|37801317|FG000|30-day Follow-up|Physician Decision|3|||
16851653|NCT01445613|37801317|FG000|30-day Follow-up|Missed visit|23|||
16851654|NCT01445613|37801317|FG000|30-day Follow-up|Death|3|||
16851655|NCT01445613|37801317|FG000|1-year Follow-up|Withdrawal by Subject|12|||
16851656|NCT01445613|37801317|FG000|1-year Follow-up|Missed visit|29|||
16851657|NCT01445613|37801317|FG000|1-year Follow-up|Lost to Follow-up|2|||
16851658|NCT01445613|37801317|FG000|1-year Follow-up|Death|30|||
16851659|NCT01445613|37801317|FG000|1-year Follow-up|Physician Decision|2|||
16851660|NCT01445613|37801317|FG000|1-year Follow-up|Received a non-study stent|2|||
16851661|NCT01445535|37801421|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
16851662|NCT01445535|37801422|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
16851663|NCT01445535|37801423|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
16851664|NCT01445535|37801424|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
16930129|NCT01051661|38073937|FG003|Overall Study|Lost to Follow-up|17|||
16930130|NCT01051661|38073938|FG004|Overall Study|Lost to Follow-up|10|||
16930131|NCT01051661|38073939|FG005|Overall Study|Lost to Follow-up|24|||
16930132|NCT01051661|38073934|FG000|Overall Study|Migrated/moved from study area|1|||
16851665|NCT01445535|37801421|FG000|Overall Study|Disease progression|1|||
16851666|NCT01445535|37801422|FG001|Overall Study|Disease progression|0|||
16851667|NCT01445535|37801423|FG002|Overall Study|Disease progression|1|||
16851668|NCT01445535|37801424|FG003|Overall Study|Disease progression|0|||
16851669|NCT01445535|37801421|FG000|Overall Study|PI discretion|0|||
16851670|NCT01445535|37801422|FG001|Overall Study|PI discretion|0|||
16851671|NCT01445535|37801423|FG002|Overall Study|PI discretion|0|||
16851672|NCT01445535|37801424|FG003|Overall Study|PI discretion|1|||
16851673|NCT01445301|37801438|FG000|Overall Study|Adverse Event|15|||
16851674|NCT01445301|37801439|FG001|Overall Study|Adverse Event|25|||
16851675|NCT01445301|37801440|FG002|Overall Study|Adverse Event|4|||
16851676|NCT01445301|37801438|FG000|Overall Study|Lack of Efficacy|0|||
16930133|NCT01051661|38073935|FG001|Overall Study|Migrated/moved from study area|6|||
16930134|NCT01051661|38073936|FG002|Overall Study|Migrated/moved from study area|6|||
16930135|NCT01051661|38073937|FG003|Overall Study|Migrated/moved from study area|8|||
16930136|NCT01051661|38073938|FG004|Overall Study|Migrated/moved from study area|7|||
16930137|NCT01051661|38073939|FG005|Overall Study|Migrated/moved from study area|3|||
16930138|NCT01051661|38073934|FG000|Overall Study|Refused blood sampling|0|||
16930139|NCT01051661|38073935|FG001|Overall Study|Refused blood sampling|0|||
16930140|NCT01051661|38073936|FG002|Overall Study|Refused blood sampling|0|||
16930141|NCT01051661|38073937|FG003|Overall Study|Refused blood sampling|0|||
16930142|NCT01051661|38073938|FG004|Overall Study|Refused blood sampling|0|||
16851677|NCT01445301|37801439|FG001|Overall Study|Lack of Efficacy|1|||
16930143|NCT01051661|38073939|FG005|Overall Study|Refused blood sampling|1|||
16930144|NCT01051661|38073934|FG000|Overall Study|Data not reliable|1|||
16930145|NCT01051661|38073935|FG001|Overall Study|Data not reliable|0|||
16930146|NCT01051661|38073936|FG002|Overall Study|Data not reliable|0|||
16930147|NCT01051661|38073937|FG003|Overall Study|Data not reliable|0|||
16930148|NCT01051661|38073938|FG004|Overall Study|Data not reliable|0|||
16930149|NCT01051661|38073939|FG005|Overall Study|Data not reliable|1|||
16930150|NCT01051661|38073934|FG000|Overall Study|Unable to attend visit(s)|2|||
16930151|NCT01051661|38073935|FG001|Overall Study|Unable to attend visit(s)|4|||
16930152|NCT01051661|38073936|FG002|Overall Study|Unable to attend visit(s)|2|||
16930153|NCT01051661|38073937|FG003|Overall Study|Unable to attend visit(s)|1|||
16930154|NCT01051661|38073938|FG004|Overall Study|Unable to attend visit(s)|3|||
16930155|NCT01051661|38073939|FG005|Overall Study|Unable to attend visit(s)|2|||
16930156|NCT01051661|38073934|FG000|Overall Study|Consent not received from both parents|0|||
16930157|NCT01051661|38073935|FG001|Overall Study|Consent not received from both parents|0|||
16930158|NCT01051661|38073936|FG002|Overall Study|Consent not received from both parents|0|||
16930159|NCT01051661|38073937|FG003|Overall Study|Consent not received from both parents|0|||
16930160|NCT01051661|38073938|FG004|Overall Study|Consent not received from both parents|0|||
16930161|NCT01051661|38073939|FG005|Overall Study|Consent not received from both parents|1|||
16930162|NCT01051661|38073934|FG000|Overall Study|Failure to comply with protocol|0|||
16930163|NCT01051661|38073935|FG001|Overall Study|Failure to comply with protocol|0|||
16930164|NCT01051661|38073936|FG002|Overall Study|Failure to comply with protocol|2|||
16930165|NCT01051661|38073937|FG003|Overall Study|Failure to comply with protocol|0|||
16930166|NCT01051661|38073938|FG004|Overall Study|Failure to comply with protocol|0|||
16930167|NCT01051661|38073939|FG005|Overall Study|Failure to comply with protocol|0|||
16930168|NCT01051661|38073934|FG000|Overall Study|Subject lost legal representation|0|||
16930169|NCT01051661|38073935|FG001|Overall Study|Subject lost legal representation|0|||
16930170|NCT01051661|38073936|FG002|Overall Study|Subject lost legal representation|0|||
16930171|NCT01051661|38073937|FG003|Overall Study|Subject lost legal representation|0|||
16930172|NCT01051661|38073938|FG004|Overall Study|Subject lost legal representation|1|||
17018958|NCT00853658|38163528|FG000|Overall Study|H.A. Request|26|||
16851678|NCT01445301|37801440|FG002|Overall Study|Lack of Efficacy|0|||
16851679|NCT01445301|37801438|FG000|Overall Study|Protocol Violation|1|||
16851680|NCT01445301|37801439|FG001|Overall Study|Protocol Violation|0|||
16930173|NCT01051661|38073939|FG005|Overall Study|Subject lost legal representation|0|||
16930174|NCT01051661|38073934|FG000|Overall Study|Protocol Violation|0|||
16930175|NCT01051661|38073935|FG001|Overall Study|Protocol Violation|0|||
16930176|NCT01051661|38073936|FG002|Overall Study|Protocol Violation|0|||
16930177|NCT01051661|38073937|FG003|Overall Study|Protocol Violation|1|||
16930178|NCT01051661|38073938|FG004|Overall Study|Protocol Violation|2|||
16930179|NCT01051661|38073939|FG005|Overall Study|Protocol Violation|1|||
16930180|NCT01051661|38073934|FG000|Overall Study|Withdrawal by Subject|16|||
16930181|NCT01051661|38073935|FG001|Overall Study|Withdrawal by Subject|30|||
16930182|NCT01051661|38073936|FG002|Overall Study|Withdrawal by Subject|13|||
16930183|NCT01051661|38073937|FG003|Overall Study|Withdrawal by Subject|28|||
16851681|NCT01445301|37801440|FG002|Overall Study|Protocol Violation|0|||
16851682|NCT01445301|37801438|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
16851683|NCT01445301|37801439|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
16851684|NCT01445301|37801440|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
16851685|NCT01445301|37801438|FG000|Overall Study|Physician Decision|0|||
16851686|NCT01445301|37801439|FG001|Overall Study|Physician Decision|2|||
16851687|NCT01445301|37801440|FG002|Overall Study|Physician Decision|0|||
16851688|NCT01445301|37801438|FG000|Overall Study|Withdrawal by Subject|5|||
16851689|NCT01445301|37801439|FG001|Overall Study|Withdrawal by Subject|6|||
16851690|NCT01445301|37801440|FG002|Overall Study|Withdrawal by Subject|4|||
16851691|NCT01409031|37801450|FG000|Overall Study|transferred to other hosp|1|||
16930184|NCT01051661|38073938|FG004|Overall Study|Withdrawal by Subject|12|||
16930185|NCT01051661|38073939|FG005|Overall Study|Withdrawal by Subject|34|||
16930186|NCT01051466|38073976|FG000|Overall Study|Adverse Event|1|||
16930187|NCT01051466|38073977|FG001|Overall Study|Adverse Event|0|||
16930188|NCT01051466|38073976|FG000|Overall Study|Lost to Follow-up|1|||
16930189|NCT01051466|38073977|FG001|Overall Study|Lost to Follow-up|1|||
16930190|NCT01051466|38073976|FG000|Overall Study|Withdrawal by Subject|5|||
16930191|NCT01051466|38073977|FG001|Overall Study|Withdrawal by Subject|1|||
16930192|NCT01051466|38073976|FG000|Overall Study|Entry Criteria Not Met|0|||
16930193|NCT01051466|38073977|FG001|Overall Study|Entry Criteria Not Met|3|||
16930194|NCT01051466|38073976|FG000|Overall Study|Physician Decision|1|||
16930195|NCT01051466|38073977|FG001|Overall Study|Physician Decision|0|||
16930196|NCT01051349|38073991|FG000|Overall Study|Adverse Event|88|||
16930197|NCT01051349|38073991|FG000|Overall Study|Consent Withdrawn|54|||
16930198|NCT01051349|38073991|FG000|Overall Study|Investigator Decision|6|||
16930199|NCT01051349|38073991|FG000|Overall Study|Lost to Follow-up|6|||
16930200|NCT01051349|38073991|FG000|Overall Study|Subject non-compliance|7|||
16930201|NCT01051349|38073991|FG000|Overall Study|Reason not Specified|12|||
16930202|NCT01050998|38074003|FG000|Overall Study|Adverse Event|1|||
16930203|NCT01050998|38074004|FG001|Overall Study|Adverse Event|0|||
16930204|NCT01050998|38074005|FG002|Overall Study|Adverse Event|1|||
16930205|NCT01050998|38074006|FG003|Overall Study|Adverse Event|0|||
16930206|NCT01050998|38074007|FG004|Overall Study|Adverse Event|2|||
16930207|NCT01050998|38074003|FG000|Overall Study|Withdrawal by Subject|0|||
16930208|NCT01050998|38074004|FG001|Overall Study|Withdrawal by Subject|0|||
16930209|NCT01050998|38074005|FG002|Overall Study|Withdrawal by Subject|0|||
16930210|NCT01050998|38074006|FG003|Overall Study|Withdrawal by Subject|1|||
16930211|NCT01050998|38074007|FG004|Overall Study|Withdrawal by Subject|3|||
16930212|NCT01050998|38074003|FG000|Overall Study|Other|3|||
16930213|NCT01050998|38074004|FG001|Overall Study|Other|2|||
16930214|NCT01050998|38074005|FG002|Overall Study|Other|1|||
16930215|NCT01050998|38074006|FG003|Overall Study|Other|1|||
16930216|NCT01050998|38074007|FG004|Overall Study|Other|5|||
16930217|NCT01050998|38074003|FG000|Overall Study|Data integrity issues|0|||
16930218|NCT01050998|38074004|FG001|Overall Study|Data integrity issues|0|||
16930219|NCT01050998|38074005|FG002|Overall Study|Data integrity issues|1|||
16930220|NCT01050998|38074006|FG003|Overall Study|Data integrity issues|1|||
16930221|NCT01050998|38074007|FG004|Overall Study|Data integrity issues|4|||
16930222|NCT00106028|38074025|FG000|Overall Study|Adverse Event|3|||
16930223|NCT00106028|38074026|FG001|Overall Study|Adverse Event|2|||
16930224|NCT00106028|38074025|FG000|Overall Study|Protocol Violation|1|||
16930225|NCT00106028|38074026|FG001|Overall Study|Protocol Violation|1|||
16930226|NCT00106028|38074025|FG000|Overall Study|Withdrawal by Subject|2|||
16930227|NCT00106028|38074026|FG001|Overall Study|Withdrawal by Subject|8|||
16930228|NCT00106028|38074025|FG000|Overall Study|Lost to Follow-up|0|||
16930229|NCT00106028|38074026|FG001|Overall Study|Lost to Follow-up|1|||
16930230|NCT01050764|38074034|FG000|Overall Study|Death, before HSCT|1|||
16930231|NCT01050764|38074034|FG000|Overall Study|Donor mobilization failure, death|1|||
16930232|NCT01050764|38074034|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
16930233|NCT01050569|38074041|FG000|Overall Study|Lost to Follow-up|20|||
16930234|NCT01050569|38074042|FG001|Overall Study|Lost to Follow-up|14|||
16930235|NCT01050569|38074043|FG002|Overall Study|Lost to Follow-up|16|||
16930236|NCT01050569|38074041|FG000|Overall Study|Withdrawal by Subject|9|||
16930237|NCT01050569|38074042|FG001|Overall Study|Withdrawal by Subject|3|||
16930238|NCT01050569|38074043|FG002|Overall Study|Withdrawal by Subject|11|||
16930239|NCT01050569|38074041|FG000|Overall Study|Lack of Efficacy|5|||
16930240|NCT01050569|38074042|FG001|Overall Study|Lack of Efficacy|4|||
16930241|NCT01050569|38074043|FG002|Overall Study|Lack of Efficacy|3|||
16930242|NCT01050569|38074041|FG000|Overall Study|Adverse Event|1|||
16930243|NCT01050569|38074042|FG001|Overall Study|Adverse Event|0|||
16851692|NCT01409031|37801451|FG001|Overall Study|transferred to other hosp|0|||
16930244|NCT01050569|38074043|FG002|Overall Study|Adverse Event|0|||
16930245|NCT01050569|38074041|FG000|Overall Study|Physician Decision|3|||
16930246|NCT01050569|38074042|FG001|Overall Study|Physician Decision|3|||
16930247|NCT01050569|38074043|FG002|Overall Study|Physician Decision|3|||
16930248|NCT01050530|38074057|FG000|Overall Study|Adverse Event|6|||
16930249|NCT01050530|38074058|FG001|Overall Study|Adverse Event|3|||
16930250|NCT01050530|38074057|FG000|Overall Study|Lack of Efficacy|1|||
16930251|NCT01050530|38074058|FG001|Overall Study|Lack of Efficacy|4|||
16930252|NCT01050530|38074057|FG000|Overall Study|Withdrawal by Subject|0|||
16930253|NCT01050530|38074058|FG001|Overall Study|Withdrawal by Subject|3|||
16930254|NCT01050530|38074057|FG000|Overall Study|Protocol Violation|1|||
16930255|NCT01050530|38074058|FG001|Overall Study|Protocol Violation|0|||
16930256|NCT01050257|38074067|FG000|Overall Study|Adverse Event|4|||
16930257|NCT01050257|38074068|FG001|Overall Study|Adverse Event|4|||
16930258|NCT01050257|38074069|FG002|Overall Study|Adverse Event|2|||
16930259|NCT01050257|38074067|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
16930260|NCT01050257|38074068|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
16930261|NCT01050257|38074069|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
16930262|NCT01050257|38074067|FG000|Overall Study|Withdrawal by Subject|0|||
16930263|NCT01050257|38074068|FG001|Overall Study|Withdrawal by Subject|3|||
16930264|NCT01050257|38074069|FG002|Overall Study|Withdrawal by Subject|0|||
16930265|NCT01050257|38074067|FG000|Overall Study|No reason specified|0|||
16930266|NCT01050257|38074068|FG001|Overall Study|No reason specified|0|||
16930267|NCT01050257|38074069|FG002|Overall Study|No reason specified|2|||
16930268|NCT01050257|38074067|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
16930269|NCT01050257|38074068|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
16930270|NCT01050257|38074069|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
16930271|NCT01050257|38074067|FG000|Overall Study|Violation criteria|0|||
16930272|NCT01050257|38074068|FG001|Overall Study|Violation criteria|1|||
16930273|NCT01050257|38074069|FG002|Overall Study|Violation criteria|0|||
16930274|NCT01050257|38074067|FG000|Overall Study|Failure to return|0|||
16851693|NCT01430403|37801460|FG000|Overall Study|Lost to Follow-up|5|||
16851694|NCT01430403|37801461|FG001|Overall Study|Lost to Follow-up|5|||
16851695|NCT01430403|37801462|FG002|Overall Study|Lost to Follow-up|3|||
16851696|NCT01430403|37801460|FG000|Overall Study|Physician Decision|1|||
16930275|NCT01050257|38074068|FG001|Overall Study|Failure to return|2|||
16851697|NCT01430403|37801461|FG001|Overall Study|Physician Decision|0|||
16851698|NCT01430403|37801462|FG002|Overall Study|Physician Decision|0|||
16851699|NCT01430403|37801460|FG000|Overall Study|Protocol Violation|2|||
16851700|NCT01430403|37801461|FG001|Overall Study|Protocol Violation|3|||
16851701|NCT01430403|37801462|FG002|Overall Study|Protocol Violation|2|||
16851702|NCT01430403|37801460|FG000|Overall Study|Withdrawal by Subject|9|||
16930276|NCT01050257|38074069|FG002|Overall Study|Failure to return|0|||
16930277|NCT01050257|38074067|FG000|Overall Study|Death|0|||
16930278|NCT01050257|38074068|FG001|Overall Study|Death|0|||
16930279|NCT01050257|38074069|FG002|Overall Study|Death|1|||
16930280|NCT01050218|38074077|FG000|Overall Study|Adverse Event|37|||
16930281|NCT01050218|38074077|FG000|Overall Study|Lack of Efficacy|8|||
16930282|NCT01050218|38074077|FG000|Overall Study|Protocol Violation|3|||
16930283|NCT01050218|38074077|FG000|Overall Study|Withdrawal by Subject|18|||
16930284|NCT01050218|38074077|FG000|Overall Study|Discontinued by sponsor|18|||
16930285|NCT01050218|38074077|FG000|Overall Study|Compliance|2|||
16930286|NCT01050218|38074077|FG000|Overall Study|Failed to return|7|||
16930287|NCT01050218|38074077|FG000|Overall Study|Serious Adverse Event|1|||
16930288|NCT01050218|38074077|FG000|Overall Study|Family emergency|1|||
16930289|NCT01050062|38074083|FG000|Overall Study|Adverse Event|75|||
16930290|NCT01050062|38074084|FG001|Overall Study|Adverse Event|22|||
16930291|NCT01050062|38074083|FG000|Overall Study|Lost to Follow-up|83|||
16930292|NCT01050062|38074084|FG001|Overall Study|Lost to Follow-up|35|||
16930293|NCT01050062|38074083|FG000|Overall Study|Lack of Efficacy|22|||
16930294|NCT01050062|38074084|FG001|Overall Study|Lack of Efficacy|35|||
16930295|NCT01050062|38074083|FG000|Overall Study|Physician Decision|74|||
16930296|NCT01050062|38074084|FG001|Overall Study|Physician Decision|9|||
16930297|NCT01050062|38074083|FG000|Overall Study|Others|17|||
16930298|NCT01050062|38074084|FG001|Overall Study|Others|11|||
16930299|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
17018959|NCT00853658|38163529|FG001|Overall Study|H.A. Request|23|||
17018960|NCT00853658|38163530|FG002|Overall Study|H.A. Request|19|||
17018961|NCT00853658|38163528|FG000|Overall Study|IRB request|0|||
16930300|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
17018962|NCT00853658|38163529|FG001|Overall Study|IRB request|0|||
17018963|NCT00853658|38163530|FG002|Overall Study|IRB request|2|||
17018964|NCT00853658|38163528|FG000|Overall Study|Vital Status known (alive) at study end|2|||
17018965|NCT00853658|38163529|FG001|Overall Study|Vital Status known (alive) at study end|3|||
17018966|NCT00853658|38163530|FG002|Overall Study|Vital Status known (alive) at study end|3|||
17018967|NCT00853658|38163528|FG000|Overall Study|Vital Status unknown at study end|1|||
16851703|NCT01430403|37801461|FG001|Overall Study|Withdrawal by Subject|1|||
16930301|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
16930302|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
16930303|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
16930304|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
16930305|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
16930306|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
16930307|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
16930308|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
16930309|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
16930310|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
16930311|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
16930312|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
16930313|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Death|1|||
16930314|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Death|0|||
16930315|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
16930316|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
16930317|NCT00105989|38074102|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
16930318|NCT00105989|38074103|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
16930319|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
16930320|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
16930321|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
16930322|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
16930323|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
16930324|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
16930325|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
16930326|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
16930327|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
16930328|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
16930329|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
16930330|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
16930331|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
16930332|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
16930333|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Death|0|||
16930334|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Death|0|||
16930335|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
16930336|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
16930337|NCT00105989|38074102|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
16930338|NCT00105989|38074103|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
16930339|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
16930340|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
16930341|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
16930342|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
16930343|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
16930344|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
16930345|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
16851704|NCT01430403|37801462|FG002|Overall Study|Withdrawal by Subject|3|||
16851705|NCT01429623|37801477|FG000|Overall Study|Death|1|||
16851706|NCT01429623|37801478|FG001|Overall Study|Death|0|||
16851707|NCT01429623|37801477|FG000|Overall Study|Adverse Event|7|||
16851708|NCT01429623|37801478|FG001|Overall Study|Adverse Event|14|||
16851709|NCT01429623|37801477|FG000|Overall Study|Withdrawal by Subject|19|||
16851710|NCT01429623|37801478|FG001|Overall Study|Withdrawal by Subject|13|||
16851711|NCT01429623|37801477|FG000|Overall Study|Physician Decision|2|||
16851712|NCT01429623|37801478|FG001|Overall Study|Physician Decision|3|||
16851713|NCT01429623|37801477|FG000|Overall Study|Protocol Violation|3|||
16851714|NCT01429623|37801478|FG001|Overall Study|Protocol Violation|2|||
16851715|NCT01429623|37801477|FG000|Overall Study|Assorted|1|||
16851716|NCT01429623|37801478|FG001|Overall Study|Assorted|2|||
16851717|NCT01429623|37801477|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
16851718|NCT01429623|37801478|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
16851719|NCT01429623|37801477|FG000|Overall Study|No post baseline data|4|||
16851720|NCT01429623|37801478|FG001|Overall Study|No post baseline data|4|||
16851721|NCT01408641|37801486|FG000|Overall Study|Physician Decision|1|||
16851722|NCT01408641|37801487|FG001|Overall Study|Physician Decision|0|||
16851723|NCT01429077|37801495|FG000|Overall Study|Lost to Follow-up|0|||
16851724|NCT01429077|37801496|FG001|Overall Study|Lost to Follow-up|3|||
16851725|NCT01428453|37801504|FG000|Overall Study|Adverse Event|2|||
16851726|NCT01428453|37801505|FG001|Overall Study|Adverse Event|7|||
16851727|NCT01428453|37801504|FG000|Overall Study|Protocol Violation|1|||
16930346|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
16930347|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
16930348|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
16930349|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
16930350|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
16930351|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
16851728|NCT01428453|37801505|FG001|Overall Study|Protocol Violation|0|||
16851729|NCT01428453|37801504|FG000|Overall Study|Lost to Follow-up|0|||
16851730|NCT01428453|37801505|FG001|Overall Study|Lost to Follow-up|1|||
16851731|NCT01428453|37801504|FG000|Overall Study|Withdrawal by Subject|3|||
16851732|NCT01428453|37801505|FG001|Overall Study|Withdrawal by Subject|1|||
16851733|NCT01408563|37801513|FG000|Overall Study|Ineligible after consent/ registration|2|||
16851734|NCT01442493|37801519|FG000|Overall Study|withdrawn from study|3|||
16851735|NCT01442493|37801520|FG001|Overall Study|withdrawn from study|2|||
16851736|NCT01442181|37801528|FG000|Overall Study|patient refused surgery|1|||
16851737|NCT01442181|37801529|FG001|Overall Study|patient refused surgery|0|||
16851738|NCT01442181|37801528|FG000|Overall Study|no insurance for surgery|1|||
16851739|NCT01442181|37801529|FG001|Overall Study|no insurance for surgery|0|||
16851740|NCT01442181|37801528|FG000|Overall Study|low ejection factor|0|||
16851741|NCT01442181|37801529|FG001|Overall Study|low ejection factor|1|||
16851742|NCT01442181|37801528|FG000|Overall Study|Lost to Follow-up|1|||
16851743|NCT01442181|37801529|FG001|Overall Study|Lost to Follow-up|1|||
16851744|NCT01442181|37801528|FG000|Overall Study|patient in an additional study|1|||
16851745|NCT01442181|37801529|FG001|Overall Study|patient in an additional study|0|||
16851746|NCT01442181|37801528|FG000|Overall Study|atrial fibrillation not noted|0|||
16851747|NCT01442181|37801529|FG001|Overall Study|atrial fibrillation not noted|1|||
16930352|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
16930353|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
16930354|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
16930355|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
16930356|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
16930357|NCT00105989|38074102|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
16930358|NCT00105989|38074103|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
16930359|NCT03277248|38074121|FG000|Overall Study|Adverse Event|3|||
16851748|NCT01442103|37801536|FG000|Overall Study|Lost to Follow-up|2|||
16851749|NCT01428219|37801540|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
16851750|NCT01428063|37801547|FG000|Overall Study|Lack of Efficacy|8|||
16851751|NCT01428063|37801548|FG001|Overall Study|Lack of Efficacy|4|||
16851752|NCT01428063|37801549|FG002|Overall Study|Lack of Efficacy|1|||
16851753|NCT01428063|37801547|FG000|Overall Study|Adverse Event|2|||
16851754|NCT01428063|37801548|FG001|Overall Study|Adverse Event|3|||
16851755|NCT01428063|37801549|FG002|Overall Study|Adverse Event|0|||
16851756|NCT01428063|37801547|FG000|Overall Study|Lost to Follow-up|0|||
16851757|NCT01428063|37801548|FG001|Overall Study|Lost to Follow-up|2|||
16851758|NCT01428063|37801549|FG002|Overall Study|Lost to Follow-up|0|||
16851759|NCT01428063|37801547|FG000|Overall Study|No longer meets study criteria|0|||
16851760|NCT01428063|37801548|FG001|Overall Study|No longer meets study criteria|1|||
16851761|NCT01428063|37801549|FG002|Overall Study|No longer meets study criteria|0|||
16851762|NCT01441635|37801713|FG000|Overall Study|Adverse Event|4|||
16851763|NCT01441635|37801714|FG001|Overall Study|Adverse Event|3|||
16851764|NCT01441635|37801715|FG002|Overall Study|Adverse Event|1|||
16851765|NCT01441635|37801716|FG003|Overall Study|Adverse Event|5|||
16851766|NCT01441635|37801717|FG004|Overall Study|Adverse Event|1|||
16851767|NCT01441635|37801718|FG005|Overall Study|Adverse Event|2|||
16851768|NCT01441635|37801719|FG006|Overall Study|Adverse Event|2|||
16851769|NCT01441635|37801720|FG007|Overall Study|Adverse Event|2|||
16851770|NCT01441635|37801721|FG008|Overall Study|Adverse Event|1|||
16851771|NCT01441635|37801722|FG009|Overall Study|Adverse Event|0|||
16851772|NCT01441635|37801713|FG000|Overall Study|Withdrawal by Subject|1|||
16851773|NCT01441635|37801714|FG001|Overall Study|Withdrawal by Subject|1|||
16851774|NCT01441635|37801715|FG002|Overall Study|Withdrawal by Subject|0|||
16851775|NCT01441635|37801716|FG003|Overall Study|Withdrawal by Subject|1|||
16851776|NCT01441635|37801717|FG004|Overall Study|Withdrawal by Subject|0|||
16851777|NCT01441635|37801718|FG005|Overall Study|Withdrawal by Subject|0|||
16851778|NCT01441635|37801719|FG006|Overall Study|Withdrawal by Subject|2|||
16851779|NCT01441635|37801720|FG007|Overall Study|Withdrawal by Subject|0|||
16851780|NCT01441635|37801721|FG008|Overall Study|Withdrawal by Subject|1|||
16930360|NCT03277248|38074122|FG001|Overall Study|Adverse Event|1|||
16851781|NCT01441635|37801722|FG009|Overall Study|Withdrawal by Subject|1|||
16851782|NCT01441635|37801713|FG000|Overall Study|Lost to Follow-up|0|||
16851783|NCT01441635|37801714|FG001|Overall Study|Lost to Follow-up|1|||
16851784|NCT01441635|37801715|FG002|Overall Study|Lost to Follow-up|1|||
16851785|NCT01441635|37801716|FG003|Overall Study|Lost to Follow-up|1|||
16851786|NCT01441635|37801717|FG004|Overall Study|Lost to Follow-up|1|||
16930361|NCT03277248|38074121|FG000|Overall Study|Subject Withdrawal of Consent|6|||
16930362|NCT03277248|38074122|FG001|Overall Study|Subject Withdrawal of Consent|23|||
16930363|NCT03277248|38074121|FG000|Overall Study|Investigator/Sponsor Decision|2|||
16930364|NCT03277248|38074122|FG001|Overall Study|Investigator/Sponsor Decision|2|||
16930365|NCT03277248|38074121|FG000|Overall Study|Pregnancy|4|||
16930366|NCT03277248|38074122|FG001|Overall Study|Pregnancy|1|||
16930367|NCT03277248|38074121|FG000|Overall Study|Lost to Follow-up|0|||
16930368|NCT03277248|38074122|FG001|Overall Study|Lost to Follow-up|2|||
16930369|NCT03277248|38074121|FG000|Overall Study|Lack of Efficacy|0|||
16930370|NCT03277248|38074122|FG001|Overall Study|Lack of Efficacy|2|||
16930371|NCT03277248|38074121|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
16930372|NCT03277248|38074122|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
16930373|NCT03276780|38074130|FG000|Overall Study|Withdrawal by Subject|5|||
16930374|NCT03276780|38074131|FG001|Overall Study|Withdrawal by Subject|3|||
16930375|NCT03276780|38074130|FG000|Overall Study|Lost to Follow-up|3|||
16930376|NCT03276780|38074131|FG001|Overall Study|Lost to Follow-up|5|||
16930377|NCT03276780|38074130|FG000|Overall Study|Moved out of state|1|||
16930378|NCT03276780|38074131|FG001|Overall Study|Moved out of state|1|||
16930379|NCT03276780|38074130|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
16930380|NCT03276780|38074131|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
16930381|NCT03276780|38074130|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
16930382|NCT03276780|38074131|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
16930383|NCT03271047|38074147|FG000|Phase 1b: Dose Finding Period|Death|8|||
16930384|NCT03271047|38074148|FG001|Phase 1b: Dose Finding Period|Death|8|||
16930385|NCT03271047|38074149|FG002|Phase 1b: Dose Finding Period|Death|0|||
16930386|NCT03271047|38074150|FG003|Phase 1b: Dose Finding Period|Death|0|||
16930387|NCT03271047|38074147|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
16930388|NCT03271047|38074148|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
16930389|NCT03271047|38074149|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
16930390|NCT03271047|38074150|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
16930391|NCT03271047|38074147|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
16930392|NCT03271047|38074148|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
16930393|NCT03271047|38074149|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
16930394|NCT03271047|38074150|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
16930395|NCT03271047|38074147|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
16851787|NCT01441635|37801718|FG005|Overall Study|Lost to Follow-up|3|||
16851788|NCT01441635|37801719|FG006|Overall Study|Lost to Follow-up|1|||
16851789|NCT01441635|37801720|FG007|Overall Study|Lost to Follow-up|1|||
16851790|NCT01441635|37801721|FG008|Overall Study|Lost to Follow-up|0|||
16851791|NCT01441635|37801722|FG009|Overall Study|Lost to Follow-up|1|||
16851792|NCT01441635|37801713|FG000|Overall Study|Noncompliance|0|||
16851793|NCT01441635|37801714|FG001|Overall Study|Noncompliance|1|||
16851794|NCT01441635|37801715|FG002|Overall Study|Noncompliance|0|||
16930396|NCT03271047|38074148|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
16930397|NCT03271047|38074149|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
16930398|NCT03271047|38074150|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
16930399|NCT03271047|38074147|FG000|Randomized Phase 2 Period|Other|0|||
16930400|NCT03271047|38074148|FG001|Randomized Phase 2 Period|Other|0|||
16930401|NCT03271047|38074149|FG002|Randomized Phase 2 Period|Other|0|||
16930402|NCT03271047|38074150|FG003|Randomized Phase 2 Period|Other|1|||
16930403|NCT03271047|38074147|FG000|Randomized Phase 2 Period|Death|0|||
16930404|NCT03271047|38074148|FG001|Randomized Phase 2 Period|Death|0|||
16930405|NCT03271047|38074149|FG002|Randomized Phase 2 Period|Death|20|||
16930406|NCT03271047|38074150|FG003|Randomized Phase 2 Period|Death|21|||
16930407|NCT03271047|38074147|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
16930408|NCT03271047|38074148|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
16930409|NCT03271047|38074149|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
16930410|NCT03271047|38074150|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
16930411|NCT03271047|38074147|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
16930412|NCT03271047|38074148|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
16930413|NCT03271047|38074149|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
16930414|NCT03271047|38074150|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
16930415|NCT03271047|38074147|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
16930416|NCT03271047|38074148|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
16930417|NCT03271047|38074149|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
16930418|NCT03271047|38074150|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
16930419|NCT03276936|38074164|FG000|Overall Study|Adverse Event|4|||
17018968|NCT00853658|38163529|FG001|Overall Study|Vital Status unknown at study end|1|||
16851795|NCT01441635|37801716|FG003|Overall Study|Noncompliance|0|||
16851796|NCT01441635|37801717|FG004|Overall Study|Noncompliance|0|||
16851797|NCT01441635|37801718|FG005|Overall Study|Noncompliance|0|||
16930420|NCT03276936|38074165|FG001|Overall Study|Adverse Event|2|||
16930421|NCT03276936|38074164|FG000|Overall Study|Lost to Follow-up|16|||
16930422|NCT03276936|38074165|FG001|Overall Study|Lost to Follow-up|13|||
16851798|NCT01441635|37801719|FG006|Overall Study|Noncompliance|1|||
16851799|NCT01441635|37801720|FG007|Overall Study|Noncompliance|0|||
16851800|NCT01441635|37801721|FG008|Overall Study|Noncompliance|0|||
16851801|NCT01441635|37801722|FG009|Overall Study|Noncompliance|0|||
16851802|NCT01441635|37801713|FG000|Overall Study|Surgery or Invasive Intervention|0|||
16851803|NCT01441635|37801714|FG001|Overall Study|Surgery or Invasive Intervention|0|||
16851804|NCT01441635|37801715|FG002|Overall Study|Surgery or Invasive Intervention|1|||
16851805|NCT01441635|37801716|FG003|Overall Study|Surgery or Invasive Intervention|0|||
16930423|NCT03276936|38074164|FG000|Overall Study|Withdrawal by Subject|30|||
16930424|NCT03276936|38074165|FG001|Overall Study|Withdrawal by Subject|20|||
16930425|NCT03276936|38074164|FG000|Overall Study|Not mentioned|6|||
16930426|NCT03276936|38074165|FG001|Overall Study|Not mentioned|3|||
16930427|NCT00106002|38074171|FG000|Overall Study|Did not take any study drug|1|||
16930428|NCT00106002|38074171|FG000|Overall Study|Ineligible after Registration|1|||
16930429|NCT00105482|38074189|FG000|Overall Study|Adverse Event|1|||
16930430|NCT00105482|38074190|FG001|Overall Study|Adverse Event|1|||
16930431|NCT00105482|38074189|FG000|Overall Study|Lost to Follow-up|26|||
16930432|NCT00105482|38074190|FG001|Overall Study|Lost to Follow-up|17|||
16930433|NCT00105482|38074189|FG000|Overall Study|Withdrawal by Subject|0|||
16930434|NCT00105482|38074190|FG001|Overall Study|Withdrawal by Subject|1|||
16930435|NCT00105482|38074189|FG000|Overall Study|Lost Interest|29|||
16930436|NCT00105482|38074190|FG001|Overall Study|Lost Interest|32|||
16930437|NCT00105482|38074189|FG000|Overall Study|Scheduling Conflict|2|||
16930438|NCT00105482|38074190|FG001|Overall Study|Scheduling Conflict|3|||
16930439|NCT00105482|38074189|FG000|Overall Study|Withdrawn by PI|1|||
16930440|NCT00105482|38074190|FG001|Overall Study|Withdrawn by PI|1|||
16930441|NCT01327651|38074205|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
16930442|NCT01327651|38074206|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
16930443|NCT01327651|38074207|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
16930444|NCT01327651|38074208|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
16930445|NCT01327651|38074209|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
16930446|NCT01327651|38074210|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
16930447|NCT01327651|38074211|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
16930448|NCT01327651|38074212|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
16930449|NCT01327651|38074213|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
16930450|NCT01327651|38074205|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
16930451|NCT01327651|38074206|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16930452|NCT01327651|38074207|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16930453|NCT01327651|38074208|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16930454|NCT01327651|38074209|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16930455|NCT01327651|38074210|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16930456|NCT01327651|38074211|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16930457|NCT01327651|38074212|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16930458|NCT01327651|38074213|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16930459|NCT01327651|38074205|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
16930460|NCT01327651|38074206|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
16930461|NCT01327651|38074207|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
16930462|NCT01327651|38074208|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
16851806|NCT01441635|37801717|FG004|Overall Study|Surgery or Invasive Intervention|0|||
16851807|NCT01441635|37801718|FG005|Overall Study|Surgery or Invasive Intervention|0|||
16851808|NCT01441635|37801719|FG006|Overall Study|Surgery or Invasive Intervention|0|||
16851809|NCT01441635|37801720|FG007|Overall Study|Surgery or Invasive Intervention|0|||
16851810|NCT01441635|37801721|FG008|Overall Study|Surgery or Invasive Intervention|0|||
16851811|NCT01441635|37801722|FG009|Overall Study|Surgery or Invasive Intervention|0|||
16851812|NCT01441635|37801713|FG000|Overall Study|Received Exclusionary Medication|1|||
16851813|NCT01441635|37801714|FG001|Overall Study|Received Exclusionary Medication|0|||
16851814|NCT01441635|37801715|FG002|Overall Study|Received Exclusionary Medication|0|||
16851815|NCT01441635|37801716|FG003|Overall Study|Received Exclusionary Medication|0|||
16930463|NCT01327651|38074209|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
16930464|NCT01327651|38074210|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
16930465|NCT01327651|38074211|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
16930466|NCT01327651|38074212|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
16930467|NCT01327651|38074213|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
16930468|NCT01327651|38074205|FG000|Post Study Follow-up|Lost to Follow-up|0|||
16930469|NCT01327651|38074206|FG001|Post Study Follow-up|Lost to Follow-up|1|||
16930470|NCT01327651|38074207|FG002|Post Study Follow-up|Lost to Follow-up|1|||
16930471|NCT01327651|38074208|FG003|Post Study Follow-up|Lost to Follow-up|0|||
16930472|NCT01327651|38074209|FG004|Post Study Follow-up|Lost to Follow-up|0|||
16851816|NCT01441635|37801717|FG004|Overall Study|Received Exclusionary Medication|0|||
16851817|NCT01441635|37801718|FG005|Overall Study|Received Exclusionary Medication|0|||
16851818|NCT01441635|37801719|FG006|Overall Study|Received Exclusionary Medication|0|||
16851819|NCT01441635|37801720|FG007|Overall Study|Received Exclusionary Medication|0|||
16851820|NCT01441635|37801721|FG008|Overall Study|Received Exclusionary Medication|0|||
16851821|NCT01441635|37801722|FG009|Overall Study|Received Exclusionary Medication|0|||
16851822|NCT01441635|37801713|FG000|Overall Study|Other|0|||
16851823|NCT01441635|37801714|FG001|Overall Study|Other|0|||
16851824|NCT01441635|37801715|FG002|Overall Study|Other|0|||
16851825|NCT01441635|37801716|FG003|Overall Study|Other|0|||
16930473|NCT01327651|38074210|FG005|Post Study Follow-up|Lost to Follow-up|0|||
16930474|NCT01327651|38074211|FG006|Post Study Follow-up|Lost to Follow-up|4|||
16930475|NCT01327651|38074212|FG007|Post Study Follow-up|Lost to Follow-up|1|||
16930476|NCT01327651|38074213|FG008|Post Study Follow-up|Lost to Follow-up|2|||
16930477|NCT00105443|38074254|FG000|Double-Blind Treatment|Adverse Event|1|||
16930478|NCT00105443|38074255|FG001|Double-Blind Treatment|Adverse Event|0|||
16930479|NCT00105443|38074256|FG002|Double-Blind Treatment|Adverse Event|0|||
16930480|NCT00105443|38074257|FG003|Double-Blind Treatment|Adverse Event|0|||
16930481|NCT00105443|38074254|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
16930482|NCT00105443|38074255|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
16930483|NCT00105443|38074256|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
16930484|NCT00105443|38074257|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
16930485|NCT00105443|38074254|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
16930486|NCT00105443|38074255|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
16930487|NCT00105443|38074256|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
16930488|NCT00105443|38074257|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
16851826|NCT01441635|37801717|FG004|Overall Study|Other|0|||
16851827|NCT01441635|37801718|FG005|Overall Study|Other|0|||
16851828|NCT01441635|37801719|FG006|Overall Study|Other|0|||
16851829|NCT01441635|37801720|FG007|Overall Study|Other|1|||
16851830|NCT01441635|37801721|FG008|Overall Study|Other|0|||
16851831|NCT01441635|37801722|FG009|Overall Study|Other|0|||
16930489|NCT00105443|38074254|FG000|Double-Blind Treatment|Physician Decision|1|||
16930490|NCT00105443|38074255|FG001|Double-Blind Treatment|Physician Decision|0|||
16930491|NCT00105443|38074256|FG002|Double-Blind Treatment|Physician Decision|2|||
16930492|NCT00105443|38074257|FG003|Double-Blind Treatment|Physician Decision|0|||
16930493|NCT00105443|38074254|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
16930494|NCT00105443|38074255|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
16930495|NCT00105443|38074256|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
16930496|NCT00105443|38074257|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
16930497|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
16930498|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
16930499|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
16930500|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
16930501|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
16930502|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
16930503|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
16930504|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
16930505|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
17102634|NCT00112437|38241460|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17198618|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Death|2|||
16851832|NCT01408485|37801744|FG000|Overall Study|Withdrawal by Subject|21|||
16851833|NCT01427907|37801750|FG000|Overall Study|Withdrawal by Subject|3|||
16851834|NCT01427907|37801751|FG001|Overall Study|Withdrawal by Subject|4|||
16851835|NCT01427751|37801759|FG000|Overall Study|Adverse Event|18|||
16851836|NCT01427751|37801760|FG001|Overall Study|Adverse Event|2|||
16851837|NCT01427751|37801759|FG000|Overall Study|No further treatment benefit expected|5|||
16851838|NCT01427751|37801760|FG001|Overall Study|No further treatment benefit expected|1|||
16851839|NCT01427751|37801759|FG000|Overall Study|Lost to Follow-up|3|||
16851840|NCT01427751|37801760|FG001|Overall Study|Lost to Follow-up|1|||
16851841|NCT01427751|37801759|FG000|Overall Study|Withdrawal of consent|2|||
16851842|NCT01427751|37801760|FG001|Overall Study|Withdrawal of consent|2|||
16851843|NCT01427751|37801759|FG000|Overall Study|Protocol Violation|6|||
16851844|NCT01427751|37801760|FG001|Overall Study|Protocol Violation|4|||
16851845|NCT01427751|37801759|FG000|Overall Study|Death|2|||
16851846|NCT01427751|37801760|FG001|Overall Study|Death|0|||
16851847|NCT01427751|37801759|FG000|Overall Study|Other miscellaneous reasons|6|||
16851848|NCT01427751|37801760|FG001|Overall Study|Other miscellaneous reasons|4|||
16851849|NCT01920061|37801786|FG000|Overall Study|Death|1|||
16851850|NCT01920061|37801787|FG001|Overall Study|Death|1|||
16930506|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
16930507|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
16930508|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
16930509|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
16851851|NCT01920061|37801788|FG002|Overall Study|Death|0|||
16851852|NCT01920061|37801789|FG003|Overall Study|Death|1|||
16851853|NCT01920061|37801790|FG004|Overall Study|Death|1|||
16851854|NCT01920061|37801791|FG005|Overall Study|Death|0|||
16851855|NCT01920061|37801792|FG006|Overall Study|Death|0|||
16851856|NCT01920061|37801793|FG007|Overall Study|Death|1|||
16851857|NCT01920061|37801794|FG008|Overall Study|Death|0|||
16851858|NCT01920061|37801795|FG009|Overall Study|Death|1|||
16851859|NCT01920061|37801796|FG010|Overall Study|Death|0|||
16930510|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
16930511|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
16930512|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
16930513|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
16930514|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
16930515|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
16930516|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
16930517|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
16930518|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
16930519|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
16930520|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
16930521|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
16930522|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
16930523|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
16930524|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
16930525|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
16930526|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
16930527|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
16930528|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
16851860|NCT01920061|37801797|FG011|Overall Study|Death|1|||
16851861|NCT01920061|37801798|FG012|Overall Study|Death|0|||
16851862|NCT01920061|37801799|FG013|Overall Study|Death|2|||
16851863|NCT01920061|37801800|FG014|Overall Study|Death|0|||
16851864|NCT01920061|37801801|FG015|Overall Study|Death|0|||
16851865|NCT01920061|37801802|FG016|Overall Study|Death|0|||
16851866|NCT01920061|37801803|FG017|Overall Study|Death|0|||
16851867|NCT01920061|37801804|FG018|Overall Study|Death|1|||
16851868|NCT01920061|37801805|FG019|Overall Study|Death|0|||
16851869|NCT01920061|37801786|FG000|Overall Study|Lost to Follow-up|0|||
16851870|NCT01920061|37801787|FG001|Overall Study|Lost to Follow-up|2|||
16851871|NCT01920061|37801788|FG002|Overall Study|Lost to Follow-up|0|||
16851872|NCT01920061|37801789|FG003|Overall Study|Lost to Follow-up|0|||
16851873|NCT01920061|37801790|FG004|Overall Study|Lost to Follow-up|0|||
16930529|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
16930530|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
16930531|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
16930532|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
16930533|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
16930534|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
16930535|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
16930536|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
16930537|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
16930538|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
16930539|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
16930540|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
16930541|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
16930542|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
16851874|NCT01920061|37801791|FG005|Overall Study|Lost to Follow-up|0|||
16851875|NCT01920061|37801792|FG006|Overall Study|Lost to Follow-up|1|||
16930543|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
16930544|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
16930545|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
16930546|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
16930547|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
16930548|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
16930549|NCT00105443|38074254|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
17198619|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Death|3|||
17198620|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
16851876|NCT01920061|37801793|FG007|Overall Study|Lost to Follow-up|0|||
16930550|NCT00105443|38074255|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
16930551|NCT00105443|38074256|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
16930552|NCT00105443|38074257|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
16930553|NCT01327612|38074273|FG000|Overall Study|Withdrawal by Subject|0|||
16930554|NCT01327612|38074274|FG001|Overall Study|Withdrawal by Subject|0|||
16930555|NCT01327612|38074275|FG002|Overall Study|Withdrawal by Subject|0|||
16930556|NCT01327612|38074276|FG003|Overall Study|Withdrawal by Subject|0|||
16930557|NCT01327612|38074277|FG004|Overall Study|Withdrawal by Subject|0|||
16930558|NCT01327612|38074278|FG005|Overall Study|Withdrawal by Subject|1|||
16930559|NCT01327612|38074279|FG006|Overall Study|Withdrawal by Subject|0|||
16930560|NCT01327612|38074273|FG000|Overall Study|Disease Progression|1|||
16930561|NCT01327612|38074274|FG001|Overall Study|Disease Progression|1|||
16930562|NCT01327612|38074275|FG002|Overall Study|Disease Progression|1|||
16930563|NCT01327612|38074276|FG003|Overall Study|Disease Progression|0|||
16930564|NCT01327612|38074277|FG004|Overall Study|Disease Progression|1|||
16851877|NCT01920061|37801794|FG008|Overall Study|Lost to Follow-up|0|||
16851878|NCT01920061|37801795|FG009|Overall Study|Lost to Follow-up|0|||
16851879|NCT01920061|37801796|FG010|Overall Study|Lost to Follow-up|3|||
16930565|NCT01327612|38074278|FG005|Overall Study|Disease Progression|2|||
16930566|NCT01327612|38074279|FG006|Overall Study|Disease Progression|2|||
16930567|NCT01327612|38074273|FG000|Overall Study|Administrative Decision|0|||
16930568|NCT01327612|38074274|FG001|Overall Study|Administrative Decision|0|||
16930569|NCT01327612|38074275|FG002|Overall Study|Administrative Decision|0|||
16930570|NCT01327612|38074276|FG003|Overall Study|Administrative Decision|1|||
16930571|NCT01327612|38074277|FG004|Overall Study|Administrative Decision|0|||
16930572|NCT01327612|38074278|FG005|Overall Study|Administrative Decision|0|||
16930573|NCT01327612|38074279|FG006|Overall Study|Administrative Decision|0|||
16930574|NCT01327612|38074273|FG000|Overall Study|Death|0|||
16930575|NCT01327612|38074274|FG001|Overall Study|Death|0|||
16930576|NCT01327612|38074275|FG002|Overall Study|Death|0|||
16930577|NCT01327612|38074276|FG003|Overall Study|Death|0|||
16930578|NCT01327612|38074277|FG004|Overall Study|Death|1|||
16930579|NCT01327612|38074278|FG005|Overall Study|Death|0|||
16930580|NCT01327612|38074279|FG006|Overall Study|Death|0|||
16930581|NCT01327573|38074298|FG000|Overall Study|Physician Decision|3|||
16930582|NCT01327573|38074299|FG001|Overall Study|Physician Decision|1|||
16930583|NCT01327495|38074312|FG000|Overall Study|Adverse Event|2|||
16930584|NCT01327495|38074313|FG001|Overall Study|Adverse Event|1|||
16930585|NCT01327495|38074314|FG002|Overall Study|Adverse Event|1|||
16930586|NCT01327495|38074315|FG003|Overall Study|Adverse Event|0|||
16930587|NCT01327495|38074316|FG004|Overall Study|Adverse Event|0|||
16930588|NCT01327495|38074317|FG005|Overall Study|Adverse Event|2|||
16930589|NCT01327495|38074312|FG000|Overall Study|Withdrawal by Subject|0|||
16930590|NCT01327495|38074313|FG001|Overall Study|Withdrawal by Subject|1|||
16930591|NCT01327495|38074314|FG002|Overall Study|Withdrawal by Subject|1|||
16930592|NCT01327495|38074315|FG003|Overall Study|Withdrawal by Subject|0|||
16930593|NCT01327495|38074316|FG004|Overall Study|Withdrawal by Subject|1|||
16930594|NCT01327495|38074317|FG005|Overall Study|Withdrawal by Subject|0|||
16930595|NCT01327495|38074312|FG000|Overall Study|Physician Decision|0|||
16930596|NCT01327495|38074313|FG001|Overall Study|Physician Decision|0|||
16930597|NCT01327495|38074314|FG002|Overall Study|Physician Decision|0|||
16851880|NCT01920061|37801797|FG011|Overall Study|Lost to Follow-up|0|||
16930598|NCT01327495|38074315|FG003|Overall Study|Physician Decision|0|||
16930599|NCT01327495|38074316|FG004|Overall Study|Physician Decision|2|||
16930600|NCT01327495|38074317|FG005|Overall Study|Physician Decision|0|||
16930601|NCT01327339|38074337|FG000|Overall Study|Protocol Violation|8|||
16930602|NCT01327300|38074341|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
16930603|NCT01327300|38074342|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
16930604|NCT01379521|38074360|FG000|Overall Study -Treatment Period|Adverse Event|3|||
16930605|NCT01379521|38074361|FG001|Overall Study -Treatment Period|Adverse Event|0|||
16930606|NCT01379521|38074360|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
16930607|NCT01379521|38074361|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
16930608|NCT01379521|38074360|FG000|Overall Study -Treatment Period|Disease Progression|23|||
16930609|NCT01379521|38074361|FG001|Overall Study -Treatment Period|Disease Progression|22|||
16930610|NCT01379521|38074360|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
16930611|NCT01379521|38074361|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
16930612|NCT01379521|38074360|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
16930613|NCT01379521|38074361|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
17102635|NCT00112437|38241461|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16851881|NCT01920061|37801798|FG012|Overall Study|Lost to Follow-up|0|||
16851882|NCT01920061|37801799|FG013|Overall Study|Lost to Follow-up|0|||
16851883|NCT01920061|37801800|FG014|Overall Study|Lost to Follow-up|0|||
16851884|NCT01920061|37801801|FG015|Overall Study|Lost to Follow-up|0|||
16851885|NCT01920061|37801802|FG016|Overall Study|Lost to Follow-up|0|||
16851886|NCT01920061|37801803|FG017|Overall Study|Lost to Follow-up|1|||
16930614|NCT01379521|38074360|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
16930615|NCT01379521|38074361|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
16930616|NCT01379521|38074360|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
16930617|NCT01379521|38074361|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
16930618|NCT01379521|38074360|FG000|Overall Study -Treatment Period|Death|2|||
16930619|NCT01379521|38074361|FG001|Overall Study -Treatment Period|Death|1|||
16930620|NCT01379521|38074360|FG000|Post-Treatment Evaluations|Disease Progression|22|||
16930621|NCT01379521|38074361|FG001|Post-Treatment Evaluations|Disease Progression|20|||
16930622|NCT01379521|38074360|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
16930623|NCT01379521|38074361|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
16930624|NCT01379521|38074360|FG000|Post-Treatment Evaluations|Death|1|||
16930625|NCT01379521|38074361|FG001|Post-Treatment Evaluations|Death|0|||
17198621|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
17198622|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
17198623|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
17198624|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
17198625|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
17198626|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
16930626|NCT01371994|38074369|FG000|Overall Study|Adverse Event|3|||
16930627|NCT01371994|38074370|FG001|Overall Study|Adverse Event|6|||
16930628|NCT01371994|38074369|FG000|Overall Study|Lack of Efficacy|3|||
16930629|NCT01371994|38074370|FG001|Overall Study|Lack of Efficacy|0|||
16930630|NCT01371994|38074369|FG000|Overall Study|Withdrawal by Subject|13|||
16930631|NCT01371994|38074370|FG001|Overall Study|Withdrawal by Subject|7|||
16930632|NCT01371994|38074369|FG000|Overall Study|Lost to Follow-up|1|||
16930633|NCT01371994|38074370|FG001|Overall Study|Lost to Follow-up|1|||
16930634|NCT01371994|38074369|FG000|Overall Study|Protocol Violation|24|||
16930635|NCT01371994|38074370|FG001|Overall Study|Protocol Violation|17|||
16930636|NCT01371994|38074369|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
16930637|NCT01371994|38074370|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
16930638|NCT01371994|38074369|FG000|Overall Study|Physician Decision|1|||
16930639|NCT01371994|38074370|FG001|Overall Study|Physician Decision|1|||
16930640|NCT01371994|38074369|FG000|Overall Study|Miscellaneous Reasons|6|||
16930641|NCT01371994|38074370|FG001|Overall Study|Miscellaneous Reasons|4|||
16930642|NCT01371877|38074378|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
16930643|NCT01371877|38074379|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
16930644|NCT01371838|38074387|FG000|Overall Study|Withdrawal by Subject|27|||
16851887|NCT01920061|37801804|FG018|Overall Study|Lost to Follow-up|4|||
16851888|NCT01920061|37801805|FG019|Overall Study|Lost to Follow-up|3|||
16851889|NCT01920061|37801786|FG000|Overall Study|Other|1|||
16851890|NCT01920061|37801787|FG001|Overall Study|Other|1|||
16851891|NCT01920061|37801788|FG002|Overall Study|Other|2|||
16851892|NCT01920061|37801789|FG003|Overall Study|Other|1|||
16851893|NCT01920061|37801790|FG004|Overall Study|Other|0|||
16851894|NCT01920061|37801791|FG005|Overall Study|Other|1|||
16851895|NCT01920061|37801792|FG006|Overall Study|Other|0|||
16851896|NCT01920061|37801793|FG007|Overall Study|Other|0|||
16851897|NCT01920061|37801794|FG008|Overall Study|Other|0|||
16851898|NCT01920061|37801795|FG009|Overall Study|Other|1|||
16851899|NCT01920061|37801796|FG010|Overall Study|Other|1|||
16851900|NCT01920061|37801797|FG011|Overall Study|Other|2|||
16851901|NCT01920061|37801798|FG012|Overall Study|Other|1|||
16851902|NCT01920061|37801799|FG013|Overall Study|Other|4|||
16851903|NCT01920061|37801800|FG014|Overall Study|Other|0|||
16851904|NCT01920061|37801801|FG015|Overall Study|Other|1|||
16851905|NCT01920061|37801802|FG016|Overall Study|Other|1|||
16851906|NCT01920061|37801803|FG017|Overall Study|Other|0|||
16851907|NCT01920061|37801804|FG018|Overall Study|Other|1|||
16851908|NCT01920061|37801805|FG019|Overall Study|Other|1|||
16851909|NCT01920061|37801786|FG000|Overall Study|Participant refused further follow-up|0|||
16851910|NCT01920061|37801787|FG001|Overall Study|Participant refused further follow-up|0|||
16851911|NCT01920061|37801788|FG002|Overall Study|Participant refused further follow-up|0|||
16851912|NCT01920061|37801789|FG003|Overall Study|Participant refused further follow-up|0|||
16851913|NCT01920061|37801790|FG004|Overall Study|Participant refused further follow-up|1|||
16851914|NCT01920061|37801791|FG005|Overall Study|Participant refused further follow-up|1|||
16851915|NCT01920061|37801792|FG006|Overall Study|Participant refused further follow-up|0|||
16851916|NCT01920061|37801793|FG007|Overall Study|Participant refused further follow-up|0|||
16851917|NCT01920061|37801794|FG008|Overall Study|Participant refused further follow-up|1|||
16851918|NCT01920061|37801795|FG009|Overall Study|Participant refused further follow-up|0|||
16851919|NCT01920061|37801796|FG010|Overall Study|Participant refused further follow-up|1|||
16851920|NCT01920061|37801797|FG011|Overall Study|Participant refused further follow-up|0|||
16851921|NCT01920061|37801798|FG012|Overall Study|Participant refused further follow-up|1|||
16851922|NCT01920061|37801799|FG013|Overall Study|Participant refused further follow-up|0|||
16851923|NCT01920061|37801800|FG014|Overall Study|Participant refused further follow-up|1|||
16851924|NCT01920061|37801801|FG015|Overall Study|Participant refused further follow-up|2|||
16930645|NCT01371838|38074388|FG001|Overall Study|Withdrawal by Subject|33|||
16851925|NCT01920061|37801802|FG016|Overall Study|Participant refused further follow-up|1|||
16851926|NCT01920061|37801803|FG017|Overall Study|Participant refused further follow-up|1|||
16851927|NCT01920061|37801804|FG018|Overall Study|Participant refused further follow-up|0|||
16851928|NCT01920061|37801805|FG019|Overall Study|Participant refused further follow-up|0|||
16851929|NCT01426425|37801868|FG000|Overall Study|Exited prior to EP study|22|||
16851930|NCT01426425|37801868|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
16851931|NCT01426425|37801868|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
16851932|NCT01426347|37801881|FG000|Overall Study|Lost to Follow-up|0|||
16851933|NCT01426347|37801882|FG001|Overall Study|Lost to Follow-up|3|||
16851934|NCT01426347|37801881|FG000|Overall Study|Protocol Violation|2|||
16851935|NCT01426347|37801882|FG001|Overall Study|Protocol Violation|0|||
16851936|NCT01426347|37801881|FG000|Overall Study|Withdrawal by Subject|5|||
16851937|NCT01426347|37801882|FG001|Overall Study|Withdrawal by Subject|0|||
16851938|NCT01882465|37801888|FG000|Period 1|Lens Discomfort|0|||
16851939|NCT01882465|37801889|FG001|Period 1|Lens Discomfort|0|||
16851940|NCT01882465|37801890|FG002|Period 1|Lens Discomfort|0|||
16851941|NCT01882465|37801891|FG003|Period 1|Lens Discomfort|1|||
16851942|NCT01882465|37801892|FG004|Period 1|Lens Discomfort|0|||
16851943|NCT01882465|37801893|FG005|Period 1|Lens Discomfort|0|||
16851944|NCT01882465|37801894|FG006|Period 1|Lens Discomfort|0|||
16851945|NCT01882465|37801888|FG000|Period 1|Withdrawal by Subject|0|||
16851946|NCT01882465|37801889|FG001|Period 1|Withdrawal by Subject|0|||
16851947|NCT01882465|37801890|FG002|Period 1|Withdrawal by Subject|0|||
16851948|NCT01882465|37801891|FG003|Period 1|Withdrawal by Subject|0|||
16851949|NCT01882465|37801892|FG004|Period 1|Withdrawal by Subject|0|||
16851950|NCT01882465|37801893|FG005|Period 1|Withdrawal by Subject|0|||
16851951|NCT01882465|37801894|FG006|Period 1|Withdrawal by Subject|1|||
16851952|NCT01882465|37801888|FG000|Period 2|Protocol Violation|0|||
16851953|NCT01882465|37801889|FG001|Period 2|Protocol Violation|0|||
16851954|NCT01882465|37801890|FG002|Period 2|Protocol Violation|0|||
16851955|NCT01882465|37801891|FG003|Period 2|Protocol Violation|0|||
16851956|NCT01882465|37801892|FG004|Period 2|Protocol Violation|1|||
16851957|NCT01882465|37801893|FG005|Period 2|Protocol Violation|0|||
16851958|NCT01882465|37801894|FG006|Period 2|Protocol Violation|0|||
16851959|NCT01426269|37801902|FG000|Period 1: 12 Weeks|Adverse Event|5|||
16851960|NCT01426269|37801903|FG001|Period 1: 12 Weeks|Adverse Event|0|||
16851961|NCT01426269|37801904|FG002|Period 1: 12 Weeks|Adverse Event|0|||
16851962|NCT01426269|37801902|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
16851963|NCT01426269|37801903|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
16851964|NCT01426269|37801904|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
16851965|NCT01426269|37801902|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
16851966|NCT01426269|37801903|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
16851967|NCT01426269|37801904|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
16851968|NCT01426269|37801902|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
16851969|NCT01426269|37801903|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
16851970|NCT01426269|37801904|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
16851971|NCT01426269|37801902|FG000|Period 1: 12 Weeks|Pregnancy|1|||
16851972|NCT01426269|37801903|FG001|Period 1: 12 Weeks|Pregnancy|0|||
16851973|NCT01426269|37801904|FG002|Period 1: 12 Weeks|Pregnancy|0|||
16851974|NCT01426269|37801902|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
16851975|NCT01426269|37801903|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
16851976|NCT01426269|37801904|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
16851977|NCT01426269|37801902|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
16851978|NCT01426269|37801903|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
16930646|NCT01371838|38074387|FG000|Overall Study|Lost to Follow-up|10|||
16930647|NCT01371838|38074388|FG001|Overall Study|Lost to Follow-up|20|||
16930648|NCT01371838|38074387|FG000|Overall Study|Death|3|||
16930649|NCT01371838|38074388|FG001|Overall Study|Death|4|||
16930650|NCT01371838|38074387|FG000|Overall Study|Protocol Violation|3|||
16930651|NCT01371838|38074388|FG001|Overall Study|Protocol Violation|0|||
16930652|NCT01371838|38074387|FG000|Overall Study|Investigator Decision|3|||
16930653|NCT01371838|38074388|FG001|Overall Study|Investigator Decision|8|||
16930654|NCT01371838|38074387|FG000|Overall Study|Last follow-up visit not conducted|2|||
16930655|NCT01371838|38074388|FG001|Overall Study|Last follow-up visit not conducted|0|||
16930656|NCT01371838|38074387|FG000|Overall Study|Lack of therapeutic response|0|||
16930657|NCT01371838|38074388|FG001|Overall Study|Lack of therapeutic response|1|||
16930658|NCT01371838|38074387|FG000|Overall Study|Surgery|1|||
16930659|NCT01371838|38074388|FG001|Overall Study|Surgery|0|||
16930660|NCT01371721|38074397|FG000|Overall Study|Adverse Event|5|||
16930661|NCT01371721|38074398|FG001|Overall Study|Adverse Event|4|||
16930662|NCT01371721|38074399|FG002|Overall Study|Adverse Event|5|||
16930663|NCT01371721|38074397|FG000|Overall Study|Protocol Violation|6|||
16930664|NCT01371721|38074398|FG001|Overall Study|Protocol Violation|4|||
16930665|NCT01371721|38074399|FG002|Overall Study|Protocol Violation|5|||
16930666|NCT01371721|38074397|FG000|Overall Study|Lost to Follow-up|8|||
16930667|NCT01371721|38074398|FG001|Overall Study|Lost to Follow-up|2|||
16930668|NCT01371721|38074399|FG002|Overall Study|Lost to Follow-up|6|||
16851979|NCT01426269|37801904|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
16851980|NCT01426269|37801902|FG000|Period 2: 40 Weeks|Adverse Event|0|||
16851981|NCT01426269|37801903|FG001|Period 2: 40 Weeks|Adverse Event|1|||
16851982|NCT01426269|37801904|FG002|Period 2: 40 Weeks|Adverse Event|2|||
16851983|NCT01426269|37801902|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
16851984|NCT01426269|37801903|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
16851985|NCT01426269|37801904|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
16851986|NCT01426269|37801902|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
16851987|NCT01426269|37801903|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
16851988|NCT01426269|37801904|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
16930669|NCT01371721|38074397|FG000|Overall Study|Withdrawal by Subject|5|||
16930670|NCT01371721|38074398|FG001|Overall Study|Withdrawal by Subject|7|||
16930671|NCT01371721|38074399|FG002|Overall Study|Withdrawal by Subject|11|||
16930672|NCT01371721|38074397|FG000|Overall Study|Other|2|||
16930673|NCT01371721|38074398|FG001|Overall Study|Other|3|||
16930674|NCT01371721|38074399|FG002|Overall Study|Other|0|||
16930675|NCT01371721|38074397|FG000|Overall Study|Lack of Efficacy|2|||
16930676|NCT01371721|38074398|FG001|Overall Study|Lack of Efficacy|4|||
16930677|NCT01371721|38074399|FG002|Overall Study|Lack of Efficacy|3|||
16930678|NCT01371721|38074397|FG000|Overall Study|Randomized but not treated|1|||
16930679|NCT01371721|38074398|FG001|Overall Study|Randomized but not treated|0|||
16930680|NCT01371721|38074399|FG002|Overall Study|Randomized but not treated|0|||
16930681|NCT01366534|38074412|FG000|Overall Study|Lost to Follow-up|1|||
16930682|NCT01366534|38074413|FG001|Overall Study|Lost to Follow-up|0|||
16930683|NCT01366534|38074414|FG002|Overall Study|Lost to Follow-up|0|||
16930684|NCT01366534|38074412|FG000|Overall Study|Migrated|1|||
16930685|NCT01366534|38074413|FG001|Overall Study|Migrated|1|||
16930686|NCT01366534|38074414|FG002|Overall Study|Migrated|0|||
16930687|NCT01366534|38074412|FG000|Overall Study|Declined challenged|0|||
16930688|NCT01366534|38074413|FG001|Overall Study|Declined challenged|1|||
16930689|NCT01366534|38074414|FG002|Overall Study|Declined challenged|0|||
16930690|NCT01365910|38074422|FG000|Overall Study|Withdrawal by Subject|7|||
16930691|NCT01365910|38074422|FG000|Overall Study|disease progression|18|||
16930692|NCT01365910|38074422|FG000|Overall Study|Adverse Event|3|||
16930693|NCT01365910|38074422|FG000|Overall Study|other complicating disease|1|||
16930694|NCT01365910|38074422|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
16930695|NCT01365481|38074430|FG000|Overall Study|Adverse Event|6|||
16930696|NCT01365481|38074431|FG001|Overall Study|Adverse Event|9|||
16930697|NCT01365481|38074432|FG002|Overall Study|Adverse Event|0|||
16930698|NCT01365481|38074433|FG003|Overall Study|Adverse Event|2|||
16930699|NCT01365481|38074430|FG000|Overall Study|Withdrawal by Subject|0|||
16930700|NCT01365481|38074431|FG001|Overall Study|Withdrawal by Subject|2|||
16930701|NCT01365481|38074432|FG002|Overall Study|Withdrawal by Subject|1|||
16930702|NCT01365481|38074433|FG003|Overall Study|Withdrawal by Subject|1|||
16930703|NCT01365481|38074430|FG000|Overall Study|Lost to Follow-up|1|||
16930704|NCT01365481|38074431|FG001|Overall Study|Lost to Follow-up|1|||
16930705|NCT01365481|38074432|FG002|Overall Study|Lost to Follow-up|2|||
16930706|NCT01365481|38074433|FG003|Overall Study|Lost to Follow-up|3|||
16930707|NCT01365481|38074430|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16930708|NCT01365481|38074431|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16930709|NCT01365481|38074432|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16930710|NCT01365481|38074433|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16930711|NCT01365481|38074430|FG000|Overall Study|Administrative problems|0|||
16930712|NCT01365481|38074431|FG001|Overall Study|Administrative problems|1|||
16930713|NCT01365481|38074432|FG002|Overall Study|Administrative problems|0|||
16930714|NCT01365481|38074433|FG003|Overall Study|Administrative problems|0|||
16930715|NCT01365481|38074430|FG000|Overall Study|Protocol deviation|0|||
16930716|NCT01365481|38074431|FG001|Overall Study|Protocol deviation|1|||
16930717|NCT01365481|38074432|FG002|Overall Study|Protocol deviation|0|||
16930718|NCT01365481|38074433|FG003|Overall Study|Protocol deviation|1|||
16930719|NCT01365481|38074430|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16930720|NCT01365481|38074431|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16930721|NCT01365481|38074432|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
16930722|NCT01365481|38074433|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16930723|NCT01357915|38074445|FG000|Overall Study|Lost to Follow-up|3|||
16930724|NCT01357915|38074446|FG001|Overall Study|Lost to Follow-up|0|||
16930725|NCT01350973|38074455|FG000|Overall Study|Adverse Event|4|||
16930726|NCT01350973|38074456|FG001|Overall Study|Adverse Event|7|||
16930727|NCT01350973|38074457|FG002|Overall Study|Adverse Event|7|||
16930728|NCT01350973|38074455|FG000|Overall Study|Voluntary Withdrawal|2|||
16930729|NCT01350973|38074456|FG001|Overall Study|Voluntary Withdrawal|1|||
16930730|NCT01350973|38074457|FG002|Overall Study|Voluntary Withdrawal|1|||
16930731|NCT01350544|38074467|FG000|Overall Study|Administrative Withdrawal|0|||
16851989|NCT01426269|37801902|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
16851990|NCT01426269|37801903|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
16930732|NCT01350544|38074468|FG001|Overall Study|Administrative Withdrawal|1|||
16930733|NCT01350544|38074467|FG000|Overall Study|Death|1|||
16930734|NCT01350544|38074468|FG001|Overall Study|Death|2|||
16930735|NCT01350544|38074467|FG000|Overall Study|Moved out of LA County|2|||
16930736|NCT01350544|38074468|FG001|Overall Study|Moved out of LA County|2|||
16930737|NCT01350544|38074467|FG000|Overall Study|Medical Issues|1|||
16930738|NCT01350544|38074468|FG001|Overall Study|Medical Issues|1|||
16930739|NCT01350544|38074467|FG000|Overall Study|Withdrawal by Subject|0|||
16930740|NCT01350544|38074468|FG001|Overall Study|Withdrawal by Subject|1|||
16930741|NCT01350544|38074467|FG000|Overall Study|Incarceration|1|||
16930742|NCT01350544|38074468|FG001|Overall Study|Incarceration|0|||
16930743|NCT01350544|38074467|FG000|Overall Study|Lost to Follow-up|18|||
16930744|NCT01350544|38074468|FG001|Overall Study|Lost to Follow-up|15|||
16930745|NCT01350505|38074474|FG000|Overall Study|Lost to Follow-up|4|||
16930746|NCT01350271|38074481|FG000|Overall Study|Lost to Follow-up|21|||
16930747|NCT01350271|38074482|FG001|Overall Study|Lost to Follow-up|17|||
16930748|NCT01350271|38074483|FG002|Overall Study|Lost to Follow-up|26|||
16930749|NCT01348828|38074494|FG000|Overall Study|Death|20|||
16930750|NCT01348828|38074494|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
16930751|NCT01348828|38074494|FG000|Overall Study|Conversion|2|||
16930752|NCT01348828|38074494|FG000|Overall Study|missed visit|1|||
16930753|NCT01348789|38074498|FG000|Overall Study|Protocol Violation|2|||
16930754|NCT01348789|38074498|FG000|Overall Study|Withdrawal by Subject|2|||
16930755|NCT01342510|38074513|FG000|Overall Study|Protocol Violation|12|||
16930756|NCT01342510|38074514|FG001|Overall Study|Protocol Violation|6|||
16930757|NCT01342510|38074515|FG002|Overall Study|Protocol Violation|13|||
16930758|NCT01342510|38074516|FG003|Overall Study|Protocol Violation|11|||
16930759|NCT01340872|38074536|FG000|Double-blind Phase|Adverse Event|6|||
16930760|NCT01340872|38074537|FG001|Double-blind Phase|Adverse Event|4|||
16930761|NCT01340872|38074538|FG002|Double-blind Phase|Adverse Event|0|||
16930762|NCT01340872|38074539|FG003|Double-blind Phase|Adverse Event|0|||
16930763|NCT01340872|38074536|FG000|Double-blind Phase|Withdrawal by Subject|3|||
16930764|NCT01340872|38074537|FG001|Double-blind Phase|Withdrawal by Subject|5|||
16930765|NCT01340872|38074538|FG002|Double-blind Phase|Withdrawal by Subject|0|||
16930766|NCT01340872|38074539|FG003|Double-blind Phase|Withdrawal by Subject|0|||
16930767|NCT01340872|38074536|FG000|Double-blind Phase|Lost to Follow-up|0|||
16930768|NCT01340872|38074537|FG001|Double-blind Phase|Lost to Follow-up|1|||
16930769|NCT01340872|38074538|FG002|Double-blind Phase|Lost to Follow-up|0|||
16930770|NCT01340872|38074539|FG003|Double-blind Phase|Lost to Follow-up|0|||
16930771|NCT01340872|38074536|FG000|Double-blind Phase|Protocol Violation|0|||
16930772|NCT01340872|38074537|FG001|Double-blind Phase|Protocol Violation|1|||
16930773|NCT01340872|38074538|FG002|Double-blind Phase|Protocol Violation|0|||
16930774|NCT01340872|38074539|FG003|Double-blind Phase|Protocol Violation|0|||
16930775|NCT01340872|38074536|FG000|Open-label Phase|Physician Decision|0|||
16930776|NCT01340872|38074537|FG001|Open-label Phase|Physician Decision|0|||
16930777|NCT01340872|38074538|FG002|Open-label Phase|Physician Decision|2|||
16930778|NCT01340872|38074539|FG003|Open-label Phase|Physician Decision|1|||
16930779|NCT01340872|38074536|FG000|Open-label Phase|Pregnancy|0|||
16930780|NCT01340872|38074537|FG001|Open-label Phase|Pregnancy|0|||
16930781|NCT01340872|38074538|FG002|Open-label Phase|Pregnancy|1|||
16930782|NCT01340872|38074539|FG003|Open-label Phase|Pregnancy|0|||
16930783|NCT01340872|38074536|FG000|Open-label Phase|Adverse Event|0|||
16930784|NCT01340872|38074537|FG001|Open-label Phase|Adverse Event|0|||
16930785|NCT01340872|38074538|FG002|Open-label Phase|Adverse Event|8|||
16930786|NCT01340872|38074539|FG003|Open-label Phase|Adverse Event|4|||
16930787|NCT01340872|38074536|FG000|Open-label Phase|Withdrawal by Subject|0|||
16930788|NCT01340872|38074537|FG001|Open-label Phase|Withdrawal by Subject|0|||
16930789|NCT01340872|38074538|FG002|Open-label Phase|Withdrawal by Subject|1|||
16930790|NCT01340872|38074539|FG003|Open-label Phase|Withdrawal by Subject|6|||
16930791|NCT01340872|38074536|FG000|Open-label Phase|Worsening of IBD|0|||
16930792|NCT01340872|38074537|FG001|Open-label Phase|Worsening of IBD|0|||
16930793|NCT01340872|38074538|FG002|Open-label Phase|Worsening of IBD|1|||
16930794|NCT01340872|38074539|FG003|Open-label Phase|Worsening of IBD|0|||
16930795|NCT01340794|38074553|FG000|Overall Study|Withdrawal by Subject|0|||
16930796|NCT01340794|38074554|FG001|Overall Study|Withdrawal by Subject|1|||
16930797|NCT01340482|38074565|FG000|Overall Study|Adverse Event|2|||
16930798|NCT01340482|38074566|FG001|Overall Study|Adverse Event|0|||
16930799|NCT01340482|38074567|FG002|Overall Study|Adverse Event|0|||
16930800|NCT01340209|38074580|FG000|Overall Study|Adverse Event|1|||
16930801|NCT01340209|38074581|FG001|Overall Study|Adverse Event|1|||
16930802|NCT01340209|38074582|FG002|Overall Study|Adverse Event|2|||
16930803|NCT01340209|38074580|FG000|Overall Study|Protocol Violation|1|||
16930804|NCT01340209|38074581|FG001|Overall Study|Protocol Violation|2|||
16930805|NCT01340209|38074582|FG002|Overall Study|Protocol Violation|1|||
16930806|NCT01340209|38074580|FG000|Overall Study|Withdrawal by Subject|0|||
16930807|NCT01340209|38074581|FG001|Overall Study|Withdrawal by Subject|0|||
16930808|NCT01340209|38074582|FG002|Overall Study|Withdrawal by Subject|1|||
16930809|NCT01340209|38074580|FG000|Overall Study|Other reason not defined above|3|||
16930810|NCT01340209|38074581|FG001|Overall Study|Other reason not defined above|5|||
16930811|NCT01340209|38074582|FG002|Overall Study|Other reason not defined above|4|||
16930812|NCT01326910|38074592|FG000|Overall Study|Withdrawal by Subject|3|||
16930813|NCT01326910|38074593|FG001|Overall Study|Withdrawal by Subject|2|||
16930814|NCT01326910|38074592|FG000|Overall Study|Protocol Violation|1|||
16930815|NCT01326910|38074593|FG001|Overall Study|Protocol Violation|1|||
16930816|NCT01326481|38074599|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
16930817|NCT01325701|38074607|FG000|Overall Study|Adverse Event|12|||
16930818|NCT01325701|38074608|FG001|Overall Study|Adverse Event|0|||
16930819|NCT01325701|38074607|FG000|Overall Study|Protocol Violation|1|||
16930820|NCT01325701|38074608|FG001|Overall Study|Protocol Violation|0|||
16930821|NCT01325701|38074607|FG000|Overall Study|Physician Decision|2|||
16930822|NCT01325701|38074608|FG001|Overall Study|Physician Decision|2|||
16930823|NCT01325701|38074607|FG000|Overall Study|Withdrawal by Subject|2|||
16930824|NCT01325701|38074608|FG001|Overall Study|Withdrawal by Subject|1|||
16930825|NCT01325701|38074607|FG000|Overall Study|Rollerover Extension Study|4|||
16930826|NCT01325701|38074608|FG001|Overall Study|Rollerover Extension Study|0|||
16930827|NCT01325623|38074615|FG000|Overall Study|Withdrawal by Subject|3|||
16930828|NCT01325584|38074652|FG000|Overall Study|Death|1|||
16930829|NCT01325428|38074656|FG000|Part A|Progressive disease according to RECIST|9|||
16930830|NCT01325428|38074656|FG000|Part A|Clinical signs, symptoms of progression|2|||
16851991|NCT01426269|37801904|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
16851992|NCT01426269|37801902|FG000|Period 2: 40 Weeks|Site closed|0|||
16851993|NCT01426269|37801903|FG001|Period 2: 40 Weeks|Site closed|6|||
16851994|NCT01426269|37801904|FG002|Period 2: 40 Weeks|Site closed|5|||
16851995|NCT01426269|37801902|FG000|Period 2: 40 Weeks|Relapsed|0|||
16851996|NCT01426269|37801903|FG001|Period 2: 40 Weeks|Relapsed|9|||
16851997|NCT01426269|37801904|FG002|Period 2: 40 Weeks|Relapsed|18|||
16851998|NCT01426113|37801917|FG000|Overall Study|Study Discontinued|1|||
16851999|NCT01426113|37801918|FG001|Overall Study|Study Discontinued|1|||
16852000|NCT01426113|37801917|FG000|Overall Study|Adverse Event|0|||
16852001|NCT01426113|37801918|FG001|Overall Study|Adverse Event|1|||
16852002|NCT01864603|37801926|FG000|Stage 2|DSMB design modification|86056|||
16852003|NCT01864603|37801927|FG001|Stage 2|DSMB design modification|92558|||
16852004|NCT01892293|37801938|FG000|Overall Study|Apheresed but not treated|4|||
16852005|NCT01393899|37801945|FG000|Overall Study|Study terminated by sponsor|1|||
16852006|NCT01393899|37801946|FG001|Overall Study|Study terminated by sponsor|0|||
16852007|NCT01393899|37801947|FG002|Overall Study|Study terminated by sponsor|1|||
16852008|NCT01393899|37801945|FG000|Overall Study|Other|1|||
16852009|NCT01393899|37801946|FG001|Overall Study|Other|0|||
16852010|NCT01393899|37801947|FG002|Overall Study|Other|0|||
16852011|NCT01393899|37801945|FG000|Overall Study|Withdrawal by Subject|2|||
16852012|NCT01393899|37801946|FG001|Overall Study|Withdrawal by Subject|2|||
16852013|NCT01393899|37801947|FG002|Overall Study|Withdrawal by Subject|1|||
16852014|NCT01393899|37801945|FG000|Overall Study|Lost to Follow-up|0|||
16852015|NCT01393899|37801946|FG001|Overall Study|Lost to Follow-up|0|||
16852016|NCT01393899|37801947|FG002|Overall Study|Lost to Follow-up|1|||
16852017|NCT01393899|37801945|FG000|Overall Study|Does not meet entrance criteria|1|||
16852018|NCT01393899|37801946|FG001|Overall Study|Does not meet entrance criteria|0|||
16852019|NCT01393899|37801947|FG002|Overall Study|Does not meet entrance criteria|1|||
16852020|NCT01393899|37801945|FG000|Overall Study|Lack of Efficacy|26|||
16852021|NCT01393899|37801946|FG001|Overall Study|Lack of Efficacy|21|||
16852022|NCT01393899|37801947|FG002|Overall Study|Lack of Efficacy|16|||
16852023|NCT01393899|37801945|FG000|Overall Study|Adverse Event|1|||
16852024|NCT01393899|37801946|FG001|Overall Study|Adverse Event|5|||
16852025|NCT01393899|37801947|FG002|Overall Study|Adverse Event|3|||
16930831|NCT01325428|38074656|FG000|Part A|Other adverse event|1|||
16930832|NCT01325428|38074656|FG000|Part A|Refused continue taking trial medication|2|||
16930833|NCT01325428|38074656|FG000|Part A|Other reason not defined above|2|||
16930834|NCT01325428|38074656|FG000|Part B|Refused continue taking trial medication|2|||
16930835|NCT01325428|38074656|FG000|Part B|Other reason not defined above|1|||
16930836|NCT01325350|38074670|FG000|Overall Study|Adverse Event|3|||
16930837|NCT01325350|38074671|FG001|Overall Study|Adverse Event|3|||
16930838|NCT01325350|38074672|FG002|Overall Study|Adverse Event|3|||
16930839|NCT01325350|38074673|FG003|Overall Study|Adverse Event|1|||
16930840|NCT01325350|38074674|FG004|Overall Study|Adverse Event|2|||
16930841|NCT01325350|38074670|FG000|Overall Study|Pregnancy|0|||
16930842|NCT01325350|38074671|FG001|Overall Study|Pregnancy|0|||
16852030|NCT01393743|37801968|FG000|Core Study|Adverse Event|5|||
16852031|NCT01393743|37801969|FG001|Core Study|Adverse Event|9|||
16852032|NCT01393743|37801970|FG002|Core Study|Adverse Event|0|||
16852033|NCT01393743|37801968|FG000|Core Study|Lost to Follow-up|1|||
16852034|NCT01393743|37801969|FG001|Core Study|Lost to Follow-up|1|||
16852035|NCT01393743|37801970|FG002|Core Study|Lost to Follow-up|0|||
16930843|NCT01325350|38074672|FG002|Overall Study|Pregnancy|1|||
16930844|NCT01325350|38074673|FG003|Overall Study|Pregnancy|0|||
16930845|NCT01325350|38074674|FG004|Overall Study|Pregnancy|1|||
16852036|NCT01393743|37801968|FG000|Core Study|Participant's Choice|2|||
16930846|NCT01325350|38074670|FG000|Overall Study|Lost to Follow-up|1|||
16930847|NCT01325350|38074671|FG001|Overall Study|Lost to Follow-up|0|||
16930848|NCT01325350|38074672|FG002|Overall Study|Lost to Follow-up|5|||
16930849|NCT01325350|38074673|FG003|Overall Study|Lost to Follow-up|1|||
16930850|NCT01325350|38074674|FG004|Overall Study|Lost to Follow-up|5|||
16930851|NCT01325350|38074670|FG000|Overall Study|Personal Reasons|2|||
16930852|NCT01325350|38074671|FG001|Overall Study|Personal Reasons|1|||
16930853|NCT01325350|38074672|FG002|Overall Study|Personal Reasons|6|||
16930854|NCT01325350|38074673|FG003|Overall Study|Personal Reasons|5|||
16930855|NCT01325350|38074674|FG004|Overall Study|Personal Reasons|3|||
16930856|NCT01325350|38074670|FG000|Overall Study|Protocol Violation|0|||
16930857|NCT01325350|38074671|FG001|Overall Study|Protocol Violation|0|||
16930858|NCT01325350|38074672|FG002|Overall Study|Protocol Violation|0|||
16930859|NCT01325350|38074673|FG003|Overall Study|Protocol Violation|1|||
16930860|NCT01325350|38074674|FG004|Overall Study|Protocol Violation|0|||
16930861|NCT01325350|38074670|FG000|Overall Study|Withdrawal by Subject|0|||
16930862|NCT01325350|38074671|FG001|Overall Study|Withdrawal by Subject|0|||
16930863|NCT01325350|38074672|FG002|Overall Study|Withdrawal by Subject|1|||
16930864|NCT01325350|38074673|FG003|Overall Study|Withdrawal by Subject|1|||
16930865|NCT01325350|38074674|FG004|Overall Study|Withdrawal by Subject|0|||
16930866|NCT01325350|38074670|FG000|Overall Study|Did Not Receive Treatment|0|||
16930867|NCT01325350|38074671|FG001|Overall Study|Did Not Receive Treatment|1|||
16930868|NCT01325350|38074672|FG002|Overall Study|Did Not Receive Treatment|1|||
16930869|NCT01325350|38074673|FG003|Overall Study|Did Not Receive Treatment|0|||
16852037|NCT01393743|37801969|FG001|Core Study|Participant's Choice|3|||
16852038|NCT01393743|37801970|FG002|Core Study|Participant's Choice|0|||
16852039|NCT01393743|37801968|FG000|Core Study|Inadequate therapeutic effect|2|||
16852040|NCT01393743|37801969|FG001|Core Study|Inadequate therapeutic effect|0|||
16852041|NCT01393743|37801970|FG002|Core Study|Inadequate therapeutic effect|0|||
16852042|NCT01393743|37801968|FG000|Extension Phase|Adverse Event|0|||
16930870|NCT01325350|38074674|FG004|Overall Study|Did Not Receive Treatment|1|||
16930871|NCT01324999|38074686|FG000|Overall Study|Adverse Event|3|||
16930872|NCT01324999|38074686|FG000|Overall Study|Withdrawal by Subject|2|||
16930873|NCT01324570|38074692|FG000|Overall Study|Adverse Event|4|||
16930874|NCT01324570|38074693|FG001|Overall Study|Adverse Event|7|||
16930875|NCT01324570|38074692|FG000|Overall Study|Withdrawal by Subject|0|||
16930876|NCT01324570|38074693|FG001|Overall Study|Withdrawal by Subject|3|||
16930877|NCT01324570|38074692|FG000|Overall Study|Lack of Efficacy|0|||
17198627|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
17198628|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
17198629|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
17198630|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
17198631|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
16852043|NCT01393743|37801969|FG001|Extension Phase|Adverse Event|0|||
16852044|NCT01393743|37801970|FG002|Extension Phase|Adverse Event|12|||
16930878|NCT01324570|38074693|FG001|Overall Study|Lack of Efficacy|1|||
16930879|NCT01324570|38074692|FG000|Overall Study|Confirmed or suspected diversion|0|||
16930880|NCT01324570|38074693|FG001|Overall Study|Confirmed or suspected diversion|1|||
16930881|NCT01324570|38074692|FG000|Overall Study|Administrative|0|||
16852045|NCT01393743|37801968|FG000|Extension Phase|Lost to Follow-up|0|||
16930882|NCT01324570|38074693|FG001|Overall Study|Administrative|2|||
16930883|NCT01324141|38074701|FG000|Overall Study|Declined to participate before treatment started|1|||
16930884|NCT01324141|38074701|FG000|Overall Study|Disease progression on study|1|||
16930885|NCT01324102|38074717|FG000|Overall Study|illness|1|||
16930886|NCT01324102|38074718|FG001|Overall Study|illness|6|||
16930887|NCT01324024|38074725|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
16930888|NCT01324024|38074726|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16930889|NCT01323946|38074739|FG000|Overall Study|Lost to Follow-up|0|||
16852046|NCT01393743|37801969|FG001|Extension Phase|Lost to Follow-up|0|||
16852047|NCT01393743|37801970|FG002|Extension Phase|Lost to Follow-up|2|||
16852048|NCT01393743|37801968|FG000|Extension Phase|Participant choice|0|||
16852049|NCT01393743|37801969|FG001|Extension Phase|Participant choice|0|||
16852050|NCT01393743|37801970|FG002|Extension Phase|Participant choice|16|||
16852051|NCT01393743|37801968|FG000|Extension Phase|Inadequate therapeutic effect|0|||
16852052|NCT01393743|37801969|FG001|Extension Phase|Inadequate therapeutic effect|0|||
16852053|NCT01393743|37801970|FG002|Extension Phase|Inadequate therapeutic effect|7|||
16852054|NCT01393743|37801968|FG000|Extension Phase|Withdrawal by Subject|0|||
16852055|NCT01393743|37801969|FG001|Extension Phase|Withdrawal by Subject|0|||
16852056|NCT01393743|37801970|FG002|Extension Phase|Withdrawal by Subject|8|||
16852057|NCT01393743|37801968|FG000|Extension Phase|Pregnancy|0|||
16852058|NCT01393743|37801969|FG001|Extension Phase|Pregnancy|0|||
16852059|NCT01393743|37801970|FG002|Extension Phase|Pregnancy|1|||
16852060|NCT01393743|37801968|FG000|Extension Phase|Other|0|||
16852061|NCT01393743|37801969|FG001|Extension Phase|Other|0|||
16930890|NCT01323946|38074740|FG001|Overall Study|Lost to Follow-up|1|||
16930891|NCT01323946|38074741|FG002|Overall Study|Lost to Follow-up|0|||
16930892|NCT01323946|38074739|FG000|Overall Study|Parents refused the last blood draw|1|||
16930893|NCT01323946|38074740|FG001|Overall Study|Parents refused the last blood draw|0|||
16930894|NCT01323946|38074741|FG002|Overall Study|Parents refused the last blood draw|0|||
16930895|NCT01323946|38074739|FG000|Overall Study|Withdrawal by Subject|2|||
16930896|NCT01323946|38074740|FG001|Overall Study|Withdrawal by Subject|2|||
16930897|NCT01323946|38074741|FG002|Overall Study|Withdrawal by Subject|0|||
16930898|NCT01323790|38074754|FG000|Overall Study|Other|3|||
16930899|NCT01323790|38074755|FG001|Overall Study|Other|2|||
16930900|NCT01323790|38074756|FG002|Overall Study|Other|1|||
16930901|NCT01323790|38074754|FG000|Overall Study|Lost to Follow-up|11|||
16930902|NCT01323790|38074755|FG001|Overall Study|Lost to Follow-up|9|||
16930903|NCT01323790|38074756|FG002|Overall Study|Lost to Follow-up|9|||
16930904|NCT01323790|38074754|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
16930905|NCT01323790|38074755|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
16930906|NCT01323790|38074756|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
16930907|NCT01323790|38074754|FG000|Overall Study|Lack of Efficacy|3|||
16930908|NCT01323790|38074755|FG001|Overall Study|Lack of Efficacy|0|||
16930909|NCT01323790|38074756|FG002|Overall Study|Lack of Efficacy|3|||
16930910|NCT01323790|38074754|FG000|Overall Study|Adverse Event|11|||
16930911|NCT01323790|38074755|FG001|Overall Study|Adverse Event|24|||
16930912|NCT01323790|38074756|FG002|Overall Study|Adverse Event|12|||
16930913|NCT01323790|38074754|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16930914|NCT01323790|38074755|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16930915|NCT01323790|38074756|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
16930916|NCT01323790|38074754|FG000|Overall Study|Withdrawal by Subject|23|||
16930917|NCT01323790|38074755|FG001|Overall Study|Withdrawal by Subject|20|||
16930918|NCT01323790|38074756|FG002|Overall Study|Withdrawal by Subject|13|||
16930919|NCT01323790|38074754|FG000|Overall Study|Did Not Receive Treatment|2|||
16930920|NCT01323790|38074755|FG001|Overall Study|Did Not Receive Treatment|0|||
16930921|NCT01323790|38074756|FG002|Overall Study|Did Not Receive Treatment|1|||
16930922|NCT01323790|38074754|FG000|Overall Study|Severe non-compliance with protocol|2|||
16930923|NCT01323790|38074755|FG001|Overall Study|Severe non-compliance with protocol|2|||
16930924|NCT01323790|38074756|FG002|Overall Study|Severe non-compliance with protocol|2|||
16930925|NCT01323673|38074766|FG000|Overall Study|Adverse Event|0|||
16930926|NCT01323673|38074767|FG001|Overall Study|Adverse Event|1|||
16930927|NCT01323673|38074766|FG000|Overall Study|Lost to Follow-up|0|||
16930928|NCT01323673|38074767|FG001|Overall Study|Lost to Follow-up|1|||
16930929|NCT01323673|38074766|FG000|Overall Study|Protocol Violation|1|||
16930930|NCT01323673|38074767|FG001|Overall Study|Protocol Violation|0|||
16930931|NCT01323673|38074766|FG000|Overall Study|Withdrawal by Subject|2|||
16930932|NCT01323673|38074767|FG001|Overall Study|Withdrawal by Subject|3|||
16930933|NCT01323634|38074775|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
16930934|NCT01323634|38074776|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
16930935|NCT01323634|38074777|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
16930936|NCT01323634|38074775|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
16930937|NCT01323634|38074776|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
16930938|NCT01323634|38074777|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
16930939|NCT01323634|38074775|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
16930940|NCT01323634|38074776|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16930941|NCT01323634|38074777|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16930942|NCT01323634|38074775|FG000|2-week Run-in Period|Physician Decision|5|||
16930943|NCT01323634|38074776|FG001|2-week Run-in Period|Physician Decision|0|||
16930944|NCT01323634|38074777|FG002|2-week Run-in Period|Physician Decision|0|||
16930945|NCT01323634|38074775|FG000|2-week Run-in Period|Protocol Violation|1|||
16930946|NCT01323634|38074776|FG001|2-week Run-in Period|Protocol Violation|0|||
16930947|NCT01323634|38074777|FG002|2-week Run-in Period|Protocol Violation|0|||
16930948|NCT01323634|38074775|FG000|2-week Run-in Period|Adverse Event|1|||
16930949|NCT01323634|38074776|FG001|2-week Run-in Period|Adverse Event|0|||
16930950|NCT01323634|38074777|FG002|2-week Run-in Period|Adverse Event|0|||
16930951|NCT01323634|38074775|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16930952|NCT01323634|38074776|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
16930953|NCT01323634|38074777|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
16930954|NCT01323634|38074775|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16930955|NCT01323634|38074776|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16930956|NCT01323634|38074777|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
16930957|NCT01323634|38074775|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16930958|NCT01323634|38074776|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
16930959|NCT01323634|38074777|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
16930960|NCT01323634|38074775|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16930961|NCT01323634|38074776|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
16930962|NCT01323634|38074777|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
16930963|NCT01323634|38074775|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
16930964|NCT01323634|38074776|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
16930965|NCT01323634|38074777|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
16930966|NCT01323634|38074775|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16930967|NCT01323634|38074776|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
16930968|NCT01323634|38074777|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
16930969|NCT01323634|38074775|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
16930970|NCT01323634|38074776|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
16930971|NCT01323634|38074777|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
16930972|NCT01323478|38074783|FG000|Overall Study|Adverse Event|7|||
16930973|NCT01323478|38074783|FG000|Overall Study|Lack of Efficacy|4|||
16930974|NCT01323478|38074783|FG000|Overall Study|Non-compliance With Study Product|3|||
16930975|NCT01323478|38074783|FG000|Overall Study|Protocol Violation|1|||
16852062|NCT01393743|37801970|FG002|Extension Phase|Other|14|||
16852063|NCT01405911|37801989|FG000|Overall Study|Pre-treatment lab AE|0|||
16852064|NCT01405911|37801990|FG001|Overall Study|Pre-treatment lab AE|1|||
16852065|NCT01405911|37801991|FG002|Overall Study|Pre-treatment lab AE|0|||
16852066|NCT01405911|37801989|FG000|Overall Study|Lost to Follow-up|0|||
16930976|NCT01323478|38074783|FG000|Overall Study|Withdrawal of Consent|1|||
16930977|NCT01323478|38074783|FG000|Overall Study|Administrative or Other Reasons|8|||
16852067|NCT01405911|37801990|FG001|Overall Study|Lost to Follow-up|1|||
16852068|NCT01405911|37801991|FG002|Overall Study|Lost to Follow-up|0|||
16930978|NCT01322386|38074789|FG000|Overall Study|Protocol Violation|0|||
16930979|NCT01322386|38074790|FG001|Overall Study|Protocol Violation|1|||
16930980|NCT01322386|38074789|FG000|Overall Study|Physician Decision|0|||
16930981|NCT01322386|38074790|FG001|Overall Study|Physician Decision|1|||
16930982|NCT01322347|38074800|FG000|Overall Study|Adverse Event|7|||
16930983|NCT01322347|38074801|FG001|Overall Study|Adverse Event|2|||
16930984|NCT01322347|38074800|FG000|Overall Study|Death|5|||
16930985|NCT01322347|38074801|FG001|Overall Study|Death|3|||
16930986|NCT01322347|38074800|FG000|Overall Study|Physician Decision|2|||
16930987|NCT01322347|38074801|FG001|Overall Study|Physician Decision|1|||
16930988|NCT01322347|38074800|FG000|Overall Study|Protocol Violation|5|||
16930989|NCT01322347|38074801|FG001|Overall Study|Protocol Violation|2|||
16930990|NCT01322347|38074800|FG000|Overall Study|Withdrawal by Subject|1|||
16930991|NCT01322347|38074801|FG001|Overall Study|Withdrawal by Subject|4|||
16930992|NCT01322347|38074800|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
16930993|NCT01322347|38074801|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
16930994|NCT01322347|38074800|FG000|Overall Study|blood transfusion|5|||
16930995|NCT01322347|38074801|FG001|Overall Study|blood transfusion|5|||
16930996|NCT01322347|38074800|FG000|Overall Study|sponsor decision|1|||
16930997|NCT01322347|38074801|FG001|Overall Study|sponsor decision|3|||
16930998|NCT01322347|38074800|FG000|Overall Study|ineligible|6|||
16930999|NCT01322347|38074801|FG001|Overall Study|ineligible|3|||
16931000|NCT01322347|38074800|FG000|Overall Study|kidney transplant|3|||
16931001|NCT01322347|38074801|FG001|Overall Study|kidney transplant|1|||
16931002|NCT01322347|38074800|FG000|Overall Study|study drug withheld > 12 wks|0|||
16931003|NCT01322347|38074801|FG001|Overall Study|study drug withheld > 12 wks|1|||
16931004|NCT01322347|38074800|FG000|Overall Study|moved/changed dialysis|2|||
16931005|NCT01322347|38074801|FG001|Overall Study|moved/changed dialysis|4|||
16931006|NCT01321879|38074808|FG000|Overall Study|Lack of Efficacy|5|||
16931007|NCT01321879|38074808|FG000|Overall Study|Adverse Event|5|||
16931008|NCT01321879|38074808|FG000|Overall Study|Death|3|||
16931009|NCT01321879|38074808|FG000|Overall Study|Withdrawal by Subject|1|||
16931010|NCT01321723|38074815|FG000|Overall Study|Adverse Event|3|||
16931011|NCT01321723|38074816|FG001|Overall Study|Adverse Event|5|||
16931012|NCT01321723|38074817|FG002|Overall Study|Adverse Event|2|||
16931013|NCT01321723|38074815|FG000|Overall Study|Withdrawal by Subject|2|||
16931014|NCT01321723|38074816|FG001|Overall Study|Withdrawal by Subject|0|||
16931015|NCT01321723|38074817|FG002|Overall Study|Withdrawal by Subject|2|||
16931016|NCT01321606|38074827|FG000|Overall Study|Lost to Follow-up|0|||
16931017|NCT01321606|38074828|FG001|Overall Study|Lost to Follow-up|0|||
16931018|NCT01321606|38074829|FG002|Overall Study|Lost to Follow-up|0|||
16931019|NCT01321606|38074830|FG003|Overall Study|Lost to Follow-up|1|||
16931020|NCT01320943|38074842|FG000|Overall Study|Lost to Follow-up|1|||
16931021|NCT01320943|38074843|FG001|Overall Study|Lost to Follow-up|0|||
16931022|NCT01320943|38074842|FG000|Overall Study|Physician Decision|0|||
16931023|NCT01320943|38074843|FG001|Overall Study|Physician Decision|1|||
16931024|NCT01320943|38074842|FG000|Overall Study|Randomized but not Treated|0|||
16931025|NCT01320943|38074843|FG001|Overall Study|Randomized but not Treated|1|||
16852069|NCT01405911|37801989|FG000|Overall Study|Protocol Violation|1|||
16852070|NCT01405911|37801990|FG001|Overall Study|Protocol Violation|0|||
16931026|NCT02482233|38074858|FG000|Overall Study|Lost to Follow-up|1|||
16931027|NCT02482233|38074859|FG001|Overall Study|Lost to Follow-up|1|||
16931028|NCT01320202|38074869|FG000|Overall Study|Adverse Event|5|||
16931029|NCT01320202|38074870|FG001|Overall Study|Adverse Event|5|||
16931030|NCT01320202|38074869|FG000|Overall Study|Death|5|||
16852071|NCT01405911|37801991|FG002|Overall Study|Protocol Violation|0|||
16852072|NCT01405911|37801989|FG000|Overall Study|Withdrawal by Subject|3|||
16931031|NCT01320202|38074870|FG001|Overall Study|Death|3|||
16931032|NCT01320202|38074869|FG000|Overall Study|Lost to Follow-up|1|||
16852073|NCT01405911|37801990|FG001|Overall Study|Withdrawal by Subject|1|||
16852074|NCT01405911|37801991|FG002|Overall Study|Withdrawal by Subject|1|||
16931033|NCT01320202|38074870|FG001|Overall Study|Lost to Follow-up|0|||
16931034|NCT01320202|38074869|FG000|Overall Study|Physician Decision|3|||
16931035|NCT01320202|38074870|FG001|Overall Study|Physician Decision|1|||
16931036|NCT01320202|38074869|FG000|Overall Study|Protocol Violation|2|||
16931037|NCT01320202|38074870|FG001|Overall Study|Protocol Violation|1|||
16931038|NCT01320202|38074869|FG000|Overall Study|Withdrawal by Subject|10|||
16931039|NCT01320202|38074870|FG001|Overall Study|Withdrawal by Subject|3|||
16931040|NCT01320202|38074869|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
16931041|NCT01320202|38074870|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
16931042|NCT01320202|38074869|FG000|Overall Study|kidney transplant|1|||
16931043|NCT01320202|38074870|FG001|Overall Study|kidney transplant|2|||
16931044|NCT01320202|38074869|FG000|Overall Study|blood transfusion|1|||
16931045|NCT01320202|38074870|FG001|Overall Study|blood transfusion|7|||
16852075|NCT01425801|37801999|FG000|Period 1|Withdrawal by Subject|0|||
16852076|NCT01425801|37802000|FG001|Period 1|Withdrawal by Subject|0|||
16852077|NCT01425801|37802001|FG002|Period 1|Withdrawal by Subject|0|||
16852078|NCT01425801|37802002|FG003|Period 1|Withdrawal by Subject|0|||
16852079|NCT01425801|37802003|FG004|Period 1|Withdrawal by Subject|1|||
16852080|NCT01425801|37802004|FG005|Period 1|Withdrawal by Subject|0|||
16931046|NCT01320202|38074869|FG000|Overall Study|moved/changed dialysis|5|||
16931047|NCT01320202|38074870|FG001|Overall Study|moved/changed dialysis|2|||
16931048|NCT01320202|38074869|FG000|Overall Study|sponsor request|2|||
16931049|NCT01320202|38074870|FG001|Overall Study|sponsor request|0|||
16931050|NCT01320202|38074869|FG000|Overall Study|ineligible|3|||
16931051|NCT01320202|38074870|FG001|Overall Study|ineligible|0|||
16931052|NCT01320202|38074869|FG000|Overall Study|regained renal function|1|||
16931053|NCT01320202|38074870|FG001|Overall Study|regained renal function|0|||
16931054|NCT01319383|38074879|FG000|Overall Study|No ex vivo or in vivo response|4|||
16931055|NCT01319383|38074880|FG001|Overall Study|No ex vivo or in vivo response|0|||
16931056|NCT01319383|38074879|FG000|Overall Study|Physician Decision|3|||
16931057|NCT01319383|38074880|FG001|Overall Study|Physician Decision|0|||
16931058|NCT01319383|38074879|FG000|Overall Study|Lack of Efficacy|5|||
16931059|NCT01319383|38074880|FG001|Overall Study|Lack of Efficacy|9|||
16852081|NCT01425801|37801999|FG000|Period 2|Withdrawal by Subject|0|||
16852082|NCT01425801|37802000|FG001|Period 2|Withdrawal by Subject|0|||
16852083|NCT01425801|37802001|FG002|Period 2|Withdrawal by Subject|0|||
16852084|NCT01425801|37802002|FG003|Period 2|Withdrawal by Subject|0|||
16852085|NCT01425801|37802003|FG004|Period 2|Withdrawal by Subject|1|||
16852086|NCT01425801|37802004|FG005|Period 2|Withdrawal by Subject|0|||
16852087|NCT01425801|37801999|FG000|Period 3|Stability criteria not fullfilled|0|||
16852088|NCT01425801|37802000|FG001|Period 3|Stability criteria not fullfilled|0|||
16931060|NCT01319383|38074879|FG000|Overall Study|No in vivo response to interval doses|0|||
16931061|NCT01319383|38074880|FG001|Overall Study|No in vivo response to interval doses|1|||
16931062|NCT01316614|38074897|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
16931063|NCT01316614|38074897|FG000|Overall Study|Cytology slides not available for review|4|||
16931064|NCT01316614|38074897|FG000|Overall Study|Cystic lesion|5|||
16931065|NCT01316614|38074897|FG000|Overall Study|Inadequate number of passes|2|||
16931066|NCT01316614|38074897|FG000|Overall Study|Medically unstable|1|||
16931067|NCT01316575|38074904|FG000|Overall Study|Withdrawal by Subject|2|||
16931068|NCT01316575|38074905|FG001|Overall Study|Withdrawal by Subject|0|||
16931069|NCT01316575|38074904|FG000|Overall Study|Required alternate treatment|0|||
16931070|NCT01316575|38074905|FG001|Overall Study|Required alternate treatment|1|||
16931071|NCT01315678|38074913|FG000|Overall Study|Withdrawal by Subject|7|||
16931072|NCT01315678|38074914|FG001|Overall Study|Withdrawal by Subject|3|||
16931073|NCT01315678|38074913|FG000|Overall Study|Adverse Event|3|||
16931074|NCT01315678|38074914|FG001|Overall Study|Adverse Event|1|||
16931075|NCT01315678|38074913|FG000|Overall Study|Lost to Follow-up|1|||
16931076|NCT01315678|38074914|FG001|Overall Study|Lost to Follow-up|0|||
16931077|NCT01315678|38074913|FG000|Overall Study|similar reason to those listed above|3|||
16931078|NCT01315678|38074914|FG001|Overall Study|similar reason to those listed above|2|||
16931079|NCT01315249|38074924|FG000|Overall Study|Adverse Event|22|||
16931080|NCT01315249|38074925|FG001|Overall Study|Adverse Event|26|||
16931081|NCT01315249|38074924|FG000|Overall Study|Withdrawal by Subject|11|||
16931082|NCT01315249|38074925|FG001|Overall Study|Withdrawal by Subject|10|||
16931083|NCT01315249|38074924|FG000|Overall Study|Protocol Violation|8|||
16931084|NCT01315249|38074925|FG001|Overall Study|Protocol Violation|5|||
16931085|NCT01315249|38074924|FG000|Overall Study|Abnormal test results|1|||
16931086|NCT01315249|38074925|FG001|Overall Study|Abnormal test results|2|||
16931087|NCT01315249|38074924|FG000|Overall Study|Administrative problems|1|||
16931088|NCT01315249|38074925|FG001|Overall Study|Administrative problems|0|||
16931089|NCT01315249|38074924|FG000|Overall Study|inability to use device|1|||
16931090|NCT01315249|38074925|FG001|Overall Study|inability to use device|0|||
16931091|NCT01315249|38074924|FG000|Overall Study|Lack of Efficacy|0|||
16931092|NCT01315249|38074925|FG001|Overall Study|Lack of Efficacy|1|||
16931093|NCT01315249|38074924|FG000|Overall Study|Lost to Follow-up|0|||
16931094|NCT01315249|38074925|FG001|Overall Study|Lost to Follow-up|2|||
16931095|NCT01315249|38074924|FG000|Overall Study|Death|0|||
16931096|NCT01315249|38074925|FG001|Overall Study|Death|1|||
16931097|NCT01315132|38074931|FG000|Overall Study|not treated due to disease progression|1|||
16931098|NCT01313767|38074937|FG000|Overall Study|Adverse Event|1|||
16931099|NCT01313767|38074938|FG001|Overall Study|Adverse Event|0|||
16931100|NCT01313767|38074937|FG000|Overall Study|Lost to Follow-up|1|||
16931101|NCT01313767|38074938|FG001|Overall Study|Lost to Follow-up|0|||
16931102|NCT01313767|38074937|FG000|Overall Study|Withdrawal by Subject|2|||
16931103|NCT01313767|38074938|FG001|Overall Study|Withdrawal by Subject|1|||
16931104|NCT01313767|38074937|FG000|Overall Study|Protocol Violation|3|||
16931105|NCT01313767|38074938|FG001|Overall Study|Protocol Violation|1|||
16931106|NCT01313728|38074944|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
16931107|NCT01313650|38074953|FG000|Overall Study|Adverse Event|9|||
16931108|NCT01313650|38074954|FG001|Overall Study|Adverse Event|34|||
16931109|NCT01313650|38074955|FG002|Overall Study|Adverse Event|24|||
16931110|NCT01313650|38074956|FG003|Overall Study|Adverse Event|23|||
16931111|NCT01313650|38074953|FG000|Overall Study|Lack of Efficacy|37|||
16931112|NCT01313650|38074954|FG001|Overall Study|Lack of Efficacy|20|||
16931113|NCT01313650|38074955|FG002|Overall Study|Lack of Efficacy|32|||
16931114|NCT01313650|38074956|FG003|Overall Study|Lack of Efficacy|20|||
16931115|NCT01313650|38074953|FG000|Overall Study|Lost to Follow-up|1|||
16931116|NCT01313650|38074954|FG001|Overall Study|Lost to Follow-up|0|||
16931117|NCT01313650|38074955|FG002|Overall Study|Lost to Follow-up|3|||
16931118|NCT01313650|38074956|FG003|Overall Study|Lost to Follow-up|2|||
16931119|NCT01313650|38074953|FG000|Overall Study|Withdrawal by Subject|16|||
16931120|NCT01313650|38074954|FG001|Overall Study|Withdrawal by Subject|20|||
16931121|NCT01313650|38074955|FG002|Overall Study|Withdrawal by Subject|15|||
16931122|NCT01313650|38074956|FG003|Overall Study|Withdrawal by Subject|15|||
16931123|NCT01313650|38074953|FG000|Overall Study|Protocol Violation|4|||
16931124|NCT01313650|38074954|FG001|Overall Study|Protocol Violation|7|||
16931125|NCT01313650|38074955|FG002|Overall Study|Protocol Violation|5|||
16931126|NCT01313650|38074956|FG003|Overall Study|Protocol Violation|6|||
16931127|NCT01313650|38074953|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
16931128|NCT01313650|38074954|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
16931129|NCT01313650|38074955|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
16931130|NCT01313650|38074956|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
16931131|NCT01313299|38074969|FG000|Overall Study|Adverse Event|3|||
16931132|NCT01313299|38074970|FG001|Overall Study|Adverse Event|1|||
16931133|NCT01313299|38074971|FG002|Overall Study|Adverse Event|1|||
16931134|NCT01313299|38074969|FG000|Overall Study|Lost to Follow-up|1|||
16931135|NCT01313299|38074970|FG001|Overall Study|Lost to Follow-up|0|||
16931136|NCT01313299|38074971|FG002|Overall Study|Lost to Follow-up|0|||
16931137|NCT01313299|38074969|FG000|Overall Study|Protocol Violation|2|||
16931138|NCT01313299|38074970|FG001|Overall Study|Protocol Violation|0|||
16931139|NCT01313299|38074971|FG002|Overall Study|Protocol Violation|0|||
16931140|NCT01313299|38074969|FG000|Overall Study|Withdrawal by Subject|1|||
17018969|NCT00853658|38163530|FG002|Overall Study|Vital Status unknown at study end|0|||
17018970|NCT00853658|38163528|FG000|Overall Study|Vital Status at study end N/A|8|||
17018971|NCT00853658|38163529|FG001|Overall Study|Vital Status at study end N/A|10|||
17018972|NCT00853658|38163530|FG002|Overall Study|Vital Status at study end N/A|10|||
16931141|NCT01313299|38074970|FG001|Overall Study|Withdrawal by Subject|0|||
16931142|NCT01313299|38074971|FG002|Overall Study|Withdrawal by Subject|2|||
16931143|NCT01313299|38074969|FG000|Overall Study|Family reason and moved out of state|0|||
16931144|NCT01313299|38074970|FG001|Overall Study|Family reason and moved out of state|2|||
16931145|NCT01313299|38074971|FG002|Overall Study|Family reason and moved out of state|0|||
16931146|NCT01313299|38074969|FG000|Overall Study|Lack of subject compliance|0|||
16931147|NCT01313299|38074970|FG001|Overall Study|Lack of subject compliance|0|||
16931148|NCT01313299|38074971|FG002|Overall Study|Lack of subject compliance|1|||
16931149|NCT01313221|38074982|FG000|Overall Study|Protocol Violation|0|||
16931150|NCT01313221|38074983|FG001|Overall Study|Protocol Violation|1|||
16931151|NCT01313221|38074984|FG002|Overall Study|Protocol Violation|1|||
16931152|NCT01313221|38074982|FG000|Overall Study|Non-compliance|3|||
16931153|NCT01313221|38074983|FG001|Overall Study|Non-compliance|0|||
16931154|NCT01313221|38074984|FG002|Overall Study|Non-compliance|2|||
16931155|NCT01313221|38074982|FG000|Overall Study|Withdrawal by Subject|2|||
16931156|NCT01313221|38074983|FG001|Overall Study|Withdrawal by Subject|3|||
16931157|NCT01313221|38074984|FG002|Overall Study|Withdrawal by Subject|5|||
16931158|NCT01313221|38074982|FG000|Overall Study|Requirement for alternative therapy|0|||
16931159|NCT01313221|38074983|FG001|Overall Study|Requirement for alternative therapy|1|||
16931160|NCT01313221|38074984|FG002|Overall Study|Requirement for alternative therapy|1|||
16931161|NCT01313221|38074982|FG000|Overall Study|Lost to Follow-up|6|||
16931162|NCT01313221|38074983|FG001|Overall Study|Lost to Follow-up|3|||
16931163|NCT01313221|38074984|FG002|Overall Study|Lost to Follow-up|1|||
16931164|NCT01313221|38074982|FG000|Overall Study|Other|1|||
16931165|NCT01313221|38074983|FG001|Overall Study|Other|0|||
16931166|NCT01313221|38074984|FG002|Overall Study|Other|0|||
16931167|NCT01313221|38074982|FG000|Overall Study|Adverse Event|0|||
16931168|NCT01313221|38074983|FG001|Overall Study|Adverse Event|0|||
16931169|NCT01313221|38074984|FG002|Overall Study|Adverse Event|7|||
16931170|NCT01313221|38074982|FG000|Overall Study|Disease progression|0|||
16931171|NCT01313221|38074983|FG001|Overall Study|Disease progression|0|||
16931172|NCT01313221|38074984|FG002|Overall Study|Disease progression|2|||
16931173|NCT01313221|38074982|FG000|Overall Study|Physician Decision|0|||
16931174|NCT01313221|38074983|FG001|Overall Study|Physician Decision|0|||
16931175|NCT01313221|38074984|FG002|Overall Study|Physician Decision|2|||
16931176|NCT01313221|38074982|FG000|Overall Study|Pregnancy|0|||
16931177|NCT01313221|38074983|FG001|Overall Study|Pregnancy|0|||
16931178|NCT01313221|38074984|FG002|Overall Study|Pregnancy|2|||
16931179|NCT01313182|38074994|FG000|Overall Study|Protocol Violation|66|||
16931180|NCT01313182|38074995|FG001|Overall Study|Protocol Violation|92|||
16931181|NCT01312909|38075004|FG000|Overall Study|Randomized but not treated|1|||
16931182|NCT01312909|38075005|FG001|Overall Study|Randomized but not treated|3|||
16931183|NCT01312909|38075006|FG002|Overall Study|Randomized but not treated|1|||
16931184|NCT01312909|38075004|FG000|Overall Study|Adverse Event|1|||
16931185|NCT01312909|38075005|FG001|Overall Study|Adverse Event|0|||
16931186|NCT01312909|38075006|FG002|Overall Study|Adverse Event|3|||
16931187|NCT01312909|38075004|FG000|Overall Study|Protocol Violation|2|||
16931188|NCT01312909|38075005|FG001|Overall Study|Protocol Violation|0|||
16931189|NCT01312909|38075006|FG002|Overall Study|Protocol Violation|2|||
16852089|NCT01425801|37802001|FG002|Period 3|Stability criteria not fullfilled|1|||
16852090|NCT01425801|37802002|FG003|Period 3|Stability criteria not fullfilled|0|||
16852091|NCT01425801|37802003|FG004|Period 3|Stability criteria not fullfilled|0|||
16852092|NCT01425801|37802004|FG005|Period 3|Stability criteria not fullfilled|0|||
16852093|NCT01425801|37801999|FG000|Period 4|Not able to maintain visit schedule|0|||
16852094|NCT01425801|37802000|FG001|Period 4|Not able to maintain visit schedule|0|||
16931190|NCT01312909|38075004|FG000|Overall Study|Other|9|||
16931191|NCT01312909|38075005|FG001|Overall Study|Other|6|||
16931192|NCT01312909|38075006|FG002|Overall Study|Other|11|||
16931193|NCT01312909|38075004|FG000|Overall Study|Withdrawal by Subject|8|||
16931194|NCT01312909|38075005|FG001|Overall Study|Withdrawal by Subject|10|||
16931195|NCT01312909|38075006|FG002|Overall Study|Withdrawal by Subject|7|||
16931196|NCT01312909|38075004|FG000|Overall Study|Lost to Follow-up|21|||
16931197|NCT01312909|38075005|FG001|Overall Study|Lost to Follow-up|17|||
16931198|NCT01312909|38075006|FG002|Overall Study|Lost to Follow-up|20|||
16931199|NCT01312909|38075004|FG000|Overall Study|Insufficient clinical response|0|||
16931200|NCT01312909|38075005|FG001|Overall Study|Insufficient clinical response|0|||
16931201|NCT01312909|38075006|FG002|Overall Study|Insufficient clinical response|1|||
16931202|NCT01312909|38075004|FG000|Overall Study|Entrance criteria not met|0|||
16931203|NCT01312909|38075005|FG001|Overall Study|Entrance criteria not met|0|||
16931204|NCT01312909|38075006|FG002|Overall Study|Entrance criteria not met|2|||
16931205|NCT01312129|38075016|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
16931206|NCT01312129|38075017|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
16931207|NCT01311661|38075023|FG000|Overall Study|Adverse Event|2|||
16931208|NCT01311661|38075023|FG000|Overall Study|Protocol Violation|3|||
16931209|NCT01311661|38075023|FG000|Overall Study|Withdrawal by Subject|2|||
16931210|NCT01311505|38075035|FG000|First Intervention Period|Protocol Violation|0|||
16931211|NCT01311505|38075036|FG001|First Intervention Period|Protocol Violation|1|||
16931212|NCT01310803|38075047|FG000|Overall Study|Subject terminated by Sponsor|1|||
16931213|NCT01310803|38075048|FG001|Overall Study|Subject terminated by Sponsor|0|||
16931214|NCT01310413|38075060|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
16852095|NCT01425801|37802001|FG002|Period 4|Not able to maintain visit schedule|1|||
16852096|NCT01425801|37802002|FG003|Period 4|Not able to maintain visit schedule|0|||
16852097|NCT01425801|37802003|FG004|Period 4|Not able to maintain visit schedule|0|||
16852098|NCT01425801|37802004|FG005|Period 4|Not able to maintain visit schedule|0|||
16852099|NCT01425723|37802029|FG000|Overall Study|Lack of Efficacy|0|||
16852100|NCT01425723|37802030|FG001|Overall Study|Lack of Efficacy|1|||
16852101|NCT01425723|37802029|FG000|Overall Study|Withdrawal by Subject|1|||
16852102|NCT01425723|37802030|FG001|Overall Study|Withdrawal by Subject|4|||
16852103|NCT01425723|37802029|FG000|Overall Study|Lost to Follow-up|0|||
16852104|NCT01425723|37802030|FG001|Overall Study|Lost to Follow-up|3|||
16852105|NCT01425723|37802029|FG000|Overall Study|Physician Decision|2|||
16852106|NCT01425723|37802030|FG001|Overall Study|Physician Decision|0|||
16852107|NCT01425723|37802029|FG000|Overall Study|Other|1|||
16852108|NCT01425723|37802030|FG001|Overall Study|Other|10|||
16852109|NCT01424397|37802061|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852110|NCT01424397|37802062|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852111|NCT01424397|37802063|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
16852112|NCT01424397|37802064|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852113|NCT01424397|37802065|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852114|NCT01424397|37802066|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
16931215|NCT01310413|38075061|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
16852115|NCT01424397|37802067|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852116|NCT01424397|37802068|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852117|NCT01424397|37802069|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852118|NCT01424397|37802070|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852119|NCT01424397|37802071|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852120|NCT01424397|37802072|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
16852121|NCT01392963|37802088|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
16931216|NCT01310413|38075062|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
16931217|NCT01310413|38075063|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
16852122|NCT01392963|37802089|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
16852123|NCT01392963|37802088|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
16852124|NCT01392963|37802089|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
16852125|NCT01392963|37802088|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
16852126|NCT01392963|37802089|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
16852127|NCT01392573|37802099|FG000|Overall Study|Adverse Event|1|||
16852128|NCT01392573|37802100|FG001|Overall Study|Adverse Event|3|||
16852129|NCT01392573|37802099|FG000|Overall Study|Lack of Efficacy|1|||
16852130|NCT01392573|37802100|FG001|Overall Study|Lack of Efficacy|2|||
16852131|NCT01392573|37802099|FG000|Overall Study|Protocol Violation|0|||
16852132|NCT01392573|37802100|FG001|Overall Study|Protocol Violation|2|||
16852133|NCT01392573|37802099|FG000|Overall Study|Withdrawal Criteria|13|||
16852134|NCT01392573|37802100|FG001|Overall Study|Withdrawal Criteria|15|||
16852135|NCT01392573|37802099|FG000|Overall Study|Site closure|8|||
16852136|NCT01392573|37802100|FG001|Overall Study|Site closure|7|||
16852137|NCT01392573|37802099|FG000|Overall Study|Unclassified|9|||
16852138|NCT01392573|37802100|FG001|Overall Study|Unclassified|6|||
16852139|NCT01392495|37802106|FG000|Overall Study|Death|3|||
16852140|NCT01392495|37802106|FG000|Overall Study|Administrative problems|8|||
16852141|NCT01392495|37802106|FG000|Overall Study|Withdrawal by Subject|2|||
16852142|NCT01392495|37802106|FG000|Overall Study|Adverse Event|3|||
16852143|NCT01405053|37802114|FG000|Overall Study|Adverse Event|3|||
16852144|NCT01405053|37802115|FG001|Overall Study|Adverse Event|0|||
16852145|NCT01405053|37802114|FG000|Overall Study|Lost to Follow-up|0|||
16852146|NCT01405053|37802115|FG001|Overall Study|Lost to Follow-up|1|||
16852147|NCT01405053|37802114|FG000|Overall Study|Participant choice|2|||
16852148|NCT01405053|37802115|FG001|Overall Study|Participant choice|1|||
16852149|NCT01405053|37802114|FG000|Overall Study|Inadequate therapeutic effect|2|||
16852150|NCT01405053|37802115|FG001|Overall Study|Inadequate therapeutic effect|1|||
16852151|NCT01405053|37802114|FG000|Overall Study|Withdrawal by Subject|3|||
16852152|NCT01405053|37802115|FG001|Overall Study|Withdrawal by Subject|4|||
16852153|NCT01405053|37802114|FG000|Overall Study|Other|0|||
16852154|NCT01405053|37802115|FG001|Overall Study|Other|1|||
16852155|NCT01403805|37802123|FG000|Overall Study|Withdrawal by Subject|0|||
16852156|NCT01403805|37802124|FG001|Overall Study|Withdrawal by Subject|4|||
16852157|NCT01403805|37802123|FG000|Overall Study|Lost to Follow-up|0|||
16852158|NCT01403805|37802124|FG001|Overall Study|Lost to Follow-up|2|||
16852159|NCT01403805|37802123|FG000|Overall Study|Death|0|||
16852160|NCT01403805|37802124|FG001|Overall Study|Death|1|||
16852161|NCT01423617|37802136|FG000|Overall Study|Lost to Follow-up|0|||
16852162|NCT01423617|37802137|FG001|Overall Study|Lost to Follow-up|1|||
16852163|NCT01392183|37802145|FG000|First Drug Administration|Adverse Event|3|||
16852164|NCT01392183|37802146|FG001|First Drug Administration|Adverse Event|2|||
16852165|NCT01392183|37802145|FG000|First Drug Administration|Death|1|||
16852166|NCT01392183|37802146|FG001|First Drug Administration|Death|0|||
16852167|NCT01392183|37802145|FG000|First Drug Administration|Withdrawal by Subject|10|||
16852168|NCT01392183|37802146|FG001|First Drug Administration|Withdrawal by Subject|17|||
16852169|NCT01751906|37802156|FG000|Overall Study|Lost to Follow-up|151|||
16852170|NCT01751906|37802157|FG001|Overall Study|Lost to Follow-up|68|||
16931218|NCT01310413|38075064|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
16931219|NCT01310413|38075065|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
16931220|NCT01310413|38075066|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
16931221|NCT01310413|38075060|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
16931222|NCT01310413|38075061|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
16931223|NCT01310413|38075062|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
16931224|NCT01310413|38075063|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
16931225|NCT01310413|38075064|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
16931226|NCT01310413|38075065|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
16931227|NCT01310413|38075066|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
16931228|NCT01310413|38075060|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
16931229|NCT01310413|38075061|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
16931230|NCT01310413|38075062|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
16931231|NCT01310413|38075063|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
16931232|NCT01310413|38075064|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
16931233|NCT01310413|38075065|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
16931234|NCT01310413|38075066|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
16931235|NCT01310413|38075060|FG000|Day 0 to Day 385|Other|1|||
16852171|NCT01751906|37802156|FG000|Overall Study|Withdrawal by Subject|22|||
16931236|NCT01310413|38075061|FG001|Day 0 to Day 385|Other|0|||
16931237|NCT01310413|38075062|FG002|Day 0 to Day 385|Other|3|||
16931238|NCT01310413|38075063|FG003|Day 0 to Day 385|Other|0|||
16931239|NCT01310413|38075064|FG004|Day 0 to Day 385|Other|0|||
16931240|NCT01310413|38075065|FG005|Day 0 to Day 385|Other|0|||
16931241|NCT01310413|38075066|FG006|Day 0 to Day 385|Other|0|||
16931242|NCT01310413|38075060|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
16931243|NCT01310413|38075061|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
16931244|NCT01310413|38075062|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
16931245|NCT01310413|38075063|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
16931246|NCT01310413|38075064|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
16931247|NCT01310413|38075065|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
16931248|NCT01310413|38075066|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
16931249|NCT01310413|38075060|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
16931250|NCT01310413|38075061|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
16931251|NCT01310413|38075062|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
16931252|NCT01310413|38075063|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
16931253|NCT01310413|38075064|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
16931254|NCT01310413|38075065|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
16931255|NCT01310413|38075066|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
16931256|NCT01309828|38075097|FG000|Overall Study|Adverse Event|10|||
16931257|NCT01309828|38075098|FG001|Overall Study|Adverse Event|11|||
16931258|NCT01309828|38075097|FG000|Overall Study|Voluntary Withdrawal|5|||
16931259|NCT01309828|38075098|FG001|Overall Study|Voluntary Withdrawal|4|||
16931260|NCT01309828|38075097|FG000|Overall Study|Major Protocol Deviation|0|||
16931261|NCT01309828|38075098|FG001|Overall Study|Major Protocol Deviation|1|||
16931262|NCT01309828|38075097|FG000|Overall Study|Other|1|||
16931263|NCT01309828|38075098|FG001|Overall Study|Other|0|||
16931264|NCT01309282|38075104|FG000|Overall Study|Lost to Follow-up|1|||
16931265|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
16931266|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
16931267|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
16931268|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
16931269|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Death|0|||
16931270|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Death|1|||
16931271|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
16931272|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
16931273|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
16931274|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
16931275|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
16931276|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
16931277|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
16931278|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
16931279|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
16931280|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
16931281|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
16931282|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
16931283|NCT01309243|38075110|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
16931284|NCT01309243|38075111|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
16931285|NCT01309243|38075110|FG000|Extension Phase|Lost to Follow-up|6|||
16931286|NCT01309243|38075111|FG001|Extension Phase|Lost to Follow-up|0|||
16931287|NCT01309204|38075119|FG000|Overall Study|Adverse Event|48|||
16931288|NCT01309204|38075120|FG001|Overall Study|Adverse Event|58|||
16931289|NCT01309204|38075119|FG000|Overall Study|Lost to Follow-up|2|||
16931290|NCT01309204|38075120|FG001|Overall Study|Lost to Follow-up|2|||
16931291|NCT01309204|38075119|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
16931292|NCT01309204|38075120|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
16931293|NCT01309204|38075119|FG000|Overall Study|Inadequate control of IOP|4|||
16931294|NCT01309204|38075120|FG001|Overall Study|Inadequate control of IOP|4|||
16931295|NCT01309204|38075119|FG000|Overall Study|Other|4|||
16931296|NCT01309204|38075120|FG001|Overall Study|Other|1|||
16931297|NCT01309165|38075128|FG000|Overall Study|Lost to Follow-up|4|||
16931298|NCT01309165|38075129|FG001|Overall Study|Lost to Follow-up|3|||
16931299|NCT01309165|38075128|FG000|Overall Study|Return to work|1|||
16931300|NCT01309165|38075129|FG001|Overall Study|Return to work|2|||
16931301|NCT01309165|38075128|FG000|Overall Study|Left country|0|||
16931302|NCT01309165|38075129|FG001|Overall Study|Left country|1|||
16931303|NCT01309165|38075128|FG000|Overall Study|No transportation|0|||
16931304|NCT01309165|38075129|FG001|Overall Study|No transportation|1|||
16931305|NCT01309165|38075128|FG000|Overall Study|Admitted to hospital for second stroke|1|||
16931306|NCT01309165|38075129|FG001|Overall Study|Admitted to hospital for second stroke|0|||
16931307|NCT01308853|38075136|FG000|Overall Study|Adverse Event|1|||
16931308|NCT01308853|38075136|FG000|Overall Study|Lost to Follow-up|2|||
16931309|NCT01308853|38075136|FG000|Overall Study|Insertion of permanent implants|1|||
16931310|NCT01308736|38075142|FG000|Overall Study|Did not attend a single session|6|||
16931311|NCT01308736|38075143|FG001|Overall Study|Did not attend a single session|5|||
16852172|NCT01751906|37802157|FG001|Overall Study|Withdrawal by Subject|18|||
16931312|NCT01308580|38075151|FG000|Overall Study|Lost to Follow-up|12|||
16931313|NCT01308580|38075152|FG001|Overall Study|Lost to Follow-up|7|||
16931314|NCT01308463|38075159|FG000|Overall Study|Study Discontinued|23|||
16931315|NCT01308463|38075159|FG000|Overall Study|Death|4|||
16931316|NCT01308463|38075159|FG000|Overall Study|Revision|2|||
16931317|NCT01308424|38075165|FG000|Baseline Eligibility|Screen Failures|71|||
16931318|NCT01308424|38075166|FG001|Baseline Eligibility|Screen Failures|0|||
16931319|NCT01308424|38075167|FG002|Baseline Eligibility|Screen Failures|0|||
16931320|NCT01308424|38075165|FG000|Randomization|Adverse Event|0|||
16931321|NCT01308424|38075166|FG001|Randomization|Adverse Event|1|||
16931322|NCT01308424|38075167|FG002|Randomization|Adverse Event|1|||
16931323|NCT01308424|38075165|FG000|Randomization|Lost to Follow-up|0|||
16931324|NCT01308424|38075166|FG001|Randomization|Lost to Follow-up|1|||
16931325|NCT01308424|38075167|FG002|Randomization|Lost to Follow-up|0|||
16931326|NCT01308424|38075165|FG000|Randomization|Physician Decision|0|||
16931327|NCT01308424|38075166|FG001|Randomization|Physician Decision|1|||
16931328|NCT01308424|38075167|FG002|Randomization|Physician Decision|1|||
17018973|NCT00853658|38163528|FG000|Overall Study|Patient's request|21|||
17018974|NCT00853658|38163529|FG001|Overall Study|Patient's request|17|||
17018975|NCT00853658|38163530|FG002|Overall Study|Patient's request|11|||
17018976|NCT00853658|38163528|FG000|Overall Study|Missing study completion information|5|||
17018977|NCT00853658|38163529|FG001|Overall Study|Missing study completion information|4|||
17018978|NCT00853658|38163530|FG002|Overall Study|Missing study completion information|6|||
17018979|NCT00666562|38163541|FG000|Overall Study|Withdrawal by Subject|0|||
17018980|NCT00666562|38163542|FG001|Overall Study|Withdrawal by Subject|1|||
17018981|NCT00666562|38163543|FG002|Overall Study|Withdrawal by Subject|0|||
17018982|NCT00666562|38163541|FG000|Overall Study|Concomitant Medication|0|||
17018983|NCT00666562|38163542|FG001|Overall Study|Concomitant Medication|1|||
17018984|NCT00666562|38163543|FG002|Overall Study|Concomitant Medication|0|||
17018985|NCT00666328|38163558|FG000|Overall Study|Death|2|||
17018986|NCT00666328|38163558|FG000|Overall Study|Lost to Follow-up|2|||
17018987|NCT00666328|38163558|FG000|Overall Study|No longer met eligibility criteria|1|||
17018988|NCT00853580|38163566|FG000|Overall Study|Lost to Follow-up|3|||
17018989|NCT00853580|38163567|FG001|Overall Study|Lost to Follow-up|5|||
17018990|NCT00853580|38163566|FG000|Overall Study|Protocol Violation|2|||
17018991|NCT00853580|38163567|FG001|Overall Study|Protocol Violation|1|||
17018992|NCT00853580|38163566|FG000|Overall Study|Withdrawal by Subject|2|||
17018993|NCT00853580|38163567|FG001|Overall Study|Withdrawal by Subject|8|||
17018994|NCT00853580|38163566|FG000|Overall Study|Commenced contraindicated therapy|0|||
17018995|NCT00853580|38163567|FG001|Overall Study|Commenced contraindicated therapy|2|||
17018996|NCT00865514|38163573|FG000|Overall Study|Infusion cost exceeded funding|2|||
17018997|NCT00865280|38163580|FG000|Overall Study|Withdrawal by Subject|4|||
17018998|NCT00865280|38163581|FG001|Overall Study|Withdrawal by Subject|1|||
17018999|NCT00865280|38163580|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
17019000|NCT00865280|38163581|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
17019001|NCT00865280|38163580|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
17019002|NCT00865280|38163581|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
17019003|NCT00865280|38163580|FG000|Overall Study|Exclusion Condition|1|||
17019004|NCT00865280|38163581|FG001|Overall Study|Exclusion Condition|0|||
17019005|NCT00865280|38163580|FG000|Overall Study|Adverse Event|0|||
17019006|NCT00865280|38163581|FG001|Overall Study|Adverse Event|1|||
17019007|NCT00865124|38163590|FG000|Overall Study|Physician Decision|2|||
17019008|NCT00865124|38163591|FG001|Overall Study|Physician Decision|1|||
16852173|NCT01751906|37802156|FG000|Overall Study|Physician Decision|5|||
16852174|NCT01751906|37802157|FG001|Overall Study|Physician Decision|2|||
16852175|NCT01751906|37802156|FG000|Overall Study|Death|84|||
16852176|NCT01751906|37802157|FG001|Overall Study|Death|43|||
16852177|NCT01751906|37802156|FG000|Overall Study|Denied on premises for follow-up by law|1|||
16852178|NCT01751906|37802157|FG001|Overall Study|Denied on premises for follow-up by law|0|||
16852179|NCT01402947|37802165|FG000|First Intervention|Adverse Event|0|||
16852180|NCT01402947|37802166|FG001|First Intervention|Adverse Event|1|||
16852181|NCT01402869|37802175|FG000|Overall Study|Required Tooth Extraction|0|||
16852182|NCT01402869|37802176|FG001|Overall Study|Required Tooth Extraction|0|||
16852183|NCT01402869|37802177|FG002|Overall Study|Required Tooth Extraction|1|||
16852184|NCT01391793|37802187|FG000|Overall Study|Ineligible|3|||
16852185|NCT01391793|37802188|FG001|Overall Study|Ineligible|0|||
16852186|NCT01391793|37802187|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
16852187|NCT01391793|37802188|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
16852188|NCT01391793|37802187|FG000|Overall Study|No DMSA|73|||
16852189|NCT01391793|37802188|FG001|Overall Study|No DMSA|57|||
16852190|NCT01422915|37802194|FG000|Overall Study|Adverse Event|1|||
16852191|NCT01727024|37802199|FG000|Period 1|Lost to Follow-up|1|||
16852192|NCT01727024|37802200|FG001|Period 1|Lost to Follow-up|1|||
16852193|NCT01727024|37802199|FG000|Period 1|Withdrawal by Subject|2|||
16852194|NCT01727024|37802200|FG001|Period 1|Withdrawal by Subject|3|||
16931329|NCT01307800|38075178|FG000|Overall Study|Adverse Event|9|||
16931330|NCT01307800|38075179|FG001|Overall Study|Adverse Event|8|||
16852195|NCT01422213|37802209|FG000|Overall Study|Adverse Event|8|||
16852196|NCT01422213|37802210|FG001|Overall Study|Adverse Event|7|||
16931331|NCT01307800|38075180|FG002|Overall Study|Adverse Event|10|||
16931332|NCT01307800|38075181|FG003|Overall Study|Adverse Event|14|||
16931333|NCT01307800|38075178|FG000|Overall Study|Entry Criteria Not Met|0|||
16931334|NCT01307800|38075179|FG001|Overall Study|Entry Criteria Not Met|0|||
16931335|NCT01307800|38075180|FG002|Overall Study|Entry Criteria Not Met|0|||
16931336|NCT01307800|38075181|FG003|Overall Study|Entry Criteria Not Met|2|||
16931337|NCT01307800|38075178|FG000|Overall Study|Lost to Follow-up|5|||
16931338|NCT01307800|38075179|FG001|Overall Study|Lost to Follow-up|6|||
16931339|NCT01307800|38075180|FG002|Overall Study|Lost to Follow-up|2|||
16931340|NCT01307800|38075181|FG003|Overall Study|Lost to Follow-up|8|||
16931341|NCT01307800|38075178|FG000|Overall Study|Perceived Lack of Efficacy|24|||
16931342|NCT01307800|38075179|FG001|Overall Study|Perceived Lack of Efficacy|23|||
16931343|NCT01307800|38075180|FG002|Overall Study|Perceived Lack of Efficacy|20|||
16931344|NCT01307800|38075181|FG003|Overall Study|Perceived Lack of Efficacy|33|||
16931345|NCT01307800|38075178|FG000|Overall Study|Protocol Violation|0|||
16931346|NCT01307800|38075179|FG001|Overall Study|Protocol Violation|3|||
16931347|NCT01307800|38075180|FG002|Overall Study|Protocol Violation|4|||
16931348|NCT01307800|38075181|FG003|Overall Study|Protocol Violation|5|||
16931349|NCT01307800|38075178|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
16931350|NCT01307800|38075179|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
16931351|NCT01307800|38075180|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
16931352|NCT01307800|38075181|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
16931353|NCT01307800|38075178|FG000|Overall Study|Sponsor Decision|6|||
16931354|NCT01307800|38075179|FG001|Overall Study|Sponsor Decision|9|||
16931355|NCT01307800|38075180|FG002|Overall Study|Sponsor Decision|12|||
16931356|NCT01307800|38075181|FG003|Overall Study|Sponsor Decision|28|||
16931357|NCT01307800|38075178|FG000|Overall Study|Withdrawal by Subject|10|||
16931358|NCT01307800|38075179|FG001|Overall Study|Withdrawal by Subject|11|||
16931359|NCT01307800|38075180|FG002|Overall Study|Withdrawal by Subject|8|||
16931360|NCT01307800|38075181|FG003|Overall Study|Withdrawal by Subject|15|||
16931361|NCT01307800|38075178|FG000|Overall Study|Participant Moved|0|||
16931362|NCT01307800|38075179|FG001|Overall Study|Participant Moved|2|||
16931363|NCT01307800|38075180|FG002|Overall Study|Participant Moved|1|||
16931364|NCT01307800|38075181|FG003|Overall Study|Participant Moved|3|||
16931365|NCT01307449|38075195|FG000|Overall Study|Adverse Event|1|||
16931366|NCT01307449|38075196|FG001|Overall Study|Adverse Event|0|||
16931367|NCT01307449|38075197|FG002|Overall Study|Adverse Event|0|||
16931368|NCT01307449|38075198|FG003|Overall Study|Adverse Event|0|||
16931369|NCT01307020|38075218|FG000|Overall Study|Lost to Follow-up|0|||
16931370|NCT01307020|38075219|FG001|Overall Study|Lost to Follow-up|0|||
16931371|NCT01307020|38075220|FG002|Overall Study|Lost to Follow-up|1|||
17019009|NCT00865124|38163592|FG002|Overall Study|Physician Decision|0|||
17019010|NCT00865124|38163590|FG000|Overall Study|Withdrawn consent|2|||
17019011|NCT00865124|38163591|FG001|Overall Study|Withdrawn consent|0|||
17019012|NCT00865124|38163592|FG002|Overall Study|Withdrawn consent|0|||
17019013|NCT00871715|38163603|FG000|Overall Study|Withdrawal by Subject|6|||
17019014|NCT00871715|38163604|FG001|Overall Study|Withdrawal by Subject|10|||
17019015|NCT00871715|38163605|FG002|Overall Study|Withdrawal by Subject|15|||
17019016|NCT00871715|38163603|FG000|Overall Study|Physician Decision|6|||
17019017|NCT00871715|38163604|FG001|Overall Study|Physician Decision|0|||
17019018|NCT00871715|38163605|FG002|Overall Study|Physician Decision|2|||
17019019|NCT00871715|38163603|FG000|Overall Study|Lost to Follow-up|3|||
17019020|NCT00871715|38163604|FG001|Overall Study|Lost to Follow-up|6|||
17019021|NCT00871715|38163605|FG002|Overall Study|Lost to Follow-up|9|||
17019022|NCT00819234|38163614|FG000|Overall Study|Withdrawal by Subject|8|||
17019023|NCT00819234|38163615|FG001|Overall Study|Withdrawal by Subject|13|||
16931372|NCT01307020|38075221|FG003|Overall Study|Lost to Follow-up|1|||
16931373|NCT01307020|38075222|FG004|Overall Study|Lost to Follow-up|0|||
16931374|NCT01307020|38075223|FG005|Overall Study|Lost to Follow-up|0|||
16931375|NCT01307020|38075224|FG006|Overall Study|Lost to Follow-up|1|||
16931376|NCT01307020|38075225|FG007|Overall Study|Lost to Follow-up|0|||
16852197|NCT01422213|37802211|FG002|Overall Study|Adverse Event|11|||
16852198|NCT01422213|37802209|FG000|Overall Study|Lack of Efficacy|10|||
16852199|NCT01422213|37802210|FG001|Overall Study|Lack of Efficacy|2|||
16852200|NCT01422213|37802211|FG002|Overall Study|Lack of Efficacy|2|||
16852201|NCT01422213|37802209|FG000|Overall Study|Non-compliance with study drug|0|||
16852202|NCT01422213|37802210|FG001|Overall Study|Non-compliance with study drug|1|||
16852203|NCT01422213|37802211|FG002|Overall Study|Non-compliance with study drug|0|||
16852204|NCT01422213|37802209|FG000|Overall Study|Protocol Violation|0|||
16852205|NCT01422213|37802210|FG001|Overall Study|Protocol Violation|2|||
17019024|NCT00819234|38163616|FG002|Overall Study|Withdrawal by Subject|6|||
17019025|NCT00819234|38163617|FG003|Overall Study|Withdrawal by Subject|3|||
16852206|NCT01422213|37802211|FG002|Overall Study|Protocol Violation|4|||
16852207|NCT01422213|37802209|FG000|Overall Study|Withdrawal of Consent|7|||
16931377|NCT01307020|38075226|FG008|Overall Study|Lost to Follow-up|0|||
16931378|NCT01307020|38075227|FG009|Overall Study|Lost to Follow-up|0|||
16931379|NCT01307020|38075218|FG000|Overall Study|Electronic data capture failure|0|||
16931380|NCT01307020|38075219|FG001|Overall Study|Electronic data capture failure|1|||
16931381|NCT01307020|38075220|FG002|Overall Study|Electronic data capture failure|0|||
16931382|NCT01307020|38075221|FG003|Overall Study|Electronic data capture failure|0|||
16931383|NCT01307020|38075222|FG004|Overall Study|Electronic data capture failure|0|||
16931384|NCT01307020|38075223|FG005|Overall Study|Electronic data capture failure|0|||
16931385|NCT01307020|38075224|FG006|Overall Study|Electronic data capture failure|0|||
16931386|NCT01307020|38075225|FG007|Overall Study|Electronic data capture failure|0|||
16931387|NCT01307020|38075226|FG008|Overall Study|Electronic data capture failure|0|||
16931388|NCT01307020|38075227|FG009|Overall Study|Electronic data capture failure|0|||
16852208|NCT01422213|37802210|FG001|Overall Study|Withdrawal of Consent|3|||
16852209|NCT01422213|37802211|FG002|Overall Study|Withdrawal of Consent|5|||
16852210|NCT01422213|37802209|FG000|Overall Study|Lost to Follow-up|3|||
16852211|NCT01422213|37802210|FG001|Overall Study|Lost to Follow-up|3|||
16852212|NCT01422213|37802211|FG002|Overall Study|Lost to Follow-up|5|||
16852213|NCT01422213|37802209|FG000|Overall Study|Administrative or Other Reason(s)|5|||
16852214|NCT01422213|37802210|FG001|Overall Study|Administrative or Other Reason(s)|4|||
16852215|NCT01422213|37802211|FG002|Overall Study|Administrative or Other Reason(s)|2|||
16852216|NCT01390857|37802219|FG000|Overall Study|Protocol Violation|2|||
16852217|NCT01390857|37802219|FG000|Overall Study|Lost to Follow-up|1|||
16852218|NCT01390857|37802219|FG000|Overall Study|No Visit after the First Visit|7|||
16852219|NCT01725386|37802225|FG000|Overall Study|Death|84|||
16852220|NCT01725386|37802226|FG001|Overall Study|Death|40|||
16931421|NCT01306201|38075267|FG000|Overall Study|Arrhythmia|4|||
16931422|NCT01306201|38075267|FG000|Overall Study|Files could not be processed|3|||
16931423|NCT01306201|38075267|FG000|Overall Study|Files unreadable|3|||
16931424|NCT01306162|38075279|FG000|Period 1|Adverse Event|0|||
16931425|NCT01306162|38075280|FG001|Period 1|Adverse Event|0|||
16931426|NCT01306162|38075281|FG002|Period 1|Adverse Event|0|||
16931427|NCT01306162|38075282|FG003|Period 1|Adverse Event|1|||
16931428|NCT01306162|38075279|FG000|Washout 1|Non-compliance to protocol|0|||
16931429|NCT01306162|38075280|FG001|Washout 1|Non-compliance to protocol|1|||
16931430|NCT01306162|38075281|FG002|Washout 1|Non-compliance to protocol|0|||
16931431|NCT01306162|38075282|FG003|Washout 1|Non-compliance to protocol|0|||
16931432|NCT01305577|38075298|FG000|Overall Study|Adverse Event|2|||
16931433|NCT01305577|38075299|FG001|Overall Study|Adverse Event|2|||
16931434|NCT01305577|38075300|FG002|Overall Study|Adverse Event|1|||
16931435|NCT01305577|38075298|FG000|Overall Study|Withdrawal by Subject|7|||
16931436|NCT01305577|38075299|FG001|Overall Study|Withdrawal by Subject|5|||
16931437|NCT01305577|38075300|FG002|Overall Study|Withdrawal by Subject|6|||
16931438|NCT01305577|38075298|FG000|Overall Study|Lost to Follow-up|4|||
16931439|NCT01305577|38075299|FG001|Overall Study|Lost to Follow-up|3|||
16931440|NCT01305577|38075300|FG002|Overall Study|Lost to Follow-up|2|||
16931441|NCT01305577|38075298|FG000|Overall Study|Protocol Deviation|0|||
16931442|NCT01305577|38075299|FG001|Overall Study|Protocol Deviation|1|||
16931443|NCT01305577|38075300|FG002|Overall Study|Protocol Deviation|1|||
16931444|NCT01304329|38075308|FG000|Third Intervention (3 Days)|Adverse Event|0|||
16931445|NCT01304329|38075309|FG001|Third Intervention (3 Days)|Adverse Event|1|||
16931446|NCT01304329|38075310|FG002|Third Intervention (3 Days)|Adverse Event|0|||
16931447|NCT01304329|38075311|FG003|Third Intervention (3 Days)|Adverse Event|0|||
16931448|NCT01304329|38075312|FG004|Third Intervention (3 Days)|Adverse Event|0|||
16931449|NCT01304329|38075313|FG005|Third Intervention (3 Days)|Adverse Event|0|||
16931450|NCT01303861|38075326|FG000|Overall Study|Lost to Follow-up|34|||
16931451|NCT01303861|38075327|FG001|Overall Study|Lost to Follow-up|14|||
16931452|NCT01303861|38075328|FG002|Overall Study|Lost to Follow-up|27|||
16931453|NCT01303861|38075329|FG003|Overall Study|Lost to Follow-up|31|||
16931454|NCT01303861|38075326|FG000|Overall Study|Lack of Efficacy|3|||
16931455|NCT01303861|38075327|FG001|Overall Study|Lack of Efficacy|2|||
16931456|NCT01303861|38075328|FG002|Overall Study|Lack of Efficacy|1|||
16931457|NCT01303861|38075329|FG003|Overall Study|Lack of Efficacy|0|||
16931458|NCT01303861|38075326|FG000|Overall Study|Withdrawal by Subject|16|||
16931459|NCT01303861|38075327|FG001|Overall Study|Withdrawal by Subject|8|||
16931460|NCT01303861|38075328|FG002|Overall Study|Withdrawal by Subject|8|||
16931461|NCT01303861|38075329|FG003|Overall Study|Withdrawal by Subject|23|||
16931462|NCT01303861|38075326|FG000|Overall Study|Adverse Event|4|||
16931463|NCT01303861|38075327|FG001|Overall Study|Adverse Event|1|||
16931464|NCT01303861|38075328|FG002|Overall Study|Adverse Event|0|||
16931465|NCT01303861|38075329|FG003|Overall Study|Adverse Event|5|||
16931466|NCT01303861|38075326|FG000|Overall Study|Pregnancy|1|||
16931467|NCT01303861|38075327|FG001|Overall Study|Pregnancy|0|||
16931468|NCT01303861|38075328|FG002|Overall Study|Pregnancy|0|||
16931469|NCT01303861|38075329|FG003|Overall Study|Pregnancy|0|||
16931470|NCT01303627|38075342|FG000|Overall Study|the failure while performing URS|0|||
16931471|NCT01303627|38075343|FG001|Overall Study|the failure while performing URS|1|||
16931472|NCT01303510|38075351|FG000|Overall Study|Lost to Follow-up|1|||
16931473|NCT01303510|38075352|FG001|Overall Study|Lost to Follow-up|0|||
16852221|NCT01725386|37802225|FG000|Overall Study|Lost to Follow-up|81|||
16852222|NCT01725386|37802226|FG001|Overall Study|Lost to Follow-up|6|||
16852223|NCT01725386|37802225|FG000|Overall Study|Withdrawal by Subject|10|||
16852224|NCT01725386|37802226|FG001|Overall Study|Withdrawal by Subject|0|||
16852225|NCT01402011|37802235|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
16852226|NCT01402011|37802236|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
16852227|NCT01402011|37802237|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
16852228|NCT01402011|37802235|FG000|Active Treatment Period|Withdrawal by Subject|1|||
16931474|NCT01303159|38075358|FG000|Overall Study|Death|16|||
16931475|NCT01303159|38075358|FG000|Overall Study|Study Termination|7|||
16931476|NCT01302964|38075364|FG000|Overall Study|Adverse Event|1|||
16931477|NCT01302964|38075365|FG001|Overall Study|Adverse Event|0|||
16931478|NCT01302691|38075373|FG000|Overall Study|Adverse Event|2|||
16931479|NCT01302691|38075374|FG001|Overall Study|Adverse Event|0|||
16931480|NCT01302691|38075373|FG000|Overall Study|Death|0|||
16931481|NCT01302691|38075374|FG001|Overall Study|Death|1|||
16931482|NCT01302691|38075373|FG000|Overall Study|Lost to Follow-up|1|||
16931483|NCT01302691|38075374|FG001|Overall Study|Lost to Follow-up|0|||
16931484|NCT01302691|38075373|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
16931485|NCT01302691|38075374|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
16931486|NCT01302691|38075373|FG000|Overall Study|Physician Decision|0|||
16931487|NCT01302691|38075374|FG001|Overall Study|Physician Decision|1|||
16931488|NCT01302691|38075373|FG000|Overall Study|Protocol Violation|1|||
16931489|NCT01302691|38075374|FG001|Overall Study|Protocol Violation|0|||
16931490|NCT01302418|38075380|FG000|Overall Study|Protocol Violation|9|||
16931491|NCT01302418|38075380|FG000|Overall Study|Non-evaluable|9|||
16931492|NCT01302067|38075387|FG000|Overall Study|Death|0|||
16931493|NCT01302067|38075388|FG001|Overall Study|Death|0|||
16931494|NCT01302067|38075389|FG002|Overall Study|Death|1|||
16931495|NCT01302067|38075387|FG000|Overall Study|Physician Decision|9|||
16931496|NCT01302067|38075388|FG001|Overall Study|Physician Decision|5|||
16931497|NCT01302067|38075389|FG002|Overall Study|Physician Decision|14|||
16852229|NCT01402011|37802236|FG001|Active Treatment Period|Withdrawal by Subject|3|||
16852230|NCT01402011|37802237|FG002|Active Treatment Period|Withdrawal by Subject|0|||
16852231|NCT01402011|37802235|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
16852232|NCT01402011|37802236|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
16852233|NCT01402011|37802237|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
16852234|NCT01421667|37802252|FG000|Overall Study|Withdrawal by Subject|0|||
16852235|NCT01421667|37802253|FG001|Overall Study|Withdrawal by Subject|1|||
16852236|NCT01421667|37802254|FG002|Overall Study|Withdrawal by Subject|2|||
16852237|NCT01421667|37802255|FG003|Overall Study|Withdrawal by Subject|1|||
16852238|NCT01421667|37802252|FG000|Overall Study|Lost to Follow-up|0|||
16852239|NCT01421667|37802253|FG001|Overall Study|Lost to Follow-up|1|||
16931498|NCT01302067|38075387|FG000|Overall Study|Lack of Efficacy|8|||
16931499|NCT01302067|38075388|FG001|Overall Study|Lack of Efficacy|4|||
16931500|NCT01302067|38075389|FG002|Overall Study|Lack of Efficacy|2|||
16931501|NCT01302067|38075387|FG000|Overall Study|Lost to Follow-up|9|||
16931502|NCT01302067|38075388|FG001|Overall Study|Lost to Follow-up|4|||
16852240|NCT01421667|37802254|FG002|Overall Study|Lost to Follow-up|0|||
16931503|NCT01302067|38075389|FG002|Overall Study|Lost to Follow-up|15|||
16931504|NCT01302067|38075387|FG000|Overall Study|Withdrawal by Subject|13|||
16931505|NCT01302067|38075388|FG001|Overall Study|Withdrawal by Subject|6|||
16931506|NCT01302067|38075389|FG002|Overall Study|Withdrawal by Subject|10|||
16931507|NCT01302067|38075387|FG000|Overall Study|Other|1|||
16931508|NCT01302067|38075388|FG001|Overall Study|Other|1|||
16931509|NCT01302067|38075389|FG002|Overall Study|Other|3|||
16931510|NCT01302067|38075387|FG000|Overall Study|Protocol Violation|11|||
16931511|NCT01302067|38075388|FG001|Overall Study|Protocol Violation|0|||
16931512|NCT01302067|38075389|FG002|Overall Study|Protocol Violation|8|||
16931513|NCT01302067|38075387|FG000|Overall Study|Adverse Event|27|||
16931514|NCT01302067|38075388|FG001|Overall Study|Adverse Event|14|||
16931515|NCT01302067|38075389|FG002|Overall Study|Adverse Event|45|||
16931516|NCT01301950|38075399|FG000|Overall Study|Surgery was cancelled by patient|0|||
16931517|NCT01301950|38075400|FG001|Overall Study|Surgery was cancelled by patient|1|||
16931518|NCT01301833|38075410|FG000|Overall Study|Adverse Event|7|||
16931519|NCT01301833|38075411|FG001|Overall Study|Adverse Event|5|||
16931520|NCT01301833|38075412|FG002|Overall Study|Adverse Event|5|||
16931521|NCT01301833|38075413|FG003|Overall Study|Adverse Event|5|||
16931522|NCT01301833|38075410|FG000|Overall Study|Lack of Efficacy|1|||
16931523|NCT01301833|38075411|FG001|Overall Study|Lack of Efficacy|1|||
16931524|NCT01301833|38075412|FG002|Overall Study|Lack of Efficacy|0|||
16931525|NCT01301833|38075413|FG003|Overall Study|Lack of Efficacy|0|||
16931526|NCT01301833|38075410|FG000|Overall Study|Physician Decision|3|||
16931527|NCT01301833|38075411|FG001|Overall Study|Physician Decision|1|||
16931528|NCT01301833|38075412|FG002|Overall Study|Physician Decision|1|||
16931529|NCT01301833|38075413|FG003|Overall Study|Physician Decision|0|||
16931530|NCT01301833|38075410|FG000|Overall Study|Withdrawal by Subject|3|||
16931531|NCT01301833|38075411|FG001|Overall Study|Withdrawal by Subject|1|||
16931532|NCT01301833|38075412|FG002|Overall Study|Withdrawal by Subject|1|||
16931533|NCT01301833|38075413|FG003|Overall Study|Withdrawal by Subject|2|||
16931534|NCT01301833|38075410|FG000|Overall Study|Personal matter|1|||
16931535|NCT01301833|38075411|FG001|Overall Study|Personal matter|0|||
16931536|NCT01301833|38075412|FG002|Overall Study|Personal matter|0|||
16931537|NCT01301833|38075413|FG003|Overall Study|Personal matter|0|||
16931538|NCT01301092|38075426|FG000|Overall Study|Lost to Follow-up|0|||
16931539|NCT01301092|38075427|FG001|Overall Study|Lost to Follow-up|0|||
16931540|NCT01301092|38075428|FG002|Overall Study|Lost to Follow-up|1|||
16931541|NCT01300819|38075443|FG000|Overall Study|Adverse Event|9|||
16931542|NCT01300819|38075444|FG001|Overall Study|Adverse Event|27|||
16931543|NCT01300819|38075443|FG000|Overall Study|Lack of Efficacy|2|||
16931544|NCT01300819|38075444|FG001|Overall Study|Lack of Efficacy|1|||
16931545|NCT01300819|38075443|FG000|Overall Study|Withdrawal by Subject|10|||
16931546|NCT01300819|38075444|FG001|Overall Study|Withdrawal by Subject|12|||
16931547|NCT01300819|38075443|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
16931548|NCT01300819|38075444|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
16931549|NCT01300819|38075443|FG000|Overall Study|Refusal to down titrate study drug|0|||
16931550|NCT01300819|38075444|FG001|Overall Study|Refusal to down titrate study drug|1|||
16931551|NCT01300819|38075443|FG000|Overall Study|Administrative reason|0|||
16931552|NCT01300819|38075444|FG001|Overall Study|Administrative reason|1|||
16931553|NCT01300819|38075443|FG000|Overall Study|Safety follow up not done by mistake|0|||
16931554|NCT01300819|38075444|FG001|Overall Study|Safety follow up not done by mistake|1|||
16931555|NCT01300819|38075443|FG000|Overall Study|Follow up call was not done|1|||
16852241|NCT01421667|37802255|FG003|Overall Study|Lost to Follow-up|0|||
16852242|NCT01390779|37802273|FG000|Overall Study|Physician Decision|1|||
16852243|NCT01891669|37802287|FG000|Overall Study|Death|0|||
16852244|NCT01891669|37802288|FG001|Overall Study|Death|0|||
16852245|NCT01891669|37802289|FG002|Overall Study|Death|0|||
16852246|NCT01891669|37802290|FG003|Overall Study|Death|0|||
16931556|NCT01300819|38075444|FG001|Overall Study|Follow up call was not done|0|||
16931557|NCT01300741|38075450|FG000|Overall Study|Lens deposits|1|||
16931558|NCT01300741|38075450|FG000|Overall Study|Lost to Follow-up|1|||
16931559|NCT01300741|38075450|FG000|Overall Study|Discomfort|1|||
16931560|NCT01300546|38075458|FG000|Overall Study|Withdrawal by Subject|1|||
16931561|NCT01300546|38075459|FG001|Overall Study|Withdrawal by Subject|0|||
16852247|NCT01891669|37802291|FG004|Overall Study|Death|0|||
16852248|NCT01891669|37802292|FG005|Overall Study|Death|0|||
16852249|NCT01891669|37802293|FG006|Overall Study|Death|0|||
16852250|NCT01891669|37802294|FG007|Overall Study|Death|1|||
16852251|NCT01891669|37802295|FG008|Overall Study|Death|0|||
16852252|NCT01891669|37802296|FG009|Overall Study|Death|1|||
16931562|NCT01300546|38075458|FG000|Overall Study|Lost to Follow-up|0|||
16931563|NCT01300546|38075459|FG001|Overall Study|Lost to Follow-up|2|||
16931564|NCT01300546|38075458|FG000|Overall Study|Lack of Efficacy|0|||
16931565|NCT01300546|38075459|FG001|Overall Study|Lack of Efficacy|3|||
16931566|NCT01300546|38075458|FG000|Overall Study|Adverse Event|0|||
16931567|NCT01300546|38075459|FG001|Overall Study|Adverse Event|1|||
16931568|NCT01300351|38075467|FG000|Overall Study|Did not receive treatment|2|||
16931569|NCT01300351|38075468|FG001|Overall Study|Did not receive treatment|0|||
16931570|NCT01300351|38075467|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
16931571|NCT01300351|38075468|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
16931572|NCT01300351|38075467|FG000|Overall Study|Lost to Follow-up|0|||
16931573|NCT01300351|38075468|FG001|Overall Study|Lost to Follow-up|1|||
16931574|NCT01300351|38075467|FG000|Overall Study|Adverse Event|0|||
16931575|NCT01300351|38075468|FG001|Overall Study|Adverse Event|4|||
16931576|NCT01300351|38075467|FG000|Overall Study|Withdrawal by Subject|7|||
16931577|NCT01300351|38075468|FG001|Overall Study|Withdrawal by Subject|10|||
16931578|NCT01300234|38075476|FG000|Overall Study|Adverse Event|1|||
16931579|NCT01300234|38075477|FG001|Overall Study|Adverse Event|1|||
16931580|NCT01300234|38075476|FG000|Overall Study|Protocol Violation|2|||
16931581|NCT01300234|38075477|FG001|Overall Study|Protocol Violation|3|||
16931582|NCT01300234|38075476|FG000|Overall Study|Withdrawal by Subject|5|||
16931583|NCT01300234|38075477|FG001|Overall Study|Withdrawal by Subject|9|||
16931584|NCT01300234|38075476|FG000|Overall Study|Lost to Follow-up|14|||
16931585|NCT01300234|38075477|FG001|Overall Study|Lost to Follow-up|12|||
16931586|NCT01300234|38075476|FG000|Overall Study|Pregnancy|2|||
16931587|NCT01300234|38075477|FG001|Overall Study|Pregnancy|1|||
16931588|NCT01300234|38075476|FG000|Overall Study|Participant reached stopping critera|2|||
16931589|NCT01300234|38075477|FG001|Overall Study|Participant reached stopping critera|0|||
16931590|NCT01300234|38075476|FG000|Overall Study|Participant stopped medication|1|||
16931591|NCT01300234|38075477|FG001|Overall Study|Participant stopped medication|1|||
16931592|NCT01300234|38075476|FG000|Overall Study|Participant refused return to hospital|1|||
16931593|NCT01300234|38075477|FG001|Overall Study|Participant refused return to hospital|0|||
16931594|NCT01299961|38075494|FG000|Overall Study|Adverse Event|3|||
16931595|NCT01299961|38075494|FG000|Overall Study|Lack of Efficacy|2|||
16931596|NCT01299961|38075494|FG000|Overall Study|Lost to Follow-up|1|||
16931597|NCT01299805|38075500|FG000|Overall Study|Adverse Event|2|||
16931598|NCT01299805|38075501|FG001|Overall Study|Adverse Event|0|||
16931599|NCT01299766|38075509|FG000|Overall Study|Death|5|||
16931600|NCT01299766|38075510|FG001|Overall Study|Death|4|||
16931601|NCT01299766|38075509|FG000|Overall Study|Withdrawal by Subject|29|||
16931602|NCT01299766|38075510|FG001|Overall Study|Withdrawal by Subject|19|||
16931603|NCT01299727|38075519|FG000|Overall Study|Withdrawal by Subject|1|||
16931604|NCT01299727|38075520|FG001|Overall Study|Withdrawal by Subject|0|||
16931605|NCT01299727|38075521|FG002|Overall Study|Withdrawal by Subject|0|||
16931606|NCT01299727|38075519|FG000|Overall Study|Adverse Event|0|||
16931607|NCT01299727|38075520|FG001|Overall Study|Adverse Event|0|||
16931608|NCT01299727|38075521|FG002|Overall Study|Adverse Event|1|||
16931609|NCT01299727|38075519|FG000|Overall Study|Completed the Treatment Period|3|||
16931610|NCT01299727|38075520|FG001|Overall Study|Completed the Treatment Period|4|||
16931611|NCT01299727|38075521|FG002|Overall Study|Completed the Treatment Period|3|||
16931612|NCT01299571|38075529|FG000|Overall Study|Protocol Violation|107|||
16931613|NCT01299376|38075536|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
16931614|NCT01299376|38075537|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
16931615|NCT01299376|38075536|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
16931616|NCT01299376|38075537|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
16931617|NCT01299376|38075536|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
16931618|NCT01299376|38075537|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
16931619|NCT01299376|38075536|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
16931620|NCT01299376|38075537|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
16931621|NCT01299376|38075536|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
16931622|NCT01299376|38075537|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
16931623|NCT01299376|38075536|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
16931624|NCT01299376|38075537|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
16931625|NCT01299376|38075536|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
16931626|NCT01299376|38075537|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
16931627|NCT01299376|38075536|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
16931628|NCT01299376|38075537|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
16931629|NCT01299376|38075536|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
17019026|NCT00819234|38163618|FG004|Overall Study|Withdrawal by Subject|0|||
17019027|NCT00819234|38163619|FG005|Overall Study|Withdrawal by Subject|4|||
17019028|NCT00819234|38163620|FG006|Overall Study|Withdrawal by Subject|4|||
17019029|NCT00819234|38163621|FG007|Overall Study|Withdrawal by Subject|8|||
17019030|NCT00819234|38163622|FG008|Overall Study|Withdrawal by Subject|5|||
17019031|NCT00819234|38163623|FG009|Overall Study|Withdrawal by Subject|3|||
17019032|NCT00819234|38163614|FG000|Overall Study|Adverse Event|0|||
16931630|NCT01299376|38075537|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
16931631|NCT01299376|38075536|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
16931632|NCT01299376|38075537|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
16931633|NCT01299376|38075536|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
17019033|NCT00819234|38163615|FG001|Overall Study|Adverse Event|0|||
16931634|NCT01299376|38075537|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
16931635|NCT01299025|38075549|FG000|Overall Study|Withdrawal by Subject|2|||
16931636|NCT01299025|38075550|FG001|Overall Study|Withdrawal by Subject|1|||
16931637|NCT01299025|38075549|FG000|Overall Study|Lost to Follow-up|1|||
16931638|NCT01299025|38075550|FG001|Overall Study|Lost to Follow-up|0|||
16931639|NCT01298596|38075558|FG000|Overall Study|Withdrawal by Subject|1|||
16931640|NCT01298596|38075559|FG001|Overall Study|Withdrawal by Subject|1|||
16931641|NCT01298596|38075558|FG000|Overall Study|Death|5|||
16931642|NCT01298596|38075559|FG001|Overall Study|Death|3|||
16931643|NCT01298596|38075558|FG000|Overall Study|Lost to Follow-up|6|||
17019034|NCT00819234|38163616|FG002|Overall Study|Adverse Event|1|||
17019035|NCT00819234|38163617|FG003|Overall Study|Adverse Event|0|||
17019036|NCT00819234|38163618|FG004|Overall Study|Adverse Event|0|||
17019037|NCT00819234|38163619|FG005|Overall Study|Adverse Event|2|||
17019038|NCT00819234|38163620|FG006|Overall Study|Adverse Event|0|||
17019039|NCT00819234|38163621|FG007|Overall Study|Adverse Event|0|||
17019040|NCT00819234|38163622|FG008|Overall Study|Adverse Event|0|||
17019041|NCT00819234|38163623|FG009|Overall Study|Adverse Event|0|||
17019042|NCT00819234|38163614|FG000|Overall Study|Physician Decision|0|||
17019043|NCT00819234|38163615|FG001|Overall Study|Physician Decision|0|||
17019044|NCT00819234|38163616|FG002|Overall Study|Physician Decision|0|||
17019045|NCT00819234|38163617|FG003|Overall Study|Physician Decision|1|||
17019046|NCT00819234|38163618|FG004|Overall Study|Physician Decision|0|||
17019047|NCT00819234|38163619|FG005|Overall Study|Physician Decision|0|||
17019048|NCT00819234|38163620|FG006|Overall Study|Physician Decision|0|||
17019049|NCT00819234|38163621|FG007|Overall Study|Physician Decision|0|||
17019050|NCT00819234|38163622|FG008|Overall Study|Physician Decision|0|||
17019051|NCT00819234|38163623|FG009|Overall Study|Physician Decision|2|||
17019052|NCT00819234|38163614|FG000|Overall Study|Protocol Violation|0|||
17019053|NCT00819234|38163615|FG001|Overall Study|Protocol Violation|0|||
17019054|NCT00819234|38163616|FG002|Overall Study|Protocol Violation|1|||
17019055|NCT00819234|38163617|FG003|Overall Study|Protocol Violation|0|||
17019056|NCT00819234|38163618|FG004|Overall Study|Protocol Violation|0|||
17019057|NCT00819234|38163619|FG005|Overall Study|Protocol Violation|0|||
17019058|NCT00819234|38163620|FG006|Overall Study|Protocol Violation|0|||
17019059|NCT00819234|38163621|FG007|Overall Study|Protocol Violation|0|||
17019060|NCT00819234|38163622|FG008|Overall Study|Protocol Violation|0|||
17019061|NCT00819234|38163623|FG009|Overall Study|Protocol Violation|0|||
17019062|NCT00819234|38163614|FG000|Overall Study|Lost to Follow-up|2|||
17019063|NCT00819234|38163615|FG001|Overall Study|Lost to Follow-up|2|||
17019064|NCT00819234|38163616|FG002|Overall Study|Lost to Follow-up|0|||
17019065|NCT00819234|38163617|FG003|Overall Study|Lost to Follow-up|2|||
17019066|NCT00819234|38163618|FG004|Overall Study|Lost to Follow-up|1|||
17019067|NCT00819234|38163619|FG005|Overall Study|Lost to Follow-up|1|||
17019068|NCT00819234|38163620|FG006|Overall Study|Lost to Follow-up|1|||
17019069|NCT00819234|38163621|FG007|Overall Study|Lost to Follow-up|1|||
17019070|NCT00819234|38163622|FG008|Overall Study|Lost to Follow-up|1|||
17019071|NCT00819234|38163623|FG009|Overall Study|Lost to Follow-up|2|||
17019072|NCT00667342|38163681|FG000|Overall Study|Protocol Violation|1|||
17019073|NCT00667342|38163682|FG001|Overall Study|Protocol Violation|0|||
17019074|NCT00667342|38163683|FG002|Overall Study|Protocol Violation|0|||
17019075|NCT00667342|38163681|FG000|Overall Study|Withdrawal by Subject|1|||
17019076|NCT00667342|38163682|FG001|Overall Study|Withdrawal by Subject|0|||
17019077|NCT00667342|38163683|FG002|Overall Study|Withdrawal by Subject|0|||
17019078|NCT00667342|38163681|FG000|Overall Study|Physician Decision|3|||
17019079|NCT00667342|38163682|FG001|Overall Study|Physician Decision|0|||
17102636|NCT00112437|38241462|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102637|NCT00112437|38241463|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17019080|NCT00667342|38163683|FG002|Overall Study|Physician Decision|0|||
17019081|NCT00667342|38163681|FG000|Overall Study|Relapse or tumor progression|9|||
17019082|NCT00667342|38163682|FG001|Overall Study|Relapse or tumor progression|0|||
17019083|NCT00667342|38163683|FG002|Overall Study|Relapse or tumor progression|7|||
17019084|NCT00667342|38163681|FG000|Overall Study|Adverse Event|0|||
17019085|NCT00667342|38163682|FG001|Overall Study|Adverse Event|0|||
17019086|NCT00667342|38163683|FG002|Overall Study|Adverse Event|1|||
17019087|NCT00667342|38163681|FG000|Overall Study|Ineligible|0|||
17019088|NCT00667342|38163682|FG001|Overall Study|Ineligible|0|||
17019089|NCT00667342|38163683|FG002|Overall Study|Ineligible|1|||
17019090|NCT00871403|38163700|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
17019091|NCT00871403|38163701|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
17019092|NCT00871403|38163702|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
17102638|NCT00112437|38241464|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102639|NCT00112437|38241465|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102640|NCT00112437|38241466|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
17102641|NCT00112437|38241441|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
17102642|NCT00112437|38241442|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
16931644|NCT01298596|38075559|FG001|Overall Study|Lost to Follow-up|14|||
16931645|NCT01298596|38075558|FG000|Overall Study|Referred for further management|16|||
16931646|NCT01298596|38075559|FG001|Overall Study|Referred for further management|15|||
16931647|NCT01298518|38075568|FG000|Overall Study|Withdrawal by Subject|0|||
16931648|NCT01298518|38075569|FG001|Overall Study|Withdrawal by Subject|0|||
16931649|NCT01298518|38075570|FG002|Overall Study|Withdrawal by Subject|1|||
16931650|NCT01298362|38075580|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
16931651|NCT01298362|38075581|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
16931652|NCT01298323|38075591|FG000|Overall Study|Adverse Event|2|||
16931653|NCT01298323|38075592|FG001|Overall Study|Adverse Event|4|||
16931654|NCT01298323|38075591|FG000|Overall Study|Death|11|||
16931655|NCT01298323|38075592|FG001|Overall Study|Death|16|||
16931656|NCT01298323|38075591|FG000|Overall Study|Lost to Follow-up|1|||
16931657|NCT01298323|38075592|FG001|Overall Study|Lost to Follow-up|0|||
16931658|NCT01298323|38075591|FG000|Overall Study|Withdrawal by Subject|6|||
16931659|NCT01298323|38075592|FG001|Overall Study|Withdrawal by Subject|3|||
16931660|NCT01298323|38075591|FG000|Overall Study|Protocol Violation|1|||
16931661|NCT01298323|38075592|FG001|Overall Study|Protocol Violation|0|||
16931662|NCT01298323|38075591|FG000|Overall Study|Other|10|||
16931663|NCT01298323|38075592|FG001|Overall Study|Other|9|||
16931664|NCT01298323|38075591|FG000|Overall Study|Ongoing|55|||
17019093|NCT00871403|38163700|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
17019094|NCT00871403|38163701|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
17019095|NCT00871403|38163702|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
17019096|NCT00871403|38163700|FG000|Combination Treatment Phase|Adverse Event|0|||
17019097|NCT00871403|38163701|FG001|Combination Treatment Phase|Adverse Event|17|||
17019098|NCT00871403|38163702|FG002|Combination Treatment Phase|Adverse Event|2|||
17019099|NCT00871403|38163700|FG000|Combination Treatment Phase|Disease Progression|0|||
17019100|NCT00871403|38163701|FG001|Combination Treatment Phase|Disease Progression|8|||
17019101|NCT00871403|38163702|FG002|Combination Treatment Phase|Disease Progression|5|||
17019102|NCT00871403|38163700|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
17019103|NCT00871403|38163701|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
17019104|NCT00871403|38163702|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
17019105|NCT00871403|38163700|FG000|Combination Treatment Phase|Physician Decision|0|||
17019106|NCT00871403|38163701|FG001|Combination Treatment Phase|Physician Decision|1|||
17019107|NCT00871403|38163702|FG002|Combination Treatment Phase|Physician Decision|3|||
17019108|NCT00871403|38163700|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
17019109|NCT00871403|38163701|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
17019110|NCT00871403|38163702|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
17019111|NCT00871403|38163700|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
17019112|NCT00871403|38163701|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
17019113|NCT00871403|38163702|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
17019114|NCT00853112|38163716|FG000|Overall Study|Randomized but not treated|0|||
17019115|NCT00853112|38163717|FG001|Overall Study|Randomized but not treated|1|||
17019116|NCT00853112|38163718|FG002|Overall Study|Randomized but not treated|0|||
17019117|NCT00853112|38163719|FG003|Overall Study|Randomized but not treated|2|||
17019118|NCT00853112|38163720|FG004|Overall Study|Randomized but not treated|0|||
17019119|NCT00853112|38163721|FG005|Overall Study|Randomized but not treated|0|||
17019120|NCT00853112|38163722|FG006|Overall Study|Randomized but not treated|1|||
17019121|NCT00460603|38163750|FG000|Phase 1|Death|1|||
17019122|NCT00460603|38163751|FG001|Phase 1|Death|0|||
17019123|NCT00460603|38163752|FG002|Phase 1|Death|0|||
17019124|NCT00460603|38163753|FG003|Phase 1|Death|2|||
17019125|NCT00460603|38163754|FG004|Phase 1|Death|0|||
17019126|NCT00460603|38163755|FG005|Phase 1|Death|0|||
17019127|NCT00460603|38163756|FG006|Phase 1|Death|0|||
17019128|NCT00460603|38163757|FG007|Phase 1|Death|0|||
17019129|NCT00460603|38163758|FG008|Phase 1|Death|1|||
17019130|NCT00460603|38163759|FG009|Phase 1|Death|0|||
17019131|NCT00460603|38163760|FG010|Phase 1|Death|0|||
17019132|NCT00460603|38163761|FG011|Phase 1|Death|0|||
17019133|NCT00460603|38163750|FG000|Phase 1|Adverse Event|3|||
17019134|NCT00460603|38163751|FG001|Phase 1|Adverse Event|1|||
17019135|NCT00460603|38163752|FG002|Phase 1|Adverse Event|1|||
17019136|NCT00460603|38163753|FG003|Phase 1|Adverse Event|2|||
17019137|NCT00460603|38163754|FG004|Phase 1|Adverse Event|0|||
17019138|NCT00460603|38163755|FG005|Phase 1|Adverse Event|0|||
17019139|NCT00460603|38163756|FG006|Phase 1|Adverse Event|3|||
17019140|NCT00460603|38163757|FG007|Phase 1|Adverse Event|0|||
16931665|NCT01298323|38075592|FG001|Overall Study|Ongoing|55|||
16931666|NCT01298323|38075591|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
17019141|NCT00460603|38163758|FG008|Phase 1|Adverse Event|4|||
17019142|NCT00460603|38163759|FG009|Phase 1|Adverse Event|0|||
17019143|NCT00460603|38163760|FG010|Phase 1|Adverse Event|0|||
17019144|NCT00460603|38163761|FG011|Phase 1|Adverse Event|0|||
17019145|NCT00460603|38163750|FG000|Phase 1|Lack of Efficacy|1|||
16931667|NCT01298323|38075592|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16931668|NCT01297504|38075598|FG000|Overall Study|Invalid Consent|1|||
16931669|NCT01297504|38075598|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
16931670|NCT01297504|38075598|FG000|Overall Study|No Study Visits|4|||
16931671|NCT01297504|38075598|FG000|Overall Study|Death|3|||
16931672|NCT01297504|38075598|FG000|Overall Study|Lost to Follow-up|43|||
16931673|NCT01297504|38075598|FG000|Overall Study|Withdrawal by Subject|9|||
16931674|NCT01297504|38075598|FG000|Overall Study|Site Closure|3|||
16931675|NCT01297504|38075598|FG000|Overall Study|Protocol Violation|3|||
16931676|NCT01297465|38075608|FG000|Overall Study|Lack of Ovarian Response|1|||
16931677|NCT01297465|38075609|FG001|Overall Study|Lack of Ovarian Response|1|||
16931678|NCT01297465|38075608|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
16931679|NCT01297465|38075609|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
16931680|NCT01297465|38075608|FG000|Overall Study|No Oocytes Retrieved|1|||
16931681|NCT01297465|38075609|FG001|Overall Study|No Oocytes Retrieved|1|||
16931682|NCT01297465|38075608|FG000|Overall Study|Poor oocyte quality|0|||
16931683|NCT01297465|38075609|FG001|Overall Study|Poor oocyte quality|1|||
16931684|NCT01297465|38075608|FG000|Overall Study|No Fertilization|6|||
16931685|NCT01297465|38075609|FG001|Overall Study|No Fertilization|4|||
16931686|NCT01297465|38075608|FG000|Overall Study|All Embryos Discarded|0|||
16931687|NCT01297465|38075609|FG001|Overall Study|All Embryos Discarded|1|||
16931688|NCT01297465|38075608|FG000|Overall Study|Intention to Freeze all Embryos|0|||
16931689|NCT01297465|38075609|FG001|Overall Study|Intention to Freeze all Embryos|1|||
16931690|NCT01297309|38075615|FG000|Overall Study|Eligibility failure|2|||
16931691|NCT01297309|38075615|FG000|Overall Study|Screen failure|2|||
16931692|NCT01297309|38075615|FG000|Overall Study|Withdrawal by Subject|5|||
16931693|NCT01297309|38075615|FG000|Overall Study|Adverse Event|1|||
16931694|NCT01297309|38075615|FG000|Overall Study|Investigator Decision|2|||
16931695|NCT01297309|38075615|FG000|Overall Study|Death|1|||
16931696|NCT01297309|38075615|FG000|Overall Study|Participant not entering extensionperiod|1|||
16931697|NCT04518462|38075622|FG000|Overall Study|Withdrawal by Subject|0|||
16931698|NCT04518462|38075623|FG001|Overall Study|Withdrawal by Subject|0|||
16931699|NCT04518462|38075624|FG002|Overall Study|Withdrawal by Subject|1|||
16931700|NCT04518462|38075622|FG000|Overall Study|Physician Decision|1|||
16931701|NCT04518462|38075623|FG001|Overall Study|Physician Decision|1|||
16931702|NCT04518462|38075624|FG002|Overall Study|Physician Decision|0|||
16931703|NCT01297270|38075635|FG000|Overall Study|Adverse Event|19|||
16931704|NCT01297270|38075636|FG001|Overall Study|Adverse Event|32|||
16931705|NCT01297270|38075637|FG002|Overall Study|Adverse Event|5|||
16852253|NCT01891669|37802287|FG000|Overall Study|Withdrawal by Subject|1|||
16852254|NCT01891669|37802288|FG001|Overall Study|Withdrawal by Subject|1|||
16852255|NCT01891669|37802289|FG002|Overall Study|Withdrawal by Subject|0|||
16931706|NCT01297270|38075635|FG000|Overall Study|Lack of Efficacy|15|||
16931707|NCT01297270|38075636|FG001|Overall Study|Lack of Efficacy|17|||
16931708|NCT01297270|38075637|FG002|Overall Study|Lack of Efficacy|15|||
16931709|NCT01297270|38075635|FG000|Overall Study|Lost to Follow-up|1|||
16931710|NCT01297270|38075636|FG001|Overall Study|Lost to Follow-up|2|||
16852256|NCT01891669|37802290|FG003|Overall Study|Withdrawal by Subject|0|||
16852257|NCT01891669|37802291|FG004|Overall Study|Withdrawal by Subject|0|||
16852258|NCT01891669|37802292|FG005|Overall Study|Withdrawal by Subject|0|||
16852259|NCT01891669|37802293|FG006|Overall Study|Withdrawal by Subject|1|||
16852260|NCT01891669|37802294|FG007|Overall Study|Withdrawal by Subject|2|||
16852261|NCT01891669|37802295|FG008|Overall Study|Withdrawal by Subject|1|||
16852262|NCT01891669|37802296|FG009|Overall Study|Withdrawal by Subject|1|||
16852263|NCT01891669|37802287|FG000|Overall Study|Other|1|||
16852264|NCT01891669|37802288|FG001|Overall Study|Other|0|||
16852265|NCT01891669|37802289|FG002|Overall Study|Other|0|||
16852266|NCT01891669|37802290|FG003|Overall Study|Other|0|||
16852267|NCT01891669|37802291|FG004|Overall Study|Other|0|||
16852268|NCT01891669|37802292|FG005|Overall Study|Other|0|||
16852269|NCT01891669|37802293|FG006|Overall Study|Other|0|||
16852270|NCT01891669|37802294|FG007|Overall Study|Other|1|||
16852271|NCT01891669|37802295|FG008|Overall Study|Other|0|||
16852272|NCT01891669|37802296|FG009|Overall Study|Other|0|||
16852273|NCT01421511|37802329|FG000|Overall Study|Lost to Follow-up|11|||
16852274|NCT01421511|37802330|FG001|Overall Study|Lost to Follow-up|14|||
16852275|NCT01421511|37802329|FG000|Overall Study|Randomized but didn't receive study drug|1|||
16852276|NCT01421511|37802330|FG001|Overall Study|Randomized but didn't receive study drug|7|||
16852277|NCT01421511|37802329|FG000|Overall Study|Physician Decision|0|||
16852278|NCT01421511|37802330|FG001|Overall Study|Physician Decision|1|||
16852279|NCT01421511|37802329|FG000|Overall Study|Withdrawal by Subject|6|||
16852280|NCT01421511|37802330|FG001|Overall Study|Withdrawal by Subject|5|||
16852281|NCT01421511|37802329|FG000|Overall Study|Death|1|||
16931711|NCT01297270|38075637|FG002|Overall Study|Lost to Follow-up|1|||
16931712|NCT01297270|38075635|FG000|Overall Study|Protocol Violation|0|||
16931713|NCT01297270|38075636|FG001|Overall Study|Protocol Violation|2|||
16931714|NCT01297270|38075637|FG002|Overall Study|Protocol Violation|0|||
16931715|NCT01297270|38075635|FG000|Overall Study|Withdrawal by Subject|7|||
16931716|NCT01297270|38075636|FG001|Overall Study|Withdrawal by Subject|15|||
16931717|NCT01297270|38075637|FG002|Overall Study|Withdrawal by Subject|7|||
16931718|NCT01297270|38075635|FG000|Overall Study|Other reason not defined above|3|||
16931719|NCT01297270|38075636|FG001|Overall Study|Other reason not defined above|3|||
16931720|NCT01297270|38075637|FG002|Overall Study|Other reason not defined above|1|||
16931721|NCT01297270|38075635|FG000|Overall Study|Not treated|0|||
16931722|NCT01297270|38075636|FG001|Overall Study|Not treated|1|||
16931723|NCT01297270|38075637|FG002|Overall Study|Not treated|0|||
16931724|NCT01296568|38075645|FG000|Continued Access Phase|Lost to Follow-up|1|||
16931725|NCT01296568|38075645|FG000|Continued Access Phase|Withdrawal by Subject|1|||
16931726|NCT01296568|38075645|FG000|Continued Access Phase|Disease Progression|1|||
16931727|NCT01296412|38075653|FG000|Overall Study|Adverse Event|8|||
16931728|NCT01296412|38075654|FG001|Overall Study|Adverse Event|29|||
16931729|NCT01296412|38075653|FG000|Overall Study|Lack of Efficacy|1|||
16931730|NCT01296412|38075654|FG001|Overall Study|Lack of Efficacy|0|||
16931731|NCT01296412|38075653|FG000|Overall Study|Lost to Follow-up|10|||
16931732|NCT01296412|38075654|FG001|Overall Study|Lost to Follow-up|7|||
16931733|NCT01296412|38075653|FG000|Overall Study|Non-compliance with study drug|1|||
16931734|NCT01296412|38075654|FG001|Overall Study|Non-compliance with study drug|2|||
16931735|NCT01296412|38075653|FG000|Overall Study|Other reason not specified|20|||
16931736|NCT01296412|38075654|FG001|Overall Study|Other reason not specified|15|||
16931737|NCT01296412|38075653|FG000|Overall Study|Physician Decision|1|||
16931738|NCT01296412|38075654|FG001|Overall Study|Physician Decision|3|||
16931739|NCT01296412|38075653|FG000|Overall Study|Pregnancy|0|||
16931740|NCT01296412|38075654|FG001|Overall Study|Pregnancy|1|||
16931741|NCT01296412|38075653|FG000|Overall Study|Withdrawal by Subject|10|||
16931742|NCT01296412|38075654|FG001|Overall Study|Withdrawal by Subject|13|||
16931743|NCT01295905|38075662|FG000|Overall Study|Did not meet inclusion criteria|1|||
16931744|NCT01295905|38075663|FG001|Overall Study|Did not meet inclusion criteria|0|||
16931745|NCT01295905|38075662|FG000|Overall Study|Met exclusion criteria|1|||
16931746|NCT01295905|38075663|FG001|Overall Study|Met exclusion criteria|0|||
16931747|NCT02596035|38075672|FG000|Overall Study|Disease Progression|64|||
16931748|NCT02596035|38075673|FG001|Overall Study|Disease Progression|32|||
16931749|NCT02596035|38075674|FG002|Overall Study|Disease Progression|1|||
16931750|NCT02596035|38075672|FG000|Overall Study|study drug toxicity|12|||
16931751|NCT02596035|38075673|FG001|Overall Study|study drug toxicity|3|||
16931752|NCT02596035|38075674|FG002|Overall Study|study drug toxicity|0|||
16931753|NCT02596035|38075672|FG000|Overall Study|AE unrelated to study drug|5|||
16931754|NCT02596035|38075673|FG001|Overall Study|AE unrelated to study drug|2|||
16931755|NCT02596035|38075674|FG002|Overall Study|AE unrelated to study drug|0|||
16931756|NCT02596035|38075672|FG000|Overall Study|participant request to discontinue study treatment|2|||
16931757|NCT02596035|38075673|FG001|Overall Study|participant request to discontinue study treatment|0|||
16931758|NCT02596035|38075674|FG002|Overall Study|participant request to discontinue study treatment|0|||
16931759|NCT02596035|38075672|FG000|Overall Study|participant withdrew consent|2|||
16931760|NCT02596035|38075673|FG001|Overall Study|participant withdrew consent|2|||
17019146|NCT00460603|38163751|FG001|Phase 1|Lack of Efficacy|0|||
17019147|NCT00460603|38163752|FG002|Phase 1|Lack of Efficacy|1|||
17019148|NCT00460603|38163753|FG003|Phase 1|Lack of Efficacy|2|||
17019149|NCT00460603|38163754|FG004|Phase 1|Lack of Efficacy|2|||
17019150|NCT00460603|38163755|FG005|Phase 1|Lack of Efficacy|2|||
17019151|NCT00460603|38163756|FG006|Phase 1|Lack of Efficacy|2|||
17019152|NCT00460603|38163757|FG007|Phase 1|Lack of Efficacy|2|||
17019153|NCT00460603|38163758|FG008|Phase 1|Lack of Efficacy|11|||
17019154|NCT00460603|38163759|FG009|Phase 1|Lack of Efficacy|0|||
17019155|NCT00460603|38163760|FG010|Phase 1|Lack of Efficacy|0|||
17019156|NCT00460603|38163761|FG011|Phase 1|Lack of Efficacy|0|||
17019157|NCT00460603|38163750|FG000|Phase 1|Withdrawal by Subject|1|||
17019158|NCT00460603|38163751|FG001|Phase 1|Withdrawal by Subject|2|||
17019159|NCT00460603|38163752|FG002|Phase 1|Withdrawal by Subject|1|||
17019160|NCT00460603|38163753|FG003|Phase 1|Withdrawal by Subject|1|||
17019161|NCT00460603|38163754|FG004|Phase 1|Withdrawal by Subject|3|||
17019162|NCT00460603|38163755|FG005|Phase 1|Withdrawal by Subject|0|||
17019163|NCT00460603|38163756|FG006|Phase 1|Withdrawal by Subject|1|||
17019164|NCT00460603|38163757|FG007|Phase 1|Withdrawal by Subject|0|||
17019165|NCT00460603|38163758|FG008|Phase 1|Withdrawal by Subject|2|||
17019166|NCT00460603|38163759|FG009|Phase 1|Withdrawal by Subject|0|||
17019167|NCT00460603|38163760|FG010|Phase 1|Withdrawal by Subject|0|||
17019168|NCT00460603|38163761|FG011|Phase 1|Withdrawal by Subject|0|||
17019169|NCT00460603|38163750|FG000|Phase 1|Other|0|||
17019170|NCT00460603|38163751|FG001|Phase 1|Other|3|||
17019171|NCT00460603|38163752|FG002|Phase 1|Other|1|||
17019172|NCT00460603|38163753|FG003|Phase 1|Other|1|||
17019173|NCT00460603|38163754|FG004|Phase 1|Other|1|||
17019174|NCT00460603|38163755|FG005|Phase 1|Other|2|||
17019175|NCT00460603|38163756|FG006|Phase 1|Other|0|||
17019176|NCT00460603|38163757|FG007|Phase 1|Other|1|||
16931761|NCT02596035|38075674|FG002|Overall Study|participant withdrew consent|0|||
16931762|NCT02596035|38075672|FG000|Overall Study|Poor/Non Comlpiance|0|||
16931763|NCT02596035|38075673|FG001|Overall Study|Poor/Non Comlpiance|1|||
16931764|NCT02596035|38075674|FG002|Overall Study|Poor/Non Comlpiance|0|||
16931765|NCT02596035|38075672|FG000|Overall Study|participant no longer meets study criteria|1|||
16931766|NCT02596035|38075673|FG001|Overall Study|participant no longer meets study criteria|0|||
17019177|NCT00460603|38163758|FG008|Phase 1|Other|0|||
17019178|NCT00460603|38163759|FG009|Phase 1|Other|0|||
17019179|NCT00460603|38163760|FG010|Phase 1|Other|0|||
17019180|NCT00460603|38163761|FG011|Phase 1|Other|0|||
16931767|NCT02596035|38075674|FG002|Overall Study|participant no longer meets study criteria|0|||
16931768|NCT02596035|38075672|FG000|Overall Study|other reasons|11|||
16931769|NCT02596035|38075673|FG001|Overall Study|other reasons|4|||
16931770|NCT02596035|38075674|FG002|Overall Study|other reasons|0|||
16931771|NCT02595372|38075683|FG000|Overall Study|Adverse Event|6|||
16931772|NCT02595372|38075683|FG000|Overall Study|Physician Decision|2|||
16931773|NCT02595372|38075683|FG000|Overall Study|Disease Progression|1|||
16931774|NCT01248962|38075703|FG000|Overall Study|Withdrawal by Subject|1|||
16931775|NCT01248962|38075704|FG001|Overall Study|Withdrawal by Subject|1|||
16931776|NCT01248962|38075703|FG000|Overall Study|Adverse Event|2|||
16931777|NCT01248962|38075704|FG001|Overall Study|Adverse Event|1|||
16931778|NCT01248962|38075703|FG000|Overall Study|Complete Response after 4 Cycles|1|||
16931779|NCT01248962|38075704|FG001|Overall Study|Complete Response after 4 Cycles|0|||
16931780|NCT01248962|38075703|FG000|Overall Study|Complete Response after 3 Cycles|0|||
16931781|NCT01248962|38075704|FG001|Overall Study|Complete Response after 3 Cycles|1|||
16931782|NCT01248962|38075703|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
16931783|NCT01248962|38075704|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
16931784|NCT01248455|38075711|FG000|Overall Study|switched to alternate treatment|1|||
16931785|NCT01247090|38075718|FG000|Overall Study|Physician Decision|1|||
16931786|NCT01247090|38075719|FG001|Overall Study|Physician Decision|0|||
16931787|NCT01247090|38075720|FG002|Overall Study|Physician Decision|0|||
16931788|NCT01247090|38075718|FG000|Overall Study|Withdrawal by Subject|0|||
16931789|NCT01247090|38075719|FG001|Overall Study|Withdrawal by Subject|1|||
16931790|NCT01247090|38075720|FG002|Overall Study|Withdrawal by Subject|0|||
16931791|NCT01249664|38075730|FG000|Overall Study|Withdrawal by Subject|5|||
16931792|NCT01249664|38075731|FG001|Overall Study|Withdrawal by Subject|0|||
16931793|NCT01249664|38075730|FG000|Overall Study|Adverse Event|1|||
16931794|NCT01249664|38075731|FG001|Overall Study|Adverse Event|0|||
16931795|NCT01249274|38075741|FG000|Overall Study|Lost to Follow-up|3|||
16931796|NCT01249274|38075742|FG001|Overall Study|Lost to Follow-up|4|||
16931797|NCT01249274|38075741|FG000|Overall Study|Received inpatient substance treatment|1|||
16931798|NCT01249274|38075742|FG001|Overall Study|Received inpatient substance treatment|2|||
16931799|NCT01249157|38075750|FG000|Overall Study|Withdrawal by Subject|1|||
16931800|NCT01249118|38075754|FG000|First Washout Period|Physician Decision|0|||
16931801|NCT01249118|38075755|FG001|First Washout Period|Physician Decision|1|||
16931802|NCT01249118|38075756|FG002|First Washout Period|Physician Decision|0|||
16931803|NCT01248884|38075766|FG000|Overall Study|Withdrawal by Subject|1|||
16931804|NCT01248884|38075767|FG001|Overall Study|Withdrawal by Subject|3|||
16931805|NCT01248884|38075768|FG002|Overall Study|Withdrawal by Subject|1|||
16931806|NCT01248884|38075766|FG000|Overall Study|Adverse Event|1|||
16931807|NCT01248884|38075767|FG001|Overall Study|Adverse Event|0|||
16931808|NCT01248884|38075768|FG002|Overall Study|Adverse Event|0|||
16931809|NCT01248728|38075780|FG000|Overall Study|Adverse Event|1|||
16931810|NCT01248728|38075781|FG001|Overall Study|Adverse Event|1|||
16931811|NCT01248728|38075780|FG000|Overall Study|Withdrawal by Subject|2|||
16931812|NCT01248728|38075781|FG001|Overall Study|Withdrawal by Subject|1|||
16931813|NCT01248728|38075780|FG000|Overall Study|Lack of Efficacy|1|||
17019181|NCT00460603|38163750|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019182|NCT00460603|38163751|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019183|NCT00460603|38163752|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019184|NCT00460603|38163753|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019185|NCT00460603|38163754|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019186|NCT00460603|38163755|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019187|NCT00460603|38163756|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019188|NCT00460603|38163757|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019189|NCT00460603|38163758|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019190|NCT00460603|38163759|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
17019191|NCT00460603|38163760|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019192|NCT00460603|38163761|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
17019193|NCT00460603|38163750|FG000|Phase 2|Adverse Event|0|||
17019194|NCT00460603|38163751|FG001|Phase 2|Adverse Event|0|||
17019195|NCT00460603|38163752|FG002|Phase 2|Adverse Event|0|||
17019196|NCT00460603|38163753|FG003|Phase 2|Adverse Event|0|||
17019197|NCT00460603|38163754|FG004|Phase 2|Adverse Event|0|||
17019198|NCT00460603|38163755|FG005|Phase 2|Adverse Event|0|||
17019199|NCT00460603|38163756|FG006|Phase 2|Adverse Event|0|||
17019200|NCT00460603|38163757|FG007|Phase 2|Adverse Event|0|||
17019201|NCT00460603|38163758|FG008|Phase 2|Adverse Event|0|||
17019202|NCT00460603|38163759|FG009|Phase 2|Adverse Event|12|||
17019203|NCT00460603|38163760|FG010|Phase 2|Adverse Event|9|||
17019204|NCT00460603|38163761|FG011|Phase 2|Adverse Event|10|||
17019205|NCT00460603|38163750|FG000|Phase 2|Death|0|||
16931814|NCT01248728|38075781|FG001|Overall Study|Lack of Efficacy|0|||
16931815|NCT01246973|38075791|FG000|Overall Study|Other|38|||
17019206|NCT00460603|38163751|FG001|Phase 2|Death|0|||
16931816|NCT01246973|38075792|FG001|Overall Study|Other|25|||
16931817|NCT01246973|38075791|FG000|Overall Study|Adverse Event|16|||
17019207|NCT00460603|38163752|FG002|Phase 2|Death|0|||
16931818|NCT01246973|38075792|FG001|Overall Study|Adverse Event|9|||
16931819|NCT01246973|38075791|FG000|Overall Study|Withdrawal by Subject|7|||
16931820|NCT01246973|38075792|FG001|Overall Study|Withdrawal by Subject|13|||
16931821|NCT01246466|38075798|FG000|Overall Study|Death|1|||
16931822|NCT01246466|38075798|FG000|Overall Study|Withdrawal by Subject|1|||
16931823|NCT01245764|38075807|FG000|Study Phase A|Other|3|||
16931824|NCT01245764|38075808|FG001|Study Phase A|Other|2|||
16931825|NCT01245764|38075809|FG002|Study Phase A|Other|3|||
16931826|NCT01245764|38075810|FG003|Study Phase A|Other|1|||
16931827|NCT01245764|38075807|FG000|Study Phase A|Protocol Violation|6|||
16931828|NCT01245764|38075808|FG001|Study Phase A|Protocol Violation|3|||
16931829|NCT01245764|38075809|FG002|Study Phase A|Protocol Violation|2|||
16931830|NCT01245764|38075810|FG003|Study Phase A|Protocol Violation|2|||
16931831|NCT01245764|38075807|FG000|Study Phase A|Lost to Follow-up|0|||
16931832|NCT01245764|38075808|FG001|Study Phase A|Lost to Follow-up|0|||
16931833|NCT01245764|38075809|FG002|Study Phase A|Lost to Follow-up|5|||
16931834|NCT01245764|38075810|FG003|Study Phase A|Lost to Follow-up|0|||
16931835|NCT01245140|38075830|FG000|Overall Study|Adverse Event|1|||
16931836|NCT01245140|38075831|FG001|Overall Study|Adverse Event|3|||
16931837|NCT01245140|38075830|FG000|Overall Study|Lack of Efficacy|2|||
16931838|NCT01245140|38075831|FG001|Overall Study|Lack of Efficacy|4|||
16931839|NCT01245140|38075830|FG000|Overall Study|Protocol Violation|0|||
16931840|NCT01245140|38075831|FG001|Overall Study|Protocol Violation|1|||
16931841|NCT01245140|38075830|FG000|Overall Study|Withdrawal by Subject|0|||
16931842|NCT01245140|38075831|FG001|Overall Study|Withdrawal by Subject|1|||
16931843|NCT01245140|38075830|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
16931844|NCT01245140|38075831|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
16931845|NCT01245101|38075839|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
16931846|NCT01245101|38075840|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
16931847|NCT01245101|38075839|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
16852282|NCT01421511|37802330|FG001|Overall Study|Death|1|||
16852283|NCT01864525|37802339|FG000|Overall Study|Adverse Event|1|||
16852284|NCT01864525|37802340|FG001|Overall Study|Adverse Event|0|||
16852285|NCT01421277|37802348|FG000|Overall Study|Lack of qualifying event|0|||
16852286|NCT01421277|37802349|FG001|Overall Study|Lack of qualifying event|61|||
16852287|NCT01421277|37802348|FG000|Overall Study|Incomplete baseline data|0|||
16852288|NCT01421277|37802349|FG001|Overall Study|Incomplete baseline data|31|||
16852289|NCT01891357|37802355|FG000|Overall Study|Protocol Violation|3|||
16931848|NCT01245101|38075840|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
16931849|NCT01245101|38075839|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
16931850|NCT01245101|38075840|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
16931851|NCT01245062|38075848|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
16931852|NCT01245062|38075849|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
16931853|NCT01245062|38075850|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
16931854|NCT01245062|38075848|FG000|Randomization and Crossover Phase|Physician Decision|2|||
16931855|NCT01245062|38075849|FG001|Randomization and Crossover Phase|Physician Decision|4|||
16931856|NCT01245062|38075850|FG002|Randomization and Crossover Phase|Physician Decision|0|||
16931857|NCT01245062|38075848|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
16931858|NCT01245062|38075849|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
16931859|NCT01245062|38075850|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
16931860|NCT01245062|38075848|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
16931861|NCT01245062|38075849|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
16931862|NCT01245062|38075850|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
16931863|NCT01245062|38075848|FG000|Cross-over Phase|Lost to Follow-up|0|||
16931864|NCT01245062|38075849|FG001|Cross-over Phase|Lost to Follow-up|0|||
16931865|NCT01245062|38075850|FG002|Cross-over Phase|Lost to Follow-up|1|||
16931866|NCT01245062|38075848|FG000|Cross-over Phase|Physician Decision|0|||
16931867|NCT01245062|38075849|FG001|Cross-over Phase|Physician Decision|0|||
16931868|NCT01245062|38075850|FG002|Cross-over Phase|Physician Decision|1|||
16931869|NCT01245062|38075848|FG000|Cross-over Phase|Withdrew Consent|0|||
16931870|NCT01245062|38075849|FG001|Cross-over Phase|Withdrew Consent|0|||
16931871|NCT01245062|38075850|FG002|Cross-over Phase|Withdrew Consent|4|||
16931872|NCT01245062|38075848|FG000|Cross-over Phase|Study closed/ terminated|0|||
16931873|NCT01245062|38075849|FG001|Cross-over Phase|Study closed/ terminated|0|||
16931874|NCT01245062|38075850|FG002|Cross-over Phase|Study closed/ terminated|11|||
16931875|NCT01244984|38075861|FG000|Overall Study|Adverse Event|2|||
16931876|NCT01244984|38075862|FG001|Overall Study|Adverse Event|11|||
16931877|NCT01244984|38075863|FG002|Overall Study|Adverse Event|2|||
16931878|NCT01244984|38075861|FG000|Overall Study|Protocol Violation|1|||
16931879|NCT01244984|38075862|FG001|Overall Study|Protocol Violation|0|||
16931880|NCT01244984|38075863|FG002|Overall Study|Protocol Violation|0|||
16931881|NCT01244984|38075861|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
16931882|NCT01244984|38075862|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
16852290|NCT01420965|37802362|FG000|Overall Study|Withdrawal by Subject|1|||
16852291|NCT01420965|37802363|FG001|Overall Study|Withdrawal by Subject|0|||
16931883|NCT01244984|38075863|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
16931884|NCT01244984|38075861|FG000|Overall Study|Withdrawal by Subject|1|||
16931885|NCT01244984|38075862|FG001|Overall Study|Withdrawal by Subject|2|||
16931886|NCT01244984|38075863|FG002|Overall Study|Withdrawal by Subject|2|||
16931887|NCT01244516|38075875|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
16931888|NCT01244516|38075876|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
16931889|NCT01244516|38075877|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
16931890|NCT01244516|38075875|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
16931891|NCT01244516|38075876|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
16931892|NCT01244516|38075877|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
16931893|NCT01244516|38075875|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
16931894|NCT01244516|38075876|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
16931895|NCT01244516|38075877|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
16931896|NCT01244516|38075875|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
16931897|NCT01244516|38075876|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
16931898|NCT01244516|38075877|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
16931899|NCT01244516|38075875|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
16931900|NCT01244516|38075876|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
16931901|NCT01244516|38075877|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
16931902|NCT01244516|38075875|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
16931903|NCT01244516|38075876|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
16931904|NCT01244516|38075877|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
16931905|NCT01244516|38075875|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
16931906|NCT01244516|38075876|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
16931907|NCT01244516|38075877|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
16931908|NCT01244126|38075889|FG000|Overall Study|Protocol Violation|3|||
16931909|NCT01244126|38075890|FG001|Overall Study|Protocol Violation|3|||
16931910|NCT01244126|38075891|FG002|Overall Study|Protocol Violation|9|||
16931911|NCT01243892|38075901|FG000|Overall Study|Did not meet eligibility criteria|2|||
16931912|NCT01243892|38075902|FG001|Overall Study|Did not meet eligibility criteria|0|||
16852292|NCT01420965|37802364|FG002|Overall Study|Withdrawal by Subject|0|||
16852293|NCT01420965|37802362|FG000|Overall Study|Adverse Event|0|||
16852294|NCT01420965|37802363|FG001|Overall Study|Adverse Event|1|||
16852295|NCT01420965|37802364|FG002|Overall Study|Adverse Event|0|||
16852296|NCT01390389|37802374|FG000|Overall Study|Withdrawal by Subject|2|||
16852297|NCT01390389|37802375|FG001|Overall Study|Withdrawal by Subject|0|||
16931913|NCT01243775|38075908|FG000|Overall Study|Withdrawal by Subject|2|||
16931914|NCT01243268|38075912|FG000|Overall Study|Lost to Follow-up|4|||
16931915|NCT01243268|38075912|FG000|Overall Study|Protocol Violation|51|||
16931916|NCT01243268|38075912|FG000|Overall Study|Deviation with contract date|7|||
16931917|NCT01243268|38075912|FG000|Overall Study|Duplicate subject|2|||
16931918|NCT01242371|38075918|FG000|Overall Study|Withdrawal by Subject|2|||
16931919|NCT01242371|38075919|FG001|Overall Study|Withdrawal by Subject|2|||
16931920|NCT01242371|38075918|FG000|Overall Study|Protocol Violation|0|||
16931921|NCT01242371|38075919|FG001|Overall Study|Protocol Violation|3|||
16931922|NCT01242176|38075925|FG000|Washout Period of 7 Days|Adverse Event|0|||
16931923|NCT01242176|38075926|FG001|Washout Period of 7 Days|Adverse Event|2|||
16931924|NCT01242176|38075925|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
16931925|NCT01242176|38075926|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
16931926|NCT01242020|38075934|FG000|Overall Study|Withdrawal by Subject|2|||
16931927|NCT01242020|38075935|FG001|Overall Study|Withdrawal by Subject|0|||
16931928|NCT01242020|38075934|FG000|Overall Study|Failed screening|1|||
16931929|NCT01242020|38075935|FG001|Overall Study|Failed screening|0|||
16931930|NCT01241786|38075941|FG000|Overall Study|Lack of Efficacy|5|||
16931931|NCT01241318|38075948|FG000|Overall Study|Woman: false pregnancies|27|||
17102643|NCT00112437|38241443|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
16852298|NCT01390389|37802374|FG000|Overall Study|Screen Fail|2|||
16852299|NCT01390389|37802375|FG001|Overall Study|Screen Fail|1|||
16852300|NCT01401465|37802387|FG000|Treatment Period 1|Adverse Event|4|||
16852301|NCT01401465|37802388|FG001|Treatment Period 1|Adverse Event|1|||
16852302|NCT01401465|37802387|FG000|Treatment Period 1|Pregnancy|0|||
16852303|NCT01401465|37802388|FG001|Treatment Period 1|Pregnancy|1|||
16852304|NCT01401465|37802387|FG000|Treatment Period 1|Protocol Violation|5|||
16852305|NCT01401465|37802388|FG001|Treatment Period 1|Protocol Violation|0|||
16852306|NCT01401465|37802387|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16852307|NCT01401465|37802388|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16852308|NCT01401465|37802387|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
16852309|NCT01401465|37802388|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
16852310|NCT01401465|37802387|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
16852311|NCT01401465|37802388|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
16852312|NCT01401465|37802387|FG000|Treatment Period 1|Scheduling Difficulties|1|||
16852313|NCT01401465|37802388|FG001|Treatment Period 1|Scheduling Difficulties|1|||
16852314|NCT01401465|37802387|FG000|Treatment Period 2|Lost to Follow-up|0|||
16931932|NCT01241318|38075949|FG001|Overall Study|Woman: false pregnancies|15|||
16931933|NCT01241318|38075948|FG000|Overall Study|Woman: miscarriage/abortion|46|||
16931934|NCT01241318|38075949|FG001|Overall Study|Woman: miscarriage/abortion|38|||
16931935|NCT01241318|38075948|FG000|Overall Study|Withdrawal by Subject|175|||
16931936|NCT01241318|38075949|FG001|Overall Study|Withdrawal by Subject|46|||
16931937|NCT01241318|38075948|FG000|Overall Study|Lost to Follow-up|740|||
16931938|NCT01241318|38075949|FG001|Overall Study|Lost to Follow-up|455|||
16931939|NCT01241318|38075948|FG000|Overall Study|Death|2|||
16931940|NCT01241318|38075949|FG001|Overall Study|Death|4|||
16931941|NCT01241318|38075948|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
16931942|NCT01241318|38075949|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
16931943|NCT01241318|38075948|FG000|Overall Study|Woman: Stillborn infant|129|||
16931944|NCT01241318|38075949|FG001|Overall Study|Woman: Stillborn infant|146|||
16931945|NCT01241279|38075960|FG000|Overall Study|Lost to Follow-up|0|||
16931946|NCT01241279|38075961|FG001|Overall Study|Lost to Follow-up|1|||
16931947|NCT01241240|38075969|FG000|Overall Study|Adverse Event|5|||
16931948|NCT01241240|38075970|FG001|Overall Study|Adverse Event|4|||
16931949|NCT01241240|38075969|FG000|Overall Study|Lost to Follow-up|2|||
16931950|NCT01241240|38075970|FG001|Overall Study|Lost to Follow-up|4|||
16931951|NCT01241240|38075969|FG000|Overall Study|Personal Reasons|1|||
16931952|NCT01241240|38075970|FG001|Overall Study|Personal Reasons|1|||
16931953|NCT01240811|38075979|FG000|Overall Study|Physician Decision|0|||
16931954|NCT01240811|38075980|FG001|Overall Study|Physician Decision|1|||
16931955|NCT01240811|38075981|FG002|Overall Study|Physician Decision|0|||
16931956|NCT01240811|38075979|FG000|Overall Study|Withdrawal by Subject|0|||
16931957|NCT01240811|38075980|FG001|Overall Study|Withdrawal by Subject|0|||
16931958|NCT01240811|38075981|FG002|Overall Study|Withdrawal by Subject|1|||
16931959|NCT01240382|38075993|FG000|Overall Study|Adverse Event|2|||
16931960|NCT01240382|38075994|FG001|Overall Study|Adverse Event|1|||
16931961|NCT01240382|38075993|FG000|Overall Study|Lack of Efficacy|0|||
16931962|NCT01240382|38075994|FG001|Overall Study|Lack of Efficacy|2|||
16931963|NCT01240382|38075993|FG000|Overall Study|Fear of adverse events|0|||
16931964|NCT01240382|38075994|FG001|Overall Study|Fear of adverse events|1|||
16931965|NCT01244828|38076000|FG000|Overall Study|Adverse Event|37|||
16931966|NCT01244828|38076000|FG000|Overall Study|Withdrawal by Subject|31|||
16931967|NCT01244828|38076000|FG000|Overall Study|Lack of Efficacy|7|||
16931968|NCT01244828|38076000|FG000|Overall Study|Lost to Follow-up|2|||
16931969|NCT01244828|38076000|FG000|Overall Study|Other reason (not specified)|1|||
16931970|NCT01249833|38076006|FG000|Overall Study|Lost to Follow-up|0|||
16931971|NCT01249833|38076007|FG001|Overall Study|Lost to Follow-up|1|||
16931972|NCT01249404|38076016|FG000|Overall Study|Study treatment not received|0|||
16931973|NCT01249404|38076017|FG001|Overall Study|Study treatment not received|1|||
16931974|NCT01249404|38076018|FG002|Overall Study|Study treatment not received|2|||
16931975|NCT01249404|38076016|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
16931976|NCT01249404|38076017|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
16931977|NCT01249404|38076018|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
16931978|NCT01249404|38076016|FG000|Overall Study|Adverse Event|2|||
16931979|NCT01249404|38076017|FG001|Overall Study|Adverse Event|2|||
16931980|NCT01249404|38076018|FG002|Overall Study|Adverse Event|2|||
16931981|NCT01249404|38076016|FG000|Overall Study|Withdrawal by Subject|2|||
16931982|NCT01249404|38076017|FG001|Overall Study|Withdrawal by Subject|2|||
16931983|NCT01249404|38076018|FG002|Overall Study|Withdrawal by Subject|0|||
16931984|NCT01249404|38076016|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
16931985|NCT01249404|38076017|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
16931986|NCT01249404|38076018|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
16931987|NCT01249404|38076016|FG000|Overall Study|Non compliance to visit schedule|0|||
16931988|NCT01249404|38076017|FG001|Overall Study|Non compliance to visit schedule|1|||
16931989|NCT01249404|38076018|FG002|Overall Study|Non compliance to visit schedule|0|||
16931990|NCT01249365|38076026|FG000|Overall Study|Lost to Follow-up|1|||
16931991|NCT01249131|38076030|FG000|Washout Period of 10 Days|Adverse Event|0|||
16931992|NCT01249131|38076031|FG001|Washout Period of 10 Days|Adverse Event|0|||
16931993|NCT01249131|38076032|FG002|Washout Period of 10 Days|Adverse Event|0|||
16931994|NCT01249131|38076033|FG003|Washout Period of 10 Days|Adverse Event|0|||
16931995|NCT01249131|38076034|FG004|Washout Period of 10 Days|Adverse Event|1|||
16931996|NCT01249131|38076035|FG005|Washout Period of 10 Days|Adverse Event|0|||
16931997|NCT01249092|38076043|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
16931998|NCT01249092|38076043|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
16931999|NCT01248936|38076049|FG000|Overall Study|Sponsor Decision|259|||
16932000|NCT01248936|38076049|FG000|Overall Study|Progression of Disease|50|||
16932001|NCT01248936|38076049|FG000|Overall Study|Death|26|||
16932002|NCT01248936|38076049|FG000|Overall Study|Withdrawal of Consent|20|||
16932003|NCT01248936|38076049|FG000|Overall Study|Adverse Event|8|||
16932004|NCT01248936|38076049|FG000|Overall Study|Lost to Follow-up|7|||
16932005|NCT01248936|38076049|FG000|Overall Study|Refused Treatment|1|||
16932006|NCT01248936|38076049|FG000|Overall Study|Other reason|3|||
16932007|NCT01248780|38076056|FG000|Overall Study|Lack of Efficacy|2|||
16932008|NCT01248780|38076057|FG001|Overall Study|Lack of Efficacy|0|||
16932009|NCT01248780|38076056|FG000|Overall Study|Lost to Follow-up|0|||
16932010|NCT01248780|38076057|FG001|Overall Study|Lost to Follow-up|1|||
16932011|NCT01248780|38076056|FG000|Overall Study|Death|0|||
16932012|NCT01248780|38076057|FG001|Overall Study|Death|1|||
16932013|NCT01248780|38076056|FG000|Overall Study|Adverse Event|2|||
16932014|NCT01248780|38076057|FG001|Overall Study|Adverse Event|7|||
16932015|NCT01248780|38076056|FG000|Overall Study|Protocol Violation|1|||
16932016|NCT01248780|38076057|FG001|Overall Study|Protocol Violation|1|||
16932017|NCT01248780|38076056|FG000|Overall Study|Withdrawal by Subject|4|||
16932018|NCT01248780|38076057|FG001|Overall Study|Withdrawal by Subject|4|||
16932019|NCT01248780|38076056|FG000|Overall Study|Not treated|0|||
16932020|NCT01248780|38076057|FG001|Overall Study|Not treated|1|||
16932021|NCT01248468|38076066|FG000|Overall Study|Administrative problem|1|||
16932022|NCT01248468|38076067|FG001|Overall Study|Administrative problem|0|||
16932023|NCT01248468|38076068|FG002|Overall Study|Administrative problem|0|||
16932024|NCT01248468|38076066|FG000|Overall Study|Lost to Follow-up|9|||
16932025|NCT01248468|38076067|FG001|Overall Study|Lost to Follow-up|12|||
16932026|NCT01248468|38076068|FG002|Overall Study|Lost to Follow-up|4|||
16932027|NCT01248468|38076066|FG000|Overall Study|Pregnancy|1|||
16932028|NCT01248468|38076067|FG001|Overall Study|Pregnancy|0|||
16932029|NCT01248468|38076068|FG002|Overall Study|Pregnancy|0|||
16932030|NCT01248468|38076066|FG000|Overall Study|Withdrawal by Subject|4|||
16932031|NCT01248468|38076067|FG001|Overall Study|Withdrawal by Subject|2|||
16932032|NCT01248468|38076068|FG002|Overall Study|Withdrawal by Subject|0|||
16932033|NCT01247922|38076076|FG000|Overall Study|Disease progression|4|||
16932034|NCT01246206|38076080|FG000|Overall Study|Patient did not receive study regiments.|1|||
16932035|NCT01246011|38076087|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
16932036|NCT01246011|38076088|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
16932037|NCT01246011|38076089|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
16932038|NCT01246011|38076087|FG000|Overall Study|Withdrawal by Subject|0|||
16932039|NCT01246011|38076088|FG001|Overall Study|Withdrawal by Subject|0|||
16932040|NCT01246011|38076089|FG002|Overall Study|Withdrawal by Subject|1|||
16932041|NCT01244490|38076101|FG000|Overall Study|Lack of Efficacy|14|||
16932042|NCT01244490|38076102|FG001|Overall Study|Lack of Efficacy|5|||
16932043|NCT01244490|38076103|FG002|Overall Study|Lack of Efficacy|5|||
16932044|NCT01244490|38076101|FG000|Overall Study|Withdrawal by Subject|4|||
16932045|NCT01244490|38076102|FG001|Overall Study|Withdrawal by Subject|4|||
16932046|NCT01244490|38076103|FG002|Overall Study|Withdrawal by Subject|9|||
16852315|NCT01401465|37802388|FG001|Treatment Period 2|Lost to Follow-up|1|||
16852316|NCT01401465|37802387|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16852317|NCT01401465|37802388|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16852318|NCT01401153|37802399|FG000|First Test Day|Learning disabilities; illness|1|||
16852319|NCT01401153|37802400|FG001|First Test Day|Learning disabilities; illness|10|||
16852320|NCT01401153|37802399|FG000|Second Test Day|illness|0|||
16852321|NCT01401153|37802400|FG001|Second Test Day|illness|5|||
16852322|NCT01890967|37802413|FG000|Overall Study|Adverse Event|3|||
16852323|NCT01890967|37802414|FG001|Overall Study|Adverse Event|3|||
16852324|NCT01890967|37802415|FG002|Overall Study|Adverse Event|3|||
16852325|NCT01890967|37802416|FG003|Overall Study|Adverse Event|2|||
16852326|NCT01890967|37802417|FG004|Overall Study|Adverse Event|1|||
16852327|NCT01890967|37802418|FG005|Overall Study|Adverse Event|7|||
16852328|NCT01890967|37802413|FG000|Overall Study|Death|1|||
16852329|NCT01890967|37802414|FG001|Overall Study|Death|0|||
16852330|NCT01890967|37802415|FG002|Overall Study|Death|0|||
16852331|NCT01890967|37802416|FG003|Overall Study|Death|0|||
16852332|NCT01890967|37802417|FG004|Overall Study|Death|0|||
16852333|NCT01890967|37802418|FG005|Overall Study|Death|0|||
16852334|NCT01890967|37802413|FG000|Overall Study|Lost to Follow-up|1|||
16852335|NCT01890967|37802414|FG001|Overall Study|Lost to Follow-up|1|||
16852336|NCT01890967|37802415|FG002|Overall Study|Lost to Follow-up|1|||
16932047|NCT01244490|38076101|FG000|Overall Study|Adverse Event|1|||
16932048|NCT01244490|38076102|FG001|Overall Study|Adverse Event|9|||
16932049|NCT01244490|38076103|FG002|Overall Study|Adverse Event|5|||
16932050|NCT01244490|38076101|FG000|Overall Study|Lost to Follow-up|0|||
16932051|NCT01244490|38076102|FG001|Overall Study|Lost to Follow-up|6|||
16932052|NCT01244490|38076103|FG002|Overall Study|Lost to Follow-up|3|||
16932053|NCT01244490|38076101|FG000|Overall Study|Other|0|||
16932054|NCT01244490|38076102|FG001|Overall Study|Other|0|||
16932055|NCT01244490|38076103|FG002|Overall Study|Other|1|||
16932056|NCT01243944|38076113|FG000|Overall Study|Adverse Event|15|||
16852337|NCT01890967|37802416|FG003|Overall Study|Lost to Follow-up|1|||
16852338|NCT01890967|37802417|FG004|Overall Study|Lost to Follow-up|0|||
16852339|NCT01890967|37802418|FG005|Overall Study|Lost to Follow-up|1|||
16852340|NCT01890967|37802413|FG000|Overall Study|Protocol Violation|0|||
16852341|NCT01890967|37802414|FG001|Overall Study|Protocol Violation|3|||
16852342|NCT01890967|37802415|FG002|Overall Study|Protocol Violation|3|||
16932057|NCT01243944|38076114|FG001|Overall Study|Adverse Event|13|||
16932058|NCT01243944|38076113|FG000|Overall Study|Lost to Follow-up|2|||
16932059|NCT01243944|38076114|FG001|Overall Study|Lost to Follow-up|1|||
16932060|NCT01243944|38076113|FG000|Overall Study|Physician Decision|2|||
16932061|NCT01243944|38076114|FG001|Overall Study|Physician Decision|7|||
16932062|NCT01243944|38076113|FG000|Overall Study|Disease progression|12|||
16932063|NCT01243944|38076114|FG001|Overall Study|Disease progression|11|||
16932064|NCT01243944|38076113|FG000|Overall Study|Protocol deviation|1|||
16932065|NCT01243944|38076114|FG001|Overall Study|Protocol deviation|1|||
16932066|NCT01243944|38076113|FG000|Overall Study|Participant decision|10|||
16932067|NCT01243944|38076114|FG001|Overall Study|Participant decision|15|||
16932068|NCT01243944|38076113|FG000|Overall Study|Death|2|||
16932069|NCT01243944|38076114|FG001|Overall Study|Death|3|||
16932070|NCT01243944|38076113|FG000|Overall Study|Non-compliance with study treatment|1|||
16932071|NCT01243944|38076114|FG001|Overall Study|Non-compliance with study treatment|0|||
16932072|NCT01243242|38076123|FG000|Overall Study|Adverse Event|1|||
16932073|NCT01243242|38076124|FG001|Overall Study|Adverse Event|1|||
16932074|NCT01243242|38076123|FG000|Overall Study|Withdrawal by Subject|1|||
17019208|NCT00460603|38163753|FG003|Phase 2|Death|0|||
17019209|NCT00460603|38163754|FG004|Phase 2|Death|0|||
17019210|NCT00460603|38163755|FG005|Phase 2|Death|0|||
17019211|NCT00460603|38163756|FG006|Phase 2|Death|0|||
17019212|NCT00460603|38163757|FG007|Phase 2|Death|0|||
17019213|NCT00460603|38163758|FG008|Phase 2|Death|0|||
17019214|NCT00460603|38163759|FG009|Phase 2|Death|4|||
17019215|NCT00460603|38163760|FG010|Phase 2|Death|2|||
17019216|NCT00460603|38163761|FG011|Phase 2|Death|2|||
16932075|NCT01243242|38076124|FG001|Overall Study|Withdrawal by Subject|1|||
16932076|NCT01243242|38076123|FG000|Overall Study|Physician Decision|0|||
16932077|NCT01243242|38076124|FG001|Overall Study|Physician Decision|1|||
16932078|NCT01243242|38076123|FG000|Overall Study|sponsor decision|0|||
16932079|NCT01243242|38076124|FG001|Overall Study|sponsor decision|1|||
17019217|NCT00460603|38163750|FG000|Phase 2|Protocol Violation|0|||
17019218|NCT00460603|38163751|FG001|Phase 2|Protocol Violation|0|||
16932080|NCT01243242|38076123|FG000|Overall Study|non compliance|1|||
16932081|NCT01243242|38076124|FG001|Overall Study|non compliance|0|||
16932082|NCT01242813|38076130|FG000|Overall Study|Lost to Follow-up|2|||
16932083|NCT01242111|38076134|FG000|Overall Study|Adverse Event|1|||
16852343|NCT01890967|37802416|FG003|Overall Study|Protocol Violation|2|||
16852344|NCT01890967|37802417|FG004|Overall Study|Protocol Violation|4|||
16852345|NCT01890967|37802418|FG005|Overall Study|Protocol Violation|1|||
16852346|NCT01890967|37802413|FG000|Overall Study|Sponsor Decision|2|||
16852347|NCT01890967|37802414|FG001|Overall Study|Sponsor Decision|0|||
16852348|NCT01890967|37802415|FG002|Overall Study|Sponsor Decision|1|||
16852349|NCT01890967|37802416|FG003|Overall Study|Sponsor Decision|3|||
16852350|NCT01890967|37802417|FG004|Overall Study|Sponsor Decision|2|||
16852351|NCT01890967|37802418|FG005|Overall Study|Sponsor Decision|3|||
16852352|NCT01890967|37802413|FG000|Overall Study|Withdrawal by Subject|3|||
16852353|NCT01890967|37802414|FG001|Overall Study|Withdrawal by Subject|4|||
16852354|NCT01890967|37802415|FG002|Overall Study|Withdrawal by Subject|2|||
16852355|NCT01890967|37802416|FG003|Overall Study|Withdrawal by Subject|3|||
16852356|NCT01890967|37802417|FG004|Overall Study|Withdrawal by Subject|3|||
16852357|NCT01890967|37802418|FG005|Overall Study|Withdrawal by Subject|1|||
16852358|NCT01400919|37802437|FG000|Overall Study|Withdrawal by Subject|4|||
16852359|NCT01400919|37802437|FG000|Overall Study|Lost to Follow-up|2|||
16852360|NCT01400919|37802437|FG000|Overall Study|Missed visit|2|||
16852361|NCT01864291|37802441|FG000|Overall Study|need for revision surgery|2|||
16852362|NCT01400841|37802445|FG000|Initial Study Phase (6 Months)|Death|1|||
16852363|NCT01400841|37802445|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
16852364|NCT01863667|37802451|FG000|Overall Study|Adverse Event|1|||
16852365|NCT01863667|37802452|FG001|Overall Study|Adverse Event|0|||
16852366|NCT01863667|37802451|FG000|Overall Study|Study terminated by Sponsor|30|||
16852367|NCT01863667|37802452|FG001|Overall Study|Study terminated by Sponsor|30|||
16852368|NCT01863667|37802451|FG000|Overall Study|Withdrawal by Subject|2|||
16852369|NCT01863667|37802452|FG001|Overall Study|Withdrawal by Subject|2|||
16852370|NCT01614769|37802458|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
16852371|NCT01614769|37802459|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
16852372|NCT01614769|37802460|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
16852373|NCT01614769|37802461|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
16852374|NCT01614769|37802462|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
16852375|NCT01614769|37802463|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
16852376|NCT01614769|37802458|FG000|Period 1|Protocol Violation|0|||
16852377|NCT01614769|37802459|FG001|Period 1|Protocol Violation|0|||
16852378|NCT01614769|37802460|FG002|Period 1|Protocol Violation|0|||
16852379|NCT01614769|37802461|FG003|Period 1|Protocol Violation|1|||
16852380|NCT01614769|37802462|FG004|Period 1|Protocol Violation|0|||
16852381|NCT01614769|37802463|FG005|Period 1|Protocol Violation|0|||
16852382|NCT01614769|37802458|FG000|Period 1|Withdrawal by Subject|1|||
16932084|NCT01242111|38076134|FG000|Overall Study|Withdrawal by Subject|1|||
16932085|NCT01242111|38076134|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
16932086|NCT01241604|38076138|FG000|Screening Period|Screen Failure|3|||
16852383|NCT01614769|37802459|FG001|Period 1|Withdrawal by Subject|0|||
16852384|NCT01614769|37802460|FG002|Period 1|Withdrawal by Subject|0|||
16852385|NCT01614769|37802461|FG003|Period 1|Withdrawal by Subject|0|||
16852386|NCT01614769|37802462|FG004|Period 1|Withdrawal by Subject|0|||
16852387|NCT01614769|37802463|FG005|Period 1|Withdrawal by Subject|0|||
16852388|NCT01614769|37802458|FG000|Period 3|Withdrawal by Subject|0|||
16852389|NCT01614769|37802459|FG001|Period 3|Withdrawal by Subject|0|||
16852390|NCT01614769|37802460|FG002|Period 3|Withdrawal by Subject|1|||
16852391|NCT01614769|37802461|FG003|Period 3|Withdrawal by Subject|0|||
16852392|NCT01614769|37802462|FG004|Period 3|Withdrawal by Subject|0|||
16852393|NCT01614769|37802463|FG005|Period 3|Withdrawal by Subject|0|||
16852394|NCT01614457|37802473|FG000|Overall Study|Non-Compliance|1|||
16852395|NCT01614457|37802474|FG001|Overall Study|Non-Compliance|0|||
16852396|NCT01614457|37802473|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
16852397|NCT01614457|37802474|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
16852398|NCT01863433|37802480|FG000|Overall Study|Protocol Violation|1|||
16852399|NCT01862029|37802484|FG000|Overall Study|Physician Decision|1|||
16852400|NCT01835431|37802491|FG000|Overall Study|Adverse Event|1|||
16932087|NCT01241604|38076139|FG001|Screening Period|Screen Failure|0|||
16932088|NCT01241604|38076140|FG002|Screening Period|Screen Failure|0|||
16932089|NCT01241292|38076149|FG000|Overall Study|Administrative Reason by Sponsor|1|||
16932090|NCT01241292|38076150|FG001|Overall Study|Administrative Reason by Sponsor|0|||
16932091|NCT01241292|38076149|FG000|Overall Study|Disease Progression|2|||
16932092|NCT01241292|38076150|FG001|Overall Study|Disease Progression|0|||
16932093|NCT01241292|38076149|FG000|Overall Study|Study Drug Toxicity|0|||
16932094|NCT01241292|38076150|FG001|Overall Study|Study Drug Toxicity|1|||
16932095|NCT01241292|38076149|FG000|Overall Study|Participant Discontinued Treatment|0|||
16932096|NCT01241292|38076150|FG001|Overall Study|Participant Discontinued Treatment|2|||
16932097|NCT01240863|38076162|FG000|Open-label Titration Period|Adverse Event|47|||
16932098|NCT01240863|38076163|FG001|Open-label Titration Period|Adverse Event|0|||
16852401|NCT01835431|37802492|FG001|Overall Study|Adverse Event|0|||
16932099|NCT01240863|38076164|FG002|Open-label Titration Period|Adverse Event|0|||
16932100|NCT01240863|38076162|FG000|Open-label Titration Period|Lack of Efficacy|19|||
16932101|NCT01240863|38076163|FG001|Open-label Titration Period|Lack of Efficacy|0|||
16932102|NCT01240863|38076164|FG002|Open-label Titration Period|Lack of Efficacy|0|||
16932103|NCT01240863|38076162|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
16932104|NCT01240863|38076163|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
16932105|NCT01240863|38076164|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
16932106|NCT01240863|38076162|FG000|Open-label Titration Period|Protocol Violation|7|||
16932107|NCT01240863|38076163|FG001|Open-label Titration Period|Protocol Violation|0|||
16932108|NCT01240863|38076164|FG002|Open-label Titration Period|Protocol Violation|0|||
16932109|NCT01240863|38076162|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
16932110|NCT01240863|38076163|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
16932111|NCT01240863|38076164|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
16932112|NCT01240863|38076162|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
16932113|NCT01240863|38076163|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
16932114|NCT01240863|38076164|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
16932115|NCT01240863|38076162|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
16932116|NCT01240863|38076163|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
16932117|NCT01240863|38076164|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
16932118|NCT01240863|38076162|FG000|Open-label Titration Period|Other|7|||
16932119|NCT01240863|38076163|FG001|Open-label Titration Period|Other|0|||
16932120|NCT01240863|38076164|FG002|Open-label Titration Period|Other|0|||
16932121|NCT01240863|38076162|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
16932122|NCT01240863|38076163|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
16932123|NCT01240863|38076164|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
16932124|NCT01240863|38076162|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
16932125|NCT01240863|38076163|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
16932126|NCT01240863|38076164|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
16932127|NCT01240863|38076162|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16932128|NCT01240863|38076163|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
16932129|NCT01240863|38076164|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
16932130|NCT01240863|38076162|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
16932131|NCT01240863|38076163|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
16932132|NCT01240863|38076164|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
16932133|NCT01240863|38076162|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
16932134|NCT01240863|38076163|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
16932135|NCT01240863|38076164|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
16932136|NCT01240863|38076162|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
16932137|NCT01240863|38076163|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
16932138|NCT01240863|38076164|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
16932139|NCT01240863|38076162|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
16932140|NCT01240863|38076163|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
16932141|NCT01240863|38076164|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
16932142|NCT01240863|38076162|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
16932143|NCT01240863|38076163|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
16932144|NCT01240863|38076164|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
16932145|NCT01240746|38076179|FG000|Overall Study|Adverse Event|2|||
16932146|NCT01240746|38076180|FG001|Overall Study|Adverse Event|0|||
16932147|NCT01240746|38076181|FG002|Overall Study|Adverse Event|10|||
16932148|NCT01240746|38076179|FG000|Overall Study|Lost to Follow-up|23|||
16932149|NCT01240746|38076180|FG001|Overall Study|Lost to Follow-up|20|||
16932150|NCT01240746|38076181|FG002|Overall Study|Lost to Follow-up|102|||
16932151|NCT01240746|38076179|FG000|Overall Study|Protocol Violation|24|||
16932152|NCT01240746|38076180|FG001|Overall Study|Protocol Violation|15|||
16932153|NCT01240746|38076181|FG002|Overall Study|Protocol Violation|72|||
16932154|NCT01240746|38076179|FG000|Overall Study|Withdrawal by Subject|10|||
16932155|NCT01240746|38076180|FG001|Overall Study|Withdrawal by Subject|13|||
16932156|NCT01240746|38076181|FG002|Overall Study|Withdrawal by Subject|59|||
16932157|NCT01240590|38076194|FG000|Phase I|Refused further treatment|0|||
16932158|NCT01240590|38076195|FG001|Phase I|Refused further treatment|0|||
16932159|NCT01240590|38076196|FG002|Phase I|Refused further treatment|3|||
16932160|NCT01240590|38076197|FG003|Phase I|Refused further treatment|0|||
16932161|NCT01240590|38076198|FG004|Phase I|Refused further treatment|0|||
16932162|NCT01240590|38076194|FG000|Phase II|Refused further treatment|0|||
16932163|NCT01240590|38076195|FG001|Phase II|Refused further treatment|0|||
16932164|NCT01240590|38076196|FG002|Phase II|Refused further treatment|0|||
16932165|NCT01240590|38076197|FG003|Phase II|Refused further treatment|2|||
16932166|NCT01240590|38076198|FG004|Phase II|Refused further treatment|1|||
17019219|NCT00460603|38163752|FG002|Phase 2|Protocol Violation|0|||
16932167|NCT01240200|38076226|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
16852402|NCT01835431|37802491|FG000|Overall Study|other|0|||
16852403|NCT01835431|37802492|FG001|Overall Study|other|2|||
16852404|NCT01835431|37802491|FG000|Overall Study|Withdrawal by Subject|6|||
16852405|NCT01835431|37802492|FG001|Overall Study|Withdrawal by Subject|10|||
16852406|NCT01835431|37802491|FG000|Overall Study|Protocol Violation|1|||
16852407|NCT01835431|37802492|FG001|Overall Study|Protocol Violation|0|||
16852408|NCT01880593|37802500|FG000|Overall Study|Adverse Event|1|||
16932168|NCT01240200|38076227|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
16932169|NCT01356966|38076238|FG000|Overall Study|Withdrawal by Subject|1|||
16932170|NCT01356966|38076239|FG001|Overall Study|Withdrawal by Subject|2|||
16932171|NCT01356966|38076238|FG000|Overall Study|Physician Decision|1|||
16932172|NCT01356966|38076239|FG001|Overall Study|Physician Decision|0|||
16932173|NCT01295827|38076268|FG000|Overall Study|Adverse Event|1|||
16932174|NCT01295827|38076269|FG001|Overall Study|Adverse Event|2|||
16932175|NCT01295827|38076270|FG002|Overall Study|Adverse Event|2|||
16932176|NCT01295827|38076271|FG003|Overall Study|Adverse Event|1|||
16932177|NCT01295827|38076272|FG004|Overall Study|Adverse Event|1|||
16932178|NCT01295827|38076273|FG005|Overall Study|Adverse Event|4|||
16932179|NCT01295827|38076274|FG006|Overall Study|Adverse Event|15|||
16932180|NCT01295827|38076275|FG007|Overall Study|Adverse Event|49|||
16932181|NCT01295827|38076276|FG008|Overall Study|Adverse Event|22|||
16932182|NCT01295827|38076277|FG009|Overall Study|Adverse Event|7|||
16932183|NCT01295827|38076278|FG010|Overall Study|Adverse Event|50|||
16932184|NCT01295827|38076279|FG011|Overall Study|Adverse Event|21|||
16932185|NCT01295827|38076280|FG012|Overall Study|Adverse Event|0|||
16932186|NCT01295827|38076281|FG013|Overall Study|Adverse Event|0|||
16932187|NCT01295827|38076282|FG014|Overall Study|Adverse Event|0|||
16932188|NCT01295827|38076268|FG000|Overall Study|Lost to Follow-up|0|||
16932189|NCT01295827|38076269|FG001|Overall Study|Lost to Follow-up|0|||
16932190|NCT01295827|38076270|FG002|Overall Study|Lost to Follow-up|3|||
16932191|NCT01295827|38076271|FG003|Overall Study|Lost to Follow-up|0|||
16932192|NCT01295827|38076272|FG004|Overall Study|Lost to Follow-up|1|||
16932193|NCT01295827|38076273|FG005|Overall Study|Lost to Follow-up|0|||
16932194|NCT01295827|38076274|FG006|Overall Study|Lost to Follow-up|4|||
16932195|NCT01295827|38076275|FG007|Overall Study|Lost to Follow-up|8|||
16932196|NCT01295827|38076276|FG008|Overall Study|Lost to Follow-up|7|||
16932197|NCT01295827|38076277|FG009|Overall Study|Lost to Follow-up|4|||
16932198|NCT01295827|38076278|FG010|Overall Study|Lost to Follow-up|7|||
16932199|NCT01295827|38076279|FG011|Overall Study|Lost to Follow-up|3|||
16932200|NCT01295827|38076280|FG012|Overall Study|Lost to Follow-up|0|||
16932201|NCT01295827|38076281|FG013|Overall Study|Lost to Follow-up|0|||
16932202|NCT01295827|38076282|FG014|Overall Study|Lost to Follow-up|0|||
16932203|NCT01295827|38076268|FG000|Overall Study|Not Reported|0|||
16932204|NCT01295827|38076269|FG001|Overall Study|Not Reported|0|||
16932205|NCT01295827|38076270|FG002|Overall Study|Not Reported|0|||
16932206|NCT01295827|38076271|FG003|Overall Study|Not Reported|1|||
16932207|NCT01295827|38076272|FG004|Overall Study|Not Reported|0|||
16932208|NCT01295827|38076273|FG005|Overall Study|Not Reported|0|||
16932209|NCT01295827|38076274|FG006|Overall Study|Not Reported|24|||
16932210|NCT01295827|38076275|FG007|Overall Study|Not Reported|58|||
16932211|NCT01295827|38076276|FG008|Overall Study|Not Reported|41|||
16932212|NCT01295827|38076277|FG009|Overall Study|Not Reported|2|||
16932213|NCT01295827|38076278|FG010|Overall Study|Not Reported|23|||
16932214|NCT01295827|38076279|FG011|Overall Study|Not Reported|13|||
16932215|NCT01295827|38076280|FG012|Overall Study|Not Reported|0|||
16932216|NCT01295827|38076281|FG013|Overall Study|Not Reported|0|||
16932217|NCT01295827|38076282|FG014|Overall Study|Not Reported|0|||
16932218|NCT01295827|38076268|FG000|Overall Study|Progressive Disease|2|||
16932219|NCT01295827|38076269|FG001|Overall Study|Progressive Disease|1|||
16932220|NCT01295827|38076270|FG002|Overall Study|Progressive Disease|5|||
16932221|NCT01295827|38076271|FG003|Overall Study|Progressive Disease|2|||
16932222|NCT01295827|38076272|FG004|Overall Study|Progressive Disease|0|||
16932223|NCT01295827|38076273|FG005|Overall Study|Progressive Disease|1|||
16932224|NCT01295827|38076274|FG006|Overall Study|Progressive Disease|87|||
16932225|NCT01295827|38076275|FG007|Overall Study|Progressive Disease|144|||
16932226|NCT01295827|38076276|FG008|Overall Study|Progressive Disease|85|||
16932227|NCT01295827|38076277|FG009|Overall Study|Progressive Disease|40|||
16932228|NCT01295827|38076278|FG010|Overall Study|Progressive Disease|175|||
16932229|NCT01295827|38076279|FG011|Overall Study|Progressive Disease|136|||
16932230|NCT01295827|38076280|FG012|Overall Study|Progressive Disease|0|||
16932231|NCT01295827|38076281|FG013|Overall Study|Progressive Disease|0|||
16932232|NCT01295827|38076282|FG014|Overall Study|Progressive Disease|0|||
16852409|NCT01880593|37802501|FG001|Overall Study|Adverse Event|0|||
16852410|NCT01880593|37802500|FG000|Overall Study|Lack of Efficacy|1|||
16932233|NCT01295827|38076268|FG000|Overall Study|Screen Failure|0|||
16932234|NCT01295827|38076269|FG001|Overall Study|Screen Failure|0|||
16932235|NCT01295827|38076270|FG002|Overall Study|Screen Failure|0|||
16932236|NCT01295827|38076271|FG003|Overall Study|Screen Failure|0|||
16932237|NCT01295827|38076272|FG004|Overall Study|Screen Failure|0|||
16932238|NCT01295827|38076273|FG005|Overall Study|Screen Failure|0|||
16932239|NCT01295827|38076274|FG006|Overall Study|Screen Failure|2|||
16932240|NCT01295827|38076275|FG007|Overall Study|Screen Failure|2|||
16932241|NCT01295827|38076276|FG008|Overall Study|Screen Failure|2|||
16932242|NCT01295827|38076277|FG009|Overall Study|Screen Failure|0|||
16932243|NCT01295827|38076278|FG010|Overall Study|Screen Failure|1|||
16932244|NCT01295827|38076279|FG011|Overall Study|Screen Failure|0|||
16932245|NCT01295827|38076280|FG012|Overall Study|Screen Failure|0|||
16932246|NCT01295827|38076281|FG013|Overall Study|Screen Failure|0|||
16932247|NCT01295827|38076282|FG014|Overall Study|Screen Failure|0|||
16932248|NCT01295827|38076268|FG000|Overall Study|Withdrawal by Subject|1|||
16932249|NCT01295827|38076269|FG001|Overall Study|Withdrawal by Subject|0|||
16932250|NCT01295827|38076270|FG002|Overall Study|Withdrawal by Subject|2|||
16932251|NCT01295827|38076271|FG003|Overall Study|Withdrawal by Subject|0|||
16932252|NCT01295827|38076272|FG004|Overall Study|Withdrawal by Subject|0|||
16932253|NCT01295827|38076273|FG005|Overall Study|Withdrawal by Subject|1|||
16932254|NCT01295827|38076274|FG006|Overall Study|Withdrawal by Subject|13|||
16932255|NCT01295827|38076275|FG007|Overall Study|Withdrawal by Subject|35|||
16932256|NCT01295827|38076276|FG008|Overall Study|Withdrawal by Subject|11|||
16932257|NCT01295827|38076277|FG009|Overall Study|Withdrawal by Subject|2|||
16932258|NCT01295827|38076278|FG010|Overall Study|Withdrawal by Subject|18|||
16932259|NCT01295827|38076279|FG011|Overall Study|Withdrawal by Subject|13|||
16932260|NCT01295827|38076280|FG012|Overall Study|Withdrawal by Subject|0|||
16852411|NCT01880593|37802501|FG001|Overall Study|Lack of Efficacy|5|||
16852412|NCT01880593|37802500|FG000|Overall Study|Withdrawal by Subject|6|||
16852413|NCT01880593|37802501|FG001|Overall Study|Withdrawal by Subject|1|||
16852414|NCT01880515|37802509|FG000|Overall Study|Lost to Follow-up|3|||
16852415|NCT01880515|37802510|FG001|Overall Study|Lost to Follow-up|2|||
16852416|NCT01880515|37802509|FG000|Overall Study|Disease Progression|5|||
16852417|NCT01880515|37802510|FG001|Overall Study|Disease Progression|7|||
16852418|NCT01400451|37802520|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
16852419|NCT01400451|37802521|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
16852420|NCT01400451|37802522|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
16852421|NCT01400451|37802520|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
16852422|NCT01400451|37802521|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
16852423|NCT01400451|37802522|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
16852424|NCT01400451|37802520|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
16932261|NCT01295827|38076281|FG013|Overall Study|Withdrawal by Subject|0|||
16932262|NCT01295827|38076282|FG014|Overall Study|Withdrawal by Subject|0|||
16932263|NCT01295827|38076268|FG000|Overall Study|Other|0|||
16932264|NCT01295827|38076269|FG001|Overall Study|Other|0|||
16932265|NCT01295827|38076270|FG002|Overall Study|Other|0|||
16932266|NCT01295827|38076271|FG003|Overall Study|Other|0|||
16932267|NCT01295827|38076272|FG004|Overall Study|Other|0|||
16932268|NCT01295827|38076273|FG005|Overall Study|Other|0|||
16932269|NCT01295827|38076274|FG006|Overall Study|Other|1|||
16932270|NCT01295827|38076275|FG007|Overall Study|Other|1|||
16932271|NCT01295827|38076276|FG008|Overall Study|Other|1|||
16932272|NCT01295827|38076277|FG009|Overall Study|Other|0|||
16932273|NCT01295827|38076278|FG010|Overall Study|Other|2|||
16932274|NCT01295827|38076279|FG011|Overall Study|Other|0|||
16932275|NCT01295827|38076280|FG012|Overall Study|Other|0|||
16932276|NCT01295827|38076281|FG013|Overall Study|Other|0|||
16932277|NCT01295827|38076282|FG014|Overall Study|Other|0|||
16932278|NCT01295671|38076338|FG000|Overall Study|Lost to Follow-up|4|||
16932279|NCT01295671|38076339|FG001|Overall Study|Lost to Follow-up|6|||
16932280|NCT01295671|38076340|FG002|Overall Study|Lost to Follow-up|3|||
16932281|NCT01295671|38076338|FG000|Overall Study|Withdrawal by Subject|3|||
16932282|NCT01295671|38076339|FG001|Overall Study|Withdrawal by Subject|1|||
16932283|NCT01295671|38076340|FG002|Overall Study|Withdrawal by Subject|0|||
16932284|NCT01295320|38076348|FG000|Overall Study|Adverse Event|2|||
16932285|NCT01295320|38076348|FG000|Overall Study|Lost to Follow-up|4|||
16852425|NCT01400451|37802521|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
16852426|NCT01400451|37802522|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
16852427|NCT01400451|37802520|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
16852428|NCT01400451|37802521|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
16932286|NCT01295320|38076348|FG000|Overall Study|Withdrawal by Subject|2|||
16932287|NCT01295320|38076348|FG000|Overall Study|Subject was bedridden|1|||
16932288|NCT01295320|38076348|FG000|Overall Study|Unable to travel|1|||
16932289|NCT01295281|38076354|FG000|First Intervention (7 Days)|Death|0|||
16932290|NCT01295281|38076355|FG001|First Intervention (7 Days)|Death|1|||
16932291|NCT01294696|38076363|FG000|Overall Study|Screening failures|7|||
16932292|NCT01294696|38076363|FG000|Overall Study|Protocol Violation|8|||
16932293|NCT01294696|38076363|FG000|Overall Study|Missing BPI Response|7|||
16852429|NCT01400451|37802522|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
16852430|NCT01400451|37802520|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
16932294|NCT01294696|38076363|FG000|Overall Study|Site closure|52|||
16932295|NCT01294579|38076368|FG000|Overall Study|Disease progression|12|||
16932296|NCT01294579|38076368|FG000|Overall Study|Adverse Event|11|||
16932297|NCT01294579|38076368|FG000|Overall Study|Study closed/terminated|3|||
16932298|NCT01294579|38076368|FG000|Overall Study|Lost to Follow-up|1|||
16932299|NCT01294579|38076368|FG000|Overall Study|Physician Decision|3|||
16932300|NCT01294579|38076368|FG000|Overall Study|Withdrawal by Subject|5|||
16932301|NCT01294462|38076374|FG000|Overall Study|Lost to Follow-up|1|||
16932302|NCT01294462|38076375|FG001|Overall Study|Lost to Follow-up|0|||
16932303|NCT01294462|38076374|FG000|Overall Study|Withdrawal by Subject|65|||
16932304|NCT01294462|38076375|FG001|Overall Study|Withdrawal by Subject|63|||
16932305|NCT01294423|38076384|FG000|Overall Study|Adverse Event|1|||
16932306|NCT01294423|38076385|FG001|Overall Study|Adverse Event|2|||
16932307|NCT01294423|38076386|FG002|Overall Study|Adverse Event|3|||
16932308|NCT01294423|38076384|FG000|Overall Study|Withdrawal by Subject|1|||
16932309|NCT01294423|38076385|FG001|Overall Study|Withdrawal by Subject|2|||
16932310|NCT01294423|38076386|FG002|Overall Study|Withdrawal by Subject|2|||
16932311|NCT01294423|38076384|FG000|Overall Study|subject no longer meets study criteria|2|||
16932312|NCT01294423|38076385|FG001|Overall Study|subject no longer meets study criteria|5|||
16932313|NCT01294423|38076386|FG002|Overall Study|subject no longer meets study criteria|2|||
16932314|NCT01294423|38076384|FG000|Overall Study|poor/non-compliance|1|||
16932315|NCT01294423|38076385|FG001|Overall Study|poor/non-compliance|0|||
16932316|NCT01294423|38076386|FG002|Overall Study|poor/non-compliance|1|||
16932317|NCT01294150|38076396|FG000|Overall Study|Physician Decision|2|||
16932318|NCT01294150|38076397|FG001|Overall Study|Physician Decision|2|||
16932319|NCT01292473|38076409|FG000|Overall Study|Adverse Event|1|||
16932320|NCT01292473|38076410|FG001|Overall Study|Adverse Event|0|||
16932321|NCT01292473|38076411|FG002|Overall Study|Adverse Event|1|||
16932322|NCT01292473|38076412|FG003|Overall Study|Adverse Event|1|||
16932323|NCT01292473|38076409|FG000|Overall Study|Lost to Follow-up|1|||
16932324|NCT01292473|38076410|FG001|Overall Study|Lost to Follow-up|1|||
16932325|NCT01292473|38076411|FG002|Overall Study|Lost to Follow-up|2|||
16932326|NCT01292473|38076412|FG003|Overall Study|Lost to Follow-up|2|||
16932327|NCT01292473|38076409|FG000|Overall Study|Withdrawal by Subject|3|||
16932328|NCT01292473|38076410|FG001|Overall Study|Withdrawal by Subject|4|||
16932329|NCT01292473|38076411|FG002|Overall Study|Withdrawal by Subject|3|||
16932330|NCT01292473|38076412|FG003|Overall Study|Withdrawal by Subject|3|||
16932331|NCT01292473|38076409|FG000|Overall Study|Physician Decision|0|||
16932332|NCT01292473|38076410|FG001|Overall Study|Physician Decision|1|||
16932333|NCT01292473|38076411|FG002|Overall Study|Physician Decision|0|||
16932334|NCT01292473|38076412|FG003|Overall Study|Physician Decision|0|||
16932335|NCT01292473|38076409|FG000|Overall Study|Disease Progression|0|||
16932336|NCT01292473|38076410|FG001|Overall Study|Disease Progression|1|||
16932337|NCT01292473|38076411|FG002|Overall Study|Disease Progression|3|||
16932338|NCT01292473|38076412|FG003|Overall Study|Disease Progression|6|||
16932339|NCT01292239|38076428|FG000|Overall Study|Other|1|||
16932340|NCT01292239|38076429|FG001|Overall Study|Other|1|||
16932341|NCT01292239|38076428|FG000|Overall Study|Withdrawal by Subject|3|||
16932342|NCT01292239|38076429|FG001|Overall Study|Withdrawal by Subject|6|||
16932343|NCT01291225|38076437|FG000|Overall Study|Lost to Follow-up|85|||
16932344|NCT01291225|38076438|FG001|Overall Study|Lost to Follow-up|39|||
16932345|NCT01290796|38076448|FG000|Overall Study|Lost to Follow-up|21|||
16932346|NCT01290796|38076448|FG000|Overall Study|Withdrawal by Subject|4|||
16932347|NCT01290796|38076448|FG000|Overall Study|Physician Decision|2|||
16932348|NCT01290796|38076448|FG000|Overall Study|Secondary Surgical Intervention|2|||
16932349|NCT01290796|38076448|FG000|Overall Study|Withdrawal by Sponsor|1|||
16932350|NCT01290757|38076454|FG000|Overall Study|Adverse Event|1|||
16932351|NCT01290757|38076455|FG001|Overall Study|Adverse Event|0|||
16932352|NCT01290757|38076454|FG000|Overall Study|Protocol Violation|1|||
16932353|NCT01290757|38076455|FG001|Overall Study|Protocol Violation|1|||
16932354|NCT01290757|38076454|FG000|Overall Study|Other|0|||
16932355|NCT01290757|38076455|FG001|Overall Study|Other|1|||
16932356|NCT01290718|38076461|FG000|Overall Study|Early termination of the study|4|||
16932357|NCT01290679|38076467|FG000|Overall Study|Adverse Event|2|||
16932358|NCT01290679|38076468|FG001|Overall Study|Adverse Event|0|||
16932359|NCT01290679|38076467|FG000|Overall Study|Lost to Follow-up|8|||
16932360|NCT01290679|38076468|FG001|Overall Study|Lost to Follow-up|10|||
16932361|NCT01290679|38076467|FG000|Overall Study|Protocol Violation|0|||
16932362|NCT01290679|38076468|FG001|Overall Study|Protocol Violation|1|||
16932363|NCT01290679|38076467|FG000|Overall Study|Withdrawal by Subject|6|||
16932364|NCT01290679|38076468|FG001|Overall Study|Withdrawal by Subject|5|||
16932365|NCT01290679|38076467|FG000|Overall Study|Subject Entered Another Trial|0|||
16932366|NCT01290679|38076468|FG001|Overall Study|Subject Entered Another Trial|5|||
16932367|NCT01290601|38076476|FG000|Overall Study|Adverse Event|0|||
16932368|NCT01290601|38076477|FG001|Overall Study|Adverse Event|2|||
16932369|NCT01290601|38076478|FG002|Overall Study|Adverse Event|0|||
16932370|NCT01290601|38076479|FG003|Overall Study|Adverse Event|0|||
16932371|NCT01290601|38076476|FG000|Overall Study|Lack of Efficacy|2|||
16932372|NCT01290601|38076477|FG001|Overall Study|Lack of Efficacy|1|||
16932373|NCT01290601|38076478|FG002|Overall Study|Lack of Efficacy|0|||
16932374|NCT01290601|38076479|FG003|Overall Study|Lack of Efficacy|0|||
16932375|NCT01290601|38076476|FG000|Overall Study|Lost to Follow-up|7|||
16932376|NCT01290601|38076477|FG001|Overall Study|Lost to Follow-up|2|||
16932377|NCT01290601|38076478|FG002|Overall Study|Lost to Follow-up|0|||
16932378|NCT01290601|38076479|FG003|Overall Study|Lost to Follow-up|0|||
16932379|NCT01290601|38076476|FG000|Overall Study|Other|1|||
16932380|NCT01290601|38076477|FG001|Overall Study|Other|0|||
16932381|NCT01290601|38076478|FG002|Overall Study|Other|0|||
16932382|NCT01290601|38076479|FG003|Overall Study|Other|0|||
16932383|NCT01290601|38076476|FG000|Overall Study|Protocol Violation|1|||
16932384|NCT01290601|38076477|FG001|Overall Study|Protocol Violation|0|||
16932385|NCT01290601|38076478|FG002|Overall Study|Protocol Violation|0|||
16932386|NCT01290601|38076479|FG003|Overall Study|Protocol Violation|0|||
16932387|NCT01290523|38076485|FG000|Overall Study|Death|3|||
16932388|NCT01290094|38076489|FG000|Overall Study|Withdrawal by Subject|1|||
16932389|NCT01290094|38076489|FG000|Overall Study|Lost to Follow-up|5|||
16932390|NCT01289821|38076502|FG000|Treatment Period|Withdrawal by Subject|1|||
16932391|NCT01289821|38076502|FG000|Treatment Period|Physician Decision|3|||
16932392|NCT01289821|38076502|FG000|Treatment Period|Adverse Event|4|||
16932393|NCT01289821|38076502|FG000|Treatment Period|Radiological Progression|43|||
17102644|NCT00112437|38241444|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
17102645|NCT00112437|38241445|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
17102646|NCT00112437|38241446|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16932394|NCT01289821|38076502|FG000|Treatment Period|Clinical Progression|2|||
16932395|NCT01289821|38076502|FG000|Treatment Period|Therapeutic procedure required|1|||
16932396|NCT01289821|38076502|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
16932397|NCT01289821|38076502|FG000|Safety Follow-up Period|Protocol Violation|3|||
16932398|NCT01289821|38076502|FG000|Safety Follow-up Period|Unspecified reason|1|||
16932399|NCT01289821|38076502|FG000|Survival Follow-up Period|Protocol Violation|1|||
16932400|NCT01289821|38076502|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
16932401|NCT01289821|38076502|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
16932402|NCT01289782|38076512|FG000|Overall Study|Lost to Follow-up|14|||
16932403|NCT01289782|38076513|FG001|Overall Study|Lost to Follow-up|7|||
16932404|NCT01289782|38076512|FG000|Overall Study|Protocol Violation|1|||
16932405|NCT01289782|38076513|FG001|Overall Study|Protocol Violation|1|||
16932406|NCT01289782|38076512|FG000|Overall Study|Withdrawal by Subject|8|||
16932407|NCT01289782|38076513|FG001|Overall Study|Withdrawal by Subject|2|||
16852431|NCT01400451|37802521|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
16852432|NCT01400451|37802522|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
16852433|NCT01400139|37802535|FG000|HYD Core Study|Adverse Event|210|||
16852434|NCT01400139|37802535|FG000|HYD Core Study|Lack of Efficacy|59|||
16852435|NCT01400139|37802535|FG000|HYD Core Study|Withdrawal by Subject|114|||
16852436|NCT01400139|37802535|FG000|HYD Core Study|Lost to Follow-up|39|||
16852437|NCT01400139|37802535|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
16852438|NCT01400139|37802535|FG000|HYD Core Study|Administrative|56|||
16852439|NCT01400139|37802535|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
16932408|NCT01289782|38076512|FG000|Overall Study|Sponsor's Decision|1|||
16932409|NCT01289782|38076513|FG001|Overall Study|Sponsor's Decision|0|||
16932410|NCT01289782|38076512|FG000|Overall Study|Reason not specified|1|||
16932411|NCT01289782|38076513|FG001|Overall Study|Reason not specified|2|||
16932412|NCT01289353|38076519|FG000|Overall Study|Lost to Follow-up|2|||
16932413|NCT01289119|38076529|FG000|Overall Study|Adverse Event|2|||
16932414|NCT01289119|38076530|FG001|Overall Study|Adverse Event|1|||
16932415|NCT01289119|38076531|FG002|Overall Study|Adverse Event|0|||
16932416|NCT01289119|38076532|FG003|Overall Study|Adverse Event|2|||
16932417|NCT01289119|38076533|FG004|Overall Study|Adverse Event|1|||
16852440|NCT01400139|37802535|FG000|HYD Extension Period|Adverse Event|8|||
16852441|NCT01400139|37802535|FG000|HYD Extension Period|Withdrawal by Subject|5|||
16852442|NCT01400139|37802535|FG000|HYD Extension Period|Administrative|10|||
16852443|NCT01399905|37802543|FG000|Overall Study|Withdrawal by Subject|1|||
16852444|NCT01399905|37802544|FG001|Overall Study|Withdrawal by Subject|1|||
16852445|NCT01725308|37802558|FG000|Treatment Period I|Did Not Receive Drug|1|||
16852446|NCT01725308|37802559|FG001|Treatment Period I|Did Not Receive Drug|0|||
16852447|NCT01725308|37802560|FG002|Treatment Period I|Did Not Receive Drug|0|||
16852448|NCT01725308|37802558|FG000|Treatment Period I|Adverse Event|5|||
16852449|NCT01725308|37802559|FG001|Treatment Period I|Adverse Event|4|||
16852450|NCT01725308|37802560|FG002|Treatment Period I|Adverse Event|21|||
16852451|NCT01725308|37802558|FG000|Treatment Period I|Insufficient Response|7|||
16852452|NCT01725308|37802559|FG001|Treatment Period I|Insufficient Response|0|||
16852453|NCT01725308|37802560|FG002|Treatment Period I|Insufficient Response|5|||
16932418|NCT01289119|38076534|FG005|Overall Study|Adverse Event|0|||
16932419|NCT01289119|38076529|FG000|Overall Study|Major Protocol Deviation|2|||
16932420|NCT01289119|38076530|FG001|Overall Study|Major Protocol Deviation|1|||
16932421|NCT01289119|38076531|FG002|Overall Study|Major Protocol Deviation|3|||
16932422|NCT01289119|38076532|FG003|Overall Study|Major Protocol Deviation|0|||
16932423|NCT01289119|38076533|FG004|Overall Study|Major Protocol Deviation|2|||
16932424|NCT01289119|38076534|FG005|Overall Study|Major Protocol Deviation|1|||
16932425|NCT01289119|38076529|FG000|Overall Study|Lost to Follow-up|0|||
16932426|NCT01289119|38076530|FG001|Overall Study|Lost to Follow-up|3|||
16932427|NCT01289119|38076531|FG002|Overall Study|Lost to Follow-up|0|||
16932428|NCT01289119|38076532|FG003|Overall Study|Lost to Follow-up|0|||
16932429|NCT01289119|38076533|FG004|Overall Study|Lost to Follow-up|0|||
16932430|NCT01289119|38076534|FG005|Overall Study|Lost to Follow-up|1|||
16932431|NCT01289119|38076529|FG000|Overall Study|Withdrawal by Subject|4|||
16932432|NCT01289119|38076530|FG001|Overall Study|Withdrawal by Subject|2|||
16932433|NCT01289119|38076531|FG002|Overall Study|Withdrawal by Subject|4|||
16932434|NCT01289119|38076532|FG003|Overall Study|Withdrawal by Subject|3|||
16932435|NCT01289119|38076533|FG004|Overall Study|Withdrawal by Subject|1|||
16932436|NCT01289119|38076534|FG005|Overall Study|Withdrawal by Subject|1|||
16932437|NCT01289119|38076529|FG000|Overall Study|Pregnancy|0|||
17102647|NCT00112437|38241447|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102648|NCT00112437|38241448|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102649|NCT00112437|38241449|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102650|NCT00112437|38241450|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102651|NCT00112437|38241451|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102652|NCT00112437|38241452|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102653|NCT00112437|38241453|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102654|NCT00112437|38241454|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16852454|NCT01725308|37802558|FG000|Treatment Period I|Worsening of the Target Disease|8|||
16932438|NCT01289119|38076530|FG001|Overall Study|Pregnancy|1|||
16932439|NCT01289119|38076531|FG002|Overall Study|Pregnancy|0|||
16932440|NCT01289119|38076532|FG003|Overall Study|Pregnancy|0|||
16932441|NCT01289119|38076533|FG004|Overall Study|Pregnancy|0|||
16932442|NCT01289119|38076534|FG005|Overall Study|Pregnancy|0|||
16932443|NCT01289119|38076529|FG000|Overall Study|Lack of Efficacy|0|||
16932444|NCT01289119|38076530|FG001|Overall Study|Lack of Efficacy|1|||
16932445|NCT01289119|38076531|FG002|Overall Study|Lack of Efficacy|1|||
16932446|NCT01289119|38076532|FG003|Overall Study|Lack of Efficacy|1|||
16932447|NCT01289119|38076533|FG004|Overall Study|Lack of Efficacy|1|||
16932448|NCT01289119|38076534|FG005|Overall Study|Lack of Efficacy|1|||
16932449|NCT01289119|38076529|FG000|Overall Study|Other|1|||
16932450|NCT01289119|38076530|FG001|Overall Study|Other|0|||
16932451|NCT01289119|38076531|FG002|Overall Study|Other|1|||
16932452|NCT01289119|38076532|FG003|Overall Study|Other|0|||
16932453|NCT01289119|38076533|FG004|Overall Study|Other|0|||
16932454|NCT01289119|38076534|FG005|Overall Study|Other|0|||
16932455|NCT01289041|38076548|FG000|Overall Study|Adverse Event|24|||
16932456|NCT01289041|38076548|FG000|Overall Study|Physician Decision|1|||
16932457|NCT01289041|38076548|FG000|Overall Study|Progressive Disease|41|||
16932458|NCT01289041|38076548|FG000|Overall Study|Withdrawal by Subject|3|||
16932459|NCT01289041|38076548|FG000|Overall Study|Death|1|||
16932460|NCT01288729|38076556|FG000|Overall Study|Withdrawal by Subject|1|||
16932461|NCT01288729|38076557|FG001|Overall Study|Withdrawal by Subject|0|||
16932462|NCT01288612|38076566|FG000|Overall Study|Unable to contact|11|||
16932463|NCT01288612|38076567|FG001|Overall Study|Unable to contact|16|||
16932464|NCT01288612|38076568|FG002|Overall Study|Unable to contact|20|||
16932465|NCT01288612|38076566|FG000|Overall Study|Declined|78|||
16932466|NCT01288612|38076567|FG001|Overall Study|Declined|63|||
16932467|NCT01288612|38076568|FG002|Overall Study|Declined|62|||
16932468|NCT01288612|38076566|FG000|Overall Study|Unable to intubate|0|||
16932469|NCT01288612|38076567|FG001|Overall Study|Unable to intubate|3|||
16852455|NCT01725308|37802559|FG001|Treatment Period I|Worsening of the Target Disease|0|||
16852456|NCT01725308|37802560|FG002|Treatment Period I|Worsening of the Target Disease|2|||
16852457|NCT01725308|37802558|FG000|Treatment Period I|Changes in the Episodes|3|||
16852458|NCT01725308|37802559|FG001|Treatment Period I|Changes in the Episodes|0|||
16852459|NCT01725308|37802560|FG002|Treatment Period I|Changes in the Episodes|2|||
16852460|NCT01725308|37802558|FG000|Treatment Period I|Withdrawal of Consent|12|||
16852461|NCT01725308|37802559|FG001|Treatment Period I|Withdrawal of Consent|7|||
16852462|NCT01725308|37802560|FG002|Treatment Period I|Withdrawal of Consent|5|||
16852463|NCT01725308|37802558|FG000|Treatment Period I|Lost to Follow-up|3|||
16852464|NCT01725308|37802559|FG001|Treatment Period I|Lost to Follow-up|2|||
16852465|NCT01725308|37802560|FG002|Treatment Period I|Lost to Follow-up|2|||
16852466|NCT01725308|37802558|FG000|Treatment Period I|Protocol Deviations|3|||
16852467|NCT01725308|37802559|FG001|Treatment Period I|Protocol Deviations|1|||
16852468|NCT01725308|37802560|FG002|Treatment Period I|Protocol Deviations|1|||
16852469|NCT01725308|37802558|FG000|Treatment Period I|Miscellaneous|2|||
16852470|NCT01725308|37802559|FG001|Treatment Period I|Miscellaneous|0|||
16932470|NCT01288612|38076568|FG002|Overall Study|Unable to intubate|0|||
16932471|NCT01287832|38076578|FG000|Overall Study|Adverse Event|1|||
16932472|NCT01287832|38076579|FG001|Overall Study|Adverse Event|0|||
16932473|NCT01287832|38076578|FG000|Overall Study|Death|0|||
16932474|NCT01287832|38076579|FG001|Overall Study|Death|1|||
16932475|NCT01287754|38076587|FG000|Overall Study|Death|2|||
16932476|NCT01287754|38076588|FG001|Overall Study|Death|12|||
16932477|NCT01287754|38076587|FG000|Overall Study|Lost to Follow-up|1|||
16932478|NCT01287754|38076588|FG001|Overall Study|Lost to Follow-up|6|||
16852471|NCT01725308|37802560|FG002|Treatment Period I|Miscellaneous|3|||
16852472|NCT01725308|37802558|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
16852473|NCT01725308|37802559|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
16852474|NCT01725308|37802560|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
16852475|NCT01725308|37802558|FG000|Treatment Period II|Did Not Receive Drug|4|||
16852476|NCT01725308|37802559|FG001|Treatment Period II|Did Not Receive Drug|0|||
16852477|NCT01725308|37802560|FG002|Treatment Period II|Did Not Receive Drug|0|||
16852478|NCT01725308|37802558|FG000|Treatment Period II|Adverse Event|13|||
16852479|NCT01725308|37802559|FG001|Treatment Period II|Adverse Event|8|||
16852480|NCT01725308|37802560|FG002|Treatment Period II|Adverse Event|20|||
16932479|NCT01287754|38076587|FG000|Overall Study|Protocol Violation|0|||
16932480|NCT01287754|38076588|FG001|Overall Study|Protocol Violation|3|||
16852481|NCT01725308|37802558|FG000|Treatment Period II|Insufficient Response|2|||
16852482|NCT01725308|37802559|FG001|Treatment Period II|Insufficient Response|4|||
16932481|NCT01287520|38076608|FG000|Overall Study|Adverse Event|2|||
16932482|NCT01287520|38076609|FG001|Overall Study|Adverse Event|2|||
16932483|NCT01287520|38076610|FG002|Overall Study|Adverse Event|2|||
16932484|NCT01287520|38076611|FG003|Overall Study|Adverse Event|1|||
16932485|NCT01287520|38076612|FG004|Overall Study|Adverse Event|1|||
16932486|NCT01287520|38076613|FG005|Overall Study|Adverse Event|2|||
16932487|NCT01287520|38076614|FG006|Overall Study|Adverse Event|0|||
16932488|NCT01287520|38076615|FG007|Overall Study|Adverse Event|2|||
16932489|NCT01287520|38076616|FG008|Overall Study|Adverse Event|0|||
16932490|NCT01287520|38076608|FG000|Overall Study|Physician Decision|1|||
16932491|NCT01287520|38076609|FG001|Overall Study|Physician Decision|1|||
16932492|NCT01287520|38076610|FG002|Overall Study|Physician Decision|2|||
16932493|NCT01287520|38076611|FG003|Overall Study|Physician Decision|0|||
16932494|NCT01287520|38076612|FG004|Overall Study|Physician Decision|1|||
16932495|NCT01287520|38076613|FG005|Overall Study|Physician Decision|1|||
17019220|NCT00460603|38163753|FG003|Phase 2|Protocol Violation|0|||
17019221|NCT00460603|38163754|FG004|Phase 2|Protocol Violation|0|||
17019222|NCT00460603|38163755|FG005|Phase 2|Protocol Violation|0|||
17019223|NCT00460603|38163756|FG006|Phase 2|Protocol Violation|0|||
17019224|NCT00460603|38163757|FG007|Phase 2|Protocol Violation|0|||
17019225|NCT00460603|38163758|FG008|Phase 2|Protocol Violation|0|||
17019226|NCT00460603|38163759|FG009|Phase 2|Protocol Violation|1|||
17019227|NCT00460603|38163760|FG010|Phase 2|Protocol Violation|1|||
17019228|NCT00460603|38163761|FG011|Phase 2|Protocol Violation|0|||
17019229|NCT00460603|38163750|FG000|Phase 2|Lost to Follow-up|0|||
17019230|NCT00460603|38163751|FG001|Phase 2|Lost to Follow-up|0|||
17019231|NCT00460603|38163752|FG002|Phase 2|Lost to Follow-up|0|||
17019232|NCT00460603|38163753|FG003|Phase 2|Lost to Follow-up|0|||
17019233|NCT00460603|38163754|FG004|Phase 2|Lost to Follow-up|0|||
17019234|NCT00460603|38163755|FG005|Phase 2|Lost to Follow-up|0|||
17019235|NCT00460603|38163756|FG006|Phase 2|Lost to Follow-up|0|||
17019236|NCT00460603|38163757|FG007|Phase 2|Lost to Follow-up|0|||
17019237|NCT00460603|38163758|FG008|Phase 2|Lost to Follow-up|0|||
17019238|NCT00460603|38163759|FG009|Phase 2|Lost to Follow-up|1|||
17019239|NCT00460603|38163760|FG010|Phase 2|Lost to Follow-up|0|||
17019240|NCT00460603|38163761|FG011|Phase 2|Lost to Follow-up|0|||
17019241|NCT00460603|38163750|FG000|Phase 2|Other|0|||
17019242|NCT00460603|38163751|FG001|Phase 2|Other|0|||
17019243|NCT00460603|38163752|FG002|Phase 2|Other|0|||
17019244|NCT00460603|38163753|FG003|Phase 2|Other|0|||
17019245|NCT00460603|38163754|FG004|Phase 2|Other|0|||
17019246|NCT00460603|38163755|FG005|Phase 2|Other|0|||
17019247|NCT00460603|38163756|FG006|Phase 2|Other|0|||
17019248|NCT00460603|38163757|FG007|Phase 2|Other|0|||
17019249|NCT00460603|38163758|FG008|Phase 2|Other|0|||
17019250|NCT00460603|38163759|FG009|Phase 2|Other|6|||
17019251|NCT00460603|38163760|FG010|Phase 2|Other|16|||
17019252|NCT00460603|38163761|FG011|Phase 2|Other|7|||
17019253|NCT00460603|38163750|FG000|Phase 2|Objective Progression or Relapse|0|||
17019254|NCT00460603|38163751|FG001|Phase 2|Objective Progression or Relapse|0|||
17019255|NCT00460603|38163752|FG002|Phase 2|Objective Progression or Relapse|0|||
17019256|NCT00460603|38163753|FG003|Phase 2|Objective Progression or Relapse|0|||
17019257|NCT00460603|38163754|FG004|Phase 2|Objective Progression or Relapse|0|||
17019258|NCT00460603|38163755|FG005|Phase 2|Objective Progression or Relapse|0|||
17019259|NCT00460603|38163756|FG006|Phase 2|Objective Progression or Relapse|0|||
17019260|NCT00460603|38163757|FG007|Phase 2|Objective Progression or Relapse|0|||
17019261|NCT00460603|38163758|FG008|Phase 2|Objective Progression or Relapse|0|||
16852483|NCT01725308|37802560|FG002|Treatment Period II|Insufficient Response|6|||
16852484|NCT01725308|37802558|FG000|Treatment Period II|Worsening of the Target Disease|1|||
16852485|NCT01725308|37802559|FG001|Treatment Period II|Worsening of the Target Disease|4|||
16932496|NCT01287520|38076614|FG006|Overall Study|Physician Decision|0|||
16932497|NCT01287520|38076615|FG007|Overall Study|Physician Decision|1|||
16932498|NCT01287520|38076616|FG008|Overall Study|Physician Decision|0|||
16932499|NCT01287520|38076608|FG000|Overall Study|Progressive disease|0|||
16932500|NCT01287520|38076609|FG001|Overall Study|Progressive disease|4|||
17019262|NCT00460603|38163759|FG009|Phase 2|Objective Progression or Relapse|9|||
17019263|NCT00460603|38163760|FG010|Phase 2|Objective Progression or Relapse|10|||
16852486|NCT01725308|37802560|FG002|Treatment Period II|Worsening of the Target Disease|2|||
16852487|NCT01725308|37802558|FG000|Treatment Period II|Changes in the Episodes|1|||
16852488|NCT01725308|37802559|FG001|Treatment Period II|Changes in the Episodes|0|||
16852489|NCT01725308|37802560|FG002|Treatment Period II|Changes in the Episodes|5|||
16852490|NCT01725308|37802558|FG000|Treatment Period II|Withdrawal of Consent|28|||
16852491|NCT01725308|37802559|FG001|Treatment Period II|Withdrawal of Consent|2|||
16852492|NCT01725308|37802560|FG002|Treatment Period II|Withdrawal of Consent|16|||
16852493|NCT01725308|37802558|FG000|Treatment Period II|Lost to Follow-up|1|||
16852494|NCT01725308|37802559|FG001|Treatment Period II|Lost to Follow-up|5|||
16852495|NCT01725308|37802560|FG002|Treatment Period II|Lost to Follow-up|3|||
16852496|NCT01725308|37802558|FG000|Treatment Period II|Protocol Deviations|0|||
16852497|NCT01725308|37802559|FG001|Treatment Period II|Protocol Deviations|0|||
16852498|NCT01725308|37802560|FG002|Treatment Period II|Protocol Deviations|1|||
16852499|NCT01725308|37802558|FG000|Treatment Period II|Miscellaneous|5|||
16852500|NCT01725308|37802559|FG001|Treatment Period II|Miscellaneous|3|||
16852501|NCT01725308|37802560|FG002|Treatment Period II|Miscellaneous|7|||
16852502|NCT01724528|37802577|FG000|Overall Study|Death|3|||
16852503|NCT01724528|37802578|FG001|Overall Study|Death|0|||
16852504|NCT01724528|37802577|FG000|Overall Study|Withdrawal by Subject|0|||
16852505|NCT01724528|37802578|FG001|Overall Study|Withdrawal by Subject|2|||
16852506|NCT01724528|37802577|FG000|Overall Study|Protocol Violation|0|||
16852507|NCT01724528|37802578|FG001|Overall Study|Protocol Violation|1|||
16932501|NCT01287520|38076610|FG002|Overall Study|Progressive disease|1|||
16932502|NCT01287520|38076611|FG003|Overall Study|Progressive disease|6|||
16932503|NCT01287520|38076612|FG004|Overall Study|Progressive disease|1|||
16932504|NCT01287520|38076613|FG005|Overall Study|Progressive disease|0|||
16932505|NCT01287520|38076614|FG006|Overall Study|Progressive disease|2|||
16932506|NCT01287520|38076615|FG007|Overall Study|Progressive disease|2|||
16932507|NCT01287520|38076616|FG008|Overall Study|Progressive disease|4|||
16932508|NCT01287520|38076608|FG000|Overall Study|Withdrawal by Subject|0|||
16932509|NCT01287520|38076609|FG001|Overall Study|Withdrawal by Subject|0|||
16932510|NCT01287520|38076610|FG002|Overall Study|Withdrawal by Subject|0|||
16932511|NCT01287520|38076611|FG003|Overall Study|Withdrawal by Subject|0|||
16932512|NCT01287520|38076612|FG004|Overall Study|Withdrawal by Subject|0|||
16932513|NCT01287520|38076613|FG005|Overall Study|Withdrawal by Subject|1|||
16932514|NCT01287520|38076614|FG006|Overall Study|Withdrawal by Subject|0|||
16932515|NCT01287520|38076615|FG007|Overall Study|Withdrawal by Subject|0|||
16932516|NCT01287520|38076616|FG008|Overall Study|Withdrawal by Subject|1|||
16932517|NCT01287403|38076665|FG000|1st Intervention (1 Day)|Adverse Event|1|||
16932518|NCT01287364|38076681|FG000|Overall Study|Adverse Event|0|||
16932519|NCT01287364|38076682|FG001|Overall Study|Adverse Event|3|||
16932520|NCT01287364|38076681|FG000|Overall Study|Protocol Violation|5|||
16932521|NCT01287364|38076682|FG001|Overall Study|Protocol Violation|5|||
16932522|NCT01287364|38076681|FG000|Overall Study|Other Reason|4|||
16932523|NCT01287364|38076682|FG001|Overall Study|Other Reason|2|||
16932524|NCT01287013|38076704|FG000|Overall Study|Non-evaluable|3|||
16932525|NCT01287013|38076705|FG001|Overall Study|Non-evaluable|5|||
16932526|NCT01287013|38076706|FG002|Overall Study|Non-evaluable|21|||
17019264|NCT00460603|38163761|FG011|Phase 2|Objective Progression or Relapse|17|||
17019265|NCT00460603|38163750|FG000|Phase 2|Global Deterioration of Health Status|0|||
17019266|NCT00460603|38163751|FG001|Phase 2|Global Deterioration of Health Status|0|||
17019267|NCT00460603|38163752|FG002|Phase 2|Global Deterioration of Health Status|0|||
17019268|NCT00460603|38163753|FG003|Phase 2|Global Deterioration of Health Status|0|||
17019269|NCT00460603|38163754|FG004|Phase 2|Global Deterioration of Health Status|0|||
17019270|NCT00460603|38163755|FG005|Phase 2|Global Deterioration of Health Status|0|||
17019271|NCT00460603|38163756|FG006|Phase 2|Global Deterioration of Health Status|0|||
17019272|NCT00460603|38163757|FG007|Phase 2|Global Deterioration of Health Status|0|||
17019273|NCT00460603|38163758|FG008|Phase 2|Global Deterioration of Health Status|0|||
17019274|NCT00460603|38163759|FG009|Phase 2|Global Deterioration of Health Status|0|||
17019275|NCT00460603|38163760|FG010|Phase 2|Global Deterioration of Health Status|1|||
17019276|NCT00460603|38163761|FG011|Phase 2|Global Deterioration of Health Status|0|||
17019277|NCT00460603|38163750|FG000|Phase 2|Withdrawal by Subject|0|||
17019278|NCT00460603|38163751|FG001|Phase 2|Withdrawal by Subject|0|||
17019279|NCT00460603|38163752|FG002|Phase 2|Withdrawal by Subject|0|||
17019280|NCT00460603|38163753|FG003|Phase 2|Withdrawal by Subject|0|||
16852508|NCT01724528|37802577|FG000|Overall Study|Patient refused to attend last visit|1|||
16932527|NCT01286779|38076714|FG000|Overall Study|Withdrawal by Subject|9|||
17019281|NCT00460603|38163754|FG004|Phase 2|Withdrawal by Subject|0|||
16932528|NCT01286779|38076714|FG000|Overall Study|Protocol Violation|5|||
16932529|NCT01286779|38076714|FG000|Overall Study|Physician Decision|2|||
16932530|NCT01286779|38076714|FG000|Overall Study|Participant had scheduled surgery|1|||
16932531|NCT01286779|38076714|FG000|Overall Study|Participant moved to another country|1|||
16932532|NCT01286779|38076714|FG000|Overall Study|Discontinued by sponsor|1|||
16932533|NCT01286740|38076728|FG000|Overall Study|Enrolled but not treated|1|||
16932534|NCT01286740|38076728|FG000|Overall Study|Protocol Violation|1|||
16932535|NCT01286311|38076734|FG000|Overall Study|Physician did not want outreach sent|14|||
16852509|NCT01724528|37802578|FG001|Overall Study|Patient refused to attend last visit|0|||
16852510|NCT01779440|37802586|FG000|Overall Study|Withdrawal by Subject|3|||
16852511|NCT01779440|37802587|FG001|Overall Study|Withdrawal by Subject|5|||
16852512|NCT01750346|37802596|FG000|Overall Study|Adverse Event|1|||
16852513|NCT01750346|37802597|FG001|Overall Study|Adverse Event|0|||
16852514|NCT01750346|37802598|FG002|Overall Study|Adverse Event|0|||
16852515|NCT01750268|37802608|FG000|Overall Study|Lost to Follow-up|0|||
16852516|NCT01750268|37802609|FG001|Overall Study|Lost to Follow-up|2|||
16932536|NCT01286311|38076735|FG001|Overall Study|Physician did not want outreach sent|0|||
16932537|NCT01286077|38076743|FG000|Overall Study|Adverse Event|2|||
16932538|NCT01286077|38076744|FG001|Overall Study|Adverse Event|0|||
16932539|NCT01286077|38076743|FG000|Overall Study|Death|1|||
16932540|NCT01286077|38076744|FG001|Overall Study|Death|0|||
16932541|NCT01286077|38076743|FG000|Overall Study|Protocol Violation|1|||
16852517|NCT01750268|37802608|FG000|Overall Study|Physician Decision|0|||
16852518|NCT01750268|37802609|FG001|Overall Study|Physician Decision|3|||
16852519|NCT01750268|37802608|FG000|Overall Study|Withdrawal by Subject|2|||
16852520|NCT01750268|37802609|FG001|Overall Study|Withdrawal by Subject|0|||
16852521|NCT01880437|37802618|FG000|Overall Study|Death|12|||
16852522|NCT01880437|37802619|FG001|Overall Study|Death|4|||
16852523|NCT01880437|37802620|FG002|Overall Study|Death|17|||
16852524|NCT01880437|37802618|FG000|Overall Study|Study terminated by Sponsor|3|||
16852525|NCT01880437|37802619|FG001|Overall Study|Study terminated by Sponsor|0|||
16852526|NCT01880437|37802620|FG002|Overall Study|Study terminated by Sponsor|2|||
16852527|NCT01861717|37802630|FG000|Overall Study|Lost to Follow-up|1|||
16852528|NCT01861717|37802630|FG000|Overall Study|Withdrawal by Subject|1|||
16852529|NCT01834729|37802639|FG000|Overall Study|Did not return bowel diaries|0|||
16852530|NCT01834729|37802640|FG001|Overall Study|Did not return bowel diaries|0|||
16852531|NCT01834729|37802641|FG002|Overall Study|Did not return bowel diaries|3|||
16852532|NCT01834729|37802642|FG003|Overall Study|Did not return bowel diaries|0|||
16932542|NCT01286077|38076744|FG001|Overall Study|Protocol Violation|1|||
16932543|NCT01286077|38076743|FG000|Overall Study|Withdrawal by Subject|0|||
16932544|NCT01286077|38076744|FG001|Overall Study|Withdrawal by Subject|2|||
16932545|NCT01286077|38076743|FG000|Overall Study|Intercurrent illness|1|||
16932546|NCT01286077|38076744|FG001|Overall Study|Intercurrent illness|0|||
17019282|NCT00460603|38163755|FG005|Phase 2|Withdrawal by Subject|0|||
17019283|NCT00460603|38163756|FG006|Phase 2|Withdrawal by Subject|0|||
17019284|NCT00460603|38163757|FG007|Phase 2|Withdrawal by Subject|0|||
17019285|NCT00460603|38163758|FG008|Phase 2|Withdrawal by Subject|0|||
17019286|NCT00460603|38163759|FG009|Phase 2|Withdrawal by Subject|5|||
17019287|NCT00460603|38163760|FG010|Phase 2|Withdrawal by Subject|4|||
17019288|NCT00460603|38163761|FG011|Phase 2|Withdrawal by Subject|5|||
17019289|NCT00460603|38163750|FG000|Phase 2|Randomized, but not treated|0|||
17019290|NCT00460603|38163751|FG001|Phase 2|Randomized, but not treated|0|||
17019291|NCT00460603|38163752|FG002|Phase 2|Randomized, but not treated|0|||
17019292|NCT00460603|38163753|FG003|Phase 2|Randomized, but not treated|0|||
17019293|NCT00460603|38163754|FG004|Phase 2|Randomized, but not treated|0|||
17019294|NCT00460603|38163755|FG005|Phase 2|Randomized, but not treated|0|||
17019295|NCT00460603|38163756|FG006|Phase 2|Randomized, but not treated|0|||
17019296|NCT00460603|38163757|FG007|Phase 2|Randomized, but not treated|0|||
17019297|NCT00460603|38163758|FG008|Phase 2|Randomized, but not treated|0|||
17019298|NCT00460603|38163759|FG009|Phase 2|Randomized, but not treated|3|||
17019299|NCT00460603|38163760|FG010|Phase 2|Randomized, but not treated|0|||
17019300|NCT00460603|38163761|FG011|Phase 2|Randomized, but not treated|0|||
17019301|NCT00662038|38163787|FG000|Overall Study|Reason not specified|3|||
17019302|NCT00662038|38163787|FG000|Overall Study|Withdrawn consent|22|||
17019303|NCT00662038|38163787|FG000|Overall Study|Withdrawal by Subject|83|||
17019304|NCT00662038|38163787|FG000|Overall Study|Sponsor decision|1|||
17019305|NCT00662038|38163787|FG000|Overall Study|Physician Decision|19|||
17019306|NCT00662038|38163787|FG000|Overall Study|Lung transplantation|44|||
17019307|NCT00662038|38163787|FG000|Overall Study|Lost to Follow-up|1|||
17019308|NCT00662038|38163787|FG000|Overall Study|Death|95|||
17019309|NCT00662038|38163787|FG000|Overall Study|Adverse Event|358|||
17019310|NCT00662038|38163787|FG000|Overall Study|Continued treatment|5|||
17019311|NCT00819156|38163797|FG000|Overall Study|Adverse Event|1|||
17019312|NCT00819156|38163798|FG001|Overall Study|Adverse Event|4|||
17019313|NCT00819156|38163799|FG002|Overall Study|Adverse Event|2|||
17019314|NCT00819156|38163800|FG003|Overall Study|Adverse Event|1|||
17019315|NCT00819156|38163801|FG004|Overall Study|Adverse Event|2|||
17019316|NCT00819156|38163802|FG005|Overall Study|Adverse Event|3|||
17019317|NCT00819156|38163797|FG000|Overall Study|Withdrawal by Subject|0|||
17019318|NCT00819156|38163798|FG001|Overall Study|Withdrawal by Subject|3|||
16852533|NCT01834729|37802639|FG000|Overall Study|Withdrawal by Subject|1|||
16852534|NCT01834729|37802640|FG001|Overall Study|Withdrawal by Subject|1|||
16932547|NCT01286077|38076743|FG000|Overall Study|Non-compliance|1|||
17019319|NCT00819156|38163799|FG002|Overall Study|Withdrawal by Subject|2|||
17019320|NCT00819156|38163800|FG003|Overall Study|Withdrawal by Subject|0|||
17102655|NCT00112437|38241455|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16932548|NCT01286077|38076744|FG001|Overall Study|Non-compliance|0|||
16932549|NCT01286077|38076743|FG000|Overall Study|The subject starts with alternative MMY|0|||
16932550|NCT01286077|38076744|FG001|Overall Study|The subject starts with alternative MMY|3|||
16932551|NCT01286077|38076743|FG000|Overall Study|Patient's decision to stop treatment|3|||
16932552|NCT01286077|38076744|FG001|Overall Study|Patient's decision to stop treatment|0|||
16932553|NCT01286077|38076743|FG000|Overall Study|Progression of disease|0|||
16932554|NCT01286077|38076744|FG001|Overall Study|Progression of disease|1|||
16932555|NCT01286077|38076743|FG000|Overall Study|refill medication not received in time|1|||
16932556|NCT01286077|38076744|FG001|Overall Study|refill medication not received in time|0|||
16932557|NCT01285960|38076750|FG000|Overall Study|Withdrawal by Subject|2|||
16932558|NCT01285960|38076750|FG000|Overall Study|Lost to Follow-up|2|||
16932559|NCT01285960|38076750|FG000|Overall Study|2 subjects received less 10 sonications|2|||
16932560|NCT01285609|38076762|FG000|Randomized|Progressive Disease|41|||
16932561|NCT01285609|38076763|FG001|Randomized|Progressive Disease|61|||
16932562|NCT01285609|38076762|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
16932563|NCT01285609|38076763|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
16932564|NCT01285609|38076762|FG000|Randomized|Study Drug Toxicity|13|||
16932565|NCT01285609|38076763|FG001|Randomized|Study Drug Toxicity|14|||
16932566|NCT01285609|38076762|FG000|Randomized|Death|5|||
16932567|NCT01285609|38076763|FG001|Randomized|Death|7|||
16932568|NCT01285609|38076762|FG000|Randomized|Withdrawal by Subject|8|||
16932569|NCT01285609|38076763|FG001|Randomized|Withdrawal by Subject|11|||
16932570|NCT01285609|38076762|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
16932571|NCT01285609|38076763|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
16932572|NCT01285609|38076762|FG000|Randomized|Undisclosed Reasons|1|||
16932573|NCT01285609|38076763|FG001|Randomized|Undisclosed Reasons|0|||
16932574|NCT01285609|38076762|FG000|Randomized|Randomized but not Treated|4|||
16932575|NCT01285609|38076763|FG001|Randomized|Randomized but not Treated|4|||
16932576|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
16932577|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
16932578|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
16932579|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
16932580|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
16932581|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
16932582|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
16932583|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
16932584|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Death|11|||
16932585|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Death|3|||
16932586|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
16932587|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
16932588|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Not Reported|0|||
16932589|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Not Reported|2|||
16932590|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
16932591|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
16932592|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
16932593|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
16932594|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
16932595|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
16932596|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
16932597|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
16932598|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
16932599|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
16932600|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
16932601|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
16932602|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
16932603|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
16932604|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
16932605|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
16932606|NCT01285609|38076762|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
16932607|NCT01285609|38076763|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
16932608|NCT01285609|38076762|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
16932609|NCT01285609|38076763|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
16932610|NCT01285492|38076773|FG000|Overall Study|Adverse Event|11|||
16932611|NCT01285492|38076774|FG001|Overall Study|Adverse Event|0|||
16932612|NCT01285492|38076773|FG000|Overall Study|Protocol Violation|3|||
16932613|NCT01285492|38076774|FG001|Overall Study|Protocol Violation|0|||
16932614|NCT01285492|38076773|FG000|Overall Study|Withdrawal by Subject|2|||
16932615|NCT01285492|38076774|FG001|Overall Study|Withdrawal by Subject|1|||
16932616|NCT01285492|38076773|FG000|Overall Study|Death|1|||
16932617|NCT01285492|38076774|FG001|Overall Study|Death|0|||
16932618|NCT01284634|38076784|FG000|Overall Study|Adverse Event|1|||
16932619|NCT01284634|38076785|FG001|Overall Study|Adverse Event|0|||
16932620|NCT01284634|38076786|FG002|Overall Study|Adverse Event|2|||
17019321|NCT00819156|38163801|FG004|Overall Study|Withdrawal by Subject|1|||
17019322|NCT00819156|38163802|FG005|Overall Study|Withdrawal by Subject|0|||
17019323|NCT00819156|38163797|FG000|Overall Study|Protocol Violation|1|||
17019324|NCT00819156|38163798|FG001|Overall Study|Protocol Violation|0|||
17019325|NCT00819156|38163799|FG002|Overall Study|Protocol Violation|1|||
17019326|NCT00819156|38163800|FG003|Overall Study|Protocol Violation|0|||
17019327|NCT00819156|38163801|FG004|Overall Study|Protocol Violation|0|||
17019328|NCT00819156|38163802|FG005|Overall Study|Protocol Violation|1|||
17019329|NCT00819156|38163797|FG000|Overall Study|Lost to Follow-up|0|||
17019330|NCT00819156|38163798|FG001|Overall Study|Lost to Follow-up|1|||
17019331|NCT00819156|38163799|FG002|Overall Study|Lost to Follow-up|0|||
17019332|NCT00819156|38163800|FG003|Overall Study|Lost to Follow-up|0|||
17019333|NCT00819156|38163801|FG004|Overall Study|Lost to Follow-up|0|||
17019334|NCT00819156|38163802|FG005|Overall Study|Lost to Follow-up|2|||
17019335|NCT00819156|38163797|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
17019336|NCT00819156|38163798|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
17019337|NCT00819156|38163799|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
17019338|NCT00819156|38163800|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
17019339|NCT00819156|38163801|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
17019340|NCT00819156|38163802|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
17019341|NCT00819156|38163797|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
17019342|NCT00819156|38163798|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
17019343|NCT00819156|38163799|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
17019344|NCT00819156|38163800|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
17019345|NCT00819156|38163801|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
17019346|NCT00819156|38163802|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
17019347|NCT00819156|38163797|FG000|Overall Study|Prostate-specific antigen progression|0|||
17019348|NCT00819156|38163798|FG001|Overall Study|Prostate-specific antigen progression|0|||
17019349|NCT00819156|38163799|FG002|Overall Study|Prostate-specific antigen progression|0|||
17019350|NCT00819156|38163800|FG003|Overall Study|Prostate-specific antigen progression|0|||
17019351|NCT00819156|38163801|FG004|Overall Study|Prostate-specific antigen progression|1|||
17019352|NCT00819156|38163802|FG005|Overall Study|Prostate-specific antigen progression|0|||
17019353|NCT00459979|38163824|FG000|Overall Study|Withdrawal by Subject|1|||
17019354|NCT00459979|38163824|FG000|Overall Study|Protocol Violation|1|||
17019355|NCT00851786|38163830|FG000|Overall Study|Withdrawal by Subject|0|||
17019356|NCT00851786|38163831|FG001|Overall Study|Withdrawal by Subject|1|||
17019357|NCT00851786|38163830|FG000|Overall Study|Protocol Violation|0|||
17019358|NCT00851786|38163831|FG001|Overall Study|Protocol Violation|1|||
17019359|NCT00851786|38163830|FG000|Overall Study|Lost to Follow-up|1|||
17019360|NCT00851786|38163831|FG001|Overall Study|Lost to Follow-up|0|||
17019361|NCT00851786|38163830|FG000|Overall Study|Incarceration|1|||
17019362|NCT00851786|38163831|FG001|Overall Study|Incarceration|0|||
17019363|NCT00851786|38163830|FG000|Overall Study|Site Closure|1|||
17019364|NCT00851786|38163831|FG001|Overall Study|Site Closure|0|||
17019365|NCT00851786|38163830|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
17019366|NCT00851786|38163831|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
17019367|NCT00665626|38163839|FG000|Overall Study|Lack of Efficacy|8|||
17019368|NCT00665626|38163840|FG001|Overall Study|Lack of Efficacy|5|||
17019369|NCT00665626|38163839|FG000|Overall Study|Lost to Follow-up|0|||
17019370|NCT00665626|38163840|FG001|Overall Study|Lost to Follow-up|2|||
17019371|NCT00665626|38163839|FG000|Overall Study|Withdrawal by Subject|0|||
17019372|NCT00665626|38163840|FG001|Overall Study|Withdrawal by Subject|1|||
17019373|NCT00665626|38163839|FG000|Overall Study|Protocol Violation|0|||
17019374|NCT00665626|38163840|FG001|Overall Study|Protocol Violation|2|||
17019375|NCT00665626|38163839|FG000|Overall Study|Adverse Event|1|||
17019376|NCT00665626|38163840|FG001|Overall Study|Adverse Event|9|||
17019377|NCT00665626|38163839|FG000|Overall Study|Due to exclusion criteria|0|||
16932621|NCT01284634|38076787|FG003|Overall Study|Adverse Event|1|||
16932622|NCT01284361|38076797|FG000|Overall Study|Withdrawal by Subject|1|||
16932623|NCT01284361|38076797|FG000|Overall Study|Protocol Violation|5|||
16932624|NCT01284361|38076797|FG000|Overall Study|Adverse Event|1|||
16932625|NCT01284361|38076797|FG000|Overall Study|Lost to Follow-up|2|||
16932626|NCT01284127|38076804|FG000|Overall Study|Adverse Event|2|||
16932627|NCT01284127|38076804|FG000|Overall Study|Withdrawal by Subject|4|||
16932628|NCT01284127|38076804|FG000|Overall Study|Physician Decision|1|||
16932629|NCT01283971|38076810|FG000|Overall Study|Adverse Event|3|||
16932630|NCT01283971|38076811|FG001|Overall Study|Adverse Event|5|||
17019378|NCT00665626|38163840|FG001|Overall Study|Due to exclusion criteria|1|||
17019379|NCT00665626|38163839|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
17019380|NCT00665626|38163840|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
17019381|NCT00665626|38163839|FG000|Overall Study|Unably to comply with dosing regimen|0|||
16932631|NCT01283971|38076810|FG000|Overall Study|Insufficient therapeutic responses|3|||
16932632|NCT01283971|38076811|FG001|Overall Study|Insufficient therapeutic responses|3|||
16932633|NCT01283971|38076810|FG000|Overall Study|Protocol Violation|5|||
16932634|NCT01283971|38076811|FG001|Overall Study|Protocol Violation|1|||
16932635|NCT01283971|38076810|FG000|Overall Study|Refused treatment|3|||
16932636|NCT01283971|38076811|FG001|Overall Study|Refused treatment|1|||
16932637|NCT01283971|38076810|FG000|Overall Study|Failure to return|0|||
16932638|NCT01283971|38076811|FG001|Overall Study|Failure to return|1|||
16932639|NCT01283971|38076810|FG000|Overall Study|Administrative reasons|1|||
16932640|NCT01283971|38076811|FG001|Overall Study|Administrative reasons|1|||
16932641|NCT01283581|38076820|FG000|Overall Study|Lost to Follow-up|8|||
16932642|NCT01283581|38076821|FG001|Overall Study|Lost to Follow-up|6|||
16932643|NCT01283581|38076822|FG002|Overall Study|Lost to Follow-up|8|||
16932644|NCT01283581|38076820|FG000|Overall Study|Withdrawal by Subject|2|||
16932645|NCT01283581|38076821|FG001|Overall Study|Withdrawal by Subject|5|||
16932646|NCT01283581|38076822|FG002|Overall Study|Withdrawal by Subject|2|||
16932647|NCT01283581|38076820|FG000|Overall Study|Adverse Event|1|||
16932648|NCT01283581|38076821|FG001|Overall Study|Adverse Event|1|||
16932649|NCT01283581|38076822|FG002|Overall Study|Adverse Event|4|||
16932650|NCT01283581|38076820|FG000|Overall Study|Physician Decision|0|||
16932651|NCT01283581|38076821|FG001|Overall Study|Physician Decision|1|||
16932652|NCT01283581|38076822|FG002|Overall Study|Physician Decision|2|||
16932653|NCT01283581|38076820|FG000|Overall Study|Protocol Violation|0|||
16932654|NCT01283581|38076821|FG001|Overall Study|Protocol Violation|1|||
16932655|NCT01283581|38076822|FG002|Overall Study|Protocol Violation|2|||
16932656|NCT01283581|38076820|FG000|Overall Study|Noncompliance|1|||
16932657|NCT01283581|38076821|FG001|Overall Study|Noncompliance|0|||
16932658|NCT01283581|38076822|FG002|Overall Study|Noncompliance|0|||
16932659|NCT01283581|38076820|FG000|Overall Study|Investigator unblinded|0|||
16932660|NCT01283581|38076821|FG001|Overall Study|Investigator unblinded|0|||
16932661|NCT01283581|38076822|FG002|Overall Study|Investigator unblinded|1|||
16932662|NCT01283581|38076820|FG000|Overall Study|"Early termination"|0|||
16932663|NCT01283581|38076821|FG001|Overall Study|"Early termination"|0|||
16932664|NCT01283581|38076822|FG002|Overall Study|"Early termination"|1|||
16932665|NCT01283542|38076833|FG000|Main Phase|Acute or progressive vision loss|1|||
16932666|NCT01283542|38076833|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
16932667|NCT01283542|38076833|FG000|Main Phase|abnormal laboratory values|5|||
16932668|NCT01283542|38076833|FG000|Extension Phase|Physician Decision|1|||
16932669|NCT01283542|38076833|FG000|Extension Phase|Adverse Event|1|||
16932670|NCT01283542|38076833|FG000|Extension Phase|Administrative problems|1|||
16932671|NCT01283464|38076857|FG000|Overall Study|Lost to Follow-up|0|||
16932672|NCT01283464|38076858|FG001|Overall Study|Lost to Follow-up|1|||
16932673|NCT01283464|38076857|FG000|Overall Study|Withdrawal by Subject|1|||
16932674|NCT01283464|38076858|FG001|Overall Study|Withdrawal by Subject|0|||
16932675|NCT01283464|38076857|FG000|Overall Study|Physician Decision|1|||
16932676|NCT01283464|38076858|FG001|Overall Study|Physician Decision|0|||
16932677|NCT01283386|38076866|FG000|Overall Study|Death|2|||
16932678|NCT01283386|38076867|FG001|Overall Study|Death|0|||
16932679|NCT01283386|38076866|FG000|Overall Study|Withdrawal by Subject|2|||
16932680|NCT01283386|38076867|FG001|Overall Study|Withdrawal by Subject|1|||
16932681|NCT01283386|38076866|FG000|Overall Study|Relapse of underlying disease|1|||
16932682|NCT01283386|38076867|FG001|Overall Study|Relapse of underlying disease|3|||
16932683|NCT01283386|38076866|FG000|Overall Study|Progression of underlying disease|2|||
16932684|NCT01283386|38076867|FG001|Overall Study|Progression of underlying disease|7|||
16932685|NCT01283386|38076866|FG000|Overall Study|Reason not specified|1|||
16932686|NCT01283386|38076867|FG001|Overall Study|Reason not specified|0|||
16932687|NCT01283386|38076866|FG000|Overall Study|Protocol Violation|0|||
16932688|NCT01283386|38076867|FG001|Overall Study|Protocol Violation|1|||
16932689|NCT01283152|38076875|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
16932690|NCT01283152|38076876|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
16932691|NCT01283152|38076875|FG000|Overall Study|Refused HESA|1|||
16932692|NCT01283152|38076876|FG001|Overall Study|Refused HESA|0|||
16932693|NCT01283035|38076882|FG000|Overall Study|Subject later found ineligible|1|||
16932694|NCT01282801|38076888|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
16932695|NCT01282801|38076889|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
16932696|NCT01282372|38076895|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
16852535|NCT01834729|37802641|FG002|Overall Study|Withdrawal by Subject|0|||
16852536|NCT01834729|37802642|FG003|Overall Study|Withdrawal by Subject|0|||
16852537|NCT01834729|37802639|FG000|Overall Study|Adverse Event|0|||
16852538|NCT01834729|37802640|FG001|Overall Study|Adverse Event|0|||
16852539|NCT01834729|37802641|FG002|Overall Study|Adverse Event|0|||
16852540|NCT01834729|37802642|FG003|Overall Study|Adverse Event|2|||
16852541|NCT01860703|37802653|FG000|Overall Study|Adverse Event|1|||
16852542|NCT01860703|37802654|FG001|Overall Study|Adverse Event|4|||
16852543|NCT01860703|37802655|FG002|Overall Study|Adverse Event|0|||
16852544|NCT01860703|37802656|FG003|Overall Study|Adverse Event|2|||
16852545|NCT01860703|37802653|FG000|Overall Study|Withdrawal by Subject|0|||
16852546|NCT01860703|37802654|FG001|Overall Study|Withdrawal by Subject|1|||
16852547|NCT01860703|37802655|FG002|Overall Study|Withdrawal by Subject|0|||
16852548|NCT01860703|37802656|FG003|Overall Study|Withdrawal by Subject|0|||
16932697|NCT01282372|38076895|FG000|Overall Study|Lost to Follow-up|23|||
16932698|NCT01282372|38076895|FG000|Overall Study|Withdrawal by Subject|11|||
16932699|NCT01282372|38076895|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
16932700|NCT01282372|38076895|FG000|Overall Study|Death|1|||
16932701|NCT01282372|38076895|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
16932702|NCT01282372|38076895|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
16932703|NCT01282372|38076895|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
16932704|NCT01282372|38076895|FG000|Overall Study|Adverse Event|12|||
16932705|NCT01282294|38076906|FG000|Overall Study|Lost to Follow-up|14|||
16932706|NCT01282294|38076906|FG000|Overall Study|Screening failure|1|||
16932707|NCT01282294|38076906|FG000|Overall Study|Adverse Event|1|||
16932708|NCT01282294|38076906|FG000|Overall Study|Patient non-compliance|2|||
16932709|NCT01282294|38076906|FG000|Overall Study|Physician Decision|1|||
16932710|NCT01282216|38076912|FG000|Overall Study|Graft failure|0|||
16932711|NCT01282216|38076913|FG001|Overall Study|Graft failure|0|||
16932712|NCT01282216|38076914|FG002|Overall Study|Graft failure|3|||
16932713|NCT01282216|38076915|FG003|Overall Study|Graft failure|2|||
16932714|NCT01282216|38076912|FG000|Overall Study|Physician Decision|0|||
16932715|NCT01282216|38076913|FG001|Overall Study|Physician Decision|0|||
16932716|NCT01282216|38076914|FG002|Overall Study|Physician Decision|11|||
16932717|NCT01282216|38076915|FG003|Overall Study|Physician Decision|0|||
16932718|NCT01282216|38076912|FG000|Overall Study|Relapse|0|||
16932719|NCT01282216|38076913|FG001|Overall Study|Relapse|0|||
16932720|NCT01282216|38076914|FG002|Overall Study|Relapse|17|||
16932721|NCT01282216|38076915|FG003|Overall Study|Relapse|6|||
16932722|NCT01282216|38076912|FG000|Overall Study|Death|0|||
16932723|NCT01282216|38076913|FG001|Overall Study|Death|0|||
16932724|NCT01282216|38076914|FG002|Overall Study|Death|2|||
16932725|NCT01282216|38076915|FG003|Overall Study|Death|0|||
16932726|NCT01281865|38076923|FG000|Overall Study|Adverse Event|1|||
16932727|NCT01281865|38076924|FG001|Overall Study|Adverse Event|1|||
16932728|NCT01281865|38076923|FG000|Overall Study|Withdrawal by Subject|1|||
16932729|NCT01281865|38076924|FG001|Overall Study|Withdrawal by Subject|0|||
16932730|NCT01281865|38076923|FG000|Overall Study|Lack of Efficacy|1|||
16932731|NCT01281865|38076924|FG001|Overall Study|Lack of Efficacy|0|||
16932732|NCT01281202|38076932|FG000|Overall Study|Adverse Event|2|||
16932733|NCT01281202|38076933|FG001|Overall Study|Adverse Event|0|||
16932734|NCT01281202|38076932|FG000|Overall Study|Withdrawal by Subject|2|||
16932735|NCT01281202|38076933|FG001|Overall Study|Withdrawal by Subject|2|||
16932736|NCT01281202|38076932|FG000|Overall Study|Protocol Violation|11|||
16932737|NCT01281202|38076933|FG001|Overall Study|Protocol Violation|10|||
16932738|NCT01281202|38076932|FG000|Overall Study|Administrative|2|||
16932739|NCT01281202|38076933|FG001|Overall Study|Administrative|8|||
16932740|NCT01281202|38076932|FG000|Overall Study|Lost to Follow-up|11|||
16932741|NCT01281202|38076933|FG001|Overall Study|Lost to Follow-up|13|||
16932742|NCT01281202|38076932|FG000|Overall Study|Incarceration|0|||
16932743|NCT01281202|38076933|FG001|Overall Study|Incarceration|3|||
16932744|NCT01281124|38076941|FG000|Overall Study|Death|1|||
16932745|NCT01280968|38076949|FG000|Overall Study|Lost to Follow-up|8|||
16932746|NCT01280968|38076950|FG001|Overall Study|Lost to Follow-up|2|||
16932747|NCT01280968|38076949|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
16932748|NCT01280968|38076950|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
16932749|NCT01280968|38076949|FG000|Overall Study|Commuting Problems|2|||
16932750|NCT01280968|38076950|FG001|Overall Study|Commuting Problems|0|||
16932751|NCT01280968|38076949|FG000|Overall Study|Anxiety|2|||
16932752|NCT01280968|38076950|FG001|Overall Study|Anxiety|0|||
16932753|NCT01280968|38076949|FG000|Overall Study|Adverse Event|1|||
16932754|NCT01280968|38076950|FG001|Overall Study|Adverse Event|0|||
16932755|NCT01280968|38076949|FG000|Overall Study|Scheduling Conflicts|1|||
16932756|NCT01280968|38076950|FG001|Overall Study|Scheduling Conflicts|1|||
16932757|NCT01280968|38076949|FG000|Overall Study|Pre-existing Neurological Condition|1|||
16932758|NCT01280968|38076950|FG001|Overall Study|Pre-existing Neurological Condition|0|||
16852549|NCT01860703|37802653|FG000|Overall Study|Personal reason|1|||
16852550|NCT01860703|37802654|FG001|Overall Study|Personal reason|0|||
16852551|NCT01860703|37802655|FG002|Overall Study|Personal reason|1|||
16852552|NCT01860703|37802656|FG003|Overall Study|Personal reason|0|||
16932759|NCT01280968|38076949|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
16932760|NCT01280968|38076950|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
17019382|NCT00665626|38163840|FG001|Overall Study|Unably to comply with dosing regimen|1|||
16852553|NCT01399593|37802674|FG000|Overall Study|Physician Decision|1|||
16852554|NCT01399593|37802675|FG001|Overall Study|Physician Decision|0|||
16852555|NCT01399593|37802674|FG000|Overall Study|Adverse Event|1|||
16852556|NCT01399593|37802675|FG001|Overall Study|Adverse Event|0|||
16852557|NCT01399593|37802674|FG000|Overall Study|Death|1|||
16932761|NCT01280812|38076960|FG000|Overall Study|Withdrawal by Subject|2|||
16932762|NCT01280812|38076961|FG001|Overall Study|Withdrawal by Subject|1|||
16932763|NCT01280812|38076962|FG002|Overall Study|Withdrawal by Subject|0|||
17019383|NCT00665626|38163839|FG000|Overall Study|Death|1|||
17019384|NCT00665626|38163840|FG001|Overall Study|Death|0|||
17019385|NCT00828672|38163848|FG000|Study Treatment|Lost to Follow-up|1|||
17019386|NCT00828672|38163849|FG001|Study Treatment|Lost to Follow-up|0|||
17019387|NCT00828672|38163848|FG000|Study Treatment|Adverse Event|0|||
17019388|NCT00828672|38163849|FG001|Study Treatment|Adverse Event|1|||
17019389|NCT00828672|38163848|FG000|Study Treatment|Complete response, no surgery|1|||
17019390|NCT00828672|38163849|FG001|Study Treatment|Complete response, no surgery|1|||
17019391|NCT00828672|38163848|FG000|Post-surgery (<30 Days)|No central review materials|0|||
17019392|NCT00828672|38163849|FG001|Post-surgery (<30 Days)|No central review materials|1|||
17019393|NCT00873119|38163857|FG000|Overall Study|Patient request|4|||
16932764|NCT01280812|38076960|FG000|Overall Study|Lost to Follow-up|1|||
16932765|NCT01280812|38076961|FG001|Overall Study|Lost to Follow-up|1|||
17019394|NCT00873119|38163858|FG001|Overall Study|Patient request|2|||
17019395|NCT00873119|38163857|FG000|Overall Study|Adverse Event|8|||
17019396|NCT00873119|38163858|FG001|Overall Study|Adverse Event|0|||
16932766|NCT01280812|38076962|FG002|Overall Study|Lost to Follow-up|1|||
16932767|NCT01280656|38076974|FG000|Overall Study|Adverse Event|1|||
17019397|NCT00873119|38163857|FG000|Overall Study|Progressive disease|26|||
17019398|NCT00873119|38163858|FG001|Overall Study|Progressive disease|18|||
17019399|NCT00873119|38163857|FG000|Overall Study|Death|2|||
17019400|NCT00873119|38163858|FG001|Overall Study|Death|1|||
17019401|NCT00873119|38163857|FG000|Overall Study|Other|2|||
17019402|NCT00873119|38163858|FG001|Overall Study|Other|5|||
17019403|NCT00873119|38163857|FG000|Overall Study|Not treated|2|||
17019404|NCT00873119|38163858|FG001|Overall Study|Not treated|0|||
17019405|NCT00661726|38163864|FG000|Overall Study|Adverse Event|1|||
17019406|NCT00865046|38163871|FG000|Overall Study|Lost to Follow-up|1|||
17019407|NCT00865046|38163872|FG001|Overall Study|Lost to Follow-up|4|||
17019408|NCT00865046|38163873|FG002|Overall Study|Lost to Follow-up|0|||
17019409|NCT00865046|38163871|FG000|Overall Study|Death|0|||
17019410|NCT00865046|38163872|FG001|Overall Study|Death|1|||
17019411|NCT00865046|38163873|FG002|Overall Study|Death|1|||
17019412|NCT00865046|38163871|FG000|Overall Study|Withdrawal by Subject|5|||
17019413|NCT00865046|38163872|FG001|Overall Study|Withdrawal by Subject|0|||
17019414|NCT00865046|38163873|FG002|Overall Study|Withdrawal by Subject|0|||
16932768|NCT01280656|38076975|FG001|Overall Study|Adverse Event|14|||
16932769|NCT01280656|38076976|FG002|Overall Study|Adverse Event|13|||
16932770|NCT01280656|38076974|FG000|Overall Study|Lack of Efficacy|1|||
16932771|NCT01280656|38076975|FG001|Overall Study|Lack of Efficacy|22|||
16932772|NCT01280656|38076976|FG002|Overall Study|Lack of Efficacy|38|||
16932773|NCT01280656|38076974|FG000|Overall Study|Treatment shortening (RGT)|0|||
17019415|NCT00828516|38163881|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
17019416|NCT00665392|38163885|FG000|Overall Study|not treated|1|||
17019417|NCT00851630|38163892|FG000|Overall Study|Death|2|||
17019418|NCT00851630|38163893|FG001|Overall Study|Death|1|||
17019419|NCT00851630|38163892|FG000|Overall Study|Clinical failure|0|||
17019420|NCT00851630|38163893|FG001|Overall Study|Clinical failure|1|||
17019421|NCT00459667|38163902|FG000|Overall Study|Adverse Event|9|||
17019422|NCT00459667|38163903|FG001|Overall Study|Adverse Event|12|||
17019423|NCT00459667|38163904|FG002|Overall Study|Adverse Event|8|||
17019424|NCT00459667|38163902|FG000|Overall Study|Lost to Follow-up|5|||
17019425|NCT00459667|38163903|FG001|Overall Study|Lost to Follow-up|9|||
17019426|NCT00459667|38163904|FG002|Overall Study|Lost to Follow-up|3|||
17019427|NCT00459667|38163902|FG000|Overall Study|Pregnancy|1|||
17019428|NCT00459667|38163903|FG001|Overall Study|Pregnancy|1|||
17019429|NCT00459667|38163904|FG002|Overall Study|Pregnancy|1|||
17019430|NCT00459667|38163902|FG000|Overall Study|Protocol Violation|1|||
17019431|NCT00459667|38163903|FG001|Overall Study|Protocol Violation|0|||
17019432|NCT00459667|38163904|FG002|Overall Study|Protocol Violation|0|||
17019433|NCT00459667|38163902|FG000|Overall Study|Withdrawal by Subject|3|||
17019434|NCT00459667|38163903|FG001|Overall Study|Withdrawal by Subject|5|||
17019435|NCT00459667|38163904|FG002|Overall Study|Withdrawal by Subject|5|||
17019436|NCT00459667|38163902|FG000|Overall Study|Other disease modifying treatment|1|||
17019437|NCT00459667|38163903|FG001|Overall Study|Other disease modifying treatment|2|||
17019438|NCT00459667|38163904|FG002|Overall Study|Other disease modifying treatment|1|||
17019439|NCT00459667|38163902|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
17019440|NCT00459667|38163903|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
17102656|NCT00112437|38241456|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16932774|NCT01280656|38076975|FG001|Overall Study|Treatment shortening (RGT)|4|||
16932775|NCT01280656|38076976|FG002|Overall Study|Treatment shortening (RGT)|5|||
16932776|NCT01280656|38076974|FG000|Overall Study|Other|1|||
17019441|NCT00459667|38163904|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
17019442|NCT00459667|38163902|FG000|Overall Study|No treatment administered|6|||
17019443|NCT00459667|38163903|FG001|Overall Study|No treatment administered|3|||
17019444|NCT00459667|38163904|FG002|Overall Study|No treatment administered|1|||
17019445|NCT00828204|38163914|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
17019446|NCT00828204|38163915|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
17102657|NCT00112437|38241457|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17019447|NCT00828204|38163914|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
17019448|NCT00828204|38163915|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
17019449|NCT00828204|38163914|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
17019450|NCT00828204|38163915|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
17019451|NCT00828204|38163914|FG000|Main Study: After Study Restart|Adverse Event|0|||
17019452|NCT00828204|38163915|FG001|Main Study: After Study Restart|Adverse Event|2|||
17019453|NCT00828204|38163914|FG000|Main Study: After Study Restart|Noncompliance|0|||
17019454|NCT00828204|38163915|FG001|Main Study: After Study Restart|Noncompliance|1|||
17019455|NCT00828204|38163914|FG000|Extension Study|Lost to Follow-up|0|||
17019456|NCT00828204|38163915|FG001|Extension Study|Lost to Follow-up|1|||
17019457|NCT00828204|38163914|FG000|Extension Study|Physician Decision|0|||
17019458|NCT00828204|38163915|FG001|Extension Study|Physician Decision|2|||
17019459|NCT00851552|38163922|FG000|Overall Study|Death|2|||
17019460|NCT00851552|38163922|FG000|Overall Study|Adverse Event|1|||
17019461|NCT00851552|38163922|FG000|Overall Study|Disease Progression|4|||
17019462|NCT00459355|38163928|FG000|Overall Study|Subject no longer met inc criteria|20|||
17019463|NCT00459355|38163929|FG001|Overall Study|Subject no longer met inc criteria|18|||
17019464|NCT00459043|38163941|FG000|Overall Study|Withdrawal by Subject|1|||
17019465|NCT00459043|38163942|FG001|Overall Study|Withdrawal by Subject|0|||
17019466|NCT00817206|38163950|FG000|Overall Study|Adverse Event|10|||
17019467|NCT00817206|38163951|FG001|Overall Study|Adverse Event|3|||
17019468|NCT00817206|38163950|FG000|Overall Study|Protocol Violation|0|||
17019469|NCT00817206|38163951|FG001|Overall Study|Protocol Violation|2|||
17019470|NCT00817206|38163950|FG000|Overall Study|Lost to Follow-up|0|||
17019471|NCT00817206|38163951|FG001|Overall Study|Lost to Follow-up|1|||
17019472|NCT00817206|38163950|FG000|Overall Study|Death|2|||
17019473|NCT00817206|38163951|FG001|Overall Study|Death|0|||
17019474|NCT00817206|38163950|FG000|Overall Study|Withdrawal by Subject|7|||
17019475|NCT00817206|38163951|FG001|Overall Study|Withdrawal by Subject|3|||
17019476|NCT00817206|38163950|FG000|Overall Study|Physician Decision|2|||
17019477|NCT00817206|38163951|FG001|Overall Study|Physician Decision|0|||
17019478|NCT00665002|38163957|FG000|Overall Study|Progression/relapse during treatment|11|||
17019479|NCT00665002|38163957|FG000|Overall Study|Cytogenetic resistance|1|||
17019480|NCT03847987|38163963|FG000|Overall Study|Lost to Follow-up|1|||
17019481|NCT03847987|38163964|FG001|Overall Study|Lost to Follow-up|0|||
17019482|NCT03847987|38163963|FG000|Overall Study|Adverse Event|2|||
17019483|NCT03847987|38163964|FG001|Overall Study|Adverse Event|0|||
17019484|NCT00660010|38163981|FG000|Overall Study|Withdrawal by Subject|2|||
17019485|NCT00660010|38163981|FG000|Overall Study|Lost to Follow-up|3|||
17019486|NCT00660010|38163981|FG000|Overall Study|Adverse Event|1|||
17019487|NCT00660010|38163981|FG000|Overall Study|Noncompliance with visit schedule|3|||
17019488|NCT00873041|38163988|FG000|Core Study|Adverse Event|2|||
17019489|NCT00873041|38163989|FG001|Core Study|Adverse Event|3|||
17019490|NCT00873041|38163990|FG002|Core Study|Adverse Event|1|||
17019491|NCT00873041|38163988|FG000|Core Study|Withdrawal by Subject|1|||
17019492|NCT00873041|38163989|FG001|Core Study|Withdrawal by Subject|2|||
17019493|NCT00873041|38163990|FG002|Core Study|Withdrawal by Subject|2|||
17019494|NCT00873041|38163988|FG000|Core Study|Lost to Follow-up|3|||
17019495|NCT00873041|38163989|FG001|Core Study|Lost to Follow-up|1|||
17019496|NCT00873041|38163990|FG002|Core Study|Lost to Follow-up|0|||
17019497|NCT00873041|38163988|FG000|Core Study|Abnormal laboratory value|0|||
17019498|NCT00873041|38163989|FG001|Core Study|Abnormal laboratory value|0|||
17019499|NCT00873041|38163990|FG002|Core Study|Abnormal laboratory value|1|||
17019500|NCT00873041|38163988|FG000|Core Study|Protocol deviation|1|||
17019501|NCT00873041|38163989|FG001|Core Study|Protocol deviation|0|||
17019502|NCT00873041|38163990|FG002|Core Study|Protocol deviation|1|||
17019503|NCT00873041|38163988|FG000|Extension Study|Adverse Event|1|||
17019504|NCT00873041|38163989|FG001|Extension Study|Adverse Event|0|||
17019505|NCT00873041|38163990|FG002|Extension Study|Adverse Event|1|||
17019506|NCT00873041|38163988|FG000|Extension Study|Administrative reasons|0|||
17019507|NCT00873041|38163989|FG001|Extension Study|Administrative reasons|0|||
17019508|NCT00873041|38163990|FG002|Extension Study|Administrative reasons|1|||
17019509|NCT00458341|38164007|FG000|Cycle 1|Adverse Event|1|||
17019510|NCT00458341|38164008|FG001|Cycle 1|Adverse Event|0|||
17019511|NCT00816036|38164016|FG000|Overall Study|Death|47|||
17019512|NCT00816036|38164017|FG001|Overall Study|Death|28|||
17019513|NCT00816036|38164016|FG000|Overall Study|Lost to Follow-up|75|||
17019514|NCT00816036|38164017|FG001|Overall Study|Lost to Follow-up|57|||
17019515|NCT00816036|38164016|FG000|Overall Study|Withdrawal by Subject|54|||
17019516|NCT00816036|38164017|FG001|Overall Study|Withdrawal by Subject|23|||
17019517|NCT00664534|38164025|FG000|Overall Study|Adverse Event|2|||
17019518|NCT00664534|38164026|FG001|Overall Study|Adverse Event|3|||
17019519|NCT00664534|38164025|FG000|Overall Study|Lost to Follow-up|6|||
17019520|NCT00664534|38164026|FG001|Overall Study|Lost to Follow-up|10|||
17019521|NCT00664534|38164025|FG000|Overall Study|Protocol Violation|10|||
17019522|NCT00664534|38164026|FG001|Overall Study|Protocol Violation|8|||
17019523|NCT00664534|38164025|FG000|Overall Study|Withdrawal by Subject|7|||
17019524|NCT00664534|38164026|FG001|Overall Study|Withdrawal by Subject|6|||
17019525|NCT00664534|38164025|FG000|Overall Study|Physician Decision|8|||
17019526|NCT00664534|38164026|FG001|Overall Study|Physician Decision|0|||
17019527|NCT00664534|38164025|FG000|Overall Study|Sponsor decision|8|||
17019528|NCT00664534|38164026|FG001|Overall Study|Sponsor decision|6|||
17019529|NCT00594035|38164034|FG000|Overall Study|Lost to Follow-up|1|||
17019530|NCT00594035|38164035|FG001|Overall Study|Lost to Follow-up|1|||
17019531|NCT00594035|38164034|FG000|Overall Study|Withdrawal by Subject|1|||
17019532|NCT00594035|38164035|FG001|Overall Study|Withdrawal by Subject|0|||
17019533|NCT00594035|38164034|FG000|Overall Study|Subject transferred to nursing home|0|||
17019534|NCT00594035|38164035|FG001|Overall Study|Subject transferred to nursing home|1|||
16932777|NCT01280656|38076975|FG001|Overall Study|Other|7|||
16932778|NCT01280656|38076976|FG002|Overall Study|Other|7|||
16932779|NCT01280617|38076986|FG000|Overall Study|Adverse Event|0|||
16932780|NCT01280617|38076987|FG001|Overall Study|Adverse Event|1|||
16932781|NCT01280266|38076995|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
16932782|NCT01280266|38076996|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
16932783|NCT01280266|38076995|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
16932784|NCT01280266|38076996|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
16932785|NCT01279447|38077008|FG000|Overall Study|Lost to Follow-up|3|||
16932786|NCT01279447|38077009|FG001|Overall Study|Lost to Follow-up|1|||
16932787|NCT01276639|38077031|FG000|Week 0 to 16|Death|1|||
16932788|NCT01276639|38077032|FG001|Week 0 to 16|Death|0|||
16932789|NCT01276639|38077033|FG002|Week 0 to 16|Death|0|||
16932790|NCT01276639|38077034|FG003|Week 0 to 16|Death|0|||
16932791|NCT01276639|38077035|FG004|Week 0 to 16|Death|0|||
16932792|NCT01276639|38077031|FG000|Week 0 to 16|Adverse Event|11|||
16932793|NCT01276639|38077032|FG001|Week 0 to 16|Adverse Event|8|||
16932794|NCT01276639|38077033|FG002|Week 0 to 16|Adverse Event|11|||
16932795|NCT01276639|38077034|FG003|Week 0 to 16|Adverse Event|0|||
16932796|NCT01276639|38077035|FG004|Week 0 to 16|Adverse Event|0|||
16932797|NCT01276639|38077031|FG000|Week 0 to 16|Lack of Efficacy|20|||
16932798|NCT01276639|38077032|FG001|Week 0 to 16|Lack of Efficacy|15|||
16932799|NCT01276639|38077033|FG002|Week 0 to 16|Lack of Efficacy|25|||
16932800|NCT01276639|38077034|FG003|Week 0 to 16|Lack of Efficacy|0|||
16932801|NCT01276639|38077035|FG004|Week 0 to 16|Lack of Efficacy|0|||
16932802|NCT01276639|38077031|FG000|Week 0 to 16|Lost to Follow-up|3|||
16932803|NCT01276639|38077032|FG001|Week 0 to 16|Lost to Follow-up|5|||
16932804|NCT01276639|38077033|FG002|Week 0 to 16|Lost to Follow-up|3|||
16932805|NCT01276639|38077034|FG003|Week 0 to 16|Lost to Follow-up|0|||
16932806|NCT01276639|38077035|FG004|Week 0 to 16|Lost to Follow-up|0|||
16932807|NCT01276639|38077031|FG000|Week 0 to 16|Withdrawal by Subject|8|||
16932808|NCT01276639|38077032|FG001|Week 0 to 16|Withdrawal by Subject|5|||
16932809|NCT01276639|38077033|FG002|Week 0 to 16|Withdrawal by Subject|4|||
16932810|NCT01276639|38077034|FG003|Week 0 to 16|Withdrawal by Subject|0|||
16932811|NCT01276639|38077035|FG004|Week 0 to 16|Withdrawal by Subject|0|||
16932812|NCT01276639|38077031|FG000|Week 0 to 16|Other|7|||
16932813|NCT01276639|38077032|FG001|Week 0 to 16|Other|7|||
16932814|NCT01276639|38077033|FG002|Week 0 to 16|Other|2|||
16932815|NCT01276639|38077034|FG003|Week 0 to 16|Other|0|||
16932816|NCT01276639|38077035|FG004|Week 0 to 16|Other|0|||
16932817|NCT01276639|38077031|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
16932818|NCT01276639|38077032|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
16932819|NCT01276639|38077033|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
16932820|NCT01276639|38077034|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
16932821|NCT01276639|38077035|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
16932822|NCT01276639|38077031|FG000|Week 16 to 52|Death|1|||
16932823|NCT01276639|38077032|FG001|Week 16 to 52|Death|0|||
16932824|NCT01276639|38077033|FG002|Week 16 to 52|Death|0|||
16932825|NCT01276639|38077034|FG003|Week 16 to 52|Death|0|||
16932826|NCT01276639|38077035|FG004|Week 16 to 52|Death|0|||
16932827|NCT01276639|38077031|FG000|Week 16 to 52|Adverse Event|10|||
16932828|NCT01276639|38077032|FG001|Week 16 to 52|Adverse Event|13|||
16932829|NCT01276639|38077033|FG002|Week 16 to 52|Adverse Event|0|||
16932830|NCT01276639|38077034|FG003|Week 16 to 52|Adverse Event|1|||
16932831|NCT01276639|38077035|FG004|Week 16 to 52|Adverse Event|3|||
16932832|NCT01276639|38077031|FG000|Week 16 to 52|Lack of Efficacy|99|||
16932833|NCT01276639|38077032|FG001|Week 16 to 52|Lack of Efficacy|71|||
16932834|NCT01276639|38077033|FG002|Week 16 to 52|Lack of Efficacy|0|||
16932835|NCT01276639|38077034|FG003|Week 16 to 52|Lack of Efficacy|14|||
16932836|NCT01276639|38077035|FG004|Week 16 to 52|Lack of Efficacy|13|||
17019535|NCT00594035|38164034|FG000|Overall Study|Subject couldn't return due to job|0|||
17019536|NCT00594035|38164035|FG001|Overall Study|Subject couldn't return due to job|1|||
16932837|NCT01276639|38077031|FG000|Week 16 to 52|Lost to Follow-up|3|||
16932838|NCT01276639|38077032|FG001|Week 16 to 52|Lost to Follow-up|1|||
16932839|NCT01276639|38077033|FG002|Week 16 to 52|Lost to Follow-up|0|||
16932840|NCT01276639|38077034|FG003|Week 16 to 52|Lost to Follow-up|0|||
16932841|NCT01276639|38077035|FG004|Week 16 to 52|Lost to Follow-up|1|||
16932842|NCT01276639|38077031|FG000|Week 16 to 52|Withdrawal by Subject|4|||
16932843|NCT01276639|38077032|FG001|Week 16 to 52|Withdrawal by Subject|4|||
16932844|NCT01276639|38077033|FG002|Week 16 to 52|Withdrawal by Subject|0|||
17019537|NCT00570310|38164043|FG000|Overall Study|Adverse Event|1|||
17019538|NCT00570310|38164044|FG001|Overall Study|Adverse Event|2|||
17019539|NCT00570310|38164043|FG000|Overall Study|Lack of Efficacy|1|||
17019540|NCT00570310|38164044|FG001|Overall Study|Lack of Efficacy|4|||
17019541|NCT00664066|38164050|FG000|Overall Study|Study terminated|3|||
17019542|NCT00814710|38164056|FG000|Overall Study|Adverse Event|1|||
17019543|NCT00814710|38164057|FG001|Overall Study|Adverse Event|0|||
17019544|NCT00814710|38164056|FG000|Overall Study|Lost to Follow-up|7|||
17019545|NCT00814710|38164057|FG001|Overall Study|Lost to Follow-up|3|||
17019546|NCT00871169|38164063|FG000|Overall Study|Protocol Violation|1|||
17019547|NCT00871169|38164063|FG000|Overall Study|Patient did not receive study treatment|2|||
17019548|NCT00814632|38164067|FG000|Overall Study|Lack of Efficacy|2|||
17019549|NCT00851318|38164075|FG000|Overall Study|Withdrawal by Subject|7|||
17019550|NCT00851318|38164076|FG001|Overall Study|Withdrawal by Subject|1|||
17019551|NCT00851318|38164077|FG002|Overall Study|Withdrawal by Subject|5|||
17019552|NCT00851318|38164078|FG003|Overall Study|Withdrawal by Subject|3|||
17019553|NCT00851318|38164075|FG000|Overall Study|Adverse Event|13|||
17019554|NCT00851318|38164076|FG001|Overall Study|Adverse Event|2|||
17019555|NCT00851318|38164077|FG002|Overall Study|Adverse Event|9|||
17019556|NCT00851318|38164078|FG003|Overall Study|Adverse Event|12|||
17019557|NCT00851318|38164075|FG000|Overall Study|Pregnancy|0|||
17019558|NCT00851318|38164076|FG001|Overall Study|Pregnancy|0|||
17019559|NCT00851318|38164077|FG002|Overall Study|Pregnancy|1|||
17019560|NCT00851318|38164078|FG003|Overall Study|Pregnancy|1|||
17019561|NCT00851318|38164075|FG000|Overall Study|Lack of Efficacy|8|||
17019562|NCT00851318|38164076|FG001|Overall Study|Lack of Efficacy|2|||
17019563|NCT00851318|38164077|FG002|Overall Study|Lack of Efficacy|4|||
17019564|NCT00851318|38164078|FG003|Overall Study|Lack of Efficacy|2|||
17019565|NCT00851318|38164075|FG000|Overall Study|Non-compliance with Study Procedures|2|||
17019566|NCT00851318|38164076|FG001|Overall Study|Non-compliance with Study Procedures|0|||
17019567|NCT00851318|38164077|FG002|Overall Study|Non-compliance with Study Procedures|1|||
17019568|NCT00851318|38164078|FG003|Overall Study|Non-compliance with Study Procedures|0|||
17019569|NCT00851318|38164075|FG000|Overall Study|Physician Decision|0|||
17019570|NCT00851318|38164076|FG001|Overall Study|Physician Decision|0|||
17019571|NCT00851318|38164077|FG002|Overall Study|Physician Decision|1|||
17019572|NCT00851318|38164078|FG003|Overall Study|Physician Decision|1|||
17019573|NCT00593957|38164091|FG000|Overall Study|Physician Decision|0|||
17019574|NCT00593957|38164092|FG001|Overall Study|Physician Decision|1|||
17019575|NCT00593957|38164093|FG002|Overall Study|Physician Decision|2|||
17019576|NCT00870233|38164115|FG000|Overall Study|Withdrawal by Subject|18|||
17019577|NCT00870233|38164115|FG000|Overall Study|Did not undergo laparotomy|3|||
17019578|NCT00870233|38164115|FG000|Overall Study|Incompatible internet browser|2|||
17019579|NCT00870233|38164115|FG000|Overall Study|Death|1|||
17019580|NCT00851084|38164122|FG000|Overall Study|Randomized but not treated|1|||
17019581|NCT00851084|38164123|FG001|Overall Study|Randomized but not treated|0|||
17019582|NCT00851084|38164122|FG000|Overall Study|Adverse Event|26|||
17019583|NCT00851084|38164123|FG001|Overall Study|Adverse Event|36|||
17019584|NCT00851084|38164122|FG000|Overall Study|Disease progression|52|||
17019585|NCT00851084|38164123|FG001|Overall Study|Disease progression|47|||
17019586|NCT00851084|38164122|FG000|Overall Study|Poor compliance to protocol|1|||
17019587|NCT00851084|38164123|FG001|Overall Study|Poor compliance to protocol|1|||
17019588|NCT00851084|38164122|FG000|Overall Study|Physician Decision|13|||
17019589|NCT00851084|38164123|FG001|Overall Study|Physician Decision|14|||
17019590|NCT00851084|38164122|FG000|Overall Study|Consent withdrawn|0|||
17019591|NCT00851084|38164123|FG001|Overall Study|Consent withdrawn|2|||
17019592|NCT00851084|38164122|FG000|Overall Study|Withdrawal by Subject|11|||
17019593|NCT00851084|38164123|FG001|Overall Study|Withdrawal by Subject|12|||
17019594|NCT00851084|38164122|FG000|Overall Study|Metastatic surgery|6|||
17019595|NCT00851084|38164123|FG001|Overall Study|Metastatic surgery|6|||
17019596|NCT00851084|38164122|FG000|Overall Study|Other|7|||
17019597|NCT00851084|38164123|FG001|Overall Study|Other|1|||
17019598|NCT00845858|38164134|FG000|Overall Study|Withdrawal by Subject|5|||
17019599|NCT00845858|38164135|FG001|Overall Study|Withdrawal by Subject|1|||
17019600|NCT00845858|38164136|FG002|Overall Study|Withdrawal by Subject|1|||
17019601|NCT00845858|38164134|FG000|Overall Study|Adverse Event|3|||
17019602|NCT00845858|38164135|FG001|Overall Study|Adverse Event|8|||
17019603|NCT00845858|38164136|FG002|Overall Study|Adverse Event|4|||
17019604|NCT00845858|38164134|FG000|Overall Study|Protocol Violation|0|||
17019605|NCT00845858|38164135|FG001|Overall Study|Protocol Violation|0|||
17019606|NCT00845858|38164136|FG002|Overall Study|Protocol Violation|1|||
17019607|NCT00845858|38164134|FG000|Overall Study|not eligible|0|||
17019608|NCT00845858|38164135|FG001|Overall Study|not eligible|3|||
17019609|NCT00845858|38164136|FG002|Overall Study|not eligible|2|||
17019610|NCT00850538|38164147|FG000|Overall Study|unable/unwilling to complete MRI|13|||
17019611|NCT00850538|38164147|FG000|Overall Study|specimen missed due to scheduling error|14|||
17019612|NCT00850538|38164147|FG000|Overall Study|specimen unusable|7|||
17019613|NCT00850538|38164147|FG000|Overall Study|Withdrawal by Subject|3|||
17019614|NCT00850538|38164147|FG000|Overall Study|radiology error|2|||
17019615|NCT00850538|38164147|FG000|Overall Study|Protocol Violation|2|||
17019616|NCT00850460|38164153|FG000|Overall Study|Lost to Follow-up|4|||
17102658|NCT00112437|38241458|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17019617|NCT00850460|38164154|FG001|Overall Study|Lost to Follow-up|4|||
17019618|NCT00661492|38164162|FG000|Overall Study|Adverse Event|16|||
17019619|NCT00661492|38164163|FG001|Overall Study|Adverse Event|13|||
17019620|NCT00661492|38164162|FG000|Overall Study|Disease Progression|44|||
17019621|NCT00661492|38164163|FG001|Overall Study|Disease Progression|14|||
17019622|NCT00661492|38164162|FG000|Overall Study|Patient Request|6|||
17019623|NCT00661492|38164163|FG001|Overall Study|Patient Request|1|||
17019624|NCT00661492|38164162|FG000|Overall Study|Investigator Request|1|||
17019625|NCT00661492|38164163|FG001|Overall Study|Investigator Request|0|||
17019626|NCT00661492|38164162|FG000|Overall Study|Lost to Follow-up|0|||
17019627|NCT00661492|38164163|FG001|Overall Study|Lost to Follow-up|1|||
17019628|NCT00661492|38164162|FG000|Overall Study|Other|1|||
17019629|NCT00661492|38164163|FG001|Overall Study|Other|0|||
17019630|NCT00850070|38164171|FG000|Overall Study|Lack of Efficacy|1|||
17019631|NCT00850070|38164172|FG001|Overall Study|Lack of Efficacy|1|||
17019632|NCT00850070|38164171|FG000|Overall Study|Adverse Event|2|||
17019633|NCT00850070|38164172|FG001|Overall Study|Adverse Event|0|||
17019634|NCT00592358|38164183|FG000|Overall Study|Withdrawal by Subject|2|||
17019635|NCT00592358|38164183|FG000|Overall Study|Adverse Event|1|||
17019636|NCT00592358|38164183|FG000|Overall Study|Lack of Efficacy|2|||
17019637|NCT00592358|38164183|FG000|Overall Study|Inability to swallow pills|1|||
17019638|NCT00814320|38164189|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
17102659|NCT00112437|38241459|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102660|NCT00112437|38241460|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102661|NCT00112437|38241461|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102662|NCT00112437|38241462|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17019639|NCT00814320|38164190|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
17019640|NCT00814320|38164189|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
17019641|NCT00814320|38164190|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
17019642|NCT00814320|38164189|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
17019643|NCT00814320|38164190|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
17019644|NCT00814320|38164189|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
17019645|NCT00814320|38164190|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
17019646|NCT00814320|38164189|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
17019647|NCT00814320|38164190|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
17019648|NCT00814320|38164189|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
17019649|NCT00814320|38164190|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
17019650|NCT00814320|38164189|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
17019651|NCT00814320|38164190|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
17019652|NCT00814320|38164189|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
17019653|NCT00814320|38164190|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
17019654|NCT00814320|38164189|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
17019655|NCT00814320|38164190|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
17019656|NCT00814320|38164189|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
17019657|NCT00814320|38164190|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
17019658|NCT00869999|38164213|FG000|Overall Study|Withdrawal by Subject|1|||
17019659|NCT00869999|38164213|FG000|Overall Study|removed prior to starting therapy|1|||
17019660|NCT00570232|38164217|FG000|Overall Study|Adverse Event|10|||
17019661|NCT00570232|38164217|FG000|Overall Study|discontinued due to medical condition|3|||
17019662|NCT00570232|38164217|FG000|Overall Study|discontinued due to recurrence|8|||
17019663|NCT00570232|38164217|FG000|Overall Study|discontinued due to noncompliance|2|||
17019664|NCT00809328|38164221|FG000|Overall Study|Lack of Efficacy|18|||
17019665|NCT00809328|38164221|FG000|Overall Study|Adverse Event|6|||
17019666|NCT00809328|38164221|FG000|Overall Study|Protocol Violation|3|||
17019667|NCT00809328|38164221|FG000|Overall Study|Withdrawal by Subject|2|||
17019668|NCT00868517|38164228|FG000|Overall Study|Withdrawal by Subject|3|||
17019669|NCT00868517|38164229|FG001|Overall Study|Withdrawal by Subject|3|||
17019670|NCT00868517|38164230|FG002|Overall Study|Withdrawal by Subject|2|||
17019671|NCT00868517|38164228|FG000|Overall Study|Protocol Violation|1|||
17019672|NCT00868517|38164229|FG001|Overall Study|Protocol Violation|1|||
17019673|NCT00868517|38164230|FG002|Overall Study|Protocol Violation|0|||
17019674|NCT00868439|38164240|FG000|Overall Study|Adverse Event|4|||
17019675|NCT00868439|38164241|FG001|Overall Study|Adverse Event|3|||
17019676|NCT00868439|38164240|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
17019677|NCT00868439|38164241|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
17019678|NCT00868439|38164240|FG000|Overall Study|Death|0|||
17019679|NCT00868439|38164241|FG001|Overall Study|Death|1|||
17019680|NCT00868439|38164240|FG000|Overall Study|Protocol Violation|1|||
17019681|NCT00868439|38164241|FG001|Overall Study|Protocol Violation|1|||
17019682|NCT00868439|38164240|FG000|Overall Study|Physician Decision|1|||
17019683|NCT00868439|38164241|FG001|Overall Study|Physician Decision|0|||
17019684|NCT00868439|38164240|FG000|Overall Study|Withdrawal by Subject|0|||
17019685|NCT00868439|38164241|FG001|Overall Study|Withdrawal by Subject|1|||
17019686|NCT00814164|38164247|FG000|Overall Study|Progression|7|||
17019687|NCT00814164|38164247|FG000|Overall Study|not stated|7|||
17019688|NCT00814164|38164247|FG000|Overall Study|Death|5|||
17019689|NCT00659230|38164253|FG000|Overall Study|Lost to Follow-up|2|||
17019690|NCT00659230|38164254|FG001|Overall Study|Lost to Follow-up|5|||
17019691|NCT00659230|38164253|FG000|Overall Study|Lost source documentation|5|||
17019692|NCT00659230|38164254|FG001|Overall Study|Lost source documentation|4|||
17019693|NCT00659230|38164253|FG000|Overall Study|Did not return post-randomization|2|||
17019694|NCT00659230|38164254|FG001|Overall Study|Did not return post-randomization|3|||
17019695|NCT00809094|38164262|FG000|Overall Study|Lost to Follow-up|0|||
17019696|NCT00809094|38164263|FG001|Overall Study|Lost to Follow-up|1|||
17019697|NCT00658996|38164269|FG000|First Intervention|Positive slit lamp finding|1|||
17019698|NCT00658996|38164270|FG001|First Intervention|Positive slit lamp finding|0|||
17019699|NCT00658996|38164269|FG000|First Intervention|Lack of lenses|0|||
17019700|NCT00658996|38164270|FG001|First Intervention|Lack of lenses|1|||
17019701|NCT00658996|38164269|FG000|Crossover Period|Physician Decision|1|||
17019702|NCT00658996|38164270|FG001|Crossover Period|Physician Decision|0|||
17019703|NCT00658996|38164269|FG000|Crossover Period|Ineligible|1|||
17019704|NCT00658996|38164270|FG001|Crossover Period|Ineligible|1|||
17019705|NCT00658996|38164269|FG000|Second Intervention|Developed a stye on upper lid|1|||
17019706|NCT00658996|38164270|FG001|Second Intervention|Developed a stye on upper lid|0|||
17019707|NCT00658996|38164269|FG000|Second Intervention|Positive slit lamp finding|0|||
17019708|NCT00658996|38164270|FG001|Second Intervention|Positive slit lamp finding|1|||
17019709|NCT00867815|38164276|FG000|Overall Study|Lost to Follow-up|1|||
17019710|NCT00452413|38164283|FG000|Overall Study|Progressive Disease|4|||
17019711|NCT00452413|38164284|FG001|Overall Study|Progressive Disease|11|||
17019712|NCT00452413|38164285|FG002|Overall Study|Progressive Disease|30|||
17019713|NCT00452413|38164283|FG000|Overall Study|Withdrawal by Subject|0|||
17019714|NCT00452413|38164284|FG001|Overall Study|Withdrawal by Subject|1|||
17019715|NCT00452413|38164285|FG002|Overall Study|Withdrawal by Subject|4|||
17019716|NCT00452413|38164283|FG000|Overall Study|Adverse Event|0|||
17019717|NCT00452413|38164284|FG001|Overall Study|Adverse Event|0|||
17019718|NCT00452413|38164285|FG002|Overall Study|Adverse Event|5|||
17019719|NCT00452413|38164283|FG000|Overall Study|Physician Decision|0|||
17019720|NCT00452413|38164284|FG001|Overall Study|Physician Decision|0|||
17019721|NCT00452413|38164285|FG002|Overall Study|Physician Decision|4|||
17019722|NCT00452413|38164283|FG000|Overall Study|Death due to study disease|0|||
17019723|NCT00452413|38164284|FG001|Overall Study|Death due to study disease|0|||
17019724|NCT00452413|38164285|FG002|Overall Study|Death due to study disease|2|||
17019725|NCT00452413|38164283|FG000|Overall Study|Death due to adverse event (AE)|0|||
17019726|NCT00452413|38164284|FG001|Overall Study|Death due to adverse event (AE)|0|||
17019727|NCT00452413|38164285|FG002|Overall Study|Death due to adverse event (AE)|1|||
17019728|NCT00452413|38164283|FG000|Overall Study|On treatment|0|||
16932845|NCT01276639|38077034|FG003|Week 16 to 52|Withdrawal by Subject|0|||
16932846|NCT01276639|38077035|FG004|Week 16 to 52|Withdrawal by Subject|1|||
16932847|NCT01276639|38077031|FG000|Week 16 to 52|Other|10|||
16932848|NCT01276639|38077032|FG001|Week 16 to 52|Other|12|||
16932849|NCT01276639|38077033|FG002|Week 16 to 52|Other|0|||
16932850|NCT01276639|38077034|FG003|Week 16 to 52|Other|1|||
16932851|NCT01276639|38077035|FG004|Week 16 to 52|Other|3|||
16932852|NCT01275625|38077050|FG000|Overall Study|Death|1|||
16932853|NCT01275625|38077050|FG000|Overall Study|Lack of Efficacy|2|||
16932854|NCT01275625|38077050|FG000|Overall Study|Lost to Follow-up|1|||
16932855|NCT01275625|38077050|FG000|Overall Study|Withdrawal by Subject|3|||
16932856|NCT01275625|38077050|FG000|Overall Study|Protocol Violation|1|||
16932857|NCT01275625|38077050|FG000|Overall Study|Adverse Event|4|||
16932858|NCT01275625|38077050|FG000|Overall Study|Other|1|||
16932859|NCT01274338|38077060|FG000|Overall Study|Lack of Efficacy|72|||
16932860|NCT01274338|38077061|FG001|Overall Study|Lack of Efficacy|108|||
16932861|NCT01274338|38077062|FG002|Overall Study|Lack of Efficacy|116|||
16932862|NCT01274338|38077063|FG003|Overall Study|Lack of Efficacy|0|||
16932863|NCT01274338|38077064|FG004|Overall Study|Lack of Efficacy|0|||
16932864|NCT01274338|38077065|FG005|Overall Study|Lack of Efficacy|0|||
16932865|NCT01274338|38077060|FG000|Overall Study|Adverse Event|272|||
16932866|NCT01274338|38077061|FG001|Overall Study|Adverse Event|105|||
16932867|NCT01274338|38077062|FG002|Overall Study|Adverse Event|180|||
16932868|NCT01274338|38077063|FG003|Overall Study|Adverse Event|1|||
16932869|NCT01274338|38077064|FG004|Overall Study|Adverse Event|0|||
16932870|NCT01274338|38077065|FG005|Overall Study|Adverse Event|0|||
16932871|NCT01274338|38077060|FG000|Overall Study|Death|8|||
16932872|NCT01274338|38077061|FG001|Overall Study|Death|1|||
16932873|NCT01274338|38077062|FG002|Overall Study|Death|0|||
16932874|NCT01274338|38077063|FG003|Overall Study|Death|0|||
16932875|NCT01274338|38077064|FG004|Overall Study|Death|0|||
17019729|NCT00452413|38164284|FG001|Overall Study|On treatment|0|||
16932876|NCT01274338|38077065|FG005|Overall Study|Death|0|||
16932877|NCT01274338|38077060|FG000|Overall Study|Withdrawal by Subject|27|||
16932878|NCT01274338|38077061|FG001|Overall Study|Withdrawal by Subject|99|||
16932879|NCT01274338|38077062|FG002|Overall Study|Withdrawal by Subject|17|||
16932880|NCT01274338|38077063|FG003|Overall Study|Withdrawal by Subject|0|||
16932881|NCT01274338|38077064|FG004|Overall Study|Withdrawal by Subject|0|||
16932882|NCT01274338|38077065|FG005|Overall Study|Withdrawal by Subject|0|||
16932883|NCT01274338|38077060|FG000|Overall Study|Did not start treatment|8|||
16932884|NCT01274338|38077061|FG001|Overall Study|Did not start treatment|116|||
16932885|NCT01274338|38077062|FG002|Overall Study|Did not start treatment|7|||
16932886|NCT01274338|38077063|FG003|Overall Study|Did not start treatment|0|||
16932887|NCT01274338|38077064|FG004|Overall Study|Did not start treatment|0|||
16932888|NCT01274338|38077065|FG005|Overall Study|Did not start treatment|0|||
16932889|NCT01274338|38077060|FG000|Overall Study|Alternative therapy|0|||
16932890|NCT01274338|38077061|FG001|Overall Study|Alternative therapy|1|||
16932891|NCT01274338|38077062|FG002|Overall Study|Alternative therapy|0|||
16932892|NCT01274338|38077063|FG003|Overall Study|Alternative therapy|0|||
16932893|NCT01274338|38077064|FG004|Overall Study|Alternative therapy|0|||
16932894|NCT01274338|38077065|FG005|Overall Study|Alternative therapy|0|||
16932895|NCT01274338|38077060|FG000|Overall Study|Other complicating diseases|0|||
16932896|NCT01274338|38077061|FG001|Overall Study|Other complicating diseases|3|||
16932897|NCT01274338|38077062|FG002|Overall Study|Other complicating diseases|1|||
16932898|NCT01274338|38077063|FG003|Overall Study|Other complicating diseases|0|||
16932899|NCT01274338|38077064|FG004|Overall Study|Other complicating diseases|0|||
16932900|NCT01274338|38077065|FG005|Overall Study|Other complicating diseases|0|||
16932901|NCT01274338|38077060|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
16932902|NCT01274338|38077061|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
16932903|NCT01274338|38077062|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
16932904|NCT01274338|38077063|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
16932905|NCT01274338|38077064|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
16932906|NCT01274338|38077065|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
16932907|NCT01274338|38077060|FG000|Overall Study|Pregnancy|0|||
16932908|NCT01274338|38077061|FG001|Overall Study|Pregnancy|0|||
16932909|NCT01274338|38077062|FG002|Overall Study|Pregnancy|1|||
16932910|NCT01274338|38077063|FG003|Overall Study|Pregnancy|0|||
16932911|NCT01274338|38077064|FG004|Overall Study|Pregnancy|0|||
16932912|NCT01274338|38077065|FG005|Overall Study|Pregnancy|0|||
16932913|NCT01274338|38077060|FG000|Overall Study|Reason not reported|12|||
16932914|NCT01274338|38077061|FG001|Overall Study|Reason not reported|21|||
16932915|NCT01274338|38077062|FG002|Overall Study|Reason not reported|3|||
16932916|NCT01274338|38077063|FG003|Overall Study|Reason not reported|0|||
16932917|NCT01274338|38077064|FG004|Overall Study|Reason not reported|1|||
16932918|NCT01274338|38077065|FG005|Overall Study|Reason not reported|0|||
16932919|NCT01272193|38077080|FG000|Overall Study|Adverse Event|1|||
16932920|NCT01272193|38077081|FG001|Overall Study|Adverse Event|1|||
16932921|NCT01272193|38077080|FG000|Overall Study|Lack of Efficacy|0|||
16932922|NCT01272193|38077081|FG001|Overall Study|Lack of Efficacy|3|||
16932923|NCT01272193|38077080|FG000|Overall Study|Withdrawal Criteria|1|||
16932924|NCT01272193|38077081|FG001|Overall Study|Withdrawal Criteria|1|||
16932925|NCT01272193|38077080|FG000|Overall Study|Unclassified|8|||
16932926|NCT01272193|38077081|FG001|Overall Study|Unclassified|7|||
16932927|NCT01270828|38077093|FG000|Pregabalin CR SB|Reason Unspecified|0|||
16932928|NCT01270828|38077094|FG001|Pregabalin CR SB|Reason Unspecified|0|||
16932929|NCT01270828|38077095|FG002|Pregabalin CR SB|Reason Unspecified|8|||
16932930|NCT01270828|38077093|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
16932931|NCT01270828|38077094|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
16932932|NCT01270828|38077095|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
16932933|NCT01270828|38077093|FG000|Pregabalin CR SB|Related adverse event|0|||
16932934|NCT01270828|38077094|FG001|Pregabalin CR SB|Related adverse event|0|||
17019730|NCT00452413|38164285|FG002|Overall Study|On treatment|3|||
17019731|NCT00867503|38164294|FG000|Overall Study|Withdrawal by Subject|1|||
17019732|NCT00867113|38164300|FG000|Treatment Period|Adverse Event|15|||
17019733|NCT00867113|38164300|FG000|Treatment Period|Death|2|||
17019734|NCT00867113|38164300|FG000|Treatment Period|Withdrawal by Subject|19|||
17019735|NCT00867113|38164300|FG000|Treatment Period|Lost to Follow-up|3|||
17019736|NCT00867113|38164300|FG000|Treatment Period|Administrative problems|1|||
17102663|NCT00112437|38241463|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16932935|NCT01270828|38077095|FG002|Pregabalin CR SB|Related adverse event|46|||
16932936|NCT01270828|38077093|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
16932937|NCT01270828|38077094|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
17102664|NCT00112437|38241464|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102665|NCT00112437|38241465|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
17102666|NCT00112437|38241466|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16932938|NCT01270828|38077095|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
16932939|NCT01270828|38077093|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
16932940|NCT01270828|38077094|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
16932941|NCT01270828|38077095|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
17019737|NCT00867113|38164300|FG000|Treatment Period|Disease progression/relapse|1|||
16932942|NCT01270828|38077093|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
16932943|NCT01270828|38077094|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
16932944|NCT01270828|38077095|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
16932945|NCT01270828|38077093|FG000|Pregabalin CR SB|Unrelated AE|0|||
16932946|NCT01270828|38077094|FG001|Pregabalin CR SB|Unrelated AE|0|||
16932947|NCT01270828|38077095|FG002|Pregabalin CR SB|Unrelated AE|8|||
16932948|NCT01270828|38077093|FG000|Pregabalin CR SB|Protocol Violation|0|||
16932949|NCT01270828|38077094|FG001|Pregabalin CR SB|Protocol Violation|0|||
16932950|NCT01270828|38077095|FG002|Pregabalin CR SB|Protocol Violation|8|||
16932951|NCT01270828|38077093|FG000|Double Blind Phase|Death|0|||
16932952|NCT01270828|38077094|FG001|Double Blind Phase|Death|1|||
16932953|NCT01270828|38077095|FG002|Double Blind Phase|Death|0|||
16932954|NCT01270828|38077093|FG000|Double Blind Phase|Protocol Violation|0|||
16932955|NCT01270828|38077094|FG001|Double Blind Phase|Protocol Violation|1|||
16932956|NCT01270828|38077095|FG002|Double Blind Phase|Protocol Violation|0|||
16932957|NCT01270828|38077093|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
16932958|NCT01270828|38077094|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
16932959|NCT01270828|38077095|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
16932960|NCT01270828|38077093|FG000|Double Blind Phase|Reason Unspecified|7|||
16932961|NCT01270828|38077094|FG001|Double Blind Phase|Reason Unspecified|4|||
16932962|NCT01270828|38077095|FG002|Double Blind Phase|Reason Unspecified|0|||
16932963|NCT01270828|38077093|FG000|Double Blind Phase|Withdrawal by Subject|6|||
16932964|NCT01270828|38077094|FG001|Double Blind Phase|Withdrawal by Subject|15|||
16932965|NCT01270828|38077095|FG002|Double Blind Phase|Withdrawal by Subject|0|||
16932966|NCT01270828|38077093|FG000|Double Blind Phase|Lost to Follow-up|1|||
16932967|NCT01270828|38077094|FG001|Double Blind Phase|Lost to Follow-up|2|||
16932968|NCT01270828|38077095|FG002|Double Blind Phase|Lost to Follow-up|0|||
16932969|NCT01270828|38077093|FG000|Double Blind Phase|Lack of Efficacy|2|||
16932970|NCT01270828|38077094|FG001|Double Blind Phase|Lack of Efficacy|11|||
16932971|NCT01270828|38077095|FG002|Double Blind Phase|Lack of Efficacy|0|||
16932972|NCT01270828|38077093|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
16932973|NCT01270828|38077094|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
16932974|NCT01270828|38077095|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
16932975|NCT01270828|38077093|FG000|Double Blind Phase|Adverse event related to study drug|5|||
16932976|NCT01270828|38077094|FG001|Double Blind Phase|Adverse event related to study drug|7|||
16932977|NCT01270828|38077095|FG002|Double Blind Phase|Adverse event related to study drug|0|||
16932978|NCT01269385|38077103|FG000|Overall Study|Adverse Event|1|||
16932979|NCT01269385|38077104|FG001|Overall Study|Adverse Event|1|||
16932980|NCT01269385|38077105|FG002|Overall Study|Adverse Event|0|||
16932981|NCT01269385|38077106|FG003|Overall Study|Adverse Event|0|||
16932982|NCT01269346|38077129|FG000|Treatment Phase|Disease progression|3|||
17019738|NCT00867113|38164300|FG000|Treatment Period|Protocol Violation|4|||
17019739|NCT00867113|38164300|FG000|Post Treatment After Survival Follow-up|Death|1|||
17019740|NCT00867113|38164300|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
17019741|NCT00867113|38164300|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
17019742|NCT00867113|38164300|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
17019743|NCT00451555|38164307|FG000|Overall Study|Protocol Violation|2|||
17019744|NCT00451555|38164308|FG001|Overall Study|Protocol Violation|2|||
17019745|NCT00451555|38164307|FG000|Overall Study|Adverse Event|3|||
17019746|NCT00451555|38164308|FG001|Overall Study|Adverse Event|1|||
17019747|NCT00451555|38164307|FG000|Overall Study|Withdrawal by Subject|6|||
17019748|NCT00451555|38164308|FG001|Overall Study|Withdrawal by Subject|0|||
17019749|NCT00451555|38164307|FG000|Overall Study|Physician Decision|2|||
17019750|NCT00451555|38164308|FG001|Overall Study|Physician Decision|1|||
17019751|NCT00808236|38164325|FG000|Overall Study|Was not resuscitated|50|||
17019752|NCT00808236|38164326|FG001|Overall Study|Was not resuscitated|56|||
17019753|NCT00808236|38164325|FG000|Overall Study|Pre-defined exclusion|13|||
17019754|NCT00808236|38164326|FG001|Overall Study|Pre-defined exclusion|3|||
17019755|NCT00808236|38164325|FG000|Overall Study|Lost to Follow-up|1|||
17019756|NCT00808236|38164326|FG001|Overall Study|Lost to Follow-up|1|||
17019757|NCT00808236|38164325|FG000|Overall Study|Physician Decision|0|||
17019758|NCT00808236|38164326|FG001|Overall Study|Physician Decision|1|||
17019759|NCT00808236|38164325|FG000|Overall Study|Death|18|||
17019760|NCT00808236|38164326|FG001|Overall Study|Death|30|||
17019761|NCT00867035|38164334|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
17019762|NCT00867035|38164335|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
17019763|NCT00867035|38164334|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
17019764|NCT00867035|38164335|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
17019765|NCT00663208|38164348|FG000|Treatment Period|Lost to Follow-up|0|||
17019766|NCT00663208|38164349|FG001|Treatment Period|Lost to Follow-up|1|||
16932983|NCT01269346|38077129|FG000|Treatment Phase|Adverse Event|3|||
17019767|NCT00663208|38164350|FG002|Treatment Period|Lost to Follow-up|0|||
17019768|NCT00663208|38164351|FG003|Treatment Period|Lost to Follow-up|0|||
17019769|NCT00663208|38164352|FG004|Treatment Period|Lost to Follow-up|0|||
17102667|NCT00112437|38241441|FG000|Year 1 (12-Month Base Study)|moved|0|||
17019770|NCT00663208|38164353|FG005|Treatment Period|Lost to Follow-up|0|||
17019771|NCT00663208|38164354|FG006|Treatment Period|Lost to Follow-up|0|||
17019772|NCT00663208|38164348|FG000|Follow-up Period|Lost to Follow-up|2|||
17019773|NCT00663208|38164349|FG001|Follow-up Period|Lost to Follow-up|0|||
17019774|NCT00663208|38164350|FG002|Follow-up Period|Lost to Follow-up|3|||
17019775|NCT00663208|38164351|FG003|Follow-up Period|Lost to Follow-up|2|||
17019776|NCT00663208|38164352|FG004|Follow-up Period|Lost to Follow-up|0|||
17019777|NCT00663208|38164353|FG005|Follow-up Period|Lost to Follow-up|0|||
17019778|NCT00663208|38164354|FG006|Follow-up Period|Lost to Follow-up|0|||
17019779|NCT00663208|38164348|FG000|Follow-up Period|Other reason|1|||
17019780|NCT00663208|38164349|FG001|Follow-up Period|Other reason|0|||
17019781|NCT00663208|38164350|FG002|Follow-up Period|Other reason|0|||
17019782|NCT00663208|38164351|FG003|Follow-up Period|Other reason|0|||
17019783|NCT00663208|38164352|FG004|Follow-up Period|Other reason|0|||
17019784|NCT00663208|38164353|FG005|Follow-up Period|Other reason|0|||
17019785|NCT00663208|38164354|FG006|Follow-up Period|Other reason|1|||
17019786|NCT00810810|38164376|FG000|Overall Study|Withdrawal by Subject|0|||
17019787|NCT00810810|38164377|FG001|Overall Study|Withdrawal by Subject|8|||
17019788|NCT00810810|38164378|FG002|Overall Study|Withdrawal by Subject|10|||
17019789|NCT00810810|38164379|FG003|Overall Study|Withdrawal by Subject|8|||
17019790|NCT00810810|38164376|FG000|Overall Study|Physician Decision|0|||
17019791|NCT00810810|38164377|FG001|Overall Study|Physician Decision|3|||
17019792|NCT00810810|38164378|FG002|Overall Study|Physician Decision|1|||
17019793|NCT00810810|38164379|FG003|Overall Study|Physician Decision|5|||
17019794|NCT00661258|38164391|FG000|Overall Study|Death|1|||
17019795|NCT00661258|38164392|FG001|Overall Study|Death|0|||
17019796|NCT00661258|38164391|FG000|Overall Study|caught by police and in detox center|2|||
17019797|NCT00661258|38164392|FG001|Overall Study|caught by police and in detox center|1|||
17019798|NCT00871871|38164400|FG000|Part I|Adverse Event|0|||
17019799|NCT00871871|38164401|FG001|Part I|Adverse Event|2|||
17019800|NCT00871871|38164402|FG002|Part I|Adverse Event|0|||
17019801|NCT00871871|38164403|FG003|Part I|Adverse Event|0|||
17019802|NCT00871871|38164400|FG000|Part I|Withdrawal by Subject|3|||
17019803|NCT00871871|38164401|FG001|Part I|Withdrawal by Subject|0|||
17019804|NCT00871871|38164402|FG002|Part I|Withdrawal by Subject|0|||
17019805|NCT00871871|38164403|FG003|Part I|Withdrawal by Subject|0|||
16932984|NCT01269346|38077129|FG000|Treatment Phase|Withdrawal by Subject|1|||
16932985|NCT01269346|38077129|FG000|Treatment Phase|Other|2|||
16932986|NCT01269346|38077129|FG000|Extension Phase|Adverse Event|6|||
16932987|NCT01269346|38077129|FG000|Extension Phase|Withdrawal by Subject|4|||
16932988|NCT01269346|38077129|FG000|Extension Phase|Disease progression|22|||
16932989|NCT01269346|38077129|FG000|Extension Phase|Physician decision or participant choice|9|||
16932990|NCT01269346|38077129|FG000|Extension Phase|Clinical progression|1|||
16932991|NCT01269346|38077129|FG000|Extension Phase|Started a prohibited con med|1|||
16932992|NCT01268683|38077134|FG000|Overall Study|Lost to Follow-up|1|||
16932993|NCT01268683|38077134|FG000|Overall Study|Death|1|||
16932994|NCT01268566|38077138|FG000|Overall Study|Lost to Follow-up|1|||
16932995|NCT01268566|38077138|FG000|Overall Study|Withdrawal by Subject|12|||
16932996|NCT01268566|38077138|FG000|Overall Study|Death|30|||
16932997|NCT01268488|38077142|FG000|Overall Study|Adverse Event|3|||
16932998|NCT01268488|38077142|FG000|Overall Study|Physician Decision|2|||
16932999|NCT01268293|38077147|FG000|Overall Study|Disease progression|7|||
16933000|NCT01268293|38077147|FG000|Overall Study|Adverse Event|1|||
16933001|NCT01268293|38077147|FG000|Overall Study|Subject choice|1|||
16933002|NCT01268098|38077153|FG000|Overall Study|Adverse Event|1|||
16933003|NCT01268098|38077154|FG001|Overall Study|Adverse Event|0|||
16933004|NCT01268059|38077164|FG000|Overall Study|Lost to Follow-up|0|||
16933005|NCT01268059|38077165|FG001|Overall Study|Lost to Follow-up|1|||
16933006|NCT01268059|38077166|FG002|Overall Study|Lost to Follow-up|0|||
16933007|NCT01268059|38077167|FG003|Overall Study|Lost to Follow-up|0|||
16933008|NCT01268059|38077164|FG000|Overall Study|Withdrawal by Subject|7|||
16933009|NCT01268059|38077165|FG001|Overall Study|Withdrawal by Subject|4|||
16933010|NCT01268059|38077166|FG002|Overall Study|Withdrawal by Subject|0|||
16933011|NCT01268059|38077167|FG003|Overall Study|Withdrawal by Subject|0|||
16933012|NCT01268059|38077164|FG000|Overall Study|Death|20|||
16933013|NCT01268059|38077165|FG001|Overall Study|Death|30|||
16933014|NCT01268059|38077166|FG002|Overall Study|Death|3|||
17019806|NCT00871871|38164400|FG000|Part I|Laboratory abnormality|0|||
17019807|NCT00871871|38164401|FG001|Part I|Laboratory abnormality|1|||
16933015|NCT01268059|38077167|FG003|Overall Study|Death|5|||
16933016|NCT01268059|38077164|FG000|Overall Study|Progression of disease|1|||
16933017|NCT01268059|38077165|FG001|Overall Study|Progression of disease|0|||
17019808|NCT00871871|38164402|FG002|Part I|Laboratory abnormality|0|||
16933018|NCT01268059|38077166|FG002|Overall Study|Progression of disease|0|||
16933019|NCT01268059|38077167|FG003|Overall Study|Progression of disease|0|||
16933020|NCT01267825|38077182|FG000|Overall Study|study terminated. no data collected.|1|||
16933021|NCT01267825|38077183|FG001|Overall Study|study terminated. no data collected.|0|||
17019809|NCT00871871|38164403|FG003|Part I|Laboratory abnormality|0|||
17019810|NCT00871871|38164400|FG000|Part II|Lack of Efficacy|0|||
17019811|NCT00871871|38164401|FG001|Part II|Lack of Efficacy|0|||
17019812|NCT00871871|38164402|FG002|Part II|Lack of Efficacy|1|||
17019813|NCT00871871|38164403|FG003|Part II|Lack of Efficacy|0|||
17019814|NCT00871871|38164400|FG000|Part II|Withdrawal by Subject|0|||
17019815|NCT00871871|38164401|FG001|Part II|Withdrawal by Subject|0|||
17019816|NCT00871871|38164402|FG002|Part II|Withdrawal by Subject|2|||
17019817|NCT00871871|38164403|FG003|Part II|Withdrawal by Subject|1|||
17019818|NCT00871871|38164400|FG000|Part II|Adverse Event|0|||
17019819|NCT00871871|38164401|FG001|Part II|Adverse Event|0|||
17019820|NCT00871871|38164402|FG002|Part II|Adverse Event|1|||
17019821|NCT00871871|38164403|FG003|Part II|Adverse Event|2|||
17019822|NCT00871871|38164400|FG000|Part II|Protocol Violation|0|||
17019823|NCT00871871|38164401|FG001|Part II|Protocol Violation|0|||
17019824|NCT00871871|38164402|FG002|Part II|Protocol Violation|0|||
17019825|NCT00871871|38164403|FG003|Part II|Protocol Violation|1|||
17019826|NCT00849680|38164421|FG000|Overall Study|Adverse Event|0|||
17019827|NCT00849680|38164422|FG001|Overall Study|Adverse Event|0|||
17019828|NCT00849680|38164423|FG002|Overall Study|Adverse Event|0|||
17019829|NCT00849680|38164424|FG003|Overall Study|Adverse Event|0|||
17019830|NCT00849680|38164425|FG004|Overall Study|Adverse Event|0|||
17019831|NCT00849680|38164426|FG005|Overall Study|Adverse Event|0|||
17019832|NCT00849680|38164427|FG006|Overall Study|Adverse Event|2|||
17019833|NCT00849680|38164428|FG007|Overall Study|Adverse Event|0|||
17019834|NCT00849680|38164421|FG000|Overall Study|Lost to Follow-up|7|||
17019835|NCT00849680|38164422|FG001|Overall Study|Lost to Follow-up|3|||
17019836|NCT00849680|38164423|FG002|Overall Study|Lost to Follow-up|12|||
17019837|NCT00849680|38164424|FG003|Overall Study|Lost to Follow-up|11|||
17019838|NCT00849680|38164425|FG004|Overall Study|Lost to Follow-up|8|||
17019839|NCT00849680|38164426|FG005|Overall Study|Lost to Follow-up|11|||
17019840|NCT00849680|38164427|FG006|Overall Study|Lost to Follow-up|12|||
17019841|NCT00849680|38164428|FG007|Overall Study|Lost to Follow-up|5|||
17019842|NCT00849680|38164421|FG000|Overall Study|Subject moved|1|||
17019843|NCT00849680|38164422|FG001|Overall Study|Subject moved|0|||
17019844|NCT00849680|38164423|FG002|Overall Study|Subject moved|3|||
17019845|NCT00849680|38164424|FG003|Overall Study|Subject moved|1|||
17019846|NCT00849680|38164425|FG004|Overall Study|Subject moved|0|||
17019847|NCT00849680|38164426|FG005|Overall Study|Subject moved|2|||
17019848|NCT00849680|38164427|FG006|Overall Study|Subject moved|2|||
17019849|NCT00849680|38164428|FG007|Overall Study|Subject moved|2|||
16933022|NCT01260181|38077189|FG000|Overall Study|Decision of Investigator|1|||
16933023|NCT01260142|38077199|FG000|Treatment Period 1|Study on hold|1|||
16933024|NCT01260142|38077200|FG001|Treatment Period 1|Study on hold|1|||
16933025|NCT01260142|38077201|FG002|Treatment Period 1|Study on hold|0|||
16933026|NCT01260142|38077202|FG003|Treatment Period 1|Study on hold|0|||
16933027|NCT01260142|38077203|FG004|Treatment Period 1|Study on hold|1|||
16933028|NCT01260142|38077204|FG005|Treatment Period 1|Study on hold|2|||
16933029|NCT01260142|38077199|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
16933030|NCT01260142|38077200|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
17019850|NCT00849680|38164421|FG000|Overall Study|Withdrawal by Subject|2|||
17019851|NCT00849680|38164422|FG001|Overall Study|Withdrawal by Subject|0|||
17019852|NCT00849680|38164423|FG002|Overall Study|Withdrawal by Subject|0|||
17019853|NCT00849680|38164424|FG003|Overall Study|Withdrawal by Subject|2|||
17019854|NCT00849680|38164425|FG004|Overall Study|Withdrawal by Subject|2|||
17019855|NCT00849680|38164426|FG005|Overall Study|Withdrawal by Subject|2|||
17019856|NCT00849680|38164427|FG006|Overall Study|Withdrawal by Subject|1|||
17019857|NCT00849680|38164428|FG007|Overall Study|Withdrawal by Subject|1|||
17019858|NCT00849680|38164421|FG000|Overall Study|Subject unable to comply with protocol|1|||
17019859|NCT00849680|38164422|FG001|Overall Study|Subject unable to comply with protocol|0|||
17019860|NCT00849680|38164423|FG002|Overall Study|Subject unable to comply with protocol|0|||
17019861|NCT00849680|38164424|FG003|Overall Study|Subject unable to comply with protocol|0|||
17019862|NCT00849680|38164425|FG004|Overall Study|Subject unable to comply with protocol|0|||
17019863|NCT00849680|38164426|FG005|Overall Study|Subject unable to comply with protocol|0|||
17019864|NCT00849680|38164427|FG006|Overall Study|Subject unable to comply with protocol|0|||
17019865|NCT00849680|38164428|FG007|Overall Study|Subject unable to comply with protocol|0|||
17019866|NCT00810342|38164448|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
17019867|NCT00810342|38164449|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
17019868|NCT00810342|38164448|FG000|Month 1 Follow-up|Pregnancy|1|||
17019869|NCT00810342|38164449|FG001|Month 1 Follow-up|Pregnancy|0|||
17019870|NCT00810342|38164448|FG000|6-month Follow-up|Lost to Follow-up|18|||
17019871|NCT00810342|38164449|FG001|6-month Follow-up|Lost to Follow-up|6|||
17019872|NCT00810342|38164448|FG000|6-month Follow-up|Pregnancy|6|||
17019873|NCT00810342|38164449|FG001|6-month Follow-up|Pregnancy|2|||
17019874|NCT00810342|38164448|FG000|12-month Followup|Pregnancy|9|||
17019875|NCT00810342|38164449|FG001|12-month Followup|Pregnancy|10|||
17019876|NCT00810342|38164448|FG000|12-month Followup|Lost to Follow-up|3|||
17102668|NCT00112437|38241442|FG001|Year 1 (12-Month Base Study)|moved|1|||
16933031|NCT01260142|38077201|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
16933032|NCT01260142|38077202|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
17019877|NCT00810342|38164449|FG001|12-month Followup|Lost to Follow-up|1|||
17019878|NCT00849524|38164457|FG000|Overall Study|Lack of Efficacy|3|||
17019879|NCT00808080|38164461|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
17019880|NCT00866723|38164466|FG000|Overall Study|Withdrawal by Subject|1|||
17019881|NCT00866723|38164466|FG000|Overall Study|Disease Progression|4|||
17019882|NCT00849290|38164470|FG000|Overall Study|Adverse Event|3|||
17019883|NCT00849290|38164470|FG000|Overall Study|Death|14|||
17019884|NCT00849290|38164470|FG000|Overall Study|Withdrawal by Subject|11|||
17019885|NCT00849290|38164470|FG000|Overall Study|Lost to Follow-up|2|||
17019886|NCT00849290|38164470|FG000|Overall Study|Protocol Violation|5|||
17019887|NCT00849290|38164470|FG000|Overall Study|Disease Progression|20|||
17019888|NCT00849212|38164474|FG000|Overall Study|Lack of Efficacy|1|||
17019889|NCT00849212|38164474|FG000|Overall Study|Withdrawal by Subject|3|||
17019890|NCT00849212|38164474|FG000|Overall Study|Adverse Event|2|||
17019891|NCT00849212|38164474|FG000|Overall Study|Miscellaneous|1|||
17019892|NCT00810264|38164478|FG000|Overall Study|Lost to Follow-up|191|||
17019893|NCT00810264|38164478|FG000|Overall Study|Withdrawal by subject or physician|721|||
17019894|NCT00810264|38164478|FG000|Overall Study|Death|641|||
17019895|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
17019896|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
17019897|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
17019898|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
17019899|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
17019900|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
17019901|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
17019902|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
17019903|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
17019904|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
17019905|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
17019906|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
17019907|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
17019908|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
17019909|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
17019910|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
17019911|NCT00849056|38164488|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
17019912|NCT00849056|38164489|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
17019913|NCT00849056|38164488|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
17019914|NCT00849056|38164489|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
17019915|NCT00849056|38164488|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
17019916|NCT00849056|38164489|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
17019917|NCT00849056|38164488|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
17019918|NCT00849056|38164489|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
16933033|NCT01260142|38077203|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
16933034|NCT01260142|38077204|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
16933035|NCT01260142|38077199|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16933036|NCT01260142|38077200|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16933037|NCT01260142|38077201|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16933038|NCT01260142|38077202|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16933039|NCT01260142|38077203|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16933040|NCT01260142|38077204|FG005|Treatment Period 1|Withdrawal by Subject|1|||
16933041|NCT01259869|38077224|FG000|Overall Study|Duplicated registration|1|||
16933042|NCT01259713|38077240|FG000|Overall Study|Adverse Event|54|||
16933043|NCT01259713|38077241|FG001|Overall Study|Adverse Event|23|||
17019919|NCT00849056|38164488|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
17019920|NCT00849056|38164489|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
17019921|NCT00849056|38164488|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
17019922|NCT00849056|38164489|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
17019923|NCT00849056|38164488|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
17019924|NCT00849056|38164489|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
17019925|NCT00849056|38164488|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
17019926|NCT00849056|38164489|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
17019927|NCT00837434|38164497|FG000|Overall Study|Physician Decision|3|||
17019928|NCT00837434|38164498|FG001|Overall Study|Physician Decision|0|||
17019929|NCT00837434|38164497|FG000|Overall Study|Lost to Follow-up|1|||
17019930|NCT00837434|38164498|FG001|Overall Study|Lost to Follow-up|1|||
17019931|NCT00837434|38164497|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
17019932|NCT00837434|38164498|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
17019933|NCT00837434|38164497|FG000|Overall Study|Noncompliant|2|||
17019934|NCT00837434|38164498|FG001|Overall Study|Noncompliant|0|||
16933044|NCT01259713|38077240|FG000|Overall Study|Death Not Related to IFI|8|||
16933045|NCT01259713|38077241|FG001|Overall Study|Death Not Related to IFI|1|||
17019935|NCT00837434|38164497|FG000|Overall Study|Baseline assessments not done in time|1|||
17019936|NCT00837434|38164498|FG001|Overall Study|Baseline assessments not done in time|0|||
17019937|NCT00837434|38164497|FG000|Overall Study|Unable to obtain study drug|1|||
17019938|NCT00837434|38164498|FG001|Overall Study|Unable to obtain study drug|0|||
17019939|NCT00827918|38164507|FG000|Overall Study|Adverse Event|4|||
17019940|NCT00827918|38164508|FG001|Overall Study|Adverse Event|0|||
17019941|NCT00827918|38164509|FG002|Overall Study|Adverse Event|0|||
17019942|NCT00827918|38164507|FG000|Overall Study|Lack of Efficacy|16|||
17019943|NCT00827918|38164508|FG001|Overall Study|Lack of Efficacy|4|||
17019944|NCT00827918|38164509|FG002|Overall Study|Lack of Efficacy|15|||
17019945|NCT00827918|38164507|FG000|Overall Study|Physician Decision|1|||
17019946|NCT00827918|38164508|FG001|Overall Study|Physician Decision|0|||
17019947|NCT00827918|38164509|FG002|Overall Study|Physician Decision|0|||
17019948|NCT00827918|38164507|FG000|Overall Study|Pregnancy|0|||
17019949|NCT00827918|38164508|FG001|Overall Study|Pregnancy|1|||
17019950|NCT00827918|38164509|FG002|Overall Study|Pregnancy|0|||
17019951|NCT00827918|38164507|FG000|Overall Study|Progressive Disease|1|||
17019952|NCT00827918|38164508|FG001|Overall Study|Progressive Disease|1|||
17019953|NCT00827918|38164509|FG002|Overall Study|Progressive Disease|0|||
17019954|NCT00827918|38164507|FG000|Overall Study|Protocol Violation|0|||
16933046|NCT01259713|38077240|FG000|Overall Study|Investigators Discretion|14|||
16933047|NCT01259713|38077241|FG001|Overall Study|Investigators Discretion|6|||
17019955|NCT00827918|38164508|FG001|Overall Study|Protocol Violation|1|||
17102669|NCT00112437|38241443|FG002|Year 1 (12-Month Base Study)|moved|1|||
17019956|NCT00827918|38164509|FG002|Overall Study|Protocol Violation|0|||
17019957|NCT00827918|38164507|FG000|Overall Study|Withdrawal by Subject|6|||
17019958|NCT00827918|38164508|FG001|Overall Study|Withdrawal by Subject|2|||
17019959|NCT00827918|38164509|FG002|Overall Study|Withdrawal by Subject|6|||
17019960|NCT00813150|38164519|FG000|Treatment Period|Adverse Event|16|||
17019961|NCT00813150|38164520|FG001|Treatment Period|Adverse Event|15|||
17019962|NCT00813150|38164519|FG000|Treatment Period|Death|2|||
17019963|NCT00813150|38164520|FG001|Treatment Period|Death|0|||
17019964|NCT00813150|38164519|FG000|Treatment Period|Progressive disease|1|||
17019965|NCT00813150|38164520|FG001|Treatment Period|Progressive disease|0|||
17019966|NCT00813150|38164519|FG000|Treatment Period|Complete response|0|||
17019967|NCT00813150|38164520|FG001|Treatment Period|Complete response|1|||
17019968|NCT00813150|38164519|FG000|Treatment Period|Stable disease|1|||
17019969|NCT00813150|38164520|FG001|Treatment Period|Stable disease|2|||
17019970|NCT00813150|38164519|FG000|Treatment Period|Protocol Violation|3|||
17019971|NCT00813150|38164520|FG001|Treatment Period|Protocol Violation|4|||
17019972|NCT00813150|38164519|FG000|Treatment Period|Withdrawal by Subject|5|||
17019973|NCT00813150|38164520|FG001|Treatment Period|Withdrawal by Subject|3|||
17019974|NCT00813150|38164519|FG000|Treatment Period|Non compliance|0|||
17019975|NCT00813150|38164520|FG001|Treatment Period|Non compliance|1|||
17019976|NCT00813150|38164519|FG000|Treatment Period|Reason not specified|3|||
17019977|NCT00813150|38164520|FG001|Treatment Period|Reason not specified|4|||
17019978|NCT00813150|38164519|FG000|Treatment Period|Data not available|1|||
17019979|NCT00813150|38164520|FG001|Treatment Period|Data not available|2|||
17019980|NCT00813150|38164519|FG000|Long Term Follow-up|Death|0|||
17019981|NCT00813150|38164520|FG001|Long Term Follow-up|Death|4|||
17019982|NCT00813150|38164519|FG000|Long Term Follow-up|Other|0|||
17019983|NCT00813150|38164520|FG001|Long Term Follow-up|Other|3|||
17019984|NCT00813150|38164519|FG000|Long Term Follow-up|Lost to Follow-up|2|||
16933048|NCT01259713|38077240|FG000|Overall Study|Lack of Efficacy|2|||
16933049|NCT01259713|38077241|FG001|Overall Study|Lack of Efficacy|0|||
16933050|NCT01259713|38077240|FG000|Overall Study|Protocol Violation|5|||
16933051|NCT01259713|38077241|FG001|Overall Study|Protocol Violation|4|||
16933052|NCT01259713|38077240|FG000|Overall Study|Subject Withdrew Consent|12|||
16933053|NCT01259713|38077241|FG001|Overall Study|Subject Withdrew Consent|7|||
16933054|NCT01259401|38077249|FG000|4-month Follow-up|Death|0|||
16933055|NCT01259401|38077250|FG001|4-month Follow-up|Death|1|||
16933056|NCT01259401|38077249|FG000|4-month Follow-up|Lost to Follow-up|0|||
16933057|NCT01259401|38077250|FG001|4-month Follow-up|Lost to Follow-up|1|||
16933058|NCT02438722|38077267|FG000|Overall Study|Adverse Event|12|||
16933059|NCT02438722|38077268|FG001|Overall Study|Adverse Event|9|||
16933060|NCT02438722|38077267|FG000|Overall Study|Refusal unrelated to AE|2|||
16933061|NCT02438722|38077268|FG001|Overall Study|Refusal unrelated to AE|5|||
16933062|NCT02438722|38077267|FG000|Overall Study|Disease progression/relapse|46|||
16933063|NCT02438722|38077268|FG001|Overall Study|Disease progression/relapse|51|||
16933064|NCT02438722|38077267|FG000|Overall Study|Death|0|||
16933065|NCT02438722|38077268|FG001|Overall Study|Death|3|||
17019985|NCT00813150|38164520|FG001|Long Term Follow-up|Lost to Follow-up|0|||
17019986|NCT00813150|38164519|FG000|Long Term Follow-up|Progression/Relapse|22|||
17019987|NCT00813150|38164520|FG001|Long Term Follow-up|Progression/Relapse|24|||
17019988|NCT00807846|38164528|FG000|Overall Study|Adverse Event|5|||
17019989|NCT00807846|38164529|FG001|Overall Study|Adverse Event|0|||
17019990|NCT00807846|38164528|FG000|Overall Study|Lack of Efficacy|2|||
17019991|NCT00807846|38164529|FG001|Overall Study|Lack of Efficacy|0|||
17019992|NCT00807846|38164528|FG000|Overall Study|Protocol Violation|2|||
16933066|NCT02438722|38077267|FG000|Overall Study|Physician Decision|2|||
16933067|NCT02438722|38077268|FG001|Overall Study|Physician Decision|2|||
16933068|NCT02438722|38077267|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
16933069|NCT02438722|38077268|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
16933070|NCT02438722|38077267|FG000|Overall Study|Withdrawal by Subject|0|||
16933071|NCT02438722|38077268|FG001|Overall Study|Withdrawal by Subject|1|||
16933072|NCT02438722|38077267|FG000|Overall Study|On protocol treatment|15|||
16933073|NCT02438722|38077268|FG001|Overall Study|On protocol treatment|14|||
16933074|NCT02438722|38077267|FG000|Overall Study|Did not receive protocol treatment|5|||
16933075|NCT02438722|38077268|FG001|Overall Study|Did not receive protocol treatment|0|||
17019993|NCT00807846|38164529|FG001|Overall Study|Protocol Violation|1|||
17019994|NCT00807846|38164528|FG000|Overall Study|Withdrawal by Subject|2|||
17019995|NCT00807846|38164529|FG001|Overall Study|Withdrawal by Subject|1|||
17019996|NCT00807846|38164528|FG000|Overall Study|Other|1|||
17019997|NCT00807846|38164529|FG001|Overall Study|Other|2|||
17019998|NCT00810108|38164537|FG000|Overall Study|Withdrawal by Subject|1|||
17019999|NCT00810108|38164538|FG001|Overall Study|Withdrawal by Subject|0|||
17020000|NCT00827606|38164545|FG000|Overall Study|Protocol Violation|4|||
17020001|NCT00827606|38164546|FG001|Overall Study|Protocol Violation|3|||
17020002|NCT00827606|38164545|FG000|Overall Study|Lost to Follow-up|3|||
17020003|NCT00827606|38164546|FG001|Overall Study|Lost to Follow-up|1|||
17020004|NCT00827606|38164545|FG000|Overall Study|Withdrawal by Subject|7|||
17020005|NCT00827606|38164546|FG001|Overall Study|Withdrawal by Subject|6|||
17020006|NCT00827606|38164545|FG000|Overall Study|Pregnancy|0|||
17020007|NCT00827606|38164546|FG001|Overall Study|Pregnancy|1|||
17020008|NCT00827606|38164545|FG000|Overall Study|Other|5|||
17020009|NCT00827606|38164546|FG001|Overall Study|Other|13|||
17020010|NCT00827606|38164545|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
17020011|NCT00827606|38164546|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
17020012|NCT00827606|38164545|FG000|Overall Study|Adverse Event|4|||
17020013|NCT00827606|38164546|FG001|Overall Study|Adverse Event|2|||
17020014|NCT00663052|38164560|FG000|Overall Study|Adverse Event|6|||
17020015|NCT00663052|38164561|FG001|Overall Study|Adverse Event|3|||
17020016|NCT00663052|38164560|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
17020017|NCT00663052|38164561|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
17020018|NCT00663052|38164560|FG000|Overall Study|Protocol Violation|1|||
16852558|NCT01399593|37802675|FG001|Overall Study|Death|1|||
16852559|NCT01399593|37802674|FG000|Overall Study|Transplantectomy|0|||
16852560|NCT01399593|37802675|FG001|Overall Study|Transplantectomy|1|||
16852561|NCT01833169|37802681|FG000|Overall Study|Disease Progression|99|||
16852562|NCT01833169|37802681|FG000|Overall Study|Adverse Event|33|||
16852563|NCT01833169|37802681|FG000|Overall Study|Withdrawal by Subject|9|||
16933076|NCT01313923|38077283|FG000|Overall Study|Physician Decision|3|||
16933077|NCT01313884|38077287|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
16852564|NCT01833169|37802681|FG000|Overall Study|Death|3|||
16852565|NCT01833169|37802681|FG000|Overall Study|Physician Decision|2|||
16852566|NCT01860079|37802687|FG000|Overall Study|Physician Decision|14|||
16852567|NCT01860079|37802688|FG001|Overall Study|Physician Decision|22|||
16933078|NCT01135459|38077293|FG000|Overall Study|Adverse Event|8|||
16933079|NCT01135459|38077294|FG001|Overall Study|Adverse Event|10|||
16933080|NCT01135459|38077293|FG000|Overall Study|Lack of Efficacy|3|||
16933081|NCT01135459|38077294|FG001|Overall Study|Lack of Efficacy|1|||
16933082|NCT01135459|38077293|FG000|Overall Study|Withdrawal by Subject|2|||
16933083|NCT01135459|38077294|FG001|Overall Study|Withdrawal by Subject|3|||
16933084|NCT01135459|38077293|FG000|Overall Study|Protocol Violation|5|||
16933085|NCT01135459|38077294|FG001|Overall Study|Protocol Violation|3|||
16933086|NCT01135459|38077293|FG000|Overall Study|Lost to Follow-up|2|||
16933087|NCT01135459|38077294|FG001|Overall Study|Lost to Follow-up|1|||
16933088|NCT01135459|38077293|FG000|Overall Study|Non-compliance to study procedures|0|||
16933089|NCT01135459|38077294|FG001|Overall Study|Non-compliance to study procedures|1|||
16933090|NCT01135459|38077293|FG000|Overall Study|Other than specified|1|||
16933091|NCT01135459|38077294|FG001|Overall Study|Other than specified|1|||
16933092|NCT01259284|38077303|FG000|Overall Study|Study Termination|2|||
16933093|NCT01259284|38077304|FG001|Overall Study|Study Termination|0|||
16933094|NCT01259284|38077305|FG002|Overall Study|Study Termination|0|||
16933095|NCT01259245|38077315|FG000|Overall Study|Withdrawal by Subject|27|||
16933096|NCT01259245|38077316|FG001|Overall Study|Withdrawal by Subject|24|||
16933097|NCT01259245|38077315|FG000|Overall Study|Death|1|||
16933098|NCT01259245|38077316|FG001|Overall Study|Death|2|||
16933099|NCT01259089|38077335|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16933100|NCT01259089|38077336|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16933101|NCT01259089|38077337|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16933102|NCT01259089|38077338|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16933103|NCT01259089|38077339|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16933104|NCT01259089|38077340|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
17020019|NCT00663052|38164561|FG001|Overall Study|Protocol Violation|0|||
17020020|NCT00663052|38164560|FG000|Overall Study|Withdrawal by Subject|2|||
17020021|NCT00663052|38164561|FG001|Overall Study|Withdrawal by Subject|5|||
17020022|NCT00663052|38164560|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
17020023|NCT00663052|38164561|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
17020024|NCT00663052|38164560|FG000|Overall Study|Other|0|||
17020025|NCT00663052|38164561|FG001|Overall Study|Other|1|||
17020026|NCT00827372|38164567|FG000|Overall Study|Adverse Event|5|||
17020027|NCT00827372|38164567|FG000|Overall Study|Lack of Efficacy|3|||
17020028|NCT00826748|38164575|FG000|Overall Study|Withdrawal by Subject|0|||
17020029|NCT00826748|38164576|FG001|Overall Study|Withdrawal by Subject|0|||
17020030|NCT00826748|38164577|FG002|Overall Study|Withdrawal by Subject|2|||
17020031|NCT00826748|38164575|FG000|Overall Study|Physician Decision|0|||
17020032|NCT00826748|38164576|FG001|Overall Study|Physician Decision|0|||
17020033|NCT00826748|38164577|FG002|Overall Study|Physician Decision|1|||
17020034|NCT00826748|38164575|FG000|Overall Study|Samples Did Not pass QC|0|||
17020035|NCT00826748|38164576|FG001|Overall Study|Samples Did Not pass QC|0|||
17020036|NCT00826748|38164577|FG002|Overall Study|Samples Did Not pass QC|1|||
17020037|NCT00806988|38164587|FG000|Overall Study|Death|15|||
17020038|NCT00806988|38164588|FG001|Overall Study|Death|16|||
17020039|NCT00806988|38164587|FG000|Overall Study|Withdrawal by Subject|8|||
17020040|NCT00806988|38164588|FG001|Overall Study|Withdrawal by Subject|8|||
17020041|NCT00806988|38164587|FG000|Overall Study|Lost to Follow-up|4|||
17020042|NCT00806988|38164588|FG001|Overall Study|Lost to Follow-up|19|||
17020043|NCT00807144|38164596|FG000|Overall Study|Lost to Follow-up|0|||
17020044|NCT00807144|38164597|FG001|Overall Study|Lost to Follow-up|1|||
17020045|NCT00591006|38164603|FG000|Overall Study|Withdrawal by Subject|0|||
17020046|NCT00591006|38164604|FG001|Overall Study|Withdrawal by Subject|0|||
17020047|NCT00591006|38164605|FG002|Overall Study|Withdrawal by Subject|0|||
17020048|NCT00591006|38164606|FG003|Overall Study|Withdrawal by Subject|0|||
17020049|NCT00591006|38164607|FG004|Overall Study|Withdrawal by Subject|0|||
17020050|NCT00591006|38164608|FG005|Overall Study|Withdrawal by Subject|0|||
17020051|NCT00591006|38164609|FG006|Overall Study|Withdrawal by Subject|0|||
17020052|NCT00591006|38164610|FG007|Overall Study|Withdrawal by Subject|0|||
17020053|NCT00591006|38164611|FG008|Overall Study|Withdrawal by Subject|0|||
17020054|NCT00591006|38164612|FG009|Overall Study|Withdrawal by Subject|0|||
17020055|NCT00591006|38164613|FG010|Overall Study|Withdrawal by Subject|0|||
17020056|NCT00591006|38164614|FG011|Overall Study|Withdrawal by Subject|0|||
17020057|NCT00591006|38164615|FG012|Overall Study|Withdrawal by Subject|0|||
17020058|NCT00591006|38164616|FG013|Overall Study|Withdrawal by Subject|0|||
17020059|NCT00591006|38164617|FG014|Overall Study|Withdrawal by Subject|0|||
17020060|NCT00591006|38164618|FG015|Overall Study|Withdrawal by Subject|1|||
17020061|NCT00591006|38164619|FG016|Overall Study|Withdrawal by Subject|0|||
17020062|NCT00591006|38164620|FG017|Overall Study|Withdrawal by Subject|0|||
17020063|NCT00591006|38164621|FG018|Overall Study|Withdrawal by Subject|0|||
17020064|NCT00591006|38164622|FG019|Overall Study|Withdrawal by Subject|0|||
17020065|NCT00591006|38164623|FG020|Overall Study|Withdrawal by Subject|0|||
17020066|NCT00591006|38164624|FG021|Overall Study|Withdrawal by Subject|0|||
17020067|NCT00591006|38164625|FG022|Overall Study|Withdrawal by Subject|0|||
17020068|NCT00591006|38164626|FG023|Overall Study|Withdrawal by Subject|1|||
17020069|NCT00591006|38164603|FG000|Overall Study|Adverse Event|0|||
17020070|NCT00591006|38164604|FG001|Overall Study|Adverse Event|0|||
17020071|NCT00591006|38164605|FG002|Overall Study|Adverse Event|0|||
17020072|NCT00591006|38164606|FG003|Overall Study|Adverse Event|0|||
17020073|NCT00591006|38164607|FG004|Overall Study|Adverse Event|0|||
17020074|NCT00591006|38164608|FG005|Overall Study|Adverse Event|0|||
17020075|NCT00591006|38164609|FG006|Overall Study|Adverse Event|0|||
17102670|NCT00112437|38241444|FG003|Year 1 (12-Month Base Study)|moved|0|||
17102671|NCT00112437|38241445|FG004|Year 1 (12-Month Base Study)|moved|0|||
17102672|NCT00112437|38241446|FG005|Year 1 (12-Month Base Study)|moved|0|||
17102673|NCT00112437|38241447|FG006|Year 1 (12-Month Base Study)|moved|0|||
17102674|NCT00112437|38241448|FG007|Year 1 (12-Month Base Study)|moved|0|||
17102675|NCT00112437|38241449|FG008|Year 1 (12-Month Base Study)|moved|0|||
17102676|NCT00112437|38241450|FG009|Year 1 (12-Month Base Study)|moved|0|||
17102677|NCT00112437|38241451|FG010|Year 1 (12-Month Base Study)|moved|0|||
17102678|NCT00112437|38241452|FG011|Year 1 (12-Month Base Study)|moved|0|||
17102679|NCT00112437|38241453|FG012|Year 1 (12-Month Base Study)|moved|0|||
17102680|NCT00112437|38241454|FG013|Year 1 (12-Month Base Study)|moved|0|||
17102681|NCT00112437|38241455|FG014|Year 1 (12-Month Base Study)|moved|0|||
17102682|NCT00112437|38241456|FG015|Year 1 (12-Month Base Study)|moved|0|||
17102683|NCT00112437|38241457|FG016|Year 1 (12-Month Base Study)|moved|0|||
17102684|NCT00112437|38241458|FG017|Year 1 (12-Month Base Study)|moved|0|||
17102685|NCT00112437|38241459|FG018|Year 1 (12-Month Base Study)|moved|0|||
17102686|NCT00112437|38241460|FG019|Year 1 (12-Month Base Study)|moved|0|||
17102687|NCT00112437|38241461|FG020|Year 1 (12-Month Base Study)|moved|0|||
17102688|NCT00112437|38241462|FG021|Year 1 (12-Month Base Study)|moved|0|||
17102689|NCT00112437|38241463|FG022|Year 1 (12-Month Base Study)|moved|0|||
17102690|NCT00112437|38241464|FG023|Year 1 (12-Month Base Study)|moved|0|||
17020076|NCT00591006|38164610|FG007|Overall Study|Adverse Event|0|||
17020077|NCT00591006|38164611|FG008|Overall Study|Adverse Event|0|||
17020078|NCT00591006|38164612|FG009|Overall Study|Adverse Event|0|||
17020079|NCT00591006|38164613|FG010|Overall Study|Adverse Event|0|||
17020080|NCT00591006|38164614|FG011|Overall Study|Adverse Event|0|||
17020081|NCT00591006|38164615|FG012|Overall Study|Adverse Event|0|||
17020082|NCT00591006|38164616|FG013|Overall Study|Adverse Event|0|||
17020083|NCT00591006|38164617|FG014|Overall Study|Adverse Event|0|||
17020084|NCT00591006|38164618|FG015|Overall Study|Adverse Event|0|||
17020085|NCT00591006|38164619|FG016|Overall Study|Adverse Event|0|||
17020086|NCT00591006|38164620|FG017|Overall Study|Adverse Event|0|||
17020087|NCT00591006|38164621|FG018|Overall Study|Adverse Event|0|||
17020088|NCT00591006|38164622|FG019|Overall Study|Adverse Event|0|||
17020089|NCT00591006|38164623|FG020|Overall Study|Adverse Event|0|||
17020090|NCT00591006|38164624|FG021|Overall Study|Adverse Event|0|||
17020091|NCT00591006|38164625|FG022|Overall Study|Adverse Event|1|||
17020092|NCT00591006|38164626|FG023|Overall Study|Adverse Event|0|||
17020093|NCT00844844|38164643|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
17020094|NCT00844844|38164643|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
17020095|NCT00844844|38164643|FG000|Extension Treatment Period|Adverse Event|2|||
17020096|NCT00844844|38164643|FG000|Post Treatment Period|Withdrawal by Subject|1|||
17020097|NCT00660790|38164647|FG000|Baseline to 3 Months|Death|1|||
17020098|NCT00660790|38164647|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
17020099|NCT00660790|38164647|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
17020100|NCT00836810|38164653|FG000|Overall Study|New diagnosis|1|||
17020101|NCT00836810|38164654|FG001|Overall Study|New diagnosis|0|||
17020102|NCT00658684|38164663|FG000|Overall Study|Adverse Event|10|||
17020103|NCT00658684|38164664|FG001|Overall Study|Adverse Event|8|||
17020104|NCT00658684|38164665|FG002|Overall Study|Adverse Event|2|||
17020105|NCT00658684|38164666|FG003|Overall Study|Adverse Event|0|||
17020106|NCT00658684|38164663|FG000|Overall Study|Withdrawal by Subject|6|||
17020107|NCT00658684|38164664|FG001|Overall Study|Withdrawal by Subject|4|||
17020108|NCT00658684|38164665|FG002|Overall Study|Withdrawal by Subject|1|||
17020109|NCT00658684|38164666|FG003|Overall Study|Withdrawal by Subject|1|||
17020110|NCT00658684|38164663|FG000|Overall Study|Lack of Efficacy|1|||
17020111|NCT00658684|38164664|FG001|Overall Study|Lack of Efficacy|1|||
17020112|NCT00658684|38164665|FG002|Overall Study|Lack of Efficacy|0|||
17020113|NCT00658684|38164666|FG003|Overall Study|Lack of Efficacy|0|||
17020114|NCT00658684|38164663|FG000|Overall Study|Protocol Violation|1|||
17020115|NCT00658684|38164664|FG001|Overall Study|Protocol Violation|1|||
17020116|NCT00658684|38164665|FG002|Overall Study|Protocol Violation|0|||
17020117|NCT00658684|38164666|FG003|Overall Study|Protocol Violation|0|||
17020118|NCT00658684|38164663|FG000|Overall Study|Pregnancy|1|||
17020119|NCT00658684|38164664|FG001|Overall Study|Pregnancy|1|||
17020120|NCT00658684|38164665|FG002|Overall Study|Pregnancy|0|||
17020121|NCT00658684|38164666|FG003|Overall Study|Pregnancy|0|||
17020122|NCT00660400|38164676|FG000|Overall Study|Lack of insurance approval|1|||
17020123|NCT00660400|38164676|FG000|Overall Study|Suboptimal organ function|1|||
17020124|NCT00660400|38164676|FG000|Overall Study|Intracranial hemorrhage|1|||
17020125|NCT00660400|38164676|FG000|Overall Study|Withdrawal by Subject|1|||
17020126|NCT00826514|38164682|FG000|Overall Study|Adverse Event|1|||
17020127|NCT00826514|38164683|FG001|Overall Study|Adverse Event|1|||
17020128|NCT00826514|38164682|FG000|Overall Study|Lack of Efficacy|0|||
17020129|NCT00826514|38164683|FG001|Overall Study|Lack of Efficacy|1|||
17020130|NCT00826514|38164682|FG000|Overall Study|Withdrawal by Subject|2|||
17020131|NCT00826514|38164683|FG001|Overall Study|Withdrawal by Subject|3|||
17020132|NCT00826280|38164692|FG000|Overall Study|Randomized but drug not received|1|||
17020133|NCT00826280|38164693|FG001|Overall Study|Randomized but drug not received|0|||
17020134|NCT00826280|38164694|FG002|Overall Study|Randomized but drug not received|1|||
17020135|NCT00826280|38164692|FG000|Overall Study|Adverse Event|1|||
17020136|NCT00826280|38164693|FG001|Overall Study|Adverse Event|3|||
17020137|NCT00826280|38164694|FG002|Overall Study|Adverse Event|0|||
17020138|NCT00826280|38164692|FG000|Overall Study|Lost to Follow-up|0|||
17020139|NCT00826280|38164693|FG001|Overall Study|Lost to Follow-up|1|||
17020140|NCT00826280|38164694|FG002|Overall Study|Lost to Follow-up|0|||
17020141|NCT00826280|38164692|FG000|Overall Study|Sponsor discontinued subject or study|1|||
17020142|NCT00826280|38164693|FG001|Overall Study|Sponsor discontinued subject or study|0|||
17020143|NCT00826280|38164694|FG002|Overall Study|Sponsor discontinued subject or study|0|||
17020144|NCT00826280|38164692|FG000|Overall Study|Reversible ischemic defect not present|43|||
17020145|NCT00826280|38164693|FG001|Overall Study|Reversible ischemic defect not present|40|||
17020146|NCT00826280|38164694|FG002|Overall Study|Reversible ischemic defect not present|44|||
17020147|NCT00826280|38164692|FG000|Overall Study|Interpretation Failure|1|||
17020148|NCT00826280|38164693|FG001|Overall Study|Interpretation Failure|0|||
17020149|NCT00826280|38164694|FG002|Overall Study|Interpretation Failure|0|||
17020150|NCT00826280|38164692|FG000|Overall Study|Machine Failure|1|||
17020151|NCT00826280|38164693|FG001|Overall Study|Machine Failure|1|||
17020152|NCT00826280|38164694|FG002|Overall Study|Machine Failure|0|||
17020153|NCT00826280|38164692|FG000|Overall Study|One or more non-interpretable scan|0|||
17020154|NCT00826280|38164693|FG001|Overall Study|One or more non-interpretable scan|1|||
17020155|NCT00826280|38164694|FG002|Overall Study|One or more non-interpretable scan|1|||
16933105|NCT01259089|38077335|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
16933106|NCT01259089|38077336|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
16933107|NCT01259089|38077337|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
16933108|NCT01259089|38077338|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
16933109|NCT01259089|38077339|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
16933110|NCT01259089|38077340|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
16933111|NCT01259089|38077335|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16933112|NCT01259089|38077336|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16933113|NCT01259089|38077337|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16933114|NCT01259089|38077338|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16933115|NCT01259089|38077339|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16933116|NCT01259089|38077340|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
16933117|NCT01259089|38077335|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
16933118|NCT01259089|38077336|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
16933119|NCT01259089|38077337|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
16933120|NCT01259089|38077338|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
16933121|NCT01259089|38077339|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
16933122|NCT01259089|38077340|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
16933123|NCT01259089|38077335|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
16933124|NCT01259089|38077336|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
16933125|NCT01259089|38077337|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
16933126|NCT01259089|38077338|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
16933127|NCT01259089|38077339|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
16933128|NCT01259089|38077340|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
16933129|NCT01259089|38077335|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
16933130|NCT01259089|38077336|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16933131|NCT01259089|38077337|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16933132|NCT01259089|38077338|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16933133|NCT01259089|38077339|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16933134|NCT01259089|38077340|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16933135|NCT01259089|38077335|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
16933136|NCT01259089|38077336|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
16933137|NCT01259089|38077337|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
16933138|NCT01259089|38077338|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
16933139|NCT01259089|38077339|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
16933140|NCT01259089|38077340|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
16933141|NCT01259089|38077335|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
16933142|NCT01259089|38077336|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
16933143|NCT01259089|38077337|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
16933144|NCT01259089|38077338|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
16933145|NCT01259089|38077339|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
16933146|NCT01259089|38077340|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
16933147|NCT01259089|38077335|FG000|Survival Follow up for Two Years|Death|3|||
16933148|NCT01259089|38077336|FG001|Survival Follow up for Two Years|Death|2|||
16933149|NCT01259089|38077337|FG002|Survival Follow up for Two Years|Death|2|||
16933150|NCT01259089|38077338|FG003|Survival Follow up for Two Years|Death|3|||
16933151|NCT01259089|38077339|FG004|Survival Follow up for Two Years|Death|6|||
16933152|NCT01259089|38077340|FG005|Survival Follow up for Two Years|Death|13|||
16933153|NCT01259089|38077335|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
16933154|NCT01259089|38077336|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
16933155|NCT01259089|38077337|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
16933156|NCT01259089|38077338|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
16933157|NCT01259089|38077339|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
16933158|NCT01259089|38077340|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
16933159|NCT01259089|38077335|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16933160|NCT01259089|38077336|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16933161|NCT01259089|38077337|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16933162|NCT01259089|38077338|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16933163|NCT01259089|38077339|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16933164|NCT01259089|38077340|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
16933165|NCT01258738|38077356|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
16933166|NCT01258738|38077357|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
16933167|NCT01258738|38077356|FG000|Double-blind Period|Withdrawal by Subject|2|||
16933168|NCT01258738|38077357|FG001|Double-blind Period|Withdrawal by Subject|2|||
16933169|NCT01258738|38077356|FG000|Double-blind Period|Protocol Violation|1|||
17020156|NCT00864851|38164705|FG000|Overall Study|Withdrawal by Subject|0|||
17020157|NCT00864851|38164706|FG001|Overall Study|Withdrawal by Subject|1|||
17020158|NCT00864851|38164707|FG002|Overall Study|Withdrawal by Subject|0|||
17020159|NCT00864851|38164705|FG000|Overall Study|Physician Decision|1|||
17020160|NCT00864851|38164706|FG001|Overall Study|Physician Decision|0|||
17020161|NCT00864851|38164707|FG002|Overall Study|Physician Decision|0|||
17020162|NCT00864851|38164705|FG000|Overall Study|Death|1|||
17020163|NCT00864851|38164706|FG001|Overall Study|Death|0|||
17020164|NCT00864851|38164707|FG002|Overall Study|Death|0|||
17020165|NCT00864851|38164705|FG000|Overall Study|Patient uncooperative|1|||
17020166|NCT00864851|38164706|FG001|Overall Study|Patient uncooperative|0|||
17020167|NCT00864851|38164707|FG002|Overall Study|Patient uncooperative|0|||
17102691|NCT00112437|38241465|FG024|Year 1 (12-Month Base Study)|moved|0|||
16933170|NCT01258738|38077357|FG001|Double-blind Period|Protocol Violation|1|||
16933171|NCT01258738|38077356|FG000|Double-blind Period|Adverse Event|3|||
16933172|NCT01258738|38077357|FG001|Double-blind Period|Adverse Event|1|||
16933173|NCT01258738|38077356|FG000|Open-label Period|Did not meet inclusion criteria|0|||
16933174|NCT01258738|38077357|FG001|Open-label Period|Did not meet inclusion criteria|1|||
16933175|NCT01258738|38077356|FG000|Open-label Period|Insufficient clinical response|5|||
16933176|NCT01258738|38077357|FG001|Open-label Period|Insufficient clinical response|3|||
16933177|NCT01258738|38077356|FG000|Open-label Period|Lost to Follow-up|0|||
16933178|NCT01258738|38077357|FG001|Open-label Period|Lost to Follow-up|2|||
16933179|NCT01258738|38077356|FG000|Open-label Period|Withdrawal by Subject|5|||
16933180|NCT01258738|38077357|FG001|Open-label Period|Withdrawal by Subject|6|||
16933181|NCT01258738|38077356|FG000|Open-label Period|Protocol Violation|2|||
16933182|NCT01258738|38077357|FG001|Open-label Period|Protocol Violation|2|||
16933183|NCT01258738|38077356|FG000|Open-label Period|Adverse Event|4|||
16933184|NCT01258738|38077357|FG001|Open-label Period|Adverse Event|5|||
16933185|NCT01258738|38077356|FG000|Open-label Period|Other Reasons|0|||
16933186|NCT01258738|38077357|FG001|Open-label Period|Other Reasons|1|||
16933187|NCT01258738|38077356|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
16933188|NCT01258738|38077357|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
16933189|NCT01258660|38077365|FG000|Overall Study|Adverse Event|2|||
16933190|NCT01258660|38077366|FG001|Overall Study|Adverse Event|4|||
16933191|NCT01258660|38077365|FG000|Overall Study|Withdrawal by Subject|3|||
16933192|NCT01258660|38077366|FG001|Overall Study|Withdrawal by Subject|0|||
16933193|NCT01258660|38077365|FG000|Overall Study|due to relocation|2|||
16933194|NCT01258660|38077366|FG001|Overall Study|due to relocation|0|||
16933195|NCT01258660|38077365|FG000|Overall Study|Protocol Violation|0|||
16933196|NCT01258660|38077366|FG001|Overall Study|Protocol Violation|1|||
16933197|NCT01258660|38077365|FG000|Overall Study|Invalid for primary analysis data set|4|||
16933198|NCT01258660|38077366|FG001|Overall Study|Invalid for primary analysis data set|6|||
16933199|NCT01258348|38077373|FG000|Overall Study|Adverse Event|1|||
16933200|NCT01258348|38077374|FG001|Overall Study|Adverse Event|1|||
16933201|NCT01258348|38077375|FG002|Overall Study|Adverse Event|3|||
16933202|NCT01258348|38077376|FG003|Overall Study|Adverse Event|2|||
16933203|NCT01258348|38077377|FG004|Overall Study|Adverse Event|4|||
16933204|NCT01258348|38077373|FG000|Overall Study|Progressive Disease|0|||
16933205|NCT01258348|38077374|FG001|Overall Study|Progressive Disease|3|||
16933206|NCT01258348|38077375|FG002|Overall Study|Progressive Disease|0|||
16933207|NCT01258348|38077376|FG003|Overall Study|Progressive Disease|2|||
16933208|NCT01258348|38077377|FG004|Overall Study|Progressive Disease|2|||
16933209|NCT01258348|38077373|FG000|Overall Study|Physician Decision|0|||
16933210|NCT01258348|38077374|FG001|Overall Study|Physician Decision|0|||
16933211|NCT01258348|38077375|FG002|Overall Study|Physician Decision|0|||
16933212|NCT01258348|38077376|FG003|Overall Study|Physician Decision|2|||
16933213|NCT01258348|38077377|FG004|Overall Study|Physician Decision|0|||
16933214|NCT01258348|38077373|FG000|Overall Study|Withdrawal by Subject|0|||
16933215|NCT01258348|38077374|FG001|Overall Study|Withdrawal by Subject|1|||
16933216|NCT01258348|38077375|FG002|Overall Study|Withdrawal by Subject|0|||
16933217|NCT01258348|38077376|FG003|Overall Study|Withdrawal by Subject|0|||
16933218|NCT01258348|38077377|FG004|Overall Study|Withdrawal by Subject|0|||
16933219|NCT01258075|38077393|FG000|Overall Study|Adverse Event|8|||
16933220|NCT01258075|38077394|FG001|Overall Study|Adverse Event|3|||
16933221|NCT01258075|38077393|FG000|Overall Study|Lost to Follow-up|11|||
16933222|NCT01258075|38077394|FG001|Overall Study|Lost to Follow-up|6|||
16933223|NCT01258075|38077393|FG000|Overall Study|Withdrawal by Subject|10|||
16933224|NCT01258075|38077394|FG001|Overall Study|Withdrawal by Subject|7|||
16933225|NCT01258075|38077393|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
16933226|NCT01258075|38077394|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
16933227|NCT01258075|38077393|FG000|Overall Study|Other|12|||
16933228|NCT01258075|38077394|FG001|Overall Study|Other|5|||
16933229|NCT01257568|38077400|FG000|Overall Study|Lost to Follow-up|2|||
16933230|NCT01257568|38077400|FG000|Overall Study|Withdrawal by Subject|6|||
16933231|NCT01257568|38077400|FG000|Overall Study|Terminated|1|||
16933232|NCT01257568|38077400|FG000|Overall Study|Component Revision|24|||
16933233|NCT01256788|38077409|FG000|Overall Study|Lost to Follow-up|5|||
16933234|NCT01256788|38077410|FG001|Overall Study|Lost to Follow-up|8|||
16933235|NCT01256788|38077411|FG002|Overall Study|Lost to Follow-up|3|||
16933236|NCT01256671|38077419|FG000|Overall Study|Adverse Event|29|||
16933237|NCT01256671|38077419|FG000|Overall Study|Lost to Follow-up|16|||
16933238|NCT01256671|38077419|FG000|Overall Study|Withdrawal by Subject|31|||
16933239|NCT01256671|38077419|FG000|Overall Study|Physician Decision|3|||
16933240|NCT01256671|38077419|FG000|Overall Study|Lack of Efficacy|4|||
16933241|NCT01256671|38077419|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
16933242|NCT01256593|38077423|FG000|Overall Study|Protocol Violation|26|||
16933243|NCT01256593|38077423|FG000|Overall Study|No Drug Administration Information|2|||
16933244|NCT01256593|38077423|FG000|Overall Study|No Visit After Treatment|186|||
16933245|NCT01256476|38077429|FG000|Overall Study|Adverse Event|2|||
16933246|NCT01256476|38077430|FG001|Overall Study|Adverse Event|1|||
16933247|NCT01256476|38077429|FG000|Overall Study|Withdrawal by Subject|2|||
16933248|NCT01256476|38077430|FG001|Overall Study|Withdrawal by Subject|1|||
16933249|NCT01256476|38077429|FG000|Overall Study|Lost to Follow-up|1|||
16933250|NCT01256476|38077430|FG001|Overall Study|Lost to Follow-up|2|||
16933251|NCT01256476|38077429|FG000|Overall Study|Persistent ALT or AST elevation|1|||
16933252|NCT01256476|38077430|FG001|Overall Study|Persistent ALT or AST elevation|0|||
16933253|NCT01256476|38077429|FG000|Overall Study|Physician Decision|0|||
16933254|NCT01256476|38077430|FG001|Overall Study|Physician Decision|1|||
16933255|NCT01256476|38077429|FG000|Overall Study|Subject non-compliance|0|||
16933256|NCT01256476|38077430|FG001|Overall Study|Subject non-compliance|1|||
16933257|NCT01256476|38077429|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
16933258|NCT01256476|38077430|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
16933259|NCT01256398|38077436|FG000|Overall Study|Withdrawal by Subject|1|||
16933260|NCT01256008|38077443|FG000|Overall Study|Lost to Follow-up|6|||
16933261|NCT01256008|38077444|FG001|Overall Study|Lost to Follow-up|4|||
16933262|NCT01256008|38077445|FG002|Overall Study|Lost to Follow-up|11|||
16933263|NCT01256008|38077443|FG000|Overall Study|Withdrawal by Subject|2|||
16933264|NCT01256008|38077444|FG001|Overall Study|Withdrawal by Subject|3|||
16933265|NCT01256008|38077445|FG002|Overall Study|Withdrawal by Subject|10|||
16933266|NCT01255423|38077457|FG000|Overall Study|Abnormal Laboratory value|3|||
16933267|NCT01255423|38077458|FG001|Overall Study|Abnormal Laboratory value|2|||
16933268|NCT01255423|38077457|FG000|Overall Study|Use of prohibited medications|0|||
16933269|NCT01255423|38077458|FG001|Overall Study|Use of prohibited medications|1|||
16933270|NCT01255306|38077466|FG000|Overall Study|Physician Decision|1|||
16933271|NCT01255306|38077467|FG001|Overall Study|Physician Decision|1|||
16933272|NCT01254721|38077478|FG000|Overall Study|Lost to Follow-up|0|||
16933273|NCT01254721|38077479|FG001|Overall Study|Lost to Follow-up|4|||
16933274|NCT01254721|38077478|FG000|Overall Study|Lack of Efficacy|4|||
16933275|NCT01254721|38077479|FG001|Overall Study|Lack of Efficacy|2|||
16933276|NCT01254721|38077478|FG000|Overall Study|Death|0|||
16933277|NCT01254721|38077479|FG001|Overall Study|Death|1|||
16933278|NCT01254721|38077478|FG000|Overall Study|technical problum|1|||
16933279|NCT01254721|38077479|FG001|Overall Study|technical problum|0|||
16933280|NCT01254721|38077478|FG000|Overall Study|Adverse Event|2|||
16933281|NCT01254721|38077479|FG001|Overall Study|Adverse Event|3|||
16933282|NCT01254721|38077478|FG000|Overall Study|Withdrawal by Subject|8|||
16933283|NCT01254721|38077479|FG001|Overall Study|Withdrawal by Subject|11|||
16933284|NCT01254721|38077478|FG000|Overall Study|Wrongly randomization|0|||
16933285|NCT01254721|38077479|FG001|Overall Study|Wrongly randomization|1|||
16933286|NCT01254643|38077485|FG000|Overall Study|Withdrawal by Subject|1|||
16933287|NCT01254604|38077491|FG000|Overall Study|Lost to Follow-up|1|||
16933288|NCT01254604|38077492|FG001|Overall Study|Lost to Follow-up|1|||
16933289|NCT01254604|38077491|FG000|Overall Study|Protocol Violation|2|||
16933290|NCT01254604|38077492|FG001|Overall Study|Protocol Violation|2|||
16933291|NCT01254604|38077491|FG000|Overall Study|Withdrawal by Subject|2|||
16933292|NCT01254604|38077492|FG001|Overall Study|Withdrawal by Subject|4|||
16933293|NCT01254604|38077491|FG000|Overall Study|Adverse Event|3|||
16933294|NCT01254604|38077492|FG001|Overall Study|Adverse Event|2|||
16933295|NCT01254565|38077504|FG000|Overall Study|Non-compliance to Study Procedures|0|||
16933296|NCT01254565|38077505|FG001|Overall Study|Non-compliance to Study Procedures|0|||
16933297|NCT01254565|38077506|FG002|Overall Study|Non-compliance to Study Procedures|0|||
16933298|NCT01254565|38077507|FG003|Overall Study|Non-compliance to Study Procedures|0|||
16933299|NCT01254565|38077508|FG004|Overall Study|Non-compliance to Study Procedures|1|||
16852568|NCT01388985|37802696|FG000|Overall Study|Death|0|||
16852569|NCT01388985|37802697|FG001|Overall Study|Death|1|||
16852570|NCT01388985|37802696|FG000|Overall Study|Lost to Follow-up|30|||
16852571|NCT01388985|37802697|FG001|Overall Study|Lost to Follow-up|30|||
16852572|NCT01388985|37802696|FG000|Overall Study|Withdrawal by Subject|13|||
16852573|NCT01388985|37802697|FG001|Overall Study|Withdrawal by Subject|4|||
16852574|NCT01388985|37802696|FG000|Overall Study|Subject unavailable|1|||
16852575|NCT01388985|37802697|FG001|Overall Study|Subject unavailable|1|||
16852576|NCT01388985|37802696|FG000|Overall Study|Other (no reason)|0|||
16852577|NCT01388985|37802697|FG001|Overall Study|Other (no reason)|1|||
16852578|NCT01388985|37802696|FG000|Overall Study|Error of nurse|5|||
16852579|NCT01388985|37802697|FG001|Overall Study|Error of nurse|1|||
16933300|NCT01254565|38077509|FG005|Overall Study|Non-compliance to Study Procedures|0|||
16933301|NCT01254565|38077504|FG000|Overall Study|Did not Receive Treatment|1|||
16933302|NCT01254565|38077505|FG001|Overall Study|Did not Receive Treatment|1|||
16933303|NCT01254565|38077506|FG002|Overall Study|Did not Receive Treatment|0|||
16933304|NCT01254565|38077507|FG003|Overall Study|Did not Receive Treatment|0|||
16933305|NCT01254565|38077508|FG004|Overall Study|Did not Receive Treatment|3|||
16933306|NCT01254565|38077509|FG005|Overall Study|Did not Receive Treatment|4|||
16933307|NCT01254565|38077504|FG000|Overall Study|Other|0|||
16933308|NCT01254565|38077505|FG001|Overall Study|Other|0|||
16933309|NCT01254565|38077506|FG002|Overall Study|Other|0|||
16933310|NCT01254565|38077507|FG003|Overall Study|Other|1|||
16933311|NCT01254565|38077508|FG004|Overall Study|Other|0|||
16933312|NCT01254565|38077509|FG005|Overall Study|Other|0|||
16933313|NCT01254409|38077541|FG000|Overall Study|Adverse Event|0|||
16933314|NCT01254409|38077542|FG001|Overall Study|Adverse Event|1|||
16933315|NCT01254409|38077543|FG002|Overall Study|Adverse Event|0|||
16933316|NCT01254409|38077544|FG003|Overall Study|Adverse Event|0|||
16933317|NCT01254331|38077557|FG000|Initial Phase|Adverse Event|3|||
16933318|NCT01254331|38077557|FG000|Initial Phase|Withdrawal by Subject|1|||
16933319|NCT01254331|38077557|FG000|Initial Phase|Pregnancy|1|||
16933320|NCT01254331|38077557|FG000|Extension Phase|Lack of Efficacy|1|||
16933321|NCT01254331|38077557|FG000|Extension Phase|Lost to Follow-up|3|||
16933322|NCT01254292|38077572|FG000|Comparative Phase|Adverse Event|25|||
16933323|NCT01254292|38077573|FG001|Comparative Phase|Adverse Event|25|||
16933324|NCT01254292|38077572|FG000|Comparative Phase|Lost to Follow-up|3|||
16933325|NCT01254292|38077573|FG001|Comparative Phase|Lost to Follow-up|21|||
16933326|NCT01254292|38077572|FG000|Comparative Phase|Pregnancy|2|||
16933327|NCT01254292|38077573|FG001|Comparative Phase|Pregnancy|6|||
16933328|NCT01254292|38077572|FG000|Comparative Phase|Withdrawal by Subject|20|||
16933329|NCT01254292|38077573|FG001|Comparative Phase|Withdrawal by Subject|21|||
16933330|NCT01254292|38077572|FG000|Comparative Phase|Protocol Violation|1|||
16933331|NCT01254292|38077573|FG001|Comparative Phase|Protocol Violation|2|||
16933332|NCT01254292|38077572|FG000|Comparative Phase|Wish for pregnancy|4|||
16933333|NCT01254292|38077573|FG001|Comparative Phase|Wish for pregnancy|6|||
16933334|NCT01254292|38077572|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
16933335|NCT01254292|38077573|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
16933336|NCT01254292|38077572|FG000|LCS12 Extension Phase|Adverse Event|9|||
16933337|NCT01254292|38077573|FG001|LCS12 Extension Phase|Adverse Event|0|||
16933338|NCT01254292|38077572|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
16933339|NCT01254292|38077573|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
16933340|NCT01254292|38077572|FG000|LCS12 Extension Phase|Other unknown|4|||
16933341|NCT01254292|38077573|FG001|LCS12 Extension Phase|Other unknown|0|||
16933342|NCT01254292|38077572|FG000|LCS12 Extension Phase|Pregnancy|2|||
16933343|NCT01254292|38077573|FG001|LCS12 Extension Phase|Pregnancy|0|||
16933344|NCT01254292|38077572|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
16933345|NCT01254292|38077573|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
16933346|NCT01254019|38077582|FG000|Overall Study|Adverse Event|0|||
16933347|NCT01254019|38077583|FG001|Overall Study|Adverse Event|2|||
16933348|NCT01254019|38077582|FG000|Overall Study|Protocol Violation|1|||
16933349|NCT01254019|38077583|FG001|Overall Study|Protocol Violation|0|||
16933350|NCT01254019|38077582|FG000|Overall Study|Withdrawal by Subject|0|||
16933351|NCT01254019|38077583|FG001|Overall Study|Withdrawal by Subject|2|||
16933352|NCT01253317|38077592|FG000|Overall Study|Adverse Event|2|||
16933353|NCT01253200|38077605|FG000|Overall Study|Death|1|||
16933354|NCT01253200|38077606|FG001|Overall Study|Death|0|||
16933355|NCT01253200|38077607|FG002|Overall Study|Death|0|||
16933356|NCT01253200|38077608|FG003|Overall Study|Death|0|||
16933357|NCT01253200|38077609|FG004|Overall Study|Death|0|||
16933358|NCT01253200|38077605|FG000|Overall Study|Lost to Follow-up|1|||
16933359|NCT01253200|38077606|FG001|Overall Study|Lost to Follow-up|1|||
16933360|NCT01253200|38077607|FG002|Overall Study|Lost to Follow-up|0|||
16933361|NCT01253200|38077608|FG003|Overall Study|Lost to Follow-up|0|||
16933362|NCT01253200|38077609|FG004|Overall Study|Lost to Follow-up|0|||
16933363|NCT01253200|38077605|FG000|Overall Study|Withdrawal by Subject|2|||
16933364|NCT01253200|38077606|FG001|Overall Study|Withdrawal by Subject|0|||
16933365|NCT01253200|38077607|FG002|Overall Study|Withdrawal by Subject|0|||
16933366|NCT01253200|38077608|FG003|Overall Study|Withdrawal by Subject|0|||
16933367|NCT01253200|38077609|FG004|Overall Study|Withdrawal by Subject|0|||
16933368|NCT01253200|38077605|FG000|Overall Study|Protocol Violation|1|||
16933369|NCT01253200|38077606|FG001|Overall Study|Protocol Violation|4|||
16933370|NCT01253200|38077607|FG002|Overall Study|Protocol Violation|0|||
16933371|NCT01253200|38077608|FG003|Overall Study|Protocol Violation|0|||
16933372|NCT01253200|38077609|FG004|Overall Study|Protocol Violation|5|||
16933373|NCT01253200|38077605|FG000|Overall Study|intents|10|||
16933374|NCT01253200|38077606|FG001|Overall Study|intents|10|||
16933375|NCT01253200|38077607|FG002|Overall Study|intents|1|||
16933376|NCT01253200|38077608|FG003|Overall Study|intents|3|||
16933377|NCT01253200|38077609|FG004|Overall Study|intents|0|||
16933378|NCT01253200|38077605|FG000|Overall Study|Attempts|6|||
16933379|NCT01253200|38077606|FG001|Overall Study|Attempts|4|||
16933380|NCT01253200|38077607|FG002|Overall Study|Attempts|1|||
16933381|NCT01253200|38077608|FG003|Overall Study|Attempts|2|||
16933382|NCT01253200|38077609|FG004|Overall Study|Attempts|0|||
16933383|NCT01253044|38077620|FG000|Overall Study|Lost to Follow-up|38|||
16933384|NCT01253044|38077621|FG001|Overall Study|Lost to Follow-up|29|||
16933385|NCT01252966|38077629|FG000|Overall Study|Lost to Follow-up|16|||
16933386|NCT01252966|38077630|FG001|Overall Study|Lost to Follow-up|10|||
16933387|NCT01252966|38077629|FG000|Overall Study|Withdrawal by Subject|7|||
16933388|NCT01252966|38077630|FG001|Overall Study|Withdrawal by Subject|3|||
16933389|NCT01252810|38077640|FG000|Overall Study|Withdrawal by Subject|4|||
16933390|NCT01252810|38077641|FG001|Overall Study|Withdrawal by Subject|1|||
16933391|NCT01252810|38077640|FG000|Overall Study|Lost to Follow-up|0|||
16933392|NCT01252810|38077641|FG001|Overall Study|Lost to Follow-up|1|||
16933393|NCT01252810|38077640|FG000|Overall Study|Physician Decision|2|||
16933394|NCT01252810|38077641|FG001|Overall Study|Physician Decision|1|||
16933395|NCT01252810|38077640|FG000|Overall Study|Various reasons|8|||
16933396|NCT01252810|38077641|FG001|Overall Study|Various reasons|0|||
16933397|NCT01252186|38077650|FG000|Overall Study|Adverse Event|9|||
16933398|NCT01252186|38077651|FG001|Overall Study|Adverse Event|6|||
16933399|NCT01252186|38077652|FG002|Overall Study|Adverse Event|8|||
16933400|NCT01252186|38077650|FG000|Overall Study|Withdrawal by Subject|2|||
16933401|NCT01252186|38077651|FG001|Overall Study|Withdrawal by Subject|5|||
16933402|NCT01252186|38077652|FG002|Overall Study|Withdrawal by Subject|2|||
16933403|NCT01252186|38077650|FG000|Overall Study|Physician Decision|0|||
16933404|NCT01252186|38077651|FG001|Overall Study|Physician Decision|0|||
16933405|NCT01252186|38077652|FG002|Overall Study|Physician Decision|1|||
16933406|NCT01252186|38077650|FG000|Overall Study|Non-compliance|0|||
16933407|NCT01252186|38077651|FG001|Overall Study|Non-compliance|3|||
16933408|NCT01252186|38077652|FG002|Overall Study|Non-compliance|4|||
16933409|NCT01252186|38077650|FG000|Overall Study|Protocol Violation|0|||
16933410|NCT01252186|38077651|FG001|Overall Study|Protocol Violation|0|||
16933411|NCT01252186|38077652|FG002|Overall Study|Protocol Violation|1|||
16933412|NCT01252186|38077650|FG000|Overall Study|Pregnancy|2|||
16933413|NCT01252186|38077651|FG001|Overall Study|Pregnancy|2|||
16933414|NCT01252186|38077652|FG002|Overall Study|Pregnancy|0|||
16933415|NCT01252186|38077650|FG000|Overall Study|Sponsor Request|2|||
16933416|NCT01252186|38077651|FG001|Overall Study|Sponsor Request|1|||
16933417|NCT01252186|38077652|FG002|Overall Study|Sponsor Request|0|||
16933418|NCT01252186|38077650|FG000|Overall Study|Lost to Follow-up|10|||
16933419|NCT01252186|38077651|FG001|Overall Study|Lost to Follow-up|10|||
16933420|NCT01252186|38077652|FG002|Overall Study|Lost to Follow-up|11|||
16933421|NCT01252186|38077650|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
16933422|NCT01252186|38077651|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
16933423|NCT01252186|38077652|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
16933424|NCT01251952|38077687|FG000|Overall Study|Adverse Event|1|||
16933425|NCT01251367|38077691|FG000|Overall Study|Protocol Violation|1|||
16933426|NCT01251367|38077691|FG000|Overall Study|Lack of Efficacy|2|||
16933427|NCT01251367|38077691|FG000|Overall Study|Adverse Event|19|||
16933428|NCT01251367|38077691|FG000|Overall Study|Withdrawal by Subject|36|||
16933429|NCT01251367|38077691|FG000|Overall Study|Lost to Follow-up|5|||
16933430|NCT01251367|38077691|FG000|Overall Study|Subject Required Alternative Treatment|7|||
16933431|NCT01251367|38077691|FG000|Overall Study|No Study Drug Available|1|||
16933432|NCT01251367|38077691|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
16933433|NCT01251367|38077691|FG000|Overall Study|End of Study Visit Performed in Error|1|||
16933434|NCT01250509|38077697|FG000|Overall Study|Lost to Follow-up|5|||
16933435|NCT01250509|38077698|FG001|Overall Study|Lost to Follow-up|2|||
16933436|NCT01250119|38077706|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
16933437|NCT01250119|38077707|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
16933438|NCT01250119|38077706|FG000|Diagnostic Phase|Participants Not Tested|44|||
16933439|NCT01250119|38077707|FG001|Diagnostic Phase|Participants Not Tested|0|||
16933440|NCT01250119|38077706|FG000|Treatment Phase|Progressive Disease|0|||
16933441|NCT01250119|38077707|FG001|Treatment Phase|Progressive Disease|32|||
16933442|NCT01250119|38077706|FG000|Treatment Phase|Death|0|||
16933443|NCT01250119|38077707|FG001|Treatment Phase|Death|2|||
16933444|NCT01250119|38077706|FG000|Treatment Phase|Withdrawal by Subject|0|||
16933445|NCT01250119|38077707|FG001|Treatment Phase|Withdrawal by Subject|1|||
16933446|NCT01250119|38077706|FG000|Treatment Phase|Adverse Event|0|||
16933447|NCT01250119|38077707|FG001|Treatment Phase|Adverse Event|2|||
16933448|NCT01250119|38077706|FG000|Treatment Phase|Unknown reason|0|||
16933449|NCT01250119|38077707|FG001|Treatment Phase|Unknown reason|4|||
16933450|NCT01250002|38077716|FG000|Overall Study|Change to open surgical procedure|4|||
16933451|NCT01250002|38077717|FG001|Overall Study|Change to open surgical procedure|3|||
16933452|NCT01246960|38077725|FG000|Overall Study|Lost to Follow-up|3|||
16933453|NCT01246960|38077726|FG001|Overall Study|Lost to Follow-up|1|||
16933454|NCT01246960|38077725|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
16933455|NCT01246960|38077726|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
16933456|NCT01244620|38077732|FG000|Overall Study|Study terminated|4|||
16933457|NCT01244620|38077733|FG001|Overall Study|Study terminated|4|||
16933458|NCT01244620|38077734|FG002|Overall Study|Study terminated|4|||
16933459|NCT01244620|38077735|FG003|Overall Study|Study terminated|4|||
16933460|NCT01267201|38077745|FG000|First Intervention Period|Withdrawal by Subject|1|||
16933461|NCT01267201|38077746|FG001|First Intervention Period|Withdrawal by Subject|0|||
16933462|NCT01267201|38077747|FG002|First Intervention Period|Withdrawal by Subject|0|||
16933463|NCT01267201|38077748|FG003|First Intervention Period|Withdrawal by Subject|0|||
16933464|NCT01267201|38077749|FG004|First Intervention Period|Withdrawal by Subject|0|||
16933465|NCT01267201|38077750|FG005|First Intervention Period|Withdrawal by Subject|0|||
16933466|NCT01267201|38077745|FG000|Second Intervention Period|Withdrawal by Subject|0|||
16933467|NCT01267201|38077746|FG001|Second Intervention Period|Withdrawal by Subject|1|||
16933468|NCT01267201|38077747|FG002|Second Intervention Period|Withdrawal by Subject|0|||
16933469|NCT01267201|38077748|FG003|Second Intervention Period|Withdrawal by Subject|0|||
16933470|NCT01267201|38077749|FG004|Second Intervention Period|Withdrawal by Subject|0|||
16933471|NCT01267201|38077750|FG005|Second Intervention Period|Withdrawal by Subject|0|||
16933472|NCT01266967|38077760|FG000|Overall Study|Death|69|||
16933473|NCT01266967|38077761|FG001|Overall Study|Death|61|||
16933474|NCT01266967|38077760|FG000|Overall Study|Study Closed/Terminated|15|||
16933475|NCT01266967|38077761|FG001|Overall Study|Study Closed/Terminated|17|||
16933476|NCT01266967|38077760|FG000|Overall Study|Lost to Follow-up|2|||
16933477|NCT01266967|38077761|FG001|Overall Study|Lost to Follow-up|1|||
16933478|NCT01266967|38077760|FG000|Overall Study|Physician Decision|0|||
16933479|NCT01266967|38077761|FG001|Overall Study|Physician Decision|1|||
16933480|NCT01266967|38077760|FG000|Overall Study|Withdrawal by Subject|3|||
16933481|NCT01266967|38077761|FG001|Overall Study|Withdrawal by Subject|3|||
16933482|NCT01266850|38077775|FG000|Overall Study|Lost to Follow-up|19|||
16933483|NCT01266850|38077776|FG001|Overall Study|Lost to Follow-up|19|||
16933484|NCT01266850|38077777|FG002|Overall Study|Lost to Follow-up|13|||
16933485|NCT01266850|38077778|FG003|Overall Study|Lost to Follow-up|13|||
16933486|NCT01266850|38077779|FG004|Overall Study|Lost to Follow-up|12|||
16933487|NCT01266850|38077775|FG000|Overall Study|Withdrawal by Subject|8|||
16933488|NCT01266850|38077776|FG001|Overall Study|Withdrawal by Subject|9|||
16933489|NCT01266850|38077777|FG002|Overall Study|Withdrawal by Subject|6|||
16933490|NCT01266850|38077778|FG003|Overall Study|Withdrawal by Subject|9|||
16933491|NCT01266850|38077779|FG004|Overall Study|Withdrawal by Subject|12|||
16933492|NCT01266850|38077775|FG000|Overall Study|Physician Decision|3|||
16933493|NCT01266850|38077776|FG001|Overall Study|Physician Decision|6|||
16933494|NCT01266850|38077777|FG002|Overall Study|Physician Decision|4|||
16933495|NCT01266850|38077778|FG003|Overall Study|Physician Decision|4|||
16933496|NCT01266850|38077779|FG004|Overall Study|Physician Decision|3|||
16933497|NCT01266850|38077775|FG000|Overall Study|Protocol Violation|0|||
16933498|NCT01266850|38077776|FG001|Overall Study|Protocol Violation|1|||
16933499|NCT01266850|38077777|FG002|Overall Study|Protocol Violation|0|||
16933500|NCT01266850|38077778|FG003|Overall Study|Protocol Violation|1|||
16933501|NCT01266850|38077779|FG004|Overall Study|Protocol Violation|2|||
16933502|NCT01266850|38077775|FG000|Overall Study|Adverse Event|0|||
16933503|NCT01266850|38077776|FG001|Overall Study|Adverse Event|0|||
16933504|NCT01266850|38077777|FG002|Overall Study|Adverse Event|0|||
16933505|NCT01266850|38077778|FG003|Overall Study|Adverse Event|0|||
16933506|NCT01266850|38077779|FG004|Overall Study|Adverse Event|1|||
16933507|NCT01266850|38077775|FG000|Overall Study|Site Closure|0|||
16933508|NCT01266850|38077776|FG001|Overall Study|Site Closure|1|||
16933509|NCT01266850|38077777|FG002|Overall Study|Site Closure|1|||
16933510|NCT01266850|38077778|FG003|Overall Study|Site Closure|1|||
16933511|NCT01266850|38077779|FG004|Overall Study|Site Closure|0|||
16933512|NCT01266460|38077791|FG000|Overall Study|Adverse Event|3|||
16933513|NCT01266460|38077791|FG000|Overall Study|Withdrawal by Subject|5|||
16933514|NCT01266460|38077791|FG000|Overall Study|Disease Progression|18|||
16933515|NCT01266460|38077791|FG000|Overall Study|Not otherwise specified|8|||
16933516|NCT01266265|38077797|FG000|Overall Study|Death|95|||
16933517|NCT01266265|38077798|FG001|Overall Study|Death|73|||
16933518|NCT01266265|38077797|FG000|Overall Study|Lost to Follow-up|23|||
16933519|NCT01266265|38077798|FG001|Overall Study|Lost to Follow-up|28|||
16933520|NCT01266265|38077797|FG000|Overall Study|Withdrawal by Subject|13|||
16933521|NCT01266265|38077798|FG001|Overall Study|Withdrawal by Subject|11|||
16933522|NCT01266265|38077797|FG000|Overall Study|Respiratory-related adverse event|2|||
17020168|NCT00857207|38164719|FG000|Overall Study|Withdrawal by Subject|13|||
17020169|NCT00857207|38164720|FG001|Overall Study|Withdrawal by Subject|0|||
17020170|NCT00857207|38164719|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
17020171|NCT00857207|38164720|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
17020172|NCT00857207|38164719|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
16933523|NCT01266265|38077798|FG001|Overall Study|Respiratory-related adverse event|1|||
16933524|NCT01266265|38077797|FG000|Overall Study|Transferred care to another provider|22|||
16933525|NCT01266265|38077798|FG001|Overall Study|Transferred care to another provider|28|||
16933526|NCT01266265|38077797|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
16933527|NCT01266265|38077798|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
17020173|NCT00857207|38164720|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
17020174|NCT00836498|38164729|FG000|Overall Study|Adverse Event|1|||
17020175|NCT00836498|38164730|FG001|Overall Study|Adverse Event|0|||
17020176|NCT00836498|38164729|FG000|Overall Study|Lost to Follow-up|1|||
17020177|NCT00836498|38164730|FG001|Overall Study|Lost to Follow-up|0|||
17020178|NCT00836498|38164729|FG000|Overall Study|Withdrawal by Subject|2|||
17020179|NCT00836498|38164730|FG001|Overall Study|Withdrawal by Subject|1|||
17020180|NCT00856973|38164740|FG000|Overall Study|Adverse Event|5|||
17020181|NCT00856973|38164741|FG001|Overall Study|Adverse Event|5|||
17020182|NCT00856973|38164742|FG002|Overall Study|Adverse Event|3|||
17020183|NCT00856973|38164740|FG000|Overall Study|Lost to Follow-up|6|||
17020184|NCT00856973|38164741|FG001|Overall Study|Lost to Follow-up|3|||
17020185|NCT00856973|38164742|FG002|Overall Study|Lost to Follow-up|5|||
17020186|NCT00856973|38164740|FG000|Overall Study|Physician Decision|0|||
17020187|NCT00856973|38164741|FG001|Overall Study|Physician Decision|3|||
17020188|NCT00856973|38164742|FG002|Overall Study|Physician Decision|1|||
17020189|NCT00856973|38164740|FG000|Overall Study|Protocol Violation|1|||
17020190|NCT00856973|38164741|FG001|Overall Study|Protocol Violation|2|||
17020191|NCT00856973|38164742|FG002|Overall Study|Protocol Violation|1|||
17020192|NCT00856973|38164740|FG000|Overall Study|Withdrawal by Subject|13|||
17020193|NCT00856973|38164741|FG001|Overall Study|Withdrawal by Subject|16|||
17020194|NCT00856973|38164742|FG002|Overall Study|Withdrawal by Subject|15|||
17020195|NCT00856973|38164740|FG000|Overall Study|Other|11|||
17020196|NCT00856973|38164741|FG001|Overall Study|Other|12|||
17020197|NCT00856973|38164742|FG002|Overall Study|Other|13|||
17020198|NCT00844532|38164754|FG000|Overall Study|Death|16|||
17020199|NCT00844532|38164754|FG000|Overall Study|Withdrawal by Subject|16|||
17020200|NCT00844532|38164754|FG000|Overall Study|Lost to Follow-up|7|||
17020201|NCT00805194|38164760|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
17020202|NCT00805194|38164761|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
17020203|NCT00805194|38164760|FG000|Overall Study|Worsening or AE of underlying disease|64|||
17020204|NCT00805194|38164761|FG001|Overall Study|Worsening or AE of underlying disease|70|||
17020205|NCT00805194|38164760|FG000|Overall Study|Other AE|84|||
17020206|NCT00805194|38164761|FG001|Overall Study|Other AE|73|||
17020207|NCT00805194|38164760|FG000|Overall Study|Protocol Violation|9|||
17020208|NCT00805194|38164761|FG001|Overall Study|Protocol Violation|9|||
17020209|NCT00805194|38164760|FG000|Overall Study|Lost to Follow-up|5|||
17020210|NCT00805194|38164761|FG001|Overall Study|Lost to Follow-up|5|||
17020211|NCT00805194|38164760|FG000|Overall Study|Withdrawal by Subject|60|||
17102692|NCT00112437|38241466|FG025|Year 1 (12-Month Base Study)|moved|0|||
17102693|NCT00112437|38241441|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102694|NCT00112437|38241442|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102695|NCT00112437|38241443|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102696|NCT00112437|38241444|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
17102697|NCT00112437|38241445|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102698|NCT00112437|38241446|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102699|NCT00112437|38241447|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102700|NCT00112437|38241448|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102701|NCT00112437|38241449|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102702|NCT00112437|38241450|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102703|NCT00112437|38241451|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102704|NCT00112437|38241452|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102705|NCT00112437|38241453|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102706|NCT00112437|38241454|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102707|NCT00112437|38241455|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102708|NCT00112437|38241456|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102709|NCT00112437|38241457|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102710|NCT00112437|38241458|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102711|NCT00112437|38241459|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102712|NCT00112437|38241460|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102713|NCT00112437|38241461|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102714|NCT00112437|38241462|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102715|NCT00112437|38241463|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17020212|NCT00805194|38164761|FG001|Overall Study|Withdrawal by Subject|42|||
17020213|NCT00805194|38164760|FG000|Overall Study|Not treated|3|||
17020214|NCT00805194|38164761|FG001|Overall Study|Not treated|4|||
17020215|NCT00805194|38164760|FG000|Overall Study|Reasons other than stated above|20|||
17020216|NCT00805194|38164761|FG001|Overall Study|Reasons other than stated above|16|||
16852580|NCT01388907|37802705|FG000|Overall Study|Adverse Event|2|||
17020217|NCT00836186|38164772|FG000|Overall Study|Blood could not be drawn|1|||
17020218|NCT00657046|38164780|FG000|Overall Study|Adverse Event|1|||
17020219|NCT00657046|38164781|FG001|Overall Study|Adverse Event|1|||
17020220|NCT00657046|38164782|FG002|Overall Study|Adverse Event|0|||
17020221|NCT00657046|38164780|FG000|Overall Study|Protocol Violation|2|||
17020222|NCT00657046|38164781|FG001|Overall Study|Protocol Violation|2|||
17020223|NCT00657046|38164782|FG002|Overall Study|Protocol Violation|0|||
17020224|NCT00657046|38164780|FG000|Overall Study|Withdrawal by Subject|1|||
17020225|NCT00657046|38164781|FG001|Overall Study|Withdrawal by Subject|0|||
17020226|NCT00657046|38164782|FG002|Overall Study|Withdrawal by Subject|0|||
17020227|NCT00657046|38164780|FG000|Overall Study|Death|0|||
17020228|NCT00657046|38164781|FG001|Overall Study|Death|0|||
17020229|NCT00657046|38164782|FG002|Overall Study|Death|1|||
17020230|NCT00657046|38164780|FG000|Overall Study|Surgery|0|||
17020231|NCT00657046|38164781|FG001|Overall Study|Surgery|0|||
17020232|NCT00657046|38164782|FG002|Overall Study|Surgery|1|||
17020233|NCT00856661|38164792|FG000|Overall Study|Death|15|||
17020234|NCT00856661|38164793|FG001|Overall Study|Death|18|||
17020235|NCT00856661|38164792|FG000|Overall Study|Protocol Violation|2|||
17020236|NCT00856661|38164793|FG001|Overall Study|Protocol Violation|1|||
17020237|NCT00856661|38164792|FG000|Overall Study|Withdrawal by Subject|1|||
17020238|NCT00856661|38164793|FG001|Overall Study|Withdrawal by Subject|2|||
16933528|NCT01266265|38077797|FG000|Overall Study|Enrolled in another clinical study|15|||
16933529|NCT01266265|38077798|FG001|Overall Study|Enrolled in another clinical study|26|||
16933530|NCT01266265|38077797|FG000|Overall Study|Non-compliance|8|||
16933531|NCT01266265|38077798|FG001|Overall Study|Non-compliance|5|||
16933532|NCT01266265|38077797|FG000|Overall Study|Lung transplant|6|||
16933533|NCT01266265|38077798|FG001|Overall Study|Lung transplant|5|||
16933534|NCT01266265|38077797|FG000|Overall Study|Site closed early|4|||
16933535|NCT01266265|38077798|FG001|Overall Study|Site closed early|3|||
16933536|NCT01266265|38077797|FG000|Overall Study|Clinical worsening|1|||
16933537|NCT01266265|38077798|FG001|Overall Study|Clinical worsening|1|||
16933538|NCT01266148|38077823|FG000|Overall Study|Adverse Event|2|||
16933539|NCT01266148|38077824|FG001|Overall Study|Adverse Event|0|||
16933540|NCT01266148|38077823|FG000|Overall Study|Ongoing rejection|1|||
16933541|NCT01266148|38077824|FG001|Overall Study|Ongoing rejection|0|||
16933542|NCT01266148|38077823|FG000|Overall Study|2 2R rejections|1|||
16933543|NCT01266148|38077824|FG001|Overall Study|2 2R rejections|0|||
16933544|NCT01266148|38077823|FG000|Overall Study|Death|2|||
16933545|NCT01266148|38077824|FG001|Overall Study|Death|3|||
16933546|NCT01266148|38077823|FG000|Overall Study|missing mGFR value + AE|1|||
16933547|NCT01266148|38077824|FG001|Overall Study|missing mGFR value + AE|0|||
16933548|NCT01266070|38077830|FG000|Overall Study|Adverse Event|3|||
16933549|NCT01266070|38077830|FG000|Overall Study|Protocol Violation|1|||
16933550|NCT01265992|38077834|FG000|Overall Study|Lost to Follow-up|1|||
16933551|NCT01265992|38077834|FG000|Overall Study|Withdrawal by Subject|1|||
16933552|NCT01265992|38077834|FG000|Overall Study|Adverse Event|1|||
16933553|NCT01265992|38077834|FG000|Overall Study|Administrative reasons|2|||
16933554|NCT01265992|38077834|FG000|Overall Study|Stopped treatment|3|||
16933555|NCT01265992|38077834|FG000|Overall Study|Did not receive treatment|1|||
16933556|NCT01265953|38077840|FG000|Overall Study|Non compliance|5|||
16933557|NCT01265953|38077841|FG001|Overall Study|Non compliance|3|||
17020239|NCT00856661|38164792|FG000|Overall Study|Lost to Follow-up|1|||
16933558|NCT01265875|38077847|FG000|Overall Study|Uncooperative/unreliable|1|||
16933559|NCT01265797|38077858|FG000|Run-in Month|Withdrawal by Subject|0|||
16933560|NCT01265797|38077859|FG001|Run-in Month|Withdrawal by Subject|4|||
16933561|NCT01265797|38077858|FG000|Run-in Month|1st seizure during run-in month|0|||
16933562|NCT01265797|38077859|FG001|Run-in Month|1st seizure during run-in month|1|||
16933563|NCT01265797|38077858|FG000|Blinded Month|Lack of Efficacy|5|||
17020240|NCT00856661|38164793|FG001|Overall Study|Lost to Follow-up|3|||
17020241|NCT00856661|38164792|FG000|Overall Study|Physician Judgement|8|||
17020242|NCT00856661|38164793|FG001|Overall Study|Physician Judgement|5|||
17020243|NCT00844376|38164799|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
17020244|NCT00844376|38164800|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
17020245|NCT00658606|38164808|FG000|Overall Study|Adverse Event|2|||
17020246|NCT00658606|38164809|FG001|Overall Study|Adverse Event|1|||
17020247|NCT00658606|38164808|FG000|Overall Study|Lack of Efficacy|6|||
17020248|NCT00658606|38164809|FG001|Overall Study|Lack of Efficacy|3|||
17020249|NCT00658606|38164808|FG000|Overall Study|Lost to Follow-up|1|||
17020250|NCT00658606|38164809|FG001|Overall Study|Lost to Follow-up|0|||
17102716|NCT00112437|38241464|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17020251|NCT00658606|38164808|FG000|Overall Study|Withdrawal by Subject|7|||
17020252|NCT00658606|38164809|FG001|Overall Study|Withdrawal by Subject|16|||
17020253|NCT00658606|38164808|FG000|Overall Study|Lack of Compliance|0|||
17020254|NCT00658606|38164809|FG001|Overall Study|Lack of Compliance|3|||
17020255|NCT00589290|38164815|FG000|Overall Study|Withdrawal by Subject|1|||
17020256|NCT00843518|38164823|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
16933564|NCT01265797|38077859|FG001|Blinded Month|Lack of Efficacy|0|||
17020257|NCT00843518|38164824|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
17020258|NCT00843518|38164823|FG000|Period 2 (Double-blind Treatment)|Death|0|||
17020259|NCT00843518|38164824|FG001|Period 2 (Double-blind Treatment)|Death|1|||
17020260|NCT00843518|38164823|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
17020261|NCT00843518|38164824|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
17020262|NCT00843518|38164823|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
17020263|NCT00843518|38164824|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
17020264|NCT00843518|38164823|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
17020265|NCT00843518|38164824|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
17020266|NCT00843518|38164823|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
17020267|NCT00843518|38164824|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
17020268|NCT00843518|38164823|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
17020269|NCT00843518|38164824|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
17020270|NCT00843284|38164834|FG000|Overall Study|Adverse Event|39|||
17020271|NCT00843284|38164834|FG000|Overall Study|Lack of Efficacy|5|||
17020272|NCT00843284|38164834|FG000|Overall Study|Lost to Follow-up|11|||
17020273|NCT00843284|38164834|FG000|Overall Study|Other|10|||
17020274|NCT00843284|38164834|FG000|Overall Study|Withdrawal by Subject|4|||
17020275|NCT00843284|38164834|FG000|Overall Study|Death|3|||
17020276|NCT00652834|38164851|FG000|Overall Study|Withdrawal by Subject|3|||
17020277|NCT00652834|38164851|FG000|Overall Study|Lost to Follow-up|2|||
17020278|NCT00825812|38164859|FG000|Overall Study|Never entered follow up|0|||
17020279|NCT00825812|38164860|FG001|Overall Study|Never entered follow up|0|||
16933565|NCT01265797|38077858|FG000|Blinded Month|Lost to Follow-up|1|||
16933566|NCT01265797|38077859|FG001|Blinded Month|Lost to Follow-up|0|||
16933567|NCT01265797|38077858|FG000|Blinded Month|Protocol Violation|2|||
16933568|NCT01265797|38077859|FG001|Blinded Month|Protocol Violation|1|||
16933569|NCT01265797|38077858|FG000|Blinded Month|Adverse Event|2|||
16933570|NCT01265797|38077859|FG001|Blinded Month|Adverse Event|0|||
16933571|NCT01265797|38077858|FG000|Blinded Month|Diary data incomplete|0|||
16933572|NCT01265797|38077859|FG001|Blinded Month|Diary data incomplete|1|||
16933573|NCT01265797|38077858|FG000|Open Label Month|Lost to Follow-up|0|||
16933574|NCT01265797|38077859|FG001|Open Label Month|Lost to Follow-up|1|||
16933575|NCT01265719|38077869|FG000|Overall Study|Does not meet entrance criteria|0|||
16933576|NCT01265719|38077870|FG001|Overall Study|Does not meet entrance criteria|3|||
16933577|NCT01265719|38077869|FG000|Overall Study|Other reasons|2|||
16933578|NCT01265719|38077870|FG001|Overall Study|Other reasons|0|||
16933579|NCT01265719|38077869|FG000|Overall Study|Withdrawal by Subject|8|||
16933580|NCT01265719|38077870|FG001|Overall Study|Withdrawal by Subject|3|||
16933581|NCT01265719|38077869|FG000|Overall Study|Lost to Follow-up|2|||
16933582|NCT01265719|38077870|FG001|Overall Study|Lost to Follow-up|7|||
16933583|NCT01265719|38077869|FG000|Overall Study|Adverse Event|2|||
16933584|NCT01265719|38077870|FG001|Overall Study|Adverse Event|0|||
16933585|NCT01265563|38077902|FG000|Overall Study|Withdrawal by Subject|0|||
16933586|NCT01265563|38077903|FG001|Overall Study|Withdrawal by Subject|1|||
16933587|NCT01265563|38077904|FG002|Overall Study|Withdrawal by Subject|1|||
16933588|NCT01265563|38077905|FG003|Overall Study|Withdrawal by Subject|0|||
16933589|NCT01265563|38077906|FG004|Overall Study|Withdrawal by Subject|2|||
16933590|NCT01265056|38077925|FG000|Initial Study Period|Withdrawal by Subject|1|||
16933591|NCT01265056|38077926|FG001|Initial Study Period|Withdrawal by Subject|1|||
16933592|NCT01265056|38077925|FG000|Initial Study Period|Withdrawal by Subject|1|||
16933593|NCT01265056|38077926|FG001|Initial Study Period|Withdrawal by Subject|1|||
16933594|NCT01265056|38077925|FG000|Follow up|Lost to Follow-up|7|||
16933595|NCT01265056|38077926|FG001|Follow up|Lost to Follow-up|3|||
16933596|NCT01264939|38077934|FG000|Overall Study|Adverse Event|1|||
16933597|NCT01264939|38077935|FG001|Overall Study|Adverse Event|3|||
16933598|NCT01264939|38077934|FG000|Overall Study|Lost to Follow-up|0|||
16933599|NCT01264939|38077935|FG001|Overall Study|Lost to Follow-up|3|||
16933600|NCT01264939|38077934|FG000|Overall Study|Physician Decision|1|||
16933601|NCT01264939|38077935|FG001|Overall Study|Physician Decision|1|||
16933602|NCT01264939|38077934|FG000|Overall Study|Patient/Guardian Decision|8|||
16933603|NCT01264939|38077935|FG001|Overall Study|Patient/Guardian Decision|10|||
16933604|NCT01264939|38077934|FG000|Overall Study|Disease Progression|8|||
16933605|NCT01264939|38077935|FG001|Overall Study|Disease Progression|11|||
16933606|NCT01264081|38077941|FG000|Participants Screened|Screening failures|30|||
16933607|NCT01264081|38077941|FG000|Started Treatment|Withdrawal by Subject|1|||
16933608|NCT01264081|38077941|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
16933609|NCT01263925|38077947|FG000|Overall Study|Protocol Violation|1|||
16933610|NCT01263925|38077948|FG001|Overall Study|Protocol Violation|0|||
16933611|NCT01263925|38077947|FG000|Overall Study|Lack of Efficacy|0|||
16933612|NCT01263925|38077948|FG001|Overall Study|Lack of Efficacy|1|||
16933613|NCT01263925|38077947|FG000|Overall Study|Adverse Event|23|||
16933614|NCT01263925|38077948|FG001|Overall Study|Adverse Event|22|||
16933615|NCT01263925|38077947|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
16933616|NCT01263925|38077948|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
16933617|NCT01263925|38077947|FG000|Overall Study|Withdrawal by Subject|6|||
16933618|NCT01263925|38077948|FG001|Overall Study|Withdrawal by Subject|8|||
16933619|NCT01263925|38077947|FG000|Overall Study|Other|4|||
16933620|NCT01263925|38077948|FG001|Overall Study|Other|4|||
16933621|NCT01263925|38077947|FG000|Overall Study|Lost to Follow-up|3|||
16933622|NCT01263925|38077948|FG001|Overall Study|Lost to Follow-up|1|||
16933623|NCT01263925|38077947|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
16933624|NCT01263925|38077948|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
16933625|NCT01263925|38077947|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
17020280|NCT00825812|38164861|FG002|Overall Study|Never entered follow up|0|||
17020281|NCT00825812|38164862|FG003|Overall Study|Never entered follow up|1|||
17020282|NCT00825812|38164859|FG000|Overall Study|Adverse Event|0|||
17020283|NCT00825812|38164860|FG001|Overall Study|Adverse Event|0|||
17020284|NCT00825812|38164861|FG002|Overall Study|Adverse Event|0|||
17102717|NCT00112437|38241465|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102718|NCT00112437|38241466|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
17102719|NCT00112437|38241441|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102720|NCT00112437|38241442|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102721|NCT00112437|38241443|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102722|NCT00112437|38241444|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102723|NCT00112437|38241445|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
17102724|NCT00112437|38241446|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102725|NCT00112437|38241447|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17020285|NCT00825812|38164862|FG003|Overall Study|Adverse Event|1|||
17020286|NCT00825812|38164859|FG000|Overall Study|Subject withdrew consent|0|||
17020287|NCT00825812|38164860|FG001|Overall Study|Subject withdrew consent|0|||
17020288|NCT00825812|38164861|FG002|Overall Study|Subject withdrew consent|3|||
17020289|NCT00825812|38164862|FG003|Overall Study|Subject withdrew consent|2|||
17020290|NCT00825812|38164859|FG000|Overall Study|Non-compliance with protocol|0|||
17020291|NCT00825812|38164860|FG001|Overall Study|Non-compliance with protocol|0|||
17020292|NCT00825812|38164861|FG002|Overall Study|Non-compliance with protocol|0|||
17020293|NCT00825812|38164862|FG003|Overall Study|Non-compliance with protocol|1|||
17020294|NCT00825812|38164859|FG000|Overall Study|Administrative|0|||
17020295|NCT00825812|38164860|FG001|Overall Study|Administrative|1|||
17020296|NCT00825812|38164861|FG002|Overall Study|Administrative|3|||
17020297|NCT00825812|38164862|FG003|Overall Study|Administrative|5|||
17020298|NCT00824720|38164875|FG000|Overall Study|failed plug insertion|3|||
17020299|NCT00824720|38164876|FG001|Overall Study|failed plug insertion|1|||
17020300|NCT00824720|38164877|FG002|Overall Study|failed plug insertion|0|||
17020301|NCT00824720|38164875|FG000|Overall Study|Protocol Violation|0|||
17020302|NCT00824720|38164876|FG001|Overall Study|Protocol Violation|0|||
17020303|NCT00824720|38164877|FG002|Overall Study|Protocol Violation|1|||
17020304|NCT03704064|38164887|FG000|Overall Study|Lost to Follow-up|8|||
17020305|NCT03704064|38164888|FG001|Overall Study|Lost to Follow-up|4|||
17020306|NCT03704064|38164887|FG000|Overall Study|Withdrawal by Subject|1|||
17020307|NCT03704064|38164888|FG001|Overall Study|Withdrawal by Subject|1|||
17020308|NCT03704064|38164887|FG000|Overall Study|No longer available for study visits|0|||
17020309|NCT03704064|38164888|FG001|Overall Study|No longer available for study visits|1|||
17020310|NCT03704064|38164887|FG000|Overall Study|Censoring event|1|||
17020311|NCT03704064|38164888|FG001|Overall Study|Censoring event|0|||
17020312|NCT00824564|38164896|FG000|Overall Study|Lost to Follow-up|5|||
17020313|NCT00824564|38164897|FG001|Overall Study|Lost to Follow-up|7|||
17020314|NCT00824564|38164896|FG000|Overall Study|Withdrawal by Subject|1|||
17020315|NCT00824564|38164897|FG001|Overall Study|Withdrawal by Subject|1|||
17020316|NCT00824564|38164896|FG000|Overall Study|Other|1|||
17020317|NCT00824564|38164897|FG001|Overall Study|Other|2|||
17020318|NCT00824564|38164896|FG000|Overall Study|Randomized, but not treated|1|||
17020319|NCT00824564|38164897|FG001|Overall Study|Randomized, but not treated|0|||
17020320|NCT00658528|38164905|FG000|Overall Study|Adverse Event|5|||
17020321|NCT00658528|38164906|FG001|Overall Study|Adverse Event|7|||
17020322|NCT00658528|38164905|FG000|Overall Study|Lost to Follow-up|14|||
17020323|NCT00658528|38164906|FG001|Overall Study|Lost to Follow-up|22|||
17020324|NCT00658528|38164905|FG000|Overall Study|Withdrawal by Subject|8|||
17020325|NCT00658528|38164906|FG001|Overall Study|Withdrawal by Subject|6|||
17020326|NCT00658528|38164905|FG000|Overall Study|Withdrawal of consent|5|||
17020327|NCT00658528|38164906|FG001|Overall Study|Withdrawal of consent|6|||
17020328|NCT00658528|38164905|FG000|Overall Study|Other|8|||
17020329|NCT00658528|38164906|FG001|Overall Study|Other|4|||
17020330|NCT02864394|38164914|FG000|Overall Study|Death|135|||
17020331|NCT02864394|38164915|FG001|Overall Study|Death|150|||
17020332|NCT02864394|38164914|FG000|Overall Study|Withdrawal by Subject|1|||
16933626|NCT01263925|38077948|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
16933627|NCT01263925|38077947|FG000|Overall Study|AE/ Withdrawal|1|||
16933628|NCT01263925|38077948|FG001|Overall Study|AE/ Withdrawal|4|||
16933629|NCT01263925|38077947|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
16933630|NCT01263925|38077948|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
16933631|NCT01263925|38077947|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
16933632|NCT01263925|38077948|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
17020333|NCT02864394|38164915|FG001|Overall Study|Withdrawal by Subject|9|||
17020334|NCT02864394|38164914|FG000|Overall Study|Ongoing In Study|77|||
17020335|NCT02864394|38164915|FG001|Overall Study|Ongoing In Study|53|||
17020336|NCT00856583|38164923|FG000|Overall Study|Lack of Efficacy|389|||
17020337|NCT00856583|38164924|FG001|Overall Study|Lack of Efficacy|377|||
17020338|NCT00856583|38164923|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
17020339|NCT00856583|38164924|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
17020340|NCT00856583|38164923|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
17020341|NCT00856583|38164924|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
17020342|NCT00856583|38164923|FG000|Overall Study|Non-compliance|305|||
17020343|NCT00856583|38164924|FG001|Overall Study|Non-compliance|262|||
17020344|NCT00856583|38164923|FG000|Overall Study|Withdrawal by Subject|1092|||
17020345|NCT00856583|38164924|FG001|Overall Study|Withdrawal by Subject|919|||
17020346|NCT00856583|38164923|FG000|Overall Study|Physician Decision|59|||
17020347|NCT00856583|38164924|FG001|Overall Study|Physician Decision|82|||
17020348|NCT00856583|38164923|FG000|Overall Study|Pregnancy|14|||
17020349|NCT00856583|38164924|FG001|Overall Study|Pregnancy|5|||
17020350|NCT00856583|38164923|FG000|Overall Study|Other|92|||
17020351|NCT00856583|38164924|FG001|Overall Study|Other|104|||
17020352|NCT00856583|38164923|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
16933633|NCT01263925|38077947|FG000|Overall Study|Withdrawal/ Not specified|0|||
16933634|NCT01263925|38077948|FG001|Overall Study|Withdrawal/ Not specified|1|||
16933635|NCT01263769|38077954|FG000|Overall Study|Non-Compliant with treatment|1|||
16933636|NCT01263691|38077964|FG000|Overall Study|Lost to Follow-up|1|||
16933637|NCT01263691|38077965|FG001|Overall Study|Lost to Follow-up|0|||
16933638|NCT01263691|38077966|FG002|Overall Study|Lost to Follow-up|1|||
16933639|NCT01263691|38077967|FG003|Overall Study|Lost to Follow-up|1|||
16933640|NCT01263691|38077968|FG004|Overall Study|Lost to Follow-up|0|||
16933641|NCT01263691|38077969|FG005|Overall Study|Lost to Follow-up|0|||
16933642|NCT01263691|38077964|FG000|Overall Study|Withdrawal by Subject|1|||
16933643|NCT01263691|38077965|FG001|Overall Study|Withdrawal by Subject|0|||
16933644|NCT01263691|38077966|FG002|Overall Study|Withdrawal by Subject|0|||
16852581|NCT01388907|37802706|FG001|Overall Study|Adverse Event|0|||
16852582|NCT01388361|37802717|FG000|Overall Study|Adverse Event|0|||
16852583|NCT01388361|37802718|FG001|Overall Study|Adverse Event|5|||
16852584|NCT01388361|37802719|FG002|Overall Study|Adverse Event|1|||
16852585|NCT01388361|37802717|FG000|Overall Study|Protocol Violation|0|||
16852586|NCT01388361|37802718|FG001|Overall Study|Protocol Violation|0|||
16852587|NCT01388361|37802719|FG002|Overall Study|Protocol Violation|2|||
16852588|NCT01388361|37802717|FG000|Overall Study|Withdrawal criteria|12|||
16852589|NCT01388361|37802718|FG001|Overall Study|Withdrawal criteria|7|||
16852590|NCT01388361|37802719|FG002|Overall Study|Withdrawal criteria|10|||
16852591|NCT01388361|37802717|FG000|Overall Study|Unclassified|0|||
16852592|NCT01388361|37802718|FG001|Overall Study|Unclassified|0|||
16852593|NCT01388361|37802719|FG002|Overall Study|Unclassified|1|||
16852594|NCT01399125|37802729|FG000|Overall Study|Adverse Event|32|||
16852595|NCT01399125|37802730|FG001|Overall Study|Adverse Event|30|||
16852596|NCT01399125|37802729|FG000|Overall Study|Abnormal Lab values|0|||
16852597|NCT01399125|37802730|FG001|Overall Study|Abnormal Lab values|1|||
16852598|NCT01399125|37802729|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16852599|NCT01399125|37802730|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
16852600|NCT01399125|37802729|FG000|Overall Study|Withdrawal by Subject|5|||
16852601|NCT01399125|37802730|FG001|Overall Study|Withdrawal by Subject|8|||
16852602|NCT01399125|37802729|FG000|Overall Study|Lost to Follow-up|2|||
16852603|NCT01399125|37802730|FG001|Overall Study|Lost to Follow-up|3|||
16852604|NCT01399125|37802729|FG000|Overall Study|Administrative Problems|7|||
16852605|NCT01399125|37802730|FG001|Overall Study|Administrative Problems|11|||
16852606|NCT01399125|37802729|FG000|Overall Study|Death|0|||
16852607|NCT01399125|37802730|FG001|Overall Study|Death|1|||
16852608|NCT01399125|37802729|FG000|Overall Study|Protocol Deviation|5|||
16852609|NCT01399125|37802730|FG001|Overall Study|Protocol Deviation|2|||
16852610|NCT01399047|37802738|FG000|Overall Study|Withdrawal by Subject|0|||
16852611|NCT01399047|37802739|FG001|Overall Study|Withdrawal by Subject|1|||
16852612|NCT01387737|37802749|FG000|Overall Study|Adverse Event|20|||
17020353|NCT00856583|38164924|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
17020354|NCT00856349|38164930|FG000|Overall Study|Death|418|||
17020355|NCT00856349|38164930|FG000|Overall Study|Withdrawal by Subject|116|||
17020356|NCT00856349|38164930|FG000|Overall Study|Lost to Follow-up|91|||
17020357|NCT00856349|38164930|FG000|Overall Study|Protocol Violation|38|||
16933645|NCT01263691|38077967|FG003|Overall Study|Withdrawal by Subject|0|||
16852613|NCT01387737|37802750|FG001|Overall Study|Adverse Event|30|||
16852614|NCT01387737|37802749|FG000|Overall Study|Lack of Efficacy|1|||
16933646|NCT01263691|38077968|FG004|Overall Study|Withdrawal by Subject|0|||
16933647|NCT01263691|38077969|FG005|Overall Study|Withdrawal by Subject|0|||
16933648|NCT01263691|38077964|FG000|Overall Study|Adverse Event|1|||
17020358|NCT00856349|38164930|FG000|Overall Study|Physician Decision|13|||
17020359|NCT00856349|38164930|FG000|Overall Study|Subject relocation|104|||
17020360|NCT00856349|38164930|FG000|Overall Study|Device explant|33|||
17020361|NCT00856349|38164930|FG000|Overall Study|Site closure|78|||
17020362|NCT00856349|38164930|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
17020363|NCT00803244|38164938|FG000|Overall Study|Adverse Event|1|||
17020364|NCT00803244|38164939|FG001|Overall Study|Adverse Event|2|||
17020365|NCT00803244|38164938|FG000|Overall Study|Withdrawal by Subject|2|||
17020366|NCT00803244|38164939|FG001|Overall Study|Withdrawal by Subject|3|||
17020367|NCT00803244|38164938|FG000|Overall Study|Any other reason not above-mentioned|4|||
17020368|NCT00803244|38164939|FG001|Overall Study|Any other reason not above-mentioned|10|||
17020369|NCT04060212|38164945|FG000|Overall Study|Withdrawal by Subject|7|||
17020370|NCT00804570|38164951|FG000|Overall Study|Adverse Event|14|||
17020371|NCT00804570|38164952|FG001|Overall Study|Adverse Event|7|||
17020372|NCT00804570|38164951|FG000|Overall Study|Lack of Efficacy|0|||
17020373|NCT00804570|38164952|FG001|Overall Study|Lack of Efficacy|1|||
17020374|NCT00804570|38164951|FG000|Overall Study|Lost to Follow-up|18|||
17020375|NCT00804570|38164952|FG001|Overall Study|Lost to Follow-up|21|||
17020376|NCT00804570|38164951|FG000|Overall Study|Entry criteria not met|5|||
17020377|NCT00804570|38164952|FG001|Overall Study|Entry criteria not met|5|||
17020378|NCT00804570|38164951|FG000|Overall Study|Protocol Violation|12|||
17020379|NCT00804570|38164952|FG001|Overall Study|Protocol Violation|16|||
17020380|NCT00804570|38164951|FG000|Overall Study|Physician Decision|1|||
17020381|NCT00804570|38164952|FG001|Overall Study|Physician Decision|2|||
17020382|NCT00804570|38164951|FG000|Overall Study|Sponsor decision|1|||
17020383|NCT00804570|38164952|FG001|Overall Study|Sponsor decision|4|||
17020384|NCT00804570|38164951|FG000|Overall Study|Withdrawal by Subject|21|||
17020385|NCT00804570|38164952|FG001|Overall Study|Withdrawal by Subject|38|||
17020386|NCT00824408|38164964|FG000|Run-in Phase|Progressive disease|4|||
17020387|NCT00824408|38164965|FG001|Run-in Phase|Progressive disease|4|||
17020388|NCT00824408|38164966|FG002|Run-in Phase|Progressive disease|0|||
17020389|NCT00824408|38164967|FG003|Run-in Phase|Progressive disease|0|||
17020390|NCT00824408|38164968|FG004|Run-in Phase|Progressive disease|0|||
17020391|NCT00824408|38164964|FG000|Run-in Phase|Adverse Event|1|||
17020392|NCT00824408|38164965|FG001|Run-in Phase|Adverse Event|1|||
17020393|NCT00824408|38164966|FG002|Run-in Phase|Adverse Event|0|||
17020394|NCT00824408|38164967|FG003|Run-in Phase|Adverse Event|0|||
17020395|NCT00824408|38164968|FG004|Run-in Phase|Adverse Event|0|||
17020396|NCT00824408|38164964|FG000|Run-in Phase|Refused to continue medication|1|||
17020397|NCT00824408|38164965|FG001|Run-in Phase|Refused to continue medication|0|||
17020398|NCT00824408|38164966|FG002|Run-in Phase|Refused to continue medication|0|||
17020399|NCT00824408|38164967|FG003|Run-in Phase|Refused to continue medication|0|||
17020400|NCT00824408|38164968|FG004|Run-in Phase|Refused to continue medication|0|||
17020401|NCT00824408|38164964|FG000|Run-in Phase|Other reason not defined above|0|||
17020402|NCT00824408|38164965|FG001|Run-in Phase|Other reason not defined above|1|||
17020403|NCT00824408|38164966|FG002|Run-in Phase|Other reason not defined above|0|||
17020404|NCT00824408|38164967|FG003|Run-in Phase|Other reason not defined above|0|||
17020405|NCT00824408|38164968|FG004|Run-in Phase|Other reason not defined above|0|||
17020406|NCT00824408|38164964|FG000|Randomized Phase|Not treated|0|||
17020407|NCT00824408|38164965|FG001|Randomized Phase|Not treated|0|||
17020408|NCT00824408|38164966|FG002|Randomized Phase|Not treated|1|||
17020409|NCT00824408|38164967|FG003|Randomized Phase|Not treated|1|||
17020410|NCT00824408|38164968|FG004|Randomized Phase|Not treated|1|||
17020411|NCT00824408|38164964|FG000|Randomized Phase|Progressive disease|0|||
17020412|NCT00824408|38164965|FG001|Randomized Phase|Progressive disease|0|||
17020413|NCT00824408|38164966|FG002|Randomized Phase|Progressive disease|25|||
17020414|NCT00824408|38164967|FG003|Randomized Phase|Progressive disease|36|||
17020415|NCT00824408|38164968|FG004|Randomized Phase|Progressive disease|34|||
17020416|NCT00824408|38164964|FG000|Randomized Phase|Adverse Event|0|||
17020417|NCT00824408|38164965|FG001|Randomized Phase|Adverse Event|0|||
17020418|NCT00824408|38164966|FG002|Randomized Phase|Adverse Event|4|||
17020419|NCT00824408|38164967|FG003|Randomized Phase|Adverse Event|5|||
17020420|NCT00824408|38164968|FG004|Randomized Phase|Adverse Event|5|||
17020421|NCT00824408|38164964|FG000|Randomized Phase|Refused to continue medication|0|||
17020422|NCT00824408|38164965|FG001|Randomized Phase|Refused to continue medication|0|||
17020423|NCT00824408|38164966|FG002|Randomized Phase|Refused to continue medication|2|||
17020424|NCT00824408|38164967|FG003|Randomized Phase|Refused to continue medication|2|||
17020425|NCT00824408|38164968|FG004|Randomized Phase|Refused to continue medication|2|||
17020426|NCT00824408|38164964|FG000|Randomized Phase|Other reason not defined above|0|||
17020427|NCT00824408|38164965|FG001|Randomized Phase|Other reason not defined above|0|||
17020428|NCT00824408|38164966|FG002|Randomized Phase|Other reason not defined above|4|||
17020429|NCT00824408|38164967|FG003|Randomized Phase|Other reason not defined above|2|||
17020430|NCT00824408|38164968|FG004|Randomized Phase|Other reason not defined above|4|||
17020431|NCT00866333|38164989|FG000|Overall Study|Withdrawal of consent|0|||
17020432|NCT00866333|38164990|FG001|Overall Study|Withdrawal of consent|1|||
17020433|NCT00866333|38164991|FG002|Overall Study|Withdrawal of consent|2|||
17020434|NCT00866333|38164989|FG000|Overall Study|Reason not Specified|3|||
17020435|NCT00866333|38164990|FG001|Overall Study|Reason not Specified|1|||
17020436|NCT00866333|38164991|FG002|Overall Study|Reason not Specified|1|||
17020437|NCT00866333|38164989|FG000|Overall Study|Study Terminated by Sponsor|2|||
17020438|NCT00866333|38164990|FG001|Overall Study|Study Terminated by Sponsor|5|||
17020439|NCT00866333|38164991|FG002|Overall Study|Study Terminated by Sponsor|9|||
17020440|NCT00834080|38164999|FG000|Overall Study|Adverse Event|7|||
17020441|NCT00834080|38164999|FG000|Overall Study|Lost to Follow-up|7|||
17020442|NCT00834080|38164999|FG000|Overall Study|Withdrawal by Subject|5|||
17020443|NCT00834080|38164999|FG000|Overall Study|Other - Pregnancy|1|||
17020444|NCT00834080|38164999|FG000|Overall Study|Other - False positive tests of the UDS|1|||
17020445|NCT00834080|38164999|FG000|Overall Study|Physician Decision|1|||
17020446|NCT00834080|38164999|FG000|Overall Study|Subject Relocated|1|||
17020447|NCT00823472|38165005|FG000|Overall Study|Physician Decision|24|||
17020448|NCT00823472|38165006|FG001|Overall Study|Physician Decision|28|||
17020449|NCT00856193|38165012|FG000|Period 2|Abnormal test procedure results|0|||
17198632|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
16933649|NCT01263691|38077965|FG001|Overall Study|Adverse Event|0|||
16933650|NCT01263691|38077966|FG002|Overall Study|Adverse Event|0|||
16852615|NCT01387737|37802750|FG001|Overall Study|Lack of Efficacy|0|||
16852616|NCT01387737|37802749|FG000|Overall Study|Physician Decision|3|||
16852617|NCT01387737|37802750|FG001|Overall Study|Physician Decision|10|||
16852618|NCT01387737|37802749|FG000|Overall Study|Withdrawal by Subject|27|||
16852619|NCT01387737|37802750|FG001|Overall Study|Withdrawal by Subject|31|||
16852620|NCT01387737|37802749|FG000|Overall Study|Clearly not eligible for the study|1|||
16852621|NCT01387737|37802750|FG001|Overall Study|Clearly not eligible for the study|3|||
16852622|NCT01387347|37802758|FG000|Overall Study|Lost to Follow-up|2|||
16852623|NCT01387347|37802759|FG001|Overall Study|Lost to Follow-up|1|||
16852624|NCT01859923|37802773|FG000|Overall Study|Adverse Event|0|||
16852625|NCT01859923|37802774|FG001|Overall Study|Adverse Event|0|||
16852626|NCT01859923|37802775|FG002|Overall Study|Adverse Event|1|||
16852627|NCT01859923|37802776|FG003|Overall Study|Adverse Event|1|||
16852628|NCT01387269|37802791|FG000|Overall Study|Death|38|||
16852629|NCT01387269|37802792|FG001|Overall Study|Death|20|||
16852630|NCT01387269|37802791|FG000|Overall Study|Other|8|||
16852631|NCT01387269|37802792|FG001|Overall Study|Other|7|||
16852632|NCT01387269|37802791|FG000|Overall Study|Unrelated AE|12|||
16852633|NCT01387269|37802792|FG001|Overall Study|Unrelated AE|3|||
16852634|NCT01387269|37802791|FG000|Overall Study|Withdrawal by patient|32|||
16852635|NCT01387269|37802792|FG001|Overall Study|Withdrawal by patient|10|||
16852636|NCT01387269|37802791|FG000|Overall Study|Study drug-related AE|1|||
16852637|NCT01387269|37802792|FG001|Overall Study|Study drug-related AE|0|||
16852638|NCT01387269|37802791|FG000|Overall Study|Lost to Follow-up|1|||
16852639|NCT01387269|37802792|FG001|Overall Study|Lost to Follow-up|0|||
16852640|NCT01832155|37802800|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
16852641|NCT01832155|37802801|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
16852642|NCT01832155|37802800|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
16852643|NCT01832155|37802801|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
16933651|NCT01263691|38077967|FG003|Overall Study|Adverse Event|0|||
16933652|NCT01263691|38077968|FG004|Overall Study|Adverse Event|0|||
16933653|NCT01263691|38077969|FG005|Overall Study|Adverse Event|0|||
16933654|NCT01263496|38078042|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
16933655|NCT01263496|38078043|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16933656|NCT01263496|38078044|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16933657|NCT01263496|38078045|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16933658|NCT01263496|38078046|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16933659|NCT01263496|38078047|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16933660|NCT01263496|38078048|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16933661|NCT01263496|38078049|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16933662|NCT01263496|38078050|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16933663|NCT01263496|38078042|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
17020450|NCT00856193|38165013|FG001|Period 2|Abnormal test procedure results|1|||
17020451|NCT00856193|38165012|FG000|Period 2|Lost to Follow-up|0|||
17020452|NCT00856193|38165013|FG001|Period 2|Lost to Follow-up|1|||
17020453|NCT00652366|38165024|FG000|Overall Study|Adverse Event|8|||
17020454|NCT00652366|38165025|FG001|Overall Study|Adverse Event|4|||
17020455|NCT00652366|38165026|FG002|Overall Study|Adverse Event|7|||
17020456|NCT00652366|38165027|FG003|Overall Study|Adverse Event|17|||
17020457|NCT00652366|38165028|FG004|Overall Study|Adverse Event|13|||
17020458|NCT00652366|38165024|FG000|Overall Study|Death|5|||
17020459|NCT00652366|38165025|FG001|Overall Study|Death|4|||
17020460|NCT00652366|38165026|FG002|Overall Study|Death|1|||
17020461|NCT00652366|38165027|FG003|Overall Study|Death|8|||
17020462|NCT00652366|38165028|FG004|Overall Study|Death|5|||
17020463|NCT00652366|38165024|FG000|Overall Study|Lack of Efficacy|84|||
16933664|NCT01263496|38078043|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16933665|NCT01263496|38078044|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16933666|NCT01263496|38078045|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
16933667|NCT01263496|38078046|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
16933668|NCT01263496|38078047|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16933669|NCT01263496|38078048|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16933670|NCT01263496|38078049|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16933671|NCT01263496|38078050|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16933672|NCT01263496|38078042|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
16933673|NCT01263496|38078043|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
16933674|NCT01263496|38078044|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
16933675|NCT01263496|38078045|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
16933676|NCT01263496|38078046|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
16933677|NCT01263496|38078047|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
16933678|NCT01263496|38078048|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
16933679|NCT01263496|38078049|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
16933680|NCT01263496|38078050|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
16933681|NCT01263496|38078042|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16933682|NCT01263496|38078043|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
16933683|NCT01263496|38078044|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
17020464|NCT00652366|38165025|FG001|Overall Study|Lack of Efficacy|58|||
17020465|NCT00652366|38165026|FG002|Overall Study|Lack of Efficacy|53|||
17020466|NCT00652366|38165027|FG003|Overall Study|Lack of Efficacy|133|||
17020467|NCT00652366|38165028|FG004|Overall Study|Lack of Efficacy|13|||
17020468|NCT00652366|38165024|FG000|Overall Study|Violation of Selection Criteria|0|||
17020469|NCT00652366|38165025|FG001|Overall Study|Violation of Selection Criteria|0|||
17020470|NCT00652366|38165026|FG002|Overall Study|Violation of Selection Criteria|1|||
17020471|NCT00652366|38165027|FG003|Overall Study|Violation of Selection Criteria|0|||
17020472|NCT00652366|38165028|FG004|Overall Study|Violation of Selection Criteria|0|||
17020473|NCT00652366|38165024|FG000|Overall Study|Protocol Violation|1|||
17020474|NCT00652366|38165025|FG001|Overall Study|Protocol Violation|0|||
17020475|NCT00652366|38165026|FG002|Overall Study|Protocol Violation|0|||
17020476|NCT00652366|38165027|FG003|Overall Study|Protocol Violation|0|||
17020477|NCT00652366|38165028|FG004|Overall Study|Protocol Violation|0|||
17020478|NCT00652366|38165024|FG000|Overall Study|Refused treatment|3|||
17102726|NCT00112437|38241448|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102727|NCT00112437|38241449|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102728|NCT00112437|38241450|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102729|NCT00112437|38241451|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102730|NCT00112437|38241452|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102731|NCT00112437|38241453|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102732|NCT00112437|38241454|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102733|NCT00112437|38241455|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102734|NCT00112437|38241456|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102735|NCT00112437|38241457|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102736|NCT00112437|38241458|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102737|NCT00112437|38241459|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102738|NCT00112437|38241460|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102739|NCT00112437|38241461|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102740|NCT00112437|38241462|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102741|NCT00112437|38241463|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16933684|NCT01263496|38078045|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16933685|NCT01263496|38078046|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
17020479|NCT00652366|38165025|FG001|Overall Study|Refused treatment|7|||
17020480|NCT00652366|38165026|FG002|Overall Study|Refused treatment|6|||
17020481|NCT00652366|38165027|FG003|Overall Study|Refused treatment|17|||
17020482|NCT00652366|38165028|FG004|Overall Study|Refused treatment|5|||
17020483|NCT00652366|38165024|FG000|Overall Study|Other|5|||
17020484|NCT00652366|38165025|FG001|Overall Study|Other|2|||
17020485|NCT00652366|38165026|FG002|Overall Study|Other|3|||
17020486|NCT00652366|38165027|FG003|Overall Study|Other|4|||
17020487|NCT00652366|38165028|FG004|Overall Study|Other|0|||
17020488|NCT00841568|38165042|FG000|Overall Study|Adverse Event|1|||
17020489|NCT00841568|38165042|FG000|Overall Study|Death|1|||
17020490|NCT00841568|38165042|FG000|Overall Study|Withdrawal by Subject|2|||
17020491|NCT00841568|38165042|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
17020492|NCT00855959|38165050|FG000|Overall Study|Adverse Event|2|||
17020493|NCT00855959|38165050|FG000|Overall Study|Lost to Follow-up|2|||
17020494|NCT00855959|38165050|FG000|Overall Study|Withdrawal by Subject|3|||
17020495|NCT00855959|38165050|FG000|Overall Study|Pregnancy|1|||
17020496|NCT00855959|38165050|FG000|Overall Study|Incorrect enrolment|1|||
17020497|NCT00841100|38165054|FG000|Phase 1 (28 Days)|Adverse Event|1|||
17020498|NCT00841100|38165054|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
17020499|NCT00651820|38165058|FG000|Overall Study|Lost to Follow-up|2|||
17020500|NCT03307785|38165075|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
17020501|NCT03307785|38165076|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
17020502|NCT03307785|38165077|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
17020503|NCT03307785|38165078|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
17020504|NCT03307785|38165079|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
17020505|NCT03307785|38165080|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
17020506|NCT03307785|38165081|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
17020507|NCT03307785|38165082|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
17020508|NCT03307785|38165083|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
17020509|NCT03307785|38165084|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
17020510|NCT03307785|38165085|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
17020511|NCT03307785|38165075|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
17020512|NCT03307785|38165076|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
17020513|NCT03307785|38165077|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
17020514|NCT03307785|38165078|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
17020515|NCT03307785|38165079|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
17020516|NCT03307785|38165080|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
17020517|NCT03307785|38165081|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
17020518|NCT03307785|38165082|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
17020519|NCT03307785|38165083|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
17020520|NCT03307785|38165084|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
17020521|NCT03307785|38165085|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16933686|NCT01263496|38078047|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16933687|NCT01263496|38078048|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16933688|NCT01263496|38078049|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16933689|NCT01263496|38078050|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16933690|NCT01263496|38078042|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16933691|NCT01263496|38078043|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16852644|NCT01879579|37802815|FG000|Overall Study|Phone incompatible with texting platform|3|||
16852645|NCT01879579|37802816|FG001|Overall Study|Phone incompatible with texting platform|0|||
16852646|NCT01879579|37802815|FG000|Overall Study|Did not enroll in texting platform|1|||
16852647|NCT01879579|37802816|FG001|Overall Study|Did not enroll in texting platform|0|||
16852648|NCT01879579|37802815|FG000|Overall Study|Did not initiate insulin treatment|1|||
16852649|NCT01879579|37802816|FG001|Overall Study|Did not initiate insulin treatment|0|||
16852650|NCT01879579|37802815|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
17020522|NCT03307785|38165075|FG000|Part A: Up to 28.5 Months|Death|4|||
17020523|NCT03307785|38165076|FG001|Part A: Up to 28.5 Months|Death|4|||
17020524|NCT03307785|38165077|FG002|Part A: Up to 28.5 Months|Death|0|||
17020525|NCT03307785|38165078|FG003|Part A: Up to 28.5 Months|Death|0|||
17020526|NCT03307785|38165079|FG004|Part A: Up to 28.5 Months|Death|0|||
17020527|NCT03307785|38165080|FG005|Part A: Up to 28.5 Months|Death|0|||
17020528|NCT03307785|38165081|FG006|Part A: Up to 28.5 Months|Death|0|||
17020529|NCT03307785|38165082|FG007|Part A: Up to 28.5 Months|Death|0|||
16852651|NCT01879579|37802816|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
16852652|NCT01879579|37802815|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
16852653|NCT01879579|37802816|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
16852654|NCT01386645|37802828|FG000|Overall Study|Physician Decision|0|||
16852655|NCT01386645|37802829|FG001|Overall Study|Physician Decision|0|||
16852656|NCT01386645|37802830|FG002|Overall Study|Physician Decision|1|||
16933692|NCT01263496|38078044|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
17020530|NCT03307785|38165083|FG008|Part A: Up to 28.5 Months|Death|0|||
17020531|NCT03307785|38165084|FG009|Part A: Up to 28.5 Months|Death|0|||
17020532|NCT03307785|38165085|FG010|Part A: Up to 28.5 Months|Death|0|||
17020533|NCT03307785|38165075|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
17020534|NCT03307785|38165076|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
17020535|NCT03307785|38165077|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
17020536|NCT03307785|38165078|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
16933693|NCT01263496|38078045|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16933694|NCT01263496|38078046|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
16933695|NCT01263496|38078047|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16933696|NCT01263496|38078048|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16933697|NCT01263496|38078049|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16933698|NCT01263496|38078050|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16933699|NCT01263496|38078042|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
16933700|NCT01263496|38078043|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
16933701|NCT01263496|38078044|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
16933702|NCT01263496|38078045|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16933703|NCT01263496|38078046|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
16933704|NCT01263496|38078047|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
17020537|NCT03307785|38165079|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
17020538|NCT03307785|38165080|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
17020539|NCT03307785|38165081|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
17020540|NCT03307785|38165082|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
17020541|NCT03307785|38165083|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
17020542|NCT03307785|38165084|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
17020543|NCT03307785|38165085|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
17020544|NCT03307785|38165075|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
17020545|NCT03307785|38165076|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
17020546|NCT03307785|38165077|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
17020547|NCT03307785|38165078|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
17020548|NCT03307785|38165079|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
17020549|NCT03307785|38165080|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
17020550|NCT03307785|38165081|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
17020551|NCT03307785|38165082|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
17020552|NCT03307785|38165083|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
17020553|NCT03307785|38165084|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
17020554|NCT03307785|38165085|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
17020555|NCT03307785|38165075|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
17020556|NCT03307785|38165076|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
17020557|NCT03307785|38165077|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
17020558|NCT03307785|38165078|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
17020559|NCT03307785|38165079|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
17020560|NCT03307785|38165080|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
17020561|NCT03307785|38165081|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
17020562|NCT03307785|38165082|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
17020563|NCT03307785|38165083|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
17020564|NCT03307785|38165084|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
17020565|NCT03307785|38165085|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
17020566|NCT03307785|38165075|FG000|Part B: Up to 28.5 Months|Death|0|||
17020567|NCT03307785|38165076|FG001|Part B: Up to 28.5 Months|Death|0|||
17020568|NCT03307785|38165077|FG002|Part B: Up to 28.5 Months|Death|7|||
17020569|NCT03307785|38165078|FG003|Part B: Up to 28.5 Months|Death|0|||
17020570|NCT03307785|38165079|FG004|Part B: Up to 28.5 Months|Death|0|||
17020571|NCT03307785|38165080|FG005|Part B: Up to 28.5 Months|Death|0|||
17020572|NCT03307785|38165081|FG006|Part B: Up to 28.5 Months|Death|0|||
17020573|NCT03307785|38165082|FG007|Part B: Up to 28.5 Months|Death|0|||
17020574|NCT03307785|38165083|FG008|Part B: Up to 28.5 Months|Death|0|||
17020575|NCT03307785|38165084|FG009|Part B: Up to 28.5 Months|Death|0|||
17020576|NCT03307785|38165085|FG010|Part B: Up to 28.5 Months|Death|0|||
17020577|NCT03307785|38165075|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020578|NCT03307785|38165076|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020579|NCT03307785|38165077|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
16933705|NCT01263496|38078048|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
16933706|NCT01263496|38078049|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
17020580|NCT03307785|38165078|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
16933707|NCT01263496|38078050|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16933708|NCT01263496|38078042|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16933709|NCT01263496|38078043|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16933710|NCT01263496|38078044|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16933711|NCT01263496|38078045|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16933712|NCT01263496|38078046|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16933713|NCT01263496|38078047|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16933714|NCT01263496|38078048|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16933715|NCT01263496|38078049|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
17020581|NCT03307785|38165079|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020582|NCT03307785|38165080|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020583|NCT03307785|38165081|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020584|NCT03307785|38165082|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020585|NCT03307785|38165083|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020586|NCT03307785|38165084|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020587|NCT03307785|38165085|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
17020588|NCT03307785|38165075|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020589|NCT03307785|38165076|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020590|NCT03307785|38165077|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
17020591|NCT03307785|38165078|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020592|NCT03307785|38165079|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020593|NCT03307785|38165080|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020594|NCT03307785|38165081|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020595|NCT03307785|38165082|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020596|NCT03307785|38165083|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020597|NCT03307785|38165084|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020598|NCT03307785|38165085|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
17020599|NCT03307785|38165075|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
17102742|NCT00112437|38241464|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102743|NCT00112437|38241465|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102744|NCT00112437|38241466|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
17102745|NCT00112437|38241441|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
17102746|NCT00112437|38241442|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
16933716|NCT01263496|38078050|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16933717|NCT01263223|38078062|FG000|Period 2|Withdrawal by Subject|0|||
16933718|NCT01263223|38078063|FG001|Period 2|Withdrawal by Subject|1|||
16933719|NCT01263223|38078062|FG000|7-day Follow-up|Withdrawal by Subject|0|||
16933720|NCT01263223|38078063|FG001|7-day Follow-up|Withdrawal by Subject|1|||
16933721|NCT01263223|38078062|FG000|7-day Follow-up|Lost to Follow-up|1|||
16933722|NCT01263223|38078063|FG001|7-day Follow-up|Lost to Follow-up|0|||
16933723|NCT01263106|38078072|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
16933724|NCT01263106|38078073|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
16933725|NCT01263028|38078082|FG000|Overall Study|Withdrawal by Subject|1|||
16933726|NCT01263028|38078082|FG000|Overall Study|Adverse Event|1|||
16933727|NCT01263028|38078082|FG000|Overall Study|Study terminated due to low enrollment.|4|||
16933728|NCT01262989|38078086|FG000|Period 1|Lost to Follow-up|1|||
16933729|NCT01262989|38078087|FG001|Period 1|Lost to Follow-up|1|||
16933730|NCT01262989|38078086|FG000|Period 1|Intercurrent disease|0|||
16933731|NCT01262989|38078087|FG001|Period 1|Intercurrent disease|1|||
16933732|NCT01262989|38078086|FG000|Period 1|Positive answer for exclusion criteria|0|||
16933733|NCT01262989|38078087|FG001|Period 1|Positive answer for exclusion criteria|1|||
16933734|NCT01262989|38078086|FG000|Period 2|Intercurrent disease|0|||
16933735|NCT01262989|38078087|FG001|Period 2|Intercurrent disease|1|||
16933736|NCT01262872|38078101|FG000|Step 2|Death|0|||
16933737|NCT01262872|38078102|FG001|Step 2|Death|0|||
16933738|NCT01262872|38078103|FG002|Step 2|Death|0|||
16933739|NCT01262872|38078104|FG003|Step 2|Death|1|||
16933740|NCT01262872|38078105|FG004|Step 2|Death|0|||
16933741|NCT01262872|38078106|FG005|Step 2|Death|2|||
16933742|NCT01262872|38078107|FG006|Step 2|Death|2|||
16933743|NCT01262872|38078108|FG007|Step 2|Death|1|||
16933744|NCT01262872|38078101|FG000|Step 2|Protocol Violation|0|||
16933745|NCT01262872|38078102|FG001|Step 2|Protocol Violation|0|||
16933746|NCT01262872|38078103|FG002|Step 2|Protocol Violation|1|||
16933747|NCT01262872|38078104|FG003|Step 2|Protocol Violation|0|||
16933748|NCT01262872|38078105|FG004|Step 2|Protocol Violation|0|||
16933749|NCT01262872|38078106|FG005|Step 2|Protocol Violation|0|||
16933750|NCT01262872|38078107|FG006|Step 2|Protocol Violation|3|||
16933751|NCT01262872|38078108|FG007|Step 2|Protocol Violation|1|||
16933752|NCT01262872|38078101|FG000|Step 2|Withdrawal by Subject|0|||
16933753|NCT01262872|38078102|FG001|Step 2|Withdrawal by Subject|0|||
16933754|NCT01262872|38078103|FG002|Step 2|Withdrawal by Subject|4|||
16933755|NCT01262872|38078104|FG003|Step 2|Withdrawal by Subject|6|||
16933756|NCT01262872|38078105|FG004|Step 2|Withdrawal by Subject|3|||
16933757|NCT01262872|38078106|FG005|Step 2|Withdrawal by Subject|1|||
16933758|NCT01262872|38078107|FG006|Step 2|Withdrawal by Subject|2|||
16933759|NCT01262872|38078108|FG007|Step 2|Withdrawal by Subject|1|||
16933760|NCT01262872|38078101|FG000|Step 2|Migrated/moved from study area|0|||
16933761|NCT01262872|38078102|FG001|Step 2|Migrated/moved from study area|0|||
16933762|NCT01262872|38078103|FG002|Step 2|Migrated/moved from study area|4|||
16933763|NCT01262872|38078104|FG003|Step 2|Migrated/moved from study area|3|||
16933764|NCT01262872|38078105|FG004|Step 2|Migrated/moved from study area|2|||
17102747|NCT00112437|38241443|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
17102748|NCT00112437|38241444|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
17102749|NCT00112437|38241445|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
17102750|NCT00112437|38241446|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
17020600|NCT03307785|38165076|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
17020601|NCT03307785|38165077|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
17020602|NCT03307785|38165078|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
17020603|NCT03307785|38165079|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
17020604|NCT03307785|38165080|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
17020605|NCT03307785|38165081|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
17020606|NCT03307785|38165082|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
17020607|NCT03307785|38165083|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
17020608|NCT03307785|38165084|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
17020609|NCT03307785|38165085|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
17020610|NCT03307785|38165075|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
17020611|NCT03307785|38165076|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
17020612|NCT03307785|38165077|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
17020613|NCT03307785|38165078|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
17020614|NCT03307785|38165079|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
17020615|NCT03307785|38165080|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
17020616|NCT03307785|38165081|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
17020617|NCT03307785|38165082|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
17020618|NCT03307785|38165083|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
17020619|NCT03307785|38165084|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
17020620|NCT03307785|38165085|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
17020621|NCT03307785|38165075|FG000|Part C: Up to 22.5 Months|Death|0|||
17020622|NCT03307785|38165076|FG001|Part C: Up to 22.5 Months|Death|0|||
17020623|NCT03307785|38165077|FG002|Part C: Up to 22.5 Months|Death|0|||
17020624|NCT03307785|38165078|FG003|Part C: Up to 22.5 Months|Death|1|||
17020625|NCT03307785|38165079|FG004|Part C: Up to 22.5 Months|Death|4|||
17020626|NCT03307785|38165080|FG005|Part C: Up to 22.5 Months|Death|0|||
17020627|NCT03307785|38165081|FG006|Part C: Up to 22.5 Months|Death|0|||
17020628|NCT03307785|38165082|FG007|Part C: Up to 22.5 Months|Death|0|||
17020629|NCT03307785|38165083|FG008|Part C: Up to 22.5 Months|Death|0|||
17020630|NCT03307785|38165084|FG009|Part C: Up to 22.5 Months|Death|0|||
17020631|NCT03307785|38165085|FG010|Part C: Up to 22.5 Months|Death|0|||
17020632|NCT03307785|38165075|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020633|NCT03307785|38165076|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020634|NCT03307785|38165077|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020635|NCT03307785|38165078|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
17020636|NCT03307785|38165079|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020637|NCT03307785|38165080|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020638|NCT03307785|38165081|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020639|NCT03307785|38165082|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020640|NCT03307785|38165083|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020641|NCT03307785|38165084|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020642|NCT03307785|38165085|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
17020643|NCT03307785|38165075|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
17020644|NCT03307785|38165076|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
17020645|NCT03307785|38165077|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
17020646|NCT03307785|38165078|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
17020647|NCT03307785|38165079|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
17020648|NCT03307785|38165080|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
16933765|NCT01262872|38078106|FG005|Step 2|Migrated/moved from study area|6|||
16933766|NCT01262872|38078107|FG006|Step 2|Migrated/moved from study area|2|||
16933767|NCT01262872|38078108|FG007|Step 2|Migrated/moved from study area|3|||
16933768|NCT01262677|38078145|FG000|Overall Study|Does not meet entrance criteria|0|||
16933769|NCT01262677|38078146|FG001|Overall Study|Does not meet entrance criteria|2|||
16933770|NCT01262677|38078147|FG002|Overall Study|Does not meet entrance criteria|0|||
16933771|NCT01262677|38078145|FG000|Overall Study|Insufficient clinical response|0|||
16933772|NCT01262677|38078146|FG001|Overall Study|Insufficient clinical response|0|||
16933773|NCT01262677|38078147|FG002|Overall Study|Insufficient clinical response|1|||
16933774|NCT01262677|38078145|FG000|Overall Study|Lost to Follow-up|1|||
16933775|NCT01262677|38078146|FG001|Overall Study|Lost to Follow-up|0|||
16933776|NCT01262677|38078147|FG002|Overall Study|Lost to Follow-up|2|||
16933777|NCT01262677|38078145|FG000|Overall Study|No longer willing to participate|3|||
16933778|NCT01262677|38078146|FG001|Overall Study|No longer willing to participate|3|||
16933779|NCT01262677|38078147|FG002|Overall Study|No longer willing to participate|2|||
16933780|NCT01262677|38078145|FG000|Overall Study|Reason not provided|2|||
16933781|NCT01262677|38078146|FG001|Overall Study|Reason not provided|1|||
16933782|NCT01262677|38078147|FG002|Overall Study|Reason not provided|3|||
16933783|NCT01262677|38078145|FG000|Overall Study|Protocol Violation|0|||
16933784|NCT01262677|38078146|FG001|Overall Study|Protocol Violation|1|||
16933785|NCT01262677|38078147|FG002|Overall Study|Protocol Violation|1|||
16933786|NCT01262677|38078145|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
16933787|NCT01262677|38078146|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
16933788|NCT01262677|38078147|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
16933789|NCT01262638|38078159|FG000|Overall Study|Adverse Event|3|||
16933790|NCT01262638|38078160|FG001|Overall Study|Adverse Event|4|||
16933791|NCT01262638|38078161|FG002|Overall Study|Adverse Event|3|||
16933792|NCT01262638|38078162|FG003|Overall Study|Adverse Event|4|||
16933793|NCT01262638|38078159|FG000|Overall Study|Protocol Violation|1|||
16933794|NCT01262638|38078160|FG001|Overall Study|Protocol Violation|0|||
16933795|NCT01262638|38078161|FG002|Overall Study|Protocol Violation|0|||
16933796|NCT01262638|38078162|FG003|Overall Study|Protocol Violation|1|||
16933797|NCT01262638|38078159|FG000|Overall Study|Withdrawal by Subject|2|||
16933798|NCT01262638|38078160|FG001|Overall Study|Withdrawal by Subject|1|||
16933799|NCT01262638|38078161|FG002|Overall Study|Withdrawal by Subject|0|||
16933800|NCT01262638|38078162|FG003|Overall Study|Withdrawal by Subject|1|||
17020649|NCT03307785|38165081|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
17020650|NCT03307785|38165082|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
17020651|NCT03307785|38165083|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
17020652|NCT03307785|38165084|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
17020653|NCT03307785|38165085|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
17020654|NCT03307785|38165075|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
17020655|NCT03307785|38165076|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
16933801|NCT01262638|38078159|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
16933802|NCT01262638|38078160|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
16933803|NCT01262638|38078161|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
16933804|NCT01262638|38078162|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
16933805|NCT01262638|38078159|FG000|Overall Study|Lost to Follow-up|1|||
16933806|NCT01262638|38078160|FG001|Overall Study|Lost to Follow-up|1|||
16933807|NCT01262638|38078161|FG002|Overall Study|Lost to Follow-up|1|||
16933808|NCT01262638|38078162|FG003|Overall Study|Lost to Follow-up|1|||
16933809|NCT01262638|38078159|FG000|Overall Study|Participant Went Out of Town|0|||
16933810|NCT01262638|38078160|FG001|Overall Study|Participant Went Out of Town|0|||
16933811|NCT01262638|38078161|FG002|Overall Study|Participant Went Out of Town|1|||
16933812|NCT01262638|38078162|FG003|Overall Study|Participant Went Out of Town|0|||
16933813|NCT01262560|38078178|FG000|Overall Study|Protocol Violation|0|||
16933814|NCT01262560|38078179|FG001|Overall Study|Protocol Violation|1|||
16933815|NCT01262560|38078180|FG002|Overall Study|Protocol Violation|2|||
16933816|NCT01262365|38078191|FG000|Overall Study|Lack of Efficacy|35|||
16933817|NCT01262365|38078192|FG001|Overall Study|Lack of Efficacy|30|||
16933818|NCT01262365|38078193|FG002|Overall Study|Lack of Efficacy|47|||
16933819|NCT01262365|38078191|FG000|Overall Study|Protocol Violation|3|||
16933820|NCT01262365|38078192|FG001|Overall Study|Protocol Violation|1|||
16933821|NCT01262365|38078193|FG002|Overall Study|Protocol Violation|1|||
17020656|NCT03307785|38165077|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
17020657|NCT03307785|38165078|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
17020658|NCT03307785|38165079|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
17020659|NCT03307785|38165080|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
17020660|NCT03307785|38165081|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
17020661|NCT03307785|38165082|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
17020662|NCT03307785|38165083|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
17020663|NCT03307785|38165084|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
17020664|NCT03307785|38165085|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
17020665|NCT03307785|38165075|FG000|Part D: Up to 9.5 Months|Death|0|||
17020666|NCT03307785|38165076|FG001|Part D: Up to 9.5 Months|Death|0|||
17020667|NCT03307785|38165077|FG002|Part D: Up to 9.5 Months|Death|0|||
17020668|NCT03307785|38165078|FG003|Part D: Up to 9.5 Months|Death|0|||
17020669|NCT03307785|38165079|FG004|Part D: Up to 9.5 Months|Death|0|||
17020670|NCT03307785|38165080|FG005|Part D: Up to 9.5 Months|Death|1|||
17020671|NCT03307785|38165081|FG006|Part D: Up to 9.5 Months|Death|0|||
17020672|NCT03307785|38165082|FG007|Part D: Up to 9.5 Months|Death|0|||
17020673|NCT03307785|38165083|FG008|Part D: Up to 9.5 Months|Death|0|||
17020674|NCT03307785|38165084|FG009|Part D: Up to 9.5 Months|Death|0|||
17020675|NCT03307785|38165085|FG010|Part D: Up to 9.5 Months|Death|0|||
16933822|NCT01262365|38078191|FG000|Overall Study|Lost to Follow-up|3|||
16933823|NCT01262365|38078192|FG001|Overall Study|Lost to Follow-up|7|||
17020676|NCT03307785|38165075|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020677|NCT03307785|38165076|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020678|NCT03307785|38165077|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020679|NCT03307785|38165078|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020680|NCT03307785|38165079|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020681|NCT03307785|38165080|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
16933824|NCT01262365|38078193|FG002|Overall Study|Lost to Follow-up|6|||
16933825|NCT01262365|38078191|FG000|Overall Study|Withdrawal by Subject|17|||
16933826|NCT01262365|38078192|FG001|Overall Study|Withdrawal by Subject|22|||
16933827|NCT01262365|38078193|FG002|Overall Study|Withdrawal by Subject|22|||
16933828|NCT01262365|38078191|FG000|Overall Study|Death|1|||
16933829|NCT01262365|38078192|FG001|Overall Study|Death|2|||
17020682|NCT03307785|38165081|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020683|NCT03307785|38165082|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020684|NCT03307785|38165083|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020685|NCT03307785|38165084|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020686|NCT03307785|38165085|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
17020687|NCT03307785|38165075|FG000|Part E: Up to 4.4 Months|Death|0|||
17020688|NCT03307785|38165076|FG001|Part E: Up to 4.4 Months|Death|0|||
17020689|NCT03307785|38165077|FG002|Part E: Up to 4.4 Months|Death|0|||
17020690|NCT03307785|38165078|FG003|Part E: Up to 4.4 Months|Death|0|||
17020691|NCT03307785|38165079|FG004|Part E: Up to 4.4 Months|Death|0|||
17020692|NCT03307785|38165080|FG005|Part E: Up to 4.4 Months|Death|0|||
17020693|NCT03307785|38165081|FG006|Part E: Up to 4.4 Months|Death|1|||
17020694|NCT03307785|38165082|FG007|Part E: Up to 4.4 Months|Death|0|||
17020695|NCT03307785|38165083|FG008|Part E: Up to 4.4 Months|Death|0|||
17020696|NCT03307785|38165084|FG009|Part E: Up to 4.4 Months|Death|0|||
17020697|NCT03307785|38165085|FG010|Part E: Up to 4.4 Months|Death|0|||
17020698|NCT03307785|38165075|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
17020699|NCT03307785|38165076|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
17020700|NCT03307785|38165077|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
17020701|NCT03307785|38165078|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
17020702|NCT03307785|38165079|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
17020703|NCT03307785|38165080|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
17020704|NCT03307785|38165081|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
17020705|NCT03307785|38165082|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
17020706|NCT03307785|38165083|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
17020707|NCT03307785|38165084|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
17020708|NCT03307785|38165085|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
17020709|NCT03307785|38165075|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
17020710|NCT03307785|38165076|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
17020711|NCT03307785|38165077|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
17020712|NCT03307785|38165078|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
17020713|NCT03307785|38165079|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
17020714|NCT03307785|38165080|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
17020715|NCT03307785|38165081|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
17020716|NCT03307785|38165082|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
17020717|NCT03307785|38165083|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
17020718|NCT03307785|38165084|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
17020719|NCT03307785|38165085|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
17020720|NCT00866177|38165106|FG000|Overall Study|Withdrawal by Subject|1|||
17020721|NCT00866177|38165106|FG000|Overall Study|Not Treated|151|||
17020722|NCT00833924|38165110|FG000|Overall Study|Death|21|||
17020723|NCT00833924|38165110|FG000|Overall Study|Conversion|2|||
17020724|NCT00833924|38165110|FG000|Overall Study|Lost to Follow-up|2|||
17020725|NCT00833924|38165110|FG000|Overall Study|Withdrawal by Subject|13|||
17020726|NCT00833924|38165110|FG000|Overall Study|In study follow-up|71|||
17020727|NCT00840086|38165114|FG000|Overall Study|Adverse Event|1|||
17020728|NCT00840086|38165114|FG000|Overall Study|Protocol Violation|2|||
17020729|NCT00840086|38165114|FG000|Overall Study|Lost to Follow-up|1|||
17020730|NCT00822926|38165123|FG000|Second Injection Visit|Lost to Follow-up|1|||
16933830|NCT01262365|38078193|FG002|Overall Study|Death|1|||
16933831|NCT01262365|38078191|FG000|Overall Study|Adverse Event|26|||
16933832|NCT01262365|38078192|FG001|Overall Study|Adverse Event|16|||
16933833|NCT01262365|38078193|FG002|Overall Study|Adverse Event|11|||
16933834|NCT01262365|38078191|FG000|Overall Study|sponsor decision|1|||
16933835|NCT01262365|38078192|FG001|Overall Study|sponsor decision|1|||
16933836|NCT01262365|38078193|FG002|Overall Study|sponsor decision|0|||
16933837|NCT01262365|38078191|FG000|Overall Study|Randomization error|1|||
16933838|NCT01262365|38078192|FG001|Overall Study|Randomization error|0|||
16933839|NCT01262365|38078193|FG002|Overall Study|Randomization error|2|||
16933840|NCT01262365|38078191|FG000|Overall Study|Non-compliance|1|||
16933841|NCT01262365|38078192|FG001|Overall Study|Non-compliance|0|||
16933842|NCT01262365|38078193|FG002|Overall Study|Non-compliance|2|||
16933843|NCT01262365|38078191|FG000|Overall Study|Suspected pregnancy|1|||
16933844|NCT01262365|38078192|FG001|Overall Study|Suspected pregnancy|0|||
16933845|NCT01262365|38078193|FG002|Overall Study|Suspected pregnancy|0|||
17020731|NCT00822926|38165124|FG001|Second Injection Visit|Lost to Follow-up|0|||
17020732|NCT00822926|38165123|FG000|Second Injection Visit|Withdrawal by Subject|0|||
17020733|NCT00822926|38165124|FG001|Second Injection Visit|Withdrawal by Subject|1|||
17020734|NCT00822770|38165135|FG000|Overall Study|Not treated|1|||
17020735|NCT00822770|38165136|FG001|Overall Study|Not treated|0|||
17020736|NCT00822770|38165135|FG000|Overall Study|Complication/Incomplete treatment|1|||
17020737|NCT00822770|38165136|FG001|Overall Study|Complication/Incomplete treatment|0|||
16933846|NCT01262365|38078191|FG000|Overall Study|Patient pregnant|1|||
16933847|NCT01262365|38078192|FG001|Overall Study|Patient pregnant|0|||
16933848|NCT01262365|38078193|FG002|Overall Study|Patient pregnant|1|||
16933849|NCT01262365|38078191|FG000|Overall Study|Toxicity related to study drug|0|||
17020738|NCT00822770|38165135|FG000|Overall Study|Death|1|||
17020739|NCT00822770|38165136|FG001|Overall Study|Death|1|||
17020740|NCT02842086|38165144|FG000|Overall Study|Randomized but Never Treated|6|||
17020741|NCT02842086|38165145|FG001|Overall Study|Randomized but Never Treated|6|||
17020742|NCT02842086|38165144|FG000|Overall Study|Still in Double-Blind Phase|7|||
17020743|NCT02842086|38165145|FG001|Overall Study|Still in Double-Blind Phase|3|||
17020744|NCT02842086|38165144|FG000|Overall Study|Adverse Event|18|||
17020745|NCT02842086|38165145|FG001|Overall Study|Adverse Event|20|||
17020746|NCT02842086|38165144|FG000|Overall Study|Death|3|||
17020747|NCT02842086|38165145|FG001|Overall Study|Death|3|||
17020748|NCT02842086|38165144|FG000|Overall Study|Investigator's Discretion|9|||
17020749|NCT02842086|38165145|FG001|Overall Study|Investigator's Discretion|13|||
17020750|NCT02842086|38165144|FG000|Overall Study|Non-Compliance with Study Drug|9|||
17020751|NCT02842086|38165145|FG001|Overall Study|Non-Compliance with Study Drug|8|||
17020752|NCT02842086|38165144|FG000|Overall Study|Protocol Violation|8|||
17020753|NCT02842086|38165145|FG001|Overall Study|Protocol Violation|4|||
17020754|NCT02842086|38165144|FG000|Overall Study|Withdrew Consent|205|||
17020755|NCT02842086|38165145|FG001|Overall Study|Withdrew Consent|194|||
17020756|NCT02842086|38165144|FG000|Overall Study|Lost to Follow-up|274|||
17020757|NCT02842086|38165145|FG001|Overall Study|Lost to Follow-up|236|||
17020758|NCT02842086|38165144|FG000|Overall Study|HIV-1 Infection|5|||
17020759|NCT02842086|38165145|FG001|Overall Study|HIV-1 Infection|6|||
17020760|NCT00822692|38165153|FG000|Overall Study|Lost to Follow-up|17|||
17020761|NCT00822692|38165154|FG001|Overall Study|Lost to Follow-up|25|||
17020762|NCT00806442|38165160|FG000|Overall Study|Lost to Follow-up|3|||
17020763|NCT00806442|38165161|FG001|Overall Study|Lost to Follow-up|2|||
17020764|NCT00806442|38165160|FG000|Overall Study|Withdrawal by Subject|1|||
17020765|NCT00806442|38165161|FG001|Overall Study|Withdrawal by Subject|5|||
17020766|NCT00821678|38165171|FG000|Overall Study|Withdrawal by Subject|8|||
17020767|NCT00821678|38165172|FG001|Overall Study|Withdrawal by Subject|0|||
17020768|NCT00821678|38165171|FG000|Overall Study|Lost to Follow-up|13|||
17020769|NCT00821678|38165172|FG001|Overall Study|Lost to Follow-up|12|||
17020770|NCT00821678|38165171|FG000|Overall Study|Death|0|||
17020771|NCT00821678|38165172|FG001|Overall Study|Death|2|||
17020772|NCT00839852|38165180|FG000|Overall Study|Adverse Event|10|||
17020773|NCT00839852|38165180|FG000|Overall Study|Insufficient Therapeutic Response|3|||
17020774|NCT00839852|38165180|FG000|Overall Study|Protocol Violation|9|||
17020775|NCT00839852|38165180|FG000|Overall Study|Withdrawal of Consent|16|||
17020776|NCT00839852|38165180|FG000|Overall Study|Lost to Follow-up|7|||
17020777|NCT00839852|38165180|FG000|Overall Study|Lack of Compliance While in Jail|1|||
17020778|NCT00839852|38165180|FG000|Overall Study|Pregnancy|1|||
17020779|NCT00833690|38165187|FG000|Overall Study|Withdrawal by Subject|1|||
17020780|NCT00833690|38165188|FG001|Overall Study|Withdrawal by Subject|0|||
17020781|NCT00833690|38165189|FG002|Overall Study|Withdrawal by Subject|0|||
17198633|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
17198634|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
17198635|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
17198636|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
17198637|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
17198638|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
17198639|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
17198640|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
17198641|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
17198642|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
17198643|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
17198644|NCT02783573|38352308|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
17198645|NCT02783573|38352309|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
17198646|NCT02783573|38352310|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
17198647|NCT02783573|38352308|FG000|Delayed-Start Period|Sponsor Decision|0|||
17198648|NCT02783573|38352309|FG001|Delayed-Start Period|Sponsor Decision|17|||
17198649|NCT02783573|38352310|FG002|Delayed-Start Period|Sponsor Decision|12|||
17198650|NCT02766283|38352321|FG000|Overall Study|Lost to Follow-up|27|||
17198651|NCT01666652|38352334|FG000|Overall Study|Serious Adverse Event|0|||
17198652|NCT01666652|38352335|FG001|Overall Study|Serious Adverse Event|0|||
17198653|NCT01666652|38352336|FG002|Overall Study|Serious Adverse Event|0|||
17198654|NCT01666652|38352337|FG003|Overall Study|Serious Adverse Event|1|||
17198655|NCT01666652|38352338|FG004|Overall Study|Serious Adverse Event|0|||
17198656|NCT01666652|38352334|FG000|Overall Study|Withdrawal by Subject|0|||
17198657|NCT01666652|38352335|FG001|Overall Study|Withdrawal by Subject|0|||
17020782|NCT00833690|38165187|FG000|Overall Study|Discontinued study drug|3|||
17020783|NCT00833690|38165188|FG001|Overall Study|Discontinued study drug|2|||
17020784|NCT00833690|38165189|FG002|Overall Study|Discontinued study drug|0|||
17020785|NCT00820898|38165197|FG000|Overall Study|Inelgible - wrong primary site|1|||
17020786|NCT00865709|38165209|FG000|Treatment|Adverse Event|9|||
17020787|NCT00865709|38165210|FG001|Treatment|Adverse Event|6|||
17020788|NCT00865709|38165209|FG000|Treatment|Withdrawal by Subject|10|||
17020789|NCT00865709|38165210|FG001|Treatment|Withdrawal by Subject|7|||
17020790|NCT00865709|38165209|FG000|Treatment|Physician Decision|3|||
17020791|NCT00865709|38165210|FG001|Treatment|Physician Decision|2|||
17020792|NCT00865709|38165209|FG000|Treatment|Surgery|8|||
17020793|NCT00865709|38165210|FG001|Treatment|Surgery|3|||
17020794|NCT00839306|38165220|FG000|Overall Study|Adverse Event|3|||
17020795|NCT00839306|38165221|FG001|Overall Study|Adverse Event|5|||
17020796|NCT00839306|38165220|FG000|Overall Study|Lost to Follow-up|6|||
17020797|NCT00839306|38165221|FG001|Overall Study|Lost to Follow-up|9|||
17020798|NCT00839306|38165220|FG000|Overall Study|Withdrawal by Subject|5|||
17020799|NCT00839306|38165221|FG001|Overall Study|Withdrawal by Subject|7|||
17020800|NCT00839306|38165220|FG000|Overall Study|Lack of Efficacy|5|||
17020801|NCT00839306|38165221|FG001|Overall Study|Lack of Efficacy|4|||
17020802|NCT00839306|38165220|FG000|Overall Study|Other|6|||
17020803|NCT00839306|38165221|FG001|Overall Study|Other|18|||
17020804|NCT00839072|38165228|FG000|First Intervention Period|Withdrawal by Subject|1|||
17020805|NCT00839072|38165229|FG001|First Intervention Period|Withdrawal by Subject|0|||
17020806|NCT00839072|38165228|FG000|First Intervention Period|Adverse Event|1|||
17020807|NCT00839072|38165229|FG001|First Intervention Period|Adverse Event|1|||
17020808|NCT00839072|38165228|FG000|Second Intervention Period|Withdrawal by Subject|1|||
17020809|NCT00839072|38165229|FG001|Second Intervention Period|Withdrawal by Subject|0|||
17020810|NCT00855803|38165235|FG000|Overall Study|Death|2|||
17020811|NCT00855803|38165235|FG000|Overall Study|Lost to Follow-up|2|||
17020812|NCT00855803|38165235|FG000|Overall Study|Technical inability to undergo procedure|2|||
17020813|NCT00855803|38165235|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
17020814|NCT00855803|38165235|FG000|Overall Study|Withdrawal by Subject|3|||
17020815|NCT00855803|38165235|FG000|Overall Study|Physician Decision|3|||
17020816|NCT03553836|38165241|FG000|Overall Study|Ongoing in Study|460|||
17020817|NCT03553836|38165242|FG001|Overall Study|Ongoing in Study|459|||
17020818|NCT03553836|38165241|FG000|Overall Study|Withdrawal by Subject|9|||
17020819|NCT03553836|38165242|FG001|Overall Study|Withdrawal by Subject|10|||
17020820|NCT03553836|38165241|FG000|Overall Study|Lost to Follow-up|1|||
17020821|NCT03553836|38165242|FG001|Overall Study|Lost to Follow-up|3|||
17020822|NCT03553836|38165241|FG000|Overall Study|Death|17|||
17020823|NCT03553836|38165242|FG001|Overall Study|Death|17|||
17020824|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
17020825|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
17020826|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
17020827|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
17020828|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
16933850|NCT01262365|38078192|FG001|Overall Study|Toxicity related to study drug|1|||
16933851|NCT01262365|38078193|FG002|Overall Study|Toxicity related to study drug|0|||
16933852|NCT01262365|38078191|FG000|Overall Study|Cannot tolerate the protocol|0|||
16933853|NCT01262365|38078192|FG001|Overall Study|Cannot tolerate the protocol|1|||
16933854|NCT01262365|38078193|FG002|Overall Study|Cannot tolerate the protocol|0|||
16933855|NCT01262365|38078191|FG000|Overall Study|Patient unavailable|0|||
16933856|NCT01262365|38078192|FG001|Overall Study|Patient unavailable|0|||
16933857|NCT01262365|38078193|FG002|Overall Study|Patient unavailable|1|||
16933858|NCT03932812|38078203|FG000|Overall Study|Lost to Follow-up|12|||
16933859|NCT03932812|38078204|FG001|Overall Study|Lost to Follow-up|14|||
16933860|NCT03932812|38078203|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
16933861|NCT03932812|38078204|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
16933862|NCT01262287|38078213|FG000|Overall Study|Lost to Follow-up|2|||
16933863|NCT01262287|38078214|FG001|Overall Study|Lost to Follow-up|1|||
16933864|NCT01262092|38078226|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
16933865|NCT01262092|38078227|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
16933866|NCT01262092|38078226|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
16933867|NCT01262092|38078227|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
16933868|NCT01262092|38078226|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
16933869|NCT01262092|38078227|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
16933870|NCT01262092|38078226|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
16933871|NCT01262092|38078227|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
16933872|NCT01261975|38078233|FG000|Overall Study|Surgical complication|1|||
16933873|NCT01261780|38078242|FG000|Overall Study|Withdrawal by Subject|1|||
16933874|NCT01261780|38078243|FG001|Overall Study|Withdrawal by Subject|0|||
16933875|NCT01261780|38078242|FG000|Overall Study|Event not related to subject|1|||
16933876|NCT01261780|38078243|FG001|Overall Study|Event not related to subject|2|||
16933877|NCT01261624|38078251|FG000|Week 0 to Week 12|Disease Progression|1|||
16933878|NCT01261624|38078252|FG001|Week 0 to Week 12|Disease Progression|1|||
17020829|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
17020830|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
17020831|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
17020832|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
16933879|NCT01261624|38078251|FG000|Week 0 to Week 12|Insufficient Response|0|||
16933880|NCT01261624|38078252|FG001|Week 0 to Week 12|Insufficient Response|2|||
16933881|NCT01261624|38078251|FG000|Week 13 to Week 24|Insufficient Response|0|||
16933882|NCT01261624|38078252|FG001|Week 13 to Week 24|Insufficient Response|1|||
16933883|NCT03694522|38078266|FG000|Overall Study|Withdrawal by Subject|8|||
16933884|NCT03694522|38078267|FG001|Overall Study|Withdrawal by Subject|10|||
16933885|NCT03694522|38078266|FG000|Overall Study|Physician Decision|53|||
16933886|NCT03694522|38078267|FG001|Overall Study|Physician Decision|54|||
16933887|NCT03694522|38078266|FG000|Overall Study|Other|1|||
16933888|NCT03694522|38078267|FG001|Overall Study|Other|1|||
16933889|NCT03694522|38078266|FG000|Overall Study|Lost to Follow-up|0|||
16933890|NCT03694522|38078267|FG001|Overall Study|Lost to Follow-up|1|||
16933891|NCT01261390|38078277|FG000|Overall Study|Significant Concurrent Illness|1|||
16933892|NCT01261390|38078278|FG001|Overall Study|Significant Concurrent Illness|0|||
16933893|NCT01261390|38078279|FG002|Overall Study|Significant Concurrent Illness|1|||
16933894|NCT01261390|38078280|FG003|Overall Study|Significant Concurrent Illness|0|||
16933895|NCT01261390|38078277|FG000|Overall Study|Dissatisfaction with Treatment|2|||
16933896|NCT01261390|38078278|FG001|Overall Study|Dissatisfaction with Treatment|1|||
16933897|NCT01261390|38078279|FG002|Overall Study|Dissatisfaction with Treatment|1|||
16933898|NCT01261390|38078280|FG003|Overall Study|Dissatisfaction with Treatment|2|||
16933899|NCT01261390|38078277|FG000|Overall Study|Relocation|0|||
16933900|NCT01261390|38078278|FG001|Overall Study|Relocation|1|||
16933901|NCT01261390|38078279|FG002|Overall Study|Relocation|0|||
16933902|NCT01261390|38078280|FG003|Overall Study|Relocation|0|||
16933903|NCT01261390|38078277|FG000|Overall Study|Loss of Interest in the Study|3|||
16933904|NCT01261390|38078278|FG001|Overall Study|Loss of Interest in the Study|1|||
16933905|NCT01261390|38078279|FG002|Overall Study|Loss of Interest in the Study|0|||
16933906|NCT01261390|38078280|FG003|Overall Study|Loss of Interest in the Study|0|||
16933907|NCT01261390|38078277|FG000|Overall Study|Lost to Follow-up|1|||
16933908|NCT01261390|38078278|FG001|Overall Study|Lost to Follow-up|6|||
16933909|NCT01261390|38078279|FG002|Overall Study|Lost to Follow-up|5|||
16933910|NCT01261390|38078280|FG003|Overall Study|Lost to Follow-up|6|||
16933911|NCT03391882|38078301|FG000|Study Overall|Adverse Event|3|||
16933912|NCT03391882|38078302|FG001|Study Overall|Adverse Event|6|||
16933913|NCT03391882|38078303|FG002|Study Overall|Adverse Event|1|||
16933914|NCT03391882|38078304|FG003|Study Overall|Adverse Event|1|||
16933915|NCT03391882|38078305|FG004|Study Overall|Adverse Event|3|||
16933916|NCT03391882|38078306|FG005|Study Overall|Adverse Event|1|||
16933917|NCT03391882|38078301|FG000|Study Overall|Lack of Efficacy|13|||
16933918|NCT03391882|38078302|FG001|Study Overall|Lack of Efficacy|9|||
16933919|NCT03391882|38078303|FG002|Study Overall|Lack of Efficacy|0|||
16933920|NCT03391882|38078304|FG003|Study Overall|Lack of Efficacy|0|||
16933921|NCT03391882|38078305|FG004|Study Overall|Lack of Efficacy|0|||
16933922|NCT03391882|38078306|FG005|Study Overall|Lack of Efficacy|0|||
16933923|NCT03391882|38078301|FG000|Study Overall|Withdrawal by Subject|3|||
16933924|NCT03391882|38078302|FG001|Study Overall|Withdrawal by Subject|3|||
16933925|NCT03391882|38078303|FG002|Study Overall|Withdrawal by Subject|2|||
16933926|NCT03391882|38078304|FG003|Study Overall|Withdrawal by Subject|2|||
16933927|NCT03391882|38078305|FG004|Study Overall|Withdrawal by Subject|1|||
16933928|NCT03391882|38078306|FG005|Study Overall|Withdrawal by Subject|3|||
16933929|NCT03391882|38078301|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16933930|NCT03391882|38078302|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
16933931|NCT03391882|38078303|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16933932|NCT03391882|38078304|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16933933|NCT03391882|38078305|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16933934|NCT03391882|38078306|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16933935|NCT03391882|38078301|FG000|Study Overall|Protocol Violation|1|||
16933936|NCT03391882|38078302|FG001|Study Overall|Protocol Violation|0|||
16933937|NCT03391882|38078303|FG002|Study Overall|Protocol Violation|0|||
17020833|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
17020834|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
17020835|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
16933938|NCT03391882|38078304|FG003|Study Overall|Protocol Violation|0|||
16933939|NCT03391882|38078305|FG004|Study Overall|Protocol Violation|0|||
16933940|NCT03391882|38078306|FG005|Study Overall|Protocol Violation|0|||
16933941|NCT03391882|38078301|FG000|Part A - Titration Phase|Adverse Event|3|||
16933942|NCT03391882|38078302|FG001|Part A - Titration Phase|Adverse Event|6|||
17020836|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
17020837|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
17020838|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
17020839|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
17020840|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Missing|3|||
17020841|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Missing|1|||
17020842|NCT00838916|38165251|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
17020843|NCT00838916|38165252|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
17020844|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
17020845|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
17020846|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
17020847|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
17020848|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
17020849|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
17020850|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
17020851|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
17020852|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
17020853|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
17020854|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
17020855|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
17020856|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
17020857|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
17020858|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
17020859|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
17020860|NCT00838916|38165251|FG000|Follow-up Period (8 Weeks)|Missing|3|||
17020861|NCT00838916|38165252|FG001|Follow-up Period (8 Weeks)|Missing|0|||
17020862|NCT00838682|38165260|FG000|Overall Study|Lost to Follow-up|21|||
17020863|NCT00838682|38165261|FG001|Overall Study|Lost to Follow-up|14|||
17020864|NCT00838682|38165260|FG000|Overall Study|detection of exclusion criteria|4|||
17020865|NCT00838682|38165261|FG001|Overall Study|detection of exclusion criteria|3|||
17020866|NCT00838682|38165260|FG000|Overall Study|Protocol Violation|0|||
17020867|NCT00838682|38165261|FG001|Overall Study|Protocol Violation|1|||
17020868|NCT00838682|38165260|FG000|Overall Study|Withdrawal by Subject|0|||
17020869|NCT00838682|38165261|FG001|Overall Study|Withdrawal by Subject|1|||
17020870|NCT00820040|38165267|FG000|Overall Study|Death|1|||
17020871|NCT00820040|38165267|FG000|Overall Study|Sponsor terminated study|1|||
17020872|NCT00820040|38165267|FG000|Overall Study|Screen failure|1|||
17020873|NCT00803712|38165273|FG000|Overall Study|Noncompliance|3|||
17020874|NCT00803712|38165274|FG001|Overall Study|Noncompliance|0|||
17020875|NCT00803712|38165273|FG000|Overall Study|Adverse Event|5|||
17020876|NCT00803712|38165274|FG001|Overall Study|Adverse Event|0|||
17020877|NCT00803712|38165273|FG000|Overall Study|Death|8|||
17020878|NCT00803712|38165274|FG001|Overall Study|Death|7|||
17020879|NCT00803712|38165273|FG000|Overall Study|Lost to Follow-up|3|||
17020880|NCT00803712|38165274|FG001|Overall Study|Lost to Follow-up|1|||
17020881|NCT00803712|38165273|FG000|Overall Study|Withdrawal by Subject|2|||
17020882|NCT00803712|38165274|FG001|Overall Study|Withdrawal by Subject|4|||
17020883|NCT00803712|38165273|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
17020884|NCT00803712|38165274|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
17020885|NCT00803712|38165273|FG000|Overall Study|Protocol criteria (other)|0|||
17020886|NCT00803712|38165274|FG001|Overall Study|Protocol criteria (other)|2|||
17020887|NCT00803712|38165273|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
17020888|NCT00803712|38165274|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
17020889|NCT00803712|38165273|FG000|Overall Study|Administrative decision|2|||
17020890|NCT00803712|38165274|FG001|Overall Study|Administrative decision|3|||
17020891|NCT00803712|38165273|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
17020892|NCT00803712|38165274|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
17020893|NCT00591344|38165282|FG000|Overall Study|Transportation issues|1|||
17020894|NCT00591344|38165283|FG001|Overall Study|Transportation issues|0|||
17020895|NCT00591344|38165282|FG000|Overall Study|Moved out of state|1|||
17020896|NCT00591344|38165283|FG001|Overall Study|Moved out of state|0|||
17020897|NCT00591344|38165282|FG000|Overall Study|Medical complications|1|||
17020898|NCT00591344|38165283|FG001|Overall Study|Medical complications|3|||
17020899|NCT00591344|38165282|FG000|Overall Study|Underwent DBS|2|||
17020900|NCT00591344|38165283|FG001|Overall Study|Underwent DBS|2|||
17020901|NCT00591344|38165282|FG000|Overall Study|Death|0|||
17020902|NCT00591344|38165283|FG001|Overall Study|Death|1|||
17020903|NCT00591344|38165282|FG000|Overall Study|Lost to Follow-up|0|||
17020904|NCT00591344|38165283|FG001|Overall Study|Lost to Follow-up|1|||
17020905|NCT00591344|38165282|FG000|Overall Study|Did not want to come off medication|0|||
17020906|NCT00591344|38165283|FG001|Overall Study|Did not want to come off medication|1|||
17020907|NCT00803634|38165295|FG000|Overall Study|Withdrew Consent|1|||
17020908|NCT00803634|38165296|FG001|Overall Study|Withdrew Consent|0|||
17020909|NCT00803634|38165295|FG000|Overall Study|Lost to Follow-up|2|||
17020910|NCT00803634|38165296|FG001|Overall Study|Lost to Follow-up|3|||
17020911|NCT00803634|38165295|FG000|Overall Study|Death|3|||
17020912|NCT00803634|38165296|FG001|Overall Study|Death|2|||
17020913|NCT00838526|38165305|FG000|Overall Study|Adverse Event|3|||
17020914|NCT00838526|38165306|FG001|Overall Study|Adverse Event|12|||
17020915|NCT00838526|38165305|FG000|Overall Study|Lost to Follow-up|4|||
17020916|NCT00838526|38165306|FG001|Overall Study|Lost to Follow-up|12|||
17020917|NCT00838526|38165305|FG000|Overall Study|Withdrawal by Subject|4|||
17020918|NCT00838526|38165306|FG001|Overall Study|Withdrawal by Subject|5|||
17020919|NCT00838526|38165305|FG000|Overall Study|Lack of Efficacy|2|||
17020920|NCT00838526|38165306|FG001|Overall Study|Lack of Efficacy|3|||
17020921|NCT00838526|38165305|FG000|Overall Study|Other|11|||
17020922|NCT00838526|38165306|FG001|Overall Study|Other|7|||
17020923|NCT00818246|38165325|FG000|Overall Study|Impossible to match pictures|5|||
17020924|NCT00818168|38165329|FG000|Overall Study|Lack of Efficacy|18|||
17020925|NCT00818168|38165329|FG000|Overall Study|Pregnancy|2|||
17020926|NCT00818168|38165329|FG000|Overall Study|Withdrawal by Subject|16|||
17020927|NCT00818168|38165329|FG000|Overall Study|Lost to Follow-up|7|||
17020928|NCT00818168|38165329|FG000|Overall Study|Adverse Event|19|||
17020929|NCT00818168|38165329|FG000|Overall Study|Reason for Non-completion Not reported|6|||
17020930|NCT00818168|38165329|FG000|Overall Study|Participant Moved|2|||
17020931|NCT00817778|38165335|FG000|Overall Study|Adverse Event|1|||
17020932|NCT00817778|38165336|FG001|Overall Study|Adverse Event|0|||
17020933|NCT00817778|38165335|FG000|Overall Study|Withdrawal by Subject|1|||
17020934|NCT00817778|38165336|FG001|Overall Study|Withdrawal by Subject|1|||
17020935|NCT00817778|38165335|FG000|Overall Study|Protocol Violation|0|||
17020936|NCT00817778|38165336|FG001|Overall Study|Protocol Violation|1|||
17020937|NCT00817778|38165335|FG000|Overall Study|Study-specific discontinuation criteria|0|||
17020938|NCT00817778|38165336|FG001|Overall Study|Study-specific discontinuation criteria|1|||
17020939|NCT00817778|38165335|FG000|Overall Study|Poor venous access|1|||
17020940|NCT00817778|38165336|FG001|Overall Study|Poor venous access|0|||
17020941|NCT00813098|38165345|FG000|Overall Study|Adverse Event|2|||
17020942|NCT00813098|38165346|FG001|Overall Study|Adverse Event|4|||
17020943|NCT00813098|38165347|FG002|Overall Study|Adverse Event|1|||
17020944|NCT00813098|38165345|FG000|Overall Study|Withdrawal by Subject|0|||
17020945|NCT00813098|38165346|FG001|Overall Study|Withdrawal by Subject|1|||
17020946|NCT00813098|38165347|FG002|Overall Study|Withdrawal by Subject|0|||
17020947|NCT00813098|38165345|FG000|Overall Study|Inability to complete study procedures|1|||
17020948|NCT00813098|38165346|FG001|Overall Study|Inability to complete study procedures|0|||
17020949|NCT00813098|38165347|FG002|Overall Study|Inability to complete study procedures|0|||
17020950|NCT00813098|38165345|FG000|Overall Study|Lost to Follow-up|0|||
17020951|NCT00813098|38165346|FG001|Overall Study|Lost to Follow-up|1|||
17020952|NCT00813098|38165347|FG002|Overall Study|Lost to Follow-up|0|||
17020953|NCT00813098|38165345|FG000|Overall Study|Protocol Violation|0|||
17020954|NCT00813098|38165346|FG001|Overall Study|Protocol Violation|0|||
17020955|NCT00813098|38165347|FG002|Overall Study|Protocol Violation|1|||
17020956|NCT00813098|38165345|FG000|Overall Study|Principal Investigator decision|0|||
17020957|NCT00813098|38165346|FG001|Overall Study|Principal Investigator decision|1|||
17020958|NCT00813098|38165347|FG002|Overall Study|Principal Investigator decision|0|||
17020959|NCT00813098|38165345|FG000|Overall Study|Withdrew Consent|0|||
17020960|NCT00813098|38165346|FG001|Overall Study|Withdrew Consent|1|||
17020961|NCT00813098|38165347|FG002|Overall Study|Withdrew Consent|0|||
17020962|NCT00796653|38165359|FG000|Overall Study|Adverse Event|19|||
17020963|NCT00796653|38165360|FG001|Overall Study|Adverse Event|16|||
17020964|NCT00796653|38165361|FG002|Overall Study|Adverse Event|16|||
17020965|NCT00796653|38165362|FG003|Overall Study|Adverse Event|16|||
17020966|NCT00796653|38165359|FG000|Overall Study|Lost to Follow-up|2|||
17020967|NCT00796653|38165360|FG001|Overall Study|Lost to Follow-up|1|||
17020968|NCT00796653|38165361|FG002|Overall Study|Lost to Follow-up|2|||
17020969|NCT00796653|38165362|FG003|Overall Study|Lost to Follow-up|3|||
17020970|NCT00796653|38165359|FG000|Overall Study|Withdrawal by Subject|16|||
17020971|NCT00796653|38165360|FG001|Overall Study|Withdrawal by Subject|8|||
17020972|NCT00796653|38165361|FG002|Overall Study|Withdrawal by Subject|8|||
17020973|NCT00796653|38165362|FG003|Overall Study|Withdrawal by Subject|13|||
17020974|NCT00796653|38165359|FG000|Overall Study|Lack of Efficacy|8|||
17020975|NCT00796653|38165360|FG001|Overall Study|Lack of Efficacy|1|||
17020976|NCT00796653|38165361|FG002|Overall Study|Lack of Efficacy|3|||
17020977|NCT00796653|38165362|FG003|Overall Study|Lack of Efficacy|2|||
17020978|NCT00796653|38165359|FG000|Overall Study|Non compliance with protocol|2|||
17020979|NCT00796653|38165360|FG001|Overall Study|Non compliance with protocol|2|||
17020980|NCT00796653|38165361|FG002|Overall Study|Non compliance with protocol|0|||
17020981|NCT00796653|38165362|FG003|Overall Study|Non compliance with protocol|2|||
17020982|NCT00796653|38165359|FG000|Overall Study|Other reason not described above|4|||
17020983|NCT00796653|38165360|FG001|Overall Study|Other reason not described above|9|||
17020984|NCT00796653|38165361|FG002|Overall Study|Other reason not described above|7|||
17020985|NCT00796653|38165362|FG003|Overall Study|Other reason not described above|4|||
17020986|NCT00806286|38165383|FG000|Overall Study|Adverse Event|5|||
17020987|NCT00806286|38165384|FG001|Overall Study|Adverse Event|2|||
17020988|NCT00806286|38165385|FG002|Overall Study|Adverse Event|0|||
17020989|NCT00806286|38165383|FG000|Overall Study|Disease progression|31|||
17020990|NCT00806286|38165384|FG001|Overall Study|Disease progression|38|||
17020991|NCT00806286|38165385|FG002|Overall Study|Disease progression|1|||
17020992|NCT00806286|38165383|FG000|Overall Study|Death|1|||
17020993|NCT00806286|38165384|FG001|Overall Study|Death|6|||
17020994|NCT00806286|38165385|FG002|Overall Study|Death|0|||
17020995|NCT00806286|38165383|FG000|Overall Study|Lost to Follow-up|0|||
17020996|NCT00806286|38165384|FG001|Overall Study|Lost to Follow-up|1|||
17020997|NCT00806286|38165385|FG002|Overall Study|Lost to Follow-up|0|||
17020998|NCT00806286|38165383|FG000|Overall Study|Withdrawal by Subject|8|||
17020999|NCT00806286|38165384|FG001|Overall Study|Withdrawal by Subject|3|||
17021000|NCT00806286|38165385|FG002|Overall Study|Withdrawal by Subject|1|||
17021001|NCT00806286|38165383|FG000|Overall Study|Physician Decision|2|||
17021002|NCT00806286|38165384|FG001|Overall Study|Physician Decision|2|||
17021003|NCT00806286|38165385|FG002|Overall Study|Physician Decision|0|||
17021004|NCT00806286|38165383|FG000|Overall Study|Due to a variety of reasons|7|||
17021005|NCT00806286|38165384|FG001|Overall Study|Due to a variety of reasons|2|||
17021006|NCT00806286|38165385|FG002|Overall Study|Due to a variety of reasons|1|||
17021007|NCT00590538|38165393|FG000|Overall Study|Study terminated before completed|2|||
17021008|NCT00796419|38165399|FG000|Overall Study|Death|0|||
17021009|NCT00796419|38165400|FG001|Overall Study|Death|1|||
17021010|NCT00796107|38165406|FG000|Overall Study|Lack of Efficacy|1|||
17021011|NCT00796107|38165406|FG000|Overall Study|Progressive Disease|5|||
17021012|NCT00795951|38165410|FG000|Overall Study|Lost to Follow-up|1|||
17021013|NCT00795951|38165410|FG000|Overall Study|Withdrawal by Subject|1|||
17021014|NCT00795717|38165417|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
17021015|NCT00795717|38165418|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
17021016|NCT00795717|38165417|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
17021017|NCT00795717|38165418|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
17021018|NCT00795717|38165417|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
17021019|NCT00795717|38165418|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
17021020|NCT00795717|38165417|FG000|Phase II|too busy|0|||
17021021|NCT00795717|38165418|FG001|Phase II|too busy|1|||
17021022|NCT00805740|38165427|FG000|Overall Study|Death|7|||
17021023|NCT00805740|38165428|FG001|Overall Study|Death|4|||
17021024|NCT00805740|38165427|FG000|Overall Study|Withdrawal by Subject|1|||
17021025|NCT00805740|38165428|FG001|Overall Study|Withdrawal by Subject|0|||
17021026|NCT00805740|38165427|FG000|Overall Study|Lost to Follow-up|1|||
17021027|NCT00805740|38165428|FG001|Overall Study|Lost to Follow-up|0|||
17021028|NCT00805740|38165427|FG000|Overall Study|Randomized, but not treated|2|||
17021029|NCT00805740|38165428|FG001|Overall Study|Randomized, but not treated|0|||
17021030|NCT00795639|38165436|FG000|Overall Study|Death|1|||
17021031|NCT00795639|38165437|FG001|Overall Study|Death|6|||
17021032|NCT00795639|38165436|FG000|Overall Study|Withdrawal by Subject|1|||
17021033|NCT00795639|38165437|FG001|Overall Study|Withdrawal by Subject|3|||
17021034|NCT00795639|38165436|FG000|Overall Study|Pregnancy|1|||
17021035|NCT00795639|38165437|FG001|Overall Study|Pregnancy|0|||
17021036|NCT00795639|38165436|FG000|Overall Study|Adverse Event|5|||
17021037|NCT00795639|38165437|FG001|Overall Study|Adverse Event|2|||
17021038|NCT00795639|38165436|FG000|Overall Study|Other|0|||
17021039|NCT00795639|38165437|FG001|Overall Study|Other|2|||
17021040|NCT00795639|38165436|FG000|Overall Study|Terminated by sponsor|13|||
17021041|NCT00795639|38165437|FG001|Overall Study|Terminated by sponsor|12|||
17021042|NCT00795639|38165436|FG000|Overall Study|Randomized and not treated|0|||
17021043|NCT00795639|38165437|FG001|Overall Study|Randomized and not treated|1|||
17021044|NCT00589602|38165443|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
17021045|NCT00794157|38165452|FG000|Overall Study|Adverse Event|4|||
17021046|NCT00794157|38165453|FG001|Overall Study|Adverse Event|1|||
17021047|NCT00794157|38165454|FG002|Overall Study|Adverse Event|8|||
17021048|NCT00794157|38165452|FG000|Overall Study|Subject withdrew consent|2|||
17021049|NCT00794157|38165453|FG001|Overall Study|Subject withdrew consent|0|||
17021050|NCT00794157|38165454|FG002|Overall Study|Subject withdrew consent|3|||
17021051|NCT00794157|38165452|FG000|Overall Study|Lost to Follow-up|2|||
17021052|NCT00794157|38165453|FG001|Overall Study|Lost to Follow-up|0|||
17021053|NCT00794157|38165454|FG002|Overall Study|Lost to Follow-up|1|||
17021054|NCT00794157|38165452|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17021055|NCT00794157|38165453|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
17021056|NCT00794157|38165454|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
17021057|NCT00794157|38165452|FG000|Overall Study|Administrative problems|1|||
17021058|NCT00794157|38165453|FG001|Overall Study|Administrative problems|7|||
17021059|NCT00794157|38165454|FG002|Overall Study|Administrative problems|4|||
17021060|NCT00794157|38165452|FG000|Overall Study|Abnormal test procedure result(s)|0|||
17021061|NCT00794157|38165453|FG001|Overall Study|Abnormal test procedure result(s)|1|||
17021062|NCT00794157|38165454|FG002|Overall Study|Abnormal test procedure result(s)|0|||
17021063|NCT00794157|38165452|FG000|Overall Study|Protocol deviation|0|||
17021064|NCT00794157|38165453|FG001|Overall Study|Protocol deviation|1|||
17021065|NCT00794157|38165454|FG002|Overall Study|Protocol deviation|1|||
17021066|NCT00588237|38165462|FG000|Overall Study|Evaluable for toxicity only|3|||
17021067|NCT00588237|38165462|FG000|Overall Study|Patien not treated|1|||
17021068|NCT00790023|38165469|FG000|Overall Study|Adverse Event|2|||
17021069|NCT00790023|38165470|FG001|Overall Study|Adverse Event|1|||
17021070|NCT00790023|38165471|FG002|Overall Study|Adverse Event|4|||
17021071|NCT00790023|38165469|FG000|Overall Study|Protocol Violation|2|||
17021072|NCT00790023|38165470|FG001|Overall Study|Protocol Violation|4|||
17021073|NCT00790023|38165471|FG002|Overall Study|Protocol Violation|2|||
17021074|NCT00790023|38165469|FG000|Overall Study|Withdrawal by Subject|2|||
17021075|NCT00790023|38165470|FG001|Overall Study|Withdrawal by Subject|0|||
17021076|NCT00790023|38165471|FG002|Overall Study|Withdrawal by Subject|6|||
17021077|NCT00790023|38165469|FG000|Overall Study|Lost to Follow-up|0|||
17021078|NCT00790023|38165470|FG001|Overall Study|Lost to Follow-up|0|||
17021079|NCT00790023|38165471|FG002|Overall Study|Lost to Follow-up|1|||
17021080|NCT00790023|38165469|FG000|Overall Study|Other|5|||
17021081|NCT00790023|38165470|FG001|Overall Study|Other|5|||
17021082|NCT00790023|38165471|FG002|Overall Study|Other|8|||
17021083|NCT00588822|38165480|FG000|Overall Study|progression of disease|8|||
17021084|NCT00589914|38165486|FG000|Overall Study|Adverse Event|19|||
17021085|NCT00589914|38165487|FG001|Overall Study|Adverse Event|10|||
17021086|NCT00589914|38165486|FG000|Overall Study|Death|2|||
17021087|NCT00589914|38165487|FG001|Overall Study|Death|0|||
17021088|NCT00589914|38165486|FG000|Overall Study|Lack of Efficacy|40|||
17021089|NCT00589914|38165487|FG001|Overall Study|Lack of Efficacy|43|||
17021090|NCT00589914|38165486|FG000|Overall Study|Lost to Follow-up|11|||
17021091|NCT00589914|38165487|FG001|Overall Study|Lost to Follow-up|18|||
17021092|NCT00589914|38165486|FG000|Overall Study|Pregnancy|1|||
17021093|NCT00589914|38165487|FG001|Overall Study|Pregnancy|0|||
17021094|NCT00589914|38165486|FG000|Overall Study|Withdrawal by Subject|55|||
17021095|NCT00589914|38165487|FG001|Overall Study|Withdrawal by Subject|49|||
17021096|NCT00589914|38165486|FG000|Overall Study|Other|22|||
17021097|NCT00589914|38165487|FG001|Overall Study|Other|17|||
17021098|NCT00789555|38165496|FG000|Overall Study|Protocol Amendment|78|||
17021099|NCT00789555|38165497|FG001|Overall Study|Protocol Amendment|76|||
17021100|NCT00789555|38165498|FG002|Overall Study|Protocol Amendment|80|||
17021101|NCT00789555|38165496|FG000|Overall Study|Adverse Event|17|||
17021102|NCT00789555|38165497|FG001|Overall Study|Adverse Event|7|||
17021103|NCT00789555|38165498|FG002|Overall Study|Adverse Event|10|||
17021104|NCT00789555|38165496|FG000|Overall Study|Lost to Follow-up|9|||
17021105|NCT00789555|38165497|FG001|Overall Study|Lost to Follow-up|10|||
17021106|NCT00789555|38165498|FG002|Overall Study|Lost to Follow-up|18|||
17021107|NCT00789555|38165496|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
17021108|NCT00789555|38165497|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
17021109|NCT00789555|38165498|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
17021110|NCT00789555|38165496|FG000|Overall Study|Treatment failure|11|||
17021111|NCT00789555|38165497|FG001|Overall Study|Treatment failure|8|||
17021112|NCT00789555|38165498|FG002|Overall Study|Treatment failure|12|||
17021113|NCT00789555|38165496|FG000|Overall Study|Protocol Violation|6|||
17021114|NCT00789555|38165497|FG001|Overall Study|Protocol Violation|9|||
17021115|NCT00789555|38165498|FG002|Overall Study|Protocol Violation|13|||
17021116|NCT00451321|38165514|FG000|Overall Study|Lost to Follow-up|3|||
17021117|NCT00451321|38165515|FG001|Overall Study|Lost to Follow-up|3|||
17102751|NCT00112437|38241447|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
17102752|NCT00112437|38241448|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
17102753|NCT00112437|38241449|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
17102754|NCT00112437|38241450|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
17102755|NCT00112437|38241451|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
17102756|NCT00112437|38241452|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
17102757|NCT00112437|38241453|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
17102758|NCT00112437|38241454|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
17102759|NCT00112437|38241455|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
17102760|NCT00112437|38241456|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
17102761|NCT00112437|38241457|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
17102762|NCT00112437|38241458|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
17102763|NCT00112437|38241459|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
17021118|NCT00451321|38165516|FG002|Overall Study|Lost to Follow-up|1|||
17021119|NCT00451321|38165517|FG003|Overall Study|Lost to Follow-up|3|||
17021120|NCT00451321|38165518|FG004|Overall Study|Lost to Follow-up|0|||
17021121|NCT00451321|38165519|FG005|Overall Study|Lost to Follow-up|1|||
17021122|NCT00451321|38165520|FG006|Overall Study|Lost to Follow-up|0|||
17021123|NCT00451321|38165521|FG007|Overall Study|Lost to Follow-up|0|||
17021124|NCT00451321|38165514|FG000|Overall Study|Withdrawal by Subject|3|||
17021125|NCT00451321|38165515|FG001|Overall Study|Withdrawal by Subject|1|||
17021126|NCT00451321|38165516|FG002|Overall Study|Withdrawal by Subject|0|||
17021127|NCT00451321|38165517|FG003|Overall Study|Withdrawal by Subject|4|||
17021128|NCT00451321|38165518|FG004|Overall Study|Withdrawal by Subject|0|||
17021129|NCT00451321|38165519|FG005|Overall Study|Withdrawal by Subject|0|||
17102764|NCT00112437|38241460|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
17102765|NCT00112437|38241461|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
17102766|NCT00112437|38241462|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
17102767|NCT00112437|38241463|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
17102768|NCT00112437|38241464|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
17021130|NCT00451321|38165520|FG006|Overall Study|Withdrawal by Subject|0|||
17021131|NCT00451321|38165521|FG007|Overall Study|Withdrawal by Subject|0|||
17021132|NCT00451321|38165514|FG000|Overall Study|Study closed/terminated|1|||
17021133|NCT00451321|38165515|FG001|Overall Study|Study closed/terminated|1|||
17102769|NCT00112437|38241465|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
17021134|NCT00451321|38165516|FG002|Overall Study|Study closed/terminated|17|||
17021135|NCT00451321|38165517|FG003|Overall Study|Study closed/terminated|5|||
17021136|NCT00451321|38165518|FG004|Overall Study|Study closed/terminated|7|||
17021137|NCT00451321|38165519|FG005|Overall Study|Study closed/terminated|7|||
17021138|NCT00451321|38165520|FG006|Overall Study|Study closed/terminated|5|||
17021139|NCT00451321|38165521|FG007|Overall Study|Study closed/terminated|3|||
17021140|NCT00451321|38165514|FG000|Overall Study|Sponsor decision to amend protocol|0|||
17021141|NCT00451321|38165515|FG001|Overall Study|Sponsor decision to amend protocol|0|||
17021142|NCT00451321|38165516|FG002|Overall Study|Sponsor decision to amend protocol|0|||
17021143|NCT00451321|38165517|FG003|Overall Study|Sponsor decision to amend protocol|0|||
17021144|NCT00451321|38165518|FG004|Overall Study|Sponsor decision to amend protocol|0|||
17021145|NCT00451321|38165519|FG005|Overall Study|Sponsor decision to amend protocol|1|||
17021146|NCT00451321|38165520|FG006|Overall Study|Sponsor decision to amend protocol|1|||
17021147|NCT00451321|38165521|FG007|Overall Study|Sponsor decision to amend protocol|3|||
17021148|NCT00802464|38165547|FG000|Month 0 - Month 8|Adverse Event|0|||
17021149|NCT00802464|38165548|FG001|Month 0 - Month 8|Adverse Event|1|||
17021150|NCT00802464|38165549|FG002|Month 0 - Month 8|Adverse Event|1|||
17021151|NCT00802464|38165550|FG003|Month 0 - Month 8|Adverse Event|2|||
17021152|NCT00802464|38165547|FG000|Month 0 - Month 8|Protocol Violation|0|||
17021153|NCT00802464|38165548|FG001|Month 0 - Month 8|Protocol Violation|0|||
17021154|NCT00802464|38165549|FG002|Month 0 - Month 8|Protocol Violation|1|||
17021155|NCT00802464|38165550|FG003|Month 0 - Month 8|Protocol Violation|0|||
17021156|NCT00802464|38165547|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
17021157|NCT00802464|38165548|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
17021158|NCT00802464|38165549|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
17021159|NCT00802464|38165550|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
17021160|NCT00802464|38165547|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
17021161|NCT00802464|38165548|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
17021162|NCT00802464|38165549|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
17021163|NCT00802464|38165550|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
17021164|NCT00802464|38165547|FG000|Month 0 - Month 8|Other|0|||
17021165|NCT00802464|38165548|FG001|Month 0 - Month 8|Other|0|||
17021166|NCT00802464|38165549|FG002|Month 0 - Month 8|Other|1|||
17021167|NCT00802464|38165550|FG003|Month 0 - Month 8|Other|0|||
17021168|NCT00802464|38165547|FG000|Month 8 - Month 14|Adverse Event|0|||
17021169|NCT00802464|38165548|FG001|Month 8 - Month 14|Adverse Event|1|||
17021170|NCT00802464|38165549|FG002|Month 8 - Month 14|Adverse Event|0|||
17021171|NCT00802464|38165550|FG003|Month 8 - Month 14|Adverse Event|0|||
17021172|NCT00802464|38165547|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
17021173|NCT00802464|38165548|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
17021174|NCT00802464|38165549|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
17021175|NCT00802464|38165550|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
17021176|NCT00802464|38165547|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
17021177|NCT00802464|38165548|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
17021178|NCT00802464|38165549|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
17021179|NCT00802464|38165550|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
17021180|NCT00450619|38165564|FG000|Overall Study|refused treatment after randomization|2|||
17021181|NCT00450619|38165565|FG001|Overall Study|refused treatment after randomization|0|||
17021182|NCT00450619|38165564|FG000|Overall Study|did not progress; refused further trmt|1|||
17021183|NCT00450619|38165565|FG001|Overall Study|did not progress; refused further trmt|1|||
17021184|NCT00450619|38165564|FG000|Overall Study|Adverse Event|1|||
17021185|NCT00450619|38165565|FG001|Overall Study|Adverse Event|0|||
17021186|NCT00802074|38165578|FG000|Overall Study|Adverse Event|1|||
17021187|NCT00802074|38165579|FG001|Overall Study|Adverse Event|1|||
17021188|NCT00802074|38165580|FG002|Overall Study|Adverse Event|1|||
17021189|NCT00802074|38165581|FG003|Overall Study|Adverse Event|0|||
17021190|NCT00802074|38165582|FG004|Overall Study|Adverse Event|0|||
17021191|NCT00802074|38165583|FG005|Overall Study|Adverse Event|0|||
17021192|NCT00802074|38165578|FG000|Overall Study|Withdrawal by Subject|1|||
17021193|NCT00802074|38165579|FG001|Overall Study|Withdrawal by Subject|0|||
17021194|NCT00802074|38165580|FG002|Overall Study|Withdrawal by Subject|0|||
17021195|NCT00802074|38165581|FG003|Overall Study|Withdrawal by Subject|0|||
17021196|NCT00802074|38165582|FG004|Overall Study|Withdrawal by Subject|0|||
17021197|NCT00802074|38165583|FG005|Overall Study|Withdrawal by Subject|0|||
17021198|NCT00450385|38165600|FG000|Overall Study|Death|3|||
17021199|NCT00450385|38165600|FG000|Overall Study|Protocol Violation|1|||
17021200|NCT00450385|38165600|FG000|Overall Study|Withdrawal by Subject|2|||
17021201|NCT00450385|38165600|FG000|Overall Study|Lack of Efficacy|2|||
17021202|NCT00450385|38165600|FG000|Overall Study|Adverse Event|1|||
17021203|NCT00450385|38165600|FG000|Overall Study|Physician Decision|1|||
17021204|NCT00450385|38165600|FG000|Overall Study|Other|3|||
17021205|NCT00588354|38165607|FG000|Baseline to 2 Weeks|Adverse Event|1|||
17021206|NCT00588354|38165608|FG001|Baseline to 2 Weeks|Adverse Event|0|||
17021207|NCT00588354|38165607|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
17021208|NCT00588354|38165608|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
17021209|NCT00588354|38165607|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
17021210|NCT00588354|38165608|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
17021211|NCT00449761|38165615|FG000|Overall Study|Disease progression|12|||
17021212|NCT00449761|38165615|FG000|Overall Study|Death|5|||
17021213|NCT00449761|38165615|FG000|Overall Study|New cancer therapy|1|||
17021214|NCT00800982|38165622|FG000|Overall Study|Lost to Follow-up|1|||
17021215|NCT00800982|38165623|FG001|Overall Study|Lost to Follow-up|2|||
17021216|NCT00800982|38165622|FG000|Overall Study|Withdrawal by Subject|0|||
17021217|NCT00800982|38165623|FG001|Overall Study|Withdrawal by Subject|1|||
17021218|NCT00800982|38165622|FG000|Overall Study|Patient moved out of state|1|||
17021219|NCT00800982|38165623|FG001|Overall Study|Patient moved out of state|0|||
17021220|NCT00830960|38165635|FG000|Overall Study|Death|5|||
17021221|NCT00830960|38165636|FG001|Overall Study|Death|4|||
17021222|NCT00830960|38165637|FG002|Overall Study|Death|3|||
17021223|NCT00830960|38165638|FG003|Overall Study|Death|2|||
17021224|NCT00830960|38165639|FG004|Overall Study|Death|6|||
17021225|NCT00830960|38165640|FG005|Overall Study|Death|1|||
17021226|NCT00830960|38165635|FG000|Overall Study|Lost to Follow-up|1|||
17021227|NCT00830960|38165636|FG001|Overall Study|Lost to Follow-up|1|||
17021228|NCT00830960|38165637|FG002|Overall Study|Lost to Follow-up|1|||
17021229|NCT00830960|38165638|FG003|Overall Study|Lost to Follow-up|0|||
17021230|NCT00830960|38165639|FG004|Overall Study|Lost to Follow-up|0|||
17021231|NCT00830960|38165640|FG005|Overall Study|Lost to Follow-up|1|||
17021232|NCT00830960|38165635|FG000|Overall Study|Withdrawal by Subject|19|||
17021233|NCT00830960|38165636|FG001|Overall Study|Withdrawal by Subject|19|||
17021234|NCT00830960|38165637|FG002|Overall Study|Withdrawal by Subject|18|||
17021235|NCT00830960|38165638|FG003|Overall Study|Withdrawal by Subject|23|||
17021236|NCT00830960|38165639|FG004|Overall Study|Withdrawal by Subject|16|||
17021237|NCT00830960|38165640|FG005|Overall Study|Withdrawal by Subject|21|||
17102770|NCT00112437|38241466|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
17102771|NCT00112437|38241441|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102772|NCT00112437|38241442|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102773|NCT00112437|38241443|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102774|NCT00112437|38241444|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102775|NCT00112437|38241445|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102776|NCT00112437|38241446|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
17102777|NCT00112437|38241447|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
17102778|NCT00112437|38241448|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102779|NCT00112437|38241449|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102780|NCT00112437|38241450|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
17102781|NCT00112437|38241451|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102782|NCT00112437|38241452|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102783|NCT00112437|38241453|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102784|NCT00112437|38241454|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102785|NCT00112437|38241455|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102786|NCT00112437|38241456|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102787|NCT00112437|38241457|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102788|NCT00112437|38241458|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102789|NCT00112437|38241459|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102790|NCT00112437|38241460|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102791|NCT00112437|38241461|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102792|NCT00112437|38241462|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102793|NCT00112437|38241463|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102794|NCT00112437|38241464|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102795|NCT00112437|38241465|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17021238|NCT00830960|38165635|FG000|Overall Study|Sponsor Decision|1|||
17021239|NCT00830960|38165636|FG001|Overall Study|Sponsor Decision|2|||
17021240|NCT00830960|38165637|FG002|Overall Study|Sponsor Decision|3|||
17021241|NCT00830960|38165638|FG003|Overall Study|Sponsor Decision|4|||
17021242|NCT00830960|38165639|FG004|Overall Study|Sponsor Decision|5|||
17021243|NCT00830960|38165640|FG005|Overall Study|Sponsor Decision|7|||
17021244|NCT00830960|38165635|FG000|Overall Study|No study drug received|7|||
17021245|NCT00830960|38165636|FG001|Overall Study|No study drug received|2|||
17021246|NCT00830960|38165637|FG002|Overall Study|No study drug received|4|||
17021247|NCT00830960|38165638|FG003|Overall Study|No study drug received|3|||
17021248|NCT00830960|38165639|FG004|Overall Study|No study drug received|5|||
17021249|NCT00830960|38165640|FG005|Overall Study|No study drug received|7|||
17021250|NCT00830804|38165677|FG000|Overall Study|Lost to Follow-up|4|||
17021251|NCT00830804|38165677|FG000|Overall Study|Death|1|||
17021252|NCT00830804|38165677|FG000|Overall Study|Unable to get to clinic|7|||
17021253|NCT00830804|38165677|FG000|Overall Study|Consent withdrawn|2|||
17021254|NCT00830804|38165677|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
17021255|NCT00789477|38165687|FG000|Overall Study|Withdrawal by Subject|2|||
17021256|NCT00789477|38165688|FG001|Overall Study|Withdrawal by Subject|1|||
17021257|NCT00789477|38165689|FG002|Overall Study|Withdrawal by Subject|3|||
17021258|NCT00789477|38165690|FG003|Overall Study|Withdrawal by Subject|2|||
17021259|NCT00789477|38165691|FG004|Overall Study|Withdrawal by Subject|3|||
17021260|NCT00789477|38165687|FG000|Overall Study|Protocol Violation|1|||
17021261|NCT00789477|38165688|FG001|Overall Study|Protocol Violation|0|||
17021262|NCT00789477|38165689|FG002|Overall Study|Protocol Violation|0|||
17021263|NCT00789477|38165690|FG003|Overall Study|Protocol Violation|1|||
17021264|NCT00789477|38165691|FG004|Overall Study|Protocol Violation|0|||
17021265|NCT00789477|38165687|FG000|Overall Study|Adverse Event|3|||
17021266|NCT00789477|38165688|FG001|Overall Study|Adverse Event|3|||
17021267|NCT00789477|38165689|FG002|Overall Study|Adverse Event|1|||
17021268|NCT00789477|38165690|FG003|Overall Study|Adverse Event|0|||
17021269|NCT00789477|38165691|FG004|Overall Study|Adverse Event|0|||
17021270|NCT00789477|38165687|FG000|Overall Study|Death|1|||
17021271|NCT00789477|38165688|FG001|Overall Study|Death|1|||
17021272|NCT00789477|38165689|FG002|Overall Study|Death|2|||
17021273|NCT00789477|38165690|FG003|Overall Study|Death|2|||
17021274|NCT00789477|38165691|FG004|Overall Study|Death|0|||
17021275|NCT00789477|38165687|FG000|Overall Study|Lost to Follow-up|0|||
17021276|NCT00789477|38165688|FG001|Overall Study|Lost to Follow-up|1|||
17021277|NCT00789477|38165689|FG002|Overall Study|Lost to Follow-up|4|||
17021278|NCT00789477|38165690|FG003|Overall Study|Lost to Follow-up|2|||
17021279|NCT00789477|38165691|FG004|Overall Study|Lost to Follow-up|4|||
17021280|NCT00789477|38165687|FG000|Overall Study|Lack of Efficacy|2|||
17021281|NCT00789477|38165688|FG001|Overall Study|Lack of Efficacy|0|||
17021282|NCT00789477|38165689|FG002|Overall Study|Lack of Efficacy|0|||
17021283|NCT00789477|38165690|FG003|Overall Study|Lack of Efficacy|0|||
17021284|NCT00789477|38165691|FG004|Overall Study|Lack of Efficacy|0|||
17021285|NCT00789477|38165687|FG000|Overall Study|Other|2|||
17021286|NCT00789477|38165688|FG001|Overall Study|Other|0|||
17021287|NCT00789477|38165689|FG002|Overall Study|Other|1|||
17021288|NCT00789477|38165690|FG003|Overall Study|Other|3|||
17021289|NCT00789477|38165691|FG004|Overall Study|Other|0|||
17021290|NCT00796614|38165709|FG000|Overall Study|Adverse Event|1|||
17021291|NCT00796614|38165710|FG001|Overall Study|Adverse Event|2|||
17021292|NCT00796614|38165711|FG002|Overall Study|Adverse Event|0|||
17021293|NCT00796614|38165712|FG003|Overall Study|Adverse Event|0|||
17021294|NCT00796614|38165709|FG000|Overall Study|Protocol Violation|0|||
17021295|NCT00796614|38165710|FG001|Overall Study|Protocol Violation|0|||
17021296|NCT00796614|38165711|FG002|Overall Study|Protocol Violation|2|||
17021297|NCT00796614|38165712|FG003|Overall Study|Protocol Violation|0|||
16933943|NCT03391882|38078303|FG002|Part A - Titration Phase|Adverse Event|0|||
16933944|NCT03391882|38078304|FG003|Part A - Titration Phase|Adverse Event|0|||
16933945|NCT03391882|38078305|FG004|Part A - Titration Phase|Adverse Event|0|||
16933946|NCT03391882|38078306|FG005|Part A - Titration Phase|Adverse Event|0|||
16933947|NCT03391882|38078301|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
16933948|NCT03391882|38078302|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
17021298|NCT00796614|38165709|FG000|Overall Study|Lost to Follow-up|2|||
17021299|NCT00796614|38165710|FG001|Overall Study|Lost to Follow-up|2|||
17021300|NCT00796614|38165711|FG002|Overall Study|Lost to Follow-up|1|||
17021301|NCT00796614|38165712|FG003|Overall Study|Lost to Follow-up|0|||
17021302|NCT00796614|38165709|FG000|Overall Study|Withdrawal by Subject|1|||
17021303|NCT00796614|38165710|FG001|Overall Study|Withdrawal by Subject|0|||
17021304|NCT00796614|38165711|FG002|Overall Study|Withdrawal by Subject|0|||
16933949|NCT03391882|38078303|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
16933950|NCT03391882|38078304|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
16933951|NCT03391882|38078305|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
16933952|NCT03391882|38078306|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
16933953|NCT03391882|38078301|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
16933954|NCT03391882|38078302|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
16933955|NCT03391882|38078303|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
16933956|NCT03391882|38078304|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
16933957|NCT03391882|38078305|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
16933958|NCT03391882|38078306|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
16933959|NCT03391882|38078301|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16933960|NCT03391882|38078302|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
16933961|NCT03391882|38078303|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16933962|NCT03391882|38078304|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16933963|NCT03391882|38078305|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16933964|NCT03391882|38078306|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16933965|NCT03391882|38078301|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
16933966|NCT03391882|38078302|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
17021305|NCT00796614|38165712|FG003|Overall Study|Withdrawal by Subject|1|||
17021306|NCT00796614|38165709|FG000|Overall Study|Other than stated|1|||
17021307|NCT00796614|38165710|FG001|Overall Study|Other than stated|0|||
17021308|NCT00796614|38165711|FG002|Overall Study|Other than stated|0|||
17021309|NCT00796614|38165712|FG003|Overall Study|Other than stated|0|||
17021310|NCT00448747|38165724|FG000|Overall Study|collapsed veins|1|||
17021311|NCT00448747|38165725|FG001|Overall Study|collapsed veins|0|||
17021312|NCT00830180|38165741|FG000|Overall Study|Adverse Event|6|||
17021313|NCT00830180|38165741|FG000|Overall Study|Death|11|||
17021314|NCT00830180|38165741|FG000|Overall Study|Insufficient clinical response|1|||
17021315|NCT00830180|38165741|FG000|Overall Study|Withdrawal by Subject|5|||
17021316|NCT00830180|38165741|FG000|Overall Study|Progressive disease|2|||
17021317|NCT00830180|38165741|FG000|Overall Study|Other - Unspecified|1|||
17021318|NCT00863681|38165750|FG000|Overall Study|Other|2|||
17021319|NCT00863681|38165751|FG001|Overall Study|Other|0|||
17021320|NCT00863681|38165752|FG002|Overall Study|Other|0|||
17021321|NCT00863681|38165750|FG000|Overall Study|Missing|1|||
17021322|NCT00863681|38165751|FG001|Overall Study|Missing|0|||
17021323|NCT00863681|38165752|FG002|Overall Study|Missing|0|||
17102796|NCT00112437|38241466|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
17102797|NCT00112437|38241441|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102798|NCT00112437|38241442|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102799|NCT00112437|38241443|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102800|NCT00112437|38241444|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102801|NCT00112437|38241445|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102802|NCT00112437|38241446|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102803|NCT00112437|38241447|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102804|NCT00112437|38241448|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102805|NCT00112437|38241449|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
17102806|NCT00112437|38241450|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102807|NCT00112437|38241451|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102808|NCT00112437|38241452|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102809|NCT00112437|38241453|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102810|NCT00112437|38241454|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102811|NCT00112437|38241455|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102812|NCT00112437|38241456|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102813|NCT00112437|38241457|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102814|NCT00112437|38241458|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102815|NCT00112437|38241459|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102816|NCT00112437|38241460|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102817|NCT00112437|38241461|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102818|NCT00112437|38241462|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102819|NCT00112437|38241463|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102820|NCT00112437|38241464|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102821|NCT00112437|38241465|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102822|NCT00112437|38241466|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
17102823|NCT00112437|38241441|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102824|NCT00112437|38241442|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102825|NCT00112437|38241443|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102826|NCT00112437|38241444|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102827|NCT00112437|38241445|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102828|NCT00112437|38241446|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102829|NCT00112437|38241447|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102830|NCT00112437|38241448|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102831|NCT00112437|38241449|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
17102832|NCT00112437|38241450|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102833|NCT00112437|38241451|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102834|NCT00112437|38241452|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102835|NCT00112437|38241453|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102836|NCT00112437|38241454|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102837|NCT00112437|38241455|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102838|NCT00112437|38241456|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102839|NCT00112437|38241457|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
17021324|NCT00863681|38165750|FG000|Overall Study|Death|40|||
17021325|NCT00863681|38165751|FG001|Overall Study|Death|23|||
17021326|NCT00863681|38165752|FG002|Overall Study|Death|6|||
17021327|NCT00863681|38165750|FG000|Overall Study|Withdrawal by Subject|12|||
17021328|NCT00863681|38165751|FG001|Overall Study|Withdrawal by Subject|5|||
17021329|NCT00863681|38165752|FG002|Overall Study|Withdrawal by Subject|2|||
17021330|NCT00863681|38165750|FG000|Overall Study|Protocol Violation|2|||
17021331|NCT00863681|38165751|FG001|Overall Study|Protocol Violation|0|||
17021332|NCT00863681|38165752|FG002|Overall Study|Protocol Violation|0|||
17021333|NCT00863681|38165750|FG000|Overall Study|Lost to Follow-up|3|||
17021334|NCT00863681|38165751|FG001|Overall Study|Lost to Follow-up|0|||
17021335|NCT00863681|38165752|FG002|Overall Study|Lost to Follow-up|3|||
17021336|NCT00863681|38165750|FG000|Overall Study|Adverse Event|28|||
17021337|NCT00863681|38165751|FG001|Overall Study|Adverse Event|10|||
17021338|NCT00863681|38165752|FG002|Overall Study|Adverse Event|6|||
17021339|NCT00863681|38165750|FG000|Overall Study|Lack of Efficacy|2|||
17021340|NCT00863681|38165751|FG001|Overall Study|Lack of Efficacy|2|||
17021341|NCT00863681|38165752|FG002|Overall Study|Lack of Efficacy|1|||
17021342|NCT00863681|38165750|FG000|Overall Study|Non-compliance with study drug|1|||
17021343|NCT00863681|38165751|FG001|Overall Study|Non-compliance with study drug|3|||
17021344|NCT00863681|38165752|FG002|Overall Study|Non-compliance with study drug|0|||
17021345|NCT00789321|38165762|FG000|Overall Study|Adverse Event|0|||
17021346|NCT00789321|38165763|FG001|Overall Study|Adverse Event|1|||
17021347|NCT00811928|38165771|FG000|Overall Study|AEs and SAEs Including Death|7|||
17021348|NCT00811928|38165772|FG001|Overall Study|AEs and SAEs Including Death|11|||
17021349|NCT00811928|38165771|FG000|Overall Study|Withdrawal by Subject|18|||
17021350|NCT00811928|38165772|FG001|Overall Study|Withdrawal by Subject|12|||
17021351|NCT00811928|38165771|FG000|Overall Study|Did Not Take Study Drug|3|||
17021352|NCT00811928|38165772|FG001|Overall Study|Did Not Take Study Drug|0|||
17021353|NCT00811928|38165771|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
17021354|NCT00811928|38165772|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
17102840|NCT00112437|38241458|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102841|NCT00112437|38241459|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102842|NCT00112437|38241460|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102843|NCT00112437|38241461|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102844|NCT00112437|38241462|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102845|NCT00112437|38241463|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102846|NCT00112437|38241464|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102847|NCT00112437|38241465|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102848|NCT00112437|38241466|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
17102849|NCT00112437|38241441|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17021355|NCT00811928|38165771|FG000|Overall Study|Investigator Decision|2|||
17021356|NCT00811928|38165772|FG001|Overall Study|Investigator Decision|1|||
17021357|NCT00811928|38165771|FG000|Overall Study|Poor Compliance|2|||
17021358|NCT00811928|38165772|FG001|Overall Study|Poor Compliance|5|||
17021359|NCT00788775|38165780|FG000|Overall Study|Progressive Disease|8|||
17021360|NCT00788775|38165781|FG001|Overall Study|Progressive Disease|6|||
17021361|NCT00788775|38165780|FG000|Overall Study|Withdrawal by Subject|0|||
17021362|NCT00788775|38165781|FG001|Overall Study|Withdrawal by Subject|2|||
17021363|NCT00788775|38165780|FG000|Overall Study|Patient Non-Compliance|1|||
17021364|NCT00788775|38165781|FG001|Overall Study|Patient Non-Compliance|0|||
17021365|NCT00788775|38165780|FG000|Overall Study|Patient's measurable disease resected.|1|||
17021366|NCT00788775|38165781|FG001|Overall Study|Patient's measurable disease resected.|0|||
17021367|NCT00448669|38165789|FG000|Overall Study|Lost to Follow-up|52|||
17021368|NCT00448669|38165790|FG001|Overall Study|Lost to Follow-up|63|||
17021369|NCT00448669|38165789|FG000|Overall Study|Withdrawal by Subject|90|||
17021370|NCT00448669|38165790|FG001|Overall Study|Withdrawal by Subject|74|||
17021371|NCT00448669|38165789|FG000|Overall Study|Relocated|49|||
17021372|NCT00448669|38165790|FG001|Overall Study|Relocated|36|||
17021373|NCT00448669|38165789|FG000|Overall Study|Were withdrawn by investigator|10|||
17021374|NCT00448669|38165790|FG001|Overall Study|Were withdrawn by investigator|6|||
17021375|NCT00448669|38165789|FG000|Overall Study|Death|2|||
17021376|NCT00448669|38165790|FG001|Overall Study|Death|4|||
17021377|NCT00448669|38165789|FG000|Overall Study|Had other reasons|5|||
17021378|NCT00448669|38165790|FG001|Overall Study|Had other reasons|6|||
17021379|NCT00448669|38165789|FG000|Overall Study|HIV-infected at enrollment|1|||
17021380|NCT00448669|38165790|FG001|Overall Study|HIV-infected at enrollment|2|||
17102850|NCT00112437|38241442|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102851|NCT00112437|38241443|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102852|NCT00112437|38241444|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102853|NCT00112437|38241445|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102854|NCT00112437|38241446|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
17102855|NCT00112437|38241447|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
17102856|NCT00112437|38241448|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
17102857|NCT00112437|38241449|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
17102858|NCT00112437|38241450|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
17102859|NCT00112437|38241451|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102860|NCT00112437|38241452|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102861|NCT00112437|38241453|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102862|NCT00112437|38241454|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17021381|NCT00448669|38165789|FG000|Overall Study|Never started drug|9|||
17021382|NCT00448669|38165790|FG001|Overall Study|Never started drug|7|||
17021383|NCT00591734|38165798|FG000|Overall Study|Lack of Efficacy|35|||
17021384|NCT00591734|38165798|FG000|Overall Study|Adverse Event|5|||
17021385|NCT00591734|38165798|FG000|Overall Study|Physician Decision|5|||
16852657|NCT01386645|37802828|FG000|Overall Study|Withdrawal by Subject|0|||
16852658|NCT01386645|37802829|FG001|Overall Study|Withdrawal by Subject|1|||
16852659|NCT01386645|37802830|FG002|Overall Study|Withdrawal by Subject|1|||
16852660|NCT01859143|37802840|FG000|Overall Study|Lost to Follow-up|2|||
17021386|NCT00591734|38165798|FG000|Overall Study|Intercurrent Illness|8|||
17021387|NCT00788697|38165802|FG000|Overall Study|No study drug administered|12|||
17021388|NCT00788697|38165802|FG000|Overall Study|Training Patients|74|||
17021389|NCT00788697|38165802|FG000|Overall Study|no truth standard procedure available|5|||
17021390|NCT00788697|38165802|FG000|Overall Study|Technically inadequate truth standard|1|||
17021391|NCT00788697|38165802|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
17021392|NCT00848549|38165816|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
17021393|NCT00848549|38165817|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
17021394|NCT00848549|38165816|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
17021395|NCT00848549|38165817|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
17021396|NCT00848549|38165816|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
17021397|NCT00848549|38165817|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
17021398|NCT00848549|38165816|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
17021399|NCT00848549|38165817|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
17021400|NCT00848549|38165816|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
17021401|NCT00848549|38165817|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
17021402|NCT00848549|38165816|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
17021403|NCT00848549|38165817|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
17021404|NCT00848549|38165816|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
17021405|NCT00848549|38165817|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
17021406|NCT00848549|38165816|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
17021407|NCT00848549|38165817|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
17021408|NCT00848549|38165816|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
17021409|NCT00848549|38165817|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
17021410|NCT00848549|38165816|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
16933967|NCT03391882|38078303|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
16933968|NCT03391882|38078304|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
16933969|NCT03391882|38078305|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
16933970|NCT03391882|38078306|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
17021411|NCT00848549|38165817|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
17021412|NCT00848549|38165816|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
17021413|NCT00848549|38165817|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
17021414|NCT00848549|38165816|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
17021415|NCT00848549|38165817|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
17021416|NCT00848549|38165816|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
17021417|NCT00848549|38165817|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
17021418|NCT00848549|38165816|FG000|E2090-E044-314 (Extension Study)|Other|5|||
17021419|NCT00848549|38165817|FG001|E2090-E044-314 (Extension Study)|Other|6|||
16852661|NCT01859143|37802841|FG001|Overall Study|Lost to Follow-up|0|||
17021420|NCT00788151|38165827|FG000|Overall Study|Other adverse event|0|||
17102863|NCT00112437|38241455|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102864|NCT00112437|38241456|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102865|NCT00112437|38241457|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102866|NCT00112437|38241458|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102867|NCT00112437|38241459|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102868|NCT00112437|38241460|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102869|NCT00112437|38241461|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102870|NCT00112437|38241462|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102871|NCT00112437|38241463|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102872|NCT00112437|38241464|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102873|NCT00112437|38241465|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102874|NCT00112437|38241466|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
17102875|NCT00112437|38241441|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102876|NCT00112437|38241442|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102877|NCT00112437|38241443|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102878|NCT00112437|38241444|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102879|NCT00112437|38241445|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102880|NCT00112437|38241446|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102881|NCT00112437|38241447|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102882|NCT00112437|38241448|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102883|NCT00112437|38241449|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102884|NCT00112437|38241450|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
17102885|NCT00112437|38241451|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16852662|NCT01878253|37802848|FG000|Overall Study|Death|1|||
16852663|NCT01878253|37802848|FG000|Overall Study|SIdus System Removal|3|||
16852664|NCT01878253|37802848|FG000|Overall Study|Withdrawal by Subject|1|||
16852665|NCT01878253|37802848|FG000|Overall Study|Lost to Follow-up|2|||
16852666|NCT01878253|37802848|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
16852667|NCT01878175|37802857|FG000|Overall Study|Developed contraindicated health problem|2|||
16852668|NCT01878097|37802864|FG000|Baseline|Surveys not fully completed|2497|||
16852669|NCT01878097|37802865|FG001|Baseline|Surveys not fully completed|1800|||
16933971|NCT03391882|38078301|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
16933972|NCT03391882|38078302|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
16933973|NCT03391882|38078303|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
17021421|NCT00788151|38165828|FG001|Overall Study|Other adverse event|2|||
17021422|NCT00788151|38165827|FG000|Overall Study|Protocol Violation|0|||
17021423|NCT00788151|38165828|FG001|Overall Study|Protocol Violation|1|||
17021424|NCT00788151|38165827|FG000|Overall Study|Withdrawal by Subject|13|||
17021425|NCT00788151|38165828|FG001|Overall Study|Withdrawal by Subject|6|||
17021426|NCT00788151|38165827|FG000|Overall Study|Enrolled but not treated|1|||
17021427|NCT00788151|38165828|FG001|Overall Study|Enrolled but not treated|1|||
16852670|NCT01878097|37802864|FG000|Implementation Year 1|Surveys not fully completed|3202|||
16852671|NCT01878097|37802865|FG001|Implementation Year 1|Surveys not fully completed|2549|||
16852672|NCT01878097|37802864|FG000|Implementation Year 2|Surveys not fully completed|3281|||
16852673|NCT01878097|37802865|FG001|Implementation Year 2|Surveys not fully completed|2841|||
16852674|NCT01878097|37802864|FG000|Implementation Year 3|Surveys not fully completed|3494|||
17021428|NCT00788073|38165836|FG000|STX209 Then Placebo|Adverse Event|1|||
17021429|NCT00788073|38165837|FG001|STX209 Then Placebo|Adverse Event|0|||
17021430|NCT00788073|38165836|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
17021431|NCT00788073|38165837|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
17021432|NCT00788073|38165836|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
17021433|NCT00788073|38165837|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
17021434|NCT00788073|38165836|FG000|STX209 Then Placebo|unable to return due to travel|0|||
17021435|NCT00788073|38165837|FG001|STX209 Then Placebo|unable to return due to travel|1|||
17021436|NCT00788073|38165836|FG000|Placebo Then STX209|Adverse Event|2|||
17021437|NCT00788073|38165837|FG001|Placebo Then STX209|Adverse Event|0|||
17021438|NCT00788073|38165836|FG000|Placebo Then STX209|Protocol Violation|0|||
17021439|NCT00788073|38165837|FG001|Placebo Then STX209|Protocol Violation|1|||
17021440|NCT00848393|38165846|FG000|Overall Study|Protocol Violation|0|||
17021441|NCT00848393|38165847|FG001|Overall Study|Protocol Violation|0|||
16852675|NCT01878097|37802865|FG001|Implementation Year 3|Surveys not fully completed|2980|||
16852676|NCT01878097|37802864|FG000|Implementation Year 4|Surveys not fully completed|3604|||
16852677|NCT01878097|37802865|FG001|Implementation Year 4|Surveys not fully completed|3007|||
16933974|NCT03391882|38078304|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
16933975|NCT03391882|38078305|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
16933976|NCT03391882|38078306|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
16933977|NCT03391882|38078301|FG000|Part B - Treatment Phase|Adverse Event|0|||
16933978|NCT03391882|38078302|FG001|Part B - Treatment Phase|Adverse Event|0|||
16933979|NCT03391882|38078303|FG002|Part B - Treatment Phase|Adverse Event|1|||
16933980|NCT03391882|38078304|FG003|Part B - Treatment Phase|Adverse Event|1|||
16933981|NCT03391882|38078305|FG004|Part B - Treatment Phase|Adverse Event|3|||
16933982|NCT03391882|38078306|FG005|Part B - Treatment Phase|Adverse Event|1|||
16933983|NCT03391882|38078301|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
16933984|NCT03391882|38078302|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
16933985|NCT03391882|38078303|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
16933986|NCT03391882|38078304|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
16933987|NCT03391882|38078305|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
16933988|NCT03391882|38078306|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
16933989|NCT01261000|38078316|FG000|Overall Study|Screen failure|1|||
16933990|NCT01234402|38078349|FG000|Overall Study|Lost to Follow-up|0|||
16933991|NCT01234402|38078350|FG001|Overall Study|Lost to Follow-up|1|||
16933992|NCT01234402|38078351|FG002|Overall Study|Lost to Follow-up|3|||
16933993|NCT01234402|38078349|FG000|Overall Study|Withdrawal by Subject|1|||
16933994|NCT01234402|38078350|FG001|Overall Study|Withdrawal by Subject|3|||
16933995|NCT01234402|38078351|FG002|Overall Study|Withdrawal by Subject|4|||
16933996|NCT01234402|38078349|FG000|Overall Study|Never treated: Death|0|||
16933997|NCT01234402|38078350|FG001|Overall Study|Never treated: Death|0|||
16933998|NCT01234402|38078351|FG002|Overall Study|Never treated: Death|1|||
16933999|NCT01234402|38078349|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
16934000|NCT01234402|38078350|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
16934001|NCT01234402|38078351|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
16934002|NCT01234402|38078349|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
16934003|NCT01234402|38078350|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
16934004|NCT01234402|38078351|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
16934005|NCT01260922|38078363|FG000|First Intervention|Withdrawal by Subject|0|||
16934006|NCT01260922|38078364|FG001|First Intervention|Withdrawal by Subject|1|||
16934007|NCT01260922|38078363|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
16934008|NCT01260922|38078364|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
16934009|NCT01260922|38078363|FG000|Second Intervention|Emesis|0|||
16934010|NCT01260922|38078364|FG001|Second Intervention|Emesis|2|||
16934011|NCT01233817|38078370|FG000|Overall Study|Lost to Follow-up|1|||
16934012|NCT01233817|38078370|FG000|Overall Study|Withdrawal by Subject|2|||
16934013|NCT01233232|38078377|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
16934014|NCT01233232|38078378|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
17021442|NCT00848393|38165848|FG002|Overall Study|Protocol Violation|1|||
17021443|NCT00848393|38165846|FG000|Overall Study|surgical complications unrelated to stud|0|||
17021444|NCT00848393|38165847|FG001|Overall Study|surgical complications unrelated to stud|0|||
17021445|NCT00848393|38165848|FG002|Overall Study|surgical complications unrelated to stud|2|||
17021446|NCT00815516|38165862|FG000|Overall Study|Death|3|||
17021447|NCT00815516|38165863|FG001|Overall Study|Death|1|||
17021448|NCT00815516|38165862|FG000|Overall Study|Physician Decision|1|||
17021449|NCT00815516|38165863|FG001|Overall Study|Physician Decision|0|||
17021450|NCT00787917|38165871|FG000|Blinded Treatment|Adverse Event|1|||
17021451|NCT00787917|38165872|FG001|Blinded Treatment|Adverse Event|0|||
17021452|NCT00787917|38165871|FG000|Blinded Treatment|Lack of Efficacy|1|||
17021453|NCT00787917|38165872|FG001|Blinded Treatment|Lack of Efficacy|0|||
17021454|NCT00787917|38165871|FG000|Blinded Treatment|Administrative problems|3|||
17021455|NCT00787917|38165872|FG001|Blinded Treatment|Administrative problems|2|||
17021456|NCT00787917|38165871|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
17021457|NCT00787917|38165872|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
17021458|NCT00787917|38165871|FG000|Open Label|Administrative problems|3|||
17021459|NCT00787917|38165872|FG001|Open Label|Administrative problems|0|||
17021460|NCT00814892|38165880|FG000|Overall Study|Disease Progression|1|||
17021461|NCT00814892|38165880|FG000|Overall Study|Study Termination|1|||
17021462|NCT00787839|38165884|FG000|Overall Study|Failure to have the OGTT was most common|404|||
17021463|NCT00829244|38165907|FG000|Overall Study|Adverse Event|1|||
17021464|NCT00829244|38165908|FG001|Overall Study|Adverse Event|3|||
17021465|NCT00829244|38165907|FG000|Overall Study|Protocol Violation|1|||
17021466|NCT00829244|38165908|FG001|Overall Study|Protocol Violation|0|||
17021467|NCT00829244|38165907|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
17021468|NCT00829244|38165908|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
17021469|NCT00829244|38165907|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
17021470|NCT00829244|38165908|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
17021471|NCT00829244|38165907|FG000|Overall Study|No fertilization|2|||
17021472|NCT00829244|38165908|FG001|Overall Study|No fertilization|2|||
17021473|NCT00829244|38165907|FG000|Overall Study|All embryos discarded|0|||
17021474|NCT00829244|38165908|FG001|Overall Study|All embryos discarded|3|||
17021475|NCT00829244|38165907|FG000|Overall Study|No embryo cleavage|0|||
17021476|NCT00829244|38165908|FG001|Overall Study|No embryo cleavage|2|||
17021477|NCT00787605|38165916|FG000|Overall Study|Administrative Problems|3|||
17021478|NCT00787605|38165917|FG001|Overall Study|Administrative Problems|0|||
17021479|NCT00787605|38165916|FG000|Overall Study|Adverse Event|14|||
17021480|NCT00787605|38165917|FG001|Overall Study|Adverse Event|25|||
17021481|NCT00787605|38165916|FG000|Overall Study|Lost to Follow-up|3|||
17021482|NCT00787605|38165917|FG001|Overall Study|Lost to Follow-up|6|||
16934015|NCT01233232|38078379|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
16934016|NCT01233076|38078389|FG000|Period 2, One Week|Lost to Follow-up|1|||
16934017|NCT01233076|38078390|FG001|Period 2, One Week|Lost to Follow-up|0|||
16934018|NCT01212094|38078399|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
16934019|NCT01212094|38078400|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
16934020|NCT01212094|38078401|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
16934021|NCT01212094|38078399|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
16934022|NCT01212094|38078400|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
16934023|NCT01212094|38078401|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
16934024|NCT01212094|38078399|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
16934025|NCT01212094|38078400|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
16934026|NCT01212094|38078401|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
17021483|NCT00787605|38165916|FG000|Overall Study|Protocol Violation|7|||
17021484|NCT00787605|38165917|FG001|Overall Study|Protocol Violation|3|||
17021485|NCT00787605|38165916|FG000|Overall Study|Withdrawal by Subject|6|||
17021486|NCT00787605|38165917|FG001|Overall Study|Withdrawal by Subject|13|||
17021487|NCT00787605|38165916|FG000|Overall Study|Lack of Efficacy|13|||
17021488|NCT00787605|38165917|FG001|Overall Study|Lack of Efficacy|9|||
17021489|NCT00448591|38165923|FG000|Overall Study|Withdrawal by Subject|178|||
17021490|NCT00448591|38165923|FG000|Overall Study|Progressive Disease|1382|||
17021491|NCT00448591|38165923|FG000|Overall Study|Adverse Event|382|||
17021492|NCT00448591|38165923|FG000|Overall Study|Protocol Violation|41|||
17021493|NCT00448591|38165923|FG000|Overall Study|Lost to Follow-up|19|||
17021494|NCT00448591|38165923|FG000|Overall Study|Treatment Regimen Completed|70|||
17021495|NCT00448591|38165923|FG000|Overall Study|Other|154|||
17021496|NCT00448591|38165923|FG000|Overall Study|Termination of Study|70|||
17021497|NCT00651664|38165939|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
17021498|NCT00651664|38165940|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
17021499|NCT00651664|38165941|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
17021500|NCT00651664|38165942|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
17021501|NCT00651664|38165943|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
17021502|NCT00651664|38165944|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
17021503|NCT00651664|38165945|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
17021504|NCT00651664|38165946|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
17021505|NCT00651664|38165947|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
17021506|NCT00651664|38165948|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
17021507|NCT00651664|38165939|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
17021508|NCT00651664|38165940|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
17021509|NCT00651664|38165941|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
17021510|NCT00651664|38165942|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
17021511|NCT00651664|38165943|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
17021512|NCT00651664|38165944|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
17021513|NCT00651664|38165945|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
17021514|NCT00651664|38165946|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
17021515|NCT00651664|38165947|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
17021516|NCT00651664|38165948|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
17021517|NCT00651664|38165939|FG000|Overall Study|Progressive Disease|3|||
17021518|NCT00651664|38165940|FG001|Overall Study|Progressive Disease|3|||
17021519|NCT00651664|38165941|FG002|Overall Study|Progressive Disease|3|||
17021520|NCT00651664|38165942|FG003|Overall Study|Progressive Disease|12|||
17021521|NCT00651664|38165943|FG004|Overall Study|Progressive Disease|4|||
17021522|NCT00651664|38165944|FG005|Overall Study|Progressive Disease|1|||
17021523|NCT00651664|38165945|FG006|Overall Study|Progressive Disease|3|||
17021524|NCT00651664|38165946|FG007|Overall Study|Progressive Disease|6|||
17021525|NCT00651664|38165947|FG008|Overall Study|Progressive Disease|5|||
17021526|NCT00651664|38165948|FG009|Overall Study|Progressive Disease|5|||
17021527|NCT00651664|38165939|FG000|Overall Study|Patient Declined Further Treatment|0|||
17021528|NCT00651664|38165940|FG001|Overall Study|Patient Declined Further Treatment|0|||
17021529|NCT00651664|38165941|FG002|Overall Study|Patient Declined Further Treatment|0|||
17021530|NCT00651664|38165942|FG003|Overall Study|Patient Declined Further Treatment|1|||
17021531|NCT00651664|38165943|FG004|Overall Study|Patient Declined Further Treatment|1|||
17021532|NCT00651664|38165944|FG005|Overall Study|Patient Declined Further Treatment|1|||
17021533|NCT00651664|38165945|FG006|Overall Study|Patient Declined Further Treatment|0|||
17021534|NCT00651664|38165946|FG007|Overall Study|Patient Declined Further Treatment|0|||
17021535|NCT00651664|38165947|FG008|Overall Study|Patient Declined Further Treatment|0|||
17021536|NCT00651664|38165948|FG009|Overall Study|Patient Declined Further Treatment|1|||
17021537|NCT00651664|38165939|FG000|Overall Study|Symptomatic Deterioration|0|||
17021538|NCT00651664|38165940|FG001|Overall Study|Symptomatic Deterioration|0|||
17021539|NCT00651664|38165941|FG002|Overall Study|Symptomatic Deterioration|0|||
17021540|NCT00651664|38165942|FG003|Overall Study|Symptomatic Deterioration|1|||
17021541|NCT00651664|38165943|FG004|Overall Study|Symptomatic Deterioration|0|||
17021542|NCT00651664|38165944|FG005|Overall Study|Symptomatic Deterioration|0|||
16934027|NCT01212094|38078399|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
16934028|NCT01212094|38078400|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
16934029|NCT01212094|38078401|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
16934030|NCT01212094|38078399|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
16934031|NCT01212094|38078400|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
16934032|NCT01212094|38078401|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
16934033|NCT01212094|38078399|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
16934034|NCT01212094|38078400|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
16934035|NCT01212094|38078401|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
16934036|NCT01232569|38078410|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
17021543|NCT00651664|38165945|FG006|Overall Study|Symptomatic Deterioration|1|||
17021544|NCT00651664|38165946|FG007|Overall Study|Symptomatic Deterioration|0|||
17021545|NCT00651664|38165947|FG008|Overall Study|Symptomatic Deterioration|1|||
17021546|NCT00651664|38165948|FG009|Overall Study|Symptomatic Deterioration|0|||
17021547|NCT00651664|38165939|FG000|Overall Study|Reason not Specified|0|||
17021548|NCT00651664|38165940|FG001|Overall Study|Reason not Specified|0|||
17021549|NCT00651664|38165941|FG002|Overall Study|Reason not Specified|0|||
17021550|NCT00651664|38165942|FG003|Overall Study|Reason not Specified|0|||
17021551|NCT00651664|38165943|FG004|Overall Study|Reason not Specified|0|||
17021552|NCT00651664|38165944|FG005|Overall Study|Reason not Specified|0|||
17021553|NCT00651664|38165945|FG006|Overall Study|Reason not Specified|1|||
17021554|NCT00651664|38165946|FG007|Overall Study|Reason not Specified|0|||
16852678|NCT01750190|37802873|FG000|Overall Study|Adverse Event|47|||
16852679|NCT01750190|37802874|FG001|Overall Study|Adverse Event|19|||
16852680|NCT01750190|37802873|FG000|Overall Study|Death|38|||
16852681|NCT01750190|37802874|FG001|Overall Study|Death|11|||
16852682|NCT01750190|37802873|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
16852683|NCT01750190|37802874|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
16852684|NCT01750190|37802873|FG000|Overall Study|Lost to Follow-up|28|||
16852685|NCT01750190|37802874|FG001|Overall Study|Lost to Follow-up|7|||
16852686|NCT01750190|37802873|FG000|Overall Study|Physician Decision|16|||
16852687|NCT01750190|37802874|FG001|Overall Study|Physician Decision|17|||
17021555|NCT00651664|38165947|FG008|Overall Study|Reason not Specified|0|||
16852688|NCT01750190|37802873|FG000|Overall Study|Protocol Violation|6|||
16934037|NCT01232569|38078411|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
16934038|NCT01232569|38078412|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
17021556|NCT00651664|38165948|FG009|Overall Study|Reason not Specified|0|||
17021557|NCT00787527|38165974|FG000|Overall Study|Toxicity|3|||
17021558|NCT00787137|38165985|FG000|Overall Study|Study Termination|0|||
17021559|NCT00787137|38165986|FG001|Overall Study|Study Termination|0|||
17021560|NCT00787137|38165987|FG002|Overall Study|Study Termination|1|||
17021561|NCT00448435|38165995|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
17021562|NCT00448435|38165996|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
17021563|NCT00448279|38166007|FG000|Overall Study|Lost to Follow-up|2|||
16934039|NCT01232569|38078413|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
16934040|NCT01232569|38078410|FG000|Double-blind Treatment Period|Escape|2|||
16934041|NCT01232569|38078411|FG001|Double-blind Treatment Period|Escape|2|||
16934042|NCT01232569|38078412|FG002|Double-blind Treatment Period|Escape|0|||
17021564|NCT00448279|38166008|FG001|Overall Study|Lost to Follow-up|2|||
17021565|NCT00448279|38166007|FG000|Overall Study|Adverse Event|1|||
17021566|NCT00448279|38166008|FG001|Overall Study|Adverse Event|1|||
17021567|NCT00448279|38166007|FG000|Overall Study|Disease progression|16|||
17021568|NCT00448279|38166008|FG001|Overall Study|Disease progression|18|||
17021569|NCT00448279|38166007|FG000|Overall Study|Withdrawal by Subject|4|||
17021570|NCT00448279|38166008|FG001|Overall Study|Withdrawal by Subject|3|||
17021571|NCT00448279|38166007|FG000|Overall Study|Other|6|||
17021572|NCT00448279|38166008|FG001|Overall Study|Other|4|||
17021573|NCT00448279|38166007|FG000|Overall Study|Protocol Violation|0|||
17021574|NCT00448279|38166008|FG001|Overall Study|Protocol Violation|1|||
17021575|NCT00448123|38166016|FG000|Overall Study|Lost to Follow-up|9|||
17021576|NCT00448123|38166017|FG001|Overall Study|Lost to Follow-up|6|||
17021577|NCT00448123|38166016|FG000|Overall Study|Physician Decision|6|||
17021578|NCT00448123|38166017|FG001|Overall Study|Physician Decision|6|||
17021579|NCT00447499|38166026|FG000|Overall Study|Adverse Event|1|||
17021580|NCT00447499|38166026|FG000|Overall Study|Patient Decision|4|||
17021581|NCT00447499|38166026|FG000|Overall Study|Sponsor Decision|1|||
17021582|NCT00447499|38166026|FG000|Overall Study|Physician Decision|1|||
17021583|NCT00800436|38166039|FG000|Overall Study|Withdrawal by Subject|0|||
17021584|NCT00800436|38166040|FG001|Overall Study|Withdrawal by Subject|0|||
17021585|NCT00800436|38166041|FG002|Overall Study|Withdrawal by Subject|1|||
17021586|NCT00800436|38166042|FG003|Overall Study|Withdrawal by Subject|1|||
17021587|NCT00800436|38166043|FG004|Overall Study|Withdrawal by Subject|0|||
17021588|NCT00800436|38166044|FG005|Overall Study|Withdrawal by Subject|0|||
17021589|NCT00800436|38166045|FG006|Overall Study|Withdrawal by Subject|0|||
17021590|NCT00655564|38166061|FG000|Overall Study|Adverse Event|1|||
17021591|NCT00655564|38166061|FG000|Overall Study|Lost to Follow-up|1|||
17021592|NCT00655564|38166061|FG000|Overall Study|Desired Alternate Therapy|1|||
16934043|NCT01232569|38078413|FG003|Double-blind Treatment Period|Escape|0|||
16934044|NCT01232569|38078410|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
16934045|NCT01232569|38078411|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
16934046|NCT01232569|38078412|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
16934047|NCT01232569|38078413|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
16934048|NCT01232569|38078410|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
16934049|NCT01232569|38078411|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
16934050|NCT01232569|38078412|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
16934051|NCT01232569|38078413|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
16934052|NCT01232569|38078410|FG000|Double-blind Treatment Period|Physician Decision|1|||
16934053|NCT01232569|38078411|FG001|Double-blind Treatment Period|Physician Decision|0|||
16934054|NCT01232569|38078412|FG002|Double-blind Treatment Period|Physician Decision|0|||
16934055|NCT01232569|38078413|FG003|Double-blind Treatment Period|Physician Decision|0|||
16934056|NCT01232569|38078410|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
16934057|NCT01232569|38078411|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
16934058|NCT01232569|38078412|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
16934059|NCT01232569|38078413|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
16934060|NCT01232569|38078410|FG000|Double-blind Treatment Period|Death|2|||
16934061|NCT01232569|38078411|FG001|Double-blind Treatment Period|Death|0|||
16934062|NCT01232569|38078412|FG002|Double-blind Treatment Period|Death|0|||
16934063|NCT01232569|38078413|FG003|Double-blind Treatment Period|Death|0|||
16934064|NCT01211665|38078424|FG000|Overall Study|Withdrawal by Subject|1|||
16934065|NCT01211665|38078425|FG001|Overall Study|Withdrawal by Subject|0|||
16934066|NCT01211665|38078424|FG000|Overall Study|Death|1|||
16934067|NCT01211665|38078425|FG001|Overall Study|Death|0|||
16934068|NCT01232491|38078433|FG000|Overall Study|Adverse Event|13|||
17021593|NCT00447421|38166066|FG000|Overall Study|Lack of Efficacy|1|||
17021594|NCT00447421|38166066|FG000|Overall Study|Adverse Event|3|||
17021595|NCT00447421|38166066|FG000|Overall Study|Sponsor Decision|2|||
16934069|NCT01232491|38078434|FG001|Overall Study|Adverse Event|8|||
16934070|NCT01232491|38078433|FG000|Overall Study|Lack of Efficacy|1|||
16934071|NCT01232491|38078434|FG001|Overall Study|Lack of Efficacy|5|||
17021596|NCT00651118|38166074|FG000|Overall Study|Adverse Event|4|||
16934072|NCT01232491|38078433|FG000|Overall Study|Protocol Violation|13|||
16934073|NCT01232491|38078434|FG001|Overall Study|Protocol Violation|11|||
16934074|NCT01232491|38078433|FG000|Overall Study|Withdrawal Criteria|12|||
16934075|NCT01232491|38078434|FG001|Overall Study|Withdrawal Criteria|21|||
16934076|NCT01232491|38078433|FG000|Overall Study|Other|21|||
16934077|NCT01232491|38078434|FG001|Overall Study|Other|18|||
16934078|NCT01232452|38078442|FG000|Overall Study|Adverse Event|17|||
16934079|NCT01232452|38078443|FG001|Overall Study|Adverse Event|15|||
16934080|NCT01232452|38078442|FG000|Overall Study|Withdrawal by Subject|11|||
16934081|NCT01232452|38078443|FG001|Overall Study|Withdrawal by Subject|8|||
17021597|NCT00651118|38166075|FG001|Overall Study|Adverse Event|0|||
17021598|NCT00651118|38166076|FG002|Overall Study|Adverse Event|1|||
17021599|NCT00651118|38166077|FG003|Overall Study|Adverse Event|1|||
17021600|NCT00651118|38166074|FG000|Overall Study|Protocol Violation|2|||
17021601|NCT00651118|38166075|FG001|Overall Study|Protocol Violation|2|||
17021602|NCT00651118|38166076|FG002|Overall Study|Protocol Violation|6|||
17021603|NCT00651118|38166077|FG003|Overall Study|Protocol Violation|2|||
17021604|NCT00651118|38166074|FG000|Overall Study|Lost to Follow-up|2|||
17021605|NCT00651118|38166075|FG001|Overall Study|Lost to Follow-up|0|||
17021606|NCT00651118|38166076|FG002|Overall Study|Lost to Follow-up|1|||
17021607|NCT00651118|38166077|FG003|Overall Study|Lost to Follow-up|2|||
17021608|NCT00651118|38166074|FG000|Overall Study|administrative|1|||
17021609|NCT00651118|38166075|FG001|Overall Study|administrative|4|||
17021610|NCT00651118|38166076|FG002|Overall Study|administrative|2|||
17021611|NCT00651118|38166077|FG003|Overall Study|administrative|1|||
17021612|NCT00651118|38166074|FG000|Overall Study|Withdrawal by Subject|0|||
17021613|NCT00651118|38166075|FG001|Overall Study|Withdrawal by Subject|1|||
17021614|NCT00651118|38166076|FG002|Overall Study|Withdrawal by Subject|1|||
17021615|NCT00651118|38166077|FG003|Overall Study|Withdrawal by Subject|1|||
17021616|NCT00447265|38166090|FG000|Overall Study|Physician Decision|1|||
17021617|NCT00447265|38166091|FG001|Overall Study|Physician Decision|0|||
17021618|NCT00657358|38166095|FG000|Overall Study|Lack of Efficacy|6|||
17021619|NCT00457639|38166100|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
17021620|NCT00457639|38166101|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
17021621|NCT00457639|38166100|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
17021622|NCT00457639|38166101|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
17021623|NCT00457639|38166100|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
17021624|NCT00457639|38166101|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
17021625|NCT00800202|38166109|FG000|Overall Study|Adverse Event|7|||
17021626|NCT00800202|38166110|FG001|Overall Study|Adverse Event|6|||
17021627|NCT00800202|38166109|FG000|Overall Study|Death|1|||
17021628|NCT00800202|38166110|FG001|Overall Study|Death|0|||
17021629|NCT00800202|38166109|FG000|Overall Study|Other|5|||
17021630|NCT00800202|38166110|FG001|Overall Study|Other|0|||
17021631|NCT00800202|38166109|FG000|Overall Study|Disease Progression|54|||
17021632|NCT00800202|38166110|FG001|Overall Study|Disease Progression|18|||
17021633|NCT00655486|38166116|FG000|Overall Study|Adverse Event|10|||
17021634|NCT00655486|38166116|FG000|Overall Study|Lack of Efficacy|8|||
17021635|NCT00655486|38166116|FG000|Overall Study|Withdrawal by Subject|4|||
17021636|NCT00655486|38166116|FG000|Overall Study|Protocol Violation|1|||
17021637|NCT00655486|38166116|FG000|Overall Study|Unsatisfactory compliance|2|||
17021638|NCT00655486|38166116|FG000|Overall Study|Other: Pregnancy|1|||
17021639|NCT00655486|38166116|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
17021640|NCT00655486|38166116|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
17021641|NCT00457249|38166122|FG000|Overall Study|Lost to Follow-up|3|||
17021642|NCT00457249|38166123|FG001|Overall Study|Lost to Follow-up|0|||
17021643|NCT00457249|38166122|FG000|Overall Study|Protocol Violation|4|||
17021644|NCT00457249|38166123|FG001|Overall Study|Protocol Violation|1|||
17021645|NCT00457249|38166122|FG000|Overall Study|Withdrawal by Subject|3|||
17021646|NCT00457249|38166123|FG001|Overall Study|Withdrawal by Subject|1|||
17021647|NCT00457249|38166122|FG000|Overall Study|Serious Adverse Events|2|||
17021648|NCT00457249|38166123|FG001|Overall Study|Serious Adverse Events|0|||
17021649|NCT00457015|38166133|FG000|Overall Study|Left study site against medical advice|0|||
17021650|NCT00457015|38166134|FG001|Overall Study|Left study site against medical advice|1|||
17021651|NCT00654940|38166142|FG000|Period 1|Adverse Event|0|||
17021652|NCT00654940|38166143|FG001|Period 1|Adverse Event|1|||
17021653|NCT00654940|38166142|FG000|Period 1|Intolerable Pain Level|1|||
17021654|NCT00654940|38166143|FG001|Period 1|Intolerable Pain Level|0|||
17021655|NCT00588666|38166155|FG000|Overall Study|Adverse Event|4|||
17021656|NCT00793182|38166170|FG000|Overall Study|Adverse Event|0|||
17021657|NCT00793182|38166171|FG001|Overall Study|Adverse Event|1|||
17021658|NCT00793104|38166177|FG000|Overall Study|Lost to Follow-up|1|||
17021659|NCT00446797|38166183|FG000|Overall Study|Lack of Efficacy|0|||
17021660|NCT00446797|38166184|FG001|Overall Study|Lack of Efficacy|2|||
17021661|NCT00446797|38166183|FG000|Overall Study|Lost to Follow-up|5|||
17021662|NCT00446797|38166184|FG001|Overall Study|Lost to Follow-up|3|||
16934082|NCT01232452|38078442|FG000|Overall Study|Physician Decision|8|||
16934083|NCT01232452|38078443|FG001|Overall Study|Physician Decision|12|||
17021663|NCT00446797|38166183|FG000|Overall Study|Withdrawal by Subject|2|||
17021664|NCT00446797|38166184|FG001|Overall Study|Withdrawal by Subject|2|||
17021665|NCT00446797|38166183|FG000|Overall Study|Protocol Violation|1|||
17021666|NCT00446797|38166184|FG001|Overall Study|Protocol Violation|3|||
17021667|NCT00446797|38166183|FG000|Overall Study|subject entered at another site|0|||
17021668|NCT00446797|38166184|FG001|Overall Study|subject entered at another site|1|||
17021669|NCT00446797|38166183|FG000|Overall Study|did not meet entrance criteria|0|||
17021670|NCT00446797|38166184|FG001|Overall Study|did not meet entrance criteria|1|||
17021671|NCT00855335|38166195|FG000|Overall Study|Lost to Follow-up|0|||
17021672|NCT00855335|38166196|FG001|Overall Study|Lost to Follow-up|0|||
17021673|NCT00855335|38166197|FG002|Overall Study|Lost to Follow-up|3|||
17021674|NCT00855335|38166198|FG003|Overall Study|Lost to Follow-up|1|||
17021675|NCT00855335|38166199|FG004|Overall Study|Lost to Follow-up|0|||
17021676|NCT00855335|38166195|FG000|Overall Study|Withdrawal by Subject|0|||
17021677|NCT00855335|38166196|FG001|Overall Study|Withdrawal by Subject|0|||
17021678|NCT00855335|38166197|FG002|Overall Study|Withdrawal by Subject|0|||
17021679|NCT00855335|38166198|FG003|Overall Study|Withdrawal by Subject|1|||
17021680|NCT00855335|38166199|FG004|Overall Study|Withdrawal by Subject|0|||
17021681|NCT00855335|38166195|FG000|Overall Study|Adverse Event|2|||
17021682|NCT00855335|38166196|FG001|Overall Study|Adverse Event|0|||
17021683|NCT00855335|38166197|FG002|Overall Study|Adverse Event|0|||
17021684|NCT00855335|38166198|FG003|Overall Study|Adverse Event|0|||
17021685|NCT00855335|38166199|FG004|Overall Study|Adverse Event|0|||
17021686|NCT00855335|38166195|FG000|Overall Study|Physician Decision|1|||
17021687|NCT00855335|38166196|FG001|Overall Study|Physician Decision|1|||
17021688|NCT00855335|38166197|FG002|Overall Study|Physician Decision|0|||
17021689|NCT00855335|38166198|FG003|Overall Study|Physician Decision|0|||
17021690|NCT00855335|38166199|FG004|Overall Study|Physician Decision|0|||
17021691|NCT00855335|38166195|FG000|Overall Study|Other|2|||
17021692|NCT00855335|38166196|FG001|Overall Study|Other|1|||
17021693|NCT00855335|38166197|FG002|Overall Study|Other|2|||
17021694|NCT00855335|38166198|FG003|Overall Study|Other|5|||
17021695|NCT00855335|38166199|FG004|Overall Study|Other|1|||
16934084|NCT01232452|38078442|FG000|Overall Study|Protocol entry criterion not met|0|||
16934085|NCT01232452|38078443|FG001|Overall Study|Protocol entry criterion not met|2|||
17021696|NCT00799422|38166224|FG000|First Week of Wear|Lost to Follow-up|0|||
16934086|NCT01232452|38078442|FG000|Overall Study|Sponsor Decision|3|||
16934087|NCT01232452|38078443|FG001|Overall Study|Sponsor Decision|1|||
16934088|NCT01232452|38078442|FG000|Overall Study|Protocol Violation|0|||
16934089|NCT01232452|38078443|FG001|Overall Study|Protocol Violation|1|||
16934090|NCT01211197|38078449|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16934091|NCT01211197|38078450|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
17021697|NCT00799422|38166225|FG001|First Week of Wear|Lost to Follow-up|0|||
17021698|NCT00799422|38166226|FG002|First Week of Wear|Lost to Follow-up|1|||
17021699|NCT00799422|38166227|FG003|First Week of Wear|Lost to Follow-up|0|||
17021700|NCT00799422|38166228|FG004|First Week of Wear|Lost to Follow-up|0|||
17021701|NCT00799422|38166229|FG005|First Week of Wear|Lost to Follow-up|0|||
17021702|NCT00799422|38166224|FG000|First Week of Wear|Adverse Event|0|||
17021703|NCT00799422|38166225|FG001|First Week of Wear|Adverse Event|0|||
17021704|NCT00799422|38166226|FG002|First Week of Wear|Adverse Event|0|||
17021705|NCT00799422|38166227|FG003|First Week of Wear|Adverse Event|1|||
17021706|NCT00799422|38166228|FG004|First Week of Wear|Adverse Event|0|||
17021707|NCT00799422|38166229|FG005|First Week of Wear|Adverse Event|0|||
17021708|NCT00593489|38166239|FG000|Allocation|did not attend workshop; allocation not|2|||
17021709|NCT00593489|38166240|FG001|Allocation|did not attend workshop; allocation not|1|||
17021710|NCT00446641|38166250|FG000|Overall Study|Withdrawal by Subject|8|||
17021711|NCT00446641|38166251|FG001|Overall Study|Withdrawal by Subject|3|||
17021712|NCT00446641|38166250|FG000|Overall Study|poor compliance|8|||
17021713|NCT00446641|38166251|FG001|Overall Study|poor compliance|6|||
17021714|NCT00446641|38166250|FG000|Overall Study|Lost to Follow-up|1|||
17021715|NCT00446641|38166251|FG001|Overall Study|Lost to Follow-up|1|||
17021716|NCT00646282|38166259|FG000|Overall Study|Protocol terminated|4|||
16934092|NCT01211197|38078451|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16934093|NCT01211197|38078452|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
17021717|NCT00646282|38166260|FG001|Overall Study|Protocol terminated|4|||
17021718|NCT00792636|38166269|FG000|Overall Study|Protocol Violation|17|||
17021719|NCT00792636|38166270|FG001|Overall Study|Protocol Violation|23|||
17021720|NCT00792636|38166271|FG002|Overall Study|Protocol Violation|20|||
17021721|NCT00792636|38166269|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
17021722|NCT00792636|38166270|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
17021723|NCT00792636|38166271|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
17021724|NCT00792636|38166269|FG000|Overall Study|Lost to Follow-up|13|||
17021725|NCT00792636|38166270|FG001|Overall Study|Lost to Follow-up|19|||
17021726|NCT00792636|38166271|FG002|Overall Study|Lost to Follow-up|14|||
17021727|NCT00792636|38166269|FG000|Overall Study|Withdrew Consent|10|||
17021728|NCT00792636|38166270|FG001|Overall Study|Withdrew Consent|13|||
17021729|NCT00792636|38166271|FG002|Overall Study|Withdrew Consent|9|||
16934094|NCT01211197|38078453|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
17021730|NCT00792636|38166269|FG000|Overall Study|Lack of Efficacy|3|||
17021731|NCT00792636|38166270|FG001|Overall Study|Lack of Efficacy|4|||
17021732|NCT00792636|38166271|FG002|Overall Study|Lack of Efficacy|13|||
17021733|NCT00792636|38166269|FG000|Overall Study|Adverse Event|4|||
17021734|NCT00792636|38166270|FG001|Overall Study|Adverse Event|2|||
17021735|NCT00792636|38166271|FG002|Overall Study|Adverse Event|3|||
17021736|NCT00792636|38166269|FG000|Overall Study|Investigator Discretion|2|||
17021737|NCT00792636|38166270|FG001|Overall Study|Investigator Discretion|0|||
17021738|NCT00792636|38166271|FG002|Overall Study|Investigator Discretion|2|||
17021739|NCT00446563|38166283|FG000|Overall Study|Adverse Event|4|||
17021740|NCT00446563|38166284|FG001|Overall Study|Adverse Event|3|||
17021741|NCT00446563|38166283|FG000|Overall Study|Abnormal laboratory value(s)|0|||
17021742|NCT00446563|38166284|FG001|Overall Study|Abnormal laboratory value(s)|1|||
17021743|NCT00446563|38166283|FG000|Overall Study|Abnormal test procedure result(s)|1|||
17021744|NCT00446563|38166284|FG001|Overall Study|Abnormal test procedure result(s)|0|||
17021745|NCT00446563|38166283|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
17021746|NCT00446563|38166284|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
17021747|NCT00446563|38166283|FG000|Overall Study|Withdrawal by Subject|2|||
17021748|NCT00446563|38166284|FG001|Overall Study|Withdrawal by Subject|1|||
17021749|NCT00446563|38166283|FG000|Overall Study|Administrative problems|0|||
17102886|NCT00112437|38241452|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102887|NCT00112437|38241453|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102888|NCT00112437|38241454|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102889|NCT00112437|38241455|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102890|NCT00112437|38241456|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102891|NCT00112437|38241457|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102892|NCT00112437|38241458|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102893|NCT00112437|38241459|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17021750|NCT00446563|38166284|FG001|Overall Study|Administrative problems|1|||
17021751|NCT00650806|38166294|FG000|Overall Study|Adverse Event|0|||
17021752|NCT00650806|38166295|FG001|Overall Study|Adverse Event|5|||
17021753|NCT00650806|38166296|FG002|Overall Study|Adverse Event|3|||
17021754|NCT00650806|38166297|FG003|Overall Study|Adverse Event|4|||
17021755|NCT00650806|38166294|FG000|Overall Study|Lost to Follow-up|7|||
17021756|NCT00650806|38166295|FG001|Overall Study|Lost to Follow-up|6|||
17021757|NCT00650806|38166296|FG002|Overall Study|Lost to Follow-up|11|||
17021758|NCT00650806|38166297|FG003|Overall Study|Lost to Follow-up|10|||
17021759|NCT00650806|38166294|FG000|Overall Study|Protocol Violation|0|||
17021760|NCT00650806|38166295|FG001|Overall Study|Protocol Violation|0|||
17021761|NCT00650806|38166296|FG002|Overall Study|Protocol Violation|0|||
17021762|NCT00650806|38166297|FG003|Overall Study|Protocol Violation|1|||
17021763|NCT00650806|38166294|FG000|Overall Study|Pregnancy|0|||
17021764|NCT00650806|38166295|FG001|Overall Study|Pregnancy|0|||
17021765|NCT00650806|38166296|FG002|Overall Study|Pregnancy|0|||
17021766|NCT00650806|38166297|FG003|Overall Study|Pregnancy|1|||
17021767|NCT00650806|38166294|FG000|Overall Study|Withdrawal by Subject|7|||
17021768|NCT00650806|38166295|FG001|Overall Study|Withdrawal by Subject|5|||
17021769|NCT00650806|38166296|FG002|Overall Study|Withdrawal by Subject|8|||
17021770|NCT00650806|38166297|FG003|Overall Study|Withdrawal by Subject|6|||
17021771|NCT00650806|38166294|FG000|Overall Study|Noncompliance with study drug regimen|1|||
17021772|NCT00650806|38166295|FG001|Overall Study|Noncompliance with study drug regimen|1|||
17021773|NCT00650806|38166296|FG002|Overall Study|Noncompliance with study drug regimen|0|||
17102894|NCT00112437|38241460|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102895|NCT00112437|38241461|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17021774|NCT00650806|38166297|FG003|Overall Study|Noncompliance with study drug regimen|0|||
17021775|NCT00650806|38166294|FG000|Overall Study|Study terminated by sponsor|2|||
17102896|NCT00112437|38241462|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102897|NCT00112437|38241463|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102898|NCT00112437|38241464|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102899|NCT00112437|38241465|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102900|NCT00112437|38241466|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
17102901|NCT00112437|38241441|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102902|NCT00112437|38241442|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102903|NCT00112437|38241443|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102904|NCT00112437|38241444|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102905|NCT00112437|38241445|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
17021776|NCT00650806|38166295|FG001|Overall Study|Study terminated by sponsor|3|||
17021777|NCT00650806|38166296|FG002|Overall Study|Study terminated by sponsor|5|||
17021778|NCT00650806|38166297|FG003|Overall Study|Study terminated by sponsor|4|||
17021779|NCT00650806|38166294|FG000|Overall Study|Other|1|||
17021780|NCT00650806|38166295|FG001|Overall Study|Other|1|||
17021781|NCT00650806|38166296|FG002|Overall Study|Other|2|||
17021782|NCT00650806|38166297|FG003|Overall Study|Other|0|||
17021783|NCT00863057|38166313|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
17021784|NCT00863057|38166314|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
17021785|NCT00863057|38166315|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
17021786|NCT00863057|38166316|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
17021787|NCT00863057|38166313|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
17021788|NCT00863057|38166314|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
17021789|NCT00863057|38166315|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
16934095|NCT01211197|38078454|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16934096|NCT01211197|38078449|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
16934097|NCT01211197|38078450|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
16934098|NCT01211197|38078451|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
16934099|NCT01211197|38078452|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
16934100|NCT01211197|38078453|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
16934101|NCT01211197|38078454|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
16934102|NCT01232296|38078464|FG000|Overall Study|Adverse Event|24|||
17021790|NCT00863057|38166316|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
16852689|NCT01750190|37802874|FG001|Overall Study|Protocol Violation|5|||
16852690|NCT01750190|37802873|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
16852691|NCT01750190|37802874|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
16852692|NCT01750190|37802873|FG000|Overall Study|Withdrawal by Subject|83|||
16852693|NCT01750190|37802874|FG001|Overall Study|Withdrawal by Subject|89|||
16852694|NCT01750190|37802873|FG000|Overall Study|Kidney Transplant|8|||
16852695|NCT01750190|37802874|FG001|Overall Study|Kidney Transplant|4|||
16852696|NCT01750190|37802873|FG000|Overall Study|Dialysis|22|||
16852697|NCT01750190|37802874|FG001|Overall Study|Dialysis|8|||
16852698|NCT01750190|37802873|FG000|Overall Study|Other than Specified|13|||
16852699|NCT01750190|37802874|FG001|Overall Study|Other than Specified|4|||
16852700|NCT01831765|37802883|FG000|Overall Study|Lack of Efficacy|1|||
16852701|NCT01831765|37802884|FG001|Overall Study|Lack of Efficacy|0|||
16852702|NCT01831765|37802885|FG002|Overall Study|Lack of Efficacy|0|||
16852703|NCT01831765|37802883|FG000|Overall Study|Other, sponsor withdrew subject|0|||
16852704|NCT01831765|37802884|FG001|Overall Study|Other, sponsor withdrew subject|1|||
16852705|NCT01831765|37802885|FG002|Overall Study|Other, sponsor withdrew subject|0|||
16852706|NCT01831765|37802883|FG000|Overall Study|Pregnancy|1|||
16852707|NCT01831765|37802884|FG001|Overall Study|Pregnancy|1|||
16852708|NCT01831765|37802885|FG002|Overall Study|Pregnancy|2|||
16852709|NCT01831765|37802883|FG000|Overall Study|Death|0|||
16852710|NCT01831765|37802884|FG001|Overall Study|Death|1|||
16852711|NCT01831765|37802885|FG002|Overall Study|Death|1|||
16852712|NCT01831765|37802883|FG000|Overall Study|Other, site closed|1|||
16852713|NCT01831765|37802884|FG001|Overall Study|Other, site closed|1|||
16852714|NCT01831765|37802885|FG002|Overall Study|Other, site closed|0|||
16852715|NCT01831765|37802883|FG000|Overall Study|Adverse Event|5|||
16852716|NCT01831765|37802884|FG001|Overall Study|Adverse Event|3|||
16852717|NCT01831765|37802885|FG002|Overall Study|Adverse Event|3|||
16852718|NCT01831765|37802883|FG000|Overall Study|Withdrawal by Subject|22|||
16852719|NCT01831765|37802884|FG001|Overall Study|Withdrawal by Subject|7|||
16852720|NCT01831765|37802885|FG002|Overall Study|Withdrawal by Subject|17|||
16934103|NCT01232296|38078465|FG001|Overall Study|Adverse Event|12|||
16934104|NCT01232296|38078464|FG000|Overall Study|Physician Decision|1|||
16934105|NCT01232296|38078465|FG001|Overall Study|Physician Decision|1|||
16852721|NCT01831765|37802883|FG000|Overall Study|Withdrawal criteria|12|||
16852722|NCT01831765|37802884|FG001|Overall Study|Withdrawal criteria|10|||
16852723|NCT01831765|37802885|FG002|Overall Study|Withdrawal criteria|16|||
16852724|NCT01831765|37802883|FG000|Overall Study|Lost to Follow-up|2|||
16852725|NCT01831765|37802884|FG001|Overall Study|Lost to Follow-up|3|||
16852726|NCT01831765|37802885|FG002|Overall Study|Lost to Follow-up|3|||
16934106|NCT01232296|38078464|FG000|Overall Study|Progressive disease|43|||
16934107|NCT01232296|38078465|FG001|Overall Study|Progressive disease|61|||
16934108|NCT01232296|38078464|FG000|Overall Study|Study terminated by sponsor|0|||
16934109|NCT01232296|38078465|FG001|Overall Study|Study terminated by sponsor|1|||
16934110|NCT01232296|38078464|FG000|Overall Study|Technical problems|3|||
16934111|NCT01232296|38078465|FG001|Overall Study|Technical problems|0|||
17021791|NCT00863057|38166313|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
17021792|NCT00863057|38166314|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
17021793|NCT00863057|38166315|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
17021794|NCT00863057|38166316|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
16934112|NCT01232296|38078464|FG000|Overall Study|Subject/guardian decision|10|||
16934113|NCT01232296|38078465|FG001|Overall Study|Subject/guardian decision|2|||
16934114|NCT01232296|38078464|FG000|Overall Study|Death|1|||
16934115|NCT01232296|38078465|FG001|Overall Study|Death|6|||
16934116|NCT01231984|38078473|FG000|Study Period 1|Withdrawal by Subject|0|||
17021795|NCT00863057|38166313|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
17021796|NCT00863057|38166314|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
17021797|NCT00863057|38166315|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
17021798|NCT00863057|38166316|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
17021799|NCT00829166|38166334|FG000|Overall Study|Death|305|||
17021800|NCT00829166|38166335|FG001|Overall Study|Death|333|||
17021801|NCT00829166|38166334|FG000|Overall Study|Lost to Follow-up|5|||
17021802|NCT00829166|38166335|FG001|Overall Study|Lost to Follow-up|4|||
17021803|NCT00829166|38166334|FG000|Overall Study|Physician's Decision|4|||
17021804|NCT00829166|38166335|FG001|Overall Study|Physician's Decision|3|||
17021805|NCT00829166|38166334|FG000|Overall Study|Subject's Decision|41|||
17021806|NCT00829166|38166335|FG001|Overall Study|Subject's Decision|55|||
17021807|NCT00829166|38166334|FG000|Overall Study|Sponsor's Decision|137|||
17021808|NCT00829166|38166335|FG001|Overall Study|Sponsor's Decision|98|||
17021809|NCT00829166|38166334|FG000|Overall Study|Reason Not Specified|3|||
17021810|NCT00829166|38166335|FG001|Overall Study|Reason Not Specified|3|||
17021811|NCT00799266|38166344|FG000|Overall Study|Adverse Event|0|||
17021812|NCT00799266|38166345|FG001|Overall Study|Adverse Event|1|||
17021813|NCT00799266|38166344|FG000|Overall Study|Subject withdrew consent|3|||
17021814|NCT00799266|38166345|FG001|Overall Study|Subject withdrew consent|0|||
17021815|NCT00650104|38166351|FG000|Overall Study|Adverse Event|17|||
17021816|NCT00650104|38166351|FG000|Overall Study|Death|2|||
17021817|NCT00650104|38166351|FG000|Overall Study|Withdrawal by Subject|11|||
17021818|NCT00650104|38166351|FG000|Overall Study|Physician Decision|7|||
17021819|NCT00650104|38166351|FG000|Overall Study|Lost to Follow-up|1|||
17021820|NCT00650104|38166351|FG000|Overall Study|Non-compliance|2|||
17021821|NCT00650104|38166351|FG000|Overall Study|Sponsor Terminated Dosing|1|||
17021822|NCT00654238|38166355|FG000|Overall Study|Screen Failures|4|||
17021823|NCT00862979|38166362|FG000|Overall Study|Adverse Event|6|||
17021824|NCT00862979|38166363|FG001|Overall Study|Adverse Event|3|||
17021825|NCT00862979|38166362|FG000|Overall Study|Protocol Violation|0|||
17021826|NCT00862979|38166363|FG001|Overall Study|Protocol Violation|1|||
17021827|NCT00862979|38166362|FG000|Overall Study|Patient withdrew consent|2|||
17021828|NCT00862979|38166363|FG001|Overall Study|Patient withdrew consent|1|||
17021829|NCT00862979|38166362|FG000|Overall Study|Administrative problems|0|||
17021830|NCT00862979|38166363|FG001|Overall Study|Administrative problems|1|||
17021831|NCT00862979|38166362|FG000|Overall Study|Death|0|||
17021832|NCT00862979|38166363|FG001|Overall Study|Death|1|||
17021833|NCT00483379|38166371|FG000|Treatment Period|Adverse Event|1|||
17021834|NCT00483379|38166372|FG001|Treatment Period|Adverse Event|0|||
17021835|NCT00483379|38166371|FG000|Treatment Period|Withdrawal by Subject|1|||
17021836|NCT00483379|38166372|FG001|Treatment Period|Withdrawal by Subject|0|||
17021837|NCT00446251|38166380|FG000|Overall Study|On-study Transplants|2|||
17021838|NCT00446251|38166380|FG000|Overall Study|Rituximab Infusion Reaction|2|||
17021839|NCT00446251|38166380|FG000|Overall Study|Lost to Follow-up|1|||
17021840|NCT00796224|38166386|FG000|Overall Study|Adverse Event|1|||
17021841|NCT00796224|38166387|FG001|Overall Study|Adverse Event|0|||
17021842|NCT00796224|38166386|FG000|Overall Study|Protocol Violation|0|||
17021843|NCT00796224|38166387|FG001|Overall Study|Protocol Violation|1|||
17021844|NCT00791934|38166395|FG000|Overall Study|Withdrawal by Subject|2|||
17021845|NCT00791934|38166395|FG000|Overall Study|Did not consent for extended follow-up|13|||
17021846|NCT00848081|38166401|FG000|Overall Study|Adverse Event|6|||
17021847|NCT00848081|38166402|FG001|Overall Study|Adverse Event|7|||
17021848|NCT00848081|38166401|FG000|Overall Study|Protocol Violation|8|||
17021849|NCT00848081|38166402|FG001|Overall Study|Protocol Violation|5|||
17021850|NCT00848081|38166401|FG000|Overall Study|Lost to Follow-up|1|||
17021851|NCT00848081|38166402|FG001|Overall Study|Lost to Follow-up|0|||
17021852|NCT00848081|38166401|FG000|Overall Study|Physician Decision|0|||
17021853|NCT00848081|38166402|FG001|Overall Study|Physician Decision|3|||
16934117|NCT01231984|38078474|FG001|Study Period 1|Withdrawal by Subject|0|||
17021854|NCT00848081|38166401|FG000|Overall Study|Withdrawal by Subject|5|||
17021855|NCT00848081|38166402|FG001|Overall Study|Withdrawal by Subject|3|||
17021856|NCT00654004|38166410|FG000|Overall Study|Lost to Follow-up|1|||
17021857|NCT00654004|38166411|FG001|Overall Study|Lost to Follow-up|0|||
17021858|NCT00791778|38166419|FG000|Double-blind Treatment|Adverse Event|49|||
17021859|NCT00791778|38166420|FG001|Double-blind Treatment|Adverse Event|9|||
17021860|NCT00791778|38166419|FG000|Double-blind Treatment|Physician Decision|6|||
17021861|NCT00791778|38166420|FG001|Double-blind Treatment|Physician Decision|26|||
17021862|NCT00791778|38166419|FG000|Double-blind Treatment|Protocol Violation|0|||
17021863|NCT00791778|38166420|FG001|Double-blind Treatment|Protocol Violation|4|||
17021864|NCT00791778|38166419|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
17021865|NCT00791778|38166420|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
17021866|NCT00791778|38166419|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
17021867|NCT00791778|38166420|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
17021868|NCT00791778|38166419|FG000|Follow-up|Withdrawal by Subject|3|||
17021869|NCT00791778|38166420|FG001|Follow-up|Withdrawal by Subject|0|||
17021870|NCT00791778|38166419|FG000|Follow-up|Lost to Follow-up|2|||
17021871|NCT00791778|38166420|FG001|Follow-up|Lost to Follow-up|1|||
17021872|NCT00798174|38166426|FG000|Overall Study|inability to implant azygos coil|3|||
17021873|NCT00798174|38166427|FG001|Overall Study|inability to implant azygos coil|3|||
17021874|NCT00798174|38166426|FG000|Overall Study|Inability to sedate for DFT testing|1|||
17021875|NCT00798174|38166427|FG001|Overall Study|Inability to sedate for DFT testing|0|||
17021876|NCT00798096|38166431|FG000|Overall Study|Ongoing|2|||
17021877|NCT00795600|38166437|FG000|Overall Study|Adverse Event|1|||
17021878|NCT00795600|38166438|FG001|Overall Study|Adverse Event|1|||
17021879|NCT00795600|38166437|FG000|Overall Study|Protocol Violation|1|||
17021880|NCT00795600|38166438|FG001|Overall Study|Protocol Violation|2|||
17021881|NCT00795600|38166437|FG000|Overall Study|Withdrawal by Subject|1|||
17021882|NCT00795600|38166438|FG001|Overall Study|Withdrawal by Subject|0|||
17021883|NCT00795600|38166437|FG000|Overall Study|Unclassified|1|||
17021884|NCT00795600|38166438|FG001|Overall Study|Unclassified|1|||
17021885|NCT00795132|38166444|FG000|Overall Study|Death|1|||
17021886|NCT00795132|38166444|FG000|Overall Study|Relapse|2|||
17021887|NCT00647296|38166460|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
17021888|NCT00647296|38166461|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
17021889|NCT00647296|38166462|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
17021890|NCT00647296|38166463|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
17021891|NCT00647296|38166460|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
17021892|NCT00647296|38166461|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
17021893|NCT00647296|38166462|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
17021894|NCT00647296|38166463|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
17021895|NCT00647296|38166460|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
17021896|NCT00647296|38166461|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
17021897|NCT00647296|38166462|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
17021898|NCT00647296|38166463|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
17021899|NCT00647296|38166460|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
17021900|NCT00647296|38166461|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
17021901|NCT00647296|38166462|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
17021902|NCT00647296|38166463|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
17021903|NCT00647296|38166460|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
17021904|NCT00647296|38166461|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
17021905|NCT00647296|38166462|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
17021906|NCT00647296|38166463|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
17021907|NCT00647296|38166460|FG000|Part 2: 4-week Placebo Washout|Death|3|||
17021908|NCT00647296|38166461|FG001|Part 2: 4-week Placebo Washout|Death|0|||
17021909|NCT00647296|38166462|FG002|Part 2: 4-week Placebo Washout|Death|0|||
17021910|NCT00647296|38166463|FG003|Part 2: 4-week Placebo Washout|Death|0|||
17021911|NCT00647296|38166460|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
17021912|NCT00647296|38166461|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
17021913|NCT00647296|38166462|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
17021914|NCT00647296|38166463|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
17021915|NCT00647296|38166460|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
17021916|NCT00647296|38166461|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
17021917|NCT00647296|38166462|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
17021918|NCT00647296|38166463|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
17021919|NCT00647296|38166460|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
17021920|NCT00647296|38166461|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
17021921|NCT00647296|38166462|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
17021922|NCT00647296|38166463|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
17021923|NCT00647296|38166460|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
17021924|NCT00647296|38166461|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
17021925|NCT00647296|38166462|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
17021926|NCT00647296|38166463|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
17021927|NCT00647296|38166460|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
17102906|NCT00112437|38241446|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
17021928|NCT00647296|38166461|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
17021929|NCT00647296|38166462|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
17021930|NCT00647296|38166463|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
17021931|NCT00644878|38166485|FG000|Overall Study|Adverse Event|2|||
17021932|NCT00644878|38166485|FG000|Overall Study|Abnormal laboratory value|3|||
17021933|NCT00644878|38166485|FG000|Overall Study|Protocol deviation|2|||
17021934|NCT00644878|38166485|FG000|Overall Study|Treatment duration completed as per protocol|11|||
17021935|NCT00646906|38166493|FG000|Crossover Period 1|Withdrawal by Subject|1|||
17021936|NCT00646906|38166494|FG001|Crossover Period 1|Withdrawal by Subject|0|||
17021937|NCT00646906|38166495|FG002|Crossover Period 1|Withdrawal by Subject|0|||
17021938|NCT00646906|38166496|FG003|Crossover Period 1|Withdrawal by Subject|0|||
17021939|NCT00646906|38166497|FG004|Crossover Period 1|Withdrawal by Subject|0|||
17021940|NCT00646906|38166498|FG005|Crossover Period 1|Withdrawal by Subject|1|||
17021941|NCT00646906|38166499|FG006|Crossover Period 1|Withdrawal by Subject|0|||
17021942|NCT00646906|38166493|FG000|Crossover Period 2|Withdrawal by Subject|0|||
17021943|NCT00646906|38166494|FG001|Crossover Period 2|Withdrawal by Subject|1|||
17021944|NCT00646906|38166495|FG002|Crossover Period 2|Withdrawal by Subject|2|||
17021945|NCT00646906|38166496|FG003|Crossover Period 2|Withdrawal by Subject|1|||
17021946|NCT00646906|38166497|FG004|Crossover Period 2|Withdrawal by Subject|0|||
17021947|NCT00646906|38166498|FG005|Crossover Period 2|Withdrawal by Subject|0|||
17021948|NCT00646906|38166499|FG006|Crossover Period 2|Withdrawal by Subject|0|||
17021949|NCT00646906|38166493|FG000|Crossover Period 2|Physician Decision|0|||
17021950|NCT00646906|38166494|FG001|Crossover Period 2|Physician Decision|0|||
17021951|NCT00646906|38166495|FG002|Crossover Period 2|Physician Decision|0|||
17021952|NCT00646906|38166496|FG003|Crossover Period 2|Physician Decision|0|||
17021953|NCT00646906|38166497|FG004|Crossover Period 2|Physician Decision|0|||
17021954|NCT00646906|38166498|FG005|Crossover Period 2|Physician Decision|0|||
17021955|NCT00646906|38166499|FG006|Crossover Period 2|Physician Decision|1|||
17021956|NCT00642772|38166512|FG000|Overall Study|Lost to Follow-up|3|||
17021957|NCT00642772|38166512|FG000|Overall Study|Withdrawal by Subject|7|||
17021958|NCT00446095|38166521|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
17021959|NCT00446095|38166522|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
17021960|NCT00446095|38166523|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
17021961|NCT00446095|38166524|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
17021962|NCT00446095|38166525|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
17021963|NCT00446095|38166521|FG000|Phase II (8 Weeks)|Adverse Event|0|||
17021964|NCT00446095|38166522|FG001|Phase II (8 Weeks)|Adverse Event|1|||
17021965|NCT00446095|38166523|FG002|Phase II (8 Weeks)|Adverse Event|1|||
17021966|NCT00446095|38166524|FG003|Phase II (8 Weeks)|Adverse Event|0|||
17021967|NCT00446095|38166525|FG004|Phase II (8 Weeks)|Adverse Event|0|||
17021968|NCT00446095|38166521|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
17021969|NCT00446095|38166522|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
17021970|NCT00446095|38166523|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
17021971|NCT00446095|38166524|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
17021972|NCT00446095|38166525|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
17021973|NCT00446095|38166521|FG000|Phase II (8 Weeks)|Physician Decision|1|||
17021974|NCT00446095|38166522|FG001|Phase II (8 Weeks)|Physician Decision|0|||
17021975|NCT00446095|38166523|FG002|Phase II (8 Weeks)|Physician Decision|0|||
17021976|NCT00446095|38166524|FG003|Phase II (8 Weeks)|Physician Decision|0|||
17021977|NCT00446095|38166525|FG004|Phase II (8 Weeks)|Physician Decision|0|||
17021978|NCT00446095|38166521|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
16852727|NCT01749800|37802898|FG000|Overall Study|not meeting inclusion criteria|3|||
16852728|NCT01749800|37802899|FG001|Overall Study|not meeting inclusion criteria|0|||
16852729|NCT01749800|37802900|FG002|Overall Study|not meeting inclusion criteria|0|||
16852730|NCT01749800|37802898|FG000|Overall Study|Withdrawal by Subject|0|||
16852731|NCT01749800|37802899|FG001|Overall Study|Withdrawal by Subject|1|||
17102907|NCT00112437|38241447|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
16852732|NCT01749800|37802900|FG002|Overall Study|Withdrawal by Subject|0|||
16852733|NCT01830595|37802908|FG000|First Period|Withdrawal by Subject|1|||
16852734|NCT01830595|37802909|FG001|First Period|Withdrawal by Subject|3|||
16852735|NCT01830595|37802908|FG000|Washout|Withdrawal by Subject|2|||
16852736|NCT01830595|37802909|FG001|Washout|Withdrawal by Subject|2|||
16852737|NCT01748552|37802927|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
16852738|NCT01748552|37802928|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
16852739|NCT01748552|37802929|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
17021979|NCT00446095|38166522|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
17021980|NCT00446095|38166523|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
17021981|NCT00446095|38166524|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
17021982|NCT00446095|38166525|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
17021983|NCT00446095|38166521|FG000|Phase II (8 Weeks)|Ongoing|0|||
17021984|NCT00446095|38166522|FG001|Phase II (8 Weeks)|Ongoing|0|||
17021985|NCT00446095|38166523|FG002|Phase II (8 Weeks)|Ongoing|1|||
17021986|NCT00446095|38166524|FG003|Phase II (8 Weeks)|Ongoing|0|||
16852740|NCT01748552|37802930|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
17021987|NCT00446095|38166525|FG004|Phase II (8 Weeks)|Ongoing|0|||
17021988|NCT00446095|38166521|FG000|Phase I (28 Days)|Adverse Event|0|||
17021989|NCT00446095|38166522|FG001|Phase I (28 Days)|Adverse Event|0|||
17021990|NCT00446095|38166523|FG002|Phase I (28 Days)|Adverse Event|0|||
17021991|NCT00446095|38166524|FG003|Phase I (28 Days)|Adverse Event|1|||
17021992|NCT00446095|38166525|FG004|Phase I (28 Days)|Adverse Event|0|||
17021993|NCT00446095|38166521|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
17021994|NCT00446095|38166522|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
17021995|NCT00446095|38166523|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
17021996|NCT00446095|38166524|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
17021997|NCT00446095|38166525|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
17021998|NCT00829010|38166541|FG000|Overall Study|Adverse Event|1|||
16934118|NCT01231984|38078475|FG002|Study Period 1|Withdrawal by Subject|0|||
16934119|NCT01231984|38078476|FG003|Study Period 1|Withdrawal by Subject|1|||
16934120|NCT01231984|38078473|FG000|Study Period 1|Lost to Follow-up|1|||
16934121|NCT01231984|38078474|FG001|Study Period 1|Lost to Follow-up|1|||
16934122|NCT01231984|38078475|FG002|Study Period 1|Lost to Follow-up|1|||
16934123|NCT01231984|38078476|FG003|Study Period 1|Lost to Follow-up|0|||
16934124|NCT01231984|38078473|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
16934125|NCT01231984|38078474|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
16934126|NCT01231984|38078475|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
16934127|NCT01231984|38078476|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
16934128|NCT01231984|38078473|FG000|Study Period 1|Screen Failure|0|||
16934129|NCT01231984|38078474|FG001|Study Period 1|Screen Failure|0|||
16934130|NCT01231984|38078475|FG002|Study Period 1|Screen Failure|0|||
16934131|NCT01231984|38078476|FG003|Study Period 1|Screen Failure|1|||
16934132|NCT01231984|38078473|FG000|Study Period 1|Non-compliance with study requirements|5|||
16934133|NCT01231984|38078474|FG001|Study Period 1|Non-compliance with study requirements|0|||
16934134|NCT01231984|38078475|FG002|Study Period 1|Non-compliance with study requirements|2|||
16934135|NCT01231984|38078476|FG003|Study Period 1|Non-compliance with study requirements|1|||
16934136|NCT01231984|38078473|FG000|Study Period 1|Protocol Violation|3|||
16934137|NCT01231984|38078474|FG001|Study Period 1|Protocol Violation|4|||
16934138|NCT01231984|38078475|FG002|Study Period 1|Protocol Violation|2|||
16934139|NCT01231984|38078476|FG003|Study Period 1|Protocol Violation|3|||
16934140|NCT01231984|38078473|FG000|Study Period 1|Adverse Event|1|||
16934141|NCT01231984|38078474|FG001|Study Period 1|Adverse Event|0|||
16934142|NCT01231984|38078475|FG002|Study Period 1|Adverse Event|0|||
16934143|NCT01231984|38078476|FG003|Study Period 1|Adverse Event|0|||
16934144|NCT01231984|38078473|FG000|Study Period 1|Other|0|||
16934145|NCT01231984|38078474|FG001|Study Period 1|Other|0|||
16934146|NCT01231984|38078475|FG002|Study Period 1|Other|0|||
16934147|NCT01231984|38078476|FG003|Study Period 1|Other|1|||
16934148|NCT01231984|38078473|FG000|Study Period 2|Withdrawal by Subject|1|||
16934149|NCT01231984|38078474|FG001|Study Period 2|Withdrawal by Subject|1|||
16934150|NCT01231984|38078475|FG002|Study Period 2|Withdrawal by Subject|0|||
16934151|NCT01231984|38078476|FG003|Study Period 2|Withdrawal by Subject|0|||
16934152|NCT01231984|38078473|FG000|Study Period 2|Lost to Follow-up|1|||
16934153|NCT01231984|38078474|FG001|Study Period 2|Lost to Follow-up|0|||
16934154|NCT01231984|38078475|FG002|Study Period 2|Lost to Follow-up|0|||
16934155|NCT01231984|38078476|FG003|Study Period 2|Lost to Follow-up|3|||
16934156|NCT01231984|38078473|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
16934157|NCT01231984|38078474|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
16934158|NCT01231984|38078475|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
16934159|NCT01231984|38078476|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
16934160|NCT01210807|38078496|FG000|Overall Study|Lost to Follow-up|1|||
16934161|NCT01210807|38078497|FG001|Overall Study|Lost to Follow-up|2|||
16934162|NCT01210807|38078496|FG000|Overall Study|Not implanted bilaterally|2|||
16934163|NCT01210807|38078497|FG001|Overall Study|Not implanted bilaterally|1|||
16934164|NCT01231555|38078506|FG000|Overall Study|Study terminated|8|||
16934165|NCT01231555|38078507|FG001|Overall Study|Study terminated|5|||
16934166|NCT01231555|38078508|FG002|Overall Study|Study terminated|8|||
16934167|NCT01231555|38078506|FG000|Overall Study|Withdrawal by Subject|0|||
16934168|NCT01231555|38078507|FG001|Overall Study|Withdrawal by Subject|2|||
16934169|NCT01231555|38078508|FG002|Overall Study|Withdrawal by Subject|0|||
16934170|NCT01210690|38078516|FG000|Overall Study|Adverse Event|7|||
16934171|NCT01210690|38078516|FG000|Overall Study|Lack of Efficacy|12|||
16934172|NCT01210690|38078516|FG000|Overall Study|Lost to Follow-up|3|||
16934173|NCT01210690|38078516|FG000|Overall Study|Disease Remission|1|||
16934174|NCT01210690|38078516|FG000|Overall Study|Withdrawal by Subject|1|||
16934175|NCT01210690|38078516|FG000|Overall Study|Patient refused to swallow|1|||
16934176|NCT01210690|38078516|FG000|Overall Study|Patient could not take glucose|1|||
16934177|NCT01210651|38078523|FG000|Overall Study|Lost to Follow-up|1|||
16934178|NCT01210651|38078524|FG001|Overall Study|Lost to Follow-up|1|||
16934179|NCT01210651|38078523|FG000|Overall Study|schedule conflicts|1|||
16934180|NCT01210651|38078524|FG001|Overall Study|schedule conflicts|5|||
16934181|NCT01210651|38078523|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
17021999|NCT00829010|38166542|FG001|Overall Study|Adverse Event|0|||
16934182|NCT01210651|38078524|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
16934183|NCT01210651|38078523|FG000|Overall Study|Withdrawal by Subject|1|||
16934184|NCT01210651|38078524|FG001|Overall Study|Withdrawal by Subject|1|||
16934185|NCT01210651|38078523|FG000|Overall Study|Injury outside study|2|||
16934186|NCT01210651|38078524|FG001|Overall Study|Injury outside study|0|||
16934187|NCT01210495|38078603|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
16934188|NCT01210495|38078604|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
16934189|NCT01210495|38078605|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
16934190|NCT01210495|38078606|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
16934191|NCT01210495|38078603|FG000|Overall Study|Death|14|||
16934192|NCT01210495|38078604|FG001|Overall Study|Death|7|||
17102908|NCT00112437|38241448|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102909|NCT00112437|38241449|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102910|NCT00112437|38241450|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
17102911|NCT00112437|38241451|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102912|NCT00112437|38241452|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102913|NCT00112437|38241453|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102914|NCT00112437|38241454|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102915|NCT00112437|38241455|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102916|NCT00112437|38241456|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102917|NCT00112437|38241457|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102918|NCT00112437|38241458|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102919|NCT00112437|38241459|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102920|NCT00112437|38241460|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102921|NCT00112437|38241461|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102922|NCT00112437|38241462|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102923|NCT00112437|38241463|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102924|NCT00112437|38241464|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102925|NCT00112437|38241465|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102926|NCT00112437|38241466|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
17102927|NCT00112437|38241441|FG000|Year 2 (12-Month Extension)|Moved|0|||
17102928|NCT00112437|38241442|FG001|Year 2 (12-Month Extension)|Moved|0|||
17102929|NCT00112437|38241443|FG002|Year 2 (12-Month Extension)|Moved|0|||
17102930|NCT00112437|38241444|FG003|Year 2 (12-Month Extension)|Moved|0|||
17102931|NCT00112437|38241445|FG004|Year 2 (12-Month Extension)|Moved|0|||
17102932|NCT00112437|38241446|FG005|Year 2 (12-Month Extension)|Moved|0|||
17102933|NCT00112437|38241447|FG006|Year 2 (12-Month Extension)|Moved|0|||
17102934|NCT00112437|38241448|FG007|Year 2 (12-Month Extension)|Moved|0|||
17102935|NCT00112437|38241449|FG008|Year 2 (12-Month Extension)|Moved|0|||
17102936|NCT00112437|38241450|FG009|Year 2 (12-Month Extension)|Moved|1|||
17102937|NCT00112437|38241451|FG010|Year 2 (12-Month Extension)|Moved|0|||
17102938|NCT00112437|38241452|FG011|Year 2 (12-Month Extension)|Moved|0|||
17102939|NCT00112437|38241453|FG012|Year 2 (12-Month Extension)|Moved|0|||
17102940|NCT00112437|38241454|FG013|Year 2 (12-Month Extension)|Moved|0|||
17102941|NCT00112437|38241455|FG014|Year 2 (12-Month Extension)|Moved|0|||
17102942|NCT00112437|38241456|FG015|Year 2 (12-Month Extension)|Moved|0|||
17022000|NCT00829010|38166543|FG002|Overall Study|Adverse Event|0|||
17022001|NCT00829010|38166544|FG003|Overall Study|Adverse Event|0|||
17022002|NCT00829010|38166545|FG004|Overall Study|Adverse Event|0|||
17022003|NCT00829010|38166541|FG000|Overall Study|Withdrawal by Subject|0|||
17022004|NCT00829010|38166542|FG001|Overall Study|Withdrawal by Subject|1|||
17022005|NCT00829010|38166543|FG002|Overall Study|Withdrawal by Subject|1|||
17022006|NCT00829010|38166544|FG003|Overall Study|Withdrawal by Subject|0|||
16934193|NCT01210495|38078605|FG002|Overall Study|Death|112|||
16934194|NCT01210495|38078606|FG003|Overall Study|Death|54|||
16934195|NCT01210495|38078603|FG000|Overall Study|Study Terminated by Sponsor|0|||
17022007|NCT00829010|38166545|FG004|Overall Study|Withdrawal by Subject|2|||
17022008|NCT00829010|38166541|FG000|Overall Study|Lost to Follow-up|1|||
17022009|NCT00829010|38166542|FG001|Overall Study|Lost to Follow-up|0|||
17022010|NCT00829010|38166543|FG002|Overall Study|Lost to Follow-up|2|||
17022011|NCT00829010|38166544|FG003|Overall Study|Lost to Follow-up|0|||
17022012|NCT00829010|38166545|FG004|Overall Study|Lost to Follow-up|0|||
17022013|NCT00829010|38166541|FG000|Overall Study|Fatality|5|||
17022014|NCT00829010|38166542|FG001|Overall Study|Fatality|4|||
17022015|NCT00829010|38166543|FG002|Overall Study|Fatality|0|||
17022016|NCT00829010|38166544|FG003|Overall Study|Fatality|3|||
17022017|NCT00829010|38166545|FG004|Overall Study|Fatality|0|||
17022018|NCT00829010|38166541|FG000|Overall Study|Migrated/Moved from study area|3|||
17022019|NCT00829010|38166542|FG001|Overall Study|Migrated/Moved from study area|4|||
17022020|NCT00829010|38166543|FG002|Overall Study|Migrated/Moved from study area|0|||
17022021|NCT00829010|38166544|FG003|Overall Study|Migrated/Moved from study area|5|||
17022022|NCT00829010|38166545|FG004|Overall Study|Migrated/Moved from study area|0|||
17022023|NCT00644332|38166557|FG000|Overall Study|Adverse Event|11|||
17022024|NCT00644332|38166557|FG000|Overall Study|Withdrawal by Subject|6|||
16934196|NCT01210495|38078604|FG001|Overall Study|Study Terminated by Sponsor|0|||
16934197|NCT01210495|38078605|FG002|Overall Study|Study Terminated by Sponsor|4|||
16934198|NCT01210495|38078606|FG003|Overall Study|Study Terminated by Sponsor|11|||
16934199|NCT01210495|38078603|FG000|Overall Study|Lost to Follow-up|0|||
16934200|NCT01210495|38078604|FG001|Overall Study|Lost to Follow-up|0|||
16934201|NCT01210495|38078605|FG002|Overall Study|Lost to Follow-up|1|||
16934202|NCT01210495|38078606|FG003|Overall Study|Lost to Follow-up|1|||
16934203|NCT01210495|38078603|FG000|Overall Study|Other unspecified|0|||
16934204|NCT01210495|38078604|FG001|Overall Study|Other unspecified|0|||
16934205|NCT01210495|38078605|FG002|Overall Study|Other unspecified|6|||
16934206|NCT01210495|38078606|FG003|Overall Study|Other unspecified|0|||
16934207|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
16934208|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
16934209|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
16934210|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
16934211|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
16934212|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
16934213|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
16934214|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
16934215|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
16934216|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
16934217|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
16934218|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
16934219|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
16934220|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
16934221|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
16934222|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
16934223|NCT01231516|38078618|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
16934224|NCT01231516|38078619|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
16934225|NCT01231516|38078618|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
16934226|NCT01231516|38078619|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
16934227|NCT01231516|38078618|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
16934228|NCT01231516|38078619|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
16934229|NCT01231516|38078618|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
16934230|NCT01231516|38078619|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
16934231|NCT01231516|38078618|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
16934232|NCT01231516|38078619|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
16934233|NCT01231516|38078618|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
16934234|NCT01231516|38078619|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
16934235|NCT01231516|38078618|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
16934236|NCT01231516|38078619|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
16934237|NCT01231516|38078618|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
16934238|NCT01231516|38078619|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
16934239|NCT01231321|38078625|FG000|Overall Study|Adverse Event|3|||
16934240|NCT01231321|38078625|FG000|Overall Study|Lack of Efficacy|2|||
16934241|NCT01210222|38078635|FG000|Overall Study|Ineligible|2|||
16934242|NCT01210222|38078635|FG000|Overall Study|Never treated|1|||
16934243|NCT01210144|38078647|FG000|Overall Study|Lack of ovarian response|1|||
16934244|NCT01210144|38078648|FG001|Overall Study|Lack of ovarian response|0|||
16934245|NCT01210144|38078647|FG000|Overall Study|No fertilization|1|||
16934246|NCT01210144|38078648|FG001|Overall Study|No fertilization|0|||
16934247|NCT01210144|38078647|FG000|Overall Study|No transfer|1|||
16934248|NCT01210144|38078648|FG001|Overall Study|No transfer|0|||
16934249|NCT01209949|38078655|FG000|Overall Study|Lost to Follow-up|3|||
16934250|NCT01209832|38078659|FG000|Period 1|Sponsor Decision and was not dosed|1|||
16934251|NCT01209832|38078659|FG000|Period 2|Sponsor Decision|1|||
16934252|NCT01230892|38078672|FG000|Overall Study|Withdrawal by Subject|1|||
16934253|NCT01230892|38078673|FG001|Overall Study|Withdrawal by Subject|1|||
16934254|NCT01230892|38078672|FG000|Overall Study|Lost to Follow-up|2|||
16934255|NCT01230892|38078673|FG001|Overall Study|Lost to Follow-up|0|||
16934256|NCT01230814|38078681|FG000|Overall Study|Lost to Follow-up|11|||
16934257|NCT01230814|38078682|FG001|Overall Study|Lost to Follow-up|3|||
16934258|NCT01230814|38078681|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
16934259|NCT01230814|38078682|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
16934260|NCT01230307|38078690|FG000|Overall Study|LVAD Placement|0|||
16934261|NCT01230307|38078691|FG001|Overall Study|LVAD Placement|2|||
16934262|NCT01209598|38078699|FG000|Overall Study|Withdrawal by Subject|1|||
16934263|NCT01209598|38078700|FG001|Overall Study|Withdrawal by Subject|0|||
16934264|NCT01209520|38078707|FG000|Overall Study|Withdrawal by Subject|3|||
17102943|NCT00112437|38241457|FG016|Year 2 (12-Month Extension)|Moved|0|||
16934265|NCT01209325|38078711|FG000|Overall Study|Lost to Follow-up|24|||
16934266|NCT01209325|38078711|FG000|Overall Study|Adverse Event|1|||
17022025|NCT00644332|38166557|FG000|Overall Study|Completion Status Unknown|2|||
17022026|NCT00644332|38166557|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
17022027|NCT00644332|38166557|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
17022028|NCT00445939|38166564|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
17022029|NCT00445939|38166565|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
17022030|NCT00445939|38166566|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
17102944|NCT00112437|38241458|FG017|Year 2 (12-Month Extension)|Moved|0|||
17102945|NCT00112437|38241459|FG018|Year 2 (12-Month Extension)|Moved|0|||
17102946|NCT00112437|38241460|FG019|Year 2 (12-Month Extension)|Moved|0|||
17102947|NCT00112437|38241461|FG020|Year 2 (12-Month Extension)|Moved|0|||
17102948|NCT00112437|38241462|FG021|Year 2 (12-Month Extension)|Moved|0|||
17102949|NCT00112437|38241463|FG022|Year 2 (12-Month Extension)|Moved|0|||
17102950|NCT00112437|38241464|FG023|Year 2 (12-Month Extension)|Moved|0|||
17102951|NCT00112437|38241465|FG024|Year 2 (12-Month Extension)|Moved|0|||
17022031|NCT00445939|38166567|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
17022032|NCT00445939|38166564|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
17022033|NCT00445939|38166565|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
17102952|NCT00112437|38241466|FG025|Year 2 (12-Month Extension)|Moved|0|||
17102953|NCT00112437|38241441|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
17102954|NCT00112437|38241442|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
17102955|NCT00112437|38241443|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
17102956|NCT00112437|38241444|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
17102957|NCT00112437|38241445|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
17102958|NCT00112437|38241446|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
17102959|NCT00112437|38241447|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
17022034|NCT00445939|38166566|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
17022035|NCT00445939|38166567|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
17022036|NCT00482053|38166587|FG000|Inter-treatment Period|Disease progression|1|||
17022037|NCT00455923|38166593|FG000|Overall Study|Pregnancy|0|||
17022038|NCT00455923|38166594|FG001|Overall Study|Pregnancy|2|||
17022039|NCT00455923|38166593|FG000|Overall Study|Other|3|||
17022040|NCT00455923|38166594|FG001|Overall Study|Other|1|||
17022041|NCT00642616|38166604|FG000|Overall Study|Adverse Event|2|||
17022042|NCT00642616|38166605|FG001|Overall Study|Adverse Event|0|||
17022043|NCT00642616|38166606|FG002|Overall Study|Adverse Event|1|||
17022044|NCT00642616|38166607|FG003|Overall Study|Adverse Event|0|||
17022045|NCT00642616|38166604|FG000|Overall Study|Study Terminated by Sponsor|7|||
17022046|NCT00642616|38166605|FG001|Overall Study|Study Terminated by Sponsor|6|||
17022047|NCT00642616|38166606|FG002|Overall Study|Study Terminated by Sponsor|4|||
17022048|NCT00642616|38166607|FG003|Overall Study|Study Terminated by Sponsor|5|||
17022049|NCT00642616|38166604|FG000|Overall Study|Withdrawal by Subject|0|||
17022050|NCT00642616|38166605|FG001|Overall Study|Withdrawal by Subject|1|||
17022051|NCT00642616|38166606|FG002|Overall Study|Withdrawal by Subject|1|||
17022052|NCT00642616|38166607|FG003|Overall Study|Withdrawal by Subject|1|||
17022053|NCT00642616|38166604|FG000|Overall Study|Protocol Violation|0|||
17022054|NCT00642616|38166605|FG001|Overall Study|Protocol Violation|0|||
17022055|NCT00642616|38166606|FG002|Overall Study|Protocol Violation|2|||
17022056|NCT00642616|38166607|FG003|Overall Study|Protocol Violation|0|||
17022057|NCT00642616|38166604|FG000|Overall Study|Physician Decision|0|||
17022058|NCT00642616|38166605|FG001|Overall Study|Physician Decision|0|||
17022059|NCT00642616|38166606|FG002|Overall Study|Physician Decision|1|||
17022060|NCT00642616|38166607|FG003|Overall Study|Physician Decision|1|||
17022061|NCT03844945|38166623|FG000|Overall Study|Adverse Event|1|||
17022062|NCT03844945|38166624|FG001|Overall Study|Adverse Event|1|||
17022063|NCT03844945|38166625|FG002|Overall Study|Adverse Event|4|||
17022064|NCT03844945|38166626|FG003|Overall Study|Adverse Event|0|||
17022065|NCT03844945|38166623|FG000|Overall Study|Withdrawal by Subject|0|||
17022066|NCT03844945|38166624|FG001|Overall Study|Withdrawal by Subject|0|||
17022067|NCT03844945|38166625|FG002|Overall Study|Withdrawal by Subject|1|||
17102960|NCT00112437|38241448|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
17102961|NCT00112437|38241449|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
17102962|NCT00112437|38241450|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
16934267|NCT01209325|38078711|FG000|Overall Study|Relocated|3|||
16934268|NCT01209325|38078711|FG000|Overall Study|Refusal after starting therapy|8|||
16934269|NCT01209325|38078711|FG000|Overall Study|Protocol Violation|4|||
16934270|NCT01209325|38078711|FG000|Overall Study|Refusal prior to therapy|1|||
16934271|NCT01209325|38078711|FG000|Overall Study|Incarceration|2|||
16934272|NCT01209286|38078749|FG000|Overall Study|Adverse Event|4|||
16934273|NCT01209286|38078750|FG001|Overall Study|Adverse Event|3|||
17022068|NCT03844945|38166626|FG003|Overall Study|Withdrawal by Subject|0|||
17022069|NCT03844945|38166623|FG000|Overall Study|Lack of Efficacy|0|||
17022070|NCT03844945|38166624|FG001|Overall Study|Lack of Efficacy|0|||
17022071|NCT03844945|38166625|FG002|Overall Study|Lack of Efficacy|0|||
17022072|NCT03844945|38166626|FG003|Overall Study|Lack of Efficacy|1|||
17022073|NCT00445549|38166636|FG000|Overall Study|progressive disease|12|||
17022074|NCT00445003|38166643|FG000|Overall Study|Death|1|||
17022075|NCT00445003|38166644|FG001|Overall Study|Death|2|||
17022076|NCT00445003|38166645|FG002|Overall Study|Death|1|||
17022077|NCT00445003|38166643|FG000|Overall Study|Missed Visit|3|||
17022078|NCT00445003|38166644|FG001|Overall Study|Missed Visit|5|||
17022079|NCT00445003|38166645|FG002|Overall Study|Missed Visit|1|||
17022080|NCT00445003|38166643|FG000|Overall Study|Dropped|1|||
17022081|NCT00445003|38166644|FG001|Overall Study|Dropped|3|||
17022082|NCT00445003|38166645|FG002|Overall Study|Dropped|2|||
17022083|NCT00811070|38166659|FG000|Overall Study|Death|0|||
17022084|NCT00811070|38166660|FG001|Overall Study|Death|0|||
17022085|NCT00811070|38166661|FG002|Overall Study|Death|0|||
17022086|NCT00811070|38166662|FG003|Overall Study|Death|2|||
17022087|NCT00811070|38166663|FG004|Overall Study|Death|5|||
17022088|NCT00811070|38166664|FG005|Overall Study|Death|0|||
17022089|NCT00811070|38166659|FG000|Overall Study|Other|1|||
17022090|NCT00811070|38166660|FG001|Overall Study|Other|0|||
17022091|NCT00811070|38166661|FG002|Overall Study|Other|0|||
17022092|NCT00811070|38166662|FG003|Overall Study|Other|0|||
17022093|NCT00811070|38166663|FG004|Overall Study|Other|0|||
17022094|NCT00811070|38166664|FG005|Overall Study|Other|0|||
17022095|NCT00811070|38166659|FG000|Overall Study|Withdrawal by Subject|0|||
17022096|NCT00811070|38166660|FG001|Overall Study|Withdrawal by Subject|1|||
17022097|NCT00811070|38166661|FG002|Overall Study|Withdrawal by Subject|0|||
17022098|NCT00811070|38166662|FG003|Overall Study|Withdrawal by Subject|0|||
17022099|NCT00811070|38166663|FG004|Overall Study|Withdrawal by Subject|0|||
16934274|NCT01209286|38078751|FG002|Overall Study|Adverse Event|1|||
16934275|NCT01209286|38078749|FG000|Overall Study|Hematological Relapse After Remission|0|||
16934276|NCT01209286|38078750|FG001|Overall Study|Hematological Relapse After Remission|1|||
16934277|NCT01209286|38078751|FG002|Overall Study|Hematological Relapse After Remission|1|||
16934278|NCT01209286|38078749|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
16934279|NCT01209286|38078750|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
17022100|NCT00811070|38166664|FG005|Overall Study|Withdrawal by Subject|0|||
17022101|NCT00811070|38166659|FG000|Overall Study|Physician Decision|0|||
17022102|NCT00811070|38166660|FG001|Overall Study|Physician Decision|0|||
17022103|NCT00811070|38166661|FG002|Overall Study|Physician Decision|0|||
17022104|NCT00811070|38166662|FG003|Overall Study|Physician Decision|0|||
17022105|NCT00811070|38166663|FG004|Overall Study|Physician Decision|0|||
17022106|NCT00811070|38166664|FG005|Overall Study|Physician Decision|1|||
16934280|NCT01209286|38078751|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
16934281|NCT01209286|38078749|FG000|Overall Study|Physician Decision|0|||
17022107|NCT00642460|38166682|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
17022108|NCT00642460|38166683|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
17022109|NCT00642460|38166684|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
17022110|NCT00642460|38166685|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
17022111|NCT00642460|38166686|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
17022112|NCT00642460|38166687|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
16934282|NCT01209286|38078750|FG001|Overall Study|Physician Decision|2|||
16934283|NCT01209286|38078751|FG002|Overall Study|Physician Decision|0|||
16934284|NCT01209286|38078749|FG000|Overall Study|Other|0|||
16934285|NCT01209286|38078750|FG001|Overall Study|Other|1|||
16934286|NCT01209286|38078751|FG002|Overall Study|Other|0|||
16934287|NCT01208233|38078774|FG000|Overall Study|Adverse Event|0|||
16934288|NCT01208233|38078775|FG001|Overall Study|Adverse Event|1|||
16934289|NCT01208233|38078776|FG002|Overall Study|Adverse Event|2|||
16934290|NCT01208233|38078777|FG003|Overall Study|Adverse Event|0|||
17022113|NCT00642460|38166682|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
17022114|NCT00642460|38166683|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
17022115|NCT00642460|38166684|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
17022116|NCT00642460|38166685|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
16934291|NCT01208233|38078778|FG004|Overall Study|Adverse Event|3|||
16934292|NCT01208233|38078779|FG005|Overall Study|Adverse Event|5|||
16934293|NCT01208233|38078774|FG000|Overall Study|Death|0|||
16934294|NCT01208233|38078775|FG001|Overall Study|Death|0|||
16934295|NCT01208233|38078776|FG002|Overall Study|Death|0|||
16934296|NCT01208233|38078777|FG003|Overall Study|Death|0|||
16934297|NCT01208233|38078778|FG004|Overall Study|Death|3|||
16934298|NCT01208233|38078779|FG005|Overall Study|Death|5|||
16934299|NCT01208233|38078774|FG000|Overall Study|Did not meet entrance criteria|2|||
16934300|NCT01208233|38078775|FG001|Overall Study|Did not meet entrance criteria|1|||
16934301|NCT01208233|38078776|FG002|Overall Study|Did not meet entrance criteria|1|||
16934302|NCT01208233|38078777|FG003|Overall Study|Did not meet entrance criteria|0|||
16934303|NCT01208233|38078778|FG004|Overall Study|Did not meet entrance criteria|1|||
17022117|NCT00642460|38166686|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
17022118|NCT00642460|38166687|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
17022119|NCT00642460|38166682|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
17022120|NCT00642460|38166683|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
17022121|NCT00642460|38166684|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
17022122|NCT00642460|38166685|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
16934304|NCT01208233|38078779|FG005|Overall Study|Did not meet entrance criteria|0|||
16934305|NCT01208233|38078774|FG000|Overall Study|Medication error without adverse event|0|||
16934306|NCT01208233|38078775|FG001|Overall Study|Medication error without adverse event|0|||
16934307|NCT01208233|38078776|FG002|Overall Study|Medication error without adverse event|0|||
16934308|NCT01208233|38078777|FG003|Overall Study|Medication error without adverse event|0|||
16934309|NCT01208233|38078778|FG004|Overall Study|Medication error without adverse event|0|||
16934310|NCT01208233|38078779|FG005|Overall Study|Medication error without adverse event|1|||
17022123|NCT00642460|38166686|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
17022124|NCT00642460|38166687|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
17022125|NCT00642460|38166682|FG000|Part II: Open-Label Up to Week 92|Death|0|||
17022126|NCT00642460|38166683|FG001|Part II: Open-Label Up to Week 92|Death|1|||
17022127|NCT00642460|38166684|FG002|Part II: Open-Label Up to Week 92|Death|0|||
17022128|NCT00642460|38166685|FG003|Part II: Open-Label Up to Week 92|Death|2|||
17022129|NCT00642460|38166686|FG004|Part II: Open-Label Up to Week 92|Death|0|||
17022130|NCT00642460|38166687|FG005|Part II: Open-Label Up to Week 92|Death|0|||
17022131|NCT00642460|38166682|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
17022132|NCT00642460|38166683|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
17022133|NCT00642460|38166684|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
17022134|NCT00642460|38166685|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
17022135|NCT00642460|38166686|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
17022136|NCT00642460|38166687|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
17022137|NCT00642460|38166682|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
17022138|NCT00642460|38166683|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
17022139|NCT00642460|38166684|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
17022140|NCT00642460|38166685|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
17022141|NCT00642460|38166686|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
17022142|NCT00642460|38166687|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
16934311|NCT01208233|38078774|FG000|Overall Study|Study terminated by sponsor|0|||
16934312|NCT01208233|38078775|FG001|Overall Study|Study terminated by sponsor|0|||
16934313|NCT01208233|38078776|FG002|Overall Study|Study terminated by sponsor|0|||
17022143|NCT00642460|38166682|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
17022144|NCT00642460|38166683|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
17022145|NCT00642460|38166684|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
17022146|NCT00642460|38166685|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
17022147|NCT00642460|38166686|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
17022148|NCT00642460|38166687|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
17022149|NCT00642460|38166682|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
17022150|NCT00642460|38166683|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
17022151|NCT00642460|38166684|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
17022152|NCT00642460|38166685|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
17022153|NCT00642460|38166686|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
17022154|NCT00642460|38166687|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
17022155|NCT00642460|38166682|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
17022156|NCT00642460|38166683|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
17022157|NCT00642460|38166684|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
17022158|NCT00642460|38166685|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
17022159|NCT00642460|38166686|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
17022160|NCT00642460|38166687|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
17022161|NCT00642460|38166682|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
17022162|NCT00642460|38166683|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
17022163|NCT00642460|38166684|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
17022164|NCT00642460|38166685|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
17022165|NCT00642460|38166686|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
17022166|NCT00642460|38166687|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
17022167|NCT00642460|38166682|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
17022168|NCT00642460|38166683|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
17022169|NCT00642460|38166684|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
17022170|NCT00642460|38166685|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
17022171|NCT00642460|38166686|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
17022172|NCT00642460|38166687|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
17022173|NCT00642460|38166682|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
17022174|NCT00642460|38166683|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
17022175|NCT00642460|38166684|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
17102963|NCT00112437|38241451|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
17102964|NCT00112437|38241452|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
17102965|NCT00112437|38241453|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
17022176|NCT00642460|38166685|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
17022177|NCT00642460|38166686|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
17022178|NCT00642460|38166687|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
17022179|NCT00642460|38166682|FG000|Part III: Open-Label Up to Week 260|Other|0|||
17022180|NCT00642460|38166683|FG001|Part III: Open-Label Up to Week 260|Other|0|||
17022181|NCT00642460|38166684|FG002|Part III: Open-Label Up to Week 260|Other|0|||
17022182|NCT00642460|38166685|FG003|Part III: Open-Label Up to Week 260|Other|0|||
17022183|NCT00642460|38166686|FG004|Part III: Open-Label Up to Week 260|Other|2|||
17022184|NCT00642460|38166687|FG005|Part III: Open-Label Up to Week 260|Other|2|||
17022185|NCT00642460|38166682|FG000|Part III: Open-Label Up to Week 260|Death|0|||
17022186|NCT00642460|38166683|FG001|Part III: Open-Label Up to Week 260|Death|0|||
17022187|NCT00642460|38166684|FG002|Part III: Open-Label Up to Week 260|Death|0|||
17022188|NCT00642460|38166685|FG003|Part III: Open-Label Up to Week 260|Death|0|||
17022189|NCT00642460|38166686|FG004|Part III: Open-Label Up to Week 260|Death|0|||
17022190|NCT00642460|38166687|FG005|Part III: Open-Label Up to Week 260|Death|3|||
17022191|NCT00642460|38166682|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
17022192|NCT00642460|38166683|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
17022193|NCT00642460|38166684|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
17022194|NCT00642460|38166685|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
17022195|NCT00642460|38166686|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
17022196|NCT00642460|38166687|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
17022197|NCT00642460|38166682|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
17022198|NCT00642460|38166683|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
17022199|NCT00642460|38166684|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
17022200|NCT00642460|38166685|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
17022201|NCT00642460|38166686|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
17022202|NCT00642460|38166687|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
17022203|NCT00814658|38166699|FG000|Overall Study|Lost to Follow-up|0|||
17022204|NCT00814658|38166700|FG001|Overall Study|Lost to Follow-up|1|||
17022205|NCT00814658|38166699|FG000|Overall Study|Physician Decision|1|||
17022206|NCT00814658|38166700|FG001|Overall Study|Physician Decision|0|||
17022207|NCT00814658|38166699|FG000|Overall Study|Adverse Event|3|||
17022208|NCT00814658|38166700|FG001|Overall Study|Adverse Event|3|||
17022209|NCT00642304|38166716|FG000|Overall Study|Adverse Event|1|||
17022210|NCT00642304|38166716|FG000|Overall Study|Death|1|||
17022211|NCT00642304|38166716|FG000|Overall Study|Blood transfusion|2|||
17022212|NCT00642304|38166716|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
17022213|NCT00642304|38166716|FG000|Overall Study|Transplantation|1|||
17022214|NCT00814580|38166722|FG000|Overall Study|Adverse Event|6|||
17022215|NCT00814580|38166723|FG001|Overall Study|Adverse Event|15|||
17022216|NCT00814580|38166722|FG000|Overall Study|Lack of Efficacy|18|||
17022217|NCT00814580|38166723|FG001|Overall Study|Lack of Efficacy|25|||
17022218|NCT00814580|38166722|FG000|Overall Study|Protocol Violation|2|||
17022219|NCT00814580|38166723|FG001|Overall Study|Protocol Violation|0|||
17022220|NCT00814580|38166722|FG000|Overall Study|Withdrawal by Subject|2|||
17022221|NCT00814580|38166723|FG001|Overall Study|Withdrawal by Subject|2|||
17022222|NCT00814580|38166722|FG000|Overall Study|Other|1|||
17022223|NCT00814580|38166723|FG001|Overall Study|Other|3|||
17022224|NCT00814580|38166722|FG000|Overall Study|Did Not Take Drug|2|||
17022225|NCT00814580|38166723|FG001|Overall Study|Did Not Take Drug|2|||
17022226|NCT00643162|38166743|FG000|Overall Study|Withdrawal by Subject|1|||
17022227|NCT00643162|38166744|FG001|Overall Study|Withdrawal by Subject|1|||
17022228|NCT00643006|38166752|FG000|Overall Study|Lost to Follow-up|5|||
17022229|NCT00643006|38166753|FG001|Overall Study|Lost to Follow-up|4|||
17022230|NCT00814502|38166763|FG000|Overall Study|Adverse Event|1|||
17022231|NCT00814502|38166764|FG001|Overall Study|Adverse Event|0|||
17022232|NCT00814502|38166763|FG000|Overall Study|Withdrawal by Subject|0|||
17022233|NCT00814502|38166764|FG001|Overall Study|Withdrawal by Subject|2|||
17022234|NCT00653224|38166774|FG000|Overall Study|Adverse Event|2|||
17022235|NCT00653224|38166775|FG001|Overall Study|Adverse Event|1|||
17022236|NCT00653224|38166774|FG000|Overall Study|Lack of Efficacy|1|||
17022237|NCT00653224|38166775|FG001|Overall Study|Lack of Efficacy|2|||
17022238|NCT00653224|38166774|FG000|Overall Study|Loss of efficacy|1|||
17022239|NCT00653224|38166775|FG001|Overall Study|Loss of efficacy|0|||
17022240|NCT00653224|38166774|FG000|Overall Study|Lost to Follow-up|1|||
17022241|NCT00653224|38166775|FG001|Overall Study|Lost to Follow-up|0|||
17022242|NCT00653224|38166774|FG000|Overall Study|Other|2|||
17022243|NCT00653224|38166775|FG001|Overall Study|Other|4|||
17022244|NCT00444925|38166784|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
17022245|NCT00444925|38166785|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
17022246|NCT00444925|38166786|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
17022247|NCT00444925|38166784|FG000|Double-blind Treatment Period|Death|2|||
17022248|NCT00444925|38166785|FG001|Double-blind Treatment Period|Death|0|||
17022249|NCT00444925|38166786|FG002|Double-blind Treatment Period|Death|0|||
17022250|NCT00444925|38166784|FG000|Double-blind Treatment Period|Adverse Event|6|||
17022251|NCT00444925|38166785|FG001|Double-blind Treatment Period|Adverse Event|28|||
17022252|NCT00444925|38166786|FG002|Double-blind Treatment Period|Adverse Event|44|||
17022253|NCT00444925|38166784|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
17022254|NCT00444925|38166785|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
17022255|NCT00444925|38166786|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
17022256|NCT00444925|38166784|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
17022257|NCT00444925|38166785|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
17022258|NCT00444925|38166786|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
16934314|NCT01208233|38078777|FG003|Overall Study|Study terminated by sponsor|0|||
16934315|NCT01208233|38078778|FG004|Overall Study|Study terminated by sponsor|10|||
16934316|NCT01208233|38078779|FG005|Overall Study|Study terminated by sponsor|7|||
16934317|NCT01208233|38078774|FG000|Overall Study|Protocol Violation|0|||
16934318|NCT01208233|38078775|FG001|Overall Study|Protocol Violation|0|||
16934319|NCT01208233|38078776|FG002|Overall Study|Protocol Violation|0|||
16934320|NCT01208233|38078777|FG003|Overall Study|Protocol Violation|0|||
16934321|NCT01208233|38078778|FG004|Overall Study|Protocol Violation|3|||
16934322|NCT01208233|38078779|FG005|Overall Study|Protocol Violation|0|||
16934323|NCT01208233|38078774|FG000|Overall Study|Other|2|||
16934324|NCT01208233|38078775|FG001|Overall Study|Other|1|||
16934325|NCT01208233|38078776|FG002|Overall Study|Other|0|||
16934326|NCT01208233|38078777|FG003|Overall Study|Other|0|||
16934327|NCT01208233|38078778|FG004|Overall Study|Other|0|||
16934328|NCT01208233|38078779|FG005|Overall Study|Other|1|||
16934329|NCT01208233|38078774|FG000|Overall Study|Withdrawal by Subject|1|||
16934330|NCT01208233|38078775|FG001|Overall Study|Withdrawal by Subject|0|||
16934331|NCT01208233|38078776|FG002|Overall Study|Withdrawal by Subject|1|||
16934332|NCT01208233|38078777|FG003|Overall Study|Withdrawal by Subject|1|||
16934333|NCT01208233|38078778|FG004|Overall Study|Withdrawal by Subject|4|||
17022259|NCT00444925|38166784|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
17022260|NCT00444925|38166785|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
17022261|NCT00444925|38166786|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
17022262|NCT00444925|38166784|FG000|Double-blind Treatment Period|Other|7|||
17022263|NCT00444925|38166785|FG001|Double-blind Treatment Period|Other|7|||
17022264|NCT00444925|38166786|FG002|Double-blind Treatment Period|Other|12|||
17022265|NCT00641056|38166796|FG000|Overall Study|Adverse Event|12|||
17022266|NCT00641056|38166797|FG001|Overall Study|Adverse Event|2|||
17022267|NCT00641056|38166796|FG000|Overall Study|Lost to Follow-up|2|||
17022268|NCT00641056|38166797|FG001|Overall Study|Lost to Follow-up|1|||
17022269|NCT00641056|38166796|FG000|Overall Study|Physician Decision|3|||
16934334|NCT01208233|38078779|FG005|Overall Study|Withdrawal by Subject|2|||
16934335|NCT01208038|38078799|FG000|Overall Study|Withdrawal by Subject|1|||
16934336|NCT01207687|38078803|FG000|Overall Study|Adverse Event|1|||
16934337|NCT01207687|38078803|FG000|Overall Study|Withdrawal by Subject|1|||
16934338|NCT01207453|38078815|FG000|First Intervention|Adverse Event|2|||
16934339|NCT01207453|38078816|FG001|First Intervention|Adverse Event|1|||
16934340|NCT01207453|38078815|FG000|Washout|Adverse Event|1|||
16934341|NCT01207453|38078816|FG001|Washout|Adverse Event|0|||
16934342|NCT01207453|38078815|FG000|Washout|Lost to Follow-up|1|||
16934343|NCT01207453|38078816|FG001|Washout|Lost to Follow-up|0|||
16934344|NCT01207453|38078815|FG000|2nd Intervention|Adverse Event|1|||
16934345|NCT01207453|38078816|FG001|2nd Intervention|Adverse Event|2|||
16934346|NCT01207453|38078815|FG000|2nd Intervention|Lost to Follow-up|1|||
16934347|NCT01207453|38078816|FG001|2nd Intervention|Lost to Follow-up|0|||
16934348|NCT01207414|38078827|FG000|Overall Study|Adverse Event|25|||
16934349|NCT01207414|38078828|FG001|Overall Study|Adverse Event|39|||
16934350|NCT01207414|38078827|FG000|Overall Study|Abnormal test procedure results|0|||
17022270|NCT00641056|38166797|FG001|Overall Study|Physician Decision|1|||
17022271|NCT00641056|38166796|FG000|Overall Study|Protocol Violation|2|||
17022272|NCT00641056|38166797|FG001|Overall Study|Protocol Violation|0|||
17022273|NCT00641056|38166796|FG000|Overall Study|Entry Criteria Not Met|3|||
17022274|NCT00641056|38166797|FG001|Overall Study|Entry Criteria Not Met|0|||
17022275|NCT00641056|38166796|FG000|Overall Study|Subject Decision|6|||
17022276|NCT00641056|38166797|FG001|Overall Study|Subject Decision|19|||
17022277|NCT00641056|38166796|FG000|Overall Study|Sponsor Decision|1|||
17022278|NCT00641056|38166797|FG001|Overall Study|Sponsor Decision|2|||
17022279|NCT00814346|38166809|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
17022280|NCT00814346|38166810|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
17022281|NCT00814346|38166809|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
17022282|NCT00814346|38166810|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
17022283|NCT00814346|38166809|FG000|Open Phase (17 Months)|Adverse Event|5|||
16934351|NCT01207414|38078828|FG001|Overall Study|Abnormal test procedure results|1|||
16934352|NCT01207414|38078827|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
16934353|NCT01207414|38078828|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
17022284|NCT00814346|38166810|FG001|Open Phase (17 Months)|Adverse Event|0|||
17022285|NCT00814346|38166809|FG000|Open Phase (17 Months)|Consent|2|||
17022286|NCT00814346|38166810|FG001|Open Phase (17 Months)|Consent|0|||
17022287|NCT00814346|38166809|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
17022288|NCT00814346|38166810|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
17022289|NCT00814346|38166809|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
17022290|NCT00814346|38166810|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
17022291|NCT00569374|38166829|FG000|Overall Study|Withdrawal by Subject|4|||
17022292|NCT00828464|38166833|FG000|Overall Study|Withdrawal by Subject|1|||
17022293|NCT00810602|38166837|FG000|Overall Study|Withdrawal by Subject|8|||
17022294|NCT00810602|38166838|FG001|Overall Study|Withdrawal by Subject|3|||
17022295|NCT00791700|38166846|FG000|Overall Study|Insufficient clinical response|1|||
17022296|NCT00791700|38166847|FG001|Overall Study|Insufficient clinical response|4|||
17022297|NCT00791700|38166848|FG002|Overall Study|Insufficient clinical response|1|||
17022298|NCT00791700|38166849|FG003|Overall Study|Insufficient clinical response|8|||
17022299|NCT00791700|38166846|FG000|Overall Study|No longer willing to participate|1|||
17022300|NCT00791700|38166847|FG001|Overall Study|No longer willing to participate|1|||
17022301|NCT00791700|38166848|FG002|Overall Study|No longer willing to participate|0|||
17022302|NCT00791700|38166849|FG003|Overall Study|No longer willing to participate|8|||
17022303|NCT00791700|38166846|FG000|Overall Study|Non-compliance with study treatment|0|||
17022304|NCT00791700|38166847|FG001|Overall Study|Non-compliance with study treatment|2|||
17022305|NCT00791700|38166848|FG002|Overall Study|Non-compliance with study treatment|0|||
17022306|NCT00791700|38166849|FG003|Overall Study|Non-compliance with study treatment|4|||
17022307|NCT00791700|38166846|FG000|Overall Study|Withdrawn due to pregnancy|0|||
17022308|NCT00791700|38166847|FG001|Overall Study|Withdrawn due to pregnancy|0|||
17022309|NCT00791700|38166848|FG002|Overall Study|Withdrawn due to pregnancy|0|||
17022310|NCT00791700|38166849|FG003|Overall Study|Withdrawn due to pregnancy|1|||
17022311|NCT00791700|38166846|FG000|Overall Study|Other|0|||
17022312|NCT00791700|38166847|FG001|Overall Study|Other|1|||
17022313|NCT00791700|38166848|FG002|Overall Study|Other|0|||
17022314|NCT00791700|38166849|FG003|Overall Study|Other|1|||
17022315|NCT00791700|38166846|FG000|Overall Study|Death|0|||
17022316|NCT00791700|38166847|FG001|Overall Study|Death|0|||
17022317|NCT00791700|38166848|FG002|Overall Study|Death|0|||
17022318|NCT00791700|38166849|FG003|Overall Study|Death|1|||
17022319|NCT00791700|38166846|FG000|Overall Study|Lost to Follow-up|4|||
17022320|NCT00791700|38166847|FG001|Overall Study|Lost to Follow-up|3|||
17022321|NCT00791700|38166848|FG002|Overall Study|Lost to Follow-up|4|||
17022322|NCT00791700|38166849|FG003|Overall Study|Lost to Follow-up|6|||
17022323|NCT00791700|38166846|FG000|Overall Study|Adverse Event|0|||
17022324|NCT00791700|38166847|FG001|Overall Study|Adverse Event|0|||
17022325|NCT00791700|38166848|FG002|Overall Study|Adverse Event|1|||
17022326|NCT00791700|38166849|FG003|Overall Study|Adverse Event|1|||
17022327|NCT00810368|38166872|FG000|Overall Study|Lost to Follow-up|4|||
17022328|NCT00810368|38166873|FG001|Overall Study|Lost to Follow-up|2|||
17022329|NCT00810368|38166872|FG000|Overall Study|Lack of Efficacy|2|||
17022330|NCT00810368|38166873|FG001|Overall Study|Lack of Efficacy|0|||
17022331|NCT00628108|38166883|FG000|Overall Study|Adverse Event|0|||
17022332|NCT00628108|38166884|FG001|Overall Study|Adverse Event|3|||
17022333|NCT00628108|38166883|FG000|Overall Study|Withdrawal by Subject|1|||
17022334|NCT00628108|38166884|FG001|Overall Study|Withdrawal by Subject|0|||
17022335|NCT00628030|38166892|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
17022336|NCT00628030|38166893|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
17022337|NCT00628030|38166892|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
17022338|NCT00628030|38166893|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
17022339|NCT00628030|38166892|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
17022340|NCT00628030|38166893|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
17022341|NCT00591578|38166902|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
17022342|NCT00591578|38166903|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
17022343|NCT00591578|38166904|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
17022344|NCT00591578|38166902|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
17022345|NCT00591578|38166903|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
17022346|NCT00591578|38166904|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
17022347|NCT00591578|38166902|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
17022348|NCT00591578|38166903|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
17022349|NCT00591578|38166904|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
17022350|NCT00591578|38166902|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
17022351|NCT00591578|38166903|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
17022352|NCT00591578|38166904|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
17022353|NCT00591578|38166902|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
17022354|NCT00591578|38166903|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
17022355|NCT00591578|38166904|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
16852741|NCT01748552|37802931|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
17022356|NCT00591578|38166902|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
17022357|NCT00591578|38166903|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
17022358|NCT00591578|38166904|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
17022359|NCT00591578|38166902|FG000|Double-Blind Treatment Phase|Other|4|||
17022360|NCT00591578|38166903|FG001|Double-Blind Treatment Phase|Other|9|||
17022361|NCT00591578|38166904|FG002|Double-Blind Treatment Phase|Other|4|||
17022362|NCT00591578|38166902|FG000|Open-Label Extension Phase|Adverse Event|3|||
17022363|NCT00591578|38166903|FG001|Open-Label Extension Phase|Adverse Event|5|||
17022364|NCT00591578|38166904|FG002|Open-Label Extension Phase|Adverse Event|0|||
17022365|NCT00591578|38166902|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
17022366|NCT00591578|38166903|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
17022367|NCT00591578|38166904|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
17022368|NCT00591578|38166902|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
17022369|NCT00591578|38166903|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
17022370|NCT00591578|38166904|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
17022371|NCT00591578|38166902|FG000|Open-Label Extension Phase|Other|1|||
17022372|NCT00591578|38166903|FG001|Open-Label Extension Phase|Other|0|||
17022373|NCT00591578|38166904|FG002|Open-Label Extension Phase|Other|0|||
17022374|NCT00797862|38166916|FG000|Overall Study|Adverse Event|86|||
17022375|NCT00797862|38166917|FG001|Overall Study|Adverse Event|44|||
17022376|NCT00797862|38166918|FG002|Overall Study|Adverse Event|58|||
17022377|NCT00797862|38166916|FG000|Overall Study|Abnormal Test Procedure Result|0|||
17022378|NCT00797862|38166917|FG001|Overall Study|Abnormal Test Procedure Result|1|||
17022379|NCT00797862|38166918|FG002|Overall Study|Abnormal Test Procedure Result|1|||
17022380|NCT00797862|38166916|FG000|Overall Study|Lack of Efficacy|1|||
17022381|NCT00797862|38166917|FG001|Overall Study|Lack of Efficacy|7|||
17022382|NCT00797862|38166918|FG002|Overall Study|Lack of Efficacy|6|||
17022383|NCT00797862|38166916|FG000|Overall Study|No longer required study medication|1|||
17022384|NCT00797862|38166917|FG001|Overall Study|No longer required study medication|0|||
17022385|NCT00797862|38166918|FG002|Overall Study|No longer required study medication|0|||
17022386|NCT00797862|38166916|FG000|Overall Study|Withdrawal by Subject|14|||
17022387|NCT00797862|38166917|FG001|Overall Study|Withdrawal by Subject|7|||
17022388|NCT00797862|38166918|FG002|Overall Study|Withdrawal by Subject|7|||
17022389|NCT00797862|38166916|FG000|Overall Study|Lost to Follow-up|11|||
17022390|NCT00797862|38166917|FG001|Overall Study|Lost to Follow-up|0|||
17022391|NCT00797862|38166918|FG002|Overall Study|Lost to Follow-up|5|||
17022392|NCT00797862|38166916|FG000|Overall Study|Administrative Problem|4|||
17022393|NCT00797862|38166917|FG001|Overall Study|Administrative Problem|0|||
17022394|NCT00797862|38166918|FG002|Overall Study|Administrative Problem|0|||
17022395|NCT00797862|38166916|FG000|Overall Study|Protocol Violation|4|||
17022396|NCT00797862|38166917|FG001|Overall Study|Protocol Violation|6|||
17022397|NCT00797862|38166918|FG002|Overall Study|Protocol Violation|8|||
17022398|NCT00797862|38166916|FG000|Overall Study|Mis-randomized|3|||
17022399|NCT00797862|38166917|FG001|Overall Study|Mis-randomized|3|||
17022400|NCT00797862|38166918|FG002|Overall Study|Mis-randomized|1|||
17022401|NCT00794820|38166926|FG000|Overall Study|Adverse Event|11|||
17022402|NCT00794820|38166926|FG000|Overall Study|Secondary Malignancies|2|||
17022403|NCT00794820|38166926|FG000|Overall Study|Resistant Disease|2|||
17022404|NCT00794820|38166926|FG000|Overall Study|Ineligible/Screen Failure|1|||
17022405|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
17022406|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
17022407|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
17022408|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
17022409|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
17022410|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
17022411|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
17022412|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
17022413|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
17022414|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
17022415|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
16852742|NCT01748552|37802932|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
16852743|NCT01748552|37802933|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
16852744|NCT01748552|37802934|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
16852745|NCT01748552|37802935|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
16852746|NCT01748552|37802936|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
16852747|NCT01748552|37802937|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
16852748|NCT01748552|37802938|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
16852749|NCT01748552|37802927|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16852750|NCT01748552|37802928|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16934354|NCT01207414|38078827|FG000|Overall Study|Patient withdrew consent|14|||
16934355|NCT01207414|38078828|FG001|Overall Study|Patient withdrew consent|11|||
16934356|NCT01207414|38078827|FG000|Overall Study|Lost to Follow-up|15|||
16934357|NCT01207414|38078828|FG001|Overall Study|Lost to Follow-up|17|||
16934358|NCT01207414|38078827|FG000|Overall Study|Administrative problems|1|||
16934359|NCT01207414|38078828|FG001|Overall Study|Administrative problems|1|||
16934360|NCT01207414|38078827|FG000|Overall Study|Protocol deviation|12|||
16934361|NCT01207414|38078828|FG001|Overall Study|Protocol deviation|9|||
16934362|NCT01207414|38078827|FG000|Overall Study|Randomized in error|1|||
17022416|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
17022417|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
17022418|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
17022419|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
17022420|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
17022421|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
17022422|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
17022423|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
17022424|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
17022425|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
17022426|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
17022427|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
17022428|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
17022429|NCT00455533|38166932|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
17022430|NCT00455533|38166933|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
17022431|NCT00455533|38166934|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
17022432|NCT00455533|38166932|FG000|Period Two: Randomized Period|Death|0|||
17022433|NCT00455533|38166933|FG001|Period Two: Randomized Period|Death|0|||
17022434|NCT00455533|38166934|FG002|Period Two: Randomized Period|Death|3|||
17022435|NCT00455533|38166932|FG000|Period Two: Randomized Period|Disease Progression|0|||
17022436|NCT00455533|38166933|FG001|Period Two: Randomized Period|Disease Progression|1|||
17022437|NCT00455533|38166934|FG002|Period Two: Randomized Period|Disease Progression|1|||
17022438|NCT00455533|38166932|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
17022439|NCT00455533|38166933|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
17022440|NCT00455533|38166934|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
17022441|NCT00455533|38166932|FG000|Period Two: Randomized Period|Other - need reasons|0|||
17022442|NCT00455533|38166933|FG001|Period Two: Randomized Period|Other - need reasons|1|||
17022443|NCT00455533|38166934|FG002|Period Two: Randomized Period|Other - need reasons|0|||
17022444|NCT00455533|38166932|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
16852751|NCT01748552|37802929|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16852752|NCT01748552|37802930|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16852753|NCT01748552|37802931|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16852754|NCT01748552|37802932|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16852755|NCT01748552|37802933|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
16852756|NCT01748552|37802934|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
16852757|NCT01748552|37802935|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
16852758|NCT01748552|37802936|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16852759|NCT01748552|37802937|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16852760|NCT01748552|37802938|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16852761|NCT01748162|37802980|FG000|Overall Study|no additional croup episodes to evaluate|2|||
16852762|NCT01748162|37802981|FG001|Overall Study|no additional croup episodes to evaluate|2|||
16934363|NCT01207414|38078828|FG001|Overall Study|Randomized in error|0|||
16934364|NCT01207219|38078837|FG000|Overall Study|changed diagnosis during study period|5|||
16934365|NCT01207219|38078838|FG001|Overall Study|changed diagnosis during study period|3|||
16934366|NCT01207219|38078839|FG002|Overall Study|changed diagnosis during study period|1|||
16934367|NCT01207219|38078837|FG000|Overall Study|Lost to Follow-up|6|||
16934368|NCT01207219|38078838|FG001|Overall Study|Lost to Follow-up|8|||
16934369|NCT01207219|38078839|FG002|Overall Study|Lost to Follow-up|6|||
16934370|NCT01207102|38078847|FG000|Overall Study|Withdrawal by Subject|5|||
16934371|NCT01207102|38078847|FG000|Overall Study|Adverse Event|2|||
16934372|NCT01207102|38078847|FG000|Overall Study|progression|2|||
16934373|NCT01207102|38078847|FG000|Overall Study|Withdrawal by Treating Physician|1|||
16934374|NCT01206517|38078857|FG000|Overall Study|Withdrawal by Subject|0|||
16934375|NCT01206517|38078858|FG001|Overall Study|Withdrawal by Subject|0|||
16934376|NCT01206517|38078859|FG002|Overall Study|Withdrawal by Subject|2|||
16934377|NCT01206517|38078860|FG003|Overall Study|Withdrawal by Subject|0|||
16934378|NCT01206517|38078861|FG004|Overall Study|Withdrawal by Subject|1|||
16934379|NCT01206517|38078862|FG005|Overall Study|Withdrawal by Subject|0|||
16934380|NCT01206439|38078873|FG000|Overall Study|subject did not meet inclusion criteria|1|||
16934381|NCT01206322|38078879|FG000|Overall Study|Adverse Event|0|||
16934382|NCT01206322|38078880|FG001|Overall Study|Adverse Event|0|||
16934383|NCT01206322|38078881|FG002|Overall Study|Adverse Event|0|||
16934384|NCT01206322|38078882|FG003|Overall Study|Adverse Event|1|||
16934385|NCT01206166|38078894|FG000|Overall Study|No evaluable data|2|||
16934386|NCT01206166|38078895|FG001|Overall Study|No evaluable data|3|||
16934387|NCT01205776|38078916|FG000|Overall Study|Lost to Follow-up|53|||
16934388|NCT01205776|38078917|FG001|Overall Study|Lost to Follow-up|61|||
16934389|NCT01205776|38078916|FG000|Overall Study|Withdrawal by Subject|11|||
16934390|NCT01205776|38078917|FG001|Overall Study|Withdrawal by Subject|34|||
17022445|NCT00455533|38166933|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
17022446|NCT00455533|38166934|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
17022447|NCT00455533|38166932|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
17022448|NCT00455533|38166933|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
17022449|NCT00455533|38166934|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
17022450|NCT00627094|38166944|FG000|Overall Study|Adverse Event|8|||
17022451|NCT00627094|38166945|FG001|Overall Study|Adverse Event|7|||
17022452|NCT00627094|38166944|FG000|Overall Study|Lost to Follow-up|1|||
17022453|NCT00627094|38166945|FG001|Overall Study|Lost to Follow-up|0|||
17022454|NCT00627094|38166944|FG000|Overall Study|Withdrawal by Subject|1|||
17022455|NCT00627094|38166945|FG001|Overall Study|Withdrawal by Subject|1|||
17022456|NCT00627094|38166944|FG000|Overall Study|ulcer healed|1|||
17022457|NCT00627094|38166945|FG001|Overall Study|ulcer healed|7|||
17022458|NCT00627094|38166944|FG000|Overall Study|Other reason|1|||
17022459|NCT00627094|38166945|FG001|Overall Study|Other reason|0|||
17022460|NCT00642850|38166953|FG000|Overall Study|Death|7|||
17022461|NCT00642850|38166953|FG000|Overall Study|Adverse Event|2|||
17022462|NCT00642850|38166953|FG000|Overall Study|Lack of Efficacy|1|||
17022463|NCT00642850|38166953|FG000|Overall Study|Protocol Violation|2|||
17022464|NCT00642850|38166953|FG000|Overall Study|Kidney transplantation|8|||
17022465|NCT00642850|38166953|FG000|Overall Study|Blood transfusion|6|||
17022466|NCT00642850|38166953|FG000|Overall Study|Other reasons|7|||
17022467|NCT00455455|38166957|FG000|Washout|Withdrawal by Subject|0|||
17022468|NCT00455455|38166958|FG001|Washout|Withdrawal by Subject|1|||
17022469|NCT00455455|38166957|FG000|Washout|Withdrawal by Subject|1|||
17022470|NCT00455455|38166958|FG001|Washout|Withdrawal by Subject|0|||
17022471|NCT03840811|38166970|FG000|Overall Study|Lost to Follow-up|0|||
17022472|NCT03840811|38166971|FG001|Overall Study|Lost to Follow-up|0|||
17022473|NCT03840811|38166972|FG002|Overall Study|Lost to Follow-up|1|||
17022474|NCT00640510|38166982|FG000|Overall Study|Lack of Efficacy|0|||
17102966|NCT00112437|38241454|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
17102967|NCT00112437|38241455|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
17102968|NCT00112437|38241456|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
17102969|NCT00112437|38241457|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
17102970|NCT00112437|38241458|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
17102971|NCT00112437|38241459|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
17102972|NCT00112437|38241460|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
17102973|NCT00112437|38241461|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
17102974|NCT00112437|38241462|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
17102975|NCT00112437|38241463|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
17102976|NCT00112437|38241464|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
17102977|NCT00112437|38241465|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
17022475|NCT00640510|38166983|FG001|Overall Study|Lack of Efficacy|1|||
17102978|NCT00112437|38241466|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
17102979|NCT00112437|38241441|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102980|NCT00112437|38241442|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102981|NCT00112437|38241443|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102982|NCT00112437|38241444|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17022476|NCT00640510|38166982|FG000|Overall Study|Protocol Violation|1|||
17102983|NCT00112437|38241445|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102984|NCT00112437|38241446|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16852763|NCT01748162|37802980|FG000|Overall Study|participant consented but did not begin|0|||
16852764|NCT01748162|37802981|FG001|Overall Study|participant consented but did not begin|1|||
16852765|NCT01748162|37802980|FG000|Overall Study|reasons not available|3|||
16852766|NCT01748162|37802981|FG001|Overall Study|reasons not available|2|||
16852767|NCT01724216|37802987|FG000|Overall Study|Scan was not completed|1|||
16852768|NCT01723904|37802991|FG000|Overall Study|Noncompliant|3|||
16852769|NCT01723904|37802991|FG000|Overall Study|Adverse Event|5|||
16852770|NCT01723904|37802991|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
16852771|NCT01747772|37802995|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
16852772|NCT01830127|37803005|FG000|Overall Study|Adverse Event|1|||
16852773|NCT01830127|37803006|FG001|Overall Study|Adverse Event|6|||
16852774|NCT01830127|37803005|FG000|Overall Study|Lack of Efficacy|3|||
16852775|NCT01830127|37803006|FG001|Overall Study|Lack of Efficacy|0|||
17022477|NCT00640510|38166983|FG001|Overall Study|Protocol Violation|0|||
17022478|NCT00640510|38166982|FG000|Overall Study|Physician Decision|0|||
17022479|NCT00640510|38166983|FG001|Overall Study|Physician Decision|1|||
17022480|NCT00813800|38166989|FG000|Overall Study|Screen Failure after Consent|2|||
17022481|NCT00813800|38166989|FG000|Overall Study|Adverse Event|1|||
17022482|NCT00813800|38166989|FG000|Overall Study|Worsening of depression|2|||
17022483|NCT00813800|38166989|FG000|Overall Study|Physician Decision|1|||
17022484|NCT00627016|38166995|FG000|Overall Study|Adverse Event|1|||
17102985|NCT00112437|38241447|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17022485|NCT00627016|38166996|FG001|Overall Study|Adverse Event|1|||
16852776|NCT01830127|37803005|FG000|Overall Study|Withdrawal by Subject|1|||
16852777|NCT01830127|37803006|FG001|Overall Study|Withdrawal by Subject|1|||
17022486|NCT00627016|38166995|FG000|Overall Study|Protocol Violation|0|||
17022487|NCT00627016|38166996|FG001|Overall Study|Protocol Violation|2|||
17022488|NCT00627016|38166995|FG000|Overall Study|Lost to Follow-up|0|||
17022489|NCT00627016|38166996|FG001|Overall Study|Lost to Follow-up|1|||
17022490|NCT00627016|38166995|FG000|Overall Study|Withdrawal by Subject|2|||
17022491|NCT00627016|38166996|FG001|Overall Study|Withdrawal by Subject|1|||
17022492|NCT00627016|38166995|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
17022493|NCT00627016|38166996|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
17022494|NCT00627016|38166995|FG000|Overall Study|Lack of Efficacy|1|||
17022495|NCT00627016|38166996|FG001|Overall Study|Lack of Efficacy|0|||
17022496|NCT00627016|38166995|FG000|Overall Study|Placed on Excluded Drugs|1|||
17022497|NCT00627016|38166996|FG001|Overall Study|Placed on Excluded Drugs|0|||
17022498|NCT00627016|38166995|FG000|Overall Study|Pregnancy|1|||
17022499|NCT00627016|38166996|FG001|Overall Study|Pregnancy|0|||
17022500|NCT00794664|38167004|FG000|Treatment Period|Withdrawal by Subject|0|||
17022501|NCT00794664|38167005|FG001|Treatment Period|Withdrawal by Subject|2|||
17022502|NCT00794664|38167004|FG000|Treatment Period|Protocol non-compliance|0|||
17022503|NCT00794664|38167005|FG001|Treatment Period|Protocol non-compliance|1|||
17022504|NCT00794664|38167004|FG000|Treatment Period|Other|0|||
17022505|NCT00794664|38167005|FG001|Treatment Period|Other|1|||
17022506|NCT00794664|38167004|FG000|Treatment Period|Adverse Event|1|||
17022507|NCT00794664|38167005|FG001|Treatment Period|Adverse Event|8|||
17022508|NCT00794664|38167004|FG000|Follow-up Period|Other|1|||
17022509|NCT00794664|38167005|FG001|Follow-up Period|Other|2|||
17022510|NCT00794664|38167004|FG000|Follow-up Period|Withdrawal by Subject|0|||
17022511|NCT00794664|38167005|FG001|Follow-up Period|Withdrawal by Subject|2|||
17022512|NCT00794664|38167004|FG000|Follow-up Period|Protocol non-compliance|0|||
17022513|NCT00794664|38167005|FG001|Follow-up Period|Protocol non-compliance|1|||
17022514|NCT00444535|38167011|FG000|Overall Study|Withdrawal by Subject|5|||
17022515|NCT00444535|38167011|FG000|Overall Study|Physician Decision|5|||
17022516|NCT00444535|38167011|FG000|Overall Study|progressive disease|1|||
17022517|NCT00444535|38167011|FG000|Overall Study|Adverse Event|2|||
17022518|NCT00847613|38167019|FG000|Overall Study|Ongoing at cut-off date|250|||
17022519|NCT00847613|38167020|FG001|Overall Study|Ongoing at cut-off date|265|||
17022520|NCT00847613|38167021|FG002|Overall Study|Ongoing at cut-off date|64|||
17022521|NCT00847613|38167022|FG003|Overall Study|Ongoing at cut-off date|64|||
17022522|NCT00847613|38167019|FG000|Overall Study|Death|1|||
17022523|NCT00847613|38167020|FG001|Overall Study|Death|1|||
17022524|NCT00847613|38167021|FG002|Overall Study|Death|0|||
17022525|NCT00847613|38167022|FG003|Overall Study|Death|0|||
17022526|NCT00847613|38167019|FG000|Overall Study|Adverse Event|36|||
17022527|NCT00847613|38167020|FG001|Overall Study|Adverse Event|26|||
17022528|NCT00847613|38167021|FG002|Overall Study|Adverse Event|5|||
17022529|NCT00847613|38167022|FG003|Overall Study|Adverse Event|6|||
17022530|NCT00847613|38167019|FG000|Overall Study|Lack of Efficacy|7|||
17022531|NCT00847613|38167020|FG001|Overall Study|Lack of Efficacy|3|||
17022532|NCT00847613|38167021|FG002|Overall Study|Lack of Efficacy|3|||
17022533|NCT00847613|38167022|FG003|Overall Study|Lack of Efficacy|1|||
17022534|NCT00847613|38167019|FG000|Overall Study|Study terminated by Sponsor|1|||
17022535|NCT00847613|38167020|FG001|Overall Study|Study terminated by Sponsor|0|||
17022536|NCT00847613|38167021|FG002|Overall Study|Study terminated by Sponsor|2|||
17022537|NCT00847613|38167022|FG003|Overall Study|Study terminated by Sponsor|1|||
17022538|NCT00847613|38167019|FG000|Overall Study|Lost to Follow-up|5|||
17022539|NCT00847613|38167020|FG001|Overall Study|Lost to Follow-up|0|||
17022540|NCT00847613|38167021|FG002|Overall Study|Lost to Follow-up|0|||
17022541|NCT00847613|38167022|FG003|Overall Study|Lost to Follow-up|3|||
17022542|NCT00847613|38167019|FG000|Overall Study|Protocol Violation|6|||
17022543|NCT00847613|38167020|FG001|Overall Study|Protocol Violation|6|||
17022544|NCT00847613|38167021|FG002|Overall Study|Protocol Violation|3|||
17022545|NCT00847613|38167022|FG003|Overall Study|Protocol Violation|1|||
17022546|NCT00847613|38167019|FG000|Overall Study|Pregnancy|1|||
17022547|NCT00847613|38167020|FG001|Overall Study|Pregnancy|1|||
17022548|NCT00847613|38167021|FG002|Overall Study|Pregnancy|0|||
17022549|NCT00847613|38167022|FG003|Overall Study|Pregnancy|0|||
17022550|NCT00847613|38167019|FG000|Overall Study|Site closure|1|||
17022551|NCT00847613|38167020|FG001|Overall Study|Site closure|0|||
17022552|NCT00847613|38167021|FG002|Overall Study|Site closure|0|||
17022553|NCT00847613|38167022|FG003|Overall Study|Site closure|1|||
17022554|NCT00847613|38167019|FG000|Overall Study|Withdrawal by Subject|8|||
17022555|NCT00847613|38167020|FG001|Overall Study|Withdrawal by Subject|11|||
17022556|NCT00847613|38167021|FG002|Overall Study|Withdrawal by Subject|2|||
17022557|NCT00847613|38167022|FG003|Overall Study|Withdrawal by Subject|2|||
17022558|NCT00847613|38167019|FG000|Overall Study|Participant moved|4|||
17022559|NCT00847613|38167020|FG001|Overall Study|Participant moved|1|||
17022560|NCT00847613|38167021|FG002|Overall Study|Participant moved|0|||
17022561|NCT00847613|38167022|FG003|Overall Study|Participant moved|0|||
17022562|NCT00847613|38167019|FG000|Overall Study|Sponsor request|0|||
17022563|NCT00847613|38167020|FG001|Overall Study|Sponsor request|1|||
17022564|NCT00847613|38167021|FG002|Overall Study|Sponsor request|0|||
17022565|NCT00847613|38167022|FG003|Overall Study|Sponsor request|0|||
17022566|NCT00847613|38167019|FG000|Overall Study|Randomized, but not treated|0|||
17022567|NCT00847613|38167020|FG001|Overall Study|Randomized, but not treated|3|||
17022568|NCT00847613|38167021|FG002|Overall Study|Randomized, but not treated|0|||
17022569|NCT00847613|38167022|FG003|Overall Study|Randomized, but not treated|0|||
17022570|NCT00847613|38167019|FG000|Overall Study|Other|1|||
17022571|NCT00847613|38167020|FG001|Overall Study|Other|1|||
17022572|NCT00847613|38167021|FG002|Overall Study|Other|2|||
17022573|NCT00847613|38167022|FG003|Overall Study|Other|0|||
17022574|NCT00794196|38167041|FG000|Overall Study|Lost to Follow-up|5|||
17022575|NCT00794196|38167042|FG001|Overall Study|Lost to Follow-up|23|||
17022576|NCT00807092|38167050|FG000|Overall Study|Adverse Event|0|||
17022577|NCT00807092|38167051|FG001|Overall Study|Adverse Event|1|||
17022578|NCT00807092|38167050|FG000|Overall Study|Protocol Violation|0|||
17022579|NCT00807092|38167051|FG001|Overall Study|Protocol Violation|2|||
17022580|NCT00807092|38167050|FG000|Overall Study|Withdrawal by Subject|1|||
16852778|NCT01830127|37803005|FG000|Overall Study|Other reason not defined above|0|||
17022581|NCT00807092|38167051|FG001|Overall Study|Withdrawal by Subject|0|||
17022582|NCT00807092|38167050|FG000|Overall Study|CGMS data collection failed|0|||
17022583|NCT00807092|38167051|FG001|Overall Study|CGMS data collection failed|1|||
17022584|NCT00794118|38167057|FG000|Overall Study|Lost to Follow-up|16|||
17022585|NCT00794118|38167057|FG000|Overall Study|Withdrawal by Subject|9|||
17022586|NCT00794118|38167057|FG000|Overall Study|Changed hospital center|2|||
17022587|NCT00640042|38167061|FG000|Enrollment|Did not receive study drug|83|||
17022588|NCT00807014|38167067|FG000|Overall Study|Participant Considered Disease Cured|13|||
17022589|NCT00807014|38167068|FG001|Overall Study|Participant Considered Disease Cured|2|||
17022590|NCT00807014|38167067|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
17022591|NCT00807014|38167068|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
17022592|NCT00807014|38167067|FG000|Overall Study|Protocol Violation|2|||
17022593|NCT00807014|38167068|FG001|Overall Study|Protocol Violation|8|||
17022594|NCT00807014|38167067|FG000|Overall Study|Adverse Event|0|||
17022595|NCT00807014|38167068|FG001|Overall Study|Adverse Event|2|||
17022596|NCT00807014|38167067|FG000|Overall Study|Lost to Follow-up|9|||
17022597|NCT00807014|38167068|FG001|Overall Study|Lost to Follow-up|7|||
17022598|NCT00807014|38167067|FG000|Overall Study|Recovery|1|||
17022599|NCT00807014|38167068|FG001|Overall Study|Recovery|0|||
17022600|NCT00807014|38167067|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
17022601|NCT00807014|38167068|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
17022602|NCT00847535|38167074|FG000|Overall Study|Withdrawal by Subject|2|||
17022603|NCT00847535|38167075|FG001|Overall Study|Withdrawal by Subject|1|||
17022604|NCT00847535|38167076|FG002|Overall Study|Withdrawal by Subject|1|||
17022605|NCT00847535|38167074|FG000|Overall Study|Lost to Follow-up|0|||
17022606|NCT00847535|38167075|FG001|Overall Study|Lost to Follow-up|1|||
17022607|NCT00847535|38167076|FG002|Overall Study|Lost to Follow-up|0|||
17022608|NCT00592631|38167083|FG000|Overall Study|Lost to Follow-up|0|||
17022609|NCT00592631|38167084|FG001|Overall Study|Lost to Follow-up|2|||
17022610|NCT00791388|38167095|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
17022611|NCT00791388|38167096|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
17022612|NCT00791388|38167097|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
17022613|NCT00791388|38167098|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
17022614|NCT00791388|38167099|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
17022615|NCT00791388|38167095|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
17022616|NCT00791388|38167096|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
16934391|NCT01205581|38078929|FG000|Overall Study|Withdrawal by Subject|1|||
16934392|NCT01205581|38078930|FG001|Overall Study|Withdrawal by Subject|0|||
16934393|NCT01205581|38078931|FG002|Overall Study|Withdrawal by Subject|0|||
16934394|NCT01205581|38078932|FG003|Overall Study|Withdrawal by Subject|0|||
16934395|NCT01205581|38078933|FG004|Overall Study|Withdrawal by Subject|0|||
16934396|NCT01205581|38078934|FG005|Overall Study|Withdrawal by Subject|0|||
16934397|NCT01205269|38078965|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
17022617|NCT00791388|38167097|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
17022618|NCT00791388|38167098|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
17022619|NCT00791388|38167099|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
17022620|NCT00791388|38167095|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
17022621|NCT00791388|38167096|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
17102986|NCT00112437|38241448|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102987|NCT00112437|38241449|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102988|NCT00112437|38241450|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102989|NCT00112437|38241451|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16852779|NCT01830127|37803006|FG001|Overall Study|Other reason not defined above|2|||
16852780|NCT01614067|37803014|FG000|Overall Study|Pregnancy|1|||
16852781|NCT01614067|37803015|FG001|Overall Study|Pregnancy|0|||
16852782|NCT01614067|37803014|FG000|Overall Study|Physician Decision|6|||
16852783|NCT01614067|37803015|FG001|Overall Study|Physician Decision|5|||
16852784|NCT01614067|37803014|FG000|Overall Study|Withdrawal by Subject|0|||
16852785|NCT01614067|37803015|FG001|Overall Study|Withdrawal by Subject|1|||
17022622|NCT00791388|38167097|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
17022623|NCT00791388|38167098|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
17022624|NCT00791388|38167099|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
17022625|NCT00794040|38167113|FG000|Overall Study|Withdrawal by Subject|3|||
16934398|NCT01205269|38078966|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
17022626|NCT00794040|38167114|FG001|Overall Study|Withdrawal by Subject|4|||
17022627|NCT00794040|38167113|FG000|Overall Study|Physician Decision|0|||
16934399|NCT01205269|38078967|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
16934400|NCT01205269|38078968|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
16934401|NCT01205269|38078969|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
16934402|NCT01205269|38078970|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
16934403|NCT01240915|38078995|FG000|Overall Study|Adverse Event|0|||
16934404|NCT01240915|38078996|FG001|Overall Study|Adverse Event|0|||
16934405|NCT01240915|38078997|FG002|Overall Study|Adverse Event|0|||
16934406|NCT01240915|38078998|FG003|Overall Study|Adverse Event|1|||
17022628|NCT00794040|38167114|FG001|Overall Study|Physician Decision|1|||
17022629|NCT00813488|38167120|FG000|Titration Period 1|Adverse Event|6|||
16934407|NCT01240915|38078999|FG004|Overall Study|Adverse Event|0|||
16934408|NCT01240915|38079000|FG005|Overall Study|Adverse Event|2|||
16934409|NCT01240915|38079001|FG006|Overall Study|Adverse Event|0|||
16934410|NCT01240915|38079002|FG007|Overall Study|Adverse Event|0|||
16934411|NCT01240915|38079003|FG008|Overall Study|Adverse Event|1|||
16934412|NCT01240915|38078995|FG000|Overall Study|Lost to Follow-up|0|||
16934413|NCT01240915|38078996|FG001|Overall Study|Lost to Follow-up|0|||
16934414|NCT01240915|38078997|FG002|Overall Study|Lost to Follow-up|0|||
16934415|NCT01240915|38078998|FG003|Overall Study|Lost to Follow-up|0|||
16934416|NCT01240915|38078999|FG004|Overall Study|Lost to Follow-up|1|||
16934417|NCT01240915|38079000|FG005|Overall Study|Lost to Follow-up|1|||
16934418|NCT01240915|38079001|FG006|Overall Study|Lost to Follow-up|0|||
17022630|NCT00813488|38167121|FG001|Titration Period 1|Adverse Event|1|||
17022631|NCT00813488|38167120|FG000|Titration Period 1|Lack of Efficacy|9|||
17022632|NCT00813488|38167121|FG001|Titration Period 1|Lack of Efficacy|7|||
17022633|NCT00813488|38167120|FG000|Titration Period 1|Withdrawal by Subject|2|||
17022634|NCT00813488|38167121|FG001|Titration Period 1|Withdrawal by Subject|2|||
17022635|NCT00813488|38167120|FG000|Titration Period 1|Protocol Violation|4|||
17022636|NCT00813488|38167121|FG001|Titration Period 1|Protocol Violation|3|||
17022637|NCT00813488|38167120|FG000|Titration Period 1|Non-compliance to study medication|4|||
17022638|NCT00813488|38167121|FG001|Titration Period 1|Non-compliance to study medication|1|||
17022639|NCT00813488|38167120|FG000|Titration Period 1|Non-compliance to study procedures|2|||
17022640|NCT00813488|38167121|FG001|Titration Period 1|Non-compliance to study procedures|2|||
17022641|NCT00813488|38167120|FG000|Titration Period 1|Technical Difficulties|0|||
17022642|NCT00813488|38167121|FG001|Titration Period 1|Technical Difficulties|1|||
17022643|NCT00813488|38167120|FG000|Titration Period 2|Adverse Event|2|||
17022644|NCT00813488|38167121|FG001|Titration Period 2|Adverse Event|3|||
17022645|NCT00813488|38167120|FG000|Titration Period 2|Lack of Efficacy|8|||
17022646|NCT00813488|38167121|FG001|Titration Period 2|Lack of Efficacy|4|||
17022647|NCT00813488|38167120|FG000|Titration Period 2|Protocol Violation|3|||
17022648|NCT00813488|38167121|FG001|Titration Period 2|Protocol Violation|2|||
17022649|NCT00813488|38167120|FG000|Titration Period 2|Lost to Follow-up|1|||
17022650|NCT00813488|38167121|FG001|Titration Period 2|Lost to Follow-up|0|||
17022651|NCT00813488|38167120|FG000|Titration Period 2|Non-compliance with study procedures|2|||
17022652|NCT00813488|38167121|FG001|Titration Period 2|Non-compliance with study procedures|1|||
17022653|NCT00813488|38167120|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
17022654|NCT00813488|38167121|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
17022655|NCT00813488|38167120|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
17022656|NCT00813488|38167121|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
17022657|NCT00813488|38167120|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
17022658|NCT00813488|38167121|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
17022659|NCT00813488|38167120|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
16934419|NCT01240915|38079002|FG007|Overall Study|Lost to Follow-up|1|||
16934420|NCT01240915|38079003|FG008|Overall Study|Lost to Follow-up|1|||
16934421|NCT01240915|38078995|FG000|Overall Study|Withdrawal by Subject|2|||
16934422|NCT01240915|38078996|FG001|Overall Study|Withdrawal by Subject|1|||
16934423|NCT01240915|38078997|FG002|Overall Study|Withdrawal by Subject|0|||
16934424|NCT01240915|38078998|FG003|Overall Study|Withdrawal by Subject|2|||
16934425|NCT01240915|38078999|FG004|Overall Study|Withdrawal by Subject|0|||
17102990|NCT00112437|38241452|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
17102991|NCT00112437|38241453|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102992|NCT00112437|38241454|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
17102993|NCT00112437|38241455|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16934426|NCT01240915|38079000|FG005|Overall Study|Withdrawal by Subject|4|||
16934427|NCT01240915|38079001|FG006|Overall Study|Withdrawal by Subject|2|||
16934428|NCT01240915|38079002|FG007|Overall Study|Withdrawal by Subject|3|||
16934429|NCT01240915|38079003|FG008|Overall Study|Withdrawal by Subject|3|||
16934430|NCT01240915|38078995|FG000|Overall Study|Other|0|||
17022660|NCT00813488|38167121|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
17022661|NCT00813488|38167120|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
17022662|NCT00813488|38167121|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
17022663|NCT00813488|38167120|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
16934431|NCT01240915|38078996|FG001|Overall Study|Other|0|||
16934432|NCT01240915|38078997|FG002|Overall Study|Other|0|||
16934433|NCT01240915|38078998|FG003|Overall Study|Other|0|||
16934434|NCT01240915|38078999|FG004|Overall Study|Other|2|||
16934435|NCT01240915|38079000|FG005|Overall Study|Other|0|||
16934436|NCT01240915|38079001|FG006|Overall Study|Other|0|||
16934437|NCT01240915|38079002|FG007|Overall Study|Other|0|||
16934438|NCT01240915|38079003|FG008|Overall Study|Other|0|||
16934439|NCT01240915|38078995|FG000|Overall Study|Insufficient Clinical Response|0|||
16934440|NCT01240915|38078996|FG001|Overall Study|Insufficient Clinical Response|0|||
16934441|NCT01240915|38078997|FG002|Overall Study|Insufficient Clinical Response|0|||
16934442|NCT01240915|38078998|FG003|Overall Study|Insufficient Clinical Response|0|||
16934443|NCT01240915|38078999|FG004|Overall Study|Insufficient Clinical Response|1|||
16934444|NCT01240915|38079000|FG005|Overall Study|Insufficient Clinical Response|3|||
16934445|NCT01240915|38079001|FG006|Overall Study|Insufficient Clinical Response|6|||
16934446|NCT01240915|38079002|FG007|Overall Study|Insufficient Clinical Response|0|||
16934447|NCT01240915|38079003|FG008|Overall Study|Insufficient Clinical Response|3|||
16934448|NCT01239745|38079025|FG000|Overall Study|Study terminated by sponsor|45|||
16934449|NCT01239745|38079025|FG000|Overall Study|Adverse Event|1|||
16934450|NCT01239472|38079031|FG000|Overall Study|Withdrawal by Subject|5|||
16934451|NCT01239472|38079032|FG001|Overall Study|Withdrawal by Subject|1|||
16934452|NCT01239472|38079031|FG000|Overall Study|Adverse Event|0|||
16934453|NCT01239472|38079032|FG001|Overall Study|Adverse Event|1|||
16934454|NCT01239472|38079031|FG000|Overall Study|Lack of Efficacy|0|||
16934455|NCT01239472|38079032|FG001|Overall Study|Lack of Efficacy|1|||
16934456|NCT01239394|38079040|FG000|Overall Study|Adverse Event|1|||
16934457|NCT01229449|38079049|FG000|Overall Study|Withdrawal by Subject|0|||
16934458|NCT01229449|38079050|FG001|Overall Study|Withdrawal by Subject|3|||
16934459|NCT01229449|38079051|FG002|Overall Study|Withdrawal by Subject|0|||
16934460|NCT01229449|38079052|FG003|Overall Study|Withdrawal by Subject|1|||
16934461|NCT01229449|38079053|FG004|Overall Study|Withdrawal by Subject|1|||
16934462|NCT01229449|38079049|FG000|Overall Study|Lost to Follow-up|1|||
17022664|NCT00813488|38167121|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
17022665|NCT00813488|38167120|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
17022666|NCT00813488|38167121|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
17022667|NCT00813488|38167120|FG000|Double-blind Treatment Period 2|Other|1|||
17022668|NCT00813488|38167121|FG001|Double-blind Treatment Period 2|Other|0|||
17022669|NCT00813488|38167120|FG000|Open-label Extension|Adverse Event|1|||
16934463|NCT01229449|38079050|FG001|Overall Study|Lost to Follow-up|1|||
16934464|NCT01229449|38079051|FG002|Overall Study|Lost to Follow-up|1|||
16934465|NCT01229449|38079052|FG003|Overall Study|Lost to Follow-up|0|||
16934466|NCT01229449|38079053|FG004|Overall Study|Lost to Follow-up|0|||
16934467|NCT01229449|38079049|FG000|Overall Study|Physician Decision|0|||
16934468|NCT01229449|38079050|FG001|Overall Study|Physician Decision|0|||
16934469|NCT01229449|38079051|FG002|Overall Study|Physician Decision|1|||
16934470|NCT01229449|38079052|FG003|Overall Study|Physician Decision|0|||
16934471|NCT01229449|38079053|FG004|Overall Study|Physician Decision|0|||
16934472|NCT01239316|38079065|FG000|Overall Study|Progression/Relapse|11|||
16934473|NCT01239316|38079065|FG000|Overall Study|Adverse Event|1|||
16934474|NCT01239160|38079071|FG000|Overall Study|Lost to Follow-up|3|||
16934475|NCT01239160|38079072|FG001|Overall Study|Lost to Follow-up|5|||
16934476|NCT01239160|38079073|FG002|Overall Study|Lost to Follow-up|0|||
16934477|NCT01239160|38079071|FG000|Overall Study|Withdrawal by Subject|17|||
16934478|NCT01239160|38079072|FG001|Overall Study|Withdrawal by Subject|6|||
17022670|NCT00813488|38167121|FG001|Open-label Extension|Adverse Event|2|||
17022671|NCT00813488|38167120|FG000|Open-label Extension|Lack of Efficacy|3|||
17022672|NCT00813488|38167121|FG001|Open-label Extension|Lack of Efficacy|0|||
17022673|NCT00813488|38167120|FG000|Open-label Extension|Withdrawal by Subject|0|||
16934479|NCT01239160|38079073|FG002|Overall Study|Withdrawal by Subject|2|||
16934480|NCT01239160|38079071|FG000|Overall Study|Physician Decision|5|||
16934481|NCT01239160|38079072|FG001|Overall Study|Physician Decision|7|||
16934482|NCT01239160|38079073|FG002|Overall Study|Physician Decision|2|||
16934483|NCT01239160|38079071|FG000|Overall Study|Early Termination Due to Study Closure|0|||
16934484|NCT01239160|38079072|FG001|Overall Study|Early Termination Due to Study Closure|1|||
16934485|NCT01239160|38079073|FG002|Overall Study|Early Termination Due to Study Closure|6|||
16934486|NCT01239121|38079082|FG000|Overall Study|Withdrawal by Subject|2|||
16934487|NCT01239121|38079083|FG001|Overall Study|Withdrawal by Subject|4|||
16934488|NCT01239121|38079084|FG002|Overall Study|Withdrawal by Subject|0|||
16934489|NCT01239043|38079094|FG000|Overall Study|Protocol Violation|2|||
16934490|NCT01239043|38079095|FG001|Overall Study|Protocol Violation|1|||
16934491|NCT01238848|38079103|FG000|Overall Study|Physician Decision|13|||
16934492|NCT01238848|38079104|FG001|Overall Study|Physician Decision|5|||
17022674|NCT00813488|38167121|FG001|Open-label Extension|Withdrawal by Subject|2|||
16934493|NCT01238575|38079112|FG000|Overall Study|Lack of Efficacy|2|||
16934494|NCT01238575|38079113|FG001|Overall Study|Lack of Efficacy|4|||
17022675|NCT00813488|38167120|FG000|Open-label Extension|Protocol Violation|1|||
17022676|NCT00813488|38167121|FG001|Open-label Extension|Protocol Violation|2|||
17022677|NCT00813488|38167120|FG000|Open-label Extension|Non-compliance study medication|4|||
17022678|NCT00813488|38167121|FG001|Open-label Extension|Non-compliance study medication|0|||
17022679|NCT00813488|38167120|FG000|Open-label Extension|Non-compliance study procedures|2|||
17022680|NCT00813488|38167121|FG001|Open-label Extension|Non-compliance study procedures|1|||
17022681|NCT00813488|38167120|FG000|Open-label Extension|Other|1|||
17022682|NCT00813488|38167121|FG001|Open-label Extension|Other|0|||
17022683|NCT00797316|38167133|FG000|Overall Study|Administrative problems|1|||
17022684|NCT00797316|38167134|FG001|Overall Study|Administrative problems|0|||
17022685|NCT00797316|38167133|FG000|Overall Study|Adverse Event|5|||
17022686|NCT00797316|38167134|FG001|Overall Study|Adverse Event|3|||
17022687|NCT00797316|38167133|FG000|Overall Study|Lost to Follow-up|4|||
17022688|NCT00797316|38167134|FG001|Overall Study|Lost to Follow-up|8|||
17022689|NCT00797316|38167133|FG000|Overall Study|Protocol Deviation|1|||
17022690|NCT00797316|38167134|FG001|Overall Study|Protocol Deviation|2|||
17022691|NCT00797316|38167133|FG000|Overall Study|Patient withdrew consent|12|||
17022692|NCT00797316|38167134|FG001|Overall Study|Patient withdrew consent|6|||
17022693|NCT00797316|38167133|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
17022694|NCT00797316|38167134|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
17022695|NCT00587964|38167140|FG000|Overall Study|Withdrawal by Subject|1|||
17022696|NCT00587964|38167140|FG000|Overall Study|Lost to Follow-up|1|||
17022697|NCT00587964|38167140|FG000|Overall Study|Patient found to be ineligible|1|||
17022698|NCT00587964|38167140|FG000|Overall Study|Patient did not receive intervention|5|||
17022699|NCT00587964|38167140|FG000|Overall Study|Progression of Disease|4|||
17022700|NCT00590954|38167144|FG000|Overall Study|Inevaluable|2|||
17022701|NCT00791076|38167150|FG000|Overall Study|Study was terminated,PI left institution|8|||
17022702|NCT00590720|38167158|FG000|Overall Study|Lost to Follow-up|1|||
17022703|NCT00590720|38167159|FG001|Overall Study|Lost to Follow-up|0|||
17022704|NCT00590720|38167158|FG000|Overall Study|Withdrawal by Subject|0|||
17022705|NCT00590720|38167159|FG001|Overall Study|Withdrawal by Subject|1|||
17022706|NCT00625378|38167167|FG000|Overall Study|Adverse Event|22|||
17022707|NCT00625378|38167168|FG001|Overall Study|Adverse Event|0|||
17022708|NCT00625378|38167167|FG000|Overall Study|Withdrawal by Subject|16|||
17022709|NCT00625378|38167168|FG001|Overall Study|Withdrawal by Subject|0|||
17022710|NCT00625378|38167167|FG000|Overall Study|Death|38|||
17022711|NCT00625378|38167168|FG001|Overall Study|Death|0|||
17022712|NCT00625378|38167167|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
17022713|NCT00625378|38167168|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
17022714|NCT00625378|38167167|FG000|Overall Study|Lost to Follow-up|17|||
17022715|NCT00625378|38167168|FG001|Overall Study|Lost to Follow-up|0|||
17022716|NCT00625378|38167167|FG000|Overall Study|Non-compliant with study medication|3|||
17022717|NCT00625378|38167168|FG001|Overall Study|Non-compliant with study medication|0|||
17022718|NCT00625378|38167167|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
17022719|NCT00625378|38167168|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
17022720|NCT00625378|38167167|FG000|Overall Study|Medical decision|1|||
17022721|NCT00625378|38167168|FG001|Overall Study|Medical decision|0|||
17022722|NCT00625378|38167167|FG000|Overall Study|Multiple toxicities|1|||
17022723|NCT00625378|38167168|FG001|Overall Study|Multiple toxicities|0|||
17022724|NCT00625378|38167167|FG000|Overall Study|New cancer|1|||
17022725|NCT00625378|38167168|FG001|Overall Study|New cancer|0|||
17022726|NCT00625378|38167167|FG000|Overall Study|PTA program|2|||
17022727|NCT00625378|38167168|FG001|Overall Study|PTA program|0|||
17022728|NCT00625378|38167167|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
17022729|NCT00625378|38167168|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
16934495|NCT01238575|38079112|FG000|Overall Study|Adverse Event|2|||
16934496|NCT01238575|38079113|FG001|Overall Study|Adverse Event|0|||
16934497|NCT01237951|38079119|FG000|Overall Study|Death|1|||
16934498|NCT01237678|38079126|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
16934499|NCT01237678|38079127|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
16934500|NCT01237678|38079128|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
16934501|NCT01237678|38079126|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
16934502|NCT01237678|38079127|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
17022730|NCT00625378|38167167|FG000|Overall Study|Sponsor decision|1|||
17022731|NCT00625378|38167168|FG001|Overall Study|Sponsor decision|0|||
17022732|NCT00625378|38167167|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
17022733|NCT00625378|38167168|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
17022734|NCT00625378|38167167|FG000|Overall Study|Switch to commercial drug|6|||
17022735|NCT00625378|38167168|FG001|Overall Study|Switch to commercial drug|1|||
17022736|NCT00625378|38167167|FG000|Overall Study|Missing|2|||
17022737|NCT00625378|38167168|FG001|Overall Study|Missing|0|||
17022738|NCT00625378|38167167|FG000|Overall Study|End of treatment not available|2|||
17022739|NCT00625378|38167168|FG001|Overall Study|End of treatment not available|0|||
17022740|NCT00625378|38167167|FG000|Overall Study|Never treated|2|||
17022741|NCT00625378|38167168|FG001|Overall Study|Never treated|0|||
17022742|NCT00806624|38167177|FG000|Overall Study|Adverse Event|2|||
17022743|NCT00806624|38167178|FG001|Overall Study|Adverse Event|8|||
17022744|NCT00806624|38167179|FG002|Overall Study|Adverse Event|0|||
17022745|NCT00806624|38167177|FG000|Overall Study|Death|0|||
16934503|NCT01237678|38079128|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
16934504|NCT01237678|38079126|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
16934505|NCT01237678|38079127|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
16934506|NCT01237678|38079128|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
16934507|NCT01237678|38079126|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
16934508|NCT01237678|38079127|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
16934509|NCT01237678|38079128|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
16934510|NCT01237678|38079126|FG000|Phase II|Adverse Event|0|||
16934511|NCT01237678|38079127|FG001|Phase II|Adverse Event|39|||
16934512|NCT01237678|38079128|FG002|Phase II|Adverse Event|9|||
16934513|NCT01237678|38079126|FG000|Phase II|Death|0|||
16934514|NCT01237678|38079127|FG001|Phase II|Death|0|||
16934515|NCT01237678|38079128|FG002|Phase II|Death|2|||
16934516|NCT01237678|38079126|FG000|Phase II|Lack of Efficacy|0|||
17022746|NCT00806624|38167178|FG001|Overall Study|Death|1|||
17022747|NCT00806624|38167179|FG002|Overall Study|Death|1|||
17022748|NCT00806624|38167177|FG000|Overall Study|Lost to Follow-up|1|||
17022749|NCT00806624|38167178|FG001|Overall Study|Lost to Follow-up|0|||
17022750|NCT00806624|38167179|FG002|Overall Study|Lost to Follow-up|1|||
17022751|NCT00806624|38167177|FG000|Overall Study|Withdrawal by Subject|6|||
17022752|NCT00806624|38167178|FG001|Overall Study|Withdrawal by Subject|3|||
17022753|NCT00806624|38167179|FG002|Overall Study|Withdrawal by Subject|3|||
17022754|NCT00806624|38167177|FG000|Overall Study|discontinued before start of treatment|0|||
17022755|NCT00806624|38167178|FG001|Overall Study|discontinued before start of treatment|0|||
17022756|NCT00806624|38167179|FG002|Overall Study|discontinued before start of treatment|1|||
17022757|NCT00806546|38167187|FG000|Overall Study|Enrolled, not treated|35|||
17022758|NCT00806546|38167187|FG000|Overall Study|Lost to Follow-up|32|||
17022759|NCT00806546|38167187|FG000|Overall Study|Adverse Event|74|||
17022760|NCT00806546|38167187|FG000|Overall Study|Withdrawal by Subject|75|||
17022761|NCT00806546|38167187|FG000|Overall Study|Protocol Violation|49|||
17022762|NCT00806546|38167187|FG000|Overall Study|Various|42|||
17022763|NCT00624832|38167195|FG000|Overall Study|Adverse Event|0|||
17022764|NCT00624832|38167196|FG001|Overall Study|Adverse Event|1|||
17022765|NCT00624832|38167197|FG002|Overall Study|Adverse Event|0|||
17022766|NCT00624832|38167198|FG003|Overall Study|Adverse Event|1|||
17022767|NCT00624832|38167195|FG000|Overall Study|Abnormal Laboratory Value|2|||
17022768|NCT00624832|38167196|FG001|Overall Study|Abnormal Laboratory Value|0|||
17022769|NCT00624832|38167197|FG002|Overall Study|Abnormal Laboratory Value|0|||
17022770|NCT00624832|38167198|FG003|Overall Study|Abnormal Laboratory Value|0|||
17022771|NCT00633880|38167210|FG000|Open Label Titration|Lack of Efficacy|1|||
17022772|NCT00633880|38167211|FG001|Open Label Titration|Lack of Efficacy|0|||
17022773|NCT00633880|38167212|FG002|Open Label Titration|Lack of Efficacy|0|||
17022774|NCT00633880|38167210|FG000|Open Label Titration|Adverse Event|13|||
17022775|NCT00633880|38167211|FG001|Open Label Titration|Adverse Event|0|||
17022776|NCT00633880|38167212|FG002|Open Label Titration|Adverse Event|0|||
17022777|NCT00633880|38167210|FG000|Open Label Titration|Treatment Failure|55|||
17022778|NCT00633880|38167211|FG001|Open Label Titration|Treatment Failure|0|||
17022779|NCT00633880|38167212|FG002|Open Label Titration|Treatment Failure|0|||
17022780|NCT00633880|38167210|FG000|Open Label Titration|Protocol Violation|6|||
17022781|NCT00633880|38167211|FG001|Open Label Titration|Protocol Violation|0|||
17022782|NCT00633880|38167212|FG002|Open Label Titration|Protocol Violation|0|||
17022783|NCT00633880|38167210|FG000|Open Label Titration|Physician Decision|1|||
17022784|NCT00633880|38167211|FG001|Open Label Titration|Physician Decision|0|||
17022785|NCT00633880|38167212|FG002|Open Label Titration|Physician Decision|0|||
17022786|NCT00633880|38167210|FG000|Open Label Titration|Withdrawal by Subject|4|||
17022787|NCT00633880|38167211|FG001|Open Label Titration|Withdrawal by Subject|0|||
17022788|NCT00633880|38167212|FG002|Open Label Titration|Withdrawal by Subject|0|||
17022789|NCT00590564|38167219|FG000|Overall Study|Withdrawal by Subject|4|||
17022790|NCT00590564|38167219|FG000|Overall Study|Lost to Follow-up|6|||
17022791|NCT00590564|38167219|FG000|Overall Study|Protocol Violation|1|||
17022792|NCT00590564|38167219|FG000|Overall Study|Patient Found to be Ineligible|1|||
17022793|NCT00590564|38167219|FG000|Overall Study|Patient Non-compliance|6|||
17022794|NCT00631696|38167225|FG000|Overall Study|Entered, not randomized to treatment|1|||
17022795|NCT00631696|38167226|FG001|Overall Study|Entered, not randomized to treatment|1|||
17022796|NCT00631696|38167225|FG000|Overall Study|Discontinued after database release date|1|||
17022797|NCT00631696|38167226|FG001|Overall Study|Discontinued after database release date|0|||
17022798|NCT00631696|38167225|FG000|Overall Study|Follow up after database release date|1|||
17022799|NCT00631696|38167226|FG001|Overall Study|Follow up after database release date|0|||
17022800|NCT00631696|38167225|FG000|Overall Study|Lost to Follow-up|7|||
17022801|NCT00631696|38167226|FG001|Overall Study|Lost to Follow-up|10|||
17022802|NCT00631696|38167225|FG000|Overall Study|Withdrawal by Subject|2|||
17022803|NCT00631696|38167226|FG001|Overall Study|Withdrawal by Subject|9|||
17022804|NCT00631696|38167225|FG000|Overall Study|Other|8|||
17022805|NCT00631696|38167226|FG001|Overall Study|Other|8|||
17022806|NCT00631696|38167225|FG000|Overall Study|Protocol Violation|9|||
17022807|NCT00631696|38167226|FG001|Overall Study|Protocol Violation|9|||
17022808|NCT00631696|38167225|FG000|Overall Study|Study terminated by sponsor|3|||
17022809|NCT00631696|38167226|FG001|Overall Study|Study terminated by sponsor|3|||
17022810|NCT00631696|38167225|FG000|Overall Study|Adverse Event|5|||
17022811|NCT00631696|38167226|FG001|Overall Study|Adverse Event|0|||
17022812|NCT00631540|38167232|FG000|Overall Study|Withdrawal by Subject|5|||
16934517|NCT01237678|38079127|FG001|Phase II|Lack of Efficacy|25|||
16934518|NCT01237678|38079128|FG002|Phase II|Lack of Efficacy|3|||
16934519|NCT01237678|38079126|FG000|Phase II|Withdrawal by Subject|0|||
16934520|NCT01237678|38079127|FG001|Phase II|Withdrawal by Subject|1|||
16934521|NCT01237678|38079128|FG002|Phase II|Withdrawal by Subject|5|||
16934522|NCT01237678|38079126|FG000|Phase II|Completed Cycles 4-6|0|||
16934523|NCT01237678|38079127|FG001|Phase II|Completed Cycles 4-6|11|||
16934524|NCT01237678|38079128|FG002|Phase II|Completed Cycles 4-6|21|||
16934525|NCT01237678|38079126|FG000|Phase II|Sponsor Decision/Study Closed|0|||
17022813|NCT00631540|38167232|FG000|Overall Study|Death|4|||
17022814|NCT00631540|38167232|FG000|Overall Study|Lost to Follow-up|2|||
17022815|NCT00631540|38167232|FG000|Overall Study|Core Lab Data Unavailable|3|||
17022816|NCT00630916|38167236|FG000|Overall Study|Death|110|||
17022817|NCT00630916|38167236|FG000|Overall Study|Explant|8|||
17022818|NCT00630916|38167236|FG000|Overall Study|Lost to Follow-up|5|||
17022819|NCT00630916|38167236|FG000|Overall Study|Withdrawal by Subject|30|||
17022820|NCT00630916|38167236|FG000|Overall Study|Protocol Violation|7|||
17022821|NCT00630916|38167236|FG000|Overall Study|Physician Decision|47|||
17022822|NCT00630916|38167236|FG000|Overall Study|Lack of Efficacy|3|||
17022823|NCT00630292|38167240|FG000|Overall Study|Withdrawal by Subject|1|||
17022824|NCT00626548|38167246|FG000|Overall Study|Adverse Event|164|||
17022825|NCT00626548|38167247|FG001|Overall Study|Adverse Event|44|||
16852786|NCT01614067|37803014|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
16852787|NCT01614067|37803015|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
16852788|NCT01777490|37803025|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
16852789|NCT01777490|37803026|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
16852790|NCT01777490|37803027|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
16934526|NCT01237678|38079127|FG001|Phase II|Sponsor Decision/Study Closed|18|||
16934527|NCT01237678|38079128|FG002|Phase II|Sponsor Decision/Study Closed|7|||
16852791|NCT01777490|37803028|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
16852792|NCT01397409|37803050|FG000|Stage 2|Adverse Event|0|||
16852793|NCT01397409|37803051|FG001|Stage 2|Adverse Event|0|||
16852794|NCT01397409|37803052|FG002|Stage 2|Adverse Event|0|||
16852795|NCT01397409|37803053|FG003|Stage 2|Adverse Event|0|||
16852796|NCT01397409|37803054|FG004|Stage 2|Adverse Event|6|||
16852797|NCT01397409|37803055|FG005|Stage 2|Adverse Event|3|||
16852798|NCT01397409|37803056|FG006|Stage 2|Adverse Event|0|||
16852799|NCT01397409|37803057|FG007|Stage 2|Adverse Event|0|||
16852800|NCT01397409|37803058|FG008|Stage 2|Adverse Event|0|||
16852801|NCT01397409|37803059|FG009|Stage 2|Adverse Event|0|||
16852802|NCT01397409|37803050|FG000|Stage 2|Personal Reasons|0|||
16852803|NCT01397409|37803051|FG001|Stage 2|Personal Reasons|0|||
16852804|NCT01397409|37803052|FG002|Stage 2|Personal Reasons|0|||
16852805|NCT01397409|37803053|FG003|Stage 2|Personal Reasons|0|||
16852806|NCT01397409|37803054|FG004|Stage 2|Personal Reasons|1|||
16852807|NCT01397409|37803055|FG005|Stage 2|Personal Reasons|0|||
16852808|NCT01397409|37803056|FG006|Stage 2|Personal Reasons|0|||
16852809|NCT01397409|37803057|FG007|Stage 2|Personal Reasons|0|||
16852810|NCT01397409|37803058|FG008|Stage 2|Personal Reasons|0|||
16852811|NCT01397409|37803059|FG009|Stage 2|Personal Reasons|0|||
16852812|NCT01397409|37803050|FG000|Stage 2|Other Miscellaneous Reasons|0|||
16852813|NCT01397409|37803051|FG001|Stage 2|Other Miscellaneous Reasons|0|||
16852814|NCT01397409|37803052|FG002|Stage 2|Other Miscellaneous Reasons|0|||
16852815|NCT01397409|37803053|FG003|Stage 2|Other Miscellaneous Reasons|0|||
16852816|NCT01397409|37803054|FG004|Stage 2|Other Miscellaneous Reasons|1|||
16852817|NCT01397409|37803055|FG005|Stage 2|Other Miscellaneous Reasons|1|||
16934528|NCT01237678|38079126|FG000|Phase II|Randomized but were not treated|0|||
16934529|NCT01237678|38079127|FG001|Phase II|Randomized but were not treated|4|||
16934530|NCT01237678|38079128|FG002|Phase II|Randomized but were not treated|3|||
17022826|NCT00626548|38167246|FG000|Overall Study|Withdrawal by Subject|42|||
17022827|NCT00626548|38167247|FG001|Overall Study|Withdrawal by Subject|46|||
17022828|NCT00626548|38167246|FG000|Overall Study|Protocol Violation|4|||
17022829|NCT00626548|38167247|FG001|Overall Study|Protocol Violation|11|||
17022830|NCT00626548|38167246|FG000|Overall Study|Lost to Follow-up|2|||
17022831|NCT00626548|38167247|FG001|Overall Study|Lost to Follow-up|2|||
17022832|NCT00626548|38167246|FG000|Overall Study|Other termination reason|493|||
17022833|NCT00626548|38167247|FG001|Overall Study|Other termination reason|613|||
17022834|NCT00847379|38167256|FG000|Overall Study|Study terminated by Sponsor|59|||
17022835|NCT00847379|38167257|FG001|Overall Study|Study terminated by Sponsor|57|||
17022836|NCT00847379|38167258|FG002|Overall Study|Study terminated by Sponsor|57|||
17022837|NCT00847301|38167268|FG000|Overall Study|Adverse Event|35|||
17022838|NCT00847301|38167268|FG000|Overall Study|Switch to other anticoagulants|16|||
17022839|NCT00847301|38167268|FG000|Overall Study|Lost to Follow-up|1|||
17022840|NCT00847301|38167268|FG000|Overall Study|No prescription after hospital discharge|1|||
17022841|NCT00847301|38167268|FG000|Overall Study|Other reason not defined above|1|||
17022842|NCT00624520|38167274|FG000|Overall Study|Withdrawal by Subject|12|||
17022843|NCT00624520|38167275|FG001|Overall Study|Withdrawal by Subject|7|||
17022844|NCT00624520|38167274|FG000|Overall Study|Death|0|||
17022845|NCT00624520|38167275|FG001|Overall Study|Death|1|||
17022846|NCT00847145|38167289|FG000|Overall Study|AE or Death|0|||
17022847|NCT00847145|38167290|FG001|Overall Study|AE or Death|1|||
17022848|NCT00847145|38167291|FG002|Overall Study|AE or Death|1|||
17022849|NCT00847145|38167292|FG003|Overall Study|AE or Death|0|||
17022850|NCT00847145|38167293|FG004|Overall Study|AE or Death|0|||
17022851|NCT00847145|38167294|FG005|Overall Study|AE or Death|0|||
17022852|NCT00847145|38167295|FG006|Overall Study|AE or Death|0|||
17022853|NCT00847145|38167296|FG007|Overall Study|AE or Death|0|||
17022854|NCT00847145|38167289|FG000|Overall Study|Withdrawal by Subject|3|||
17022855|NCT00847145|38167290|FG001|Overall Study|Withdrawal by Subject|4|||
17022856|NCT00847145|38167291|FG002|Overall Study|Withdrawal by Subject|6|||
17022857|NCT00847145|38167292|FG003|Overall Study|Withdrawal by Subject|1|||
17022858|NCT00847145|38167293|FG004|Overall Study|Withdrawal by Subject|0|||
17022859|NCT00847145|38167294|FG005|Overall Study|Withdrawal by Subject|0|||
17022860|NCT00847145|38167295|FG006|Overall Study|Withdrawal by Subject|1|||
17022861|NCT00847145|38167296|FG007|Overall Study|Withdrawal by Subject|1|||
17022862|NCT00847145|38167289|FG000|Overall Study|Lost to Follow-up|3|||
17022863|NCT00847145|38167290|FG001|Overall Study|Lost to Follow-up|1|||
17022864|NCT00847145|38167291|FG002|Overall Study|Lost to Follow-up|1|||
17022865|NCT00847145|38167292|FG003|Overall Study|Lost to Follow-up|0|||
17022866|NCT00847145|38167293|FG004|Overall Study|Lost to Follow-up|4|||
17022867|NCT00847145|38167294|FG005|Overall Study|Lost to Follow-up|4|||
17022868|NCT00847145|38167295|FG006|Overall Study|Lost to Follow-up|8|||
17022869|NCT00847145|38167296|FG007|Overall Study|Lost to Follow-up|2|||
17022870|NCT00847145|38167289|FG000|Overall Study|Inappropriate enrollment|0|||
17022871|NCT00847145|38167290|FG001|Overall Study|Inappropriate enrollment|0|||
17022872|NCT00847145|38167291|FG002|Overall Study|Inappropriate enrollment|0|||
17022873|NCT00847145|38167292|FG003|Overall Study|Inappropriate enrollment|0|||
17022874|NCT00847145|38167293|FG004|Overall Study|Inappropriate enrollment|1|||
17022875|NCT00847145|38167294|FG005|Overall Study|Inappropriate enrollment|0|||
17022876|NCT00847145|38167295|FG006|Overall Study|Inappropriate enrollment|0|||
17022877|NCT00847145|38167296|FG007|Overall Study|Inappropriate enrollment|0|||
17022878|NCT00847145|38167289|FG000|Overall Study|Protocol Violation|0|||
16934531|NCT01229371|38079151|FG000|Overall Study|Withdrawal by Subject|0|||
16934532|NCT01229371|38079152|FG001|Overall Study|Withdrawal by Subject|1|||
16934533|NCT01229371|38079153|FG002|Overall Study|Withdrawal by Subject|0|||
17022879|NCT00847145|38167290|FG001|Overall Study|Protocol Violation|0|||
17022880|NCT00847145|38167291|FG002|Overall Study|Protocol Violation|3|||
17022881|NCT00847145|38167292|FG003|Overall Study|Protocol Violation|0|||
16934534|NCT01229371|38079154|FG003|Overall Study|Withdrawal by Subject|0|||
16934535|NCT01237327|38079166|FG000|Overall Study|Protocol Violation: Core Study|1|||
16934536|NCT01237327|38079167|FG001|Overall Study|Protocol Violation: Core Study|0|||
16934537|NCT01237327|38079166|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
16934538|NCT01237327|38079167|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
16934539|NCT01237327|38079166|FG000|Overall Study|Progression of Disease: Core Study|18|||
16934540|NCT01237327|38079167|FG001|Overall Study|Progression of Disease: Core Study|22|||
16934541|NCT01237327|38079166|FG000|Overall Study|Progression of Disease: Extension Study|15|||
16934542|NCT01237327|38079167|FG001|Overall Study|Progression of Disease: Extension Study|13|||
16934543|NCT01237327|38079166|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
16934544|NCT01237327|38079167|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
16934545|NCT01237327|38079166|FG000|Overall Study|Withdrawal by Subject|1|||
17022882|NCT00847145|38167293|FG004|Overall Study|Protocol Violation|1|||
17022883|NCT00847145|38167294|FG005|Overall Study|Protocol Violation|0|||
17022884|NCT00847145|38167295|FG006|Overall Study|Protocol Violation|0|||
17022885|NCT00847145|38167296|FG007|Overall Study|Protocol Violation|1|||
17022886|NCT00846521|38167323|FG000|Overall Study|Withdrawal by Subject|5|||
17022887|NCT00846521|38167323|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
17022888|NCT00846521|38167323|FG000|Overall Study|Protocol Violation|1|||
17022889|NCT00862823|38167327|FG000|First Intervention|Withdrawal by Subject|1|||
17022890|NCT00862823|38167328|FG001|First Intervention|Withdrawal by Subject|1|||
17022891|NCT00790842|38167336|FG000|Dose Level 1|Adverse Event|1|||
17022892|NCT00790842|38167337|FG001|Dose Level 1|Adverse Event|0|||
17022893|NCT00790842|38167338|FG002|Dose Level 1|Adverse Event|0|||
17022894|NCT00790842|38167339|FG003|Dose Level 1|Adverse Event|2|||
17022895|NCT00790842|38167340|FG004|Dose Level 1|Adverse Event|0|||
17022896|NCT00790842|38167341|FG005|Dose Level 1|Adverse Event|0|||
17022897|NCT00790842|38167342|FG006|Dose Level 1|Adverse Event|0|||
17022898|NCT00790842|38167343|FG007|Dose Level 1|Adverse Event|1|||
17022899|NCT00790842|38167344|FG008|Dose Level 1|Adverse Event|0|||
17022900|NCT00790842|38167345|FG009|Dose Level 1|Adverse Event|0|||
17022901|NCT00790842|38167346|FG010|Dose Level 1|Adverse Event|0|||
17022902|NCT00790842|38167336|FG000|Dose Level 1|Physician Decision|1|||
17022903|NCT00790842|38167337|FG001|Dose Level 1|Physician Decision|0|||
17022904|NCT00790842|38167338|FG002|Dose Level 1|Physician Decision|0|||
17022905|NCT00790842|38167339|FG003|Dose Level 1|Physician Decision|0|||
17022906|NCT00790842|38167340|FG004|Dose Level 1|Physician Decision|0|||
17022907|NCT00790842|38167341|FG005|Dose Level 1|Physician Decision|0|||
17022908|NCT00790842|38167342|FG006|Dose Level 1|Physician Decision|0|||
17022909|NCT00790842|38167343|FG007|Dose Level 1|Physician Decision|1|||
17022910|NCT00790842|38167344|FG008|Dose Level 1|Physician Decision|0|||
17022911|NCT00790842|38167345|FG009|Dose Level 1|Physician Decision|0|||
17022912|NCT00790842|38167346|FG010|Dose Level 1|Physician Decision|0|||
17022913|NCT00790842|38167336|FG000|Dose Level 1|Withdrawal by Subject|1|||
17102994|NCT00112437|38241456|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
17102995|NCT00112437|38241457|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102996|NCT00112437|38241458|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102997|NCT00112437|38241459|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
17102998|NCT00112437|38241460|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17102999|NCT00112437|38241461|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17103000|NCT00112437|38241462|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17103001|NCT00112437|38241463|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17103002|NCT00112437|38241464|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17103003|NCT00112437|38241465|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17103004|NCT00112437|38241466|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
17103005|NCT00112437|38241441|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103006|NCT00112437|38241442|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103007|NCT00112437|38241443|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103008|NCT00112437|38241444|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103009|NCT00112437|38241445|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103010|NCT00112437|38241446|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103011|NCT00112437|38241447|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103012|NCT00112437|38241448|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103013|NCT00112437|38241449|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103014|NCT00112437|38241450|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103015|NCT00112437|38241451|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16934546|NCT01237327|38079167|FG001|Overall Study|Withdrawal by Subject|3|||
16934547|NCT01237327|38079166|FG000|Overall Study|Lost to Follow-up|3|||
17103016|NCT00112437|38241452|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103017|NCT00112437|38241453|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103018|NCT00112437|38241454|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16934548|NCT01237327|38079167|FG001|Overall Study|Lost to Follow-up|0|||
16934549|NCT01237054|38079173|FG000|Overall Study|imaging 10C0096|1|||
16934550|NCT01236352|38079210|FG000|Overall Study|Death|0|||
16934551|NCT01236352|38079211|FG001|Overall Study|Death|0|||
16934552|NCT01236352|38079212|FG002|Overall Study|Death|0|||
16934553|NCT01236352|38079213|FG003|Overall Study|Death|0|||
16934554|NCT01236352|38079214|FG004|Overall Study|Death|0|||
16934555|NCT01236352|38079215|FG005|Overall Study|Death|0|||
16934556|NCT01236352|38079216|FG006|Overall Study|Death|0|||
16934557|NCT01236352|38079217|FG007|Overall Study|Death|1|||
16934558|NCT01236352|38079218|FG008|Overall Study|Death|0|||
16934559|NCT01236352|38079219|FG009|Overall Study|Death|0|||
16934560|NCT01236352|38079220|FG010|Overall Study|Death|0|||
16934561|NCT01236352|38079210|FG000|Overall Study|Withdrawal by Subject|0|||
16934562|NCT01236352|38079211|FG001|Overall Study|Withdrawal by Subject|0|||
16934563|NCT01236352|38079212|FG002|Overall Study|Withdrawal by Subject|0|||
16934564|NCT01236352|38079213|FG003|Overall Study|Withdrawal by Subject|0|||
16934565|NCT01236352|38079214|FG004|Overall Study|Withdrawal by Subject|0|||
16934566|NCT01236352|38079215|FG005|Overall Study|Withdrawal by Subject|0|||
16934567|NCT01236352|38079216|FG006|Overall Study|Withdrawal by Subject|0|||
16934568|NCT01236352|38079217|FG007|Overall Study|Withdrawal by Subject|0|||
16934569|NCT01236352|38079218|FG008|Overall Study|Withdrawal by Subject|0|||
16934570|NCT01236352|38079219|FG009|Overall Study|Withdrawal by Subject|2|||
16934571|NCT01236352|38079220|FG010|Overall Study|Withdrawal by Subject|1|||
16934572|NCT01236352|38079210|FG000|Overall Study|Adverse Event|0|||
16934573|NCT01236352|38079211|FG001|Overall Study|Adverse Event|0|||
17022914|NCT00790842|38167337|FG001|Dose Level 1|Withdrawal by Subject|0|||
16934574|NCT01236352|38079212|FG002|Overall Study|Adverse Event|0|||
17022915|NCT00790842|38167338|FG002|Dose Level 1|Withdrawal by Subject|0|||
17022916|NCT00790842|38167339|FG003|Dose Level 1|Withdrawal by Subject|0|||
17022917|NCT00790842|38167340|FG004|Dose Level 1|Withdrawal by Subject|0|||
16934575|NCT01236352|38079213|FG003|Overall Study|Adverse Event|0|||
16934576|NCT01236352|38079214|FG004|Overall Study|Adverse Event|0|||
16934577|NCT01236352|38079215|FG005|Overall Study|Adverse Event|0|||
16934578|NCT01236352|38079216|FG006|Overall Study|Adverse Event|2|||
16934579|NCT01236352|38079217|FG007|Overall Study|Adverse Event|0|||
17022918|NCT00790842|38167341|FG005|Dose Level 1|Withdrawal by Subject|0|||
17022919|NCT00790842|38167342|FG006|Dose Level 1|Withdrawal by Subject|0|||
17022920|NCT00790842|38167343|FG007|Dose Level 1|Withdrawal by Subject|0|||
17022921|NCT00790842|38167344|FG008|Dose Level 1|Withdrawal by Subject|0|||
17022922|NCT00790842|38167345|FG009|Dose Level 1|Withdrawal by Subject|0|||
17022923|NCT00790842|38167346|FG010|Dose Level 1|Withdrawal by Subject|0|||
17022924|NCT00790842|38167336|FG000|Dose Level 2|Death|0|||
17022925|NCT00790842|38167337|FG001|Dose Level 2|Death|1|||
17022926|NCT00790842|38167338|FG002|Dose Level 2|Death|0|||
17022927|NCT00790842|38167339|FG003|Dose Level 2|Death|0|||
17022928|NCT00790842|38167340|FG004|Dose Level 2|Death|1|||
17022929|NCT00790842|38167341|FG005|Dose Level 2|Death|0|||
17022930|NCT00790842|38167342|FG006|Dose Level 2|Death|0|||
17022931|NCT00790842|38167343|FG007|Dose Level 2|Death|0|||
17022932|NCT00790842|38167344|FG008|Dose Level 2|Death|0|||
17022933|NCT00790842|38167345|FG009|Dose Level 2|Death|0|||
17022934|NCT00790842|38167346|FG010|Dose Level 2|Death|0|||
17022935|NCT00790842|38167336|FG000|Dose Level 2|Physician Decision|0|||
17022936|NCT00790842|38167337|FG001|Dose Level 2|Physician Decision|1|||
17022937|NCT00790842|38167338|FG002|Dose Level 2|Physician Decision|0|||
17022938|NCT00790842|38167339|FG003|Dose Level 2|Physician Decision|0|||
17022939|NCT00790842|38167340|FG004|Dose Level 2|Physician Decision|0|||
17022940|NCT00790842|38167341|FG005|Dose Level 2|Physician Decision|0|||
17022941|NCT00790842|38167342|FG006|Dose Level 2|Physician Decision|0|||
17022942|NCT00790842|38167343|FG007|Dose Level 2|Physician Decision|0|||
17022943|NCT00790842|38167344|FG008|Dose Level 2|Physician Decision|0|||
17022944|NCT00790842|38167345|FG009|Dose Level 2|Physician Decision|0|||
17022945|NCT00790842|38167346|FG010|Dose Level 2|Physician Decision|0|||
17022946|NCT00790842|38167336|FG000|Dose Level 2|Withdrawal by Subject|0|||
17103019|NCT00112437|38241455|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103020|NCT00112437|38241456|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
17103021|NCT00112437|38241457|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103022|NCT00112437|38241458|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103023|NCT00112437|38241459|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103024|NCT00112437|38241460|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103025|NCT00112437|38241461|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103026|NCT00112437|38241462|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103027|NCT00112437|38241463|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103028|NCT00112437|38241464|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103029|NCT00112437|38241465|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103030|NCT00112437|38241466|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
17103031|NCT00112437|38241441|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103032|NCT00112437|38241442|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103033|NCT00112437|38241443|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103034|NCT00112437|38241444|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103035|NCT00112437|38241445|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
16934580|NCT01236352|38079218|FG008|Overall Study|Adverse Event|0|||
16934581|NCT01236352|38079219|FG009|Overall Study|Adverse Event|4|||
16934582|NCT01236352|38079220|FG010|Overall Study|Adverse Event|1|||
16934583|NCT01236352|38079210|FG000|Overall Study|Study drug toxicity|0|||
16934584|NCT01236352|38079211|FG001|Overall Study|Study drug toxicity|0|||
16934585|NCT01236352|38079212|FG002|Overall Study|Study drug toxicity|0|||
16934586|NCT01236352|38079213|FG003|Overall Study|Study drug toxicity|0|||
16934587|NCT01236352|38079214|FG004|Overall Study|Study drug toxicity|0|||
16934588|NCT01236352|38079215|FG005|Overall Study|Study drug toxicity|1|||
16934589|NCT01236352|38079216|FG006|Overall Study|Study drug toxicity|1|||
16934590|NCT01236352|38079217|FG007|Overall Study|Study drug toxicity|0|||
16934591|NCT01236352|38079218|FG008|Overall Study|Study drug toxicity|0|||
16934592|NCT01236352|38079219|FG009|Overall Study|Study drug toxicity|2|||
16934593|NCT01236352|38079220|FG010|Overall Study|Study drug toxicity|2|||
16934594|NCT01236352|38079210|FG000|Overall Study|Disease progression|1|||
16934595|NCT01236352|38079211|FG001|Overall Study|Disease progression|2|||
16934596|NCT01236352|38079212|FG002|Overall Study|Disease progression|1|||
16934597|NCT01236352|38079213|FG003|Overall Study|Disease progression|2|||
16934598|NCT01236352|38079214|FG004|Overall Study|Disease progression|2|||
16934599|NCT01236352|38079215|FG005|Overall Study|Disease progression|2|||
17022947|NCT00790842|38167337|FG001|Dose Level 2|Withdrawal by Subject|1|||
17022948|NCT00790842|38167338|FG002|Dose Level 2|Withdrawal by Subject|0|||
17022949|NCT00790842|38167339|FG003|Dose Level 2|Withdrawal by Subject|0|||
17022950|NCT00790842|38167340|FG004|Dose Level 2|Withdrawal by Subject|0|||
17022951|NCT00790842|38167341|FG005|Dose Level 2|Withdrawal by Subject|0|||
17022952|NCT00790842|38167342|FG006|Dose Level 2|Withdrawal by Subject|0|||
17022953|NCT00790842|38167343|FG007|Dose Level 2|Withdrawal by Subject|0|||
17022954|NCT00790842|38167344|FG008|Dose Level 2|Withdrawal by Subject|0|||
17022955|NCT00790842|38167345|FG009|Dose Level 2|Withdrawal by Subject|0|||
17022956|NCT00790842|38167346|FG010|Dose Level 2|Withdrawal by Subject|0|||
17022957|NCT00790842|38167336|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022958|NCT00790842|38167337|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022959|NCT00790842|38167338|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022960|NCT00790842|38167339|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022961|NCT00790842|38167340|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022962|NCT00790842|38167341|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022963|NCT00790842|38167342|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022964|NCT00790842|38167343|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022965|NCT00790842|38167344|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
17022966|NCT00790842|38167345|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022967|NCT00790842|38167346|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
17022968|NCT00790842|38167336|FG000|Dose Level 3|Adverse Event|0|||
17022969|NCT00790842|38167337|FG001|Dose Level 3|Adverse Event|0|||
17022970|NCT00790842|38167338|FG002|Dose Level 3|Adverse Event|1|||
17022971|NCT00790842|38167339|FG003|Dose Level 3|Adverse Event|0|||
17022972|NCT00790842|38167340|FG004|Dose Level 3|Adverse Event|0|||
17022973|NCT00790842|38167341|FG005|Dose Level 3|Adverse Event|0|||
17022974|NCT00790842|38167342|FG006|Dose Level 3|Adverse Event|0|||
17022975|NCT00790842|38167343|FG007|Dose Level 3|Adverse Event|0|||
17022976|NCT00790842|38167344|FG008|Dose Level 3|Adverse Event|0|||
17022977|NCT00790842|38167345|FG009|Dose Level 3|Adverse Event|0|||
17022978|NCT00790842|38167346|FG010|Dose Level 3|Adverse Event|0|||
17022979|NCT00790842|38167336|FG000|Dose Level 3|Withdrawal by Subject|0|||
17022980|NCT00790842|38167337|FG001|Dose Level 3|Withdrawal by Subject|0|||
17022981|NCT00790842|38167338|FG002|Dose Level 3|Withdrawal by Subject|3|||
17022982|NCT00790842|38167339|FG003|Dose Level 3|Withdrawal by Subject|0|||
17022983|NCT00790842|38167340|FG004|Dose Level 3|Withdrawal by Subject|0|||
17022984|NCT00790842|38167341|FG005|Dose Level 3|Withdrawal by Subject|0|||
17022985|NCT00790842|38167342|FG006|Dose Level 3|Withdrawal by Subject|0|||
17022986|NCT00790842|38167343|FG007|Dose Level 3|Withdrawal by Subject|0|||
17022987|NCT00790842|38167344|FG008|Dose Level 3|Withdrawal by Subject|0|||
17022988|NCT00790842|38167345|FG009|Dose Level 3|Withdrawal by Subject|2|||
17022989|NCT00790842|38167346|FG010|Dose Level 3|Withdrawal by Subject|0|||
17022990|NCT00790842|38167336|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17022991|NCT00790842|38167337|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17022992|NCT00790842|38167338|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17022993|NCT00790842|38167339|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17022994|NCT00790842|38167340|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17022995|NCT00790842|38167341|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
17022996|NCT00790842|38167342|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17022997|NCT00790842|38167343|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17022998|NCT00790842|38167344|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17022999|NCT00790842|38167345|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17023000|NCT00790842|38167346|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
17023001|NCT00790842|38167336|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023002|NCT00790842|38167337|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023003|NCT00790842|38167338|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
17023004|NCT00790842|38167339|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023005|NCT00790842|38167340|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023006|NCT00790842|38167341|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023007|NCT00790842|38167342|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023008|NCT00790842|38167343|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023009|NCT00790842|38167344|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023010|NCT00790842|38167345|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023011|NCT00790842|38167346|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
17023012|NCT00790842|38167336|FG000|Dose Level 4|Adverse Event|0|||
17023013|NCT00790842|38167337|FG001|Dose Level 4|Adverse Event|0|||
17023014|NCT00790842|38167338|FG002|Dose Level 4|Adverse Event|0|||
17023015|NCT00790842|38167339|FG003|Dose Level 4|Adverse Event|0|||
17023016|NCT00790842|38167340|FG004|Dose Level 4|Adverse Event|0|||
17023017|NCT00790842|38167341|FG005|Dose Level 4|Adverse Event|0|||
17023018|NCT00790842|38167342|FG006|Dose Level 4|Adverse Event|1|||
17023019|NCT00790842|38167343|FG007|Dose Level 4|Adverse Event|0|||
17023020|NCT00790842|38167344|FG008|Dose Level 4|Adverse Event|0|||
17023021|NCT00790842|38167345|FG009|Dose Level 4|Adverse Event|0|||
17103036|NCT00112437|38241446|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103037|NCT00112437|38241447|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
17023022|NCT00790842|38167346|FG010|Dose Level 4|Adverse Event|0|||
17023023|NCT00790842|38167336|FG000|Dose Level 4|Physician Decision|0|||
17023024|NCT00790842|38167337|FG001|Dose Level 4|Physician Decision|0|||
17023025|NCT00790842|38167338|FG002|Dose Level 4|Physician Decision|0|||
17023026|NCT00790842|38167339|FG003|Dose Level 4|Physician Decision|0|||
16934600|NCT01236352|38079216|FG006|Overall Study|Disease progression|1|||
16934601|NCT01236352|38079217|FG007|Overall Study|Disease progression|3|||
16934602|NCT01236352|38079218|FG008|Overall Study|Disease progression|2|||
16934603|NCT01236352|38079219|FG009|Overall Study|Disease progression|2|||
16934604|NCT01236352|38079220|FG010|Overall Study|Disease progression|2|||
16934605|NCT01236352|38079210|FG000|Overall Study|Poor/Non-compliance|1|||
16934606|NCT01236352|38079211|FG001|Overall Study|Poor/Non-compliance|0|||
16934607|NCT01236352|38079212|FG002|Overall Study|Poor/Non-compliance|0|||
16934608|NCT01236352|38079213|FG003|Overall Study|Poor/Non-compliance|0|||
16934609|NCT01236352|38079214|FG004|Overall Study|Poor/Non-compliance|0|||
16934610|NCT01236352|38079215|FG005|Overall Study|Poor/Non-compliance|0|||
16934611|NCT01236352|38079216|FG006|Overall Study|Poor/Non-compliance|0|||
16934612|NCT01236352|38079217|FG007|Overall Study|Poor/Non-compliance|0|||
16934613|NCT01236352|38079218|FG008|Overall Study|Poor/Non-compliance|0|||
16934614|NCT01236352|38079219|FG009|Overall Study|Poor/Non-compliance|0|||
16934615|NCT01236352|38079220|FG010|Overall Study|Poor/Non-compliance|0|||
16934616|NCT01236352|38079210|FG000|Overall Study|Maximum clinical benefit|1|||
16934617|NCT01236352|38079211|FG001|Overall Study|Maximum clinical benefit|1|||
16934618|NCT01236352|38079212|FG002|Overall Study|Maximum clinical benefit|1|||
16934619|NCT01236352|38079213|FG003|Overall Study|Maximum clinical benefit|0|||
16934620|NCT01236352|38079214|FG004|Overall Study|Maximum clinical benefit|2|||
16934621|NCT01236352|38079215|FG005|Overall Study|Maximum clinical benefit|0|||
16934622|NCT01236352|38079216|FG006|Overall Study|Maximum clinical benefit|3|||
16934623|NCT01236352|38079217|FG007|Overall Study|Maximum clinical benefit|1|||
17023027|NCT00790842|38167340|FG004|Dose Level 4|Physician Decision|0|||
17023028|NCT00790842|38167341|FG005|Dose Level 4|Physician Decision|0|||
17023029|NCT00790842|38167342|FG006|Dose Level 4|Physician Decision|1|||
17023030|NCT00790842|38167343|FG007|Dose Level 4|Physician Decision|0|||
17023031|NCT00790842|38167344|FG008|Dose Level 4|Physician Decision|0|||
17023032|NCT00790842|38167345|FG009|Dose Level 4|Physician Decision|0|||
17023033|NCT00790842|38167346|FG010|Dose Level 4|Physician Decision|1|||
17023034|NCT00790842|38167336|FG000|Dose Level 4|Withdrawal by Subject|0|||
17023035|NCT00790842|38167337|FG001|Dose Level 4|Withdrawal by Subject|0|||
17023036|NCT00790842|38167338|FG002|Dose Level 4|Withdrawal by Subject|0|||
17023037|NCT00790842|38167339|FG003|Dose Level 4|Withdrawal by Subject|0|||
17023038|NCT00790842|38167340|FG004|Dose Level 4|Withdrawal by Subject|0|||
17023039|NCT00790842|38167341|FG005|Dose Level 4|Withdrawal by Subject|0|||
17023040|NCT00790842|38167342|FG006|Dose Level 4|Withdrawal by Subject|0|||
17023041|NCT00790842|38167343|FG007|Dose Level 4|Withdrawal by Subject|0|||
17023042|NCT00790842|38167344|FG008|Dose Level 4|Withdrawal by Subject|0|||
17023043|NCT00790842|38167345|FG009|Dose Level 4|Withdrawal by Subject|0|||
17023044|NCT00790842|38167346|FG010|Dose Level 4|Withdrawal by Subject|1|||
16934624|NCT01236352|38079218|FG008|Overall Study|Maximum clinical benefit|1|||
16934625|NCT01236352|38079219|FG009|Overall Study|Maximum clinical benefit|4|||
17023045|NCT00790842|38167336|FG000|Expansion Cohort|Adverse Event|0|||
17023046|NCT00790842|38167337|FG001|Expansion Cohort|Adverse Event|0|||
17023047|NCT00790842|38167338|FG002|Expansion Cohort|Adverse Event|0|||
17023048|NCT00790842|38167339|FG003|Expansion Cohort|Adverse Event|0|||
17023049|NCT00790842|38167340|FG004|Expansion Cohort|Adverse Event|0|||
17023050|NCT00790842|38167341|FG005|Expansion Cohort|Adverse Event|0|||
17023051|NCT00790842|38167342|FG006|Expansion Cohort|Adverse Event|1|||
17023052|NCT00790842|38167343|FG007|Expansion Cohort|Adverse Event|0|||
17023053|NCT00790842|38167344|FG008|Expansion Cohort|Adverse Event|0|||
17023054|NCT00790842|38167345|FG009|Expansion Cohort|Adverse Event|0|||
17023055|NCT00790842|38167346|FG010|Expansion Cohort|Adverse Event|0|||
17023056|NCT00790842|38167336|FG000|Expansion Cohort|Death|0|||
17023057|NCT00790842|38167337|FG001|Expansion Cohort|Death|0|||
17023058|NCT00790842|38167338|FG002|Expansion Cohort|Death|2|||
17023059|NCT00790842|38167339|FG003|Expansion Cohort|Death|0|||
17023060|NCT00790842|38167340|FG004|Expansion Cohort|Death|0|||
17023061|NCT00790842|38167341|FG005|Expansion Cohort|Death|0|||
17023062|NCT00790842|38167342|FG006|Expansion Cohort|Death|0|||
17023063|NCT00790842|38167343|FG007|Expansion Cohort|Death|0|||
17023064|NCT00790842|38167344|FG008|Expansion Cohort|Death|0|||
17023065|NCT00790842|38167345|FG009|Expansion Cohort|Death|0|||
17023066|NCT00790842|38167346|FG010|Expansion Cohort|Death|0|||
17023067|NCT00790842|38167336|FG000|Expansion Cohort|Physician Decision|0|||
17023068|NCT00790842|38167337|FG001|Expansion Cohort|Physician Decision|0|||
17023069|NCT00790842|38167338|FG002|Expansion Cohort|Physician Decision|1|||
17023070|NCT00790842|38167339|FG003|Expansion Cohort|Physician Decision|0|||
17023071|NCT00790842|38167340|FG004|Expansion Cohort|Physician Decision|0|||
17023072|NCT00790842|38167341|FG005|Expansion Cohort|Physician Decision|0|||
17023073|NCT00790842|38167342|FG006|Expansion Cohort|Physician Decision|0|||
17023074|NCT00790842|38167343|FG007|Expansion Cohort|Physician Decision|0|||
17023075|NCT00790842|38167344|FG008|Expansion Cohort|Physician Decision|0|||
17023076|NCT00790842|38167345|FG009|Expansion Cohort|Physician Decision|0|||
17023077|NCT00790842|38167346|FG010|Expansion Cohort|Physician Decision|0|||
17023078|NCT00790842|38167336|FG000|Expansion Cohort|Withdrawal by Subject|0|||
17023079|NCT00790842|38167337|FG001|Expansion Cohort|Withdrawal by Subject|0|||
17023080|NCT00790842|38167338|FG002|Expansion Cohort|Withdrawal by Subject|3|||
17023081|NCT00790842|38167339|FG003|Expansion Cohort|Withdrawal by Subject|0|||
17023082|NCT00790842|38167340|FG004|Expansion Cohort|Withdrawal by Subject|0|||
17023083|NCT00790842|38167341|FG005|Expansion Cohort|Withdrawal by Subject|0|||
17023084|NCT00790842|38167342|FG006|Expansion Cohort|Withdrawal by Subject|0|||
17023085|NCT00790842|38167343|FG007|Expansion Cohort|Withdrawal by Subject|0|||
17023086|NCT00790842|38167344|FG008|Expansion Cohort|Withdrawal by Subject|0|||
17023087|NCT00790842|38167345|FG009|Expansion Cohort|Withdrawal by Subject|0|||
17023088|NCT00790842|38167346|FG010|Expansion Cohort|Withdrawal by Subject|0|||
17023089|NCT00790842|38167336|FG000|Expansion Cohort|Study Closure|0|||
17023090|NCT00790842|38167337|FG001|Expansion Cohort|Study Closure|0|||
17023091|NCT00790842|38167338|FG002|Expansion Cohort|Study Closure|1|||
17023092|NCT00790842|38167339|FG003|Expansion Cohort|Study Closure|0|||
17023093|NCT00790842|38167340|FG004|Expansion Cohort|Study Closure|0|||
17023094|NCT00790842|38167341|FG005|Expansion Cohort|Study Closure|0|||
17023095|NCT00790842|38167342|FG006|Expansion Cohort|Study Closure|0|||
17023096|NCT00790842|38167343|FG007|Expansion Cohort|Study Closure|0|||
17023097|NCT00790842|38167344|FG008|Expansion Cohort|Study Closure|0|||
17023098|NCT00790842|38167345|FG009|Expansion Cohort|Study Closure|0|||
17023099|NCT00790842|38167346|FG010|Expansion Cohort|Study Closure|0|||
17023100|NCT00574288|38167401|FG000|Overall Study|Adverse Event|2|||
17023101|NCT00574288|38167402|FG001|Overall Study|Adverse Event|0|||
17023102|NCT00574288|38167403|FG002|Overall Study|Adverse Event|0|||
17023103|NCT00574288|38167404|FG003|Overall Study|Adverse Event|0|||
17023104|NCT00574288|38167405|FG004|Overall Study|Adverse Event|1|||
17023105|NCT00574288|38167406|FG005|Overall Study|Adverse Event|0|||
17023106|NCT00574288|38167407|FG006|Overall Study|Adverse Event|0|||
17023107|NCT00574288|38167401|FG000|Overall Study|Death|0|||
17023108|NCT00574288|38167402|FG001|Overall Study|Death|0|||
17023109|NCT00574288|38167403|FG002|Overall Study|Death|0|||
17023110|NCT00574288|38167404|FG003|Overall Study|Death|0|||
17023111|NCT00574288|38167405|FG004|Overall Study|Death|0|||
17023112|NCT00574288|38167406|FG005|Overall Study|Death|25|||
17023113|NCT00574288|38167407|FG006|Overall Study|Death|21|||
17023114|NCT00574288|38167401|FG000|Overall Study|Lost to Follow-up|0|||
17023115|NCT00574288|38167402|FG001|Overall Study|Lost to Follow-up|0|||
17023116|NCT00574288|38167403|FG002|Overall Study|Lost to Follow-up|0|||
17023117|NCT00574288|38167404|FG003|Overall Study|Lost to Follow-up|0|||
17023118|NCT00574288|38167405|FG004|Overall Study|Lost to Follow-up|0|||
17023119|NCT00574288|38167406|FG005|Overall Study|Lost to Follow-up|1|||
17023120|NCT00574288|38167407|FG006|Overall Study|Lost to Follow-up|2|||
17023121|NCT00574288|38167401|FG000|Overall Study|Study Terminated By Sponsor|0|||
17023122|NCT00574288|38167402|FG001|Overall Study|Study Terminated By Sponsor|0|||
17023123|NCT00574288|38167403|FG002|Overall Study|Study Terminated By Sponsor|0|||
17023124|NCT00574288|38167404|FG003|Overall Study|Study Terminated By Sponsor|0|||
17023125|NCT00574288|38167405|FG004|Overall Study|Study Terminated By Sponsor|0|||
17023126|NCT00574288|38167406|FG005|Overall Study|Study Terminated By Sponsor|0|||
17023127|NCT00574288|38167407|FG006|Overall Study|Study Terminated By Sponsor|5|||
17023128|NCT00574288|38167401|FG000|Overall Study|Progressive Disease|17|||
17023129|NCT00574288|38167402|FG001|Overall Study|Progressive Disease|2|||
17023130|NCT00574288|38167403|FG002|Overall Study|Progressive Disease|3|||
17023131|NCT00574288|38167404|FG003|Overall Study|Progressive Disease|2|||
17023132|NCT00574288|38167405|FG004|Overall Study|Progressive Disease|1|||
17023133|NCT00574288|38167406|FG005|Overall Study|Progressive Disease|0|||
17023134|NCT00574288|38167407|FG006|Overall Study|Progressive Disease|0|||
17023135|NCT00574288|38167401|FG000|Overall Study|Other|1|||
17023136|NCT00574288|38167402|FG001|Overall Study|Other|1|||
17023137|NCT00574288|38167403|FG002|Overall Study|Other|0|||
17023138|NCT00574288|38167404|FG003|Overall Study|Other|0|||
17023139|NCT00574288|38167405|FG004|Overall Study|Other|0|||
17023140|NCT00574288|38167406|FG005|Overall Study|Other|0|||
17023141|NCT00574288|38167407|FG006|Overall Study|Other|0|||
17023142|NCT00790452|38167435|FG000|Overall Study|Drug supply issue|1|||
17023143|NCT00790452|38167436|FG001|Overall Study|Drug supply issue|0|||
17023144|NCT00626392|38167448|FG000|Run-in Period|Adverse Event|0|||
17023145|NCT00626392|38167449|FG001|Run-in Period|Adverse Event|0|||
17023146|NCT00626392|38167450|FG002|Run-in Period|Adverse Event|1|||
17023147|NCT00626392|38167451|FG003|Run-in Period|Adverse Event|0|||
17023148|NCT00626392|38167452|FG004|Run-in Period|Adverse Event|1|||
17023149|NCT00626392|38167453|FG005|Run-in Period|Adverse Event|0|||
17023150|NCT00626392|38167448|FG000|Run-in Period|Withdrawal by Subject|0|||
17023151|NCT00626392|38167449|FG001|Run-in Period|Withdrawal by Subject|1|||
17023152|NCT00626392|38167450|FG002|Run-in Period|Withdrawal by Subject|1|||
17023153|NCT00626392|38167451|FG003|Run-in Period|Withdrawal by Subject|1|||
17023154|NCT00626392|38167452|FG004|Run-in Period|Withdrawal by Subject|3|||
17023155|NCT00626392|38167453|FG005|Run-in Period|Withdrawal by Subject|1|||
17023156|NCT00626392|38167448|FG000|Run-in Period|Noncompliance|1|||
17023157|NCT00626392|38167449|FG001|Run-in Period|Noncompliance|0|||
17023158|NCT00626392|38167450|FG002|Run-in Period|Noncompliance|1|||
17023159|NCT00626392|38167451|FG003|Run-in Period|Noncompliance|0|||
17023160|NCT00626392|38167452|FG004|Run-in Period|Noncompliance|0|||
17023161|NCT00626392|38167453|FG005|Run-in Period|Noncompliance|0|||
17023162|NCT00626392|38167448|FG000|Coadministration Period|Adverse Event|3|||
17023163|NCT00626392|38167449|FG001|Coadministration Period|Adverse Event|1|||
17023164|NCT00626392|38167450|FG002|Coadministration Period|Adverse Event|7|||
17023165|NCT00626392|38167451|FG003|Coadministration Period|Adverse Event|4|||
17023166|NCT00626392|38167452|FG004|Coadministration Period|Adverse Event|3|||
17023167|NCT00626392|38167453|FG005|Coadministration Period|Adverse Event|4|||
17023168|NCT00626392|38167448|FG000|Coadministration Period|Withdrawal by Subject|1|||
17023169|NCT00626392|38167449|FG001|Coadministration Period|Withdrawal by Subject|1|||
17023170|NCT00626392|38167450|FG002|Coadministration Period|Withdrawal by Subject|0|||
17023171|NCT00626392|38167451|FG003|Coadministration Period|Withdrawal by Subject|1|||
17023172|NCT00626392|38167452|FG004|Coadministration Period|Withdrawal by Subject|0|||
17023173|NCT00626392|38167453|FG005|Coadministration Period|Withdrawal by Subject|1|||
17023174|NCT00626392|38167448|FG000|Coadministration Period|Protocol Violation|0|||
17023175|NCT00626392|38167449|FG001|Coadministration Period|Protocol Violation|1|||
17023176|NCT00626392|38167450|FG002|Coadministration Period|Protocol Violation|0|||
17023177|NCT00626392|38167451|FG003|Coadministration Period|Protocol Violation|1|||
17023178|NCT00626392|38167452|FG004|Coadministration Period|Protocol Violation|1|||
17023179|NCT00626392|38167453|FG005|Coadministration Period|Protocol Violation|0|||
17023180|NCT00626392|38167448|FG000|Coadministration Period|Other|0|||
17023181|NCT00626392|38167449|FG001|Coadministration Period|Other|2|||
17023182|NCT00626392|38167450|FG002|Coadministration Period|Other|3|||
17023183|NCT00626392|38167451|FG003|Coadministration Period|Other|1|||
17023184|NCT00626392|38167452|FG004|Coadministration Period|Other|1|||
16934626|NCT01236352|38079220|FG010|Overall Study|Maximum clinical benefit|2|||
16934627|NCT01236352|38079210|FG000|Overall Study|Subject request to discontinue treatment|0|||
16934628|NCT01236352|38079211|FG001|Overall Study|Subject request to discontinue treatment|0|||
16934629|NCT01236352|38079212|FG002|Overall Study|Subject request to discontinue treatment|1|||
17023185|NCT00626392|38167453|FG005|Coadministration Period|Other|1|||
17023186|NCT00624286|38167461|FG000|Overall Study|Protocol Deviation|7|||
17023187|NCT00624286|38167462|FG001|Overall Study|Protocol Deviation|9|||
17023188|NCT00624286|38167461|FG000|Overall Study|Adverse Event|6|||
17023189|NCT00624286|38167462|FG001|Overall Study|Adverse Event|3|||
17023190|NCT00624286|38167461|FG000|Overall Study|Withdrawal by Subject|5|||
17023191|NCT00624286|38167462|FG001|Overall Study|Withdrawal by Subject|4|||
17023192|NCT00624286|38167461|FG000|Overall Study|Lost to Follow-up|3|||
17023193|NCT00624286|38167462|FG001|Overall Study|Lost to Follow-up|2|||
17023194|NCT00624286|38167461|FG000|Overall Study|Administrative problems|3|||
17023195|NCT00624286|38167462|FG001|Overall Study|Administrative problems|0|||
17023196|NCT00624286|38167461|FG000|Overall Study|Lack of Efficacy|1|||
17023197|NCT00624286|38167462|FG001|Overall Study|Lack of Efficacy|6|||
17023198|NCT00624286|38167461|FG000|Overall Study|Not stated|0|||
17023199|NCT00624286|38167462|FG001|Overall Study|Not stated|1|||
17023200|NCT00624286|38167461|FG000|Overall Study|Abnormal test procedure result(s)|0|||
17023201|NCT00624286|38167462|FG001|Overall Study|Abnormal test procedure result(s)|1|||
17023202|NCT00624286|38167461|FG000|Overall Study|Death|0|||
17023203|NCT00624286|38167462|FG001|Overall Study|Death|1|||
17023204|NCT00624052|38167472|FG000|Overall Study|Adverse Event|7|||
17023205|NCT00624052|38167473|FG001|Overall Study|Adverse Event|6|||
17023206|NCT00624052|38167474|FG002|Overall Study|Adverse Event|0|||
17023207|NCT00624052|38167475|FG003|Overall Study|Adverse Event|3|||
17023208|NCT00624052|38167472|FG000|Overall Study|Lack of Efficacy|1|||
17023209|NCT00624052|38167473|FG001|Overall Study|Lack of Efficacy|1|||
17023210|NCT00624052|38167474|FG002|Overall Study|Lack of Efficacy|0|||
17023211|NCT00624052|38167475|FG003|Overall Study|Lack of Efficacy|0|||
17023212|NCT00624052|38167472|FG000|Overall Study|Lost to Follow-up|2|||
17023213|NCT00624052|38167473|FG001|Overall Study|Lost to Follow-up|3|||
17023214|NCT00624052|38167474|FG002|Overall Study|Lost to Follow-up|1|||
17023215|NCT00624052|38167475|FG003|Overall Study|Lost to Follow-up|0|||
17023216|NCT00624052|38167472|FG000|Overall Study|Non compliant with the protocol|2|||
17023217|NCT00624052|38167473|FG001|Overall Study|Non compliant with the protocol|1|||
17023218|NCT00624052|38167474|FG002|Overall Study|Non compliant with the protocol|1|||
17023219|NCT00624052|38167475|FG003|Overall Study|Non compliant with the protocol|1|||
17023220|NCT00624052|38167472|FG000|Overall Study|Consent withdrawn|3|||
17023221|NCT00624052|38167473|FG001|Overall Study|Consent withdrawn|1|||
17023222|NCT00624052|38167474|FG002|Overall Study|Consent withdrawn|1|||
17023223|NCT00624052|38167475|FG003|Overall Study|Consent withdrawn|0|||
17023224|NCT00624052|38167472|FG000|Overall Study|Changed job/ran out if meds|0|||
17023225|NCT00624052|38167473|FG001|Overall Study|Changed job/ran out if meds|2|||
16934630|NCT01236352|38079213|FG003|Overall Study|Subject request to discontinue treatment|1|||
16934631|NCT01236352|38079214|FG004|Overall Study|Subject request to discontinue treatment|0|||
16934632|NCT01236352|38079215|FG005|Overall Study|Subject request to discontinue treatment|1|||
16934633|NCT01236352|38079216|FG006|Overall Study|Subject request to discontinue treatment|0|||
17023226|NCT00624052|38167474|FG002|Overall Study|Changed job/ran out if meds|0|||
17023227|NCT00624052|38167475|FG003|Overall Study|Changed job/ran out if meds|0|||
17023228|NCT00785577|38167494|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
17023229|NCT00785577|38167495|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
17023230|NCT00785577|38167496|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
17023231|NCT00785577|38167497|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
17023232|NCT00785577|38167498|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
17023233|NCT00785577|38167494|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
17023234|NCT00785577|38167495|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
17023235|NCT00785577|38167496|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
17023236|NCT00785577|38167497|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
17023237|NCT00785577|38167498|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
17023238|NCT00785577|38167494|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
17023239|NCT00785577|38167495|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
17023240|NCT00785577|38167496|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
17023241|NCT00785577|38167497|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
17023242|NCT00785577|38167498|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
17023243|NCT00785577|38167494|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
17023244|NCT00785577|38167495|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
17023245|NCT00785577|38167496|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
17023246|NCT00785577|38167497|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
17023247|NCT00785577|38167498|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
17023248|NCT00785577|38167494|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
17023249|NCT00785577|38167495|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
17023250|NCT00785577|38167496|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
17023251|NCT00785577|38167497|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
17023252|NCT00785577|38167498|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
17023253|NCT00785577|38167494|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
17023254|NCT00785577|38167495|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
17023255|NCT00785577|38167496|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
17023256|NCT00785577|38167497|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
17023257|NCT00785577|38167498|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
17023258|NCT00785577|38167494|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
17023259|NCT00785577|38167495|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
17023260|NCT00785577|38167496|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
17023261|NCT00785577|38167497|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
17023262|NCT00785577|38167498|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
17023263|NCT00785577|38167494|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
17023264|NCT00785577|38167495|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
17023265|NCT00785577|38167496|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
17023266|NCT00785577|38167497|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
17023267|NCT00785577|38167498|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
17023268|NCT00785577|38167494|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
17023269|NCT00785577|38167495|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
17023270|NCT00785577|38167496|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
17023271|NCT00785577|38167497|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
17023272|NCT00785577|38167498|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
17023273|NCT00785577|38167494|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
17023274|NCT00785577|38167495|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
17023275|NCT00785577|38167496|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
17023276|NCT00785577|38167497|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
17023277|NCT00785577|38167498|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
17023278|NCT00789828|38167522|FG000|Core Period (48 Weeks)|Administrative problems|0|||
17023279|NCT00789828|38167523|FG001|Core Period (48 Weeks)|Administrative problems|1|||
17023280|NCT00789828|38167522|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
17023281|NCT00789828|38167523|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
17023282|NCT00789828|38167522|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
17023283|NCT00789828|38167523|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
17023284|NCT00789828|38167522|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
17023285|NCT00789828|38167523|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
17023286|NCT00789828|38167522|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
17023287|NCT00789828|38167523|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
17023288|NCT00789828|38167522|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
17023289|NCT00789828|38167523|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
17023290|NCT00789828|38167522|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
17023291|NCT00789828|38167523|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
17023292|NCT00789828|38167522|FG000|Open-label Extension Period (4 Years)|Death|1|||
17023293|NCT00789828|38167523|FG001|Open-label Extension Period (4 Years)|Death|0|||
17023294|NCT00789828|38167522|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
16934634|NCT01236352|38079217|FG007|Overall Study|Subject request to discontinue treatment|0|||
16934635|NCT01236352|38079218|FG008|Overall Study|Subject request to discontinue treatment|0|||
16934636|NCT01236352|38079219|FG009|Overall Study|Subject request to discontinue treatment|1|||
16934637|NCT01236352|38079220|FG010|Overall Study|Subject request to discontinue treatment|4|||
16934638|NCT01236352|38079210|FG000|Overall Study|Subject to receive drug via EAP|1|||
16934639|NCT01236352|38079211|FG001|Overall Study|Subject to receive drug via EAP|1|||
16934640|NCT01236352|38079212|FG002|Overall Study|Subject to receive drug via EAP|1|||
16934641|NCT01236352|38079213|FG003|Overall Study|Subject to receive drug via EAP|0|||
16934642|NCT01236352|38079214|FG004|Overall Study|Subject to receive drug via EAP|0|||
16934643|NCT01236352|38079215|FG005|Overall Study|Subject to receive drug via EAP|0|||
16934644|NCT01236352|38079216|FG006|Overall Study|Subject to receive drug via EAP|0|||
16934645|NCT01236352|38079217|FG007|Overall Study|Subject to receive drug via EAP|2|||
16934646|NCT01236352|38079218|FG008|Overall Study|Subject to receive drug via EAP|0|||
16934647|NCT01236352|38079219|FG009|Overall Study|Subject to receive drug via EAP|4|||
17023295|NCT00789828|38167523|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
17023296|NCT00789828|38167522|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
17023297|NCT00789828|38167523|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
17023298|NCT00790296|38167534|FG000|Overall Study|Did not meet study eligibility criteria|1|||
17023299|NCT00790296|38167535|FG001|Overall Study|Did not meet study eligibility criteria|1|||
17023300|NCT00790296|38167534|FG000|Overall Study|Adverse Event|0|||
17023301|NCT00790296|38167535|FG001|Overall Study|Adverse Event|1|||
17023302|NCT00623194|38167541|FG000|Overall Study|Lack of Efficacy|1|||
17023303|NCT00623194|38167541|FG000|Overall Study|Protocol Violation|3|||
17023304|NCT00623194|38167541|FG000|Overall Study|Unclassified|1|||
17023305|NCT00784368|38167548|FG000|Overall Study|Physician Decision|0|||
17023306|NCT00784368|38167549|FG001|Overall Study|Physician Decision|0|||
17023307|NCT00784368|38167550|FG002|Overall Study|Physician Decision|6|||
17023308|NCT00784368|38167548|FG000|Overall Study|Lack of Efficacy|2|||
17023309|NCT00784368|38167549|FG001|Overall Study|Lack of Efficacy|0|||
17023310|NCT00784368|38167550|FG002|Overall Study|Lack of Efficacy|1|||
17023311|NCT00784368|38167548|FG000|Overall Study|Adverse Event|6|||
17023312|NCT00784368|38167549|FG001|Overall Study|Adverse Event|9|||
17023313|NCT00784368|38167550|FG002|Overall Study|Adverse Event|2|||
17023314|NCT00784368|38167548|FG000|Overall Study|Diagnosis of fever|0|||
17023315|NCT00784368|38167549|FG001|Overall Study|Diagnosis of fever|0|||
17023316|NCT00784368|38167550|FG002|Overall Study|Diagnosis of fever|1|||
17023317|NCT00784368|38167548|FG000|Overall Study|Worsening of complications|0|||
17023318|NCT00784368|38167549|FG001|Overall Study|Worsening of complications|0|||
17023319|NCT00784368|38167550|FG002|Overall Study|Worsening of complications|1|||
17023320|NCT00784368|38167548|FG000|Overall Study|Worsening of symptoms|0|||
17023321|NCT00784368|38167549|FG001|Overall Study|Worsening of symptoms|1|||
17023322|NCT00784368|38167550|FG002|Overall Study|Worsening of symptoms|0|||
17023323|NCT00784368|38167548|FG000|Overall Study|Withdrawal of informed consent|0|||
17023324|NCT00784368|38167549|FG001|Overall Study|Withdrawal of informed consent|1|||
17023325|NCT00784368|38167550|FG002|Overall Study|Withdrawal of informed consent|0|||
17023326|NCT00622726|38167563|FG000|March, 2008 to August, 2010|Death|5|||
17023327|NCT00622726|38167564|FG001|March, 2008 to August, 2010|Death|2|||
17023328|NCT00622726|38167563|FG000|August, 2010 to April, 2013|Death|1|||
17023329|NCT00622726|38167564|FG001|August, 2010 to April, 2013|Death|5|||
17023330|NCT00623428|38167576|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
17023331|NCT00623428|38167577|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
17023332|NCT00623428|38167576|FG000|Treatment Period|Death|0|||
17023333|NCT00623428|38167577|FG001|Treatment Period|Death|1|||
17023334|NCT00623428|38167576|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
17023335|NCT00623428|38167577|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
17023336|NCT00623428|38167576|FG000|Treatment Period|Insufficient therapeutic response|0|||
17023337|NCT00623428|38167577|FG001|Treatment Period|Insufficient therapeutic response|2|||
17023338|NCT00623428|38167576|FG000|Treatment Period|Other|0|||
17023339|NCT00623428|38167577|FG001|Treatment Period|Other|1|||
17023340|NCT00623428|38167576|FG000|Treatment Period|Withdrawal by Subject|0|||
17023341|NCT00623428|38167577|FG001|Treatment Period|Withdrawal by Subject|1|||
17023342|NCT00623428|38167576|FG000|Follow-up Period|Relapse post-treatment|11|||
17023343|NCT00623428|38167577|FG001|Follow-up Period|Relapse post-treatment|3|||
17023344|NCT00623428|38167576|FG000|Follow-up Period|Failure to return|10|||
17023345|NCT00623428|38167577|FG001|Follow-up Period|Failure to return|2|||
17023346|NCT00623428|38167576|FG000|Follow-up Period|Patient withdrew consent|5|||
17023347|NCT00623428|38167577|FG001|Follow-up Period|Patient withdrew consent|4|||
17023348|NCT00623428|38167576|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
17023349|NCT00623428|38167577|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
17023350|NCT00623428|38167576|FG000|Follow-up Period|Did not cooperate|0|||
17023351|NCT00623428|38167577|FG001|Follow-up Period|Did not cooperate|3|||
16934648|NCT01236352|38079220|FG010|Overall Study|Subject to receive drug via EAP|0|||
17103038|NCT00112437|38241448|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
16934649|NCT01236352|38079210|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
16934650|NCT01236352|38079211|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
16934651|NCT01236352|38079212|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
16934652|NCT01236352|38079213|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
16934653|NCT01236352|38079214|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
16934654|NCT01236352|38079215|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
16934655|NCT01236352|38079216|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
16934656|NCT01236352|38079217|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
16934657|NCT01236352|38079218|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
16934658|NCT01236352|38079219|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
16934659|NCT01236352|38079220|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
16934660|NCT01236352|38079210|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934661|NCT01236352|38079211|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934662|NCT01236352|38079212|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934663|NCT01236352|38079213|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934664|NCT01236352|38079214|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934665|NCT01236352|38079215|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934666|NCT01236352|38079216|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934667|NCT01236352|38079217|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934668|NCT01236352|38079218|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934669|NCT01236352|38079219|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16934670|NCT01236352|38079220|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
16934671|NCT01236352|38079210|FG000|Overall Study|Lack of response to drug|0|||
16934672|NCT01236352|38079211|FG001|Overall Study|Lack of response to drug|0|||
16934673|NCT01236352|38079212|FG002|Overall Study|Lack of response to drug|0|||
16934674|NCT01236352|38079213|FG003|Overall Study|Lack of response to drug|0|||
16934675|NCT01236352|38079214|FG004|Overall Study|Lack of response to drug|0|||
16934676|NCT01236352|38079215|FG005|Overall Study|Lack of response to drug|0|||
16934677|NCT01236352|38079216|FG006|Overall Study|Lack of response to drug|0|||
16934678|NCT01236352|38079217|FG007|Overall Study|Lack of response to drug|0|||
16934679|NCT01236352|38079218|FG008|Overall Study|Lack of response to drug|0|||
16934680|NCT01236352|38079219|FG009|Overall Study|Lack of response to drug|1|||
16934681|NCT01236352|38079220|FG010|Overall Study|Lack of response to drug|1|||
16934682|NCT01236352|38079210|FG000|Overall Study|Patient transferred to IST|0|||
16934683|NCT01236352|38079211|FG001|Overall Study|Patient transferred to IST|0|||
16934684|NCT01236352|38079212|FG002|Overall Study|Patient transferred to IST|0|||
16934685|NCT01236352|38079213|FG003|Overall Study|Patient transferred to IST|0|||
16934686|NCT01236352|38079214|FG004|Overall Study|Patient transferred to IST|0|||
16934687|NCT01236352|38079215|FG005|Overall Study|Patient transferred to IST|0|||
16934688|NCT01236352|38079216|FG006|Overall Study|Patient transferred to IST|0|||
16934689|NCT01236352|38079217|FG007|Overall Study|Patient transferred to IST|0|||
16934690|NCT01236352|38079218|FG008|Overall Study|Patient transferred to IST|0|||
16934691|NCT01236352|38079219|FG009|Overall Study|Patient transferred to IST|2|||
16934692|NCT01236352|38079220|FG010|Overall Study|Patient transferred to IST|6|||
16934693|NCT01236118|38079247|FG000|Overall Study|Adverse Event|2|||
16934694|NCT01236118|38079248|FG001|Overall Study|Adverse Event|0|||
16934695|NCT01236118|38079249|FG002|Overall Study|Adverse Event|2|||
16934696|NCT01236118|38079247|FG000|Overall Study|Physician Decision|0|||
16934697|NCT01236118|38079248|FG001|Overall Study|Physician Decision|1|||
16934698|NCT01236118|38079249|FG002|Overall Study|Physician Decision|0|||
16934699|NCT01236118|38079247|FG000|Overall Study|Withdrawal by Subject|0|||
16934700|NCT01236118|38079248|FG001|Overall Study|Withdrawal by Subject|0|||
16934701|NCT01236118|38079249|FG002|Overall Study|Withdrawal by Subject|1|||
16934702|NCT01236001|38079259|FG000|Overall Study|Adverse Event|5|||
16934703|NCT01236001|38079260|FG001|Overall Study|Adverse Event|14|||
16934704|NCT01236001|38079259|FG000|Overall Study|Lack of Efficacy|6|||
16934705|NCT01236001|38079260|FG001|Overall Study|Lack of Efficacy|6|||
16934706|NCT01236001|38079259|FG000|Overall Study|Lost to Follow-up|6|||
16934707|NCT01236001|38079260|FG001|Overall Study|Lost to Follow-up|1|||
16934708|NCT01236001|38079259|FG000|Overall Study|Incompliance|1|||
17023352|NCT00623428|38167576|FG000|Follow-up Period|Reason not specified|1|||
17023353|NCT00623428|38167577|FG001|Follow-up Period|Reason not specified|1|||
17023354|NCT00623428|38167576|FG000|Follow-up Period|Death|0|||
17023355|NCT00623428|38167577|FG001|Follow-up Period|Death|1|||
17023356|NCT00784134|38167585|FG000|Overall Study|Lost to Follow-up|3|||
17023357|NCT00784134|38167586|FG001|Overall Study|Lost to Follow-up|6|||
17023358|NCT00776100|38167594|FG000|Overall Study|Disease Progression|1|||
17023359|NCT00776100|38167595|FG001|Overall Study|Disease Progression|0|||
17023360|NCT00783432|38167603|FG000|Overall Study|Adverse Event|22|||
17023361|NCT00783432|38167604|FG001|Overall Study|Adverse Event|17|||
17023362|NCT00783432|38167603|FG000|Overall Study|Lack of Efficacy|20|||
16934709|NCT01236001|38079260|FG001|Overall Study|Incompliance|0|||
17023363|NCT00783432|38167604|FG001|Overall Study|Lack of Efficacy|21|||
17023364|NCT00783432|38167603|FG000|Overall Study|Lost to Follow-up|11|||
17023365|NCT00783432|38167604|FG001|Overall Study|Lost to Follow-up|6|||
17023366|NCT00783432|38167603|FG000|Overall Study|Withdrawal by Subject|23|||
17023367|NCT00783432|38167604|FG001|Overall Study|Withdrawal by Subject|20|||
17023368|NCT00783432|38167603|FG000|Overall Study|subject moved|3|||
17023369|NCT00783432|38167604|FG001|Overall Study|subject moved|5|||
17023370|NCT00783432|38167603|FG000|Overall Study|Protocol Violation|6|||
17023371|NCT00783432|38167604|FG001|Overall Study|Protocol Violation|9|||
17023372|NCT00783198|38167613|FG000|Overall Study|Adverse Event|15|||
17023373|NCT00783198|38167614|FG001|Overall Study|Adverse Event|19|||
17023374|NCT00783198|38167615|FG002|Overall Study|Adverse Event|3|||
17023375|NCT00783198|38167613|FG000|Overall Study|Lost to Follow-up|11|||
17023376|NCT00783198|38167614|FG001|Overall Study|Lost to Follow-up|1|||
17023377|NCT00783198|38167615|FG002|Overall Study|Lost to Follow-up|7|||
17023378|NCT00783198|38167613|FG000|Overall Study|Withdrawal by Subject|22|||
17023379|NCT00783198|38167614|FG001|Overall Study|Withdrawal by Subject|14|||
17023380|NCT00783198|38167615|FG002|Overall Study|Withdrawal by Subject|20|||
17023381|NCT00783198|38167613|FG000|Overall Study|Noncompliance with protocol|7|||
17023382|NCT00783198|38167614|FG001|Overall Study|Noncompliance with protocol|7|||
17023383|NCT00783198|38167615|FG002|Overall Study|Noncompliance with protocol|10|||
17023384|NCT00783198|38167613|FG000|Overall Study|Did not meet protocol eligibility|0|||
17023385|NCT00783198|38167614|FG001|Overall Study|Did not meet protocol eligibility|1|||
17023386|NCT00783198|38167615|FG002|Overall Study|Did not meet protocol eligibility|0|||
17023387|NCT00783198|38167613|FG000|Overall Study|Administrative|2|||
17023388|NCT00783198|38167614|FG001|Overall Study|Administrative|1|||
17023389|NCT00783198|38167615|FG002|Overall Study|Administrative|2|||
17023390|NCT00789360|38167625|FG000|Overall Study|Protocol Violation|3|||
17023391|NCT00789360|38167626|FG001|Overall Study|Protocol Violation|1|||
17023392|NCT00782496|38167635|FG000|Overall Study|Lost to Follow-up|14|||
17023393|NCT00782496|38167636|FG001|Overall Study|Lost to Follow-up|15|||
17023394|NCT00782418|38167643|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
17023395|NCT00782418|38167644|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
17023396|NCT00782418|38167645|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
17023397|NCT00782418|38167646|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
17023398|NCT00782418|38167647|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
17023399|NCT00782418|38167648|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
17023400|NCT00782418|38167649|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
17023401|NCT00782418|38167643|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
17023402|NCT00782418|38167644|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
17023403|NCT00782418|38167645|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
17023404|NCT00782418|38167646|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
17023405|NCT00782418|38167647|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
17023406|NCT00782418|38167648|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
17023407|NCT00782418|38167649|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
17023408|NCT00782340|38167666|FG000|Open Label Titration|Adverse Event|12|||
17023409|NCT00782340|38167667|FG001|Open Label Titration|Adverse Event|0|||
17023410|NCT00782340|38167668|FG002|Open Label Titration|Adverse Event|0|||
17023411|NCT00782340|38167666|FG000|Open Label Titration|Treatment failure|50|||
17023412|NCT00782340|38167667|FG001|Open Label Titration|Treatment failure|0|||
17023413|NCT00782340|38167668|FG002|Open Label Titration|Treatment failure|0|||
17023414|NCT00782340|38167666|FG000|Open Label Titration|Protocol Violation|5|||
17023415|NCT00782340|38167667|FG001|Open Label Titration|Protocol Violation|0|||
17023416|NCT00782340|38167668|FG002|Open Label Titration|Protocol Violation|0|||
17023417|NCT00782340|38167666|FG000|Open Label Titration|Withdrawal by Subject|5|||
17023418|NCT00782340|38167667|FG001|Open Label Titration|Withdrawal by Subject|0|||
17023419|NCT00782340|38167668|FG002|Open Label Titration|Withdrawal by Subject|0|||
17023420|NCT00782340|38167666|FG000|Open Label Titration|Enrollment capped|16|||
17023421|NCT00782340|38167667|FG001|Open Label Titration|Enrollment capped|0|||
17023422|NCT00782340|38167668|FG002|Open Label Titration|Enrollment capped|0|||
17023423|NCT00782340|38167666|FG000|Open Label Titration|Did not meet responder criteria|2|||
17023424|NCT00782340|38167667|FG001|Open Label Titration|Did not meet responder criteria|0|||
17023425|NCT00782340|38167668|FG002|Open Label Titration|Did not meet responder criteria|0|||
17023426|NCT00782340|38167666|FG000|Open Label Titration|Lost to Follow-up|5|||
17023427|NCT00782340|38167667|FG001|Open Label Titration|Lost to Follow-up|0|||
17023428|NCT00782340|38167668|FG002|Open Label Titration|Lost to Follow-up|0|||
17023429|NCT00782340|38167666|FG000|Open Label Titration|Randomized in error|6|||
17023430|NCT00782340|38167667|FG001|Open Label Titration|Randomized in error|0|||
17023431|NCT00782340|38167668|FG002|Open Label Titration|Randomized in error|0|||
17023432|NCT00774852|38167677|FG000|Overall Study|Adverse Event|9|||
17023433|NCT00774852|38167678|FG001|Overall Study|Adverse Event|6|||
17023434|NCT00774852|38167677|FG000|Overall Study|Death|2|||
17023435|NCT00774852|38167678|FG001|Overall Study|Death|1|||
17023436|NCT00774852|38167677|FG000|Overall Study|Lack of Efficacy|3|||
17023437|NCT00774852|38167678|FG001|Overall Study|Lack of Efficacy|7|||
17023438|NCT00774852|38167677|FG000|Overall Study|Lost to Follow-up|9|||
17023439|NCT00774852|38167678|FG001|Overall Study|Lost to Follow-up|5|||
17023440|NCT00774852|38167677|FG000|Overall Study|Physician Decision|2|||
17023441|NCT00774852|38167678|FG001|Overall Study|Physician Decision|6|||
17023442|NCT00774852|38167677|FG000|Overall Study|Pregnancy|1|||
17023443|NCT00774852|38167678|FG001|Overall Study|Pregnancy|2|||
17023444|NCT00774852|38167677|FG000|Overall Study|Withdrawal by Subject|2|||
17023445|NCT00774852|38167678|FG001|Overall Study|Withdrawal by Subject|2|||
17023446|NCT00774852|38167677|FG000|Overall Study|Non-responder|15|||
17023447|NCT00774852|38167678|FG001|Overall Study|Non-responder|11|||
17023448|NCT00774852|38167677|FG000|Overall Study|Subject non-compliance|0|||
17023449|NCT00774852|38167678|FG001|Overall Study|Subject non-compliance|1|||
17023450|NCT00774852|38167677|FG000|Overall Study|Protocol Violation|1|||
17023451|NCT00774852|38167678|FG001|Overall Study|Protocol Violation|0|||
17023452|NCT00774852|38167677|FG000|Overall Study|Subject received prohibited medication|1|||
17023453|NCT00774852|38167678|FG001|Overall Study|Subject received prohibited medication|0|||
17023454|NCT00774306|38167698|FG000|Overall Study|Adverse Event|3|||
17023455|NCT00774306|38167699|FG001|Overall Study|Adverse Event|0|||
17023456|NCT00774306|38167700|FG002|Overall Study|Adverse Event|0|||
17023457|NCT00774306|38167701|FG003|Overall Study|Adverse Event|0|||
17023458|NCT00774306|38167698|FG000|Overall Study|Protocol Violation|2|||
17023459|NCT00774306|38167699|FG001|Overall Study|Protocol Violation|0|||
17023460|NCT00774306|38167700|FG002|Overall Study|Protocol Violation|3|||
17023461|NCT00774306|38167701|FG003|Overall Study|Protocol Violation|0|||
17023462|NCT00774306|38167698|FG000|Overall Study|Withdrawal by Subject|6|||
17023463|NCT00774306|38167699|FG001|Overall Study|Withdrawal by Subject|1|||
17023464|NCT00774306|38167700|FG002|Overall Study|Withdrawal by Subject|1|||
17023465|NCT00774306|38167701|FG003|Overall Study|Withdrawal by Subject|0|||
17023466|NCT00774306|38167698|FG000|Overall Study|Lost to Follow-up|6|||
17023467|NCT00774306|38167699|FG001|Overall Study|Lost to Follow-up|0|||
17023468|NCT00774306|38167700|FG002|Overall Study|Lost to Follow-up|4|||
17023469|NCT00774306|38167701|FG003|Overall Study|Lost to Follow-up|5|||
17023470|NCT00774306|38167698|FG000|Overall Study|Death|1|||
17023471|NCT00774306|38167699|FG001|Overall Study|Death|1|||
17023472|NCT00774306|38167700|FG002|Overall Study|Death|0|||
17023473|NCT00774306|38167701|FG003|Overall Study|Death|0|||
17023474|NCT00781326|38167711|FG000|Phase I|Adverse Event|1|||
17023475|NCT00781326|38167711|FG000|Phase I|Withdrawal by Subject|1|||
17023476|NCT00781326|38167711|FG000|Phase I|Physician Decision|2|||
17023477|NCT00787800|38167717|FG000|Overall Study|Withdrawal by Subject|3|||
17023478|NCT00787800|38167718|FG001|Overall Study|Withdrawal by Subject|5|||
17023479|NCT00787800|38167717|FG000|Overall Study|Death|0|||
17023480|NCT00787800|38167718|FG001|Overall Study|Death|2|||
17023481|NCT00773838|38167725|FG000|Overall Study|Adverse Event|29|||
17023482|NCT00773838|38167725|FG000|Overall Study|Lost to Follow-up|1|||
17023483|NCT00773838|38167725|FG000|Overall Study|Physician Decision|8|||
17023484|NCT00773838|38167725|FG000|Overall Study|Progressive Disease|82|||
17023485|NCT00773838|38167725|FG000|Overall Study|Protocol Violation|2|||
17023486|NCT00773838|38167725|FG000|Overall Study|Withdrawal by Subject|21|||
17023487|NCT00787644|38167731|FG000|Overall Study|Lost to Follow-up|1|||
17023488|NCT00787644|38167732|FG001|Overall Study|Lost to Follow-up|1|||
17023489|NCT00787644|38167731|FG000|Overall Study|Withdrawal by Subject|1|||
17023490|NCT00787644|38167732|FG001|Overall Study|Withdrawal by Subject|1|||
17023491|NCT00787566|38167741|FG000|Overall Study|AE related to chemotherapy|0|||
17023492|NCT00787566|38167742|FG001|Overall Study|AE related to chemotherapy|1|||
17023493|NCT00787566|38167743|FG002|Overall Study|AE related to chemotherapy|0|||
17023494|NCT00787254|38167753|FG000|Overall Study|Adverse Event|24|||
17023495|NCT00787254|38167754|FG001|Overall Study|Adverse Event|23|||
17023496|NCT00787254|38167753|FG000|Overall Study|Protocol Violation|26|||
17023497|NCT00787254|38167754|FG001|Overall Study|Protocol Violation|23|||
17023498|NCT00787254|38167753|FG000|Overall Study|Withdrawal by Subject|16|||
17023499|NCT00787254|38167754|FG001|Overall Study|Withdrawal by Subject|11|||
17023500|NCT00787254|38167753|FG000|Overall Study|Lack of Efficacy|4|||
17023501|NCT00787254|38167754|FG001|Overall Study|Lack of Efficacy|15|||
17023502|NCT00787254|38167753|FG000|Overall Study|NSAIDs discontinuation|1|||
17023503|NCT00787254|38167754|FG001|Overall Study|NSAIDs discontinuation|2|||
17023504|NCT00787254|38167753|FG000|Overall Study|Institution closed|1|||
17023505|NCT00787254|38167754|FG001|Overall Study|Institution closed|0|||
17023506|NCT00787254|38167753|FG000|Overall Study|Physician Decision|4|||
17023507|NCT00787254|38167754|FG001|Overall Study|Physician Decision|8|||
17023508|NCT00625846|38167764|FG000|Overall Study|Withdrawal by Subject|2|||
17023509|NCT00625846|38167765|FG001|Overall Study|Withdrawal by Subject|0|||
17023510|NCT00625846|38167766|FG002|Overall Study|Withdrawal by Subject|1|||
17023511|NCT00625846|38167767|FG003|Overall Study|Withdrawal by Subject|2|||
17023512|NCT00773292|38167781|FG000|Treatment 48 Weeks|Adverse Event|1|||
17023513|NCT00773292|38167781|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
17023514|NCT00786864|38167787|FG000|Overall Study|Lost to Follow-up|0|||
17023515|NCT00786864|38167788|FG001|Overall Study|Lost to Follow-up|1|||
17023516|NCT00786864|38167787|FG000|Overall Study|Sustained serious back injury|1|||
17023517|NCT00786864|38167788|FG001|Overall Study|Sustained serious back injury|0|||
17023518|NCT00621322|38167800|FG000|Overall Study|Lost to Follow-up|0|||
17023519|NCT00621322|38167801|FG001|Overall Study|Lost to Follow-up|0|||
17023520|NCT00621322|38167802|FG002|Overall Study|Lost to Follow-up|0|||
17023521|NCT00621322|38167803|FG003|Overall Study|Lost to Follow-up|0|||
17023522|NCT00621322|38167804|FG004|Overall Study|Lost to Follow-up|1|||
17023523|NCT00621322|38167805|FG005|Overall Study|Lost to Follow-up|0|||
17023524|NCT00621322|38167800|FG000|Overall Study|Physician Decision|0|||
17023525|NCT00621322|38167801|FG001|Overall Study|Physician Decision|0|||
17023526|NCT00621322|38167802|FG002|Overall Study|Physician Decision|1|||
17023527|NCT00621322|38167803|FG003|Overall Study|Physician Decision|1|||
17023528|NCT00621322|38167804|FG004|Overall Study|Physician Decision|0|||
17023529|NCT00621322|38167805|FG005|Overall Study|Physician Decision|0|||
17023530|NCT00621322|38167800|FG000|Overall Study|Withdrawal by Subject|0|||
17023531|NCT00621322|38167801|FG001|Overall Study|Withdrawal by Subject|0|||
17023532|NCT00621322|38167802|FG002|Overall Study|Withdrawal by Subject|0|||
17023533|NCT00621322|38167803|FG003|Overall Study|Withdrawal by Subject|1|||
17023534|NCT00621322|38167804|FG004|Overall Study|Withdrawal by Subject|0|||
17023535|NCT00621322|38167805|FG005|Overall Study|Withdrawal by Subject|2|||
17023536|NCT00621322|38167800|FG000|Overall Study|Migrated/moved from study area|1|||
17023537|NCT00621322|38167801|FG001|Overall Study|Migrated/moved from study area|0|||
17023538|NCT00621322|38167802|FG002|Overall Study|Migrated/moved from study area|1|||
17023539|NCT00621322|38167803|FG003|Overall Study|Migrated/moved from study area|1|||
17023540|NCT00621322|38167804|FG004|Overall Study|Migrated/moved from study area|0|||
17023541|NCT00621322|38167805|FG005|Overall Study|Migrated/moved from study area|2|||
17023542|NCT00853385|38167824|FG000|Overall Study|Death|0|||
17023543|NCT00853385|38167825|FG001|Overall Study|Death|0|||
17023544|NCT00853385|38167826|FG002|Overall Study|Death|0|||
16934710|NCT01236001|38079259|FG000|Overall Study|Planned Visit After End of Study|0|||
16934711|NCT01236001|38079260|FG001|Overall Study|Planned Visit After End of Study|1|||
16934712|NCT01229254|38079270|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
16934713|NCT01229254|38079271|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
16934714|NCT01229254|38079272|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
16934715|NCT01229254|38079270|FG000|Overall Study|Adverse Event|4|||
16934716|NCT01229254|38079271|FG001|Overall Study|Adverse Event|5|||
16934717|NCT01229254|38079272|FG002|Overall Study|Adverse Event|3|||
16934718|NCT01229254|38079270|FG000|Overall Study|Lost to Follow-up|3|||
16934719|NCT01229254|38079271|FG001|Overall Study|Lost to Follow-up|0|||
16934720|NCT01229254|38079272|FG002|Overall Study|Lost to Follow-up|1|||
16934721|NCT01229254|38079270|FG000|Overall Study|Physician Decision|0|||
17023545|NCT00853385|38167827|FG003|Overall Study|Death|0|||
17103039|NCT00112437|38241449|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103040|NCT00112437|38241450|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103041|NCT00112437|38241451|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103042|NCT00112437|38241452|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103043|NCT00112437|38241453|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103044|NCT00112437|38241454|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103045|NCT00112437|38241455|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103046|NCT00112437|38241456|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
17103047|NCT00112437|38241457|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103048|NCT00112437|38241458|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103049|NCT00112437|38241459|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103050|NCT00112437|38241460|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103051|NCT00112437|38241461|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103052|NCT00112437|38241462|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103053|NCT00112437|38241463|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103054|NCT00112437|38241464|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103055|NCT00112437|38241465|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103056|NCT00112437|38241466|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
17103057|NCT00112437|38241441|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16852818|NCT01397409|37803056|FG006|Stage 2|Other Miscellaneous Reasons|0|||
16852819|NCT01397409|37803057|FG007|Stage 2|Other Miscellaneous Reasons|0|||
16852820|NCT01397409|37803058|FG008|Stage 2|Other Miscellaneous Reasons|0|||
16852821|NCT01397409|37803059|FG009|Stage 2|Other Miscellaneous Reasons|0|||
16852822|NCT01397409|37803050|FG000|Stage 3|Adverse Event|0|||
16852823|NCT01397409|37803051|FG001|Stage 3|Adverse Event|0|||
16852824|NCT01397409|37803052|FG002|Stage 3|Adverse Event|0|||
16852825|NCT01397409|37803053|FG003|Stage 3|Adverse Event|0|||
16934722|NCT01229254|38079271|FG001|Overall Study|Physician Decision|3|||
16934723|NCT01229254|38079272|FG002|Overall Study|Physician Decision|0|||
16934724|NCT01229254|38079270|FG000|Overall Study|Protocol Violation|4|||
16934725|NCT01229254|38079271|FG001|Overall Study|Protocol Violation|6|||
16852826|NCT01397409|37803054|FG004|Stage 3|Adverse Event|0|||
16934726|NCT01229254|38079272|FG002|Overall Study|Protocol Violation|5|||
16934727|NCT01229254|38079270|FG000|Overall Study|Withdrawal by Subject|1|||
17103058|NCT00112437|38241442|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16934728|NCT01229254|38079271|FG001|Overall Study|Withdrawal by Subject|0|||
17023546|NCT00853385|38167828|FG004|Overall Study|Death|1|||
17023547|NCT00853385|38167824|FG000|Overall Study|Adverse Event|24|||
17023548|NCT00853385|38167825|FG001|Overall Study|Adverse Event|24|||
17023549|NCT00853385|38167826|FG002|Overall Study|Adverse Event|2|||
17023550|NCT00853385|38167827|FG003|Overall Study|Adverse Event|5|||
17023551|NCT00853385|38167828|FG004|Overall Study|Adverse Event|22|||
16852827|NCT01397409|37803055|FG005|Stage 3|Adverse Event|0|||
16852828|NCT01397409|37803056|FG006|Stage 3|Adverse Event|0|||
16852829|NCT01397409|37803057|FG007|Stage 3|Adverse Event|1|||
16852830|NCT01397409|37803058|FG008|Stage 3|Adverse Event|0|||
16852831|NCT01397409|37803059|FG009|Stage 3|Adverse Event|0|||
16852832|NCT01397409|37803050|FG000|Stage 3|Other Miscellaneous Reasons|0|||
16852833|NCT01397409|37803051|FG001|Stage 3|Other Miscellaneous Reasons|0|||
16852834|NCT01397409|37803052|FG002|Stage 3|Other Miscellaneous Reasons|0|||
16852835|NCT01397409|37803053|FG003|Stage 3|Other Miscellaneous Reasons|0|||
16852836|NCT01397409|37803054|FG004|Stage 3|Other Miscellaneous Reasons|0|||
16852837|NCT01397409|37803055|FG005|Stage 3|Other Miscellaneous Reasons|0|||
16852838|NCT01397409|37803056|FG006|Stage 3|Other Miscellaneous Reasons|0|||
16852839|NCT01397409|37803057|FG007|Stage 3|Other Miscellaneous Reasons|1|||
16852840|NCT01397409|37803058|FG008|Stage 3|Other Miscellaneous Reasons|0|||
16852841|NCT01397409|37803059|FG009|Stage 3|Other Miscellaneous Reasons|0|||
16852842|NCT01397253|37803084|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
16852843|NCT01397253|37803085|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
16852844|NCT01777334|37803093|FG000|Overall Study|Adverse Event|18|||
16852845|NCT01777334|37803094|FG001|Overall Study|Adverse Event|14|||
17103059|NCT00112437|38241443|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103060|NCT00112437|38241444|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103061|NCT00112437|38241445|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103062|NCT00112437|38241446|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103063|NCT00112437|38241447|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103064|NCT00112437|38241448|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103065|NCT00112437|38241449|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103066|NCT00112437|38241450|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103067|NCT00112437|38241451|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103068|NCT00112437|38241452|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
17103069|NCT00112437|38241453|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103070|NCT00112437|38241454|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17198658|NCT01666652|38352336|FG002|Overall Study|Withdrawal by Subject|0|||
17198659|NCT01666652|38352337|FG003|Overall Study|Withdrawal by Subject|0|||
17198660|NCT01666652|38352338|FG004|Overall Study|Withdrawal by Subject|1|||
17023552|NCT00853385|38167824|FG000|Overall Study|Lack of Efficacy|6|||
17023553|NCT00853385|38167825|FG001|Overall Study|Lack of Efficacy|7|||
17023554|NCT00853385|38167826|FG002|Overall Study|Lack of Efficacy|3|||
17023555|NCT00853385|38167827|FG003|Overall Study|Lack of Efficacy|3|||
17023556|NCT00853385|38167828|FG004|Overall Study|Lack of Efficacy|6|||
17023557|NCT00853385|38167824|FG000|Overall Study|Lost to Follow-up|2|||
17023558|NCT00853385|38167825|FG001|Overall Study|Lost to Follow-up|1|||
17198661|NCT01666652|38352334|FG000|Overall Study|Moved from study area|1|||
17198662|NCT01666652|38352335|FG001|Overall Study|Moved from study area|0|||
17198663|NCT01666652|38352336|FG002|Overall Study|Moved from study area|0|||
17198664|NCT01666652|38352337|FG003|Overall Study|Moved from study area|2|||
17198665|NCT01666652|38352338|FG004|Overall Study|Moved from study area|0|||
17198666|NCT01666652|38352334|FG000|Overall Study|Lost to Follow-up|1|||
17198667|NCT01666652|38352335|FG001|Overall Study|Lost to Follow-up|1|||
17198668|NCT01666652|38352336|FG002|Overall Study|Lost to Follow-up|1|||
17198669|NCT01666652|38352337|FG003|Overall Study|Lost to Follow-up|1|||
17198670|NCT01666652|38352338|FG004|Overall Study|Lost to Follow-up|0|||
17198671|NCT00109733|38352352|FG000|Overall Study|Protocol Violation|0|||
17198672|NCT00109733|38352353|FG001|Overall Study|Protocol Violation|1|||
17198673|NCT00109733|38352352|FG000|Overall Study|Stopped taking study drug|1|||
17198674|NCT00109733|38352353|FG001|Overall Study|Stopped taking study drug|1|||
17198675|NCT00109733|38352352|FG000|Overall Study|Non-compliant|0|||
16852846|NCT01777334|37803093|FG000|Overall Study|Lack of Efficacy|15|||
16852847|NCT01777334|37803094|FG001|Overall Study|Lack of Efficacy|29|||
16852848|NCT01777334|37803093|FG000|Overall Study|Protocol Violation|3|||
16934729|NCT01229254|38079272|FG002|Overall Study|Withdrawal by Subject|1|||
16934730|NCT01229254|38079270|FG000|Overall Study|Non-compliance with Study Drug|0|||
16934731|NCT01229254|38079271|FG001|Overall Study|Non-compliance with Study Drug|1|||
16934732|NCT01229254|38079272|FG002|Overall Study|Non-compliance with Study Drug|1|||
16934733|NCT01235728|38079281|FG000|Overall Study|Protocol Violation|0|||
17023559|NCT00853385|38167826|FG002|Overall Study|Lost to Follow-up|0|||
17103071|NCT00112437|38241455|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
17103072|NCT00112437|38241456|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17198676|NCT00109733|38352353|FG001|Overall Study|Non-compliant|1|||
17198677|NCT00109733|38352352|FG000|Overall Study|Could not commit time for study|1|||
17198678|NCT00109733|38352353|FG001|Overall Study|Could not commit time for study|1|||
17023560|NCT00853385|38167827|FG003|Overall Study|Lost to Follow-up|0|||
17023561|NCT00853385|38167828|FG004|Overall Study|Lost to Follow-up|0|||
17023562|NCT00853385|38167824|FG000|Overall Study|Withdrawal by Subject|4|||
17023563|NCT00853385|38167825|FG001|Overall Study|Withdrawal by Subject|2|||
17023564|NCT00853385|38167826|FG002|Overall Study|Withdrawal by Subject|0|||
17023565|NCT00853385|38167827|FG003|Overall Study|Withdrawal by Subject|1|||
17023566|NCT00853385|38167828|FG004|Overall Study|Withdrawal by Subject|1|||
17023567|NCT00853385|38167824|FG000|Overall Study|Other|18|||
17023568|NCT00853385|38167825|FG001|Overall Study|Other|9|||
17023569|NCT00853385|38167826|FG002|Overall Study|Other|4|||
17023570|NCT00853385|38167827|FG003|Overall Study|Other|4|||
17023571|NCT00853385|38167828|FG004|Overall Study|Other|12|||
17023572|NCT00622336|38167850|FG000|Treatment Phase|Progression of Disease|181|||
17023573|NCT00622336|38167850|FG000|Treatment Phase|Adverse Event|46|||
17023574|NCT00622336|38167850|FG000|Treatment Phase|Other|40|||
17023575|NCT00622336|38167850|FG000|Treatment Phase|Death|14|||
17023576|NCT00622336|38167850|FG000|Treatment Phase|Lack of therapeutic effect|13|||
17023577|NCT00622336|38167850|FG000|Treatment Phase|Withdrawal by Subject|13|||
17023578|NCT00622336|38167850|FG000|Treatment Phase|Lost to Follow-up|2|||
17023579|NCT00622336|38167850|FG000|Extension Phase|Adverse Event|2|||
17023580|NCT00622336|38167850|FG000|Extension Phase|Progressive Disease|6|||
17023581|NCT00622336|38167850|FG000|Extension Phase|Lack of therapeutic effect|2|||
17023582|NCT00622336|38167850|FG000|Extension Phase|Withdrawal by Subject|1|||
17023583|NCT00622336|38167850|FG000|Extension Phase|Lost to Follow-up|1|||
17023584|NCT00622336|38167850|FG000|Extension Phase|Other|9|||
17023585|NCT00779766|38167858|FG000|Month 24|Serious Adverse Event|2|||
17023586|NCT00779766|38167859|FG001|Month 24|Serious Adverse Event|3|||
17023587|NCT00779766|38167858|FG000|Month 24|Adverse Event|3|||
17023588|NCT00779766|38167859|FG001|Month 24|Adverse Event|3|||
17023589|NCT00779766|38167858|FG000|Month 24|Protocol Violation|3|||
17023590|NCT00779766|38167859|FG001|Month 24|Protocol Violation|1|||
17023591|NCT00779766|38167858|FG000|Month 24|Withdrawal by Subject|159|||
17023592|NCT00779766|38167859|FG001|Month 24|Withdrawal by Subject|127|||
17023593|NCT00779766|38167858|FG000|Month 24|Migrated/moved from study area|138|||
17023594|NCT00779766|38167859|FG001|Month 24|Migrated/moved from study area|162|||
17023595|NCT00779766|38167858|FG000|Month 24|Lost to Follow-up|9|||
17023596|NCT00779766|38167859|FG001|Month 24|Lost to Follow-up|9|||
17023597|NCT00779766|38167858|FG000|Month 24|Other|18|||
17023598|NCT00779766|38167859|FG001|Month 24|Other|27|||
17023599|NCT00779766|38167858|FG000|Month 48|Withdrawal by Subject|68|||
17023600|NCT00779766|38167859|FG001|Month 48|Withdrawal by Subject|63|||
17023601|NCT00779766|38167858|FG000|Month 48|Migrated/moved from study area|76|||
17023602|NCT00779766|38167859|FG001|Month 48|Migrated/moved from study area|75|||
17023603|NCT00779766|38167858|FG000|Month 48|Lost to Follow-up|29|||
17023604|NCT00779766|38167859|FG001|Month 48|Lost to Follow-up|30|||
17023605|NCT00779766|38167858|FG000|Month 48|Other|1|||
17023606|NCT00779766|38167859|FG001|Month 48|Other|0|||
17023607|NCT00779766|38167858|FG000|Month 72|Withdrawal by Subject|55|||
17023608|NCT00779766|38167859|FG001|Month 72|Withdrawal by Subject|71|||
17023609|NCT00779766|38167858|FG000|Month 72|Migrated/moved from study area|124|||
17023610|NCT00779766|38167859|FG001|Month 72|Migrated/moved from study area|109|||
17023611|NCT00779766|38167858|FG000|Month 72|Lost to Follow-up|6|||
17023612|NCT00779766|38167859|FG001|Month 72|Lost to Follow-up|8|||
17023613|NCT00779766|38167858|FG000|Month 72|Other|0|||
17023614|NCT00779766|38167859|FG001|Month 72|Other|1|||
17023615|NCT00846365|38167869|FG000|Overall Study|Adverse Event|20|||
17023616|NCT00846365|38167870|FG001|Overall Study|Adverse Event|30|||
17023617|NCT00846365|38167871|FG002|Overall Study|Adverse Event|11|||
17023618|NCT00846365|38167869|FG000|Overall Study|Protocol Violation|5|||
17023619|NCT00846365|38167870|FG001|Overall Study|Protocol Violation|4|||
17023620|NCT00846365|38167871|FG002|Overall Study|Protocol Violation|0|||
17023621|NCT00846365|38167869|FG000|Overall Study|Lost to Follow-up|8|||
17023622|NCT00846365|38167870|FG001|Overall Study|Lost to Follow-up|2|||
17023623|NCT00846365|38167871|FG002|Overall Study|Lost to Follow-up|5|||
17023624|NCT00846365|38167869|FG000|Overall Study|Withdrawal by Subject|11|||
17023625|NCT00846365|38167870|FG001|Overall Study|Withdrawal by Subject|11|||
17023626|NCT00846365|38167871|FG002|Overall Study|Withdrawal by Subject|9|||
17023627|NCT00846365|38167869|FG000|Overall Study|Pregnancy|1|||
17023628|NCT00846365|38167870|FG001|Overall Study|Pregnancy|0|||
17023629|NCT00846365|38167871|FG002|Overall Study|Pregnancy|0|||
17023630|NCT00846365|38167869|FG000|Overall Study|Lack of Efficacy|1|||
17023631|NCT00846365|38167870|FG001|Overall Study|Lack of Efficacy|1|||
17023632|NCT00846365|38167871|FG002|Overall Study|Lack of Efficacy|2|||
17023633|NCT00846365|38167869|FG000|Overall Study|Other|9|||
17023634|NCT00846365|38167870|FG001|Overall Study|Other|1|||
17023635|NCT00846365|38167871|FG002|Overall Study|Other|6|||
17023636|NCT00779142|38167879|FG000|Overall Study|Screen Failures|3|||
17023637|NCT00622180|38167884|FG000|Overall Study|Lost to Follow-up|1|||
17023638|NCT00622180|38167885|FG001|Overall Study|Lost to Follow-up|2|||
17023639|NCT00773136|38167891|FG000|Overall Study|Physician Decision|2|||
17023640|NCT00853307|38167898|FG000|Overall Study|Adverse Event|1|||
17023641|NCT00853307|38167899|FG001|Overall Study|Adverse Event|2|||
16934734|NCT01235728|38079282|FG001|Overall Study|Protocol Violation|0|||
16934735|NCT01235728|38079283|FG002|Overall Study|Protocol Violation|0|||
16934736|NCT01235728|38079284|FG003|Overall Study|Protocol Violation|1|||
16934737|NCT01235728|38079285|FG004|Overall Study|Protocol Violation|0|||
16934738|NCT01235728|38079286|FG005|Overall Study|Protocol Violation|0|||
16934739|NCT01235728|38079287|FG006|Overall Study|Protocol Violation|0|||
16934740|NCT01235728|38079288|FG007|Overall Study|Protocol Violation|0|||
16934741|NCT01235689|38079298|FG000|Overall Study|Adverse Event|12|||
16934742|NCT01235689|38079299|FG001|Overall Study|Adverse Event|16|||
16934743|NCT01235689|38079298|FG000|Overall Study|Lack of Efficacy|12|||
16934744|NCT01235689|38079299|FG001|Overall Study|Lack of Efficacy|5|||
16934745|NCT01235689|38079298|FG000|Overall Study|Withdrawal by Subject|3|||
16934746|NCT01235689|38079299|FG001|Overall Study|Withdrawal by Subject|4|||
16934747|NCT01235689|38079298|FG000|Overall Study|Lost to Follow-up|1|||
17023642|NCT00853307|38167898|FG000|Overall Study|Withdrawal by Subject|1|||
17023643|NCT00853307|38167899|FG001|Overall Study|Withdrawal by Subject|2|||
17023644|NCT00853307|38167898|FG000|Overall Study|Reason Not Specified|0|||
17023645|NCT00853307|38167899|FG001|Overall Study|Reason Not Specified|1|||
17023646|NCT00778830|38167907|FG000|Overall Study|Ongoing at data cut-off|0|||
17023647|NCT00778830|38167908|FG001|Overall Study|Ongoing at data cut-off|1|||
17023648|NCT00772668|38167914|FG000|Overall Study|Physician Decision|3|||
17023649|NCT00786474|38167921|FG000|Overall Study|Death|5|||
17023650|NCT00786474|38167922|FG001|Overall Study|Death|4|||
17023651|NCT00786474|38167921|FG000|Overall Study|Withdrawal by Subject|23|||
17023652|NCT00786474|38167922|FG001|Overall Study|Withdrawal by Subject|31|||
17023653|NCT00786474|38167921|FG000|Overall Study|Lost to Follow-up|3|||
17023654|NCT00786474|38167922|FG001|Overall Study|Lost to Follow-up|3|||
17023655|NCT00786474|38167921|FG000|Overall Study|Physician Decision|2|||
17023656|NCT00786474|38167922|FG001|Overall Study|Physician Decision|1|||
17023657|NCT00786474|38167921|FG000|Overall Study|Other|4|||
17023658|NCT00786474|38167922|FG001|Overall Study|Other|4|||
17023659|NCT00784875|38167932|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
17023660|NCT00784875|38167933|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
17023661|NCT00784875|38167934|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
17023662|NCT00784875|38167935|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
17023663|NCT00784875|38167932|FG000|Period A - Baseline|Adverse Event|0|||
17023664|NCT00784875|38167933|FG001|Period A - Baseline|Adverse Event|0|||
17023665|NCT00784875|38167934|FG002|Period A - Baseline|Adverse Event|0|||
17023666|NCT00784875|38167935|FG003|Period A - Baseline|Adverse Event|8|||
17023667|NCT00784875|38167932|FG000|Period A - Baseline|Protocol Violation|0|||
17023668|NCT00784875|38167933|FG001|Period A - Baseline|Protocol Violation|0|||
17023669|NCT00784875|38167934|FG002|Period A - Baseline|Protocol Violation|0|||
17023670|NCT00784875|38167935|FG003|Period A - Baseline|Protocol Violation|25|||
17023671|NCT00784875|38167932|FG000|Period A - Baseline|Withdrawal by Subject|0|||
17023672|NCT00784875|38167933|FG001|Period A - Baseline|Withdrawal by Subject|0|||
17023673|NCT00784875|38167934|FG002|Period A - Baseline|Withdrawal by Subject|0|||
17023674|NCT00784875|38167935|FG003|Period A - Baseline|Withdrawal by Subject|27|||
17023675|NCT00784875|38167932|FG000|Period A - Baseline|Physician Decision|0|||
17023676|NCT00784875|38167933|FG001|Period A - Baseline|Physician Decision|0|||
17023677|NCT00784875|38167934|FG002|Period A - Baseline|Physician Decision|0|||
17023678|NCT00784875|38167935|FG003|Period A - Baseline|Physician Decision|2|||
17023679|NCT00784875|38167932|FG000|Period A - Baseline|Sponsor Decision|0|||
17023680|NCT00784875|38167933|FG001|Period A - Baseline|Sponsor Decision|0|||
17023681|NCT00784875|38167934|FG002|Period A - Baseline|Sponsor Decision|0|||
17023682|NCT00784875|38167935|FG003|Period A - Baseline|Sponsor Decision|113|||
17023683|NCT00784875|38167932|FG000|Period A - Baseline|Lost to Follow-up|0|||
17023684|NCT00784875|38167933|FG001|Period A - Baseline|Lost to Follow-up|0|||
17023685|NCT00784875|38167934|FG002|Period A - Baseline|Lost to Follow-up|0|||
17023686|NCT00784875|38167935|FG003|Period A - Baseline|Lost to Follow-up|2|||
17023687|NCT00784875|38167932|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
17023688|NCT00784875|38167933|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
17023689|NCT00784875|38167934|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
17023690|NCT00784875|38167935|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
17023691|NCT00784875|38167932|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
17023692|NCT00784875|38167933|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
17023693|NCT00784875|38167934|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
17023694|NCT00784875|38167935|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
17023695|NCT00784875|38167932|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
17023696|NCT00784875|38167933|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
17023697|NCT00784875|38167934|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
17023698|NCT00784875|38167935|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
17023699|NCT00784875|38167932|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
17023700|NCT00784875|38167933|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
17023701|NCT00784875|38167934|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
17198679|NCT02706405|38352367|FG000|Overall Study|Death|3|||
16934748|NCT01235689|38079299|FG001|Overall Study|Lost to Follow-up|2|||
17023702|NCT00784875|38167935|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
17023703|NCT00784875|38167932|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
17023704|NCT00784875|38167933|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
17023705|NCT00784875|38167934|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
17023706|NCT00784875|38167935|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
17023707|NCT00784875|38167932|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
17023708|NCT00784875|38167933|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
17023709|NCT00784875|38167934|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
17023710|NCT00784875|38167935|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
17023711|NCT00784875|38167932|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
17023712|NCT00784875|38167933|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
17023713|NCT00784875|38167934|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
17023714|NCT00784875|38167935|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
17023715|NCT00784875|38167932|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
17023716|NCT00784875|38167933|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
17023717|NCT00784875|38167934|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
17023718|NCT00784875|38167935|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
17023719|NCT00784875|38167932|FG000|Period C|Adverse Event|1|||
17023720|NCT00784875|38167933|FG001|Period C|Adverse Event|0|||
17023721|NCT00784875|38167934|FG002|Period C|Adverse Event|4|||
17023722|NCT00784875|38167935|FG003|Period C|Adverse Event|2|||
17023723|NCT00784875|38167932|FG000|Period C|Protocol Violation|0|||
17023724|NCT00784875|38167933|FG001|Period C|Protocol Violation|0|||
17023725|NCT00784875|38167934|FG002|Period C|Protocol Violation|1|||
17023726|NCT00784875|38167935|FG003|Period C|Protocol Violation|2|||
17023727|NCT00784875|38167932|FG000|Period C|Lack of Efficacy|0|||
17023728|NCT00784875|38167933|FG001|Period C|Lack of Efficacy|0|||
17023729|NCT00784875|38167934|FG002|Period C|Lack of Efficacy|1|||
17023730|NCT00784875|38167935|FG003|Period C|Lack of Efficacy|0|||
17023731|NCT00784875|38167932|FG000|Period C|Withdrawal by Subject|1|||
17023732|NCT00784875|38167933|FG001|Period C|Withdrawal by Subject|1|||
17023733|NCT00784875|38167934|FG002|Period C|Withdrawal by Subject|2|||
17023734|NCT00784875|38167935|FG003|Period C|Withdrawal by Subject|0|||
17023735|NCT00784875|38167932|FG000|Period C|Physician Decision|0|||
17023736|NCT00784875|38167933|FG001|Period C|Physician Decision|0|||
17023737|NCT00784875|38167934|FG002|Period C|Physician Decision|1|||
17023738|NCT00784875|38167935|FG003|Period C|Physician Decision|1|||
17023739|NCT00784875|38167932|FG000|Period C|Sponsor Decision|5|||
17023740|NCT00784875|38167933|FG001|Period C|Sponsor Decision|5|||
17023741|NCT00784875|38167934|FG002|Period C|Sponsor Decision|4|||
17023742|NCT00784875|38167935|FG003|Period C|Sponsor Decision|2|||
17023743|NCT00784875|38167932|FG000|Period D|Adverse Event|0|||
17023744|NCT00784875|38167933|FG001|Period D|Adverse Event|2|||
17023745|NCT00784875|38167934|FG002|Period D|Adverse Event|2|||
17023746|NCT00784875|38167935|FG003|Period D|Adverse Event|0|||
17023747|NCT00784875|38167932|FG000|Period D|Protocol Violation|1|||
17023748|NCT00784875|38167933|FG001|Period D|Protocol Violation|0|||
17023749|NCT00784875|38167934|FG002|Period D|Protocol Violation|0|||
17023750|NCT00784875|38167935|FG003|Period D|Protocol Violation|0|||
17023751|NCT00784875|38167932|FG000|Period D|Withdrawal by Subject|2|||
17023752|NCT00784875|38167933|FG001|Period D|Withdrawal by Subject|0|||
17023753|NCT00784875|38167934|FG002|Period D|Withdrawal by Subject|2|||
17023754|NCT00784875|38167935|FG003|Period D|Withdrawal by Subject|0|||
17023755|NCT00784875|38167932|FG000|Period D|Physician Decision|0|||
17023756|NCT00784875|38167933|FG001|Period D|Physician Decision|1|||
17023757|NCT00784875|38167934|FG002|Period D|Physician Decision|0|||
17023758|NCT00784875|38167935|FG003|Period D|Physician Decision|0|||
17023759|NCT00784875|38167932|FG000|Period D|Sponsor Decision|1|||
17023760|NCT00784875|38167933|FG001|Period D|Sponsor Decision|1|||
17023761|NCT00784875|38167934|FG002|Period D|Sponsor Decision|1|||
17023762|NCT00784875|38167935|FG003|Period D|Sponsor Decision|0|||
17023763|NCT00784875|38167932|FG000|Period D|Lost to Follow-up|1|||
17023764|NCT00784875|38167933|FG001|Period D|Lost to Follow-up|0|||
17023765|NCT00784875|38167934|FG002|Period D|Lost to Follow-up|1|||
17023766|NCT00784875|38167935|FG003|Period D|Lost to Follow-up|1|||
17023767|NCT00592553|38167961|FG000|Overall Study|Protocol Noncompliance|1|||
17023768|NCT00592553|38167962|FG001|Overall Study|Protocol Noncompliance|0|||
17023769|NCT00592553|38167963|FG002|Overall Study|Protocol Noncompliance|0|||
17023770|NCT00853229|38167973|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
17023771|NCT00853229|38167974|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
17023772|NCT00853151|38167986|FG000|Overall Study|Adverse Event|1|||
17023773|NCT00853151|38167987|FG001|Overall Study|Adverse Event|4|||
17023774|NCT00853151|38167988|FG002|Overall Study|Adverse Event|2|||
17023775|NCT00853151|38167989|FG003|Overall Study|Adverse Event|0|||
17023776|NCT00853151|38167986|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
17023777|NCT00853151|38167987|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17023778|NCT00853151|38167988|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17023779|NCT00853151|38167989|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
17023780|NCT00853151|38167986|FG000|Overall Study|Lost to Follow-up|2|||
17023781|NCT00853151|38167987|FG001|Overall Study|Lost to Follow-up|0|||
17023782|NCT00853151|38167988|FG002|Overall Study|Lost to Follow-up|3|||
17023783|NCT00853151|38167989|FG003|Overall Study|Lost to Follow-up|0|||
17023784|NCT00853151|38167986|FG000|Overall Study|Death|1|||
17023785|NCT00853151|38167987|FG001|Overall Study|Death|0|||
17023786|NCT00853151|38167988|FG002|Overall Study|Death|0|||
17023787|NCT00853151|38167989|FG003|Overall Study|Death|1|||
17023788|NCT00853151|38167986|FG000|Overall Study|Protocol Violation|0|||
17023789|NCT00853151|38167987|FG001|Overall Study|Protocol Violation|0|||
17023790|NCT00853151|38167988|FG002|Overall Study|Protocol Violation|0|||
17023791|NCT00853151|38167989|FG003|Overall Study|Protocol Violation|1|||
17023792|NCT00853151|38167986|FG000|Overall Study|Withdrawal by Subject|5|||
17023793|NCT00853151|38167987|FG001|Overall Study|Withdrawal by Subject|4|||
17023794|NCT00853151|38167988|FG002|Overall Study|Withdrawal by Subject|2|||
17023795|NCT00853151|38167989|FG003|Overall Study|Withdrawal by Subject|1|||
17023796|NCT00853151|38167986|FG000|Overall Study|Physician Decision|0|||
17023797|NCT00853151|38167987|FG001|Overall Study|Physician Decision|2|||
17023798|NCT00853151|38167988|FG002|Overall Study|Physician Decision|1|||
17023799|NCT00853151|38167989|FG003|Overall Study|Physician Decision|0|||
17023800|NCT00853151|38167986|FG000|Overall Study|Sponsor Decision|0|||
17023801|NCT00853151|38167987|FG001|Overall Study|Sponsor Decision|3|||
17023802|NCT00853151|38167988|FG002|Overall Study|Sponsor Decision|0|||
17023803|NCT00853151|38167989|FG003|Overall Study|Sponsor Decision|0|||
17023804|NCT00853073|38168004|FG000|Overall Study|Withdrawal by Subject|3|||
17023805|NCT00853073|38168005|FG001|Overall Study|Withdrawal by Subject|2|||
17023806|NCT00846053|38168013|FG000|Overall Study|Physician Decision|3|||
17023807|NCT00846053|38168014|FG001|Overall Study|Physician Decision|0|||
17023808|NCT00845897|38168025|FG000|Overall Study|Lost to Follow-up|1|||
17023809|NCT00845897|38168026|FG001|Overall Study|Lost to Follow-up|1|||
17023810|NCT00845897|38168027|FG002|Overall Study|Lost to Follow-up|0|||
17023811|NCT00845897|38168025|FG000|Overall Study|Withdrawal by Subject|0|||
17023812|NCT00845897|38168026|FG001|Overall Study|Withdrawal by Subject|3|||
17023813|NCT00845897|38168027|FG002|Overall Study|Withdrawal by Subject|2|||
17023814|NCT00845897|38168025|FG000|Overall Study|Ulcer did not heal|1|||
17023815|NCT00845897|38168026|FG001|Overall Study|Ulcer did not heal|0|||
17023816|NCT00845897|38168027|FG002|Overall Study|Ulcer did not heal|1|||
17023817|NCT00845897|38168025|FG000|Overall Study|Too ill to participate|0|||
17023818|NCT00845897|38168026|FG001|Overall Study|Too ill to participate|1|||
17023819|NCT00845897|38168027|FG002|Overall Study|Too ill to participate|0|||
17023820|NCT00862277|38168038|FG000|Overall Study|Protocol Violation|1|||
17023821|NCT00862277|38168039|FG001|Overall Study|Protocol Violation|2|||
17023822|NCT00862277|38168040|FG002|Overall Study|Protocol Violation|5|||
17023823|NCT00852995|38168053|FG000|Overall Study|Adverse Event|1|||
17023824|NCT00852995|38168054|FG001|Overall Study|Adverse Event|0|||
17023825|NCT00852995|38168055|FG002|Overall Study|Adverse Event|4|||
17023826|NCT00852995|38168056|FG003|Overall Study|Adverse Event|0|||
17023827|NCT00852995|38168057|FG004|Overall Study|Adverse Event|0|||
17023828|NCT00852995|38168053|FG000|Overall Study|Lost to Follow-up|0|||
17023829|NCT00852995|38168054|FG001|Overall Study|Lost to Follow-up|1|||
17023830|NCT00852995|38168055|FG002|Overall Study|Lost to Follow-up|1|||
17023831|NCT00852995|38168056|FG003|Overall Study|Lost to Follow-up|0|||
17023832|NCT00852995|38168057|FG004|Overall Study|Lost to Follow-up|0|||
17023833|NCT00852995|38168053|FG000|Overall Study|Withdrawal by Subject|4|||
17023834|NCT00852995|38168054|FG001|Overall Study|Withdrawal by Subject|0|||
17023835|NCT00852995|38168055|FG002|Overall Study|Withdrawal by Subject|0|||
17023836|NCT00852995|38168056|FG003|Overall Study|Withdrawal by Subject|1|||
17023837|NCT00852995|38168057|FG004|Overall Study|Withdrawal by Subject|2|||
17023838|NCT00852995|38168053|FG000|Overall Study|Non-Compliance|0|||
17023839|NCT00852995|38168054|FG001|Overall Study|Non-Compliance|0|||
17103073|NCT00112437|38241457|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16934749|NCT01235689|38079298|FG000|Overall Study|Miscellaneous|1|||
16934750|NCT01235689|38079299|FG001|Overall Study|Miscellaneous|5|||
16934751|NCT01229176|38079313|FG000|Overall Study|Withdrawal by Subject|0|||
16934752|NCT01229176|38079314|FG001|Overall Study|Withdrawal by Subject|0|||
16934753|NCT01229176|38079315|FG002|Overall Study|Withdrawal by Subject|0|||
16934754|NCT01229176|38079316|FG003|Overall Study|Withdrawal by Subject|1|||
16934755|NCT01229176|38079317|FG004|Overall Study|Withdrawal by Subject|1|||
16934756|NCT01229176|38079318|FG005|Overall Study|Withdrawal by Subject|1|||
16934757|NCT01229176|38079319|FG006|Overall Study|Withdrawal by Subject|0|||
16934758|NCT01229176|38079320|FG007|Overall Study|Withdrawal by Subject|1|||
16934759|NCT01229176|38079313|FG000|Overall Study|Lost to Follow-up|0|||
16934760|NCT01229176|38079314|FG001|Overall Study|Lost to Follow-up|3|||
17023840|NCT00852995|38168055|FG002|Overall Study|Non-Compliance|0|||
17023841|NCT00852995|38168056|FG003|Overall Study|Non-Compliance|2|||
17023842|NCT00852995|38168057|FG004|Overall Study|Non-Compliance|0|||
17023843|NCT00852995|38168053|FG000|Overall Study|Progressive Disease|1|||
17023844|NCT00852995|38168054|FG001|Overall Study|Progressive Disease|0|||
17023845|NCT00852995|38168055|FG002|Overall Study|Progressive Disease|0|||
17023846|NCT00852995|38168056|FG003|Overall Study|Progressive Disease|2|||
17023847|NCT00852995|38168057|FG004|Overall Study|Progressive Disease|1|||
16934761|NCT01229176|38079315|FG002|Overall Study|Lost to Follow-up|0|||
16934762|NCT01229176|38079316|FG003|Overall Study|Lost to Follow-up|0|||
16934763|NCT01229176|38079317|FG004|Overall Study|Lost to Follow-up|1|||
16934764|NCT01229176|38079318|FG005|Overall Study|Lost to Follow-up|1|||
16934765|NCT01229176|38079319|FG006|Overall Study|Lost to Follow-up|0|||
16934766|NCT01229176|38079320|FG007|Overall Study|Lost to Follow-up|2|||
16934767|NCT01228747|38079340|FG000|Overall Study|Adverse Event|8|||
16934768|NCT01228747|38079341|FG001|Overall Study|Adverse Event|4|||
16934769|NCT01228747|38079340|FG000|Overall Study|Lack of Efficacy|40|||
16934770|NCT01228747|38079341|FG001|Overall Study|Lack of Efficacy|27|||
16934771|NCT01228747|38079340|FG000|Overall Study|Protocol Violation|6|||
16934772|NCT01228747|38079341|FG001|Overall Study|Protocol Violation|5|||
16934773|NCT01228747|38079340|FG000|Overall Study|Lost to Follow-up|4|||
16934774|NCT01228747|38079341|FG001|Overall Study|Lost to Follow-up|3|||
16934775|NCT01228747|38079340|FG000|Overall Study|Withdrawal by Subject|5|||
16934776|NCT01228747|38079341|FG001|Overall Study|Withdrawal by Subject|1|||
16934777|NCT01228747|38079340|FG000|Overall Study|Other Reason|2|||
16934778|NCT01228747|38079341|FG001|Overall Study|Other Reason|5|||
16934779|NCT01228591|38079347|FG000|Baseline|Lack of Efficacy|1|||
16934780|NCT01228591|38079348|FG001|Baseline|Lack of Efficacy|2|||
16934781|NCT01235338|38079360|FG000|Overall Study|Adverse Event|3|||
17023848|NCT00852995|38168053|FG000|Overall Study|Physician Decision|1|||
17023849|NCT00852995|38168054|FG001|Overall Study|Physician Decision|0|||
17023850|NCT00852995|38168055|FG002|Overall Study|Physician Decision|0|||
17023851|NCT00852995|38168056|FG003|Overall Study|Physician Decision|0|||
17023852|NCT00852995|38168057|FG004|Overall Study|Physician Decision|0|||
17023853|NCT00852995|38168053|FG000|Overall Study|Protocol Violation|0|||
17023854|NCT00852995|38168054|FG001|Overall Study|Protocol Violation|0|||
17023855|NCT00852995|38168055|FG002|Overall Study|Protocol Violation|0|||
17023856|NCT00852995|38168056|FG003|Overall Study|Protocol Violation|0|||
17023857|NCT00852995|38168057|FG004|Overall Study|Protocol Violation|1|||
17023858|NCT00852995|38168053|FG000|Overall Study|Moved Out of Area|1|||
17023859|NCT00852995|38168054|FG001|Overall Study|Moved Out of Area|0|||
17023860|NCT00852995|38168055|FG002|Overall Study|Moved Out of Area|0|||
17103074|NCT00112437|38241458|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103075|NCT00112437|38241459|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103076|NCT00112437|38241460|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103077|NCT00112437|38241461|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17023861|NCT00852995|38168056|FG003|Overall Study|Moved Out of Area|0|||
17023862|NCT00852995|38168057|FG004|Overall Study|Moved Out of Area|0|||
17023863|NCT00592319|38168076|FG000|Overall Study|Lost to Follow-up|0|||
17023864|NCT00592319|38168077|FG001|Overall Study|Lost to Follow-up|3|||
17023865|NCT00862121|38168087|FG000|Overall Study|Adverse Event|1|||
17103078|NCT00112437|38241462|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103079|NCT00112437|38241463|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103080|NCT00112437|38241464|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103081|NCT00112437|38241465|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
17103082|NCT00112437|38241466|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16934782|NCT01235338|38079361|FG001|Overall Study|Adverse Event|2|||
17023866|NCT00862121|38168088|FG001|Overall Study|Adverse Event|2|||
17023867|NCT00862121|38168087|FG000|Overall Study|Lack of Efficacy|0|||
17023868|NCT00862121|38168088|FG001|Overall Study|Lack of Efficacy|3|||
17023869|NCT00862121|38168087|FG000|Overall Study|Protocol Violation|0|||
17023870|NCT00862121|38168088|FG001|Overall Study|Protocol Violation|1|||
17023871|NCT00862121|38168087|FG000|Overall Study|Exclusion criterion violation|0|||
17023872|NCT00862121|38168088|FG001|Overall Study|Exclusion criterion violation|1|||
17023873|NCT00862121|38168087|FG000|Overall Study|Incorrect randomisation|0|||
17023874|NCT00862121|38168088|FG001|Overall Study|Incorrect randomisation|1|||
17023875|NCT00784719|38168101|FG000|Overall Study|Adverse Event|0|||
17023876|NCT00784719|38168102|FG001|Overall Study|Adverse Event|2|||
17023877|NCT00784719|38168103|FG002|Overall Study|Adverse Event|0|||
17023878|NCT00784719|38168104|FG003|Overall Study|Adverse Event|0|||
17023879|NCT00784719|38168105|FG004|Overall Study|Adverse Event|1|||
17023880|NCT00784719|38168106|FG005|Overall Study|Adverse Event|1|||
17023881|NCT00784719|38168107|FG006|Overall Study|Adverse Event|1|||
17023882|NCT00784719|38168101|FG000|Overall Study|Lost to Follow-up|0|||
17023883|NCT00784719|38168102|FG001|Overall Study|Lost to Follow-up|0|||
17023884|NCT00784719|38168103|FG002|Overall Study|Lost to Follow-up|0|||
17023885|NCT00784719|38168104|FG003|Overall Study|Lost to Follow-up|0|||
17023886|NCT00784719|38168105|FG004|Overall Study|Lost to Follow-up|1|||
17023887|NCT00784719|38168106|FG005|Overall Study|Lost to Follow-up|1|||
16934783|NCT01235338|38079360|FG000|Overall Study|Protocol Violation|1|||
17023888|NCT00784719|38168107|FG006|Overall Study|Lost to Follow-up|0|||
17023889|NCT00784719|38168101|FG000|Overall Study|Other|2|||
17023890|NCT00784719|38168102|FG001|Overall Study|Other|1|||
17023891|NCT00784719|38168103|FG002|Overall Study|Other|1|||
17023892|NCT00784719|38168104|FG003|Overall Study|Other|0|||
17198680|NCT02706405|38352368|FG001|Overall Study|Death|2|||
16934784|NCT01235338|38079361|FG001|Overall Study|Protocol Violation|1|||
16934785|NCT01235338|38079360|FG000|Overall Study|Withdrawal by Subject|5|||
17023893|NCT00784719|38168105|FG004|Overall Study|Other|2|||
17023894|NCT00784719|38168106|FG005|Overall Study|Other|1|||
17023895|NCT00784719|38168107|FG006|Overall Study|Other|3|||
17023896|NCT00784719|38168101|FG000|Overall Study|Withdrawal by Subject|1|||
17023897|NCT00784719|38168102|FG001|Overall Study|Withdrawal by Subject|0|||
16934786|NCT01235338|38079361|FG001|Overall Study|Withdrawal by Subject|0|||
16934787|NCT01235338|38079360|FG000|Overall Study|Exclusion criteria violations|1|||
16934788|NCT01235338|38079361|FG001|Overall Study|Exclusion criteria violations|1|||
16934789|NCT01235338|38079360|FG000|Overall Study|Positive drug screen|0|||
16934790|NCT01235338|38079361|FG001|Overall Study|Positive drug screen|1|||
16934791|NCT01235338|38079360|FG000|Overall Study|Prohibited meds|1|||
16934792|NCT01235338|38079361|FG001|Overall Study|Prohibited meds|0|||
16934793|NCT01234675|38079369|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
16934794|NCT01234675|38079370|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
16934795|NCT01234675|38079369|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
16934796|NCT01234675|38079370|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
16934797|NCT01228318|38079378|FG000|Overall Study|Clinic no show to receive intervention|1|||
16934798|NCT01228318|38079379|FG001|Overall Study|Clinic no show to receive intervention|0|||
16934799|NCT01228318|38079378|FG000|Overall Study|Unable to contact|2|||
16934800|NCT01228318|38079379|FG001|Overall Study|Unable to contact|5|||
16934801|NCT01228318|38079378|FG000|Overall Study|Moved|0|||
16934802|NCT01228318|38079379|FG001|Overall Study|Moved|2|||
16934803|NCT01228318|38079378|FG000|Overall Study|Incarcerated|1|||
16934804|NCT01228318|38079379|FG001|Overall Study|Incarcerated|0|||
16934805|NCT01234480|38079385|FG000|Overall Study|Pregnancy|88|||
16934806|NCT01234480|38079385|FG000|Overall Study|>36/Normal History|50|||
16934807|NCT01234480|38079385|FG000|Overall Study|Age|3|||
16934808|NCT01234480|38079385|FG000|Overall Study|HPV Vaccine History|28|||
16934809|NCT01234480|38079385|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
16934810|NCT01234480|38079385|FG000|Overall Study|Hysterectomy|2|||
16934811|NCT01234480|38079385|FG000|Overall Study|Hysterectomy post enrollment|1|||
16934812|NCT01234480|38079385|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
16934813|NCT01234480|38079385|FG000|Overall Study|Informed Consent Form Violation|30|||
16934814|NCT01234480|38079385|FG000|Overall Study|Incorrect Visit|3|||
16934815|NCT01234480|38079385|FG000|Overall Study|No Florida Lab License|20|||
16934816|NCT01234480|38079385|FG000|Overall Study|Out of Window|42|||
16934817|NCT01234480|38079385|FG000|Overall Study|Sample Processing/Storage|92|||
16934818|NCT01234480|38079385|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
16934819|NCT01234480|38079385|FG000|Overall Study|Site/Subject non-compliance|44|||
16934820|NCT01234480|38079385|FG000|Overall Study|Missing Sample|9|||
16934821|NCT01227967|38079394|FG000|Overall Study|Protocol Violation|3|||
16934822|NCT01227967|38079395|FG001|Overall Study|Protocol Violation|1|||
16934823|NCT01227967|38079394|FG000|Overall Study|Death|0|||
16934824|NCT01227967|38079395|FG001|Overall Study|Death|1|||
16934825|NCT01227967|38079394|FG000|Overall Study|Lost to Follow-up|8|||
16934826|NCT01227967|38079395|FG001|Overall Study|Lost to Follow-up|3|||
16934827|NCT01227967|38079394|FG000|Overall Study|Withdrawal by Subject|4|||
16934828|NCT01227967|38079395|FG001|Overall Study|Withdrawal by Subject|3|||
16934829|NCT01227967|38079394|FG000|Overall Study|Physician Decision|0|||
16934830|NCT01227967|38079395|FG001|Overall Study|Physician Decision|1|||
16934831|NCT01227967|38079394|FG000|Overall Study|Never Started Treatment|0|||
16934832|NCT01227967|38079395|FG001|Overall Study|Never Started Treatment|4|||
16934833|NCT01227967|38079394|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
16934834|NCT01227967|38079395|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
16934835|NCT01227928|38079403|FG000|Overall Study|Lost to Follow-up|4|||
16934836|NCT01227928|38079404|FG001|Overall Study|Lost to Follow-up|2|||
16934837|NCT01227928|38079403|FG000|Overall Study|Withdrawal by Subject|4|||
16934838|NCT01227928|38079404|FG001|Overall Study|Withdrawal by Subject|3|||
16934839|NCT01227928|38079403|FG000|Overall Study|Death|14|||
16934840|NCT01227928|38079404|FG001|Overall Study|Death|12|||
16934841|NCT01227889|38079412|FG000|Randomized Phase (RP)|Adverse Event|13|||
16934842|NCT01227889|38079413|FG001|Randomized Phase (RP)|Adverse Event|0|||
16934843|NCT01227889|38079412|FG000|Randomized Phase (RP)|Physician Decision|13|||
16934844|NCT01227889|38079413|FG001|Randomized Phase (RP)|Physician Decision|5|||
16934845|NCT01227889|38079412|FG000|Randomized Phase (RP)|Progressive Disease|135|||
16934846|NCT01227889|38079413|FG001|Randomized Phase (RP)|Progressive Disease|52|||
16934847|NCT01227889|38079412|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
16934848|NCT01227889|38079413|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
16934849|NCT01227889|38079412|FG000|Randomized Phase (RP)|Missing|1|||
16934850|NCT01227889|38079413|FG001|Randomized Phase (RP)|Missing|3|||
16934851|NCT01227889|38079412|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
16934852|NCT01227889|38079413|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
16934853|NCT01227889|38079412|FG000|Crossover Phase|Adverse Event|0|||
16934854|NCT01227889|38079413|FG001|Crossover Phase|Adverse Event|1|||
17023898|NCT00784719|38168103|FG002|Overall Study|Withdrawal by Subject|0|||
16934855|NCT01227889|38079412|FG000|Crossover Phase|Physician Decision|0|||
16934856|NCT01227889|38079413|FG001|Crossover Phase|Physician Decision|3|||
16934857|NCT01227889|38079412|FG000|Crossover Phase|Progressive Disease|0|||
16934858|NCT01227889|38079413|FG001|Crossover Phase|Progressive Disease|31|||
16934859|NCT01227889|38079412|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
16934860|NCT01227889|38079413|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
16934861|NCT01227889|38079412|FG000|Crossover Phase|Withdrawal by Subject|0|||
16934862|NCT01227889|38079413|FG001|Crossover Phase|Withdrawal by Subject|1|||
16934863|NCT01227577|38079427|FG000|Overall Study|Protocol deviation|3|||
16934864|NCT01227577|38079427|FG000|Overall Study|Death|3|||
16934865|NCT01227577|38079427|FG000|Overall Study|Administrative problems|2|||
16934866|NCT01227577|38079427|FG000|Overall Study|Lost to Follow-up|1|||
16934867|NCT01227577|38079427|FG000|Overall Study|Withdrawal by Subject|4|||
16934868|NCT01227577|38079427|FG000|Overall Study|Lack of Efficacy|5|||
16934869|NCT01227577|38079427|FG000|Overall Study|Adverse Event|17|||
16934870|NCT01227421|38079447|FG000|Overall Study|Lost to Follow-up|6|||
16934871|NCT01227421|38079448|FG001|Overall Study|Lost to Follow-up|7|||
16934872|NCT01227421|38079449|FG002|Overall Study|Lost to Follow-up|5|||
16934873|NCT01227421|38079447|FG000|Overall Study|Adverse Event|2|||
16934874|NCT01227421|38079448|FG001|Overall Study|Adverse Event|7|||
16934875|NCT01227421|38079449|FG002|Overall Study|Adverse Event|2|||
16934876|NCT01227421|38079447|FG000|Overall Study|Withdrawal by Subject|1|||
16934877|NCT01227421|38079448|FG001|Overall Study|Withdrawal by Subject|2|||
16934878|NCT01227421|38079449|FG002|Overall Study|Withdrawal by Subject|1|||
16934879|NCT01227421|38079447|FG000|Overall Study|Protocol Violation|1|||
16934880|NCT01227421|38079448|FG001|Overall Study|Protocol Violation|1|||
16934881|NCT01227421|38079449|FG002|Overall Study|Protocol Violation|2|||
16934882|NCT01227421|38079447|FG000|Overall Study|Randomized in error|1|||
16934883|NCT01227421|38079448|FG001|Overall Study|Randomized in error|1|||
16934884|NCT01227421|38079449|FG002|Overall Study|Randomized in error|0|||
17023899|NCT00784719|38168104|FG003|Overall Study|Withdrawal by Subject|0|||
17023900|NCT00784719|38168105|FG004|Overall Study|Withdrawal by Subject|2|||
17023901|NCT00784719|38168106|FG005|Overall Study|Withdrawal by Subject|0|||
17023902|NCT00784719|38168107|FG006|Overall Study|Withdrawal by Subject|1|||
17023903|NCT00852917|38168127|FG000|Overall Study|Adverse Event|13|||
17023904|NCT00852917|38168128|FG001|Overall Study|Adverse Event|20|||
17023905|NCT00852917|38168129|FG002|Overall Study|Adverse Event|35|||
17023906|NCT00852917|38168130|FG003|Overall Study|Adverse Event|17|||
17023907|NCT00852917|38168127|FG000|Overall Study|Lack of Efficacy|21|||
17023908|NCT00852917|38168128|FG001|Overall Study|Lack of Efficacy|11|||
17103083|NCT00112437|38241441|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103084|NCT00112437|38241442|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103085|NCT00112437|38241443|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103086|NCT00112437|38241444|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103087|NCT00112437|38241445|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103088|NCT00112437|38241446|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103089|NCT00112437|38241447|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103090|NCT00112437|38241448|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103091|NCT00112437|38241449|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103092|NCT00112437|38241450|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103093|NCT00112437|38241451|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
17103094|NCT00112437|38241452|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
17103095|NCT00112437|38241453|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103096|NCT00112437|38241454|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103097|NCT00112437|38241455|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16934885|NCT01227265|38079460|FG000|Overall Study|Did Not Receive Treatment|1|||
16934886|NCT01227265|38079461|FG001|Overall Study|Did Not Receive Treatment|2|||
16934887|NCT01227265|38079462|FG002|Overall Study|Did Not Receive Treatment|0|||
17023909|NCT00852917|38168129|FG002|Overall Study|Lack of Efficacy|11|||
17023910|NCT00852917|38168130|FG003|Overall Study|Lack of Efficacy|47|||
17023911|NCT00852917|38168127|FG000|Overall Study|Withdrawal by Subject|4|||
17023912|NCT00852917|38168128|FG001|Overall Study|Withdrawal by Subject|8|||
17023913|NCT00852917|38168129|FG002|Overall Study|Withdrawal by Subject|10|||
17023914|NCT00852917|38168130|FG003|Overall Study|Withdrawal by Subject|9|||
17023915|NCT00852917|38168127|FG000|Overall Study|Physician Decision|6|||
17023916|NCT00852917|38168128|FG001|Overall Study|Physician Decision|7|||
16934888|NCT01227265|38079460|FG000|Overall Study|Administrative|1|||
16934889|NCT01227265|38079461|FG001|Overall Study|Administrative|0|||
16934890|NCT01227265|38079462|FG002|Overall Study|Administrative|2|||
16934891|NCT01227265|38079460|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
17023917|NCT00852917|38168129|FG002|Overall Study|Physician Decision|2|||
17023918|NCT00852917|38168130|FG003|Overall Study|Physician Decision|19|||
17023919|NCT00852917|38168127|FG000|Overall Study|Death|0|||
17023920|NCT00852917|38168128|FG001|Overall Study|Death|0|||
17023921|NCT00852917|38168129|FG002|Overall Study|Death|0|||
17023922|NCT00852917|38168130|FG003|Overall Study|Death|1|||
17023923|NCT00845429|38168143|FG000|Overall Study|Protocol Violation|5|||
17023924|NCT00845429|38168144|FG001|Overall Study|Protocol Violation|4|||
17023925|NCT00845429|38168145|FG002|Overall Study|Protocol Violation|7|||
17023926|NCT00845429|38168143|FG000|Overall Study|Lost to Follow-up|7|||
17023927|NCT00845429|38168144|FG001|Overall Study|Lost to Follow-up|9|||
17023928|NCT00845429|38168145|FG002|Overall Study|Lost to Follow-up|10|||
17023929|NCT00845429|38168143|FG000|Overall Study|Withdrawal by Subject|2|||
17023930|NCT00845429|38168144|FG001|Overall Study|Withdrawal by Subject|2|||
17023931|NCT00845429|38168145|FG002|Overall Study|Withdrawal by Subject|2|||
17023932|NCT00845429|38168143|FG000|Overall Study|Serious adverse event|0|||
17023933|NCT00845429|38168144|FG001|Overall Study|Serious adverse event|0|||
17023934|NCT00845429|38168145|FG002|Overall Study|Serious adverse event|1|||
17023935|NCT00593333|38168155|FG000|Overall Study|Lost to Follow-up|10|||
17023936|NCT00593333|38168156|FG001|Overall Study|Lost to Follow-up|11|||
17023937|NCT00844883|38168162|FG000|Overall Study|Bridged to liver transplant|3|||
17023938|NCT00844883|38168162|FG000|Overall Study|Bridged to resection|1|||
17023939|NCT00851903|38168166|FG000|Overall Study|Withdrawal by Subject|2|||
17023940|NCT00587457|38168173|FG000|Overall Study|Adverse Event|1|||
17023941|NCT00587457|38168174|FG001|Overall Study|Adverse Event|2|||
17023942|NCT00587457|38168175|FG002|Overall Study|Adverse Event|1|||
17023943|NCT00587457|38168173|FG000|Overall Study|Disease progression|2|||
17023944|NCT00587457|38168174|FG001|Overall Study|Disease progression|0|||
17023945|NCT00587457|38168175|FG002|Overall Study|Disease progression|2|||
17023946|NCT00587457|38168173|FG000|Overall Study|Initiation of alternative therapy|0|||
17023947|NCT00587457|38168174|FG001|Overall Study|Initiation of alternative therapy|1|||
17023948|NCT00587457|38168175|FG002|Overall Study|Initiation of alternative therapy|0|||
17023949|NCT00587457|38168173|FG000|Overall Study|Undefined|0|||
17023950|NCT00587457|38168174|FG001|Overall Study|Undefined|0|||
17023951|NCT00587457|38168175|FG002|Overall Study|Undefined|1|||
17023952|NCT00587457|38168173|FG000|Overall Study|Development of neutralizing Abs|0|||
17023953|NCT00587457|38168174|FG001|Overall Study|Development of neutralizing Abs|0|||
17023954|NCT00587457|38168175|FG002|Overall Study|Development of neutralizing Abs|1|||
17023955|NCT00851747|38168186|FG000|Overall Study|Physician Decision|6|||
17103098|NCT00112437|38241456|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103099|NCT00112437|38241457|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103100|NCT00112437|38241458|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17023956|NCT00851747|38168187|FG001|Overall Study|Physician Decision|6|||
17023957|NCT00851747|38168188|FG002|Overall Study|Physician Decision|6|||
17023958|NCT00767325|38168195|FG000|Overall Study|Lack of Efficacy|2|||
17023959|NCT00767325|38168195|FG000|Overall Study|Adverse Event|7|||
17023960|NCT00767325|38168195|FG000|Overall Study|Lost to Follow-up|3|||
17023961|NCT00767325|38168195|FG000|Overall Study|No longer met study criteria|2|||
17023962|NCT00767325|38168195|FG000|Overall Study|Missed visit due to family reasons|1|||
17103101|NCT00112437|38241459|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103102|NCT00112437|38241460|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103103|NCT00112437|38241461|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17023963|NCT00851591|38168201|FG000|Overall Study|Withdrawal by Subject|2|||
17023964|NCT00851591|38168202|FG001|Overall Study|Withdrawal by Subject|0|||
17023965|NCT00861341|38168208|FG000|Overall Study|Withdrawal by Subject|2|||
17023966|NCT00766467|38168214|FG000|Overall Study|Withdrawal by Subject|7|||
17023967|NCT00766467|38168215|FG001|Overall Study|Withdrawal by Subject|2|||
17023968|NCT00766467|38168214|FG000|Overall Study|Adverse Event|1|||
17023969|NCT00766467|38168215|FG001|Overall Study|Adverse Event|1|||
17023970|NCT00766467|38168214|FG000|Overall Study|Protocol Violation|2|||
17023971|NCT00766467|38168215|FG001|Overall Study|Protocol Violation|4|||
17023972|NCT00766467|38168214|FG000|Overall Study|Tumor Progression on Study|0|||
17023973|NCT00766467|38168215|FG001|Overall Study|Tumor Progression on Study|1|||
17023974|NCT00766467|38168214|FG000|Overall Study|Physician Decision|1|||
17023975|NCT00766467|38168215|FG001|Overall Study|Physician Decision|0|||
17023976|NCT00850499|38168223|FG000|Overall Study|Adverse Event|3|||
17023977|NCT00850499|38168224|FG001|Overall Study|Adverse Event|1|||
17023978|NCT00850499|38168223|FG000|Overall Study|Lack of Efficacy|0|||
17023979|NCT00850499|38168224|FG001|Overall Study|Lack of Efficacy|1|||
17023980|NCT00860951|38168230|FG000|Overall Study|Withdrawal by Subject|2|||
17023981|NCT00860951|38168230|FG000|Overall Study|Lost to Follow-up|5|||
17023982|NCT00844805|38168248|FG000|Treatment Phase|Adverse Event|5|||
17103104|NCT00112437|38241462|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103105|NCT00112437|38241463|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103106|NCT00112437|38241464|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103107|NCT00112437|38241465|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17103108|NCT00112437|38241466|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
17023983|NCT00844805|38168249|FG001|Treatment Phase|Adverse Event|1|||
17023984|NCT00844805|38168250|FG002|Treatment Phase|Adverse Event|0|||
17023985|NCT00844805|38168251|FG003|Treatment Phase|Adverse Event|0|||
17023986|NCT00844805|38168248|FG000|Treatment Phase|Withdrawal by Subject|3|||
17023987|NCT00844805|38168249|FG001|Treatment Phase|Withdrawal by Subject|4|||
17023988|NCT00844805|38168250|FG002|Treatment Phase|Withdrawal by Subject|0|||
17023989|NCT00844805|38168251|FG003|Treatment Phase|Withdrawal by Subject|0|||
16934892|NCT01227265|38079461|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
16934893|NCT01227265|38079462|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
16934894|NCT01227265|38079460|FG000|Overall Study|Protocol Violation|2|||
16934895|NCT01227265|38079461|FG001|Overall Study|Protocol Violation|1|||
16934896|NCT01227265|38079462|FG002|Overall Study|Protocol Violation|0|||
16934897|NCT01227265|38079460|FG000|Overall Study|Withdrawal by Subject|7|||
16934898|NCT01227265|38079461|FG001|Overall Study|Withdrawal by Subject|7|||
16934899|NCT01227265|38079462|FG002|Overall Study|Withdrawal by Subject|3|||
16934900|NCT01227265|38079460|FG000|Overall Study|Lost to Follow-up|2|||
16934901|NCT01227265|38079461|FG001|Overall Study|Lost to Follow-up|0|||
16934902|NCT01227265|38079462|FG002|Overall Study|Lost to Follow-up|3|||
16934903|NCT01227265|38079460|FG000|Overall Study|Adverse Event|6|||
16934904|NCT01227265|38079461|FG001|Overall Study|Adverse Event|10|||
16934905|NCT01227265|38079462|FG002|Overall Study|Adverse Event|5|||
16934906|NCT01226095|38079470|FG000|Overall Study|Poor compliance|1|||
16934907|NCT01225822|38079486|FG000|Overall Study|Adverse Event|13|||
16934908|NCT01225822|38079487|FG001|Overall Study|Adverse Event|31|||
16934909|NCT01225822|38079488|FG002|Overall Study|Adverse Event|18|||
16934910|NCT01225822|38079489|FG003|Overall Study|Adverse Event|23|||
16934911|NCT01225822|38079490|FG004|Overall Study|Adverse Event|14|||
16934912|NCT01225822|38079486|FG000|Overall Study|Protocol Violation|6|||
16934913|NCT01225822|38079487|FG001|Overall Study|Protocol Violation|8|||
16934914|NCT01225822|38079488|FG002|Overall Study|Protocol Violation|6|||
16934915|NCT01225822|38079489|FG003|Overall Study|Protocol Violation|7|||
16934916|NCT01225822|38079490|FG004|Overall Study|Protocol Violation|4|||
16934917|NCT01225822|38079486|FG000|Overall Study|Lost to Follow-up|0|||
16934918|NCT01225822|38079487|FG001|Overall Study|Lost to Follow-up|0|||
16934919|NCT01225822|38079488|FG002|Overall Study|Lost to Follow-up|0|||
16934920|NCT01225822|38079489|FG003|Overall Study|Lost to Follow-up|1|||
16934921|NCT01225822|38079490|FG004|Overall Study|Lost to Follow-up|0|||
16934922|NCT01225822|38079486|FG000|Overall Study|Withdrawal by Subject|6|||
16934923|NCT01225822|38079487|FG001|Overall Study|Withdrawal by Subject|7|||
16934924|NCT01225822|38079488|FG002|Overall Study|Withdrawal by Subject|7|||
16934925|NCT01225822|38079489|FG003|Overall Study|Withdrawal by Subject|11|||
16934926|NCT01225822|38079490|FG004|Overall Study|Withdrawal by Subject|6|||
16934927|NCT01225822|38079486|FG000|Overall Study|Other|13|||
16934928|NCT01225822|38079487|FG001|Overall Study|Other|10|||
16934929|NCT01225822|38079488|FG002|Overall Study|Other|7|||
16934930|NCT01225822|38079489|FG003|Overall Study|Other|10|||
16934931|NCT01225822|38079490|FG004|Overall Study|Other|7|||
16934932|NCT01225549|38079505|FG000|Period 4 - Washout|Disallowed medication|0|||
16934933|NCT01225549|38079506|FG001|Period 4 - Washout|Disallowed medication|1|||
16934934|NCT01225549|38079507|FG002|Period 4 - Washout|Disallowed medication|0|||
16934935|NCT01225549|38079508|FG003|Period 4 - Washout|Disallowed medication|0|||
16934936|NCT01225549|38079509|FG004|Period 4 - Washout|Disallowed medication|0|||
16934937|NCT01225549|38079510|FG005|Period 4 - Washout|Disallowed medication|0|||
16934938|NCT01225549|38079511|FG006|Period 4 - Washout|Disallowed medication|0|||
16934939|NCT01225549|38079512|FG007|Period 4 - Washout|Disallowed medication|0|||
16934940|NCT01225549|38079513|FG008|Period 4 - Washout|Disallowed medication|0|||
16934941|NCT01225549|38079514|FG009|Period 4 - Washout|Disallowed medication|0|||
16934942|NCT01225549|38079505|FG000|Period 6 - Washout|Disallowed medication|0|||
16934943|NCT01225549|38079506|FG001|Period 6 - Washout|Disallowed medication|0|||
16934944|NCT01225549|38079507|FG002|Period 6 - Washout|Disallowed medication|0|||
16934945|NCT01225549|38079508|FG003|Period 6 - Washout|Disallowed medication|1|||
16934946|NCT01225549|38079509|FG004|Period 6 - Washout|Disallowed medication|0|||
16934947|NCT01225549|38079510|FG005|Period 6 - Washout|Disallowed medication|0|||
16934948|NCT01225549|38079511|FG006|Period 6 - Washout|Disallowed medication|0|||
16934949|NCT01225549|38079512|FG007|Period 6 - Washout|Disallowed medication|0|||
16934950|NCT01225549|38079513|FG008|Period 6 - Washout|Disallowed medication|0|||
16934951|NCT01225549|38079514|FG009|Period 6 - Washout|Disallowed medication|0|||
16934952|NCT01225159|38079526|FG000|Overall Study|Change operation|1|||
16934953|NCT01225159|38079527|FG001|Overall Study|Change operation|0|||
16934954|NCT01224925|38079535|FG000|Overall Study|Lost to Follow-up|3|||
16934955|NCT01224925|38079536|FG001|Overall Study|Lost to Follow-up|2|||
16934956|NCT01223404|38079544|FG000|First Intervention (1 Day)|Adverse Event|0|||
16934957|NCT01223404|38079545|FG001|First Intervention (1 Day)|Adverse Event|0|||
16934958|NCT01223404|38079546|FG002|First Intervention (1 Day)|Adverse Event|0|||
16934959|NCT01223404|38079547|FG003|First Intervention (1 Day)|Adverse Event|1|||
16934960|NCT01223404|38079548|FG004|First Intervention (1 Day)|Adverse Event|0|||
16934961|NCT01223404|38079549|FG005|First Intervention (1 Day)|Adverse Event|0|||
16934962|NCT01223404|38079544|FG000|Second Intervention (1 Day)|Adverse Event|1|||
16934963|NCT01223404|38079545|FG001|Second Intervention (1 Day)|Adverse Event|0|||
16934964|NCT01223404|38079546|FG002|Second Intervention (1 Day)|Adverse Event|0|||
16934965|NCT01223404|38079547|FG003|Second Intervention (1 Day)|Adverse Event|0|||
16934966|NCT01223404|38079548|FG004|Second Intervention (1 Day)|Adverse Event|0|||
16934967|NCT01223404|38079549|FG005|Second Intervention (1 Day)|Adverse Event|0|||
16934968|NCT01223404|38079544|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16934969|NCT01223404|38079545|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16934970|NCT01223404|38079546|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16934971|NCT01223404|38079547|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
16934972|NCT01223404|38079548|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16934973|NCT01223404|38079549|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16934974|NCT01223365|38079597|FG000|Open-label Titration Period|Enrolled but not treated|1|||
16934975|NCT01223365|38079597|FG000|Open-label Titration Period|Adverse Event|23|||
16934976|NCT01223365|38079597|FG000|Open-label Titration Period|Lack of Efficacy|3|||
16934977|NCT01223365|38079597|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
16934978|NCT01223365|38079597|FG000|Open-label Titration Period|Protocol Violation|1|||
16934979|NCT01223365|38079597|FG000|Open-label Titration Period|Lost to Follow-up|2|||
16934980|NCT01223365|38079597|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
16934981|NCT01223365|38079597|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
16934982|NCT01223365|38079597|FG000|Open-label Titration Period|Starting physical therapy|1|||
16934983|NCT01223365|38079597|FG000|Open-label Treatment Period|Adverse Event|39|||
16934984|NCT01223365|38079597|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
16934985|NCT01223365|38079597|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
16934986|NCT01223365|38079597|FG000|Open-label Treatment Period|Protocol Violation|15|||
16934987|NCT01223365|38079597|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
16934988|NCT01223365|38079597|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
16934989|NCT01223365|38079597|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
16934990|NCT01223365|38079597|FG000|Open-label Treatment Period|Moved out of area|2|||
16934991|NCT01223365|38079597|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
16934992|NCT01223365|38079597|FG000|Open-label Treatment Period|"Out of window"|1|||
16934993|NCT01223365|38079597|FG000|Open-label Treatment Period|Starting physical therapy|1|||
16934994|NCT01223365|38079597|FG000|Open-label Treatment Period|Physician Decision|2|||
16934995|NCT01222507|38079606|FG000|Overall Study|Physician Decision|1|||
16934996|NCT01222507|38079606|FG000|Overall Study|Withdrawal by Subject|1|||
16934997|NCT01222078|38079610|FG000|Overall Study|Early termination of the study|1|||
16934998|NCT01221727|38079617|FG000|Overall Study|Physician Decision|2|||
16934999|NCT01221727|38079618|FG001|Overall Study|Physician Decision|0|||
16935000|NCT01221727|38079617|FG000|Overall Study|Withdrawal by Subject|1|||
16935001|NCT01221727|38079618|FG001|Overall Study|Withdrawal by Subject|1|||
16935002|NCT01221181|38079630|FG000|Overall Study|Lost to Follow-up|1|||
16935003|NCT01220557|38079636|FG000|Overall Study|Lost to Follow-up|5|||
16935004|NCT01220557|38079637|FG001|Overall Study|Lost to Follow-up|3|||
16935005|NCT01220557|38079636|FG000|Overall Study|attended less than 6 lessons|1|||
16935006|NCT01220557|38079637|FG001|Overall Study|attended less than 6 lessons|2|||
16935007|NCT01220401|38079643|FG000|Overall Study|Withdrawal by Subject|2|||
16935008|NCT01220401|38079643|FG000|Overall Study|Protocol Violation|1|||
16935009|NCT01220167|38079650|FG000|Period 3|Urine positive for substance abuse|0|||
16935010|NCT01220167|38079651|FG001|Period 3|Urine positive for substance abuse|1|||
16935011|NCT01220167|38079652|FG002|Period 3|Urine positive for substance abuse|0|||
16935012|NCT01220128|38079665|FG000|Overall Study|Progressive disease|0|||
16935013|NCT01220128|38079666|FG001|Overall Study|Progressive disease|0|||
16935014|NCT01220128|38079667|FG002|Overall Study|Progressive disease|2|||
16935015|NCT01220128|38079668|FG003|Overall Study|Progressive disease|0|||
16935016|NCT01220128|38079669|FG004|Overall Study|Progressive disease|0|||
16935017|NCT01220128|38079670|FG005|Overall Study|Progressive disease|0|||
16935018|NCT01220128|38079671|FG006|Overall Study|Progressive disease|0|||
16935019|NCT01220128|38079665|FG000|Overall Study|Sponsor study termination|0|||
16935020|NCT01220128|38079666|FG001|Overall Study|Sponsor study termination|1|||
16935021|NCT01220128|38079667|FG002|Overall Study|Sponsor study termination|0|||
16935022|NCT01220128|38079668|FG003|Overall Study|Sponsor study termination|0|||
16935023|NCT01220128|38079669|FG004|Overall Study|Sponsor study termination|0|||
16935024|NCT01220128|38079670|FG005|Overall Study|Sponsor study termination|0|||
16935025|NCT01220128|38079671|FG006|Overall Study|Sponsor study termination|1|||
16935026|NCT01220128|38079665|FG000|Overall Study|Adverse event, serious fatal|2|||
16935027|NCT01220128|38079666|FG001|Overall Study|Adverse event, serious fatal|0|||
16935028|NCT01220128|38079667|FG002|Overall Study|Adverse event, serious fatal|0|||
16935029|NCT01220128|38079668|FG003|Overall Study|Adverse event, serious fatal|0|||
16935030|NCT01220128|38079669|FG004|Overall Study|Adverse event, serious fatal|0|||
16935031|NCT01220128|38079670|FG005|Overall Study|Adverse event, serious fatal|0|||
16935032|NCT01220128|38079671|FG006|Overall Study|Adverse event, serious fatal|1|||
16935033|NCT01220128|38079665|FG000|Overall Study|Adverse event, non-fatal|1|||
16935034|NCT01220128|38079666|FG001|Overall Study|Adverse event, non-fatal|0|||
16935035|NCT01220128|38079667|FG002|Overall Study|Adverse event, non-fatal|0|||
16935036|NCT01220128|38079668|FG003|Overall Study|Adverse event, non-fatal|0|||
16935037|NCT01220128|38079669|FG004|Overall Study|Adverse event, non-fatal|0|||
16935038|NCT01220128|38079670|FG005|Overall Study|Adverse event, non-fatal|0|||
16935039|NCT01220128|38079671|FG006|Overall Study|Adverse event, non-fatal|3|||
16935040|NCT01220128|38079665|FG000|Overall Study|Other|0|||
16935041|NCT01220128|38079666|FG001|Overall Study|Other|0|||
16935042|NCT01220128|38079667|FG002|Overall Study|Other|1|||
16935043|NCT01220128|38079668|FG003|Overall Study|Other|0|||
16935044|NCT01220128|38079669|FG004|Overall Study|Other|0|||
16935045|NCT01220128|38079670|FG005|Overall Study|Other|0|||
16935046|NCT01220128|38079671|FG006|Overall Study|Other|0|||
16935047|NCT01220128|38079665|FG000|Overall Study|Consent withdrawn by subject|1|||
16935048|NCT01220128|38079666|FG001|Overall Study|Consent withdrawn by subject|0|||
16935049|NCT01220128|38079667|FG002|Overall Study|Consent withdrawn by subject|0|||
16935050|NCT01220128|38079668|FG003|Overall Study|Consent withdrawn by subject|0|||
16935051|NCT01220128|38079669|FG004|Overall Study|Consent withdrawn by subject|0|||
16935052|NCT01220128|38079670|FG005|Overall Study|Consent withdrawn by subject|0|||
16935053|NCT01220128|38079671|FG006|Overall Study|Consent withdrawn by subject|0|||
16935054|NCT01219933|38079688|FG000|Overall Study|Adverse Event|8|||
16935055|NCT01219933|38079688|FG000|Overall Study|No LDA reached|5|||
16935056|NCT01219933|38079688|FG000|Overall Study|No LDA maintained|7|||
16935057|NCT01219933|38079688|FG000|Overall Study|Lost to Follow-up|3|||
16935058|NCT01219933|38079688|FG000|Overall Study|GC free|1|||
16935059|NCT01219933|38079688|FG000|Overall Study|Withdrawal by Subject|5|||
16935060|NCT01219933|38079688|FG000|Overall Study|Protocol Violation|8|||
16935061|NCT01219933|38079688|FG000|Overall Study|Lack of Efficacy|1|||
16935062|NCT01218802|38079695|FG000|Overall Study|Lost to Follow-up|5|||
16935063|NCT01218802|38079696|FG001|Overall Study|Lost to Follow-up|6|||
16935064|NCT01218802|38079695|FG000|Overall Study|Withdrawal by Subject|3|||
16935065|NCT01218802|38079696|FG001|Overall Study|Withdrawal by Subject|10|||
16935066|NCT01218802|38079695|FG000|Overall Study|Adverse Event|0|||
16935067|NCT01218802|38079696|FG001|Overall Study|Adverse Event|2|||
16935068|NCT01218802|38079695|FG000|Overall Study|Incarcerated|2|||
16935069|NCT01218802|38079696|FG001|Overall Study|Incarcerated|0|||
16935070|NCT01218646|38079706|FG000|Overall Study|Adverse Event|0|||
16935071|NCT01218646|38079707|FG001|Overall Study|Adverse Event|0|||
16935072|NCT01218646|38079708|FG002|Overall Study|Adverse Event|1|||
16935073|NCT01218646|38079709|FG003|Overall Study|Adverse Event|0|||
16935074|NCT01218646|38079706|FG000|Overall Study|Lost to Follow-up|1|||
16935075|NCT01218646|38079707|FG001|Overall Study|Lost to Follow-up|0|||
16935076|NCT01218646|38079708|FG002|Overall Study|Lost to Follow-up|0|||
16935077|NCT01218646|38079709|FG003|Overall Study|Lost to Follow-up|0|||
16935078|NCT01218646|38079706|FG000|Overall Study|Protocol Violation|0|||
16935079|NCT01218646|38079707|FG001|Overall Study|Protocol Violation|0|||
16935080|NCT01218646|38079708|FG002|Overall Study|Protocol Violation|1|||
16935081|NCT01218646|38079709|FG003|Overall Study|Protocol Violation|1|||
16935082|NCT01188772|38079723|FG000|Overall Study|Randomized but Not Treated|0|||
16935083|NCT01188772|38079724|FG001|Overall Study|Randomized but Not Treated|1|||
16935084|NCT01188772|38079725|FG002|Overall Study|Randomized but Not Treated|0|||
16935085|NCT01188772|38079726|FG003|Overall Study|Randomized but Not Treated|0|||
16935086|NCT01188772|38079723|FG000|Overall Study|Adverse Event|0|||
16935087|NCT01188772|38079724|FG001|Overall Study|Adverse Event|1|||
16935088|NCT01188772|38079725|FG002|Overall Study|Adverse Event|2|||
16935089|NCT01188772|38079726|FG003|Overall Study|Adverse Event|0|||
16935090|NCT01188772|38079723|FG000|Overall Study|Lost to Follow-up|4|||
16935091|NCT01188772|38079724|FG001|Overall Study|Lost to Follow-up|1|||
16935092|NCT01188772|38079725|FG002|Overall Study|Lost to Follow-up|1|||
16935093|NCT01188772|38079726|FG003|Overall Study|Lost to Follow-up|1|||
16935094|NCT01188772|38079723|FG000|Overall Study|Non-responder|0|||
16935095|NCT01188772|38079724|FG001|Overall Study|Non-responder|0|||
16935096|NCT01188772|38079725|FG002|Overall Study|Non-responder|3|||
16935097|NCT01188772|38079726|FG003|Overall Study|Non-responder|0|||
16935098|NCT01188772|38079723|FG000|Overall Study|Physician Decision|0|||
16935099|NCT01188772|38079724|FG001|Overall Study|Physician Decision|0|||
16935100|NCT01188772|38079725|FG002|Overall Study|Physician Decision|1|||
16935101|NCT01188772|38079726|FG003|Overall Study|Physician Decision|0|||
16935102|NCT01188772|38079723|FG000|Overall Study|Terminated by Sponsor|0|||
16935103|NCT01188772|38079724|FG001|Overall Study|Terminated by Sponsor|0|||
16935104|NCT01188772|38079725|FG002|Overall Study|Terminated by Sponsor|1|||
16935105|NCT01188772|38079726|FG003|Overall Study|Terminated by Sponsor|0|||
16935106|NCT01188772|38079723|FG000|Overall Study|Treatment Failure|0|||
16935107|NCT01188772|38079724|FG001|Overall Study|Treatment Failure|0|||
16935108|NCT01188772|38079725|FG002|Overall Study|Treatment Failure|1|||
16935109|NCT01188772|38079726|FG003|Overall Study|Treatment Failure|0|||
16935110|NCT01188772|38079723|FG000|Overall Study|Virologic Failure|1|||
16935111|NCT01188772|38079724|FG001|Overall Study|Virologic Failure|0|||
16935112|NCT01188772|38079725|FG002|Overall Study|Virologic Failure|0|||
16935113|NCT01188772|38079726|FG003|Overall Study|Virologic Failure|0|||
16935114|NCT01188772|38079723|FG000|Overall Study|Withdrawal by Subject|0|||
16935115|NCT01188772|38079724|FG001|Overall Study|Withdrawal by Subject|0|||
16935116|NCT01188772|38079725|FG002|Overall Study|Withdrawal by Subject|2|||
16935117|NCT01188772|38079726|FG003|Overall Study|Withdrawal by Subject|0|||
16935118|NCT01188655|38079739|FG000|Overall Study|Lack of Efficacy|1|||
16935119|NCT01188655|38079739|FG000|Overall Study|Lost to Follow-up|1|||
16935120|NCT01188655|38079739|FG000|Overall Study|Other|11|||
16935121|NCT01188538|38079745|FG000|Overall Study|Lost to Follow-up|0|||
16935122|NCT01188538|38079746|FG001|Overall Study|Lost to Follow-up|1|||
16935123|NCT01188343|38079757|FG000|Overall Study|Not vaccinated|0|||
16935124|NCT01188343|38079758|FG001|Overall Study|Not vaccinated|2|||
16935125|NCT01188343|38079759|FG002|Overall Study|Not vaccinated|1|||
16935126|NCT01188343|38079757|FG000|Overall Study|Withdrawal by Subject|1|||
16935127|NCT01188343|38079758|FG001|Overall Study|Withdrawal by Subject|24|||
17103109|NCT00112437|38241441|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103110|NCT00112437|38241442|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17023990|NCT00844805|38168248|FG000|Treatment Phase|Noncompliance With Protocol|1|||
17023991|NCT00844805|38168249|FG001|Treatment Phase|Noncompliance With Protocol|0|||
17023992|NCT00844805|38168250|FG002|Treatment Phase|Noncompliance With Protocol|0|||
17023993|NCT00844805|38168251|FG003|Treatment Phase|Noncompliance With Protocol|0|||
17023994|NCT00844805|38168248|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
17023995|NCT00844805|38168249|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
17023996|NCT00844805|38168250|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
17103111|NCT00112437|38241443|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16852849|NCT01777334|37803094|FG001|Overall Study|Protocol Violation|7|||
17023997|NCT00844805|38168251|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
17023998|NCT00844805|38168248|FG000|Follow-Up Phase|Adverse Event|0|||
17023999|NCT00844805|38168249|FG001|Follow-Up Phase|Adverse Event|0|||
17024000|NCT00844805|38168250|FG002|Follow-Up Phase|Adverse Event|1|||
17024001|NCT00844805|38168251|FG003|Follow-Up Phase|Adverse Event|0|||
17024002|NCT00844805|38168248|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
17024003|NCT00844805|38168249|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
16852850|NCT01777334|37803093|FG000|Overall Study|Lost to Follow-up|3|||
16852851|NCT01777334|37803094|FG001|Overall Study|Lost to Follow-up|2|||
16852852|NCT01777334|37803093|FG000|Overall Study|Withdrawal by Subject|14|||
16852853|NCT01777334|37803094|FG001|Overall Study|Withdrawal by Subject|11|||
16852854|NCT01383993|37803103|FG000|Overall Study|Adverse Event|1|||
16852855|NCT01383993|37803104|FG001|Overall Study|Adverse Event|1|||
16852856|NCT01383993|37803105|FG002|Overall Study|Adverse Event|0|||
16852857|NCT01383993|37803103|FG000|Overall Study|Withdrawal by Subject|0|||
16852858|NCT01383993|37803104|FG001|Overall Study|Withdrawal by Subject|0|||
16852859|NCT01383993|37803105|FG002|Overall Study|Withdrawal by Subject|1|||
16852860|NCT01383993|37803103|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
16852861|NCT01383993|37803104|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
16852862|NCT01383993|37803105|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
16852863|NCT01396395|37803116|FG000|Overall Study|Withdrawal by Subject|10|||
16852864|NCT01396395|37803117|FG001|Overall Study|Withdrawal by Subject|12|||
16852865|NCT01396395|37803116|FG000|Overall Study|Protocol Violation|3|||
16852866|NCT01396395|37803117|FG001|Overall Study|Protocol Violation|1|||
16852867|NCT01396395|37803116|FG000|Overall Study|Adverse Event|10|||
16852868|NCT01396395|37803117|FG001|Overall Study|Adverse Event|2|||
16852869|NCT01396395|37803116|FG000|Overall Study|Lost to Follow-up|17|||
16852870|NCT01396395|37803117|FG001|Overall Study|Lost to Follow-up|11|||
16852871|NCT01396395|37803116|FG000|Overall Study|Other|0|||
16852872|NCT01396395|37803117|FG001|Overall Study|Other|1|||
16852873|NCT01396317|37803127|FG000|Overall Study|Adverse Event|1|||
16852874|NCT01396317|37803128|FG001|Overall Study|Adverse Event|0|||
16852875|NCT01396161|37803143|FG000|Overall Study|Withdrawal by Subject|0|||
16852876|NCT01396161|37803144|FG001|Overall Study|Withdrawal by Subject|0|||
16852877|NCT01396161|37803145|FG002|Overall Study|Withdrawal by Subject|0|||
16935128|NCT01188343|38079759|FG002|Overall Study|Withdrawal by Subject|0|||
16935129|NCT01188226|38079770|FG000|Overall Study|Withdrawal by Subject|4|||
16935130|NCT01218100|38079788|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
16935131|NCT01218100|38079789|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
16935132|NCT01218100|38079790|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
16935133|NCT01218100|38079791|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
17024004|NCT00844805|38168250|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
17024005|NCT00844805|38168251|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
17024006|NCT00844805|38168248|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
17024007|NCT00844805|38168249|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
17024008|NCT00844805|38168250|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
17024009|NCT00844805|38168251|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
17024010|NCT00844805|38168248|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
16935134|NCT01218100|38079788|FG000|Overall Study|Adverse Event|4|||
17024011|NCT00844805|38168249|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
17024012|NCT00844805|38168250|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
16852878|NCT01396161|37803146|FG003|Overall Study|Withdrawal by Subject|0|||
16935135|NCT01218100|38079789|FG001|Overall Study|Adverse Event|6|||
16935136|NCT01218100|38079790|FG002|Overall Study|Adverse Event|6|||
16935137|NCT01218100|38079791|FG003|Overall Study|Adverse Event|7|||
16935138|NCT01218100|38079788|FG000|Overall Study|Lack of Efficacy|9|||
16935139|NCT01218100|38079789|FG001|Overall Study|Lack of Efficacy|6|||
16935140|NCT01218100|38079790|FG002|Overall Study|Lack of Efficacy|5|||
16935141|NCT01218100|38079791|FG003|Overall Study|Lack of Efficacy|12|||
16935142|NCT01218100|38079788|FG000|Overall Study|Protocol Violation|0|||
16935143|NCT01218100|38079789|FG001|Overall Study|Protocol Violation|0|||
16935144|NCT01218100|38079790|FG002|Overall Study|Protocol Violation|1|||
16935145|NCT01218100|38079791|FG003|Overall Study|Protocol Violation|1|||
16935146|NCT01218100|38079788|FG000|Overall Study|Withdrawal by Subject|5|||
16935147|NCT01218100|38079789|FG001|Overall Study|Withdrawal by Subject|2|||
16935148|NCT01218100|38079790|FG002|Overall Study|Withdrawal by Subject|6|||
16935149|NCT01218100|38079791|FG003|Overall Study|Withdrawal by Subject|7|||
16935150|NCT01218100|38079788|FG000|Overall Study|Lost to Follow-up|3|||
16935151|NCT01218100|38079789|FG001|Overall Study|Lost to Follow-up|8|||
16935152|NCT01218100|38079790|FG002|Overall Study|Lost to Follow-up|2|||
16935153|NCT01218100|38079791|FG003|Overall Study|Lost to Follow-up|1|||
16935154|NCT01218100|38079788|FG000|Overall Study|Other Reason|2|||
16935155|NCT01218100|38079789|FG001|Overall Study|Other Reason|2|||
16935156|NCT01218100|38079790|FG002|Overall Study|Other Reason|6|||
16935157|NCT01218100|38079791|FG003|Overall Study|Other Reason|4|||
16935158|NCT01187953|38079837|FG000|Overall Study|Death|11|||
16935159|NCT01187953|38079838|FG001|Overall Study|Death|13|||
16935160|NCT01187953|38079837|FG000|Overall Study|Adverse Event|1|||
16935161|NCT01187953|38079838|FG001|Overall Study|Adverse Event|2|||
16935162|NCT01187953|38079837|FG000|Overall Study|Lost to Follow-up|0|||
16935163|NCT01187953|38079838|FG001|Overall Study|Lost to Follow-up|3|||
16935164|NCT01187953|38079837|FG000|Overall Study|Withdrawal by Subject|3|||
16935165|NCT01187953|38079838|FG001|Overall Study|Withdrawal by Subject|3|||
16935166|NCT01217944|38079847|FG000|Overall Study|Protocol Violation|1|||
16935167|NCT01217944|38079848|FG001|Overall Study|Protocol Violation|1|||
16935168|NCT01217944|38079849|FG002|Overall Study|Protocol Violation|0|||
16935169|NCT01217944|38079847|FG000|Overall Study|Lost to Follow-up|3|||
16935170|NCT01217944|38079848|FG001|Overall Study|Lost to Follow-up|1|||
16935171|NCT01217944|38079849|FG002|Overall Study|Lost to Follow-up|0|||
16935172|NCT01217944|38079847|FG000|Overall Study|Withdrawal by Subject|1|||
16935173|NCT01217944|38079848|FG001|Overall Study|Withdrawal by Subject|2|||
16935174|NCT01217944|38079849|FG002|Overall Study|Withdrawal by Subject|0|||
16935175|NCT01217944|38079847|FG000|Overall Study|Lack of Efficacy|1|||
16935176|NCT01217944|38079848|FG001|Overall Study|Lack of Efficacy|0|||
16935177|NCT01217944|38079849|FG002|Overall Study|Lack of Efficacy|0|||
16935178|NCT01187446|38079861|FG000|Overall Study|Patient started non-protocol therapy|0|||
16935179|NCT01187446|38079862|FG001|Overall Study|Patient started non-protocol therapy|1|||
16935180|NCT01187407|38079872|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
16935181|NCT01187407|38079873|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16935182|NCT01187407|38079874|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16935183|NCT01187407|38079875|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16935184|NCT01187407|38079876|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16935185|NCT01187407|38079872|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
16935186|NCT01187407|38079873|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16935187|NCT01187407|38079874|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16935188|NCT01187407|38079875|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16935189|NCT01187407|38079876|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16935190|NCT01187407|38079872|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
16935191|NCT01187407|38079873|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16935192|NCT01187407|38079874|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16935193|NCT01187407|38079875|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16935194|NCT01187407|38079876|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16935195|NCT01187407|38079872|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
16935196|NCT01187407|38079873|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16935197|NCT01187407|38079874|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16935198|NCT01187407|38079875|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16935199|NCT01187407|38079876|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16935200|NCT01187407|38079872|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
16935201|NCT01187407|38079873|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16935202|NCT01187407|38079874|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16935203|NCT01187407|38079875|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16935204|NCT01187407|38079876|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16935205|NCT01187407|38079872|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
16935206|NCT01187407|38079873|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16935207|NCT01187407|38079874|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16935208|NCT01187407|38079875|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16935209|NCT01187407|38079876|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16935210|NCT01187407|38079872|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
16935211|NCT01187407|38079873|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16935212|NCT01187407|38079874|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16935213|NCT01187407|38079875|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16935214|NCT01187407|38079876|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16935215|NCT01187407|38079872|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
16935216|NCT01187407|38079873|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
16935217|NCT01187407|38079874|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
16935218|NCT01187407|38079875|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
16935219|NCT01187407|38079876|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
16935220|NCT01187407|38079872|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
17024013|NCT00844805|38168251|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
17024014|NCT00844805|38168248|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
17024015|NCT00844805|38168249|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
17024016|NCT00844805|38168250|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
17024017|NCT00844805|38168251|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
17024018|NCT00765999|38168262|FG000|Overall Study|Adverse Event|203|||
17024019|NCT00765999|38168262|FG000|Overall Study|Insufficient Therapeutic Response|100|||
17024020|NCT00765999|38168262|FG000|Overall Study|Protocol Violation|95|||
17024021|NCT00765999|38168262|FG000|Overall Study|Consent Withdrawn|202|||
17024022|NCT00765999|38168262|FG000|Overall Study|Lost to Follow-up|131|||
17024023|NCT00765999|38168262|FG000|Overall Study|Study Terminated by Sponsor|2|||
17024024|NCT00765999|38168262|FG000|Overall Study|Other Miscellaneous Reasons|51|||
17024025|NCT00765843|38168271|FG000|Overall Study|Lost to Follow-up|1|||
17024026|NCT00765843|38168272|FG001|Overall Study|Lost to Follow-up|3|||
17024027|NCT00765843|38168273|FG002|Overall Study|Lost to Follow-up|2|||
17024028|NCT00765843|38168271|FG000|Overall Study|did not return to receive intervention|0|||
17024029|NCT00765843|38168272|FG001|Overall Study|did not return to receive intervention|1|||
17024030|NCT00765843|38168273|FG002|Overall Study|did not return to receive intervention|0|||
17024031|NCT00765843|38168271|FG000|Overall Study|Adverse Event|0|||
17024032|NCT00765843|38168272|FG001|Overall Study|Adverse Event|0|||
17024033|NCT00765843|38168273|FG002|Overall Study|Adverse Event|1|||
16935221|NCT01187407|38079873|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
17024034|NCT00765063|38168281|FG000|Overall Study|Lack of Efficacy|5|||
17024035|NCT00765063|38168281|FG000|Overall Study|Withdrawal by Subject|1|||
17024036|NCT00765063|38168281|FG000|Overall Study|Other|16|||
17024037|NCT00765063|38168281|FG000|Overall Study|Protocol Violation|6|||
17024038|NCT00765063|38168281|FG000|Overall Study|Adverse Event|4|||
17024039|NCT00764751|38168287|FG000|Overall Study|Adverse Event|1|||
17024040|NCT00764751|38168288|FG001|Overall Study|Adverse Event|1|||
17103112|NCT00112437|38241444|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103113|NCT00112437|38241445|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103114|NCT00112437|38241446|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103115|NCT00112437|38241447|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103116|NCT00112437|38241448|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103117|NCT00112437|38241449|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103118|NCT00112437|38241450|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103119|NCT00112437|38241451|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17024041|NCT00764751|38168287|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
17024042|NCT00764751|38168288|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
17024043|NCT00764673|38168299|FG000|Overall Study|Death|1|||
17024044|NCT00764673|38168299|FG000|Overall Study|Lost to Follow-up|3|||
17024045|NCT00764673|38168299|FG000|Overall Study|Withdrawal by Subject|6|||
17024046|NCT00764673|38168299|FG000|Overall Study|Revision of Device|2|||
17024047|NCT00764517|38168305|FG000|Overall Study|Adverse Event|9|||
17024048|NCT00764517|38168306|FG001|Overall Study|Adverse Event|3|||
17024049|NCT00764517|38168305|FG000|Overall Study|Death|3|||
17024050|NCT00764517|38168306|FG001|Overall Study|Death|11|||
17024051|NCT00764517|38168305|FG000|Overall Study|Physician Decision|3|||
17024052|NCT00764517|38168306|FG001|Overall Study|Physician Decision|0|||
17024053|NCT00764361|38168314|FG000|Overall Study|Withdrawal by Subject|2|||
17024054|NCT00764361|38168315|FG001|Overall Study|Withdrawal by Subject|3|||
17024055|NCT00764361|38168314|FG000|Overall Study|Adverse Event|0|||
17024056|NCT00764361|38168315|FG001|Overall Study|Adverse Event|1|||
17024057|NCT00763971|38168324|FG000|Overall Study|Adverse Event|5|||
17024058|NCT00763971|38168325|FG001|Overall Study|Adverse Event|2|||
17024059|NCT00763971|38168326|FG002|Overall Study|Adverse Event|4|||
17024060|NCT00763971|38168324|FG000|Overall Study|Protocol Violation|3|||
17024061|NCT00763971|38168325|FG001|Overall Study|Protocol Violation|3|||
17024062|NCT00763971|38168326|FG002|Overall Study|Protocol Violation|2|||
17024063|NCT00763971|38168324|FG000|Overall Study|Withdrawal by Subject|4|||
17024064|NCT00763971|38168325|FG001|Overall Study|Withdrawal by Subject|5|||
17024065|NCT00763971|38168326|FG002|Overall Study|Withdrawal by Subject|5|||
17103120|NCT00112437|38241452|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17024066|NCT00763971|38168324|FG000|Overall Study|Lost to Follow-up|0|||
17024067|NCT00763971|38168325|FG001|Overall Study|Lost to Follow-up|1|||
17024068|NCT00763971|38168326|FG002|Overall Study|Lost to Follow-up|0|||
17024069|NCT00763971|38168324|FG000|Overall Study|Lack of Efficacy|11|||
17024070|NCT00763971|38168325|FG001|Overall Study|Lack of Efficacy|22|||
17024071|NCT00763971|38168326|FG002|Overall Study|Lack of Efficacy|54|||
17024072|NCT00763971|38168324|FG000|Overall Study|Unable to swallow capsule|2|||
17024073|NCT00763971|38168325|FG001|Overall Study|Unable to swallow capsule|1|||
17024074|NCT00763971|38168326|FG002|Overall Study|Unable to swallow capsule|1|||
17024075|NCT00763971|38168324|FG000|Overall Study|Personal reason|3|||
17024076|NCT00763971|38168325|FG001|Overall Study|Personal reason|0|||
16935222|NCT01187407|38079874|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
17024077|NCT00763971|38168326|FG002|Overall Study|Personal reason|0|||
17024078|NCT00763971|38168324|FG000|Overall Study|Exclusion criteria met|1|||
17024079|NCT00763971|38168325|FG001|Overall Study|Exclusion criteria met|0|||
17024080|NCT00763971|38168326|FG002|Overall Study|Exclusion criteria met|0|||
17024081|NCT00763971|38168324|FG000|Overall Study|Sponsor decision|1|||
16935223|NCT01187407|38079875|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
16935224|NCT01187407|38079876|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
16935225|NCT01187407|38079872|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
16935226|NCT01187407|38079873|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
16935227|NCT01187407|38079874|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
16935228|NCT01187407|38079875|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
17024082|NCT00763971|38168325|FG001|Overall Study|Sponsor decision|0|||
17024083|NCT00763971|38168326|FG002|Overall Study|Sponsor decision|0|||
17024084|NCT00763971|38168324|FG000|Overall Study|Due to holiday season|2|||
17024085|NCT00763971|38168325|FG001|Overall Study|Due to holiday season|0|||
17024086|NCT00763971|38168326|FG002|Overall Study|Due to holiday season|1|||
17024087|NCT00763971|38168324|FG000|Overall Study|Randomization error|0|||
17024088|NCT00763971|38168325|FG001|Overall Study|Randomization error|0|||
17024089|NCT00763971|38168326|FG002|Overall Study|Randomization error|1|||
17024090|NCT00763971|38168324|FG000|Overall Study|Medical monitor decision|0|||
17024091|NCT00763971|38168325|FG001|Overall Study|Medical monitor decision|0|||
17024092|NCT00763971|38168326|FG002|Overall Study|Medical monitor decision|1|||
17024093|NCT00763971|38168324|FG000|Overall Study|Moved to another country|0|||
17024094|NCT00763971|38168325|FG001|Overall Study|Moved to another country|1|||
17024095|NCT00763971|38168326|FG002|Overall Study|Moved to another country|0|||
17024096|NCT00763971|38168324|FG000|Overall Study|Subject wanted dose reduction|0|||
17024097|NCT00763971|38168325|FG001|Overall Study|Subject wanted dose reduction|1|||
17024098|NCT00763971|38168326|FG002|Overall Study|Subject wanted dose reduction|0|||
17024099|NCT00763971|38168324|FG000|Overall Study|Lack of availability|0|||
17024100|NCT00763971|38168325|FG001|Overall Study|Lack of availability|1|||
17024101|NCT00763971|38168326|FG002|Overall Study|Lack of availability|0|||
17024102|NCT00763971|38168324|FG000|Overall Study|Performed final visit on phone|0|||
17024103|NCT00763971|38168325|FG001|Overall Study|Performed final visit on phone|1|||
17024104|NCT00763971|38168326|FG002|Overall Study|Performed final visit on phone|0|||
17024105|NCT00763971|38168324|FG000|Overall Study|Participation in 489-326 required|1|||
17024106|NCT00763971|38168325|FG001|Overall Study|Participation in 489-326 required|0|||
17024107|NCT00763971|38168326|FG002|Overall Study|Participation in 489-326 required|0|||
17024108|NCT00763815|38168336|FG000|Overall Study|Adverse Event|14|||
17024109|NCT00763815|38168337|FG001|Overall Study|Adverse Event|29|||
17024110|NCT00763815|38168336|FG000|Overall Study|Lack of Efficacy|10|||
17024111|NCT00763815|38168337|FG001|Overall Study|Lack of Efficacy|11|||
17024112|NCT00763815|38168336|FG000|Overall Study|Poor Compliance to Protocol|6|||
17024113|NCT00763815|38168337|FG001|Overall Study|Poor Compliance to Protocol|6|||
17024114|NCT00763815|38168336|FG000|Overall Study|Lost to Follow-up|2|||
17024115|NCT00763815|38168337|FG001|Overall Study|Lost to Follow-up|4|||
17024116|NCT00763815|38168336|FG000|Overall Study|Early Termination|1|||
17024117|NCT00763815|38168337|FG001|Overall Study|Early Termination|0|||
17024118|NCT00763815|38168336|FG000|Overall Study|Familial and Personal Reasons|9|||
17024119|NCT00763815|38168337|FG001|Overall Study|Familial and Personal Reasons|16|||
17024120|NCT00763815|38168336|FG000|Overall Study|Physician Decision|1|||
17024121|NCT00763815|38168337|FG001|Overall Study|Physician Decision|0|||
17024122|NCT00763815|38168336|FG000|Overall Study|Withdrawal by Subject|7|||
17024123|NCT00763815|38168337|FG001|Overall Study|Withdrawal by Subject|12|||
17024124|NCT00763815|38168336|FG000|Overall Study|Protocol Violation|2|||
17024125|NCT00763815|38168337|FG001|Overall Study|Protocol Violation|5|||
17024126|NCT00763815|38168336|FG000|Overall Study|Sponsor's Decision|0|||
17024127|NCT00763815|38168337|FG001|Overall Study|Sponsor's Decision|1|||
17024128|NCT00763269|38168345|FG000|Overall Study|Lost to Follow-up|12|||
16852879|NCT01396161|37803147|FG004|Overall Study|Withdrawal by Subject|1|||
16852880|NCT01396161|37803148|FG005|Overall Study|Withdrawal by Subject|0|||
17024129|NCT00763269|38168346|FG001|Overall Study|Lost to Follow-up|13|||
17024130|NCT00763035|38168352|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
17024131|NCT00763035|38168353|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
17024132|NCT00763035|38168352|FG000|First Intervention|Adverse Event|0|||
17024133|NCT00763035|38168353|FG001|First Intervention|Adverse Event|1|||
17024134|NCT00763035|38168352|FG000|Second Intervention|Adverse Event|1|||
17024135|NCT00763035|38168353|FG001|Second Intervention|Adverse Event|0|||
17024136|NCT00763035|38168352|FG000|Second Intervention|Physician Decision|2|||
17024137|NCT00763035|38168353|FG001|Second Intervention|Physician Decision|0|||
17024138|NCT00844649|38168361|FG000|Overall Study|Progressive Disease|196|||
17024139|NCT00844649|38168362|FG001|Overall Study|Progressive Disease|245|||
17024140|NCT00844649|38168361|FG000|Overall Study|Adverse Event|128|||
17024141|NCT00844649|38168362|FG001|Overall Study|Adverse Event|73|||
17024142|NCT00844649|38168361|FG000|Overall Study|Physician Decision|25|||
17024143|NCT00844649|38168362|FG001|Overall Study|Physician Decision|18|||
17024144|NCT00844649|38168361|FG000|Overall Study|Protocol Violation|10|||
17024145|NCT00844649|38168362|FG001|Overall Study|Protocol Violation|6|||
17024146|NCT00844649|38168361|FG000|Overall Study|Withdrawal by Subject|28|||
17024147|NCT00844649|38168362|FG001|Overall Study|Withdrawal by Subject|39|||
17024148|NCT00844649|38168361|FG000|Overall Study|Other|7|||
17024149|NCT00844649|38168362|FG001|Overall Study|Other|10|||
17024150|NCT00844649|38168361|FG000|Overall Study|Withdrew prior to starting treatment|11|||
17024151|NCT00844649|38168362|FG001|Overall Study|Withdrew prior to starting treatment|27|||
17024152|NCT00762723|38168373|FG000|Overall Study|Study Terminated slow enrollement|5|||
17024153|NCT00762723|38168374|FG001|Overall Study|Study Terminated slow enrollement|5|||
17024154|NCT00762723|38168375|FG002|Overall Study|Study Terminated slow enrollement|3|||
17024155|NCT00850343|38168387|FG000|Overall Study|Withdrawal by Subject|11|||
17024156|NCT00850343|38168388|FG001|Overall Study|Withdrawal by Subject|0|||
17024157|NCT00850343|38168389|FG002|Overall Study|Withdrawal by Subject|3|||
17024158|NCT00850343|38168390|FG003|Overall Study|Withdrawal by Subject|2|||
17024159|NCT00850343|38168387|FG000|Overall Study|Adverse Event|15|||
17024160|NCT00850343|38168388|FG001|Overall Study|Adverse Event|2|||
17024161|NCT00850343|38168389|FG002|Overall Study|Adverse Event|6|||
17024162|NCT00850343|38168390|FG003|Overall Study|Adverse Event|6|||
17024163|NCT00850343|38168387|FG000|Overall Study|Pregnancy|0|||
17024164|NCT00850343|38168388|FG001|Overall Study|Pregnancy|0|||
17024165|NCT00850343|38168389|FG002|Overall Study|Pregnancy|0|||
17103121|NCT00112437|38241453|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103122|NCT00112437|38241454|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103123|NCT00112437|38241455|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103124|NCT00112437|38241456|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103125|NCT00112437|38241457|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103126|NCT00112437|38241458|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103127|NCT00112437|38241459|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103128|NCT00112437|38241460|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103129|NCT00112437|38241461|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
17103130|NCT00112437|38241462|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
17103131|NCT00112437|38241463|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103132|NCT00112437|38241464|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103133|NCT00112437|38241465|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103134|NCT00112437|38241466|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
17103135|NCT00112437|38241441|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103136|NCT00112437|38241442|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103137|NCT00112437|38241443|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103138|NCT00112437|38241444|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17024166|NCT00850343|38168390|FG003|Overall Study|Pregnancy|1|||
17024167|NCT00850343|38168387|FG000|Overall Study|Lack of Efficacy|17|||
17024168|NCT00850343|38168388|FG001|Overall Study|Lack of Efficacy|0|||
17024169|NCT00850343|38168389|FG002|Overall Study|Lack of Efficacy|3|||
17024170|NCT00850343|38168390|FG003|Overall Study|Lack of Efficacy|2|||
17024171|NCT00850343|38168387|FG000|Overall Study|Non-compliance with Study Procedures|1|||
17024172|NCT00850343|38168388|FG001|Overall Study|Non-compliance with Study Procedures|0|||
17024173|NCT00850343|38168389|FG002|Overall Study|Non-compliance with Study Procedures|1|||
17024174|NCT00850343|38168390|FG003|Overall Study|Non-compliance with Study Procedures|1|||
17024175|NCT00850343|38168387|FG000|Overall Study|Physician Decision|2|||
17024176|NCT00850343|38168388|FG001|Overall Study|Physician Decision|1|||
17024177|NCT00850343|38168389|FG002|Overall Study|Physician Decision|1|||
17024178|NCT00850343|38168390|FG003|Overall Study|Physician Decision|1|||
17103139|NCT00112437|38241445|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103140|NCT00112437|38241446|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103141|NCT00112437|38241447|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103142|NCT00112437|38241448|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103143|NCT00112437|38241449|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103144|NCT00112437|38241450|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17024179|NCT00849875|38168403|FG000|Overall Study|Death|28|||
17024180|NCT00849875|38168403|FG000|Overall Study|Ongoing (unknown completion status)|11|||
17024181|NCT00849875|38168403|FG000|Overall Study|Others|6|||
17024182|NCT00849875|38168403|FG000|Overall Study|Lost to Follow-up|2|||
17024183|NCT00844415|38168414|FG000|Overall Study|Withdrawal by Subject|1|||
17024184|NCT00843635|38168422|FG000|Overall Study|Adverse Event|2|||
17024185|NCT00843635|38168423|FG001|Overall Study|Adverse Event|2|||
17024186|NCT00843635|38168424|FG002|Overall Study|Adverse Event|0|||
17024187|NCT00843167|38168438|FG000|Treatment Period|Adverse Event|1|||
17024188|NCT00843167|38168439|FG001|Treatment Period|Adverse Event|5|||
17024189|NCT00843167|38168438|FG000|Treatment Period|Withdrawal by Subject|2|||
17024190|NCT00843167|38168439|FG001|Treatment Period|Withdrawal by Subject|3|||
17024191|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
17024192|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
17024193|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
17024194|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
17024195|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
17024196|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
17024197|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
17024198|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
17024199|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
17024200|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
17024201|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
17024202|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
17024203|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
17024204|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
17024205|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
17024206|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
17024207|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
17024208|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
17024209|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
17024210|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
17024211|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
17024212|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
17024213|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
17024214|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
17024215|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
17024216|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
17024217|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
17024218|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
17024219|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
17024220|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
17024221|NCT00849017|38168452|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
17024222|NCT00849017|38168453|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
17024223|NCT00849017|38168454|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
17024224|NCT00849017|38168452|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
17024225|NCT00849017|38168453|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
17024226|NCT00849017|38168454|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
16935229|NCT01187407|38079876|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
16935230|NCT01187407|38079872|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16935231|NCT01187407|38079873|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16935232|NCT01187407|38079874|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16935233|NCT01187407|38079875|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
16935234|NCT01187407|38079876|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
17024227|NCT00849017|38168452|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
17024228|NCT00849017|38168453|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
17024229|NCT00849017|38168454|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
17024230|NCT00849017|38168452|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
17024231|NCT00849017|38168453|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
17024232|NCT00849017|38168454|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
17024233|NCT00849017|38168452|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
16935235|NCT01187407|38079872|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
16935236|NCT01187407|38079873|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
16935237|NCT01187407|38079874|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16935238|NCT01187407|38079875|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
16935239|NCT01187407|38079876|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
16935240|NCT01187407|38079872|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
16935241|NCT01187407|38079873|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
16935242|NCT01187407|38079874|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
16935243|NCT01187407|38079875|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
16935244|NCT01187407|38079876|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
16935245|NCT01187407|38079872|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
17024234|NCT00849017|38168453|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
17024235|NCT00849017|38168454|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
17024236|NCT00849017|38168452|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
17024237|NCT00849017|38168453|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
17024238|NCT00849017|38168454|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
17024239|NCT00849017|38168452|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
17024240|NCT00849017|38168453|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
17024241|NCT00849017|38168454|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
17024242|NCT00849017|38168452|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
17024243|NCT00849017|38168453|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
17024244|NCT00849017|38168454|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
17024245|NCT00849017|38168452|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
17024246|NCT00849017|38168453|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
17024247|NCT00849017|38168454|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
17024248|NCT00842543|38168470|FG000|Overall Study|Withdrawal by Subject|2|||
17024249|NCT00842543|38168471|FG001|Overall Study|Withdrawal by Subject|0|||
17024250|NCT00842543|38168472|FG002|Overall Study|Withdrawal by Subject|3|||
17024251|NCT00842543|38168473|FG003|Overall Study|Withdrawal by Subject|4|||
17024252|NCT00785928|38168492|FG000|Treatment Phase|Adverse Event|1|||
17024253|NCT00785928|38168493|FG001|Treatment Phase|Adverse Event|1|||
17024254|NCT00785928|38168494|FG002|Treatment Phase|Adverse Event|2|||
17024255|NCT00785928|38168495|FG003|Treatment Phase|Adverse Event|0|||
17024256|NCT00785928|38168496|FG004|Treatment Phase|Adverse Event|0|||
17024257|NCT00785928|38168497|FG005|Treatment Phase|Adverse Event|0|||
17024258|NCT00785928|38168498|FG006|Treatment Phase|Adverse Event|2|||
17024259|NCT00785928|38168492|FG000|Treatment Phase|Inadequate Response|0|||
17024260|NCT00785928|38168493|FG001|Treatment Phase|Inadequate Response|1|||
17024261|NCT00785928|38168494|FG002|Treatment Phase|Inadequate Response|0|||
17024262|NCT00785928|38168495|FG003|Treatment Phase|Inadequate Response|0|||
17024263|NCT00785928|38168496|FG004|Treatment Phase|Inadequate Response|0|||
17024264|NCT00785928|38168497|FG005|Treatment Phase|Inadequate Response|0|||
17024265|NCT00785928|38168498|FG006|Treatment Phase|Inadequate Response|0|||
17024266|NCT00785928|38168492|FG000|Treatment Phase|Lack of Efficacy|0|||
17024267|NCT00785928|38168493|FG001|Treatment Phase|Lack of Efficacy|1|||
17024268|NCT00785928|38168494|FG002|Treatment Phase|Lack of Efficacy|1|||
17024269|NCT00785928|38168495|FG003|Treatment Phase|Lack of Efficacy|0|||
17024270|NCT00785928|38168496|FG004|Treatment Phase|Lack of Efficacy|0|||
17024271|NCT00785928|38168497|FG005|Treatment Phase|Lack of Efficacy|0|||
17024272|NCT00785928|38168498|FG006|Treatment Phase|Lack of Efficacy|0|||
17024273|NCT00785928|38168492|FG000|Treatment Phase|Physician Decision|0|||
17024274|NCT00785928|38168493|FG001|Treatment Phase|Physician Decision|0|||
17024275|NCT00785928|38168494|FG002|Treatment Phase|Physician Decision|0|||
17024276|NCT00785928|38168495|FG003|Treatment Phase|Physician Decision|0|||
17024277|NCT00785928|38168496|FG004|Treatment Phase|Physician Decision|1|||
17024278|NCT00785928|38168497|FG005|Treatment Phase|Physician Decision|0|||
17024279|NCT00785928|38168498|FG006|Treatment Phase|Physician Decision|0|||
17024280|NCT00785928|38168492|FG000|Treatment Phase|Sponsor Decision|1|||
17024281|NCT00785928|38168493|FG001|Treatment Phase|Sponsor Decision|0|||
17024282|NCT00785928|38168494|FG002|Treatment Phase|Sponsor Decision|0|||
17024283|NCT00785928|38168495|FG003|Treatment Phase|Sponsor Decision|0|||
17024284|NCT00785928|38168496|FG004|Treatment Phase|Sponsor Decision|0|||
17024285|NCT00785928|38168497|FG005|Treatment Phase|Sponsor Decision|0|||
17024286|NCT00785928|38168498|FG006|Treatment Phase|Sponsor Decision|1|||
17024287|NCT00785928|38168492|FG000|Treatment Phase|Withdrawal by Subject|1|||
17024288|NCT00785928|38168493|FG001|Treatment Phase|Withdrawal by Subject|2|||
17024289|NCT00785928|38168494|FG002|Treatment Phase|Withdrawal by Subject|0|||
17024290|NCT00785928|38168495|FG003|Treatment Phase|Withdrawal by Subject|0|||
17024291|NCT00785928|38168496|FG004|Treatment Phase|Withdrawal by Subject|1|||
16935246|NCT01187407|38079873|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
16935247|NCT01187407|38079874|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
16935248|NCT01187407|38079875|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
16935249|NCT01187407|38079876|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
16935250|NCT01186978|38079893|FG000|Overall Study|Withdrawal by Subject|1|||
16935251|NCT01186939|38079897|FG000|Overall Study|Death|7|||
16935252|NCT01186939|38079897|FG000|Overall Study|Withdrawal by Subject|2|||
16935253|NCT01186939|38079897|FG000|Overall Study|No longer receiving clinical benefit|17|||
16935254|NCT01186939|38079897|FG000|Overall Study|Program closed|5|||
16935255|NCT01186939|38079897|FG000|Overall Study|Sponsor decision|4|||
16935256|NCT01186939|38079897|FG000|Overall Study|Started additional treatment|1|||
16935257|NCT01186939|38079897|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
16935258|NCT01186939|38079897|FG000|Overall Study|Myocardial infarction|1|||
16935259|NCT01186939|38079897|FG000|Overall Study|Bone marrow transplant|1|||
16935260|NCT01186939|38079897|FG000|Overall Study|Transformation to AML|1|||
16935261|NCT01186744|38079961|FG000|Overall Study|Lack of Efficacy|156|||
16935262|NCT01186744|38079962|FG001|Overall Study|Lack of Efficacy|99|||
16935263|NCT01186744|38079963|FG002|Overall Study|Lack of Efficacy|0|||
16935264|NCT01186744|38079964|FG003|Overall Study|Lack of Efficacy|2|||
16935265|NCT01186744|38079965|FG004|Overall Study|Lack of Efficacy|2|||
16935266|NCT01186744|38079966|FG005|Overall Study|Lack of Efficacy|5|||
16935267|NCT01186744|38079961|FG000|Overall Study|Protocol Violation|1|||
16935268|NCT01186744|38079962|FG001|Overall Study|Protocol Violation|2|||
16935269|NCT01186744|38079963|FG002|Overall Study|Protocol Violation|0|||
16935270|NCT01186744|38079964|FG003|Overall Study|Protocol Violation|1|||
16935271|NCT01186744|38079965|FG004|Overall Study|Protocol Violation|1|||
16935272|NCT01186744|38079966|FG005|Overall Study|Protocol Violation|2|||
16935273|NCT01186744|38079961|FG000|Overall Study|Lost to Follow-up|15|||
17024292|NCT00785928|38168497|FG005|Treatment Phase|Withdrawal by Subject|0|||
17024293|NCT00785928|38168498|FG006|Treatment Phase|Withdrawal by Subject|0|||
17024294|NCT00842309|38168538|FG000|Overall Study|Withdrawal by Subject|3|||
17024295|NCT00842309|38168539|FG001|Overall Study|Withdrawal by Subject|1|||
17024296|NCT00842153|38168547|FG000|Overall Study|Adverse Event|0|||
17024297|NCT00842153|38168548|FG001|Overall Study|Adverse Event|1|||
17024298|NCT00842153|38168547|FG000|Overall Study|Lost to Follow-up|1|||
17024299|NCT00842153|38168548|FG001|Overall Study|Lost to Follow-up|2|||
17024300|NCT00762411|38168556|FG000|Initial Treatment|Death|7|||
17024301|NCT00762411|38168557|FG001|Initial Treatment|Death|6|||
17024302|NCT00762411|38168556|FG000|Initial Treatment|Adverse Event|132|||
17024303|NCT00762411|38168557|FG001|Initial Treatment|Adverse Event|40|||
17024304|NCT00762411|38168556|FG000|Initial Treatment|Protocol Violation|4|||
17024305|NCT00762411|38168557|FG001|Initial Treatment|Protocol Violation|1|||
17024306|NCT00762411|38168556|FG000|Initial Treatment|Withdrawal by Subject|65|||
17024307|NCT00762411|38168557|FG001|Initial Treatment|Withdrawal by Subject|52|||
17024308|NCT00762411|38168556|FG000|Initial Treatment|Physician Decision|1|||
17024309|NCT00762411|38168557|FG001|Initial Treatment|Physician Decision|0|||
17024310|NCT00762411|38168556|FG000|Initial Treatment|Sponsor Decision|293|||
17024311|NCT00762411|38168557|FG001|Initial Treatment|Sponsor Decision|401|||
17024312|NCT00762411|38168556|FG000|Initial Treatment|Lost to Follow-up|5|||
17024313|NCT00762411|38168557|FG001|Initial Treatment|Lost to Follow-up|0|||
17024314|NCT00762411|38168556|FG000|Initial Treatment|Caregiver Decision|21|||
17024315|NCT00762411|38168557|FG001|Initial Treatment|Caregiver Decision|16|||
17024316|NCT00762411|38168556|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
17024317|NCT00762411|38168557|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
17024318|NCT00762411|38168556|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
17024319|NCT00762411|38168557|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
17024320|NCT00762411|38168556|FG000|Delayed Start|Adverse Event|0|||
17024321|NCT00762411|38168557|FG001|Delayed Start|Adverse Event|4|||
17024322|NCT00762411|38168556|FG000|Delayed Start|Protocol Violation|0|||
17024323|NCT00762411|38168557|FG001|Delayed Start|Protocol Violation|1|||
17024324|NCT00762411|38168556|FG000|Delayed Start|Sponsor Decision|16|||
17024325|NCT00762411|38168557|FG001|Delayed Start|Sponsor Decision|20|||
17024326|NCT00762411|38168556|FG000|Delayed Start|Caregiver Decision|1|||
17024327|NCT00762411|38168557|FG001|Delayed Start|Caregiver Decision|1|||
17024328|NCT00762411|38168556|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
17024329|NCT00762411|38168557|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
17024330|NCT00762411|38168556|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
17024331|NCT00762411|38168557|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
17024332|NCT00762411|38168556|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
17024333|NCT00762411|38168557|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
17024334|NCT00762411|38168556|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
17024335|NCT00762411|38168557|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
17024336|NCT00762411|38168556|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
17024337|NCT00762411|38168557|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
17024338|NCT00762411|38168556|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
17024339|NCT00762411|38168557|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
17024340|NCT00761865|38168569|FG000|Overall Study|Lost to Follow-up|8|||
17024341|NCT00761865|38168570|FG001|Overall Study|Lost to Follow-up|7|||
17024342|NCT00841763|38168578|FG000|Overall Study|Withdrawal by Subject|60|||
17024343|NCT00841763|38168579|FG001|Overall Study|Withdrawal by Subject|17|||
17024344|NCT00841763|38168580|FG002|Overall Study|Withdrawal by Subject|4|||
17024345|NCT00841763|38168581|FG003|Overall Study|Withdrawal by Subject|1|||
17024346|NCT00841763|38168578|FG000|Overall Study|Adverse Event|9|||
17024347|NCT00841763|38168579|FG001|Overall Study|Adverse Event|10|||
17024348|NCT00841763|38168580|FG002|Overall Study|Adverse Event|3|||
17024349|NCT00841763|38168581|FG003|Overall Study|Adverse Event|2|||
17024350|NCT00841763|38168578|FG000|Overall Study|Lost to Follow-up|63|||
17024351|NCT00841763|38168579|FG001|Overall Study|Lost to Follow-up|25|||
17024352|NCT00841763|38168580|FG002|Overall Study|Lost to Follow-up|0|||
17024353|NCT00841763|38168581|FG003|Overall Study|Lost to Follow-up|0|||
17024354|NCT00841763|38168578|FG000|Overall Study|Protocol Violation|20|||
17024355|NCT00841763|38168579|FG001|Overall Study|Protocol Violation|3|||
17024356|NCT00841763|38168580|FG002|Overall Study|Protocol Violation|1|||
17024357|NCT00841763|38168581|FG003|Overall Study|Protocol Violation|0|||
17024358|NCT00841763|38168578|FG000|Overall Study|Administrative Reasons|3|||
16935274|NCT01186744|38079962|FG001|Overall Study|Lost to Follow-up|16|||
16935275|NCT01186744|38079963|FG002|Overall Study|Lost to Follow-up|2|||
16935276|NCT01186744|38079964|FG003|Overall Study|Lost to Follow-up|1|||
16935277|NCT01186744|38079965|FG004|Overall Study|Lost to Follow-up|1|||
17024359|NCT00841763|38168579|FG001|Overall Study|Administrative Reasons|1|||
17024360|NCT00841763|38168580|FG002|Overall Study|Administrative Reasons|0|||
17024361|NCT00841763|38168581|FG003|Overall Study|Administrative Reasons|0|||
17024362|NCT00841763|38168578|FG000|Overall Study|Unable to Classify|7|||
17024363|NCT00841763|38168579|FG001|Overall Study|Unable to Classify|1|||
17024364|NCT00841763|38168580|FG002|Overall Study|Unable to Classify|0|||
17024365|NCT00841763|38168581|FG003|Overall Study|Unable to Classify|0|||
17024366|NCT00838331|38168626|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
17024367|NCT00785538|38168634|FG000|Treatment Period|Adverse Event|1|||
17024368|NCT00785538|38168635|FG001|Treatment Period|Adverse Event|2|||
17024369|NCT00785538|38168636|FG002|Treatment Period|Adverse Event|2|||
17024370|NCT00785538|38168637|FG003|Treatment Period|Adverse Event|0|||
17024371|NCT00785538|38168634|FG000|Treatment Period|Withdrawal by Subject|0|||
17024372|NCT00785538|38168635|FG001|Treatment Period|Withdrawal by Subject|0|||
17024373|NCT00785538|38168636|FG002|Treatment Period|Withdrawal by Subject|0|||
17024374|NCT00785538|38168637|FG003|Treatment Period|Withdrawal by Subject|1|||
17024375|NCT00860405|38168650|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
17024376|NCT00860405|38168651|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
17024377|NCT00838097|38168657|FG000|Overall Study|Ineligibility determined|6|||
17024378|NCT00838097|38168657|FG000|Overall Study|Adverse Event|2|||
17024379|NCT00838097|38168657|FG000|Overall Study|Withdrawal by Subject|3|||
17024380|NCT00838097|38168657|FG000|Overall Study|Requirement for alternative therapy|2|||
17024381|NCT00838097|38168657|FG000|Overall Study|Physician Decision|4|||
16935278|NCT01186744|38079966|FG005|Overall Study|Lost to Follow-up|4|||
16935279|NCT01186744|38079961|FG000|Overall Study|Screen failure|1|||
16935280|NCT01186744|38079962|FG001|Overall Study|Screen failure|1|||
16935281|NCT01186744|38079963|FG002|Overall Study|Screen failure|0|||
16935282|NCT01186744|38079964|FG003|Overall Study|Screen failure|1|||
16935283|NCT01186744|38079965|FG004|Overall Study|Screen failure|0|||
16935284|NCT01186744|38079966|FG005|Overall Study|Screen failure|0|||
16935285|NCT01186744|38079961|FG000|Overall Study|Withdrawal by Subject|14|||
16935286|NCT01186744|38079962|FG001|Overall Study|Withdrawal by Subject|10|||
16935287|NCT01186744|38079963|FG002|Overall Study|Withdrawal by Subject|2|||
16935288|NCT01186744|38079964|FG003|Overall Study|Withdrawal by Subject|5|||
16935289|NCT01186744|38079965|FG004|Overall Study|Withdrawal by Subject|0|||
16935290|NCT01186744|38079966|FG005|Overall Study|Withdrawal by Subject|6|||
17024382|NCT00838097|38168657|FG000|Overall Study|Lost to Follow-up|11|||
17024383|NCT00838097|38168657|FG000|Overall Study|Death|6|||
17024384|NCT00838097|38168657|FG000|Overall Study|Protocol-specified criteria|142|||
17024385|NCT00840827|38168661|FG000|Overall Study|Adverse Event|1|||
17024386|NCT00840827|38168661|FG000|Overall Study|Lack of Efficacy|4|||
17024387|NCT00840827|38168661|FG000|Overall Study|Physician Decision|1|||
17024388|NCT00860249|38168668|FG000|Overall Study|trial was terminated prior to completion|21|||
17024389|NCT00860249|38168669|FG001|Overall Study|trial was terminated prior to completion|18|||
17024390|NCT00860249|38168670|FG002|Overall Study|trial was terminated prior to completion|21|||
17024391|NCT00840749|38168680|FG000|Overall Study|Death|1|||
17024392|NCT00840749|38168681|FG001|Overall Study|Death|2|||
17024393|NCT00840749|38168680|FG000|Overall Study|not treated on study arm|11|||
17024394|NCT00840749|38168681|FG001|Overall Study|not treated on study arm|11|||
17024395|NCT00840749|38168680|FG000|Overall Study|study closed|19|||
17024396|NCT00840749|38168681|FG001|Overall Study|study closed|14|||
17024397|NCT00859937|38168689|FG000|Overall Study|Protocol Violation|1|||
17024398|NCT00859937|38168690|FG001|Overall Study|Protocol Violation|0|||
17024399|NCT00592007|38168696|FG000|Overall Study|Withdrawal by Subject|1|||
17024400|NCT00592007|38168696|FG000|Overall Study|patient ineligible (out of lab range)|1|||
17024401|NCT00591851|38168700|FG000|Overall Study|Withdrawal by Subject|3|||
17024402|NCT00591851|38168700|FG000|Overall Study|Adverse Event|2|||
17024403|NCT00591851|38168700|FG000|Overall Study|Progressive Disease|1|||
17024404|NCT00837473|38168704|FG000|Overall Study|Lost to Follow-up|1|||
17198681|NCT02706405|38352369|FG002|Overall Study|Death|0|||
17024405|NCT00837473|38168704|FG000|Overall Study|Withdrawal by Subject|2|||
17024406|NCT00839423|38168712|FG000|Overall Study|Adverse Event|4|||
17024407|NCT00839423|38168713|FG001|Overall Study|Adverse Event|3|||
17024408|NCT00839423|38168714|FG002|Overall Study|Adverse Event|7|||
17024409|NCT00839423|38168715|FG003|Overall Study|Adverse Event|16|||
17024410|NCT00839423|38168712|FG000|Overall Study|Lack of Efficacy|6|||
17024411|NCT00839423|38168713|FG001|Overall Study|Lack of Efficacy|6|||
17024412|NCT00839423|38168714|FG002|Overall Study|Lack of Efficacy|3|||
16935291|NCT01186744|38079961|FG000|Overall Study|Study terminated by Sponsor|1|||
17024413|NCT00839423|38168715|FG003|Overall Study|Lack of Efficacy|2|||
17024414|NCT00839423|38168712|FG000|Overall Study|Non-compliance|0|||
17024415|NCT00839423|38168713|FG001|Overall Study|Non-compliance|0|||
17024416|NCT00839423|38168714|FG002|Overall Study|Non-compliance|0|||
17024417|NCT00839423|38168715|FG003|Overall Study|Non-compliance|1|||
17024418|NCT00839423|38168712|FG000|Overall Study|Protocol Violation|0|||
17024419|NCT00839423|38168713|FG001|Overall Study|Protocol Violation|1|||
17024420|NCT00839423|38168714|FG002|Overall Study|Protocol Violation|2|||
17024421|NCT00839423|38168715|FG003|Overall Study|Protocol Violation|0|||
17024422|NCT00839423|38168712|FG000|Overall Study|Withdrawal of consent|4|||
17103145|NCT00112437|38241451|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103146|NCT00112437|38241452|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16852881|NCT01396161|37803149|FG006|Overall Study|Withdrawal by Subject|0|||
16852882|NCT01396161|37803143|FG000|Overall Study|Other|0|||
16852883|NCT01396161|37803144|FG001|Overall Study|Other|0|||
16852884|NCT01396161|37803145|FG002|Overall Study|Other|0|||
16852885|NCT01396161|37803146|FG003|Overall Study|Other|0|||
16852886|NCT01396161|37803147|FG004|Overall Study|Other|0|||
16852887|NCT01396161|37803148|FG005|Overall Study|Other|0|||
16852888|NCT01396161|37803149|FG006|Overall Study|Other|1|||
16852889|NCT01396083|37803172|FG000|Overall Study|Adverse Event|2|||
16852890|NCT01396083|37803173|FG001|Overall Study|Adverse Event|28|||
16852891|NCT01396083|37803172|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16852892|NCT01396083|37803173|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
16852893|NCT01396083|37803172|FG000|Overall Study|Consent withdrawn|4|||
16852894|NCT01396083|37803173|FG001|Overall Study|Consent withdrawn|5|||
16852895|NCT01396083|37803172|FG000|Overall Study|Protocol deviation(s)|0|||
16852896|NCT01396083|37803173|FG001|Overall Study|Protocol deviation(s)|1|||
16852897|NCT01396083|37803172|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16852898|NCT01396083|37803173|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16852899|NCT01396083|37803172|FG000|Overall Study|Administrative problems|1|||
16852900|NCT01396083|37803173|FG001|Overall Study|Administrative problems|0|||
16852901|NCT01396083|37803172|FG000|Overall Study|Lost to Follow-up|1|||
16852902|NCT01396083|37803173|FG001|Overall Study|Lost to Follow-up|0|||
16852903|NCT01723826|37803183|FG000|Overall Study|Adverse Event|4|||
16852904|NCT01723826|37803184|FG001|Overall Study|Adverse Event|1|||
16852905|NCT01723826|37803185|FG002|Overall Study|Adverse Event|4|||
16852906|NCT01723826|37803186|FG003|Overall Study|Adverse Event|5|||
16852907|NCT01723826|37803183|FG000|Overall Study|Death according to AE eCRF|2|||
16852908|NCT01723826|37803184|FG001|Overall Study|Death according to AE eCRF|3|||
16852909|NCT01723826|37803185|FG002|Overall Study|Death according to AE eCRF|3|||
16852910|NCT01723826|37803186|FG003|Overall Study|Death according to AE eCRF|7|||
16852911|NCT01723826|37803183|FG000|Overall Study|Lost to Follow-up|1|||
16852912|NCT01723826|37803184|FG001|Overall Study|Lost to Follow-up|3|||
16852913|NCT01723826|37803185|FG002|Overall Study|Lost to Follow-up|1|||
16852914|NCT01723826|37803186|FG003|Overall Study|Lost to Follow-up|1|||
17103147|NCT00112437|38241453|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103148|NCT00112437|38241454|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103149|NCT00112437|38241455|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103150|NCT00112437|38241456|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103151|NCT00112437|38241457|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103152|NCT00112437|38241458|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103153|NCT00112437|38241459|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103154|NCT00112437|38241460|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103155|NCT00112437|38241461|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
17103156|NCT00112437|38241462|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103157|NCT00112437|38241463|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103158|NCT00112437|38241464|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103159|NCT00112437|38241465|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103160|NCT00112437|38241466|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
17103161|NCT00112437|38241441|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103162|NCT00112437|38241442|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16852915|NCT01723826|37803183|FG000|Overall Study|Non-compliance|0|||
16852916|NCT01723826|37803184|FG001|Overall Study|Non-compliance|1|||
16852917|NCT01723826|37803185|FG002|Overall Study|Non-compliance|3|||
16852918|NCT01723826|37803186|FG003|Overall Study|Non-compliance|3|||
16852919|NCT01723826|37803183|FG000|Overall Study|Non-compliance With Study Drug|0|||
16852920|NCT01723826|37803184|FG001|Overall Study|Non-compliance With Study Drug|1|||
16852921|NCT01723826|37803185|FG002|Overall Study|Non-compliance With Study Drug|0|||
16852922|NCT01723826|37803186|FG003|Overall Study|Non-compliance With Study Drug|0|||
16852923|NCT01723826|37803183|FG000|Overall Study|Other Reason|8|||
16852924|NCT01723826|37803184|FG001|Overall Study|Other Reason|6|||
16852925|NCT01723826|37803185|FG002|Overall Study|Other Reason|12|||
16852926|NCT01723826|37803186|FG003|Overall Study|Other Reason|14|||
17024423|NCT00839423|38168713|FG001|Overall Study|Withdrawal of consent|0|||
17024424|NCT00839423|38168714|FG002|Overall Study|Withdrawal of consent|4|||
16935292|NCT01186744|38079962|FG001|Overall Study|Study terminated by Sponsor|0|||
16935293|NCT01186744|38079963|FG002|Overall Study|Study terminated by Sponsor|0|||
17024425|NCT00839423|38168715|FG003|Overall Study|Withdrawal of consent|1|||
17024426|NCT00839423|38168712|FG000|Overall Study|Lost to Follow-up|1|||
17024427|NCT00839423|38168713|FG001|Overall Study|Lost to Follow-up|0|||
17024428|NCT00839423|38168714|FG002|Overall Study|Lost to Follow-up|1|||
17024429|NCT00839423|38168715|FG003|Overall Study|Lost to Follow-up|0|||
17024430|NCT00839423|38168712|FG000|Overall Study|Administrative or other reasons|3|||
17024431|NCT00839423|38168713|FG001|Overall Study|Administrative or other reasons|0|||
17024432|NCT00839423|38168714|FG002|Overall Study|Administrative or other reasons|1|||
17024433|NCT00839423|38168715|FG003|Overall Study|Administrative or other reasons|0|||
17024434|NCT00837161|38168725|FG000|Overall Study|refused hysterectomy|2|||
17024435|NCT00859547|38168729|FG000|Overall Study|Lost to Follow-up|1|||
17024436|NCT00859547|38168729|FG000|Overall Study|Parent withdrew consent|1|||
17024437|NCT00859469|38168733|FG000|Overall Study|Adverse Event|2|||
17024438|NCT00859469|38168733|FG000|Overall Study|Lack of Efficacy|9|||
17024439|NCT00859469|38168733|FG000|Overall Study|Withdrawal by Subject|1|||
17024440|NCT00859469|38168733|FG000|Overall Study|Death|16|||
17024441|NCT00859313|38168737|FG000|Overall Study|Lack of Efficacy|2|||
17024442|NCT00859313|38168737|FG000|Overall Study|Adverse Event|1|||
17024443|NCT00859313|38168737|FG000|Overall Study|staff error|1|||
17024444|NCT00771810|38168744|FG000|Overall Study|Adverse Event|3|||
17024445|NCT00771810|38168745|FG001|Overall Study|Adverse Event|0|||
17024446|NCT00771810|38168746|FG002|Overall Study|Adverse Event|2|||
17024447|NCT00771810|38168744|FG000|Overall Study|Lost to Follow-up|0|||
17024448|NCT00771810|38168745|FG001|Overall Study|Lost to Follow-up|0|||
17024449|NCT00771810|38168746|FG002|Overall Study|Lost to Follow-up|1|||
17024450|NCT00771810|38168744|FG000|Overall Study|Physician Decision|1|||
17024451|NCT00771810|38168745|FG001|Overall Study|Physician Decision|2|||
17024452|NCT00771810|38168746|FG002|Overall Study|Physician Decision|2|||
17024453|NCT00771810|38168744|FG000|Overall Study|Protocol Violation|0|||
17024454|NCT00771810|38168745|FG001|Overall Study|Protocol Violation|1|||
17024455|NCT00771810|38168746|FG002|Overall Study|Protocol Violation|1|||
17024456|NCT00771810|38168744|FG000|Overall Study|Withdrawal by Subject|1|||
17024457|NCT00771810|38168745|FG001|Overall Study|Withdrawal by Subject|2|||
17024458|NCT00771810|38168746|FG002|Overall Study|Withdrawal by Subject|0|||
17024459|NCT00771810|38168744|FG000|Overall Study|Other|0|||
17024460|NCT00771810|38168745|FG001|Overall Study|Other|0|||
17024461|NCT00771810|38168746|FG002|Overall Study|Other|1|||
17024462|NCT00836927|38168760|FG000|Overall Study|Progressive disease|2|||
17024463|NCT00836927|38168761|FG001|Overall Study|Progressive disease|0|||
17024464|NCT00836927|38168762|FG002|Overall Study|Progressive disease|0|||
17024465|NCT00836927|38168763|FG003|Overall Study|Progressive disease|1|||
17024466|NCT00836927|38168764|FG004|Overall Study|Progressive disease|1|||
17024467|NCT00836927|38168760|FG000|Overall Study|Withdrawal by Subject|1|||
17024468|NCT00836927|38168761|FG001|Overall Study|Withdrawal by Subject|0|||
17024469|NCT00836927|38168762|FG002|Overall Study|Withdrawal by Subject|0|||
17024470|NCT00836927|38168763|FG003|Overall Study|Withdrawal by Subject|0|||
17024471|NCT00836927|38168764|FG004|Overall Study|Withdrawal by Subject|0|||
17024472|NCT00771030|38168785|FG000|Overall Study|Adverse Event|0|||
17024473|NCT00771030|38168786|FG001|Overall Study|Adverse Event|1|||
17024474|NCT00771030|38168787|FG002|Overall Study|Adverse Event|0|||
17024475|NCT00771030|38168788|FG003|Overall Study|Adverse Event|0|||
17024476|NCT00771030|38168789|FG004|Overall Study|Adverse Event|0|||
17024477|NCT00771030|38168790|FG005|Overall Study|Adverse Event|0|||
17024478|NCT00771030|38168791|FG006|Overall Study|Adverse Event|0|||
17024479|NCT00768300|38168814|FG000|Overall Study|Randomized but not treated|1|||
17024480|NCT00768300|38168815|FG001|Overall Study|Randomized but not treated|1|||
17024481|NCT00768300|38168814|FG000|Overall Study|Adverse Event|10|||
17024482|NCT00768300|38168815|FG001|Overall Study|Adverse Event|2|||
16935294|NCT01186744|38079964|FG003|Overall Study|Study terminated by Sponsor|0|||
16935295|NCT01186744|38079965|FG004|Overall Study|Study terminated by Sponsor|0|||
16935296|NCT01186744|38079966|FG005|Overall Study|Study terminated by Sponsor|0|||
16935297|NCT01186744|38079961|FG000|Overall Study|Other|9|||
16935298|NCT01186744|38079962|FG001|Overall Study|Other|10|||
16935299|NCT01186744|38079963|FG002|Overall Study|Other|1|||
16935300|NCT01186744|38079964|FG003|Overall Study|Other|2|||
16935301|NCT01186744|38079965|FG004|Overall Study|Other|1|||
16935302|NCT01186744|38079966|FG005|Overall Study|Other|5|||
16935303|NCT01186744|38079961|FG000|Overall Study|Adverse Event|10|||
16935304|NCT01186744|38079962|FG001|Overall Study|Adverse Event|14|||
16935305|NCT01186744|38079963|FG002|Overall Study|Adverse Event|1|||
16935306|NCT01186744|38079964|FG003|Overall Study|Adverse Event|0|||
17024483|NCT00768300|38168814|FG000|Overall Study|Protocol Violation|6|||
17024484|NCT00768300|38168815|FG001|Overall Study|Protocol Violation|1|||
17024485|NCT00768300|38168814|FG000|Overall Study|Withdrawal by Subject|13|||
17024486|NCT00768300|38168815|FG001|Overall Study|Withdrawal by Subject|7|||
17024487|NCT00768300|38168814|FG000|Overall Study|Physician Decision|2|||
17024488|NCT00768300|38168815|FG001|Overall Study|Physician Decision|3|||
16935307|NCT01186744|38079965|FG004|Overall Study|Adverse Event|1|||
16935308|NCT01186744|38079966|FG005|Overall Study|Adverse Event|4|||
16935309|NCT01186744|38079961|FG000|Overall Study|Death|1|||
17024489|NCT00768300|38168814|FG000|Overall Study|Study discontinued by Sponsor|271|||
17024490|NCT00768300|38168815|FG001|Overall Study|Study discontinued by Sponsor|140|||
17024491|NCT00768300|38168814|FG000|Overall Study|Death|21|||
17024492|NCT00768300|38168815|FG001|Overall Study|Death|5|||
17024493|NCT00768300|38168814|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
17024494|NCT00768300|38168815|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
17024495|NCT00768300|38168814|FG000|Overall Study|Screen failure following randomization|1|||
17024496|NCT00768300|38168815|FG001|Overall Study|Screen failure following randomization|0|||
17024497|NCT00768300|38168814|FG000|Overall Study|Received lung transplant|1|||
17024498|NCT00768300|38168815|FG001|Overall Study|Received lung transplant|1|||
17024499|NCT00768300|38168814|FG000|Overall Study|Lost to Follow-up|0|||
17024500|NCT00768300|38168815|FG001|Overall Study|Lost to Follow-up|1|||
17024501|NCT00768300|38168814|FG000|Overall Study|Began prohibited concomitant medication|0|||
17024502|NCT00768300|38168815|FG001|Overall Study|Began prohibited concomitant medication|1|||
17024503|NCT00768300|38168814|FG000|Overall Study|Treated but never dosed with Study drug|1|||
17024504|NCT00768300|38168815|FG001|Overall Study|Treated but never dosed with Study drug|0|||
17024505|NCT00768300|38168814|FG000|Overall Study|Missing data|1|||
17024506|NCT00768300|38168815|FG001|Overall Study|Missing data|0|||
17024507|NCT00768222|38168823|FG000|Overall Study|Lost to Follow-up|1|||
17024508|NCT00768222|38168824|FG001|Overall Study|Lost to Follow-up|1|||
17024509|NCT00768222|38168823|FG000|Overall Study|Withdrawal by Subject|3|||
17024510|NCT00768222|38168824|FG001|Overall Study|Withdrawal by Subject|1|||
17024511|NCT00768222|38168823|FG000|Overall Study|Protocol Violation|0|||
17024512|NCT00768222|38168824|FG001|Overall Study|Protocol Violation|2|||
17024513|NCT00768144|38168830|FG000|Overall Study|Adverse Event|13|||
17024514|NCT00768144|38168830|FG000|Overall Study|Progressive Disease|21|||
17024515|NCT00768144|38168830|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
17024516|NCT00768144|38168830|FG000|Overall Study|Pt Withdrew Consent|1|||
17024517|NCT00784836|38168834|FG000|Overall Study|Early Study Termination|3|||
17024518|NCT00784758|38168840|FG000|Overall Study|Withdrawal by Subject|3|||
17024519|NCT00784758|38168841|FG001|Overall Study|Withdrawal by Subject|0|||
17024520|NCT00784758|38168840|FG000|Overall Study|Adverse Event|1|||
17024521|NCT00784758|38168841|FG001|Overall Study|Adverse Event|0|||
17024522|NCT00768066|38168852|FG000|Overall Study|Did not receive study product injection.|3|||
17024523|NCT00768066|38168853|FG001|Overall Study|Did not receive study product injection.|3|||
17024524|NCT00768066|38168854|FG002|Overall Study|Did not receive study product injection.|0|||
17024525|NCT00767676|38168862|FG000|Overall Study|Investigator error|54|||
17024526|NCT00767520|38168868|FG000|Overall Study|Participants still on treatment|11|||
17024527|NCT00767520|38168869|FG001|Overall Study|Participants still on treatment|15|||
17024528|NCT00767520|38168868|FG000|Overall Study|Randomized in error and Never treated|0|||
17024529|NCT00767520|38168869|FG001|Overall Study|Randomized in error and Never treated|2|||
17024530|NCT00838565|38168881|FG000|Overall Study|Withdrawal by Subject|0|||
17024531|NCT00838565|38168882|FG001|Overall Study|Withdrawal by Subject|0|||
17024532|NCT00838565|38168883|FG002|Overall Study|Withdrawal by Subject|1|||
17024533|NCT00838565|38168884|FG003|Overall Study|Withdrawal by Subject|0|||
17024534|NCT00838565|38168885|FG004|Overall Study|Withdrawal by Subject|0|||
17024535|NCT00838565|38168886|FG005|Overall Study|Withdrawal by Subject|2|||
17024536|NCT00838565|38168881|FG000|Overall Study|Other|0|||
17024537|NCT00838565|38168882|FG001|Overall Study|Other|2|||
17024538|NCT00838565|38168883|FG002|Overall Study|Other|0|||
17024539|NCT00838565|38168884|FG003|Overall Study|Other|0|||
17024540|NCT00838565|38168885|FG004|Overall Study|Other|0|||
17024541|NCT00838565|38168886|FG005|Overall Study|Other|0|||
17024542|NCT00838565|38168881|FG000|Overall Study|Randomized but not Treated|0|||
17024543|NCT00838565|38168882|FG001|Overall Study|Randomized but not Treated|1|||
17024544|NCT00838565|38168883|FG002|Overall Study|Randomized but not Treated|0|||
17024545|NCT00838565|38168884|FG003|Overall Study|Randomized but not Treated|0|||
17024546|NCT00838565|38168885|FG004|Overall Study|Randomized but not Treated|0|||
17024547|NCT00838565|38168886|FG005|Overall Study|Randomized but not Treated|0|||
16935310|NCT01186744|38079962|FG001|Overall Study|Death|0|||
16935311|NCT01186744|38079963|FG002|Overall Study|Death|0|||
16935312|NCT01186744|38079964|FG003|Overall Study|Death|0|||
16935313|NCT01186744|38079965|FG004|Overall Study|Death|0|||
16935314|NCT01186744|38079966|FG005|Overall Study|Death|0|||
16935315|NCT01185964|38080004|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
16935316|NCT01185964|38080005|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
16935317|NCT01185964|38080006|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
16935318|NCT01185964|38080007|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
17024548|NCT00858845|38168907|FG000|Overall Study|Patient underwent heart transplant.|0|||
17024549|NCT00858845|38168908|FG001|Overall Study|Patient underwent heart transplant.|1|||
17024550|NCT00770562|38168916|FG000|Overall Study|Did not take treatment|1|||
17024551|NCT00770562|38168917|FG001|Overall Study|Did not take treatment|1|||
17024552|NCT00836693|38168926|FG000|Overall Study|Adverse Event|4|||
17024553|NCT00836693|38168927|FG001|Overall Study|Adverse Event|1|||
17024554|NCT00836693|38168926|FG000|Overall Study|Sponsor Decision|0|||
17024555|NCT00836693|38168927|FG001|Overall Study|Sponsor Decision|1|||
17024556|NCT00836693|38168926|FG000|Overall Study|Physician Decision|2|||
17024557|NCT00836693|38168927|FG001|Overall Study|Physician Decision|0|||
17024558|NCT00836693|38168926|FG000|Overall Study|Withdrawal by Subject|9|||
17024559|NCT00836693|38168927|FG001|Overall Study|Withdrawal by Subject|4|||
17024560|NCT00836693|38168926|FG000|Overall Study|Protocol Violation|1|||
17024561|NCT00836693|38168927|FG001|Overall Study|Protocol Violation|0|||
16935319|NCT01185964|38080004|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
16935320|NCT01185964|38080005|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
16935321|NCT01185964|38080006|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
16935322|NCT01185964|38080007|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
16935323|NCT01185964|38080004|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
16935324|NCT01185964|38080005|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
17024562|NCT00836693|38168926|FG000|Overall Study|Lost to Follow-up|1|||
17024563|NCT00836693|38168927|FG001|Overall Study|Lost to Follow-up|0|||
17024564|NCT00770484|38168935|FG000|Overall Study|Withdrawal by Subject|1|||
17024565|NCT00770484|38168936|FG001|Overall Study|Withdrawal by Subject|0|||
17024566|NCT00835679|38168946|FG000|Overall Study|Withdrawal by Subject|1|||
17024567|NCT00835679|38168947|FG001|Overall Study|Withdrawal by Subject|0|||
17024568|NCT00835679|38168948|FG002|Overall Study|Withdrawal by Subject|0|||
17024569|NCT00835679|38168949|FG003|Overall Study|Withdrawal by Subject|0|||
17024570|NCT00766506|38168965|FG000|Overall Study|Use rescue medication after 3 hours|3|||
17024571|NCT00766506|38168966|FG001|Overall Study|Use rescue medication after 3 hours|0|||
17024572|NCT00766506|38168965|FG000|Overall Study|Other|2|||
17024573|NCT00766506|38168966|FG001|Overall Study|Other|2|||
17024574|NCT00770328|38168974|FG000|Overall Study|Adverse Event|11|||
17024575|NCT00770328|38168975|FG001|Overall Study|Adverse Event|2|||
17024576|NCT00770328|38168974|FG000|Overall Study|Lost to Follow-up|2|||
17024577|NCT00770328|38168975|FG001|Overall Study|Lost to Follow-up|2|||
17024578|NCT00766038|38168983|FG000|Overall Study|Lost to Follow-up|15|||
17024579|NCT00766038|38168984|FG001|Overall Study|Lost to Follow-up|14|||
17024580|NCT00765882|38168995|FG000|Overall Study|Adverse Event|10|||
17024581|NCT00765882|38168996|FG001|Overall Study|Adverse Event|21|||
17024582|NCT00765882|38168997|FG002|Overall Study|Adverse Event|20|||
17024583|NCT00765882|38168995|FG000|Overall Study|Lack of Efficacy|4|||
16935325|NCT01185964|38080006|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
16935326|NCT01185964|38080007|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
16935327|NCT01185964|38080004|FG000|Phase 1b and Phase 2|Adverse Event|1|||
16935328|NCT01185964|38080005|FG001|Phase 1b and Phase 2|Adverse Event|0|||
16935329|NCT01185964|38080006|FG002|Phase 1b and Phase 2|Adverse Event|2|||
16935330|NCT01185964|38080007|FG003|Phase 1b and Phase 2|Adverse Event|0|||
16935331|NCT01185964|38080004|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
16935332|NCT01185964|38080005|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
16935333|NCT01185964|38080006|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
16935334|NCT01185964|38080007|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
16935335|NCT01185964|38080004|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
16935336|NCT01185964|38080005|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
16935337|NCT01185964|38080006|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
16935338|NCT01185964|38080007|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
16935339|NCT01185964|38080004|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
17024584|NCT00765882|38168996|FG001|Overall Study|Lack of Efficacy|0|||
17024585|NCT00765882|38168997|FG002|Overall Study|Lack of Efficacy|1|||
17024586|NCT00765882|38168995|FG000|Overall Study|Protocol Violation|4|||
17024587|NCT00765882|38168996|FG001|Overall Study|Protocol Violation|3|||
17024588|NCT00765882|38168997|FG002|Overall Study|Protocol Violation|1|||
17024589|NCT00765882|38168995|FG000|Overall Study|Withdrawal by Subject|2|||
17024590|NCT00765882|38168996|FG001|Overall Study|Withdrawal by Subject|6|||
17024591|NCT00765882|38168997|FG002|Overall Study|Withdrawal by Subject|6|||
17024592|NCT00765882|38168995|FG000|Overall Study|Lost to Follow-up|1|||
17024593|NCT00765882|38168996|FG001|Overall Study|Lost to Follow-up|9|||
17024594|NCT00765882|38168997|FG002|Overall Study|Lost to Follow-up|6|||
17024595|NCT00765882|38168995|FG000|Overall Study|Other Reason|3|||
17103163|NCT00112437|38241443|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103164|NCT00112437|38241444|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103165|NCT00112437|38241445|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103166|NCT00112437|38241446|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103167|NCT00112437|38241447|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103168|NCT00112437|38241448|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103169|NCT00112437|38241449|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103170|NCT00112437|38241450|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103171|NCT00112437|38241451|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103172|NCT00112437|38241452|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17024596|NCT00765882|38168996|FG001|Overall Study|Other Reason|1|||
17024597|NCT00765882|38168997|FG002|Overall Study|Other Reason|2|||
17024598|NCT00769860|38169007|FG000|Overall Study|Withdrawal by Subject|2|||
17024599|NCT00769860|38169008|FG001|Overall Study|Withdrawal by Subject|0|||
17024600|NCT00858143|38169014|FG000|Overall Study|Adverse Event|16|||
17024601|NCT00858143|38169014|FG000|Overall Study|Lack of Efficacy|4|||
17024602|NCT00858143|38169014|FG000|Overall Study|Death|7|||
17024603|NCT00858143|38169014|FG000|Overall Study|Other|23|||
17024604|NCT00828113|38169020|FG000|Overall Study|Withdrawal by Subject|27|||
17024605|NCT00828113|38169021|FG001|Overall Study|Withdrawal by Subject|26|||
17024606|NCT00828113|38169020|FG000|Overall Study|Lost to Follow-up|3|||
17024607|NCT00828113|38169021|FG001|Overall Study|Lost to Follow-up|5|||
17024608|NCT00769704|38169029|FG000|Overall Study|Lost to Follow-up|3|||
17024609|NCT00769704|38169030|FG001|Overall Study|Lost to Follow-up|2|||
17024610|NCT00769704|38169029|FG000|Overall Study|Death|95|||
17024611|NCT00769704|38169030|FG001|Overall Study|Death|190|||
17024612|NCT00769704|38169029|FG000|Overall Study|Withdrawal by Subject|12|||
16935340|NCT01185964|38080005|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
16935341|NCT01185964|38080006|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
16935342|NCT01185964|38080007|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
16935343|NCT01185964|38080004|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
16935344|NCT01185964|38080005|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
16935345|NCT01185964|38080006|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
16935346|NCT01185964|38080007|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
16935347|NCT01217476|38080025|FG000|Overall Study|Adverse Event|6|||
16935348|NCT01217476|38080026|FG001|Overall Study|Adverse Event|1|||
16935349|NCT01217476|38080025|FG000|Overall Study|Physician Decision|0|||
16935350|NCT01217476|38080026|FG001|Overall Study|Physician Decision|1|||
16935351|NCT01217476|38080025|FG000|Overall Study|Withdrawal by Subject|3|||
16935352|NCT01217476|38080026|FG001|Overall Study|Withdrawal by Subject|3|||
16935353|NCT01217476|38080025|FG000|Overall Study|Surgery on the Target Limb|0|||
16935354|NCT01217476|38080026|FG001|Overall Study|Surgery on the Target Limb|2|||
16935355|NCT01217476|38080025|FG000|Overall Study|Protocol Deviation|1|||
16935356|NCT01217476|38080026|FG001|Overall Study|Protocol Deviation|0|||
16935357|NCT01217476|38080025|FG000|Overall Study|Other|2|||
16935358|NCT01217476|38080026|FG001|Overall Study|Other|0|||
16935359|NCT01217437|38080047|FG000|Overall Study|Adverse Event|0|||
16935360|NCT01217437|38080048|FG001|Overall Study|Adverse Event|8|||
16935361|NCT01217437|38080047|FG000|Overall Study|Death|5|||
16935362|NCT01217437|38080048|FG001|Overall Study|Death|0|||
16935363|NCT01217437|38080047|FG000|Overall Study|Lack of Efficacy|29|||
16935364|NCT01217437|38080048|FG001|Overall Study|Lack of Efficacy|25|||
16935365|NCT01217437|38080047|FG000|Overall Study|Physician Decision|8|||
17024613|NCT00769704|38169030|FG001|Overall Study|Withdrawal by Subject|5|||
17024614|NCT00769704|38169029|FG000|Overall Study|Other|1|||
16935366|NCT01217437|38080048|FG001|Overall Study|Physician Decision|5|||
16935367|NCT01217437|38080047|FG000|Overall Study|Withdrawal by Subject|0|||
16935368|NCT01217437|38080048|FG001|Overall Study|Withdrawal by Subject|2|||
16935369|NCT01217437|38080047|FG000|Overall Study|Ineligible|1|||
16935370|NCT01217437|38080048|FG001|Overall Study|Ineligible|1|||
16935371|NCT01217047|38080058|FG000|Overall Study|Lost to Follow-up|0|||
16935372|NCT01217047|38080059|FG001|Overall Study|Lost to Follow-up|1|||
16935373|NCT01217047|38080060|FG002|Overall Study|Lost to Follow-up|0|||
16935374|NCT01185340|38080072|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
16935375|NCT01185340|38080073|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16935376|NCT01185340|38080074|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16935377|NCT01185340|38080075|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16935378|NCT01185340|38080072|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
16935379|NCT01185340|38080073|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16935380|NCT01185340|38080074|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
17103173|NCT00112437|38241453|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103174|NCT00112437|38241454|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16935381|NCT01185340|38080075|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16935382|NCT01185340|38080072|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
16935383|NCT01185340|38080073|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16935384|NCT01185340|38080074|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16935385|NCT01185340|38080075|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16935386|NCT01185340|38080072|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
16935387|NCT01185340|38080073|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16935388|NCT01185340|38080074|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16935389|NCT01185340|38080075|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16935390|NCT01185340|38080072|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
16935391|NCT01185340|38080073|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
17024615|NCT00769704|38169030|FG001|Overall Study|Other|2|||
17024616|NCT00818753|38169040|FG000|Overall Study|Protocol Violation|1|||
17198682|NCT02706405|38352370|FG003|Overall Study|Death|1|||
16935392|NCT01185340|38080074|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16935393|NCT01185340|38080075|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16935394|NCT01185340|38080072|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
16935395|NCT01185340|38080073|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16935396|NCT01185340|38080074|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16935397|NCT01185340|38080075|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16935398|NCT01185340|38080072|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
16935399|NCT01185340|38080073|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16935400|NCT01185340|38080074|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16935401|NCT01185340|38080075|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16935402|NCT01185340|38080072|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
16935403|NCT01185340|38080073|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
16935404|NCT01185340|38080074|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
16935405|NCT01185340|38080075|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
16935406|NCT01185340|38080072|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
16935407|NCT01185340|38080073|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
16935408|NCT01185340|38080074|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
17024617|NCT00818753|38169041|FG001|Overall Study|Protocol Violation|0|||
17024618|NCT00818753|38169042|FG002|Overall Study|Protocol Violation|0|||
17024619|NCT00818753|38169040|FG000|Overall Study|Other reason (not specified)|0|||
17024620|NCT00818753|38169041|FG001|Overall Study|Other reason (not specified)|0|||
17024621|NCT00818753|38169042|FG002|Overall Study|Other reason (not specified)|1|||
17024622|NCT00818753|38169040|FG000|Overall Study|Randomised and not treated|2|||
17024623|NCT00818753|38169041|FG001|Overall Study|Randomised and not treated|0|||
17024624|NCT00818753|38169042|FG002|Overall Study|Randomised and not treated|0|||
17024625|NCT00765726|38169050|FG000|Overall Study|Withdrawal by Subject|1|||
17024626|NCT00765726|38169050|FG000|Overall Study|Discontinuation of study by sponsor|8|||
17024627|NCT00765336|38169056|FG000|Overall Study|Protocol Violation|4|||
17024628|NCT00765336|38169057|FG001|Overall Study|Protocol Violation|2|||
17024629|NCT00765336|38169056|FG000|Overall Study|Withdrawal by Subject|6|||
17024630|NCT00765336|38169057|FG001|Overall Study|Withdrawal by Subject|4|||
17024631|NCT00765336|38169056|FG000|Overall Study|Lost to Follow-up|7|||
17024632|NCT00765336|38169057|FG001|Overall Study|Lost to Follow-up|9|||
17024633|NCT00765336|38169056|FG000|Overall Study|Adverse Event|2|||
17024634|NCT00765336|38169057|FG001|Overall Study|Adverse Event|1|||
17024635|NCT00818519|38169065|FG000|Overall Study|Adverse Event|2|||
17024636|NCT00818519|38169066|FG001|Overall Study|Adverse Event|2|||
17024637|NCT00818519|38169065|FG000|Overall Study|Lost to Follow-up|4|||
17024638|NCT00818519|38169066|FG001|Overall Study|Lost to Follow-up|6|||
17024639|NCT00818519|38169065|FG000|Overall Study|Protocol Violation|2|||
17024640|NCT00818519|38169066|FG001|Overall Study|Protocol Violation|1|||
17024641|NCT00818519|38169065|FG000|Overall Study|Pregnancy|0|||
17024642|NCT00818519|38169066|FG001|Overall Study|Pregnancy|1|||
17024643|NCT00818519|38169065|FG000|Overall Study|Withdrawal by Subject|4|||
17024644|NCT00818519|38169066|FG001|Overall Study|Withdrawal by Subject|9|||
17024645|NCT00818519|38169065|FG000|Overall Study|participant recovered completely|1|||
17024646|NCT00818519|38169066|FG001|Overall Study|participant recovered completely|0|||
17024647|NCT00818519|38169065|FG000|Overall Study|participant will leave for long tme|1|||
17024648|NCT00818519|38169066|FG001|Overall Study|participant will leave for long tme|0|||
17024649|NCT00827567|38169072|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
17024650|NCT00765102|38169076|FG000|Overall Study|Progressive disease|18|||
17024651|NCT00765102|38169076|FG000|Overall Study|Adverse Event|6|||
17024652|NCT00765102|38169076|FG000|Overall Study|Physician Decision|4|||
16935409|NCT01185340|38080075|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
16935410|NCT01185340|38080072|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
16935411|NCT01185340|38080073|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
16935412|NCT01185340|38080074|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
16935413|NCT01185340|38080075|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
16935414|NCT01185340|38080072|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16935415|NCT01185340|38080073|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
16935416|NCT01185340|38080074|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16935417|NCT01185340|38080075|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
16935418|NCT01185340|38080072|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
16935419|NCT01185340|38080073|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16935420|NCT01185340|38080074|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
16935421|NCT01185340|38080075|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16935422|NCT01185340|38080072|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
16935423|NCT01185340|38080073|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
17024653|NCT00765102|38169076|FG000|Overall Study|Withdrawal by Subject|2|||
17024654|NCT00765102|38169076|FG000|Overall Study|Protocol Violation|1|||
17024655|NCT00809354|38169092|FG000|Overall Study|Adverse Event|32|||
17024656|NCT00809354|38169093|FG001|Overall Study|Adverse Event|45|||
17024657|NCT00809354|38169094|FG002|Overall Study|Adverse Event|37|||
17024658|NCT00809354|38169095|FG003|Overall Study|Adverse Event|53|||
17024659|NCT00809354|38169096|FG004|Overall Study|Adverse Event|26|||
17024660|NCT00809354|38169097|FG005|Overall Study|Adverse Event|33|||
17024661|NCT00809354|38169098|FG006|Overall Study|Adverse Event|44|||
17024662|NCT00809354|38169099|FG007|Overall Study|Adverse Event|40|||
17103175|NCT00112437|38241455|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103176|NCT00112437|38241456|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103177|NCT00112437|38241457|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103178|NCT00112437|38241458|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103179|NCT00112437|38241459|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103180|NCT00112437|38241460|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103181|NCT00112437|38241461|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103182|NCT00112437|38241462|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
17103183|NCT00112437|38241463|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103184|NCT00112437|38241464|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103185|NCT00112437|38241465|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103186|NCT00112437|38241466|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
17103187|NCT00112437|38241441|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103188|NCT00112437|38241442|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103189|NCT00112437|38241443|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103190|NCT00112437|38241444|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103191|NCT00112437|38241445|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103192|NCT00112437|38241446|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103193|NCT00112437|38241447|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103194|NCT00112437|38241448|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103195|NCT00112437|38241449|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103196|NCT00112437|38241450|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103197|NCT00112437|38241451|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103198|NCT00112437|38241452|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103199|NCT00112437|38241453|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103200|NCT00112437|38241454|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103201|NCT00112437|38241455|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103202|NCT00112437|38241456|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103203|NCT00112437|38241457|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103204|NCT00112437|38241458|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103205|NCT00112437|38241459|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103206|NCT00112437|38241460|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103207|NCT00112437|38241461|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103208|NCT00112437|38241462|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
17103209|NCT00112437|38241463|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103210|NCT00112437|38241464|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103211|NCT00112437|38241465|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103212|NCT00112437|38241466|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
17103213|NCT00112437|38241441|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103214|NCT00112437|38241442|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103215|NCT00112437|38241443|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103216|NCT00112437|38241444|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103217|NCT00112437|38241445|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103218|NCT00112437|38241446|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103219|NCT00112437|38241447|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103220|NCT00112437|38241448|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103221|NCT00112437|38241449|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103222|NCT00112437|38241450|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103223|NCT00112437|38241451|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103224|NCT00112437|38241452|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103225|NCT00112437|38241453|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103226|NCT00112437|38241454|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103227|NCT00112437|38241455|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103228|NCT00112437|38241456|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17024663|NCT00809354|38169100|FG008|Overall Study|Adverse Event|46|||
17024664|NCT00809354|38169101|FG009|Overall Study|Adverse Event|26|||
17024665|NCT00809354|38169092|FG000|Overall Study|Lack of Efficacy|23|||
17024666|NCT00809354|38169093|FG001|Overall Study|Lack of Efficacy|23|||
17024667|NCT00809354|38169094|FG002|Overall Study|Lack of Efficacy|22|||
17024668|NCT00809354|38169095|FG003|Overall Study|Lack of Efficacy|15|||
17024669|NCT00809354|38169096|FG004|Overall Study|Lack of Efficacy|40|||
17024670|NCT00809354|38169097|FG005|Overall Study|Lack of Efficacy|19|||
17024671|NCT00809354|38169098|FG006|Overall Study|Lack of Efficacy|21|||
17024672|NCT00809354|38169099|FG007|Overall Study|Lack of Efficacy|15|||
17024673|NCT00809354|38169100|FG008|Overall Study|Lack of Efficacy|18|||
17024674|NCT00809354|38169101|FG009|Overall Study|Lack of Efficacy|38|||
17024675|NCT00809354|38169092|FG000|Overall Study|Lost to Follow-up|10|||
17024676|NCT00809354|38169093|FG001|Overall Study|Lost to Follow-up|11|||
17024677|NCT00809354|38169094|FG002|Overall Study|Lost to Follow-up|8|||
17024678|NCT00809354|38169095|FG003|Overall Study|Lost to Follow-up|13|||
17024679|NCT00809354|38169096|FG004|Overall Study|Lost to Follow-up|6|||
17024680|NCT00809354|38169097|FG005|Overall Study|Lost to Follow-up|2|||
17024681|NCT00809354|38169098|FG006|Overall Study|Lost to Follow-up|0|||
17024682|NCT00809354|38169099|FG007|Overall Study|Lost to Follow-up|5|||
17024683|NCT00809354|38169100|FG008|Overall Study|Lost to Follow-up|4|||
17024684|NCT00809354|38169101|FG009|Overall Study|Lost to Follow-up|0|||
17024685|NCT00809354|38169092|FG000|Overall Study|Protocol Violation|7|||
17024686|NCT00809354|38169093|FG001|Overall Study|Protocol Violation|14|||
17024687|NCT00809354|38169094|FG002|Overall Study|Protocol Violation|14|||
17024688|NCT00809354|38169095|FG003|Overall Study|Protocol Violation|12|||
17024689|NCT00809354|38169096|FG004|Overall Study|Protocol Violation|14|||
17024690|NCT00809354|38169097|FG005|Overall Study|Protocol Violation|6|||
17024691|NCT00809354|38169098|FG006|Overall Study|Protocol Violation|4|||
17024692|NCT00809354|38169099|FG007|Overall Study|Protocol Violation|6|||
17024693|NCT00809354|38169100|FG008|Overall Study|Protocol Violation|9|||
17024694|NCT00809354|38169101|FG009|Overall Study|Protocol Violation|3|||
17024695|NCT00809354|38169092|FG000|Overall Study|Withdrawal by Subject|32|||
17024696|NCT00809354|38169093|FG001|Overall Study|Withdrawal by Subject|27|||
17024697|NCT00809354|38169094|FG002|Overall Study|Withdrawal by Subject|31|||
17024698|NCT00809354|38169095|FG003|Overall Study|Withdrawal by Subject|33|||
17024699|NCT00809354|38169096|FG004|Overall Study|Withdrawal by Subject|34|||
17024700|NCT00809354|38169097|FG005|Overall Study|Withdrawal by Subject|29|||
17024701|NCT00809354|38169098|FG006|Overall Study|Withdrawal by Subject|27|||
17024702|NCT00809354|38169099|FG007|Overall Study|Withdrawal by Subject|19|||
17024703|NCT00809354|38169100|FG008|Overall Study|Withdrawal by Subject|18|||
17024704|NCT00809354|38169101|FG009|Overall Study|Withdrawal by Subject|20|||
17024705|NCT00809354|38169092|FG000|Overall Study|Other|10|||
17024706|NCT00809354|38169093|FG001|Overall Study|Other|2|||
17024707|NCT00809354|38169094|FG002|Overall Study|Other|7|||
17024708|NCT00809354|38169095|FG003|Overall Study|Other|10|||
17024709|NCT00809354|38169096|FG004|Overall Study|Other|5|||
17024710|NCT00809354|38169097|FG005|Overall Study|Other|3|||
17024711|NCT00809354|38169098|FG006|Overall Study|Other|2|||
17024712|NCT00809354|38169099|FG007|Overall Study|Other|3|||
17024713|NCT00809354|38169100|FG008|Overall Study|Other|4|||
17024714|NCT00809354|38169101|FG009|Overall Study|Other|3|||
17024715|NCT00809354|38169092|FG000|Overall Study|Study terminated by sponsor|138|||
17024716|NCT00809354|38169093|FG001|Overall Study|Study terminated by sponsor|134|||
17024717|NCT00809354|38169094|FG002|Overall Study|Study terminated by sponsor|129|||
17024718|NCT00809354|38169095|FG003|Overall Study|Study terminated by sponsor|120|||
17024719|NCT00809354|38169096|FG004|Overall Study|Study terminated by sponsor|126|||
17024720|NCT00809354|38169097|FG005|Overall Study|Study terminated by sponsor|133|||
17024721|NCT00809354|38169098|FG006|Overall Study|Study terminated by sponsor|124|||
17024722|NCT00809354|38169099|FG007|Overall Study|Study terminated by sponsor|148|||
17024723|NCT00809354|38169100|FG008|Overall Study|Study terminated by sponsor|127|||
17024724|NCT00809354|38169101|FG009|Overall Study|Study terminated by sponsor|135|||
17024725|NCT00809354|38169092|FG000|Overall Study|Withdrawn due to pregnancy|0|||
17024726|NCT00809354|38169093|FG001|Overall Study|Withdrawn due to pregnancy|1|||
17024727|NCT00809354|38169094|FG002|Overall Study|Withdrawn due to pregnancy|0|||
17024728|NCT00809354|38169095|FG003|Overall Study|Withdrawn due to pregnancy|0|||
17024729|NCT00809354|38169096|FG004|Overall Study|Withdrawn due to pregnancy|0|||
17024730|NCT00809354|38169097|FG005|Overall Study|Withdrawn due to pregnancy|0|||
17024731|NCT00809354|38169098|FG006|Overall Study|Withdrawn due to pregnancy|0|||
17024732|NCT00809354|38169099|FG007|Overall Study|Withdrawn due to pregnancy|0|||
17024733|NCT00809354|38169100|FG008|Overall Study|Withdrawn due to pregnancy|0|||
17024734|NCT00809354|38169101|FG009|Overall Study|Withdrawn due to pregnancy|0|||
17024735|NCT00809354|38169092|FG000|Overall Study|Randomized but not Treated|3|||
17024736|NCT00809354|38169093|FG001|Overall Study|Randomized but not Treated|1|||
16935424|NCT01185340|38080074|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
16935425|NCT01185340|38080075|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
17024737|NCT00809354|38169094|FG002|Overall Study|Randomized but not Treated|6|||
17024738|NCT00809354|38169095|FG003|Overall Study|Randomized but not Treated|0|||
17198683|NCT02706405|38352371|FG004|Overall Study|Death|0|||
16935426|NCT01185340|38080072|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16935427|NCT01185340|38080073|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16935428|NCT01185340|38080074|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
16935429|NCT01185340|38080075|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
16935430|NCT01216189|38080089|FG000|Overall Study|Lost to Follow-up|21|||
16935431|NCT01216189|38080090|FG001|Overall Study|Lost to Follow-up|3|||
16935432|NCT01216189|38080089|FG000|Overall Study|Death|4|||
16935433|NCT01216189|38080090|FG001|Overall Study|Death|2|||
17024739|NCT00809354|38169096|FG004|Overall Study|Randomized but not Treated|5|||
17024740|NCT00809354|38169097|FG005|Overall Study|Randomized but not Treated|0|||
17024741|NCT00809354|38169098|FG006|Overall Study|Randomized but not Treated|1|||
17024742|NCT00809354|38169099|FG007|Overall Study|Randomized but not Treated|1|||
17024743|NCT00809354|38169100|FG008|Overall Study|Randomized but not Treated|2|||
17024744|NCT00809354|38169101|FG009|Overall Study|Randomized but not Treated|1|||
17024745|NCT00809354|38169092|FG000|Overall Study|Death|0|||
17024746|NCT00809354|38169093|FG001|Overall Study|Death|0|||
17024747|NCT00809354|38169094|FG002|Overall Study|Death|0|||
17024748|NCT00809354|38169095|FG003|Overall Study|Death|0|||
17024749|NCT00809354|38169096|FG004|Overall Study|Death|0|||
17024750|NCT00809354|38169097|FG005|Overall Study|Death|0|||
17024751|NCT00809354|38169098|FG006|Overall Study|Death|0|||
17024752|NCT00809354|38169099|FG007|Overall Study|Death|1|||
17024753|NCT00809354|38169100|FG008|Overall Study|Death|0|||
17024754|NCT00809354|38169101|FG009|Overall Study|Death|0|||
17024755|NCT00834899|38169130|FG000|Overall Study|Withdrawal by Subject|1|||
17024756|NCT00834899|38169131|FG001|Overall Study|Withdrawal by Subject|1|||
17024757|NCT00764946|38169140|FG000|Overall Study|Lack of Efficacy|1|||
17024758|NCT00764946|38169141|FG001|Overall Study|Lack of Efficacy|0|||
17024759|NCT00764946|38169142|FG002|Overall Study|Lack of Efficacy|0|||
17024760|NCT00764946|38169140|FG000|Overall Study|Lost to Follow-up|3|||
17024761|NCT00764946|38169141|FG001|Overall Study|Lost to Follow-up|4|||
17024762|NCT00764946|38169142|FG002|Overall Study|Lost to Follow-up|0|||
17024763|NCT00764946|38169140|FG000|Overall Study|Physician Decision|2|||
17024764|NCT00764946|38169141|FG001|Overall Study|Physician Decision|4|||
17024765|NCT00764946|38169142|FG002|Overall Study|Physician Decision|0|||
17024766|NCT00764946|38169140|FG000|Overall Study|Adverse Event|3|||
17024767|NCT00764946|38169141|FG001|Overall Study|Adverse Event|2|||
17024768|NCT00764946|38169142|FG002|Overall Study|Adverse Event|1|||
16935434|NCT01185301|38080100|FG000|Overall Study|Adverse Event|3|||
16935435|NCT01185301|38080101|FG001|Overall Study|Adverse Event|0|||
16935436|NCT01185301|38080102|FG002|Overall Study|Adverse Event|2|||
16935437|NCT01185301|38080103|FG003|Overall Study|Adverse Event|3|||
16935438|NCT01185301|38080100|FG000|Overall Study|Withdrawal by Subject|7|||
16935439|NCT01185301|38080101|FG001|Overall Study|Withdrawal by Subject|5|||
16935440|NCT01185301|38080102|FG002|Overall Study|Withdrawal by Subject|2|||
16935441|NCT01185301|38080103|FG003|Overall Study|Withdrawal by Subject|3|||
16935442|NCT01185301|38080100|FG000|Overall Study|Lost to Follow-up|2|||
16935443|NCT01185301|38080101|FG001|Overall Study|Lost to Follow-up|0|||
16935444|NCT01185301|38080102|FG002|Overall Study|Lost to Follow-up|0|||
16935445|NCT01185301|38080103|FG003|Overall Study|Lost to Follow-up|1|||
16935446|NCT01185301|38080100|FG000|Overall Study|Other Reason|3|||
16935447|NCT01185301|38080101|FG001|Overall Study|Other Reason|2|||
16935448|NCT01185301|38080102|FG002|Overall Study|Other Reason|2|||
16935449|NCT01185301|38080103|FG003|Overall Study|Other Reason|2|||
16935450|NCT01216072|38080115|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
16935451|NCT01216072|38080116|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
16935452|NCT01216072|38080115|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
16935453|NCT01216072|38080116|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
16935454|NCT01216072|38080115|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
16935455|NCT01216072|38080116|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
16935456|NCT01216072|38080115|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
16935457|NCT01216072|38080116|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
16935458|NCT01216072|38080115|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
16935459|NCT01216072|38080116|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
16935460|NCT01216072|38080115|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
16935461|NCT01216072|38080116|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
16935462|NCT01216072|38080115|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
16935463|NCT01216072|38080116|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
16935464|NCT01216072|38080115|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
16935465|NCT01216072|38080116|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
16935466|NCT01216072|38080115|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
16935467|NCT01216072|38080116|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
16935468|NCT01216072|38080115|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
16935469|NCT01216072|38080116|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
16935470|NCT01184989|38080125|FG000|Overall Study|Adverse Event|11|||
16935471|NCT01184989|38080125|FG000|Overall Study|Withdrawal by Subject|1|||
16935472|NCT01215955|38080133|FG000|Overall Study|Adverse Event|1|||
16935473|NCT01215955|38080134|FG001|Overall Study|Adverse Event|4|||
16935474|NCT01215955|38080135|FG002|Overall Study|Adverse Event|2|||
16935475|NCT01215955|38080136|FG003|Overall Study|Adverse Event|3|||
16935476|NCT01215955|38080133|FG000|Overall Study|Death|2|||
17024769|NCT00764946|38169140|FG000|Overall Study|Withdrawal by Subject|3|||
17024770|NCT00764946|38169141|FG001|Overall Study|Withdrawal by Subject|6|||
17024771|NCT00764946|38169142|FG002|Overall Study|Withdrawal by Subject|2|||
16935477|NCT01215955|38080134|FG001|Overall Study|Death|0|||
16935478|NCT01215955|38080135|FG002|Overall Study|Death|1|||
16935479|NCT01215955|38080136|FG003|Overall Study|Death|3|||
16935480|NCT01215955|38080133|FG000|Overall Study|Entry Criteria Not Met|1|||
16935481|NCT01215955|38080134|FG001|Overall Study|Entry Criteria Not Met|3|||
16935482|NCT01215955|38080135|FG002|Overall Study|Entry Criteria Not Met|4|||
16935483|NCT01215955|38080136|FG003|Overall Study|Entry Criteria Not Met|7|||
16935484|NCT01215955|38080133|FG000|Overall Study|Lack of Efficacy|1|||
16935485|NCT01215955|38080134|FG001|Overall Study|Lack of Efficacy|2|||
16935486|NCT01215955|38080135|FG002|Overall Study|Lack of Efficacy|1|||
16935487|NCT01215955|38080136|FG003|Overall Study|Lack of Efficacy|0|||
16935488|NCT01215955|38080133|FG000|Overall Study|Lost to Follow-up|4|||
16935489|NCT01215955|38080134|FG001|Overall Study|Lost to Follow-up|4|||
16935490|NCT01215955|38080135|FG002|Overall Study|Lost to Follow-up|8|||
16935491|NCT01215955|38080136|FG003|Overall Study|Lost to Follow-up|9|||
16935492|NCT01215955|38080133|FG000|Overall Study|Physician Decision|4|||
16935493|NCT01215955|38080134|FG001|Overall Study|Physician Decision|10|||
16935494|NCT01215955|38080135|FG002|Overall Study|Physician Decision|8|||
16935495|NCT01215955|38080136|FG003|Overall Study|Physician Decision|11|||
16935496|NCT01215955|38080133|FG000|Overall Study|Protocol Violation|17|||
16935497|NCT01215955|38080134|FG001|Overall Study|Protocol Violation|13|||
16935498|NCT01215955|38080135|FG002|Overall Study|Protocol Violation|8|||
16935499|NCT01215955|38080136|FG003|Overall Study|Protocol Violation|8|||
16935500|NCT01215955|38080133|FG000|Overall Study|Sponsor Decision|1|||
16935501|NCT01215955|38080134|FG001|Overall Study|Sponsor Decision|2|||
16935502|NCT01215955|38080135|FG002|Overall Study|Sponsor Decision|0|||
16935503|NCT01215955|38080136|FG003|Overall Study|Sponsor Decision|1|||
16935504|NCT01215955|38080133|FG000|Overall Study|Withdrawal by Subject|14|||
16935505|NCT01215955|38080134|FG001|Overall Study|Withdrawal by Subject|15|||
16935506|NCT01215955|38080135|FG002|Overall Study|Withdrawal by Subject|13|||
16935507|NCT01215955|38080136|FG003|Overall Study|Withdrawal by Subject|9|||
16935508|NCT01215955|38080133|FG000|Overall Study|Quality Issues|0|||
16935509|NCT01215955|38080134|FG001|Overall Study|Quality Issues|0|||
16935510|NCT01215955|38080135|FG002|Overall Study|Quality Issues|3|||
16935511|NCT01215955|38080136|FG003|Overall Study|Quality Issues|2|||
16935512|NCT01215916|38080175|FG000|Overall Study|Progressive Disease|0|||
16935513|NCT01215916|38080176|FG001|Overall Study|Progressive Disease|2|||
16935514|NCT01215916|38080177|FG002|Overall Study|Progressive Disease|1|||
16935515|NCT01215916|38080178|FG003|Overall Study|Progressive Disease|2|||
16935516|NCT01215916|38080179|FG004|Overall Study|Progressive Disease|5|||
16935517|NCT01215916|38080180|FG005|Overall Study|Progressive Disease|4|||
16935518|NCT01215916|38080181|FG006|Overall Study|Progressive Disease|5|||
16935519|NCT01215916|38080182|FG007|Overall Study|Progressive Disease|3|||
16935520|NCT01215916|38080183|FG008|Overall Study|Progressive Disease|1|||
16935521|NCT01215916|38080175|FG000|Overall Study|Adverse Event|1|||
16935522|NCT01215916|38080176|FG001|Overall Study|Adverse Event|1|||
16935523|NCT01215916|38080177|FG002|Overall Study|Adverse Event|0|||
16935524|NCT01215916|38080178|FG003|Overall Study|Adverse Event|1|||
16935525|NCT01215916|38080179|FG004|Overall Study|Adverse Event|0|||
16935526|NCT01215916|38080180|FG005|Overall Study|Adverse Event|0|||
16935527|NCT01215916|38080181|FG006|Overall Study|Adverse Event|3|||
16935528|NCT01215916|38080182|FG007|Overall Study|Adverse Event|0|||
16935529|NCT01215916|38080183|FG008|Overall Study|Adverse Event|0|||
16935530|NCT01215916|38080175|FG000|Overall Study|Withdrawal by Subject|0|||
16935531|NCT01215916|38080176|FG001|Overall Study|Withdrawal by Subject|1|||
16935532|NCT01215916|38080177|FG002|Overall Study|Withdrawal by Subject|1|||
16935533|NCT01215916|38080178|FG003|Overall Study|Withdrawal by Subject|2|||
16935534|NCT01215916|38080179|FG004|Overall Study|Withdrawal by Subject|0|||
16935535|NCT01215916|38080180|FG005|Overall Study|Withdrawal by Subject|0|||
16935536|NCT01215916|38080181|FG006|Overall Study|Withdrawal by Subject|1|||
16935537|NCT01215916|38080182|FG007|Overall Study|Withdrawal by Subject|0|||
16935538|NCT01215916|38080183|FG008|Overall Study|Withdrawal by Subject|0|||
16935539|NCT01215916|38080175|FG000|Overall Study|Death|0|||
16935540|NCT01215916|38080176|FG001|Overall Study|Death|1|||
16935541|NCT01215916|38080177|FG002|Overall Study|Death|0|||
16935542|NCT01215916|38080178|FG003|Overall Study|Death|0|||
16935543|NCT01215916|38080179|FG004|Overall Study|Death|1|||
16935544|NCT01215916|38080180|FG005|Overall Study|Death|0|||
16935545|NCT01215916|38080181|FG006|Overall Study|Death|0|||
16935546|NCT01215916|38080182|FG007|Overall Study|Death|0|||
16935547|NCT01215916|38080183|FG008|Overall Study|Death|1|||
16935548|NCT01215916|38080175|FG000|Overall Study|Physician Decision|0|||
16935549|NCT01215916|38080176|FG001|Overall Study|Physician Decision|0|||
16935550|NCT01215916|38080177|FG002|Overall Study|Physician Decision|1|||
16935551|NCT01215916|38080178|FG003|Overall Study|Physician Decision|1|||
16935552|NCT01215916|38080179|FG004|Overall Study|Physician Decision|0|||
16935553|NCT01215916|38080180|FG005|Overall Study|Physician Decision|0|||
16935554|NCT01215916|38080181|FG006|Overall Study|Physician Decision|0|||
16935555|NCT01215916|38080182|FG007|Overall Study|Physician Decision|0|||
16935556|NCT01215916|38080183|FG008|Overall Study|Physician Decision|0|||
16935557|NCT01184872|38080209|FG000|Overall Study|Adverse Event|3|||
16935558|NCT01184872|38080210|FG001|Overall Study|Adverse Event|4|||
16935559|NCT01184872|38080209|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16935560|NCT01184872|38080210|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16935561|NCT01184872|38080209|FG000|Overall Study|Withdrawal by Subject|2|||
16935562|NCT01184872|38080210|FG001|Overall Study|Withdrawal by Subject|0|||
16935563|NCT01184872|38080209|FG000|Overall Study|Lost to Follow-up|0|||
16935564|NCT01184872|38080210|FG001|Overall Study|Lost to Follow-up|1|||
16935565|NCT01184872|38080209|FG000|Overall Study|Administrative problems|1|||
16935566|NCT01184872|38080210|FG001|Overall Study|Administrative problems|1|||
16935567|NCT01184872|38080209|FG000|Overall Study|Protocol deviation|1|||
16935568|NCT01184872|38080210|FG001|Overall Study|Protocol deviation|0|||
16935569|NCT01215721|38080216|FG000|Overall Study|Adverse Event|2|||
16935570|NCT01184326|38080223|FG000|Overall Study|Adverse Event|1|||
16935571|NCT01184326|38080224|FG001|Overall Study|Adverse Event|2|||
16935572|NCT01184326|38080225|FG002|Overall Study|Adverse Event|0|||
16935573|NCT01184326|38080223|FG000|Overall Study|Death|0|||
17024772|NCT00764946|38169140|FG000|Overall Study|Never Treated|1|||
17024773|NCT00764946|38169141|FG001|Overall Study|Never Treated|1|||
17024774|NCT00764946|38169142|FG002|Overall Study|Never Treated|1|||
17024775|NCT00764868|38169156|FG000|Overall Study|Adverse Event|18|||
17024776|NCT00764868|38169156|FG000|Overall Study|Withdrawal by Subject|31|||
17024777|NCT00764868|38169156|FG000|Overall Study|Non-compliance|16|||
17024778|NCT00764868|38169156|FG000|Overall Study|Lost to Follow-up|25|||
17024779|NCT00764868|38169156|FG000|Overall Study|Lack of Efficacy|5|||
17024780|NCT00764868|38169156|FG000|Overall Study|Subject moved|7|||
17024781|NCT00764868|38169156|FG000|Overall Study|Pregnancy|3|||
17024782|NCT00764868|38169156|FG000|Overall Study|Prohibited medication|1|||
17024783|NCT00764868|38169156|FG000|Overall Study|Out of town|1|||
17024784|NCT00764868|38169156|FG000|Overall Study|Misuse and compliance of study drug|1|||
17024785|NCT00764868|38169156|FG000|Overall Study|Subject sent to boarding school|1|||
17024786|NCT00764868|38169156|FG000|Overall Study|Met an exclusion criteria|1|||
17024787|NCT00764868|38169156|FG000|Overall Study|Positive drug screen|2|||
17024788|NCT00764868|38169156|FG000|Overall Study|Sponsor requested withdrawal|1|||
17024789|NCT00764790|38169163|FG000|Overall Study|Protocol Violation|0|||
17024790|NCT00764790|38169164|FG001|Overall Study|Protocol Violation|0|||
17024791|NCT00764790|38169165|FG002|Overall Study|Protocol Violation|1|||
17024792|NCT00764790|38169163|FG000|Overall Study|Withdrawal by Subject|10|||
17024793|NCT00764790|38169164|FG001|Overall Study|Withdrawal by Subject|12|||
17024794|NCT00764790|38169165|FG002|Overall Study|Withdrawal by Subject|6|||
17024795|NCT00764790|38169163|FG000|Overall Study|Lost to Follow-up|28|||
17103229|NCT00112437|38241457|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103230|NCT00112437|38241458|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103231|NCT00112437|38241459|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103232|NCT00112437|38241460|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103233|NCT00112437|38241461|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
17103234|NCT00112437|38241462|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
17024796|NCT00764790|38169164|FG001|Overall Study|Lost to Follow-up|29|||
17024797|NCT00764790|38169165|FG002|Overall Study|Lost to Follow-up|23|||
17024798|NCT00756444|38169175|FG000|Overall Study|Adverse Event|1|||
17024799|NCT00756444|38169176|FG001|Overall Study|Adverse Event|1|||
17024800|NCT00756444|38169175|FG000|Overall Study|Withdrawal by Subject|6|||
17024801|NCT00756444|38169176|FG001|Overall Study|Withdrawal by Subject|8|||
17024802|NCT00756444|38169175|FG000|Overall Study|Lost to Follow-up|0|||
17024803|NCT00756444|38169176|FG001|Overall Study|Lost to Follow-up|1|||
17024804|NCT00756444|38169175|FG000|Overall Study|Death|5|||
17024805|NCT00756444|38169176|FG001|Overall Study|Death|4|||
17024806|NCT00756444|38169175|FG000|Overall Study|Disease Progression|2|||
17024807|NCT00756444|38169176|FG001|Overall Study|Disease Progression|7|||
17024808|NCT00756444|38169175|FG000|Overall Study|Ineligibility Determined|1|||
17024809|NCT00756444|38169176|FG001|Overall Study|Ineligibility Determined|0|||
16852927|NCT01723826|37803183|FG000|Overall Study|Physician Decision|1|||
16852928|NCT01723826|37803184|FG001|Overall Study|Physician Decision|3|||
16852929|NCT01723826|37803185|FG002|Overall Study|Physician Decision|4|||
16935574|NCT01184326|38080224|FG001|Overall Study|Death|0|||
16852930|NCT01723826|37803186|FG003|Overall Study|Physician Decision|11|||
16852931|NCT01723826|37803183|FG000|Overall Study|Protocol Violation|1|||
16852932|NCT01723826|37803184|FG001|Overall Study|Protocol Violation|1|||
16852933|NCT01723826|37803185|FG002|Overall Study|Protocol Violation|3|||
16852934|NCT01723826|37803186|FG003|Overall Study|Protocol Violation|1|||
16852935|NCT01723826|37803183|FG000|Overall Study|Withdrawal by Subject|10|||
16852936|NCT01723826|37803184|FG001|Overall Study|Withdrawal by Subject|17|||
16852937|NCT01723826|37803185|FG002|Overall Study|Withdrawal by Subject|27|||
16852938|NCT01723826|37803186|FG003|Overall Study|Withdrawal by Subject|48|||
16935575|NCT01184326|38080225|FG002|Overall Study|Death|1|||
16852939|NCT01721954|37803198|FG000|Overall Study|Death|58|||
16852940|NCT01721954|37803199|FG001|Overall Study|Death|64|||
16935576|NCT01184326|38080223|FG000|Overall Study|Withdrawal by Subject|0|||
16935577|NCT01184326|38080224|FG001|Overall Study|Withdrawal by Subject|0|||
16935578|NCT01184326|38080225|FG002|Overall Study|Withdrawal by Subject|1|||
16935579|NCT01184326|38080223|FG000|Overall Study|Physician Decision|1|||
16935580|NCT01184326|38080224|FG001|Overall Study|Physician Decision|1|||
16935581|NCT01184326|38080225|FG002|Overall Study|Physician Decision|0|||
16935582|NCT01184326|38080223|FG000|Overall Study|Disease Progression|1|||
17024810|NCT00769002|38169187|FG000|Overall Study|Study was not completed, no data|9|||
17024811|NCT00769002|38169188|FG001|Overall Study|Study was not completed, no data|9|||
17024812|NCT00753012|38169195|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
17024813|NCT00753012|38169196|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
17024814|NCT00753012|38169195|FG000|Overall Study|Adverse Event|2|||
17024815|NCT00753012|38169196|FG001|Overall Study|Adverse Event|0|||
17024816|NCT00753012|38169195|FG000|Overall Study|Withdrawal by Subject|0|||
17024817|NCT00753012|38169196|FG001|Overall Study|Withdrawal by Subject|1|||
17024818|NCT00753012|38169195|FG000|Overall Study|Lost to Follow-up|4|||
17024819|NCT00753012|38169196|FG001|Overall Study|Lost to Follow-up|0|||
17024820|NCT00753012|38169195|FG000|Overall Study|Confounded endpoint data|1|||
17024821|NCT00753012|38169196|FG001|Overall Study|Confounded endpoint data|0|||
17024822|NCT00806156|38169205|FG000|Overall Study|Death|35|||
17024823|NCT00806156|38169206|FG001|Overall Study|Death|95|||
17024824|NCT00806156|38169205|FG000|Overall Study|Did not meet eligibility criteria|1|||
17024825|NCT00806156|38169206|FG001|Overall Study|Did not meet eligibility criteria|0|||
17024826|NCT00806156|38169205|FG000|Overall Study|Study terminated by Sponsor|2|||
17024827|NCT00806156|38169206|FG001|Overall Study|Study terminated by Sponsor|40|||
17024828|NCT00806156|38169205|FG000|Overall Study|Consent withdrawn by subject|1|||
17024829|NCT00806156|38169206|FG001|Overall Study|Consent withdrawn by subject|3|||
17024830|NCT00806156|38169205|FG000|Overall Study|Lost to Follow-up|0|||
16852941|NCT01721954|37803198|FG000|Overall Study|Withdrawal by Subject|8|||
16852942|NCT01721954|37803199|FG001|Overall Study|Withdrawal by Subject|4|||
16852943|NCT01721954|37803198|FG000|Overall Study|Adverse Event|2|||
16852944|NCT01721954|37803199|FG001|Overall Study|Adverse Event|0|||
16852945|NCT01721954|37803198|FG000|Overall Study|Lost to Follow-up|2|||
16852946|NCT01721954|37803199|FG001|Overall Study|Lost to Follow-up|1|||
16852947|NCT01776554|37803207|FG000|Overall Study|Adverse Event|1|||
16852948|NCT01776554|37803208|FG001|Overall Study|Adverse Event|0|||
16852949|NCT01776554|37803207|FG000|Overall Study|Withdrawal by Subject|3|||
16852950|NCT01776554|37803208|FG001|Overall Study|Withdrawal by Subject|8|||
16852951|NCT01776554|37803207|FG000|Overall Study|Lost to Follow-up|6|||
16852952|NCT01776554|37803208|FG001|Overall Study|Lost to Follow-up|9|||
16852953|NCT01776554|37803207|FG000|Overall Study|Administrative Reason|2|||
16852954|NCT01776554|37803208|FG001|Overall Study|Administrative Reason|5|||
16852955|NCT01776554|37803207|FG000|Overall Study|Protocol Violation|1|||
16852956|NCT01776554|37803208|FG001|Overall Study|Protocol Violation|0|||
16852957|NCT01776554|37803207|FG000|Overall Study|Unclassified|4|||
16852958|NCT01776554|37803208|FG001|Overall Study|Unclassified|1|||
16852959|NCT01776008|37803215|FG000|Overall Study|ineligible|2|||
16852960|NCT01746368|37803221|FG000|Overall Study|Lost to Follow-up|2|||
16852961|NCT01746368|37803222|FG001|Overall Study|Lost to Follow-up|0|||
16852962|NCT01746368|37803221|FG000|Overall Study|Withdrawal by Subject|0|||
16852963|NCT01746368|37803222|FG001|Overall Study|Withdrawal by Subject|1|||
16852964|NCT01381575|37803231|FG000|Overall Study|Serious Adverse Event|1|||
16852965|NCT01381575|37803232|FG001|Overall Study|Serious Adverse Event|0|||
16852966|NCT01381575|37803233|FG002|Overall Study|Serious Adverse Event|0|||
16852967|NCT01381575|37803231|FG000|Overall Study|Non-Serious Adverse Event|0|||
16852968|NCT01381575|37803232|FG001|Overall Study|Non-Serious Adverse Event|0|||
16852969|NCT01381575|37803233|FG002|Overall Study|Non-Serious Adverse Event|1|||
16852970|NCT01381575|37803231|FG000|Overall Study|Protocol Violation|0|||
16852971|NCT01381575|37803232|FG001|Overall Study|Protocol Violation|1|||
16852972|NCT01381575|37803233|FG002|Overall Study|Protocol Violation|1|||
16852973|NCT01381575|37803231|FG000|Overall Study|Withdrawal by Subject|15|||
16852974|NCT01381575|37803232|FG001|Overall Study|Withdrawal by Subject|9|||
16852975|NCT01381575|37803233|FG002|Overall Study|Withdrawal by Subject|7|||
16935583|NCT01184326|38080224|FG001|Overall Study|Disease Progression|3|||
16935584|NCT01184326|38080225|FG002|Overall Study|Disease Progression|12|||
16935585|NCT01215253|38080238|FG000|Overall Study|Withdrawal by Subject|57|||
16935586|NCT01215253|38080239|FG001|Overall Study|Withdrawal by Subject|35|||
16935587|NCT01215253|38080238|FG000|Overall Study|Physician Decision|9|||
16935588|NCT01215253|38080239|FG001|Overall Study|Physician Decision|12|||
16935589|NCT01215253|38080238|FG000|Overall Study|Lost to Follow-up|6|||
16935590|NCT01215253|38080239|FG001|Overall Study|Lost to Follow-up|4|||
16935591|NCT01215253|38080238|FG000|Overall Study|Other|14|||
16935592|NCT01215253|38080239|FG001|Overall Study|Other|12|||
16935593|NCT01184053|38080246|FG000|Overall Study|progression while on treatment|3|||
17024831|NCT00806156|38169206|FG001|Overall Study|Lost to Follow-up|1|||
16852976|NCT01381575|37803231|FG000|Overall Study|Migrated/moved from study area|2|||
16852977|NCT01381575|37803232|FG001|Overall Study|Migrated/moved from study area|12|||
16852978|NCT01381575|37803233|FG002|Overall Study|Migrated/moved from study area|2|||
16852979|NCT01381575|37803231|FG000|Overall Study|Lost to Follow-up|8|||
16852980|NCT01381575|37803232|FG001|Overall Study|Lost to Follow-up|17|||
16935594|NCT01183975|38080251|FG000|Overall Study|Lost to Follow-up|73|||
16935595|NCT01183858|38080257|FG000|Overall Study|Death not related to Progressive Disease|5|||
16935596|NCT01183858|38080258|FG001|Overall Study|Death not related to Progressive Disease|6|||
16935597|NCT01183858|38080257|FG000|Overall Study|Adverse Event|14|||
16935598|NCT01183858|38080258|FG001|Overall Study|Adverse Event|11|||
16935599|NCT01183858|38080257|FG000|Overall Study|Investigator's Decision|0|||
16935600|NCT01183858|38080258|FG001|Overall Study|Investigator's Decision|3|||
16935601|NCT01183858|38080257|FG000|Overall Study|Insufficient Therapeutic Response|2|||
16935602|NCT01183858|38080258|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16935603|NCT01183858|38080257|FG000|Overall Study|Refused Treatment|1|||
16935604|NCT01183858|38080258|FG001|Overall Study|Refused Treatment|4|||
16935605|NCT01183858|38080257|FG000|Overall Study|Withdrew Consent|4|||
16935606|NCT01183858|38080258|FG001|Overall Study|Withdrew Consent|4|||
16935607|NCT01183858|38080257|FG000|Overall Study|Discontinued Smoking|3|||
16935608|NCT01183858|38080258|FG001|Overall Study|Discontinued Smoking|1|||
16935609|NCT01183858|38080257|FG000|Overall Study|Protocol Violation|1|||
16935610|NCT01183858|38080258|FG001|Overall Study|Protocol Violation|0|||
16935611|NCT01183858|38080257|FG000|Overall Study|Administrative/Other|6|||
16935612|NCT01183858|38080258|FG001|Overall Study|Administrative/Other|6|||
16935613|NCT01183858|38080257|FG000|Overall Study|Progressive Disease|112|||
16935614|NCT01183858|38080258|FG001|Overall Study|Progressive Disease|115|||
16935615|NCT01183858|38080257|FG000|Overall Study|Death related to Progressive Disease|4|||
16935616|NCT01183858|38080258|FG001|Overall Study|Death related to Progressive Disease|5|||
16935617|NCT01183858|38080257|FG000|Overall Study|Lost to Follow-up|1|||
16935618|NCT01183858|38080258|FG001|Overall Study|Lost to Follow-up|1|||
16935619|NCT01215175|38080269|FG000|Overall Study|Lost to Follow-up|0|||
16935620|NCT01215175|38080270|FG001|Overall Study|Lost to Follow-up|1|||
16935621|NCT01215175|38080271|FG002|Overall Study|Lost to Follow-up|0|||
16935622|NCT01215175|38080272|FG003|Overall Study|Lost to Follow-up|1|||
16935623|NCT01215175|38080273|FG004|Overall Study|Lost to Follow-up|0|||
16935624|NCT01215097|38080287|FG000|Overall Study|Adverse Event|1|||
16935625|NCT01215097|38080288|FG001|Overall Study|Adverse Event|3|||
16935626|NCT01215097|38080287|FG000|Overall Study|Protocol Violation|0|||
16935627|NCT01215097|38080288|FG001|Overall Study|Protocol Violation|2|||
17024832|NCT00764478|38169227|FG000|Overall Study|Adverse Event|1|||
17024833|NCT00764478|38169228|FG001|Overall Study|Adverse Event|1|||
17024834|NCT00764478|38169229|FG002|Overall Study|Adverse Event|1|||
17024835|NCT00764478|38169227|FG000|Overall Study|Withdrawal by Subject|7|||
17024836|NCT00764478|38169228|FG001|Overall Study|Withdrawal by Subject|12|||
17024837|NCT00764478|38169229|FG002|Overall Study|Withdrawal by Subject|1|||
17024838|NCT00764478|38169227|FG000|Overall Study|Lost to Follow-up|7|||
17024839|NCT00764478|38169228|FG001|Overall Study|Lost to Follow-up|8|||
17024840|NCT00764478|38169229|FG002|Overall Study|Lost to Follow-up|5|||
17024841|NCT00764478|38169227|FG000|Overall Study|Protocol Violation|0|||
17024842|NCT00764478|38169228|FG001|Overall Study|Protocol Violation|1|||
17024843|NCT00764478|38169229|FG002|Overall Study|Protocol Violation|1|||
17024844|NCT00805766|38169237|FG000|Screening Period|Adverse Event|1|||
17024845|NCT00805766|38169237|FG000|Screening Period|Lack of Efficacy|2|||
17024846|NCT00805766|38169237|FG000|Screening Period|Pregnancy|1|||
17024847|NCT00805766|38169237|FG000|Screening Period|Responder|2|||
17024848|NCT00805766|38169237|FG000|Increased Dose Period|Adverse Event|4|||
17024849|NCT00805766|38169237|FG000|Increased Dose Period|Lack of Efficacy|7|||
17024850|NCT00805766|38169237|FG000|Increased Dose Period|Pregnancy|1|||
17024851|NCT00805766|38169237|FG000|Increased Dose Period|Withdrawal by Subject|1|||
17024852|NCT00805532|38169247|FG000|Overall Study|invalid data|0|||
17024853|NCT00805532|38169248|FG001|Overall Study|invalid data|1|||
17024854|NCT00764322|38169258|FG000|Overall Study|Withdrawal by Subject|11|||
17024855|NCT00764322|38169258|FG000|Overall Study|No CYP2D6 genotyping|9|||
17024856|NCT00752856|38169277|FG000|Overall Study|randomized but did not do viral kinetics|0|||
17024857|NCT00752856|38169278|FG001|Overall Study|randomized but did not do viral kinetics|1|||
17024858|NCT00755196|38169284|FG000|Overall Study|Lost to Follow-up|1|||
17024859|NCT00755196|38169284|FG000|Overall Study|Lack of Efficiency|1|||
17024860|NCT00805142|38169291|FG000|Titration Period|Adverse Event|3|||
17024861|NCT00805142|38169292|FG001|Titration Period|Adverse Event|3|||
17024862|NCT00805142|38169291|FG000|Titration Period|Lack of Efficacy|1|||
17024863|NCT00805142|38169292|FG001|Titration Period|Lack of Efficacy|1|||
17024864|NCT00805142|38169291|FG000|Titration Period|Lost to Follow-up|0|||
17024865|NCT00805142|38169292|FG001|Titration Period|Lost to Follow-up|1|||
17024866|NCT00805142|38169291|FG000|Titration Period|Disease Progression|2|||
17024867|NCT00805142|38169292|FG001|Titration Period|Disease Progression|1|||
17024868|NCT00805142|38169291|FG000|Titration Period|Withdrawal of consent|0|||
17024869|NCT00805142|38169292|FG001|Titration Period|Withdrawal of consent|1|||
17024870|NCT00805142|38169291|FG000|Titration Period|Other|0|||
17024871|NCT00805142|38169292|FG001|Titration Period|Other|3|||
17024872|NCT00805142|38169291|FG000|Maintenance Period|Adverse Event|0|||
17024873|NCT00805142|38169292|FG001|Maintenance Period|Adverse Event|1|||
17024874|NCT00805142|38169291|FG000|Maintenance Period|Other|0|||
16935628|NCT01215097|38080287|FG000|Overall Study|Lost to Follow-up|2|||
17024875|NCT00805142|38169292|FG001|Maintenance Period|Other|1|||
17024876|NCT00761631|38169309|FG000|Overall Study|Parent/legal guardian request|8|||
17024877|NCT00761631|38169310|FG001|Overall Study|Parent/legal guardian request|3|||
17024878|NCT00761631|38169311|FG002|Overall Study|Parent/legal guardian request|8|||
17024879|NCT00761631|38169312|FG003|Overall Study|Parent/legal guardian request|0|||
17024880|NCT00761631|38169313|FG004|Overall Study|Parent/legal guardian request|5|||
17024881|NCT00761631|38169314|FG005|Overall Study|Parent/legal guardian request|0|||
17024882|NCT00761631|38169309|FG000|Overall Study|Lost to Follow-up|2|||
17024883|NCT00761631|38169310|FG001|Overall Study|Lost to Follow-up|4|||
17024884|NCT00761631|38169311|FG002|Overall Study|Lost to Follow-up|7|||
17024885|NCT00761631|38169312|FG003|Overall Study|Lost to Follow-up|1|||
17024886|NCT00761631|38169313|FG004|Overall Study|Lost to Follow-up|6|||
17024887|NCT00761631|38169314|FG005|Overall Study|Lost to Follow-up|1|||
17024888|NCT00761631|38169309|FG000|Overall Study|Protocol Violation|2|||
17024889|NCT00761631|38169310|FG001|Overall Study|Protocol Violation|0|||
17024890|NCT00761631|38169311|FG002|Overall Study|Protocol Violation|0|||
17024891|NCT00761631|38169312|FG003|Overall Study|Protocol Violation|1|||
17024892|NCT00761631|38169313|FG004|Overall Study|Protocol Violation|5|||
17024893|NCT00761631|38169314|FG005|Overall Study|Protocol Violation|1|||
17024894|NCT00761631|38169309|FG000|Overall Study|Randomized, not treated|1|||
17024895|NCT00761631|38169310|FG001|Overall Study|Randomized, not treated|0|||
17024896|NCT00761631|38169311|FG002|Overall Study|Randomized, not treated|0|||
17024897|NCT00761631|38169312|FG003|Overall Study|Randomized, not treated|0|||
17024898|NCT00761631|38169313|FG004|Overall Study|Randomized, not treated|0|||
17024899|NCT00761631|38169314|FG005|Overall Study|Randomized, not treated|0|||
17024900|NCT00761631|38169309|FG000|Overall Study|Failed to return|1|||
17024901|NCT00761631|38169310|FG001|Overall Study|Failed to return|0|||
17024902|NCT00761631|38169311|FG002|Overall Study|Failed to return|1|||
17024903|NCT00761631|38169312|FG003|Overall Study|Failed to return|1|||
17024904|NCT00761631|38169313|FG004|Overall Study|Failed to return|5|||
17024905|NCT00761631|38169314|FG005|Overall Study|Failed to return|2|||
17024906|NCT00761631|38169309|FG000|Overall Study|Physician Decision|1|||
17024907|NCT00761631|38169310|FG001|Overall Study|Physician Decision|0|||
17024908|NCT00761631|38169311|FG002|Overall Study|Physician Decision|0|||
17024909|NCT00761631|38169312|FG003|Overall Study|Physician Decision|0|||
17024910|NCT00761631|38169313|FG004|Overall Study|Physician Decision|0|||
17024911|NCT00761631|38169314|FG005|Overall Study|Physician Decision|0|||
17103235|NCT00112437|38241463|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17024912|NCT00761631|38169309|FG000|Overall Study|Other|0|||
17024913|NCT00761631|38169310|FG001|Overall Study|Other|0|||
17024914|NCT00761631|38169311|FG002|Overall Study|Other|0|||
17024915|NCT00761631|38169312|FG003|Overall Study|Other|0|||
17024916|NCT00761631|38169313|FG004|Overall Study|Other|1|||
17103236|NCT00112437|38241464|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103237|NCT00112437|38241465|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103238|NCT00112437|38241466|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
17103239|NCT00112437|38241441|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103240|NCT00112437|38241442|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103241|NCT00112437|38241443|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103242|NCT00112437|38241444|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103243|NCT00112437|38241445|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103244|NCT00112437|38241446|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103245|NCT00112437|38241447|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103246|NCT00112437|38241448|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103247|NCT00112437|38241449|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17024917|NCT00761631|38169314|FG005|Overall Study|Other|1|||
17024918|NCT00763698|38169337|FG000|Overall Study|Unsuccessful Implant|5|||
17024919|NCT00763698|38169337|FG000|Overall Study|Death|4|||
17024920|NCT00763698|38169337|FG000|Overall Study|Withdrawal by Subject|1|||
17103248|NCT00112437|38241450|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103249|NCT00112437|38241451|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103250|NCT00112437|38241452|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103251|NCT00112437|38241453|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103252|NCT00112437|38241454|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103253|NCT00112437|38241455|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103254|NCT00112437|38241456|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103255|NCT00112437|38241457|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103256|NCT00112437|38241458|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103257|NCT00112437|38241459|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103258|NCT00112437|38241460|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17024921|NCT00763386|38169344|FG000|Overall Study|Adverse Event|43|||
17024922|NCT00763386|38169345|FG001|Overall Study|Adverse Event|33|||
17024923|NCT00763386|38169344|FG000|Overall Study|Death|1|||
17024924|NCT00763386|38169345|FG001|Overall Study|Death|2|||
17024925|NCT00763386|38169344|FG000|Overall Study|Lost to Follow-up|3|||
17024926|NCT00763386|38169345|FG001|Overall Study|Lost to Follow-up|3|||
17024927|NCT00763386|38169344|FG000|Overall Study|Withdrawal by Subject|0|||
17024928|NCT00763386|38169345|FG001|Overall Study|Withdrawal by Subject|1|||
17024929|NCT00763386|38169344|FG000|Overall Study|CRF missing|0|||
17024930|NCT00763386|38169345|FG001|Overall Study|CRF missing|1|||
17024931|NCT00763386|38169344|FG000|Overall Study|Study Prosthesis Removed|1|||
17024932|NCT00763386|38169345|FG001|Overall Study|Study Prosthesis Removed|0|||
16935629|NCT01215097|38080288|FG001|Overall Study|Lost to Follow-up|0|||
16935630|NCT01215097|38080287|FG000|Overall Study|Withdrawal by Subject|6|||
17024933|NCT00761319|38169353|FG000|Overall Study|Protocol Violation|21|||
17024934|NCT00761319|38169354|FG001|Overall Study|Protocol Violation|14|||
16935631|NCT01215097|38080288|FG001|Overall Study|Withdrawal by Subject|3|||
16935632|NCT01215097|38080287|FG000|Overall Study|Lack of Efficacy|0|||
16935633|NCT01215097|38080288|FG001|Overall Study|Lack of Efficacy|3|||
16935634|NCT01215097|38080287|FG000|Overall Study|patient's refusal to come|2|||
16935635|NCT01215097|38080288|FG001|Overall Study|patient's refusal to come|2|||
16935636|NCT01215097|38080287|FG000|Overall Study|patient's private reason|1|||
16935637|NCT01215097|38080288|FG001|Overall Study|patient's private reason|1|||
16935638|NCT03303339|38080306|FG000|Overall Study|Death|2|||
16935639|NCT03303339|38080307|FG001|Overall Study|Death|2|||
16935640|NCT03303339|38080308|FG002|Overall Study|Death|2|||
17024935|NCT00761319|38169353|FG000|Overall Study|Adverse Event|11|||
17024936|NCT00761319|38169354|FG001|Overall Study|Adverse Event|7|||
17024937|NCT00761319|38169353|FG000|Overall Study|Withdrawal by Subject|8|||
17024938|NCT00761319|38169354|FG001|Overall Study|Withdrawal by Subject|7|||
17024939|NCT00761319|38169353|FG000|Overall Study|Noncompliance|4|||
17024940|NCT00761319|38169354|FG001|Overall Study|Noncompliance|3|||
17024941|NCT00761319|38169353|FG000|Overall Study|Lost to Follow-up|1|||
17024942|NCT00761319|38169354|FG001|Overall Study|Lost to Follow-up|1|||
17024943|NCT00761319|38169353|FG000|Overall Study|Nonspecified|2|||
17024944|NCT00761319|38169354|FG001|Overall Study|Nonspecified|2|||
17024945|NCT00761319|38169353|FG000|Overall Study|Missing|1|||
17024946|NCT00761319|38169354|FG001|Overall Study|Missing|0|||
17024947|NCT00762996|38169360|FG000|Period One|Protocol Violation|0|||
17024948|NCT00762996|38169361|FG001|Period One|Protocol Violation|0|||
17024949|NCT00762996|38169362|FG002|Period One|Protocol Violation|1|||
17024950|NCT00762996|38169363|FG003|Period One|Protocol Violation|0|||
17024951|NCT00762996|38169360|FG000|Period One|ineligible|0|||
17024952|NCT00762996|38169361|FG001|Period One|ineligible|0|||
17024953|NCT00762996|38169362|FG002|Period One|ineligible|1|||
17024954|NCT00762996|38169363|FG003|Period One|ineligible|1|||
17024955|NCT00762996|38169360|FG000|Period One|Adverse Event|0|||
17024956|NCT00762996|38169361|FG001|Period One|Adverse Event|0|||
17024957|NCT00762996|38169362|FG002|Period One|Adverse Event|1|||
17024958|NCT00762996|38169363|FG003|Period One|Adverse Event|0|||
17024959|NCT00762996|38169360|FG000|Period One|Withdrawal by Subject|0|||
17024960|NCT00762996|38169361|FG001|Period One|Withdrawal by Subject|0|||
17024961|NCT00762996|38169362|FG002|Period One|Withdrawal by Subject|1|||
17024962|NCT00762996|38169363|FG003|Period One|Withdrawal by Subject|0|||
17024963|NCT00762606|38169373|FG000|Overall Study|Lost to Follow-up|18|||
16935641|NCT03303339|38080309|FG003|Overall Study|Death|1|||
17024964|NCT00762606|38169374|FG001|Overall Study|Lost to Follow-up|13|||
17024965|NCT00818441|38169382|FG000|Overall Study|Death|69|||
17024966|NCT00818441|38169383|FG001|Overall Study|Death|26|||
17024967|NCT00818441|38169382|FG000|Overall Study|Other|5|||
17024968|NCT00818441|38169383|FG001|Overall Study|Other|0|||
17024969|NCT00818441|38169382|FG000|Overall Study|Lost to Follow-up|2|||
17024970|NCT00818441|38169383|FG001|Overall Study|Lost to Follow-up|1|||
17024971|NCT00818441|38169382|FG000|Overall Study|Withdrawal by Subject|2|||
17024972|NCT00818441|38169383|FG001|Overall Study|Withdrawal by Subject|0|||
17024973|NCT00818441|38169382|FG000|Overall Study|Adverse Event|0|||
17024974|NCT00818441|38169383|FG001|Overall Study|Adverse Event|1|||
17103259|NCT00112437|38241461|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17024975|NCT00818441|38169382|FG000|Overall Study|Study terminated by sponsor|11|||
17024976|NCT00818441|38169383|FG001|Overall Study|Study terminated by sponsor|2|||
17024977|NCT00826943|38169390|FG000|Overall Study|Withdrawal by Subject|0|||
17024978|NCT00826943|38169391|FG001|Overall Study|Withdrawal by Subject|0|||
17024979|NCT00826943|38169392|FG002|Overall Study|Withdrawal by Subject|0|||
17024980|NCT00826943|38169393|FG003|Overall Study|Withdrawal by Subject|0|||
17024981|NCT00826943|38169394|FG004|Overall Study|Withdrawal by Subject|1|||
17024982|NCT00826943|38169395|FG005|Overall Study|Withdrawal by Subject|0|||
17024983|NCT00834041|38169405|FG000|Overall Study|Withdrawal by Subject|1|||
17024984|NCT00834041|38169406|FG001|Overall Study|Withdrawal by Subject|0|||
17024985|NCT00834041|38169405|FG000|Overall Study|Lost to Follow-up|0|||
17024986|NCT00834041|38169406|FG001|Overall Study|Lost to Follow-up|1|||
16935642|NCT03303339|38080310|FG004|Overall Study|Death|4|||
16935643|NCT03303339|38080311|FG005|Overall Study|Death|2|||
17024987|NCT00760929|38169416|FG000|Overall Study|Adverse Event|2|||
17024988|NCT00760929|38169417|FG001|Overall Study|Adverse Event|0|||
17024989|NCT00760929|38169418|FG002|Overall Study|Adverse Event|6|||
17024990|NCT00760929|38169419|FG003|Overall Study|Adverse Event|10|||
17024991|NCT00760929|38169416|FG000|Overall Study|Lack of Efficacy|0|||
16935644|NCT03303339|38080312|FG006|Overall Study|Death|2|||
16935645|NCT03303339|38080313|FG007|Overall Study|Death|2|||
16935646|NCT03303339|38080314|FG008|Overall Study|Death|3|||
16935647|NCT03303339|38080315|FG009|Overall Study|Death|3|||
16935648|NCT03303339|38080316|FG010|Overall Study|Death|4|||
16935649|NCT03303339|38080317|FG011|Overall Study|Death|24|||
16935650|NCT03303339|38080306|FG000|Overall Study|Study Terminated by Sponsor|0|||
16935651|NCT03303339|38080307|FG001|Overall Study|Study Terminated by Sponsor|0|||
16935652|NCT03303339|38080308|FG002|Overall Study|Study Terminated by Sponsor|0|||
16935653|NCT03303339|38080309|FG003|Overall Study|Study Terminated by Sponsor|0|||
16935654|NCT03303339|38080310|FG004|Overall Study|Study Terminated by Sponsor|0|||
16935655|NCT03303339|38080311|FG005|Overall Study|Study Terminated by Sponsor|0|||
16935656|NCT03303339|38080312|FG006|Overall Study|Study Terminated by Sponsor|0|||
17103260|NCT00112437|38241462|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103261|NCT00112437|38241463|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
17103262|NCT00112437|38241464|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
17103263|NCT00112437|38241465|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
17103264|NCT00112437|38241466|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
17103265|NCT00112437|38241441|FG000|Years 6-10 (60-Month Extension)|Death|0|||
17103266|NCT00112437|38241442|FG001|Years 6-10 (60-Month Extension)|Death|0|||
16935657|NCT03303339|38080313|FG007|Overall Study|Study Terminated by Sponsor|0|||
16935658|NCT03303339|38080314|FG008|Overall Study|Study Terminated by Sponsor|1|||
16935659|NCT03303339|38080315|FG009|Overall Study|Study Terminated by Sponsor|0|||
16935660|NCT03303339|38080316|FG010|Overall Study|Study Terminated by Sponsor|1|||
17024992|NCT00760929|38169417|FG001|Overall Study|Lack of Efficacy|2|||
17024993|NCT00760929|38169418|FG002|Overall Study|Lack of Efficacy|1|||
17024994|NCT00760929|38169419|FG003|Overall Study|Lack of Efficacy|0|||
17024995|NCT00760929|38169416|FG000|Overall Study|Withdrawal by Subject|1|||
17024996|NCT00760929|38169417|FG001|Overall Study|Withdrawal by Subject|0|||
17024997|NCT00760929|38169418|FG002|Overall Study|Withdrawal by Subject|9|||
17024998|NCT00760929|38169419|FG003|Overall Study|Withdrawal by Subject|1|||
17024999|NCT00760929|38169416|FG000|Overall Study|Lost to Follow-up|0|||
17025000|NCT00760929|38169417|FG001|Overall Study|Lost to Follow-up|0|||
17025001|NCT00760929|38169418|FG002|Overall Study|Lost to Follow-up|1|||
17025002|NCT00760929|38169419|FG003|Overall Study|Lost to Follow-up|0|||
17025003|NCT00760929|38169416|FG000|Overall Study|Progression of Disease|21|||
17025004|NCT00760929|38169417|FG001|Overall Study|Progression of Disease|26|||
17025005|NCT00760929|38169418|FG002|Overall Study|Progression of Disease|38|||
17025006|NCT00760929|38169419|FG003|Overall Study|Progression of Disease|42|||
17025007|NCT00760929|38169416|FG000|Overall Study|Other|2|||
17025008|NCT00760929|38169417|FG001|Overall Study|Other|0|||
17025009|NCT00760929|38169418|FG002|Overall Study|Other|2|||
16935661|NCT03303339|38080317|FG011|Overall Study|Study Terminated by Sponsor|1|||
17103267|NCT00112437|38241443|FG002|Years 6-10 (60-Month Extension)|Death|0|||
17103268|NCT00112437|38241444|FG003|Years 6-10 (60-Month Extension)|Death|0|||
17103269|NCT00112437|38241445|FG004|Years 6-10 (60-Month Extension)|Death|0|||
17103270|NCT00112437|38241446|FG005|Years 6-10 (60-Month Extension)|Death|0|||
17103271|NCT00112437|38241447|FG006|Years 6-10 (60-Month Extension)|Death|0|||
17103272|NCT00112437|38241448|FG007|Years 6-10 (60-Month Extension)|Death|0|||
17103273|NCT00112437|38241449|FG008|Years 6-10 (60-Month Extension)|Death|0|||
17103274|NCT00112437|38241450|FG009|Years 6-10 (60-Month Extension)|Death|0|||
17103275|NCT00112437|38241451|FG010|Years 6-10 (60-Month Extension)|Death|0|||
17103276|NCT00112437|38241452|FG011|Years 6-10 (60-Month Extension)|Death|0|||
17103277|NCT00112437|38241453|FG012|Years 6-10 (60-Month Extension)|Death|0|||
17103278|NCT00112437|38241454|FG013|Years 6-10 (60-Month Extension)|Death|0|||
17103279|NCT00112437|38241455|FG014|Years 6-10 (60-Month Extension)|Death|0|||
17103280|NCT00112437|38241456|FG015|Years 6-10 (60-Month Extension)|Death|0|||
17103281|NCT00112437|38241457|FG016|Years 6-10 (60-Month Extension)|Death|0|||
17103282|NCT00112437|38241458|FG017|Years 6-10 (60-Month Extension)|Death|0|||
17103283|NCT00112437|38241459|FG018|Years 6-10 (60-Month Extension)|Death|0|||
17103284|NCT00112437|38241460|FG019|Years 6-10 (60-Month Extension)|Death|0|||
17103285|NCT00112437|38241461|FG020|Years 6-10 (60-Month Extension)|Death|0|||
17103286|NCT00112437|38241462|FG021|Years 6-10 (60-Month Extension)|Death|0|||
17103287|NCT00112437|38241463|FG022|Years 6-10 (60-Month Extension)|Death|0|||
17103288|NCT00112437|38241464|FG023|Years 6-10 (60-Month Extension)|Death|2|||
17198684|NCT02706405|38352372|FG005|Overall Study|Death|0|||
16935662|NCT03303339|38080306|FG000|Overall Study|Withdrawal by Subject|1|||
16935663|NCT03303339|38080307|FG001|Overall Study|Withdrawal by Subject|0|||
17025010|NCT00760929|38169419|FG003|Overall Study|Other|1|||
17025011|NCT00760929|38169416|FG000|Overall Study|Death|0|||
17025012|NCT00760929|38169417|FG001|Overall Study|Death|0|||
17025013|NCT00760929|38169418|FG002|Overall Study|Death|1|||
17025014|NCT00760929|38169419|FG003|Overall Study|Death|0|||
17025015|NCT00760929|38169416|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
17025016|NCT00760929|38169417|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
17025017|NCT00760929|38169418|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
17025018|NCT00760929|38169419|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
17025019|NCT00818207|38169430|FG000|Overall Study|Adverse Event|6|||
17025020|NCT00818207|38169431|FG001|Overall Study|Adverse Event|0|||
17025021|NCT00818207|38169430|FG000|Overall Study|Lost to Follow-up|160|||
17025022|NCT00818207|38169431|FG001|Overall Study|Lost to Follow-up|146|||
17025023|NCT00818207|38169430|FG000|Overall Study|Multiple reasons|11|||
17025024|NCT00818207|38169431|FG001|Overall Study|Multiple reasons|12|||
17025025|NCT00818207|38169430|FG000|Overall Study|Withdrawal by Subject|42|||
17025026|NCT00818207|38169431|FG001|Overall Study|Withdrawal by Subject|104|||
17025027|NCT00818207|38169430|FG000|Overall Study|Death|3|||
17025028|NCT00818207|38169431|FG001|Overall Study|Death|5|||
17025029|NCT00760617|38169440|FG000|Overall Study|Adverse Event|5|||
17025030|NCT00760617|38169441|FG001|Overall Study|Adverse Event|2|||
17025031|NCT00760617|38169442|FG002|Overall Study|Adverse Event|0|||
17025032|NCT00760617|38169440|FG000|Overall Study|Lost to Follow-up|0|||
17025033|NCT00760617|38169441|FG001|Overall Study|Lost to Follow-up|0|||
17025034|NCT00760617|38169442|FG002|Overall Study|Lost to Follow-up|5|||
17025035|NCT00760383|38169452|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
17025036|NCT00760383|38169453|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
17025037|NCT00759915|38169461|FG000|Overall Study|Withdrawal by Subject|1|||
17025038|NCT00759915|38169462|FG001|Overall Study|Withdrawal by Subject|0|||
17025039|NCT00759915|38169461|FG000|Overall Study|Adverse Event|0|||
17025040|NCT00759915|38169462|FG001|Overall Study|Adverse Event|1|||
17025041|NCT00759759|38169470|FG000|Overall Study|didn't return for period 2|1|||
17025042|NCT00759759|38169471|FG001|Overall Study|didn't return for period 2|0|||
17025043|NCT00759759|38169470|FG000|Overall Study|Didn't receive drug in period 2|1|||
17025044|NCT00759759|38169471|FG001|Overall Study|Didn't receive drug in period 2|0|||
17025045|NCT00759759|38169470|FG000|Overall Study|Withdrawal by Subject|2|||
17025046|NCT00759759|38169471|FG001|Overall Study|Withdrawal by Subject|1|||
17025047|NCT00759681|38169479|FG000|Overall Study|Death|2|||
17025048|NCT00759681|38169480|FG001|Overall Study|Death|5|||
17025049|NCT00759681|38169479|FG000|Overall Study|Lost to Follow-up|8|||
17025050|NCT00759681|38169480|FG001|Overall Study|Lost to Follow-up|5|||
17025051|NCT00826241|38169487|FG000|Overall Study|Withdrawal from Follow-up|1|||
17025052|NCT00826241|38169487|FG000|Overall Study|Withdrew consent|2|||
17025053|NCT00826241|38169487|FG000|Overall Study|Death|4|||
17025054|NCT00826241|38169487|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
17025055|NCT00826241|38169487|FG000|Overall Study|Non-compliance|1|||
16935664|NCT03303339|38080308|FG002|Overall Study|Withdrawal by Subject|0|||
16935665|NCT03303339|38080309|FG003|Overall Study|Withdrawal by Subject|0|||
16935666|NCT03303339|38080310|FG004|Overall Study|Withdrawal by Subject|0|||
16935667|NCT03303339|38080311|FG005|Overall Study|Withdrawal by Subject|1|||
16935668|NCT03303339|38080312|FG006|Overall Study|Withdrawal by Subject|1|||
16935669|NCT03303339|38080313|FG007|Overall Study|Withdrawal by Subject|0|||
16935670|NCT03303339|38080314|FG008|Overall Study|Withdrawal by Subject|0|||
16935671|NCT03303339|38080315|FG009|Overall Study|Withdrawal by Subject|0|||
16935672|NCT03303339|38080316|FG010|Overall Study|Withdrawal by Subject|0|||
16935673|NCT03303339|38080317|FG011|Overall Study|Withdrawal by Subject|2|||
16935674|NCT03303339|38080306|FG000|Overall Study|Physician Decision|0|||
16935675|NCT03303339|38080307|FG001|Overall Study|Physician Decision|0|||
16935676|NCT03303339|38080308|FG002|Overall Study|Physician Decision|0|||
16935677|NCT03303339|38080309|FG003|Overall Study|Physician Decision|0|||
16935678|NCT03303339|38080310|FG004|Overall Study|Physician Decision|1|||
16935679|NCT03303339|38080311|FG005|Overall Study|Physician Decision|0|||
16935680|NCT03303339|38080312|FG006|Overall Study|Physician Decision|0|||
16935681|NCT03303339|38080313|FG007|Overall Study|Physician Decision|0|||
16935682|NCT03303339|38080314|FG008|Overall Study|Physician Decision|0|||
16935683|NCT03303339|38080315|FG009|Overall Study|Physician Decision|0|||
16935684|NCT03303339|38080316|FG010|Overall Study|Physician Decision|0|||
16935685|NCT03303339|38080317|FG011|Overall Study|Physician Decision|0|||
16935686|NCT03303339|38080306|FG000|Overall Study|Safety/Non-compliance|0|||
16935687|NCT03303339|38080307|FG001|Overall Study|Safety/Non-compliance|0|||
16935688|NCT03303339|38080308|FG002|Overall Study|Safety/Non-compliance|0|||
16935689|NCT03303339|38080309|FG003|Overall Study|Safety/Non-compliance|0|||
16935690|NCT03303339|38080310|FG004|Overall Study|Safety/Non-compliance|0|||
16935691|NCT03303339|38080311|FG005|Overall Study|Safety/Non-compliance|0|||
16935692|NCT03303339|38080312|FG006|Overall Study|Safety/Non-compliance|0|||
16935693|NCT03303339|38080313|FG007|Overall Study|Safety/Non-compliance|0|||
16935694|NCT03303339|38080314|FG008|Overall Study|Safety/Non-compliance|0|||
16935695|NCT03303339|38080315|FG009|Overall Study|Safety/Non-compliance|0|||
16935696|NCT03303339|38080316|FG010|Overall Study|Safety/Non-compliance|0|||
16935697|NCT03303339|38080317|FG011|Overall Study|Safety/Non-compliance|1|||
16935698|NCT01183780|38080362|FG000|Overall Study|Withdrawal by Subject|25|||
16935699|NCT01183780|38080363|FG001|Overall Study|Withdrawal by Subject|14|||
16935700|NCT01183780|38080362|FG000|Overall Study|Lost to Follow-up|6|||
17025056|NCT00826241|38169487|FG000|Overall Study|Progression of disease|1|||
17025057|NCT00826241|38169487|FG000|Overall Study|Patient refused follow-up|3|||
17025058|NCT00826241|38169487|FG000|Overall Study|Lost to Follow-up|9|||
16935701|NCT01183780|38080363|FG001|Overall Study|Lost to Follow-up|11|||
16935702|NCT01183468|38080373|FG000|Overall Study|Lost to Follow-up|2|||
16935703|NCT01183468|38080374|FG001|Overall Study|Lost to Follow-up|1|||
16935704|NCT01183468|38080375|FG002|Overall Study|Lost to Follow-up|0|||
16935705|NCT01183468|38080376|FG003|Overall Study|Lost to Follow-up|0|||
16935706|NCT01183468|38080373|FG000|Overall Study|Physician Decision|1|||
16935707|NCT01183468|38080374|FG001|Overall Study|Physician Decision|0|||
16935708|NCT01183468|38080375|FG002|Overall Study|Physician Decision|0|||
16935709|NCT01183468|38080376|FG003|Overall Study|Physician Decision|0|||
16935710|NCT01183468|38080373|FG000|Overall Study|Withdrawal by Subject|0|||
16935711|NCT01183468|38080374|FG001|Overall Study|Withdrawal by Subject|1|||
16935712|NCT01183468|38080375|FG002|Overall Study|Withdrawal by Subject|0|||
16935713|NCT01183468|38080376|FG003|Overall Study|Withdrawal by Subject|0|||
16935714|NCT01183390|38080386|FG000|First Intervention|Adverse Event|0|||
16935715|NCT01183390|38080387|FG001|First Intervention|Adverse Event|1|||
16935716|NCT01214668|38080416|FG000|Overall Study|Adverse Event|0|||
16935717|NCT01214668|38080417|FG001|Overall Study|Adverse Event|1|||
16935718|NCT01214668|38080418|FG002|Overall Study|Adverse Event|0|||
16935719|NCT01214668|38080419|FG003|Overall Study|Adverse Event|2|||
16935720|NCT01214668|38080420|FG004|Overall Study|Adverse Event|1|||
16935721|NCT01214668|38080421|FG005|Overall Study|Adverse Event|1|||
17025059|NCT00826241|38169487|FG000|Overall Study|Could not obtain records|1|||
17025060|NCT00826241|38169487|FG000|Overall Study|Screen failure|2|||
17025061|NCT00826241|38169487|FG000|Overall Study|Pt unable to proceed to registration|1|||
17025062|NCT00826241|38169487|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
17025063|NCT00758589|38169495|FG000|Overall Study|Adverse Event|3|||
17025064|NCT00758589|38169496|FG001|Overall Study|Adverse Event|2|||
17025065|NCT00758589|38169497|FG002|Overall Study|Adverse Event|5|||
17025066|NCT00758589|38169498|FG003|Overall Study|Adverse Event|4|||
17025067|NCT00758589|38169495|FG000|Overall Study|Withdrawal by Subject|0|||
17025068|NCT00758589|38169496|FG001|Overall Study|Withdrawal by Subject|1|||
17025069|NCT00758589|38169497|FG002|Overall Study|Withdrawal by Subject|1|||
17025070|NCT00758589|38169498|FG003|Overall Study|Withdrawal by Subject|1|||
17025071|NCT00758589|38169495|FG000|Overall Study|Palm stopped to work|0|||
17025072|NCT00758589|38169496|FG001|Overall Study|Palm stopped to work|0|||
17025073|NCT00758589|38169497|FG002|Overall Study|Palm stopped to work|0|||
17025074|NCT00758589|38169498|FG003|Overall Study|Palm stopped to work|1|||
17025075|NCT00833417|38169510|FG000|Overall Study|Adverse Event|5|||
17025076|NCT00833417|38169511|FG001|Overall Study|Adverse Event|16|||
17025077|NCT00833417|38169510|FG000|Overall Study|Death|1|||
17025078|NCT00833417|38169511|FG001|Overall Study|Death|3|||
17025079|NCT00833417|38169510|FG000|Overall Study|Lost to Follow-up|1|||
17025080|NCT00833417|38169511|FG001|Overall Study|Lost to Follow-up|2|||
17025081|NCT00833417|38169510|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
17025082|NCT00833417|38169511|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
17025083|NCT00833417|38169510|FG000|Overall Study|Patient Decision to Withdraw|4|||
17025084|NCT00833417|38169511|FG001|Overall Study|Patient Decision to Withdraw|23|||
17025085|NCT00833417|38169510|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
17025086|NCT00833417|38169511|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
17025087|NCT00833417|38169510|FG000|Overall Study|Disease Progression|18|||
17025088|NCT00833417|38169511|FG001|Overall Study|Disease Progression|17|||
17025089|NCT00833417|38169510|FG000|Overall Study|Reason Not Specified|0|||
17025090|NCT00833417|38169511|FG001|Overall Study|Reason Not Specified|1|||
17025091|NCT00762372|38169521|FG000|Overall Study|Adverse Event|1|||
17025092|NCT00762372|38169522|FG001|Overall Study|Adverse Event|0|||
17025093|NCT00762372|38169523|FG002|Overall Study|Adverse Event|0|||
17025094|NCT00833261|38169537|FG000|Overall Study|Withdrawal by Subject|4|||
17025095|NCT00833105|38169541|FG000|Overall Study|Withdrawal by Subject|1|||
17025096|NCT00833105|38169541|FG000|Overall Study|Adverse Event|2|||
17025097|NCT00833027|38169547|FG000|Overall Study|Adverse Event|33|||
17025098|NCT00833027|38169547|FG000|Overall Study|Death|1|||
17025099|NCT00833027|38169547|FG000|Overall Study|Lack of Efficacy|12|||
17025100|NCT00833027|38169547|FG000|Overall Study|Lost to Follow-up|24|||
17025101|NCT00833027|38169547|FG000|Overall Study|Protocol Violation|115|||
17025102|NCT00833027|38169547|FG000|Overall Study|Withdrawal by Subject|16|||
17025103|NCT00833027|38169547|FG000|Overall Study|Missing|10|||
17025104|NCT00752622|38169551|FG000|Induction Phase|Adverse Event|3|||
17025105|NCT00752622|38169551|FG000|Induction Phase|Other|3|||
17025106|NCT00752622|38169551|FG000|Induction Phase|Non-responder|14|||
17025107|NCT00752622|38169551|FG000|Induction Phase|Withdrawal by Subject|1|||
17025108|NCT00752622|38169551|FG000|Induction Phase|Premature study termination|14|||
17025109|NCT00752622|38169551|FG000|Observational Phase|Premature Study Termination|36|||
17025110|NCT00752622|38169551|FG000|Observational Phase|Non-responder|2|||
17025111|NCT00752622|38169551|FG000|Observational Phase|Withdrawal by Subject|2|||
16935722|NCT01214668|38080416|FG000|Overall Study|Death|0|||
16935723|NCT01214668|38080417|FG001|Overall Study|Death|0|||
17025112|NCT00752622|38169551|FG000|Observational Phase|Adverse Event|1|||
17025113|NCT00752622|38169551|FG000|Observational Phase|Other|2|||
17025114|NCT00752622|38169551|FG000|Interventional Phase|Non-responder|2|||
17025115|NCT00752622|38169551|FG000|Interventional Phase|Physician Decision|1|||
17025116|NCT00752622|38169551|FG000|Interventional Phase|Premature Study Termination|5|||
17025117|NCT00754650|38169556|FG000|Overall Study|Disease Progression|2|||
17025118|NCT00761748|38169560|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
17025119|NCT00761748|38169561|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
17025120|NCT00761748|38169560|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
17025121|NCT00761748|38169561|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
17025122|NCT00825305|38169569|FG000|Overall Study|Adverse Event|1|||
17025123|NCT00825305|38169570|FG001|Overall Study|Adverse Event|1|||
17025124|NCT00825305|38169569|FG000|Overall Study|Withdrawal by Subject|6|||
17025125|NCT00825305|38169570|FG001|Overall Study|Withdrawal by Subject|12|||
17025126|NCT00825305|38169569|FG000|Overall Study|Inappropriate inclusion|1|||
17025127|NCT00825305|38169570|FG001|Overall Study|Inappropriate inclusion|0|||
17025128|NCT00825305|38169569|FG000|Overall Study|Protocol Violation|9|||
17025129|NCT00825305|38169570|FG001|Overall Study|Protocol Violation|9|||
17025130|NCT00825305|38169569|FG000|Overall Study|Can not be classified|0|||
17025131|NCT00825305|38169570|FG001|Overall Study|Can not be classified|1|||
17025132|NCT00754572|38169576|FG000|Overall Study|Adverse Event|19|||
17025133|NCT00754572|38169576|FG000|Overall Study|Other|39|||
17025134|NCT00754572|38169576|FG000|Overall Study|Protocol Violation|3|||
17025135|NCT00754572|38169576|FG000|Overall Study|Withdrawal by Subject|3|||
17025136|NCT00754572|38169576|FG000|Overall Study|Lack of Efficacy|2|||
17025137|NCT00754572|38169576|FG000|Overall Study|Death|1|||
17025138|NCT00754572|38169576|FG000|Overall Study|Administrative Reason|3|||
17025139|NCT00754572|38169576|FG000|Overall Study|Lost to Follow-up|1|||
17025140|NCT00824993|38169582|FG000|Overall Study|Withdrawal by Subject|1|||
17025141|NCT00824993|38169583|FG001|Overall Study|Withdrawal by Subject|1|||
17025142|NCT00824993|38169582|FG000|Overall Study|Malignancy Relapse|9|||
17025143|NCT00824993|38169583|FG001|Overall Study|Malignancy Relapse|10|||
17025144|NCT00824993|38169582|FG000|Overall Study|Rapid Bone Loss|0|||
17025145|NCT00824993|38169583|FG001|Overall Study|Rapid Bone Loss|1|||
17025146|NCT00824993|38169582|FG000|Overall Study|Non-Compliant|2|||
17025147|NCT00824993|38169583|FG001|Overall Study|Non-Compliant|1|||
17025148|NCT00824993|38169582|FG000|Overall Study|Insurance Issue|2|||
17025149|NCT00824993|38169583|FG001|Overall Study|Insurance Issue|1|||
17025150|NCT00824993|38169582|FG000|Overall Study|Death|0|||
17025151|NCT00824993|38169583|FG001|Overall Study|Death|3|||
17025152|NCT00832091|38169591|FG000|Overall Study|Adverse Event|1|||
17025153|NCT00832091|38169592|FG001|Overall Study|Adverse Event|1|||
17025154|NCT00832091|38169591|FG000|Overall Study|Protocol Violation|1|||
17025155|NCT00832091|38169592|FG001|Overall Study|Protocol Violation|0|||
17025156|NCT00832091|38169591|FG000|Overall Study|Withdrawal by Subject|2|||
17025157|NCT00832091|38169592|FG001|Overall Study|Withdrawal by Subject|1|||
17103289|NCT00112437|38241465|FG024|Years 6-10 (60-Month Extension)|Death|0|||
17103290|NCT00112437|38241466|FG025|Years 6-10 (60-Month Extension)|Death|0|||
17103291|NCT00112437|38241441|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103292|NCT00112437|38241442|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103293|NCT00112437|38241443|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103294|NCT00112437|38241444|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103295|NCT00112437|38241445|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103296|NCT00112437|38241446|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17198685|NCT02706405|38352373|FG006|Overall Study|Death|3|||
17198686|NCT02706405|38352374|FG007|Overall Study|Death|4|||
17198687|NCT02706405|38352367|FG000|Overall Study|Disease progression|0|||
17198688|NCT02706405|38352368|FG001|Overall Study|Disease progression|0|||
17198689|NCT02706405|38352369|FG002|Overall Study|Disease progression|0|||
17198690|NCT02706405|38352370|FG003|Overall Study|Disease progression|0|||
17198691|NCT02706405|38352371|FG004|Overall Study|Disease progression|0|||
17198692|NCT02706405|38352372|FG005|Overall Study|Disease progression|0|||
17198693|NCT02706405|38352373|FG006|Overall Study|Disease progression|0|||
17198694|NCT02706405|38352374|FG007|Overall Study|Disease progression|1|||
17198695|NCT02706405|38352367|FG000|Overall Study|Pt moved to new therapy|0|||
17198696|NCT02706405|38352368|FG001|Overall Study|Pt moved to new therapy|0|||
17198697|NCT02706405|38352369|FG002|Overall Study|Pt moved to new therapy|0|||
17198698|NCT02706405|38352370|FG003|Overall Study|Pt moved to new therapy|0|||
17198699|NCT02706405|38352371|FG004|Overall Study|Pt moved to new therapy|0|||
17198700|NCT02706405|38352372|FG005|Overall Study|Pt moved to new therapy|1|||
17198701|NCT02706405|38352373|FG006|Overall Study|Pt moved to new therapy|0|||
17198702|NCT02706405|38352374|FG007|Overall Study|Pt moved to new therapy|1|||
17025158|NCT00832091|38169591|FG000|Overall Study|Prohibited Medication|1|||
17025159|NCT00832091|38169592|FG001|Overall Study|Prohibited Medication|0|||
17025160|NCT00754338|38169602|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
17025161|NCT00754338|38169603|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
17025162|NCT00754338|38169604|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
17025163|NCT00754338|38169605|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
17025164|NCT00754338|38169602|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
16935724|NCT01214668|38080418|FG002|Overall Study|Death|1|||
17025165|NCT00754338|38169603|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
17025166|NCT00754338|38169604|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
17025167|NCT00754338|38169605|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
17025168|NCT00761514|38169617|FG000|Overall Study|Adverse Event|1|||
17025169|NCT00761514|38169617|FG000|Overall Study|Withdrawal by Subject|2|||
17025170|NCT00761514|38169617|FG000|Overall Study|Lost to Follow-up|1|||
17025171|NCT00761514|38169617|FG000|Overall Study|Health insurance didn't cover study drug|1|||
17025172|NCT00761514|38169617|FG000|Overall Study|Problem complying with study visit|1|||
17025173|NCT00761514|38169617|FG000|Overall Study|Unable to pay for medications|1|||
17025174|NCT00831779|38169623|FG000|Overall Study|Lost to Follow-up|1|||
16935725|NCT01214668|38080419|FG003|Overall Study|Death|0|||
17025175|NCT00831779|38169624|FG001|Overall Study|Lost to Follow-up|0|||
17025176|NCT00831779|38169623|FG000|Overall Study|No longer met criteria|0|||
17025177|NCT00831779|38169624|FG001|Overall Study|No longer met criteria|1|||
17025178|NCT00758043|38169634|FG000|Overall Study|Adverse Event|1|||
17025179|NCT00758043|38169635|FG001|Overall Study|Adverse Event|20|||
17025180|NCT00758043|38169636|FG002|Overall Study|Adverse Event|12|||
17025181|NCT00758043|38169637|FG003|Overall Study|Adverse Event|62|||
17025182|NCT00758043|38169634|FG000|Overall Study|Lack of Efficacy|0|||
17025183|NCT00758043|38169635|FG001|Overall Study|Lack of Efficacy|6|||
17025184|NCT00758043|38169636|FG002|Overall Study|Lack of Efficacy|18|||
17025185|NCT00758043|38169637|FG003|Overall Study|Lack of Efficacy|12|||
17025186|NCT00758043|38169634|FG000|Overall Study|Refused Further Treatment|0|||
17025187|NCT00758043|38169635|FG001|Overall Study|Refused Further Treatment|11|||
17025188|NCT00758043|38169636|FG002|Overall Study|Refused Further Treatment|5|||
17025189|NCT00758043|38169637|FG003|Overall Study|Refused Further Treatment|8|||
17025190|NCT00758043|38169634|FG000|Overall Study|Lost to Follow-up|0|||
17025191|NCT00758043|38169635|FG001|Overall Study|Lost to Follow-up|2|||
17025192|NCT00758043|38169636|FG002|Overall Study|Lost to Follow-up|2|||
17025193|NCT00758043|38169637|FG003|Overall Study|Lost to Follow-up|5|||
17025194|NCT00758043|38169634|FG000|Overall Study|Withdrawal by Subject|0|||
17025195|NCT00758043|38169635|FG001|Overall Study|Withdrawal by Subject|1|||
17025196|NCT00758043|38169636|FG002|Overall Study|Withdrawal by Subject|1|||
17025197|NCT00758043|38169637|FG003|Overall Study|Withdrawal by Subject|4|||
17025198|NCT00758043|38169634|FG000|Overall Study|Required Prohibited Medication|0|||
17025199|NCT00758043|38169635|FG001|Overall Study|Required Prohibited Medication|0|||
17025200|NCT00758043|38169636|FG002|Overall Study|Required Prohibited Medication|1|||
17025201|NCT00758043|38169637|FG003|Overall Study|Required Prohibited Medication|3|||
17025202|NCT00758043|38169634|FG000|Overall Study|Non-Compliant With study Drug|0|||
17025203|NCT00758043|38169635|FG001|Overall Study|Non-Compliant With study Drug|0|||
17025204|NCT00758043|38169636|FG002|Overall Study|Non-Compliant With study Drug|0|||
16935726|NCT01214668|38080420|FG004|Overall Study|Death|0|||
16935727|NCT01214668|38080421|FG005|Overall Study|Death|0|||
16935728|NCT01214668|38080416|FG000|Overall Study|Progressive Disease|4|||
16935729|NCT01214668|38080417|FG001|Overall Study|Progressive Disease|2|||
16935730|NCT01214668|38080418|FG002|Overall Study|Progressive Disease|5|||
16935731|NCT01214668|38080419|FG003|Overall Study|Progressive Disease|4|||
16935732|NCT01214668|38080420|FG004|Overall Study|Progressive Disease|4|||
16935733|NCT01214668|38080421|FG005|Overall Study|Progressive Disease|5|||
16935734|NCT01214668|38080416|FG000|Overall Study|Withdrawal by Subject|0|||
16935735|NCT01214668|38080417|FG001|Overall Study|Withdrawal by Subject|0|||
16935736|NCT01214668|38080418|FG002|Overall Study|Withdrawal by Subject|0|||
16935737|NCT01214668|38080419|FG003|Overall Study|Withdrawal by Subject|0|||
16935738|NCT01214668|38080420|FG004|Overall Study|Withdrawal by Subject|1|||
16935739|NCT01214668|38080421|FG005|Overall Study|Withdrawal by Subject|0|||
16935740|NCT01191268|38080439|FG000|Overall Study|Withdrawal by Subject|19|||
17025205|NCT00758043|38169637|FG003|Overall Study|Non-Compliant With study Drug|1|||
17025206|NCT00758043|38169634|FG000|Overall Study|Other Reasons|0|||
17025207|NCT00758043|38169635|FG001|Overall Study|Other Reasons|1|||
17025208|NCT00758043|38169636|FG002|Overall Study|Other Reasons|0|||
17025209|NCT00758043|38169637|FG003|Overall Study|Other Reasons|5|||
17025210|NCT00831701|38169655|FG000|Overall Study|Withdrawal by Subject|2|||
17025211|NCT00831701|38169656|FG001|Overall Study|Withdrawal by Subject|0|||
17025212|NCT00831701|38169655|FG000|Overall Study|Stone expulsion before first medication|2|||
17025213|NCT00831701|38169656|FG001|Overall Study|Stone expulsion before first medication|2|||
17025214|NCT00831701|38169655|FG000|Overall Study|Lost to Follow-up|1|||
17025215|NCT00831701|38169656|FG001|Overall Study|Lost to Follow-up|3|||
17025216|NCT00752895|38169664|FG000|Overall Study|Withdrawal by Subject|8|||
17025217|NCT00752895|38169665|FG001|Overall Study|Withdrawal by Subject|3|||
17025218|NCT00831389|38169673|FG000|Overall Study|Withdrawal by Subject|0|||
17025219|NCT00831389|38169674|FG001|Overall Study|Withdrawal by Subject|1|||
17025220|NCT00831311|38169682|FG000|Overall Study|Definitive Contraindication|3|||
17025221|NCT00831311|38169683|FG001|Overall Study|Definitive Contraindication|3|||
16935741|NCT01191268|38080440|FG001|Overall Study|Withdrawal by Subject|25|||
16935742|NCT01191268|38080441|FG002|Overall Study|Withdrawal by Subject|21|||
17025222|NCT00831311|38169682|FG000|Overall Study|Lost to Follow-up|3|||
17025223|NCT00831311|38169683|FG001|Overall Study|Lost to Follow-up|0|||
17025224|NCT00831311|38169682|FG000|Overall Study|Physician Decision|0|||
17025225|NCT00831311|38169683|FG001|Overall Study|Physician Decision|1|||
17025226|NCT00831311|38169682|FG000|Overall Study|Withdrawal by Subject|6|||
17025227|NCT00831311|38169683|FG001|Overall Study|Withdrawal by Subject|4|||
17025228|NCT00831233|38169692|FG000|Overall Study|Adverse Event|0|||
17025229|NCT00831233|38169693|FG001|Overall Study|Adverse Event|1|||
17025230|NCT00831233|38169692|FG000|Overall Study|Protocol Violation|1|||
17025231|NCT00831233|38169693|FG001|Overall Study|Protocol Violation|0|||
17025232|NCT00831233|38169692|FG000|Overall Study|Selection Criteria Not Met|2|||
17025233|NCT00831233|38169693|FG001|Overall Study|Selection Criteria Not Met|0|||
17025234|NCT00761280|38169710|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
17025235|NCT00761280|38169711|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
17025236|NCT00761280|38169710|FG000|Randomization to First Dose|Sponsor decision|1|||
17025237|NCT00761280|38169711|FG001|Randomization to First Dose|Sponsor decision|0|||
17025238|NCT00761280|38169710|FG000|Randomization to First Dose|Other|1|||
17025239|NCT00761280|38169711|FG001|Randomization to First Dose|Other|0|||
17025240|NCT00761280|38169710|FG000|First Dose to End of Study|End of trial|5|||
17025241|NCT00761280|38169711|FG001|First Dose to End of Study|End of trial|5|||
17025242|NCT00761280|38169710|FG000|First Dose to End of Study|Progressive disease|5|||
17025243|NCT00761280|38169711|FG001|First Dose to End of Study|Progressive disease|3|||
16935743|NCT01191268|38080439|FG000|Overall Study|Adverse Event|21|||
17025244|NCT00761280|38169710|FG000|First Dose to End of Study|Sponsor decision|1|||
17025245|NCT00761280|38169711|FG001|First Dose to End of Study|Sponsor decision|2|||
17025246|NCT00761280|38169710|FG000|First Dose to End of Study|Death|1|||
17025247|NCT00761280|38169711|FG001|First Dose to End of Study|Death|0|||
17025248|NCT00761280|38169710|FG000|First Dose to End of Study|Lost to Follow-up|0|||
17025249|NCT00761280|38169711|FG001|First Dose to End of Study|Lost to Follow-up|1|||
17025250|NCT00824369|38169723|FG000|Overall Study|Nolonger willing to participate in study|1|||
17025251|NCT00824369|38169724|FG001|Overall Study|Nolonger willing to participate in study|0|||
17025252|NCT00824369|38169725|FG002|Overall Study|Nolonger willing to participate in study|1|||
17025253|NCT00824369|38169726|FG003|Overall Study|Nolonger willing to participate in study|2|||
17025254|NCT00824369|38169727|FG004|Overall Study|Nolonger willing to participate in study|0|||
17025255|NCT00824369|38169728|FG005|Overall Study|Nolonger willing to participate in study|1|||
17025256|NCT00824369|38169723|FG000|Overall Study|Lost to Follow-up|0|||
17025257|NCT00824369|38169724|FG001|Overall Study|Lost to Follow-up|0|||
17025258|NCT00824369|38169725|FG002|Overall Study|Lost to Follow-up|0|||
17025259|NCT00824369|38169726|FG003|Overall Study|Lost to Follow-up|0|||
17025260|NCT00824369|38169727|FG004|Overall Study|Lost to Follow-up|1|||
17025261|NCT00824369|38169728|FG005|Overall Study|Lost to Follow-up|0|||
17025262|NCT00824291|38169744|FG000|Overall Study|Adverse Event|15|||
17025263|NCT00824291|38169745|FG001|Overall Study|Adverse Event|6|||
17025264|NCT00824291|38169744|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
17025265|NCT00824291|38169745|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
17025266|NCT00824291|38169744|FG000|Overall Study|Lost to Follow-up|11|||
17025267|NCT00824291|38169745|FG001|Overall Study|Lost to Follow-up|9|||
17025268|NCT00824291|38169744|FG000|Overall Study|Non-compliance|1|||
17025269|NCT00824291|38169745|FG001|Overall Study|Non-compliance|1|||
17025270|NCT00824291|38169744|FG000|Overall Study|Protocol Violation|4|||
17025271|NCT00824291|38169745|FG001|Overall Study|Protocol Violation|1|||
17025272|NCT00824291|38169744|FG000|Overall Study|Withdrawal by Subject|14|||
17025273|NCT00824291|38169745|FG001|Overall Study|Withdrawal by Subject|8|||
17025274|NCT00824291|38169744|FG000|Overall Study|Lack of Efficacy|7|||
17025275|NCT00824291|38169745|FG001|Overall Study|Lack of Efficacy|8|||
17025276|NCT00824291|38169744|FG000|Overall Study|Participant on prohibited medication|1|||
17025277|NCT00824291|38169745|FG001|Overall Study|Participant on prohibited medication|0|||
17103297|NCT00112437|38241447|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17198703|NCT02706405|38352367|FG000|Overall Study|Physician Decision|1|||
16935744|NCT01191268|38080440|FG001|Overall Study|Adverse Event|13|||
16935745|NCT01191268|38080441|FG002|Overall Study|Adverse Event|8|||
16935746|NCT01191268|38080439|FG000|Overall Study|Physician Decision|6|||
16935747|NCT01191268|38080440|FG001|Overall Study|Physician Decision|8|||
16935748|NCT01191268|38080441|FG002|Overall Study|Physician Decision|9|||
16935749|NCT01191268|38080439|FG000|Overall Study|Lost to Follow-up|8|||
16935750|NCT01191268|38080440|FG001|Overall Study|Lost to Follow-up|5|||
16935751|NCT01191268|38080441|FG002|Overall Study|Lost to Follow-up|9|||
16935752|NCT01191268|38080439|FG000|Overall Study|Entry Criteria Not Met|3|||
16935753|NCT01191268|38080440|FG001|Overall Study|Entry Criteria Not Met|1|||
16935754|NCT01191268|38080441|FG002|Overall Study|Entry Criteria Not Met|1|||
16935755|NCT01191268|38080439|FG000|Overall Study|Death|0|||
16935756|NCT01191268|38080440|FG001|Overall Study|Death|1|||
16935757|NCT01191268|38080441|FG002|Overall Study|Death|3|||
16935758|NCT01191268|38080439|FG000|Overall Study|Protocol Violation|1|||
16935759|NCT01191268|38080440|FG001|Overall Study|Protocol Violation|0|||
16935760|NCT01191268|38080441|FG002|Overall Study|Protocol Violation|1|||
17198704|NCT02706405|38352368|FG001|Overall Study|Physician Decision|0|||
17025278|NCT00804986|38169757|FG000|Overall Study|Adverse Event|0|||
17025279|NCT00804986|38169758|FG001|Overall Study|Adverse Event|1|||
17025280|NCT00804986|38169759|FG002|Overall Study|Adverse Event|2|||
17025281|NCT00804986|38169760|FG003|Overall Study|Adverse Event|1|||
17025282|NCT00804986|38169761|FG004|Overall Study|Adverse Event|3|||
17025283|NCT00804986|38169762|FG005|Overall Study|Adverse Event|0|||
17025284|NCT00804986|38169757|FG000|Overall Study|Lack of Efficacy|0|||
17025285|NCT00804986|38169758|FG001|Overall Study|Lack of Efficacy|0|||
17025286|NCT00804986|38169759|FG002|Overall Study|Lack of Efficacy|0|||
17025287|NCT00804986|38169760|FG003|Overall Study|Lack of Efficacy|1|||
17025288|NCT00804986|38169761|FG004|Overall Study|Lack of Efficacy|0|||
17025289|NCT00804986|38169762|FG005|Overall Study|Lack of Efficacy|3|||
17025290|NCT00804986|38169757|FG000|Overall Study|Lost to Follow-up|0|||
17025291|NCT00804986|38169758|FG001|Overall Study|Lost to Follow-up|0|||
17025292|NCT00804986|38169759|FG002|Overall Study|Lost to Follow-up|0|||
17025293|NCT00804986|38169760|FG003|Overall Study|Lost to Follow-up|1|||
17025294|NCT00804986|38169761|FG004|Overall Study|Lost to Follow-up|1|||
17025295|NCT00804986|38169762|FG005|Overall Study|Lost to Follow-up|3|||
17025296|NCT00804986|38169757|FG000|Overall Study|Protocol Violation|0|||
17025297|NCT00804986|38169758|FG001|Overall Study|Protocol Violation|1|||
17025298|NCT00804986|38169759|FG002|Overall Study|Protocol Violation|0|||
17025299|NCT00804986|38169760|FG003|Overall Study|Protocol Violation|1|||
17025300|NCT00804986|38169761|FG004|Overall Study|Protocol Violation|0|||
17025301|NCT00804986|38169762|FG005|Overall Study|Protocol Violation|0|||
17025302|NCT00804986|38169757|FG000|Overall Study|Withdrawal by Subject|0|||
17025303|NCT00804986|38169758|FG001|Overall Study|Withdrawal by Subject|3|||
17025304|NCT00804986|38169759|FG002|Overall Study|Withdrawal by Subject|0|||
17025305|NCT00804986|38169760|FG003|Overall Study|Withdrawal by Subject|3|||
17025306|NCT00804986|38169761|FG004|Overall Study|Withdrawal by Subject|5|||
17025307|NCT00804986|38169762|FG005|Overall Study|Withdrawal by Subject|3|||
17025308|NCT00804986|38169757|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
17025309|NCT00804986|38169758|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
17025310|NCT00804986|38169759|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
17025311|NCT00804986|38169760|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
17025312|NCT00804986|38169761|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
17103298|NCT00112437|38241448|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16852981|NCT01381575|37803233|FG002|Overall Study|Lost to Follow-up|9|||
16852982|NCT01858363|37803244|FG000|Overall Study|Death|35|||
16852983|NCT01858363|37803245|FG001|Overall Study|Death|9|||
16852984|NCT01858363|37803244|FG000|Overall Study|Withdrawal by Subject|28|||
16852985|NCT01858363|37803245|FG001|Overall Study|Withdrawal by Subject|14|||
16852986|NCT01858363|37803244|FG000|Overall Study|Lost to Follow-up|13|||
16852987|NCT01858363|37803245|FG001|Overall Study|Lost to Follow-up|3|||
16852988|NCT01877551|37803253|FG000|Overall Study|Physician Decision|0|||
16852989|NCT01877551|37803254|FG001|Overall Study|Physician Decision|1|||
16852990|NCT01396005|37803262|FG000|Overall Study|Withdrawal by Subject|0|||
16852991|NCT01396005|37803263|FG001|Overall Study|Withdrawal by Subject|1|||
16852992|NCT01396005|37803262|FG000|Overall Study|Non-compliance with protocol|0|||
16852993|NCT01396005|37803263|FG001|Overall Study|Non-compliance with protocol|1|||
16852994|NCT01877239|37803271|FG000|Overall Study|Adverse Event|4|||
16852995|NCT01877239|37803271|FG000|Overall Study|Disease Remission|1|||
16852996|NCT01877239|37803271|FG000|Overall Study|Withdrawal by Subject|4|||
16852997|NCT01877239|37803271|FG000|Overall Study|Other|2|||
16852998|NCT01877239|37803271|FG000|Overall Study|Lack of Efficacy|4|||
16852999|NCT01877239|37803271|FG000|Overall Study|Data not available|35|||
16853000|NCT01877083|37803275|FG000|Treatment Phase|Disease Progression|10|||
16853001|NCT01877083|37803275|FG000|Treatment Phase|Clinical Progression|1|||
16853002|NCT01877083|37803275|FG000|Treatment Phase|Adverse Event|6|||
16853003|NCT01877083|37803275|FG000|Treatment Phase|Withdrawal by Subject|2|||
16853004|NCT01877083|37803275|FG000|Treatment Phase|Lost to Follow-up|1|||
16853005|NCT01877083|37803275|FG000|Extension Phase|Disease Progression|3|||
16853006|NCT01877083|37803275|FG000|Extension Phase|Adverse Event|2|||
16853007|NCT01380327|37803282|FG000|Overall Study|Lost to Follow-up|0|||
16853008|NCT01380327|37803283|FG001|Overall Study|Lost to Follow-up|1|||
16853009|NCT01380327|37803284|FG002|Overall Study|Lost to Follow-up|1|||
16853010|NCT01380327|37803282|FG000|Overall Study|Protocol Violation|3|||
16853011|NCT01380327|37803283|FG001|Overall Study|Protocol Violation|2|||
16853012|NCT01380327|37803284|FG002|Overall Study|Protocol Violation|3|||
16853013|NCT01380327|37803282|FG000|Overall Study|Withdrawal by Subject|0|||
16853014|NCT01380327|37803283|FG001|Overall Study|Withdrawal by Subject|0|||
16853015|NCT01380327|37803284|FG002|Overall Study|Withdrawal by Subject|1|||
17025313|NCT00804986|38169762|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
17025314|NCT00804986|38169757|FG000|Overall Study|Sponsor Decision|0|||
17025315|NCT00804986|38169758|FG001|Overall Study|Sponsor Decision|1|||
17025316|NCT00804986|38169759|FG002|Overall Study|Sponsor Decision|0|||
17025317|NCT00804986|38169760|FG003|Overall Study|Sponsor Decision|0|||
17025318|NCT00804986|38169761|FG004|Overall Study|Sponsor Decision|0|||
17025319|NCT00804986|38169762|FG005|Overall Study|Sponsor Decision|0|||
17025320|NCT00804986|38169757|FG000|Overall Study|Physician Decision|1|||
17025321|NCT00804986|38169758|FG001|Overall Study|Physician Decision|0|||
17025322|NCT00804986|38169759|FG002|Overall Study|Physician Decision|0|||
17025323|NCT00804986|38169760|FG003|Overall Study|Physician Decision|0|||
17025324|NCT00804986|38169761|FG004|Overall Study|Physician Decision|0|||
17025325|NCT00804986|38169762|FG005|Overall Study|Physician Decision|0|||
17025326|NCT00752232|38169783|FG000|Overall Study|Protocol Violation|0|||
17025327|NCT00752232|38169784|FG001|Overall Study|Protocol Violation|0|||
17025328|NCT00752232|38169785|FG002|Overall Study|Protocol Violation|0|||
17025329|NCT00752232|38169786|FG003|Overall Study|Protocol Violation|0|||
17025330|NCT00752232|38169787|FG004|Overall Study|Protocol Violation|0|||
17025331|NCT00752232|38169788|FG005|Overall Study|Protocol Violation|1|||
17025332|NCT00752232|38169789|FG006|Overall Study|Protocol Violation|0|||
17025333|NCT00752232|38169783|FG000|Overall Study|Caregiver request|2|||
17025334|NCT00752232|38169784|FG001|Overall Study|Caregiver request|0|||
17025335|NCT00752232|38169785|FG002|Overall Study|Caregiver request|0|||
17025336|NCT00752232|38169786|FG003|Overall Study|Caregiver request|0|||
17025337|NCT00752232|38169787|FG004|Overall Study|Caregiver request|1|||
17025338|NCT00752232|38169788|FG005|Overall Study|Caregiver request|0|||
17025339|NCT00752232|38169789|FG006|Overall Study|Caregiver request|0|||
17025340|NCT00752232|38169783|FG000|Overall Study|Investigator request|0|||
17025341|NCT00752232|38169784|FG001|Overall Study|Investigator request|0|||
17025342|NCT00752232|38169785|FG002|Overall Study|Investigator request|0|||
17025343|NCT00752232|38169786|FG003|Overall Study|Investigator request|0|||
17025344|NCT00752232|38169787|FG004|Overall Study|Investigator request|1|||
17025345|NCT00752232|38169788|FG005|Overall Study|Investigator request|0|||
17025346|NCT00752232|38169789|FG006|Overall Study|Investigator request|0|||
17025347|NCT00752232|38169783|FG000|Overall Study|Subject request|0|||
17025348|NCT00752232|38169784|FG001|Overall Study|Subject request|0|||
17025349|NCT00752232|38169785|FG002|Overall Study|Subject request|1|||
17025350|NCT00752232|38169786|FG003|Overall Study|Subject request|0|||
17025351|NCT00752232|38169787|FG004|Overall Study|Subject request|0|||
17025352|NCT00752232|38169788|FG005|Overall Study|Subject request|0|||
17025353|NCT00752232|38169789|FG006|Overall Study|Subject request|0|||
17025354|NCT00752232|38169783|FG000|Overall Study|Group home admission|0|||
17025355|NCT00752232|38169784|FG001|Overall Study|Group home admission|0|||
17025356|NCT00752232|38169785|FG002|Overall Study|Group home admission|0|||
17025357|NCT00752232|38169786|FG003|Overall Study|Group home admission|1|||
17025358|NCT00752232|38169787|FG004|Overall Study|Group home admission|0|||
17025359|NCT00752232|38169788|FG005|Overall Study|Group home admission|0|||
17025360|NCT00752232|38169789|FG006|Overall Study|Group home admission|0|||
17025361|NCT00752232|38169783|FG000|Overall Study|Caregiver could not attend the subject|0|||
17025362|NCT00752232|38169784|FG001|Overall Study|Caregiver could not attend the subject|0|||
17025363|NCT00752232|38169785|FG002|Overall Study|Caregiver could not attend the subject|0|||
17025364|NCT00752232|38169786|FG003|Overall Study|Caregiver could not attend the subject|0|||
17025365|NCT00752232|38169787|FG004|Overall Study|Caregiver could not attend the subject|1|||
17025366|NCT00752232|38169788|FG005|Overall Study|Caregiver could not attend the subject|0|||
17025367|NCT00752232|38169789|FG006|Overall Study|Caregiver could not attend the subject|0|||
17025368|NCT00760266|38169808|FG000|Overall Study|Adverse Event|13|||
17025369|NCT00760266|38169809|FG001|Overall Study|Adverse Event|7|||
17025370|NCT00760266|38169808|FG000|Overall Study|Abnormal laboratory value(s)|1|||
17025371|NCT00760266|38169809|FG001|Overall Study|Abnormal laboratory value(s)|0|||
17025372|NCT00760266|38169808|FG000|Overall Study|Abnormal test procedure result(s)|1|||
17103299|NCT00112437|38241449|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103300|NCT00112437|38241450|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103301|NCT00112437|38241451|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103302|NCT00112437|38241452|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103303|NCT00112437|38241453|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103304|NCT00112437|38241454|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103305|NCT00112437|38241455|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103306|NCT00112437|38241456|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103307|NCT00112437|38241457|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103308|NCT00112437|38241458|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103309|NCT00112437|38241459|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103310|NCT00112437|38241460|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103311|NCT00112437|38241461|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17025373|NCT00760266|38169809|FG001|Overall Study|Abnormal test procedure result(s)|0|||
17025374|NCT00760266|38169808|FG000|Overall Study|Lack of Efficacy|2|||
17025375|NCT00760266|38169809|FG001|Overall Study|Lack of Efficacy|2|||
17025376|NCT00760266|38169808|FG000|Overall Study|Protocol deviation|2|||
17025377|NCT00760266|38169809|FG001|Overall Study|Protocol deviation|4|||
17025378|NCT00760266|38169808|FG000|Overall Study|Patient withdrew consent|3|||
17025379|NCT00760266|38169809|FG001|Overall Study|Patient withdrew consent|3|||
17025380|NCT00760266|38169808|FG000|Overall Study|Lost to Follow-up|2|||
17025381|NCT00760266|38169809|FG001|Overall Study|Lost to Follow-up|1|||
17025382|NCT00760266|38169808|FG000|Overall Study|Administrative Problems|0|||
17025383|NCT00760266|38169809|FG001|Overall Study|Administrative Problems|1|||
17025384|NCT00753714|38169817|FG000|Overall Study|Lack of Efficacy|21|||
17025385|NCT00753714|38169818|FG001|Overall Study|Lack of Efficacy|34|||
17025386|NCT00753714|38169817|FG000|Overall Study|Adverse Event|26|||
17025387|NCT00753714|38169818|FG001|Overall Study|Adverse Event|18|||
16853016|NCT01380327|37803282|FG000|Overall Study|Housing situation precluded ability to k|0|||
16853017|NCT01380327|37803283|FG001|Overall Study|Housing situation precluded ability to k|0|||
16853018|NCT01380327|37803284|FG002|Overall Study|Housing situation precluded ability to k|1|||
16853019|NCT01380327|37803282|FG000|Overall Study|Questionable onset of epilepsy|0|||
16853020|NCT01380327|37803283|FG001|Overall Study|Questionable onset of epilepsy|0|||
16853021|NCT01380327|37803284|FG002|Overall Study|Questionable onset of epilepsy|1|||
16935761|NCT01191268|38080439|FG000|Overall Study|Sponsor Decision|0|||
17103312|NCT00112437|38241462|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103313|NCT00112437|38241463|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103314|NCT00112437|38241464|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103315|NCT00112437|38241465|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
17103316|NCT00112437|38241466|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
17103317|NCT00112437|38241441|FG000|Years 6-10 (60-Month Extension)|Other|0|||
17103318|NCT00112437|38241442|FG001|Years 6-10 (60-Month Extension)|Other|0|||
17103319|NCT00112437|38241443|FG002|Years 6-10 (60-Month Extension)|Other|0|||
17103320|NCT00112437|38241444|FG003|Years 6-10 (60-Month Extension)|Other|0|||
17103321|NCT00112437|38241445|FG004|Years 6-10 (60-Month Extension)|Other|0|||
17103322|NCT00112437|38241446|FG005|Years 6-10 (60-Month Extension)|Other|0|||
17103323|NCT00112437|38241447|FG006|Years 6-10 (60-Month Extension)|Other|0|||
17103324|NCT00112437|38241448|FG007|Years 6-10 (60-Month Extension)|Other|0|||
17103325|NCT00112437|38241449|FG008|Years 6-10 (60-Month Extension)|Other|0|||
17103326|NCT00112437|38241450|FG009|Years 6-10 (60-Month Extension)|Other|0|||
17103327|NCT00112437|38241451|FG010|Years 6-10 (60-Month Extension)|Other|0|||
17103328|NCT00112437|38241452|FG011|Years 6-10 (60-Month Extension)|Other|0|||
17025388|NCT00753714|38169817|FG000|Overall Study|Protocol Violation|1|||
17025389|NCT00753714|38169818|FG001|Overall Study|Protocol Violation|0|||
17025390|NCT00753714|38169817|FG000|Overall Study|Lost to Follow-up|0|||
17025391|NCT00753714|38169818|FG001|Overall Study|Lost to Follow-up|1|||
17103329|NCT00112437|38241453|FG012|Years 6-10 (60-Month Extension)|Other|0|||
17103330|NCT00112437|38241454|FG013|Years 6-10 (60-Month Extension)|Other|0|||
17103331|NCT00112437|38241455|FG014|Years 6-10 (60-Month Extension)|Other|0|||
17103332|NCT00112437|38241456|FG015|Years 6-10 (60-Month Extension)|Other|0|||
17103333|NCT00112437|38241457|FG016|Years 6-10 (60-Month Extension)|Other|0|||
17103334|NCT00112437|38241458|FG017|Years 6-10 (60-Month Extension)|Other|0|||
17103335|NCT00112437|38241459|FG018|Years 6-10 (60-Month Extension)|Other|0|||
17103336|NCT00112437|38241460|FG019|Years 6-10 (60-Month Extension)|Other|0|||
17103337|NCT00112437|38241461|FG020|Years 6-10 (60-Month Extension)|Other|0|||
17103338|NCT00112437|38241462|FG021|Years 6-10 (60-Month Extension)|Other|0|||
17103339|NCT00112437|38241463|FG022|Years 6-10 (60-Month Extension)|Other|0|||
17103340|NCT00112437|38241464|FG023|Years 6-10 (60-Month Extension)|Other|0|||
17103341|NCT00112437|38241465|FG024|Years 6-10 (60-Month Extension)|Other|1|||
16935762|NCT01191268|38080440|FG001|Overall Study|Sponsor Decision|2|||
16935763|NCT01191268|38080441|FG002|Overall Study|Sponsor Decision|0|||
16935764|NCT01191190|38080450|FG000|Overall Study|Withdrawal by Subject|1|||
16935765|NCT01214629|38080478|FG000|Overall Study|Progressive Disease|1|||
16935766|NCT01214629|38080479|FG001|Overall Study|Progressive Disease|1|||
16935767|NCT01214629|38080480|FG002|Overall Study|Progressive Disease|0|||
16935768|NCT01214629|38080481|FG003|Overall Study|Progressive Disease|1|||
17025392|NCT00753714|38169817|FG000|Overall Study|Withdrawal by Subject|2|||
17103342|NCT00112437|38241466|FG025|Years 6-10 (60-Month Extension)|Other|0|||
17103343|NCT00112437|38241441|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103344|NCT00112437|38241442|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103345|NCT00112437|38241443|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103346|NCT00112437|38241444|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17198705|NCT02706405|38352369|FG002|Overall Study|Physician Decision|0|||
17025393|NCT00753714|38169818|FG001|Overall Study|Withdrawal by Subject|1|||
17025394|NCT00753714|38169817|FG000|Overall Study|Death|3|||
17025395|NCT00753714|38169818|FG001|Overall Study|Death|3|||
17025396|NCT00753714|38169817|FG000|Overall Study|Other|7|||
17025397|NCT00753714|38169818|FG001|Overall Study|Other|5|||
17025398|NCT00759954|38169829|FG000|Overall Study|Personal reason|1|||
16853022|NCT01829425|37803294|FG000|Overall Study|Withdrawal by Subject|4|||
16853023|NCT01829425|37803295|FG001|Overall Study|Withdrawal by Subject|3|||
16853024|NCT01829425|37803294|FG000|Overall Study|Lost to Follow-up|2|||
16853025|NCT01829425|37803295|FG001|Overall Study|Lost to Follow-up|1|||
16853026|NCT01394991|37803312|FG000|Overall Study|Adverse Event|0|||
16853027|NCT01394991|37803313|FG001|Overall Study|Adverse Event|4|||
16853028|NCT01394991|37803312|FG000|Overall Study|Lack of Efficacy|5|||
17025399|NCT00759954|38169830|FG001|Overall Study|Personal reason|0|||
17103347|NCT00112437|38241445|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17025400|NCT00759954|38169829|FG000|Overall Study|Adverse Event|1|||
17025401|NCT00759954|38169830|FG001|Overall Study|Adverse Event|2|||
17025402|NCT00804908|38169839|FG000|Overall Study|Other|115|||
17025403|NCT00804908|38169840|FG001|Overall Study|Other|116|||
17025404|NCT00804908|38169841|FG002|Overall Study|Other|114|||
17025405|NCT00808808|38169852|FG000|Overall Study|Vaccinated; survey not completed|131|||
17103348|NCT00112437|38241446|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103349|NCT00112437|38241447|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103350|NCT00112437|38241448|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103351|NCT00112437|38241449|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103352|NCT00112437|38241450|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103353|NCT00112437|38241451|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103354|NCT00112437|38241452|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17025406|NCT00808808|38169853|FG001|Overall Study|Vaccinated; survey not completed|169|||
17025407|NCT00808808|38169854|FG002|Overall Study|Vaccinated; survey not completed|302|||
17025408|NCT00808808|38169852|FG000|Overall Study|Employee was not vaccinated.|2686|||
17103355|NCT00112437|38241453|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103356|NCT00112437|38241454|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17025409|NCT00808808|38169853|FG001|Overall Study|Employee was not vaccinated.|2268|||
17025410|NCT00808808|38169854|FG002|Overall Study|Employee was not vaccinated.|2255|||
17025411|NCT00589784|38169870|FG000|Overall Study|Withdrawal by Subject|0|||
17025412|NCT00589784|38169871|FG001|Overall Study|Withdrawal by Subject|6|||
17025413|NCT00589784|38169870|FG000|Overall Study|Patient inevaluable|1|||
17025414|NCT00589784|38169871|FG001|Overall Study|Patient inevaluable|0|||
17025415|NCT00589784|38169870|FG000|Overall Study|Adverse Event|0|||
17025416|NCT00589784|38169871|FG001|Overall Study|Adverse Event|4|||
17025417|NCT00759876|38169876|FG000|Overall Study|Sponsor terminated study early|36|||
17025418|NCT00823979|38169883|FG000|Overall Study|Lack of Efficacy|13|||
17025419|NCT00823979|38169884|FG001|Overall Study|Lack of Efficacy|16|||
17025420|NCT00823979|38169885|FG002|Overall Study|Lack of Efficacy|9|||
17025421|NCT00823979|38169883|FG000|Overall Study|Lost to Follow-up|2|||
17025422|NCT00823979|38169884|FG001|Overall Study|Lost to Follow-up|1|||
17025423|NCT00823979|38169885|FG002|Overall Study|Lost to Follow-up|0|||
17025424|NCT00823979|38169883|FG000|Overall Study|Withdrawal by Subject|2|||
17025425|NCT00823979|38169884|FG001|Overall Study|Withdrawal by Subject|3|||
17025426|NCT00823979|38169885|FG002|Overall Study|Withdrawal by Subject|2|||
17103357|NCT00112437|38241455|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103358|NCT00112437|38241456|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103359|NCT00112437|38241457|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103360|NCT00112437|38241458|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103361|NCT00112437|38241459|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103362|NCT00112437|38241460|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17025427|NCT00823979|38169883|FG000|Overall Study|Protocol Violation|1|||
17025428|NCT00823979|38169884|FG001|Overall Study|Protocol Violation|1|||
17103363|NCT00112437|38241461|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103364|NCT00112437|38241462|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103365|NCT00112437|38241463|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103366|NCT00112437|38241464|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
17103367|NCT00112437|38241465|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103368|NCT00112437|38241466|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
17103369|NCT00112437|38241441|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103370|NCT00112437|38241442|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17025429|NCT00823979|38169885|FG002|Overall Study|Protocol Violation|0|||
17025430|NCT00823979|38169883|FG000|Overall Study|Pregnancy|0|||
17025431|NCT00823979|38169884|FG001|Overall Study|Pregnancy|1|||
17025432|NCT00823979|38169885|FG002|Overall Study|Pregnancy|0|||
17025433|NCT00823979|38169883|FG000|Overall Study|Adverse Event|0|||
17025434|NCT00823979|38169884|FG001|Overall Study|Adverse Event|2|||
17025435|NCT00823979|38169885|FG002|Overall Study|Adverse Event|4|||
17025436|NCT00823979|38169883|FG000|Overall Study|Other|2|||
17025437|NCT00823979|38169884|FG001|Overall Study|Other|0|||
17025438|NCT00823979|38169885|FG002|Overall Study|Other|1|||
17025439|NCT00823979|38169883|FG000|Overall Study|Randomized but not Treated|4|||
17025440|NCT00823979|38169884|FG001|Overall Study|Randomized but not Treated|3|||
17025441|NCT00823979|38169885|FG002|Overall Study|Randomized but not Treated|1|||
17025442|NCT00823979|38169883|FG000|Overall Study|Study Terminated by Sponsor|5|||
17025443|NCT00823979|38169884|FG001|Overall Study|Study Terminated by Sponsor|5|||
17025444|NCT00823979|38169885|FG002|Overall Study|Study Terminated by Sponsor|7|||
17025445|NCT00823901|38169895|FG000|Overall Study|Adverse Event|1|||
17025446|NCT00823901|38169896|FG001|Overall Study|Adverse Event|1|||
17025447|NCT00823901|38169895|FG000|Overall Study|Lack of Efficacy|1|||
17025448|NCT00823901|38169896|FG001|Overall Study|Lack of Efficacy|0|||
17025449|NCT00823901|38169895|FG000|Overall Study|Lost to Follow-up|2|||
17025450|NCT00823901|38169896|FG001|Overall Study|Lost to Follow-up|1|||
17025451|NCT00823823|38169904|FG000|Overall Study|Lost to Follow-up|3|||
17025452|NCT00823823|38169905|FG001|Overall Study|Lost to Follow-up|1|||
17025453|NCT00823823|38169904|FG000|Overall Study|Protocol Violation|5|||
17025454|NCT00823823|38169905|FG001|Overall Study|Protocol Violation|5|||
17025455|NCT00759564|38169925|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
17025456|NCT00759564|38169926|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
17025457|NCT00759564|38169927|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
17025458|NCT00759564|38169928|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
17025459|NCT00759564|38169929|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
17025460|NCT00816023|38169965|FG000|Overall Study|Lost to Follow-up|1|||
17025461|NCT00816023|38169966|FG001|Overall Study|Lost to Follow-up|1|||
17025462|NCT00816023|38169967|FG002|Overall Study|Lost to Follow-up|0|||
17025463|NCT00816023|38169968|FG003|Overall Study|Lost to Follow-up|0|||
17025464|NCT00816023|38169965|FG000|Overall Study|Withdrawal by Subject|1|||
17025465|NCT00816023|38169966|FG001|Overall Study|Withdrawal by Subject|0|||
17025466|NCT00816023|38169967|FG002|Overall Study|Withdrawal by Subject|0|||
17025467|NCT00816023|38169968|FG003|Overall Study|Withdrawal by Subject|0|||
17025468|NCT00816023|38169965|FG000|Overall Study|Physician Decision|0|||
17025469|NCT00816023|38169966|FG001|Overall Study|Physician Decision|0|||
17025470|NCT00816023|38169967|FG002|Overall Study|Physician Decision|1|||
17025471|NCT00816023|38169968|FG003|Overall Study|Physician Decision|0|||
17025472|NCT00816023|38169965|FG000|Overall Study|assessments complete prior to window|1|||
17025473|NCT00816023|38169966|FG001|Overall Study|assessments complete prior to window|1|||
17025474|NCT00816023|38169967|FG002|Overall Study|assessments complete prior to window|2|||
17025475|NCT00816023|38169968|FG003|Overall Study|assessments complete prior to window|1|||
17025476|NCT00816023|38169965|FG000|Overall Study|Randomized Not Treated|6|||
17025477|NCT00816023|38169966|FG001|Overall Study|Randomized Not Treated|4|||
17025478|NCT00816023|38169967|FG002|Overall Study|Randomized Not Treated|6|||
17025479|NCT00816023|38169968|FG003|Overall Study|Randomized Not Treated|11|||
17025480|NCT00759174|38169980|FG000|Overall Study|Other|0|||
17025481|NCT00759174|38169981|FG001|Overall Study|Other|2|||
17025482|NCT00815633|38169988|FG000|Overall Study|study terminated|1|||
17025483|NCT03631784|38169994|FG000|Overall Study|Death|48|||
17025484|NCT03631784|38169995|FG001|Overall Study|Death|28|||
17025485|NCT03631784|38169994|FG000|Overall Study|Lost to Follow-up|1|||
17025486|NCT03631784|38169995|FG001|Overall Study|Lost to Follow-up|0|||
17025487|NCT03631784|38169994|FG000|Overall Study|Withdrawal by Subject|0|||
17025488|NCT03631784|38169995|FG001|Overall Study|Withdrawal by Subject|3|||
17025489|NCT03631784|38169994|FG000|Overall Study|Participants Ongoing|63|||
17025490|NCT03631784|38169995|FG001|Overall Study|Participants Ongoing|71|||
17025491|NCT00830765|38170003|FG000|Overall Study|Protocol Violation|3|||
17025492|NCT00830765|38170004|FG001|Overall Study|Protocol Violation|2|||
17025493|NCT00830375|38170010|FG000|Overall Study|Lost to Follow-up|1|||
17025494|NCT00803270|38170016|FG000|Overall Study|Lost to Follow-up|1|||
17025495|NCT00803270|38170017|FG001|Overall Study|Lost to Follow-up|2|||
17025496|NCT00751998|38170023|FG000|Overall Study|Lost to Follow-up|7|||
17025497|NCT00751998|38170023|FG000|Overall Study|Death|11|||
17025498|NCT00751998|38170023|FG000|Overall Study|Withdrawal by Subject|2|||
17025499|NCT00803738|38170029|FG000|Overall Study|Adverse Event|3|||
17025500|NCT00803738|38170030|FG001|Overall Study|Adverse Event|5|||
17025501|NCT00803738|38170029|FG000|Overall Study|Lost to Follow-up|4|||
17025502|NCT00803738|38170030|FG001|Overall Study|Lost to Follow-up|4|||
17025503|NCT00803738|38170029|FG000|Overall Study|Protocol Violation|18|||
17025504|NCT00803738|38170030|FG001|Overall Study|Protocol Violation|10|||
17025505|NCT00803738|38170029|FG000|Overall Study|Withdrawal by Subject|1|||
17025506|NCT00803738|38170030|FG001|Overall Study|Withdrawal by Subject|4|||
17025507|NCT00803738|38170029|FG000|Overall Study|Lack of Efficacy|10|||
17025508|NCT00803738|38170030|FG001|Overall Study|Lack of Efficacy|16|||
17025509|NCT00803738|38170029|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
17025510|NCT00803738|38170030|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
17025511|NCT00803738|38170029|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
17025512|NCT00803738|38170030|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
17025513|NCT00758706|38170038|FG000|Overall Study|Adverse Event|4|||
17025514|NCT00758706|38170039|FG001|Overall Study|Adverse Event|4|||
17025515|NCT00591266|38170048|FG000|Overall Study|Adverse Event|2|||
17025516|NCT00591266|38170049|FG001|Overall Study|Adverse Event|2|||
17025517|NCT00591266|38170050|FG002|Overall Study|Adverse Event|3|||
17025518|NCT00591266|38170048|FG000|Overall Study|Lost to Follow-up|0|||
17025519|NCT00591266|38170049|FG001|Overall Study|Lost to Follow-up|1|||
17025520|NCT00591266|38170050|FG002|Overall Study|Lost to Follow-up|0|||
17025521|NCT00591266|38170048|FG000|Overall Study|Protocol Violation|0|||
17025522|NCT00591266|38170049|FG001|Overall Study|Protocol Violation|0|||
17025523|NCT00591266|38170050|FG002|Overall Study|Protocol Violation|1|||
17025524|NCT00591266|38170048|FG000|Overall Study|Withdrawal by Subject|6|||
17025525|NCT00591266|38170049|FG001|Overall Study|Withdrawal by Subject|2|||
17025526|NCT00591266|38170050|FG002|Overall Study|Withdrawal by Subject|5|||
17025527|NCT00591266|38170048|FG000|Overall Study|Lack of Efficacy|0|||
17025528|NCT00591266|38170049|FG001|Overall Study|Lack of Efficacy|2|||
17025529|NCT00591266|38170050|FG002|Overall Study|Lack of Efficacy|0|||
17025530|NCT00591266|38170048|FG000|Overall Study|Other|1|||
17025531|NCT00591266|38170049|FG001|Overall Study|Other|4|||
17025532|NCT00591266|38170050|FG002|Overall Study|Other|5|||
17025533|NCT00758394|38170062|FG000|2nd Intervention Order|Lost to Follow-up|0|||
17025534|NCT00758394|38170063|FG001|2nd Intervention Order|Lost to Follow-up|1|||
17025535|NCT00758394|38170064|FG002|2nd Intervention Order|Lost to Follow-up|0|||
17025536|NCT00758394|38170065|FG003|2nd Intervention Order|Lost to Follow-up|0|||
17025537|NCT00758394|38170062|FG000|3rd Intervention|Lost to Follow-up|1|||
17025538|NCT00758394|38170063|FG001|3rd Intervention|Lost to Follow-up|0|||
17025539|NCT00758394|38170064|FG002|3rd Intervention|Lost to Follow-up|0|||
17025540|NCT00758394|38170065|FG003|3rd Intervention|Lost to Follow-up|1|||
17025541|NCT04450394|38170078|FG000|Overall Study|Adverse Event|2|||
17025542|NCT04450394|38170079|FG001|Overall Study|Adverse Event|0|||
17025543|NCT04450394|38170080|FG002|Overall Study|Adverse Event|0|||
17025544|NCT04450394|38170078|FG000|Overall Study|Death|0|||
17025545|NCT04450394|38170079|FG001|Overall Study|Death|1|||
17025546|NCT04450394|38170080|FG002|Overall Study|Death|0|||
17025547|NCT04450394|38170078|FG000|Overall Study|Lost to Follow-up|0|||
17025548|NCT04450394|38170079|FG001|Overall Study|Lost to Follow-up|3|||
17025549|NCT04450394|38170080|FG002|Overall Study|Lost to Follow-up|0|||
17025550|NCT04450394|38170078|FG000|Overall Study|Physician Decision|0|||
17025551|NCT04450394|38170079|FG001|Overall Study|Physician Decision|1|||
17025552|NCT04450394|38170080|FG002|Overall Study|Physician Decision|0|||
17025553|NCT04450394|38170078|FG000|Overall Study|Protocol Violation|2|||
17025554|NCT04450394|38170079|FG001|Overall Study|Protocol Violation|0|||
17025555|NCT04450394|38170080|FG002|Overall Study|Protocol Violation|0|||
17025556|NCT04450394|38170078|FG000|Overall Study|Withdrawal by Subject|6|||
17025557|NCT04450394|38170079|FG001|Overall Study|Withdrawal by Subject|9|||
17025558|NCT04450394|38170080|FG002|Overall Study|Withdrawal by Subject|0|||
17025559|NCT00758160|38170087|FG000|Overall Study|No Longer Requires Study Medication|4|||
17025560|NCT00758160|38170087|FG000|Overall Study|Administration Problems|3|||
17025561|NCT00758160|38170087|FG000|Overall Study|Adverse Event|15|||
17025562|NCT00758160|38170087|FG000|Overall Study|Lack of Efficacy|10|||
17025563|NCT00758160|38170087|FG000|Overall Study|Lost to Follow-up|14|||
17025564|NCT00758160|38170087|FG000|Overall Study|Protocol Violation|12|||
17025565|NCT00758160|38170087|FG000|Overall Study|Withdrawal by Subject|8|||
16853029|NCT01394991|37803313|FG001|Overall Study|Lack of Efficacy|7|||
16853030|NCT01394991|37803312|FG000|Overall Study|Lost to Follow-up|6|||
16853031|NCT01394991|37803313|FG001|Overall Study|Lost to Follow-up|8|||
16853032|NCT01394991|37803312|FG000|Overall Study|Physician Decision|1|||
16853033|NCT01394991|37803313|FG001|Overall Study|Physician Decision|3|||
16853034|NCT01394991|37803312|FG000|Overall Study|Protocol Violation|1|||
16853035|NCT01394991|37803313|FG001|Overall Study|Protocol Violation|1|||
16853036|NCT01394991|37803312|FG000|Overall Study|Withdrawal by Subject|20|||
16853037|NCT01394991|37803313|FG001|Overall Study|Withdrawal by Subject|17|||
16853038|NCT01394991|37803312|FG000|Overall Study|Chemotherapy Termination|10|||
16853039|NCT01394991|37803313|FG001|Overall Study|Chemotherapy Termination|15|||
16853040|NCT01394991|37803312|FG000|Overall Study|Disease Progression|7|||
16853041|NCT01394991|37803313|FG001|Overall Study|Disease Progression|7|||
16853042|NCT01394991|37803312|FG000|Overall Study|Prematurely Termination of Trial|9|||
16853043|NCT01394991|37803313|FG001|Overall Study|Prematurely Termination of Trial|10|||
16853044|NCT01829347|37803321|FG000|VTI-210|Death|5|||
16853045|NCT01829347|37803322|FG001|VTI-210|Death|3|||
16853046|NCT01829347|37803321|FG000|VTI-210|Withdrawal by Subject|1|||
16853047|NCT01829347|37803322|FG001|VTI-210|Withdrawal by Subject|0|||
16853048|NCT01829347|37803321|FG000|VTI-210E|Death|2|||
16853049|NCT01829347|37803322|FG001|VTI-210E|Death|1|||
16853050|NCT01829347|37803321|FG000|VTI-210E|Study terminated prematurely|1|||
16853051|NCT01829347|37803322|FG001|VTI-210E|Study terminated prematurely|5|||
16853052|NCT01394523|37803331|FG000|Overall Study|Unable to place block|1|||
16853053|NCT01394523|37803332|FG001|Overall Study|Unable to place block|0|||
16853054|NCT01394523|37803333|FG002|Overall Study|Unable to place block|0|||
16853055|NCT01857973|37803341|FG000|Overall Study|Subject did not meet required BG range|3|||
16853056|NCT01857973|37803341|FG000|Overall Study|drop out after 3 failed attempts|1|||
16853057|NCT01857973|37803341|FG000|Overall Study|Physician Decision|1|||
16853058|NCT01857583|37803349|FG000|Overall Study|Adverse Event|0|||
16853059|NCT01857583|37803350|FG001|Overall Study|Adverse Event|0|||
16853060|NCT01857583|37803351|FG002|Overall Study|Adverse Event|1|||
16853061|NCT01857583|37803352|FG003|Overall Study|Adverse Event|1|||
17025566|NCT00757848|38170097|FG000|Overall Study|Voluntary discontinuation|1|||
16853062|NCT01857583|37803349|FG000|Overall Study|Death|0|||
16853063|NCT01857583|37803350|FG001|Overall Study|Death|1|||
16853064|NCT01857583|37803351|FG002|Overall Study|Death|1|||
16853065|NCT01857583|37803352|FG003|Overall Study|Death|0|||
16853066|NCT01857583|37803349|FG000|Overall Study|Physician Decision|0|||
16853067|NCT01857583|37803350|FG001|Overall Study|Physician Decision|0|||
16853068|NCT01857583|37803351|FG002|Overall Study|Physician Decision|0|||
17025567|NCT00757848|38170098|FG001|Overall Study|Voluntary discontinuation|0|||
16935769|NCT01214629|38080482|FG004|Overall Study|Progressive Disease|2|||
16935770|NCT01214629|38080483|FG005|Overall Study|Progressive Disease|3|||
16935771|NCT01214629|38080484|FG006|Overall Study|Progressive Disease|1|||
16935772|NCT01214629|38080485|FG007|Overall Study|Progressive Disease|1|||
16935773|NCT01214629|38080486|FG008|Overall Study|Progressive Disease|1|||
16935774|NCT01214629|38080487|FG009|Overall Study|Progressive Disease|5|||
16935775|NCT01214629|38080488|FG010|Overall Study|Progressive Disease|1|||
16935776|NCT01214629|38080478|FG000|Overall Study|Adverse Event|0|||
16935777|NCT01214629|38080479|FG001|Overall Study|Adverse Event|0|||
16935778|NCT01214629|38080480|FG002|Overall Study|Adverse Event|0|||
16935779|NCT01214629|38080481|FG003|Overall Study|Adverse Event|1|||
17025568|NCT00757848|38170097|FG000|Overall Study|Adverse Event|1|||
17025569|NCT00757848|38170098|FG001|Overall Study|Adverse Event|2|||
17025570|NCT00757848|38170097|FG000|Overall Study|Incorrect enrolment|1|||
17025571|NCT00757848|38170098|FG001|Overall Study|Incorrect enrolment|0|||
17025572|NCT00751296|38170104|FG000|Overall Study|Adverse Event|2|||
17025573|NCT00751140|38170108|FG000|Overall Study|benign angioma excluded from analysis|1|||
17025574|NCT00751881|38170119|FG000|Core Treatment Period|Not treated|1|||
17025575|NCT00751881|38170120|FG001|Core Treatment Period|Not treated|1|||
17025576|NCT00751881|38170121|FG002|Core Treatment Period|Not treated|2|||
17025577|NCT00751881|38170119|FG000|Core Treatment Period|Adverse Event|26|||
17025578|NCT00751881|38170120|FG001|Core Treatment Period|Adverse Event|54|||
17025579|NCT00751881|38170121|FG002|Core Treatment Period|Adverse Event|58|||
17025580|NCT00751881|38170119|FG000|Core Treatment Period|Lack of Efficacy|37|||
17025581|NCT00751881|38170120|FG001|Core Treatment Period|Lack of Efficacy|30|||
17025582|NCT00751881|38170121|FG002|Core Treatment Period|Lack of Efficacy|20|||
17025583|NCT00751881|38170119|FG000|Core Treatment Period|Poor compliance to protocol|15|||
17025584|NCT00751881|38170120|FG001|Core Treatment Period|Poor compliance to protocol|3|||
17025585|NCT00751881|38170121|FG002|Core Treatment Period|Poor compliance to protocol|4|||
17025586|NCT00751881|38170119|FG000|Core Treatment Period|Lost to Follow-up|6|||
17025587|NCT00751881|38170120|FG001|Core Treatment Period|Lost to Follow-up|4|||
17025588|NCT00751881|38170121|FG002|Core Treatment Period|Lost to Follow-up|3|||
17025589|NCT00751881|38170119|FG000|Core Treatment Period|Other: protocol deviation|3|||
17025590|NCT00751881|38170120|FG001|Core Treatment Period|Other: protocol deviation|3|||
17025591|NCT00751881|38170121|FG002|Core Treatment Period|Other: protocol deviation|7|||
17025592|NCT00751881|38170119|FG000|Core Treatment Period|Other: wish to parent|5|||
17025593|NCT00751881|38170120|FG001|Core Treatment Period|Other: wish to parent|7|||
17025594|NCT00751881|38170121|FG002|Core Treatment Period|Other: wish to parent|4|||
17025595|NCT00751881|38170119|FG000|Core Treatment Period|Other: personal/family constraints|6|||
17025596|NCT00751881|38170120|FG001|Core Treatment Period|Other: personal/family constraints|7|||
17025597|NCT00751881|38170121|FG002|Core Treatment Period|Other: personal/family constraints|10|||
17025598|NCT00751881|38170119|FG000|Core Treatment Period|Other: MS treatment change|6|||
17025599|NCT00751881|38170120|FG001|Core Treatment Period|Other: MS treatment change|4|||
17025600|NCT00751881|38170121|FG002|Core Treatment Period|Other: MS treatment change|4|||
17025601|NCT00751881|38170119|FG000|Core Treatment Period|Other: tolerability complaints|2|||
17025602|NCT00751881|38170120|FG001|Core Treatment Period|Other: tolerability complaints|0|||
17025603|NCT00751881|38170121|FG002|Core Treatment Period|Other: tolerability complaints|0|||
17025604|NCT00751881|38170119|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
17025605|NCT00751881|38170120|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
17025606|NCT00751881|38170121|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
17025607|NCT00751881|38170119|FG000|Extension Study Period|Adverse Event|18|||
17025608|NCT00751881|38170120|FG001|Extension Study Period|Adverse Event|20|||
17025609|NCT00751881|38170121|FG002|Extension Study Period|Adverse Event|21|||
17025610|NCT00751881|38170119|FG000|Extension Study Period|Lack of Efficacy|14|||
17025611|NCT00751881|38170120|FG001|Extension Study Period|Lack of Efficacy|10|||
17025612|NCT00751881|38170121|FG002|Extension Study Period|Lack of Efficacy|20|||
17025613|NCT00751881|38170119|FG000|Extension Study Period|Lost to Follow-up|4|||
17025614|NCT00751881|38170120|FG001|Extension Study Period|Lost to Follow-up|9|||
17025615|NCT00751881|38170121|FG002|Extension Study Period|Lost to Follow-up|6|||
17025616|NCT00751881|38170119|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
17025617|NCT00751881|38170120|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
17025618|NCT00751881|38170121|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
17025619|NCT00751881|38170119|FG000|Extension Study Period|Other than specified above|26|||
17025620|NCT00751881|38170120|FG001|Extension Study Period|Other than specified above|30|||
17025621|NCT00751881|38170121|FG002|Extension Study Period|Other than specified above|18|||
17025622|NCT00747474|38170135|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025623|NCT00747474|38170136|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025624|NCT00747474|38170137|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025625|NCT00747474|38170138|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025626|NCT00747474|38170139|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025627|NCT00747474|38170140|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17198706|NCT02706405|38352370|FG003|Overall Study|Physician Decision|0|||
17025628|NCT00747474|38170141|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025629|NCT00747474|38170142|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
17025630|NCT00747474|38170143|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025631|NCT00747474|38170144|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025632|NCT00747474|38170145|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025633|NCT00747474|38170146|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
17025634|NCT00830063|38170155|FG000|Overall Study|Adverse Event|7|||
16853069|NCT01857583|37803352|FG003|Overall Study|Physician Decision|1|||
16853070|NCT01857583|37803349|FG000|Overall Study|Withdrawal by Subject|1|||
16853071|NCT01857583|37803350|FG001|Overall Study|Withdrawal by Subject|0|||
16853072|NCT01857583|37803351|FG002|Overall Study|Withdrawal by Subject|1|||
16853073|NCT01857583|37803352|FG003|Overall Study|Withdrawal by Subject|2|||
16853074|NCT01829191|37803364|FG000|Overall Study|Relocation|0|||
16853075|NCT01829191|37803365|FG001|Overall Study|Relocation|1|||
16853076|NCT01829191|37803364|FG000|Overall Study|Lens discomfort|0|||
16853077|NCT01829191|37803365|FG001|Overall Study|Lens discomfort|3|||
16853078|NCT01829191|37803364|FG000|Overall Study|Lens handling difficulty|1|||
16853079|NCT01829191|37803365|FG001|Overall Study|Lens handling difficulty|4|||
16853080|NCT01829191|37803364|FG000|Overall Study|Protocol Violation|4|||
16853081|NCT01829191|37803365|FG001|Overall Study|Protocol Violation|1|||
16853082|NCT01829191|37803364|FG000|Overall Study|Withdrawal by Subject|2|||
16853083|NCT01829191|37803365|FG001|Overall Study|Withdrawal by Subject|3|||
16853084|NCT01829191|37803364|FG000|Overall Study|Lost to Follow-up|0|||
16853085|NCT01829191|37803365|FG001|Overall Study|Lost to Follow-up|1|||
16853086|NCT01829191|37803364|FG000|Overall Study|Subject was fit for ortho - k|0|||
16853087|NCT01829191|37803365|FG001|Overall Study|Subject was fit for ortho - k|1|||
16853088|NCT00211185|37803370|FG000|Overall Study|Death|2|||
16853089|NCT00211185|37803370|FG000|Overall Study|Disease progression|7|||
16853090|NCT00211185|37803370|FG000|Overall Study|Withdrawal by Subject|6|||
16853091|NCT00211185|37803370|FG000|Overall Study|Physician Decision|5|||
16853092|NCT00210639|37803376|FG000|Overall Study|Lost to Follow-up|37|||
16853093|NCT00210639|37803377|FG001|Overall Study|Lost to Follow-up|29|||
16853094|NCT00210639|37803376|FG000|Overall Study|Withdrawal by Subject|8|||
16853095|NCT00210639|37803377|FG001|Overall Study|Withdrawal by Subject|1|||
16853096|NCT00210639|37803376|FG000|Overall Study|Other|18|||
16853097|NCT00210639|37803377|FG001|Overall Study|Other|12|||
16853098|NCT01829113|37803385|FG000|Overall Study|Disease Progression|37|||
16853099|NCT01829113|37803386|FG001|Overall Study|Disease Progression|48|||
16853100|NCT01829113|37803385|FG000|Overall Study|Adverse Event|14|||
16853101|NCT01829113|37803386|FG001|Overall Study|Adverse Event|10|||
16853102|NCT01829113|37803385|FG000|Overall Study|Withdrawal by Subject|17|||
16853103|NCT01829113|37803386|FG001|Overall Study|Withdrawal by Subject|10|||
16853104|NCT01829113|37803385|FG000|Overall Study|Death|4|||
16853105|NCT01829113|37803386|FG001|Overall Study|Death|6|||
16853106|NCT01829113|37803385|FG000|Overall Study|Sponsor Decision|1|||
16853107|NCT01829113|37803386|FG001|Overall Study|Sponsor Decision|1|||
16853108|NCT01829113|37803385|FG000|Overall Study|No Study Treatment Received|3|||
16853109|NCT01829113|37803386|FG001|Overall Study|No Study Treatment Received|2|||
16853110|NCT01829113|37803385|FG000|Overall Study|Physician Decision|1|||
16853111|NCT01829113|37803386|FG001|Overall Study|Physician Decision|1|||
16853112|NCT01857271|37803394|FG000|Overall Study|Lost to Follow-up|1|||
16853113|NCT01745120|37803400|FG000|Overall Study|Investigator decision|1|||
16853114|NCT01745120|37803401|FG001|Overall Study|Investigator decision|0|||
16853115|NCT01828567|37803412|FG000|Overall Study|Lost to Follow-up|27|||
16853116|NCT01828567|37803413|FG001|Overall Study|Lost to Follow-up|9|||
16853117|NCT01828567|37803412|FG000|Overall Study|Excluded - did not meet criteria|4|||
16853118|NCT01828567|37803413|FG001|Overall Study|Excluded - did not meet criteria|1|||
16853119|NCT01721486|37803421|FG000|Overall Study|Protocol Violation|1|||
16853120|NCT01721486|37803422|FG001|Overall Study|Protocol Violation|0|||
16853121|NCT01721486|37803421|FG000|Overall Study|Physician Decision|0|||
16853122|NCT01721486|37803422|FG001|Overall Study|Physician Decision|1|||
16853123|NCT01775930|37803428|FG000|Overall Study|Futility stopping boundary met|1|||
16853124|NCT01856569|37803432|FG000|Overall Study|Other|1|||
16853125|NCT01856569|37803432|FG000|Overall Study|Changed Site/Structure|1|||
16853126|NCT01856569|37803432|FG000|Overall Study|Lost to Follow-up|3|||
16853127|NCT01856569|37803432|FG000|Overall Study|Did not met inclusion criteria|8|||
16853128|NCT01721408|37803438|FG000|Overall Study|Adverse Event|6|||
16853129|NCT01721408|37803439|FG001|Overall Study|Adverse Event|1|||
16853130|NCT01721408|37803438|FG000|Overall Study|Death|1|||
16853131|NCT01721408|37803439|FG001|Overall Study|Death|0|||
16853132|NCT01721408|37803438|FG000|Overall Study|Insufficient clinical response|15|||
16853133|NCT01721408|37803439|FG001|Overall Study|Insufficient clinical response|6|||
16853134|NCT01721408|37803438|FG000|Overall Study|No longer willing to participate study|9|||
16853135|NCT01721408|37803439|FG001|Overall Study|No longer willing to participate study|10|||
16853136|NCT01721408|37803438|FG000|Overall Study|Protocol Violation|0|||
16853137|NCT01721408|37803439|FG001|Overall Study|Protocol Violation|2|||
16853138|NCT01721408|37803438|FG000|Overall Study|Other|3|||
17025635|NCT00830063|38170156|FG001|Overall Study|Adverse Event|13|||
17025636|NCT00830063|38170157|FG002|Overall Study|Adverse Event|16|||
17025637|NCT00830063|38170158|FG003|Overall Study|Adverse Event|13|||
17025638|NCT00830063|38170155|FG000|Overall Study|Death|1|||
17025639|NCT00830063|38170156|FG001|Overall Study|Death|0|||
17025640|NCT00830063|38170157|FG002|Overall Study|Death|0|||
17025641|NCT00830063|38170158|FG003|Overall Study|Death|0|||
17025642|NCT00830063|38170155|FG000|Overall Study|Lost to Follow-up|0|||
17025643|NCT00830063|38170156|FG001|Overall Study|Lost to Follow-up|0|||
17025644|NCT00830063|38170157|FG002|Overall Study|Lost to Follow-up|3|||
17025645|NCT00830063|38170158|FG003|Overall Study|Lost to Follow-up|1|||
17025646|NCT00830063|38170155|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
17025647|NCT00830063|38170156|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
17025648|NCT00830063|38170157|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
17025649|NCT00830063|38170158|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
17025650|NCT00830063|38170155|FG000|Overall Study|Lack of Efficacy|51|||
17025651|NCT00830063|38170156|FG001|Overall Study|Lack of Efficacy|23|||
17025652|NCT00830063|38170157|FG002|Overall Study|Lack of Efficacy|25|||
17025653|NCT00830063|38170158|FG003|Overall Study|Lack of Efficacy|32|||
17025654|NCT00830063|38170155|FG000|Overall Study|Other|5|||
17025655|NCT00830063|38170156|FG001|Overall Study|Other|5|||
17025656|NCT00830063|38170157|FG002|Overall Study|Other|8|||
17025657|NCT00830063|38170158|FG003|Overall Study|Other|6|||
17025658|NCT00830063|38170155|FG000|Overall Study|Withdrawal by Subject|16|||
17025659|NCT00830063|38170156|FG001|Overall Study|Withdrawal by Subject|10|||
17025660|NCT00830063|38170157|FG002|Overall Study|Withdrawal by Subject|16|||
17025661|NCT00830063|38170158|FG003|Overall Study|Withdrawal by Subject|13|||
17025662|NCT00830063|38170155|FG000|Overall Study|Protocol Violation|1|||
17025663|NCT00830063|38170156|FG001|Overall Study|Protocol Violation|0|||
17025664|NCT00830063|38170157|FG002|Overall Study|Protocol Violation|3|||
17025665|NCT00830063|38170158|FG003|Overall Study|Protocol Violation|2|||
17025666|NCT00830063|38170155|FG000|Overall Study|Randomized But Not Treated|0|||
17025667|NCT00830063|38170156|FG001|Overall Study|Randomized But Not Treated|2|||
17025668|NCT00830063|38170157|FG002|Overall Study|Randomized But Not Treated|0|||
17025669|NCT00830063|38170158|FG003|Overall Study|Randomized But Not Treated|2|||
17025670|NCT00750438|38170172|FG000|Overall Study|Protocol Violation|4|||
17025671|NCT00750438|38170173|FG001|Overall Study|Protocol Violation|1|||
17025672|NCT00750438|38170172|FG000|Overall Study|Physician Decision|2|||
17025673|NCT00750438|38170173|FG001|Overall Study|Physician Decision|2|||
17025674|NCT00750438|38170172|FG000|Overall Study|Withdrawal by Subject|1|||
17025675|NCT00750438|38170173|FG001|Overall Study|Withdrawal by Subject|1|||
17025676|NCT00586326|38170179|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
16935780|NCT01214629|38080482|FG004|Overall Study|Adverse Event|0|||
16935781|NCT01214629|38080483|FG005|Overall Study|Adverse Event|1|||
17025677|NCT00586326|38170179|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
17025678|NCT00586326|38170179|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
17025679|NCT00586326|38170179|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
17025680|NCT00586326|38170179|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
17025681|NCT00586326|38170179|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
17025682|NCT00586326|38170179|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
17025683|NCT00586326|38170179|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
17025684|NCT00586326|38170179|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
17025685|NCT00586326|38170179|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
16935782|NCT01214629|38080484|FG006|Overall Study|Adverse Event|0|||
16935783|NCT01214629|38080485|FG007|Overall Study|Adverse Event|0|||
16935784|NCT01214629|38080486|FG008|Overall Study|Adverse Event|0|||
16935785|NCT01214629|38080487|FG009|Overall Study|Adverse Event|1|||
16935786|NCT01214629|38080488|FG010|Overall Study|Adverse Event|0|||
16935787|NCT01214629|38080478|FG000|Overall Study|Physician Decision|0|||
16935788|NCT01214629|38080479|FG001|Overall Study|Physician Decision|0|||
16935789|NCT01214629|38080480|FG002|Overall Study|Physician Decision|0|||
16935790|NCT01214629|38080481|FG003|Overall Study|Physician Decision|0|||
16935791|NCT01214629|38080482|FG004|Overall Study|Physician Decision|0|||
16935792|NCT01214629|38080483|FG005|Overall Study|Physician Decision|0|||
16935793|NCT01214629|38080484|FG006|Overall Study|Physician Decision|0|||
16935794|NCT01214629|38080485|FG007|Overall Study|Physician Decision|0|||
16935795|NCT01214629|38080486|FG008|Overall Study|Physician Decision|0|||
16935796|NCT01214629|38080487|FG009|Overall Study|Physician Decision|0|||
16935797|NCT01214629|38080488|FG010|Overall Study|Physician Decision|1|||
16935798|NCT01214629|38080478|FG000|Overall Study|Withdrawal by Subject|0|||
16935799|NCT01214629|38080479|FG001|Overall Study|Withdrawal by Subject|0|||
16935800|NCT01214629|38080480|FG002|Overall Study|Withdrawal by Subject|0|||
16935801|NCT01214629|38080481|FG003|Overall Study|Withdrawal by Subject|0|||
16935802|NCT01214629|38080482|FG004|Overall Study|Withdrawal by Subject|0|||
16935803|NCT01214629|38080483|FG005|Overall Study|Withdrawal by Subject|0|||
16935804|NCT01214629|38080484|FG006|Overall Study|Withdrawal by Subject|0|||
17025686|NCT00586326|38170179|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
17025687|NCT00586326|38170179|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
17025688|NCT00586326|38170179|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
17025689|NCT00586326|38170179|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
17025690|NCT00586326|38170179|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
17025691|NCT00586326|38170179|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
17025692|NCT00586326|38170179|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
17025693|NCT00751101|38170189|FG000|Overall Study|Withdrawal by Subject|1|||
17025694|NCT00751101|38170190|FG001|Overall Study|Withdrawal by Subject|0|||
17025695|NCT00751101|38170189|FG000|Overall Study|No HFS / Never Started Patch/|0|||
17025696|NCT00751101|38170190|FG001|Overall Study|No HFS / Never Started Patch/|4|||
17025697|NCT00751101|38170189|FG000|Overall Study|Never began capecitabine|1|||
17025698|NCT00751101|38170190|FG001|Overall Study|Never began capecitabine|0|||
17025699|NCT00751101|38170189|FG000|Overall Study|Physician Decision|0|||
17025700|NCT00751101|38170190|FG001|Overall Study|Physician Decision|1|||
17025701|NCT00750204|38170202|FG000|Overall Study|study halted prematurely|1|||
17025702|NCT00750204|38170203|FG001|Overall Study|study halted prematurely|1|||
17025703|NCT00751023|38170211|FG000|Overall Study|Lost to Follow-up|11|||
17025704|NCT00751023|38170212|FG001|Overall Study|Lost to Follow-up|7|||
17025705|NCT00591773|38170221|FG000|Overall Study|Adverse Event|9|||
17025706|NCT00591773|38170222|FG001|Overall Study|Adverse Event|9|||
17025707|NCT00591773|38170223|FG002|Overall Study|Adverse Event|6|||
17025708|NCT00591773|38170221|FG000|Overall Study|Protocol Violation|2|||
17025709|NCT00591773|38170222|FG001|Overall Study|Protocol Violation|3|||
17025710|NCT00591773|38170223|FG002|Overall Study|Protocol Violation|0|||
17025711|NCT00591773|38170221|FG000|Overall Study|Lost to Follow-up|1|||
17025712|NCT00591773|38170222|FG001|Overall Study|Lost to Follow-up|4|||
17025713|NCT00591773|38170223|FG002|Overall Study|Lost to Follow-up|1|||
17025714|NCT00591773|38170221|FG000|Overall Study|Withdrawal by Subject|2|||
17025715|NCT00591773|38170222|FG001|Overall Study|Withdrawal by Subject|5|||
17025716|NCT00591773|38170223|FG002|Overall Study|Withdrawal by Subject|3|||
17025717|NCT00591773|38170221|FG000|Overall Study|Lack of Efficacy|1|||
17025718|NCT00591773|38170222|FG001|Overall Study|Lack of Efficacy|2|||
17025719|NCT00591773|38170223|FG002|Overall Study|Lack of Efficacy|2|||
17025720|NCT00591773|38170221|FG000|Overall Study|Other|1|||
17025721|NCT00591773|38170222|FG001|Overall Study|Other|1|||
17025722|NCT00591773|38170223|FG002|Overall Study|Other|4|||
17025723|NCT00750867|38170231|FG000|Overall Study|Adverse Event|2|||
17025724|NCT00744042|38170235|FG000|Overall Study|Withdrawal by Subject|1|||
17025725|NCT00829829|38170248|FG000|Overall Study|Protocol Violation|0|||
17025726|NCT00829829|38170249|FG001|Overall Study|Protocol Violation|3|||
17025727|NCT00829829|38170250|FG002|Overall Study|Protocol Violation|0|||
17025728|NCT00829829|38170248|FG000|Overall Study|Adverse Event|4|||
17025729|NCT00829829|38170249|FG001|Overall Study|Adverse Event|4|||
17025730|NCT00829829|38170250|FG002|Overall Study|Adverse Event|3|||
17025731|NCT00829829|38170248|FG000|Overall Study|Withdrawal by Subject|8|||
17025732|NCT00829829|38170249|FG001|Overall Study|Withdrawal by Subject|4|||
17025733|NCT00829829|38170250|FG002|Overall Study|Withdrawal by Subject|2|||
17025734|NCT00829829|38170248|FG000|Overall Study|Decision by the Sponsor|1|||
17025735|NCT00829829|38170249|FG001|Overall Study|Decision by the Sponsor|0|||
17025736|NCT00829829|38170250|FG002|Overall Study|Decision by the Sponsor|2|||
17025737|NCT00829829|38170248|FG000|Overall Study|Lost to Follow-up|7|||
17025738|NCT00829829|38170249|FG001|Overall Study|Lost to Follow-up|3|||
17025739|NCT00829829|38170250|FG002|Overall Study|Lost to Follow-up|3|||
17025740|NCT00829829|38170248|FG000|Overall Study|Other than specified above|2|||
17025741|NCT00829829|38170249|FG001|Overall Study|Other than specified above|2|||
17025742|NCT00829829|38170250|FG002|Overall Study|Other than specified above|1|||
17025743|NCT00823199|38170259|FG000|Overall Study|Withdrawal by Subject|2|||
17025744|NCT00829439|38170264|FG000|Overall Study|Adverse Event|0|||
17025745|NCT00829439|38170265|FG001|Overall Study|Adverse Event|0|||
17025746|NCT00829439|38170266|FG002|Overall Study|Adverse Event|1|||
17025747|NCT00829439|38170267|FG003|Overall Study|Adverse Event|0|||
17025748|NCT00749775|38170271|FG000|Overall Study|Protocol Violation|24|||
17025749|NCT00749775|38170271|FG000|Overall Study|Lost to Follow-up|36|||
17025750|NCT00749775|38170271|FG000|Overall Study|No visit after first day of treatment|44|||
17025751|NCT00749775|38170271|FG000|Overall Study|No drug administration|3|||
17025752|NCT00829283|38170287|FG000|Overall Study|Lost to Follow-up|7|||
17025753|NCT00829283|38170288|FG001|Overall Study|Lost to Follow-up|25|||
16853139|NCT01721408|37803439|FG001|Overall Study|Other|3|||
16853140|NCT01721408|37803438|FG000|Overall Study|Lost to Follow-up|1|||
16853141|NCT01721408|37803439|FG001|Overall Study|Lost to Follow-up|2|||
17025754|NCT00821873|38170294|FG000|Overall Study|Lost to Follow-up|4|||
17025755|NCT00749463|38170301|FG000|Overall Study|Adverse Event|0|||
16853142|NCT01721408|37803438|FG000|Overall Study|Does not meet entrance criteria|1|||
16853143|NCT01721408|37803439|FG001|Overall Study|Does not meet entrance criteria|0|||
16853144|NCT01744496|37803447|FG000|Titration Period|Adverse Event|2|||
17025756|NCT00749463|38170302|FG001|Overall Study|Adverse Event|4|||
17025757|NCT00749463|38170303|FG002|Overall Study|Adverse Event|1|||
17025758|NCT00749463|38170301|FG000|Overall Study|Withdrawal by Subject|1|||
17025759|NCT00749463|38170302|FG001|Overall Study|Withdrawal by Subject|0|||
17025760|NCT00749463|38170303|FG002|Overall Study|Withdrawal by Subject|0|||
17025761|NCT00821327|38170311|FG000|Overall Study|Adverse Event|13|||
17025762|NCT00821327|38170311|FG000|Overall Study|Patient Request|1|||
17025763|NCT00821327|38170311|FG000|Overall Study|Investigator Request|2|||
17025764|NCT00821327|38170311|FG000|Overall Study|Sponsor Request|1|||
17025765|NCT00821327|38170311|FG000|Overall Study|Disease Progression|13|||
17025766|NCT00821327|38170311|FG000|Overall Study|Other/Unknown|5|||
17025767|NCT00821093|38170317|FG000|Overall Study|Adverse Event|20|||
17025768|NCT00821093|38170318|FG001|Overall Study|Adverse Event|12|||
17025769|NCT00821093|38170317|FG000|Overall Study|Withdrawal by Subject|9|||
17025770|NCT00821093|38170318|FG001|Overall Study|Withdrawal by Subject|13|||
17025771|NCT00821093|38170317|FG000|Overall Study|Lost to Follow-up|9|||
17025772|NCT00821093|38170318|FG001|Overall Study|Lost to Follow-up|3|||
17025773|NCT00821093|38170317|FG000|Overall Study|Protocol deviation|3|||
17025774|NCT00821093|38170318|FG001|Overall Study|Protocol deviation|6|||
17025775|NCT00821093|38170317|FG000|Overall Study|Abnormal laboratory value(s)|2|||
17025776|NCT00821093|38170318|FG001|Overall Study|Abnormal laboratory value(s)|0|||
17025777|NCT00821093|38170317|FG000|Overall Study|Lack of Efficacy|2|||
17025778|NCT00821093|38170318|FG001|Overall Study|Lack of Efficacy|2|||
17025779|NCT00821093|38170317|FG000|Overall Study|Death|2|||
17025780|NCT00821093|38170318|FG001|Overall Study|Death|1|||
17025781|NCT00821093|38170317|FG000|Overall Study|Abnormal test procedure result(s)|1|||
17025782|NCT00821093|38170318|FG001|Overall Study|Abnormal test procedure result(s)|1|||
17025783|NCT00821093|38170317|FG000|Overall Study|Administrative problems|1|||
17025784|NCT00821093|38170318|FG001|Overall Study|Administrative problems|2|||
17025785|NCT00821015|38170324|FG000|Overall Study|Lost to Follow-up|12|||
17025786|NCT00814463|38170328|FG000|Overall Study|Lost to Follow-up|1|||
17025787|NCT00743652|38170338|FG000|Overall Study|Parent/Legal Guardian Request|3|||
17025788|NCT00743652|38170339|FG001|Overall Study|Parent/Legal Guardian Request|2|||
17025789|NCT00743652|38170340|FG002|Overall Study|Parent/Legal Guardian Request|2|||
17025790|NCT00743652|38170341|FG003|Overall Study|Parent/Legal Guardian Request|2|||
17025791|NCT00743652|38170342|FG004|Overall Study|Parent/Legal Guardian Request|0|||
17025792|NCT00743652|38170338|FG000|Overall Study|Adverse Event|3|||
17025793|NCT00743652|38170339|FG001|Overall Study|Adverse Event|0|||
17025794|NCT00743652|38170340|FG002|Overall Study|Adverse Event|0|||
17025795|NCT00743652|38170341|FG003|Overall Study|Adverse Event|0|||
17025796|NCT00743652|38170342|FG004|Overall Study|Adverse Event|0|||
17025797|NCT00743652|38170338|FG000|Overall Study|Death|2|||
17025798|NCT00743652|38170339|FG001|Overall Study|Death|0|||
17025799|NCT00743652|38170340|FG002|Overall Study|Death|0|||
17025800|NCT00743652|38170341|FG003|Overall Study|Death|0|||
17025801|NCT00743652|38170342|FG004|Overall Study|Death|0|||
17025802|NCT00743652|38170338|FG000|Overall Study|Investigator Request|0|||
17025803|NCT00743652|38170339|FG001|Overall Study|Investigator Request|0|||
17025804|NCT00743652|38170340|FG002|Overall Study|Investigator Request|0|||
17025805|NCT00743652|38170341|FG003|Overall Study|Investigator Request|2|||
17025806|NCT00743652|38170342|FG004|Overall Study|Investigator Request|0|||
17025807|NCT00743652|38170338|FG000|Overall Study|Other|1|||
17025808|NCT00743652|38170339|FG001|Overall Study|Other|1|||
17025809|NCT00743652|38170340|FG002|Overall Study|Other|0|||
17025810|NCT00743652|38170341|FG003|Overall Study|Other|0|||
17025811|NCT00743652|38170342|FG004|Overall Study|Other|0|||
17025812|NCT00743652|38170338|FG000|Overall Study|Lost to Follow-up|1|||
17025813|NCT00743652|38170339|FG001|Overall Study|Lost to Follow-up|0|||
17025814|NCT00743652|38170340|FG002|Overall Study|Lost to Follow-up|0|||
17025815|NCT00743652|38170341|FG003|Overall Study|Lost to Follow-up|0|||
17025816|NCT00743652|38170342|FG004|Overall Study|Lost to Follow-up|0|||
17025817|NCT00748215|38170360|FG000|Overall Study|Withdrawal by Subject|7|||
17025818|NCT00748215|38170361|FG001|Overall Study|Withdrawal by Subject|7|||
17025819|NCT00748215|38170360|FG000|Overall Study|Treatment change|2|||
17025820|NCT00748215|38170361|FG001|Overall Study|Treatment change|1|||
17025821|NCT00748215|38170360|FG000|Overall Study|Change in patient condition|0|||
17025822|NCT00748215|38170361|FG001|Overall Study|Change in patient condition|3|||
17025823|NCT00748215|38170360|FG000|Overall Study|Non-compliant|0|||
17025824|NCT00748215|38170361|FG001|Overall Study|Non-compliant|2|||
17025825|NCT00748215|38170360|FG000|Overall Study|Adverse Event|0|||
17025826|NCT00748215|38170361|FG001|Overall Study|Adverse Event|5|||
17025827|NCT00749892|38170367|FG000|Overall Study|Withdrawal by Subject|3|||
17025828|NCT00749580|38170373|FG000|Overall Study|Lost to Follow-up|4|||
17025829|NCT00749580|38170374|FG001|Overall Study|Lost to Follow-up|8|||
17025830|NCT00749580|38170373|FG000|Overall Study|Adverse Event|0|||
17025831|NCT00749580|38170374|FG001|Overall Study|Adverse Event|1|||
17025832|NCT00747006|38170383|FG000|Overall Study|Adverse Event|1|||
17025833|NCT00747006|38170384|FG001|Overall Study|Adverse Event|0|||
17025834|NCT00747006|38170385|FG002|Overall Study|Adverse Event|0|||
17025835|NCT00747006|38170383|FG000|Overall Study|Lost to Follow-up|0|||
17025836|NCT00747006|38170384|FG001|Overall Study|Lost to Follow-up|1|||
17025837|NCT00747006|38170385|FG002|Overall Study|Lost to Follow-up|0|||
17025838|NCT00747006|38170383|FG000|Overall Study|Physician Decision|2|||
17025839|NCT00747006|38170384|FG001|Overall Study|Physician Decision|0|||
17025840|NCT00747006|38170385|FG002|Overall Study|Physician Decision|1|||
17025841|NCT00743340|38170396|FG000|Overall Study|Study medication non-compliance|1|||
17025842|NCT00743340|38170396|FG000|Overall Study|Lost to Follow-up|1|||
17025843|NCT00743340|38170396|FG000|Overall Study|Withdrawal from the Study|5|||
17025844|NCT00743340|38170396|FG000|Overall Study|Protocol Violation|1|||
17025845|NCT00743340|38170396|FG000|Overall Study|Virologic failure|8|||
17025846|NCT00743340|38170396|FG000|Overall Study|Pregnancy|1|||
17025847|NCT00743340|38170396|FG000|Overall Study|Rolled over to other Gilead Study|23|||
17025848|NCT00743340|38170396|FG000|Overall Study|Participant Relocated|1|||
17025849|NCT00749190|38170407|FG000|Overall Study|Adverse Event|0|||
17025850|NCT00749190|38170408|FG001|Overall Study|Adverse Event|2|||
17025851|NCT00749190|38170409|FG002|Overall Study|Adverse Event|0|||
17025852|NCT00749190|38170410|FG003|Overall Study|Adverse Event|4|||
17025853|NCT00749190|38170411|FG004|Overall Study|Adverse Event|0|||
17025854|NCT00749190|38170412|FG005|Overall Study|Adverse Event|3|||
17025855|NCT00749190|38170413|FG006|Overall Study|Adverse Event|0|||
17025856|NCT00749190|38170407|FG000|Overall Study|Lack of Efficacy|3|||
17025857|NCT00749190|38170408|FG001|Overall Study|Lack of Efficacy|1|||
17025858|NCT00749190|38170409|FG002|Overall Study|Lack of Efficacy|1|||
17025859|NCT00749190|38170410|FG003|Overall Study|Lack of Efficacy|0|||
17025860|NCT00749190|38170411|FG004|Overall Study|Lack of Efficacy|0|||
17025861|NCT00749190|38170412|FG005|Overall Study|Lack of Efficacy|1|||
17025862|NCT00749190|38170413|FG006|Overall Study|Lack of Efficacy|0|||
17025863|NCT00749190|38170407|FG000|Overall Study|Withdrawal by Subject|2|||
17025864|NCT00749190|38170408|FG001|Overall Study|Withdrawal by Subject|1|||
17025865|NCT00749190|38170409|FG002|Overall Study|Withdrawal by Subject|0|||
17025866|NCT00749190|38170410|FG003|Overall Study|Withdrawal by Subject|0|||
17025867|NCT00749190|38170411|FG004|Overall Study|Withdrawal by Subject|0|||
17025868|NCT00749190|38170412|FG005|Overall Study|Withdrawal by Subject|1|||
17025869|NCT00749190|38170413|FG006|Overall Study|Withdrawal by Subject|0|||
17025870|NCT00749190|38170407|FG000|Overall Study|Protocol Violation|0|||
17025871|NCT00749190|38170408|FG001|Overall Study|Protocol Violation|1|||
17025872|NCT00749190|38170409|FG002|Overall Study|Protocol Violation|0|||
17025873|NCT00749190|38170410|FG003|Overall Study|Protocol Violation|0|||
17025874|NCT00749190|38170411|FG004|Overall Study|Protocol Violation|0|||
17025875|NCT00749190|38170412|FG005|Overall Study|Protocol Violation|0|||
17025876|NCT00749190|38170413|FG006|Overall Study|Protocol Violation|1|||
17025877|NCT00749190|38170407|FG000|Overall Study|Other reason not defined above|0|||
17025878|NCT00749190|38170408|FG001|Overall Study|Other reason not defined above|0|||
16853145|NCT01744496|37803448|FG001|Titration Period|Adverse Event|1|||
16853146|NCT01744496|37803447|FG000|Titration Period|Personal reasons|0|||
16853147|NCT01744496|37803448|FG001|Titration Period|Personal reasons|1|||
16853148|NCT01744496|37803447|FG000|Maintenance Period|Adverse Event|1|||
16853149|NCT01744496|37803448|FG001|Maintenance Period|Adverse Event|3|||
16853150|NCT01744496|37803447|FG000|Maintenance Period|Protocol Violation|1|||
16853151|NCT01744496|37803448|FG001|Maintenance Period|Protocol Violation|0|||
16853152|NCT01744496|37803447|FG000|Maintenance Period|Withdrawal by Subject|1|||
16853153|NCT01744496|37803448|FG001|Maintenance Period|Withdrawal by Subject|1|||
16853154|NCT01744496|37803447|FG000|Maintenance Period|Subject left town|1|||
16853155|NCT01744496|37803448|FG001|Maintenance Period|Subject left town|0|||
16853156|NCT01721330|37803456|FG000|Overall Study|Withdrawal by Subject|0|||
16853157|NCT01721330|37803457|FG001|Overall Study|Withdrawal by Subject|1|||
16853158|NCT01828099|37803475|FG000|Overall Study|Adverse Event|15|||
16853159|NCT01828099|37803476|FG001|Overall Study|Adverse Event|18|||
16853160|NCT01828099|37803475|FG000|Overall Study|Death|9|||
16853161|NCT01828099|37803476|FG001|Overall Study|Death|11|||
16853162|NCT01828099|37803475|FG000|Overall Study|Lost to Follow-up|2|||
16853163|NCT01828099|37803476|FG001|Overall Study|Lost to Follow-up|0|||
16853164|NCT01828099|37803475|FG000|Overall Study|Non-compliance with study treatment|2|||
16853165|NCT01828099|37803476|FG001|Overall Study|Non-compliance with study treatment|0|||
16853166|NCT01828099|37803475|FG000|Overall Study|Physician Decision|7|||
16853167|NCT01828099|37803476|FG001|Overall Study|Physician Decision|11|||
16853168|NCT01828099|37803475|FG000|Overall Study|Progressive disease|51|||
16853169|NCT01828099|37803476|FG001|Overall Study|Progressive disease|94|||
16853170|NCT01828099|37803475|FG000|Overall Study|Protocol Violation|1|||
16853171|NCT01828099|37803476|FG001|Overall Study|Protocol Violation|0|||
16853172|NCT01828099|37803475|FG000|Overall Study|Subject/guardian decision|7|||
16853173|NCT01828099|37803476|FG001|Overall Study|Subject/guardian decision|23|||
16853174|NCT01828021|37803482|FG000|Overall Study|Adverse Event|5|||
16853175|NCT01828021|37803482|FG000|Overall Study|Lack of Efficacy|17|||
16853176|NCT01828021|37803482|FG000|Overall Study|Withdrawal by Subject|2|||
16853177|NCT01828021|37803482|FG000|Overall Study|Ileal obstruction, unrelated|1|||
16853178|NCT01827943|37803486|FG000|Overall Study|Protocol Violation|8|||
17025879|NCT00749190|38170409|FG002|Overall Study|Other reason not defined above|0|||
17025880|NCT00749190|38170410|FG003|Overall Study|Other reason not defined above|1|||
17025881|NCT00749190|38170411|FG004|Overall Study|Other reason not defined above|0|||
17025882|NCT00749190|38170412|FG005|Overall Study|Other reason not defined above|0|||
17025883|NCT00749190|38170413|FG006|Overall Study|Other reason not defined above|0|||
17025884|NCT00748566|38170434|FG000|Overall Study|Adverse Event|49|||
17025885|NCT00748566|38170434|FG000|Overall Study|Death|1|||
17025886|NCT00748566|38170434|FG000|Overall Study|Lack of Efficacy|12|||
17025887|NCT00748566|38170434|FG000|Overall Study|Lost to Follow-up|1|||
17025888|NCT00748566|38170434|FG000|Overall Study|Protocol Violation|13|||
17025889|NCT00748566|38170434|FG000|Overall Study|Withdrawal by Subject|22|||
17025890|NCT00748566|38170434|FG000|Overall Study|Study terminated by sponsor|5|||
17025891|NCT00748566|38170434|FG000|Overall Study|Other|9|||
17025892|NCT00743106|38170440|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
17025893|NCT00743106|38170441|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
17025894|NCT00738699|38170449|FG000|Overall Study|Withdrawal by Subject|5|||
17025895|NCT00738699|38170450|FG001|Overall Study|Withdrawal by Subject|0|||
17025896|NCT00738699|38170449|FG000|Overall Study|Lost to Follow-up|1|||
16935805|NCT01214629|38080485|FG007|Overall Study|Withdrawal by Subject|0|||
16935806|NCT01214629|38080486|FG008|Overall Study|Withdrawal by Subject|0|||
17025897|NCT00738699|38170450|FG001|Overall Study|Lost to Follow-up|0|||
17025898|NCT00738699|38170449|FG000|Overall Study|Death|144|||
17025899|NCT00738699|38170450|FG001|Overall Study|Death|68|||
17025900|NCT00738699|38170449|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
17025901|NCT00738699|38170450|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
17025902|NCT00738699|38170449|FG000|Overall Study|Other|2|||
17025903|NCT00738699|38170450|FG001|Overall Study|Other|0|||
17025904|NCT00814307|38170460|FG000|Overall Study|Randomized but not treated|1|||
17025905|NCT00814307|38170461|FG001|Overall Study|Randomized but not treated|0|||
17025906|NCT00814307|38170462|FG002|Overall Study|Randomized but not treated|0|||
17025907|NCT00814307|38170463|FG003|Overall Study|Randomized but not treated|0|||
17025908|NCT00814307|38170460|FG000|Overall Study|Adverse Event|3|||
17025909|NCT00814307|38170461|FG001|Overall Study|Adverse Event|9|||
17025910|NCT00814307|38170462|FG002|Overall Study|Adverse Event|3|||
17025911|NCT00814307|38170463|FG003|Overall Study|Adverse Event|2|||
17025912|NCT00814307|38170460|FG000|Overall Study|Lack of Efficacy|1|||
17025913|NCT00814307|38170461|FG001|Overall Study|Lack of Efficacy|1|||
17025914|NCT00814307|38170462|FG002|Overall Study|Lack of Efficacy|3|||
17025915|NCT00814307|38170463|FG003|Overall Study|Lack of Efficacy|4|||
17025916|NCT00814307|38170460|FG000|Overall Study|Other|1|||
17025917|NCT00814307|38170461|FG001|Overall Study|Other|2|||
17025918|NCT00814307|38170462|FG002|Overall Study|Other|0|||
17025919|NCT00814307|38170463|FG003|Overall Study|Other|1|||
17025920|NCT00814307|38170460|FG000|Overall Study|Protocol Violation|2|||
17025921|NCT00814307|38170461|FG001|Overall Study|Protocol Violation|8|||
17025922|NCT00814307|38170462|FG002|Overall Study|Protocol Violation|1|||
17025923|NCT00814307|38170463|FG003|Overall Study|Protocol Violation|1|||
17025924|NCT00814307|38170460|FG000|Overall Study|Withdrawal by Subject|4|||
17025925|NCT00814307|38170461|FG001|Overall Study|Withdrawal by Subject|6|||
17025926|NCT00814307|38170462|FG002|Overall Study|Withdrawal by Subject|0|||
17103371|NCT00112437|38241443|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103372|NCT00112437|38241444|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103373|NCT00112437|38241445|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103374|NCT00112437|38241446|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103375|NCT00112437|38241447|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103376|NCT00112437|38241448|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103377|NCT00112437|38241449|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17025927|NCT00814307|38170463|FG003|Overall Study|Withdrawal by Subject|2|||
17025928|NCT00814307|38170460|FG000|Overall Study|Death|0|||
17025929|NCT00814307|38170461|FG001|Overall Study|Death|1|||
17025930|NCT00814307|38170462|FG002|Overall Study|Death|0|||
17025931|NCT00814307|38170463|FG003|Overall Study|Death|0|||
17025932|NCT00748098|38170475|FG000|First Treatment Intervention Period|Adverse Event|1|||
17025933|NCT00748098|38170476|FG001|First Treatment Intervention Period|Adverse Event|1|||
17025934|NCT00748098|38170475|FG000|First Treatment Intervention Period|Protocol Violation|1|||
17103378|NCT00112437|38241450|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16935807|NCT01214629|38080487|FG009|Overall Study|Withdrawal by Subject|1|||
16935808|NCT01214629|38080488|FG010|Overall Study|Withdrawal by Subject|0|||
16935809|NCT01214434|38080528|FG000|Overall Study|Withdrawal by Subject|1|||
16935810|NCT01214434|38080529|FG001|Overall Study|Withdrawal by Subject|0|||
16935811|NCT01214434|38080528|FG000|Overall Study|Lost to Follow-up|2|||
16935812|NCT01214434|38080529|FG001|Overall Study|Lost to Follow-up|2|||
16935813|NCT01214434|38080528|FG000|Overall Study|Site error|1|||
16935814|NCT01214434|38080529|FG001|Overall Study|Site error|0|||
16935815|NCT01214395|38080535|FG000|Overall Study|All patients had infection|5|||
16935816|NCT01214239|38080542|FG000|Overall Study|Adverse Event|3|||
16935817|NCT01214239|38080543|FG001|Overall Study|Adverse Event|4|||
17025935|NCT00748098|38170476|FG001|First Treatment Intervention Period|Protocol Violation|0|||
17025936|NCT00748098|38170475|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
17025937|NCT00748098|38170476|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
17025938|NCT00748098|38170475|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
17025939|NCT00748098|38170476|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
17025940|NCT00748098|38170475|FG000|First Taper Period|Protocol Violation|1|||
17025941|NCT00748098|38170476|FG001|First Taper Period|Protocol Violation|0|||
17025942|NCT00748098|38170475|FG000|First Taper Period|Withdrawal by Subject|2|||
17025943|NCT00748098|38170476|FG001|First Taper Period|Withdrawal by Subject|0|||
17025944|NCT00748098|38170475|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
17025945|NCT00748098|38170476|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
17025946|NCT00748098|38170475|FG000|1-Week Washout Period|Adverse Event|0|||
17025947|NCT00748098|38170476|FG001|1-Week Washout Period|Adverse Event|1|||
17025948|NCT00748098|38170475|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
17025949|NCT00748098|38170476|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
17025950|NCT00748098|38170475|FG000|Second Treatment Intervention Period|Adverse Event|4|||
17103379|NCT00112437|38241451|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103380|NCT00112437|38241452|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103381|NCT00112437|38241453|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103382|NCT00112437|38241454|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103383|NCT00112437|38241455|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103384|NCT00112437|38241456|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103385|NCT00112437|38241457|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103386|NCT00112437|38241458|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103387|NCT00112437|38241459|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103388|NCT00112437|38241460|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103389|NCT00112437|38241461|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103390|NCT00112437|38241462|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103391|NCT00112437|38241463|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
17103392|NCT00112437|38241464|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
17103393|NCT00112437|38241465|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
17103394|NCT00112437|38241466|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
17103395|NCT03653416|38241522|FG000|Overall Study|Protocol Violation|6|||
17103396|NCT03653416|38241523|FG001|Overall Study|Protocol Violation|1|||
17103397|NCT00112359|38241531|FG000|Overall Study|Unrelated adverse event|16|||
17103398|NCT00112359|38241532|FG001|Overall Study|Unrelated adverse event|8|||
17103399|NCT00112359|38241531|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
17103400|NCT00112359|38241532|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
17103401|NCT00112359|38241531|FG000|Overall Study|Related adverse event|5|||
17103402|NCT00112359|38241532|FG001|Overall Study|Related adverse event|3|||
17103403|NCT00112359|38241531|FG000|Overall Study|Lost to Follow-up|0|||
17103404|NCT00112359|38241532|FG001|Overall Study|Lost to Follow-up|1|||
17103405|NCT00112359|38241531|FG000|Overall Study|Personal/administrative|1|||
17103406|NCT00112359|38241532|FG001|Overall Study|Personal/administrative|1|||
17103407|NCT00112359|38241531|FG000|Overall Study|Other|3|||
17103408|NCT00112359|38241532|FG001|Overall Study|Other|0|||
17103409|NCT00119379|38241540|FG000|Overall Study|Adverse Event|4|||
17103410|NCT00119379|38241541|FG001|Overall Study|Adverse Event|1|||
17103411|NCT00118911|38241549|FG000|Overall Study|Withdrawal by Subject|2|||
17103412|NCT00118911|38241550|FG001|Overall Study|Withdrawal by Subject|5|||
17103413|NCT00131937|38241556|FG000|Overall Study|Adverse Event|3|||
17103414|NCT00131937|38241556|FG000|Overall Study|Withdrawal by Subject|2|||
17103415|NCT00131937|38241556|FG000|Overall Study|Physician Decision|1|||
17103416|NCT00131937|38241556|FG000|Overall Study|Disease Progression|7|||
17198707|NCT02706405|38352371|FG004|Overall Study|Physician Decision|0|||
17198708|NCT02706405|38352372|FG005|Overall Study|Physician Decision|0|||
17025951|NCT00748098|38170476|FG001|Second Treatment Intervention Period|Adverse Event|1|||
17025952|NCT00748098|38170475|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
17025953|NCT00748098|38170476|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
17025954|NCT00748098|38170475|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
17025955|NCT00748098|38170476|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
17025956|NCT00813995|38170485|FG000|Overall Study|Clinical adverse event|9|||
17025957|NCT00813995|38170486|FG001|Overall Study|Clinical adverse event|3|||
17025958|NCT00813995|38170485|FG000|Overall Study|Laboratory adverse event|0|||
17025959|NCT00813995|38170486|FG001|Overall Study|Laboratory adverse event|2|||
17025960|NCT00813995|38170485|FG000|Overall Study|Lack of Efficacy|1|||
17025961|NCT00813995|38170486|FG001|Overall Study|Lack of Efficacy|0|||
17025962|NCT00813995|38170485|FG000|Overall Study|Lost to Follow-up|4|||
17025963|NCT00813995|38170486|FG001|Overall Study|Lost to Follow-up|2|||
17025964|NCT00813995|38170485|FG000|Overall Study|Other reason|2|||
17025965|NCT00813995|38170486|FG001|Overall Study|Other reason|2|||
17025966|NCT00813995|38170485|FG000|Overall Study|Protocol Violation|3|||
17025967|NCT00813995|38170486|FG001|Overall Study|Protocol Violation|2|||
17025968|NCT00813995|38170485|FG000|Overall Study|Subject moved|4|||
17025969|NCT00813995|38170486|FG001|Overall Study|Subject moved|0|||
17025970|NCT00813995|38170485|FG000|Overall Study|Withdrawal by Subject|0|||
17025971|NCT00813995|38170486|FG001|Overall Study|Withdrawal by Subject|5|||
17025972|NCT00737529|38170496|FG000|Overall Study|Disease Progression|95|||
17025973|NCT00737529|38170496|FG000|Overall Study|Adverse Event|24|||
17025974|NCT00737529|38170496|FG000|Overall Study|Withdrawal by Subject|5|||
17025975|NCT00737529|38170496|FG000|Overall Study|Death|4|||
17025976|NCT00737529|38170496|FG000|Overall Study|Protocol Violation|1|||
17025977|NCT00737529|38170496|FG000|Overall Study|Other|4|||
17025978|NCT00813917|38170502|FG000|Overall Study|Adverse Event|0|||
17025979|NCT00813917|38170503|FG001|Overall Study|Adverse Event|1|||
17025980|NCT00813917|38170502|FG000|Overall Study|Withdrawal by Subject|3|||
17025981|NCT00813917|38170503|FG001|Overall Study|Withdrawal by Subject|4|||
17025982|NCT00813917|38170502|FG000|Overall Study|Lost to Follow-up|3|||
17025983|NCT00813917|38170503|FG001|Overall Study|Lost to Follow-up|1|||
17025984|NCT00737061|38170509|FG000|Waiting Period|Lost to Follow-up|6|||
17103417|NCT00131937|38241556|FG000|Overall Study|Alternative therapy|1|||
17103418|NCT00131469|38241562|FG000|Overall Study|Withdrawal by Subject|3|||
17103419|NCT00131469|38241563|FG001|Overall Study|Withdrawal by Subject|4|||
17103420|NCT00131469|38241562|FG000|Overall Study|Protocol Violation|3|||
17103421|NCT00131469|38241563|FG001|Overall Study|Protocol Violation|1|||
17103422|NCT00131469|38241562|FG000|Overall Study|Death|0|||
17103423|NCT00131469|38241563|FG001|Overall Study|Death|1|||
17103424|NCT00131469|38241562|FG000|Overall Study|Lost to Follow-up|0|||
17103425|NCT00131469|38241563|FG001|Overall Study|Lost to Follow-up|1|||
17103426|NCT00131469|38241562|FG000|Overall Study|scan not analyzable|3|||
17103427|NCT00131469|38241563|FG001|Overall Study|scan not analyzable|6|||
17103428|NCT00372593|38241572|FG000|Overall Study|Adverse Event|43|||
17103429|NCT00372593|38241573|FG001|Overall Study|Adverse Event|45|||
17103430|NCT00372593|38241574|FG002|Overall Study|Adverse Event|0|||
17103431|NCT00372593|38241572|FG000|Overall Study|Death|16|||
17103432|NCT00372593|38241573|FG001|Overall Study|Death|20|||
17103433|NCT00372593|38241574|FG002|Overall Study|Death|1|||
17103434|NCT00372593|38241572|FG000|Overall Study|Lack of Efficacy|82|||
17103435|NCT00372593|38241573|FG001|Overall Study|Lack of Efficacy|71|||
17103436|NCT00372593|38241574|FG002|Overall Study|Lack of Efficacy|2|||
17103437|NCT00372593|38241572|FG000|Overall Study|Lost to Follow-up|1|||
17103438|NCT00372593|38241573|FG001|Overall Study|Lost to Follow-up|0|||
17103439|NCT00372593|38241574|FG002|Overall Study|Lost to Follow-up|0|||
17103440|NCT00372593|38241572|FG000|Overall Study|Physician Decision|42|||
17025985|NCT00737061|38170509|FG000|Waiting Period|Withdrawal by Subject|1|||
17025986|NCT00737061|38170509|FG000|Waiting Period|Bilateral placement failure|34|||
17025987|NCT00737061|38170509|FG000|Waiting Period|Deemed patent following HSG|26|||
17025988|NCT00737061|38170509|FG000|Waiting Period|Alternative contraception failure|3|||
17025989|NCT00737061|38170509|FG000|Waiting Period|Elected surgical tubal ligation|5|||
17103441|NCT00372593|38241573|FG001|Overall Study|Physician Decision|41|||
17103442|NCT00372593|38241574|FG002|Overall Study|Physician Decision|0|||
17103443|NCT00372593|38241572|FG000|Overall Study|Ineligible|20|||
17103444|NCT00372593|38241573|FG001|Overall Study|Ineligible|21|||
17103445|NCT00372593|38241574|FG002|Overall Study|Ineligible|1|||
17103446|NCT03666988|38241589|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
17103447|NCT03666988|38241590|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
17103448|NCT03666988|38241591|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
17103449|NCT03666988|38241592|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
17103450|NCT03666988|38241593|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
17103451|NCT03666988|38241594|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
17103452|NCT03666988|38241589|FG000|Part 1 (Up to 28 Months)|Other|0|||
17103453|NCT03666988|38241590|FG001|Part 1 (Up to 28 Months)|Other|1|||
17103454|NCT03666988|38241591|FG002|Part 1 (Up to 28 Months)|Other|1|||
17103455|NCT03666988|38241592|FG003|Part 1 (Up to 28 Months)|Other|0|||
17103456|NCT03666988|38241593|FG004|Part 1 (Up to 28 Months)|Other|0|||
17103457|NCT03666988|38241594|FG005|Part 1 (Up to 28 Months)|Other|0|||
17103458|NCT03666988|38241589|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
17103459|NCT03666988|38241590|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
17103460|NCT03666988|38241591|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
17103461|NCT03666988|38241592|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
17103462|NCT03666988|38241593|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
17103463|NCT03666988|38241594|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
17103464|NCT03666988|38241589|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
17103465|NCT03666988|38241590|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
17103466|NCT03666988|38241591|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
16935818|NCT01214239|38080542|FG000|Overall Study|Protocol Violation|2|||
17025990|NCT00737061|38170509|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
17025991|NCT00737061|38170509|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
17025992|NCT00737061|38170509|FG000|1 Year Wearing Period|Discontinued reilance|3|||
17025993|NCT00737061|38170509|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
17103467|NCT03666988|38241592|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
17103468|NCT03666988|38241593|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
17103469|NCT03666988|38241594|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
17103470|NCT03666988|38241589|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
17025994|NCT00585975|38170515|FG000|Overall Study|Withdrawal by Subject|3|||
17025995|NCT00585975|38170516|FG001|Overall Study|Withdrawal by Subject|3|||
17025996|NCT00585975|38170515|FG000|Overall Study|Lost to Follow-up|2|||
17025997|NCT00585975|38170516|FG001|Overall Study|Lost to Follow-up|1|||
17025998|NCT00585975|38170515|FG000|Overall Study|Enrollment met/over-enrolled|10|||
17103471|NCT03666988|38241590|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
17103472|NCT03666988|38241591|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
17103473|NCT03666988|38241592|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
17103474|NCT03666988|38241593|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
17103475|NCT03666988|38241594|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
17103476|NCT00382109|38241614|FG000|Overall Study|Adverse Event|3|||
17103477|NCT00382109|38241615|FG001|Overall Study|Adverse Event|0|||
17103478|NCT00382109|38241614|FG000|Overall Study|Physician Decision|6|||
17103479|NCT00382109|38241615|FG001|Overall Study|Physician Decision|1|||
17103480|NCT00382109|38241614|FG000|Overall Study|Withdrawal by Subject|1|||
17103481|NCT00382109|38241615|FG001|Overall Study|Withdrawal by Subject|0|||
17103482|NCT00382109|38241614|FG000|Overall Study|ineligible|2|||
17103483|NCT00382109|38241615|FG001|Overall Study|ineligible|0|||
17103484|NCT00382109|38241614|FG000|Overall Study|Other|0|||
17103485|NCT00382109|38241615|FG001|Overall Study|Other|2|||
17103486|NCT00382109|38241614|FG000|Overall Study|consent withdrawal|0|||
17103487|NCT00382109|38241615|FG001|Overall Study|consent withdrawal|1|||
17103488|NCT03651622|38241627|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
17103489|NCT03651622|38241628|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
17103490|NCT03651622|38241629|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
17103491|NCT03651622|38241627|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
17103492|NCT03651622|38241628|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
17103493|NCT03651622|38241629|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
17103494|NCT03651622|38241627|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
17103495|NCT03651622|38241628|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
17103496|NCT03651622|38241629|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
17103497|NCT03651622|38241627|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
17103498|NCT03651622|38241628|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
17103499|NCT03651622|38241629|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
17103500|NCT03651622|38241627|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
17103501|NCT03651622|38241628|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
17103502|NCT03651622|38241629|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
17103503|NCT00381797|38241642|FG000|Overall Study|Withdrawal by Subject|1|||
17103504|NCT00381797|38241643|FG001|Overall Study|Withdrawal by Subject|1|||
17103505|NCT00381797|38241644|FG002|Overall Study|Withdrawal by Subject|0|||
17103506|NCT00381797|38241645|FG003|Overall Study|Withdrawal by Subject|0|||
17103507|NCT00381797|38241646|FG004|Overall Study|Withdrawal by Subject|2|||
17103508|NCT00381797|38241642|FG000|Overall Study|Ineligible|0|||
17103509|NCT00381797|38241643|FG001|Overall Study|Ineligible|0|||
17103510|NCT00381797|38241644|FG002|Overall Study|Ineligible|0|||
17103511|NCT00381797|38241645|FG003|Overall Study|Ineligible|1|||
17103512|NCT00381797|38241646|FG004|Overall Study|Ineligible|0|||
17103513|NCT03665038|38241682|FG000|Overall Study|Lost to Follow-up|0|||
17103514|NCT03665038|38241683|FG001|Overall Study|Lost to Follow-up|0|||
17103515|NCT03665038|38241684|FG002|Overall Study|Lost to Follow-up|1|||
17103516|NCT03664024|38241694|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
17103517|NCT03664024|38241694|FG000|Overall Study|Lost to Follow-up|2|||
17103518|NCT03664024|38241694|FG000|Overall Study|Withdrawal by Subject|2|||
17103519|NCT03664024|38241694|FG000|Overall Study|Death|80|||
17103520|NCT00381641|38241703|FG000|Overall Study|Withdrawal by Subject|0|||
17103521|NCT00381641|38241704|FG001|Overall Study|Withdrawal by Subject|2|||
17198709|NCT02706405|38352373|FG006|Overall Study|Physician Decision|0|||
17198710|NCT02706405|38352374|FG007|Overall Study|Physician Decision|0|||
17198711|NCT02761993|38352403|FG000|Overall Study|Adverse Event|0|||
17198712|NCT02761993|38352404|FG001|Overall Study|Adverse Event|2|||
17198713|NCT02761993|38352405|FG002|Overall Study|Adverse Event|0|||
17198714|NCT02761993|38352403|FG000|Overall Study|Lost to Follow-up|1|||
17198715|NCT02761993|38352404|FG001|Overall Study|Lost to Follow-up|3|||
17198716|NCT02761993|38352405|FG002|Overall Study|Lost to Follow-up|2|||
17198717|NCT02761993|38352403|FG000|Overall Study|Withdrawal by Subject|1|||
17198718|NCT02761993|38352404|FG001|Overall Study|Withdrawal by Subject|1|||
17025999|NCT00585975|38170516|FG001|Overall Study|Enrollment met/over-enrolled|9|||
17026000|NCT00585585|38170522|FG000|Overall Study|Adverse Event|1|||
17026001|NCT00734097|38170526|FG000|Screening|Protocol Violation|12|||
17026002|NCT00734097|38170526|FG000|Screening|Withdrawal by Subject|5|||
17026003|NCT00734097|38170526|FG000|Screening|Lost to Follow-up|2|||
17026004|NCT00734097|38170526|FG000|Screening|Unconfirmed pregnancy|1|||
17026005|NCT00734097|38170526|FG000|Open Label|Lost to Follow-up|7|||
17026006|NCT00734097|38170526|FG000|Open Label|Withdrawal by Subject|5|||
17026007|NCT00734097|38170526|FG000|Open Label|Protocol Violation|4|||
17103522|NCT00381563|38241712|FG000|Overall Study|Withdrawal by Subject|5|||
17026008|NCT00819767|38170532|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17026009|NCT00819767|38170533|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
17026010|NCT00733005|38170541|FG000|Overall Study|Adverse Event|0|||
16935819|NCT01214239|38080543|FG001|Overall Study|Protocol Violation|1|||
16935820|NCT01214239|38080542|FG000|Overall Study|Lost to Follow-up|1|||
16935821|NCT01214239|38080543|FG001|Overall Study|Lost to Follow-up|1|||
16935822|NCT01214239|38080542|FG000|Overall Study|Withdrawal by Subject|4|||
16935823|NCT01214239|38080543|FG001|Overall Study|Withdrawal by Subject|9|||
16935824|NCT01214239|38080542|FG000|Overall Study|Lack of Efficacy|1|||
16935825|NCT01214239|38080543|FG001|Overall Study|Lack of Efficacy|2|||
16935826|NCT01214239|38080542|FG000|Overall Study|patient's private reason|1|||
16935827|NCT01214239|38080543|FG001|Overall Study|patient's private reason|1|||
16935828|NCT01214200|38080549|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
16935829|NCT01214200|38080549|FG000|Overall Study|Withdrawal by Subject|2|||
16935830|NCT01214044|38080555|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
16935831|NCT01214044|38080555|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
17103523|NCT00381563|38241713|FG001|Overall Study|Withdrawal by Subject|5|||
17103524|NCT00381563|38241712|FG000|Overall Study|Lost to Follow-up|2|||
17103525|NCT00381563|38241713|FG001|Overall Study|Lost to Follow-up|0|||
17103526|NCT00381563|38241712|FG000|Overall Study|Protocol Violation|0|||
17103527|NCT00381563|38241713|FG001|Overall Study|Protocol Violation|1|||
17103528|NCT03624946|38241720|FG000|Overall Study|Lost to Follow-up|0|||
17103529|NCT03624946|38241721|FG001|Overall Study|Lost to Follow-up|1|||
17103530|NCT00381095|38241733|FG000|Overall Study|Death|3|||
17103531|NCT00381095|38241734|FG001|Overall Study|Death|4|||
17103532|NCT00381095|38241733|FG000|Overall Study|Lack of Efficacy|2|||
17103533|NCT00381095|38241734|FG001|Overall Study|Lack of Efficacy|4|||
17103534|NCT00381095|38241733|FG000|Overall Study|Other|2|||
17103535|NCT00381095|38241734|FG001|Overall Study|Other|2|||
17103536|NCT00381095|38241733|FG000|Overall Study|Protocol Violation|1|||
17103537|NCT00381095|38241734|FG001|Overall Study|Protocol Violation|1|||
17103538|NCT00381095|38241733|FG000|Overall Study|Withdrawal by Subject|3|||
17103539|NCT00381095|38241734|FG001|Overall Study|Withdrawal by Subject|3|||
17103540|NCT00381095|38241733|FG000|Overall Study|Adverse Event|2|||
17103541|NCT00381095|38241734|FG001|Overall Study|Adverse Event|7|||
17103542|NCT03619174|38241742|FG000|Overall Study|Lost to Follow-up|3|||
17103543|NCT03619174|38241743|FG001|Overall Study|Lost to Follow-up|0|||
17103544|NCT03619174|38241742|FG000|Overall Study|Withdrawal by Subject|4|||
17103545|NCT03619174|38241743|FG001|Overall Study|Withdrawal by Subject|3|||
17103546|NCT03619174|38241742|FG000|Overall Study|Pregnancy|1|||
17103547|NCT03619174|38241743|FG001|Overall Study|Pregnancy|1|||
17103548|NCT03619174|38241742|FG000|Overall Study|Discomfort during treatment|1|||
17103549|NCT03619174|38241743|FG001|Overall Study|Discomfort during treatment|0|||
17103550|NCT00112047|38241751|FG000|Randomized Phase|Lost to Follow-up|26|||
17103551|NCT00112047|38241752|FG001|Randomized Phase|Lost to Follow-up|33|||
17103552|NCT00112047|38241751|FG000|Randomized Phase|Adverse Event|10|||
17103553|NCT00112047|38241752|FG001|Randomized Phase|Adverse Event|10|||
17103554|NCT00112047|38241751|FG000|Randomized Phase|Withrawal of consent|10|||
17103555|NCT00112047|38241752|FG001|Randomized Phase|Withrawal of consent|18|||
17103556|NCT00112047|38241751|FG000|Randomized Phase|Sub-optimal virological response|3|||
17103557|NCT00112047|38241752|FG001|Randomized Phase|Sub-optimal virological response|13|||
17103558|NCT00112047|38241751|FG000|Randomized Phase|Noncompliance|8|||
17103559|NCT00112047|38241752|FG001|Randomized Phase|Noncompliance|4|||
17103560|NCT00112047|38241751|FG000|Randomized Phase|Protocol Violation|2|||
17026011|NCT00733005|38170542|FG001|Overall Study|Adverse Event|1|||
17026012|NCT00733005|38170541|FG000|Overall Study|Treatment Failure|0|||
17026013|NCT00733005|38170542|FG001|Overall Study|Treatment Failure|1|||
17103561|NCT00112047|38241752|FG001|Randomized Phase|Protocol Violation|0|||
17103562|NCT00112047|38241751|FG000|Randomized Phase|Pregnancy|3|||
16935832|NCT01214044|38080555|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
16935833|NCT01214044|38080555|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
16935834|NCT01214044|38080555|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
17026014|NCT00733005|38170541|FG000|Overall Study|Withdrawal by Subject|0|||
17103563|NCT00112047|38241752|FG001|Randomized Phase|Pregnancy|1|||
17103564|NCT00112047|38241751|FG000|Randomized Phase|Death|1|||
17103565|NCT00112047|38241752|FG001|Randomized Phase|Death|3|||
17103566|NCT00112047|38241751|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
17103567|NCT00112047|38241752|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
17103568|NCT00112047|38241751|FG000|Randomized Phase|Inability to swallow pills|0|||
17103569|NCT00112047|38241752|FG001|Randomized Phase|Inability to swallow pills|1|||
17103570|NCT00112047|38241751|FG000|Randomized Phase|Incarceration|3|||
17103571|NCT00112047|38241752|FG001|Randomized Phase|Incarceration|2|||
17103572|NCT00112047|38241751|FG000|Randomized Phase|Moved out of State|0|||
17026015|NCT00733005|38170542|FG001|Overall Study|Withdrawal by Subject|1|||
17103573|NCT00112047|38241752|FG001|Randomized Phase|Moved out of State|1|||
17103574|NCT00112047|38241751|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
17103575|NCT00112047|38241752|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
16935835|NCT01214044|38080555|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
16935836|NCT01213966|38080567|FG000|Overall Study|Protocol Violation|1|||
16935837|NCT01213966|38080568|FG001|Overall Study|Protocol Violation|0|||
16935838|NCT01213966|38080569|FG002|Overall Study|Protocol Violation|3|||
16935839|NCT01213966|38080570|FG003|Overall Study|Protocol Violation|1|||
16935840|NCT01213264|38080583|FG000|Overall Study|Adverse Event|1|||
16935841|NCT01213264|38080584|FG001|Overall Study|Adverse Event|0|||
16935842|NCT01213264|38080585|FG002|Overall Study|Adverse Event|0|||
16935843|NCT01213264|38080583|FG000|Overall Study|Lost to Follow-up|1|||
16935844|NCT01213264|38080584|FG001|Overall Study|Lost to Follow-up|2|||
16853179|NCT01827943|37803486|FG000|Overall Study|Never treated because of an rapid progression|1|||
16853180|NCT00217971|37803492|FG000|Overall Study|Adverse Event|1|||
16853181|NCT00217971|37803493|FG001|Overall Study|Adverse Event|1|||
16853182|NCT00217971|37803492|FG000|Overall Study|Lost to Follow-up|15|||
16853183|NCT00217971|37803493|FG001|Overall Study|Lost to Follow-up|19|||
16853184|NCT00217971|37803492|FG000|Overall Study|Physician Decision|0|||
16853185|NCT00217971|37803493|FG001|Overall Study|Physician Decision|1|||
16853186|NCT00217971|37803492|FG000|Overall Study|Withdrawal by Subject|7|||
16853187|NCT00217971|37803493|FG001|Overall Study|Withdrawal by Subject|12|||
16853188|NCT00217971|37803492|FG000|Overall Study|non compliant|1|||
16853189|NCT00217971|37803493|FG001|Overall Study|non compliant|0|||
16853190|NCT00217581|37803499|FG000|Overall Study|Withdrawal by Subject|1|||
16853191|NCT00217425|37803504|FG000|Overall Study|Never started treatment|2|||
16853192|NCT00217425|37803504|FG000|Overall Study|Patient ineligible|5|||
16853193|NCT00217425|37803504|FG000|Overall Study|Lack of Efficacy|13|||
16853194|NCT00217425|37803504|FG000|Overall Study|Adverse Event|8|||
16853195|NCT00217425|37803504|FG000|Overall Study|Withdrawal by Subject|4|||
16853196|NCT00217425|37803504|FG000|Overall Study|Other complicating disease|1|||
16853197|NCT00217425|37803504|FG000|Overall Study|Other|4|||
16853198|NCT01856257|37803511|FG000|Overall Study|Death|2|||
16853199|NCT01856257|37803512|FG001|Overall Study|Death|0|||
16853200|NCT01856257|37803513|FG002|Overall Study|Death|0|||
16853201|NCT01856257|37803514|FG003|Overall Study|Death|0|||
16853202|NCT01856257|37803511|FG000|Overall Study|Physician Decision|0|||
16853203|NCT01856257|37803512|FG001|Overall Study|Physician Decision|0|||
16853204|NCT01856257|37803513|FG002|Overall Study|Physician Decision|0|||
16853205|NCT01856257|37803514|FG003|Overall Study|Physician Decision|1|||
16853206|NCT01856257|37803511|FG000|Overall Study|Withdrawal by Subject|1|||
16853207|NCT01856257|37803512|FG001|Overall Study|Withdrawal by Subject|1|||
16853208|NCT01856257|37803513|FG002|Overall Study|Withdrawal by Subject|0|||
16853209|NCT01856257|37803514|FG003|Overall Study|Withdrawal by Subject|0|||
16853210|NCT01856257|37803511|FG000|Overall Study|Donor complication|0|||
16853211|NCT01856257|37803512|FG001|Overall Study|Donor complication|0|||
16853212|NCT01856257|37803513|FG002|Overall Study|Donor complication|0|||
16853213|NCT01856257|37803514|FG003|Overall Study|Donor complication|1|||
16853214|NCT00215943|37803525|FG000|Overall Study|Disease Progression|3|||
16853215|NCT00215943|37803526|FG001|Overall Study|Disease Progression|5|||
16853216|NCT00215943|37803525|FG000|Overall Study|Alternate therapy|0|||
16853217|NCT00215943|37803526|FG001|Overall Study|Alternate therapy|1|||
16853218|NCT00215943|37803525|FG000|Overall Study|Adverse Event|3|||
16853219|NCT00215943|37803526|FG001|Overall Study|Adverse Event|6|||
16853220|NCT00215943|37803525|FG000|Overall Study|Other disease|0|||
16853221|NCT00215943|37803526|FG001|Overall Study|Other disease|1|||
16853222|NCT00215943|37803525|FG000|Overall Study|Other complications|3|||
16853223|NCT00215943|37803526|FG001|Overall Study|Other complications|1|||
16853224|NCT01827319|37803532|FG000|Overall Study|Lost to Follow-up|3|||
16853225|NCT01827163|37803536|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
16853226|NCT01827163|37803536|FG000|Overall Study|Adverse Event|9|||
16853227|NCT00215553|37803547|FG000|Overall Study|Adverse Event|0|||
16853228|NCT00215553|37803548|FG001|Overall Study|Adverse Event|1|||
16853229|NCT00215553|37803549|FG002|Overall Study|Adverse Event|2|||
16853230|NCT00215553|37803550|FG003|Overall Study|Adverse Event|1|||
16853231|NCT00215553|37803551|FG004|Overall Study|Adverse Event|2|||
16853232|NCT00215553|37803552|FG005|Overall Study|Adverse Event|6|||
16853233|NCT00215553|37803553|FG006|Overall Study|Adverse Event|0|||
16853234|NCT00214461|37803573|FG000|Overall Study|Adverse Event|0|||
16853235|NCT00214461|37803574|FG001|Overall Study|Adverse Event|0|||
16853236|NCT00214461|37803575|FG002|Overall Study|Adverse Event|1|||
16853237|NCT00214461|37803576|FG003|Overall Study|Adverse Event|1|||
16853238|NCT00214461|37803573|FG000|Overall Study|Withdrawal by Subject|0|||
16853239|NCT00214461|37803574|FG001|Overall Study|Withdrawal by Subject|0|||
16853240|NCT00214461|37803575|FG002|Overall Study|Withdrawal by Subject|1|||
16935845|NCT01213264|38080585|FG002|Overall Study|Lost to Follow-up|6|||
16853241|NCT00214461|37803576|FG003|Overall Study|Withdrawal by Subject|0|||
16853242|NCT00214383|37803588|FG000|Overall Study|Lost to Follow-up|16|||
16853243|NCT00214383|37803589|FG001|Overall Study|Lost to Follow-up|26|||
16853244|NCT00212355|37803595|FG000|Overall Study|Adverse Event|1|||
16853245|NCT00212355|37803595|FG000|Overall Study|Withdrawal by Subject|1|||
16853246|NCT00212355|37803595|FG000|Overall Study|A change of address|1|||
16853247|NCT00211887|37803602|FG000|Overall Study|Adverse Event|8|||
17026016|NCT00733005|38170541|FG000|Overall Study|Protocol Violation|2|||
17026017|NCT00733005|38170542|FG001|Overall Study|Protocol Violation|0|||
17026018|NCT00812981|38170550|FG000|Overall Study|Other|0|||
17026019|NCT00812981|38170551|FG001|Overall Study|Other|1|||
17026020|NCT00732615|38170559|FG000|Overall Study|Withdrawal by Subject|3|||
17026021|NCT00732615|38170560|FG001|Overall Study|Withdrawal by Subject|1|||
17026022|NCT00732615|38170559|FG000|Overall Study|Lost to Follow-up|0|||
17026023|NCT00732615|38170560|FG001|Overall Study|Lost to Follow-up|1|||
17026024|NCT00732615|38170559|FG000|Overall Study|Adverse Event|0|||
17026025|NCT00732615|38170560|FG001|Overall Study|Adverse Event|2|||
17026026|NCT00732615|38170559|FG000|Overall Study|Physician Decision|3|||
17026027|NCT00732615|38170560|FG001|Overall Study|Physician Decision|0|||
17026028|NCT00732615|38170559|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
17026029|NCT00732615|38170560|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
17026030|NCT00732381|38170569|FG000|Overall Study|Adverse Event|1|||
17026031|NCT00732381|38170570|FG001|Overall Study|Adverse Event|0|||
17026032|NCT00732381|38170569|FG000|Overall Study|Treatment Failure|1|||
17026033|NCT00732381|38170570|FG001|Overall Study|Treatment Failure|1|||
17026034|NCT00732303|38170576|FG000|Overall Study|Study Terminated|2|||
17026035|NCT00813761|38170582|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
17026036|NCT00813761|38170583|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
17026037|NCT00813761|38170584|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
17026038|NCT00813761|38170585|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
17026039|NCT00813761|38170582|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
17026040|NCT00813761|38170583|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
17026041|NCT00813761|38170584|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
17026042|NCT00813761|38170585|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
17026043|NCT00813761|38170582|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
17026044|NCT00813761|38170583|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
17026045|NCT00813761|38170584|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
17026046|NCT00813761|38170585|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
17026047|NCT00813761|38170582|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
17026048|NCT00813761|38170583|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
17026049|NCT00813761|38170584|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
17026050|NCT00813761|38170585|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
17026051|NCT00813761|38170582|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
17026052|NCT00813761|38170583|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
17026053|NCT00813761|38170584|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
17026054|NCT00813761|38170585|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
17026055|NCT00813761|38170582|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
17026056|NCT00813761|38170583|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
17026057|NCT00813761|38170584|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
17026058|NCT00813761|38170585|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
17026059|NCT00813761|38170582|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
17026060|NCT00813761|38170583|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
17026061|NCT00813761|38170584|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
17026062|NCT00813761|38170585|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
17026063|NCT00813761|38170582|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
17026064|NCT00813761|38170583|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
17026065|NCT00813761|38170584|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
17026066|NCT00813761|38170585|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
17026067|NCT00813761|38170582|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
17026068|NCT00813761|38170583|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
17026069|NCT00813761|38170584|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
17026070|NCT00813761|38170585|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
17026071|NCT00813761|38170582|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
17026072|NCT00813761|38170583|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
17026073|NCT00813761|38170584|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
17026074|NCT00813761|38170585|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
17026075|NCT00813761|38170582|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
17026076|NCT00813761|38170583|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
16853248|NCT00211887|37803603|FG001|Overall Study|Adverse Event|4|||
17026077|NCT00813761|38170584|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
17026078|NCT00813761|38170585|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
17026079|NCT00813761|38170582|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
17026080|NCT00813761|38170583|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
17026081|NCT00813761|38170584|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
17026082|NCT00813761|38170585|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
17026083|NCT00732069|38170601|FG000|Washout After First Study Drug|Adverse Event|1|||
17026084|NCT00732069|38170602|FG001|Washout After First Study Drug|Adverse Event|0|||
17026085|NCT00732069|38170603|FG002|Washout After First Study Drug|Adverse Event|0|||
17103576|NCT00112047|38241751|FG000|Randomized Phase|High Hepatitis B DNA|0|||
17103577|NCT00112047|38241752|FG001|Randomized Phase|High Hepatitis B DNA|1|||
17026086|NCT00732069|38170604|FG003|Washout After First Study Drug|Adverse Event|0|||
17026087|NCT00732069|38170605|FG004|Washout After First Study Drug|Adverse Event|0|||
17026088|NCT00732069|38170606|FG005|Washout After First Study Drug|Adverse Event|0|||
17026089|NCT00731679|38170616|FG000|Overall Study|Adverse Event|7|||
17026090|NCT00731679|38170617|FG001|Overall Study|Adverse Event|8|||
17026091|NCT00731679|38170616|FG000|Overall Study|Withdrawal by Subject|8|||
17026092|NCT00731679|38170617|FG001|Overall Study|Withdrawal by Subject|8|||
17026093|NCT00731679|38170616|FG000|Overall Study|Lost to Follow-up|7|||
17026094|NCT00731679|38170617|FG001|Overall Study|Lost to Follow-up|8|||
17026095|NCT00731679|38170616|FG000|Overall Study|Noncompliance|0|||
17026096|NCT00731679|38170617|FG001|Overall Study|Noncompliance|1|||
17026097|NCT00731679|38170616|FG000|Overall Study|Pregnancy|0|||
17026098|NCT00731679|38170617|FG001|Overall Study|Pregnancy|1|||
17026099|NCT00731133|38170623|FG000|Overall Study|Withdrawal by Subject|10|||
17026100|NCT00730275|38170631|FG000|Overall Study|Withdrawal by Subject|0|||
17026101|NCT00730275|38170632|FG001|Overall Study|Withdrawal by Subject|0|||
17026102|NCT00730275|38170633|FG002|Overall Study|Withdrawal by Subject|0|||
17026103|NCT00730275|38170634|FG003|Overall Study|Withdrawal by Subject|1|||
17026104|NCT00730041|38170652|FG000|Overall Study|Lost to Follow-up|0|||
17026105|NCT00730041|38170653|FG001|Overall Study|Lost to Follow-up|2|||
17026106|NCT00729651|38170661|FG000|Overall Study|Withdrawal by Subject|5|||
17026107|NCT00729651|38170662|FG001|Overall Study|Withdrawal by Subject|6|||
17026108|NCT00729651|38170661|FG000|Overall Study|Lost to Follow-up|5|||
17026109|NCT00729651|38170662|FG001|Overall Study|Lost to Follow-up|4|||
17026110|NCT00729651|38170661|FG000|Overall Study|Protocol Violation|0|||
17026111|NCT00729651|38170662|FG001|Overall Study|Protocol Violation|1|||
17026112|NCT00729651|38170661|FG000|Overall Study|Adverse Event|7|||
17026113|NCT00729651|38170662|FG001|Overall Study|Adverse Event|3|||
17026114|NCT00729651|38170661|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
17026115|NCT00729651|38170662|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
17026116|NCT00729651|38170661|FG000|Overall Study|Subject's private reason|2|||
17026117|NCT00729651|38170662|FG001|Overall Study|Subject's private reason|0|||
17026118|NCT00729183|38170670|FG000|Overall Study|Adverse Event|11|||
17026119|NCT00729183|38170671|FG001|Overall Study|Adverse Event|5|||
17026120|NCT00729183|38170670|FG000|Overall Study|Lack of Efficacy|0|||
17026121|NCT00729183|38170671|FG001|Overall Study|Lack of Efficacy|1|||
17026122|NCT00729183|38170670|FG000|Overall Study|Lost to Follow-up|3|||
17026123|NCT00729183|38170671|FG001|Overall Study|Lost to Follow-up|1|||
17026124|NCT00729183|38170670|FG000|Overall Study|Physician Decision|1|||
17026125|NCT00729183|38170671|FG001|Overall Study|Physician Decision|1|||
17026126|NCT00729183|38170670|FG000|Overall Study|Protocol Violation|1|||
17026127|NCT00729183|38170671|FG001|Overall Study|Protocol Violation|0|||
17026128|NCT00729183|38170670|FG000|Overall Study|Withdrawal by Subject|9|||
17026129|NCT00729183|38170671|FG001|Overall Study|Withdrawal by Subject|7|||
17026130|NCT00811733|38170679|FG000|Overall Study|Investigator Discretion|10|||
17026131|NCT00811733|38170680|FG001|Overall Study|Investigator Discretion|8|||
17026132|NCT00811733|38170679|FG000|Overall Study|Withdrawal by Subject|1|||
17026133|NCT00811733|38170680|FG001|Overall Study|Withdrawal by Subject|2|||
17026134|NCT00728949|38170688|FG000|Overall Study|Adverse Event|8|||
17026135|NCT00728949|38170689|FG001|Overall Study|Adverse Event|0|||
17026136|NCT00728949|38170688|FG000|Overall Study|Withdrawal by Subject|2|||
17026137|NCT00728949|38170689|FG001|Overall Study|Withdrawal by Subject|2|||
17026138|NCT00728949|38170688|FG000|Overall Study|Abnormal Lab Results|0|||
17026139|NCT00728949|38170689|FG001|Overall Study|Abnormal Lab Results|2|||
17026140|NCT00728949|38170688|FG000|Overall Study|On treatment at cutoff date|1|||
17026141|NCT00728949|38170689|FG001|Overall Study|On treatment at cutoff date|0|||
17026142|NCT00728481|38170697|FG000|Overall Study|Withdrawal by Subject|0|||
17026143|NCT00728481|38170698|FG001|Overall Study|Withdrawal by Subject|1|||
17026144|NCT00728481|38170697|FG000|Overall Study|Adverse Event|0|||
17026145|NCT00728481|38170698|FG001|Overall Study|Adverse Event|1|||
17026146|NCT00728481|38170697|FG000|Overall Study|Study medication non-compliance|0|||
17026147|NCT00728481|38170698|FG001|Overall Study|Study medication non-compliance|2|||
17026148|NCT00728481|38170697|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
16853249|NCT00211887|37803604|FG002|Overall Study|Adverse Event|6|||
16853250|NCT00211887|37803602|FG000|Overall Study|Death|1|||
17026149|NCT00728481|38170698|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
17026150|NCT00811655|38170704|FG000|Overall Study|Physician Decision|1|||
17026151|NCT00727311|38170708|FG000|Overall Study|Did not receive drug|316|||
17026152|NCT00727311|38170708|FG000|Overall Study|Missing end of therapy data|205|||
17026153|NCT00727311|38170708|FG000|Overall Study|Adverse Event|58|||
17026154|NCT00727311|38170708|FG000|Overall Study|Lack of Efficacy|242|||
17026155|NCT00727311|38170708|FG000|Overall Study|Lost to Follow-up|73|||
17026156|NCT00727311|38170708|FG000|Overall Study|Withdrawal by Subject|77|||
17026157|NCT00727311|38170708|FG000|Overall Study|Other|97|||
17026158|NCT00727311|38170708|FG000|Overall Study|Multiple reasons|39|||
17026159|NCT00726999|38170714|FG000|Overall Study|Physician Decision|0|||
17026160|NCT00726999|38170715|FG001|Overall Study|Physician Decision|1|||
17026161|NCT00726999|38170714|FG000|Overall Study|Withdrawal by Subject|2|||
17026162|NCT00726999|38170715|FG001|Overall Study|Withdrawal by Subject|0|||
17026163|NCT00726999|38170714|FG000|Overall Study|Protocol Violation|1|||
17026164|NCT00726999|38170715|FG001|Overall Study|Protocol Violation|0|||
17026165|NCT00585351|38170729|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
17026166|NCT00585351|38170730|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
17026167|NCT00585351|38170731|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
17026168|NCT00585351|38170732|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
17026169|NCT00585351|38170733|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
17026170|NCT00585351|38170734|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
17026171|NCT00585351|38170735|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
17026172|NCT00585351|38170736|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
17026173|NCT00585351|38170729|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
17026174|NCT00585351|38170730|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
17026175|NCT00585351|38170731|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
17026176|NCT00585351|38170732|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
17026177|NCT00585351|38170733|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
17026178|NCT00585351|38170734|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
17026179|NCT00585351|38170735|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
17026180|NCT00585351|38170736|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
17026181|NCT00585351|38170729|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
17026182|NCT00585351|38170730|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
17026183|NCT00585351|38170731|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
17026184|NCT00585351|38170732|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
17026185|NCT00585351|38170733|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
17026186|NCT00585351|38170734|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
17026187|NCT00585351|38170735|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
17026188|NCT00585351|38170736|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
17026189|NCT00585351|38170729|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
17026190|NCT00585351|38170730|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
17026191|NCT00585351|38170731|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
17026192|NCT00585351|38170732|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
17026193|NCT00585351|38170733|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
17026194|NCT00585351|38170734|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
17026195|NCT00585351|38170735|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
17026196|NCT00585351|38170736|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
17026197|NCT00585351|38170729|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
17026198|NCT00585351|38170730|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
17026199|NCT00585351|38170731|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
17026200|NCT00585351|38170732|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
17026201|NCT00585351|38170733|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
17026202|NCT00585351|38170734|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
17026203|NCT00585351|38170735|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
17026204|NCT00585351|38170736|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
17026205|NCT00585351|38170729|FG000|Enrollment Period (Intervention)|Death|0|||
17026206|NCT00585351|38170730|FG001|Enrollment Period (Intervention)|Death|0|||
17026207|NCT00585351|38170731|FG002|Enrollment Period (Intervention)|Death|0|||
17026208|NCT00585351|38170732|FG003|Enrollment Period (Intervention)|Death|0|||
17026209|NCT00585351|38170733|FG004|Enrollment Period (Intervention)|Death|1|||
17026210|NCT00585351|38170734|FG005|Enrollment Period (Intervention)|Death|0|||
17026211|NCT00585351|38170735|FG006|Enrollment Period (Intervention)|Death|1|||
17026212|NCT00585351|38170736|FG007|Enrollment Period (Intervention)|Death|0|||
17026213|NCT00585351|38170729|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
17026214|NCT00585351|38170730|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
17026215|NCT00585351|38170731|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
17026216|NCT00585351|38170732|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
17026217|NCT00585351|38170733|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
17026218|NCT00585351|38170734|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
17026219|NCT00585351|38170735|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
17026220|NCT00585351|38170736|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
17026221|NCT00813293|38170752|FG000|Overall Study|Intercurrent illness|1|||
17026222|NCT00813293|38170753|FG001|Overall Study|Intercurrent illness|0|||
17026223|NCT00813293|38170752|FG000|Overall Study|Adverse Event|0|||
17026224|NCT00813293|38170753|FG001|Overall Study|Adverse Event|1|||
17026225|NCT00726609|38170759|FG000|Overall Study|Adverse Event|10|||
17026226|NCT00726609|38170759|FG000|Overall Study|Withdrawal by Subject|2|||
17026227|NCT00726609|38170759|FG000|Overall Study|Lack of Efficacy|25|||
17026228|NCT00726609|38170759|FG000|Overall Study|Other|16|||
17026229|NCT00726609|38170759|FG000|Overall Study|Missing|42|||
17026230|NCT00726609|38170759|FG000|Overall Study|Other|3|||
17026231|NCT00726453|38170765|FG000|Primary Enrollment Group|Death|18|||
17026232|NCT00726453|38170766|FG001|Primary Enrollment Group|Death|0|||
17026233|NCT00726453|38170765|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
17026234|NCT00726453|38170766|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
17026235|NCT00726453|38170765|FG000|38 mm Length Group|Death|0|||
17026236|NCT00726453|38170766|FG001|38 mm Length Group|Death|3|||
16935846|NCT01212991|38080598|FG000|Double-blind|Lost to Follow-up|8|||
16935847|NCT01212991|38080599|FG001|Double-blind|Lost to Follow-up|4|||
16935848|NCT01212991|38080600|FG002|Double-blind|Lost to Follow-up|0|||
16935849|NCT01212991|38080598|FG000|Double-blind|Death|699|||
16935850|NCT01212991|38080599|FG001|Double-blind|Death|550|||
16935851|NCT01212991|38080600|FG002|Double-blind|Death|0|||
16935852|NCT01212991|38080598|FG000|Double-blind|Withdrawal by Subject|16|||
16935853|NCT01212991|38080599|FG001|Double-blind|Withdrawal by Subject|19|||
16935854|NCT01212991|38080600|FG002|Double-blind|Withdrawal by Subject|0|||
17026237|NCT00726063|38170773|FG000|Overall Study|Adverse Event|9|||
17026238|NCT00726063|38170774|FG001|Overall Study|Adverse Event|7|||
17026239|NCT00808028|38170784|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
17026240|NCT00808028|38170785|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
17026241|NCT00808028|38170786|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
17026242|NCT00808028|38170787|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
17026243|NCT00808028|38170784|FG000|Stage 1 (6 Months)|Other|1|||
17026244|NCT00808028|38170785|FG001|Stage 1 (6 Months)|Other|0|||
17026245|NCT00808028|38170786|FG002|Stage 1 (6 Months)|Other|2|||
17026246|NCT00808028|38170787|FG003|Stage 1 (6 Months)|Other|4|||
17026247|NCT00808028|38170784|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
17026248|NCT00808028|38170785|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
17026249|NCT00808028|38170786|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
17026250|NCT00808028|38170787|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
17026251|NCT00808028|38170784|FG000|Stage 1 (6 Months)|Adverse Event|0|||
17026252|NCT00808028|38170785|FG001|Stage 1 (6 Months)|Adverse Event|0|||
17026253|NCT00808028|38170786|FG002|Stage 1 (6 Months)|Adverse Event|1|||
17026254|NCT00808028|38170787|FG003|Stage 1 (6 Months)|Adverse Event|2|||
17026255|NCT00808028|38170784|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
17026256|NCT00808028|38170785|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
17026257|NCT00808028|38170786|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
17026258|NCT00808028|38170787|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
17026259|NCT00808028|38170784|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
17026260|NCT00808028|38170785|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
17026261|NCT00808028|38170786|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
17026262|NCT00808028|38170787|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
17026263|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
17026264|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
17026265|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
17026266|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
17026267|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
17026268|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
17026269|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
17026270|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
17026271|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
17026272|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
17026273|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
17026274|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
17026275|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
17026276|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
17026277|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
17026278|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
17026279|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
17026280|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
17026281|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
17026282|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
17026283|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
17026284|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
17026285|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
17026286|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
17026287|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
17026288|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
17026289|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
17026290|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
17026291|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
17026292|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
17026293|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
17026294|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
17026295|NCT00808028|38170784|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
17026296|NCT00808028|38170785|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
17026297|NCT00808028|38170786|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
17026298|NCT00808028|38170787|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
17026299|NCT00809783|38170810|FG000|Overall Study|Death|1|||
17026300|NCT00809783|38170811|FG001|Overall Study|Death|0|||
17026301|NCT00809783|38170812|FG002|Overall Study|Death|0|||
17026302|NCT00809783|38170810|FG000|Overall Study|Adverse Event|34|||
17026303|NCT00809783|38170811|FG001|Overall Study|Adverse Event|52|||
17026304|NCT00809783|38170812|FG002|Overall Study|Adverse Event|71|||
17026305|NCT00809783|38170810|FG000|Overall Study|Lack of Efficacy|39|||
17026306|NCT00809783|38170811|FG001|Overall Study|Lack of Efficacy|52|||
17026307|NCT00809783|38170812|FG002|Overall Study|Lack of Efficacy|63|||
17026308|NCT00809783|38170810|FG000|Overall Study|Lost to Follow-up|0|||
17026309|NCT00809783|38170811|FG001|Overall Study|Lost to Follow-up|3|||
17026310|NCT00809783|38170812|FG002|Overall Study|Lost to Follow-up|4|||
17026311|NCT00809783|38170810|FG000|Overall Study|Withdrawal by Subject|47|||
17026312|NCT00809783|38170811|FG001|Overall Study|Withdrawal by Subject|72|||
17026313|NCT00809783|38170812|FG002|Overall Study|Withdrawal by Subject|64|||
17026314|NCT00809783|38170810|FG000|Overall Study|Protocol Violation|2|||
17026315|NCT00809783|38170811|FG001|Overall Study|Protocol Violation|6|||
17026316|NCT00809783|38170812|FG002|Overall Study|Protocol Violation|5|||
17026317|NCT00809783|38170810|FG000|Overall Study|Randomized, but not treated|3|||
17026318|NCT00809783|38170811|FG001|Overall Study|Randomized, but not treated|0|||
17026319|NCT00809783|38170812|FG002|Overall Study|Randomized, but not treated|2|||
17026320|NCT00809783|38170810|FG000|Overall Study|Study Terminated by Sponsor|378|||
17026321|NCT00809783|38170811|FG001|Overall Study|Study Terminated by Sponsor|626|||
17026322|NCT00809783|38170812|FG002|Overall Study|Study Terminated by Sponsor|565|||
17026323|NCT00809783|38170810|FG000|Overall Study|Other|21|||
17026324|NCT00809783|38170811|FG001|Overall Study|Other|21|||
17026325|NCT00809783|38170812|FG002|Overall Study|Other|16|||
17026326|NCT00809471|38170823|FG000|Overall Study|Protocol non-compliance|15|||
17026327|NCT00809471|38170824|FG001|Overall Study|Protocol non-compliance|15|||
17026328|NCT00809471|38170825|FG002|Overall Study|Protocol non-compliance|6|||
17026329|NCT00809471|38170823|FG000|Overall Study|Lost to Follow-up|4|||
17026330|NCT00809471|38170824|FG001|Overall Study|Lost to Follow-up|2|||
17026331|NCT00809471|38170825|FG002|Overall Study|Lost to Follow-up|9|||
17026332|NCT00809471|38170823|FG000|Overall Study|Adverse Event|0|||
17026333|NCT00809471|38170824|FG001|Overall Study|Adverse Event|2|||
17026334|NCT00809471|38170825|FG002|Overall Study|Adverse Event|2|||
17026335|NCT00809471|38170823|FG000|Overall Study|Requirement for restricted medication|1|||
17026336|NCT00809471|38170824|FG001|Overall Study|Requirement for restricted medication|1|||
17026337|NCT00809471|38170825|FG002|Overall Study|Requirement for restricted medication|0|||
17026338|NCT00807248|38170837|FG000|Overall Study|Adverse Event|1|||
17026339|NCT00807248|38170838|FG001|Overall Study|Adverse Event|2|||
17026340|NCT00807248|38170839|FG002|Overall Study|Adverse Event|2|||
17026341|NCT00807248|38170840|FG003|Overall Study|Adverse Event|6|||
17026342|NCT00807248|38170837|FG000|Overall Study|Lack of Efficacy|14|||
17026343|NCT00807248|38170838|FG001|Overall Study|Lack of Efficacy|4|||
17026344|NCT00807248|38170839|FG002|Overall Study|Lack of Efficacy|8|||
17026345|NCT00807248|38170840|FG003|Overall Study|Lack of Efficacy|3|||
17026346|NCT00807248|38170837|FG000|Overall Study|Protocol Violation|0|||
17026347|NCT00807248|38170838|FG001|Overall Study|Protocol Violation|1|||
17026348|NCT00807248|38170839|FG002|Overall Study|Protocol Violation|1|||
17026349|NCT00807248|38170840|FG003|Overall Study|Protocol Violation|0|||
17026350|NCT00807248|38170837|FG000|Overall Study|Withdrawal of Consent|5|||
17026351|NCT00807248|38170838|FG001|Overall Study|Withdrawal of Consent|5|||
17026352|NCT00807248|38170839|FG002|Overall Study|Withdrawal of Consent|5|||
17026353|NCT00807248|38170840|FG003|Overall Study|Withdrawal of Consent|5|||
17026354|NCT00807248|38170837|FG000|Overall Study|Lost to Follow-up|1|||
17026355|NCT00807248|38170838|FG001|Overall Study|Lost to Follow-up|0|||
17026356|NCT00807248|38170839|FG002|Overall Study|Lost to Follow-up|0|||
17026357|NCT00807248|38170840|FG003|Overall Study|Lost to Follow-up|0|||
17026358|NCT00807248|38170837|FG000|Overall Study|Other Reason|0|||
17026359|NCT00807248|38170838|FG001|Overall Study|Other Reason|0|||
17026360|NCT00807248|38170839|FG002|Overall Study|Other Reason|2|||
17026361|NCT00807248|38170840|FG003|Overall Study|Other Reason|0|||
17026362|NCT00589628|38170852|FG000|Overall Study|Lost to Follow-up|0|||
17026363|NCT00589628|38170853|FG001|Overall Study|Lost to Follow-up|1|||
17026364|NCT00588848|38170861|FG000|Overall Study|Physician Decision|0|||
17026365|NCT00588848|38170862|FG001|Overall Study|Physician Decision|3|||
17026366|NCT00797108|38170873|FG000|Overall Study|Adverse Event|1|||
17026367|NCT00797108|38170874|FG001|Overall Study|Adverse Event|0|||
17026368|NCT00797108|38170875|FG002|Overall Study|Adverse Event|3|||
17026369|NCT00797108|38170873|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
17026370|NCT00797108|38170874|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
17026371|NCT00797108|38170875|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
17026372|NCT00797108|38170873|FG000|Overall Study|Global Deterioration of Health Status|0|||
17026373|NCT00797108|38170874|FG001|Overall Study|Global Deterioration of Health Status|1|||
17026374|NCT00797108|38170875|FG002|Overall Study|Global Deterioration of Health Status|0|||
17026375|NCT00797108|38170873|FG000|Overall Study|Lack of Efficacy|1|||
17026376|NCT00797108|38170874|FG001|Overall Study|Lack of Efficacy|0|||
17026377|NCT00797108|38170875|FG002|Overall Study|Lack of Efficacy|1|||
17026378|NCT00797108|38170873|FG000|Overall Study|Other|0|||
17026379|NCT00797108|38170874|FG001|Overall Study|Other|0|||
17026380|NCT00797108|38170875|FG002|Overall Study|Other|2|||
17026381|NCT00797108|38170873|FG000|Overall Study|Randomized but not Treated|2|||
17026382|NCT00797108|38170874|FG001|Overall Study|Randomized but not Treated|0|||
17026383|NCT00797108|38170875|FG002|Overall Study|Randomized but not Treated|0|||
17026384|NCT00742560|38170888|FG000|Overall Study|Adverse Event|0|||
17026385|NCT00742560|38170889|FG001|Overall Study|Adverse Event|0|||
17026386|NCT00742560|38170890|FG002|Overall Study|Adverse Event|1|||
17026387|NCT00742560|38170891|FG003|Overall Study|Adverse Event|1|||
17026388|NCT00742560|38170892|FG004|Overall Study|Adverse Event|1|||
17026389|NCT00742560|38170888|FG000|Overall Study|Death|0|||
17026390|NCT00742560|38170889|FG001|Overall Study|Death|2|||
17026391|NCT00742560|38170890|FG002|Overall Study|Death|0|||
17026392|NCT00742560|38170891|FG003|Overall Study|Death|2|||
17026393|NCT00742560|38170892|FG004|Overall Study|Death|3|||
17026394|NCT00742560|38170888|FG000|Overall Study|Subject's Decision|1|||
17026395|NCT00742560|38170889|FG001|Overall Study|Subject's Decision|0|||
17026396|NCT00742560|38170890|FG002|Overall Study|Subject's Decision|2|||
17026397|NCT00742560|38170891|FG003|Overall Study|Subject's Decision|3|||
17026398|NCT00742560|38170892|FG004|Overall Study|Subject's Decision|3|||
17026399|NCT00742560|38170888|FG000|Overall Study|Investigator's Decision|0|||
17026400|NCT00742560|38170889|FG001|Overall Study|Investigator's Decision|0|||
17026401|NCT00742560|38170890|FG002|Overall Study|Investigator's Decision|4|||
17026402|NCT00742560|38170891|FG003|Overall Study|Investigator's Decision|1|||
17026403|NCT00742560|38170892|FG004|Overall Study|Investigator's Decision|0|||
17026404|NCT00742560|38170888|FG000|Overall Study|Disease Progression|1|||
17026405|NCT00742560|38170889|FG001|Overall Study|Disease Progression|0|||
17026406|NCT00742560|38170890|FG002|Overall Study|Disease Progression|5|||
17026407|NCT00742560|38170891|FG003|Overall Study|Disease Progression|17|||
17026408|NCT00742560|38170892|FG004|Overall Study|Disease Progression|16|||
17026409|NCT00742560|38170888|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
17026410|NCT00742560|38170889|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
17026411|NCT00742560|38170890|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
17026412|NCT00742560|38170891|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
17026413|NCT00742560|38170892|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
17026414|NCT00742560|38170888|FG000|Overall Study|Other|0|||
17026415|NCT00742560|38170889|FG001|Overall Study|Other|1|||
17026416|NCT00742560|38170890|FG002|Overall Study|Other|8|||
17026417|NCT00742560|38170891|FG003|Overall Study|Other|9|||
17026418|NCT00742560|38170892|FG004|Overall Study|Other|9|||
17026419|NCT00742560|38170888|FG000|Overall Study|MIssing|0|||
17026420|NCT00742560|38170889|FG001|Overall Study|MIssing|0|||
17026421|NCT00742560|38170890|FG002|Overall Study|MIssing|0|||
17026422|NCT00742560|38170891|FG003|Overall Study|MIssing|0|||
17026423|NCT00742560|38170892|FG004|Overall Study|MIssing|1|||
17026424|NCT00740220|38170923|FG000|Overall Study|screen failures (non-COPD patients)|9|||
17026425|NCT00796718|38170927|FG000|Overall Study|Adverse Event|2|||
17026426|NCT00796718|38170927|FG000|Overall Study|Exclusion Criteria|1|||
17026427|NCT00796718|38170927|FG000|Overall Study|Lost to Follow-up|5|||
17026428|NCT00796718|38170927|FG000|Overall Study|Withdrawal by Informed Consent|1|||
17026429|NCT00809159|38170935|FG000|Part 1|Adverse Event|1|||
17026430|NCT00809159|38170936|FG001|Part 1|Adverse Event|1|||
17026431|NCT00809159|38170937|FG002|Part 1|Adverse Event|0|||
17026432|NCT00809159|38170938|FG003|Part 1|Adverse Event|0|||
17026433|NCT00809159|38170939|FG004|Part 1|Adverse Event|0|||
17026434|NCT00809159|38170940|FG005|Part 1|Adverse Event|0|||
17026435|NCT00809159|38170935|FG000|Part 1|Lost to Follow-up|1|||
17026436|NCT00809159|38170936|FG001|Part 1|Lost to Follow-up|0|||
17026437|NCT00809159|38170937|FG002|Part 1|Lost to Follow-up|0|||
17026438|NCT00809159|38170938|FG003|Part 1|Lost to Follow-up|0|||
17026439|NCT00809159|38170939|FG004|Part 1|Lost to Follow-up|0|||
17026440|NCT00809159|38170940|FG005|Part 1|Lost to Follow-up|0|||
17026441|NCT00809159|38170935|FG000|Part 1|Withdrawal by Subject|3|||
17026442|NCT00809159|38170936|FG001|Part 1|Withdrawal by Subject|1|||
17026443|NCT00809159|38170937|FG002|Part 1|Withdrawal by Subject|0|||
17026444|NCT00809159|38170938|FG003|Part 1|Withdrawal by Subject|0|||
17026445|NCT00809159|38170939|FG004|Part 1|Withdrawal by Subject|0|||
17026446|NCT00809159|38170940|FG005|Part 1|Withdrawal by Subject|0|||
17026447|NCT00809159|38170935|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
17026448|NCT00809159|38170936|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
17026449|NCT00809159|38170937|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
17026450|NCT00809159|38170938|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
17026451|NCT00809159|38170939|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
17026452|NCT00809159|38170940|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
17026453|NCT00809159|38170935|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
17026454|NCT00809159|38170936|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
17026455|NCT00809159|38170937|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
17026456|NCT00809159|38170938|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
17026457|NCT00809159|38170939|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
17026458|NCT00809159|38170940|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
17026459|NCT00809159|38170935|FG000|Part 1 and 2|Administrative problems|0|||
17026460|NCT00809159|38170936|FG001|Part 1 and 2|Administrative problems|0|||
17026461|NCT00809159|38170937|FG002|Part 1 and 2|Administrative problems|0|||
17026462|NCT00809159|38170938|FG003|Part 1 and 2|Administrative problems|1|||
17026463|NCT00809159|38170939|FG004|Part 1 and 2|Administrative problems|0|||
17026464|NCT00809159|38170940|FG005|Part 1 and 2|Administrative problems|0|||
17026465|NCT00809159|38170935|FG000|Part 1 and 2|Adverse Event|0|||
17026466|NCT00809159|38170936|FG001|Part 1 and 2|Adverse Event|0|||
17026467|NCT00809159|38170937|FG002|Part 1 and 2|Adverse Event|1|||
17026468|NCT00809159|38170938|FG003|Part 1 and 2|Adverse Event|0|||
17026469|NCT00809159|38170939|FG004|Part 1 and 2|Adverse Event|1|||
17026470|NCT00809159|38170940|FG005|Part 1 and 2|Adverse Event|1|||
17026471|NCT00809159|38170935|FG000|Part 1 and 2|Lost to Follow-up|0|||
17026472|NCT00809159|38170936|FG001|Part 1 and 2|Lost to Follow-up|0|||
17026473|NCT00809159|38170937|FG002|Part 1 and 2|Lost to Follow-up|1|||
17026474|NCT00809159|38170938|FG003|Part 1 and 2|Lost to Follow-up|1|||
17026475|NCT00809159|38170939|FG004|Part 1 and 2|Lost to Follow-up|0|||
17026476|NCT00809159|38170940|FG005|Part 1 and 2|Lost to Follow-up|0|||
17026477|NCT00809159|38170935|FG000|Part 1 and 2|Withdrawal by Subject|0|||
17026478|NCT00809159|38170936|FG001|Part 1 and 2|Withdrawal by Subject|0|||
17026479|NCT00809159|38170937|FG002|Part 1 and 2|Withdrawal by Subject|4|||
17026480|NCT00809159|38170938|FG003|Part 1 and 2|Withdrawal by Subject|0|||
17026481|NCT00809159|38170939|FG004|Part 1 and 2|Withdrawal by Subject|0|||
17026482|NCT00809159|38170940|FG005|Part 1 and 2|Withdrawal by Subject|1|||
17026483|NCT00745368|38170954|FG000|Overall Study|Unable to provide sample|3|||
17026484|NCT00589472|38170958|FG000|Overall Study|Adverse Event|1|||
17026485|NCT00811577|38170964|FG000|Overall Study|Lost to Follow-up|7|||
17026486|NCT00811577|38170965|FG001|Overall Study|Lost to Follow-up|1|||
17026487|NCT00811577|38170964|FG000|Overall Study|Withdrawal by Subject|3|||
17026488|NCT00811577|38170965|FG001|Overall Study|Withdrawal by Subject|0|||
17026489|NCT00802178|38171014|FG000|Overall Study|Lack of Efficacy|36|||
17026490|NCT00802178|38171014|FG000|Overall Study|Insufficient tolerability (IT)|17|||
17026491|NCT00802178|38171014|FG000|Overall Study|Withdrawal by Subject|18|||
17026492|NCT00802178|38171014|FG000|Overall Study|Other|32|||
17026493|NCT00802178|38171014|FG000|Overall Study|Lack of efficacy and patient wish|1|||
17026494|NCT00802178|38171014|FG000|Overall Study|IT and patient wish|8|||
17103578|NCT00112047|38241751|FG000|Atripla Phase|Adverse Event|2|||
17103579|NCT00112047|38241752|FG001|Atripla Phase|Adverse Event|1|||
17103580|NCT00112047|38241751|FG000|Atripla Phase|Lost to Follow-up|5|||
17103581|NCT00112047|38241752|FG001|Atripla Phase|Lost to Follow-up|7|||
17103582|NCT00112047|38241751|FG000|Atripla Phase|Pregnancy|0|||
17103583|NCT00112047|38241752|FG001|Atripla Phase|Pregnancy|1|||
17103584|NCT00112047|38241751|FG000|Atripla Phase|Death|0|||
17103585|NCT00112047|38241752|FG001|Atripla Phase|Death|2|||
17103586|NCT00112047|38241751|FG000|Atripla Phase|Withdrew consent|7|||
17103587|NCT00112047|38241752|FG001|Atripla Phase|Withdrew consent|7|||
17103588|NCT00112047|38241751|FG000|Atripla Phase|Sub-optimal virological response|0|||
17103589|NCT00112047|38241752|FG001|Atripla Phase|Sub-optimal virological response|1|||
17026495|NCT00802178|38171014|FG000|Overall Study|Patients wish and other reason|1|||
17026496|NCT00744978|38171020|FG000|Period 1|Lost to Follow-up|1|||
17026497|NCT00744978|38171021|FG001|Period 1|Lost to Follow-up|0|||
17026498|NCT00744978|38171020|FG000|Period 1|Withdrawal by Subject|0|||
17026499|NCT00744978|38171021|FG001|Period 1|Withdrawal by Subject|2|||
17026500|NCT00744978|38171020|FG000|Period 1|Other|0|||
17026501|NCT00744978|38171021|FG001|Period 1|Other|2|||
17026502|NCT00744978|38171020|FG000|Period 1|Adverse Event|4|||
17026503|NCT00744978|38171021|FG001|Period 1|Adverse Event|0|||
17026504|NCT00744978|38171020|FG000|Period 1|Randomized but not Treated|1|||
17026505|NCT00744978|38171021|FG001|Period 1|Randomized but not Treated|1|||
17026506|NCT00744978|38171020|FG000|Period 2|Adverse Event|0|||
17026507|NCT00744978|38171021|FG001|Period 2|Adverse Event|1|||
17103590|NCT00112047|38241751|FG000|Atripla Phase|Non-compliance|1|||
17103591|NCT00112047|38241752|FG001|Atripla Phase|Non-compliance|0|||
17103592|NCT00112047|38241751|FG000|Atripla Phase|Other|3|||
17103593|NCT00112047|38241752|FG001|Atripla Phase|Other|1|||
17103594|NCT03658876|38241765|FG000|Overall Study|Protocol Violation|3|||
17103595|NCT03658876|38241766|FG001|Overall Study|Protocol Violation|2|||
17026508|NCT00739908|38171029|FG000|Overall Study|Adverse Event|5|||
17026509|NCT00739908|38171030|FG001|Overall Study|Adverse Event|6|||
17103596|NCT03658876|38241765|FG000|Overall Study|Withdrawal by Subject|2|||
17103597|NCT03658876|38241766|FG001|Overall Study|Withdrawal by Subject|0|||
17103598|NCT03658876|38241765|FG000|Overall Study|Death|0|||
17026510|NCT00739908|38171029|FG000|Overall Study|Withdrawal by Subject|4|||
17026511|NCT00739908|38171030|FG001|Overall Study|Withdrawal by Subject|2|||
17026512|NCT00739908|38171029|FG000|Overall Study|Lost to Follow-up|14|||
17026513|NCT00739908|38171030|FG001|Overall Study|Lost to Follow-up|9|||
17026514|NCT00739908|38171029|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
17026515|NCT00739908|38171030|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
17026516|NCT00739908|38171029|FG000|Overall Study|Non-Compliance With Study Medication|0|||
17026517|NCT00739908|38171030|FG001|Overall Study|Non-Compliance With Study Medication|3|||
17026518|NCT00739908|38171029|FG000|Overall Study|Lack of Efficacy|0|||
17026519|NCT00739908|38171030|FG001|Overall Study|Lack of Efficacy|1|||
17026520|NCT00739908|38171029|FG000|Overall Study|Relocation|0|||
17026521|NCT00739908|38171030|FG001|Overall Study|Relocation|1|||
17026522|NCT00739596|38171040|FG000|Overall Study|Adverse Event|12|||
17026523|NCT00739596|38171041|FG001|Overall Study|Adverse Event|6|||
17026524|NCT00739596|38171040|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
17026525|NCT00739596|38171041|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
17026526|NCT00739596|38171040|FG000|Overall Study|Patient Withdrew Consent|8|||
17026527|NCT00739596|38171041|FG001|Overall Study|Patient Withdrew Consent|8|||
17026528|NCT00739596|38171040|FG000|Overall Study|Lost to Follow-up|0|||
17026529|NCT00739596|38171041|FG001|Overall Study|Lost to Follow-up|2|||
17026530|NCT00739596|38171040|FG000|Overall Study|Protocol Deviation|1|||
17026531|NCT00739596|38171041|FG001|Overall Study|Protocol Deviation|1|||
17026532|NCT00742326|38171049|FG000|Overall Study|Physician Decision|0|||
17026533|NCT00742326|38171050|FG001|Overall Study|Physician Decision|1|||
17026534|NCT00741936|38171058|FG000|Overall Study|Lost to Follow-up|1|||
17026535|NCT00741936|38171059|FG001|Overall Study|Lost to Follow-up|1|||
17026536|NCT00741936|38171058|FG000|Overall Study|Adverse Event|3|||
17026537|NCT00741936|38171059|FG001|Overall Study|Adverse Event|4|||
17026538|NCT00741936|38171058|FG000|Overall Study|Pregnancy|0|||
17026539|NCT00741936|38171059|FG001|Overall Study|Pregnancy|1|||
17026540|NCT00741936|38171058|FG000|Overall Study|Protocol Violation|2|||
17026541|NCT00741936|38171059|FG001|Overall Study|Protocol Violation|0|||
17026542|NCT00741936|38171058|FG000|Overall Study|Lack of Efficacy|0|||
17026543|NCT00741936|38171059|FG001|Overall Study|Lack of Efficacy|2|||
17026544|NCT00741936|38171058|FG000|Overall Study|Low compliance|3|||
17026545|NCT00741936|38171059|FG001|Overall Study|Low compliance|0|||
17026546|NCT00811187|38171067|FG000|Overall Study|Unable to place device / procedure abort|3|||
17026547|NCT00811187|38171068|FG001|Overall Study|Unable to place device / procedure abort|3|||
17026548|NCT00591149|38171074|FG000|Overall Study|Adverse Event|4|||
17026549|NCT00591149|38171074|FG000|Overall Study|Withdrawal by Subject|1|||
17026550|NCT00735072|38171080|FG000|Overall Study|interrupted study med during ARV change|1|||
17026551|NCT00735072|38171081|FG001|Overall Study|interrupted study med during ARV change|0|||
17026552|NCT00735072|38171080|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
17026553|NCT00735072|38171081|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
17026554|NCT00810641|38171092|FG000|Overall Study|Withdrawal by Subject|0|||
17026555|NCT00810641|38171093|FG001|Overall Study|Withdrawal by Subject|1|||
17026556|NCT00810641|38171094|FG002|Overall Study|Withdrawal by Subject|2|||
17026557|NCT00793598|38171107|FG000|Overall Study|Patient Request|0|||
17026558|NCT00793598|38171108|FG001|Overall Study|Patient Request|1|||
17026559|NCT00793598|38171109|FG002|Overall Study|Patient Request|0|||
17026560|NCT00793598|38171110|FG003|Overall Study|Patient Request|0|||
17026561|NCT00793598|38171111|FG004|Overall Study|Patient Request|0|||
17026562|NCT00793598|38171112|FG005|Overall Study|Patient Request|0|||
17026563|NCT00793598|38171113|FG006|Overall Study|Patient Request|0|||
17026564|NCT00793598|38171114|FG007|Overall Study|Patient Request|0|||
17026565|NCT00793598|38171107|FG000|Overall Study|Protocol Violation|0|||
17026566|NCT00793598|38171108|FG001|Overall Study|Protocol Violation|0|||
17026567|NCT00793598|38171109|FG002|Overall Study|Protocol Violation|0|||
17026568|NCT00793598|38171110|FG003|Overall Study|Protocol Violation|0|||
17026569|NCT00793598|38171111|FG004|Overall Study|Protocol Violation|0|||
17026570|NCT00793598|38171112|FG005|Overall Study|Protocol Violation|0|||
17026571|NCT00793598|38171113|FG006|Overall Study|Protocol Violation|0|||
17026572|NCT00793598|38171114|FG007|Overall Study|Protocol Violation|1|||
17026573|NCT00793598|38171107|FG000|Overall Study|Subject not dosed|0|||
17026574|NCT00793598|38171108|FG001|Overall Study|Subject not dosed|0|||
17026575|NCT00793598|38171109|FG002|Overall Study|Subject not dosed|0|||
17026576|NCT00793598|38171110|FG003|Overall Study|Subject not dosed|0|||
17026577|NCT00793598|38171111|FG004|Overall Study|Subject not dosed|0|||
17026578|NCT00793598|38171112|FG005|Overall Study|Subject not dosed|1|||
17026579|NCT00793598|38171113|FG006|Overall Study|Subject not dosed|0|||
17026580|NCT00793598|38171114|FG007|Overall Study|Subject not dosed|0|||
17026581|NCT00796562|38171136|FG000|Overall Study|Death|49|||
17026582|NCT00801632|38171140|FG000|Overall Study|Re-transplant|1|||
17026583|NCT00806819|38171146|FG000|Overall Study|progressive disease (modified RECIST )|217|||
17026584|NCT00806819|38171147|FG001|Overall Study|progressive disease (modified RECIST )|216|||
17026585|NCT00806819|38171146|FG000|Overall Study|Worsening or AE of underlying disease|18|||
17026586|NCT00806819|38171147|FG001|Overall Study|Worsening or AE of underlying disease|25|||
17026587|NCT00806819|38171146|FG000|Overall Study|Other AE|38|||
17026588|NCT00806819|38171147|FG001|Overall Study|Other AE|40|||
17026589|NCT00806819|38171146|FG000|Overall Study|Protocol Violation|9|||
17026590|NCT00806819|38171147|FG001|Overall Study|Protocol Violation|4|||
17026591|NCT00806819|38171146|FG000|Overall Study|Lost to Follow-up|1|||
17026592|NCT00806819|38171147|FG001|Overall Study|Lost to Follow-up|0|||
17026593|NCT00806819|38171146|FG000|Overall Study|Withdrawal by Subject|32|||
17026594|NCT00806819|38171147|FG001|Overall Study|Withdrawal by Subject|29|||
17026595|NCT00806819|38171146|FG000|Overall Study|Not treated|6|||
17103599|NCT03658876|38241766|FG001|Overall Study|Death|1|||
17103600|NCT03658876|38241765|FG000|Overall Study|Intercurrent illness|6|||
17103601|NCT03658876|38241766|FG001|Overall Study|Intercurrent illness|4|||
17103602|NCT03658876|38241765|FG000|Overall Study|Transplantation/other operation|1|||
17103603|NCT03658876|38241766|FG001|Overall Study|Transplantation/other operation|5|||
17103604|NCT03618628|38241772|FG000|Overall Study|Death|1|||
17103605|NCT03618628|38241772|FG000|Overall Study|Lost to Follow-up|1|||
17103606|NCT03617770|38241778|FG000|Overall Study|Lost to Follow-up|1|||
17103607|NCT03617770|38241779|FG001|Overall Study|Lost to Follow-up|0|||
17103608|NCT03616600|38241787|FG000|Overall Study|Withdrawal by Subject|1|||
17103609|NCT03616600|38241788|FG001|Overall Study|Withdrawal by Subject|0|||
17103610|NCT00380393|38241797|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
17103611|NCT00380393|38241798|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
17103612|NCT00380393|38241797|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
17103613|NCT00380393|38241798|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
17103614|NCT00380393|38241797|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
17103615|NCT00380393|38241798|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
17103616|NCT00380393|38241797|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
17103617|NCT00380393|38241798|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
17103618|NCT00380393|38241797|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
17103619|NCT00380393|38241798|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
17103620|NCT00380393|38241797|FG000|Month 14|Withdrawal by Subject|9|||
17103621|NCT00380393|38241798|FG001|Month 14|Withdrawal by Subject|7|||
17103622|NCT00380393|38241797|FG000|Month 14|Death|1|||
17103623|NCT00380393|38241798|FG001|Month 14|Death|0|||
17103624|NCT00380393|38241797|FG000|Month 14|Lost to Follow-up|0|||
17103625|NCT00380393|38241798|FG001|Month 14|Lost to Follow-up|1|||
17103626|NCT00380393|38241797|FG000|Month 14|Migrated/moved from study area|39|||
17103627|NCT00380393|38241798|FG001|Month 14|Migrated/moved from study area|42|||
17103628|NCT00380393|38241797|FG000|Month 14|Protocol Violation|2|||
17103629|NCT00380393|38241798|FG001|Month 14|Protocol Violation|0|||
17103630|NCT00380393|38241797|FG000|Month 14|Others|6|||
17103631|NCT00380393|38241798|FG001|Month 14|Others|6|||
17103632|NCT00380081|38241810|FG000|Overall Study|Withdrawal by Subject|0|||
17103633|NCT00380081|38241811|FG001|Overall Study|Withdrawal by Subject|0|||
17103634|NCT00380081|38241812|FG002|Overall Study|Withdrawal by Subject|0|||
17103635|NCT00380081|38241813|FG003|Overall Study|Withdrawal by Subject|0|||
17026596|NCT00806819|38171147|FG001|Overall Study|Not treated|3|||
17026597|NCT00806819|38171146|FG000|Overall Study|Reasons other than stated above|25|||
17026598|NCT00806819|38171147|FG001|Overall Study|Reasons other than stated above|41|||
17026599|NCT00801242|38171154|FG000|Overall Study|Adverse Event|10|||
17026600|NCT00801242|38171154|FG000|Overall Study|Withdrawal by Subject|13|||
17026601|NCT00801242|38171154|FG000|Overall Study|Protocol Violation|5|||
17026602|NCT00801242|38171154|FG000|Overall Study|Physician Decision|3|||
17026603|NCT00801242|38171154|FG000|Overall Study|Lost to Follow-up|1|||
17026604|NCT00801242|38171154|FG000|Overall Study|Miscellaneous reasons|20|||
17026605|NCT00800540|38171158|FG000|Period One: 6 Weeks|Noncompliance|1|||
17026606|NCT00800540|38171159|FG001|Period One: 6 Weeks|Noncompliance|0|||
17026607|NCT00800540|38171158|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
17026608|NCT00800540|38171159|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
17026609|NCT00800540|38171158|FG000|Period 2: 6 Weeks|Adverse Event|0|||
17026610|NCT00800540|38171159|FG001|Period 2: 6 Weeks|Adverse Event|1|||
17026611|NCT00800384|38171167|FG000|Overall Study|Withdrawal by Subject|24|||
17026612|NCT00800384|38171168|FG001|Overall Study|Withdrawal by Subject|17|||
17026613|NCT00800384|38171167|FG000|Overall Study|Lost to Follow-up|17|||
17026614|NCT00800384|38171168|FG001|Overall Study|Lost to Follow-up|26|||
17026615|NCT00796328|38171175|FG000|Overall Study|experienced hypotension requiring tx|6|||
17026616|NCT00588692|38171181|FG000|Overall Study|Withdrawal by Subject|4|||
17026617|NCT00588692|38171182|FG001|Overall Study|Withdrawal by Subject|2|||
17026618|NCT00588692|38171181|FG000|Overall Study|Hip Surgery|0|||
17026619|NCT00588692|38171182|FG001|Overall Study|Hip Surgery|1|||
17026620|NCT00588692|38171181|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
17103636|NCT00380081|38241814|FG004|Overall Study|Withdrawal by Subject|1|||
17103637|NCT00380081|38241815|FG005|Overall Study|Withdrawal by Subject|0|||
17103638|NCT00380081|38241810|FG000|Overall Study|Family Emergency|0|||
17103639|NCT00380081|38241811|FG001|Overall Study|Family Emergency|0|||
17026621|NCT00588692|38171182|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
17103640|NCT00380081|38241812|FG002|Overall Study|Family Emergency|0|||
17026622|NCT00588692|38171181|FG000|Overall Study|Cancer|1|||
17026623|NCT00588692|38171182|FG001|Overall Study|Cancer|0|||
17026624|NCT00588692|38171181|FG000|Overall Study|Death|1|||
17026625|NCT00588692|38171182|FG001|Overall Study|Death|0|||
17026626|NCT00588146|38171190|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
17026627|NCT00588146|38171191|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
17026628|NCT00795704|38171199|FG000|Overall Study|Withdrawal by Subject|3|||
16853251|NCT00211887|37803603|FG001|Overall Study|Death|1|||
16853252|NCT00211887|37803604|FG002|Overall Study|Death|1|||
16853253|NCT00211887|37803602|FG000|Overall Study|Lost to Follow-up|28|||
16853254|NCT00211887|37803603|FG001|Overall Study|Lost to Follow-up|13|||
16853255|NCT00211887|37803604|FG002|Overall Study|Lost to Follow-up|9|||
16853256|NCT00211887|37803602|FG000|Overall Study|Non-medical reason|31|||
16853257|NCT00211887|37803603|FG001|Overall Study|Non-medical reason|14|||
16853258|NCT00211887|37803604|FG002|Overall Study|Non-medical reason|8|||
16853259|NCT00211887|37803602|FG000|Overall Study|Other medical reason|15|||
16853260|NCT00211887|37803603|FG001|Overall Study|Other medical reason|11|||
16853261|NCT00211887|37803604|FG002|Overall Study|Other medical reason|7|||
16853262|NCT00211887|37803602|FG000|Overall Study|Side effects|19|||
16853263|NCT00211887|37803603|FG001|Overall Study|Side effects|13|||
16853264|NCT00211887|37803604|FG002|Overall Study|Side effects|5|||
16853265|NCT01855945|37803624|FG000|Overall Study|Adverse Event|0|||
16853266|NCT01855945|37803625|FG001|Overall Study|Adverse Event|0|||
16853267|NCT01855945|37803626|FG002|Overall Study|Adverse Event|0|||
16853268|NCT01855945|37803627|FG003|Overall Study|Adverse Event|0|||
16853269|NCT01855945|37803628|FG004|Overall Study|Adverse Event|0|||
16853270|NCT01855945|37803629|FG005|Overall Study|Adverse Event|0|||
16853271|NCT01855945|37803630|FG006|Overall Study|Adverse Event|1|||
16853272|NCT01855945|37803631|FG007|Overall Study|Adverse Event|0|||
16853273|NCT01855945|37803632|FG008|Overall Study|Adverse Event|0|||
16853274|NCT01855945|37803633|FG009|Overall Study|Adverse Event|0|||
16853275|NCT01855945|37803634|FG010|Overall Study|Adverse Event|0|||
16853276|NCT01855945|37803635|FG011|Overall Study|Adverse Event|0|||
16853277|NCT01855945|37803624|FG000|Overall Study|Death|0|||
16853278|NCT01855945|37803625|FG001|Overall Study|Death|0|||
16853279|NCT01855945|37803626|FG002|Overall Study|Death|0|||
16853280|NCT01855945|37803627|FG003|Overall Study|Death|0|||
16853281|NCT01855945|37803628|FG004|Overall Study|Death|0|||
16853282|NCT01855945|37803629|FG005|Overall Study|Death|0|||
16853283|NCT01855945|37803630|FG006|Overall Study|Death|2|||
16853284|NCT01855945|37803631|FG007|Overall Study|Death|0|||
16853285|NCT01855945|37803632|FG008|Overall Study|Death|0|||
16853286|NCT01855945|37803633|FG009|Overall Study|Death|0|||
16853287|NCT01855945|37803634|FG010|Overall Study|Death|0|||
16853288|NCT01855945|37803635|FG011|Overall Study|Death|0|||
16853289|NCT01855945|37803624|FG000|Overall Study|Lost to Follow-up|11|||
16853290|NCT01855945|37803625|FG001|Overall Study|Lost to Follow-up|10|||
16853291|NCT01855945|37803626|FG002|Overall Study|Lost to Follow-up|7|||
16853292|NCT01855945|37803627|FG003|Overall Study|Lost to Follow-up|3|||
16853293|NCT01855945|37803628|FG004|Overall Study|Lost to Follow-up|0|||
16853294|NCT01855945|37803629|FG005|Overall Study|Lost to Follow-up|3|||
16853295|NCT01855945|37803630|FG006|Overall Study|Lost to Follow-up|4|||
16853296|NCT01855945|37803631|FG007|Overall Study|Lost to Follow-up|7|||
16853297|NCT01855945|37803632|FG008|Overall Study|Lost to Follow-up|2|||
16853298|NCT01855945|37803633|FG009|Overall Study|Lost to Follow-up|0|||
16853299|NCT01855945|37803634|FG010|Overall Study|Lost to Follow-up|0|||
16853300|NCT01855945|37803635|FG011|Overall Study|Lost to Follow-up|2|||
16853301|NCT01855945|37803624|FG000|Overall Study|Other - Unclassified|1|||
16853302|NCT01855945|37803625|FG001|Overall Study|Other - Unclassified|1|||
16853303|NCT01855945|37803626|FG002|Overall Study|Other - Unclassified|1|||
16853304|NCT01855945|37803627|FG003|Overall Study|Other - Unclassified|0|||
16853305|NCT01855945|37803628|FG004|Overall Study|Other - Unclassified|0|||
16853306|NCT01855945|37803629|FG005|Overall Study|Other - Unclassified|0|||
16853307|NCT01855945|37803630|FG006|Overall Study|Other - Unclassified|2|||
16853308|NCT01855945|37803631|FG007|Overall Study|Other - Unclassified|1|||
16853309|NCT01855945|37803632|FG008|Overall Study|Other - Unclassified|0|||
16853310|NCT01855945|37803633|FG009|Overall Study|Other - Unclassified|0|||
16853311|NCT01855945|37803634|FG010|Overall Study|Other - Unclassified|1|||
16853312|NCT01855945|37803635|FG011|Overall Study|Other - Unclassified|0|||
16853313|NCT01855945|37803624|FG000|Overall Study|Withdrawal by Subject|4|||
16853314|NCT01855945|37803625|FG001|Overall Study|Withdrawal by Subject|0|||
16853315|NCT01855945|37803626|FG002|Overall Study|Withdrawal by Subject|4|||
17026629|NCT00795704|38171200|FG001|Overall Study|Withdrawal by Subject|2|||
17026630|NCT00795704|38171199|FG000|Overall Study|Adverse Event|1|||
17026631|NCT00795704|38171200|FG001|Overall Study|Adverse Event|1|||
16853316|NCT01855945|37803627|FG003|Overall Study|Withdrawal by Subject|1|||
16853317|NCT01855945|37803628|FG004|Overall Study|Withdrawal by Subject|1|||
16853318|NCT01855945|37803629|FG005|Overall Study|Withdrawal by Subject|0|||
16853319|NCT01855945|37803630|FG006|Overall Study|Withdrawal by Subject|1|||
17026632|NCT00444457|38171210|FG000|Infant Series|Other|0|||
17026633|NCT00444457|38171211|FG001|Infant Series|Other|1|||
17026634|NCT00444457|38171212|FG002|Infant Series|Other|0|||
17026635|NCT00444457|38171213|FG003|Infant Series|Other|0|||
17026636|NCT00444457|38171210|FG000|Infant Series|Parent or legal guardian request|18|||
17026637|NCT00444457|38171211|FG001|Infant Series|Parent or legal guardian request|29|||
17026638|NCT00444457|38171212|FG002|Infant Series|Parent or legal guardian request|34|||
17026639|NCT00444457|38171213|FG003|Infant Series|Parent or legal guardian request|14|||
17026640|NCT00444457|38171210|FG000|Infant Series|Lost to Follow-up|10|||
17026641|NCT00444457|38171211|FG001|Infant Series|Lost to Follow-up|11|||
17026642|NCT00444457|38171212|FG002|Infant Series|Lost to Follow-up|7|||
17026643|NCT00444457|38171213|FG003|Infant Series|Lost to Follow-up|6|||
17026644|NCT00444457|38171210|FG000|Infant Series|Protocol Violation|16|||
17026645|NCT00444457|38171211|FG001|Infant Series|Protocol Violation|8|||
17026646|NCT00444457|38171212|FG002|Infant Series|Protocol Violation|6|||
17026647|NCT00444457|38171213|FG003|Infant Series|Protocol Violation|3|||
17026648|NCT00444457|38171210|FG000|Infant Series|Failed to return|5|||
17026649|NCT00444457|38171211|FG001|Infant Series|Failed to return|4|||
17026650|NCT00444457|38171212|FG002|Infant Series|Failed to return|4|||
17026651|NCT00444457|38171213|FG003|Infant Series|Failed to return|2|||
17026652|NCT00444457|38171210|FG000|Infant Series|Investigator request|4|||
17026653|NCT00444457|38171211|FG001|Infant Series|Investigator request|3|||
17026654|NCT00444457|38171212|FG002|Infant Series|Investigator request|3|||
17026655|NCT00444457|38171213|FG003|Infant Series|Investigator request|2|||
17026656|NCT00444457|38171210|FG000|Infant Series|Other|0|||
17026657|NCT00444457|38171211|FG001|Infant Series|Other|2|||
17026658|NCT00444457|38171212|FG002|Infant Series|Other|4|||
17026659|NCT00444457|38171213|FG003|Infant Series|Other|0|||
17026660|NCT00444457|38171210|FG000|Infant Series|Adverse Event|1|||
17026661|NCT00444457|38171211|FG001|Infant Series|Adverse Event|2|||
17026662|NCT00444457|38171212|FG002|Infant Series|Adverse Event|2|||
17026663|NCT00444457|38171213|FG003|Infant Series|Adverse Event|0|||
17026664|NCT00444457|38171210|FG000|Infant Series|Death|0|||
17026665|NCT00444457|38171211|FG001|Infant Series|Death|1|||
17026666|NCT00444457|38171212|FG002|Infant Series|Death|1|||
17026667|NCT00444457|38171213|FG003|Infant Series|Death|1|||
17026668|NCT00444457|38171210|FG000|After Infant Series|Other|0|||
17026669|NCT00444457|38171211|FG001|After Infant Series|Other|1|||
17026670|NCT00444457|38171212|FG002|After Infant Series|Other|1|||
17026671|NCT00444457|38171213|FG003|After Infant Series|Other|1|||
17026672|NCT00444457|38171210|FG000|After Infant Series|Parent or legal guardian request|4|||
17026673|NCT00444457|38171211|FG001|After Infant Series|Parent or legal guardian request|11|||
17026674|NCT00444457|38171212|FG002|After Infant Series|Parent or legal guardian request|6|||
17026675|NCT00444457|38171213|FG003|After Infant Series|Parent or legal guardian request|3|||
17026676|NCT00444457|38171210|FG000|After Infant Series|Failed to return|7|||
17026677|NCT00444457|38171211|FG001|After Infant Series|Failed to return|6|||
17026678|NCT00444457|38171212|FG002|After Infant Series|Failed to return|5|||
17026679|NCT00444457|38171213|FG003|After Infant Series|Failed to return|1|||
17026680|NCT00444457|38171210|FG000|After Infant Series|Lost to Follow-up|5|||
17026681|NCT00444457|38171211|FG001|After Infant Series|Lost to Follow-up|5|||
17026682|NCT00444457|38171212|FG002|After Infant Series|Lost to Follow-up|5|||
17026683|NCT00444457|38171213|FG003|After Infant Series|Lost to Follow-up|2|||
17026684|NCT00444457|38171210|FG000|After Infant Series|Protocol Violation|2|||
17026685|NCT00444457|38171211|FG001|After Infant Series|Protocol Violation|4|||
17026686|NCT00444457|38171212|FG002|After Infant Series|Protocol Violation|2|||
17026687|NCT00444457|38171213|FG003|After Infant Series|Protocol Violation|2|||
17026688|NCT00444457|38171210|FG000|After Infant Series|Adverse Event|2|||
17026689|NCT00444457|38171211|FG001|After Infant Series|Adverse Event|2|||
17026690|NCT00444457|38171212|FG002|After Infant Series|Adverse Event|0|||
17026691|NCT00444457|38171213|FG003|After Infant Series|Adverse Event|0|||
17026692|NCT00444457|38171210|FG000|After Infant Series|Investigator request|0|||
17026693|NCT00444457|38171211|FG001|After Infant Series|Investigator request|0|||
17026694|NCT00444457|38171212|FG002|After Infant Series|Investigator request|0|||
17026695|NCT00444457|38171213|FG003|After Infant Series|Investigator request|1|||
17026696|NCT00444457|38171210|FG000|After Infant Series|Other|0|||
17026697|NCT00444457|38171211|FG001|After Infant Series|Other|1|||
17026698|NCT00444457|38171212|FG002|After Infant Series|Other|0|||
17026699|NCT00444457|38171213|FG003|After Infant Series|Other|0|||
17026700|NCT00444457|38171210|FG000|Toddler Dose|Lost to Follow-up|4|||
17026701|NCT00444457|38171211|FG001|Toddler Dose|Lost to Follow-up|1|||
17026702|NCT00444457|38171212|FG002|Toddler Dose|Lost to Follow-up|1|||
17026703|NCT00444457|38171213|FG003|Toddler Dose|Lost to Follow-up|3|||
17026704|NCT00444457|38171210|FG000|Toddler Dose|Failed to return|2|||
17026705|NCT00444457|38171211|FG001|Toddler Dose|Failed to return|2|||
17026706|NCT00444457|38171212|FG002|Toddler Dose|Failed to return|1|||
17026707|NCT00444457|38171213|FG003|Toddler Dose|Failed to return|3|||
17026708|NCT00444457|38171210|FG000|Toddler Dose|Parent or legal guardian request|0|||
17026709|NCT00444457|38171211|FG001|Toddler Dose|Parent or legal guardian request|3|||
17026710|NCT00444457|38171212|FG002|Toddler Dose|Parent or legal guardian request|2|||
17026711|NCT00444457|38171213|FG003|Toddler Dose|Parent or legal guardian request|1|||
17026712|NCT00444457|38171210|FG000|Toddler Dose|Protocol Violation|1|||
17026713|NCT00444457|38171211|FG001|Toddler Dose|Protocol Violation|0|||
17026714|NCT00444457|38171212|FG002|Toddler Dose|Protocol Violation|0|||
17026715|NCT00444457|38171213|FG003|Toddler Dose|Protocol Violation|1|||
17026716|NCT00799058|38171237|FG000|Overall Study|Withdrawal by Subject|2|||
17026717|NCT00799058|38171238|FG001|Overall Study|Withdrawal by Subject|2|||
17026718|NCT00799058|38171239|FG002|Overall Study|Withdrawal by Subject|2|||
17026719|NCT00799058|38171237|FG000|Overall Study|Lost to Follow-up|1|||
17026720|NCT00799058|38171238|FG001|Overall Study|Lost to Follow-up|2|||
17026721|NCT00799058|38171239|FG002|Overall Study|Lost to Follow-up|1|||
17026722|NCT00799058|38171237|FG000|Overall Study|Adverse Event|0|||
17026723|NCT00799058|38171238|FG001|Overall Study|Adverse Event|2|||
17026724|NCT00799058|38171239|FG002|Overall Study|Adverse Event|0|||
17026725|NCT00799058|38171237|FG000|Overall Study|Pregnancy|1|||
17026726|NCT00799058|38171238|FG001|Overall Study|Pregnancy|0|||
17026727|NCT00799058|38171239|FG002|Overall Study|Pregnancy|0|||
17026728|NCT00799058|38171237|FG000|Overall Study|Not adherent|3|||
17026729|NCT00799058|38171238|FG001|Overall Study|Not adherent|2|||
17026730|NCT00799058|38171239|FG002|Overall Study|Not adherent|1|||
17026731|NCT00799058|38171237|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
17026732|NCT00799058|38171238|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
17026733|NCT00799058|38171239|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
17026734|NCT00799058|38171237|FG000|Overall Study|IP dispensing error|1|||
17026735|NCT00799058|38171238|FG001|Overall Study|IP dispensing error|0|||
17103641|NCT00380081|38241813|FG003|Overall Study|Family Emergency|0|||
17103642|NCT00380081|38241814|FG004|Overall Study|Family Emergency|0|||
17103643|NCT00380081|38241815|FG005|Overall Study|Family Emergency|1|||
17103644|NCT03579940|38241834|FG000|Period 2|Withdrawal by Subject|0|||
17103645|NCT03579940|38241835|FG001|Period 2|Withdrawal by Subject|0|||
17103646|NCT03579940|38241836|FG002|Period 2|Withdrawal by Subject|1|||
17103647|NCT03579940|38241837|FG003|Period 2|Withdrawal by Subject|0|||
17103648|NCT03579940|38241838|FG004|Period 2|Withdrawal by Subject|0|||
17103649|NCT03579940|38241839|FG005|Period 2|Withdrawal by Subject|0|||
17103650|NCT03579940|38241840|FG006|Period 2|Withdrawal by Subject|0|||
17103651|NCT03579940|38241841|FG007|Period 2|Withdrawal by Subject|0|||
17103652|NCT03579940|38241842|FG008|Period 2|Withdrawal by Subject|0|||
17103653|NCT03579940|38241843|FG009|Period 2|Withdrawal by Subject|0|||
17103654|NCT03579940|38241844|FG010|Period 2|Withdrawal by Subject|0|||
17103655|NCT00098306|38241879|FG000|Double Blind|Randomized, not treated|9|||
17103656|NCT00098306|38241880|FG001|Double Blind|Randomized, not treated|5|||
17103657|NCT00098306|38241881|FG002|Double Blind|Randomized, not treated|2|||
17103658|NCT00098306|38241882|FG003|Double Blind|Randomized, not treated|0|||
17103659|NCT00098306|38241883|FG004|Double Blind|Randomized, not treated|0|||
17103660|NCT00098306|38241884|FG005|Double Blind|Randomized, not treated|0|||
17103661|NCT00098306|38241885|FG006|Double Blind|Randomized, not treated|0|||
17103662|NCT00098306|38241879|FG000|Double Blind|Ongoing at cut-off date|151|||
17026736|NCT00799058|38171239|FG002|Overall Study|IP dispensing error|0|||
17026737|NCT00799058|38171237|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
17026738|NCT00799058|38171238|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
17026739|NCT00799058|38171239|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
17026740|NCT00799058|38171237|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
17026741|NCT00799058|38171238|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
17026742|NCT00799058|38171239|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
17026743|NCT00799058|38171237|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
17026744|NCT00799058|38171238|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
17026745|NCT00799058|38171239|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
17026746|NCT00799058|38171237|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
17026747|NCT00799058|38171238|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
17026748|NCT00799058|38171239|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
17026749|NCT00725985|38171252|FG000|ITP- Treatment Disposition|Adverse Event|20|||
17026750|NCT00725985|38171253|FG001|ITP- Treatment Disposition|Adverse Event|10|||
17026751|NCT00725985|38171254|FG002|ITP- Treatment Disposition|Adverse Event|5|||
17026752|NCT00725985|38171255|FG003|ITP- Treatment Disposition|Adverse Event|0|||
17103663|NCT00098306|38241880|FG001|Double Blind|Ongoing at cut-off date|166|||
17103664|NCT00098306|38241881|FG002|Double Blind|Ongoing at cut-off date|72|||
17103665|NCT00098306|38241882|FG003|Double Blind|Ongoing at cut-off date|0|||
17103666|NCT00098306|38241883|FG004|Double Blind|Ongoing at cut-off date|0|||
17103667|NCT00098306|38241884|FG005|Double Blind|Ongoing at cut-off date|0|||
17103668|NCT00098306|38241885|FG006|Double Blind|Ongoing at cut-off date|0|||
17103669|NCT00098306|38241879|FG000|Double Blind|Adverse Event|11|||
17103670|NCT00098306|38241880|FG001|Double Blind|Adverse Event|10|||
17103671|NCT00098306|38241881|FG002|Double Blind|Adverse Event|6|||
17103672|NCT00098306|38241882|FG003|Double Blind|Adverse Event|0|||
17026753|NCT00725985|38171256|FG004|ITP- Treatment Disposition|Adverse Event|0|||
17026754|NCT00725985|38171257|FG005|ITP- Treatment Disposition|Adverse Event|0|||
17026755|NCT00725985|38171258|FG006|ITP- Treatment Disposition|Adverse Event|0|||
17026756|NCT00725985|38171259|FG007|ITP- Treatment Disposition|Adverse Event|0|||
17026757|NCT00725985|38171260|FG008|ITP- Treatment Disposition|Adverse Event|0|||
17026758|NCT00725985|38171261|FG009|ITP- Treatment Disposition|Adverse Event|0|||
17026759|NCT00725985|38171262|FG010|ITP- Treatment Disposition|Adverse Event|0|||
17026760|NCT00725985|38171263|FG011|ITP- Treatment Disposition|Adverse Event|0|||
17026761|NCT00725985|38171252|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026762|NCT00725985|38171253|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026763|NCT00725985|38171254|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
17026764|NCT00725985|38171255|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026765|NCT00725985|38171256|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026766|NCT00725985|38171257|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026767|NCT00725985|38171258|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026768|NCT00725985|38171259|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026769|NCT00725985|38171260|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026770|NCT00725985|38171261|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026771|NCT00725985|38171262|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026772|NCT00725985|38171263|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
17026773|NCT00725985|38171252|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
17026774|NCT00725985|38171253|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
17026775|NCT00725985|38171254|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
17026776|NCT00725985|38171255|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
17026777|NCT00725985|38171256|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
17026778|NCT00725985|38171257|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
17026779|NCT00725985|38171258|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
17026780|NCT00725985|38171259|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
17026781|NCT00725985|38171260|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
17026782|NCT00725985|38171261|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
17026783|NCT00725985|38171262|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
17026784|NCT00725985|38171263|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
17026785|NCT00725985|38171252|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
17026786|NCT00725985|38171253|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
17026787|NCT00725985|38171254|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
17026788|NCT00725985|38171255|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
17026789|NCT00725985|38171256|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
17026790|NCT00725985|38171257|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
17026791|NCT00725985|38171258|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
17026792|NCT00725985|38171259|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
17026793|NCT00725985|38171260|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
17026794|NCT00725985|38171261|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
17026795|NCT00725985|38171262|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
17026796|NCT00725985|38171263|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
17026797|NCT00725985|38171252|FG000|ITP- Treatment Disposition|Other|50|||
17026798|NCT00725985|38171253|FG001|ITP- Treatment Disposition|Other|38|||
17026799|NCT00725985|38171254|FG002|ITP- Treatment Disposition|Other|24|||
17026800|NCT00725985|38171255|FG003|ITP- Treatment Disposition|Other|0|||
17026801|NCT00725985|38171256|FG004|ITP- Treatment Disposition|Other|0|||
17026802|NCT00725985|38171257|FG005|ITP- Treatment Disposition|Other|0|||
17026803|NCT00725985|38171258|FG006|ITP- Treatment Disposition|Other|0|||
17026804|NCT00725985|38171259|FG007|ITP- Treatment Disposition|Other|0|||
17026805|NCT00725985|38171260|FG008|ITP- Treatment Disposition|Other|0|||
17026806|NCT00725985|38171261|FG009|ITP- Treatment Disposition|Other|0|||
17026807|NCT00725985|38171262|FG010|ITP- Treatment Disposition|Other|0|||
17026808|NCT00725985|38171263|FG011|ITP- Treatment Disposition|Other|0|||
17026809|NCT00725985|38171252|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026810|NCT00725985|38171253|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026811|NCT00725985|38171254|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026812|NCT00725985|38171255|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
17026813|NCT00725985|38171256|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
17026814|NCT00725985|38171257|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
17026815|NCT00725985|38171258|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026816|NCT00725985|38171259|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026817|NCT00725985|38171260|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026818|NCT00725985|38171261|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026819|NCT00725985|38171262|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026820|NCT00725985|38171263|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
17026821|NCT00725985|38171252|FG000|OLMP (Up to 96 Weeks)|Death|0|||
17026822|NCT00725985|38171253|FG001|OLMP (Up to 96 Weeks)|Death|0|||
17026823|NCT00725985|38171254|FG002|OLMP (Up to 96 Weeks)|Death|0|||
17026824|NCT00725985|38171255|FG003|OLMP (Up to 96 Weeks)|Death|0|||
17026825|NCT00725985|38171256|FG004|OLMP (Up to 96 Weeks)|Death|1|||
17026826|NCT00725985|38171257|FG005|OLMP (Up to 96 Weeks)|Death|0|||
17026827|NCT00725985|38171258|FG006|OLMP (Up to 96 Weeks)|Death|0|||
17026828|NCT00725985|38171259|FG007|OLMP (Up to 96 Weeks)|Death|0|||
17026829|NCT00725985|38171260|FG008|OLMP (Up to 96 Weeks)|Death|0|||
17026830|NCT00725985|38171261|FG009|OLMP (Up to 96 Weeks)|Death|0|||
17026831|NCT00725985|38171262|FG010|OLMP (Up to 96 Weeks)|Death|0|||
17026832|NCT00725985|38171263|FG011|OLMP (Up to 96 Weeks)|Death|0|||
17026833|NCT00725985|38171252|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026834|NCT00725985|38171253|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026835|NCT00725985|38171254|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026836|NCT00725985|38171255|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
17026837|NCT00725985|38171256|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026838|NCT00725985|38171257|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026839|NCT00725985|38171258|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026840|NCT00725985|38171259|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026841|NCT00725985|38171260|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026842|NCT00725985|38171261|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026843|NCT00725985|38171262|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026844|NCT00725985|38171263|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
17026845|NCT00725985|38171252|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026846|NCT00725985|38171253|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026847|NCT00725985|38171254|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026848|NCT00725985|38171255|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026849|NCT00725985|38171256|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026850|NCT00725985|38171257|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
17026851|NCT00725985|38171258|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026852|NCT00725985|38171259|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026853|NCT00725985|38171260|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026854|NCT00725985|38171261|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026855|NCT00725985|38171262|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026856|NCT00725985|38171263|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
17026857|NCT00725985|38171252|FG000|OLMP (Up to 96 Weeks)|Other|0|||
17026858|NCT00725985|38171253|FG001|OLMP (Up to 96 Weeks)|Other|0|||
17026859|NCT00725985|38171254|FG002|OLMP (Up to 96 Weeks)|Other|0|||
17026860|NCT00725985|38171255|FG003|OLMP (Up to 96 Weeks)|Other|15|||
17026861|NCT00725985|38171256|FG004|OLMP (Up to 96 Weeks)|Other|20|||
17026862|NCT00725985|38171257|FG005|OLMP (Up to 96 Weeks)|Other|44|||
17026863|NCT00725985|38171258|FG006|OLMP (Up to 96 Weeks)|Other|0|||
17026864|NCT00725985|38171259|FG007|OLMP (Up to 96 Weeks)|Other|0|||
17026865|NCT00725985|38171260|FG008|OLMP (Up to 96 Weeks)|Other|0|||
17026866|NCT00725985|38171261|FG009|OLMP (Up to 96 Weeks)|Other|0|||
17026867|NCT00725985|38171262|FG010|OLMP (Up to 96 Weeks)|Other|0|||
17026868|NCT00725985|38171263|FG011|OLMP (Up to 96 Weeks)|Other|0|||
17026869|NCT00725985|38171252|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026870|NCT00725985|38171253|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026871|NCT00725985|38171254|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026872|NCT00725985|38171255|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026873|NCT00725985|38171256|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026874|NCT00725985|38171257|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026875|NCT00725985|38171258|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026876|NCT00725985|38171259|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
17026877|NCT00725985|38171260|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026878|NCT00725985|38171261|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026879|NCT00725985|38171262|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026880|NCT00725985|38171263|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
17026881|NCT00725985|38171252|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026882|NCT00725985|38171253|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026883|NCT00725985|38171254|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026884|NCT00725985|38171255|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026885|NCT00725985|38171256|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026886|NCT00725985|38171257|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026887|NCT00725985|38171258|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026888|NCT00725985|38171259|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026889|NCT00725985|38171260|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
17026890|NCT00725985|38171261|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026891|NCT00725985|38171262|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026892|NCT00725985|38171263|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
17026893|NCT00725985|38171252|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026894|NCT00725985|38171253|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026895|NCT00725985|38171254|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026896|NCT00725985|38171255|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026897|NCT00725985|38171256|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026898|NCT00725985|38171257|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026899|NCT00725985|38171258|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
17026900|NCT00725985|38171259|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
17026901|NCT00725985|38171260|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
17026902|NCT00725985|38171261|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026903|NCT00725985|38171262|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026904|NCT00725985|38171263|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
17026905|NCT00725985|38171252|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026906|NCT00725985|38171253|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026907|NCT00725985|38171254|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026908|NCT00725985|38171255|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026909|NCT00725985|38171256|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026910|NCT00725985|38171257|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026911|NCT00725985|38171258|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026912|NCT00725985|38171259|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026913|NCT00725985|38171260|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
17026914|NCT00725985|38171261|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
17026915|NCT00725985|38171262|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
17026916|NCT00725985|38171263|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
17026917|NCT00793910|38171291|FG000|Overall Study|discarded study pills|0|||
17026918|NCT00793910|38171292|FG001|Overall Study|discarded study pills|1|||
17026919|NCT00793910|38171291|FG000|Overall Study|did not pick up medications|1|||
17026920|NCT00793910|38171292|FG001|Overall Study|did not pick up medications|1|||
17026921|NCT00793910|38171291|FG000|Overall Study|ineligible based on entry criteria|2|||
17026922|NCT00793910|38171292|FG001|Overall Study|ineligible based on entry criteria|3|||
17026923|NCT00793910|38171291|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
17026924|NCT00793910|38171292|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
17026925|NCT00793910|38171291|FG000|Overall Study|Withdrawal by Subject|0|||
17026926|NCT00793910|38171292|FG001|Overall Study|Withdrawal by Subject|1|||
17026927|NCT00444145|38171298|FG000|Overall Study|Withdrawal by Subject|2|||
17026928|NCT00444145|38171298|FG000|Overall Study|Lost to Follow-up|1|||
17026929|NCT00444145|38171298|FG000|Overall Study|non-compliant|11|||
17026930|NCT00444145|38171298|FG000|Overall Study|Screen Failures|5|||
17026931|NCT00725283|38171302|FG000|Overall Study|Missing Code|3|||
17026932|NCT00725283|38171302|FG000|Overall Study|Death|5|||
17026933|NCT00725283|38171302|FG000|Overall Study|Other|6|||
17026934|NCT00725283|38171302|FG000|Overall Study|Withdrawal by Subject|10|||
17026935|NCT00444067|38171308|FG000|Overall Study|Lost to Follow-up|0|||
17026936|NCT00444067|38171309|FG001|Overall Study|Lost to Follow-up|1|||
17026937|NCT00789854|38171318|FG000|Overall Study|Adverse Event|28|||
17026938|NCT00789854|38171319|FG001|Overall Study|Adverse Event|23|||
17198719|NCT02761993|38352405|FG002|Overall Study|Withdrawal by Subject|2|||
17198720|NCT02761915|38352428|FG000|Overall Study|Death|3|||
17198721|NCT02761915|38352429|FG001|Overall Study|Death|1|||
17198722|NCT02761915|38352430|FG002|Overall Study|Death|1|||
17198723|NCT02761915|38352431|FG003|Overall Study|Death|1|||
17198724|NCT02761915|38352432|FG004|Overall Study|Death|0|||
17198725|NCT02761915|38352433|FG005|Overall Study|Death|1|||
17198726|NCT02761915|38352428|FG000|Overall Study|Withdrawal by Subject|1|||
17198727|NCT02761915|38352429|FG001|Overall Study|Withdrawal by Subject|0|||
17198728|NCT02761915|38352430|FG002|Overall Study|Withdrawal by Subject|0|||
17198729|NCT02761915|38352431|FG003|Overall Study|Withdrawal by Subject|0|||
17198730|NCT02761915|38352432|FG004|Overall Study|Withdrawal by Subject|1|||
17198731|NCT02761915|38352433|FG005|Overall Study|Withdrawal by Subject|2|||
17198732|NCT02761915|38352428|FG000|Overall Study|Disease Progression|0|||
17198733|NCT02761915|38352429|FG001|Overall Study|Disease Progression|0|||
17198734|NCT02761915|38352430|FG002|Overall Study|Disease Progression|0|||
17198735|NCT02761915|38352431|FG003|Overall Study|Disease Progression|2|||
17198736|NCT02761915|38352432|FG004|Overall Study|Disease Progression|2|||
17198737|NCT02761915|38352433|FG005|Overall Study|Disease Progression|2|||
17198738|NCT02706327|38352454|FG000|Overall Study|Lost to Follow-up|1|||
17198739|NCT02706327|38352455|FG001|Overall Study|Lost to Follow-up|1|||
17198740|NCT02706327|38352456|FG002|Overall Study|Lost to Follow-up|2|||
17198741|NCT02764333|38352464|FG000|Overall Study|Ineligible|1|||
17198742|NCT02705625|38352471|FG000|Overall Study|Protocol Violation|1|||
17198743|NCT02705625|38352472|FG001|Overall Study|Protocol Violation|0|||
17198744|NCT02705625|38352473|FG002|Overall Study|Protocol Violation|0|||
17198745|NCT02705625|38352471|FG000|Overall Study|Adverse Event|6|||
17198746|NCT02705625|38352472|FG001|Overall Study|Adverse Event|5|||
17198747|NCT02705625|38352473|FG002|Overall Study|Adverse Event|2|||
17198748|NCT02705625|38352471|FG000|Overall Study|Death|0|||
17198749|NCT02705625|38352472|FG001|Overall Study|Death|0|||
17026939|NCT00789854|38171320|FG002|Overall Study|Adverse Event|18|||
17026940|NCT00789854|38171318|FG000|Overall Study|Lost to Follow-up|1|||
17026941|NCT00789854|38171319|FG001|Overall Study|Lost to Follow-up|1|||
17026942|NCT00789854|38171320|FG002|Overall Study|Lost to Follow-up|4|||
17026943|NCT00789854|38171318|FG000|Overall Study|Withdrawal by Subject|9|||
17026944|NCT00789854|38171319|FG001|Overall Study|Withdrawal by Subject|6|||
17198750|NCT02705625|38352473|FG002|Overall Study|Death|1|||
17026945|NCT00789854|38171320|FG002|Overall Study|Withdrawal by Subject|17|||
17026946|NCT00789854|38171318|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
17026947|NCT00789854|38171319|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
17026948|NCT00789854|38171320|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
17026949|NCT00789854|38171318|FG000|Overall Study|Severe non-compliance to the protocol|3|||
17026950|NCT00789854|38171319|FG001|Overall Study|Severe non-compliance to the protocol|0|||
16853320|NCT01855945|37803631|FG007|Overall Study|Withdrawal by Subject|0|||
16853321|NCT01855945|37803632|FG008|Overall Study|Withdrawal by Subject|0|||
16853322|NCT01855945|37803633|FG009|Overall Study|Withdrawal by Subject|2|||
17026951|NCT00789854|38171320|FG002|Overall Study|Severe non-compliance to the protocol|0|||
17026952|NCT00789854|38171318|FG000|Overall Study|Safety reasons|0|||
17026953|NCT00789854|38171319|FG001|Overall Study|Safety reasons|0|||
17026954|NCT00789854|38171320|FG002|Overall Study|Safety reasons|2|||
17026955|NCT00789854|38171318|FG000|Overall Study|Other|6|||
17026956|NCT00789854|38171319|FG001|Overall Study|Other|0|||
17026957|NCT00789854|38171320|FG002|Overall Study|Other|5|||
17026958|NCT00725205|38171328|FG000|Overall Study|Adverse Event|22|||
17026959|NCT00725205|38171328|FG000|Overall Study|Investigator Discontinued|1|||
17026960|NCT00725205|38171328|FG000|Overall Study|Non-compliance With Protocol|14|||
17026961|NCT00725205|38171328|FG000|Overall Study|Other|8|||
17026962|NCT00725205|38171328|FG000|Overall Study|Protocol Defined Clinical Event|1|||
17026963|NCT00725205|38171328|FG000|Overall Study|Treatment Failure|41|||
17026964|NCT00443755|38171334|FG000|Overall Study|Withdrawal by Subject|2|||
17026965|NCT00443755|38171335|FG001|Overall Study|Withdrawal by Subject|1|||
17026966|NCT00724971|38171341|FG000|Overall Study|Adverse Event|5|||
17026967|NCT00724971|38171341|FG000|Overall Study|Withdrawal by Subject|1|||
17026968|NCT00443599|38171347|FG000|Overall Study|Physician Decision|2|||
17026969|NCT00443599|38171348|FG001|Overall Study|Physician Decision|1|||
17026970|NCT00443599|38171347|FG000|Overall Study|Death|1|||
17026971|NCT00443599|38171348|FG001|Overall Study|Death|1|||
17026972|NCT00443599|38171347|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
17026973|NCT00443599|38171348|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
17026974|NCT00455143|38171354|FG000|Overall Study|Physician Decision|1|||
17026975|NCT00455143|38171354|FG000|Overall Study|Withdrawal by Subject|1|||
16853323|NCT01855945|37803634|FG010|Overall Study|Withdrawal by Subject|4|||
16853324|NCT01855945|37803635|FG011|Overall Study|Withdrawal by Subject|1|||
16853325|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Adverse Event|37|||
16853326|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Adverse Event|0|||
16853327|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Adverse Event|0|||
16853328|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Adverse Event|0|||
16853329|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Death|2|||
16853330|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Death|0|||
16853331|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Death|0|||
16853332|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Death|0|||
16853333|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
16853334|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
16853335|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
16853336|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
16853337|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
16853338|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
16853339|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
16853340|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
16853341|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
16853342|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
16853343|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
16853344|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
16853345|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
16853346|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
16853347|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
16853348|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
16853349|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Physician Decision|4|||
16853350|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Physician Decision|0|||
16853351|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Physician Decision|0|||
16853352|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Physician Decision|0|||
16853353|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Pregnancy|1|||
16853354|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Pregnancy|0|||
16853355|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Pregnancy|0|||
16853356|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Pregnancy|0|||
16853357|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
16853358|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
16853359|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
16853360|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
17026976|NCT00455143|38171354|FG000|Overall Study|Staff was not avail to follow patient|2|||
17026977|NCT00455143|38171354|FG000|Overall Study|No longer met Inclusion Criteria|1|||
17026978|NCT00455143|38171354|FG000|Overall Study|Surgical time, staff not available|1|||
17026979|NCT00454987|38171362|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
17026980|NCT00454987|38171363|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
17026981|NCT00454987|38171364|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
17026982|NCT00454987|38171362|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
17026983|NCT00454987|38171363|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
17026984|NCT00454987|38171364|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
17026985|NCT00454987|38171362|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
17026986|NCT00454987|38171363|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
17026987|NCT00454987|38171364|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
17026988|NCT00724893|38171375|FG000|Overall Study|Adverse Event|76|||
17026989|NCT00724893|38171376|FG001|Overall Study|Adverse Event|142|||
17026990|NCT00724893|38171375|FG000|Overall Study|Withdrawal by Subject|0|||
17026991|NCT00724893|38171376|FG001|Overall Study|Withdrawal by Subject|1|||
17026992|NCT00724893|38171375|FG000|Overall Study|Lack of virologic response|94|||
17026993|NCT00724893|38171376|FG001|Overall Study|Lack of virologic response|202|||
17026994|NCT00724893|38171375|FG000|Overall Study|Reason not specified|193|||
17026995|NCT00724893|38171376|FG001|Overall Study|Reason not specified|7|||
17026996|NCT00724893|38171375|FG000|Overall Study|Patient choice|0|||
17026997|NCT00724893|38171376|FG001|Overall Study|Patient choice|26|||
17026998|NCT00724893|38171375|FG000|Overall Study|Geographic reasons|0|||
17026999|NCT00724893|38171376|FG001|Overall Study|Geographic reasons|11|||
17027000|NCT00724893|38171375|FG000|Overall Study|Incarceration|0|||
17027001|NCT00724893|38171376|FG001|Overall Study|Incarceration|9|||
17027002|NCT00724893|38171375|FG000|Overall Study|Substance abuse|0|||
17027003|NCT00724893|38171376|FG001|Overall Study|Substance abuse|3|||
17027004|NCT00724893|38171375|FG000|Overall Study|Financial reasons|0|||
17027005|NCT00724893|38171376|FG001|Overall Study|Financial reasons|2|||
17027006|NCT00724893|38171375|FG000|Overall Study|Assigned shorter treatment|0|||
17027007|NCT00724893|38171376|FG001|Overall Study|Assigned shorter treatment|2|||
17027008|NCT00724893|38171375|FG000|Overall Study|Lost to Follow-up|0|||
17027009|NCT00724893|38171376|FG001|Overall Study|Lost to Follow-up|52|||
17027010|NCT00724893|38171375|FG000|Overall Study|Unknown, missing data|1|||
17027011|NCT00724893|38171376|FG001|Overall Study|Unknown, missing data|1|||
17027012|NCT00789698|38171401|FG000|Overall Study|Lack of Efficacy|10|||
17027013|NCT00789698|38171402|FG001|Overall Study|Lack of Efficacy|4|||
17027014|NCT00789698|38171403|FG002|Overall Study|Lack of Efficacy|5|||
17027015|NCT00789698|38171404|FG003|Overall Study|Lack of Efficacy|18|||
17027016|NCT00789698|38171401|FG000|Overall Study|Adverse Event|5|||
17027017|NCT00789698|38171402|FG001|Overall Study|Adverse Event|5|||
17027018|NCT00789698|38171403|FG002|Overall Study|Adverse Event|3|||
17027019|NCT00789698|38171404|FG003|Overall Study|Adverse Event|4|||
17027020|NCT00789698|38171401|FG000|Overall Study|Lost to Follow-up|5|||
17027021|NCT00789698|38171402|FG001|Overall Study|Lost to Follow-up|5|||
17027022|NCT00789698|38171403|FG002|Overall Study|Lost to Follow-up|2|||
17027023|NCT00789698|38171404|FG003|Overall Study|Lost to Follow-up|9|||
17027024|NCT00789698|38171401|FG000|Overall Study|Protocol Violation|6|||
17027025|NCT00789698|38171402|FG001|Overall Study|Protocol Violation|1|||
17027026|NCT00789698|38171403|FG002|Overall Study|Protocol Violation|2|||
17027027|NCT00789698|38171404|FG003|Overall Study|Protocol Violation|1|||
17027028|NCT00789698|38171401|FG000|Overall Study|Withdrawal by Subject|14|||
17027029|NCT00789698|38171402|FG001|Overall Study|Withdrawal by Subject|15|||
17027030|NCT00789698|38171403|FG002|Overall Study|Withdrawal by Subject|12|||
17027031|NCT00789698|38171404|FG003|Overall Study|Withdrawal by Subject|19|||
17027032|NCT00789698|38171401|FG000|Overall Study|Administrative|0|||
17027033|NCT00789698|38171402|FG001|Overall Study|Administrative|3|||
17027034|NCT00789698|38171403|FG002|Overall Study|Administrative|3|||
17027035|NCT00789698|38171404|FG003|Overall Study|Administrative|1|||
17027036|NCT00724815|38171415|FG000|Overall Study|Randomized, not treated|31|||
17027037|NCT00724815|38171416|FG001|Overall Study|Randomized, not treated|30|||
17027038|NCT00724815|38171415|FG000|Overall Study|Adverse Event|5|||
17027039|NCT00724815|38171416|FG001|Overall Study|Adverse Event|3|||
17027040|NCT00724815|38171415|FG000|Overall Study|Lost to Follow-up|4|||
17027041|NCT00724815|38171416|FG001|Overall Study|Lost to Follow-up|1|||
17027042|NCT00724815|38171415|FG000|Overall Study|Other Various|3|||
17027043|NCT00724815|38171416|FG001|Overall Study|Other Various|5|||
17027044|NCT00454909|38171425|FG000|Overall Study|Withdrawal by Subject|1|||
17027045|NCT00454909|38171426|FG001|Overall Study|Withdrawal by Subject|0|||
17027046|NCT00454909|38171427|FG002|Overall Study|Withdrawal by Subject|0|||
17027047|NCT00454909|38171425|FG000|Overall Study|Migrated/moved from study area|0|||
17027048|NCT00454909|38171426|FG001|Overall Study|Migrated/moved from study area|0|||
17027049|NCT00454909|38171427|FG002|Overall Study|Migrated/moved from study area|1|||
17027050|NCT00454909|38171425|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
17027051|NCT00454909|38171426|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
17027052|NCT00454909|38171427|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
17027053|NCT00454909|38171425|FG000|Overall Study|Others|1|||
17027054|NCT00454909|38171426|FG001|Overall Study|Others|0|||
17027055|NCT00454909|38171427|FG002|Overall Study|Others|0|||
17027056|NCT00798590|38171438|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
17027057|NCT00798590|38171439|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
17027058|NCT00481195|38171447|FG000|Overall Study|Adverse Event|16|||
17027059|NCT00481195|38171448|FG001|Overall Study|Adverse Event|11|||
17027060|NCT00481195|38171447|FG000|Overall Study|Lack of Efficacy|1|||
17027061|NCT00481195|38171448|FG001|Overall Study|Lack of Efficacy|3|||
17027062|NCT00481195|38171447|FG000|Overall Study|Lost to Follow-up|4|||
17027063|NCT00481195|38171448|FG001|Overall Study|Lost to Follow-up|6|||
17027064|NCT00481195|38171447|FG000|Overall Study|Physician Decision|3|||
17027065|NCT00481195|38171448|FG001|Overall Study|Physician Decision|1|||
17027066|NCT00481195|38171447|FG000|Overall Study|Protocol Violation|10|||
17027067|NCT00481195|38171448|FG001|Overall Study|Protocol Violation|7|||
17027068|NCT00481195|38171447|FG000|Overall Study|Withdrawal by Subject|3|||
17027069|NCT00481195|38171448|FG001|Overall Study|Withdrawal by Subject|9|||
17027070|NCT00481195|38171447|FG000|Overall Study|Miscellaneous|2|||
17027071|NCT00481195|38171448|FG001|Overall Study|Miscellaneous|2|||
17027072|NCT00454363|38171465|FG000|Overall Study|Adverse Event|1|||
17027073|NCT00454363|38171466|FG001|Overall Study|Adverse Event|2|||
17027074|NCT00454363|38171465|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
17027075|NCT00454363|38171466|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
17027076|NCT00454207|38171473|FG000|Overall Study|Adverse Event|3|||
17027077|NCT00454207|38171474|FG001|Overall Study|Adverse Event|1|||
17027078|NCT00454207|38171473|FG000|Overall Study|Lack of Efficacy|1|||
17027079|NCT00454207|38171474|FG001|Overall Study|Lack of Efficacy|0|||
17027080|NCT00454207|38171473|FG000|Overall Study|Protocol Violation|0|||
17027081|NCT00454207|38171474|FG001|Overall Study|Protocol Violation|1|||
17027082|NCT00738894|38171494|FG000|Overall Study|Lost to Follow-up|23|||
17027083|NCT00738894|38171495|FG001|Overall Study|Lost to Follow-up|13|||
17027084|NCT00738894|38171494|FG000|Overall Study|Withdrawal by Subject|10|||
17027085|NCT00738894|38171495|FG001|Overall Study|Withdrawal by Subject|15|||
17027086|NCT00738894|38171494|FG000|Overall Study|Physician Decision|4|||
17027087|NCT00738894|38171495|FG001|Overall Study|Physician Decision|5|||
17027088|NCT00738894|38171494|FG000|Overall Study|Death|2|||
17027089|NCT00738894|38171495|FG001|Overall Study|Death|0|||
17027090|NCT00480493|38171503|FG000|Overall Study|moved|2|||
17027091|NCT00480493|38171504|FG001|Overall Study|moved|7|||
17027092|NCT00734994|38171512|FG000|Overall Study|Withdrawal by Subject|1|||
17027093|NCT00798434|38171519|FG000|Double-Blind|Adverse Event|22|||
17027094|NCT00798434|38171520|FG001|Double-Blind|Adverse Event|46|||
17027095|NCT00798434|38171519|FG000|Double-Blind|Death|0|||
17027096|NCT00798434|38171520|FG001|Double-Blind|Death|1|||
17027097|NCT00798434|38171519|FG000|Double-Blind|Lost to Follow-up|1|||
17027098|NCT00798434|38171520|FG001|Double-Blind|Lost to Follow-up|0|||
17027099|NCT00798434|38171519|FG000|Double-Blind|Lack of Efficacy|8|||
17027100|NCT00798434|38171520|FG001|Double-Blind|Lack of Efficacy|12|||
17027101|NCT00798434|38171519|FG000|Double-Blind|Withdrawal by Subject|17|||
17027102|NCT00798434|38171520|FG001|Double-Blind|Withdrawal by Subject|14|||
17027103|NCT00798434|38171519|FG000|Double-Blind|Protocol Violation|1|||
17027104|NCT00798434|38171520|FG001|Double-Blind|Protocol Violation|4|||
17027105|NCT00798434|38171519|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
17027106|NCT00798434|38171520|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
17027107|NCT00798434|38171519|FG000|Double-Blind|Other|1|||
17027108|NCT00798434|38171520|FG001|Double-Blind|Other|0|||
17027109|NCT00798434|38171519|FG000|Double-Blind|Not Treated|3|||
17027110|NCT00798434|38171520|FG001|Double-Blind|Not Treated|6|||
17027111|NCT00798434|38171519|FG000|Open-Label|Adverse Event|33|||
17027112|NCT00798434|38171520|FG001|Open-Label|Adverse Event|11|||
17027113|NCT00798434|38171519|FG000|Open-Label|Lack of Efficacy|5|||
17027114|NCT00798434|38171520|FG001|Open-Label|Lack of Efficacy|11|||
17027115|NCT00798434|38171519|FG000|Open-Label|Withdrawal by Subject|2|||
17027116|NCT00798434|38171520|FG001|Open-Label|Withdrawal by Subject|7|||
17027117|NCT00798434|38171519|FG000|Open-Label|Protocol Violation|1|||
17027118|NCT00798434|38171520|FG001|Open-Label|Protocol Violation|0|||
17027119|NCT00798434|38171519|FG000|Open-Label|Other|1|||
17027120|NCT00798434|38171520|FG001|Open-Label|Other|2|||
17027121|NCT00798434|38171519|FG000|Open-Label|Not Treated|0|||
17027122|NCT00798434|38171520|FG001|Open-Label|Not Treated|1|||
17027123|NCT00724503|38171533|FG000|Overall Study|Lost to Follow-up|4|||
17027124|NCT00724503|38171534|FG001|Overall Study|Lost to Follow-up|8|||
17027125|NCT00724503|38171533|FG000|Overall Study|Withdrawal by Subject|11|||
17027126|NCT00724503|38171534|FG001|Overall Study|Withdrawal by Subject|23|||
17027127|NCT00724503|38171533|FG000|Overall Study|Death|190|||
17027128|NCT00724503|38171534|FG001|Overall Study|Death|182|||
17027129|NCT00724503|38171533|FG000|Overall Study|Adverse Event|1|||
17027130|NCT00724503|38171534|FG001|Overall Study|Adverse Event|0|||
17027131|NCT00724503|38171533|FG000|Overall Study|Not otherwise specified|4|||
17027132|NCT00724503|38171534|FG001|Overall Study|Not otherwise specified|7|||
17027133|NCT00791648|38171544|FG000|Overall Study|Physician Decision|0|||
17027134|NCT00791648|38171545|FG001|Overall Study|Physician Decision|1|||
17027135|NCT00791648|38171544|FG000|Overall Study|Withdrawal by Subject|0|||
17027136|NCT00791648|38171545|FG001|Overall Study|Withdrawal by Subject|1|||
17027137|NCT00791492|38171553|FG000|Overall Study|Withdrawal by Subject|1|||
17027138|NCT00791492|38171554|FG001|Overall Study|Withdrawal by Subject|2|||
17027139|NCT00791492|38171553|FG000|Overall Study|Liver transplantation|5|||
17027140|NCT00791492|38171554|FG001|Overall Study|Liver transplantation|1|||
17027141|NCT00723957|38171562|FG000|Overall Study|Adverse event unrelated to study drug|1|||
17027142|NCT00723957|38171563|FG001|Overall Study|Adverse event unrelated to study drug|4|||
17027143|NCT00723957|38171562|FG000|Overall Study|Death|3|||
17027144|NCT00723957|38171563|FG001|Overall Study|Death|4|||
17027145|NCT00723957|38171562|FG000|Overall Study|Disease progression|27|||
17027146|NCT00723957|38171563|FG001|Overall Study|Disease progression|25|||
17027147|NCT00723957|38171562|FG000|Overall Study|Maximum clinical benefit|4|||
17027148|NCT00723957|38171563|FG001|Overall Study|Maximum clinical benefit|5|||
17027149|NCT00723957|38171562|FG000|Overall Study|Investigator decision|1|||
17027150|NCT00723957|38171563|FG001|Overall Study|Investigator decision|1|||
17027151|NCT00723957|38171562|FG000|Overall Study|Study drug toxicity|4|||
17027152|NCT00723957|38171563|FG001|Overall Study|Study drug toxicity|6|||
17027153|NCT00723957|38171562|FG000|Overall Study|Withdrawal by Subject|7|||
17027154|NCT00723957|38171563|FG001|Overall Study|Withdrawal by Subject|5|||
17027155|NCT00723957|38171562|FG000|Overall Study|Reason not analyzed|1|||
17027156|NCT00723957|38171563|FG001|Overall Study|Reason not analyzed|0|||
17027157|NCT00723957|38171562|FG000|Overall Study|Never received treatment|3|||
17027158|NCT00723957|38171563|FG001|Overall Study|Never received treatment|3|||
17027159|NCT00723801|38171571|FG000|Overall Study|Lost to Follow-up|1|||
17027160|NCT00723801|38171572|FG001|Overall Study|Lost to Follow-up|2|||
17027161|NCT00723801|38171571|FG000|Overall Study|Protocol Violation|2|||
17027162|NCT00723801|38171572|FG001|Overall Study|Protocol Violation|1|||
16853361|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
16853362|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
16853363|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
16853364|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
16853365|NCT01855789|37803698|FG000|1) Baseline up to Week 24|Other|4|||
16853366|NCT01855789|37803699|FG001|1) Baseline up to Week 24|Other|0|||
16853367|NCT01855789|37803700|FG002|1) Baseline up to Week 24|Other|0|||
16853368|NCT01855789|37803701|FG003|1) Baseline up to Week 24|Other|0|||
16853369|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
16853370|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
16853371|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
16853372|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
16853373|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
16853374|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
16853375|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
16853376|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
16853377|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
16853378|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
16853379|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
16853380|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
16853381|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
16853382|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
16853383|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
16853384|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
16853385|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
16853386|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
16853387|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
16853388|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
16853389|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
16853390|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
16853391|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
16853392|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
16853393|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
16853394|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
16853395|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
16853396|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
16853397|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
16853398|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
16853399|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
16853400|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
16853401|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
16853402|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
16853403|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
16853404|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
17027163|NCT00797966|38171582|FG000|Phase A|Lost to Follow-up|0|||
17027164|NCT00797966|38171583|FG001|Phase A|Lost to Follow-up|0|||
17027165|NCT00797966|38171584|FG002|Phase A|Lost to Follow-up|0|||
17027166|NCT00797966|38171585|FG003|Phase A|Lost to Follow-up|0|||
17027167|NCT00797966|38171586|FG004|Phase A|Lost to Follow-up|33|||
17027168|NCT00797966|38171587|FG005|Phase A|Lost to Follow-up|0|||
17027169|NCT00797966|38171582|FG000|Phase A|Adverse Event|0|||
17027170|NCT00797966|38171583|FG001|Phase A|Adverse Event|0|||
17027171|NCT00797966|38171584|FG002|Phase A|Adverse Event|0|||
17027172|NCT00797966|38171585|FG003|Phase A|Adverse Event|0|||
17027173|NCT00797966|38171586|FG004|Phase A|Adverse Event|46|||
17027174|NCT00797966|38171587|FG005|Phase A|Adverse Event|0|||
17027175|NCT00797966|38171582|FG000|Phase A|Met withdrawal criteria|0|||
17027176|NCT00797966|38171583|FG001|Phase A|Met withdrawal criteria|0|||
17027177|NCT00797966|38171584|FG002|Phase A|Met withdrawal criteria|0|||
17027178|NCT00797966|38171585|FG003|Phase A|Met withdrawal criteria|0|||
17027179|NCT00797966|38171586|FG004|Phase A|Met withdrawal criteria|4|||
17027180|NCT00797966|38171587|FG005|Phase A|Met withdrawal criteria|0|||
17027181|NCT00797966|38171582|FG000|Phase A|Physician Decision|0|||
17027182|NCT00797966|38171583|FG001|Phase A|Physician Decision|0|||
17027183|NCT00797966|38171584|FG002|Phase A|Physician Decision|0|||
17027184|NCT00797966|38171585|FG003|Phase A|Physician Decision|0|||
17027185|NCT00797966|38171586|FG004|Phase A|Physician Decision|13|||
17027186|NCT00797966|38171587|FG005|Phase A|Physician Decision|0|||
17027187|NCT00797966|38171582|FG000|Phase A|Withdrawal by Subject|0|||
17027188|NCT00797966|38171583|FG001|Phase A|Withdrawal by Subject|0|||
17027189|NCT00797966|38171584|FG002|Phase A|Withdrawal by Subject|0|||
17027190|NCT00797966|38171585|FG003|Phase A|Withdrawal by Subject|0|||
17027191|NCT00797966|38171586|FG004|Phase A|Withdrawal by Subject|33|||
17027192|NCT00797966|38171587|FG005|Phase A|Withdrawal by Subject|0|||
17027193|NCT00797966|38171582|FG000|Phase A|Protocol deviation|0|||
17027194|NCT00797966|38171583|FG001|Phase A|Protocol deviation|0|||
17027195|NCT00797966|38171584|FG002|Phase A|Protocol deviation|0|||
17027196|NCT00797966|38171585|FG003|Phase A|Protocol deviation|0|||
17027197|NCT00797966|38171586|FG004|Phase A|Protocol deviation|56|||
17027198|NCT00797966|38171587|FG005|Phase A|Protocol deviation|0|||
17027199|NCT00797966|38171582|FG000|Phase B|Lost to Follow-up|0|||
17027200|NCT00797966|38171583|FG001|Phase B|Lost to Follow-up|1|||
17027201|NCT00797966|38171584|FG002|Phase B|Lost to Follow-up|3|||
17027202|NCT00797966|38171585|FG003|Phase B|Lost to Follow-up|0|||
17027203|NCT00797966|38171586|FG004|Phase B|Lost to Follow-up|0|||
17027204|NCT00797966|38171587|FG005|Phase B|Lost to Follow-up|0|||
17027205|NCT00797966|38171582|FG000|Phase B|Adverse Event|2|||
17027206|NCT00797966|38171583|FG001|Phase B|Adverse Event|1|||
17027207|NCT00797966|38171584|FG002|Phase B|Adverse Event|3|||
17027208|NCT00797966|38171585|FG003|Phase B|Adverse Event|1|||
17027209|NCT00797966|38171586|FG004|Phase B|Adverse Event|0|||
17027210|NCT00797966|38171587|FG005|Phase B|Adverse Event|0|||
17027211|NCT00797966|38171582|FG000|Phase B|Met Withdrawal Criteria|3|||
17027212|NCT00797966|38171583|FG001|Phase B|Met Withdrawal Criteria|3|||
17027213|NCT00797966|38171584|FG002|Phase B|Met Withdrawal Criteria|6|||
17027214|NCT00797966|38171585|FG003|Phase B|Met Withdrawal Criteria|1|||
17027215|NCT00797966|38171586|FG004|Phase B|Met Withdrawal Criteria|0|||
17027216|NCT00797966|38171587|FG005|Phase B|Met Withdrawal Criteria|0|||
17027217|NCT00797966|38171582|FG000|Phase B|Physician Decision|1|||
17027218|NCT00797966|38171583|FG001|Phase B|Physician Decision|0|||
17027219|NCT00797966|38171584|FG002|Phase B|Physician Decision|3|||
17027220|NCT00797966|38171585|FG003|Phase B|Physician Decision|1|||
17027221|NCT00797966|38171586|FG004|Phase B|Physician Decision|0|||
17027222|NCT00797966|38171587|FG005|Phase B|Physician Decision|0|||
17027223|NCT00797966|38171582|FG000|Phase B|Withdrawal by Subject|1|||
17027224|NCT00797966|38171583|FG001|Phase B|Withdrawal by Subject|4|||
17027225|NCT00797966|38171584|FG002|Phase B|Withdrawal by Subject|3|||
17027226|NCT00797966|38171585|FG003|Phase B|Withdrawal by Subject|3|||
17027227|NCT00797966|38171586|FG004|Phase B|Withdrawal by Subject|0|||
17027228|NCT00797966|38171587|FG005|Phase B|Withdrawal by Subject|0|||
17027229|NCT00797966|38171582|FG000|Phase B|Protocol Deviation|4|||
17027230|NCT00797966|38171583|FG001|Phase B|Protocol Deviation|8|||
17027231|NCT00797966|38171584|FG002|Phase B|Protocol Deviation|2|||
17027232|NCT00797966|38171585|FG003|Phase B|Protocol Deviation|6|||
17027233|NCT00797966|38171586|FG004|Phase B|Protocol Deviation|0|||
17027234|NCT00797966|38171587|FG005|Phase B|Protocol Deviation|0|||
17027235|NCT00797966|38171582|FG000|Phase B|Lack of Efficacy|0|||
17027236|NCT00797966|38171583|FG001|Phase B|Lack of Efficacy|1|||
17027237|NCT00797966|38171584|FG002|Phase B|Lack of Efficacy|1|||
17027238|NCT00797966|38171585|FG003|Phase B|Lack of Efficacy|4|||
17027239|NCT00797966|38171586|FG004|Phase B|Lack of Efficacy|0|||
17027240|NCT00797966|38171587|FG005|Phase B|Lack of Efficacy|0|||
17103673|NCT00098306|38241883|FG004|Double Blind|Adverse Event|0|||
17027241|NCT00797966|38171582|FG000|Phase A+|Lost to Follow-up|0|||
17027242|NCT00797966|38171583|FG001|Phase A+|Lost to Follow-up|0|||
17027243|NCT00797966|38171584|FG002|Phase A+|Lost to Follow-up|0|||
17027244|NCT00797966|38171585|FG003|Phase A+|Lost to Follow-up|0|||
17027245|NCT00797966|38171586|FG004|Phase A+|Lost to Follow-up|0|||
17103674|NCT00098306|38241884|FG005|Double Blind|Adverse Event|0|||
17027246|NCT00797966|38171587|FG005|Phase A+|Lost to Follow-up|9|||
17027247|NCT00797966|38171582|FG000|Phase A+|Met withdrawal criteria|0|||
17027248|NCT00797966|38171583|FG001|Phase A+|Met withdrawal criteria|0|||
17027249|NCT00797966|38171584|FG002|Phase A+|Met withdrawal criteria|0|||
17027250|NCT00797966|38171585|FG003|Phase A+|Met withdrawal criteria|0|||
17027251|NCT00797966|38171586|FG004|Phase A+|Met withdrawal criteria|0|||
17027252|NCT00797966|38171587|FG005|Phase A+|Met withdrawal criteria|5|||
17027253|NCT00797966|38171582|FG000|Phase A+|Withdrawal by Subject|0|||
17027254|NCT00797966|38171583|FG001|Phase A+|Withdrawal by Subject|0|||
17027255|NCT00797966|38171584|FG002|Phase A+|Withdrawal by Subject|0|||
17027256|NCT00797966|38171585|FG003|Phase A+|Withdrawal by Subject|0|||
17027257|NCT00797966|38171586|FG004|Phase A+|Withdrawal by Subject|0|||
17027258|NCT00797966|38171587|FG005|Phase A+|Withdrawal by Subject|6|||
17027259|NCT00797966|38171582|FG000|Phase A+|Adverse Event|0|||
17027260|NCT00797966|38171583|FG001|Phase A+|Adverse Event|0|||
17027261|NCT00797966|38171584|FG002|Phase A+|Adverse Event|0|||
17027262|NCT00797966|38171585|FG003|Phase A+|Adverse Event|0|||
17027263|NCT00797966|38171586|FG004|Phase A+|Adverse Event|0|||
17027264|NCT00797966|38171587|FG005|Phase A+|Adverse Event|4|||
17027265|NCT00797966|38171582|FG000|Phase A+|Protocol deviation|0|||
17027266|NCT00797966|38171583|FG001|Phase A+|Protocol deviation|0|||
17027267|NCT00797966|38171584|FG002|Phase A+|Protocol deviation|0|||
17027268|NCT00797966|38171585|FG003|Phase A+|Protocol deviation|0|||
17027269|NCT00797966|38171586|FG004|Phase A+|Protocol deviation|0|||
17027270|NCT00797966|38171587|FG005|Phase A+|Protocol deviation|4|||
17027271|NCT00723489|38171603|FG000|Overall Study|Physician Decision|0|||
17027272|NCT00723489|38171604|FG001|Overall Study|Physician Decision|1|||
17027273|NCT00723489|38171605|FG002|Overall Study|Physician Decision|0|||
17027274|NCT00723489|38171606|FG003|Overall Study|Physician Decision|0|||
17027275|NCT00723489|38171603|FG000|Overall Study|Pregnancy|0|||
17027276|NCT00723489|38171604|FG001|Overall Study|Pregnancy|0|||
17027277|NCT00723489|38171605|FG002|Overall Study|Pregnancy|0|||
17027278|NCT00723489|38171606|FG003|Overall Study|Pregnancy|1|||
17027279|NCT00723489|38171603|FG000|Overall Study|Withdrawal by Subject|0|||
17027280|NCT00723489|38171604|FG001|Overall Study|Withdrawal by Subject|0|||
17027281|NCT00723489|38171605|FG002|Overall Study|Withdrawal by Subject|0|||
17027282|NCT00723489|38171606|FG003|Overall Study|Withdrawal by Subject|1|||
17027283|NCT00723489|38171603|FG000|Overall Study|Seropositive at baseline|1|||
17027284|NCT00723489|38171604|FG001|Overall Study|Seropositive at baseline|0|||
17027285|NCT00723489|38171605|FG002|Overall Study|Seropositive at baseline|0|||
17027286|NCT00723489|38171606|FG003|Overall Study|Seropositive at baseline|0|||
17027287|NCT00723489|38171603|FG000|Overall Study|Prohibited Medication|0|||
17027288|NCT00723489|38171604|FG001|Overall Study|Prohibited Medication|0|||
17027289|NCT00723489|38171605|FG002|Overall Study|Prohibited Medication|0|||
17027290|NCT00723489|38171606|FG003|Overall Study|Prohibited Medication|1|||
17027291|NCT00723489|38171603|FG000|Overall Study|Samples Collected Out of Window|0|||
17027292|NCT00723489|38171604|FG001|Overall Study|Samples Collected Out of Window|3|||
17027293|NCT00723489|38171605|FG002|Overall Study|Samples Collected Out of Window|0|||
17027294|NCT00723489|38171606|FG003|Overall Study|Samples Collected Out of Window|0|||
17027295|NCT00587990|38171619|FG000|Overall Study|Death|0|||
17027296|NCT00587990|38171620|FG001|Overall Study|Death|0|||
17027297|NCT00587990|38171621|FG002|Overall Study|Death|1|||
17027298|NCT00723255|38171629|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
17027299|NCT00723255|38171629|FG000|Overall Study|Ineligible: Second primary|1|||
17027300|NCT00723255|38171629|FG000|Overall Study|Ineligible: Wrong Primary|2|||
17027301|NCT00791258|38171645|FG000|Overall Study|Adverse Event|87|||
17027302|NCT00791258|38171645|FG000|Overall Study|Lost to Follow-up|18|||
17027303|NCT00791258|38171645|FG000|Overall Study|Protocol Violation|109|||
17027304|NCT00791258|38171645|FG000|Overall Study|Withdrawal by Subject|40|||
17027305|NCT00791258|38171645|FG000|Overall Study|Did not take medication for >3 days|1|||
17027306|NCT00791258|38171645|FG000|Overall Study|subject left area|2|||
17027307|NCT00791258|38171645|FG000|Overall Study|non-compliance|3|||
17027308|NCT00791258|38171645|FG000|Overall Study|Subject incarcerated|1|||
17027309|NCT00791258|38171645|FG000|Overall Study|Subject required restricted medication|1|||
17027310|NCT00791258|38171645|FG000|Overall Study|Lack of Efficacy|1|||
17027311|NCT00808067|38171651|FG000|Overall Study|Major/minor bleed|30|||
16935855|NCT01212991|38080598|FG000|Double-blind|Other|7|||
17027312|NCT00808067|38171652|FG001|Overall Study|Major/minor bleed|44|||
17027313|NCT00808067|38171651|FG000|Overall Study|Outcome event - other|33|||
17027314|NCT00808067|38171652|FG001|Overall Study|Outcome event - other|25|||
17027315|NCT00808067|38171651|FG000|Overall Study|Adverse Event|111|||
17027316|NCT00808067|38171652|FG001|Overall Study|Adverse Event|121|||
17027317|NCT00808067|38171651|FG000|Overall Study|Hospitalization (not including surgery)|18|||
17027318|NCT00808067|38171652|FG001|Overall Study|Hospitalization (not including surgery)|17|||
17027319|NCT00808067|38171651|FG000|Overall Study|Hospitalization due to surgery|37|||
17027320|NCT00808067|38171652|FG001|Overall Study|Hospitalization due to surgery|40|||
17027321|NCT00808067|38171651|FG000|Overall Study|Reduced creatinine clearance|53|||
17027322|NCT00808067|38171652|FG001|Overall Study|Reduced creatinine clearance|55|||
17103675|NCT00098306|38241885|FG006|Double Blind|Adverse Event|0|||
17027323|NCT00808067|38171651|FG000|Overall Study|Elevated LFT results|7|||
17027324|NCT00808067|38171652|FG001|Overall Study|Elevated LFT results|3|||
17027325|NCT00808067|38171651|FG000|Overall Study|Patient refused to take study medication|65|||
17027326|NCT00808067|38171652|FG001|Overall Study|Patient refused to take study medication|76|||
17027327|NCT00808067|38171651|FG000|Overall Study|Missing|1|||
17027328|NCT00808067|38171652|FG001|Overall Study|Missing|0|||
17027329|NCT00808067|38171651|FG000|Overall Study|Death|1|||
17027330|NCT00808067|38171652|FG001|Overall Study|Death|1|||
17027331|NCT00808067|38171651|FG000|Overall Study|Procedure|6|||
17027332|NCT00808067|38171652|FG001|Overall Study|Procedure|7|||
17027333|NCT00808067|38171651|FG000|Overall Study|Withdrawal by Subject|21|||
17027334|NCT00808067|38171652|FG001|Overall Study|Withdrawal by Subject|25|||
17027335|NCT00808067|38171651|FG000|Overall Study|Site closed|4|||
17027336|NCT00808067|38171652|FG001|Overall Study|Site closed|3|||
17027337|NCT00808067|38171651|FG000|Overall Study|Physician Decision|47|||
17027338|NCT00808067|38171652|FG001|Overall Study|Physician Decision|38|||
17027339|NCT00808067|38171651|FG000|Overall Study|Protocol Violation|3|||
17027340|NCT00808067|38171652|FG001|Overall Study|Protocol Violation|11|||
17027341|NCT00808067|38171651|FG000|Overall Study|Patient elected|7|||
17027342|NCT00808067|38171652|FG001|Overall Study|Patient elected|9|||
17027343|NCT00808067|38171651|FG000|Overall Study|Site closed for cause|19|||
17027344|NCT00808067|38171652|FG001|Overall Study|Site closed for cause|19|||
17027345|NCT00808067|38171651|FG000|Overall Study|Other reason not defined above|5|||
17027346|NCT00808067|38171652|FG001|Overall Study|Other reason not defined above|5|||
17027347|NCT00808067|38171651|FG000|Overall Study|Excluded from analysis|13|||
17027348|NCT00808067|38171652|FG001|Overall Study|Excluded from analysis|19|||
17027349|NCT00723021|38171658|FG000|Intervention Period 4|Adverse Event|0|||
17027350|NCT00723021|38171659|FG001|Intervention Period 4|Adverse Event|0|||
17027351|NCT00723021|38171660|FG002|Intervention Period 4|Adverse Event|0|||
17027352|NCT00723021|38171661|FG003|Intervention Period 4|Adverse Event|0|||
17027353|NCT00723021|38171662|FG004|Intervention Period 4|Adverse Event|1|||
17027354|NCT00721227|38171683|FG000|Overall Study|Lost to Follow-up|3|||
17027355|NCT00721227|38171684|FG001|Overall Study|Lost to Follow-up|0|||
17027356|NCT00721227|38171683|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
17027357|NCT00721227|38171684|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
17027358|NCT00807599|38171692|FG000|Overall Study|Not treated on protocol study|0|||
17027359|NCT00807599|38171693|FG001|Overall Study|Not treated on protocol study|0|||
17027360|NCT00807599|38171694|FG002|Overall Study|Not treated on protocol study|2|||
17027361|NCT00807599|38171692|FG000|Overall Study|Adverse Event|0|||
17027362|NCT00807599|38171693|FG001|Overall Study|Adverse Event|0|||
17027363|NCT00807599|38171694|FG002|Overall Study|Adverse Event|5|||
17027364|NCT00807599|38171692|FG000|Overall Study|Inadequate response to induction|0|||
17027365|NCT00807599|38171693|FG001|Overall Study|Inadequate response to induction|0|||
17027366|NCT00807599|38171694|FG002|Overall Study|Inadequate response to induction|9|||
17027367|NCT00807599|38171692|FG000|Overall Study|Withdrawal by Subject|0|||
17027368|NCT00807599|38171693|FG001|Overall Study|Withdrawal by Subject|0|||
17027369|NCT00807599|38171694|FG002|Overall Study|Withdrawal by Subject|1|||
17027370|NCT00721149|38171700|FG000|Overall Study|Physician Decision|1|||
17027371|NCT00788372|38171704|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
17027372|NCT00788372|38171704|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
17027373|NCT00788372|38171704|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
17027374|NCT00788372|38171704|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
17027375|NCT00788372|38171704|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
17027376|NCT00788372|38171704|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
17027377|NCT00788372|38171704|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
17027378|NCT00738582|38171708|FG000|Combination Therapy|Completed Combination Therapy|1|||
17027379|NCT00738582|38171709|FG001|Combination Therapy|Completed Combination Therapy|0|||
17027380|NCT00738582|38171708|FG000|Combination Therapy|Physician Decision|1|||
17027381|NCT00738582|38171709|FG001|Combination Therapy|Physician Decision|0|||
17027382|NCT00738582|38171708|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
17027383|NCT00738582|38171709|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
17027384|NCT00738582|38171708|FG000|Combination Therapy|Other|5|||
17027385|NCT00738582|38171709|FG001|Combination Therapy|Other|0|||
17027386|NCT00738582|38171708|FG000|Combination Therapy|Adverse Event|16|||
17027387|NCT00738582|38171709|FG001|Combination Therapy|Adverse Event|0|||
17027388|NCT00738582|38171708|FG000|Combination Therapy|Progressive Disease|9|||
17027389|NCT00738582|38171709|FG001|Combination Therapy|Progressive Disease|0|||
17027390|NCT00738582|38171708|FG000|Maintenance Therapy|Other|0|||
17027391|NCT00738582|38171709|FG001|Maintenance Therapy|Other|2|||
17027392|NCT00738582|38171708|FG000|Maintenance Therapy|Adverse Event|0|||
17027393|NCT00738582|38171709|FG001|Maintenance Therapy|Adverse Event|6|||
17027394|NCT00738582|38171708|FG000|Maintenance Therapy|Progressive Disease|0|||
17027395|NCT00738582|38171709|FG001|Maintenance Therapy|Progressive Disease|47|||
17027396|NCT00738582|38171708|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
17027397|NCT00738582|38171709|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
17027398|NCT00720759|38171720|FG000|Overall Study|Lost to Follow-up|0|||
17027399|NCT00720759|38171721|FG001|Overall Study|Lost to Follow-up|1|||
17027400|NCT00720759|38171722|FG002|Overall Study|Lost to Follow-up|1|||
17027401|NCT00720759|38171723|FG003|Overall Study|Lost to Follow-up|0|||
17027402|NCT00720213|38171733|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
17027403|NCT00720213|38171734|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
17027404|NCT00720213|38171735|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
17027405|NCT00810407|38171743|FG000|Overall Study|Protocol Violation|3|||
17027406|NCT00810407|38171743|FG000|Overall Study|No Visit After First Day of Treatment|3|||
17027407|NCT00720057|38171749|FG000|Overall Study|Lost to Follow-up|0|||
17027408|NCT00720057|38171750|FG001|Overall Study|Lost to Follow-up|2|||
17027409|NCT00720057|38171749|FG000|Overall Study|Protocol Violation|1|||
17027410|NCT00720057|38171750|FG001|Overall Study|Protocol Violation|0|||
17027411|NCT00720057|38171749|FG000|Overall Study|Withdrawal by Subject|0|||
17027412|NCT00720057|38171750|FG001|Overall Study|Withdrawal by Subject|1|||
17027413|NCT00790868|38171758|FG000|Overall Study|Withdrawal by Subject|4|||
17027414|NCT00790868|38171759|FG001|Overall Study|Withdrawal by Subject|5|||
17027415|NCT00790868|38171758|FG000|Overall Study|Lost to Follow-up|2|||
17027416|NCT00790868|38171759|FG001|Overall Study|Lost to Follow-up|12|||
17027417|NCT00719901|38171767|FG000|Overall Study|Adverse Event|5|||
17027418|NCT00719901|38171767|FG000|Overall Study|Withdrawal by Subject|1|||
17027419|NCT00719901|38171767|FG000|Overall Study|Alternate Treatment|1|||
17027420|NCT00719901|38171767|FG000|Overall Study|Disease Progression|3|||
17027421|NCT00719901|38171767|FG000|Overall Study|Availability of Study Drug|1|||
17027422|NCT00807365|38171771|FG000|Overall Study|Study Terminated|5|||
17027423|NCT00719355|38171777|FG000|Overall Study|Death|0|||
17027424|NCT00719355|38171778|FG001|Overall Study|Death|1|||
17027425|NCT00719355|38171777|FG000|Overall Study|Medical|14|||
17027426|NCT00719355|38171778|FG001|Overall Study|Medical|5|||
17027427|NCT00719355|38171777|FG000|Overall Study|Compliance|4|||
17027428|NCT00719355|38171778|FG001|Overall Study|Compliance|6|||
17027429|NCT00719355|38171777|FG000|Overall Study|Moved|0|||
17027430|NCT00719355|38171778|FG001|Overall Study|Moved|1|||
17027431|NCT00590759|38171784|FG000|Overall Study|Death|52|||
17027432|NCT00590759|38171784|FG000|Overall Study|Lost to Follow-up|28|||
17027433|NCT00734604|38171794|FG000|Overall Study|Adverse Event|0|||
16853405|NCT01855789|37803698|FG000|2) Week 24 up to End of Study|Other|0|||
16853406|NCT01855789|37803699|FG001|2) Week 24 up to End of Study|Other|0|||
16853407|NCT01855789|37803700|FG002|2) Week 24 up to End of Study|Other|0|||
16853408|NCT01855789|37803701|FG003|2) Week 24 up to End of Study|Other|1|||
16853409|NCT01610791|37803707|FG000|Overall Study|Lost to Follow-up|7|||
16853410|NCT01610791|37803707|FG000|Overall Study|Adverse Event|6|||
16853411|NCT01610791|37803707|FG000|Overall Study|Physician Decision|1|||
16853412|NCT01610791|37803707|FG000|Overall Study|Adverse event and Investigator decision|1|||
16853413|NCT01610791|37803707|FG000|Overall Study|Death|1|||
16853414|NCT01610791|37803707|FG000|Overall Study|Not determined|5|||
16853415|NCT01876381|37803711|FG000|Overall Study|Lack of Efficacy|5|||
16853416|NCT01876381|37803711|FG000|Overall Study|Physician Decision|1|||
16853417|NCT01876381|37803711|FG000|Overall Study|Withdrawal by Subject|1|||
16853418|NCT01855399|37803717|FG000|6 Month|Lost to Follow-up|12|||
16853419|NCT01855399|37803718|FG001|6 Month|Lost to Follow-up|9|||
16853420|NCT01855399|37803717|FG000|6 Month|Withdrawal by Subject|8|||
16853421|NCT01855399|37803718|FG001|6 Month|Withdrawal by Subject|6|||
16853422|NCT01855399|37803717|FG000|12 Month|Lost to Follow-up|7|||
16853423|NCT01855399|37803718|FG001|12 Month|Lost to Follow-up|11|||
16853424|NCT01875991|37803726|FG000|Overall Study|Withdrawal by Subject|6|||
16853425|NCT01875991|37803727|FG001|Overall Study|Withdrawal by Subject|6|||
16853426|NCT01875991|37803726|FG000|Overall Study|Sponsor Decision|1|||
16853427|NCT01875991|37803727|FG001|Overall Study|Sponsor Decision|0|||
16853428|NCT01855243|37803739|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
16853429|NCT01855243|37803740|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
16853430|NCT01855243|37803741|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
16853431|NCT01825837|37803753|FG000|PART I|Withdrawal by Subject|0|||
16853432|NCT01825837|37803754|FG001|PART I|Withdrawal by Subject|0|||
16853433|NCT01825837|37803755|FG002|PART I|Withdrawal by Subject|0|||
16853434|NCT01825837|37803756|FG003|PART I|Withdrawal by Subject|6|||
16853435|NCT01825837|37803753|FG000|PART I|Patient non-compliance|0|||
16853436|NCT01825837|37803754|FG001|PART I|Patient non-compliance|0|||
16853437|NCT01825837|37803755|FG002|PART I|Patient non-compliance|0|||
16853438|NCT01825837|37803756|FG003|PART I|Patient non-compliance|1|||
16853439|NCT01825837|37803753|FG000|PART I|Treatment failure|0|||
16853440|NCT01825837|37803754|FG001|PART I|Treatment failure|0|||
16853441|NCT01825837|37803755|FG002|PART I|Treatment failure|0|||
17027434|NCT00734604|38171795|FG001|Overall Study|Adverse Event|2|||
16853442|NCT01825837|37803756|FG003|PART I|Treatment failure|7|||
16853443|NCT01825837|37803753|FG000|PART I|reason unspecified|0|||
16853444|NCT01825837|37803754|FG001|PART I|reason unspecified|0|||
16853445|NCT01825837|37803755|FG002|PART I|reason unspecified|0|||
16853446|NCT01825837|37803756|FG003|PART I|reason unspecified|3|||
17027435|NCT00734604|38171796|FG002|Overall Study|Adverse Event|0|||
17027436|NCT00734604|38171797|FG003|Overall Study|Adverse Event|2|||
17027437|NCT00734604|38171798|FG004|Overall Study|Adverse Event|1|||
17027438|NCT00734604|38171799|FG005|Overall Study|Adverse Event|1|||
17027439|NCT00734604|38171794|FG000|Overall Study|Serious Adverse Event|1|||
17027440|NCT00734604|38171795|FG001|Overall Study|Serious Adverse Event|0|||
17027441|NCT00734604|38171796|FG002|Overall Study|Serious Adverse Event|1|||
17027442|NCT00734604|38171797|FG003|Overall Study|Serious Adverse Event|2|||
17027443|NCT00734604|38171798|FG004|Overall Study|Serious Adverse Event|0|||
17027444|NCT00734604|38171799|FG005|Overall Study|Serious Adverse Event|1|||
17027445|NCT00734604|38171794|FG000|Overall Study|Lost to Follow-up|1|||
17027446|NCT00734604|38171795|FG001|Overall Study|Lost to Follow-up|2|||
17027447|NCT00734604|38171796|FG002|Overall Study|Lost to Follow-up|2|||
17027448|NCT00734604|38171797|FG003|Overall Study|Lost to Follow-up|4|||
17027449|NCT00734604|38171798|FG004|Overall Study|Lost to Follow-up|2|||
17027450|NCT00734604|38171799|FG005|Overall Study|Lost to Follow-up|3|||
17027451|NCT00734604|38171794|FG000|Overall Study|Physician Decision|0|||
17027452|NCT00734604|38171795|FG001|Overall Study|Physician Decision|1|||
17027453|NCT00734604|38171796|FG002|Overall Study|Physician Decision|1|||
17027454|NCT00734604|38171797|FG003|Overall Study|Physician Decision|0|||
17027455|NCT00734604|38171798|FG004|Overall Study|Physician Decision|0|||
17027456|NCT00734604|38171799|FG005|Overall Study|Physician Decision|0|||
17027457|NCT00734604|38171794|FG000|Overall Study|Protocol Violation|0|||
17027458|NCT00734604|38171795|FG001|Overall Study|Protocol Violation|2|||
17027459|NCT00734604|38171796|FG002|Overall Study|Protocol Violation|0|||
17027460|NCT00734604|38171797|FG003|Overall Study|Protocol Violation|0|||
17027461|NCT00734604|38171798|FG004|Overall Study|Protocol Violation|1|||
17027462|NCT00734604|38171799|FG005|Overall Study|Protocol Violation|0|||
17027463|NCT00734604|38171794|FG000|Overall Study|Sponsor Decision|1|||
17027464|NCT00734604|38171795|FG001|Overall Study|Sponsor Decision|2|||
17027465|NCT00734604|38171796|FG002|Overall Study|Sponsor Decision|1|||
17027466|NCT00734604|38171797|FG003|Overall Study|Sponsor Decision|0|||
17027467|NCT00734604|38171798|FG004|Overall Study|Sponsor Decision|2|||
17027468|NCT00734604|38171799|FG005|Overall Study|Sponsor Decision|0|||
17027469|NCT00734604|38171794|FG000|Overall Study|Withdrawal by Subject|0|||
17027470|NCT00734604|38171795|FG001|Overall Study|Withdrawal by Subject|2|||
17027471|NCT00734604|38171796|FG002|Overall Study|Withdrawal by Subject|0|||
17027472|NCT00734604|38171797|FG003|Overall Study|Withdrawal by Subject|1|||
17027473|NCT00734604|38171798|FG004|Overall Study|Withdrawal by Subject|2|||
17027474|NCT00734604|38171799|FG005|Overall Study|Withdrawal by Subject|1|||
17027475|NCT00734604|38171794|FG000|Overall Study|Lack of Efficacy|0|||
17027476|NCT00734604|38171795|FG001|Overall Study|Lack of Efficacy|1|||
17027477|NCT00734604|38171796|FG002|Overall Study|Lack of Efficacy|1|||
17027478|NCT00734604|38171797|FG003|Overall Study|Lack of Efficacy|0|||
17027479|NCT00734604|38171798|FG004|Overall Study|Lack of Efficacy|0|||
17027480|NCT00734604|38171799|FG005|Overall Study|Lack of Efficacy|0|||
17027481|NCT00590681|38171810|FG000|Overall Study|Withdrawal by Subject|7|||
17027482|NCT00590681|38171810|FG000|Overall Study|Adverse Event|8|||
17027483|NCT00590681|38171810|FG000|Overall Study|Death|3|||
17027484|NCT00590681|38171810|FG000|Overall Study|Lost to Follow-up|1|||
17027485|NCT00590681|38171810|FG000|Overall Study|disease progression|1|||
17027486|NCT00727272|38171814|FG000|Washout Period A|Adverse Event|0|||
17027487|NCT00727272|38171815|FG001|Washout Period A|Adverse Event|0|||
17027488|NCT00727272|38171816|FG002|Washout Period A|Adverse Event|1|||
17027489|NCT00727272|38171814|FG000|Washout Period B|Withdrawal by Subject|0|||
17027490|NCT00727272|38171815|FG001|Washout Period B|Withdrawal by Subject|0|||
17027491|NCT00727272|38171816|FG002|Washout Period B|Withdrawal by Subject|1|||
17027492|NCT00805025|38171826|FG000|Overall Study|Screened but not enrolled/treated|42|||
17027493|NCT00805025|38171826|FG000|Overall Study|Adverse Event|4|||
17027494|NCT00805025|38171826|FG000|Overall Study|Withdrawal by Subject|2|||
17027495|NCT00805025|38171826|FG000|Overall Study|Physician Decision|1|||
17027496|NCT00734214|38171832|FG000|Overall Study|Withdrawal by Subject|3|||
17027497|NCT00734214|38171833|FG001|Overall Study|Withdrawal by Subject|4|||
17027498|NCT00734214|38171832|FG000|Overall Study|MD withdrawal|1|||
17027499|NCT00734214|38171833|FG001|Overall Study|MD withdrawal|0|||
17027500|NCT00787202|38171844|FG000|Overall Study|Adverse Event|3|||
17027501|NCT00787202|38171845|FG001|Overall Study|Adverse Event|2|||
17027502|NCT00787202|38171846|FG002|Overall Study|Adverse Event|0|||
17027503|NCT00787202|38171847|FG003|Overall Study|Adverse Event|0|||
17027504|NCT00787202|38171848|FG004|Overall Study|Adverse Event|2|||
17027505|NCT00787202|38171844|FG000|Overall Study|Lack of Efficacy|5|||
17027506|NCT00787202|38171845|FG001|Overall Study|Lack of Efficacy|6|||
17027507|NCT00787202|38171846|FG002|Overall Study|Lack of Efficacy|5|||
17027508|NCT00787202|38171847|FG003|Overall Study|Lack of Efficacy|2|||
17027509|NCT00787202|38171848|FG004|Overall Study|Lack of Efficacy|1|||
17027510|NCT00787202|38171844|FG000|Overall Study|Lost to Follow-up|1|||
17027511|NCT00787202|38171845|FG001|Overall Study|Lost to Follow-up|0|||
17027512|NCT00787202|38171846|FG002|Overall Study|Lost to Follow-up|0|||
17027513|NCT00787202|38171847|FG003|Overall Study|Lost to Follow-up|0|||
17027514|NCT00787202|38171848|FG004|Overall Study|Lost to Follow-up|0|||
17027515|NCT00787202|38171844|FG000|Overall Study|Withdrawal by Subject|2|||
17103676|NCT00098306|38241879|FG000|Double Blind|Lack of Efficacy|43|||
17027516|NCT00787202|38171845|FG001|Overall Study|Withdrawal by Subject|2|||
17027517|NCT00787202|38171846|FG002|Overall Study|Withdrawal by Subject|2|||
17027518|NCT00787202|38171847|FG003|Overall Study|Withdrawal by Subject|0|||
17027519|NCT00787202|38171848|FG004|Overall Study|Withdrawal by Subject|0|||
17027520|NCT00787202|38171844|FG000|Overall Study|Protocol Violation|2|||
17027521|NCT00787202|38171845|FG001|Overall Study|Protocol Violation|1|||
17027522|NCT00787202|38171846|FG002|Overall Study|Protocol Violation|0|||
17027523|NCT00787202|38171847|FG003|Overall Study|Protocol Violation|0|||
16853447|NCT01825837|37803753|FG000|PART II|Withdrawal by Subject|3|||
16853448|NCT01825837|37803754|FG001|PART II|Withdrawal by Subject|3|||
16853449|NCT01825837|37803755|FG002|PART II|Withdrawal by Subject|7|||
16853450|NCT01825837|37803756|FG003|PART II|Withdrawal by Subject|0|||
16853451|NCT01825837|37803753|FG000|PART II|Patient non-compliance|5|||
16853452|NCT01825837|37803754|FG001|PART II|Patient non-compliance|2|||
16853453|NCT01825837|37803755|FG002|PART II|Patient non-compliance|4|||
16853454|NCT01825837|37803756|FG003|PART II|Patient non-compliance|0|||
16853455|NCT01825837|37803753|FG000|PART II|Adverse Event|3|||
16853456|NCT01825837|37803754|FG001|PART II|Adverse Event|3|||
16853457|NCT01825837|37803755|FG002|PART II|Adverse Event|1|||
16853458|NCT01825837|37803756|FG003|PART II|Adverse Event|0|||
16853459|NCT01825837|37803753|FG000|PART II|Treatment failure|6|||
16853460|NCT01825837|37803754|FG001|PART II|Treatment failure|4|||
16853461|NCT01825837|37803755|FG002|PART II|Treatment failure|5|||
16853462|NCT01825837|37803756|FG003|PART II|Treatment failure|0|||
16853463|NCT01825837|37803753|FG000|PART II|reason unspecified|2|||
16853464|NCT01825837|37803754|FG001|PART II|reason unspecified|2|||
16853465|NCT01825837|37803755|FG002|PART II|reason unspecified|2|||
16853466|NCT01825837|37803756|FG003|PART II|reason unspecified|0|||
16853467|NCT01854697|37803769|FG000|Overall Study|Adverse Event|1|||
16853468|NCT01854697|37803770|FG001|Overall Study|Adverse Event|0|||
16853469|NCT01854697|37803771|FG002|Overall Study|Adverse Event|0|||
16853470|NCT01854697|37803772|FG003|Overall Study|Adverse Event|0|||
16853471|NCT01854697|37803773|FG004|Overall Study|Adverse Event|1|||
16853472|NCT01854697|37803769|FG000|Overall Study|Lost to Follow-up|4|||
16853473|NCT01854697|37803770|FG001|Overall Study|Lost to Follow-up|1|||
16853474|NCT01854697|37803771|FG002|Overall Study|Lost to Follow-up|1|||
16853475|NCT01854697|37803772|FG003|Overall Study|Lost to Follow-up|2|||
16853476|NCT01854697|37803773|FG004|Overall Study|Lost to Follow-up|0|||
16853477|NCT01854697|37803769|FG000|Overall Study|To enter another AbbVie study|1|||
16853478|NCT01854697|37803770|FG001|Overall Study|To enter another AbbVie study|0|||
16853479|NCT01854697|37803771|FG002|Overall Study|To enter another AbbVie study|0|||
16853480|NCT01854697|37803772|FG003|Overall Study|To enter another AbbVie study|0|||
16853481|NCT01854697|37803773|FG004|Overall Study|To enter another AbbVie study|1|||
16853482|NCT01854697|37803769|FG000|Overall Study|Withdrew Consent|0|||
16853483|NCT01854697|37803770|FG001|Overall Study|Withdrew Consent|1|||
16853484|NCT01854697|37803771|FG002|Overall Study|Withdrew Consent|0|||
16853485|NCT01854697|37803772|FG003|Overall Study|Withdrew Consent|1|||
16853486|NCT01854697|37803773|FG004|Overall Study|Withdrew Consent|0|||
16853487|NCT01854697|37803769|FG000|Overall Study|Other|0|||
16853488|NCT01854697|37803770|FG001|Overall Study|Other|1|||
16853489|NCT01854697|37803771|FG002|Overall Study|Other|1|||
16853490|NCT01854697|37803772|FG003|Overall Study|Other|0|||
16853491|NCT01854697|37803773|FG004|Overall Study|Other|0|||
16853492|NCT01824979|37803785|FG000|Overall Study|Withdrawal by Subject|5|||
16853493|NCT01824979|37803786|FG001|Overall Study|Withdrawal by Subject|0|||
16853494|NCT01824979|37803785|FG000|Overall Study|Physician Decision|2|||
16853495|NCT01824979|37803786|FG001|Overall Study|Physician Decision|0|||
16853496|NCT01824979|37803785|FG000|Overall Study|Protocol Violation|6|||
16853497|NCT01824979|37803786|FG001|Overall Study|Protocol Violation|13|||
16853498|NCT01824823|37803794|FG000|Overall Study|Lack of Efficacy|1|||
16853499|NCT01824823|37803795|FG001|Overall Study|Lack of Efficacy|1|||
16853500|NCT01824823|37803794|FG000|Overall Study|Off-treatment reason not submitted|1|||
16853501|NCT01824823|37803795|FG001|Overall Study|Off-treatment reason not submitted|0|||
16853502|NCT01875367|37803803|FG000|Overall Study|Not complete at least 2 questionaries|4|||
16853503|NCT01875367|37803804|FG001|Overall Study|Not complete at least 2 questionaries|2|||
16853504|NCT01875367|37803803|FG000|Overall Study|Not receive study treatment|1|||
16853505|NCT01875367|37803804|FG001|Overall Study|Not receive study treatment|0|||
16853506|NCT01853839|37803814|FG000|Overall Study|Violated inclusion criteria|2|||
16853507|NCT01853839|37803814|FG000|Overall Study|Not meet ITT population definition|58|||
16853508|NCT01853839|37803814|FG000|Overall Study|End of treatment visit too early|33|||
16853509|NCT01853839|37803814|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
16853510|NCT01874665|37803824|FG000|Overall Study|Adverse Event|6|||
16853511|NCT01874665|37803825|FG001|Overall Study|Adverse Event|2|||
16853512|NCT01874665|37803824|FG000|Overall Study|Withdrawal by Subject|4|||
16853513|NCT01874665|37803825|FG001|Overall Study|Withdrawal by Subject|1|||
16853514|NCT01874665|37803824|FG000|Overall Study|Physician Decision|3|||
16853515|NCT01874665|37803825|FG001|Overall Study|Physician Decision|0|||
16853516|NCT01874665|37803824|FG000|Overall Study|Clinical Progressive Disease|4|||
17027524|NCT00787202|38171848|FG004|Overall Study|Protocol Violation|1|||
17027525|NCT00787202|38171844|FG000|Overall Study|Randomized, not treated|1|||
17027526|NCT00787202|38171845|FG001|Overall Study|Randomized, not treated|0|||
17027527|NCT00787202|38171846|FG002|Overall Study|Randomized, not treated|0|||
17027528|NCT00787202|38171847|FG003|Overall Study|Randomized, not treated|0|||
17027529|NCT00787202|38171848|FG004|Overall Study|Randomized, not treated|0|||
17027530|NCT04033367|38171866|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
17027531|NCT04033367|38171867|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
17027532|NCT04033367|38171866|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
17027533|NCT04033367|38171867|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
17027534|NCT04033367|38171866|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
17027535|NCT04033367|38171867|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
17027536|NCT04033367|38171866|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
17027537|NCT04033367|38171867|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
17027538|NCT00733980|38171879|FG000|Overall Study|Adverse Event|5|||
17027539|NCT00733980|38171880|FG001|Overall Study|Adverse Event|2|||
17027540|NCT00733980|38171879|FG000|Overall Study|Lack of Efficacy|0|||
17027541|NCT00733980|38171880|FG001|Overall Study|Lack of Efficacy|1|||
17027542|NCT00733980|38171879|FG000|Overall Study|Protocol Violation|2|||
17027543|NCT00733980|38171880|FG001|Overall Study|Protocol Violation|1|||
17027544|NCT00733980|38171879|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
17027545|NCT00733980|38171880|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
17027546|NCT00733980|38171879|FG000|Overall Study|Lost to Follow-up|6|||
17027547|NCT00733980|38171880|FG001|Overall Study|Lost to Follow-up|11|||
17027548|NCT00733980|38171879|FG000|Overall Study|Physician Decision|2|||
17027549|NCT00733980|38171880|FG001|Overall Study|Physician Decision|3|||
17027550|NCT00733980|38171879|FG000|Overall Study|Withdrawal by Subject|6|||
17027551|NCT00733980|38171880|FG001|Overall Study|Withdrawal by Subject|2|||
17027552|NCT00806585|38171892|FG000|Overall Study|Study terminated by Sponsor|0|||
17027553|NCT00806585|38171893|FG001|Overall Study|Study terminated by Sponsor|0|||
17027554|NCT00806585|38171894|FG002|Overall Study|Study terminated by Sponsor|1|||
17027555|NCT00806585|38171895|FG003|Overall Study|Study terminated by Sponsor|2|||
17027556|NCT00806585|38171896|FG004|Overall Study|Study terminated by Sponsor|0|||
17027557|NCT00806585|38171892|FG000|Overall Study|Protocol Violation|3|||
17027558|NCT00806585|38171893|FG001|Overall Study|Protocol Violation|1|||
17027559|NCT00806585|38171894|FG002|Overall Study|Protocol Violation|2|||
17027560|NCT00806585|38171895|FG003|Overall Study|Protocol Violation|0|||
17027561|NCT00806585|38171896|FG004|Overall Study|Protocol Violation|0|||
17027562|NCT00806585|38171892|FG000|Overall Study|Physician Decision|0|||
17027563|NCT00806585|38171893|FG001|Overall Study|Physician Decision|2|||
17027564|NCT00806585|38171894|FG002|Overall Study|Physician Decision|3|||
17027565|NCT00806585|38171895|FG003|Overall Study|Physician Decision|0|||
17027566|NCT00806585|38171896|FG004|Overall Study|Physician Decision|1|||
17027567|NCT00806585|38171892|FG000|Overall Study|Lost to Follow-up|2|||
17027568|NCT00806585|38171893|FG001|Overall Study|Lost to Follow-up|1|||
17027569|NCT00806585|38171894|FG002|Overall Study|Lost to Follow-up|2|||
17027570|NCT00806585|38171895|FG003|Overall Study|Lost to Follow-up|2|||
17027571|NCT00806585|38171896|FG004|Overall Study|Lost to Follow-up|5|||
17027572|NCT00806585|38171892|FG000|Overall Study|Lack of Efficacy|1|||
17027573|NCT00806585|38171893|FG001|Overall Study|Lack of Efficacy|0|||
17027574|NCT00806585|38171894|FG002|Overall Study|Lack of Efficacy|0|||
17027575|NCT00806585|38171895|FG003|Overall Study|Lack of Efficacy|0|||
17027576|NCT00806585|38171896|FG004|Overall Study|Lack of Efficacy|0|||
17027577|NCT00806585|38171892|FG000|Overall Study|Adverse Event|1|||
17027578|NCT00806585|38171893|FG001|Overall Study|Adverse Event|5|||
17027579|NCT00806585|38171894|FG002|Overall Study|Adverse Event|3|||
17027580|NCT00806585|38171895|FG003|Overall Study|Adverse Event|4|||
17027581|NCT00806585|38171896|FG004|Overall Study|Adverse Event|2|||
17027582|NCT00806585|38171892|FG000|Overall Study|Withdrawal by Subject|10|||
17027583|NCT00806585|38171893|FG001|Overall Study|Withdrawal by Subject|8|||
17027584|NCT00806585|38171894|FG002|Overall Study|Withdrawal by Subject|9|||
17027585|NCT00806585|38171895|FG003|Overall Study|Withdrawal by Subject|3|||
17027586|NCT00806585|38171896|FG004|Overall Study|Withdrawal by Subject|11|||
17027587|NCT00806585|38171892|FG000|Overall Study|Completion status unknown|15|||
17027588|NCT00806585|38171893|FG001|Overall Study|Completion status unknown|14|||
17027589|NCT00806585|38171894|FG002|Overall Study|Completion status unknown|12|||
17027590|NCT00806585|38171895|FG003|Overall Study|Completion status unknown|4|||
17027591|NCT00806585|38171896|FG004|Overall Study|Completion status unknown|12|||
17027592|NCT00480025|38171910|FG000|Overall Study|Protocol Violation|12|||
17027593|NCT00480025|38171911|FG001|Overall Study|Protocol Violation|7|||
17027594|NCT00480025|38171910|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
17027595|NCT00480025|38171911|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
17027596|NCT00480025|38171910|FG000|Overall Study|Disease Progression / Recurrence|449|||
17027597|NCT00480025|38171911|FG001|Overall Study|Disease Progression / Recurrence|224|||
17027598|NCT00480025|38171910|FG000|Overall Study|Adverse Event|44|||
17027599|NCT00480025|38171911|FG001|Overall Study|Adverse Event|12|||
17027600|NCT00480025|38171910|FG000|Overall Study|Other|70|||
17027601|NCT00480025|38171911|FG001|Overall Study|Other|29|||
17027602|NCT00480025|38171910|FG000|Overall Study|SAE including intercurrent illness|76|||
17027603|NCT00480025|38171911|FG001|Overall Study|SAE including intercurrent illness|42|||
17027604|NCT00806351|38171925|FG000|Overall Study|Death|5|||
17027605|NCT00806351|38171926|FG001|Overall Study|Death|4|||
17027606|NCT00733902|38171936|FG000|Overall Study|Death|0|||
17027607|NCT00733902|38171937|FG001|Overall Study|Death|0|||
17027608|NCT00733902|38171938|FG002|Overall Study|Death|0|||
17027609|NCT00733902|38171939|FG003|Overall Study|Death|1|||
17027610|NCT00733902|38171936|FG000|Overall Study|Adverse Event|3|||
17027611|NCT00733902|38171937|FG001|Overall Study|Adverse Event|4|||
17027612|NCT00733902|38171938|FG002|Overall Study|Adverse Event|7|||
17027613|NCT00733902|38171939|FG003|Overall Study|Adverse Event|11|||
17027614|NCT00733902|38171936|FG000|Overall Study|Lack of Efficacy|56|||
17027615|NCT00733902|38171937|FG001|Overall Study|Lack of Efficacy|21|||
17027616|NCT00733902|38171938|FG002|Overall Study|Lack of Efficacy|34|||
17027617|NCT00733902|38171939|FG003|Overall Study|Lack of Efficacy|23|||
17027618|NCT00733902|38171936|FG000|Overall Study|Protocol Violation|4|||
17027619|NCT00733902|38171937|FG001|Overall Study|Protocol Violation|6|||
17027620|NCT00733902|38171938|FG002|Overall Study|Protocol Violation|3|||
17027621|NCT00733902|38171939|FG003|Overall Study|Protocol Violation|3|||
17027622|NCT00733902|38171936|FG000|Overall Study|Withdrawal by Subject|10|||
17027623|NCT00733902|38171937|FG001|Overall Study|Withdrawal by Subject|5|||
17027624|NCT00733902|38171938|FG002|Overall Study|Withdrawal by Subject|4|||
17027625|NCT00733902|38171939|FG003|Overall Study|Withdrawal by Subject|16|||
17027626|NCT00733902|38171936|FG000|Overall Study|Entered extension study|89|||
17027627|NCT00733902|38171937|FG001|Overall Study|Entered extension study|124|||
17027628|NCT00733902|38171938|FG002|Overall Study|Entered extension study|111|||
17027629|NCT00733902|38171939|FG003|Overall Study|Entered extension study|109|||
17027630|NCT00733902|38171936|FG000|Overall Study|Randomized but not treated|2|||
17027631|NCT00733902|38171937|FG001|Overall Study|Randomized but not treated|2|||
17027632|NCT00733902|38171938|FG002|Overall Study|Randomized but not treated|2|||
17027633|NCT00733902|38171939|FG003|Overall Study|Randomized but not treated|1|||
17027634|NCT00790790|38171952|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
17027635|NCT00790790|38171953|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
17027636|NCT00790790|38171954|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
17027637|NCT00790790|38171952|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
17027638|NCT00790790|38171953|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
17027639|NCT00790790|38171954|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
17027640|NCT00790790|38171952|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
17027641|NCT00790790|38171953|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
17027642|NCT00790790|38171954|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
17027643|NCT00790790|38171952|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
17027644|NCT00790790|38171953|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
17027645|NCT00790790|38171954|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
17027646|NCT00790790|38171952|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
17027647|NCT00790790|38171953|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
17027648|NCT00790790|38171954|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
17027649|NCT00719043|38171974|FG000|Overall Study|Adverse Event|5|||
17027650|NCT00719043|38171975|FG001|Overall Study|Adverse Event|1|||
17027651|NCT00719043|38171976|FG002|Overall Study|Adverse Event|2|||
17027652|NCT00719043|38171977|FG003|Overall Study|Adverse Event|2|||
17027653|NCT00719043|38171978|FG004|Overall Study|Adverse Event|1|||
17027654|NCT00719043|38171979|FG005|Overall Study|Adverse Event|4|||
17027655|NCT00719043|38171980|FG006|Overall Study|Adverse Event|4|||
17027656|NCT00719043|38171974|FG000|Overall Study|Lost to Follow-up|14|||
17027657|NCT00719043|38171975|FG001|Overall Study|Lost to Follow-up|10|||
17103677|NCT00098306|38241880|FG001|Double Blind|Lack of Efficacy|34|||
16935856|NCT01212991|38080599|FG001|Double-blind|Other|0|||
16935857|NCT01212991|38080600|FG002|Double-blind|Other|0|||
16935858|NCT01212991|38080598|FG000|Double-blind|Sponsor decision|142|||
16935859|NCT01212991|38080599|FG001|Double-blind|Sponsor decision|38|||
16935860|NCT01212991|38080600|FG002|Double-blind|Sponsor decision|0|||
16935861|NCT01212991|38080598|FG000|Open-label|Death|0|||
16935862|NCT01212991|38080599|FG001|Open-label|Death|0|||
16935863|NCT01212991|38080600|FG002|Open-label|Death|166|||
16935864|NCT01212991|38080598|FG000|Open-label|Lost to Follow-up|0|||
16935865|NCT01212991|38080599|FG001|Open-label|Lost to Follow-up|0|||
16935866|NCT01212991|38080600|FG002|Open-label|Lost to Follow-up|5|||
16935867|NCT01212991|38080598|FG000|Open-label|Withdrawal by Subject|0|||
16935868|NCT01212991|38080599|FG001|Open-label|Withdrawal by Subject|0|||
16935869|NCT01212991|38080600|FG002|Open-label|Withdrawal by Subject|7|||
16935870|NCT01212991|38080598|FG000|Open-label|Sponsor decision|0|||
17027658|NCT00719043|38171976|FG002|Overall Study|Lost to Follow-up|8|||
17027659|NCT00719043|38171977|FG003|Overall Study|Lost to Follow-up|9|||
17027660|NCT00719043|38171978|FG004|Overall Study|Lost to Follow-up|10|||
17027661|NCT00719043|38171979|FG005|Overall Study|Lost to Follow-up|9|||
16935871|NCT01212991|38080599|FG001|Open-label|Sponsor decision|0|||
16935872|NCT01212991|38080600|FG002|Open-label|Sponsor decision|53|||
17027662|NCT00719043|38171980|FG006|Overall Study|Lost to Follow-up|9|||
17027663|NCT00719043|38171974|FG000|Overall Study|Protocol Violation|0|||
17027664|NCT00719043|38171975|FG001|Overall Study|Protocol Violation|0|||
17027665|NCT00719043|38171976|FG002|Overall Study|Protocol Violation|0|||
17027666|NCT00719043|38171977|FG003|Overall Study|Protocol Violation|0|||
17027667|NCT00719043|38171978|FG004|Overall Study|Protocol Violation|0|||
17027668|NCT00719043|38171979|FG005|Overall Study|Protocol Violation|1|||
17027669|NCT00719043|38171980|FG006|Overall Study|Protocol Violation|0|||
17027670|NCT00719043|38171974|FG000|Overall Study|Other|1|||
17027671|NCT00719043|38171975|FG001|Overall Study|Other|0|||
17027672|NCT00719043|38171976|FG002|Overall Study|Other|1|||
17027673|NCT00719043|38171977|FG003|Overall Study|Other|2|||
17027674|NCT00719043|38171978|FG004|Overall Study|Other|0|||
17027675|NCT00719043|38171979|FG005|Overall Study|Other|2|||
17027676|NCT00719043|38171980|FG006|Overall Study|Other|1|||
17027677|NCT00719043|38171974|FG000|Overall Study|Withdrawal by Subject|12|||
17027678|NCT00719043|38171975|FG001|Overall Study|Withdrawal by Subject|14|||
16853517|NCT01874665|37803825|FG001|Overall Study|Clinical Progressive Disease|3|||
16853518|NCT01874665|37803824|FG000|Overall Study|Study Terminated by Sponsor|0|||
16853519|NCT01874665|37803825|FG001|Overall Study|Study Terminated by Sponsor|2|||
16853520|NCT01874665|37803824|FG000|Overall Study|Documented Progressive Disease|11|||
16853521|NCT01874665|37803825|FG001|Overall Study|Documented Progressive Disease|7|||
16853522|NCT01874665|37803824|FG000|Overall Study|Other|2|||
16853523|NCT01874665|37803825|FG001|Overall Study|Other|0|||
16853524|NCT01874431|37803840|FG000|Overall Study|Physician Decision|0|||
16853525|NCT01874431|37803841|FG001|Overall Study|Physician Decision|0|||
16853526|NCT01874431|37803842|FG002|Overall Study|Physician Decision|1|||
16853527|NCT01874431|37803843|FG003|Overall Study|Physician Decision|0|||
16853528|NCT01874431|37803844|FG004|Overall Study|Physician Decision|0|||
16853529|NCT01874431|37803845|FG005|Overall Study|Physician Decision|0|||
16853530|NCT01874431|37803846|FG006|Overall Study|Physician Decision|0|||
16853531|NCT01874431|37803847|FG007|Overall Study|Physician Decision|0|||
16853532|NCT01874431|37803840|FG000|Overall Study|Adverse Event|5|||
16853533|NCT01874431|37803841|FG001|Overall Study|Adverse Event|4|||
16853534|NCT01874431|37803842|FG002|Overall Study|Adverse Event|6|||
16853535|NCT01874431|37803843|FG003|Overall Study|Adverse Event|5|||
16853536|NCT01874431|37803844|FG004|Overall Study|Adverse Event|2|||
16853537|NCT01874431|37803845|FG005|Overall Study|Adverse Event|8|||
16853538|NCT01874431|37803846|FG006|Overall Study|Adverse Event|2|||
16853539|NCT01874431|37803847|FG007|Overall Study|Adverse Event|3|||
16853540|NCT01874431|37803840|FG000|Overall Study|Protocol Violation|1|||
16853541|NCT01874431|37803841|FG001|Overall Study|Protocol Violation|1|||
16853542|NCT01874431|37803842|FG002|Overall Study|Protocol Violation|1|||
16853543|NCT01874431|37803843|FG003|Overall Study|Protocol Violation|0|||
16853544|NCT01874431|37803844|FG004|Overall Study|Protocol Violation|3|||
16853545|NCT01874431|37803845|FG005|Overall Study|Protocol Violation|2|||
16853546|NCT01874431|37803846|FG006|Overall Study|Protocol Violation|1|||
16853547|NCT01874431|37803847|FG007|Overall Study|Protocol Violation|1|||
16853548|NCT01874431|37803840|FG000|Overall Study|Non-compliance|0|||
16853549|NCT01874431|37803841|FG001|Overall Study|Non-compliance|0|||
16853550|NCT01874431|37803842|FG002|Overall Study|Non-compliance|0|||
16853551|NCT01874431|37803843|FG003|Overall Study|Non-compliance|0|||
16853552|NCT01874431|37803844|FG004|Overall Study|Non-compliance|1|||
16853553|NCT01874431|37803845|FG005|Overall Study|Non-compliance|0|||
16853554|NCT01874431|37803846|FG006|Overall Study|Non-compliance|1|||
16853555|NCT01874431|37803847|FG007|Overall Study|Non-compliance|0|||
16853556|NCT01874431|37803840|FG000|Overall Study|Logistical difficulties|0|||
16853557|NCT01874431|37803841|FG001|Overall Study|Logistical difficulties|0|||
16853558|NCT01874431|37803842|FG002|Overall Study|Logistical difficulties|0|||
16853559|NCT01874431|37803843|FG003|Overall Study|Logistical difficulties|0|||
16853560|NCT01874431|37803844|FG004|Overall Study|Logistical difficulties|0|||
16853561|NCT01874431|37803845|FG005|Overall Study|Logistical difficulties|0|||
16853562|NCT01874431|37803846|FG006|Overall Study|Logistical difficulties|1|||
16853563|NCT01874431|37803847|FG007|Overall Study|Logistical difficulties|0|||
16853564|NCT01874431|37803840|FG000|Overall Study|Withdrawal by Subject|0|||
16853565|NCT01874431|37803841|FG001|Overall Study|Withdrawal by Subject|0|||
16853566|NCT01874431|37803842|FG002|Overall Study|Withdrawal by Subject|1|||
16853567|NCT01874431|37803843|FG003|Overall Study|Withdrawal by Subject|2|||
16853568|NCT01874431|37803844|FG004|Overall Study|Withdrawal by Subject|1|||
16853569|NCT01874431|37803845|FG005|Overall Study|Withdrawal by Subject|1|||
16853570|NCT01874431|37803846|FG006|Overall Study|Withdrawal by Subject|3|||
16853571|NCT01874431|37803847|FG007|Overall Study|Withdrawal by Subject|0|||
16853572|NCT01874431|37803840|FG000|Overall Study|Sponsor decision|0|||
16853573|NCT01874431|37803841|FG001|Overall Study|Sponsor decision|0|||
16853574|NCT01874431|37803842|FG002|Overall Study|Sponsor decision|0|||
16853575|NCT01874431|37803843|FG003|Overall Study|Sponsor decision|0|||
16853576|NCT01874431|37803844|FG004|Overall Study|Sponsor decision|1|||
16853577|NCT01874431|37803845|FG005|Overall Study|Sponsor decision|0|||
16853578|NCT01874431|37803846|FG006|Overall Study|Sponsor decision|0|||
17027679|NCT00719043|38171976|FG002|Overall Study|Withdrawal by Subject|9|||
16853579|NCT01874431|37803847|FG007|Overall Study|Sponsor decision|0|||
16853580|NCT01874431|37803840|FG000|Overall Study|Lost to Follow-up|0|||
17027680|NCT00719043|38171977|FG003|Overall Study|Withdrawal by Subject|10|||
17027681|NCT00719043|38171978|FG004|Overall Study|Withdrawal by Subject|16|||
17027682|NCT00719043|38171979|FG005|Overall Study|Withdrawal by Subject|18|||
17027683|NCT00719043|38171980|FG006|Overall Study|Withdrawal by Subject|14|||
17027684|NCT00786422|38172008|FG000|Rivaroxaban Treatment|Death|2|||
17027685|NCT00786422|38172008|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
17027686|NCT00786422|38172008|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
17027687|NCT00786422|38172008|FG000|Rivaroxaban Treatment|Physician Decision|1|||
17027688|NCT00786422|38172008|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
17027689|NCT00786422|38172008|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
17027690|NCT00786422|38172008|FG000|Rivaroxaban Treatment|Adverse Event|2|||
17027691|NCT00786422|38172008|FG000|Follow-up Period|Death|1|||
17027692|NCT00786422|38172008|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
17027693|NCT00718887|38172016|FG000|Overall Study|Withdrawal by Subject|3|||
17027694|NCT00718887|38172017|FG001|Overall Study|Withdrawal by Subject|2|||
17027695|NCT00718887|38172016|FG000|Overall Study|Not identified|2|||
17027696|NCT00718887|38172017|FG001|Overall Study|Not identified|7|||
17027697|NCT00786188|38172031|FG000|Overall Study|Adverse Event|3|||
17027698|NCT00786188|38172032|FG001|Overall Study|Adverse Event|1|||
17027699|NCT00786188|38172031|FG000|Overall Study|Withdrawal by Subject|2|||
17027700|NCT00786188|38172032|FG001|Overall Study|Withdrawal by Subject|0|||
16853581|NCT01874431|37803841|FG001|Overall Study|Lost to Follow-up|0|||
17027701|NCT00790556|38172040|FG000|Treatment Period 1|Physician Decision|1|||
17027702|NCT00790556|38172041|FG001|Treatment Period 1|Physician Decision|0|||
17027703|NCT00790556|38172040|FG000|Treatment Period 1|Withdrawal by Subject|1|||
17027704|NCT00790556|38172041|FG001|Treatment Period 1|Withdrawal by Subject|0|||
17027705|NCT00733824|38172052|FG000|Phase I|Withdrawal by Subject|1|||
17027706|NCT00733824|38172053|FG001|Phase I|Withdrawal by Subject|0|||
17027707|NCT00733824|38172054|FG002|Phase I|Withdrawal by Subject|0|||
17027708|NCT00733824|38172055|FG003|Phase I|Withdrawal by Subject|0|||
17027709|NCT00733824|38172056|FG004|Phase I|Withdrawal by Subject|0|||
17027710|NCT00718809|38172072|FG000|Overall Study|Disease progression|9|||
17027711|NCT00718809|38172073|FG001|Overall Study|Disease progression|7|||
17027712|NCT00718809|38172072|FG000|Overall Study|Adverse Event|1|||
17027713|NCT00718809|38172073|FG001|Overall Study|Adverse Event|1|||
17027714|NCT00718809|38172072|FG000|Overall Study|Withdrawal by Subject|0|||
17027715|NCT00718809|38172073|FG001|Overall Study|Withdrawal by Subject|1|||
17027716|NCT00718809|38172072|FG000|Overall Study|Lost to Follow-up|1|||
17027717|NCT00718809|38172073|FG001|Overall Study|Lost to Follow-up|0|||
17027718|NCT00718809|38172072|FG000|Overall Study|Noncompliance|1|||
17027719|NCT00718809|38172073|FG001|Overall Study|Noncompliance|0|||
17027720|NCT00585039|38172081|FG000|Overall Study|medication spilled|2|||
17027721|NCT00585039|38172082|FG001|Overall Study|medication spilled|0|||
17027722|NCT00806195|38172094|FG000|Overall Study|Death|6|||
17027723|NCT00806195|38172095|FG001|Overall Study|Death|0|||
17027724|NCT00806195|38172096|FG002|Overall Study|Death|1|||
17027725|NCT00806195|38172097|FG003|Overall Study|Death|0|||
17027726|NCT00806195|38172094|FG000|Overall Study|Adverse Event|25|||
17027727|NCT00806195|38172095|FG001|Overall Study|Adverse Event|5|||
17027728|NCT00806195|38172096|FG002|Overall Study|Adverse Event|11|||
17027729|NCT00806195|38172097|FG003|Overall Study|Adverse Event|2|||
17027730|NCT00806195|38172094|FG000|Overall Study|Withdrawal by Subject|119|||
17027731|NCT00806195|38172095|FG001|Overall Study|Withdrawal by Subject|31|||
17027732|NCT00806195|38172096|FG002|Overall Study|Withdrawal by Subject|76|||
17027733|NCT00806195|38172097|FG003|Overall Study|Withdrawal by Subject|35|||
17027734|NCT00806195|38172094|FG000|Overall Study|Lost to Follow-up|217|||
17027735|NCT00806195|38172095|FG001|Overall Study|Lost to Follow-up|66|||
17027736|NCT00806195|38172096|FG002|Overall Study|Lost to Follow-up|90|||
17027737|NCT00806195|38172097|FG003|Overall Study|Lost to Follow-up|34|||
17027738|NCT00806195|38172094|FG000|Overall Study|Inappropriate Enrollment|0|||
17027739|NCT00806195|38172095|FG001|Overall Study|Inappropriate Enrollment|1|||
17027740|NCT00806195|38172096|FG002|Overall Study|Inappropriate Enrollment|0|||
17027741|NCT00806195|38172097|FG003|Overall Study|Inappropriate Enrollment|0|||
17027742|NCT00806195|38172094|FG000|Overall Study|Administrative Reason|113|||
17027743|NCT00806195|38172095|FG001|Overall Study|Administrative Reason|35|||
17027744|NCT00806195|38172096|FG002|Overall Study|Administrative Reason|66|||
17027745|NCT00806195|38172097|FG003|Overall Study|Administrative Reason|26|||
17027746|NCT00806195|38172094|FG000|Overall Study|Protocol Violation|34|||
17027747|NCT00806195|38172095|FG001|Overall Study|Protocol Violation|24|||
17027748|NCT00806195|38172096|FG002|Overall Study|Protocol Violation|26|||
17027749|NCT00806195|38172097|FG003|Overall Study|Protocol Violation|9|||
17027750|NCT00733746|38172109|FG000|Overall Study|Ineligible|5|||
17027751|NCT00718419|38172115|FG000|Overall Study|Adverse Event|2|||
17027752|NCT00718419|38172116|FG001|Overall Study|Adverse Event|1|||
17027753|NCT00718419|38172115|FG000|Overall Study|Physician Decision|1|||
17027754|NCT00718419|38172116|FG001|Overall Study|Physician Decision|6|||
17027755|NCT00718419|38172115|FG000|Overall Study|Sponsor decision|0|||
17027756|NCT00718419|38172116|FG001|Overall Study|Sponsor decision|1|||
17027757|NCT00718419|38172115|FG000|Overall Study|Withdrawal by Subject|0|||
17027758|NCT00718419|38172116|FG001|Overall Study|Withdrawal by Subject|5|||
17027759|NCT00718419|38172115|FG000|Overall Study|Progressive Disease|7|||
17027760|NCT00718419|38172116|FG001|Overall Study|Progressive Disease|25|||
17027761|NCT00718419|38172115|FG000|Overall Study|Death Due to Progressive Disease|2|||
17027762|NCT00718419|38172116|FG001|Overall Study|Death Due to Progressive Disease|0|||
17027763|NCT00718419|38172115|FG000|Overall Study|Death Due to Study Drug Related|0|||
17027764|NCT00718419|38172116|FG001|Overall Study|Death Due to Study Drug Related|1|||
17027765|NCT00718419|38172115|FG000|Overall Study|Death Due to Adverse Events|1|||
17027766|NCT00718419|38172116|FG001|Overall Study|Death Due to Adverse Events|0|||
17027767|NCT00717249|38172124|FG000|Overall Study|Lens Discomfort|4|||
17027768|NCT00717249|38172125|FG001|Overall Study|Lens Discomfort|1|||
17027769|NCT00717249|38172124|FG000|Overall Study|Unsatisfactory visual Response|0|||
17027770|NCT00717249|38172125|FG001|Overall Study|Unsatisfactory visual Response|2|||
17027771|NCT00717249|38172124|FG000|Overall Study|Adverse Event|4|||
17027772|NCT00717249|38172125|FG001|Overall Study|Adverse Event|2|||
17027773|NCT00717249|38172124|FG000|Overall Study|Lost to Follow-up|2|||
17027774|NCT00717249|38172125|FG001|Overall Study|Lost to Follow-up|0|||
17027775|NCT00717249|38172124|FG000|Overall Study|Withdrawal by Subject|1|||
17027776|NCT00717249|38172125|FG001|Overall Study|Withdrawal by Subject|2|||
17027777|NCT00717249|38172124|FG000|Overall Study|Pregnancy|6|||
17027778|NCT00717249|38172125|FG001|Overall Study|Pregnancy|3|||
17027779|NCT00717249|38172124|FG000|Overall Study|Protocol Violation|0|||
17027780|NCT00717249|38172125|FG001|Overall Study|Protocol Violation|2|||
17027781|NCT00717249|38172124|FG000|Overall Study|Subject became Ineligible|1|||
17027782|NCT00717249|38172125|FG001|Overall Study|Subject became Ineligible|1|||
17027783|NCT00717249|38172124|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
17027784|NCT00717249|38172125|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
17027785|NCT00717249|38172124|FG000|Overall Study|Gastric Surgery|0|||
17027786|NCT00717249|38172125|FG001|Overall Study|Gastric Surgery|1|||
17027787|NCT00717249|38172124|FG000|Overall Study|Diagnosed with Diabetes|1|||
17027788|NCT00717249|38172125|FG001|Overall Study|Diagnosed with Diabetes|0|||
17027789|NCT00717249|38172124|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
17027790|NCT00717249|38172125|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
17027791|NCT00717249|38172124|FG000|Overall Study|Subject relocated|1|||
17027792|NCT00717249|38172125|FG001|Overall Study|Subject relocated|0|||
17027793|NCT00717249|38172124|FG000|Overall Study|Headaches|1|||
17027794|NCT00717249|38172125|FG001|Overall Study|Headaches|0|||
17198751|NCT02705625|38352471|FG000|Overall Study|Withdrawal by Subject|1|||
17198752|NCT02705625|38352472|FG001|Overall Study|Withdrawal by Subject|4|||
17198753|NCT02705625|38352473|FG002|Overall Study|Withdrawal by Subject|5|||
17198754|NCT02705625|38352471|FG000|Overall Study|Lost to Follow-up|0|||
17198755|NCT02705625|38352472|FG001|Overall Study|Lost to Follow-up|0|||
17198756|NCT02705625|38352473|FG002|Overall Study|Lost to Follow-up|1|||
17198757|NCT02705625|38352471|FG000|Overall Study|Non-compliance|0|||
17198758|NCT02705625|38352472|FG001|Overall Study|Non-compliance|1|||
17198759|NCT02705625|38352473|FG002|Overall Study|Non-compliance|1|||
17198760|NCT02705625|38352471|FG000|Overall Study|Overdosing|0|||
17198761|NCT02705625|38352472|FG001|Overall Study|Overdosing|0|||
17198762|NCT02705625|38352473|FG002|Overall Study|Overdosing|1|||
17198763|NCT02588612|38352481|FG000|Overall Study|Physician Decision|1|||
17198764|NCT02588612|38352481|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
17198765|NCT02588612|38352481|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
17198766|NCT02588612|38352481|FG000|Overall Study|Death prior to T-cell infusion|1|||
17198767|NCT02704689|38352498|FG000|Overall Study|Physician Decision|1|||
17198768|NCT02704689|38352498|FG000|Overall Study|Study device not implanted|2|||
17198769|NCT02704143|38352502|FG000|Overall Study|disease progression|10|||
17198770|NCT02586506|38352506|FG000|Overall Study|Protocol Violation|6|||
17198771|NCT02586506|38352506|FG000|Overall Study|Lost to Follow-up|1|||
17198772|NCT02586506|38352506|FG000|Overall Study|Other Reason|2|||
17198773|NCT00109031|38352514|FG000|Overall Study|Adverse Event|0|||
17198774|NCT00109031|38352515|FG001|Overall Study|Adverse Event|0|||
17198775|NCT00109031|38352516|FG002|Overall Study|Adverse Event|1|||
17198776|NCT00109031|38352517|FG003|Overall Study|Adverse Event|0|||
17198777|NCT00109031|38352514|FG000|Overall Study|Withdrawal by Subject|0|||
17198778|NCT00109031|38352515|FG001|Overall Study|Withdrawal by Subject|1|||
17198779|NCT00109031|38352516|FG002|Overall Study|Withdrawal by Subject|0|||
17198780|NCT00109031|38352517|FG003|Overall Study|Withdrawal by Subject|0|||
17198781|NCT00109031|38352514|FG000|Overall Study|Physician Decision|0|||
17198782|NCT00109031|38352515|FG001|Overall Study|Physician Decision|1|||
17198783|NCT00109031|38352516|FG002|Overall Study|Physician Decision|0|||
17027795|NCT00727194|38172131|FG000|Screening Period|Low QMG scores|0|||
17027796|NCT00727194|38172132|FG001|Screening Period|Low QMG scores|0|||
17027797|NCT00727194|38172133|FG002|Screening Period|Low QMG scores|6|||
17027798|NCT00727194|38172131|FG000|Screening Period|Lacked AChR antibodies|0|||
17198784|NCT00109031|38352517|FG003|Overall Study|Physician Decision|0|||
17027799|NCT00727194|38172132|FG001|Screening Period|Lacked AChR antibodies|0|||
17027800|NCT00727194|38172133|FG002|Screening Period|Lacked AChR antibodies|5|||
17027801|NCT00727194|38172131|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
17027802|NCT00727194|38172132|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
17027803|NCT00727194|38172133|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
17027804|NCT00727194|38172131|FG000|Screening Period|Severe infections|0|||
17027805|NCT00727194|38172132|FG001|Screening Period|Severe infections|0|||
17027806|NCT00727194|38172133|FG002|Screening Period|Severe infections|2|||
17027807|NCT00727194|38172131|FG000|Screening Period|History of thymoma|0|||
17027808|NCT00727194|38172132|FG001|Screening Period|History of thymoma|0|||
17027809|NCT00727194|38172133|FG002|Screening Period|History of thymoma|1|||
17027810|NCT00727194|38172131|FG000|Treatment Period 2|Lack of Efficacy|0|||
17027811|NCT00727194|38172132|FG001|Treatment Period 2|Lack of Efficacy|1|||
17027812|NCT00727194|38172133|FG002|Treatment Period 2|Lack of Efficacy|0|||
17027813|NCT00717093|38172149|FG000|Overall Study|Adverse Event|19|||
17027814|NCT00717093|38172150|FG001|Overall Study|Adverse Event|9|||
17027815|NCT00717093|38172149|FG000|Overall Study|Lack of Efficacy|3|||
17027816|NCT00717093|38172150|FG001|Overall Study|Lack of Efficacy|13|||
17027817|NCT00717093|38172149|FG000|Overall Study|Lost to Follow-up|9|||
17027818|NCT00717093|38172150|FG001|Overall Study|Lost to Follow-up|6|||
17027819|NCT00717093|38172149|FG000|Overall Study|Withdrawal by Subject|12|||
17027820|NCT00717093|38172150|FG001|Overall Study|Withdrawal by Subject|19|||
17027821|NCT00717093|38172149|FG000|Overall Study|Other|0|||
17027822|NCT00717093|38172150|FG001|Overall Study|Other|1|||
17027823|NCT00717093|38172149|FG000|Overall Study|Randomized but not treated|1|||
17027824|NCT00717093|38172150|FG001|Overall Study|Randomized but not treated|0|||
17027825|NCT00716859|38172158|FG000|Overall Study|Adverse Event|4|||
17027826|NCT00716859|38172159|FG001|Overall Study|Adverse Event|1|||
17027827|NCT00716859|38172158|FG000|Overall Study|Lack of Efficacy|3|||
17027828|NCT00716859|38172159|FG001|Overall Study|Lack of Efficacy|0|||
17027829|NCT00716859|38172158|FG000|Overall Study|Withdrawal by Subject|1|||
17027830|NCT00716859|38172159|FG001|Overall Study|Withdrawal by Subject|3|||
17027831|NCT00716859|38172158|FG000|Overall Study|Not treated|1|||
17027832|NCT00716859|38172159|FG001|Overall Study|Not treated|1|||
17027833|NCT00589121|38172167|FG000|Overall Study|Protocol Violation|2|||
17027834|NCT00589121|38172168|FG001|Overall Study|Protocol Violation|6|||
17027835|NCT00589121|38172167|FG000|Overall Study|No protocol treatment received|0|||
17027836|NCT00589121|38172168|FG001|Overall Study|No protocol treatment received|1|||
17027837|NCT00590135|38172177|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
17027838|NCT00589667|38172182|FG000|Overall Study|Adverse Event|2|||
17027839|NCT00589667|38172182|FG000|Overall Study|Withdrawal by Subject|1|||
17027840|NCT00737568|38172188|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
17027841|NCT00737568|38172189|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
17027842|NCT00737568|38172188|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
17027843|NCT00737568|38172189|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
17027844|NCT00737568|38172188|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
17027845|NCT00737568|38172189|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
17027846|NCT00737568|38172188|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
17027847|NCT00737568|38172189|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
17027848|NCT00737568|38172188|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
17027849|NCT00737568|38172189|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
17027850|NCT00737568|38172188|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
17027851|NCT00737568|38172189|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
17027852|NCT00737568|38172188|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
17027853|NCT00737568|38172189|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
17027854|NCT00737568|38172188|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
17027855|NCT00737568|38172189|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
17027856|NCT00737568|38172188|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
17027857|NCT00737568|38172189|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
17027858|NCT00737100|38172198|FG000|Overall Study|Adverse Event|6|||
17027859|NCT00737100|38172199|FG001|Overall Study|Adverse Event|5|||
17027860|NCT00737100|38172200|FG002|Overall Study|Adverse Event|3|||
17027861|NCT00737100|38172198|FG000|Overall Study|Lost to Follow-up|0|||
17027862|NCT00737100|38172199|FG001|Overall Study|Lost to Follow-up|1|||
17027863|NCT00737100|38172200|FG002|Overall Study|Lost to Follow-up|0|||
17027864|NCT00737100|38172198|FG000|Overall Study|Withdrawal by Subject|0|||
17027865|NCT00737100|38172199|FG001|Overall Study|Withdrawal by Subject|0|||
17027866|NCT00737100|38172200|FG002|Overall Study|Withdrawal by Subject|3|||
17027867|NCT00737100|38172198|FG000|Overall Study|Reason discontinued not explained above|1|||
17027868|NCT00737100|38172199|FG001|Overall Study|Reason discontinued not explained above|1|||
17027869|NCT00737100|38172200|FG002|Overall Study|Reason discontinued not explained above|1|||
17027870|NCT00732498|38172210|FG000|Overall Study|Ineligible|1|||
17027871|NCT00732498|38172210|FG000|Overall Study|Adverse Event|2|||
17027872|NCT00732498|38172210|FG000|Overall Study|Physician Decision|3|||
17027873|NCT00726882|38172214|FG000|Overall Study|Withdrawal by Subject|5|||
17027874|NCT00726882|38172214|FG000|Overall Study|Lost to Follow-up|7|||
17027875|NCT00726882|38172214|FG000|Overall Study|Other|10|||
17027876|NCT00790400|38172222|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
17027877|NCT00790400|38172223|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
17027878|NCT00790400|38172222|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
17027879|NCT00790400|38172223|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
17027880|NCT00790400|38172222|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
17027881|NCT00790400|38172223|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
17027882|NCT00790400|38172222|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
17027883|NCT00790400|38172223|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
17027884|NCT00790400|38172222|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
17027885|NCT00790400|38172223|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
17027886|NCT00790400|38172222|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
17027887|NCT00790400|38172223|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
17027888|NCT00790400|38172222|FG000|Double-blind Period (Core Phase)|Death|1|||
17027889|NCT00790400|38172223|FG001|Double-blind Period (Core Phase)|Death|0|||
17027890|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
17027891|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
17027892|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
17027893|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
17027894|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
17027895|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
17027896|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
17027897|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
17027898|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
17027899|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
17027900|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|Death|1|||
17027901|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|Death|0|||
17027902|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
17027903|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
17027904|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
17027905|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
17027906|NCT00790400|38172222|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
17027907|NCT00790400|38172223|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
17027908|NCT00786032|38172232|FG000|Overall Study|Death|4|||
17027909|NCT00786032|38172232|FG000|Overall Study|Withdrawal by Subject|14|||
17027910|NCT00786032|38172232|FG000|Overall Study|Did not complete in the timeframe|6|||
17027911|NCT00716625|38172238|FG000|Overall Study|Safety was not Assessable|1|||
17027912|NCT00785486|38172256|FG000|Midazolam Alone|Withdrawal by Subject|1|||
17027913|NCT00589979|38172279|FG000|Run-In Period|Adverse Event|5|||
17027914|NCT00589979|38172280|FG001|Run-In Period|Adverse Event|0|||
17027915|NCT00589979|38172281|FG002|Run-In Period|Adverse Event|0|||
17027916|NCT00589979|38172279|FG000|Run-In Period|Protocol Violation|3|||
17027917|NCT00589979|38172280|FG001|Run-In Period|Protocol Violation|0|||
17027918|NCT00589979|38172281|FG002|Run-In Period|Protocol Violation|0|||
17027919|NCT00589979|38172279|FG000|Run-In Period|Did not qualify for randomization|54|||
17027920|NCT00589979|38172280|FG001|Run-In Period|Did not qualify for randomization|0|||
17027921|NCT00589979|38172281|FG002|Run-In Period|Did not qualify for randomization|0|||
17027922|NCT00589979|38172279|FG000|Run-In Period|Withdrawal by Subject|10|||
17027923|NCT00589979|38172280|FG001|Run-In Period|Withdrawal by Subject|0|||
17027924|NCT00589979|38172281|FG002|Run-In Period|Withdrawal by Subject|0|||
17027925|NCT00589979|38172279|FG000|Run-In Period|Informed Consent Withdrawn|4|||
17027926|NCT00589979|38172280|FG001|Run-In Period|Informed Consent Withdrawn|0|||
17027927|NCT00589979|38172281|FG002|Run-In Period|Informed Consent Withdrawn|0|||
17027928|NCT00589979|38172279|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
17027929|NCT00589979|38172280|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
17027930|NCT00589979|38172281|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
17027931|NCT00589979|38172279|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
17027932|NCT00589979|38172280|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
17027933|NCT00589979|38172281|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
17027934|NCT00589979|38172279|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
17027935|NCT00589979|38172280|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
17027936|NCT00589979|38172281|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
17027937|NCT00589979|38172279|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
17027938|NCT00589979|38172280|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
17027939|NCT00589979|38172281|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
17027940|NCT00589979|38172279|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
17027941|NCT00589979|38172280|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
17027942|NCT00589979|38172281|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
17027943|NCT00589979|38172279|FG000|Double-Blind Treatment Period 2|Other|0|||
17027944|NCT00589979|38172280|FG001|Double-Blind Treatment Period 2|Other|0|||
17027945|NCT00589979|38172281|FG002|Double-Blind Treatment Period 2|Other|1|||
17027946|NCT00589979|38172279|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
17027947|NCT00589979|38172280|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
17027948|NCT00589979|38172281|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
17027949|NCT00589979|38172279|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
17027950|NCT00589979|38172280|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
17027951|NCT00589979|38172281|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
17027952|NCT00797732|38172295|FG000|Overall Study|Withdrawal by Subject|3|||
17027953|NCT00797732|38172296|FG001|Overall Study|Withdrawal by Subject|3|||
17027954|NCT00797732|38172297|FG002|Overall Study|Withdrawal by Subject|0|||
17027955|NCT00797732|38172295|FG000|Overall Study|Lost to Follow-up|1|||
17027956|NCT00797732|38172296|FG001|Overall Study|Lost to Follow-up|0|||
17027957|NCT00797732|38172297|FG002|Overall Study|Lost to Follow-up|0|||
17027958|NCT00797732|38172295|FG000|Overall Study|Death|1|||
17027959|NCT00797732|38172296|FG001|Overall Study|Death|0|||
17027960|NCT00797732|38172297|FG002|Overall Study|Death|0|||
17027961|NCT00797732|38172295|FG000|Overall Study|Not meet inclusion criteria|0|||
17027962|NCT00797732|38172296|FG001|Overall Study|Not meet inclusion criteria|0|||
17027963|NCT00797732|38172297|FG002|Overall Study|Not meet inclusion criteria|7|||
17027964|NCT00797732|38172295|FG000|Overall Study|Excluded due to time constraints|0|||
17027965|NCT00797732|38172296|FG001|Overall Study|Excluded due to time constraints|0|||
17027966|NCT00797732|38172297|FG002|Overall Study|Excluded due to time constraints|24|||
17027967|NCT00797732|38172295|FG000|Overall Study|Refused to Participate|0|||
17027968|NCT00797732|38172296|FG001|Overall Study|Refused to Participate|0|||
17027969|NCT00797732|38172297|FG002|Overall Study|Refused to Participate|123|||
17027970|NCT00790088|38172303|FG000|Overall Study|Protocol Violation|11|||
17027971|NCT00790088|38172303|FG000|Overall Study|Withdrawal by Subject|17|||
17027972|NCT00790088|38172303|FG000|Overall Study|Lost to Follow-up|7|||
17027973|NCT00790088|38172303|FG000|Overall Study|Physician Decision|4|||
17027974|NCT00736944|38172309|FG000|Induction|Death|1|||
17027975|NCT00736944|38172309|FG000|Definitive Treatment|Physician Decision|1|||
17103678|NCT00098306|38241881|FG002|Double Blind|Lack of Efficacy|17|||
17103679|NCT00098306|38241882|FG003|Double Blind|Lack of Efficacy|0|||
17103680|NCT00098306|38241883|FG004|Double Blind|Lack of Efficacy|0|||
17103681|NCT00098306|38241884|FG005|Double Blind|Lack of Efficacy|0|||
17103682|NCT00098306|38241885|FG006|Double Blind|Lack of Efficacy|0|||
17103683|NCT00098306|38241879|FG000|Double Blind|Death|1|||
17103684|NCT00098306|38241880|FG001|Double Blind|Death|4|||
17103685|NCT00098306|38241881|FG002|Double Blind|Death|1|||
17103686|NCT00098306|38241882|FG003|Double Blind|Death|0|||
17103687|NCT00098306|38241883|FG004|Double Blind|Death|0|||
17103688|NCT00098306|38241884|FG005|Double Blind|Death|0|||
17103689|NCT00098306|38241885|FG006|Double Blind|Death|0|||
17103690|NCT00098306|38241879|FG000|Double Blind|Participant defaulted|19|||
17103691|NCT00098306|38241880|FG001|Double Blind|Participant defaulted|18|||
17103692|NCT00098306|38241881|FG002|Double Blind|Participant defaulted|11|||
17103693|NCT00098306|38241882|FG003|Double Blind|Participant defaulted|0|||
17103694|NCT00098306|38241883|FG004|Double Blind|Participant defaulted|0|||
17103695|NCT00098306|38241884|FG005|Double Blind|Participant defaulted|0|||
17103696|NCT00098306|38241885|FG006|Double Blind|Participant defaulted|0|||
17103697|NCT00098306|38241879|FG000|Double Blind|Un-specified|7|||
17103698|NCT00098306|38241880|FG001|Double Blind|Un-specified|3|||
17103699|NCT00098306|38241881|FG002|Double Blind|Un-specified|11|||
17103700|NCT00098306|38241882|FG003|Double Blind|Un-specified|0|||
17103701|NCT00098306|38241883|FG004|Double Blind|Un-specified|0|||
17103702|NCT00098306|38241884|FG005|Double Blind|Un-specified|0|||
17103703|NCT00098306|38241885|FG006|Double Blind|Un-specified|0|||
17103704|NCT00098306|38241879|FG000|Open Label|Lack of Efficacy|0|||
17103705|NCT00098306|38241880|FG001|Open Label|Lack of Efficacy|0|||
17103706|NCT00098306|38241881|FG002|Open Label|Lack of Efficacy|0|||
17103707|NCT00098306|38241882|FG003|Open Label|Lack of Efficacy|13|||
17103708|NCT00098306|38241883|FG004|Open Label|Lack of Efficacy|0|||
17103709|NCT00098306|38241884|FG005|Open Label|Lack of Efficacy|0|||
17103710|NCT00098306|38241885|FG006|Open Label|Lack of Efficacy|0|||
17103711|NCT00098306|38241879|FG000|Open Label|Adverse Event|0|||
17103712|NCT00098306|38241880|FG001|Open Label|Adverse Event|0|||
17103713|NCT00098306|38241881|FG002|Open Label|Adverse Event|0|||
17103714|NCT00098306|38241882|FG003|Open Label|Adverse Event|2|||
17103715|NCT00098306|38241883|FG004|Open Label|Adverse Event|0|||
17103716|NCT00098306|38241884|FG005|Open Label|Adverse Event|0|||
17103717|NCT00098306|38241885|FG006|Open Label|Adverse Event|0|||
17103718|NCT00098306|38241879|FG000|Open Label|Death|0|||
17103719|NCT00098306|38241880|FG001|Open Label|Death|0|||
17103720|NCT00098306|38241881|FG002|Open Label|Death|0|||
17103721|NCT00098306|38241882|FG003|Open Label|Death|4|||
17103722|NCT00098306|38241883|FG004|Open Label|Death|0|||
17103723|NCT00098306|38241884|FG005|Open Label|Death|0|||
17103724|NCT00098306|38241885|FG006|Open Label|Death|0|||
17103725|NCT00098306|38241879|FG000|Open Label|Participant defaulted|0|||
17103726|NCT00098306|38241880|FG001|Open Label|Participant defaulted|0|||
17103727|NCT00098306|38241881|FG002|Open Label|Participant defaulted|0|||
17103728|NCT00098306|38241882|FG003|Open Label|Participant defaulted|24|||
17103729|NCT00098306|38241883|FG004|Open Label|Participant defaulted|0|||
17103730|NCT00098306|38241884|FG005|Open Label|Participant defaulted|0|||
17103731|NCT00098306|38241885|FG006|Open Label|Participant defaulted|0|||
17103732|NCT00098306|38241879|FG000|Open Label|Un-specified|0|||
17103733|NCT00098306|38241880|FG001|Open Label|Un-specified|0|||
17103734|NCT00098306|38241881|FG002|Open Label|Un-specified|0|||
17103735|NCT00098306|38241882|FG003|Open Label|Un-specified|15|||
17103736|NCT00098306|38241883|FG004|Open Label|Un-specified|0|||
17103737|NCT00098306|38241884|FG005|Open Label|Un-specified|0|||
17103738|NCT00098306|38241885|FG006|Open Label|Un-specified|0|||
17103739|NCT00098306|38241879|FG000|Open Label|Ongoing at cut-off date|0|||
17103740|NCT00098306|38241880|FG001|Open Label|Ongoing at cut-off date|0|||
17103741|NCT00098306|38241881|FG002|Open Label|Ongoing at cut-off date|0|||
17103742|NCT00098306|38241882|FG003|Open Label|Ongoing at cut-off date|269|||
17103743|NCT00098306|38241883|FG004|Open Label|Ongoing at cut-off date|62|||
17103744|NCT00098306|38241884|FG005|Open Label|Ongoing at cut-off date|0|||
17103745|NCT00098306|38241885|FG006|Open Label|Ongoing at cut-off date|0|||
17103746|NCT00098306|38241879|FG000|Observational Phase|Death|0|||
17103747|NCT00098306|38241880|FG001|Observational Phase|Death|0|||
17103748|NCT00098306|38241881|FG002|Observational Phase|Death|0|||
17103749|NCT00098306|38241882|FG003|Observational Phase|Death|0|||
17103750|NCT00098306|38241883|FG004|Observational Phase|Death|0|||
17103751|NCT00098306|38241884|FG005|Observational Phase|Death|5|||
17103752|NCT00098306|38241885|FG006|Observational Phase|Death|4|||
17103753|NCT00098306|38241879|FG000|Observational Phase|Participant defaulted|0|||
17103754|NCT00098306|38241880|FG001|Observational Phase|Participant defaulted|0|||
17103755|NCT00098306|38241881|FG002|Observational Phase|Participant defaulted|0|||
17103756|NCT00098306|38241882|FG003|Observational Phase|Participant defaulted|0|||
17103757|NCT00098306|38241883|FG004|Observational Phase|Participant defaulted|0|||
17103758|NCT00098306|38241884|FG005|Observational Phase|Participant defaulted|34|||
17103759|NCT00098306|38241885|FG006|Observational Phase|Participant defaulted|18|||
17103760|NCT00098306|38241879|FG000|Observational Phase|Un-specified|0|||
17103761|NCT00098306|38241880|FG001|Observational Phase|Un-specified|0|||
17103762|NCT00098306|38241881|FG002|Observational Phase|Un-specified|0|||
17103763|NCT00098306|38241882|FG003|Observational Phase|Un-specified|0|||
17103764|NCT00098306|38241883|FG004|Observational Phase|Un-specified|0|||
17103765|NCT00098306|38241884|FG005|Observational Phase|Un-specified|7|||
17103766|NCT00098306|38241885|FG006|Observational Phase|Un-specified|4|||
17103767|NCT03615040|38241900|FG000|Overall Study|Withdrawal by Subject|2|||
17103768|NCT03615040|38241901|FG001|Overall Study|Withdrawal by Subject|1|||
17103769|NCT03615040|38241900|FG000|Overall Study|Physician Decision|2|||
17103770|NCT03615040|38241901|FG001|Overall Study|Physician Decision|2|||
17103771|NCT03615040|38241900|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
17103772|NCT03615040|38241901|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
17103773|NCT03615040|38241900|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
17103774|NCT03615040|38241901|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
17103775|NCT03615040|38241900|FG000|Overall Study|Death|0|||
17103776|NCT03615040|38241901|FG001|Overall Study|Death|2|||
17103777|NCT00068822|38241909|FG000|First Randomized Intervention|Lost to Follow-up|1|||
17103778|NCT00068822|38241910|FG001|First Randomized Intervention|Lost to Follow-up|2|||
17103779|NCT00068588|38241919|FG000|Overall Study|Adverse Event|0|||
17103780|NCT00068588|38241920|FG001|Overall Study|Adverse Event|0|||
17103781|NCT00068588|38241921|FG002|Overall Study|Adverse Event|2|||
17103782|NCT00068588|38241919|FG000|Overall Study|Withdrawal by Subject|0|||
17103783|NCT00068588|38241920|FG001|Overall Study|Withdrawal by Subject|0|||
17103784|NCT00068588|38241921|FG002|Overall Study|Withdrawal by Subject|1|||
17103785|NCT00068588|38241919|FG000|Overall Study|Poor KPS|0|||
17103786|NCT00068588|38241920|FG001|Overall Study|Poor KPS|0|||
17103787|NCT00068588|38241921|FG002|Overall Study|Poor KPS|1|||
17103788|NCT03650452|38241930|FG000|Overall Study|Physician Decision|1|||
17103789|NCT03650452|38241931|FG001|Overall Study|Physician Decision|0|||
17103790|NCT03650452|38241930|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
17103791|NCT03650452|38241931|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
17103792|NCT03650452|38241930|FG000|Overall Study|Adverse Event|3|||
17103793|NCT03650452|38241931|FG001|Overall Study|Adverse Event|4|||
17103794|NCT03650452|38241930|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
17103795|NCT03650452|38241931|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
17103796|NCT03575806|38241939|FG000|Overall Study|Withdrawal by Subject|0|||
17103797|NCT03575806|38241940|FG001|Overall Study|Withdrawal by Subject|2|||
17103798|NCT03575806|38241939|FG000|Overall Study|Protocol Violation|0|||
17103799|NCT03575806|38241940|FG001|Overall Study|Protocol Violation|2|||
17103800|NCT03610048|38241946|FG000|Overall Study|Study terminated by sponsor|84|||
17103801|NCT03610048|38241946|FG000|Overall Study|Adverse Event|32|||
17103802|NCT03610048|38241946|FG000|Overall Study|Withdrawal by Subject|31|||
17103803|NCT03610048|38241946|FG000|Overall Study|Lost to Follow-up|8|||
17103804|NCT03610048|38241946|FG000|Overall Study|Other|4|||
17103805|NCT03610048|38241946|FG000|Overall Study|Physician Decision|1|||
17103806|NCT03610048|38241946|FG000|Overall Study|Pregnancy|1|||
17103807|NCT03608254|38241950|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
17103808|NCT03608254|38241950|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
17103809|NCT03606460|38241956|FG000|Overall Study|Lost to Follow-up|1|||
17103810|NCT03606460|38241957|FG001|Overall Study|Lost to Follow-up|8|||
17103811|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
17103812|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
17103813|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
17103814|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
17103815|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
17103816|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
17103817|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
17103818|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
17103819|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
17103820|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
17103821|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
17103822|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
17103823|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
17103824|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
17103825|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
17103826|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
17103827|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
17103828|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
17103829|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
17103830|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
17103831|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
17103832|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
17103833|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
17103834|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
17103835|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
17103836|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
17103837|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
17103838|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
17103839|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
17103840|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
17103841|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
17103842|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
17103843|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
17103844|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
17103845|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
17103846|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
17103847|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
17103848|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
17103849|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
17103850|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
17103851|NCT03605836|38241968|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
17103852|NCT03605836|38241969|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
17103853|NCT03605836|38241970|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
17103854|NCT03605836|38241971|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
17103855|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
17103856|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
17103857|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
17103858|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
17103859|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
17103860|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
17103861|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
17103862|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
17103863|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
17103864|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
17103865|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
17103866|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
17198785|NCT00109031|38352514|FG000|Overall Study|Protocol Violation|0|||
17103867|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
17103868|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
17103869|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
17103870|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
17103871|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
17103872|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
17103873|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
17103874|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
17103875|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
17103876|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
17103877|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
17103878|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
17103879|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
17103880|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
17103881|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
17103882|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
17103883|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
17103884|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
17103885|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
17103886|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
17103887|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
17103888|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
17103889|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
17103890|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
17103891|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
17103892|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
17103893|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
17103894|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
17103895|NCT03605836|38241968|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
17103896|NCT03605836|38241969|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
17103897|NCT03605836|38241970|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
17103898|NCT03605836|38241971|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
17103899|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
17103900|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
17103901|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
17103902|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
17103903|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
17103904|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
17103905|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
17103906|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
17103907|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
17103908|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
17103909|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
17103910|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
17103911|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
17103912|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
17103913|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
17103914|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
17103915|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
17103916|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
17103917|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
17103918|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
17103919|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
17103920|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
17103921|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
17103922|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
17103923|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
17103924|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
17103925|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
17103926|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
17103927|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
17103928|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
17103929|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
17103930|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
17103931|NCT03605680|38241984|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
17103932|NCT03605680|38241985|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
17103933|NCT03605680|38241986|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
17103934|NCT03605680|38241987|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
17103935|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
17103936|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
17103937|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
17103938|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
17103939|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
17103940|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
17103941|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
17103942|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
17103943|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
17103944|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
17103945|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
17103946|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
17103947|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
17103948|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
17103949|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
17103950|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
17103951|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
17103952|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
17103953|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
17103954|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
17103955|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
17103956|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
17103957|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
17103958|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
17103959|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
17103960|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
17103961|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
17103962|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
17103963|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
17103964|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
17103965|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
17103966|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
17103967|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
17103968|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
17103969|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
17103970|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
17103971|NCT03605680|38241984|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
17103972|NCT03605680|38241985|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
17103973|NCT03605680|38241986|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
17103974|NCT03605680|38241987|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
17103975|NCT03572218|38241998|FG000|Overall Study|Lost to Follow-up|3|||
17103976|NCT03572218|38241999|FG001|Overall Study|Lost to Follow-up|2|||
17103977|NCT03572218|38241998|FG000|Overall Study|No longer available for study visits|2|||
17103978|NCT03572218|38241999|FG001|Overall Study|No longer available for study visits|1|||
17103979|NCT03572218|38241998|FG000|Overall Study|No longer interested|1|||
17103980|NCT03572218|38241999|FG001|Overall Study|No longer interested|2|||
17103981|NCT00111813|38242005|FG000|Overall Study|Adverse Event|1|||
17103982|NCT00111813|38242006|FG001|Overall Study|Adverse Event|2|||
17103983|NCT00111813|38242007|FG002|Overall Study|Adverse Event|4|||
17103984|NCT00111813|38242008|FG003|Overall Study|Adverse Event|2|||
17103985|NCT00111813|38242009|FG004|Overall Study|Adverse Event|2|||
17103986|NCT00111813|38242010|FG005|Overall Study|Adverse Event|2|||
17103987|NCT00111813|38242005|FG000|Overall Study|Progressive disease|2|||
17103988|NCT00111813|38242006|FG001|Overall Study|Progressive disease|1|||
17103989|NCT00111813|38242007|FG002|Overall Study|Progressive disease|5|||
17103990|NCT00111813|38242008|FG003|Overall Study|Progressive disease|3|||
17103991|NCT00111813|38242009|FG004|Overall Study|Progressive disease|4|||
17103992|NCT00111813|38242010|FG005|Overall Study|Progressive disease|3|||
17103993|NCT00111813|38242005|FG000|Overall Study|Lack of Efficacy|0|||
17103994|NCT00111813|38242006|FG001|Overall Study|Lack of Efficacy|0|||
17103995|NCT00111813|38242007|FG002|Overall Study|Lack of Efficacy|0|||
17103996|NCT00111813|38242008|FG003|Overall Study|Lack of Efficacy|0|||
17103997|NCT00111813|38242009|FG004|Overall Study|Lack of Efficacy|0|||
17103998|NCT00111813|38242010|FG005|Overall Study|Lack of Efficacy|1|||
17103999|NCT00111813|38242005|FG000|Overall Study|Other|0|||
17104000|NCT00111813|38242006|FG001|Overall Study|Other|0|||
17104001|NCT00111813|38242007|FG002|Overall Study|Other|1|||
17104002|NCT00111813|38242008|FG003|Overall Study|Other|0|||
17104003|NCT00111813|38242009|FG004|Overall Study|Other|0|||
17104004|NCT00111813|38242010|FG005|Overall Study|Other|0|||
17104005|NCT00118287|38242025|FG000|Overall Study|Intracranial haemorrhage|1|||
17104006|NCT00118287|38242025|FG000|Overall Study|Muscle pain|1|||
17104007|NCT00130689|38242029|FG000|Overall Study|Progressive Disease|29|||
17104008|NCT00130689|38242029|FG000|Overall Study|Death|1|||
17104009|NCT00130689|38242029|FG000|Overall Study|Clinical Deterioration|4|||
17104010|NCT00130689|38242029|FG000|Overall Study|Withdrawal by Subject|3|||
17104011|NCT00130689|38242029|FG000|Overall Study|Ineligible|6|||
17104012|NCT03605212|38242038|FG000|Treatment Period|Adverse Event|1|||
17104013|NCT03605212|38242039|FG001|Treatment Period|Adverse Event|0|||
17104014|NCT03605212|38242040|FG002|Treatment Period|Adverse Event|0|||
17104015|NCT03605212|38242041|FG003|Treatment Period|Adverse Event|0|||
17104016|NCT03605212|38242042|FG004|Treatment Period|Adverse Event|0|||
17104017|NCT03605212|38242038|FG000|Treatment Period|Physician Decision|0|||
17104018|NCT03605212|38242039|FG001|Treatment Period|Physician Decision|0|||
17104019|NCT03605212|38242040|FG002|Treatment Period|Physician Decision|0|||
17104020|NCT03605212|38242041|FG003|Treatment Period|Physician Decision|0|||
17104021|NCT03605212|38242042|FG004|Treatment Period|Physician Decision|1|||
17104022|NCT03603652|38242055|FG000|Overall Study|Death|2|||
17104023|NCT00117507|38242059|FG000|Overall Study|Adverse Event|4|||
17104024|NCT00117507|38242059|FG000|Overall Study|Abnormal laboratory values|3|||
17104025|NCT00117507|38242059|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17104026|NCT00117507|38242059|FG000|Overall Study|Patient withdrew consent|4|||
17104027|NCT00117507|38242059|FG000|Overall Study|Death|3|||
17104028|NCT03603496|38242066|FG000|Overall Study|Death|19|||
17104029|NCT03603496|38242067|FG001|Overall Study|Death|24|||
17104030|NCT03603496|38242066|FG000|Overall Study|Lost to Follow-up|141|||
17104031|NCT03603496|38242067|FG001|Overall Study|Lost to Follow-up|141|||
17104032|NCT03603496|38242066|FG000|Overall Study|Withdrawal by Subject|26|||
17104033|NCT03603496|38242067|FG001|Overall Study|Withdrawal by Subject|20|||
17104034|NCT03603028|38242073|FG000|Overall Study|Withdrawal by Subject|1|||
17104035|NCT03602482|38242079|FG000|Overall Study|Withdrawal by Subject|6|||
17104036|NCT03602482|38242080|FG001|Overall Study|Withdrawal by Subject|7|||
17104037|NCT03602482|38242081|FG002|Overall Study|Withdrawal by Subject|0|||
17104038|NCT03602482|38242082|FG003|Overall Study|Withdrawal by Subject|0|||
17104039|NCT00096135|38242097|FG000|Overall Study|Physician Decision|20|||
17104040|NCT00096135|38242098|FG001|Overall Study|Physician Decision|4|||
17104041|NCT00096135|38242097|FG000|Overall Study|Refusal of further protocol therapy|4|||
17104042|NCT00096135|38242098|FG001|Overall Study|Refusal of further protocol therapy|1|||
17104043|NCT00096135|38242097|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
17104044|NCT00096135|38242098|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
17104045|NCT00096135|38242097|FG000|Overall Study|Other, specify|15|||
17104046|NCT00096135|38242098|FG001|Overall Study|Other, specify|3|||
17104047|NCT00096135|38242097|FG000|Overall Study|Ineligible|2|||
17104048|NCT00096135|38242098|FG001|Overall Study|Ineligible|0|||
17104049|NCT00116805|38242106|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
17104050|NCT00116805|38242107|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
17104051|NCT00116805|38242106|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
17104052|NCT00116805|38242107|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
17104053|NCT00116805|38242106|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
17104054|NCT00116805|38242107|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
17104055|NCT00116805|38242106|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
17104056|NCT00116805|38242107|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
17104057|NCT00116805|38242106|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
17104058|NCT00116805|38242107|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
17104059|NCT00116805|38242106|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
17104060|NCT00116805|38242107|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
17104061|NCT00116805|38242106|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
17104062|NCT00116805|38242107|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
17104063|NCT00116805|38242106|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
17104064|NCT00116805|38242107|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
17104065|NCT00116805|38242106|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
17104066|NCT00116805|38242107|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
17104067|NCT00116805|38242106|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
17104068|NCT00116805|38242107|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
17104069|NCT00116805|38242106|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
17104070|NCT00116805|38242107|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
17104071|NCT00116805|38242106|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
17104072|NCT00116805|38242107|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
17104073|NCT00116805|38242106|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
17104074|NCT00116805|38242107|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
17104075|NCT00116805|38242106|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
17104076|NCT00116805|38242107|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
17104077|NCT00116805|38242106|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
17104078|NCT00116805|38242107|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
17104079|NCT00116805|38242106|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
17104080|NCT00116805|38242107|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
17104081|NCT00116805|38242106|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
17104082|NCT00116805|38242107|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
17104083|NCT00116805|38242106|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
17104084|NCT00116805|38242107|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
17104085|NCT00116805|38242106|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
17104086|NCT00116805|38242107|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
17104087|NCT00116805|38242106|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
17104088|NCT00116805|38242107|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
17104089|NCT00116805|38242106|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
17104090|NCT00116805|38242107|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
17104091|NCT00116805|38242106|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
17104092|NCT00116805|38242107|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
17104093|NCT00116805|38242106|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
17104094|NCT00116805|38242107|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
17104095|NCT00116805|38242106|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
17104096|NCT00116805|38242107|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
17104097|NCT00116805|38242106|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
17104098|NCT00116805|38242107|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
17104099|NCT00116805|38242106|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
17104100|NCT00116805|38242107|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
17104101|NCT00116805|38242106|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
17104102|NCT00116805|38242107|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
17104103|NCT00116805|38242106|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
17104104|NCT00116805|38242107|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
17104105|NCT00116805|38242106|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
17104106|NCT00116805|38242107|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
17104107|NCT00116805|38242106|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
17104108|NCT00116805|38242107|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
17104109|NCT00116805|38242106|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
17104110|NCT00116805|38242107|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
17104111|NCT00116805|38242106|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
17104112|NCT00116805|38242107|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
17104113|NCT00116805|38242106|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
17104114|NCT00116805|38242107|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
17104115|NCT00116805|38242106|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
17104116|NCT00116805|38242107|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
17104117|NCT00116805|38242106|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
17104118|NCT00116805|38242107|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
17104119|NCT00116805|38242106|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
17104120|NCT00116805|38242107|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
17104121|NCT00116805|38242106|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
17104122|NCT00116805|38242107|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
17104123|NCT00116805|38242106|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
17104124|NCT00116805|38242107|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
17104125|NCT00116805|38242106|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
17104126|NCT00116805|38242107|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
17104127|NCT00116805|38242106|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
17104128|NCT00116805|38242107|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
17104129|NCT00116805|38242106|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
17104130|NCT00116805|38242107|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
17104131|NCT00116805|38242106|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
17104132|NCT00116805|38242107|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
17104133|NCT00116805|38242106|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
17104134|NCT00116805|38242107|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
17104135|NCT00116805|38242106|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
17104136|NCT00116805|38242107|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
17104137|NCT00116805|38242106|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
17104138|NCT00116805|38242107|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
17104139|NCT00116649|38242122|FG000|Overall Study|Adverse Event|20|||
17104140|NCT00116649|38242122|FG000|Overall Study|Lack of Efficacy|1|||
17104141|NCT00116649|38242122|FG000|Overall Study|Lost to Follow-up|32|||
17104142|NCT00116649|38242122|FG000|Overall Study|Withdrawal by Subject|68|||
17104143|NCT00116649|38242122|FG000|Overall Study|Local Skin Reaction|9|||
17104144|NCT00116649|38242122|FG000|Overall Study|Various Reasons|18|||
17104145|NCT00116649|38242122|FG000|Overall Study|Protocol Specified|7|||
17104146|NCT00083889|38242128|FG000|Overall Study|Adverse Event|76|||
17104147|NCT00083889|38242129|FG001|Overall Study|Adverse Event|86|||
17104148|NCT00083889|38242128|FG000|Overall Study|Protocol Violation|2|||
17104149|NCT00083889|38242129|FG001|Overall Study|Protocol Violation|2|||
17104150|NCT00083889|38242128|FG000|Overall Study|Withdrawal by Subject|22|||
17104151|NCT00083889|38242129|FG001|Overall Study|Withdrawal by Subject|24|||
17104152|NCT00083889|38242128|FG000|Overall Study|Lack of Efficacy|240|||
17104153|NCT00083889|38242129|FG001|Overall Study|Lack of Efficacy|219|||
17104154|NCT00083889|38242128|FG000|Overall Study|Decision of sponsor|32|||
17104155|NCT00083889|38242129|FG001|Overall Study|Decision of sponsor|4|||
17104156|NCT00083889|38242128|FG000|Overall Study|Randomized: did not take study drug|0|||
17104157|NCT00083889|38242129|FG001|Overall Study|Randomized: did not take study drug|15|||
17104158|NCT00083889|38242128|FG000|Overall Study|Completed on marketed sunitinub|3|||
17104159|NCT00083889|38242129|FG001|Overall Study|Completed on marketed sunitinub|0|||
17104160|NCT00083889|38242128|FG000|Overall Study|Crossover to SU011248|0|||
17104161|NCT00083889|38242129|FG001|Overall Study|Crossover to SU011248|25|||
17104162|NCT03572062|38242148|FG000|Overall Study|Adverse Event|0|||
17104163|NCT03572062|38242149|FG001|Overall Study|Adverse Event|0|||
17104164|NCT03572062|38242150|FG002|Overall Study|Adverse Event|0|||
17104165|NCT03572062|38242151|FG003|Overall Study|Adverse Event|0|||
17104166|NCT03572062|38242152|FG004|Overall Study|Adverse Event|0|||
17104167|NCT03572062|38242153|FG005|Overall Study|Adverse Event|0|||
17104168|NCT03572062|38242154|FG006|Overall Study|Adverse Event|0|||
17104169|NCT03572062|38242155|FG007|Overall Study|Adverse Event|0|||
17104170|NCT03572062|38242156|FG008|Overall Study|Adverse Event|1|||
17104171|NCT03572062|38242157|FG009|Overall Study|Adverse Event|3|||
17104172|NCT03572062|38242148|FG000|Overall Study|Death|0|||
17104173|NCT03572062|38242149|FG001|Overall Study|Death|0|||
17104174|NCT03572062|38242150|FG002|Overall Study|Death|0|||
17104175|NCT03572062|38242151|FG003|Overall Study|Death|0|||
17104176|NCT03572062|38242152|FG004|Overall Study|Death|0|||
17104177|NCT03572062|38242153|FG005|Overall Study|Death|1|||
17104178|NCT03572062|38242154|FG006|Overall Study|Death|0|||
17104179|NCT03572062|38242155|FG007|Overall Study|Death|0|||
17104180|NCT03572062|38242156|FG008|Overall Study|Death|0|||
17104181|NCT03572062|38242157|FG009|Overall Study|Death|0|||
17104182|NCT03572062|38242148|FG000|Overall Study|Lost to Follow-up|0|||
17104183|NCT03572062|38242149|FG001|Overall Study|Lost to Follow-up|0|||
17104184|NCT03572062|38242150|FG002|Overall Study|Lost to Follow-up|0|||
17104185|NCT03572062|38242151|FG003|Overall Study|Lost to Follow-up|0|||
17104186|NCT03572062|38242152|FG004|Overall Study|Lost to Follow-up|0|||
17104187|NCT03572062|38242153|FG005|Overall Study|Lost to Follow-up|1|||
17104188|NCT03572062|38242154|FG006|Overall Study|Lost to Follow-up|1|||
17104189|NCT03572062|38242155|FG007|Overall Study|Lost to Follow-up|0|||
17104190|NCT03572062|38242156|FG008|Overall Study|Lost to Follow-up|0|||
17104191|NCT03572062|38242157|FG009|Overall Study|Lost to Follow-up|0|||
17104192|NCT03572062|38242148|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104193|NCT03572062|38242149|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104194|NCT03572062|38242150|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104195|NCT03572062|38242151|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104196|NCT03572062|38242152|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104197|NCT03572062|38242153|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104198|NCT03572062|38242154|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104199|NCT03572062|38242155|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104200|NCT03572062|38242156|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
17104201|NCT03572062|38242157|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
17104202|NCT03572062|38242148|FG000|Overall Study|Study Terminated By Sponsor|0|||
17104203|NCT03572062|38242149|FG001|Overall Study|Study Terminated By Sponsor|0|||
17104204|NCT03572062|38242150|FG002|Overall Study|Study Terminated By Sponsor|0|||
17104205|NCT03572062|38242151|FG003|Overall Study|Study Terminated By Sponsor|0|||
17104206|NCT03572062|38242152|FG004|Overall Study|Study Terminated By Sponsor|0|||
17104207|NCT03572062|38242153|FG005|Overall Study|Study Terminated By Sponsor|0|||
17104208|NCT03572062|38242154|FG006|Overall Study|Study Terminated By Sponsor|0|||
17104209|NCT03572062|38242155|FG007|Overall Study|Study Terminated By Sponsor|0|||
17104210|NCT03572062|38242156|FG008|Overall Study|Study Terminated By Sponsor|29|||
17104211|NCT03572062|38242157|FG009|Overall Study|Study Terminated By Sponsor|27|||
17104212|NCT03572062|38242148|FG000|Overall Study|Physician Decision|0|||
17104213|NCT03572062|38242149|FG001|Overall Study|Physician Decision|0|||
17104214|NCT03572062|38242150|FG002|Overall Study|Physician Decision|0|||
17104215|NCT03572062|38242151|FG003|Overall Study|Physician Decision|0|||
17104216|NCT03572062|38242152|FG004|Overall Study|Physician Decision|0|||
17104217|NCT03572062|38242153|FG005|Overall Study|Physician Decision|0|||
17104218|NCT03572062|38242154|FG006|Overall Study|Physician Decision|0|||
17104219|NCT03572062|38242155|FG007|Overall Study|Physician Decision|0|||
17104220|NCT03572062|38242156|FG008|Overall Study|Physician Decision|1|||
17104221|NCT03572062|38242157|FG009|Overall Study|Physician Decision|0|||
17104222|NCT03572062|38242148|FG000|Overall Study|Withdrawal by Subject|0|||
17104223|NCT03572062|38242149|FG001|Overall Study|Withdrawal by Subject|0|||
17104224|NCT03572062|38242150|FG002|Overall Study|Withdrawal by Subject|0|||
17104225|NCT03572062|38242151|FG003|Overall Study|Withdrawal by Subject|0|||
17104226|NCT03572062|38242152|FG004|Overall Study|Withdrawal by Subject|0|||
17104227|NCT03572062|38242153|FG005|Overall Study|Withdrawal by Subject|0|||
17104228|NCT03572062|38242154|FG006|Overall Study|Withdrawal by Subject|0|||
17104229|NCT03572062|38242155|FG007|Overall Study|Withdrawal by Subject|0|||
17104230|NCT03572062|38242156|FG008|Overall Study|Withdrawal by Subject|0|||
17104231|NCT03572062|38242157|FG009|Overall Study|Withdrawal by Subject|1|||
17104232|NCT03572062|38242148|FG000|Overall Study|Randomized But Not Treated|0|||
17104233|NCT03572062|38242149|FG001|Overall Study|Randomized But Not Treated|0|||
17104234|NCT03572062|38242150|FG002|Overall Study|Randomized But Not Treated|0|||
17104235|NCT03572062|38242151|FG003|Overall Study|Randomized But Not Treated|0|||
17104236|NCT03572062|38242152|FG004|Overall Study|Randomized But Not Treated|1|||
17104237|NCT03572062|38242153|FG005|Overall Study|Randomized But Not Treated|2|||
17104238|NCT03572062|38242154|FG006|Overall Study|Randomized But Not Treated|0|||
17104239|NCT03572062|38242155|FG007|Overall Study|Randomized But Not Treated|1|||
17104240|NCT03572062|38242156|FG008|Overall Study|Randomized But Not Treated|0|||
17104241|NCT03572062|38242157|FG009|Overall Study|Randomized But Not Treated|0|||
17104242|NCT03571516|38242179|FG000|Overall Study|Severe diarrhea|1|||
17104243|NCT03571516|38242180|FG001|Overall Study|Severe diarrhea|0|||
17104244|NCT03571516|38242179|FG000|Overall Study|Withdrawal by Subject|0|||
17104245|NCT03571516|38242180|FG001|Overall Study|Withdrawal by Subject|1|||
17104246|NCT03600376|38242188|FG000|Overall Study|Adverse Event|1|||
17104247|NCT03600376|38242189|FG001|Overall Study|Adverse Event|1|||
17104248|NCT03600376|38242188|FG000|Overall Study|Transferred to other facility|1|||
17104249|NCT03600376|38242189|FG001|Overall Study|Transferred to other facility|0|||
17104250|NCT03600376|38242188|FG000|Overall Study|Investigator Decision|0|||
17104251|NCT03600376|38242189|FG001|Overall Study|Investigator Decision|4|||
17104252|NCT03600376|38242188|FG000|Overall Study|Determined to be ineligible for study|0|||
17104253|NCT03600376|38242189|FG001|Overall Study|Determined to be ineligible for study|1|||
17104254|NCT03599362|38242195|FG000|Overall Study|Screen Failure|3|||
17104255|NCT03598036|38242201|FG000|Overall Study|Withdrawal by Subject|1|||
17104256|NCT03598036|38242202|FG001|Overall Study|Withdrawal by Subject|0|||
17104257|NCT00082407|38242212|FG000|Overall Study|Adverse Event|20|||
17104258|NCT00082407|38242213|FG001|Overall Study|Adverse Event|0|||
17104259|NCT00082407|38242212|FG000|Overall Study|Protocol Violation|14|||
17104260|NCT00082407|38242213|FG001|Overall Study|Protocol Violation|12|||
17104261|NCT00082407|38242212|FG000|Overall Study|Patient Decision|13|||
17104262|NCT00082407|38242213|FG001|Overall Study|Patient Decision|6|||
17104263|NCT00082407|38242212|FG000|Overall Study|Physician Decision|5|||
17104264|NCT00082407|38242213|FG001|Overall Study|Physician Decision|3|||
17104265|NCT00082407|38242212|FG000|Overall Study|Loss of Glucose Control|2|||
17104266|NCT00082407|38242213|FG001|Overall Study|Loss of Glucose Control|2|||
17104267|NCT00082407|38242212|FG000|Overall Study|Death|2|||
17104268|NCT00082407|38242213|FG001|Overall Study|Death|1|||
17104269|NCT00082407|38242212|FG000|Overall Study|Lost to Follow-up|0|||
17104270|NCT00082407|38242213|FG001|Overall Study|Lost to Follow-up|3|||
17104271|NCT03643432|38242221|FG000|Overall Study|Lost to Follow-up|1|||
17104272|NCT03643432|38242222|FG001|Overall Study|Lost to Follow-up|0|||
17104273|NCT03810183|38242230|FG000|Overall Study|Study terminated by Sponsor|2|||
17104274|NCT03810183|38242231|FG001|Overall Study|Study terminated by Sponsor|1|||
17104275|NCT03597022|38242241|FG000|Overall Study|Premature termination of the study|7|||
17104276|NCT03597022|38242242|FG001|Overall Study|Premature termination of the study|7|||
17104277|NCT03597022|38242243|FG002|Overall Study|Premature termination of the study|8|||
17104278|NCT03597022|38242241|FG000|Overall Study|Serious adverse event|1|||
17104279|NCT03597022|38242242|FG001|Overall Study|Serious adverse event|1|||
17104280|NCT03597022|38242243|FG002|Overall Study|Serious adverse event|0|||
17104281|NCT03571204|38242254|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
17104282|NCT03571204|38242255|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
17104283|NCT03571204|38242256|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
17104284|NCT03571204|38242254|FG000|Overall Study|Physician Decision|0|||
17104285|NCT03571204|38242255|FG001|Overall Study|Physician Decision|1|||
17104286|NCT03571204|38242256|FG002|Overall Study|Physician Decision|0|||
17104287|NCT03569098|38242268|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
17104288|NCT03569098|38242269|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
17104289|NCT03569098|38242270|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
17104290|NCT03569098|38242268|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
17104291|NCT03569098|38242269|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
17104292|NCT03569098|38242270|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
17104293|NCT03569098|38242268|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
17104294|NCT03569098|38242269|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
17104295|NCT03569098|38242270|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
17104296|NCT03569098|38242268|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
17104297|NCT03569098|38242269|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
17104298|NCT03569098|38242270|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
17104299|NCT03569098|38242268|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
17104300|NCT03569098|38242269|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
17104301|NCT03569098|38242270|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
17104302|NCT03569098|38242268|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
17104303|NCT03569098|38242269|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
17104304|NCT03569098|38242270|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
17104305|NCT03569098|38242268|FG000|Double-Blind Treatment Cycle 1|Other|1|||
17104306|NCT03569098|38242269|FG001|Double-Blind Treatment Cycle 1|Other|0|||
17104307|NCT03569098|38242270|FG002|Double-Blind Treatment Cycle 1|Other|1|||
17104308|NCT03569098|38242268|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
17104309|NCT03569098|38242269|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
17104310|NCT03569098|38242270|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
17104311|NCT03569098|38242268|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
17104312|NCT03569098|38242269|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
17104313|NCT03569098|38242270|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
17104314|NCT03569098|38242268|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
17104315|NCT03569098|38242269|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
17104316|NCT03569098|38242270|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
17104317|NCT03569098|38242268|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
17104318|NCT03569098|38242269|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
17104319|NCT03569098|38242270|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
17104320|NCT03569098|38242268|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
17104321|NCT03569098|38242269|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
17104322|NCT03569098|38242270|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
17104323|NCT03569098|38242268|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
17104324|NCT03569098|38242269|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
17104325|NCT03569098|38242270|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
17104326|NCT03568942|38242281|FG000|Overall Study|Family emergency|1|||
17104327|NCT03568942|38242281|FG000|Overall Study|Lost to Follow-up|1|||
17104328|NCT00110019|38242287|FG000|Overall Study|Lack of Efficacy|253|||
17104329|NCT00110019|38242288|FG001|Overall Study|Lack of Efficacy|285|||
17104330|NCT00110019|38242287|FG000|Overall Study|Adverse Event|61|||
17104331|NCT00110019|38242288|FG001|Overall Study|Adverse Event|40|||
17104332|NCT00110019|38242287|FG000|Overall Study|Death|13|||
17104333|NCT00110019|38242288|FG001|Overall Study|Death|15|||
17104334|NCT00110019|38242287|FG000|Overall Study|Withdrawal by Subject|21|||
17104335|NCT00110019|38242288|FG001|Overall Study|Withdrawal by Subject|9|||
17104336|NCT00110019|38242287|FG000|Overall Study|alternative therapy|5|||
17104337|NCT00110019|38242288|FG001|Overall Study|alternative therapy|1|||
17104338|NCT00110019|38242287|FG000|Overall Study|complicating disease|1|||
17104339|NCT00110019|38242288|FG001|Overall Study|complicating disease|1|||
17104340|NCT00110019|38242287|FG000|Overall Study|symptom deterioration|13|||
17104341|NCT00110019|38242288|FG001|Overall Study|symptom deterioration|16|||
17104342|NCT00110019|38242287|FG000|Overall Study|Not start protocol therapy|17|||
17104343|NCT00110019|38242288|FG001|Overall Study|Not start protocol therapy|16|||
17104344|NCT00110019|38242287|FG000|Overall Study|other reasons|22|||
17104345|NCT00110019|38242288|FG001|Overall Study|other reasons|30|||
17104346|NCT03595618|38242298|FG000|Overall Study|Adverse Event|16|||
17104347|NCT03595618|38242299|FG001|Overall Study|Adverse Event|17|||
17104348|NCT03595618|38242300|FG002|Overall Study|Adverse Event|20|||
17104349|NCT03595618|38242301|FG003|Overall Study|Adverse Event|8|||
16853582|NCT01874431|37803842|FG002|Overall Study|Lost to Follow-up|1|||
16853583|NCT01874431|37803843|FG003|Overall Study|Lost to Follow-up|0|||
16853584|NCT01874431|37803844|FG004|Overall Study|Lost to Follow-up|0|||
16853585|NCT01874431|37803845|FG005|Overall Study|Lost to Follow-up|0|||
16853586|NCT01874431|37803846|FG006|Overall Study|Lost to Follow-up|0|||
16853587|NCT01874431|37803847|FG007|Overall Study|Lost to Follow-up|0|||
16853588|NCT01824355|37803865|FG000|Overall Study|Adverse Event|2|||
16853589|NCT01824355|37803865|FG000|Overall Study|unevaluable reference method results per|1|||
16853590|NCT01823341|37803873|FG000|Overall Study|Failed run-in|7|||
16853591|NCT01823341|37803873|FG000|Overall Study|Withdrawal by Subject|7|||
16853592|NCT01823341|37803873|FG000|Overall Study|Adverse Event|1|||
16853593|NCT01853137|37803882|FG000|Overall Study|Lost to Follow-up|4|||
17104350|NCT03595618|38242298|FG000|Overall Study|Withdrawal by Subject|12|||
17104351|NCT03595618|38242299|FG001|Overall Study|Withdrawal by Subject|14|||
17198786|NCT00109031|38352515|FG001|Overall Study|Protocol Violation|0|||
17198787|NCT00109031|38352516|FG002|Overall Study|Protocol Violation|1|||
17198788|NCT00109031|38352517|FG003|Overall Study|Protocol Violation|0|||
17198789|NCT01664624|38352531|FG000|Overall Study|Adverse Event|0|||
17198790|NCT01664624|38352532|FG001|Overall Study|Adverse Event|1|||
17198791|NCT01664624|38352533|FG002|Overall Study|Adverse Event|0|||
17198792|NCT01664624|38352534|FG003|Overall Study|Adverse Event|0|||
17198793|NCT02702193|38352546|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
17198794|NCT02702193|38352547|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
17198795|NCT02702193|38352546|FG000|4 Month Follow up|Withdrawal by Subject|1|||
17198796|NCT02702193|38352547|FG001|4 Month Follow up|Withdrawal by Subject|0|||
17198797|NCT02702193|38352546|FG000|4 Month Follow up|Lost to Follow-up|17|||
17198798|NCT02702193|38352547|FG001|4 Month Follow up|Lost to Follow-up|18|||
17198799|NCT02702193|38352546|FG000|8 Month Follow up|Withdrawal by Subject|1|||
17198800|NCT02702193|38352547|FG001|8 Month Follow up|Withdrawal by Subject|0|||
17198801|NCT02702193|38352546|FG000|8 Month Follow up|Lost to Follow-up|14|||
17198802|NCT02702193|38352547|FG001|8 Month Follow up|Lost to Follow-up|18|||
17198803|NCT02702193|38352546|FG000|12 Month Follow up|Withdrawal by Subject|1|||
17198804|NCT02702193|38352547|FG001|12 Month Follow up|Withdrawal by Subject|0|||
17198805|NCT02702193|38352546|FG000|12 Month Follow up|Lost to Follow-up|16|||
17198806|NCT02702193|38352547|FG001|12 Month Follow up|Lost to Follow-up|18|||
17198807|NCT02761057|38352557|FG000|Overall Study|Currently On Study Treatment|0|||
17198808|NCT02761057|38352558|FG001|Overall Study|Currently On Study Treatment|3|||
17198809|NCT02761057|38352559|FG002|Overall Study|Currently On Study Treatment|0|||
17198810|NCT02761057|38352560|FG003|Overall Study|Currently On Study Treatment|0|||
17198811|NCT02761057|38352557|FG000|Overall Study|Adverse Event|11|||
17198812|NCT02761057|38352558|FG001|Overall Study|Adverse Event|9|||
17198813|NCT02761057|38352559|FG002|Overall Study|Adverse Event|5|||
17198814|NCT02761057|38352560|FG003|Overall Study|Adverse Event|3|||
17198815|NCT02761057|38352557|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
17198816|NCT02761057|38352558|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
17198817|NCT02761057|38352559|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
16853594|NCT01853137|37803883|FG001|Overall Study|Lost to Follow-up|1|||
16853595|NCT01823107|37803890|FG000|Overall Study|Withdrawal by Subject|1|||
16853596|NCT01874275|37803896|FG000|Overall Study|Lost to Follow-up|1|||
16935873|NCT01212991|38080598|FG000|Open-label|Other|0|||
16935874|NCT01212991|38080599|FG001|Open-label|Other|0|||
16935875|NCT01212991|38080600|FG002|Open-label|Other|3|||
16935876|NCT01212757|38080611|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
16935877|NCT01212757|38080612|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
16935878|NCT01212757|38080613|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
16935879|NCT01212757|38080614|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16935880|NCT01212757|38080615|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16935881|NCT01212757|38080616|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16935882|NCT01212757|38080617|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16935883|NCT01212757|38080618|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16935884|NCT01212757|38080619|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16935885|NCT01212757|38080611|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
16935886|NCT01212757|38080612|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
16935887|NCT01212757|38080613|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
16935888|NCT01212757|38080614|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16935889|NCT01212757|38080615|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16935890|NCT01212757|38080616|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
17198818|NCT02761057|38352560|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
17198819|NCT02761057|38352557|FG000|Overall Study|Progression/Relapse|29|||
17198820|NCT02761057|38352558|FG001|Overall Study|Progression/Relapse|27|||
16853597|NCT01874275|37803897|FG001|Overall Study|Lost to Follow-up|0|||
16853598|NCT01873729|37803909|FG000|Overall Study|Withdrawal by Subject|1|||
16853599|NCT01873495|37803913|FG000|Overall Study|Withdrawal by Subject|1|||
16853600|NCT01873495|37803913|FG000|Overall Study|Physician Decision|3|||
16853601|NCT01873495|37803913|FG000|Overall Study|Adverse Event|1|||
16853602|NCT01873495|37803913|FG000|Overall Study|Removed for Transplantation|1|||
16853603|NCT01873495|37803913|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
16853604|NCT01852825|37803920|FG000|Overall Study|Withdrawal by Subject|2|||
16853605|NCT01852825|37803921|FG001|Overall Study|Withdrawal by Subject|0|||
16853606|NCT01852825|37803922|FG002|Overall Study|Withdrawal by Subject|0|||
16853607|NCT01822561|37803930|FG000|Overall Study|Withdrawal by Subject|2|||
16853608|NCT01852591|37803955|FG000|Overall Study|Withdrawal by Subject|2|||
16853609|NCT01852591|37803955|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
16853610|NCT01852045|37803962|FG000|Overall Study|Adverse Event|1|||
16853611|NCT01852045|37803963|FG001|Overall Study|Adverse Event|0|||
17198821|NCT02761057|38352559|FG002|Overall Study|Progression/Relapse|20|||
17198822|NCT02761057|38352560|FG003|Overall Study|Progression/Relapse|23|||
17198823|NCT02761057|38352557|FG000|Overall Study|Death|2|||
17198824|NCT02761057|38352558|FG001|Overall Study|Death|2|||
17198825|NCT02761057|38352559|FG002|Overall Study|Death|1|||
17198826|NCT02761057|38352560|FG003|Overall Study|Death|1|||
17198827|NCT02761057|38352557|FG000|Overall Study|Other - Not Protocol Specified|2|||
17198828|NCT02761057|38352558|FG001|Overall Study|Other - Not Protocol Specified|1|||
17198829|NCT02761057|38352559|FG002|Overall Study|Other - Not Protocol Specified|2|||
17198830|NCT02761057|38352560|FG003|Overall Study|Other - Not Protocol Specified|0|||
17198831|NCT02584634|38352572|FG000|Overall Study|Adverse Event|3|||
17198832|NCT02584634|38352573|FG001|Overall Study|Adverse Event|3|||
17198833|NCT02584634|38352572|FG000|Overall Study|Death|0|||
17198834|NCT02584634|38352573|FG001|Overall Study|Death|1|||
17198835|NCT02584634|38352572|FG000|Overall Study|Lost to Follow-up|0|||
17198836|NCT02584634|38352573|FG001|Overall Study|Lost to Follow-up|1|||
17198837|NCT02584634|38352572|FG000|Overall Study|Physician Decision|1|||
17198838|NCT02584634|38352573|FG001|Overall Study|Physician Decision|1|||
17198839|NCT02584634|38352572|FG000|Overall Study|Progressive disease|7|||
17198840|NCT02584634|38352573|FG001|Overall Study|Progressive disease|14|||
17198841|NCT02584634|38352572|FG000|Overall Study|Withdrawal by Subject|1|||
17198842|NCT02584634|38352573|FG001|Overall Study|Withdrawal by Subject|1|||
17198843|NCT02584634|38352572|FG000|Overall Study|Other|0|||
17198844|NCT02584634|38352573|FG001|Overall Study|Other|2|||
17198845|NCT02584634|38352572|FG000|Overall Study|Ongoing|0|||
17198846|NCT02584634|38352573|FG001|Overall Study|Ongoing|8|||
17198847|NCT02701413|38352584|FG000|Overall Study|Withdrawal by Subject|7|||
17198848|NCT02701413|38352585|FG001|Overall Study|Withdrawal by Subject|11|||
17198849|NCT02759185|38352595|FG000|Stage 1|Adverse Event|0|||
17198850|NCT02759185|38352596|FG001|Stage 1|Adverse Event|1|||
17198851|NCT02759185|38352597|FG002|Stage 1|Adverse Event|3|||
17198852|NCT02759185|38352598|FG003|Stage 1|Adverse Event|0|||
17198853|NCT02759185|38352599|FG004|Stage 1|Adverse Event|0|||
17198854|NCT02759185|38352600|FG005|Stage 1|Adverse Event|0|||
17198855|NCT02759185|38352601|FG006|Stage 1|Adverse Event|0|||
17198856|NCT02759185|38352595|FG000|Stage 1|Withdrawal by Subject|1|||
17198857|NCT02759185|38352596|FG001|Stage 1|Withdrawal by Subject|0|||
17198858|NCT02759185|38352597|FG002|Stage 1|Withdrawal by Subject|0|||
17198859|NCT02759185|38352598|FG003|Stage 1|Withdrawal by Subject|0|||
17198860|NCT02759185|38352599|FG004|Stage 1|Withdrawal by Subject|0|||
17198861|NCT02759185|38352600|FG005|Stage 1|Withdrawal by Subject|0|||
17198862|NCT02759185|38352601|FG006|Stage 1|Withdrawal by Subject|0|||
17198863|NCT02759185|38352595|FG000|Stage 2|Adverse Event|0|||
17198864|NCT02759185|38352596|FG001|Stage 2|Adverse Event|0|||
17198865|NCT02759185|38352597|FG002|Stage 2|Adverse Event|0|||
17198866|NCT02759185|38352598|FG003|Stage 2|Adverse Event|0|||
17198867|NCT02759185|38352599|FG004|Stage 2|Adverse Event|1|||
17198868|NCT02759185|38352600|FG005|Stage 2|Adverse Event|2|||
17198869|NCT02759185|38352601|FG006|Stage 2|Adverse Event|0|||
17198870|NCT02759185|38352595|FG000|Stage 2|Withdrawal by Subject|0|||
17198871|NCT02759185|38352596|FG001|Stage 2|Withdrawal by Subject|0|||
17198872|NCT02759185|38352597|FG002|Stage 2|Withdrawal by Subject|0|||
17198873|NCT02759185|38352598|FG003|Stage 2|Withdrawal by Subject|0|||
17198874|NCT02759185|38352599|FG004|Stage 2|Withdrawal by Subject|1|||
17198875|NCT02759185|38352600|FG005|Stage 2|Withdrawal by Subject|1|||
17198876|NCT02759185|38352601|FG006|Stage 2|Withdrawal by Subject|1|||
17198877|NCT02582684|38352623|FG000|Overall Study|Unable to contact subject/parent|4|||
17198878|NCT02582684|38352623|FG000|Overall Study|Subject not able to get to clinic|10|||
17198879|NCT02582684|38352623|FG000|Overall Study|Subject withdrew consent|1|||
17198880|NCT02582684|38352623|FG000|Overall Study|Found to be ineligible after enrollment|2|||
17198881|NCT02585960|38352630|FG000|PK/Safety Assessment Period|Physician Decision|0|||
17198882|NCT02585960|38352631|FG001|PK/Safety Assessment Period|Physician Decision|1|||
17198883|NCT02585960|38352632|FG002|PK/Safety Assessment Period|Physician Decision|0|||
17198884|NCT02585960|38352630|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
17198885|NCT02585960|38352631|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
17198886|NCT02585960|38352632|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
17198887|NCT02585960|38352630|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
17198888|NCT02585960|38352631|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
17198889|NCT02585960|38352632|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
17198890|NCT02585960|38352630|FG000|PK/Safety Assessment Period|Other|4|||
17198891|NCT02585960|38352631|FG001|PK/Safety Assessment Period|Other|4|||
17198892|NCT02585960|38352632|FG002|PK/Safety Assessment Period|Other|0|||
17198893|NCT02585960|38352630|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
17198894|NCT02585960|38352631|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
16853612|NCT01852045|37803964|FG002|Overall Study|Adverse Event|0|||
17198895|NCT02585960|38352632|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
17198896|NCT02585960|38352630|FG000|PK/Safety Assessment Period|Screen Failure|0|||
17198897|NCT02585960|38352631|FG001|PK/Safety Assessment Period|Screen Failure|0|||
17198898|NCT02585960|38352632|FG002|PK/Safety Assessment Period|Screen Failure|1|||
17198899|NCT02585960|38352630|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
17198900|NCT02585960|38352631|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
17198901|NCT02585960|38352632|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
17198902|NCT02585960|38352630|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
17198903|NCT02585960|38352631|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
17198904|NCT02585960|38352632|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
17198905|NCT02760433|38352648|FG000|Overall Study|Lost to Follow-up|1|||
17198906|NCT02760433|38352649|FG001|Overall Study|Lost to Follow-up|0|||
17198907|NCT02760433|38352650|FG002|Overall Study|Lost to Follow-up|1|||
17198908|NCT02760433|38352651|FG003|Overall Study|Lost to Follow-up|0|||
17198909|NCT02760433|38352652|FG004|Overall Study|Lost to Follow-up|0|||
17198910|NCT02760433|38352648|FG000|Overall Study|Withdrawal by Subject|23|||
17198911|NCT02760433|38352649|FG001|Overall Study|Withdrawal by Subject|9|||
17198912|NCT02760433|38352650|FG002|Overall Study|Withdrawal by Subject|0|||
17198913|NCT02760433|38352651|FG003|Overall Study|Withdrawal by Subject|2|||
17198914|NCT02760433|38352652|FG004|Overall Study|Withdrawal by Subject|9|||
17198915|NCT02760433|38352648|FG000|Overall Study|Lack of Response At Week 14|0|||
17198916|NCT02760433|38352649|FG001|Overall Study|Lack of Response At Week 14|0|||
17198917|NCT02760433|38352650|FG002|Overall Study|Lack of Response At Week 14|0|||
17198918|NCT02760433|38352651|FG003|Overall Study|Lack of Response At Week 14|0|||
17198919|NCT02760433|38352652|FG004|Overall Study|Lack of Response At Week 14|1|||
17198920|NCT02760433|38352648|FG000|Overall Study|Subject refused to continue the study|1|||
17198921|NCT02760433|38352649|FG001|Overall Study|Subject refused to continue the study|0|||
17198922|NCT02760433|38352650|FG002|Overall Study|Subject refused to continue the study|0|||
17198923|NCT02760433|38352651|FG003|Overall Study|Subject refused to continue the study|0|||
17198924|NCT02760433|38352652|FG004|Overall Study|Subject refused to continue the study|0|||
17198925|NCT02760433|38352648|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
17198926|NCT02760433|38352649|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
17198927|NCT02760433|38352650|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
17198928|NCT02760433|38352651|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
17198929|NCT02760433|38352652|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
17198930|NCT02760433|38352648|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
17198931|NCT02760433|38352649|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
17198932|NCT02760433|38352650|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
17198933|NCT02760433|38352651|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
17198934|NCT02760433|38352652|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
17198935|NCT02699463|38352671|FG000|Overall Study|Lost to Follow-up|11|||
17198936|NCT02699463|38352672|FG001|Overall Study|Lost to Follow-up|8|||
17198937|NCT02699463|38352671|FG000|Overall Study|Withdrawal by Subject|4|||
17198938|NCT02699463|38352672|FG001|Overall Study|Withdrawal by Subject|1|||
17198939|NCT00100789|38352678|FG000|Overall Study|Adverse Event|10|||
17198940|NCT00100789|38352678|FG000|Overall Study|Withdrawal by Subject|1|||
17198941|NCT00100789|38352678|FG000|Overall Study|Progression/relapse|42|||
17198942|NCT00100789|38352678|FG000|Overall Study|Death|2|||
17198943|NCT00100789|38352678|FG000|Overall Study|Not protocol specified|5|||
17198944|NCT00100789|38352678|FG000|Overall Study|Ineligible|3|||
17198945|NCT00100789|38352678|FG000|Overall Study|Never received treatment|1|||
17198946|NCT00708123|38352683|FG000|Period 1|Protocol Violation|0|||
17198947|NCT00708123|38352684|FG001|Period 1|Protocol Violation|1|||
17198948|NCT00708123|38352685|FG002|Period 1|Protocol Violation|0|||
17198949|NCT00708123|38352686|FG003|Period 1|Protocol Violation|1|||
17198950|NCT00708123|38352687|FG004|Period 1|Protocol Violation|0|||
17198951|NCT00708123|38352683|FG000|Period 1|Adverse Event|0|||
17198952|NCT00708123|38352684|FG001|Period 1|Adverse Event|0|||
17198953|NCT00708123|38352685|FG002|Period 1|Adverse Event|1|||
17198954|NCT00708123|38352686|FG003|Period 1|Adverse Event|0|||
17198955|NCT00708123|38352687|FG004|Period 1|Adverse Event|0|||
17198956|NCT00708123|38352683|FG000|Period 2|Protocol Violation|0|||
17198957|NCT00708123|38352684|FG001|Period 2|Protocol Violation|0|||
17198958|NCT00708123|38352685|FG002|Period 2|Protocol Violation|0|||
17198959|NCT00708123|38352686|FG003|Period 2|Protocol Violation|1|||
17198960|NCT00708123|38352687|FG004|Period 2|Protocol Violation|0|||
17198961|NCT00708123|38352683|FG000|Period 2|Other Reason|1|||
17198962|NCT00708123|38352684|FG001|Period 2|Other Reason|0|||
17198963|NCT00708123|38352685|FG002|Period 2|Other Reason|0|||
17198964|NCT00708123|38352686|FG003|Period 2|Other Reason|0|||
17198965|NCT00708123|38352687|FG004|Period 2|Other Reason|0|||
17198966|NCT00708123|38352683|FG000|Period 3|Lost to Follow-up|0|||
17198967|NCT00708123|38352684|FG001|Period 3|Lost to Follow-up|0|||
17198968|NCT00708123|38352685|FG002|Period 3|Lost to Follow-up|1|||
16853613|NCT01852045|37803962|FG000|Overall Study|Lack of Efficacy|3|||
17198969|NCT00708123|38352686|FG003|Period 3|Lost to Follow-up|1|||
17198970|NCT00708123|38352687|FG004|Period 3|Lost to Follow-up|0|||
17198971|NCT00708123|38352683|FG000|Period 4|Protocol Violation|0|||
17198972|NCT00708123|38352684|FG001|Period 4|Protocol Violation|1|||
17198973|NCT00708123|38352685|FG002|Period 4|Protocol Violation|0|||
17198974|NCT00708123|38352686|FG003|Period 4|Protocol Violation|0|||
17198975|NCT00708123|38352687|FG004|Period 4|Protocol Violation|0|||
17198976|NCT02165215|38352706|FG000|Induction Phase|Adverse Event|1|||
17198977|NCT02165215|38352707|FG001|Induction Phase|Adverse Event|0|||
17198978|NCT02165215|38352708|FG002|Induction Phase|Adverse Event|0|||
17198979|NCT02165215|38352706|FG000|Induction Phase|Withdrawal by Subject|10|||
17198980|NCT02165215|38352707|FG001|Induction Phase|Withdrawal by Subject|0|||
17198981|NCT02165215|38352708|FG002|Induction Phase|Withdrawal by Subject|0|||
17198982|NCT02165215|38352706|FG000|Induction Phase|Protocol Violation|1|||
17198983|NCT02165215|38352707|FG001|Induction Phase|Protocol Violation|0|||
17198984|NCT02165215|38352708|FG002|Induction Phase|Protocol Violation|0|||
17198985|NCT02165215|38352706|FG000|Induction Phase|Physician Decision|1|||
17198986|NCT02165215|38352707|FG001|Induction Phase|Physician Decision|0|||
17198987|NCT02165215|38352708|FG002|Induction Phase|Physician Decision|0|||
17198988|NCT02165215|38352706|FG000|Induction Phase|Lack of Efficacy|2|||
17198989|NCT02165215|38352707|FG001|Induction Phase|Lack of Efficacy|0|||
17198990|NCT02165215|38352708|FG002|Induction Phase|Lack of Efficacy|0|||
17198991|NCT02165215|38352706|FG000|Induction Phase|Non-Compliance|2|||
17198992|NCT02165215|38352707|FG001|Induction Phase|Non-Compliance|0|||
17198993|NCT02165215|38352708|FG002|Induction Phase|Non-Compliance|0|||
17198994|NCT02165215|38352706|FG000|Induction Phase|Lost to Follow-up|6|||
17198995|NCT02165215|38352707|FG001|Induction Phase|Lost to Follow-up|0|||
17198996|NCT02165215|38352708|FG002|Induction Phase|Lost to Follow-up|0|||
17198997|NCT02165215|38352706|FG000|Maintenance Phase|Withdrawal by Subject|0|||
17198998|NCT02165215|38352707|FG001|Maintenance Phase|Withdrawal by Subject|7|||
17198999|NCT02165215|38352708|FG002|Maintenance Phase|Withdrawal by Subject|3|||
17199000|NCT02165215|38352706|FG000|Maintenance Phase|Multiple reasons|0|||
17199001|NCT02165215|38352707|FG001|Maintenance Phase|Multiple reasons|2|||
17104352|NCT03595618|38242300|FG002|Overall Study|Withdrawal by Subject|14|||
17104353|NCT03595618|38242301|FG003|Overall Study|Withdrawal by Subject|10|||
17104354|NCT03595618|38242298|FG000|Overall Study|Lost to Follow-up|6|||
17104355|NCT03595618|38242299|FG001|Overall Study|Lost to Follow-up|4|||
17104356|NCT03595618|38242300|FG002|Overall Study|Lost to Follow-up|5|||
17104357|NCT03595618|38242301|FG003|Overall Study|Lost to Follow-up|6|||
17104358|NCT03595618|38242298|FG000|Overall Study|Protocol Violation|2|||
17104359|NCT03595618|38242299|FG001|Overall Study|Protocol Violation|0|||
17104360|NCT03595618|38242300|FG002|Overall Study|Protocol Violation|6|||
17104361|NCT03595618|38242301|FG003|Overall Study|Protocol Violation|2|||
17104362|NCT03595618|38242298|FG000|Overall Study|Physician Decision|0|||
17104363|NCT03595618|38242299|FG001|Overall Study|Physician Decision|0|||
17199002|NCT02165215|38352708|FG002|Maintenance Phase|Multiple reasons|1|||
17199003|NCT02165215|38352706|FG000|Maintenance Phase|Lost to Follow-up|0|||
17199004|NCT02165215|38352707|FG001|Maintenance Phase|Lost to Follow-up|2|||
17199005|NCT02165215|38352708|FG002|Maintenance Phase|Lost to Follow-up|0|||
17199006|NCT02165215|38352706|FG000|Maintenance Phase|Adverse Event|0|||
17199007|NCT02165215|38352707|FG001|Maintenance Phase|Adverse Event|1|||
17199008|NCT02165215|38352708|FG002|Maintenance Phase|Adverse Event|1|||
17199009|NCT02757625|38352723|FG000|Overall Study|Investigator's discretion|0|||
17199010|NCT02757625|38352724|FG001|Overall Study|Investigator's discretion|0|||
17199011|NCT02757625|38352725|FG002|Overall Study|Investigator's discretion|1|||
17199012|NCT02757625|38352726|FG003|Overall Study|Investigator's discretion|0|||
17199013|NCT02757625|38352723|FG000|Overall Study|Adverse Event|0|||
17199014|NCT02757625|38352724|FG001|Overall Study|Adverse Event|0|||
17199015|NCT02757625|38352725|FG002|Overall Study|Adverse Event|1|||
17199016|NCT02757625|38352726|FG003|Overall Study|Adverse Event|0|||
17199017|NCT02581202|38352738|FG000|Overall Study|Lack of Efficacy|2|||
17199018|NCT02581202|38352738|FG000|Overall Study|Withdrawal by Subject|4|||
17199019|NCT02581202|38352738|FG000|Overall Study|Lost to Follow-up|5|||
17199020|NCT02581202|38352738|FG000|Overall Study|Pregnancy|3|||
17199021|NCT02758171|38352745|FG000|Wash-out|Withdrawal by Subject|1|||
17199022|NCT02758171|38352746|FG001|Wash-out|Withdrawal by Subject|0|||
17199023|NCT02758171|38352745|FG000|Wash-out|Other reason|1|||
17199024|NCT02758171|38352746|FG001|Wash-out|Other reason|0|||
17199025|NCT00101101|38352752|FG000|Overall Study|never received vaccine|20|||
17104364|NCT03595618|38242300|FG002|Overall Study|Physician Decision|1|||
17104365|NCT03595618|38242301|FG003|Overall Study|Physician Decision|2|||
17104366|NCT03595618|38242298|FG000|Overall Study|Miscellaneous|7|||
17104367|NCT03595618|38242299|FG001|Overall Study|Miscellaneous|5|||
17104368|NCT03595618|38242300|FG002|Overall Study|Miscellaneous|10|||
17104369|NCT03595618|38242301|FG003|Overall Study|Miscellaneous|6|||
17199026|NCT01664078|38352779|FG000|Overall Study|Death|9|||
17199027|NCT01664078|38352779|FG000|Overall Study|Withdrawal by Subject|4|||
17199028|NCT01664078|38352779|FG000|Overall Study|Lost to Follow-up|2|||
17199029|NCT01664078|38352779|FG000|Overall Study|missed 5 year visit|1|||
17199030|NCT01664078|38352779|FG000|Overall Study|Other|53|||
17199031|NCT03367403|38352832|FG000|Overall Study|Adverse Event|20|||
17199032|NCT03367403|38352833|FG001|Overall Study|Adverse Event|6|||
17199033|NCT03367403|38352834|FG002|Overall Study|Adverse Event|2|||
17199034|NCT03367403|38352832|FG000|Overall Study|Withdrawal by Subject|12|||
17199035|NCT03367403|38352833|FG001|Overall Study|Withdrawal by Subject|13|||
17199036|NCT03367403|38352834|FG002|Overall Study|Withdrawal by Subject|1|||
17199037|NCT03367403|38352832|FG000|Overall Study|Death|1|||
17199038|NCT03367403|38352833|FG001|Overall Study|Death|2|||
17199039|NCT03367403|38352834|FG002|Overall Study|Death|0|||
17199040|NCT03367403|38352832|FG000|Overall Study|Physician Decision|0|||
17199041|NCT03367403|38352833|FG001|Overall Study|Physician Decision|1|||
17199042|NCT03367403|38352834|FG002|Overall Study|Physician Decision|0|||
17199043|NCT03367403|38352832|FG000|Overall Study|Protocol Violation|1|||
17199044|NCT03367403|38352833|FG001|Overall Study|Protocol Violation|1|||
17199045|NCT03367403|38352834|FG002|Overall Study|Protocol Violation|0|||
17199046|NCT03367403|38352832|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
17199047|NCT03367403|38352833|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
17199048|NCT03367403|38352834|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
17199049|NCT03367403|38352832|FG000|Overall Study|COVID-19|3|||
17199050|NCT03367403|38352833|FG001|Overall Study|COVID-19|6|||
17199051|NCT03367403|38352834|FG002|Overall Study|COVID-19|0|||
17199052|NCT03367403|38352832|FG000|Overall Study|Abuse of Alcohol Intake|0|||
17199053|NCT03367403|38352833|FG001|Overall Study|Abuse of Alcohol Intake|1|||
17199054|NCT03367403|38352834|FG002|Overall Study|Abuse of Alcohol Intake|0|||
17199055|NCT03367403|38352832|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
17199056|NCT03367403|38352833|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
17199057|NCT03367403|38352834|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
17199058|NCT02577146|38352842|FG000|Overall Study|Lost to Follow-up|8|||
17199059|NCT02577146|38352842|FG000|Overall Study|Physician Decision|3|||
17199060|NCT02577146|38352842|FG000|Overall Study|Screen Failure|17|||
17199061|NCT00109967|38352848|FG000|Overall Study|Cancel Prior to Treatment|2|||
17199062|NCT00109967|38352849|FG001|Overall Study|Cancel Prior to Treatment|0|||
17199063|NCT00109967|38352848|FG000|Overall Study|Adverse Event|12|||
17199064|NCT00109967|38352849|FG001|Overall Study|Adverse Event|1|||
17199065|NCT00109967|38352848|FG000|Overall Study|Withdrawal by Subject|5|||
17199066|NCT00109967|38352849|FG001|Overall Study|Withdrawal by Subject|0|||
17199067|NCT00109967|38352848|FG000|Overall Study|Physician Decision|1|||
17199068|NCT00109967|38352849|FG001|Overall Study|Physician Decision|3|||
17199069|NCT00109967|38352848|FG000|Overall Study|Death|0|||
17199070|NCT00109967|38352849|FG001|Overall Study|Death|2|||
16853614|NCT01852045|37803963|FG001|Overall Study|Lack of Efficacy|0|||
17104370|NCT02954848|38242313|FG000|Overall Study|Randomized but Not Treated|0|||
17104371|NCT02954848|38242314|FG001|Overall Study|Randomized but Not Treated|1|||
17104372|NCT02954848|38242313|FG000|Overall Study|Adverse Event|2|||
17104373|NCT02954848|38242314|FG001|Overall Study|Adverse Event|3|||
17104374|NCT02954848|38242313|FG000|Overall Study|Withdrawal by Participant|0|||
17104375|NCT02954848|38242314|FG001|Overall Study|Withdrawal by Participant|1|||
17104376|NCT03642262|38242320|FG000|Period 1|Withdrawal by Subject|1|||
17104377|NCT03642262|38242321|FG001|Period 1|Withdrawal by Subject|1|||
17104378|NCT03642262|38242320|FG000|Period 1|Adverse Event|0|||
17104379|NCT03642262|38242321|FG001|Period 1|Adverse Event|1|||
17104380|NCT00109707|38242331|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
17104381|NCT00109707|38242332|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
17104382|NCT00109707|38242333|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
17104383|NCT00109707|38242331|FG000|Overall Study|Abnormal laboratory values|1|||
17104384|NCT00109707|38242332|FG001|Overall Study|Abnormal laboratory values|0|||
17104385|NCT00109707|38242333|FG002|Overall Study|Abnormal laboratory values|0|||
17104386|NCT00109707|38242331|FG000|Overall Study|Administrative problems|2|||
17104387|NCT00109707|38242332|FG001|Overall Study|Administrative problems|0|||
17104388|NCT00109707|38242333|FG002|Overall Study|Administrative problems|1|||
17104389|NCT00109707|38242331|FG000|Overall Study|Adverse Event|10|||
17104390|NCT00109707|38242332|FG001|Overall Study|Adverse Event|2|||
17104391|NCT00109707|38242333|FG002|Overall Study|Adverse Event|3|||
17104392|NCT00109707|38242331|FG000|Overall Study|Death|4|||
17104393|NCT00109707|38242332|FG001|Overall Study|Death|0|||
17104394|NCT00109707|38242333|FG002|Overall Study|Death|0|||
17104395|NCT00109707|38242331|FG000|Overall Study|Disease progression|12|||
17104396|NCT00109707|38242332|FG001|Overall Study|Disease progression|4|||
17104397|NCT00109707|38242333|FG002|Overall Study|Disease progression|3|||
17104398|NCT00109707|38242331|FG000|Overall Study|Lost to Follow-up|3|||
17104399|NCT00109707|38242332|FG001|Overall Study|Lost to Follow-up|0|||
17104400|NCT00109707|38242333|FG002|Overall Study|Lost to Follow-up|0|||
17104401|NCT00109707|38242331|FG000|Overall Study|Protocol Violation|1|||
17104402|NCT00109707|38242332|FG001|Overall Study|Protocol Violation|0|||
17104403|NCT00109707|38242333|FG002|Overall Study|Protocol Violation|0|||
17199071|NCT02579096|38352857|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
17199072|NCT02579096|38352858|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
17199073|NCT02579096|38352857|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
17199074|NCT02579096|38352858|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
17199075|NCT02579096|38352857|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
17199076|NCT02579096|38352858|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
17199077|NCT02579096|38352857|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
17199078|NCT02579096|38352858|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
17199079|NCT02579096|38352857|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
17199080|NCT02579096|38352858|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
17199081|NCT02579096|38352857|FG000|Phase 2, Weeks 25 - 48|Death|2|||
17199082|NCT02579096|38352858|FG001|Phase 2, Weeks 25 - 48|Death|4|||
17199083|NCT02579096|38352857|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
17199084|NCT02579096|38352858|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
17199085|NCT02579096|38352857|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
17199086|NCT02579096|38352858|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
17199087|NCT02579096|38352857|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
17199088|NCT02579096|38352858|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
17199089|NCT02579096|38352857|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
17199090|NCT02579096|38352858|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
17199091|NCT02579096|38352857|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
17199092|NCT02579096|38352858|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
17199093|NCT02579096|38352857|FG000|Phase 3, Weeks 49 - 72|Death|3|||
17199094|NCT02579096|38352858|FG001|Phase 3, Weeks 49 - 72|Death|2|||
17199095|NCT02579096|38352857|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
17199096|NCT02579096|38352858|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
17199097|NCT02579096|38352857|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
17199098|NCT02579096|38352858|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
17199099|NCT02579096|38352857|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
17199100|NCT02579096|38352858|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
17199101|NCT02579096|38352857|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
17199102|NCT02579096|38352858|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
17199103|NCT02579096|38352857|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
17199104|NCT02579096|38352858|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
17199105|NCT02579096|38352857|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
17199106|NCT02579096|38352858|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
17199107|NCT02578940|38352864|FG000|Overall Study|Screening failure|5|||
17199108|NCT02578940|38352864|FG000|Overall Study|Lost to Follow-up|1|||
17199109|NCT02578862|38352872|FG000|Overall Study|Withdrawal by Subject|0|||
17199110|NCT02578862|38352873|FG001|Overall Study|Withdrawal by Subject|1|||
17199111|NCT02578862|38352872|FG000|Overall Study|Unplanned unilateral procedure|0|||
17199112|NCT02578862|38352873|FG001|Overall Study|Unplanned unilateral procedure|1|||
17199113|NCT02578706|38352882|FG000|Overall Study|Withdrawal by Subject|1|||
17199114|NCT02578706|38352883|FG001|Overall Study|Withdrawal by Subject|0|||
17199115|NCT02578706|38352884|FG002|Overall Study|Withdrawal by Subject|0|||
17199116|NCT02578706|38352882|FG000|Overall Study|Lost to Follow-up|0|||
17199117|NCT02578706|38352883|FG001|Overall Study|Lost to Follow-up|4|||
17199118|NCT02578706|38352884|FG002|Overall Study|Lost to Follow-up|0|||
17199119|NCT02578706|38352882|FG000|Overall Study|Physician Decision|0|||
17199120|NCT02578706|38352883|FG001|Overall Study|Physician Decision|1|||
17199121|NCT02578706|38352884|FG002|Overall Study|Physician Decision|0|||
17199122|NCT00108953|38352894|FG000|Follow-up|Death|18|||
17199123|NCT00108953|38352895|FG001|Follow-up|Death|26|||
17199124|NCT00108953|38352894|FG000|Follow-up|Lost to Follow-up|1|||
17199125|NCT00108953|38352895|FG001|Follow-up|Lost to Follow-up|1|||
17199126|NCT00108953|38352894|FG000|Follow-up|Study terminated by sponsor|10|||
17199127|NCT00108953|38352895|FG001|Follow-up|Study terminated by sponsor|6|||
17199128|NCT02578316|38352903|FG000|Extension Phase|Progression of disease|6|||
17199129|NCT03025880|38352913|FG000|Overall Study|Adverse Event|1|||
17199130|NCT03025880|38352914|FG001|Overall Study|Adverse Event|0|||
17199131|NCT03025880|38352913|FG000|Overall Study|Death|1|||
17199132|NCT03025880|38352914|FG001|Overall Study|Death|1|||
17199133|NCT03025880|38352913|FG000|Overall Study|Withdrawal by Subject|0|||
17199134|NCT03025880|38352914|FG001|Overall Study|Withdrawal by Subject|1|||
17199135|NCT03025880|38352913|FG000|Overall Study|Physician Decision|0|||
17199136|NCT03025880|38352914|FG001|Overall Study|Physician Decision|1|||
17199137|NCT03025880|38352913|FG000|Overall Study|Progressive Disease|12|||
17199138|NCT03025880|38352914|FG001|Overall Study|Progressive Disease|19|||
17199139|NCT02576678|38352925|FG000|Overall Study|Adverse Event|0|||
17199140|NCT02576678|38352926|FG001|Overall Study|Adverse Event|0|||
17199141|NCT02576678|38352927|FG002|Overall Study|Adverse Event|2|||
17199142|NCT02576678|38352925|FG000|Overall Study|Withdrawal by Subject|3|||
17199143|NCT02576678|38352926|FG001|Overall Study|Withdrawal by Subject|1|||
17199144|NCT02576678|38352927|FG002|Overall Study|Withdrawal by Subject|2|||
17199145|NCT02576678|38352925|FG000|Overall Study|Lost to Follow-up|0|||
17199146|NCT02576678|38352926|FG001|Overall Study|Lost to Follow-up|0|||
17199147|NCT02576678|38352927|FG002|Overall Study|Lost to Follow-up|1|||
17199148|NCT02576678|38352925|FG000|Overall Study|Miscellaneous|2|||
17199149|NCT02576678|38352926|FG001|Overall Study|Miscellaneous|0|||
17199150|NCT02576678|38352927|FG002|Overall Study|Miscellaneous|0|||
17199151|NCT00108745|38352938|FG000|Overall Study|Withdrawal by Subject|19|||
17199152|NCT00108745|38352939|FG001|Overall Study|Withdrawal by Subject|12|||
17199153|NCT00108745|38352940|FG002|Overall Study|Withdrawal by Subject|12|||
17199154|NCT00108745|38352938|FG000|Overall Study|Never Treated|8|||
17199155|NCT00108745|38352939|FG001|Overall Study|Never Treated|10|||
17199156|NCT00108745|38352940|FG002|Overall Study|Never Treated|12|||
17199157|NCT00108745|38352938|FG000|Overall Study|Ineligible|7|||
17199158|NCT00108745|38352939|FG001|Overall Study|Ineligible|13|||
17199159|NCT00108745|38352940|FG002|Overall Study|Ineligible|13|||
17199160|NCT02581982|38352970|FG000|Overall Study|Lack of Efficacy|12|||
17199161|NCT02581982|38352970|FG000|Overall Study|Adverse Event|3|||
17199162|NCT02581982|38352970|FG000|Overall Study|Physician Decision|1|||
17199163|NCT02716805|38352974|FG000|Overall Study|Progressive disease|2|||
17199164|NCT02716805|38352975|FG001|Overall Study|Progressive disease|0|||
17199165|NCT02716805|38352976|FG002|Overall Study|Progressive disease|0|||
17199166|NCT02716805|38352977|FG003|Overall Study|Progressive disease|0|||
17199167|NCT02576990|38352983|FG000|Overall Study|Death|29|||
17199168|NCT02576990|38352984|FG001|Overall Study|Death|18|||
17199169|NCT02576990|38352983|FG000|Overall Study|Physician Decision|1|||
17199170|NCT02576990|38352984|FG001|Overall Study|Physician Decision|0|||
17199171|NCT02576990|38352983|FG000|Overall Study|Screen failure|2|||
17199172|NCT02576990|38352984|FG001|Overall Study|Screen failure|0|||
17199173|NCT02576990|38352983|FG000|Overall Study|Sponsor's decision|24|||
17199174|NCT02576990|38352984|FG001|Overall Study|Sponsor's decision|4|||
17199175|NCT02576990|38352983|FG000|Overall Study|Withdrawal by Subject|0|||
17199176|NCT02576990|38352984|FG001|Overall Study|Withdrawal by Subject|2|||
17199177|NCT04510285|38352990|FG000|Overall Study|Death|1|||
17199178|NCT02576054|38352994|FG000|Overall Study|Withdrawal by Subject|1|||
17199179|NCT01606202|38353002|FG000|Overall Study|Adverse Event|5|||
17199180|NCT01606202|38353003|FG001|Overall Study|Adverse Event|0|||
17199181|NCT01606202|38353002|FG000|Overall Study|Withdrawal by Subject|2|||
17199182|NCT01606202|38353003|FG001|Overall Study|Withdrawal by Subject|1|||
17199183|NCT01606202|38353002|FG000|Overall Study|Personal problems|0|||
17199184|NCT01606202|38353003|FG001|Overall Study|Personal problems|1|||
17199185|NCT01606202|38353002|FG000|Overall Study|Problems with administration|0|||
17199186|NCT01606202|38353003|FG001|Overall Study|Problems with administration|1|||
17199187|NCT02756611|38353009|FG000|Overall Study|Death|39|||
17199188|NCT02756611|38353009|FG000|Overall Study|Withdrawal by Subject|1|||
17199189|NCT02756611|38353009|FG000|Overall Study|Lost to Follow-up|2|||
17199190|NCT02756611|38353009|FG000|Overall Study|Other|7|||
17199191|NCT02756611|38353009|FG000|Overall Study|Missing|2|||
17199192|NCT02756611|38353009|FG000|Overall Study|Active on Study|205|||
17199193|NCT01493960|38353015|FG000|Overall Study|Adverse Event|0|||
17199194|NCT01493960|38353016|FG001|Overall Study|Adverse Event|1|||
17199195|NCT01493960|38353015|FG000|Overall Study|Lack of Efficacy|15|||
17199196|NCT01493960|38353016|FG001|Overall Study|Lack of Efficacy|9|||
17104404|NCT00109707|38242331|FG000|Overall Study|Patient withdrew consent|6|||
17104405|NCT00109707|38242332|FG001|Overall Study|Patient withdrew consent|1|||
17104406|NCT00109707|38242333|FG002|Overall Study|Patient withdrew consent|0|||
17104407|NCT00095979|38242345|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
17104408|NCT00082173|38242356|FG000|Overall Study|Withdrawal by Subject|3|||
17104409|NCT00082173|38242357|FG001|Overall Study|Withdrawal by Subject|5|||
17104410|NCT00082173|38242356|FG000|Overall Study|Lost to Follow-up|1|||
17104411|NCT00082173|38242357|FG001|Overall Study|Lost to Follow-up|0|||
17104412|NCT00082173|38242356|FG000|Overall Study|Adverse Event|1|||
17104413|NCT00082173|38242357|FG001|Overall Study|Adverse Event|0|||
17104414|NCT00082173|38242356|FG000|Overall Study|Culture negative or resistant at baselin|5|||
17104415|NCT00082173|38242357|FG001|Overall Study|Culture negative or resistant at baselin|6|||
17104416|NCT03568318|38242369|FG000|Overall Study|Adverse Event|3|||
17104417|NCT03568318|38242370|FG001|Overall Study|Adverse Event|1|||
17104418|NCT03568318|38242371|FG002|Overall Study|Adverse Event|1|||
17104419|NCT03568318|38242372|FG003|Overall Study|Adverse Event|0|||
17104420|NCT03568318|38242373|FG004|Overall Study|Adverse Event|1|||
17104421|NCT03568318|38242374|FG005|Overall Study|Adverse Event|0|||
17104422|NCT03568318|38242369|FG000|Overall Study|Withdrawal by Subject|6|||
17104423|NCT03568318|38242370|FG001|Overall Study|Withdrawal by Subject|5|||
17104424|NCT03568318|38242371|FG002|Overall Study|Withdrawal by Subject|2|||
17104425|NCT03568318|38242372|FG003|Overall Study|Withdrawal by Subject|1|||
17104426|NCT03568318|38242373|FG004|Overall Study|Withdrawal by Subject|0|||
17104427|NCT03568318|38242374|FG005|Overall Study|Withdrawal by Subject|0|||
17104428|NCT03568318|38242369|FG000|Overall Study|Lost to Follow-up|3|||
17104429|NCT03568318|38242370|FG001|Overall Study|Lost to Follow-up|2|||
17199197|NCT01493960|38353015|FG000|Overall Study|Protocol Violation|3|||
17199198|NCT01493960|38353016|FG001|Overall Study|Protocol Violation|0|||
17199199|NCT01493960|38353015|FG000|Overall Study|Withdrawal by Subject|10|||
17199200|NCT01493960|38353016|FG001|Overall Study|Withdrawal by Subject|4|||
17199201|NCT01493960|38353015|FG000|Overall Study|Non-specified|4|||
17199202|NCT01493960|38353016|FG001|Overall Study|Non-specified|4|||
17199203|NCT02630459|38353026|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
17199204|NCT02630459|38353027|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
17199205|NCT02630459|38353028|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
17199206|NCT02630459|38353029|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
17199207|NCT02630459|38353030|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
17199208|NCT02630459|38353031|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
17199209|NCT02630459|38353032|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
17199210|NCT02630459|38353033|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
17199211|NCT02630459|38353026|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
17199212|NCT02630459|38353027|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
17199213|NCT02630459|38353028|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
17199214|NCT02630459|38353029|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
17199215|NCT02630459|38353030|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
17199216|NCT02630459|38353031|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
17199217|NCT02630459|38353032|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
17199218|NCT02630459|38353033|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
17199219|NCT02630459|38353026|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
17199220|NCT02630459|38353027|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
17199221|NCT02630459|38353028|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
17199222|NCT02630459|38353029|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
17199223|NCT02630459|38353030|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
17199224|NCT02630459|38353031|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
17199225|NCT02630459|38353032|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
17199226|NCT02630459|38353033|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
17199227|NCT02630459|38353026|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
17199228|NCT02630459|38353027|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
17199229|NCT02630459|38353028|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
17199230|NCT02630459|38353029|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
17199231|NCT02630459|38353030|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
17199232|NCT02630459|38353031|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
17199233|NCT02630459|38353032|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
17199234|NCT02630459|38353033|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
17199235|NCT02630459|38353026|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
17199236|NCT02630459|38353027|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
17199237|NCT02630459|38353028|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
17199238|NCT02630459|38353029|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
17199239|NCT02630459|38353030|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
17199240|NCT02630459|38353031|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
17199241|NCT02630459|38353032|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
17199242|NCT02630459|38353033|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
17199243|NCT02630459|38353026|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
17199244|NCT02630459|38353027|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
17199245|NCT02630459|38353028|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
17199246|NCT02630459|38353029|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
17199247|NCT02630459|38353030|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
17199248|NCT02630459|38353031|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
17199249|NCT02630459|38353032|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
17199250|NCT02630459|38353033|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
17199251|NCT02630459|38353026|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
17199252|NCT02630459|38353027|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
17199253|NCT02630459|38353028|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
17199254|NCT02630459|38353029|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
17199255|NCT02630459|38353030|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
17199256|NCT02630459|38353031|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
17199257|NCT02630459|38353032|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
17199258|NCT02630459|38353033|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
17199259|NCT02573948|38353058|FG000|Longitudinal Cohort|Death|9|||
17199260|NCT02573948|38353058|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
17199261|NCT02573948|38353058|FG000|Longitudinal Cohort|Incarcerated|25|||
17199262|NCT01464593|38353065|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
16853615|NCT01852045|37803964|FG002|Overall Study|Lack of Efficacy|0|||
17199263|NCT01361711|38353069|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
17199264|NCT01361711|38353069|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
17199265|NCT01361711|38353069|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
17199266|NCT01361711|38353069|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
17199267|NCT01361711|38353069|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
17199268|NCT01361711|38353069|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
17199269|NCT01361711|38353069|FG000|Completed Week 18 of Treatment|Other|9|||
17199270|NCT01361711|38353069|FG000|10 Year Follow-up|Still in follow-up|22|||
17199271|NCT01361711|38353069|FG000|10 Year Follow-up|Death|7|||
17199272|NCT01361711|38353069|FG000|10 Year Follow-up|Developed new cancer|1|||
17199273|NCT01361711|38353069|FG000|10 Year Follow-up|Lost to Follow-up|2|||
17199274|NCT01361711|38353069|FG000|10 Year Follow-up|New treatment started|6|||
17199275|NCT01361711|38353069|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
17199276|NCT01361711|38353069|FG000|10 Year Follow-up|Progressive Disease|1|||
17199277|NCT02572388|38353077|FG000|Overall Study|Withdrawal by Subject|1|||
17199278|NCT02572388|38353078|FG001|Overall Study|Withdrawal by Subject|1|||
17199279|NCT02572388|38353079|FG002|Overall Study|Withdrawal by Subject|2|||
17199280|NCT02572388|38353080|FG003|Overall Study|Withdrawal by Subject|2|||
17199281|NCT02573870|38353092|FG000|Overall Study|Adverse Event|0|||
17199282|NCT02573870|38353093|FG001|Overall Study|Adverse Event|2|||
17199283|NCT02573870|38353092|FG000|Overall Study|Lack of Efficacy|0|||
17199284|NCT02573870|38353093|FG001|Overall Study|Lack of Efficacy|1|||
17199285|NCT02573870|38353092|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
17199286|NCT02573870|38353093|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
17199287|NCT02573870|38353092|FG000|Overall Study|Lost to Follow-up|0|||
17199288|NCT02573870|38353093|FG001|Overall Study|Lost to Follow-up|1|||
17199289|NCT02573870|38353092|FG000|Overall Study|Other: Fail to Meet Visit|0|||
17199290|NCT02573870|38353093|FG001|Overall Study|Other: Fail to Meet Visit|2|||
17199291|NCT02572076|38353099|FG000|Overall Study|Protocol Violation|1|||
17199292|NCT02571452|38353105|FG000|Overall Study Treatment|Protocol Violation|0|||
17199293|NCT02571452|38353106|FG001|Overall Study Treatment|Protocol Violation|1|||
17199294|NCT02571452|38353105|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
17199295|NCT02571452|38353106|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
17199296|NCT02571452|38353105|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
17199297|NCT02571452|38353106|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
17199298|NCT02574260|38353112|FG000|Overall Study|Disease Progression|1|||
17199299|NCT02570126|38353118|FG000|Overall Study|Lost to Follow-up|2|||
17199300|NCT02570126|38353119|FG001|Overall Study|Lost to Follow-up|0|||
17199301|NCT02570126|38353118|FG000|Overall Study|Unable To Arrange Visit 3|1|||
17199302|NCT02570126|38353119|FG001|Overall Study|Unable To Arrange Visit 3|0|||
17199303|NCT02570126|38353118|FG000|Overall Study|Violation Of Procedures GSK|0|||
17199304|NCT02570126|38353119|FG001|Overall Study|Violation Of Procedures GSK|1|||
17199305|NCT02570126|38353118|FG000|Overall Study|Protocol Violation|0|||
17199306|NCT02570126|38353119|FG001|Overall Study|Protocol Violation|1|||
17199307|NCT02570126|38353118|FG000|Overall Study|Withdrawal by Subject|3|||
17199308|NCT02570126|38353119|FG001|Overall Study|Withdrawal by Subject|7|||
17199309|NCT04424641|38353133|FG000|Overall Study|Death|1|||
17199310|NCT04424641|38353134|FG001|Overall Study|Death|2|||
17199311|NCT04424641|38353135|FG002|Overall Study|Death|3|||
17199312|NCT04424641|38353136|FG003|Overall Study|Death|0|||
17199313|NCT04424641|38353137|FG004|Overall Study|Death|3|||
17199314|NCT04424641|38353138|FG005|Overall Study|Death|0|||
17199315|NCT04424641|38353139|FG006|Overall Study|Death|1|||
17199316|NCT04424641|38353140|FG007|Overall Study|Death|2|||
17199317|NCT04424641|38353133|FG000|Overall Study|Sponsor decision|0|||
17199318|NCT04424641|38353134|FG001|Overall Study|Sponsor decision|2|||
17199319|NCT04424641|38353135|FG002|Overall Study|Sponsor decision|3|||
17199320|NCT04424641|38353136|FG003|Overall Study|Sponsor decision|7|||
17199321|NCT04424641|38353137|FG004|Overall Study|Sponsor decision|2|||
17199322|NCT04424641|38353138|FG005|Overall Study|Sponsor decision|2|||
17199323|NCT04424641|38353139|FG006|Overall Study|Sponsor decision|3|||
17199324|NCT04424641|38353140|FG007|Overall Study|Sponsor decision|4|||
17199325|NCT04424641|38353133|FG000|Overall Study|Withdrawal by Subject|0|||
17199326|NCT04424641|38353134|FG001|Overall Study|Withdrawal by Subject|0|||
17199327|NCT04424641|38353135|FG002|Overall Study|Withdrawal by Subject|0|||
17199328|NCT04424641|38353136|FG003|Overall Study|Withdrawal by Subject|0|||
17199329|NCT04424641|38353137|FG004|Overall Study|Withdrawal by Subject|1|||
17199330|NCT04424641|38353138|FG005|Overall Study|Withdrawal by Subject|0|||
17199331|NCT04424641|38353139|FG006|Overall Study|Withdrawal by Subject|0|||
17199332|NCT04424641|38353140|FG007|Overall Study|Withdrawal by Subject|0|||
17199333|NCT04424641|38353133|FG000|Overall Study|Other|0|||
17199334|NCT04424641|38353134|FG001|Overall Study|Other|0|||
17199335|NCT04424641|38353135|FG002|Overall Study|Other|1|||
17199336|NCT04424641|38353136|FG003|Overall Study|Other|0|||
17199337|NCT04424641|38353137|FG004|Overall Study|Other|0|||
17199338|NCT04424641|38353138|FG005|Overall Study|Other|0|||
17199339|NCT04424641|38353139|FG006|Overall Study|Other|0|||
17199340|NCT04424641|38353140|FG007|Overall Study|Other|0|||
17199341|NCT02755831|38353160|FG000|Overall Study|Lost to Follow-up|3|||
17199342|NCT02755831|38353161|FG001|Overall Study|Lost to Follow-up|3|||
17199343|NCT02573246|38353172|FG000|Overall Study|Lost to Follow-up|2|||
17199344|NCT02573246|38353173|FG001|Overall Study|Lost to Follow-up|0|||
17199345|NCT02573246|38353174|FG002|Overall Study|Lost to Follow-up|0|||
17199346|NCT02573246|38353175|FG003|Overall Study|Lost to Follow-up|0|||
17199347|NCT02573246|38353176|FG004|Overall Study|Lost to Follow-up|1|||
17199348|NCT02573246|38353172|FG000|Overall Study|Withdrawal by Subject|0|||
17199349|NCT02573246|38353173|FG001|Overall Study|Withdrawal by Subject|0|||
17199350|NCT02573246|38353174|FG002|Overall Study|Withdrawal by Subject|0|||
17199351|NCT02573246|38353175|FG003|Overall Study|Withdrawal by Subject|0|||
17199352|NCT02573246|38353176|FG004|Overall Study|Withdrawal by Subject|1|||
17199353|NCT02573246|38353172|FG000|Overall Study|Physician Decision|1|||
17199354|NCT02573246|38353173|FG001|Overall Study|Physician Decision|1|||
17199355|NCT02573246|38353174|FG002|Overall Study|Physician Decision|3|||
17199356|NCT02573246|38353175|FG003|Overall Study|Physician Decision|2|||
17199357|NCT02573246|38353176|FG004|Overall Study|Physician Decision|2|||
17199358|NCT02570750|38353195|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
17199359|NCT02570750|38353196|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
17199360|NCT02570750|38353195|FG000|Overall Study|Protocol deviation|4|||
17199361|NCT02570750|38353196|FG001|Overall Study|Protocol deviation|2|||
17199362|NCT02570750|38353195|FG000|Overall Study|Withdrawal by Subject|5|||
17199363|NCT02570750|38353196|FG001|Overall Study|Withdrawal by Subject|0|||
17199364|NCT02570750|38353195|FG000|Overall Study|Lost to Follow-up|2|||
17199365|NCT02570750|38353196|FG001|Overall Study|Lost to Follow-up|2|||
17199366|NCT02570750|38353195|FG000|Overall Study|Adverse Event|2|||
17199367|NCT02570750|38353196|FG001|Overall Study|Adverse Event|1|||
17199368|NCT02573012|38353204|FG000|Overall Study|Adverse Event|5|||
17199369|NCT02573012|38353205|FG001|Overall Study|Adverse Event|5|||
17199370|NCT02573012|38353204|FG000|Overall Study|Lack of Efficacy|5|||
17199371|NCT02573012|38353205|FG001|Overall Study|Lack of Efficacy|4|||
17199372|NCT02573012|38353204|FG000|Overall Study|Non-compliance|1|||
17199373|NCT02573012|38353205|FG001|Overall Study|Non-compliance|2|||
17199374|NCT02573012|38353204|FG000|Overall Study|Withdrawal by Subject|2|||
17199375|NCT02573012|38353205|FG001|Overall Study|Withdrawal by Subject|2|||
17199376|NCT02573012|38353204|FG000|Overall Study|Study Ended per Protocol|1|||
17199377|NCT02573012|38353205|FG001|Overall Study|Study Ended per Protocol|0|||
17199378|NCT02573012|38353204|FG000|Overall Study|Physician Decision|1|||
17199379|NCT02573012|38353205|FG001|Overall Study|Physician Decision|2|||
17199380|NCT02752633|38353211|FG000|Overall Study|Withdrawal by Subject|1|||
17199381|NCT02752087|38353215|FG000|Washout|Physician Decision|1|||
17199382|NCT02752087|38353216|FG001|Washout|Physician Decision|0|||
17199383|NCT02563028|38353222|FG000|Overall Study|Lack of equipment|1|||
17199384|NCT02563028|38353222|FG000|Overall Study|Unable to elicit VEP post induction|1|||
17199385|NCT02192827|38353228|FG000|Overall Study|Lost to Follow-up|25|||
17199386|NCT02192827|38353229|FG001|Overall Study|Lost to Follow-up|27|||
17199387|NCT02192827|38353228|FG000|Overall Study|Given additional steroids with admission|13|||
17199388|NCT02192827|38353229|FG001|Overall Study|Given additional steroids with admission|11|||
17199389|NCT02562716|38353237|FG000|Overall Study|Adverse Event|7|||
17199390|NCT02562716|38353238|FG001|Overall Study|Adverse Event|14|||
17199391|NCT02562716|38353237|FG000|Overall Study|Withdrawal unrelated to AE|7|||
17199392|NCT02562716|38353238|FG001|Overall Study|Withdrawal unrelated to AE|1|||
17199393|NCT02562716|38353237|FG000|Overall Study|Progression|8|||
17199394|NCT02562716|38353238|FG001|Overall Study|Progression|10|||
17199395|NCT02562716|38353237|FG000|Overall Study|Death|2|||
17199396|NCT02562716|38353238|FG001|Overall Study|Death|1|||
17199397|NCT02562716|38353237|FG000|Overall Study|Not protocol specified|4|||
17199398|NCT02562716|38353238|FG001|Overall Study|Not protocol specified|2|||
17199399|NCT02562482|38353248|FG000|Overall Study|Enrolled, but did not receive product|4|||
17199400|NCT02562482|38353249|FG001|Overall Study|Enrolled, but did not receive product|0|||
17199401|NCT02562482|38353248|FG000|Overall Study|Lost to Follow-up|9|||
17199402|NCT02562482|38353249|FG001|Overall Study|Lost to Follow-up|6|||
17199403|NCT02562482|38353248|FG000|Overall Study|Moved from area|2|||
17199404|NCT02562482|38353249|FG001|Overall Study|Moved from area|3|||
17199405|NCT02562482|38353248|FG000|Overall Study|Withdrawal by Subject|5|||
17199406|NCT02562482|38353249|FG001|Overall Study|Withdrawal by Subject|3|||
17199407|NCT02562482|38353248|FG000|Overall Study|Physician Decision|1|||
17199408|NCT02562482|38353249|FG001|Overall Study|Physician Decision|3|||
17199409|NCT02562482|38353248|FG000|Overall Study|Illness/Injury unrelated to product|0|||
17199410|NCT02562482|38353249|FG001|Overall Study|Illness/Injury unrelated to product|1|||
17199411|NCT02568254|38353264|FG000|Period 2|Adverse Event|0|||
17199412|NCT02568254|38353265|FG001|Period 2|Adverse Event|0|||
17199413|NCT02568254|38353266|FG002|Period 2|Adverse Event|1|||
17199414|NCT02568254|38353267|FG003|Period 2|Adverse Event|0|||
17199415|NCT02568254|38353268|FG004|Period 2|Adverse Event|0|||
16853616|NCT01852045|37803962|FG000|Overall Study|Lost to Follow-up|0|||
17199416|NCT02568254|38353269|FG005|Period 2|Adverse Event|0|||
17199417|NCT02568254|38353264|FG000|Period 3|Unstatisfactory Lens fitting|0|||
17199418|NCT02568254|38353265|FG001|Period 3|Unstatisfactory Lens fitting|0|||
17199419|NCT02568254|38353266|FG002|Period 3|Unstatisfactory Lens fitting|0|||
17199420|NCT02568254|38353267|FG003|Period 3|Unstatisfactory Lens fitting|0|||
17199421|NCT02568254|38353268|FG004|Period 3|Unstatisfactory Lens fitting|1|||
17199422|NCT02568254|38353269|FG005|Period 3|Unstatisfactory Lens fitting|0|||
17199423|NCT02567708|38353277|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
17199424|NCT02567708|38353278|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
17199425|NCT02567708|38353277|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
17199426|NCT02567708|38353278|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
17199427|NCT02567708|38353277|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
17199428|NCT02567708|38353278|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
17199429|NCT02567708|38353277|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
17199430|NCT02567708|38353278|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
17199431|NCT02751931|38353287|FG000|Overall Study|Adverse Event|3|||
17199432|NCT02751931|38353288|FG001|Overall Study|Adverse Event|0|||
17199433|NCT02751931|38353287|FG000|Overall Study|Other: Miscelleneous|10|||
17199434|NCT02751931|38353288|FG001|Overall Study|Other: Miscelleneous|8|||
17199435|NCT02561156|38353313|FG000|Part 2|Adverse Event|0|||
17199436|NCT02561156|38353314|FG001|Part 2|Adverse Event|0|||
17199437|NCT02561156|38353315|FG002|Part 2|Adverse Event|0|||
17199438|NCT02561156|38353316|FG003|Part 2|Adverse Event|0|||
17199439|NCT02561156|38353317|FG004|Part 2|Adverse Event|0|||
17199440|NCT02561156|38353318|FG005|Part 2|Adverse Event|0|||
17199441|NCT02561156|38353319|FG006|Part 2|Adverse Event|0|||
17199442|NCT02561156|38353320|FG007|Part 2|Adverse Event|0|||
17199443|NCT02561156|38353321|FG008|Part 2|Adverse Event|0|||
17199444|NCT02561156|38353322|FG009|Part 2|Adverse Event|0|||
17199445|NCT02561156|38353323|FG010|Part 2|Adverse Event|0|||
17199446|NCT02561156|38353324|FG011|Part 2|Adverse Event|1|||
17199447|NCT02561156|38353325|FG012|Part 2|Adverse Event|0|||
17199448|NCT02561078|38353371|FG000|Overall Study|Adverse Event|5|||
17199449|NCT02561078|38353372|FG001|Overall Study|Adverse Event|2|||
17199450|NCT02561078|38353371|FG000|Overall Study|Death|2|||
17199451|NCT02561078|38353372|FG001|Overall Study|Death|1|||
17199452|NCT02561078|38353371|FG000|Overall Study|Lost to Follow-up|2|||
17199453|NCT02561078|38353372|FG001|Overall Study|Lost to Follow-up|6|||
17199454|NCT02561078|38353371|FG000|Overall Study|Non-Compliance with Study Drug|6|||
17199455|NCT02561078|38353372|FG001|Overall Study|Non-Compliance with Study Drug|3|||
17199456|NCT02561078|38353371|FG000|Overall Study|Physician Decision|2|||
17199457|NCT02561078|38353372|FG001|Overall Study|Physician Decision|3|||
17199458|NCT02561078|38353371|FG000|Overall Study|Withdrawal by Subject|13|||
17199459|NCT02561078|38353372|FG001|Overall Study|Withdrawal by Subject|10|||
16853617|NCT01852045|37803963|FG001|Overall Study|Lost to Follow-up|1|||
16853618|NCT01852045|37803964|FG002|Overall Study|Lost to Follow-up|1|||
16853619|NCT01852045|37803962|FG000|Overall Study|Withdrawal by Subject|1|||
16853620|NCT01852045|37803963|FG001|Overall Study|Withdrawal by Subject|0|||
16853621|NCT01852045|37803964|FG002|Overall Study|Withdrawal by Subject|1|||
16853622|NCT01852045|37803962|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16853623|NCT01852045|37803963|FG001|Overall Study|Other Miscellaneous Reasons|3|||
16853624|NCT01852045|37803964|FG002|Overall Study|Other Miscellaneous Reasons|2|||
16853625|NCT01821937|37803983|FG000|Overall Study|Adverse Event|0|||
16853626|NCT01821937|37803984|FG001|Overall Study|Adverse Event|3|||
16853627|NCT01821625|37803992|FG000|Overall Study|Withdrawal by Subject|2|||
16853628|NCT01821625|37803992|FG000|Overall Study|Lack of Efficacy|2|||
16853629|NCT01821625|37803992|FG000|Overall Study|Adverse Event|1|||
16853630|NCT01821625|37803992|FG000|Overall Study|Medical contraindication|1|||
16853631|NCT01821391|37803998|FG000|Overall Study|Adverse Event|1|||
16853632|NCT01821391|37803999|FG001|Overall Study|Adverse Event|0|||
16853633|NCT01873417|37804007|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
16853634|NCT01873417|37804007|FG000|Overall Study|Adverse Event|24|||
16853635|NCT01873417|37804007|FG000|Overall Study|Lost to Follow-up|2|||
16853636|NCT01873417|37804007|FG000|Overall Study|Withdrawal by Subject|2|||
16853637|NCT01873417|37804007|FG000|Overall Study|Physician Decision|3|||
16853638|NCT01872715|37804011|FG000|Overall Study|Adverse Event|1|||
16853639|NCT01872715|37804011|FG000|Overall Study|Protocol Violation|1|||
16853640|NCT01872715|37804011|FG000|Overall Study|Withdrawal by Subject|2|||
16853641|NCT01871545|37804027|FG000|Overall Study|Death|2|||
16853642|NCT01871545|37804028|FG001|Overall Study|Death|0|||
16853643|NCT01871545|37804027|FG000|Overall Study|Lack of Efficacy|11|||
16853644|NCT01871545|37804028|FG001|Overall Study|Lack of Efficacy|2|||
16853645|NCT01871545|37804027|FG000|Overall Study|Physician Decision|4|||
16853646|NCT01871545|37804028|FG001|Overall Study|Physician Decision|0|||
17104430|NCT03568318|38242371|FG002|Overall Study|Lost to Follow-up|2|||
17199460|NCT02567552|38353380|FG000|Overall Study|Adverse Event|0|||
17199461|NCT02567552|38353381|FG001|Overall Study|Adverse Event|1|||
17199462|NCT02561000|38353395|FG000|Overall Study|Withdrawal by Subject|2|||
17199463|NCT02561000|38353396|FG001|Overall Study|Withdrawal by Subject|3|||
17199464|NCT02561000|38353397|FG002|Overall Study|Withdrawal by Subject|0|||
17199465|NCT02561000|38353395|FG000|Overall Study|Adverse Event|0|||
17199466|NCT02561000|38353396|FG001|Overall Study|Adverse Event|1|||
17199467|NCT02561000|38353397|FG002|Overall Study|Adverse Event|0|||
17199468|NCT01663532|38353407|FG000|Overall Study|Lost to Follow-up|9|||
17199469|NCT01663532|38353408|FG001|Overall Study|Lost to Follow-up|10|||
17199470|NCT01663532|38353407|FG000|Overall Study|Adverse Event|7|||
17199471|NCT01663532|38353408|FG001|Overall Study|Adverse Event|13|||
17199472|NCT01663532|38353407|FG000|Overall Study|Met Withdrawal Criteria|7|||
17199473|NCT01663532|38353408|FG001|Overall Study|Met Withdrawal Criteria|6|||
17199474|NCT01663532|38353407|FG000|Overall Study|Physician Decision|1|||
17199475|NCT01663532|38353408|FG001|Overall Study|Physician Decision|1|||
17199476|NCT01663532|38353407|FG000|Overall Study|Withdrawal by Subject|35|||
17199477|NCT01663532|38353408|FG001|Overall Study|Withdrawal by Subject|17|||
17199478|NCT01663532|38353407|FG000|Overall Study|Lack of Efficacy|15|||
17199479|NCT01663532|38353408|FG001|Overall Study|Lack of Efficacy|60|||
17199480|NCT02525939|38353416|FG000|Overall Study|Lost to Follow-up|27|||
17199481|NCT02525939|38353417|FG001|Overall Study|Lost to Follow-up|24|||
17199482|NCT02525939|38353416|FG000|Overall Study|Physician Decision|0|||
17199483|NCT02525939|38353417|FG001|Overall Study|Physician Decision|1|||
17199484|NCT02525939|38353416|FG000|Overall Study|Withdrawal by Subject|24|||
17199485|NCT02525939|38353417|FG001|Overall Study|Withdrawal by Subject|39|||
17199486|NCT02525939|38353416|FG000|Overall Study|Death|180|||
17199487|NCT02525939|38353417|FG001|Overall Study|Death|179|||
17199488|NCT02697591|38353454|FG000|Overall Study|Lost to Follow-up|0|||
17199489|NCT02697591|38353455|FG001|Overall Study|Lost to Follow-up|0|||
17199490|NCT02697591|38353456|FG002|Overall Study|Lost to Follow-up|0|||
17199491|NCT02697591|38353457|FG003|Overall Study|Lost to Follow-up|0|||
17199492|NCT02697591|38353458|FG004|Overall Study|Lost to Follow-up|0|||
17199493|NCT02697591|38353459|FG005|Overall Study|Lost to Follow-up|1|||
17199494|NCT02697591|38353460|FG006|Overall Study|Lost to Follow-up|1|||
17199495|NCT02697591|38353461|FG007|Overall Study|Lost to Follow-up|0|||
17199496|NCT02697591|38353462|FG008|Overall Study|Lost to Follow-up|0|||
17199497|NCT02697591|38353463|FG009|Overall Study|Lost to Follow-up|1|||
17199498|NCT02697591|38353454|FG000|Overall Study|Withdrawal by Subject|1|||
17199499|NCT02697591|38353455|FG001|Overall Study|Withdrawal by Subject|1|||
17199500|NCT02697591|38353456|FG002|Overall Study|Withdrawal by Subject|2|||
17199501|NCT02697591|38353457|FG003|Overall Study|Withdrawal by Subject|1|||
17199502|NCT02697591|38353458|FG004|Overall Study|Withdrawal by Subject|7|||
17199503|NCT02697591|38353459|FG005|Overall Study|Withdrawal by Subject|6|||
17199504|NCT02697591|38353460|FG006|Overall Study|Withdrawal by Subject|9|||
17199505|NCT02697591|38353461|FG007|Overall Study|Withdrawal by Subject|1|||
17199506|NCT02697591|38353462|FG008|Overall Study|Withdrawal by Subject|6|||
17199507|NCT02697591|38353463|FG009|Overall Study|Withdrawal by Subject|10|||
17199508|NCT02697591|38353454|FG000|Overall Study|Physician Decision|1|||
17199509|NCT02697591|38353455|FG001|Overall Study|Physician Decision|0|||
17199510|NCT02697591|38353456|FG002|Overall Study|Physician Decision|0|||
17199511|NCT02697591|38353457|FG003|Overall Study|Physician Decision|0|||
17199512|NCT02697591|38353458|FG004|Overall Study|Physician Decision|1|||
17199513|NCT02697591|38353459|FG005|Overall Study|Physician Decision|2|||
17199514|NCT02697591|38353460|FG006|Overall Study|Physician Decision|0|||
17199515|NCT02697591|38353461|FG007|Overall Study|Physician Decision|0|||
17199516|NCT02697591|38353462|FG008|Overall Study|Physician Decision|1|||
17199517|NCT02697591|38353463|FG009|Overall Study|Physician Decision|1|||
17199518|NCT02697591|38353454|FG000|Overall Study|Death|2|||
17199519|NCT02697591|38353455|FG001|Overall Study|Death|3|||
17199520|NCT02697591|38353456|FG002|Overall Study|Death|1|||
17199521|NCT02697591|38353457|FG003|Overall Study|Death|1|||
17199522|NCT02697591|38353458|FG004|Overall Study|Death|4|||
17199523|NCT02697591|38353459|FG005|Overall Study|Death|5|||
17199524|NCT02697591|38353460|FG006|Overall Study|Death|3|||
17199525|NCT02697591|38353461|FG007|Overall Study|Death|1|||
17104431|NCT03568318|38242372|FG003|Overall Study|Lost to Follow-up|2|||
17104432|NCT03568318|38242373|FG004|Overall Study|Lost to Follow-up|1|||
17104433|NCT03568318|38242374|FG005|Overall Study|Lost to Follow-up|0|||
17104434|NCT03568318|38242369|FG000|Overall Study|Other|3|||
17104435|NCT03568318|38242370|FG001|Overall Study|Other|1|||
17104436|NCT03568318|38242371|FG002|Overall Study|Other|3|||
17104437|NCT03568318|38242372|FG003|Overall Study|Other|0|||
17104438|NCT03568318|38242373|FG004|Overall Study|Other|0|||
16853647|NCT01871545|37804027|FG000|Overall Study|Withdrawal by Subject|0|||
16853648|NCT01871545|37804028|FG001|Overall Study|Withdrawal by Subject|1|||
16853649|NCT01613599|37804037|FG000|Overall Study|Death|9|||
17199526|NCT02697591|38353462|FG008|Overall Study|Death|1|||
17199527|NCT02697591|38353463|FG009|Overall Study|Death|5|||
17104439|NCT03568318|38242374|FG005|Overall Study|Other|0|||
17199528|NCT02697591|38353454|FG000|Overall Study|Reason not Specified|0|||
16853650|NCT01613599|37804037|FG000|Overall Study|Lost to Follow-up|5|||
17104440|NCT03568318|38242369|FG000|Overall Study|Ongoing at Time of Analysis|5|||
17199529|NCT02697591|38353455|FG001|Overall Study|Reason not Specified|0|||
17199530|NCT02697591|38353456|FG002|Overall Study|Reason not Specified|0|||
17199531|NCT02697591|38353457|FG003|Overall Study|Reason not Specified|1|||
17199532|NCT02697591|38353458|FG004|Overall Study|Reason not Specified|1|||
17199533|NCT02697591|38353459|FG005|Overall Study|Reason not Specified|2|||
17199534|NCT02697591|38353460|FG006|Overall Study|Reason not Specified|3|||
17199535|NCT02697591|38353461|FG007|Overall Study|Reason not Specified|1|||
17199536|NCT02697591|38353462|FG008|Overall Study|Reason not Specified|1|||
17199537|NCT02697591|38353463|FG009|Overall Study|Reason not Specified|3|||
17199538|NCT02697435|38353488|FG000|Overall Study|Withdrawal by Subject|1|||
17199539|NCT02697435|38353489|FG001|Overall Study|Withdrawal by Subject|0|||
17199540|NCT02697435|38353488|FG000|Overall Study|Physician Decision|0|||
17199541|NCT02697435|38353489|FG001|Overall Study|Physician Decision|4|||
17199542|NCT02174861|38353496|FG000|Overall Study|Decision by sponsor|8|||
17199543|NCT02174861|38353496|FG000|Overall Study|Withdrawal by Subject|124|||
17199544|NCT02174861|38353496|FG000|Overall Study|Lost to Follow-up|26|||
17199545|NCT00140855|38353502|FG000|Overall Study|Progressive disease|2|||
17199546|NCT00700635|38353509|FG000|Overall Study|Adverse Event|1|||
17199547|NCT00700635|38353510|FG001|Overall Study|Adverse Event|0|||
17199548|NCT00700635|38353511|FG002|Overall Study|Adverse Event|0|||
17199549|NCT00700635|38353509|FG000|Overall Study|Lost to Follow-up|1|||
17199550|NCT00700635|38353510|FG001|Overall Study|Lost to Follow-up|3|||
17199551|NCT00700635|38353511|FG002|Overall Study|Lost to Follow-up|0|||
17199552|NCT00700635|38353509|FG000|Overall Study|Protocol Violation|2|||
17199553|NCT00700635|38353510|FG001|Overall Study|Protocol Violation|2|||
17199554|NCT00700635|38353511|FG002|Overall Study|Protocol Violation|0|||
17199555|NCT00700635|38353509|FG000|Overall Study|Withdrawal by Subject|7|||
17199556|NCT00700635|38353510|FG001|Overall Study|Withdrawal by Subject|3|||
17199557|NCT00700635|38353511|FG002|Overall Study|Withdrawal by Subject|1|||
17199558|NCT02780687|38353521|FG000|Overall Study|Adverse Event|1|||
17199559|NCT02780687|38353522|FG001|Overall Study|Adverse Event|1|||
17199560|NCT02780687|38353521|FG000|Overall Study|Withdrawal by Subject|2|||
17199561|NCT02780687|38353522|FG001|Overall Study|Withdrawal by Subject|1|||
17199562|NCT02780687|38353521|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
17199563|NCT02780687|38353522|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
17199564|NCT02780687|38353521|FG000|Overall Study|progressive disease|29|||
17199565|NCT02780687|38353522|FG001|Overall Study|progressive disease|6|||
17199566|NCT02698371|38353527|FG000|All Participants Flow|Lost to Follow-up|3|||
17199567|NCT02698371|38353527|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
17199568|NCT02698371|38353527|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
17199569|NCT02698371|38353527|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
17199570|NCT02698371|38353527|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
17199571|NCT02698371|38353527|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
17199572|NCT02698371|38353527|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
17199573|NCT02781311|38353546|FG000|Overall Study|Adverse Event|2|||
17199574|NCT02781311|38353547|FG001|Overall Study|Adverse Event|6|||
17199575|NCT02781311|38353548|FG002|Overall Study|Adverse Event|1|||
17199576|NCT02781311|38353546|FG000|Overall Study|Withdrawal of Consent|11|||
17199577|NCT02781311|38353547|FG001|Overall Study|Withdrawal of Consent|12|||
17199578|NCT02781311|38353548|FG002|Overall Study|Withdrawal of Consent|2|||
17199579|NCT02781311|38353546|FG000|Overall Study|Lost to Follow-up|11|||
17199580|NCT02781311|38353547|FG001|Overall Study|Lost to Follow-up|8|||
17199581|NCT02781311|38353548|FG002|Overall Study|Lost to Follow-up|1|||
17199582|NCT02781311|38353546|FG000|Overall Study|Non-Compliance with Study Drug|2|||
17199583|NCT02781311|38353547|FG001|Overall Study|Non-Compliance with Study Drug|0|||
17199584|NCT02781311|38353548|FG002|Overall Study|Non-Compliance with Study Drug|0|||
17199585|NCT02564198|38353558|FG000|Overall Study|Withdrawal by Subject|2|||
17199586|NCT02564198|38353559|FG001|Overall Study|Withdrawal by Subject|4|||
17199587|NCT02564198|38353560|FG002|Overall Study|Withdrawal by Subject|0|||
17199588|NCT02564198|38353558|FG000|Overall Study|Adverse Event|0|||
17199589|NCT02564198|38353559|FG001|Overall Study|Adverse Event|1|||
17199590|NCT02564198|38353560|FG002|Overall Study|Adverse Event|0|||
17199591|NCT02564120|38353575|FG000|Overall Study|Did not return release forms|160|||
17199592|NCT02564120|38353575|FG000|Overall Study|Death|58|||
17199593|NCT02564120|38353575|FG000|Overall Study|Withdrawal by Subject|204|||
17199594|NCT02564120|38353575|FG000|Overall Study|Other medical condition|24|||
17199595|NCT00705783|38353591|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
17199596|NCT00705783|38353592|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
17199597|NCT00705783|38353593|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
17199598|NCT00705783|38353591|FG000|Conversion Phase|Lost to Follow-up|13|||
17199599|NCT00705783|38353592|FG001|Conversion Phase|Lost to Follow-up|0|||
17199600|NCT00705783|38353593|FG002|Conversion Phase|Lost to Follow-up|0|||
17199601|NCT00705783|38353591|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
17199602|NCT00705783|38353592|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
17199603|NCT00705783|38353593|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
17199604|NCT00705783|38353591|FG000|Conversion Phase|Withdrawn by Investigator|4|||
17199605|NCT00705783|38353592|FG001|Conversion Phase|Withdrawn by Investigator|0|||
17199606|NCT00705783|38353593|FG002|Conversion Phase|Withdrawn by Investigator|0|||
17199607|NCT00705783|38353591|FG000|Conversion Phase|Withdrew Consent|24|||
17199608|NCT00705783|38353592|FG001|Conversion Phase|Withdrew Consent|0|||
17199609|NCT00705783|38353593|FG002|Conversion Phase|Withdrew Consent|0|||
17199610|NCT00705783|38353591|FG000|Conversion Phase|Protocol Deviation|2|||
17199611|NCT00705783|38353592|FG001|Conversion Phase|Protocol Deviation|0|||
17199612|NCT00705783|38353593|FG002|Conversion Phase|Protocol Deviation|0|||
17199613|NCT00705783|38353591|FG000|Conversion Phase|Adverse Event|11|||
17199614|NCT00705783|38353592|FG001|Conversion Phase|Adverse Event|0|||
17199615|NCT00705783|38353593|FG002|Conversion Phase|Adverse Event|0|||
17199616|NCT00705783|38353591|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
17199617|NCT00705783|38353592|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
17199618|NCT00705783|38353593|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
17199619|NCT00705783|38353591|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
17199620|NCT00705783|38353592|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
17199621|NCT00705783|38353593|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
17199622|NCT00705783|38353591|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
17199623|NCT00705783|38353592|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
17199624|NCT00705783|38353593|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
17199625|NCT00705783|38353591|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
17199626|NCT00705783|38353592|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
17199627|NCT00705783|38353593|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
17199628|NCT00705783|38353591|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
17199629|NCT00705783|38353592|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
17199630|NCT00705783|38353593|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
17199631|NCT00705783|38353591|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
17199632|NCT00705783|38353592|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
17199633|NCT00705783|38353593|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
17199634|NCT00705783|38353591|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
17199635|NCT00705783|38353592|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
17199636|NCT00705783|38353593|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
17199637|NCT00705783|38353591|FG000|Oral Stabilization Phase|Adverse Event|14|||
17199638|NCT00705783|38353592|FG001|Oral Stabilization Phase|Adverse Event|0|||
17199639|NCT00705783|38353593|FG002|Oral Stabilization Phase|Adverse Event|0|||
17199640|NCT00705783|38353591|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
17199641|NCT00705783|38353592|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
17199642|NCT00705783|38353593|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
17199643|NCT00705783|38353591|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
17199644|NCT00705783|38353592|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
17199645|NCT00705783|38353593|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
17199646|NCT00705783|38353591|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
17199647|NCT00705783|38353592|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
17199648|NCT00705783|38353593|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
17199649|NCT00705783|38353591|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
17199650|NCT00705783|38353592|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
17199651|NCT00705783|38353593|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
17199652|NCT00705783|38353591|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
17199653|NCT00705783|38353592|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
17199654|NCT00705783|38353593|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
17199655|NCT00705783|38353591|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
17199656|NCT00705783|38353592|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
17199657|NCT00705783|38353593|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
17199658|NCT00705783|38353591|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
17199659|NCT00705783|38353592|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
17199660|NCT00705783|38353593|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
17199661|NCT00705783|38353591|FG000|Depot Stabilization Phase|Adverse Event|17|||
17199662|NCT00705783|38353592|FG001|Depot Stabilization Phase|Adverse Event|0|||
17199663|NCT00705783|38353593|FG002|Depot Stabilization Phase|Adverse Event|0|||
17199664|NCT00705783|38353591|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
17199665|NCT00705783|38353592|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
17104441|NCT03568318|38242370|FG001|Overall Study|Ongoing at Time of Analysis|3|||
17104442|NCT03568318|38242371|FG002|Overall Study|Ongoing at Time of Analysis|2|||
17104443|NCT03568318|38242372|FG003|Overall Study|Ongoing at Time of Analysis|1|||
17104444|NCT03568318|38242373|FG004|Overall Study|Ongoing at Time of Analysis|0|||
17104445|NCT03568318|38242374|FG005|Overall Study|Ongoing at Time of Analysis|0|||
17199666|NCT00705783|38353593|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
17199667|NCT00705783|38353591|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
17199668|NCT00705783|38353592|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
17199669|NCT00705783|38353593|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
17199670|NCT00705783|38353591|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
17199671|NCT00705783|38353592|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
17199672|NCT00705783|38353593|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
17199673|NCT00705783|38353591|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
17199674|NCT00705783|38353592|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
17199675|NCT00705783|38353593|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
17199676|NCT00705783|38353591|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
17199677|NCT00705783|38353592|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
17199678|NCT00705783|38353593|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
17199679|NCT00705783|38353591|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
17199680|NCT00705783|38353592|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
17199681|NCT00705783|38353593|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
17104446|NCT00108069|38242390|FG000|Overall Study|Never rec'd study drug|0|||
17104447|NCT00108069|38242391|FG001|Overall Study|Never rec'd study drug|1|||
17104448|NCT00108069|38242390|FG000|Overall Study|Adverse Event|1|||
17199682|NCT00705783|38353591|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
17199683|NCT00705783|38353592|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
17199684|NCT00705783|38353593|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
17199685|NCT00705783|38353591|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
17199686|NCT00705783|38353592|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
17199687|NCT00705783|38353593|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
17199688|NCT00705783|38353591|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
17199689|NCT00705783|38353592|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
17199690|NCT00705783|38353593|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
17199691|NCT00705783|38353591|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
17199692|NCT00705783|38353592|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
17199693|NCT00705783|38353593|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
17199694|NCT00705783|38353591|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
17199695|NCT00705783|38353592|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
17199696|NCT00705783|38353593|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
17199697|NCT02694549|38353602|FG000|Overall Study|screen failures|2|||
17199698|NCT02782325|38353608|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
17199699|NCT02782325|38353609|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
17199700|NCT02782325|38353610|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
17199701|NCT02782325|38353608|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
17199702|NCT02782325|38353609|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
17199703|NCT02782325|38353610|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
17199704|NCT02693691|38353618|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
17199705|NCT02693691|38353618|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
17199706|NCT02693691|38353618|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
17199707|NCT02693691|38353618|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
17199708|NCT02693691|38353618|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
17199709|NCT02693691|38353618|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
17199710|NCT02693691|38353618|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
17199711|NCT04203667|38353622|FG000|Overall Study|Withdrawal by Subject|1|||
17199712|NCT04203667|38353622|FG000|Overall Study|Lost to Follow-up|1|||
17199713|NCT04203667|38353622|FG000|Overall Study|Death|1|||
17199714|NCT04203667|38353622|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
17199715|NCT02782169|38353629|FG000|Overall Study|Lost to Follow-up|1|||
17199716|NCT02782169|38353630|FG001|Overall Study|Lost to Follow-up|2|||
17199717|NCT02564042|38353642|FG000|Overall Study|Adverse Event|4|||
17199718|NCT02564042|38353643|FG001|Overall Study|Adverse Event|4|||
17199719|NCT02564042|38353644|FG002|Overall Study|Adverse Event|3|||
17199720|NCT02564042|38353645|FG003|Overall Study|Adverse Event|0|||
17199721|NCT02564042|38353646|FG004|Overall Study|Adverse Event|0|||
17199722|NCT02564042|38353647|FG005|Overall Study|Adverse Event|1|||
17199723|NCT02564042|38353642|FG000|Overall Study|Lost to Follow-up|1|||
17199724|NCT02564042|38353643|FG001|Overall Study|Lost to Follow-up|1|||
17199725|NCT02564042|38353644|FG002|Overall Study|Lost to Follow-up|1|||
17199726|NCT02564042|38353645|FG003|Overall Study|Lost to Follow-up|0|||
17199727|NCT02564042|38353646|FG004|Overall Study|Lost to Follow-up|1|||
17199728|NCT02564042|38353647|FG005|Overall Study|Lost to Follow-up|1|||
17199729|NCT02564042|38353642|FG000|Overall Study|Physician Decision|1|||
17199730|NCT02564042|38353643|FG001|Overall Study|Physician Decision|0|||
17199731|NCT02564042|38353644|FG002|Overall Study|Physician Decision|0|||
17199732|NCT02564042|38353645|FG003|Overall Study|Physician Decision|1|||
17199733|NCT02564042|38353646|FG004|Overall Study|Physician Decision|0|||
17199734|NCT02564042|38353647|FG005|Overall Study|Physician Decision|0|||
17199735|NCT02564042|38353642|FG000|Overall Study|Withdrawal by Subject|5|||
17199736|NCT02564042|38353643|FG001|Overall Study|Withdrawal by Subject|3|||
17199737|NCT02564042|38353644|FG002|Overall Study|Withdrawal by Subject|2|||
17199738|NCT02564042|38353645|FG003|Overall Study|Withdrawal by Subject|2|||
17199739|NCT02564042|38353646|FG004|Overall Study|Withdrawal by Subject|10|||
17199740|NCT02564042|38353647|FG005|Overall Study|Withdrawal by Subject|12|||
17199741|NCT02695719|38353680|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
17199742|NCT02695719|38353681|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
17199743|NCT02695719|38353680|FG000|Overall Study|Significant Protocol Deviation|0|||
17199744|NCT02695719|38353681|FG001|Overall Study|Significant Protocol Deviation|1|||
17199745|NCT02695719|38353680|FG000|Overall Study|Voluntary Withdrawal|1|||
17199746|NCT02695719|38353681|FG001|Overall Study|Voluntary Withdrawal|0|||
17199747|NCT02563106|38353698|FG000|Overall Study|Withdrawal by Subject|7|||
17199748|NCT02563106|38353699|FG001|Overall Study|Withdrawal by Subject|8|||
17199749|NCT02563106|38353698|FG000|Overall Study|Adverse Event|17|||
17199750|NCT02563106|38353699|FG001|Overall Study|Adverse Event|15|||
17199751|NCT02563106|38353698|FG000|Overall Study|Protocol Violation|1|||
17199752|NCT02563106|38353699|FG001|Overall Study|Protocol Violation|0|||
17199753|NCT02563106|38353698|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
17199754|NCT02563106|38353699|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
17199755|NCT02563106|38353698|FG000|Overall Study|Lost to Follow-up|3|||
17199756|NCT02563106|38353699|FG001|Overall Study|Lost to Follow-up|2|||
17199757|NCT02563106|38353698|FG000|Overall Study|Physician Decision|3|||
17199758|NCT02563106|38353699|FG001|Overall Study|Physician Decision|1|||
17199759|NCT02563106|38353698|FG000|Overall Study|Other reason - not specified|2|||
17199760|NCT02563106|38353699|FG001|Overall Study|Other reason - not specified|1|||
17199761|NCT02691741|38353707|FG000|Overall Study|Adverse Event|0|||
17199762|NCT02691741|38353708|FG001|Overall Study|Adverse Event|2|||
17199763|NCT02691741|38353707|FG000|Overall Study|Lost to Follow-up|1|||
17199764|NCT02691741|38353708|FG001|Overall Study|Lost to Follow-up|0|||
17199765|NCT02691741|38353707|FG000|Overall Study|Physician Decision|0|||
17199766|NCT02691741|38353708|FG001|Overall Study|Physician Decision|1|||
17199767|NCT02691741|38353707|FG000|Overall Study|Withdrawal by Subject|0|||
17199768|NCT02691741|38353708|FG001|Overall Study|Withdrawal by Subject|4|||
17199769|NCT02691507|38353721|FG000|Overall Study|Missed Visit 3|0|||
17199770|NCT02691507|38353722|FG001|Overall Study|Missed Visit 3|1|||
17199771|NCT04579393|38353730|FG000|Overall Study|Withdrawal by Subject|2|||
17199772|NCT04579393|38353731|FG001|Overall Study|Withdrawal by Subject|2|||
17199773|NCT04579393|38353730|FG000|Overall Study|Death|1|||
17199774|NCT04579393|38353731|FG001|Overall Study|Death|3|||
17199775|NCT02776553|38353740|FG000|Overall Study|Lost to Follow-up|1|||
16853651|NCT01613599|37804037|FG000|Overall Study|Withdrawal by Subject|8|||
16853652|NCT01613599|37804037|FG000|Overall Study|Reason not specified|3|||
16853653|NCT01850641|37804041|FG000|Overall Study|Physician Decision|1|||
16853654|NCT01850641|37804041|FG000|Overall Study|Decrease in serum phosphorus|1|||
16853655|NCT01850641|37804041|FG000|Overall Study|Decrease in serum calcium|2|||
16853656|NCT01850641|37804041|FG000|Overall Study|Increase in serum ferritin|1|||
16853657|NCT01850563|37804047|FG000|Overall Study|Not eligible|3|||
16853658|NCT01850563|37804048|FG001|Overall Study|Not eligible|0|||
16853659|NCT01819129|37804061|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
16853660|NCT01819129|37804062|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
16853661|NCT01819129|37804061|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
16853662|NCT01819129|37804062|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
16853663|NCT01819129|37804061|FG000|Overall Study|Other, Subject moved out of the country|0|||
16853664|NCT01819129|37804062|FG001|Overall Study|Other, Subject moved out of the country|1|||
16853665|NCT01819129|37804061|FG000|Overall Study|Withdrawal by Subject|15|||
16853666|NCT01819129|37804062|FG001|Overall Study|Withdrawal by Subject|15|||
16853667|NCT01819129|37804061|FG000|Overall Study|Lost to Follow-up|5|||
16853668|NCT01819129|37804062|FG001|Overall Study|Lost to Follow-up|2|||
16853669|NCT01819129|37804061|FG000|Overall Study|Lack of Efficacy|0|||
16853670|NCT01819129|37804062|FG001|Overall Study|Lack of Efficacy|1|||
16853671|NCT01819129|37804061|FG000|Overall Study|Adverse Event|1|||
16853672|NCT01819129|37804062|FG001|Overall Study|Adverse Event|4|||
16853673|NCT01819129|37804061|FG000|Overall Study|Death|1|||
16853674|NCT01819129|37804062|FG001|Overall Study|Death|1|||
16853675|NCT01819129|37804061|FG000|Overall Study|Withdrawal Criteria|20|||
16853676|NCT01819129|37804062|FG001|Overall Study|Withdrawal Criteria|15|||
16853677|NCT04022889|37804070|FG000|Stage 1: Period 1|Adverse Event|1|||
16853678|NCT04022889|37804071|FG001|Stage 1: Period 1|Adverse Event|0|||
16853679|NCT04022889|37804072|FG002|Stage 1: Period 1|Adverse Event|0|||
16853680|NCT04022889|37804070|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
16853681|NCT04022889|37804071|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
16853682|NCT04022889|37804072|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
16853683|NCT04022889|37804070|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
16853684|NCT04022889|37804071|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
17199776|NCT02776553|38353741|FG001|Overall Study|Lost to Follow-up|0|||
17199777|NCT02776553|38353740|FG000|Overall Study|got liver transplant|1|||
17199778|NCT02776553|38353741|FG001|Overall Study|got liver transplant|2|||
17199779|NCT02776553|38353740|FG000|Overall Study|had other surgery|1|||
17199780|NCT02776553|38353741|FG001|Overall Study|had other surgery|0|||
16853685|NCT04022889|37804072|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
16853686|NCT04022889|37804070|FG000|Stage 2|Screen Failure|0|||
16853687|NCT04022889|37804071|FG001|Stage 2|Screen Failure|0|||
16853688|NCT04022889|37804072|FG002|Stage 2|Screen Failure|3|||
16853689|NCT04022889|37804070|FG000|Stage 2|Ineligible for apheresis donation|0|||
16853690|NCT04022889|37804071|FG001|Stage 2|Ineligible for apheresis donation|0|||
16853691|NCT04022889|37804072|FG002|Stage 2|Ineligible for apheresis donation|2|||
16853692|NCT04022889|37804070|FG000|Stage 2|Adverse Event|0|||
16853693|NCT04022889|37804071|FG001|Stage 2|Adverse Event|0|||
16853694|NCT04022889|37804072|FG002|Stage 2|Adverse Event|2|||
16853695|NCT04022889|37804070|FG000|Stage 2|Protocol Violation|0|||
16853696|NCT04022889|37804071|FG001|Stage 2|Protocol Violation|0|||
16853697|NCT04022889|37804072|FG002|Stage 2|Protocol Violation|1|||
16853698|NCT04022889|37804070|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
16853699|NCT04022889|37804071|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
16853700|NCT04022889|37804072|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
16853701|NCT01849783|37804104|FG000|Overall Study|Adverse Event|5|||
16853702|NCT01849783|37804104|FG000|Overall Study|Death|2|||
16853703|NCT01849783|37804104|FG000|Overall Study|Physician Decision|1|||
16853704|NCT01849783|37804104|FG000|Overall Study|Withdrawal by Subject|1|||
16853705|NCT01849783|37804104|FG000|Overall Study|Unable to comply|2|||
16853706|NCT01849783|37804104|FG000|Overall Study|Disease progression|11|||
16853707|NCT01611883|37804116|FG000|Overall Study|Adverse Event|1|||
16853708|NCT01611883|37804117|FG001|Overall Study|Adverse Event|1|||
16853709|NCT01848457|37804127|FG000|Overall Study|Death|1|||
16853710|NCT01848457|37804128|FG001|Overall Study|Death|0|||
16853711|NCT01848457|37804129|FG002|Overall Study|Death|0|||
16853712|NCT01848457|37804130|FG003|Overall Study|Death|0|||
16853713|NCT01817959|37804150|FG000|Overall Study|Graft loss|1|||
16853714|NCT01817959|37804151|FG001|Overall Study|Graft loss|1|||
16853715|NCT01817959|37804150|FG000|Overall Study|forbidden medication|1|||
16853716|NCT01817959|37804151|FG001|Overall Study|forbidden medication|1|||
16853717|NCT01817959|37804150|FG000|Overall Study|Adverse Event|1|||
16853718|NCT01817959|37804151|FG001|Overall Study|Adverse Event|0|||
16853719|NCT01817959|37804150|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
16853720|NCT01817959|37804151|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
16853721|NCT01817725|37804157|FG000|Overall Study|Withdrawal by Subject|1|||
16853722|NCT01870999|37804164|FG000|Overall Study|Adverse Event|0|||
16853723|NCT01870999|37804165|FG001|Overall Study|Adverse Event|4|||
16853724|NCT01870999|37804166|FG002|Overall Study|Adverse Event|1|||
16853725|NCT01870999|37804164|FG000|Overall Study|Subject met withdrawal criteria|3|||
16853726|NCT01870999|37804165|FG001|Overall Study|Subject met withdrawal criteria|2|||
16853727|NCT01870999|37804166|FG002|Overall Study|Subject met withdrawal criteria|0|||
16853728|NCT01870999|37804164|FG000|Overall Study|Subject withdrawn by Investigator|1|||
16853729|NCT01870999|37804165|FG001|Overall Study|Subject withdrawn by Investigator|0|||
16853730|NCT01870999|37804166|FG002|Overall Study|Subject withdrawn by Investigator|0|||
16853731|NCT01870999|37804164|FG000|Overall Study|Withdrawal by Subject|0|||
16853732|NCT01870999|37804165|FG001|Overall Study|Withdrawal by Subject|2|||
16853733|NCT01870999|37804166|FG002|Overall Study|Withdrawal by Subject|5|||
16853734|NCT01870999|37804164|FG000|Overall Study|Protocol Violation|0|||
16853735|NCT01870999|37804165|FG001|Overall Study|Protocol Violation|0|||
16853736|NCT01870999|37804166|FG002|Overall Study|Protocol Violation|1|||
16853737|NCT01870921|37804174|FG000|Overall Study|Subject decision|80|||
16853738|NCT01870921|37804174|FG000|Overall Study|Severe non-compliance to protocol|7|||
16853739|NCT01870921|37804174|FG000|Overall Study|Subject Lost to Follow up|2|||
16853740|NCT01870921|37804174|FG000|Overall Study|Other|1|||
16853741|NCT01848145|37804187|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
16853742|NCT01848145|37804187|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
16853743|NCT01848145|37804187|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
16853744|NCT01848145|37804187|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
16853745|NCT01848145|37804187|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
16853746|NCT01848145|37804187|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
16853747|NCT01848145|37804187|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
16853748|NCT01847755|37804191|FG000|Overall Study|Adverse Event|2|||
16853749|NCT01847755|37804191|FG000|Overall Study|Withdrawal by Subject|2|||
16853750|NCT01847755|37804191|FG000|Overall Study|Physician Decision|1|||
16853751|NCT01847443|37804222|FG000|Study Period 1|Withdrawal by Subject|0|||
16853752|NCT01847443|37804223|FG001|Study Period 1|Withdrawal by Subject|1|||
16853753|NCT01847443|37804224|FG002|Study Period 1|Withdrawal by Subject|0|||
16853754|NCT01847443|37804225|FG003|Study Period 1|Withdrawal by Subject|0|||
16853755|NCT01847443|37804222|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
16853756|NCT01847443|37804223|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
16853757|NCT01847443|37804224|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
16853758|NCT01847443|37804225|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
16853759|NCT01847443|37804222|FG000|Washout Period Before Study Period 2|Other reason|1|||
16853760|NCT01847443|37804223|FG001|Washout Period Before Study Period 2|Other reason|0|||
16853761|NCT01847443|37804224|FG002|Washout Period Before Study Period 2|Other reason|0|||
16853762|NCT01847443|37804225|FG003|Washout Period Before Study Period 2|Other reason|0|||
16853763|NCT01847443|37804222|FG000|Washout Period Before Study Period 3|Other reason|1|||
16853764|NCT01847443|37804223|FG001|Washout Period Before Study Period 3|Other reason|0|||
16853765|NCT01847443|37804224|FG002|Washout Period Before Study Period 3|Other reason|0|||
17104449|NCT00108069|38242391|FG001|Overall Study|Adverse Event|1|||
17104450|NCT00108069|38242390|FG000|Overall Study|Withdrawal by Subject|1|||
17104451|NCT00108069|38242391|FG001|Overall Study|Withdrawal by Subject|0|||
17104452|NCT00108069|38242390|FG000|Overall Study|Death|1|||
17104453|NCT00108069|38242391|FG001|Overall Study|Death|0|||
17104454|NCT00108069|38242390|FG000|Overall Study|Progessive disease|27|||
17104455|NCT00108069|38242391|FG001|Overall Study|Progessive disease|11|||
17104456|NCT00079274|38242410|FG000|Overall Study|Withdrawal by Subject|111|||
17104457|NCT00079274|38242411|FG001|Overall Study|Withdrawal by Subject|10|||
17104458|NCT00079274|38242412|FG002|Overall Study|Withdrawal by Subject|12|||
17104459|NCT00079274|38242413|FG003|Overall Study|Withdrawal by Subject|163|||
17104460|NCT00079274|38242414|FG004|Overall Study|Withdrawal by Subject|7|||
17104461|NCT00079274|38242415|FG005|Overall Study|Withdrawal by Subject|8|||
17104462|NCT00079274|38242416|FG006|Overall Study|Withdrawal by Subject|0|||
17104463|NCT00079274|38242410|FG000|Overall Study|Adverse Event|130|||
17104464|NCT00079274|38242411|FG001|Overall Study|Adverse Event|8|||
17104465|NCT00079274|38242412|FG002|Overall Study|Adverse Event|8|||
17104466|NCT00079274|38242413|FG003|Overall Study|Adverse Event|184|||
17104467|NCT00079274|38242414|FG004|Overall Study|Adverse Event|7|||
17104468|NCT00079274|38242415|FG005|Overall Study|Adverse Event|8|||
17104469|NCT00079274|38242416|FG006|Overall Study|Adverse Event|0|||
17104470|NCT00079274|38242410|FG000|Overall Study|Recurrence|21|||
17104471|NCT00079274|38242411|FG001|Overall Study|Recurrence|0|||
17104472|NCT00079274|38242412|FG002|Overall Study|Recurrence|1|||
17104473|NCT00079274|38242413|FG003|Overall Study|Recurrence|15|||
17104474|NCT00079274|38242414|FG004|Overall Study|Recurrence|0|||
17104475|NCT00079274|38242415|FG005|Overall Study|Recurrence|2|||
17104476|NCT00079274|38242416|FG006|Overall Study|Recurrence|0|||
17104477|NCT00079274|38242410|FG000|Overall Study|Alternate Treatment|6|||
17104478|NCT00079274|38242411|FG001|Overall Study|Alternate Treatment|1|||
17104479|NCT00079274|38242412|FG002|Overall Study|Alternate Treatment|0|||
17104480|NCT00079274|38242413|FG003|Overall Study|Alternate Treatment|3|||
17104481|NCT00079274|38242414|FG004|Overall Study|Alternate Treatment|0|||
17104482|NCT00079274|38242415|FG005|Overall Study|Alternate Treatment|0|||
17104483|NCT00079274|38242416|FG006|Overall Study|Alternate Treatment|0|||
17104484|NCT00079274|38242410|FG000|Overall Study|Other Medical Problems|6|||
17104485|NCT00079274|38242411|FG001|Overall Study|Other Medical Problems|1|||
17104486|NCT00079274|38242412|FG002|Overall Study|Other Medical Problems|0|||
17104487|NCT00079274|38242413|FG003|Overall Study|Other Medical Problems|7|||
17104488|NCT00079274|38242414|FG004|Overall Study|Other Medical Problems|0|||
17104489|NCT00079274|38242415|FG005|Overall Study|Other Medical Problems|0|||
17104490|NCT00079274|38242416|FG006|Overall Study|Other Medical Problems|0|||
17104491|NCT00079274|38242410|FG000|Overall Study|Death|4|||
17104492|NCT00079274|38242411|FG001|Overall Study|Death|0|||
17104493|NCT00079274|38242412|FG002|Overall Study|Death|1|||
17104494|NCT00079274|38242413|FG003|Overall Study|Death|15|||
17104495|NCT00079274|38242414|FG004|Overall Study|Death|0|||
17104496|NCT00079274|38242415|FG005|Overall Study|Death|0|||
17104497|NCT00079274|38242416|FG006|Overall Study|Death|0|||
17104498|NCT00079274|38242410|FG000|Overall Study|Cytogenetic resistance|0|||
17104499|NCT00079274|38242411|FG001|Overall Study|Cytogenetic resistance|0|||
17104500|NCT00079274|38242412|FG002|Overall Study|Cytogenetic resistance|0|||
17104501|NCT00079274|38242413|FG003|Overall Study|Cytogenetic resistance|2|||
17104502|NCT00079274|38242414|FG004|Overall Study|Cytogenetic resistance|0|||
17104503|NCT00079274|38242415|FG005|Overall Study|Cytogenetic resistance|0|||
17104504|NCT00079274|38242416|FG006|Overall Study|Cytogenetic resistance|0|||
17104505|NCT00079274|38242410|FG000|Overall Study|Other|43|||
17104506|NCT00079274|38242411|FG001|Overall Study|Other|7|||
17104507|NCT00079274|38242412|FG002|Overall Study|Other|5|||
17104508|NCT00079274|38242413|FG003|Overall Study|Other|55|||
17104509|NCT00079274|38242414|FG004|Overall Study|Other|1|||
17104510|NCT00079274|38242415|FG005|Overall Study|Other|2|||
17104511|NCT00079274|38242416|FG006|Overall Study|Other|0|||
17104512|NCT00079040|38242429|FG000|Overall Study|Withdrew before treatment|1|||
17104513|NCT00079040|38242429|FG000|Overall Study|Ineligible|1|||
17104514|NCT00078806|38242433|FG000|Part 1A|Adverse Event|2|||
17104515|NCT00078806|38242434|FG001|Part 1A|Adverse Event|0|||
17104516|NCT00078806|38242435|FG002|Part 1A|Adverse Event|0|||
17104517|NCT00078806|38242436|FG003|Part 1A|Adverse Event|0|||
16853766|NCT01847443|37804225|FG003|Washout Period Before Study Period 3|Other reason|0|||
17104518|NCT00078806|38242433|FG000|Part 1A|Lack of Efficacy|7|||
17104519|NCT00078806|38242434|FG001|Part 1A|Lack of Efficacy|0|||
17104520|NCT00078806|38242435|FG002|Part 1A|Lack of Efficacy|0|||
17104521|NCT00078806|38242436|FG003|Part 1A|Lack of Efficacy|0|||
17104522|NCT00078806|38242433|FG000|Part 1A|Other|1|||
17104523|NCT00078806|38242434|FG001|Part 1A|Other|0|||
16853767|NCT01847443|37804222|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
16853768|NCT01847443|37804223|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
16853769|NCT01847443|37804224|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
16853770|NCT01847443|37804225|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
16853771|NCT01847443|37804222|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
17104524|NCT00078806|38242435|FG002|Part 1A|Other|0|||
16853772|NCT01847443|37804223|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
16853773|NCT01847443|37804224|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
16853774|NCT01847443|37804225|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
16853775|NCT01847209|37804244|FG000|Overall Study|Withdrawal by Subject|1|||
16853776|NCT01847209|37804244|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
16853777|NCT01846741|37804248|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
16853778|NCT01870843|37804287|FG000|Overall Study|Adverse Event|10|||
16853779|NCT01870843|37804287|FG000|Overall Study|Lost to Follow-up|24|||
16853780|NCT01870843|37804287|FG000|Overall Study|Death|1|||
16853781|NCT01870843|37804287|FG000|Overall Study|Withdrawal by Subject|18|||
16853782|NCT01816477|37804293|FG000|Overall Study|Withdrawal by Subject|13|||
16853783|NCT01816477|37804294|FG001|Overall Study|Withdrawal by Subject|1|||
16853784|NCT01816477|37804293|FG000|Overall Study|Unable to tolerate catheter placement|3|||
16853785|NCT01816477|37804294|FG001|Overall Study|Unable to tolerate catheter placement|0|||
16853786|NCT01846507|37804300|FG000|Overall Study|Lost to Follow-up|4|||
16853787|NCT01846507|37804300|FG000|Overall Study|Protocol Violation|1|||
16853788|NCT01846507|37804300|FG000|Overall Study|Missing data|2|||
16853789|NCT01846039|37804306|FG000|Overall Study|Protocol Violation|1|||
16853790|NCT01846039|37804306|FG000|Overall Study|Subject Withdrew Consent|1|||
16853791|NCT01610167|37804313|FG000|Overall Study|Scheduling conflict.|0|||
16853792|NCT01610167|37804314|FG001|Overall Study|Scheduling conflict.|0|||
16853793|NCT01610167|37804315|FG002|Overall Study|Scheduling conflict.|2|||
16853794|NCT01816243|37804323|FG000|Overall Study|Adverse Event|6|||
16853795|NCT01816243|37804323|FG000|Overall Study|Lost to Follow-up|1|||
16853796|NCT01816243|37804323|FG000|Overall Study|Lack of Efficacy|1|||
16853797|NCT01816243|37804323|FG000|Overall Study|Not eligible for the study|1|||
16853798|NCT01816243|37804323|FG000|Overall Study|Amputation|3|||
16853799|NCT01845805|37804329|FG000|Overall Study|Withdrawal by Subject|1|||
16853800|NCT01845805|37804330|FG001|Overall Study|Withdrawal by Subject|2|||
16853801|NCT01845805|37804329|FG000|Overall Study|Disease Progression|13|||
16853802|NCT01845805|37804330|FG001|Overall Study|Disease Progression|14|||
16935891|NCT01212757|38080617|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16935892|NCT01212757|38080618|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16935893|NCT01212757|38080619|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16935894|NCT01212757|38080611|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
16935895|NCT01212757|38080612|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
16935896|NCT01212757|38080613|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
16935897|NCT01212757|38080614|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16935898|NCT01212757|38080615|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16935899|NCT01212757|38080616|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16935900|NCT01212757|38080617|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16935901|NCT01212757|38080618|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16935902|NCT01212757|38080619|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16935903|NCT01212757|38080611|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
16935904|NCT01212757|38080612|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16935905|NCT01212757|38080613|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
16935906|NCT01212757|38080614|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16935907|NCT01212757|38080615|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16935908|NCT01212757|38080616|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16935909|NCT01212757|38080617|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16935910|NCT01212757|38080618|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16935911|NCT01212757|38080619|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16935912|NCT01212757|38080611|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16935913|NCT01212757|38080612|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16935914|NCT01212757|38080613|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
16935915|NCT01212757|38080614|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16935916|NCT01212757|38080615|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16935917|NCT01212757|38080616|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16935918|NCT01212757|38080617|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16935919|NCT01212757|38080618|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16935920|NCT01212757|38080619|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16853803|NCT01845805|37804329|FG000|Overall Study|Drug-related Toxicity|4|||
16853804|NCT01845805|37804330|FG001|Overall Study|Drug-related Toxicity|0|||
16853805|NCT01845025|37804338|FG000|Overall Study|Adverse Event|6|||
16853806|NCT01845025|37804339|FG001|Overall Study|Adverse Event|3|||
16853807|NCT01845025|37804338|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16853808|NCT01845025|37804339|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16853809|NCT01845025|37804338|FG000|Overall Study|Withdrawal by Subject|48|||
16853810|NCT01845025|37804339|FG001|Overall Study|Withdrawal by Subject|44|||
16853811|NCT01845025|37804338|FG000|Overall Study|Lost to Follow-up|13|||
16853812|NCT01845025|37804339|FG001|Overall Study|Lost to Follow-up|13|||
16853813|NCT01845025|37804338|FG000|Overall Study|Administrative problems|8|||
16853814|NCT01845025|37804339|FG001|Overall Study|Administrative problems|8|||
16853815|NCT01845025|37804338|FG000|Overall Study|Death|2|||
16853816|NCT01845025|37804339|FG001|Overall Study|Death|0|||
16853817|NCT01845025|37804338|FG000|Overall Study|Protocol deviation|3|||
16853818|NCT01845025|37804339|FG001|Overall Study|Protocol deviation|6|||
16853819|NCT01845025|37804338|FG000|Overall Study|Missing|1|||
16853820|NCT01845025|37804339|FG001|Overall Study|Missing|1|||
16853821|NCT01870297|37804380|FG000|Overall Study|Adverse Event|0|||
16853822|NCT01870297|37804381|FG001|Overall Study|Adverse Event|0|||
16853823|NCT01870297|37804382|FG002|Overall Study|Adverse Event|0|||
16853824|NCT01870297|37804383|FG003|Overall Study|Adverse Event|0|||
16853825|NCT01870297|37804384|FG004|Overall Study|Adverse Event|2|||
16853826|NCT01870297|37804385|FG005|Overall Study|Adverse Event|0|||
16853827|NCT01870297|37804386|FG006|Overall Study|Adverse Event|0|||
16853828|NCT01870297|37804380|FG000|Overall Study|Lost to Follow-up|0|||
16853829|NCT01870297|37804381|FG001|Overall Study|Lost to Follow-up|1|||
16853830|NCT01870297|37804382|FG002|Overall Study|Lost to Follow-up|1|||
16853831|NCT01870297|37804383|FG003|Overall Study|Lost to Follow-up|0|||
16853832|NCT01870297|37804384|FG004|Overall Study|Lost to Follow-up|0|||
16853833|NCT01870297|37804385|FG005|Overall Study|Lost to Follow-up|0|||
16853834|NCT01870297|37804386|FG006|Overall Study|Lost to Follow-up|0|||
16853835|NCT01870297|37804380|FG000|Overall Study|Withdrawal by Subject|0|||
16853836|NCT01870297|37804381|FG001|Overall Study|Withdrawal by Subject|0|||
16853837|NCT01870297|37804382|FG002|Overall Study|Withdrawal by Subject|0|||
16853838|NCT01870297|37804383|FG003|Overall Study|Withdrawal by Subject|0|||
16853839|NCT01870297|37804384|FG004|Overall Study|Withdrawal by Subject|1|||
16853840|NCT01870297|37804385|FG005|Overall Study|Withdrawal by Subject|1|||
16853841|NCT01870297|37804386|FG006|Overall Study|Withdrawal by Subject|1|||
16853842|NCT01870297|37804380|FG000|Overall Study|Sponsor Decision|0|||
16853843|NCT01870297|37804381|FG001|Overall Study|Sponsor Decision|6|||
16853844|NCT01870297|37804382|FG002|Overall Study|Sponsor Decision|0|||
16853845|NCT01870297|37804383|FG003|Overall Study|Sponsor Decision|0|||
16853846|NCT01870297|37804384|FG004|Overall Study|Sponsor Decision|0|||
16853847|NCT01870297|37804385|FG005|Overall Study|Sponsor Decision|0|||
16853848|NCT01870297|37804386|FG006|Overall Study|Sponsor Decision|1|||
16853849|NCT01814761|37804413|FG000|Overall Study|Other Reasons|1|||
16853850|NCT01814761|37804414|FG001|Overall Study|Other Reasons|10|||
16853851|NCT01814761|37804413|FG000|Overall Study|Ocular Adverse Event|6|||
16853852|NCT01814761|37804414|FG001|Overall Study|Ocular Adverse Event|15|||
16853853|NCT01814761|37804413|FG000|Overall Study|Lost to Follow-up|1|||
16853854|NCT01814761|37804414|FG001|Overall Study|Lost to Follow-up|5|||
16853855|NCT01843933|37804422|FG000|Overall Study|Data lost|6|||
16853856|NCT01843933|37804423|FG001|Overall Study|Data lost|4|||
16853857|NCT01814371|37804431|FG000|Overall Study|Lost to Follow-up|30|||
16853858|NCT01814371|37804432|FG001|Overall Study|Lost to Follow-up|27|||
16853859|NCT01814137|37804506|FG000|Overall Study|Adverse Event|0|||
16853860|NCT01814137|37804507|FG001|Overall Study|Adverse Event|1|||
16853861|NCT01814137|37804506|FG000|Overall Study|Withdrawal by Subject|2|||
16853862|NCT01814137|37804507|FG001|Overall Study|Withdrawal by Subject|2|||
16853863|NCT01814137|37804506|FG000|Overall Study|Physician Decision|1|||
16853864|NCT01814137|37804507|FG001|Overall Study|Physician Decision|1|||
16853865|NCT01814137|37804506|FG000|Overall Study|Unclassified|2|||
16853866|NCT01814137|37804507|FG001|Overall Study|Unclassified|1|||
16853867|NCT01813435|37804524|FG000|Overall Study|did not finish experimental regimen|1902|||
16853868|NCT01813435|37804525|FG001|Overall Study|did not finish experimental regimen|770|||
16853869|NCT01813435|37804524|FG000|Overall Study|Lost to Follow-up|268|||
16853870|NCT01813435|37804525|FG001|Overall Study|Lost to Follow-up|237|||
16853871|NCT01813357|37804533|FG000|Overall Study|Lost to Follow-up|5|||
16853872|NCT01813357|37804534|FG001|Overall Study|Lost to Follow-up|6|||
16853873|NCT01812655|37804543|FG000|Overall Study|Protocol Violation|1|||
16853874|NCT01812655|37804544|FG001|Overall Study|Protocol Violation|1|||
16853875|NCT01812655|37804545|FG002|Overall Study|Protocol Violation|0|||
16853876|NCT01812109|37804566|FG000|Overall Study|research personnel delay|16|||
16853877|NCT01812109|37804566|FG000|Overall Study|NIRS Unattainable|17|||
16853878|NCT01811953|37804576|FG000|Overall Study|Adverse Event|0|||
16853879|NCT01811953|37804577|FG001|Overall Study|Adverse Event|0|||
16853880|NCT01811953|37804578|FG002|Overall Study|Adverse Event|0|||
16853881|NCT01811953|37804579|FG003|Overall Study|Adverse Event|1|||
16853882|NCT01811953|37804580|FG004|Overall Study|Adverse Event|0|||
16853883|NCT01811953|37804581|FG005|Overall Study|Adverse Event|1|||
16853884|NCT01811953|37804576|FG000|Overall Study|Protocol Violation|0|||
16853885|NCT01811953|37804577|FG001|Overall Study|Protocol Violation|0|||
16853886|NCT01811953|37804578|FG002|Overall Study|Protocol Violation|0|||
16853887|NCT01811953|37804579|FG003|Overall Study|Protocol Violation|0|||
16853888|NCT01811953|37804580|FG004|Overall Study|Protocol Violation|1|||
16853889|NCT01811953|37804581|FG005|Overall Study|Protocol Violation|0|||
16853890|NCT01811563|37804597|FG000|Overall Study|Lost to Follow-up|5|||
16853891|NCT01811563|37804598|FG001|Overall Study|Lost to Follow-up|2|||
16853892|NCT01811563|37804597|FG000|Overall Study|Incorrect Randomization procedure|0|||
16853893|NCT01811563|37804598|FG001|Overall Study|Incorrect Randomization procedure|1|||
16853894|NCT01811485|37804607|FG000|Overall Study|Adverse Event|1|||
16853895|NCT01811485|37804608|FG001|Overall Study|Adverse Event|3|||
16853896|NCT01811485|37804609|FG002|Overall Study|Adverse Event|2|||
16853897|NCT01811485|37804607|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16853898|NCT01811485|37804608|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16853899|NCT01811485|37804609|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
16853900|NCT01811485|37804607|FG000|Overall Study|Administrative problems|1|||
16853901|NCT01811485|37804608|FG001|Overall Study|Administrative problems|0|||
16853902|NCT01811485|37804609|FG002|Overall Study|Administrative problems|0|||
16853903|NCT01811485|37804607|FG000|Overall Study|Protocol Deviation|0|||
16853904|NCT01811485|37804608|FG001|Overall Study|Protocol Deviation|1|||
16853905|NCT01811485|37804609|FG002|Overall Study|Protocol Deviation|0|||
16853906|NCT01810939|37804620|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
16853907|NCT01810939|37804621|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
16853908|NCT01810939|37804622|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
16853909|NCT01810939|37804620|FG000|Part A Treatment Period|Protocol Violation|2|||
16853910|NCT01810939|37804621|FG001|Part A Treatment Period|Protocol Violation|0|||
16853911|NCT01810939|37804622|FG002|Part A Treatment Period|Protocol Violation|0|||
16853912|NCT01810939|37804620|FG000|Part A Treatment Period|Adverse Event|10|||
16853913|NCT01810939|37804621|FG001|Part A Treatment Period|Adverse Event|0|||
16853914|NCT01810939|37804622|FG002|Part A Treatment Period|Adverse Event|0|||
16853915|NCT01810939|37804620|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
16853916|NCT01810939|37804621|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
16853917|NCT01810939|37804622|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
16853918|NCT01810939|37804620|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
16853919|NCT01810939|37804621|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
16853920|NCT01810939|37804622|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
16853921|NCT01810939|37804620|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
16853922|NCT01810939|37804621|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
16853923|NCT01810939|37804622|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
16853924|NCT01810939|37804620|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
16853925|NCT01810939|37804621|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
16853926|NCT01810939|37804622|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
16853927|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
16853928|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
16853929|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
16853930|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
16853931|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
16853932|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
16853933|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
16853934|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
16853935|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
16853936|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
16853937|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
16853938|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
16853939|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
16853940|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
16853941|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
16853942|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
16853943|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
16853944|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
16853945|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
16853946|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
16853947|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
16853948|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
16853949|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
16853950|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
16853951|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
17104525|NCT00078806|38242436|FG003|Part 1A|Other|0|||
16853952|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
16853953|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
16853954|NCT01810939|37804620|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
16853955|NCT01810939|37804621|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
16853956|NCT01810939|37804622|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
16853957|NCT01810783|37804641|FG000|Overall Study|Adverse Event|32|||
16853958|NCT01810783|37804641|FG000|Overall Study|Withdrawal by Subject|22|||
16853959|NCT01810783|37804641|FG000|Overall Study|Lack of Efficacy|12|||
16853960|NCT01810783|37804641|FG000|Overall Study|Lost to Follow-up|10|||
16853961|NCT01810783|37804641|FG000|Overall Study|Protocol Violation|5|||
16853962|NCT01810783|37804641|FG000|Overall Study|Non-compliance with IMP|4|||
16853963|NCT01810783|37804641|FG000|Overall Study|Adminstrative or other reason(s)|23|||
16853964|NCT01810783|37804641|FG000|Overall Study|Enrolled, not treated|1|||
16853965|NCT01808209|37804662|FG000|Overall Study|Lost to Follow-up|0|||
16853966|NCT01808209|37804663|FG001|Overall Study|Lost to Follow-up|1|||
17104526|NCT00078806|38242433|FG000|Part 1B|Adverse Event|1|||
17104527|NCT00078806|38242434|FG001|Part 1B|Adverse Event|0|||
17104528|NCT00078806|38242435|FG002|Part 1B|Adverse Event|0|||
17104529|NCT00078806|38242436|FG003|Part 1B|Adverse Event|0|||
17104530|NCT00078806|38242433|FG000|Part 1B|Lack of Efficacy|7|||
17104531|NCT00078806|38242434|FG001|Part 1B|Lack of Efficacy|0|||
17104532|NCT00078806|38242435|FG002|Part 1B|Lack of Efficacy|0|||
17104533|NCT00078806|38242436|FG003|Part 1B|Lack of Efficacy|0|||
17104534|NCT00078806|38242433|FG000|Part 2|Adverse Event|0|||
17104535|NCT00078806|38242434|FG001|Part 2|Adverse Event|1|||
17104536|NCT00078806|38242435|FG002|Part 2|Adverse Event|0|||
17104537|NCT00078806|38242436|FG003|Part 2|Adverse Event|0|||
17104538|NCT00078338|38242453|FG000|Overall Study|Adverse Event|31|||
17104539|NCT00078338|38242454|FG001|Overall Study|Adverse Event|24|||
17104540|NCT00078338|38242453|FG000|Overall Study|Lost to Follow-up|17|||
17104541|NCT00078338|38242454|FG001|Overall Study|Lost to Follow-up|2|||
17104542|NCT00078338|38242453|FG000|Overall Study|Protocol Violation|2|||
17104543|NCT00078338|38242454|FG001|Overall Study|Protocol Violation|2|||
17104544|NCT00078338|38242453|FG000|Overall Study|Disease Progression|4|||
17104545|NCT00078338|38242454|FG001|Overall Study|Disease Progression|7|||
17104546|NCT00078338|38242453|FG000|Overall Study|Other|28|||
17104547|NCT00078338|38242454|FG001|Overall Study|Other|16|||
17104548|NCT00078338|38242453|FG000|Overall Study|Subjects randomized, but not treated|3|||
17104549|NCT00078338|38242454|FG001|Overall Study|Subjects randomized, but not treated|3|||
17104550|NCT03808688|38242462|FG000|Overall Study|Adverse Event|13|||
17104551|NCT03808688|38242463|FG001|Overall Study|Adverse Event|17|||
17104552|NCT03808688|38242462|FG000|Overall Study|Lack of Efficacy|2|||
17104553|NCT03808688|38242463|FG001|Overall Study|Lack of Efficacy|0|||
17104554|NCT03808688|38242462|FG000|Overall Study|Lost to Follow-up|0|||
17104555|NCT03808688|38242463|FG001|Overall Study|Lost to Follow-up|2|||
17104556|NCT03808688|38242462|FG000|Overall Study|Withdrawal by Subject|1|||
17104557|NCT03808688|38242463|FG001|Overall Study|Withdrawal by Subject|0|||
17104558|NCT03808688|38242462|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
17104559|NCT03808688|38242463|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
17104560|NCT03808688|38242462|FG000|Overall Study|IOP Too High|1|||
17104561|NCT03808688|38242463|FG001|Overall Study|IOP Too High|1|||
17104562|NCT03808688|38242462|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
17104563|NCT03808688|38242463|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
17104564|NCT03808688|38242462|FG000|Overall Study|Visit Out of Window|0|||
17104565|NCT03808688|38242463|FG001|Overall Study|Visit Out of Window|1|||
17104566|NCT03808688|38242462|FG000|Overall Study|Medication Non-Compliance|0|||
17104567|NCT03808688|38242463|FG001|Overall Study|Medication Non-Compliance|1|||
17104568|NCT03808298|38242471|FG000|Overall Study|Adverse Event|3|||
17104569|NCT03808298|38242471|FG000|Overall Study|Physician Decision|1|||
17104570|NCT03808298|38242471|FG000|Overall Study|Withdrawal by Subject|1|||
16853967|NCT01807117|37804673|FG000|Overall Study|Physician Decision|2|||
16853968|NCT01807117|37804673|FG000|Overall Study|Disease diagnosis not a study disease|1|||
16853969|NCT01806961|37804679|FG000|Overall Study|sponsor decision|16|||
16853970|NCT01613131|37804685|FG000|Overall Study|Withdrawal by Subject|3|||
16853971|NCT01613131|37804686|FG001|Overall Study|Withdrawal by Subject|5|||
16853972|NCT01868893|37804692|FG000|Overall Study|Adverse Event|2|||
16853973|NCT01868893|37804692|FG000|Overall Study|Commercial availability of study drug|17|||
16853974|NCT01868893|37804692|FG000|Overall Study|Neutropenia|1|||
16853975|NCT01868503|37804698|FG000|Overall Study|Withdrawal by Subject|1|||
16853976|NCT01868503|37804698|FG000|Overall Study|Protocol Violation|1|||
16853977|NCT01868035|37804708|FG000|Overall Study|Lost to Follow-up|3|||
16853978|NCT01868035|37804708|FG000|Overall Study|Withdrawal by Subject|1|||
16853979|NCT01868035|37804708|FG000|Overall Study|Progressive Disease|2|||
17104571|NCT03808298|38242471|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
16853980|NCT01868035|37804708|FG000|Overall Study|Non-compliance|1|||
16853981|NCT01609933|37804712|FG000|Overall Study|Adverse Event|1|||
16853982|NCT01609933|37804712|FG000|Overall Study|Withdrawal by Subject|3|||
17104572|NCT00077636|38242502|FG000|Overall Study|Refused Treatment|9|||
16853983|NCT01843777|37804720|FG000|Overall Study|Withdrawal by Subject|1|||
16853984|NCT01843777|37804721|FG001|Overall Study|Withdrawal by Subject|0|||
16853985|NCT01842607|37804727|FG000|Overall Study|Adverse Event|11|||
16853986|NCT01842607|37804727|FG000|Overall Study|Lack of Efficacy|19|||
16853987|NCT01842607|37804727|FG000|Overall Study|Protocol Violation|8|||
16853988|NCT01842607|37804727|FG000|Overall Study|Protocol defined stopping criteria|2|||
16853989|NCT01842607|37804727|FG000|Overall Study|Lost to Follow-up|3|||
16853990|NCT01842607|37804727|FG000|Overall Study|Physician Decision|9|||
16853991|NCT01842607|37804727|FG000|Overall Study|Withdrawal by Subject|14|||
16853992|NCT01803607|37804733|FG000|Overall Study|Adverse Event|5|||
16853993|NCT01803607|37804734|FG001|Overall Study|Adverse Event|3|||
16853994|NCT01803607|37804733|FG000|Overall Study|Lack of Efficacy|0|||
16853995|NCT01803607|37804734|FG001|Overall Study|Lack of Efficacy|1|||
16853996|NCT01803607|37804733|FG000|Overall Study|Protocol Violation|3|||
16853997|NCT01803607|37804734|FG001|Overall Study|Protocol Violation|2|||
16853998|NCT01803607|37804733|FG000|Overall Study|Study terminated by sponsor|54|||
16853999|NCT01803607|37804734|FG001|Overall Study|Study terminated by sponsor|56|||
16854000|NCT01803607|37804733|FG000|Overall Study|Withdrawal by Subject|6|||
16854001|NCT01803607|37804734|FG001|Overall Study|Withdrawal by Subject|5|||
16854002|NCT01867021|37804742|FG000|Overall Study|Adverse Event|0|||
16854003|NCT01867021|37804743|FG001|Overall Study|Adverse Event|1|||
16854004|NCT01867021|37804742|FG000|Overall Study|Not Eligible|0|||
16854005|NCT01867021|37804743|FG001|Overall Study|Not Eligible|1|||
16854006|NCT01867021|37804742|FG000|Overall Study|Death|1|||
16854007|NCT01867021|37804743|FG001|Overall Study|Death|0|||
16854008|NCT01867021|37804742|FG000|Overall Study|Lost to Follow-up|0|||
16854009|NCT01867021|37804743|FG001|Overall Study|Lost to Follow-up|2|||
16854010|NCT01867021|37804742|FG000|Overall Study|Withdrawal by Subject|1|||
16854011|NCT01867021|37804743|FG001|Overall Study|Withdrawal by Subject|6|||
16854012|NCT01866709|37804756|FG000|Overall Study|Adverse Event|1|||
16854013|NCT01866709|37804757|FG001|Overall Study|Adverse Event|0|||
16854014|NCT01841593|37804765|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
16854015|NCT01841593|37804766|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
16854016|NCT01841593|37804765|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
16854017|NCT01841593|37804766|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
16854018|NCT01866319|37805034|FG000|Overall Study|Adverse Event|12|||
16854019|NCT01866319|37805035|FG001|Overall Study|Adverse Event|5|||
16854020|NCT01866319|37805036|FG002|Overall Study|Adverse Event|9|||
16854021|NCT01866319|37805034|FG000|Overall Study|Clinical progression|3|||
16854022|NCT01866319|37805035|FG001|Overall Study|Clinical progression|2|||
16854023|NCT01866319|37805036|FG002|Overall Study|Clinical progression|2|||
16854024|NCT01866319|37805034|FG000|Overall Study|Death|153|||
16854025|NCT01866319|37805035|FG001|Overall Study|Death|154|||
16854026|NCT01866319|37805036|FG002|Overall Study|Death|147|||
16854027|NCT01866319|37805034|FG000|Overall Study|Lost to Follow-up|6|||
16854028|NCT01866319|37805035|FG001|Overall Study|Lost to Follow-up|3|||
16854029|NCT01866319|37805036|FG002|Overall Study|Lost to Follow-up|8|||
16854030|NCT01866319|37805034|FG000|Overall Study|Physician Decision|1|||
16854031|NCT01866319|37805035|FG001|Overall Study|Physician Decision|0|||
16854032|NCT01866319|37805036|FG002|Overall Study|Physician Decision|1|||
16854033|NCT01866319|37805034|FG000|Overall Study|Protocol Violation|0|||
16854034|NCT01866319|37805035|FG001|Overall Study|Protocol Violation|0|||
16854035|NCT01866319|37805036|FG002|Overall Study|Protocol Violation|1|||
16854036|NCT01866319|37805034|FG000|Overall Study|Withdrawal by Subject|32|||
16854037|NCT01866319|37805035|FG001|Overall Study|Withdrawal by Subject|14|||
16854038|NCT01866319|37805036|FG002|Overall Study|Withdrawal by Subject|12|||
16854039|NCT01802515|37805063|FG000|Overall Study|Withdrawal by Subject|3|||
16854040|NCT01802515|37805064|FG001|Overall Study|Withdrawal by Subject|0|||
16854041|NCT01802515|37805065|FG002|Overall Study|Withdrawal by Subject|0|||
16854042|NCT01802437|37805075|FG000|Overall Study|Lost to Follow-up|1|||
16854043|NCT01802437|37805076|FG001|Overall Study|Lost to Follow-up|0|||
16854044|NCT01802437|37805075|FG000|Overall Study|Withdrawal by Subject|3|||
16854045|NCT01802437|37805076|FG001|Overall Study|Withdrawal by Subject|4|||
16854046|NCT01802281|37805185|FG000|Overall Study|Death|1|||
16854047|NCT01802281|37805186|FG001|Overall Study|Death|2|||
16854048|NCT01802281|37805185|FG000|Overall Study|Withdrawal by Subject|2|||
16854049|NCT01802281|37805186|FG001|Overall Study|Withdrawal by Subject|1|||
16854050|NCT01802281|37805185|FG000|Overall Study|Ineligible|5|||
16854051|NCT01802281|37805186|FG001|Overall Study|Ineligible|3|||
16854052|NCT01801735|37805192|FG000|Overall Study|Adverse Event|79|||
16854053|NCT01801735|37805192|FG000|Overall Study|Lack of Efficacy|28|||
16854054|NCT01801735|37805192|FG000|Overall Study|Withdrawal by Subject|27|||
16854055|NCT01801735|37805192|FG000|Overall Study|Protocol Violation|25|||
16854056|NCT01801735|37805192|FG000|Overall Study|Lost to Follow-up|15|||
16854057|NCT01801735|37805192|FG000|Overall Study|Non-compliance with Trial Drug|13|||
16854058|NCT01801735|37805192|FG000|Overall Study|Physician Decision|3|||
16854059|NCT01801735|37805192|FG000|Overall Study|Death|1|||
16854060|NCT01801735|37805192|FG000|Overall Study|Other, including site closure|19|||
16935921|NCT01212757|38080611|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16854061|NCT01841359|37805196|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
16854062|NCT01841359|37805196|FG000|Overall Study|Concommitant medical issues|2|||
16854063|NCT01841359|37805196|FG000|Overall Study|Adverse Event|3|||
16854064|NCT01841359|37805196|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
16854065|NCT01840579|37805979|FG000|Overall Study|Status not recorded|0|||
16854066|NCT01840579|37805980|FG001|Overall Study|Status not recorded|0|||
16854067|NCT01840579|37805981|FG002|Overall Study|Status not recorded|2|||
16854068|NCT01840579|37805982|FG003|Overall Study|Status not recorded|3|||
16854069|NCT01840579|37805983|FG004|Overall Study|Status not recorded|4|||
16854070|NCT01840579|37805984|FG005|Overall Study|Status not recorded|3|||
16854071|NCT01840579|37805985|FG006|Overall Study|Status not recorded|0|||
16854072|NCT01840579|37805986|FG007|Overall Study|Status not recorded|3|||
16854073|NCT01840579|37805987|FG008|Overall Study|Status not recorded|3|||
16854074|NCT01840579|37805988|FG009|Overall Study|Status not recorded|3|||
16854075|NCT01840579|37805979|FG000|Overall Study|Progressive disease|3|||
16854076|NCT01840579|37805980|FG001|Overall Study|Progressive disease|5|||
16854077|NCT01840579|37805981|FG002|Overall Study|Progressive disease|0|||
16854078|NCT01840579|37805982|FG003|Overall Study|Progressive disease|0|||
16854079|NCT01840579|37805983|FG004|Overall Study|Progressive disease|0|||
16854080|NCT01840579|37805984|FG005|Overall Study|Progressive disease|0|||
16854081|NCT01840579|37805985|FG006|Overall Study|Progressive disease|0|||
16854082|NCT01840579|37805986|FG007|Overall Study|Progressive disease|0|||
16854083|NCT01840579|37805987|FG008|Overall Study|Progressive disease|0|||
16854084|NCT01840579|37805988|FG009|Overall Study|Progressive disease|0|||
16854085|NCT01840579|37805979|FG000|Overall Study|Ongoing in study|0|||
16854086|NCT01840579|37805980|FG001|Overall Study|Ongoing in study|1|||
16854087|NCT01840579|37805981|FG002|Overall Study|Ongoing in study|0|||
16854088|NCT01840579|37805982|FG003|Overall Study|Ongoing in study|0|||
16854089|NCT01840579|37805983|FG004|Overall Study|Ongoing in study|0|||
16854090|NCT01840579|37805984|FG005|Overall Study|Ongoing in study|0|||
16854091|NCT01840579|37805985|FG006|Overall Study|Ongoing in study|0|||
16854092|NCT01840579|37805986|FG007|Overall Study|Ongoing in study|0|||
16854093|NCT01840579|37805987|FG008|Overall Study|Ongoing in study|0|||
16854094|NCT01840579|37805988|FG009|Overall Study|Ongoing in study|0|||
16854095|NCT01840579|37805979|FG000|Overall Study|Death|0|||
16854096|NCT01840579|37805980|FG001|Overall Study|Death|0|||
16854097|NCT01840579|37805981|FG002|Overall Study|Death|0|||
16854098|NCT01840579|37805982|FG003|Overall Study|Death|0|||
16854099|NCT01840579|37805983|FG004|Overall Study|Death|0|||
16854100|NCT01840579|37805984|FG005|Overall Study|Death|1|||
16854101|NCT01840579|37805985|FG006|Overall Study|Death|0|||
16854102|NCT01840579|37805986|FG007|Overall Study|Death|0|||
16854103|NCT01840579|37805987|FG008|Overall Study|Death|0|||
16854104|NCT01840579|37805988|FG009|Overall Study|Death|0|||
16854105|NCT01840579|37805979|FG000|Overall Study|Adverse Event|0|||
16854106|NCT01840579|37805980|FG001|Overall Study|Adverse Event|1|||
16854107|NCT01840579|37805981|FG002|Overall Study|Adverse Event|0|||
16854108|NCT01840579|37805982|FG003|Overall Study|Adverse Event|0|||
16854109|NCT01840579|37805983|FG004|Overall Study|Adverse Event|0|||
16854110|NCT01840579|37805984|FG005|Overall Study|Adverse Event|0|||
16854111|NCT01840579|37805985|FG006|Overall Study|Adverse Event|0|||
16854112|NCT01840579|37805986|FG007|Overall Study|Adverse Event|0|||
16854113|NCT01840579|37805987|FG008|Overall Study|Adverse Event|0|||
16854114|NCT01840579|37805988|FG009|Overall Study|Adverse Event|0|||
16854115|NCT01840579|37805979|FG000|Overall Study|Follow-up ended by Sponsor|0|||
16935922|NCT01212757|38080612|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16935923|NCT01212757|38080613|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16935924|NCT01212757|38080614|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16935925|NCT01212757|38080615|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16935926|NCT01212757|38080616|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16935927|NCT01212757|38080617|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16935928|NCT01212757|38080618|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16935929|NCT01212757|38080619|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16935930|NCT01212757|38080611|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
16935931|NCT01212757|38080612|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
16935932|NCT01212757|38080613|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16935933|NCT01212757|38080614|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16854116|NCT01840579|37805980|FG001|Overall Study|Follow-up ended by Sponsor|0|||
16854117|NCT01840579|37805981|FG002|Overall Study|Follow-up ended by Sponsor|0|||
16854118|NCT01840579|37805982|FG003|Overall Study|Follow-up ended by Sponsor|0|||
16854119|NCT01840579|37805983|FG004|Overall Study|Follow-up ended by Sponsor|0|||
16854120|NCT01840579|37805984|FG005|Overall Study|Follow-up ended by Sponsor|0|||
16854121|NCT01840579|37805985|FG006|Overall Study|Follow-up ended by Sponsor|2|||
16854122|NCT01840579|37805986|FG007|Overall Study|Follow-up ended by Sponsor|0|||
16854123|NCT01840579|37805987|FG008|Overall Study|Follow-up ended by Sponsor|0|||
16854124|NCT01840579|37805988|FG009|Overall Study|Follow-up ended by Sponsor|0|||
16854125|NCT01801111|37806067|FG000|Overall Study|Adverse Event|12|||
16854126|NCT01801111|37806067|FG000|Overall Study|Death|8|||
16854127|NCT01801111|37806067|FG000|Overall Study|Physician Decision|5|||
16854128|NCT01801111|37806067|FG000|Overall Study|Other|1|||
16854129|NCT01801111|37806067|FG000|Overall Study|Withdrawal by Subject|4|||
16854130|NCT01801111|37806067|FG000|Overall Study|Study Terminated by Sponsor|27|||
16854131|NCT01801111|37806067|FG000|Overall Study|Progressive Disease|81|||
16854132|NCT01773967|37806099|FG000|Overall Study|Lost to Follow-up|15|||
16854133|NCT01773967|37806100|FG001|Overall Study|Lost to Follow-up|13|||
16854134|NCT01773889|37806110|FG000|Overall Study|lack of funding|2|||
16854135|NCT01839487|37806288|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
16854136|NCT01839487|37806289|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16854137|NCT01839487|37806290|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16854138|NCT01839487|37806291|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16854139|NCT01839487|37806292|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16854140|NCT01839487|37806293|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16854141|NCT01839487|37806288|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
16854142|NCT01839487|37806289|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
16854143|NCT01839487|37806290|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
16854144|NCT01839487|37806291|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
16854145|NCT01839487|37806292|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
16854146|NCT01839487|37806293|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
16854147|NCT01839487|37806288|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16854148|NCT01839487|37806289|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
16854149|NCT01839487|37806290|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16854150|NCT01839487|37806291|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16854151|NCT01839487|37806292|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16854152|NCT01839487|37806293|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16854153|NCT01839487|37806288|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
16854154|NCT01839487|37806289|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16854155|NCT01839487|37806290|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16854156|NCT01839487|37806291|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16854157|NCT01839487|37806292|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16854158|NCT01839487|37806293|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16854159|NCT01839487|37806288|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
16854160|NCT01839487|37806289|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
16854161|NCT01839487|37806290|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
16854162|NCT01839487|37806291|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
16854163|NCT01839487|37806292|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
16854164|NCT01839487|37806293|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
16854165|NCT01839487|37806288|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
16854166|NCT01839487|37806289|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
16854167|NCT01839487|37806290|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
16854168|NCT01839487|37806291|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
16854169|NCT01839487|37806292|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
16854170|NCT01839487|37806293|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
16854171|NCT01839487|37806288|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
16854172|NCT01839487|37806289|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
16854173|NCT01839487|37806290|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
16854174|NCT01839487|37806291|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
16854175|NCT01839487|37806292|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
16854176|NCT01839487|37806293|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
16854177|NCT01839487|37806288|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
16854178|NCT01839487|37806289|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
16854179|NCT01839487|37806290|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
16854180|NCT01839487|37806291|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
16854181|NCT01839487|37806292|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
16854182|NCT01839487|37806293|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
16854183|NCT01839487|37806288|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
16854184|NCT01839487|37806289|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
16854185|NCT01839487|37806290|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
16854186|NCT01839487|37806291|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
16854187|NCT01839487|37806292|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
16854188|NCT01839487|37806293|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
16854189|NCT01799941|37806320|FG000|Overall Study|Adverse Event|34|||
16854190|NCT01799941|37806320|FG000|Overall Study|Withdrawal by Subject|21|||
16854191|NCT01799941|37806320|FG000|Overall Study|Death|2|||
16854192|NCT01799941|37806320|FG000|Overall Study|Investigator Decision|4|||
16854193|NCT01799941|37806320|FG000|Overall Study|Lack of Efficacy|3|||
16854194|NCT01799941|37806320|FG000|Overall Study|Lost to Follow-up|17|||
16854195|NCT01799941|37806320|FG000|Overall Study|Other|15|||
16854196|NCT01799239|37806348|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
16854197|NCT01799239|37806349|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
16854198|NCT01799239|37806348|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
16854199|NCT01799239|37806349|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
16854200|NCT01799239|37806348|FG000|Period 1 (7 Days)|Protocol Violation|0|||
16854201|NCT01799239|37806349|FG001|Period 1 (7 Days)|Protocol Violation|1|||
16854202|NCT01799239|37806348|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
16854203|NCT01799239|37806349|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
16854204|NCT01799239|37806348|FG000|Period 2 (7 Days)|Protocol Violation|1|||
16854205|NCT01799239|37806349|FG001|Period 2 (7 Days)|Protocol Violation|0|||
16854206|NCT02999854|37806373|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
16854207|NCT02999854|37806374|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
16854208|NCT02999854|37806373|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
16854209|NCT02999854|37806374|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
16854210|NCT02999854|37806373|FG000|Active Study Phase (up to 18 Months)|Death|7|||
16854211|NCT02999854|37806374|FG001|Active Study Phase (up to 18 Months)|Death|5|||
16854212|NCT02999854|37806373|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
16854213|NCT02999854|37806374|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
16854214|NCT02999854|37806373|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
16854215|NCT02999854|37806374|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
16854216|NCT02999854|37806373|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
16854217|NCT02999854|37806374|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
16854218|NCT02999854|37806373|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
16854219|NCT02999854|37806374|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
16854220|NCT02999854|37806373|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
16854221|NCT02999854|37806374|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
16854222|NCT04146363|37806507|FG000|Induction Period|Adverse Event|1|||
16854223|NCT04146363|37806508|FG001|Induction Period|Adverse Event|2|||
16854224|NCT04146363|37806509|FG002|Induction Period|Adverse Event|0|||
16854225|NCT04146363|37806510|FG003|Induction Period|Adverse Event|0|||
16854226|NCT04146363|37806511|FG004|Induction Period|Adverse Event|0|||
16854227|NCT04146363|37806512|FG005|Induction Period|Adverse Event|0|||
16854228|NCT04146363|37806513|FG006|Induction Period|Adverse Event|0|||
16854229|NCT04146363|37806514|FG007|Induction Period|Adverse Event|0|||
16854230|NCT04146363|37806515|FG008|Induction Period|Adverse Event|0|||
16854231|NCT04146363|37806516|FG009|Induction Period|Adverse Event|0|||
16854232|NCT04146363|37806517|FG010|Induction Period|Adverse Event|0|||
16854233|NCT04146363|37806507|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
16854234|NCT04146363|37806508|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
16854235|NCT04146363|37806509|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
16854236|NCT04146363|37806510|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
16854237|NCT04146363|37806511|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
16854238|NCT04146363|37806512|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
16854239|NCT04146363|37806513|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
16854240|NCT04146363|37806514|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
16854241|NCT04146363|37806515|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
16854242|NCT04146363|37806516|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
16854243|NCT04146363|37806517|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
16854244|NCT04146363|37806507|FG000|Induction Period|Lack of Efficacy|7|||
16854245|NCT04146363|37806508|FG001|Induction Period|Lack of Efficacy|2|||
16854246|NCT04146363|37806509|FG002|Induction Period|Lack of Efficacy|0|||
16854247|NCT04146363|37806510|FG003|Induction Period|Lack of Efficacy|0|||
16854248|NCT04146363|37806511|FG004|Induction Period|Lack of Efficacy|0|||
16854249|NCT04146363|37806512|FG005|Induction Period|Lack of Efficacy|0|||
16854250|NCT04146363|37806513|FG006|Induction Period|Lack of Efficacy|0|||
16854251|NCT04146363|37806514|FG007|Induction Period|Lack of Efficacy|0|||
16854252|NCT04146363|37806515|FG008|Induction Period|Lack of Efficacy|0|||
16854253|NCT04146363|37806516|FG009|Induction Period|Lack of Efficacy|0|||
16854254|NCT04146363|37806517|FG010|Induction Period|Lack of Efficacy|0|||
16854255|NCT04146363|37806507|FG000|Induction Period|Lost to Follow-up|1|||
16854256|NCT04146363|37806508|FG001|Induction Period|Lost to Follow-up|4|||
16854257|NCT04146363|37806509|FG002|Induction Period|Lost to Follow-up|0|||
16854258|NCT04146363|37806510|FG003|Induction Period|Lost to Follow-up|0|||
16854259|NCT04146363|37806511|FG004|Induction Period|Lost to Follow-up|0|||
16854260|NCT04146363|37806512|FG005|Induction Period|Lost to Follow-up|0|||
16854261|NCT04146363|37806513|FG006|Induction Period|Lost to Follow-up|0|||
16854262|NCT04146363|37806514|FG007|Induction Period|Lost to Follow-up|0|||
16854263|NCT04146363|37806515|FG008|Induction Period|Lost to Follow-up|0|||
16854264|NCT04146363|37806516|FG009|Induction Period|Lost to Follow-up|0|||
16854265|NCT04146363|37806517|FG010|Induction Period|Lost to Follow-up|0|||
16854266|NCT04146363|37806507|FG000|Induction Period|Positive quantiferon test|0|||
16854267|NCT04146363|37806508|FG001|Induction Period|Positive quantiferon test|1|||
16854268|NCT04146363|37806509|FG002|Induction Period|Positive quantiferon test|0|||
16854269|NCT04146363|37806510|FG003|Induction Period|Positive quantiferon test|0|||
16854270|NCT04146363|37806511|FG004|Induction Period|Positive quantiferon test|0|||
16854271|NCT04146363|37806512|FG005|Induction Period|Positive quantiferon test|0|||
16854272|NCT04146363|37806513|FG006|Induction Period|Positive quantiferon test|0|||
16854273|NCT04146363|37806514|FG007|Induction Period|Positive quantiferon test|0|||
16854274|NCT04146363|37806515|FG008|Induction Period|Positive quantiferon test|0|||
16854275|NCT04146363|37806516|FG009|Induction Period|Positive quantiferon test|0|||
16854276|NCT04146363|37806517|FG010|Induction Period|Positive quantiferon test|0|||
16854277|NCT04146363|37806507|FG000|Induction Period|Protocol Deviation|5|||
16854278|NCT04146363|37806508|FG001|Induction Period|Protocol Deviation|6|||
16854279|NCT04146363|37806509|FG002|Induction Period|Protocol Deviation|0|||
16854280|NCT04146363|37806510|FG003|Induction Period|Protocol Deviation|0|||
16854281|NCT04146363|37806511|FG004|Induction Period|Protocol Deviation|0|||
16854282|NCT04146363|37806512|FG005|Induction Period|Protocol Deviation|0|||
16854283|NCT04146363|37806513|FG006|Induction Period|Protocol Deviation|0|||
16854284|NCT04146363|37806514|FG007|Induction Period|Protocol Deviation|0|||
16854285|NCT04146363|37806515|FG008|Induction Period|Protocol Deviation|0|||
16854286|NCT04146363|37806516|FG009|Induction Period|Protocol Deviation|0|||
16854287|NCT04146363|37806517|FG010|Induction Period|Protocol Deviation|0|||
16854288|NCT04146363|37806507|FG000|Induction Period|Withdrawal by Subject|6|||
16854289|NCT04146363|37806508|FG001|Induction Period|Withdrawal by Subject|3|||
16854290|NCT04146363|37806509|FG002|Induction Period|Withdrawal by Subject|0|||
16854291|NCT04146363|37806510|FG003|Induction Period|Withdrawal by Subject|0|||
16854292|NCT04146363|37806511|FG004|Induction Period|Withdrawal by Subject|0|||
16854293|NCT04146363|37806512|FG005|Induction Period|Withdrawal by Subject|0|||
16854294|NCT04146363|37806513|FG006|Induction Period|Withdrawal by Subject|0|||
16854295|NCT04146363|37806514|FG007|Induction Period|Withdrawal by Subject|0|||
16854296|NCT04146363|37806515|FG008|Induction Period|Withdrawal by Subject|0|||
16854297|NCT04146363|37806516|FG009|Induction Period|Withdrawal by Subject|0|||
16854298|NCT04146363|37806517|FG010|Induction Period|Withdrawal by Subject|0|||
16854299|NCT04146363|37806507|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854300|NCT04146363|37806508|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854301|NCT04146363|37806509|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854302|NCT04146363|37806510|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854303|NCT04146363|37806511|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854304|NCT04146363|37806512|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854305|NCT04146363|37806513|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
16854306|NCT04146363|37806514|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
16854307|NCT04146363|37806515|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854308|NCT04146363|37806516|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854309|NCT04146363|37806517|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
16854310|NCT04146363|37806507|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854311|NCT04146363|37806508|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854312|NCT04146363|37806509|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854313|NCT04146363|37806510|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854314|NCT04146363|37806511|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854315|NCT04146363|37806512|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854316|NCT04146363|37806513|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854317|NCT04146363|37806514|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
16854318|NCT04146363|37806515|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854319|NCT04146363|37806516|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854320|NCT04146363|37806517|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16854321|NCT04146363|37806507|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854322|NCT04146363|37806508|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854323|NCT04146363|37806509|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854324|NCT04146363|37806510|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854325|NCT04146363|37806511|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854326|NCT04146363|37806512|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854327|NCT04146363|37806513|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
16854328|NCT04146363|37806514|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
16854329|NCT04146363|37806515|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854330|NCT04146363|37806516|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854331|NCT04146363|37806517|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16854332|NCT04146363|37806507|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854333|NCT04146363|37806508|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854334|NCT04146363|37806509|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
16854335|NCT04146363|37806510|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854336|NCT04146363|37806511|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854337|NCT04146363|37806512|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
16854338|NCT04146363|37806513|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854339|NCT04146363|37806514|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854340|NCT04146363|37806515|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854341|NCT04146363|37806516|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854342|NCT04146363|37806517|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
16854343|NCT04146363|37806507|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16854344|NCT04146363|37806508|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16854345|NCT04146363|37806509|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16854346|NCT04146363|37806510|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16854347|NCT04146363|37806511|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
16854348|NCT04146363|37806512|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
16854349|NCT04146363|37806513|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
16854350|NCT04146363|37806514|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
16854351|NCT04146363|37806515|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16854352|NCT04146363|37806516|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16854353|NCT04146363|37806517|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16854354|NCT04146363|37806507|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16854355|NCT04146363|37806508|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16854356|NCT04146363|37806509|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
16854357|NCT04146363|37806510|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16854358|NCT04146363|37806511|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16854359|NCT04146363|37806512|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
16854360|NCT04146363|37806513|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
16854361|NCT04146363|37806514|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
16854362|NCT04146363|37806515|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16854363|NCT04146363|37806516|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16854364|NCT04146363|37806517|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16854365|NCT04146363|37806507|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854366|NCT04146363|37806508|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854367|NCT04146363|37806509|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854368|NCT04146363|37806510|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854369|NCT04146363|37806511|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854370|NCT04146363|37806512|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854371|NCT04146363|37806513|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854372|NCT04146363|37806514|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854373|NCT04146363|37806515|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
16854374|NCT04146363|37806516|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
16854375|NCT04146363|37806517|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
16854376|NCT04146363|37806507|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16854377|NCT04146363|37806508|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16854378|NCT04146363|37806509|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16854379|NCT04146363|37806510|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16854380|NCT04146363|37806511|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16854381|NCT04146363|37806512|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16854382|NCT04146363|37806513|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16854383|NCT04146363|37806514|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16854384|NCT04146363|37806515|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
16854385|NCT04146363|37806516|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
16854386|NCT04146363|37806517|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
16854387|NCT04146363|37806507|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854388|NCT04146363|37806508|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854389|NCT04146363|37806509|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854390|NCT04146363|37806510|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854391|NCT04146363|37806511|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854392|NCT04146363|37806512|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854393|NCT04146363|37806513|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854394|NCT04146363|37806514|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854395|NCT04146363|37806515|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
16854396|NCT04146363|37806516|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
16854397|NCT04146363|37806517|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16854398|NCT04146363|37806507|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
16854399|NCT04146363|37806508|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
16854400|NCT04146363|37806509|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
16854401|NCT04146363|37806510|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
17104573|NCT00077636|38242503|FG001|Overall Study|Refused Treatment|31|||
16854402|NCT04146363|37806511|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
16854403|NCT04146363|37806512|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
16854404|NCT04146363|37806513|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
16854405|NCT04146363|37806514|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
16854406|NCT04146363|37806515|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
16854407|NCT04146363|37806516|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
16854408|NCT04146363|37806517|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
16854409|NCT04146363|37806507|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16854410|NCT04146363|37806508|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16854411|NCT04146363|37806509|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16854412|NCT04146363|37806510|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16854413|NCT04146363|37806511|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16854414|NCT04146363|37806512|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16854415|NCT04146363|37806513|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16854416|NCT04146363|37806514|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16854417|NCT04146363|37806515|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
16854418|NCT04146363|37806516|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
16854419|NCT04146363|37806517|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
16854420|NCT04146363|37806507|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854421|NCT04146363|37806508|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854422|NCT04146363|37806509|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854423|NCT04146363|37806510|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854424|NCT04146363|37806511|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854425|NCT04146363|37806512|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854426|NCT04146363|37806513|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854427|NCT04146363|37806514|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854428|NCT04146363|37806515|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854429|NCT04146363|37806516|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
16854430|NCT04146363|37806517|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
16854431|NCT04146363|37806507|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854432|NCT04146363|37806508|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854433|NCT04146363|37806509|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854434|NCT04146363|37806510|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854435|NCT04146363|37806511|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854436|NCT04146363|37806512|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854437|NCT04146363|37806513|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854438|NCT04146363|37806514|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854439|NCT04146363|37806515|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854440|NCT04146363|37806516|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
16854441|NCT04146363|37806517|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16854442|NCT01773421|37806542|FG000|Treatment Phase|Other|0|||
16854443|NCT01773421|37806543|FG001|Treatment Phase|Other|0|||
16854444|NCT01773421|37806544|FG002|Treatment Phase|Other|2|||
16854445|NCT01773421|37806545|FG003|Treatment Phase|Other|0|||
16854446|NCT01773421|37806546|FG004|Treatment Phase|Other|0|||
16854447|NCT01773421|37806547|FG005|Treatment Phase|Other|0|||
16854448|NCT01773421|37806548|FG006|Treatment Phase|Other|0|||
16854449|NCT01773421|37806542|FG000|Treatment Phase|Adverse Event|0|||
16854450|NCT01773421|37806543|FG001|Treatment Phase|Adverse Event|0|||
16854451|NCT01773421|37806544|FG002|Treatment Phase|Adverse Event|3|||
16854452|NCT01773421|37806545|FG003|Treatment Phase|Adverse Event|1|||
16854453|NCT01773421|37806546|FG004|Treatment Phase|Adverse Event|0|||
16854454|NCT01773421|37806547|FG005|Treatment Phase|Adverse Event|0|||
16854455|NCT01773421|37806548|FG006|Treatment Phase|Adverse Event|0|||
16854456|NCT01773421|37806542|FG000|Treatment Phase|Withdrawal by Subject|0|||
16854457|NCT01773421|37806543|FG001|Treatment Phase|Withdrawal by Subject|0|||
16854458|NCT01773421|37806544|FG002|Treatment Phase|Withdrawal by Subject|1|||
16854459|NCT01773421|37806545|FG003|Treatment Phase|Withdrawal by Subject|1|||
16854460|NCT01773421|37806546|FG004|Treatment Phase|Withdrawal by Subject|0|||
16854461|NCT01773421|37806547|FG005|Treatment Phase|Withdrawal by Subject|0|||
16854462|NCT01773421|37806548|FG006|Treatment Phase|Withdrawal by Subject|0|||
16854463|NCT01773421|37806542|FG000|Extension Phase|Other|0|||
16854464|NCT01773421|37806543|FG001|Extension Phase|Other|0|||
16854465|NCT01773421|37806544|FG002|Extension Phase|Other|0|||
16854466|NCT01773421|37806545|FG003|Extension Phase|Other|0|||
16854467|NCT01773421|37806546|FG004|Extension Phase|Other|1|||
16854468|NCT01773421|37806547|FG005|Extension Phase|Other|2|||
16854469|NCT01773421|37806548|FG006|Extension Phase|Other|0|||
16854470|NCT01773421|37806542|FG000|Extension Phase|Adverse Event|0|||
16854471|NCT01773421|37806543|FG001|Extension Phase|Adverse Event|0|||
16854472|NCT01773421|37806544|FG002|Extension Phase|Adverse Event|0|||
16854473|NCT01773421|37806545|FG003|Extension Phase|Adverse Event|0|||
16854474|NCT01773421|37806546|FG004|Extension Phase|Adverse Event|2|||
16854475|NCT01773421|37806547|FG005|Extension Phase|Adverse Event|0|||
16854476|NCT01773421|37806548|FG006|Extension Phase|Adverse Event|0|||
16854477|NCT01838941|37806568|FG000|Overall Study|Adverse Event|1|||
16854478|NCT01838941|37806568|FG000|Overall Study|Withdrawal by Subject|1|||
16854479|NCT01773109|37806573|FG000|Overall Study|Symptomatic Progression|2|||
16854480|NCT01773109|37806573|FG000|Overall Study|Death|1|||
16854481|NCT01772719|37806577|FG000|Overall Study|Withdrawal by Subject|3|||
16854482|NCT01772719|37806577|FG000|Overall Study|Adverse Event|2|||
16854483|NCT01772719|37806577|FG000|Overall Study|Protocol Violation|1|||
16854484|NCT01772719|37806577|FG000|Overall Study|Lost to Follow-up|1|||
16854485|NCT01798927|37806584|FG000|Overall Study|Withdrawal by Subject|1|||
16854486|NCT01276288|37806653|FG000|Overall Study|Adverse Event|1|||
16854487|NCT01276288|37806654|FG001|Overall Study|Adverse Event|1|||
16854488|NCT01276288|37806655|FG002|Overall Study|Adverse Event|0|||
16854489|NCT01276288|37806656|FG003|Overall Study|Adverse Event|0|||
16854490|NCT01276288|37806653|FG000|Overall Study|not treated|1|||
16854491|NCT01276288|37806654|FG001|Overall Study|not treated|0|||
16854492|NCT01276288|37806655|FG002|Overall Study|not treated|0|||
16854493|NCT01276288|37806656|FG003|Overall Study|not treated|0|||
16854494|NCT02702271|37806680|FG000|Overall Study|Death|36|||
16854495|NCT02702271|37806681|FG001|Overall Study|Death|7|||
16854496|NCT02702271|37806680|FG000|Overall Study|Lost to Follow-up|12|||
16854497|NCT02702271|37806681|FG001|Overall Study|Lost to Follow-up|0|||
16854498|NCT02702271|37806680|FG000|Overall Study|Withdrawal by Subject|8|||
16854499|NCT02702271|37806681|FG001|Overall Study|Withdrawal by Subject|1|||
16854500|NCT02702271|37806680|FG000|Overall Study|Physician Decision|2|||
16854501|NCT02702271|37806681|FG001|Overall Study|Physician Decision|0|||
16854502|NCT02702271|37806680|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
16854503|NCT02702271|37806681|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
16854504|NCT01276054|37806766|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
16854505|NCT01276054|37806767|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
16854506|NCT01798849|37806776|FG000|Overall Study|Physician Decision|0|||
16854507|NCT01798849|37806777|FG001|Overall Study|Physician Decision|0|||
16854508|NCT01798849|37806778|FG002|Overall Study|Physician Decision|1|||
16854509|NCT01797835|37806858|FG000|Overall Study|Lost to Follow-up|31|||
16854510|NCT01797835|37806859|FG001|Overall Study|Lost to Follow-up|27|||
16854511|NCT01275430|37806865|FG000|Overall Study|Adverse Event|1|||
16854512|NCT01275430|37806865|FG000|Overall Study|No Contrast Injection|6|||
16854513|NCT01275430|37806865|FG000|Overall Study|Device Malfunction|1|||
17104574|NCT00077636|38242502|FG000|Overall Study|Admin|3|||
17104575|NCT00077636|38242503|FG001|Overall Study|Admin|3|||
17104576|NCT00077636|38242502|FG000|Overall Study|Withdrawal by Subject|2|||
17104577|NCT00077636|38242503|FG001|Overall Study|Withdrawal by Subject|2|||
17104578|NCT00077636|38242502|FG000|Overall Study|Adverse Event|17|||
17104579|NCT00077636|38242503|FG001|Overall Study|Adverse Event|34|||
17104580|NCT00077636|38242502|FG000|Overall Study|Protocol Violation|0|||
17104581|NCT00077636|38242503|FG001|Overall Study|Protocol Violation|2|||
17104582|NCT00077636|38242502|FG000|Overall Study|Lost to Follow-up|10|||
17104583|NCT00077636|38242503|FG001|Overall Study|Lost to Follow-up|18|||
17104584|NCT00077636|38242502|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
17104585|NCT00077636|38242503|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
17104586|NCT00095199|38242514|FG000|Overall Study|Adverse Event|40|||
17104587|NCT00095199|38242515|FG001|Overall Study|Adverse Event|22|||
17104588|NCT00095199|38242516|FG002|Overall Study|Adverse Event|26|||
17104589|NCT00095199|38242517|FG003|Overall Study|Adverse Event|11|||
17104590|NCT00095199|38242514|FG000|Overall Study|Progressive disease|213|||
17104591|NCT00095199|38242515|FG001|Overall Study|Progressive disease|179|||
17104592|NCT00095199|38242516|FG002|Overall Study|Progressive disease|105|||
17104593|NCT00095199|38242517|FG003|Overall Study|Progressive disease|98|||
17104594|NCT00095199|38242514|FG000|Overall Study|Death|10|||
17104595|NCT00095199|38242515|FG001|Overall Study|Death|6|||
17104596|NCT00095199|38242516|FG002|Overall Study|Death|11|||
17104597|NCT00095199|38242517|FG003|Overall Study|Death|9|||
17104598|NCT00095199|38242514|FG000|Overall Study|Withdrawal by Subject|21|||
17104599|NCT00095199|38242515|FG001|Overall Study|Withdrawal by Subject|16|||
17104600|NCT00095199|38242516|FG002|Overall Study|Withdrawal by Subject|13|||
17104601|NCT00095199|38242517|FG003|Overall Study|Withdrawal by Subject|22|||
17104602|NCT00095199|38242514|FG000|Overall Study|Protocol Violation|4|||
17104603|NCT00095199|38242515|FG001|Overall Study|Protocol Violation|4|||
17104604|NCT00095199|38242516|FG002|Overall Study|Protocol Violation|2|||
17104605|NCT00095199|38242517|FG003|Overall Study|Protocol Violation|0|||
17104606|NCT00095199|38242514|FG000|Overall Study|Liver function test results elevated|0|||
17104607|NCT00095199|38242515|FG001|Overall Study|Liver function test results elevated|0|||
16854514|NCT01275430|37806865|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
17104608|NCT00095199|38242516|FG002|Overall Study|Liver function test results elevated|1|||
17104609|NCT00095199|38242517|FG003|Overall Study|Liver function test results elevated|1|||
17104610|NCT00095199|38242514|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
17104611|NCT00095199|38242515|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
16854515|NCT01838551|37806870|FG000|Overall Study|Adverse Event|16|||
16854516|NCT01838551|37806870|FG000|Overall Study|Death|1|||
16854517|NCT01838551|37806870|FG000|Overall Study|Lack of Efficacy|10|||
16854518|NCT01838551|37806870|FG000|Overall Study|Physician Decision|4|||
16854519|NCT01838551|37806870|FG000|Overall Study|Withdrawal by Subject|10|||
16854520|NCT01838551|37806870|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
16854521|NCT01797445|37806876|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
16854522|NCT01797445|37806877|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
16854523|NCT01797445|37806876|FG000|Double-Blind Phase|Adverse Event|3|||
16854524|NCT01797445|37806877|FG001|Double-Blind Phase|Adverse Event|0|||
16854525|NCT01797445|37806876|FG000|Double-Blind Phase|Death|5|||
16854526|NCT01797445|37806877|FG001|Double-Blind Phase|Death|4|||
16854527|NCT01797445|37806876|FG000|Double-Blind Phase|Pregnancy|0|||
16854528|NCT01797445|37806877|FG001|Double-Blind Phase|Pregnancy|1|||
16854529|NCT01797445|37806876|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16854530|NCT01797445|37806877|FG001|Double-Blind Phase|Lack of Efficacy|2|||
16854531|NCT01797445|37806876|FG000|Double-Blind Phase|Investigator's Discretion|15|||
16854532|NCT01797445|37806877|FG001|Double-Blind Phase|Investigator's Discretion|17|||
16854533|NCT01797445|37806876|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
16854534|NCT01797445|37806877|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
16854535|NCT01797445|37806876|FG000|Double-Blind Phase|Protocol Violation|0|||
16854536|NCT01797445|37806877|FG001|Double-Blind Phase|Protocol Violation|1|||
16854537|NCT01797445|37806876|FG000|Double-Blind Phase|Withdrew Consent|20|||
16854538|NCT01797445|37806877|FG001|Double-Blind Phase|Withdrew Consent|35|||
16854539|NCT01797445|37806876|FG000|Double-Blind Phase|Lost to Follow-up|34|||
16854540|NCT01797445|37806877|FG001|Double-Blind Phase|Lost to Follow-up|26|||
16854541|NCT01797445|37806876|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
16854542|NCT01797445|37806877|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
16854543|NCT01611259|37806885|FG000|Overall Study|Physician Decision|1|||
16854544|NCT01611259|37806885|FG000|Overall Study|Lack of Efficacy|2|||
16854545|NCT01611259|37806885|FG000|Overall Study|Adverse Event|4|||
16854546|NCT01611259|37806885|FG000|Overall Study|Withdrawal by Subject|7|||
16854547|NCT01796197|37806889|FG000|Overall Study|Lost to Follow-up|1|||
16854548|NCT01796197|37806889|FG000|Overall Study|Lack of Efficacy|1|||
16854549|NCT01795495|37806896|FG000|Overall Study|Protocol Violation|1|||
16854550|NCT01795495|37806897|FG001|Overall Study|Protocol Violation|0|||
16854551|NCT01795495|37806898|FG002|Overall Study|Protocol Violation|1|||
16854552|NCT01795495|37806896|FG000|Overall Study|Physician Decision|0|||
16854553|NCT01795495|37806897|FG001|Overall Study|Physician Decision|0|||
16854554|NCT01795495|37806898|FG002|Overall Study|Physician Decision|1|||
16854555|NCT01794949|37806908|FG000|Overall Study|Lost to Follow-up|1|||
16854556|NCT01794949|37806909|FG001|Overall Study|Lost to Follow-up|0|||
16854557|NCT01770379|37806918|FG000|Overall Study|Technical issues|1|||
16854558|NCT01770379|37806919|FG001|Overall Study|Technical issues|0|||
16854559|NCT01770379|37806920|FG002|Overall Study|Technical issues|0|||
16854560|NCT01770379|37806918|FG000|Overall Study|Withdrawal by Subject|7|||
16854561|NCT01770379|37806919|FG001|Overall Study|Withdrawal by Subject|10|||
16854562|NCT01770379|37806920|FG002|Overall Study|Withdrawal by Subject|7|||
16854563|NCT01770379|37806918|FG000|Overall Study|study terminated by sponsor|22|||
16854564|NCT01770379|37806919|FG001|Overall Study|study terminated by sponsor|23|||
16854565|NCT01770379|37806920|FG002|Overall Study|study terminated by sponsor|22|||
16854566|NCT01770379|37806918|FG000|Overall Study|Protocol Violation|0|||
16854567|NCT01770379|37806919|FG001|Overall Study|Protocol Violation|1|||
16854568|NCT01770379|37806920|FG002|Overall Study|Protocol Violation|1|||
16854569|NCT01770379|37806918|FG000|Overall Study|Physician Decision|0|||
16854570|NCT01770379|37806919|FG001|Overall Study|Physician Decision|1|||
16854571|NCT01770379|37806920|FG002|Overall Study|Physician Decision|2|||
16854572|NCT01770379|37806918|FG000|Overall Study|Lost to Follow-up|0|||
16854573|NCT01770379|37806919|FG001|Overall Study|Lost to Follow-up|0|||
16854574|NCT01770379|37806920|FG002|Overall Study|Lost to Follow-up|2|||
16854575|NCT01770379|37806918|FG000|Overall Study|Lack of Efficacy|8|||
16854576|NCT01770379|37806919|FG001|Overall Study|Lack of Efficacy|6|||
16854577|NCT01770379|37806920|FG002|Overall Study|Lack of Efficacy|6|||
16854578|NCT01770379|37806918|FG000|Overall Study|Adverse Event|1|||
16854579|NCT01770379|37806919|FG001|Overall Study|Adverse Event|3|||
16854580|NCT01770379|37806920|FG002|Overall Study|Adverse Event|2|||
16854581|NCT01986881|37806933|FG000|Overall Study|Death|228|||
16854582|NCT01986881|37806934|FG001|Overall Study|Death|233|||
16854583|NCT01986881|37806935|FG002|Overall Study|Death|247|||
16854584|NCT01986881|37806933|FG000|Overall Study|Lost to Follow-up|51|||
16854585|NCT01986881|37806934|FG001|Overall Study|Lost to Follow-up|44|||
16854586|NCT01986881|37806935|FG002|Overall Study|Lost to Follow-up|55|||
16854587|NCT01986881|37806933|FG000|Overall Study|Physician Decision|7|||
16854588|NCT01986881|37806934|FG001|Overall Study|Physician Decision|4|||
16854589|NCT01986881|37806935|FG002|Overall Study|Physician Decision|6|||
16854590|NCT01986881|37806933|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
16854591|NCT01986881|37806934|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
16854592|NCT01986881|37806935|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
16854593|NCT01986881|37806933|FG000|Overall Study|Withdrawal by Subject|41|||
16854594|NCT01986881|37806934|FG001|Overall Study|Withdrawal by Subject|60|||
16854595|NCT01986881|37806935|FG002|Overall Study|Withdrawal by Subject|45|||
16854596|NCT01986881|37806933|FG000|Overall Study|Subject Moved|0|||
16854597|NCT01986881|37806934|FG001|Overall Study|Subject Moved|1|||
16854598|NCT01986881|37806935|FG002|Overall Study|Subject Moved|0|||
16854599|NCT01986881|37806933|FG000|Overall Study|Other|1|||
16854600|NCT01986881|37806934|FG001|Overall Study|Other|2|||
16854601|NCT01986881|37806935|FG002|Overall Study|Other|2|||
16854602|NCT01770145|37806966|FG000|Baseline|Adverse Event|20|||
16854603|NCT01770145|37806966|FG000|Baseline|Withdrawal by Subject|1|||
16854604|NCT01770145|37806966|FG000|Baseline|Lost to Follow-up|1|||
16854605|NCT01770145|37806966|FG000|Baseline|Unable to define optimal dose|4|||
16854606|NCT01770145|37806966|FG000|Treatment|Adverse Event|3|||
16854607|NCT01770145|37806966|FG000|Treatment|Withdrawal by Subject|1|||
16854608|NCT01609543|37806970|FG000|Overall Study|Disease Progression|28|||
16854609|NCT01609543|37806970|FG000|Overall Study|Adverse Event|5|||
16854610|NCT01609543|37806970|FG000|Overall Study|Withdrawal by Subject|1|||
17104612|NCT00095199|38242516|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
17104613|NCT00095199|38242517|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
16854611|NCT01609543|37806970|FG000|Overall Study|Protocol Violation|1|||
16854612|NCT01609543|37806970|FG000|Overall Study|Death|7|||
16854613|NCT02003183|37806977|FG000|Overall Study|Lost to Follow-up|0|||
16854614|NCT02003183|37806978|FG001|Overall Study|Lost to Follow-up|2|||
16854615|NCT01986647|37806988|FG000|Overall Study|Lost to Follow-up|4|||
16854616|NCT01986647|37806989|FG001|Overall Study|Lost to Follow-up|1|||
16854617|NCT01986647|37806990|FG002|Overall Study|Lost to Follow-up|4|||
16854618|NCT01986647|37806991|FG003|Overall Study|Lost to Follow-up|4|||
16854619|NCT01986647|37806988|FG000|Overall Study|Withdrawal by Subject|1|||
16854620|NCT01986647|37806989|FG001|Overall Study|Withdrawal by Subject|3|||
16854621|NCT01986647|37806990|FG002|Overall Study|Withdrawal by Subject|2|||
16854622|NCT01986647|37806991|FG003|Overall Study|Withdrawal by Subject|3|||
16854623|NCT01986647|37806988|FG000|Overall Study|Health|5|||
16854624|NCT01986647|37806989|FG001|Overall Study|Health|3|||
16854625|NCT01986647|37806990|FG002|Overall Study|Health|6|||
16854626|NCT01986647|37806991|FG003|Overall Study|Health|4|||
16854627|NCT02002091|37807007|FG000|Screening|Lost to Follow-up|10|||
16854628|NCT02002091|37807008|FG001|Screening|Lost to Follow-up|12|||
16854629|NCT02002091|37807007|FG000|Screening|Death|3|||
16854630|NCT02002091|37807008|FG001|Screening|Death|2|||
16854631|NCT01985321|37807045|FG000|Overall Study|Protocol Violation|4|||
16854632|NCT01985321|37807046|FG001|Overall Study|Protocol Violation|3|||
16854633|NCT01985321|37807045|FG000|Overall Study|Withdrawal by Subject|1|||
16854634|NCT01985321|37807046|FG001|Overall Study|Withdrawal by Subject|0|||
16854635|NCT01985321|37807045|FG000|Overall Study|Lost to Follow-up|5|||
16854636|NCT01985321|37807046|FG001|Overall Study|Lost to Follow-up|2|||
16854637|NCT01985321|37807045|FG000|Overall Study|Subject treated wrong type of sore|1|||
16854638|NCT01985321|37807046|FG001|Overall Study|Subject treated wrong type of sore|0|||
16854639|NCT02000921|37807055|FG000|Overall Study|Withdrawal by Subject|3|||
16854640|NCT02000921|37807056|FG001|Overall Study|Withdrawal by Subject|10|||
16854641|NCT02000921|37807057|FG002|Overall Study|Withdrawal by Subject|5|||
16854642|NCT02000921|37807055|FG000|Overall Study|Lost to Follow-up|2|||
16854643|NCT02000921|37807056|FG001|Overall Study|Lost to Follow-up|4|||
16854644|NCT02000921|37807057|FG002|Overall Study|Lost to Follow-up|5|||
16854645|NCT02000921|37807055|FG000|Overall Study|Physician Decision|0|||
16854646|NCT02000921|37807056|FG001|Overall Study|Physician Decision|2|||
17104614|NCT00095199|38242514|FG000|Overall Study|Physician Decision|5|||
17104615|NCT00095199|38242515|FG001|Overall Study|Physician Decision|6|||
17104616|NCT00095199|38242516|FG002|Overall Study|Physician Decision|1|||
17104617|NCT00095199|38242517|FG003|Overall Study|Physician Decision|1|||
17104618|NCT00095199|38242514|FG000|Overall Study|Not eligible|1|||
17104619|NCT00095199|38242515|FG001|Overall Study|Not eligible|7|||
17104620|NCT00095199|38242516|FG002|Overall Study|Not eligible|0|||
17104621|NCT00095199|38242517|FG003|Overall Study|Not eligible|1|||
17104622|NCT00095199|38242514|FG000|Overall Study|Started Palliative Radiotherapy|1|||
17104623|NCT00095199|38242515|FG001|Overall Study|Started Palliative Radiotherapy|0|||
17104624|NCT00095199|38242516|FG002|Overall Study|Started Palliative Radiotherapy|0|||
17104625|NCT00095199|38242517|FG003|Overall Study|Started Palliative Radiotherapy|0|||
17104626|NCT00095199|38242514|FG000|Overall Study|Started radiotherapy regimen|0|||
17104627|NCT00095199|38242515|FG001|Overall Study|Started radiotherapy regimen|1|||
17104628|NCT00095199|38242516|FG002|Overall Study|Started radiotherapy regimen|0|||
16854647|NCT02000921|37807057|FG002|Overall Study|Physician Decision|0|||
16854648|NCT01836523|37807103|FG000|Overall Study|Adverse Event|15|||
16854649|NCT01836523|37807104|FG001|Overall Study|Adverse Event|41|||
16854650|NCT01836523|37807105|FG002|Overall Study|Adverse Event|49|||
16854651|NCT01836523|37807106|FG003|Overall Study|Adverse Event|14|||
16854652|NCT01836523|37807103|FG000|Overall Study|Protocol Violation|6|||
16854653|NCT01836523|37807104|FG001|Overall Study|Protocol Violation|3|||
17104629|NCT00095199|38242517|FG003|Overall Study|Started radiotherapy regimen|0|||
16854654|NCT01836523|37807105|FG002|Overall Study|Protocol Violation|2|||
16854655|NCT01836523|37807106|FG003|Overall Study|Protocol Violation|4|||
16854656|NCT01836523|37807103|FG000|Overall Study|Met Withdrawal Criteria|13|||
16854657|NCT01836523|37807104|FG001|Overall Study|Met Withdrawal Criteria|13|||
16854658|NCT01836523|37807105|FG002|Overall Study|Met Withdrawal Criteria|21|||
16854659|NCT01836523|37807106|FG003|Overall Study|Met Withdrawal Criteria|27|||
16854660|NCT01836523|37807103|FG000|Overall Study|Unclassified|17|||
16854661|NCT01836523|37807104|FG001|Overall Study|Unclassified|28|||
16854662|NCT01836523|37807105|FG002|Overall Study|Unclassified|19|||
16854663|NCT01836523|37807106|FG003|Overall Study|Unclassified|29|||
16854664|NCT01275196|37807118|FG000|Overall Study|Adverse Event|3|||
16854665|NCT01275196|37807119|FG001|Overall Study|Adverse Event|5|||
16854666|NCT01275196|37807118|FG000|Overall Study|Withdrawal by Subject|4|||
16854667|NCT01275196|37807119|FG001|Overall Study|Withdrawal by Subject|5|||
16854668|NCT01275196|37807118|FG000|Overall Study|Lost to Follow-up|1|||
16854669|NCT01275196|37807119|FG001|Overall Study|Lost to Follow-up|0|||
16854670|NCT01275196|37807118|FG000|Overall Study|Disease Progression|6|||
16854671|NCT01275196|37807119|FG001|Overall Study|Disease Progression|5|||
16854672|NCT01275196|37807118|FG000|Overall Study|Protocol Violation|1|||
16854673|NCT01275196|37807119|FG001|Overall Study|Protocol Violation|0|||
16854674|NCT01275196|37807118|FG000|Overall Study|Suboptimal response/treatment failure|5|||
16854675|NCT01275196|37807119|FG001|Overall Study|Suboptimal response/treatment failure|6|||
16935934|NCT01212757|38080615|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16935935|NCT01212757|38080616|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16935936|NCT01212757|38080617|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17104630|NCT00095199|38242514|FG000|Overall Study|Primary tumor removed in other surgery|0|||
17104631|NCT00095199|38242515|FG001|Overall Study|Primary tumor removed in other surgery|1|||
17104632|NCT00095199|38242516|FG002|Overall Study|Primary tumor removed in other surgery|0|||
17104633|NCT00095199|38242517|FG003|Overall Study|Primary tumor removed in other surgery|0|||
17104634|NCT00095199|38242514|FG000|Overall Study|Data inadvertently lost by site|1|||
17104635|NCT00095199|38242515|FG001|Overall Study|Data inadvertently lost by site|0|||
17104636|NCT00095199|38242516|FG002|Overall Study|Data inadvertently lost by site|0|||
17104637|NCT00095199|38242517|FG003|Overall Study|Data inadvertently lost by site|0|||
17104638|NCT00075764|38242534|FG000|Overall Study|Adverse Event|5|||
17104639|NCT00075764|38242535|FG001|Overall Study|Adverse Event|12|||
17104640|NCT00075764|38242534|FG000|Overall Study|Death|4|||
17104641|NCT00075764|38242535|FG001|Overall Study|Death|8|||
17104642|NCT00075764|38242534|FG000|Overall Study|Withdrawal by Subject|28|||
17104643|NCT00075764|38242535|FG001|Overall Study|Withdrawal by Subject|18|||
17104644|NCT00075764|38242534|FG000|Overall Study|Progression|269|||
17104645|NCT00075764|38242535|FG001|Overall Study|Progression|274|||
17104646|NCT00075764|38242534|FG000|Overall Study|Still on treatment|8|||
16935937|NCT01212757|38080618|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16935938|NCT01212757|38080619|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
17104647|NCT00075764|38242535|FG001|Overall Study|Still on treatment|15|||
17104648|NCT00075764|38242534|FG000|Overall Study|Delinquent|4|||
17104649|NCT00075764|38242535|FG001|Overall Study|Delinquent|2|||
17104650|NCT00075764|38242534|FG000|Overall Study|Not protocol specified|27|||
17104651|NCT00075764|38242535|FG001|Overall Study|Not protocol specified|19|||
17104652|NCT00075764|38242534|FG000|Overall Study|Under review|0|||
17104653|NCT00075764|38242535|FG001|Overall Study|Under review|1|||
17104654|NCT03568162|38242549|FG000|Overall Study|Adverse Event|0|||
17104655|NCT03568162|38242550|FG001|Overall Study|Adverse Event|1|||
17104656|NCT03568162|38242551|FG002|Overall Study|Adverse Event|2|||
17104657|NCT03568162|38242552|FG003|Overall Study|Adverse Event|0|||
17104658|NCT03568162|38242553|FG004|Overall Study|Adverse Event|0|||
17104659|NCT03568162|38242554|FG005|Overall Study|Adverse Event|1|||
17104660|NCT03568162|38242549|FG000|Overall Study|Death|0|||
17104661|NCT03568162|38242550|FG001|Overall Study|Death|0|||
17104662|NCT03568162|38242551|FG002|Overall Study|Death|0|||
17104663|NCT03568162|38242552|FG003|Overall Study|Death|0|||
17104664|NCT03568162|38242553|FG004|Overall Study|Death|1|||
17104665|NCT03568162|38242554|FG005|Overall Study|Death|0|||
17104666|NCT03568162|38242549|FG000|Overall Study|Lost to Follow-up|3|||
17104667|NCT03568162|38242550|FG001|Overall Study|Lost to Follow-up|2|||
17104668|NCT03568162|38242551|FG002|Overall Study|Lost to Follow-up|4|||
17104669|NCT03568162|38242552|FG003|Overall Study|Lost to Follow-up|2|||
17104670|NCT03568162|38242553|FG004|Overall Study|Lost to Follow-up|3|||
17104671|NCT03568162|38242554|FG005|Overall Study|Lost to Follow-up|2|||
16935939|NCT01212757|38080611|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16935940|NCT01212757|38080612|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
16935941|NCT01212757|38080613|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
17104672|NCT03568162|38242549|FG000|Overall Study|Physician Decision|0|||
17104673|NCT03568162|38242550|FG001|Overall Study|Physician Decision|1|||
17104674|NCT03568162|38242551|FG002|Overall Study|Physician Decision|1|||
17104675|NCT03568162|38242552|FG003|Overall Study|Physician Decision|0|||
17104676|NCT03568162|38242553|FG004|Overall Study|Physician Decision|1|||
17104677|NCT03568162|38242554|FG005|Overall Study|Physician Decision|0|||
16935942|NCT01212757|38080614|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
16935943|NCT01212757|38080615|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16935944|NCT01212757|38080616|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
16935945|NCT01212757|38080617|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16935946|NCT01212757|38080618|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16935947|NCT01212757|38080619|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16935948|NCT01212757|38080611|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16935949|NCT01212757|38080612|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
16935950|NCT01212757|38080613|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
16935951|NCT01212757|38080614|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
16935952|NCT01212757|38080615|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16935953|NCT01212757|38080616|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
16935954|NCT01212757|38080617|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16935955|NCT01212757|38080618|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16935956|NCT01212757|38080619|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16935957|NCT01212757|38080611|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16935958|NCT01212757|38080612|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16935959|NCT01212757|38080613|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
16935960|NCT01212757|38080614|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16935961|NCT01212757|38080615|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16935962|NCT01212757|38080616|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16935963|NCT01212757|38080617|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16935964|NCT01212757|38080618|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16935965|NCT01212757|38080619|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16935966|NCT01212757|38080611|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16935967|NCT01212757|38080612|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
16935968|NCT01212757|38080613|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
16935969|NCT01212757|38080614|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
16935970|NCT01212757|38080615|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
16935971|NCT01212757|38080616|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
16935972|NCT01212757|38080617|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16935973|NCT01212757|38080618|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16935974|NCT01212757|38080619|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16935975|NCT01212757|38080611|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16935976|NCT01212757|38080612|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
16935977|NCT01212757|38080613|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16935978|NCT01212757|38080614|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16935979|NCT01212757|38080615|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
16935980|NCT01212757|38080616|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16935981|NCT01212757|38080617|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16935982|NCT01212757|38080618|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16935983|NCT01212757|38080619|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16935984|NCT01212757|38080611|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16935985|NCT01212757|38080612|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
16935986|NCT01212757|38080613|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
16935987|NCT01212757|38080614|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16935988|NCT01212757|38080615|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16935989|NCT01212757|38080616|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16935990|NCT01212757|38080617|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16935991|NCT01212757|38080618|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16935992|NCT01212757|38080619|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16935993|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16935994|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16935995|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16935996|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16935997|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16935998|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16935999|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16936000|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16936001|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
16936002|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16936003|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
16936004|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
16936005|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16936006|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16936007|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16936008|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16936009|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
16936010|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
16936011|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16936012|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
16936013|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
16936014|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16936015|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16936016|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16936017|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16936018|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
16936019|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16936020|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16936021|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
16936022|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
16936023|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16936024|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16936025|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16936026|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16936027|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
16936028|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
16936029|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16936030|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16936031|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
16936032|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16936033|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16936034|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16936035|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16936036|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16936037|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16936038|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16936039|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
16936040|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
16936041|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16936042|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16936043|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16936044|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16936045|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
16936046|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16936047|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16936048|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
16936049|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
16936050|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16936051|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16936052|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16936053|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16936054|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
16936055|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
16936056|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16936057|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16936058|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
16936059|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16936060|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16936061|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16936062|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16936063|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16936064|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16936065|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16936066|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
16936067|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16936068|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16936069|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16936070|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16936071|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16936072|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16936073|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
17104678|NCT03568162|38242549|FG000|Overall Study|Pregnancy|0|||
16936074|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16936075|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16936076|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16936077|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16936078|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16936079|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16936080|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16936081|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16936082|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
16936083|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16936084|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
16936085|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16936086|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16936087|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16936088|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16936089|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16936090|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16936091|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16936092|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16936093|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16936094|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
16936095|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16936096|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16936097|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16936098|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16936099|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16936100|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
16936101|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16936102|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
16936103|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16936104|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16936105|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16936106|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16936107|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16936108|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16936109|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
16936110|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16936111|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
16936112|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
16936113|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16936114|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16936115|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16936116|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16936117|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
16936118|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
16936119|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16936120|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
16936121|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
16936122|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16936123|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16936124|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16936125|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16936126|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
16936127|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
16936128|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16936129|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
16936130|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
16936131|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16936132|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16936133|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16936134|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16936135|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
16936136|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
16936137|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
16936138|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
16936139|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
16936140|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
16936141|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
16936142|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
16936143|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
16936144|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
16936145|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
16936146|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16936147|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
17104679|NCT03568162|38242550|FG001|Overall Study|Pregnancy|0|||
17104680|NCT03568162|38242551|FG002|Overall Study|Pregnancy|0|||
17104681|NCT03568162|38242552|FG003|Overall Study|Pregnancy|1|||
17104682|NCT03568162|38242553|FG004|Overall Study|Pregnancy|0|||
16936148|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16936149|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16936150|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16936151|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16936152|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16936153|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
16936154|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16936155|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16936156|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
16936157|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
16936158|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16936159|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16936160|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16936161|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16936162|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16936163|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16936164|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16936165|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
16936166|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
16936167|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16936168|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16936169|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16936170|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16936171|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
16936172|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16936173|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16936174|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
16936175|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
16936176|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16936177|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
17104683|NCT03568162|38242554|FG005|Overall Study|Pregnancy|0|||
17104684|NCT03568162|38242549|FG000|Overall Study|Protocol Violation|1|||
17104685|NCT03568162|38242550|FG001|Overall Study|Protocol Violation|0|||
17104686|NCT03568162|38242551|FG002|Overall Study|Protocol Violation|1|||
17104687|NCT03568162|38242552|FG003|Overall Study|Protocol Violation|1|||
17104688|NCT03568162|38242553|FG004|Overall Study|Protocol Violation|1|||
17104689|NCT03568162|38242554|FG005|Overall Study|Protocol Violation|1|||
17104690|NCT03568162|38242549|FG000|Overall Study|Withdrawal by Subject|15|||
17104691|NCT03568162|38242550|FG001|Overall Study|Withdrawal by Subject|15|||
17104692|NCT03568162|38242551|FG002|Overall Study|Withdrawal by Subject|26|||
17104693|NCT03568162|38242552|FG003|Overall Study|Withdrawal by Subject|22|||
17104694|NCT03568162|38242553|FG004|Overall Study|Withdrawal by Subject|6|||
17104695|NCT03568162|38242554|FG005|Overall Study|Withdrawal by Subject|9|||
17104696|NCT03568162|38242549|FG000|Overall Study|Others|3|||
17104697|NCT03568162|38242550|FG001|Overall Study|Others|4|||
17104698|NCT03568162|38242551|FG002|Overall Study|Others|1|||
17104699|NCT03568162|38242552|FG003|Overall Study|Others|4|||
17104700|NCT03568162|38242553|FG004|Overall Study|Others|2|||
17104701|NCT03568162|38242554|FG005|Overall Study|Others|1|||
17104702|NCT03567616|38242573|FG000|Overall Study|Disease progression|4|||
17104703|NCT03567616|38242573|FG000|Overall Study|Withdrawal by Subject|1|||
17104704|NCT03567616|38242573|FG000|Overall Study|Physician Decision|1|||
17104705|NCT03567616|38242573|FG000|Overall Study|Death|1|||
17104706|NCT03567616|38242573|FG000|Overall Study|Adverse Event|1|||
17104707|NCT03567382|38242582|FG000|Overall Study|Lost to Follow-up|1|||
17104708|NCT03567382|38242583|FG001|Overall Study|Lost to Follow-up|21|||
17104709|NCT03567382|38242584|FG002|Overall Study|Lost to Follow-up|1|||
17104710|NCT03567382|38242585|FG003|Overall Study|Lost to Follow-up|21|||
17104711|NCT03567382|38242582|FG000|Overall Study|Withdrawal by Subject|2|||
17104712|NCT03567382|38242583|FG001|Overall Study|Withdrawal by Subject|14|||
17104713|NCT03567382|38242584|FG002|Overall Study|Withdrawal by Subject|1|||
17104714|NCT03567382|38242585|FG003|Overall Study|Withdrawal by Subject|12|||
17104715|NCT03595384|38242596|FG000|Overall Study|Other time commitments|8|||
17104716|NCT03595384|38242596|FG000|Overall Study|Changes to session time|7|||
17104717|NCT03595384|38242596|FG000|Overall Study|Relocation out of country|1|||
17104718|NCT03591874|38242602|FG000|Overall Study|Adverse Event|4|||
16936178|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16936179|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16936180|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
16936181|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
16936182|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16936183|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
16936184|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16936185|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16936186|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16936187|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16936188|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16936189|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16936190|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16936191|NCT01212757|38080611|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16936192|NCT01212757|38080612|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
16936193|NCT01212757|38080613|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
16936194|NCT01212757|38080614|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16936195|NCT01212757|38080615|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16936196|NCT01212757|38080616|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16936197|NCT01212757|38080617|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16936198|NCT01212757|38080618|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16936199|NCT01212757|38080619|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16936200|NCT01190410|38080639|FG000|Overall Study|Adverse Event|0|||
16936201|NCT01190410|38080640|FG001|Overall Study|Adverse Event|3|||
16936202|NCT01190410|38080639|FG000|Overall Study|Lack of Efficacy|0|||
16936203|NCT01190410|38080640|FG001|Overall Study|Lack of Efficacy|2|||
16936204|NCT01190410|38080639|FG000|Overall Study|Withdrawal by Subject|0|||
16936205|NCT01190410|38080640|FG001|Overall Study|Withdrawal by Subject|2|||
16936206|NCT01190410|38080639|FG000|Overall Study|Administrative decision|1|||
16936207|NCT01190410|38080640|FG001|Overall Study|Administrative decision|0|||
16936208|NCT01190410|38080639|FG000|Overall Study|PI discretion|0|||
16936209|NCT01190410|38080640|FG001|Overall Study|PI discretion|2|||
16936210|NCT01190254|38080655|FG000|Overall Study|Adverse Event|3|||
16936211|NCT01190254|38080656|FG001|Overall Study|Adverse Event|6|||
16936212|NCT01190254|38080657|FG002|Overall Study|Adverse Event|8|||
16936213|NCT01190254|38080655|FG000|Overall Study|Lack of Efficacy|7|||
16936214|NCT01190254|38080656|FG001|Overall Study|Lack of Efficacy|4|||
16936215|NCT01190254|38080657|FG002|Overall Study|Lack of Efficacy|5|||
16936216|NCT01190254|38080655|FG000|Overall Study|Lost to Follow-up|4|||
16936217|NCT01190254|38080656|FG001|Overall Study|Lost to Follow-up|2|||
16936218|NCT01190254|38080657|FG002|Overall Study|Lost to Follow-up|0|||
16936219|NCT01190254|38080655|FG000|Overall Study|Withdrawal by Subject|4|||
16936220|NCT01190254|38080656|FG001|Overall Study|Withdrawal by Subject|5|||
16936221|NCT01190254|38080657|FG002|Overall Study|Withdrawal by Subject|7|||
16936222|NCT01190254|38080655|FG000|Overall Study|Protocol Violation|2|||
16936223|NCT01190254|38080656|FG001|Overall Study|Protocol Violation|0|||
16936224|NCT01190254|38080657|FG002|Overall Study|Protocol Violation|2|||
16936225|NCT01190254|38080655|FG000|Overall Study|Did not meet protocol eligibility|1|||
16936226|NCT01190254|38080656|FG001|Overall Study|Did not meet protocol eligibility|0|||
16936227|NCT01190254|38080657|FG002|Overall Study|Did not meet protocol eligibility|0|||
16936228|NCT01190839|38080667|FG000|Overall Study|Adverse Event|32|||
16936229|NCT01190839|38080668|FG001|Overall Study|Adverse Event|41|||
16936230|NCT01190839|38080667|FG000|Overall Study|Protocol Violation|2|||
16936231|NCT01190839|38080668|FG001|Overall Study|Protocol Violation|2|||
16936232|NCT01190839|38080667|FG000|Overall Study|Lost to Follow-up|7|||
16936233|NCT01190839|38080668|FG001|Overall Study|Lost to Follow-up|1|||
16936234|NCT01190839|38080667|FG000|Overall Study|Death|1|||
16936235|NCT01190839|38080668|FG001|Overall Study|Death|0|||
16936236|NCT01190839|38080667|FG000|Overall Study|Trial stopped by Sponsor|71|||
16936237|NCT01190839|38080668|FG001|Overall Study|Trial stopped by Sponsor|68|||
16936238|NCT01190839|38080667|FG000|Overall Study|Undefined|35|||
16936239|NCT01190839|38080668|FG001|Overall Study|Undefined|31|||
16936240|NCT01190839|38080667|FG000|Overall Study|Randomized but not treated|2|||
16936241|NCT01190839|38080668|FG001|Overall Study|Randomized but not treated|4|||
16936242|NCT01190215|38080678|FG000|Up to Month 6|Lost to Follow-up|2|||
16936243|NCT01190215|38080679|FG001|Up to Month 6|Lost to Follow-up|0|||
16936244|NCT01190449|38080687|FG000|Overall Study|Ineligible|0|||
16936245|NCT01190449|38080688|FG001|Overall Study|Ineligible|4|||
16936246|NCT01190176|38080694|FG000|Overall Study|Withdrawal by Subject|1|||
16936247|NCT01190176|38080694|FG000|Overall Study|Lost to Follow-up|1|||
16936248|NCT01190098|38080700|FG000|Overall Study|Adverse Event|2|||
16936249|NCT01190098|38080701|FG001|Overall Study|Adverse Event|0|||
16936250|NCT01190098|38080700|FG000|Overall Study|Patient coomorbidity|0|||
17104719|NCT03591874|38242603|FG001|Overall Study|Adverse Event|0|||
16936251|NCT01190098|38080701|FG001|Overall Study|Patient coomorbidity|1|||
16936252|NCT01190098|38080700|FG000|Overall Study|Lack of transportation|1|||
16936253|NCT01190098|38080701|FG001|Overall Study|Lack of transportation|0|||
16936254|NCT01190098|38080700|FG000|Overall Study|Other|0|||
16936255|NCT01190098|38080701|FG001|Overall Study|Other|1|||
16936256|NCT01190020|38080709|FG000|Overall Study|Adverse Event|2|||
16936257|NCT01190020|38080710|FG001|Overall Study|Adverse Event|0|||
16936258|NCT01190020|38080709|FG000|Overall Study|Lost to Follow-up|2|||
17104720|NCT03591874|38242602|FG000|Overall Study|Withdrawal by Subject|2|||
17104721|NCT03591874|38242603|FG001|Overall Study|Withdrawal by Subject|1|||
17104722|NCT03591874|38242602|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
17104723|NCT03591874|38242603|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
17104724|NCT03591874|38242602|FG000|Overall Study|On Study at Time of Study Termination|12|||
17104725|NCT03591874|38242603|FG001|Overall Study|On Study at Time of Study Termination|6|||
17104726|NCT03566680|38242609|FG000|Overall Study|Pregnancy|1|||
17104727|NCT03566680|38242609|FG000|Overall Study|Lost to Follow-up|13|||
17104728|NCT03566680|38242609|FG000|Overall Study|Withdrawal by Subject|3|||
17104729|NCT00106353|38242615|FG000|Part 1|Disease progression|3|||
17104730|NCT00106353|38242616|FG001|Part 1|Disease progression|4|||
17104731|NCT00106353|38242617|FG002|Part 1|Disease progression|1|||
17104732|NCT00106353|38242618|FG003|Part 1|Disease progression|3|||
17104733|NCT00106353|38242619|FG004|Part 1|Disease progression|0|||
17104734|NCT00106353|38242620|FG005|Part 1|Disease progression|0|||
17104735|NCT00106353|38242621|FG006|Part 1|Disease progression|0|||
17104736|NCT00106353|38242615|FG000|Part 1|Withdrawal by Subject|0|||
17104737|NCT00106353|38242616|FG001|Part 1|Withdrawal by Subject|0|||
17104738|NCT00106353|38242617|FG002|Part 1|Withdrawal by Subject|1|||
17104739|NCT00106353|38242618|FG003|Part 1|Withdrawal by Subject|2|||
17104740|NCT00106353|38242619|FG004|Part 1|Withdrawal by Subject|0|||
17104741|NCT00106353|38242620|FG005|Part 1|Withdrawal by Subject|0|||
17104742|NCT00106353|38242621|FG006|Part 1|Withdrawal by Subject|0|||
17104743|NCT00106353|38242615|FG000|Part 1|Symptomatic deterioration|0|||
17104744|NCT00106353|38242616|FG001|Part 1|Symptomatic deterioration|0|||
17104745|NCT00106353|38242617|FG002|Part 1|Symptomatic deterioration|1|||
17104746|NCT00106353|38242618|FG003|Part 1|Symptomatic deterioration|0|||
17104747|NCT00106353|38242619|FG004|Part 1|Symptomatic deterioration|0|||
17104748|NCT00106353|38242620|FG005|Part 1|Symptomatic deterioration|0|||
17104749|NCT00106353|38242621|FG006|Part 1|Symptomatic deterioration|0|||
17104750|NCT00106353|38242615|FG000|Part 1|Entered follow-up phase|1|||
17104751|NCT00106353|38242616|FG001|Part 1|Entered follow-up phase|1|||
17104752|NCT00106353|38242617|FG002|Part 1|Entered follow-up phase|0|||
17104753|NCT00106353|38242618|FG003|Part 1|Entered follow-up phase|1|||
17104754|NCT00106353|38242619|FG004|Part 1|Entered follow-up phase|0|||
17104755|NCT00106353|38242620|FG005|Part 1|Entered follow-up phase|0|||
17104756|NCT00106353|38242621|FG006|Part 1|Entered follow-up phase|0|||
17104757|NCT00106353|38242615|FG000|Part 1|Adverse Event|0|||
17104758|NCT00106353|38242616|FG001|Part 1|Adverse Event|0|||
17104759|NCT00106353|38242617|FG002|Part 1|Adverse Event|0|||
17104760|NCT00106353|38242618|FG003|Part 1|Adverse Event|1|||
17104761|NCT00106353|38242619|FG004|Part 1|Adverse Event|0|||
17104762|NCT00106353|38242620|FG005|Part 1|Adverse Event|0|||
17104763|NCT00106353|38242621|FG006|Part 1|Adverse Event|0|||
17104764|NCT00106353|38242615|FG000|Part 2|Disease progression|0|||
17104765|NCT00106353|38242616|FG001|Part 2|Disease progression|0|||
17104766|NCT00106353|38242617|FG002|Part 2|Disease progression|0|||
17104767|NCT00106353|38242618|FG003|Part 2|Disease progression|0|||
17104768|NCT00106353|38242619|FG004|Part 2|Disease progression|8|||
17104769|NCT00106353|38242620|FG005|Part 2|Disease progression|14|||
17104770|NCT00106353|38242621|FG006|Part 2|Disease progression|13|||
17104771|NCT00106353|38242615|FG000|Part 2|Death|0|||
17104772|NCT00106353|38242616|FG001|Part 2|Death|0|||
17104773|NCT00106353|38242617|FG002|Part 2|Death|0|||
17104774|NCT00106353|38242618|FG003|Part 2|Death|0|||
17104775|NCT00106353|38242619|FG004|Part 2|Death|3|||
17104776|NCT00106353|38242620|FG005|Part 2|Death|0|||
17104777|NCT00106353|38242621|FG006|Part 2|Death|1|||
17104778|NCT00106353|38242615|FG000|Part 2|Symptomatic deterioration|0|||
17104779|NCT00106353|38242616|FG001|Part 2|Symptomatic deterioration|0|||
16936259|NCT01190020|38080710|FG001|Overall Study|Lost to Follow-up|0|||
17104780|NCT00106353|38242617|FG002|Part 2|Symptomatic deterioration|0|||
17104781|NCT00106353|38242618|FG003|Part 2|Symptomatic deterioration|0|||
17104782|NCT00106353|38242619|FG004|Part 2|Symptomatic deterioration|3|||
17104783|NCT00106353|38242620|FG005|Part 2|Symptomatic deterioration|0|||
17104784|NCT00106353|38242621|FG006|Part 2|Symptomatic deterioration|0|||
17104785|NCT00106353|38242615|FG000|Part 2|Adverse Event|0|||
17104786|NCT00106353|38242616|FG001|Part 2|Adverse Event|0|||
17104787|NCT00106353|38242617|FG002|Part 2|Adverse Event|0|||
17104788|NCT00106353|38242618|FG003|Part 2|Adverse Event|0|||
17104789|NCT00106353|38242619|FG004|Part 2|Adverse Event|0|||
17104790|NCT00106353|38242620|FG005|Part 2|Adverse Event|2|||
17104791|NCT00106353|38242621|FG006|Part 2|Adverse Event|1|||
17104792|NCT00106353|38242615|FG000|Part 2|Other|0|||
17104793|NCT00106353|38242616|FG001|Part 2|Other|0|||
17104794|NCT00106353|38242617|FG002|Part 2|Other|0|||
16936260|NCT01190020|38080709|FG000|Overall Study|Withdrawal by Subject|3|||
16936261|NCT01190020|38080710|FG001|Overall Study|Withdrawal by Subject|0|||
16936262|NCT01189435|38080716|FG000|Overall Study|Withdrawal by Subject|1|||
16936263|NCT01189435|38080716|FG000|Overall Study|Physician Decision|1|||
16936264|NCT01165996|38080720|FG000|Overall Study|Death|1|||
16936265|NCT01165996|38080720|FG000|Overall Study|Physician Decision|1|||
16936266|NCT01165684|38080727|FG000|Overall Study|Adverse Event|1|||
16936267|NCT01165684|38080728|FG001|Overall Study|Adverse Event|1|||
16936268|NCT01165684|38080727|FG000|Overall Study|Lack of Efficacy|2|||
16936269|NCT01165684|38080728|FG001|Overall Study|Lack of Efficacy|1|||
16936270|NCT01165684|38080727|FG000|Overall Study|Protocol Violation|7|||
16936271|NCT01165684|38080728|FG001|Overall Study|Protocol Violation|15|||
16936272|NCT01165684|38080727|FG000|Overall Study|Withdrawal Criteria|2|||
16936273|NCT01165684|38080728|FG001|Overall Study|Withdrawal Criteria|13|||
16936274|NCT01165684|38080727|FG000|Overall Study|Unclassified|16|||
16936275|NCT01165684|38080728|FG001|Overall Study|Unclassified|22|||
16936276|NCT01189201|38080734|FG000|Overall Study|Adverse Event|1|||
16936277|NCT01188967|38080751|FG000|Overall Study|Withdrawal by Subject|1|||
16936278|NCT01188967|38080752|FG001|Overall Study|Withdrawal by Subject|1|||
16936279|NCT01188967|38080751|FG000|Overall Study|Physician Decision|1|||
16936280|NCT01188967|38080752|FG001|Overall Study|Physician Decision|1|||
16936281|NCT01188967|38080751|FG000|Overall Study|Lost to Follow-up|3|||
16936282|NCT01188967|38080752|FG001|Overall Study|Lost to Follow-up|2|||
16936283|NCT01188811|38080762|FG000|Overall Study|Withdrawal by Subject|0|||
16936284|NCT01188811|38080763|FG001|Overall Study|Withdrawal by Subject|2|||
16936285|NCT01188811|38080762|FG000|Overall Study|Adverse Event|6|||
16936286|NCT01188811|38080763|FG001|Overall Study|Adverse Event|0|||
16936287|NCT01183234|38080771|FG000|First Intervention|Adverse Event|1|||
16936288|NCT01183234|38080772|FG001|First Intervention|Adverse Event|0|||
16936289|NCT01165216|38080780|FG000|Overall Study|Adverse Event|6|||
16936290|NCT01165216|38080781|FG001|Overall Study|Adverse Event|3|||
16936291|NCT01165216|38080780|FG000|Overall Study|Withdrawal by Subject|1|||
16936292|NCT01165216|38080781|FG001|Overall Study|Withdrawal by Subject|1|||
16936293|NCT01165216|38080780|FG000|Overall Study|Disease progression|1|||
16936294|NCT01165216|38080781|FG001|Overall Study|Disease progression|3|||
16936295|NCT01165177|38080804|FG000|Overall Study|Serious Adverse Event|227|||
16936296|NCT01165177|38080805|FG001|Overall Study|Serious Adverse Event|235|||
16936297|NCT01165177|38080804|FG000|Overall Study|Withdrawal by Subject|368|||
16936298|NCT01165177|38080805|FG001|Overall Study|Withdrawal by Subject|354|||
16936299|NCT01165177|38080804|FG000|Overall Study|Protocol Violation|19|||
16936300|NCT01165177|38080805|FG001|Overall Study|Protocol Violation|21|||
16936301|NCT01165177|38080804|FG000|Overall Study|Non-serious adverse event|30|||
16936302|NCT01165177|38080805|FG001|Overall Study|Non-serious adverse event|18|||
16936303|NCT01165177|38080804|FG000|Overall Study|Other unspecified reasons|47|||
16936304|NCT01165177|38080805|FG001|Overall Study|Other unspecified reasons|35|||
16936305|NCT01165177|38080804|FG000|Overall Study|Suspected HZ episode|0|||
16936306|NCT01165177|38080805|FG001|Overall Study|Suspected HZ episode|2|||
16936307|NCT01165177|38080804|FG000|Overall Study|Lost to Follow-up|183|||
16936308|NCT01165177|38080805|FG001|Overall Study|Lost to Follow-up|194|||
16936309|NCT01165177|38080804|FG000|Overall Study|Migrated/ moved from study area|48|||
16936310|NCT01165177|38080805|FG001|Overall Study|Migrated/ moved from study area|43|||
16936311|NCT01165138|38080822|FG000|Overall Study|Adverse Event|0|||
16936312|NCT01165138|38080823|FG001|Overall Study|Adverse Event|1|||
16936313|NCT01165138|38080824|FG002|Overall Study|Adverse Event|0|||
16936314|NCT01165138|38080825|FG003|Overall Study|Adverse Event|2|||
16936315|NCT01165138|38080822|FG000|Overall Study|Lack of Efficacy|0|||
16936316|NCT01165138|38080823|FG001|Overall Study|Lack of Efficacy|32|||
16936317|NCT01165138|38080824|FG002|Overall Study|Lack of Efficacy|6|||
16936318|NCT01165138|38080825|FG003|Overall Study|Lack of Efficacy|7|||
16936319|NCT01165138|38080822|FG000|Overall Study|Protocol Violation|0|||
16936320|NCT01165138|38080823|FG001|Overall Study|Protocol Violation|7|||
16936321|NCT01165138|38080824|FG002|Overall Study|Protocol Violation|0|||
16936322|NCT01165138|38080825|FG003|Overall Study|Protocol Violation|2|||
16936323|NCT01165138|38080822|FG000|Overall Study|Lost to Follow-up|0|||
16936324|NCT01165138|38080823|FG001|Overall Study|Lost to Follow-up|0|||
16936325|NCT01165138|38080824|FG002|Overall Study|Lost to Follow-up|1|||
16936326|NCT01165138|38080825|FG003|Overall Study|Lost to Follow-up|2|||
16936327|NCT01165138|38080822|FG000|Overall Study|Physician Decision|0|||
16936328|NCT01165138|38080823|FG001|Overall Study|Physician Decision|6|||
16936329|NCT01165138|38080824|FG002|Overall Study|Physician Decision|7|||
16936330|NCT01165138|38080825|FG003|Overall Study|Physician Decision|6|||
16936331|NCT01165138|38080822|FG000|Overall Study|Withdrawal by Subject|0|||
16936332|NCT01165138|38080823|FG001|Overall Study|Withdrawal by Subject|6|||
16936333|NCT01165138|38080824|FG002|Overall Study|Withdrawal by Subject|6|||
16936334|NCT01165138|38080825|FG003|Overall Study|Withdrawal by Subject|3|||
16936335|NCT01165021|38080833|FG000|Overall Study|Death|1|||
16936336|NCT01182844|38080839|FG000|Overall Study|Withdrawal by Subject|0|||
16936337|NCT01182844|38080840|FG001|Overall Study|Withdrawal by Subject|2|||
16936338|NCT01164865|38080848|FG000|Overall Study|Lost to Follow-up|2|||
16936339|NCT01164865|38080849|FG001|Overall Study|Lost to Follow-up|1|||
16936340|NCT01164475|38080857|FG000|Overall Study|Lack of Efficacy|1|||
16936341|NCT01164475|38080858|FG001|Overall Study|Lack of Efficacy|0|||
16936342|NCT01164475|38080857|FG000|Overall Study|Other|0|||
16936343|NCT01164475|38080858|FG001|Overall Study|Other|1|||
16936344|NCT01164475|38080857|FG000|Overall Study|Progressive disease|0|||
16936345|NCT01164475|38080858|FG001|Overall Study|Progressive disease|1|||
16936346|NCT01164475|38080857|FG000|Overall Study|Protocol Violation|1|||
16936347|NCT01164475|38080858|FG001|Overall Study|Protocol Violation|0|||
16936348|NCT01164007|38080864|FG000|Overall Study|Adverse Event|5|||
16936349|NCT01164007|38080864|FG000|Overall Study|Progression of Disease|30|||
16936350|NCT01164007|38080864|FG000|Overall Study|Protocol Violation|1|||
16936351|NCT01164007|38080864|FG000|Overall Study|Withdrawal by Subject|1|||
16936352|NCT01164007|38080864|FG000|Overall Study|Medical Decision|3|||
16936353|NCT01163851|38080870|FG000|Overall Study|Site Closure|0|||
16936354|NCT01163851|38080871|FG001|Overall Study|Site Closure|1|||
16936355|NCT01163851|38080870|FG000|Overall Study|Enrolled but not treated|1|||
16936356|NCT01163851|38080871|FG001|Overall Study|Enrolled but not treated|0|||
16936357|NCT01182415|38080877|FG000|Overall Study|Lost to Follow-up|1|||
16936358|NCT01163617|38080881|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16936359|NCT01163617|38080882|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
16936360|NCT01163617|38080883|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16936361|NCT01163617|38080884|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16936362|NCT01163617|38080885|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16936363|NCT01163617|38080886|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16936364|NCT01163617|38080887|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16936365|NCT01163617|38080888|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16936366|NCT01163617|38080881|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16936367|NCT01163617|38080882|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
16936368|NCT01163617|38080883|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16936369|NCT01163617|38080884|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16936370|NCT01163617|38080885|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16936371|NCT01163617|38080886|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16936372|NCT01163617|38080887|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16936373|NCT01163617|38080888|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16936374|NCT01163617|38080881|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16936375|NCT01163617|38080882|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16936376|NCT01163617|38080883|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
16936377|NCT01163617|38080884|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16936378|NCT01163617|38080885|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16936379|NCT01163617|38080886|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16936380|NCT01163617|38080887|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16936381|NCT01163617|38080888|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16936382|NCT01182337|38080910|FG000|Overall Study|Withdrawal by Subject|3|||
16936383|NCT01182337|38080911|FG001|Overall Study|Withdrawal by Subject|1|||
16936384|NCT01182337|38080910|FG000|Overall Study|Lost to Follow-up|0|||
16936385|NCT01182337|38080911|FG001|Overall Study|Lost to Follow-up|1|||
16936386|NCT01182298|38080918|FG000|Overall Study|Lack of Efficacy|4|||
16936387|NCT01182298|38080918|FG000|Overall Study|Withdrawal by Subject|2|||
16936388|NCT01163266|38080925|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
16936389|NCT01163266|38080926|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
16936390|NCT01163266|38080927|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
16936391|NCT01163266|38080925|FG000|Overall Study|Lack of Efficacy|1|||
16936392|NCT01163266|38080926|FG001|Overall Study|Lack of Efficacy|3|||
16936393|NCT01163266|38080927|FG002|Overall Study|Lack of Efficacy|1|||
16936394|NCT01163266|38080925|FG000|Overall Study|Noncompliance with Study Drug|0|||
16936395|NCT01163266|38080926|FG001|Overall Study|Noncompliance with Study Drug|2|||
16936396|NCT01163266|38080927|FG002|Overall Study|Noncompliance with Study Drug|0|||
16936397|NCT01163266|38080925|FG000|Overall Study|Protocol Deviations|2|||
16936398|NCT01163266|38080926|FG001|Overall Study|Protocol Deviations|2|||
16936399|NCT01163266|38080927|FG002|Overall Study|Protocol Deviations|5|||
16936400|NCT01163266|38080925|FG000|Overall Study|Withdrawal of Consent|5|||
16936401|NCT01163266|38080926|FG001|Overall Study|Withdrawal of Consent|7|||
16936402|NCT01163266|38080927|FG002|Overall Study|Withdrawal of Consent|3|||
16936403|NCT01163266|38080925|FG000|Overall Study|Lost to Follow-up|7|||
16936404|NCT01163266|38080926|FG001|Overall Study|Lost to Follow-up|7|||
16936405|NCT01163266|38080927|FG002|Overall Study|Lost to Follow-up|10|||
16936406|NCT01163266|38080925|FG000|Overall Study|Other|1|||
16936407|NCT01163266|38080926|FG001|Overall Study|Other|1|||
16936408|NCT01163266|38080927|FG002|Overall Study|Other|2|||
16936409|NCT01163149|38080989|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
16936410|NCT01163149|38080990|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
16936411|NCT01163149|38080991|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
16936412|NCT01163149|38080989|FG000|Extension Treatment Period|Adverse Event|0|||
16936413|NCT01163149|38080990|FG001|Extension Treatment Period|Adverse Event|1|||
16936414|NCT01163149|38080991|FG002|Extension Treatment Period|Adverse Event|0|||
16936415|NCT01163149|38080989|FG000|Extension Treatment Period|Noncompliance|0|||
16936416|NCT01163149|38080990|FG001|Extension Treatment Period|Noncompliance|0|||
16936417|NCT01163149|38080991|FG002|Extension Treatment Period|Noncompliance|1|||
16936418|NCT01163032|38081016|FG000|Randomization Phase|Withdrawal by Subject|2|||
16936419|NCT01163032|38081017|FG001|Randomization Phase|Withdrawal by Subject|3|||
16936420|NCT01163032|38081018|FG002|Randomization Phase|Withdrawal by Subject|0|||
16936421|NCT01163032|38081016|FG000|Randomization Phase|Adverse Event|3|||
16936422|NCT01163032|38081017|FG001|Randomization Phase|Adverse Event|3|||
16936423|NCT01163032|38081018|FG002|Randomization Phase|Adverse Event|0|||
16936424|NCT01163032|38081016|FG000|Randomization Phase|Protocol Violation|0|||
16936425|NCT01163032|38081017|FG001|Randomization Phase|Protocol Violation|1|||
16936426|NCT01163032|38081018|FG002|Randomization Phase|Protocol Violation|0|||
16936427|NCT01163032|38081016|FG000|Randomization Phase|Various*|5|||
16936428|NCT01163032|38081017|FG001|Randomization Phase|Various*|4|||
16936429|NCT01163032|38081018|FG002|Randomization Phase|Various*|0|||
16936430|NCT01163032|38081016|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
16936431|NCT01163032|38081017|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
16936432|NCT01163032|38081018|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
16936433|NCT01163032|38081016|FG000|Open Label Extension Phase|Adverse Event|0|||
16936434|NCT01163032|38081017|FG001|Open Label Extension Phase|Adverse Event|0|||
16936435|NCT01163032|38081018|FG002|Open Label Extension Phase|Adverse Event|3|||
16936436|NCT01163032|38081016|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
16936437|NCT01163032|38081017|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
16936438|NCT01163032|38081018|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
16936439|NCT01163032|38081016|FG000|Open Label Extension Phase|Protocol Violation|0|||
16936440|NCT01163032|38081017|FG001|Open Label Extension Phase|Protocol Violation|0|||
16936441|NCT01163032|38081018|FG002|Open Label Extension Phase|Protocol Violation|1|||
16936442|NCT01163032|38081016|FG000|Open Label Extension Phase|Study Termination|0|||
16936443|NCT01163032|38081017|FG001|Open Label Extension Phase|Study Termination|0|||
16936444|NCT01163032|38081018|FG002|Open Label Extension Phase|Study Termination|7|||
16936445|NCT01163032|38081016|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
16936446|NCT01163032|38081017|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
16936447|NCT01163032|38081018|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
16936448|NCT01162486|38081031|FG000|Overall Study|low ANC|1|||
16936449|NCT01162486|38081032|FG001|Overall Study|low ANC|0|||
16936450|NCT01162486|38081033|FG002|Overall Study|low ANC|0|||
16936451|NCT01162486|38081034|FG003|Overall Study|low ANC|0|||
16936452|NCT01162486|38081035|FG004|Overall Study|low ANC|0|||
16936453|NCT01162486|38081031|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
16936454|NCT01162486|38081032|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
16936455|NCT01162486|38081033|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
16936456|NCT01162486|38081034|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
16936457|NCT01162486|38081035|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
16936458|NCT01162486|38081031|FG000|Overall Study|elevated LFTs|0|||
16936459|NCT01162486|38081032|FG001|Overall Study|elevated LFTs|0|||
16936460|NCT01162486|38081033|FG002|Overall Study|elevated LFTs|1|||
16936461|NCT01162486|38081034|FG003|Overall Study|elevated LFTs|0|||
16936462|NCT01162486|38081035|FG004|Overall Study|elevated LFTs|0|||
16936463|NCT01162486|38081031|FG000|Overall Study|Pregnancy|0|||
16936464|NCT01162486|38081032|FG001|Overall Study|Pregnancy|0|||
16936465|NCT01162486|38081033|FG002|Overall Study|Pregnancy|0|||
16936466|NCT01162486|38081034|FG003|Overall Study|Pregnancy|1|||
16936467|NCT01162486|38081035|FG004|Overall Study|Pregnancy|0|||
16936468|NCT01162135|38081051|FG000|Overall Study|Withdrawal by Subject|1|||
16936469|NCT01162135|38081051|FG000|Overall Study|Severe back pain|1|||
16936470|NCT01162135|38081051|FG000|Overall Study|Ineligible|1|||
16936471|NCT01161628|38081055|FG000|Overall Study|Death|6|||
16936472|NCT01161628|38081055|FG000|Overall Study|Lack of Efficacy|2|||
16936473|NCT01161472|38081059|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
17104795|NCT00106353|38242618|FG003|Part 2|Other|0|||
16936474|NCT01161472|38081060|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
16936475|NCT01161472|38081061|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
16936476|NCT01161472|38081062|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
16936477|NCT01161043|38081072|FG000|Overall Study|Withdrawal by Subject|3|||
16936478|NCT01160770|38081076|FG000|Overall Study|Adverse Event|10|||
16936479|NCT01160770|38081076|FG000|Overall Study|Protocol Violation|2|||
16936480|NCT01160770|38081076|FG000|Overall Study|Subject/parent/caregiver request|33|||
16936481|NCT01160770|38081076|FG000|Overall Study|Physician Decision|1|||
17104796|NCT00106353|38242619|FG004|Part 2|Other|1|||
16936482|NCT01160770|38081076|FG000|Overall Study|Lost to Follow-up|7|||
16936483|NCT01160770|38081076|FG000|Overall Study|Study termination or sponsor request|1|||
16936484|NCT01160770|38081076|FG000|Overall Study|Death|9|||
16936485|NCT01160770|38081076|FG000|Overall Study|Lack of Efficacy|15|||
16936486|NCT01160770|38081076|FG000|Overall Study|Other Reasons|1|||
16936487|NCT01160614|38081082|FG000|Overall Study|Withdrawal by Subject|0|||
16936488|NCT01160614|38081083|FG001|Overall Study|Withdrawal by Subject|2|||
16936489|NCT01159912|38081110|FG000|Overall Study|Adverse Event|2|||
16936490|NCT01159912|38081111|FG001|Overall Study|Adverse Event|2|||
16936491|NCT01159912|38081112|FG002|Overall Study|Adverse Event|3|||
16936492|NCT01159912|38081110|FG000|Overall Study|Lack of Efficacy|23|||
16936493|NCT01159912|38081111|FG001|Overall Study|Lack of Efficacy|15|||
16936494|NCT01159912|38081112|FG002|Overall Study|Lack of Efficacy|14|||
16936495|NCT01159912|38081110|FG000|Overall Study|Protocol Violation|1|||
16936496|NCT01159912|38081111|FG001|Overall Study|Protocol Violation|2|||
16936497|NCT01159912|38081112|FG002|Overall Study|Protocol Violation|3|||
16936498|NCT01159912|38081110|FG000|Overall Study|Lost to Follow-up|4|||
16936499|NCT01159912|38081111|FG001|Overall Study|Lost to Follow-up|0|||
16936500|NCT01159912|38081112|FG002|Overall Study|Lost to Follow-up|0|||
16936501|NCT01159912|38081110|FG000|Overall Study|Physician Decision|0|||
16936502|NCT01159912|38081111|FG001|Overall Study|Physician Decision|0|||
16936503|NCT01159912|38081112|FG002|Overall Study|Physician Decision|3|||
16936504|NCT01159912|38081110|FG000|Overall Study|Withdrawal by Subject|10|||
16936505|NCT01159912|38081111|FG001|Overall Study|Withdrawal by Subject|3|||
16936506|NCT01159912|38081112|FG002|Overall Study|Withdrawal by Subject|3|||
16936507|NCT01159600|38081128|FG000|Overall Study|Not treated|0|||
16936508|NCT01159600|38081129|FG001|Overall Study|Not treated|0|||
16936509|NCT01159600|38081130|FG002|Overall Study|Not treated|1|||
16936510|NCT01159600|38081131|FG003|Overall Study|Not treated|0|||
16936511|NCT01159600|38081132|FG004|Overall Study|Not treated|0|||
16936512|NCT01159600|38081133|FG005|Overall Study|Not treated|1|||
16936513|NCT01159600|38081134|FG006|Overall Study|Not treated|2|||
16936514|NCT01159600|38081135|FG007|Overall Study|Not treated|2|||
16936515|NCT01159600|38081128|FG000|Overall Study|Adverse Event|7|||
16936516|NCT01159600|38081129|FG001|Overall Study|Adverse Event|2|||
16936517|NCT01159600|38081130|FG002|Overall Study|Adverse Event|5|||
16936518|NCT01159600|38081131|FG003|Overall Study|Adverse Event|1|||
16936519|NCT01159600|38081132|FG004|Overall Study|Adverse Event|8|||
16936520|NCT01159600|38081133|FG005|Overall Study|Adverse Event|6|||
16936521|NCT01159600|38081134|FG006|Overall Study|Adverse Event|7|||
16936522|NCT01159600|38081135|FG007|Overall Study|Adverse Event|5|||
16936523|NCT01159600|38081128|FG000|Overall Study|Lack of Efficacy|0|||
16936524|NCT01159600|38081129|FG001|Overall Study|Lack of Efficacy|0|||
16936525|NCT01159600|38081130|FG002|Overall Study|Lack of Efficacy|0|||
16936526|NCT01159600|38081131|FG003|Overall Study|Lack of Efficacy|0|||
16936527|NCT01159600|38081132|FG004|Overall Study|Lack of Efficacy|2|||
16936528|NCT01159600|38081133|FG005|Overall Study|Lack of Efficacy|0|||
16936529|NCT01159600|38081134|FG006|Overall Study|Lack of Efficacy|0|||
16936530|NCT01159600|38081135|FG007|Overall Study|Lack of Efficacy|1|||
16936531|NCT01159600|38081128|FG000|Overall Study|Non compliant with protocol|2|||
16936532|NCT01159600|38081129|FG001|Overall Study|Non compliant with protocol|1|||
16936533|NCT01159600|38081130|FG002|Overall Study|Non compliant with protocol|0|||
16936534|NCT01159600|38081131|FG003|Overall Study|Non compliant with protocol|0|||
16936535|NCT01159600|38081132|FG004|Overall Study|Non compliant with protocol|2|||
16936536|NCT01159600|38081133|FG005|Overall Study|Non compliant with protocol|0|||
16936537|NCT01159600|38081134|FG006|Overall Study|Non compliant with protocol|2|||
16936538|NCT01159600|38081135|FG007|Overall Study|Non compliant with protocol|0|||
16936539|NCT01159600|38081128|FG000|Overall Study|Lost to Follow-up|2|||
16936540|NCT01159600|38081129|FG001|Overall Study|Lost to Follow-up|3|||
16936541|NCT01159600|38081130|FG002|Overall Study|Lost to Follow-up|4|||
16936542|NCT01159600|38081131|FG003|Overall Study|Lost to Follow-up|3|||
16936543|NCT01159600|38081132|FG004|Overall Study|Lost to Follow-up|3|||
16936544|NCT01159600|38081133|FG005|Overall Study|Lost to Follow-up|0|||
16936545|NCT01159600|38081134|FG006|Overall Study|Lost to Follow-up|3|||
16936546|NCT01159600|38081135|FG007|Overall Study|Lost to Follow-up|2|||
16936547|NCT01159600|38081128|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
16936548|NCT01159600|38081129|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
16936549|NCT01159600|38081130|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
16936550|NCT01159600|38081131|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
16936551|NCT01159600|38081132|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
16936552|NCT01159600|38081133|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
16936553|NCT01159600|38081134|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
16936554|NCT01159600|38081135|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
16936555|NCT01159600|38081128|FG000|Overall Study|Other reason not defined above|3|||
16936556|NCT01159600|38081129|FG001|Overall Study|Other reason not defined above|0|||
16936557|NCT01159600|38081130|FG002|Overall Study|Other reason not defined above|4|||
16936558|NCT01159600|38081131|FG003|Overall Study|Other reason not defined above|2|||
16936559|NCT01159600|38081132|FG004|Overall Study|Other reason not defined above|5|||
16936560|NCT01159600|38081133|FG005|Overall Study|Other reason not defined above|7|||
16936561|NCT01159600|38081134|FG006|Overall Study|Other reason not defined above|3|||
16936562|NCT01159600|38081135|FG007|Overall Study|Other reason not defined above|3|||
16936563|NCT01159171|38081154|FG000|Overall Study|Adverse Event|11|||
16936564|NCT01159171|38081154|FG000|Overall Study|Progression of Disease|28|||
16936565|NCT01159171|38081154|FG000|Overall Study|Protocol Violation|1|||
16936566|NCT01159171|38081154|FG000|Overall Study|Need for Surgery|5|||
16936567|NCT01159171|38081154|FG000|Overall Study|Medical Decision|4|||
16936568|NCT01159171|38081154|FG000|Overall Study|Death|1|||
16936569|NCT01158118|38081161|FG000|Overall Study|Screen failure|1|||
16936570|NCT01158118|38081162|FG001|Overall Study|Screen failure|0|||
16936571|NCT01158118|38081161|FG000|Overall Study|Donor match was a screen failure|0|||
16936572|NCT01158118|38081162|FG001|Overall Study|Donor match was a screen failure|1|||
16936573|NCT01158118|38081161|FG000|Overall Study|Suffered stroke prior to transplant|0|||
16936574|NCT01158118|38081162|FG001|Overall Study|Suffered stroke prior to transplant|1|||
16936575|NCT01158118|38081161|FG000|Overall Study|Death|0|||
16936576|NCT01158118|38081162|FG001|Overall Study|Death|1|||
16936577|NCT01157845|38081168|FG000|Overall Study|Lost to Follow-up|5|||
16936578|NCT01157845|38081168|FG000|Overall Study|Withdrawal by Subject|12|||
16936579|NCT01157845|38081168|FG000|Overall Study|Physician Decision|3|||
16936580|NCT01157845|38081168|FG000|Overall Study|Protocol Violation|13|||
16936581|NCT01157845|38081168|FG000|Overall Study|Study was ended|1|||
16936582|NCT01157845|38081168|FG000|Overall Study|Device malfunction|1|||
16936583|NCT01157377|38081179|FG000|Overall Study|Lost to Follow-up|0|||
16936584|NCT01157377|38081180|FG001|Overall Study|Lost to Follow-up|0|||
16936585|NCT01157377|38081181|FG002|Overall Study|Lost to Follow-up|1|||
16936586|NCT01157377|38081182|FG003|Overall Study|Lost to Follow-up|0|||
16936587|NCT01157377|38081183|FG004|Overall Study|Lost to Follow-up|1|||
16936588|NCT01157377|38081184|FG005|Overall Study|Lost to Follow-up|1|||
16936589|NCT01157377|38081185|FG006|Overall Study|Lost to Follow-up|0|||
16936590|NCT01157377|38081179|FG000|Overall Study|Personal Reasons|2|||
16936591|NCT01157377|38081180|FG001|Overall Study|Personal Reasons|1|||
16936592|NCT01157377|38081181|FG002|Overall Study|Personal Reasons|0|||
16936593|NCT01157377|38081182|FG003|Overall Study|Personal Reasons|1|||
16936594|NCT01157377|38081183|FG004|Overall Study|Personal Reasons|0|||
16936595|NCT01157377|38081184|FG005|Overall Study|Personal Reasons|0|||
16936596|NCT01157377|38081185|FG006|Overall Study|Personal Reasons|0|||
16936597|NCT01157377|38081179|FG000|Overall Study|Protocol Violation|0|||
16936598|NCT01157377|38081180|FG001|Overall Study|Protocol Violation|0|||
16936599|NCT01157377|38081181|FG002|Overall Study|Protocol Violation|0|||
16936600|NCT01157377|38081182|FG003|Overall Study|Protocol Violation|0|||
16936601|NCT01157377|38081183|FG004|Overall Study|Protocol Violation|0|||
16936602|NCT01157377|38081184|FG005|Overall Study|Protocol Violation|1|||
16936603|NCT01157377|38081185|FG006|Overall Study|Protocol Violation|0|||
16936604|NCT01157377|38081179|FG000|Overall Study|Lack of Efficacy|0|||
16936605|NCT01157377|38081180|FG001|Overall Study|Lack of Efficacy|0|||
16936606|NCT01157377|38081181|FG002|Overall Study|Lack of Efficacy|0|||
16936607|NCT01157377|38081182|FG003|Overall Study|Lack of Efficacy|0|||
16936608|NCT01157377|38081183|FG004|Overall Study|Lack of Efficacy|0|||
16936609|NCT01157377|38081184|FG005|Overall Study|Lack of Efficacy|0|||
16936610|NCT01157377|38081185|FG006|Overall Study|Lack of Efficacy|1|||
16936611|NCT01157377|38081179|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16936612|NCT01157377|38081180|FG001|Overall Study|Other Miscellaneous Reasons|2|||
16936613|NCT01157377|38081181|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16936614|NCT01157377|38081182|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16936615|NCT01157377|38081183|FG004|Overall Study|Other Miscellaneous Reasons|1|||
16936616|NCT01157377|38081184|FG005|Overall Study|Other Miscellaneous Reasons|1|||
16936617|NCT01157377|38081185|FG006|Overall Study|Other Miscellaneous Reasons|1|||
16936618|NCT01157182|38081203|FG000|Washout of 28 Days|Adverse Event|2|||
16936619|NCT01157182|38081204|FG001|Washout of 28 Days|Adverse Event|0|||
16936620|NCT01157065|38081212|FG000|Overall Study|Death|0|||
16936621|NCT01157065|38081213|FG001|Overall Study|Death|1|||
16936622|NCT01156792|38081219|FG000|Overall Study|Adverse Event|1|||
16936623|NCT01156792|38081219|FG000|Overall Study|Lack of Efficacy|36|||
16936624|NCT01156792|38081219|FG000|Overall Study|Protocol Violation|6|||
16936625|NCT01156792|38081219|FG000|Overall Study|Lost to Follow-up|3|||
16936626|NCT01156792|38081219|FG000|Overall Study|Physician Decision|3|||
16936627|NCT01156792|38081219|FG000|Overall Study|Withdrawal by Subject|9|||
16936628|NCT01156792|38081219|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
16936629|NCT01156714|38081237|FG000|Overall Study|Withdrawal by Subject|9|||
16936630|NCT01156714|38081238|FG001|Overall Study|Withdrawal by Subject|4|||
16936631|NCT01156714|38081239|FG002|Overall Study|Withdrawal by Subject|3|||
16936632|NCT01156675|38081253|FG000|Overall Study|Death|5|||
16936633|NCT01156675|38081254|FG001|Overall Study|Death|3|||
16936634|NCT01156675|38081255|FG002|Overall Study|Death|0|||
16936635|NCT01156675|38081253|FG000|Overall Study|No data|29|||
16936636|NCT01156675|38081254|FG001|Overall Study|No data|22|||
16936637|NCT01156675|38081255|FG002|Overall Study|No data|2|||
16936638|NCT01156480|38081266|FG000|Overall Study|change in diagnosis|0|||
16936639|NCT01156480|38081267|FG001|Overall Study|change in diagnosis|1|||
16936640|NCT01156363|38081275|FG000|Overall Study|Adverse Event|6|||
16936641|NCT01156363|38081275|FG000|Overall Study|Insufficient Therapeutic Response|5|||
16936642|NCT01156363|38081275|FG000|Overall Study|Failure to Return|1|||
16936643|NCT01156363|38081275|FG000|Overall Study|Refused Treatment|4|||
16936644|NCT01156363|38081275|FG000|Overall Study|Other|6|||
16936645|NCT01156051|38081288|FG000|Overall Study|Lost to Follow-up|1|||
16936646|NCT01156051|38081289|FG001|Overall Study|Lost to Follow-up|0|||
16936647|NCT01156051|38081288|FG000|Overall Study|patient not compliant with protocol|0|||
16936648|NCT01156051|38081289|FG001|Overall Study|patient not compliant with protocol|1|||
16936649|NCT01156012|38081297|FG000|Overall Study|Adverse Event|3|||
16936650|NCT01156012|38081298|FG001|Overall Study|Adverse Event|1|||
16936651|NCT01156012|38081297|FG000|Overall Study|Lost to Follow-up|1|||
16936652|NCT01156012|38081298|FG001|Overall Study|Lost to Follow-up|0|||
16936653|NCT01156012|38081297|FG000|Overall Study|Withdrawal by Subject|1|||
16936654|NCT01156012|38081298|FG001|Overall Study|Withdrawal by Subject|0|||
16936655|NCT01156012|38081297|FG000|Overall Study|use of commercial drug instead of study|0|||
16936656|NCT01156012|38081298|FG001|Overall Study|use of commercial drug instead of study|1|||
16936657|NCT01156012|38081297|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
16936658|NCT01156012|38081298|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
16936659|NCT01155661|38081304|FG000|Overall Study|Adverse Event|101|||
16936660|NCT01155661|38081304|FG000|Overall Study|Death|1|||
16936661|NCT01155661|38081304|FG000|Overall Study|Lack of Efficacy|32|||
16936662|NCT01155661|38081304|FG000|Overall Study|Lost to Follow-up|22|||
16936663|NCT01155661|38081304|FG000|Overall Study|Physician Decision|3|||
16936664|NCT01155661|38081304|FG000|Overall Study|Protocol Violation|35|||
16936665|NCT01155661|38081304|FG000|Overall Study|Withdrawal by Subject|73|||
16936666|NCT01155661|38081304|FG000|Overall Study|Sponsor Decision|13|||
16936667|NCT01155583|38081319|FG000|Phase I|Screen failure - did not start treatment|0|||
16936668|NCT01155583|38081320|FG001|Phase I|Screen failure - did not start treatment|0|||
16936669|NCT01155583|38081321|FG002|Phase I|Screen failure - did not start treatment|0|||
16936670|NCT01155583|38081322|FG003|Phase I|Screen failure - did not start treatment|0|||
16936671|NCT01155583|38081323|FG004|Phase I|Screen failure - did not start treatment|1|||
16936672|NCT01155583|38081324|FG005|Phase I|Screen failure - did not start treatment|0|||
16936673|NCT01155583|38081325|FG006|Phase I|Screen failure - did not start treatment|0|||
16936674|NCT01155583|38081326|FG007|Phase I|Screen failure - did not start treatment|2|||
16936675|NCT01155583|38081327|FG008|Phase I|Screen failure - did not start treatment|0|||
16936676|NCT01155583|38081319|FG000|Phase I|Withdrawal by Subject|0|||
16936677|NCT01155583|38081320|FG001|Phase I|Withdrawal by Subject|0|||
16936678|NCT01155583|38081321|FG002|Phase I|Withdrawal by Subject|0|||
16936679|NCT01155583|38081322|FG003|Phase I|Withdrawal by Subject|0|||
16936680|NCT01155583|38081323|FG004|Phase I|Withdrawal by Subject|0|||
16936681|NCT01155583|38081324|FG005|Phase I|Withdrawal by Subject|0|||
16936682|NCT01155583|38081325|FG006|Phase I|Withdrawal by Subject|0|||
16936683|NCT01155583|38081326|FG007|Phase I|Withdrawal by Subject|1|||
16936684|NCT01155583|38081327|FG008|Phase I|Withdrawal by Subject|0|||
16936685|NCT01155466|38081348|FG000|Overall Study|Adverse Event|13|||
16936686|NCT01155466|38081349|FG001|Overall Study|Adverse Event|15|||
16936687|NCT01155466|38081350|FG002|Overall Study|Adverse Event|6|||
16936688|NCT01155466|38081351|FG003|Overall Study|Adverse Event|17|||
16936689|NCT01155466|38081352|FG004|Overall Study|Adverse Event|18|||
16936690|NCT01155466|38081348|FG000|Overall Study|Lost to Follow-up|0|||
16936691|NCT01155466|38081349|FG001|Overall Study|Lost to Follow-up|0|||
16936692|NCT01155466|38081350|FG002|Overall Study|Lost to Follow-up|0|||
16936693|NCT01155466|38081351|FG003|Overall Study|Lost to Follow-up|0|||
16936694|NCT01155466|38081352|FG004|Overall Study|Lost to Follow-up|2|||
16936695|NCT01155466|38081348|FG000|Overall Study|Withdrawal by Subject|7|||
16936696|NCT01155466|38081349|FG001|Overall Study|Withdrawal by Subject|5|||
16936697|NCT01155466|38081350|FG002|Overall Study|Withdrawal by Subject|9|||
16936698|NCT01155466|38081351|FG003|Overall Study|Withdrawal by Subject|4|||
16936699|NCT01155466|38081352|FG004|Overall Study|Withdrawal by Subject|4|||
16936700|NCT01155466|38081348|FG000|Overall Study|Protocol Violation|0|||
16936701|NCT01155466|38081349|FG001|Overall Study|Protocol Violation|0|||
16936702|NCT01155466|38081350|FG002|Overall Study|Protocol Violation|2|||
16936703|NCT01155466|38081351|FG003|Overall Study|Protocol Violation|0|||
16936704|NCT01155466|38081352|FG004|Overall Study|Protocol Violation|1|||
16936705|NCT01155466|38081348|FG000|Overall Study|Administrative|0|||
16936706|NCT01155466|38081349|FG001|Overall Study|Administrative|3|||
16936707|NCT01155466|38081350|FG002|Overall Study|Administrative|0|||
16936708|NCT01155466|38081351|FG003|Overall Study|Administrative|0|||
16936709|NCT01155466|38081352|FG004|Overall Study|Administrative|0|||
16936710|NCT01155466|38081348|FG000|Overall Study|Randomized not treated|2|||
16936711|NCT01155466|38081349|FG001|Overall Study|Randomized not treated|2|||
16936712|NCT01155466|38081350|FG002|Overall Study|Randomized not treated|3|||
16936713|NCT01155466|38081351|FG003|Overall Study|Randomized not treated|0|||
16936714|NCT01155466|38081352|FG004|Overall Study|Randomized not treated|2|||
16936715|NCT01155388|38081366|FG000|Overall Study|Adverse Event|1|||
16936716|NCT01155388|38081367|FG001|Overall Study|Adverse Event|0|||
16936717|NCT01154452|38081378|FG000|Phase Ib|Not Treated|1|||
16936718|NCT01154452|38081379|FG001|Phase Ib|Not Treated|0|||
16936719|NCT01154452|38081380|FG002|Phase Ib|Not Treated|0|||
16936720|NCT01154452|38081381|FG003|Phase Ib|Not Treated|0|||
16936721|NCT01154452|38081378|FG000|Phase Ib|Adverse Event|2|||
16936722|NCT01154452|38081379|FG001|Phase Ib|Adverse Event|1|||
16936723|NCT01154452|38081380|FG002|Phase Ib|Adverse Event|0|||
16936724|NCT01154452|38081381|FG003|Phase Ib|Adverse Event|0|||
16936725|NCT01154452|38081378|FG000|Phase II|Withdrawal by Subject|0|||
16936726|NCT01154452|38081379|FG001|Phase II|Withdrawal by Subject|0|||
16936727|NCT01154452|38081380|FG002|Phase II|Withdrawal by Subject|1|||
16936728|NCT01154452|38081381|FG003|Phase II|Withdrawal by Subject|2|||
16936729|NCT01154452|38081378|FG000|Phase II|Adverse Event|0|||
16936730|NCT01154452|38081379|FG001|Phase II|Adverse Event|0|||
16936731|NCT01154452|38081380|FG002|Phase II|Adverse Event|4|||
16936732|NCT01154452|38081381|FG003|Phase II|Adverse Event|4|||
16936733|NCT01154296|38081396|FG000|Randomization and Intervention|Decided to decline|1|||
16936734|NCT01154296|38081397|FG001|Randomization and Intervention|Decided to decline|1|||
16936735|NCT01154296|38081396|FG000|Randomization and Intervention|Declined by staff|1|||
16936736|NCT01154296|38081397|FG001|Randomization and Intervention|Declined by staff|0|||
16936737|NCT01154296|38081396|FG000|Randomization and Intervention|Did not return|1|||
16936738|NCT01154296|38081397|FG001|Randomization and Intervention|Did not return|0|||
16936739|NCT01154296|38081396|FG000|Randomization and Intervention|Left before test|0|||
16936740|NCT01154296|38081397|FG001|Randomization and Intervention|Left before test|1|||
16936741|NCT01154296|38081396|FG000|Randomization and Intervention|Left clinic early|2|||
16936742|NCT01154296|38081397|FG001|Randomization and Intervention|Left clinic early|0|||
16936743|NCT01154296|38081396|FG000|6-month Follow-up|Lost contact|269|||
16936744|NCT01154296|38081397|FG001|6-month Follow-up|Lost contact|275|||
16936745|NCT01154296|38081396|FG000|6-month Follow-up|Incarcerated|37|||
16936746|NCT01154296|38081397|FG001|6-month Follow-up|Incarcerated|32|||
16936747|NCT01154296|38081396|FG000|6-month Follow-up|Withdrew consent|14|||
16936748|NCT01154296|38081397|FG001|6-month Follow-up|Withdrew consent|15|||
16936749|NCT01154296|38081396|FG000|6-month Follow-up|Death|3|||
16936750|NCT01154296|38081397|FG001|6-month Follow-up|Death|2|||
16936751|NCT01154296|38081396|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
16936752|NCT01154296|38081397|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
16936753|NCT01154218|38081403|FG000|Third Intervention Period|Adverse Event|0|||
16936754|NCT01154218|38081404|FG001|Third Intervention Period|Adverse Event|1|||
16936755|NCT01154218|38081405|FG002|Third Intervention Period|Adverse Event|0|||
16936756|NCT01154218|38081406|FG003|Third Intervention Period|Adverse Event|0|||
16936757|NCT01154218|38081403|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16936758|NCT01154218|38081404|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16936759|NCT01154218|38081405|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16936760|NCT01154218|38081406|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
16936761|NCT01154218|38081403|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
16936762|NCT01154218|38081404|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
16936763|NCT01154218|38081405|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
16936764|NCT01154218|38081406|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
16936765|NCT01154140|38081431|FG000|Overall Study|Death|71|||
16936766|NCT01154140|38081432|FG001|Overall Study|Death|81|||
16936767|NCT01154140|38081431|FG000|Overall Study|Lost to Follow-up|4|||
16936768|NCT01154140|38081432|FG001|Overall Study|Lost to Follow-up|5|||
16936769|NCT01154140|38081431|FG000|Overall Study|Withdrawal by Subject|12|||
16936770|NCT01154140|38081432|FG001|Overall Study|Withdrawal by Subject|13|||
16936771|NCT01154140|38081431|FG000|Overall Study|Other|3|||
16936772|NCT01154140|38081432|FG001|Overall Study|Other|1|||
16936773|NCT01154140|38081431|FG000|Overall Study|Randomized but not treated|1|||
16936774|NCT01154140|38081432|FG001|Overall Study|Randomized but not treated|2|||
16936775|NCT01154101|38081443|FG000|Overall Study|Adverse Event|0|||
16936776|NCT01154101|38081444|FG001|Overall Study|Adverse Event|2|||
16936777|NCT01154101|38081445|FG002|Overall Study|Adverse Event|1|||
16936778|NCT01154101|38081446|FG003|Overall Study|Adverse Event|1|||
16936779|NCT01154101|38081447|FG004|Overall Study|Adverse Event|0|||
16936780|NCT01154101|38081443|FG000|Overall Study|Lost to Follow-up|0|||
16936781|NCT01154101|38081444|FG001|Overall Study|Lost to Follow-up|1|||
16936782|NCT01154101|38081445|FG002|Overall Study|Lost to Follow-up|0|||
16936783|NCT01154101|38081446|FG003|Overall Study|Lost to Follow-up|1|||
16936784|NCT01154101|38081447|FG004|Overall Study|Lost to Follow-up|0|||
16936785|NCT01154101|38081443|FG000|Overall Study|Withdrawal by Subject|0|||
16936786|NCT01154101|38081444|FG001|Overall Study|Withdrawal by Subject|1|||
16936787|NCT01154101|38081445|FG002|Overall Study|Withdrawal by Subject|2|||
16936788|NCT01154101|38081446|FG003|Overall Study|Withdrawal by Subject|0|||
16936789|NCT01154101|38081447|FG004|Overall Study|Withdrawal by Subject|1|||
16936790|NCT01153984|38081464|FG000|Overall Study|Withdrawal by Subject|1|||
16936791|NCT01153984|38081464|FG000|Overall Study|Adverse Event|1|||
16936792|NCT01153633|38081470|FG000|Overall Study|Protocol Violation|1|||
16936793|NCT01153633|38081471|FG001|Overall Study|Protocol Violation|1|||
16936794|NCT01153633|38081470|FG000|Overall Study|Therapeutic failure|3|||
16936795|NCT01153633|38081471|FG001|Overall Study|Therapeutic failure|3|||
16936796|NCT01153516|38081481|FG000|Overall Study|Both subjects refused surgery|2|||
16936797|NCT01153516|38081482|FG001|Overall Study|Both subjects refused surgery|0|||
16936798|NCT01153321|38081490|FG000|Overall Study|Development of study withdrawal criteria|0|||
16936799|NCT01153321|38081491|FG001|Overall Study|Development of study withdrawal criteria|1|||
16936800|NCT01153321|38081490|FG000|Overall Study|Withdrawal by Subject|0|||
16936801|NCT01153321|38081491|FG001|Overall Study|Withdrawal by Subject|1|||
16936802|NCT01153321|38081490|FG000|Overall Study|Adverse Event|1|||
16936803|NCT01153321|38081491|FG001|Overall Study|Adverse Event|1|||
16936804|NCT01153009|38081501|FG000|Overall Study|Adverse Event|4|||
16936805|NCT01153009|38081502|FG001|Overall Study|Adverse Event|14|||
16936806|NCT01153009|38081503|FG002|Overall Study|Adverse Event|14|||
16936807|NCT01153009|38081504|FG003|Overall Study|Adverse Event|10|||
16936808|NCT01153009|38081501|FG000|Overall Study|Lack of Efficacy|9|||
16936809|NCT01153009|38081502|FG001|Overall Study|Lack of Efficacy|0|||
16936810|NCT01153009|38081503|FG002|Overall Study|Lack of Efficacy|2|||
16936811|NCT01153009|38081504|FG003|Overall Study|Lack of Efficacy|1|||
16936812|NCT01153009|38081501|FG000|Overall Study|Noncompliance with Study Medication|1|||
16936813|NCT01153009|38081502|FG001|Overall Study|Noncompliance with Study Medication|3|||
16936814|NCT01153009|38081503|FG002|Overall Study|Noncompliance with Study Medication|4|||
16936815|NCT01153009|38081504|FG003|Overall Study|Noncompliance with Study Medication|1|||
16936816|NCT01153009|38081501|FG000|Overall Study|Protocol Deviations|4|||
16936817|NCT01153009|38081502|FG001|Overall Study|Protocol Deviations|3|||
16936818|NCT01153009|38081503|FG002|Overall Study|Protocol Deviations|3|||
16936819|NCT01153009|38081504|FG003|Overall Study|Protocol Deviations|2|||
16936820|NCT01153009|38081501|FG000|Overall Study|Withdrawal of Consent|5|||
16936821|NCT01153009|38081502|FG001|Overall Study|Withdrawal of Consent|5|||
16936822|NCT01153009|38081503|FG002|Overall Study|Withdrawal of Consent|4|||
16936823|NCT01153009|38081504|FG003|Overall Study|Withdrawal of Consent|6|||
16936824|NCT01153009|38081501|FG000|Overall Study|Lost to Follow-up|8|||
16936825|NCT01153009|38081502|FG001|Overall Study|Lost to Follow-up|8|||
16936826|NCT01153009|38081503|FG002|Overall Study|Lost to Follow-up|11|||
16936827|NCT01153009|38081504|FG003|Overall Study|Lost to Follow-up|15|||
16936828|NCT01153009|38081501|FG000|Overall Study|Other|1|||
16936829|NCT01153009|38081502|FG001|Overall Study|Other|1|||
16936830|NCT01153009|38081503|FG002|Overall Study|Other|3|||
16936831|NCT01153009|38081504|FG003|Overall Study|Other|2|||
16936832|NCT01152814|38081514|FG000|Overall Study|Lost to Follow-up|2|||
16936833|NCT01152580|38081520|FG000|Overall Study|Withdrawal by Subject|0|||
16936834|NCT01152580|38081521|FG001|Overall Study|Withdrawal by Subject|1|||
16936835|NCT01152385|38081531|FG000|Overall Study|Withdrawal by Subject|3|||
16936836|NCT01152385|38081532|FG001|Overall Study|Withdrawal by Subject|1|||
16936837|NCT01152385|38081533|FG002|Overall Study|Withdrawal by Subject|1|||
16936838|NCT01152385|38081534|FG003|Overall Study|Withdrawal by Subject|1|||
16936839|NCT01152385|38081531|FG000|Overall Study|Protocol Violation|0|||
16936840|NCT01152385|38081532|FG001|Overall Study|Protocol Violation|0|||
16936841|NCT01152385|38081533|FG002|Overall Study|Protocol Violation|0|||
16936842|NCT01152385|38081534|FG003|Overall Study|Protocol Violation|1|||
16936843|NCT01152385|38081531|FG000|Overall Study|Adverse Event|1|||
16936844|NCT01152385|38081532|FG001|Overall Study|Adverse Event|1|||
16936845|NCT01152385|38081533|FG002|Overall Study|Adverse Event|0|||
16936846|NCT01152385|38081534|FG003|Overall Study|Adverse Event|0|||
16936847|NCT01152385|38081531|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16936848|NCT01152385|38081532|FG001|Overall Study|Study-specific withdrawal criteria|1|||
16936849|NCT01152385|38081533|FG002|Overall Study|Study-specific withdrawal criteria|2|||
16936850|NCT01152385|38081534|FG003|Overall Study|Study-specific withdrawal criteria|0|||
16936851|NCT01152385|38081531|FG000|Overall Study|Other|4|||
16936852|NCT01152385|38081532|FG001|Overall Study|Other|3|||
16936853|NCT01152385|38081533|FG002|Overall Study|Other|2|||
16936854|NCT01152385|38081534|FG003|Overall Study|Other|3|||
16936855|NCT01152190|38081550|FG000|Overall Study|Adverse Event|2|||
16936856|NCT01152190|38081551|FG001|Overall Study|Adverse Event|4|||
16936857|NCT01152190|38081550|FG000|Overall Study|Death|1|||
16936858|NCT01152190|38081551|FG001|Overall Study|Death|0|||
16936859|NCT01152190|38081550|FG000|Overall Study|Protocol Violation|1|||
16936860|NCT01152190|38081551|FG001|Overall Study|Protocol Violation|1|||
16936861|NCT01152190|38081550|FG000|Overall Study|Withdrawal by Subject|1|||
16936862|NCT01152190|38081551|FG001|Overall Study|Withdrawal by Subject|3|||
16936863|NCT01151410|38081559|FG000|Overall Study|Withdrawal by Subject|3|||
16936864|NCT01151410|38081560|FG001|Overall Study|Withdrawal by Subject|5|||
16936865|NCT01151410|38081559|FG000|Overall Study|Lost to Follow-up|3|||
16936866|NCT01151410|38081560|FG001|Overall Study|Lost to Follow-up|4|||
16936867|NCT01151410|38081559|FG000|Overall Study|Adverse Event|1|||
16936868|NCT01151410|38081560|FG001|Overall Study|Adverse Event|2|||
16936869|NCT01151410|38081559|FG000|Overall Study|Protocol deviation|2|||
16936870|NCT01151410|38081560|FG001|Overall Study|Protocol deviation|1|||
16936871|NCT01151410|38081559|FG000|Overall Study|Administrative problems|1|||
16936872|NCT01151410|38081560|FG001|Overall Study|Administrative problems|1|||
16936873|NCT01151410|38081559|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16936874|NCT01151410|38081560|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16936875|NCT01151410|38081559|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16936876|NCT01151410|38081560|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16936877|NCT01151215|38081569|FG000|Overall Study|Worsening of condition under study|1|||
16936878|NCT01151215|38081570|FG001|Overall Study|Worsening of condition under study|1|||
16936879|NCT01151215|38081571|FG002|Overall Study|Worsening of condition under study|1|||
16936880|NCT01151215|38081569|FG000|Overall Study|Death|16|||
16936881|NCT01151215|38081570|FG001|Overall Study|Death|20|||
16936882|NCT01151215|38081571|FG002|Overall Study|Death|11|||
16936883|NCT01151215|38081569|FG000|Overall Study|Lost to Follow-up|0|||
16936884|NCT01151215|38081570|FG001|Overall Study|Lost to Follow-up|0|||
16936885|NCT01151215|38081571|FG002|Overall Study|Lost to Follow-up|3|||
16936886|NCT01151215|38081569|FG000|Overall Study|Withdrawal by Subject|3|||
16936887|NCT01151215|38081570|FG001|Overall Study|Withdrawal by Subject|1|||
16936888|NCT01151215|38081571|FG002|Overall Study|Withdrawal by Subject|2|||
16936889|NCT01151215|38081569|FG000|Overall Study|Disease progression|0|||
16936890|NCT01151215|38081570|FG001|Overall Study|Disease progression|1|||
16936891|NCT01151215|38081571|FG002|Overall Study|Disease progression|1|||
16936892|NCT01151215|38081569|FG000|Overall Study|Safety as judged by the investigator|0|||
16936893|NCT01151215|38081570|FG001|Overall Study|Safety as judged by the investigator|0|||
17104797|NCT00106353|38242620|FG005|Part 2|Other|1|||
17104798|NCT00106353|38242621|FG006|Part 2|Other|1|||
17104799|NCT00106353|38242615|FG000|Part 2|Withdrawal by Subject|0|||
16936894|NCT01151215|38081571|FG002|Overall Study|Safety as judged by the investigator|1|||
16936895|NCT01151137|38081581|FG000|Overall Study|Death|15|||
16936896|NCT01151137|38081582|FG001|Overall Study|Death|27|||
16936897|NCT01151137|38081581|FG000|Overall Study|Lost to Follow-up|1|||
16936898|NCT01151137|38081582|FG001|Overall Study|Lost to Follow-up|1|||
16936899|NCT01151098|38081588|FG000|Overall Study|Adverse Event|82|||
16936900|NCT01151098|38081588|FG000|Overall Study|Lost to Follow-up|6|||
16936901|NCT01151098|38081588|FG000|Overall Study|Lack of Efficacy|15|||
16936902|NCT01151098|38081588|FG000|Overall Study|Protocol Violation|1|||
16936903|NCT01151098|38081588|FG000|Overall Study|Miscellaneous|13|||
16936904|NCT01151020|38081592|FG000|Overall Study|Death|25|||
16936905|NCT01151020|38081592|FG000|Overall Study|Conversion to open repair|1|||
16936906|NCT01151020|38081592|FG000|Overall Study|Lost to Follow-up|4|||
16936907|NCT01151020|38081592|FG000|Overall Study|Withdrawal by Subject|22|||
16936908|NCT01151020|38081592|FG000|Overall Study|Patients did not receive the device|2|||
16936909|NCT01150474|38081598|FG000|Overall Study|Withdrawal by Subject|5|||
16936910|NCT01150474|38081599|FG001|Overall Study|Withdrawal by Subject|2|||
16936911|NCT01150474|38081598|FG000|Overall Study|Cancer found|1|||
16936912|NCT01150474|38081599|FG001|Overall Study|Cancer found|0|||
17104800|NCT00106353|38242616|FG001|Part 2|Withdrawal by Subject|0|||
17104801|NCT00106353|38242617|FG002|Part 2|Withdrawal by Subject|0|||
17104802|NCT00106353|38242618|FG003|Part 2|Withdrawal by Subject|0|||
17104803|NCT00106353|38242619|FG004|Part 2|Withdrawal by Subject|1|||
17104804|NCT00106353|38242620|FG005|Part 2|Withdrawal by Subject|0|||
17104805|NCT00106353|38242621|FG006|Part 2|Withdrawal by Subject|0|||
16936913|NCT01150474|38081598|FG000|Overall Study|Multiple Studies|0|||
16936914|NCT01150474|38081599|FG001|Overall Study|Multiple Studies|1|||
16936915|NCT01150474|38081598|FG000|Overall Study|Rectotomy|1|||
16936916|NCT01150474|38081599|FG001|Overall Study|Rectotomy|0|||
16936917|NCT01150474|38081598|FG000|Overall Study|Drug did not arrive in time|1|||
16936918|NCT01150474|38081599|FG001|Overall Study|Drug did not arrive in time|0|||
16936919|NCT01150474|38081598|FG000|Overall Study|Drug not administered|1|||
16936920|NCT01150474|38081599|FG001|Overall Study|Drug not administered|0|||
16936921|NCT01150474|38081598|FG000|Overall Study|Surgery Changed|1|||
16936922|NCT01150474|38081599|FG001|Overall Study|Surgery Changed|0|||
16936923|NCT01150357|38081608|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
16936924|NCT01150357|38081609|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
17104806|NCT00106353|38242615|FG000|Part 2|Physician Decision|0|||
17104807|NCT00106353|38242616|FG001|Part 2|Physician Decision|0|||
17104808|NCT00106353|38242617|FG002|Part 2|Physician Decision|0|||
17104809|NCT00106353|38242618|FG003|Part 2|Physician Decision|0|||
17104810|NCT00106353|38242619|FG004|Part 2|Physician Decision|0|||
17104811|NCT00106353|38242620|FG005|Part 2|Physician Decision|1|||
17104812|NCT00106353|38242621|FG006|Part 2|Physician Decision|0|||
17104813|NCT00080301|38242644|FG000|Overall Study|Randomized but Never Treated|5|||
17104814|NCT00080301|38242645|FG001|Overall Study|Randomized but Never Treated|10|||
17104815|NCT00080301|38242644|FG000|Overall Study|Still on Treatment as of CSR date|0|||
17104816|NCT00080301|38242645|FG001|Overall Study|Still on Treatment as of CSR date|1|||
17104817|NCT00079677|38242654|FG000|Overall Study|Adverse Event|5|||
17104818|NCT00079677|38242655|FG001|Overall Study|Adverse Event|6|||
17104819|NCT00079677|38242654|FG000|Overall Study|Lack of Efficacy|1|||
17104820|NCT00079677|38242655|FG001|Overall Study|Lack of Efficacy|0|||
17104821|NCT00079677|38242654|FG000|Overall Study|Lost to Follow-up|2|||
17104822|NCT00079677|38242655|FG001|Overall Study|Lost to Follow-up|2|||
17104823|NCT00079677|38242654|FG000|Overall Study|Physician Decision|3|||
17104824|NCT00079677|38242655|FG001|Overall Study|Physician Decision|0|||
16936925|NCT01150357|38081610|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
16936926|NCT01150357|38081608|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
16936927|NCT01150357|38081609|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
16936928|NCT01150357|38081610|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
16936929|NCT01150357|38081608|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
16936930|NCT01150357|38081609|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
16936931|NCT01150357|38081610|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
16936932|NCT01150357|38081608|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
16936933|NCT01150357|38081609|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
16936934|NCT01150357|38081610|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
16936935|NCT01150357|38081608|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
16936936|NCT01150357|38081609|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
16936937|NCT01150357|38081610|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
16936938|NCT01150357|38081608|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
16936939|NCT01150357|38081609|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
16936940|NCT01150357|38081610|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
16936941|NCT01150357|38081608|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
16936942|NCT01150357|38081609|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
16936943|NCT01150357|38081610|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
16936944|NCT01150123|38081660|FG000|Overall Study|Withdrawal by Subject|1|||
16936945|NCT01150123|38081661|FG001|Overall Study|Withdrawal by Subject|1|||
16936946|NCT01150123|38081662|FG002|Overall Study|Withdrawal by Subject|2|||
16936947|NCT01150123|38081663|FG003|Overall Study|Withdrawal by Subject|1|||
16936948|NCT01150123|38081664|FG004|Overall Study|Withdrawal by Subject|1|||
16936949|NCT01150123|38081665|FG005|Overall Study|Withdrawal by Subject|1|||
16936950|NCT01150123|38081666|FG006|Overall Study|Withdrawal by Subject|0|||
16936951|NCT01150123|38081667|FG007|Overall Study|Withdrawal by Subject|3|||
16936952|NCT01150123|38081668|FG008|Overall Study|Withdrawal by Subject|2|||
16936953|NCT01150123|38081669|FG009|Overall Study|Withdrawal by Subject|0|||
16936954|NCT01150123|38081670|FG010|Overall Study|Withdrawal by Subject|1|||
16936955|NCT01150123|38081671|FG011|Overall Study|Withdrawal by Subject|0|||
16936956|NCT01150123|38081672|FG012|Overall Study|Withdrawal by Subject|1|||
16936957|NCT01150123|38081673|FG013|Overall Study|Withdrawal by Subject|0|||
16936958|NCT01150123|38081674|FG014|Overall Study|Withdrawal by Subject|0|||
16936959|NCT01150123|38081675|FG015|Overall Study|Withdrawal by Subject|1|||
16936960|NCT01150123|38081676|FG016|Overall Study|Withdrawal by Subject|0|||
16936961|NCT01150123|38081677|FG017|Overall Study|Withdrawal by Subject|1|||
16936962|NCT01150123|38081660|FG000|Overall Study|Lost to Follow-up|2|||
16936963|NCT01150123|38081661|FG001|Overall Study|Lost to Follow-up|1|||
16936964|NCT01150123|38081662|FG002|Overall Study|Lost to Follow-up|2|||
16936965|NCT01150123|38081663|FG003|Overall Study|Lost to Follow-up|2|||
16936966|NCT01150123|38081664|FG004|Overall Study|Lost to Follow-up|2|||
16936967|NCT01150123|38081665|FG005|Overall Study|Lost to Follow-up|5|||
16936968|NCT01150123|38081666|FG006|Overall Study|Lost to Follow-up|0|||
16936969|NCT01150123|38081667|FG007|Overall Study|Lost to Follow-up|0|||
16936970|NCT01150123|38081668|FG008|Overall Study|Lost to Follow-up|3|||
16936971|NCT01150123|38081669|FG009|Overall Study|Lost to Follow-up|1|||
16936972|NCT01150123|38081670|FG010|Overall Study|Lost to Follow-up|1|||
16936973|NCT01150123|38081671|FG011|Overall Study|Lost to Follow-up|1|||
16936974|NCT01150123|38081672|FG012|Overall Study|Lost to Follow-up|2|||
16936975|NCT01150123|38081673|FG013|Overall Study|Lost to Follow-up|0|||
16936976|NCT01150123|38081674|FG014|Overall Study|Lost to Follow-up|0|||
16936977|NCT01150123|38081675|FG015|Overall Study|Lost to Follow-up|0|||
16936978|NCT01150123|38081676|FG016|Overall Study|Lost to Follow-up|0|||
16936979|NCT01150123|38081677|FG017|Overall Study|Lost to Follow-up|0|||
16936980|NCT01149655|38081736|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
16936981|NCT01149655|38081737|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
16936982|NCT01149655|38081738|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
16936983|NCT01149655|38081739|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
16936984|NCT01149655|38081736|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
16936985|NCT01149655|38081737|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
16936986|NCT01149655|38081738|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
16936987|NCT01149655|38081739|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
16936988|NCT01149655|38081736|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
16936989|NCT01149655|38081737|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
16936990|NCT01149655|38081738|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
16936991|NCT01149655|38081739|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
16936992|NCT01149655|38081736|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
16936993|NCT01149655|38081737|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
16936994|NCT01149655|38081738|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
16936995|NCT01149655|38081739|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
16936996|NCT01149655|38081736|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
16936997|NCT01149655|38081737|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
16936998|NCT01149655|38081738|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
16936999|NCT01149655|38081739|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
16937000|NCT01149655|38081736|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
16937001|NCT01149655|38081737|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
16937002|NCT01149655|38081738|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
16937003|NCT01149655|38081739|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
16937004|NCT01149655|38081736|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
16937005|NCT01149655|38081737|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
16937006|NCT01149655|38081738|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
16937007|NCT01149655|38081739|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
16937008|NCT01149655|38081736|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
16937009|NCT01149655|38081737|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
16937010|NCT01149655|38081738|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
16937011|NCT01149655|38081739|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
16937012|NCT01149655|38081736|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
16937013|NCT01149655|38081737|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
16937014|NCT01149655|38081738|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
16937015|NCT01149655|38081739|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
16937016|NCT01149655|38081736|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
16937017|NCT01149655|38081737|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
16937018|NCT01149655|38081738|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
16937019|NCT01149655|38081739|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
16937020|NCT01149655|38081736|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
16937021|NCT01149655|38081737|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
16937022|NCT01149655|38081738|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
16937023|NCT01149655|38081739|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
16937024|NCT01149655|38081736|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
16937025|NCT01149655|38081737|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
16937026|NCT01149655|38081738|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
16937027|NCT01149655|38081739|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
16937028|NCT01149655|38081736|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
16937029|NCT01149655|38081737|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
16937030|NCT01149655|38081738|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
16937031|NCT01149655|38081739|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
16937032|NCT01149655|38081736|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
16937033|NCT01149655|38081737|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
16937034|NCT01149655|38081738|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
16937035|NCT01149655|38081739|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
16937036|NCT01149655|38081736|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
16937037|NCT01149655|38081737|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
16937038|NCT01149655|38081738|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
16937039|NCT01149655|38081739|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
16937040|NCT01149655|38081736|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
16937041|NCT01149655|38081737|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
16937042|NCT01149655|38081738|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
16937043|NCT01149655|38081739|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
16937044|NCT01149538|38081749|FG000|Overall Study|Lost to Follow-up|0|||
16937045|NCT01149538|38081750|FG001|Overall Study|Lost to Follow-up|1|||
16937046|NCT01149538|38081749|FG000|Overall Study|Withdrawal by Subject|5|||
16937047|NCT01149538|38081750|FG001|Overall Study|Withdrawal by Subject|3|||
16937048|NCT01149460|38081758|FG000|Overall Study|Withdrawal by Subject|0|||
16937049|NCT01149460|38081759|FG001|Overall Study|Withdrawal by Subject|2|||
16937050|NCT01149421|38081768|FG000|Overall Study|Adverse Event|22|||
16937051|NCT01149421|38081769|FG001|Overall Study|Adverse Event|6|||
16937052|NCT01149421|38081770|FG002|Overall Study|Adverse Event|11|||
16937053|NCT01149421|38081768|FG000|Overall Study|Withdrawal by Subject|20|||
16937054|NCT01149421|38081769|FG001|Overall Study|Withdrawal by Subject|12|||
16937055|NCT01149421|38081770|FG002|Overall Study|Withdrawal by Subject|13|||
16937056|NCT01149421|38081768|FG000|Overall Study|Sponsor Decision|0|||
16937057|NCT01149421|38081769|FG001|Overall Study|Sponsor Decision|1|||
16937058|NCT01149421|38081770|FG002|Overall Study|Sponsor Decision|1|||
16937059|NCT01149421|38081768|FG000|Overall Study|Lost to Follow-up|2|||
16937060|NCT01149421|38081769|FG001|Overall Study|Lost to Follow-up|4|||
16937061|NCT01149421|38081770|FG002|Overall Study|Lost to Follow-up|5|||
16937062|NCT01149421|38081768|FG000|Overall Study|Physician Decision|5|||
16937063|NCT01149421|38081769|FG001|Overall Study|Physician Decision|3|||
16937064|NCT01149421|38081770|FG002|Overall Study|Physician Decision|6|||
16937065|NCT01149421|38081768|FG000|Overall Study|Entry Criteria Not Met|1|||
16937066|NCT01149421|38081769|FG001|Overall Study|Entry Criteria Not Met|1|||
16937067|NCT01149421|38081770|FG002|Overall Study|Entry Criteria Not Met|2|||
16937068|NCT01149421|38081768|FG000|Overall Study|Protocol Violation|2|||
16937069|NCT01149421|38081769|FG001|Overall Study|Protocol Violation|2|||
16937070|NCT01149421|38081770|FG002|Overall Study|Protocol Violation|6|||
16937071|NCT01149343|38081788|FG000|Overall Study|Withdrawal by Subject|1|||
16937072|NCT01149343|38081789|FG001|Overall Study|Withdrawal by Subject|1|||
16937073|NCT01149343|38081790|FG002|Overall Study|Withdrawal by Subject|1|||
16937074|NCT01149343|38081791|FG003|Overall Study|Withdrawal by Subject|5|||
16937075|NCT01149343|38081788|FG000|Overall Study|Death|10|||
16937076|NCT01149343|38081789|FG001|Overall Study|Death|13|||
16937077|NCT01149343|38081790|FG002|Overall Study|Death|18|||
16937078|NCT01149343|38081791|FG003|Overall Study|Death|18|||
16937079|NCT01149343|38081788|FG000|Overall Study|Lost to Follow-up|1|||
16937080|NCT01149343|38081789|FG001|Overall Study|Lost to Follow-up|0|||
16937081|NCT01149343|38081790|FG002|Overall Study|Lost to Follow-up|0|||
16937082|NCT01149343|38081791|FG003|Overall Study|Lost to Follow-up|1|||
16937083|NCT01149343|38081788|FG000|Overall Study|Other|8|||
16937084|NCT01149343|38081789|FG001|Overall Study|Other|10|||
16937085|NCT01149343|38081790|FG002|Overall Study|Other|2|||
16937086|NCT01149343|38081791|FG003|Overall Study|Other|14|||
16937087|NCT01149343|38081788|FG000|Overall Study|Sponsor study termination|0|||
16937088|NCT01149343|38081789|FG001|Overall Study|Sponsor study termination|0|||
16937089|NCT01149343|38081790|FG002|Overall Study|Sponsor study termination|0|||
16937090|NCT01149343|38081791|FG003|Overall Study|Sponsor study termination|2|||
16937091|NCT01149343|38081788|FG000|Overall Study|Recurrence / Progressive disease|0|||
16937092|NCT01149343|38081789|FG001|Overall Study|Recurrence / Progressive disease|0|||
16937093|NCT01149343|38081790|FG002|Overall Study|Recurrence / Progressive disease|1|||
16937094|NCT01149343|38081791|FG003|Overall Study|Recurrence / Progressive disease|0|||
16937095|NCT01149148|38081807|FG000|Overall Study|Lost to Follow-up|1|||
16937096|NCT01149148|38081808|FG001|Overall Study|Lost to Follow-up|2|||
16937097|NCT01149148|38081807|FG000|Overall Study|Death|1|||
16937098|NCT01149148|38081808|FG001|Overall Study|Death|0|||
16937099|NCT01148017|38081819|FG000|Overall Study|Withdrawal by Subject|31|||
16937100|NCT01148017|38081820|FG001|Overall Study|Withdrawal by Subject|14|||
16937101|NCT01148017|38081821|FG002|Overall Study|Withdrawal by Subject|0|||
16937102|NCT01148017|38081822|FG003|Overall Study|Withdrawal by Subject|0|||
16937103|NCT01148017|38081819|FG000|Overall Study|Lost to Follow-up|23|||
16937104|NCT01148017|38081820|FG001|Overall Study|Lost to Follow-up|10|||
16937105|NCT01148017|38081821|FG002|Overall Study|Lost to Follow-up|0|||
16937106|NCT01148017|38081822|FG003|Overall Study|Lost to Follow-up|0|||
16937107|NCT01148017|38081819|FG000|Overall Study|Inappropriate enrollment|1|||
16937108|NCT01148017|38081820|FG001|Overall Study|Inappropriate enrollment|0|||
16937109|NCT01148017|38081821|FG002|Overall Study|Inappropriate enrollment|0|||
16937110|NCT01148017|38081822|FG003|Overall Study|Inappropriate enrollment|0|||
16937111|NCT01148017|38081819|FG000|Overall Study|Administrative reason|22|||
16937112|NCT01148017|38081820|FG001|Overall Study|Administrative reason|9|||
16937113|NCT01148017|38081821|FG002|Overall Study|Administrative reason|0|||
16937114|NCT01148017|38081822|FG003|Overall Study|Administrative reason|0|||
16937115|NCT01148017|38081819|FG000|Overall Study|Unable to classify|3|||
16937116|NCT01148017|38081820|FG001|Overall Study|Unable to classify|1|||
16937117|NCT01148017|38081821|FG002|Overall Study|Unable to classify|0|||
16937118|NCT01148017|38081822|FG003|Overall Study|Unable to classify|0|||
16937119|NCT01147900|38081836|FG000|At Year 10|Lost to Follow-up|0|||
16937120|NCT01147900|38081837|FG001|At Year 10|Lost to Follow-up|1|||
16937121|NCT01147900|38081838|FG002|At Year 10|Lost to Follow-up|0|||
16937122|NCT01147744|38081853|FG000|Overall Study|Protocol Violation|1|||
16937123|NCT01147744|38081854|FG001|Overall Study|Protocol Violation|0|||
16937124|NCT01147744|38081855|FG002|Overall Study|Protocol Violation|1|||
16937125|NCT01147744|38081856|FG003|Overall Study|Protocol Violation|0|||
16937126|NCT01147744|38081857|FG004|Overall Study|Protocol Violation|1|||
16937127|NCT01147744|38081858|FG005|Overall Study|Protocol Violation|3|||
16937128|NCT01147744|38081859|FG006|Overall Study|Protocol Violation|1|||
16937129|NCT01147744|38081853|FG000|Overall Study|Physician Decision|0|||
17104825|NCT00079677|38242654|FG000|Overall Study|Protocol Violation|2|||
17104826|NCT00079677|38242655|FG001|Overall Study|Protocol Violation|3|||
17104827|NCT00079677|38242654|FG000|Overall Study|Withdrawal by Subject|5|||
17104828|NCT00079677|38242655|FG001|Overall Study|Withdrawal by Subject|3|||
17104829|NCT00079677|38242654|FG000|Overall Study|Miscellaneous|2|||
17104830|NCT00079677|38242655|FG001|Overall Study|Miscellaneous|0|||
17104831|NCT00095121|38242663|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
17104832|NCT00095121|38242664|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
17104833|NCT00095121|38242663|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
17104834|NCT00095121|38242664|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
17104835|NCT00094809|38242682|FG000|Overall Study|Protocol deviation|2|||
16937130|NCT01147744|38081854|FG001|Overall Study|Physician Decision|1|||
16937131|NCT01147744|38081855|FG002|Overall Study|Physician Decision|1|||
16937132|NCT01147744|38081856|FG003|Overall Study|Physician Decision|0|||
16937133|NCT01147744|38081857|FG004|Overall Study|Physician Decision|0|||
17104836|NCT00094809|38242683|FG001|Overall Study|Protocol deviation|2|||
16937134|NCT01147744|38081858|FG005|Overall Study|Physician Decision|0|||
16937135|NCT01147744|38081859|FG006|Overall Study|Physician Decision|1|||
16937136|NCT01147744|38081853|FG000|Overall Study|Lack of Efficacy|11|||
17104837|NCT00094809|38242682|FG000|Overall Study|Noncompliance|1|||
17104838|NCT00094809|38242683|FG001|Overall Study|Noncompliance|0|||
17104839|NCT00094809|38242682|FG000|Overall Study|Adverse Event|3|||
17104840|NCT00094809|38242683|FG001|Overall Study|Adverse Event|1|||
17104841|NCT00094809|38242682|FG000|Overall Study|Withdrawal by Subject|8|||
17104842|NCT00094809|38242683|FG001|Overall Study|Withdrawal by Subject|9|||
17104843|NCT00094809|38242682|FG000|Overall Study|Disease progression|3|||
17104844|NCT00094809|38242683|FG001|Overall Study|Disease progression|3|||
17104845|NCT00094809|38242682|FG000|Overall Study|Physician Decision|3|||
17104846|NCT00094809|38242683|FG001|Overall Study|Physician Decision|5|||
17104847|NCT00094809|38242682|FG000|Overall Study|Lost to Follow-up|6|||
17104848|NCT00094809|38242683|FG001|Overall Study|Lost to Follow-up|6|||
17104849|NCT00094809|38242682|FG000|Overall Study|Death|19|||
17104850|NCT00094809|38242683|FG001|Overall Study|Death|25|||
17104851|NCT00094809|38242682|FG000|Overall Study|Protocol-specified criteria|1|||
17104852|NCT00094809|38242683|FG001|Overall Study|Protocol-specified criteria|1|||
17104853|NCT00094809|38242682|FG000|Overall Study|Other|2|||
17104854|NCT00094809|38242683|FG001|Overall Study|Other|4|||
17104855|NCT00094809|38242682|FG000|Overall Study|Informed consent signed after treatment|1|||
17104856|NCT00094809|38242683|FG001|Overall Study|Informed consent signed after treatment|0|||
17104857|NCT00094809|38242682|FG000|Overall Study|Study drug not received|2|||
17104858|NCT00094809|38242683|FG001|Overall Study|Study drug not received|8|||
17104859|NCT00094809|38242682|FG000|Overall Study|Other|1|||
17104860|NCT00094809|38242683|FG001|Overall Study|Other|1|||
17104861|NCT00075218|38242691|FG000|Double-Blind Treatment|Adverse Event|23|||
17104862|NCT00075218|38242692|FG001|Double-Blind Treatment|Adverse Event|4|||
17104863|NCT00075218|38242693|FG002|Double-Blind Treatment|Adverse Event|0|||
17104864|NCT00075218|38242691|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
17104865|NCT00075218|38242692|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
17104866|NCT00075218|38242693|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
17104867|NCT00075218|38242691|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
17104868|NCT00075218|38242692|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
17104869|NCT00075218|38242693|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
17104870|NCT00075218|38242691|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
17104871|NCT00075218|38242692|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
17104872|NCT00075218|38242693|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
17104873|NCT00075218|38242691|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
17104874|NCT00075218|38242692|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
16937137|NCT01147744|38081854|FG001|Overall Study|Lack of Efficacy|11|||
16937138|NCT01147744|38081855|FG002|Overall Study|Lack of Efficacy|9|||
16937139|NCT01147744|38081856|FG003|Overall Study|Lack of Efficacy|11|||
16937140|NCT01147744|38081857|FG004|Overall Study|Lack of Efficacy|13|||
16937141|NCT01147744|38081858|FG005|Overall Study|Lack of Efficacy|8|||
16937142|NCT01147744|38081859|FG006|Overall Study|Lack of Efficacy|7|||
16937143|NCT01147744|38081853|FG000|Overall Study|Adverse Event|1|||
16937144|NCT01147744|38081854|FG001|Overall Study|Adverse Event|2|||
16937145|NCT01147744|38081855|FG002|Overall Study|Adverse Event|3|||
16937146|NCT01147744|38081856|FG003|Overall Study|Adverse Event|0|||
16937147|NCT01147744|38081857|FG004|Overall Study|Adverse Event|2|||
16937148|NCT01147744|38081858|FG005|Overall Study|Adverse Event|1|||
16937149|NCT01147744|38081859|FG006|Overall Study|Adverse Event|2|||
16937150|NCT01147744|38081853|FG000|Overall Study|Withdrawal by Subject|8|||
16937151|NCT01147744|38081854|FG001|Overall Study|Withdrawal by Subject|4|||
16937152|NCT01147744|38081855|FG002|Overall Study|Withdrawal by Subject|2|||
16937153|NCT01147744|38081856|FG003|Overall Study|Withdrawal by Subject|2|||
16937154|NCT01147744|38081857|FG004|Overall Study|Withdrawal by Subject|2|||
16937155|NCT01147744|38081858|FG005|Overall Study|Withdrawal by Subject|5|||
16937156|NCT01147744|38081859|FG006|Overall Study|Withdrawal by Subject|2|||
16937157|NCT01147744|38081853|FG000|Overall Study|Lost to Follow-up|0|||
16937158|NCT01147744|38081854|FG001|Overall Study|Lost to Follow-up|1|||
16937159|NCT01147744|38081855|FG002|Overall Study|Lost to Follow-up|0|||
16937160|NCT01147744|38081856|FG003|Overall Study|Lost to Follow-up|0|||
16937161|NCT01147744|38081857|FG004|Overall Study|Lost to Follow-up|0|||
17104875|NCT00075218|38242693|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
16937162|NCT01147744|38081858|FG005|Overall Study|Lost to Follow-up|0|||
16937163|NCT01147744|38081859|FG006|Overall Study|Lost to Follow-up|0|||
16937164|NCT01147744|38081853|FG000|Overall Study|Sponsor decision to amend protocol|7|||
16937165|NCT01147744|38081854|FG001|Overall Study|Sponsor decision to amend protocol|4|||
16937166|NCT01147744|38081855|FG002|Overall Study|Sponsor decision to amend protocol|2|||
16937167|NCT01147744|38081856|FG003|Overall Study|Sponsor decision to amend protocol|5|||
16937168|NCT01147744|38081857|FG004|Overall Study|Sponsor decision to amend protocol|7|||
16937169|NCT01147744|38081858|FG005|Overall Study|Sponsor decision to amend protocol|2|||
17104876|NCT00075218|38242691|FG000|Double-Blind Treatment|No study medication taken|2|||
17104877|NCT00075218|38242692|FG001|Double-Blind Treatment|No study medication taken|0|||
16937170|NCT01147744|38081859|FG006|Overall Study|Sponsor decision to amend protocol|6|||
16937171|NCT01147744|38081853|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16937172|NCT01147744|38081854|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16937173|NCT01147744|38081855|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16937174|NCT01147744|38081856|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16937175|NCT01147744|38081857|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16937176|NCT01147744|38081858|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16937177|NCT01147744|38081859|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16937178|NCT01147471|38081883|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
16937179|NCT01147471|38081884|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
16937180|NCT01147471|38081883|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
16937181|NCT01147471|38081884|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
16937182|NCT01147471|38081883|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
16937183|NCT01147471|38081884|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
16937184|NCT01147471|38081883|FG000|3 Month Follow Up|Lost to Follow-up|1|||
16937185|NCT01147471|38081884|FG001|3 Month Follow Up|Lost to Follow-up|1|||
16937186|NCT01147471|38081883|FG000|3 Month Follow Up|Physician Decision|0|||
16937187|NCT01147471|38081884|FG001|3 Month Follow Up|Physician Decision|1|||
16937188|NCT01147471|38081883|FG000|6 Month Follow Up|Lost to Follow-up|4|||
16937189|NCT01147471|38081884|FG001|6 Month Follow Up|Lost to Follow-up|2|||
16937190|NCT01147393|38081890|FG000|Dose Level 1|Dose limiting Toxicity|2|||
16937191|NCT01147393|38081890|FG000|Dose Level -1|Dose Limited Toxicity|1|||
16937192|NCT01146652|38081897|FG000|Overall Study|Adverse Event|506|||
16937193|NCT01146652|38081898|FG001|Overall Study|Adverse Event|15|||
16937194|NCT01146652|38081897|FG000|Overall Study|Lack of Efficacy|91|||
16937195|NCT01146652|38081898|FG001|Overall Study|Lack of Efficacy|7|||
16937196|NCT01146652|38081897|FG000|Overall Study|Poor compliance to protocol|38|||
16937197|NCT01146652|38081898|FG001|Overall Study|Poor compliance to protocol|1|||
16937198|NCT01146652|38081897|FG000|Overall Study|Other unspecified reasons|314|||
16937199|NCT01146652|38081898|FG001|Overall Study|Other unspecified reasons|22|||
16937200|NCT01146652|38081897|FG000|Overall Study|Enrolled but not treated|2|||
16937201|NCT01146652|38081898|FG001|Overall Study|Enrolled but not treated|0|||
16937202|NCT01146613|38081913|FG000|Overall Study|Lost to Follow-up|3|||
16937203|NCT01146613|38081914|FG001|Overall Study|Lost to Follow-up|8|||
16937204|NCT01146613|38081913|FG000|Overall Study|Lack of Efficacy|0|||
16937205|NCT01146613|38081914|FG001|Overall Study|Lack of Efficacy|1|||
16937206|NCT01146613|38081913|FG000|Overall Study|Death|1|||
16937207|NCT01146613|38081914|FG001|Overall Study|Death|0|||
16937208|NCT01146613|38081913|FG000|Overall Study|Physician Decision|1|||
16937209|NCT01146613|38081914|FG001|Overall Study|Physician Decision|0|||
16937210|NCT01146613|38081913|FG000|Overall Study|Withdrawal by Subject|0|||
16937211|NCT01146613|38081914|FG001|Overall Study|Withdrawal by Subject|3|||
16937212|NCT01146613|38081913|FG000|Overall Study|schedule conflict|1|||
16937213|NCT01146613|38081914|FG001|Overall Study|schedule conflict|0|||
16937214|NCT01146613|38081913|FG000|Overall Study|Outpatient detox|1|||
16937215|NCT01146613|38081914|FG001|Overall Study|Outpatient detox|0|||
16937216|NCT01145755|38081923|FG000|Overall Study|Adverse Event|2|||
16937217|NCT01145755|38081924|FG001|Overall Study|Adverse Event|4|||
16937218|NCT01145755|38081925|FG002|Overall Study|Adverse Event|2|||
16937219|NCT01145755|38081923|FG000|Overall Study|Withdrawal by Subject|2|||
16937220|NCT01145755|38081924|FG001|Overall Study|Withdrawal by Subject|2|||
16937221|NCT01145755|38081925|FG002|Overall Study|Withdrawal by Subject|2|||
16937222|NCT01145755|38081923|FG000|Overall Study|Lost to Follow-up|2|||
16937223|NCT01145755|38081924|FG001|Overall Study|Lost to Follow-up|3|||
16937224|NCT01145755|38081925|FG002|Overall Study|Lost to Follow-up|1|||
16937225|NCT01145755|38081923|FG000|Overall Study|Protocol Violation|0|||
16937226|NCT01145755|38081924|FG001|Overall Study|Protocol Violation|3|||
16937227|NCT01145755|38081925|FG002|Overall Study|Protocol Violation|1|||
16937228|NCT01145755|38081923|FG000|Overall Study|Study Closure|14|||
16937229|NCT01145755|38081924|FG001|Overall Study|Study Closure|14|||
16937230|NCT01145755|38081925|FG002|Overall Study|Study Closure|17|||
16937231|NCT01145755|38081923|FG000|Overall Study|Lack of Efficacy|0|||
16937232|NCT01145755|38081924|FG001|Overall Study|Lack of Efficacy|1|||
16937233|NCT01145755|38081925|FG002|Overall Study|Lack of Efficacy|0|||
16937234|NCT01145755|38081923|FG000|Overall Study|Patient could not swollow medication|0|||
16937235|NCT01145755|38081924|FG001|Overall Study|Patient could not swollow medication|0|||
16937236|NCT01145755|38081925|FG002|Overall Study|Patient could not swollow medication|1|||
16937237|NCT01145755|38081923|FG000|Overall Study|Withdrawal by Subject|0|||
16937238|NCT01145755|38081924|FG001|Overall Study|Withdrawal by Subject|0|||
16937239|NCT01145755|38081925|FG002|Overall Study|Withdrawal by Subject|1|||
16937240|NCT01145755|38081923|FG000|Overall Study|Positive urine ethanol|0|||
16937241|NCT01145755|38081924|FG001|Overall Study|Positive urine ethanol|1|||
16937242|NCT01145755|38081925|FG002|Overall Study|Positive urine ethanol|0|||
16937243|NCT01145560|38081936|FG000|Overall Study|Withdrawal by Subject|2|||
16937244|NCT01145560|38081937|FG001|Overall Study|Withdrawal by Subject|1|||
16937245|NCT01145560|38081938|FG002|Overall Study|Withdrawal by Subject|0|||
16937246|NCT01145560|38081936|FG000|Overall Study|Lost to Follow-up|1|||
16937247|NCT01145560|38081937|FG001|Overall Study|Lost to Follow-up|1|||
16937248|NCT01145560|38081938|FG002|Overall Study|Lost to Follow-up|1|||
16937249|NCT01145560|38081936|FG000|Overall Study|No study drug by 24h after organ failure|1|||
16937250|NCT01145560|38081937|FG001|Overall Study|No study drug by 24h after organ failure|0|||
16937251|NCT01145560|38081938|FG002|Overall Study|No study drug by 24h after organ failure|0|||
16937252|NCT01145560|38081936|FG000|Overall Study|Accidental unblinding of study treatment|0|||
16937253|NCT01145560|38081937|FG001|Overall Study|Accidental unblinding of study treatment|1|||
16937254|NCT01145560|38081938|FG002|Overall Study|Accidental unblinding of study treatment|0|||
16937255|NCT01145560|38081936|FG000|Overall Study|False insurance information|0|||
16937256|NCT01145560|38081937|FG001|Overall Study|False insurance information|1|||
16937257|NCT01145560|38081938|FG002|Overall Study|False insurance information|0|||
16937258|NCT01145560|38081936|FG000|Overall Study|Withdrawal of therapy|0|||
16937259|NCT01145560|38081937|FG001|Overall Study|Withdrawal of therapy|0|||
16937260|NCT01145560|38081938|FG002|Overall Study|Withdrawal of therapy|1|||
16937261|NCT01145482|38081948|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
16937262|NCT01145482|38081949|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
16937263|NCT01145053|38081955|FG000|Overall Study|Adverse Event|22|||
16937264|NCT01145053|38081955|FG000|Overall Study|Lost to Follow-up|28|||
16937265|NCT01145053|38081955|FG000|Overall Study|Withdrawal by Subject|25|||
16937266|NCT01145053|38081955|FG000|Overall Study|Other|18|||
16937267|NCT01144663|38081963|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
16937268|NCT01144663|38081964|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
16937269|NCT01144663|38081965|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
16937270|NCT01144663|38081966|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
16937271|NCT01144663|38081963|FG000|Primary Vaccination Phase|Adverse Event|1|||
16937272|NCT01144663|38081964|FG001|Primary Vaccination Phase|Adverse Event|0|||
16937273|NCT01144663|38081965|FG002|Primary Vaccination Phase|Adverse Event|0|||
16937274|NCT01144663|38081966|FG003|Primary Vaccination Phase|Adverse Event|1|||
16937275|NCT01144663|38081963|FG000|Primary Vaccination Phase|Protocol Violation|2|||
16937276|NCT01144663|38081964|FG001|Primary Vaccination Phase|Protocol Violation|0|||
16937277|NCT01144663|38081965|FG002|Primary Vaccination Phase|Protocol Violation|1|||
16937278|NCT01144663|38081966|FG003|Primary Vaccination Phase|Protocol Violation|0|||
16937279|NCT01144663|38081963|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
16937280|NCT01144663|38081964|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
16937281|NCT01144663|38081965|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
16937282|NCT01144663|38081966|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
16937283|NCT01144663|38081963|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
16937284|NCT01144663|38081964|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
16937285|NCT01144663|38081965|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
16937286|NCT01144663|38081966|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
16937287|NCT01144663|38081963|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
16937288|NCT01144663|38081964|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
16937289|NCT01144663|38081965|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
16937290|NCT01144663|38081966|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
16937291|NCT01144663|38081963|FG000|Primary Vaccination Phase|Other|0|||
16937292|NCT01144663|38081964|FG001|Primary Vaccination Phase|Other|1|||
16937293|NCT01144663|38081965|FG002|Primary Vaccination Phase|Other|0|||
16937294|NCT01144663|38081966|FG003|Primary Vaccination Phase|Other|2|||
16937295|NCT01144663|38081963|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
16937296|NCT01144663|38081964|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
16937297|NCT01144663|38081965|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
16937298|NCT01144663|38081966|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
16937299|NCT01144663|38081963|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
16937300|NCT01144663|38081964|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
16937301|NCT01144663|38081965|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
16937302|NCT01144663|38081966|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
16937303|NCT01144663|38081963|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
16937304|NCT01144663|38081964|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
16937305|NCT01144663|38081965|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
16937306|NCT01144663|38081966|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
16937307|NCT01144663|38081963|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
16937308|NCT01144663|38081964|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
16937309|NCT01144663|38081965|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
16937310|NCT01144663|38081966|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
16937311|NCT01144663|38081963|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
16937312|NCT01144663|38081964|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
16937313|NCT01144663|38081965|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
16937314|NCT01144663|38081966|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
16937315|NCT01144663|38081963|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
16937316|NCT01144663|38081964|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
16937317|NCT01144663|38081965|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
16937318|NCT01144663|38081966|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
16937319|NCT01143337|38081978|FG000|Overall Study|Adverse Event|3|||
16937320|NCT01143337|38081979|FG001|Overall Study|Adverse Event|9|||
16937321|NCT01143337|38081980|FG002|Overall Study|Adverse Event|5|||
16937322|NCT01143337|38081978|FG000|Overall Study|Lack of Efficacy|6|||
16937323|NCT01143337|38081979|FG001|Overall Study|Lack of Efficacy|2|||
16937324|NCT01143337|38081980|FG002|Overall Study|Lack of Efficacy|1|||
16937325|NCT01143337|38081978|FG000|Overall Study|Protocol Violation|1|||
16937326|NCT01143337|38081979|FG001|Overall Study|Protocol Violation|0|||
16937327|NCT01143337|38081980|FG002|Overall Study|Protocol Violation|0|||
16937328|NCT01143337|38081978|FG000|Overall Study|Withdrawal by Subject|0|||
16937329|NCT01143337|38081979|FG001|Overall Study|Withdrawal by Subject|0|||
16937330|NCT01143337|38081980|FG002|Overall Study|Withdrawal by Subject|1|||
16937331|NCT01143337|38081978|FG000|Overall Study|Other reason|0|||
16937332|NCT01143337|38081979|FG001|Overall Study|Other reason|0|||
16937333|NCT01143337|38081980|FG002|Overall Study|Other reason|5|||
16937334|NCT01143259|38081988|FG000|Overall Study|Withdrawal by Subject|3|||
16937335|NCT01143259|38081989|FG001|Overall Study|Withdrawal by Subject|2|||
16937336|NCT01143259|38081988|FG000|Overall Study|Protocol Violation|13|||
16937337|NCT01143259|38081989|FG001|Overall Study|Protocol Violation|9|||
16937338|NCT01143259|38081988|FG000|Overall Study|Screen Failure|7|||
16937339|NCT01143259|38081989|FG001|Overall Study|Screen Failure|9|||
16937340|NCT01142908|38081997|FG000|Overall Study|Lost to Follow-up|19|||
16937341|NCT01142908|38081998|FG001|Overall Study|Lost to Follow-up|13|||
16937342|NCT01142908|38081997|FG000|Overall Study|Death|1|||
16937343|NCT01142908|38081998|FG001|Overall Study|Death|4|||
16937344|NCT01142908|38081997|FG000|Overall Study|Excluded - did not meet criteria|9|||
16937345|NCT01142908|38081998|FG001|Overall Study|Excluded - did not meet criteria|5|||
16937346|NCT01142908|38081997|FG000|Overall Study|Withdrawal by Subject|3|||
16937347|NCT01142908|38081998|FG001|Overall Study|Withdrawal by Subject|0|||
16937348|NCT01142791|38082004|FG000|Overall Study|Alternative Treatment|1|||
16937349|NCT01142791|38082005|FG001|Overall Study|Alternative Treatment|0|||
16937350|NCT01142791|38082004|FG000|Overall Study|Lost to Follow-up|1|||
16937351|NCT01142791|38082005|FG001|Overall Study|Lost to Follow-up|0|||
16937352|NCT01142791|38082004|FG000|Overall Study|Withdrawal by Subject|5|||
16937353|NCT01142791|38082005|FG001|Overall Study|Withdrawal by Subject|0|||
16937354|NCT01142791|38082004|FG000|Overall Study|Received only 1 sonication|0|||
16937355|NCT01142791|38082005|FG001|Overall Study|Received only 1 sonication|6|||
16937356|NCT01142596|38082011|FG000|Overall Study|Withdrawal by Subject|9|||
16937357|NCT01142596|38082012|FG001|Overall Study|Withdrawal by Subject|35|||
16937358|NCT01142596|38082011|FG000|Overall Study|Adverse Event|8|||
16937359|NCT01142596|38082012|FG001|Overall Study|Adverse Event|35|||
16937360|NCT01142596|38082011|FG000|Overall Study|Lack of Efficacy|5|||
16937361|NCT01142596|38082012|FG001|Overall Study|Lack of Efficacy|9|||
16937362|NCT01142596|38082011|FG000|Overall Study|Lost to Follow-up|2|||
16937363|NCT01142596|38082012|FG001|Overall Study|Lost to Follow-up|3|||
16937364|NCT01142596|38082011|FG000|Overall Study|Other reason (not specified)|5|||
16937365|NCT01142596|38082012|FG001|Overall Study|Other reason (not specified)|4|||
16937366|NCT01142128|38082022|FG000|Overall Study|Physician Decision|1|||
16937367|NCT01142128|38082022|FG000|Overall Study|Lost to Follow-up|1|||
16937368|NCT01142128|38082022|FG000|Overall Study|Withdrawal by Subject|2|||
16937369|NCT01142089|38082034|FG000|Overall Study|Physician Decision|1|||
16937370|NCT01142089|38082035|FG001|Overall Study|Physician Decision|0|||
16937371|NCT01142089|38082034|FG000|Overall Study|Withdrawal by Subject|1|||
16937372|NCT01142089|38082035|FG001|Overall Study|Withdrawal by Subject|2|||
16937373|NCT01142089|38082034|FG000|Overall Study|Use of prohibited medications|0|||
16937374|NCT01142089|38082035|FG001|Overall Study|Use of prohibited medications|1|||
17104878|NCT00075218|38242693|FG002|Double-Blind Treatment|No study medication taken|0|||
17104879|NCT00075218|38242691|FG000|Open-Label Treatment|Lack of Efficacy|0|||
17104880|NCT00075218|38242692|FG001|Open-Label Treatment|Lack of Efficacy|0|||
17104881|NCT00075218|38242693|FG002|Open-Label Treatment|Lack of Efficacy|174|||
17104882|NCT00075218|38242691|FG000|Open-Label Treatment|Adverse Event|0|||
16937375|NCT01142089|38082034|FG000|Overall Study|Noncompliance with study procedures|2|||
16937376|NCT01142089|38082035|FG001|Overall Study|Noncompliance with study procedures|1|||
16937377|NCT01142089|38082034|FG000|Overall Study|Patient required rescue medication|8|||
16937378|NCT01142089|38082035|FG001|Overall Study|Patient required rescue medication|17|||
16937379|NCT01141660|38082043|FG000|Overall Study|Physician Decision|0|||
16937380|NCT01141660|38082044|FG001|Overall Study|Physician Decision|12|||
16937381|NCT01140880|38082052|FG000|Overall Study|Death|0|||
16937382|NCT01140880|38082053|FG001|Overall Study|Death|1|||
16937383|NCT01140880|38082052|FG000|Overall Study|Withdrawal by Subject|6|||
16937384|NCT01140880|38082053|FG001|Overall Study|Withdrawal by Subject|3|||
16937385|NCT01140880|38082052|FG000|Overall Study|Lost to Follow-up|8|||
16937386|NCT01140880|38082053|FG001|Overall Study|Lost to Follow-up|10|||
16937387|NCT01140880|38082052|FG000|Overall Study|Protocol Violation|0|||
16937388|NCT01140880|38082053|FG001|Overall Study|Protocol Violation|30|||
16937389|NCT01140646|38082059|FG000|Overall Study|Adverse Event|4|||
16937390|NCT01140646|38082059|FG000|Overall Study|Refused Further Treatment|5|||
16937391|NCT01140568|38082063|FG000|Overall Study|disease progression|31|||
16937392|NCT01140568|38082063|FG000|Overall Study|Withdrawal by Subject|1|||
16937393|NCT01140568|38082063|FG000|Overall Study|Screen Fail|4|||
16937394|NCT01140451|38082069|FG000|Overall Study|Withdrawal by Subject|26|||
16937395|NCT01140451|38082070|FG001|Overall Study|Withdrawal by Subject|33|||
16937396|NCT01140451|38082069|FG000|Overall Study|Adverse Event|2|||
16937397|NCT01140451|38082070|FG001|Overall Study|Adverse Event|6|||
16937398|NCT01140451|38082069|FG000|Overall Study|Physician Decision|5|||
16937399|NCT01140451|38082070|FG001|Overall Study|Physician Decision|3|||
16937400|NCT01140451|38082069|FG000|Overall Study|Lost to Follow-up|2|||
16937401|NCT01140451|38082070|FG001|Overall Study|Lost to Follow-up|0|||
16937402|NCT01140451|38082069|FG000|Overall Study|Participants Planning Pregnancy|3|||
16937403|NCT01140451|38082070|FG001|Overall Study|Participants Planning Pregnancy|0|||
16937404|NCT01140061|38082087|FG000|Part I|Adverse Event|1|||
16937405|NCT01140061|38082088|FG001|Part I|Adverse Event|0|||
16937406|NCT01140061|38082089|FG002|Part I|Adverse Event|0|||
16937407|NCT01140061|38082090|FG003|Part I|Adverse Event|0|||
16937408|NCT01140061|38082091|FG004|Part I|Adverse Event|0|||
16937409|NCT01140061|38082092|FG005|Part I|Adverse Event|0|||
16937410|NCT01140061|38082093|FG006|Part I|Adverse Event|0|||
16937411|NCT01140061|38082094|FG007|Part I|Adverse Event|0|||
16937412|NCT01140061|38082095|FG008|Part I|Adverse Event|0|||
16937413|NCT01140061|38082096|FG009|Part I|Adverse Event|0|||
16937414|NCT01140061|38082087|FG000|Extension|Laboratory Adverse Event|0|||
16937415|NCT01140061|38082088|FG001|Extension|Laboratory Adverse Event|0|||
16937416|NCT01140061|38082089|FG002|Extension|Laboratory Adverse Event|0|||
16937417|NCT01140061|38082090|FG003|Extension|Laboratory Adverse Event|0|||
16937418|NCT01140061|38082091|FG004|Extension|Laboratory Adverse Event|0|||
16937419|NCT01140061|38082092|FG005|Extension|Laboratory Adverse Event|0|||
16937420|NCT01140061|38082093|FG006|Extension|Laboratory Adverse Event|0|||
16937421|NCT01140061|38082094|FG007|Extension|Laboratory Adverse Event|0|||
16937422|NCT01140061|38082095|FG008|Extension|Laboratory Adverse Event|0|||
16937423|NCT01140061|38082096|FG009|Extension|Laboratory Adverse Event|1|||
16937424|NCT01139164|38082114|FG000|Overall Study|Withdrawn prior to study start|0|||
16937425|NCT01139164|38082115|FG001|Overall Study|Withdrawn prior to study start|2|||
16937426|NCT01139164|38082116|FG002|Overall Study|Withdrawn prior to study start|0|||
16937427|NCT01139125|38082124|FG000|Overall Study|Withdrawal by Subject|1|||
16937428|NCT01139047|38082128|FG000|Overall Study|Withdrawal by Subject|1|||
16937429|NCT01139008|38082135|FG000|Overall Study|Withdrawal by Subject|5|||
16937430|NCT01139008|38082135|FG000|Overall Study|Non-compliant, lost product|1|||
16937431|NCT01138657|38082144|FG000|Overall Study|Adverse Event|3|||
16937432|NCT01138657|38082145|FG001|Overall Study|Adverse Event|10|||
16937433|NCT01138657|38082144|FG000|Overall Study|Lack of Efficacy|2|||
16937434|NCT01138657|38082145|FG001|Overall Study|Lack of Efficacy|1|||
16937435|NCT01138657|38082144|FG000|Overall Study|Lost to Follow-up|0|||
16937436|NCT01138657|38082145|FG001|Overall Study|Lost to Follow-up|3|||
16937437|NCT01138657|38082144|FG000|Overall Study|Miscellaneous Reasons|3|||
16937438|NCT01138657|38082145|FG001|Overall Study|Miscellaneous Reasons|4|||
16937439|NCT01138501|38082153|FG000|Overall Study|Protocol Violation|2|||
16937440|NCT01138501|38082153|FG000|Overall Study|Withdrawal by Subject|3|||
16937441|NCT01138150|38082159|FG000|Overall Study|blood unable to be processed|0|||
16937442|NCT01138150|38082160|FG001|Overall Study|blood unable to be processed|1|||
16937443|NCT01138150|38082159|FG000|Overall Study|Physician Decision|1|||
16937444|NCT01138150|38082160|FG001|Overall Study|Physician Decision|0|||
16937445|NCT01138111|38082176|FG000|Overall Study|Withdrawal by Subject|5|||
16937446|NCT01138111|38082176|FG000|Overall Study|Adverse Event|1|||
16937447|NCT01138111|38082176|FG000|Overall Study|Death|1|||
16937448|NCT01138111|38082176|FG000|Overall Study|Lost to Follow-up|2|||
16937449|NCT01137955|38082207|FG000|Overall Study|Withdrawal by Subject|5|||
16937450|NCT01137955|38082208|FG001|Overall Study|Withdrawal by Subject|4|||
16937451|NCT01137682|38082218|FG000|Overall Study|Adverse Event-CORE|2|||
16937452|NCT01137682|38082219|FG001|Overall Study|Adverse Event-CORE|4|||
16937453|NCT01137682|38082220|FG002|Overall Study|Adverse Event-CORE|0|||
16937454|NCT01137682|38082218|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
16937455|NCT01137682|38082219|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
16937456|NCT01137682|38082220|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
16937457|NCT01137682|38082218|FG000|Overall Study|Administrative problems-CORE|2|||
16937458|NCT01137682|38082219|FG001|Overall Study|Administrative problems-CORE|1|||
16937459|NCT01137682|38082220|FG002|Overall Study|Administrative problems-CORE|0|||
16937460|NCT01137682|38082218|FG000|Overall Study|Protocol Violation-CORE|0|||
16937461|NCT01137682|38082219|FG001|Overall Study|Protocol Violation-CORE|1|||
16937462|NCT01137682|38082220|FG002|Overall Study|Protocol Violation-CORE|1|||
16937463|NCT01137682|38082218|FG000|Overall Study|Adverse Event-Extension|4|||
16937464|NCT01137682|38082219|FG001|Overall Study|Adverse Event-Extension|8|||
16937465|NCT01137682|38082220|FG002|Overall Study|Adverse Event-Extension|7|||
16937466|NCT01137682|38082218|FG000|Overall Study|Lack of Efficacy-Extension|15|||
16937467|NCT01137682|38082219|FG001|Overall Study|Lack of Efficacy-Extension|9|||
16937468|NCT01137682|38082220|FG002|Overall Study|Lack of Efficacy-Extension|13|||
16937469|NCT01137682|38082218|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
16937470|NCT01137682|38082219|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
16937471|NCT01137682|38082220|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
16937472|NCT01137682|38082218|FG000|Overall Study|Lost to Follow Up-Extension|0|||
16937473|NCT01137682|38082219|FG001|Overall Study|Lost to Follow Up-Extension|1|||
16937474|NCT01137682|38082220|FG002|Overall Study|Lost to Follow Up-Extension|0|||
16937475|NCT01137682|38082218|FG000|Overall Study|Administrative problems-Extension|0|||
16937476|NCT01137682|38082219|FG001|Overall Study|Administrative problems-Extension|2|||
16937477|NCT01137682|38082220|FG002|Overall Study|Administrative problems-Extension|0|||
16937478|NCT01137682|38082218|FG000|Overall Study|Death-Extension|2|||
16937479|NCT01137682|38082219|FG001|Overall Study|Death-Extension|0|||
16937480|NCT01137682|38082220|FG002|Overall Study|Death-Extension|0|||
16937481|NCT01137682|38082218|FG000|Overall Study|Protocol Violation-Extension|2|||
16937482|NCT01137682|38082219|FG001|Overall Study|Protocol Violation-Extension|1|||
16937483|NCT01137682|38082220|FG002|Overall Study|Protocol Violation-Extension|0|||
16937484|NCT01137682|38082218|FG000|Overall Study|Did not enter extension|2|||
16937485|NCT01137682|38082219|FG001|Overall Study|Did not enter extension|3|||
16937486|NCT01137682|38082220|FG002|Overall Study|Did not enter extension|2|||
16937487|NCT01137682|38082218|FG000|Overall Study|Did not receive treatment in extension|0|||
16937488|NCT01137682|38082219|FG001|Overall Study|Did not receive treatment in extension|0|||
16937489|NCT01137682|38082220|FG002|Overall Study|Did not receive treatment in extension|1|||
16937490|NCT03452397|38082236|FG000|Overall Study|Adverse Event|1|||
16937491|NCT03452397|38082237|FG001|Overall Study|Adverse Event|0|||
16937492|NCT03452397|38082238|FG002|Overall Study|Adverse Event|0|||
16937493|NCT03452397|38082239|FG003|Overall Study|Adverse Event|0|||
16937494|NCT03452397|38082236|FG000|Overall Study|Administrative reason|0|||
16937495|NCT03452397|38082237|FG001|Overall Study|Administrative reason|0|||
16937496|NCT03452397|38082238|FG002|Overall Study|Administrative reason|1|||
16937497|NCT03452397|38082239|FG003|Overall Study|Administrative reason|1|||
16937498|NCT03452397|38082236|FG000|Overall Study|Withdrawal by Subject|0|||
16937499|NCT03452397|38082237|FG001|Overall Study|Withdrawal by Subject|0|||
16937500|NCT03452397|38082238|FG002|Overall Study|Withdrawal by Subject|1|||
16937501|NCT03452397|38082239|FG003|Overall Study|Withdrawal by Subject|0|||
16937502|NCT00199875|38082273|FG000|Overall Study|Withdrawal by Subject|0|||
16937503|NCT00199875|38082274|FG001|Overall Study|Withdrawal by Subject|0|||
16937504|NCT00199875|38082275|FG002|Overall Study|Withdrawal by Subject|0|||
16937505|NCT00199875|38082276|FG003|Overall Study|Withdrawal by Subject|0|||
16937506|NCT00199875|38082277|FG004|Overall Study|Withdrawal by Subject|1|||
16937507|NCT00199836|38082289|FG000|Overall Study|Progressive Disease|5|||
16937508|NCT00199836|38082289|FG000|Overall Study|Death|1|||
16937509|NCT00199797|38082294|FG000|Overall Study|Progressive Disease|1|||
16937510|NCT00199797|38082294|FG000|Overall Study|Adverse Event|1|||
16937511|NCT00199797|38082294|FG000|Overall Study|Physician Decision|1|||
16937512|NCT01137604|38082303|FG000|Overall Study|Adverse Event|3|||
16937513|NCT01137604|38082304|FG001|Overall Study|Adverse Event|6|||
16937514|NCT01137604|38082305|FG002|Overall Study|Adverse Event|9|||
16937515|NCT01137604|38082306|FG003|Overall Study|Adverse Event|9|||
16937516|NCT01137604|38082303|FG000|Overall Study|Participant Choice|0|||
16937517|NCT01137604|38082304|FG001|Overall Study|Participant Choice|2|||
16937518|NCT01137604|38082305|FG002|Overall Study|Participant Choice|2|||
16937519|NCT01137604|38082306|FG003|Overall Study|Participant Choice|0|||
16937520|NCT01137604|38082303|FG000|Overall Study|Withdrawal of consent|0|||
16937521|NCT01137604|38082304|FG001|Overall Study|Withdrawal of consent|0|||
16937522|NCT01137604|38082305|FG002|Overall Study|Withdrawal of consent|0|||
16937523|NCT01137604|38082306|FG003|Overall Study|Withdrawal of consent|2|||
16937524|NCT01137604|38082303|FG000|Overall Study|Clinical progression/deterioration|1|||
16937525|NCT01137604|38082304|FG001|Overall Study|Clinical progression/deterioration|2|||
16937526|NCT01137604|38082305|FG002|Overall Study|Clinical progression/deterioration|2|||
16937527|NCT01137604|38082306|FG003|Overall Study|Clinical progression/deterioration|0|||
16937528|NCT00198822|38082319|FG000|Overall Study|Lost to Follow-up|14|||
16937529|NCT00198822|38082320|FG001|Overall Study|Lost to Follow-up|20|||
16937530|NCT00198822|38082321|FG002|Overall Study|Lost to Follow-up|21|||
16937531|NCT01137292|38082329|FG000|Overall Study|Death|30|||
16937532|NCT01137292|38082329|FG000|Overall Study|Adverse Event|3|||
17104883|NCT00075218|38242692|FG001|Open-Label Treatment|Adverse Event|0|||
17104884|NCT00075218|38242693|FG002|Open-Label Treatment|Adverse Event|51|||
16937533|NCT01137292|38082329|FG000|Overall Study|Lack of Efficacy|13|||
16937534|NCT01137292|38082329|FG000|Overall Study|Lost to Follow-up|1|||
16937535|NCT01137292|38082329|FG000|Overall Study|Other|7|||
16937536|NCT00197496|38082335|FG000|Baseline to Discharge|not interested|1|||
16937537|NCT00197496|38082336|FG001|Baseline to Discharge|not interested|0|||
16937538|NCT00197496|38082335|FG000|Baseline to Discharge|MRSA|1|||
16937539|NCT00197496|38082336|FG001|Baseline to Discharge|MRSA|0|||
16937540|NCT00197496|38082335|FG000|Baseline to Discharge|Physician Decision|0|||
16937541|NCT00197496|38082336|FG001|Baseline to Discharge|Physician Decision|1|||
16937542|NCT00197496|38082335|FG000|Baseline to Discharge|Protocol Violation|0|||
16937543|NCT00197496|38082336|FG001|Baseline to Discharge|Protocol Violation|1|||
16937544|NCT00197496|38082335|FG000|Follow-up|Lost to Follow-up|2|||
16937545|NCT00197496|38082336|FG001|Follow-up|Lost to Follow-up|1|||
16937546|NCT00197145|38082344|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
16937547|NCT00197145|38082345|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
16937548|NCT00197145|38082344|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
16937549|NCT00197145|38082345|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
16937550|NCT00197145|38082344|FG000|Period 1: Randomized Treatment Phase|Other|2|||
16937551|NCT00197145|38082345|FG001|Period 1: Randomized Treatment Phase|Other|2|||
16937552|NCT00197145|38082344|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
16937553|NCT00197145|38082345|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
16937554|NCT00197145|38082344|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
16937555|NCT00197145|38082345|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
16937556|NCT00197145|38082344|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
16937557|NCT00197145|38082345|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
16937558|NCT00197145|38082344|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
16937559|NCT00197145|38082345|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
16937560|NCT00197145|38082344|FG000|Period 2 : Open Label Phase|Other|1|||
16937561|NCT00197145|38082345|FG001|Period 2 : Open Label Phase|Other|0|||
16937562|NCT01136785|38082354|FG000|Overall Study|Protocol Violation|2|||
16937563|NCT01136785|38082355|FG001|Overall Study|Protocol Violation|1|||
16937564|NCT00197106|38082367|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
16937565|NCT00197106|38082368|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
16937566|NCT00197106|38082369|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
16937567|NCT00197106|38082367|FG000|Overall Treatment Period|Lack of Efficacy|0|||
16937568|NCT00197106|38082368|FG001|Overall Treatment Period|Lack of Efficacy|1|||
16937569|NCT00197106|38082369|FG002|Overall Treatment Period|Lack of Efficacy|0|||
16937570|NCT00197106|38082367|FG000|Overall Treatment Period|Lost to Follow-up|0|||
16937571|NCT00197106|38082368|FG001|Overall Treatment Period|Lost to Follow-up|0|||
16937572|NCT00197106|38082369|FG002|Overall Treatment Period|Lost to Follow-up|2|||
16937573|NCT00197106|38082367|FG000|Overall Treatment Period|Protocol Violation|0|||
16937574|NCT00197106|38082368|FG001|Overall Treatment Period|Protocol Violation|0|||
16937575|NCT00197106|38082369|FG002|Overall Treatment Period|Protocol Violation|2|||
16937576|NCT00197106|38082367|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
16937577|NCT00197106|38082368|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
16937578|NCT00197106|38082369|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
16937579|NCT01136746|38082377|FG000|Overall Study|Lost to Follow-up|0|||
16937580|NCT01136746|38082378|FG001|Overall Study|Lost to Follow-up|2|||
16937581|NCT01136746|38082377|FG000|Overall Study|Protocol Violation|2|||
16937582|NCT01136746|38082378|FG001|Overall Study|Protocol Violation|1|||
16937583|NCT01136746|38082377|FG000|Overall Study|Death|1|||
16937584|NCT01136746|38082378|FG001|Overall Study|Death|0|||
16937585|NCT01136356|38082384|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
16937586|NCT01136356|38082385|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
16937587|NCT01136356|38082384|FG000|First 18-day Withdrawal|Physician Decision|1|||
16937588|NCT01136356|38082385|FG001|First 18-day Withdrawal|Physician Decision|0|||
16937589|NCT01136356|38082384|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
16937590|NCT01136356|38082385|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
16937591|NCT00196326|38082390|FG000|Overall Study|Did not meet protocol requirements|64|||
16937592|NCT00196326|38082390|FG000|Overall Study|Non-compliance with the protocol|81|||
16937593|NCT00196326|38082390|FG000|Overall Study|Physician Decision|3|||
16937594|NCT00196326|38082390|FG000|Overall Study|Withdrawal by Subject|225|||
16937595|NCT00196326|38082390|FG000|Overall Study|Adverse Event|253|||
16937596|NCT00196326|38082390|FG000|Overall Study|Pregnancy|34|||
16937597|NCT00196326|38082390|FG000|Overall Study|Lost to Follow-up|304|||
16937598|NCT00196326|38082390|FG000|Overall Study|Other|22|||
16937599|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
16937600|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
16937601|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
16937602|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Death|0|||
16937603|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Death|2|||
16937604|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Death|0|||
16937605|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
16937606|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
16937607|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
16937608|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
16937609|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
16937610|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
16937611|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
16937612|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
16937613|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
16937614|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
16937615|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
16937616|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
16937617|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
16937618|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
16937619|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
16937620|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Recovery|1|||
16937621|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Recovery|0|||
16937622|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Recovery|1|||
16937623|NCT00195663|38082397|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
16937624|NCT00195663|38082398|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
16937625|NCT00195663|38082399|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
16937626|NCT00195663|38082397|FG000|Open-Label Extension Period|Adverse Event|21|||
16937627|NCT00195663|38082398|FG001|Open-Label Extension Period|Adverse Event|32|||
16937628|NCT00195663|38082399|FG002|Open-Label Extension Period|Adverse Event|36|||
16937629|NCT00195663|38082397|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
16937630|NCT00195663|38082398|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
16937631|NCT00195663|38082399|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
16937632|NCT00195663|38082397|FG000|Open-Label Extension Period|Recovery|0|||
16937633|NCT00195663|38082398|FG001|Open-Label Extension Period|Recovery|2|||
16937634|NCT00195663|38082399|FG002|Open-Label Extension Period|Recovery|2|||
16937635|NCT00195663|38082397|FG000|Open-Label Extension Period|Protocol Violation|3|||
16937636|NCT00195663|38082398|FG001|Open-Label Extension Period|Protocol Violation|4|||
16937637|NCT00195663|38082399|FG002|Open-Label Extension Period|Protocol Violation|4|||
16937638|NCT00195663|38082397|FG000|Open-Label Extension Period|Death|2|||
16937639|NCT00195663|38082398|FG001|Open-Label Extension Period|Death|2|||
16937640|NCT00195663|38082399|FG002|Open-Label Extension Period|Death|2|||
16937641|NCT00195663|38082397|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
16937642|NCT00195663|38082398|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
16937643|NCT00195663|38082399|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
16937644|NCT00195663|38082397|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
16937645|NCT00195663|38082398|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
16937646|NCT00195663|38082399|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
16937647|NCT00195663|38082397|FG000|Open-Label Extension Period|Administrative reasons|11|||
16937648|NCT00195663|38082398|FG001|Open-Label Extension Period|Administrative reasons|11|||
16937649|NCT00195663|38082399|FG002|Open-Label Extension Period|Administrative reasons|13|||
16937650|NCT01135498|38082417|FG000|Overall Study|Adverse Event|20|||
16937651|NCT01135498|38082417|FG000|Overall Study|Progressive disease|38|||
16937652|NCT01135498|38082417|FG000|Overall Study|Investigator judgement|25|||
16937653|NCT01135498|38082417|FG000|Overall Study|Withdrawal by Subject|4|||
16937654|NCT01135498|38082417|FG000|Overall Study|Death|1|||
16937655|NCT01135498|38082417|FG000|Overall Study|Ongoing at time of analysis|2|||
16937656|NCT00195507|38082424|FG000|Overall Study|Adverse Event|24|||
16937657|NCT00195507|38082425|FG001|Overall Study|Adverse Event|13|||
16937658|NCT00195507|38082424|FG000|Overall Study|Death|0|||
16937659|NCT00195507|38082425|FG001|Overall Study|Death|1|||
16937660|NCT00195507|38082424|FG000|Overall Study|Failed to Return|4|||
16937661|NCT00195507|38082425|FG001|Overall Study|Failed to Return|3|||
16937662|NCT00195507|38082424|FG000|Overall Study|Physician Decision|1|||
16937663|NCT00195507|38082425|FG001|Overall Study|Physician Decision|2|||
16937664|NCT00195507|38082424|FG000|Overall Study|Lost to Follow-up|3|||
16937665|NCT00195507|38082425|FG001|Overall Study|Lost to Follow-up|2|||
16937666|NCT00195507|38082424|FG000|Overall Study|Protocol Violation|5|||
16937667|NCT00195507|38082425|FG001|Overall Study|Protocol Violation|4|||
16937668|NCT00195507|38082424|FG000|Overall Study|Lack of Efficacy|40|||
16937669|NCT00195507|38082425|FG001|Overall Study|Lack of Efficacy|67|||
16937670|NCT00195507|38082424|FG000|Overall Study|Withdrawal by Subject|16|||
16937671|NCT00195507|38082425|FG001|Overall Study|Withdrawal by Subject|23|||
16937672|NCT00195507|38082424|FG000|Overall Study|Protocol Deviation|6|||
16937673|NCT00195507|38082425|FG001|Overall Study|Protocol Deviation|3|||
16937674|NCT01134562|38082436|FG000|Overall Study|Adverse Event|0|||
16937675|NCT01134562|38082437|FG001|Overall Study|Adverse Event|1|||
16937676|NCT01134562|38082438|FG002|Overall Study|Adverse Event|0|||
16937677|NCT01134562|38082439|FG003|Overall Study|Adverse Event|0|||
16937678|NCT01134562|38082440|FG004|Overall Study|Adverse Event|0|||
16937679|NCT00195429|38082467|FG000|Overall Study|Adverse Event|2|||
16937680|NCT00195429|38082468|FG001|Overall Study|Adverse Event|4|||
16937681|NCT00195429|38082467|FG000|Overall Study|Lack of Efficacy|2|||
16937682|NCT00195429|38082468|FG001|Overall Study|Lack of Efficacy|1|||
16937683|NCT00195429|38082467|FG000|Overall Study|Lost to Follow-up|1|||
16937684|NCT00195429|38082468|FG001|Overall Study|Lost to Follow-up|0|||
16937685|NCT00195351|38082476|FG000|Overall Study|Lost to Follow-up|9|||
16937686|NCT00195351|38082477|FG001|Overall Study|Lost to Follow-up|9|||
16937687|NCT00195351|38082476|FG000|Overall Study|Withdrawal by Subject|6|||
16937688|NCT00195351|38082477|FG001|Overall Study|Withdrawal by Subject|3|||
16937689|NCT00195351|38082476|FG000|Overall Study|Protocol Deviation|3|||
16937690|NCT00195351|38082477|FG001|Overall Study|Protocol Deviation|2|||
16937691|NCT00195351|38082476|FG000|Overall Study|Death|3|||
16937692|NCT00195351|38082477|FG001|Overall Study|Death|1|||
16937693|NCT00195351|38082476|FG000|Overall Study|Lack of Efficacy|0|||
16937694|NCT00195351|38082477|FG001|Overall Study|Lack of Efficacy|1|||
16937695|NCT00195273|38082485|FG000|Overall Study|Adverse Event|9|||
16937696|NCT00195273|38082486|FG001|Overall Study|Adverse Event|9|||
16937697|NCT00195273|38082485|FG000|Overall Study|Protocol deviation|0|||
16937698|NCT00195273|38082486|FG001|Overall Study|Protocol deviation|1|||
16937699|NCT00195273|38082485|FG000|Overall Study|Lack of Efficacy|3|||
16937700|NCT00195273|38082486|FG001|Overall Study|Lack of Efficacy|1|||
16937701|NCT00195273|38082485|FG000|Overall Study|Procedural complications|9|||
16937702|NCT00195273|38082486|FG001|Overall Study|Procedural complications|3|||
16937703|NCT00193479|38082492|FG000|Induction Chemotherapy|Adverse Event|2|||
16937704|NCT00193479|38082492|FG000|Induction Chemotherapy|Disease Progression|1|||
16937705|NCT00193479|38082492|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
16937706|NCT00193479|38082492|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
16937707|NCT00193206|38082496|FG000|Preoperative Therapy|Lack of Efficacy|2|||
16937708|NCT00193206|38082496|FG000|Preoperative Therapy|Adverse Event|2|||
16937709|NCT00193206|38082496|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
16937710|NCT00193206|38082496|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
16937711|NCT00193206|38082496|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
16937712|NCT00193206|38082496|FG000|Postoperative Therapy|Physician Decision|3|||
16937713|NCT00193206|38082496|FG000|Postoperative Therapy|Intercurrent Illness|2|||
16937714|NCT00193206|38082496|FG000|Postoperative Therapy|Lack of Efficacy|1|||
16937715|NCT00193206|38082496|FG000|Postoperative Therapy|Protocol Violation|1|||
16937716|NCT00193050|38082500|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
16937717|NCT00193050|38082500|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
16937718|NCT00193050|38082500|FG000|Neoadjuvant Treatment|Physician Decision|2|||
16937719|NCT00193050|38082500|FG000|Neoadjuvant Treatment|Adverse Event|2|||
16937720|NCT00193050|38082500|FG000|Adjuvant|Physician Decision|5|||
16937721|NCT00193050|38082500|FG000|Adjuvant|Intercurrent Hospitalization|3|||
16937722|NCT00193050|38082500|FG000|Adjuvant|Lack of Efficacy|2|||
16937723|NCT00192504|38082509|FG000|Overall Study|Lost to Follow-up|1|||
16937724|NCT00192504|38082510|FG001|Overall Study|Lost to Follow-up|0|||
16937725|NCT00192504|38082511|FG002|Overall Study|Lost to Follow-up|0|||
16937726|NCT00192504|38082512|FG003|Overall Study|Lost to Follow-up|0|||
16937727|NCT00192504|38082509|FG000|Overall Study|Dosing window missed|0|||
16937728|NCT00192504|38082510|FG001|Overall Study|Dosing window missed|0|||
16937729|NCT00192504|38082511|FG002|Overall Study|Dosing window missed|1|||
16937730|NCT00192504|38082512|FG003|Overall Study|Dosing window missed|0|||
16937731|NCT00192114|38082522|FG000|Overall Study|Objective Tumor Progression|19|||
16937732|NCT00192114|38082522|FG000|Overall Study|Adverse Event|2|||
16937733|NCT00192114|38082522|FG000|Overall Study|Clinical Progression|2|||
16937734|NCT00192114|38082522|FG000|Overall Study|Death|1|||
16937735|NCT00192075|38082528|FG000|Overall Study|Disease Progression|23|||
16937736|NCT00192075|38082529|FG001|Overall Study|Disease Progression|6|||
16937737|NCT00192075|38082528|FG000|Overall Study|Adverse Event|1|||
16937738|NCT00192075|38082529|FG001|Overall Study|Adverse Event|3|||
16937739|NCT00192075|38082528|FG000|Overall Study|Death|0|||
16937740|NCT00192075|38082529|FG001|Overall Study|Death|1|||
16937741|NCT00192075|38082528|FG000|Overall Study|Lack of Efficacy|0|||
16937742|NCT00192075|38082529|FG001|Overall Study|Lack of Efficacy|0|||
16937743|NCT00192075|38082528|FG000|Overall Study|Physician Decision|3|||
16937744|NCT00192075|38082529|FG001|Overall Study|Physician Decision|0|||
16937745|NCT00192075|38082528|FG000|Overall Study|Withdrawal by Subject|5|||
16937746|NCT00192075|38082529|FG001|Overall Study|Withdrawal by Subject|5|||
16937747|NCT00192075|38082528|FG000|Overall Study|Patient Non-Compliance|0|||
16937748|NCT00192075|38082529|FG001|Overall Study|Patient Non-Compliance|1|||
16937749|NCT00192075|38082528|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
16937750|NCT00192075|38082529|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
16937751|NCT00192075|38082528|FG000|Overall Study|Other|5|||
16937752|NCT00192075|38082529|FG001|Overall Study|Other|2|||
16937753|NCT00192036|38082540|FG000|Overall Study|Protocol Violation|3|||
16937754|NCT00192036|38082540|FG000|Overall Study|Adverse Event|6|||
16937755|NCT00192036|38082540|FG000|Overall Study|Patient/Physician Perception|1|||
16937756|NCT00192036|38082540|FG000|Overall Study|Objective Tumor Progression|4|||
16937757|NCT00192036|38082540|FG000|Overall Study|Clinical Disease Progression|1|||
16937758|NCT00192036|38082540|FG000|Overall Study|Death|1|||
16937759|NCT00192036|38082540|FG000|Overall Study|Unknown or Not Specified|5|||
16937760|NCT00191724|38082549|FG000|Overall Study|Adverse Event|0|||
16937761|NCT00191724|38082550|FG001|Overall Study|Adverse Event|0|||
16937762|NCT00191724|38082551|FG002|Overall Study|Adverse Event|1|||
16937763|NCT00191724|38082552|FG003|Overall Study|Adverse Event|0|||
16937764|NCT00191724|38082553|FG004|Overall Study|Adverse Event|0|||
16937765|NCT00191724|38082549|FG000|Overall Study|Lost to Follow-up|1|||
16937766|NCT00191724|38082550|FG001|Overall Study|Lost to Follow-up|1|||
16937767|NCT00191724|38082551|FG002|Overall Study|Lost to Follow-up|0|||
16937768|NCT00191724|38082552|FG003|Overall Study|Lost to Follow-up|2|||
16937769|NCT00191724|38082553|FG004|Overall Study|Lost to Follow-up|3|||
16937770|NCT00191724|38082549|FG000|Overall Study|Withdrawal by Subject|0|||
16937771|NCT00191724|38082550|FG001|Overall Study|Withdrawal by Subject|0|||
16937772|NCT00191724|38082551|FG002|Overall Study|Withdrawal by Subject|0|||
16937773|NCT00191724|38082552|FG003|Overall Study|Withdrawal by Subject|1|||
16937774|NCT00191724|38082553|FG004|Overall Study|Withdrawal by Subject|0|||
16937775|NCT00191646|38082567|FG000|Overall Study|Toxicity|26|||
16937776|NCT00191646|38082568|FG001|Overall Study|Toxicity|37|||
16937777|NCT00191646|38082567|FG000|Overall Study|Disease Progression|5|||
16937778|NCT00191646|38082568|FG001|Overall Study|Disease Progression|6|||
16937779|NCT00191646|38082567|FG000|Overall Study|Physician Decision|20|||
16937780|NCT00191646|38082568|FG001|Overall Study|Physician Decision|11|||
16937781|NCT00191646|38082567|FG000|Overall Study|Withdrawal by Subject|58|||
16937782|NCT00191646|38082568|FG001|Overall Study|Withdrawal by Subject|39|||
16937783|NCT00191646|38082567|FG000|Overall Study|Protocol Violation|5|||
16937784|NCT00191646|38082568|FG001|Overall Study|Protocol Violation|7|||
16937785|NCT00191646|38082567|FG000|Overall Study|Death|6|||
16937786|NCT00191646|38082568|FG001|Overall Study|Death|8|||
16937787|NCT00191646|38082567|FG000|Overall Study|Other|33|||
16937788|NCT00191646|38082568|FG001|Overall Study|Other|34|||
16937789|NCT00191646|38082567|FG000|Overall Study|Missing Data|18|||
16937790|NCT00191646|38082568|FG001|Overall Study|Missing Data|11|||
16937791|NCT00191451|38082585|FG000|Overall Study|Withdrawal by Subject|2|||
16937792|NCT00191451|38082586|FG001|Overall Study|Withdrawal by Subject|3|||
16937793|NCT00191451|38082587|FG002|Overall Study|Withdrawal by Subject|5|||
16937794|NCT00191451|38082585|FG000|Overall Study|Physician Decision|2|||
16937795|NCT00191451|38082586|FG001|Overall Study|Physician Decision|9|||
16937796|NCT00191451|38082587|FG002|Overall Study|Physician Decision|6|||
16937797|NCT00191451|38082585|FG000|Overall Study|Sponsor Decision|1|||
16937798|NCT00191451|38082586|FG001|Overall Study|Sponsor Decision|0|||
16937799|NCT00191451|38082587|FG002|Overall Study|Sponsor Decision|0|||
16937800|NCT00191451|38082585|FG000|Overall Study|Ineligible|0|||
16937801|NCT00191451|38082586|FG001|Overall Study|Ineligible|1|||
16937802|NCT00191451|38082587|FG002|Overall Study|Ineligible|0|||
16937803|NCT00191451|38082585|FG000|Overall Study|Reason Not Specified|2|||
16937804|NCT00191451|38082586|FG001|Overall Study|Reason Not Specified|1|||
16937805|NCT00191451|38082587|FG002|Overall Study|Reason Not Specified|3|||
16937806|NCT00191334|38082595|FG000|Overall Study|Adverse Event|4|||
16937807|NCT00191334|38082595|FG000|Overall Study|Disease Progression or Relapse|8|||
16937808|NCT00191334|38082595|FG000|Overall Study|Physician Decision|1|||
16937809|NCT00191334|38082595|FG000|Overall Study|Withdrawal by Subject|4|||
16937810|NCT00191139|38082601|FG000|Overall Study|Adverse Event|2|||
16937811|NCT00191139|38082602|FG001|Overall Study|Adverse Event|6|||
16937812|NCT00191139|38082601|FG000|Overall Study|Death|2|||
16937813|NCT00191139|38082602|FG001|Overall Study|Death|0|||
16937814|NCT00191139|38082601|FG000|Overall Study|Withdrawal by Subject|0|||
16937815|NCT00191139|38082602|FG001|Overall Study|Withdrawal by Subject|3|||
16937816|NCT00191139|38082601|FG000|Overall Study|Disease Progression|0|||
16937817|NCT00191139|38082602|FG001|Overall Study|Disease Progression|1|||
16937818|NCT00191139|38082601|FG000|Overall Study|Other|1|||
16937819|NCT00191139|38082602|FG001|Overall Study|Other|2|||
16937820|NCT00190983|38082608|FG000|Overall Study|Inevaluable (never treated)|2|||
16937821|NCT00190749|38082614|FG000|Overall Study|Lost to Follow-up|8|||
16937822|NCT00190749|38082615|FG001|Overall Study|Lost to Follow-up|11|||
16937823|NCT00190749|38082614|FG000|Overall Study|Withdrawal by Subject|10|||
16937824|NCT00190749|38082615|FG001|Overall Study|Withdrawal by Subject|6|||
16937825|NCT00190749|38082614|FG000|Overall Study|Protocol Violation|5|||
16937826|NCT00190749|38082615|FG001|Overall Study|Protocol Violation|4|||
16937827|NCT00190749|38082614|FG000|Overall Study|Adverse Event|0|||
16937828|NCT00190749|38082615|FG001|Overall Study|Adverse Event|5|||
16937829|NCT00190749|38082614|FG000|Overall Study|Lack of Efficacy|2|||
16937830|NCT00190749|38082615|FG001|Overall Study|Lack of Efficacy|3|||
16937831|NCT00190749|38082614|FG000|Overall Study|Reason Not Specified|0|||
16937832|NCT00190749|38082615|FG001|Overall Study|Reason Not Specified|2|||
16937833|NCT00190749|38082614|FG000|Overall Study|Sponsor Decision|1|||
16937834|NCT00190749|38082615|FG001|Overall Study|Sponsor Decision|0|||
16937835|NCT00190671|38082623|FG000|Overall Study|Satisfactory Response|4|||
16937836|NCT00190671|38082624|FG001|Overall Study|Satisfactory Response|7|||
16937837|NCT00190671|38082623|FG000|Overall Study|Lack of Efficacy|19|||
16937838|NCT00190671|38082624|FG001|Overall Study|Lack of Efficacy|24|||
16937839|NCT00190671|38082623|FG000|Overall Study|Death from Study Disease|1|||
16937840|NCT00190671|38082624|FG001|Overall Study|Death from Study Disease|1|||
16937841|NCT00190671|38082623|FG000|Overall Study|Adverse Event|3|||
16937842|NCT00190671|38082624|FG001|Overall Study|Adverse Event|2|||
16937843|NCT00190671|38082623|FG000|Overall Study|Clinical Relapse|0|||
16937844|NCT00190671|38082624|FG001|Overall Study|Clinical Relapse|1|||
16937845|NCT00190671|38082623|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
16937846|NCT00190671|38082624|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
16937847|NCT00190671|38082623|FG000|Overall Study|Death from Other Causes|0|||
16937848|NCT00190671|38082624|FG001|Overall Study|Death from Other Causes|2|||
16937849|NCT00190671|38082623|FG000|Overall Study|Protocol Violation|0|||
16937850|NCT00190671|38082624|FG001|Overall Study|Protocol Violation|1|||
16937851|NCT00190671|38082623|FG000|Overall Study|Withdrawal by Subject|0|||
16937852|NCT00190671|38082624|FG001|Overall Study|Withdrawal by Subject|2|||
16937853|NCT00477165|38082646|FG000|Overall Study|Adverse Event|7|||
16937854|NCT00477165|38082647|FG001|Overall Study|Adverse Event|2|||
16937855|NCT00476229|38082653|FG000|Overall Study|Progressive shortness of breath|1|||
16937856|NCT00476151|38082659|FG000|Overall Study|Adverse Event|0|||
16937857|NCT00476151|38082660|FG001|Overall Study|Adverse Event|2|||
16937858|NCT00476151|38082659|FG000|Overall Study|Protocol Violation|1|||
16937859|NCT00476151|38082660|FG001|Overall Study|Protocol Violation|3|||
16937860|NCT00476151|38082659|FG000|Overall Study|Withdrawal by Subject|2|||
16937861|NCT00476151|38082660|FG001|Overall Study|Withdrawal by Subject|0|||
16937862|NCT00476151|38082659|FG000|Overall Study|Physician Decision|0|||
16937863|NCT00476151|38082660|FG001|Overall Study|Physician Decision|2|||
16937864|NCT00475644|38082666|FG000|Overall Study|Protocol Violation|13|||
16937865|NCT00474903|38082673|FG000|Overall Study|Protocol Violation|1|||
16937866|NCT00474903|38082674|FG001|Overall Study|Protocol Violation|5|||
16937867|NCT00474903|38082675|FG002|Overall Study|Protocol Violation|2|||
16937868|NCT01134055|38082690|FG000|Overall Study|Adverse Event|5|||
16937869|NCT01134055|38082691|FG001|Overall Study|Adverse Event|2|||
16937870|NCT01134055|38082692|FG002|Overall Study|Adverse Event|2|||
16937871|NCT01134055|38082693|FG003|Overall Study|Adverse Event|2|||
16937872|NCT01134055|38082694|FG004|Overall Study|Adverse Event|5|||
16937873|NCT01134055|38082695|FG005|Overall Study|Adverse Event|7|||
16937874|NCT01134055|38082696|FG006|Overall Study|Adverse Event|2|||
16937875|NCT01134055|38082690|FG000|Overall Study|Lost to Follow-up|0|||
16937876|NCT01134055|38082691|FG001|Overall Study|Lost to Follow-up|1|||
16937877|NCT01134055|38082692|FG002|Overall Study|Lost to Follow-up|0|||
16937878|NCT01134055|38082693|FG003|Overall Study|Lost to Follow-up|1|||
16937879|NCT01134055|38082694|FG004|Overall Study|Lost to Follow-up|0|||
16937880|NCT01134055|38082695|FG005|Overall Study|Lost to Follow-up|0|||
16937881|NCT01134055|38082696|FG006|Overall Study|Lost to Follow-up|0|||
16937882|NCT01134055|38082690|FG000|Overall Study|Withdrawal by Subject|3|||
16937883|NCT01134055|38082691|FG001|Overall Study|Withdrawal by Subject|3|||
16937884|NCT01134055|38082692|FG002|Overall Study|Withdrawal by Subject|1|||
16937885|NCT01134055|38082693|FG003|Overall Study|Withdrawal by Subject|2|||
16937886|NCT01134055|38082694|FG004|Overall Study|Withdrawal by Subject|0|||
16937887|NCT01134055|38082695|FG005|Overall Study|Withdrawal by Subject|0|||
16937888|NCT01134055|38082696|FG006|Overall Study|Withdrawal by Subject|8|||
16937889|NCT01134055|38082690|FG000|Overall Study|Protocol Violation|0|||
16937890|NCT01134055|38082691|FG001|Overall Study|Protocol Violation|0|||
16937891|NCT01134055|38082692|FG002|Overall Study|Protocol Violation|0|||
16937892|NCT01134055|38082693|FG003|Overall Study|Protocol Violation|1|||
16937893|NCT01134055|38082694|FG004|Overall Study|Protocol Violation|1|||
16937894|NCT01134055|38082695|FG005|Overall Study|Protocol Violation|0|||
17104885|NCT00075218|38242691|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
17104886|NCT00075218|38242692|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
17104887|NCT00075218|38242693|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
17104888|NCT00075218|38242691|FG000|Open-Label Treatment|Decision of Sponsor|0|||
17104889|NCT00075218|38242692|FG001|Open-Label Treatment|Decision of Sponsor|0|||
17104890|NCT00075218|38242693|FG002|Open-Label Treatment|Decision of Sponsor|8|||
17104891|NCT00075218|38242691|FG000|Open-Label Treatment|Protocol Violation|0|||
17104892|NCT00075218|38242692|FG001|Open-Label Treatment|Protocol Violation|0|||
17104893|NCT00075218|38242693|FG002|Open-Label Treatment|Protocol Violation|1|||
17104894|NCT00075218|38242691|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
17104895|NCT00075218|38242692|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
17104896|NCT00075218|38242693|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
17104897|NCT00094653|38242703|FG000|Overall Study|Death|306|||
17104898|NCT00094653|38242704|FG001|Overall Study|Death|100|||
17104899|NCT00094653|38242705|FG002|Overall Study|Death|119|||
17104900|NCT00094653|38242703|FG000|Overall Study|Subject Withdrew Consent|10|||
17104901|NCT00094653|38242704|FG001|Overall Study|Subject Withdrew Consent|2|||
17104902|NCT00094653|38242705|FG002|Overall Study|Subject Withdrew Consent|3|||
17104903|NCT00094653|38242703|FG000|Overall Study|Other|2|||
17104904|NCT00094653|38242704|FG001|Overall Study|Other|2|||
17104905|NCT00094653|38242705|FG002|Overall Study|Other|2|||
17104906|NCT00094653|38242703|FG000|Overall Study|Lost to Follow-up|3|||
16937895|NCT01134055|38082696|FG006|Overall Study|Protocol Violation|0|||
16937896|NCT01134055|38082690|FG000|Overall Study|Physician Decision|0|||
16937897|NCT01134055|38082691|FG001|Overall Study|Physician Decision|0|||
16937898|NCT01134055|38082692|FG002|Overall Study|Physician Decision|0|||
16937899|NCT01134055|38082693|FG003|Overall Study|Physician Decision|0|||
17104907|NCT00094653|38242704|FG001|Overall Study|Lost to Follow-up|2|||
17104908|NCT00094653|38242705|FG002|Overall Study|Lost to Follow-up|1|||
17104909|NCT00094653|38242703|FG000|Overall Study|Protocol Violation|0|||
17104910|NCT00094653|38242704|FG001|Overall Study|Protocol Violation|0|||
17104911|NCT00094653|38242705|FG002|Overall Study|Protocol Violation|1|||
17104912|NCT00104247|38242716|FG000|Overall Study|Withdrawal by Subject|1|||
17104913|NCT00104247|38242717|FG001|Overall Study|Withdrawal by Subject|0|||
17104914|NCT00104247|38242716|FG000|Overall Study|Noncompliant with dosing|0|||
17104915|NCT00104247|38242717|FG001|Overall Study|Noncompliant with dosing|1|||
17104916|NCT03565900|38242725|FG000|Overall Study|Disposition Unknown|4|||
17104917|NCT03565900|38242726|FG001|Overall Study|Disposition Unknown|1|||
17104918|NCT03565900|38242725|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
17104919|NCT03565900|38242726|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
17104920|NCT03565900|38242725|FG000|Overall Study|Withdrawal by Subject|4|||
17104921|NCT03565900|38242726|FG001|Overall Study|Withdrawal by Subject|5|||
17104922|NCT03565900|38242725|FG000|Overall Study|Randomized By Mistake|0|||
17104923|NCT03565900|38242726|FG001|Overall Study|Randomized By Mistake|2|||
17104924|NCT03565900|38242725|FG000|Overall Study|Physician Decision|7|||
17104925|NCT03565900|38242726|FG001|Overall Study|Physician Decision|11|||
16937900|NCT01134055|38082694|FG004|Overall Study|Physician Decision|0|||
16937901|NCT01134055|38082695|FG005|Overall Study|Physician Decision|0|||
16937902|NCT01134055|38082696|FG006|Overall Study|Physician Decision|1|||
16937903|NCT00474708|38082720|FG000|Overall Study|Lack of Efficacy|11|||
16937904|NCT00474708|38082721|FG001|Overall Study|Lack of Efficacy|5|||
16937905|NCT00474708|38082720|FG000|Overall Study|Suicide ideation/behavior|0|||
16937906|NCT00474708|38082721|FG001|Overall Study|Suicide ideation/behavior|1|||
16937907|NCT00474708|38082720|FG000|Overall Study|Withdrawal by Subject|7|||
16937908|NCT00474708|38082721|FG001|Overall Study|Withdrawal by Subject|0|||
16937909|NCT00474708|38082720|FG000|Overall Study|Lack of compliance|12|||
16937910|NCT00474708|38082721|FG001|Overall Study|Lack of compliance|4|||
16937911|NCT00474708|38082720|FG000|Overall Study|Lost to Follow-up|18|||
16937912|NCT00474708|38082721|FG001|Overall Study|Lost to Follow-up|9|||
16937913|NCT00474708|38082720|FG000|Overall Study|Physician Decision|9|||
16937914|NCT00474708|38082721|FG001|Overall Study|Physician Decision|6|||
16937915|NCT00474240|38082733|FG000|Overall Study|Withdrawal by Subject|1|||
16937916|NCT00474240|38082734|FG001|Overall Study|Withdrawal by Subject|1|||
16937917|NCT00474240|38082735|FG002|Overall Study|Withdrawal by Subject|0|||
17104926|NCT03565900|38242725|FG000|Overall Study|Death|9|||
17104927|NCT03565900|38242726|FG001|Overall Study|Death|7|||
17104928|NCT03591406|38242750|FG000|Overall Study|Adverse Event|5|||
17104929|NCT03591406|38242751|FG001|Overall Study|Adverse Event|3|||
17104930|NCT03591406|38242750|FG000|Overall Study|Protocol Violation|2|||
17104931|NCT03591406|38242751|FG001|Overall Study|Protocol Violation|1|||
17104932|NCT03591406|38242750|FG000|Overall Study|Withdrawal by Subject|0|||
17104933|NCT03591406|38242751|FG001|Overall Study|Withdrawal by Subject|5|||
17104934|NCT03560986|38242759|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
17104935|NCT03560986|38242760|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
17104936|NCT03560986|38242759|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
17104937|NCT03560986|38242760|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
17104938|NCT03560986|38242759|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
17104939|NCT03560986|38242760|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
17104940|NCT03560986|38242759|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
17104941|NCT03560986|38242760|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
17104942|NCT03560986|38242759|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
17104943|NCT03560986|38242760|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
17104944|NCT03560986|38242759|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
17104945|NCT03560986|38242760|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
17104946|NCT03560986|38242759|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
17104947|NCT03560986|38242760|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
17104948|NCT03560518|38242775|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
17104949|NCT03560518|38242776|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
17104950|NCT03560518|38242777|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
17104951|NCT03560518|38242775|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
17104952|NCT03560518|38242776|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
17104953|NCT03560518|38242777|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
17104954|NCT03560518|38242775|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16937918|NCT00474240|38082736|FG003|Overall Study|Withdrawal by Subject|2|||
16937919|NCT00474240|38082737|FG004|Overall Study|Withdrawal by Subject|3|||
16937920|NCT00474240|38082738|FG005|Overall Study|Withdrawal by Subject|1|||
16937921|NCT00474240|38082733|FG000|Overall Study|Adverse Event|0|||
16937922|NCT00474240|38082734|FG001|Overall Study|Adverse Event|0|||
16937923|NCT00474240|38082735|FG002|Overall Study|Adverse Event|9|||
16937924|NCT00474240|38082736|FG003|Overall Study|Adverse Event|14|||
16937925|NCT00474240|38082737|FG004|Overall Study|Adverse Event|5|||
16937926|NCT00474240|38082738|FG005|Overall Study|Adverse Event|16|||
16937927|NCT00474240|38082733|FG000|Overall Study|Removed due to lab value|0|||
16937928|NCT00474240|38082734|FG001|Overall Study|Removed due to lab value|0|||
16937929|NCT00474240|38082735|FG002|Overall Study|Removed due to lab value|0|||
16937930|NCT00474240|38082736|FG003|Overall Study|Removed due to lab value|0|||
16937931|NCT00474240|38082737|FG004|Overall Study|Removed due to lab value|0|||
16937932|NCT00474240|38082738|FG005|Overall Study|Removed due to lab value|1|||
16937933|NCT00473889|38082754|FG000|Overall Study|Did not receive study medication|1|||
16937934|NCT00473889|38082755|FG001|Overall Study|Did not receive study medication|4|||
16937935|NCT00473889|38082754|FG000|Overall Study|Adverse Event|30|||
16937936|NCT00473889|38082755|FG001|Overall Study|Adverse Event|17|||
16937937|NCT00473889|38082754|FG000|Overall Study|Protocol Violation|4|||
16937938|NCT00473889|38082755|FG001|Overall Study|Protocol Violation|2|||
16937939|NCT00473889|38082754|FG000|Overall Study|Lack of Efficacy|28|||
16937940|NCT00473889|38082755|FG001|Overall Study|Lack of Efficacy|29|||
16937941|NCT00473889|38082754|FG000|Overall Study|Lost to Follow-up|2|||
16937942|NCT00473889|38082755|FG001|Overall Study|Lost to Follow-up|1|||
16937943|NCT00473889|38082754|FG000|Overall Study|Physician Decision|10|||
16937944|NCT00473889|38082755|FG001|Overall Study|Physician Decision|5|||
16937945|NCT00473889|38082754|FG000|Overall Study|Trial Terminated|3|||
16937946|NCT00473889|38082755|FG001|Overall Study|Trial Terminated|6|||
16937947|NCT00473889|38082754|FG000|Overall Study|Withdrawal by Subject|5|||
16937948|NCT00473889|38082755|FG001|Overall Study|Withdrawal by Subject|0|||
16937949|NCT00473694|38082765|FG000|Overall Study|Adverse Event|0|||
16937950|NCT00473694|38082766|FG001|Overall Study|Adverse Event|1|||
16937951|NCT00473694|38082767|FG002|Overall Study|Adverse Event|0|||
16937952|NCT00473694|38082768|FG003|Overall Study|Adverse Event|0|||
16937953|NCT00473694|38082765|FG000|Overall Study|Participants did not receive treatment|11|||
16937954|NCT00473694|38082766|FG001|Overall Study|Participants did not receive treatment|3|||
16937955|NCT00473694|38082767|FG002|Overall Study|Participants did not receive treatment|5|||
16937956|NCT00473694|38082768|FG003|Overall Study|Participants did not receive treatment|6|||
16937957|NCT00473694|38082765|FG000|Overall Study|Lost to Follow-up|0|||
16937958|NCT00473694|38082766|FG001|Overall Study|Lost to Follow-up|0|||
16937959|NCT00473694|38082767|FG002|Overall Study|Lost to Follow-up|0|||
17104955|NCT03560518|38242776|FG001|Double Blind Treatment Period|Protocol Violation|2|||
17104956|NCT03560518|38242777|FG002|Double Blind Treatment Period|Protocol Violation|0|||
17104957|NCT03560518|38242775|FG000|Double Blind Treatment Period|Pregnancy|0|||
17104958|NCT03560518|38242776|FG001|Double Blind Treatment Period|Pregnancy|2|||
17104959|NCT03560518|38242777|FG002|Double Blind Treatment Period|Pregnancy|0|||
17104960|NCT03560518|38242775|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
17104961|NCT03560518|38242776|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
17104962|NCT03560518|38242777|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
17104963|NCT03560518|38242775|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
17104964|NCT03560518|38242776|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
17104965|NCT03560518|38242777|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
17104966|NCT03560518|38242775|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
17104967|NCT03560518|38242776|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
17104968|NCT03560518|38242777|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
17104969|NCT03560518|38242775|FG000|Double Blind Treatment Period|Adverse Event|0|||
17104970|NCT03560518|38242776|FG001|Double Blind Treatment Period|Adverse Event|3|||
17104971|NCT03560518|38242777|FG002|Double Blind Treatment Period|Adverse Event|1|||
17104972|NCT03635320|38242787|FG000|Overall Study|not implanted the device|1|||
17104973|NCT03635320|38242788|FG001|Overall Study|not implanted the device|2|||
17104974|NCT03635320|38242787|FG000|Overall Study|Withdrawal by Subject|11|||
17104975|NCT03635320|38242788|FG001|Overall Study|Withdrawal by Subject|6|||
17104976|NCT03560206|38242796|FG000|Overall Study|Lost to Follow-up|19|||
17104977|NCT03560206|38242797|FG001|Overall Study|Lost to Follow-up|11|||
17104978|NCT03560206|38242796|FG000|Overall Study|Withdrawal by Subject|2|||
17104979|NCT03560206|38242797|FG001|Overall Study|Withdrawal by Subject|4|||
17104980|NCT03560206|38242796|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
17104981|NCT03560206|38242797|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
17104982|NCT03560206|38242796|FG000|Overall Study|Busy schedule|14|||
17104983|NCT03560206|38242797|FG001|Overall Study|Busy schedule|2|||
17199781|NCT02776553|38353740|FG000|Overall Study|Protocol Violation|0|||
16937960|NCT00473694|38082768|FG003|Overall Study|Lost to Follow-up|1|||
16937961|NCT00473655|38082784|FG000|Overall Study|Lost to Follow-up|9|||
16937962|NCT00473655|38082785|FG001|Overall Study|Lost to Follow-up|5|||
16937963|NCT00473655|38082786|FG002|Overall Study|Lost to Follow-up|8|||
16937964|NCT00473382|38082797|FG000|Core Study|Adverse Event|3|||
16937965|NCT00473382|38082798|FG001|Core Study|Adverse Event|1|||
16937966|NCT00473382|38082799|FG002|Core Study|Adverse Event|1|||
16937967|NCT00473382|38082797|FG000|Core Study|Death|3|||
17104984|NCT03560206|38242796|FG000|Overall Study|patients' new health condition such as cancer|10|||
17104985|NCT03560206|38242797|FG001|Overall Study|patients' new health condition such as cancer|1|||
17104986|NCT02892760|38242803|FG000|Overall Study|Withdrawal by Subject|3|||
17104987|NCT03635086|38242812|FG000|Overall Study|Withdrawal of consent|0|||
17104988|NCT03635086|38242813|FG001|Overall Study|Withdrawal of consent|0|||
17104989|NCT03635086|38242814|FG002|Overall Study|Withdrawal of consent|1|||
17104990|NCT03635086|38242815|FG003|Overall Study|Withdrawal of consent|0|||
17104991|NCT03635086|38242816|FG004|Overall Study|Withdrawal of consent|0|||
17104992|NCT03635086|38242812|FG000|Overall Study|Adverse Event|0|||
17104993|NCT03635086|38242813|FG001|Overall Study|Adverse Event|1|||
17104994|NCT03635086|38242814|FG002|Overall Study|Adverse Event|0|||
17104995|NCT03635086|38242815|FG003|Overall Study|Adverse Event|0|||
17104996|NCT03635086|38242816|FG004|Overall Study|Adverse Event|0|||
17104997|NCT03635086|38242812|FG000|Overall Study|Lost to Follow-up|1|||
17104998|NCT03635086|38242813|FG001|Overall Study|Lost to Follow-up|0|||
17104999|NCT03635086|38242814|FG002|Overall Study|Lost to Follow-up|0|||
17105000|NCT03635086|38242815|FG003|Overall Study|Lost to Follow-up|0|||
17105001|NCT03635086|38242816|FG004|Overall Study|Lost to Follow-up|0|||
17105002|NCT03588910|38242831|FG000|Overall Study|Withdrawal by Subject|1|||
17105003|NCT03588910|38242832|FG001|Overall Study|Withdrawal by Subject|0|||
17105004|NCT03588910|38242831|FG000|Overall Study|Allergy|2|||
17105005|NCT03588910|38242832|FG001|Overall Study|Allergy|0|||
17105006|NCT03588910|38242831|FG000|Overall Study|Protocol Violation|0|||
17105007|NCT03588910|38242832|FG001|Overall Study|Protocol Violation|3|||
17105008|NCT03588910|38242831|FG000|Overall Study|Did not complete Day 1 Survey|5|||
17105009|NCT03588910|38242832|FG001|Overall Study|Did not complete Day 1 Survey|10|||
17105010|NCT03588910|38242831|FG000|Overall Study|Did not complete Day 7 Survey|5|||
17105011|NCT03588910|38242832|FG001|Overall Study|Did not complete Day 7 Survey|2|||
17105012|NCT03587974|38242840|FG000|Overall Study|caregiver demented, care recipient died|3|||
17105013|NCT03587974|38242841|FG001|Overall Study|caregiver demented, care recipient died|3|||
17105014|NCT03587974|38242840|FG000|Overall Study|Withdrawal by Subject|2|||
17105015|NCT03587974|38242841|FG001|Overall Study|Withdrawal by Subject|1|||
17105016|NCT00103857|38242854|FG000|54-Week Base Study|Adverse Event|12|||
17105017|NCT00103857|38242855|FG001|54-Week Base Study|Adverse Event|9|||
17105018|NCT00103857|38242856|FG002|54-Week Base Study|Adverse Event|11|||
17105019|NCT00103857|38242857|FG003|54-Week Base Study|Adverse Event|6|||
17105020|NCT00103857|38242858|FG004|54-Week Base Study|Adverse Event|5|||
17105021|NCT00103857|38242859|FG005|54-Week Base Study|Adverse Event|11|||
17105022|NCT00103857|38242860|FG006|54-Week Base Study|Adverse Event|3|||
17105023|NCT00103857|38242854|FG000|54-Week Base Study|Death|0|||
17105024|NCT00103857|38242855|FG001|54-Week Base Study|Death|0|||
17105025|NCT00103857|38242856|FG002|54-Week Base Study|Death|0|||
17105026|NCT00103857|38242857|FG003|54-Week Base Study|Death|0|||
17105027|NCT00103857|38242858|FG004|54-Week Base Study|Death|1|||
17105028|NCT00103857|38242859|FG005|54-Week Base Study|Death|1|||
17105029|NCT00103857|38242860|FG006|54-Week Base Study|Death|0|||
17105030|NCT00103857|38242854|FG000|54-Week Base Study|Lack of Efficacy|11|||
17105031|NCT00103857|38242855|FG001|54-Week Base Study|Lack of Efficacy|14|||
17105032|NCT00103857|38242856|FG002|54-Week Base Study|Lack of Efficacy|8|||
17105033|NCT00103857|38242857|FG003|54-Week Base Study|Lack of Efficacy|4|||
17105034|NCT00103857|38242858|FG004|54-Week Base Study|Lack of Efficacy|3|||
17105035|NCT00103857|38242859|FG005|54-Week Base Study|Lack of Efficacy|14|||
17105036|NCT00103857|38242860|FG006|54-Week Base Study|Lack of Efficacy|19|||
17105037|NCT00103857|38242854|FG000|54-Week Base Study|Lost to Follow-up|5|||
17105038|NCT00103857|38242855|FG001|54-Week Base Study|Lost to Follow-up|4|||
17105039|NCT00103857|38242856|FG002|54-Week Base Study|Lost to Follow-up|7|||
17105040|NCT00103857|38242857|FG003|54-Week Base Study|Lost to Follow-up|5|||
17105041|NCT00103857|38242858|FG004|54-Week Base Study|Lost to Follow-up|10|||
17105042|NCT00103857|38242859|FG005|54-Week Base Study|Lost to Follow-up|9|||
17105043|NCT00103857|38242860|FG006|54-Week Base Study|Lost to Follow-up|3|||
17105044|NCT00103857|38242854|FG000|54-Week Base Study|Physician Decision|1|||
17105045|NCT00103857|38242855|FG001|54-Week Base Study|Physician Decision|1|||
17105046|NCT00103857|38242856|FG002|54-Week Base Study|Physician Decision|0|||
17105047|NCT00103857|38242857|FG003|54-Week Base Study|Physician Decision|0|||
17105048|NCT00103857|38242858|FG004|54-Week Base Study|Physician Decision|1|||
17105049|NCT00103857|38242859|FG005|54-Week Base Study|Physician Decision|0|||
17105050|NCT00103857|38242860|FG006|54-Week Base Study|Physician Decision|0|||
17105051|NCT00103857|38242854|FG000|54-Week Base Study|Pregnancy|1|||
17105052|NCT00103857|38242855|FG001|54-Week Base Study|Pregnancy|0|||
17105053|NCT00103857|38242856|FG002|54-Week Base Study|Pregnancy|0|||
17105054|NCT00103857|38242857|FG003|54-Week Base Study|Pregnancy|0|||
17105055|NCT00103857|38242858|FG004|54-Week Base Study|Pregnancy|1|||
17105056|NCT00103857|38242859|FG005|54-Week Base Study|Pregnancy|0|||
17105057|NCT00103857|38242860|FG006|54-Week Base Study|Pregnancy|1|||
17105058|NCT00103857|38242854|FG000|54-Week Base Study|Protocol Violation|6|||
17105059|NCT00103857|38242855|FG001|54-Week Base Study|Protocol Violation|4|||
17105060|NCT00103857|38242856|FG002|54-Week Base Study|Protocol Violation|2|||
16937968|NCT00473382|38082798|FG001|Core Study|Death|5|||
16937969|NCT00473382|38082799|FG002|Core Study|Death|10|||
16937970|NCT00473382|38082797|FG000|Core Study|Lost to Follow-up|3|||
16937971|NCT00473382|38082798|FG001|Core Study|Lost to Follow-up|3|||
16937972|NCT00473382|38082799|FG002|Core Study|Lost to Follow-up|3|||
16937973|NCT00473382|38082797|FG000|Core Study|Physician Decision|1|||
16937974|NCT00473382|38082798|FG001|Core Study|Physician Decision|2|||
16937975|NCT00473382|38082799|FG002|Core Study|Physician Decision|2|||
16937976|NCT00473382|38082797|FG000|Core Study|Subject non-compliance|5|||
16937977|NCT00473382|38082798|FG001|Core Study|Subject non-compliance|2|||
16937978|NCT00473382|38082799|FG002|Core Study|Subject non-compliance|1|||
16937979|NCT00473382|38082797|FG000|Core Study|Subject needed other treatment|1|||
16937980|NCT00473382|38082798|FG001|Core Study|Subject needed other treatment|3|||
16937981|NCT00473382|38082799|FG002|Core Study|Subject needed other treatment|2|||
16937982|NCT00473382|38082797|FG000|Core Study|Subject's decision|12|||
16937983|NCT00473382|38082798|FG001|Core Study|Subject's decision|11|||
16937984|NCT00473382|38082799|FG002|Core Study|Subject's decision|10|||
16937985|NCT00473382|38082797|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
16937986|NCT00473382|38082798|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
16937987|NCT00473382|38082799|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
16937988|NCT00473382|38082797|FG000|Open-label Extension Through Month 48|Death|1|||
16937989|NCT00473382|38082798|FG001|Open-label Extension Through Month 48|Death|3|||
16937990|NCT00473382|38082799|FG002|Open-label Extension Through Month 48|Death|3|||
16937991|NCT00473382|38082797|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
16937992|NCT00473382|38082798|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
16937993|NCT00473382|38082799|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
16937994|NCT00473382|38082797|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
16937995|NCT00473382|38082798|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
16937996|NCT00473382|38082799|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
16937997|NCT00473382|38082797|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
16937998|NCT00473382|38082798|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
16937999|NCT00473382|38082799|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
16938000|NCT00473382|38082797|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
16938001|NCT00473382|38082798|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
16938002|NCT00473382|38082799|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
16938003|NCT00473382|38082797|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
16938004|NCT00473382|38082798|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
16938005|NCT00473382|38082799|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
16938006|NCT00473382|38082797|FG000|Open-label Extension Through Month 60|Death|1|||
16938007|NCT00473382|38082798|FG001|Open-label Extension Through Month 60|Death|7|||
16938008|NCT00473382|38082799|FG002|Open-label Extension Through Month 60|Death|4|||
16938009|NCT00473382|38082797|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
16938010|NCT00473382|38082798|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
16938011|NCT00473382|38082799|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
16938012|NCT00473382|38082797|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
16938013|NCT00473382|38082798|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
16938014|NCT00473382|38082799|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
16938015|NCT00473382|38082797|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
16938016|NCT00473382|38082798|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
16938017|NCT00473382|38082799|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
16938018|NCT00473382|38082797|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
16938019|NCT00473382|38082798|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
16938020|NCT00473382|38082799|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
16938021|NCT00473265|38082825|FG000|Overall Study|Unrelated adverse event|5|||
16938022|NCT00473265|38082825|FG000|Overall Study|Off treatment early|15|||
16938023|NCT00472641|38082829|FG000|Overall Study|Lack of Efficacy|3|||
16938024|NCT00472641|38082829|FG000|Overall Study|Adverse Event|3|||
16938025|NCT00472641|38082829|FG000|Overall Study|Lost to Follow-up|1|||
16938026|NCT01133977|38082838|FG000|Overall Study|Adverse Event|0|||
16938027|NCT01133977|38082839|FG001|Overall Study|Adverse Event|0|||
16938028|NCT01133977|38082840|FG002|Overall Study|Adverse Event|1|||
16938029|NCT01133977|38082841|FG003|Overall Study|Adverse Event|0|||
16938030|NCT01133977|38082842|FG004|Overall Study|Adverse Event|0|||
16938031|NCT01133977|38082838|FG000|Overall Study|Death|1|||
16938032|NCT01133977|38082839|FG001|Overall Study|Death|1|||
16938033|NCT01133977|38082840|FG002|Overall Study|Death|1|||
16938034|NCT01133977|38082841|FG003|Overall Study|Death|7|||
16938035|NCT01133977|38082842|FG004|Overall Study|Death|3|||
16938036|NCT01133977|38082838|FG000|Overall Study|Started a New Line of Therapy|2|||
16938037|NCT01133977|38082839|FG001|Overall Study|Started a New Line of Therapy|6|||
16938038|NCT01133977|38082840|FG002|Overall Study|Started a New Line of Therapy|4|||
16938039|NCT01133977|38082841|FG003|Overall Study|Started a New Line of Therapy|25|||
16938040|NCT01133977|38082842|FG004|Overall Study|Started a New Line of Therapy|33|||
16938041|NCT01133977|38082838|FG000|Overall Study|Lost to Follow-up|0|||
16938042|NCT01133977|38082839|FG001|Overall Study|Lost to Follow-up|0|||
16938043|NCT01133977|38082840|FG002|Overall Study|Lost to Follow-up|0|||
16938044|NCT01133977|38082841|FG003|Overall Study|Lost to Follow-up|2|||
16938045|NCT01133977|38082842|FG004|Overall Study|Lost to Follow-up|1|||
16938046|NCT01133977|38082838|FG000|Overall Study|Withdrawal by Subject|0|||
16938047|NCT01133977|38082839|FG001|Overall Study|Withdrawal by Subject|0|||
16938048|NCT01133977|38082840|FG002|Overall Study|Withdrawal by Subject|0|||
16938049|NCT01133977|38082841|FG003|Overall Study|Withdrawal by Subject|5|||
16938050|NCT01133977|38082842|FG004|Overall Study|Withdrawal by Subject|1|||
16938051|NCT01133821|38082859|FG000|Overall Study|Lost to Follow-up|8|||
16938052|NCT01133821|38082860|FG001|Overall Study|Lost to Follow-up|11|||
16938053|NCT01133821|38082859|FG000|Overall Study|Withdrawal by Subject|8|||
16938054|NCT01133821|38082860|FG001|Overall Study|Withdrawal by Subject|3|||
16938055|NCT01133821|38082859|FG000|Overall Study|preferred other treatment|1|||
16938056|NCT01133821|38082860|FG001|Overall Study|preferred other treatment|1|||
16938057|NCT01133821|38082859|FG000|Overall Study|Protocol Violation|0|||
16938058|NCT01133821|38082860|FG001|Overall Study|Protocol Violation|1|||
16938059|NCT01133821|38082859|FG000|Overall Study|Refused participation|1|||
16938060|NCT01133821|38082860|FG001|Overall Study|Refused participation|3|||
16938061|NCT00472446|38082870|FG000|Overall Study|Protocol Violation|0|||
16938062|NCT00472446|38082871|FG001|Overall Study|Protocol Violation|0|||
16938063|NCT00472446|38082872|FG002|Overall Study|Protocol Violation|0|||
16938064|NCT00472446|38082873|FG003|Overall Study|Protocol Violation|1|||
16938065|NCT00472446|38082870|FG000|Overall Study|Reintervention|0|||
16938066|NCT00472446|38082871|FG001|Overall Study|Reintervention|0|||
16938067|NCT00472446|38082872|FG002|Overall Study|Reintervention|1|||
16938068|NCT00472446|38082873|FG003|Overall Study|Reintervention|1|||
16938069|NCT00472446|38082870|FG000|Overall Study|Questionnaires not returned|5|||
16938070|NCT00472446|38082871|FG001|Overall Study|Questionnaires not returned|6|||
16938071|NCT00472446|38082872|FG002|Overall Study|Questionnaires not returned|6|||
16938072|NCT00472446|38082873|FG003|Overall Study|Questionnaires not returned|4|||
16938073|NCT00472290|38082883|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
16938074|NCT00472290|38082883|FG000|Overall Study|Protocol Specified Criteria|7|||
16938075|NCT00472290|38082883|FG000|Overall Study|Administrative Decision|37|||
16938076|NCT00472290|38082883|FG000|Overall Study|Death|3|||
16938077|NCT00472290|38082883|FG000|Overall Study|Lost to Follow-up|1|||
16938078|NCT00472290|38082883|FG000|Overall Study|Lack of Efficacy|1|||
16938079|NCT00472290|38082883|FG000|Overall Study|Disease Progression|4|||
16938080|NCT00472290|38082883|FG000|Overall Study|Withdrawal by Subject|5|||
16938081|NCT00472290|38082883|FG000|Overall Study|Adverse Event|6|||
16938082|NCT00472290|38082883|FG000|Overall Study|Requirement for alternative therapy|7|||
16938083|NCT01133704|38082889|FG000|Overall Study|Death|44|||
16938084|NCT01133704|38082890|FG001|Overall Study|Death|26|||
16938085|NCT01133704|38082889|FG000|Overall Study|Patient refused to continue|4|||
16938086|NCT01133704|38082890|FG001|Overall Study|Patient refused to continue|0|||
16938087|NCT01133704|38082889|FG000|Overall Study|Study Closure|1|||
16938088|NCT01133704|38082890|FG001|Overall Study|Study Closure|0|||
16938089|NCT01133665|38082896|FG000|Overall Study|Physician Decision|2|||
16938090|NCT01133626|38082903|FG000|Overall Study|Adverse Event|0|||
16938091|NCT01133626|38082904|FG001|Overall Study|Adverse Event|1|||
16938092|NCT01133626|38082905|FG002|Overall Study|Adverse Event|0|||
16938093|NCT01133626|38082903|FG000|Overall Study|Withdrawal by Subject|1|||
16938094|NCT01133626|38082904|FG001|Overall Study|Withdrawal by Subject|2|||
16938095|NCT01133626|38082905|FG002|Overall Study|Withdrawal by Subject|2|||
16938096|NCT01133626|38082903|FG000|Overall Study|Other|0|||
16938097|NCT01133626|38082904|FG001|Overall Study|Other|2|||
16938098|NCT01133626|38082905|FG002|Overall Study|Other|0|||
16938099|NCT00472212|38082915|FG000|Overall Study|Lost to Follow-up|6|||
16938100|NCT00472212|38082916|FG001|Overall Study|Lost to Follow-up|4|||
16938101|NCT01133392|38082924|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
16938102|NCT01133392|38082925|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
16938103|NCT01133392|38082924|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
16938104|NCT01133392|38082925|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
16938105|NCT00471354|38082931|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
16938106|NCT00471354|38082931|FG000|Overall Study|Adverse Event|13|||
16938107|NCT00471354|38082931|FG000|Overall Study|Protocol Violation|12|||
16938108|NCT00471354|38082931|FG000|Overall Study|Withdrawal by Subject|1|||
16938109|NCT00471354|38082931|FG000|Overall Study|Physician Decision|4|||
16938110|NCT00471354|38082931|FG000|Overall Study|Sponsor Decision|1|||
16938111|NCT00471354|38082931|FG000|Overall Study|Lost to Follow-up|3|||
16938112|NCT00471354|38082931|FG000|Overall Study|Lack of Efficacy|5|||
16938113|NCT00471354|38082931|FG000|Overall Study|Patient/Caregiver Decision|12|||
16938114|NCT01133275|38082935|FG000|Overall Study|Withdrawal by Subject|1|||
16938115|NCT01133275|38082935|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
16938116|NCT00471315|38082939|FG000|Overall Study|Adverse Event|7|||
16938117|NCT00471315|38082939|FG000|Overall Study|Withdrawal by Subject|1|||
16938118|NCT00471237|38082950|FG000|Overall Study|Adverse Event|6|||
16938119|NCT00471237|38082951|FG001|Overall Study|Adverse Event|5|||
16938120|NCT00471237|38082952|FG002|Overall Study|Adverse Event|4|||
16938121|NCT00471237|38082953|FG003|Overall Study|Adverse Event|8|||
16938122|NCT00471237|38082954|FG004|Overall Study|Adverse Event|7|||
16938123|NCT00471237|38082955|FG005|Overall Study|Adverse Event|5|||
16938124|NCT00471237|38082956|FG006|Overall Study|Adverse Event|0|||
16938125|NCT00471237|38082950|FG000|Overall Study|Lost to Follow-up|1|||
16938126|NCT00471237|38082951|FG001|Overall Study|Lost to Follow-up|1|||
16938127|NCT00471237|38082952|FG002|Overall Study|Lost to Follow-up|0|||
16938128|NCT00471237|38082953|FG003|Overall Study|Lost to Follow-up|2|||
16938129|NCT00471237|38082954|FG004|Overall Study|Lost to Follow-up|3|||
16938130|NCT00471237|38082955|FG005|Overall Study|Lost to Follow-up|0|||
16938131|NCT00471237|38082956|FG006|Overall Study|Lost to Follow-up|0|||
16938132|NCT00471237|38082950|FG000|Overall Study|Protocol Violation|3|||
16938133|NCT00471237|38082951|FG001|Overall Study|Protocol Violation|6|||
16938134|NCT00471237|38082952|FG002|Overall Study|Protocol Violation|3|||
16938135|NCT00471237|38082953|FG003|Overall Study|Protocol Violation|2|||
16938136|NCT00471237|38082954|FG004|Overall Study|Protocol Violation|2|||
16938137|NCT00471237|38082955|FG005|Overall Study|Protocol Violation|4|||
16938138|NCT00471237|38082956|FG006|Overall Study|Protocol Violation|1|||
16938139|NCT00471237|38082950|FG000|Overall Study|Withdrawal by Subject|8|||
16938140|NCT00471237|38082951|FG001|Overall Study|Withdrawal by Subject|6|||
17105061|NCT00103857|38242857|FG003|54-Week Base Study|Protocol Violation|4|||
17105062|NCT00103857|38242858|FG004|54-Week Base Study|Protocol Violation|0|||
17105063|NCT00103857|38242859|FG005|54-Week Base Study|Protocol Violation|3|||
17105064|NCT00103857|38242860|FG006|54-Week Base Study|Protocol Violation|3|||
17105065|NCT00103857|38242854|FG000|54-Week Base Study|Withdrawal by Subject|17|||
17105066|NCT00103857|38242855|FG001|54-Week Base Study|Withdrawal by Subject|16|||
17105067|NCT00103857|38242856|FG002|54-Week Base Study|Withdrawal by Subject|16|||
17105068|NCT00103857|38242857|FG003|54-Week Base Study|Withdrawal by Subject|15|||
17105069|NCT00103857|38242858|FG004|54-Week Base Study|Withdrawal by Subject|10|||
17105070|NCT00103857|38242859|FG005|54-Week Base Study|Withdrawal by Subject|15|||
17105071|NCT00103857|38242860|FG006|54-Week Base Study|Withdrawal by Subject|4|||
17105072|NCT00103857|38242854|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
17105073|NCT00103857|38242855|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
17105074|NCT00103857|38242856|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
17105075|NCT00103857|38242857|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
17105076|NCT00103857|38242858|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
17105077|NCT00103857|38242859|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
17105078|NCT00103857|38242860|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
17105079|NCT00103857|38242854|FG000|54-Week Base Study|patient moved|0|||
17105080|NCT00103857|38242855|FG001|54-Week Base Study|patient moved|1|||
17105081|NCT00103857|38242856|FG002|54-Week Base Study|patient moved|1|||
17105082|NCT00103857|38242857|FG003|54-Week Base Study|patient moved|2|||
17105083|NCT00103857|38242858|FG004|54-Week Base Study|patient moved|3|||
17105084|NCT00103857|38242859|FG005|54-Week Base Study|patient moved|1|||
17105085|NCT00103857|38242860|FG006|54-Week Base Study|patient moved|0|||
17105086|NCT00103857|38242854|FG000|54-Week Base Study|non-compliance with study procedures|1|||
17105087|NCT00103857|38242855|FG001|54-Week Base Study|non-compliance with study procedures|2|||
17105088|NCT00103857|38242856|FG002|54-Week Base Study|non-compliance with study procedures|0|||
17105089|NCT00103857|38242857|FG003|54-Week Base Study|non-compliance with study procedures|0|||
17105090|NCT00103857|38242858|FG004|54-Week Base Study|non-compliance with study procedures|0|||
17105091|NCT00103857|38242859|FG005|54-Week Base Study|non-compliance with study procedures|2|||
17105092|NCT00103857|38242860|FG006|54-Week Base Study|non-compliance with study procedures|0|||
17105093|NCT00103857|38242854|FG000|54-Week Base Study|patient incarcerated|0|||
17105094|NCT00103857|38242855|FG001|54-Week Base Study|patient incarcerated|0|||
17105095|NCT00103857|38242856|FG002|54-Week Base Study|patient incarcerated|0|||
17105096|NCT00103857|38242857|FG003|54-Week Base Study|patient incarcerated|0|||
17105097|NCT00103857|38242858|FG004|54-Week Base Study|patient incarcerated|1|||
17105098|NCT00103857|38242859|FG005|54-Week Base Study|patient incarcerated|1|||
17105099|NCT00103857|38242860|FG006|54-Week Base Study|patient incarcerated|0|||
17105100|NCT00103857|38242854|FG000|54-Week Base Study|laboratory reporting error|0|||
17105101|NCT00103857|38242855|FG001|54-Week Base Study|laboratory reporting error|0|||
17105102|NCT00103857|38242856|FG002|54-Week Base Study|laboratory reporting error|0|||
17105103|NCT00103857|38242857|FG003|54-Week Base Study|laboratory reporting error|0|||
17105104|NCT00103857|38242858|FG004|54-Week Base Study|laboratory reporting error|1|||
17105105|NCT00103857|38242859|FG005|54-Week Base Study|laboratory reporting error|0|||
17105106|NCT00103857|38242860|FG006|54-Week Base Study|laboratory reporting error|0|||
17105107|NCT00103857|38242854|FG000|54-Week Base Study|site error|0|||
17105108|NCT00103857|38242855|FG001|54-Week Base Study|site error|0|||
17105109|NCT00103857|38242856|FG002|54-Week Base Study|site error|0|||
16938141|NCT00471237|38082952|FG002|Overall Study|Withdrawal by Subject|5|||
16938142|NCT00471237|38082953|FG003|Overall Study|Withdrawal by Subject|8|||
17105110|NCT00103857|38242857|FG003|54-Week Base Study|site error|0|||
17105111|NCT00103857|38242858|FG004|54-Week Base Study|site error|0|||
17105112|NCT00103857|38242859|FG005|54-Week Base Study|site error|1|||
17105113|NCT00103857|38242860|FG006|54-Week Base Study|site error|0|||
17105114|NCT00103857|38242854|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
17105115|NCT00103857|38242855|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
17105116|NCT00103857|38242856|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
17105117|NCT00103857|38242857|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
17105118|NCT00103857|38242858|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
17105119|NCT00103857|38242859|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
17105120|NCT00103857|38242860|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
17105121|NCT00103857|38242854|FG000|50-Week Extension Study|Adverse Event|2|||
17105122|NCT00103857|38242855|FG001|50-Week Extension Study|Adverse Event|3|||
17105123|NCT00103857|38242856|FG002|50-Week Extension Study|Adverse Event|2|||
17105124|NCT00103857|38242857|FG003|50-Week Extension Study|Adverse Event|0|||
17105125|NCT00103857|38242858|FG004|50-Week Extension Study|Adverse Event|1|||
17105126|NCT00103857|38242859|FG005|50-Week Extension Study|Adverse Event|1|||
17105127|NCT00103857|38242860|FG006|50-Week Extension Study|Adverse Event|0|||
17105128|NCT00103857|38242854|FG000|50-Week Extension Study|Death|0|||
17105129|NCT00103857|38242855|FG001|50-Week Extension Study|Death|0|||
17105130|NCT00103857|38242856|FG002|50-Week Extension Study|Death|0|||
17105131|NCT00103857|38242857|FG003|50-Week Extension Study|Death|1|||
17105132|NCT00103857|38242858|FG004|50-Week Extension Study|Death|0|||
17105133|NCT00103857|38242859|FG005|50-Week Extension Study|Death|1|||
17105134|NCT00103857|38242860|FG006|50-Week Extension Study|Death|0|||
17105135|NCT00103857|38242854|FG000|50-Week Extension Study|Lack of Efficacy|26|||
17105136|NCT00103857|38242855|FG001|50-Week Extension Study|Lack of Efficacy|15|||
17105137|NCT00103857|38242856|FG002|50-Week Extension Study|Lack of Efficacy|13|||
17105138|NCT00103857|38242857|FG003|50-Week Extension Study|Lack of Efficacy|16|||
17105139|NCT00103857|38242858|FG004|50-Week Extension Study|Lack of Efficacy|8|||
17105140|NCT00103857|38242859|FG005|50-Week Extension Study|Lack of Efficacy|8|||
17105141|NCT00103857|38242860|FG006|50-Week Extension Study|Lack of Efficacy|0|||
17105142|NCT00103857|38242854|FG000|50-Week Extension Study|Lost to Follow-up|4|||
17105143|NCT00103857|38242855|FG001|50-Week Extension Study|Lost to Follow-up|0|||
17105144|NCT00103857|38242856|FG002|50-Week Extension Study|Lost to Follow-up|1|||
16938143|NCT00471237|38082954|FG004|Overall Study|Withdrawal by Subject|7|||
16938144|NCT00471237|38082955|FG005|Overall Study|Withdrawal by Subject|4|||
16938145|NCT00471237|38082956|FG006|Overall Study|Withdrawal by Subject|2|||
16938146|NCT00471237|38082950|FG000|Overall Study|Sponsor terminated study|20|||
16938147|NCT00471237|38082951|FG001|Overall Study|Sponsor terminated study|23|||
16938148|NCT00471237|38082952|FG002|Overall Study|Sponsor terminated study|19|||
16938149|NCT00471237|38082953|FG003|Overall Study|Sponsor terminated study|22|||
16938150|NCT00471237|38082954|FG004|Overall Study|Sponsor terminated study|18|||
16938151|NCT00471237|38082955|FG005|Overall Study|Sponsor terminated study|24|||
16938152|NCT00471237|38082956|FG006|Overall Study|Sponsor terminated study|0|||
16938153|NCT00471237|38082950|FG000|Overall Study|Non-compliance|0|||
16938154|NCT00471237|38082951|FG001|Overall Study|Non-compliance|1|||
16938155|NCT00471237|38082952|FG002|Overall Study|Non-compliance|0|||
16938156|NCT00471237|38082953|FG003|Overall Study|Non-compliance|1|||
16938157|NCT00471237|38082954|FG004|Overall Study|Non-compliance|0|||
16938158|NCT00471237|38082955|FG005|Overall Study|Non-compliance|0|||
16938159|NCT00471237|38082956|FG006|Overall Study|Non-compliance|0|||
16938160|NCT00471237|38082950|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
16938161|NCT00471237|38082951|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
16938162|NCT00471237|38082952|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
16938163|NCT00471237|38082953|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
16938164|NCT00471237|38082954|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
16938165|NCT00471237|38082955|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
16938166|NCT00471237|38082956|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
16938167|NCT00471237|38082950|FG000|Overall Study|Early stopping due to non-efficacy|1|||
16938168|NCT00471237|38082951|FG001|Overall Study|Early stopping due to non-efficacy|0|||
16938169|NCT00471237|38082952|FG002|Overall Study|Early stopping due to non-efficacy|0|||
16938170|NCT00471237|38082953|FG003|Overall Study|Early stopping due to non-efficacy|0|||
16938171|NCT00471237|38082954|FG004|Overall Study|Early stopping due to non-efficacy|1|||
16938172|NCT00471237|38082955|FG005|Overall Study|Early stopping due to non-efficacy|0|||
16938173|NCT00471237|38082956|FG006|Overall Study|Early stopping due to non-efficacy|0|||
16938174|NCT00471237|38082950|FG000|Overall Study|Participant planned to travel to abraod|1|||
16938175|NCT00471237|38082951|FG001|Overall Study|Participant planned to travel to abraod|0|||
16938176|NCT00471237|38082952|FG002|Overall Study|Participant planned to travel to abraod|0|||
16938177|NCT00471237|38082953|FG003|Overall Study|Participant planned to travel to abraod|0|||
17105145|NCT00103857|38242857|FG003|50-Week Extension Study|Lost to Follow-up|4|||
17105146|NCT00103857|38242858|FG004|50-Week Extension Study|Lost to Follow-up|3|||
17105147|NCT00103857|38242859|FG005|50-Week Extension Study|Lost to Follow-up|3|||
16938178|NCT00471237|38082954|FG004|Overall Study|Participant planned to travel to abraod|0|||
16938179|NCT00471237|38082955|FG005|Overall Study|Participant planned to travel to abraod|1|||
16938180|NCT00471237|38082956|FG006|Overall Study|Participant planned to travel to abraod|0|||
16938181|NCT00471237|38082950|FG000|Overall Study|High parathyroid hormone|0|||
16938182|NCT00471237|38082951|FG001|Overall Study|High parathyroid hormone|0|||
16938183|NCT00471237|38082952|FG002|Overall Study|High parathyroid hormone|1|||
16938184|NCT00471237|38082953|FG003|Overall Study|High parathyroid hormone|0|||
16938185|NCT00471237|38082954|FG004|Overall Study|High parathyroid hormone|0|||
16938186|NCT00471237|38082955|FG005|Overall Study|High parathyroid hormone|0|||
16938187|NCT00471237|38082956|FG006|Overall Study|High parathyroid hormone|0|||
16938188|NCT00471237|38082950|FG000|Overall Study|Participant lost medication|0|||
16938189|NCT00471237|38082951|FG001|Overall Study|Participant lost medication|0|||
16938190|NCT00471237|38082952|FG002|Overall Study|Participant lost medication|0|||
16938191|NCT00471237|38082953|FG003|Overall Study|Participant lost medication|0|||
16938192|NCT00471237|38082954|FG004|Overall Study|Participant lost medication|1|||
16938193|NCT00471237|38082955|FG005|Overall Study|Participant lost medication|0|||
16938194|NCT00471237|38082956|FG006|Overall Study|Participant lost medication|0|||
16938195|NCT00471237|38082950|FG000|Overall Study|Administration of prohibited medicine|0|||
16938196|NCT00471237|38082951|FG001|Overall Study|Administration of prohibited medicine|0|||
17105148|NCT00103857|38242860|FG006|50-Week Extension Study|Lost to Follow-up|0|||
17105149|NCT00103857|38242854|FG000|50-Week Extension Study|Physician Decision|0|||
17105150|NCT00103857|38242855|FG001|50-Week Extension Study|Physician Decision|1|||
17105151|NCT00103857|38242856|FG002|50-Week Extension Study|Physician Decision|1|||
17105152|NCT00103857|38242857|FG003|50-Week Extension Study|Physician Decision|0|||
17105153|NCT00103857|38242858|FG004|50-Week Extension Study|Physician Decision|0|||
17105154|NCT00103857|38242859|FG005|50-Week Extension Study|Physician Decision|0|||
17105155|NCT00103857|38242860|FG006|50-Week Extension Study|Physician Decision|0|||
17105156|NCT00103857|38242854|FG000|50-Week Extension Study|Pregnancy|0|||
17105157|NCT00103857|38242855|FG001|50-Week Extension Study|Pregnancy|0|||
17105158|NCT00103857|38242856|FG002|50-Week Extension Study|Pregnancy|1|||
17105159|NCT00103857|38242857|FG003|50-Week Extension Study|Pregnancy|0|||
17105160|NCT00103857|38242858|FG004|50-Week Extension Study|Pregnancy|1|||
17105161|NCT00103857|38242859|FG005|50-Week Extension Study|Pregnancy|0|||
17105162|NCT00103857|38242860|FG006|50-Week Extension Study|Pregnancy|0|||
17105163|NCT00103857|38242854|FG000|50-Week Extension Study|Protocol Violation|1|||
17105164|NCT00103857|38242855|FG001|50-Week Extension Study|Protocol Violation|1|||
17105165|NCT00103857|38242856|FG002|50-Week Extension Study|Protocol Violation|1|||
17105166|NCT00103857|38242857|FG003|50-Week Extension Study|Protocol Violation|2|||
17105167|NCT00103857|38242858|FG004|50-Week Extension Study|Protocol Violation|0|||
17105168|NCT00103857|38242859|FG005|50-Week Extension Study|Protocol Violation|1|||
17105169|NCT00103857|38242860|FG006|50-Week Extension Study|Protocol Violation|0|||
17105170|NCT00103857|38242854|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
17105171|NCT00103857|38242855|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
17105172|NCT00103857|38242856|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
17105173|NCT00103857|38242857|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
17105174|NCT00103857|38242858|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
17105175|NCT00103857|38242859|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
17105176|NCT00103857|38242860|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
17105177|NCT00103857|38242854|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
17105178|NCT00103857|38242855|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
17105179|NCT00103857|38242856|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
17105180|NCT00103857|38242857|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
17105181|NCT00103857|38242858|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
17105182|NCT00103857|38242859|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
17105183|NCT00103857|38242860|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
17105184|NCT00103857|38242854|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
17105185|NCT00103857|38242855|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
17105186|NCT00103857|38242856|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
17105187|NCT00103857|38242857|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
17105188|NCT00103857|38242858|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
17105189|NCT00103857|38242859|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
17105190|NCT00103857|38242860|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
17105191|NCT00103857|38242854|FG000|50-Week Extension Study|patient moved|0|||
17105192|NCT00103857|38242855|FG001|50-Week Extension Study|patient moved|0|||
17105193|NCT00103857|38242856|FG002|50-Week Extension Study|patient moved|1|||
17105194|NCT00103857|38242857|FG003|50-Week Extension Study|patient moved|2|||
17105195|NCT00103857|38242858|FG004|50-Week Extension Study|patient moved|0|||
17105196|NCT00103857|38242859|FG005|50-Week Extension Study|patient moved|0|||
17105197|NCT00103857|38242860|FG006|50-Week Extension Study|patient moved|0|||
17105198|NCT00103857|38242854|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
17199782|NCT02776553|38353741|FG001|Overall Study|Protocol Violation|1|||
16938197|NCT00471237|38082952|FG002|Overall Study|Administration of prohibited medicine|0|||
16938198|NCT00471237|38082953|FG003|Overall Study|Administration of prohibited medicine|0|||
16938199|NCT00471237|38082954|FG004|Overall Study|Administration of prohibited medicine|1|||
16938200|NCT00471237|38082955|FG005|Overall Study|Administration of prohibited medicine|0|||
16938201|NCT00471237|38082956|FG006|Overall Study|Administration of prohibited medicine|0|||
16938202|NCT00471237|38082950|FG000|Overall Study|Participant shifted residence|0|||
16938203|NCT00471237|38082951|FG001|Overall Study|Participant shifted residence|0|||
16938204|NCT00471237|38082952|FG002|Overall Study|Participant shifted residence|0|||
16938205|NCT00471237|38082953|FG003|Overall Study|Participant shifted residence|0|||
16938206|NCT00471237|38082954|FG004|Overall Study|Participant shifted residence|1|||
16938207|NCT00471237|38082955|FG005|Overall Study|Participant shifted residence|0|||
16938208|NCT00471237|38082956|FG006|Overall Study|Participant shifted residence|0|||
16938209|NCT00471237|38082950|FG000|Overall Study|Participant's decision|0|||
16938210|NCT00471237|38082951|FG001|Overall Study|Participant's decision|0|||
16938211|NCT00471237|38082952|FG002|Overall Study|Participant's decision|0|||
16938212|NCT00471237|38082953|FG003|Overall Study|Participant's decision|0|||
16938213|NCT00471237|38082954|FG004|Overall Study|Participant's decision|0|||
16938214|NCT00471237|38082955|FG005|Overall Study|Participant's decision|1|||
16938215|NCT00471237|38082956|FG006|Overall Study|Participant's decision|0|||
16938216|NCT00471081|38082978|FG000|Active Phase|Protocol Violation|1|||
16938217|NCT00471081|38082979|FG001|Active Phase|Protocol Violation|1|||
16938218|NCT00471081|38082978|FG000|Active Phase|Withdrawal by Subject|0|||
16938219|NCT00471081|38082979|FG001|Active Phase|Withdrawal by Subject|3|||
16938220|NCT00471081|38082978|FG000|Active Phase|Lost to Follow-up|0|||
16938221|NCT00471081|38082979|FG001|Active Phase|Lost to Follow-up|1|||
16938222|NCT00471081|38082978|FG000|Active Phase|Lost health plan/insurance|1|||
17105199|NCT00103857|38242855|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
17105200|NCT00103857|38242856|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
17105201|NCT00103857|38242857|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
17105202|NCT00103857|38242858|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
17105203|NCT00103857|38242859|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
17105204|NCT00103857|38242860|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
17105205|NCT00103857|38242854|FG000|50-Week Extension Study|reason unspecified|0|||
17105206|NCT00103857|38242855|FG001|50-Week Extension Study|reason unspecified|0|||
17105207|NCT00103857|38242856|FG002|50-Week Extension Study|reason unspecified|0|||
17105208|NCT00103857|38242857|FG003|50-Week Extension Study|reason unspecified|0|||
17105209|NCT00103857|38242858|FG004|50-Week Extension Study|reason unspecified|1|||
17105210|NCT00103857|38242859|FG005|50-Week Extension Study|reason unspecified|0|||
17105211|NCT00103857|38242860|FG006|50-Week Extension Study|reason unspecified|0|||
17105212|NCT03587584|38242877|FG000|Overall Study|SOC deviations|4|||
17105213|NCT03587584|38242878|FG001|Overall Study|SOC deviations|6|||
17105214|NCT03587584|38242877|FG000|Overall Study|Incomplete data|0|||
17105215|NCT03587584|38242878|FG001|Overall Study|Incomplete data|3|||
17105216|NCT03586726|38242884|FG000|Overall Study|Withdrawal by Subject|1|||
17105217|NCT03586648|38242888|FG000|Period 1|Withdrawal by Subject|0|||
17105218|NCT03586648|38242889|FG001|Period 1|Withdrawal by Subject|1|||
17105219|NCT03586648|38242888|FG000|Period 1|Lost to Follow-up|1|||
17105220|NCT03586648|38242889|FG001|Period 1|Lost to Follow-up|1|||
17105221|NCT03586648|38242888|FG000|Period 1|Adverse Event|1|||
17105222|NCT03586648|38242889|FG001|Period 1|Adverse Event|0|||
17105223|NCT03586648|38242888|FG000|Period 1|Study related symptoms or complaints|2|||
17105224|NCT03586648|38242889|FG001|Period 1|Study related symptoms or complaints|1|||
17105225|NCT03586648|38242888|FG000|Period 1|Physician Decision|0|||
17105226|NCT03586648|38242889|FG001|Period 1|Physician Decision|1|||
17105227|NCT03586648|38242888|FG000|Period 2|Adverse Event|1|||
17105228|NCT03586648|38242889|FG001|Period 2|Adverse Event|0|||
17105229|NCT02892448|38242898|FG000|Overall Study|Screening failure|2|||
17105230|NCT02892448|38242899|FG001|Overall Study|Screening failure|2|||
17105231|NCT02892448|38242900|FG002|Overall Study|Screening failure|1|||
17105232|NCT03585712|38242908|FG000|Treatment Period 1|Protocol Violation|1|||
17105233|NCT03585712|38242909|FG001|Treatment Period 1|Protocol Violation|0|||
17105234|NCT03585712|38242910|FG002|Treatment Period 1|Protocol Violation|0|||
17105235|NCT03585712|38242908|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
17105236|NCT03585712|38242909|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
17105237|NCT03585712|38242910|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
17105238|NCT03585712|38242908|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
17105239|NCT03585712|38242909|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
16938223|NCT00471081|38082979|FG001|Active Phase|Lost health plan/insurance|8|||
16938224|NCT00471081|38082978|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
16938225|NCT00471081|38082979|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
16938226|NCT00471081|38082978|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
16938227|NCT00471081|38082979|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
16938228|NCT00471081|38082978|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
16938229|NCT00471081|38082979|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
16938230|NCT00470847|38082986|FG000|Overall Study|Pt still receiving treatment|1|||
16938231|NCT00470535|38082992|FG000|Overall Study|Disease Progression|13|||
16938232|NCT00470535|38082992|FG000|Overall Study|Withdrawal by Subject|1|||
16938233|NCT00470535|38082992|FG000|Overall Study|Adverse Event|1|||
16938234|NCT00470535|38082992|FG000|Overall Study|Death|1|||
16938235|NCT00470535|38082992|FG000|Overall Study|Other|2|||
16938236|NCT00470418|38082998|FG000|Overall Study|Withdrawal by Subject|1|||
16938237|NCT00470418|38082999|FG001|Overall Study|Withdrawal by Subject|0|||
16938238|NCT00470184|38083005|FG000|Overall Study|Not Treated(became ineligible)|4|||
16938239|NCT00470184|38083005|FG000|Overall Study|Not treated (other)|1|||
16938240|NCT00470184|38083005|FG000|Overall Study|disease Progression|4|||
16938241|NCT00470184|38083005|FG000|Overall Study|Adverse Event|3|||
16938242|NCT00470184|38083005|FG000|Overall Study|Withdrawal by Subject|4|||
16938243|NCT00470184|38083005|FG000|Overall Study|other|5|||
16938244|NCT00470184|38083005|FG000|Overall Study|recurrence|1|||
16938245|NCT00470067|38083010|FG000|Overall Study|Death|1|||
16938246|NCT00470067|38083010|FG000|Overall Study|Disease Progression|6|||
16938247|NCT00475020|38083014|FG000|Overall Study|Physician Decision|3|||
16938248|NCT00475020|38083014|FG000|Overall Study|Insurance Denial|1|||
16938249|NCT00475020|38083014|FG000|Overall Study|Donor not able to donate the last minute|1|||
16938250|NCT02484456|38083020|FG000|Washout Period|Withdrawal by Subject|0|||
16938251|NCT02484456|38083021|FG001|Washout Period|Withdrawal by Subject|1|||
16938252|NCT02484456|38083020|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
16938253|NCT02484456|38083021|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
16938254|NCT02484456|38083020|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
16938255|NCT02484456|38083021|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
16938256|NCT02484456|38083020|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
16938257|NCT02484456|38083021|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
16938258|NCT01132807|38083028|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
16938259|NCT01132807|38083029|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
16938260|NCT01132807|38083030|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
16938261|NCT01132807|38083028|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
16938262|NCT01132807|38083029|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
16938263|NCT01132807|38083030|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
16938264|NCT01132651|38083040|FG000|Overall Study|Lost to Follow-up|1|||
16938265|NCT01132651|38083041|FG001|Overall Study|Lost to Follow-up|1|||
16938266|NCT01089543|38083051|FG000|Overall Study|Withdrawal by Subject|2|||
16938267|NCT01089543|38083052|FG001|Overall Study|Withdrawal by Subject|3|||
16938268|NCT01089543|38083053|FG002|Overall Study|Withdrawal by Subject|3|||
16938269|NCT01089543|38083054|FG003|Overall Study|Withdrawal by Subject|1|||
16938270|NCT01089543|38083051|FG000|Overall Study|Physician Decision|1|||
16938271|NCT01089543|38083052|FG001|Overall Study|Physician Decision|0|||
16938272|NCT01089543|38083053|FG002|Overall Study|Physician Decision|0|||
16938273|NCT01089543|38083054|FG003|Overall Study|Physician Decision|1|||
16938274|NCT01089543|38083051|FG000|Overall Study|Adverse Event|0|||
16938275|NCT01089543|38083052|FG001|Overall Study|Adverse Event|1|||
16938276|NCT01089543|38083053|FG002|Overall Study|Adverse Event|0|||
16938277|NCT01089543|38083054|FG003|Overall Study|Adverse Event|0|||
16938278|NCT01089504|38083066|FG000|Overall Study|Lost to Follow-up|1|||
16938279|NCT01089504|38083067|FG001|Overall Study|Lost to Follow-up|1|||
16938280|NCT01089504|38083066|FG000|Overall Study|Withdrawal by Subject|2|||
16938281|NCT01089504|38083067|FG001|Overall Study|Withdrawal by Subject|0|||
16938282|NCT01088997|38083075|FG000|Overall Study|Physician Decision|1|||
16938283|NCT01088997|38083076|FG001|Overall Study|Physician Decision|1|||
16938284|NCT01088997|38083075|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
16938285|NCT01088997|38083076|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
16938286|NCT01088997|38083075|FG000|Overall Study|Excluded prior to receiving drug|1|||
16938287|NCT01088997|38083076|FG001|Overall Study|Excluded prior to receiving drug|1|||
16938288|NCT01088529|38083087|FG000|Overall Study|Did not receive study treatment|0|||
16938289|NCT01088529|38083088|FG001|Overall Study|Did not receive study treatment|1|||
16938290|NCT01087944|38083094|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
16938291|NCT01087944|38083095|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
16938292|NCT01087944|38083094|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
16938293|NCT01087944|38083095|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
16938294|NCT01132612|38083104|FG000|Overall Study|Death|0|||
16938295|NCT01132612|38083105|FG001|Overall Study|Death|0|||
16938296|NCT01132612|38083106|FG002|Overall Study|Death|1|||
16938297|NCT01132612|38083104|FG000|Overall Study|Protocol deviation|0|||
16938298|NCT01132612|38083105|FG001|Overall Study|Protocol deviation|0|||
16938299|NCT01132612|38083106|FG002|Overall Study|Protocol deviation|3|||
16938300|NCT01132612|38083104|FG000|Overall Study|Lost to Follow-up|2|||
16938301|NCT01132612|38083105|FG001|Overall Study|Lost to Follow-up|2|||
16938302|NCT01132612|38083106|FG002|Overall Study|Lost to Follow-up|7|||
16938303|NCT01132612|38083104|FG000|Overall Study|Adverse Event|5|||
16938304|NCT01132612|38083105|FG001|Overall Study|Adverse Event|2|||
16938305|NCT01132612|38083106|FG002|Overall Study|Adverse Event|15|||
16938306|NCT01132612|38083104|FG000|Overall Study|Withdrawal by Subject|5|||
16938307|NCT01132612|38083105|FG001|Overall Study|Withdrawal by Subject|8|||
16938308|NCT01132612|38083106|FG002|Overall Study|Withdrawal by Subject|19|||
16938309|NCT01132612|38083104|FG000|Overall Study|Administrative problems|5|||
16938310|NCT01132612|38083105|FG001|Overall Study|Administrative problems|1|||
16938311|NCT01132612|38083106|FG002|Overall Study|Administrative problems|52|||
16938312|NCT01132612|38083104|FG000|Overall Study|Lack of Efficacy|23|||
16938313|NCT01132612|38083105|FG001|Overall Study|Lack of Efficacy|22|||
16938314|NCT01132612|38083106|FG002|Overall Study|Lack of Efficacy|73|||
16938315|NCT01132495|38083118|FG000|Overall Study|Various reasons|40|||
16938316|NCT01132495|38083119|FG001|Overall Study|Various reasons|38|||
16938317|NCT01132495|38083120|FG002|Overall Study|Various reasons|20|||
16938318|NCT01132495|38083121|FG003|Overall Study|Various reasons|12|||
16938319|NCT01087905|38083140|FG000|Overall Study|Lost to Follow-up|24|||
16938320|NCT01087905|38083141|FG001|Overall Study|Lost to Follow-up|28|||
16938321|NCT01087905|38083142|FG002|Overall Study|Lost to Follow-up|18|||
16938322|NCT01087905|38083143|FG003|Overall Study|Lost to Follow-up|31|||
16938323|NCT01087905|38083144|FG004|Overall Study|Lost to Follow-up|27|||
16938324|NCT01087905|38083145|FG005|Overall Study|Lost to Follow-up|25|||
16938325|NCT01087905|38083146|FG006|Overall Study|Lost to Follow-up|20|||
16938326|NCT01087905|38083147|FG007|Overall Study|Lost to Follow-up|24|||
16938327|NCT01087905|38083140|FG000|Overall Study|Withdrawal by Subject|5|||
16938328|NCT01087905|38083141|FG001|Overall Study|Withdrawal by Subject|4|||
16938329|NCT01087905|38083142|FG002|Overall Study|Withdrawal by Subject|4|||
16938330|NCT01087905|38083143|FG003|Overall Study|Withdrawal by Subject|5|||
16938331|NCT01087905|38083144|FG004|Overall Study|Withdrawal by Subject|4|||
16938332|NCT01087905|38083145|FG005|Overall Study|Withdrawal by Subject|3|||
16938333|NCT01087905|38083146|FG006|Overall Study|Withdrawal by Subject|3|||
16938334|NCT01087905|38083147|FG007|Overall Study|Withdrawal by Subject|5|||
16938335|NCT01087788|38083166|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
16938336|NCT01087788|38083167|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
16938337|NCT01087788|38083168|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
16938338|NCT01087788|38083166|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
16938339|NCT01087788|38083167|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
16938340|NCT01087788|38083168|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
16938341|NCT01087788|38083166|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
16938342|NCT01087788|38083167|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
16938343|NCT01087788|38083168|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
16938344|NCT01087788|38083166|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
16938345|NCT01087788|38083167|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
16938346|NCT01087788|38083168|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
16938347|NCT01087788|38083166|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
16938348|NCT01087788|38083167|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
16938349|NCT01087788|38083168|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
16938350|NCT01087788|38083166|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
16938351|NCT01087788|38083167|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
16938352|NCT01087788|38083168|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
16938353|NCT01087788|38083166|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
16938354|NCT01087788|38083167|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
16938355|NCT01087788|38083168|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
16938356|NCT01087788|38083166|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
16938357|NCT01087788|38083167|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
16938358|NCT01087788|38083168|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
16938359|NCT01087788|38083166|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
16938360|NCT01087788|38083167|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
16938361|NCT01087788|38083168|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
16938362|NCT01087788|38083166|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
16938363|NCT01087788|38083167|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
16938364|NCT01087788|38083168|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
16938365|NCT01087788|38083166|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
16938366|NCT01087788|38083167|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
16938367|NCT01087788|38083168|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
16938368|NCT01087788|38083166|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
16938369|NCT01087788|38083167|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
16938370|NCT01087788|38083168|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
16938371|NCT01087788|38083166|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
16938372|NCT01087788|38083167|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
16938373|NCT01087788|38083168|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
16938374|NCT01087788|38083166|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
16938375|NCT01087788|38083167|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
16938376|NCT01087788|38083168|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
16938377|NCT01087788|38083166|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
16938378|NCT01087788|38083167|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
16938379|NCT01087788|38083168|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
16938380|NCT01087788|38083166|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
16938381|NCT01087788|38083167|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
16938382|NCT01087788|38083168|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
16938383|NCT01087788|38083166|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
16938384|NCT01087788|38083167|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
16938385|NCT01087788|38083168|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
16938386|NCT01087788|38083166|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
16938387|NCT01087788|38083167|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
16938388|NCT01087788|38083168|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
16938389|NCT01087788|38083166|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
16938390|NCT01087788|38083167|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
16938391|NCT01087788|38083168|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
16938392|NCT01087788|38083166|FG000|24-weeks Dose-blind Period|Patient moved|0|||
16938393|NCT01087788|38083167|FG001|24-weeks Dose-blind Period|Patient moved|0|||
16938394|NCT01087788|38083168|FG002|24-weeks Dose-blind Period|Patient moved|1|||
16938395|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
16938396|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
16938397|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
16938398|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
16938399|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
16938400|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
16938401|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
16938402|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
16938403|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
16938404|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
16938405|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
16938406|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
16938407|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
16938408|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
16938409|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
16938410|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
16938411|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
16938412|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
16938413|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
16938414|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
16938415|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
16938416|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
16938417|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
16938418|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
16938419|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
16938420|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
16938421|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
16938422|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
16938423|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
16938424|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
16938425|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
16938426|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
16938427|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
16938428|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
16938429|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
16938430|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
16938431|NCT01087788|38083166|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
16938432|NCT01087788|38083167|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
16938433|NCT01087788|38083168|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
16938434|NCT01086969|38083180|FG000|Overall Study|Withdrawal by Subject|1|||
16938435|NCT01086969|38083181|FG001|Overall Study|Withdrawal by Subject|2|||
16938436|NCT01086969|38083182|FG002|Overall Study|Withdrawal by Subject|0|||
16938437|NCT01086423|38083193|FG000|Overall Study|Protocol Violation|0|||
16938438|NCT01086423|38083194|FG001|Overall Study|Protocol Violation|0|||
16938439|NCT01086423|38083195|FG002|Overall Study|Protocol Violation|1|||
16938440|NCT01086423|38083193|FG000|Overall Study|Migrated/moved from study area|2|||
16938441|NCT01086423|38083194|FG001|Overall Study|Migrated/moved from study area|0|||
16938442|NCT01086423|38083195|FG002|Overall Study|Migrated/moved from study area|4|||
16938443|NCT01086423|38083193|FG000|Overall Study|Adverse event, fatal|1|||
16938444|NCT01086423|38083194|FG001|Overall Study|Adverse event, fatal|1|||
16938445|NCT01086423|38083195|FG002|Overall Study|Adverse event, fatal|0|||
16938446|NCT01086423|38083193|FG000|Overall Study|Adverse event, non-fatal|2|||
16938447|NCT01086423|38083194|FG001|Overall Study|Adverse event, non-fatal|1|||
16938448|NCT01086423|38083195|FG002|Overall Study|Adverse event, non-fatal|0|||
16938449|NCT01086423|38083193|FG000|Overall Study|Withdrawal by Subject|5|||
16938450|NCT01086423|38083194|FG001|Overall Study|Withdrawal by Subject|1|||
16938451|NCT01086423|38083195|FG002|Overall Study|Withdrawal by Subject|3|||
16938452|NCT01086423|38083193|FG000|Overall Study|Lost to Follow-up|0|||
16938453|NCT01086423|38083194|FG001|Overall Study|Lost to Follow-up|0|||
16938454|NCT01086423|38083195|FG002|Overall Study|Lost to Follow-up|1|||
16938455|NCT01086150|38083206|FG000|Overall Study|Withdrawal by Subject|0|||
16938456|NCT01086150|38083207|FG001|Overall Study|Withdrawal by Subject|4|||
16938457|NCT01086150|38083208|FG002|Overall Study|Withdrawal by Subject|1|||
16938458|NCT01086150|38083206|FG000|Overall Study|Lost to Follow-up|0|||
16938459|NCT01086150|38083207|FG001|Overall Study|Lost to Follow-up|1|||
16938460|NCT01086150|38083208|FG002|Overall Study|Lost to Follow-up|0|||
16938461|NCT01086150|38083206|FG000|Overall Study|Screen Failure|0|||
16938462|NCT01086150|38083207|FG001|Overall Study|Screen Failure|1|||
16938463|NCT01086150|38083208|FG002|Overall Study|Screen Failure|0|||
16938464|NCT01086033|38083216|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
16938465|NCT01086033|38083216|FG000|Overall Study|Lost to Follow-up|86|||
16938466|NCT01086033|38083216|FG000|Overall Study|Adverse Event|42|||
16938467|NCT01086033|38083216|FG000|Overall Study|Withdrawal by Subject|41|||
16938468|NCT01086033|38083216|FG000|Overall Study|Other|14|||
16938469|NCT01086033|38083216|FG000|Overall Study|Other|13|||
16938470|NCT01086033|38083216|FG000|Overall Study|AE and Withdrew Consent|5|||
16938471|NCT01086033|38083216|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
16938472|NCT01086033|38083216|FG000|Overall Study|Withdrew consent and Other Reason|4|||
16938473|NCT01086033|38083216|FG000|Overall Study|AE and Lack of Efficacy|4|||
16938474|NCT01086033|38083216|FG000|Overall Study|Death|1|||
16938475|NCT01086033|38083216|FG000|Overall Study|AE and Lost to Follow-up|1|||
16938476|NCT01086033|38083216|FG000|Overall Study|AE and Other Reason|1|||
16938477|NCT01086033|38083216|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
16938478|NCT01085682|38083225|FG000|Overall Study|Withdrawal by Subject|25|||
16938479|NCT01085682|38083226|FG001|Overall Study|Withdrawal by Subject|25|||
16938480|NCT01085214|38083232|FG000|Overall Study|Alternate treatment required|1|||
16938481|NCT01085136|38083236|FG000|Part A|Other Adverse event|223|||
16938482|NCT01085136|38083237|FG001|Part A|Other Adverse event|0|||
16938483|NCT01085136|38083238|FG002|Part A|Other Adverse event|0|||
16938484|NCT01085136|38083236|FG000|Part A|Protocol Violation|3|||
16938485|NCT01085136|38083237|FG001|Part A|Protocol Violation|0|||
16938486|NCT01085136|38083238|FG002|Part A|Protocol Violation|0|||
16938487|NCT01085136|38083236|FG000|Part A|Lost to Follow-up|3|||
16938488|NCT01085136|38083237|FG001|Part A|Lost to Follow-up|0|||
16938489|NCT01085136|38083238|FG002|Part A|Lost to Follow-up|0|||
16938490|NCT01085136|38083236|FG000|Part A|Refusal to continue trial medication|64|||
16938491|NCT01085136|38083237|FG001|Part A|Refusal to continue trial medication|0|||
16938492|NCT01085136|38083238|FG002|Part A|Refusal to continue trial medication|0|||
16938493|NCT01085136|38083236|FG000|Part A|Other reason not defined above|30|||
16938494|NCT01085136|38083237|FG001|Part A|Other reason not defined above|0|||
16938495|NCT01085136|38083238|FG002|Part A|Other reason not defined above|0|||
16938496|NCT01085136|38083236|FG000|Part B|Other AE|0|||
16938497|NCT01085136|38083237|FG001|Part B|Other AE|29|||
16938498|NCT01085136|38083238|FG002|Part B|Other AE|8|||
16938499|NCT01085136|38083236|FG000|Part B|Refusal to continue trial medication|0|||
16938500|NCT01085136|38083237|FG001|Part B|Refusal to continue trial medication|12|||
16938501|NCT01085136|38083238|FG002|Part B|Refusal to continue trial medication|7|||
16938502|NCT01085136|38083236|FG000|Part B|Not treated|0|||
16938503|NCT01085136|38083237|FG001|Part B|Not treated|4|||
16938504|NCT01085136|38083238|FG002|Part B|Not treated|8|||
16938505|NCT01085136|38083236|FG000|Part B|Other reason not defined above|0|||
16938506|NCT01085136|38083237|FG001|Part B|Other reason not defined above|6|||
16938507|NCT01085136|38083238|FG002|Part B|Other reason not defined above|3|||
16938508|NCT01084707|38083248|FG000|Overall Study|Withdrawal by Subject|6|||
16938509|NCT01084668|38083260|FG000|Overall Study|Lack of Efficacy|5|||
16938510|NCT01084668|38083260|FG000|Overall Study|Withdrawal by Subject|2|||
16938511|NCT01084668|38083260|FG000|Overall Study|Pregnancy|1|||
16938512|NCT01084668|38083260|FG000|Overall Study|Non-compliance|1|||
16938513|NCT01084551|38083269|FG000|Overall Study|Adverse Event|2|||
16938514|NCT01084551|38083270|FG001|Overall Study|Adverse Event|9|||
16938515|NCT01084551|38083271|FG002|Overall Study|Adverse Event|4|||
16938516|NCT01084551|38083269|FG000|Overall Study|Lack of Efficacy|2|||
16938517|NCT01084551|38083270|FG001|Overall Study|Lack of Efficacy|0|||
16938518|NCT01084551|38083271|FG002|Overall Study|Lack of Efficacy|1|||
16938519|NCT01084551|38083269|FG000|Overall Study|Withdrawal by Subject|2|||
16938520|NCT01084551|38083270|FG001|Overall Study|Withdrawal by Subject|1|||
16938521|NCT01084551|38083271|FG002|Overall Study|Withdrawal by Subject|0|||
16938522|NCT01084551|38083269|FG000|Overall Study|Protocol Violation|2|||
16938523|NCT01084551|38083270|FG001|Overall Study|Protocol Violation|4|||
16938524|NCT01084551|38083271|FG002|Overall Study|Protocol Violation|0|||
16938525|NCT01084551|38083269|FG000|Overall Study|Lost to Follow-up|0|||
16938526|NCT01084551|38083270|FG001|Overall Study|Lost to Follow-up|0|||
16938527|NCT01084551|38083271|FG002|Overall Study|Lost to Follow-up|3|||
16938528|NCT01084551|38083269|FG000|Overall Study|Physician Decision|1|||
16938529|NCT01084551|38083270|FG001|Overall Study|Physician Decision|0|||
16938530|NCT01084551|38083271|FG002|Overall Study|Physician Decision|0|||
16938531|NCT01084083|38083279|FG000|Overall Study|Adverse Event|5|||
16938532|NCT01084083|38083279|FG000|Overall Study|Death|1|||
16938533|NCT01084083|38083279|FG000|Overall Study|Withdrawal by Subject|2|||
16938534|NCT01084083|38083279|FG000|Overall Study|Complicating disease|1|||
16938535|NCT01084083|38083279|FG000|Overall Study|Other|2|||
16938536|NCT01084083|38083279|FG000|Overall Study|Never started assigned therapy|1|||
16938537|NCT01084005|38083286|FG000|Overall Study|Adverse Event|1|||
16938538|NCT01084005|38083287|FG001|Overall Study|Adverse Event|8|||
16938539|NCT01084005|38083286|FG000|Overall Study|Protocol Violation|3|||
16938540|NCT01084005|38083287|FG001|Overall Study|Protocol Violation|7|||
16938541|NCT01084005|38083286|FG000|Overall Study|Withdrawal by Subject|1|||
16938542|NCT01084005|38083287|FG001|Overall Study|Withdrawal by Subject|1|||
16938543|NCT01083810|38083296|FG000|Overall Study|Lost to Follow-up|23|||
16938544|NCT01083810|38083297|FG001|Overall Study|Lost to Follow-up|11|||
16938545|NCT01083810|38083298|FG002|Overall Study|Lost to Follow-up|4|||
16938546|NCT01083810|38083296|FG000|Overall Study|Adverse Event|15|||
16938547|NCT01083810|38083297|FG001|Overall Study|Adverse Event|11|||
16938548|NCT01083810|38083298|FG002|Overall Study|Adverse Event|4|||
16938549|NCT01083810|38083296|FG000|Overall Study|Withdrawal by Subject|7|||
16938550|NCT01083810|38083297|FG001|Overall Study|Withdrawal by Subject|2|||
16938551|NCT01083810|38083298|FG002|Overall Study|Withdrawal by Subject|4|||
16938552|NCT01083810|38083296|FG000|Overall Study|Reason not reported|6|||
16938553|NCT01083810|38083297|FG001|Overall Study|Reason not reported|1|||
16938554|NCT01083810|38083298|FG002|Overall Study|Reason not reported|1|||
16938555|NCT01083810|38083296|FG000|Overall Study|Non-compliance|4|||
16938556|NCT01083810|38083297|FG001|Overall Study|Non-compliance|7|||
16938557|NCT01083810|38083298|FG002|Overall Study|Non-compliance|2|||
16938558|NCT01083810|38083296|FG000|Overall Study|Simplification|4|||
16938559|NCT01083810|38083297|FG001|Overall Study|Simplification|1|||
16938560|NCT01083810|38083298|FG002|Overall Study|Simplification|0|||
16938561|NCT01083810|38083296|FG000|Overall Study|Death|2|||
16938562|NCT01083810|38083297|FG001|Overall Study|Death|2|||
16938563|NCT01083810|38083298|FG002|Overall Study|Death|3|||
16938564|NCT01083810|38083296|FG000|Overall Study|Co-morbidities|1|||
16938565|NCT01083810|38083297|FG001|Overall Study|Co-morbidities|0|||
16938566|NCT01083810|38083298|FG002|Overall Study|Co-morbidities|0|||
16938567|NCT01083810|38083296|FG000|Overall Study|Participation in study|1|||
16938568|NCT01083810|38083297|FG001|Overall Study|Participation in study|0|||
16938569|NCT01083810|38083298|FG002|Overall Study|Participation in study|0|||
16938570|NCT01083810|38083296|FG000|Overall Study|Therapy break|1|||
16938571|NCT01083810|38083297|FG001|Overall Study|Therapy break|2|||
16938572|NCT01083810|38083298|FG002|Overall Study|Therapy break|2|||
16938573|NCT01083810|38083296|FG000|Overall Study|Virologic failure|1|||
16938574|NCT01083810|38083297|FG001|Overall Study|Virologic failure|8|||
16938575|NCT01083810|38083298|FG002|Overall Study|Virologic failure|0|||
16938576|NCT01083771|38083304|FG000|Overall Study|non-compliant|2|||
16938577|NCT01083771|38083304|FG000|Overall Study|Withdrawal by Subject|3|||
16938578|NCT01083693|38083311|FG000|Overall Study|Adverse Event|1|||
16938579|NCT01083693|38083312|FG001|Overall Study|Adverse Event|1|||
16938580|NCT01083693|38083313|FG002|Overall Study|Adverse Event|0|||
16938581|NCT01083693|38083311|FG000|Overall Study|Lost to Follow-up|2|||
16938582|NCT01083693|38083312|FG001|Overall Study|Lost to Follow-up|0|||
16938583|NCT01083693|38083313|FG002|Overall Study|Lost to Follow-up|2|||
16938584|NCT01083693|38083311|FG000|Overall Study|Lack of effectiveness|13|||
16938585|NCT01083693|38083312|FG001|Overall Study|Lack of effectiveness|2|||
16938586|NCT01083693|38083313|FG002|Overall Study|Lack of effectiveness|2|||
16938587|NCT01083693|38083311|FG000|Overall Study|Patient Moved|0|||
16938588|NCT01083693|38083312|FG001|Overall Study|Patient Moved|1|||
16938589|NCT01083693|38083313|FG002|Overall Study|Patient Moved|0|||
16938590|NCT01083693|38083311|FG000|Overall Study|Complete remission|0|||
16938591|NCT01083693|38083312|FG001|Overall Study|Complete remission|1|||
16938592|NCT01083693|38083313|FG002|Overall Study|Complete remission|0|||
16938593|NCT01083693|38083311|FG000|Overall Study|Other medical condition/surgery|1|||
16938594|NCT01083693|38083312|FG001|Overall Study|Other medical condition/surgery|1|||
16938595|NCT01083693|38083313|FG002|Overall Study|Other medical condition/surgery|0|||
16938596|NCT01083693|38083311|FG000|Overall Study|Withdrawal by Subject|3|||
16938597|NCT01083693|38083312|FG001|Overall Study|Withdrawal by Subject|0|||
16938598|NCT01083693|38083313|FG002|Overall Study|Withdrawal by Subject|2|||
16938599|NCT01083693|38083311|FG000|Overall Study|Reason unknown|0|||
16938600|NCT01083693|38083312|FG001|Overall Study|Reason unknown|0|||
16938601|NCT01083693|38083313|FG002|Overall Study|Reason unknown|1|||
16938602|NCT01083576|38083327|FG000|Overall Study|Treatment Failure|6|||
16938603|NCT01083576|38083328|FG001|Overall Study|Treatment Failure|1|||
16938604|NCT01083186|38083335|FG000|Overall Study|Lost to Follow-up|48|||
16938605|NCT01083186|38083335|FG000|Overall Study|Consent Withdrawal|7|||
16938606|NCT01083186|38083335|FG000|Overall Study|Death|3|||
16938607|NCT01083186|38083335|FG000|Overall Study|Adverse Event|3|||
16938608|NCT01083186|38083335|FG000|Overall Study|Lack of Efficacy|2|||
16938609|NCT01083186|38083335|FG000|Overall Study|Hemodialysis Initiation|28|||
16938610|NCT01083186|38083335|FG000|Overall Study|Administrative Reasons|2|||
16938611|NCT01083186|38083335|FG000|Overall Study|Non-compliance to Study Treatment|1|||
16938612|NCT01082640|38083362|FG000|Overall Study|Adverse Event|9|||
16938613|NCT01082640|38083363|FG001|Overall Study|Adverse Event|5|||
16938614|NCT01082640|38083364|FG002|Overall Study|Adverse Event|3|||
16938615|NCT01082640|38083362|FG000|Overall Study|Withdrawal by Subject|3|||
16938616|NCT01082640|38083363|FG001|Overall Study|Withdrawal by Subject|3|||
16938617|NCT01082640|38083364|FG002|Overall Study|Withdrawal by Subject|2|||
16938618|NCT01082640|38083362|FG000|Overall Study|Major protocol deviation|3|||
16938619|NCT01082640|38083363|FG001|Overall Study|Major protocol deviation|3|||
16938620|NCT01082640|38083364|FG002|Overall Study|Major protocol deviation|0|||
16938621|NCT01082640|38083362|FG000|Overall Study|Lost to Follow-up|0|||
16938622|NCT01082640|38083363|FG001|Overall Study|Lost to Follow-up|3|||
16938623|NCT01082640|38083364|FG002|Overall Study|Lost to Follow-up|0|||
16938624|NCT01082640|38083362|FG000|Overall Study|Other|2|||
16938625|NCT01082640|38083363|FG001|Overall Study|Other|1|||
16938626|NCT01082640|38083364|FG002|Overall Study|Other|3|||
16938627|NCT01082367|38083377|FG000|Double-blind Period|Administrative problems|0|||
16938628|NCT01082367|38083378|FG001|Double-blind Period|Administrative problems|1|||
16938629|NCT01082367|38083377|FG000|Double-blind Period|Lack of Efficacy|5|||
16938630|NCT01082367|38083378|FG001|Double-blind Period|Lack of Efficacy|11|||
16938631|NCT01082367|38083377|FG000|Double-blind Period|Adverse Event|0|||
16938632|NCT01082367|38083378|FG001|Double-blind Period|Adverse Event|1|||
16938633|NCT01082367|38083377|FG000|Follow-up (F-U) Period|Administrative problems|1|||
16938634|NCT01082367|38083378|FG001|Follow-up (F-U) Period|Administrative problems|0|||
16938635|NCT01082367|38083377|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
16938636|NCT01082367|38083378|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
16938637|NCT01082367|38083377|FG000|Follow-up (F-U) Period|Adverse Event|0|||
16938638|NCT01082367|38083378|FG001|Follow-up (F-U) Period|Adverse Event|1|||
16938639|NCT01082211|38083388|FG000|Overall Study|Protocol Violation|4|||
16938640|NCT01082211|38083388|FG000|Overall Study|No protocol treatment received|3|||
16938641|NCT01081665|38083395|FG000|Overall Study|Death|41|||
16938642|NCT01081665|38083395|FG000|Overall Study|Lost to Follow-up|18|||
16938643|NCT01081665|38083395|FG000|Overall Study|Withdrawal by Subject|17|||
16938644|NCT01081665|38083395|FG000|Overall Study|Change of dialysis unit|10|||
16938645|NCT01081665|38083395|FG000|Overall Study|Regulation of iPTH|5|||
16938646|NCT01081665|38083395|FG000|Overall Study|Change in renal replacement therapy|2|||
16938647|NCT01081665|38083395|FG000|Overall Study|Adverse Event|1|||
16938648|NCT01081665|38083395|FG000|Overall Study|Lack of Efficacy|1|||
16938649|NCT01081626|38083401|FG000|Overall Study|Dosing error|1|||
16938650|NCT01081626|38083402|FG001|Overall Study|Dosing error|1|||
16938651|NCT01081626|38083401|FG000|Overall Study|Missing Estradiol|25|||
16938652|NCT01081626|38083402|FG001|Overall Study|Missing Estradiol|28|||
16938653|NCT01081626|38083401|FG000|Overall Study|Low antral follicle count|1|||
16938654|NCT01081626|38083402|FG001|Overall Study|Low antral follicle count|0|||
16938655|NCT01081626|38083401|FG000|Overall Study|Overstimulation|0|||
16938656|NCT01081626|38083402|FG001|Overall Study|Overstimulation|1|||
16938657|NCT01081626|38083401|FG000|Overall Study|Lost to Follow-up|0|||
16938658|NCT01081626|38083402|FG001|Overall Study|Lost to Follow-up|1|||
16938659|NCT01081626|38083401|FG000|Overall Study|Other|33|||
16938660|NCT01081626|38083402|FG001|Overall Study|Other|30|||
16938661|NCT01080768|38083410|FG000|Overall Study|Protocol Deviation|2|||
16938662|NCT01080768|38083411|FG001|Overall Study|Protocol Deviation|1|||
16938663|NCT01080300|38083419|FG000|Overall Study|Adverse Event|49|||
16938664|NCT01080300|38083420|FG001|Overall Study|Adverse Event|35|||
16938665|NCT01080300|38083419|FG000|Overall Study|Lack of Efficacy|12|||
16938666|NCT01080300|38083420|FG001|Overall Study|Lack of Efficacy|15|||
16938667|NCT01080300|38083419|FG000|Overall Study|Protocol Violation|7|||
16938668|NCT01080300|38083420|FG001|Overall Study|Protocol Violation|13|||
16938669|NCT01080300|38083419|FG000|Overall Study|Lost to Follow-up|10|||
16938670|NCT01080300|38083420|FG001|Overall Study|Lost to Follow-up|6|||
16938671|NCT01080300|38083419|FG000|Overall Study|Death|0|||
16938672|NCT01080300|38083420|FG001|Overall Study|Death|1|||
16938673|NCT01080300|38083419|FG000|Overall Study|Withdrawal by Subject|12|||
16938674|NCT01080300|38083420|FG001|Overall Study|Withdrawal by Subject|28|||
16938675|NCT01080300|38083419|FG000|Overall Study|Reasons not specified|4|||
16938676|NCT01080300|38083420|FG001|Overall Study|Reasons not specified|6|||
16938677|NCT01085097|38083431|FG000|Overall Study|Adverse Event|0|||
16938678|NCT01085097|38083432|FG001|Overall Study|Adverse Event|0|||
16938679|NCT01085097|38083433|FG002|Overall Study|Adverse Event|2|||
16938680|NCT01085097|38083431|FG000|Overall Study|Treatment failure|2|||
16938681|NCT01085097|38083432|FG001|Overall Study|Treatment failure|0|||
16938682|NCT01085097|38083433|FG002|Overall Study|Treatment failure|0|||
16938683|NCT03450629|38083447|FG000|Overall Study|Adverse Event|15|||
16938684|NCT03450629|38083448|FG001|Overall Study|Adverse Event|14|||
16938685|NCT03450629|38083447|FG000|Overall Study|Physician Decision|2|||
16938686|NCT03450629|38083448|FG001|Overall Study|Physician Decision|2|||
16938687|NCT03450629|38083447|FG000|Overall Study|Lack of Efficacy|2|||
16938688|NCT03450629|38083448|FG001|Overall Study|Lack of Efficacy|0|||
16938689|NCT03450629|38083447|FG000|Overall Study|Lost to Follow-up|4|||
16938690|NCT03450629|38083448|FG001|Overall Study|Lost to Follow-up|2|||
16938691|NCT03450629|38083447|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16938692|NCT03450629|38083448|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
16938693|NCT03450629|38083447|FG000|Overall Study|Non-Compliance With Study Drug|2|||
16938694|NCT03450629|38083448|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16938695|NCT03450629|38083447|FG000|Overall Study|Protocol Violation|11|||
16938696|NCT03450629|38083448|FG001|Overall Study|Protocol Violation|8|||
16938697|NCT03450629|38083447|FG000|Overall Study|Withdrawal by Subject|12|||
16938698|NCT03450629|38083448|FG001|Overall Study|Withdrawal by Subject|6|||
16938699|NCT00198029|38083454|FG000|Overall Study|Withdrawal by Subject|4|||
16938700|NCT00197054|38083461|FG000|Overall Study|Withdrawal by Subject|9|||
16938701|NCT00197054|38083462|FG001|Overall Study|Withdrawal by Subject|3|||
16938702|NCT00197054|38083463|FG002|Overall Study|Withdrawal by Subject|3|||
16938703|NCT00197054|38083461|FG000|Overall Study|Moved from area|7|||
16938704|NCT00197054|38083462|FG001|Overall Study|Moved from area|14|||
16938705|NCT00197054|38083463|FG002|Overall Study|Moved from area|9|||
16938706|NCT00197054|38083461|FG000|Overall Study|Lost to Follow-up|1|||
16938707|NCT00197054|38083462|FG001|Overall Study|Lost to Follow-up|4|||
16938708|NCT00197054|38083463|FG002|Overall Study|Lost to Follow-up|0|||
16938709|NCT00197015|38083484|FG000|Overall Study|Adverse Event|3|||
16938710|NCT00197015|38083485|FG001|Overall Study|Adverse Event|0|||
16938711|NCT00197015|38083486|FG002|Overall Study|Adverse Event|1|||
16938712|NCT00197015|38083484|FG000|Overall Study|Protocol Violation|0|||
16938713|NCT00197015|38083485|FG001|Overall Study|Protocol Violation|3|||
16938714|NCT00197015|38083486|FG002|Overall Study|Protocol Violation|3|||
16938715|NCT00197015|38083484|FG000|Overall Study|Withdrawal by Subject|17|||
16938716|NCT00197015|38083485|FG001|Overall Study|Withdrawal by Subject|37|||
16938717|NCT00197015|38083486|FG002|Overall Study|Withdrawal by Subject|34|||
16938718|NCT00197015|38083484|FG000|Overall Study|Lost to Follow-up|28|||
16938719|NCT00197015|38083485|FG001|Overall Study|Lost to Follow-up|46|||
16938720|NCT00197015|38083486|FG002|Overall Study|Lost to Follow-up|37|||
16938721|NCT00197015|38083484|FG000|Overall Study|Other|2|||
16938722|NCT00197015|38083485|FG001|Overall Study|Other|3|||
16938723|NCT00197015|38083486|FG002|Overall Study|Other|2|||
16938724|NCT00196976|38083508|FG000|Primary Study|Migrated from study area|0|||
16938725|NCT00196976|38083509|FG001|Primary Study|Migrated from study area|0|||
16938726|NCT00196976|38083510|FG002|Primary Study|Migrated from study area|0|||
16938727|NCT00196976|38083511|FG003|Primary Study|Migrated from study area|0|||
16938728|NCT00196976|38083512|FG004|Primary Study|Migrated from study area|0|||
16938729|NCT00196976|38083513|FG005|Primary Study|Migrated from study area|0|||
16938730|NCT00196976|38083514|FG006|Primary Study|Migrated from study area|0|||
16938731|NCT00196976|38083515|FG007|Primary Study|Migrated from study area|1|||
16938732|NCT00196976|38083516|FG008|Primary Study|Migrated from study area|0|||
16938733|NCT00196976|38083517|FG009|Primary Study|Migrated from study area|0|||
16938734|NCT00196976|38083518|FG010|Primary Study|Migrated from study area|0|||
16938735|NCT00196976|38083519|FG011|Primary Study|Migrated from study area|0|||
16938736|NCT00196976|38083520|FG012|Primary Study|Migrated from study area|0|||
16938737|NCT00196976|38083521|FG013|Primary Study|Migrated from study area|0|||
16938738|NCT00196976|38083508|FG000|Primary Study|Protocol Violation|0|||
16938739|NCT00196976|38083509|FG001|Primary Study|Protocol Violation|1|||
16938740|NCT00196976|38083510|FG002|Primary Study|Protocol Violation|1|||
16938741|NCT00196976|38083511|FG003|Primary Study|Protocol Violation|0|||
16938742|NCT00196976|38083512|FG004|Primary Study|Protocol Violation|0|||
16938743|NCT00196976|38083513|FG005|Primary Study|Protocol Violation|0|||
16938744|NCT00196976|38083514|FG006|Primary Study|Protocol Violation|0|||
16938745|NCT00196976|38083515|FG007|Primary Study|Protocol Violation|0|||
16938746|NCT00196976|38083516|FG008|Primary Study|Protocol Violation|0|||
16938747|NCT00196976|38083517|FG009|Primary Study|Protocol Violation|0|||
16938748|NCT00196976|38083518|FG010|Primary Study|Protocol Violation|0|||
16938749|NCT00196976|38083519|FG011|Primary Study|Protocol Violation|0|||
16938750|NCT00196976|38083520|FG012|Primary Study|Protocol Violation|0|||
16938751|NCT00196976|38083521|FG013|Primary Study|Protocol Violation|0|||
16938752|NCT00196976|38083508|FG000|Primary Study|Withdrawal by Subject|1|||
16938753|NCT00196976|38083509|FG001|Primary Study|Withdrawal by Subject|0|||
16938754|NCT00196976|38083510|FG002|Primary Study|Withdrawal by Subject|1|||
16938755|NCT00196976|38083511|FG003|Primary Study|Withdrawal by Subject|1|||
16938756|NCT00196976|38083512|FG004|Primary Study|Withdrawal by Subject|2|||
16938757|NCT00196976|38083513|FG005|Primary Study|Withdrawal by Subject|1|||
16938758|NCT00196976|38083514|FG006|Primary Study|Withdrawal by Subject|0|||
16938759|NCT00196976|38083515|FG007|Primary Study|Withdrawal by Subject|0|||
16938760|NCT00196976|38083516|FG008|Primary Study|Withdrawal by Subject|0|||
16938761|NCT00196976|38083517|FG009|Primary Study|Withdrawal by Subject|1|||
16938762|NCT00196976|38083518|FG010|Primary Study|Withdrawal by Subject|0|||
16938763|NCT00196976|38083519|FG011|Primary Study|Withdrawal by Subject|0|||
16938764|NCT00196976|38083520|FG012|Primary Study|Withdrawal by Subject|0|||
17105240|NCT03585712|38242910|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
17105241|NCT03585712|38242908|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
17105242|NCT03585712|38242909|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
17105243|NCT03585712|38242910|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
17105244|NCT03585244|38242927|FG000|Overall Study|Withdrawal by Subject|15|||
17105245|NCT00074984|38242933|FG000|Overall Study|Death|1|||
17105246|NCT00074984|38242934|FG001|Overall Study|Death|2|||
17105247|NCT00074984|38242933|FG000|Overall Study|Withdrawal by Subject|2|||
17105248|NCT00074984|38242934|FG001|Overall Study|Withdrawal by Subject|3|||
17105249|NCT00074984|38242933|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
17105250|NCT00074984|38242934|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
17105251|NCT03583606|38242944|FG000|Overall Study|Lost to Follow-up|0|||
17105252|NCT03583606|38242945|FG001|Overall Study|Lost to Follow-up|1|||
17105253|NCT03583606|38242946|FG002|Overall Study|Lost to Follow-up|0|||
17105254|NCT03583606|38242944|FG000|Overall Study|Ineligible at baseline|1|||
17105255|NCT03583606|38242945|FG001|Overall Study|Ineligible at baseline|0|||
17105256|NCT03583606|38242946|FG002|Overall Study|Ineligible at baseline|0|||
17105257|NCT03583450|38242957|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
17105258|NCT03583450|38242958|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
17105259|NCT03583372|38242970|FG000|Overall Study|Withdrawal by Subject|6|||
17105260|NCT03583372|38242971|FG001|Overall Study|Withdrawal by Subject|11|||
17105261|NCT03583372|38242972|FG002|Overall Study|Withdrawal by Subject|7|||
17105262|NCT03583372|38242973|FG003|Overall Study|Withdrawal by Subject|8|||
17105263|NCT03583372|38242970|FG000|Overall Study|Lost to Follow-up|4|||
17105264|NCT03583372|38242971|FG001|Overall Study|Lost to Follow-up|6|||
17105265|NCT03583372|38242972|FG002|Overall Study|Lost to Follow-up|3|||
17105266|NCT03583372|38242973|FG003|Overall Study|Lost to Follow-up|2|||
17105267|NCT03583372|38242970|FG000|Overall Study|Adverse Event|1|||
17105268|NCT03583372|38242971|FG001|Overall Study|Adverse Event|3|||
17105269|NCT03583372|38242972|FG002|Overall Study|Adverse Event|4|||
17105270|NCT03583372|38242973|FG003|Overall Study|Adverse Event|4|||
17105271|NCT03583372|38242970|FG000|Overall Study|Physician Decision|0|||
17105272|NCT03583372|38242971|FG001|Overall Study|Physician Decision|1|||
17105273|NCT03583372|38242972|FG002|Overall Study|Physician Decision|1|||
17105274|NCT03583372|38242973|FG003|Overall Study|Physician Decision|1|||
17105275|NCT03583372|38242970|FG000|Overall Study|Lack of Efficacy|0|||
17105276|NCT03583372|38242971|FG001|Overall Study|Lack of Efficacy|1|||
17105277|NCT03583372|38242972|FG002|Overall Study|Lack of Efficacy|0|||
17105278|NCT03583372|38242973|FG003|Overall Study|Lack of Efficacy|1|||
17105279|NCT03583372|38242970|FG000|Overall Study|Death|1|||
17105280|NCT03583372|38242971|FG001|Overall Study|Death|0|||
17105281|NCT03583372|38242972|FG002|Overall Study|Death|0|||
17105282|NCT03583372|38242973|FG003|Overall Study|Death|0|||
17105283|NCT03583372|38242970|FG000|Overall Study|Protocol Violation|0|||
17105284|NCT03583372|38242971|FG001|Overall Study|Protocol Violation|1|||
17105285|NCT03583372|38242972|FG002|Overall Study|Protocol Violation|0|||
17105286|NCT03583372|38242973|FG003|Overall Study|Protocol Violation|0|||
17105287|NCT03583372|38242970|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
17105288|NCT03583372|38242971|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
17105289|NCT03583372|38242972|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
17105290|NCT03583372|38242973|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
17105291|NCT03583372|38242970|FG000|Overall Study|Did Not Receive Study Drug|0|||
17105292|NCT03583372|38242971|FG001|Overall Study|Did Not Receive Study Drug|1|||
17105293|NCT03583372|38242972|FG002|Overall Study|Did Not Receive Study Drug|0|||
17105294|NCT03583372|38242973|FG003|Overall Study|Did Not Receive Study Drug|0|||
17105295|NCT03583372|38242970|FG000|Overall Study|Captured as Other in the Database|1|||
17105296|NCT03583372|38242971|FG001|Overall Study|Captured as Other in the Database|2|||
17105297|NCT03583372|38242972|FG002|Overall Study|Captured as Other in the Database|4|||
17105298|NCT03583372|38242973|FG003|Overall Study|Captured as Other in the Database|1|||
17105299|NCT00074282|38242983|FG000|Step 1|Adverse Event|32|||
17105300|NCT00074282|38242984|FG001|Step 1|Adverse Event|0|||
17105301|NCT00074282|38242985|FG002|Step 1|Adverse Event|0|||
17105302|NCT00074282|38242983|FG000|Step 1|Death|6|||
17105303|NCT00074282|38242984|FG001|Step 1|Death|0|||
17105304|NCT00074282|38242985|FG002|Step 1|Death|0|||
17105305|NCT00074282|38242983|FG000|Step 1|Withdrawal by Subject|7|||
17105306|NCT00074282|38242984|FG001|Step 1|Withdrawal by Subject|0|||
17105307|NCT00074282|38242985|FG002|Step 1|Withdrawal by Subject|0|||
16938765|NCT00196976|38083521|FG013|Primary Study|Withdrawal by Subject|0|||
16938766|NCT00196976|38083508|FG000|Primary Study|Lost to Follow-up|0|||
16938767|NCT00196976|38083509|FG001|Primary Study|Lost to Follow-up|0|||
16938768|NCT00196976|38083510|FG002|Primary Study|Lost to Follow-up|0|||
17105308|NCT00074282|38242983|FG000|Step 1|Disease progression|2|||
17105309|NCT00074282|38242984|FG001|Step 1|Disease progression|0|||
17105310|NCT00074282|38242985|FG002|Step 1|Disease progression|0|||
16938769|NCT00196976|38083511|FG003|Primary Study|Lost to Follow-up|0|||
16938770|NCT00196976|38083512|FG004|Primary Study|Lost to Follow-up|1|||
16938771|NCT00196976|38083513|FG005|Primary Study|Lost to Follow-up|1|||
16938772|NCT00196976|38083514|FG006|Primary Study|Lost to Follow-up|0|||
16938773|NCT00196976|38083515|FG007|Primary Study|Lost to Follow-up|2|||
17105311|NCT00074282|38242983|FG000|Step 1|Alternative therapy|2|||
17105312|NCT00074282|38242984|FG001|Step 1|Alternative therapy|0|||
17105313|NCT00074282|38242985|FG002|Step 1|Alternative therapy|0|||
17105314|NCT00074282|38242983|FG000|Step 1|Other complicating disease|2|||
17105315|NCT00074282|38242984|FG001|Step 1|Other complicating disease|0|||
17105316|NCT00074282|38242985|FG002|Step 1|Other complicating disease|0|||
17105317|NCT00074282|38242983|FG000|Step 1|Physician Decision|1|||
17105318|NCT00074282|38242984|FG001|Step 1|Physician Decision|0|||
17105319|NCT00074282|38242985|FG002|Step 1|Physician Decision|0|||
17105320|NCT00074282|38242983|FG000|Step 1|Ineligible|4|||
17105321|NCT00074282|38242984|FG001|Step 1|Ineligible|0|||
17105322|NCT00074282|38242985|FG002|Step 1|Ineligible|0|||
17105323|NCT00074282|38242983|FG000|Step 1|Never started treatment|2|||
17105324|NCT00074282|38242984|FG001|Step 1|Never started treatment|0|||
17105325|NCT00074282|38242985|FG002|Step 1|Never started treatment|0|||
17105326|NCT00074282|38242983|FG000|Step 2|Adverse Event|0|||
17105327|NCT00074282|38242984|FG001|Step 2|Adverse Event|2|||
17105328|NCT00074282|38242985|FG002|Step 2|Adverse Event|12|||
17105329|NCT00074282|38242983|FG000|Step 2|Disease progression|0|||
17105330|NCT00074282|38242984|FG001|Step 2|Disease progression|0|||
17105331|NCT00074282|38242985|FG002|Step 2|Disease progression|5|||
17105332|NCT00074282|38242983|FG000|Step 2|Death|0|||
17105333|NCT00074282|38242984|FG001|Step 2|Death|0|||
17105334|NCT00074282|38242985|FG002|Step 2|Death|3|||
17105335|NCT00074282|38242983|FG000|Step 2|Withdrawal by Subject|0|||
17105336|NCT00074282|38242984|FG001|Step 2|Withdrawal by Subject|0|||
17105337|NCT00074282|38242985|FG002|Step 2|Withdrawal by Subject|2|||
17105338|NCT00074282|38242983|FG000|Step 2|Physician Decision|0|||
17105339|NCT00074282|38242984|FG001|Step 2|Physician Decision|0|||
17105340|NCT00074282|38242985|FG002|Step 2|Physician Decision|1|||
17105341|NCT00074282|38242983|FG000|Step 2|Ineligible|0|||
17105342|NCT00074282|38242984|FG001|Step 2|Ineligible|0|||
17105343|NCT00074282|38242985|FG002|Step 2|Ineligible|1|||
17105344|NCT03582826|38242995|FG000|Overall Study|Lost to Follow-up|39|||
17105345|NCT03582826|38242996|FG001|Overall Study|Lost to Follow-up|0|||
17105346|NCT03582826|38242995|FG000|Overall Study|Withdrawal by Subject|2|||
17105347|NCT03582826|38242996|FG001|Overall Study|Withdrawal by Subject|0|||
16938774|NCT00196976|38083516|FG008|Primary Study|Lost to Follow-up|0|||
16938775|NCT00196976|38083517|FG009|Primary Study|Lost to Follow-up|0|||
16938776|NCT00196976|38083518|FG010|Primary Study|Lost to Follow-up|0|||
17105348|NCT03518008|38243011|FG000|Period 2, Second Week of Wear|Family emergency|0|||
17105349|NCT03518008|38243012|FG001|Period 2, Second Week of Wear|Family emergency|1|||
17105350|NCT03810014|38243022|FG000|Overall Study|Pregnancy|2|||
17105351|NCT03810014|38243023|FG001|Overall Study|Pregnancy|2|||
17105352|NCT03810014|38243024|FG002|Overall Study|Pregnancy|0|||
17105353|NCT03810014|38243025|FG003|Overall Study|Pregnancy|2|||
17105354|NCT04881747|38243041|FG000|Period 2 Washout|Adverse Event|1|||
16938777|NCT00196976|38083519|FG011|Primary Study|Lost to Follow-up|0|||
16938778|NCT00196976|38083520|FG012|Primary Study|Lost to Follow-up|0|||
16938779|NCT00196976|38083521|FG013|Primary Study|Lost to Follow-up|0|||
16938780|NCT00196976|38083508|FG000|Primary Study|Other|0|||
16938781|NCT00196976|38083509|FG001|Primary Study|Other|0|||
16938782|NCT00196976|38083510|FG002|Primary Study|Other|2|||
16938783|NCT00196976|38083511|FG003|Primary Study|Other|0|||
16938784|NCT00196976|38083512|FG004|Primary Study|Other|0|||
16938785|NCT00196976|38083513|FG005|Primary Study|Other|0|||
16938786|NCT00196976|38083514|FG006|Primary Study|Other|0|||
16938787|NCT00196976|38083515|FG007|Primary Study|Other|0|||
16938788|NCT00196976|38083516|FG008|Primary Study|Other|0|||
16938789|NCT00196976|38083517|FG009|Primary Study|Other|0|||
16938790|NCT00196976|38083518|FG010|Primary Study|Other|0|||
16938791|NCT00196976|38083519|FG011|Primary Study|Other|0|||
16938792|NCT00196976|38083520|FG012|Primary Study|Other|0|||
16938793|NCT00196976|38083521|FG013|Primary Study|Other|0|||
16938794|NCT00196976|38083508|FG000|Booster Study|Withdrawal by Subject|0|||
16938795|NCT00196976|38083509|FG001|Booster Study|Withdrawal by Subject|0|||
16938796|NCT00196976|38083510|FG002|Booster Study|Withdrawal by Subject|0|||
16938797|NCT00196976|38083511|FG003|Booster Study|Withdrawal by Subject|0|||
16938798|NCT00196976|38083512|FG004|Booster Study|Withdrawal by Subject|0|||
16938799|NCT00196976|38083513|FG005|Booster Study|Withdrawal by Subject|0|||
16938800|NCT00196976|38083514|FG006|Booster Study|Withdrawal by Subject|0|||
16938801|NCT00196976|38083515|FG007|Booster Study|Withdrawal by Subject|0|||
16938802|NCT00196976|38083516|FG008|Booster Study|Withdrawal by Subject|0|||
16938803|NCT00196976|38083517|FG009|Booster Study|Withdrawal by Subject|0|||
17105355|NCT04881747|38243042|FG001|Period 2 Washout|Adverse Event|0|||
17105356|NCT04881747|38243043|FG002|Period 2 Washout|Adverse Event|0|||
17105357|NCT04881747|38243044|FG003|Period 2 Washout|Adverse Event|0|||
17105358|NCT04881747|38243045|FG004|Period 2 Washout|Adverse Event|1|||
17105359|NCT04881747|38243046|FG005|Period 2 Washout|Adverse Event|0|||
16938804|NCT00196976|38083518|FG010|Booster Study|Withdrawal by Subject|1|||
16938805|NCT00196976|38083519|FG011|Booster Study|Withdrawal by Subject|0|||
16938806|NCT00196976|38083520|FG012|Booster Study|Withdrawal by Subject|0|||
16938807|NCT00196976|38083521|FG013|Booster Study|Withdrawal by Subject|0|||
16938808|NCT00196976|38083508|FG000|Booster Study|Lost to Follow-up|0|||
16938809|NCT00196976|38083509|FG001|Booster Study|Lost to Follow-up|0|||
16938810|NCT00196976|38083510|FG002|Booster Study|Lost to Follow-up|0|||
16938811|NCT00196976|38083511|FG003|Booster Study|Lost to Follow-up|0|||
16938812|NCT00196976|38083512|FG004|Booster Study|Lost to Follow-up|0|||
16938813|NCT00196976|38083513|FG005|Booster Study|Lost to Follow-up|0|||
17105360|NCT04881747|38243041|FG000|Period 2 Washout|Withdrawal by Subject|1|||
17105361|NCT04881747|38243042|FG001|Period 2 Washout|Withdrawal by Subject|0|||
17105362|NCT04881747|38243043|FG002|Period 2 Washout|Withdrawal by Subject|0|||
17105363|NCT04881747|38243044|FG003|Period 2 Washout|Withdrawal by Subject|1|||
17105364|NCT04881747|38243045|FG004|Period 2 Washout|Withdrawal by Subject|0|||
17105365|NCT04881747|38243046|FG005|Period 2 Washout|Withdrawal by Subject|0|||
17105366|NCT04795622|38243056|FG000|Overall Study|Adverse Event|1|||
17105367|NCT04795622|38243057|FG001|Overall Study|Adverse Event|0|||
17105368|NCT04795622|38243056|FG000|Overall Study|Withdrawal by Subject|3|||
17105369|NCT04795622|38243057|FG001|Overall Study|Withdrawal by Subject|3|||
17105370|NCT04795622|38243056|FG000|Overall Study|Protocol Violation|0|||
17105371|NCT04795622|38243057|FG001|Overall Study|Protocol Violation|2|||
17105372|NCT04795622|38243056|FG000|Overall Study|Lost to Follow-up|2|||
17105373|NCT04795622|38243057|FG001|Overall Study|Lost to Follow-up|3|||
17105374|NCT04795622|38243056|FG000|Overall Study|Other|7|||
17105375|NCT04795622|38243057|FG001|Overall Study|Other|8|||
17105376|NCT04652245|38243078|FG000|Wash-Out Period|Adverse Event|0|||
17105377|NCT04652245|38243079|FG001|Wash-Out Period|Adverse Event|2|||
17105378|NCT04652245|38243078|FG000|Wash-Out Period|Withdrawal by Subject|0|||
17105379|NCT04652245|38243079|FG001|Wash-Out Period|Withdrawal by Subject|2|||
17105380|NCT04405739|38243096|FG000|Overall Study|Adverse Event|0|||
17105381|NCT04405739|38243097|FG001|Overall Study|Adverse Event|1|||
17105382|NCT04405739|38243098|FG002|Overall Study|Adverse Event|0|||
17105383|NCT04405739|38243099|FG003|Overall Study|Adverse Event|0|||
17105384|NCT04405739|38243096|FG000|Overall Study|Lost to Follow-up|0|||
17105385|NCT04405739|38243097|FG001|Overall Study|Lost to Follow-up|2|||
17105386|NCT04405739|38243098|FG002|Overall Study|Lost to Follow-up|1|||
17105387|NCT04405739|38243099|FG003|Overall Study|Lost to Follow-up|3|||
17105388|NCT04405739|38243096|FG000|Overall Study|Withdrawal by Subject|0|||
17105389|NCT04405739|38243097|FG001|Overall Study|Withdrawal by Subject|2|||
17105390|NCT04405739|38243098|FG002|Overall Study|Withdrawal by Subject|1|||
17105391|NCT04405739|38243099|FG003|Overall Study|Withdrawal by Subject|1|||
17105392|NCT04405739|38243096|FG000|Overall Study|Death|0|||
17105393|NCT04405739|38243097|FG001|Overall Study|Death|0|||
17105394|NCT04405739|38243098|FG002|Overall Study|Death|1|||
17105395|NCT04405739|38243099|FG003|Overall Study|Death|0|||
17105396|NCT04405739|38243096|FG000|Overall Study|Transferred to rehab|0|||
17105397|NCT04405739|38243097|FG001|Overall Study|Transferred to rehab|0|||
17105398|NCT04405739|38243098|FG002|Overall Study|Transferred to rehab|0|||
17105399|NCT04405739|38243099|FG003|Overall Study|Transferred to rehab|1|||
17105400|NCT04405739|38243096|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
17105401|NCT04405739|38243097|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
17105402|NCT04405739|38243098|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
17105403|NCT04405739|38243099|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
17105404|NCT04241315|38243111|FG000|Overall Study|Withdrawal by Subject|0|||
17105405|NCT04241315|38243112|FG001|Overall Study|Withdrawal by Subject|1|||
17105406|NCT04225026|38243118|FG000|Overall Study|Withdrawal by Subject|4|||
17105407|NCT04225026|38243118|FG000|Overall Study|Adverse Event|1|||
17105408|NCT04225026|38243118|FG000|Overall Study|Other|1|||
17105409|NCT04225026|38243118|FG000|Overall Study|Death|11|||
17105410|NCT04225026|38243118|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
17105411|NCT04203823|38243125|FG000|Overall Study|Withdrawal by Subject|2|||
17105412|NCT04203823|38243126|FG001|Overall Study|Withdrawal by Subject|2|||
17105413|NCT04203823|38243125|FG000|Overall Study|Adverse Event|1|||
17105414|NCT04203823|38243126|FG001|Overall Study|Adverse Event|1|||
17105415|NCT04203823|38243125|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
17105416|NCT04203823|38243126|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
17105417|NCT03493958|38243542|FG000|Overall Study|Withdrawal by Subject|6|||
17105418|NCT03493958|38243542|FG000|Overall Study|Lost to Follow-up|7|||
17105419|NCT03493958|38243542|FG000|Overall Study|Did not complete all required study procedures|2|||
17105420|NCT03486223|38243548|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
17105421|NCT03486223|38243549|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
17105422|NCT03482024|38243560|FG000|Overall Study|Physician Decision|1|||
17105423|NCT03482024|38243561|FG001|Overall Study|Physician Decision|0|||
17105424|NCT03482024|38243562|FG002|Overall Study|Physician Decision|0|||
17105425|NCT03482024|38243563|FG003|Overall Study|Physician Decision|0|||
17105426|NCT03482024|38243564|FG004|Overall Study|Physician Decision|0|||
16938814|NCT00196976|38083514|FG006|Booster Study|Lost to Follow-up|0|||
16938815|NCT00196976|38083515|FG007|Booster Study|Lost to Follow-up|0|||
16938816|NCT00196976|38083516|FG008|Booster Study|Lost to Follow-up|0|||
16938817|NCT00196976|38083517|FG009|Booster Study|Lost to Follow-up|0|||
16938818|NCT00196976|38083518|FG010|Booster Study|Lost to Follow-up|1|||
16938819|NCT00196976|38083519|FG011|Booster Study|Lost to Follow-up|2|||
16938820|NCT00196976|38083520|FG012|Booster Study|Lost to Follow-up|0|||
16938821|NCT00196976|38083521|FG013|Booster Study|Lost to Follow-up|0|||
16938822|NCT00196313|38083563|FG000|Overall Study|Protocol Violation|2|||
16938823|NCT00196313|38083564|FG001|Overall Study|Protocol Violation|3|||
16938824|NCT00196313|38083563|FG000|Overall Study|Withdrawal by Subject|3|||
16938825|NCT00196313|38083564|FG001|Overall Study|Withdrawal by Subject|1|||
16938826|NCT00196313|38083563|FG000|Overall Study|Adverse Event|3|||
16938827|NCT00196313|38083564|FG001|Overall Study|Adverse Event|1|||
16938828|NCT00196313|38083563|FG000|Overall Study|Subject Pregnant|1|||
16938829|NCT00196313|38083564|FG001|Overall Study|Subject Pregnant|1|||
16938830|NCT00196313|38083563|FG000|Overall Study|Lost to Follow-up|2|||
16938831|NCT00196313|38083564|FG001|Overall Study|Lost to Follow-up|2|||
16938832|NCT00196196|38083571|FG000|Overall Study|Withdrawal by Subject|2|||
16938833|NCT00196196|38083571|FG000|Overall Study|Did not have required condition (hydroce|5|||
16938834|NCT00195650|38083575|FG000|Overall Study|Adverse Event|194|||
16938835|NCT00195650|38083575|FG000|Overall Study|Lack of Efficacy|99|||
16938836|NCT00195650|38083575|FG000|Overall Study|Withdrawal by Subject|67|||
16938837|NCT00195650|38083575|FG000|Overall Study|Lost to Follow-up|44|||
16938838|NCT00195650|38083575|FG000|Overall Study|Death|23|||
16938839|NCT00195650|38083575|FG000|Overall Study|Protocol Violation|15|||
16938840|NCT00195650|38083575|FG000|Overall Study|Administrative reasons|83|||
16938841|NCT00195494|38083581|FG000|Year 1|Adverse Event|0|||
16938842|NCT00195494|38083582|FG001|Year 1|Adverse Event|0|||
16938843|NCT00195494|38083583|FG002|Year 1|Adverse Event|0|||
16938844|NCT00195494|38083584|FG003|Year 1|Adverse Event|0|||
16938845|NCT00195494|38083585|FG004|Year 1|Adverse Event|34|||
16938846|NCT00195494|38083586|FG005|Year 1|Adverse Event|27|||
16938847|NCT00195494|38083581|FG000|Year 1|System Toxicity|0|||
16938848|NCT00195494|38083582|FG001|Year 1|System Toxicity|0|||
16938849|NCT00195494|38083583|FG002|Year 1|System Toxicity|0|||
16938850|NCT00195494|38083584|FG003|Year 1|System Toxicity|0|||
16938851|NCT00195494|38083585|FG004|Year 1|System Toxicity|0|||
16938852|NCT00195494|38083586|FG005|Year 1|System Toxicity|1|||
16938853|NCT00195494|38083581|FG000|Year 1|Lack of Efficacy|0|||
16938854|NCT00195494|38083582|FG001|Year 1|Lack of Efficacy|0|||
16938855|NCT00195494|38083583|FG002|Year 1|Lack of Efficacy|0|||
17105427|NCT03468309|38243576|FG000|Overall Study|Lost to Follow-up|4|||
17105428|NCT03468309|38243576|FG000|Overall Study|Withdrawal by Subject|2|||
17105429|NCT03423147|38243582|FG000|Overall Study|Lost to Follow-up|5|||
17105430|NCT03423147|38243583|FG001|Overall Study|Lost to Follow-up|8|||
17105431|NCT03423147|38243582|FG000|Overall Study|Withdrawal by Subject|1|||
17105432|NCT03423147|38243583|FG001|Overall Study|Withdrawal by Subject|0|||
17105433|NCT03423147|38243582|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
17105434|NCT03423147|38243583|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
17105435|NCT03423147|38243582|FG000|Overall Study|Age < 18|1|||
17105436|NCT03423147|38243583|FG001|Overall Study|Age < 18|0|||
17105437|NCT03423147|38243582|FG000|Overall Study|No Trial of Labor|0|||
17105438|NCT03423147|38243583|FG001|Overall Study|No Trial of Labor|1|||
17105439|NCT03322631|38243593|FG000|Overall Study|Withdrawal by Subject|0|||
17105440|NCT03322631|38243594|FG001|Overall Study|Withdrawal by Subject|1|||
17105441|NCT03322631|38243595|FG002|Overall Study|Withdrawal by Subject|0|||
17105442|NCT03322631|38243596|FG003|Overall Study|Withdrawal by Subject|0|||
17105443|NCT03322631|38243593|FG000|Overall Study|Adverse Event|0|||
17105444|NCT03322631|38243594|FG001|Overall Study|Adverse Event|0|||
17105445|NCT03322631|38243595|FG002|Overall Study|Adverse Event|1|||
17105446|NCT03322631|38243596|FG003|Overall Study|Adverse Event|0|||
17105447|NCT03173248|38243611|FG000|Overall Study|Death|28|||
17105448|NCT03173248|38243612|FG001|Overall Study|Death|46|||
16938856|NCT00195494|38083584|FG003|Year 1|Lack of Efficacy|0|||
16938857|NCT00195494|38083585|FG004|Year 1|Lack of Efficacy|24|||
16938858|NCT00195494|38083586|FG005|Year 1|Lack of Efficacy|9|||
16938859|NCT00195494|38083581|FG000|Year 1|Compliance|0|||
16938860|NCT00195494|38083582|FG001|Year 1|Compliance|0|||
16938861|NCT00195494|38083583|FG002|Year 1|Compliance|0|||
17105449|NCT03173248|38243611|FG000|Overall Study|Lost to Follow-up|0|||
17105450|NCT03173248|38243612|FG001|Overall Study|Lost to Follow-up|1|||
16938862|NCT00195494|38083584|FG003|Year 1|Compliance|0|||
16938863|NCT00195494|38083585|FG004|Year 1|Compliance|5|||
16938864|NCT00195494|38083586|FG005|Year 1|Compliance|1|||
16938865|NCT00195494|38083581|FG000|Year 1|Lost to Follow-up|0|||
16938866|NCT00195494|38083582|FG001|Year 1|Lost to Follow-up|0|||
16938867|NCT00195494|38083583|FG002|Year 1|Lost to Follow-up|0|||
16938868|NCT00195494|38083584|FG003|Year 1|Lost to Follow-up|0|||
16938869|NCT00195494|38083585|FG004|Year 1|Lost to Follow-up|1|||
16938870|NCT00195494|38083586|FG005|Year 1|Lost to Follow-up|0|||
16938871|NCT00195494|38083581|FG000|Year 1|Missed >4 consecutive doses|0|||
16938872|NCT00195494|38083582|FG001|Year 1|Missed >4 consecutive doses|0|||
16938873|NCT00195494|38083583|FG002|Year 1|Missed >4 consecutive doses|0|||
16938874|NCT00195494|38083584|FG003|Year 1|Missed >4 consecutive doses|0|||
16938875|NCT00195494|38083585|FG004|Year 1|Missed >4 consecutive doses|3|||
16938876|NCT00195494|38083586|FG005|Year 1|Missed >4 consecutive doses|2|||
16938877|NCT00195494|38083581|FG000|Year 1|Protocol deviation|0|||
16938878|NCT00195494|38083582|FG001|Year 1|Protocol deviation|0|||
16938879|NCT00195494|38083583|FG002|Year 1|Protocol deviation|0|||
16938880|NCT00195494|38083584|FG003|Year 1|Protocol deviation|0|||
16938881|NCT00195494|38083585|FG004|Year 1|Protocol deviation|2|||
16938882|NCT00195494|38083586|FG005|Year 1|Protocol deviation|3|||
16938883|NCT00195494|38083581|FG000|Year 1|Physician Decision|0|||
16938884|NCT00195494|38083582|FG001|Year 1|Physician Decision|0|||
16938885|NCT00195494|38083583|FG002|Year 1|Physician Decision|0|||
16938886|NCT00195494|38083584|FG003|Year 1|Physician Decision|0|||
16938887|NCT00195494|38083585|FG004|Year 1|Physician Decision|1|||
16938888|NCT00195494|38083586|FG005|Year 1|Physician Decision|0|||
16938889|NCT00195494|38083581|FG000|Year 1|Withdrawal by Subject|0|||
16938890|NCT00195494|38083582|FG001|Year 1|Withdrawal by Subject|0|||
16938891|NCT00195494|38083583|FG002|Year 1|Withdrawal by Subject|0|||
16938892|NCT00195494|38083584|FG003|Year 1|Withdrawal by Subject|0|||
16938893|NCT00195494|38083585|FG004|Year 1|Withdrawal by Subject|8|||
16938894|NCT00195494|38083586|FG005|Year 1|Withdrawal by Subject|9|||
16938895|NCT00195494|38083581|FG000|Year 1|Protocol Violation|0|||
16938896|NCT00195494|38083582|FG001|Year 1|Protocol Violation|0|||
16938897|NCT00195494|38083583|FG002|Year 1|Protocol Violation|0|||
16938898|NCT00195494|38083584|FG003|Year 1|Protocol Violation|0|||
16938899|NCT00195494|38083585|FG004|Year 1|Protocol Violation|1|||
16938900|NCT00195494|38083586|FG005|Year 1|Protocol Violation|1|||
16938901|NCT00195494|38083581|FG000|Year 2|Adverse Event|3|||
16938902|NCT00195494|38083582|FG001|Year 2|Adverse Event|7|||
16938903|NCT00195494|38083583|FG002|Year 2|Adverse Event|5|||
16938904|NCT00195494|38083584|FG003|Year 2|Adverse Event|9|||
16938905|NCT00195494|38083585|FG004|Year 2|Adverse Event|0|||
16938906|NCT00195494|38083586|FG005|Year 2|Adverse Event|0|||
16938907|NCT00195494|38083581|FG000|Year 2|Lack of Efficacy|0|||
16938908|NCT00195494|38083582|FG001|Year 2|Lack of Efficacy|1|||
16938909|NCT00195494|38083583|FG002|Year 2|Lack of Efficacy|7|||
16938910|NCT00195494|38083584|FG003|Year 2|Lack of Efficacy|7|||
16938911|NCT00195494|38083585|FG004|Year 2|Lack of Efficacy|0|||
16938912|NCT00195494|38083586|FG005|Year 2|Lack of Efficacy|0|||
16938913|NCT00195494|38083581|FG000|Year 2|Compliance|1|||
16938914|NCT00195494|38083582|FG001|Year 2|Compliance|0|||
16938915|NCT00195494|38083583|FG002|Year 2|Compliance|0|||
16938916|NCT00195494|38083584|FG003|Year 2|Compliance|2|||
16938917|NCT00195494|38083585|FG004|Year 2|Compliance|0|||
16938918|NCT00195494|38083586|FG005|Year 2|Compliance|0|||
16938919|NCT00195494|38083581|FG000|Year 2|Lost to Follow-up|0|||
16938920|NCT00195494|38083582|FG001|Year 2|Lost to Follow-up|0|||
16938921|NCT00195494|38083583|FG002|Year 2|Lost to Follow-up|1|||
16938922|NCT00195494|38083584|FG003|Year 2|Lost to Follow-up|1|||
16938923|NCT00195494|38083585|FG004|Year 2|Lost to Follow-up|0|||
16938924|NCT00195494|38083586|FG005|Year 2|Lost to Follow-up|0|||
16938925|NCT00195494|38083581|FG000|Year 2|Missed >4 consecutive doses|1|||
16938926|NCT00195494|38083582|FG001|Year 2|Missed >4 consecutive doses|1|||
16938927|NCT00195494|38083583|FG002|Year 2|Missed >4 consecutive doses|1|||
16938928|NCT00195494|38083584|FG003|Year 2|Missed >4 consecutive doses|0|||
16938929|NCT00195494|38083585|FG004|Year 2|Missed >4 consecutive doses|0|||
17105451|NCT03173248|38243611|FG000|Overall Study|Withdrawal by Subject|6|||
16938930|NCT00195494|38083586|FG005|Year 2|Missed >4 consecutive doses|0|||
16938931|NCT00195494|38083581|FG000|Year 2|Protocol deviation|0|||
16938932|NCT00195494|38083582|FG001|Year 2|Protocol deviation|1|||
16938933|NCT00195494|38083583|FG002|Year 2|Protocol deviation|0|||
16938934|NCT00195494|38083584|FG003|Year 2|Protocol deviation|0|||
16938935|NCT00195494|38083585|FG004|Year 2|Protocol deviation|0|||
16938936|NCT00195494|38083586|FG005|Year 2|Protocol deviation|0|||
16938937|NCT00195494|38083581|FG000|Year 2|Physician Decision|1|||
16938938|NCT00195494|38083582|FG001|Year 2|Physician Decision|1|||
16938939|NCT00195494|38083583|FG002|Year 2|Physician Decision|0|||
16938940|NCT00195494|38083584|FG003|Year 2|Physician Decision|0|||
17105452|NCT03173248|38243612|FG001|Overall Study|Withdrawal by Subject|4|||
17105453|NCT03173248|38243611|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
17105454|NCT03173248|38243612|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
17105455|NCT03018704|38243624|FG000|Overall Study|Lost to Follow-up|1|||
17105456|NCT03018704|38243625|FG001|Overall Study|Lost to Follow-up|1|||
17105457|NCT02663349|38243631|FG000|Overall Study|Withdrawal by Subject|6|||
17105458|NCT02558491|38243635|FG000|First Invention|Withdrawal by Subject|3|||
17105459|NCT02558491|38243636|FG001|First Invention|Withdrawal by Subject|1|||
16938941|NCT00195494|38083585|FG004|Year 2|Physician Decision|0|||
16938942|NCT00195494|38083586|FG005|Year 2|Physician Decision|0|||
16938943|NCT00195494|38083581|FG000|Year 2|Withdrawal by Subject|1|||
16938944|NCT00195494|38083582|FG001|Year 2|Withdrawal by Subject|5|||
16938945|NCT00195494|38083583|FG002|Year 2|Withdrawal by Subject|4|||
16938946|NCT00195494|38083584|FG003|Year 2|Withdrawal by Subject|3|||
16938947|NCT00195494|38083585|FG004|Year 2|Withdrawal by Subject|0|||
16938948|NCT00195494|38083586|FG005|Year 2|Withdrawal by Subject|0|||
16938949|NCT00195494|38083581|FG000|Year 2|System toxicity|0|||
16938950|NCT00195494|38083582|FG001|Year 2|System toxicity|0|||
16938951|NCT00195494|38083583|FG002|Year 2|System toxicity|0|||
16938952|NCT00195494|38083584|FG003|Year 2|System toxicity|1|||
16938953|NCT00195494|38083585|FG004|Year 2|System toxicity|0|||
16938954|NCT00195494|38083586|FG005|Year 2|System toxicity|0|||
16938955|NCT00194987|38083604|FG000|Overall Study|Withdrawal by Subject|0|||
16938956|NCT00194987|38083605|FG001|Overall Study|Withdrawal by Subject|3|||
16938957|NCT00194792|38083613|FG000|Overall Study|Withdrawal by Subject|1|||
17105460|NCT02558491|38243635|FG000|First Invention|Data collection issues|1|||
17105461|NCT02558491|38243636|FG001|First Invention|Data collection issues|0|||
17105462|NCT02558491|38243635|FG000|First Invention|Stopping criteria|0|||
17105463|NCT02558491|38243636|FG001|First Invention|Stopping criteria|1|||
17105464|NCT02558491|38243635|FG000|First Invention|Changed parameters during trial|1|||
17105465|NCT02558491|38243636|FG001|First Invention|Changed parameters during trial|0|||
17105466|NCT02558491|38243635|FG000|Second Intervention|Withdrawal by Subject|1|||
17105467|NCT02558491|38243636|FG001|Second Intervention|Withdrawal by Subject|0|||
17105468|NCT02558491|38243635|FG000|Second Intervention|Stopping Criteria|1|||
17105469|NCT02558491|38243636|FG001|Second Intervention|Stopping Criteria|0|||
17105470|NCT02490878|38243645|FG000|Overall Study|deemed ineligible|0|||
17105471|NCT02490878|38243646|FG001|Overall Study|deemed ineligible|1|||
17105472|NCT02490878|38243645|FG000|Overall Study|progression prior to treatment|0|||
17105473|NCT02490878|38243646|FG001|Overall Study|progression prior to treatment|1|||
17105474|NCT02490878|38243645|FG000|Overall Study|only submitted baseline QOL|0|||
17105475|NCT02490878|38243646|FG001|Overall Study|only submitted baseline QOL|1|||
17105476|NCT02421601|38243652|FG000|Overall Study|Adverse Event|4|||
17105477|NCT02421601|38243652|FG000|Overall Study|Lack of Efficacy|5|||
17105478|NCT02421601|38243652|FG000|Overall Study|Physician Decision|1|||
17105479|NCT02421601|38243652|FG000|Overall Study|Withdrawal by Subject|31|||
17105480|NCT02421601|38243652|FG000|Overall Study|Others|41|||
17105481|NCT01934218|38243658|FG000|Double-blind Phase|Adverse Event|8|||
17105482|NCT01934218|38243659|FG001|Double-blind Phase|Adverse Event|8|||
17105483|NCT01934218|38243658|FG000|Double-blind Phase|Lack of Efficacy|6|||
17105484|NCT01934218|38243659|FG001|Double-blind Phase|Lack of Efficacy|7|||
17105485|NCT01934218|38243658|FG000|Double-blind Phase|Lost to Follow-up|7|||
17105486|NCT01934218|38243659|FG001|Double-blind Phase|Lost to Follow-up|14|||
17105487|NCT01934218|38243658|FG000|Double-blind Phase|Physician Decision|1|||
17105488|NCT01934218|38243659|FG001|Double-blind Phase|Physician Decision|2|||
17105489|NCT01934218|38243658|FG000|Double-blind Phase|Protocol Violation|4|||
17105490|NCT01934218|38243659|FG001|Double-blind Phase|Protocol Violation|0|||
17105491|NCT01934218|38243658|FG000|Double-blind Phase|Withdrawal by Subject|16|||
17105492|NCT01934218|38243659|FG001|Double-blind Phase|Withdrawal by Subject|13|||
17105493|NCT01934218|38243658|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
17105494|NCT01934218|38243659|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
17105495|NCT01934218|38243658|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
17105496|NCT01934218|38243659|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
17105497|NCT01934218|38243658|FG000|Open-Label Phase|Adverse Event|2|||
17105498|NCT01934218|38243659|FG001|Open-Label Phase|Adverse Event|4|||
17105499|NCT01934218|38243658|FG000|Open-Label Phase|Lack of Efficacy|1|||
17105500|NCT01934218|38243659|FG001|Open-Label Phase|Lack of Efficacy|4|||
17105501|NCT01934218|38243658|FG000|Open-Label Phase|Lost to Follow-up|4|||
17105502|NCT01934218|38243659|FG001|Open-Label Phase|Lost to Follow-up|2|||
17105503|NCT01934218|38243658|FG000|Open-Label Phase|Physician Decision|1|||
17105504|NCT01934218|38243659|FG001|Open-Label Phase|Physician Decision|0|||
17105505|NCT01934218|38243658|FG000|Open-Label Phase|Protocol Violation|1|||
17105506|NCT01934218|38243659|FG001|Open-Label Phase|Protocol Violation|0|||
17105507|NCT01934218|38243658|FG000|Open-Label Phase|Withdrawal by Subject|13|||
17105508|NCT01934218|38243659|FG001|Open-Label Phase|Withdrawal by Subject|11|||
17105509|NCT01934218|38243658|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
17105510|NCT01934218|38243659|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
17105511|NCT01934218|38243658|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
17105512|NCT01934218|38243659|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
17105513|NCT01702805|38243667|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
17105514|NCT01702805|38243668|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
17105515|NCT01702805|38243667|FG000|Overall Study|Incomplete Follow-up|18|||
17105516|NCT01702805|38243668|FG001|Overall Study|Incomplete Follow-up|15|||
17105517|NCT01702805|38243667|FG000|Overall Study|Vital Status Assessment Only|40|||
17105518|NCT01702805|38243668|FG001|Overall Study|Vital Status Assessment Only|39|||
17105519|NCT01702805|38243667|FG000|Overall Study|Lost to Follow-up|5|||
17105520|NCT01702805|38243668|FG001|Overall Study|Lost to Follow-up|5|||
17105521|NCT01698905|38243674|FG000|Overall Study|Adverse Event|4|||
17105522|NCT01698905|38243674|FG000|Overall Study|Physician Decision|2|||
16938958|NCT00194675|38083628|FG000|Overall Study|Lost to Follow-up|1|||
17105523|NCT01698905|38243674|FG000|Overall Study|Pregnancy|1|||
16938959|NCT00194675|38083629|FG001|Overall Study|Lost to Follow-up|1|||
16938960|NCT00194675|38083628|FG000|Overall Study|lack of interest|1|||
16938961|NCT00194675|38083629|FG001|Overall Study|lack of interest|1|||
16938962|NCT00194675|38083628|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
16938963|NCT00194675|38083629|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
16938964|NCT00194675|38083628|FG000|Overall Study|Protocol Violation|1|||
16938965|NCT00194675|38083629|FG001|Overall Study|Protocol Violation|0|||
16938966|NCT00194675|38083628|FG000|Overall Study|Death|1|||
16938967|NCT00194675|38083629|FG001|Overall Study|Death|0|||
16938968|NCT00194012|38083639|FG000|Randomized Phase|Lack of Efficacy|8|||
16938969|NCT00194012|38083640|FG001|Randomized Phase|Lack of Efficacy|18|||
16938970|NCT00194012|38083639|FG000|Randomized Phase|Study nonadherence|2|||
16938971|NCT00194012|38083640|FG001|Randomized Phase|Study nonadherence|1|||
16938972|NCT00194012|38083639|FG000|Randomized Phase|Withdrawal by Subject|3|||
16938973|NCT00194012|38083640|FG001|Randomized Phase|Withdrawal by Subject|3|||
16938974|NCT00194012|38083639|FG000|Randomized Phase|Adverse Event|2|||
16938975|NCT00194012|38083640|FG001|Randomized Phase|Adverse Event|1|||
16938976|NCT00194012|38083639|FG000|Randomized Phase|Participant reported having a rash|1|||
16938977|NCT00194012|38083640|FG001|Randomized Phase|Participant reported having a rash|0|||
16938978|NCT00194012|38083639|FG000|Randomized Phase|Emesis and enuresis|0|||
16938979|NCT00194012|38083640|FG001|Randomized Phase|Emesis and enuresis|1|||
16938980|NCT00194012|38083639|FG000|Randomized Phase|Oral/nasal twitching|0|||
16938981|NCT00194012|38083640|FG001|Randomized Phase|Oral/nasal twitching|1|||
16938982|NCT00194012|38083639|FG000|Open Label Extension (OLE)|Weight Gain|1|||
16938983|NCT00194012|38083640|FG001|Open Label Extension (OLE)|Weight Gain|0|||
16938984|NCT00194012|38083639|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
16938985|NCT00194012|38083640|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
16938986|NCT00194012|38083639|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
16938987|NCT00194012|38083640|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
16938988|NCT00194012|38083639|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
16938989|NCT00194012|38083640|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
16938990|NCT00192647|38083654|FG000|Overall Study|Death|1|||
16938991|NCT00192647|38083655|FG001|Overall Study|Death|1|||
16938992|NCT00192647|38083654|FG000|Overall Study|Adverse Event|35|||
16938993|NCT00192647|38083655|FG001|Overall Study|Adverse Event|29|||
16938994|NCT00192647|38083654|FG000|Overall Study|Laboratory Test Abnormality|4|||
16938995|NCT00192647|38083655|FG001|Overall Study|Laboratory Test Abnormality|2|||
16938996|NCT00192647|38083654|FG000|Overall Study|Insufficient Therapeutic Response|53|||
16938997|NCT00192647|38083655|FG001|Overall Study|Insufficient Therapeutic Response|83|||
16938998|NCT00192647|38083654|FG000|Overall Study|Entry Criteria Violation|6|||
16938999|NCT00192647|38083655|FG001|Overall Study|Entry Criteria Violation|6|||
16939000|NCT00192647|38083654|FG000|Overall Study|Protocol Violation|3|||
16939001|NCT00192647|38083655|FG001|Overall Study|Protocol Violation|1|||
16939002|NCT00192647|38083654|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
16939003|NCT00192647|38083655|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
16939004|NCT00192647|38083654|FG000|Overall Study|Failure to Return|11|||
16939005|NCT00192647|38083655|FG001|Overall Study|Failure to Return|13|||
16939006|NCT00192647|38083654|FG000|Overall Study|Other/Administrative|5|||
16939007|NCT00192647|38083655|FG001|Overall Study|Other/Administrative|3|||
16939008|NCT00192296|38083665|FG000|Overall Study|Withdrawal by Subject|0|||
16939009|NCT00192296|38083666|FG001|Overall Study|Withdrawal by Subject|1|||
16939010|NCT00192296|38083667|FG002|Overall Study|Withdrawal by Subject|0|||
16939011|NCT00192296|38083668|FG003|Overall Study|Withdrawal by Subject|0|||
16939012|NCT00192023|38083680|FG000|Period III - Double-Blind|Adverse Event|3|||
16939013|NCT00192023|38083681|FG001|Period III - Double-Blind|Adverse Event|0|||
16939014|NCT00192023|38083680|FG000|Period III - Double-Blind|Physician Decision|2|||
16939015|NCT00192023|38083681|FG001|Period III - Double-Blind|Physician Decision|0|||
16939016|NCT00192023|38083680|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
16939017|NCT00192023|38083681|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
16939018|NCT00192023|38083680|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
16939019|NCT00192023|38083681|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
16939020|NCT00192023|38083680|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
16939021|NCT00192023|38083681|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
16939022|NCT00192023|38083680|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
16939023|NCT00192023|38083681|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
16939024|NCT00192023|38083680|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
16939025|NCT00192023|38083681|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
16939026|NCT00192023|38083680|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
16939027|NCT00192023|38083681|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
16939028|NCT00192023|38083680|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
16939029|NCT00192023|38083681|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
16939030|NCT00192023|38083680|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
16939031|NCT00192023|38083681|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
16939032|NCT00191984|38083687|FG000|Overall Study|Disease Progression|21|||
16939033|NCT00191984|38083687|FG000|Overall Study|Adverse Event|4|||
16939034|NCT00191984|38083687|FG000|Overall Study|Death|2|||
16939035|NCT00191984|38083687|FG000|Overall Study|Entry Criteria Exclusion|1|||
16939036|NCT00191984|38083687|FG000|Overall Study|Withdrawal by Subject|7|||
16939037|NCT00191984|38083687|FG000|Overall Study|Physician Decision|4|||
16939038|NCT00191906|38083695|FG000|Study Period II|Adverse Event|0|||
16939039|NCT00191906|38083696|FG001|Study Period II|Adverse Event|1|||
16939040|NCT00191906|38083697|FG002|Study Period II|Adverse Event|0|||
16939041|NCT00191906|38083698|FG003|Study Period II|Adverse Event|0|||
16939042|NCT00191906|38083695|FG000|Study Period II|Withdrawal by Subject|0|||
16939043|NCT00191906|38083696|FG001|Study Period II|Withdrawal by Subject|3|||
16939044|NCT00191906|38083697|FG002|Study Period II|Withdrawal by Subject|0|||
16939045|NCT00191906|38083698|FG003|Study Period II|Withdrawal by Subject|0|||
16939046|NCT00191906|38083695|FG000|Study Period II|Parent/Caregiver Decision|0|||
16939047|NCT00191906|38083696|FG001|Study Period II|Parent/Caregiver Decision|1|||
16939048|NCT00191906|38083697|FG002|Study Period II|Parent/Caregiver Decision|0|||
16939049|NCT00191906|38083698|FG003|Study Period II|Parent/Caregiver Decision|0|||
16939050|NCT00191906|38083695|FG000|Study Period II|Entry Criteria Exclusion|0|||
16939051|NCT00191906|38083696|FG001|Study Period II|Entry Criteria Exclusion|0|||
16939052|NCT00191906|38083697|FG002|Study Period II|Entry Criteria Exclusion|1|||
16939053|NCT00191906|38083698|FG003|Study Period II|Entry Criteria Exclusion|0|||
16939054|NCT00191906|38083695|FG000|Study Period III|Adverse Event|1|||
16939055|NCT00191906|38083696|FG001|Study Period III|Adverse Event|0|||
16939056|NCT00191906|38083697|FG002|Study Period III|Adverse Event|0|||
16939057|NCT00191906|38083698|FG003|Study Period III|Adverse Event|0|||
16939058|NCT00191906|38083695|FG000|Study Period III|Lost to Follow-up|0|||
16939059|NCT00191906|38083696|FG001|Study Period III|Lost to Follow-up|1|||
16939060|NCT00191906|38083697|FG002|Study Period III|Lost to Follow-up|0|||
16939061|NCT00191906|38083698|FG003|Study Period III|Lost to Follow-up|0|||
16939062|NCT00191906|38083695|FG000|Study Period III|Parent/Caregiver Decision|1|||
16939063|NCT00191906|38083696|FG001|Study Period III|Parent/Caregiver Decision|0|||
16939064|NCT00191906|38083697|FG002|Study Period III|Parent/Caregiver Decision|0|||
16939065|NCT00191906|38083698|FG003|Study Period III|Parent/Caregiver Decision|0|||
16939066|NCT00191906|38083695|FG000|Study Period III|Lack of Efficacy|3|||
16939067|NCT00191906|38083696|FG001|Study Period III|Lack of Efficacy|3|||
16939068|NCT00191906|38083697|FG002|Study Period III|Lack of Efficacy|0|||
16939069|NCT00191906|38083698|FG003|Study Period III|Lack of Efficacy|0|||
16939070|NCT00191789|38083714|FG000|Overall Study|Adverse Event|5|||
16939071|NCT00191789|38083714|FG000|Overall Study|Patient: Satisfactory Response|5|||
16939072|NCT00191789|38083714|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
16939073|NCT00191789|38083714|FG000|Overall Study|Withdrawal by Subject|4|||
16939074|NCT00191789|38083714|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
16939075|NCT00191789|38083714|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
16939076|NCT00191789|38083714|FG000|Overall Study|Death - Not Study-Drug Related|1|||
16939077|NCT00191282|38083720|FG000|Overall Study|Adverse Event|5|||
16939078|NCT00191282|38083721|FG001|Overall Study|Adverse Event|6|||
16939079|NCT00191282|38083720|FG000|Overall Study|Death|51|||
16939080|NCT00191282|38083721|FG001|Overall Study|Death|51|||
16939081|NCT00191282|38083720|FG000|Overall Study|Lack of Efficacy|11|||
16939082|NCT00191282|38083721|FG001|Overall Study|Lack of Efficacy|6|||
16939083|NCT00191282|38083720|FG000|Overall Study|Noncompliance|14|||
16939084|NCT00191282|38083721|FG001|Overall Study|Noncompliance|17|||
16939085|NCT00191282|38083720|FG000|Overall Study|Patient moved|11|||
16939086|NCT00191282|38083721|FG001|Overall Study|Patient moved|14|||
16939087|NCT00191282|38083720|FG000|Overall Study|Withdrawal by Subject|59|||
16939088|NCT00191282|38083721|FG001|Overall Study|Withdrawal by Subject|44|||
16939089|NCT00191282|38083720|FG000|Overall Study|Physician Decision|18|||
16939090|NCT00191282|38083721|FG001|Overall Study|Physician Decision|15|||
16939091|NCT00191282|38083720|FG000|Overall Study|Protocol entry criteria not met|14|||
16939092|NCT00191282|38083721|FG001|Overall Study|Protocol entry criteria not met|9|||
16939093|NCT00191282|38083720|FG000|Overall Study|Protocol Violation|9|||
16939094|NCT00191282|38083721|FG001|Overall Study|Protocol Violation|12|||
16939095|NCT00191282|38083720|FG000|Overall Study|Severity of outcome|2|||
16939096|NCT00191282|38083721|FG001|Overall Study|Severity of outcome|5|||
16939097|NCT00191282|38083720|FG000|Overall Study|Sponsor's decision|2|||
16939098|NCT00191282|38083721|FG001|Overall Study|Sponsor's decision|2|||
16939099|NCT00191282|38083720|FG000|Overall Study|Lost to Follow-up|24|||
16939100|NCT00191282|38083721|FG001|Overall Study|Lost to Follow-up|31|||
16939101|NCT00191165|38083729|FG000|Overall Study|Adverse Event|2|||
16939102|NCT00191165|38083730|FG001|Overall Study|Adverse Event|0|||
16939103|NCT00191165|38083729|FG000|Overall Study|Protocol Violation|0|||
16939104|NCT00191165|38083730|FG001|Overall Study|Protocol Violation|1|||
16939105|NCT00191165|38083729|FG000|Overall Study|Participant Moved Away|0|||
16939106|NCT00191165|38083730|FG001|Overall Study|Participant Moved Away|1|||
16939107|NCT00190775|38083738|FG000|Overall Study|Adverse Event|57|||
16939108|NCT00190775|38083739|FG001|Overall Study|Adverse Event|22|||
16939109|NCT00190775|38083738|FG000|Overall Study|Satisfactory Response|1|||
16939110|NCT00190775|38083739|FG001|Overall Study|Satisfactory Response|0|||
16939111|NCT00190775|38083738|FG000|Overall Study|Lack of Efficacy|28|||
16939112|NCT00190775|38083739|FG001|Overall Study|Lack of Efficacy|32|||
16939113|NCT00190775|38083738|FG000|Overall Study|Lost to Follow-up|31|||
16939114|NCT00190775|38083739|FG001|Overall Study|Lost to Follow-up|23|||
16939115|NCT00190775|38083738|FG000|Overall Study|Participant Moved|0|||
16939116|NCT00190775|38083739|FG001|Overall Study|Participant Moved|1|||
16939117|NCT00190775|38083738|FG000|Overall Study|Withdrawal by Subject|24|||
16939118|NCT00190775|38083739|FG001|Overall Study|Withdrawal by Subject|13|||
16939119|NCT00190775|38083738|FG000|Overall Study|Sponsor Decision|1|||
16939120|NCT00190775|38083739|FG001|Overall Study|Sponsor Decision|0|||
16939121|NCT00190775|38083738|FG000|Overall Study|Physician Decision|3|||
16939122|NCT00190775|38083739|FG001|Overall Study|Physician Decision|0|||
16939123|NCT00190775|38083738|FG000|Overall Study|Noncompliance|3|||
16939124|NCT00190775|38083739|FG001|Overall Study|Noncompliance|5|||
16939125|NCT00190775|38083738|FG000|Overall Study|Protocol Violation|0|||
16939126|NCT00190775|38083739|FG001|Overall Study|Protocol Violation|1|||
16939127|NCT00190775|38083738|FG000|Overall Study|Exclusion Criteria Met|1|||
16939128|NCT00190775|38083739|FG001|Overall Study|Exclusion Criteria Met|3|||
16939129|NCT00199901|38083754|FG000|Overall Study|Protocol Violation|2|||
16939130|NCT00199901|38083755|FG001|Overall Study|Protocol Violation|0|||
16939131|NCT00199901|38083754|FG000|Overall Study|Withdrawal by Subject|1|||
16939132|NCT00199901|38083755|FG001|Overall Study|Withdrawal by Subject|0|||
16939133|NCT00199901|38083754|FG000|Overall Study|Progressive Disease|24|||
16939134|NCT00199901|38083755|FG001|Overall Study|Progressive Disease|24|||
16939135|NCT00198107|38083765|FG000|Double-Blind Period|Adverse Event|1|||
16939136|NCT00198107|38083766|FG001|Double-Blind Period|Adverse Event|1|||
16939137|NCT00198107|38083767|FG002|Double-Blind Period|Adverse Event|0|||
16939138|NCT00198107|38083765|FG000|Double-Blind Period|Lack of Efficacy|2|||
16939139|NCT00198107|38083766|FG001|Double-Blind Period|Lack of Efficacy|0|||
16939140|NCT00198107|38083767|FG002|Double-Blind Period|Lack of Efficacy|0|||
16939141|NCT00198107|38083765|FG000|Double-Blind Period|Lost to Follow-up|2|||
17105524|NCT01698905|38243674|FG000|Overall Study|Protocol Violation|1|||
17105525|NCT01698905|38243674|FG000|Overall Study|Subject/guardian decision|2|||
16939142|NCT00198107|38083766|FG001|Double-Blind Period|Lost to Follow-up|1|||
16939143|NCT00198107|38083767|FG002|Double-Blind Period|Lost to Follow-up|0|||
16939144|NCT00198107|38083765|FG000|Double-Blind Period|Physician Decision|1|||
16939145|NCT00198107|38083766|FG001|Double-Blind Period|Physician Decision|0|||
16939146|NCT00198107|38083767|FG002|Double-Blind Period|Physician Decision|0|||
16939147|NCT00198107|38083765|FG000|Double-Blind Period|Withdrawal by Subject|0|||
16939148|NCT00198107|38083766|FG001|Double-Blind Period|Withdrawal by Subject|1|||
16939149|NCT00198107|38083767|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16939150|NCT00198107|38083765|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
17105526|NCT01698905|38243674|FG000|Overall Study|Death|1|||
17105527|NCT00097370|38243756|FG000|Stage 1|Adverse Event|3|||
17105528|NCT00097370|38243756|FG000|Stage 1|Withdrawal by Subject|1|||
17105529|NCT00097370|38243756|FG000|Stage 1|Lack of Efficacy|2|||
16939151|NCT00198107|38083766|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
16939152|NCT00198107|38083767|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
16939153|NCT00179660|38083775|FG000|Overall Study|Adverse Event|7|||
16939154|NCT00179660|38083775|FG000|Overall Study|Lack of therapeutic effect|28|||
16939155|NCT00179660|38083775|FG000|Overall Study|Withdrawal by Subject|2|||
16939156|NCT00179660|38083775|FG000|Overall Study|Lost to Follow-up|1|||
16939157|NCT00179660|38083775|FG000|Overall Study|Death|3|||
16939158|NCT00179660|38083775|FG000|Overall Study|Other - Unspecified|9|||
16939159|NCT00178256|38083779|FG000|Overall Study|Adverse Event|2|||
16939160|NCT00178256|38083780|FG001|Overall Study|Adverse Event|0|||
16939161|NCT00178256|38083781|FG002|Overall Study|Adverse Event|0|||
16939162|NCT00178256|38083782|FG003|Overall Study|Adverse Event|0|||
16939163|NCT00178256|38083779|FG000|Overall Study|Death|0|||
17105530|NCT00097370|38243756|FG000|Stage 2|Adverse Event|5|||
17105531|NCT00097370|38243756|FG000|Stage 2|Withdrawal by Subject|1|||
17105532|NCT00097370|38243756|FG000|Stage 2|Lack of Efficacy|3|||
17105533|NCT00097370|38243756|FG000|Stage 2|Pregnancy|1|||
17105534|NCT00097370|38243756|FG000|Stage 2|Sponsor Terminated Study|2|||
17105535|NCT00097370|38243756|FG000|Stage 2|Lost to Follow-up|1|||
17105536|NCT00097370|38243756|FG000|Stage 3|Adverse Event|2|||
17105537|NCT00097370|38243756|FG000|Stage 3|Withdrawal by Subject|3|||
17105538|NCT00097370|38243756|FG000|Stage 3|Lack of Efficacy|1|||
17105539|NCT00097370|38243756|FG000|Stage 3|Sponsor Terminated Study|52|||
17105540|NCT00097370|38243756|FG000|Stage 3|Lost to Follow-up|1|||
17105541|NCT03515824|38243763|FG000|Overall Study|Death|3|||
16939164|NCT00178256|38083780|FG001|Overall Study|Death|1|||
16939165|NCT00178256|38083781|FG002|Overall Study|Death|0|||
16939166|NCT00178256|38083782|FG003|Overall Study|Death|1|||
16939167|NCT00178256|38083779|FG000|Overall Study|Cancer progression|2|||
16939168|NCT00178256|38083780|FG001|Overall Study|Cancer progression|0|||
16939169|NCT00178256|38083781|FG002|Overall Study|Cancer progression|0|||
16939170|NCT00178256|38083782|FG003|Overall Study|Cancer progression|1|||
16939171|NCT00177164|38083791|FG000|Overall Study|Protocol Violation|0|||
16939172|NCT00177164|38083792|FG001|Overall Study|Protocol Violation|7|||
17105542|NCT03515824|38243764|FG001|Overall Study|Death|2|||
16939173|NCT00177164|38083791|FG000|Overall Study|Lost to Follow-up|4|||
16939174|NCT00177164|38083792|FG001|Overall Study|Lost to Follow-up|5|||
16939175|NCT00177164|38083791|FG000|Overall Study|increase in alcohol and drug use|1|||
16939176|NCT00177164|38083792|FG001|Overall Study|increase in alcohol and drug use|2|||
16939177|NCT00177164|38083791|FG000|Overall Study|Adverse Event|1|||
16939178|NCT00177164|38083792|FG001|Overall Study|Adverse Event|0|||
16939179|NCT00177164|38083791|FG000|Overall Study|discharge from hospital|1|||
16939180|NCT00177164|38083792|FG001|Overall Study|discharge from hospital|0|||
16939181|NCT00177164|38083791|FG000|Overall Study|Lack of Efficacy|2|||
16939182|NCT00177164|38083792|FG001|Overall Study|Lack of Efficacy|1|||
16939183|NCT00177164|38083791|FG000|Overall Study|Pregnancy|0|||
16939184|NCT00177164|38083792|FG001|Overall Study|Pregnancy|1|||
16939185|NCT02489942|38083815|FG000|Overall Study|Request by patient|602|||
16939186|NCT02489942|38083815|FG000|Overall Study|Improvement/remission|157|||
16939187|NCT02489942|38083815|FG000|Overall Study|No change/Progressive disease|263|||
16939188|NCT02489942|38083815|FG000|Overall Study|Adverse Event|522|||
16939189|NCT02489942|38083815|FG000|Overall Study|Other personal reasons|1218|||
16939190|NCT02489942|38083815|FG000|Overall Study|Lost to Follow-up|456|||
16939191|NCT02489942|38083815|FG000|Overall Study|Not continuously investigated|7|||
16939192|NCT02489942|38083815|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
16939193|NCT02489942|38083815|FG000|Overall Study|Multiple registration|1|||
16939194|NCT02489942|38083815|FG000|Overall Study|No patient visit after entry|100|||
16939195|NCT02489942|38083815|FG000|Overall Study|No treatment with Jardiance|2|||
16939196|NCT02489942|38083815|FG000|Overall Study|Patient received Jardiance before registration|1|||
16939197|NCT02489942|38083815|FG000|Overall Study|No CRF collected|86|||
16939198|NCT00176462|38083821|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
16939199|NCT00176462|38083822|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
16939200|NCT00176462|38083821|FG000|Induction (4 Weeks)|Death|1|||
16939201|NCT00176462|38083822|FG001|Induction (4 Weeks)|Death|2|||
16939202|NCT00176462|38083821|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
16939203|NCT00176462|38083822|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
16939204|NCT00176462|38083821|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
16939205|NCT00176462|38083822|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
16939206|NCT00176462|38083821|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
16939207|NCT00176462|38083822|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
16939208|NCT00176462|38083821|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
16939209|NCT00176462|38083822|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
16939210|NCT00176462|38083821|FG000|Consolidation (12 Weeks)|Not documented|0|||
16939211|NCT00176462|38083822|FG001|Consolidation (12 Weeks)|Not documented|1|||
16939212|NCT00176462|38083821|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
16939213|NCT00176462|38083822|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
16939214|NCT00176462|38083821|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
16939215|NCT00176462|38083822|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
16939216|NCT00175019|38083832|FG000|Overall Study|Adverse Event|54|||
16939217|NCT00175019|38083833|FG001|Overall Study|Adverse Event|22|||
16939218|NCT00175019|38083834|FG002|Overall Study|Adverse Event|2|||
16939219|NCT00175019|38083832|FG000|Overall Study|Protocol Violation|6|||
16939220|NCT00175019|38083833|FG001|Overall Study|Protocol Violation|3|||
16939221|NCT00175019|38083834|FG002|Overall Study|Protocol Violation|3|||
16939222|NCT00175019|38083832|FG000|Overall Study|Lost to Follow-up|42|||
16939223|NCT00175019|38083833|FG001|Overall Study|Lost to Follow-up|39|||
16939224|NCT00175019|38083834|FG002|Overall Study|Lost to Follow-up|9|||
16939225|NCT00175019|38083832|FG000|Overall Study|Did not continue under Amendment 4|1|||
16939226|NCT00175019|38083833|FG001|Overall Study|Did not continue under Amendment 4|1|||
16939227|NCT00175019|38083834|FG002|Overall Study|Did not continue under Amendment 4|2|||
16939228|NCT00175019|38083832|FG000|Overall Study|Personal Reason(s)|39|||
16939229|NCT00175019|38083833|FG001|Overall Study|Personal Reason(s)|31|||
17105543|NCT03515824|38243765|FG002|Overall Study|Death|6|||
17105544|NCT03515824|38243766|FG003|Overall Study|Death|0|||
17105545|NCT03515824|38243763|FG000|Overall Study|Lost to Follow-up|0|||
17105546|NCT03515824|38243764|FG001|Overall Study|Lost to Follow-up|1|||
17105547|NCT03515824|38243765|FG002|Overall Study|Lost to Follow-up|1|||
17105548|NCT03515824|38243766|FG003|Overall Study|Lost to Follow-up|0|||
17105549|NCT03515824|38243763|FG000|Overall Study|Study terminated by sponsor|0|||
17105550|NCT03515824|38243764|FG001|Overall Study|Study terminated by sponsor|1|||
17105551|NCT03515824|38243765|FG002|Overall Study|Study terminated by sponsor|6|||
17105552|NCT03515824|38243766|FG003|Overall Study|Study terminated by sponsor|0|||
17105553|NCT03515824|38243763|FG000|Overall Study|Status not recorded|0|||
17105554|NCT03515824|38243764|FG001|Overall Study|Status not recorded|0|||
17105555|NCT03515824|38243765|FG002|Overall Study|Status not recorded|2|||
17105556|NCT03515824|38243766|FG003|Overall Study|Status not recorded|0|||
17105557|NCT03511378|38243776|FG000|Overall Study|Withdrawal by Subject|2|||
17105558|NCT03511378|38243777|FG001|Overall Study|Withdrawal by Subject|2|||
17105559|NCT03511378|38243776|FG000|Overall Study|Patient not coming or schedule visit|1|||
17105560|NCT03511378|38243777|FG001|Overall Study|Patient not coming or schedule visit|0|||
17105561|NCT03511066|38243786|FG000|Overall Study|Withdrawal by Subject|1|||
16939230|NCT00175019|38083834|FG002|Overall Study|Personal Reason(s)|8|||
16939231|NCT00175019|38083832|FG000|Overall Study|Therapeutic Failure|10|||
16939232|NCT00175019|38083833|FG001|Overall Study|Therapeutic Failure|38|||
16939233|NCT00175019|38083834|FG002|Overall Study|Therapeutic Failure|22|||
16939234|NCT00175019|38083832|FG000|Overall Study|Gout Flare|2|||
16939235|NCT00175019|38083833|FG001|Overall Study|Gout Flare|3|||
16939236|NCT00175019|38083834|FG002|Overall Study|Gout Flare|0|||
16939237|NCT00175019|38083832|FG000|Overall Study|Reason Not Specified|40|||
16939238|NCT00175019|38083833|FG001|Overall Study|Reason Not Specified|34|||
17105562|NCT03511066|38243787|FG001|Overall Study|Withdrawal by Subject|2|||
17105563|NCT03511066|38243788|FG002|Overall Study|Withdrawal by Subject|3|||
17105564|NCT03511066|38243786|FG000|Overall Study|Lost to Follow-up|2|||
17105565|NCT03511066|38243787|FG001|Overall Study|Lost to Follow-up|3|||
17105566|NCT03511066|38243788|FG002|Overall Study|Lost to Follow-up|0|||
17105567|NCT03510910|38243798|FG000|Overall Study|Incomplete Survey|2|||
17105568|NCT03510910|38243799|FG001|Overall Study|Incomplete Survey|3|||
17105569|NCT03509350|38243807|FG000|Overall Study|Withdrawal by Subject|0|||
17105570|NCT03509350|38243808|FG001|Overall Study|Withdrawal by Subject|2|||
17105571|NCT00072410|38243816|FG000|Overall Study|Progressive disease|0|||
17105572|NCT00072410|38243817|FG001|Overall Study|Progressive disease|3|||
17105573|NCT03478696|38243825|FG000|Overall Study|Adverse Event|1|||
17105574|NCT03478696|38243826|FG001|Overall Study|Adverse Event|5|||
17105575|NCT03478696|38243825|FG000|Overall Study|Lost to Follow-up|1|||
17105576|NCT03478696|38243826|FG001|Overall Study|Lost to Follow-up|0|||
17105577|NCT03478696|38243825|FG000|Overall Study|Physician Decision|6|||
17105578|NCT03478696|38243826|FG001|Overall Study|Physician Decision|3|||
17105579|NCT03478696|38243825|FG000|Overall Study|Withdrawal by Subject|9|||
17105580|NCT03478696|38243826|FG001|Overall Study|Withdrawal by Subject|4|||
17105581|NCT03477838|38243832|FG000|Overall Study|Lost to Follow-up|14|||
17105582|NCT00072176|38243838|FG000|Overall Study|Withdrawal by Subject|1|||
17105583|NCT00072176|38243839|FG001|Overall Study|Withdrawal by Subject|0|||
17105584|NCT00072176|38243838|FG000|Overall Study|Protocol Violation|0|||
17105585|NCT00072176|38243839|FG001|Overall Study|Protocol Violation|1|||
17105586|NCT00071396|38243845|FG000|Overall Study|Withdrawal by Subject|1|||
17105587|NCT00071396|38243845|FG000|Overall Study|Physician Decision|2|||
16939239|NCT00175019|38083834|FG002|Overall Study|Reason Not Specified|11|||
16939240|NCT00174941|38083845|FG000|Overall Study|Adverse Event|1|||
17105588|NCT03473236|38243859|FG000|Overall Study|Withdrawal by Subject|0|||
17105589|NCT03473236|38243860|FG001|Overall Study|Withdrawal by Subject|0|||
17105590|NCT03473236|38243861|FG002|Overall Study|Withdrawal by Subject|0|||
17105591|NCT03473236|38243862|FG003|Overall Study|Withdrawal by Subject|0|||
17105592|NCT03473236|38243863|FG004|Overall Study|Withdrawal by Subject|0|||
17105593|NCT03473236|38243864|FG005|Overall Study|Withdrawal by Subject|1|||
17105594|NCT03473236|38243865|FG006|Overall Study|Withdrawal by Subject|0|||
17105595|NCT03473236|38243866|FG007|Overall Study|Withdrawal by Subject|0|||
17105596|NCT03473236|38243867|FG008|Overall Study|Withdrawal by Subject|1|||
17105597|NCT03473236|38243868|FG009|Overall Study|Withdrawal by Subject|0|||
17105598|NCT03550378|38243900|FG000|Overall Study|Death|0|||
17105599|NCT03550378|38243901|FG001|Overall Study|Death|1|||
17105600|NCT03472534|38243908|FG000|Overall Study|Withdrawal by Subject|9|||
17105601|NCT03472534|38243908|FG000|Overall Study|Adverse Event|2|||
17105602|NCT03549130|38243914|FG000|Overall Study|Adverse Event|0|||
17105603|NCT03549130|38243915|FG001|Overall Study|Adverse Event|1|||
16939241|NCT00174941|38083846|FG001|Overall Study|Adverse Event|10|||
16939242|NCT00174941|38083847|FG002|Overall Study|Adverse Event|2|||
16939243|NCT00174941|38083848|FG003|Overall Study|Adverse Event|13|||
16939244|NCT00174941|38083845|FG000|Overall Study|Protocol Violation|0|||
16939245|NCT00174941|38083846|FG001|Overall Study|Protocol Violation|1|||
16939246|NCT00174941|38083847|FG002|Overall Study|Protocol Violation|0|||
16939247|NCT00174941|38083848|FG003|Overall Study|Protocol Violation|1|||
16939248|NCT00174941|38083845|FG000|Overall Study|Lost to Follow-up|0|||
16939249|NCT00174941|38083846|FG001|Overall Study|Lost to Follow-up|3|||
16939250|NCT00174941|38083847|FG002|Overall Study|Lost to Follow-up|2|||
16939251|NCT00174941|38083848|FG003|Overall Study|Lost to Follow-up|5|||
16939252|NCT00174941|38083845|FG000|Overall Study|Personal Reason(s)|0|||
16939253|NCT00174941|38083846|FG001|Overall Study|Personal Reason(s)|14|||
16939254|NCT00174941|38083847|FG002|Overall Study|Personal Reason(s)|8|||
16939255|NCT00174941|38083848|FG003|Overall Study|Personal Reason(s)|22|||
16939256|NCT00174941|38083845|FG000|Overall Study|Gout Flare|0|||
16939257|NCT00174941|38083846|FG001|Overall Study|Gout Flare|4|||
16939258|NCT00174941|38083847|FG002|Overall Study|Gout Flare|4|||
16939259|NCT00174941|38083848|FG003|Overall Study|Gout Flare|8|||
16939260|NCT00174941|38083845|FG000|Overall Study|Reason Not Specified|1|||
16939261|NCT00174941|38083846|FG001|Overall Study|Reason Not Specified|6|||
16939262|NCT00174941|38083847|FG002|Overall Study|Reason Not Specified|2|||
16939263|NCT00174941|38083848|FG003|Overall Study|Reason Not Specified|9|||
16939264|NCT00171704|38083860|FG000|Overall Study|Adverse Event|24|||
17105604|NCT03549130|38243914|FG000|Overall Study|Lost to Follow-up|0|||
17105605|NCT03549130|38243915|FG001|Overall Study|Lost to Follow-up|1|||
17105606|NCT03470194|38243925|FG000|Overall Study|Lost to Follow-up|11|||
16939265|NCT00171704|38083861|FG001|Overall Study|Adverse Event|33|||
16939266|NCT00171704|38083860|FG000|Overall Study|Disease Progression|14|||
16939267|NCT00171704|38083861|FG001|Overall Study|Disease Progression|9|||
16939268|NCT00171704|38083860|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
16939269|NCT00171704|38083861|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
16939270|NCT00171704|38083860|FG000|Overall Study|Administrative Problems|2|||
16939271|NCT00171704|38083861|FG001|Overall Study|Administrative Problems|1|||
16939272|NCT00171704|38083860|FG000|Overall Study|Death|2|||
16939273|NCT00171704|38083861|FG001|Overall Study|Death|2|||
16939274|NCT00171704|38083860|FG000|Overall Study|Withdrawal by Subject|1|||
16939275|NCT00171704|38083861|FG001|Overall Study|Withdrawal by Subject|3|||
16939276|NCT00171704|38083860|FG000|Overall Study|Protocol Violation|0|||
16939277|NCT00171704|38083861|FG001|Overall Study|Protocol Violation|1|||
16939278|NCT00171314|38083869|FG000|Overall Study|Adverse Event|44|||
16939279|NCT00171314|38083870|FG001|Overall Study|Adverse Event|41|||
16939280|NCT00171314|38083869|FG000|Overall Study|Lack of Efficacy|19|||
16939281|NCT00171314|38083870|FG001|Overall Study|Lack of Efficacy|14|||
16939282|NCT00171314|38083869|FG000|Overall Study|Withdrawal by Subject|9|||
16939283|NCT00171314|38083870|FG001|Overall Study|Withdrawal by Subject|6|||
16939284|NCT00171314|38083869|FG000|Overall Study|Abnormal Test Procedure Results|9|||
16939285|NCT00171314|38083870|FG001|Overall Study|Abnormal Test Procedure Results|3|||
16939286|NCT00171314|38083869|FG000|Overall Study|Protocol Violation|3|||
16939287|NCT00171314|38083870|FG001|Overall Study|Protocol Violation|7|||
16939288|NCT00171314|38083869|FG000|Overall Study|Administrative Problems|4|||
16939289|NCT00171314|38083870|FG001|Overall Study|Administrative Problems|3|||
16939290|NCT00171314|38083869|FG000|Overall Study|Lost to Follow-up|1|||
16939291|NCT00171314|38083870|FG001|Overall Study|Lost to Follow-up|3|||
16939292|NCT00171314|38083869|FG000|Overall Study|Death|2|||
16939293|NCT00171314|38083870|FG001|Overall Study|Death|1|||
16939294|NCT00171158|38083876|FG000|Core Study|Death|27|||
16939295|NCT00171158|38083876|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
16939296|NCT00171158|38083876|FG000|Core Study|Protocol Violation|4|||
16939297|NCT00171158|38083876|FG000|Core Study|Administrative problems|1|||
16939298|NCT00171158|38083876|FG000|Core Study|Adverse event, non-fatal|21|||
16939299|NCT00171158|38083876|FG000|Core Study|Consent withdrawn by subject|6|||
16939300|NCT00171158|38083876|FG000|Core Study|No longer required drug (BMT)|14|||
16939301|NCT00171158|38083876|FG000|Core Study|Abnormal Laboratory Values|2|||
16939302|NCT00171158|38083876|FG000|Core Study|Lost to Follow-up|1|||
16939303|NCT00171158|38083876|FG000|E2 Extension|Other|7|||
16939304|NCT00170846|38083883|FG000|Overall Study|Subject withdrew Informed Consent|5|||
16939305|NCT00170846|38083884|FG001|Overall Study|Subject withdrew Informed Consent|12|||
16939306|NCT00170846|38083885|FG002|Overall Study|Subject withdrew Informed Consent|8|||
16939307|NCT00170846|38083883|FG000|Overall Study|Lost to Follow-up|6|||
16939308|NCT00170846|38083884|FG001|Overall Study|Lost to Follow-up|3|||
16939309|NCT00170846|38083885|FG002|Overall Study|Lost to Follow-up|2|||
16939310|NCT00170846|38083883|FG000|Overall Study|Death|0|||
16939311|NCT00170846|38083884|FG001|Overall Study|Death|3|||
16939312|NCT00170846|38083885|FG002|Overall Study|Death|3|||
16939313|NCT00170846|38083883|FG000|Overall Study|Reason Missing|0|||
16939314|NCT00170846|38083884|FG001|Overall Study|Reason Missing|1|||
16939315|NCT00170846|38083885|FG002|Overall Study|Reason Missing|0|||
16939316|NCT00479882|38083897|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
16939317|NCT00479882|38083898|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
16939318|NCT00479882|38083899|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
16939319|NCT00479882|38083900|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
16939320|NCT00479882|38083897|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
16939321|NCT00479882|38083898|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
16939322|NCT00479882|38083899|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
16939323|NCT00479882|38083900|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
16939324|NCT00479882|38083897|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
16939325|NCT00479882|38083898|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
16939326|NCT00479882|38083899|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
16939327|NCT00479882|38083900|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
16939328|NCT00479882|38083897|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
16939329|NCT00479882|38083898|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
17105607|NCT03470194|38243926|FG001|Overall Study|Lost to Follow-up|17|||
17105608|NCT03469336|38243932|FG000|Overall Study|Adverse Event|1|||
17105609|NCT03469258|38243942|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
17105610|NCT03503188|38243948|FG000|Overall Study|Non eligible in the sub study|0|||
17105611|NCT03503188|38243949|FG001|Overall Study|Non eligible in the sub study|1|||
17105612|NCT03502798|38243957|FG000|Overall Study|equipment failure|0|||
17105613|NCT03502798|38243958|FG001|Overall Study|equipment failure|7|||
17105614|NCT00066170|38243968|FG000|Overall Study|Adverse Event|2|||
17105615|NCT00066170|38243969|FG001|Overall Study|Adverse Event|4|||
17105616|NCT00066170|38243970|FG002|Overall Study|Adverse Event|1|||
16939330|NCT00479882|38083899|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
16939331|NCT00479882|38083900|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
16939332|NCT00479882|38083897|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
16939333|NCT00479882|38083898|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
16939334|NCT00479882|38083899|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
16939335|NCT00479882|38083900|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
16939336|NCT00479882|38083897|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
16939337|NCT00479882|38083898|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
16939338|NCT00479882|38083899|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
16939339|NCT00479882|38083900|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
16939340|NCT00479882|38083897|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
16939341|NCT00479882|38083898|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
16939342|NCT00479882|38083899|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
16939343|NCT00479882|38083900|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
16939344|NCT00479882|38083897|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
16939345|NCT00479882|38083898|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
16939346|NCT00479882|38083899|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
16939347|NCT00479882|38083900|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
16939348|NCT00479882|38083897|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
17105617|NCT00066170|38243971|FG003|Overall Study|Adverse Event|7|||
17105618|NCT00066170|38243968|FG000|Overall Study|Serious Adverse Event|0|||
17105619|NCT00066170|38243969|FG001|Overall Study|Serious Adverse Event|0|||
17105620|NCT00066170|38243970|FG002|Overall Study|Serious Adverse Event|1|||
17105621|NCT00066170|38243971|FG003|Overall Study|Serious Adverse Event|1|||
17105622|NCT00066170|38243968|FG000|Overall Study|Lost to Follow-up|0|||
17105623|NCT00066170|38243969|FG001|Overall Study|Lost to Follow-up|1|||
17105624|NCT00066170|38243970|FG002|Overall Study|Lost to Follow-up|0|||
17105625|NCT00066170|38243971|FG003|Overall Study|Lost to Follow-up|0|||
17105626|NCT00066170|38243968|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
17105627|NCT00066170|38243969|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
17105628|NCT00066170|38243970|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
17105629|NCT00066170|38243971|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
17105630|NCT00066170|38243968|FG000|Overall Study|Protocol Violation|3|||
17105631|NCT00066170|38243969|FG001|Overall Study|Protocol Violation|0|||
17105632|NCT00066170|38243970|FG002|Overall Study|Protocol Violation|0|||
17105633|NCT00066170|38243971|FG003|Overall Study|Protocol Violation|0|||
17105634|NCT00066170|38243968|FG000|Overall Study|Other|1|||
17105635|NCT00066170|38243969|FG001|Overall Study|Other|5|||
17105636|NCT00066170|38243970|FG002|Overall Study|Other|2|||
17105637|NCT00066170|38243971|FG003|Overall Study|Other|0|||
16939349|NCT00479882|38083898|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
16939350|NCT00479882|38083899|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
16939351|NCT00479882|38083900|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
16939352|NCT00479882|38083897|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
16939353|NCT00479882|38083898|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
16939354|NCT00479882|38083899|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
16939355|NCT00479882|38083900|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
16939356|NCT00479882|38083897|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
16939357|NCT00479882|38083898|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
16939358|NCT00479882|38083899|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
16939359|NCT00479882|38083900|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
17105638|NCT00065468|38243984|FG000|Overall Study|Death|172|||
17105639|NCT00065468|38243985|FG001|Overall Study|Death|169|||
17105640|NCT00065468|38243986|FG002|Overall Study|Death|171|||
17105641|NCT00065468|38243984|FG000|Overall Study|Withdrawal by Subject|3|||
17105642|NCT00065468|38243985|FG001|Overall Study|Withdrawal by Subject|4|||
17105643|NCT00065468|38243986|FG002|Overall Study|Withdrawal by Subject|5|||
17105644|NCT00065468|38243984|FG000|Overall Study|Lost to Follow-up|5|||
17105645|NCT00065468|38243985|FG001|Overall Study|Lost to Follow-up|3|||
17105646|NCT00065468|38243986|FG002|Overall Study|Lost to Follow-up|2|||
17105647|NCT00065468|38243984|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
17105648|NCT00065468|38243985|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
17105649|NCT00065468|38243986|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
17105650|NCT00065468|38243984|FG000|Overall Study|Disease progression|0|||
17105651|NCT00065468|38243985|FG001|Overall Study|Disease progression|0|||
17105652|NCT00065468|38243986|FG002|Overall Study|Disease progression|1|||
17105653|NCT00065468|38243984|FG000|Overall Study|Other|14|||
17105654|NCT00065468|38243985|FG001|Overall Study|Other|24|||
17105655|NCT00065468|38243986|FG002|Overall Study|Other|18|||
17105656|NCT00071006|38243994|FG000|Overall Study|Lack of Efficacy|7|||
17105657|NCT00071006|38243994|FG000|Overall Study|Adverse Event|1|||
17105658|NCT00071006|38243994|FG000|Overall Study|Withdrawal by Subject|1|||
17105659|NCT00071006|38243994|FG000|Overall Study|Other|3|||
16939360|NCT00479882|38083897|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
16939361|NCT00479882|38083898|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
16939362|NCT00479882|38083899|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
16939363|NCT00479882|38083900|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
16939364|NCT00479882|38083897|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
16939365|NCT00479882|38083898|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
16939366|NCT00479882|38083899|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
16939367|NCT00479882|38083900|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
16939368|NCT00479882|38083897|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
16939369|NCT00479882|38083898|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
16939370|NCT00479882|38083899|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
16939371|NCT00479882|38083900|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
16939372|NCT00479765|38083926|FG000|Overall Study|study terminated|4|||
16939373|NCT00479687|38083932|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
16939374|NCT00479687|38083933|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
16939375|NCT00479687|38083934|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
16939376|NCT00479687|38083932|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
16939377|NCT00479687|38083933|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
16939378|NCT00479687|38083934|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
16939379|NCT00479687|38083932|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
16939380|NCT00479687|38083933|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
16939381|NCT00479687|38083934|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
16939382|NCT00479687|38083932|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
16939383|NCT00479687|38083933|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
16939384|NCT00479687|38083934|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
16939385|NCT00479687|38083932|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
16939386|NCT00479687|38083933|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
16939387|NCT00479687|38083934|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
16939388|NCT00479687|38083932|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
16939389|NCT00479687|38083933|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
16939390|NCT00479687|38083934|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
16939391|NCT00479687|38083932|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
16939392|NCT00479687|38083933|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
16939393|NCT00479687|38083934|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
16939394|NCT00479687|38083932|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
16939395|NCT00479687|38083933|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
16939396|NCT00479687|38083934|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
16939397|NCT00479687|38083932|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
16939398|NCT00479687|38083933|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
16939399|NCT00479687|38083934|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
16939400|NCT00479336|38083945|FG000|Overall Study|Adverse Event|1|||
16939401|NCT00479336|38083946|FG001|Overall Study|Adverse Event|1|||
16939402|NCT00479336|38083947|FG002|Overall Study|Adverse Event|1|||
16939403|NCT00479336|38083948|FG003|Overall Study|Adverse Event|3|||
16939404|NCT00479336|38083945|FG000|Overall Study|Lack of Efficacy|1|||
16939405|NCT00479336|38083946|FG001|Overall Study|Lack of Efficacy|0|||
16939406|NCT00479336|38083947|FG002|Overall Study|Lack of Efficacy|0|||
16939407|NCT00479336|38083948|FG003|Overall Study|Lack of Efficacy|0|||
16939408|NCT00479336|38083945|FG000|Overall Study|Protocol Violation|0|||
16939409|NCT00479336|38083946|FG001|Overall Study|Protocol Violation|1|||
16939410|NCT00479336|38083947|FG002|Overall Study|Protocol Violation|0|||
16939411|NCT00479336|38083948|FG003|Overall Study|Protocol Violation|0|||
16939412|NCT00479336|38083945|FG000|Overall Study|Withdrawal by Subject|1|||
16939413|NCT00479336|38083946|FG001|Overall Study|Withdrawal by Subject|2|||
16939414|NCT00479336|38083947|FG002|Overall Study|Withdrawal by Subject|0|||
16939415|NCT00479336|38083948|FG003|Overall Study|Withdrawal by Subject|0|||
16939416|NCT00479336|38083945|FG000|Overall Study|Physician Decision|0|||
16939417|NCT00479336|38083946|FG001|Overall Study|Physician Decision|1|||
16939418|NCT00479336|38083947|FG002|Overall Study|Physician Decision|0|||
16939419|NCT00479336|38083948|FG003|Overall Study|Physician Decision|2|||
16939420|NCT00479336|38083945|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
16939421|NCT00479336|38083946|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
16939422|NCT00479336|38083947|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
16939423|NCT00479336|38083948|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
16939424|NCT00478244|38083958|FG000|Overall Study|Did not receive transplant|1|||
16939425|NCT00478205|38083964|FG000|Overall Study|Adverse Event|182|||
16939426|NCT00478205|38083965|FG001|Overall Study|Adverse Event|39|||
16939427|NCT00478205|38083964|FG000|Overall Study|Medication Non-compliance|9|||
16939428|NCT00478205|38083965|FG001|Overall Study|Medication Non-compliance|4|||
16939429|NCT00478205|38083964|FG000|Overall Study|Protocol Violation|15|||
16939430|NCT00478205|38083965|FG001|Overall Study|Protocol Violation|5|||
16939431|NCT00478205|38083964|FG000|Overall Study|Request of Investigator or Sponsor|4|||
16939432|NCT00478205|38083965|FG001|Overall Study|Request of Investigator or Sponsor|5|||
16939433|NCT00478205|38083964|FG000|Overall Study|Withdrawal by Subject|61|||
16939434|NCT00478205|38083965|FG001|Overall Study|Withdrawal by Subject|22|||
16939435|NCT00478205|38083964|FG000|Overall Study|Lack of Efficacy|1|||
16939436|NCT00478205|38083965|FG001|Overall Study|Lack of Efficacy|0|||
16939437|NCT00478205|38083964|FG000|Overall Study|Other|24|||
16939438|NCT00478205|38083965|FG001|Overall Study|Other|12|||
16939439|NCT00477971|38083973|FG000|Overall Study|Disease progression|6|||
16939440|NCT00477971|38083974|FG001|Overall Study|Disease progression|0|||
16939441|NCT00477971|38083973|FG000|Overall Study|Withdrawal by Subject|3|||
16939442|NCT00477971|38083974|FG001|Overall Study|Withdrawal by Subject|1|||
16939443|NCT00477971|38083973|FG000|Overall Study|Adverse Event|3|||
16939444|NCT00477971|38083974|FG001|Overall Study|Adverse Event|0|||
16939445|NCT00477971|38083973|FG000|Overall Study|Death|2|||
16939446|NCT00477971|38083974|FG001|Overall Study|Death|4|||
16939447|NCT00477971|38083973|FG000|Overall Study|Alternative treatment|3|||
16939448|NCT00477971|38083974|FG001|Overall Study|Alternative treatment|1|||
16939449|NCT00477464|38083980|FG000|Overall Study|Lost to Follow-up|1|||
16939450|NCT00477464|38083980|FG000|Overall Study|Death|36|||
16939451|NCT00477464|38083980|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
16939452|NCT00477386|38083988|FG000|Overall Study|Adverse Event|4|||
16939453|NCT00477386|38083989|FG001|Overall Study|Adverse Event|8|||
16939454|NCT00477386|38083988|FG000|Overall Study|Disease progression, relapse|3|||
16939455|NCT00477386|38083989|FG001|Overall Study|Disease progression, relapse|4|||
16939456|NCT00477386|38083988|FG000|Overall Study|Disease progression, refractory|1|||
16939457|NCT00477386|38083989|FG001|Overall Study|Disease progression, refractory|3|||
16939458|NCT00477386|38083988|FG000|Overall Study|Other|1|||
16939459|NCT00477386|38083989|FG001|Overall Study|Other|2|||
16939460|NCT00477386|38083988|FG000|Overall Study|Physician Decision|1|||
16939461|NCT00477386|38083989|FG001|Overall Study|Physician Decision|0|||
16939462|NCT00477386|38083988|FG000|Overall Study|Withdrawal by Subject|1|||
16939463|NCT00477386|38083989|FG001|Overall Study|Withdrawal by Subject|0|||
16939464|NCT00477269|38083997|FG000|Core Study|Adverse Event|6|||
16939465|NCT00477269|38083998|FG001|Core Study|Adverse Event|4|||
16939466|NCT00477269|38083999|FG002|Core Study|Adverse Event|0|||
16939467|NCT00477269|38083997|FG000|Core Study|Death|3|||
16939468|NCT00477269|38083998|FG001|Core Study|Death|3|||
16939469|NCT00477269|38083999|FG002|Core Study|Death|0|||
16939470|NCT00477269|38083997|FG000|Core Study|Withdrawn Consent|0|||
16939471|NCT00477269|38083998|FG001|Core Study|Withdrawn Consent|1|||
16939472|NCT00477269|38083999|FG002|Core Study|Withdrawn Consent|0|||
16939473|NCT00477269|38083997|FG000|Open Label Extension|Adverse Event|0|||
16939474|NCT00477269|38083998|FG001|Open Label Extension|Adverse Event|0|||
16939475|NCT00477269|38083999|FG002|Open Label Extension|Adverse Event|4|||
16939476|NCT00477269|38083997|FG000|Open Label Extension|Abnormal laboratory values|0|||
16939477|NCT00477269|38083998|FG001|Open Label Extension|Abnormal laboratory values|0|||
16939478|NCT00477269|38083999|FG002|Open Label Extension|Abnormal laboratory values|1|||
16939479|NCT00477269|38083997|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
16939480|NCT00477269|38083998|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
16939481|NCT00477269|38083999|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
16939482|NCT00477269|38083997|FG000|Open Label Extension|Adminiatrative problems|0|||
16939483|NCT00477269|38083998|FG001|Open Label Extension|Adminiatrative problems|0|||
16939484|NCT00477269|38083999|FG002|Open Label Extension|Adminiatrative problems|2|||
16939485|NCT00477269|38083997|FG000|Open Label Extension|Death|0|||
16939486|NCT00477269|38083998|FG001|Open Label Extension|Death|0|||
16939487|NCT00477269|38083999|FG002|Open Label Extension|Death|4|||
17105660|NCT00094575|38244000|FG000|Overall Study|Death|146|||
17105661|NCT00094575|38244001|FG001|Overall Study|Death|146|||
17105662|NCT00057746|38244012|FG000|Overall Study|Withdrawal by Subject|0|||
17105663|NCT00057746|38244013|FG001|Overall Study|Withdrawal by Subject|0|||
17105664|NCT00057746|38244014|FG002|Overall Study|Withdrawal by Subject|1|||
17105665|NCT00094107|38244022|FG000|Overall Study|Lack of Efficacy|23|||
17105666|NCT00094107|38244022|FG000|Overall Study|Death|5|||
17105667|NCT00094107|38244022|FG000|Overall Study|Adverse Event|3|||
17105668|NCT00094107|38244022|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
17105669|NCT00102063|38244029|FG000|Overall Study|Lack of Efficacy|5|||
17105670|NCT00102063|38244030|FG001|Overall Study|Lack of Efficacy|1|||
17105671|NCT00102063|38244031|FG002|Overall Study|Lack of Efficacy|1|||
17105672|NCT00102063|38244029|FG000|Overall Study|Adverse Event|7|||
17105673|NCT00102063|38244030|FG001|Overall Study|Adverse Event|4|||
17105674|NCT00102063|38244031|FG002|Overall Study|Adverse Event|2|||
17105675|NCT00102063|38244029|FG000|Overall Study|Withdrawal by Subject|4|||
17105676|NCT00102063|38244030|FG001|Overall Study|Withdrawal by Subject|12|||
17105677|NCT00102063|38244031|FG002|Overall Study|Withdrawal by Subject|5|||
17105678|NCT00102063|38244029|FG000|Overall Study|Lost to Follow-up|0|||
17105679|NCT00102063|38244030|FG001|Overall Study|Lost to Follow-up|0|||
16939488|NCT00477152|38084007|FG000|Overall Study|Parent withdrew consent|2|||
16939489|NCT00477152|38084007|FG000|Overall Study|Adverse Event|1|||
16939490|NCT00476996|38084014|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
16939491|NCT00476996|38084015|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
16939492|NCT00476996|38084016|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
16939493|NCT00476996|38084017|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
16939494|NCT00476996|38084014|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
16939495|NCT00476996|38084015|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
16939496|NCT00476996|38084016|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
16939497|NCT00476996|38084017|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
16939498|NCT00476996|38084014|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
16939499|NCT00476996|38084015|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
16939500|NCT00476996|38084016|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
16939501|NCT00476996|38084017|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
16939502|NCT00476996|38084014|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
16939503|NCT00476996|38084015|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
16939504|NCT00476996|38084016|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
16939505|NCT00476996|38084017|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
16939506|NCT00476996|38084014|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
16939507|NCT00476996|38084015|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
16939508|NCT00476996|38084016|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
16939509|NCT00476996|38084017|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
16939510|NCT00476996|38084014|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
16939511|NCT00476996|38084015|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
16939512|NCT00476996|38084016|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
16939513|NCT00476996|38084017|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
16939514|NCT00476996|38084014|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
16939515|NCT00476996|38084015|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
16939516|NCT00476996|38084016|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
16939517|NCT00476996|38084017|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
16939518|NCT00476996|38084014|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
16939519|NCT00476996|38084015|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
16939520|NCT00476996|38084016|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
16939521|NCT00476996|38084017|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
16939522|NCT00476996|38084014|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
16939523|NCT00476996|38084015|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
16939524|NCT00476996|38084016|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
16939525|NCT00476996|38084017|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
16939526|NCT00476996|38084014|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
16939527|NCT00476996|38084015|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
16939528|NCT00476996|38084016|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
16939529|NCT00476996|38084017|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
16939530|NCT00476996|38084014|FG000|OLE Phase (From Week 48)|Death|0|||
16939531|NCT00476996|38084015|FG001|OLE Phase (From Week 48)|Death|0|||
16939532|NCT00476996|38084016|FG002|OLE Phase (From Week 48)|Death|0|||
16939533|NCT00476996|38084017|FG003|OLE Phase (From Week 48)|Death|7|||
16939534|NCT00476996|38084014|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
16939535|NCT00476996|38084015|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
16939536|NCT00476996|38084016|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
16939537|NCT00476996|38084017|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
16939538|NCT00476996|38084014|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
16939539|NCT00476996|38084015|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
16939540|NCT00476996|38084016|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
16939541|NCT00476996|38084017|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
16939542|NCT00476996|38084014|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
16939543|NCT00476996|38084015|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
16939544|NCT00476996|38084016|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
16939545|NCT00476996|38084017|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
16939546|NCT00476996|38084014|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
16939547|NCT00476996|38084015|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
16939548|NCT00476996|38084016|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
16939549|NCT00476996|38084017|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
16939550|NCT00476957|38084028|FG000|Overall Study|Lost to Follow-up|176|||
16939551|NCT00476957|38084029|FG001|Overall Study|Lost to Follow-up|193|||
16939552|NCT00475865|38084038|FG000|Overall Study|Adverse Event|0|||
16939553|NCT00475865|38084039|FG001|Overall Study|Adverse Event|3|||
16939554|NCT00475865|38084040|FG002|Overall Study|Adverse Event|4|||
16939555|NCT00475865|38084038|FG000|Overall Study|Lack of Efficacy|1|||
16939556|NCT00475865|38084039|FG001|Overall Study|Lack of Efficacy|0|||
16939557|NCT00475865|38084040|FG002|Overall Study|Lack of Efficacy|0|||
16939558|NCT00475865|38084038|FG000|Overall Study|Progressive disease|0|||
16939559|NCT00475865|38084039|FG001|Overall Study|Progressive disease|1|||
16939560|NCT00475865|38084040|FG002|Overall Study|Progressive disease|2|||
16939561|NCT00475865|38084038|FG000|Overall Study|Participant did not wish to continue|1|||
16939562|NCT00475865|38084039|FG001|Overall Study|Participant did not wish to continue|0|||
16939563|NCT00475865|38084040|FG002|Overall Study|Participant did not wish to continue|0|||
16939564|NCT00475865|38084038|FG000|Overall Study|Other than above|0|||
16939565|NCT00475865|38084039|FG001|Overall Study|Other than above|1|||
16939566|NCT00475865|38084040|FG002|Overall Study|Other than above|0|||
16939567|NCT00475709|38084050|FG000|Overall Study|Did not meet eligibility criteria|8|||
16939568|NCT00475709|38084050|FG000|Overall Study|Death|41|||
16939569|NCT00475709|38084050|FG000|Overall Study|Device Explant|6|||
16939570|NCT00475709|38084050|FG000|Overall Study|Lost to Follow-up|21|||
16939571|NCT00475670|38084056|FG000|Overall Study|Death|0|||
16939572|NCT00475670|38084057|FG001|Overall Study|Death|1|||
16939573|NCT00475670|38084056|FG000|Overall Study|Lack of Efficacy|3|||
16939574|NCT00475670|38084057|FG001|Overall Study|Lack of Efficacy|34|||
16939575|NCT00475670|38084056|FG000|Overall Study|Refused treatment|0|||
16939576|NCT00475670|38084057|FG001|Overall Study|Refused treatment|2|||
16939577|NCT00475670|38084056|FG000|Overall Study|Failure to Return|0|||
16939578|NCT00475670|38084057|FG001|Overall Study|Failure to Return|1|||
16939579|NCT00475670|38084056|FG000|Overall Study|Other|0|||
16939580|NCT00475670|38084057|FG001|Overall Study|Other|3|||
16939581|NCT00474968|38084065|FG000|Overall Study|Withdrawal by Subject|8|||
16939582|NCT00474968|38084066|FG001|Overall Study|Withdrawal by Subject|7|||
16939583|NCT00474968|38084065|FG000|Overall Study|Protocol Violation|9|||
16939584|NCT00474968|38084066|FG001|Overall Study|Protocol Violation|8|||
16939585|NCT00474968|38084065|FG000|Overall Study|Sample not collected|1|||
16939586|NCT00474968|38084066|FG001|Overall Study|Sample not collected|1|||
16939587|NCT00474929|38084077|FG000|Overall Study|Withdrawal by Subject|0|||
16939588|NCT00474929|38084078|FG001|Overall Study|Withdrawal by Subject|1|||
16939589|NCT00474929|38084079|FG002|Overall Study|Withdrawal by Subject|0|||
16939590|NCT00474929|38084080|FG003|Overall Study|Withdrawal by Subject|0|||
16939591|NCT00474929|38084081|FG004|Overall Study|Withdrawal by Subject|0|||
16939592|NCT00474929|38084077|FG000|Overall Study|Unrelated medical condition|0|||
16939593|NCT00474929|38084078|FG001|Overall Study|Unrelated medical condition|0|||
16939594|NCT00474929|38084079|FG002|Overall Study|Unrelated medical condition|1|||
16939595|NCT00474929|38084080|FG003|Overall Study|Unrelated medical condition|0|||
16939596|NCT00474929|38084081|FG004|Overall Study|Unrelated medical condition|0|||
16939597|NCT00474929|38084077|FG000|Overall Study|Physician Decision|0|||
16939598|NCT00474929|38084078|FG001|Overall Study|Physician Decision|0|||
16939599|NCT00474929|38084079|FG002|Overall Study|Physician Decision|1|||
16939600|NCT00474929|38084080|FG003|Overall Study|Physician Decision|2|||
16939601|NCT00474929|38084081|FG004|Overall Study|Physician Decision|0|||
16939602|NCT00474812|38084094|FG000|Overall Study|Withdrawal by Subject|5|||
16939603|NCT00474812|38084094|FG000|Overall Study|No Initiation of treatment|2|||
16939604|NCT00474383|38084098|FG000|Main Study|Adverse Event|11|||
16939605|NCT00474383|38084099|FG001|Main Study|Adverse Event|0|||
16939606|NCT00474383|38084098|FG000|Main Study|Symptomatic Deterioration|1|||
16939607|NCT00474383|38084099|FG001|Main Study|Symptomatic Deterioration|0|||
16939608|NCT00474383|38084098|FG000|Main Study|Progressive Disease|23|||
16939609|NCT00474383|38084099|FG001|Main Study|Progressive Disease|0|||
16939610|NCT00474383|38084098|FG000|Main Study|Other|1|||
16939611|NCT00474383|38084099|FG001|Main Study|Other|0|||
16939612|NCT00474383|38084098|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
16939613|NCT00474383|38084099|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
16939614|NCT00474383|38084098|FG000|Extension|Progressive Disease|0|||
16939615|NCT00474383|38084099|FG001|Extension|Progressive Disease|5|||
16939616|NCT00474266|38084107|FG000|Overall Study|Withdrawal by Subject|7|||
16939617|NCT00474266|38084108|FG001|Overall Study|Withdrawal by Subject|20|||
16939618|NCT00474266|38084109|FG002|Overall Study|Withdrawal by Subject|4|||
16939619|NCT00474266|38084110|FG003|Overall Study|Withdrawal by Subject|7|||
16939620|NCT00473564|38084123|FG000|Overall Study|robot surgery aborted in OR|23|||
16939621|NCT00472199|38084129|FG000|Overall Study|Adverse Event|19|||
16939622|NCT00472199|38084130|FG001|Overall Study|Adverse Event|23|||
16939623|NCT00472199|38084129|FG000|Overall Study|Lack of Efficacy|4|||
16939624|NCT00472199|38084130|FG001|Overall Study|Lack of Efficacy|25|||
16939625|NCT00472199|38084129|FG000|Overall Study|Lost to Follow-up|2|||
16939626|NCT00472199|38084130|FG001|Overall Study|Lost to Follow-up|4|||
16939627|NCT00472199|38084129|FG000|Overall Study|Protocol Violation|3|||
16939628|NCT00472199|38084130|FG001|Overall Study|Protocol Violation|2|||
16939629|NCT00472199|38084129|FG000|Overall Study|Withdrawal by Subject|6|||
16939630|NCT00472199|38084130|FG001|Overall Study|Withdrawal by Subject|5|||
16939631|NCT00472199|38084129|FG000|Overall Study|personal reason|0|||
16939632|NCT00472199|38084130|FG001|Overall Study|personal reason|1|||
16939633|NCT00472199|38084129|FG000|Overall Study|patient was asymptomatic|1|||
16939634|NCT00472199|38084130|FG001|Overall Study|patient was asymptomatic|0|||
16939635|NCT00472082|38084136|FG000|Overall Study|Study prematurely terminated|5|||
16939636|NCT00471887|38084140|FG000|Overall Study|Adverse Event|9|||
16939637|NCT00471536|38084144|FG000|Overall Study|Withdrawal by Subject|1|||
16939638|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
16939639|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
16939640|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Adverse Event|7|||
16939641|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Adverse Event|6|||
16939642|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
16939643|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
16939644|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Physician Decision|4|||
16939645|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Physician Decision|4|||
16939646|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
16939647|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
16939648|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
16939649|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
16939650|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
16939651|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
16939652|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Non-compliance|1|||
16939653|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Non-compliance|0|||
16939654|NCT00470834|38084150|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
16939655|NCT00470834|38084151|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
16939656|NCT00470834|38084150|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
16939657|NCT00470834|38084151|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
16939658|NCT00470834|38084150|FG000|Extension Period (24 Months)|Adverse Event|3|||
16939659|NCT00470834|38084151|FG001|Extension Period (24 Months)|Adverse Event|4|||
17105680|NCT00102063|38244031|FG002|Overall Study|Lost to Follow-up|1|||
17105681|NCT00102063|38244029|FG000|Overall Study|Protocol Violation|0|||
17105682|NCT00102063|38244030|FG001|Overall Study|Protocol Violation|1|||
17105683|NCT00102063|38244031|FG002|Overall Study|Protocol Violation|1|||
17105684|NCT00065156|38244039|FG000|Overall Study|Adverse Event|37|||
17105685|NCT00065156|38244039|FG000|Overall Study|Lack of Efficacy|52|||
17105686|NCT00065156|38244039|FG000|Overall Study|Withdrawal by Subject|8|||
17105687|NCT00065156|38244039|FG000|Overall Study|Lost to Follow-up|1|||
17105688|NCT00065156|38244039|FG000|Overall Study|Death|11|||
17105689|NCT00065156|38244039|FG000|Overall Study|Study Closed by Sponsor|2|||
17105690|NCT00065156|38244039|FG000|Overall Study|Disease Progression|7|||
17105691|NCT00065156|38244039|FG000|Overall Study|Investigator Decision|2|||
17105692|NCT00065156|38244039|FG000|Overall Study|Non-Compliance|2|||
17105693|NCT00065156|38244039|FG000|Overall Study|Loss of Response|1|||
17105694|NCT00065156|38244039|FG000|Overall Study|Secondary Malign Disease|1|||
17105695|NCT00064298|38244045|FG000|Overall Study|Withdrawal by Subject|2|||
17105696|NCT00064298|38244046|FG001|Overall Study|Withdrawal by Subject|1|||
17105697|NCT00064298|38244045|FG000|Overall Study|Lost to Follow-up|2|||
17105698|NCT00064298|38244046|FG001|Overall Study|Lost to Follow-up|2|||
17105699|NCT00064298|38244045|FG000|Overall Study|Death|0|||
17105700|NCT00064298|38244046|FG001|Overall Study|Death|1|||
17105701|NCT00064298|38244045|FG000|Overall Study|Disease Progression|2|||
17105702|NCT00064298|38244046|FG001|Overall Study|Disease Progression|1|||
17105703|NCT00078819|38244054|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
17105704|NCT00078819|38244055|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
17105705|NCT00078819|38244056|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
17105706|NCT00078819|38244057|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
17105707|NCT00078819|38244054|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
17105708|NCT00078819|38244055|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
17105709|NCT00078819|38244056|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
17105710|NCT00078819|38244057|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
17105711|NCT00078819|38244054|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
17105712|NCT00078819|38244055|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
17105713|NCT00078819|38244056|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
17105714|NCT00078819|38244057|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
17105715|NCT00078819|38244054|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
17105716|NCT00078819|38244055|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
17105717|NCT00078819|38244056|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
17105718|NCT00078819|38244057|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
17105719|NCT00078819|38244054|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
17105720|NCT00078819|38244055|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
17105721|NCT00078819|38244056|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
17105722|NCT00078819|38244057|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
17105723|NCT00078819|38244054|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
16939660|NCT00470834|38084150|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
16939661|NCT00470834|38084151|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
16939662|NCT00470834|38084150|FG000|Extension Period (24 Months)|Physician Decision|4|||
16939663|NCT00470834|38084151|FG001|Extension Period (24 Months)|Physician Decision|3|||
16939664|NCT00470834|38084150|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
16939665|NCT00470834|38084151|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
16939666|NCT00470834|38084150|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
16939667|NCT00470834|38084151|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
16939668|NCT00470834|38084150|FG000|Extension Period (24 Months)|Non-compliance|0|||
16939669|NCT00470834|38084151|FG001|Extension Period (24 Months)|Non-compliance|1|||
16939670|NCT00470834|38084150|FG000|Extension Period (24 Months)|Disease Progression|0|||
16939671|NCT00470834|38084151|FG001|Extension Period (24 Months)|Disease Progression|1|||
16939672|NCT00470366|38084157|FG000|Overall Study|Adverse Event|3|||
16939673|NCT00470366|38084157|FG000|Overall Study|Poor compliance|1|||
16939674|NCT00470093|38084161|FG000|Overall Study|Adverse Event|2|||
16939675|NCT00470054|38084165|FG000|Overall Study|Ineligible|1|||
16939676|NCT00474188|38084169|FG000|Overall Study|Withdrawal by Subject|1|||
16939677|NCT00474188|38084169|FG000|Overall Study|Study discontinued by sponsor|5|||
16939678|NCT00475982|38084174|FG000|Overall Study|surgery rescheduled|7|||
16939679|NCT00475982|38084175|FG001|Overall Study|surgery rescheduled|3|||
16939680|NCT01089647|38084183|FG000|Overall Study|Lost to Follow-up|2|||
16939681|NCT01089647|38084184|FG001|Overall Study|Lost to Follow-up|2|||
16939682|NCT01089647|38084183|FG000|Overall Study|Withdrawal by Subject|2|||
16939683|NCT01089647|38084184|FG001|Overall Study|Withdrawal by Subject|1|||
16939684|NCT01089647|38084183|FG000|Overall Study|Adverse Event|0|||
16939685|NCT01089647|38084184|FG001|Overall Study|Adverse Event|1|||
16939686|NCT01089608|38084192|FG000|Overall Study|Adverse Event|0|||
16939687|NCT01089608|38084193|FG001|Overall Study|Adverse Event|4|||
16939688|NCT01089608|38084192|FG000|Overall Study|Lost to Follow-up|0|||
16939689|NCT01089608|38084193|FG001|Overall Study|Lost to Follow-up|2|||
16939690|NCT01089413|38084202|FG000|Overall Study|Lost to Follow-up|1|||
16939691|NCT01089413|38084202|FG000|Overall Study|Progressive Disease|93|||
16939692|NCT01089413|38084202|FG000|Overall Study|Participant Withdrew Consent|1|||
16939693|NCT01089413|38084202|FG000|Overall Study|Unacceptable Toxicity|12|||
16939694|NCT01089413|38084202|FG000|Overall Study|Death|10|||
16939695|NCT01089413|38084202|FG000|Overall Study|Metastasectomy|13|||
16939696|NCT01089413|38084202|FG000|Overall Study|Other|71|||
16939697|NCT01089023|38084212|FG000|Overall Study|Lost to Follow-up|3|||
16939698|NCT01089023|38084212|FG000|Overall Study|Adverse Event|1|||
16939699|NCT01089023|38084212|FG000|Overall Study|Withdrawal by Subject|1|||
16939700|NCT01089023|38084212|FG000|Overall Study|Protocol Violation|1|||
16939701|NCT01089023|38084212|FG000|Overall Study|Lack of Efficacy|1|||
16939702|NCT01088984|38084218|FG000|Phase 1|Death|2|||
16939703|NCT01088984|38084219|FG001|Phase 1|Death|1|||
16939704|NCT01088984|38084218|FG000|Phase 1|Disease Progression|2|||
16939705|NCT01088984|38084219|FG001|Phase 1|Disease Progression|4|||
16939706|NCT01088984|38084218|FG000|Phase 1|Other|1|||
16939707|NCT01088984|38084219|FG001|Phase 1|Other|1|||
16939708|NCT01088984|38084218|FG000|Phase 2|Death|0|||
16939709|NCT01088984|38084219|FG001|Phase 2|Death|5|||
16939710|NCT01088984|38084218|FG000|Phase 2|Withdrawal by Subject|0|||
16939711|NCT01088984|38084219|FG001|Phase 2|Withdrawal by Subject|1|||
16939712|NCT01088984|38084218|FG000|Phase 2|DIsease Progression|0|||
16939713|NCT01088984|38084219|FG001|Phase 2|DIsease Progression|25|||
16939714|NCT01088984|38084218|FG000|Phase 2|Other|0|||
16939715|NCT01088984|38084219|FG001|Phase 2|Other|1|||
16939716|NCT01088438|38084230|FG000|Overall Study|Withdrawal by Subject|11|||
16939717|NCT01088438|38084231|FG001|Overall Study|Withdrawal by Subject|6|||
16939718|NCT01088438|38084230|FG000|Overall Study|Lost to Follow-up|18|||
16939719|NCT01088438|38084231|FG001|Overall Study|Lost to Follow-up|30|||
16939720|NCT01088243|38084239|FG000|Overall Study|Adverse Event|1|||
16939721|NCT01088243|38084240|FG001|Overall Study|Adverse Event|0|||
16939722|NCT01088048|38084256|FG000|Overall Study|Adverse Event|7|||
16939723|NCT01088048|38084257|FG001|Overall Study|Adverse Event|9|||
16939724|NCT01088048|38084258|FG002|Overall Study|Adverse Event|7|||
16939725|NCT01088048|38084259|FG003|Overall Study|Adverse Event|5|||
16939726|NCT01088048|38084260|FG004|Overall Study|Adverse Event|6|||
16939727|NCT01088048|38084261|FG005|Overall Study|Adverse Event|3|||
16939728|NCT01088048|38084262|FG006|Overall Study|Adverse Event|3|||
16939729|NCT01088048|38084263|FG007|Overall Study|Adverse Event|0|||
16939730|NCT01088048|38084264|FG008|Overall Study|Adverse Event|2|||
16939731|NCT01088048|38084265|FG009|Overall Study|Adverse Event|2|||
16939732|NCT01088048|38084256|FG000|Overall Study|Withdrew Consent|1|||
16939733|NCT01088048|38084257|FG001|Overall Study|Withdrew Consent|1|||
16939734|NCT01088048|38084258|FG002|Overall Study|Withdrew Consent|1|||
16939735|NCT01088048|38084259|FG003|Overall Study|Withdrew Consent|1|||
16939736|NCT01088048|38084260|FG004|Overall Study|Withdrew Consent|2|||
16939737|NCT01088048|38084261|FG005|Overall Study|Withdrew Consent|1|||
16939738|NCT01088048|38084262|FG006|Overall Study|Withdrew Consent|0|||
16939739|NCT01088048|38084263|FG007|Overall Study|Withdrew Consent|2|||
16939740|NCT01088048|38084264|FG008|Overall Study|Withdrew Consent|2|||
16939741|NCT01088048|38084265|FG009|Overall Study|Withdrew Consent|1|||
16939742|NCT01088048|38084256|FG000|Overall Study|Concomitant Medication Prohibited|1|||
16939743|NCT01088048|38084257|FG001|Overall Study|Concomitant Medication Prohibited|0|||
16939744|NCT01088048|38084258|FG002|Overall Study|Concomitant Medication Prohibited|0|||
16939745|NCT01088048|38084259|FG003|Overall Study|Concomitant Medication Prohibited|0|||
16939746|NCT01088048|38084260|FG004|Overall Study|Concomitant Medication Prohibited|0|||
16939747|NCT01088048|38084261|FG005|Overall Study|Concomitant Medication Prohibited|0|||
16939748|NCT01088048|38084262|FG006|Overall Study|Concomitant Medication Prohibited|0|||
16939749|NCT01088048|38084263|FG007|Overall Study|Concomitant Medication Prohibited|0|||
16939750|NCT01088048|38084264|FG008|Overall Study|Concomitant Medication Prohibited|0|||
16939751|NCT01088048|38084265|FG009|Overall Study|Concomitant Medication Prohibited|0|||
16939752|NCT01088048|38084256|FG000|Overall Study|Investigator Request|2|||
16939753|NCT01088048|38084257|FG001|Overall Study|Investigator Request|2|||
16939754|NCT01088048|38084258|FG002|Overall Study|Investigator Request|0|||
16939755|NCT01088048|38084259|FG003|Overall Study|Investigator Request|0|||
16939756|NCT01088048|38084260|FG004|Overall Study|Investigator Request|3|||
16939757|NCT01088048|38084261|FG005|Overall Study|Investigator Request|1|||
16939758|NCT01088048|38084262|FG006|Overall Study|Investigator Request|1|||
17105724|NCT00078819|38244055|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
17105725|NCT00078819|38244056|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
17105726|NCT00078819|38244057|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
17105727|NCT00078819|38244054|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
17105728|NCT00078819|38244055|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
17105729|NCT00078819|38244056|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
17105730|NCT00078819|38244057|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
17105731|NCT00078819|38244054|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
17105732|NCT00078819|38244055|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
17105733|NCT00078819|38244056|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
17105734|NCT00078819|38244057|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
17105735|NCT00063986|38244074|FG000|Overall Study|Withdrawal by Subject|1|||
17105736|NCT00063986|38244074|FG000|Overall Study|Ineligible|1|||
17105737|NCT00063986|38244074|FG000|Overall Study|Intra-operatively ineligible|4|||
17105738|NCT00098865|38244078|FG000|Overall Study|Progressive Disease|6|||
17105739|NCT00098865|38244078|FG000|Overall Study|Adverse Event|2|||
17105740|NCT00098865|38244078|FG000|Overall Study|Alternative Therapy|1|||
17105741|NCT00098787|38244085|FG000|Overall Study|Never started treatment|3|||
17105742|NCT00098787|38244086|FG001|Overall Study|Never started treatment|2|||
17105743|NCT00098787|38244087|FG002|Overall Study|Never started treatment|1|||
17105744|NCT00098787|38244085|FG000|Overall Study|Ineligible|9|||
17105745|NCT00098787|38244086|FG001|Overall Study|Ineligible|7|||
17105746|NCT00098787|38244087|FG002|Overall Study|Ineligible|3|||
17105747|NCT00098787|38244085|FG000|Overall Study|Disease progression|28|||
17105748|NCT00098787|38244086|FG001|Overall Study|Disease progression|17|||
17105749|NCT00098787|38244087|FG002|Overall Study|Disease progression|23|||
17105750|NCT00098787|38244085|FG000|Overall Study|Adverse Event|8|||
17105751|NCT00098787|38244086|FG001|Overall Study|Adverse Event|17|||
17105752|NCT00098787|38244087|FG002|Overall Study|Adverse Event|8|||
17105753|NCT00098787|38244085|FG000|Overall Study|Death|6|||
17105754|NCT00098787|38244086|FG001|Overall Study|Death|1|||
17105755|NCT00098787|38244087|FG002|Overall Study|Death|0|||
17105756|NCT00098787|38244085|FG000|Overall Study|Withdrawal by Subject|4|||
17105757|NCT00098787|38244086|FG001|Overall Study|Withdrawal by Subject|12|||
17105758|NCT00098787|38244087|FG002|Overall Study|Withdrawal by Subject|6|||
17105759|NCT00098787|38244085|FG000|Overall Study|Alternative therapy|8|||
17105760|NCT00098787|38244086|FG001|Overall Study|Alternative therapy|13|||
17105761|NCT00098787|38244087|FG002|Overall Study|Alternative therapy|13|||
17105762|NCT00098787|38244085|FG000|Overall Study|Other|7|||
17105763|NCT00098787|38244086|FG001|Overall Study|Other|6|||
17105764|NCT00098787|38244087|FG002|Overall Study|Other|9|||
17105765|NCT02954458|38244099|FG000|Overall Study|Adverse Event|0|||
17105766|NCT02954458|38244100|FG001|Overall Study|Adverse Event|0|||
17105767|NCT02954458|38244101|FG002|Overall Study|Adverse Event|0|||
17105768|NCT02954458|38244102|FG003|Overall Study|Adverse Event|1|||
16939759|NCT01088048|38084263|FG007|Overall Study|Investigator Request|0|||
17105769|NCT02954458|38244099|FG000|Overall Study|Withdrawal by Subject|0|||
17105770|NCT02954458|38244100|FG001|Overall Study|Withdrawal by Subject|0|||
17105771|NCT02954458|38244101|FG002|Overall Study|Withdrawal by Subject|0|||
17105772|NCT02954458|38244102|FG003|Overall Study|Withdrawal by Subject|1|||
17105773|NCT02954458|38244099|FG000|Overall Study|Physician Decision|0|||
17105774|NCT02954458|38244100|FG001|Overall Study|Physician Decision|0|||
17105775|NCT02954458|38244101|FG002|Overall Study|Physician Decision|1|||
16939760|NCT01088048|38084264|FG008|Overall Study|Investigator Request|0|||
16939761|NCT01088048|38084265|FG009|Overall Study|Investigator Request|0|||
16939762|NCT01088048|38084256|FG000|Overall Study|Patient Non-compliance|0|||
17105776|NCT02954458|38244102|FG003|Overall Study|Physician Decision|1|||
16939763|NCT01088048|38084257|FG001|Overall Study|Patient Non-compliance|1|||
16939764|NCT01088048|38084258|FG002|Overall Study|Patient Non-compliance|0|||
16939765|NCT01088048|38084259|FG003|Overall Study|Patient Non-compliance|0|||
16939766|NCT01088048|38084260|FG004|Overall Study|Patient Non-compliance|0|||
16939767|NCT01088048|38084261|FG005|Overall Study|Patient Non-compliance|0|||
16939768|NCT01088048|38084262|FG006|Overall Study|Patient Non-compliance|0|||
16939769|NCT01088048|38084263|FG007|Overall Study|Patient Non-compliance|0|||
16939770|NCT01088048|38084264|FG008|Overall Study|Patient Non-compliance|0|||
16939771|NCT01088048|38084265|FG009|Overall Study|Patient Non-compliance|0|||
16939772|NCT01088048|38084256|FG000|Overall Study|Disease Progression|7|||
16939773|NCT01088048|38084257|FG001|Overall Study|Disease Progression|4|||
16939774|NCT01088048|38084258|FG002|Overall Study|Disease Progression|3|||
16939775|NCT01088048|38084259|FG003|Overall Study|Disease Progression|5|||
16939776|NCT01088048|38084260|FG004|Overall Study|Disease Progression|3|||
16939777|NCT01088048|38084261|FG005|Overall Study|Disease Progression|3|||
16939778|NCT01088048|38084262|FG006|Overall Study|Disease Progression|2|||
16939779|NCT01088048|38084263|FG007|Overall Study|Disease Progression|1|||
16939780|NCT01088048|38084264|FG008|Overall Study|Disease Progression|0|||
16939781|NCT01088048|38084265|FG009|Overall Study|Disease Progression|0|||
16939782|NCT01088048|38084256|FG000|Overall Study|Death|1|||
16939783|NCT01088048|38084257|FG001|Overall Study|Death|5|||
16939784|NCT01088048|38084258|FG002|Overall Study|Death|3|||
16939785|NCT01088048|38084259|FG003|Overall Study|Death|3|||
16939786|NCT01088048|38084260|FG004|Overall Study|Death|1|||
16939787|NCT01088048|38084261|FG005|Overall Study|Death|3|||
16939788|NCT01088048|38084262|FG006|Overall Study|Death|0|||
16939789|NCT01088048|38084263|FG007|Overall Study|Death|0|||
16939790|NCT01088048|38084264|FG008|Overall Study|Death|3|||
16939791|NCT01088048|38084265|FG009|Overall Study|Death|1|||
16939792|NCT01088048|38084256|FG000|Overall Study|Other|3|||
16939793|NCT01088048|38084257|FG001|Overall Study|Other|5|||
16939794|NCT01088048|38084258|FG002|Overall Study|Other|0|||
16939795|NCT01088048|38084259|FG003|Overall Study|Other|0|||
16939796|NCT01088048|38084260|FG004|Overall Study|Other|2|||
16939797|NCT01088048|38084261|FG005|Overall Study|Other|0|||
16939798|NCT01088048|38084262|FG006|Overall Study|Other|0|||
16939799|NCT01088048|38084263|FG007|Overall Study|Other|2|||
16939800|NCT01088048|38084264|FG008|Overall Study|Other|0|||
16939801|NCT01088048|38084265|FG009|Overall Study|Other|0|||
16939802|NCT01087970|38084298|FG000|Overall Study|Protocol Violation|2|||
16939803|NCT01087814|38084305|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
16939804|NCT01087814|38084306|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
16939805|NCT01087814|38084305|FG000|Second Intervention (5 Days)|Physician Decision|1|||
16939806|NCT01087814|38084306|FG001|Second Intervention (5 Days)|Physician Decision|0|||
16939807|NCT01087775|38084312|FG000|Overall Study|failed inclusion criteria|2|||
16939808|NCT01087502|38084319|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
16939809|NCT01087502|38084320|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
16939810|NCT01087502|38084319|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
16939811|NCT01087502|38084320|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
16939812|NCT01087502|38084319|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
16939813|NCT01087502|38084320|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
16939814|NCT01087502|38084319|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
16939815|NCT01087502|38084320|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
16939816|NCT01087502|38084319|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
16939817|NCT01087502|38084320|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
16939818|NCT01087502|38084319|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
16939819|NCT01087502|38084320|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
16939820|NCT01087502|38084319|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
16939821|NCT01087502|38084320|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
16939822|NCT01087502|38084319|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
16939823|NCT01087502|38084320|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
16939824|NCT01087502|38084319|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
16939825|NCT01087502|38084320|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
17105777|NCT02954458|38244099|FG000|Overall Study|Lost to Follow-up|1|||
17105778|NCT02954458|38244100|FG001|Overall Study|Lost to Follow-up|0|||
17105779|NCT02954458|38244101|FG002|Overall Study|Lost to Follow-up|0|||
17105780|NCT02954458|38244102|FG003|Overall Study|Lost to Follow-up|1|||
17105781|NCT02954458|38244099|FG000|Overall Study|Death|0|||
17105782|NCT02954458|38244100|FG001|Overall Study|Death|0|||
17105783|NCT02954458|38244101|FG002|Overall Study|Death|0|||
17105784|NCT02954458|38244102|FG003|Overall Study|Death|1|||
17105785|NCT02954458|38244099|FG000|Overall Study|Other|0|||
17105786|NCT02954458|38244100|FG001|Overall Study|Other|0|||
17105787|NCT02954458|38244101|FG002|Overall Study|Other|0|||
17105788|NCT02954458|38244102|FG003|Overall Study|Other|7|||
17105789|NCT03500692|38244116|FG000|Overall Study|Death|76|||
17105790|NCT03500692|38244116|FG000|Overall Study|Missed visit|30|||
17105791|NCT03500692|38244116|FG000|Overall Study|Termination Reasons|3|||
17199783|NCT02690727|38353747|FG000|Overall Study|Adverse Event|2|||
16939826|NCT01087502|38084319|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
16939827|NCT01087502|38084320|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
16939828|NCT01087502|38084319|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
16939829|NCT01087502|38084320|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
16939830|NCT01087502|38084319|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
16939831|NCT01087502|38084320|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
16939832|NCT01086410|38084332|FG000|Overall Study|Adverse Event|1|||
16939833|NCT01086410|38084333|FG001|Overall Study|Adverse Event|0|||
16939834|NCT01086410|38084334|FG002|Overall Study|Adverse Event|0|||
16939835|NCT01086410|38084335|FG003|Overall Study|Adverse Event|2|||
16939836|NCT01086410|38084332|FG000|Overall Study|Lack of Efficacy|1|||
16939837|NCT01086410|38084333|FG001|Overall Study|Lack of Efficacy|1|||
16939838|NCT01086410|38084334|FG002|Overall Study|Lack of Efficacy|0|||
16939839|NCT01086410|38084335|FG003|Overall Study|Lack of Efficacy|0|||
16939840|NCT01086410|38084332|FG000|Overall Study|Protocol Violation|1|||
16939841|NCT01086410|38084333|FG001|Overall Study|Protocol Violation|1|||
16939842|NCT01086410|38084334|FG002|Overall Study|Protocol Violation|0|||
16939843|NCT01086410|38084335|FG003|Overall Study|Protocol Violation|0|||
16939844|NCT01086410|38084332|FG000|Overall Study|Lost to Follow-up|0|||
16939845|NCT01086410|38084333|FG001|Overall Study|Lost to Follow-up|0|||
16939846|NCT01086410|38084334|FG002|Overall Study|Lost to Follow-up|1|||
16939847|NCT01086410|38084335|FG003|Overall Study|Lost to Follow-up|0|||
16939848|NCT04553679|38084347|FG000|Overall Study|Withdrawal by Subject|2|||
16939849|NCT04553679|38084348|FG001|Overall Study|Withdrawal by Subject|0|||
16939850|NCT04553679|38084347|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
16939851|NCT04553679|38084348|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
16939852|NCT01086215|38084362|FG000|Overall Study|Death|14|||
16939853|NCT01086215|38084363|FG001|Overall Study|Death|8|||
16939854|NCT01086215|38084364|FG002|Overall Study|Death|8|||
16939855|NCT01086215|38084365|FG003|Overall Study|Death|1|||
16939856|NCT01086215|38084362|FG000|Overall Study|Lost to Follow-up|22|||
16939857|NCT01086215|38084363|FG001|Overall Study|Lost to Follow-up|39|||
16939858|NCT01086215|38084364|FG002|Overall Study|Lost to Follow-up|18|||
16939859|NCT01086215|38084365|FG003|Overall Study|Lost to Follow-up|2|||
16939860|NCT01085591|38084378|FG000|Overall Study|Adverse Event|0|||
16939861|NCT01085591|38084379|FG001|Overall Study|Adverse Event|1|||
16939862|NCT01085591|38084380|FG002|Overall Study|Adverse Event|3|||
16939863|NCT01085591|38084378|FG000|Overall Study|Physician Decision|1|||
16939864|NCT01085591|38084379|FG001|Overall Study|Physician Decision|0|||
16939865|NCT01085591|38084380|FG002|Overall Study|Physician Decision|1|||
16939866|NCT01085591|38084378|FG000|Overall Study|Withdrawal by Subject|0|||
16939867|NCT01085591|38084379|FG001|Overall Study|Withdrawal by Subject|2|||
16939868|NCT01085591|38084380|FG002|Overall Study|Withdrawal by Subject|1|||
16939869|NCT01085591|38084378|FG000|Overall Study|Lost to Follow-up|0|||
16939870|NCT01085591|38084379|FG001|Overall Study|Lost to Follow-up|1|||
16939871|NCT01085591|38084380|FG002|Overall Study|Lost to Follow-up|1|||
16939872|NCT01085591|38084378|FG000|Overall Study|Protocol Violation|1|||
16939873|NCT01085591|38084379|FG001|Overall Study|Protocol Violation|1|||
16939874|NCT01085591|38084380|FG002|Overall Study|Protocol Violation|1|||
16939875|NCT01085591|38084378|FG000|Overall Study|Other|0|||
16939876|NCT01085591|38084379|FG001|Overall Study|Other|1|||
16939877|NCT01085591|38084380|FG002|Overall Study|Other|0|||
16939878|NCT01085591|38084378|FG000|Overall Study|Not Properly Consented|1|||
16939879|NCT01085591|38084379|FG001|Overall Study|Not Properly Consented|0|||
16939880|NCT01085591|38084380|FG002|Overall Study|Not Properly Consented|0|||
16939881|NCT01085357|38084391|FG000|Overall Study|Adverse Event|1|||
16939882|NCT01085357|38084392|FG001|Overall Study|Adverse Event|1|||
16939883|NCT01085357|38084391|FG000|Overall Study|Subject Decision|4|||
16939884|NCT01085357|38084392|FG001|Overall Study|Subject Decision|3|||
16939885|NCT01085357|38084391|FG000|Overall Study|Investigator Decision|1|||
16939886|NCT01085357|38084392|FG001|Overall Study|Investigator Decision|1|||
16939887|NCT01085357|38084391|FG000|Overall Study|Death|11|||
16939888|NCT01085357|38084392|FG001|Overall Study|Death|1|||
16939889|NCT01085357|38084391|FG000|Overall Study|Lost to Follow-up|2|||
16939890|NCT01085357|38084392|FG001|Overall Study|Lost to Follow-up|0|||
16939891|NCT01085201|38084403|FG000|Overall Study|Scheduling conflict|1|||
16939892|NCT01085201|38084404|FG001|Overall Study|Scheduling conflict|0|||
16939893|NCT01085201|38084405|FG002|Overall Study|Scheduling conflict|1|||
16939894|NCT01085201|38084406|FG003|Overall Study|Scheduling conflict|0|||
17105792|NCT03500224|38244120|FG000|Overall Study|Withdrawal by Subject|2|||
17105793|NCT03495154|38244124|FG000|Overall Study|Screen Failures Pre-Operatively|3|||
17105794|NCT03495154|38244124|FG000|Overall Study|Withdrawn Prior to Surgery|11|||
17105795|NCT03495154|38244124|FG000|Overall Study|Screen Failures During Surgery|6|||
17105796|NCT03495154|38244124|FG000|Overall Study|Death|2|||
17105797|NCT03495154|38244124|FG000|Overall Study|Lost to Follow-up|6|||
17105798|NCT03495154|38244124|FG000|Overall Study|Protocol Violation|1|||
17105799|NCT03495154|38244124|FG000|Overall Study|Withdrawal by Subject|1|||
17105800|NCT00077649|38244132|FG000|Overall Study|Adverse Event|5|||
16939895|NCT01085201|38084407|FG004|Overall Study|Scheduling conflict|0|||
16939896|NCT01085201|38084403|FG000|Overall Study|Unknown- no study drug|2|||
16939897|NCT01085201|38084404|FG001|Overall Study|Unknown- no study drug|0|||
16939898|NCT01085201|38084405|FG002|Overall Study|Unknown- no study drug|0|||
16939899|NCT01085201|38084406|FG003|Overall Study|Unknown- no study drug|0|||
16939900|NCT01085201|38084407|FG004|Overall Study|Unknown- no study drug|0|||
16939901|NCT01085201|38084403|FG000|Overall Study|Fond ineligible after consent|0|||
16939902|NCT01085201|38084404|FG001|Overall Study|Fond ineligible after consent|1|||
16939903|NCT01085201|38084405|FG002|Overall Study|Fond ineligible after consent|1|||
16939904|NCT01085201|38084406|FG003|Overall Study|Fond ineligible after consent|0|||
16939905|NCT01085201|38084407|FG004|Overall Study|Fond ineligible after consent|0|||
16939906|NCT01085084|38084427|FG000|Overall Study|Withdrawal by Subject|1|||
16939907|NCT01085084|38084428|FG001|Overall Study|Withdrawal by Subject|0|||
16939908|NCT01085084|38084429|FG002|Overall Study|Withdrawal by Subject|0|||
16939909|NCT01085084|38084427|FG000|Overall Study|Lost to Follow-up|2|||
16939910|NCT01085084|38084428|FG001|Overall Study|Lost to Follow-up|1|||
16939911|NCT01085084|38084429|FG002|Overall Study|Lost to Follow-up|1|||
16939912|NCT01085084|38084427|FG000|Overall Study|Adverse Event|4|||
16939913|NCT01085084|38084428|FG001|Overall Study|Adverse Event|3|||
16939914|NCT01085084|38084429|FG002|Overall Study|Adverse Event|6|||
16939915|NCT01085084|38084427|FG000|Overall Study|Treatment Failure|0|||
16939916|NCT01085084|38084428|FG001|Overall Study|Treatment Failure|1|||
16939917|NCT01085084|38084429|FG002|Overall Study|Treatment Failure|2|||
16939918|NCT01085045|38084437|FG000|Part A|Withdrawal by Subject|4|||
16939919|NCT01085045|38084437|FG000|Part A|Adverse Event|6|||
16939920|NCT01085045|38084437|FG000|Part A|Protocol Violation|1|||
16939921|NCT01085045|38084437|FG000|Part A|Protocol Specified Criteria|7|||
16939922|NCT01085045|38084437|FG000|Part B|Withdrawal by Subject|2|||
16939923|NCT01085045|38084437|FG000|Part B|Protocol Specified Criteria|6|||
16939924|NCT01085045|38084437|FG000|Part B|Lost to Follow-up|1|||
16939925|NCT01085045|38084437|FG000|Part B|Adverse Event|6|||
16939926|NCT01084772|38084459|FG000|Baseline|Withdrawal by Subject|7|||
16939927|NCT01084772|38084460|FG001|Baseline|Withdrawal by Subject|6|||
16939928|NCT01084772|38084459|FG000|3 Months|Death|1|||
16939929|NCT01084772|38084460|FG001|3 Months|Death|0|||
16939930|NCT01084772|38084459|FG000|3 Months|Study Termination|2|||
16939931|NCT01084772|38084460|FG001|3 Months|Study Termination|2|||
16939932|NCT01084772|38084459|FG000|1 Year|Withdrawal by Subject|0|||
16939933|NCT01084772|38084460|FG001|1 Year|Withdrawal by Subject|1|||
16939934|NCT01084772|38084459|FG000|1 Year|Lost to Follow-up|3|||
16939935|NCT01084772|38084460|FG001|1 Year|Lost to Follow-up|0|||
16939936|NCT01084772|38084459|FG000|1 Year|Study Termination|0|||
16939937|NCT01084772|38084460|FG001|1 Year|Study Termination|7|||
16939938|NCT01084772|38084459|FG000|2 Years|Withdrawal by Subject|1|||
16939939|NCT01084772|38084460|FG001|2 Years|Withdrawal by Subject|0|||
16939940|NCT01084772|38084459|FG000|2 Years|Lost to Follow-up|5|||
16939941|NCT01084772|38084460|FG001|2 Years|Lost to Follow-up|2|||
16939942|NCT01084772|38084459|FG000|2 Years|Study Termination|3|||
16939943|NCT01084772|38084460|FG001|2 Years|Study Termination|2|||
16939944|NCT00179673|38084466|FG000|Overall Study|Adverse Event|7|||
16939945|NCT00179673|38084466|FG000|Overall Study|Lack of Efficacy|15|||
16939946|NCT00179673|38084466|FG000|Overall Study|Withdrawal by Subject|3|||
16939947|NCT00179673|38084466|FG000|Overall Study|Death|4|||
16939948|NCT00179673|38084466|FG000|Overall Study|Other Observations and options|14|||
16939949|NCT01084655|38084473|FG000|Overall Study|Radiographic disease progression|3|||
16939950|NCT01084655|38084474|FG001|Overall Study|Radiographic disease progression|2|||
16939951|NCT01084655|38084475|FG002|Overall Study|Radiographic disease progression|8|||
16939952|NCT01084655|38084473|FG000|Overall Study|Withdrawal by Subject|1|||
16939953|NCT01084655|38084474|FG001|Overall Study|Withdrawal by Subject|0|||
16939954|NCT01084655|38084475|FG002|Overall Study|Withdrawal by Subject|4|||
16939955|NCT01084655|38084473|FG000|Overall Study|Adverse Event|2|||
16939956|NCT01084655|38084474|FG001|Overall Study|Adverse Event|1|||
16939957|NCT01084655|38084475|FG002|Overall Study|Adverse Event|2|||
16939958|NCT01084655|38084473|FG000|Overall Study|Other|0|||
16939959|NCT01084655|38084474|FG001|Overall Study|Other|3|||
16939960|NCT01084655|38084475|FG002|Overall Study|Other|2|||
16939961|NCT01084655|38084473|FG000|Overall Study|Symptomatic deterioration|0|||
16939962|NCT01084655|38084474|FG001|Overall Study|Symptomatic deterioration|0|||
16939963|NCT01084655|38084475|FG002|Overall Study|Symptomatic deterioration|2|||
16939964|NCT01084655|38084473|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
16939965|NCT01084655|38084474|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
16939966|NCT01084655|38084475|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
16939967|NCT01084538|38084487|FG000|Overall Study|Drug not available|30|||
16939968|NCT01084538|38084487|FG000|Overall Study|Adverse Event|9|||
16939969|NCT01084538|38084487|FG000|Overall Study|Kidney transplant|6|||
16939970|NCT01084538|38084487|FG000|Overall Study|Serious Adverse Event|3|||
16939971|NCT01084538|38084487|FG000|Overall Study|Lack of effectiveness|2|||
16939972|NCT01084538|38084487|FG000|Overall Study|Patient noncompliance|2|||
16939973|NCT01084538|38084487|FG000|Overall Study|Hyperphosphatemia|2|||
16939974|NCT01084538|38084487|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
16939975|NCT01084538|38084487|FG000|Overall Study|Change of residence|2|||
16939976|NCT01084538|38084487|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
16939977|NCT01084538|38084487|FG000|Overall Study|Reason unknown|8|||
16939978|NCT01083680|38084491|FG000|Overall Study|Lost to Follow-up|2758|||
16939979|NCT01083680|38084491|FG000|Overall Study|Withdrawal by Subject|1086|||
16939980|NCT00179517|38084497|FG000|Overall Study|Withdrawal by Subject|2|||
16939981|NCT00179517|38084498|FG001|Overall Study|Withdrawal by Subject|1|||
16939982|NCT01083641|38084504|FG000|Overall Study|Withdrawal by Subject|2|||
16939983|NCT00179010|38084510|FG000|Overall Study|Muscle probe defective|1|||
16939984|NCT00179010|38084511|FG001|Overall Study|Muscle probe defective|1|||
16939985|NCT00179010|38084510|FG000|Overall Study|Failure to place arterial line|0|||
16939986|NCT00179010|38084511|FG001|Overall Study|Failure to place arterial line|1|||
16939987|NCT01083602|38084518|FG000|Overall Study|Adverse Event|11|||
16939988|NCT01083602|38084518|FG000|Overall Study|New Cancer Therapy|2|||
16939989|NCT01083602|38084518|FG000|Overall Study|Death|1|||
16939990|NCT01083602|38084518|FG000|Overall Study|Withdrawal by Subject|5|||
16939991|NCT01083602|38084518|FG000|Overall Study|Lack of Efficacy|36|||
16939992|NCT00178464|38084522|FG000|Overall Study|Withdrawal by Subject|1|||
16939993|NCT00178464|38084522|FG000|Overall Study|Physician Decision|1|||
16939994|NCT01083485|38084528|FG000|Overall Study|Adverse Event|0|||
16939995|NCT01083485|38084529|FG001|Overall Study|Adverse Event|1|||
16939996|NCT01083485|38084528|FG000|Overall Study|Protocol Violation|1|||
16939997|NCT01083485|38084529|FG001|Overall Study|Protocol Violation|0|||
16939998|NCT01083485|38084528|FG000|Overall Study|Withdrawal by Subject|5|||
16939999|NCT01083485|38084529|FG001|Overall Study|Withdrawal by Subject|2|||
16940000|NCT01083485|38084528|FG000|Overall Study|Other|1|||
16940001|NCT01083485|38084529|FG001|Overall Study|Other|0|||
16940002|NCT01083173|38084537|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
16940003|NCT01083173|38084538|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
16940004|NCT01083173|38084537|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
16940005|NCT01083173|38084538|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
16940006|NCT01083173|38084537|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
16940007|NCT01083173|38084538|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
16940008|NCT01083173|38084537|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
16940009|NCT01083173|38084538|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
16940010|NCT01083173|38084537|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
16940011|NCT01083173|38084538|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
16940012|NCT01083173|38084537|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
16940013|NCT01083173|38084538|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
17105801|NCT00077649|38244133|FG001|Overall Study|Adverse Event|1|||
17105802|NCT00077649|38244134|FG002|Overall Study|Adverse Event|7|||
17105803|NCT00077649|38244135|FG003|Overall Study|Adverse Event|9|||
17105804|NCT00077649|38244132|FG000|Overall Study|Lack of Efficacy|5|||
16940014|NCT01083173|38084537|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
16940015|NCT01083173|38084538|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
16940016|NCT01083173|38084537|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
16940017|NCT01083173|38084538|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
16940018|NCT01083173|38084537|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
16940019|NCT01083173|38084538|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
16940020|NCT01083173|38084537|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
16940021|NCT01083173|38084538|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
16940022|NCT01083173|38084537|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
16940023|NCT01083173|38084538|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
16940024|NCT00177294|38084549|FG000|Overall Study|Withdrawal by Subject|7|||
17105805|NCT00077649|38244133|FG001|Overall Study|Lack of Efficacy|3|||
17105806|NCT00077649|38244134|FG002|Overall Study|Lack of Efficacy|3|||
17105807|NCT00077649|38244135|FG003|Overall Study|Lack of Efficacy|2|||
17105808|NCT00077649|38244132|FG000|Overall Study|Withdrawal by Subject|0|||
17105809|NCT00077649|38244133|FG001|Overall Study|Withdrawal by Subject|1|||
17105810|NCT00077649|38244134|FG002|Overall Study|Withdrawal by Subject|1|||
17105811|NCT00077649|38244135|FG003|Overall Study|Withdrawal by Subject|2|||
17105812|NCT00077649|38244132|FG000|Overall Study|Lost to Follow-up|2|||
17105813|NCT00077649|38244133|FG001|Overall Study|Lost to Follow-up|2|||
17105814|NCT00077649|38244134|FG002|Overall Study|Lost to Follow-up|3|||
17105815|NCT00077649|38244135|FG003|Overall Study|Lost to Follow-up|2|||
17105816|NCT00077649|38244132|FG000|Overall Study|Abnormality of Laboratory Test|1|||
17105817|NCT00077649|38244133|FG001|Overall Study|Abnormality of Laboratory Test|2|||
17105818|NCT00077649|38244134|FG002|Overall Study|Abnormality of Laboratory Test|1|||
17105819|NCT00077649|38244135|FG003|Overall Study|Abnormality of Laboratory Test|2|||
16940025|NCT00177294|38084550|FG001|Overall Study|Withdrawal by Subject|5|||
16940026|NCT01082081|38084559|FG000|Overall Study|Lost to Follow-up|0|||
16940027|NCT01082081|38084560|FG001|Overall Study|Lost to Follow-up|0|||
16940028|NCT01082081|38084561|FG002|Overall Study|Lost to Follow-up|1|||
16940029|NCT01082081|38084559|FG000|Overall Study|Withdrawal by Subject|0|||
16940030|NCT01082081|38084560|FG001|Overall Study|Withdrawal by Subject|0|||
16940031|NCT01082081|38084561|FG002|Overall Study|Withdrawal by Subject|1|||
16940032|NCT01082081|38084559|FG000|Overall Study|Other Reason|0|||
16940033|NCT01082081|38084560|FG001|Overall Study|Other Reason|1|||
16940034|NCT01082081|38084561|FG002|Overall Study|Other Reason|0|||
16940035|NCT00177216|38084572|FG000|Overall Study|Withdrawal by Subject|6|||
16940036|NCT00177216|38084573|FG001|Overall Study|Withdrawal by Subject|3|||
16940037|NCT00177216|38084574|FG002|Overall Study|Withdrawal by Subject|1|||
16940038|NCT01081886|38084588|FG000|Overall Study|Study termination|11|||
16940039|NCT01081886|38084589|FG001|Overall Study|Study termination|13|||
16940040|NCT01081769|38084597|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
16940041|NCT01081769|38084598|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
16940042|NCT01081769|38084597|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
16940043|NCT01081769|38084598|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
16940044|NCT01081769|38084597|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
16940045|NCT01081769|38084598|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
16940046|NCT01081769|38084597|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
16940047|NCT01081769|38084598|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
16940048|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Adverse Event|14|||
16940049|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Adverse Event|11|||
16940050|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Death|1|||
16940051|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Death|1|||
16940052|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
16940053|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
16940054|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
16940055|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
16940056|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Pregnancy|1|||
16940057|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Pregnancy|0|||
16940058|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
16940059|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
16940060|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
16940061|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
16940062|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Other|0|||
16940063|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Other|1|||
16940064|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Ineligibility|3|||
16940065|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Ineligibility|4|||
16940066|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
16940067|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
16940068|NCT01081769|38084597|FG000|CORE Intent-To-Treat|Patient Moved|2|||
16940069|NCT01081769|38084598|FG001|CORE Intent-To-Treat|Patient Moved|2|||
16940070|NCT01081301|38084604|FG000|Overall Study|Bereaved|3|||
16940071|NCT01081301|38084604|FG000|Overall Study|Too busy|5|||
16940072|NCT01081301|38084604|FG000|Overall Study|Patient too ill|2|||
16940073|NCT01081301|38084604|FG000|Overall Study|Lost to Follow-up|4|||
16940074|NCT00174954|38084625|FG000|Overall Study|Adverse Event|2|||
16940075|NCT00174954|38084625|FG000|Overall Study|No tophi found in MRI|1|||
16940076|NCT00174954|38084625|FG000|Overall Study|Physician Decision|1|||
16940077|NCT01081145|38084629|FG000|Open-Label Phase|Lack of Efficacy|56|||
16940078|NCT01081145|38084630|FG001|Open-Label Phase|Lack of Efficacy|0|||
16940079|NCT01081145|38084629|FG000|Open-Label Phase|Response criteria not met|46|||
16940080|NCT01081145|38084630|FG001|Open-Label Phase|Response criteria not met|0|||
16940081|NCT01081145|38084629|FG000|Open-Label Phase|Adverse Event|42|||
16940082|NCT01081145|38084630|FG001|Open-Label Phase|Adverse Event|0|||
16940083|NCT01081145|38084629|FG000|Open-Label Phase|Withdrawal by Subject|41|||
16940084|NCT01081145|38084630|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16940085|NCT01081145|38084629|FG000|Open-Label Phase|Other|12|||
16940086|NCT01081145|38084630|FG001|Open-Label Phase|Other|0|||
16940087|NCT01081145|38084629|FG000|Open-Label Phase|Lost to Follow-up|11|||
16940088|NCT01081145|38084630|FG001|Open-Label Phase|Lost to Follow-up|0|||
16940089|NCT01081145|38084629|FG000|Open-Label Phase|Protocol Violation|4|||
16940090|NCT01081145|38084630|FG001|Open-Label Phase|Protocol Violation|0|||
16940091|NCT01081145|38084629|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
16940092|NCT01081145|38084630|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
16940093|NCT01081145|38084629|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
16940094|NCT01081145|38084630|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
16940095|NCT01081145|38084629|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
16940096|NCT01081145|38084630|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
16940097|NCT01081145|38084629|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
17199784|NCT02690727|38353748|FG001|Overall Study|Adverse Event|2|||
16940098|NCT01081145|38084630|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
16940099|NCT01081145|38084629|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
16940100|NCT01081145|38084630|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
16940101|NCT01081145|38084629|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
16940102|NCT01081145|38084630|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
16940103|NCT01081145|38084629|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
16940104|NCT01081145|38084630|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
16940105|NCT00174915|38084643|FG000|Overall Study|Lost to Follow-up|19|||
16940106|NCT00174915|38084644|FG001|Overall Study|Lost to Follow-up|17|||
16940107|NCT00174915|38084645|FG002|Overall Study|Lost to Follow-up|9|||
16940108|NCT00174915|38084646|FG003|Overall Study|Lost to Follow-up|17|||
16940109|NCT00174915|38084647|FG004|Overall Study|Lost to Follow-up|10|||
16940110|NCT00174915|38084643|FG000|Overall Study|Adverse Event|18|||
16940111|NCT00174915|38084644|FG001|Overall Study|Adverse Event|16|||
16940112|NCT00174915|38084645|FG002|Overall Study|Adverse Event|11|||
16940113|NCT00174915|38084646|FG003|Overall Study|Adverse Event|18|||
16940114|NCT00174915|38084647|FG004|Overall Study|Adverse Event|5|||
16940115|NCT00174915|38084643|FG000|Overall Study|Personal Reason(s)|16|||
16940116|NCT00174915|38084644|FG001|Overall Study|Personal Reason(s)|16|||
16940117|NCT00174915|38084645|FG002|Overall Study|Personal Reason(s)|9|||
16940118|NCT00174915|38084646|FG003|Overall Study|Personal Reason(s)|9|||
16940119|NCT00174915|38084647|FG004|Overall Study|Personal Reason(s)|9|||
16940120|NCT00174915|38084643|FG000|Overall Study|Other|15|||
16940121|NCT00174915|38084644|FG001|Overall Study|Other|8|||
16940122|NCT00174915|38084645|FG002|Overall Study|Other|6|||
16940123|NCT00174915|38084646|FG003|Overall Study|Other|5|||
16940124|NCT00174915|38084647|FG004|Overall Study|Other|3|||
16940125|NCT00174915|38084643|FG000|Overall Study|Gout Flare|13|||
16940126|NCT00174915|38084644|FG001|Overall Study|Gout Flare|6|||
16940127|NCT00174915|38084645|FG002|Overall Study|Gout Flare|8|||
16940128|NCT00174915|38084646|FG003|Overall Study|Gout Flare|1|||
16940129|NCT00174915|38084647|FG004|Overall Study|Gout Flare|0|||
16940130|NCT00174915|38084643|FG000|Overall Study|Protocol Violation|6|||
16940131|NCT00174915|38084644|FG001|Overall Study|Protocol Violation|3|||
16940132|NCT00174915|38084645|FG002|Overall Study|Protocol Violation|3|||
16940133|NCT00174915|38084646|FG003|Overall Study|Protocol Violation|6|||
16940134|NCT00174915|38084647|FG004|Overall Study|Protocol Violation|3|||
16940135|NCT00174915|38084643|FG000|Overall Study|Therapeutic Failure|6|||
16940136|NCT00174915|38084644|FG001|Overall Study|Therapeutic Failure|3|||
16940137|NCT00174915|38084645|FG002|Overall Study|Therapeutic Failure|2|||
16940138|NCT00174915|38084646|FG003|Overall Study|Therapeutic Failure|1|||
16940139|NCT00174915|38084647|FG004|Overall Study|Therapeutic Failure|3|||
16940140|NCT01080716|38084663|FG000|Part 1|Physician Decision|1|||
16940141|NCT01080716|38084664|FG001|Part 1|Physician Decision|0|||
16940142|NCT01080716|38084665|FG002|Part 1|Physician Decision|0|||
16940143|NCT01080716|38084666|FG003|Part 1|Physician Decision|0|||
16940144|NCT00172185|38084684|FG000|Overall Study|Adverse Event|0|||
16940145|NCT00172185|38084685|FG001|Overall Study|Adverse Event|1|||
16940146|NCT00172185|38084686|FG002|Overall Study|Adverse Event|3|||
16940147|NCT00172185|38084687|FG003|Overall Study|Adverse Event|4|||
16940148|NCT00172185|38084684|FG000|Overall Study|Physician Decision|0|||
16940149|NCT00172185|38084685|FG001|Overall Study|Physician Decision|0|||
16940150|NCT00172185|38084686|FG002|Overall Study|Physician Decision|1|||
16940151|NCT00172185|38084687|FG003|Overall Study|Physician Decision|0|||
16940152|NCT00172185|38084684|FG000|Overall Study|SPONSOR Decision|0|||
16940153|NCT00172185|38084685|FG001|Overall Study|SPONSOR Decision|1|||
16940154|NCT00172185|38084686|FG002|Overall Study|SPONSOR Decision|0|||
16940155|NCT00172185|38084687|FG003|Overall Study|SPONSOR Decision|0|||
16940156|NCT00172185|38084684|FG000|Overall Study|Withdrawal by Subject|0|||
16940157|NCT00172185|38084685|FG001|Overall Study|Withdrawal by Subject|0|||
16940158|NCT00172185|38084686|FG002|Overall Study|Withdrawal by Subject|1|||
16940159|NCT00172185|38084687|FG003|Overall Study|Withdrawal by Subject|0|||
16940160|NCT01080326|38084701|FG000|Overall Study|Patient deterioration prior to procedure|3|||
16940161|NCT01080326|38084701|FG000|Overall Study|Surgeon decision|1|||
16940162|NCT00171951|38084705|FG000|Overall Study|Adverse Event|1|||
16940163|NCT00171951|38084705|FG000|Overall Study|Abnormal Laboratory Values|2|||
16940164|NCT00171951|38084705|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16940165|NCT00171951|38084705|FG000|Overall Study|Participants Withdrew Consent|3|||
16940166|NCT00171951|38084705|FG000|Overall Study|New Cancer Therapy|5|||
16940167|NCT00171951|38084705|FG000|Overall Study|Reason not Specified|2|||
16940168|NCT01080131|38084714|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
16940169|NCT01080131|38084715|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
16940170|NCT01080131|38084714|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
16940171|NCT01080131|38084715|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
16940172|NCT01080131|38084714|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
16940173|NCT01080131|38084715|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
16940174|NCT01080131|38084714|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
16940175|NCT01080131|38084715|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
16940176|NCT01080131|38084714|FG000|Core Study (0- 12 Weeks)|Death|1|||
16940177|NCT01080131|38084715|FG001|Core Study (0- 12 Weeks)|Death|0|||
16940178|NCT01080131|38084714|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
16940179|NCT01080131|38084715|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
16940180|NCT01080131|38084714|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
16940181|NCT01080131|38084715|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
16940182|NCT01080131|38084714|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
16940183|NCT01080131|38084715|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
16940184|NCT01080131|38084714|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
16940185|NCT01080131|38084715|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
16940186|NCT01080131|38084714|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
16940187|NCT01080131|38084715|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
16940188|NCT01080131|38084714|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
16940189|NCT01080131|38084715|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
16940190|NCT01080131|38084714|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
16940191|NCT01080131|38084715|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
16940192|NCT01080131|38084714|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
16940193|NCT01080131|38084715|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
16940194|NCT00171873|38084741|FG000|Overall Study|Withdrawal by Subject|4|||
16940195|NCT00171873|38084742|FG001|Overall Study|Withdrawal by Subject|2|||
16940196|NCT00171873|38084741|FG000|Overall Study|Adverse Event|5|||
16940197|NCT00171873|38084742|FG001|Overall Study|Adverse Event|0|||
16940198|NCT00171873|38084741|FG000|Overall Study|Switched to Octreotide|0|||
16940199|NCT00171873|38084742|FG001|Overall Study|Switched to Octreotide|1|||
16940200|NCT00171834|38084755|FG000|Overall Study|Adverse Event|2|||
16940201|NCT00171834|38084756|FG001|Overall Study|Adverse Event|1|||
16940202|NCT00171834|38084757|FG002|Overall Study|Adverse Event|3|||
16940203|NCT00171834|38084758|FG003|Overall Study|Adverse Event|2|||
16940204|NCT00171834|38084759|FG004|Overall Study|Adverse Event|2|||
16940205|NCT00171834|38084760|FG005|Overall Study|Adverse Event|15|||
16940206|NCT00171834|38084761|FG006|Overall Study|Adverse Event|1|||
16940207|NCT00171834|38084755|FG000|Overall Study|Withdrawal by Subject|0|||
16940208|NCT00171834|38084756|FG001|Overall Study|Withdrawal by Subject|2|||
16940209|NCT00171834|38084757|FG002|Overall Study|Withdrawal by Subject|0|||
16940210|NCT00171834|38084758|FG003|Overall Study|Withdrawal by Subject|1|||
16940211|NCT00171834|38084759|FG004|Overall Study|Withdrawal by Subject|1|||
16940212|NCT00171834|38084760|FG005|Overall Study|Withdrawal by Subject|1|||
16940213|NCT00171834|38084761|FG006|Overall Study|Withdrawal by Subject|0|||
16940214|NCT00171834|38084755|FG000|Overall Study|Death from study indication|0|||
16940215|NCT00171834|38084756|FG001|Overall Study|Death from study indication|1|||
16940216|NCT00171834|38084757|FG002|Overall Study|Death from study indication|0|||
16940217|NCT00171834|38084758|FG003|Overall Study|Death from study indication|0|||
16940218|NCT00171834|38084759|FG004|Overall Study|Death from study indication|1|||
16940219|NCT00171834|38084760|FG005|Overall Study|Death from study indication|0|||
16940220|NCT00171834|38084761|FG006|Overall Study|Death from study indication|0|||
16940221|NCT00171834|38084755|FG000|Overall Study|Disease Progression|4|||
16940222|NCT00171834|38084756|FG001|Overall Study|Disease Progression|8|||
16940223|NCT00171834|38084757|FG002|Overall Study|Disease Progression|8|||
16940224|NCT00171834|38084758|FG003|Overall Study|Disease Progression|9|||
16940225|NCT00171834|38084759|FG004|Overall Study|Disease Progression|2|||
16940226|NCT00171834|38084760|FG005|Overall Study|Disease Progression|18|||
16940227|NCT00171834|38084761|FG006|Overall Study|Disease Progression|3|||
16940228|NCT00171834|38084755|FG000|Overall Study|Treatment Duration Completed|0|||
16940229|NCT00171834|38084756|FG001|Overall Study|Treatment Duration Completed|0|||
16940230|NCT00171834|38084757|FG002|Overall Study|Treatment Duration Completed|1|||
16940231|NCT00171834|38084758|FG003|Overall Study|Treatment Duration Completed|0|||
16940232|NCT00171834|38084759|FG004|Overall Study|Treatment Duration Completed|2|||
16940233|NCT00171834|38084760|FG005|Overall Study|Treatment Duration Completed|1|||
16940234|NCT00171834|38084761|FG006|Overall Study|Treatment Duration Completed|0|||
16940235|NCT00171249|38084791|FG000|Overall Study|Withdrawal by Subject|2|||
16940236|NCT00171249|38084792|FG001|Overall Study|Withdrawal by Subject|0|||
16940237|NCT00171249|38084793|FG002|Overall Study|Withdrawal by Subject|0|||
16940238|NCT00171249|38084794|FG003|Overall Study|Withdrawal by Subject|6|||
16940239|NCT00171249|38084795|FG004|Overall Study|Withdrawal by Subject|0|||
16940240|NCT00171249|38084796|FG005|Overall Study|Withdrawal by Subject|0|||
16940241|NCT00171249|38084797|FG006|Overall Study|Withdrawal by Subject|0|||
17105820|NCT00077649|38244132|FG000|Overall Study|Randomized but never dosed|1|||
17105821|NCT00077649|38244133|FG001|Overall Study|Randomized but never dosed|0|||
17105822|NCT00077649|38244134|FG002|Overall Study|Randomized but never dosed|0|||
17105823|NCT00077649|38244135|FG003|Overall Study|Randomized but never dosed|0|||
17105824|NCT00038948|38244151|FG000|Overall Study|Adverse Event|131|||
16940242|NCT00171249|38084791|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
16940243|NCT00171249|38084792|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16940244|NCT00171249|38084793|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
16940245|NCT00171249|38084794|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
16940246|NCT00171249|38084795|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16940247|NCT00171249|38084796|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
16940248|NCT00171249|38084797|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
16940249|NCT00171249|38084791|FG000|Overall Study|Death|7|||
16940250|NCT00171249|38084792|FG001|Overall Study|Death|1|||
16940251|NCT00171249|38084793|FG002|Overall Study|Death|0|||
16940252|NCT00171249|38084794|FG003|Overall Study|Death|4|||
16940253|NCT00171249|38084795|FG004|Overall Study|Death|0|||
16940254|NCT00171249|38084796|FG005|Overall Study|Death|3|||
16940255|NCT00171249|38084797|FG006|Overall Study|Death|1|||
16940256|NCT00171249|38084791|FG000|Overall Study|Other|10|||
16940257|NCT00171249|38084792|FG001|Overall Study|Other|0|||
16940258|NCT00171249|38084793|FG002|Overall Study|Other|0|||
16940259|NCT00171249|38084794|FG003|Overall Study|Other|43|||
16940260|NCT00171249|38084795|FG004|Overall Study|Other|0|||
16940261|NCT00171249|38084796|FG005|Overall Study|Other|2|||
16940262|NCT00171249|38084797|FG006|Overall Study|Other|0|||
16940263|NCT00171249|38084791|FG000|Overall Study|No Longer Requires Study Drug|4|||
16940264|NCT00171249|38084792|FG001|Overall Study|No Longer Requires Study Drug|0|||
16940265|NCT00171249|38084793|FG002|Overall Study|No Longer Requires Study Drug|0|||
16940266|NCT00171249|38084794|FG003|Overall Study|No Longer Requires Study Drug|3|||
16940267|NCT00171249|38084795|FG004|Overall Study|No Longer Requires Study Drug|0|||
16940268|NCT00171249|38084796|FG005|Overall Study|No Longer Requires Study Drug|5|||
16940269|NCT00171249|38084797|FG006|Overall Study|No Longer Requires Study Drug|0|||
16940270|NCT00171249|38084791|FG000|Overall Study|Administrative Problems|1|||
16940271|NCT00171249|38084792|FG001|Overall Study|Administrative Problems|0|||
16940272|NCT00171249|38084793|FG002|Overall Study|Administrative Problems|0|||
16940273|NCT00171249|38084794|FG003|Overall Study|Administrative Problems|2|||
16940274|NCT00171249|38084795|FG004|Overall Study|Administrative Problems|0|||
16940275|NCT00171249|38084796|FG005|Overall Study|Administrative Problems|0|||
16940276|NCT00171249|38084797|FG006|Overall Study|Administrative Problems|0|||
16940277|NCT00171249|38084791|FG000|Overall Study|Adverse Event|3|||
16940278|NCT00171249|38084792|FG001|Overall Study|Adverse Event|1|||
16940279|NCT00171249|38084793|FG002|Overall Study|Adverse Event|0|||
16940280|NCT00171249|38084794|FG003|Overall Study|Adverse Event|15|||
16940281|NCT00171249|38084795|FG004|Overall Study|Adverse Event|0|||
16940282|NCT00171249|38084796|FG005|Overall Study|Adverse Event|2|||
16940283|NCT00171249|38084797|FG006|Overall Study|Adverse Event|0|||
16940284|NCT00171249|38084791|FG000|Overall Study|Lost to Follow-up|5|||
16940285|NCT00171249|38084792|FG001|Overall Study|Lost to Follow-up|0|||
16940286|NCT00171249|38084793|FG002|Overall Study|Lost to Follow-up|0|||
16940287|NCT00171249|38084794|FG003|Overall Study|Lost to Follow-up|9|||
16940288|NCT00171249|38084795|FG004|Overall Study|Lost to Follow-up|0|||
16940289|NCT00171249|38084796|FG005|Overall Study|Lost to Follow-up|0|||
16940290|NCT00171249|38084797|FG006|Overall Study|Lost to Follow-up|0|||
16940291|NCT01085630|38084808|FG000|Overall Study|Insufficient data|1|||
16940292|NCT01085630|38084809|FG001|Overall Study|Insufficient data|0|||
16940293|NCT01085630|38084808|FG000|Overall Study|Ineligible|3|||
16940294|NCT01085630|38084809|FG001|Overall Study|Ineligible|0|||
16940295|NCT00171210|38084817|FG000|Overall Study|Adverse Event|16|||
16940296|NCT00171210|38084818|FG001|Overall Study|Adverse Event|27|||
16940297|NCT00171210|38084817|FG000|Overall Study|Abnormal laboratory value(s)|6|||
16940298|NCT00171210|38084818|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16940299|NCT00171210|38084817|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16940300|NCT00171210|38084818|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16940301|NCT00171210|38084817|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
16940302|NCT00171210|38084818|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
16940303|NCT00171210|38084817|FG000|Overall Study|Protocol Violation|0|||
16940304|NCT00171210|38084818|FG001|Overall Study|Protocol Violation|2|||
16940305|NCT00171210|38084817|FG000|Overall Study|Withdrawal by Subject|32|||
16940306|NCT00171210|38084818|FG001|Overall Study|Withdrawal by Subject|30|||
16940307|NCT00171210|38084817|FG000|Overall Study|Lost to Follow-up|1|||
16940308|NCT00171210|38084818|FG001|Overall Study|Lost to Follow-up|0|||
16940309|NCT00171210|38084817|FG000|Overall Study|Administrative problems|1|||
16940310|NCT00171210|38084818|FG001|Overall Study|Administrative problems|1|||
16940311|NCT00171210|38084817|FG000|Overall Study|Death|2|||
16940312|NCT00171210|38084818|FG001|Overall Study|Death|3|||
16940313|NCT00171210|38084817|FG000|Overall Study|Stopped at end of core|0|||
16940314|NCT00171210|38084818|FG001|Overall Study|Stopped at end of core|32|||
16940315|NCT00171210|38084817|FG000|Overall Study|Stopped at end of extension 1|0|||
16940316|NCT00171210|38084818|FG001|Overall Study|Stopped at end of extension 1|1|||
16940317|NCT00171054|38084826|FG000|Overall Study|Protocol Violation|1|||
16940318|NCT00171054|38084827|FG001|Overall Study|Protocol Violation|2|||
16940319|NCT00171054|38084826|FG000|Overall Study|Patient withdrew consent|1|||
16940320|NCT00171054|38084827|FG001|Overall Study|Patient withdrew consent|0|||
16940321|NCT00171054|38084826|FG000|Overall Study|Lost to Follow-up|0|||
16940322|NCT00171054|38084827|FG001|Overall Study|Lost to Follow-up|1|||
16940323|NCT00171054|38084826|FG000|Overall Study|Adverse Event|8|||
16940324|NCT00171054|38084827|FG001|Overall Study|Adverse Event|8|||
16940325|NCT00171054|38084826|FG000|Overall Study|Condition no longer required study drug|0|||
16940326|NCT00171054|38084827|FG001|Overall Study|Condition no longer required study drug|1|||
16940327|NCT01084694|38084835|FG000|Overall Study|Withdrawal by Subject|2|||
16940328|NCT01084694|38084836|FG001|Overall Study|Withdrawal by Subject|1|||
16940329|NCT01084694|38084835|FG000|Overall Study|Death|2|||
16940330|NCT01084694|38084836|FG001|Overall Study|Death|12|||
16940331|NCT01084694|38084835|FG000|Overall Study|eligibility not maintained|2|||
16940332|NCT01084694|38084836|FG001|Overall Study|eligibility not maintained|7|||
16940333|NCT00479856|38084850|FG000|Overall Study|Adverse Event|1|||
16940334|NCT00479856|38084850|FG000|Overall Study|Withdrawal by Subject|1|||
16940335|NCT00479856|38084850|FG000|Overall Study|Physician Decision|1|||
16940336|NCT00479466|38084860|FG000|Overall Study|Adverse Event|5|||
16940337|NCT00479466|38084861|FG001|Overall Study|Adverse Event|1|||
16940338|NCT00479466|38084862|FG002|Overall Study|Adverse Event|0|||
16940339|NCT00479466|38084863|FG003|Overall Study|Adverse Event|1|||
16940340|NCT00479466|38084864|FG004|Overall Study|Adverse Event|2|||
16940341|NCT00479466|38084865|FG005|Overall Study|Adverse Event|0|||
16940342|NCT00479466|38084860|FG000|Overall Study|Hyperglycemia|0|||
16940343|NCT00479466|38084861|FG001|Overall Study|Hyperglycemia|0|||
16940344|NCT00479466|38084862|FG002|Overall Study|Hyperglycemia|0|||
16940345|NCT00479466|38084863|FG003|Overall Study|Hyperglycemia|0|||
16940346|NCT00479466|38084864|FG004|Overall Study|Hyperglycemia|0|||
16940347|NCT00479466|38084865|FG005|Overall Study|Hyperglycemia|1|||
16940348|NCT00479466|38084860|FG000|Overall Study|Lack of Efficacy|2|||
16940349|NCT00479466|38084861|FG001|Overall Study|Lack of Efficacy|0|||
16940350|NCT00479466|38084862|FG002|Overall Study|Lack of Efficacy|1|||
16940351|NCT00479466|38084863|FG003|Overall Study|Lack of Efficacy|0|||
16940352|NCT00479466|38084864|FG004|Overall Study|Lack of Efficacy|0|||
16940353|NCT00479466|38084865|FG005|Overall Study|Lack of Efficacy|0|||
16940354|NCT00479466|38084860|FG000|Overall Study|Lost to Follow-up|0|||
16940355|NCT00479466|38084861|FG001|Overall Study|Lost to Follow-up|1|||
16940356|NCT00479466|38084862|FG002|Overall Study|Lost to Follow-up|1|||
16940357|NCT00479466|38084863|FG003|Overall Study|Lost to Follow-up|0|||
16940358|NCT00479466|38084864|FG004|Overall Study|Lost to Follow-up|2|||
16940359|NCT00479466|38084865|FG005|Overall Study|Lost to Follow-up|2|||
16940360|NCT00479466|38084860|FG000|Overall Study|Physician Decision|2|||
16940361|NCT00479466|38084861|FG001|Overall Study|Physician Decision|1|||
16940362|NCT00479466|38084862|FG002|Overall Study|Physician Decision|1|||
16940363|NCT00479466|38084863|FG003|Overall Study|Physician Decision|0|||
16940364|NCT00479466|38084864|FG004|Overall Study|Physician Decision|0|||
16940365|NCT00479466|38084865|FG005|Overall Study|Physician Decision|0|||
16940366|NCT00479466|38084860|FG000|Overall Study|Pregnancy|0|||
16940367|NCT00479466|38084861|FG001|Overall Study|Pregnancy|0|||
16940368|NCT00479466|38084862|FG002|Overall Study|Pregnancy|0|||
16940369|NCT00479466|38084863|FG003|Overall Study|Pregnancy|0|||
16940370|NCT00479466|38084864|FG004|Overall Study|Pregnancy|1|||
16940371|NCT00479466|38084865|FG005|Overall Study|Pregnancy|0|||
16940372|NCT00479466|38084860|FG000|Overall Study|Protocol Violation|1|||
16940373|NCT00479466|38084861|FG001|Overall Study|Protocol Violation|0|||
16940374|NCT00479466|38084862|FG002|Overall Study|Protocol Violation|0|||
16940375|NCT00479466|38084863|FG003|Overall Study|Protocol Violation|0|||
16940376|NCT00479466|38084864|FG004|Overall Study|Protocol Violation|0|||
16940377|NCT00479466|38084865|FG005|Overall Study|Protocol Violation|0|||
16940378|NCT00479466|38084860|FG000|Overall Study|Withdrawal by Subject|3|||
16940379|NCT00479466|38084861|FG001|Overall Study|Withdrawal by Subject|5|||
16940380|NCT00479466|38084862|FG002|Overall Study|Withdrawal by Subject|0|||
16940381|NCT00479466|38084863|FG003|Overall Study|Withdrawal by Subject|2|||
16940382|NCT00479466|38084864|FG004|Overall Study|Withdrawal by Subject|3|||
16940383|NCT00479466|38084865|FG005|Overall Study|Withdrawal by Subject|1|||
16940384|NCT00479388|38084881|FG000|Overall Study|Adverse Event|90|||
16940385|NCT00479388|38084882|FG001|Overall Study|Adverse Event|45|||
16940386|NCT00479388|38084881|FG000|Overall Study|Lost to Follow-up|0|||
16940387|NCT00479388|38084882|FG001|Overall Study|Lost to Follow-up|2|||
16940388|NCT00479388|38084881|FG000|Overall Study|Protocol Violation|10|||
16940389|NCT00479388|38084882|FG001|Overall Study|Protocol Violation|9|||
16940390|NCT00479388|38084881|FG000|Overall Study|Withdrawal by Subject|32|||
16940391|NCT00479388|38084882|FG001|Overall Study|Withdrawal by Subject|17|||
16940392|NCT00479232|38084890|FG000|Overall Study|Adverse Event|0|||
16940393|NCT00479232|38084891|FG001|Overall Study|Adverse Event|0|||
16940394|NCT00479232|38084892|FG002|Overall Study|Adverse Event|5|||
16940395|NCT00479232|38084893|FG003|Overall Study|Adverse Event|0|||
16940396|NCT00479232|38084894|FG004|Overall Study|Adverse Event|0|||
16940397|NCT00479232|38084895|FG005|Overall Study|Adverse Event|10|||
16940398|NCT00479232|38084890|FG000|Overall Study|Deviation from Protocol|0|||
16940399|NCT00479232|38084891|FG001|Overall Study|Deviation from Protocol|0|||
16940400|NCT00479232|38084892|FG002|Overall Study|Deviation from Protocol|1|||
16940401|NCT00479232|38084893|FG003|Overall Study|Deviation from Protocol|0|||
16940402|NCT00479232|38084894|FG004|Overall Study|Deviation from Protocol|0|||
17105825|NCT00038948|38244152|FG001|Overall Study|Adverse Event|43|||
16940403|NCT00479232|38084895|FG005|Overall Study|Deviation from Protocol|0|||
16940404|NCT00479232|38084890|FG000|Overall Study|Lack of Efficacy|0|||
16940405|NCT00479232|38084891|FG001|Overall Study|Lack of Efficacy|0|||
16940406|NCT00479232|38084892|FG002|Overall Study|Lack of Efficacy|2|||
16940407|NCT00479232|38084893|FG003|Overall Study|Lack of Efficacy|0|||
16940408|NCT00479232|38084894|FG004|Overall Study|Lack of Efficacy|0|||
16940409|NCT00479232|38084895|FG005|Overall Study|Lack of Efficacy|4|||
16940410|NCT00479232|38084890|FG000|Overall Study|Physician Decision|0|||
16940411|NCT00479232|38084891|FG001|Overall Study|Physician Decision|0|||
16940412|NCT00479232|38084892|FG002|Overall Study|Physician Decision|2|||
16940413|NCT00479232|38084893|FG003|Overall Study|Physician Decision|0|||
16940414|NCT00479232|38084894|FG004|Overall Study|Physician Decision|0|||
16940415|NCT00479232|38084895|FG005|Overall Study|Physician Decision|1|||
16940416|NCT00479232|38084890|FG000|Overall Study|Progressive Disease|3|||
16940417|NCT00479232|38084891|FG001|Overall Study|Progressive Disease|1|||
16940418|NCT00479232|38084892|FG002|Overall Study|Progressive Disease|12|||
16940419|NCT00479232|38084893|FG003|Overall Study|Progressive Disease|3|||
16940420|NCT00479232|38084894|FG004|Overall Study|Progressive Disease|3|||
16940421|NCT00479232|38084895|FG005|Overall Study|Progressive Disease|12|||
16940422|NCT00479232|38084890|FG000|Overall Study|Withdrew Consent|0|||
16940423|NCT00479232|38084891|FG001|Overall Study|Withdrew Consent|2|||
16940424|NCT00479232|38084892|FG002|Overall Study|Withdrew Consent|6|||
16940425|NCT00479232|38084893|FG003|Overall Study|Withdrew Consent|0|||
16940426|NCT00479232|38084894|FG004|Overall Study|Withdrew Consent|1|||
16940427|NCT00479232|38084895|FG005|Overall Study|Withdrew Consent|3|||
16940428|NCT00478881|38084915|FG000|Overall Study|Adverse Event|31|||
16940429|NCT00478881|38084916|FG001|Overall Study|Adverse Event|12|||
16940430|NCT00478881|38084915|FG000|Overall Study|Lack of Efficacy|0|||
16940431|NCT00478881|38084916|FG001|Overall Study|Lack of Efficacy|3|||
16940432|NCT00478881|38084915|FG000|Overall Study|Lost to Follow-up|0|||
16940433|NCT00478881|38084916|FG001|Overall Study|Lost to Follow-up|1|||
16940434|NCT00478881|38084915|FG000|Overall Study|Protocol Violation|2|||
16940435|NCT00478881|38084916|FG001|Overall Study|Protocol Violation|2|||
16940436|NCT00478881|38084915|FG000|Overall Study|Withdrawal by Subject|6|||
16940437|NCT00478881|38084916|FG001|Overall Study|Withdrawal by Subject|2|||
16940438|NCT00478881|38084915|FG000|Overall Study|Non-Compliance with Study Medication|0|||
16940439|NCT00478881|38084916|FG001|Overall Study|Non-Compliance with Study Medication|2|||
16940440|NCT00478647|38084922|FG000|Overall Study|Adverse Event|1|||
16940441|NCT00478647|38084922|FG000|Overall Study|Withdrawal by Subject|1|||
16940442|NCT00478608|38084926|FG000|Overall Study|Adverse Event|1|||
16940443|NCT00478608|38084926|FG000|Overall Study|Serious Adverse Event|14|||
16940444|NCT00478608|38084926|FG000|Overall Study|Withdrawal by Subject|2|||
16940445|NCT00478608|38084926|FG000|Overall Study|Protocol Violation|3|||
16940446|NCT00478257|38084932|FG000|Overall Study|Withdrawal by Subject|8|||
16940447|NCT00478257|38084933|FG001|Overall Study|Withdrawal by Subject|3|||
16940448|NCT00478140|38084939|FG000|Overall Study|Clinical Disease Progression|1|||
16940449|NCT00478023|38084948|FG000|Overall Study|Adverse Event|11|||
16940450|NCT00478023|38084949|FG001|Overall Study|Adverse Event|7|||
16940451|NCT00478023|38084950|FG002|Overall Study|Adverse Event|8|||
16940452|NCT00478023|38084951|FG003|Overall Study|Adverse Event|14|||
17105826|NCT00038948|38244151|FG000|Overall Study|Lost to Follow-up|4|||
17105827|NCT00038948|38244152|FG001|Overall Study|Lost to Follow-up|4|||
17105828|NCT00038948|38244151|FG000|Overall Study|Nonmedical event|5|||
17105829|NCT00038948|38244152|FG001|Overall Study|Nonmedical event|7|||
17105830|NCT00038948|38244151|FG000|Overall Study|Withdrawal by Subject|23|||
16940453|NCT00478023|38084952|FG004|Overall Study|Adverse Event|6|||
16940454|NCT00478023|38084948|FG000|Overall Study|Death|1|||
17105831|NCT00038948|38244152|FG001|Overall Study|Withdrawal by Subject|10|||
17105832|NCT00038948|38244151|FG000|Overall Study|Protocol Violation|3|||
17105833|NCT00038948|38244152|FG001|Overall Study|Protocol Violation|7|||
17105834|NCT00038948|38244151|FG000|Overall Study|Lack of Efficacy|3|||
17105835|NCT00038948|38244152|FG001|Overall Study|Lack of Efficacy|6|||
17105836|NCT00054704|38244166|FG000|Overall Study|Lack of Efficacy|2|||
17105837|NCT00054704|38244167|FG001|Overall Study|Lack of Efficacy|3|||
16940455|NCT00478023|38084949|FG001|Overall Study|Death|0|||
16940456|NCT00478023|38084950|FG002|Overall Study|Death|0|||
16940457|NCT00478023|38084951|FG003|Overall Study|Death|0|||
16940458|NCT00478023|38084952|FG004|Overall Study|Death|0|||
16940459|NCT00478023|38084948|FG000|Overall Study|Lack of Efficacy|11|||
16940460|NCT00478023|38084949|FG001|Overall Study|Lack of Efficacy|10|||
16940461|NCT00478023|38084950|FG002|Overall Study|Lack of Efficacy|4|||
16940462|NCT00478023|38084951|FG003|Overall Study|Lack of Efficacy|5|||
16940463|NCT00478023|38084952|FG004|Overall Study|Lack of Efficacy|41|||
16940464|NCT00478023|38084948|FG000|Overall Study|Lost to Follow-up|3|||
16940465|NCT00478023|38084949|FG001|Overall Study|Lost to Follow-up|1|||
16940466|NCT00478023|38084950|FG002|Overall Study|Lost to Follow-up|1|||
17105838|NCT00054704|38244166|FG000|Overall Study|Adverse Event|3|||
17105839|NCT00054704|38244167|FG001|Overall Study|Adverse Event|1|||
16940467|NCT00478023|38084951|FG003|Overall Study|Lost to Follow-up|1|||
16940468|NCT00478023|38084952|FG004|Overall Study|Lost to Follow-up|0|||
16940469|NCT00478023|38084948|FG000|Overall Study|Withdrawal by Subject|2|||
16940470|NCT00478023|38084949|FG001|Overall Study|Withdrawal by Subject|3|||
16940471|NCT00478023|38084950|FG002|Overall Study|Withdrawal by Subject|2|||
16940472|NCT00478023|38084951|FG003|Overall Study|Withdrawal by Subject|4|||
16940473|NCT00478023|38084952|FG004|Overall Study|Withdrawal by Subject|5|||
16940474|NCT00478023|38084948|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
16940475|NCT00478023|38084949|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
16940476|NCT00478023|38084950|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
16940477|NCT00478023|38084951|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
16940478|NCT00478023|38084952|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
16940479|NCT00477750|38084964|FG000|Overall Study|Currently Receiving Treatment|11|||
16940480|NCT00477672|38084973|FG000|Overall Study|Adverse Event|3|||
16940481|NCT00477672|38084974|FG001|Overall Study|Adverse Event|5|||
16940482|NCT00477672|38084975|FG002|Overall Study|Adverse Event|6|||
16940483|NCT00477672|38084973|FG000|Overall Study|Death|0|||
16940484|NCT00477672|38084974|FG001|Overall Study|Death|1|||
16940485|NCT00477672|38084975|FG002|Overall Study|Death|0|||
16940486|NCT00477672|38084973|FG000|Overall Study|Disease progression|0|||
16940487|NCT00477672|38084974|FG001|Overall Study|Disease progression|1|||
16940488|NCT00477672|38084975|FG002|Overall Study|Disease progression|0|||
16940489|NCT00477672|38084973|FG000|Overall Study|Physician Decision|1|||
16940490|NCT00477672|38084974|FG001|Overall Study|Physician Decision|0|||
16940491|NCT00477672|38084975|FG002|Overall Study|Physician Decision|0|||
16940492|NCT00477672|38084973|FG000|Overall Study|Protocol noncompliance|0|||
16940493|NCT00477672|38084974|FG001|Overall Study|Protocol noncompliance|2|||
16940494|NCT00477672|38084975|FG002|Overall Study|Protocol noncompliance|0|||
16940495|NCT00477672|38084973|FG000|Overall Study|Consent withdrawn|2|||
16940496|NCT00477672|38084974|FG001|Overall Study|Consent withdrawn|5|||
16940497|NCT00477672|38084975|FG002|Overall Study|Consent withdrawn|10|||
16940498|NCT00477672|38084973|FG000|Overall Study|Discretion of Sponsor|1|||
16940499|NCT00477672|38084974|FG001|Overall Study|Discretion of Sponsor|2|||
16940500|NCT00477672|38084975|FG002|Overall Study|Discretion of Sponsor|0|||
16940501|NCT00477633|38084983|FG000|Overall Study|Did not receive treatment|23|||
16940502|NCT00477633|38084983|FG000|Overall Study|Adverse Event|143|||
16940503|NCT00477633|38084983|FG000|Overall Study|Pregnancy|23|||
16940504|NCT00477633|38084983|FG000|Overall Study|Lost to Follow-up|271|||
16940505|NCT00477633|38084983|FG000|Overall Study|Withdrawal by Subject|149|||
16940506|NCT00477633|38084983|FG000|Overall Study|Protocol Violation|25|||
16940507|NCT00477633|38084983|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
16940508|NCT01131676|38084999|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
16940509|NCT01131676|38085000|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
16940510|NCT01131676|38085001|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
16940511|NCT01131676|38084999|FG000|Discontinuation From Treatment|Not treated|4|||
16940512|NCT01131676|38085000|FG001|Discontinuation From Treatment|Not treated|2|||
16940513|NCT01131676|38085001|FG002|Discontinuation From Treatment|Not treated|2|||
16940514|NCT01131676|38084999|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
16940515|NCT01131676|38085000|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
16940516|NCT01131676|38085001|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
16940517|NCT01131676|38084999|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
16940518|NCT01131676|38085000|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
16940519|NCT01131676|38085001|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
16940520|NCT01131676|38084999|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
16940521|NCT01131676|38085000|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
16940522|NCT01131676|38085001|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
16940523|NCT01131676|38084999|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
16940524|NCT01131676|38085000|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
16940525|NCT01131676|38085001|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
16940526|NCT01131676|38084999|FG000|Discontinuation From Treatment|Other than those specified|162|||
16940527|NCT01131676|38085000|FG001|Discontinuation From Treatment|Other than those specified|142|||
16940528|NCT01131676|38085001|FG002|Discontinuation From Treatment|Other than those specified|125|||
16940529|NCT01131676|38084999|FG000|Discontinuation From Treatment|Adverse Event|303|||
16940530|NCT01131676|38085000|FG001|Discontinuation From Treatment|Adverse Event|267|||
16940531|NCT01131676|38085001|FG002|Discontinuation From Treatment|Adverse Event|273|||
16940532|NCT01131676|38084999|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
16940533|NCT01131676|38085000|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
16940534|NCT01131676|38085001|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
16940535|NCT01131676|38084999|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
16940536|NCT01131676|38085000|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
16940537|NCT01131676|38085001|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
17105840|NCT00054704|38244166|FG000|Overall Study|Lost to Follow-up|0|||
16940538|NCT01131676|38084999|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
16940539|NCT01131676|38085000|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
16940540|NCT01131676|38085001|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
16940541|NCT01131676|38084999|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
16940542|NCT01131676|38085000|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
16940543|NCT01131676|38085001|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
16940544|NCT01131676|38084999|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
16940545|NCT01131676|38085000|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
16940546|NCT01131676|38085001|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
16940547|NCT01131676|38084999|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
16940548|NCT01131676|38085000|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
16940549|NCT01131676|38085001|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
16940550|NCT01131520|38085023|FG000|Overall Study|Computer problem|1|||
16940551|NCT01131520|38085024|FG001|Overall Study|Computer problem|0|||
16940552|NCT01131520|38085023|FG000|Overall Study|Counselor not available|0|||
16940553|NCT01131520|38085024|FG001|Overall Study|Counselor not available|3|||
16940554|NCT01131520|38085023|FG000|Overall Study|Subject changed history after enrollment|0|||
16940555|NCT01131520|38085024|FG001|Overall Study|Subject changed history after enrollment|1|||
16940556|NCT01131325|38085030|FG000|Overall Study|Adverse Event|1|||
16940557|NCT01131325|38085030|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
16940558|NCT01131130|38085034|FG000|Period 1 - Baseline|Pregnancy|1|||
16940559|NCT01131130|38085034|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
16940560|NCT01130974|38085044|FG000|Overall Study|Protocol Violation|10|||
16940561|NCT01130974|38085045|FG001|Overall Study|Protocol Violation|10|||
16940562|NCT01130974|38085044|FG000|Overall Study|Withdrawal by Subject|0|||
16940563|NCT01130974|38085045|FG001|Overall Study|Withdrawal by Subject|1|||
16940564|NCT01130974|38085044|FG000|Overall Study|Ineligibility criteria|5|||
16940565|NCT01130974|38085045|FG001|Overall Study|Ineligibility criteria|2|||
16940566|NCT01130272|38085057|FG000|Overall Study|Adverse Event|2|||
16940567|NCT01130272|38085058|FG001|Overall Study|Adverse Event|5|||
16940568|NCT01130272|38085059|FG002|Overall Study|Adverse Event|6|||
16940569|NCT01130272|38085060|FG003|Overall Study|Adverse Event|22|||
16940570|NCT01130272|38085061|FG004|Overall Study|Adverse Event|7|||
16940571|NCT01130272|38085057|FG000|Overall Study|IVRS-confirmed constipation|0|||
16940572|NCT01130272|38085058|FG001|Overall Study|IVRS-confirmed constipation|1|||
16940573|NCT01130272|38085059|FG002|Overall Study|IVRS-confirmed constipation|1|||
16940574|NCT01130272|38085060|FG003|Overall Study|IVRS-confirmed constipation|2|||
16940575|NCT01130272|38085061|FG004|Overall Study|IVRS-confirmed constipation|0|||
16940576|NCT01130272|38085057|FG000|Overall Study|Rescue medications due to diarrhea|3|||
16940577|NCT01130272|38085058|FG001|Overall Study|Rescue medications due to diarrhea|5|||
16940578|NCT01130272|38085059|FG002|Overall Study|Rescue medications due to diarrhea|8|||
16940579|NCT01130272|38085060|FG003|Overall Study|Rescue medications due to diarrhea|8|||
16940580|NCT01130272|38085061|FG004|Overall Study|Rescue medications due to diarrhea|6|||
16940581|NCT01130272|38085057|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
16940582|NCT01130272|38085058|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
16940583|NCT01130272|38085059|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
16940584|NCT01130272|38085060|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
16940585|NCT01130272|38085061|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
16940586|NCT01130272|38085057|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
16940587|NCT01130272|38085058|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
16940588|NCT01130272|38085059|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
16940589|NCT01130272|38085060|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
16940590|NCT01130272|38085061|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
16940591|NCT01130272|38085057|FG000|Overall Study|Protocol Violation|0|||
16940592|NCT01130272|38085058|FG001|Overall Study|Protocol Violation|0|||
16940593|NCT01130272|38085059|FG002|Overall Study|Protocol Violation|3|||
16940594|NCT01130272|38085060|FG003|Overall Study|Protocol Violation|5|||
16940595|NCT01130272|38085061|FG004|Overall Study|Protocol Violation|5|||
16940596|NCT01130272|38085057|FG000|Overall Study|Lost to Follow-up|4|||
16940597|NCT01130272|38085058|FG001|Overall Study|Lost to Follow-up|3|||
16940598|NCT01130272|38085059|FG002|Overall Study|Lost to Follow-up|4|||
16940599|NCT01130272|38085060|FG003|Overall Study|Lost to Follow-up|7|||
16940600|NCT01130272|38085061|FG004|Overall Study|Lost to Follow-up|6|||
16940601|NCT01130272|38085057|FG000|Overall Study|Withdrawal by Subject|4|||
16940602|NCT01130272|38085058|FG001|Overall Study|Withdrawal by Subject|11|||
16940603|NCT01130272|38085059|FG002|Overall Study|Withdrawal by Subject|10|||
16940604|NCT01130272|38085060|FG003|Overall Study|Withdrawal by Subject|9|||
16940605|NCT01130272|38085061|FG004|Overall Study|Withdrawal by Subject|8|||
16940606|NCT01130272|38085057|FG000|Overall Study|Physician Decision|1|||
16940607|NCT01130272|38085058|FG001|Overall Study|Physician Decision|1|||
16940608|NCT01130272|38085059|FG002|Overall Study|Physician Decision|0|||
16940609|NCT01130272|38085060|FG003|Overall Study|Physician Decision|1|||
16940610|NCT01130272|38085061|FG004|Overall Study|Physician Decision|2|||
16940611|NCT01130272|38085057|FG000|Overall Study|Sponsor decision|6|||
16940612|NCT01130272|38085058|FG001|Overall Study|Sponsor decision|15|||
16940613|NCT01130272|38085059|FG002|Overall Study|Sponsor decision|16|||
16940614|NCT01130272|38085060|FG003|Overall Study|Sponsor decision|13|||
16940615|NCT01130272|38085061|FG004|Overall Study|Sponsor decision|16|||
16940616|NCT01130272|38085057|FG000|Overall Study|Study arm discontinued|38|||
16940617|NCT01130272|38085058|FG001|Overall Study|Study arm discontinued|0|||
16940618|NCT01130272|38085059|FG002|Overall Study|Study arm discontinued|0|||
16940619|NCT01130272|38085060|FG003|Overall Study|Study arm discontinued|0|||
16940620|NCT01130272|38085061|FG004|Overall Study|Study arm discontinued|0|||
16940621|NCT01129960|38085077|FG000|Overall Study|Withdrawal by Subject|3|||
16940622|NCT01129960|38085078|FG001|Overall Study|Withdrawal by Subject|0|||
16940623|NCT01129960|38085079|FG002|Overall Study|Withdrawal by Subject|3|||
16940624|NCT01129960|38085080|FG003|Overall Study|Withdrawal by Subject|2|||
16940625|NCT01129960|38085077|FG000|Overall Study|Lack of Efficacy|1|||
16940626|NCT01129960|38085078|FG001|Overall Study|Lack of Efficacy|1|||
16940627|NCT01129960|38085079|FG002|Overall Study|Lack of Efficacy|1|||
16940628|NCT01129960|38085080|FG003|Overall Study|Lack of Efficacy|1|||
16940629|NCT01129960|38085077|FG000|Overall Study|Adverse Event|23|||
16940630|NCT01129960|38085078|FG001|Overall Study|Adverse Event|16|||
16940631|NCT01129960|38085079|FG002|Overall Study|Adverse Event|16|||
16940632|NCT01129960|38085080|FG003|Overall Study|Adverse Event|7|||
16940633|NCT01129960|38085077|FG000|Overall Study|Protocol Violation|1|||
16940634|NCT01129960|38085078|FG001|Overall Study|Protocol Violation|2|||
16940635|NCT01129960|38085079|FG002|Overall Study|Protocol Violation|3|||
16940636|NCT01129960|38085080|FG003|Overall Study|Protocol Violation|0|||
16940637|NCT01129960|38085077|FG000|Overall Study|Lost to Follow-up|0|||
16940638|NCT01129960|38085078|FG001|Overall Study|Lost to Follow-up|2|||
16940639|NCT01129960|38085079|FG002|Overall Study|Lost to Follow-up|3|||
16940640|NCT01129960|38085080|FG003|Overall Study|Lost to Follow-up|3|||
16940641|NCT01129960|38085077|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
16940642|NCT01129960|38085078|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
16940643|NCT01129960|38085079|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
16940644|NCT01129960|38085080|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
16940645|NCT01129960|38085077|FG000|Overall Study|Physician Decision|1|||
16940646|NCT01129960|38085078|FG001|Overall Study|Physician Decision|0|||
16940647|NCT01129960|38085079|FG002|Overall Study|Physician Decision|0|||
16940648|NCT01129960|38085080|FG003|Overall Study|Physician Decision|0|||
16940649|NCT01129960|38085077|FG000|Overall Study|Pregnancy|1|||
16940650|NCT01129960|38085078|FG001|Overall Study|Pregnancy|0|||
16940651|NCT01129960|38085079|FG002|Overall Study|Pregnancy|0|||
16940652|NCT01129960|38085080|FG003|Overall Study|Pregnancy|0|||
16940653|NCT01129921|38085092|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
16940654|NCT01129921|38085093|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
16940655|NCT01129921|38085092|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
16940656|NCT01129921|38085093|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
16940657|NCT01129921|38085092|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
16940658|NCT01129921|38085093|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
16940659|NCT01129921|38085092|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
16940660|NCT01129921|38085093|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
16940661|NCT01129882|38085103|FG000|Overall Study|Adverse Event|39|||
16940662|NCT01129882|38085103|FG000|Overall Study|Death|6|||
16940663|NCT01129882|38085103|FG000|Overall Study|Lack of Efficacy|5|||
16940664|NCT01129882|38085103|FG000|Overall Study|Lost to Follow-up|13|||
16940665|NCT01129882|38085103|FG000|Overall Study|Physician Decision|27|||
16940666|NCT01129882|38085103|FG000|Overall Study|Protocol Deviation|3|||
16940667|NCT01129882|38085103|FG000|Overall Study|Withdrawal Criteria Met|19|||
16940668|NCT01129882|38085103|FG000|Overall Study|Trial Termination by Sponsor|6|||
16940669|NCT01129882|38085103|FG000|Overall Study|Withdrawal by Subject|160|||
16940670|NCT01129336|38085109|FG000|Overall Study|Protocol Violation|1|||
16940671|NCT01129336|38085110|FG001|Overall Study|Protocol Violation|0|||
16940672|NCT01129336|38085109|FG000|Overall Study|Disease Progression|1|||
16940673|NCT01129336|38085110|FG001|Overall Study|Disease Progression|4|||
16940674|NCT01129336|38085109|FG000|Overall Study|Lost to Follow-up|1|||
16940675|NCT01129336|38085110|FG001|Overall Study|Lost to Follow-up|0|||
16940676|NCT01129336|38085109|FG000|Overall Study|Withdrawal by Subject|7|||
16940677|NCT01129336|38085110|FG001|Overall Study|Withdrawal by Subject|4|||
16940678|NCT01129336|38085109|FG000|Overall Study|Adverse Event|0|||
16940679|NCT01129336|38085110|FG001|Overall Study|Adverse Event|1|||
16940680|NCT01129336|38085109|FG000|Overall Study|Missing Study Completion Status|2|||
16940681|NCT01129336|38085110|FG001|Overall Study|Missing Study Completion Status|3|||
16940682|NCT01129336|38085109|FG000|Overall Study|Death|0|||
16940683|NCT01129336|38085110|FG001|Overall Study|Death|4|||
16940684|NCT01129102|38085119|FG000|Overall Study|No study drug treatment|2|||
16940685|NCT01129102|38085120|FG001|Overall Study|No study drug treatment|3|||
16940686|NCT01129102|38085121|FG002|Overall Study|No study drug treatment|1|||
16940687|NCT01129102|38085119|FG000|Overall Study|Withdrawal by Subject|2|||
16940688|NCT01129102|38085120|FG001|Overall Study|Withdrawal by Subject|0|||
16940689|NCT01129102|38085121|FG002|Overall Study|Withdrawal by Subject|3|||
16940690|NCT01129102|38085119|FG000|Overall Study|Protocol Violation|0|||
16940691|NCT01129102|38085120|FG001|Overall Study|Protocol Violation|1|||
16940692|NCT01129102|38085121|FG002|Overall Study|Protocol Violation|1|||
16940693|NCT01129102|38085119|FG000|Overall Study|Pregnancy|0|||
16940694|NCT01129102|38085120|FG001|Overall Study|Pregnancy|0|||
16940695|NCT01129102|38085121|FG002|Overall Study|Pregnancy|1|||
16940696|NCT01129102|38085119|FG000|Overall Study|Adverse Event|2|||
16940697|NCT01129102|38085120|FG001|Overall Study|Adverse Event|2|||
16940698|NCT01129102|38085121|FG002|Overall Study|Adverse Event|1|||
16940699|NCT01129102|38085119|FG000|Overall Study|Lost to Follow-up|2|||
16940700|NCT01129102|38085120|FG001|Overall Study|Lost to Follow-up|0|||
16940701|NCT01129102|38085121|FG002|Overall Study|Lost to Follow-up|0|||
16940702|NCT01129024|38085128|FG000|Overall Study|Physician Decision|5|||
16940703|NCT01129024|38085128|FG000|Overall Study|Study Terminated by Sponsor|8|||
16940704|NCT01129024|38085128|FG000|Overall Study|Withdrawal by Subject|2|||
16940705|NCT01129024|38085128|FG000|Overall Study|Lack of Efficacy|3|||
16940706|NCT01129024|38085128|FG000|Overall Study|Needed a Platelet Transfusion|1|||
16940707|NCT01128946|38085132|FG000|Period I|Protocol Violation|0|||
16940708|NCT01128946|38085133|FG001|Period I|Protocol Violation|1|||
16940709|NCT01128946|38085134|FG002|Period I|Protocol Violation|0|||
16940710|NCT01128946|38085135|FG003|Period I|Protocol Violation|0|||
16940711|NCT01128946|38085132|FG000|Period I|Withdrawal by Subject|0|||
16940712|NCT01128946|38085133|FG001|Period I|Withdrawal by Subject|0|||
16940713|NCT01128946|38085134|FG002|Period I|Withdrawal by Subject|1|||
16940714|NCT01128946|38085135|FG003|Period I|Withdrawal by Subject|1|||
16940715|NCT01128946|38085132|FG000|Period II|Protocol Violation|0|||
16940716|NCT01128946|38085133|FG001|Period II|Protocol Violation|1|||
16940717|NCT01128946|38085134|FG002|Period II|Protocol Violation|0|||
16940718|NCT01128946|38085135|FG003|Period II|Protocol Violation|0|||
16940719|NCT01128946|38085132|FG000|Period II|Withdrawal by Subject|0|||
16940720|NCT01128946|38085133|FG001|Period II|Withdrawal by Subject|0|||
16940721|NCT01128946|38085134|FG002|Period II|Withdrawal by Subject|0|||
16940722|NCT01128946|38085135|FG003|Period II|Withdrawal by Subject|1|||
16940723|NCT01128946|38085132|FG000|Period III|Protocol Violation|1|||
16940724|NCT01128946|38085133|FG001|Period III|Protocol Violation|0|||
16940725|NCT01128946|38085134|FG002|Period III|Protocol Violation|0|||
16940726|NCT01128946|38085135|FG003|Period III|Protocol Violation|0|||
16940727|NCT01128595|38085146|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16940728|NCT01128595|38085147|FG001|Treatment Period 3|Withdrawal by Subject|1|||
16940729|NCT01128595|38085148|FG002|Treatment Period 3|Withdrawal by Subject|0|||
16940730|NCT01128595|38085149|FG003|Treatment Period 3|Withdrawal by Subject|0|||
16940731|NCT01128400|38085163|FG000|Overall Study|Lost to Follow-up|1|||
16940732|NCT01128400|38085164|FG001|Overall Study|Lost to Follow-up|0|||
16940733|NCT01128400|38085165|FG002|Overall Study|Lost to Follow-up|1|||
16940734|NCT01128400|38085163|FG000|Overall Study|Screening failure|1|||
16940735|NCT01128400|38085164|FG001|Overall Study|Screening failure|0|||
16940736|NCT01128400|38085165|FG002|Overall Study|Screening failure|0|||
16940737|NCT01128400|38085163|FG000|Overall Study|were not invited to participate on taste|0|||
16940738|NCT01128400|38085164|FG001|Overall Study|were not invited to participate on taste|0|||
16940739|NCT01128400|38085165|FG002|Overall Study|were not invited to participate on taste|15|||
16940740|NCT01128400|38085163|FG000|Overall Study|Excluded due to sinus problems|0|||
16940741|NCT01128400|38085164|FG001|Overall Study|Excluded due to sinus problems|1|||
17105841|NCT00054704|38244167|FG001|Overall Study|Lost to Follow-up|1|||
17105842|NCT00031694|38244173|FG000|Overall Study|Adverse Event|12|||
17105843|NCT00031694|38244173|FG000|Overall Study|Death|2|||
17105844|NCT00031694|38244173|FG000|Overall Study|Withdrawal by Subject|5|||
17105845|NCT00093795|38244181|FG000|Overall Study|No follow up data|20|||
17105846|NCT00093795|38244182|FG001|Overall Study|No follow up data|16|||
17105847|NCT00093795|38244183|FG002|Overall Study|No follow up data|17|||
17105848|NCT03467152|38244193|FG000|Overall Study|Adverse Event|4|||
17105849|NCT03467152|38244194|FG001|Overall Study|Adverse Event|5|||
17105850|NCT03467152|38244195|FG002|Overall Study|Adverse Event|0|||
17105851|NCT03467152|38244193|FG000|Overall Study|Subject Choice|1|||
17105852|NCT03467152|38244194|FG001|Overall Study|Subject Choice|3|||
17105853|NCT03467152|38244195|FG002|Overall Study|Subject Choice|0|||
17105854|NCT03467152|38244193|FG000|Overall Study|Lost to Follow-up|1|||
17105855|NCT03467152|38244194|FG001|Overall Study|Lost to Follow-up|0|||
17105856|NCT03467152|38244195|FG002|Overall Study|Lost to Follow-up|0|||
17105857|NCT03467152|38244193|FG000|Overall Study|Withdrawal by Subject|4|||
17105858|NCT03467152|38244194|FG001|Overall Study|Withdrawal by Subject|2|||
17105859|NCT03467152|38244195|FG002|Overall Study|Withdrawal by Subject|0|||
17105860|NCT03467152|38244193|FG000|Overall Study|Others|3|||
17105861|NCT03467152|38244194|FG001|Overall Study|Others|0|||
17105862|NCT03467152|38244195|FG002|Overall Study|Others|0|||
16940742|NCT01128400|38085165|FG002|Overall Study|Excluded due to sinus problems|0|||
16940743|NCT01128361|38085175|FG000|Overall Study|Lost to Follow-up|0|||
16940744|NCT01128361|38085176|FG001|Overall Study|Lost to Follow-up|1|||
16940745|NCT01128361|38085175|FG000|Overall Study|Withdrawal by Subject|5|||
16940746|NCT01128361|38085176|FG001|Overall Study|Withdrawal by Subject|2|||
16940747|NCT01128244|38085182|FG000|Overall Study|Adverse Event|1|||
16940748|NCT01128244|38085182|FG000|Overall Study|Scheduling conflict|2|||
16940749|NCT01127893|38085190|FG000|Overall Study|Study Termination by the Sponsor|1|||
16940750|NCT01126879|38085196|FG000|Overall Study|Progressive Disease|3|||
16940751|NCT01126879|38085197|FG001|Overall Study|Progressive Disease|1|||
16940752|NCT01126879|38085196|FG000|Overall Study|Withdrawal by Subject|1|||
16940753|NCT01126879|38085197|FG001|Overall Study|Withdrawal by Subject|0|||
16940754|NCT01126879|38085196|FG000|Overall Study|Adverse Event|0|||
16940755|NCT01126879|38085197|FG001|Overall Study|Adverse Event|1|||
16940756|NCT01126879|38085196|FG000|Overall Study|Physician Decision|1|||
16940757|NCT01126879|38085197|FG001|Overall Study|Physician Decision|0|||
16940758|NCT01126060|38085205|FG000|Overall Study|Protocol Violation|0|||
16940759|NCT01126060|38085206|FG001|Overall Study|Protocol Violation|2|||
16940760|NCT01125748|38085214|FG000|Overall Study|Adverse Event|0|||
16940761|NCT01125748|38085215|FG001|Overall Study|Adverse Event|2|||
16940762|NCT01125748|38085214|FG000|Overall Study|Lost to Follow-up|0|||
16940763|NCT01125748|38085215|FG001|Overall Study|Lost to Follow-up|1|||
16940764|NCT01125748|38085214|FG000|Overall Study|Physician Decision|8|||
16940765|NCT01125748|38085215|FG001|Overall Study|Physician Decision|7|||
16940766|NCT01125748|38085214|FG000|Overall Study|Patient Decision to Withdraw|2|||
16940767|NCT01125748|38085215|FG001|Overall Study|Patient Decision to Withdraw|4|||
16940768|NCT01125514|38085221|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
16940769|NCT01125514|38085221|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
16940770|NCT01125514|38085221|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
16940771|NCT01125514|38085221|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
16940772|NCT01125514|38085221|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
16940773|NCT01125514|38085221|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
16940774|NCT01125358|38085239|FG000|Overall Study|Adverse Event|3|||
16940775|NCT01125358|38085240|FG001|Overall Study|Adverse Event|0|||
16940776|NCT01125358|38085241|FG002|Overall Study|Adverse Event|0|||
16940777|NCT01125358|38085242|FG003|Overall Study|Adverse Event|2|||
16940778|NCT01125358|38085239|FG000|Overall Study|Perceived Lack of Efficacy|6|||
16940779|NCT01125358|38085240|FG001|Overall Study|Perceived Lack of Efficacy|3|||
16940780|NCT01125358|38085241|FG002|Overall Study|Perceived Lack of Efficacy|7|||
16940781|NCT01125358|38085242|FG003|Overall Study|Perceived Lack of Efficacy|4|||
16940782|NCT01125358|38085239|FG000|Overall Study|Protocol Violation|1|||
16940783|NCT01125358|38085240|FG001|Overall Study|Protocol Violation|0|||
16940784|NCT01125358|38085241|FG002|Overall Study|Protocol Violation|0|||
16940785|NCT01125358|38085242|FG003|Overall Study|Protocol Violation|0|||
16940786|NCT01125358|38085239|FG000|Overall Study|Sponsor Decision|0|||
16940787|NCT01125358|38085240|FG001|Overall Study|Sponsor Decision|0|||
16940788|NCT01125358|38085241|FG002|Overall Study|Sponsor Decision|1|||
16940789|NCT01125358|38085242|FG003|Overall Study|Sponsor Decision|1|||
16940790|NCT01125358|38085239|FG000|Overall Study|Withdrawal by Subject|2|||
16940791|NCT01125358|38085240|FG001|Overall Study|Withdrawal by Subject|1|||
16940792|NCT01125358|38085241|FG002|Overall Study|Withdrawal by Subject|1|||
16940793|NCT01125358|38085242|FG003|Overall Study|Withdrawal by Subject|1|||
16940794|NCT01125046|38085252|FG000|First 6 Months of Treatment|Death|1|||
16940795|NCT01125046|38085252|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
16940796|NCT01125046|38085252|FG000|First 6 Months of Treatment|Non-compliance|1|||
16940797|NCT01125046|38085252|FG000|First 6 Months of Treatment|Surgery|1|||
16940798|NCT01125046|38085252|FG000|First 6 Months of Treatment|Progressive Disease|7|||
16940799|NCT01125046|38085252|FG000|First 6 Months of Treatment|Adverse Event|2|||
16940800|NCT01125046|38085252|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
16940801|NCT01125046|38085252|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
16940802|NCT01125046|38085252|FG000|Follow-up/Data Cut Off Point|Death|29|||
16940803|NCT01125046|38085252|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
16940804|NCT01124734|38085256|FG000|Overall Study|Disease progression|13|||
16940805|NCT01124734|38085256|FG000|Overall Study|Adverse Event|1|||
16940806|NCT01124734|38085256|FG000|Overall Study|Withdrawal by Subject|1|||
16940807|NCT01124734|38085256|FG000|Overall Study|Elected for alternative treatment|2|||
16940808|NCT01124617|38085267|FG000|Overall Study|Adverse Event|5|||
16940809|NCT01124617|38085268|FG001|Overall Study|Adverse Event|2|||
16940810|NCT01124617|38085267|FG000|Overall Study|Lack of Efficacy|2|||
16940811|NCT01124617|38085268|FG001|Overall Study|Lack of Efficacy|1|||
16940812|NCT01124617|38085267|FG000|Overall Study|Protocol Violation|1|||
16940813|NCT01124617|38085268|FG001|Overall Study|Protocol Violation|1|||
16940814|NCT01124617|38085267|FG000|Overall Study|Withdrawal by Subject|9|||
16940815|NCT01124617|38085268|FG001|Overall Study|Withdrawal by Subject|1|||
16940816|NCT01124617|38085267|FG000|Overall Study|Other|2|||
16940817|NCT01124617|38085268|FG001|Overall Study|Other|1|||
17105863|NCT03467152|38244193|FG000|Overall Study|Not treated|3|||
16940818|NCT01124422|38085276|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
16940819|NCT01124422|38085277|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
16940820|NCT01124422|38085278|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
16940821|NCT01124422|38085276|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
16940822|NCT01124422|38085277|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
16940823|NCT01124422|38085278|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
16940824|NCT01124422|38085276|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
16940825|NCT01124422|38085277|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
16940826|NCT01124422|38085278|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
16940827|NCT01124422|38085276|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
16940828|NCT01124422|38085277|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
16940829|NCT01124422|38085278|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
16940830|NCT01124422|38085276|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
16940831|NCT01124422|38085277|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
16940832|NCT01124422|38085278|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
16940833|NCT01124422|38085276|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
16940834|NCT01124422|38085277|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
16940835|NCT01124422|38085278|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
16940836|NCT01124422|38085276|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
16940837|NCT01124422|38085277|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
16940838|NCT01124422|38085278|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
16940839|NCT01124422|38085276|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
16940840|NCT01124422|38085277|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
16940841|NCT01124422|38085278|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
16940842|NCT01124422|38085276|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
16940843|NCT01124422|38085277|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
16940844|NCT01124422|38085278|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
16940845|NCT01124422|38085276|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
16940846|NCT01124422|38085277|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
16940847|NCT01124422|38085278|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
16940848|NCT01124149|38085285|FG000|Acute Phase|Withdrawal by Subject|22|||
16940849|NCT01124149|38085285|FG000|Acute Phase|Adverse Event|21|||
16940850|NCT01124149|38085285|FG000|Acute Phase|Lack of Efficacy|17|||
16940851|NCT01124149|38085285|FG000|Acute Phase|Protocol Violation|14|||
16940852|NCT01124149|38085285|FG000|Acute Phase|Lost to Follow-up|2|||
16940853|NCT01124149|38085285|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
16940854|NCT01124149|38085285|FG000|Acute Phase|Sponsor request|1|||
16940855|NCT01124149|38085285|FG000|Acute Phase|UC symptoms not ameliorated|1|||
16940856|NCT01124149|38085285|FG000|Acute Phase|Non-compliance|1|||
17105864|NCT03467152|38244194|FG001|Overall Study|Not treated|1|||
17105865|NCT03467152|38244195|FG002|Overall Study|Not treated|6|||
17105866|NCT03466060|38244204|FG000|Period 1|Test Lens Damage|0|||
17105867|NCT03466060|38244205|FG001|Period 1|Test Lens Damage|2|||
17105868|NCT03466060|38244206|FG002|Period 1|Test Lens Damage|0|||
17105869|NCT03466060|38244207|FG003|Period 1|Test Lens Damage|0|||
17105870|NCT03466060|38244208|FG004|Period 1|Test Lens Damage|0|||
17105871|NCT03466060|38244209|FG005|Period 1|Test Lens Damage|0|||
17105872|NCT03466060|38244204|FG000|Period 1|Withdrawal by Subject|0|||
17105873|NCT03466060|38244205|FG001|Period 1|Withdrawal by Subject|0|||
17105874|NCT03466060|38244206|FG002|Period 1|Withdrawal by Subject|2|||
17105875|NCT03466060|38244207|FG003|Period 1|Withdrawal by Subject|0|||
17105876|NCT03466060|38244208|FG004|Period 1|Withdrawal by Subject|0|||
17105877|NCT03466060|38244209|FG005|Period 1|Withdrawal by Subject|0|||
16940857|NCT01124149|38085285|FG000|Acute Phase|Low hemoglobin|1|||
16940858|NCT01124149|38085285|FG000|Acute Phase|Travelling to another country|1|||
16940859|NCT01124149|38085285|FG000|Acute Phase|Sponsor decision|1|||
16940860|NCT01124149|38085285|FG000|Maintenance Phase|Lack of Efficacy|40|||
16940861|NCT01124149|38085285|FG000|Maintenance Phase|Adverse Event|24|||
16940862|NCT01124149|38085285|FG000|Maintenance Phase|Lost to Follow-up|15|||
16940863|NCT01124149|38085285|FG000|Maintenance Phase|Withdrawal by Subject|10|||
16940864|NCT01124149|38085285|FG000|Maintenance Phase|Protocol Violation|5|||
16940865|NCT01124149|38085285|FG000|Maintenance Phase|Coordinator error|1|||
17105878|NCT03466060|38244204|FG000|Period 1|Lost to Follow-up|0|||
17105879|NCT03466060|38244205|FG001|Period 1|Lost to Follow-up|0|||
17105880|NCT03466060|38244206|FG002|Period 1|Lost to Follow-up|0|||
17105881|NCT03466060|38244207|FG003|Period 1|Lost to Follow-up|1|||
17105882|NCT03466060|38244208|FG004|Period 1|Lost to Follow-up|0|||
17105883|NCT03466060|38244209|FG005|Period 1|Lost to Follow-up|0|||
17105884|NCT03466060|38244204|FG000|Period 1|Grade 2 Conjunctivitis|0|||
17105885|NCT03466060|38244205|FG001|Period 1|Grade 2 Conjunctivitis|0|||
17105886|NCT03466060|38244206|FG002|Period 1|Grade 2 Conjunctivitis|1|||
16940866|NCT01124149|38085285|FG000|Maintenance Phase|Non-compliance|1|||
17105887|NCT03466060|38244207|FG003|Period 1|Grade 2 Conjunctivitis|0|||
17105888|NCT03466060|38244208|FG004|Period 1|Grade 2 Conjunctivitis|0|||
17105889|NCT03466060|38244209|FG005|Period 1|Grade 2 Conjunctivitis|0|||
16940867|NCT01123642|38085292|FG000|Overall Study|Lost to Follow-up|23|||
16940868|NCT01123642|38085292|FG000|Overall Study|Withdrawal by Subject|9|||
16940869|NCT01123642|38085292|FG000|Overall Study|ineligible at baseline assessment|36|||
16940870|NCT01122862|38085297|FG000|Period 1|Protocol Violation|0|||
16940871|NCT01122862|38085298|FG001|Period 1|Protocol Violation|1|||
16940872|NCT01122862|38085299|FG002|Period 1|Protocol Violation|0|||
16940873|NCT01122862|38085297|FG000|Period 2|Adverse Event|0|||
16940874|NCT01122862|38085298|FG001|Period 2|Adverse Event|0|||
16940875|NCT01122862|38085299|FG002|Period 2|Adverse Event|1|||
16940876|NCT01122394|38085310|FG000|Overall Study|Withdrawal by Subject|1|||
16940877|NCT01122394|38085311|FG001|Overall Study|Withdrawal by Subject|1|||
16940878|NCT01122394|38085310|FG000|Overall Study|Lost to Follow-up|2|||
16940879|NCT01122394|38085311|FG001|Overall Study|Lost to Follow-up|2|||
16940880|NCT01122394|38085310|FG000|Overall Study|Adverse Event|0|||
16940881|NCT01122394|38085311|FG001|Overall Study|Adverse Event|1|||
16940882|NCT01121926|38085319|FG000|First Intervention Period|Adverse Event|1|||
16940883|NCT01121926|38085320|FG001|First Intervention Period|Adverse Event|0|||
16940884|NCT01121926|38085319|FG000|Washout Period|Adverse Event|0|||
16940885|NCT01121926|38085320|FG001|Washout Period|Adverse Event|1|||
16940886|NCT01121926|38085319|FG000|Washout Period|Positive pregnancy test|0|||
16940887|NCT01121926|38085320|FG001|Washout Period|Positive pregnancy test|1|||
16940888|NCT01121575|38085332|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
16940889|NCT01121575|38085333|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
16940890|NCT01121575|38085334|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
16940891|NCT01121575|38085335|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
16940892|NCT01121575|38085336|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
16940893|NCT01121575|38085337|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
16940894|NCT01121575|38085332|FG000|Overall Study|Unspecified Reasons|8|||
16940895|NCT01121575|38085333|FG001|Overall Study|Unspecified Reasons|6|||
16940896|NCT01121575|38085334|FG002|Overall Study|Unspecified Reasons|7|||
16940897|NCT01121575|38085335|FG003|Overall Study|Unspecified Reasons|5|||
16940898|NCT01121575|38085336|FG004|Overall Study|Unspecified Reasons|13|||
16940899|NCT01121575|38085337|FG005|Overall Study|Unspecified Reasons|10|||
16940900|NCT01121575|38085332|FG000|Overall Study|Death|6|||
16940901|NCT01121575|38085333|FG001|Overall Study|Death|0|||
16940902|NCT01121575|38085334|FG002|Overall Study|Death|0|||
16940903|NCT01121575|38085335|FG003|Overall Study|Death|1|||
16940904|NCT01121575|38085336|FG004|Overall Study|Death|7|||
16940905|NCT01121575|38085337|FG005|Overall Study|Death|1|||
16940906|NCT01121536|38085360|FG000|Overall Study|Adverse Event|63|||
16940907|NCT01121536|38085360|FG000|Overall Study|Lack of Efficacy|35|||
16940908|NCT01121536|38085360|FG000|Overall Study|Withdrawal by Subject|65|||
16940909|NCT01121536|38085360|FG000|Overall Study|Protocol Violation|20|||
16940910|NCT01121536|38085360|FG000|Overall Study|Noncompliance with study medication|12|||
16940911|NCT01121536|38085360|FG000|Overall Study|Noncompliance with study procedures|9|||
16940912|NCT01121536|38085360|FG000|Overall Study|Lost to Follow-up|39|||
16940913|NCT01121536|38085360|FG000|Overall Study|Other|118|||
16940914|NCT01121263|38085366|FG000|Overall Study|Death|3|||
16940915|NCT01121263|38085367|FG001|Overall Study|Death|2|||
16940916|NCT01121263|38085366|FG000|Overall Study|Lost to Follow-up|22|||
16940917|NCT01121263|38085367|FG001|Overall Study|Lost to Follow-up|12|||
16940918|NCT01121263|38085366|FG000|Overall Study|Withdrawal by Subject|0|||
16940919|NCT01121263|38085367|FG001|Overall Study|Withdrawal by Subject|1|||
16940920|NCT01121185|38085377|FG000|Overall Study|Not infused|0|||
16940921|NCT01121185|38085378|FG001|Overall Study|Not infused|1|||
16940922|NCT01121185|38085377|FG000|Overall Study|Not transplanted|1|||
16940923|NCT01121185|38085378|FG001|Overall Study|Not transplanted|0|||
16940924|NCT01121146|38085386|FG000|Overall Study|Death|17|||
16940925|NCT01121146|38085387|FG001|Overall Study|Death|15|||
16940926|NCT01121146|38085386|FG000|Overall Study|Adverse Event|2|||
16940927|NCT01121146|38085387|FG001|Overall Study|Adverse Event|11|||
16940928|NCT01121146|38085386|FG000|Overall Study|Lost to Follow-up|7|||
16940929|NCT01121146|38085387|FG001|Overall Study|Lost to Follow-up|16|||
16940930|NCT01120756|38085396|FG000|Overall Study|Withdrawal by Subject|1|||
16940931|NCT01120756|38085397|FG001|Overall Study|Withdrawal by Subject|1|||
16940932|NCT01120717|38085405|FG000|Overall Study|Withdrawal by Subject|11|||
16940933|NCT01120717|38085406|FG001|Overall Study|Withdrawal by Subject|6|||
16940934|NCT01120717|38085405|FG000|Overall Study|Adverse Event|10|||
16940935|NCT01120717|38085406|FG001|Overall Study|Adverse Event|6|||
16940936|NCT01120717|38085405|FG000|Overall Study|Protocol Deviation|2|||
16940937|NCT01120717|38085406|FG001|Overall Study|Protocol Deviation|5|||
16940938|NCT01120717|38085405|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16940939|NCT01120717|38085406|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
17105890|NCT03466060|38244204|FG000|Period 2|Lens Handling Difficulties|0|||
16940940|NCT01120717|38085405|FG000|Overall Study|Lost to Follow-up|2|||
16940941|NCT01120717|38085406|FG001|Overall Study|Lost to Follow-up|3|||
16940942|NCT01120717|38085405|FG000|Overall Study|Death|3|||
16940943|NCT01120717|38085406|FG001|Overall Study|Death|1|||
16940944|NCT01120717|38085405|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
16940945|NCT01120717|38085406|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
16940946|NCT01120600|38085414|FG000|Overall Study|Adverse Event|7|||
16940947|NCT01120600|38085415|FG001|Overall Study|Adverse Event|7|||
16940948|NCT01120600|38085414|FG000|Overall Study|Excessive Bone Loss|0|||
16940949|NCT01120600|38085415|FG001|Overall Study|Excessive Bone Loss|4|||
16940950|NCT01120600|38085414|FG000|Overall Study|Lost to Follow-up|1|||
16940951|NCT01120600|38085415|FG001|Overall Study|Lost to Follow-up|3|||
16940952|NCT01120600|38085414|FG000|Overall Study|Physician Decision|1|||
16940953|NCT01120600|38085415|FG001|Overall Study|Physician Decision|3|||
16940954|NCT01120600|38085414|FG000|Overall Study|Protocol Violation|0|||
16940955|NCT01120600|38085415|FG001|Overall Study|Protocol Violation|4|||
16940956|NCT01120600|38085414|FG000|Overall Study|Withdrawal by Subject|10|||
16940957|NCT01120600|38085415|FG001|Overall Study|Withdrawal by Subject|11|||
16940958|NCT01120210|38085423|FG000|MAIN INFUSION|Adverse Event|1|||
16940959|NCT01120210|38085424|FG001|MAIN INFUSION|Adverse Event|0|||
16940960|NCT01120210|38085423|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
16940961|NCT01120210|38085424|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
16940962|NCT01120093|38085430|FG000|Treatment Period 1|Adverse Event|0|||
16940963|NCT01120093|38085431|FG001|Treatment Period 1|Adverse Event|0|||
16940964|NCT01120093|38085432|FG002|Treatment Period 1|Adverse Event|1|||
16940965|NCT01120093|38085433|FG003|Treatment Period 1|Adverse Event|0|||
16940966|NCT01120093|38085434|FG004|Treatment Period 1|Adverse Event|1|||
16940967|NCT01120093|38085430|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16940968|NCT01120093|38085431|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16940969|NCT01120093|38085432|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16940970|NCT01120093|38085433|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16940971|NCT01120093|38085434|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16940972|NCT01120093|38085430|FG000|Treatment Period 2|Adverse Event|0|||
16940973|NCT01120093|38085431|FG001|Treatment Period 2|Adverse Event|0|||
16940974|NCT01120093|38085432|FG002|Treatment Period 2|Adverse Event|0|||
16940975|NCT01120093|38085433|FG003|Treatment Period 2|Adverse Event|1|||
16940976|NCT01120093|38085434|FG004|Treatment Period 2|Adverse Event|0|||
16940977|NCT01120093|38085430|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16940978|NCT01120093|38085431|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16940979|NCT01120093|38085432|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16940980|NCT01120093|38085433|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16940981|NCT01120093|38085434|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16940982|NCT01120093|38085430|FG000|Treatment Period 3|Lack of Efficacy|0|||
16940983|NCT01120093|38085431|FG001|Treatment Period 3|Lack of Efficacy|0|||
16940984|NCT01120093|38085432|FG002|Treatment Period 3|Lack of Efficacy|0|||
16940985|NCT01120093|38085433|FG003|Treatment Period 3|Lack of Efficacy|1|||
16940986|NCT01120093|38085434|FG004|Treatment Period 3|Lack of Efficacy|0|||
16940987|NCT01120093|38085430|FG000|Treatment Period 3|Adverse Event|0|||
16940988|NCT01120093|38085431|FG001|Treatment Period 3|Adverse Event|0|||
16940989|NCT01120093|38085432|FG002|Treatment Period 3|Adverse Event|0|||
16940990|NCT01120093|38085433|FG003|Treatment Period 3|Adverse Event|0|||
16940991|NCT01120093|38085434|FG004|Treatment Period 3|Adverse Event|1|||
16940992|NCT01120093|38085430|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16940993|NCT01120093|38085431|FG001|Treatment Period 3|Withdrawal by Subject|0|||
16940994|NCT01120093|38085432|FG002|Treatment Period 3|Withdrawal by Subject|1|||
16940995|NCT01120093|38085433|FG003|Treatment Period 3|Withdrawal by Subject|0|||
16940996|NCT01120093|38085434|FG004|Treatment Period 3|Withdrawal by Subject|0|||
16940997|NCT01120093|38085430|FG000|Treatment Period 4|Adverse Event|1|||
16940998|NCT01120093|38085431|FG001|Treatment Period 4|Adverse Event|0|||
16940999|NCT01120093|38085432|FG002|Treatment Period 4|Adverse Event|0|||
16941000|NCT01120093|38085433|FG003|Treatment Period 4|Adverse Event|0|||
16941001|NCT01120093|38085434|FG004|Treatment Period 4|Adverse Event|0|||
16941002|NCT01120093|38085430|FG000|Treatment Period 5|Adverse Event|0|||
16941003|NCT01120093|38085431|FG001|Treatment Period 5|Adverse Event|1|||
17105891|NCT03466060|38244205|FG001|Period 2|Lens Handling Difficulties|0|||
17105892|NCT03466060|38244206|FG002|Period 2|Lens Handling Difficulties|1|||
17105893|NCT03466060|38244207|FG003|Period 2|Lens Handling Difficulties|0|||
17105894|NCT03466060|38244208|FG004|Period 2|Lens Handling Difficulties|0|||
17105895|NCT03466060|38244209|FG005|Period 2|Lens Handling Difficulties|0|||
17105896|NCT00092547|38244225|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
17105897|NCT00092547|38244226|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
17105898|NCT00092547|38244227|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
17105899|NCT00092547|38244225|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
17105900|NCT00092547|38244226|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
17105901|NCT00092547|38244227|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
17105902|NCT00092547|38244225|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
17105903|NCT00092547|38244226|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
16941004|NCT01120093|38085432|FG002|Treatment Period 5|Adverse Event|0|||
16941005|NCT01120093|38085433|FG003|Treatment Period 5|Adverse Event|1|||
16941006|NCT01120093|38085434|FG004|Treatment Period 5|Adverse Event|0|||
16941007|NCT01119937|38085448|FG000|Overall Study|Adverse Event|11|||
16941008|NCT01119937|38085449|FG001|Overall Study|Adverse Event|5|||
16941009|NCT01119937|38085448|FG000|Overall Study|Protocol deviation|3|||
16941010|NCT01119937|38085449|FG001|Overall Study|Protocol deviation|1|||
16941011|NCT01119937|38085448|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16941012|NCT01119937|38085449|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16941013|NCT01119937|38085448|FG000|Overall Study|Withdrawal by Subject|2|||
16941014|NCT01119937|38085449|FG001|Overall Study|Withdrawal by Subject|1|||
16941015|NCT01119898|38085457|FG000|Overall Study|Adverse Event|4|||
16941016|NCT01119898|38085458|FG001|Overall Study|Adverse Event|5|||
16941017|NCT01119898|38085457|FG000|Overall Study|Withdrawal by Subject|1|||
16941018|NCT01119898|38085458|FG001|Overall Study|Withdrawal by Subject|4|||
16941019|NCT01119898|38085457|FG000|Overall Study|Lack of Efficacy|0|||
16941020|NCT01119898|38085458|FG001|Overall Study|Lack of Efficacy|2|||
16941021|NCT01119898|38085457|FG000|Overall Study|Protocol Violation|1|||
16941022|NCT01119898|38085458|FG001|Overall Study|Protocol Violation|1|||
16941023|NCT01119898|38085457|FG000|Overall Study|Medical procedure|1|||
16941024|NCT01119898|38085458|FG001|Overall Study|Medical procedure|0|||
16941025|NCT01119898|38085457|FG000|Overall Study|Randomized in error did not participate|1|||
16941026|NCT01119898|38085458|FG001|Overall Study|Randomized in error did not participate|0|||
16941027|NCT01119859|38085466|FG000|Overall Study|Adverse Event|9|||
16941028|NCT01119859|38085467|FG001|Overall Study|Adverse Event|10|||
16941029|NCT01119859|38085466|FG000|Overall Study|Death|2|||
16941030|NCT01119859|38085467|FG001|Overall Study|Death|0|||
16941031|NCT01119859|38085466|FG000|Overall Study|Insufficient therapeutic response|7|||
16941032|NCT01119859|38085467|FG001|Overall Study|Insufficient therapeutic response|14|||
16941033|NCT01119859|38085466|FG000|Overall Study|Refused treatment|3|||
16941034|NCT01119859|38085467|FG001|Overall Study|Refused treatment|6|||
16941035|NCT01119859|38085466|FG000|Overall Study|Failure to return|3|||
16941036|NCT01119859|38085467|FG001|Overall Study|Failure to return|0|||
16941037|NCT01119703|38085475|FG000|Overall Study|Adverse Event|0|||
16941038|NCT01119703|38085476|FG001|Overall Study|Adverse Event|1|||
16941039|NCT01119625|38085483|FG000|Overall Study|Lost to Follow-up|1|||
16941040|NCT01119625|38085484|FG001|Overall Study|Lost to Follow-up|2|||
16941041|NCT01119625|38085483|FG000|Overall Study|Withdrawal by Subject|2|||
16941042|NCT01119625|38085484|FG001|Overall Study|Withdrawal by Subject|1|||
16941043|NCT01119625|38085483|FG000|Overall Study|Other|0|||
16941044|NCT01119625|38085484|FG001|Overall Study|Other|1|||
16941045|NCT01119118|38085490|FG000|Overall Study|Adverse Event|1|||
16941046|NCT01119001|38085494|FG000|Overall Study|Withdrawal by Subject|2|||
16941047|NCT01118962|38085500|FG000|Overall Study|Adverse Event|2|||
16941048|NCT01118962|38085500|FG000|Overall Study|Lack of Efficacy|1|||
16941049|NCT01118962|38085500|FG000|Overall Study|Protocol Violation|1|||
16941050|NCT01118962|38085500|FG000|Overall Study|Withdrawal by Subject|4|||
16941051|NCT01118962|38085500|FG000|Overall Study|Pregnancy|1|||
16941052|NCT01118962|38085500|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
16941053|NCT01118728|38085504|FG000|Overall Study|Adverse Event|17|||
16941054|NCT01118728|38085504|FG000|Overall Study|Lack of Efficacy|27|||
16941055|NCT01118728|38085504|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
16941056|NCT01118728|38085504|FG000|Overall Study|Withdrawal by Subject|3|||
16941057|NCT01118728|38085504|FG000|Overall Study|Lost to Follow-up|4|||
16941058|NCT01118455|38085510|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
16941059|NCT01118455|38085511|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
16941060|NCT01118377|38085525|FG000|Overall Study|Did Not Receive Study Medication|1|||
16941061|NCT01118377|38085525|FG000|Overall Study|Death|38|||
16941062|NCT01118377|38085525|FG000|Overall Study|Failure to Return|3|||
16941063|NCT01118299|38085531|FG000|Overall Study|Death|7|||
16941064|NCT01118299|38085532|FG001|Overall Study|Death|5|||
16941065|NCT01118299|38085531|FG000|Overall Study|Withdrawal by Subject|8|||
16941066|NCT01118299|38085532|FG001|Overall Study|Withdrawal by Subject|8|||
16941067|NCT01118299|38085531|FG000|Overall Study|Lost to Follow-up|2|||
16941068|NCT01118299|38085532|FG001|Overall Study|Lost to Follow-up|1|||
16941069|NCT01118299|38085531|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
16941070|NCT01118299|38085532|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
16941071|NCT01118143|38085539|FG000|Overall Study|Withdrawal by Subject|2|||
16941072|NCT01118143|38085540|FG001|Overall Study|Withdrawal by Subject|5|||
16941073|NCT01117987|38085550|FG000|Overall Study|Protocol deviation|0|||
16941074|NCT01117987|38085551|FG001|Overall Study|Protocol deviation|1|||
16941075|NCT01117987|38085550|FG000|Overall Study|Subject no longer requires study drug|1|||
16941076|NCT01117987|38085551|FG001|Overall Study|Subject no longer requires study drug|0|||
16941077|NCT01117987|38085550|FG000|Overall Study|Lost to Follow-up|1|||
16941078|NCT01117987|38085551|FG001|Overall Study|Lost to Follow-up|1|||
16941079|NCT01117987|38085550|FG000|Overall Study|Abnormal test procedure result|2|||
16941080|NCT01117987|38085551|FG001|Overall Study|Abnormal test procedure result|0|||
16941081|NCT01117987|38085550|FG000|Overall Study|Lack of Efficacy|3|||
16941082|NCT01117987|38085551|FG001|Overall Study|Lack of Efficacy|4|||
16941083|NCT01117987|38085550|FG000|Overall Study|Death|5|||
16941084|NCT01117987|38085551|FG001|Overall Study|Death|10|||
16941085|NCT01117987|38085550|FG000|Overall Study|Withdrawal by Subject|5|||
16941086|NCT01117987|38085551|FG001|Overall Study|Withdrawal by Subject|10|||
16941087|NCT01117987|38085550|FG000|Overall Study|Adverse Event|19|||
16941088|NCT01117987|38085551|FG001|Overall Study|Adverse Event|26|||
16941089|NCT01117987|38085550|FG000|Overall Study|Administrative problems|25|||
16941090|NCT01117987|38085551|FG001|Overall Study|Administrative problems|22|||
16941091|NCT01117870|38085559|FG000|Overall Study|Inability to place needle|1|||
16941092|NCT01117870|38085560|FG001|Overall Study|Inability to place needle|0|||
16941093|NCT01117792|38085570|FG000|Overall Study|Death|1|||
16941094|NCT01117792|38085570|FG000|Overall Study|Adverse Event|3|||
16941095|NCT01117480|38085574|FG000|Overall Study|Protocol Violation|8|||
16941096|NCT01117480|38085574|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
16941097|NCT01117051|38085580|FG000|Overall Study|Withdrawal by Subject|5|||
16941098|NCT01117051|38085581|FG001|Overall Study|Withdrawal by Subject|3|||
16941099|NCT01117051|38085580|FG000|Overall Study|Adverse Event|4|||
16941100|NCT01117051|38085581|FG001|Overall Study|Adverse Event|3|||
16941101|NCT01117051|38085580|FG000|Overall Study|Lost to Follow-up|0|||
16941102|NCT01117051|38085581|FG001|Overall Study|Lost to Follow-up|1|||
16941103|NCT01117051|38085580|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
16941104|NCT01117051|38085581|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
16941105|NCT01117051|38085580|FG000|Overall Study|Sponsor's decision|3|||
16941106|NCT01117051|38085581|FG001|Overall Study|Sponsor's decision|1|||
16941107|NCT01117051|38085580|FG000|Overall Study|Surgical procedure|0|||
16941108|NCT01117051|38085581|FG001|Overall Study|Surgical procedure|1|||
16941109|NCT01117051|38085580|FG000|Overall Study|Randomized by mistake|0|||
16941110|NCT01117051|38085581|FG001|Overall Study|Randomized by mistake|1|||
16941111|NCT01117051|38085580|FG000|Overall Study|Convenience issue|1|||
16941112|NCT01117051|38085581|FG001|Overall Study|Convenience issue|0|||
16941113|NCT02211417|38085590|FG000|Overall Study|Withdrawal by Subject|11|||
16941114|NCT02211417|38085591|FG001|Overall Study|Withdrawal by Subject|8|||
16941115|NCT02211417|38085590|FG000|Overall Study|Protocol Violation|1|||
16941116|NCT02211417|38085591|FG001|Overall Study|Protocol Violation|0|||
16941117|NCT02211417|38085590|FG000|Overall Study|Pregnancy|0|||
16941118|NCT02211417|38085591|FG001|Overall Study|Pregnancy|1|||
16941119|NCT02211417|38085590|FG000|Overall Study|Lost to Follow-up|2|||
16941120|NCT02211417|38085591|FG001|Overall Study|Lost to Follow-up|3|||
16941121|NCT02211417|38085590|FG000|Overall Study|Adverse Event|1|||
16941122|NCT02211417|38085591|FG001|Overall Study|Adverse Event|4|||
16941123|NCT01117012|38085604|FG000|Overall Study|Adverse Event|0|||
16941124|NCT01117012|38085605|FG001|Overall Study|Adverse Event|1|||
16941125|NCT01117012|38085604|FG000|Overall Study|Death|1|||
16941126|NCT01117012|38085605|FG001|Overall Study|Death|1|||
16941127|NCT01117012|38085604|FG000|Overall Study|Withdrawal by Subject|3|||
17105904|NCT00092547|38244227|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
17105905|NCT00092547|38244225|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
17105906|NCT00092547|38244226|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
17105907|NCT00092547|38244227|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
17105908|NCT00092547|38244225|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
17105909|NCT00092547|38244226|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
17105910|NCT00092547|38244227|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
17105911|NCT00092547|38244225|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
17105912|NCT00092547|38244226|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
17105913|NCT00092547|38244227|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
17105914|NCT00092547|38244225|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
17105915|NCT00092547|38244226|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
17105916|NCT00092547|38244227|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
17105917|NCT00092547|38244225|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
17105918|NCT00092547|38244226|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
17105919|NCT00092547|38244227|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
17105920|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
17105921|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
17105922|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
17105923|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
17105924|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
17105925|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
17105926|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
17105927|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
17105928|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
17105929|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
17105930|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
17105931|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
16941128|NCT01117012|38085605|FG001|Overall Study|Withdrawal by Subject|0|||
16941129|NCT01117012|38085604|FG000|Overall Study|Undefined|4|||
16941130|NCT01117012|38085605|FG001|Overall Study|Undefined|3|||
16941131|NCT01116739|38085613|FG000|Overall Study|Child had 2 years of HS|110|||
16941132|NCT01116739|38085614|FG001|Overall Study|Child had 2 years of HS|128|||
16941133|NCT01116739|38085613|FG000|Overall Study|Withdrawal by Subject|6|||
16941134|NCT01116739|38085614|FG001|Overall Study|Withdrawal by Subject|0|||
16941135|NCT01116739|38085613|FG000|Overall Study|child too young|2|||
16941136|NCT01116739|38085614|FG001|Overall Study|child too young|6|||
16941137|NCT01116739|38085613|FG000|Overall Study|child not enrolled in head start|10|||
16941138|NCT01116739|38085614|FG001|Overall Study|child not enrolled in head start|2|||
16941139|NCT01116739|38085613|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
16941140|NCT01116739|38085614|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
16941141|NCT01116544|38085622|FG000|Overall Study|Protocol Violation|1|||
16941142|NCT01116544|38085623|FG001|Overall Study|Protocol Violation|0|||
16941143|NCT01116544|38085622|FG000|Overall Study|Withdrawal by Subject|1|||
16941144|NCT01116544|38085623|FG001|Overall Study|Withdrawal by Subject|1|||
16941145|NCT01116427|38085631|FG000|Core Phase|Adverse Event|0|||
16941146|NCT01116427|38085632|FG001|Core Phase|Adverse Event|1|||
16941147|NCT01116427|38085631|FG000|Core Phase|Lost to Follow-up|1|||
16941148|NCT01116427|38085632|FG001|Core Phase|Lost to Follow-up|0|||
16941149|NCT01116427|38085631|FG000|Core Phase|Withdrawal by Subject|3|||
16941150|NCT01116427|38085632|FG001|Core Phase|Withdrawal by Subject|0|||
16941151|NCT01116427|38085631|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
16941152|NCT01116427|38085632|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
16941153|NCT01116427|38085631|FG000|Extension Phase|Adverse Event|1|||
16941154|NCT01116427|38085632|FG001|Extension Phase|Adverse Event|1|||
16941155|NCT01116427|38085631|FG000|Extension Phase|Lost to Follow-up|2|||
16941156|NCT01116427|38085632|FG001|Extension Phase|Lost to Follow-up|0|||
16941157|NCT01116427|38085631|FG000|Extension Phase|Withdrawal by Subject|5|||
16941158|NCT01116427|38085632|FG001|Extension Phase|Withdrawal by Subject|1|||
16941159|NCT01116427|38085631|FG000|Extension Phase|Not using appropriate birth control|1|||
16941160|NCT01116427|38085632|FG001|Extension Phase|Not using appropriate birth control|0|||
16941161|NCT01116232|38085642|FG000|Overall Study|Progressive diease|4|||
16941162|NCT01115998|38085651|FG000|Overall Study|Lost to Follow-up|6|||
16941163|NCT01115998|38085652|FG001|Overall Study|Lost to Follow-up|6|||
16941164|NCT01205230|38085660|FG000|Overall Study|Adverse Event|4|||
16941165|NCT01205230|38085661|FG001|Overall Study|Adverse Event|0|||
16941166|NCT01205230|38085660|FG000|Overall Study|Physician Decision|1|||
16941167|NCT01205230|38085661|FG001|Overall Study|Physician Decision|0|||
16941168|NCT01205152|38085672|FG000|Overall Study|Death|1|||
16941169|NCT01205035|38085680|FG000|Overall Study|Withdrawal by Subject|1|||
16941170|NCT01205035|38085681|FG001|Overall Study|Withdrawal by Subject|0|||
16941171|NCT01205035|38085680|FG000|Overall Study|Physician Decision|1|||
17105932|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
17105933|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
17105934|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
17105935|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
17105936|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
17105937|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
17105938|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
17105939|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
17105940|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
17105941|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
17105942|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
17105943|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
16941172|NCT01205035|38085681|FG001|Overall Study|Physician Decision|0|||
16941173|NCT01204918|38085690|FG000|Overall Study|Withdrawal by Subject|4|||
16941174|NCT01204918|38085691|FG001|Overall Study|Withdrawal by Subject|10|||
16941175|NCT01204918|38085692|FG002|Overall Study|Withdrawal by Subject|5|||
16941176|NCT01204294|38085707|FG000|Overall Study|Adverse Event|2|||
16941177|NCT01204294|38085708|FG001|Overall Study|Adverse Event|6|||
16941178|NCT01204294|38085709|FG002|Overall Study|Adverse Event|0|||
16941179|NCT01204294|38085710|FG003|Overall Study|Adverse Event|7|||
16941180|NCT01204294|38085711|FG004|Overall Study|Adverse Event|1|||
16941181|NCT01204294|38085712|FG005|Overall Study|Adverse Event|4|||
16941182|NCT01204294|38085713|FG006|Overall Study|Adverse Event|0|||
16941183|NCT01204294|38085707|FG000|Overall Study|Protocol Violation|1|||
16941184|NCT01204294|38085708|FG001|Overall Study|Protocol Violation|0|||
16941185|NCT01204294|38085709|FG002|Overall Study|Protocol Violation|2|||
16941186|NCT01204294|38085710|FG003|Overall Study|Protocol Violation|1|||
16941187|NCT01204294|38085711|FG004|Overall Study|Protocol Violation|0|||
16941188|NCT01204294|38085712|FG005|Overall Study|Protocol Violation|0|||
16941189|NCT01204294|38085713|FG006|Overall Study|Protocol Violation|0|||
16941190|NCT01204294|38085707|FG000|Overall Study|Withdrawal by Subject|0|||
16941191|NCT01204294|38085708|FG001|Overall Study|Withdrawal by Subject|2|||
16941192|NCT01204294|38085709|FG002|Overall Study|Withdrawal by Subject|2|||
16941193|NCT01204294|38085710|FG003|Overall Study|Withdrawal by Subject|1|||
16941194|NCT01204294|38085711|FG004|Overall Study|Withdrawal by Subject|1|||
16941195|NCT01204294|38085712|FG005|Overall Study|Withdrawal by Subject|1|||
16941196|NCT01204294|38085713|FG006|Overall Study|Withdrawal by Subject|2|||
16941197|NCT01204294|38085707|FG000|Overall Study|Lack of Efficacy|0|||
16941198|NCT01204294|38085708|FG001|Overall Study|Lack of Efficacy|0|||
16941199|NCT01204294|38085709|FG002|Overall Study|Lack of Efficacy|0|||
16941200|NCT01204294|38085710|FG003|Overall Study|Lack of Efficacy|2|||
16941201|NCT01204294|38085711|FG004|Overall Study|Lack of Efficacy|0|||
16941202|NCT01204294|38085712|FG005|Overall Study|Lack of Efficacy|0|||
16941203|NCT01204294|38085713|FG006|Overall Study|Lack of Efficacy|0|||
16941204|NCT01204294|38085707|FG000|Overall Study|Other (house moving)|0|||
16941205|NCT01204294|38085708|FG001|Overall Study|Other (house moving)|0|||
16941206|NCT01204294|38085709|FG002|Overall Study|Other (house moving)|1|||
16941207|NCT01204294|38085710|FG003|Overall Study|Other (house moving)|0|||
16941208|NCT01204294|38085711|FG004|Overall Study|Other (house moving)|0|||
16941209|NCT01204294|38085712|FG005|Overall Study|Other (house moving)|0|||
16941210|NCT01204294|38085713|FG006|Overall Study|Other (house moving)|0|||
16941211|NCT01182181|38085731|FG000|First Intervention|Adverse Event|1|||
16941212|NCT01182181|38085732|FG001|First Intervention|Adverse Event|0|||
16941213|NCT01182181|38085731|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
16941214|NCT01182181|38085732|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
16941215|NCT01181986|38085740|FG000|Phase 1|Lost to Follow-up|0|||
16941216|NCT01181986|38085741|FG001|Phase 1|Lost to Follow-up|1|||
16941217|NCT01181986|38085742|FG002|Phase 1|Lost to Follow-up|1|||
16941218|NCT01181986|38085740|FG000|Phase 1|Adverse Event|0|||
16941219|NCT01181986|38085741|FG001|Phase 1|Adverse Event|0|||
16941220|NCT01181986|38085742|FG002|Phase 1|Adverse Event|1|||
16941221|NCT01181986|38085740|FG000|Phase 1|Protocol Violation|1|||
16941222|NCT01181986|38085741|FG001|Phase 1|Protocol Violation|0|||
16941223|NCT01181986|38085742|FG002|Phase 1|Protocol Violation|0|||
16941224|NCT01181986|38085740|FG000|Phase 2|Adverse Event|0|||
16941225|NCT01181986|38085741|FG001|Phase 2|Adverse Event|3|||
16941226|NCT01181986|38085742|FG002|Phase 2|Adverse Event|0|||
16941227|NCT01181986|38085740|FG000|Phase 2|Medical condition|0|||
16941228|NCT01181986|38085741|FG001|Phase 2|Medical condition|1|||
16941229|NCT01181986|38085742|FG002|Phase 2|Medical condition|0|||
16941230|NCT01181167|38085758|FG000|Overall Study|Adverse Event|11|||
16941231|NCT01181167|38085759|FG001|Overall Study|Adverse Event|21|||
16941232|NCT01181167|38085758|FG000|Overall Study|Lost to Follow-up|1|||
16941233|NCT01181167|38085759|FG001|Overall Study|Lost to Follow-up|0|||
16941234|NCT01181167|38085758|FG000|Overall Study|Physician Decision|2|||
16941235|NCT01181167|38085759|FG001|Overall Study|Physician Decision|3|||
16941236|NCT01181167|38085758|FG000|Overall Study|Protocol Violation|3|||
16941237|NCT01181167|38085759|FG001|Overall Study|Protocol Violation|0|||
16941238|NCT01181167|38085758|FG000|Overall Study|Withdrawal by Subject|6|||
16941239|NCT01181167|38085759|FG001|Overall Study|Withdrawal by Subject|8|||
16941240|NCT01181128|38085768|FG000|Overall Study|Withdrawal by Subject|2|||
16941241|NCT01181128|38085769|FG001|Overall Study|Withdrawal by Subject|2|||
16941242|NCT01181128|38085770|FG002|Overall Study|Withdrawal by Subject|0|||
16941243|NCT01181128|38085768|FG000|Overall Study|Death|1|||
16941244|NCT01181128|38085769|FG001|Overall Study|Death|0|||
16941245|NCT01181128|38085770|FG002|Overall Study|Death|0|||
16941246|NCT01181128|38085768|FG000|Overall Study|Physician Decision|2|||
16941247|NCT01181128|38085769|FG001|Overall Study|Physician Decision|0|||
16941248|NCT01181128|38085770|FG002|Overall Study|Physician Decision|0|||
16941249|NCT01181128|38085768|FG000|Overall Study|Adverse Event|0|||
16941250|NCT01181128|38085769|FG001|Overall Study|Adverse Event|2|||
16941251|NCT01181128|38085770|FG002|Overall Study|Adverse Event|0|||
16941252|NCT01181128|38085768|FG000|Overall Study|Other|1|||
16941253|NCT01181128|38085769|FG001|Overall Study|Other|1|||
16941254|NCT01181128|38085770|FG002|Overall Study|Other|1|||
16941255|NCT01203787|38085792|FG000|Overall Study|Death|12|||
16941256|NCT01203787|38085793|FG001|Overall Study|Death|10|||
16941257|NCT01203787|38085792|FG000|Overall Study|Withdrawal by Subject|6|||
16941258|NCT01203787|38085793|FG001|Overall Study|Withdrawal by Subject|2|||
16941259|NCT01203787|38085792|FG000|Overall Study|Lost to Follow-up|2|||
16941260|NCT01203787|38085793|FG001|Overall Study|Lost to Follow-up|0|||
16941261|NCT01203787|38085792|FG000|Overall Study|Adverse Event|11|||
16941262|NCT01203787|38085793|FG001|Overall Study|Adverse Event|15|||
16941263|NCT01181011|38085801|FG000|Overall Study|Adverse Event|2|||
16941264|NCT01181011|38085801|FG000|Overall Study|Lost to Follow-up|1|||
16941265|NCT01180777|38085810|FG000|Overall Study|Protocol Violation|6|||
16941266|NCT01180777|38085810|FG000|Overall Study|Poor lens fit|4|||
16941267|NCT01180777|38085810|FG000|Overall Study|Lost to Follow-up|1|||
16941268|NCT01180777|38085810|FG000|Overall Study|Adverse Event|1|||
16941269|NCT01648023|38085818|FG000|Overall Study|Screen Fail Post Randomization|1|||
16941270|NCT01648023|38085819|FG001|Overall Study|Screen Fail Post Randomization|2|||
16941271|NCT02756208|38085833|FG000|Overall Study|Withdrawal by Subject|1|||
16941272|NCT02756208|38085834|FG001|Overall Study|Withdrawal by Subject|0|||
16941273|NCT02756208|38085835|FG002|Overall Study|Withdrawal by Subject|1|||
16941274|NCT02756208|38085836|FG003|Overall Study|Withdrawal by Subject|3|||
16941275|NCT02756208|38085833|FG000|Overall Study|Lost to Follow-up|3|||
16941276|NCT02756208|38085834|FG001|Overall Study|Lost to Follow-up|1|||
16941277|NCT02756208|38085835|FG002|Overall Study|Lost to Follow-up|1|||
16941278|NCT02756208|38085836|FG003|Overall Study|Lost to Follow-up|1|||
16941279|NCT02756208|38085833|FG000|Overall Study|Physician Decision|1|||
16941280|NCT02756208|38085834|FG001|Overall Study|Physician Decision|0|||
16941281|NCT02756208|38085835|FG002|Overall Study|Physician Decision|0|||
16941282|NCT02756208|38085836|FG003|Overall Study|Physician Decision|0|||
16941283|NCT02756208|38085833|FG000|Overall Study|Protocol Violation|0|||
16941284|NCT02756208|38085834|FG001|Overall Study|Protocol Violation|1|||
16941285|NCT02756208|38085835|FG002|Overall Study|Protocol Violation|0|||
16941286|NCT02756208|38085836|FG003|Overall Study|Protocol Violation|0|||
16941287|NCT02756013|38085846|FG000|Overall Study|Adverse Event|1|||
16941288|NCT02756013|38085846|FG000|Overall Study|Hypersensitivity|1|||
17105944|NCT00092547|38244225|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
17105945|NCT00092547|38244226|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
17105946|NCT00092547|38244227|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
17105947|NCT00092547|38244225|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
17105948|NCT00092547|38244226|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
17105949|NCT00092547|38244227|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
17105950|NCT00092547|38244225|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
17105951|NCT00092547|38244226|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
17105952|NCT00092547|38244227|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
17105953|NCT00092547|38244225|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
17105954|NCT00092547|38244226|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
17105955|NCT00092547|38244227|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
17105956|NCT00092547|38244225|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
17105957|NCT00092547|38244226|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
17105958|NCT00092547|38244227|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
17105959|NCT03802994|38244243|FG000|Overall Study|Lost to Follow-up|0|||
17105960|NCT03802994|38244244|FG001|Overall Study|Lost to Follow-up|2|||
17105961|NCT03802994|38244245|FG002|Overall Study|Lost to Follow-up|3|||
17105962|NCT03802994|38244246|FG003|Overall Study|Lost to Follow-up|2|||
17105963|NCT03802994|38244247|FG004|Overall Study|Lost to Follow-up|2|||
17105964|NCT03465904|38244272|FG000|Overall Study|Withdrawal by Subject|9|||
17105965|NCT03465904|38244273|FG001|Overall Study|Withdrawal by Subject|5|||
17105966|NCT03465904|38244272|FG000|Overall Study|Lost to Follow-up|10|||
17105967|NCT03465904|38244273|FG001|Overall Study|Lost to Follow-up|9|||
17105968|NCT03465904|38244272|FG000|Overall Study|Protocol Violation|8|||
17105969|NCT03465904|38244273|FG001|Overall Study|Protocol Violation|5|||
17105970|NCT03465904|38244272|FG000|Overall Study|Ineligible for mITT analysis|62|||
17105971|NCT03465904|38244273|FG001|Overall Study|Ineligible for mITT analysis|47|||
17105972|NCT03802916|38244281|FG000|Overall Study|Adverse Event|0|||
17105973|NCT03802916|38244282|FG001|Overall Study|Adverse Event|1|||
17105974|NCT03802916|38244281|FG000|Overall Study|Withdrawal by Subject|0|||
17105975|NCT03802916|38244282|FG001|Overall Study|Withdrawal by Subject|1|||
17105976|NCT00076011|38244290|FG000|Overall Study|Death|1|||
17105977|NCT00076011|38244290|FG000|Overall Study|Adverse Event|10|||
17105978|NCT00076011|38244290|FG000|Overall Study|Lack of Efficacy|25|||
17105979|NCT00076011|38244290|FG000|Overall Study|Withdrawal by Subject|1|||
17105980|NCT00076011|38244290|FG000|Overall Study|Study terminated by sponsor|3|||
17105981|NCT00076011|38244290|FG000|Overall Study|Other|11|||
17105982|NCT00076011|38244290|FG000|Overall Study|Ongoing|1|||
17105983|NCT03465436|38244298|FG000|Period 1|Protocol Violation|0|||
17105984|NCT03465436|38244299|FG001|Period 1|Protocol Violation|0|||
17105985|NCT03465436|38244300|FG002|Period 1|Protocol Violation|1|||
17105986|NCT03465436|38244301|FG003|Period 1|Protocol Violation|0|||
17105987|NCT03465436|38244298|FG000|Period 2|Protocol Violation|0|||
17105988|NCT03465436|38244299|FG001|Period 2|Protocol Violation|1|||
17105989|NCT03465436|38244300|FG002|Period 2|Protocol Violation|0|||
17105990|NCT03465436|38244301|FG003|Period 2|Protocol Violation|0|||
17105991|NCT03465436|38244298|FG000|Period 3|Protocol Violation|1|||
17105992|NCT03465436|38244299|FG001|Period 3|Protocol Violation|1|||
17105993|NCT03465436|38244300|FG002|Period 3|Protocol Violation|0|||
17105994|NCT03465436|38244301|FG003|Period 3|Protocol Violation|0|||
17105995|NCT03465436|38244298|FG000|Period 4|Protocol Violation|0|||
17105996|NCT03465436|38244299|FG001|Period 4|Protocol Violation|0|||
17105997|NCT03465436|38244300|FG002|Period 4|Protocol Violation|1|||
17105998|NCT03465436|38244301|FG003|Period 4|Protocol Violation|0|||
17105999|NCT00053846|38244315|FG000|Overall Study|Changed mind|8|||
17106000|NCT00053846|38244316|FG001|Overall Study|Changed mind|13|||
17106001|NCT00053846|38244315|FG000|Overall Study|Became too ill|8|||
17106002|NCT00053846|38244316|FG001|Overall Study|Became too ill|7|||
17106003|NCT00053846|38244315|FG000|Overall Study|Expired|5|||
17106004|NCT00053846|38244316|FG001|Overall Study|Expired|0|||
17106005|NCT00053846|38244315|FG000|Overall Study|Became ineligible|3|||
17106006|NCT00053846|38244316|FG001|Overall Study|Became ineligible|1|||
17106007|NCT00053846|38244315|FG000|Overall Study|Did not return data|1|||
17106008|NCT00053846|38244316|FG001|Overall Study|Did not return data|2|||
17106009|NCT00053846|38244315|FG000|Overall Study|Quit due to side effects|1|||
17106010|NCT00053846|38244316|FG001|Overall Study|Quit due to side effects|3|||
17106011|NCT00053846|38244315|FG000|Overall Study|Pills too large|0|||
17106012|NCT00053846|38244316|FG001|Overall Study|Pills too large|1|||
17106013|NCT00090987|38244322|FG000|Overall Study|Adverse Event|5|||
17106014|NCT00090987|38244322|FG000|Overall Study|Lack of Efficacy|7|||
17106015|NCT00090987|38244322|FG000|Overall Study|Withdrawal by Subject|3|||
17106016|NCT00090987|38244322|FG000|Overall Study|alternative therapy|1|||
17106017|NCT00090987|38244322|FG000|Overall Study|Non-compliance|4|||
17106018|NCT00090987|38244322|FG000|Overall Study|Incarcerated|1|||
17106019|NCT03464422|38244326|FG000|Overall Study|Lost to Follow-up|2|||
17106020|NCT03464422|38244326|FG000|Overall Study|Withdrawal by Subject|2|||
17106021|NCT03489304|38244332|FG000|Overall Study|Lost to Follow-up|4|||
17106022|NCT03543358|38244336|FG000|Overall Study|Death|1|||
17106023|NCT03543358|38244337|FG001|Overall Study|Death|0|||
17106024|NCT03543358|38244336|FG000|Overall Study|Disease Progression|1|||
17106025|NCT03543358|38244337|FG001|Overall Study|Disease Progression|0|||
17106026|NCT03543358|38244336|FG000|Overall Study|Parent Study Closure|1|||
17106027|NCT03543358|38244337|FG001|Overall Study|Parent Study Closure|0|||
17106028|NCT03485950|38244343|FG000|Overall Study|Adverse Event|1|||
17106029|NCT03485950|38244344|FG001|Overall Study|Adverse Event|0|||
17106030|NCT03485950|38244343|FG000|Overall Study|Death|3|||
17106031|NCT03485950|38244344|FG001|Overall Study|Death|2|||
17106032|NCT03485950|38244343|FG000|Overall Study|Withdrawal by Subject|3|||
17106033|NCT03485950|38244344|FG001|Overall Study|Withdrawal by Subject|0|||
17106034|NCT00060944|38244352|FG000|Overall Study|Adverse Event|12|||
17106035|NCT00060944|38244353|FG001|Overall Study|Adverse Event|10|||
17106036|NCT00060944|38244352|FG000|Overall Study|Death|2|||
17106037|NCT00060944|38244353|FG001|Overall Study|Death|3|||
17106038|NCT00060944|38244352|FG000|Overall Study|Withdrawal by Subject|18|||
17106039|NCT00060944|38244353|FG001|Overall Study|Withdrawal by Subject|5|||
17106040|NCT00060944|38244352|FG000|Overall Study|Disease Progression|93|||
17106041|NCT00060944|38244353|FG001|Overall Study|Disease Progression|94|||
17106042|NCT00060944|38244352|FG000|Overall Study|Lost to Follow-up|1|||
17106043|NCT00060944|38244353|FG001|Overall Study|Lost to Follow-up|0|||
17106044|NCT00060944|38244352|FG000|Overall Study|Subject Ineligible To Continue|2|||
17106045|NCT00060944|38244353|FG001|Overall Study|Subject Ineligible To Continue|1|||
17106046|NCT00060944|38244352|FG000|Overall Study|Treatment Switch|0|||
17106047|NCT00060944|38244353|FG001|Overall Study|Treatment Switch|13|||
17106048|NCT00060944|38244352|FG000|Overall Study|Other|2|||
17106049|NCT00060944|38244353|FG001|Overall Study|Other|4|||
17106050|NCT00060944|38244352|FG000|Overall Study|randomized but not treated|6|||
17106051|NCT00060944|38244353|FG001|Overall Study|randomized but not treated|4|||
17106052|NCT03462082|38244359|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
17106053|NCT03462082|38244360|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
17106054|NCT03462082|38244361|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
17106055|NCT03462082|38244362|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
17106056|NCT03462082|38244363|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
17106057|NCT03462082|38244364|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
17106058|NCT03462082|38244365|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
17106059|NCT03462082|38244366|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
17106060|NCT03461146|38244376|FG000|Overall Study|Adverse Event|2|||
17106061|NCT03461146|38244376|FG000|Overall Study|Physician Decision|1|||
17106062|NCT03541252|38244380|FG000|Overall Study|Withdrawal by Subject|1|||
17106063|NCT00031460|38244386|FG000|Overall Study|Lost to Follow-up|0|||
17106064|NCT00031460|38244387|FG001|Overall Study|Lost to Follow-up|1|||
17106065|NCT00031460|38244386|FG000|Overall Study|Withdrawal by Subject|1|||
17106066|NCT00031460|38244387|FG001|Overall Study|Withdrawal by Subject|1|||
17106067|NCT00031460|38244386|FG000|Overall Study|Non-Compliant|1|||
17106068|NCT00031460|38244387|FG001|Overall Study|Non-Compliant|1|||
17106069|NCT00031460|38244386|FG000|Overall Study|Death|0|||
17106070|NCT00031460|38244387|FG001|Overall Study|Death|1|||
17106071|NCT00031460|38244386|FG000|Overall Study|Reactivation of Disease|5|||
17106072|NCT00031460|38244387|FG001|Overall Study|Reactivation of Disease|9|||
17106073|NCT00031460|38244386|FG000|Overall Study|Disruption of blinded drug supply|2|||
17106074|NCT00031460|38244387|FG001|Overall Study|Disruption of blinded drug supply|0|||
17106075|NCT00031460|38244386|FG000|Overall Study|Confirmed unevaluable|0|||
17106076|NCT00031460|38244387|FG001|Overall Study|Confirmed unevaluable|1|||
17106077|NCT03540160|38244393|FG000|Overall Study|Protocol Violation|1|||
17106078|NCT03540160|38244393|FG000|Overall Study|Physician Decision|8|||
17106079|NCT03540160|38244393|FG000|Overall Study|Lack of Efficacy|60|||
17106080|NCT03540160|38244393|FG000|Overall Study|Pregnancy|1|||
17106081|NCT03540160|38244393|FG000|Overall Study|Adverse Event|20|||
17106082|NCT03540160|38244393|FG000|Overall Study|Withdrawal by Subject|68|||
17106083|NCT03540160|38244393|FG000|Overall Study|COVID-19|2|||
17106084|NCT03540160|38244393|FG000|Overall Study|Study Closure|10|||
17106085|NCT03540160|38244393|FG000|Overall Study|Lost to Follow-up|18|||
17106086|NCT03540160|38244393|FG000|Overall Study|Sponsor decision|191|||
17106087|NCT03459196|38244397|FG000|Overall Study|Subject didn't receive study catheter|2|||
17106088|NCT03459040|38244401|FG000|Overall Study|Death|8|||
17106089|NCT03459040|38244401|FG000|Overall Study|Withdrawal by Subject|1|||
17106090|NCT03457636|38244406|FG000|Overall Study|Lost to Follow-up|2|||
17106091|NCT03481816|38244412|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
17106092|NCT03481816|38244413|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
17106093|NCT03481816|38244412|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
17106094|NCT03481816|38244413|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
17106095|NCT03481816|38244412|FG000|Dose Expansion|Withdrawal by Subject|0|||
17106096|NCT03481816|38244413|FG001|Dose Expansion|Withdrawal by Subject|2|||
17106097|NCT03481816|38244412|FG000|Dose Expansion|Physician Decision|0|||
17106098|NCT03481816|38244413|FG001|Dose Expansion|Physician Decision|5|||
17106099|NCT03538054|38244421|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
17106100|NCT03538054|38244421|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
17106101|NCT03538054|38244421|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
17106102|NCT03480802|38244429|FG000|Overall Study|Lost to Follow-up|5|||
17106103|NCT03480802|38244430|FG001|Overall Study|Lost to Follow-up|1|||
17106104|NCT03480802|38244429|FG000|Overall Study|Withdrawal by Subject|2|||
17106105|NCT03480802|38244430|FG001|Overall Study|Withdrawal by Subject|1|||
17106106|NCT03480802|38244429|FG000|Overall Study|Relocated|0|||
17106107|NCT03480802|38244430|FG001|Overall Study|Relocated|1|||
17106108|NCT00050960|38244440|FG000|Overall Study|Progressive Disease|137|||
17106109|NCT00050960|38244441|FG001|Overall Study|Progressive Disease|93|||
17106110|NCT00050960|38244440|FG000|Overall Study|Stable Disease|19|||
17106111|NCT00050960|38244441|FG001|Overall Study|Stable Disease|48|||
17106112|NCT00050960|38244440|FG000|Overall Study|Partial Response|14|||
17106113|NCT00050960|38244441|FG001|Overall Study|Partial Response|19|||
17106114|NCT00050960|38244440|FG000|Overall Study|Complete Response|0|||
17106115|NCT00050960|38244441|FG001|Overall Study|Complete Response|2|||
17106116|NCT00050960|38244440|FG000|Overall Study|Adverse Event|62|||
17106117|NCT00050960|38244441|FG001|Overall Study|Adverse Event|61|||
17106118|NCT00050960|38244440|FG000|Overall Study|Lost to Follow-up|0|||
17106119|NCT00050960|38244441|FG001|Overall Study|Lost to Follow-up|1|||
17106120|NCT00050960|38244440|FG000|Overall Study|Withdrawal by Subject|23|||
17106121|NCT00050960|38244441|FG001|Overall Study|Withdrawal by Subject|18|||
17106122|NCT00050960|38244440|FG000|Overall Study|Administrative|31|||
17106123|NCT00050960|38244441|FG001|Overall Study|Administrative|46|||
17106124|NCT00050960|38244440|FG000|Overall Study|Non-compliance|3|||
17106125|NCT00050960|38244441|FG001|Overall Study|Non-compliance|1|||
17106126|NCT00050960|38244440|FG000|Overall Study|Death|13|||
17106127|NCT00050960|38244441|FG001|Overall Study|Death|15|||
17106128|NCT03456856|38244447|FG000|Overall Study|Lost to Follow-up|2|||
17106129|NCT03456856|38244447|FG000|Overall Study|Withdrawal by Subject|1|||
17106130|NCT00058214|38244451|FG000|Overall Study|Adverse Event|1|||
17106131|NCT00097773|38244459|FG000|Overall Study|Lost to Follow-up|2|||
17106132|NCT00097773|38244460|FG001|Overall Study|Lost to Follow-up|2|||
17106133|NCT00097773|38244461|FG002|Overall Study|Lost to Follow-up|0|||
17106134|NCT00097773|38244462|FG003|Overall Study|Lost to Follow-up|1|||
17106135|NCT00097773|38244459|FG000|Overall Study|Physician Decision|2|||
17106136|NCT00097773|38244460|FG001|Overall Study|Physician Decision|2|||
17106137|NCT00097773|38244461|FG002|Overall Study|Physician Decision|3|||
17106138|NCT00097773|38244462|FG003|Overall Study|Physician Decision|1|||
17106139|NCT00097773|38244459|FG000|Overall Study|Withdrawal by Subject|3|||
17106140|NCT00097773|38244460|FG001|Overall Study|Withdrawal by Subject|3|||
17106141|NCT00097773|38244461|FG002|Overall Study|Withdrawal by Subject|3|||
17106142|NCT00097773|38244462|FG003|Overall Study|Withdrawal by Subject|1|||
17106143|NCT00097773|38244459|FG000|Overall Study|Adverse Event|0|||
17106144|NCT00097773|38244460|FG001|Overall Study|Adverse Event|1|||
17106145|NCT00097773|38244461|FG002|Overall Study|Adverse Event|0|||
17106146|NCT00097773|38244462|FG003|Overall Study|Adverse Event|0|||
17106147|NCT00097773|38244459|FG000|Overall Study|Other|1|||
17106148|NCT00097773|38244460|FG001|Overall Study|Other|0|||
17106149|NCT00097773|38244461|FG002|Overall Study|Other|2|||
17106150|NCT00097773|38244462|FG003|Overall Study|Other|0|||
17106151|NCT03480022|38244479|FG000|Overall Study|Pregnancy|2|||
17106152|NCT03480022|38244480|FG001|Overall Study|Pregnancy|0|||
17106153|NCT03480022|38244479|FG000|Overall Study|Adverse Event|6|||
17106154|NCT03480022|38244480|FG001|Overall Study|Adverse Event|0|||
17106155|NCT03480022|38244479|FG000|Overall Study|Lack of Efficacy|0|||
17106156|NCT03480022|38244480|FG001|Overall Study|Lack of Efficacy|2|||
17106157|NCT03480022|38244479|FG000|Overall Study|Physician Decision|0|||
17106158|NCT03480022|38244480|FG001|Overall Study|Physician Decision|1|||
17106159|NCT03480022|38244479|FG000|Overall Study|Withdrawal by Subject|2|||
17106160|NCT03480022|38244480|FG001|Overall Study|Withdrawal by Subject|0|||
17106161|NCT03480022|38244479|FG000|Overall Study|Medication concerns|1|||
17106162|NCT03480022|38244480|FG001|Overall Study|Medication concerns|0|||
17106163|NCT03480022|38244479|FG000|Overall Study|Family member COVID exposure|0|||
17106164|NCT03480022|38244480|FG001|Overall Study|Family member COVID exposure|1|||
17106165|NCT03533608|38244486|FG000|Overall Study|Withdrawal by Subject|3|||
17106166|NCT03533608|38244486|FG000|Overall Study|Physician Decision|2|||
17106167|NCT00049322|38244493|FG000|Overall Study|disease burden|0|||
17106168|NCT00049322|38244494|FG001|Overall Study|disease burden|3|||
17106169|NCT00049322|38244493|FG000|Overall Study|Adverse Event|1|||
17106170|NCT00049322|38244494|FG001|Overall Study|Adverse Event|0|||
17106171|NCT00049322|38244493|FG000|Overall Study|refused angio|0|||
17106172|NCT00049322|38244494|FG001|Overall Study|refused angio|3|||
17106173|NCT03437512|38244504|FG000|Randomized|Withdrawal by Subject|0|||
17106174|NCT03437512|38244505|FG001|Randomized|Withdrawal by Subject|2|||
17106175|NCT03437512|38244504|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
17106176|NCT03437512|38244505|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
17106177|NCT00058058|38244511|FG000|Overall Study|Withdrawal by Subject|4|||
17106178|NCT00058058|38244511|FG000|Overall Study|Ineligible|20|||
17106179|NCT00058058|38244511|FG000|Overall Study|Claustrophobic|5|||
17106180|NCT00058058|38244511|FG000|Overall Study|technical issues|6|||
17106181|NCT00058058|38244511|FG000|Overall Study|Poor positioning, illness,pain|3|||
17106182|NCT03532048|38244518|FG000|Overall Study|Lost to Follow-up|12|||
17106183|NCT03532048|38244519|FG001|Overall Study|Lost to Follow-up|17|||
17106184|NCT03532048|38244518|FG000|Overall Study|Withdrawal by Subject|7|||
17106185|NCT03532048|38244519|FG001|Overall Study|Withdrawal by Subject|0|||
17106186|NCT00008138|38244525|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
17106187|NCT00008138|38244525|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
17106188|NCT00008138|38244525|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
17106189|NCT00008138|38244525|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
17106190|NCT00008138|38244525|FG000|Interval Debulking|Withdrawal by Subject|2|||
17106191|NCT00008138|38244525|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
17106192|NCT00008138|38244525|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
17106193|NCT00008138|38244525|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
17106194|NCT03436732|38244532|FG000|Overall Study|Not treated-enrolled in different study|1|||
17106195|NCT03436732|38244533|FG001|Overall Study|Not treated-enrolled in different study|0|||
17106196|NCT03436732|38244532|FG000|Overall Study|Off study after cycle 1|1|||
17106197|NCT03436732|38244533|FG001|Overall Study|Off study after cycle 1|0|||
17106198|NCT03436732|38244532|FG000|Overall Study|Adverse Event|2|||
17106199|NCT03436732|38244533|FG001|Overall Study|Adverse Event|0|||
17106200|NCT03436732|38244532|FG000|Overall Study|Death|0|||
17106201|NCT03436732|38244533|FG001|Overall Study|Death|1|||
17106202|NCT03436420|38244540|FG000|Overall Study|Lack of Efficacy|3|||
17106203|NCT00027560|38244544|FG000|Overall Study|Withdrawal by Subject|1|||
17106204|NCT03451084|38244554|FG000|Overall Study|Withdrawal by Subject|2|||
17106205|NCT03451084|38244555|FG001|Overall Study|Withdrawal by Subject|1|||
17106206|NCT03451084|38244556|FG002|Overall Study|Withdrawal by Subject|2|||
17106207|NCT03451084|38244557|FG003|Overall Study|Withdrawal by Subject|1|||
17106208|NCT03451084|38244554|FG000|Overall Study|Disease recurrence|0|||
17106209|NCT03451084|38244555|FG001|Overall Study|Disease recurrence|2|||
17106210|NCT03451084|38244556|FG002|Overall Study|Disease recurrence|0|||
17106211|NCT03451084|38244557|FG003|Overall Study|Disease recurrence|0|||
17106212|NCT03451084|38244554|FG000|Overall Study|Lack of Efficacy|0|||
17106213|NCT03451084|38244555|FG001|Overall Study|Lack of Efficacy|3|||
17106214|NCT03451084|38244556|FG002|Overall Study|Lack of Efficacy|0|||
17106215|NCT03451084|38244557|FG003|Overall Study|Lack of Efficacy|1|||
17106216|NCT03451084|38244554|FG000|Overall Study|Death|1|||
17106217|NCT03451084|38244555|FG001|Overall Study|Death|0|||
17106218|NCT03451084|38244556|FG002|Overall Study|Death|2|||
17106219|NCT03451084|38244557|FG003|Overall Study|Death|0|||
17106220|NCT03451084|38244554|FG000|Overall Study|Physician Decision|0|||
17106221|NCT03451084|38244555|FG001|Overall Study|Physician Decision|0|||
17106222|NCT03451084|38244556|FG002|Overall Study|Physician Decision|2|||
17106223|NCT03451084|38244557|FG003|Overall Study|Physician Decision|2|||
17106224|NCT03451084|38244554|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
17106225|NCT03451084|38244555|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
17106226|NCT03451084|38244556|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
17106227|NCT03451084|38244557|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
17106228|NCT03451006|38244569|FG000|Overall Study|Withdrawal by Subject|2|||
17106229|NCT03451006|38244570|FG001|Overall Study|Withdrawal by Subject|2|||
17106230|NCT03450070|38244576|FG000|Overall Study|Withdrawal by Subject|8|||
17106231|NCT03449758|38244580|FG000|Overall Study|Major protocol deviation|1|||
17106232|NCT03449758|38244580|FG000|Overall Study|Treatment inefficacy|5|||
17106233|NCT03449758|38244580|FG000|Overall Study|Adverse Event|9|||
17106234|NCT03449758|38244580|FG000|Overall Study|Consent withdrawal|1|||
17106235|NCT03449758|38244580|FG000|Overall Study|Other unspecified reason|3|||
17106236|NCT03449446|38244592|FG000|Overall Study|Randomized but Never Treated|0|||
17106237|NCT03449446|38244593|FG001|Overall Study|Randomized but Never Treated|0|||
17106238|NCT03449446|38244594|FG002|Overall Study|Randomized but Never Treated|1|||
17106239|NCT03449446|38244595|FG003|Overall Study|Randomized but Never Treated|1|||
17106240|NCT03449446|38244596|FG004|Overall Study|Randomized but Never Treated|1|||
17106241|NCT03449446|38244597|FG005|Overall Study|Randomized but Never Treated|0|||
17106242|NCT03449446|38244598|FG006|Overall Study|Randomized but Never Treated|0|||
17106243|NCT03449446|38244592|FG000|Overall Study|Unknown Reason|33|||
17106244|NCT03449446|38244593|FG001|Overall Study|Unknown Reason|1|||
17106245|NCT03449446|38244594|FG002|Overall Study|Unknown Reason|1|||
17106246|NCT03449446|38244595|FG003|Overall Study|Unknown Reason|1|||
17106247|NCT03449446|38244596|FG004|Overall Study|Unknown Reason|2|||
17106248|NCT03449446|38244597|FG005|Overall Study|Unknown Reason|2|||
17106249|NCT03449446|38244598|FG006|Overall Study|Unknown Reason|0|||
17106250|NCT03449446|38244592|FG000|Overall Study|Withdrew Consent|1|||
17106251|NCT03449446|38244593|FG001|Overall Study|Withdrew Consent|3|||
17106252|NCT03449446|38244594|FG002|Overall Study|Withdrew Consent|1|||
17106253|NCT03449446|38244595|FG003|Overall Study|Withdrew Consent|4|||
17106254|NCT03449446|38244596|FG004|Overall Study|Withdrew Consent|4|||
17106255|NCT03449446|38244597|FG005|Overall Study|Withdrew Consent|4|||
17106256|NCT03449446|38244598|FG006|Overall Study|Withdrew Consent|1|||
17106257|NCT03449446|38244592|FG000|Overall Study|Adverse Event|1|||
17106258|NCT03449446|38244593|FG001|Overall Study|Adverse Event|2|||
17106259|NCT03449446|38244594|FG002|Overall Study|Adverse Event|1|||
17106260|NCT03449446|38244595|FG003|Overall Study|Adverse Event|0|||
17106261|NCT03449446|38244596|FG004|Overall Study|Adverse Event|0|||
17106262|NCT03449446|38244597|FG005|Overall Study|Adverse Event|2|||
17106263|NCT03449446|38244598|FG006|Overall Study|Adverse Event|0|||
17106264|NCT03449446|38244592|FG000|Overall Study|Lost to Follow-up|0|||
17106265|NCT03449446|38244593|FG001|Overall Study|Lost to Follow-up|0|||
17106266|NCT03449446|38244594|FG002|Overall Study|Lost to Follow-up|2|||
17106267|NCT03449446|38244595|FG003|Overall Study|Lost to Follow-up|1|||
17106268|NCT03449446|38244596|FG004|Overall Study|Lost to Follow-up|3|||
17106269|NCT03449446|38244597|FG005|Overall Study|Lost to Follow-up|0|||
17106270|NCT03449446|38244598|FG006|Overall Study|Lost to Follow-up|0|||
17106271|NCT03449446|38244592|FG000|Overall Study|Investigator's Discretion|0|||
17106272|NCT03449446|38244593|FG001|Overall Study|Investigator's Discretion|1|||
17106273|NCT03449446|38244594|FG002|Overall Study|Investigator's Discretion|1|||
17106274|NCT03449446|38244595|FG003|Overall Study|Investigator's Discretion|2|||
17106275|NCT03449446|38244596|FG004|Overall Study|Investigator's Discretion|0|||
17106276|NCT03449446|38244597|FG005|Overall Study|Investigator's Discretion|0|||
17106277|NCT03449446|38244598|FG006|Overall Study|Investigator's Discretion|0|||
17106278|NCT03449446|38244592|FG000|Overall Study|Non Compliance with Study Drug|1|||
17106279|NCT03449446|38244593|FG001|Overall Study|Non Compliance with Study Drug|0|||
17106280|NCT03449446|38244594|FG002|Overall Study|Non Compliance with Study Drug|0|||
17106281|NCT03449446|38244595|FG003|Overall Study|Non Compliance with Study Drug|0|||
17106282|NCT03449446|38244596|FG004|Overall Study|Non Compliance with Study Drug|0|||
17106283|NCT03449446|38244597|FG005|Overall Study|Non Compliance with Study Drug|0|||
17106284|NCT03449446|38244598|FG006|Overall Study|Non Compliance with Study Drug|0|||
17106285|NCT03449446|38244592|FG000|Overall Study|Protocol Violation|0|||
17106286|NCT03449446|38244593|FG001|Overall Study|Protocol Violation|0|||
17106287|NCT03449446|38244594|FG002|Overall Study|Protocol Violation|0|||
17106288|NCT03449446|38244595|FG003|Overall Study|Protocol Violation|0|||
17106289|NCT03449446|38244596|FG004|Overall Study|Protocol Violation|1|||
17106290|NCT03449446|38244597|FG005|Overall Study|Protocol Violation|1|||
17106291|NCT03449446|38244598|FG006|Overall Study|Protocol Violation|0|||
17106292|NCT03449446|38244592|FG000|Overall Study|Death|0|||
17106293|NCT03449446|38244593|FG001|Overall Study|Death|0|||
17106294|NCT03449446|38244594|FG002|Overall Study|Death|0|||
17106295|NCT03449446|38244595|FG003|Overall Study|Death|0|||
17106296|NCT03449446|38244596|FG004|Overall Study|Death|1|||
17106297|NCT03449446|38244597|FG005|Overall Study|Death|0|||
17106298|NCT03449446|38244598|FG006|Overall Study|Death|0|||
17106299|NCT03449134|38244617|FG000|52-Week Treatment Period|Death|2|||
17106300|NCT03449134|38244618|FG001|52-Week Treatment Period|Death|1|||
17106301|NCT03449134|38244619|FG002|52-Week Treatment Period|Death|0|||
17106302|NCT03449134|38244617|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
17106303|NCT03449134|38244618|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
17106304|NCT03449134|38244619|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
17106305|NCT03449134|38244617|FG000|52-Week Treatment Period|Physician Decision|2|||
17106306|NCT03449134|38244618|FG001|52-Week Treatment Period|Physician Decision|3|||
17106307|NCT03449134|38244619|FG002|52-Week Treatment Period|Physician Decision|3|||
17106308|NCT03449134|38244617|FG000|52-Week Treatment Period|Screen Failure|1|||
17106309|NCT03449134|38244618|FG001|52-Week Treatment Period|Screen Failure|0|||
17106310|NCT03449134|38244619|FG002|52-Week Treatment Period|Screen Failure|1|||
17106311|NCT03449134|38244617|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
17106312|NCT03449134|38244618|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
17106313|NCT03449134|38244619|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
17106314|NCT03449134|38244617|FG000|52-Week Treatment Period|Site Closure|1|||
17106315|NCT03449134|38244618|FG001|52-Week Treatment Period|Site Closure|0|||
17106316|NCT03449134|38244619|FG002|52-Week Treatment Period|Site Closure|0|||
17106317|NCT03529162|38244632|FG000|Overall Study|Lost to Follow-up|2|||
17106318|NCT03529162|38244633|FG001|Overall Study|Lost to Follow-up|2|||
17106319|NCT03447730|38244644|FG000|Overall Study|Adverse Event|0|||
17106320|NCT03447730|38244645|FG001|Overall Study|Adverse Event|2|||
17106321|NCT03447730|38244646|FG002|Overall Study|Adverse Event|0|||
17106322|NCT03429556|38244658|FG000|Overall Study|Lost to Follow-up|0|||
17106323|NCT03429556|38244659|FG001|Overall Study|Lost to Follow-up|1|||
17106324|NCT03429556|38244660|FG002|Overall Study|Lost to Follow-up|0|||
17106325|NCT03429556|38244661|FG003|Overall Study|Lost to Follow-up|0|||
17106326|NCT03428152|38244673|FG000|Overall Study|Physician Decision|4|||
17106327|NCT03428152|38244674|FG001|Overall Study|Physician Decision|2|||
17106328|NCT03428152|38244673|FG000|Overall Study|Protocol Violation|3|||
17106329|NCT03428152|38244674|FG001|Overall Study|Protocol Violation|5|||
17106330|NCT03428152|38244673|FG000|Overall Study|Lack of Efficacy|0|||
17106331|NCT03428152|38244674|FG001|Overall Study|Lack of Efficacy|4|||
17106332|NCT03444766|38244680|FG000|Overall Study|Other Reasons|2|||
17106333|NCT03444766|38244680|FG000|Overall Study|Participant Withdrew Consent|5|||
17106334|NCT03444766|38244680|FG000|Overall Study|Lost to Follow-up|2|||
17106335|NCT03444766|38244680|FG000|Overall Study|Death|2|||
17106336|NCT03444766|38244680|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
17106337|NCT03444766|38244680|FG000|Overall Study|Disease Progression|49|||
17106338|NCT03426436|38244684|FG000|Overall Study|Incorrect lead placement|12|||
17106339|NCT03426436|38244684|FG000|Overall Study|Withdrawal by Subject|2|||
17106340|NCT03426436|38244684|FG000|Overall Study|Consent issue|1|||
17106341|NCT03426436|38244684|FG000|Overall Study|ECGs not saved|4|||
17106342|NCT03425188|38244688|FG000|Overall Study|Withdrawal by Subject|1|||
17106343|NCT03423238|38244695|FG000|Overall Study|Lost to Follow-up|1|||
17106344|NCT03423238|38244696|FG001|Overall Study|Lost to Follow-up|0|||
17106345|NCT03423238|38244695|FG000|Overall Study|Withdrawal by Subject|1|||
17106346|NCT03423238|38244696|FG001|Overall Study|Withdrawal by Subject|0|||
17106347|NCT02953678|38244703|FG000|Overall Study|Adverse Event|20|||
17106348|NCT02953678|38244703|FG000|Overall Study|Death|7|||
17106349|NCT02953678|38244703|FG000|Overall Study|Physician Decision|23|||
17106350|NCT02953678|38244703|FG000|Overall Study|Progressive Disease of GVHD|7|||
17106351|NCT02953678|38244703|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
17106352|NCT02953678|38244703|FG000|Overall Study|Withdrawal by participant|3|||
17106353|NCT02953678|38244703|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
17106354|NCT02953678|38244703|FG000|Overall Study|Participants were transferred to commercial product.|3|||
17106355|NCT03412084|38244710|FG000|Overall Study|Withdrawal by Subject|2|||
17106356|NCT03412084|38244711|FG001|Overall Study|Withdrawal by Subject|0|||
17106357|NCT03412084|38244710|FG000|Overall Study|Participant moved|1|||
17106358|NCT03412084|38244711|FG001|Overall Study|Participant moved|0|||
17106359|NCT03412084|38244710|FG000|Overall Study|Lost to Follow-up|1|||
17106360|NCT03412084|38244711|FG001|Overall Study|Lost to Follow-up|1|||
17106361|NCT00090753|38244719|FG000|First Treatment Period|Adverse Event|20|||
17106362|NCT00090753|38244720|FG001|First Treatment Period|Adverse Event|8|||
17106363|NCT00090753|38244719|FG000|First Treatment Period|Death|88|||
17106364|NCT00090753|38244720|FG001|First Treatment Period|Death|62|||
17106365|NCT00090753|38244719|FG000|First Treatment Period|Lack of Efficacy|2|||
17106366|NCT00090753|38244720|FG001|First Treatment Period|Lack of Efficacy|1|||
17106367|NCT00090753|38244719|FG000|First Treatment Period|Refused Treatment|32|||
17106368|NCT00090753|38244720|FG001|First Treatment Period|Refused Treatment|25|||
17106369|NCT00090753|38244719|FG000|First Treatment Period|Lost to Follow-up|4|||
17106370|NCT00090753|38244720|FG001|First Treatment Period|Lost to Follow-up|4|||
17106371|NCT00090753|38244719|FG000|First Treatment Period|Renal Transplant|70|||
17106372|NCT00090753|38244720|FG001|First Treatment Period|Renal Transplant|50|||
17106373|NCT00090753|38244719|FG000|First Treatment Period|Mircera Commercialization|1|||
17106374|NCT00090753|38244720|FG001|First Treatment Period|Mircera Commercialization|0|||
17106375|NCT00090753|38244719|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
17106376|NCT00090753|38244720|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
17106377|NCT00090753|38244719|FG000|Extended Treatment Period|Adverse Event|11|||
17106378|NCT00090753|38244720|FG001|Extended Treatment Period|Adverse Event|0|||
17106379|NCT00090753|38244719|FG000|Extended Treatment Period|Death|58|||
17106380|NCT00090753|38244720|FG001|Extended Treatment Period|Death|30|||
17106381|NCT00090753|38244719|FG000|Extended Treatment Period|Lack of Efficacy|1|||
17106382|NCT00090753|38244720|FG001|Extended Treatment Period|Lack of Efficacy|0|||
17106383|NCT00090753|38244719|FG000|Extended Treatment Period|Refused Treatment|18|||
17106384|NCT00090753|38244720|FG001|Extended Treatment Period|Refused Treatment|12|||
17106385|NCT00090753|38244719|FG000|Extended Treatment Period|Lost to Follow-up|3|||
17106386|NCT00090753|38244720|FG001|Extended Treatment Period|Lost to Follow-up|1|||
17106387|NCT00090753|38244719|FG000|Extended Treatment Period|Renal Transplant|15|||
17106388|NCT00090753|38244720|FG001|Extended Treatment Period|Renal Transplant|12|||
17106389|NCT00090753|38244719|FG000|Extended Treatment Period|Mircera Commercialization|188|||
17106390|NCT00090753|38244720|FG001|Extended Treatment Period|Mircera Commercialization|93|||
17106391|NCT00090753|38244719|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
17106392|NCT00090753|38244720|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
17106393|NCT00048932|38244728|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
17106394|NCT00048932|38244729|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
17106395|NCT00048932|38244730|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
17106396|NCT00048932|38244728|FG000|Double Blind Period (DB)|Adverse Event|51|||
17106397|NCT00048932|38244729|FG001|Double Blind Period (DB)|Adverse Event|19|||
17106398|NCT00048932|38244730|FG002|Double Blind Period (DB)|Adverse Event|0|||
17106399|NCT00048932|38244728|FG000|Double Blind Period (DB)|Death|5|||
17106400|NCT00048932|38244729|FG001|Double Blind Period (DB)|Death|3|||
17106401|NCT00048932|38244730|FG002|Double Blind Period (DB)|Death|0|||
17106402|NCT00048932|38244728|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
17106403|NCT00048932|38244729|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
17106404|NCT00048932|38244730|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
17106405|NCT00048932|38244728|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
17106406|NCT00048932|38244729|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
17106407|NCT00048932|38244730|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
17106408|NCT00048932|38244728|FG000|Double Blind Period (DB)|Relocation|1|||
17106409|NCT00048932|38244729|FG001|Double Blind Period (DB)|Relocation|0|||
17106410|NCT00048932|38244730|FG002|Double Blind Period (DB)|Relocation|0|||
17106411|NCT00048932|38244728|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
17106412|NCT00048932|38244729|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
17106413|NCT00048932|38244730|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
17106414|NCT00048932|38244728|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
17106415|NCT00048932|38244729|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
17106416|NCT00048932|38244730|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
17106417|NCT00048932|38244728|FG000|Double Blind Period (DB)|Pregnancy|1|||
17106418|NCT00048932|38244729|FG001|Double Blind Period (DB)|Pregnancy|0|||
17106419|NCT00048932|38244730|FG002|Double Blind Period (DB)|Pregnancy|0|||
17106420|NCT00048932|38244728|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
17106421|NCT00048932|38244729|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
17106422|NCT00048932|38244730|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
17106423|NCT00048932|38244728|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
17106424|NCT00048932|38244729|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
17106425|NCT00048932|38244730|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
17106426|NCT00048932|38244728|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
17106427|NCT00048932|38244729|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
17106428|NCT00048932|38244730|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
17106429|NCT00048932|38244728|FG000|Open Label Period (OL)|Death|0|||
17106430|NCT00048932|38244729|FG001|Open Label Period (OL)|Death|0|||
17106431|NCT00048932|38244730|FG002|Open Label Period (OL)|Death|25|||
17106432|NCT00048932|38244728|FG000|Open Label Period (OL)|Adverse Event|0|||
17106433|NCT00048932|38244729|FG001|Open Label Period (OL)|Adverse Event|0|||
17106434|NCT00048932|38244730|FG002|Open Label Period (OL)|Adverse Event|103|||
17106435|NCT00048932|38244728|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
17106436|NCT00048932|38244729|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
17106437|NCT00048932|38244730|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
17106438|NCT00048932|38244728|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
17106439|NCT00048932|38244729|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
17106440|NCT00048932|38244730|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
17106441|NCT00048932|38244728|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
17106442|NCT00048932|38244729|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
17106443|NCT00048932|38244730|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
17106444|NCT00048932|38244728|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
17106445|NCT00048932|38244729|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
17106446|NCT00048932|38244730|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
17106447|NCT00048932|38244728|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
17106448|NCT00048932|38244729|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
17106449|NCT00048932|38244730|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
17106450|NCT00048932|38244728|FG000|Open Label Period (OL)|Pregnancy|0|||
17106451|NCT00048932|38244729|FG001|Open Label Period (OL)|Pregnancy|0|||
17106452|NCT00048932|38244730|FG002|Open Label Period (OL)|Pregnancy|6|||
17106453|NCT00048932|38244728|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
17106454|NCT00048932|38244729|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
17106455|NCT00048932|38244730|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
17106456|NCT00048932|38244728|FG000|Open Label Period (OL)|Investigator Retiring|0|||
17106457|NCT00048932|38244729|FG001|Open Label Period (OL)|Investigator Retiring|0|||
17106458|NCT00048932|38244730|FG002|Open Label Period (OL)|Investigator Retiring|2|||
17106459|NCT00048932|38244728|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
17106460|NCT00048932|38244729|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
17106461|NCT00048932|38244730|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
17106462|NCT00048932|38244728|FG000|Open Label Period (OL)|Participant Relocated|0|||
17106463|NCT00048932|38244729|FG001|Open Label Period (OL)|Participant Relocated|0|||
17106464|NCT00048932|38244730|FG002|Open Label Period (OL)|Participant Relocated|6|||
17106465|NCT00048932|38244728|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
17106466|NCT00048932|38244729|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
17106467|NCT00048932|38244730|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
17106468|NCT00048932|38244728|FG000|Open Label Period (OL)|Site Closure|0|||
17106469|NCT00048932|38244729|FG001|Open Label Period (OL)|Site Closure|0|||
17106470|NCT00048932|38244730|FG002|Open Label Period (OL)|Site Closure|3|||
17106471|NCT00048932|38244728|FG000|Open Label Period (OL)|Trial Terminated|0|||
17106472|NCT00048932|38244729|FG001|Open Label Period (OL)|Trial Terminated|0|||
17106473|NCT00048932|38244730|FG002|Open Label Period (OL)|Trial Terminated|1|||
17106474|NCT00048932|38244728|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
17106475|NCT00048932|38244729|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
17106476|NCT00048932|38244730|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
17106477|NCT00048932|38244728|FG000|Open Label Period (OL)|Patient Decision|0|||
17106478|NCT00048932|38244729|FG001|Open Label Period (OL)|Patient Decision|0|||
17106479|NCT00048932|38244730|FG002|Open Label Period (OL)|Patient Decision|4|||
17106480|NCT00048932|38244728|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
17106481|NCT00048932|38244729|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
17106482|NCT00048932|38244730|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
17106483|NCT00048932|38244728|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
17106484|NCT00048932|38244729|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
17106485|NCT00048932|38244730|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
17106486|NCT00048932|38244728|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
17106487|NCT00048932|38244729|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
17106488|NCT00048932|38244730|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
17106489|NCT00048932|38244728|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
17106490|NCT00048932|38244729|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
17106491|NCT00048932|38244730|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
17106492|NCT00048932|38244728|FG000|Open Label Period (OL)|Investigator Decision|0|||
17106493|NCT00048932|38244729|FG001|Open Label Period (OL)|Investigator Decision|0|||
17106494|NCT00048932|38244730|FG002|Open Label Period (OL)|Investigator Decision|4|||
17106495|NCT00048932|38244728|FG000|Open Label Period (OL)|Site Staff Issues|0|||
17106496|NCT00048932|38244729|FG001|Open Label Period (OL)|Site Staff Issues|0|||
17106497|NCT00048932|38244730|FG002|Open Label Period (OL)|Site Staff Issues|2|||
17106498|NCT00048932|38244728|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
17106499|NCT00048932|38244729|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
17106500|NCT00048932|38244730|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
17106501|NCT00048932|38244728|FG000|Open Label Period (OL)|Participant Surgery|0|||
17106502|NCT00048932|38244729|FG001|Open Label Period (OL)|Participant Surgery|0|||
17106503|NCT00048932|38244730|FG002|Open Label Period (OL)|Participant Surgery|1|||
17106504|NCT00073983|38244739|FG000|Overall Study|not evaluable|1|||
17106505|NCT03812679|38244745|FG000|Overall Study|Adverse Event|2|||
17106506|NCT03812679|38244745|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
17106507|NCT03812679|38244745|FG000|Overall Study|Renal transplant|1|||
17106508|NCT03812679|38244745|FG000|Overall Study|Withdrawal by Subject|1|||
17106509|NCT03812679|38244745|FG000|Overall Study|Termination of study|2|||
17106510|NCT03812679|38244745|FG000|Overall Study|Water device replacement|1|||
17106511|NCT02952820|38244752|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
17106512|NCT02952820|38244753|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
17106513|NCT02952820|38244754|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
17106514|NCT02952820|38244752|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
17106515|NCT02952820|38244753|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
17106516|NCT02952820|38244754|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
17106517|NCT02952820|38244752|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
17106518|NCT02952820|38244753|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
17106519|NCT02952820|38244754|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
17106520|NCT02952820|38244752|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
17106521|NCT02952820|38244753|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
17106522|NCT02952820|38244754|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
17106523|NCT02952820|38244752|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
17106524|NCT02952820|38244753|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
17106525|NCT02952820|38244754|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
17106526|NCT02952820|38244752|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
17106527|NCT02952820|38244753|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
17106528|NCT02952820|38244754|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
17106529|NCT02952820|38244752|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
17106530|NCT02952820|38244753|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
17106531|NCT02952820|38244754|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
17106532|NCT02952820|38244752|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
17106533|NCT02952820|38244753|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
17106534|NCT02952820|38244754|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
17106535|NCT02952820|38244752|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
17106536|NCT02952820|38244753|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
17106537|NCT02952820|38244754|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
17106538|NCT02952820|38244752|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
17106539|NCT02952820|38244753|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
17106540|NCT02952820|38244754|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
17106541|NCT02952820|38244752|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
17106542|NCT02952820|38244753|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
17106543|NCT02952820|38244754|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
17106544|NCT02952820|38244752|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
17106545|NCT02952820|38244753|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
17106546|NCT02952820|38244754|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
17106547|NCT02952820|38244752|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
17106548|NCT02952820|38244753|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
17106549|NCT02952820|38244754|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
17106550|NCT02952820|38244752|FG000|Active Treatment Period (6 Months)|Not treated|0|||
17106551|NCT02952820|38244753|FG001|Active Treatment Period (6 Months)|Not treated|0|||
17106552|NCT02952820|38244754|FG002|Active Treatment Period (6 Months)|Not treated|1|||
17106553|NCT00006392|38244769|FG000|Overall Study|Ineligible|11|||
17106554|NCT00006392|38244770|FG001|Overall Study|Ineligible|3|||
17106555|NCT00006392|38244771|FG002|Overall Study|Ineligible|5|||
17106556|NCT00006392|38244772|FG003|Overall Study|Ineligible|5|||
17106557|NCT00006392|38244769|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
17106558|NCT00006392|38244770|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
17106559|NCT00006392|38244771|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
17106560|NCT00006392|38244772|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
17106561|NCT00379769|38244786|FG000|Main Study|Death|57|||
17106562|NCT00379769|38244787|FG001|Main Study|Death|67|||
17106563|NCT00379769|38244788|FG002|Main Study|Death|54|||
17106564|NCT00379769|38244789|FG003|Main Study|Death|72|||
17106565|NCT00379769|38244790|FG004|Main Study|Death|0|||
17106566|NCT00379769|38244791|FG005|Main Study|Death|0|||
17106567|NCT00379769|38244786|FG000|Main Study|Adverse Event|5|||
17106568|NCT00379769|38244787|FG001|Main Study|Adverse Event|8|||
17106569|NCT00379769|38244788|FG002|Main Study|Adverse Event|10|||
17106570|NCT00379769|38244789|FG003|Main Study|Adverse Event|11|||
17106571|NCT00379769|38244790|FG004|Main Study|Adverse Event|0|||
17106572|NCT00379769|38244791|FG005|Main Study|Adverse Event|0|||
17106573|NCT00379769|38244786|FG000|Main Study|Lost to Follow-up|29|||
17106574|NCT00379769|38244787|FG001|Main Study|Lost to Follow-up|29|||
17106575|NCT00379769|38244788|FG002|Main Study|Lost to Follow-up|25|||
17106576|NCT00379769|38244789|FG003|Main Study|Lost to Follow-up|26|||
17106577|NCT00379769|38244790|FG004|Main Study|Lost to Follow-up|0|||
17106578|NCT00379769|38244791|FG005|Main Study|Lost to Follow-up|0|||
17106579|NCT00379769|38244786|FG000|Main Study|Withdrawal by Subject|46|||
17106580|NCT00379769|38244787|FG001|Main Study|Withdrawal by Subject|56|||
17106581|NCT00379769|38244788|FG002|Main Study|Withdrawal by Subject|72|||
17106582|NCT00379769|38244789|FG003|Main Study|Withdrawal by Subject|70|||
17106583|NCT00379769|38244790|FG004|Main Study|Withdrawal by Subject|0|||
17106584|NCT00379769|38244791|FG005|Main Study|Withdrawal by Subject|0|||
17106585|NCT00379769|38244786|FG000|Main Study|Moved to survival status follow-up only|27|||
17106586|NCT00379769|38244787|FG001|Main Study|Moved to survival status follow-up only|25|||
17106587|NCT00379769|38244788|FG002|Main Study|Moved to survival status follow-up only|32|||
17106588|NCT00379769|38244789|FG003|Main Study|Moved to survival status follow-up only|36|||
17106589|NCT00379769|38244790|FG004|Main Study|Moved to survival status follow-up only|0|||
17106590|NCT00379769|38244791|FG005|Main Study|Moved to survival status follow-up only|0|||
17106591|NCT00379769|38244786|FG000|Main Study|Participant moved|3|||
17106592|NCT00379769|38244787|FG001|Main Study|Participant moved|2|||
17106593|NCT00379769|38244788|FG002|Main Study|Participant moved|3|||
17106594|NCT00379769|38244789|FG003|Main Study|Participant moved|3|||
17106595|NCT00379769|38244790|FG004|Main Study|Participant moved|0|||
17106596|NCT00379769|38244791|FG005|Main Study|Participant moved|0|||
17106597|NCT00379769|38244786|FG000|Main Study|Poor compliance|3|||
17106598|NCT00379769|38244787|FG001|Main Study|Poor compliance|2|||
17106599|NCT00379769|38244788|FG002|Main Study|Poor compliance|2|||
17106600|NCT00379769|38244789|FG003|Main Study|Poor compliance|1|||
17106601|NCT00379769|38244790|FG004|Main Study|Poor compliance|0|||
17106602|NCT00379769|38244791|FG005|Main Study|Poor compliance|0|||
17106603|NCT00379769|38244786|FG000|Main Study|Prohibited glucose lowering medication|0|||
17106604|NCT00379769|38244787|FG001|Main Study|Prohibited glucose lowering medication|3|||
17106605|NCT00379769|38244788|FG002|Main Study|Prohibited glucose lowering medication|0|||
17106606|NCT00379769|38244789|FG003|Main Study|Prohibited glucose lowering medication|1|||
17106607|NCT00379769|38244790|FG004|Main Study|Prohibited glucose lowering medication|0|||
17106608|NCT00379769|38244791|FG005|Main Study|Prohibited glucose lowering medication|0|||
17106609|NCT00379769|38244786|FG000|Main Study|Site closed|4|||
17106610|NCT00379769|38244787|FG001|Main Study|Site closed|4|||
17106611|NCT00379769|38244788|FG002|Main Study|Site closed|4|||
17106612|NCT00379769|38244789|FG003|Main Study|Site closed|8|||
17106613|NCT00379769|38244790|FG004|Main Study|Site closed|0|||
17106614|NCT00379769|38244791|FG005|Main Study|Site closed|0|||
17106615|NCT00379769|38244786|FG000|Main Study|Entry criteria violation|0|||
17106616|NCT00379769|38244787|FG001|Main Study|Entry criteria violation|0|||
17106617|NCT00379769|38244788|FG002|Main Study|Entry criteria violation|1|||
17106618|NCT00379769|38244789|FG003|Main Study|Entry criteria violation|1|||
17106619|NCT00379769|38244790|FG004|Main Study|Entry criteria violation|0|||
17106620|NCT00379769|38244791|FG005|Main Study|Entry criteria violation|0|||
17106621|NCT00379769|38244786|FG000|Main Study|Participant did not take study drug|0|||
17106622|NCT00379769|38244787|FG001|Main Study|Participant did not take study drug|0|||
17106623|NCT00379769|38244788|FG002|Main Study|Participant did not take study drug|1|||
17106624|NCT00379769|38244789|FG003|Main Study|Participant did not take study drug|0|||
17106625|NCT00379769|38244790|FG004|Main Study|Participant did not take study drug|0|||
17106626|NCT00379769|38244791|FG005|Main Study|Participant did not take study drug|0|||
17106627|NCT00379769|38244786|FG000|Main Study|Physician Decision|2|||
17106628|NCT00379769|38244787|FG001|Main Study|Physician Decision|2|||
17106629|NCT00379769|38244788|FG002|Main Study|Physician Decision|1|||
17106630|NCT00379769|38244789|FG003|Main Study|Physician Decision|1|||
17106631|NCT00379769|38244790|FG004|Main Study|Physician Decision|0|||
17106632|NCT00379769|38244791|FG005|Main Study|Physician Decision|0|||
17106633|NCT00379769|38244786|FG000|Main Study|Participant completed study at visit 27|1|||
17106634|NCT00379769|38244787|FG001|Main Study|Participant completed study at visit 27|0|||
17106635|NCT00379769|38244788|FG002|Main Study|Participant completed study at visit 27|0|||
17106636|NCT00379769|38244789|FG003|Main Study|Participant completed study at visit 27|0|||
17106637|NCT00379769|38244790|FG004|Main Study|Participant completed study at visit 27|0|||
17106638|NCT00379769|38244791|FG005|Main Study|Participant completed study at visit 27|0|||
17106639|NCT00379769|38244786|FG000|Main Study|Personal reasons|1|||
17106640|NCT00379769|38244787|FG001|Main Study|Personal reasons|0|||
17106641|NCT00379769|38244788|FG002|Main Study|Personal reasons|0|||
17106642|NCT00379769|38244789|FG003|Main Study|Personal reasons|0|||
17106643|NCT00379769|38244790|FG004|Main Study|Personal reasons|0|||
17106644|NCT00379769|38244791|FG005|Main Study|Personal reasons|0|||
17106645|NCT00379769|38244786|FG000|Main Study|Risk of heart failure|0|||
17106646|NCT00379769|38244787|FG001|Main Study|Risk of heart failure|1|||
17106647|NCT00379769|38244788|FG002|Main Study|Risk of heart failure|0|||
17106648|NCT00379769|38244789|FG003|Main Study|Risk of heart failure|0|||
17106649|NCT00379769|38244790|FG004|Main Study|Risk of heart failure|0|||
17106650|NCT00379769|38244791|FG005|Main Study|Risk of heart failure|0|||
17106651|NCT00379769|38244786|FG000|Main Study|Investigator refused to log temperature|0|||
17106652|NCT00379769|38244787|FG001|Main Study|Investigator refused to log temperature|0|||
17106653|NCT00379769|38244788|FG002|Main Study|Investigator refused to log temperature|1|||
17106654|NCT00379769|38244789|FG003|Main Study|Investigator refused to log temperature|0|||
17106655|NCT00379769|38244790|FG004|Main Study|Investigator refused to log temperature|0|||
17106656|NCT00379769|38244791|FG005|Main Study|Investigator refused to log temperature|0|||
17106657|NCT00379769|38244786|FG000|Main Study|Reason unspecified|0|||
17106658|NCT00379769|38244787|FG001|Main Study|Reason unspecified|0|||
17106659|NCT00379769|38244788|FG002|Main Study|Reason unspecified|1|||
17106660|NCT00379769|38244789|FG003|Main Study|Reason unspecified|0|||
17106661|NCT00379769|38244790|FG004|Main Study|Reason unspecified|0|||
17106662|NCT00379769|38244791|FG005|Main Study|Reason unspecified|0|||
17106663|NCT00379769|38244786|FG000|Observational Follow-up|Death|0|||
17106664|NCT00379769|38244787|FG001|Observational Follow-up|Death|0|||
17106665|NCT00379769|38244788|FG002|Observational Follow-up|Death|0|||
17106666|NCT00379769|38244789|FG003|Observational Follow-up|Death|0|||
17106667|NCT00379769|38244790|FG004|Observational Follow-up|Death|78|||
17106668|NCT00379769|38244791|FG005|Observational Follow-up|Death|70|||
17106669|NCT00379769|38244786|FG000|Observational Follow-up|Adverse Event|0|||
17106670|NCT00379769|38244787|FG001|Observational Follow-up|Adverse Event|0|||
17106671|NCT00379769|38244788|FG002|Observational Follow-up|Adverse Event|0|||
17106672|NCT00379769|38244789|FG003|Observational Follow-up|Adverse Event|0|||
17106673|NCT00379769|38244790|FG004|Observational Follow-up|Adverse Event|1|||
17106674|NCT00379769|38244791|FG005|Observational Follow-up|Adverse Event|0|||
17106675|NCT00379769|38244786|FG000|Observational Follow-up|Lost to Follow-up|0|||
17106676|NCT00379769|38244787|FG001|Observational Follow-up|Lost to Follow-up|0|||
17106677|NCT00379769|38244788|FG002|Observational Follow-up|Lost to Follow-up|0|||
17106678|NCT00379769|38244789|FG003|Observational Follow-up|Lost to Follow-up|0|||
17106679|NCT00379769|38244790|FG004|Observational Follow-up|Lost to Follow-up|25|||
17106680|NCT00379769|38244791|FG005|Observational Follow-up|Lost to Follow-up|27|||
17106681|NCT00379769|38244786|FG000|Observational Follow-up|Withdrawal by Subject|0|||
17106682|NCT00379769|38244787|FG001|Observational Follow-up|Withdrawal by Subject|0|||
17106683|NCT00379769|38244788|FG002|Observational Follow-up|Withdrawal by Subject|0|||
17106684|NCT00379769|38244789|FG003|Observational Follow-up|Withdrawal by Subject|0|||
17106685|NCT00379769|38244790|FG004|Observational Follow-up|Withdrawal by Subject|12|||
17106686|NCT00379769|38244791|FG005|Observational Follow-up|Withdrawal by Subject|12|||
17106687|NCT00379769|38244786|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
17106688|NCT00379769|38244787|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
17106689|NCT00379769|38244788|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
17106690|NCT00379769|38244789|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
17106691|NCT00379769|38244790|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
17106692|NCT00379769|38244791|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
17106693|NCT00379769|38244786|FG000|Observational Follow-up|Physician Decision|0|||
17106694|NCT00379769|38244787|FG001|Observational Follow-up|Physician Decision|0|||
17106695|NCT00379769|38244788|FG002|Observational Follow-up|Physician Decision|0|||
17106696|NCT00379769|38244789|FG003|Observational Follow-up|Physician Decision|0|||
17106697|NCT00379769|38244790|FG004|Observational Follow-up|Physician Decision|8|||
17106698|NCT00379769|38244791|FG005|Observational Follow-up|Physician Decision|8|||
17106699|NCT00379769|38244786|FG000|Observational Follow-up|Site Closed Early|0|||
17106700|NCT00379769|38244787|FG001|Observational Follow-up|Site Closed Early|0|||
17106701|NCT00379769|38244788|FG002|Observational Follow-up|Site Closed Early|0|||
17106702|NCT00379769|38244789|FG003|Observational Follow-up|Site Closed Early|0|||
17106703|NCT00379769|38244790|FG004|Observational Follow-up|Site Closed Early|6|||
17106704|NCT00379769|38244791|FG005|Observational Follow-up|Site Closed Early|7|||
17106705|NCT00379769|38244786|FG000|Observational Follow-up|Participant Moved|0|||
17106706|NCT00379769|38244787|FG001|Observational Follow-up|Participant Moved|0|||
17106707|NCT00379769|38244788|FG002|Observational Follow-up|Participant Moved|0|||
17106708|NCT00379769|38244789|FG003|Observational Follow-up|Participant Moved|0|||
17106709|NCT00379769|38244790|FG004|Observational Follow-up|Participant Moved|0|||
17106710|NCT00379769|38244791|FG005|Observational Follow-up|Participant Moved|1|||
17106711|NCT00379769|38244786|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
17106712|NCT00379769|38244787|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
17106713|NCT00379769|38244788|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
17106714|NCT00379769|38244789|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
17106715|NCT00379769|38244790|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
17106716|NCT00379769|38244791|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
17106717|NCT00006164|38244820|FG000|Overall Study|Withdrew or lost to follow-up|70|||
17106718|NCT00006164|38244821|FG001|Overall Study|Withdrew or lost to follow-up|81|||
17106719|NCT00378599|38244827|FG000|Overall Study|Adverse Event|38|||
17106720|NCT00378599|38244827|FG000|Overall Study|Protocol Violation|2|||
17106721|NCT00378599|38244827|FG000|Overall Study|Treatment failure|7|||
17106722|NCT00378599|38244827|FG000|Overall Study|Withdrawal by Subject|5|||
17106723|NCT00378209|38244831|FG000|Overall Study|Progressive disease|11|||
17106724|NCT00378209|38244831|FG000|Overall Study|Adverse Event|3|||
17106725|NCT00378209|38244831|FG000|Overall Study|Initiation of non-protocol therapy|3|||
17106726|NCT00378209|38244831|FG000|Overall Study|Physician Decision|3|||
17106727|NCT00378209|38244831|FG000|Overall Study|Death|1|||
17106728|NCT00378209|38244831|FG000|Overall Study|Treatment delay|1|||
17106729|NCT03410992|38244838|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106730|NCT03410992|38244839|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
17106731|NCT03410992|38244840|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106732|NCT03410992|38244841|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106733|NCT03410992|38244842|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106734|NCT03410992|38244843|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106735|NCT03410992|38244844|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106736|NCT03410992|38244845|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106737|NCT03410992|38244846|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106738|NCT03410992|38244847|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106739|NCT03410992|38244848|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
17106740|NCT03410992|38244838|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
17106741|NCT03410992|38244839|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
17106742|NCT03410992|38244840|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106743|NCT03410992|38244841|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106744|NCT03410992|38244842|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106745|NCT03410992|38244843|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106746|NCT03410992|38244844|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106747|NCT03410992|38244845|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106748|NCT03410992|38244846|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106749|NCT03410992|38244847|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106750|NCT03410992|38244848|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
17106751|NCT03410992|38244838|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
17106752|NCT03410992|38244839|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
17106753|NCT03410992|38244840|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106754|NCT03410992|38244841|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106755|NCT03410992|38244842|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106756|NCT03410992|38244843|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106757|NCT03410992|38244844|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106758|NCT03410992|38244845|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106759|NCT03410992|38244846|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106760|NCT03410992|38244847|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106761|NCT03410992|38244848|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
17106762|NCT03410992|38244838|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
17106763|NCT03410992|38244839|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106764|NCT03410992|38244840|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106765|NCT03410992|38244841|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106766|NCT03410992|38244842|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106767|NCT03410992|38244843|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106768|NCT03410992|38244844|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106769|NCT03410992|38244845|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106770|NCT03410992|38244846|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106771|NCT03410992|38244847|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106772|NCT03410992|38244848|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
17106773|NCT03410992|38244838|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
17106774|NCT03410992|38244839|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
17106775|NCT03410992|38244840|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106776|NCT03410992|38244841|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106777|NCT03410992|38244842|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106778|NCT03410992|38244843|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106779|NCT03410992|38244844|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106780|NCT03410992|38244845|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106781|NCT03410992|38244846|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106782|NCT03410992|38244847|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106783|NCT03410992|38244848|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
17106784|NCT03410992|38244838|FG000|Week 16 Assessment|Incorrect escapers|0|||
17106785|NCT03410992|38244839|FG001|Week 16 Assessment|Incorrect escapers|6|||
17106786|NCT03410992|38244840|FG002|Week 16 Assessment|Incorrect escapers|0|||
17106787|NCT03410992|38244841|FG003|Week 16 Assessment|Incorrect escapers|0|||
17106788|NCT03410992|38244842|FG004|Week 16 Assessment|Incorrect escapers|0|||
17106789|NCT03410992|38244843|FG005|Week 16 Assessment|Incorrect escapers|0|||
17106790|NCT03410992|38244844|FG006|Week 16 Assessment|Incorrect escapers|0|||
17106791|NCT03410992|38244845|FG007|Week 16 Assessment|Incorrect escapers|0|||
17106792|NCT03410992|38244846|FG008|Week 16 Assessment|Incorrect escapers|0|||
17106793|NCT03410992|38244847|FG009|Week 16 Assessment|Incorrect escapers|0|||
17106794|NCT03410992|38244848|FG010|Week 16 Assessment|Incorrect escapers|0|||
17106795|NCT03410992|38244838|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106796|NCT03410992|38244839|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106797|NCT03410992|38244840|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106798|NCT03410992|38244841|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
17106799|NCT03410992|38244842|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
17106800|NCT03410992|38244843|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106801|NCT03410992|38244844|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106802|NCT03410992|38244845|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106803|NCT03410992|38244846|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106804|NCT03410992|38244847|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106805|NCT03410992|38244848|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
17106806|NCT03410992|38244838|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
17106807|NCT03410992|38244839|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
17106808|NCT03410992|38244840|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
17106809|NCT03410992|38244841|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
17106810|NCT03410992|38244842|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
17106811|NCT03410992|38244843|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
17106812|NCT03410992|38244844|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
17106813|NCT03410992|38244845|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
17106814|NCT03410992|38244846|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
17106815|NCT03410992|38244847|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
17106816|NCT03410992|38244848|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
17106817|NCT03410992|38244838|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106818|NCT03410992|38244839|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106819|NCT03410992|38244840|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106820|NCT03410992|38244841|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106821|NCT03410992|38244842|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106822|NCT03410992|38244843|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
17106823|NCT03410992|38244844|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106824|NCT03410992|38244845|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106825|NCT03410992|38244846|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106826|NCT03410992|38244847|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106827|NCT03410992|38244848|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
17106828|NCT03410992|38244838|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
17106829|NCT03410992|38244839|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
17106830|NCT03410992|38244840|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
17106831|NCT03410992|38244841|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
17106832|NCT03410992|38244842|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
17106833|NCT03410992|38244843|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
17106834|NCT03410992|38244844|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
17106835|NCT03410992|38244845|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
17106836|NCT03410992|38244846|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
17106837|NCT03410992|38244847|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
17106838|NCT03410992|38244848|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
17106839|NCT03410992|38244838|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106840|NCT03410992|38244839|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106841|NCT03410992|38244840|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106842|NCT03410992|38244841|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106843|NCT03410992|38244842|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106844|NCT03410992|38244843|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106845|NCT03410992|38244844|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106846|NCT03410992|38244845|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
17106847|NCT03410992|38244846|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106848|NCT03410992|38244847|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106849|NCT03410992|38244848|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
17106850|NCT03410992|38244838|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106851|NCT03410992|38244839|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106852|NCT03410992|38244840|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106853|NCT03410992|38244841|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106854|NCT03410992|38244842|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106855|NCT03410992|38244843|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106856|NCT03410992|38244844|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106857|NCT03410992|38244845|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106858|NCT03410992|38244846|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
17106859|NCT03410992|38244847|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106860|NCT03410992|38244848|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
17106861|NCT00377819|38244880|FG000|Overall Study|Adverse Event|2|||
17106862|NCT00377819|38244881|FG001|Overall Study|Adverse Event|3|||
17106863|NCT00377819|38244880|FG000|Overall Study|Withdrawal by Subject|10|||
17106864|NCT00377819|38244881|FG001|Overall Study|Withdrawal by Subject|4|||
17106865|NCT00377819|38244880|FG000|Overall Study|Death|0|||
17106866|NCT00377819|38244881|FG001|Overall Study|Death|1|||
17106867|NCT00377819|38244880|FG000|Overall Study|Lost to Follow-up|0|||
17106868|NCT00377819|38244881|FG001|Overall Study|Lost to Follow-up|1|||
17106869|NCT00377819|38244880|FG000|Overall Study|Protocol Violation|1|||
17106870|NCT00377819|38244881|FG001|Overall Study|Protocol Violation|1|||
17106871|NCT03419962|38244887|FG000|Overall Study|Change to other medication|1|||
17106872|NCT03419962|38244887|FG000|Overall Study|Refusal of continuing with trial drug|1|||
17106873|NCT03419962|38244887|FG000|Overall Study|Lost to Follow-up|3|||
17106874|NCT03419962|38244887|FG000|Overall Study|Difficulty in inhaling the doses|1|||
17106875|NCT03419962|38244887|FG000|Overall Study|Missing completion data|31|||
17106876|NCT00377429|38244891|FG000|Overall Study|Withdrawal by Subject|5|||
17106877|NCT00377429|38244891|FG000|Overall Study|Adverse Event|8|||
17106878|NCT00377429|38244891|FG000|Overall Study|Physician Decision|1|||
17106879|NCT00377429|38244891|FG000|Overall Study|Patient non-compliance|1|||
17106880|NCT00376961|38244895|FG000|Initial Registration|Adverse Event|1|||
17106881|NCT00376961|38244896|FG001|Initial Registration|Adverse Event|0|||
17106882|NCT00376961|38244895|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
17106883|NCT00376961|38244896|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
17106884|NCT00376961|38244895|FG000|Initial Registration|Progression/relapse|1|||
17106885|NCT00376961|38244896|FG001|Initial Registration|Progression/relapse|0|||
17106886|NCT00376961|38244895|FG000|Initial Registration|Ineligible|3|||
17106887|NCT00376961|38244896|FG001|Initial Registration|Ineligible|0|||
17106888|NCT00376961|38244895|FG000|Maintenance|Adverse Event|0|||
17106889|NCT00376961|38244896|FG001|Maintenance|Adverse Event|1|||
17106890|NCT00376961|38244895|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
17106891|NCT00376961|38244896|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
17106892|NCT00376961|38244895|FG000|Maintenance|Progression/relapse|0|||
17106893|NCT00376961|38244896|FG001|Maintenance|Progression/relapse|18|||
17106894|NCT00376961|38244895|FG000|Maintenance|Ineligible|0|||
17106895|NCT00376961|38244896|FG001|Maintenance|Ineligible|3|||
17106896|NCT03418324|38244906|FG000|Overall Study|Death|0|||
17106897|NCT03418324|38244907|FG001|Overall Study|Death|1|||
17106898|NCT03418324|38244906|FG000|Overall Study|Physician Decision|1|||
17106899|NCT03418324|38244907|FG001|Overall Study|Physician Decision|1|||
17106900|NCT00376259|38244915|FG000|Overall Study|Sponsor request - study termination|21|||
17106901|NCT00376259|38244916|FG001|Overall Study|Sponsor request - study termination|21|||
17106902|NCT00376259|38244915|FG000|Overall Study|Patient request|1|||
17106903|NCT00376259|38244916|FG001|Overall Study|Patient request|0|||
17106904|NCT03410056|38244926|FG000|Overall Study|Decision by Sponsor|0|||
17106905|NCT03410056|38244927|FG001|Overall Study|Decision by Sponsor|0|||
17106906|NCT03410056|38244928|FG002|Overall Study|Decision by Sponsor|3|||
17106907|NCT03410056|38244929|FG003|Overall Study|Decision by Sponsor|0|||
17106908|NCT03410056|38244930|FG004|Overall Study|Decision by Sponsor|0|||
17106909|NCT03410056|38244931|FG005|Overall Study|Decision by Sponsor|0|||
17106910|NCT03410056|38244932|FG006|Overall Study|Decision by Sponsor|0|||
17106911|NCT03410056|38244926|FG000|Overall Study|Withdrawal by Subject|0|||
17106912|NCT03410056|38244927|FG001|Overall Study|Withdrawal by Subject|2|||
17106913|NCT03410056|38244928|FG002|Overall Study|Withdrawal by Subject|5|||
17106914|NCT03410056|38244929|FG003|Overall Study|Withdrawal by Subject|5|||
17106915|NCT03410056|38244930|FG004|Overall Study|Withdrawal by Subject|0|||
17106916|NCT03410056|38244931|FG005|Overall Study|Withdrawal by Subject|0|||
17106917|NCT03410056|38244932|FG006|Overall Study|Withdrawal by Subject|0|||
17106918|NCT03409666|38244950|FG000|Overall Study|Physician Decision|0|||
17106919|NCT03409666|38244951|FG001|Overall Study|Physician Decision|1|||
17106920|NCT03409666|38244950|FG000|Overall Study|Protocol Violation|0|||
17106921|NCT03409666|38244951|FG001|Overall Study|Protocol Violation|3|||
17106922|NCT03440944|38244959|FG000|Overall Study|Physician Decision|1|||
17106923|NCT03440944|38244960|FG001|Overall Study|Physician Decision|0|||
17106924|NCT03440944|38244959|FG000|Overall Study|No Acceptable Vasculature|0|||
17106925|NCT03440944|38244960|FG001|Overall Study|No Acceptable Vasculature|1|||
17106926|NCT00365105|38244969|FG000|Overall Study|Protocol Violation|5|||
17106927|NCT00365105|38244970|FG001|Overall Study|Protocol Violation|8|||
17106928|NCT00399893|38244978|FG000|Overall Study|Withdrawal by Subject|1|||
17106929|NCT00399893|38244979|FG001|Overall Study|Withdrawal by Subject|0|||
17106930|NCT00048542|38244989|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
17106931|NCT00048542|38244990|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
17106932|NCT00048542|38244991|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
17106933|NCT00048542|38244992|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
17106934|NCT00048542|38244993|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
17106935|NCT00048542|38244994|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
17106936|NCT00048542|38244995|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
17106937|NCT00048542|38244996|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
17106938|NCT00048542|38244989|FG000|Double-Blind Phase|Protocol Violation|0|||
17106939|NCT00048542|38244990|FG001|Double-Blind Phase|Protocol Violation|0|||
17106940|NCT00048542|38244991|FG002|Double-Blind Phase|Protocol Violation|1|||
17106941|NCT00048542|38244992|FG003|Double-Blind Phase|Protocol Violation|0|||
17106942|NCT00048542|38244993|FG004|Double-Blind Phase|Protocol Violation|0|||
17106943|NCT00048542|38244994|FG005|Double-Blind Phase|Protocol Violation|0|||
17106944|NCT00048542|38244995|FG006|Double-Blind Phase|Protocol Violation|0|||
17106945|NCT00048542|38244996|FG007|Double-Blind Phase|Protocol Violation|0|||
17106946|NCT00048542|38244989|FG000|Double-Blind Phase|Sponsor request or decision|2|||
17106947|NCT00048542|38244990|FG001|Double-Blind Phase|Sponsor request or decision|0|||
17106948|NCT00048542|38244991|FG002|Double-Blind Phase|Sponsor request or decision|0|||
17106949|NCT00048542|38244992|FG003|Double-Blind Phase|Sponsor request or decision|0|||
17106950|NCT00048542|38244993|FG004|Double-Blind Phase|Sponsor request or decision|0|||
17106951|NCT00048542|38244994|FG005|Double-Blind Phase|Sponsor request or decision|0|||
17106952|NCT00048542|38244995|FG006|Double-Blind Phase|Sponsor request or decision|0|||
17106953|NCT00048542|38244996|FG007|Double-Blind Phase|Sponsor request or decision|0|||
17106954|NCT00048542|38244989|FG000|Double-Blind Phase|Randomized in error|1|||
17106955|NCT00048542|38244990|FG001|Double-Blind Phase|Randomized in error|0|||
17106956|NCT00048542|38244991|FG002|Double-Blind Phase|Randomized in error|0|||
17106957|NCT00048542|38244992|FG003|Double-Blind Phase|Randomized in error|0|||
17106958|NCT00048542|38244993|FG004|Double-Blind Phase|Randomized in error|0|||
17106959|NCT00048542|38244994|FG005|Double-Blind Phase|Randomized in error|0|||
17106960|NCT00048542|38244995|FG006|Double-Blind Phase|Randomized in error|0|||
17106961|NCT00048542|38244996|FG007|Double-Blind Phase|Randomized in error|0|||
17106962|NCT00048542|38244989|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
17106963|NCT00048542|38244990|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
17106964|NCT00048542|38244991|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
17106965|NCT00048542|38244992|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
17106966|NCT00048542|38244993|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
17106967|NCT00048542|38244994|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
17106968|NCT00048542|38244995|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
17106969|NCT00048542|38244996|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
17106970|NCT00048542|38244989|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
17106971|NCT00048542|38244990|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
17106972|NCT00048542|38244991|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
17106973|NCT00048542|38244992|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
17106974|NCT00048542|38244993|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
17106975|NCT00048542|38244994|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
17106976|NCT00048542|38244995|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
17106977|NCT00048542|38244996|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
17106978|NCT00048542|38244989|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
17106979|NCT00048542|38244990|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
17106980|NCT00048542|38244991|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
17106981|NCT00048542|38244992|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
17106982|NCT00048542|38244993|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
17106983|NCT00048542|38244994|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
17106984|NCT00048542|38244995|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
17106985|NCT00048542|38244996|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
17106986|NCT00048542|38244989|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
17106987|NCT00048542|38244990|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
17106988|NCT00048542|38244991|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
17106989|NCT00048542|38244992|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
17106990|NCT00048542|38244993|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
17106991|NCT00048542|38244994|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
17106992|NCT00048542|38244995|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
17106993|NCT00048542|38244996|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
17106994|NCT00048542|38244989|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
17106995|NCT00048542|38244990|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
17106996|NCT00048542|38244991|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
17106997|NCT00048542|38244992|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
17106998|NCT00048542|38244993|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
17106999|NCT00048542|38244994|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
17107000|NCT00048542|38244995|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
17107001|NCT00048542|38244996|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
17107002|NCT00048542|38244989|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
17107003|NCT00048542|38244990|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
17107004|NCT00048542|38244991|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
17107005|NCT00048542|38244992|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
17107006|NCT00048542|38244993|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
17107007|NCT00048542|38244994|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
17107008|NCT00048542|38244995|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
17107009|NCT00048542|38244996|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
17107010|NCT00048542|38244989|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
17107011|NCT00048542|38244990|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
17107012|NCT00048542|38244991|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
17107013|NCT00048542|38244992|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
17107014|NCT00048542|38244993|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
17107015|NCT00048542|38244994|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
17107016|NCT00048542|38244995|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
17107017|NCT00048542|38244996|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
17107018|NCT00048542|38244989|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
17107019|NCT00048542|38244990|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
17107020|NCT00048542|38244991|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
17107021|NCT00048542|38244992|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
17107022|NCT00048542|38244993|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
17107023|NCT00048542|38244994|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
17107024|NCT00048542|38244995|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
17107025|NCT00048542|38244996|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
17107026|NCT00048542|38244989|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
17107027|NCT00048542|38244990|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
17107028|NCT00048542|38244991|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
17107029|NCT00048542|38244992|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
17107030|NCT00048542|38244993|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
17107031|NCT00048542|38244994|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
17107032|NCT00048542|38244995|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
17107033|NCT00048542|38244996|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
17107034|NCT00048542|38244989|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
17107035|NCT00048542|38244990|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
17107036|NCT00048542|38244991|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
17107037|NCT00048542|38244992|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
17107038|NCT00048542|38244993|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
17107039|NCT00048542|38244994|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
17107040|NCT00048542|38244995|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
17107041|NCT00048542|38244996|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
17107042|NCT00048542|38244989|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
17107043|NCT00048542|38244990|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
17107044|NCT00048542|38244991|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
17107045|NCT00048542|38244992|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
17107046|NCT00048542|38244993|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
17107047|NCT00048542|38244994|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
17107048|NCT00048542|38244995|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
17107049|NCT00048542|38244996|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
17107050|NCT03814590|38245039|FG000|Overall Study|Adverse Event|0|||
17107051|NCT03814590|38245040|FG001|Overall Study|Adverse Event|0|||
17107052|NCT03814590|38245041|FG002|Overall Study|Adverse Event|0|||
17107053|NCT03814590|38245042|FG003|Overall Study|Adverse Event|0|||
17107054|NCT03814590|38245043|FG004|Overall Study|Adverse Event|0|||
17107055|NCT03814590|38245044|FG005|Overall Study|Adverse Event|1|||
17107056|NCT03814590|38245045|FG006|Overall Study|Adverse Event|1|||
17107057|NCT03814590|38245046|FG007|Overall Study|Adverse Event|1|||
17107058|NCT03814590|38245047|FG008|Overall Study|Adverse Event|0|||
17107059|NCT03814590|38245048|FG009|Overall Study|Adverse Event|0|||
17107060|NCT03814590|38245049|FG010|Overall Study|Adverse Event|1|||
17107061|NCT03814590|38245050|FG011|Overall Study|Adverse Event|0|||
17107062|NCT03814590|38245051|FG012|Overall Study|Adverse Event|3|||
17107063|NCT03814590|38245052|FG013|Overall Study|Adverse Event|0|||
17107064|NCT03814590|38245039|FG000|Overall Study|Lost to Follow-up|0|||
17107065|NCT03814590|38245040|FG001|Overall Study|Lost to Follow-up|2|||
17107066|NCT03814590|38245041|FG002|Overall Study|Lost to Follow-up|1|||
17107067|NCT03814590|38245042|FG003|Overall Study|Lost to Follow-up|0|||
17107068|NCT03814590|38245043|FG004|Overall Study|Lost to Follow-up|1|||
17107069|NCT03814590|38245044|FG005|Overall Study|Lost to Follow-up|1|||
17107070|NCT03814590|38245045|FG006|Overall Study|Lost to Follow-up|1|||
17107071|NCT03814590|38245046|FG007|Overall Study|Lost to Follow-up|1|||
17107072|NCT03814590|38245047|FG008|Overall Study|Lost to Follow-up|0|||
17107073|NCT03814590|38245048|FG009|Overall Study|Lost to Follow-up|0|||
17107074|NCT03814590|38245049|FG010|Overall Study|Lost to Follow-up|1|||
17107075|NCT03814590|38245050|FG011|Overall Study|Lost to Follow-up|0|||
17107076|NCT03814590|38245051|FG012|Overall Study|Lost to Follow-up|0|||
17107077|NCT03814590|38245052|FG013|Overall Study|Lost to Follow-up|1|||
17107078|NCT03814590|38245039|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107079|NCT03814590|38245040|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107080|NCT03814590|38245041|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107081|NCT03814590|38245042|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107082|NCT03814590|38245043|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107083|NCT03814590|38245044|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107084|NCT03814590|38245045|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107085|NCT03814590|38245046|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107086|NCT03814590|38245047|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107087|NCT03814590|38245048|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
17107088|NCT03814590|38245049|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107089|NCT03814590|38245050|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107090|NCT03814590|38245051|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107091|NCT03814590|38245052|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
17107092|NCT03814590|38245039|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
17107093|NCT03814590|38245040|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
17199785|NCT02777333|38353758|FG000|Overall Study|Withdrawal by Subject|0|||
17107094|NCT03814590|38245041|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
17107095|NCT03814590|38245042|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
17107096|NCT03814590|38245043|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
17107097|NCT03814590|38245044|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
17107098|NCT03814590|38245045|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
17107099|NCT03814590|38245046|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
17107100|NCT03814590|38245047|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
17107101|NCT03814590|38245048|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
17107102|NCT03814590|38245049|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
17107103|NCT03814590|38245050|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
17107104|NCT03814590|38245051|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
17107105|NCT03814590|38245052|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
17107106|NCT03814590|38245039|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107107|NCT03814590|38245040|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107108|NCT03814590|38245041|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107109|NCT03814590|38245042|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107110|NCT03814590|38245043|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107111|NCT03814590|38245044|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107112|NCT03814590|38245045|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107113|NCT03814590|38245046|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
17107114|NCT03814590|38245047|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107115|NCT03814590|38245048|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
17107116|NCT03814590|38245049|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107117|NCT03814590|38245050|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107118|NCT03814590|38245051|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107119|NCT03814590|38245052|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
17107120|NCT03814590|38245039|FG000|Overall Study|UNKNOWN REASON|0|||
17107121|NCT03814590|38245040|FG001|Overall Study|UNKNOWN REASON|0|||
17107122|NCT03814590|38245041|FG002|Overall Study|UNKNOWN REASON|0|||
17107123|NCT03814590|38245042|FG003|Overall Study|UNKNOWN REASON|0|||
17107124|NCT03814590|38245043|FG004|Overall Study|UNKNOWN REASON|0|||
17107125|NCT03814590|38245044|FG005|Overall Study|UNKNOWN REASON|0|||
17107126|NCT03814590|38245045|FG006|Overall Study|UNKNOWN REASON|0|||
17107127|NCT03814590|38245046|FG007|Overall Study|UNKNOWN REASON|1|||
17107128|NCT03814590|38245047|FG008|Overall Study|UNKNOWN REASON|0|||
17107129|NCT03814590|38245048|FG009|Overall Study|UNKNOWN REASON|0|||
17107130|NCT03814590|38245049|FG010|Overall Study|UNKNOWN REASON|0|||
17107131|NCT03814590|38245050|FG011|Overall Study|UNKNOWN REASON|0|||
17107132|NCT03814590|38245051|FG012|Overall Study|UNKNOWN REASON|0|||
17107133|NCT03814590|38245052|FG013|Overall Study|UNKNOWN REASON|0|||
17107134|NCT00048074|38245095|FG000|Overall Study|Adverse Event|46|||
17107135|NCT00048074|38245096|FG001|Overall Study|Adverse Event|41|||
17107136|NCT00048074|38245097|FG002|Overall Study|Adverse Event|53|||
17107137|NCT00048074|38245095|FG000|Overall Study|Death|3|||
17107138|NCT00048074|38245096|FG001|Overall Study|Death|3|||
17107139|NCT00048074|38245097|FG002|Overall Study|Death|2|||
17107140|NCT00048074|38245095|FG000|Overall Study|Lost to Follow-up|2|||
17107141|NCT00048074|38245096|FG001|Overall Study|Lost to Follow-up|6|||
17107142|NCT00048074|38245097|FG002|Overall Study|Lost to Follow-up|6|||
17107143|NCT00048074|38245095|FG000|Overall Study|Withdrawal by Subject|28|||
17107144|NCT00048074|38245096|FG001|Overall Study|Withdrawal by Subject|30|||
17107145|NCT00048074|38245097|FG002|Overall Study|Withdrawal by Subject|35|||
17107146|NCT00048074|38245095|FG000|Overall Study|Protocol Violation|1|||
17107147|NCT00048074|38245096|FG001|Overall Study|Protocol Violation|3|||
17107148|NCT00048074|38245097|FG002|Overall Study|Protocol Violation|0|||
17107149|NCT00048074|38245095|FG000|Overall Study|Study participation was terminated|0|||
17107150|NCT00048074|38245096|FG001|Overall Study|Study participation was terminated|1|||
17107151|NCT00048074|38245097|FG002|Overall Study|Study participation was terminated|0|||
17107152|NCT00048074|38245095|FG000|Overall Study|Husband ill|0|||
17107153|NCT00048074|38245096|FG001|Overall Study|Husband ill|1|||
17107154|NCT00048074|38245097|FG002|Overall Study|Husband ill|0|||
17107155|NCT00048074|38245095|FG000|Overall Study|Poor compliance|0|||
17107156|NCT00048074|38245096|FG001|Overall Study|Poor compliance|1|||
17107157|NCT00048074|38245097|FG002|Overall Study|Poor compliance|0|||
17107158|NCT00048074|38245095|FG000|Overall Study|Out of station|0|||
17107159|NCT00048074|38245096|FG001|Overall Study|Out of station|1|||
17107160|NCT00048074|38245097|FG002|Overall Study|Out of station|1|||
17107161|NCT00048074|38245095|FG000|Overall Study|Social reasons|1|||
17107162|NCT00048074|38245096|FG001|Overall Study|Social reasons|0|||
17107163|NCT00048074|38245097|FG002|Overall Study|Social reasons|0|||
17107164|NCT03831191|38245109|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
17107165|NCT03831191|38245110|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
17107166|NCT03831191|38245111|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
17107167|NCT03831191|38245112|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
17107168|NCT03831191|38245113|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
17107169|NCT03831191|38245114|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
17107170|NCT03831191|38245115|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
17107171|NCT03831191|38245116|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
17107172|NCT03831191|38245117|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
17107173|NCT03831191|38245118|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
17107174|NCT03831191|38245119|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
17107175|NCT03831191|38245120|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
17107176|NCT03831191|38245121|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
17107177|NCT03831191|38245122|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
17107178|NCT03831191|38245123|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
17107179|NCT03831191|38245109|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
17107180|NCT03831191|38245110|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
17107181|NCT03831191|38245111|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107182|NCT03831191|38245112|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107183|NCT03831191|38245113|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107184|NCT03831191|38245114|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107185|NCT03831191|38245115|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107186|NCT03831191|38245116|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107187|NCT03831191|38245117|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107188|NCT03831191|38245118|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107189|NCT03831191|38245119|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107190|NCT03831191|38245120|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107191|NCT03831191|38245121|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107192|NCT03831191|38245122|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107193|NCT03831191|38245123|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
17107194|NCT03831191|38245109|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
17107195|NCT03831191|38245110|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
17107196|NCT03831191|38245111|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
17107197|NCT03831191|38245112|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
17107198|NCT03831191|38245113|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
17107199|NCT03831191|38245114|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
17107200|NCT03831191|38245115|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
17107201|NCT03831191|38245116|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
17107202|NCT03831191|38245117|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
17107203|NCT03831191|38245118|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
17107204|NCT03831191|38245119|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
17107205|NCT03831191|38245120|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
17107206|NCT03831191|38245121|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
17107207|NCT03831191|38245122|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
17107208|NCT03831191|38245123|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
17107209|NCT03831191|38245109|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
17107210|NCT03831191|38245110|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
17107211|NCT03831191|38245111|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
17107212|NCT03831191|38245112|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
17107213|NCT03831191|38245113|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
17107214|NCT03831191|38245114|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
17107215|NCT03831191|38245115|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
17107216|NCT03831191|38245116|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
17107217|NCT03831191|38245117|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
17107218|NCT03831191|38245118|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
17107219|NCT03831191|38245119|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
17107220|NCT03831191|38245120|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
17107221|NCT03831191|38245121|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
17107222|NCT03831191|38245122|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
17107223|NCT03831191|38245123|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
17107224|NCT03831191|38245109|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
17107225|NCT03831191|38245110|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
17107226|NCT03831191|38245111|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
17107227|NCT03831191|38245112|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
17107228|NCT03831191|38245113|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107229|NCT03831191|38245114|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107230|NCT03831191|38245115|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107231|NCT03831191|38245116|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107232|NCT03831191|38245117|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107233|NCT03831191|38245118|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107234|NCT03831191|38245119|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107235|NCT03831191|38245120|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107236|NCT03831191|38245121|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107237|NCT03831191|38245122|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107238|NCT03831191|38245123|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
17107239|NCT03831191|38245109|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
17107240|NCT03831191|38245110|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
17107241|NCT03831191|38245111|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
17107242|NCT03831191|38245112|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
17107243|NCT03831191|38245113|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107244|NCT03831191|38245114|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107245|NCT03831191|38245115|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107246|NCT03831191|38245116|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107247|NCT03831191|38245117|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107248|NCT03831191|38245118|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107249|NCT03831191|38245119|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107250|NCT03831191|38245120|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107251|NCT03831191|38245121|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107252|NCT03831191|38245122|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107253|NCT03831191|38245123|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
17107254|NCT03831191|38245109|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107255|NCT03831191|38245110|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107256|NCT03831191|38245111|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107257|NCT03831191|38245112|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
17107258|NCT03831191|38245113|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107259|NCT03831191|38245114|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107260|NCT03831191|38245115|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107261|NCT03831191|38245116|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107262|NCT03831191|38245117|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107263|NCT03831191|38245118|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107264|NCT03831191|38245119|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107265|NCT03831191|38245120|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107266|NCT03831191|38245121|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107267|NCT03831191|38245122|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107268|NCT03831191|38245123|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
17107269|NCT03831191|38245109|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
17107270|NCT03831191|38245110|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
17107271|NCT03831191|38245111|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
17107272|NCT03831191|38245112|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
17107273|NCT03831191|38245113|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
17107274|NCT03831191|38245114|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
17107275|NCT03831191|38245115|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
17107276|NCT03831191|38245116|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
17107277|NCT03831191|38245117|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
17107278|NCT03831191|38245118|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
17107279|NCT03831191|38245119|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
17107280|NCT03831191|38245120|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
17107281|NCT03831191|38245121|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
17107282|NCT03831191|38245122|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
17107283|NCT03831191|38245123|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
17107284|NCT03831191|38245109|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107285|NCT03831191|38245110|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107286|NCT03831191|38245111|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107287|NCT03831191|38245112|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107288|NCT03831191|38245113|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107289|NCT03831191|38245114|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107290|NCT03831191|38245115|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107291|NCT03831191|38245116|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107292|NCT03831191|38245117|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107293|NCT03831191|38245118|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107294|NCT03831191|38245119|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107295|NCT03831191|38245120|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107296|NCT03831191|38245121|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107297|NCT03831191|38245122|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
17107298|NCT03831191|38245123|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
17107299|NCT03831191|38245109|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107300|NCT03831191|38245110|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107301|NCT03831191|38245111|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107302|NCT03831191|38245112|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107303|NCT03831191|38245113|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107304|NCT03831191|38245114|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107305|NCT03831191|38245115|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107306|NCT03831191|38245116|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107307|NCT03831191|38245117|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107308|NCT03831191|38245118|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107309|NCT03831191|38245119|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107310|NCT03831191|38245120|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107311|NCT03831191|38245121|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107312|NCT03831191|38245122|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
17107313|NCT03831191|38245123|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
17107314|NCT00005906|38245156|FG000|Overall Study|Lack of Efficacy|3|||
17107315|NCT00066690|38245163|FG000|Overall Study|Adverse Event|145|||
17107316|NCT00066690|38245164|FG001|Overall Study|Adverse Event|58|||
17107317|NCT00066690|38245165|FG002|Overall Study|Adverse Event|126|||
17107318|NCT00066690|38245163|FG000|Overall Study|Death|3|||
17107319|NCT00066690|38245164|FG001|Overall Study|Death|0|||
17107320|NCT00066690|38245165|FG002|Overall Study|Death|2|||
17107321|NCT00066690|38245163|FG000|Overall Study|Lack of Efficacy|114|||
17107322|NCT00066690|38245164|FG001|Overall Study|Lack of Efficacy|110|||
17107323|NCT00066690|38245165|FG002|Overall Study|Lack of Efficacy|76|||
17107324|NCT00066690|38245163|FG000|Overall Study|Lost to Follow-up|40|||
17107325|NCT00066690|38245164|FG001|Overall Study|Lost to Follow-up|21|||
17107326|NCT00066690|38245165|FG002|Overall Study|Lost to Follow-up|29|||
17107327|NCT00066690|38245163|FG000|Overall Study|Withdrawal by Subject|50|||
17107328|NCT00066690|38245164|FG001|Overall Study|Withdrawal by Subject|55|||
17107329|NCT00066690|38245165|FG002|Overall Study|Withdrawal by Subject|49|||
17107330|NCT00066690|38245163|FG000|Overall Study|Treatment Ongoing|246|||
17107331|NCT00066690|38245164|FG001|Overall Study|Treatment Ongoing|278|||
17107332|NCT00066690|38245165|FG002|Overall Study|Treatment Ongoing|282|||
17107333|NCT03409276|38245181|FG000|Overall Study|Withdrawal by Subject|0|||
17107334|NCT03409276|38245182|FG001|Overall Study|Withdrawal by Subject|0|||
17107335|NCT03409276|38245183|FG002|Overall Study|Withdrawal by Subject|0|||
17107336|NCT03409276|38245184|FG003|Overall Study|Withdrawal by Subject|0|||
17107337|NCT03409276|38245185|FG004|Overall Study|Withdrawal by Subject|1|||
17107338|NCT03409276|38245181|FG000|Overall Study|Lost to Follow-up|0|||
17107339|NCT03409276|38245182|FG001|Overall Study|Lost to Follow-up|0|||
17107340|NCT03409276|38245183|FG002|Overall Study|Lost to Follow-up|0|||
17107341|NCT03409276|38245184|FG003|Overall Study|Lost to Follow-up|2|||
17107342|NCT03409276|38245185|FG004|Overall Study|Lost to Follow-up|2|||
17107343|NCT00004562|38245203|FG000|Overall Study|Lost to Follow-up|102|||
17107344|NCT00004562|38245204|FG001|Overall Study|Lost to Follow-up|91|||
17107345|NCT00004412|38245213|FG000|Randomized Period|Moved to Crossover Period|3|||
17107346|NCT00004412|38245214|FG001|Randomized Period|Moved to Crossover Period|0|||
17107347|NCT00004412|38245215|FG002|Randomized Period|Moved to Crossover Period|0|||
17107348|NCT03440320|38245225|FG000|Overall Study|Withdrawal by Subject|0|||
17107349|NCT03440320|38245226|FG001|Overall Study|Withdrawal by Subject|1|||
17107350|NCT00004088|38245234|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
17107351|NCT00004088|38245234|FG000|Overall Study|Withdrawal by Subject|1|||
17107352|NCT00004088|38245234|FG000|Overall Study|Protocol Violation|3|||
17107353|NCT00004088|38245234|FG000|Overall Study|Physician Decision|1|||
17107354|NCT03439072|38245238|FG000|Overall Study|Withdrawal by Subject|2|||
17107355|NCT03439072|38245239|FG001|Overall Study|Withdrawal by Subject|3|||
17107356|NCT03439072|38245238|FG000|Overall Study|Physician Decision|0|||
17107357|NCT03439072|38245239|FG001|Overall Study|Physician Decision|1|||
17107358|NCT00078312|38245245|FG000|Overall Study|Adverse Event|43|||
17107359|NCT00078312|38245245|FG000|Overall Study|Lack of Efficacy|15|||
17107360|NCT00078312|38245245|FG000|Overall Study|Lost to Follow-up|41|||
17107361|NCT00078312|38245245|FG000|Overall Study|Physician Decision|9|||
17107362|NCT00078312|38245245|FG000|Overall Study|Protocol Violation|3|||
17107363|NCT00078312|38245245|FG000|Overall Study|Withdrawal by Subject|33|||
17107364|NCT00078312|38245245|FG000|Overall Study|Miscellaneous|33|||
17107365|NCT00003896|38245249|FG000|Overall Study|Adverse Event|16|||
17107366|NCT00003896|38245249|FG000|Overall Study|Withdrawal by Subject|1|||
17107367|NCT00003896|38245249|FG000|Overall Study|Lack of Efficacy|1|||
17107368|NCT00003896|38245249|FG000|Overall Study|Death|3|||
17107369|NCT00003896|38245249|FG000|Overall Study|not protocol specified|3|||
17107370|NCT00003896|38245249|FG000|Overall Study|ineligible|5|||
17107371|NCT00003830|38245256|FG000|Overall Study|No follow up data|3|||
17107372|NCT00003830|38245257|FG001|Overall Study|No follow up data|0|||
17107373|NCT00003830|38245256|FG000|Overall Study|Sentinel node positive patients|829|||
17107374|NCT00003830|38245257|FG001|Overall Study|Sentinel node positive patients|793|||
17107375|NCT03407482|38245265|FG000|Overall Study|Adverse Event|12|||
17107376|NCT03407482|38245265|FG000|Overall Study|Disease Relapse|1|||
17107377|NCT03407482|38245265|FG000|Overall Study|Lost to Follow-up|1|||
17107378|NCT03407482|38245265|FG000|Overall Study|Non-Compliance With Study Drug|1|||
17107379|NCT03407482|38245265|FG000|Overall Study|Pregnancy|2|||
17107380|NCT03407482|38245265|FG000|Overall Study|Protocol Violation|1|||
17107381|NCT03407482|38245265|FG000|Overall Study|Study Terminated By Sponsor|106|||
17107382|NCT03407482|38245265|FG000|Overall Study|Withdrawal by Subject|6|||
17107383|NCT03407482|38245265|FG000|Overall Study|Data Entry Error|1|||
17107384|NCT00003782|38245272|FG000|Overall Study|No follow up data|30|||
17107385|NCT00003782|38245273|FG001|Overall Study|No follow up data|31|||
17107386|NCT00003782|38245274|FG002|Overall Study|No follow up data|26|||
17107387|NCT03389308|38245282|FG000|Overall Study|Withdrawal by Subject|5|||
17107388|NCT03389308|38245282|FG000|Overall Study|Lost to Follow-up|3|||
17107389|NCT03389308|38245282|FG000|Overall Study|Adverse Event|2|||
17107390|NCT03389308|38245282|FG000|Overall Study|Sponsor Request|2|||
17107391|NCT03407170|38245286|FG000|Overall Study|Adverse Event|1|||
17107392|NCT03406858|38245290|FG000|Overall Study|Failure to receive treatment drug.|1|||
17107393|NCT03406858|38245290|FG000|Overall Study|ineligible|1|||
17107394|NCT03406702|38245294|FG000|Overall Study|Missed Day 27 Dosing|1|||
17107395|NCT00003656|38245312|FG000|Overall Study|Adverse Event|0|||
17107396|NCT00003656|38245313|FG001|Overall Study|Adverse Event|1|||
17107397|NCT00003590|38245320|FG000|Overall Study|Ineligible Patient|1|||
17107398|NCT00003590|38245320|FG000|Overall Study|Adverse Event|7|||
17107399|NCT00003590|38245320|FG000|Overall Study|Withdrawal by Subject|1|||
17107400|NCT00003590|38245320|FG000|Overall Study|Lack of Efficacy|11|||
17107401|NCT00003590|38245320|FG000|Overall Study|Death|1|||
17107402|NCT00003590|38245320|FG000|Overall Study|Physician Decision|1|||
17107403|NCT03416374|38245326|FG000|Between Treatment Period I and II|Other|0|||
17107404|NCT03416374|38245327|FG001|Between Treatment Period I and II|Other|9|||
17107405|NCT03416374|38245326|FG000|Treatment Period II|Lack of Efficacy|3|||
17107406|NCT03416374|38245327|FG001|Treatment Period II|Lack of Efficacy|11|||
17107407|NCT03416374|38245326|FG000|Treatment Period II|Adverse Event|1|||
17107408|NCT03416374|38245327|FG001|Treatment Period II|Adverse Event|4|||
17107409|NCT03416374|38245326|FG000|Treatment Period II|Death|0|||
17107410|NCT03416374|38245327|FG001|Treatment Period II|Death|1|||
17107411|NCT03416374|38245326|FG000|Treatment Period II|Other|0|||
17107412|NCT03416374|38245327|FG001|Treatment Period II|Other|2|||
17107413|NCT03799952|38245338|FG000|Overall Study|Program was too easy, discontinued|1|||
17107414|NCT03799952|38245339|FG001|Overall Study|Program was too easy, discontinued|0|||
17107415|NCT03799952|38245338|FG000|Overall Study|Lost to Follow-up|0|||
17107416|NCT03799952|38245339|FG001|Overall Study|Lost to Follow-up|2|||
17107417|NCT00077766|38245347|FG000|Overall Study|Adverse Event|1|||
17107418|NCT00077766|38245348|FG001|Overall Study|Adverse Event|1|||
17107419|NCT00077766|38245347|FG000|Overall Study|Withdrawal by Subject|4|||
17107420|NCT00077766|38245348|FG001|Overall Study|Withdrawal by Subject|3|||
17107421|NCT00077766|38245347|FG000|Overall Study|Death|12|||
17107422|NCT00077766|38245348|FG001|Overall Study|Death|10|||
17107423|NCT00077766|38245347|FG000|Overall Study|Lost to Follow-up|2|||
17107424|NCT00077766|38245348|FG001|Overall Study|Lost to Follow-up|0|||
17107425|NCT00077766|38245347|FG000|Overall Study|Protocol Violation|1|||
17107426|NCT00077766|38245348|FG001|Overall Study|Protocol Violation|0|||
17107427|NCT00077766|38245347|FG000|Overall Study|Kidney Transplantation|9|||
17107428|NCT00077766|38245348|FG001|Overall Study|Kidney Transplantation|5|||
17107429|NCT00077766|38245347|FG000|Overall Study|Transplantation|5|||
17107430|NCT00077766|38245348|FG001|Overall Study|Transplantation|1|||
17107431|NCT00077766|38245347|FG000|Overall Study|Investigators Discretion|1|||
17107432|NCT00077766|38245348|FG001|Overall Study|Investigators Discretion|0|||
17107433|NCT00077766|38245347|FG000|Overall Study|Participant's decision|1|||
17107434|NCT00077766|38245348|FG001|Overall Study|Participant's decision|0|||
17107435|NCT00077766|38245347|FG000|Overall Study|Dialysis Discontinued|1|||
17107436|NCT00077766|38245348|FG001|Overall Study|Dialysis Discontinued|0|||
17107437|NCT00077766|38245347|FG000|Overall Study|Dialysis|0|||
17107438|NCT00077766|38245348|FG001|Overall Study|Dialysis|1|||
17107439|NCT00077766|38245347|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
17107440|NCT00077766|38245348|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
17107441|NCT00077766|38245347|FG000|Overall Study|Started Nocturnal Dialysis|0|||
17107442|NCT00077766|38245348|FG001|Overall Study|Started Nocturnal Dialysis|1|||
17107443|NCT00077766|38245347|FG000|Overall Study|Stop Dialysis|0|||
17107444|NCT00077766|38245348|FG001|Overall Study|Stop Dialysis|1|||
17107445|NCT00077766|38245347|FG000|Overall Study|Participants Vacation|2|||
17107446|NCT00077766|38245348|FG001|Overall Study|Participants Vacation|1|||
17107447|NCT03799718|38245355|FG000|Overall Study|Adverse Event|2|||
17107448|NCT03388138|38245361|FG000|Overall Study|Protocol Violation|1|||
17107449|NCT03388138|38245362|FG001|Overall Study|Protocol Violation|0|||
17107450|NCT02952898|38245371|FG000|Overall Study|Withdrawal by Subject|10|||
17107451|NCT02952898|38245372|FG001|Overall Study|Withdrawal by Subject|8|||
17107452|NCT02952898|38245373|FG002|Overall Study|Withdrawal by Subject|8|||
17107453|NCT02952898|38245371|FG000|Overall Study|Adverse Event|8|||
17107454|NCT02952898|38245372|FG001|Overall Study|Adverse Event|8|||
17107455|NCT02952898|38245373|FG002|Overall Study|Adverse Event|3|||
17107456|NCT02952898|38245371|FG000|Overall Study|Lost to Follow-up|3|||
17107457|NCT02952898|38245372|FG001|Overall Study|Lost to Follow-up|2|||
17107458|NCT02952898|38245373|FG002|Overall Study|Lost to Follow-up|2|||
17107459|NCT02952898|38245371|FG000|Overall Study|Non-compliance with study drug|1|||
17107460|NCT02952898|38245372|FG001|Overall Study|Non-compliance with study drug|1|||
17107461|NCT02952898|38245373|FG002|Overall Study|Non-compliance with study drug|2|||
17107462|NCT00045734|38245381|FG000|Overall Study|Protocol Violation|1|||
17107463|NCT03387046|38245387|FG000|Overall Study|Adverse Event|1|||
17107464|NCT03387046|38245388|FG001|Overall Study|Adverse Event|1|||
17107465|NCT00045110|38245397|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
17107466|NCT00045110|38245398|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
17107467|NCT00045110|38245399|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
17107468|NCT00045110|38245397|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
17107469|NCT00045110|38245398|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
17107470|NCT00045110|38245399|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
17107471|NCT00045110|38245397|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
17107472|NCT00045110|38245398|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
17107473|NCT00045110|38245399|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
17107474|NCT03353740|38245416|FG000|Overall Study|Images for these participants not viable|52|||
17107475|NCT00003476|38245420|FG000|Overall Study|Not evaluable|1|||
17107476|NCT00003470|38245424|FG000|Overall Study|Not evaluable|6|||
17107477|NCT03386344|38245431|FG000|Overall Study|Adverse Event|6|||
17107478|NCT03386344|38245432|FG001|Overall Study|Adverse Event|3|||
17107479|NCT03386344|38245433|FG002|Overall Study|Adverse Event|1|||
17107480|NCT03386344|38245431|FG000|Overall Study|Poor Compliance to Protocol|0|||
17107481|NCT03386344|38245432|FG001|Overall Study|Poor Compliance to Protocol|1|||
17107482|NCT03386344|38245433|FG002|Overall Study|Poor Compliance to Protocol|0|||
17107483|NCT03386344|38245431|FG000|Overall Study|Study Terminated by Sponsor|101|||
17107484|NCT03386344|38245432|FG001|Overall Study|Study Terminated by Sponsor|102|||
17107485|NCT03386344|38245433|FG002|Overall Study|Study Terminated by Sponsor|106|||
17107486|NCT03386344|38245431|FG000|Overall Study|Lost to Follow-up|3|||
17107487|NCT03386344|38245432|FG001|Overall Study|Lost to Follow-up|2|||
17107488|NCT03386344|38245433|FG002|Overall Study|Lost to Follow-up|1|||
17107489|NCT03386344|38245431|FG000|Overall Study|At the Participant's own Request|7|||
17107490|NCT03386344|38245432|FG001|Overall Study|At the Participant's own Request|7|||
17107491|NCT03386344|38245433|FG002|Overall Study|At the Participant's own Request|8|||
17107492|NCT03386344|38245431|FG000|Overall Study|Reason not Specified|0|||
17107493|NCT03386344|38245432|FG001|Overall Study|Reason not Specified|1|||
17107494|NCT03386344|38245433|FG002|Overall Study|Reason not Specified|0|||
17107495|NCT00399035|38245444|FG000|Overall Study|Death|289|||
17107496|NCT00399035|38245445|FG001|Overall Study|Death|141|||
17107497|NCT00399035|38245446|FG002|Overall Study|Death|234|||
17107498|NCT00399035|38245444|FG000|Overall Study|Lost to Follow-up|2|||
17107499|NCT00399035|38245445|FG001|Overall Study|Lost to Follow-up|1|||
17107500|NCT00399035|38245446|FG002|Overall Study|Lost to Follow-up|5|||
17107501|NCT00399035|38245444|FG000|Overall Study|Withdrawal by Subject|19|||
17107502|NCT00399035|38245445|FG001|Overall Study|Withdrawal by Subject|15|||
17107503|NCT00399035|38245446|FG002|Overall Study|Withdrawal by Subject|12|||
17107504|NCT00399035|38245444|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
17107505|NCT00399035|38245445|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
17107506|NCT00399035|38245446|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
17107507|NCT00399035|38245444|FG000|Overall Study|Severe non-compliance with protocol|2|||
17107508|NCT00399035|38245445|FG001|Overall Study|Severe non-compliance with protocol|1|||
17107509|NCT00399035|38245446|FG002|Overall Study|Severe non-compliance with protocol|0|||
17107510|NCT00073749|38245460|FG000|Overall Study|Disease Progression|2|||
17107511|NCT00073749|38245461|FG001|Overall Study|Disease Progression|0|||
17107512|NCT00073749|38245462|FG002|Overall Study|Disease Progression|3|||
17107513|NCT00073749|38245463|FG003|Overall Study|Disease Progression|2|||
17107514|NCT00073749|38245464|FG004|Overall Study|Disease Progression|3|||
17107515|NCT00073749|38245465|FG005|Overall Study|Disease Progression|1|||
17107516|NCT00073749|38245466|FG006|Overall Study|Disease Progression|3|||
17107517|NCT00073749|38245460|FG000|Overall Study|Death|0|||
17107518|NCT00073749|38245461|FG001|Overall Study|Death|1|||
17107519|NCT00073749|38245462|FG002|Overall Study|Death|1|||
17107520|NCT00073749|38245463|FG003|Overall Study|Death|0|||
17107521|NCT00073749|38245464|FG004|Overall Study|Death|0|||
17107522|NCT00073749|38245465|FG005|Overall Study|Death|0|||
17107523|NCT00073749|38245466|FG006|Overall Study|Death|29|||
17107524|NCT00073749|38245460|FG000|Overall Study|Adverse Event|0|||
17107525|NCT00073749|38245461|FG001|Overall Study|Adverse Event|3|||
17107526|NCT00073749|38245462|FG002|Overall Study|Adverse Event|6|||
17107527|NCT00073749|38245463|FG003|Overall Study|Adverse Event|4|||
17107528|NCT00073749|38245464|FG004|Overall Study|Adverse Event|2|||
17107529|NCT00073749|38245465|FG005|Overall Study|Adverse Event|1|||
17107530|NCT00073749|38245466|FG006|Overall Study|Adverse Event|0|||
17107531|NCT00073749|38245460|FG000|Overall Study|Physician Decision|0|||
17107532|NCT00073749|38245461|FG001|Overall Study|Physician Decision|0|||
17107533|NCT00073749|38245462|FG002|Overall Study|Physician Decision|1|||
17107534|NCT00073749|38245463|FG003|Overall Study|Physician Decision|0|||
17107535|NCT00073749|38245464|FG004|Overall Study|Physician Decision|0|||
17107536|NCT00073749|38245465|FG005|Overall Study|Physician Decision|2|||
17107537|NCT00073749|38245466|FG006|Overall Study|Physician Decision|0|||
17107538|NCT00073749|38245460|FG000|Overall Study|Withdrawal by Subject|0|||
17107539|NCT00073749|38245461|FG001|Overall Study|Withdrawal by Subject|1|||
17107540|NCT00073749|38245462|FG002|Overall Study|Withdrawal by Subject|0|||
17107541|NCT00073749|38245463|FG003|Overall Study|Withdrawal by Subject|0|||
17107542|NCT00073749|38245464|FG004|Overall Study|Withdrawal by Subject|1|||
17107543|NCT00073749|38245465|FG005|Overall Study|Withdrawal by Subject|0|||
17107544|NCT00073749|38245466|FG006|Overall Study|Withdrawal by Subject|2|||
17107545|NCT00073749|38245460|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
17107546|NCT00073749|38245461|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
17107547|NCT00073749|38245462|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
17107548|NCT00073749|38245463|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
17107549|NCT00073749|38245464|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
17107550|NCT00073749|38245465|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
17107551|NCT00073749|38245466|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
17107552|NCT00073749|38245460|FG000|Overall Study|Lost to Follow-up|0|||
17107553|NCT00073749|38245461|FG001|Overall Study|Lost to Follow-up|0|||
17107554|NCT00073749|38245462|FG002|Overall Study|Lost to Follow-up|0|||
17107555|NCT00073749|38245463|FG003|Overall Study|Lost to Follow-up|0|||
17107556|NCT00073749|38245464|FG004|Overall Study|Lost to Follow-up|0|||
17107557|NCT00073749|38245465|FG005|Overall Study|Lost to Follow-up|0|||
17107558|NCT00073749|38245466|FG006|Overall Study|Lost to Follow-up|2|||
17107559|NCT00073749|38245460|FG000|Overall Study|Other|0|||
17107560|NCT00073749|38245461|FG001|Overall Study|Other|0|||
17107561|NCT00073749|38245462|FG002|Overall Study|Other|0|||
17107562|NCT00073749|38245463|FG003|Overall Study|Other|0|||
17107563|NCT00073749|38245464|FG004|Overall Study|Other|0|||
17107564|NCT00073749|38245465|FG005|Overall Study|Other|2|||
17107565|NCT00073749|38245466|FG006|Overall Study|Other|0|||
17107566|NCT00398567|38245488|FG000|Overall Study|Disease Progression|3|||
17107567|NCT00398567|38245489|FG001|Overall Study|Disease Progression|4|||
17107568|NCT00398567|38245490|FG002|Overall Study|Disease Progression|27|||
17107569|NCT00398567|38245488|FG000|Overall Study|Withdrawal by Subject|1|||
17107570|NCT00398567|38245489|FG001|Overall Study|Withdrawal by Subject|0|||
17107571|NCT00398567|38245490|FG002|Overall Study|Withdrawal by Subject|4|||
17107572|NCT00398567|38245488|FG000|Overall Study|Adverse Event|0|||
17107573|NCT00398567|38245489|FG001|Overall Study|Adverse Event|0|||
17107574|NCT00398567|38245490|FG002|Overall Study|Adverse Event|2|||
17107575|NCT00398567|38245488|FG000|Overall Study|Protocol Violation|0|||
17107576|NCT00398567|38245489|FG001|Overall Study|Protocol Violation|0|||
17107577|NCT00398567|38245490|FG002|Overall Study|Protocol Violation|1|||
17107578|NCT01347580|38245498|FG000|Overall Study|Withdrawal by Subject|13|||
17107579|NCT01347580|38245499|FG001|Overall Study|Withdrawal by Subject|23|||
17107580|NCT01347580|38245498|FG000|Overall Study|Death|30|||
17107581|NCT01347580|38245499|FG001|Overall Study|Death|19|||
17107582|NCT01347580|38245498|FG000|Overall Study|Protocol Violation|10|||
17107583|NCT01347580|38245499|FG001|Overall Study|Protocol Violation|7|||
17107584|NCT01347580|38245498|FG000|Overall Study|Lost to Follow-up|3|||
17107585|NCT01347580|38245499|FG001|Overall Study|Lost to Follow-up|1|||
17107586|NCT01347580|38245498|FG000|Overall Study|Had other reason|9|||
17107587|NCT01347580|38245499|FG001|Overall Study|Had other reason|6|||
17107588|NCT00398411|38245507|FG000|Overall Study|Death|0|||
17107589|NCT00398411|38245508|FG001|Overall Study|Death|1|||
17107590|NCT03352414|38245516|FG000|Overall Study|Ineligible by operative criteria|12|||
17107591|NCT03352414|38245517|FG001|Overall Study|Ineligible by operative criteria|10|||
17107592|NCT00364793|38245529|FG000|Overall Study|Adverse Event|2|||
17107593|NCT00364793|38245530|FG001|Overall Study|Adverse Event|0|||
17107594|NCT00364793|38245531|FG002|Overall Study|Adverse Event|0|||
17107595|NCT00364793|38245532|FG003|Overall Study|Adverse Event|0|||
17107596|NCT00364793|38245529|FG000|Overall Study|Death|1|||
17107597|NCT00364793|38245530|FG001|Overall Study|Death|0|||
17107598|NCT00364793|38245531|FG002|Overall Study|Death|1|||
17107599|NCT00364793|38245532|FG003|Overall Study|Death|0|||
17107600|NCT00364793|38245529|FG000|Overall Study|Lack of Efficacy|3|||
17107601|NCT00364793|38245530|FG001|Overall Study|Lack of Efficacy|3|||
17107602|NCT00364793|38245531|FG002|Overall Study|Lack of Efficacy|1|||
17107603|NCT00364793|38245532|FG003|Overall Study|Lack of Efficacy|1|||
17107604|NCT00364793|38245529|FG000|Overall Study|Lost to Follow-up|1|||
17107605|NCT00364793|38245530|FG001|Overall Study|Lost to Follow-up|0|||
17107606|NCT00364793|38245531|FG002|Overall Study|Lost to Follow-up|2|||
17107607|NCT00364793|38245532|FG003|Overall Study|Lost to Follow-up|0|||
17107608|NCT00364793|38245529|FG000|Overall Study|Poor or non-compliance|1|||
17107609|NCT00364793|38245530|FG001|Overall Study|Poor or non-compliance|1|||
17107610|NCT00364793|38245531|FG002|Overall Study|Poor or non-compliance|0|||
17107611|NCT00364793|38245532|FG003|Overall Study|Poor or non-compliance|1|||
17107612|NCT00364793|38245529|FG000|Overall Study|No longer meets criteria|0|||
17107613|NCT00364793|38245530|FG001|Overall Study|No longer meets criteria|0|||
17107614|NCT00364793|38245531|FG002|Overall Study|No longer meets criteria|0|||
17107615|NCT00364793|38245532|FG003|Overall Study|No longer meets criteria|1|||
17107616|NCT00364793|38245529|FG000|Overall Study|Withdrawal by Subject|0|||
17107617|NCT00364793|38245530|FG001|Overall Study|Withdrawal by Subject|1|||
17107618|NCT00364793|38245531|FG002|Overall Study|Withdrawal by Subject|0|||
17107619|NCT00364793|38245532|FG003|Overall Study|Withdrawal by Subject|0|||
17107620|NCT03351478|38245548|FG000|Overall Study|At the subject's own request|11|||
17107621|NCT03351478|38245549|FG001|Overall Study|At the subject's own request|12|||
17107622|NCT03351478|38245550|FG002|Overall Study|At the subject's own request|5|||
17107623|NCT03351478|38245548|FG000|Overall Study|Adverse Event|1|||
17107624|NCT03351478|38245549|FG001|Overall Study|Adverse Event|2|||
17107625|NCT03351478|38245550|FG002|Overall Study|Adverse Event|1|||
17107626|NCT03351478|38245548|FG000|Overall Study|Poor compliance to protocol|1|||
17107627|NCT03351478|38245549|FG001|Overall Study|Poor compliance to protocol|0|||
17107628|NCT03351478|38245550|FG002|Overall Study|Poor compliance to protocol|0|||
17107629|NCT03351478|38245548|FG000|Overall Study|Reason not Specified|1|||
17107630|NCT03351478|38245549|FG001|Overall Study|Reason not Specified|3|||
17107631|NCT03351478|38245550|FG002|Overall Study|Reason not Specified|0|||
17107632|NCT03351478|38245548|FG000|Overall Study|Lost to Follow-up|0|||
17107633|NCT03351478|38245549|FG001|Overall Study|Lost to Follow-up|0|||
17107634|NCT03351478|38245550|FG002|Overall Study|Lost to Follow-up|1|||
17107635|NCT00363545|38245560|FG000|Overall Study|Serious Adverse Event|0|||
17107636|NCT00363545|38245561|FG001|Overall Study|Serious Adverse Event|1|||
17107637|NCT00363545|38245560|FG000|Overall Study|Withdrawal by Subject|12|||
17107638|NCT00363545|38245561|FG001|Overall Study|Withdrawal by Subject|15|||
17107639|NCT00363545|38245560|FG000|Overall Study|Migrated/moved from study area|3|||
17107640|NCT00363545|38245561|FG001|Overall Study|Migrated/moved from study area|6|||
17107641|NCT00363545|38245560|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
17107642|NCT00363545|38245561|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
17107643|NCT00363545|38245560|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
17107644|NCT00363545|38245561|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
17107645|NCT00363545|38245560|FG000|Overall Study|Others|1|||
17107646|NCT00363545|38245561|FG001|Overall Study|Others|0|||
17107647|NCT03351244|38245570|FG000|Overall Study|Adverse Event|7|||
17107648|NCT03351244|38245571|FG001|Overall Study|Adverse Event|11|||
17107649|NCT03351244|38245572|FG002|Overall Study|Adverse Event|12|||
17107650|NCT03351244|38245570|FG000|Overall Study|Investigator's decision|0|||
17107651|NCT03351244|38245571|FG001|Overall Study|Investigator's decision|0|||
17107652|NCT03351244|38245572|FG002|Overall Study|Investigator's decision|2|||
17107653|NCT03351244|38245570|FG000|Overall Study|System error|0|||
17107654|NCT03351244|38245571|FG001|Overall Study|System error|0|||
17107655|NCT03351244|38245572|FG002|Overall Study|System error|2|||
17107656|NCT03351244|38245570|FG000|Overall Study|COVID-19 restrictions|3|||
17107657|NCT03351244|38245571|FG001|Overall Study|COVID-19 restrictions|0|||
17107658|NCT03351244|38245572|FG002|Overall Study|COVID-19 restrictions|1|||
17107659|NCT03351244|38245570|FG000|Overall Study|Non-compliance|2|||
17107660|NCT03351244|38245571|FG001|Overall Study|Non-compliance|5|||
17107661|NCT03351244|38245572|FG002|Overall Study|Non-compliance|0|||
17107662|NCT03351244|38245570|FG000|Overall Study|Withdrawal by Subject|11|||
17107663|NCT03351244|38245571|FG001|Overall Study|Withdrawal by Subject|16|||
17107664|NCT03351244|38245572|FG002|Overall Study|Withdrawal by Subject|13|||
17107665|NCT03351244|38245570|FG000|Overall Study|Lost to Follow-up|2|||
17107666|NCT03351244|38245571|FG001|Overall Study|Lost to Follow-up|6|||
17107667|NCT03351244|38245572|FG002|Overall Study|Lost to Follow-up|4|||
17107668|NCT03351244|38245570|FG000|Overall Study|Protocol Violation|2|||
17107669|NCT03351244|38245571|FG001|Overall Study|Protocol Violation|2|||
17107670|NCT03351244|38245572|FG002|Overall Study|Protocol Violation|0|||
17107671|NCT03386032|38245585|FG000|Overall Study|Lack of Efficacy|6|||
17107672|NCT03386032|38245586|FG001|Overall Study|Lack of Efficacy|2|||
17107673|NCT03386032|38245587|FG002|Overall Study|Lack of Efficacy|0|||
17107674|NCT03386032|38245585|FG000|Overall Study|Adverse Event|2|||
17107675|NCT03386032|38245586|FG001|Overall Study|Adverse Event|2|||
17107676|NCT03386032|38245587|FG002|Overall Study|Adverse Event|0|||
17107677|NCT03386032|38245585|FG000|Overall Study|Withdrawal by Subject|1|||
17107678|NCT03386032|38245586|FG001|Overall Study|Withdrawal by Subject|0|||
17107679|NCT03386032|38245587|FG002|Overall Study|Withdrawal by Subject|0|||
17107680|NCT03386032|38245585|FG000|Overall Study|Lost to Follow-up|9|||
17107681|NCT03386032|38245586|FG001|Overall Study|Lost to Follow-up|3|||
17107682|NCT03386032|38245587|FG002|Overall Study|Lost to Follow-up|0|||
17107683|NCT00077610|38245598|FG000|Overall Study|Adverse Event|9|||
17107684|NCT00077610|38245599|FG001|Overall Study|Adverse Event|7|||
17107685|NCT00077610|38245600|FG002|Overall Study|Adverse Event|1|||
17107686|NCT00077610|38245598|FG000|Overall Study|Lost to Follow-up|0|||
17107687|NCT00077610|38245599|FG001|Overall Study|Lost to Follow-up|1|||
17107688|NCT00077610|38245600|FG002|Overall Study|Lost to Follow-up|2|||
17107689|NCT00077610|38245598|FG000|Overall Study|Withdrawal by Subject|4|||
17107690|NCT00077610|38245599|FG001|Overall Study|Withdrawal by Subject|10|||
17107691|NCT00077610|38245600|FG002|Overall Study|Withdrawal by Subject|6|||
17107692|NCT00077610|38245598|FG000|Overall Study|Death|17|||
17107693|NCT00077610|38245599|FG001|Overall Study|Death|13|||
17107694|NCT00077610|38245600|FG002|Overall Study|Death|13|||
17107695|NCT00077610|38245598|FG000|Overall Study|Renal transplant|12|||
17107696|NCT00077610|38245599|FG001|Overall Study|Renal transplant|15|||
17107697|NCT00077610|38245600|FG002|Overall Study|Renal transplant|11|||
17107698|NCT00077610|38245598|FG000|Overall Study|Withdrew from dialysis care|5|||
17107699|NCT00077610|38245599|FG001|Overall Study|Withdrew from dialysis care|0|||
17107700|NCT00077610|38245600|FG002|Overall Study|Withdrew from dialysis care|3|||
17107701|NCT00077610|38245598|FG000|Overall Study|Insufficient Therapeutic Response|1|||
17107702|NCT00077610|38245599|FG001|Overall Study|Insufficient Therapeutic Response|0|||
17107703|NCT00077610|38245600|FG002|Overall Study|Insufficient Therapeutic Response|0|||
17107704|NCT00077610|38245598|FG000|Overall Study|Multiple blood transfusions|0|||
17107705|NCT00077610|38245599|FG001|Overall Study|Multiple blood transfusions|0|||
17107706|NCT00077610|38245600|FG002|Overall Study|Multiple blood transfusions|1|||
17107707|NCT00077610|38245598|FG000|Overall Study|Principal Investigator's decision|1|||
17107708|NCT00077610|38245599|FG001|Overall Study|Principal Investigator's decision|0|||
17107709|NCT00077610|38245600|FG002|Overall Study|Principal Investigator's decision|1|||
17107710|NCT00077610|38245598|FG000|Overall Study|Worsening of health condition|1|||
17107711|NCT00077610|38245599|FG001|Overall Study|Worsening of health condition|1|||
17107712|NCT00077610|38245600|FG002|Overall Study|Worsening of health condition|0|||
17107713|NCT00077610|38245598|FG000|Overall Study|Given Epogen in hospital|1|||
17107714|NCT00077610|38245599|FG001|Overall Study|Given Epogen in hospital|0|||
17107715|NCT00077610|38245600|FG002|Overall Study|Given Epogen in hospital|0|||
17107716|NCT00077610|38245598|FG000|Overall Study|Transferred to other unit|0|||
17107717|NCT00077610|38245599|FG001|Overall Study|Transferred to other unit|0|||
17107718|NCT00077610|38245600|FG002|Overall Study|Transferred to other unit|1|||
17107719|NCT00077610|38245598|FG000|Overall Study|Transferred to nursing home|0|||
17107720|NCT00077610|38245599|FG001|Overall Study|Transferred to nursing home|0|||
17107721|NCT00077610|38245600|FG002|Overall Study|Transferred to nursing home|1|||
17107722|NCT00077610|38245598|FG000|Overall Study|Transfer to satellite unit|1|||
17107723|NCT00077610|38245599|FG001|Overall Study|Transfer to satellite unit|0|||
17107724|NCT00077610|38245600|FG002|Overall Study|Transfer to satellite unit|0|||
17107725|NCT00077610|38245598|FG000|Overall Study|Transfer to other center for surgery|1|||
17107726|NCT00077610|38245599|FG001|Overall Study|Transfer to other center for surgery|0|||
17107727|NCT00077610|38245600|FG002|Overall Study|Transfer to other center for surgery|0|||
17107728|NCT00077610|38245598|FG000|Overall Study|Change in dialysis modality|1|||
17107729|NCT00077610|38245599|FG001|Overall Study|Change in dialysis modality|0|||
17107730|NCT00077610|38245600|FG002|Overall Study|Change in dialysis modality|0|||
17107731|NCT00077610|38245598|FG000|Overall Study|Relocation|0|||
17107732|NCT00077610|38245599|FG001|Overall Study|Relocation|8|||
17107733|NCT00077610|38245600|FG002|Overall Study|Relocation|5|||
17107734|NCT00077610|38245598|FG000|Overall Study|Financial issues|0|||
17107735|NCT00077610|38245599|FG001|Overall Study|Financial issues|1|||
17107736|NCT00077610|38245600|FG002|Overall Study|Financial issues|0|||
17107737|NCT00077610|38245598|FG000|Overall Study|Sponsors decision to withdraw|0|||
17107738|NCT00077610|38245599|FG001|Overall Study|Sponsors decision to withdraw|0|||
17107739|NCT00077610|38245600|FG002|Overall Study|Sponsors decision to withdraw|1|||
17107740|NCT03385564|38245617|FG000|Overall Study|Adverse Event|0|||
17107741|NCT03385564|38245618|FG001|Overall Study|Adverse Event|0|||
17107742|NCT03385564|38245619|FG002|Overall Study|Adverse Event|3|||
17107743|NCT03385564|38245620|FG003|Overall Study|Adverse Event|3|||
17107744|NCT03385564|38245617|FG000|Overall Study|Other than listed|0|||
17107745|NCT03385564|38245618|FG001|Overall Study|Other than listed|0|||
17107746|NCT03385564|38245619|FG002|Overall Study|Other than listed|0|||
17107747|NCT03385564|38245620|FG003|Overall Study|Other than listed|5|||
17107748|NCT03385564|38245617|FG000|Overall Study|Withdrawal by Subject|0|||
17107749|NCT03385564|38245618|FG001|Overall Study|Withdrawal by Subject|1|||
17107750|NCT03385564|38245619|FG002|Overall Study|Withdrawal by Subject|1|||
17107751|NCT03385564|38245620|FG003|Overall Study|Withdrawal by Subject|0|||
17107752|NCT03385564|38245617|FG000|Overall Study|Lack of Efficacy|0|||
17107753|NCT03385564|38245618|FG001|Overall Study|Lack of Efficacy|0|||
17107754|NCT03385564|38245619|FG002|Overall Study|Lack of Efficacy|0|||
17107755|NCT03385564|38245620|FG003|Overall Study|Lack of Efficacy|1|||
17107756|NCT03385564|38245617|FG000|Overall Study|Death|0|||
17107757|NCT03385564|38245618|FG001|Overall Study|Death|0|||
17107758|NCT03385564|38245619|FG002|Overall Study|Death|1|||
17107759|NCT03385564|38245620|FG003|Overall Study|Death|0|||
17107760|NCT00066222|38245630|FG000|Overall Study|No protocol treatment received|1|||
17107761|NCT00397943|38245639|FG000|Overall Study|Unspecified reasons|12|||
17107762|NCT00397943|38245640|FG001|Overall Study|Unspecified reasons|9|||
17107763|NCT00397943|38245641|FG002|Overall Study|Unspecified reasons|0|||
17107764|NCT00397943|38245642|FG003|Overall Study|Unspecified reasons|0|||
17107765|NCT00397943|38245643|FG004|Overall Study|Unspecified reasons|0|||
17107766|NCT00066066|38245658|FG000|Overall Study|Lost to Follow-up|6|||
17107767|NCT00066066|38245659|FG001|Overall Study|Lost to Follow-up|4|||
17107768|NCT00066066|38245660|FG002|Overall Study|Lost to Follow-up|7|||
17107769|NCT00066066|38245661|FG003|Overall Study|Lost to Follow-up|4|||
17107770|NCT00066066|38245662|FG004|Overall Study|Lost to Follow-up|3|||
17107771|NCT00066066|38245663|FG005|Overall Study|Lost to Follow-up|5|||
17107772|NCT00363467|38245677|FG000|Overall Study|Physician Decision|1|||
17107773|NCT00397631|38245683|FG000|Overall Study|Adverse Event|5|||
17107774|NCT00397631|38245684|FG001|Overall Study|Adverse Event|6|||
17107775|NCT00397631|38245683|FG000|Overall Study|Lack of Efficacy|7|||
17107776|NCT00397631|38245684|FG001|Overall Study|Lack of Efficacy|10|||
17107777|NCT00397631|38245683|FG000|Overall Study|Lost to Follow-up|8|||
17107778|NCT00397631|38245684|FG001|Overall Study|Lost to Follow-up|9|||
17107779|NCT00397631|38245683|FG000|Overall Study|Physician Decision|2|||
17107780|NCT00397631|38245684|FG001|Overall Study|Physician Decision|0|||
17107781|NCT00397631|38245683|FG000|Overall Study|Protocol Violation|0|||
17107782|NCT00397631|38245684|FG001|Overall Study|Protocol Violation|1|||
17107783|NCT00397631|38245683|FG000|Overall Study|Withdrawal by Subject|7|||
17107784|NCT00397631|38245684|FG001|Overall Study|Withdrawal by Subject|14|||
17107785|NCT00397631|38245683|FG000|Overall Study|protocol discontinuation criteria|1|||
17107786|NCT00397631|38245684|FG001|Overall Study|protocol discontinuation criteria|4|||
17107787|NCT00077376|38245690|FG000|Overall Study|Adverse Event|8|||
17107788|NCT00077376|38245690|FG000|Overall Study|Withdrawal by Subject|2|||
17107789|NCT00077376|38245690|FG000|Overall Study|Death|1|||
17107790|NCT00077376|38245690|FG000|Overall Study|Physician Decision|1|||
17107791|NCT00077376|38245690|FG000|Overall Study|Alternative therapy|5|||
17107792|NCT00077376|38245690|FG000|Overall Study|Complicating disease|1|||
17107793|NCT00077376|38245690|FG000|Overall Study|Still on treatment|1|||
17107794|NCT00077376|38245690|FG000|Overall Study|Symptomatic deterioration|1|||
17107795|NCT00077376|38245690|FG000|Overall Study|Surgery|1|||
17107796|NCT00077376|38245690|FG000|Overall Study|Insurance ran out|1|||
17107797|NCT03406156|38245696|FG000|Overall Study|Death|6|||
17107798|NCT03406156|38245697|FG001|Overall Study|Death|2|||
17107799|NCT03406156|38245696|FG000|Overall Study|Withdrawal by Subject|0|||
17107800|NCT03406156|38245697|FG001|Overall Study|Withdrawal by Subject|2|||
17107801|NCT03406156|38245696|FG000|Overall Study|COVID-19 infection|1|||
17107802|NCT03406156|38245697|FG001|Overall Study|COVID-19 infection|0|||
17107803|NCT03406156|38245696|FG000|Overall Study|Non-compliance with study procedures|0|||
17107804|NCT03406156|38245697|FG001|Overall Study|Non-compliance with study procedures|1|||
17107805|NCT03406156|38245696|FG000|Overall Study|Other, not specified|0|||
17107806|NCT03406156|38245697|FG001|Overall Study|Other, not specified|1|||
17107807|NCT00363311|38245707|FG000|Overall Study|Adverse Event|6|||
17107808|NCT00363311|38245708|FG001|Overall Study|Adverse Event|4|||
17107809|NCT00363311|38245707|FG000|Overall Study|Lost to Follow-up|3|||
17107810|NCT00363311|38245708|FG001|Overall Study|Lost to Follow-up|0|||
17107811|NCT00363311|38245707|FG000|Overall Study|Protocol Violation|1|||
17107812|NCT00363311|38245708|FG001|Overall Study|Protocol Violation|2|||
17107813|NCT00363311|38245707|FG000|Overall Study|Withdrawal by Subject|12|||
17107814|NCT00363311|38245708|FG001|Overall Study|Withdrawal by Subject|6|||
17107815|NCT00363311|38245707|FG000|Overall Study|Physician Decision|1|||
17107816|NCT00363311|38245708|FG001|Overall Study|Physician Decision|1|||
17107817|NCT00363311|38245707|FG000|Overall Study|Sponsor Terminated Study|2|||
17107818|NCT00363311|38245708|FG001|Overall Study|Sponsor Terminated Study|2|||
17107819|NCT00363311|38245707|FG000|Overall Study|Disease Progression|46|||
17107820|NCT00363311|38245708|FG001|Overall Study|Disease Progression|26|||
17107821|NCT00363311|38245707|FG000|Overall Study|Non-Compliance|1|||
17107822|NCT00363311|38245708|FG001|Overall Study|Non-Compliance|1|||
17107823|NCT00363311|38245707|FG000|Overall Study|Participant Refused Biopsy|1|||
17107824|NCT00363311|38245708|FG001|Overall Study|Participant Refused Biopsy|0|||
17107825|NCT00363311|38245707|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
17107826|NCT00363311|38245708|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
17107827|NCT00363311|38245707|FG000|Overall Study|Participant Opted for Treatment|1|||
17107828|NCT00363311|38245708|FG001|Overall Study|Participant Opted for Treatment|0|||
17107829|NCT00363311|38245707|FG000|Overall Study|Participant Moved to Another Country|1|||
17107830|NCT00363311|38245708|FG001|Overall Study|Participant Moved to Another Country|0|||
17107831|NCT00363311|38245707|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
17107832|NCT00363311|38245708|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
17107833|NCT00363311|38245707|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
17107834|NCT00363311|38245708|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
17107835|NCT00363311|38245707|FG000|Overall Study|Participant Moved to Louisiana|0|||
17107836|NCT00363311|38245708|FG001|Overall Study|Participant Moved to Louisiana|1|||
17107837|NCT00362609|38245716|FG000|Overall Study|Withdrawal by Subject|0|||
17107838|NCT00362609|38245717|FG001|Overall Study|Withdrawal by Subject|1|||
17107839|NCT00362609|38245716|FG000|Overall Study|Protocol Violation|0|||
17107840|NCT00362609|38245717|FG001|Overall Study|Protocol Violation|1|||
17107841|NCT00362375|38245725|FG000|Overall Study|Lost to Follow-up|40|||
17107842|NCT00362375|38245726|FG001|Overall Study|Lost to Follow-up|35|||
17107843|NCT00362297|38245734|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
17107844|NCT00362297|38245735|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
17107845|NCT00065442|38245743|FG000|Overall Study|Lost to Follow-up|1|||
17107846|NCT00065442|38245744|FG001|Overall Study|Lost to Follow-up|1|||
17107847|NCT00065442|38245743|FG000|Overall Study|Death|121|||
17107848|NCT00065442|38245744|FG001|Overall Study|Death|210|||
17107849|NCT00065442|38245743|FG000|Overall Study|Withdrawal by Subject|3|||
17107850|NCT00065442|38245744|FG001|Overall Study|Withdrawal by Subject|9|||
17107851|NCT00090402|38245753|FG000|Overall Study|Death|1|||
17107852|NCT00090402|38245754|FG001|Overall Study|Death|1|||
17107853|NCT00090402|38245755|FG002|Overall Study|Death|0|||
17107854|NCT00090402|38245753|FG000|Overall Study|subject moved|0|||
17107855|NCT00090402|38245754|FG001|Overall Study|subject moved|1|||
17107856|NCT00090402|38245755|FG002|Overall Study|subject moved|0|||
17107857|NCT00090402|38245753|FG000|Overall Study|stopped taking study medication|1|||
17107858|NCT00090402|38245754|FG001|Overall Study|stopped taking study medication|0|||
17107859|NCT00090402|38245755|FG002|Overall Study|stopped taking study medication|1|||
17107860|NCT00361283|38245766|FG000|Overall Study|Lost to Follow-up|27|||
17107861|NCT00077064|38245772|FG000|Overall Study|Adverse Event|0|||
17107862|NCT00077064|38245773|FG001|Overall Study|Adverse Event|4|||
17107863|NCT00077064|38245772|FG000|Overall Study|Patient refusal|0|||
17107864|NCT00077064|38245773|FG001|Overall Study|Patient refusal|2|||
17107865|NCT00396383|38245780|FG000|Overall Study|Death|2|||
17107866|NCT00396383|38245780|FG000|Overall Study|Lost to Follow-up|1|||
17107867|NCT00395447|38245786|FG000|Overall Study|Death|37|||
17107868|NCT00395447|38245787|FG001|Overall Study|Death|32|||
17107869|NCT00395447|38245786|FG000|Overall Study|Lost to Follow-up|52|||
17107870|NCT00395447|38245787|FG001|Overall Study|Lost to Follow-up|43|||
17107871|NCT00395447|38245786|FG000|Overall Study|Withdrawal by Subject|24|||
17107872|NCT00395447|38245787|FG001|Overall Study|Withdrawal by Subject|19|||
17107873|NCT00395447|38245786|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
17107874|NCT00395447|38245787|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
17107875|NCT03404674|38245799|FG000|Overall Study|Inability to Attend Future Visits|0|||
17107876|NCT03404674|38245800|FG001|Overall Study|Inability to Attend Future Visits|1|||
17107877|NCT03404674|38245801|FG002|Overall Study|Inability to Attend Future Visits|1|||
17107878|NCT03404674|38245802|FG003|Overall Study|Inability to Attend Future Visits|0|||
17107879|NCT03404674|38245803|FG004|Overall Study|Inability to Attend Future Visits|0|||
17107880|NCT03404674|38245804|FG005|Overall Study|Inability to Attend Future Visits|0|||
17107881|NCT03404674|38245799|FG000|Overall Study|Behavioral Problems|0|||
17107882|NCT03404674|38245800|FG001|Overall Study|Behavioral Problems|0|||
17107883|NCT03404674|38245801|FG002|Overall Study|Behavioral Problems|1|||
17107884|NCT03404674|38245802|FG003|Overall Study|Behavioral Problems|0|||
17107885|NCT03404674|38245803|FG004|Overall Study|Behavioral Problems|0|||
17107886|NCT03404674|38245804|FG005|Overall Study|Behavioral Problems|0|||
17107887|NCT03404674|38245799|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
17107888|NCT03404674|38245800|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
17107889|NCT03404674|38245801|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
17107890|NCT03404674|38245802|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
17107891|NCT03404674|38245803|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
17107892|NCT03404674|38245804|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
17107893|NCT00064662|38245821|FG000|Overall Study|Death|1|||
17107894|NCT00064662|38245822|FG001|Overall Study|Death|1|||
17107895|NCT00064662|38245821|FG000|Overall Study|Lost to Follow-up|57|||
17107896|NCT00064662|38245822|FG001|Overall Study|Lost to Follow-up|44|||
17107897|NCT00064662|38245821|FG000|Overall Study|Withdrawal by Subject|14|||
17107898|NCT00064662|38245822|FG001|Overall Study|Withdrawal by Subject|14|||
17107899|NCT00064662|38245821|FG000|Overall Study|Administratively withdrawn|2|||
17107900|NCT00064662|38245822|FG001|Overall Study|Administratively withdrawn|2|||
17107901|NCT03404518|38245830|FG000|Overall Study|Lost to Follow-up|28|||
17107902|NCT03404518|38245831|FG001|Overall Study|Lost to Follow-up|30|||
17107903|NCT03404518|38245830|FG000|Overall Study|Protocol Violation|13|||
17107904|NCT03404518|38245831|FG001|Overall Study|Protocol Violation|6|||
17107905|NCT03404206|38245840|FG000|Overall Study|Withdrawal by Subject|1|||
17107906|NCT03404206|38245841|FG001|Overall Study|Withdrawal by Subject|1|||
17107907|NCT03404206|38245842|FG002|Overall Study|Withdrawal by Subject|0|||
17107908|NCT03404206|38245840|FG000|Overall Study|Lost to Follow-up|3|||
17107909|NCT03404206|38245841|FG001|Overall Study|Lost to Follow-up|1|||
17107910|NCT03404206|38245842|FG002|Overall Study|Lost to Follow-up|0|||
17107911|NCT03403426|38245850|FG000|Overall Study|Death|1|||
17107912|NCT03403426|38245850|FG000|Overall Study|Lost to Follow-up|2|||
17107913|NCT00394901|38245858|FG000|Baseline Phase|Protocol Violation|0|||
17107914|NCT00394901|38245859|FG001|Baseline Phase|Protocol Violation|0|||
17107915|NCT00394901|38245860|FG002|Baseline Phase|Protocol Violation|1|||
17107916|NCT00394901|38245861|FG003|Baseline Phase|Protocol Violation|0|||
17107917|NCT00394901|38245858|FG000|Double-blind Phase|Adverse Event|5|||
17107918|NCT00394901|38245859|FG001|Double-blind Phase|Adverse Event|7|||
17107919|NCT00394901|38245860|FG002|Double-blind Phase|Adverse Event|16|||
17107920|NCT00394901|38245861|FG003|Double-blind Phase|Adverse Event|20|||
17107921|NCT00394901|38245858|FG000|Double-blind Phase|Lack of Efficacy|6|||
17107922|NCT00394901|38245859|FG001|Double-blind Phase|Lack of Efficacy|4|||
17107923|NCT00394901|38245860|FG002|Double-blind Phase|Lack of Efficacy|1|||
17107924|NCT00394901|38245861|FG003|Double-blind Phase|Lack of Efficacy|3|||
17107925|NCT00394901|38245858|FG000|Double-blind Phase|Withdrawal by Subject|2|||
17107926|NCT00394901|38245859|FG001|Double-blind Phase|Withdrawal by Subject|0|||
17107927|NCT00394901|38245860|FG002|Double-blind Phase|Withdrawal by Subject|0|||
17107928|NCT00394901|38245861|FG003|Double-blind Phase|Withdrawal by Subject|0|||
17107929|NCT00394901|38245858|FG000|Double-blind Phase|Lost to Follow-up|0|||
17107930|NCT00394901|38245859|FG001|Double-blind Phase|Lost to Follow-up|0|||
17107931|NCT00394901|38245860|FG002|Double-blind Phase|Lost to Follow-up|0|||
17107932|NCT00394901|38245861|FG003|Double-blind Phase|Lost to Follow-up|1|||
17107933|NCT00394901|38245858|FG000|Double-blind Phase|Protocol Violation|0|||
17107934|NCT00394901|38245859|FG001|Double-blind Phase|Protocol Violation|0|||
17107935|NCT00394901|38245860|FG002|Double-blind Phase|Protocol Violation|0|||
17107936|NCT00394901|38245861|FG003|Double-blind Phase|Protocol Violation|1|||
17107937|NCT00394901|38245858|FG000|Double-blind Phase|Death|1|||
17107938|NCT00394901|38245859|FG001|Double-blind Phase|Death|0|||
17107939|NCT00394901|38245860|FG002|Double-blind Phase|Death|0|||
17107940|NCT00394901|38245861|FG003|Double-blind Phase|Death|0|||
17107941|NCT00394901|38245858|FG000|Double-blind Phase|Subject's Personal Reason|1|||
17107942|NCT00394901|38245859|FG001|Double-blind Phase|Subject's Personal Reason|0|||
17107943|NCT00394901|38245860|FG002|Double-blind Phase|Subject's Personal Reason|0|||
17107944|NCT00394901|38245861|FG003|Double-blind Phase|Subject's Personal Reason|1|||
17107945|NCT00394901|38245858|FG000|Double-blind Phase|Lack of Compliance|0|||
17107946|NCT00394901|38245859|FG001|Double-blind Phase|Lack of Compliance|3|||
17107947|NCT00394901|38245860|FG002|Double-blind Phase|Lack of Compliance|0|||
17107948|NCT00394901|38245861|FG003|Double-blind Phase|Lack of Compliance|0|||
17107949|NCT00394901|38245858|FG000|Double-blind Phase|Entry into another study was found|0|||
17107950|NCT00394901|38245859|FG001|Double-blind Phase|Entry into another study was found|0|||
17107951|NCT00394901|38245860|FG002|Double-blind Phase|Entry into another study was found|1|||
17107952|NCT00394901|38245861|FG003|Double-blind Phase|Entry into another study was found|0|||
17107953|NCT00394901|38245858|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
17107954|NCT00394901|38245859|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
17107955|NCT00394901|38245860|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
17107956|NCT00394901|38245861|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
17107957|NCT03349060|38245877|FG000|Overall Study|Adverse Event|9|||
17107958|NCT03349060|38245878|FG001|Overall Study|Adverse Event|9|||
17107959|NCT03349060|38245879|FG002|Overall Study|Adverse Event|7|||
17107960|NCT03349060|38245877|FG000|Overall Study|Lack of Efficacy|1|||
17107961|NCT03349060|38245878|FG001|Overall Study|Lack of Efficacy|0|||
17107962|NCT03349060|38245879|FG002|Overall Study|Lack of Efficacy|2|||
17107963|NCT03349060|38245877|FG000|Overall Study|Lost to Follow-up|2|||
17107964|NCT03349060|38245878|FG001|Overall Study|Lost to Follow-up|1|||
17107965|NCT03349060|38245879|FG002|Overall Study|Lost to Follow-up|1|||
17107966|NCT03349060|38245877|FG000|Overall Study|Protocol Violation|2|||
17107967|NCT03349060|38245878|FG001|Overall Study|Protocol Violation|2|||
17107968|NCT03349060|38245879|FG002|Overall Study|Protocol Violation|1|||
17107969|NCT03349060|38245877|FG000|Overall Study|Withdrawal by Subject|5|||
17107970|NCT03349060|38245878|FG001|Overall Study|Withdrawal by Subject|3|||
17107971|NCT03349060|38245879|FG002|Overall Study|Withdrawal by Subject|4|||
17107972|NCT03349060|38245877|FG000|Overall Study|Medication error,no linked adverse event|0|||
17107973|NCT03349060|38245878|FG001|Overall Study|Medication error,no linked adverse event|0|||
17107974|NCT03349060|38245879|FG002|Overall Study|Medication error,no linked adverse event|1|||
17107975|NCT03349060|38245877|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
17107976|NCT03349060|38245878|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
17107977|NCT03349060|38245879|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
17107978|NCT03349060|38245877|FG000|Overall Study|Other|2|||
17107979|NCT03349060|38245878|FG001|Overall Study|Other|1|||
17107980|NCT03349060|38245879|FG002|Overall Study|Other|0|||
17107981|NCT03348904|38245890|FG000|Overall Study|Administrative reason by the sponsor|0|||
17107982|NCT03348904|38245891|FG001|Overall Study|Administrative reason by the sponsor|1|||
17107983|NCT03348904|38245892|FG002|Overall Study|Administrative reason by the sponsor|0|||
17107984|NCT00359021|38245902|FG000|Overall Study|Adverse Event|26|||
17107985|NCT00359021|38245903|FG001|Overall Study|Adverse Event|8|||
17107986|NCT00359021|38245902|FG000|Overall Study|Subject Non-Compliant|1|||
17107987|NCT00359021|38245903|FG001|Overall Study|Subject Non-Compliant|2|||
17107988|NCT00359021|38245902|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
17107989|NCT00359021|38245903|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
17107990|NCT00359021|38245902|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
17107991|NCT00359021|38245903|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
17107992|NCT00359021|38245902|FG000|Overall Study|Withdrawal by Subject|2|||
17107993|NCT00359021|38245903|FG001|Overall Study|Withdrawal by Subject|9|||
17107994|NCT00359021|38245902|FG000|Overall Study|Lost to Follow-up|1|||
17107995|NCT00359021|38245903|FG001|Overall Study|Lost to Follow-up|0|||
17107996|NCT00359021|38245902|FG000|Overall Study|Other|4|||
17107997|NCT00359021|38245903|FG001|Overall Study|Other|1|||
17107998|NCT00359021|38245902|FG000|Overall Study|Pregnancy|1|||
17107999|NCT00359021|38245903|FG001|Overall Study|Pregnancy|0|||
17108000|NCT00064350|38245914|FG000|Induction Treatment|Disease Progression|5|||
17108001|NCT00064350|38245915|FG001|Induction Treatment|Disease Progression|1|||
17108002|NCT00064350|38245916|FG002|Induction Treatment|Disease Progression|110|||
17108003|NCT00064350|38245914|FG000|Induction Treatment|Adverse Event|0|||
17108004|NCT00064350|38245915|FG001|Induction Treatment|Adverse Event|2|||
17108005|NCT00064350|38245916|FG002|Induction Treatment|Adverse Event|49|||
17108006|NCT00064350|38245914|FG000|Induction Treatment|Death|0|||
17108007|NCT00064350|38245915|FG001|Induction Treatment|Death|0|||
17108008|NCT00064350|38245916|FG002|Induction Treatment|Death|9|||
17108009|NCT00064350|38245914|FG000|Induction Treatment|Withdrawal by Subject|0|||
17108010|NCT00064350|38245915|FG001|Induction Treatment|Withdrawal by Subject|0|||
17108011|NCT00064350|38245916|FG002|Induction Treatment|Withdrawal by Subject|21|||
17108012|NCT00064350|38245914|FG000|Induction Treatment|Ineligible or never started treatment|3|||
17108013|NCT00064350|38245915|FG001|Induction Treatment|Ineligible or never started treatment|6|||
17108014|NCT00064350|38245916|FG002|Induction Treatment|Ineligible or never started treatment|34|||
17108015|NCT00064350|38245914|FG000|Induction Treatment|Other|0|||
17108016|NCT00064350|38245915|FG001|Induction Treatment|Other|0|||
17108017|NCT00064350|38245916|FG002|Induction Treatment|Other|13|||
17108018|NCT00064350|38245914|FG000|Randomization|Adverse Event|8|||
17108019|NCT00064350|38245915|FG001|Randomization|Adverse Event|3|||
17108020|NCT00064350|38245916|FG002|Randomization|Adverse Event|0|||
17108021|NCT00064350|38245914|FG000|Randomization|Death|3|||
17108022|NCT00064350|38245915|FG001|Randomization|Death|0|||
17108023|NCT00064350|38245916|FG002|Randomization|Death|0|||
17108024|NCT00064350|38245914|FG000|Randomization|Withdrawal by Subject|1|||
17108025|NCT00064350|38245915|FG001|Randomization|Withdrawal by Subject|0|||
17108026|NCT00064350|38245916|FG002|Randomization|Withdrawal by Subject|0|||
17108027|NCT00064350|38245914|FG000|Randomization|Ineligible or never started treatment|9|||
17108028|NCT00064350|38245915|FG001|Randomization|Ineligible or never started treatment|15|||
17108029|NCT00064350|38245916|FG002|Randomization|Ineligible or never started treatment|0|||
17108030|NCT00064350|38245914|FG000|Randomization|Other|5|||
17108031|NCT00064350|38245915|FG001|Randomization|Other|0|||
17108032|NCT00064350|38245916|FG002|Randomization|Other|0|||
17108033|NCT00064350|38245914|FG000|Cross-Over|Adverse Event|0|||
17108034|NCT00064350|38245915|FG001|Cross-Over|Adverse Event|1|||
17108035|NCT00064350|38245916|FG002|Cross-Over|Adverse Event|0|||
17108036|NCT00064350|38245914|FG000|Cross-Over|Death|1|||
17108037|NCT00064350|38245915|FG001|Cross-Over|Death|3|||
17108038|NCT00064350|38245916|FG002|Cross-Over|Death|0|||
17108039|NCT00064350|38245914|FG000|Cross-Over|Withdrawal by Subject|2|||
17108040|NCT00064350|38245915|FG001|Cross-Over|Withdrawal by Subject|2|||
17108041|NCT00064350|38245916|FG002|Cross-Over|Withdrawal by Subject|0|||
17108042|NCT00064350|38245914|FG000|Cross-Over|Ineligible or never started treatment|3|||
17108043|NCT00064350|38245915|FG001|Cross-Over|Ineligible or never started treatment|6|||
17108044|NCT00064350|38245916|FG002|Cross-Over|Ineligible or never started treatment|0|||
17108045|NCT00064350|38245914|FG000|Cross-Over|Other|0|||
17108046|NCT00064350|38245915|FG001|Cross-Over|Other|2|||
17108047|NCT00064350|38245916|FG002|Cross-Over|Other|0|||
17108048|NCT00360269|38245927|FG000|Overall Study|Lost to Follow-up|7|||
17108049|NCT00360269|38245928|FG001|Overall Study|Lost to Follow-up|9|||
17108050|NCT00360269|38245927|FG000|Overall Study|Physician Decision|1|||
17108051|NCT00360269|38245928|FG001|Overall Study|Physician Decision|2|||
17108052|NCT00360269|38245927|FG000|Overall Study|Adverse Event|1|||
17108053|NCT00360269|38245928|FG001|Overall Study|Adverse Event|0|||
17108054|NCT00360269|38245927|FG000|Overall Study|Withdrawal by Subject|1|||
17108055|NCT00360269|38245928|FG001|Overall Study|Withdrawal by Subject|1|||
17108056|NCT00076752|38245934|FG000|Overall Study|Death|2|||
17108057|NCT00076752|38245934|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
17108058|NCT03384940|38245942|FG000|Overall Study|Progressive disease|36|||
17108059|NCT03384940|38245943|FG001|Overall Study|Progressive disease|11|||
17108060|NCT03384940|38245944|FG002|Overall Study|Progressive disease|13|||
17108061|NCT03384940|38245942|FG000|Overall Study|Clinical progression|4|||
17108062|NCT03384940|38245943|FG001|Overall Study|Clinical progression|0|||
17108063|NCT03384940|38245944|FG002|Overall Study|Clinical progression|3|||
17108064|NCT03384940|38245942|FG000|Overall Study|Adverse Event|7|||
17108065|NCT03384940|38245943|FG001|Overall Study|Adverse Event|1|||
17108066|NCT03384940|38245944|FG002|Overall Study|Adverse Event|1|||
17108067|NCT03384940|38245942|FG000|Overall Study|Withdrawal by Subject|3|||
17108068|NCT03384940|38245943|FG001|Overall Study|Withdrawal by Subject|1|||
17108069|NCT03384940|38245944|FG002|Overall Study|Withdrawal by Subject|0|||
17108070|NCT03384940|38245942|FG000|Overall Study|Physician Decision|1|||
17108071|NCT03384940|38245943|FG001|Overall Study|Physician Decision|1|||
17108072|NCT03384940|38245944|FG002|Overall Study|Physician Decision|0|||
17108073|NCT03384940|38245942|FG000|Overall Study|Death|2|||
17108074|NCT03384940|38245943|FG001|Overall Study|Death|1|||
17108075|NCT03384940|38245944|FG002|Overall Study|Death|0|||
17108076|NCT03384940|38245942|FG000|Overall Study|Other|0|||
17108077|NCT03384940|38245943|FG001|Overall Study|Other|0|||
17108078|NCT03384940|38245944|FG002|Overall Study|Other|1|||
17108079|NCT00075582|38245954|FG000|Overall Study|Adverse Event|3|||
17108080|NCT00075582|38245955|FG001|Overall Study|Adverse Event|1|||
17108081|NCT00075582|38245954|FG000|Overall Study|Lack of Efficacy|4|||
17108082|NCT00075582|38245955|FG001|Overall Study|Lack of Efficacy|8|||
17108083|NCT00075582|38245954|FG000|Overall Study|Physician Decision|5|||
17108084|NCT00075582|38245955|FG001|Overall Study|Physician Decision|8|||
17108085|NCT00075582|38245954|FG000|Overall Study|Withdrawal by Subject|2|||
17108086|NCT00075582|38245955|FG001|Overall Study|Withdrawal by Subject|2|||
17108087|NCT00075582|38245954|FG000|Overall Study|Ineligible for study|36|||
17108088|NCT00075582|38245955|FG001|Overall Study|Ineligible for study|16|||
17108089|NCT00063258|38245967|FG000|Overall Study|Physician Decision|2|||
17108090|NCT00063258|38245968|FG001|Overall Study|Physician Decision|0|||
17108091|NCT00063258|38245967|FG000|Overall Study|Lack of Efficacy|2|||
17108092|NCT00063258|38245968|FG001|Overall Study|Lack of Efficacy|0|||
17108093|NCT00088530|38245976|FG000|Overall Study|Progressive/Relapsed Disease|28|||
17108094|NCT00088530|38245977|FG001|Overall Study|Progressive/Relapsed Disease|39|||
17108095|NCT00088530|38245976|FG000|Overall Study|Adverse Event|15|||
17108096|NCT00088530|38245977|FG001|Overall Study|Adverse Event|9|||
17108097|NCT00088530|38245976|FG000|Overall Study|Withdrawal by Subject|2|||
17108098|NCT00088530|38245977|FG001|Overall Study|Withdrawal by Subject|5|||
17108099|NCT00088530|38245976|FG000|Overall Study|Lost to Follow-up|2|||
17108100|NCT00088530|38245977|FG001|Overall Study|Lost to Follow-up|0|||
17108101|NCT00088530|38245976|FG000|Overall Study|Physician Decision|2|||
17108102|NCT00088530|38245977|FG001|Overall Study|Physician Decision|0|||
17108103|NCT00088530|38245976|FG000|Overall Study|Sponsor decision|0|||
17108104|NCT00088530|38245977|FG001|Overall Study|Sponsor decision|1|||
17108105|NCT00088530|38245976|FG000|Overall Study|Patient never treated|1|||
17108106|NCT00088530|38245977|FG001|Overall Study|Patient never treated|0|||
17108107|NCT00359801|38245985|FG000|Overall Study|Lost to Follow-up|72|||
17108108|NCT00359801|38245986|FG001|Overall Study|Lost to Follow-up|58|||
17108109|NCT00359801|38245985|FG000|Overall Study|Withdrawal by Subject|143|||
17108110|NCT00359801|38245986|FG001|Overall Study|Withdrawal by Subject|96|||
17108111|NCT00359801|38245985|FG000|Overall Study|Other|66|||
17108112|NCT00359801|38245986|FG001|Overall Study|Other|46|||
17108113|NCT00359801|38245985|FG000|Overall Study|Final Status Unknown: missing data|7|||
17108114|NCT00359801|38245986|FG001|Overall Study|Final Status Unknown: missing data|4|||
17108115|NCT00359801|38245985|FG000|Overall Study|Sponsor Decision|17|||
17108116|NCT00359801|38245986|FG001|Overall Study|Sponsor Decision|16|||
17108117|NCT00045032|38245995|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
17108118|NCT00045032|38245996|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
17108119|NCT00045032|38245997|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
17108120|NCT00045032|38245995|FG000|Overall Study|Death|22|||
17108121|NCT00045032|38245996|FG001|Overall Study|Death|24|||
17108122|NCT00045032|38245997|FG002|Overall Study|Death|17|||
17108123|NCT00045032|38245995|FG000|Overall Study|Insufficient Therapeutic Response|542|||
17108124|NCT00045032|38245996|FG001|Overall Study|Insufficient Therapeutic Response|437|||
17108125|NCT00045032|38245997|FG002|Overall Study|Insufficient Therapeutic Response|445|||
17108126|NCT00045032|38245995|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
17108127|NCT00045032|38245996|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
17108128|NCT00045032|38245997|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
17108129|NCT00045032|38245995|FG000|Overall Study|Other Protocol Violation|2|||
17108130|NCT00045032|38245996|FG001|Overall Study|Other Protocol Violation|0|||
17108131|NCT00045032|38245997|FG002|Overall Study|Other Protocol Violation|1|||
17108132|NCT00045032|38245995|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
17108133|NCT00045032|38245996|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
17108134|NCT00045032|38245997|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
17108135|NCT00045032|38245995|FG000|Overall Study|Failure to Return|57|||
17108136|NCT00045032|38245996|FG001|Overall Study|Failure to Return|62|||
17108137|NCT00045032|38245997|FG002|Overall Study|Failure to Return|61|||
17108138|NCT00045032|38245995|FG000|Overall Study|Other|93|||
17108139|NCT00045032|38245996|FG001|Overall Study|Other|84|||
17108140|NCT00045032|38245997|FG002|Overall Study|Other|105|||
17108141|NCT00356915|38246010|FG000|Overall Study|Non compliance|1|||
17108142|NCT00356915|38246011|FG001|Overall Study|Non compliance|2|||
17108143|NCT00356915|38246012|FG002|Overall Study|Non compliance|1|||
17108144|NCT00356915|38246010|FG000|Overall Study|Protocol Violation|2|||
17108145|NCT00356915|38246011|FG001|Overall Study|Protocol Violation|3|||
17108146|NCT00356915|38246012|FG002|Overall Study|Protocol Violation|2|||
17108147|NCT00356915|38246010|FG000|Overall Study|Withdrawal by Subject|14|||
17108148|NCT00356915|38246011|FG001|Overall Study|Withdrawal by Subject|14|||
17108149|NCT00356915|38246012|FG002|Overall Study|Withdrawal by Subject|10|||
17108150|NCT00356915|38246010|FG000|Overall Study|Lack of Efficacy|0|||
17108151|NCT00356915|38246011|FG001|Overall Study|Lack of Efficacy|0|||
17108152|NCT00356915|38246012|FG002|Overall Study|Lack of Efficacy|3|||
17108153|NCT00356915|38246010|FG000|Overall Study|Lost to Follow-up|27|||
17108154|NCT00356915|38246011|FG001|Overall Study|Lost to Follow-up|34|||
17108155|NCT00356915|38246012|FG002|Overall Study|Lost to Follow-up|14|||
17108156|NCT00356915|38246010|FG000|Overall Study|Administrative Decision|0|||
17108157|NCT00356915|38246011|FG001|Overall Study|Administrative Decision|0|||
17108158|NCT00356915|38246012|FG002|Overall Study|Administrative Decision|1|||
17108159|NCT00356915|38246010|FG000|Overall Study|Physician Decision|0|||
17108160|NCT00356915|38246011|FG001|Overall Study|Physician Decision|2|||
17108161|NCT00356915|38246012|FG002|Overall Study|Physician Decision|0|||
17108162|NCT00356915|38246010|FG000|Overall Study|Adverse Event|21|||
17108163|NCT00356915|38246011|FG001|Overall Study|Adverse Event|31|||
17108164|NCT00356915|38246012|FG002|Overall Study|Adverse Event|8|||
17108165|NCT00356915|38246010|FG000|Overall Study|Miscellaneous reasons|11|||
17108166|NCT00356915|38246011|FG001|Overall Study|Miscellaneous reasons|8|||
17108167|NCT00356915|38246012|FG002|Overall Study|Miscellaneous reasons|3|||
17108168|NCT00356759|38246028|FG000|Overall Study|Death|5|||
17108169|NCT00356759|38246029|FG001|Overall Study|Death|2|||
17108170|NCT00356759|38246028|FG000|Overall Study|Withdrawal by Subject|2|||
17108171|NCT00356759|38246029|FG001|Overall Study|Withdrawal by Subject|2|||
17108172|NCT00356759|38246028|FG000|Overall Study|Adverse Event|1|||
17108173|NCT00356759|38246029|FG001|Overall Study|Adverse Event|3|||
17108174|NCT00356759|38246028|FG000|Overall Study|Lost to Follow-up|1|||
17108175|NCT00356759|38246029|FG001|Overall Study|Lost to Follow-up|1|||
17108176|NCT00356759|38246028|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
17108177|NCT00356759|38246029|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
17108178|NCT03804710|38246037|FG000|Overall Study|Adverse Event|0|||
17108179|NCT03804710|38246038|FG001|Overall Study|Adverse Event|3|||
17108180|NCT03804710|38246037|FG000|Overall Study|Withdrawal by Subject|2|||
17108181|NCT03804710|38246038|FG001|Overall Study|Withdrawal by Subject|1|||
17108182|NCT03804710|38246037|FG000|Overall Study|Other|0|||
17108183|NCT03804710|38246038|FG001|Overall Study|Other|1|||
17108184|NCT00356603|38246050|FG000|Overall Study|Other|6|||
17108185|NCT00356603|38246051|FG001|Overall Study|Other|3|||
17108186|NCT00002558|38246061|FG000|Overall Study|Withdrawal by Subject|0|||
17108187|NCT00002558|38246062|FG001|Overall Study|Withdrawal by Subject|1|||
17108188|NCT00002540|38246070|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
17108189|NCT00002540|38246071|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
17108190|NCT00002540|38246070|FG000|Overall Study|Died Before Randomization|2|||
17108191|NCT00002540|38246071|FG001|Overall Study|Died Before Randomization|6|||
17108192|NCT00002540|38246070|FG000|Overall Study|Died Before ASU (Control)|202|||
17108193|NCT00002540|38246071|FG001|Overall Study|Died Before ASU (Control)|0|||
17108194|NCT00002540|38246070|FG000|Overall Study|Refused ASU (Control)|597|||
17108195|NCT00002540|38246071|FG001|Overall Study|Refused ASU (Control)|0|||
17108196|NCT00002540|38246070|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
17108197|NCT00002540|38246071|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
17108198|NCT00001880|38246077|FG000|Overall Study|Death|14|||
17108199|NCT00043550|38246084|FG000|Overall Study|Withdrawal by Subject|22|||
17108200|NCT00043550|38246085|FG001|Overall Study|Withdrawal by Subject|12|||
17108201|NCT00043550|38246086|FG002|Overall Study|Withdrawal by Subject|20|||
17108202|NCT00041756|38246099|FG000|Overall Study|Adverse Event|4|||
17108203|NCT00041756|38246100|FG001|Overall Study|Adverse Event|10|||
17108204|NCT00041756|38246101|FG002|Overall Study|Adverse Event|6|||
17108205|NCT00041756|38246102|FG003|Overall Study|Adverse Event|11|||
17108206|NCT00041756|38246103|FG004|Overall Study|Adverse Event|34|||
17108207|NCT00041756|38246099|FG000|Overall Study|Protocol Violation|1|||
17108208|NCT00041756|38246100|FG001|Overall Study|Protocol Violation|1|||
17108209|NCT00041756|38246101|FG002|Overall Study|Protocol Violation|2|||
17108210|NCT00041756|38246102|FG003|Overall Study|Protocol Violation|2|||
17108211|NCT00041756|38246103|FG004|Overall Study|Protocol Violation|1|||
17108212|NCT00041756|38246099|FG000|Overall Study|Withdrawal by Subject|3|||
17108213|NCT00041756|38246100|FG001|Overall Study|Withdrawal by Subject|3|||
17108214|NCT00041756|38246101|FG002|Overall Study|Withdrawal by Subject|4|||
17108215|NCT00041756|38246102|FG003|Overall Study|Withdrawal by Subject|2|||
17108216|NCT00041756|38246103|FG004|Overall Study|Withdrawal by Subject|3|||
17108217|NCT00041756|38246099|FG000|Overall Study|Lost to Follow-up|0|||
17108218|NCT00041756|38246100|FG001|Overall Study|Lost to Follow-up|1|||
17108219|NCT00041756|38246101|FG002|Overall Study|Lost to Follow-up|0|||
17108220|NCT00041756|38246102|FG003|Overall Study|Lost to Follow-up|1|||
17108221|NCT00041756|38246103|FG004|Overall Study|Lost to Follow-up|0|||
17108222|NCT00041756|38246099|FG000|Overall Study|Unable to meet protocol criteria|0|||
17108223|NCT00041756|38246100|FG001|Overall Study|Unable to meet protocol criteria|0|||
17108224|NCT00041756|38246101|FG002|Overall Study|Unable to meet protocol criteria|1|||
17108225|NCT00041756|38246102|FG003|Overall Study|Unable to meet protocol criteria|0|||
17108226|NCT00041756|38246103|FG004|Overall Study|Unable to meet protocol criteria|1|||
17108227|NCT00041756|38246099|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
17108228|NCT00041756|38246100|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
17108229|NCT00041756|38246101|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
17108230|NCT00041756|38246102|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
17108231|NCT00041756|38246103|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
17108232|NCT00041132|38246115|FG000|Overall Study|Adverse Event|19|||
17108233|NCT00041132|38246115|FG000|Overall Study|Death|1|||
17108234|NCT00041132|38246115|FG000|Overall Study|Not Eligible|7|||
17108235|NCT00041132|38246115|FG000|Overall Study|Withdrawal by Subject|1|||
17108236|NCT00041132|38246115|FG000|Overall Study|Physician Decision|2|||
17108237|NCT00040742|38246123|FG000|Overall Study|Death|0|||
17108238|NCT00040742|38246124|FG001|Overall Study|Death|0|||
17108239|NCT00040742|38246125|FG002|Overall Study|Death|1|||
17108240|NCT00040742|38246126|FG003|Overall Study|Death|0|||
17108241|NCT00040742|38246123|FG000|Overall Study|Adverse Event|15|||
17108242|NCT00040742|38246124|FG001|Overall Study|Adverse Event|16|||
17108243|NCT00040742|38246125|FG002|Overall Study|Adverse Event|21|||
17108244|NCT00040742|38246126|FG003|Overall Study|Adverse Event|9|||
17108245|NCT00040742|38246123|FG000|Overall Study|Withdrawal by Subject|7|||
17108246|NCT00040742|38246124|FG001|Overall Study|Withdrawal by Subject|15|||
17108247|NCT00040742|38246125|FG002|Overall Study|Withdrawal by Subject|10|||
17108248|NCT00040742|38246126|FG003|Overall Study|Withdrawal by Subject|13|||
17108249|NCT00040742|38246123|FG000|Overall Study|Chemotoxicity|4|||
17108250|NCT00040742|38246124|FG001|Overall Study|Chemotoxicity|3|||
17108251|NCT00040742|38246125|FG002|Overall Study|Chemotoxicity|5|||
17108252|NCT00040742|38246126|FG003|Overall Study|Chemotoxicity|2|||
17108253|NCT00040742|38246123|FG000|Overall Study|Incomplete Forms|6|||
17108254|NCT00040742|38246124|FG001|Overall Study|Incomplete Forms|10|||
17108255|NCT00040742|38246125|FG002|Overall Study|Incomplete Forms|4|||
17108256|NCT00040742|38246126|FG003|Overall Study|Incomplete Forms|5|||
17108257|NCT00040742|38246123|FG000|Overall Study|Other medical|7|||
17108258|NCT00040742|38246124|FG001|Overall Study|Other medical|5|||
17108259|NCT00040742|38246125|FG002|Overall Study|Other medical|5|||
17108260|NCT00040742|38246126|FG003|Overall Study|Other medical|5|||
17108261|NCT00040664|38246136|FG000|Overall Study|Adverse Event|12|||
17108262|NCT00040664|38246137|FG001|Overall Study|Adverse Event|3|||
17108263|NCT00040664|38246138|FG002|Overall Study|Adverse Event|2|||
17108264|NCT00040664|38246139|FG003|Overall Study|Adverse Event|7|||
17108265|NCT00040664|38246136|FG000|Overall Study|Lack of Efficacy|9|||
17108266|NCT00040664|38246137|FG001|Overall Study|Lack of Efficacy|2|||
17108267|NCT00040664|38246138|FG002|Overall Study|Lack of Efficacy|3|||
17108268|NCT00040664|38246139|FG003|Overall Study|Lack of Efficacy|4|||
17108269|NCT00040664|38246136|FG000|Overall Study|Insufficient CD4 response|1|||
17108270|NCT00040664|38246137|FG001|Overall Study|Insufficient CD4 response|0|||
17108271|NCT00040664|38246138|FG002|Overall Study|Insufficient CD4 response|1|||
17108272|NCT00040664|38246139|FG003|Overall Study|Insufficient CD4 response|0|||
17108273|NCT00040664|38246136|FG000|Overall Study|Lost to Follow-up|4|||
17108274|NCT00040664|38246137|FG001|Overall Study|Lost to Follow-up|2|||
17108275|NCT00040664|38246138|FG002|Overall Study|Lost to Follow-up|0|||
17108276|NCT00040664|38246139|FG003|Overall Study|Lost to Follow-up|2|||
17108277|NCT00040664|38246136|FG000|Overall Study|Protocol Violation|2|||
17108278|NCT00040664|38246137|FG001|Overall Study|Protocol Violation|1|||
17108279|NCT00040664|38246138|FG002|Overall Study|Protocol Violation|0|||
17108280|NCT00040664|38246139|FG003|Overall Study|Protocol Violation|1|||
17108281|NCT00040664|38246136|FG000|Overall Study|Withdrawal by Subject|7|||
17108282|NCT00040664|38246137|FG001|Overall Study|Withdrawal by Subject|0|||
17108283|NCT00040664|38246138|FG002|Overall Study|Withdrawal by Subject|3|||
17108284|NCT00040664|38246139|FG003|Overall Study|Withdrawal by Subject|4|||
17108285|NCT00040664|38246136|FG000|Overall Study|Pregnancy|3|||
17108286|NCT00040664|38246137|FG001|Overall Study|Pregnancy|0|||
17108287|NCT00040664|38246138|FG002|Overall Study|Pregnancy|0|||
17108288|NCT00040664|38246139|FG003|Overall Study|Pregnancy|3|||
17108289|NCT00040664|38246136|FG000|Overall Study|Medication adherence/compliance problems|8|||
17108290|NCT00040664|38246137|FG001|Overall Study|Medication adherence/compliance problems|2|||
17108291|NCT00040664|38246138|FG002|Overall Study|Medication adherence/compliance problems|1|||
17108292|NCT00040664|38246139|FG003|Overall Study|Medication adherence/compliance problems|5|||
17108293|NCT00040664|38246136|FG000|Overall Study|Poor taste|2|||
17108294|NCT00040664|38246137|FG001|Overall Study|Poor taste|0|||
17108295|NCT00040664|38246138|FG002|Overall Study|Poor taste|2|||
17108296|NCT00040664|38246139|FG003|Overall Study|Poor taste|0|||
17108297|NCT00040664|38246136|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
17108298|NCT00040664|38246137|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
17108299|NCT00040664|38246138|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
17108300|NCT00040664|38246139|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
17108301|NCT00040664|38246136|FG000|Overall Study|Change of formulation|2|||
17108302|NCT00040664|38246137|FG001|Overall Study|Change of formulation|2|||
17108303|NCT00040664|38246138|FG002|Overall Study|Change of formulation|0|||
17108304|NCT00040664|38246139|FG003|Overall Study|Change of formulation|0|||
17108305|NCT00040664|38246136|FG000|Overall Study|Non-viability of oral suspension|1|||
17108306|NCT00040664|38246137|FG001|Overall Study|Non-viability of oral suspension|0|||
17108307|NCT00040664|38246138|FG002|Overall Study|Non-viability of oral suspension|1|||
17108308|NCT00040664|38246139|FG003|Overall Study|Non-viability of oral suspension|0|||
17108309|NCT02952586|38246159|FG000|Lead-In Phase (7 Days)|Death|0|||
17108310|NCT02952586|38246160|FG001|Lead-In Phase (7 Days)|Death|1|||
17108311|NCT02952586|38246159|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
17108312|NCT02952586|38246160|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
17108313|NCT02952586|38246159|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
17108314|NCT02952586|38246160|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
17108315|NCT02952586|38246159|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
17108316|NCT02952586|38246160|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
17108317|NCT02952586|38246159|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
17108318|NCT02952586|38246160|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
17108319|NCT02952586|38246159|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
17108320|NCT02952586|38246160|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
17108321|NCT02952586|38246159|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
17108322|NCT02952586|38246160|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
17108323|NCT02952586|38246159|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
17108324|NCT02952586|38246160|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
17108325|NCT02952586|38246159|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
17108326|NCT02952586|38246160|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
17108327|NCT02952586|38246159|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
17108328|NCT02952586|38246160|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
17108329|NCT02952586|38246159|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
17108330|NCT02952586|38246160|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
17108331|NCT02952586|38246159|FG000|CRT for Cisplatin (63 Days)|Death|3|||
17108332|NCT02952586|38246160|FG001|CRT for Cisplatin (63 Days)|Death|8|||
17108333|NCT02952586|38246159|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
17108334|NCT02952586|38246160|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
17108335|NCT02952586|38246159|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
17108336|NCT02952586|38246160|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
17108337|NCT02952586|38246159|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
17108338|NCT02952586|38246160|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
17108339|NCT02952586|38246159|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
17108340|NCT02952586|38246160|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
17108341|NCT02952586|38246159|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
17108342|NCT02952586|38246160|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
17108343|NCT02952586|38246159|FG000|CRT for Cisplatin (63 Days)|Other|1|||
17108344|NCT02952586|38246160|FG001|CRT for Cisplatin (63 Days)|Other|1|||
17108345|NCT02952586|38246159|FG000|CRT for IMRT (63 Days)|Death|5|||
17108346|NCT02952586|38246160|FG001|CRT for IMRT (63 Days)|Death|8|||
17108347|NCT02952586|38246159|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
17108348|NCT02952586|38246160|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
17108349|NCT02952586|38246159|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
17108350|NCT02952586|38246160|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
17108351|NCT02952586|38246159|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
17108352|NCT02952586|38246160|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
17108353|NCT02952586|38246159|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
17108354|NCT02952586|38246160|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
17108355|NCT02952586|38246159|FG000|CRT for IMRT (63 Days)|Other|1|||
17108356|NCT02952586|38246160|FG001|CRT for IMRT (63 Days)|Other|0|||
17108357|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Death|17|||
17108358|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Death|11|||
17108359|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
17108360|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
17108361|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
17108362|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
17108363|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
17108364|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
17108365|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
17108366|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
17108367|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
17108368|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
17108369|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
17108370|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
17108371|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
17108372|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
17108373|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Other|2|||
17108374|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Other|1|||
17108375|NCT02952586|38246159|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
17108376|NCT02952586|38246160|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
17108377|NCT02952586|38246159|FG000|Follow-Up Phase (90 Days)|Death|12|||
17108378|NCT02952586|38246160|FG001|Follow-Up Phase (90 Days)|Death|10|||
17108379|NCT02952586|38246159|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
17108380|NCT02952586|38246160|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
17108381|NCT02952586|38246159|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
17108382|NCT02952586|38246160|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
17108383|NCT02952586|38246159|FG000|Follow-Up Phase (90 Days)|Other|7|||
17108384|NCT02952586|38246160|FG001|Follow-Up Phase (90 Days)|Other|5|||
17108385|NCT02952586|38246159|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
17108386|NCT02952586|38246160|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
17108387|NCT02952586|38246159|FG000|LT Follow-up (up to 45 Months)|Death|51|||
17108388|NCT02952586|38246160|FG001|LT Follow-up (up to 45 Months)|Death|31|||
17108389|NCT02952586|38246159|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
17108390|NCT02952586|38246160|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
17108391|NCT02952586|38246159|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
17108392|NCT02952586|38246160|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
17108393|NCT02952586|38246159|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
17108394|NCT02952586|38246160|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
17108395|NCT03384316|38246169|FG000|Overall Study|Screen failure|0|||
17108396|NCT03384316|38246170|FG001|Overall Study|Screen failure|1|||
17108397|NCT03403192|38246182|FG000|Overall Study|Lost to Follow-up|1|||
17108398|NCT03403192|38246183|FG001|Overall Study|Lost to Follow-up|2|||
17108399|NCT03403192|38246184|FG002|Overall Study|Lost to Follow-up|0|||
17108400|NCT03403192|38246185|FG003|Overall Study|Lost to Follow-up|0|||
17108401|NCT03403192|38246182|FG000|Overall Study|Unable to respond|0|||
17108402|NCT03403192|38246183|FG001|Overall Study|Unable to respond|1|||
17108403|NCT03403192|38246184|FG002|Overall Study|Unable to respond|0|||
17108404|NCT03403192|38246185|FG003|Overall Study|Unable to respond|0|||
17108405|NCT03403192|38246182|FG000|Overall Study|Incomplete|3|||
17108406|NCT03403192|38246183|FG001|Overall Study|Incomplete|1|||
17108407|NCT03403192|38246184|FG002|Overall Study|Incomplete|3|||
17108408|NCT03403192|38246185|FG003|Overall Study|Incomplete|6|||
17108409|NCT03383692|38246197|FG000|Overall Study|Progressive disease as per RECIST|3|||
17108410|NCT03383692|38246198|FG001|Overall Study|Progressive disease as per RECIST|3|||
17108411|NCT03383692|38246197|FG000|Overall Study|Clinical progression|0|||
17108412|NCT03383692|38246198|FG001|Overall Study|Clinical progression|1|||
17108413|NCT03383692|38246197|FG000|Overall Study|Adverse Event|3|||
17108414|NCT03383692|38246198|FG001|Overall Study|Adverse Event|0|||
17108415|NCT00356525|38246210|FG000|Overall Study|Progressive Disease|8|||
17108416|NCT00356525|38246211|FG001|Overall Study|Progressive Disease|5|||
17108417|NCT00356525|38246212|FG002|Overall Study|Progressive Disease|4|||
17108418|NCT00356525|38246213|FG003|Overall Study|Progressive Disease|2|||
17108419|NCT00356525|38246210|FG000|Overall Study|Adverse Event|1|||
17108420|NCT00356525|38246211|FG001|Overall Study|Adverse Event|3|||
17108421|NCT00356525|38246212|FG002|Overall Study|Adverse Event|1|||
17108422|NCT00356525|38246213|FG003|Overall Study|Adverse Event|1|||
17108423|NCT00356525|38246210|FG000|Overall Study|Lost to Follow-up|1|||
17108424|NCT00356525|38246211|FG001|Overall Study|Lost to Follow-up|0|||
17108425|NCT00356525|38246212|FG002|Overall Study|Lost to Follow-up|0|||
17108426|NCT00356525|38246213|FG003|Overall Study|Lost to Follow-up|0|||
17108427|NCT00356525|38246210|FG000|Overall Study|Physician Decision|2|||
17108428|NCT00356525|38246211|FG001|Overall Study|Physician Decision|2|||
17108429|NCT00356525|38246212|FG002|Overall Study|Physician Decision|2|||
17108430|NCT00356525|38246213|FG003|Overall Study|Physician Decision|1|||
17108431|NCT00356525|38246210|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
17108432|NCT00356525|38246211|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
17108433|NCT00356525|38246212|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
17108434|NCT00356525|38246213|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
17108435|NCT00356525|38246210|FG000|Overall Study|Withdrawal by Subject|1|||
17108436|NCT00356525|38246211|FG001|Overall Study|Withdrawal by Subject|1|||
17108437|NCT00356525|38246212|FG002|Overall Study|Withdrawal by Subject|0|||
17108438|NCT00356525|38246213|FG003|Overall Study|Withdrawal by Subject|3|||
17108439|NCT00356525|38246210|FG000|Overall Study|Death|0|||
17108440|NCT00356525|38246211|FG001|Overall Study|Death|0|||
17108441|NCT00356525|38246212|FG002|Overall Study|Death|0|||
17108442|NCT00356525|38246213|FG003|Overall Study|Death|1|||
17108443|NCT00356525|38246210|FG000|Overall Study|Sponsor Decision|0|||
17108444|NCT00356525|38246211|FG001|Overall Study|Sponsor Decision|0|||
17108445|NCT00356525|38246212|FG002|Overall Study|Sponsor Decision|0|||
17108446|NCT00356525|38246213|FG003|Overall Study|Sponsor Decision|1|||
17108447|NCT00356369|38246225|FG000|Active Phase|Withdrawal by Subject|2|||
17108448|NCT00356369|38246226|FG001|Active Phase|Withdrawal by Subject|1|||
17108449|NCT03383614|38246236|FG000|Overall Study|Withdrawal by Subject|0|||
17108450|NCT03383614|38246237|FG001|Overall Study|Withdrawal by Subject|1|||
17108451|NCT03383614|38246238|FG002|Overall Study|Withdrawal by Subject|0|||
17108452|NCT03383614|38246239|FG003|Overall Study|Withdrawal by Subject|0|||
17108453|NCT03403036|38246254|FG000|Overall Study|Lack of Efficacy|5|||
17108454|NCT00356135|38246261|FG000|Overall Study|Protocol Violation|1|||
17108455|NCT00356135|38246262|FG001|Overall Study|Protocol Violation|0|||
17108456|NCT00356135|38246263|FG002|Overall Study|Protocol Violation|0|||
17108457|NCT00356135|38246261|FG000|Overall Study|Adverse Event|1|||
17108458|NCT00356135|38246262|FG001|Overall Study|Adverse Event|0|||
17108459|NCT00356135|38246263|FG002|Overall Study|Adverse Event|0|||
17108460|NCT00356135|38246261|FG000|Overall Study|Lost to Follow-up|0|||
17108461|NCT00356135|38246262|FG001|Overall Study|Lost to Follow-up|0|||
17108462|NCT00356135|38246263|FG002|Overall Study|Lost to Follow-up|1|||
17108463|NCT00356135|38246261|FG000|Overall Study|Physician Decision|1|||
17108464|NCT00356135|38246262|FG001|Overall Study|Physician Decision|1|||
17108465|NCT00356135|38246263|FG002|Overall Study|Physician Decision|1|||
17108466|NCT00356135|38246261|FG000|Overall Study|Subject non-compliance|1|||
17108467|NCT00356135|38246262|FG001|Overall Study|Subject non-compliance|1|||
17108468|NCT00356135|38246263|FG002|Overall Study|Subject non-compliance|3|||
17108469|NCT03383146|38246275|FG000|Overall Study|Screen Failure|1|||
17108470|NCT03383146|38246276|FG001|Overall Study|Screen Failure|0|||
17108471|NCT03383146|38246275|FG000|Overall Study|Adverse Event|6|||
17108472|NCT03383146|38246276|FG001|Overall Study|Adverse Event|18|||
17108473|NCT03383146|38246275|FG000|Overall Study|Lack of Efficacy|0|||
17108474|NCT03383146|38246276|FG001|Overall Study|Lack of Efficacy|3|||
17108475|NCT03383146|38246275|FG000|Overall Study|Withdrawal by Subject|20|||
17108476|NCT03383146|38246276|FG001|Overall Study|Withdrawal by Subject|36|||
17108477|NCT03383146|38246275|FG000|Overall Study|Lost to Follow-up|5|||
17108478|NCT03383146|38246276|FG001|Overall Study|Lost to Follow-up|15|||
17108479|NCT03383146|38246275|FG000|Overall Study|Death|0|||
17108480|NCT03383146|38246276|FG001|Overall Study|Death|2|||
17108481|NCT03383146|38246275|FG000|Overall Study|Physician Decision|0|||
17108482|NCT03383146|38246276|FG001|Overall Study|Physician Decision|1|||
17108483|NCT03383146|38246275|FG000|Overall Study|Protocol Deviation|1|||
17108484|NCT03383146|38246276|FG001|Overall Study|Protocol Deviation|8|||
17108485|NCT03383146|38246275|FG000|Overall Study|Study Terminated by the Sponsor|48|||
17108486|NCT03383146|38246276|FG001|Overall Study|Study Terminated by the Sponsor|95|||
17108487|NCT03383146|38246275|FG000|Overall Study|Reason not Specified|4|||
17108488|NCT03383146|38246276|FG001|Overall Study|Reason not Specified|6|||
17108489|NCT03616964|38246286|FG000|Overall Study|Adverse Event|15|||
17108490|NCT03616964|38246287|FG001|Overall Study|Adverse Event|10|||
17108491|NCT03616964|38246288|FG002|Overall Study|Adverse Event|16|||
17108492|NCT03616964|38246286|FG000|Overall Study|Death|3|||
17108493|NCT03616964|38246287|FG001|Overall Study|Death|0|||
17108494|NCT03616964|38246288|FG002|Overall Study|Death|4|||
17108495|NCT03616964|38246286|FG000|Overall Study|Lack of Efficacy|4|||
17108496|NCT03616964|38246287|FG001|Overall Study|Lack of Efficacy|8|||
17108497|NCT03616964|38246288|FG002|Overall Study|Lack of Efficacy|8|||
17108498|NCT03616964|38246286|FG000|Overall Study|Lost to Follow-up|2|||
17108499|NCT03616964|38246287|FG001|Overall Study|Lost to Follow-up|1|||
17108500|NCT03616964|38246288|FG002|Overall Study|Lost to Follow-up|3|||
17108501|NCT03616964|38246286|FG000|Overall Study|Withdrawal by Subject|18|||
17108502|NCT03616964|38246287|FG001|Overall Study|Withdrawal by Subject|14|||
17108503|NCT03616964|38246288|FG002|Overall Study|Withdrawal by Subject|21|||
17108504|NCT03616964|38246286|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
17108505|NCT03616964|38246287|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
17108506|NCT03616964|38246288|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
17108507|NCT03616964|38246286|FG000|Overall Study|Sponsor's Decision|1|||
17108508|NCT03616964|38246287|FG001|Overall Study|Sponsor's Decision|0|||
17108509|NCT03616964|38246288|FG002|Overall Study|Sponsor's Decision|0|||
17108510|NCT03616964|38246286|FG000|Overall Study|Physician Decision|0|||
17108511|NCT03616964|38246287|FG001|Overall Study|Physician Decision|2|||
17108512|NCT03616964|38246288|FG002|Overall Study|Physician Decision|0|||
17108513|NCT03616964|38246286|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
17108514|NCT03616964|38246287|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
17108515|NCT03616964|38246288|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
17108516|NCT03616964|38246286|FG000|Overall Study|Protocol Violation|0|||
17108517|NCT03616964|38246287|FG001|Overall Study|Protocol Violation|1|||
17108518|NCT03616964|38246288|FG002|Overall Study|Protocol Violation|0|||
17108519|NCT03616964|38246286|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
17108520|NCT03616964|38246287|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
17108521|NCT03616964|38246288|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
17108522|NCT03616964|38246286|FG000|Overall Study|Randomized but Never Treated|1|||
17108523|NCT03616964|38246287|FG001|Overall Study|Randomized but Never Treated|1|||
17108524|NCT03616964|38246288|FG002|Overall Study|Randomized but Never Treated|1|||
17108525|NCT00350519|38246300|FG000|Overall Study|Death|0|||
17108526|NCT00350519|38246301|FG001|Overall Study|Death|1|||
17108527|NCT00350519|38246300|FG000|Overall Study|Physician Decision|0|||
17108528|NCT00350519|38246301|FG001|Overall Study|Physician Decision|1|||
17108529|NCT00350519|38246300|FG000|Overall Study|Protocol Violation|1|||
17108530|NCT00350519|38246301|FG001|Overall Study|Protocol Violation|2|||
17108531|NCT00350519|38246300|FG000|Overall Study|Withdrawal by Subject|3|||
17108532|NCT00350519|38246301|FG001|Overall Study|Withdrawal by Subject|2|||
17108533|NCT03382912|38246309|FG000|Overall Study|Physician Decision|0|||
17108534|NCT03382912|38246310|FG001|Overall Study|Physician Decision|1|||
17108535|NCT03382912|38246309|FG000|Overall Study|Sponsor Decision|6|||
17108536|NCT03382912|38246310|FG001|Overall Study|Sponsor Decision|6|||
17108537|NCT03382912|38246309|FG000|Overall Study|Withdrawal by Subject|0|||
17108538|NCT03382912|38246310|FG001|Overall Study|Withdrawal by Subject|5|||
17108539|NCT00350207|38246319|FG000|Overall Study|Adverse Event|5|||
17108540|NCT00350207|38246320|FG001|Overall Study|Adverse Event|2|||
17108541|NCT00350207|38246321|FG002|Overall Study|Adverse Event|2|||
17108542|NCT00350207|38246319|FG000|Overall Study|Lack of Efficacy|1|||
17108543|NCT00350207|38246320|FG001|Overall Study|Lack of Efficacy|0|||
17108544|NCT00350207|38246321|FG002|Overall Study|Lack of Efficacy|2|||
17108545|NCT00350207|38246319|FG000|Overall Study|Lost to Follow-up|1|||
17108546|NCT00350207|38246320|FG001|Overall Study|Lost to Follow-up|0|||
17108547|NCT00350207|38246321|FG002|Overall Study|Lost to Follow-up|1|||
17108548|NCT00350207|38246319|FG000|Overall Study|Withdrawal by Subject|0|||
17108549|NCT00350207|38246320|FG001|Overall Study|Withdrawal by Subject|1|||
17108550|NCT00350207|38246321|FG002|Overall Study|Withdrawal by Subject|1|||
17108551|NCT00350207|38246319|FG000|Overall Study|Other|1|||
17108552|NCT00350207|38246320|FG001|Overall Study|Other|3|||
17108553|NCT00350207|38246321|FG002|Overall Study|Other|1|||
17108554|NCT00349973|38246331|FG000|Overall Study|Adverse Event|3|||
17108555|NCT00349973|38246332|FG001|Overall Study|Adverse Event|3|||
17108556|NCT00349973|38246331|FG000|Overall Study|Withdrawal by Subject|1|||
17108557|NCT00349973|38246332|FG001|Overall Study|Withdrawal by Subject|0|||
17108558|NCT03187262|38246338|FG000|Induction|Lack of Efficacy|2|||
17108559|NCT03187262|38246338|FG000|Induction|Progressive Disease|4|||
17108560|NCT03187262|38246338|FG000|Consolidation|Progressive Disease|5|||
17108561|NCT03381196|38246344|FG000|Overall Study|Withdrawal by Subject|7|||
17108562|NCT03381196|38246345|FG001|Overall Study|Withdrawal by Subject|7|||
17108563|NCT03381196|38246344|FG000|Overall Study|Other|0|||
17108564|NCT03381196|38246345|FG001|Overall Study|Other|1|||
17108565|NCT03381196|38246344|FG000|Overall Study|Lost to Follow-up|5|||
17108566|NCT03381196|38246345|FG001|Overall Study|Lost to Follow-up|4|||
17108567|NCT03381196|38246344|FG000|Overall Study|Death|0|||
17108568|NCT03381196|38246345|FG001|Overall Study|Death|1|||
17108569|NCT03381196|38246344|FG000|Overall Study|Adverse Event|1|||
17108570|NCT03381196|38246345|FG001|Overall Study|Adverse Event|0|||
17108571|NCT03381196|38246344|FG000|Overall Study|Randomized, not treated|3|||
17108572|NCT03381196|38246345|FG001|Overall Study|Randomized, not treated|6|||
17108573|NCT02950558|38246353|FG000|Overall Study|Lost to Follow-up|2|||
17108574|NCT02950558|38246354|FG001|Overall Study|Lost to Follow-up|0|||
17108575|NCT03345472|38246361|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
17108576|NCT03345472|38246361|FG000|Implant to 3 Months|Physician Decision|1|||
17108577|NCT03345472|38246361|FG000|Implant to 3 Months|Adverse Event|1|||
17108578|NCT03345472|38246361|FG000|3 Months to 12 Months|Physician Decision|3|||
17108579|NCT03345472|38246361|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
17108580|NCT03345472|38246361|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
17108581|NCT03345472|38246361|FG000|3 Months to 12 Months|Adverse Event|1|||
17108582|NCT03345472|38246361|FG000|3 Months to 12 Months|Death|1|||
17108583|NCT00349349|38246368|FG000|Overall Study|Adverse Event|5|||
17108584|NCT00349349|38246369|FG001|Overall Study|Adverse Event|6|||
17108585|NCT00349349|38246370|FG002|Overall Study|Adverse Event|2|||
17108586|NCT00349349|38246368|FG000|Overall Study|Withdrawal by Subject|5|||
17108587|NCT00349349|38246369|FG001|Overall Study|Withdrawal by Subject|2|||
17108588|NCT00349349|38246370|FG002|Overall Study|Withdrawal by Subject|1|||
17108589|NCT00349349|38246368|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
17108590|NCT00349349|38246369|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
17108591|NCT00349349|38246370|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
17108592|NCT00349349|38246368|FG000|Overall Study|Death|13|||
17108593|NCT00349349|38246369|FG001|Overall Study|Death|10|||
17108594|NCT00349349|38246370|FG002|Overall Study|Death|1|||
17108595|NCT00349349|38246368|FG000|Overall Study|Other Treatment Selected|2|||
17108596|NCT00349349|38246369|FG001|Overall Study|Other Treatment Selected|0|||
17108597|NCT00349349|38246370|FG002|Overall Study|Other Treatment Selected|0|||
17108598|NCT00349349|38246368|FG000|Overall Study|Participant Reduced General Condition|0|||
17108599|NCT00349349|38246369|FG001|Overall Study|Participant Reduced General Condition|1|||
17108600|NCT00349349|38246370|FG002|Overall Study|Participant Reduced General Condition|0|||
17108601|NCT00349349|38246368|FG000|Overall Study|Physician Decision|1|||
17108602|NCT00349349|38246369|FG001|Overall Study|Physician Decision|2|||
17108603|NCT00349349|38246370|FG002|Overall Study|Physician Decision|1|||
17108604|NCT00349349|38246368|FG000|Overall Study|No Response|0|||
17108605|NCT00349349|38246369|FG001|Overall Study|No Response|3|||
17108606|NCT00349349|38246370|FG002|Overall Study|No Response|0|||
17108607|NCT00349349|38246368|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
17108608|NCT00349349|38246369|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
17108609|NCT00349349|38246370|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
17108610|NCT02950480|38246382|FG000|Overall Study|Withdrawal by Subject|1|||
17108611|NCT02950480|38246383|FG001|Overall Study|Withdrawal by Subject|0|||
17108612|NCT00348881|38246391|FG000|Overall Study|Lost to Follow-up|12|||
17108613|NCT00348881|38246392|FG001|Overall Study|Lost to Follow-up|6|||
17108614|NCT00348881|38246391|FG000|Overall Study|Withdrawal by Subject|3|||
17108615|NCT00348881|38246392|FG001|Overall Study|Withdrawal by Subject|4|||
17108616|NCT00348881|38246391|FG000|Overall Study|Adverse Event|2|||
17108617|NCT00348881|38246392|FG001|Overall Study|Adverse Event|0|||
17108618|NCT00348881|38246391|FG000|Overall Study|Serious Adverse Event|0|||
17108619|NCT00348881|38246392|FG001|Overall Study|Serious Adverse Event|2|||
17108620|NCT03376516|38246402|FG000|Overall Study|Not treated|1|||
17108621|NCT03376516|38246402|FG000|Overall Study|Consent withdrawn|1|||
17108622|NCT03797144|38246428|FG000|Enrollment|Protocol Violation|4|||
17108623|NCT03797144|38246429|FG001|Enrollment|Protocol Violation|1|||
17108624|NCT03797144|38246428|FG000|Surgery|Protocol Violation|1|||
17108625|NCT03797144|38246429|FG001|Surgery|Protocol Violation|0|||
17108626|NCT03797144|38246428|FG000|3 Month|Early termination cut-off date|2|||
17108627|NCT03797144|38246429|FG001|3 Month|Early termination cut-off date|0|||
17108628|NCT03797144|38246428|FG000|12 Month|Early termination cut-off date|8|||
17108629|NCT03797144|38246429|FG001|12 Month|Early termination cut-off date|9|||
17108630|NCT03797144|38246428|FG000|24 Month|Early termination cut-off date|1|||
17108631|NCT03797144|38246429|FG001|24 Month|Early termination cut-off date|1|||
17108632|NCT00347009|38246436|FG000|Overall Study|Death|1|||
17108633|NCT00347009|38246436|FG000|Overall Study|Adverse Event|6|||
17108634|NCT00347009|38246436|FG000|Overall Study|Withdrawal by Subject|3|||
17108635|NCT00347009|38246436|FG000|Overall Study|Physician Decision|5|||
17108636|NCT00347009|38246436|FG000|Overall Study|Lost to Follow-up|4|||
17108637|NCT00347009|38246436|FG000|Overall Study|Protocol Violation|2|||
17108638|NCT00347009|38246436|FG000|Overall Study|Adverse Laboratory Experience|1|||
17108639|NCT00347009|38246436|FG000|Overall Study|Insufficient Viral Suppression|3|||
17108640|NCT00347009|38246436|FG000|Overall Study|Increased ALT/HBV DNA|1|||
17108641|NCT00347009|38246436|FG000|Overall Study|Serious Adverse Event|1|||
17108642|NCT00346775|38246444|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
17108643|NCT00346775|38246445|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
17108644|NCT00346775|38246444|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
17108645|NCT00346775|38246445|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
17108646|NCT00346775|38246444|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
17108647|NCT00346775|38246445|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
17108648|NCT00346697|38246457|FG000|Overall Study|Lost to Follow-up|0|||
17108649|NCT00346697|38246458|FG001|Overall Study|Lost to Follow-up|1|||
17108650|NCT03400852|38246468|FG000|Blinded Treatment Period|Physician Decision|0|||
17108651|NCT03400852|38246469|FG001|Blinded Treatment Period|Physician Decision|1|||
17108652|NCT03400852|38246470|FG002|Blinded Treatment Period|Physician Decision|0|||
17108653|NCT03400852|38246468|FG000|Blinded Treatment Period|Adverse Event|1|||
17108654|NCT03400852|38246469|FG001|Blinded Treatment Period|Adverse Event|1|||
17108655|NCT03400852|38246470|FG002|Blinded Treatment Period|Adverse Event|0|||
17108656|NCT03400852|38246468|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
17108657|NCT03400852|38246469|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
17108658|NCT03400852|38246470|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
17108659|NCT03400852|38246468|FG000|Open Label Period|Physician Decision|0|||
17108660|NCT03400852|38246469|FG001|Open Label Period|Physician Decision|0|||
17108661|NCT03400852|38246470|FG002|Open Label Period|Physician Decision|1|||
17108662|NCT03400852|38246468|FG000|Open Label Period|Study terminated by sponsor|0|||
17108663|NCT03400852|38246469|FG001|Open Label Period|Study terminated by sponsor|0|||
17108664|NCT03400852|38246470|FG002|Open Label Period|Study terminated by sponsor|21|||
17108665|NCT03398356|38246481|FG000|Before Treatment|Lost to Follow-up|1|||
17108666|NCT03398356|38246482|FG001|Before Treatment|Lost to Follow-up|2|||
17108667|NCT03398356|38246483|FG002|Before Treatment|Lost to Follow-up|0|||
17108668|NCT03398356|38246481|FG000|Before Treatment|drug intolerance|2|||
17108669|NCT03398356|38246482|FG001|Before Treatment|drug intolerance|1|||
17108670|NCT03398356|38246483|FG002|Before Treatment|drug intolerance|0|||
17108671|NCT03398356|38246481|FG000|Before Treatment|Withdrawal by Subject|0|||
17108672|NCT03398356|38246482|FG001|Before Treatment|Withdrawal by Subject|5|||
17108673|NCT03398356|38246483|FG002|Before Treatment|Withdrawal by Subject|0|||
17108674|NCT03398356|38246481|FG000|Before Treatment|Physician Decision|0|||
17108675|NCT03398356|38246482|FG001|Before Treatment|Physician Decision|0|||
17108676|NCT03398356|38246483|FG002|Before Treatment|Physician Decision|11|||
17108677|NCT03398356|38246481|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
17108678|NCT03398356|38246482|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
17108679|NCT03398356|38246483|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
17108680|NCT00346151|38246491|FG000|Overall Study|Withdrawal by Subject|3|||
17108681|NCT00130286|38246499|FG000|Overall Study|Withdrawal by Subject|0|||
17108682|NCT00130286|38246500|FG001|Overall Study|Withdrawal by Subject|1|||
17108683|NCT00130286|38246501|FG002|Overall Study|Withdrawal by Subject|2|||
17108684|NCT00130286|38246502|FG003|Overall Study|Withdrawal by Subject|2|||
17108685|NCT00130286|38246499|FG000|Overall Study|Adverse Event|0|||
17108686|NCT00130286|38246500|FG001|Overall Study|Adverse Event|0|||
17108687|NCT00130286|38246501|FG002|Overall Study|Adverse Event|2|||
17108688|NCT00130286|38246502|FG003|Overall Study|Adverse Event|0|||
17108689|NCT00130286|38246499|FG000|Overall Study|Missing lab specimens|0|||
17108690|NCT00130286|38246500|FG001|Overall Study|Missing lab specimens|2|||
17108691|NCT00130286|38246501|FG002|Overall Study|Missing lab specimens|0|||
17108692|NCT00130286|38246502|FG003|Overall Study|Missing lab specimens|0|||
17108693|NCT00346073|38246514|FG000|Overall Study|Serious Adverse Event|2|||
17108694|NCT00346073|38246515|FG001|Overall Study|Serious Adverse Event|0|||
17108695|NCT00346073|38246514|FG000|Overall Study|Lost to Follow-up|39|||
17108696|NCT00346073|38246515|FG001|Overall Study|Lost to Follow-up|24|||
17108697|NCT03374488|38246523|FG000|Overall Study|Death|13|||
17108698|NCT03374488|38246524|FG001|Overall Study|Death|13|||
17108699|NCT03374488|38246523|FG000|Overall Study|Withdrawal by Subject|3|||
17108700|NCT03374488|38246524|FG001|Overall Study|Withdrawal by Subject|1|||
17108701|NCT03374488|38246523|FG000|Overall Study|Physician Decision|3|||
17108702|NCT03374488|38246524|FG001|Overall Study|Physician Decision|0|||
17108703|NCT00345683|38246533|FG000|Overall Study|Lost to Follow-up|19|||
17108704|NCT00345683|38246534|FG001|Overall Study|Lost to Follow-up|7|||
17108705|NCT00345683|38246533|FG000|Overall Study|Other|6|||
17108706|NCT00345683|38246534|FG001|Overall Study|Other|2|||
17108707|NCT03828383|38246542|FG000|Overall Study|Lost to Follow-up|3|||
17108708|NCT03828383|38246543|FG001|Overall Study|Lost to Follow-up|2|||
17108709|NCT03828383|38246542|FG000|Overall Study|Withdrawal by Subject|4|||
17108710|NCT03828383|38246543|FG001|Overall Study|Withdrawal by Subject|5|||
17108711|NCT00345605|38246549|FG000|Arm 1|Adverse Event|0|||
17108712|NCT00345605|38246550|FG001|Arm 1|Adverse Event|1|||
17108713|NCT00345605|38246549|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
17108714|NCT00345605|38246550|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
17108715|NCT03394924|38246561|FG000|Overall Study|Adverse Event|0|||
17108716|NCT03394924|38246562|FG001|Overall Study|Adverse Event|5|||
17108717|NCT03394924|38246563|FG002|Overall Study|Adverse Event|0|||
17108718|NCT03394924|38246561|FG000|Overall Study|Withdrawal by Subject|2|||
17108719|NCT03394924|38246562|FG001|Overall Study|Withdrawal by Subject|0|||
17108720|NCT03394924|38246563|FG002|Overall Study|Withdrawal by Subject|0|||
17108721|NCT03394924|38246561|FG000|Overall Study|Lost to Follow-up|0|||
17108722|NCT03394924|38246562|FG001|Overall Study|Lost to Follow-up|1|||
17108723|NCT03394924|38246563|FG002|Overall Study|Lost to Follow-up|0|||
17108724|NCT03394924|38246561|FG000|Overall Study|Did not meet all inclusion criteria|1|||
17108725|NCT03394924|38246562|FG001|Overall Study|Did not meet all inclusion criteria|0|||
17108726|NCT03394924|38246563|FG002|Overall Study|Did not meet all inclusion criteria|0|||
17108727|NCT00345293|38246573|FG000|Overall Study|Unable to access line for sample|1|||
17108728|NCT00345293|38246574|FG001|Overall Study|Unable to access line for sample|0|||
17108729|NCT00345293|38246573|FG000|Overall Study|Withdrawal by Subject|1|||
17108730|NCT00345293|38246574|FG001|Overall Study|Withdrawal by Subject|0|||
17108731|NCT00355121|38246583|FG000|Overall Study|Did not receive study vaccine|1|||
17108732|NCT00355121|38246584|FG001|Overall Study|Did not receive study vaccine|0|||
17108733|NCT00355121|38246585|FG002|Overall Study|Did not receive study vaccine|1|||
17108734|NCT00355121|38246583|FG000|Overall Study|Adverse Event|0|||
17108735|NCT00355121|38246584|FG001|Overall Study|Adverse Event|1|||
17108736|NCT00355121|38246585|FG002|Overall Study|Adverse Event|0|||
17108737|NCT00355121|38246583|FG000|Overall Study|Protocol Violation|7|||
17108738|NCT00355121|38246584|FG001|Overall Study|Protocol Violation|9|||
17108739|NCT00355121|38246585|FG002|Overall Study|Protocol Violation|1|||
17108740|NCT00355121|38246583|FG000|Overall Study|Lost to Follow-up|4|||
17108741|NCT00355121|38246584|FG001|Overall Study|Lost to Follow-up|7|||
17108742|NCT00355121|38246585|FG002|Overall Study|Lost to Follow-up|1|||
17108743|NCT00355121|38246583|FG000|Overall Study|Withdrawal by Subject|9|||
17108744|NCT00355121|38246584|FG001|Overall Study|Withdrawal by Subject|10|||
17108745|NCT00355121|38246585|FG002|Overall Study|Withdrawal by Subject|2|||
17108746|NCT00355121|38246583|FG000|Overall Study|Serious adverse events|0|||
17108747|NCT00355121|38246584|FG001|Overall Study|Serious adverse events|2|||
17108748|NCT00355121|38246585|FG002|Overall Study|Serious adverse events|0|||
17108749|NCT00343889|38246598|FG000|Overall Study|Lost to Follow-up|2|||
17108750|NCT00343889|38246599|FG001|Overall Study|Lost to Follow-up|0|||
17108751|NCT00343889|38246598|FG000|Overall Study|Withdrawal by Subject|0|||
17108752|NCT00343889|38246599|FG001|Overall Study|Withdrawal by Subject|1|||
17108753|NCT00343889|38246598|FG000|Overall Study|Protocol Violation|1|||
17108754|NCT00343889|38246599|FG001|Overall Study|Protocol Violation|0|||
17108755|NCT03343054|38246608|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
17108756|NCT03343054|38246609|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
17108757|NCT03343054|38246610|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
17108758|NCT03343054|38246608|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
17108759|NCT03343054|38246609|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
17108760|NCT03343054|38246610|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
17108761|NCT03343054|38246608|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
17108762|NCT03343054|38246609|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
17108763|NCT03343054|38246610|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
17108764|NCT03343054|38246608|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
17108765|NCT03343054|38246609|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
17108766|NCT03343054|38246610|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
17108767|NCT00354341|38246621|FG000|Overall Study|Adverse Event|1|||
17108768|NCT00354341|38246622|FG001|Overall Study|Adverse Event|0|||
17108769|NCT00354341|38246621|FG000|Overall Study|Death|0|||
17108770|NCT00354341|38246622|FG001|Overall Study|Death|2|||
17108771|NCT00354341|38246621|FG000|Overall Study|Refused treatment|1|||
17108772|NCT00354341|38246622|FG001|Overall Study|Refused treatment|2|||
17108773|NCT00354341|38246621|FG000|Overall Study|Failure to return|0|||
17108774|NCT00354341|38246622|FG001|Overall Study|Failure to return|1|||
17108775|NCT00354341|38246621|FG000|Overall Study|Other|1|||
17108776|NCT00354341|38246622|FG001|Overall Study|Other|2|||
17108777|NCT00354107|38246628|FG000|Overall Study|Adverse Event|2|||
17108778|NCT00354107|38246628|FG000|Overall Study|Physician Decision|2|||
17108779|NCT00354107|38246628|FG000|Overall Study|Withdrawal by Subject|1|||
17108780|NCT00354029|38246634|FG000|Overall Study|Protocol Violation|4|||
17108781|NCT00354029|38246635|FG001|Overall Study|Protocol Violation|2|||
17108782|NCT00353873|38246643|FG000|Overall Study|Protocol Violation|1|||
17108783|NCT00353873|38246644|FG001|Overall Study|Protocol Violation|2|||
17108784|NCT00353873|38246643|FG000|Overall Study|Exacerbation|1|||
17108785|NCT00353873|38246644|FG001|Overall Study|Exacerbation|0|||
17108786|NCT00353873|38246643|FG000|Overall Study|Adverse Event|1|||
17108787|NCT00353873|38246644|FG001|Overall Study|Adverse Event|0|||
17108788|NCT00353873|38246643|FG000|Overall Study|Physician Decision|2|||
17108789|NCT00353873|38246644|FG001|Overall Study|Physician Decision|0|||
17108790|NCT00353873|38246643|FG000|Overall Study|Withdrawal by Subject|1|||
17108791|NCT00353873|38246644|FG001|Overall Study|Withdrawal by Subject|1|||
17108792|NCT03796676|38246653|FG000|Overall Study|Adverse Event|2|||
17108793|NCT03796676|38246654|FG001|Overall Study|Adverse Event|1|||
17108794|NCT03796676|38246655|FG002|Overall Study|Adverse Event|2|||
17108795|NCT03796676|38246653|FG000|Overall Study|Lost to Follow-up|2|||
17108796|NCT03796676|38246654|FG001|Overall Study|Lost to Follow-up|1|||
17108797|NCT03796676|38246655|FG002|Overall Study|Lost to Follow-up|0|||
17108798|NCT03796676|38246653|FG000|Overall Study|Protocol Violation|0|||
17108799|NCT03796676|38246654|FG001|Overall Study|Protocol Violation|0|||
17108800|NCT03796676|38246655|FG002|Overall Study|Protocol Violation|1|||
17108801|NCT03796676|38246653|FG000|Overall Study|Withdrawal by Subject|1|||
17108802|NCT03796676|38246654|FG001|Overall Study|Withdrawal by Subject|1|||
17108803|NCT03796676|38246655|FG002|Overall Study|Withdrawal by Subject|0|||
17108804|NCT03796676|38246653|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
17108805|NCT03796676|38246654|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
17108806|NCT03796676|38246655|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
17108807|NCT03342898|38246669|FG000|Overall Study|Adverse Event|3|||
17108808|NCT03342898|38246670|FG001|Overall Study|Adverse Event|1|||
17108809|NCT03342898|38246671|FG002|Overall Study|Adverse Event|0|||
17108810|NCT03342898|38246669|FG000|Overall Study|Lost to Follow-up|44|||
17108811|NCT03342898|38246670|FG001|Overall Study|Lost to Follow-up|40|||
17108812|NCT03342898|38246671|FG002|Overall Study|Lost to Follow-up|42|||
17108813|NCT03342898|38246669|FG000|Overall Study|Withdrawal of Consent|5|||
17108814|NCT03342898|38246670|FG001|Overall Study|Withdrawal of Consent|9|||
17108815|NCT03342898|38246671|FG002|Overall Study|Withdrawal of Consent|11|||
17108816|NCT03342898|38246669|FG000|Overall Study|Death|0|||
17108817|NCT03342898|38246670|FG001|Overall Study|Death|1|||
17108818|NCT03342898|38246671|FG002|Overall Study|Death|1|||
17108819|NCT03342898|38246669|FG000|Overall Study|Reason not Specified|2|||
17108820|NCT03342898|38246670|FG001|Overall Study|Reason not Specified|2|||
17108821|NCT03342898|38246671|FG002|Overall Study|Reason not Specified|0|||
17108822|NCT00339833|38246681|FG000|Overall Study|Withdrawal by Subject|1|||
17108823|NCT00339833|38246682|FG001|Overall Study|Withdrawal by Subject|2|||
17108824|NCT00339833|38246681|FG000|Overall Study|toothache|0|||
17108825|NCT00339833|38246682|FG001|Overall Study|toothache|1|||
17108826|NCT00339833|38246681|FG000|Overall Study|indigestion|0|||
17108827|NCT00339833|38246682|FG001|Overall Study|indigestion|1|||
17108828|NCT00339833|38246681|FG000|Overall Study|Chest pain|0|||
17108829|NCT00339833|38246682|FG001|Overall Study|Chest pain|1|||
17108830|NCT00339833|38246681|FG000|Overall Study|minor infection|0|||
17108831|NCT00339833|38246682|FG001|Overall Study|minor infection|1|||
17108832|NCT00339833|38246681|FG000|Overall Study|Poor venous access|2|||
17108833|NCT00339833|38246682|FG001|Overall Study|Poor venous access|2|||
17108834|NCT00339833|38246681|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
17108835|NCT00339833|38246682|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
17108836|NCT00339833|38246681|FG000|Overall Study|Error in data records|1|||
17108837|NCT00339833|38246682|FG001|Overall Study|Error in data records|0|||
17108838|NCT03793556|38246690|FG000|Overall Study|Withdrawal by Subject|12|||
17108839|NCT03793556|38246691|FG001|Overall Study|Withdrawal by Subject|1|||
17108840|NCT03793556|38246690|FG000|Overall Study|Lost to Follow-up|1|||
17108841|NCT03793556|38246691|FG001|Overall Study|Lost to Follow-up|1|||
17108842|NCT03392194|38246702|FG000|Overall Study|Withdrawal by Subject|1|||
17108843|NCT03392194|38246703|FG001|Overall Study|Withdrawal by Subject|2|||
17108844|NCT03392194|38246702|FG000|Overall Study|Conflicts with personal schedule|1|||
17108845|NCT03392194|38246703|FG001|Overall Study|Conflicts with personal schedule|0|||
17108846|NCT03828617|38246713|FG000|Overall Study|Lost to Follow-up|22|||
17108847|NCT03828617|38246714|FG001|Overall Study|Lost to Follow-up|12|||
17108848|NCT03828617|38246715|FG002|Overall Study|Lost to Follow-up|23|||
17108849|NCT03828617|38246716|FG003|Overall Study|Lost to Follow-up|7|||
17108850|NCT03828617|38246713|FG000|Overall Study|No longer met eligibility criteria|0|||
17108851|NCT03828617|38246714|FG001|Overall Study|No longer met eligibility criteria|1|||
17108852|NCT03828617|38246715|FG002|Overall Study|No longer met eligibility criteria|1|||
17108853|NCT03828617|38246716|FG003|Overall Study|No longer met eligibility criteria|3|||
17108854|NCT03828617|38246713|FG000|Overall Study|Protocol Violation|0|||
17108855|NCT03828617|38246714|FG001|Overall Study|Protocol Violation|2|||
17108856|NCT03828617|38246715|FG002|Overall Study|Protocol Violation|0|||
17108857|NCT03828617|38246716|FG003|Overall Study|Protocol Violation|0|||
17108858|NCT03828617|38246713|FG000|Overall Study|Withdrawal by Subject|2|||
17108859|NCT03828617|38246714|FG001|Overall Study|Withdrawal by Subject|0|||
17108860|NCT03828617|38246715|FG002|Overall Study|Withdrawal by Subject|2|||
17108861|NCT03828617|38246716|FG003|Overall Study|Withdrawal by Subject|0|||
17108862|NCT03391960|38246725|FG000|Overall Study|Protocol Violation|0|||
17108863|NCT03391960|38246726|FG001|Overall Study|Protocol Violation||||
17108864|NCT03390166|38246752|FG000|Overall Study|Death|0|||
17108865|NCT03390166|38246753|FG001|Overall Study|Death|1|||
17108866|NCT03390166|38246752|FG000|Overall Study|Lost to Follow-up|6|||
17108867|NCT03390166|38246753|FG001|Overall Study|Lost to Follow-up|4|||
17108868|NCT03390166|38246752|FG000|Overall Study|Physician Decision|2|||
17108869|NCT03390166|38246753|FG001|Overall Study|Physician Decision|1|||
17108870|NCT03390166|38246752|FG000|Overall Study|Move from study area|3|||
17108871|NCT03390166|38246753|FG001|Overall Study|Move from study area|2|||
17108872|NCT03390166|38246752|FG000|Overall Study|To militarycamp for conscript|1|||
17108873|NCT03390166|38246753|FG001|Overall Study|To militarycamp for conscript|0|||
17108874|NCT03390166|38246752|FG000|Overall Study|To drug therapy course|0|||
17108875|NCT03390166|38246753|FG001|Overall Study|To drug therapy course|1|||
17108876|NCT03390166|38246752|FG000|Overall Study|Move to work oversea|0|||
17108877|NCT03390166|38246753|FG001|Overall Study|Move to work oversea|1|||
17108878|NCT03828539|38246761|FG000|Overall Study|Adverse Event|3|||
17108879|NCT03828539|38246762|FG001|Overall Study|Adverse Event|12|||
17108880|NCT03828539|38246761|FG000|Overall Study|Patient's/guardian's decision|3|||
17108881|NCT03828539|38246762|FG001|Overall Study|Patient's/guardian's decision|5|||
17108882|NCT03828539|38246761|FG000|Overall Study|Lost to Follow-up|4|||
17108883|NCT03828539|38246762|FG001|Overall Study|Lost to Follow-up|2|||
17108884|NCT03828539|38246761|FG000|Overall Study|Protocol Violation|3|||
17108885|NCT03828539|38246762|FG001|Overall Study|Protocol Violation|2|||
17108886|NCT03828539|38246761|FG000|Overall Study|Withdrawal of informed consent|2|||
17108887|NCT03828539|38246762|FG001|Overall Study|Withdrawal of informed consent|1|||
17108888|NCT03828539|38246761|FG000|Overall Study|New therapy for study indication|1|||
17108889|NCT03828539|38246762|FG001|Overall Study|New therapy for study indication|0|||
17108890|NCT03336502|38246770|FG000|Overall Study|Physician Decision|0|||
17108891|NCT03336502|38246771|FG001|Overall Study|Physician Decision|1|||
17108892|NCT03336502|38246770|FG000|Overall Study|Prohibited Drugs|1|||
17108893|NCT03336502|38246771|FG001|Overall Study|Prohibited Drugs|1|||
17108894|NCT03336502|38246770|FG000|Overall Study|Death|1|||
17108895|NCT03336502|38246771|FG001|Overall Study|Death|2|||
17108896|NCT03336502|38246770|FG000|Overall Study|Adverse Event|2|||
17108897|NCT03336502|38246771|FG001|Overall Study|Adverse Event|5|||
17108898|NCT02949934|38246783|FG000|Natural Drinking Period|Adverse Event|1|||
17108899|NCT02949934|38246784|FG001|Natural Drinking Period|Adverse Event|0|||
17108900|NCT02949934|38246785|FG002|Natural Drinking Period|Adverse Event|0|||
17108901|NCT02949934|38246786|FG003|Natural Drinking Period|Adverse Event|1|||
17108902|NCT02949934|38246787|FG004|Natural Drinking Period|Adverse Event|0|||
17108903|NCT02949934|38246788|FG005|Natural Drinking Period|Adverse Event|0|||
17108904|NCT02949934|38246783|FG000|Natural Drinking Period|Lost to Follow-up|0|||
17108905|NCT02949934|38246784|FG001|Natural Drinking Period|Lost to Follow-up|0|||
17108906|NCT02949934|38246785|FG002|Natural Drinking Period|Lost to Follow-up|0|||
17108907|NCT02949934|38246786|FG003|Natural Drinking Period|Lost to Follow-up|0|||
17108908|NCT02949934|38246787|FG004|Natural Drinking Period|Lost to Follow-up|1|||
17108909|NCT02949934|38246788|FG005|Natural Drinking Period|Lost to Follow-up|0|||
17108910|NCT02949934|38246783|FG000|Neuroimaging|Protocol Violation|2|||
17108911|NCT02949934|38246784|FG001|Neuroimaging|Protocol Violation|0|||
17108912|NCT02949934|38246785|FG002|Neuroimaging|Protocol Violation|0|||
17108913|NCT02949934|38246786|FG003|Neuroimaging|Protocol Violation|0|||
17108914|NCT02949934|38246787|FG004|Neuroimaging|Protocol Violation|1|||
17108915|NCT02949934|38246788|FG005|Neuroimaging|Protocol Violation|0|||
17108916|NCT02949934|38246783|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
17108917|NCT02949934|38246784|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
17108918|NCT02949934|38246785|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
17108919|NCT02949934|38246786|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
17108920|NCT02949934|38246787|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
17108921|NCT02949934|38246788|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
17108922|NCT02949934|38246783|FG000|Neuroimaging|Not scanned|0|||
17108923|NCT02949934|38246784|FG001|Neuroimaging|Not scanned|0|||
17108924|NCT02949934|38246785|FG002|Neuroimaging|Not scanned|1|||
17108925|NCT02949934|38246786|FG003|Neuroimaging|Not scanned|0|||
17108926|NCT02949934|38246787|FG004|Neuroimaging|Not scanned|0|||
17108927|NCT02949934|38246788|FG005|Neuroimaging|Not scanned|2|||
17108928|NCT02949934|38246783|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
17108929|NCT02949934|38246784|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
17108930|NCT02949934|38246785|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
17108931|NCT02949934|38246786|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
17108932|NCT02949934|38246787|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
17108933|NCT02949934|38246788|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
17108934|NCT02949934|38246783|FG000|Bar Laboratory|Adverse Event|1|||
17108935|NCT02949934|38246784|FG001|Bar Laboratory|Adverse Event|0|||
17108936|NCT02949934|38246785|FG002|Bar Laboratory|Adverse Event|2|||
17108937|NCT02949934|38246786|FG003|Bar Laboratory|Adverse Event|0|||
17108938|NCT02949934|38246787|FG004|Bar Laboratory|Adverse Event|1|||
17108939|NCT02949934|38246788|FG005|Bar Laboratory|Adverse Event|0|||
17108940|NCT02949934|38246783|FG000|Bar Laboratory|Protocol Violation|0|||
17108941|NCT02949934|38246784|FG001|Bar Laboratory|Protocol Violation|0|||
17108942|NCT02949934|38246785|FG002|Bar Laboratory|Protocol Violation|0|||
17108943|NCT02949934|38246786|FG003|Bar Laboratory|Protocol Violation|1|||
17108944|NCT02949934|38246787|FG004|Bar Laboratory|Protocol Violation|0|||
17108945|NCT02949934|38246788|FG005|Bar Laboratory|Protocol Violation|0|||
17108946|NCT00338741|38246804|FG000|Overall Study|Lost to Follow-up|2|||
17108947|NCT00338741|38246805|FG001|Overall Study|Lost to Follow-up|0|||
17108948|NCT03370510|38246813|FG000|Overall Study|COVID-19|2|||
17108949|NCT03370510|38246814|FG001|Overall Study|COVID-19|0|||
17108950|NCT00351611|38246822|FG000|Overall Study|Adverse Event|11|||
17108951|NCT00351611|38246823|FG001|Overall Study|Adverse Event|3|||
17108952|NCT00351611|38246822|FG000|Overall Study|Death|1|||
17108953|NCT00351611|38246823|FG001|Overall Study|Death|0|||
17108954|NCT00351611|38246822|FG000|Overall Study|Lost to Follow-up|1|||
17108955|NCT00351611|38246823|FG001|Overall Study|Lost to Follow-up|0|||
17108956|NCT00351611|38246822|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
17108957|NCT00351611|38246823|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
17108958|NCT00351611|38246822|FG000|Overall Study|Other|1|||
17108959|NCT00351611|38246823|FG001|Overall Study|Other|0|||
17108960|NCT00351611|38246822|FG000|Overall Study|Protocol Violation|0|||
17108961|NCT00351611|38246823|FG001|Overall Study|Protocol Violation|2|||
17108962|NCT03789110|38246829|FG000|Overall Study|Adverse Event|2|||
17108963|NCT03789110|38246829|FG000|Overall Study|Physician Decision|1|||
17108964|NCT03789110|38246829|FG000|Overall Study|Withdrawal by Subject|2|||
17108965|NCT03789110|38246829|FG000|Overall Study|Lack of Efficacy|22|||
17108966|NCT03789110|38246829|FG000|Overall Study|still on treatment|3|||
17108967|NCT00351533|38246835|FG000|Overall Study|Extubated before first BAL|1|||
17108968|NCT00351533|38246836|FG001|Overall Study|Extubated before first BAL|0|||
17108969|NCT00351533|38246835|FG000|Overall Study|Lost to Follow-up|1|||
17108970|NCT00351533|38246836|FG001|Overall Study|Lost to Follow-up|3|||
17108971|NCT00351533|38246835|FG000|Overall Study|Physician Decision|0|||
17108972|NCT00351533|38246836|FG001|Overall Study|Physician Decision|1|||
17108973|NCT00351533|38246835|FG000|Overall Study|Withdrawal by Subject|0|||
17108974|NCT00351533|38246836|FG001|Overall Study|Withdrawal by Subject|1|||
17108975|NCT00351377|38246842|FG000|Overall Study|Adverse Event|5|||
17108976|NCT00351377|38246842|FG000|Overall Study|Death|1|||
17108977|NCT00351377|38246842|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
17108978|NCT00337727|38246848|FG000|Overall Study|Adverse Event|5|||
17108979|NCT00337727|38246849|FG001|Overall Study|Adverse Event|3|||
17108980|NCT00337727|38246848|FG000|Overall Study|Lost to Follow-up|5|||
17108981|NCT00337727|38246849|FG001|Overall Study|Lost to Follow-up|4|||
17108982|NCT00337727|38246848|FG000|Overall Study|Physician Decision|1|||
17108983|NCT00337727|38246849|FG001|Overall Study|Physician Decision|0|||
17108984|NCT00337727|38246848|FG000|Overall Study|Protocol Violation|4|||
17108985|NCT00337727|38246849|FG001|Overall Study|Protocol Violation|0|||
17108986|NCT00337727|38246848|FG000|Overall Study|Withdrawal by Subject|3|||
17108987|NCT00337727|38246849|FG001|Overall Study|Withdrawal by Subject|5|||
17108988|NCT00324233|38246857|FG000|First Period|unable to insert catheter|1|||
17108989|NCT00324233|38246858|FG001|First Period|unable to insert catheter|0|||
17108990|NCT00324233|38246857|FG000|Second Period|unable to insert catheter|1|||
17108991|NCT00324233|38246858|FG001|Second Period|unable to insert catheter|1|||
17108992|NCT00324233|38246857|FG000|Second Period|Protocol Violation|4|||
17108993|NCT00324233|38246858|FG001|Second Period|Protocol Violation|6|||
17108994|NCT02949700|38246868|FG000|Phase I|Withdrawal by Subject|1|||
17108995|NCT02949700|38246869|FG001|Phase I|Withdrawal by Subject|1|||
17108996|NCT02949700|38246870|FG002|Phase I|Withdrawal by Subject|0|||
17108997|NCT02949700|38246871|FG003|Phase I|Withdrawal by Subject|0|||
17108998|NCT02949700|38246868|FG000|Phase I|Protocol Violation|1|||
17108999|NCT02949700|38246869|FG001|Phase I|Protocol Violation|0|||
17109000|NCT02949700|38246870|FG002|Phase I|Protocol Violation|0|||
17109001|NCT02949700|38246871|FG003|Phase I|Protocol Violation|0|||
17109002|NCT02949700|38246868|FG000|Phase II|Withdrawal by Subject|0|||
17109003|NCT02949700|38246869|FG001|Phase II|Withdrawal by Subject|0|||
17109004|NCT02949700|38246870|FG002|Phase II|Withdrawal by Subject|0|||
17109005|NCT02949700|38246871|FG003|Phase II|Withdrawal by Subject|2|||
17109006|NCT02949700|38246868|FG000|Phase II|Protocol Violation|0|||
17109007|NCT02949700|38246869|FG001|Phase II|Protocol Violation|0|||
17109008|NCT02949700|38246870|FG002|Phase II|Protocol Violation|1|||
17109009|NCT02949700|38246871|FG003|Phase II|Protocol Violation|3|||
17109010|NCT03335566|38246882|FG000|Overall Study|Adverse Event|0|||
17109011|NCT03335566|38246883|FG001|Overall Study|Adverse Event|1|||
17109012|NCT03335566|38246882|FG000|Overall Study|Lost to Follow-up|1|||
17109013|NCT03335566|38246883|FG001|Overall Study|Lost to Follow-up|0|||
17109014|NCT03335566|38246882|FG000|Overall Study|Technical Problems|1|||
17109015|NCT03335566|38246883|FG001|Overall Study|Technical Problems|0|||
17109016|NCT03335566|38246882|FG000|Overall Study|Protocol Violation|1|||
17109017|NCT03335566|38246883|FG001|Overall Study|Protocol Violation|0|||
17109018|NCT03335566|38246882|FG000|Overall Study|Other than specified above|1|||
17109019|NCT03335566|38246883|FG001|Overall Study|Other than specified above|2|||
17109020|NCT03369418|38246891|FG000|Overall Study|Withdrawal by Subject|3|||
17109021|NCT03369418|38246892|FG001|Overall Study|Withdrawal by Subject|3|||
17109022|NCT03334630|38246900|FG000|Overall Study|Withdrawal by Subject|7|||
17109023|NCT03334630|38246901|FG001|Overall Study|Withdrawal by Subject|7|||
17109024|NCT03334630|38246900|FG000|Overall Study|Lost to Follow-up|3|||
17109025|NCT03334630|38246901|FG001|Overall Study|Lost to Follow-up|1|||
17109026|NCT03334630|38246900|FG000|Overall Study|Adverse Event|0|||
17109027|NCT03334630|38246901|FG001|Overall Study|Adverse Event|1|||
17109028|NCT03334630|38246900|FG000|Overall Study|Physician Decision|1|||
17109029|NCT03334630|38246901|FG001|Overall Study|Physician Decision|1|||
17109030|NCT03334630|38246900|FG000|Overall Study|Enrollment closed|2|||
17109031|NCT03334630|38246901|FG001|Overall Study|Enrollment closed|1|||
17109032|NCT03334630|38246900|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
17109033|NCT03334630|38246901|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
17109034|NCT03334630|38246900|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
17109035|NCT03334630|38246901|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
17109036|NCT03368170|38246909|FG000|Overall Study|Adverse Event|2|||
17109037|NCT03368170|38246910|FG001|Overall Study|Adverse Event|1|||
17109038|NCT00324155|38246918|FG000|Enrolled and Randomized|No longer met study criteria|3|||
17109039|NCT00324155|38246919|FG001|Enrolled and Randomized|No longer met study criteria|0|||
17109040|NCT00324155|38246918|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
17109041|NCT00324155|38246919|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
17109042|NCT00324155|38246918|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
17109043|NCT00324155|38246919|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
17109044|NCT00324155|38246918|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
17109045|NCT00324155|38246919|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
17109046|NCT00324155|38246918|FG000|Received Treatment in Induction Phase|Death|8|||
17109047|NCT00324155|38246919|FG001|Received Treatment in Induction Phase|Death|15|||
17109048|NCT00324155|38246918|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
17109049|NCT00324155|38246919|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
17109050|NCT00324155|38246918|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
17109051|NCT00324155|38246919|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
17109052|NCT00324155|38246918|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
17109053|NCT00324155|38246919|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
17109054|NCT00324155|38246918|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
17109055|NCT00324155|38246919|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
17109056|NCT00324155|38246918|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
17109057|NCT00324155|38246919|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
17109058|NCT00324155|38246918|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
17109059|NCT00324155|38246919|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
17109060|NCT00324155|38246918|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
17109061|NCT00324155|38246919|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
17109062|NCT00324155|38246918|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
17109063|NCT00324155|38246919|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
17109064|NCT00324155|38246918|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
17109065|NCT00324155|38246919|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
17109066|NCT00324155|38246918|FG000|Follow-up Phase|On-going participants still on drug|11|||
17109067|NCT00324155|38246919|FG001|Follow-up Phase|On-going participants still on drug|6|||
17109068|NCT03334396|38246946|FG000|Overall Study|Adverse Event|1|||
17109069|NCT03334396|38246947|FG001|Overall Study|Adverse Event|0|||
17109070|NCT03334396|38246948|FG002|Overall Study|Adverse Event|1|||
17109071|NCT03334396|38246949|FG003|Overall Study|Adverse Event|0|||
17109072|NCT03334396|38246950|FG004|Overall Study|Adverse Event|0|||
17109073|NCT03334396|38246951|FG005|Overall Study|Adverse Event|0|||
17109074|NCT03334396|38246952|FG006|Overall Study|Adverse Event|0|||
17109075|NCT03334396|38246953|FG007|Overall Study|Adverse Event|0|||
17109076|NCT03334396|38246946|FG000|Overall Study|Lack of Efficacy|10|||
17109077|NCT03334396|38246947|FG001|Overall Study|Lack of Efficacy|4|||
17109078|NCT03334396|38246948|FG002|Overall Study|Lack of Efficacy|1|||
17109079|NCT03334396|38246949|FG003|Overall Study|Lack of Efficacy|3|||
17109080|NCT03334396|38246950|FG004|Overall Study|Lack of Efficacy|1|||
17109081|NCT03334396|38246951|FG005|Overall Study|Lack of Efficacy|0|||
17109082|NCT03334396|38246952|FG006|Overall Study|Lack of Efficacy|0|||
17109083|NCT03334396|38246953|FG007|Overall Study|Lack of Efficacy|1|||
17109084|NCT03334396|38246946|FG000|Overall Study|Lost to Follow-up|0|||
17109085|NCT03334396|38246947|FG001|Overall Study|Lost to Follow-up|0|||
17109086|NCT03334396|38246948|FG002|Overall Study|Lost to Follow-up|1|||
17109087|NCT03334396|38246949|FG003|Overall Study|Lost to Follow-up|0|||
17109088|NCT03334396|38246950|FG004|Overall Study|Lost to Follow-up|0|||
17109089|NCT03334396|38246951|FG005|Overall Study|Lost to Follow-up|0|||
17109090|NCT03334396|38246952|FG006|Overall Study|Lost to Follow-up|1|||
17109091|NCT03334396|38246953|FG007|Overall Study|Lost to Follow-up|0|||
17109092|NCT03334396|38246946|FG000|Overall Study|Physician Decision|1|||
17109093|NCT03334396|38246947|FG001|Overall Study|Physician Decision|0|||
17109094|NCT03334396|38246948|FG002|Overall Study|Physician Decision|0|||
17109095|NCT03334396|38246949|FG003|Overall Study|Physician Decision|0|||
17109096|NCT03334396|38246950|FG004|Overall Study|Physician Decision|0|||
17109097|NCT03334396|38246951|FG005|Overall Study|Physician Decision|0|||
17109098|NCT03334396|38246952|FG006|Overall Study|Physician Decision|0|||
17109099|NCT03334396|38246953|FG007|Overall Study|Physician Decision|0|||
17109100|NCT03334396|38246946|FG000|Overall Study|Withdrawal by Subject|10|||
17109101|NCT03334396|38246947|FG001|Overall Study|Withdrawal by Subject|5|||
17109102|NCT03334396|38246948|FG002|Overall Study|Withdrawal by Subject|7|||
17109103|NCT03334396|38246949|FG003|Overall Study|Withdrawal by Subject|2|||
17109104|NCT03334396|38246950|FG004|Overall Study|Withdrawal by Subject|2|||
17109105|NCT03334396|38246951|FG005|Overall Study|Withdrawal by Subject|1|||
17109106|NCT03334396|38246952|FG006|Overall Study|Withdrawal by Subject|2|||
17109107|NCT03334396|38246953|FG007|Overall Study|Withdrawal by Subject|0|||
17109108|NCT03334396|38246946|FG000|Overall Study|Pregnancy|0|||
17109109|NCT03334396|38246947|FG001|Overall Study|Pregnancy|1|||
17109110|NCT03334396|38246948|FG002|Overall Study|Pregnancy|0|||
17109111|NCT03334396|38246949|FG003|Overall Study|Pregnancy|0|||
17109112|NCT03334396|38246950|FG004|Overall Study|Pregnancy|0|||
17109113|NCT03334396|38246951|FG005|Overall Study|Pregnancy|0|||
17109114|NCT03334396|38246952|FG006|Overall Study|Pregnancy|0|||
17109115|NCT03334396|38246953|FG007|Overall Study|Pregnancy|0|||
17109116|NCT03334396|38246946|FG000|Overall Study|Ineligible|0|||
17109117|NCT03334396|38246947|FG001|Overall Study|Ineligible|1|||
17109118|NCT03334396|38246948|FG002|Overall Study|Ineligible|0|||
17109119|NCT03334396|38246949|FG003|Overall Study|Ineligible|0|||
17109120|NCT03334396|38246950|FG004|Overall Study|Ineligible|0|||
17109121|NCT03334396|38246951|FG005|Overall Study|Ineligible|0|||
17109122|NCT03334396|38246952|FG006|Overall Study|Ineligible|0|||
17109123|NCT03334396|38246953|FG007|Overall Study|Ineligible|0|||
17109124|NCT03334396|38246946|FG000|Overall Study|Started New Job|1|||
17109125|NCT03334396|38246947|FG001|Overall Study|Started New Job|0|||
17109126|NCT03334396|38246948|FG002|Overall Study|Started New Job|0|||
17109127|NCT03334396|38246949|FG003|Overall Study|Started New Job|0|||
17109128|NCT03334396|38246950|FG004|Overall Study|Started New Job|0|||
17109129|NCT03334396|38246951|FG005|Overall Study|Started New Job|0|||
17109130|NCT03334396|38246952|FG006|Overall Study|Started New Job|0|||
17109131|NCT03334396|38246953|FG007|Overall Study|Started New Job|0|||
17109132|NCT03338998|38246972|FG000|Treatment Period|Withdrawal by Subject|1|||
17109133|NCT03338998|38246973|FG001|Treatment Period|Withdrawal by Subject|1|||
17109134|NCT03338998|38246972|FG000|Treatment Period|Adverse Event|0|||
17109135|NCT03338998|38246973|FG001|Treatment Period|Adverse Event|2|||
17109136|NCT03338998|38246972|FG000|Treatment Period|Protocol deviation|1|||
17109137|NCT03338998|38246973|FG001|Treatment Period|Protocol deviation|0|||
17109138|NCT03338998|38246972|FG000|Treatment Period|Physician Decision|2|||
17109139|NCT03338998|38246973|FG001|Treatment Period|Physician Decision|0|||
17109140|NCT03338998|38246972|FG000|Treatment Period|Subject failed swallow test|4|||
17109141|NCT03338998|38246973|FG001|Treatment Period|Subject failed swallow test|0|||
17109142|NCT03338998|38246972|FG000|Safety Follow-Up Period|Adverse Event|0|||
17109143|NCT03338998|38246973|FG001|Safety Follow-Up Period|Adverse Event|1|||
17109144|NCT03338998|38246972|FG000|Safety Follow-Up Period|Protocol deviation|1|||
17109145|NCT03338998|38246973|FG001|Safety Follow-Up Period|Protocol deviation|0|||
17109146|NCT03338998|38246972|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
17109147|NCT03338998|38246973|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
17109148|NCT03338296|38246982|FG000|Overall Study|Adverse Event|0|||
17109149|NCT03338296|38246983|FG001|Overall Study|Adverse Event|1|||
17109150|NCT03338296|38246982|FG000|Overall Study|Withdrawal by Subject|14|||
17109151|NCT03338296|38246983|FG001|Overall Study|Withdrawal by Subject|13|||
17109152|NCT03338296|38246982|FG000|Overall Study|Lost to Follow-up|10|||
17109153|NCT03338296|38246983|FG001|Overall Study|Lost to Follow-up|10|||
17109154|NCT03338296|38246982|FG000|Overall Study|Study Terminated by Sponsor|77|||
17109155|NCT03338296|38246983|FG001|Overall Study|Study Terminated by Sponsor|76|||
17109156|NCT03338296|38246982|FG000|Overall Study|Other|2|||
17109157|NCT03338296|38246983|FG001|Overall Study|Other|7|||
17109158|NCT03338296|38246982|FG000|Overall Study|Missing|0|||
17109159|NCT03338296|38246983|FG001|Overall Study|Missing|1|||
17109160|NCT03338062|38246991|FG000|Overall Study|Alternative Therapy|1|||
17109161|NCT03338062|38246992|FG001|Overall Study|Alternative Therapy|0|||
17109162|NCT03364192|38246999|FG000|Overall Study|Ineligible|10|||
17109163|NCT03364192|38246999|FG000|Overall Study|Withdrawal by Subject|5|||
17109164|NCT03364192|38246999|FG000|Overall Study|Lost to Follow-up|1|||
17109165|NCT03783962|38247006|FG000|Overall Study|Lost to Follow-up|3|||
17109166|NCT03783962|38247007|FG001|Overall Study|Lost to Follow-up|6|||
17109167|NCT03783962|38247006|FG000|Overall Study|Protocol Violation|0|||
17109168|NCT03783962|38247007|FG001|Overall Study|Protocol Violation|1|||
17109169|NCT03361228|38247015|FG000|Overall Study|Other|1|||
17109170|NCT03361228|38247016|FG001|Overall Study|Other|1|||
17109171|NCT03361228|38247015|FG000|Overall Study|Death|3|||
17109172|NCT03361228|38247016|FG001|Overall Study|Death|0|||
17109173|NCT03359590|38247022|FG000|First Intervention|Withdrawal by Subject|1|||
17109174|NCT03359590|38247023|FG001|First Intervention|Withdrawal by Subject|1|||
17109175|NCT03359590|38247022|FG000|First Intervention|Protocol Violation|0|||
17109176|NCT03359590|38247023|FG001|First Intervention|Protocol Violation|1|||
17109177|NCT05085964|38247031|FG000|Overall Study|Premature termination of study|21|||
17109178|NCT05085964|38247032|FG001|Overall Study|Premature termination of study|0|||
17109179|NCT02891200|38247041|FG000|Overall Study|Lost to Follow-up|31|||
17109180|NCT02891200|38247042|FG001|Overall Study|Lost to Follow-up|36|||
17109181|NCT02891200|38247041|FG000|Overall Study|Death|10|||
17109182|NCT02891200|38247042|FG001|Overall Study|Death|9|||
17109183|NCT02891200|38247041|FG000|Overall Study|Withdrawal by Subject|1|||
17109184|NCT02891200|38247042|FG001|Overall Study|Withdrawal by Subject|4|||
17109185|NCT02946580|38247050|FG000|Overall Study|Withdrawal by Subject|1|||
17109186|NCT02946580|38247051|FG001|Overall Study|Withdrawal by Subject|2|||
17109187|NCT02946580|38247050|FG000|Overall Study|Adverse Event|0|||
17109188|NCT02946580|38247051|FG001|Overall Study|Adverse Event|2|||
17109189|NCT02946580|38247050|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
17109190|NCT02946580|38247051|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
17109191|NCT00323609|38247059|FG000|Overall Study|Death|16|||
17109192|NCT00323609|38247060|FG001|Overall Study|Death|21|||
17109193|NCT00323609|38247061|FG002|Overall Study|Death|0|||
17109194|NCT00323609|38247062|FG003|Overall Study|Death|0|||
17109195|NCT00323609|38247059|FG000|Overall Study|Lost to Follow-up|9|||
17109196|NCT00323609|38247060|FG001|Overall Study|Lost to Follow-up|10|||
17109197|NCT00323609|38247061|FG002|Overall Study|Lost to Follow-up|0|||
17109198|NCT00323609|38247062|FG003|Overall Study|Lost to Follow-up|0|||
17109199|NCT00323609|38247059|FG000|Overall Study|Physician Decision|2|||
17109200|NCT00323609|38247060|FG001|Overall Study|Physician Decision|0|||
17109201|NCT00323609|38247061|FG002|Overall Study|Physician Decision|0|||
17109202|NCT00323609|38247062|FG003|Overall Study|Physician Decision|1|||
17109203|NCT00323609|38247059|FG000|Overall Study|Withdrawal by Subject|11|||
17109204|NCT00323609|38247060|FG001|Overall Study|Withdrawal by Subject|23|||
17109205|NCT00323609|38247061|FG002|Overall Study|Withdrawal by Subject|4|||
17109206|NCT00323609|38247062|FG003|Overall Study|Withdrawal by Subject|4|||
17109207|NCT00323609|38247059|FG000|Overall Study|Other non-VCF-related medical condition|3|||
17109208|NCT00323609|38247060|FG001|Overall Study|Other non-VCF-related medical condition|2|||
17109209|NCT00323609|38247061|FG002|Overall Study|Other non-VCF-related medical condition|0|||
17109210|NCT00323609|38247062|FG003|Overall Study|Other non-VCF-related medical condition|0|||
17109211|NCT00323609|38247059|FG000|Overall Study|Sponsor discontinued trial|29|||
17109212|NCT00323609|38247060|FG001|Overall Study|Sponsor discontinued trial|29|||
17109213|NCT00323609|38247061|FG002|Overall Study|Sponsor discontinued trial|0|||
17109214|NCT00323609|38247062|FG003|Overall Study|Sponsor discontinued trial|0|||
17109215|NCT00323609|38247059|FG000|Overall Study|Unrelenting or severe back pain|1|||
17109216|NCT00323609|38247060|FG001|Overall Study|Unrelenting or severe back pain|1|||
17109217|NCT00323609|38247061|FG002|Overall Study|Unrelenting or severe back pain|0|||
17109218|NCT00323609|38247062|FG003|Overall Study|Unrelenting or severe back pain|0|||
17109219|NCT00323609|38247059|FG000|Overall Study|Logistical withdrawal|9|||
17109220|NCT00323609|38247060|FG001|Overall Study|Logistical withdrawal|5|||
17109221|NCT00323609|38247061|FG002|Overall Study|Logistical withdrawal|0|||
17109222|NCT00323609|38247062|FG003|Overall Study|Logistical withdrawal|1|||
17109223|NCT00323609|38247059|FG000|Overall Study|Other reason|11|||
17109224|NCT00323609|38247060|FG001|Overall Study|Other reason|8|||
17109225|NCT00323609|38247061|FG002|Overall Study|Other reason|4|||
17109226|NCT00323609|38247062|FG003|Overall Study|Other reason|9|||
17109227|NCT04598152|38247068|FG000|Overall Study|Lost to Follow-up|0|||
17109228|NCT04598152|38247069|FG001|Overall Study|Lost to Follow-up|1|||
17109229|NCT00323297|38247077|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
17109230|NCT00323297|38247078|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
17109231|NCT00323297|38247077|FG000|Part A (Double Blind Randomized)|Death|0|||
17109232|NCT00323297|38247078|FG001|Part A (Double Blind Randomized)|Death|1|||
17109233|NCT00323297|38247077|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
17109234|NCT00323297|38247078|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
17109235|NCT00323297|38247077|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
17109236|NCT00323297|38247078|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
17109237|NCT00323297|38247077|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
17109238|NCT00323297|38247078|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
17109239|NCT00323297|38247077|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
17109240|NCT00323297|38247078|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
17109241|NCT00323297|38247077|FG000|Part B (Open-label)|Death|0|||
17109242|NCT00323297|38247078|FG001|Part B (Open-label)|Death|1|||
17109243|NCT00323297|38247077|FG000|Part B (Open-label)|Reason unspecified|0|||
17109244|NCT00323297|38247078|FG001|Part B (Open-label)|Reason unspecified|1|||
17109245|NCT00323297|38247077|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
17109246|NCT00323297|38247078|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
17109247|NCT00323297|38247077|FG000|Part B (Open-label)|Lack of Efficacy|3|||
17109248|NCT00323297|38247078|FG001|Part B (Open-label)|Lack of Efficacy|1|||
17109249|NCT00323297|38247077|FG000|Part B (Open-label)|Adverse Event|5|||
17109250|NCT00323297|38247078|FG001|Part B (Open-label)|Adverse Event|5|||
17109251|NCT00323297|38247077|FG000|Part B (Open-label)|Protocol Violation|0|||
17109252|NCT00323297|38247078|FG001|Part B (Open-label)|Protocol Violation|1|||
17109253|NCT00323063|38247086|FG000|Overall Study|Adverse Event|1|||
17109254|NCT00323063|38247087|FG001|Overall Study|Adverse Event|0|||
17109255|NCT00323063|38247086|FG000|Overall Study|brain mets discovered prior to treatment|1|||
17109256|NCT00323063|38247087|FG001|Overall Study|brain mets discovered prior to treatment|0|||
17109257|NCT00322049|38247097|FG000|Overall Study|Moved out of area|0|||
17109258|NCT00322049|38247098|FG001|Overall Study|Moved out of area|0|||
17109259|NCT00322049|38247099|FG002|Overall Study|Moved out of area|0|||
17109260|NCT00322049|38247100|FG003|Overall Study|Moved out of area|1|||
17109261|NCT00322049|38247097|FG000|Overall Study|Infected with Dengue during study|0|||
17109262|NCT00322049|38247098|FG001|Overall Study|Infected with Dengue during study|1|||
17109263|NCT00322049|38247099|FG002|Overall Study|Infected with Dengue during study|0|||
17109264|NCT00322049|38247100|FG003|Overall Study|Infected with Dengue during study|0|||
17109265|NCT00321893|38247121|FG000|Overall Study|Non-Compliance/Refusal|16|||
17109266|NCT00321893|38247122|FG001|Overall Study|Non-Compliance/Refusal|10|||
17109267|NCT00321893|38247121|FG000|Overall Study|Lost to Follow-up|2|||
17109268|NCT00321893|38247122|FG001|Overall Study|Lost to Follow-up|1|||
17109269|NCT00321893|38247121|FG000|Overall Study|Adverse Event|6|||
17109270|NCT00321893|38247122|FG001|Overall Study|Adverse Event|3|||
17109271|NCT00371345|38247130|FG000|Overall Study|Disease Progression|21|||
17109272|NCT00371345|38247131|FG001|Overall Study|Disease Progression|35|||
17109273|NCT00371345|38247130|FG000|Overall Study|Study Drug Toxicity|1|||
17109274|NCT00371345|38247131|FG001|Overall Study|Study Drug Toxicity|7|||
17109275|NCT00371345|38247130|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
17109276|NCT00371345|38247131|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
17109277|NCT00371345|38247130|FG000|Overall Study|Participant Request|1|||
17109278|NCT00371345|38247131|FG001|Overall Study|Participant Request|1|||
17109279|NCT00371345|38247130|FG000|Overall Study|Participant Withdrew Consent|0|||
17109280|NCT00371345|38247131|FG001|Overall Study|Participant Withdrew Consent|1|||
17109281|NCT00321737|38247154|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
17109282|NCT00321737|38247155|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
17109283|NCT00321737|38247156|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
17109284|NCT00321737|38247154|FG000|Overall Study|Adverse Event|11|||
17109285|NCT00321737|38247155|FG001|Overall Study|Adverse Event|3|||
17109286|NCT00321737|38247156|FG002|Overall Study|Adverse Event|6|||
17109287|NCT00321737|38247154|FG000|Overall Study|Lost to Follow-up|5|||
17109288|NCT00321737|38247155|FG001|Overall Study|Lost to Follow-up|5|||
17109289|NCT00321737|38247156|FG002|Overall Study|Lost to Follow-up|6|||
17109290|NCT00321737|38247154|FG000|Overall Study|Withdrawal by Subject|19|||
17109291|NCT00321737|38247155|FG001|Overall Study|Withdrawal by Subject|12|||
17109292|NCT00321737|38247156|FG002|Overall Study|Withdrawal by Subject|17|||
17109293|NCT00321737|38247154|FG000|Overall Study|Protocol Violation|0|||
17109294|NCT00321737|38247155|FG001|Overall Study|Protocol Violation|0|||
17109295|NCT00321737|38247156|FG002|Overall Study|Protocol Violation|1|||
17109296|NCT00321737|38247154|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
17109297|NCT00321737|38247155|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
17109298|NCT00321737|38247156|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
17109299|NCT00321737|38247154|FG000|Overall Study|Possible Barrett's Esophagus|2|||
17109300|NCT00321737|38247155|FG001|Overall Study|Possible Barrett's Esophagus|1|||
17109301|NCT00321737|38247156|FG002|Overall Study|Possible Barrett's Esophagus|1|||
17109302|NCT00321737|38247154|FG000|Overall Study|Therapeutic Failure|6|||
17109303|NCT00321737|38247155|FG001|Overall Study|Therapeutic Failure|0|||
17109304|NCT00321737|38247156|FG002|Overall Study|Therapeutic Failure|2|||
17109305|NCT00321737|38247154|FG000|Overall Study|Pregnancy|0|||
17109306|NCT00321737|38247155|FG001|Overall Study|Pregnancy|2|||
17109307|NCT00321737|38247156|FG002|Overall Study|Pregnancy|0|||
17109308|NCT00321737|38247154|FG000|Overall Study|Noncompliance|2|||
17109309|NCT00321737|38247155|FG001|Overall Study|Noncompliance|0|||
17109310|NCT00321737|38247156|FG002|Overall Study|Noncompliance|0|||
17109311|NCT00321737|38247154|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
17109312|NCT00321737|38247155|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
17109313|NCT00321737|38247156|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
17109314|NCT00320801|38247166|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
17109315|NCT00320801|38247167|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
17109316|NCT00320801|38247168|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
17109317|NCT00320801|38247169|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
17109318|NCT00320801|38247166|FG000|Open-label Run-in Period|Adverse Event|33|||
17109319|NCT00320801|38247167|FG001|Open-label Run-in Period|Adverse Event|0|||
17109320|NCT00320801|38247168|FG002|Open-label Run-in Period|Adverse Event|0|||
17109321|NCT00320801|38247169|FG003|Open-label Run-in Period|Adverse Event|0|||
17109322|NCT00320801|38247166|FG000|Open-label Run-in Period|Administrative|10|||
17109323|NCT00320801|38247167|FG001|Open-label Run-in Period|Administrative|0|||
17109324|NCT00320801|38247168|FG002|Open-label Run-in Period|Administrative|0|||
17109325|NCT00320801|38247169|FG003|Open-label Run-in Period|Administrative|0|||
17109326|NCT00320801|38247166|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
17109327|NCT00320801|38247167|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
17109328|NCT00320801|38247168|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
17109329|NCT00320801|38247169|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
17109330|NCT00320801|38247166|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
17109331|NCT00320801|38247167|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
17109332|NCT00320801|38247168|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
17109333|NCT00320801|38247169|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
17109334|NCT00320801|38247166|FG000|Open-label Run-in Period|Did not qualify|1|||
17109335|NCT00320801|38247167|FG001|Open-label Run-in Period|Did not qualify|0|||
17109336|NCT00320801|38247168|FG002|Open-label Run-in Period|Did not qualify|0|||
17109337|NCT00320801|38247169|FG003|Open-label Run-in Period|Did not qualify|0|||
17109338|NCT00320801|38247166|FG000|Double-blind Phase|Withdrawal by Subject|0|||
17109339|NCT00320801|38247167|FG001|Double-blind Phase|Withdrawal by Subject|0|||
17109340|NCT00320801|38247168|FG002|Double-blind Phase|Withdrawal by Subject|1|||
17109341|NCT00320801|38247169|FG003|Double-blind Phase|Withdrawal by Subject|0|||
17109342|NCT00320801|38247166|FG000|Double-blind Phase|Adverse Event|0|||
17109343|NCT00320801|38247167|FG001|Double-blind Phase|Adverse Event|2|||
17109344|NCT00320801|38247168|FG002|Double-blind Phase|Adverse Event|8|||
17109345|NCT00320801|38247169|FG003|Double-blind Phase|Adverse Event|0|||
17109346|NCT00320801|38247166|FG000|Double-blind Phase|Administrative|0|||
17109347|NCT00320801|38247167|FG001|Double-blind Phase|Administrative|0|||
17109348|NCT00320801|38247168|FG002|Double-blind Phase|Administrative|4|||
17109349|NCT00320801|38247169|FG003|Double-blind Phase|Administrative|0|||
17109350|NCT00320801|38247166|FG000|Double-blind Phase|Lack of Efficacy|0|||
17109351|NCT00320801|38247167|FG001|Double-blind Phase|Lack of Efficacy|9|||
17109352|NCT00320801|38247168|FG002|Double-blind Phase|Lack of Efficacy|1|||
17109353|NCT00320801|38247169|FG003|Double-blind Phase|Lack of Efficacy|0|||
17109354|NCT00320801|38247166|FG000|Extension Phase|Withdrawal by Subject|0|||
17109355|NCT00320801|38247167|FG001|Extension Phase|Withdrawal by Subject|0|||
17109356|NCT00320801|38247168|FG002|Extension Phase|Withdrawal by Subject|0|||
17109357|NCT00320801|38247169|FG003|Extension Phase|Withdrawal by Subject|6|||
17109358|NCT00320801|38247166|FG000|Extension Phase|Adverse Event|0|||
17109359|NCT00320801|38247167|FG001|Extension Phase|Adverse Event|0|||
17109360|NCT00320801|38247168|FG002|Extension Phase|Adverse Event|0|||
17109361|NCT00320801|38247169|FG003|Extension Phase|Adverse Event|8|||
17109362|NCT00320801|38247166|FG000|Extension Phase|Administrative|0|||
17109363|NCT00320801|38247167|FG001|Extension Phase|Administrative|0|||
17109364|NCT00320801|38247168|FG002|Extension Phase|Administrative|0|||
17109365|NCT00320801|38247169|FG003|Extension Phase|Administrative|29|||
17109366|NCT00320801|38247166|FG000|Extension Phase|Lack of Efficacy|0|||
17109367|NCT00320801|38247167|FG001|Extension Phase|Lack of Efficacy|0|||
17109368|NCT00320801|38247168|FG002|Extension Phase|Lack of Efficacy|0|||
17109369|NCT00320801|38247169|FG003|Extension Phase|Lack of Efficacy|2|||
17109370|NCT00320801|38247166|FG000|Extension Phase|Lost to Follow-up|0|||
17109371|NCT00320801|38247167|FG001|Extension Phase|Lost to Follow-up|0|||
17109372|NCT00320801|38247168|FG002|Extension Phase|Lost to Follow-up|0|||
17109373|NCT00320801|38247169|FG003|Extension Phase|Lost to Follow-up|3|||
17109374|NCT00320489|38247181|FG000|Overall Study|Adverse Event|26|||
17109375|NCT00320489|38247182|FG001|Overall Study|Adverse Event|25|||
17109376|NCT00320489|38247181|FG000|Overall Study|Clinical Relapse|26|||
17109377|NCT00320489|38247182|FG001|Overall Study|Clinical Relapse|20|||
17109378|NCT00320489|38247181|FG000|Overall Study|Death|0|||
17109379|NCT00320489|38247182|FG001|Overall Study|Death|2|||
17109380|NCT00320489|38247181|FG000|Overall Study|Entry Criteria Exclusion|2|||
17109381|NCT00320489|38247182|FG001|Overall Study|Entry Criteria Exclusion|4|||
17109382|NCT00320489|38247181|FG000|Overall Study|Lack of Efficacy|16|||
17109383|NCT00320489|38247182|FG001|Overall Study|Lack of Efficacy|7|||
17109384|NCT00320489|38247181|FG000|Overall Study|Lost to Follow-up|21|||
17109385|NCT00320489|38247182|FG001|Overall Study|Lost to Follow-up|22|||
17109386|NCT00320489|38247181|FG000|Overall Study|Physician Decision|8|||
17109387|NCT00320489|38247182|FG001|Overall Study|Physician Decision|8|||
17109388|NCT00320489|38247181|FG000|Overall Study|Protocol Violation|4|||
17109389|NCT00320489|38247182|FG001|Overall Study|Protocol Violation|4|||
17109390|NCT00320489|38247181|FG000|Overall Study|Sponsor Decision|3|||
17109391|NCT00320489|38247182|FG001|Overall Study|Sponsor Decision|3|||
17109392|NCT00320489|38247181|FG000|Overall Study|Withdrawal by Subject|39|||
17109393|NCT00320489|38247182|FG001|Overall Study|Withdrawal by Subject|41|||
17109394|NCT03928028|38247191|FG000|Overall Study|Physician Decision|9|||
17109395|NCT03928028|38247192|FG001|Overall Study|Physician Decision|6|||
17109396|NCT03928028|38247193|FG002|Overall Study|Physician Decision|3|||
17109397|NCT03928028|38247191|FG000|Overall Study|Withdrawal by Subject|12|||
17109398|NCT03928028|38247192|FG001|Overall Study|Withdrawal by Subject|3|||
17109399|NCT03928028|38247193|FG002|Overall Study|Withdrawal by Subject|3|||
17109400|NCT00320411|38247201|FG000|Overall Study|No investigational product admin.|4|||
17109401|NCT00320255|38247211|FG000|Overall Study|Lack of Efficacy|1|||
17109402|NCT00320255|38247212|FG001|Overall Study|Lack of Efficacy|0|||
17109403|NCT00320255|38247213|FG002|Overall Study|Lack of Efficacy|0|||
17109404|NCT00320255|38247214|FG003|Overall Study|Lack of Efficacy|0|||
17109405|NCT00320255|38247215|FG004|Overall Study|Lack of Efficacy|0|||
17109406|NCT00320255|38247216|FG005|Overall Study|Lack of Efficacy|0|||
17109407|NCT00320255|38247211|FG000|Overall Study|Adverse Event|5|||
17109408|NCT00320255|38247212|FG001|Overall Study|Adverse Event|2|||
17109409|NCT00320255|38247213|FG002|Overall Study|Adverse Event|3|||
17109410|NCT00320255|38247214|FG003|Overall Study|Adverse Event|2|||
17109411|NCT00320255|38247215|FG004|Overall Study|Adverse Event|0|||
17109412|NCT00320255|38247216|FG005|Overall Study|Adverse Event|0|||
17109413|NCT00320255|38247211|FG000|Overall Study|Withdrawal by Subject|1|||
17109414|NCT00320255|38247212|FG001|Overall Study|Withdrawal by Subject|2|||
17109415|NCT00320255|38247213|FG002|Overall Study|Withdrawal by Subject|2|||
17109416|NCT00320255|38247214|FG003|Overall Study|Withdrawal by Subject|4|||
17109417|NCT00320255|38247215|FG004|Overall Study|Withdrawal by Subject|0|||
17109418|NCT00320255|38247216|FG005|Overall Study|Withdrawal by Subject|0|||
17109419|NCT00320255|38247211|FG000|Overall Study|Poor compliance/noncompliance|1|||
17109420|NCT00320255|38247212|FG001|Overall Study|Poor compliance/noncompliance|1|||
17109421|NCT00320255|38247213|FG002|Overall Study|Poor compliance/noncompliance|0|||
17109422|NCT00320255|38247214|FG003|Overall Study|Poor compliance/noncompliance|1|||
17109423|NCT00320255|38247215|FG004|Overall Study|Poor compliance/noncompliance|0|||
17109424|NCT00320255|38247216|FG005|Overall Study|Poor compliance/noncompliance|0|||
17109425|NCT00320255|38247211|FG000|Overall Study|No longer meets study criteria|0|||
17109426|NCT00320255|38247212|FG001|Overall Study|No longer meets study criteria|0|||
17109427|NCT00320255|38247213|FG002|Overall Study|No longer meets study criteria|0|||
17109428|NCT00320255|38247214|FG003|Overall Study|No longer meets study criteria|1|||
17109429|NCT00320255|38247215|FG004|Overall Study|No longer meets study criteria|0|||
17109430|NCT00320255|38247216|FG005|Overall Study|No longer meets study criteria|0|||
17109431|NCT00320255|38247211|FG000|Overall Study|Other|3|||
17109432|NCT00320255|38247212|FG001|Overall Study|Other|2|||
17109433|NCT00320255|38247213|FG002|Overall Study|Other|1|||
17109434|NCT00320255|38247214|FG003|Overall Study|Other|0|||
17109435|NCT00320255|38247215|FG004|Overall Study|Other|0|||
17109436|NCT00320255|38247216|FG005|Overall Study|Other|0|||
17109437|NCT00370331|38247233|FG000|Overall Study|Adverse Event|4|||
17109438|NCT00370331|38247234|FG001|Overall Study|Adverse Event|13|||
17109439|NCT00370331|38247233|FG000|Overall Study|Withdrawal by Subject|2|||
17109440|NCT00370331|38247234|FG001|Overall Study|Withdrawal by Subject|4|||
17109441|NCT00370331|38247233|FG000|Overall Study|Lost to Follow-up|0|||
17109442|NCT00370331|38247234|FG001|Overall Study|Lost to Follow-up|3|||
17109443|NCT00370331|38247233|FG000|Overall Study|Lack of Efficacy|0|||
17109444|NCT00370331|38247234|FG001|Overall Study|Lack of Efficacy|1|||
17109445|NCT00370331|38247233|FG000|Overall Study|Non-compliance|0|||
17109446|NCT00370331|38247234|FG001|Overall Study|Non-compliance|1|||
17109447|NCT00370331|38247233|FG000|Overall Study|Protocol Violation|1|||
17109448|NCT00370331|38247234|FG001|Overall Study|Protocol Violation|1|||
17109449|NCT03284710|38247244|FG000|Overall Study|Withdrawal by Subject|1|||
17109450|NCT03284710|38247245|FG001|Overall Study|Withdrawal by Subject|0|||
17109451|NCT03284710|38247246|FG002|Overall Study|Withdrawal by Subject|1|||
17109452|NCT03284710|38247247|FG003|Overall Study|Withdrawal by Subject|6|||
17109453|NCT03284710|38247244|FG000|Overall Study|Lost to Follow-up|3|||
17109454|NCT03284710|38247245|FG001|Overall Study|Lost to Follow-up|3|||
17109455|NCT03284710|38247246|FG002|Overall Study|Lost to Follow-up|1|||
17109456|NCT03284710|38247247|FG003|Overall Study|Lost to Follow-up|0|||
17109457|NCT03284710|38247244|FG000|Overall Study|Physician Decision|1|||
17109458|NCT03284710|38247245|FG001|Overall Study|Physician Decision|0|||
17109459|NCT03284710|38247246|FG002|Overall Study|Physician Decision|0|||
17109460|NCT03284710|38247247|FG003|Overall Study|Physician Decision|0|||
17109461|NCT03284710|38247244|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
17109462|NCT03284710|38247245|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
17109463|NCT03284710|38247246|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
17109464|NCT03284710|38247247|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
17109465|NCT03284710|38247244|FG000|Overall Study|HIV Infection|0|||
17109466|NCT03284710|38247245|FG001|Overall Study|HIV Infection|2|||
17109467|NCT03284710|38247246|FG002|Overall Study|HIV Infection|2|||
17109468|NCT03284710|38247247|FG003|Overall Study|HIV Infection|1|||
17109469|NCT02962960|38247265|FG000|Overall Study|Withdrawal by Subject|1|||
17109470|NCT02962960|38247266|FG001|Overall Study|Withdrawal by Subject|1|||
17109471|NCT02962960|38247267|FG002|Overall Study|Withdrawal by Subject|0|||
17109472|NCT02962960|38247265|FG000|Overall Study|Adverse Event|1|||
17109473|NCT02962960|38247266|FG001|Overall Study|Adverse Event|1|||
17109474|NCT02962960|38247267|FG002|Overall Study|Adverse Event|0|||
17109475|NCT02962960|38247265|FG000|Overall Study|Protocol Violation|1|||
17109476|NCT02962960|38247266|FG001|Overall Study|Protocol Violation|0|||
17109477|NCT02962960|38247267|FG002|Overall Study|Protocol Violation|0|||
17109478|NCT00369941|38247279|FG000|Overall Study|Never Treated|1|||
17109479|NCT00369941|38247280|FG001|Overall Study|Never Treated|2|||
17109480|NCT00369941|38247279|FG000|Overall Study|Adverse Event|14|||
17109481|NCT00369941|38247280|FG001|Overall Study|Adverse Event|28|||
17109482|NCT00369941|38247279|FG000|Overall Study|Lack of Efficacy|6|||
17109483|NCT00369941|38247280|FG001|Overall Study|Lack of Efficacy|10|||
17109484|NCT00369941|38247279|FG000|Overall Study|Lost to Follow-up|12|||
17109485|NCT00369941|38247280|FG001|Overall Study|Lost to Follow-up|22|||
17109486|NCT00369941|38247279|FG000|Overall Study|Protocol Violation|5|||
17109487|NCT00369941|38247280|FG001|Overall Study|Protocol Violation|3|||
17109488|NCT00369941|38247279|FG000|Overall Study|Withdrawal by Subject|5|||
17109489|NCT00369941|38247280|FG001|Overall Study|Withdrawal by Subject|18|||
17109490|NCT00369941|38247279|FG000|Overall Study|Pregnancy|4|||
17109491|NCT00369941|38247280|FG001|Overall Study|Pregnancy|2|||
17109492|NCT00369941|38247279|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
17109493|NCT00369941|38247280|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
17109494|NCT00369941|38247279|FG000|Overall Study|Moved|11|||
17109495|NCT00369941|38247280|FG001|Overall Study|Moved|5|||
17109496|NCT00369941|38247279|FG000|Overall Study|Treatment with Prohibited Medication|3|||
17109497|NCT00369941|38247280|FG001|Overall Study|Treatment with Prohibited Medication|1|||
17109498|NCT00369941|38247279|FG000|Overall Study|Employment Interfered with Study Visits|1|||
17109499|NCT00369941|38247280|FG001|Overall Study|Employment Interfered with Study Visits|0|||
17109500|NCT00369941|38247279|FG000|Overall Study|Study Site Terminated|2|||
17109501|NCT00369941|38247280|FG001|Overall Study|Study Site Terminated|0|||
17109502|NCT00369941|38247279|FG000|Overall Study|Miscellaneous|3|||
17109503|NCT00369941|38247280|FG001|Overall Study|Miscellaneous|3|||
17109504|NCT00319553|38247289|FG000|Overall Study|Protocol Violation|1|||
17109505|NCT00319553|38247290|FG001|Overall Study|Protocol Violation|2|||
17109506|NCT00319553|38247289|FG000|Overall Study|Lost to Follow-up|2|||
17109507|NCT00319553|38247290|FG001|Overall Study|Lost to Follow-up|1|||
17109508|NCT00319553|38247289|FG000|Overall Study|Withdrawal by Subject|1|||
17109509|NCT00319553|38247290|FG001|Overall Study|Withdrawal by Subject|1|||
17109510|NCT00369785|38247298|FG000|Overall Study|Physician Decision|3|||
17109511|NCT00369785|38247299|FG001|Overall Study|Physician Decision|2|||
17109512|NCT00369785|38247298|FG000|Overall Study|Death|1|||
17109513|NCT00369785|38247299|FG001|Overall Study|Death|2|||
17109514|NCT00369785|38247298|FG000|Overall Study|Withdrawal by Subject|7|||
17109515|NCT00369785|38247299|FG001|Overall Study|Withdrawal by Subject|6|||
17109516|NCT00369785|38247298|FG000|Overall Study|Toxicity|6|||
17109517|NCT00369785|38247299|FG001|Overall Study|Toxicity|4|||
17109518|NCT00369785|38247298|FG000|Overall Study|Never started|0|||
17109519|NCT00369785|38247299|FG001|Overall Study|Never started|2|||
17109520|NCT00369785|38247298|FG000|Overall Study|Progression|4|||
17109521|NCT00369785|38247299|FG001|Overall Study|Progression|4|||
17109522|NCT00369785|38247298|FG000|Overall Study|Multiple reasons|6|||
17109523|NCT00369785|38247299|FG001|Overall Study|Multiple reasons|5|||
17109524|NCT00369707|38247305|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
17109525|NCT00369707|38247305|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
17109526|NCT00369707|38247305|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
17109527|NCT00369707|38247305|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
17109528|NCT00369707|38247305|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
17109529|NCT00369707|38247305|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
17109530|NCT00369707|38247305|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
17109531|NCT00369707|38247305|FG000|Follow up for 2 Years After Treatment|Death|1|||
17109532|NCT00369707|38247305|FG000|Follow up for 2 Years After Treatment|Other|2|||
17109533|NCT02943460|38247312|FG000|Blinded Study Phase|Adverse Event|3|||
17109534|NCT02943460|38247313|FG001|Blinded Study Phase|Adverse Event|0|||
17109535|NCT02943460|38247314|FG002|Blinded Study Phase|Adverse Event|0|||
17109536|NCT02943460|38247312|FG000|Blinded Study Phase|Withdrew Consent|0|||
17109537|NCT02943460|38247313|FG001|Blinded Study Phase|Withdrew Consent|1|||
17109538|NCT02943460|38247314|FG002|Blinded Study Phase|Withdrew Consent|0|||
17109539|NCT02943460|38247312|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
17109540|NCT02943460|38247313|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
17109541|NCT02943460|38247314|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
17109542|NCT02943460|38247312|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
17109543|NCT02943460|38247313|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
17109544|NCT02943460|38247314|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
17109545|NCT02943460|38247312|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
17109546|NCT02943460|38247313|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
17109547|NCT02943460|38247314|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
17109548|NCT03768206|38247325|FG000|Overall Study|Lost to Follow-up|2|||
17109549|NCT03768206|38247326|FG001|Overall Study|Lost to Follow-up|1|||
17109550|NCT03768206|38247325|FG000|Overall Study|Withdrawal by Subject|0|||
17109551|NCT03768206|38247326|FG001|Overall Study|Withdrawal by Subject|1|||
17109552|NCT03767894|38247333|FG000|Overall Study|Withdrawal by Subject|1|||
17109553|NCT03766646|38247339|FG000|Overall Study|Withdrawal by Subject|1|||
17109554|NCT03766646|38247340|FG001|Overall Study|Withdrawal by Subject|0|||
17109555|NCT03766646|38247339|FG000|Overall Study|Protocol Violation|0|||
17109556|NCT03766646|38247340|FG001|Overall Study|Protocol Violation|3|||
17109557|NCT03765164|38247348|FG000|Pre-intervention|Withdrawal by Subject|5|||
17109558|NCT03765164|38247349|FG001|Pre-intervention|Withdrawal by Subject|6|||
17109559|NCT00369629|38247355|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
17109560|NCT00369629|38247356|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
17109561|NCT00369629|38247357|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
17109562|NCT00369629|38247358|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
17109563|NCT00369629|38247355|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
17109564|NCT00369629|38247356|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
17109565|NCT00369629|38247357|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
17109566|NCT00369629|38247358|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
17109567|NCT00369629|38247355|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
17109568|NCT00369629|38247356|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
17109569|NCT00369629|38247357|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
17109570|NCT00369629|38247358|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
17109571|NCT00369629|38247355|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
17109572|NCT00369629|38247356|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
17109573|NCT00369629|38247357|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
17109574|NCT00369629|38247358|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
17109575|NCT00369629|38247355|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
17109576|NCT00369629|38247356|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
17109577|NCT00369629|38247357|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
17109578|NCT00369629|38247358|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
17109579|NCT00369629|38247355|FG000|Completed 4 More Cycles|Progressive disease|2|||
17109580|NCT00369629|38247356|FG001|Completed 4 More Cycles|Progressive disease|1|||
17109581|NCT00369629|38247357|FG002|Completed 4 More Cycles|Progressive disease|2|||
17109582|NCT00369629|38247358|FG003|Completed 4 More Cycles|Progressive disease|0|||
17109583|NCT00369629|38247355|FG000|Follow up for 1 Year|Death|2|||
17109584|NCT00369629|38247356|FG001|Follow up for 1 Year|Death|1|||
17109585|NCT00369629|38247357|FG002|Follow up for 1 Year|Death|1|||
17109586|NCT00369629|38247358|FG003|Follow up for 1 Year|Death|0|||
17109587|NCT00369629|38247355|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
17109588|NCT00369629|38247356|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
17109589|NCT00369629|38247357|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
17109590|NCT00369629|38247358|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
17109591|NCT00369629|38247355|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
17109592|NCT00369629|38247356|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
17109593|NCT00369629|38247357|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
17109594|NCT00369629|38247358|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
17109595|NCT02469064|38247370|FG000|Overall Study|Request not to receive intervention.|1|||
17109596|NCT02469064|38247371|FG001|Overall Study|Request not to receive intervention.|3|||
17109597|NCT02446912|38247380|FG000|Overall Study|Adverse Event|3|||
17109598|NCT02446912|38247381|FG001|Overall Study|Adverse Event|13|||
17109599|NCT02446912|38247382|FG002|Overall Study|Adverse Event|5|||
17109600|NCT02446912|38247380|FG000|Overall Study|Condition under investigation worsened|0|||
17109601|NCT02446912|38247381|FG001|Overall Study|Condition under investigation worsened|1|||
17109602|NCT02446912|38247382|FG002|Overall Study|Condition under investigation worsened|1|||
17109603|NCT02446912|38247380|FG000|Overall Study|Study-specific withdrawal criteria|1|||
17109604|NCT02446912|38247381|FG001|Overall Study|Study-specific withdrawal criteria|0|||
17109605|NCT02446912|38247382|FG002|Overall Study|Study-specific withdrawal criteria|0|||
17109606|NCT02446912|38247380|FG000|Overall Study|Lack of Efficacy|1|||
17109607|NCT02446912|38247381|FG001|Overall Study|Lack of Efficacy|4|||
17109608|NCT02446912|38247382|FG002|Overall Study|Lack of Efficacy|7|||
17109609|NCT02446912|38247380|FG000|Overall Study|Lost to Follow-up|0|||
17109610|NCT02446912|38247381|FG001|Overall Study|Lost to Follow-up|0|||
17109611|NCT02446912|38247382|FG002|Overall Study|Lost to Follow-up|2|||
17109612|NCT02446912|38247380|FG000|Overall Study|Severe non-compliance to protocol|1|||
17109613|NCT02446912|38247381|FG001|Overall Study|Severe non-compliance to protocol|0|||
17109614|NCT02446912|38247382|FG002|Overall Study|Severe non-compliance to protocol|1|||
17109615|NCT02446912|38247380|FG000|Overall Study|Withdrawal by Subject|10|||
17109616|NCT02446912|38247381|FG001|Overall Study|Withdrawal by Subject|15|||
17109617|NCT02446912|38247382|FG002|Overall Study|Withdrawal by Subject|15|||
17109618|NCT02446912|38247380|FG000|Overall Study|Miscellaneous|2|||
17109619|NCT02446912|38247381|FG001|Overall Study|Miscellaneous|2|||
17109620|NCT02446912|38247382|FG002|Overall Study|Miscellaneous|4|||
17109621|NCT00736840|38247390|FG000|Overall Study|Lost to Follow-up|13|||
17109622|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Adverse Event|11|||
17109623|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Adverse Event|23|||
17109624|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Adverse Event|29|||
17109625|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Adverse Event|2|||
17109626|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Adverse Event|8|||
17109627|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
17109628|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
17109629|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
17109630|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
17109631|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
17109632|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
17109633|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
17109634|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
17109635|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
17109636|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
17109637|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
17109638|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
17109639|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
17109640|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
17109641|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
17109642|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
17109643|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
17109644|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
17109645|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
17109646|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
17109647|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
17109648|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
17109649|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
17109650|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
17109651|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
17109652|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
17109653|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
17109654|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
17109655|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
17109656|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
17109657|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Move|0|||
17109658|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Move|1|||
17109659|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Move|0|||
17109660|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Move|0|||
17109661|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Move|0|||
17109662|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
17109663|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
17109664|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
17109665|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
17109666|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
17109667|NCT00318461|38247399|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
17109668|NCT00318461|38247400|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
17109669|NCT00318461|38247401|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
17109670|NCT00318461|38247402|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
17109671|NCT00318461|38247403|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
17109672|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Work commitment|0|||
17109673|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Work commitment|0|||
17109674|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Work commitment|0|||
17109675|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Work commitment|0|||
17109676|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Work commitment|1|||
17109677|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Investigator decision|0|||
17109678|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Investigator decision|0|||
17109679|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Investigator decision|0|||
17109680|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Investigator decision|0|||
17109681|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Investigator decision|1|||
17109682|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Lack of time|1|||
17109683|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Lack of time|0|||
17109684|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Lack of time|0|||
17109685|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Lack of time|0|||
17109686|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Lack of time|0|||
17109687|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
17109688|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
17109689|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
17109690|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
17109691|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
17109692|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
17109693|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
17109694|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
17109695|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
17109696|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
17109697|NCT00318461|38247399|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
17109698|NCT00318461|38247400|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
17109699|NCT00318461|38247401|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
17109700|NCT00318461|38247402|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
17109701|NCT00318461|38247403|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
17109702|NCT00318461|38247399|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
17109703|NCT00318461|38247400|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
17109704|NCT00318461|38247401|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
17109705|NCT00318461|38247402|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
17109706|NCT00318461|38247403|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
17109707|NCT00318461|38247399|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
17109708|NCT00318461|38247400|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
17109709|NCT00318461|38247401|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
17109710|NCT00318461|38247402|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
17109711|NCT00318461|38247403|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
17109712|NCT00318461|38247399|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
17109713|NCT00318461|38247400|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
17109714|NCT00318461|38247401|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
17109715|NCT00318461|38247402|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
17109716|NCT00318461|38247403|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
17109717|NCT00318461|38247399|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
17109718|NCT00318461|38247400|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
17109719|NCT00318461|38247401|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
17109720|NCT00318461|38247402|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
17109721|NCT00318461|38247403|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
17109722|NCT00318461|38247399|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
17109723|NCT00318461|38247400|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
17109724|NCT00318461|38247401|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
17109725|NCT00318461|38247402|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
17109726|NCT00318461|38247403|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
17109727|NCT03764072|38247430|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
17109728|NCT03764072|38247431|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
17109729|NCT03764072|38247432|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
17109730|NCT03764072|38247433|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
17109731|NCT03764072|38247434|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
17109732|NCT03764072|38247435|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
17109733|NCT03764072|38247430|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
17109734|NCT03764072|38247431|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
17109735|NCT03764072|38247432|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
17109736|NCT03764072|38247433|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
17109737|NCT03764072|38247434|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
17109738|NCT03764072|38247435|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
17109739|NCT03764072|38247430|FG000|Overall Study|Lost to Follow-up|0|||
17109740|NCT03764072|38247431|FG001|Overall Study|Lost to Follow-up|0|||
17109741|NCT03764072|38247432|FG002|Overall Study|Lost to Follow-up|0|||
17109742|NCT03764072|38247433|FG003|Overall Study|Lost to Follow-up|0|||
17109743|NCT03764072|38247434|FG004|Overall Study|Lost to Follow-up|1|||
17109744|NCT03764072|38247435|FG005|Overall Study|Lost to Follow-up|0|||
17109745|NCT03333928|38247457|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
17109746|NCT03333928|38247458|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
17109747|NCT03333928|38247459|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
17109748|NCT03333928|38247457|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
17109749|NCT03333928|38247458|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
17109750|NCT03333928|38247459|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
17109751|NCT03333928|38247457|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
17109752|NCT03333928|38247458|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
17109753|NCT03333928|38247459|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
17109754|NCT03333928|38247457|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
17109755|NCT03333928|38247458|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
17109756|NCT03333928|38247459|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
17109757|NCT03333928|38247457|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
17109758|NCT03333928|38247458|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
17109759|NCT03333928|38247459|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
17109760|NCT03333928|38247457|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
17109761|NCT03333928|38247458|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
17109762|NCT03333928|38247459|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
17109763|NCT03333928|38247457|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
17109764|NCT03333928|38247458|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
17109765|NCT03333928|38247459|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
17109766|NCT03333928|38247457|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
17109767|NCT03333928|38247458|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
17109768|NCT03333928|38247459|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
17109769|NCT02945410|38247481|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
17109770|NCT02945410|38247482|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
17109771|NCT02945410|38247483|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
17109772|NCT02945410|38247484|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
17109773|NCT02945410|38247485|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
17109774|NCT02945410|38247486|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
17109775|NCT02945410|38247481|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
17109776|NCT02945410|38247482|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
17109777|NCT02945410|38247483|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
17109778|NCT02945410|38247484|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
17109779|NCT02945410|38247485|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
17109780|NCT02945410|38247486|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
17109781|NCT02945410|38247481|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
17109782|NCT02945410|38247482|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
17109783|NCT02945410|38247483|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
17109784|NCT02945410|38247484|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
17109785|NCT02945410|38247485|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
17109786|NCT02945410|38247486|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
17109787|NCT02945254|38247496|FG000|Overall Study|Lost to Follow-up|1|||
17109788|NCT02945254|38247497|FG001|Overall Study|Lost to Follow-up|0|||
17109789|NCT02945254|38247496|FG000|Overall Study|Withdrawal by Subject|1|||
17109790|NCT02945254|38247497|FG001|Overall Study|Withdrawal by Subject|0|||
17109791|NCT02943070|38247519|FG000|Overall Study|Physician Decision|1|||
17109792|NCT02943070|38247519|FG000|Overall Study|Adverse Event|2|||
17109793|NCT02943070|38247519|FG000|Overall Study|Death|2|||
17109794|NCT02943070|38247519|FG000|Overall Study|Withdrawal by Subject|3|||
17109795|NCT02943070|38247519|FG000|Overall Study|Lost to Follow-up|4|||
17109796|NCT02943070|38247519|FG000|Overall Study|Retreatment or TURP|13|||
17109797|NCT02943070|38247519|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
17109798|NCT03332212|38247543|FG000|Overall Study|Not treated|0|||
17109799|NCT03332212|38247544|FG001|Overall Study|Not treated|1|||
17109800|NCT03332212|38247545|FG002|Overall Study|Not treated|0|||
17109801|NCT03332212|38247546|FG003|Overall Study|Not treated|0|||
17109802|NCT03332212|38247543|FG000|Overall Study|Adverse Event|0|||
17109803|NCT03332212|38247544|FG001|Overall Study|Adverse Event|0|||
17109804|NCT03332212|38247545|FG002|Overall Study|Adverse Event|0|||
17109805|NCT03332212|38247546|FG003|Overall Study|Adverse Event|1|||
17109806|NCT03332212|38247543|FG000|Overall Study|worsening of disease under study|1|||
17109807|NCT03332212|38247544|FG001|Overall Study|worsening of disease under study|1|||
17109808|NCT03332212|38247545|FG002|Overall Study|worsening of disease under study|0|||
17109809|NCT03332212|38247546|FG003|Overall Study|worsening of disease under study|0|||
17109810|NCT03331666|38247556|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
17109811|NCT03331666|38247557|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
17109812|NCT03331042|38247567|FG000|Overall Study|Protocol Violation|1|||
17109813|NCT03331042|38247568|FG001|Overall Study|Protocol Violation|0|||
17109814|NCT03331042|38247569|FG002|Overall Study|Protocol Violation|0|||
17109815|NCT03331042|38247570|FG003|Overall Study|Protocol Violation|0|||
17109816|NCT03331042|38247567|FG000|Overall Study|Physician Decision|0|||
17109817|NCT03331042|38247568|FG001|Overall Study|Physician Decision|0|||
17109818|NCT03331042|38247569|FG002|Overall Study|Physician Decision|1|||
17109819|NCT03331042|38247570|FG003|Overall Study|Physician Decision|0|||
17109820|NCT03331042|38247567|FG000|Overall Study|Lost to Follow-up|0|||
17109821|NCT03331042|38247568|FG001|Overall Study|Lost to Follow-up|0|||
17109822|NCT03331042|38247569|FG002|Overall Study|Lost to Follow-up|0|||
17109823|NCT03331042|38247570|FG003|Overall Study|Lost to Follow-up|1|||
17109824|NCT03762668|38247588|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
17109825|NCT03762668|38247589|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
17109826|NCT03762200|38247595|FG000|Overall Study|Death|2|||
17109827|NCT03329404|38247601|FG000|Overall Study|The study was suspended.|1|||
17109828|NCT03329404|38247602|FG001|Overall Study|The study was suspended.|4|||
17109829|NCT03478930|38247610|FG000|Overall Study|Adverse Event|0|||
17109830|NCT03478930|38247611|FG001|Overall Study|Adverse Event|1|||
17109831|NCT03478930|38247610|FG000|Overall Study|Lack of Efficacy|3|||
17109832|NCT03478930|38247611|FG001|Overall Study|Lack of Efficacy|3|||
17109833|NCT03478930|38247610|FG000|Overall Study|Withdrawal by Subject|6|||
17109834|NCT03478930|38247611|FG001|Overall Study|Withdrawal by Subject|5|||
17109835|NCT03038438|38247617|FG000|Overall Study|Death|3|||
17109836|NCT03038438|38247617|FG000|Overall Study|Lost to Follow-up|8|||
17109837|NCT03038438|38247617|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
17109838|NCT03038438|38247617|FG000|Overall Study|Withdrawal by Subject|5|||
17109839|NCT03038438|38247617|FG000|Overall Study|No 36-Month Follow-Up|18|||
17109840|NCT03523000|38247621|FG000|Overall Study|Withdrawal by Subject|3|||
17109841|NCT03523000|38247622|FG001|Overall Study|Withdrawal by Subject|0|||
17109842|NCT03523000|38247621|FG000|Overall Study|Unsuccessful trial|2|||
17109843|NCT03523000|38247622|FG001|Overall Study|Unsuccessful trial|0|||
17109844|NCT03327220|38247633|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
17109845|NCT03327220|38247634|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
17109846|NCT03327220|38247633|FG000|Overall Study|Investigator Decision|2|||
17109847|NCT03327220|38247634|FG001|Overall Study|Investigator Decision|0|||
17109848|NCT03327220|38247633|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
17109849|NCT03327220|38247634|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
17109850|NCT03327220|38247633|FG000|Overall Study|Fungal infection|1|||
17109851|NCT03327220|38247634|FG001|Overall Study|Fungal infection|0|||
17109852|NCT03327220|38247633|FG000|Overall Study|Discharged to Rehabilitation|0|||
17109853|NCT03327220|38247634|FG001|Overall Study|Discharged to Rehabilitation|1|||
17109854|NCT03327220|38247633|FG000|Overall Study|Missing|1|||
17109855|NCT03327220|38247634|FG001|Overall Study|Missing|0|||
17109856|NCT00318149|38247646|FG000|Overall Study|Adverse Event|0|||
17109857|NCT00318149|38247647|FG001|Overall Study|Adverse Event|0|||
17109858|NCT00318149|38247648|FG002|Overall Study|Adverse Event|0|||
17109859|NCT00318149|38247649|FG003|Overall Study|Adverse Event|0|||
17109860|NCT00318149|38247650|FG004|Overall Study|Adverse Event|0|||
17109861|NCT00318149|38247651|FG005|Overall Study|Adverse Event|2|||
17109862|NCT00317603|38247667|FG000|Overall Study|Progressive Disease|3|||
17109863|NCT03326518|38247674|FG000|Overall Study|Protocol Violation|1|||
17109864|NCT03326518|38247675|FG001|Overall Study|Protocol Violation|0|||
17109865|NCT03326518|38247676|FG002|Overall Study|Protocol Violation|0|||
17109866|NCT03326518|38247674|FG000|Overall Study|Withdrawal by Subject|1|||
17109867|NCT03326518|38247675|FG001|Overall Study|Withdrawal by Subject|0|||
17109868|NCT03326518|38247676|FG002|Overall Study|Withdrawal by Subject|0|||
17109869|NCT03326518|38247674|FG000|Overall Study|Lost to Follow-up|1|||
17109870|NCT03326518|38247675|FG001|Overall Study|Lost to Follow-up|0|||
17109871|NCT03326518|38247676|FG002|Overall Study|Lost to Follow-up|1|||
17109872|NCT00317369|38247687|FG000|Overall Study|Adverse Event|2|||
17109873|NCT00317369|38247688|FG001|Overall Study|Adverse Event|1|||
17109874|NCT00317369|38247689|FG002|Overall Study|Adverse Event|0|||
17109875|NCT00317369|38247687|FG000|Overall Study|Lack of Efficacy|0|||
17109876|NCT00317369|38247688|FG001|Overall Study|Lack of Efficacy|1|||
17109877|NCT00317369|38247689|FG002|Overall Study|Lack of Efficacy|1|||
17109878|NCT00317369|38247687|FG000|Overall Study|Withdrawal by Subject|0|||
17109879|NCT00317369|38247688|FG001|Overall Study|Withdrawal by Subject|0|||
17109880|NCT00317369|38247689|FG002|Overall Study|Withdrawal by Subject|1|||
17109881|NCT03325894|38247699|FG000|Overall Study|Adverse Event|2|||
17109882|NCT03325894|38247700|FG001|Overall Study|Adverse Event|3|||
17109883|NCT03325894|38247699|FG000|Overall Study|Protocol Violation|1|||
17109884|NCT03325894|38247700|FG001|Overall Study|Protocol Violation|2|||
17109885|NCT03325894|38247699|FG000|Overall Study|Withdrawal by Subject|10|||
17109886|NCT03325894|38247700|FG001|Overall Study|Withdrawal by Subject|6|||
17109887|NCT03325894|38247699|FG000|Overall Study|Lost to Follow-up|4|||
17109888|NCT03325894|38247700|FG001|Overall Study|Lost to Follow-up|9|||
17109889|NCT03325894|38247699|FG000|Overall Study|Lack of Efficacy|8|||
17109890|NCT03325894|38247700|FG001|Overall Study|Lack of Efficacy|14|||
17109891|NCT03325894|38247699|FG000|Overall Study|Study Terminated by Sponsor|38|||
17109892|NCT03325894|38247700|FG001|Overall Study|Study Terminated by Sponsor|43|||
17109893|NCT03325894|38247699|FG000|Overall Study|Other (Not received Treatment)|1|||
17109894|NCT03325894|38247700|FG001|Overall Study|Other (Not received Treatment)|0|||
17109895|NCT01239368|38247719|FG000|Overall Study|Principal investigator discretion|1|||
17109896|NCT01239368|38247720|FG001|Overall Study|Principal investigator discretion|0|||
17109897|NCT01239368|38247721|FG002|Overall Study|Principal investigator discretion|0|||
17109898|NCT01239368|38247722|FG003|Overall Study|Principal investigator discretion|0|||
17109899|NCT01239368|38247723|FG004|Overall Study|Principal investigator discretion|1|||
17109900|NCT01239368|38247724|FG005|Overall Study|Principal investigator discretion|2|||
17109901|NCT01239368|38247725|FG006|Overall Study|Principal investigator discretion|0|||
17109902|NCT01239368|38247726|FG007|Overall Study|Principal investigator discretion|0|||
17109903|NCT01239368|38247727|FG008|Overall Study|Principal investigator discretion|0|||
17109904|NCT01239368|38247728|FG009|Overall Study|Principal investigator discretion|1|||
17109905|NCT01239368|38247719|FG000|Overall Study|Disease progression on study|1|||
17109906|NCT01239368|38247720|FG001|Overall Study|Disease progression on study|1|||
17109907|NCT01239368|38247721|FG002|Overall Study|Disease progression on study|1|||
17109908|NCT01239368|38247722|FG003|Overall Study|Disease progression on study|1|||
17109909|NCT01239368|38247723|FG004|Overall Study|Disease progression on study|4|||
17109910|NCT01239368|38247724|FG005|Overall Study|Disease progression on study|2|||
17109911|NCT01239368|38247725|FG006|Overall Study|Disease progression on study|5|||
17109912|NCT01239368|38247726|FG007|Overall Study|Disease progression on study|0|||
17109913|NCT01239368|38247727|FG008|Overall Study|Disease progression on study|0|||
17109914|NCT01239368|38247728|FG009|Overall Study|Disease progression on study|2|||
17109915|NCT01239368|38247719|FG000|Overall Study|Refused further treatment|0|||
17109916|NCT01239368|38247720|FG001|Overall Study|Refused further treatment|0|||
17109917|NCT01239368|38247721|FG002|Overall Study|Refused further treatment|0|||
17109918|NCT01239368|38247722|FG003|Overall Study|Refused further treatment|0|||
17109919|NCT01239368|38247723|FG004|Overall Study|Refused further treatment|0|||
17109920|NCT01239368|38247724|FG005|Overall Study|Refused further treatment|0|||
17109921|NCT01239368|38247725|FG006|Overall Study|Refused further treatment|0|||
17109922|NCT01239368|38247726|FG007|Overall Study|Refused further treatment|0|||
17109923|NCT01239368|38247727|FG008|Overall Study|Refused further treatment|0|||
17109924|NCT01239368|38247728|FG009|Overall Study|Refused further treatment|1|||
17109925|NCT01239368|38247719|FG000|Overall Study|Death|0|||
17109926|NCT01239368|38247720|FG001|Overall Study|Death|0|||
17109927|NCT01239368|38247721|FG002|Overall Study|Death|0|||
17109928|NCT01239368|38247722|FG003|Overall Study|Death|0|||
17109929|NCT01239368|38247723|FG004|Overall Study|Death|0|||
17109930|NCT01239368|38247724|FG005|Overall Study|Death|0|||
17109931|NCT01239368|38247725|FG006|Overall Study|Death|1|||
17109932|NCT01239368|38247726|FG007|Overall Study|Death|0|||
17109933|NCT01239368|38247727|FG008|Overall Study|Death|0|||
17109934|NCT01239368|38247728|FG009|Overall Study|Death|0|||
17109935|NCT02903420|38247770|FG000|Overall Study|Death|3|||
17109936|NCT00369161|38247780|FG000|Overall Study|Adverse Event|15|||
17109937|NCT00369161|38247781|FG001|Overall Study|Adverse Event|13|||
17109938|NCT00369161|38247780|FG000|Overall Study|Abnormal laboratory value|0|||
17109939|NCT00369161|38247781|FG001|Overall Study|Abnormal laboratory value|1|||
17109940|NCT00369161|38247780|FG000|Overall Study|Lack of Efficacy|3|||
17109941|NCT00369161|38247781|FG001|Overall Study|Lack of Efficacy|1|||
17109942|NCT00369161|38247780|FG000|Overall Study|Protocol Violation|0|||
17109943|NCT00369161|38247781|FG001|Overall Study|Protocol Violation|2|||
17109944|NCT00369161|38247780|FG000|Overall Study|Withdrawal by Subject|2|||
17109945|NCT00369161|38247781|FG001|Overall Study|Withdrawal by Subject|3|||
17109946|NCT00369161|38247780|FG000|Overall Study|Death|1|||
17109947|NCT00369161|38247781|FG001|Overall Study|Death|2|||
17109948|NCT00369161|38247780|FG000|Overall Study|Graft loss|4|||
17109949|NCT00369161|38247781|FG001|Overall Study|Graft loss|0|||
17109950|NCT00369161|38247780|FG000|Overall Study|Administrative Problem|2|||
17109951|NCT00369161|38247781|FG001|Overall Study|Administrative Problem|2|||
17109952|NCT00337571|38247791|FG000|Overall Study|Lack of Efficacy|3|||
17109953|NCT00337571|38247792|FG001|Overall Study|Lack of Efficacy|0|||
17109954|NCT00337571|38247793|FG002|Overall Study|Lack of Efficacy|0|||
17109955|NCT00337571|38247794|FG003|Overall Study|Lack of Efficacy|0|||
17109956|NCT00337571|38247791|FG000|Overall Study|Adverse Event|4|||
17109957|NCT00337571|38247792|FG001|Overall Study|Adverse Event|5|||
17109958|NCT00337571|38247793|FG002|Overall Study|Adverse Event|8|||
17109959|NCT00337571|38247794|FG003|Overall Study|Adverse Event|4|||
17109960|NCT00337571|38247791|FG000|Overall Study|Withdrawal by Subject|2|||
17109961|NCT00337571|38247792|FG001|Overall Study|Withdrawal by Subject|2|||
17109962|NCT00337571|38247793|FG002|Overall Study|Withdrawal by Subject|1|||
17109963|NCT00337571|38247794|FG003|Overall Study|Withdrawal by Subject|0|||
17109964|NCT00337571|38247791|FG000|Overall Study|Lost to Follow-up|3|||
17109965|NCT00337571|38247792|FG001|Overall Study|Lost to Follow-up|1|||
17109966|NCT00337571|38247793|FG002|Overall Study|Lost to Follow-up|0|||
17109967|NCT00337571|38247794|FG003|Overall Study|Lost to Follow-up|1|||
17109968|NCT00337571|38247791|FG000|Overall Study|Poor/noncompliance|1|||
17109969|NCT00337571|38247792|FG001|Overall Study|Poor/noncompliance|1|||
17109970|NCT00337571|38247793|FG002|Overall Study|Poor/noncompliance|1|||
17109971|NCT00337571|38247794|FG003|Overall Study|Poor/noncompliance|1|||
17109972|NCT00337571|38247791|FG000|Overall Study|No longer met study criteria|1|||
17109973|NCT00337571|38247792|FG001|Overall Study|No longer met study criteria|0|||
17109974|NCT00337571|38247793|FG002|Overall Study|No longer met study criteria|0|||
17109975|NCT00337571|38247794|FG003|Overall Study|No longer met study criteria|0|||
17109976|NCT00337571|38247791|FG000|Overall Study|High Potassium level|0|||
17109977|NCT00337571|38247792|FG001|Overall Study|High Potassium level|0|||
17109978|NCT00337571|38247793|FG002|Overall Study|High Potassium level|0|||
17109979|NCT00337571|38247794|FG003|Overall Study|High Potassium level|1|||
17109980|NCT00368927|38247806|FG000|Overall Study|Lost to Follow-up|2|||
17109981|NCT00368927|38247807|FG001|Overall Study|Lost to Follow-up|0|||
17109982|NCT00368927|38247806|FG000|Overall Study|Adverse Event|1|||
17109983|NCT00368927|38247807|FG001|Overall Study|Adverse Event|1|||
17109984|NCT00368927|38247806|FG000|Overall Study|Withdrawal by Subject|1|||
17109985|NCT00368927|38247807|FG001|Overall Study|Withdrawal by Subject|2|||
17109986|NCT00368927|38247806|FG000|Overall Study|Physician Decision|1|||
17109987|NCT00368927|38247807|FG001|Overall Study|Physician Decision|0|||
17109988|NCT00316589|38247830|FG000|Overall Study|Withdrawal by Subject|0|||
17109989|NCT00316589|38247831|FG001|Overall Study|Withdrawal by Subject|5|||
17109990|NCT00316589|38247832|FG002|Overall Study|Withdrawal by Subject|0|||
17109991|NCT00316589|38247833|FG003|Overall Study|Withdrawal by Subject|1|||
17109992|NCT00316589|38247830|FG000|Overall Study|Subject unwilling/unable to comply|0|||
17109993|NCT00316589|38247831|FG001|Overall Study|Subject unwilling/unable to comply|6|||
17109994|NCT00316589|38247832|FG002|Overall Study|Subject unwilling/unable to comply|0|||
17109995|NCT00316589|38247833|FG003|Overall Study|Subject unwilling/unable to comply|2|||
17109996|NCT00316589|38247830|FG000|Overall Study|Adverse Event|1|||
17109997|NCT00316589|38247831|FG001|Overall Study|Adverse Event|0|||
17109998|NCT00316589|38247832|FG002|Overall Study|Adverse Event|0|||
17109999|NCT00316589|38247833|FG003|Overall Study|Adverse Event|1|||
17110000|NCT00316589|38247830|FG000|Overall Study|Physician Decision|0|||
17110001|NCT00316589|38247831|FG001|Overall Study|Physician Decision|1|||
17110002|NCT00316589|38247832|FG002|Overall Study|Physician Decision|0|||
17110003|NCT00316589|38247833|FG003|Overall Study|Physician Decision|0|||
17110004|NCT00316589|38247830|FG000|Overall Study|Other reason|0|||
17110005|NCT00316589|38247831|FG001|Overall Study|Other reason|12|||
17110006|NCT00316589|38247832|FG002|Overall Study|Other reason|1|||
17110007|NCT00316589|38247833|FG003|Overall Study|Other reason|1|||
17110008|NCT00316277|38247847|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
17110009|NCT00316277|38247848|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
17110010|NCT00316277|38247847|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
17110011|NCT00316277|38247848|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
17110012|NCT00316277|38247847|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
17110013|NCT00316277|38247848|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
17110014|NCT00316277|38247847|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
17110015|NCT00316277|38247848|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
17110016|NCT00316277|38247847|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
17110017|NCT00316277|38247848|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
17110018|NCT00368849|38247862|FG000|Overall Study|Withdrawal by Subject|0|||
17110019|NCT00368849|38247863|FG001|Overall Study|Withdrawal by Subject|1|||
17110020|NCT00368849|38247862|FG000|Overall Study|Physician Decision|0|||
17110021|NCT00368849|38247863|FG001|Overall Study|Physician Decision|1|||
17110022|NCT00316199|38247870|FG000|Overall Study|Adverse Event|2|||
17110023|NCT00316199|38247870|FG000|Overall Study|Death|8|||
17110024|NCT00316199|38247870|FG000|Overall Study|Lost to Follow-up|2|||
17110025|NCT00316121|38247876|FG000|Overall Study|Death|1|||
17110026|NCT00316121|38247877|FG001|Overall Study|Death|0|||
17110027|NCT00316121|38247876|FG000|Overall Study|Lost to Follow-up|14|||
17110028|NCT00316121|38247877|FG001|Overall Study|Lost to Follow-up|8|||
17110029|NCT00316121|38247876|FG000|Overall Study|Withdrawal by Subject|2|||
17110030|NCT00316121|38247877|FG001|Overall Study|Withdrawal by Subject|0|||
17110031|NCT00316121|38247876|FG000|Overall Study|Reason is missing|1|||
17110032|NCT00316121|38247877|FG001|Overall Study|Reason is missing|0|||
17110033|NCT00316121|38247876|FG000|Overall Study|Subject relocated|1|||
17110034|NCT00316121|38247877|FG001|Overall Study|Subject relocated|1|||
17110035|NCT00316121|38247876|FG000|Overall Study|Subject refused to return|1|||
17110036|NCT00316121|38247877|FG001|Overall Study|Subject refused to return|0|||
17110037|NCT00316121|38247876|FG000|Overall Study|Subject no show for visit x 3|1|||
17110038|NCT00316121|38247877|FG001|Overall Study|Subject no show for visit x 3|0|||
17110039|NCT00316121|38247876|FG000|Overall Study|Subject did not have 24 month visit|1|||
17110040|NCT00316121|38247877|FG001|Overall Study|Subject did not have 24 month visit|0|||
17110041|NCT00337103|38247896|FG000|Overall Study|Progressive Disease|414|||
17110042|NCT00337103|38247897|FG001|Overall Study|Progressive Disease|410|||
17110043|NCT00337103|38247896|FG000|Overall Study|Adverse Event|45|||
17110044|NCT00337103|38247897|FG001|Overall Study|Adverse Event|59|||
17110045|NCT00337103|38247896|FG000|Overall Study|Subject Choice|34|||
17110046|NCT00337103|38247897|FG001|Overall Study|Subject Choice|27|||
17110047|NCT00337103|38247896|FG000|Overall Study|Clinical Progression|27|||
17110048|NCT00337103|38247897|FG001|Overall Study|Clinical Progression|24|||
17110049|NCT00337103|38247896|FG000|Overall Study|Physician Decision|15|||
17110050|NCT00337103|38247897|FG001|Overall Study|Physician Decision|14|||
17110051|NCT00337103|38247896|FG000|Overall Study|Withdrawal by Subject|8|||
17110052|NCT00337103|38247897|FG001|Overall Study|Withdrawal by Subject|5|||
17110053|NCT00337103|38247896|FG000|Overall Study|Other|5|||
17110054|NCT00337103|38247897|FG001|Overall Study|Other|6|||
17110055|NCT00337103|38247896|FG000|Overall Study|Entry Criteria Not Met|4|||
17110056|NCT00337103|38247897|FG001|Overall Study|Entry Criteria Not Met|1|||
17110057|NCT00337103|38247896|FG000|Overall Study|Lost to Follow-up|1|||
17110058|NCT00337103|38247897|FG001|Overall Study|Lost to Follow-up|2|||
17110059|NCT00337103|38247896|FG000|Overall Study|Death|1|||
17110060|NCT00337103|38247897|FG001|Overall Study|Death|0|||
17110061|NCT00415532|38247906|FG000|Treatment Period|Adverse Event|2|||
17110062|NCT00415532|38247907|FG001|Treatment Period|Adverse Event|3|||
17110063|NCT00415532|38247906|FG000|Treatment Period|Death|2|||
17110064|NCT00415532|38247907|FG001|Treatment Period|Death|1|||
17110065|NCT00415532|38247906|FG000|Treatment Period|Lost to Follow-up|1|||
17110066|NCT00415532|38247907|FG001|Treatment Period|Lost to Follow-up|1|||
17110067|NCT00415532|38247906|FG000|Treatment Period|Protocol Violation|1|||
17110068|NCT00415532|38247907|FG001|Treatment Period|Protocol Violation|0|||
17110069|NCT00415532|38247906|FG000|Treatment Period|Withdrawal by Subject|6|||
17110070|NCT00415532|38247907|FG001|Treatment Period|Withdrawal by Subject|6|||
17110071|NCT00415532|38247906|FG000|Treatment Period|Other|2|||
17110072|NCT00415532|38247907|FG001|Treatment Period|Other|2|||
17110073|NCT00415532|38247906|FG000|Treatment Period|Ineligibility determined|1|||
17110074|NCT00415532|38247907|FG001|Treatment Period|Ineligibility determined|1|||
17110075|NCT00415532|38247906|FG000|Treatment Period|Noncompliance|1|||
17110076|NCT00415532|38247907|FG001|Treatment Period|Noncompliance|1|||
17110077|NCT00415532|38247906|FG000|Treatment Period|Requirement for alternative therapy|1|||
17110078|NCT00415532|38247907|FG001|Treatment Period|Requirement for alternative therapy|0|||
17110079|NCT00415532|38247906|FG000|Safety Follow Up Period|Adverse Event|1|||
17110080|NCT00415532|38247907|FG001|Safety Follow Up Period|Adverse Event|3|||
17110081|NCT00415532|38247906|FG000|Safety Follow Up Period|Death|3|||
17110082|NCT00415532|38247907|FG001|Safety Follow Up Period|Death|0|||
17110083|NCT00415532|38247906|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
17110084|NCT00415532|38247907|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
17110085|NCT00415532|38247906|FG000|Safety Follow Up Period|Other|1|||
17110086|NCT00415532|38247907|FG001|Safety Follow Up Period|Other|4|||
17110087|NCT00415532|38247906|FG000|Safety Follow Up Period|Ineligibility determined|1|||
17110088|NCT00415532|38247907|FG001|Safety Follow Up Period|Ineligibility determined|1|||
17110089|NCT00415532|38247906|FG000|Safety Follow Up Period|Noncompliance|1|||
17110090|NCT00415532|38247907|FG001|Safety Follow Up Period|Noncompliance|0|||
17110091|NCT00415532|38247906|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
17110092|NCT00415532|38247907|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
17110093|NCT00315731|38247913|FG000|Overall Study|Lost to Follow-up|1|||
17110094|NCT00315731|38247913|FG000|Overall Study|Death|5|||
17110095|NCT00062868|38247940|FG000|Dose Level 1|Death|2|||
17110096|NCT00062868|38247941|FG001|Dose Level 1|Death|0|||
17110097|NCT00062868|38247942|FG002|Dose Level 1|Death|0|||
17110098|NCT00062868|38247943|FG003|Dose Level 1|Death|2|||
17110099|NCT00062868|38247944|FG004|Dose Level 1|Death|0|||
17110100|NCT00062868|38247945|FG005|Dose Level 1|Death|0|||
17110101|NCT00062868|38247946|FG006|Dose Level 1|Death|3|||
17110102|NCT00062868|38247947|FG007|Dose Level 1|Death|0|||
17110103|NCT00062868|38247948|FG008|Dose Level 1|Death|0|||
17110104|NCT00062868|38247949|FG009|Dose Level 1|Death|0|||
17110105|NCT00062868|38247950|FG010|Dose Level 1|Death|0|||
17110106|NCT00062868|38247951|FG011|Dose Level 1|Death|0|||
17110107|NCT00062868|38247952|FG012|Dose Level 1|Death|0|||
17110108|NCT00062868|38247953|FG013|Dose Level 1|Death|0|||
17110109|NCT00062868|38247954|FG014|Dose Level 1|Death|0|||
17110110|NCT00062868|38247955|FG015|Dose Level 1|Death|0|||
17110111|NCT00062868|38247956|FG016|Dose Level 1|Death|0|||
17110112|NCT00062868|38247957|FG017|Dose Level 1|Death|0|||
17110113|NCT00062868|38247958|FG018|Dose Level 1|Death|7|||
17110114|NCT00062868|38247959|FG019|Dose Level 1|Death|0|||
17110115|NCT00062868|38247960|FG020|Dose Level 1|Death|1|||
17110116|NCT00062868|38247940|FG000|Dose Level 1|Lost to Follow-up|0|||
17110117|NCT00062868|38247941|FG001|Dose Level 1|Lost to Follow-up|0|||
17110118|NCT00062868|38247942|FG002|Dose Level 1|Lost to Follow-up|0|||
17110119|NCT00062868|38247943|FG003|Dose Level 1|Lost to Follow-up|0|||
17110120|NCT00062868|38247944|FG004|Dose Level 1|Lost to Follow-up|0|||
17110121|NCT00062868|38247945|FG005|Dose Level 1|Lost to Follow-up|0|||
17110122|NCT00062868|38247946|FG006|Dose Level 1|Lost to Follow-up|0|||
17110123|NCT00062868|38247947|FG007|Dose Level 1|Lost to Follow-up|0|||
17110124|NCT00062868|38247948|FG008|Dose Level 1|Lost to Follow-up|0|||
17110125|NCT00062868|38247949|FG009|Dose Level 1|Lost to Follow-up|0|||
17110126|NCT00062868|38247950|FG010|Dose Level 1|Lost to Follow-up|0|||
17110127|NCT00062868|38247951|FG011|Dose Level 1|Lost to Follow-up|0|||
17110128|NCT00062868|38247952|FG012|Dose Level 1|Lost to Follow-up|1|||
17110129|NCT00062868|38247953|FG013|Dose Level 1|Lost to Follow-up|0|||
17110130|NCT00062868|38247954|FG014|Dose Level 1|Lost to Follow-up|0|||
17110131|NCT00062868|38247955|FG015|Dose Level 1|Lost to Follow-up|0|||
17110132|NCT00062868|38247956|FG016|Dose Level 1|Lost to Follow-up|0|||
17110133|NCT00062868|38247957|FG017|Dose Level 1|Lost to Follow-up|0|||
17110134|NCT00062868|38247958|FG018|Dose Level 1|Lost to Follow-up|2|||
17110135|NCT00062868|38247959|FG019|Dose Level 1|Lost to Follow-up|0|||
17110136|NCT00062868|38247960|FG020|Dose Level 1|Lost to Follow-up|1|||
17110137|NCT00062868|38247940|FG000|Dose Level 2|Death|0|||
17110138|NCT00062868|38247941|FG001|Dose Level 2|Death|3|||
17110139|NCT00062868|38247942|FG002|Dose Level 2|Death|0|||
17110140|NCT00062868|38247943|FG003|Dose Level 2|Death|0|||
17110141|NCT00062868|38247944|FG004|Dose Level 2|Death|2|||
17110142|NCT00062868|38247945|FG005|Dose Level 2|Death|0|||
17110143|NCT00062868|38247946|FG006|Dose Level 2|Death|0|||
17110144|NCT00062868|38247947|FG007|Dose Level 2|Death|0|||
17110145|NCT00062868|38247948|FG008|Dose Level 2|Death|0|||
17110146|NCT00062868|38247949|FG009|Dose Level 2|Death|0|||
17110147|NCT00062868|38247950|FG010|Dose Level 2|Death|1|||
17110148|NCT00062868|38247951|FG011|Dose Level 2|Death|0|||
17110149|NCT00062868|38247952|FG012|Dose Level 2|Death|0|||
17110150|NCT00062868|38247953|FG013|Dose Level 2|Death|0|||
17110151|NCT00062868|38247954|FG014|Dose Level 2|Death|0|||
17110152|NCT00062868|38247955|FG015|Dose Level 2|Death|0|||
17110153|NCT00062868|38247956|FG016|Dose Level 2|Death|2|||
17110154|NCT00062868|38247957|FG017|Dose Level 2|Death|0|||
17110155|NCT00062868|38247958|FG018|Dose Level 2|Death|0|||
17110156|NCT00062868|38247959|FG019|Dose Level 2|Death|0|||
17110157|NCT00062868|38247960|FG020|Dose Level 2|Death|0|||
17110158|NCT00062868|38247940|FG000|Dose Level 2|Lost to Follow-up|0|||
17110159|NCT00062868|38247941|FG001|Dose Level 2|Lost to Follow-up|0|||
17110160|NCT00062868|38247942|FG002|Dose Level 2|Lost to Follow-up|0|||
17110161|NCT00062868|38247943|FG003|Dose Level 2|Lost to Follow-up|0|||
17110162|NCT00062868|38247944|FG004|Dose Level 2|Lost to Follow-up|0|||
17110163|NCT00062868|38247945|FG005|Dose Level 2|Lost to Follow-up|0|||
17110164|NCT00062868|38247946|FG006|Dose Level 2|Lost to Follow-up|0|||
17110165|NCT00062868|38247947|FG007|Dose Level 2|Lost to Follow-up|0|||
17110166|NCT00062868|38247948|FG008|Dose Level 2|Lost to Follow-up|0|||
17110167|NCT00062868|38247949|FG009|Dose Level 2|Lost to Follow-up|0|||
17110168|NCT00062868|38247950|FG010|Dose Level 2|Lost to Follow-up|0|||
17110169|NCT00062868|38247951|FG011|Dose Level 2|Lost to Follow-up|0|||
17110170|NCT00062868|38247952|FG012|Dose Level 2|Lost to Follow-up|0|||
17110171|NCT00062868|38247953|FG013|Dose Level 2|Lost to Follow-up|1|||
17110172|NCT00062868|38247954|FG014|Dose Level 2|Lost to Follow-up|0|||
17110173|NCT00062868|38247955|FG015|Dose Level 2|Lost to Follow-up|0|||
17110174|NCT00062868|38247956|FG016|Dose Level 2|Lost to Follow-up|1|||
17110175|NCT00062868|38247957|FG017|Dose Level 2|Lost to Follow-up|0|||
17110176|NCT00062868|38247958|FG018|Dose Level 2|Lost to Follow-up|0|||
17110177|NCT00062868|38247959|FG019|Dose Level 2|Lost to Follow-up|0|||
17110178|NCT00062868|38247960|FG020|Dose Level 2|Lost to Follow-up|0|||
17110179|NCT00062868|38247940|FG000|Dose Level 3|Death|0|||
17110180|NCT00062868|38247941|FG001|Dose Level 3|Death|0|||
17110181|NCT00062868|38247942|FG002|Dose Level 3|Death|0|||
17110182|NCT00062868|38247943|FG003|Dose Level 3|Death|0|||
17110183|NCT00062868|38247944|FG004|Dose Level 3|Death|0|||
17110184|NCT00062868|38247945|FG005|Dose Level 3|Death|0|||
17110185|NCT00062868|38247946|FG006|Dose Level 3|Death|0|||
17110186|NCT00062868|38247947|FG007|Dose Level 3|Death|0|||
17110187|NCT00062868|38247948|FG008|Dose Level 3|Death|0|||
17110188|NCT00062868|38247949|FG009|Dose Level 3|Death|0|||
17110189|NCT00062868|38247950|FG010|Dose Level 3|Death|0|||
17110190|NCT00062868|38247951|FG011|Dose Level 3|Death|1|||
17110191|NCT00062868|38247952|FG012|Dose Level 3|Death|0|||
17110192|NCT00062868|38247953|FG013|Dose Level 3|Death|0|||
17110193|NCT00062868|38247954|FG014|Dose Level 3|Death|0|||
17110194|NCT00062868|38247955|FG015|Dose Level 3|Death|0|||
17110195|NCT00062868|38247956|FG016|Dose Level 3|Death|0|||
17110196|NCT00062868|38247957|FG017|Dose Level 3|Death|1|||
17110197|NCT00062868|38247958|FG018|Dose Level 3|Death|0|||
17110198|NCT00062868|38247959|FG019|Dose Level 3|Death|0|||
17110199|NCT00062868|38247960|FG020|Dose Level 3|Death|0|||
17110200|NCT00062868|38247940|FG000|Dose Level 3|Lost to Follow-up|0|||
17110201|NCT00062868|38247941|FG001|Dose Level 3|Lost to Follow-up|0|||
17110202|NCT00062868|38247942|FG002|Dose Level 3|Lost to Follow-up|0|||
17110203|NCT00062868|38247943|FG003|Dose Level 3|Lost to Follow-up|0|||
17110204|NCT00062868|38247944|FG004|Dose Level 3|Lost to Follow-up|0|||
17110205|NCT00062868|38247945|FG005|Dose Level 3|Lost to Follow-up|0|||
17110206|NCT00062868|38247946|FG006|Dose Level 3|Lost to Follow-up|0|||
17110207|NCT00062868|38247947|FG007|Dose Level 3|Lost to Follow-up|0|||
17110208|NCT00062868|38247948|FG008|Dose Level 3|Lost to Follow-up|0|||
17110209|NCT00062868|38247949|FG009|Dose Level 3|Lost to Follow-up|0|||
17110210|NCT00062868|38247950|FG010|Dose Level 3|Lost to Follow-up|0|||
17110211|NCT00062868|38247951|FG011|Dose Level 3|Lost to Follow-up|0|||
17110212|NCT00062868|38247952|FG012|Dose Level 3|Lost to Follow-up|0|||
17110213|NCT00062868|38247953|FG013|Dose Level 3|Lost to Follow-up|0|||
17110214|NCT00062868|38247954|FG014|Dose Level 3|Lost to Follow-up|1|||
17110215|NCT00062868|38247955|FG015|Dose Level 3|Lost to Follow-up|0|||
17110216|NCT00062868|38247956|FG016|Dose Level 3|Lost to Follow-up|0|||
17110217|NCT00062868|38247957|FG017|Dose Level 3|Lost to Follow-up|0|||
17110218|NCT00062868|38247958|FG018|Dose Level 3|Lost to Follow-up|0|||
17110219|NCT00062868|38247959|FG019|Dose Level 3|Lost to Follow-up|0|||
17110220|NCT00062868|38247960|FG020|Dose Level 3|Lost to Follow-up|0|||
17110221|NCT00062868|38247940|FG000|Dose Level 3|Withdrew|0|||
17110222|NCT00062868|38247941|FG001|Dose Level 3|Withdrew|0|||
17110223|NCT00062868|38247942|FG002|Dose Level 3|Withdrew|2|||
17110224|NCT00062868|38247943|FG003|Dose Level 3|Withdrew|0|||
17110225|NCT00062868|38247944|FG004|Dose Level 3|Withdrew|0|||
17110226|NCT00062868|38247945|FG005|Dose Level 3|Withdrew|0|||
17110227|NCT00062868|38247946|FG006|Dose Level 3|Withdrew|0|||
17110228|NCT00062868|38247947|FG007|Dose Level 3|Withdrew|0|||
17110229|NCT00062868|38247948|FG008|Dose Level 3|Withdrew|0|||
17110230|NCT00062868|38247949|FG009|Dose Level 3|Withdrew|0|||
17110231|NCT00062868|38247950|FG010|Dose Level 3|Withdrew|0|||
17110232|NCT00062868|38247951|FG011|Dose Level 3|Withdrew|0|||
17110233|NCT00062868|38247952|FG012|Dose Level 3|Withdrew|0|||
17110234|NCT00062868|38247953|FG013|Dose Level 3|Withdrew|0|||
17110235|NCT00062868|38247954|FG014|Dose Level 3|Withdrew|0|||
17110236|NCT00062868|38247955|FG015|Dose Level 3|Withdrew|0|||
17110237|NCT00062868|38247956|FG016|Dose Level 3|Withdrew|0|||
17110238|NCT00062868|38247957|FG017|Dose Level 3|Withdrew|0|||
17110239|NCT00062868|38247958|FG018|Dose Level 3|Withdrew|0|||
17110240|NCT00062868|38247959|FG019|Dose Level 3|Withdrew|0|||
17110241|NCT00062868|38247960|FG020|Dose Level 3|Withdrew|0|||
17110242|NCT00075504|38248006|FG000|Overall Study|Withdrawal by Subject|9|||
17110243|NCT00075504|38248007|FG001|Overall Study|Withdrawal by Subject|7|||
17110244|NCT00062166|38248013|FG000|Overall Study|Withdrawal by Subject|6|||
17110245|NCT00087438|38248018|FG000|Overall Study|Ineligible / No protocol treatment|4|||
17110246|NCT00321464|38248026|FG000|Overall Study|Death|169|||
17110247|NCT00321464|38248027|FG001|Overall Study|Death|174|||
17110248|NCT00321464|38248026|FG000|Overall Study|Disease progression|124|||
17110249|NCT00321464|38248027|FG001|Overall Study|Disease progression|124|||
17110250|NCT00321464|38248026|FG000|Overall Study|Withdrawal by Subject|117|||
17110251|NCT00321464|38248027|FG001|Overall Study|Withdrawal by Subject|118|||
17110252|NCT00321464|38248026|FG000|Overall Study|Participant request|57|||
17110253|NCT00321464|38248027|FG001|Overall Study|Participant request|61|||
17110254|NCT00321464|38248026|FG000|Overall Study|Adverse Event|43|||
17110255|NCT00321464|38248027|FG001|Overall Study|Adverse Event|28|||
17110256|NCT00321464|38248026|FG000|Overall Study|Physician Decision|15|||
17110257|NCT00321464|38248027|FG001|Overall Study|Physician Decision|14|||
17110258|NCT00321464|38248026|FG000|Overall Study|Noncompliance|4|||
17110259|NCT00321464|38248027|FG001|Overall Study|Noncompliance|10|||
17110260|NCT00321464|38248026|FG000|Overall Study|Lost to Follow-up|7|||
17110261|NCT00321464|38248027|FG001|Overall Study|Lost to Follow-up|8|||
17110262|NCT00321464|38248026|FG000|Overall Study|Protocol deviation|0|||
17110263|NCT00321464|38248027|FG001|Overall Study|Protocol deviation|2|||
17110264|NCT00321464|38248026|FG000|Overall Study|Ineligibility determined|2|||
17110265|NCT00321464|38248027|FG001|Overall Study|Ineligibility determined|1|||
17110266|NCT00321464|38248026|FG000|Overall Study|Other|21|||
17110267|NCT00321464|38248027|FG001|Overall Study|Other|18|||
17110268|NCT02889796|38248037|FG000|Overall Study|Withdrew Consent|18|||
17110269|NCT02889796|38248038|FG001|Overall Study|Withdrew Consent|29|||
17110270|NCT02889796|38248039|FG002|Overall Study|Withdrew Consent|20|||
17110271|NCT02889796|38248040|FG003|Overall Study|Withdrew Consent|1|||
17110272|NCT02889796|38248041|FG004|Overall Study|Withdrew Consent|2|||
17110273|NCT02889796|38248042|FG005|Overall Study|Withdrew Consent|35|||
17110274|NCT02889796|38248037|FG000|Overall Study|Investigator's Discretion|10|||
17110275|NCT02889796|38248038|FG001|Overall Study|Investigator's Discretion|9|||
17110276|NCT02889796|38248039|FG002|Overall Study|Investigator's Discretion|10|||
17110277|NCT02889796|38248040|FG003|Overall Study|Investigator's Discretion|3|||
17110278|NCT02889796|38248041|FG004|Overall Study|Investigator's Discretion|0|||
17110279|NCT02889796|38248042|FG005|Overall Study|Investigator's Discretion|15|||
17110280|NCT02889796|38248037|FG000|Overall Study|Adverse Event|17|||
17110281|NCT02889796|38248038|FG001|Overall Study|Adverse Event|8|||
17110282|NCT02889796|38248039|FG002|Overall Study|Adverse Event|8|||
17110283|NCT02889796|38248040|FG003|Overall Study|Adverse Event|4|||
17110284|NCT02889796|38248041|FG004|Overall Study|Adverse Event|1|||
17110285|NCT02889796|38248042|FG005|Overall Study|Adverse Event|7|||
17110286|NCT02889796|38248037|FG000|Overall Study|Lost to Follow-up|5|||
17110287|NCT02889796|38248038|FG001|Overall Study|Lost to Follow-up|7|||
17110288|NCT02889796|38248039|FG002|Overall Study|Lost to Follow-up|2|||
17110289|NCT02889796|38248040|FG003|Overall Study|Lost to Follow-up|0|||
17110290|NCT02889796|38248041|FG004|Overall Study|Lost to Follow-up|2|||
17110291|NCT02889796|38248042|FG005|Overall Study|Lost to Follow-up|6|||
17110292|NCT02889796|38248037|FG000|Overall Study|Protocol Violation|0|||
17110293|NCT02889796|38248038|FG001|Overall Study|Protocol Violation|1|||
17110294|NCT02889796|38248039|FG002|Overall Study|Protocol Violation|3|||
17110295|NCT02889796|38248040|FG003|Overall Study|Protocol Violation|0|||
17110296|NCT02889796|38248041|FG004|Overall Study|Protocol Violation|0|||
17110297|NCT02889796|38248042|FG005|Overall Study|Protocol Violation|4|||
17110298|NCT02889796|38248037|FG000|Overall Study|Non-compliance With Study Drug|0|||
17110299|NCT02889796|38248038|FG001|Overall Study|Non-compliance With Study Drug|2|||
17110300|NCT02889796|38248039|FG002|Overall Study|Non-compliance With Study Drug|0|||
17110301|NCT02889796|38248040|FG003|Overall Study|Non-compliance With Study Drug|0|||
17110302|NCT02889796|38248041|FG004|Overall Study|Non-compliance With Study Drug|1|||
17110303|NCT02889796|38248042|FG005|Overall Study|Non-compliance With Study Drug|2|||
17110304|NCT02889796|38248037|FG000|Overall Study|Death|1|||
17110305|NCT02889796|38248038|FG001|Overall Study|Death|1|||
17110306|NCT02889796|38248039|FG002|Overall Study|Death|0|||
17110307|NCT02889796|38248040|FG003|Overall Study|Death|1|||
17110308|NCT02889796|38248041|FG004|Overall Study|Death|0|||
17110309|NCT02889796|38248042|FG005|Overall Study|Death|1|||
17110310|NCT02889796|38248037|FG000|Overall Study|Pregnancy|0|||
17110311|NCT02889796|38248038|FG001|Overall Study|Pregnancy|1|||
17110312|NCT02889796|38248039|FG002|Overall Study|Pregnancy|1|||
17110313|NCT02889796|38248040|FG003|Overall Study|Pregnancy|0|||
17110314|NCT02889796|38248041|FG004|Overall Study|Pregnancy|0|||
17110315|NCT02889796|38248042|FG005|Overall Study|Pregnancy|0|||
17110316|NCT02889796|38248037|FG000|Overall Study|Randomized but not Dosed|2|||
17110317|NCT02889796|38248038|FG001|Overall Study|Randomized but not Dosed|0|||
17110318|NCT02889796|38248039|FG002|Overall Study|Randomized but not Dosed|0|||
17110319|NCT02889796|38248040|FG003|Overall Study|Randomized but not Dosed|0|||
17110320|NCT02889796|38248041|FG004|Overall Study|Randomized but not Dosed|0|||
17110321|NCT02889796|38248042|FG005|Overall Study|Randomized but not Dosed|2|||
17110322|NCT02889562|38248067|FG000|Overall Study|Physician Decision|0|||
17110323|NCT02889562|38248068|FG001|Overall Study|Physician Decision|1|||
17110324|NCT02889562|38248067|FG000|Overall Study|Withdrawal by Subject|0|||
17110325|NCT02889562|38248068|FG001|Overall Study|Withdrawal by Subject|1|||
17110326|NCT03323164|38248076|FG000|Overall Study|Poor quality imaging/scans|2|||
17110327|NCT03323164|38248077|FG001|Overall Study|Poor quality imaging/scans|2|||
17110328|NCT03323086|38248089|FG000|Overall Study|Lost to Follow-up|3|||
17110329|NCT03323086|38248090|FG001|Overall Study|Lost to Follow-up|2|||
17110330|NCT02888080|38248098|FG000|Overall Study|Subject / Guardian decision|1|||
17110331|NCT02888080|38248099|FG001|Overall Study|Subject / Guardian decision|3|||
17110332|NCT02888080|38248098|FG000|Overall Study|New Therapy for study indication|1|||
17110333|NCT02888080|38248099|FG001|Overall Study|New Therapy for study indication|0|||
17110334|NCT02888080|38248098|FG000|Overall Study|Lack of Efficacy|0|||
17110335|NCT02888080|38248099|FG001|Overall Study|Lack of Efficacy|1|||
17110336|NCT02888080|38248098|FG000|Overall Study|Adverse Event|0|||
17110337|NCT02888080|38248099|FG001|Overall Study|Adverse Event|1|||
17110338|NCT03322462|38248105|FG000|Overall Study|Technical difficulties|2|||
17110339|NCT03322462|38248105|FG000|Overall Study|Other|1|||
17110340|NCT00086580|38248113|FG000|Treatment Period|Disease progression|9|||
17110341|NCT00086580|38248114|FG001|Treatment Period|Disease progression|8|||
17110342|NCT00086580|38248113|FG000|Treatment Period|Unable to comply with protocol|3|||
17110343|NCT00086580|38248114|FG001|Treatment Period|Unable to comply with protocol|1|||
17110344|NCT00086580|38248113|FG000|Treatment Period|Withdrawal by Subject|7|||
17110345|NCT00086580|38248114|FG001|Treatment Period|Withdrawal by Subject|8|||
17110346|NCT00086580|38248113|FG000|Treatment Period|Physician Decision|13|||
17110347|NCT00086580|38248114|FG001|Treatment Period|Physician Decision|7|||
17110348|NCT00086580|38248113|FG000|Treatment Period|AE - not treatment related|7|||
17110349|NCT00086580|38248114|FG001|Treatment Period|AE - not treatment related|7|||
17110350|NCT00086580|38248113|FG000|Treatment Period|Toxicity - treatment related|15|||
17110351|NCT00086580|38248114|FG001|Treatment Period|Toxicity - treatment related|15|||
17110352|NCT00086580|38248113|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
17110353|NCT00086580|38248114|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
17110354|NCT00086580|38248113|FG000|Treatment Period|Death|5|||
17110355|NCT00086580|38248114|FG001|Treatment Period|Death|7|||
17110356|NCT00086580|38248113|FG000|Treatment Period|Other|5|||
17110357|NCT00086580|38248114|FG001|Treatment Period|Other|3|||
17110358|NCT00086580|38248113|FG000|Follow-up Period|Disease progression|72|||
17110359|NCT00086580|38248114|FG001|Follow-up Period|Disease progression|99|||
17110360|NCT00086580|38248113|FG000|Follow-up Period|Unable to comply with protocol|5|||
17110361|NCT00086580|38248114|FG001|Follow-up Period|Unable to comply with protocol|0|||
17110362|NCT00086580|38248113|FG000|Follow-up Period|Withdrawal by Subject|6|||
17110363|NCT00086580|38248114|FG001|Follow-up Period|Withdrawal by Subject|6|||
17110364|NCT00086580|38248113|FG000|Follow-up Period|Physician Decision|0|||
17110365|NCT00086580|38248114|FG001|Follow-up Period|Physician Decision|1|||
17110366|NCT00086580|38248113|FG000|Follow-up Period|AE - not related|1|||
17110367|NCT00086580|38248114|FG001|Follow-up Period|AE - not related|0|||
17110368|NCT00086580|38248113|FG000|Follow-up Period|Death|13|||
17110369|NCT00086580|38248114|FG001|Follow-up Period|Death|7|||
17110370|NCT00086580|38248113|FG000|Follow-up Period|Other|7|||
17110371|NCT00086580|38248114|FG001|Follow-up Period|Other|6|||
17110372|NCT00086580|38248113|FG000|Observation Period|Unable to comply with protocol|1|||
17110373|NCT00086580|38248114|FG001|Observation Period|Unable to comply with protocol|1|||
17110374|NCT00086580|38248113|FG000|Observation Period|Withdrawal by Subject|4|||
17110375|NCT00086580|38248114|FG001|Observation Period|Withdrawal by Subject|2|||
17110376|NCT00086580|38248113|FG000|Observation Period|Death|33|||
17110377|NCT00086580|38248114|FG001|Observation Period|Death|55|||
17110378|NCT00086580|38248113|FG000|Observation Period|Other|8|||
17110379|NCT00086580|38248114|FG001|Observation Period|Other|7|||
17110380|NCT03321526|38248122|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
17110381|NCT03321526|38248123|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
17110382|NCT03321526|38248122|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
17110383|NCT03321526|38248123|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
17110384|NCT03321526|38248122|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
17110385|NCT03321526|38248123|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
17110386|NCT03321526|38248122|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
17110387|NCT03321526|38248123|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
17110388|NCT03321526|38248122|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
17110389|NCT03321526|38248123|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
17110390|NCT03321526|38248122|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
17110391|NCT03321526|38248123|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
17110392|NCT03321526|38248122|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
17110393|NCT03321526|38248123|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
17110394|NCT03321526|38248122|FG000|Follow-up Phase (2 Weeks)|Other|24|||
17110395|NCT03321526|38248123|FG001|Follow-up Phase (2 Weeks)|Other|24|||
17110396|NCT00086502|38248137|FG000|Overall Study|Adverse Event|11|||
17110397|NCT00086502|38248138|FG001|Overall Study|Adverse Event|2|||
17110398|NCT00086502|38248137|FG000|Overall Study|Lack of Efficacy|0|||
17110399|NCT00086502|38248138|FG001|Overall Study|Lack of Efficacy|2|||
17110400|NCT00086502|38248137|FG000|Overall Study|Lost to Follow-up|3|||
17110401|NCT00086502|38248138|FG001|Overall Study|Lost to Follow-up|1|||
17110402|NCT00086502|38248137|FG000|Overall Study|Physician Decision|1|||
17110403|NCT00086502|38248138|FG001|Overall Study|Physician Decision|1|||
17110404|NCT00086502|38248137|FG000|Overall Study|Pregnancy|0|||
17110405|NCT00086502|38248138|FG001|Overall Study|Pregnancy|1|||
17110406|NCT00086502|38248137|FG000|Overall Study|Protocol Violation|3|||
17110407|NCT00086502|38248138|FG001|Overall Study|Protocol Violation|3|||
17110408|NCT00086502|38248137|FG000|Overall Study|Withdrawal by Subject|5|||
17110409|NCT00086502|38248138|FG001|Overall Study|Withdrawal by Subject|6|||
17110410|NCT00086502|38248137|FG000|Overall Study|Patient Moved|1|||
17110411|NCT00086502|38248138|FG001|Overall Study|Patient Moved|1|||
17110412|NCT00086502|38248137|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
17110413|NCT00086502|38248138|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
17110414|NCT00086502|38248137|FG000|Overall Study|Patient Accidentally Unblinded|1|||
17110415|NCT00086502|38248138|FG001|Overall Study|Patient Accidentally Unblinded|0|||
17110416|NCT03826667|38248144|FG000|Overall Study|Protocol deviation|21|||
17110417|NCT03636542|38248156|FG000|Overall Study|Lost to Follow-up|1|||
17110418|NCT03636542|38248157|FG001|Overall Study|Lost to Follow-up|1|||
17110419|NCT03636542|38248156|FG000|Overall Study|Physician Decision|0|||
17110420|NCT03636542|38248157|FG001|Overall Study|Physician Decision|1|||
17110421|NCT03636542|38248156|FG000|Overall Study|Withdrawal by Subject|1|||
17110422|NCT03636542|38248157|FG001|Overall Study|Withdrawal by Subject|0|||
17110423|NCT03305770|38248165|FG000|Overall Study|Physician Decision - prior to dispense|0|||
17110424|NCT03305770|38248166|FG001|Overall Study|Physician Decision - prior to dispense|1|||
17110425|NCT03305770|38248165|FG000|Overall Study|Subject moved|1|||
17110426|NCT03305770|38248166|FG001|Overall Study|Subject moved|0|||
17110427|NCT00086190|38248177|FG000|Overall Study|Adverse Event|6|||
17110428|NCT00086190|38248178|FG001|Overall Study|Adverse Event|2|||
17110429|NCT00086190|38248179|FG002|Overall Study|Adverse Event|2|||
17110430|NCT00086190|38248177|FG000|Overall Study|Withdrawal by Subject|0|||
17110431|NCT00086190|38248178|FG001|Overall Study|Withdrawal by Subject|2|||
17110432|NCT00086190|38248179|FG002|Overall Study|Withdrawal by Subject|2|||
17110433|NCT00086190|38248177|FG000|Overall Study|Protocol Violation|1|||
17110434|NCT00086190|38248178|FG001|Overall Study|Protocol Violation|0|||
17110435|NCT00086190|38248179|FG002|Overall Study|Protocol Violation|0|||
17110436|NCT00086190|38248177|FG000|Overall Study|Moved|1|||
17110437|NCT00086190|38248178|FG001|Overall Study|Moved|0|||
17110438|NCT00086190|38248179|FG002|Overall Study|Moved|0|||
17110439|NCT00086190|38248177|FG000|Overall Study|Worsening depression|0|||
17110440|NCT00086190|38248178|FG001|Overall Study|Worsening depression|0|||
17110441|NCT00086190|38248179|FG002|Overall Study|Worsening depression|2|||
17110442|NCT03320824|38248189|FG000|Overall Study|Withdrawal by Subject|8|||
17110443|NCT03320824|38248190|FG001|Overall Study|Withdrawal by Subject|1|||
17110444|NCT03320824|38248189|FG000|Overall Study|Lost to Follow-up|10|||
17110445|NCT03320824|38248190|FG001|Overall Study|Lost to Follow-up|1|||
17110446|NCT03320824|38248189|FG000|Overall Study|moved out of state|0|||
17110447|NCT03320824|38248190|FG001|Overall Study|moved out of state|1|||
17110448|NCT03320824|38248189|FG000|Overall Study|could not complete final visit|0|||
17110449|NCT03320824|38248190|FG001|Overall Study|could not complete final visit|1|||
17110450|NCT03275350|38248202|FG000|Overall Study|Lost to Follow-up|4|||
17110451|NCT03275350|38248203|FG001|Overall Study|Lost to Follow-up|6|||
17110452|NCT03275350|38248202|FG000|Overall Study|Death|2|||
17110453|NCT03275350|38248203|FG001|Overall Study|Death|1|||
17110454|NCT03275350|38248202|FG000|Overall Study|Physician Decision|1|||
17110455|NCT03275350|38248203|FG001|Overall Study|Physician Decision|0|||
17110456|NCT03275350|38248202|FG000|Overall Study|Incarcerated|1|||
17110457|NCT03275350|38248203|FG001|Overall Study|Incarcerated|1|||
17110458|NCT03319732|38248210|FG000|Overall Study|Adverse Event|40|||
17110459|NCT03319732|38248210|FG000|Overall Study|Withdrawal by Subject|50|||
17110460|NCT03319732|38248210|FG000|Overall Study|MS relapse|10|||
17110461|NCT03319732|38248210|FG000|Overall Study|reason not specified|5|||
17110462|NCT03304522|38248217|FG000|Overall Study|Adverse Event|0|||
17110463|NCT03304522|38248218|FG001|Overall Study|Adverse Event|4|||
17110464|NCT03304522|38248217|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
17110465|NCT03304522|38248218|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
17110466|NCT03304522|38248217|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
17110467|NCT03304522|38248218|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
17110468|NCT03304522|38248217|FG000|Overall Study|Other|0|||
17110469|NCT03304522|38248218|FG001|Overall Study|Other|1|||
17110470|NCT03315286|38248226|FG000|Overall Study|Lost to Follow-up|0|||
17110471|NCT03315286|38248227|FG001|Overall Study|Lost to Follow-up|3|||
17110472|NCT03315286|38248226|FG000|Overall Study|Withdrawal by Subject|1|||
17110473|NCT03315286|38248227|FG001|Overall Study|Withdrawal by Subject|0|||
17110474|NCT03315286|38248226|FG000|Overall Study|Protocol Violation|0|||
17110475|NCT03315286|38248227|FG001|Overall Study|Protocol Violation|1|||
17110476|NCT03273946|38248233|FG000|Overall Study|Withdrawal by Subject|5|||
17110477|NCT03273946|38248233|FG000|Overall Study|Unwillingness of the guardian|1|||
17110478|NCT03273946|38248233|FG000|Overall Study|Participant refused to use the drug|2|||
17110479|NCT03273946|38248233|FG000|Overall Study|Participant relative refused to use drug|1|||
17110480|NCT00314951|38248239|FG000|Treatment|Didn't meet criteria for mITT population|16|||
17110481|NCT00314951|38248240|FG001|Treatment|Didn't meet criteria for mITT population|11|||
17110482|NCT00314951|38248239|FG000|Follow-up|mITT failure|44|||
17110483|NCT00314951|38248240|FG001|Follow-up|mITT failure|34|||
17110484|NCT00085644|38248248|FG000|Double-Blind Period|Adverse Event|5|||
17110485|NCT00085644|38248249|FG001|Double-Blind Period|Adverse Event|2|||
17110486|NCT00085644|38248250|FG002|Double-Blind Period|Adverse Event|0|||
17110487|NCT00085644|38248248|FG000|Double-Blind Period|Withdrawal by Subject|3|||
17110488|NCT00085644|38248249|FG001|Double-Blind Period|Withdrawal by Subject|0|||
17110489|NCT00085644|38248250|FG002|Double-Blind Period|Withdrawal by Subject|0|||
17110490|NCT00085644|38248248|FG000|Double-Blind Period|Lost to Follow-up|2|||
17110491|NCT00085644|38248249|FG001|Double-Blind Period|Lost to Follow-up|1|||
17110492|NCT00085644|38248250|FG002|Double-Blind Period|Lost to Follow-up|0|||
17110493|NCT00085644|38248248|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
17110494|NCT00085644|38248249|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
17110495|NCT00085644|38248250|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
17110496|NCT00085644|38248248|FG000|Double-Blind Period|Contemplating pregnancy|1|||
17110497|NCT00085644|38248249|FG001|Double-Blind Period|Contemplating pregnancy|0|||
17110498|NCT00085644|38248250|FG002|Double-Blind Period|Contemplating pregnancy|0|||
17110499|NCT00085644|38248248|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
17110500|NCT00085644|38248249|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
17110501|NCT00085644|38248250|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
17110502|NCT00085644|38248248|FG000|Open-Label Period|Adverse Event|0|||
17110503|NCT00085644|38248249|FG001|Open-Label Period|Adverse Event|0|||
17110504|NCT00085644|38248250|FG002|Open-Label Period|Adverse Event|38|||
17110505|NCT00085644|38248248|FG000|Open-Label Period|Withdrawal by Subject|0|||
17110506|NCT00085644|38248249|FG001|Open-Label Period|Withdrawal by Subject|0|||
17110507|NCT00085644|38248250|FG002|Open-Label Period|Withdrawal by Subject|29|||
17110508|NCT00085644|38248248|FG000|Open-Label Period|Lost to Follow-up|0|||
17110509|NCT00085644|38248249|FG001|Open-Label Period|Lost to Follow-up|0|||
17110510|NCT00085644|38248250|FG002|Open-Label Period|Lost to Follow-up|13|||
17110511|NCT00085644|38248248|FG000|Open-Label Period|Lack of Efficacy|0|||
17110512|NCT00085644|38248249|FG001|Open-Label Period|Lack of Efficacy|0|||
17110513|NCT00085644|38248250|FG002|Open-Label Period|Lack of Efficacy|15|||
17110514|NCT00085644|38248248|FG000|Open-Label Period|Pregnancy|0|||
17110515|NCT00085644|38248249|FG001|Open-Label Period|Pregnancy|0|||
17110516|NCT00085644|38248250|FG002|Open-Label Period|Pregnancy|3|||
17110517|NCT00085644|38248248|FG000|Open-Label Period|Contemplating pregnancy|0|||
17110518|NCT00085644|38248249|FG001|Open-Label Period|Contemplating pregnancy|0|||
17110519|NCT00085644|38248250|FG002|Open-Label Period|Contemplating pregnancy|3|||
17110520|NCT00085644|38248248|FG000|Open-Label Period|Protocol Violation|0|||
17110521|NCT00085644|38248249|FG001|Open-Label Period|Protocol Violation|0|||
17110522|NCT00085644|38248250|FG002|Open-Label Period|Protocol Violation|4|||
17110523|NCT00085644|38248248|FG000|Open-Label Period|Personal reason|0|||
17110524|NCT00085644|38248249|FG001|Open-Label Period|Personal reason|0|||
17110525|NCT00085644|38248250|FG002|Open-Label Period|Personal reason|4|||
17110526|NCT03315208|38248259|FG000|Overall Study|Lost to Follow-up|11|||
17110527|NCT03315208|38248260|FG001|Overall Study|Lost to Follow-up|6|||
17110528|NCT03315208|38248259|FG000|Overall Study|Withdrawal by Subject|2|||
17110529|NCT03315208|38248260|FG001|Overall Study|Withdrawal by Subject|0|||
17110530|NCT00314795|38248267|FG000|Overall Study|Adverse Event|8|||
17110531|NCT00314795|38248267|FG000|Overall Study|Death|4|||
17110532|NCT00314795|38248267|FG000|Overall Study|Reason not Specified|3|||
17110533|NCT00314795|38248267|FG000|Overall Study|Renal Transplant|3|||
17110534|NCT00314795|38248267|FG000|Overall Study|Participants Withdrew Consent|2|||
17110535|NCT00314327|38248271|FG000|Overall Study|Withdrawal by Subject|1|||
17110536|NCT00336479|38248279|FG000|Overall Study|Adverse Event|8|||
17110537|NCT00336479|38248280|FG001|Overall Study|Adverse Event|11|||
17110538|NCT00336479|38248281|FG002|Overall Study|Adverse Event|18|||
17110539|NCT00336479|38248282|FG003|Overall Study|Adverse Event|4|||
17110540|NCT00336479|38248279|FG000|Overall Study|Noncompliant|1|||
17110541|NCT00336479|38248280|FG001|Overall Study|Noncompliant|7|||
17110542|NCT00336479|38248281|FG002|Overall Study|Noncompliant|3|||
17110543|NCT00336479|38248282|FG003|Overall Study|Noncompliant|0|||
17110544|NCT00336479|38248279|FG000|Overall Study|Physician Decision|2|||
17110545|NCT00336479|38248280|FG001|Overall Study|Physician Decision|3|||
17110546|NCT00336479|38248281|FG002|Overall Study|Physician Decision|1|||
17110547|NCT00336479|38248282|FG003|Overall Study|Physician Decision|0|||
17110548|NCT00336479|38248279|FG000|Overall Study|Lost to Follow-up|3|||
17110549|NCT00336479|38248280|FG001|Overall Study|Lost to Follow-up|2|||
17110550|NCT00336479|38248281|FG002|Overall Study|Lost to Follow-up|0|||
17110551|NCT00336479|38248282|FG003|Overall Study|Lost to Follow-up|0|||
17110552|NCT00336479|38248279|FG000|Overall Study|Withdrawal by Subject|3|||
17110553|NCT00336479|38248280|FG001|Overall Study|Withdrawal by Subject|2|||
17110554|NCT00336479|38248281|FG002|Overall Study|Withdrawal by Subject|3|||
17110555|NCT00336479|38248282|FG003|Overall Study|Withdrawal by Subject|0|||
17110556|NCT00336479|38248279|FG000|Overall Study|Other|0|||
17110557|NCT00336479|38248280|FG001|Overall Study|Other|0|||
17110558|NCT00336479|38248281|FG002|Overall Study|Other|1|||
17110559|NCT00336479|38248282|FG003|Overall Study|Other|0|||
17110560|NCT00336479|38248279|FG000|Overall Study|Virologic Stopping Rule|20|||
17110561|NCT00336479|38248280|FG001|Overall Study|Virologic Stopping Rule|0|||
17110562|NCT00336479|38248281|FG002|Overall Study|Virologic Stopping Rule|0|||
17110563|NCT00336479|38248282|FG003|Overall Study|Virologic Stopping Rule|0|||
17110564|NCT00314249|38248295|FG000|Overall Study|Adverse Event|73|||
17110565|NCT00314249|38248296|FG001|Overall Study|Adverse Event|94|||
17110566|NCT00314249|38248295|FG000|Overall Study|Lack of Efficacy|33|||
17110567|NCT00314249|38248296|FG001|Overall Study|Lack of Efficacy|24|||
17110568|NCT00314249|38248295|FG000|Overall Study|Withdrawal by Subject|21|||
17110569|NCT00314249|38248296|FG001|Overall Study|Withdrawal by Subject|28|||
17110570|NCT00314249|38248295|FG000|Overall Study|Lost to Follow-up|15|||
17110571|NCT00314249|38248296|FG001|Overall Study|Lost to Follow-up|9|||
17110572|NCT00314249|38248295|FG000|Overall Study|Physician Decision|1|||
17110573|NCT00314249|38248296|FG001|Overall Study|Physician Decision|1|||
17110574|NCT00314249|38248295|FG000|Overall Study|Withdrawn for other reasons|4|||
17110575|NCT00314249|38248296|FG001|Overall Study|Withdrawn for other reasons|1|||
17110576|NCT00314249|38248295|FG000|Overall Study|Non-Compliant|5|||
17110577|NCT00314249|38248296|FG001|Overall Study|Non-Compliant|6|||
17110578|NCT03315130|38248305|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
17110579|NCT03315130|38248306|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
17110580|NCT03315130|38248307|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
17110581|NCT03315130|38248308|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
17110582|NCT03315130|38248305|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
17110583|NCT03315130|38248306|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
17110584|NCT03315130|38248307|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
17110585|NCT03315130|38248308|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
17110586|NCT03315130|38248305|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
17110587|NCT03315130|38248306|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
17110588|NCT03315130|38248307|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
17110589|NCT03315130|38248308|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
17110590|NCT03315130|38248305|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
17110591|NCT03315130|38248306|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
17110592|NCT03315130|38248307|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
17110593|NCT03315130|38248308|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
17110594|NCT03315130|38248305|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
17110595|NCT03315130|38248306|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
17110596|NCT03315130|38248307|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
17110597|NCT03315130|38248308|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
17110598|NCT03315130|38248305|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
17110599|NCT03315130|38248306|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
17110600|NCT03315130|38248307|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
17110601|NCT03315130|38248308|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
17110602|NCT03273166|38248328|FG000|Overall Study|Withdrawn prior to Completion|31|||
17110603|NCT03314662|38248336|FG000|Overall Study|Withdrawal by Subject|1|||
17110604|NCT03314662|38248337|FG001|Overall Study|Withdrawal by Subject|1|||
17110605|NCT03314662|38248338|FG002|Overall Study|Withdrawal by Subject|1|||
17110606|NCT03314662|38248336|FG000|Overall Study|Lost to Follow-up|5|||
17110607|NCT03314662|38248337|FG001|Overall Study|Lost to Follow-up|4|||
17110608|NCT03314662|38248338|FG002|Overall Study|Lost to Follow-up|4|||
17110609|NCT03314662|38248336|FG000|Overall Study|Death|2|||
17110610|NCT03314662|38248337|FG001|Overall Study|Death|0|||
17110611|NCT03314662|38248338|FG002|Overall Study|Death|0|||
17110612|NCT03271528|38248356|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
17110613|NCT03271528|38248357|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
17110614|NCT03271528|38248356|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
17110615|NCT03271528|38248357|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
17110616|NCT03271528|38248356|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
17110617|NCT03271528|38248357|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
17110618|NCT03271528|38248356|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
17110619|NCT03271528|38248357|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
17110620|NCT03271528|38248356|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
17110621|NCT03271528|38248357|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
17110622|NCT03271528|38248356|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
17110623|NCT03271528|38248357|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
17110624|NCT03271528|38248356|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
17110625|NCT03271528|38248357|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
17110626|NCT03301714|38248366|FG000|Overall Study|Lost to Follow-up|10|||
17110627|NCT03301714|38248367|FG001|Overall Study|Lost to Follow-up|4|||
17110628|NCT03301714|38248368|FG002|Overall Study|Lost to Follow-up|4|||
17110629|NCT03301714|38248366|FG000|Overall Study|Did not receive allocated intervention|0|||
17110630|NCT03301714|38248367|FG001|Overall Study|Did not receive allocated intervention|2|||
17110631|NCT03301714|38248368|FG002|Overall Study|Did not receive allocated intervention|3|||
17110632|NCT03299686|38248381|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
17110633|NCT03299686|38248382|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
17110634|NCT03299686|38248381|FG000|Treatment Epoch|Physician Decision|1|||
17110635|NCT03299686|38248382|FG001|Treatment Epoch|Physician Decision|0|||
17110636|NCT03299686|38248381|FG000|Treatment Epoch|Adverse Event|8|||
17110637|NCT03299686|38248382|FG001|Treatment Epoch|Adverse Event|4|||
17110638|NCT03299686|38248381|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
17110639|NCT03299686|38248382|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
17110640|NCT00075270|38248390|FG000|Overall Study|Withdrawal by Subject|28|||
17110641|NCT00075270|38248391|FG001|Overall Study|Withdrawal by Subject|21|||
17110642|NCT00075270|38248390|FG000|Overall Study|Lost to Follow-up|25|||
17110643|NCT00075270|38248391|FG001|Overall Study|Lost to Follow-up|28|||
17110644|NCT00075270|38248390|FG000|Overall Study|Protocol Violation|0|||
17110645|NCT00075270|38248391|FG001|Overall Study|Protocol Violation|2|||
17110646|NCT00075270|38248390|FG000|Overall Study|Death|198|||
17110647|NCT00075270|38248391|FG001|Overall Study|Death|215|||
17110648|NCT00075270|38248390|FG000|Overall Study|Other/Unknown|9|||
17110649|NCT00075270|38248391|FG001|Overall Study|Other/Unknown|5|||
17110650|NCT00075270|38248390|FG000|Overall Study|Missing|26|||
17110651|NCT00075270|38248391|FG001|Overall Study|Missing|13|||
17110652|NCT00074958|38248398|FG000|Overall Study|Adverse Event|1|||
17110653|NCT03298984|38248406|FG000|Overall Study|Physician Decision|1|||
17110654|NCT03298984|38248407|FG001|Overall Study|Physician Decision|0|||
17110655|NCT03298984|38248408|FG002|Overall Study|Physician Decision|0|||
17110656|NCT03298984|38248409|FG003|Overall Study|Physician Decision|6|||
17110657|NCT03298984|38248406|FG000|Overall Study|Lack of Efficacy|0|||
17110658|NCT03298984|38248407|FG001|Overall Study|Lack of Efficacy|1|||
17110659|NCT03298984|38248408|FG002|Overall Study|Lack of Efficacy|1|||
17110660|NCT03298984|38248409|FG003|Overall Study|Lack of Efficacy|4|||
17110661|NCT03298984|38248406|FG000|Overall Study|Relapsed disease (following remission)|0|||
17110662|NCT03298984|38248407|FG001|Overall Study|Relapsed disease (following remission)|0|||
17110663|NCT03298984|38248408|FG002|Overall Study|Relapsed disease (following remission)|1|||
17110664|NCT03298984|38248409|FG003|Overall Study|Relapsed disease (following remission)|1|||
17110665|NCT03298984|38248406|FG000|Overall Study|Adverse Event|0|||
17110666|NCT03298984|38248407|FG001|Overall Study|Adverse Event|0|||
17110667|NCT03298984|38248408|FG002|Overall Study|Adverse Event|0|||
17110668|NCT03298984|38248409|FG003|Overall Study|Adverse Event|1|||
17110669|NCT03298984|38248406|FG000|Overall Study|Death|0|||
17110670|NCT03298984|38248407|FG001|Overall Study|Death|0|||
17110671|NCT03298984|38248408|FG002|Overall Study|Death|0|||
17110672|NCT03298984|38248409|FG003|Overall Study|Death|2|||
17110673|NCT03298984|38248406|FG000|Overall Study|Insurance Company Decision|0|||
17110674|NCT03298984|38248407|FG001|Overall Study|Insurance Company Decision|0|||
17110675|NCT03298984|38248408|FG002|Overall Study|Insurance Company Decision|0|||
17110676|NCT03298984|38248409|FG003|Overall Study|Insurance Company Decision|1|||
17110677|NCT02940574|38248422|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
17110678|NCT02940574|38248423|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
17110679|NCT02940574|38248422|FG000|1-year Follow-up|Lost to Follow-up|3|||
17110680|NCT02940574|38248423|FG001|1-year Follow-up|Lost to Follow-up|4|||
17110681|NCT03606512|38248435|FG000|Overall Study|Lost to Follow-up|0|||
17110682|NCT03606512|38248436|FG001|Overall Study|Lost to Follow-up|1|||
17110683|NCT03606512|38248435|FG000|Overall Study|'moved from study area|0|||
17110684|NCT03606512|38248436|FG001|Overall Study|'moved from study area|1|||
17110685|NCT03760250|38248458|FG000|Overall Study|Withdrawal by Subject|1|||
17110686|NCT03760250|38248458|FG000|Overall Study|Physician Decision|1|||
17110687|NCT03757988|38248462|FG000|Overall Study|Withdrawal by Subject|1|||
17110688|NCT00313781|38248469|FG000|Before Crossover|Death|22|||
17110689|NCT00313781|38248470|FG001|Before Crossover|Death|8|||
17110690|NCT00313781|38248471|FG002|Before Crossover|Death|0|||
17110691|NCT00313781|38248469|FG000|Before Crossover|Lost to Follow-up|0|||
17110692|NCT00313781|38248470|FG001|Before Crossover|Lost to Follow-up|3|||
17110693|NCT00313781|38248471|FG002|Before Crossover|Lost to Follow-up|0|||
17110694|NCT00313781|38248469|FG000|Before Crossover|Withdrawal by Subject|3|||
17110695|NCT00313781|38248470|FG001|Before Crossover|Withdrawal by Subject|1|||
17110696|NCT00313781|38248471|FG002|Before Crossover|Withdrawal by Subject|0|||
17110697|NCT00313781|38248469|FG000|Before Crossover|Other|45|||
17110698|NCT00313781|38248470|FG001|Before Crossover|Other|30|||
17110699|NCT00313781|38248471|FG002|Before Crossover|Other|0|||
17110700|NCT00313781|38248469|FG000|Before Crossover|Crossover|0|||
17110701|NCT00313781|38248470|FG001|Before Crossover|Crossover|37|||
17110702|NCT00313781|38248471|FG002|Before Crossover|Crossover|0|||
17110703|NCT00313781|38248469|FG000|Before Crossover|Randomized, not treated|5|||
17110704|NCT00313781|38248470|FG001|Before Crossover|Randomized, not treated|0|||
17110705|NCT00313781|38248471|FG002|Before Crossover|Randomized, not treated|0|||
17110706|NCT00313781|38248469|FG000|After Crossover|Death|0|||
17110707|NCT00313781|38248470|FG001|After Crossover|Death|0|||
17110708|NCT00313781|38248471|FG002|After Crossover|Death|6|||
17110709|NCT00313781|38248469|FG000|After Crossover|Withdrawal by Subject|0|||
17110710|NCT00313781|38248470|FG001|After Crossover|Withdrawal by Subject|0|||
17110711|NCT00313781|38248471|FG002|After Crossover|Withdrawal by Subject|3|||
17110712|NCT00313781|38248469|FG000|After Crossover|Other|0|||
17110713|NCT00313781|38248470|FG001|After Crossover|Other|0|||
17110714|NCT00313781|38248471|FG002|After Crossover|Other|18|||
17110715|NCT00368537|38248482|FG000|Randomization|No study drug dosed|13|||
17110716|NCT00368537|38248483|FG001|Randomization|No study drug dosed|6|||
17110717|NCT00368537|38248482|FG000|Baseline Participants|Lost to Follow-up|16|||
17110718|NCT00368537|38248483|FG001|Baseline Participants|Lost to Follow-up|17|||
17110719|NCT00368537|38248482|FG000|Baseline Participants|Withdrawal by Subject|6|||
17110720|NCT00368537|38248483|FG001|Baseline Participants|Withdrawal by Subject|4|||
17110721|NCT00368537|38248482|FG000|Baseline Participants|Death|1|||
17110722|NCT00368537|38248483|FG001|Baseline Participants|Death|2|||
17110723|NCT00368537|38248482|FG000|Baseline Participants|No susceptibility|1|||
17110724|NCT00368537|38248483|FG001|Baseline Participants|No susceptibility|0|||
17110725|NCT00368537|38248482|FG000|Baseline Participants|Patient uncompliant|0|||
17110726|NCT00368537|38248483|FG001|Baseline Participants|Patient uncompliant|1|||
17110727|NCT00313703|38248493|FG000|Overall Study|Lost to Follow-up|11|||
17110728|NCT00313703|38248494|FG001|Overall Study|Lost to Follow-up|2|||
17110729|NCT00313703|38248495|FG002|Overall Study|Lost to Follow-up|5|||
17110730|NCT00313703|38248496|FG003|Overall Study|Lost to Follow-up|12|||
17110731|NCT00313313|38248509|FG000|Overall Study|Lack of Efficacy|14|||
17110732|NCT00313313|38248510|FG001|Overall Study|Lack of Efficacy|9|||
17110733|NCT00313313|38248511|FG002|Overall Study|Lack of Efficacy|20|||
17110734|NCT00313313|38248509|FG000|Overall Study|Withdrawal of consent by subject|18|||
17110735|NCT00313313|38248510|FG001|Overall Study|Withdrawal of consent by subject|17|||
17110736|NCT00313313|38248511|FG002|Overall Study|Withdrawal of consent by subject|31|||
17110737|NCT00313313|38248509|FG000|Overall Study|Lost to Follow-up|10|||
17110738|NCT00313313|38248510|FG001|Overall Study|Lost to Follow-up|7|||
17110739|NCT00313313|38248511|FG002|Overall Study|Lost to Follow-up|9|||
17110740|NCT00313313|38248509|FG000|Overall Study|Adverse Event|15|||
17110741|NCT00313313|38248510|FG001|Overall Study|Adverse Event|16|||
17110742|NCT00313313|38248511|FG002|Overall Study|Adverse Event|12|||
17110743|NCT00313313|38248509|FG000|Overall Study|Physician Decision|2|||
17110744|NCT00313313|38248510|FG001|Overall Study|Physician Decision|6|||
17110745|NCT00313313|38248511|FG002|Overall Study|Physician Decision|4|||
17110746|NCT00313313|38248509|FG000|Overall Study|Poor/Noncompliance|3|||
17110747|NCT00313313|38248510|FG001|Overall Study|Poor/Noncompliance|6|||
17110748|NCT00313313|38248511|FG002|Overall Study|Poor/Noncompliance|2|||
17110749|NCT00313313|38248509|FG000|Overall Study|Pregnancy|1|||
17110750|NCT00313313|38248510|FG001|Overall Study|Pregnancy|2|||
17110751|NCT00313313|38248511|FG002|Overall Study|Pregnancy|0|||
17110752|NCT00313313|38248509|FG000|Overall Study|Death|0|||
17110753|NCT00313313|38248510|FG001|Overall Study|Death|0|||
17110754|NCT00313313|38248511|FG002|Overall Study|Death|2|||
17110755|NCT00313313|38248509|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
17110756|NCT00313313|38248510|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
17110757|NCT00313313|38248511|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
17110758|NCT00312845|38248521|FG000|Overall Study|Adverse Event|19|||
17110759|NCT00312845|38248522|FG001|Overall Study|Adverse Event|5|||
17110760|NCT00312845|38248521|FG000|Overall Study|Death|2|||
17110761|NCT00312845|38248522|FG001|Overall Study|Death|2|||
17110762|NCT00312845|38248521|FG000|Overall Study|Withdrawal by Subject|14|||
17110763|NCT00312845|38248522|FG001|Overall Study|Withdrawal by Subject|6|||
17110764|NCT00312845|38248521|FG000|Overall Study|Disease Progression|56|||
17110765|NCT00312845|38248522|FG001|Overall Study|Disease Progression|77|||
17110766|NCT00312845|38248521|FG000|Overall Study|Lost to Follow-up|2|||
17110767|NCT00312845|38248522|FG001|Overall Study|Lost to Follow-up|0|||
17110768|NCT00312845|38248521|FG000|Overall Study|Other|6|||
17110769|NCT00312845|38248522|FG001|Overall Study|Other|5|||
17110770|NCT00368069|38248530|FG000|Overall Study|Adverse Event|5|||
17110771|NCT00368069|38248531|FG001|Overall Study|Adverse Event|2|||
17110772|NCT00368069|38248530|FG000|Overall Study|Lack of Efficacy|0|||
17110773|NCT00368069|38248531|FG001|Overall Study|Lack of Efficacy|1|||
17110774|NCT00368069|38248530|FG000|Overall Study|Lost to Follow-up|1|||
17110775|NCT00368069|38248531|FG001|Overall Study|Lost to Follow-up|0|||
17110776|NCT00368069|38248530|FG000|Overall Study|Protocol Violation|0|||
17110777|NCT00368069|38248531|FG001|Overall Study|Protocol Violation|2|||
17110778|NCT00368069|38248530|FG000|Overall Study|Withdrawal of Consent|2|||
17110779|NCT00368069|38248531|FG001|Overall Study|Withdrawal of Consent|1|||
17110780|NCT00368069|38248530|FG000|Overall Study|no blood sampling possible|0|||
17110781|NCT00368069|38248531|FG001|Overall Study|no blood sampling possible|1|||
17110782|NCT00367991|38248539|FG000|Overall Study|Withdrawal by Subject|1|||
17110783|NCT00367991|38248540|FG001|Overall Study|Withdrawal by Subject|1|||
17110784|NCT00367991|38248539|FG000|Overall Study|Adverse Event|1|||
17110785|NCT00367991|38248540|FG001|Overall Study|Adverse Event|1|||
17110786|NCT00367835|38248548|FG000|Overall Study|Adverse Event|14|||
17110787|NCT00367835|38248549|FG001|Overall Study|Adverse Event|1|||
17110788|NCT00367835|38248548|FG000|Overall Study|Protocol Violation|1|||
17110789|NCT00367835|38248549|FG001|Overall Study|Protocol Violation|7|||
17110790|NCT00367835|38248548|FG000|Overall Study|Withdrawal by Subject|7|||
17110791|NCT00367835|38248549|FG001|Overall Study|Withdrawal by Subject|6|||
17110792|NCT00367835|38248548|FG000|Overall Study|Lost to Follow-up|1|||
17110793|NCT00367835|38248549|FG001|Overall Study|Lost to Follow-up|4|||
17110794|NCT00367835|38248548|FG000|Overall Study|Lack of Efficacy|3|||
17110795|NCT00367835|38248549|FG001|Overall Study|Lack of Efficacy|12|||
17110796|NCT00367835|38248548|FG000|Overall Study|Subject in juvenile detention center|1|||
17110797|NCT00367835|38248549|FG001|Overall Study|Subject in juvenile detention center|0|||
17110798|NCT00367835|38248548|FG000|Overall Study|refused blood collection|1|||
17110799|NCT00367835|38248549|FG001|Overall Study|refused blood collection|0|||
17110800|NCT00367835|38248548|FG000|Overall Study|Did not respond to calls|1|||
17110801|NCT00367835|38248549|FG001|Overall Study|Did not respond to calls|0|||
17110802|NCT00367835|38248548|FG000|Overall Study|History of lead poisoning|0|||
17110803|NCT00367835|38248549|FG001|Overall Study|History of lead poisoning|1|||
17110804|NCT03267940|38248561|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
17110805|NCT03267940|38248562|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
17110806|NCT03267940|38248563|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
17110807|NCT03267940|38248564|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
17110808|NCT03267940|38248565|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
17110809|NCT03267940|38248566|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
17110810|NCT03267940|38248561|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
17110811|NCT03267940|38248562|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
17110812|NCT03267940|38248563|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
17110813|NCT03267940|38248564|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
17110814|NCT03267940|38248565|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
17110815|NCT03267940|38248566|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
17110816|NCT03267940|38248561|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
17110817|NCT03267940|38248562|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
17110818|NCT03267940|38248563|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
17110819|NCT03267940|38248564|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
17110820|NCT03267940|38248565|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
17110821|NCT03267940|38248566|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
17110822|NCT03267940|38248561|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
17110823|NCT03267940|38248562|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
17110824|NCT03267940|38248563|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
17110825|NCT03267940|38248564|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
17110826|NCT03267940|38248565|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
17110827|NCT03267940|38248566|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
17110828|NCT03267940|38248561|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
17110829|NCT03267940|38248562|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
17110830|NCT03267940|38248563|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
17110831|NCT03267940|38248564|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
17110832|NCT03267940|38248565|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
17110833|NCT03267940|38248566|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
17110834|NCT03267940|38248561|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
17110835|NCT03267940|38248562|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
17110836|NCT03267940|38248563|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
17110837|NCT03267940|38248564|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
17110838|NCT03267940|38248565|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
17110839|NCT03267940|38248566|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
17110840|NCT03267940|38248561|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
17110841|NCT03267940|38248562|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
17110842|NCT03267940|38248563|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
17110843|NCT03267940|38248564|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
17110844|NCT03267940|38248565|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
17110845|NCT03267940|38248566|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
17110846|NCT03267940|38248561|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
17110847|NCT03267940|38248562|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
17110848|NCT03267940|38248563|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
17110849|NCT03267940|38248564|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
17110850|NCT03267940|38248565|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
17110851|NCT03267940|38248566|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
17110852|NCT03267940|38248561|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
17110853|NCT03267940|38248562|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
17110854|NCT03267940|38248563|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
17110855|NCT03267940|38248564|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
17110856|NCT03267940|38248565|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
17110857|NCT03267940|38248566|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
17110858|NCT03296566|38248586|FG000|Overall Study|Lost to Follow-up|19|||
17110859|NCT03296566|38248587|FG001|Overall Study|Lost to Follow-up|46|||
17110860|NCT03296566|38248586|FG000|Overall Study|Withdrawal by Subject|0|||
17110861|NCT03296566|38248587|FG001|Overall Study|Withdrawal by Subject|3|||
17110862|NCT03755882|38248593|FG000|Period 1|Protocol Violation|1|||
17110863|NCT03755882|38248594|FG001|Period 1|Protocol Violation|0|||
17110864|NCT03755882|38248593|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
17110865|NCT03755882|38248594|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
17110866|NCT00312377|38248602|FG000|Overall Study|Death|403|||
17110867|NCT00312377|38248603|FG001|Overall Study|Death|418|||
17110868|NCT00312377|38248602|FG000|Overall Study|Withdrawal by Subject|23|||
17110869|NCT00312377|38248603|FG001|Overall Study|Withdrawal by Subject|30|||
17110870|NCT00312377|38248602|FG000|Overall Study|Lost to Follow-up|9|||
17110871|NCT00312377|38248603|FG001|Overall Study|Lost to Follow-up|12|||
17110872|NCT00312377|38248602|FG000|Overall Study|Non-compliance|0|||
17110873|NCT00312377|38248603|FG001|Overall Study|Non-compliance|2|||
17110874|NCT00312377|38248602|FG000|Overall Study|Randomised but never received treatment|6|||
17110875|NCT00312377|38248603|FG001|Overall Study|Randomised but never received treatment|6|||
17110876|NCT00312377|38248602|FG000|Overall Study|Discontinue treatment survival follow up|202|||
17110877|NCT00312377|38248603|FG001|Overall Study|Discontinue treatment survival follow up|200|||
17110878|NCT00312377|38248602|FG000|Overall Study|Site ended participation in study|1|||
17110879|NCT00312377|38248603|FG001|Overall Study|Site ended participation in study|0|||
17110880|NCT03295318|38248612|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
17110881|NCT03295318|38248613|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
17110882|NCT03295318|38248614|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
17110883|NCT03295318|38248612|FG000|Overall Study|Death|1|||
17110884|NCT03295318|38248613|FG001|Overall Study|Death|1|||
17110885|NCT03295318|38248614|FG002|Overall Study|Death|1|||
17110886|NCT03295318|38248612|FG000|Overall Study|Protocol Violation|4|||
17110887|NCT03295318|38248613|FG001|Overall Study|Protocol Violation|3|||
17110888|NCT03295318|38248614|FG002|Overall Study|Protocol Violation|3|||
17110889|NCT03295318|38248612|FG000|Overall Study|Withdrawal by Subject|0|||
17110890|NCT03295318|38248613|FG001|Overall Study|Withdrawal by Subject|0|||
17110891|NCT03295318|38248614|FG002|Overall Study|Withdrawal by Subject|1|||
17110892|NCT03295318|38248612|FG000|Overall Study|Subject discontinued due to travel|0|||
17110893|NCT03295318|38248613|FG001|Overall Study|Subject discontinued due to travel|1|||
17110894|NCT03295318|38248614|FG002|Overall Study|Subject discontinued due to travel|0|||
17110895|NCT03311230|38248644|FG000|Overall Study|Withdrawal by Subject|1|||
17110896|NCT03311230|38248645|FG001|Overall Study|Withdrawal by Subject|4|||
17110897|NCT03311230|38248646|FG002|Overall Study|Withdrawal by Subject|2|||
17110898|NCT03311230|38248647|FG003|Overall Study|Withdrawal by Subject|7|||
17110899|NCT03311230|38248644|FG000|Overall Study|Unrelated injury|0|||
17110900|NCT03311230|38248645|FG001|Overall Study|Unrelated injury|1|||
17110901|NCT03311230|38248646|FG002|Overall Study|Unrelated injury|0|||
17110902|NCT03311230|38248647|FG003|Overall Study|Unrelated injury|0|||
17110903|NCT00312221|38248660|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
17110904|NCT00312221|38248661|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
17110905|NCT00312221|38248662|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
17110906|NCT00312221|38248663|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
17110907|NCT00312221|38248660|FG000|Open-label Run-in Period|Adverse Event|74|||
17110908|NCT00312221|38248661|FG001|Open-label Run-in Period|Adverse Event|0|||
17110909|NCT00312221|38248662|FG002|Open-label Run-in Period|Adverse Event|0|||
17110910|NCT00312221|38248663|FG003|Open-label Run-in Period|Adverse Event|0|||
17110911|NCT00312221|38248660|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
17110912|NCT00312221|38248661|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
17110913|NCT00312221|38248662|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
17110914|NCT00312221|38248663|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
17110915|NCT00312221|38248660|FG000|Open-label Run-in Period|Administrative|42|||
17110916|NCT00312221|38248661|FG001|Open-label Run-in Period|Administrative|0|||
17110917|NCT00312221|38248662|FG002|Open-label Run-in Period|Administrative|0|||
17110918|NCT00312221|38248663|FG003|Open-label Run-in Period|Administrative|0|||
17110919|NCT00312221|38248660|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
17110920|NCT00312221|38248661|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
17110921|NCT00312221|38248662|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
17110922|NCT00312221|38248663|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
17110923|NCT00312221|38248660|FG000|Open-label Run-in Period|Did not qualify|5|||
17110924|NCT00312221|38248661|FG001|Open-label Run-in Period|Did not qualify|0|||
17110925|NCT00312221|38248662|FG002|Open-label Run-in Period|Did not qualify|0|||
17110926|NCT00312221|38248663|FG003|Open-label Run-in Period|Did not qualify|0|||
17110927|NCT00312221|38248660|FG000|Double-blind Phase|Withdrawal by Subject|0|||
17110928|NCT00312221|38248661|FG001|Double-blind Phase|Withdrawal by Subject|6|||
17110929|NCT00312221|38248662|FG002|Double-blind Phase|Withdrawal by Subject|8|||
17110930|NCT00312221|38248663|FG003|Double-blind Phase|Withdrawal by Subject|7|||
17110931|NCT00312221|38248660|FG000|Double-blind Phase|Adverse Event|0|||
17110932|NCT00312221|38248661|FG001|Double-blind Phase|Adverse Event|10|||
17110933|NCT00312221|38248662|FG002|Double-blind Phase|Adverse Event|19|||
17110934|NCT00312221|38248663|FG003|Double-blind Phase|Adverse Event|18|||
17110935|NCT00312221|38248660|FG000|Double-blind Phase|Lost to Follow-up|0|||
17110936|NCT00312221|38248661|FG001|Double-blind Phase|Lost to Follow-up|0|||
17110937|NCT00312221|38248662|FG002|Double-blind Phase|Lost to Follow-up|2|||
17110938|NCT00312221|38248663|FG003|Double-blind Phase|Lost to Follow-up|2|||
17110939|NCT00312221|38248660|FG000|Double-blind Phase|Administrative|0|||
17110940|NCT00312221|38248661|FG001|Double-blind Phase|Administrative|26|||
17110941|NCT00312221|38248662|FG002|Double-blind Phase|Administrative|37|||
17110942|NCT00312221|38248663|FG003|Double-blind Phase|Administrative|33|||
17110943|NCT00312221|38248660|FG000|Double-blind Phase|Lack of Efficacy|0|||
17110944|NCT00312221|38248661|FG001|Double-blind Phase|Lack of Efficacy|17|||
17110945|NCT00312221|38248662|FG002|Double-blind Phase|Lack of Efficacy|6|||
17110946|NCT00312221|38248663|FG003|Double-blind Phase|Lack of Efficacy|10|||
17110947|NCT03294538|38248687|FG000|Overall Study|Adverse Event|0|||
17110948|NCT03294538|38248688|FG001|Overall Study|Adverse Event|1|||
17110949|NCT03294538|38248689|FG002|Overall Study|Adverse Event|1|||
17110950|NCT03294538|38248687|FG000|Overall Study|Lost to Follow-up|1|||
17110951|NCT03294538|38248688|FG001|Overall Study|Lost to Follow-up|0|||
17110952|NCT03294538|38248689|FG002|Overall Study|Lost to Follow-up|0|||
17110953|NCT03294538|38248687|FG000|Overall Study|Outside of Visit Window|4|||
17110954|NCT03294538|38248688|FG001|Overall Study|Outside of Visit Window|4|||
17110955|NCT03294538|38248689|FG002|Overall Study|Outside of Visit Window|1|||
17110956|NCT03265600|38248699|FG000|Overall Study|Lost to Follow-up|17|||
17110957|NCT03265600|38248700|FG001|Overall Study|Lost to Follow-up|5|||
17110958|NCT03265600|38248699|FG000|Overall Study|Withdrawal by Subject|4|||
17110959|NCT03265600|38248700|FG001|Overall Study|Withdrawal by Subject|2|||
17110960|NCT03265600|38248699|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
17110961|NCT03265600|38248700|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
17110962|NCT00335153|38248706|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
17110963|NCT00335153|38248706|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
17110964|NCT00335153|38248706|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
17110965|NCT00335153|38248706|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
17110966|NCT00335153|38248706|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
17110967|NCT00335153|38248706|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
17110968|NCT00335153|38248706|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
17110969|NCT00335153|38248706|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
17110970|NCT00335153|38248706|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
17110971|NCT00335153|38248706|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
17110972|NCT03265132|38248712|FG000|Overall Study|Adverse Event|0|||
17110973|NCT03265132|38248713|FG001|Overall Study|Adverse Event|1|||
17110974|NCT03265132|38248712|FG000|Overall Study|Lack of Efficacy|0|||
17110975|NCT03265132|38248713|FG001|Overall Study|Lack of Efficacy|2|||
17110976|NCT03265132|38248712|FG000|Overall Study|Progressive disease|0|||
17110977|NCT03265132|38248713|FG001|Overall Study|Progressive disease|2|||
17110978|NCT03265132|38248712|FG000|Overall Study|Withdrawal by Subject|0|||
17110979|NCT03265132|38248713|FG001|Overall Study|Withdrawal by Subject|1|||
17110980|NCT02939950|38248723|FG000|Overall Study|Lost to Follow-up|13|||
17110981|NCT02939950|38248724|FG001|Overall Study|Lost to Follow-up|16|||
17110982|NCT02939950|38248723|FG000|Overall Study|Positive slit lamp findings|0|||
17110983|NCT02939950|38248724|FG001|Overall Study|Positive slit lamp findings|1|||
17110984|NCT02939950|38248723|FG000|Overall Study|Chalazion upper lid|0|||
17110985|NCT02939950|38248724|FG001|Overall Study|Chalazion upper lid|1|||
17110986|NCT02939950|38248723|FG000|Overall Study|Lack of motivation|0|||
17110987|NCT02939950|38248724|FG001|Overall Study|Lack of motivation|2|||
17110988|NCT02939950|38248723|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
17110989|NCT02939950|38248724|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
17110990|NCT02939950|38248723|FG000|Overall Study|Military orders|1|||
17110991|NCT02939950|38248724|FG001|Overall Study|Military orders|0|||
17110992|NCT02939950|38248723|FG000|Overall Study|Participant Relocated|5|||
17110993|NCT02939950|38248724|FG001|Overall Study|Participant Relocated|3|||
17110994|NCT02939950|38248723|FG000|Overall Study|Study related symptoms|8|||
17110995|NCT02939950|38248724|FG001|Overall Study|Study related symptoms|8|||
17110996|NCT02939950|38248723|FG000|Overall Study|Unacceptable lens movement|2|||
17110997|NCT02939950|38248724|FG001|Overall Study|Unacceptable lens movement|0|||
17110998|NCT02939950|38248723|FG000|Overall Study|Protocol Violation|6|||
17110999|NCT02939950|38248724|FG001|Overall Study|Protocol Violation|3|||
17111000|NCT02939950|38248723|FG000|Overall Study|Physician Decision|2|||
17111001|NCT02939950|38248724|FG001|Overall Study|Physician Decision|0|||
17111002|NCT02939950|38248723|FG000|Overall Study|Pregnancy|6|||
17111003|NCT02939950|38248724|FG001|Overall Study|Pregnancy|7|||
17111004|NCT02939950|38248723|FG000|Overall Study|Withdrawal by Subject|12|||
17111005|NCT02939950|38248724|FG001|Overall Study|Withdrawal by Subject|28|||
17111006|NCT02939950|38248723|FG000|Overall Study|Adverse Event|7|||
17111007|NCT02939950|38248724|FG001|Overall Study|Adverse Event|3|||
17111008|NCT02939950|38248723|FG000|Overall Study|Randomized, not dispensed|1|||
17111009|NCT02939950|38248724|FG001|Overall Study|Randomized, not dispensed|0|||
17111010|NCT02939950|38248723|FG000|Overall Study|Ineligible at Baseline|2|||
17111011|NCT02939950|38248724|FG001|Overall Study|Ineligible at Baseline|8|||
17111012|NCT03753542|38248732|FG000|Overall Study|Lost to Follow-up|9|||
17111013|NCT03753542|38248733|FG001|Overall Study|Lost to Follow-up|14|||
17111014|NCT03292588|38248741|FG000|Overall Study|Death|1|||
17111015|NCT03292588|38248742|FG001|Overall Study|Death|0|||
17111016|NCT03292588|38248741|FG000|Overall Study|Lost to Follow-up|12|||
17111017|NCT03292588|38248742|FG001|Overall Study|Lost to Follow-up|16|||
17111018|NCT03292588|38248741|FG000|Overall Study|Physician Decision|0|||
17111019|NCT03292588|38248742|FG001|Overall Study|Physician Decision|1|||
17111020|NCT03292588|38248741|FG000|Overall Study|Withdrawal by Subject|4|||
17111021|NCT03292588|38248742|FG001|Overall Study|Withdrawal by Subject|4|||
17111022|NCT03292588|38248741|FG000|Overall Study|Move out of town|1|||
17111023|NCT03292588|38248742|FG001|Overall Study|Move out of town|0|||
17111024|NCT03292588|38248741|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
17111025|NCT03292588|38248742|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
17111026|NCT03752528|38248750|FG000|Part A|Lost to Follow-up|1|||
17111027|NCT03752528|38248750|FG000|Part A|Protocol Violation|1|||
17111028|NCT03752528|38248750|FG000|Part B|Protocol Violation|1|||
17111029|NCT03752528|38248750|FG000|Part B|Study terminated by sponsor|3|||
17111030|NCT00334295|38248757|FG000|Overall Study|Patients received fewer than 3 injection|5|||
17111031|NCT03292432|38248763|FG000|Overall Study|Lost to Follow-up|11|||
17111032|NCT03292432|38248764|FG001|Overall Study|Lost to Follow-up|8|||
17111033|NCT03292432|38248763|FG000|Overall Study|Death|2|||
17111034|NCT03292432|38248764|FG001|Overall Study|Death|1|||
17111035|NCT03292432|38248763|FG000|Overall Study|Withdrawal by Subject|1|||
17111036|NCT03292432|38248764|FG001|Overall Study|Withdrawal by Subject|2|||
17111037|NCT03292432|38248763|FG000|Overall Study|Site closed before any data collected|1|||
17111038|NCT03292432|38248764|FG001|Overall Study|Site closed before any data collected|0|||
17111039|NCT03291808|38248770|FG000|Overall Study|Lost to Follow-up|6|||
17111040|NCT03291808|38248770|FG000|Overall Study|Research burden|4|||
17111041|NCT03263806|38248776|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
17111042|NCT03263806|38248777|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
17111043|NCT03263806|38248776|FG000|Overall Study|Withdrawal by Subject|0|||
17111044|NCT03263806|38248777|FG001|Overall Study|Withdrawal by Subject|1|||
17111045|NCT03263806|38248776|FG000|Overall Study|Study Termination|5|||
17111046|NCT03263806|38248777|FG001|Overall Study|Study Termination|6|||
17111047|NCT03751280|38248785|FG000|Overall Study|Adverse Event|0|||
17111048|NCT03751280|38248786|FG001|Overall Study|Adverse Event|1|||
17111049|NCT03751280|38248785|FG000|Overall Study|Lost to Follow-up|3|||
17111050|NCT03751280|38248786|FG001|Overall Study|Lost to Follow-up|5|||
17111051|NCT03751280|38248785|FG000|Overall Study|Physician Decision|0|||
17111052|NCT03751280|38248786|FG001|Overall Study|Physician Decision|2|||
17111053|NCT03751280|38248785|FG000|Overall Study|Protocol Violation|0|||
17111054|NCT03751280|38248786|FG001|Overall Study|Protocol Violation|2|||
17111055|NCT03751280|38248785|FG000|Overall Study|Withdrawal by Subject|5|||
17111056|NCT03751280|38248786|FG001|Overall Study|Withdrawal by Subject|2|||
17111057|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
17111058|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
17111059|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
17111060|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
17111061|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
17111062|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
17111063|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
17111064|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
17111065|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
17111066|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
17111067|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
17111068|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
17111069|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
17111070|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
17111071|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
17111072|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
17111073|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
17111074|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
17111075|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
17111076|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
17111077|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
17111078|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
17111079|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
17111080|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
17111081|NCT00311363|38248796|FG000|24-Week Single-Blind Treatment Period|Death|1|||
17111082|NCT00311363|38248797|FG001|24-Week Single-Blind Treatment Period|Death|0|||
17111083|NCT00311363|38248798|FG002|24-Week Single-Blind Treatment Period|Death|0|||
17111084|NCT00311363|38248796|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
17111085|NCT00311363|38248797|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
17111086|NCT00311363|38248798|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
17111087|NCT00311363|38248796|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
17111088|NCT00311363|38248797|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
17111089|NCT00311363|38248798|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
17111090|NCT00311363|38248796|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
17111091|NCT00311363|38248797|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
17111092|NCT00311363|38248798|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
17111093|NCT00311363|38248796|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
17111094|NCT00311363|38248797|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
17111095|NCT00311363|38248798|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
17111096|NCT00311363|38248796|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
17111097|NCT00311363|38248797|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
17111098|NCT00311363|38248798|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
17111099|NCT00311363|38248796|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
17111100|NCT00311363|38248797|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
17111101|NCT00311363|38248798|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
17111102|NCT00333983|38248811|FG000|Overall Study|Lost to Follow-up|2|||
17111103|NCT00333983|38248812|FG001|Overall Study|Lost to Follow-up|1|||
17111104|NCT00333983|38248813|FG002|Overall Study|Lost to Follow-up|0|||
17111105|NCT00333983|38248811|FG000|Overall Study|Adverse Event|1|||
17111106|NCT00333983|38248812|FG001|Overall Study|Adverse Event|1|||
17111107|NCT00333983|38248813|FG002|Overall Study|Adverse Event|1|||
17111108|NCT00333983|38248811|FG000|Overall Study|Withdrawal by Subject|0|||
17111109|NCT00333983|38248812|FG001|Overall Study|Withdrawal by Subject|3|||
17111110|NCT00333983|38248813|FG002|Overall Study|Withdrawal by Subject|1|||
17111111|NCT03262012|38248825|FG000|Overall Study|Withdrawal by Subject|15|||
17111112|NCT03262012|38248826|FG001|Overall Study|Withdrawal by Subject|13|||
17111113|NCT03262012|38248827|FG002|Overall Study|Withdrawal by Subject|8|||
17111114|NCT03262012|38248828|FG003|Overall Study|Withdrawal by Subject|7|||
17111115|NCT03262012|38248825|FG000|Overall Study|Adverse Event|10|||
17111116|NCT03262012|38248826|FG001|Overall Study|Adverse Event|12|||
17111117|NCT03262012|38248827|FG002|Overall Study|Adverse Event|4|||
17111118|NCT03262012|38248828|FG003|Overall Study|Adverse Event|6|||
17111119|NCT03262012|38248825|FG000|Overall Study|Physician Decision|2|||
17111120|NCT03262012|38248826|FG001|Overall Study|Physician Decision|5|||
17111121|NCT03262012|38248827|FG002|Overall Study|Physician Decision|1|||
17111122|NCT03262012|38248828|FG003|Overall Study|Physician Decision|0|||
17111123|NCT03262012|38248825|FG000|Overall Study|Lack of Efficacy|0|||
17111124|NCT03262012|38248826|FG001|Overall Study|Lack of Efficacy|5|||
17111125|NCT03262012|38248827|FG002|Overall Study|Lack of Efficacy|1|||
17111126|NCT03262012|38248828|FG003|Overall Study|Lack of Efficacy|2|||
17111127|NCT03262012|38248825|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
17111128|NCT03262012|38248826|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
17111129|NCT03262012|38248827|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
17111130|NCT03262012|38248828|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
17111131|NCT03288142|38248840|FG000|Overall Study|Lost to Follow-up|22|||
17111132|NCT03288142|38248841|FG001|Overall Study|Lost to Follow-up|15|||
17111133|NCT00310817|38248853|FG000|Overall Study|AE or Death|3|||
17111134|NCT00310817|38248854|FG001|Overall Study|AE or Death|1|||
17111135|NCT00310817|38248855|FG002|Overall Study|AE or Death|0|||
17111136|NCT00310817|38248856|FG003|Overall Study|AE or Death|0|||
17111137|NCT00310817|38248853|FG000|Overall Study|Withdrawal by Subject|1|||
17111138|NCT00310817|38248854|FG001|Overall Study|Withdrawal by Subject|4|||
17111139|NCT00310817|38248855|FG002|Overall Study|Withdrawal by Subject|6|||
17111140|NCT00310817|38248856|FG003|Overall Study|Withdrawal by Subject|7|||
17111141|NCT00310817|38248853|FG000|Overall Study|Lost to Follow-up|2|||
17111142|NCT00310817|38248854|FG001|Overall Study|Lost to Follow-up|1|||
17111143|NCT00310817|38248855|FG002|Overall Study|Lost to Follow-up|0|||
17111144|NCT00310817|38248856|FG003|Overall Study|Lost to Follow-up|0|||
17111145|NCT00310817|38248853|FG000|Overall Study|Inappropriate Enrollment|1|||
17111146|NCT00310817|38248854|FG001|Overall Study|Inappropriate Enrollment|0|||
17111147|NCT00310817|38248855|FG002|Overall Study|Inappropriate Enrollment|1|||
17111148|NCT00310817|38248856|FG003|Overall Study|Inappropriate Enrollment|0|||
17111149|NCT00310817|38248853|FG000|Overall Study|Protocol Violation|1|||
17111150|NCT00310817|38248854|FG001|Overall Study|Protocol Violation|1|||
17111151|NCT00310817|38248855|FG002|Overall Study|Protocol Violation|1|||
17111152|NCT00310817|38248856|FG003|Overall Study|Protocol Violation|1|||
17111153|NCT00310817|38248853|FG000|Overall Study|Unable to classify|3|||
17111154|NCT00310817|38248854|FG001|Overall Study|Unable to classify|1|||
17111155|NCT00310817|38248855|FG002|Overall Study|Unable to classify|0|||
17111156|NCT00310817|38248856|FG003|Overall Study|Unable to classify|0|||
17111157|NCT02940886|38248901|FG000|Overall Study|Adverse Event|7|||
17111158|NCT02940886|38248902|FG001|Overall Study|Adverse Event|3|||
17111159|NCT02940886|38248901|FG000|Overall Study|Protocol Violation|0|||
17111160|NCT02940886|38248902|FG001|Overall Study|Protocol Violation|2|||
17111161|NCT02940886|38248901|FG000|Overall Study|Withdrawal by Subject|28|||
17111162|NCT02940886|38248902|FG001|Overall Study|Withdrawal by Subject|20|||
17111163|NCT02940886|38248901|FG000|Overall Study|Death|1|||
17111164|NCT02940886|38248902|FG001|Overall Study|Death|0|||
17111165|NCT02940886|38248901|FG000|Overall Study|Lack of Efficacy|1|||
17111166|NCT02940886|38248902|FG001|Overall Study|Lack of Efficacy|0|||
17111167|NCT02940886|38248901|FG000|Overall Study|Lost to Follow-up|49|||
17111168|NCT02940886|38248902|FG001|Overall Study|Lost to Follow-up|21|||
17111169|NCT02940886|38248901|FG000|Overall Study|Physician Decision|9|||
17111170|NCT02940886|38248902|FG001|Overall Study|Physician Decision|4|||
17111171|NCT02940886|38248901|FG000|Overall Study|Sponsor decision|0|||
17111172|NCT02940886|38248902|FG001|Overall Study|Sponsor decision|1|||
17111173|NCT02940886|38248901|FG000|Overall Study|No treatment|7|||
17111174|NCT02940886|38248902|FG001|Overall Study|No treatment|2|||
17111175|NCT02940886|38248901|FG000|Overall Study|Enrolment error|0|||
17111176|NCT02940886|38248902|FG001|Overall Study|Enrolment error|1|||
17111177|NCT03285958|38248912|FG000|Overall Study|Lost to Follow-up|1|||
17111178|NCT03285958|38248913|FG001|Overall Study|Lost to Follow-up|1|||
17111179|NCT03285958|38248912|FG000|Overall Study|Withdrawal by Subject|1|||
17111180|NCT03285958|38248913|FG001|Overall Study|Withdrawal by Subject|0|||
17111181|NCT03285958|38248912|FG000|Overall Study|Not able to attend required orientation|3|||
17111182|NCT03285958|38248913|FG001|Overall Study|Not able to attend required orientation|0|||
17111183|NCT03285646|38248922|FG000|Overall Study|Adverse Event|1|||
17111184|NCT03285646|38248923|FG001|Overall Study|Adverse Event|0|||
17111185|NCT03285646|38248922|FG000|Overall Study|Withdrawal by Subject|10|||
17111186|NCT03285646|38248923|FG001|Overall Study|Withdrawal by Subject|2|||
17111187|NCT03285646|38248922|FG000|Overall Study|Lost to Follow-up|2|||
17111188|NCT03285646|38248923|FG001|Overall Study|Lost to Follow-up|1|||
17111189|NCT03285646|38248922|FG000|Overall Study|Investigator/Sponsor Decision|0|||
17111190|NCT03285646|38248923|FG001|Overall Study|Investigator/Sponsor Decision|1|||
17111191|NCT03309202|38248934|FG000|Overall Study|Lost to Follow-up|1|||
17111192|NCT03309202|38248935|FG001|Overall Study|Lost to Follow-up|0|||
17111193|NCT03309202|38248936|FG002|Overall Study|Lost to Follow-up|0|||
17111194|NCT03309202|38248937|FG003|Overall Study|Lost to Follow-up|0|||
17111195|NCT00074490|38248952|FG000|Overall Study|Progressive malignancy|0|||
17111196|NCT00074490|38248953|FG001|Overall Study|Progressive malignancy|7|||
17111197|NCT00074490|38248954|FG002|Overall Study|Progressive malignancy|0|||
17111198|NCT00074490|38248955|FG003|Overall Study|Progressive malignancy|0|||
17111199|NCT00074490|38248956|FG004|Overall Study|Progressive malignancy|3|||
17111200|NCT00074490|38248957|FG005|Overall Study|Progressive malignancy|0|||
17111201|NCT03285490|38248972|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
17111202|NCT03285490|38248973|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
17111203|NCT03285490|38248972|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
17111204|NCT03285490|38248973|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
17111205|NCT02939716|38248980|FG000|Overall Study|scanner failure|0|||
17111206|NCT02939716|38248981|FG001|Overall Study|scanner failure|0|||
17111207|NCT02939716|38248982|FG002|Overall Study|scanner failure|0|||
17111208|NCT02939716|38248983|FG003|Overall Study|scanner failure|1|||
17111209|NCT02939716|38248984|FG004|Overall Study|scanner failure|1|||
17111210|NCT02939716|38248985|FG005|Overall Study|scanner failure|1|||
17111211|NCT00367133|38249014|FG000|2 Years|Death|20|||
17111212|NCT00367133|38249015|FG001|2 Years|Death|12|||
17111213|NCT00367133|38249016|FG002|2 Years|Death|12|||
17111214|NCT00367133|38249014|FG000|2 Years|Dropped|34|||
17111215|NCT00367133|38249015|FG001|2 Years|Dropped|19|||
17111216|NCT00367133|38249016|FG002|2 Years|Dropped|33|||
17111217|NCT00367133|38249014|FG000|2 Years|Missed visit|4|||
17111218|NCT00367133|38249015|FG001|2 Years|Missed visit|5|||
17111219|NCT00367133|38249016|FG002|2 Years|Missed visit|4|||
17111220|NCT00367055|38249026|FG000|Overall Study|Adverse Event|6|||
17111221|NCT00367055|38249027|FG001|Overall Study|Adverse Event|3|||
17111222|NCT00367055|38249026|FG000|Overall Study|Patient's Willing|3|||
17111223|NCT00367055|38249027|FG001|Overall Study|Patient's Willing|2|||
17111224|NCT00367055|38249026|FG000|Overall Study|Lack of Efficacy|1|||
17111225|NCT00367055|38249027|FG001|Overall Study|Lack of Efficacy|2|||
17111226|NCT00367055|38249026|FG000|Overall Study|Lost to Follow-up|1|||
17111227|NCT00367055|38249027|FG001|Overall Study|Lost to Follow-up|1|||
17111228|NCT00367055|38249026|FG000|Overall Study|Protocol Violation|0|||
17111229|NCT00367055|38249027|FG001|Overall Study|Protocol Violation|1|||
17111230|NCT00367055|38249026|FG000|Overall Study|Stopping Criterion Met|0|||
17111231|NCT00367055|38249027|FG001|Overall Study|Stopping Criterion Met|1|||
17111232|NCT00367055|38249026|FG000|Overall Study|Participant Living too Far from Hospital|0|||
17111233|NCT00367055|38249027|FG001|Overall Study|Participant Living too Far from Hospital|1|||
17111234|NCT00057330|38249035|FG000|Overall Study|Adverse Event|9|||
17111235|NCT00057330|38249036|FG001|Overall Study|Adverse Event|12|||
17111236|NCT00057330|38249035|FG000|Overall Study|Death|1|||
17111237|NCT00057330|38249036|FG001|Overall Study|Death|0|||
17111238|NCT00057330|38249035|FG000|Overall Study|Protocol Violation|1|||
17111239|NCT00057330|38249036|FG001|Overall Study|Protocol Violation|1|||
17111240|NCT00057330|38249035|FG000|Overall Study|Withdrawal by Subject|115|||
17111241|NCT00057330|38249036|FG001|Overall Study|Withdrawal by Subject|84|||
17111242|NCT00057330|38249035|FG000|Overall Study|Lost to Follow-up|745|||
17111243|NCT00057330|38249036|FG001|Overall Study|Lost to Follow-up|617|||
17111244|NCT00057330|38249035|FG000|Overall Study|Physician Decision|1|||
17111245|NCT00057330|38249036|FG001|Overall Study|Physician Decision|0|||
17111246|NCT00057330|38249035|FG000|Overall Study|Other|260|||
17111247|NCT00057330|38249036|FG001|Overall Study|Other|206|||
17111248|NCT03283696|38249044|FG000|Overall Study|Physician Decision|5|||
17111249|NCT03283696|38249045|FG001|Overall Study|Physician Decision|6|||
17111250|NCT03283696|38249044|FG000|Overall Study|Withdrawal by Subject|2|||
17111251|NCT03283696|38249045|FG001|Overall Study|Withdrawal by Subject|0|||
17111252|NCT02939560|38249051|FG000|Overall Study|Withdrawal by Subject|2|||
17111253|NCT02939560|38249051|FG000|Overall Study|Protocol Violation|1|||
17111254|NCT03748706|38249055|FG000|Overall Study|Lost to Follow-up|1|||
17111255|NCT00062010|38249059|FG000|Overall Study|Ineligible|3|||
17111256|NCT03747302|38249065|FG000|Overall Study|Withdrawal by Subject|1|||
17111257|NCT03747302|38249066|FG001|Overall Study|Withdrawal by Subject|2|||
17111258|NCT00056862|38249076|FG000|Overall Study|Protocol Violation|1|||
17111259|NCT00056862|38249077|FG001|Overall Study|Protocol Violation|0|||
17111260|NCT00056316|38249085|FG000|Overall Study|Withdrawal by Subject|2|||
17111261|NCT00056316|38249086|FG001|Overall Study|Withdrawal by Subject|2|||
17111262|NCT00056316|38249085|FG000|Overall Study|Death/NH placement of pt|1|||
17111263|NCT00056316|38249086|FG001|Overall Study|Death/NH placement of pt|1|||
17111264|NCT03308968|38249095|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
17111265|NCT03308968|38249096|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
17111266|NCT03308968|38249097|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
17111267|NCT03308968|38249095|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
17111268|NCT03308968|38249096|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
17111269|NCT03308968|38249097|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
17111270|NCT03308968|38249095|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
17111271|NCT03308968|38249096|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
17111272|NCT03308968|38249097|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
17111273|NCT03308968|38249095|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
17111274|NCT03308968|38249096|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
17111275|NCT03308968|38249097|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
17111276|NCT03308968|38249095|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
17111277|NCT03308968|38249096|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
17111278|NCT03308968|38249097|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
17111279|NCT03308968|38249095|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
17111280|NCT03308968|38249096|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
17111281|NCT03308968|38249097|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
17111282|NCT03308968|38249095|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
17111283|NCT03308968|38249096|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
17111284|NCT03308968|38249097|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
17111285|NCT03308968|38249095|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
17111286|NCT03308968|38249096|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
17111287|NCT03308968|38249097|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
17111288|NCT03308968|38249095|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
17111289|NCT03308968|38249096|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
17111290|NCT03308968|38249097|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
17111291|NCT03308968|38249095|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
17111292|NCT03308968|38249096|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
17111293|NCT03308968|38249097|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
17111294|NCT03308968|38249095|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
17111295|NCT03308968|38249096|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
17111296|NCT03308968|38249097|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
17111297|NCT03308968|38249095|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
17111298|NCT03308968|38249096|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
17111299|NCT03308968|38249097|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
17111300|NCT03308968|38249095|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
17111301|NCT03308968|38249096|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
17111302|NCT03308968|38249097|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
17111303|NCT03308968|38249095|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
17111304|NCT03308968|38249096|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
17111305|NCT03308968|38249097|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
17111306|NCT02940730|38249110|FG000|Intervention 2|Physician Decision|7|||
17111307|NCT02940730|38249111|FG001|Intervention 2|Physician Decision|0|||
17111308|NCT03741062|38249119|FG000|Overall Study|Protocol Violation|1|||
17111309|NCT03741062|38249120|FG001|Overall Study|Protocol Violation|0|||
17111310|NCT03281668|38249126|FG000|Overall Study|Physician Decision|1|||
17111311|NCT03281668|38249126|FG000|Overall Study|scheduling conflict, family circumstance|2|||
17111312|NCT03281668|38249126|FG000|Overall Study|Withdrawal by Subject|4|||
17111313|NCT03281668|38249126|FG000|Overall Study|Lost to Follow-up|1|||
17111314|NCT03307252|38249141|FG000|Part 2, Period 1|Treatment not received|0|||
17111315|NCT03307252|38249142|FG001|Part 2, Period 1|Treatment not received|0|||
17111316|NCT03307252|38249143|FG002|Part 2, Period 1|Treatment not received|0|||
17111317|NCT03307252|38249144|FG003|Part 2, Period 1|Treatment not received|0|||
17111318|NCT03307252|38249145|FG004|Part 2, Period 1|Treatment not received|0|||
17111319|NCT03307252|38249146|FG005|Part 2, Period 1|Treatment not received|1|||
17111320|NCT03307252|38249147|FG006|Part 2, Period 1|Treatment not received|0|||
17111321|NCT03307252|38249148|FG007|Part 2, Period 1|Treatment not received|0|||
17111322|NCT03307252|38249149|FG008|Part 2, Period 1|Treatment not received|0|||
17111323|NCT03307252|38249150|FG009|Part 2, Period 1|Treatment not received|0|||
17111324|NCT03307252|38249151|FG010|Part 2, Period 1|Treatment not received|0|||
17111325|NCT03307252|38249141|FG000|Part 2, Period 3|Other than listed|0|||
17111326|NCT03307252|38249142|FG001|Part 2, Period 3|Other than listed|0|||
17111327|NCT03307252|38249143|FG002|Part 2, Period 3|Other than listed|0|||
17111328|NCT03307252|38249144|FG003|Part 2, Period 3|Other than listed|0|||
17111329|NCT03307252|38249145|FG004|Part 2, Period 3|Other than listed|1|||
17111330|NCT03307252|38249146|FG005|Part 2, Period 3|Other than listed|0|||
17111331|NCT03307252|38249147|FG006|Part 2, Period 3|Other than listed|0|||
17111332|NCT03307252|38249148|FG007|Part 2, Period 3|Other than listed|0|||
17111333|NCT03307252|38249149|FG008|Part 2, Period 3|Other than listed|0|||
17111334|NCT03307252|38249150|FG009|Part 2, Period 3|Other than listed|0|||
17111335|NCT03307252|38249151|FG010|Part 2, Period 3|Other than listed|0|||
17111336|NCT03307252|38249141|FG000|Part 2, Period 4|Other than listed|0|||
17111337|NCT03307252|38249142|FG001|Part 2, Period 4|Other than listed|0|||
17111338|NCT03307252|38249143|FG002|Part 2, Period 4|Other than listed|0|||
17111339|NCT03307252|38249144|FG003|Part 2, Period 4|Other than listed|0|||
17111340|NCT03307252|38249145|FG004|Part 2, Period 4|Other than listed|0|||
17111341|NCT03307252|38249146|FG005|Part 2, Period 4|Other than listed|0|||
17111342|NCT03307252|38249147|FG006|Part 2, Period 4|Other than listed|1|||
17111343|NCT03307252|38249148|FG007|Part 2, Period 4|Other than listed|0|||
17111344|NCT03307252|38249149|FG008|Part 2, Period 4|Other than listed|0|||
17111345|NCT03307252|38249150|FG009|Part 2, Period 4|Other than listed|0|||
17111346|NCT03307252|38249151|FG010|Part 2, Period 4|Other than listed|0|||
17111347|NCT03307252|38249141|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111348|NCT03307252|38249142|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111349|NCT03307252|38249143|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111350|NCT03307252|38249144|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111351|NCT03307252|38249145|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111352|NCT03307252|38249146|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111353|NCT03307252|38249147|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111354|NCT03307252|38249148|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111355|NCT03307252|38249149|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111356|NCT03307252|38249150|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
17111357|NCT03307252|38249151|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
17111358|NCT03307174|38249169|FG000|Overall Study|Unplanned ICU Administrion|5|||
17111359|NCT03307174|38249170|FG001|Overall Study|Unplanned ICU Administrion|3|||
17111360|NCT03307174|38249169|FG000|Overall Study|Aborted Surgery|1|||
17111361|NCT03307174|38249170|FG001|Overall Study|Aborted Surgery|2|||
17111362|NCT03307174|38249169|FG000|Overall Study|Hypotension|6|||
17111363|NCT03307174|38249170|FG001|Overall Study|Hypotension|0|||
17111364|NCT03307174|38249169|FG000|Overall Study|Nonfunctional epidural|1|||
17111365|NCT03307174|38249170|FG001|Overall Study|Nonfunctional epidural|1|||
17111366|NCT03307174|38249169|FG000|Overall Study|Planned epidural removal|1|||
17111367|NCT03307174|38249170|FG001|Overall Study|Planned epidural removal|0|||
17111368|NCT03307174|38249169|FG000|Overall Study|Intrathecal catheter placement|0|||
17111369|NCT03307174|38249170|FG001|Overall Study|Intrathecal catheter placement|1|||
17111370|NCT03258814|38249178|FG000|Overall Study|Early Termination|4|||
17111371|NCT03258814|38249179|FG001|Overall Study|Early Termination|3|||
17111372|NCT03258814|38249180|FG002|Overall Study|Early Termination|10|||
17111373|NCT03257410|38249189|FG000|Overall Study|Adverse Event|2|||
17111374|NCT03257410|38249190|FG001|Overall Study|Adverse Event|3|||
17111375|NCT03257410|38249189|FG000|Overall Study|Protocol Violation|1|||
17111376|NCT03257410|38249190|FG001|Overall Study|Protocol Violation|2|||
17111377|NCT03257410|38249189|FG000|Overall Study|Lost to Follow-up|1|||
17111378|NCT03257410|38249190|FG001|Overall Study|Lost to Follow-up|0|||
17111379|NCT03257410|38249189|FG000|Overall Study|Withdrawal by Subject|1|||
17111380|NCT03257410|38249190|FG001|Overall Study|Withdrawal by Subject|2|||
17111381|NCT03257410|38249189|FG000|Overall Study|Physician Decision|1|||
17111382|NCT03257410|38249190|FG001|Overall Study|Physician Decision|1|||
17111383|NCT03257410|38249189|FG000|Overall Study|Renal transplantation|2|||
17111384|NCT03257410|38249190|FG001|Overall Study|Renal transplantation|0|||
17111385|NCT03257410|38249189|FG000|Overall Study|Switch to peritoneal dialysis|1|||
17111386|NCT03257410|38249190|FG001|Overall Study|Switch to peritoneal dialysis|0|||
17111387|NCT03257410|38249189|FG000|Overall Study|Death|3|||
17111388|NCT03257410|38249190|FG001|Overall Study|Death|2|||
17111389|NCT03257410|38249189|FG000|Overall Study|Change to another dialysis center|2|||
17111390|NCT03257410|38249190|FG001|Overall Study|Change to another dialysis center|2|||
17111391|NCT03257410|38249189|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
17111392|NCT03257410|38249190|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
17111393|NCT03257410|38249189|FG000|Overall Study|Miscellaneous|2|||
17111394|NCT03257410|38249190|FG001|Overall Study|Miscellaneous|2|||
17111395|NCT03257410|38249189|FG000|Overall Study|Other|0|||
17111396|NCT03257410|38249190|FG001|Overall Study|Other|1|||
17111397|NCT00056160|38249198|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
17111398|NCT00056160|38249199|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
17111399|NCT00056160|38249198|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
17111400|NCT00056160|38249199|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
17111401|NCT00056160|38249198|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
17111402|NCT00056160|38249199|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
17111403|NCT00056160|38249198|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
17111404|NCT00056160|38249199|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
17111405|NCT00056160|38249198|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
17111406|NCT00056160|38249199|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
17111407|NCT00056160|38249198|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
17111408|NCT00056160|38249199|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
17111409|NCT00056160|38249198|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
17111410|NCT00056160|38249199|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
17111411|NCT00056160|38249198|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
17111412|NCT00056160|38249199|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
17111413|NCT00056160|38249198|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
17111414|NCT00056160|38249199|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
17111415|NCT00056160|38249198|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
17111416|NCT00056160|38249199|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
17111417|NCT00056160|38249198|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
17111418|NCT00056160|38249199|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
17111419|NCT00056160|38249198|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
17111420|NCT00056160|38249199|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
17111421|NCT00056160|38249198|FG000|Final Follow-up|Transferred into expanded access study.|3|||
17111422|NCT00056160|38249199|FG001|Final Follow-up|Transferred into expanded access study.|0|||
17111423|NCT00056160|38249198|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
17111424|NCT00056160|38249199|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
17111425|NCT00056160|38249198|FG000|Final Follow-up|Adverse Event|1|||
17111426|NCT00056160|38249199|FG001|Final Follow-up|Adverse Event|0|||
17111427|NCT00061932|38249207|FG000|Overall Study|Withdrawal by Subject|13|||
17111428|NCT00061932|38249208|FG001|Overall Study|Withdrawal by Subject|4|||
17111429|NCT03280264|38249215|FG000|Overall Study|Adverse Event|1|||
17111430|NCT03280264|38249215|FG000|Overall Study|Physician Decision|1|||
17111431|NCT03280264|38249215|FG000|Overall Study|Withdrawal by Subject|1|||
17111432|NCT00060840|38249222|FG000|Overall Study|Change in surgical plan|2|||
17111433|NCT00060840|38249223|FG001|Overall Study|Change in surgical plan|6|||
17111434|NCT00060840|38249222|FG000|Overall Study|Death|0|||
17111435|NCT00060840|38249223|FG001|Overall Study|Death|1|||
17111436|NCT00060840|38249222|FG000|Overall Study|Withdrawal by Subject|0|||
17111437|NCT00060840|38249223|FG001|Overall Study|Withdrawal by Subject|1|||
17111438|NCT00060840|38249222|FG000|Overall Study|Subinvestigator unavailable|0|||
17111439|NCT00060840|38249223|FG001|Overall Study|Subinvestigator unavailable|1|||
17111440|NCT00060840|38249222|FG000|Overall Study|Physician Decision|1|||
17111441|NCT00060840|38249223|FG001|Overall Study|Physician Decision|0|||
17111442|NCT00060840|38249222|FG000|Overall Study|Other|1|||
17111443|NCT00060840|38249223|FG001|Overall Study|Other|0|||
17111444|NCT03280108|38249231|FG000|Overall Study|Lost to Follow-up|2|||
17111445|NCT03280108|38249232|FG001|Overall Study|Lost to Follow-up|0|||
17111446|NCT00059202|38249245|FG000|Overall Study|Withdrawal by Subject|5|||
17111447|NCT00059202|38249246|FG001|Overall Study|Withdrawal by Subject|9|||
17111448|NCT00059202|38249245|FG000|Overall Study|Protocol Violation|1|||
17111449|NCT00059202|38249246|FG001|Overall Study|Protocol Violation|3|||
17111450|NCT00059202|38249245|FG000|Overall Study|drug toxicity|0|||
17111451|NCT00059202|38249246|FG001|Overall Study|drug toxicity|3|||
17111452|NCT03278626|38249255|FG000|Overall Study|Death|2|||
17111453|NCT03278626|38249255|FG000|Overall Study|Toxicity|1|||
17111454|NCT03278626|38249255|FG000|Overall Study|Disease Progression|2|||
17111455|NCT03277846|38249261|FG000|Overall Study|Inpatient stay too brief|12|||
17111456|NCT03277846|38249262|FG001|Overall Study|Inpatient stay too brief|11|||
17111457|NCT00073008|38249270|FG000|Overall Study|Missing|6|||
17111458|NCT00073008|38249271|FG001|Overall Study|Missing|6|||
17111459|NCT00073008|38249270|FG000|Overall Study|Withdrawal by Subject|2|||
17111460|NCT00073008|38249271|FG001|Overall Study|Withdrawal by Subject|2|||
17111461|NCT00073008|38249270|FG000|Overall Study|Lost to Follow-up|1|||
17111462|NCT00073008|38249271|FG001|Overall Study|Lost to Follow-up|3|||
17111463|NCT00073008|38249270|FG000|Overall Study|Death|46|||
17111464|NCT00073008|38249271|FG001|Overall Study|Death|47|||
17111465|NCT00073008|38249270|FG000|Overall Study|"Other selected on Case Report Form"|7|||
17111466|NCT00073008|38249271|FG001|Overall Study|"Other selected on Case Report Form"|5|||
17111467|NCT00058422|38249277|FG000|Overall Study|Not treated|2|||
17111468|NCT00072384|38249281|FG000|Overall Study|Physician Decision|1|||
17111469|NCT00072384|38249281|FG000|Overall Study|Ineligible|8|||
17111470|NCT00054132|38249287|FG000|Overall Study|Not Treated|1|||
17111471|NCT00071760|38249292|FG000|Overall Study|Adverse Event|3|||
17111472|NCT00071760|38249292|FG000|Overall Study|Lost to Follow-up|4|||
17111473|NCT00071760|38249292|FG000|Overall Study|Protocol Violation|1|||
17111474|NCT00071760|38249292|FG000|Overall Study|Withdrawal by Subject|3|||
17111475|NCT00071760|38249292|FG000|Overall Study|Insufficient Viral Load Response|3|||
17111476|NCT00071760|38249292|FG000|Overall Study|Pulmonary Tuberculosis|1|||
17111477|NCT00071760|38249292|FG000|Overall Study|Unavailability of RTV|8|||
17111478|NCT00071760|38249292|FG000|Overall Study|Relocation|1|||
17111479|NCT00071760|38249292|FG000|Overall Study|Investigator's Recommendation (Rec.)|4|||
17111480|NCT00071760|38249292|FG000|Overall Study|Study Team Rec./Resistance|1|||
17111481|NCT00071760|38249292|FG000|Overall Study|Ongoing|25|||
17111482|NCT00057954|38249302|FG000|Overall Study|Death|1|||
17111483|NCT00057954|38249302|FG000|Overall Study|Disease progression|1|||
17111484|NCT00057876|38249308|FG000|Overall Study|Adverse Event|8|||
17111485|NCT00057876|38249309|FG001|Overall Study|Adverse Event|8|||
17111486|NCT00057876|38249308|FG000|Overall Study|Death|2|||
17111487|NCT00057876|38249309|FG001|Overall Study|Death|1|||
17111488|NCT00057876|38249308|FG000|Overall Study|Withdrawal by Subject|5|||
17111489|NCT00057876|38249309|FG001|Overall Study|Withdrawal by Subject|6|||
17111490|NCT00057876|38249308|FG000|Overall Study|Lack of Efficacy|10|||
17111491|NCT00057876|38249309|FG001|Overall Study|Lack of Efficacy|8|||
17111492|NCT00057876|38249308|FG000|Overall Study|Ineligible|1|||
17111493|NCT00057876|38249309|FG001|Overall Study|Ineligible|2|||
17111494|NCT00057876|38249308|FG000|Overall Study|other reason|2|||
17111495|NCT00057876|38249309|FG001|Overall Study|other reason|2|||
17111496|NCT00057876|38249308|FG000|Overall Study|other complicating disease|1|||
17111497|NCT00057876|38249309|FG001|Overall Study|other complicating disease|0|||
17111498|NCT00053898|38249317|FG000|Overall Study|No follow-up data from any source|9|||
17111499|NCT00053898|38249318|FG001|Overall Study|No follow-up data from any source|12|||
17111500|NCT00053898|38249317|FG000|Overall Study|Follow-up from telephone contact only|5|||
17111501|NCT00053898|38249318|FG001|Overall Study|Follow-up from telephone contact only|1|||
17111502|NCT03256552|38249354|FG000|Overall Study|Protocol Violation|1|||
17111503|NCT03256552|38249354|FG000|Overall Study|Physician Decision|1|||
17111504|NCT03256552|38249354|FG000|Overall Study|Adverse Event|1|||
17111505|NCT03256552|38249354|FG000|Overall Study|Withdrawal by Subject|2|||
17111506|NCT00071058|38249364|FG000|Overall Study|brain tumor-removed from study|1|||
17111507|NCT00053352|38249371|FG000|Overall Study|Lost to Follow-up|0|||
17111508|NCT00053352|38249372|FG001|Overall Study|Lost to Follow-up|1|||
17111509|NCT00053352|38249371|FG000|Overall Study|Physician Decision|11|||
17111510|NCT00053352|38249372|FG001|Overall Study|Physician Decision|1|||
17111511|NCT00053352|38249371|FG000|Overall Study|Withdrawal by Subject|1|||
17111512|NCT00053352|38249372|FG001|Overall Study|Withdrawal by Subject|0|||
17111513|NCT00053352|38249371|FG000|Overall Study|Ineligible|8|||
17111514|NCT00053352|38249372|FG001|Overall Study|Ineligible|8|||
17111515|NCT00053352|38249371|FG000|Overall Study|Disease at new site|1|||
17111516|NCT00053352|38249372|FG001|Overall Study|Disease at new site|0|||
17111517|NCT03245398|38249381|FG000|Overall Study|Travelled to another island|1|||
17111518|NCT03245398|38249382|FG001|Overall Study|Travelled to another island|0|||
17111519|NCT03244618|38249392|FG000|Overall Study|Lost to Follow-up|3|||
17111520|NCT03244618|38249393|FG001|Overall Study|Lost to Follow-up|4|||
17111521|NCT03244618|38249392|FG000|Overall Study|Protocol Violation|4|||
17111522|NCT03244618|38249393|FG001|Overall Study|Protocol Violation|3|||
17111523|NCT03244618|38249392|FG000|Overall Study|Withdrawal by Subject|0|||
17111524|NCT03244618|38249393|FG001|Overall Study|Withdrawal by Subject|2|||
17111525|NCT00052962|38249401|FG000|Overall Study|Not evaluable|0|||
17111526|NCT00052962|38249402|FG001|Overall Study|Not evaluable|2|||
17111527|NCT00052962|38249401|FG000|Overall Study|Not randomized/not evaluable|1|||
17111528|NCT00052962|38249402|FG001|Overall Study|Not randomized/not evaluable|0|||
17111529|NCT00051636|38249410|FG000|Period 1 - Core|Adverse Event|2|||
17111530|NCT00051636|38249411|FG001|Period 1 - Core|Adverse Event|2|||
17111531|NCT00051636|38249410|FG000|Period 1 - Core|Protocol Violation|1|||
17111532|NCT00051636|38249411|FG001|Period 1 - Core|Protocol Violation|0|||
17111533|NCT00051636|38249410|FG000|Period 1 - Core|Withdrawal by Subject|1|||
17111534|NCT00051636|38249411|FG001|Period 1 - Core|Withdrawal by Subject|2|||
17111535|NCT00051636|38249410|FG000|Period 1 - Core|Lost to Follow-up|0|||
17111536|NCT00051636|38249411|FG001|Period 1 - Core|Lost to Follow-up|2|||
17111537|NCT00051636|38249410|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
17111538|NCT00051636|38249411|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
17111539|NCT00051636|38249410|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
17111540|NCT00051636|38249411|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
17111541|NCT00051636|38249410|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
17111542|NCT00051636|38249411|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
17111543|NCT00051636|38249410|FG000|Period 2- Extended Observation Period|Death|4|||
17111544|NCT00051636|38249411|FG001|Period 2- Extended Observation Period|Death|5|||
17111545|NCT00051636|38249410|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
17111546|NCT00051636|38249411|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
17111547|NCT03255382|38249419|FG000|Overall Study|Adverse Event|3|||
17111548|NCT03255382|38249420|FG001|Overall Study|Adverse Event|0|||
17111549|NCT03255382|38249419|FG000|Overall Study|Lost to Follow-up|2|||
17111550|NCT03255382|38249420|FG001|Overall Study|Lost to Follow-up|0|||
17111551|NCT03255382|38249419|FG000|Overall Study|Withdrawal by Subject|2|||
17111552|NCT03255382|38249420|FG001|Overall Study|Withdrawal by Subject|0|||
17111553|NCT03255382|38249419|FG000|Overall Study|Other|6|||
17111554|NCT03255382|38249420|FG001|Overall Study|Other|0|||
17111555|NCT03254602|38249427|FG000|Overall Study|Lost to Follow-up|4|||
17111556|NCT00038142|38249433|FG000|Overall Study|Ineligible|1|||
17111557|NCT00038142|38249434|FG001|Overall Study|Ineligible|0|||
17111558|NCT00038142|38249433|FG000|Overall Study|Progressive Disease|11|||
17111559|NCT00038142|38249434|FG001|Overall Study|Progressive Disease|7|||
17111560|NCT00038142|38249433|FG000|Overall Study|Death|1|||
17111561|NCT00038142|38249434|FG001|Overall Study|Death|0|||
17111562|NCT00038142|38249433|FG000|Overall Study|Adverse Event|1|||
17111563|NCT00038142|38249434|FG001|Overall Study|Adverse Event|0|||
17111564|NCT00038142|38249433|FG000|Overall Study|Unknown Reason|8|||
17111565|NCT00038142|38249434|FG001|Overall Study|Unknown Reason|0|||
17111566|NCT00366899|38249442|FG000|Infant Series|Withdrawal by Subject|4|||
17111567|NCT00366899|38249443|FG001|Infant Series|Withdrawal by Subject|7|||
17111568|NCT00366899|38249442|FG000|Infant Series|Protocol Violation|2|||
17111569|NCT00366899|38249443|FG001|Infant Series|Protocol Violation|1|||
17111570|NCT00366899|38249442|FG000|Infant Series|Failed to return|1|||
17111571|NCT00366899|38249443|FG001|Infant Series|Failed to return|1|||
17111572|NCT00366899|38249442|FG000|Infant Series|Lost to Follow-up|0|||
17111573|NCT00366899|38249443|FG001|Infant Series|Lost to Follow-up|2|||
17111574|NCT00366899|38249442|FG000|Infant Series|Adverse Event|0|||
17111575|NCT00366899|38249443|FG001|Infant Series|Adverse Event|1|||
17111576|NCT00366899|38249442|FG000|Infant Series|Physician Decision|1|||
17111577|NCT00366899|38249443|FG001|Infant Series|Physician Decision|0|||
17111578|NCT00366899|38249442|FG000|Infant Series|Randomized but not consented|1|||
17111579|NCT00366899|38249443|FG001|Infant Series|Randomized but not consented|0|||
17111580|NCT00366899|38249442|FG000|After Infant Series|Lost to Follow-up|4|||
17111581|NCT00366899|38249443|FG001|After Infant Series|Lost to Follow-up|3|||
17111582|NCT00366899|38249442|FG000|After Infant Series|Withdrawal by Subject|1|||
17111583|NCT00366899|38249443|FG001|After Infant Series|Withdrawal by Subject|4|||
17111584|NCT00366899|38249442|FG000|After Infant Series|Adverse Event|1|||
17111585|NCT00366899|38249443|FG001|After Infant Series|Adverse Event|2|||
17111586|NCT00366899|38249442|FG000|After Infant Series|Protocol Violation|1|||
17111587|NCT00366899|38249443|FG001|After Infant Series|Protocol Violation|0|||
17111588|NCT00366899|38249442|FG000|Toddler Dose|Withdrawal by Subject|1|||
17111589|NCT00366899|38249443|FG001|Toddler Dose|Withdrawal by Subject|1|||
17111590|NCT00366899|38249442|FG000|Toddler Dose|Protocol Violation|1|||
17111591|NCT00366899|38249443|FG001|Toddler Dose|Protocol Violation|0|||
17111592|NCT03254134|38249477|FG000|Overall Study|Not eligible patients|599|||
17111593|NCT03254134|38249478|FG001|Overall Study|Not eligible patients|3630|||
17111594|NCT00037830|38249487|FG000|Overall Study|Adverse Event|2|||
17111595|NCT00037830|38249488|FG001|Overall Study|Adverse Event|0|||
17111596|NCT00037830|38249489|FG002|Overall Study|Adverse Event|0|||
17111597|NCT00037830|38249487|FG000|Overall Study|Withdrawal by Subject|4|||
17111598|NCT00037830|38249488|FG001|Overall Study|Withdrawal by Subject|5|||
17111599|NCT00037830|38249489|FG002|Overall Study|Withdrawal by Subject|1|||
17111600|NCT00037830|38249487|FG000|Overall Study|Protocol Violation|2|||
17111601|NCT00037830|38249488|FG001|Overall Study|Protocol Violation|2|||
17111602|NCT00037830|38249489|FG002|Overall Study|Protocol Violation|0|||
17111603|NCT00037830|38249487|FG000|Overall Study|Unrelated Medical Problem|2|||
17111604|NCT00037830|38249488|FG001|Overall Study|Unrelated Medical Problem|0|||
17111605|NCT00037830|38249489|FG002|Overall Study|Unrelated Medical Problem|0|||
17111606|NCT03242434|38249499|FG000|Overall Study|Death|0|||
17111607|NCT03242434|38249500|FG001|Overall Study|Death|2|||
17111608|NCT02939014|38249509|FG000|Overall Study|Lost to Follow-up|1|||
17111609|NCT02939014|38249510|FG001|Overall Study|Lost to Follow-up|0|||
17111610|NCT02939014|38249509|FG000|Overall Study|Death|4|||
17111611|NCT02939014|38249510|FG001|Overall Study|Death|3|||
17111612|NCT00051558|38249519|FG000|Overall Study|Adverse Event|30|||
17111613|NCT00051558|38249520|FG001|Overall Study|Adverse Event|18|||
17111614|NCT00051558|38249519|FG000|Overall Study|Withdrawal by Subject|29|||
17111615|NCT00051558|38249520|FG001|Overall Study|Withdrawal by Subject|42|||
17111616|NCT00051558|38249519|FG000|Overall Study|Death|9|||
17111617|NCT00051558|38249520|FG001|Overall Study|Death|15|||
17111618|NCT00051558|38249519|FG000|Overall Study|Lost to Follow-up|4|||
17111619|NCT00051558|38249520|FG001|Overall Study|Lost to Follow-up|13|||
17111620|NCT00051558|38249519|FG000|Overall Study|Protocol Violation|3|||
17111621|NCT00051558|38249520|FG001|Overall Study|Protocol Violation|4|||
17111622|NCT00051558|38249519|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
17111623|NCT00051558|38249520|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
17111624|NCT00051558|38249519|FG000|Overall Study|Sponsor Decision|6|||
17111625|NCT00051558|38249520|FG001|Overall Study|Sponsor Decision|1|||
17111626|NCT00051558|38249519|FG000|Overall Study|Other|2|||
17111627|NCT00051558|38249520|FG001|Overall Study|Other|1|||
17111628|NCT00051558|38249519|FG000|Overall Study|Significant Lab Value|2|||
17111629|NCT00051558|38249520|FG001|Overall Study|Significant Lab Value|0|||
17111630|NCT00051558|38249519|FG000|Overall Study|Physician Decision|5|||
17111631|NCT00051558|38249520|FG001|Overall Study|Physician Decision|0|||
17111632|NCT03251482|38249531|FG000|Overall Study|Withdrawal by Subject|0|||
17111633|NCT03251482|38249532|FG001|Overall Study|Withdrawal by Subject|1|||
17111634|NCT03251482|38249533|FG002|Overall Study|Withdrawal by Subject|0|||
17111635|NCT03251482|38249534|FG003|Overall Study|Withdrawal by Subject|0|||
17111636|NCT03251482|38249535|FG004|Overall Study|Withdrawal by Subject|0|||
17111637|NCT03249454|38249547|FG000|Overall Study|Withdrawal by Subject|0|||
17111638|NCT03249454|38249548|FG001|Overall Study|Withdrawal by Subject|0|||
17111639|NCT03249454|38249549|FG002|Overall Study|Withdrawal by Subject|0|||
17111640|NCT03249454|38249550|FG003|Overall Study|Withdrawal by Subject|0|||
17111641|NCT03249454|38249551|FG004|Overall Study|Withdrawal by Subject|0|||
17111642|NCT03249454|38249552|FG005|Overall Study|Withdrawal by Subject|0|||
17111643|NCT03249454|38249553|FG006|Overall Study|Withdrawal by Subject|0|||
17111644|NCT03249454|38249554|FG007|Overall Study|Withdrawal by Subject|0|||
17111645|NCT03249454|38249555|FG008|Overall Study|Withdrawal by Subject|0|||
17111646|NCT03249454|38249556|FG009|Overall Study|Withdrawal by Subject|1|||
17111647|NCT03249454|38249557|FG010|Overall Study|Withdrawal by Subject|1|||
17111648|NCT03732248|38249570|FG000|Overall Study|Withdrawal by Subject|1|||
17111649|NCT03732248|38249571|FG001|Overall Study|Withdrawal by Subject|0|||
17111650|NCT00310037|38249579|FG000|Overall Study|Adverse Event|7|||
17111651|NCT00310037|38249580|FG001|Overall Study|Adverse Event|14|||
17111652|NCT00310037|38249579|FG000|Overall Study|Withdrawal by Subject|4|||
17111653|NCT00310037|38249580|FG001|Overall Study|Withdrawal by Subject|3|||
17111654|NCT00310037|38249579|FG000|Overall Study|Progression|6|||
17111655|NCT00310037|38249580|FG001|Overall Study|Progression|0|||
17111656|NCT00310037|38249579|FG000|Overall Study|Non-protocol treatment|1|||
17111657|NCT00310037|38249580|FG001|Overall Study|Non-protocol treatment|0|||
17111658|NCT00309959|38249586|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
17111659|NCT03238924|38249597|FG000|Overall Study|Withdrawal by Subject|2|||
17111660|NCT03238924|38249598|FG001|Overall Study|Withdrawal by Subject|2|||
17111661|NCT03247816|38249604|FG000|Overall Study|Adverse Event|12|||
17111662|NCT03247816|38249604|FG000|Overall Study|Physician Decision|3|||
17111663|NCT03247816|38249604|FG000|Overall Study|Lack of Efficacy|1|||
17111664|NCT03247816|38249604|FG000|Overall Study|Lost to Follow-up|10|||
17111665|NCT03247816|38249604|FG000|Overall Study|Missing Feraccru stop date|3|||
17111666|NCT00333359|38249622|FG000|Overall Study|Adverse Event|29|||
17111667|NCT00333359|38249623|FG001|Overall Study|Adverse Event|35|||
17111668|NCT00333359|38249622|FG000|Overall Study|Withdrawal by Subject|19|||
17111669|NCT00333359|38249623|FG001|Overall Study|Withdrawal by Subject|37|||
17111670|NCT00333359|38249622|FG000|Overall Study|Physician Decision|2|||
17111671|NCT00333359|38249623|FG001|Overall Study|Physician Decision|2|||
17111672|NCT00333359|38249622|FG000|Overall Study|Protocol Non-compliance|2|||
17111673|NCT00333359|38249623|FG001|Overall Study|Protocol Non-compliance|8|||
17111674|NCT00333359|38249622|FG000|Overall Study|Lost to Follow-up|15|||
17111675|NCT00333359|38249623|FG001|Overall Study|Lost to Follow-up|25|||
17111676|NCT00333359|38249622|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
17111677|NCT00333359|38249623|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
17111678|NCT00333359|38249622|FG000|Overall Study|Treatment Failure|3|||
17111679|NCT00333359|38249623|FG001|Overall Study|Treatment Failure|8|||
17111680|NCT00333359|38249622|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
17111681|NCT00333359|38249623|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
17111682|NCT03246724|38249635|FG000|Overall Study|Withdrawal by Subject|5|||
17111683|NCT03246724|38249636|FG001|Overall Study|Withdrawal by Subject|2|||
17111684|NCT03246724|38249637|FG002|Overall Study|Withdrawal by Subject|4|||
17111685|NCT03246724|38249638|FG003|Overall Study|Withdrawal by Subject|2|||
17111686|NCT03246724|38249635|FG000|Overall Study|Ineligible on day of surgery|7|||
17111687|NCT03246724|38249636|FG001|Overall Study|Ineligible on day of surgery|2|||
17111688|NCT03246724|38249637|FG002|Overall Study|Ineligible on day of surgery|0|||
17111689|NCT03246724|38249638|FG003|Overall Study|Ineligible on day of surgery|3|||
17111690|NCT03246724|38249635|FG000|Overall Study|Study completed before surgical date|2|||
17111691|NCT03246724|38249636|FG001|Overall Study|Study completed before surgical date|1|||
17111692|NCT03246724|38249637|FG002|Overall Study|Study completed before surgical date|8|||
17111693|NCT03246724|38249638|FG003|Overall Study|Study completed before surgical date|1|||
17111694|NCT03246724|38249635|FG000|Overall Study|Transferred to other arm|0|||
17111695|NCT03246724|38249636|FG001|Overall Study|Transferred to other arm|0|||
17111696|NCT03246724|38249637|FG002|Overall Study|Transferred to other arm|1|||
17111697|NCT03246724|38249638|FG003|Overall Study|Transferred to other arm|0|||
17111698|NCT03246724|38249635|FG000|Overall Study|Unable to obtain medication timely|0|||
17111699|NCT03246724|38249636|FG001|Overall Study|Unable to obtain medication timely|2|||
17111700|NCT03246724|38249637|FG002|Overall Study|Unable to obtain medication timely|2|||
17111701|NCT03246724|38249638|FG003|Overall Study|Unable to obtain medication timely|1|||
17111702|NCT03246724|38249635|FG000|Overall Study|Re-consented to participate|0|||
17111703|NCT03246724|38249636|FG001|Overall Study|Re-consented to participate|0|||
17111704|NCT03246724|38249637|FG002|Overall Study|Re-consented to participate|0|||
17111705|NCT03246724|38249638|FG003|Overall Study|Re-consented to participate|1|||
17111706|NCT03246646|38249650|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
17111707|NCT03246646|38249651|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
17111708|NCT03246646|38249650|FG000|Overall Study|Withdrawal by Subject|3|||
17111709|NCT03246646|38249651|FG001|Overall Study|Withdrawal by Subject|0|||
17111710|NCT03246646|38249650|FG000|Overall Study|Lost to Follow-up|7|||
17111711|NCT03246646|38249651|FG001|Overall Study|Lost to Follow-up|0|||
17111712|NCT01347112|38249659|FG000|Overall Study|Withdrawal by Subject|1|||
17111713|NCT01347112|38249660|FG001|Overall Study|Withdrawal by Subject|7|||
17111714|NCT01347112|38249659|FG000|Overall Study|Lost to Follow-up|3|||
17111715|NCT01347112|38249660|FG001|Overall Study|Lost to Follow-up|5|||
17111716|NCT00308711|38249670|FG000|Overall Study|Withdrawal by Subject|1|||
17111717|NCT00308711|38249671|FG001|Overall Study|Withdrawal by Subject|0|||
17111718|NCT00308711|38249672|FG002|Overall Study|Withdrawal by Subject|1|||
17111719|NCT00308711|38249670|FG000|Overall Study|Protocol Violation|0|||
17111720|NCT00308711|38249671|FG001|Overall Study|Protocol Violation|1|||
17111721|NCT00308711|38249672|FG002|Overall Study|Protocol Violation|1|||
17111722|NCT00308711|38249670|FG000|Overall Study|Lost to Follow-up|0|||
17111723|NCT00308711|38249671|FG001|Overall Study|Lost to Follow-up|1|||
17111724|NCT00308711|38249672|FG002|Overall Study|Lost to Follow-up|0|||
17111725|NCT00308711|38249670|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
17111726|NCT00308711|38249671|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
17111727|NCT00308711|38249672|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
17111728|NCT00308711|38249670|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
17111729|NCT00308711|38249671|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
17111730|NCT00308711|38249672|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
17111731|NCT00308555|38249682|FG000|Overall Study|Withdrawal by Subject|1|||
17111732|NCT00308555|38249683|FG001|Overall Study|Withdrawal by Subject|0|||
17111733|NCT00308555|38249682|FG000|Overall Study|Physician Decision|2|||
17111734|NCT00308555|38249683|FG001|Overall Study|Physician Decision|0|||
17111735|NCT00050778|38249692|FG000|Overall Study|Adverse Event|13|||
17111736|NCT00050778|38249693|FG001|Overall Study|Adverse Event|3|||
17111737|NCT00050778|38249694|FG002|Overall Study|Adverse Event|2|||
17111738|NCT00050778|38249692|FG000|Overall Study|Death|0|||
17111739|NCT00050778|38249693|FG001|Overall Study|Death|1|||
17111740|NCT00050778|38249694|FG002|Overall Study|Death|1|||
17111741|NCT00050778|38249692|FG000|Overall Study|Lack of Efficacy|16|||
17111742|NCT00050778|38249693|FG001|Overall Study|Lack of Efficacy|2|||
17111743|NCT00050778|38249694|FG002|Overall Study|Lack of Efficacy|2|||
17111744|NCT00050778|38249692|FG000|Overall Study|Lost to Follow-up|0|||
17111745|NCT00050778|38249693|FG001|Overall Study|Lost to Follow-up|2|||
17111746|NCT00050778|38249694|FG002|Overall Study|Lost to Follow-up|4|||
17111747|NCT00050778|38249692|FG000|Overall Study|Physician Decision|3|||
17111748|NCT00050778|38249693|FG001|Overall Study|Physician Decision|0|||
17111749|NCT00050778|38249694|FG002|Overall Study|Physician Decision|2|||
17111750|NCT00050778|38249692|FG000|Overall Study|Protocol Violation|2|||
17111751|NCT00050778|38249693|FG001|Overall Study|Protocol Violation|0|||
17111752|NCT00050778|38249694|FG002|Overall Study|Protocol Violation|1|||
17111753|NCT00050778|38249692|FG000|Overall Study|Withdrawal by Subject|6|||
17111754|NCT00050778|38249693|FG001|Overall Study|Withdrawal by Subject|8|||
17111755|NCT00050778|38249694|FG002|Overall Study|Withdrawal by Subject|4|||
17111756|NCT00050778|38249692|FG000|Overall Study|Randomized but not treated|4|||
17111757|NCT00050778|38249693|FG001|Overall Study|Randomized but not treated|5|||
17111758|NCT00050778|38249694|FG002|Overall Study|Randomized but not treated|2|||
17111759|NCT00050778|38249692|FG000|Overall Study|Familial and personal reasons|1|||
17111760|NCT00050778|38249693|FG001|Overall Study|Familial and personal reasons|0|||
17111761|NCT00050778|38249694|FG002|Overall Study|Familial and personal reasons|0|||
17111762|NCT00050622|38249704|FG000|Overall Study|Adverse Event|1|||
17111763|NCT00308087|38249730|FG000|Overall Study|Progressive Disease|19|||
17111764|NCT00308087|38249731|FG001|Overall Study|Progressive Disease|21|||
17111765|NCT00308087|38249730|FG000|Overall Study|Study Closure|11|||
17111766|NCT00308087|38249731|FG001|Overall Study|Study Closure|12|||
17111767|NCT00308087|38249730|FG000|Overall Study|Withdrawal by Subject|2|||
17111768|NCT00308087|38249731|FG001|Overall Study|Withdrawal by Subject|1|||
17111769|NCT00308087|38249730|FG000|Overall Study|Other|4|||
17111770|NCT00308087|38249731|FG001|Overall Study|Other|3|||
17111771|NCT00307931|38249737|FG000|Overall Study|Adverse Event|1|||
17111772|NCT02796170|38249743|FG000|Overall Study|Lost to Follow-up|3|||
17111773|NCT02796170|38249744|FG001|Overall Study|Lost to Follow-up|0|||
17111774|NCT00049842|38249752|FG000|Treatment Phase|Adverse Event|47|||
17111775|NCT00049842|38249753|FG001|Treatment Phase|Adverse Event|12|||
17111776|NCT00049842|38249752|FG000|Treatment Phase|Withdrawal by Subject|35|||
17111777|NCT00049842|38249753|FG001|Treatment Phase|Withdrawal by Subject|46|||
17111778|NCT00049842|38249752|FG000|Treatment Phase|Non-compliance with protocol|7|||
17111779|NCT00049842|38249753|FG001|Treatment Phase|Non-compliance with protocol|8|||
17111780|NCT00049842|38249752|FG000|Treatment Phase|Lost to Follow-up|4|||
17111781|NCT00049842|38249753|FG001|Treatment Phase|Lost to Follow-up|8|||
17111782|NCT00049842|38249752|FG000|Treatment Phase|Administrative|0|||
17111783|NCT00049842|38249753|FG001|Treatment Phase|Administrative|3|||
17111784|NCT00049842|38249752|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
17111785|NCT00049842|38249753|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
17111786|NCT00049842|38249752|FG000|Follow-up Phase|Adverse Event|6|||
17111787|NCT00049842|38249753|FG001|Follow-up Phase|Adverse Event|1|||
17111788|NCT00049842|38249752|FG000|Follow-up Phase|Other|1|||
17111789|NCT00049842|38249753|FG001|Follow-up Phase|Other|4|||
17111790|NCT00307151|38249763|FG000|Overall Study|Death|4|||
17111791|NCT00307151|38249764|FG001|Overall Study|Death|3|||
17111792|NCT00307151|38249765|FG002|Overall Study|Death|10|||
17111793|NCT00307151|38249766|FG003|Overall Study|Death|3|||
17111794|NCT00307151|38249763|FG000|Overall Study|Severe debilitation, unable to continue|1|||
17111795|NCT00307151|38249764|FG001|Overall Study|Severe debilitation, unable to continue|0|||
17111796|NCT00307151|38249765|FG002|Overall Study|Severe debilitation, unable to continue|0|||
17111797|NCT00307151|38249766|FG003|Overall Study|Severe debilitation, unable to continue|0|||
17111798|NCT00307151|38249763|FG000|Overall Study|Subject unable to get to clinic|1|||
17111799|NCT00307151|38249764|FG001|Overall Study|Subject unable to get to clinic|0|||
17111800|NCT00307151|38249765|FG002|Overall Study|Subject unable to get to clinic|6|||
17111801|NCT00307151|38249766|FG003|Overall Study|Subject unable to get to clinic|2|||
17111802|NCT00307151|38249763|FG000|Overall Study|Withdrew consent|0|||
17111803|NCT00307151|38249764|FG001|Overall Study|Withdrew consent|1|||
17111804|NCT00307151|38249765|FG002|Overall Study|Withdrew consent|1|||
17111805|NCT00307151|38249766|FG003|Overall Study|Withdrew consent|3|||
17111806|NCT00307151|38249763|FG000|Overall Study|Not willing to adhere to study reqs|2|||
17111807|NCT00307151|38249764|FG001|Overall Study|Not willing to adhere to study reqs|0|||
17111808|NCT00307151|38249765|FG002|Overall Study|Not willing to adhere to study reqs|2|||
17111809|NCT00307151|38249766|FG003|Overall Study|Not willing to adhere to study reqs|2|||
17111810|NCT00307151|38249763|FG000|Overall Study|Clinic unable to contact subject|3|||
17111811|NCT00307151|38249764|FG001|Overall Study|Clinic unable to contact subject|3|||
17111812|NCT00307151|38249765|FG002|Overall Study|Clinic unable to contact subject|1|||
17111813|NCT00307151|38249766|FG003|Overall Study|Clinic unable to contact subject|1|||
17111814|NCT02654132|38249778|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
17111815|NCT02654132|38249779|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
17111816|NCT02654132|38249778|FG000|Treatment Period|Disease progression|43|||
17111817|NCT02654132|38249779|FG001|Treatment Period|Disease progression|38|||
17111818|NCT02654132|38249778|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
17111819|NCT02654132|38249779|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
17111820|NCT02654132|38249778|FG000|Treatment Period|Other reasons|4|||
17111821|NCT02654132|38249779|FG001|Treatment Period|Other reasons|2|||
17111822|NCT02654132|38249778|FG000|Treatment Period|Study drug toxicity|2|||
17111823|NCT02654132|38249779|FG001|Treatment Period|Study drug toxicity|2|||
17111824|NCT02654132|38249778|FG000|Treatment Period|Withdrawal by Subject|2|||
17111825|NCT02654132|38249779|FG001|Treatment Period|Withdrawal by Subject|1|||
17111826|NCT02654132|38249778|FG000|Treatment Period|Maximum Clinical Benefit|0|||
17111827|NCT02654132|38249779|FG001|Treatment Period|Maximum Clinical Benefit|2|||
17111828|NCT02654132|38249778|FG000|Treatment Period|Participant request to discontinue|2|||
17111829|NCT02654132|38249779|FG001|Treatment Period|Participant request to discontinue|0|||
17111830|NCT02654132|38249778|FG000|Treatment Period|Administrative reasons by sponsor|0|||
17111831|NCT02654132|38249779|FG001|Treatment Period|Administrative reasons by sponsor|1|||
17111832|NCT02654132|38249778|FG000|Treatment Period|Death|1|||
17111833|NCT02654132|38249779|FG001|Treatment Period|Death|0|||
17111834|NCT03241342|38249788|FG000|Overall Study|Adverse Event|5|||
17111835|NCT03241342|38249789|FG001|Overall Study|Adverse Event|8|||
17111836|NCT03241342|38249790|FG002|Overall Study|Adverse Event|4|||
17111837|NCT03241342|38249788|FG000|Overall Study|Lack of Efficacy|0|||
17111838|NCT03241342|38249789|FG001|Overall Study|Lack of Efficacy|0|||
17111839|NCT03241342|38249790|FG002|Overall Study|Lack of Efficacy|1|||
17111840|NCT03241342|38249788|FG000|Overall Study|noncompliance with study drug|2|||
17111841|NCT03241342|38249789|FG001|Overall Study|noncompliance with study drug|1|||
17111842|NCT03241342|38249790|FG002|Overall Study|noncompliance with study drug|1|||
17111843|NCT03241342|38249788|FG000|Overall Study|sponsor decision|0|||
17111844|NCT03241342|38249789|FG001|Overall Study|sponsor decision|1|||
17111845|NCT03241342|38249790|FG002|Overall Study|sponsor decision|2|||
17111846|NCT03241342|38249788|FG000|Overall Study|not reported|15|||
17111847|NCT03241342|38249789|FG001|Overall Study|not reported|21|||
17111848|NCT03241342|38249790|FG002|Overall Study|not reported|19|||
17111849|NCT02618408|38249801|FG000|Overall Study|Withdrawal by Subject|1|||
17111850|NCT02618408|38249802|FG001|Overall Study|Withdrawal by Subject|0|||
17111851|NCT02618408|38249803|FG002|Overall Study|Withdrawal by Subject|4|||
17111852|NCT02618408|38249801|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
17111853|NCT02618408|38249802|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
17111854|NCT02618408|38249803|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
17111855|NCT02618408|38249801|FG000|Overall Study|Lost to Follow-up|4|||
17111856|NCT02618408|38249802|FG001|Overall Study|Lost to Follow-up|2|||
17111857|NCT02618408|38249803|FG002|Overall Study|Lost to Follow-up|6|||
17111858|NCT02618408|38249801|FG000|Overall Study|Adverse Event|4|||
17111859|NCT02618408|38249802|FG001|Overall Study|Adverse Event|0|||
17111860|NCT02618408|38249803|FG002|Overall Study|Adverse Event|10|||
17111861|NCT02618408|38249801|FG000|Overall Study|Physician Decision|1|||
17111862|NCT02618408|38249802|FG001|Overall Study|Physician Decision|1|||
17111863|NCT02618408|38249803|FG002|Overall Study|Physician Decision|2|||
17111864|NCT02618408|38249801|FG000|Overall Study|Protocol Violation|1|||
17111865|NCT02618408|38249802|FG001|Overall Study|Protocol Violation|1|||
17111866|NCT02618408|38249803|FG002|Overall Study|Protocol Violation|2|||
17111867|NCT02618408|38249801|FG000|Overall Study|Other, Multiple Categories|0|||
17111868|NCT02618408|38249802|FG001|Overall Study|Other, Multiple Categories|0|||
17111869|NCT02618408|38249803|FG002|Overall Study|Other, Multiple Categories|4|||
17111870|NCT00306995|38249821|FG000|Study Part I|Withdrawal by Subject|0|||
17111871|NCT00306995|38249822|FG001|Study Part I|Withdrawal by Subject|0|||
17111872|NCT00306995|38249823|FG002|Study Part I|Withdrawal by Subject|0|||
17111873|NCT00306995|38249824|FG003|Study Part I|Withdrawal by Subject|0|||
17111874|NCT00306995|38249825|FG004|Study Part I|Withdrawal by Subject|0|||
17111875|NCT00306995|38249826|FG005|Study Part I|Withdrawal by Subject|0|||
17111876|NCT00306995|38249827|FG006|Study Part I|Withdrawal by Subject|1|||
17111877|NCT00306995|38249821|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
17111878|NCT00306995|38249822|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
17111879|NCT00306995|38249823|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
17111880|NCT00306995|38249824|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
17111881|NCT00306995|38249825|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
17111882|NCT00306995|38249826|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
17111883|NCT00306995|38249827|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
17111884|NCT00121108|38249874|FG000|Overall Study|Lost to Follow-up|10|||
17111885|NCT00121108|38249875|FG001|Overall Study|Lost to Follow-up|22|||
17111886|NCT00121108|38249874|FG000|Overall Study|Withdrawal by Subject|106|||
17111887|NCT00121108|38249875|FG001|Overall Study|Withdrawal by Subject|195|||
17111888|NCT00121108|38249874|FG000|Overall Study|Death|5|||
17111889|NCT00121108|38249875|FG001|Overall Study|Death|8|||
17111890|NCT02387996|38249882|FG000|Overall Study|Disease Progression|167|||
17111891|NCT02387996|38249882|FG000|Overall Study|Study Drug Toxicity|31|||
17111892|NCT02387996|38249882|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
17111893|NCT02387996|38249882|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
17111894|NCT02387996|38249882|FG000|Overall Study|Subject Withdrew Consent|5|||
17111895|NCT02387996|38249882|FG000|Overall Study|Lost to Follow-up|1|||
17111896|NCT02387996|38249882|FG000|Overall Study|Poor/Non-Compliance|1|||
17111897|NCT02387996|38249882|FG000|Overall Study|Other Reasons|5|||
17111898|NCT02387996|38249882|FG000|Overall Study|Death|1|||
17111899|NCT03214198|38249886|FG000|Overall Study|Case Report Forms Uncollected|18|||
17111900|NCT03214198|38249886|FG000|Overall Study|Protocol Deviation|18|||
17111901|NCT03212326|38249890|FG000|Overall Study|Physician Decision|4|||
17111902|NCT03229486|38249896|FG000|Overall Study|Protocol Violation|0|||
17111903|NCT03229486|38249897|FG001|Overall Study|Protocol Violation|1|||
17111904|NCT01779050|38249905|FG000|Overall Study|Withdrawal by Subject|1|||
17111905|NCT01779050|38249906|FG001|Overall Study|Withdrawal by Subject|0|||
17111906|NCT00306527|38249916|FG000|Overall Study|Lost to Follow-up|3|||
17111907|NCT00306527|38249917|FG001|Overall Study|Lost to Follow-up|4|||
17111908|NCT00306527|38249918|FG002|Overall Study|Lost to Follow-up|3|||
17111909|NCT00306527|38249919|FG003|Overall Study|Lost to Follow-up|0|||
17111910|NCT00306527|38249916|FG000|Overall Study|Withdrawal by Subject|2|||
17111911|NCT00306527|38249917|FG001|Overall Study|Withdrawal by Subject|3|||
17111912|NCT00306527|38249918|FG002|Overall Study|Withdrawal by Subject|0|||
17111913|NCT00306527|38249919|FG003|Overall Study|Withdrawal by Subject|3|||
17111914|NCT00306527|38249916|FG000|Overall Study|Adverse Event|0|||
17111915|NCT00306527|38249917|FG001|Overall Study|Adverse Event|0|||
17111916|NCT00306527|38249918|FG002|Overall Study|Adverse Event|1|||
17111917|NCT00306527|38249919|FG003|Overall Study|Adverse Event|1|||
17111918|NCT00306527|38249916|FG000|Overall Study|Death|1|||
17111919|NCT00306527|38249917|FG001|Overall Study|Death|0|||
17111920|NCT00306527|38249918|FG002|Overall Study|Death|1|||
17111921|NCT00306527|38249919|FG003|Overall Study|Death|2|||
17111922|NCT00306293|38249933|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
17111923|NCT00306293|38249934|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
17111924|NCT00306293|38249933|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
17111925|NCT00306293|38249934|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
17111926|NCT00306293|38249933|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
17111927|NCT00306293|38249934|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
17111928|NCT00306293|38249933|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
17111929|NCT00306293|38249934|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
17111930|NCT00306293|38249933|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
17111931|NCT00306293|38249934|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
17111932|NCT00306293|38249933|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
17111933|NCT00306293|38249934|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
17111934|NCT00306293|38249933|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
17111935|NCT00306293|38249934|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
17111936|NCT00306293|38249933|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
17111937|NCT00306293|38249934|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
17111938|NCT00294671|38249944|FG000|Overall Study|Lack of Efficacy|11|||
17111939|NCT00294671|38249945|FG001|Overall Study|Lack of Efficacy|23|||
17111940|NCT00294671|38249944|FG000|Overall Study|Liver transplant|7|||
17111941|NCT00294671|38249945|FG001|Overall Study|Liver transplant|9|||
17111942|NCT00294671|38249944|FG000|Overall Study|Drug related adverse event (AE)|4|||
17111943|NCT00294671|38249945|FG001|Overall Study|Drug related adverse event (AE)|2|||
17111944|NCT00294671|38249944|FG000|Overall Study|Non-drug related AE|3|||
17111945|NCT00294671|38249945|FG001|Overall Study|Non-drug related AE|2|||
17111946|NCT00294671|38249944|FG000|Overall Study|Lost to Follow-up|1|||
17111947|NCT00294671|38249945|FG001|Overall Study|Lost to Follow-up|3|||
17111948|NCT00294671|38249944|FG000|Overall Study|Non-compliance|1|||
17111949|NCT00294671|38249945|FG001|Overall Study|Non-compliance|0|||
17111950|NCT00294671|38249944|FG000|Overall Study|Death|0|||
17111951|NCT00294671|38249945|FG001|Overall Study|Death|1|||
17111952|NCT01495598|38249951|FG000|Overall Study|Death during follow up period|2|||
17111953|NCT01495598|38249951|FG000|Overall Study|Death on study|1|||
17111954|NCT01495598|38249951|FG000|Overall Study|Lost to Follow-up|3|||
17111955|NCT01495598|38249951|FG000|Overall Study|Physician Decision|8|||
17111956|NCT02937454|38249982|FG000|Overall Study|Adverse Event|0|||
17111957|NCT02937454|38249983|FG001|Overall Study|Adverse Event|1|||
17111958|NCT02937454|38249982|FG000|Overall Study|Death|98|||
17111959|NCT02937454|38249983|FG001|Overall Study|Death|95|||
17111960|NCT02937454|38249982|FG000|Overall Study|Lost to Follow-up|1|||
17111961|NCT02937454|38249983|FG001|Overall Study|Lost to Follow-up|1|||
17111962|NCT02937454|38249982|FG000|Overall Study|Physician Decision|0|||
17111963|NCT02937454|38249983|FG001|Overall Study|Physician Decision|1|||
17111964|NCT02937454|38249982|FG000|Overall Study|Protocol Violation|6|||
17111965|NCT02937454|38249983|FG001|Overall Study|Protocol Violation|10|||
17111966|NCT02937454|38249982|FG000|Overall Study|Withdrawal by Subject|27|||
17111967|NCT02937454|38249983|FG001|Overall Study|Withdrawal by Subject|15|||
17111968|NCT02937454|38249982|FG000|Overall Study|Other|8|||
17111969|NCT02937454|38249983|FG001|Overall Study|Other|5|||
17111970|NCT03211858|38250002|FG000|Overall Study|Adverse Event|8|||
17111971|NCT03211858|38250003|FG001|Overall Study|Adverse Event|6|||
17111972|NCT03211858|38250002|FG000|Overall Study|Lack of Efficacy|0|||
17111973|NCT03211858|38250003|FG001|Overall Study|Lack of Efficacy|4|||
17111974|NCT03211858|38250002|FG000|Overall Study|Poor compliance to protocol|6|||
17111975|NCT03211858|38250003|FG001|Overall Study|Poor compliance to protocol|2|||
17111976|NCT03211858|38250002|FG000|Overall Study|Non-serious Hypoglycemia|1|||
17111977|NCT03211858|38250003|FG001|Overall Study|Non-serious Hypoglycemia|0|||
17111978|NCT03211858|38250002|FG000|Overall Study|Other than specified above|22|||
17111979|NCT03211858|38250003|FG001|Overall Study|Other than specified above|21|||
17111980|NCT03211156|38250015|FG000|Overall Study|Withdrawal by Subject|0|||
17111981|NCT03211156|38250016|FG001|Overall Study|Withdrawal by Subject|2|||
17111982|NCT03211156|38250015|FG000|Overall Study|Lost to Follow-up|1|||
17111983|NCT03211156|38250016|FG001|Overall Study|Lost to Follow-up|1|||
17111984|NCT03211156|38250015|FG000|Overall Study|Adverse Event|1|||
17111985|NCT03211156|38250016|FG001|Overall Study|Adverse Event|0|||
17111986|NCT04472494|38250024|FG000|Pre-treatment|Other reasons|2|||
17111987|NCT04472494|38250025|FG001|Pre-treatment|Other reasons|0|||
17111988|NCT04472494|38250024|FG000|Treatment|Death|5|||
17111989|NCT04472494|38250025|FG001|Treatment|Death|2|||
17111990|NCT04472494|38250024|FG000|Treatment|Hospital discharge|1|||
17111991|NCT04472494|38250025|FG001|Treatment|Hospital discharge|1|||
17111992|NCT04419506|38250035|FG000|Overall Study|Adverse Event|0|||
17111993|NCT04419506|38250036|FG001|Overall Study|Adverse Event|10|||
17111994|NCT04419506|38250037|FG002|Overall Study|Adverse Event|0|||
17111995|NCT04419506|38250038|FG003|Overall Study|Adverse Event|3|||
17111996|NCT04419506|38250035|FG000|Overall Study|Withdrawal by Subject|0|||
17111997|NCT04419506|38250036|FG001|Overall Study|Withdrawal by Subject|0|||
17111998|NCT04419506|38250037|FG002|Overall Study|Withdrawal by Subject|0|||
17111999|NCT04419506|38250038|FG003|Overall Study|Withdrawal by Subject|1|||
17112000|NCT04419506|38250035|FG000|Overall Study|poor-compliance|0|||
17112001|NCT04419506|38250036|FG001|Overall Study|poor-compliance|0|||
17112002|NCT04419506|38250037|FG002|Overall Study|poor-compliance|0|||
17112003|NCT04419506|38250038|FG003|Overall Study|poor-compliance|1|||
17112004|NCT03236506|38250051|FG000|Overall Study|Death|1|||
17112005|NCT03236506|38250052|FG001|Overall Study|Death|1|||
17112006|NCT03236506|38250053|FG002|Overall Study|Death|1|||
17112007|NCT03236506|38250051|FG000|Overall Study|Withdrawal by Subject|3|||
17112008|NCT03236506|38250052|FG001|Overall Study|Withdrawal by Subject|3|||
17112009|NCT03236506|38250053|FG002|Overall Study|Withdrawal by Subject|4|||
17112010|NCT03236506|38250051|FG000|Overall Study|Did not initiate treatment|2|||
17112011|NCT03236506|38250052|FG001|Overall Study|Did not initiate treatment|1|||
17112012|NCT03236506|38250053|FG002|Overall Study|Did not initiate treatment|2|||
17112013|NCT03227692|38250072|FG000|Overall Study|Protocol Violation|1|||
17112014|NCT03227692|38250073|FG001|Overall Study|Protocol Violation|1|||
17112015|NCT03227692|38250072|FG000|Overall Study|Lost to Follow-up|4|||
17112016|NCT03227692|38250073|FG001|Overall Study|Lost to Follow-up|2|||
17112017|NCT03227692|38250072|FG000|Overall Study|Adverse Event|0|||
17112018|NCT03227692|38250073|FG001|Overall Study|Adverse Event|2|||
17112019|NCT03210220|38250081|FG000|Overall Study|Physician Decision|1|||
17112020|NCT03210220|38250082|FG001|Overall Study|Physician Decision|0|||
17112021|NCT03209518|38250088|FG000|Overall Study|Case Report Forms Uncollected|1|||
17112022|NCT03209518|38250088|FG000|Overall Study|Protocol Deviation|1|||
17112023|NCT03227224|38250096|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
17112024|NCT03227224|38250097|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
17112025|NCT03227224|38250098|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
17112026|NCT03227224|38250099|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
17112027|NCT03227224|38250096|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
17112028|NCT03227224|38250097|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
17112029|NCT03227224|38250098|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
17112030|NCT03227224|38250099|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
17112031|NCT03227224|38250096|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
17112032|NCT03227224|38250097|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
17112033|NCT03227224|38250098|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
17112034|NCT03227224|38250099|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
17112035|NCT03227224|38250096|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
17112036|NCT03227224|38250097|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
17112037|NCT03227224|38250098|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
17112038|NCT03227224|38250099|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
17112039|NCT03227224|38250096|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
17112040|NCT03227224|38250097|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
17112041|NCT03227224|38250098|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
17112042|NCT03227224|38250099|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
17112043|NCT03227224|38250096|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
17112044|NCT03227224|38250097|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
17112045|NCT03227224|38250098|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
17112046|NCT03227224|38250099|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
17112047|NCT03227224|38250096|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
17112048|NCT03227224|38250097|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
17112049|NCT03227224|38250098|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
17112050|NCT03227224|38250099|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
17112051|NCT03227224|38250096|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
17112052|NCT03227224|38250097|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
17112053|NCT03227224|38250098|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
17112054|NCT03227224|38250099|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
17112055|NCT03227224|38250096|FG000|Follow-up Phase (2 Weeks)|Other|4|||
17112056|NCT03227224|38250097|FG001|Follow-up Phase (2 Weeks)|Other|4|||
17112057|NCT03227224|38250098|FG002|Follow-up Phase (2 Weeks)|Other|6|||
17112058|NCT03227224|38250099|FG003|Follow-up Phase (2 Weeks)|Other|3|||
17112059|NCT03725852|38250118|FG000|Overall Study|Death|1|||
17112060|NCT03725852|38250119|FG001|Overall Study|Death|0|||
17112061|NCT03725852|38250118|FG000|Overall Study|Withdrawal by Subject|1|||
17112062|NCT03725852|38250119|FG001|Overall Study|Withdrawal by Subject|0|||
17112063|NCT03725852|38250118|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
17112064|NCT03725852|38250119|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
17112065|NCT00304031|38250128|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
17112066|NCT00304031|38250129|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
17112067|NCT00304031|38250130|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
17112068|NCT00304031|38250128|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
17112069|NCT00304031|38250129|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
17112070|NCT00304031|38250130|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
17112071|NCT00304031|38250128|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
17112072|NCT00304031|38250129|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
17112073|NCT00304031|38250130|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
17112074|NCT00304031|38250128|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
17112075|NCT00304031|38250129|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
17112076|NCT00304031|38250130|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
17112077|NCT00304031|38250128|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
17112078|NCT00304031|38250129|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
17112079|NCT00304031|38250130|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
17112080|NCT00304031|38250128|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
17112081|NCT00304031|38250129|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
17112082|NCT00304031|38250130|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
17112083|NCT00304031|38250128|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
17112084|NCT00304031|38250129|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
17112085|NCT00304031|38250130|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
17112086|NCT00304031|38250128|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
17112087|NCT00304031|38250129|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
17112088|NCT00304031|38250130|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
17112089|NCT00304031|38250128|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
17112090|NCT00304031|38250129|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
17112091|NCT00304031|38250130|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
17112092|NCT00332189|38250145|FG000|Overall Study|Adverse Event|3|||
17112093|NCT00332189|38250145|FG000|Overall Study|Uncooperative/Noncompliant|3|||
17112094|NCT00332189|38250145|FG000|Overall Study|Withdrawal by Subject|9|||
17112095|NCT00332189|38250145|FG000|Overall Study|Lack of Efficacy|4|||
17112096|NCT00332189|38250145|FG000|Overall Study|Moved out of country|2|||
17112097|NCT00331799|38250150|FG000|Overall Study|Withdrawal by Subject|2|||
17112098|NCT00331799|38250150|FG000|Overall Study|Sedation|1|||
17112099|NCT00303953|38250154|FG000|Overall Study|Ineligible|1|||
17112100|NCT00303953|38250154|FG000|Overall Study|Death|1|||
17112101|NCT00303953|38250154|FG000|Overall Study|Adverse Event|4|||
17112102|NCT00303953|38250154|FG000|Overall Study|Lack of Efficacy|12|||
17112103|NCT00303953|38250154|FG000|Overall Study|Physician Decision|1|||
17112104|NCT00303719|38250160|FG000|Overall Study|Not evaluable, prior therapies|0|||
17112105|NCT00303719|38250161|FG001|Overall Study|Not evaluable, prior therapies|30|||
17112106|NCT00303719|38250160|FG000|Overall Study|Lost to Follow-up|0|||
17112107|NCT00303719|38250161|FG001|Overall Study|Lost to Follow-up|7|||
17112108|NCT00331409|38250168|FG000|Overall Study|Lack of Efficacy|4|||
17112109|NCT00303485|38250174|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
17112110|NCT00303485|38250175|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
17112111|NCT00303485|38250174|FG000|Overall Study|Failure to return|0|||
17112112|NCT00303485|38250175|FG001|Overall Study|Failure to return|1|||
17112113|NCT00303485|38250174|FG000|Overall Study|Withdrawal by Subject|1|||
17112114|NCT00303485|38250175|FG001|Overall Study|Withdrawal by Subject|0|||
17112115|NCT03235726|38250189|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112116|NCT03235726|38250190|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112117|NCT03235726|38250191|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112118|NCT03235726|38250192|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112119|NCT03235726|38250193|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
17112120|NCT03235726|38250194|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112121|NCT03235726|38250195|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112122|NCT03235726|38250196|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112123|NCT03235726|38250197|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112124|NCT03235726|38250198|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
17112125|NCT03235726|38250189|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112126|NCT03235726|38250190|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112127|NCT03235726|38250191|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112128|NCT03235726|38250192|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112129|NCT03235726|38250193|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
17112130|NCT03235726|38250194|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112131|NCT03235726|38250195|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112132|NCT03235726|38250196|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112133|NCT03235726|38250197|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112134|NCT03235726|38250198|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
17112135|NCT03723590|38250233|FG000|Overall Study|Withdrawal by Subject|3|||
17112136|NCT02935894|38250237|FG000|Overall Study|Subject dismissed|1|||
17112137|NCT03224182|38250243|FG000|Overall Study|Study Drug Not Instilled|6|||
17112138|NCT03224182|38250244|FG001|Overall Study|Study Drug Not Instilled|1|||
17112139|NCT03224182|38250243|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
17112140|NCT03224182|38250244|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
17112141|NCT03224182|38250243|FG000|Overall Study|Withdrew of Consent|4|||
17112142|NCT03224182|38250244|FG001|Overall Study|Withdrew of Consent|2|||
17112143|NCT03224182|38250243|FG000|Overall Study|Investigator Decision|3|||
17112144|NCT03224182|38250244|FG001|Overall Study|Investigator Decision|1|||
17112145|NCT03224182|38250243|FG000|Overall Study|Sponsor Decision|26|||
17112146|NCT03224182|38250244|FG001|Overall Study|Sponsor Decision|12|||
17112147|NCT03224182|38250243|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
17112148|NCT03224182|38250244|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
17112149|NCT03224182|38250243|FG000|Overall Study|Lost to Follow-up|1|||
17112150|NCT03224182|38250244|FG001|Overall Study|Lost to Follow-up|0|||
17112151|NCT03224182|38250243|FG000|Overall Study|Participant Had Recurrence|11|||
17112152|NCT03224182|38250244|FG001|Overall Study|Participant Had Recurrence|5|||
17112153|NCT03224182|38250243|FG000|Overall Study|Death|0|||
17112154|NCT03224182|38250244|FG001|Overall Study|Death|1|||
17112155|NCT03224182|38250243|FG000|Overall Study|Reason not Specified|3|||
17112156|NCT03224182|38250244|FG001|Overall Study|Reason not Specified|3|||
17112157|NCT03224182|38250243|FG000|Overall Study|Other|1|||
17112158|NCT03224182|38250244|FG001|Overall Study|Other|0|||
17112159|NCT02935192|38250252|FG000|Overall Study|Withdrawal by Subject|8|||
17112160|NCT02935192|38250253|FG001|Overall Study|Withdrawal by Subject|4|||
17112161|NCT03722264|38250259|FG000|Overall Study|Physician Decision|3|||
17112162|NCT03722030|38250267|FG000|Overall Study|Withdrawal by Subject|1|||
17112163|NCT03722030|38250268|FG001|Overall Study|Withdrawal by Subject|0|||
17112164|NCT03221842|38250275|FG000|Period 1 (Open-label)|Adverse Event|4|||
17112165|NCT03221842|38250276|FG001|Period 1 (Open-label)|Adverse Event|0|||
17112166|NCT03221842|38250275|FG000|Period 1 (Open-label)|Physician Decision|2|||
17112167|NCT03221842|38250276|FG001|Period 1 (Open-label)|Physician Decision|0|||
17112168|NCT03221842|38250275|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
17112169|NCT03221842|38250276|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
17112170|NCT03221842|38250275|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
17112171|NCT03221842|38250276|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
17112172|NCT03221842|38250275|FG000|Period 1 (Open-label)|Other|2|||
17112173|NCT03221842|38250276|FG001|Period 1 (Open-label)|Other|0|||
17112174|NCT03221842|38250275|FG000|Period 2 (Randomized, Blinded)|Death|0|||
17112175|NCT03221842|38250276|FG001|Period 2 (Randomized, Blinded)|Death|1|||
17112176|NCT03221842|38250275|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
17112177|NCT03221842|38250276|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
17112178|NCT03364738|38250286|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
17112179|NCT03364738|38250286|FG000|Overall Study|Withdrawal by Subject|1|||
17112180|NCT03364738|38250286|FG000|Overall Study|Adverse Event|1|||
17112181|NCT00303329|38250293|FG000|Overall Study|Adverse Event|7|||
17112182|NCT00303329|38250294|FG001|Overall Study|Adverse Event|14|||
17112183|NCT00303329|38250293|FG000|Overall Study|Abnormal Laboratory Values|0|||
17112184|NCT00303329|38250294|FG001|Overall Study|Abnormal Laboratory Values|1|||
17112185|NCT00303329|38250293|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
17112186|NCT00303329|38250294|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
17112187|NCT00303329|38250293|FG000|Overall Study|Condition no longer requires study drug|0|||
17112188|NCT00303329|38250294|FG001|Overall Study|Condition no longer requires study drug|8|||
17112189|NCT00303329|38250293|FG000|Overall Study|Protocol Violation|3|||
17112190|NCT00303329|38250294|FG001|Overall Study|Protocol Violation|0|||
17112191|NCT00303329|38250293|FG000|Overall Study|Withdrawal by Subject|9|||
17112192|NCT00303329|38250294|FG001|Overall Study|Withdrawal by Subject|15|||
17112193|NCT00303329|38250293|FG000|Overall Study|Lost to Follow-up|0|||
17112194|NCT00303329|38250294|FG001|Overall Study|Lost to Follow-up|1|||
17112195|NCT00303329|38250293|FG000|Overall Study|Administrative problems|1|||
17112196|NCT00303329|38250294|FG001|Overall Study|Administrative problems|0|||
17112197|NCT00303329|38250293|FG000|Overall Study|Death|2|||
17112198|NCT00303329|38250294|FG001|Overall Study|Death|12|||
17112199|NCT00303329|38250293|FG000|Overall Study|Stopped at end of core|3|||
17112200|NCT00303329|38250294|FG001|Overall Study|Stopped at end of core|9|||
17112201|NCT00303329|38250293|FG000|Overall Study|Stopped at end of extension 1|1|||
17112202|NCT00303329|38250294|FG001|Overall Study|Stopped at end of extension 1|0|||
17112203|NCT00329849|38250302|FG000|Overall Study|Withdrawal by Subject|6|||
17112204|NCT00329849|38250303|FG001|Overall Study|Withdrawal by Subject|4|||
17112205|NCT02934178|38250315|FG000|Received Vaccination 2|Death|0|||
17112206|NCT02934178|38250316|FG001|Received Vaccination 2|Death|1|||
17112207|NCT02934178|38250315|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
17112208|NCT02934178|38250316|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
17112209|NCT00329303|38250325|FG000|Overall Study|Lack of Efficacy|1|||
17112210|NCT00329303|38250326|FG001|Overall Study|Lack of Efficacy|0|||
17112211|NCT00329303|38250325|FG000|Overall Study|Decision of the sponsor|0|||
17112212|NCT00329303|38250326|FG001|Overall Study|Decision of the sponsor|1|||
17112213|NCT00329303|38250325|FG000|Overall Study|Patient no longer available|1|||
17112214|NCT00329303|38250326|FG001|Overall Study|Patient no longer available|0|||
17112215|NCT00329303|38250325|FG000|Overall Study|Patient relocated|0|||
17112216|NCT00329303|38250326|FG001|Overall Study|Patient relocated|1|||
17112217|NCT03216850|38250333|FG000|Overall Study|Pre-analytical error|6|||
17112218|NCT00302159|38250337|FG000|Overall Study|pt declined before treatment started|1|||
17112219|NCT00302159|38250337|FG000|Overall Study|pt started Avastin|1|||
17112220|NCT00302081|38250345|FG000|Overall Study|Adverse Event|6|||
17112221|NCT00302081|38250346|FG001|Overall Study|Adverse Event|5|||
17112222|NCT00302081|38250347|FG002|Overall Study|Adverse Event|4|||
17112223|NCT00302081|38250345|FG000|Overall Study|Lost to Follow-up|21|||
17112224|NCT00302081|38250346|FG001|Overall Study|Lost to Follow-up|18|||
17112225|NCT00302081|38250347|FG002|Overall Study|Lost to Follow-up|28|||
17112226|NCT00302081|38250345|FG000|Overall Study|Withdrawal by Subject|8|||
17112227|NCT00302081|38250346|FG001|Overall Study|Withdrawal by Subject|12|||
17112228|NCT00302081|38250347|FG002|Overall Study|Withdrawal by Subject|8|||
17112229|NCT00302081|38250345|FG000|Overall Study|Protocol Violation|5|||
17112230|NCT00302081|38250346|FG001|Overall Study|Protocol Violation|1|||
17112231|NCT00302081|38250347|FG002|Overall Study|Protocol Violation|2|||
17112232|NCT00302081|38250345|FG000|Overall Study|Lack of Efficacy|1|||
17112233|NCT00302081|38250346|FG001|Overall Study|Lack of Efficacy|0|||
17112234|NCT00302081|38250347|FG002|Overall Study|Lack of Efficacy|5|||
17112235|NCT00302081|38250345|FG000|Overall Study|Death|2|||
17112236|NCT00302081|38250346|FG001|Overall Study|Death|1|||
17112237|NCT00302081|38250347|FG002|Overall Study|Death|0|||
17112238|NCT00302081|38250345|FG000|Overall Study|Other|13|||
17112239|NCT00302081|38250346|FG001|Overall Study|Other|6|||
17112240|NCT00302081|38250347|FG002|Overall Study|Other|5|||
17112241|NCT00302003|38250355|FG000|Overall Study|Lack of Efficacy|62|||
17112242|NCT00302003|38250355|FG000|Overall Study|Lost to Follow-up|1|||
17112243|NCT00302003|38250355|FG000|Overall Study|Physician Decision|2|||
17112244|NCT00302003|38250355|FG000|Overall Study|Withdrawal by Subject|5|||
17112245|NCT00302003|38250355|FG000|Overall Study|Ineligible|9|||
17112246|NCT00302003|38250355|FG000|Overall Study|Protocol Violation|1|||
17112247|NCT00036270|38250361|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
17112248|NCT00036270|38250362|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
17112249|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
17112250|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
17112251|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
17112252|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
17112253|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
17112254|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
17112255|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Other|277|||
17112256|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Other|288|||
17112257|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
17112258|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
17112259|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
17112260|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
17112261|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
17112262|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
17112263|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
17112264|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
17112265|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
17112266|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
17112267|NCT00036270|38250361|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
17112268|NCT00036270|38250362|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
17112269|NCT00049530|38250368|FG000|Overall Study|Lack of Efficacy|25|||
17112270|NCT00049530|38250368|FG000|Overall Study|Adverse Event|2|||
17112271|NCT00049530|38250368|FG000|Overall Study|Death|1|||
17112272|NCT00049530|38250368|FG000|Overall Study|symptomatic deterioration|1|||
17112273|NCT00049530|38250368|FG000|Overall Study|ineligible|3|||
17112274|NCT00301067|38250372|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
17112275|NCT00301067|38250373|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
17112276|NCT00301067|38250374|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
17112277|NCT00301067|38250375|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
17112278|NCT00301067|38250372|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
17112279|NCT00301067|38250373|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
17112280|NCT00301067|38250374|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
17112281|NCT00301067|38250375|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
17112282|NCT00301067|38250372|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
17112283|NCT00301067|38250373|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
17112284|NCT00301067|38250374|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
17112285|NCT00301067|38250375|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
17112286|NCT00301067|38250372|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
17112287|NCT00301067|38250373|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
17112288|NCT00301067|38250374|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
17112289|NCT00301067|38250375|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
17112290|NCT00301067|38250372|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
17112291|NCT00301067|38250373|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
17112292|NCT00301067|38250374|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
17112293|NCT00301067|38250375|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
17112294|NCT00301067|38250372|FG000|Follow up Until Death|Alive at last data cut point|1|||
17112295|NCT00301067|38250373|FG001|Follow up Until Death|Alive at last data cut point|0|||
17112296|NCT00301067|38250374|FG002|Follow up Until Death|Alive at last data cut point|0|||
17112297|NCT00301067|38250375|FG003|Follow up Until Death|Alive at last data cut point|1|||
17112298|NCT00007020|38250386|FG000|Overall Study|Death|16|||
17112299|NCT00007020|38250386|FG000|Overall Study|Lost to Follow-up|13|||
17112300|NCT00007020|38250386|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
17112301|NCT00007020|38250386|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
17112302|NCT00007020|38250386|FG000|Overall Study|Pt cared for by outside physician|4|||
17112303|NCT00007020|38250386|FG000|Overall Study|No evidence of treatment|6|||
17112304|NCT00300755|38250395|FG000|Overall Study|Adverse Event|1|||
17112305|NCT00300755|38250396|FG001|Overall Study|Adverse Event|2|||
17112306|NCT00300755|38250397|FG002|Overall Study|Adverse Event|1|||
17112307|NCT00300755|38250395|FG000|Overall Study|Withdrawal by Subject|0|||
17112308|NCT00300755|38250396|FG001|Overall Study|Withdrawal by Subject|2|||
17112309|NCT00300755|38250397|FG002|Overall Study|Withdrawal by Subject|0|||
17112310|NCT00300755|38250395|FG000|Overall Study|Protocol Violation|0|||
17112311|NCT00300755|38250396|FG001|Overall Study|Protocol Violation|0|||
17112312|NCT00300755|38250397|FG002|Overall Study|Protocol Violation|1|||
17112313|NCT00033540|38250405|FG000|Overall Study|Adverse Event|14|||
17112314|NCT00033540|38250405|FG000|Overall Study|Death|1|||
17112315|NCT00033540|38250405|FG000|Overall Study|Progression|26|||
17112316|NCT00033540|38250405|FG000|Overall Study|Withdrawal by Subject|6|||
17112317|NCT00033540|38250405|FG000|Overall Study|Other|5|||
17112318|NCT00033540|38250405|FG000|Overall Study|Ineligible|3|||
17112319|NCT00033540|38250405|FG000|Overall Study|Never received treatment|2|||
17112320|NCT00300365|38250412|FG000|Overall Study|Lost to Follow-up|1|||
17112321|NCT00300365|38250413|FG001|Overall Study|Lost to Follow-up|0|||
17112322|NCT00300365|38250412|FG000|Overall Study|Physician Decision|2|||
17112323|NCT00300365|38250413|FG001|Overall Study|Physician Decision|0|||
17112324|NCT00300365|38250412|FG000|Overall Study|Withdrawal by Subject|1|||
17112325|NCT00300365|38250413|FG001|Overall Study|Withdrawal by Subject|0|||
17112326|NCT00300365|38250412|FG000|Overall Study|Adverse Event|0|||
17112327|NCT00300365|38250413|FG001|Overall Study|Adverse Event|2|||
17112328|NCT00048048|38250428|FG000|Core Treatment|Withdrawal by Subject|0|||
17112329|NCT00048048|38250429|FG001|Core Treatment|Withdrawal by Subject|0|||
17112330|NCT00048048|38250430|FG002|Core Treatment|Withdrawal by Subject|1|||
17112331|NCT00048048|38250431|FG003|Core Treatment|Withdrawal by Subject|0|||
17112332|NCT00048048|38250432|FG004|Core Treatment|Withdrawal by Subject|0|||
17112333|NCT00048048|38250433|FG005|Core Treatment|Withdrawal by Subject|0|||
17112334|NCT00048048|38250434|FG006|Core Treatment|Withdrawal by Subject|0|||
17112335|NCT00048048|38250435|FG007|Core Treatment|Withdrawal by Subject|0|||
17112336|NCT00048048|38250436|FG008|Core Treatment|Withdrawal by Subject|0|||
17112337|NCT00048048|38250437|FG009|Core Treatment|Withdrawal by Subject|0|||
17112338|NCT00048048|38250438|FG010|Core Treatment|Withdrawal by Subject|0|||
17112339|NCT00048048|38250439|FG011|Core Treatment|Withdrawal by Subject|0|||
17112340|NCT00048048|38250428|FG000|Core Treatment|Adverse Event|0|||
17112341|NCT00048048|38250429|FG001|Core Treatment|Adverse Event|0|||
17112342|NCT00048048|38250430|FG002|Core Treatment|Adverse Event|0|||
17112343|NCT00048048|38250431|FG003|Core Treatment|Adverse Event|0|||
17112344|NCT00048048|38250432|FG004|Core Treatment|Adverse Event|0|||
17112345|NCT00048048|38250433|FG005|Core Treatment|Adverse Event|0|||
17112346|NCT00048048|38250434|FG006|Core Treatment|Adverse Event|0|||
17112347|NCT00048048|38250435|FG007|Core Treatment|Adverse Event|1|||
17112348|NCT00048048|38250436|FG008|Core Treatment|Adverse Event|0|||
17112349|NCT00048048|38250437|FG009|Core Treatment|Adverse Event|0|||
17112350|NCT00048048|38250438|FG010|Core Treatment|Adverse Event|0|||
17112351|NCT00048048|38250439|FG011|Core Treatment|Adverse Event|0|||
17112352|NCT00048048|38250428|FG000|Extension Year 1|Early withdrawals|0|||
17112353|NCT00048048|38250429|FG001|Extension Year 1|Early withdrawals|0|||
17112354|NCT00048048|38250430|FG002|Extension Year 1|Early withdrawals|0|||
17112355|NCT00048048|38250431|FG003|Extension Year 1|Early withdrawals|0|||
17112356|NCT00048048|38250432|FG004|Extension Year 1|Early withdrawals|0|||
17112357|NCT00048048|38250433|FG005|Extension Year 1|Early withdrawals|0|||
17112358|NCT00048048|38250434|FG006|Extension Year 1|Early withdrawals|0|||
17112359|NCT00048048|38250435|FG007|Extension Year 1|Early withdrawals|0|||
17112360|NCT00048048|38250436|FG008|Extension Year 1|Early withdrawals|0|||
17112361|NCT00048048|38250437|FG009|Extension Year 1|Early withdrawals|2|||
17112362|NCT00048048|38250438|FG010|Extension Year 1|Early withdrawals|2|||
17112363|NCT00048048|38250439|FG011|Extension Year 1|Early withdrawals|4|||
17112364|NCT00048048|38250428|FG000|Extension Year 2|Early withdrawals|0|||
17112365|NCT00048048|38250429|FG001|Extension Year 2|Early withdrawals|0|||
17112366|NCT00048048|38250430|FG002|Extension Year 2|Early withdrawals|0|||
17112367|NCT00048048|38250431|FG003|Extension Year 2|Early withdrawals|0|||
17112368|NCT00048048|38250432|FG004|Extension Year 2|Early withdrawals|0|||
17112369|NCT00048048|38250433|FG005|Extension Year 2|Early withdrawals|0|||
17112370|NCT00048048|38250434|FG006|Extension Year 2|Early withdrawals|0|||
17112371|NCT00048048|38250435|FG007|Extension Year 2|Early withdrawals|0|||
17112372|NCT00048048|38250436|FG008|Extension Year 2|Early withdrawals|0|||
17112373|NCT00048048|38250437|FG009|Extension Year 2|Early withdrawals|0|||
17112374|NCT00048048|38250438|FG010|Extension Year 2|Early withdrawals|4|||
17112375|NCT00048048|38250439|FG011|Extension Year 2|Early withdrawals|2|||
17112376|NCT00300053|38250469|FG000|Overall Study|Patient/Caregiver Preference|2|||
17112377|NCT00300053|38250470|FG001|Overall Study|Patient/Caregiver Preference|2|||
17112378|NCT00300053|38250471|FG002|Overall Study|Patient/Caregiver Preference|3|||
17112379|NCT00300053|38250469|FG000|Overall Study|Death|0|||
17112380|NCT00300053|38250470|FG001|Overall Study|Death|0|||
17112381|NCT00300053|38250471|FG002|Overall Study|Death|3|||
17112382|NCT00300053|38250469|FG000|Overall Study|Lost to Follow-up|0|||
17112383|NCT00300053|38250470|FG001|Overall Study|Lost to Follow-up|1|||
17112384|NCT00300053|38250471|FG002|Overall Study|Lost to Follow-up|0|||
17112385|NCT00299975|38250483|FG000|Overall Study|Adverse Event|1|||
17112386|NCT00299975|38250484|FG001|Overall Study|Adverse Event|0|||
17112387|NCT00299975|38250485|FG002|Overall Study|Adverse Event|2|||
17112388|NCT00299975|38250483|FG000|Overall Study|Pregnancy|0|||
17112389|NCT00299975|38250484|FG001|Overall Study|Pregnancy|0|||
17112390|NCT00299975|38250485|FG002|Overall Study|Pregnancy|1|||
17112391|NCT00299975|38250483|FG000|Overall Study|Lack of Efficacy|1|||
17112392|NCT00299975|38250484|FG001|Overall Study|Lack of Efficacy|0|||
17112393|NCT00299975|38250485|FG002|Overall Study|Lack of Efficacy|1|||
17112394|NCT00299975|38250483|FG000|Overall Study|Lost to Follow-up|1|||
17112395|NCT00299975|38250484|FG001|Overall Study|Lost to Follow-up|0|||
17112396|NCT00299975|38250485|FG002|Overall Study|Lost to Follow-up|0|||
17112397|NCT00299975|38250483|FG000|Overall Study|Withdrawal by Subject|0|||
17112398|NCT00299975|38250484|FG001|Overall Study|Withdrawal by Subject|1|||
17112399|NCT00299975|38250485|FG002|Overall Study|Withdrawal by Subject|3|||
17112400|NCT00299975|38250483|FG000|Overall Study|Physician Decision|0|||
17112401|NCT00299975|38250484|FG001|Overall Study|Physician Decision|0|||
17112402|NCT00299975|38250485|FG002|Overall Study|Physician Decision|1|||
17112403|NCT00004980|38250495|FG000|Overall Study|Withdrawal by Subject|1|||
17112404|NCT00004980|38250496|FG001|Overall Study|Withdrawal by Subject|0|||
17112405|NCT00004980|38250495|FG000|Overall Study|memory difficulties|1|||
17112406|NCT00004980|38250496|FG001|Overall Study|memory difficulties|1|||
17112407|NCT00004980|38250495|FG000|Overall Study|Physician Decision|0|||
17112408|NCT00004980|38250496|FG001|Overall Study|Physician Decision|1|||
17112409|NCT00326963|38250502|FG000|Overall Study|Adverse Event|2|||
17112410|NCT00326963|38250502|FG000|Overall Study|Injection site reaction|1|||
17112411|NCT00326963|38250502|FG000|Overall Study|Death|1|||
17112412|NCT00326963|38250502|FG000|Overall Study|Failure to return|10|||
17112413|NCT00326963|38250502|FG000|Overall Study|Withdrawal by Subject|10|||
17112414|NCT00326963|38250502|FG000|Overall Study|Refused treatment / did not cooperate|5|||
17112415|NCT00326963|38250502|FG000|Overall Study|Violation of selection criteria at entry|2|||
17112416|NCT00326963|38250502|FG000|Overall Study|Other protocol violation|1|||
17112417|NCT00326963|38250502|FG000|Overall Study|Administrative / other|1|||
17112418|NCT00326885|38250507|FG000|Overall Study|Adverse Event|1|||
17112419|NCT00326885|38250507|FG000|Overall Study|Withdrawal by Subject|3|||
17112420|NCT00326885|38250507|FG000|Overall Study|Physician Decision|1|||
17112421|NCT00326885|38250507|FG000|Overall Study|Hospice withdrew consent|2|||
17112422|NCT00326495|38250512|FG000|Overall Study|Switched to alternative treatment|1|||
17112423|NCT00326495|38250512|FG000|Overall Study|Disease progression before treatment|1|||
17112424|NCT00326495|38250512|FG000|Overall Study|Refused further treatment|2|||
17112425|NCT00326495|38250512|FG000|Overall Study|Subject off study before assessment|1|||
17112426|NCT00326417|38250518|FG000|Overall Study|Withdrawal by Subject|0|||
17112427|NCT00326417|38250519|FG001|Overall Study|Withdrawal by Subject|0|||
17112428|NCT00326417|38250520|FG002|Overall Study|Withdrawal by Subject|1|||
17112429|NCT00326417|38250521|FG003|Overall Study|Withdrawal by Subject|0|||
17112430|NCT00326417|38250518|FG000|Overall Study|Arm Closed|7|||
17112431|NCT00326417|38250519|FG001|Overall Study|Arm Closed|0|||
17112432|NCT00326417|38250520|FG002|Overall Study|Arm Closed|0|||
17112433|NCT00326417|38250521|FG003|Overall Study|Arm Closed|3|||
17112434|NCT00326417|38250518|FG000|Overall Study|Death|7|||
17112435|NCT00326417|38250519|FG001|Overall Study|Death|0|||
17112436|NCT00326417|38250520|FG002|Overall Study|Death|0|||
17112437|NCT00326417|38250521|FG003|Overall Study|Death|0|||
17112438|NCT03825341|38250531|FG000|Overall Study|Withdrawal by Subject|0|||
17112439|NCT03825341|38250532|FG001|Overall Study|Withdrawal by Subject|1|||
17112440|NCT00297479|38250543|FG000|Overall Study|Lost to Follow-up|37|||
17112441|NCT00297479|38250544|FG001|Overall Study|Lost to Follow-up|54|||
17112442|NCT00297479|38250545|FG002|Overall Study|Lost to Follow-up|51|||
17112443|NCT00688870|38250555|FG000|Infant Series|Parent or legal guardian request|4|||
17112444|NCT00688870|38250556|FG001|Infant Series|Parent or legal guardian request|0|||
17112445|NCT00297167|38250566|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
17112446|NCT00297167|38250567|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
17112447|NCT00297167|38250568|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
17112448|NCT00297167|38250566|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
17112449|NCT00297167|38250567|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
17112450|NCT00297167|38250568|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
17112451|NCT03216226|38250577|FG000|Overall Study|Adverse Event|3|||
17112452|NCT03216226|38250578|FG001|Overall Study|Adverse Event|0|||
17112453|NCT03216226|38250577|FG000|Overall Study|Protocol Violation|1|||
17112454|NCT03216226|38250578|FG001|Overall Study|Protocol Violation|3|||
17112455|NCT03216226|38250577|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
17112456|NCT03216226|38250578|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
17112457|NCT03216226|38250577|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
17112458|NCT03216226|38250578|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
17112459|NCT03216226|38250577|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
17112460|NCT03216226|38250578|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
17112461|NCT03215758|38250586|FG000|Overall Study|Technical Problems|1|||
17112462|NCT03215758|38250587|FG001|Overall Study|Technical Problems|0|||
17112463|NCT03215758|38250586|FG000|Overall Study|Protocol deviation|0|||
17112464|NCT03215758|38250587|FG001|Overall Study|Protocol deviation|1|||
17112465|NCT03215758|38250586|FG000|Overall Study|Physician Decision|0|||
17112466|NCT03215758|38250587|FG001|Overall Study|Physician Decision|1|||
17112467|NCT03215758|38250586|FG000|Overall Study|Death|0|||
17112468|NCT03215758|38250587|FG001|Overall Study|Death|1|||
17112469|NCT03215758|38250586|FG000|Overall Study|Adverse Event|1|||
17112470|NCT03215758|38250587|FG001|Overall Study|Adverse Event|2|||
17112471|NCT03215758|38250586|FG000|Overall Study|Subject/Guardian Decision|3|||
17112472|NCT03215758|38250587|FG001|Overall Study|Subject/Guardian Decision|3|||
17112473|NCT00290771|38250595|FG000|Overall Study|Disease progression|95|||
17112474|NCT00290771|38250596|FG001|Overall Study|Disease progression|73|||
17112475|NCT00290771|38250595|FG000|Overall Study|Death|11|||
17112476|NCT00290771|38250596|FG001|Overall Study|Death|10|||
17112477|NCT00290771|38250595|FG000|Overall Study|Adverse Event|12|||
17112478|NCT00290771|38250596|FG001|Overall Study|Adverse Event|6|||
17112479|NCT00290771|38250595|FG000|Overall Study|Withdrawal by Subject|5|||
17112480|NCT00290771|38250596|FG001|Overall Study|Withdrawal by Subject|6|||
17112481|NCT00290771|38250595|FG000|Overall Study|Administrative problems|2|||
17112482|NCT00290771|38250596|FG001|Overall Study|Administrative problems|1|||
17112483|NCT00290771|38250595|FG000|Overall Study|Protocol Violation|2|||
17112484|NCT00290771|38250596|FG001|Overall Study|Protocol Violation|0|||
17112485|NCT00290771|38250595|FG000|Overall Study|Lost to Follow-up|0|||
17112486|NCT00290771|38250596|FG001|Overall Study|Lost to Follow-up|1|||
17112487|NCT00274625|38250605|FG000|Overall Study|Lost to Follow-up|46|||
17112488|NCT00274625|38250606|FG001|Overall Study|Lost to Follow-up|54|||
17112489|NCT00274625|38250605|FG000|Overall Study|Excluded from analysis|14|||
17112490|NCT00274625|38250606|FG001|Overall Study|Excluded from analysis|8|||
17112491|NCT00290693|38250612|FG000|Overall Study|Withdrawal by Subject|2|||
17112492|NCT03214666|38250623|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
17112493|NCT03214666|38250624|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
17112494|NCT03214666|38250625|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
17112495|NCT03214666|38250626|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
17112496|NCT03214666|38250627|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
17112497|NCT03214666|38250628|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
17112498|NCT00274469|38250645|FG000|Overall Study|Death|63|||
17112499|NCT00274469|38250646|FG001|Overall Study|Death|74|||
17112500|NCT00274469|38250645|FG000|Overall Study|Did not consent to OS follow-up|16|||
17112501|NCT00274469|38250646|FG001|Overall Study|Did not consent to OS follow-up|19|||
17112502|NCT03214588|38250655|FG000|Overall Study|Adverse Event|1|||
17112503|NCT03214588|38250656|FG001|Overall Study|Adverse Event|0|||
17112504|NCT03214588|38250657|FG002|Overall Study|Adverse Event|2|||
17112505|NCT03214588|38250655|FG000|Overall Study|Reason Not Specified|0|||
17112506|NCT03214588|38250656|FG001|Overall Study|Reason Not Specified|1|||
17112507|NCT03214588|38250657|FG002|Overall Study|Reason Not Specified|0|||
17112508|NCT03166618|38250667|FG000|Overall Study|Study was Terminated|0|||
17112509|NCT03166618|38250668|FG001|Overall Study|Study was Terminated|1|||
17112510|NCT03164356|38250687|FG000|Overall Study|Lost to Follow-up|1|||
17112511|NCT03164356|38250688|FG001|Overall Study|Lost to Follow-up|1|||
17112512|NCT03164356|38250689|FG002|Overall Study|Lost to Follow-up|2|||
17112513|NCT03164356|38250690|FG003|Overall Study|Lost to Follow-up|1|||
17112514|NCT03164356|38250687|FG000|Overall Study|Physician Decision|0|||
17112515|NCT03164356|38250688|FG001|Overall Study|Physician Decision|0|||
17112516|NCT03164356|38250689|FG002|Overall Study|Physician Decision|3|||
17112517|NCT03164356|38250690|FG003|Overall Study|Physician Decision|0|||
17112518|NCT03164356|38250687|FG000|Overall Study|Protocol Violation|2|||
17112519|NCT03164356|38250688|FG001|Overall Study|Protocol Violation|1|||
17112520|NCT03164356|38250689|FG002|Overall Study|Protocol Violation|0|||
17112521|NCT03164356|38250690|FG003|Overall Study|Protocol Violation|0|||
17112522|NCT03164356|38250687|FG000|Overall Study|Withdrawal by Subject|1|||
17112523|NCT03164356|38250688|FG001|Overall Study|Withdrawal by Subject|0|||
17112524|NCT03164356|38250689|FG002|Overall Study|Withdrawal by Subject|0|||
17112525|NCT03164356|38250690|FG003|Overall Study|Withdrawal by Subject|0|||
17112526|NCT03164356|38250687|FG000|Overall Study|Study timeframe interrupted by COVID-19|1|||
17112527|NCT03164356|38250688|FG001|Overall Study|Study timeframe interrupted by COVID-19|0|||
17112528|NCT03164356|38250689|FG002|Overall Study|Study timeframe interrupted by COVID-19|0|||
17112529|NCT03164356|38250690|FG003|Overall Study|Study timeframe interrupted by COVID-19|1|||
17112530|NCT03164356|38250687|FG000|Overall Study|Subject Incarcerated|0|||
17112531|NCT03164356|38250688|FG001|Overall Study|Subject Incarcerated|1|||
17112532|NCT03164356|38250689|FG002|Overall Study|Subject Incarcerated|0|||
17112533|NCT03164356|38250690|FG003|Overall Study|Subject Incarcerated|0|||
17112534|NCT03164356|38250687|FG000|Overall Study|Prosthetist unable to participate|0|||
17112535|NCT03164356|38250688|FG001|Overall Study|Prosthetist unable to participate|2|||
17112536|NCT03164356|38250689|FG002|Overall Study|Prosthetist unable to participate|1|||
17112537|NCT03164356|38250690|FG003|Overall Study|Prosthetist unable to participate|0|||
17112538|NCT03162796|38250713|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
17112539|NCT03162796|38250714|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
17112540|NCT03162796|38250715|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
17112541|NCT03162796|38250713|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
17112542|NCT03162796|38250714|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
17112543|NCT03162796|38250715|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
17112544|NCT03162796|38250713|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
17112545|NCT03162796|38250714|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
17112546|NCT03162796|38250715|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
17112547|NCT03162796|38250713|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
17112548|NCT03162796|38250714|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
17112549|NCT03162796|38250715|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
17112550|NCT03162796|38250713|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
17112551|NCT03162796|38250714|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
17112552|NCT03162796|38250715|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
17112553|NCT03162796|38250713|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
17112554|NCT03162796|38250714|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
17112555|NCT03162796|38250715|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
17112556|NCT03162796|38250713|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
17112557|NCT03162796|38250714|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
17112558|NCT03162796|38250715|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
17112559|NCT03162796|38250713|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
17112560|NCT03162796|38250714|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
17112561|NCT03162796|38250715|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
17112562|NCT03162796|38250713|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
17112563|NCT03162796|38250714|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
17112564|NCT03162796|38250715|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
17112565|NCT03162796|38250713|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
17112566|NCT03162796|38250714|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
17112567|NCT03162796|38250715|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
17112568|NCT03162796|38250713|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
17112569|NCT03162796|38250714|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
17112570|NCT03162796|38250715|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
17112571|NCT03162328|38250728|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
17112572|NCT03162328|38250729|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
17112573|NCT03162328|38250730|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
17112574|NCT03162328|38250728|FG000|Screening Period|Withdrawal by Subject|1|||
17112575|NCT03162328|38250729|FG001|Screening Period|Withdrawal by Subject|0|||
17112576|NCT03162328|38250730|FG002|Screening Period|Withdrawal by Subject|0|||
17112577|NCT03162328|38250728|FG000|Study Period|Withdrawal by Subject|0|||
17112578|NCT03162328|38250729|FG001|Study Period|Withdrawal by Subject|0|||
17112579|NCT03162328|38250730|FG002|Study Period|Withdrawal by Subject|1|||
17112580|NCT00272987|38250744|FG000|Overall Study|Adverse Event|1|||
17112581|NCT00272987|38250745|FG001|Overall Study|Adverse Event|0|||
17112582|NCT00272987|38250746|FG002|Overall Study|Adverse Event|0|||
17112583|NCT00272987|38250744|FG000|Overall Study|Lost to Follow-up|3|||
17112584|NCT00272987|38250745|FG001|Overall Study|Lost to Follow-up|1|||
17112585|NCT00272987|38250746|FG002|Overall Study|Lost to Follow-up|1|||
17112586|NCT00272987|38250744|FG000|Overall Study|Withdrawal by Subject|1|||
17112587|NCT00272987|38250745|FG001|Overall Study|Withdrawal by Subject|0|||
17112588|NCT00272987|38250746|FG002|Overall Study|Withdrawal by Subject|3|||
17112589|NCT00272987|38250744|FG000|Overall Study|Sponsor Terminated study|0|||
17112590|NCT00272987|38250745|FG001|Overall Study|Sponsor Terminated study|1|||
17112591|NCT00272987|38250746|FG002|Overall Study|Sponsor Terminated study|1|||
17112592|NCT00272987|38250744|FG000|Overall Study|Disease progression|1|||
17112593|NCT00272987|38250745|FG001|Overall Study|Disease progression|1|||
17112594|NCT00272987|38250746|FG002|Overall Study|Disease progression|2|||
17112595|NCT00272987|38250744|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
17112596|NCT00272987|38250745|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
17112597|NCT00272987|38250746|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
17112598|NCT00272987|38250744|FG000|Overall Study|Death|1|||
17112599|NCT00272987|38250745|FG001|Overall Study|Death|0|||
17112600|NCT00272987|38250746|FG002|Overall Study|Death|0|||
17112601|NCT01730950|38250756|FG000|Overall Study|Protocol Violation|6|||
17112602|NCT01730950|38250757|FG001|Overall Study|Protocol Violation|6|||
17112603|NCT00271505|38250764|FG000|Overall Study|Screen Failure|3|||
17112604|NCT00271505|38250764|FG000|Overall Study|Adverse Event|1|||
17112605|NCT00271505|38250764|FG000|Overall Study|Death|1|||
17112606|NCT01642186|38250772|FG000|Overall Study|Death|0|||
17112607|NCT01642186|38250773|FG001|Overall Study|Death|2|||
17112608|NCT01642186|38250774|FG002|Overall Study|Death|2|||
17112609|NCT01642186|38250772|FG000|Overall Study|Lost to Follow-up|0|||
17112610|NCT01642186|38250773|FG001|Overall Study|Lost to Follow-up|0|||
17112611|NCT01642186|38250774|FG002|Overall Study|Lost to Follow-up|1|||
17112612|NCT00423514|38250784|FG000|Overall Study|Ineligible|1|||
17112613|NCT00423514|38250785|FG001|Overall Study|Ineligible|0|||
17112614|NCT00289991|38250793|FG000|Overall Study|Death|35|||
17112615|NCT00289991|38250794|FG001|Overall Study|Death|38|||
17112616|NCT00289991|38250793|FG000|Overall Study|Adverse Event|15|||
17112617|NCT00289991|38250794|FG001|Overall Study|Adverse Event|13|||
17112618|NCT00289991|38250793|FG000|Overall Study|Failure of prophylaxis|1|||
17112619|NCT00289991|38250794|FG001|Overall Study|Failure of prophylaxis|1|||
17112620|NCT00289991|38250793|FG000|Overall Study|Fungal breakthrough infection|0|||
17112621|NCT00289991|38250794|FG001|Overall Study|Fungal breakthrough infection|1|||
17112622|NCT00289991|38250793|FG000|Overall Study|Lost to Follow-up|0|||
17112623|NCT00289991|38250794|FG001|Overall Study|Lost to Follow-up|1|||
17112624|NCT00289991|38250793|FG000|Overall Study|Withdrawal by Subject|2|||
17112625|NCT00289991|38250794|FG001|Overall Study|Withdrawal by Subject|12|||
17112626|NCT00289991|38250793|FG000|Overall Study|Other|5|||
17112627|NCT00289991|38250794|FG001|Overall Study|Other|14|||
17112628|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112629|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
17112630|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112631|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112632|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112633|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
17112634|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
17112635|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
17112636|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
17112637|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
17112638|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
17112639|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
17112640|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
17112641|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
17112642|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
17112643|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
17112644|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
17112645|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
17112646|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
17112647|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
17112648|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112649|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112650|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112651|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
17112652|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112653|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
17112654|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
17112655|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
17112656|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
17112657|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
17112658|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
17112659|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
17112660|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
17112661|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
17112662|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
17112663|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
17112664|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
17112665|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
17112666|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
17112667|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
17112668|NCT00289913|38250805|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
17112669|NCT00289913|38250806|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
17112670|NCT00289913|38250807|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
17112671|NCT00289913|38250808|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
17112672|NCT00289913|38250809|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
17112673|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112674|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112675|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
17112676|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112677|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112678|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
17112679|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
17112680|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
17112681|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
17112682|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
17112683|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
17112684|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
17112685|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
17112686|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
17112687|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
17112688|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
17112689|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
17112690|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
17112691|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
17112692|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
17112693|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
17112694|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112695|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
17112696|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112697|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112698|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
17112699|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
17112700|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
17112701|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
17112702|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
17112703|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
17112704|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
17112705|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
17112706|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
17112707|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
17112708|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
17112709|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
17112710|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
17112711|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
17112712|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
17112713|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
17112714|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
17112715|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
17112716|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
17112717|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
17112718|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
17112719|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
17112720|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
17112721|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
17112722|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
17112723|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
17112724|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
17112725|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
17112726|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
17112727|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
17112728|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
17112729|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
17112730|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
17112731|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
17112732|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
17112733|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
17112734|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
17112735|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
17112736|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
17112737|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
17112738|NCT00289913|38250805|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
17112739|NCT00289913|38250806|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
17112740|NCT00289913|38250807|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
17112741|NCT00289913|38250808|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
17112742|NCT00289913|38250809|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
17112743|NCT00289913|38250805|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112744|NCT00289913|38250806|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
17112745|NCT00289913|38250807|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112746|NCT00289913|38250808|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112747|NCT00289913|38250809|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
17112748|NCT00289913|38250805|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
17112749|NCT00289913|38250806|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
17112750|NCT00289913|38250807|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
17112751|NCT00289913|38250808|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
17112752|NCT00289913|38250809|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
17112753|NCT00289913|38250805|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
17112754|NCT00289913|38250806|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
17112755|NCT00289913|38250807|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
17112756|NCT00289913|38250808|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
17112757|NCT00289913|38250809|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
17112758|NCT00289913|38250805|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112759|NCT00289913|38250806|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112760|NCT00289913|38250807|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112761|NCT00289913|38250808|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
17112762|NCT00289913|38250809|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
17112763|NCT00289913|38250805|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
17112764|NCT00289913|38250806|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
17112765|NCT00289913|38250807|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
17112766|NCT00289913|38250808|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
17112767|NCT00289913|38250809|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
17112768|NCT00289913|38250805|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
17112769|NCT00289913|38250806|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
17112770|NCT00289913|38250807|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
17112771|NCT00289913|38250808|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
17112772|NCT00289913|38250809|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
17112773|NCT00289913|38250805|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
17112774|NCT00289913|38250806|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
17112775|NCT00289913|38250807|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
17112776|NCT00289913|38250808|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
17112777|NCT00289913|38250809|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
17112778|NCT00289913|38250805|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
17112779|NCT00289913|38250806|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
17112780|NCT00289913|38250807|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
17112781|NCT00289913|38250808|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
17112782|NCT00289913|38250809|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
17112783|NCT00289289|38250827|FG000|Overall Study|Withdrawal by Subject|5|||
17112784|NCT00289289|38250828|FG001|Overall Study|Withdrawal by Subject|3|||
17112785|NCT00289289|38250829|FG002|Overall Study|Withdrawal by Subject|15|||
17112786|NCT00289289|38250827|FG000|Overall Study|Lost to Follow-up|1|||
17112787|NCT00289289|38250828|FG001|Overall Study|Lost to Follow-up|0|||
17112788|NCT00289289|38250829|FG002|Overall Study|Lost to Follow-up|1|||
17112789|NCT00289289|38250827|FG000|Overall Study|Death|4|||
17112790|NCT00289289|38250828|FG001|Overall Study|Death|2|||
17112791|NCT00289289|38250829|FG002|Overall Study|Death|5|||
17112792|NCT00289289|38250827|FG000|Overall Study|No implant attempted|0|||
17112793|NCT00289289|38250828|FG001|Overall Study|No implant attempted|0|||
17112794|NCT00289289|38250829|FG002|Overall Study|No implant attempted|1|||
17112795|NCT00289289|38250827|FG000|Overall Study|Physician Decision|1|||
17112796|NCT00289289|38250828|FG001|Overall Study|Physician Decision|0|||
17112797|NCT00289289|38250829|FG002|Overall Study|Physician Decision|6|||
17112798|NCT00289289|38250827|FG000|Overall Study|Non-study device implanted|2|||
17112799|NCT00289289|38250828|FG001|Overall Study|Non-study device implanted|1|||
17112800|NCT00289289|38250829|FG002|Overall Study|Non-study device implanted|3|||
17112801|NCT00289289|38250827|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
17112802|NCT00289289|38250828|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
17112803|NCT00289289|38250829|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
17112804|NCT00289289|38250827|FG000|Overall Study|Other Exit Reason|6|||
17112805|NCT00289289|38250828|FG001|Overall Study|Other Exit Reason|4|||
17112806|NCT00289289|38250829|FG002|Overall Study|Other Exit Reason|12|||
17112807|NCT00270257|38250838|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
17112808|NCT00270257|38250839|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
17112809|NCT00269633|38250849|FG000|Overall Study|Withdrawal by Subject|1|||
17112810|NCT00269633|38250850|FG001|Overall Study|Withdrawal by Subject|0|||
17112811|NCT00269477|38250860|FG000|Overall Study|Protocol Violation|5|||
17112812|NCT00269477|38250861|FG001|Overall Study|Protocol Violation|5|||
17112813|NCT00269477|38250862|FG002|Overall Study|Protocol Violation|1|||
17112814|NCT00269477|38250863|FG003|Overall Study|Protocol Violation|0|||
17112815|NCT00269477|38250860|FG000|Overall Study|Missed post-vaccination blood draw|0|||
17112816|NCT00269477|38250861|FG001|Overall Study|Missed post-vaccination blood draw|1|||
17112817|NCT00269477|38250862|FG002|Overall Study|Missed post-vaccination blood draw|0|||
17112818|NCT00269477|38250863|FG003|Overall Study|Missed post-vaccination blood draw|0|||
17112819|NCT00269399|38250875|FG000|Overall Study|Lack of Efficacy|27|||
17112820|NCT00269399|38250876|FG001|Overall Study|Lack of Efficacy|10|||
17112821|NCT00269399|38250875|FG000|Overall Study|Adverse Event|10|||
17112822|NCT00269399|38250876|FG001|Overall Study|Adverse Event|4|||
17112823|NCT00269399|38250875|FG000|Overall Study|Withdrawal by Subject|2|||
17112824|NCT00269399|38250876|FG001|Overall Study|Withdrawal by Subject|5|||
17112825|NCT00269399|38250875|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
17112826|NCT00269399|38250876|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
17112827|NCT00269399|38250875|FG000|Overall Study|Other|0|||
17112828|NCT00269399|38250876|FG001|Overall Study|Other|4|||
17112829|NCT00269399|38250875|FG000|Overall Study|Development of exclusion criteria|0|||
17112830|NCT00269399|38250876|FG001|Overall Study|Development of exclusion criteria|1|||
17112831|NCT00269087|38250882|FG000|Overall Study|Adverse Event|20|||
17112832|NCT00269087|38250882|FG000|Overall Study|Withdrawal by Subject|1|||
17112833|NCT00269087|38250882|FG000|Overall Study|Exacerbation of COPD|13|||
17112834|NCT00289133|38250888|FG000|Overall Study|Non-study device implanted|12|||
17112835|NCT00289133|38250889|FG001|Overall Study|Non-study device implanted|0|||
17112836|NCT00289133|38250888|FG000|Overall Study|Protocol Violation|32|||
17112837|NCT00289133|38250889|FG001|Overall Study|Protocol Violation|38|||
17112838|NCT00289133|38250888|FG000|Overall Study|Withdrawal by Subject|9|||
17112839|NCT00289133|38250889|FG001|Overall Study|Withdrawal by Subject|10|||
17112840|NCT00289133|38250888|FG000|Overall Study|Death|5|||
17112841|NCT00289133|38250889|FG001|Overall Study|Death|10|||
17112842|NCT00289133|38250888|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
17112843|NCT00289133|38250889|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
17112844|NCT00289133|38250888|FG000|Overall Study|Physician Decision|41|||
17112845|NCT00289133|38250889|FG001|Overall Study|Physician Decision|45|||
17112846|NCT00289133|38250888|FG000|Overall Study|Revision|8|||
17112847|NCT00289133|38250889|FG001|Overall Study|Revision|6|||
17112848|NCT00289133|38250888|FG000|Overall Study|Lost to Follow-up|92|||
17112849|NCT00289133|38250889|FG001|Overall Study|Lost to Follow-up|115|||
17112850|NCT00288587|38250901|FG000|Overall Study|Death|4|||
17112851|NCT00288587|38250902|FG001|Overall Study|Death|4|||
17112852|NCT00288587|38250901|FG000|Overall Study|Transplant|0|||
17112853|NCT00288587|38250902|FG001|Overall Study|Transplant|3|||
17112854|NCT00288587|38250901|FG000|Overall Study|Adverse Event|0|||
17112855|NCT00288587|38250902|FG001|Overall Study|Adverse Event|1|||
17112856|NCT00288587|38250901|FG000|Overall Study|Physician Decision|0|||
17112857|NCT00288587|38250902|FG001|Overall Study|Physician Decision|2|||
17112858|NCT00288587|38250901|FG000|Overall Study|Severe Aortic Stenosis|1|||
17112859|NCT00288587|38250902|FG001|Overall Study|Severe Aortic Stenosis|0|||
17112860|NCT00268463|38250910|FG000|Overall Study|study terminated due to low accrual|10|||
17112861|NCT00268463|38250911|FG001|Overall Study|study terminated due to low accrual|12|||
17112862|NCT00288509|38250917|FG000|Treatment Cycle 1|Adverse Event|1|||
17112863|NCT00288509|38250917|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
17112864|NCT00288509|38250917|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
17112865|NCT00288509|38250917|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
17112866|NCT00288509|38250917|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
17112867|NCT00288509|38250917|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
17112868|NCT00288509|38250917|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
17112869|NCT00288509|38250917|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
17112870|NCT00288509|38250917|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
17112871|NCT00288509|38250917|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
17112872|NCT00288509|38250917|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
17112873|NCT00288509|38250917|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
17112874|NCT00288509|38250917|FG000|Treatment Cycle 4|Physician Decision|4|||
17112875|NCT00288509|38250917|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
17112876|NCT00266825|38250923|FG000|Completed Follow-Up|Lost to Follow-up|14|||
17112877|NCT00266825|38250924|FG001|Completed Follow-Up|Lost to Follow-up|19|||
17112878|NCT00266825|38250923|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
17112879|NCT00266825|38250924|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
17112880|NCT00265889|38250932|FG000|Overall Study|Physician Decision|1|||
17112881|NCT00265889|38250932|FG000|Overall Study|Protocol Violation|1|||
17112882|NCT00265889|38250932|FG000|Overall Study|Insurance denied the request|3|||
17112883|NCT02795182|38250940|FG000|Overall Study|Death|5|||
17112884|NCT02795182|38250941|FG001|Overall Study|Death|4|||
17112885|NCT02795182|38250942|FG002|Overall Study|Death|4|||
17112886|NCT02795182|38250943|FG003|Overall Study|Death|18|||
17112887|NCT02795182|38250940|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
17112888|NCT02795182|38250941|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
17112889|NCT02795182|38250942|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
17112890|NCT02795182|38250943|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
17112891|NCT02795182|38250940|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
17112892|NCT02795182|38250941|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
17112893|NCT02795182|38250942|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
17112894|NCT02795182|38250943|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
17112895|NCT02795182|38250940|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
17112896|NCT02795182|38250941|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
17112897|NCT02795182|38250942|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
17112898|NCT02795182|38250943|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
17112899|NCT02795182|38250940|FG000|Overall Study|Withdrawal by Subject|4|||
17112900|NCT02795182|38250941|FG001|Overall Study|Withdrawal by Subject|0|||
17112901|NCT02795182|38250942|FG002|Overall Study|Withdrawal by Subject|0|||
17112902|NCT02795182|38250943|FG003|Overall Study|Withdrawal by Subject|3|||
17112903|NCT02795182|38250940|FG000|Overall Study|Lost to Follow-up|0|||
17112904|NCT02795182|38250941|FG001|Overall Study|Lost to Follow-up|0|||
17112905|NCT02795182|38250942|FG002|Overall Study|Lost to Follow-up|1|||
17112906|NCT02795182|38250943|FG003|Overall Study|Lost to Follow-up|1|||
17112907|NCT02795182|38250940|FG000|Overall Study|Roll Over to Long Term Extension|3|||
17112908|NCT02795182|38250941|FG001|Overall Study|Roll Over to Long Term Extension|3|||
17112909|NCT02795182|38250942|FG002|Overall Study|Roll Over to Long Term Extension|2|||
17112910|NCT02795182|38250943|FG003|Overall Study|Roll Over to Long Term Extension|5|||
17112911|NCT02795182|38250940|FG000|Overall Study|Progressive Disease|0|||
17112912|NCT02795182|38250941|FG001|Overall Study|Progressive Disease|1|||
17112913|NCT02795182|38250942|FG002|Overall Study|Progressive Disease|0|||
17112914|NCT02795182|38250943|FG003|Overall Study|Progressive Disease|4|||
17112915|NCT02795182|38250940|FG000|Overall Study|Physician Decision|0|||
17112916|NCT02795182|38250941|FG001|Overall Study|Physician Decision|0|||
17112917|NCT02795182|38250942|FG002|Overall Study|Physician Decision|0|||
17112918|NCT02795182|38250943|FG003|Overall Study|Physician Decision|1|||
17112919|NCT03209362|38250962|FG000|Overall Study|Adverse Event|0|||
17112920|NCT03209362|38250963|FG001|Overall Study|Adverse Event|1|||
17112921|NCT03209362|38250962|FG000|Overall Study|Lost to Follow-up|0|||
17112922|NCT03209362|38250963|FG001|Overall Study|Lost to Follow-up|1|||
17112923|NCT03209362|38250962|FG000|Overall Study|Withdrawal by Subject|2|||
17112924|NCT03209362|38250963|FG001|Overall Study|Withdrawal by Subject|0|||
17112925|NCT03209362|38250962|FG000|Overall Study|Other|0|||
17112926|NCT03209362|38250963|FG001|Overall Study|Other|1|||
17112927|NCT02932462|38250971|FG000|Overall Study|Adverse Event|1|||
17112928|NCT02932462|38250972|FG001|Overall Study|Adverse Event|2|||
17112929|NCT02932462|38250971|FG000|Overall Study|Lost to Follow-up|4|||
17112930|NCT02932462|38250972|FG001|Overall Study|Lost to Follow-up|1|||
17112931|NCT02932462|38250971|FG000|Overall Study|Protocol Violation|0|||
17112932|NCT02932462|38250972|FG001|Overall Study|Protocol Violation|5|||
17112933|NCT02932462|38250971|FG000|Overall Study|Withdrawal by Subject|1|||
17112934|NCT02932462|38250972|FG001|Overall Study|Withdrawal by Subject|4|||
17112935|NCT02932462|38250971|FG000|Overall Study|Non-Compliance With Study Drug|0|||
17112936|NCT02932462|38250972|FG001|Overall Study|Non-Compliance With Study Drug|1|||
17112937|NCT02932462|38250971|FG000|Overall Study|Progressive Disease|1|||
17112938|NCT02932462|38250972|FG001|Overall Study|Progressive Disease|0|||
17112939|NCT03206788|38250980|FG000|Overall Study|Withdrawal by Subject|0|||
17112940|NCT03206788|38250981|FG001|Overall Study|Withdrawal by Subject|1|||
17112941|NCT03206788|38250980|FG000|Overall Study|Adverse Event|0|||
17112942|NCT03206788|38250981|FG001|Overall Study|Adverse Event|1|||
17112943|NCT03206788|38250980|FG000|Overall Study|Physician Decision|0|||
17112944|NCT03206788|38250981|FG001|Overall Study|Physician Decision|1|||
17112945|NCT03205150|38250990|FG000|Overall Study|Protocol deviation|1|||
17112946|NCT03205150|38250991|FG001|Overall Study|Protocol deviation|3|||
17112947|NCT03205150|38250992|FG002|Overall Study|Protocol deviation|0|||
17112948|NCT03205150|38250990|FG000|Overall Study|Patient/guardian decision|0|||
17112949|NCT03205150|38250991|FG001|Overall Study|Patient/guardian decision|3|||
17112950|NCT03205150|38250992|FG002|Overall Study|Patient/guardian decision|0|||
17112951|NCT03205150|38250990|FG000|Overall Study|Adverse Event|1|||
17112952|NCT03205150|38250991|FG001|Overall Study|Adverse Event|1|||
17112953|NCT03205150|38250992|FG002|Overall Study|Adverse Event|1|||
17112954|NCT03205150|38250990|FG000|Overall Study|Lost to Follow-up|0|||
17112955|NCT03205150|38250991|FG001|Overall Study|Lost to Follow-up|0|||
17112956|NCT03205150|38250992|FG002|Overall Study|Lost to Follow-up|1|||
17112957|NCT02932306|38251003|FG000|Overall Study|Withdrawal by Subject|16|||
17112958|NCT02932306|38251004|FG001|Overall Study|Withdrawal by Subject|25|||
17112959|NCT02932306|38251003|FG000|Overall Study|Adverse Event|3|||
17112960|NCT02932306|38251004|FG001|Overall Study|Adverse Event|0|||
17112961|NCT02932306|38251003|FG000|Overall Study|Pregnancy|2|||
17112962|NCT02932306|38251004|FG001|Overall Study|Pregnancy|0|||
17112963|NCT02932306|38251003|FG000|Overall Study|Protocol Violation|1|||
17112964|NCT02932306|38251004|FG001|Overall Study|Protocol Violation|1|||
17112965|NCT02932306|38251003|FG000|Overall Study|Noncompliance with Study Drug|1|||
17112966|NCT02932306|38251004|FG001|Overall Study|Noncompliance with Study Drug|1|||
17112967|NCT02932306|38251003|FG000|Overall Study|Lost to Follow-up|36|||
17112968|NCT02932306|38251004|FG001|Overall Study|Lost to Follow-up|40|||
17112969|NCT02932306|38251003|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
17112970|NCT02932306|38251004|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
17112971|NCT02932306|38251003|FG000|Overall Study|Lack of Efficacy|0|||
17112972|NCT02932306|38251004|FG001|Overall Study|Lack of Efficacy|2|||
17112973|NCT02932306|38251003|FG000|Overall Study|Worsening condition|2|||
17112974|NCT02932306|38251004|FG001|Overall Study|Worsening condition|0|||
17112975|NCT02932306|38251003|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
17112976|NCT02932306|38251004|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
17112977|NCT02932228|38251012|FG000|Overall Study|Death|8|||
17112978|NCT02932228|38251013|FG001|Overall Study|Death|23|||
17112979|NCT02932228|38251012|FG000|Overall Study|not eligible upon chart review|2|||
17112980|NCT02932228|38251013|FG001|Overall Study|not eligible upon chart review|5|||
17112981|NCT02931838|38251027|FG000|Overall Study|Reason not provided by investigator|1|||
17112982|NCT02931838|38251028|FG001|Overall Study|Reason not provided by investigator|0|||
17112983|NCT02931838|38251029|FG002|Overall Study|Reason not provided by investigator|1|||
17112984|NCT02931838|38251030|FG003|Overall Study|Reason not provided by investigator|0|||
17112985|NCT02931838|38251031|FG004|Overall Study|Reason not provided by investigator|0|||
17112986|NCT02931838|38251032|FG005|Overall Study|Reason not provided by investigator|0|||
17112987|NCT02931838|38251027|FG000|Overall Study|Poor/non-compliance|0|||
17112988|NCT02931838|38251028|FG001|Overall Study|Poor/non-compliance|0|||
17112989|NCT02931838|38251029|FG002|Overall Study|Poor/non-compliance|1|||
17112990|NCT02931838|38251030|FG003|Overall Study|Poor/non-compliance|0|||
17112991|NCT02931838|38251031|FG004|Overall Study|Poor/non-compliance|0|||
17112992|NCT02931838|38251032|FG005|Overall Study|Poor/non-compliance|0|||
17112993|NCT02931838|38251027|FG000|Overall Study|Lack of Efficacy|5|||
17112994|NCT02931838|38251028|FG001|Overall Study|Lack of Efficacy|4|||
17112995|NCT02931838|38251029|FG002|Overall Study|Lack of Efficacy|0|||
17112996|NCT02931838|38251030|FG003|Overall Study|Lack of Efficacy|0|||
17112997|NCT02931838|38251031|FG004|Overall Study|Lack of Efficacy|0|||
17112998|NCT02931838|38251032|FG005|Overall Study|Lack of Efficacy|1|||
17112999|NCT02931838|38251027|FG000|Overall Study|Lost to Follow-up|1|||
17113000|NCT02931838|38251028|FG001|Overall Study|Lost to Follow-up|0|||
17113001|NCT02931838|38251029|FG002|Overall Study|Lost to Follow-up|1|||
17113002|NCT02931838|38251030|FG003|Overall Study|Lost to Follow-up|1|||
17113003|NCT02931838|38251031|FG004|Overall Study|Lost to Follow-up|2|||
17113004|NCT02931838|38251032|FG005|Overall Study|Lost to Follow-up|0|||
17113005|NCT02931838|38251027|FG000|Overall Study|Subject request to discontinue treatment|4|||
17113006|NCT02931838|38251028|FG001|Overall Study|Subject request to discontinue treatment|3|||
17113007|NCT02931838|38251029|FG002|Overall Study|Subject request to discontinue treatment|3|||
17113008|NCT02931838|38251030|FG003|Overall Study|Subject request to discontinue treatment|0|||
17113009|NCT02931838|38251031|FG004|Overall Study|Subject request to discontinue treatment|1|||
17113010|NCT02931838|38251032|FG005|Overall Study|Subject request to discontinue treatment|0|||
17113011|NCT02931838|38251027|FG000|Overall Study|Withdrawal by Subject|1|||
17113012|NCT02931838|38251028|FG001|Overall Study|Withdrawal by Subject|2|||
17113013|NCT02931838|38251029|FG002|Overall Study|Withdrawal by Subject|0|||
17113014|NCT02931838|38251030|FG003|Overall Study|Withdrawal by Subject|1|||
17113015|NCT02931838|38251031|FG004|Overall Study|Withdrawal by Subject|0|||
17113016|NCT02931838|38251032|FG005|Overall Study|Withdrawal by Subject|0|||
17113017|NCT02931838|38251027|FG000|Overall Study|Adverse Event|2|||
17113018|NCT02931838|38251028|FG001|Overall Study|Adverse Event|1|||
17113019|NCT02931838|38251029|FG002|Overall Study|Adverse Event|2|||
17113020|NCT02931838|38251030|FG003|Overall Study|Adverse Event|1|||
17113021|NCT02931838|38251031|FG004|Overall Study|Adverse Event|3|||
17113022|NCT02931838|38251032|FG005|Overall Study|Adverse Event|1|||
17113023|NCT03201562|38251054|FG000|Overall Study|Physician Decision|0|||
17113024|NCT03201562|38251055|FG001|Overall Study|Physician Decision|0|||
17113025|NCT03201562|38251056|FG002|Overall Study|Physician Decision|1|||
17113026|NCT03201562|38251054|FG000|Overall Study|Adverse Event|0|||
17113027|NCT03201562|38251055|FG001|Overall Study|Adverse Event|0|||
17113028|NCT03201562|38251056|FG002|Overall Study|Adverse Event|1|||
17113029|NCT03201562|38251054|FG000|Overall Study|Lost to Follow-up|0|||
17113030|NCT03201562|38251055|FG001|Overall Study|Lost to Follow-up|1|||
17113031|NCT03201562|38251056|FG002|Overall Study|Lost to Follow-up|2|||
17113032|NCT03200860|38251066|FG000|Overall Study|Withdrawal by Subject|1|||
17113033|NCT03200860|38251067|FG001|Overall Study|Withdrawal by Subject|0|||
17113034|NCT03198754|38251075|FG000|Overall Study|Withdrawal by Subject|5|||
17113035|NCT03198754|38251076|FG001|Overall Study|Withdrawal by Subject|4|||
17113036|NCT03198754|38251075|FG000|Overall Study|Lost to Follow-up|4|||
17113037|NCT03198754|38251076|FG001|Overall Study|Lost to Follow-up|3|||
17113038|NCT03198754|38251075|FG000|Overall Study|Ineligible|2|||
17113039|NCT03198754|38251076|FG001|Overall Study|Ineligible|1|||
17113040|NCT03198520|38251082|FG000|Overall Study|Physician Decision|2|||
17113041|NCT03198520|38251082|FG000|Overall Study|Protocol Violation|2|||
17113042|NCT03198520|38251082|FG000|Overall Study|Withdrawal by Subject|1|||
17113043|NCT03198520|38251082|FG000|Overall Study|Study Ended|1|||
17113044|NCT03194464|38251094|FG000|Overall Study|data not usable|2|||
17113045|NCT03192904|38251102|FG000|Overall Study|Physician Decision|3|||
17113046|NCT03192904|38251103|FG001|Overall Study|Physician Decision|1|||
17113047|NCT03192904|38251102|FG000|Overall Study|Lost to Follow-up|0|||
17113048|NCT03192904|38251103|FG001|Overall Study|Lost to Follow-up|1|||
17113049|NCT03268954|38251111|FG000|Overall Study|Ongoing|23|||
17113050|NCT03268954|38251112|FG001|Overall Study|Ongoing|31|||
17113051|NCT03268954|38251111|FG000|Overall Study|Adverse Event|53|||
17113052|NCT03268954|38251112|FG001|Overall Study|Adverse Event|62|||
17113053|NCT03268954|38251111|FG000|Overall Study|Withdrawal by Subject|25|||
17113054|NCT03268954|38251112|FG001|Overall Study|Withdrawal by Subject|16|||
17113055|NCT03268954|38251111|FG000|Overall Study|Progressive Disease|61|||
17113056|NCT03268954|38251112|FG001|Overall Study|Progressive Disease|48|||
17113057|NCT03268954|38251111|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
17113058|NCT03268954|38251112|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
17113059|NCT03268954|38251111|FG000|Overall Study|Reason not Specified|40|||
17113060|NCT03268954|38251112|FG001|Overall Study|Reason not Specified|40|||
17113061|NCT03188536|38251118|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
17113062|NCT03188536|38251118|FG000|Overall Study|Not participated/met inclusion criteria|1|||
17113063|NCT03187756|38251122|FG000|Overall Study|Termination of study|4|||
17113064|NCT03187132|38251128|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
17113065|NCT03187132|38251129|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
17113066|NCT03187132|38251128|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
17113067|NCT03187132|38251129|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
17113068|NCT03187132|38251128|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
17113069|NCT03187132|38251129|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
17113070|NCT03187132|38251128|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
17113071|NCT03187132|38251129|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
17113072|NCT03187132|38251128|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
17113073|NCT03187132|38251129|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
17113074|NCT03187132|38251128|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
17113075|NCT03187132|38251129|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
17113076|NCT03187132|38251128|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
17113077|NCT03187132|38251129|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
17113078|NCT03187132|38251128|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
17113079|NCT03187132|38251129|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
17113080|NCT03187132|38251128|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
17113081|NCT03187132|38251129|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
17113082|NCT03187132|38251128|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
17113083|NCT03187132|38251129|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
17113084|NCT03187132|38251128|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
17113085|NCT03187132|38251129|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
17113086|NCT03184558|38251135|FG000|Overall Study|Withdrawal by Subject|2|||
17113087|NCT03184558|38251135|FG000|Overall Study|Death|16|||
17113088|NCT03184558|38251135|FG000|Overall Study|Lost to Follow-up|2|||
17113089|NCT03184558|38251135|FG000|Overall Study|Other|9|||
17113090|NCT03183778|38251139|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
17113091|NCT03182686|38251145|FG000|Overall Study|Lost to Follow-up|2|||
17113092|NCT03182686|38251146|FG001|Overall Study|Lost to Follow-up|0|||
17113093|NCT03182686|38251145|FG000|Overall Study|Adverse Event|2|||
17113094|NCT03182686|38251146|FG001|Overall Study|Adverse Event|0|||
17113095|NCT03182686|38251145|FG000|Overall Study|Withdrawal by Subject|3|||
17113096|NCT03182686|38251146|FG001|Overall Study|Withdrawal by Subject|0|||
17113097|NCT03181594|38251152|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
17113098|NCT03181594|38251152|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
17113099|NCT03181594|38251152|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
17113100|NCT03181594|38251152|FG000|Initial Study Protocol (12-month FU)|Death|1|||
17113101|NCT03181594|38251152|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
17113102|NCT03181594|38251152|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
17113103|NCT03180736|38251158|FG000|Overall Study|Adverse Event|3|||
17113104|NCT03180736|38251159|FG001|Overall Study|Adverse Event|4|||
17113105|NCT03180736|38251158|FG000|Overall Study|Death|10|||
17113106|NCT03180736|38251159|FG001|Overall Study|Death|7|||
17113107|NCT03180736|38251158|FG000|Overall Study|Withdrawal by Subject|5|||
17113108|NCT03180736|38251159|FG001|Overall Study|Withdrawal by Subject|12|||
17113109|NCT03180736|38251158|FG000|Overall Study|Lost to Follow-up|1|||
17113110|NCT03180736|38251159|FG001|Overall Study|Lost to Follow-up|0|||
17113111|NCT03180736|38251158|FG000|Overall Study|Lack of Efficacy|66|||
17113112|NCT03180736|38251159|FG001|Overall Study|Lack of Efficacy|87|||
17113113|NCT03180736|38251158|FG000|Overall Study|Physician Decision|4|||
17113114|NCT03180736|38251159|FG001|Overall Study|Physician Decision|7|||
17113115|NCT03180736|38251158|FG000|Overall Study|randomized but not treated|2|||
17113116|NCT03180736|38251159|FG001|Overall Study|randomized but not treated|3|||
17113117|NCT03178942|38251172|FG000|Overall Study|Withdrawal by Subject|2|||
17113118|NCT03178942|38251173|FG001|Overall Study|Withdrawal by Subject|0|||
17113119|NCT03178942|38251172|FG000|Overall Study|Lost to Follow-up|1|||
17113120|NCT03178942|38251173|FG001|Overall Study|Lost to Follow-up|2|||
17113121|NCT03175198|38251179|FG000|Overall Study|Adverse Event|480|||
17113122|NCT03175198|38251179|FG000|Overall Study|No actual visit|120|||
17113123|NCT03175198|38251179|FG000|Overall Study|Registration rule not followed|4|||
17113124|NCT03175198|38251179|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
17113125|NCT03175198|38251179|FG000|Overall Study|Other personal reason|509|||
17113126|NCT03175198|38251179|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
17113127|NCT03175198|38251179|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
17113128|NCT03175198|38251179|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
17113129|NCT03175198|38251179|FG000|Overall Study|To conduct invasive treatment of operation|53|||
17113130|NCT03175198|38251179|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
17113131|NCT03175120|38251185|FG000|Overall Study|Adverse Event|2|||
17113132|NCT03175120|38251186|FG001|Overall Study|Adverse Event|2|||
17113133|NCT03175120|38251185|FG000|Overall Study|Protocol Violation|5|||
17113134|NCT03175120|38251186|FG001|Overall Study|Protocol Violation|2|||
17113135|NCT03175120|38251185|FG000|Overall Study|Lost to Follow-up|1|||
17113136|NCT03175120|38251186|FG001|Overall Study|Lost to Follow-up|0|||
17113137|NCT03175120|38251185|FG000|Overall Study|Withdrawal by Subject|2|||
17113138|NCT03175120|38251186|FG001|Overall Study|Withdrawal by Subject|5|||
17113139|NCT03175120|38251185|FG000|Overall Study|Other|2|||
17113140|NCT03175120|38251186|FG001|Overall Study|Other|3|||
17113141|NCT03172702|38251192|FG000|Overall Study|Adverse Event|9|||
17113142|NCT03172702|38251192|FG000|Overall Study|Death|2|||
17113143|NCT03172702|38251192|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
17113144|NCT03172702|38251192|FG000|Overall Study|Withdrawal by Subject|5|||
17113145|NCT03172702|38251192|FG000|Overall Study|Other|2|||
17113146|NCT03167242|38251209|FG000|Overall Study|Patient/Guardian Decision|0|||
17113147|NCT03167242|38251210|FG001|Overall Study|Patient/Guardian Decision|1|||
17113148|NCT03167242|38251211|FG002|Overall Study|Patient/Guardian Decision|2|||
17113149|NCT03167242|38251212|FG003|Overall Study|Patient/Guardian Decision|1|||
17113150|NCT03167242|38251213|FG004|Overall Study|Patient/Guardian Decision|1|||
17113151|NCT03167242|38251214|FG005|Overall Study|Patient/Guardian Decision|1|||
17113152|NCT03167242|38251215|FG006|Overall Study|Patient/Guardian Decision|0|||
17113153|NCT03167242|38251216|FG007|Overall Study|Patient/Guardian Decision|0|||
17113154|NCT03167242|38251217|FG008|Overall Study|Patient/Guardian Decision|0|||
17113155|NCT03167242|38251218|FG009|Overall Study|Patient/Guardian Decision|0|||
17113156|NCT03167242|38251219|FG010|Overall Study|Patient/Guardian Decision|1|||
17113157|NCT03167242|38251220|FG011|Overall Study|Patient/Guardian Decision|0|||
17113158|NCT03167242|38251209|FG000|Overall Study|Lost to Follow-up|0|||
17113159|NCT03167242|38251210|FG001|Overall Study|Lost to Follow-up|0|||
17113160|NCT03167242|38251211|FG002|Overall Study|Lost to Follow-up|1|||
17113161|NCT03167242|38251212|FG003|Overall Study|Lost to Follow-up|0|||
17113162|NCT03167242|38251213|FG004|Overall Study|Lost to Follow-up|0|||
17113163|NCT03167242|38251214|FG005|Overall Study|Lost to Follow-up|1|||
17113164|NCT03167242|38251215|FG006|Overall Study|Lost to Follow-up|2|||
17113165|NCT03167242|38251216|FG007|Overall Study|Lost to Follow-up|1|||
17113166|NCT03167242|38251217|FG008|Overall Study|Lost to Follow-up|0|||
17113167|NCT03167242|38251218|FG009|Overall Study|Lost to Follow-up|0|||
17113168|NCT03167242|38251219|FG010|Overall Study|Lost to Follow-up|1|||
17113169|NCT03167242|38251220|FG011|Overall Study|Lost to Follow-up|1|||
17113170|NCT03167242|38251209|FG000|Overall Study|Reason not provided|0|||
17113171|NCT03167242|38251210|FG001|Overall Study|Reason not provided|0|||
17113172|NCT03167242|38251211|FG002|Overall Study|Reason not provided|0|||
17113173|NCT03167242|38251212|FG003|Overall Study|Reason not provided|0|||
17113174|NCT03167242|38251213|FG004|Overall Study|Reason not provided|0|||
17113175|NCT03167242|38251214|FG005|Overall Study|Reason not provided|0|||
17113176|NCT03167242|38251215|FG006|Overall Study|Reason not provided|0|||
17113177|NCT03167242|38251216|FG007|Overall Study|Reason not provided|0|||
17113178|NCT03167242|38251217|FG008|Overall Study|Reason not provided|1|||
17113179|NCT03167242|38251218|FG009|Overall Study|Reason not provided|0|||
17113180|NCT03167242|38251219|FG010|Overall Study|Reason not provided|0|||
17113181|NCT03167242|38251220|FG011|Overall Study|Reason not provided|0|||
17113182|NCT03286426|38251272|FG000|Overall Study|Physician Decision|3|||
17113183|NCT02882152|38251291|FG000|Overall Study|Lost to Follow-up|1|||
17113184|NCT02882152|38251292|FG001|Overall Study|Lost to Follow-up|0|||
17113185|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
17113186|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
17113187|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
17113188|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
17113189|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Death|58|||
17113190|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Death|65|||
17113191|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Adverse Event|28|||
17113192|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Adverse Event|40|||
17113193|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Disease Progression|22|||
17113194|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Disease Progression|35|||
17113195|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Other|25|||
17113196|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Other|33|||
17113197|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
17113198|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
17113199|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Noncompliance|8|||
17113200|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Noncompliance|8|||
17113201|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
17113202|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
17113203|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
17113204|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
17113205|NCT00286091|38251300|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
17113206|NCT00286091|38251301|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
17113207|NCT00286091|38251300|FG000|Open-label Treatment Phase|Physician Decision|24|||
17113208|NCT00286091|38251301|FG001|Open-label Treatment Phase|Physician Decision|21|||
17113209|NCT00286091|38251300|FG000|Open-label Treatment Phase|Adverse Event|5|||
17113210|NCT00286091|38251301|FG001|Open-label Treatment Phase|Adverse Event|16|||
17113211|NCT00286091|38251300|FG000|Open-label Treatment Phase|Other|11|||
17113212|NCT00286091|38251301|FG001|Open-label Treatment Phase|Other|11|||
17113213|NCT00286091|38251300|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
17113214|NCT00286091|38251301|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
17113215|NCT00286091|38251300|FG000|Open-label Treatment Phase|Death|10|||
17113216|NCT00286091|38251301|FG001|Open-label Treatment Phase|Death|7|||
17113217|NCT00286091|38251300|FG000|Open-label Treatment Phase|Disease Progression|9|||
17113218|NCT00286091|38251301|FG001|Open-label Treatment Phase|Disease Progression|3|||
17113219|NCT00286091|38251300|FG000|Open-label Treatment Phase|Noncompliance|3|||
17113220|NCT00286091|38251301|FG001|Open-label Treatment Phase|Noncompliance|1|||
17113221|NCT00286091|38251300|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
17113222|NCT00286091|38251301|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
17113223|NCT00286091|38251300|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
17113224|NCT00286091|38251301|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
17113225|NCT00286091|38251300|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
17113226|NCT00286091|38251301|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
17113227|NCT00285857|38251309|FG000|Overall Study|Withdrawal by Subject|2|||
17113228|NCT00285857|38251309|FG000|Overall Study|Inadequate initial breast cytology|1|||
17113229|NCT00285857|38251309|FG000|Overall Study|Adverse Event|1|||
17113230|NCT00284141|38251318|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
17113231|NCT00284141|38251318|FG000|Overall Study|Adverse Event|19|||
17113232|NCT00284141|38251318|FG000|Overall Study|Participant's request|9|||
17113233|NCT00284141|38251318|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
17113234|NCT00284141|38251318|FG000|Overall Study|Clinical deterioration / death|2|||
17113235|NCT00284141|38251318|FG000|Overall Study|General decline|1|||
17113236|NCT00284141|38251318|FG000|Overall Study|Pneumonia|1|||
17113237|NCT00284141|38251318|FG000|Overall Study|Did not take study medication|2|||
17113238|NCT00284141|38251318|FG000|Overall Study|Ongoing treatment|2|||
17113239|NCT00265343|38251326|FG000|Overall Study|Adverse Event|10|||
17113240|NCT00265343|38251327|FG001|Overall Study|Adverse Event|7|||
17113241|NCT00265343|38251326|FG000|Overall Study|Withdrawal by Subject|3|||
17113242|NCT00265343|38251327|FG001|Overall Study|Withdrawal by Subject|9|||
17113243|NCT00265343|38251326|FG000|Overall Study|Other|8|||
17113244|NCT00265343|38251327|FG001|Overall Study|Other|3|||
17113245|NCT00283595|38251335|FG000|Overall Study|Withdrawal by Subject|1|||
17113246|NCT00283595|38251336|FG001|Overall Study|Withdrawal by Subject|2|||
17113247|NCT00265109|38251342|FG000|Overall Study|Withdrawal by Subject|5|||
17113248|NCT00265109|38251342|FG000|Overall Study|Adverse Event|1|||
17113249|NCT03235024|38251349|FG000|Overall Study|Adverse Event|2|||
17113250|NCT03235024|38251350|FG001|Overall Study|Adverse Event|2|||
17113251|NCT03235024|38251349|FG000|Overall Study|Death|1|||
17113252|NCT03235024|38251350|FG001|Overall Study|Death|0|||
17113253|NCT03235024|38251349|FG000|Overall Study|Lost to Follow-up|2|||
17113254|NCT03235024|38251350|FG001|Overall Study|Lost to Follow-up|5|||
17113255|NCT03235024|38251349|FG000|Overall Study|Protocol Violation|1|||
17113256|NCT03235024|38251350|FG001|Overall Study|Protocol Violation|0|||
17113257|NCT03235024|38251349|FG000|Overall Study|Withdrawal by Subject|0|||
17113258|NCT03235024|38251350|FG001|Overall Study|Withdrawal by Subject|3|||
17113259|NCT03233308|38251356|FG000|Overall Study|Adverse Event|1|||
17113260|NCT03233308|38251356|FG000|Overall Study|Protocol Violation|1|||
17113261|NCT00283439|38251371|FG000|Overall Study|Adverse Event|0|||
17113262|NCT00283439|38251372|FG001|Overall Study|Adverse Event|0|||
17113263|NCT00283439|38251373|FG002|Overall Study|Adverse Event|0|||
17113264|NCT00283439|38251374|FG003|Overall Study|Adverse Event|1|||
17113265|NCT00283439|38251371|FG000|Overall Study|Death|0|||
17113266|NCT00283439|38251372|FG001|Overall Study|Death|0|||
17113267|NCT00283439|38251373|FG002|Overall Study|Death|1|||
17113268|NCT00283439|38251374|FG003|Overall Study|Death|0|||
17113269|NCT00283439|38251371|FG000|Overall Study|Disease progression|0|||
17113270|NCT00283439|38251372|FG001|Overall Study|Disease progression|1|||
17113271|NCT00283439|38251373|FG002|Overall Study|Disease progression|0|||
17113272|NCT00283439|38251374|FG003|Overall Study|Disease progression|0|||
17113273|NCT00283439|38251371|FG000|Overall Study|Requirement for alternative therapy|1|||
17113274|NCT00283439|38251372|FG001|Overall Study|Requirement for alternative therapy|2|||
17113275|NCT00283439|38251373|FG002|Overall Study|Requirement for alternative therapy|5|||
17113276|NCT00283439|38251374|FG003|Overall Study|Requirement for alternative therapy|2|||
17113277|NCT00283439|38251371|FG000|Overall Study|Stem cell transplant|6|||
17113278|NCT00283439|38251372|FG001|Overall Study|Stem cell transplant|6|||
17113279|NCT00283439|38251373|FG002|Overall Study|Stem cell transplant|4|||
17113280|NCT00283439|38251374|FG003|Overall Study|Stem cell transplant|3|||
17113281|NCT00283439|38251371|FG000|Overall Study|Treatment discontinued|0|||
17113282|NCT00283439|38251372|FG001|Overall Study|Treatment discontinued|2|||
17113283|NCT00283439|38251373|FG002|Overall Study|Treatment discontinued|1|||
17113284|NCT00283439|38251374|FG003|Overall Study|Treatment discontinued|3|||
17113285|NCT00283439|38251371|FG000|Overall Study|Other|1|||
17113286|NCT00283439|38251372|FG001|Overall Study|Other|0|||
17113287|NCT00283439|38251373|FG002|Overall Study|Other|0|||
17113288|NCT00283439|38251374|FG003|Overall Study|Other|0|||
17113289|NCT03233230|38251388|FG000|Overall Study|Adverse Event|6|||
17113290|NCT03233230|38251389|FG001|Overall Study|Adverse Event|3|||
17113291|NCT03233230|38251390|FG002|Overall Study|Adverse Event|6|||
17113292|NCT03233230|38251391|FG003|Overall Study|Adverse Event|3|||
17113293|NCT03233230|38251388|FG000|Overall Study|Protocol Violation|1|||
17113294|NCT03233230|38251389|FG001|Overall Study|Protocol Violation|2|||
17113295|NCT03233230|38251390|FG002|Overall Study|Protocol Violation|1|||
17113296|NCT03233230|38251391|FG003|Overall Study|Protocol Violation|1|||
17113297|NCT03233230|38251388|FG000|Overall Study|Lack of Efficacy|1|||
17113298|NCT03233230|38251389|FG001|Overall Study|Lack of Efficacy|0|||
17113299|NCT03233230|38251390|FG002|Overall Study|Lack of Efficacy|0|||
17113300|NCT03233230|38251391|FG003|Overall Study|Lack of Efficacy|0|||
17113301|NCT03233230|38251388|FG000|Overall Study|Other|5|||
17113302|NCT03233230|38251389|FG001|Overall Study|Other|5|||
17113303|NCT03233230|38251390|FG002|Overall Study|Other|5|||
17113304|NCT03233230|38251391|FG003|Overall Study|Other|3|||
17113305|NCT03233230|38251388|FG000|Overall Study|Withdrawal by Subject|2|||
17113306|NCT03233230|38251389|FG001|Overall Study|Withdrawal by Subject|2|||
17113307|NCT03233230|38251390|FG002|Overall Study|Withdrawal by Subject|0|||
17113308|NCT03233230|38251391|FG003|Overall Study|Withdrawal by Subject|1|||
17113309|NCT03233230|38251388|FG000|Overall Study|Lost to Follow-up|0|||
17113310|NCT03233230|38251389|FG001|Overall Study|Lost to Follow-up|3|||
17113311|NCT03233230|38251390|FG002|Overall Study|Lost to Follow-up|0|||
17113312|NCT03233230|38251391|FG003|Overall Study|Lost to Follow-up|0|||
17113313|NCT00283049|38251404|FG000|Overall Study|Adverse Event|6|||
17113314|NCT00283049|38251405|FG001|Overall Study|Adverse Event|1|||
17113315|NCT00283049|38251406|FG002|Overall Study|Adverse Event|4|||
17113316|NCT00283049|38251404|FG000|Overall Study|Protocol Violation|3|||
17113317|NCT00283049|38251405|FG001|Overall Study|Protocol Violation|0|||
17113318|NCT00283049|38251406|FG002|Overall Study|Protocol Violation|3|||
17113319|NCT00283049|38251404|FG000|Overall Study|Death|1|||
17113320|NCT00283049|38251405|FG001|Overall Study|Death|1|||
17113321|NCT00283049|38251406|FG002|Overall Study|Death|1|||
17113322|NCT00283049|38251404|FG000|Overall Study|Lack of Efficacy|0|||
17113323|NCT00283049|38251405|FG001|Overall Study|Lack of Efficacy|1|||
17113324|NCT00283049|38251406|FG002|Overall Study|Lack of Efficacy|1|||
17113325|NCT00283049|38251404|FG000|Overall Study|Lost to Follow-up|4|||
17113326|NCT00283049|38251405|FG001|Overall Study|Lost to Follow-up|2|||
17113327|NCT00283049|38251406|FG002|Overall Study|Lost to Follow-up|5|||
17113328|NCT00283049|38251404|FG000|Overall Study|Withdrawal by Subject|26|||
17113329|NCT00283049|38251405|FG001|Overall Study|Withdrawal by Subject|24|||
17113330|NCT00283049|38251406|FG002|Overall Study|Withdrawal by Subject|19|||
17113331|NCT00283049|38251404|FG000|Overall Study|Discontinuation of Study|18|||
17113332|NCT00283049|38251405|FG001|Overall Study|Discontinuation of Study|16|||
17113333|NCT00283049|38251406|FG002|Overall Study|Discontinuation of Study|20|||
17113334|NCT00283049|38251404|FG000|Overall Study|No longer requires study treatment|0|||
17113335|NCT00283049|38251405|FG001|Overall Study|No longer requires study treatment|0|||
17113336|NCT00283049|38251406|FG002|Overall Study|No longer requires study treatment|1|||
17113337|NCT00264875|38251414|FG000|Overall Study|Adverse Event|6|||
17113338|NCT00264875|38251414|FG000|Overall Study|Lost to Follow-up|6|||
17113339|NCT00264875|38251414|FG000|Overall Study|Protocol Violation|11|||
17113340|NCT00264875|38251414|FG000|Overall Study|Withdrawal by Subject|7|||
17113341|NCT03152110|38251418|FG000|Overall Study|Withdrawal by Subject|3|||
17113342|NCT03151408|38251425|FG000|Overall Study|Adverse Event|24|||
17113343|NCT03151408|38251426|FG001|Overall Study|Adverse Event|23|||
17113344|NCT03151408|38251425|FG000|Overall Study|Death|46|||
17113345|NCT03151408|38251426|FG001|Overall Study|Death|26|||
17113346|NCT03151408|38251425|FG000|Overall Study|Physician Decision|13|||
17113347|NCT03151408|38251426|FG001|Overall Study|Physician Decision|19|||
17113348|NCT03151408|38251425|FG000|Overall Study|Withdrawal by Subject|16|||
17113349|NCT03151408|38251426|FG001|Overall Study|Withdrawal by Subject|20|||
17113350|NCT03151408|38251425|FG000|Overall Study|Progressive disease|45|||
17113351|NCT03151408|38251426|FG001|Overall Study|Progressive disease|61|||
17113352|NCT03151408|38251425|FG000|Overall Study|non-compliance by patient|1|||
17113353|NCT03151408|38251426|FG001|Overall Study|non-compliance by patient|0|||
17113354|NCT03151408|38251425|FG000|Overall Study|other reasons|56|||
17113355|NCT03151408|38251426|FG001|Overall Study|other reasons|52|||
17113356|NCT03151408|38251425|FG000|Overall Study|randomized and not treated|2|||
17113357|NCT03151408|38251426|FG001|Overall Study|randomized and not treated|2|||
17113358|NCT00546754|38251434|FG000|Overall Study|Serious Adverse Event|1|||
17113359|NCT00546754|38251435|FG001|Overall Study|Serious Adverse Event|1|||
17113360|NCT00546754|38251434|FG000|Overall Study|Adverse Event|11|||
17113361|NCT00546754|38251435|FG001|Overall Study|Adverse Event|16|||
17113362|NCT00546754|38251434|FG000|Overall Study|Lack of Efficacy|1|||
17113363|NCT00546754|38251435|FG001|Overall Study|Lack of Efficacy|1|||
17113364|NCT00546754|38251434|FG000|Overall Study|Lost to Follow-up|9|||
17113365|NCT00546754|38251435|FG001|Overall Study|Lost to Follow-up|15|||
17113366|NCT00546754|38251434|FG000|Overall Study|Protocol Violation|3|||
17113367|NCT00546754|38251435|FG001|Overall Study|Protocol Violation|0|||
17113368|NCT00546754|38251434|FG000|Overall Study|Withdrawal by Subject|6|||
17113369|NCT00546754|38251435|FG001|Overall Study|Withdrawal by Subject|7|||
17113370|NCT00546754|38251434|FG000|Overall Study|Dyspnea|1|||
17113371|NCT00546754|38251435|FG001|Overall Study|Dyspnea|0|||
17113372|NCT00546754|38251434|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
17113373|NCT00546754|38251435|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
17113374|NCT00546754|38251434|FG000|Overall Study|Hip Replacement|1|||
17113375|NCT00546754|38251435|FG001|Overall Study|Hip Replacement|0|||
17113376|NCT00546754|38251434|FG000|Overall Study|Suicide|1|||
17113377|NCT00546754|38251435|FG001|Overall Study|Suicide|0|||
17113378|NCT00546754|38251434|FG000|Overall Study|Missing Cooperation|1|||
17113379|NCT00546754|38251435|FG001|Overall Study|Missing Cooperation|0|||
17113380|NCT00546754|38251434|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
17113381|NCT00546754|38251435|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
17113382|NCT00546754|38251434|FG000|Overall Study|Patient's Decision|0|||
17113383|NCT00546754|38251435|FG001|Overall Study|Patient's Decision|1|||
17113384|NCT00546754|38251434|FG000|Overall Study|Missing|14|||
17113385|NCT00546754|38251435|FG001|Overall Study|Missing|7|||
17113386|NCT00282347|38251443|FG000|Treatment Period|Death|2|||
17113387|NCT00282347|38251444|FG001|Treatment Period|Death|0|||
17113388|NCT00282347|38251443|FG000|Treatment Period|Lost to Follow-up|2|||
17113389|NCT00282347|38251444|FG001|Treatment Period|Lost to Follow-up|5|||
17113390|NCT00282347|38251443|FG000|Treatment Period|Withdrawal by Subject|1|||
17113391|NCT00282347|38251444|FG001|Treatment Period|Withdrawal by Subject|3|||
17113392|NCT00282347|38251443|FG000|Treatment Period|Physician Decision|0|||
17113393|NCT00282347|38251444|FG001|Treatment Period|Physician Decision|1|||
17113394|NCT00282347|38251443|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
17113395|NCT00282347|38251444|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
17113396|NCT00282347|38251443|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
17113397|NCT00282347|38251444|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
17113398|NCT00282347|38251443|FG000|Safety Follow-up Period|Physician Decision|1|||
17113399|NCT00282347|38251444|FG001|Safety Follow-up Period|Physician Decision|1|||
17113400|NCT00282347|38251443|FG000|Safety Follow-up Period|Protocol Deviation|0|||
17113401|NCT00282347|38251444|FG001|Safety Follow-up Period|Protocol Deviation|2|||
17113402|NCT00282347|38251443|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
17113403|NCT00282347|38251444|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
17113404|NCT00282347|38251443|FG000|B Cell Follow-up Period|Physician Decision|1|||
17113405|NCT00282347|38251444|FG001|B Cell Follow-up Period|Physician Decision|0|||
17113406|NCT00282347|38251443|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
17113407|NCT00282347|38251444|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
17113408|NCT00405964|38251454|FG000|Overall Study|Treatment Failure|17|||
17113409|NCT00405964|38251455|FG001|Overall Study|Treatment Failure|45|||
17113410|NCT00405964|38251454|FG000|Overall Study|Adverse Event|7|||
17113411|NCT00405964|38251455|FG001|Overall Study|Adverse Event|16|||
17113412|NCT00405964|38251454|FG000|Overall Study|Lost to Follow-up|5|||
17113413|NCT00405964|38251455|FG001|Overall Study|Lost to Follow-up|5|||
17113414|NCT00405964|38251454|FG000|Overall Study|Withdrawal by Subject|19|||
17113415|NCT00405964|38251455|FG001|Overall Study|Withdrawal by Subject|23|||
17113416|NCT00405964|38251454|FG000|Overall Study|Protocol Violation|11|||
17113417|NCT00405964|38251455|FG001|Overall Study|Protocol Violation|6|||
17113418|NCT00264797|38251463|FG000|Overall Study|Withdrawal by Subject|11|||
17113419|NCT00264797|38251464|FG001|Overall Study|Withdrawal by Subject|11|||
17113420|NCT00264797|38251463|FG000|Overall Study|Lost to Follow-up|9|||
17113421|NCT00264797|38251464|FG001|Overall Study|Lost to Follow-up|17|||
17113422|NCT00264797|38251463|FG000|Overall Study|Moved from area|3|||
17113423|NCT00264797|38251464|FG001|Overall Study|Moved from area|1|||
17113424|NCT00264797|38251463|FG000|Overall Study|Practical Problems|2|||
17113425|NCT00264797|38251464|FG001|Overall Study|Practical Problems|3|||
17113426|NCT00264797|38251463|FG000|Overall Study|Incarceration|4|||
17113427|NCT00264797|38251464|FG001|Overall Study|Incarceration|5|||
17113428|NCT00264797|38251463|FG000|Overall Study|Pressure/advice from Outsiders|1|||
17113429|NCT00264797|38251464|FG001|Overall Study|Pressure/advice from Outsiders|1|||
17113430|NCT00264797|38251463|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
17113431|NCT00264797|38251464|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
17113432|NCT00264797|38251463|FG000|Overall Study|Other|3|||
17113433|NCT00264797|38251464|FG001|Overall Study|Other|4|||
17113434|NCT03148756|38251472|FG000|Overall Study|Study Terminated|0|||
17113435|NCT03148756|38251473|FG001|Overall Study|Study Terminated|1|||
17113436|NCT00282113|38251482|FG000|Overall Study|Removed at parents request|1|||
17113437|NCT00282113|38251483|FG001|Overall Study|Removed at parents request|0|||
17113438|NCT00282113|38251484|FG002|Overall Study|Removed at parents request|0|||
17113439|NCT00281957|38251494|FG000|Overall Study|Adverse Event|7|||
17113440|NCT00281957|38251495|FG001|Overall Study|Adverse Event|2|||
17113441|NCT00281957|38251494|FG000|Overall Study|Death|1|||
17113442|NCT00281957|38251495|FG001|Overall Study|Death|0|||
17113443|NCT00281957|38251494|FG000|Overall Study|Progression/relapse|47|||
17113444|NCT00281957|38251495|FG001|Overall Study|Progression/relapse|35|||
17113445|NCT00281957|38251494|FG000|Overall Study|Not protocol specified|8|||
17113446|NCT00281957|38251495|FG001|Overall Study|Not protocol specified|1|||
17113447|NCT00281957|38251494|FG000|Overall Study|Not eligible|1|||
17113448|NCT00281957|38251495|FG001|Overall Study|Not eligible|2|||
17113449|NCT00281957|38251494|FG000|Overall Study|Did not start treatment|3|||
17113450|NCT00281957|38251495|FG001|Overall Study|Did not start treatment|1|||
17113451|NCT00281957|38251494|FG000|Overall Study|Refusal unrelated to adverse events|0|||
17113452|NCT00281957|38251495|FG001|Overall Study|Refusal unrelated to adverse events|1|||
17113453|NCT00281099|38251505|FG000|Overall Study|Death|46|||
17113454|NCT00281099|38251506|FG001|Overall Study|Death|57|||
17113455|NCT00281099|38251505|FG000|Overall Study|Lost to Follow-up|10|||
17113456|NCT00281099|38251506|FG001|Overall Study|Lost to Follow-up|19|||
17113457|NCT00281099|38251505|FG000|Overall Study|Withdrawal by Subject|65|||
17113458|NCT00281099|38251506|FG001|Overall Study|Withdrawal by Subject|70|||
17113459|NCT00281099|38251505|FG000|Overall Study|Physician Decision|79|||
17113460|NCT00281099|38251506|FG001|Overall Study|Physician Decision|72|||
17113461|NCT00281099|38251505|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
17113462|NCT00281099|38251506|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
17113463|NCT00262925|38251513|FG000|Overall Study|Lack of Efficacy|3|||
17113464|NCT00262925|38251513|FG000|Overall Study|Adverse Event|4|||
17113465|NCT00262925|38251513|FG000|Overall Study|Death|2|||
17113466|NCT00262925|38251513|FG000|Overall Study|alternative therapy|1|||
17113467|NCT00262925|38251513|FG000|Overall Study|Other|1|||
17113468|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
17113469|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
17113470|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
17113471|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
17113472|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
17113473|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
17113474|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
17113475|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
17113476|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
17113477|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
17113478|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
17113479|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
17113480|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
17113481|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
17113482|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
17113483|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
17113484|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
17113485|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
17113486|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
17113487|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
17113488|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
17113489|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
17113490|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
17113491|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
17113492|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
17113493|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
17113494|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
17113495|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
17113496|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
17113497|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
17113498|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
17113499|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
17113500|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
17113501|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
17113502|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
17113503|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
17113504|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
17113505|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
17113506|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
17113507|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
17113508|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
17113509|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
17113510|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
17113511|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
17113512|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
17113513|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
17113514|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
17113515|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
17113516|NCT03720470|38251523|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
17113517|NCT03720470|38251524|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
17113518|NCT03720470|38251525|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
17113519|NCT03720470|38251526|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
17113520|NCT03720470|38251527|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
17113521|NCT03720470|38251528|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
17113522|NCT03720470|38251523|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
17113523|NCT03720470|38251524|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
17113524|NCT03720470|38251525|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
17113525|NCT03720470|38251526|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
17113526|NCT03720470|38251527|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
17113527|NCT03720470|38251528|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
17113528|NCT03720470|38251523|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
17113529|NCT03720470|38251524|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
17113530|NCT03720470|38251525|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
17113531|NCT03720470|38251526|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
17113532|NCT03720470|38251527|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
17113533|NCT03720470|38251528|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
17113534|NCT03720470|38251523|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
17113535|NCT03720470|38251524|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
17113536|NCT03720470|38251525|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
17113537|NCT03720470|38251526|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
17113538|NCT03720470|38251527|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
17113539|NCT03720470|38251528|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
17113540|NCT03720470|38251523|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
17113541|NCT03720470|38251524|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
17113542|NCT03720470|38251525|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
17113543|NCT03720470|38251526|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
17113544|NCT03720470|38251527|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
17113545|NCT03720470|38251528|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
17113546|NCT03720470|38251523|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
17113547|NCT03720470|38251524|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
17113548|NCT03720470|38251525|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
17113549|NCT03720470|38251526|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
17113550|NCT03720470|38251527|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
17113551|NCT03720470|38251528|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
17113552|NCT03720470|38251523|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
17113553|NCT03720470|38251524|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
17113554|NCT03720470|38251525|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
17113555|NCT03720470|38251526|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
17113556|NCT03720470|38251527|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
17113557|NCT03720470|38251528|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
17113558|NCT03720470|38251523|FG000|Treatment Period: Final 4 Weeks|Other|0|||
17113559|NCT03720470|38251524|FG001|Treatment Period: Final 4 Weeks|Other|1|||
17113560|NCT03720470|38251525|FG002|Treatment Period: Final 4 Weeks|Other|0|||
17113561|NCT03720470|38251526|FG003|Treatment Period: Final 4 Weeks|Other|2|||
17113562|NCT03720470|38251527|FG004|Treatment Period: Final 4 Weeks|Other|1|||
17113563|NCT03720470|38251528|FG005|Treatment Period: Final 4 Weeks|Other|0|||
17113564|NCT00262847|38251551|FG000|Overall Study|Disease Progression|309|||
17113565|NCT00262847|38251552|FG001|Overall Study|Disease Progression|274|||
17113566|NCT00262847|38251553|FG002|Overall Study|Disease Progression|195|||
17113567|NCT00262847|38251551|FG000|Overall Study|Patient Refusal|41|||
17113568|NCT00262847|38251552|FG001|Overall Study|Patient Refusal|52|||
17113569|NCT00262847|38251553|FG002|Overall Study|Patient Refusal|47|||
17113570|NCT00262847|38251551|FG000|Overall Study|Adverse Event|74|||
17113571|NCT00262847|38251552|FG001|Overall Study|Adverse Event|88|||
17113572|NCT00262847|38251553|FG002|Overall Study|Adverse Event|108|||
17113573|NCT00262847|38251551|FG000|Overall Study|Death|8|||
17113574|NCT00262847|38251552|FG001|Overall Study|Death|8|||
17113575|NCT00262847|38251553|FG002|Overall Study|Death|11|||
17113576|NCT00262847|38251551|FG000|Overall Study|Concomitant disease|3|||
17113577|NCT00262847|38251552|FG001|Overall Study|Concomitant disease|2|||
17113578|NCT00262847|38251553|FG002|Overall Study|Concomitant disease|4|||
17113579|NCT00262847|38251551|FG000|Overall Study|Other Reasons|79|||
17113580|NCT00262847|38251552|FG001|Overall Study|Other Reasons|88|||
17113581|NCT00262847|38251553|FG002|Overall Study|Other Reasons|27|||
17113582|NCT00262847|38251551|FG000|Overall Study|Did not receive study treatment|4|||
17113583|NCT00262847|38251552|FG001|Overall Study|Did not receive study treatment|1|||
17113584|NCT00262847|38251553|FG002|Overall Study|Did not receive study treatment|4|||
17113585|NCT00280397|38251564|FG000|Overall Study|Adverse Event|1|||
17113586|NCT00262301|38251573|FG000|Double-blind Phase|Lost to Follow-up|1|||
17113587|NCT00262301|38251574|FG001|Double-blind Phase|Lost to Follow-up|0|||
17113588|NCT00262301|38251575|FG002|Double-blind Phase|Lost to Follow-up|0|||
17113589|NCT00262301|38251573|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
17113590|NCT00262301|38251574|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
17113591|NCT00262301|38251575|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
17113592|NCT00279305|38251585|FG000|Overall Study|Pregnancy|1|||
17113593|NCT00279305|38251586|FG001|Overall Study|Pregnancy|0|||
17113594|NCT00279305|38251585|FG000|Overall Study|Withdrawal by Subject|2|||
17113595|NCT00279305|38251586|FG001|Overall Study|Withdrawal by Subject|0|||
17113596|NCT00279305|38251585|FG000|Overall Study|Dificulting establishing IV|1|||
17113597|NCT00279305|38251586|FG001|Overall Study|Dificulting establishing IV|0|||
17113598|NCT00279305|38251585|FG000|Overall Study|FDA Safety Alert|4|||
17113599|NCT00279305|38251586|FG001|Overall Study|FDA Safety Alert|1|||
17113600|NCT00278993|38251592|FG000|Overall Study|Adverse Event|24|||
17113601|NCT00278993|38251592|FG000|Overall Study|Withdrawal by Subject|5|||
17113602|NCT00278993|38251592|FG000|Overall Study|Progressive Disease|65|||
17113603|NCT00278993|38251592|FG000|Overall Study|Physician Decision|9|||
17113604|NCT00278993|38251592|FG000|Overall Study|Not Otherwise Specified|4|||
17113605|NCT00277355|38251598|FG000|Overall Study|Withdrawal by Subject|3|||
17113606|NCT00277355|38251599|FG001|Overall Study|Withdrawal by Subject|3|||
17113607|NCT00277355|38251598|FG000|Overall Study|Lost to Follow-up|2|||
17113608|NCT00277355|38251599|FG001|Overall Study|Lost to Follow-up|2|||
17113609|NCT00277355|38251598|FG000|Overall Study|Adverse Event|5|||
17113610|NCT00277355|38251599|FG001|Overall Study|Adverse Event|0|||
17113611|NCT00277355|38251598|FG000|Overall Study|Death|3|||
17113612|NCT00277355|38251599|FG001|Overall Study|Death|0|||
17113613|NCT00277355|38251598|FG000|Overall Study|Physician Decision|1|||
17113614|NCT00277355|38251599|FG001|Overall Study|Physician Decision|0|||
17113615|NCT00262223|38251608|FG000|Treatment Phase|Withdrawal by Subject|3|||
17113616|NCT00262223|38251609|FG001|Treatment Phase|Withdrawal by Subject|6|||
17113617|NCT00262223|38251608|FG000|Treatment Phase|Adverse Event|1|||
17113618|NCT00262223|38251609|FG001|Treatment Phase|Adverse Event|2|||
17113619|NCT00262223|38251608|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
17113620|NCT00262223|38251609|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
17113621|NCT00262223|38251608|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
17113622|NCT00262223|38251609|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
17113623|NCT00262223|38251608|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
17113624|NCT00262223|38251609|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
17113625|NCT00276419|38251618|FG000|First Intervention|Adverse Event|1|||
17113626|NCT00276419|38251619|FG001|First Intervention|Adverse Event|0|||
17113627|NCT00276419|38251618|FG000|First Intervention|Withdrawal by Subject|0|||
17113628|NCT00276419|38251619|FG001|First Intervention|Withdrawal by Subject|2|||
17113629|NCT00262067|38251640|FG000|Overall Study|Death|190|||
17113630|NCT00262067|38251641|FG001|Overall Study|Death|89|||
17113631|NCT00262067|38251642|FG002|Overall Study|Death|186|||
17113632|NCT00262067|38251643|FG003|Overall Study|Death|99|||
17113633|NCT00262067|38251640|FG000|Overall Study|Lost to Follow-up|5|||
17113634|NCT00262067|38251641|FG001|Overall Study|Lost to Follow-up|4|||
17113635|NCT00262067|38251642|FG002|Overall Study|Lost to Follow-up|7|||
17113636|NCT00262067|38251643|FG003|Overall Study|Lost to Follow-up|5|||
17113637|NCT00262067|38251640|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
17113638|NCT00262067|38251641|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
17113639|NCT00262067|38251642|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
17113640|NCT00262067|38251643|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
17113641|NCT00262067|38251640|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
17113642|NCT00262067|38251641|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
17113643|NCT00262067|38251642|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
17113644|NCT00262067|38251643|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
17113645|NCT00275561|38251655|FG000|Overall Study|Withdrawal by Subject|0|||
17113646|NCT00275561|38251656|FG001|Overall Study|Withdrawal by Subject|1|||
17113647|NCT00275561|38251655|FG000|Overall Study|Travel|1|||
17113648|NCT00275561|38251656|FG001|Overall Study|Travel|1|||
17113649|NCT00275561|38251655|FG000|Overall Study|Scheduling|1|||
17113650|NCT00275561|38251656|FG001|Overall Study|Scheduling|2|||
17113651|NCT00275561|38251655|FG000|Overall Study|Family Issues|0|||
17113652|NCT00275561|38251656|FG001|Overall Study|Family Issues|2|||
17113653|NCT00274937|38251666|FG000|Overall Study|Physician Decision|10|||
17113654|NCT00274937|38251666|FG000|Overall Study|Withdrawal by Subject|6|||
17113655|NCT00274937|38251666|FG000|Overall Study|Progressive Disease|4|||
17113656|NCT00251693|38251673|FG000|Overall Study|Adverse Event|17|||
17113657|NCT00251693|38251674|FG001|Overall Study|Adverse Event|9|||
17113658|NCT00251693|38251675|FG002|Overall Study|Adverse Event|9|||
17113659|NCT00251693|38251673|FG000|Overall Study|Protocol Violation|2|||
17113660|NCT00251693|38251674|FG001|Overall Study|Protocol Violation|0|||
17113661|NCT00251693|38251675|FG002|Overall Study|Protocol Violation|2|||
17113662|NCT00251693|38251673|FG000|Overall Study|Lost to Follow-up|12|||
17113663|NCT00251693|38251674|FG001|Overall Study|Lost to Follow-up|7|||
17113664|NCT00251693|38251675|FG002|Overall Study|Lost to Follow-up|8|||
17113665|NCT00251693|38251673|FG000|Overall Study|Withdrawal by Subject|11|||
17113666|NCT00251693|38251674|FG001|Overall Study|Withdrawal by Subject|17|||
17113667|NCT00251693|38251675|FG002|Overall Study|Withdrawal by Subject|14|||
17113668|NCT00251693|38251673|FG000|Overall Study|Lack of Efficacy|0|||
17113669|NCT00251693|38251674|FG001|Overall Study|Lack of Efficacy|1|||
17113670|NCT00251693|38251675|FG002|Overall Study|Lack of Efficacy|0|||
17113671|NCT00251693|38251673|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
17113672|NCT00251693|38251674|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
17113673|NCT00251693|38251675|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
17113674|NCT00251693|38251673|FG000|Overall Study|Noncompliant|0|||
17113675|NCT00251693|38251674|FG001|Overall Study|Noncompliant|0|||
17113676|NCT00251693|38251675|FG002|Overall Study|Noncompliant|2|||
17113677|NCT00251693|38251673|FG000|Overall Study|Possible Barrett's esophagus|3|||
17113678|NCT00251693|38251674|FG001|Overall Study|Possible Barrett's esophagus|5|||
17113679|NCT00251693|38251675|FG002|Overall Study|Possible Barrett's esophagus|2|||
17113680|NCT00251693|38251673|FG000|Overall Study|Subject request/subject unavailable|1|||
17113681|NCT00251693|38251674|FG001|Overall Study|Subject request/subject unavailable|2|||
17113682|NCT00251693|38251675|FG002|Overall Study|Subject request/subject unavailable|0|||
17113683|NCT00251693|38251673|FG000|Overall Study|Abnormal laboratory findings|0|||
17113684|NCT00251693|38251674|FG001|Overall Study|Abnormal laboratory findings|0|||
17113685|NCT00251693|38251675|FG002|Overall Study|Abnormal laboratory findings|1|||
17113686|NCT00250835|38251683|FG000|Overall Study|Withdrawal by Subject|1|||
17113687|NCT03716024|38251693|FG000|Overall Study|Randomized, not Treated|7|||
17113688|NCT03716024|38251694|FG001|Overall Study|Randomized, not Treated|8|||
17113689|NCT03716024|38251693|FG000|Overall Study|Adverse Event|1|||
17113690|NCT03716024|38251694|FG001|Overall Study|Adverse Event|2|||
17113691|NCT03716024|38251693|FG000|Overall Study|Treatment Failure|1|||
17113692|NCT03716024|38251694|FG001|Overall Study|Treatment Failure|0|||
17113693|NCT03716024|38251693|FG000|Overall Study|Lost to Follow-up|2|||
17113694|NCT03716024|38251694|FG001|Overall Study|Lost to Follow-up|6|||
17113695|NCT03716024|38251693|FG000|Overall Study|Withdrawal by Subject|0|||
17113696|NCT03716024|38251694|FG001|Overall Study|Withdrawal by Subject|1|||
17113697|NCT03716024|38251693|FG000|Overall Study|Missing Reason|0|||
17113698|NCT03716024|38251694|FG001|Overall Study|Missing Reason|1|||
17113699|NCT00250679|38251703|FG000|Overall Study|Adverse Event|12|||
17113700|NCT00250679|38251704|FG001|Overall Study|Adverse Event|15|||
17113701|NCT00250679|38251705|FG002|Overall Study|Adverse Event|16|||
17113702|NCT00250679|38251703|FG000|Overall Study|Protocol Violation|2|||
17113703|NCT00250679|38251704|FG001|Overall Study|Protocol Violation|4|||
17113704|NCT00250679|38251705|FG002|Overall Study|Protocol Violation|3|||
17113705|NCT00250679|38251703|FG000|Overall Study|Withdrawal by Subject|15|||
17113706|NCT00250679|38251704|FG001|Overall Study|Withdrawal by Subject|18|||
17113707|NCT00250679|38251705|FG002|Overall Study|Withdrawal by Subject|15|||
17113708|NCT00250679|38251703|FG000|Overall Study|Lost to Follow-up|3|||
17113709|NCT00250679|38251704|FG001|Overall Study|Lost to Follow-up|4|||
17113710|NCT00250679|38251705|FG002|Overall Study|Lost to Follow-up|2|||
17113711|NCT00250679|38251703|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
17113712|NCT00250679|38251704|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
17113713|NCT00250679|38251705|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
17113714|NCT00250679|38251703|FG000|Overall Study|Lack of Efficacy|0|||
17113715|NCT00250679|38251704|FG001|Overall Study|Lack of Efficacy|1|||
17113716|NCT00250679|38251705|FG002|Overall Study|Lack of Efficacy|3|||
17113717|NCT00250679|38251703|FG000|Overall Study|Technical Holter issues|1|||
17113718|NCT00250679|38251704|FG001|Overall Study|Technical Holter issues|0|||
17113719|NCT00250679|38251705|FG002|Overall Study|Technical Holter issues|2|||
17113720|NCT00250679|38251703|FG000|Overall Study|Moved|1|||
17113721|NCT00250679|38251704|FG001|Overall Study|Moved|1|||
17113722|NCT00250679|38251705|FG002|Overall Study|Moved|0|||
17113723|NCT00250679|38251703|FG000|Overall Study|Non-compliance|1|||
17113724|NCT00250679|38251704|FG001|Overall Study|Non-compliance|1|||
17113725|NCT00250679|38251705|FG002|Overall Study|Non-compliance|0|||
17113726|NCT00250679|38251703|FG000|Overall Study|various single events: hip surgery,diary|3|||
17113727|NCT00250679|38251704|FG001|Overall Study|various single events: hip surgery,diary|1|||
17113728|NCT00250679|38251705|FG002|Overall Study|various single events: hip surgery,diary|1|||
17113729|NCT00261833|38251715|FG000|Overall Study|Death|1|||
17113730|NCT00261833|38251716|FG001|Overall Study|Death|3|||
17113731|NCT00261833|38251715|FG000|Overall Study|Adverse Event|1|||
17113732|NCT00261833|38251716|FG001|Overall Study|Adverse Event|4|||
17113733|NCT00261833|38251715|FG000|Overall Study|Withdrawal by Subject|5|||
17113734|NCT00261833|38251716|FG001|Overall Study|Withdrawal by Subject|7|||
17113735|NCT00261833|38251715|FG000|Overall Study|Protocol Violation|0|||
17113736|NCT00261833|38251716|FG001|Overall Study|Protocol Violation|1|||
17113737|NCT00261833|38251715|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
17113738|NCT00261833|38251716|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
17113739|NCT00261833|38251715|FG000|Overall Study|Lung transplantation|1|||
17113740|NCT00261833|38251716|FG001|Overall Study|Lung transplantation|1|||
17113741|NCT00261833|38251715|FG000|Overall Study|Missing reason|1|||
17113742|NCT00261833|38251716|FG001|Overall Study|Missing reason|0|||
17113743|NCT00261833|38251715|FG000|Overall Study|Not interested in being participant|0|||
17113744|NCT00261833|38251716|FG001|Overall Study|Not interested in being participant|1|||
17113745|NCT03713684|38251727|FG000|Overall Study|Adverse Event|1|||
17113746|NCT03713684|38251728|FG001|Overall Study|Adverse Event|3|||
17113747|NCT03713684|38251729|FG002|Overall Study|Adverse Event|1|||
17113748|NCT03713684|38251730|FG003|Overall Study|Adverse Event|0|||
17113749|NCT03713684|38251727|FG000|Overall Study|Poor compliance to protocol|2|||
17113750|NCT03713684|38251728|FG001|Overall Study|Poor compliance to protocol|1|||
17113751|NCT03713684|38251729|FG002|Overall Study|Poor compliance to protocol|0|||
17113752|NCT03713684|38251730|FG003|Overall Study|Poor compliance to protocol|1|||
17113753|NCT03713684|38251727|FG000|Overall Study|Withdrawal by Subject|14|||
17113754|NCT03713684|38251728|FG001|Overall Study|Withdrawal by Subject|6|||
17113755|NCT03713684|38251729|FG002|Overall Study|Withdrawal by Subject|14|||
17113756|NCT03713684|38251730|FG003|Overall Study|Withdrawal by Subject|16|||
17113757|NCT03713684|38251727|FG000|Overall Study|Other than specified|69|||
17113758|NCT03713684|38251728|FG001|Overall Study|Other than specified|77|||
17113759|NCT03713684|38251729|FG002|Overall Study|Other than specified|73|||
17113760|NCT03713684|38251730|FG003|Overall Study|Other than specified|70|||
17113761|NCT03711266|38251740|FG000|Overall Study|Lost to Follow-up|10|||
17113762|NCT00261443|38251746|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
17113763|NCT00261443|38251747|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
17113764|NCT00261443|38251748|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
17113765|NCT00261443|38251746|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
17113766|NCT00261443|38251747|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
17113767|NCT00261443|38251748|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
17113768|NCT00261443|38251746|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
17113769|NCT00261443|38251747|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
17113770|NCT00261443|38251748|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
17113771|NCT00261443|38251746|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
17113772|NCT00261443|38251747|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
17113773|NCT00261443|38251748|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
17113774|NCT00261443|38251746|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
17113775|NCT00261443|38251747|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
17113776|NCT00261443|38251748|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
17113777|NCT00261443|38251746|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
17113778|NCT00261443|38251747|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
17113779|NCT00261443|38251748|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
17113780|NCT00261443|38251746|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
17113781|NCT00261443|38251747|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
17113782|NCT00261443|38251748|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
17113783|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
17113784|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
17113785|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
17113786|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
17113787|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
17113788|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
17113789|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
17113790|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
17113791|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
17113792|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
17113793|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
17113794|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
17113795|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
17113796|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
17113797|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
17113798|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
17113799|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
17113800|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
17113801|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
17113802|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
17113803|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
17113804|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
17113805|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
17113806|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
17113807|NCT00261443|38251746|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
17113808|NCT00261443|38251747|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
17113809|NCT00261443|38251748|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
17113810|NCT00261443|38251746|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
17113811|NCT00261443|38251747|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
17113812|NCT00261443|38251748|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
17113813|NCT00261443|38251746|FG000|3: Assessment of Relapse|Adverse Event|0|||
17113814|NCT00261443|38251747|FG001|3: Assessment of Relapse|Adverse Event|15|||
17113815|NCT00261443|38251748|FG002|3: Assessment of Relapse|Adverse Event|19|||
17113816|NCT00261443|38251746|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
17113817|NCT00261443|38251747|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
17113818|NCT00261443|38251748|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
17113819|NCT00261443|38251746|FG000|3: Assessment of Relapse|Death|0|||
17113820|NCT00261443|38251747|FG001|3: Assessment of Relapse|Death|0|||
17113821|NCT00261443|38251748|FG002|3: Assessment of Relapse|Death|1|||
17113822|NCT00261443|38251746|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
17113823|NCT00261443|38251747|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
17113824|NCT00261443|38251748|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
17113825|NCT00261443|38251746|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
17113826|NCT00261443|38251747|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
17113827|NCT00261443|38251748|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
17113828|NCT00261443|38251746|FG000|3: Assessment of Relapse|Pregnancy|0|||
17113829|NCT00261443|38251747|FG001|3: Assessment of Relapse|Pregnancy|2|||
17113830|NCT00261443|38251748|FG002|3: Assessment of Relapse|Pregnancy|1|||
17113831|NCT00261443|38251746|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
17113832|NCT00261443|38251747|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
17113833|NCT00261443|38251748|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
17113834|NCT00261443|38251746|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
17113835|NCT00261443|38251747|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
17113836|NCT00261443|38251748|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
17113837|NCT00261443|38251746|FG000|3: Assessment of Relapse|Other Reasons|0|||
17113838|NCT00261443|38251747|FG001|3: Assessment of Relapse|Other Reasons|4|||
17113839|NCT00261443|38251748|FG002|3: Assessment of Relapse|Other Reasons|3|||
17113840|NCT00261443|38251746|FG000|4: Extension Phase|Adverse Event|0|||
17113841|NCT00261443|38251747|FG001|4: Extension Phase|Adverse Event|1|||
17113842|NCT00261443|38251748|FG002|4: Extension Phase|Adverse Event|0|||
17113843|NCT00261443|38251746|FG000|4: Extension Phase|Withdrawal by Subject|0|||
17113844|NCT00261443|38251747|FG001|4: Extension Phase|Withdrawal by Subject|1|||
17113845|NCT00261443|38251748|FG002|4: Extension Phase|Withdrawal by Subject|2|||
17113846|NCT00261443|38251746|FG000|4: Extension Phase|Lost to Follow-up|0|||
17113847|NCT00261443|38251747|FG001|4: Extension Phase|Lost to Follow-up|1|||
17113848|NCT00261443|38251748|FG002|4: Extension Phase|Lost to Follow-up|0|||
17113849|NCT03150862|38251767|FG000|Overall Study|Death|2|||
17113850|NCT03150862|38251768|FG001|Overall Study|Death|7|||
17113851|NCT03150862|38251769|FG002|Overall Study|Death|8|||
17113852|NCT03150862|38251770|FG003|Overall Study|Death|27|||
17113853|NCT03150862|38251771|FG004|Overall Study|Death|4|||
17113854|NCT03150862|38251772|FG005|Overall Study|Death|8|||
17113855|NCT03150862|38251773|FG006|Overall Study|Death|6|||
17113856|NCT03150862|38251774|FG007|Overall Study|Death|21|||
17113857|NCT03150862|38251767|FG000|Overall Study|Withdrawal by Subject|1|||
17113858|NCT03150862|38251768|FG001|Overall Study|Withdrawal by Subject|1|||
17113859|NCT03150862|38251769|FG002|Overall Study|Withdrawal by Subject|0|||
17113860|NCT03150862|38251770|FG003|Overall Study|Withdrawal by Subject|3|||
17113861|NCT03150862|38251771|FG004|Overall Study|Withdrawal by Subject|1|||
17113862|NCT03150862|38251772|FG005|Overall Study|Withdrawal by Subject|1|||
17113863|NCT03150862|38251773|FG006|Overall Study|Withdrawal by Subject|1|||
17113864|NCT03150862|38251774|FG007|Overall Study|Withdrawal by Subject|3|||
17113865|NCT03150862|38251767|FG000|Overall Study|Lost to Follow-up|0|||
17113866|NCT03150862|38251768|FG001|Overall Study|Lost to Follow-up|0|||
17113867|NCT03150862|38251769|FG002|Overall Study|Lost to Follow-up|1|||
17113868|NCT03150862|38251770|FG003|Overall Study|Lost to Follow-up|0|||
17113869|NCT03150862|38251771|FG004|Overall Study|Lost to Follow-up|0|||
17113870|NCT03150862|38251772|FG005|Overall Study|Lost to Follow-up|0|||
17113871|NCT03150862|38251773|FG006|Overall Study|Lost to Follow-up|0|||
17113872|NCT03150862|38251774|FG007|Overall Study|Lost to Follow-up|2|||
17113873|NCT03150862|38251767|FG000|Overall Study|Sponsor's decision|0|||
17113874|NCT03150862|38251768|FG001|Overall Study|Sponsor's decision|0|||
17113875|NCT03150862|38251769|FG002|Overall Study|Sponsor's decision|0|||
17113876|NCT03150862|38251770|FG003|Overall Study|Sponsor's decision|10|||
17113877|NCT03150862|38251771|FG004|Overall Study|Sponsor's decision|3|||
17113878|NCT03150862|38251772|FG005|Overall Study|Sponsor's decision|0|||
17113879|NCT03150862|38251773|FG006|Overall Study|Sponsor's decision|1|||
17113880|NCT03150862|38251774|FG007|Overall Study|Sponsor's decision|1|||
17113881|NCT03150862|38251767|FG000|Overall Study|Change in Methylation status|0|||
17113882|NCT03150862|38251768|FG001|Overall Study|Change in Methylation status|0|||
17113883|NCT03150862|38251769|FG002|Overall Study|Change in Methylation status|0|||
17113884|NCT03150862|38251770|FG003|Overall Study|Change in Methylation status|0|||
17113885|NCT03150862|38251771|FG004|Overall Study|Change in Methylation status|1|||
17113886|NCT03150862|38251772|FG005|Overall Study|Change in Methylation status|0|||
17113887|NCT03150862|38251773|FG006|Overall Study|Change in Methylation status|0|||
17113888|NCT03150862|38251774|FG007|Overall Study|Change in Methylation status|0|||
17113889|NCT03150862|38251767|FG000|Overall Study|Roll over in to Long Term Extension|0|||
17113890|NCT03150862|38251768|FG001|Overall Study|Roll over in to Long Term Extension|0|||
17113891|NCT03150862|38251769|FG002|Overall Study|Roll over in to Long Term Extension|0|||
17113892|NCT03150862|38251770|FG003|Overall Study|Roll over in to Long Term Extension|0|||
17113893|NCT03150862|38251771|FG004|Overall Study|Roll over in to Long Term Extension|0|||
17113894|NCT03150862|38251772|FG005|Overall Study|Roll over in to Long Term Extension|0|||
17113895|NCT03150862|38251773|FG006|Overall Study|Roll over in to Long Term Extension|0|||
17113896|NCT03150862|38251774|FG007|Overall Study|Roll over in to Long Term Extension|1|||
17113897|NCT03150862|38251767|FG000|Overall Study|Progressive Disease|0|||
17113898|NCT03150862|38251768|FG001|Overall Study|Progressive Disease|0|||
17113899|NCT03150862|38251769|FG002|Overall Study|Progressive Disease|0|||
17113900|NCT03150862|38251770|FG003|Overall Study|Progressive Disease|0|||
17113901|NCT03150862|38251771|FG004|Overall Study|Progressive Disease|0|||
17113902|NCT03150862|38251772|FG005|Overall Study|Progressive Disease|0|||
17113903|NCT03150862|38251773|FG006|Overall Study|Progressive Disease|0|||
17113904|NCT03150862|38251774|FG007|Overall Study|Progressive Disease|2|||
17113905|NCT00260429|38251803|FG000|Overall Study|failure to follow appointments|1|||
17113906|NCT00260429|38251804|FG001|Overall Study|failure to follow appointments|0|||
17113907|NCT00260429|38251803|FG000|Overall Study|scheduled hand surgery|1|||
17113908|NCT00260429|38251804|FG001|Overall Study|scheduled hand surgery|0|||
17113909|NCT00379288|38251814|FG000|Overall Study|Adverse Event|5|||
17113910|NCT00379288|38251815|FG001|Overall Study|Adverse Event|6|||
17113911|NCT00379288|38251816|FG002|Overall Study|Adverse Event|2|||
17113912|NCT00379288|38251817|FG003|Overall Study|Adverse Event|0|||
17113913|NCT00379288|38251814|FG000|Overall Study|Treatment Failure|0|||
17113914|NCT00379288|38251815|FG001|Overall Study|Treatment Failure|1|||
17113915|NCT00379288|38251816|FG002|Overall Study|Treatment Failure|0|||
17113916|NCT00379288|38251817|FG003|Overall Study|Treatment Failure|1|||
17113917|NCT00379288|38251814|FG000|Overall Study|Lost to Follow-up|3|||
17113918|NCT00379288|38251815|FG001|Overall Study|Lost to Follow-up|3|||
17113919|NCT00379288|38251816|FG002|Overall Study|Lost to Follow-up|2|||
17113920|NCT00379288|38251817|FG003|Overall Study|Lost to Follow-up|0|||
17113921|NCT00379288|38251814|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
17113922|NCT00379288|38251815|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
17113923|NCT00379288|38251816|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
17113924|NCT00379288|38251817|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
17113925|NCT00379288|38251814|FG000|Overall Study|Subject withdrew-related to study drug|1|||
17113926|NCT00379288|38251815|FG001|Overall Study|Subject withdrew-related to study drug|0|||
17113927|NCT00379288|38251816|FG002|Overall Study|Subject withdrew-related to study drug|0|||
17113928|NCT00379288|38251817|FG003|Overall Study|Subject withdrew-related to study drug|1|||
17113929|NCT00379288|38251814|FG000|Overall Study|Noncompliance with protocol|8|||
17113930|NCT00379288|38251815|FG001|Overall Study|Noncompliance with protocol|6|||
17113931|NCT00379288|38251816|FG002|Overall Study|Noncompliance with protocol|2|||
17113932|NCT00379288|38251817|FG003|Overall Study|Noncompliance with protocol|1|||
17113933|NCT00379288|38251814|FG000|Overall Study|Did not meet protocol eligibility|0|||
17113934|NCT00379288|38251815|FG001|Overall Study|Did not meet protocol eligibility|1|||
17113935|NCT00379288|38251816|FG002|Overall Study|Did not meet protocol eligibility|0|||
17113936|NCT00379288|38251817|FG003|Overall Study|Did not meet protocol eligibility|2|||
17113937|NCT00379288|38251814|FG000|Overall Study|Administrative|2|||
17113938|NCT00379288|38251815|FG001|Overall Study|Administrative|2|||
17113939|NCT00379288|38251816|FG002|Overall Study|Administrative|0|||
17113940|NCT00379288|38251817|FG003|Overall Study|Administrative|1|||
17113941|NCT00243503|38251827|FG000|Overall Study|Adverse Event|11|||
17113942|NCT00243503|38251827|FG000|Overall Study|Withdrawal by Subject|1|||
17113943|NCT00243503|38251827|FG000|Overall Study|Lack of Efficacy|44|||
17113944|NCT00243503|38251827|FG000|Overall Study|Death|1|||
17113945|NCT00243503|38251827|FG000|Overall Study|Other|1|||
17113946|NCT00239837|38251834|FG000|Overall Study|Lost to Follow-up|3|||
17113947|NCT00239837|38251835|FG001|Overall Study|Lost to Follow-up|7|||
17113948|NCT00259649|38251843|FG000|Overall Study|Lost to Follow-up|7|||
17113949|NCT00259649|38251843|FG000|Overall Study|irregular menses|3|||
17113950|NCT03712280|38251851|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
17113951|NCT03712280|38251852|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
17113952|NCT03712280|38251853|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
17113953|NCT03712280|38251854|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
17113954|NCT03712280|38251851|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
17113955|NCT03712280|38251852|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
17113956|NCT03712280|38251853|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
17113957|NCT03712280|38251854|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
17113958|NCT03712280|38251851|FG000|Overall Study|Adverse Event|0|||
17113959|NCT03712280|38251852|FG001|Overall Study|Adverse Event|0|||
17113960|NCT03712280|38251853|FG002|Overall Study|Adverse Event|1|||
17113961|NCT03712280|38251854|FG003|Overall Study|Adverse Event|0|||
17113962|NCT01345240|38251869|FG000|Overall Study|Adverse Event|3|||
17113963|NCT01345240|38251870|FG001|Overall Study|Adverse Event|5|||
17113964|NCT01345240|38251871|FG002|Overall Study|Adverse Event|4|||
17113965|NCT01345240|38251872|FG003|Overall Study|Adverse Event|2|||
17113966|NCT01345240|38251873|FG004|Overall Study|Adverse Event|1|||
17113967|NCT01345240|38251869|FG000|Overall Study|Lost to Follow-up|8|||
17113968|NCT01345240|38251870|FG001|Overall Study|Lost to Follow-up|9|||
17113969|NCT01345240|38251871|FG002|Overall Study|Lost to Follow-up|14|||
17113970|NCT01345240|38251872|FG003|Overall Study|Lost to Follow-up|7|||
17113971|NCT01345240|38251873|FG004|Overall Study|Lost to Follow-up|9|||
17113972|NCT03707912|38251905|FG000|Overall Study|Violation of inclusion criteria|1|||
17113973|NCT03707912|38251906|FG001|Overall Study|Violation of inclusion criteria|0|||
17113974|NCT02883244|38251914|FG000|Overall Study|Lost to Follow-up|0|||
17113975|NCT02883244|38251915|FG001|Overall Study|Lost to Follow-up|1|||
17113976|NCT02882854|38251923|FG000|Overall Study|Lost to Follow-up|1|||
17113977|NCT02882854|38251924|FG001|Overall Study|Lost to Follow-up|2|||
17113978|NCT02882854|38251923|FG000|Overall Study|Physician Decision|0|||
17113979|NCT02882854|38251924|FG001|Overall Study|Physician Decision|1|||
17113980|NCT03707522|38251934|FG000|Overall Study|Lost to Follow-up|24|||
17113981|NCT03707522|38251935|FG001|Overall Study|Lost to Follow-up|27|||
17113982|NCT03707522|38251936|FG002|Overall Study|Lost to Follow-up|41|||
17113983|NCT03707522|38251937|FG003|Overall Study|Lost to Follow-up|36|||
17113984|NCT03150082|38251947|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
17113985|NCT03150082|38251948|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
17113986|NCT03142750|38251976|FG000|Overall Study|Lost to Follow-up|4|||
17113987|NCT03142750|38251977|FG001|Overall Study|Lost to Follow-up|1|||
17113988|NCT03149848|38251987|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
17113989|NCT03149848|38251987|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
17113990|NCT03706040|38251997|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
17113991|NCT03706040|38251998|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
17113992|NCT03706040|38251999|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
17113993|NCT03706040|38252000|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
17113994|NCT03706040|38252001|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
17113995|NCT03706040|38252002|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
17113996|NCT03706040|38252003|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
17113997|NCT03706040|38251997|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
17113998|NCT03706040|38251998|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
17113999|NCT03706040|38251999|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
17114000|NCT03706040|38252000|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
17114001|NCT03706040|38252001|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
17114002|NCT03706040|38252002|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
17114003|NCT03706040|38252003|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
17114004|NCT03706040|38251997|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
17114005|NCT03706040|38251998|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
17114006|NCT03706040|38251999|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
17114007|NCT03706040|38252000|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
17114008|NCT03706040|38252001|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
17114009|NCT03706040|38252002|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
17114010|NCT03706040|38252003|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
17114011|NCT03706040|38251997|FG000|Period A (Week 0 to Week 16)|Other|2|||
17114012|NCT03706040|38251998|FG001|Period A (Week 0 to Week 16)|Other|0|||
17114013|NCT03706040|38251999|FG002|Period A (Week 0 to Week 16)|Other|2|||
17114014|NCT03706040|38252000|FG003|Period A (Week 0 to Week 16)|Other|0|||
17114015|NCT03706040|38252001|FG004|Period A (Week 0 to Week 16)|Other|0|||
17114016|NCT03706040|38252002|FG005|Period A (Week 0 to Week 16)|Other|0|||
17114017|NCT03706040|38252003|FG006|Period A (Week 0 to Week 16)|Other|0|||
17114018|NCT03706040|38251997|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
17114019|NCT03706040|38251998|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
17114020|NCT03706040|38251999|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
17114021|NCT03706040|38252000|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
17114022|NCT03706040|38252001|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
17114023|NCT03706040|38252002|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
17114024|NCT03706040|38252003|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
17114025|NCT03706040|38251997|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
17114026|NCT03706040|38251998|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
17114027|NCT03706040|38251999|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
17114028|NCT03706040|38252000|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
17114029|NCT03706040|38252001|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
17114030|NCT03706040|38252002|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
17114031|NCT03706040|38252003|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
17114032|NCT03706040|38251997|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
17114033|NCT03706040|38251998|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
17114034|NCT03706040|38251999|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
17114035|NCT03706040|38252000|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
17114036|NCT03706040|38252001|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
17114037|NCT03706040|38252002|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
17114038|NCT03706040|38252003|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
17114039|NCT03706040|38251997|FG000|Period B (Week 16 to Week 52)|Other|0|||
17114040|NCT03706040|38251998|FG001|Period B (Week 16 to Week 52)|Other|0|||
17114041|NCT03706040|38251999|FG002|Period B (Week 16 to Week 52)|Other|0|||
17114042|NCT03706040|38252000|FG003|Period B (Week 16 to Week 52)|Other|4|||
17114043|NCT03706040|38252001|FG004|Period B (Week 16 to Week 52)|Other|5|||
17114044|NCT03706040|38252002|FG005|Period B (Week 16 to Week 52)|Other|23|||
17114045|NCT03706040|38252003|FG006|Period B (Week 16 to Week 52)|Other|17|||
17114046|NCT03770000|38252024|FG000|Overall Study|Premature discontinuation due to PD|0|||
17114047|NCT03770000|38252025|FG001|Overall Study|Premature discontinuation due to PD|0|||
17114048|NCT03770000|38252026|FG002|Overall Study|Premature discontinuation due to PD|1|||
17114049|NCT03770000|38252027|FG003|Overall Study|Premature discontinuation due to PD|3|||
17114050|NCT03770000|38252028|FG004|Overall Study|Premature discontinuation due to PD|2|||
17114051|NCT03158272|38252047|FG000|Overall Study|Disease progression|3|||
17114052|NCT03158272|38252048|FG001|Overall Study|Disease progression|3|||
17114053|NCT03158272|38252049|FG002|Overall Study|Disease progression|4|||
17114054|NCT03158272|38252050|FG003|Overall Study|Disease progression|6|||
17114055|NCT03158272|38252047|FG000|Overall Study|Death|0|||
17114056|NCT03158272|38252048|FG001|Overall Study|Death|0|||
17114057|NCT03158272|38252049|FG002|Overall Study|Death|1|||
17114058|NCT03158272|38252050|FG003|Overall Study|Death|0|||
17114059|NCT03158272|38252047|FG000|Overall Study|Other reasons|0|||
17114060|NCT03158272|38252048|FG001|Overall Study|Other reasons|0|||
17114061|NCT03158272|38252049|FG002|Overall Study|Other reasons|1|||
17114062|NCT03158272|38252050|FG003|Overall Study|Other reasons|0|||
17114063|NCT03158272|38252047|FG000|Overall Study|Adverse event unrelated to the drug|0|||
17114064|NCT03158272|38252048|FG001|Overall Study|Adverse event unrelated to the drug|1|||
17114065|NCT03158272|38252049|FG002|Overall Study|Adverse event unrelated to the drug|0|||
17114066|NCT03158272|38252050|FG003|Overall Study|Adverse event unrelated to the drug|0|||
17114067|NCT03705494|38252064|FG000|Overall Study|Lost to Follow-up|2|||
17114068|NCT03705494|38252065|FG001|Overall Study|Lost to Follow-up|1|||
17114069|NCT03705494|38252064|FG000|Overall Study|Withdrawal by Subject|5|||
17114070|NCT03705494|38252065|FG001|Overall Study|Withdrawal by Subject|2|||
17114071|NCT01431508|38252071|FG000|Overall Study|Lack of Efficacy|1|||
17114072|NCT01431508|38252071|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
17114073|NCT00654628|38252075|FG000|6-week Active Treatment Period|Adverse Event|9|||
17114074|NCT00654628|38252075|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
17114075|NCT00654628|38252075|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
17114076|NCT00654628|38252075|FG000|6-week Active Treatment Period|Out of window period|1|||
17114077|NCT00654628|38252075|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
17114078|NCT00654628|38252075|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
17114079|NCT00536380|38252082|FG000|Overall Study|Adverse Event|0|||
17114080|NCT00536380|38252083|FG001|Overall Study|Adverse Event|2|||
17114081|NCT00536380|38252084|FG002|Overall Study|Adverse Event|2|||
17114082|NCT00536380|38252082|FG000|Overall Study|Lost to Follow-up|0|||
17114083|NCT00536380|38252083|FG001|Overall Study|Lost to Follow-up|0|||
17114084|NCT00536380|38252084|FG002|Overall Study|Lost to Follow-up|1|||
17114085|NCT00536380|38252082|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
17114086|NCT00536380|38252083|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
17114087|NCT00536380|38252084|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
17114088|NCT00536380|38252082|FG000|Overall Study|Withdrawal related to study drug|7|||
17114089|NCT00536380|38252083|FG001|Overall Study|Withdrawal related to study drug|5|||
17114090|NCT00536380|38252084|FG002|Overall Study|Withdrawal related to study drug|2|||
17114091|NCT00536380|38252082|FG000|Overall Study|Noncompliance with protocol|3|||
17114092|NCT00536380|38252083|FG001|Overall Study|Noncompliance with protocol|2|||
17114093|NCT00536380|38252084|FG002|Overall Study|Noncompliance with protocol|2|||
17114094|NCT00536380|38252082|FG000|Overall Study|Did not meet protocol eligibility|0|||
17114095|NCT00536380|38252083|FG001|Overall Study|Did not meet protocol eligibility|0|||
17114096|NCT00536380|38252084|FG002|Overall Study|Did not meet protocol eligibility|1|||
17114097|NCT00536380|38252082|FG000|Overall Study|Administrative|0|||
17114098|NCT00536380|38252083|FG001|Overall Study|Administrative|0|||
17114099|NCT00536380|38252084|FG002|Overall Study|Administrative|1|||
17114100|NCT00496834|38252094|FG000|Overall Study|Withdrawal by Subject|4|||
17114101|NCT00496834|38252095|FG001|Overall Study|Withdrawal by Subject|6|||
17114102|NCT00496834|38252094|FG000|Overall Study|Contraindicated medication administered|0|||
17114103|NCT00496834|38252095|FG001|Overall Study|Contraindicated medication administered|1|||
17114104|NCT00496834|38252094|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
17114105|NCT00496834|38252095|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
17114106|NCT00496834|38252094|FG000|Overall Study|Adverse Event|5|||
17114107|NCT00496834|38252095|FG001|Overall Study|Adverse Event|3|||
17114108|NCT00496834|38252094|FG000|Overall Study|IP administration violation|2|||
17114109|NCT00496834|38252095|FG001|Overall Study|IP administration violation|0|||
17114110|NCT00496834|38252094|FG000|Overall Study|Lost to Follow-up|2|||
17114111|NCT00496834|38252095|FG001|Overall Study|Lost to Follow-up|0|||
17114112|NCT00496834|38252094|FG000|Overall Study|Blood Pressure control failure|2|||
17114113|NCT00496834|38252095|FG001|Overall Study|Blood Pressure control failure|1|||
17114114|NCT05244122|38252103|FG000|Overall Study|Withdrawal by Subject|318|||
17114115|NCT00166504|38252124|FG000|Overall Study|Adverse Event|3|||
17114116|NCT00166504|38252125|FG001|Overall Study|Adverse Event|3|||
17114117|NCT00166504|38252124|FG000|Overall Study|Lost to Follow-up|1|||
17114118|NCT00166504|38252125|FG001|Overall Study|Lost to Follow-up|1|||
17114119|NCT00166504|38252124|FG000|Overall Study|Withdrawal by Subject|1|||
17114120|NCT00166504|38252125|FG001|Overall Study|Withdrawal by Subject|0|||
17114121|NCT03137992|38252131|FG000|Washout Period 1|Adverse Event|1|||
17114122|NCT03137992|38252132|FG001|Washout Period 1|Adverse Event|1|||
17114123|NCT03137992|38252133|FG002|Washout Period 1|Adverse Event|0|||
17114124|NCT03137992|38252134|FG003|Washout Period 1|Adverse Event|0|||
17114125|NCT03137992|38252135|FG004|Washout Period 1|Adverse Event|0|||
17114126|NCT03137992|38252136|FG005|Washout Period 1|Adverse Event|1|||
17114127|NCT03137992|38252131|FG000|Washout Period 1|Withdrawal by Subject|0|||
17114128|NCT03137992|38252132|FG001|Washout Period 1|Withdrawal by Subject|1|||
17114129|NCT03137992|38252133|FG002|Washout Period 1|Withdrawal by Subject|1|||
17114130|NCT03137992|38252134|FG003|Washout Period 1|Withdrawal by Subject|0|||
17114131|NCT03137992|38252135|FG004|Washout Period 1|Withdrawal by Subject|0|||
17114132|NCT03137992|38252136|FG005|Washout Period 1|Withdrawal by Subject|0|||
17114133|NCT03137992|38252131|FG000|Washout Period 1|Principal Investigator Discretion|0|||
17114134|NCT03137992|38252132|FG001|Washout Period 1|Principal Investigator Discretion|1|||
17114135|NCT03137992|38252133|FG002|Washout Period 1|Principal Investigator Discretion|0|||
17114136|NCT03137992|38252134|FG003|Washout Period 1|Principal Investigator Discretion|0|||
17114137|NCT03137992|38252135|FG004|Washout Period 1|Principal Investigator Discretion|0|||
17114138|NCT03137992|38252136|FG005|Washout Period 1|Principal Investigator Discretion|0|||
17114139|NCT03137992|38252131|FG000|Washout Period 1|COPD Exacerbation|1|||
17114140|NCT03137992|38252132|FG001|Washout Period 1|COPD Exacerbation|1|||
17114141|NCT03137992|38252133|FG002|Washout Period 1|COPD Exacerbation|1|||
17114142|NCT03137992|38252134|FG003|Washout Period 1|COPD Exacerbation|0|||
17114143|NCT03137992|38252135|FG004|Washout Period 1|COPD Exacerbation|1|||
17114144|NCT03137992|38252136|FG005|Washout Period 1|COPD Exacerbation|1|||
17114145|NCT03137992|38252131|FG000|Washout Period 1|Subject Noncompliance|1|||
17114146|NCT03137992|38252132|FG001|Washout Period 1|Subject Noncompliance|0|||
17114147|NCT03137992|38252133|FG002|Washout Period 1|Subject Noncompliance|0|||
17114148|NCT03137992|38252134|FG003|Washout Period 1|Subject Noncompliance|0|||
17114149|NCT03137992|38252135|FG004|Washout Period 1|Subject Noncompliance|1|||
17114150|NCT03137992|38252136|FG005|Washout Period 1|Subject Noncompliance|0|||
17114151|NCT03137992|38252131|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
17114152|NCT03137992|38252132|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
17114153|NCT03137992|38252133|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
17114154|NCT03137992|38252134|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
17114155|NCT03137992|38252135|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
17114156|NCT03137992|38252136|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
17114157|NCT03137992|38252131|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
17114158|NCT03137992|38252132|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
17114159|NCT03137992|38252133|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
17114160|NCT03137992|38252134|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
17114161|NCT03137992|38252135|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
17114162|NCT03137992|38252136|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
17114163|NCT03137992|38252131|FG000|Period 2 (Visit 3)|Adverse Event|0|||
17114164|NCT03137992|38252132|FG001|Period 2 (Visit 3)|Adverse Event|1|||
17114165|NCT03137992|38252133|FG002|Period 2 (Visit 3)|Adverse Event|0|||
17114166|NCT03137992|38252134|FG003|Period 2 (Visit 3)|Adverse Event|0|||
17114167|NCT03137992|38252135|FG004|Period 2 (Visit 3)|Adverse Event|0|||
17114168|NCT03137992|38252136|FG005|Period 2 (Visit 3)|Adverse Event|0|||
17114169|NCT03137992|38252131|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
17114170|NCT03137992|38252132|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
17114171|NCT03137992|38252133|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
17114172|NCT03137992|38252134|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
17114173|NCT03137992|38252135|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
17114174|NCT03137992|38252136|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
17114175|NCT03137992|38252131|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
17114176|NCT03137992|38252132|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
17114177|NCT03137992|38252133|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
17114178|NCT03137992|38252134|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
17114179|NCT03137992|38252135|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
17114180|NCT03137992|38252136|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
17114181|NCT03137992|38252131|FG000|Washout Period 2|COPD Exacerbation|1|||
17114182|NCT03137992|38252132|FG001|Washout Period 2|COPD Exacerbation|1|||
17114183|NCT03137992|38252133|FG002|Washout Period 2|COPD Exacerbation|0|||
17114184|NCT03137992|38252134|FG003|Washout Period 2|COPD Exacerbation|0|||
17114185|NCT03137992|38252135|FG004|Washout Period 2|COPD Exacerbation|1|||
17114186|NCT03137992|38252136|FG005|Washout Period 2|COPD Exacerbation|0|||
17114187|NCT03137992|38252131|FG000|Washout Period 2|Subject Non-compliance|0|||
17114188|NCT03137992|38252132|FG001|Washout Period 2|Subject Non-compliance|1|||
17114189|NCT03137992|38252133|FG002|Washout Period 2|Subject Non-compliance|0|||
17114190|NCT03137992|38252134|FG003|Washout Period 2|Subject Non-compliance|0|||
17114191|NCT03137992|38252135|FG004|Washout Period 2|Subject Non-compliance|0|||
17114192|NCT03137992|38252136|FG005|Washout Period 2|Subject Non-compliance|0|||
17114193|NCT03137992|38252131|FG000|Washout Period 2|Adverse Event|0|||
17114194|NCT03137992|38252132|FG001|Washout Period 2|Adverse Event|0|||
17114195|NCT03137992|38252133|FG002|Washout Period 2|Adverse Event|0|||
17114196|NCT03137992|38252134|FG003|Washout Period 2|Adverse Event|1|||
17114197|NCT03137992|38252135|FG004|Washout Period 2|Adverse Event|1|||
17114198|NCT03137992|38252136|FG005|Washout Period 2|Adverse Event|0|||
17114199|NCT03137992|38252131|FG000|Washout Period 2|Withdrawal by Subject|1|||
17114200|NCT03137992|38252132|FG001|Washout Period 2|Withdrawal by Subject|0|||
17114201|NCT03137992|38252133|FG002|Washout Period 2|Withdrawal by Subject|0|||
17114202|NCT03137992|38252134|FG003|Washout Period 2|Withdrawal by Subject|0|||
17114203|NCT03137992|38252135|FG004|Washout Period 2|Withdrawal by Subject|1|||
17114204|NCT03137992|38252136|FG005|Washout Period 2|Withdrawal by Subject|0|||
17114205|NCT03137992|38252131|FG000|Washout Period 2|Sponsor Decision|0|||
17114206|NCT03137992|38252132|FG001|Washout Period 2|Sponsor Decision|0|||
17114207|NCT03137992|38252133|FG002|Washout Period 2|Sponsor Decision|0|||
17114208|NCT03137992|38252134|FG003|Washout Period 2|Sponsor Decision|0|||
17114209|NCT03137992|38252135|FG004|Washout Period 2|Sponsor Decision|0|||
17114210|NCT03137992|38252136|FG005|Washout Period 2|Sponsor Decision|1|||
17114211|NCT03137992|38252131|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
17114212|NCT03137992|38252132|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
17114213|NCT03137992|38252133|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
17114214|NCT03137992|38252134|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
17114215|NCT03137992|38252135|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
17114216|NCT03137992|38252136|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
17114217|NCT03137992|38252131|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
17114218|NCT03137992|38252132|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
17114219|NCT03137992|38252133|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
17114220|NCT03137992|38252134|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
17114221|NCT03137992|38252135|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
17114222|NCT03137992|38252136|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
17114223|NCT03137992|38252131|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
17114224|NCT03137992|38252132|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
17114225|NCT03137992|38252133|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
17114226|NCT03137992|38252134|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
17114227|NCT03137992|38252135|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
17114228|NCT03137992|38252136|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
17114229|NCT03137992|38252131|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
17114230|NCT03137992|38252132|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
17114231|NCT03137992|38252133|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
17114232|NCT03137992|38252134|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
17114233|NCT03137992|38252135|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
17114234|NCT03137992|38252136|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
17114235|NCT03137992|38252131|FG000|Part 2 (Open-label Extension)|Per study team|1|||
17114236|NCT03137992|38252132|FG001|Part 2 (Open-label Extension)|Per study team|0|||
17114237|NCT03137992|38252133|FG002|Part 2 (Open-label Extension)|Per study team|0|||
17114238|NCT03137992|38252134|FG003|Part 2 (Open-label Extension)|Per study team|0|||
17114239|NCT03137992|38252135|FG004|Part 2 (Open-label Extension)|Per study team|0|||
17114240|NCT03137992|38252136|FG005|Part 2 (Open-label Extension)|Per study team|0|||
17114241|NCT03137992|38252131|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
17114242|NCT03137992|38252132|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
17114243|NCT03137992|38252133|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
17114244|NCT03137992|38252134|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
17114245|NCT03137992|38252135|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
17114246|NCT03137992|38252136|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
17114247|NCT03703466|38252147|FG000|Overall Study|Death|2|||
17114248|NCT03703466|38252148|FG001|Overall Study|Death|1|||
17114249|NCT03703466|38252149|FG002|Overall Study|Death|0|||
17114250|NCT03703466|38252147|FG000|Overall Study|Protocol Violation|1|||
17114251|NCT03703466|38252148|FG001|Overall Study|Protocol Violation|0|||
17114252|NCT03703466|38252149|FG002|Overall Study|Protocol Violation|0|||
17114253|NCT03703466|38252147|FG000|Overall Study|Withdrawal by Subject|0|||
17114254|NCT03703466|38252148|FG001|Overall Study|Withdrawal by Subject|3|||
17114255|NCT03703466|38252149|FG002|Overall Study|Withdrawal by Subject|0|||
17114256|NCT03703466|38252147|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
17114257|NCT03703466|38252148|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
17114258|NCT03703466|38252149|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
17114259|NCT03704636|38252158|FG000|Overall Study|Inadequate Venous Flow|3|||
17114260|NCT05096312|38252173|FG000|Overall Study|Lost to Follow-up|2|||
17114261|NCT05096312|38252174|FG001|Overall Study|Lost to Follow-up|4|||
17114262|NCT05096312|38252173|FG000|Overall Study|Adverse Event|1|||
17114263|NCT05096312|38252174|FG001|Overall Study|Adverse Event|0|||
17114264|NCT04908488|38252182|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
17114265|NCT04908488|38252183|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
17114266|NCT04908488|38252182|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
17114267|NCT04908488|38252183|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
17114268|NCT04876274|38252194|FG000|Overall Study|Lost to Follow-up|9|||
17114269|NCT04876274|38252195|FG001|Overall Study|Lost to Follow-up|12|||
17114270|NCT04865354|38252203|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
17114271|NCT04865354|38252204|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
17114272|NCT04865354|38252203|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
17114273|NCT04865354|38252204|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
17114274|NCT04865354|38252203|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
17114275|NCT04865354|38252204|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
17114276|NCT04860518|38252215|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
17114277|NCT04860518|38252216|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
17114278|NCT03110380|38252224|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
17114279|NCT03110380|38252225|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
17114280|NCT03110380|38252226|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
17114281|NCT03110380|38252227|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
17114282|NCT03110380|38252224|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
17114283|NCT03110380|38252225|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
17114284|NCT03110380|38252226|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
17114285|NCT03110380|38252227|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
17114286|NCT03110380|38252224|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
17114287|NCT03110380|38252225|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
17114288|NCT03110380|38252226|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
17114289|NCT03110380|38252227|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
17114290|NCT03110380|38252224|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
17114291|NCT03110380|38252225|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
17114292|NCT03110380|38252226|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
17114293|NCT03110380|38252227|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
17114294|NCT03110380|38252224|FG000|Double-Blind Treatment Phase|Death|2|||
17114295|NCT03110380|38252225|FG001|Double-Blind Treatment Phase|Death|1|||
17114296|NCT03110380|38252226|FG002|Double-Blind Treatment Phase|Death|0|||
17114297|NCT03110380|38252227|FG003|Double-Blind Treatment Phase|Death|0|||
17114298|NCT03110380|38252224|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
17114299|NCT03110380|38252225|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
17114300|NCT03110380|38252226|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
17114301|NCT03110380|38252227|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
17114302|NCT03110380|38252224|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
17114303|NCT03110380|38252225|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
17114304|NCT03110380|38252226|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
17114305|NCT03110380|38252227|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
17114306|NCT03110380|38252224|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
17114307|NCT03110380|38252225|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
17114308|NCT03110380|38252226|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
17114309|NCT03110380|38252227|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
17114310|NCT03110380|38252224|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
17114311|NCT03110380|38252225|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
17114312|NCT03110380|38252226|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
17114313|NCT03110380|38252227|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
17114314|NCT03110380|38252224|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
17114315|NCT03110380|38252225|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
17114316|NCT03110380|38252226|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
17114317|NCT03110380|38252227|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
17114318|NCT03110380|38252224|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
17114319|NCT03110380|38252225|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
17114320|NCT03110380|38252226|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
17114321|NCT03110380|38252227|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
17114322|NCT04851314|38252237|FG000|Overall Study|Unable to complete research set-up procedures|0|||
17114323|NCT04851314|38252238|FG001|Overall Study|Unable to complete research set-up procedures|2|||
17114324|NCT04851314|38252237|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
17114325|NCT04851314|38252238|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
17114326|NCT04848662|38252246|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
17114327|NCT04848662|38252247|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
17114328|NCT03701516|38252253|FG000|Period 1|Lost to Follow-up|0|||
17114329|NCT03701516|38252254|FG001|Period 1|Lost to Follow-up|1|||
17114330|NCT03701516|38252253|FG000|Period 1|Adverse Event|0|||
17114331|NCT03701516|38252254|FG001|Period 1|Adverse Event|2|||
17114332|NCT03701516|38252253|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
17114333|NCT03701516|38252254|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
17114334|NCT03701516|38252253|FG000|Period 1|Non Compliance to Protocol|2|||
17114335|NCT03701516|38252254|FG001|Period 1|Non Compliance to Protocol|1|||
17114336|NCT03701516|38252253|FG000|Period 1|Withdrawal by Subject|0|||
17114337|NCT03701516|38252254|FG001|Period 1|Withdrawal by Subject|1|||
17114338|NCT03701516|38252253|FG000|Period 2|failed to meet all eligibility creiteria|1|||
17114339|NCT03701516|38252254|FG001|Period 2|failed to meet all eligibility creiteria|0|||
17114340|NCT03701516|38252253|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
17114341|NCT03701516|38252254|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
17114342|NCT03700892|38252262|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
17114343|NCT03700892|38252263|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
17114344|NCT03700892|38252264|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
17114345|NCT03700736|38252275|FG000|Overall Study|Pregnancy|1|||
17114346|NCT03700736|38252276|FG001|Overall Study|Pregnancy|1|||
17114347|NCT03700736|38252275|FG000|Overall Study|Withdrawal by Subject|2|||
17114348|NCT03700736|38252276|FG001|Overall Study|Withdrawal by Subject|6|||
17114349|NCT04737278|38252287|FG000|Overall Study|Lost to Follow-up|1|||
17114350|NCT04737278|38252288|FG001|Overall Study|Lost to Follow-up|1|||
17114351|NCT04737278|38252287|FG000|Overall Study|Withdrawal by Subject|1|||
17114352|NCT04737278|38252288|FG001|Overall Study|Withdrawal by Subject|0|||
17114353|NCT04737278|38252287|FG000|Overall Study|Protocol Violation|1|||
17114354|NCT04737278|38252288|FG001|Overall Study|Protocol Violation|1|||
17114355|NCT04737278|38252287|FG000|Overall Study|failure to complete questionnaire|1|||
17114356|NCT04737278|38252288|FG001|Overall Study|failure to complete questionnaire|1|||
17114357|NCT04725500|38252294|FG000|Screening|Screen Failure|26|||
17114358|NCT04725500|38252294|FG000|Screening|Withdrawal by Subject|1|||
17114359|NCT04725500|38252294|FG000|2 Week Take Home|Screen Fail|5|||
17114360|NCT04684394|38252300|FG000|Overall Study|Death|1|||
17114361|NCT04684394|38252301|FG001|Overall Study|Death|2|||
17114362|NCT04684394|38252300|FG000|Overall Study|Lost to Follow-up|1|||
17114363|NCT04684394|38252301|FG001|Overall Study|Lost to Follow-up|0|||
17114364|NCT04684394|38252300|FG000|Overall Study|Withdrawal by Subject|2|||
17114365|NCT04684394|38252301|FG001|Overall Study|Withdrawal by Subject|0|||
17114366|NCT04684394|38252300|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
17114367|NCT04684394|38252301|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
17114368|NCT04674644|38252307|FG000|Overall Study|with missing data|37|||
17114369|NCT04668950|38252314|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
17114370|NCT04668950|38252315|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
17114371|NCT04668950|38252314|FG000|Overall Study|Could not confirm started study medication|15|||
17114372|NCT04668950|38252315|FG001|Overall Study|Could not confirm started study medication|15|||
17114373|NCT04668950|38252314|FG000|Overall Study|Could not confirm baseline status|6|||
17114374|NCT04668950|38252315|FG001|Overall Study|Could not confirm baseline status|2|||
17114375|NCT04668950|38252314|FG000|Overall Study|Drop out and did not start medication|15|||
17114376|NCT04668950|38252315|FG001|Overall Study|Drop out and did not start medication|17|||
17114377|NCT04668950|38252314|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
17114378|NCT04668950|38252315|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
17114379|NCT04668950|38252314|FG000|Overall Study|Other|2|||
17114380|NCT04668950|38252315|FG001|Overall Study|Other|4|||
17114381|NCT03078478|38252323|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
17114382|NCT03078478|38252324|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
17114383|NCT03078478|38252323|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
17114384|NCT03078478|38252324|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
17114385|NCT03078478|38252323|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
17114386|NCT03078478|38252324|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
17114387|NCT03078478|38252323|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
17114388|NCT03078478|38252324|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
17114389|NCT03078478|38252323|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
17114390|NCT03078478|38252324|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
17114391|NCT03078478|38252323|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
17114392|NCT03078478|38252324|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
17114393|NCT03078478|38252323|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
17114394|NCT03078478|38252324|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
17114395|NCT03078478|38252323|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
17114396|NCT03078478|38252324|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
17114397|NCT03539458|38252330|FG000|Overall Study|Death|1|||
17114398|NCT02879578|38252337|FG000|Overall Study|Adverse Event|1|||
17114399|NCT02879578|38252338|FG001|Overall Study|Adverse Event|2|||
17114400|NCT02879578|38252339|FG002|Overall Study|Adverse Event|14|||
17114401|NCT02879578|38252337|FG000|Overall Study|Protocol Violation|0|||
17114402|NCT02879578|38252338|FG001|Overall Study|Protocol Violation|1|||
17114403|NCT02879578|38252339|FG002|Overall Study|Protocol Violation|1|||
17114404|NCT02879578|38252337|FG000|Overall Study|Withdrawal by Subject|8|||
17114405|NCT02879578|38252338|FG001|Overall Study|Withdrawal by Subject|6|||
17114406|NCT02879578|38252339|FG002|Overall Study|Withdrawal by Subject|9|||
17114407|NCT02879578|38252337|FG000|Overall Study|Lost to Follow-up|1|||
17114408|NCT02879578|38252338|FG001|Overall Study|Lost to Follow-up|0|||
17114409|NCT02879578|38252339|FG002|Overall Study|Lost to Follow-up|4|||
17114410|NCT02879578|38252337|FG000|Overall Study|Physician Decision|0|||
17114411|NCT02879578|38252338|FG001|Overall Study|Physician Decision|0|||
17114412|NCT02879578|38252339|FG002|Overall Study|Physician Decision|4|||
17114413|NCT00045942|38252356|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
17114414|NCT00045942|38252357|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
17114415|NCT00045942|38252358|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
17114416|NCT00045942|38252359|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
17114417|NCT00045942|38252360|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
17114418|NCT00045942|38252361|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
17114419|NCT00045942|38252362|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
17114420|NCT00045942|38252363|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
17114421|NCT00045942|38252364|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
17114422|NCT00045942|38252356|FG000|PKC412A2104 (Core)|Adverse Event|5|||
17114423|NCT00045942|38252357|FG001|PKC412A2104 (Core)|Adverse Event|0|||
17114424|NCT00045942|38252358|FG002|PKC412A2104 (Core)|Adverse Event|0|||
17114425|NCT00045942|38252359|FG003|PKC412A2104 (Core)|Adverse Event|0|||
17114426|NCT00045942|38252360|FG004|PKC412A2104 (Core)|Adverse Event|0|||
17114427|NCT00045942|38252361|FG005|PKC412A2104 (Core)|Adverse Event|0|||
17114428|NCT00045942|38252362|FG006|PKC412A2104 (Core)|Adverse Event|0|||
17114429|NCT00045942|38252363|FG007|PKC412A2104 (Core)|Adverse Event|0|||
17114430|NCT00045942|38252364|FG008|PKC412A2104 (Core)|Adverse Event|0|||
17114431|NCT00045942|38252356|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
17114432|NCT00045942|38252357|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
17114433|NCT00045942|38252358|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
17114434|NCT00045942|38252359|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
17114435|NCT00045942|38252360|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
17114436|NCT00045942|38252361|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
17114437|NCT00045942|38252362|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
17114438|NCT00045942|38252363|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
17114439|NCT00045942|38252364|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
17114440|NCT00045942|38252356|FG000|PKC412A2104 (Core)|Death|1|||
17114441|NCT00045942|38252357|FG001|PKC412A2104 (Core)|Death|0|||
17114442|NCT00045942|38252358|FG002|PKC412A2104 (Core)|Death|0|||
17114443|NCT00045942|38252359|FG003|PKC412A2104 (Core)|Death|0|||
17114444|NCT00045942|38252360|FG004|PKC412A2104 (Core)|Death|0|||
17114445|NCT00045942|38252361|FG005|PKC412A2104 (Core)|Death|0|||
17114446|NCT00045942|38252362|FG006|PKC412A2104 (Core)|Death|0|||
17114447|NCT00045942|38252363|FG007|PKC412A2104 (Core)|Death|0|||
17114448|NCT00045942|38252364|FG008|PKC412A2104 (Core)|Death|0|||
17114449|NCT00045942|38252356|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
17114450|NCT00045942|38252357|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
17114451|NCT00045942|38252358|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
17114452|NCT00045942|38252359|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
17114453|NCT00045942|38252360|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
17114454|NCT00045942|38252361|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
17114455|NCT00045942|38252362|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
17114456|NCT00045942|38252363|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
17114457|NCT00045942|38252364|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
17114458|NCT00045942|38252356|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
17114459|NCT00045942|38252357|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
17114460|NCT00045942|38252358|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
17114461|NCT00045942|38252359|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
17114462|NCT00045942|38252360|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
17114463|NCT00045942|38252361|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
17114464|NCT00045942|38252362|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
17114465|NCT00045942|38252363|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
17114466|NCT00045942|38252364|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
17114467|NCT00045942|38252356|FG000|PKC412A2104E1|Lack of Efficacy|0|||
17114468|NCT00045942|38252357|FG001|PKC412A2104E1|Lack of Efficacy|11|||
17114469|NCT00045942|38252358|FG002|PKC412A2104E1|Lack of Efficacy|11|||
17114470|NCT00045942|38252359|FG003|PKC412A2104E1|Lack of Efficacy|23|||
17114471|NCT00045942|38252360|FG004|PKC412A2104E1|Lack of Efficacy|17|||
17114472|NCT00045942|38252361|FG005|PKC412A2104E1|Lack of Efficacy|0|||
17114473|NCT00045942|38252362|FG006|PKC412A2104E1|Lack of Efficacy|0|||
17114474|NCT00045942|38252363|FG007|PKC412A2104E1|Lack of Efficacy|0|||
17114475|NCT00045942|38252364|FG008|PKC412A2104E1|Lack of Efficacy|0|||
17114476|NCT00045942|38252356|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
17114477|NCT00045942|38252357|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
17114478|NCT00045942|38252358|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
17114479|NCT00045942|38252359|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
17114480|NCT00045942|38252360|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
17114481|NCT00045942|38252361|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
17114482|NCT00045942|38252362|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
17114483|NCT00045942|38252363|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
17114484|NCT00045942|38252364|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
17114485|NCT00045942|38252356|FG000|PKC412A2104E1|Adverse Event|0|||
17114486|NCT00045942|38252357|FG001|PKC412A2104E1|Adverse Event|1|||
17114487|NCT00045942|38252358|FG002|PKC412A2104E1|Adverse Event|1|||
17114488|NCT00045942|38252359|FG003|PKC412A2104E1|Adverse Event|3|||
17114489|NCT00045942|38252360|FG004|PKC412A2104E1|Adverse Event|6|||
17114490|NCT00045942|38252361|FG005|PKC412A2104E1|Adverse Event|0|||
17114491|NCT00045942|38252362|FG006|PKC412A2104E1|Adverse Event|0|||
17114492|NCT00045942|38252363|FG007|PKC412A2104E1|Adverse Event|0|||
17114493|NCT00045942|38252364|FG008|PKC412A2104E1|Adverse Event|0|||
17114494|NCT00045942|38252356|FG000|PKC412A2104E1|Death|0|||
17114495|NCT00045942|38252357|FG001|PKC412A2104E1|Death|4|||
17114496|NCT00045942|38252358|FG002|PKC412A2104E1|Death|1|||
17114497|NCT00045942|38252359|FG003|PKC412A2104E1|Death|1|||
17114498|NCT00045942|38252360|FG004|PKC412A2104E1|Death|1|||
17114499|NCT00045942|38252361|FG005|PKC412A2104E1|Death|0|||
17114500|NCT00045942|38252362|FG006|PKC412A2104E1|Death|0|||
17114501|NCT00045942|38252363|FG007|PKC412A2104E1|Death|0|||
17114502|NCT00045942|38252364|FG008|PKC412A2104E1|Death|0|||
17114503|NCT00045942|38252356|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
17114504|NCT00045942|38252357|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
17114505|NCT00045942|38252358|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
17114506|NCT00045942|38252359|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
17114507|NCT00045942|38252360|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
17114508|NCT00045942|38252361|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
17114509|NCT00045942|38252362|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
17114510|NCT00045942|38252363|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
17114511|NCT00045942|38252364|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
17114512|NCT00045942|38252356|FG000|PKC412A2104E2|Lost to Follow-up|0|||
17114513|NCT00045942|38252357|FG001|PKC412A2104E2|Lost to Follow-up|0|||
17114514|NCT00045942|38252358|FG002|PKC412A2104E2|Lost to Follow-up|0|||
17114515|NCT00045942|38252359|FG003|PKC412A2104E2|Lost to Follow-up|0|||
17114516|NCT00045942|38252360|FG004|PKC412A2104E2|Lost to Follow-up|0|||
17114517|NCT00045942|38252361|FG005|PKC412A2104E2|Lost to Follow-up|0|||
17114518|NCT00045942|38252362|FG006|PKC412A2104E2|Lost to Follow-up|0|||
17114519|NCT00045942|38252363|FG007|PKC412A2104E2|Lost to Follow-up|3|||
17114520|NCT00045942|38252364|FG008|PKC412A2104E2|Lost to Follow-up|0|||
17114521|NCT00045942|38252356|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
17114522|NCT00045942|38252357|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
17114523|NCT00045942|38252358|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
17114524|NCT00045942|38252359|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
17114525|NCT00045942|38252360|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
17114526|NCT00045942|38252361|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
17114527|NCT00045942|38252362|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
17114528|NCT00045942|38252363|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
17114529|NCT00045942|38252364|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
17114530|NCT00045942|38252356|FG000|PKC412A2104E2|Lack of Efficacy|0|||
17114531|NCT00045942|38252357|FG001|PKC412A2104E2|Lack of Efficacy|0|||
17114532|NCT00045942|38252358|FG002|PKC412A2104E2|Lack of Efficacy|0|||
17114533|NCT00045942|38252359|FG003|PKC412A2104E2|Lack of Efficacy|0|||
17114534|NCT00045942|38252360|FG004|PKC412A2104E2|Lack of Efficacy|0|||
17114535|NCT00045942|38252361|FG005|PKC412A2104E2|Lack of Efficacy|3|||
17114536|NCT00045942|38252362|FG006|PKC412A2104E2|Lack of Efficacy|2|||
17114537|NCT00045942|38252363|FG007|PKC412A2104E2|Lack of Efficacy|2|||
17114538|NCT00045942|38252364|FG008|PKC412A2104E2|Lack of Efficacy|6|||
17114539|NCT00045942|38252356|FG000|PKC412A2104E2|Adverse Event|0|||
17114540|NCT00045942|38252357|FG001|PKC412A2104E2|Adverse Event|0|||
17114541|NCT00045942|38252358|FG002|PKC412A2104E2|Adverse Event|0|||
17114542|NCT00045942|38252359|FG003|PKC412A2104E2|Adverse Event|0|||
17114543|NCT00045942|38252360|FG004|PKC412A2104E2|Adverse Event|0|||
17114544|NCT00045942|38252361|FG005|PKC412A2104E2|Adverse Event|4|||
17114545|NCT00045942|38252362|FG006|PKC412A2104E2|Adverse Event|3|||
17114546|NCT00045942|38252363|FG007|PKC412A2104E2|Adverse Event|1|||
17114547|NCT00045942|38252364|FG008|PKC412A2104E2|Adverse Event|0|||
17114548|NCT00045942|38252356|FG000|PKC412A2104E2|Death|0|||
17114549|NCT00045942|38252357|FG001|PKC412A2104E2|Death|0|||
17114550|NCT00045942|38252358|FG002|PKC412A2104E2|Death|0|||
17114551|NCT00045942|38252359|FG003|PKC412A2104E2|Death|0|||
17114552|NCT00045942|38252360|FG004|PKC412A2104E2|Death|0|||
17114553|NCT00045942|38252361|FG005|PKC412A2104E2|Death|1|||
17114554|NCT00045942|38252362|FG006|PKC412A2104E2|Death|2|||
17114555|NCT00045942|38252363|FG007|PKC412A2104E2|Death|0|||
17114556|NCT00045942|38252364|FG008|PKC412A2104E2|Death|0|||
17114557|NCT04386616|38252391|FG000|Overall Study|Death|22|||
17114558|NCT04386616|38252392|FG001|Overall Study|Death|22|||
17114559|NCT04386616|38252393|FG002|Overall Study|Death|21|||
17114560|NCT04386616|38252391|FG000|Overall Study|Lost to Follow-up|5|||
17114561|NCT04386616|38252392|FG001|Overall Study|Lost to Follow-up|8|||
17114562|NCT04386616|38252393|FG002|Overall Study|Lost to Follow-up|6|||
17114563|NCT04386616|38252391|FG000|Overall Study|Withdrawal by Subject|2|||
17114564|NCT04386616|38252392|FG001|Overall Study|Withdrawal by Subject|4|||
17114565|NCT04386616|38252393|FG002|Overall Study|Withdrawal by Subject|1|||
17114566|NCT04386616|38252391|FG000|Overall Study|Adverse Event|1|||
17114567|NCT04386616|38252392|FG001|Overall Study|Adverse Event|1|||
17114568|NCT04386616|38252393|FG002|Overall Study|Adverse Event|0|||
17114569|NCT00045708|38252413|FG000|Phase 1|early progressive disease|0|||
17114570|NCT00045708|38252414|FG001|Phase 1|early progressive disease|1|||
17114571|NCT00045708|38252415|FG002|Phase 1|early progressive disease|0|||
17114572|NCT00045630|38252432|FG000|Overall Study|Adverse Event|1|||
17114573|NCT00045630|38252432|FG000|Overall Study|Refusal unrelated to adverse event|1|||
17114574|NCT00045630|38252432|FG000|Overall Study|Progression/relapse|1|||
17114575|NCT00045630|38252432|FG000|Overall Study|Death|1|||
17114576|NCT00045630|38252432|FG000|Overall Study|Ineligible|2|||
17199786|NCT02777333|38353759|FG001|Overall Study|Withdrawal by Subject|1|||
17199787|NCT02777333|38353758|FG000|Overall Study|Lost to Follow-up|0|||
17199788|NCT02777333|38353759|FG001|Overall Study|Lost to Follow-up|1|||
17199789|NCT02695329|38353767|FG000|Overall Study|Adverse Event|1|||
17199790|NCT02695329|38353768|FG001|Overall Study|Adverse Event|0|||
17199791|NCT02695329|38353767|FG000|Overall Study|Poor X-ray quality for measurement|4|||
17199792|NCT02695329|38353768|FG001|Overall Study|Poor X-ray quality for measurement|5|||
17199793|NCT02690649|38353776|FG000|Overall Study|Withdrawal by Subject|1|||
17199794|NCT02690649|38353777|FG001|Overall Study|Withdrawal by Subject|1|||
17199795|NCT02690649|38353776|FG000|Overall Study|Protocol Violation|0|||
17199796|NCT02690649|38353777|FG001|Overall Study|Protocol Violation|3|||
17199797|NCT01358864|38353793|FG000|Overall Study|Adverse Event|0|||
17199798|NCT01358864|38353794|FG001|Overall Study|Adverse Event|6|||
17199799|NCT01358864|38353795|FG002|Overall Study|Adverse Event|9|||
17199800|NCT01358864|38353796|FG003|Overall Study|Adverse Event|0|||
17199801|NCT01358864|38353797|FG004|Overall Study|Adverse Event|4|||
17199802|NCT01358864|38353798|FG005|Overall Study|Adverse Event|8|||
17199803|NCT01358864|38353799|FG006|Overall Study|Adverse Event|12|||
17199804|NCT01358864|38353800|FG007|Overall Study|Adverse Event|7|||
17199805|NCT01358864|38353793|FG000|Overall Study|Lack of Efficacy|26|||
17199806|NCT01358864|38353794|FG001|Overall Study|Lack of Efficacy|3|||
17199807|NCT01358864|38353795|FG002|Overall Study|Lack of Efficacy|4|||
17199808|NCT01358864|38353796|FG003|Overall Study|Lack of Efficacy|19|||
17199809|NCT01358864|38353797|FG004|Overall Study|Lack of Efficacy|7|||
17199810|NCT01358864|38353798|FG005|Overall Study|Lack of Efficacy|4|||
17199811|NCT01358864|38353799|FG006|Overall Study|Lack of Efficacy|49|||
17199812|NCT01358864|38353800|FG007|Overall Study|Lack of Efficacy|44|||
17199813|NCT01358864|38353793|FG000|Overall Study|Lost to Follow-up|0|||
17199814|NCT01358864|38353794|FG001|Overall Study|Lost to Follow-up|0|||
17199815|NCT01358864|38353795|FG002|Overall Study|Lost to Follow-up|1|||
17199816|NCT01358864|38353796|FG003|Overall Study|Lost to Follow-up|0|||
17199817|NCT01358864|38353797|FG004|Overall Study|Lost to Follow-up|0|||
17199818|NCT01358864|38353798|FG005|Overall Study|Lost to Follow-up|0|||
17199819|NCT01358864|38353799|FG006|Overall Study|Lost to Follow-up|0|||
17199820|NCT01358864|38353800|FG007|Overall Study|Lost to Follow-up|1|||
17199821|NCT01358864|38353793|FG000|Overall Study|Withdrawal by Subject|3|||
17199822|NCT01358864|38353794|FG001|Overall Study|Withdrawal by Subject|4|||
17199823|NCT01358864|38353795|FG002|Overall Study|Withdrawal by Subject|2|||
17199824|NCT01358864|38353796|FG003|Overall Study|Withdrawal by Subject|0|||
17199825|NCT01358864|38353797|FG004|Overall Study|Withdrawal by Subject|0|||
17199826|NCT01358864|38353798|FG005|Overall Study|Withdrawal by Subject|1|||
17199827|NCT01358864|38353799|FG006|Overall Study|Withdrawal by Subject|1|||
17199828|NCT01358864|38353800|FG007|Overall Study|Withdrawal by Subject|3|||
17199829|NCT01358864|38353793|FG000|Overall Study|Other reason not defined above|2|||
17199830|NCT01358864|38353794|FG001|Overall Study|Other reason not defined above|0|||
17199831|NCT01358864|38353795|FG002|Overall Study|Other reason not defined above|0|||
17199832|NCT01358864|38353796|FG003|Overall Study|Other reason not defined above|0|||
17199833|NCT01358864|38353797|FG004|Overall Study|Other reason not defined above|0|||
17199834|NCT01358864|38353798|FG005|Overall Study|Other reason not defined above|0|||
17199835|NCT01358864|38353799|FG006|Overall Study|Other reason not defined above|2|||
17199836|NCT01358864|38353800|FG007|Overall Study|Other reason not defined above|0|||
17199837|NCT01358864|38353793|FG000|Overall Study|Not treated|0|||
17199838|NCT01358864|38353794|FG001|Overall Study|Not treated|0|||
17199839|NCT01358864|38353795|FG002|Overall Study|Not treated|0|||
17199840|NCT01358864|38353796|FG003|Overall Study|Not treated|0|||
17199841|NCT01358864|38353797|FG004|Overall Study|Not treated|0|||
17199842|NCT01358864|38353798|FG005|Overall Study|Not treated|0|||
17199843|NCT01358864|38353799|FG006|Overall Study|Not treated|1|||
17199844|NCT01358864|38353800|FG007|Overall Study|Not treated|0|||
17199845|NCT02750761|38353826|FG000|Overall Study|Lost to Follow-up|0|||
17199846|NCT02750761|38353827|FG001|Overall Study|Lost to Follow-up|0|||
17199847|NCT02750761|38353828|FG002|Overall Study|Lost to Follow-up|1|||
17199848|NCT02750761|38353829|FG003|Overall Study|Lost to Follow-up|0|||
17199849|NCT02750761|38353830|FG004|Overall Study|Lost to Follow-up|0|||
17199850|NCT02750761|38353831|FG005|Overall Study|Lost to Follow-up|0|||
17199851|NCT02688933|38353874|FG000|Overall Study|Adverse Event|3|||
17199852|NCT02688933|38353875|FG001|Overall Study|Adverse Event|1|||
17199853|NCT02688933|38353874|FG000|Overall Study|Lack of Efficacy|2|||
17199854|NCT02688933|38353875|FG001|Overall Study|Lack of Efficacy|2|||
17199855|NCT02688933|38353874|FG000|Overall Study|Poor compliance to protocol|7|||
17199856|NCT02688933|38353875|FG001|Overall Study|Poor compliance to protocol|4|||
17199857|NCT02688933|38353874|FG000|Overall Study|Hypoglycemia|2|||
17199858|NCT02688933|38353875|FG001|Overall Study|Hypoglycemia|0|||
17199859|NCT02688933|38353874|FG000|Overall Study|Other than Specified|14|||
17199860|NCT02688933|38353875|FG001|Overall Study|Other than Specified|25|||
17199861|NCT02688933|38353874|FG000|Overall Study|Lost to Follow-up|1|||
17199862|NCT02688933|38353875|FG001|Overall Study|Lost to Follow-up|5|||
17199863|NCT02688621|38353895|FG000|Overall Study|Pregnancy|1|||
17199864|NCT02688621|38353896|FG001|Overall Study|Pregnancy|3|||
17199865|NCT02688621|38353895|FG000|Overall Study|Lost to Follow-up|38|||
17199866|NCT02688621|38353896|FG001|Overall Study|Lost to Follow-up|15|||
17199867|NCT02688621|38353895|FG000|Overall Study|Withdrawal by Subject|1|||
17199868|NCT02688621|38353896|FG001|Overall Study|Withdrawal by Subject|0|||
17199869|NCT04227704|38353908|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
17199870|NCT04227704|38353909|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
17199871|NCT04227704|38353910|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
17199872|NCT04227704|38353908|FG000|Overall Study|due to C/S being cancelled|1|||
17199873|NCT04227704|38353909|FG001|Overall Study|due to C/S being cancelled|0|||
17199874|NCT04227704|38353910|FG002|Overall Study|due to C/S being cancelled|0|||
17199875|NCT03530293|38353920|FG000|Pre-randomization|Adverse Event|12|||
17199876|NCT03530293|38353921|FG001|Pre-randomization|Adverse Event|0|||
17199877|NCT03530293|38353922|FG002|Pre-randomization|Adverse Event|0|||
17199878|NCT03530293|38353920|FG000|Pre-randomization|Protocol Violation|2|||
17199879|NCT03530293|38353921|FG001|Pre-randomization|Protocol Violation|0|||
17199880|NCT03530293|38353922|FG002|Pre-randomization|Protocol Violation|0|||
17199881|NCT03530293|38353920|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
17199882|NCT03530293|38353921|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
17199883|NCT03530293|38353922|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
17199884|NCT03530293|38353920|FG000|Pre-randomization|Withdrawal by Subject|5|||
17199885|NCT03530293|38353921|FG001|Pre-randomization|Withdrawal by Subject|0|||
17199886|NCT03530293|38353922|FG002|Pre-randomization|Withdrawal by Subject|0|||
17199887|NCT03530293|38353920|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
17199888|NCT03530293|38353921|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
17199889|NCT03530293|38353922|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
17199890|NCT03530293|38353920|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
17199891|NCT03530293|38353921|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
17199892|NCT03530293|38353922|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
17199893|NCT03530293|38353920|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
17199894|NCT03530293|38353921|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
17199895|NCT03530293|38353922|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
17199896|NCT03530293|38353920|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
17199897|NCT03530293|38353921|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
17199898|NCT03530293|38353922|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
17199899|NCT03530293|38353920|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
17199900|NCT03530293|38353921|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
17199901|NCT03530293|38353922|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
17199902|NCT01662986|38353957|FG000|Overall Study|Adverse Event|5|||
17199903|NCT01662986|38353958|FG001|Overall Study|Adverse Event|4|||
17199904|NCT01662986|38353957|FG000|Overall Study|Protocol Violation|2|||
17199905|NCT01662986|38353958|FG001|Overall Study|Protocol Violation|3|||
17199906|NCT01662986|38353957|FG000|Overall Study|Lost to Follow-up|5|||
17199907|NCT01662986|38353958|FG001|Overall Study|Lost to Follow-up|4|||
17199908|NCT01662986|38353957|FG000|Overall Study|Withdrawal by Subject|2|||
17199909|NCT01662986|38353958|FG001|Overall Study|Withdrawal by Subject|2|||
17199910|NCT01662986|38353957|FG000|Overall Study|Not Treated|1|||
17199911|NCT01662986|38353958|FG001|Overall Study|Not Treated|0|||
17199912|NCT01662986|38353957|FG000|Overall Study|Other than stated above|3|||
17199913|NCT01662986|38353958|FG001|Overall Study|Other than stated above|0|||
17199914|NCT01337167|38353966|FG000|Infant Series|Adverse Event|1|||
17199915|NCT01337167|38353967|FG001|Infant Series|Adverse Event|1|||
17199916|NCT01337167|38353966|FG000|Infant Series|Death|1|||
17199917|NCT01337167|38353967|FG001|Infant Series|Death|1|||
17199918|NCT01337167|38353966|FG000|Infant Series|Lost to Follow-up|13|||
17199919|NCT01337167|38353967|FG001|Infant Series|Lost to Follow-up|7|||
17199920|NCT01337167|38353966|FG000|Infant Series|Non-compliance with study drug|2|||
17199921|NCT01337167|38353967|FG001|Infant Series|Non-compliance with study drug|1|||
17199922|NCT01337167|38353966|FG000|Infant Series|Physician Decision|3|||
17199923|NCT01337167|38353967|FG001|Infant Series|Physician Decision|1|||
17199924|NCT01337167|38353966|FG000|Infant Series|Protocol Violation|22|||
17199925|NCT01337167|38353967|FG001|Infant Series|Protocol Violation|9|||
17199926|NCT01337167|38353966|FG000|Infant Series|Withdrawal by Subject|15|||
17199927|NCT01337167|38353967|FG001|Infant Series|Withdrawal by Subject|4|||
17199928|NCT01337167|38353966|FG000|Infant Series|Randomized but not vaccinated|5|||
17199929|NCT01337167|38353967|FG001|Infant Series|Randomized but not vaccinated|3|||
17199930|NCT01337167|38353966|FG000|Interim Period|Lost to Follow-up|51|||
17199931|NCT01337167|38353967|FG001|Interim Period|Lost to Follow-up|23|||
17199932|NCT01337167|38353966|FG000|Interim Period|Non-compliance with study drug|1|||
17199933|NCT01337167|38353967|FG001|Interim Period|Non-compliance with study drug|0|||
17199934|NCT01337167|38353966|FG000|Interim Period|Physician Decision|6|||
17199935|NCT01337167|38353967|FG001|Interim Period|Physician Decision|3|||
17199936|NCT01337167|38353966|FG000|Interim Period|Protocol Violation|5|||
17199937|NCT01337167|38353967|FG001|Interim Period|Protocol Violation|3|||
17199938|NCT01337167|38353966|FG000|Interim Period|Withdrawal by Subject|18|||
17199939|NCT01337167|38353967|FG001|Interim Period|Withdrawal by Subject|10|||
17199940|NCT01337167|38353966|FG000|Interim Period|Other protocol criterion not met|0|||
17199941|NCT01337167|38353967|FG001|Interim Period|Other protocol criterion not met|1|||
17199942|NCT01337167|38353966|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
17199943|NCT01337167|38353967|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
17199944|NCT01337167|38353966|FG000|Toddler Vaccinations|Protocol Violation|0|||
17199945|NCT01337167|38353967|FG001|Toddler Vaccinations|Protocol Violation|1|||
17199946|NCT01337167|38353966|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
17199947|NCT01337167|38353967|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
17199948|NCT01338025|38353975|FG000|Overall Study|Unexpected closure of study|10|||
17199949|NCT01338025|38353976|FG001|Overall Study|Unexpected closure of study|9|||
17199950|NCT01338025|38353975|FG000|Overall Study|Withdrawal by Subject|0|||
17199951|NCT01338025|38353976|FG001|Overall Study|Withdrawal by Subject|2|||
17199952|NCT01338025|38353975|FG000|Overall Study|Found ineligible after starting|1|||
17199953|NCT01338025|38353976|FG001|Overall Study|Found ineligible after starting|0|||
17199954|NCT02559206|38354020|FG000|Overall Study|Adverse Event|0|||
17199955|NCT02559206|38354021|FG001|Overall Study|Adverse Event|4|||
17199956|NCT02559206|38354022|FG002|Overall Study|Adverse Event|1|||
17199957|NCT02559206|38354023|FG003|Overall Study|Adverse Event|5|||
17199958|NCT02559206|38354024|FG004|Overall Study|Adverse Event|3|||
17199959|NCT02559206|38354025|FG005|Overall Study|Adverse Event|0|||
17199960|NCT02559206|38354026|FG006|Overall Study|Adverse Event|1|||
17199961|NCT02559206|38354027|FG007|Overall Study|Adverse Event|0|||
17199962|NCT02559206|38354020|FG000|Overall Study|Protocol Violation|1|||
17199963|NCT02559206|38354021|FG001|Overall Study|Protocol Violation|0|||
17199964|NCT02559206|38354022|FG002|Overall Study|Protocol Violation|1|||
17199965|NCT02559206|38354023|FG003|Overall Study|Protocol Violation|0|||
17199966|NCT02559206|38354024|FG004|Overall Study|Protocol Violation|0|||
17199967|NCT02559206|38354025|FG005|Overall Study|Protocol Violation|2|||
17199968|NCT02559206|38354026|FG006|Overall Study|Protocol Violation|0|||
17199969|NCT02559206|38354027|FG007|Overall Study|Protocol Violation|0|||
17199970|NCT02559206|38354020|FG000|Overall Study|Withdrawal by Subject|3|||
17199971|NCT02559206|38354021|FG001|Overall Study|Withdrawal by Subject|3|||
17199972|NCT02559206|38354022|FG002|Overall Study|Withdrawal by Subject|1|||
17199973|NCT02559206|38354023|FG003|Overall Study|Withdrawal by Subject|3|||
17199974|NCT02559206|38354024|FG004|Overall Study|Withdrawal by Subject|5|||
17199975|NCT02559206|38354025|FG005|Overall Study|Withdrawal by Subject|4|||
17199976|NCT02559206|38354026|FG006|Overall Study|Withdrawal by Subject|1|||
17199977|NCT02559206|38354027|FG007|Overall Study|Withdrawal by Subject|2|||
17199978|NCT02559206|38354020|FG000|Overall Study|Lost to Follow-up|3|||
17199979|NCT02559206|38354021|FG001|Overall Study|Lost to Follow-up|5|||
17199980|NCT02559206|38354022|FG002|Overall Study|Lost to Follow-up|3|||
17199981|NCT02559206|38354023|FG003|Overall Study|Lost to Follow-up|3|||
17199982|NCT02559206|38354024|FG004|Overall Study|Lost to Follow-up|2|||
17199983|NCT02559206|38354025|FG005|Overall Study|Lost to Follow-up|5|||
17199984|NCT02559206|38354026|FG006|Overall Study|Lost to Follow-up|1|||
17199985|NCT02559206|38354027|FG007|Overall Study|Lost to Follow-up|4|||
17199986|NCT02559206|38354020|FG000|Overall Study|Lack of Efficacy|1|||
17199987|NCT02559206|38354021|FG001|Overall Study|Lack of Efficacy|0|||
17199988|NCT02559206|38354022|FG002|Overall Study|Lack of Efficacy|3|||
17199989|NCT02559206|38354023|FG003|Overall Study|Lack of Efficacy|2|||
17199990|NCT02559206|38354024|FG004|Overall Study|Lack of Efficacy|2|||
17199991|NCT02559206|38354025|FG005|Overall Study|Lack of Efficacy|3|||
17199992|NCT02559206|38354026|FG006|Overall Study|Lack of Efficacy|3|||
17199993|NCT02559206|38354027|FG007|Overall Study|Lack of Efficacy|3|||
17199994|NCT02559206|38354020|FG000|Overall Study|Other Not Specified|0|||
17199995|NCT02559206|38354021|FG001|Overall Study|Other Not Specified|0|||
17199996|NCT02559206|38354022|FG002|Overall Study|Other Not Specified|0|||
17199997|NCT02559206|38354023|FG003|Overall Study|Other Not Specified|1|||
17199998|NCT02559206|38354024|FG004|Overall Study|Other Not Specified|0|||
17199999|NCT02559206|38354025|FG005|Overall Study|Other Not Specified|0|||
17200000|NCT02559206|38354026|FG006|Overall Study|Other Not Specified|0|||
17200001|NCT02559206|38354027|FG007|Overall Study|Other Not Specified|0|||
17200002|NCT02558894|38354047|FG000|Overall Study|Death; any cause, entire study duration|28|||
17200003|NCT02558894|38354048|FG001|Overall Study|Death; any cause, entire study duration|31|||
17200004|NCT02558894|38354047|FG000|Overall Study|Withdrawal by Subject|2|||
17200005|NCT02558894|38354048|FG001|Overall Study|Withdrawal by Subject|1|||
17200006|NCT02558894|38354047|FG000|Overall Study|Closure of Part A|2|||
17200007|NCT02558894|38354048|FG001|Overall Study|Closure of Part A|1|||
17200008|NCT02688387|38354058|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200009|NCT02688387|38354059|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200010|NCT02688387|38354060|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
17200011|NCT02688387|38354061|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200012|NCT02688387|38354062|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200013|NCT02688387|38354063|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200014|NCT02688387|38354064|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200015|NCT02688387|38354065|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200016|NCT02688387|38354066|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200017|NCT02688387|38354067|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200018|NCT02688387|38354068|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200019|NCT02688387|38354069|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200020|NCT02688387|38354070|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200021|NCT02688387|38354071|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200022|NCT02688387|38354072|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200023|NCT02688387|38354073|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200024|NCT02688387|38354074|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200025|NCT02688387|38354075|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200026|NCT02688387|38354076|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200027|NCT02688387|38354077|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200028|NCT02688387|38354078|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200029|NCT02688387|38354079|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
17200030|NCT02688387|38354058|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200031|NCT02688387|38354059|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200032|NCT02688387|38354060|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200033|NCT02688387|38354061|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
17200034|NCT02688387|38354062|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200035|NCT02688387|38354063|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200036|NCT02688387|38354064|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200037|NCT02688387|38354065|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200038|NCT02688387|38354066|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200039|NCT02688387|38354067|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200040|NCT02688387|38354068|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200041|NCT02688387|38354069|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200042|NCT02688387|38354070|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200043|NCT02688387|38354071|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200044|NCT02688387|38354072|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200045|NCT02688387|38354073|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200046|NCT02688387|38354074|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200047|NCT02688387|38354075|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200048|NCT02688387|38354076|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200049|NCT02688387|38354077|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200050|NCT02688387|38354078|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200051|NCT02688387|38354079|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200052|NCT02688387|38354058|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200053|NCT02688387|38354059|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
17200054|NCT02688387|38354060|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200055|NCT02688387|38354061|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200056|NCT02688387|38354062|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200057|NCT02688387|38354063|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200058|NCT02688387|38354064|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200059|NCT02688387|38354065|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200060|NCT02688387|38354066|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200061|NCT02688387|38354067|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200062|NCT02688387|38354068|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200063|NCT02688387|38354069|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200064|NCT02688387|38354070|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200065|NCT02688387|38354071|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200066|NCT02688387|38354072|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200067|NCT02688387|38354073|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200068|NCT02688387|38354074|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200069|NCT02688387|38354075|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200070|NCT02688387|38354076|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200071|NCT02688387|38354077|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200072|NCT02688387|38354078|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200073|NCT02688387|38354079|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
17200074|NCT02688387|38354058|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200075|NCT02688387|38354059|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200076|NCT02688387|38354060|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
17200077|NCT02688387|38354061|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200078|NCT02688387|38354062|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
17200079|NCT02688387|38354063|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200080|NCT02688387|38354064|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200081|NCT02688387|38354065|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200082|NCT02688387|38354066|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200083|NCT02688387|38354067|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200084|NCT02688387|38354068|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200085|NCT02688387|38354069|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200086|NCT02688387|38354070|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200087|NCT02688387|38354071|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200088|NCT02688387|38354072|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200089|NCT02688387|38354073|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200090|NCT02688387|38354074|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200091|NCT02688387|38354075|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200092|NCT02688387|38354076|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200093|NCT02688387|38354077|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200094|NCT02688387|38354078|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200095|NCT02688387|38354079|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
17200096|NCT02688387|38354058|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
17200097|NCT02688387|38354059|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200098|NCT02688387|38354060|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200099|NCT02688387|38354061|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200100|NCT02688387|38354062|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200101|NCT02688387|38354063|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200102|NCT02688387|38354064|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200103|NCT02688387|38354065|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200104|NCT02688387|38354066|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200105|NCT02688387|38354067|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200106|NCT02688387|38354068|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200107|NCT02688387|38354069|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200108|NCT02688387|38354070|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200109|NCT02688387|38354071|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200110|NCT02688387|38354072|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200111|NCT02688387|38354073|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200112|NCT02688387|38354074|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200113|NCT02688387|38354075|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200114|NCT02688387|38354076|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200115|NCT02688387|38354077|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200116|NCT02688387|38354078|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200117|NCT02688387|38354079|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
17200118|NCT02688387|38354058|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200119|NCT02688387|38354059|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200120|NCT02688387|38354060|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200121|NCT02688387|38354061|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200122|NCT02688387|38354062|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200123|NCT02688387|38354063|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200124|NCT02688387|38354064|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200125|NCT02688387|38354065|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200126|NCT02688387|38354066|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200127|NCT02688387|38354067|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200128|NCT02688387|38354068|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
17200129|NCT02688387|38354069|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200130|NCT02688387|38354070|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200131|NCT02688387|38354071|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200132|NCT02688387|38354072|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200133|NCT02688387|38354073|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200134|NCT02688387|38354074|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200135|NCT02688387|38354075|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200136|NCT02688387|38354076|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200137|NCT02688387|38354077|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200138|NCT02688387|38354078|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200139|NCT02688387|38354079|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
17200140|NCT02688387|38354058|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200141|NCT02688387|38354059|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200142|NCT02688387|38354060|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200143|NCT02688387|38354061|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200144|NCT02688387|38354062|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200145|NCT02688387|38354063|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200146|NCT02688387|38354064|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200147|NCT02688387|38354065|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200148|NCT02688387|38354066|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200149|NCT02688387|38354067|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200150|NCT02688387|38354068|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200151|NCT02688387|38354069|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200152|NCT02688387|38354070|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200153|NCT02688387|38354071|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200154|NCT02688387|38354072|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
17200155|NCT02688387|38354073|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200156|NCT02688387|38354074|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200157|NCT02688387|38354075|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200158|NCT02688387|38354076|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200159|NCT02688387|38354077|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200160|NCT02688387|38354078|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200161|NCT02688387|38354079|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
17200162|NCT02688387|38354058|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200163|NCT02688387|38354059|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200164|NCT02688387|38354060|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200165|NCT02688387|38354061|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200166|NCT02688387|38354062|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200167|NCT02688387|38354063|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200168|NCT02688387|38354064|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200169|NCT02688387|38354065|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200170|NCT02688387|38354066|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200171|NCT02688387|38354067|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200172|NCT02688387|38354068|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200173|NCT02688387|38354069|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200174|NCT02688387|38354070|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200175|NCT02688387|38354071|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200176|NCT02688387|38354072|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200177|NCT02688387|38354073|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200178|NCT02688387|38354074|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200179|NCT02688387|38354075|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200180|NCT02688387|38354076|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200181|NCT02688387|38354077|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200182|NCT02688387|38354078|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
17200183|NCT02688387|38354079|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
17200184|NCT02688387|38354058|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200185|NCT02688387|38354059|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200186|NCT02688387|38354060|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200187|NCT02688387|38354061|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200188|NCT02688387|38354062|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200189|NCT02688387|38354063|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200190|NCT02688387|38354064|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200191|NCT02688387|38354065|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200192|NCT02688387|38354066|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200193|NCT02688387|38354067|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200194|NCT02688387|38354068|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200195|NCT02688387|38354069|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200196|NCT02688387|38354070|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200197|NCT02688387|38354071|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200198|NCT02688387|38354072|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200199|NCT02688387|38354073|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200200|NCT02688387|38354074|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200201|NCT02688387|38354075|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200202|NCT02688387|38354076|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
17200203|NCT02688387|38354077|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200204|NCT02688387|38354078|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
17200205|NCT02688387|38354079|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
17200206|NCT02688387|38354058|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200207|NCT02688387|38354059|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200208|NCT02688387|38354060|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200209|NCT02688387|38354061|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200210|NCT02688387|38354062|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200211|NCT02688387|38354063|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200212|NCT02688387|38354064|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200213|NCT02688387|38354065|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200214|NCT02688387|38354066|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200215|NCT02688387|38354067|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200216|NCT02688387|38354068|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200217|NCT02688387|38354069|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200218|NCT02688387|38354070|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200219|NCT02688387|38354071|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200220|NCT02688387|38354072|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200221|NCT02688387|38354073|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200222|NCT02688387|38354074|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200223|NCT02688387|38354075|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200224|NCT02688387|38354076|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200225|NCT02688387|38354077|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
17200226|NCT02688387|38354078|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200227|NCT02688387|38354079|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
17200228|NCT02476201|38354125|FG000|Overall Study|Unable to program MPP|9|||
17200229|NCT02476201|38354125|FG000|Overall Study|Study echo not performed|5|||
17200230|NCT02476201|38354125|FG000|Overall Study|Adverse Event|4|||
17200231|NCT02476201|38354125|FG000|Overall Study|Death|2|||
17200232|NCT02476201|38354125|FG000|Overall Study|Lost to Follow-up|2|||
17200233|NCT02476201|38354125|FG000|Overall Study|MPP programmed to OFF|2|||
17200234|NCT02476201|38354125|FG000|Overall Study|Withdrawal by Subject|1|||
17200235|NCT02476201|38354125|FG000|Overall Study|Unsuccessful implant|1|||
17200236|NCT04112173|38354130|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
17200237|NCT02688153|38354136|FG000|Overall Study|Death|7|||
17200238|NCT02688153|38354137|FG001|Overall Study|Death|5|||
17200239|NCT02688153|38354136|FG000|Overall Study|Withdrawal by Subject|4|||
17200240|NCT02688153|38354137|FG001|Overall Study|Withdrawal by Subject|2|||
17200241|NCT02688153|38354136|FG000|Overall Study|Valve Explant|1|||
17200242|NCT02688153|38354137|FG001|Overall Study|Valve Explant|0|||
17200243|NCT02688153|38354136|FG000|Overall Study|Conversion to Commercial Valve|3|||
17200244|NCT02688153|38354137|FG001|Overall Study|Conversion to Commercial Valve|0|||
17200245|NCT02687919|38354146|FG000|Overall Study|Withdrawal by Subject|6|||
17200246|NCT02687919|38354147|FG001|Overall Study|Withdrawal by Subject|6|||
17200247|NCT02687919|38354146|FG000|Overall Study|Protocol Violation|2|||
17200248|NCT02687919|38354147|FG001|Overall Study|Protocol Violation|0|||
17200249|NCT02687451|38354159|FG000|Overall Study|Withdrawal by Subject|1|||
17200250|NCT02687451|38354160|FG001|Overall Study|Withdrawal by Subject|0|||
17200251|NCT02687451|38354161|FG002|Overall Study|Withdrawal by Subject|0|||
17200252|NCT02687451|38354162|FG003|Overall Study|Withdrawal by Subject|0|||
17200253|NCT02687451|38354163|FG004|Overall Study|Withdrawal by Subject|0|||
17200254|NCT02687451|38354164|FG005|Overall Study|Withdrawal by Subject|1|||
17200255|NCT02557646|38354180|FG000|Overall Study|Adverse Event|40|||
17200256|NCT02557646|38354180|FG000|Overall Study|Death|1|||
17200257|NCT02557646|38354180|FG000|Overall Study|Lack of Efficacy|186|||
17200258|NCT02557646|38354180|FG000|Overall Study|Withdrawal by Subject|18|||
17200259|NCT02557646|38354180|FG000|Overall Study|Lost to Follow-up|17|||
17200260|NCT02557646|38354180|FG000|Overall Study|Other|14|||
17200261|NCT02679573|38354186|FG000|Overall Study|Adverse Event|13|||
17200262|NCT02679573|38354187|FG001|Overall Study|Adverse Event|6|||
17200263|NCT02679573|38354186|FG000|Overall Study|Lack of Efficacy|12|||
17200264|NCT02679573|38354187|FG001|Overall Study|Lack of Efficacy|15|||
17200265|NCT02679573|38354186|FG000|Overall Study|Could not complete required study visits|6|||
17200266|NCT02679573|38354187|FG001|Overall Study|Could not complete required study visits|2|||
17200267|NCT02679573|38354186|FG000|Overall Study|Withdrawal by Subject|2|||
17200268|NCT02679573|38354187|FG001|Overall Study|Withdrawal by Subject|9|||
17200269|NCT02679573|38354186|FG000|Overall Study|Death|2|||
17200270|NCT02679573|38354187|FG001|Overall Study|Death|0|||
17200271|NCT02679573|38354186|FG000|Overall Study|Physician Decision|2|||
17200272|NCT02679573|38354187|FG001|Overall Study|Physician Decision|4|||
17200273|NCT02679573|38354186|FG000|Overall Study|Lost to Follow-up|0|||
17200274|NCT02679573|38354187|FG001|Overall Study|Lost to Follow-up|3|||
17200275|NCT02685033|38354195|FG000|Overall Study|Withdrawal of Consent|0|||
17200276|NCT02685033|38354196|FG001|Overall Study|Withdrawal of Consent|1|||
17200277|NCT02685033|38354195|FG000|Overall Study|Lost to Follow-up|2|||
17200278|NCT02685033|38354196|FG001|Overall Study|Lost to Follow-up|1|||
17200279|NCT02685033|38354195|FG000|Overall Study|Adverse Event|1|||
17200280|NCT02685033|38354196|FG001|Overall Study|Adverse Event|0|||
17200281|NCT02684097|38354204|FG000|Overall Study|Lack of Efficacy|13|||
17200282|NCT02684097|38354205|FG001|Overall Study|Lack of Efficacy|6|||
17200283|NCT02555618|38354213|FG000|Overall Study|Sponsor's Circumstances|1|||
17200284|NCT02555618|38354214|FG001|Overall Study|Sponsor's Circumstances|0|||
17200285|NCT02557100|38354240|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
17200286|NCT02557100|38354241|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
17200287|NCT02557100|38354242|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
17200288|NCT02557100|38354240|FG000|Single Blind Treatment Period|Death|0|||
17200289|NCT02557100|38354241|FG001|Single Blind Treatment Period|Death|1|||
17200290|NCT02557100|38354242|FG002|Single Blind Treatment Period|Death|0|||
17200291|NCT02557100|38354240|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
17200292|NCT02557100|38354241|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
17200293|NCT02557100|38354242|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
17200294|NCT02557100|38354240|FG000|Single Blind Treatment Period|Adverse Event|0|||
17200295|NCT02557100|38354241|FG001|Single Blind Treatment Period|Adverse Event|1|||
17200296|NCT02557100|38354242|FG002|Single Blind Treatment Period|Adverse Event|0|||
17200297|NCT02557100|38354240|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
17200298|NCT02557100|38354241|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
17200299|NCT02557100|38354242|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
17200300|NCT02557100|38354240|FG000|Cumulative Abatacept Period|Other Reasons|0|||
17200301|NCT02557100|38354241|FG001|Cumulative Abatacept Period|Other Reasons|0|||
17200302|NCT02557100|38354242|FG002|Cumulative Abatacept Period|Other Reasons|1|||
17200303|NCT02557100|38354240|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
17200304|NCT02557100|38354241|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
17200305|NCT02557100|38354242|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
17200306|NCT02557100|38354240|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
17200307|NCT02557100|38354241|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
17200308|NCT02557100|38354242|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
17200309|NCT01337635|38354252|FG000|Overall Study|Lost to Follow-up|0|||
17200310|NCT01337635|38354253|FG001|Overall Study|Lost to Follow-up|1|||
17200311|NCT02556710|38354261|FG000|Overall Study|Surgical treatment|3|||
17200312|NCT02556710|38354262|FG001|Overall Study|Surgical treatment|0|||
17200313|NCT02556710|38354261|FG000|Overall Study|Required proscribed pain medication|2|||
17200314|NCT02556710|38354262|FG001|Overall Study|Required proscribed pain medication|1|||
17200315|NCT02556710|38354261|FG000|Overall Study|Lack of Efficacy|1|||
17200316|NCT02556710|38354262|FG001|Overall Study|Lack of Efficacy|0|||
17200317|NCT02556710|38354261|FG000|Overall Study|Worsening osteoarthritis|1|||
17200318|NCT02556710|38354262|FG001|Overall Study|Worsening osteoarthritis|0|||
17200319|NCT02556710|38354261|FG000|Overall Study|Moved out of state|1|||
17200320|NCT02556710|38354262|FG001|Overall Study|Moved out of state|0|||
17200321|NCT02556710|38354261|FG000|Overall Study|Missing reason|3|||
17200322|NCT02556710|38354262|FG001|Overall Study|Missing reason|1|||
17200323|NCT02556710|38354261|FG000|Overall Study|Pain as lack of efficacy|0|||
17200324|NCT02556710|38354262|FG001|Overall Study|Pain as lack of efficacy|4|||
17200325|NCT02556632|38354273|FG000|Overall Study|Lost to Follow-up|1|||
17200326|NCT02556632|38354274|FG001|Overall Study|Lost to Follow-up|0|||
17200327|NCT02556632|38354275|FG002|Overall Study|Lost to Follow-up|0|||
17200328|NCT02556632|38354273|FG000|Overall Study|Disliked Intervention|1|||
17200329|NCT02556632|38354274|FG001|Overall Study|Disliked Intervention|1|||
17200330|NCT02556632|38354275|FG002|Overall Study|Disliked Intervention|1|||
17200331|NCT02556632|38354273|FG000|Overall Study|No Reason|1|||
17200332|NCT02556632|38354274|FG001|Overall Study|No Reason|0|||
17200333|NCT02556632|38354275|FG002|Overall Study|No Reason|1|||
17200334|NCT02556632|38354273|FG000|Overall Study|Personal Issues|0|||
17200335|NCT02556632|38354274|FG001|Overall Study|Personal Issues|1|||
17200336|NCT02556632|38354275|FG002|Overall Study|Personal Issues|1|||
17200337|NCT02556632|38354273|FG000|Overall Study|Changed Mind|0|||
17200338|NCT02556632|38354274|FG001|Overall Study|Changed Mind|1|||
17200339|NCT02556632|38354275|FG002|Overall Study|Changed Mind|0|||
17200340|NCT02556632|38354273|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
17200341|NCT02556632|38354274|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
17200342|NCT02556632|38354275|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
17200343|NCT02556632|38354273|FG000|Overall Study|Unrelated Adverse Event|1|||
17200344|NCT02556632|38354274|FG001|Overall Study|Unrelated Adverse Event|0|||
17200345|NCT02556632|38354275|FG002|Overall Study|Unrelated Adverse Event|3|||
17200346|NCT02556632|38354273|FG000|Overall Study|Related Adverse Event|0|||
17200347|NCT02556632|38354274|FG001|Overall Study|Related Adverse Event|1|||
17200348|NCT02556632|38354275|FG002|Overall Study|Related Adverse Event|0|||
17200349|NCT02556632|38354273|FG000|Overall Study|Possibly Related Adverse Event|0|||
17200350|NCT02556632|38354274|FG001|Overall Study|Possibly Related Adverse Event|0|||
17200351|NCT02556632|38354275|FG002|Overall Study|Possibly Related Adverse Event|1|||
17200352|NCT02556632|38354273|FG000|Overall Study|Did Not Start RT|0|||
17200353|NCT02556632|38354274|FG001|Overall Study|Did Not Start RT|1|||
17200354|NCT02556632|38354275|FG002|Overall Study|Did Not Start RT|0|||
17200355|NCT02556632|38354273|FG000|Overall Study|Ineligible|0|||
17200356|NCT02556632|38354274|FG001|Overall Study|Ineligible|1|||
17200357|NCT02556632|38354275|FG002|Overall Study|Ineligible|0|||
17200358|NCT02556632|38354273|FG000|Overall Study|Disliked Study Procedures|0|||
17200359|NCT02556632|38354274|FG001|Overall Study|Disliked Study Procedures|0|||
17200360|NCT02556632|38354275|FG002|Overall Study|Disliked Study Procedures|1|||
17200361|NCT02556632|38354273|FG000|Overall Study|Treatment or Change Delay|0|||
17200362|NCT02556632|38354274|FG001|Overall Study|Treatment or Change Delay|0|||
17200363|NCT02556632|38354275|FG002|Overall Study|Treatment or Change Delay|1|||
17200364|NCT01662440|38354287|FG000|Overall Study|Adverse Event|1|||
17200365|NCT01662440|38354288|FG001|Overall Study|Adverse Event|0|||
17200366|NCT01662440|38354289|FG002|Overall Study|Adverse Event|0|||
17200367|NCT01662440|38354290|FG003|Overall Study|Adverse Event|1|||
17200368|NCT01662440|38354287|FG000|Overall Study|Death|0|||
17200369|NCT01662440|38354288|FG001|Overall Study|Death|1|||
17200370|NCT01662440|38354289|FG002|Overall Study|Death|0|||
17200371|NCT01662440|38354290|FG003|Overall Study|Death|0|||
17200372|NCT01662440|38354287|FG000|Overall Study|Lost to Follow-up|2|||
17200373|NCT01662440|38354288|FG001|Overall Study|Lost to Follow-up|2|||
17200374|NCT01662440|38354289|FG002|Overall Study|Lost to Follow-up|4|||
17200375|NCT01662440|38354290|FG003|Overall Study|Lost to Follow-up|1|||
17200376|NCT01662440|38354287|FG000|Overall Study|Subject moved to another country.|0|||
17200377|NCT01662440|38354288|FG001|Overall Study|Subject moved to another country.|1|||
17200378|NCT01662440|38354289|FG002|Overall Study|Subject moved to another country.|0|||
17200379|NCT01662440|38354290|FG003|Overall Study|Subject moved to another country.|0|||
17200380|NCT01662440|38354287|FG000|Overall Study|Protocol Violation|1|||
17200381|NCT01662440|38354288|FG001|Overall Study|Protocol Violation|0|||
17200382|NCT01662440|38354289|FG002|Overall Study|Protocol Violation|0|||
17200383|NCT01662440|38354290|FG003|Overall Study|Protocol Violation|0|||
17200384|NCT01662440|38354287|FG000|Overall Study|Withdrawal by Subject|5|||
17200385|NCT01662440|38354288|FG001|Overall Study|Withdrawal by Subject|2|||
17200386|NCT01662440|38354289|FG002|Overall Study|Withdrawal by Subject|2|||
17200387|NCT01662440|38354290|FG003|Overall Study|Withdrawal by Subject|2|||
17200388|NCT01662362|38354310|FG000|Overall Study|Lost to Follow-up|38|||
17200389|NCT02554682|38354325|FG000|Overall Study|Lost to Follow-up|11|||
17200390|NCT02554682|38354326|FG001|Overall Study|Lost to Follow-up|9|||
17200391|NCT02554682|38354327|FG002|Overall Study|Lost to Follow-up|4|||
17200392|NCT02554682|38354328|FG003|Overall Study|Lost to Follow-up|3|||
17200393|NCT02554682|38354329|FG004|Overall Study|Lost to Follow-up|2|||
17200394|NCT02554682|38354330|FG005|Overall Study|Lost to Follow-up|1|||
17200395|NCT02554682|38354331|FG006|Overall Study|Lost to Follow-up|6|||
17200396|NCT02554682|38354332|FG007|Overall Study|Lost to Follow-up|6|||
17200397|NCT02554682|38354333|FG008|Overall Study|Lost to Follow-up|2|||
17200398|NCT02554682|38354334|FG009|Overall Study|Lost to Follow-up|2|||
17200399|NCT02554682|38354325|FG000|Overall Study|Withdrawal by Subject|2|||
17200400|NCT02554682|38354326|FG001|Overall Study|Withdrawal by Subject|1|||
17200401|NCT02554682|38354327|FG002|Overall Study|Withdrawal by Subject|0|||
17200402|NCT02554682|38354328|FG003|Overall Study|Withdrawal by Subject|0|||
17200403|NCT02554682|38354329|FG004|Overall Study|Withdrawal by Subject|0|||
17200404|NCT02554682|38354330|FG005|Overall Study|Withdrawal by Subject|0|||
17200405|NCT02554682|38354331|FG006|Overall Study|Withdrawal by Subject|0|||
17200406|NCT02554682|38354332|FG007|Overall Study|Withdrawal by Subject|0|||
17200407|NCT02554682|38354333|FG008|Overall Study|Withdrawal by Subject|0|||
17200408|NCT02554682|38354334|FG009|Overall Study|Withdrawal by Subject|0|||
17200409|NCT02554682|38354325|FG000|Overall Study|Physician Decision|2|||
17200410|NCT02554682|38354326|FG001|Overall Study|Physician Decision|2|||
17200411|NCT02554682|38354327|FG002|Overall Study|Physician Decision|0|||
17200412|NCT02554682|38354328|FG003|Overall Study|Physician Decision|0|||
17200413|NCT02554682|38354329|FG004|Overall Study|Physician Decision|0|||
17200414|NCT02554682|38354330|FG005|Overall Study|Physician Decision|0|||
17200415|NCT02554682|38354331|FG006|Overall Study|Physician Decision|0|||
17200416|NCT02554682|38354332|FG007|Overall Study|Physician Decision|0|||
17200417|NCT02554682|38354333|FG008|Overall Study|Physician Decision|0|||
17200418|NCT02554682|38354334|FG009|Overall Study|Physician Decision|0|||
17200419|NCT00154063|38354370|FG000|Overall Study|Adverse Event|4|||
17200420|NCT00154063|38354371|FG001|Overall Study|Adverse Event|8|||
17200421|NCT00154063|38354370|FG000|Overall Study|Protocol Violation|1|||
17200422|NCT00154063|38354371|FG001|Overall Study|Protocol Violation|1|||
17200423|NCT00154063|38354370|FG000|Overall Study|Investigator or Sponsor Request|0|||
17200424|NCT00154063|38354371|FG001|Overall Study|Investigator or Sponsor Request|1|||
17200425|NCT00154063|38354370|FG000|Overall Study|Withdrawal by Subject|4|||
17200426|NCT00154063|38354371|FG001|Overall Study|Withdrawal by Subject|9|||
17200427|NCT00154063|38354370|FG000|Overall Study|Other|3|||
17200428|NCT00154063|38354371|FG001|Overall Study|Other|3|||
17200429|NCT02683941|38354383|FG000|Double-blind Phase|Adverse Event|0|||
17200430|NCT02683941|38354384|FG001|Double-blind Phase|Adverse Event|1|||
17200431|NCT02683941|38354383|FG000|Double-blind Phase|Withdrawal by Subject|4|||
17200432|NCT02683941|38354384|FG001|Double-blind Phase|Withdrawal by Subject|2|||
17200433|NCT02683941|38354383|FG000|Double-blind Phase|Lost to Follow-up|1|||
17200434|NCT02683941|38354384|FG001|Double-blind Phase|Lost to Follow-up|0|||
17200435|NCT02683941|38354383|FG000|Double-blind Phase|Disease Progression|5|||
17200436|NCT02683941|38354384|FG001|Double-blind Phase|Disease Progression|2|||
17200437|NCT02683941|38354383|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
17200438|NCT02683941|38354384|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
17200439|NCT02683941|38354383|FG000|Open-label Treatment Phase|Disease Progression|1|||
17200440|NCT02683941|38354384|FG001|Open-label Treatment Phase|Disease Progression|2|||
17200441|NCT02683941|38354383|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
17200442|NCT02683941|38354384|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
17200443|NCT02683941|38354383|FG000|Open-label Treatment Phase|Other|1|||
17200444|NCT02683941|38354384|FG001|Open-label Treatment Phase|Other|0|||
17200445|NCT02683941|38354383|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
17200446|NCT02683941|38354384|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
17200447|NCT02683941|38354383|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
17200448|NCT02683941|38354384|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
17200449|NCT02683941|38354383|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
17200450|NCT02683941|38354384|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
17200451|NCT02683941|38354383|FG000|Open-label Follow-up Phase|Other|8|||
17200452|NCT02683941|38354384|FG001|Open-label Follow-up Phase|Other|1|||
17200453|NCT02678247|38354396|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
17200454|NCT02678247|38354397|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
17200455|NCT02678247|38354396|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
17200456|NCT02678247|38354397|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
17200457|NCT02678247|38354396|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
17200458|NCT02678247|38354397|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
17200459|NCT02678247|38354396|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
17200460|NCT02678247|38354397|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
17200461|NCT02678247|38354396|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
17200462|NCT02678247|38354397|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
17200463|NCT02678247|38354396|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
17200464|NCT02678247|38354397|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
17200465|NCT02683785|38354410|FG000|Overall Study|Withdrawal by Subject|1|||
17200466|NCT02683785|38354411|FG001|Overall Study|Withdrawal by Subject|1|||
17200467|NCT02683785|38354410|FG000|Overall Study|Lost to Follow-up|0|||
17200468|NCT02683785|38354411|FG001|Overall Study|Lost to Follow-up|1|||
17200469|NCT02683785|38354410|FG000|Overall Study|Adverse Event|0|||
17200470|NCT02683785|38354411|FG001|Overall Study|Adverse Event|2|||
17200471|NCT02913482|38354422|FG000|Overall Study|Death|0|||
17200472|NCT02913482|38354423|FG001|Overall Study|Death|2|||
17200473|NCT02913482|38354424|FG002|Overall Study|Death|2|||
17200474|NCT02913482|38354422|FG000|Overall Study|Progressive Disease|1|||
17200475|NCT02913482|38354423|FG001|Overall Study|Progressive Disease|1|||
17200476|NCT02913482|38354424|FG002|Overall Study|Progressive Disease|1|||
17200477|NCT02543294|38354434|FG000|Overall Study|Lost to Follow-up|3|||
17200478|NCT02543294|38354434|FG000|Overall Study|Physician Decision|2|||
17200479|NCT02543294|38354434|FG000|Overall Study|Withdrawal by Subject|7|||
17200480|NCT02728076|38354439|FG000|Overall Study|Physician Decision|4|||
17200481|NCT02551874|38354445|FG000|Overall Study|Lost to Follow-up|0|||
17200482|NCT02551874|38354446|FG001|Overall Study|Lost to Follow-up|2|||
17200483|NCT02551874|38354445|FG000|Overall Study|Pregnancy|0|||
17200484|NCT02551874|38354446|FG001|Overall Study|Pregnancy|1|||
17200485|NCT02551874|38354445|FG000|Overall Study|Reason not reported|10|||
17200486|NCT02551874|38354446|FG001|Overall Study|Reason not reported|4|||
17200487|NCT02551874|38354445|FG000|Overall Study|Did not receive randomized treatment|0|||
17200488|NCT02551874|38354446|FG001|Overall Study|Did not receive randomized treatment|7|||
17200489|NCT02551874|38354445|FG000|Overall Study|Did not enter long-term study|18|||
17200490|NCT02551874|38354446|FG001|Overall Study|Did not enter long-term study|25|||
17200491|NCT02682927|38354471|FG000|Overall Study|Adverse Event|0|||
17200492|NCT02682927|38354472|FG001|Overall Study|Adverse Event|0|||
17200493|NCT02682927|38354473|FG002|Overall Study|Adverse Event|5|||
17200494|NCT02682927|38354474|FG003|Overall Study|Adverse Event|1|||
17200495|NCT02682927|38354475|FG004|Overall Study|Adverse Event|0|||
17200496|NCT02682927|38354476|FG005|Overall Study|Adverse Event|2|||
17200497|NCT02682927|38354471|FG000|Overall Study|Death|0|||
17200498|NCT02682927|38354472|FG001|Overall Study|Death|0|||
17200499|NCT02682927|38354473|FG002|Overall Study|Death|0|||
17200500|NCT02682927|38354474|FG003|Overall Study|Death|1|||
17200501|NCT02682927|38354475|FG004|Overall Study|Death|0|||
17200502|NCT02682927|38354476|FG005|Overall Study|Death|0|||
17200503|NCT02682927|38354471|FG000|Overall Study|Lack of Efficacy|1|||
17200504|NCT02682927|38354472|FG001|Overall Study|Lack of Efficacy|0|||
17200505|NCT02682927|38354473|FG002|Overall Study|Lack of Efficacy|0|||
17200506|NCT02682927|38354474|FG003|Overall Study|Lack of Efficacy|1|||
17200507|NCT02682927|38354475|FG004|Overall Study|Lack of Efficacy|0|||
17200508|NCT02682927|38354476|FG005|Overall Study|Lack of Efficacy|0|||
17200509|NCT02682927|38354471|FG000|Overall Study|Other|0|||
17200510|NCT02682927|38354472|FG001|Overall Study|Other|0|||
17200511|NCT02682927|38354473|FG002|Overall Study|Other|0|||
17200512|NCT02682927|38354474|FG003|Overall Study|Other|2|||
17200513|NCT02682927|38354475|FG004|Overall Study|Other|0|||
17200514|NCT02682927|38354476|FG005|Overall Study|Other|0|||
17200515|NCT02682927|38354471|FG000|Overall Study|Withdrawal by Subject|2|||
17200516|NCT02682927|38354472|FG001|Overall Study|Withdrawal by Subject|0|||
17200517|NCT02682927|38354473|FG002|Overall Study|Withdrawal by Subject|1|||
17200518|NCT02682927|38354474|FG003|Overall Study|Withdrawal by Subject|0|||
17200519|NCT02682927|38354475|FG004|Overall Study|Withdrawal by Subject|1|||
17200520|NCT02682927|38354476|FG005|Overall Study|Withdrawal by Subject|1|||
17200521|NCT02550938|38354500|FG000|Overall Study|Lost to Follow-up|8|||
17200522|NCT02550938|38354501|FG001|Overall Study|Lost to Follow-up|7|||
17200523|NCT02550938|38354502|FG002|Overall Study|Lost to Follow-up|12|||
17200524|NCT02550938|38354503|FG003|Overall Study|Lost to Follow-up|11|||
17200525|NCT02769065|38354543|FG000|Overall Study|Voluntary Withdrawal|1|||
17200526|NCT02769065|38354544|FG001|Overall Study|Voluntary Withdrawal|0|||
17200527|NCT02769065|38354545|FG002|Overall Study|Voluntary Withdrawal|0|||
17200528|NCT02769065|38354546|FG003|Overall Study|Voluntary Withdrawal|0|||
17200529|NCT02769065|38354547|FG004|Overall Study|Voluntary Withdrawal|0|||
17200530|NCT02769065|38354548|FG005|Overall Study|Voluntary Withdrawal|0|||
17200531|NCT02769065|38354549|FG006|Overall Study|Voluntary Withdrawal|0|||
17200532|NCT02769065|38354550|FG007|Overall Study|Voluntary Withdrawal|0|||
17200533|NCT02769065|38354551|FG008|Overall Study|Voluntary Withdrawal|0|||
17200534|NCT02769065|38354552|FG009|Overall Study|Voluntary Withdrawal|0|||
17200535|NCT02769065|38354553|FG010|Overall Study|Voluntary Withdrawal|0|||
17200536|NCT02769065|38354554|FG011|Overall Study|Voluntary Withdrawal|0|||
17200537|NCT02769065|38354555|FG012|Overall Study|Voluntary Withdrawal|0|||
17200538|NCT02769065|38354556|FG013|Overall Study|Voluntary Withdrawal|0|||
17200539|NCT02769065|38354557|FG014|Overall Study|Voluntary Withdrawal|0|||
17200540|NCT02769065|38354558|FG015|Overall Study|Voluntary Withdrawal|0|||
17200541|NCT02769065|38354559|FG016|Overall Study|Voluntary Withdrawal|0|||
17200542|NCT02769065|38354560|FG017|Overall Study|Voluntary Withdrawal|0|||
17200543|NCT02769065|38354561|FG018|Overall Study|Voluntary Withdrawal|0|||
17200544|NCT02769065|38354562|FG019|Overall Study|Voluntary Withdrawal|0|||
17200545|NCT02769065|38354563|FG020|Overall Study|Voluntary Withdrawal|0|||
17200546|NCT02769065|38354564|FG021|Overall Study|Voluntary Withdrawal|0|||
17200547|NCT02769065|38354565|FG022|Overall Study|Voluntary Withdrawal|0|||
17200548|NCT02769065|38354566|FG023|Overall Study|Voluntary Withdrawal|0|||
17200549|NCT02769065|38354567|FG024|Overall Study|Voluntary Withdrawal|0|||
17200550|NCT02769065|38354568|FG025|Overall Study|Voluntary Withdrawal|0|||
17200551|NCT02769065|38354569|FG026|Overall Study|Voluntary Withdrawal|0|||
17200552|NCT02769065|38354570|FG027|Overall Study|Voluntary Withdrawal|0|||
17200553|NCT02769065|38354571|FG028|Overall Study|Voluntary Withdrawal|0|||
17200554|NCT02769065|38354572|FG029|Overall Study|Voluntary Withdrawal|0|||
17200555|NCT02769065|38354543|FG000|Overall Study|Reason Not Specified|0|||
17200556|NCT02769065|38354544|FG001|Overall Study|Reason Not Specified|0|||
17200557|NCT02769065|38354545|FG002|Overall Study|Reason Not Specified|0|||
17200558|NCT02769065|38354546|FG003|Overall Study|Reason Not Specified|0|||
17200559|NCT02769065|38354547|FG004|Overall Study|Reason Not Specified|0|||
17200560|NCT02769065|38354548|FG005|Overall Study|Reason Not Specified|0|||
17200561|NCT02769065|38354549|FG006|Overall Study|Reason Not Specified|1|||
17200562|NCT02769065|38354550|FG007|Overall Study|Reason Not Specified|0|||
17200563|NCT02769065|38354551|FG008|Overall Study|Reason Not Specified|0|||
17200564|NCT02769065|38354552|FG009|Overall Study|Reason Not Specified|0|||
17200565|NCT02769065|38354553|FG010|Overall Study|Reason Not Specified|0|||
17200566|NCT02769065|38354554|FG011|Overall Study|Reason Not Specified|0|||
17200567|NCT02769065|38354555|FG012|Overall Study|Reason Not Specified|0|||
17200568|NCT02769065|38354556|FG013|Overall Study|Reason Not Specified|0|||
17200569|NCT02769065|38354557|FG014|Overall Study|Reason Not Specified|0|||
17200570|NCT02769065|38354558|FG015|Overall Study|Reason Not Specified|0|||
17200571|NCT02769065|38354559|FG016|Overall Study|Reason Not Specified|0|||
17200572|NCT02769065|38354560|FG017|Overall Study|Reason Not Specified|0|||
17200573|NCT02769065|38354561|FG018|Overall Study|Reason Not Specified|0|||
17200574|NCT02769065|38354562|FG019|Overall Study|Reason Not Specified|0|||
17200575|NCT02769065|38354563|FG020|Overall Study|Reason Not Specified|0|||
17200576|NCT02769065|38354564|FG021|Overall Study|Reason Not Specified|0|||
17200577|NCT02769065|38354565|FG022|Overall Study|Reason Not Specified|0|||
17200578|NCT02769065|38354566|FG023|Overall Study|Reason Not Specified|0|||
17200579|NCT02769065|38354567|FG024|Overall Study|Reason Not Specified|0|||
17200580|NCT02769065|38354568|FG025|Overall Study|Reason Not Specified|0|||
17200581|NCT02769065|38354569|FG026|Overall Study|Reason Not Specified|0|||
17200582|NCT02769065|38354570|FG027|Overall Study|Reason Not Specified|0|||
17200583|NCT02769065|38354571|FG028|Overall Study|Reason Not Specified|0|||
17200584|NCT02769065|38354572|FG029|Overall Study|Reason Not Specified|0|||
17200585|NCT02769065|38354543|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200586|NCT02769065|38354544|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200587|NCT02769065|38354545|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200588|NCT02769065|38354546|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200589|NCT02769065|38354547|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200590|NCT02769065|38354548|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200591|NCT02769065|38354549|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200592|NCT02769065|38354550|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200593|NCT02769065|38354551|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200594|NCT02769065|38354552|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200595|NCT02769065|38354553|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
17200596|NCT02769065|38354554|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200597|NCT02769065|38354555|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200598|NCT02769065|38354556|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200599|NCT02769065|38354557|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200600|NCT02769065|38354558|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200601|NCT02769065|38354559|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200602|NCT02769065|38354560|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200603|NCT02769065|38354561|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200604|NCT02769065|38354562|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200605|NCT02769065|38354563|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200606|NCT02769065|38354564|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200607|NCT02769065|38354565|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200608|NCT02769065|38354566|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200609|NCT02769065|38354567|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200610|NCT02769065|38354568|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200611|NCT02769065|38354569|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200612|NCT02769065|38354570|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200613|NCT02769065|38354571|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200614|NCT02769065|38354572|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
17200615|NCT02681523|38354665|FG000|Overall Study|Adverse Event|1|||
17200616|NCT02681523|38354665|FG000|Overall Study|Patient Non-compliance|1|||
17200617|NCT02540954|38354671|FG000|Overall Study|Physician Decision|3|||
17200618|NCT02540954|38354672|FG001|Overall Study|Physician Decision|1|||
17200619|NCT02540954|38354671|FG000|Overall Study|Withdrawal by Subject|6|||
17200620|NCT02540954|38354672|FG001|Overall Study|Withdrawal by Subject|5|||
17200621|NCT02540954|38354671|FG000|Overall Study|Lost to Follow-up|1|||
17200622|NCT02540954|38354672|FG001|Overall Study|Lost to Follow-up|1|||
17200623|NCT02540954|38354671|FG000|Overall Study|Adverse Event|4|||
17200624|NCT02540954|38354672|FG001|Overall Study|Adverse Event|2|||
17200625|NCT02540954|38354671|FG000|Overall Study|Death|0|||
17200626|NCT02540954|38354672|FG001|Overall Study|Death|3|||
17200627|NCT02540954|38354671|FG000|Overall Study|Treatment failure|1|||
17200628|NCT02540954|38354672|FG001|Overall Study|Treatment failure|0|||
17200629|NCT02540954|38354671|FG000|Overall Study|Other reason|4|||
17200630|NCT02540954|38354672|FG001|Overall Study|Other reason|2|||
17200631|NCT02658812|38354678|FG000|Overall Study|Disease Progression|7|||
17200632|NCT02658812|38354678|FG000|Overall Study|Unrelated to study treatment|1|||
17200633|NCT02658812|38354678|FG000|Overall Study|Adverse Event|1|||
17200634|NCT02680665|38354682|FG000|Overall Study|No visit after the first prescription|5|||
17200635|NCT00154375|38354688|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
17200636|NCT00154375|38354689|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
17200637|NCT00154375|38354688|FG000|Overall Study|Adverse Event|18|||
17200638|NCT00154375|38354689|FG001|Overall Study|Adverse Event|20|||
17200639|NCT00154375|38354688|FG000|Overall Study|Withdrawal by Subject|14|||
17200640|NCT00154375|38354689|FG001|Overall Study|Withdrawal by Subject|10|||
17200641|NCT00154375|38354688|FG000|Overall Study|Death|5|||
17200642|NCT00154375|38354689|FG001|Overall Study|Death|13|||
17200643|NCT00154375|38354688|FG000|Overall Study|Study drug no longer required|5|||
17200644|NCT00154375|38354689|FG001|Overall Study|Study drug no longer required|3|||
17200645|NCT00154375|38354688|FG000|Overall Study|Lost to Follow-up|2|||
17200646|NCT00154375|38354689|FG001|Overall Study|Lost to Follow-up|1|||
17200647|NCT00154375|38354688|FG000|Overall Study|Abnormal laboratory value(s)|0|||
17200648|NCT00154375|38354689|FG001|Overall Study|Abnormal laboratory value(s)|2|||
17200649|NCT00154375|38354688|FG000|Overall Study|Protocol Violation|0|||
17200650|NCT00154375|38354689|FG001|Overall Study|Protocol Violation|1|||
17200651|NCT00154375|38354688|FG000|Overall Study|Suspected progression of disease|44|||
17200652|NCT00154375|38354689|FG001|Overall Study|Suspected progression of disease|30|||
17200653|NCT02765399|38354698|FG000|Overall Study|Nausea|1|||
17200654|NCT02765399|38354699|FG001|Overall Study|Nausea|0|||
17200655|NCT02676765|38354707|FG000|Overall Study|Lost to Follow-up|0|||
17200656|NCT02676765|38354708|FG001|Overall Study|Lost to Follow-up|1|||
17200657|NCT02680041|38354714|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
17200658|NCT02680041|38354714|FG000|Overall Study|Lost to Follow-up|2|||
17200659|NCT02547974|38354723|FG000|Overall Study|Withdrawal by Subject|1|||
17200660|NCT02547974|38354724|FG001|Overall Study|Withdrawal by Subject|0|||
17200661|NCT02547974|38354725|FG002|Overall Study|Withdrawal by Subject|0|||
17200662|NCT02547974|38354726|FG003|Overall Study|Withdrawal by Subject|0|||
17200663|NCT00154297|38354741|FG000|Overall Study|Death|5|||
17200664|NCT00154297|38354742|FG001|Overall Study|Death|2|||
17200665|NCT00154297|38354741|FG000|Overall Study|Withdrawal by Subject|0|||
17200666|NCT00154297|38354742|FG001|Overall Study|Withdrawal by Subject|5|||
17200667|NCT00154297|38354741|FG000|Overall Study|Lost to Follow-up|3|||
17200668|NCT00154297|38354742|FG001|Overall Study|Lost to Follow-up|0|||
17200669|NCT02679729|38354757|FG000|Overall Study|Lost to Follow-up|0|||
17200670|NCT02679729|38354758|FG001|Overall Study|Lost to Follow-up|1|||
17200671|NCT02679729|38354759|FG002|Overall Study|Lost to Follow-up|0|||
17200672|NCT02679729|38354760|FG003|Overall Study|Lost to Follow-up|0|||
17200673|NCT02679729|38354761|FG004|Overall Study|Lost to Follow-up|1|||
17200674|NCT02679729|38354762|FG005|Overall Study|Lost to Follow-up|0|||
17200675|NCT02679729|38354763|FG006|Overall Study|Lost to Follow-up|0|||
17200676|NCT02679729|38354764|FG007|Overall Study|Lost to Follow-up|0|||
17200677|NCT02679729|38354765|FG008|Overall Study|Lost to Follow-up|0|||
17200678|NCT02679729|38354757|FG000|Overall Study|Participant decision|0|||
17200679|NCT02679729|38354758|FG001|Overall Study|Participant decision|1|||
17200680|NCT02679729|38354759|FG002|Overall Study|Participant decision|0|||
17200681|NCT02679729|38354760|FG003|Overall Study|Participant decision|0|||
17200682|NCT02679729|38354761|FG004|Overall Study|Participant decision|0|||
17200683|NCT02679729|38354762|FG005|Overall Study|Participant decision|0|||
17200684|NCT02679729|38354763|FG006|Overall Study|Participant decision|1|||
17200685|NCT02679729|38354764|FG007|Overall Study|Participant decision|0|||
17200686|NCT02679729|38354765|FG008|Overall Study|Participant decision|0|||
17200687|NCT02765165|38354804|FG000|Treatment Period|Progressive disease|3|||
17200688|NCT02765165|38354805|FG001|Treatment Period|Progressive disease|2|||
17200689|NCT02765165|38354806|FG002|Treatment Period|Progressive disease|3|||
17200690|NCT02765165|38354807|FG003|Treatment Period|Progressive disease|3|||
17200691|NCT02765165|38354808|FG004|Treatment Period|Progressive disease|4|||
17200692|NCT02765165|38354809|FG005|Treatment Period|Progressive disease|2|||
17200693|NCT02765165|38354810|FG006|Treatment Period|Progressive disease|2|||
17200694|NCT02765165|38354804|FG000|Treatment Period|Physician Decision|0|||
17200695|NCT02765165|38354805|FG001|Treatment Period|Physician Decision|1|||
17200696|NCT02765165|38354806|FG002|Treatment Period|Physician Decision|0|||
17200697|NCT02765165|38354807|FG003|Treatment Period|Physician Decision|0|||
17200698|NCT02765165|38354808|FG004|Treatment Period|Physician Decision|0|||
17200699|NCT02765165|38354809|FG005|Treatment Period|Physician Decision|0|||
17200700|NCT02765165|38354810|FG006|Treatment Period|Physician Decision|0|||
17200701|NCT02765165|38354804|FG000|Treatment Period|Adverse Event|0|||
17200702|NCT02765165|38354805|FG001|Treatment Period|Adverse Event|1|||
17200703|NCT02765165|38354806|FG002|Treatment Period|Adverse Event|0|||
17200704|NCT02765165|38354807|FG003|Treatment Period|Adverse Event|0|||
17200705|NCT02765165|38354808|FG004|Treatment Period|Adverse Event|0|||
17200706|NCT02765165|38354809|FG005|Treatment Period|Adverse Event|0|||
17200707|NCT02765165|38354810|FG006|Treatment Period|Adverse Event|0|||
17200708|NCT02765165|38354804|FG000|Treatment Period|Withdrawal by Subject|0|||
17200709|NCT02765165|38354805|FG001|Treatment Period|Withdrawal by Subject|0|||
17200710|NCT02765165|38354806|FG002|Treatment Period|Withdrawal by Subject|0|||
17200711|NCT02765165|38354807|FG003|Treatment Period|Withdrawal by Subject|0|||
17200712|NCT02765165|38354808|FG004|Treatment Period|Withdrawal by Subject|2|||
17200713|NCT02765165|38354809|FG005|Treatment Period|Withdrawal by Subject|0|||
17200714|NCT02765165|38354810|FG006|Treatment Period|Withdrawal by Subject|0|||
17200715|NCT02765165|38354804|FG000|Treatment Period|Study terminated|0|||
17200716|NCT02765165|38354805|FG001|Treatment Period|Study terminated|0|||
17200717|NCT02765165|38354806|FG002|Treatment Period|Study terminated|0|||
17200718|NCT02765165|38354807|FG003|Treatment Period|Study terminated|0|||
17200719|NCT02765165|38354808|FG004|Treatment Period|Study terminated|0|||
17200720|NCT02765165|38354809|FG005|Treatment Period|Study terminated|1|||
17200721|NCT02765165|38354810|FG006|Treatment Period|Study terminated|2|||
17200722|NCT02765165|38354804|FG000|Post-treatment Follow-up|Death|1|||
17200723|NCT02765165|38354805|FG001|Post-treatment Follow-up|Death|2|||
17200724|NCT02765165|38354806|FG002|Post-treatment Follow-up|Death|1|||
17200725|NCT02765165|38354807|FG003|Post-treatment Follow-up|Death|1|||
17200726|NCT02765165|38354808|FG004|Post-treatment Follow-up|Death|1|||
17200727|NCT02765165|38354809|FG005|Post-treatment Follow-up|Death|1|||
17200728|NCT02765165|38354810|FG006|Post-treatment Follow-up|Death|0|||
17200729|NCT02765165|38354804|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
17200730|NCT02765165|38354805|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
17200731|NCT02765165|38354806|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
17200732|NCT02765165|38354807|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
17200733|NCT02765165|38354808|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
17200734|NCT02765165|38354809|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
17200735|NCT02765165|38354810|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
17200736|NCT02765165|38354804|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
17200737|NCT02765165|38354805|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
17200738|NCT02765165|38354806|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
17200739|NCT02765165|38354807|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
17200740|NCT02765165|38354808|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
17200741|NCT02765165|38354809|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
17200742|NCT02765165|38354810|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
17200743|NCT02765165|38354804|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
17200744|NCT02765165|38354805|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
17200745|NCT02765165|38354806|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
17200746|NCT02765165|38354807|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
17200747|NCT02765165|38354808|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
17200748|NCT02765165|38354809|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
17200749|NCT02765165|38354810|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
17200750|NCT02765165|38354804|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
17200751|NCT02765165|38354805|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
17200752|NCT02765165|38354806|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
17200753|NCT02765165|38354807|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
17200754|NCT02765165|38354808|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
17200755|NCT02765165|38354809|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
17200756|NCT02765165|38354810|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
17200757|NCT02765165|38354804|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
17200758|NCT02765165|38354805|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
17200759|NCT02765165|38354806|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
17200760|NCT02765165|38354807|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
17200761|NCT02765165|38354808|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
17200762|NCT02765165|38354809|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
17200763|NCT02765165|38354810|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
17200764|NCT02675907|38354832|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
17200765|NCT02675907|38354833|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
17200766|NCT02675907|38354832|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
17200767|NCT02675907|38354833|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
17200768|NCT02675907|38354832|FG000|Study Overall|Lack of Efficacy|1|||
17200769|NCT02675907|38354833|FG001|Study Overall|Lack of Efficacy|0|||
17200770|NCT02675907|38354832|FG000|Study Overall|Withdrawal by Subject|2|||
17200771|NCT02675907|38354833|FG001|Study Overall|Withdrawal by Subject|2|||
17200772|NCT02675907|38354832|FG000|Study Overall|Lost to Follow-up|0|||
17200773|NCT02675907|38354833|FG001|Study Overall|Lost to Follow-up|2|||
17200774|NCT02675517|38354839|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
17200775|NCT02675517|38354839|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
17200776|NCT02764775|38354843|FG000|Overall Study|Death|1|||
17200777|NCT02764775|38354843|FG000|Overall Study|Lost to Follow-up|2|||
17200778|NCT02764775|38354843|FG000|Overall Study|Withdrawal by Subject|3|||
17200779|NCT02774681|38354847|FG000|Treatment on Study|Progressive Disease|7|||
17200780|NCT02774681|38354847|FG000|Follow-Up for 3 Years|Death|11|||
17200781|NCT02774681|38354847|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
17200782|NCT02547428|38354853|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
17200783|NCT02547428|38354854|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
17200784|NCT02547428|38354853|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
17200785|NCT02547428|38354854|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
17200786|NCT02547428|38354853|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
17200787|NCT02547428|38354854|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
17200788|NCT02547428|38354853|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
17200789|NCT02547428|38354854|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
17200790|NCT02547428|38354853|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
17200791|NCT02547428|38354854|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
17200792|NCT02547428|38354853|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
17200793|NCT02547428|38354854|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
17200794|NCT02547428|38354853|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
17200795|NCT02547428|38354854|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
17200796|NCT02547428|38354853|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
17200797|NCT02547428|38354854|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
17200798|NCT01374087|38354869|FG000|Overall Study|Adverse Event|1|||
17200799|NCT01374087|38354870|FG001|Overall Study|Adverse Event|0|||
17200800|NCT01374087|38354869|FG000|Overall Study|Disease progression|2|||
17200801|NCT01374087|38354870|FG001|Overall Study|Disease progression|2|||
17200802|NCT01374087|38354869|FG000|Overall Study|Study discontinued|13|||
17200803|NCT01374087|38354870|FG001|Overall Study|Study discontinued|13|||
17200804|NCT00152971|38354879|FG000|Overall Study|Adverse Event|12|||
17200805|NCT00152971|38354880|FG001|Overall Study|Adverse Event|10|||
17200806|NCT00152971|38354881|FG002|Overall Study|Adverse Event|9|||
17200807|NCT00152971|38354879|FG000|Overall Study|Protocol Violation|10|||
17200808|NCT00152971|38354880|FG001|Overall Study|Protocol Violation|11|||
17200809|NCT00152971|38354881|FG002|Overall Study|Protocol Violation|8|||
17200810|NCT00152971|38354879|FG000|Overall Study|Lost to Follow-up|17|||
17200811|NCT00152971|38354880|FG001|Overall Study|Lost to Follow-up|14|||
17200812|NCT00152971|38354881|FG002|Overall Study|Lost to Follow-up|13|||
17200813|NCT00152971|38354879|FG000|Overall Study|Withdrawal by Subject|9|||
17200814|NCT00152971|38354880|FG001|Overall Study|Withdrawal by Subject|8|||
17200815|NCT00152971|38354881|FG002|Overall Study|Withdrawal by Subject|14|||
17200816|NCT00152971|38354879|FG000|Overall Study|Other|3|||
17200817|NCT00152971|38354880|FG001|Overall Study|Other|5|||
17200818|NCT00152971|38354881|FG002|Overall Study|Other|5|||
17200819|NCT00152971|38354879|FG000|Treatment|Adverse Event|49|||
17200820|NCT00152971|38354880|FG001|Treatment|Adverse Event|40|||
17200821|NCT00152971|38354881|FG002|Treatment|Adverse Event|54|||
17200822|NCT00152971|38354879|FG000|Treatment|Protocol Violation|8|||
17200823|NCT00152971|38354880|FG001|Treatment|Protocol Violation|6|||
17200824|NCT00152971|38354881|FG002|Treatment|Protocol Violation|10|||
17200825|NCT00152971|38354879|FG000|Treatment|Lost to Follow-up|1|||
17200826|NCT00152971|38354880|FG001|Treatment|Lost to Follow-up|2|||
17200827|NCT00152971|38354881|FG002|Treatment|Lost to Follow-up|1|||
17200828|NCT00152971|38354879|FG000|Treatment|Withdrawal by Subject|4|||
17200829|NCT00152971|38354880|FG001|Treatment|Withdrawal by Subject|4|||
17200830|NCT00152971|38354881|FG002|Treatment|Withdrawal by Subject|5|||
17200831|NCT00152971|38354879|FG000|Treatment|Other|9|||
17200832|NCT00152971|38354880|FG001|Treatment|Other|11|||
17200833|NCT00152971|38354881|FG002|Treatment|Other|10|||
17200834|NCT02538614|38354889|FG000|Overall Study|Progressive Disease|2|||
17200835|NCT04620135|38354897|FG000|Study Completion|Adverse Event|2|||
17200836|NCT04620135|38354898|FG001|Study Completion|Adverse Event|3|||
17200837|NCT04620135|38354897|FG000|Study Completion|Withdrawal by Subject|2|||
17200838|NCT04620135|38354898|FG001|Study Completion|Withdrawal by Subject|0|||
17200839|NCT02552966|38354904|FG000|Overall Study|Lost to Follow-up|2|||
17200840|NCT02552966|38354904|FG000|Overall Study|Withdrawal by Subject|3|||
17200841|NCT02552888|38354910|FG000|Overall Study|Lost to Follow-up|1|||
17200842|NCT02552888|38354911|FG001|Overall Study|Lost to Follow-up|1|||
17200843|NCT01373931|38354930|FG000|Lead-in Period|Adverse Event|2|||
17200844|NCT01373931|38354931|FG001|Lead-in Period|Adverse Event|0|||
17200845|NCT01373931|38354930|FG000|Period 1|Adverse Event|2|||
17200846|NCT01373931|38354931|FG001|Period 1|Adverse Event|0|||
17200847|NCT01373931|38354930|FG000|Period 1|Withdrawal by Subject|0|||
17200848|NCT01373931|38354931|FG001|Period 1|Withdrawal by Subject|2|||
17200849|NCT02552732|38354938|FG000|Overall Study|Lost to Follow-up|2|||
17200850|NCT02552732|38354938|FG000|Overall Study|Physician Decision|1|||
17200851|NCT02552732|38354938|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
17200852|NCT02552732|38354938|FG000|Overall Study|Withdrawal by Subject|6|||
17200853|NCT02547038|38354945|FG000|Overall Study|Lost to Follow-up|3|||
17200854|NCT02547038|38354946|FG001|Overall Study|Lost to Follow-up|2|||
17200855|NCT02764697|38354952|FG000|Overall Study|Lack of Efficacy|3|||
17200856|NCT02673489|38354958|FG000|Treatment Period|Lost to Follow-up|3|||
17200857|NCT02673489|38354959|FG001|Treatment Period|Lost to Follow-up|0|||
17200858|NCT02673489|38354958|FG000|Treatment Period|Participant request to discontinue|1|||
17200859|NCT02673489|38354959|FG001|Treatment Period|Participant request to discontinue|1|||
17200860|NCT02673489|38354958|FG000|Treatment Period|Participant moved to another province|1|||
17200861|NCT02673489|38354959|FG001|Treatment Period|Participant moved to another province|0|||
17200862|NCT02673489|38354958|FG000|Treatment Period|Participant was incarcerated|0|||
17200863|NCT02673489|38354959|FG001|Treatment Period|Participant was incarcerated|1|||
17200864|NCT02673489|38354958|FG000|Treatment Period|Adverse Event|0|||
17200865|NCT02673489|38354959|FG001|Treatment Period|Adverse Event|1|||
17200866|NCT02673489|38354958|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
17200867|NCT02673489|38354959|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
17200868|NCT02673489|38354958|FG000|Follow Up Period|Unable to return for follow-up|0|||
17200869|NCT02673489|38354959|FG001|Follow Up Period|Unable to return for follow-up|1|||
17200870|NCT02772809|38354966|FG000|Overall Study|not completed some tasks|6|||
17200871|NCT02537678|38354977|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
17200872|NCT02537678|38354978|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
17200873|NCT02537678|38354977|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
17200874|NCT02537678|38354978|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
17200875|NCT02537678|38354977|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
17200876|NCT02537678|38354978|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
17200877|NCT02537678|38354977|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
17200878|NCT02537678|38354978|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
17200879|NCT02537678|38354977|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
17200880|NCT02537678|38354978|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
17200881|NCT02537678|38354977|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
17200882|NCT02537678|38354978|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
17200883|NCT02537678|38354977|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
17200884|NCT02537678|38354978|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
17200885|NCT02766023|38354990|FG000|Overall Study|Lost to Follow-up|23|||
17200886|NCT02766023|38354991|FG001|Overall Study|Lost to Follow-up|11|||
17200887|NCT02766023|38354990|FG000|Overall Study|Pregnancy|1|||
17200888|NCT02766023|38354991|FG001|Overall Study|Pregnancy|0|||
17200889|NCT02766023|38354990|FG000|Overall Study|Adverse Event|1|||
17200890|NCT02766023|38354991|FG001|Overall Study|Adverse Event|0|||
17200891|NCT02766023|38354990|FG000|Overall Study|Withdrawal by Subject|4|||
17200892|NCT02766023|38354991|FG001|Overall Study|Withdrawal by Subject|5|||
17200893|NCT02766023|38354990|FG000|Overall Study|Physician Decision|1|||
17200894|NCT02766023|38354991|FG001|Overall Study|Physician Decision|0|||
17200895|NCT02766023|38354990|FG000|Overall Study|Not Eligible at Enrollment|0|||
17200896|NCT02766023|38354991|FG001|Overall Study|Not Eligible at Enrollment|1|||
17200897|NCT02764229|38354997|FG000|Overall Study|Withdrawal by Subject|15|||
17200898|NCT02764229|38354997|FG000|Overall Study|Adverse Event|9|||
17200899|NCT02764229|38354997|FG000|Overall Study|Physician Decision|5|||
17200900|NCT02764229|38354997|FG000|Overall Study|Lost to Follow-up|3|||
17200901|NCT02764229|38354997|FG000|Overall Study|Lack of Efficacy|1|||
17200902|NCT02764229|38354997|FG000|Overall Study|Study Stopped by Sponsor|69|||
17200903|NCT02537522|38355001|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
17200904|NCT02537522|38355002|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
17200905|NCT02537522|38355003|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
17200906|NCT02537522|38355004|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
17200907|NCT02537522|38355001|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
17200908|NCT02537522|38355002|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
17200909|NCT02537522|38355003|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
17200910|NCT02537522|38355004|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
17200911|NCT02537522|38355001|FG000|Phase I - Contralateral|incorrect randomization|0|||
17200912|NCT02537522|38355002|FG001|Phase I - Contralateral|incorrect randomization|1|||
17200913|NCT02537522|38355003|FG002|Phase I - Contralateral|incorrect randomization|0|||
17200914|NCT02537522|38355004|FG003|Phase I - Contralateral|incorrect randomization|0|||
17200915|NCT02537522|38355001|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
17200916|NCT02537522|38355002|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
17200917|NCT02537522|38355003|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
17200918|NCT02537522|38355004|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
17200919|NCT02537522|38355001|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
17200920|NCT02537522|38355002|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
17200921|NCT02537522|38355003|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
17200922|NCT02537522|38355004|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
17200923|NCT02536976|38355012|FG000|Overall Study|Physician Decision|0|||
17200924|NCT02536976|38355013|FG001|Overall Study|Physician Decision|1|||
17200925|NCT02672553|38355023|FG000|Overall Study|Death|3|||
17200926|NCT02672553|38355024|FG001|Overall Study|Death|5|||
17200927|NCT02672553|38355023|FG000|Overall Study|Valve Explant|1|||
17200928|NCT02672553|38355024|FG001|Overall Study|Valve Explant|0|||
17200929|NCT02672553|38355023|FG000|Overall Study|Conversion to Commercial Valve|3|||
17200930|NCT02672553|38355024|FG001|Overall Study|Conversion to Commercial Valve|0|||
17200931|NCT02672553|38355023|FG000|Overall Study|Withdrawal by Subject|3|||
17200932|NCT02672553|38355024|FG001|Overall Study|Withdrawal by Subject|3|||
17200933|NCT02672553|38355023|FG000|Overall Study|Intraoperative screen failure|2|||
17200934|NCT02672553|38355024|FG001|Overall Study|Intraoperative screen failure|0|||
17200935|NCT01373229|38355031|FG000|Overall Study|Death|3|||
17200936|NCT01373229|38355031|FG000|Overall Study|Physician Decision|3|||
17200937|NCT02671461|38355038|FG000|Treatment|Adverse Event|0|||
17200938|NCT02671461|38355039|FG001|Treatment|Adverse Event|0|||
17200939|NCT02671461|38355040|FG002|Treatment|Adverse Event|1|||
17200940|NCT02671461|38355038|FG000|Treatment|Administrative Reason by Sponsor|1|||
17200941|NCT02671461|38355039|FG001|Treatment|Administrative Reason by Sponsor|3|||
17200942|NCT02671461|38355040|FG002|Treatment|Administrative Reason by Sponsor|4|||
17200943|NCT02671461|38355038|FG000|Treatment|Randomized, not treated|1|||
17200944|NCT02671461|38355039|FG001|Treatment|Randomized, not treated|0|||
17200945|NCT02671461|38355040|FG002|Treatment|Randomized, not treated|0|||
17200946|NCT02671461|38355038|FG000|Follow-up|Withdrawal by Subject|1|||
17200947|NCT02671461|38355039|FG001|Follow-up|Withdrawal by Subject|0|||
17200948|NCT02671461|38355040|FG002|Follow-up|Withdrawal by Subject|0|||
17200949|NCT02671461|38355038|FG000|Follow-up|Lost to Follow-up|0|||
17200950|NCT02671461|38355039|FG001|Follow-up|Lost to Follow-up|0|||
17200951|NCT02671461|38355040|FG002|Follow-up|Lost to Follow-up|1|||
17200952|NCT02671461|38355038|FG000|Follow-up|Administrative Reason by Sponsor|0|||
17200953|NCT02671461|38355039|FG001|Follow-up|Administrative Reason by Sponsor|1|||
17200954|NCT02671461|38355040|FG002|Follow-up|Administrative Reason by Sponsor|0|||
17200955|NCT02535416|38355057|FG000|Overall Study|Family bereavement overseas|1|||
17200956|NCT02535416|38355058|FG001|Overall Study|Family bereavement overseas|0|||
17200957|NCT02535416|38355059|FG002|Overall Study|Family bereavement overseas|0|||
17200958|NCT02535416|38355060|FG003|Overall Study|Family bereavement overseas|0|||
17200959|NCT02535416|38355061|FG004|Overall Study|Family bereavement overseas|0|||
17200960|NCT02535416|38355062|FG005|Overall Study|Family bereavement overseas|0|||
17200961|NCT02535416|38355063|FG006|Overall Study|Family bereavement overseas|0|||
17200962|NCT02535416|38355064|FG007|Overall Study|Family bereavement overseas|0|||
17200963|NCT02535416|38355065|FG008|Overall Study|Family bereavement overseas|0|||
17200964|NCT02670915|38355115|FG000|Overall Study|Withdrawal by Subject|0|||
17200965|NCT02670915|38355116|FG001|Overall Study|Withdrawal by Subject|1|||
17200966|NCT02670915|38355117|FG002|Overall Study|Withdrawal by Subject|4|||
17200967|NCT02670915|38355115|FG000|Overall Study|Withdrawal by parent/guardian|4|||
17200968|NCT02670915|38355116|FG001|Overall Study|Withdrawal by parent/guardian|4|||
17200969|NCT02670915|38355117|FG002|Overall Study|Withdrawal by parent/guardian|1|||
17200970|NCT02670915|38355115|FG000|Overall Study|Unclassified|0|||
17200971|NCT02670915|38355116|FG001|Overall Study|Unclassified|3|||
17200972|NCT02670915|38355117|FG002|Overall Study|Unclassified|0|||
17200973|NCT02545868|38355128|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
17200974|NCT02545868|38355129|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
17200975|NCT02545868|38355130|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
17200976|NCT02764151|38355147|FG000|Overall Study|Subject refused further follow-up|0|||
17200977|NCT02764151|38355148|FG001|Overall Study|Subject refused further follow-up|0|||
17200978|NCT02764151|38355149|FG002|Overall Study|Subject refused further follow-up|0|||
17200979|NCT02764151|38355150|FG003|Overall Study|Subject refused further follow-up|1|||
17200980|NCT02764151|38355147|FG000|Overall Study|Other|0|||
17200981|NCT02764151|38355148|FG001|Overall Study|Other|0|||
17200982|NCT02764151|38355149|FG002|Overall Study|Other|0|||
17200983|NCT02764151|38355150|FG003|Overall Study|Other|2|||
17200984|NCT02545322|38355160|FG000|Overall Study|Withdrawal by Subject|3|||
17200985|NCT02763215|38355164|FG000|Overall Study|Participants withdrew from study|3|||
17200986|NCT02763215|38355164|FG000|Overall Study|Missed visit|1|||
17200987|NCT02763215|38355164|FG000|Overall Study|Visit outside visit-window|1|||
17200988|NCT02763215|38355164|FG000|Overall Study|Death|1|||
17200989|NCT02763215|38355164|FG000|Overall Study|Lost to Follow-up|1|||
17200990|NCT02770547|38355183|FG000|Overall Study|Patient non-compliant|1|||
17200991|NCT02770547|38355184|FG001|Overall Study|Patient non-compliant|0|||
17200992|NCT02770547|38355183|FG000|Overall Study|Adverse Event|0|||
17200993|NCT02770547|38355184|FG001|Overall Study|Adverse Event|1|||
17200994|NCT01661972|38355192|FG000|Overall Study|Adverse Event|1|||
17200995|NCT01661972|38355193|FG001|Overall Study|Adverse Event|2|||
17200996|NCT01661972|38355192|FG000|Overall Study|Death during Treatment period|1|||
17200997|NCT01661972|38355193|FG001|Overall Study|Death during Treatment period|1|||
17200998|NCT01661972|38355192|FG000|Overall Study|Withdrawal by Subject|0|||
17200999|NCT01661972|38355193|FG001|Overall Study|Withdrawal by Subject|1|||
17201000|NCT00888355|38355205|FG000|Overall Study|Adverse Event|10|||
17201001|NCT00888355|38355206|FG001|Overall Study|Adverse Event|0|||
17201002|NCT00888355|38355207|FG002|Overall Study|Adverse Event|3|||
17201003|NCT00888355|38355208|FG003|Overall Study|Adverse Event|3|||
17201004|NCT00888355|38355205|FG000|Overall Study|Lack of Efficacy|9|||
17201005|NCT00888355|38355206|FG001|Overall Study|Lack of Efficacy|2|||
17201006|NCT00888355|38355207|FG002|Overall Study|Lack of Efficacy|5|||
17201007|NCT00888355|38355208|FG003|Overall Study|Lack of Efficacy|2|||
17201008|NCT00888355|38355205|FG000|Overall Study|Lost to Follow-up|0|||
17201009|NCT00888355|38355206|FG001|Overall Study|Lost to Follow-up|2|||
17201010|NCT00888355|38355207|FG002|Overall Study|Lost to Follow-up|2|||
17201011|NCT00888355|38355208|FG003|Overall Study|Lost to Follow-up|0|||
17201012|NCT00888355|38355205|FG000|Overall Study|Protocol Violation|3|||
17201013|NCT00888355|38355206|FG001|Overall Study|Protocol Violation|2|||
17201014|NCT00888355|38355207|FG002|Overall Study|Protocol Violation|1|||
17201015|NCT00888355|38355208|FG003|Overall Study|Protocol Violation|2|||
17201016|NCT00888355|38355205|FG000|Overall Study|Withdrawal by Subject|0|||
17201017|NCT00888355|38355206|FG001|Overall Study|Withdrawal by Subject|3|||
17201018|NCT00888355|38355207|FG002|Overall Study|Withdrawal by Subject|1|||
17201019|NCT00888355|38355208|FG003|Overall Study|Withdrawal by Subject|3|||
17201020|NCT00794677|38355216|FG000|First Intervention|Withdrawal by Subject|2|||
17201021|NCT00794677|38355217|FG001|First Intervention|Withdrawal by Subject|0|||
17201022|NCT02770391|38355221|FG000|Overall Study|Lost to Follow-up|2|||
17201023|NCT02770391|38355221|FG000|Overall Study|Withdrawal by Subject|1|||
17201024|NCT02770391|38355221|FG000|Overall Study|Surgery delayed unevaluable|2|||
17201025|NCT02770391|38355221|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
17201026|NCT02536664|38355227|FG000|Overall Study|Inadequate completion of documentation|2|||
17201027|NCT02536664|38355228|FG001|Overall Study|Inadequate completion of documentation|4|||
17201028|NCT02536664|38355227|FG000|Overall Study|Progression|13|||
17201029|NCT02536664|38355228|FG001|Overall Study|Progression|18|||
17201030|NCT02536664|38355227|FG000|Overall Study|Death due to lymphoma|2|||
17201031|NCT02536664|38355228|FG001|Overall Study|Death due to lymphoma|1|||
17201032|NCT02536664|38355227|FG000|Overall Study|Death due to other reason|3|||
17201033|NCT02536664|38355228|FG001|Overall Study|Death due to other reason|2|||
17201034|NCT02536664|38355227|FG000|Overall Study|Intolerability|8|||
17201035|NCT02536664|38355228|FG001|Overall Study|Intolerability|6|||
17201036|NCT02536664|38355227|FG000|Overall Study|Withdrawal by Subject|8|||
17201037|NCT02536664|38355228|FG001|Overall Study|Withdrawal by Subject|5|||
17201038|NCT02536664|38355227|FG000|Overall Study|Other|18|||
17201039|NCT02536664|38355228|FG001|Overall Study|Other|24|||
17201040|NCT02536664|38355227|FG000|Overall Study|Missing|53|||
17201041|NCT02536664|38355228|FG001|Overall Study|Missing|20|||
17201042|NCT02536508|38355237|FG000|Overall Study|Withdrawal by Subject|18|||
17201043|NCT02536508|38355238|FG001|Overall Study|Withdrawal by Subject|13|||
17201044|NCT02536508|38355239|FG002|Overall Study|Withdrawal by Subject|7|||
17201045|NCT02536508|38355237|FG000|Overall Study|Adverse Event|14|||
17201046|NCT02536508|38355238|FG001|Overall Study|Adverse Event|13|||
17201047|NCT02536508|38355239|FG002|Overall Study|Adverse Event|6|||
17201048|NCT02536508|38355237|FG000|Overall Study|Lost to Follow-up|12|||
17201049|NCT02536508|38355238|FG001|Overall Study|Lost to Follow-up|4|||
17201050|NCT02536508|38355239|FG002|Overall Study|Lost to Follow-up|0|||
17201051|NCT02536508|38355237|FG000|Overall Study|Lack of Efficacy|3|||
17201052|NCT02536508|38355238|FG001|Overall Study|Lack of Efficacy|5|||
17201053|NCT02536508|38355239|FG002|Overall Study|Lack of Efficacy|4|||
17201054|NCT02536508|38355237|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
17201055|NCT02536508|38355238|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
17201056|NCT02536508|38355239|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
17201057|NCT02536508|38355237|FG000|Overall Study|Physician Decision|0|||
17201058|NCT02536508|38355238|FG001|Overall Study|Physician Decision|4|||
17201059|NCT02536508|38355239|FG002|Overall Study|Physician Decision|2|||
17201060|NCT02536508|38355237|FG000|Overall Study|Major Protocol Deviation|2|||
17201061|NCT02536508|38355238|FG001|Overall Study|Major Protocol Deviation|2|||
17201062|NCT02536508|38355239|FG002|Overall Study|Major Protocol Deviation|2|||
17201063|NCT02536508|38355237|FG000|Overall Study|Administrative Reasons|0|||
17201064|NCT02536508|38355238|FG001|Overall Study|Administrative Reasons|1|||
17201065|NCT02536508|38355239|FG002|Overall Study|Administrative Reasons|0|||
17201066|NCT00103259|38355256|FG000|Overall Study|Death|3|||
17201067|NCT00103259|38355257|FG001|Overall Study|Death|2|||
17201068|NCT00103259|38355256|FG000|Overall Study|Withdrawal by Subject|2|||
17201069|NCT00103259|38355257|FG001|Overall Study|Withdrawal by Subject|3|||
17201070|NCT00103259|38355256|FG000|Overall Study|alternative therapy|1|||
17201071|NCT00103259|38355257|FG001|Overall Study|alternative therapy|0|||
17201072|NCT00103259|38355256|FG000|Overall Study|other (reasons were not specified)|2|||
17201073|NCT00103259|38355257|FG001|Overall Study|other (reasons were not specified)|1|||
17201074|NCT00103259|38355256|FG000|Overall Study|ineligible/no protocol therapy|4|||
17201075|NCT00103259|38355257|FG001|Overall Study|ineligible/no protocol therapy|6|||
17201076|NCT02544152|38355267|FG000|Overall Study|Adverse Event|0|||
17201077|NCT02544152|38355268|FG001|Overall Study|Adverse Event|4|||
17201078|NCT02544152|38355267|FG000|Overall Study|Withdrawal by Subject|0|||
17201079|NCT02544152|38355268|FG001|Overall Study|Withdrawal by Subject|3|||
17201080|NCT02544152|38355267|FG000|Overall Study|Other|1|||
17201081|NCT02544152|38355268|FG001|Overall Study|Other|0|||
17201082|NCT02534324|38355276|FG000|Overall Study|Protocol Violation|4|||
17201083|NCT02534324|38355277|FG001|Overall Study|Protocol Violation|1|||
17201084|NCT02534324|38355276|FG000|Overall Study|Lost to Follow-up|20|||
17201085|NCT02534324|38355277|FG001|Overall Study|Lost to Follow-up|7|||
17201086|NCT02534324|38355276|FG000|Overall Study|Adverse Event|1|||
17201087|NCT02534324|38355277|FG001|Overall Study|Adverse Event|0|||
17201088|NCT02761733|38355287|FG000|Overall Study|Death|3|||
17201089|NCT02761733|38355288|FG001|Overall Study|Death|5|||
17201090|NCT02761733|38355289|FG002|Overall Study|Death|1|||
17201091|NCT02761733|38355290|FG003|Overall Study|Death|1|||
17201092|NCT02761733|38355287|FG000|Overall Study|Lost to Follow-up|6|||
17201093|NCT02761733|38355288|FG001|Overall Study|Lost to Follow-up|7|||
17201094|NCT02761733|38355289|FG002|Overall Study|Lost to Follow-up|0|||
17201095|NCT02761733|38355290|FG003|Overall Study|Lost to Follow-up|3|||
17201096|NCT02761733|38355287|FG000|Overall Study|Physician Decision|4|||
17201097|NCT02761733|38355288|FG001|Overall Study|Physician Decision|0|||
17201098|NCT02761733|38355289|FG002|Overall Study|Physician Decision|0|||
17201099|NCT02761733|38355290|FG003|Overall Study|Physician Decision|0|||
17201100|NCT02761733|38355287|FG000|Overall Study|Withdrawal by Subject|2|||
17201101|NCT02761733|38355288|FG001|Overall Study|Withdrawal by Subject|0|||
17201102|NCT02761733|38355289|FG002|Overall Study|Withdrawal by Subject|0|||
17201103|NCT02761733|38355290|FG003|Overall Study|Withdrawal by Subject|0|||
17201104|NCT02761733|38355287|FG000|Overall Study|Discharged from Study Site|10|||
17201105|NCT02761733|38355288|FG001|Overall Study|Discharged from Study Site|9|||
17201106|NCT02761733|38355289|FG002|Overall Study|Discharged from Study Site|25|||
17201107|NCT02761733|38355290|FG003|Overall Study|Discharged from Study Site|11|||
17201108|NCT02761733|38355287|FG000|Overall Study|Cognitive Impairment|5|||
17201109|NCT02761733|38355288|FG001|Overall Study|Cognitive Impairment|0|||
17201110|NCT02761733|38355289|FG002|Overall Study|Cognitive Impairment|1|||
17201111|NCT02761733|38355290|FG003|Overall Study|Cognitive Impairment|0|||
17201112|NCT03715465|38355302|FG000|Overall Study|Withdrawal by Subject|1|||
17201113|NCT03715465|38355303|FG001|Overall Study|Withdrawal by Subject|2|||
17201114|NCT00840073|38355311|FG000|Second Intervention|Missed 72 hour blood draw|1|||
17201115|NCT00840073|38355312|FG001|Second Intervention|Missed 72 hour blood draw|1|||
17201116|NCT00838279|38355318|FG000|Washout|Protocol Violation|1|||
17201117|NCT00838279|38355319|FG001|Washout|Protocol Violation|0|||
17201118|NCT00838279|38355318|FG000|Washout|Withdrawal by Subject|0|||
17201119|NCT00838279|38355319|FG001|Washout|Withdrawal by Subject|1|||
17201120|NCT02759939|38355327|FG000|Overall Study|Missing data on first outcome assessed|11|||
17201121|NCT02759939|38355328|FG001|Overall Study|Missing data on first outcome assessed|2|||
17201122|NCT02759939|38355329|FG002|Overall Study|Missing data on first outcome assessed|5|||
17201123|NCT02759939|38355330|FG003|Overall Study|Missing data on first outcome assessed|2|||
17201124|NCT02759939|38355327|FG000|Overall Study|Ineligible for T2 and T3|310|||
17201125|NCT02759939|38355328|FG001|Overall Study|Ineligible for T2 and T3|179|||
17201126|NCT02759939|38355329|FG002|Overall Study|Ineligible for T2 and T3|366|||
17201127|NCT02759939|38355330|FG003|Overall Study|Ineligible for T2 and T3|391|||
17201128|NCT02759939|38355327|FG000|Overall Study|Lost to Follow-up|735|||
17201129|NCT02759939|38355328|FG001|Overall Study|Lost to Follow-up|791|||
17201130|NCT02759939|38355329|FG002|Overall Study|Lost to Follow-up|783|||
17201131|NCT02759939|38355330|FG003|Overall Study|Lost to Follow-up|650|||
17201132|NCT00835705|38355349|FG000|First Intervention|Difficulty with vein|1|||
17201133|NCT00835705|38355350|FG001|First Intervention|Difficulty with vein|0|||
17201134|NCT00835705|38355349|FG000|Second Intervention|Difficulty with vein|1|||
17201135|NCT00835705|38355350|FG001|Second Intervention|Difficulty with vein|0|||
17201136|NCT02938520|38355356|FG000|Overall Study|On-going at the time of analysis|258|||
17201137|NCT02938520|38355357|FG001|Overall Study|On-going at the time of analysis|261|||
17201138|NCT02938520|38355356|FG000|Overall Study|Physician Decision|2|||
17201139|NCT02938520|38355357|FG001|Overall Study|Physician Decision|5|||
17201140|NCT02938520|38355356|FG000|Overall Study|Lost to Follow-up|2|||
17201141|NCT02938520|38355357|FG001|Overall Study|Lost to Follow-up|2|||
17201142|NCT02938520|38355356|FG000|Overall Study|Withdrawal by Subject|7|||
17201143|NCT02938520|38355357|FG001|Overall Study|Withdrawal by Subject|7|||
17201144|NCT02938520|38355356|FG000|Overall Study|Protocol Violation|0|||
17201145|NCT02938520|38355357|FG001|Overall Study|Protocol Violation|1|||
17201146|NCT02938520|38355356|FG000|Overall Study|Lack of Efficacy|5|||
17201147|NCT02938520|38355357|FG001|Overall Study|Lack of Efficacy|3|||
17201148|NCT02938520|38355356|FG000|Overall Study|Adverse Event|9|||
17201149|NCT02938520|38355357|FG001|Overall Study|Adverse Event|4|||
17201150|NCT02759471|38355366|FG000|Overall Study|discomfort|2|||
17201151|NCT00835549|38355374|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
17201152|NCT00835549|38355375|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
17201153|NCT03945825|38355385|FG000|Overall Study|Enrolled but treatment not administered|0|||
17201154|NCT03945825|38355386|FG001|Overall Study|Enrolled but treatment not administered|0|||
17201155|NCT03945825|38355387|FG002|Overall Study|Enrolled but treatment not administered|0|||
17201156|NCT03945825|38355388|FG003|Overall Study|Enrolled but treatment not administered|0|||
17201157|NCT03945825|38355389|FG004|Overall Study|Enrolled but treatment not administered|1|||
17201158|NCT03945825|38355390|FG005|Overall Study|Enrolled but treatment not administered|0|||
17201159|NCT03945825|38355385|FG000|Overall Study|Lost to Follow-up|1|||
17201160|NCT03945825|38355386|FG001|Overall Study|Lost to Follow-up|5|||
17201161|NCT03945825|38355387|FG002|Overall Study|Lost to Follow-up|0|||
17201162|NCT03945825|38355388|FG003|Overall Study|Lost to Follow-up|1|||
17201163|NCT03945825|38355389|FG004|Overall Study|Lost to Follow-up|2|||
17201164|NCT03945825|38355390|FG005|Overall Study|Lost to Follow-up|2|||
17201165|NCT03945825|38355385|FG000|Overall Study|Withdrawal by Subject|1|||
17201166|NCT03945825|38355386|FG001|Overall Study|Withdrawal by Subject|0|||
17201167|NCT03945825|38355387|FG002|Overall Study|Withdrawal by Subject|1|||
17201168|NCT03945825|38355388|FG003|Overall Study|Withdrawal by Subject|1|||
17201169|NCT03945825|38355389|FG004|Overall Study|Withdrawal by Subject|0|||
17201170|NCT03945825|38355390|FG005|Overall Study|Withdrawal by Subject|1|||
17201171|NCT02759315|38355418|FG000|Overall Study|Adverse Event|0|||
17201172|NCT02759315|38355419|FG001|Overall Study|Adverse Event|0|||
17201173|NCT02759315|38355420|FG002|Overall Study|Adverse Event|0|||
17201174|NCT02759315|38355421|FG003|Overall Study|Adverse Event|1|||
17201175|NCT02759315|38355422|FG004|Overall Study|Adverse Event|0|||
17201176|NCT02759315|38355418|FG000|Overall Study|Death|0|||
17201177|NCT02759315|38355419|FG001|Overall Study|Death|0|||
17201178|NCT02759315|38355420|FG002|Overall Study|Death|1|||
17201179|NCT02759315|38355421|FG003|Overall Study|Death|0|||
17201180|NCT02759315|38355422|FG004|Overall Study|Death|0|||
17201181|NCT02759315|38355418|FG000|Overall Study|Lost to Follow-up|2|||
17201182|NCT02759315|38355419|FG001|Overall Study|Lost to Follow-up|0|||
17201183|NCT02759315|38355420|FG002|Overall Study|Lost to Follow-up|4|||
17201184|NCT02759315|38355421|FG003|Overall Study|Lost to Follow-up|0|||
17201185|NCT02759315|38355422|FG004|Overall Study|Lost to Follow-up|0|||
17201186|NCT02759315|38355418|FG000|Overall Study|Protocol Violation|0|||
17201187|NCT02759315|38355419|FG001|Overall Study|Protocol Violation|1|||
17201188|NCT02759315|38355420|FG002|Overall Study|Protocol Violation|0|||
17201189|NCT02759315|38355421|FG003|Overall Study|Protocol Violation|0|||
17201190|NCT02759315|38355422|FG004|Overall Study|Protocol Violation|0|||
17201191|NCT02759315|38355418|FG000|Overall Study|Study terminated prior to completion|2|||
17201192|NCT02759315|38355419|FG001|Overall Study|Study terminated prior to completion|0|||
17201193|NCT02759315|38355420|FG002|Overall Study|Study terminated prior to completion|5|||
17201194|NCT02759315|38355421|FG003|Overall Study|Study terminated prior to completion|0|||
17201195|NCT02759315|38355422|FG004|Overall Study|Study terminated prior to completion|1|||
17201196|NCT00835081|38355438|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
17201197|NCT00835081|38355439|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
17201198|NCT02543918|38355445|FG000|Overall Study|Never treated|0|||
17201199|NCT02543918|38355446|FG001|Overall Study|Never treated|1|||
17201200|NCT02543918|38355445|FG000|Overall Study|Lost to Follow-up|1|||
17201201|NCT02543918|38355446|FG001|Overall Study|Lost to Follow-up|1|||
17201202|NCT02543918|38355445|FG000|Overall Study|Withdrawal by Subject|1|||
17201203|NCT02543918|38355446|FG001|Overall Study|Withdrawal by Subject|1|||
17201204|NCT02543918|38355445|FG000|Overall Study|Adverse Event|1|||
17201205|NCT02543918|38355446|FG001|Overall Study|Adverse Event|1|||
17201206|NCT01372995|38355455|FG000|Overall Study|Spouse withdrew participant from study|0|||
17201207|NCT01372995|38355456|FG001|Overall Study|Spouse withdrew participant from study|1|||
17201208|NCT01372995|38355457|FG002|Overall Study|Spouse withdrew participant from study|0|||
17201209|NCT01372995|38355455|FG000|Overall Study|Physician Decision|0|||
17201210|NCT01372995|38355456|FG001|Overall Study|Physician Decision|0|||
17201211|NCT01372995|38355457|FG002|Overall Study|Physician Decision|1|||
17201212|NCT02757521|38355467|FG000|Overall Study|Adverse Event|1|||
17201213|NCT02757521|38355468|FG001|Overall Study|Adverse Event|0|||
17201214|NCT00834613|38355476|FG000|First Intervention|Protocol Violation|1|||
17201215|NCT00834613|38355477|FG001|First Intervention|Protocol Violation|0|||
17201216|NCT00834067|38355494|FG000|Washout of 21 Days|Protocol Violation|0|||
17201217|NCT00834067|38355495|FG001|Washout of 21 Days|Protocol Violation|1|||
17201218|NCT02758613|38355503|FG000|Treatment|Physician and Sponsor Decision|1|||
17201219|NCT02758613|38355504|FG001|Treatment|Physician and Sponsor Decision|0|||
17201220|NCT02758613|38355505|FG002|Treatment|Physician and Sponsor Decision|0|||
17201221|NCT02758613|38355506|FG003|Treatment|Physician and Sponsor Decision|0|||
17201222|NCT02758613|38355503|FG000|Treatment|Withdrawal by Subject|1|||
17201223|NCT02758613|38355504|FG001|Treatment|Withdrawal by Subject|0|||
17201224|NCT02758613|38355505|FG002|Treatment|Withdrawal by Subject|1|||
17201225|NCT02758613|38355506|FG003|Treatment|Withdrawal by Subject|0|||
17201226|NCT02758301|38355521|FG000|Overall Study|Death|12|||
17201227|NCT02758301|38355522|FG001|Overall Study|Death|0|||
17201228|NCT02758301|38355521|FG000|Overall Study|Physician Decision|10|||
17201229|NCT02758301|38355522|FG001|Overall Study|Physician Decision|1|||
17201230|NCT02758301|38355521|FG000|Overall Study|Withdrawal by Subject|5|||
17201231|NCT02758301|38355522|FG001|Overall Study|Withdrawal by Subject|6|||
17201232|NCT02758301|38355521|FG000|Overall Study|Lost to Follow-up|7|||
17201233|NCT02758301|38355522|FG001|Overall Study|Lost to Follow-up|0|||
17201234|NCT02758301|38355521|FG000|Overall Study|Protocol Violation|0|||
17201235|NCT02758301|38355522|FG001|Overall Study|Protocol Violation|1|||
17201236|NCT02669667|38355542|FG000|Overall Study|Lost to Follow-up|0|||
17201237|NCT02669667|38355543|FG001|Overall Study|Lost to Follow-up|0|||
17201238|NCT02669667|38355544|FG002|Overall Study|Lost to Follow-up|0|||
17201239|NCT02669667|38355545|FG003|Overall Study|Lost to Follow-up|0|||
17201240|NCT02669667|38355546|FG004|Overall Study|Lost to Follow-up|0|||
17201241|NCT02669667|38355547|FG005|Overall Study|Lost to Follow-up|1|||
17201242|NCT02669667|38355548|FG006|Overall Study|Lost to Follow-up|0|||
17201243|NCT02669433|38355573|FG000|Overall Study|Protocol Violation|0|||
17201244|NCT02669433|38355574|FG001|Overall Study|Protocol Violation|4|||
17201245|NCT02669433|38355575|FG002|Overall Study|Protocol Violation|1|||
17201246|NCT02669433|38355573|FG000|Overall Study|Disease Progression|1|||
17201247|NCT02669433|38355574|FG001|Overall Study|Disease Progression|0|||
17201248|NCT02669433|38355575|FG002|Overall Study|Disease Progression|0|||
17201249|NCT02669433|38355573|FG000|Overall Study|Physician Decision|1|||
17201250|NCT02669433|38355574|FG001|Overall Study|Physician Decision|1|||
17201251|NCT02669433|38355575|FG002|Overall Study|Physician Decision|0|||
17201252|NCT02669433|38355573|FG000|Overall Study|Adverse Event|6|||
17201253|NCT02669433|38355574|FG001|Overall Study|Adverse Event|7|||
17201254|NCT02669433|38355575|FG002|Overall Study|Adverse Event|10|||
17201255|NCT02669433|38355573|FG000|Overall Study|Sponsor Termination|1|||
17201256|NCT02669433|38355574|FG001|Overall Study|Sponsor Termination|0|||
17201257|NCT02669433|38355575|FG002|Overall Study|Sponsor Termination|1|||
17201258|NCT02669433|38355573|FG000|Overall Study|Withdrawal by Subject|5|||
17201259|NCT02669433|38355574|FG001|Overall Study|Withdrawal by Subject|1|||
17201260|NCT02669433|38355575|FG002|Overall Study|Withdrawal by Subject|0|||
17201261|NCT02669433|38355573|FG000|Overall Study|Withdrawal by Caregiver|1|||
17201262|NCT02669433|38355574|FG001|Overall Study|Withdrawal by Caregiver|0|||
17201263|NCT02669433|38355575|FG002|Overall Study|Withdrawal by Caregiver|2|||
17201264|NCT02669433|38355573|FG000|Overall Study|Death|0|||
17201265|NCT02669433|38355574|FG001|Overall Study|Death|1|||
17201266|NCT02669433|38355575|FG002|Overall Study|Death|1|||
17201267|NCT02756819|38355583|FG000|Overall Study|Lost for observation|23|||
17201268|NCT02756819|38355583|FG000|Overall Study|Patient's unwillingness|16|||
17201269|NCT02756819|38355583|FG000|Overall Study|Insufficient efficacy|2|||
17201270|NCT02756819|38355583|FG000|Overall Study|Adverse Event|2|||
17201271|NCT02756819|38355583|FG000|Overall Study|Reason not Specified|9|||
17201272|NCT00829309|38355589|FG000|Washout: 7 Days|Protocol Violation|1|||
17201273|NCT00829309|38355590|FG001|Washout: 7 Days|Protocol Violation|0|||
17201274|NCT02669121|38355596|FG000|Overall Study|Adverse Event|4|||
17201275|NCT02669121|38355597|FG001|Overall Study|Adverse Event|5|||
17201276|NCT02669121|38355596|FG000|Overall Study|Lost to Follow-up|15|||
17201277|NCT02669121|38355597|FG001|Overall Study|Lost to Follow-up|27|||
17201278|NCT02669121|38355596|FG000|Overall Study|Withdrawal by Subject|132|||
17201279|NCT02669121|38355597|FG001|Overall Study|Withdrawal by Subject|140|||
17201280|NCT02669121|38355596|FG000|Overall Study|Pregnancy|0|||
17201281|NCT02669121|38355597|FG001|Overall Study|Pregnancy|1|||
17201282|NCT02669121|38355596|FG000|Overall Study|Discharged from US Military Active Service|117|||
17201283|NCT02669121|38355597|FG001|Overall Study|Discharged from US Military Active Service|91|||
17201284|NCT02669121|38355596|FG000|Overall Study|Reason not Specified|22|||
17201285|NCT02669121|38355597|FG001|Overall Study|Reason not Specified|18|||
17201286|NCT02743117|38355605|FG000|Overall Study|Lost to Follow-up|0|||
17201287|NCT02743117|38355606|FG001|Overall Study|Lost to Follow-up|1|||
17201288|NCT02743117|38355605|FG000|Overall Study|Other|1|||
17201289|NCT02743117|38355606|FG001|Overall Study|Other|0|||
17201290|NCT02669043|38355621|FG000|Overall Study|Didn't meet I/E criteria|4|||
17201291|NCT02760407|38355629|FG000|Overall Study|Death|2|||
17201292|NCT02760407|38355630|FG001|Overall Study|Death|3|||
17201293|NCT02760407|38355631|FG002|Overall Study|Death|1|||
17201294|NCT02760407|38355632|FG003|Overall Study|Death|1|||
17201295|NCT02760407|38355629|FG000|Overall Study|Lost to Follow-up|1|||
17201296|NCT02760407|38355630|FG001|Overall Study|Lost to Follow-up|7|||
17201297|NCT02760407|38355631|FG002|Overall Study|Lost to Follow-up|4|||
17201298|NCT02760407|38355632|FG003|Overall Study|Lost to Follow-up|6|||
17201299|NCT02760407|38355629|FG000|Overall Study|Withdrawal by Subject|25|||
17201300|NCT02760407|38355630|FG001|Overall Study|Withdrawal by Subject|31|||
17201301|NCT02760407|38355631|FG002|Overall Study|Withdrawal by Subject|37|||
17201302|NCT02760407|38355632|FG003|Overall Study|Withdrawal by Subject|25|||
17201303|NCT02760407|38355629|FG000|Overall Study|Violation of Eligibility criteria|0|||
17201304|NCT02760407|38355630|FG001|Overall Study|Violation of Eligibility criteria|0|||
17201305|NCT02760407|38355631|FG002|Overall Study|Violation of Eligibility criteria|1|||
17201306|NCT02760407|38355632|FG003|Overall Study|Violation of Eligibility criteria|1|||
17201307|NCT02760407|38355629|FG000|Overall Study|Personal reasons|0|||
17201308|NCT02760407|38355630|FG001|Overall Study|Personal reasons|0|||
17201309|NCT02760407|38355631|FG002|Overall Study|Personal reasons|0|||
17201310|NCT02760407|38355632|FG003|Overall Study|Personal reasons|1|||
17201311|NCT02760407|38355629|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
17201312|NCT02760407|38355630|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
17201313|NCT02760407|38355631|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
17201314|NCT02760407|38355632|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
17201315|NCT02760407|38355629|FG000|Overall Study|Use of prohibited Medication|0|||
17201316|NCT02760407|38355630|FG001|Overall Study|Use of prohibited Medication|0|||
17201317|NCT02760407|38355631|FG002|Overall Study|Use of prohibited Medication|1|||
17201318|NCT02760407|38355632|FG003|Overall Study|Use of prohibited Medication|0|||
17201319|NCT02760407|38355629|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
17201320|NCT02760407|38355630|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
17201321|NCT02760407|38355631|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
17201322|NCT02760407|38355632|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
17201323|NCT02760407|38355629|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
17201324|NCT02760407|38355630|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
17201325|NCT02760407|38355631|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
17201326|NCT02760407|38355632|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
17201327|NCT02760407|38355629|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
17201328|NCT02760407|38355630|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
17201329|NCT02760407|38355631|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
17201330|NCT02760407|38355632|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
17201331|NCT02760407|38355629|FG000|Overall Study|Inadequately Enrolled|0|||
17201332|NCT02760407|38355630|FG001|Overall Study|Inadequately Enrolled|0|||
17201333|NCT02760407|38355631|FG002|Overall Study|Inadequately Enrolled|0|||
17201334|NCT02760407|38355632|FG003|Overall Study|Inadequately Enrolled|1|||
17201335|NCT02760407|38355629|FG000|Overall Study|Withdrawal By PI's Decision|0|||
17201336|NCT02760407|38355630|FG001|Overall Study|Withdrawal By PI's Decision|1|||
17201337|NCT02760407|38355631|FG002|Overall Study|Withdrawal By PI's Decision|0|||
17201338|NCT02760407|38355632|FG003|Overall Study|Withdrawal By PI's Decision|0|||
17201339|NCT02760407|38355629|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
17201340|NCT02760407|38355630|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
17201341|NCT02760407|38355631|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
17201342|NCT02760407|38355632|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
17201343|NCT02760407|38355629|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
17201344|NCT02760407|38355630|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
17201345|NCT02760407|38355631|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
17201346|NCT02760407|38355632|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
17201347|NCT02760407|38355629|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
17201348|NCT02760407|38355630|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
17201349|NCT02760407|38355631|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
17201350|NCT02760407|38355632|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
17201351|NCT02760407|38355629|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
17201352|NCT02760407|38355630|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
17201353|NCT02760407|38355631|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
17201354|NCT02760407|38355632|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
17201355|NCT02760407|38355629|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
17201356|NCT02760407|38355630|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
17201357|NCT02760407|38355631|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
17201358|NCT02760407|38355632|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
17201359|NCT02760407|38355629|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
17201360|NCT02760407|38355630|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
17201361|NCT02760407|38355631|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
17201362|NCT02760407|38355632|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
17201363|NCT02760407|38355629|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
17201364|NCT02760407|38355630|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
17201365|NCT02760407|38355631|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
17201366|NCT02760407|38355632|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
17201367|NCT02760407|38355629|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
17201368|NCT02760407|38355630|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
17201369|NCT02760407|38355631|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
17201370|NCT02760407|38355632|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
17201371|NCT02760407|38355629|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
17201372|NCT02760407|38355630|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
17201373|NCT02760407|38355631|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
17201374|NCT02760407|38355632|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
